id|nct_id|organization|name|phone|email|extension
282257|NCT00845975|McDonald hearing Aid Centers|Louis A Looper, MA, CCC-A|916-218-4100|llooper@hearingmed.com|
282258|NCT00846027|Hoffmann-La Roche|Medical Communications|800 821-8590||
282259|NCT00846040|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Kevin Hall, PhD|3014028248|kevinh@niddk.nih.gov|
292949|NCT01458132|GlaxoSmithKline|GSK Response Center|866-435-7343||
292950|NCT01458171|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
292951|NCT01458210|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292952|NCT01458249|Eisai Co., Ltd.|Sun Asami|+81-3-3817-5252||5252
292953|NCT01458275|Sunovion|Respiratory Medical Director|1-866-503-6351||
292954|NCT01458288|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
303640|NCT02187055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
303641|NCT02187159|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
303642|NCT02187172|University of Pennsylvania|Dr. Joel Gelfand|215-662-3514|joel.gelfand@pennmedicine.upenn.edu|
303643|NCT02187471|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
303644|NCT02187744|Pfizer, Inc.|Pfizer CT.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
314322|NCT03289052|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
314323|NCT03289208|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please Email|cti-inq-ml@ml.mt-pharma.co.jp|
314324|NCT03289234|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please Email|cti-inq-ml@ml.mt-pharma.co.jp|
314325|NCT03289455|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
314326|NCT03289481|Clinical Research|Caroline Knight|2079218959|CKnight@pbmc.org|
314327|NCT03289533|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
314328|NCT03289676|UNIVERSITY OF MASSACHUSETTS BOSTON|Dr. Sun Kim|6172875372|sun.kim@umb.edu|6172875372
314329|NCT03289858|University of Massachusetts, Worcester|Eric Swart|503-880-7125|eric.swart@umassmemorial.org|
314330|NCT03290027|Dr. Reddys Laboratories Inc.|Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
314331|NCT03290300|Aerin Medical, Inc.|Scott Wolf, M.D.; Chief Medical Officer|650-597-0111|swolf@aerinmedical.com|
314332|NCT03290378|Avenue Therapeutics|VP of Clinical Operations and Program Management|781-652-4514|mryan@avenuetx.com|
314333|NCT03290768|Savvysherpa, LLC|Jared Jones|763-549-3540|JaredJones@savvysherpa.com|8116
314334|NCT03291041|Vanda Pharmaceuticals|Vanda Pharmaceuticals|2027343400|clinicaltrials@vandapharma.com|
314335|NCT03291080|Nova Laboratories|Dr Hussain Mulla|+44 (0) 116 223 0100|hussain.mulla@novalabs.co.uk|
314336|NCT03291197|Physical Medicine and Rehabilitation Ottawa Resident|Dr. Marc Monsour|6137377350|mmonsour051@gmail.com|
314337|NCT03291288|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
314338|NCT03291379|Biocompatibles UK Ltd|Sarah Cooper|07805354224|Sarah-Jane.Cooper@bsci.com|
314339|NCT03291613|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
314340|NCT03292016|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
314341|NCT03292406|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
271562|NCT00248170|Novartis|Study Director|862-778-8300||
271563|NCT00248495|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
271564|NCT00248534|North American Brain Tumor Consortium|Lauren Abrey, MD|410-955-3657|jfisher@jhmi.edu|
271565|NCT00248547|Oregon Health & Science University, Knight Cancer Institute|Joseph Bubalo, PharmD|503-494-1054|bubaloj@ohsu.edu|
271566|NCT00248560|Barbara Ann Karmanos Cancer Institute|Ammar Sukari, M.D.|313-576-8751|sukaria@karmanos.org|
271567|NCT00248612|Center for Anxiety and Related Disorders at Boston University|Todd J. Farchione, PhD|617 353 9610|tfarchio@bu.edu|
271568|NCT00248625|University of Pittsburgh|Robert H. Squires, Jr.|412-692-8648|squiresr@upmc.edu|
271569|NCT00248638|Emory University|Thomas R. Ziegler M.D.|4047277354|Tzieg01@emory.edu|
271570|NCT00248651|Mayo Clinic|Dr. Yuri A. Saito Loftus|507-266-9094|saito.yuri@mayo.edu|
271571|NCT00248781|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
271572|NCT00248794|VA Connecticut Healthcare System|Gary Bryson|860-594-6348|gary.bryson@va.gov|
271573|NCT00248807|James J Peters VAMC|Dr. Jill M. Wecht; Principal Investigator|718 584-9000|JM.Wecht@va.gov|3122
271574|NCT00248833|WRAIR|Paul B. Keiser|866-856-3259|clinical1@na.amedd.army.mil|
271575|NCT00249002|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
271576|NCT00249249|Kowa Research Europe, Ltd.|Dr Neil Hounslow|+44 118 922 9004|nhounslow@kowa.co.uk|
271577|NCT00249288|Schizophrenia Program, Massachusetts General Hospital|Michelle Hill|617-912-7846|michelehill1@gmail.com|
281763|NCT00821119|Instituto Materno Infantil prof. Fernando Figueira|Jucille Meneses|55 (81) 2122-4100|jmeneses@elogica.com.br|4135
281764|NCT00821184|Lahey Clinic|John T. Stoffel, MD|781-744-5481|John.T.Stoffel@lahey.org|
282260|NCT00846053|Washington University|Thomas Ferkol, MD|314 454 6000||
282261|NCT00846066|Childrens Mercy Hospital|Nasreen Talib MD, MPH.|816-234-3242|ntalib@cmh.edu|
282262|NCT00846287|UMass Medical School|Dr. Mitchell Albert|(807) 684-7270|albertmi@tbh.net|
282263|NCT00846365|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
282264|NCT00846391|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282265|NCT00846482|Montefiore Medical Center|Dr. Sanjay Goel|718-405-8404|sgoel@montefiore.org|
292955|NCT01458327|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
282266|NCT00846495|Clinvest|Rebecca Browning|417-841-3664|rbrowning@clinvest.com|
282267|NCT00846521|Yale University School of Medicine|Tania Burgurt, MD|203-785-7152|tania.burgurt@yale.edu|
282268|NCT00846547|Seaside Therapeutics|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|617-374-9009|pwang@seasidetherapeutics.com|1015
282269|NCT00846573|UMass Medical School|Dr. Mitchell Albert|(617) 875-2141|albertmi@tbh.net|
282270|NCT00846586|Novartis Pharmaceuticals|Study Director|862 778-8300||
282271|NCT00846651|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
282272|NCT00846742|St. Jude Children's Research Hospital|Monika Metzger, MD|(901) 595-4974|monika.metzger@stjude.org|
271578|NCT00249379|Virginia Commonwealth University|Michael Weaver, MD|804-828-1283|mweaver@mcvh-vcu.edu|
282273|NCT00846768|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282274|NCT00846807|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282275|NCT00846846|Medtronic Cardiovascular|Lisa Bousquette, Director Clinical Research Coronary and Renal Denervation||lisa.r.bousquette@medtronic.com|
292537|NCT01432561|University of California San Diego|Dr. Ranjan Dohil, P.I.|619-471-9554|rdohil@ucsd.edu|
292956|NCT01458366|Sidney Kimmel Cancer Center at Thomas Jefferson University|Joanna Filicko-O'Hara, MD|215-503-7787|Joanna.Filicko@jefferson.edu|
292957|NCT01458392|Acceleron Pharma Inc.|Dr. Matthew Sherman, Chief Medical Officer|617-649-9200|msherman@acceleronpharma.com|
292958|NCT01458418|Children's Mercy Hospital|Corey Schurman|8162343000|crschurman@cmh.edu|
292959|NCT01458522|Duke University|Aatif M. Husain, M.D.|919-668-8700|aatif.husain@duke.edu|
292960|NCT01458535|AbbVie|Global Medical Services|800-633-9110||
292961|NCT01458561|CryoLife, Inc.|Scott B. Capps, Vice President, Clinical Research|770-419-3355|capps.scott@cryolife.com|
292962|NCT01458574|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292963|NCT01458587|DUSA Pharmaceuticals, Inc.|Anna Houlihan|9147608796|houlihana@dusapharma.com|
292964|NCT01458639|Cyclomedica Australia Pty Ltd|Gary Somerville, Quality and Regulatory Manager|+61 (0)2 9541 0411|gsomerville@cyclomedica.com.au|
292965|NCT01458951|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292966|NCT01458990|Hunter Holmes McGuire VA Medical Center|Jasmohan Bajaj|804 675 5802|jasmohan.bajaj@va.gov|
292967|NCT01459016|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271579|NCT00249444|Columbia University|Dr Wilfrid Raby|212-923-3031|rabywil@nyspi.columbia.edu|
271580|NCT00249470|Johns Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
271581|NCT00249496|Johns Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
292968|NCT01459068|Johns Hopkins Bloomberg School of Public Health|Courtland Robinson|4104155266|crobinso@jhsph.edu|
292969|NCT01459588|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
292970|NCT01459614|Sidney Kimmel Comprehensive Cancer Center|Dr. Dung Le|443-287-0002|dle2@jhmi.edu|
292971|NCT01459653|Sandoz GmBH|Andriy Krendyukov, Global Medical Director|+49 8024 4764855|andriy.krendyukov@sandoz.com|
292972|NCT01459705|DCoE|Gregory A. Gahm, PhD|253-320-5772|gregory.a.gahm.civ@mail.mil|
292973|NCT01459718|Novartis Pharmaceuticals|Study Director|862-778-1873||
292974|NCT01459783|University of California Los Angeles|Joshua Chodosh or Barbara Vickrey|310-206-7671|jchodosh@mednet.ucla.edu|
292975|NCT01459796|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
292976|NCT01459913|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
292977|NCT01460225|Dartmouth-Hitchcock Medical Center|Dr. Brian Lacy|603-650-5215|brian.e.lacy@hitchcock.org|
292978|NCT01460290|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|2168442808|martha.sajatovic@uhhospitals.org|
292979|NCT01460303|UMass Medical School|Dr. Michael K. Flynn||Michael.Flynn@umassmemorial.org|
292980|NCT01460342|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292981|NCT01460368|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292982|NCT01460381|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292983|NCT01460407|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292984|NCT01460446|Hoffmann-La Roche|Medical Communications|800 821-8590||
292985|NCT01460628|Brigham & Women's Hospital|Dr. Hadine Joffe|617-732-4906|hjoffe@partners.org|
292986|NCT01460719|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292987|NCT01460732|Hypertension Center, Third University Department of Medicine|George S. Stergiou|0030 210 7763117|gstergi@med.uoa.gr|
292988|NCT01460875|The Ohio State University Comprehensive Cancer Center|William Carson, MD|614-293-6306|William.Carson@osumc.edu|
292989|NCT01460901|Children's Mercy Hospitals and Clinics|Dr. Gary Douglas Myers|8163026817|gdmyers@cmh.edu|7-6817
292990|NCT01460927|El.En. Electronic Engineering S.p.A.|Alessandro Bizzarri|+39 055 8826807|a.bizzarri@elen.it|
303645|NCT02187783|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
303646|NCT02187809|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
292991|NCT01460940|The Ohio State University Comprehensive Cancer Center|Dr. Kristie Blum|614-293-4590|Kristie.Blum@osumc.edu|
303647|NCT02187861|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
303648|NCT02187887|RAND|Eric Pedersen|3103930411|ericp@rand.org|6078
313855|NCT03213210|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
313856|NCT03213366|Albert Einstein College of Medicine|Dr. Viraj V Patel|718.920-7102|vpatel@montefiore.org|
313857|NCT03213405|Pontificia Universidad Católica de Chile|Dr. Alexis Kalergis|+56223541924|akalergis@bio.puc.cl|
313858|NCT03213509|Ariadne Labs|Dr. Katherine Semrau|617-384-6555|betterbirth@ariadnelabs.org|
313859|NCT03213626|IndianaU|Dr. Patrick Loehrer|(317) 278-7418|ploehrer@iu.edu|
282276|NCT00847015|Memorial Sloan Kettering Cancer Center|Dr. M. Catherine Pietanza|646-888-4203|pietanzm@mskcc.org|
282277|NCT00847132|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|jhuffman@partners.org|
271582|NCT00249613|UCLA Integrated Substance Abuse Programs|Michael Prendergast|310-267-5503|mlp@ucla.edu|
271583|NCT00249769|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
282278|NCT00847145|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
282279|NCT00847171|Johns Hopkins University|Dr. Leisha Emens||emensle@jhmi.edu|
282280|NCT00847197|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282281|NCT00847210|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
282282|NCT00847288|Medtronic Cardiac Rhythm Disease Management|OptiVol Care Pathway Clinical Team|1-800-328-2518|medtronicCRMtrials@medtronic.com|
282283|NCT00847301|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282284|NCT00847379|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
282285|NCT00847522|Huntsman Cancer Institute|Mark Wade|8012135746|mark.wade@hci.utah.edu|
292992|NCT01461005|MCRA|Justin Eggleton, Senior Director, Spine Regulatory Affairs|2025525804|jeggleston@mcra.com|
292993|NCT01461044|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
292994|NCT01461057|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
292995|NCT01461096|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
292996|NCT01461369|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
292997|NCT01461473|Stanford University|Clete A. Kushida, M.D., Ph.D.|650-721-7560|clete@stanford.edu|
292998|NCT01461499|Shiga University of Medical Science|Steering Committee: Takashi Uzu|81-77-548-2222|takuzu@belle.shiga-med.ac.jp|
292999|NCT01461538|Seattle Genetics, Inc.|Chief Medical Office|855-473-2436|medinfo@seagen.com|
293000|NCT01461551|Ruijin Hospital|Dr. Lijie Jia|13916667704|litery0301@163.com|
271584|NCT00249795|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
293001|NCT01461655|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
293002|NCT01461668|University of California Irvine|Raveena Singh|949-824-9285|ravsingh@uci.edu|
293003|NCT01461707|University of California, San Francisco|JiWon Choi|415-514-2534|jiwon.choi@ucsf.edu|
293004|NCT01461733|The Ottawa Hospital Research Institute|Salmaan Kanji|613-737-8899|skanji@toh.on.ca|78159
293005|NCT01461811|Alcon Research, Ltd.|Mary Fahmy, OD, Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
293006|NCT01461824|The Research Institute at Nationwide Children's Hospital|Dr. Andrea Bonny|614-722-2450|andrea.bonny@nationwidechildrens.org|
293007|NCT01461863|Dartmouth-Hitchcock|Dr. Charles Fordham von Reyn|6036505000|fvr@dartmouth.edu|8840
293008|NCT01461928|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
303649|NCT02188160|Kala Pharmaceuticals, Inc.|VP, Clinical Development|781-996-5252|results002@kalarx.com|
303650|NCT02188303|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
303651|NCT02188459|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@pennmedicine.upenn.edu|
303652|NCT02188485|University of Rochester|Kim Van Orden, PhD|585-275-5176|kimberly_vanorden@urmc.rochester.edu|
303653|NCT02188576|Boston Childrens Hospital|Dr. Susan Goobie, PI|6173557737|susan.goobie@childrens.harvard.edu|
303654|NCT02188589|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
303655|NCT02188719|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
303656|NCT02188784|Duke Clinical Research Institute|Dr. Adrian Hernandez|919-668-7515|adrian.hernandez@duke.edu|
303657|NCT02188849|Institute of Nutrition and Food Technology University of Chile|Sandra Hirsch MD|+56 229781485|shirsch@inta.uchile.cl|
303658|NCT02189122|VANDERBILT UNIVERSITY MEDICAL CENTER|Nancy J. Brown, M.D.|6153438701|nancy.j.brown@vanderbilt.edu|
303659|NCT02189161|Laser Surgery Care|Dr. Stephen E. Goldstone, MD|212-242-6500|segmd@prodigy.net|
303660|NCT02189213|RFMH|Amir Levine|646 481 2566|amir.levine@nyspi.columbia.edu|
303661|NCT02189252|AstraZeneca AB|Hong Yang, Study Statistician|+46-(0)317762397|hong.yang1@astrazeneca.com|
303662|NCT02189317|Emory University|John W Xerogeanes, MD|404-778-7202|jxeroge@emory.edu|
303663|NCT02189382|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
303664|NCT02189473|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
303665|NCT02189629|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
303666|NCT02189668|Nationwide Children's Hospital|Peter Minneci|6147223066|peter.minneci@nationwidechildrens.org|
303667|NCT02189759|University of Alabama at Birmingham|Manimaran Ramani|2054731425|mramani@peds.uab.edu|
303668|NCT02189837|Amgen Inc.|Study Director|866-572-6436||
303669|NCT02189850|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
303670|NCT02189863|Alcon Research, Ltd.|Global Brand Lead, Global Medical Affairs, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
303671|NCT02189889|UT Southwestern Medical Center|Philip Greilich -PROFESSOR|214/645-8018|PHILIP.GREILICH@UTSouthwestern.edu|
303672|NCT02189915|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
303673|NCT02189941|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
303674|NCT02189954|DorkuzEU|Anaesthesiology and Reanimation, Dr. Sule Ozbilgin|0905055252901|ozbilginsule@gmail.com|
293009|NCT01461980|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293010|NCT01461993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282286|NCT00847535|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
282287|NCT00847561|The Johns Hopkins University School of Medicine|Dr. Golda Ginsburg|410-955-1544|gginsbu@jhmi.edu|
282288|NCT00847587|UUtah|Kirtly Parker Jones|801-581-3834|kirtly.jones@hsc.utah.edu|
271585|NCT00249808|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
271586|NCT00249821|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
282289|NCT00847613|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282290|NCT00847626|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
282291|NCT00847665|University Hospital Virgen de las Nieves|Dr. Francisco Manzano|34958020125|fmanzano@mailpersonal.com|
282292|NCT00847704|Oregon Health & Science University|Paul J. Cordo|503-418-2520|cordop@ohsu.edu|
282293|NCT00847730|KCI|VP, Global Clinical Affairs|2102555595|jane.hart@kci1.com|
293011|NCT01462045|University of New Mexico|Sang Hwan Kim, PhD/Lead Investigator|5057954545|sanghk@gmail.com|
293012|NCT01462084|Stanford Sleep Medicine|Michelle Cao, DO, FAASM|(650) 723-6601|michellecao2007@gmail.com|
293013|NCT01462110|Johnson & Johnson Consumer Inc.|Michael Lynch|908-433-6423|mlynch23@ITS.JNJ.com|
293014|NCT01462162|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
293015|NCT01462227|Yale University|Robert Stanley Sherwin, MD|203 737 1932|robert.sherwin@yale.edu|
293016|NCT01462253|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
293017|NCT01462266|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293018|NCT01462279|Beth Israel Deaconess Medical Center|Dr. Michael W. Donnino|6177542341|mdonnino@bidmc.harvard.edu|
293019|NCT01462292|GlaxoSmithKline|GSK Response Center|866-435-7343||
293020|NCT01462305|Philips|Sr. Clinical Development Scientisit|+41 79 460 0622|fatima.sertkuniyoshi@philips.com|
293021|NCT01462318|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
293022|NCT01462344|GlaxoSmithKline|GSK Response Center|866-435-7343||
293023|NCT01462357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
293024|NCT01462435|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
293025|NCT01462565|GlaxoSmithKline|GSK Response Center|866-435-7343||
293026|NCT01462695|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
293027|NCT01462773|The Ohio State University Comprehensive Cancer Center|William Carson|614-293-6306|william.carson@osumc.edu|
293028|NCT01462812|OptiNose|Sr. Director of Clinical Development|(267) 364-3620|jennifer.carothers@optinose.com|
293029|NCT01462877|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
293030|NCT01462929|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
293031|NCT01462942|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
293032|NCT01463007|BrUOG-Brown University Oncology Research Group|Dr. Jaroslaw Hepel|4018633000|kristen_mitchell@brown.edu|
293033|NCT01463033|Children's National Medical Center|Dr. Pavel Klein, P.I.|301-704-4925|kleinp@epilepsydc.com|
293034|NCT01463098|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
293035|NCT01463111|Emory University|Dr. Boadie Dunlop|404-727-8969|bdunlop@emory.edu|
293036|NCT01463202|Center for Family Planning Research|Principal Investigator|412-641-5496|fpr@upmc.edu|
293037|NCT01463267|Kent State University|Joel Hughes|3306727721|jhughes1@kent.edu|
293038|NCT01463306|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293039|NCT01463358|Casa di Cura san Pio XI|Massimo Santini MD FESC FACC|+390666494491|m.santini@rmnet.it|
293040|NCT01463384|Huntington Medical Research Institutes|Principal Investigator|6263975840|mrs@hmri.org|
293041|NCT01463527|Yale University|Dr. Melissa Langhan|203-737-7413|melissa.langhan@yale.edu|
293042|NCT01463631|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293043|NCT01463683|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
271587|NCT00249834|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
293044|NCT01463696|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293045|NCT01463878|Eastern Virginia Medical School|Dr Paul Marik|757-446-8910|marikpe@evms.edu|
293046|NCT01463982|HanmiPharma|Director of clinical research team|8224109038|jajung@hanmi.co.kr|
293047|NCT01464021|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
293048|NCT01464190|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
303622|NCT02186171|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
303623|NCT02186210|Seoul National University Hospital Dept of Anesthesiology|Dr Yunseok Jeon|82-2-2072-2465|jeonyunseok@gmail.com|
303624|NCT02186223|Bio2 Medical, Inc.|Chief Medical Officer|720-833-5675|langel@bio2medical.com|
303625|NCT02186301|Clovis Oncology|Vi Nguyen|+1 415 915 9982|vnguyen@clovisoncology.com|
303675|NCT02190045|CAVHS/ UAMS|Kalpana Padala, MD|501-257-1000|kppadala@uams.edu|
303676|NCT02190279|National Cancer Institute|Dr. Maria Liza Lindenberg|240-760-6109|liza.lindenberg@nih.gov|
303677|NCT02190435|William Beaumont Hospital|Denise Koueiter, MS|248-551-5166|denise.koueiter@beaumont.org|
303678|NCT02190552|Neuravi Limited|Mairsil Claffey|0035391394123|mclaffey@neuravi.com|
303679|NCT02190591|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
303680|NCT02190604|Novartis|Study Director|862-778-8300||
303626|NCT02186509|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Wenyin Shi|215-955-6702|Wenyin.Shi@jefferson.edu|
303627|NCT02186561|Medtronic Neurovascular, Clinical Affairs|Senior Project Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
282294|NCT00847808|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
282295|NCT00847886|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH - Medical Director, Drug Safety|281-863-3000||
282296|NCT00847912|Providence VA mendical Center|Martin Weinstock MD, PhD|401-457-3333|Martin.Weinstock@va.gov; Martin_Weinstock_MD@brown.edu|
282297|NCT00847938|Clinique Jules Verne|Dr Florent CAPRON|0251171775|florent.capron@mla.fr|33
282298|NCT00848016|Mayo Clinic Cancer Center|Michael E. Menefee, M.D.||menefee.michael@mayo.edu|
282299|NCT00848042|Nanospectra Biosciences, Inc.|Robin Dickson|7138422720|rdickson@nanospectra.com|216
271588|NCT00249873|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
271589|NCT00250276|GlaxoSmithKline|GSK Response Center|866-435-7343||
271590|NCT00250432|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282300|NCT00848081|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282301|NCT00848107|United Therapeutics Corporation|Rex Mauthe, Assoc VP, Regulatory Affairs|(919) 485-8350|RMauthe@unither.com|
282302|NCT00848120|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
282303|NCT00848172|NINDS|Mark Hallett|301-496-9526|hallettm@ninds.nih.gov|
271591|NCT00250484|Beth Israel Deaconess|Steven D. Freedman, MD Phd|631-667-2132|sfreedma@bidmc.harvard.edu|
282304|NCT00848185|IVI Madrid|Dra Cerrillo|911802900|maria.cerrillo@ivi.es|
282305|NCT00848198|TearLab, Inc.|Michael Berg, VP of Regulatory|858-795-6887|mberg@TearLab.com|
271592|NCT00250497|University_of_Minnesota|Dr. Dianne Neumark-Sztainer, Professor|612-624-0880|neuma011@umn.edu|
282306|NCT00848211|Thymon LLC|Gideon Goldstein, MD, PhD|(973) 467-9558|gidgold@gmail.com|
282307|NCT00848237|University of north Carolina|Nicholas Shaheen|(919) 966-7047|nshaheen@med.unc.edu|
282308|NCT00848250|Vanderbilt University Medical Center|Mias Pretorius|615-8757402|mias.pretorius@vanderbilt.edu|
282309|NCT00848354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282310|NCT00848367|Ottawa Hospital Research Institute|Dr. Giorgio Tasca|1-613-737-8085|gtasca@toh.on.ca|
282311|NCT00848393|Nationwide Children's Hospital|Aymen Naguib, MD|6147220596|Aymen.Naguib@nationwidechildrens.org|
282312|NCT00848484|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282313|NCT00848497|Baylor College of Medicine|Mohit Khera, MD|713-798-6593|mkhera@bcm.edu|
282314|NCT00848510|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
282315|NCT00848536|Alcon Research, Ltd.|Director Alcon Clinical|888.451.3937 or 817.568.6725||
282316|NCT00848549|Eisai Call Center|Eisai Inc.|888-422-4743||
282317|NCT00848718|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282318|NCT00848744|Northwestern University|Dermatology CTU|312-503-5944|NUdermatologyCTU@northwestern.edu|
282319|NCT00848783|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
282320|NCT00848926|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
282321|NCT00848965|GlaxoSmithKline|GSK Response Center|866-435-7343||
282322|NCT00849017|GlaxoSmithKline|GSK Response Center|866-435-7343||
282323|NCT00849056|GlaxoSmithKline|GSK Response Center|866-435-7343||
282324|NCT00849108|Lantheus Medical Imaging|Cesare Orlandi, MD, Chief Medical Officer|978-671-8686|cesare.orlandi@lantheus.com|
282325|NCT00849121|University of Wisconsin Carbone Cancer Center|Dr. Douglas McNeel|608-265-8131|dm3@medicine.wisc.edu|
282326|NCT00849147|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
282327|NCT00849186|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
282328|NCT00849212|Eisai Call Center|Eisai Inc.|888-422-4743||
282329|NCT00849251|University of Washington|Dr. Pamela Becker|206-616-1589|pbecker@uw.edu|
282330|NCT00849290|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com|
282331|NCT00849381|GlaxoSmithKline|GSK Response Center|866-435-7343||
282332|NCT00849472|GlaxoSmithKline|GSK Response Center|866-435-7343||
282333|NCT00849680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
282334|NCT00849693|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282335|NCT00849810|University of Mississippi Medical Center|Professor of Medicine|601-984-5600|DMinor@umc.edu|
282336|NCT00849875|GlaxoSmithKline|GSK Response Center|866-435-7343||
282337|NCT00849901|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282338|NCT00849940|Duke University Medical Center|David MacLeod, M.B.|919-681-3551|david.macleod@dm.duke.edu|
282339|NCT00850031|AcuFocus, Inc|Eugenia Thomas, Director Clinical Trials|949/585-9511|nthomas@acufocus.com|129
282340|NCT00850070|The Children's Health Council|Glen R. Elliott, Ph.D., M.D.|650.688.3649|gelliott@chconline.org|
282341|NCT00850096|CPEX Pharmaceuticals, Inc.|Chief Medical Officer|603-658-6100||503
282342|NCT00850135|Stanford University School of Medicine|Yasser El-Sayed, MD|(650) 723-3198|Yasser.el-sayed@stanford.edu|
282343|NCT00850200|University of Florida Proton Therapy Institute|Bradford Hoppe, MD, MPH|904-588-1800|bhoppe@floridaproton.org|
282344|NCT00850343|Astellas Pharma Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@astellas.com|
282345|NCT00850395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293049|NCT01464229|MGH|Esther Howe|617-726-8895|ehowe3@partners.org|
293050|NCT01464255|Clinical Research Center, University of California, Berkeley, School of Optometry|Thao N Yeh, O.D.|(510) 642-9649|thaoyeh@berkeley.edu|
293051|NCT01464307|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
293052|NCT01464333|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
293053|NCT01464346|Medtronic Diabetes Clinical Research|Pamela Haworth||pamela.c.haworth@medtronic.com|
271593|NCT00250588|CCHMC|Michael Seid|5138030083|michael.seid@cchmc.org|
282346|NCT00850460|The Rockefeller University Center for Clinical and Translational|Principal Investigator|212 327-8408|trinnamaningatmd@yahoo.com|
282347|NCT00850473|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
282348|NCT00850499|Johnson & Johnson Pharmaceutical Research & Development|Andrew Cakana, MD, FRC Path||[ACAKANA@ITS.JNJ.COM|
292538|NCT01432574|H. Lee Moffitt Cancer Center and Research Institute|Anna Giuliano, Ph.D.|813-745-6820|anna.giuliano@moffitt.org|
292539|NCT01432600|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rachid Baz|813-745-8212|rachid.baz@moffitt.org|
292540|NCT01432626|University of Pittsburgh|Dr. Prem Soman|412 647 3435|somanp@upmc.edu|
292541|NCT01432730|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292542|NCT01432756|Boston Children's Hospital|Laura Bogart|857-218-4073|laura.bogart@childrens.harvard.edu|
292543|NCT01432886|Eisai Co., Ltd.|Tadashi Nakanishi|81-3-3817-5252||5252
292544|NCT01432938|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292545|NCT01432951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
292546|NCT01433016|Exalenz Bioscience|Clinical Trials Manager|+972-8-9737513|avrahamh@exalenz.com|
292547|NCT01433042|Given Imaging Ltd.|Director of Clinical affairs|+972-4-9097774|Hila.Debby@givenimaging.com|
292548|NCT01433055|Maryland Psychiatric Research Center|Deanna L. Kelly, Pharm.D., BCPP|410-402-6861|dkelly@mprc.umaryland.edu|
293054|NCT01464359|University of Minnesota, Pediatrics Blood and Marrow Transplant|Michael R Verneris|612-626-2961|verneris@umn.edu|
293055|NCT01464424|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
293056|NCT01464619|The Children's Hospital of Philadelphia|James Guevara, MD, MPH|215-590-1130|guevara@email.chop.edu|
293057|NCT01464697|University of British Columbia|Dr. Jerilynn C. Prior, Professor|6048755927|jerilynn.prior@ubc.ca|
293058|NCT01464775|MercyMC|Dr. Fermin Barrueto|410-321-8452|fbarrueto@mdmercy.com|
293059|NCT01464788|McGovern Medical School UTHealth - Houston|Dr. Andrew Barreto|713-500-7002|andrew.d.barreto@uth.tmc.edu|
293060|NCT01464827|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
293061|NCT01464840|University of Alabama at Birmingham|Amelia Sutton, M.D., Ph.D.|205-934-5612|alsutton@uab.edu|
293062|NCT01464879|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
293063|NCT01464931|Amgen Inc.|Study Director|866-572-6436||
293064|NCT01464996|University of North Carolina at Chapel Hill School of Dentistry|Dr. Andre Ritter, Professor and Chair|919-537-3987|andre_ritter@unc.edu|
293065|NCT01465022|University of New Mexico|Eve Espey MD, MPH, Principal Investigator|505 272 6372|eespey@salud.unm.edu|
293066|NCT01465048|University of Oxford|Dr Susanne Sheehy||susanne.sheehy@balliol.ox.ac.uk|
293067|NCT01465178|University of Wisconsin|Neil Binkley|608-265-6410|nbinkley@wisc.edu|
293068|NCT01465191|Columbia University|Richard Smiley, MD|212-342-2742|rms7@cumc.columbia.edu|
303681|NCT02190747|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
303682|NCT02190903|University of Pennsylvania School of Medicine|Mark D Neuman|2157467468|neumanm@mail.med.upenn.edu|
303683|NCT02191033|Yale University|Deepa Camenga, MD|203-737-8310|deepa.camenga@yale.edu|
303684|NCT02191046|Thammasat university|Dr.Araya Satdhabudha|0813414900|araya221@gmail.com|662
303685|NCT02191137|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
303686|NCT02191267|Brigham and Women's Hospital|Dr. Martha Shenton|617-699-6152|shenton@bwh.harvard.edu|
303687|NCT02191397|GlaxoSmithKline|GSK Response Center|866-435-7343||
303688|NCT02191579|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
303689|NCT02191605|Wayne State University, Merrill Palmer Skillman Institute|Dr. Jessica Beatty|3136642518|jbeatty@wayne.edu|
303690|NCT02191618|Sequent Medical, Inc|Director, Clinical Operations|714-247-8000|anne.hurley@microvention.com|
303691|NCT02191865|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
303692|NCT02192099|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
271594|NCT00250679|Sepracor Inc.|Respiratory Medical Director|1-866-503-6351||
271595|NCT00250705|The University of Iowa|An Open Label Trial of Aripiprazole in the Treatment of Conduct Disorder in Adolescents.|319-356-1482|Samuel-Kuperman@uiowa.edu|
303693|NCT02192164|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
303694|NCT02192190|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
303695|NCT02192307|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
303696|NCT02192541|National Cancer Institute|Alice P. Chen, M.D.|(240) 781-3320|chenali@mail.nih.gov|
293069|NCT01465334|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(617) 632-3316|Jennifer_Brown@dfci.harvard.edu|
303697|NCT02192606|Brigham and Women's Hospital|Jon I. Einarsson|617-732-5500|jeinarsson@partners.org|
303698|NCT02192684|Stanford Universtiy|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
303699|NCT02192814|UCB Pharma|UCB Clinical Trial Call Center|+1877 822||9493
303700|NCT02192879|Duke University Medical Center|Elizabeth Malinzak, MD|919-681-9660|elizabeth.malinzak@duke.edu|
303701|NCT02192905|University of Massachusetts Medical School|Sherry Pagoto, Professor|508-856-5159|study@umassmed.edu|
303702|NCT02192970|University of Wisconsin - Madison|Michael M Altaweel, MD|(608) 263-7290|mmaltaweel@wisc.edu|
314342|NCT03292432|University of North Carolina at Chapel Hill|Rachel Goolsby - Research Manager|9198430685|rwgoolsby@unc.edu|
314343|NCT03292562|The University of Texas Health Science Center at Houston|Amir Khan, MD|713-500-5519|Amir.M.Khan@uth.tmc.edu|
314344|NCT03292614|Dietrich-Bonhoeffer-Klinikum|Ulrike Holland|+49 395 775 3427|aug-st2@dbknb.de|
314345|NCT03292640|Dr. Reddy's Laboratoris, Inc|Srinivas Sidgiddi, Senior Director, Clinical Development|9084585362|srinivassidgiddi@drreddys.com|
271596|NCT00250835|University of New Mexico|Fa-Chyi Lee, MD|5059250405|flee@salud.unm.edu|
271597|NCT00250926|Dana Farber Cancer Institute|Steven P. Treon MD PhD|617 632 2681|steven_treon@dfci.harvard.edu|
271598|NCT00251004|Novartis Pharmaceuticals|Study Director|862-778-8300||
271599|NCT00251225|University of Pittsburgh Cancer Institute|Leonard J. Appleman, MD, PhD|412-648-6507|applemanlj@upmc.edu|
282349|NCT00850538|New England Baptist Hospital|Carl Talmo|617-724-5474|ctalmo@nebh.org|
282350|NCT00850564|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
282351|NCT00850603|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
271600|NCT00251238|Radboud University Nijmegen, The Netherlands|Dr. SJH Bredie, MD, PhD|0031 24 3618819|bas.bredie@radboudumc.nl|
282352|NCT00850642|GlaxoSmithKline|GSK Response Center|866-435-7343||
282353|NCT00850759|UAB|David Schwebel|205-934-8745|schwebel@uab.edu|
282354|NCT00850889|Allergan, Inc.|Steven P. James, MD, VP, Global Medical Affairs|714-246-4500|james_steven@allergan.com|
282355|NCT00850993|Mallinckrodt Pharmaceuticals|Medical Information Call Center|1-800-844-2830|clinicaltrials@mnk.com|5
282356|NCT00851006|University of Utah|Douglas Kondo, M.D.|801-587-1549|doug.kondo@hsc.utah.edu|
282357|NCT00851084|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
282358|NCT00851253|Boston Medical Center|Dr. Minh Tam Truong|617-638-7070|Minh-Tam.Truong@bmc.org|
282359|NCT00851279|Stereotaxis Inc.|Dr Qun Sha, MD, Director of Clinical Trials|314 678 6143|qun.sha@stereotaxis.com|
271601|NCT00251303|National Institute of Mental Health, Pediatrics and Developmental Neuroscience Branch|Dr. Susan E. Swedo|301-496-5323|swedos@mail.nih.gov|
282360|NCT00851318|Astellas Pharma Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@astellas.com|
282361|NCT00851357|UCSD|Principal Investigator|858-300-1056|szhu@ucsd.edu|
282362|NCT00851409|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
282363|NCT00851630|Duke University Medical Center|Dr. Nathan Thielman|919-6687174|n.thielman@duke.edu|
282364|NCT00851643|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
282365|NCT00851721|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
282366|NCT00851786|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
282367|NCT00851799|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
282368|NCT00851877|UT Southwestern Medical Center|Director of Clinical Trial||ClinicalTrials@utsouthwestern.edu|
293070|NCT01465347|Diffusion Pharmaceuticals Inc|Chief Executive Officer|(434) 220-0718|DKalergis@diffusionpharma.com|
293071|NCT01465386|FHCRC|Elihu Estey, MD|206-288-7176|eestey@seattlecca.org|
293072|NCT01465412|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293073|NCT01465464|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
293074|NCT01465659|Northwestern University|Sheetal Kircher, MD|312-695-0990|sheetal.kircher@nm.org|
293075|NCT01465763|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293076|NCT01465802|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293077|NCT01465841|Penumbra, Inc.|Michaella Corso|415-815-8904|mcorso@penumbrainc.com|
293078|NCT01465958|Grifols Therapeutics Inc|Henry Li, PhD|800-20-2807|henry.li@grifols.com|
293079|NCT01465997|Cares|UCB|+1844 599||2273
293080|NCT01466062|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
293081|NCT01466075|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
293082|NCT01466127|Massachusetts General Hospital|Elizabeth Hoge, M.D.|617-724-0859|ehoge@mgh.harvard.edu|
293083|NCT01466153|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazenca.com|
293084|NCT01466166|Horizon Pharma Rheumatology LLC|Jeffery Nieves, PharmD|224-383-3000|clinicaltrials@horizonpharma.com|
293085|NCT01466179|Amgen Inc.|Study Director|866-572-6436||
293086|NCT01466192|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
293087|NCT01466270|Wake Forest School of Medicine|Dr. Doug Case|336-716-1048|dcase@wakehealth.edu|
293088|NCT01466348|GlaxoSmithKline|GSK Response Center|866-435-7343||
293089|NCT01466361|GlaxoSmithKline|GSK Response Center|866-435-7343||
293090|NCT01466387|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
293091|NCT01466491|Oregon Health & Science University|Dr. Paula Bednarek|503-494-3666|whru@ohsu.edu|
293092|NCT01466595|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
293093|NCT01466660|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
293094|NCT01466673|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-739-7200||5888
293095|NCT01466751|Stanford University|Amit Etkin|650-725-5736|amitetkin@stanford.edu|
293096|NCT01466764|Stanford University|Gary Peltz|650-721-2487|gpeltz@stanford.edu|
293097|NCT01466790|Janssen Research & Development, LLC|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
293098|NCT01466881|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|hongli@fredhutch.org|
303703|NCT02193074|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
282369|NCT00851890|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
282370|NCT00851903|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
293099|NCT01466972|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7070|Hope.Rugo@ucsf.edu|
293100|NCT01466985|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
303704|NCT02193087|Takeda|Medical Director Clinical Science, Study Official|+1-877-825-3327|trialdisclosures@takeda.com|
271602|NCT00251316|NIDDK, NIH|Dr. Monica Skarulis|301-496-6087|monicas@intra.niddk.nih.gov|
282371|NCT00852137|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
282372|NCT00852202|Allergan Sales LLC|Therapeutic Area Head,|877-277-8566|IR-CTRegistration@allergan.com|
282373|NCT00852397|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282374|NCT00852475|Baltimore VAMC and University of Maryland Medical Center|Michael Miller, MD|4103286299|mmiller@medicine.umaryland.edu|
282375|NCT00852527|Southern AZ VA Health Care System|Dr. Judith Babcock-Parziale, PI|520-7921450|judith.babcock@va.gov|5698
282376|NCT00852540|GlaxoSmithKline|GSK Response Center|866-435-7343||
282377|NCT00852592|UPittsburgh|Assistant Professor of Psychiatry|412-246-5248|sitdk@upmc.edu|
282378|NCT00852631|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
282379|NCT00852644|Boston Medical Center|Minh Tam Truong|617-638-7070|minh-tam.truong@bmc.org|
282380|NCT00852761|GlaxoSmithKline|GSK Response Center|866-435-7343||
282381|NCT00852917|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
282382|NCT00852930|Vanderbilt University School of Nursing|Sheila H, Ridner, PHD|615-322-0831|Sheila.Ridner@Vanderbilt.edu|
282383|NCT00852969|Tufts Medical Center|Mark Sarnak, MD|617 636-1182|msarnak@tuftsmedicalcenter.org|
282384|NCT00852995|Smith & Nephew|Jamie E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
282385|NCT00853021|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
282386|NCT00853047|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
282387|NCT00853073|Wills Eye Hospital|Marlene R. Moster, MD|215-928-3123|marlenemoster@gmail.com|
282388|NCT00853099|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
282389|NCT00853112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282390|NCT00853125|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
293101|NCT01467037|McGill University Health Centre|Dr Caroline Quach, Pediatric Infectious Diseases Consultant & Medical Microbiologist|514-934-1934|caroline.quach@mcgill.ca|24485
293102|NCT01467063|Nemours Children's Health System|Dominique Darmaun|904-697-3674|Ddarmaun@nemours.org|
293103|NCT01467076|Wayne State University|Beena Sood, M.D.|313-745-5638|bsood@med.wayne.edu|
293104|NCT01467271|Guerbet|Corinne Dubourdieu, Head of Clinical Projects and Medical Writing|+33(0)1 45 91 50 00|corinne.dubourdieu@guerbet.com|
293105|NCT01467427|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
293106|NCT01467466|MAVERIC, VA Boston|Christopher Donnelly, Chief of Data Management|857-364-2332|christopher.donnelly2@va.gov|
293107|NCT01467479|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
293108|NCT01467492|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
293109|NCT01467505|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
293110|NCT01467557|Vistakon|Jurandir Araujo|+1 904 443-1379|jaraujo7@its.jnj.com|
271603|NCT00251589|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
271604|NCT00251641|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
293111|NCT01467570|The Medical University of Warsaw|Hanna Szajewska, Malgorzata Piescik-Lech|+48-22-45-23-309|hania@ipgate.pl|
293112|NCT01467583|Harper University Hospital|Krista Wahby, Critical Care Pharmacist in the Medical ICU|313-745-2711|kwahby@dmc.org|
271605|NCT00251693|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
303705|NCT02193152|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5737|danielmorgensztern@wustl.edu|
303706|NCT02193165|Colgate Palmolive|William Devizio|732-878-7901|william_devizio@colpal.com|
303707|NCT02193178|CooperVision, Inc.|Sr. Manager, Clinical Research|9257306754|pchamberlain@coopervision.com|
303708|NCT02193347|Duke University|Katy Peters, M.D., Ph.D.|919-684-6173|katherine.peters@duke.edu|
303709|NCT02193490|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
271606|NCT00251719|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
271607|NCT00251745|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
271608|NCT00251758|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
303710|NCT02193776|TB Alliance|Almari Conradie, Director, Clinical Operations|+27 12 991 6328|almari.conradie@tballiance.org|
303711|NCT02193815|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
303712|NCT02193828|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
303713|NCT02193880|University of Alabama at Birmingham|Tiffany D Hill|205-996-8023|tiffanydhill@uabmc.edu|
303714|NCT02194062|Yale School of Medicine|Paul Neubauer|2037855430|paul.neubauer@yale.edu|
271609|NCT00251862|Boston Medical Center|Dr. Paul C. Schroy III|617-638-8335|paul.schroy@bmc.org|
303715|NCT02194088|Brigham and Women's Hospital|Edwards Robert|617-732-9486|rredwards@partners.org|
303716|NCT02194439|IndianaU|Sophie Paczesny|317-278-5487|sophpacz@iu.edu|
303717|NCT02194465|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282391|NCT00853151|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
303718|NCT02194621|RBHS-Rutgers School of Dental Medicine, Oral Biology Department|Daniel Fine, DMD|973-972-3728|finedh@sdm.rutgers.edu|
303719|NCT02194699|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
303720|NCT02194933|Otsuka Data Transparency Organization|Global Clinical Development||DT-inquiry@otsuka.jp|
303721|NCT02194985|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
282392|NCT00853242|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
271610|NCT00251927|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
271611|NCT00251979|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
271612|NCT00252057|Boston Medical Center|Brian Jack PI|617-414-44675|brian.jack@bmc.org|
271613|NCT00252187|Mayo Clinic|Dr. Horng H. Chen|507-778-2354|chen.horng@mayo.edu|
271614|NCT00252239|University of Virginia Health System|Dr. E. Clarke Haley, Jr.|434-924-8041|ech@virginia.edu|
282393|NCT00853307|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
282394|NCT00853333|University of Alabama at Birmigham|Michael Froelich|(205)975-0145|froelich@uab.edu|
282395|NCT00853372|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
282396|NCT00853385|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282397|NCT00853489|Saint Louis University|Dr. Lisa Kaye Cannada|3145778850|LCannada@slu.edu|7
282398|NCT00853580|The University of Alabama at Birmingham|Bruce R. Korf|205.934.9411|bkorf@uabmc.edu|
282399|NCT00853593|Medtronic, Inc|4396 Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62808
282400|NCT00853606|Vivus, Inc|Wesley W Day PhD|650-934-5200||
282401|NCT00853645|Boston Scientific|Gena Kantor, MPH|1-800-227-3422|gena.kantor@bsci.com|
282402|NCT00853658|Novartis Pharmaceuticals|Study Director|862-778-8300||
282403|NCT00853671|Massachusetts General Hospital|Dr. Brian B. Ghoshhajra|617-726-3745|bghoshhajra@partners.org|
282404|NCT00853723|UPittsburgh|Mara J Horwitz|4126922848|horwitz@pitt.edu|
282405|NCT00853749|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282406|NCT00853762|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
282407|NCT00853827|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
282408|NCT00853840|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
282409|NCT00853905|Wills Eye Hospital Glaucoma Research Center|Marlene Moster MD|215-825-4713|jmolineaux@willseye.org|
282410|NCT00853957|Novartis Pharmaceuticals|Study Director|862-778-8300||
293113|NCT01467661|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
293114|NCT01467700|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
293115|NCT01467713|Takeda|Medical Director, Clinical Science|1-877-825-3327|trialdisclosures@takeda.com|
293116|NCT01467882|Debiopharm International, S.A.|Eija Lundström|:+41 21 3210111|eija.lundstrom@debiopharm.com|
293117|NCT01467934|Columbia University|Melissa Stockwell|212-342-5732|mss2112@columbia.edu|
293118|NCT01467947|CSL Behring|Program Director, Clinical R&D|Use email contact|clinicaltrials@cslbehring.com|
271615|NCT00252382|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
293119|NCT01467960|Villa Melitta|Sarah Dassati|+39 0471 471|sarahdassati@yahoo.it|471
293120|NCT01467999|NYSPI|daniel brooks|6467746171|daniel.brooks@nyspi.columbia.edu|
271616|NCT00252499|VA Puget Sound Health Care System|Kristina Utzschneider, MD|206-277-3568|kristina.utzschneider@va.gov|
293121|NCT01468012|New York State Psychiatric Institute|Adam Bisaga|646-774-6155|bisagaa@nyspi.columbia.edu|
293122|NCT01468077|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
293123|NCT01468181|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293124|NCT01468207|AbbVie|Global Medical Information|1-800-633-9110||
293125|NCT01468233|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
293126|NCT01468311|National Cancer Institute|Dr. Kevin C. Conlon|240-858-3570|gconlonkc@mail.nih.gov|
293127|NCT01468337|National Eye Institute|Emily Chew, MD|301-496-6583|emily.chew@nih.gov|
271617|NCT00252512|Minneapolis VA Health Care System|Hildi Hagedorn|612-467-3875|hildi.hagedorn@va.gov|
293128|NCT01468350|Acorda Therapeutics, Inc.|Vice President - Clinical Development & Medical Affairs|914-347-4300|hhenney@acorda.com|
293129|NCT01468454|Children's Hospital of Philadelphia - Department of Radiology|Lisa J. States, MD|267-245-7146|states@chop.edu|
293130|NCT01468532|Barbara Ann Karmanos Cancer Institute|Ulka N. Vaishampayan|313-576-8718|vaishamu@karmanos.org|
293131|NCT01468558|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
293132|NCT01468584|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
293133|NCT01468597|Medical University of Graz|Elisabeth Mahla, MD|0043 316 385 13027|elisabeth.mahla@medunigraz.at|
293134|NCT01468675|Brigham and Women's Hospital|Jennifer Haas, M.D.|617-525-6652|jhaas@partners.org|
293135|NCT01468701|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
293136|NCT01468818|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
293137|NCT01468844|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
293138|NCT01468896|The Ohio State University Comprehensive Cancer Center|William Carson, MD|614-293-6306|William.Carson@osumc.edu|
293139|NCT01468909|NRG Oncology|Linda Gedeon on behalf of Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
293140|NCT01468974|Abbott Vascular|Nadia bouhdi||nadia.bouhdi@av.abbott.com|
293141|NCT01468987|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293142|NCT01469000|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
293143|NCT01469013|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
313860|NCT03213938|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
271618|NCT00252538|VA Long Beach Healthcare System|Peter Hauser|562 826 8000|peter.hauser2@va.gov|2629
282411|NCT00853970|ISTA Pharmaceuticals, Inc.|Tim McNamara, Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
282412|NCT00853996|University of Kansas Mecical Center|Bruce F. Kimler Ph.D|913-588-4523|bkimler@kumc.edu|
293144|NCT01469039|Alkermes, Inc.|ARISTADA Medical Information|866-274-7823||
282413|NCT00854061|Bausch Health|Study Director||susan.harris@bauschhealth.com|
282414|NCT00854087|SCTI Research Foundation|Dr. Tarek Hassanein|6195220330|thassanein@livercenters.com|
282415|NCT00854100|Allergan, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
282416|NCT00854113|Theracos|Yuan-Di Halvorsen|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu|
282417|NCT00854308|Hoffman-LaRoche|Medical Communications|800-821-8590||
282418|NCT00854360|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
282419|NCT00854373|University of California, San Francisco|Mitchell P. Rosen, MD|415-353-7475|rosenm@obgyn.ucsf.edu|
282420|NCT00854581|University of Miami|Juan Carlos Ramos MD|305-243-4909|jramos2@med.miami.edu|
282421|NCT00854594|Louis Stokes VA Medical Center|Jeneen Shell-Boyd|(216) 791-2300|Jeneen.shell-boyd@va.gov|5831
282422|NCT00854607|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293145|NCT01469052|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293146|NCT01469065|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293147|NCT01469182|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
293148|NCT01469221|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
303628|NCT02186587|University of Missouri - Department of Orthopaedic Surgery|Sonny B. Bal, MD, PI|573-882-6762|BalB@health.missouri.edu|
303629|NCT02186652|Duke Clinical Research Institute|Chad Livingston|919-668-1935|chad.livingston@duke.edu|
303630|NCT02186665|Galderma|Michael Graeber|(817)961-5000|michael.graeber@galderma.com|
303631|NCT02186795|MUSC|Sylvia Wilson, MD|843-732-2322|wilsosh@musc.edu|
303632|NCT02186808|Nobel Biocare|Head of Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
303633|NCT02186821|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
303634|NCT02186847|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
303635|NCT02186873|Johnson&Johnson|Senior Director Clinical Development, Immunology General||ClinicalTrialDisclosure@its.jnj.com|
303636|NCT02186938|MUSC|Dr Hand|843-792-5442|handw@musc.edu|
303637|NCT02187016|Silverstone Research Group|Pejjmon Amini, DMD|702-901-444||
303638|NCT02187029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
303639|NCT02187042|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
303722|NCT02194998|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
303723|NCT02195011|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
303724|NCT02195232|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617.667.9299|jzwicker@bidmc.harvard.edu|
303725|NCT02195310|KCI Europe Holding B.V.|Daniela Weichert, PhD|+353 (0) 860436155|daniela.weichert@acelity.com|
303726|NCT02195349|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
303727|NCT02195414|The General Hospital of Shenyang Military Region|Yaling Han, Study Chair of Clinical Trials|+86-024-28856123|hanyaling@263.net|
303728|NCT02195427|Teoxane|Clinical Project Manager|+41 (0) 22 344 96 36|m.chenet@teoxane.com|
303729|NCT02195518|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
303730|NCT02195531|Philips Research|Senior Scientist|+31628041122|Joyca.lacroix@philips.com|
303731|NCT02195583|GlaxoSmithKline|GSK Response Center|866-435-7343||
303732|NCT02195622|IU Health Physicians Urology|James Lingeman, MD|317-962-3700||
303733|NCT02195687|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
303734|NCT02195700|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
303735|NCT02195713|Theranova, LLC|Devyani Nanduri|415-926-8616|dnanduri@theranova.com|
303736|NCT02195869|Pharmacyclics LLC, An AbbVie Company|Manuela Juretic, Associate Director, Clinical Operations|(408) 215.3628|mjuretic@pcyc.com|
303737|NCT02195895|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
303738|NCT02195921|Tianjin University of Traditional Chinese Medicine|Acupuncture for Chemotherapy-Induced Nausea and Vomiting: A Randomized Clinical Trial|+86 13920921016|guoyi_168@163.com|
303739|NCT02195986|Mylan Inc.|Abhijit Barve, Head of Global Clinical Research||abhijit.barve@mylan.com|
303740|NCT02196038|Wake Forest School of Medicine|Dr. Dalane Kitzman|336-716-3274|dkitzman@wakehealth.edu|
303741|NCT02196077|Pearl Therapeutics Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
303742|NCT02196168|London Health Sciences centre|Dr.Eric Winquist|519-685-8500|Winquist@lhsc.on.ca|
303743|NCT02196259|University of Michigan|Dr. Scott Peltier|734-647-8077|spelt@umich.edu|
303744|NCT02196324|Menlo Therapeutics Inc. (formerly Tigercat Pharma, Inc.)|Iain Stuart, PhD.|1- 800-775-7936|Iain.Stuart@foamix.com|
303745|NCT02196506|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
303746|NCT02196558|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
303747|NCT02196675|Ethicon|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
303748|NCT02196688|Hutchison Medipharma Ltd|Dr. Songhua Fan|+86 21 2067 3058|songhuaf@hmplglobal.com|5058
313861|NCT03214081|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313862|NCT03214094|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313863|NCT03214198|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313864|NCT03214224|Penn State College of Medicine|Andrew Geronimo|717-531-0003|geronimo@psu.edu|282576
313865|NCT03214367|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
313866|NCT03214380|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
282423|NCT00854620|Stanford University, Stanford Cancer Center|Sandy Srinivas, MD|650-725-2078|sandysri@stanford.edu|
282424|NCT00854724|BPRL, McLean Hospital|David M. Penetar|617-855-2913|dpenetar@mclean.harvard.edu|
282425|NCT00854828|Washington University|Keith H. Bridwell, MD|314-747-2655|bridwellk@wustl.edu|
282426|NCT00854906|University of Arkansas for Medical Sciences|Richard Harper|501 526-6000|harperricharda@uams.edu|2616
282427|NCT00855010|UT Southwestern Medical Center|Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
282428|NCT00855062|Harvard School of Public Health|Sachiko Miyahara|617-432-2837|miyahara@sdac.harvard.edu|
282429|NCT00855166|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
282430|NCT00855218|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com|
282431|NCT00855309|Comprehensive Cancer Center of Wake Forest University|LeAnne Kenndy, PharmD|336-713-3416|lakenned@wakehealth.edu|
282432|NCT00855335|Janssen Scientific Affairs, LLC|Medical Leader, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
282433|NCT00855413|The University of North Carolina|Dr. Cynthia Gay|9198432726|cynthia_gay@med.unc.edu|
293149|NCT01469234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
293150|NCT01469364|Duke University|Dr. Scott Palmer|919-684-0245|palme002@mc.duke.edu|
293151|NCT01469377|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
293152|NCT01469546|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden, M.D.|734-936-0453|fworden@umich.edu|
293153|NCT01469585|University of Hawaii|Investigator|808-203-6500|blissk@hawaii.edu|
293154|NCT01469637|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
293155|NCT01469715|University of Virginia|Stacey Anderson, MD||sg4c@virginia.edu|
293156|NCT01469767|Wake Forest University Health Sciences|Steve Feldman MD|336-716=3775|sfeldman@wakehealth.edu|
293157|NCT01469819|Texas Tech University Health Sciences Center El Paso|Dr. Irene Sarosiek|(915)215-5254|irene.sarosiek@ttuhsc.edu|
293158|NCT01470001|University at Buffalo|Dr Tova Ablove|716-878-7138|tablove@buffalo.edu|
293159|NCT01470027|Weill Cornell Medicine|Dr. Dikoma C. Shungu, Professor of Physics in Radiology|2127462481|dcs7001@med.cornell.edu|
293160|NCT01470118|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
293161|NCT01470144|Actelion Pharmaceuticals Ltd|Thomas Pfister, PhD||thomas.pfister@actelion.com|
293162|NCT01470170|Department of Thoracic Medicine|Dr. Yu-Lun, Lo|+886-3-3281200|loyulun@hotmail.com|5108
293163|NCT01470196|Dana-Farber Cancer Institute|Steven P. Treon, MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
293164|NCT01470248|Emory University|Taofeek K. Owonikoko, MD, PhD, MSCR|404-778-1900|towonik@emory.edu|
293165|NCT01470417|University of Florida|Thomas J. George, Jr., MD|(352) 273-8008|thom.george@medicine.ufl.edu|
293166|NCT01470469|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
293167|NCT01470599|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293168|NCT01470612|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293169|NCT01470651|New York State Psychiatric Institute-Research Foundation for Mental Hygene|Judith Rabkin|646-774-8075|jgr1@cumc.columbia.edu|
293170|NCT01470781|McLean Hospital/Harvard Medical School|Dr. Kathryn Lewandowski|617-855-2886|klewandowski@mclean.harvard.edu|
293171|NCT01470859|Department of Neurology, Huashan Hospital affiliated to Fudan University.|Dr. Jian Wang|+86-13321934789|wangjian336@hotmail.com|
293172|NCT01470989|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
293173|NCT01471015|University of Utah|Dr. Mariana Baserga|801-581-7052|mariana.baserga@hsc.utah.edu|
293174|NCT01471028|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
293175|NCT01471041|Vital Access|Mark Crawford|8014339390|mcrawford@vital-access.com|
293176|NCT01471054|Oncology Service, Wills Eye Hospital|Arman Mashayekhi, MD|215-928-3105|arman_mash@yahoo.com|
303749|NCT02196701|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
303750|NCT02196714|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
303751|NCT02196766|Coopervision Japan|Taku Muraoka, OD, Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
303752|NCT02196831|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@mgh.harvard.edu|
303753|NCT02196857|The University of Texas MD Anderson Cancer Center|Ravandi-Kashani,Farhad MD./Professor|713-745-0394|fravandi@mdanderson.org|
303754|NCT02196922|Northwell Health|Renee Pekmezaris, Ph.D., Vice President Community Health & Health Services Research|516 465-3161|rpekmeza@northwell.edu|
303755|NCT02197065|Hospital for Special Surgery|Anne R. Bass, MD|212-774-7043|bassa@hss.edu|
303756|NCT02197078|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
303757|NCT02197130|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
303758|NCT02197247|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
303759|NCT02197273|OhioHealth|Deborah Napier|614-566-5575|Deborah.Napier@ohiohealth.com|
303760|NCT02197377|DorkuzEU|Anaesthesiology and Reanimation|0905055252901|ozbilginsule@gmail.com|
303761|NCT02197416|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
303762|NCT02197455|Yale Univ School of Medicine|Brett King, MD|2037854092|brett.king@yale.edu|
303763|NCT02197481|The Second Affiliated Hospital of Anhui Medical University|Dr.Jiang-ming Chen|15855518651|chenjm10@126.com|86
303764|NCT02197520|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
303765|NCT02197572|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303766|NCT02197767|Mayo Clinic|Dr. Stephen B. Erickson|507-284-4083|Erickson.Stephen@mayo.edu|
303767|NCT02197806|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
303768|NCT02197897|Baylor College of Medicine|Dr. Guilherme Godoy|713-798-4001|godoy@bcm.edu|
271619|NCT00252564|US Oncology|Allen L. Cohn|303- 388-4876|Allen.Cohn@USOncology.com|
271620|NCT00252577|VA San Diego Healthcare System|John Kelsoe|858-552-8585|john.kelsoe@va.gov|5704
293177|NCT01471093|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
293178|NCT01471171|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
293179|NCT01471197|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
293180|NCT01471353|University of Florida|Dr. Thomas J. George, Jr.|352-273-8008|thom.george@medicine.ufl.edu|
293181|NCT01471379|UNC Chapel Hill|Dr. Spencer Dorn Associate Professor|919-966-0141|sdorn@med.unc.edu|
293182|NCT01471457|University of New Mexico|Kate Meriwether|5052495967|meriwet2@salud.unm.edu|
293183|NCT01471522|NYU Langone Health|Anna Naumova|212.263.6927|Anna.Naumova@nyulangone.org|
293184|NCT01471574|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
293185|NCT01471626|CHU St Pierre|Dr Marie Bruyneel|003225354219|marie_bruyneel@tpierre-bru.be|
293186|NCT01471639|Cleveland Clinic Healthcare System|Sharon Mace MD|216-445-4598|maces@ccf.org|
293187|NCT01471691|Thomas Hanscom AMC|Thomas O'Hearn MD|310-829-3303|tohearn@gmail.com|
293188|NCT01471782|Amgen, Inc|Study Director|866-572-6436||
293189|NCT01472185|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
293190|NCT01472289|TotipotentSC|Dr. Venkatesh Ponemone|+91-124-4976860|venkatesh.ponemone@totipotentsc.com|
293191|NCT01472341|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293192|NCT01472380|Mutual Pharmaceutical Company, Inc.|VP, Clinical Development and Medical Affairs|215-697-1743|clinicaltrials@urlmutual.com|
293193|NCT01472432|Second University Naples|Dr Raffaele Marfella|++390815665110|raffaele.marfella@unina2.it|
293194|NCT01472445|Stanford University|Melinda Telli, Associate Professor of Medicine (Oncology)|650-724-9533|mtelli@stanford.edu|
293195|NCT01472549|Washington University|Methodius Tuuli|6785582874|methodiustuuli@yahoo.com|
293196|NCT01472562|Weill Cornell Medicine|Jia Ruan M.D, Ph.D|646.962.2064|amr2017@med.cornell.edu|
293197|NCT01472718|Cardiac Catheterization Laboratory, Cardiothoracic and Vascular Department, Azienda Ospedaliero-Universitaria Pisana,|Marco De Carlo, MD, PHD|+39 050995326|marcodecarlo@gmail.com|
293198|NCT01472757|Vectura Limited|Gary Burgess, MD|+44(0)1249 667700|clinical.enquiries@vectura.com|
293199|NCT01472822|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Jeong-Hwan Seo, MD|82-63-276-8284|vivaseo@jbnu.ac.kr|
293200|NCT01472835|Johns Hopkins|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
293201|NCT01472874|Yale|Dr. Schilsky|203-785-2565|michael.schilsky@yale.edu|
293202|NCT01472939|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
293203|NCT01472965|St. Jude Children's Research Hospital|Joshua Wolf, MBBS, BA|901-595-1475|joshua.wolf@stjude.org|
293204|NCT01473160|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|+49 6022 240 520|joachim.nick@cibavision.com|
293205|NCT01473355|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
293206|NCT01473368|Beth Israel Deacones Medical Center|Ciaran Kelly, MD|617-667-1272|ckelly2@bidmc.harvard.edu|
293207|NCT01473381|Forest Research Institute|Suresh Durgam, MD Clinical Asset Lead for Vilazodone - Senior Director - Clinical Development|201 427-8000|suresh.durgam@frx.com|8172
293208|NCT01473394|Forest Research Institute, Inc.|Carl Gommoll|201 427-8000||
293209|NCT01473407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293210|NCT01473420|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293211|NCT01473524|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
293212|NCT01473563|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293213|NCT01473589|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293214|NCT01473602|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293215|NCT01473745|ChangGungMH|Dr. Yi Hsuan Chen|+886227135211|acantehr@gmail.com|3533
293216|NCT01473758|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
293217|NCT01473836|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293218|NCT01473940|Northwestern University|Mary Mulcahy, MD|312-695-0990|Mary.Mulcahy@nm.org|
293219|NCT01473953|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
293220|NCT01473992|University of South Florida|M. Jason Highsmith|8139743806|mhighsmi@health.usf.edu|
293221|NCT01474018|Baylor Endocrine Center|Dr. Erin D. Roe|214-820-3466|edr@roemd.com|
293222|NCT01474109|Actelion Pharmaceuticals Ltd|Angelina Marr|+41 61 565 63 69|angelina.marr@actelion.com|
293223|NCT01474122|Actelion Pharmaceuticals Ltd|Angelina Marr|+41 61 565 63 69|angelina.marr@actelion.com|
293224|NCT01474200|Baxter Healthcare Corporation|Drew Jones, MD, Senior Medical Director|224-270-2659|drew_jones@baxter.com|
293225|NCT01474213|Department of Anaesthetics, Shanghai Ninth People's Hospital affiliated to Shanghai Jiao Tong University, School of Medicine|Dr. Jiang Hong|86-21-13512122883|hr310@vip.sina.com.cn|
293226|NCT01474239|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
293227|NCT01474291|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
303769|NCT02198040|Universidad de Murcia|Rubén Cuesta-Barriuso, PhD|+34 913146508|ruben.cuestab@gmail.com|
303770|NCT02198235|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
314346|NCT03292653|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
271621|NCT00252590|VA San Diego Healthcare/University of California, San Diego|Dr. Susan Tate|619-426-9402|srtate@ucsd.edu|
303771|NCT02198430|Real Fundación Victoria Eugenia|Dr. Rubén Cuesta-Barriuso|+34913146508|ruben.cuestab@gmail.com|
293228|NCT01474317|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
271622|NCT00252629|Northport, VAMC|Mohammad M. Amin, MD|6312614400|mohammad.amin2@va.gov|2469
271623|NCT00252694|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
293229|NCT01474434|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
293230|NCT01474486|Phoenix VA Health Care System|Diane J. Parrington|602-277-5551|diane.parrington@va.gov|7532
293231|NCT01474512|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293232|NCT01474538|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293233|NCT01474551|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
293234|NCT01474590|University of Western Ontario and Windsor Clinical Research Inc., 2224 Walker Rd. Suite 300, Windsor, ON, Canada|Dr. Jerry Tan||jerrytan@bellnet.ca|
293235|NCT01474681|Novartis Pharmaceuticals|Study Director|862-778-8300||
293236|NCT01474746|University of California, Davis, MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
293237|NCT01474772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293238|NCT01474863|Vanderbilt University Medical Center|Todd Rice, MD|6153223412|todd.rice@vanderbilt.edu|
293239|NCT01474876|AbbVie|Global Medical Information|800-633-9110||
293240|NCT01474915|The Ohio State University Department of Anesthesiology|Andrew Otey|6142933559|Andrew.otey@osumc.edu|
293241|NCT01474993|UMass Medical School|Andrew Zimmerman, M.D.|508-856-3279|Andrew.Zimmerman@umassmemorial.org|
293242|NCT01475071|Galderma|Cyril Moulin|+33 4 92 38 30 14|cyril.moulin@galderma.com|
293243|NCT01475097|GE Healthcare|Debra Mansfield|609-514-6329|dabra.mansfield@ge.com|
293244|NCT01475136|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293245|NCT01475162|Medical College of Wisconsin|William R. Drobyski|414-456-4941|wdrobysk@mcw.edu|
293246|NCT01475175|Medtronic CRDM|AdOpt CRT Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62736
293247|NCT01475214|Jean Mayer Human Nutrition Research Center on Aging at Tufts University|Dr. Bess Dawson-Hughes|617-556-3066|bess.dawson-hughes@tufts.edu|
293248|NCT01475253|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
303772|NCT02198651|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
303773|NCT02198664|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
303774|NCT02198963|Mercury Street Medical|Dr. John Pullman|(406) 723-1375|john.pullman@mecurystmed.com|
303775|NCT02199028|Stanford University|Dr Bruce Buckingham|(408) 356-0911|buckingham@stanford.edu|
303776|NCT02199041|St. Jude Children's Research Hospital|Brandon Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
303777|NCT02199080|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Antoine Milhem|+33546455050|antoine.milhem@ch-larochelle.fr|
303778|NCT02199197|Huntsman Cancer Institute Research Compliance Office|Data Manager|801-585-0601|compliance@hci.utah.edu|
303779|NCT02199314|Cincinnati Children's Hospital Medical Center|John J McAuliffe, MD|1513-636-4408|john.mcauliffe@cchmc.org|
303780|NCT02199496|NIAID - LCIM|Fuss, Ivan|+1 301 496 9663|ifuss@niaid.nih.gov|
303781|NCT02199509|National Institutes of Health|Dr. Mark Hallett||hallettm@ninds.nih.gov|
303782|NCT02199574|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
303783|NCT02199652|Medical College of Georgia; Augusta University|William Vaughn McCall|7067216719|WMCCALL@augusta.edu|
303784|NCT02199691|Sanofi Pasteur|Trial Transparency Team|800-633-1610 ext 1#|Contact-US@sanofi.com|
303785|NCT02199717|Hospital for Sick Children|Vanessa Bouskill NP|4168135871|vanessa.bouskill@sickkids.ca|
303786|NCT02199743|UT Southwestern Medical Center|Debra Bushong, MS, LPC|214-648-4653|debra.bushong@utsouthwestern.edu|
303787|NCT02199795|MetroHealth Medical Center|Dr. Jayme Knutson|2169573557|jsk12@case.edu|
303788|NCT02199964|Baylor College of Medicine|Stephen Pflugfelder, M.D.|713-798-6100|stevenp@bcm.edu|
303789|NCT02200055|General Surgery, Naval Medical Center Porstmouth|Dr. Christopher Oxner|757-953-2495|christopher.r.oxner.mil@mail.mil|
303790|NCT02200211|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
303791|NCT02200445|Brigham and Women's Hospital|Dr. Jessica Allegretti|617-732-5500|jallegretti@bwh.harvard.edu|
303792|NCT02200458|Christie Medical Holdings, Inc.|Clinical Affairs Manager|901-721-0330|christiemedinfo@christiedigital.com|
303793|NCT02200510|CincinnatiChildrens|Lori Crosby|5136365380|lori.crosby@cchmc.org|
303794|NCT02200523|Cleveland Medical Devices|Sarah Weimer|216-791-6720|sweimer@clevemed.com|
303795|NCT02200536|Damascus University|Assistant Professor Easter Joury|00963955650456|easterjoury@icloud.com|
303796|NCT02200614|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
303797|NCT02201056|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303798|NCT02201108|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
303799|NCT02201212|Dana Farber Cancer Institute|Dr. David Kwiatkowski|8573070781|dk@rics.bwh.harvard.edu|
303800|NCT02201251|Janssen Research & Development, LLC|Director - Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
303801|NCT02201277|University of California, San Francisco, Interventional Radiology|Maureen Kohi, MD|(415) 353-1300|maureen.kohi@ucsf.edu|
303802|NCT02201290|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
303803|NCT02201329|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
303804|NCT02201394|Atherothrombosis Research Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai|Dr. Juan J. Badimon||Juan.Badimon@mssm.edu|
303805|NCT02201420|Navidea Biopharmaceuticals, Inc.|Dr. Frederick O. Cope, Chief Scientific Officer|614-793-7500|fcope@navidea.com|140
303806|NCT02201446|Department of Burn Surgery, Changhai Hospital, The Second Military Medical University, Shanghai, People's Republic of China|Guo-sheng Wu|+86 18019359841|drwuguosheng@sina.cn|
314347|NCT03292692|University of Miami|Dr. Brian Doss|305-284-1101|bdoss@miami.edu|
271624|NCT00252720|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
293249|NCT01475305|Medimmune, LLC|Hasan Jafri, Medical Director|301-398-4431|jafrih@medimmune.com|
293250|NCT01475331|Milton S. Hershey Medical Center|Dr. Matthew T. Moyer|717-531-3694|mmoyer@pennstatehealth.psu.edu|
293251|NCT01475370|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
293252|NCT01475461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293253|NCT01475474|Renew Medical, Inc.|Victoria Mackinnon, Vice President, Regulatory, Clinical & Quality|1-888-987-2929|victoria@renew-medical.com|
293254|NCT01475487|Department of Anesthesia and Pain Management, Mount Sinai Hospital Toronto, Canada|Dr Naveed Siddiqui|4165864800|naveed.siddiqui@uhn.ca|5270
293255|NCT01475513|Virginia Commonwealth University|Kai Cheang|8049863269|kicheang@vcu.edu|
293256|NCT01475643|Valeant Pharmaceuticals NA|Denise Raimondo|9089721885|denise.raimondo@valeant.com|
293257|NCT01475721|GlaxoSmithKline|GSK Response Center|866-435-7343||
293258|NCT01475734|GlaxoSmithKline|GSK Response Center|866-435-7343||
303807|NCT02201524|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
303808|NCT02201771|Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr. Yunpeng Zhu|008613816819346|zypB1014@rjh.com.cn|
303809|NCT02201784|Jawaharlal Nehru Medical College, AMU, Aligarh, India|Dr. Manazir Athar|+918868056469|drmanazirathar@gmail.com|
303810|NCT02201901|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
303811|NCT02201940|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
303812|NCT02201953|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
303813|NCT02202031|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
303814|NCT02202109|University of Miami|Dr. Erin Kobetz|3052436185|ekobetz@med.miami.edu|
303815|NCT02202135|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
303816|NCT02202161|GlaxoSmithKline|GSK Response Center|866-435-7343||
303817|NCT02202252|Diskapi Training and Research Hospital|Melih Akinci, MD, Associate Prof|90 312 5962080|melihakinci@yahoo.com|
303818|NCT02202317|University of Miami Miller School of Medicine|Dr Jason Salsamendi|305-585-7500|jsalsamendi@miami.edu|
303819|NCT02202499|H. Lee Moffitt Cancer Center and Research Institute|Dr. Thomas Brandon|813-745-1750|thomas.brandon@moffitt.org|
303820|NCT02202538|Parker Hannifin Corporation|Ryan Farris|(216) 896-3335|ryan.farris@parker.com|
303821|NCT02202551|Adamas Pharmaceuticals, Inc.|Reed Johnson|510-450-3500|rjohnson@adamaspharma.com|
303822|NCT02202616|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
303823|NCT02202746|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
303824|NCT02202759|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303825|NCT02202785|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303826|NCT02202837|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
303827|NCT02202850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
303828|NCT02202980|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
303829|NCT02203019|Texas Tech University|Dr Kenneth Nugent|18067436847|kenneth.nugent@ttuhsc.edu|
303830|NCT02203032|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
303831|NCT02203071|University of Missouri|Research Project Analyst|573-882-7583|jonesvicki@health.missouri.edu|
303832|NCT02203149|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
303833|NCT02203162|Montefiore Medical Center|Peter Dicpinigaitis, MD|718-904-2676|pdicpini@montefiore.org|
303834|NCT02203331|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
303835|NCT02203357|Peking University Health Science Center|Dr. Hui Zhuang|86-10-82801617|zhuangbmu@126.com|
303836|NCT02203565|Stanford University School of Medicine|Dr. Kathleen Horst|6507256009|kateh@stanford.edu|
303837|NCT02203578|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
303838|NCT02203591|3M|Joan Paulson|651-736-6583|jepaulson@mmm.com|
303839|NCT02203630|Vanderbilt University Medical Center|Raj Keriwala|615-322-3412||
303840|NCT02203721|Abbott Medical Optics|Kendra Hileman, Ph.D., Director of Clinical Research and Development|714-247-8613|kendra.hileman@abbott.com|
303841|NCT02203747|Abbott Medical Optics|Carrie Garufis|714-566-3728|carrie.garufis@abbott.com|
303842|NCT02203786|Centre for Addiction and Mental Health|Dr. Daniela Lobo, Qualified Investigator for Study, Clinician-Scientist|416-535-8501|Daniela.Lobo@camh.ca|36568
303843|NCT02203838|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
303844|NCT02203851|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
303845|NCT02203916|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303846|NCT02204007|Cleveland Clinic Foundation|Dr. Carlos A Higuera, MD|2166361136|higuerc@ccf.org|
303847|NCT02204124|Washington University School of Medicine|William Hawkins, M.D.|314-286-0702|hawkinsw@wustl.edu|
303848|NCT02204150|Mass General Hospital|Gary Tearney|617-724-2979|gtearney@partners.org|
313867|NCT03214406|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
313868|NCT03214588|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
313869|NCT03214640|Wake Forest Health Science|Peter Pan, MD|336-716-1228|ppan@wakehealth.edu|
313870|NCT03214952|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313871|NCT03215667|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
293259|NCT01475825|Kastle Therapeutics, LLC|Medical Information|1-800-745-4447|medinfo@genzyme.com|
313872|NCT03215706|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
293260|NCT01475838|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
293261|NCT01475851|GlaxoSmithKline|GSK Response Center|866-435-7343||
293262|NCT01475955|DUSA Pharmaceuticals, Inc|Manager of Clinical Studies||houlihana@dusapharma.com|
293263|NCT01476202|GlaxoSmithKline|GSK Response Center|866-435-7343||
293264|NCT01476267|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
293265|NCT01476345|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293266|NCT01476449|Retina Vitreous Associates of Florida|David Eichenbaum, MD|727-323-0077|deichenbaum@retinavitreous.com|
293267|NCT01476475|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
293268|NCT01476644|Wills Eye Hospital, Glaucoma Research Center|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
293269|NCT01476696|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
303849|NCT02204176|Wayne State University and Michigan State University|Dr. Phuong Vo|616-634-0566|votrucph@msu.edu|
303850|NCT02204293|Helios Fachklinik Vogelsang-Gommern GmbH, Germany|Prof. Dr Eugen Feist|+49 30 450 513 192|eugen.feist@charite.de|
303851|NCT02204319|ProHealth Care|Linda LaBorde PT|262-928-5139|linda.laborde@phci.org|
303852|NCT02204371|GlaxoSmithKline|GSK Response Center|866-435-7343||
303853|NCT02204410|Massachusetts General Hospital|Dr. Timothy Wilens|(617)643-3481|twilens@mgh.harvard.edu|
303854|NCT02204449|UHN Toronto|Dr. Sherry Grace|416.736.2100|sgrace@yorku.ca|22364
303855|NCT02204566|Massachusetts General Hospital|Dr. Gary Tearney, PI|617-724-2979|GTEARNEY@PARTNERS.ORG|
303856|NCT02204579|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
303857|NCT02204657|University Malaya Medical Centre|Dr Sharmila SP|60379492299|sharmsp13@gmail.com|
303858|NCT02204748|The University of Tennessee|Adrija Sharma, Ph. D.|8659742093|asharma1@utk.edu|
303859|NCT02204761|University of Washington Medical Center|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
303860|NCT02204917|Children's Hospital of Philadelphia|Dr. Kassa Darge, MD, PhD, Radiologist-in-Chief|267-425-7110|DARGE@email.chop.edu|
303861|NCT02204982|Verastem, Inc.|Gloria Patrick|1-781-469-1594|gpatrick@verastem.com|
303862|NCT02205177|Mayo Clinic|Stephen P Whiteside, PhD, LP|507-284-2933|Whiteside.Stephen@mayo.edu|
303863|NCT02205307|Novadaq Technologies|Alicia Wilton|416-949-4992|alicia.wilton@stryker.com|
303864|NCT02205333|MedImmune, LLC|Victoria Chiou|301-398-4330|chiouv@MedImmune.com|
303865|NCT02205476|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
303866|NCT02205801|The University of Chicago Medicine & Biological Sciences|Dr. Raymond H. Grogan|773-702-7125|rgrogan@surgery.bsd.uchicago.edu|
303867|NCT02205814|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
303868|NCT02205983|University of Chicago|Dr. Harriet de Wit|773-702-3560|dewitlab@yoda.bsd.uchicago.edu|
303869|NCT02206061|University of Rochester|Jill Halterman, MD|5852755798|jill_halterman@urmc.rochester.edu|
303870|NCT02206152|University of Minenesota|Elizabeth Seaquist, MD|612-624-9176|chape044@umn.edu|
303871|NCT02206217|School of Optometry, The Hong Kong Polytechnic University|Prof. Carly Sin Yin Lam|2766 6091|carly.lam@polyu.edu.hk|
303872|NCT02206607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
303873|NCT02206620|Oregon Health & Science University|Dr. Martina Mancini|5034182602|mancinim@ohsu.edu|
303874|NCT02206685|Baylor College of Medicine|Kim P. Nguyen, MD, Principal Investigator|832-824-5907|kpnguyen@texaschildrens.org|
303875|NCT02206776|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|650-723-4095|ocdresearch@stanford.edu|
303876|NCT02206828|Medtronic|Djamila Bennat|33474089000|djamila.bennat@medtronic.com|1591
303877|NCT02207088|AbbVie|Global Medical Services|800-633-9110||
303878|NCT02207231|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
303879|NCT02207244|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
303880|NCT02207322|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
303881|NCT02207374|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
303882|NCT02207400|GlaxoSmithKline|GSK Response Center|866-435-7343||
303883|NCT02207413|GlaxoSmithKline|GSK Response Center|866-435-7343||
303884|NCT02207478|Shanghai Chest hospital|Dr. Jiayuan Sun|+86 18017321598|jysun1976@163.com|
303885|NCT02207491|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
303886|NCT02207530|AstraZeneca LP|Jean Fan, MD, Global Clinical Lead|1-301-398-5080|jean.fan@astrazeneca.com|
303887|NCT02207556|Medical College of Wisconsin|Dr. Anita D'Souza|414-805-0637|dsouza@mcw.edu|
303888|NCT02207569|Medtronic|Kristin Smith|763-526-3095|kristin.m.smith@medtronic.com|
303889|NCT02207608|University of Rome Tor Vergata|Prof. Enrico Finazzi Agro|+393296152920|efinazzi@tin.it|
303890|NCT02207621|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
303891|NCT02207634|Amgen Inc.|Study Director|866-572-6436||
303892|NCT02207725|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
303893|NCT02207803|Virginia Commonwealth University|Dr. Paul Perrin|8048273894|pperrin@vcu.edu|
303894|NCT02207816|GlaxoSmithKline|GSK Response Center|866-435-7343|cc781166@gsk.com|
303895|NCT02207829|GlaxoSmithKline|GSK Response Center|866-435-7343||
303896|NCT02207907|GlaxoSmithKline|GSK Response Center|866-435-7343||
293270|NCT01476722|alcon Blobal Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
303897|NCT02207946|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
293271|NCT01476748|BWH|Dr. JI Einarsson|617-525-8582|jeinarsson@partners.org|
293272|NCT01477320|University of Louisville|Dr. Mohamed Saad|5028525841|mohamed.saad@louisville.edu|
303898|NCT02207972|Mount Sinai West|Dr Barbara Orlando MD and PI|2125236915|barbara.orlando@mountsinai.org|
303899|NCT02208037|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
271625|NCT00252733|AstraZeneca|Niklas Berglind, GPS Atacand|+46 31 7766310|ClinicalTrialTransparency@astrazeneca.com|
293273|NCT01477333|United Therapeutics Corp.|Kevin LaLiberte, PharmD|919-425-8176|KLaliberte@unither.com|
293274|NCT01477450|University of Cincinnati|Richard Branson||bransord@uc.edu|
293275|NCT01477463|Stanford University School of Medicine|Jean Y Tang MD PhD, assistant professor|650-721-7149|baileyhi@stanford.edu|
293276|NCT01477567|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293277|NCT01477710|University of Cincinnati|Richard Branson|513-558-6785|bransonrd@uc.edu|
293278|NCT01477749|Dendreon Pharmaceuticals, Inc.|Lynn Ngo|206-274-6763|lngo@dendreon.com|
293279|NCT01477762|Emory University|Dr. Tanja Jovanovic|(404) 778-1485|tjovano@emory.edu|
293280|NCT01477853|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293281|NCT01477892|Seoul National University Hospital|Pf. Han-suk Kim|+82-2-2072-0647|kimhans@snu.ac.kr|
303900|NCT02208050|St. Vincent's University Hospital|Professor Christopher McGuigan|+35312214209|C.McGuigan@svhg.ie|
303901|NCT02208063|Cumberland Pharmaceuticals Inc.|Senior Director of Clinical and Regulatory Affairs|615-255-0068|ahaeberle@cumberlandpharma.com|
303902|NCT02208089|Moorfields Eye Hospital NHS Foundation Trust|Mr Bruce Allan|02075662320|bruce.allan@ucl.ac.uk|
303903|NCT02208297|Bausch Health|Study Director||susan.harris@bauschhealth.com|
303904|NCT02208310|University of Michigan|Peter Higgins|7346472964|phiggins@umich.edu|
303905|NCT02208349|St Vincent Hospital|Jestin Carlson|8144525000|jcarlson@svhs.org|
303906|NCT02208466|Spaulding Rehabilitation Hospital|Dr. Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
303907|NCT02208843|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
303908|NCT02208999|CEMKA|Stéphane Bouée, Medical director|331.41.87.95.25|stephane.bouee@cemka.fr|
303909|NCT02209064|EpiEP|Pam Bunes CEO & Founder|+1 864 423 2526|pbunes@epiep.com|
303910|NCT02209181|McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.|Joseph Aquilina, MD, Senior Director, Clinical Research|(215) 273-8025|JAquilin@its.jnj.com|
303911|NCT02209259|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
303912|NCT02209272|Mayo Clinic|Dr. Jacob L. Sellon|507-284-2608|sellon.jacob@mayo.edu|
303913|NCT02209454|Menarini Ricerche S.p.A.|Corporate Director of Clinical Research|0555680|acapriati@menarini-ricerche.it|9990
303914|NCT02209506|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303915|NCT02209519|University of Alabama at Birmingham|Jane Schwebke, MD|205-975-5665|jschwebk@uabmc.edu|
303916|NCT02209532|Novadaq Technologies|Alicia Wilton|416-949-4992|alicia.wilton@stryker.com|
303917|NCT02209597|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
303918|NCT02209610|VAORD|Dr Markus Amann|801-582-1565|markus.amann@hsc.utah.edu|4358
303919|NCT02209766|CO RIA TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
303920|NCT02209948|MFAR Clinical Research|Pau Doñate|0034934344412|investigacion@mfar.net|
303921|NCT02210000|GlaxoSmithKline|GSK Response Center|866-435-7343||
303922|NCT02210039|Massachusetts General Hospital|Guillermo Tearney, PI|617-724-2979|gtearney@partners.org|
303923|NCT02210052|Mayo Clinic|Dr. Tim J. Lamer, M.D.|507 778-8760|lamer.tim@mayo.edu|
303924|NCT02210065|U.T. MD Anderson Cancer Center|Dr. Betul Oran / Associate Professor, Stem Cell Transplantation|713-745-2820|BOran@mdanderson.org|
303925|NCT02210091|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
303926|NCT02210195|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
303927|NCT02210208|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
303928|NCT02210221|UZA|Prof. Em. Dr Andrew Maas|0032 3 821 45 37|andrew.maas@uza.be|
303929|NCT02210247|Pacira Pharmaceuticals Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
303930|NCT02210286|Stanford University|Alison Myoraku|6507244559|myoraku@stanford.edu|
303931|NCT02210689|Teva Pharmaceuticals USA. Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
303932|NCT02210780|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
303933|NCT02211014|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
303934|NCT02211261|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
303935|NCT02211313|Washington University School of Medicine|Alana Desai, M.D.|(314) 362-7581|desaia@wustl.edu|
303936|NCT02211456|Oxford University Hospitals NHS FT|Dr James Gamble|00441865221012|james.gamble@ouh.nhs.uk|
303937|NCT02211495|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
303938|NCT02211534|Regenesis Biomedical|Heather Vander Ploeg|602-4287041|Heather.VanderPloeg@regenesisbio.com|
303939|NCT02211638|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303940|NCT02212028|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
303941|NCT02212106|bioCSL PTY LTD|Clinical Program Director||bioCSL.ClinicalTrials@biocsl.com.au|
303942|NCT02212197|Camurus AB|Clinical Trial Manager||info@camurus.com|
303943|NCT02212301|Johnson & Johnson Vision Care Inc.|Tawnya Wilson OD|904-443-3500|TWilson@ITS.JNJ.com|1834
303944|NCT02212379|Inserm, Sorbonne Universite, IPLESP|Dr Lambert Assoumou|0142164280|lambert.assoumou@iplesp.upmc.fr|
303945|NCT02212457|GlaxoSmithKline|GSK Response Center|866-435-7343||
303946|NCT02212587|Hospital of Sick Children|Dr. Valerie Waters|416-813-1500|valerie.waters@sickkids.ca|
303947|NCT02212678|University of Minnesota|Lisa Coles, MS, PhD|4109264788|durh0016@umn.edu|
303948|NCT02212730|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
313873|NCT03215758|Novartis Pharmaceutical|Study Director|862-778-8300|Novartis.email@novartis.com|
313874|NCT03215771|Northwestern University|Dr. Stefania Fatone, Principle Investigator|3125035717|s-fatone@northwestern.edu|
271626|NCT00252967|Brown University|Samuel Dudley, MD, PhD|4014443024|samuel_dudley@brown.edu|
271627|NCT00253019|Emory University|Carrie Cwiak, MD, MPH|404-778-1696|ccwiak@emory.edu|
271628|NCT00253370|ECOG Statistical Office|Study Statistician|617-632-3012||
271629|NCT00253435|Chidlren's Hospital Los Angeles|Araz Marachelian, MD, NANT Medical Director|323-3691-5687|amarachelian@chla.usc.edu|
271630|NCT00253448|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Research Investigator|937-395-8646|douglas.einstein@khnetwork.org|
271631|NCT00253513|OHSU Knight Cancer Institute|Eneida Nemecek, MD|(503) 494-0829|nemeceke@ohsu.edu|
271632|NCT00253630|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
271633|NCT00253643|Oregon Health & Science University|Dr. Jackilen Shannon|503-220-8262|shannoja@ohsu.edu|54868
271634|NCT00253708|Beth Israel Deaconess Medical Center|Russell S. Phillips, MD|6174322222|Russell_phillips@hms.harvard.edu|
293282|NCT01478009|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Chang-Seop Lee|82-63-276-8284|lcsmd@jbnu.ac.kr|
293283|NCT01478048|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
293284|NCT01478087|Mayo Clinic|Jeffrey Lawrence Winters, MD|507-538-1707|winters.jeffrey@mayo.edu|
293285|NCT01478256|George John MD|George John|5028949757|grjohn777@yahoo.com|
293286|NCT01478321|Northwestern University|Karan Dixit, MD|312-695-1301|karan.dixit@northwestern.edu|
293287|NCT01478347|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
293288|NCT01478360|Novartis Pharmaceuticals|Study Director|862-778-8300||
293289|NCT01478373|Novartis Pharmaceuticals|Study Director|862-778-8300||
293290|NCT01478581|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
293291|NCT01478594|AVEO|Medical Director|1.617.588.1960|clinical@aveooncology.com|
293292|NCT01478620|"Kiev regional City Hospital"|Ivanov, Dmitry|+38 (039) 247 12 36|ivanovdd@i.kiev.ua|
303949|NCT02212834|Group Health Research Institute|Karen J. Wernli, PhD|206-287-2934|wernli.k@ghc.org|
303950|NCT02212977|Duke University Medical Center|Dr. Charles Kim|9196847424|charles.kim@duke.edu|
303951|NCT02213042|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
303952|NCT02213055|The Deirdre Imus Environmental Health Center at HackensackUMC|Project Manager, Environmental Research|551-996-8071|dimuscenter@hackensackumc.org|
303953|NCT02213068|Northwestern University|Lorenzo Gallon, MD|312-695-4457|l-gallon@northwestern.edu|
303954|NCT02213094|UNC at Chapel Hill|Kim Boggess MD Principal Investigator|919-966-1601|kboggess@med.unc.edu|
303955|NCT02213133|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
303956|NCT02213198|UTHSCSA|Dr. Dawn Velligan|210-567-5508|velligand@uthscsa.edu|
303957|NCT02213250|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|(001)8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
303958|NCT02213263|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
303959|NCT02213289|University of Chicago|Daniel Catenacci, MD|2-1000|dcatenac@bsd.uchicago.edu|
303960|NCT02213380|The second affiliated hospital and Yuying children's hospital of Wenzhou medical university|Ting Li|008613587876896|liting1021@aliyun.com|
303961|NCT02213458|University of California, San Francisco|Dr. Katherine Possin|(415) 476-1889|katherine.possin@ucsf.edu|
303962|NCT02213510|UC San Diego School of Medicine|Ulrika Birgersdotter-Green, MD|858-657-5310|ubgreen@ucsd.edu|
303963|NCT02213666|Beth Israel Deaconess Medical Center|Elad Anter, MD|617-632-9209|eanter@bidmc.harvard.edu|
303964|NCT02213900|Indiana University|Babar Khan, MD|317-274-9132|bakhan@iu.edu|
303965|NCT02214017|Herning Hospital|Finn Lauszus|+45 78434614|finlau@rm.dk|
303966|NCT02214121|AstraZeneca|Brilinta Global Clinical Lead|+46 31 776 1000|kontakt@astrazeneca.com|
303967|NCT02214147|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303968|NCT02214186|Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo|M.D. Wallace Andrino da Silva|+551126616787|wallaceandrino@yahoo.com.br|
303969|NCT02214212|University of Washington|Jeanne Hoffman|2062216511|jeanneh@u.washington.edu|
303970|NCT02214225|Seqirus|Seqirus Clinical Trial Disclosure Lead||Seqirus.ClinicalTrials@Seqirus.com|
303971|NCT02214238|Fisher & Paykel Healthcare|Clinical Research Scientist|+6495740123|cpaptrial@fphcare.co.nz|
303972|NCT02214277|Claret Medical|Director of Clinical Research|707-528-9300|info@claretmedical.com|
303973|NCT02214290|Texas Tech University|Dr. Arturo Figueroa|8068345587|arturo.figueroa@ttu.edu|
303974|NCT02214420|Scripps Clinic|Dr. Paul Pockros|(858) 554-8879|Pockros.paul@scrippshealth.org|
303975|NCT02214615|VAMC and Yale University|Stephen Waxman|203-937-3802|stephen.waxman@yale.edu|
303976|NCT02214628|Ophthotech Corp.|Keith Westby|732-824-7474|keith.westby@ophthotech.com|
303977|NCT02215070|Duke University|Anthony Sung|919-668-1000|anthony.sung@duke.edu|
303978|NCT02215161|University of California, San Francisco|Charles Ryan, MD|877-827-3222|clinicaltrials@ucsf.edu|
303979|NCT02215200|Benaroya Research Institute|Carla Greenbaum, MD|1-800-425-8361|cjgreen@benaroyaresearch.org|
303980|NCT02215252|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
303981|NCT02215369|Angiodynamics|Ariel Bloch|7742453646|abloch@angiodynamics.com|
303982|NCT02215616|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
303983|NCT02215954|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
303984|NCT02215967|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
303985|NCT02216071|Exela Pharma Sciences|Aruna Koganti, VP Clinical Programs|828-758-5474|akoganti@exela.us|
303986|NCT02216097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293293|NCT01478828|The SKCCC at Johns Hopkins|Dr. Phuoc Tran|410-614-6477|tranp@jhmi.edu|
303987|NCT02216123|GlaxoSmithKline|GSK Response Center|866-435-7343||
271635|NCT00253747|University of CIncinnati|Dr. Theresa Winhusen|513-487-7800|winhusen@carc.uc.edu|
271636|NCT00253890|Butler Hospital|Dr. Michael D. Stein, MD|401-455-6646|mstein@butler.org|
271637|NCT00254072|UC Irvine Medical Center|Ninh T. Nguyen, M.D.|714-456-8580|ninhn@uci.edu|
293294|NCT01478854|Johns Hopkins University School of Medicine|Kristin Redmond, MD|410-955-6980|kjanson3@jhmi.edu|
293295|NCT01478958|University of Reading|Professor Julie Lovegrove|+44 (0)118 3786418|j.a.lovegrove@reading.ac.uk|
293296|NCT01478971|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
293297|NCT01479127|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
293298|NCT01479270|MetroHealth Medical Center|Robert Pollard|216-778-4444|rpollard@metrohealth.org|
293299|NCT01479348|National Cancer Institute|Dr. Karen Kurdziel|804-897-1207|kurdziek@nih.gov|
293300|NCT01479374|Alcon Research, Ltd.|Abhijit Narvekar, MS, MBBS|1-888-451-3937|alcon.medinfo@alcon.com|
293301|NCT01479426|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Jong-Kwan Park, MD|82-63-276-8284|rain@chonbuk.ac.kr|
293302|NCT01479439|Cincinnati Children's Hospital Medical Center|Dr. Charles Quinn|5138033086|charles.quinn@cchmc.org|
303988|NCT02216136|Washington University School of Medicine|Terence M. Myckatyn, M.D.|314-996-3873|myckatyn@wustl.edu|
303989|NCT02216214|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
303990|NCT02216357|Cumberland Pharmaceuticals Inc.|Senior Manger, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|250
303991|NCT02216422|AbbVie|Global Medical Services|800-633-9110||
303992|NCT02216526|Charité Universitätsmedizin Berlin, Germany|PD Dr. Jan Kottner|+49 (0)30 450 518 218|jan.kottner@charite.de|
303993|NCT02216591|Duke University School of Medicine|Dr. Sheri Towe|919-668-4030|sheri.towe@duke.edu|
303994|NCT02216695|Derby Teaching Hospital NHS Trust|Nitin V Kolhe|01332788266|nitin.kolhe@nhs.net|
303995|NCT02216773|Imperial College London|Professor Long Jiao|+44 2033133937|l.jiao@imperial.ac.uk|
303996|NCT02216812|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
303997|NCT02216851|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
303998|NCT02217280|Missouri Orthopaedic Institute|Dr. Christina Goldstein|573-884-9022|goldsteincl@health.missouri.edu|
303999|NCT02217332|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
304000|NCT02217410|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
304001|NCT02217436|Rady Children's Hospital San Diego|Dr. Amy Williams Bryl|8589668036|abryl@rchsd.org|
304002|NCT02217475|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
304003|NCT02217501|UT Southwestern Medical Center|Subhash Banerjee, MD|214-857-1608|Subhash.Banerjee@utsouthwestern.edu|
304004|NCT02217527|Univ of Pittsburgh|Dr. Kenneth A. Perkins, Prof of Psychiatry|412-246-5395|perkinska@upmc.edu|
304005|NCT02217566|Janssen Research & Development, LLC|Regional Medical Affairs Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
304006|NCT02217618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
304007|NCT02217800|Strongbridge Biopharma|Fredric Cohen, MD|610-254-9200|f.cohen@strongbridgebio.com|
304008|NCT02217878|Collegium Medicum, Nicolaus Copernicus University|Prof. Jacek Kubica|+485854023|jkubica@cm.umk.pl|
304009|NCT02217904|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304010|NCT02217982|Rocky Mountain MS Research Group|Tammy Hoyt|8014085711|thoyt@rmmsc.com|
304011|NCT02218008|Alkermes, Inc.|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
304012|NCT02218164|H. Lee Moffitt Cancer Center and Research Institute|Dr. Christine Chung|813-745-5061|christine.chung@moffitt.org|
304013|NCT02218190|Washington University School of Medicine|Michael P. Kelly, MD, MSc|314-747-2511|kellymi@wustl.edu|
304014|NCT02218203|Translational Pain Research, Brigham and Women's Hospital|Christine N. Sang, MD, MPH|617-525-7246|paintrials@partners.org|
304015|NCT02218216|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
304016|NCT02218242|University of Kentucky|Angela Mahan|859 257 4488|angela.mahan@uky.edu|
304017|NCT02218268|University of Florida|Michael Haller|352-265-0111|hallemj@peds.ufl.edu|
304018|NCT02218307|University of Miami|Dr. Roy Casiano|305-243-1870|rcasiano@miami.edu|
304019|NCT02218320|University of North Carolina at Chapel Hill|Dr. Angela Kashuba|919 966-9998|akashuba@unc.edu|
304020|NCT02218372|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
304021|NCT02218424|Ann & Robert H. Lurie Children's Hospital of Chicago|Hubert Benzon, MD; Primary Investigator|312-227-5122|hbenzon@luriechildrens.org|
304022|NCT02218463|University of Missouri-Kansas City School of Medicine|Dr. Tazim Dowlut-McElroy, M.D., M.S.|816-404-5150|tdowlut@cmh.edu|
304023|NCT02218489|Kala Pharmaceuticals, Inc|VP, Clinical Development|781-996-5252|Results003@kalarx.com|
304024|NCT02218541|University of North Carolina at Chapel Hill|Gidgetta Jenkins|919-537-3968|gidget_jenkins@unc.edu|
304025|NCT02218736|Duke Clnical Research Institute|Kathy Hijek, Associate Director of Clinical Operations|919-668-8700|kathy.hijek@duke.edu|
304026|NCT02219009|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
304027|NCT02219048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
304028|NCT02219087|OhioHealth|Sara Jordan Clinical Pharmacist for Surgery Services|614-461-8174|sara.jordan@ohiohealth.com|
304029|NCT02219256|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
304030|NCT02219282|DorkuzEU|Semih Kucukguclu|902324125707|semih.kucukguclu@gmail.com|
304031|NCT02219308|University of California, San Diego|Dr. Sheila Mody|858-249-1205|smody@ucsd.edu|
304032|NCT02219321|University of Texas Southwestern Medical Center|Enas Kandil|214-648|Enas.Kandil@UTSouthwestern.edu|9374
304033|NCT02219334|Baylor College of Medicine|Shabana Yusuf/Associate Professor of Pediatrics|832-824-5388|syusuf@bcm.edu|
304034|NCT02219438|UCSD|Dr Brian Ilfeld|(619) 543-5560|bilfeld@ucsd.edu|
271638|NCT00254163|Ocala Oncology|Dr. Craig Reynolds|(352) 732-4032|Craig.Reynolds@USOncology.com|
293303|NCT01479465|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
293304|NCT01479478|Stanford University|Dr. Natali Aziz, MD|650-725-5720|mfmresearch@stanford.edu|
293305|NCT01479517|Rock Dental Clinic|Christina Sletten, DDS|719-599-9700||
293306|NCT01479530|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
293307|NCT01479543|Hero Institute for Infant Nutrition|Esther Matencio Hilla|+0034 968 89 89 00|esther.matencio@hero.es|
293308|NCT01479595|Novartis|Study Director|862-778-8300||
293309|NCT01479621|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000||
293310|NCT01479725|Beaumont Hospital, Royal Oak|Dr. Kenneth Peters|248-551-0387|Kenneth.Peters@Beaumont.edu|
293311|NCT01479764|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
304035|NCT02219464|Vanderbilt University Medical Center|Cindy Pastern, RN BSN CCRP|615-343-0259|cindy.pastern@vanderbilt.edu|
304036|NCT02219477|AbbVie|Global Medical Services|800-633-9110||
304037|NCT02219503|AbbVie|Global Medical Services|800-633-9110||
304038|NCT02219516|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
304039|NCT02219685|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
304040|NCT02219815|St. Boniface Hospital|Dr. Rakesh Arora|2042581078|rarora@sbgh.mb.ca|
304041|NCT02219932|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
304042|NCT02219997|Alcon Research, Ltd.|Global Brand Med Affairs Lead, VGR|1-888-451-3937|alcon.medinfo@alcon.com|
304043|NCT02220205|Beth Israel Deaconess Medical Center|Siripanth Nippita|617-667-4165|snippita@bidmc.harvard.edu|
304044|NCT02220712|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
304045|NCT02220725|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
304046|NCT02220764|Zahnärztliche Prothetik|Dr. Konstantinidis Ioannis|+49 351 458 4231|ioannis.konstantinidis@uniklinikum-dresden.de|
304047|NCT02220855|IndianaU|Dr. Patrick Loehrer|317-944-0920|ploehrer@iu.edu|
271639|NCT00254293|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
304048|NCT02220907|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
313875|NCT03215901|Boston University|Jacob Bor, Assistant Professor|617-358-2176|jbor@bu.edu|
313876|NCT03216200|DeviceFarm|VP Operations|510-295-5293|timgrammer@devicefarmtech.com|
313877|NCT03216226|Zealand Pharma A/S|Kim Mark Knudsen|+45 50603780|KMKnudsen@zealandpharma.com|
313878|NCT03216265|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313879|NCT03216382|Ryerson University|Dr. Naomi Koerner|416-979-5000|naomi.koerner@ryerson.ca|ext. 5521
313880|NCT03216512|Duke University|Dr Scott Kollins|919-681-0014|scott.kollins@duke.edu|
313881|NCT03216746|UFParaná|Dr Luciana Reichert Assunção Zanon|554133604025|lurassuncao@yahoo.com.br|
313882|NCT03216850|University Hospital Hradec Kralove|Dr. David Astapenko|+420495833218|astapenko.d@seznam.cz|
313883|NCT03216902|Santen Inc|R&D Quality Manager|+1 415 268 9199|clinicaltrials@santen.com|
313884|NCT03216954|University of Kentucky|William W. Stoops, PhD|859-257-5388|william.stoops@uky.edu|
313885|NCT03217968|CEFALY Technology|Clinical Trial Department director|+3243676722|info@cefaly.com|
313886|NCT03218397|Duke University|Vance Fowler, MD, MHS|919-613-5678|vance.fowler@duke.edu|
313887|NCT03218566|Penumbra, Inc.|Erin Archard, Sr. Clinical Study Manager|+1 510 995 9801|earchard@penumbrainc.com|
313888|NCT03218592|University of North Carolina at Chapel Hill|Dr. Angela Kashuba|9199969998|akashuba@unc.edu|
313889|NCT03218787|Abbott|Lijuan Jenn Wang, Advisor, Clinical Affairs|01-408-8453133|Lijuan.wang1@abbott.com|
313890|NCT03219216|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
313891|NCT03219294|Maine Medical Center|Research Coordinator|2076622862|richaj3@mmc.org|
313892|NCT03219320|Aptinyx|Aptinyx Clinical Development|847-871-0377|clinicalstudies@aptinyx.com|1
313893|NCT03219723|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313894|NCT03219840|The University of Texas Health Science Center at Houston|Flavia S. Lakschevitz, DDS, PhD, MSc|604-822-3863|flavia.lakschevitz@dentistry.ubc.ca|
313895|NCT03219866|Wake Forest Health Science|Jill Ohar, MD|336-716-1210|johar@wakehealth.edu|
313896|NCT03219892|Xuanwu Hospital|Piu Chan|010-83198677|pbchan@hotmail.com|
313897|NCT03220048|hVIVO|Tim Sharpington|02071480862|t.sharpington@hvivo.com|
313898|NCT03220204|Massachusetts General Hospital|Dr. Christopher Celano|617-726-6485|ccelano@partners.org|
313899|NCT03220217|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
313900|NCT03220230|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271640|NCT00254397|University of Texas MD Anderson Cancer Center|Patrick Hwu, MD / Professor, Melanoma Medical Oncology|713-792-2921|phwu@mdanderson.org|
313901|NCT03220412|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
282434|NCT00855439|University of Michigan|Rodica Pop-Busui, MD, PhD|734 647-9809|rpbusui@med.umich.edu|
313902|NCT03220737|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
313903|NCT03220958|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
313904|NCT03221192|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313905|NCT03221387|Lewis Katz School of Medicine at Temple University|Adam Nester, JD, MS|215-707-1986|coisom@temple.edu|
313906|NCT03221595|Denver Health Medical Center|Research Coordinator|303-602-6213|Kiara.Leasia@dhha.org|
282435|NCT00855465|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
313907|NCT03221660|Ivoclar Vivadent AG|Dr. med. dent. Lukas Enggist, Dentist internal clinic (Principal Investigator)|+423 235 34 46|lukas.enggist@ivoclarvivadent.com|
314348|NCT03292809|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
271641|NCT00254410|The University of Texas MD Anderson Cancer Center|Wierda,William G, MD./Professor|713-745-0428|wwierda@mdanderson.org|
271642|NCT00254462|University of Nebraska Medical Center|Christopher J. Kratochvil, M.D.|402-552-6005|ckratoch@unmc.ed|
293312|NCT01479777|Hugo W. Moser Research Institute at Kennedy Krieger, Inc.|Dr. Cristina Sadowsky|443-923-9210|sadowsky@kennedykrieger.org|
293313|NCT01479868|Janssen Research & Development|Director & Study Responsible Scientist||ClinicalTrialDisclosure@its.jnj.com|
293314|NCT01479985|Washington University in St. Louis|Dr. Tessa Madden, MD, MPH|314-747-6495|maddent@wudosis.wustl.edu|
293315|NCT01480076|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
293316|NCT01480089|Loyola University|Elizabeth Mueller, M.D.|708-216-2180|emuelle@lumc.edu|
293317|NCT01480219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293318|NCT01480232|Massachusetts General Hospital-Center for Addiction Medicine|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
271643|NCT00254488|Weill Cornell Medical College|Robert C. Young, MD, Professor of Psychiatry|914-997-5886|ryoung@med.cornell.edu|
293319|NCT01480258|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293320|NCT01480284|GlaxoSmithKline|GSK Response Center|866-435-7343||
304049|NCT02220920|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
304050|NCT02220998|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
304051|NCT02221219|University of Kentucky|Research Protocol Manager/Clinical/UKHC|(859) 257-1000|hong.huang@uky.edu|
304052|NCT02221284|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
304053|NCT02221349|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
304054|NCT02221557|Sunstar Americas, Inc.|Akane Takemura, R&D Senior Manager|847-794-4276|akane.takemura@us.sunstar.com|
304055|NCT02221648|Yale University School of Medicine|Bahman Jabbari M.D, , Professor of Neurology|203-737-2464|bahman.jabbari@yale.edu|
304056|NCT02221674|Grünenthal GmbH|Director of Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
304057|NCT02221739|Weill Cornell Medical College|Silvia Formenti, M.D.|646-962-4065|formenti@med.cornell.edu|
304058|NCT02221869|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
304059|NCT02221882|Eli Lilly and Company|Chief Medical Officer|800+545-5979|ClinicalTrials.gov@lilly.com|
304060|NCT02221947|Neurotrope BioScience, Inc|Vice President, Regulatory Affairs|973-826-5109|dcrockford@neurotropebioscience.com|
304061|NCT02222129|USAF|Richard Knight, MD|+44 1638 528186|richard_b_knight@yahoo.com|
304062|NCT02222181|Unesp|Fernanda Mariana de Oliveira|+551636640217|femoliveira12@gmail.com|
304063|NCT02222207|BAYER|Therapeutic Area Head||Clinical-Trial-Disclosure@bayer.com|
304064|NCT02222246|Duke University|Dr. Paula Tanabe|919-613-6038|paula.tanabe@duke.edu|
304065|NCT02222337|Lombardi Comprehensive Cancer Center, Georgetown University|Kristi Graves, PhD|202-687-1591|Kristi.Graves@georgetown.edu|
304066|NCT02222493|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
304067|NCT02222558|TesoRx Pharma, LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
304068|NCT02222610|Retina Consultants of Texas|Dr. Amy C. Schefler|(713) 524-3434|acsmd@retinaconsultantstexas.com|
304069|NCT02222688|University of California, San Diego|Thomas Kipps, MD, PhD|858-534-5400|tkipps@ucsd.edu|
304070|NCT02222714|Cedars-Sinai Medical Center|Patrick Lyden, MD, FAAN, FAHA|(310) 423-5166|Patrick.Lyden@cshs.org|
304071|NCT02222818|Medtronic Cardiac Rhythm and Heart Failure|CRTee Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
304072|NCT02222870|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
304073|NCT02222896|Microbac|Dr. Bashir|703-925-9366|muhammad.bashir@microbac.com|
304074|NCT02222922|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
304075|NCT02223065|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
304076|NCT02223260|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
304077|NCT02223338|Loma Linda University|Dr. David Sierpina|9095582154|dsierpina@llu.edu|
304078|NCT02223351|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
304079|NCT02223364|Mayo Clinic|Dr. Sandra L. Kopp|507-284-6637|Kopp.Sandra@mayo.edu|
304080|NCT02223390|Duke University (Currently at Columbia University)|Kathleen Sikkema, PhD|212-305-8236|ks3364@cumc.columbia.edu|
304081|NCT02223429|Emory University|Dr. James Rilling|404-727-3062|jrillin@emory.edu|
304082|NCT02223455|CADRE - Iowa City VAHCS|Heather Reisinger|319-338-0581|heather.reisinger@va.gov|7715
304083|NCT02223546|Medical University of Graz|Gerald Seidel, MD|+43 316 385 12394|gerald.seidel@medunigraz.at|
304084|NCT02223637|GlaxoSmithKline|GSK Response Center|866-435-7343|geetha.x.kamath@gsk.com|
304085|NCT02223650|Jaeb Center for Health Research|Ray Kraker, M.S.P.H., Director of PEDIG Coordinating Center|(813) 975-8690|rkraker@jaeb.org|
304086|NCT02223689|Medline Industries, Inc.|Lori Rotolo|8476434640|lrotolo@medline.com|
304087|NCT02223702|Kocaeli University|Chair and Associate Professor of Periodontology|+902623442222|esragd@yahoo.com|5102
304088|NCT02223715|Otsuka Pharmaceutical Co., LTD.|Study Director, Yoshitaka Kotobuki, Mr|+81-3-6361-7366||
304089|NCT02223754|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, O.D., M.S., F.A.A.O., Sr. Principal Research Optemtrist|904-443-3500|TKarkkai@its.jnj.com|3402
304090|NCT02223793|University of Oslo|Karianne Svendsen|+4795026445|karianne.svendsen@medisin.uio.no|
304091|NCT02223858|Veterans Affairs Pittsburgh Healthcare System|Dr. Leslie R.M. Hausmann|412-360-2112|leslie.hausmann@va.gov|
304092|NCT02223871|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure desk||clinical-trials-disclosure@idorsia.com|
304093|NCT02224053|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
271644|NCT00254501|University of Florida|Dale Kraemer||Dale.Kraemer@jax.ufl.edu|
271645|NCT00254540|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
293321|NCT01480297|The University of Michigan|Rodica Pop-Busui, MD, PhD|734-763-3056|rpbusui@umich.edu|
293322|NCT01480596|GlaxoSmithKline|GSK Response Center|866-435-7343||
293323|NCT01480674|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
293324|NCT01480843|Joslin Diabetes Center|Medha Munshi, MD|617-309-4683|medha.munshi@joslin.harvard.edu|
293325|NCT01481116|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
293326|NCT01481129|Centre Léon Bérard (now CHLS)|Dr Hervé Ghesquieres|0426556824|herve.ghesquieres@chu-lyon.fr|
293327|NCT01481324|Shriners Hospital for Children|Dr. Todd Milbrandt|859-266-2101|tmilbrandt@shrinenet.org|
293328|NCT01481376|Surgical Department of the Protestant Hospital|Docteur Dieter BIRK|06332 422120||
293329|NCT01481545|National Cancer Institute of Naples|Dr. Antonio Avallone|+39 081 5903629|a.avallone@istitutotumori.na.it|
293330|NCT01481558|University of Sao Paulo|Claudia Kimie Suemoto|551130618249|cksuemoto@usp.br|
304094|NCT02224157|AstraZeneca AB|Stefan Ivanov|000000000|information.center@astrazeneca.com|
304095|NCT02224274|UMC Ljubljana|Marko Noc|+386 1 522 22 96|marko.noc@mf.uni-lj.si|
304096|NCT02224313|Eastern Virginia Medical School|Dr.David Archer|7574467444|archerdf@evms.edu|
304097|NCT02224404|Universitair Ziekenhuis Gent|Dr. Hilde Beele|09/332 22 87|Hilde.Beele@uzgent.be|
304098|NCT02224482|Fox Chase Cancer Center|Dr. Suzanne Miller|215-728-4069|Suzanne.Miller@fccc.edu|
304099|NCT02224508|Group Health Research Institute|Michael Von Korff, ScD|206-287-2874|vonkorff.m@ghc.org|
304100|NCT02224560|GW Research Ltd|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
304101|NCT02224612|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
304102|NCT02224625|Bioscience Labs|C Beausoleil|406-587-5735|cbeausoleil@bioscience.com|
304103|NCT02224638|Swedish Covenant Hospital|Nancy Chaiken|847-372-3500|nchaiken@comcast.net|
304104|NCT02224664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
304105|NCT02224690|GW Research Ltd.|Medical Enquires||medinfo.USA@gwpharm.com, medinfo@greenwichbiosciences.com|
304106|NCT02224703|GW Research Ltd|Medical Enquiries|+44 01223 238170; +18778862810|medinfo@gwpharm.com; medinfo@greenwichbiosciences.com|
304107|NCT02224729|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Joanne Filicko, O'Hara|215-955-8874|joanne.filicko@jeffersron.edu|
304108|NCT02224755|Abbott|Joyce Chuang/Principal scientist|925-353-5817|joyce.chuang@abbott.com|
304109|NCT02224820|Dept of Transplant Surgery, Uppsala University Hospital|Dr. Tomas Lorant|+46 70 677 29 01|tomas.lorant@surgsci.uu.se|
304110|NCT02224846|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
304111|NCT02225080|Integra LifeSciences Corporation|Director, Global Clinical Affairs|609-936-5490|andrew.tummon@integralife.com|
304112|NCT02225106|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732-|Ramon.Diaz-Arrastia@uphs.upenn.edu|
304113|NCT02225132|National Heart Lung and Blood Institute|Fitzhugh, Courtney|+1 301 402 6496|courtney.fitzhugh@nih.gov|
304114|NCT02225223|Merit Medical|Casey Holland|1 (617) 842-0251|casey.holland@merit.com|
304115|NCT02225353|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|clinical-trials@grunenthal.com|
304116|NCT02225587|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304117|NCT02225665|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
304118|NCT02225743|Medical University of South Carolina|Sylvia Wilson, MD|843-792-2322|wilsosh@musc.edu|
304119|NCT02225860|Tufts Medical Center|Ronald D. Perrone|6176362372|rperrone@tuftsmedicalcenter.org|
304120|NCT02225925|Johns Hopkins University|Daniel Song|410-502-5875|dsong2@jhmi.edu|
304121|NCT02226003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304122|NCT02226120|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
304123|NCT02226159|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
304124|NCT02226172|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
304125|NCT02226198|AstraZeneca Plc|Robin Mukherjee|+46 31 776 1000|robin.mukherjee@astrazeneca.com|
304126|NCT02226549|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
304127|NCT02226562|GlaxoSmithKline|GSK Response Center|866-435-7343||
304128|NCT02226653|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
304129|NCT02226796|University of Minnesota Duluth|Sharyl Samargia-Grivette|218-726-8347|samargia@d.umn.edu|
304130|NCT02226965|Sierra Oncology, Inc.|Corporate Affairs||info@sierraoncology.com|
304131|NCT02227108|MedImmune LLC|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazenea.com|
304132|NCT02227121|Medtronic Cardiac Rhythm and Heart Failure|Griet Wouters|800-328-2518|MedtronicCRMtrials@medtronic.com|
304133|NCT02227147|Dompé|Flavio Mantelli, MD, PhD|02 583831|info@dompe.com|
304134|NCT02227316|UCLA Department of Radiological Sciences|Director of Clinical Research|310-794-8995|schaabane@mednet.ucla.edu|
304135|NCT02227329|Mayo Clinic|Dr. Ryan Hurt|507-284-4461|Hurt.Ryan@mayo.edu|
304136|NCT02227368|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD|+1 302-885-8976|Naeem.Khan@astrazeneca.com|
304137|NCT02227446|METRC|Susan Collins|4105028966|scolli21@jhu.edu|
304138|NCT02227485|Shiraz University of Medical Sciences|Dr. Mahsa Rostami-Chijan|+989111960300|mahsa_59_2007@yahoo.com|
271646|NCT00254566|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
293331|NCT01481740|Department of Women's & Obstetric Anesthesia, IWK Health Centre|Dr. Ronald B George|902-470-6627|rbgeorge@dal.ca|
304139|NCT02227667|Memorial Sloan Kettering Cancer Center|Dr. Neil Segal, MD, PhD|646-888-4187|segaln@mskcc.org|
271647|NCT00254592|University of California Irvine Medical Center|Rita S. MEHTA, MD|(714) 456-5153|rsmehta@uci.edu|
271648|NCT00254982|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
293332|NCT01481779|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293333|NCT01481896|Anderson Orthopaedic Research Institute|Robert H. Hopper, Jr., PhD|(703) 619-4411|research@aori.org|
293334|NCT01482065|Johns Hopkins University|Dr. Seva Polotsky, M.D., PhD|410-550-6386|vpolots1@jhmi.edu|
293335|NCT01482091|Albert Einstein College of Medicine/Children's Hospital at Montefiore|Dr. Daniel Fein|718-920-5312|dfein@montefiore.org|
293336|NCT01482169|Ochsner Clinic Foundation|Dr. Robert Bober|504-842-4135|rbober@ochsner.org|
293337|NCT01482221|AstraZeneca|Sanjeev Pathak||ClinicalTrialTransparency@astrazeneca.com|
293338|NCT01482312|Alcon Research|Director of Alcon Clinical|1-800-241-7629||
293339|NCT01482351|George Mason University|Dr. Kathy C. Richards|(703) 946-3725|kricha11@gmu.edu|
293340|NCT01482429|Federal University of Uberlândia|Liliane Barbosa da Silva Passos|553432182150|lilibsp@yahoo.com.br|
293341|NCT01482715|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
304140|NCT02227693|Eisai Inc.|Eisai Medical Services|1-888-274-2378|esi_medinfo@eisai.com|
304141|NCT02227706|ETHICON Inc|Patricia Schleckser|9082182244|pschleck@its.jnj.com|
304142|NCT02227758|St Jude Medical/Abbott|Clinical Study Director||rdiaz@sjm.com|
304143|NCT02227784|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
304144|NCT02227810|Chang Gung memorial hospital|Dr Huang Chung-Chi|88632118800|yhchen@mail.cgu.edu.tw|5233
304145|NCT02227836|Mayo Clinic|Karthik Ravi, MD|507-284-4824|Ravi.Karthik@mayo.edu|
304146|NCT02227849|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
304147|NCT02227862|Mylan Inc.|David Gillogly, Head of Global Clinical Operations|+1 (724) 4856581|david.gillogly@mylan.com|
304148|NCT02227875|Mylan, Inc.|Keri L. Vaughan, Director Global Clinical Operations, General Medicine||keri.vaughan@mylan.com|
313908|NCT03221738|Massachusetts General Hospital|Anna Schwartzberg|617-724-7161|aschwartzberg@mgh.harvard.edu|
313909|NCT03221764|University of Louisville|Dr. Victor van Berkel|502-588-7600|victor.vanberkel@ulp.org|
313910|NCT03222037|Johnson & Johnson Vision Care, INC.|Chantal Coles-Brennan -PRINCIPAL RESEARCH OPTOMETRIST|1-904-443-3449|CColesb@its.jnj.com|
313911|NCT03222141|Edwards Lifesciences|Edwards THV Clinical Affairs|(949) 250-2500|THV_CT.gov@Edwards.com|
313912|NCT03222349|Aquestive Therapeutics|Director of Clinical Operations|908-941-1887|denis.scheper@aquestive.com|
313913|NCT03222414|Vanderbilt University Medical Center|Laura Sorabella||laura.sorabella@vumc.org|
313914|NCT03222427|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
313915|NCT03222505|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
313916|NCT03222583|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
313917|NCT03223246|Massachusetts General Hospital|Dr. Margaret Samuels-Kalow|6177262000|msamuels-kalow@mgh.harvard.edu|
313918|NCT03223272|UAB|Physician|4346545260|dacalhou@sentara.com|
313919|NCT03223337|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313920|NCT03223649|National Institutes of Health|Jack A. Yanovski, MD, PhD|3014960858|jy15i@nih.gov|
313921|NCT03223909|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
313922|NCT03224130|Cincinnati Children's Hospital Medical Center|Dr. Heidi Sucharew (Biostatistician)|513-803-1920|heidi.sucharew@cchmc.org|
313923|NCT03224182|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
313924|NCT03224234|Emory University|Dr. Umpierrez|404-251-8957|geumpie@emory.edu|
313925|NCT03224299|Becton Dickinson|Erin Zook|224-358-5019|erin.zook@bd.com|
313926|NCT03224325|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|+1
313927|NCT03224351|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
313928|NCT03224390|Duke University|Dr. Eric Green|9196817289|eric.green@duke.edu|
313929|NCT03224403|JNJWorldwide|Andrew Myers, MD|(215) 273-8421 USA EST|AMyers3@its.jnj.com|
313930|NCT03224520|University of Massachusetts Medical School|Rajani Sadasivam|508-856-8923|rajani.sadasivam@umassmed.edu|
313931|NCT03224585|VCU Health|Antonio Abbate, MD, PhD|804-828-0513|antonio.abbate@vcuhealth.org|
313932|NCT03224598|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
313933|NCT03225001|Edwards Lifesciences|Edwards THV Clinical Affairs|(949) 250-2500|THV_CT.gov@Edwards.com|
313934|NCT03225313|Theodor Bilharz Research Institute|Dr Muhammed Hussein|00201001434459|muhamed.hussein@gmail.com|
313935|NCT03225573|AIn Shams University|Professor Ali Gamal Zohni|+2 01004931448|zohniali@gmail.com|
313936|NCT03225599|Northwell Health|Administrative Director, Clinical Research|(516) 881-7064|dcannone1@northwell.edu|
313937|NCT03225859|Minneapolis VA Medical Center|Shannon Kehle-Forbes, PhD|612-467-4772|Shannon.Kehle-Forbes@va.gov|
313938|NCT03226223|New York State Psychiatric Institute|Dr. Jermaine Jones|6467746113|jermaine.jones@nyspi.columbia.edu|
313939|NCT03226249|Northwestern University, Feinberg School of Medicine|Jane N. Winter, M.D.|(312) 695-4538|j-winter@northwestern.edu|
313940|NCT03226275|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
313941|NCT03226353|CooperVision|Jose A. Vega OD MSc FAAO|(925) 621- 3761|javega@coopervision.com|
313942|NCT03226366|Intermountain Healthcare|Director, Office of Research|(801) 408-1991|officeofresearch@imail.org|
293342|NCT01482767|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
313943|NCT03226392|Novartis pharmaceutical|Study Director|862-778-8300|Novartis.email@novartis.com|
313944|NCT03226457|University of Dundee|Dr Natalie Mordi (Principle Investigator)|+ 44 (0) 1382 383 667|n.a.mordi@dundee.ac.uk|
271649|NCT00254995|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
293343|NCT01482819|Johnson & Johnson Vision Care|Daria Wicks, Senior Clinical Research Manager|904-443-1391|RA-ClnclStds@its.jnj.com|
293344|NCT01482884|AstraZeneca|Mark Berner Hansen|+46 31 776 4794|Mark.Berner.Hansen@astrazeneca.com|
293345|NCT01482910|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
293346|NCT01482962|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
293347|NCT01483118|Columbia University, Department of OBGYN|Roger A. Lobo M.D.|212-3056337|ral35@columbia.edu|
293348|NCT01483144|Cancer Prevention Pharmaceuticals|Michelle Boytim|520-908-7774|mboytim@canprevent.com|
304149|NCT02228096|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
304150|NCT02228174|Gynesonics|Taraneh G. Farazi, Ph.D. (Vice President, Clinical Affairs)|650-216-3878|tfarazi@gynesonics.com|
304151|NCT02228395|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
304152|NCT02228408|New York University Medical Center|David Charytan|(646) 501-9086|david.charytan@nyulangone.org|
304153|NCT02228460|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
304154|NCT02228499|The George Washington University|Dr. Seema Agrawal|202 699 1648|seema300@yahoo.com|
304155|NCT02228564|Becton Dickinson|Spark Yamanoglu|480-597-8604|Spark.yamanoglu@bd.com|
304156|NCT02228590|Sunovion Pharmaceuticals Inc.|CNS Medical Director|866-503-6351|clinicaltrialdisclosure@sunovion.com|
304157|NCT02228681|GOG Foundation|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
304158|NCT02228720|Intersect ENT|James Stambaugh|6506412103|jstambaugh@intersectent.com|
304159|NCT02228824|University of Pittsburgh|Dr. Saul Shiffman|412-567-1761|shiffman@pinneyassociates.com|
304160|NCT02228967|San Diego State University Research Foundation|Mark B. Reed/Professor and Interim Associate Dean|619-594-6664|mreed@sdsu.edu|
304161|NCT02228980|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
304162|NCT02229214|VIVUS Inc.|Craig Peterson, Sr. Director, Clinical Research|650-934-5200|ClinicalTrials@vivus.com|
304163|NCT02229227|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
304164|NCT02229318|The Children's Hospital of Philadelphia|Dr Christina Bergqvist, M.D., Study Principal Investigator|+1 215 590 1719|Bergqvist@Email.CHoP.Edu|
304165|NCT02229383|AstraZeneca|Global Clinical Leader|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
304166|NCT02229396|AstraZeneca|Global Clinical Leader|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
304167|NCT02229461|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
304168|NCT02229474|Northumbria Healthcare NHS Foundation Trust|Professor Richard Walker|+441912932709|richard.walker@nhct.nhs.uk|
304169|NCT02229487|Ramathibodii Hospital, Mahidol University|Sirimon Reutrakul|66922011647|sreutrakul@yahoo.com|708
304170|NCT02229513|Baylor University Medical Center|Dr. Janice Mitchell, PI|713-705-6240|janicemitchellmd@gmail.com|
304171|NCT02229539|Mayo Clinic|Robert C. Miller, MD, MS|904-953-1003|miller.robert@mayo.edu|
304172|NCT02229552|SUNY Buffalo|Leonard H Epstein|716-826-3400|ckk@buffalo.edu|
304173|NCT02229851|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
304174|NCT02229864|Abbott Vascular|Latania Chura|503-935-3002|latania.chura@abbott.com|
304175|NCT02230085|Fisher & Paykel Healthcare|Clinical Research Scientist|+6495740123|cpaptrial@fphcare.co.nz|
304176|NCT02230306|University of Pittsburgh Cancer Institute|Melissa Burgess, MD|412-623-7277|burgessma@upmc.edu|
304177|NCT02230332|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.531.3584|dmauger@psu.edu|
304178|NCT02230384|University of Pittsburgh|K.N. Roy Chengappa, MD / Principal Investigator|412-246-5006|chengappakn@upmc.edu|412
304179|NCT02230527|Cleveland Clinic|Joseph Campbell, MD|216-444-9836|campbej10@ccf.org|
304180|NCT02230540|Rigshospitalet, Department of Urology|Per Bagi, MD|+45 3545 8310|Per.bagi@regionh.dk|
304181|NCT02230566|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
271650|NCT00255008|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
304182|NCT02230579|Medicines for Malaria Venture|Dr Cristina Donini - Associate Director|00 41 22 555 03 12|doninic@mmv.org|
304183|NCT02230670|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
304184|NCT02230683|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
304185|NCT02230696|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
304186|NCT02230761|Topokine Therapeutics, Inc.|Chief Scientific Officer|617 203 2034|CSO@topokine.com|
304187|NCT02230904|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
304188|NCT02230956|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
304189|NCT02230995|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
304190|NCT02231086|Amsterdam UMC|Prof. dr. P.J. Tanis|+31-20-4444444|p.j.tanis@amsterdamumc.nl|
304191|NCT02231164|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
304192|NCT02231177|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
304193|NCT02231580|Ipsen|Vice President Early Development & Clinical Pharmacology||clinical.trials@ipsen.com|
304194|NCT02231749|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
304195|NCT02231918|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
304196|NCT02232009|GE Healthcare|Yvonne Celestial|+33 130709133|MarieYvonne.CELESTIAL@ge.com|
304197|NCT02232022|Northwell Health|Jeffrey M. Katz|516-562-3062|jkatz2@northwell.edu|
304198|NCT02232061|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
304199|NCT02232074|Boston Medical Center|Tracy Battaglia|617.638.8036|tracy.battaglia@bmc.org|
271651|NCT00255034|Merck, Sharp & Dohme Corp.|Senior Vice Predsident, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
293349|NCT01483183|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
293350|NCT01483352|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
293351|NCT01483378|NYU Langone Medical Center|Dr. Elisabeth J. Cohen|212-263-3262|elisabeth.cohen@nyumc.org|
293352|NCT01483560|University of Glasgow|Prof John Petrie|+44 141 330|John.Petrie@glasgow.ac.uk|3325
293353|NCT01483599|Janssen Research & Development, LLC|Senior Director, Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
293354|NCT01483625|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
293355|NCT01483651|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
293356|NCT01483690|Therapeutic Advancements of Childhood Leukemia and Lymphoma|Clinical Research Coordinator, Consortia|323-361-5312|rleong@chla.usc.edu|
293357|NCT01483807|VA SALT LAKE CITY HEALTHCARE SYSTEM|Dr. Julie Wambaugh|8015821565|julie.wambaugh@health.utah.eduj|1363
293358|NCT01483820|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
304200|NCT02232087|Quotient Clinical Ltd|Pui Leung|44(0)115 974 9000|Pui Leung <Pui.Leung@quotientclinical.com>|
304201|NCT02232126|University of Southern California|Dr. Susan Enguidanos|213-740-9822|enguidan@usc.edu|
271652|NCT00255047|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
304202|NCT02232178|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
304203|NCT02232243|University of Kentucky|Peng Wang|(859) 257-4488|p.wang@uky.edu|
304204|NCT02232282|Loyola University Chicago|Larissa Bresler, MD|7086433827|lbresler@lumc.edu|
304205|NCT02232425|Ixchelsis Limited|Chief Medical Officer|44(0)1227-832760|ian.osterloh@ixchelsis.com|
304206|NCT02232698|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
304207|NCT02232802|Chemi SpA (Part of Italfarmaco Group)|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
304208|NCT02232893|Tsumura USA Inc|Yu Tanaka|609-799-2083|Yu Tanaka <tanaka_yuu@mail.tsumura.co.jp>|
304209|NCT02232984|Boston Scientific|Eszter Pais|6515825307|eszter.pais@bsci.com|
304210|NCT02233101|Rush University Medical Center|Craig J. Della Valle, MD|312-432-2350|craigdellavalle@rushortho.com|
304211|NCT02233296|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
304212|NCT02233309|University of Nebraska Children's Hospital & Medical Center|Jessica K. Goeller, DO|(402) 955-4303|JGoeller@childrensOmaha.org|
304213|NCT02233413|Massachusetts General Hospital|Dr. Rajiv Gupta|617-726-0369|rgupta1@mgh.harvard.edu|
304214|NCT02233478|Center for Human Nutrition, Department of Medicine, UCLA David Geffen School of Medicine|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|61987
304215|NCT02233517|VAORD|Elizabeth Van Voorhees|(919) 286-0411|elizabeth.vanvoorhees@va.gov|6435
304216|NCT02233530|University of Ibadan, Ibadan, Nigeria|Dr Adesola Ogunniyi|+2348038094173|aogunniyi892@gmail.com|
304217|NCT02233543|Novartis Pharmaceuticals|Study Director|862-778-8300||
304218|NCT02233647|University of Kentucky|William W. Stoops, Ph.D.|859-257-5388|william.stoops@uky.edu|
304219|NCT02233738|Ralph H. Johnson VA Medical Cneter|Dr. Elizabeth Santa Ana|843-789-7168|Elizabeth.Santaana2@va.gov|
304220|NCT02233751|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
304221|NCT02233803|GlaxoSmithKline|GSK Response Center|866-435-7343||
304222|NCT02233842|National Cancer Institute (NCI)|Dr. Stephanie Land|240-276-6946|stephanie.land@nih.gov|
304223|NCT02233946|Boston Children's Hospital|Dr. Sion Kim Harris|8572184304|sion.harris@childrens.harvard.edu|
304224|NCT02233985|Instituto Mexicano del Seguro Social|Dr. Gloria Patricia Sosa-Bustamante|01 52 4777174800|patriciasosab@hotmail.com|31828
304225|NCT02233998|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
304226|NCT02234063|Icahn School of Medicine at Mount Sinai|Dr. Carol R. Horowitz|212-659-9564|carol.horowitz@mssm.edu|
304227|NCT02234115|Foresee Pharmaceuticals co., Ltd.|Dr. John Mao||john.mao@foreseepharma.com|
304228|NCT02234128|Lung Bioengineering Inc.|Michael Roberts, Director Regulatory Affairs|2406502261|mroberts@lungbioengineering.com|
304229|NCT02234141|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
304230|NCT02234180|Memorial Sloan-Kettering Cancer Center|Yelena Y. Janjigian MD|646-888-4186|janjigiy@mskcc.org|
304231|NCT02234284|University of California San Francisco|Dr. David Thom|415-206-2278|David.Thom@UCSF.edu|
304232|NCT02234310|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
304233|NCT02234323|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
304234|NCT02234362|MGH Center for Women's Mental Health|Dr. Marlene Freeman|617-723-6403|mfreeman@partners.org|
304235|NCT02234427|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
304236|NCT02234479|University of Maryland|Elizabeth Nichols, MD|410-328-2324|enichols1@umm.edu|
304237|NCT02234570|University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
304238|NCT02234583|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
304239|NCT02234596|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian,|646-888-4186|janjigiy@mskcc.org|
304240|NCT02234622|Roudebush VA Medical Center|Louanne Davis Psy.D.|317-710-1338|louannedavis52@gmail.com|
304241|NCT02234713|Hospital for Sick Children|Dr. Ann Yeh|416-813-7353|ann.yeh@sickkids.ca|207353
304242|NCT02234752|George Washington University, Washington, DC|Maju Koola|678-200-8613|majumkoola@gmail.com|
304243|NCT02235064|Cooper University Health System|Dr. Richard L Fischer|856-342-2491|fischer-richard@cooperhealth.edu|
304244|NCT02235077|Duke Clinical Research Institute|Adrian Hernandez, MD|919 668 7515|adrian.hernandez@duke.edu|
304245|NCT02235285|The Department of Plastic Surgery, Winners Clinic|Dr. Cheol Hwan Kim|.+82.2.511.9446|winners511@naver.com|
271653|NCT00255086|VA Palo Alto Health Care System|Wes Ashford, PhD, MD|650-493-5000|wes.ashford@va.gov|
271654|NCT00255125|Kansas City VA Medical Center|Dr. Peter Van Veldhuizen|816-861-4700|peter.vanveldhuizen@va.gov|
293359|NCT01483924|ApoPharma Inc.|Fernando Tricta, MD|Phone: 416-401-7332|ftricta@apopharma.com|
293360|NCT01483937|BalanceSense LLC|Karen L. Atkins PhD PT|407 625 9680|atkins.balancesense@gmail.com|
293361|NCT01483963|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
293362|NCT01484028|Vistakon, Johnson and Johnson Vision Care|Dr. Michael Mayers, O.D., FAAO, Senior Research Optometrist|1 904 443 3252|mmayers@its.jnj.com|
293363|NCT01484041|Georgetown University|Dr. Claudine Isaacs|2024443677|isaacsc@georgetown.edu|
293364|NCT01484054|Johnson & Johnson Vision Care|Michael Mayers, OD, FAAO|904-443-3252|mmayers@its.jnj.com|
293365|NCT01484132|New England Research Institutes|Felicia Trachtenberg, Principal Research Scientist|617-972-3120|ftrachtenberg@neriscience.com|
293366|NCT01484197|Novartis Pharmaceuticals|Study Director|862-778-8300||
293367|NCT01484275|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
293368|NCT01484288|CVRx|Vice President, Global Clinical Research|763-416-2876|egalle@cvrx.com|
304246|NCT02235298|University of Miami|Gianluca Iacobellis, MD|305-243-3636|giacobellis@miami.edu|
304247|NCT02235311|University of Missouri - Columbia|Ashley McCormick, PharmD, BCPS|573-771-7798|ausmusash@health.missouri.edu|
304248|NCT02235454|Duke University|Sanjay Asrani|919-684-8656|sanjay.asrani@duke.edu|
313945|NCT03226652|Imperial College London|Professor M Cowie|+44 (0)207 3518856|m.cowie@imperial.ac.uk|
313946|NCT03226691|National Heart Lung and Blood Institute|John Tisdale|+1 301 402 6497|johntis@nhlbi.nih.gov|
313947|NCT03226769|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
313948|NCT03226899|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
313949|NCT03227445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313950|NCT03227692|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
313951|NCT03227861|Janssen Scientific Affairs, LLC|Senior director medical leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
313952|NCT03228017|NYU Langone|Dr. Michael Garshick|212-263-0855|michael.garshick@nyulangone.org|
313953|NCT03228212|Johnson & Johnson Vision Care Inc.|John Buch -SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
313954|NCT03228420|Nevro Corp.|Donald Middlebrook|(650) 433-2218|don.middlebrook@nevro.com|
314349|NCT03292952|KemPharm|Gerald Orehostky|321-250-3699|gorehostky@kempharm.com|
314350|NCT03293238|Andrews Research & Education Foundation|Dr. Joshua Hackel|850-916-8796|jghackelmd@yahoo.com|
314351|NCT03293394|Spedali Civili di Brescia|Prof. Barbara Borroni|+39 0303995631|bborroni@inwind.it|
314352|NCT03293485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
314353|NCT03293654|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
314354|NCT03294213|Ambu A/S|Anna Lundgaard|+4529643748|aclu@ambu.com|
282436|NCT00855582|Eli Lilly and Company|Chief Medical Office|800-545-5979||
293369|NCT01484340|Johns Hopkins University School of Medicine|Dr. Jonathan E. Golub|443-287-2969|jgolub@jhmi.edu|
293370|NCT01484431|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
293371|NCT01484496|GlaxoSmithKline|GSK Response Center|866-435-7343||
293372|NCT01484561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293373|NCT01484626|Loyola University Medical Center|Scott Smith, M.D., Ph.D.|708-327-3142|ssmith8@lumc.edu|
293374|NCT01484652|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
293375|NCT01484834|UNESC|Dr. Antonio Jose Grande|04834312500|grandeto@unesc.net|2571
293376|NCT01484873|Vanderbilt University|Ashley Shoemaker|615-343-8116|ashley.h.shoemaker@vanderbilt.edu|
293377|NCT01484912|Sinphar Pharmaceutical Co., Ltd. Taiwan|Justine Tang||justine@sinphar.com.tw|
293378|NCT01484938|Alcon Research, Ltd.|Jami Kern, Ph.D., Global Medical Affairs|800-862-5266||
293379|NCT01484951|Alcon Global Medical Affairs|Abayomi Ogundele, Pharm.D|1-888-451-3937||
293380|NCT01484977|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
293381|NCT01485055|Nationwide Childrens Hospital|Rajinder Bajwa|6147222000|rajinder.bajwa@nationwidechildrens.org|
293382|NCT01485094|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
293383|NCT01485120|GE Healthcare|Jeff Conner|414-721-2423||
293384|NCT01485172|GlaxoSmithKline|GSK Response Center|866-435-7343||
293385|NCT01485354|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
293386|NCT01485380|Massachusetts General Hospital|Dr. Oluwaseun Johnson-Akeju|6177247200|oluwaseun.akeju@mgh.harvard.edu|
293387|NCT01485393|MGH|Dr. Johnson-Akeju|6177247200|ojohnsonakeju@partners.org|
293388|NCT01485536|The University of Texas (UT) MD Anderson Cancer Center|Yasuhiro Oki, Associate Professor, Lymphoma/Myeloma|713-792-7734|CR_Study_Registration@mdanderson.org|
293389|NCT01485588|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
293390|NCT01485614|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
271655|NCT00255151|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
271656|NCT00255164|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
293391|NCT01485627|UNIVERSITY OF ROCHESTER DEPARTMENT OF FAMILY MEDICINE|Ronald Epstein MD|5855069484|ronald_epstein@urmc.rochester.edu|
293392|NCT01485640|Sunovion|Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
293393|NCT01485770|Jazz Pharmaceuticals|Director, Disclosure & Transparency|(215) 970-7145|ClinicalTrialDisclosure@JazzPharma.com|
293394|NCT01485796|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
293395|NCT01485887|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293396|NCT01485991|Janssen IDV - Janssen Dx|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
293397|NCT01486043|Children's Hospital Los Angeles|Dr. Jamie Wood|323-361-7388|jawood@chla.usc.edu|
293398|NCT01486199|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
293399|NCT01486238|Valley Retina Institute, PA|Victor Gonzalez, MD|956-631-8875|research@vritx.com|
293400|NCT01486264|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
304249|NCT02235493|Alexion Pharmaceuticals|Senior Medical Director, Clinical Development|203-272-2596|clinicaltrials@alxn.com|
304250|NCT02235831|Alcon Research, Ltd.|Sr. Global Brand Lead, GCRA, Vision Care|1-888-451-3937||
304251|NCT02235870|Obalon Therapeutics, Inc.|Amy VandenBerg, Vice-President, Clinical Affairs and Regulatory Affairs|760.795.6551|avandenberg@obalon.com|
304252|NCT02235987|Strongbridge Biopharma|Fredric Cohen, MD|610-254-9200|f.cohen@strongbridgebio.com|
304253|NCT02236130|University of Mississippi Medical Center|Madhankumar Sathyamoorthy|6018157066|msathyamoorthy@umc.edu|
304254|NCT02236338|Virginia Commonwealth University|Dr. Malcolm Sydnor|(804) 828-0534|malcolm.sydnor@vcuhealth.org|
304255|NCT02236520|Vanderbilt University Medical Center|Alp Ikizler|(615) 343-7592|alp.ikizler@vumc.org|
304256|NCT02236559|McGovern Medical School at The University of Texas Health Science Center at Houston|Dr. Pratik Doshi, MD||pratik.b.doshi@uth.tmc.edu|
304257|NCT02236598|Duke University Health System|Ranee Chatterjee Montgomery, M.D.||ranee.chatterjee@duke.edu|
304258|NCT02236611|GlaxoSmithKline|GSK Response Center|866-435-7343||
304259|NCT02236767|Hartford Hospital|Gretchen Diefenbach|860-545-7396|gretchen.diefenbach@hhchealth.org|
304260|NCT02236988|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
304261|NCT02237001|Smith+Nephew, Inc.|Kirsten Wall|720-338-9460|Kirsten.wall@smith-nephew.com|
304262|NCT02237092|Tver Regional Perinatal Center|Dr. Alexandr Ronenson|011-7-4822-776213|ronensonam@gmail.com|
304263|NCT02237118|Clinique Mutualiste du Medoc|Dr Anne Solanilla|+33 5 56 73 11 43|annasolanilla@yahoo.fr|
304264|NCT02237157|RenovoRx|Charles Li|(650) 284-4433|charles@renovorx.com|
304265|NCT02237196|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
304266|NCT02237417|Otsuka|Wilt, Timothy|240.683.3095|timothy.wilt@otsuka-us.com|
304267|NCT02237898|Yale School of Medicine|Dr. Megan Smith|(203) 764-8655|megan.smith@yale.edu|
304268|NCT02237911|University of Pittsburgh|Dr. Sara Piva|(412) 383-6712|spiva@pitt.edu|
304269|NCT02237950|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
304270|NCT02237989|Eskisehir Osmangazi University|Dr. Fulya Bakılan|+905057737335|fulyabakilan@gmail.com|
304271|NCT02238028|Fudan University|Dr. Haidong Kan|+86-021-54237908|kanh@fudan.edu.cn|
304272|NCT02238067|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
304273|NCT02238080|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
304274|NCT02238379|Yale University|Dr. Helena Rutherford|203-737-3408|helena.rutherford@yale.edu|
304275|NCT02238483|AstraZeneca|Ziad Taib|+46 708 46 73 56|ziad.taib@astrazeneca.com|
304276|NCT02238626|MediciNova, Inc.|Director, Scientific Affairs|8583444535|makhay@medicinova.com|
304277|NCT02238782|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
304278|NCT02238847|Boston Scientific Corporation|Lina Ginnetti, Clinical Endoscopy Director|508-683-4512|lina.ginnetti@bsci.com|
304279|NCT02238925|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency||tom.chmielewski@jazzpharma.com|
304280|NCT02238977|University of Arkansas for Medical Sciences|Pedro Delgado, M.D.|501-526-8100|pldelgado@uams.edu|
304281|NCT02239094|Depression Evaluation Service (New York State Psychiatric Institute)|David J. Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
304282|NCT02239120|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
304283|NCT02239224|aTyR Pharma|Gennyne Walker|858 731 8389|clinicaltrials@atyrpharma.com|
304284|NCT02239263|cochlear|Lori O'Neill Director of Research|8005235798|loneill@cochlear.com|
304285|NCT02239289|Université du Québec à Trois-Rivières|Martin Descarreaux|1-819-376-5011|martin.descarreaux@uqtr.ca|3791
304286|NCT02239328|Washington University|Dr. Benjamin Kozower|314-362-8089|kozower@wustl.edu|
304287|NCT02239380|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
304288|NCT02239510|TriHealth Hatton Research Institute|Jenni Steinbrunner|513-862-4033|jenni_steinbrunner@trihealth.com|
304289|NCT02239536|Seoul ST. Mary's hospital|Bo-In Lee|821083671055|gidoc4u@gmail.com|
304290|NCT02239562|University of Miami|Christopher O'Brien|305-243-2329|CObrien@med.miami.edu|
304291|NCT02239601|CancerCare Manitoba|Marshall Pitz|2044751431|Mpitz@cc.umanitoba.ca|
304292|NCT02239640|Medtronic|Oscar Bolanos|949-527-0822|Oscar.bolanos@medtronic.com|
304293|NCT02239679|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|Anna.Houlihan@sunpharma.com|
304294|NCT02239692|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
304295|NCT02239744|Department of Environmental Health, School of Public Health, Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
304296|NCT02239770|Penn State College of Medicine|Dr. Patricia Sue Grigson|717-531-5772|psg6@psu.edu|
271657|NCT00255177|VGX Pharmaceuticals, LLC|Mary Giffear, Sr. Clinical Scientist|267 440 4220|mgiffear@inovio.com|
293401|NCT01486316|Medtronic, Inc|Rachael Rose, Clinical Research Specialist|763-526-2332|rachael.k.rose@medtronic.com|
293402|NCT01486446|Xenon Pharmaceuticals Inc.|Dr. Y Paul Goldberg|604 484 3300|pgoldberg@xenon-pharma.com|
293403|NCT01486615|B. P. Koirala Institute of Health Sciences|Dr Krishna Pokharel|0977-9841986321|drkrishnapokharel@gmail.com|
293404|NCT01486758|Washington University in St. Louis|Dr. Avraham Beigelman (PI)|314-454-2694|beigelman_a@kids.wustl.edu|
293405|NCT01486784|Abramson Cancer Center at the University of Pennsylvania|Dr. Noelle Frey||noelle.frey@pennmedicine.upenn.edu|
293406|NCT01486810|New York Psychiatric Institute|Dr. John Mariani|646-774-8181|John.mariani@nyspi.columbia.edu|
293407|NCT01486927|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
293408|NCT01486966|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
293409|NCT01487161|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
293410|NCT01487200|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
304297|NCT02239939|WFSM|Dr. Barbara Nicklas|3367138569|bnicklas@wakehealth.edu|
304298|NCT02239978|Salt Lake City VA|Dr. Daniel Peterson|6028242279|daniel.peterson1@asu.edu|
304299|NCT02240030|Acorda Therapeutics|Charles Oh|914-326-5455|coh@acorda.com|
304300|NCT02240108|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
304301|NCT02240121|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
304302|NCT02240186|Mayo Clinic|Dr. Kenton Kaufman, Principal Investigator|507-284-2262|kaufman.kenton@mayo.edu|
304303|NCT02240329|University of Florida|Erin Pearson Ph.D CCC/SLP|352-339-4100|epearson@ufl.edu|
304304|NCT02240368|University of Foggia|Alberto Sciusco||alberto.sciusco@gmail.com|
304305|NCT02240589|Indiana University School of Medicine|Flora Hammond, MD|317-329-2106|flora.hammond@rhin.com|
304306|NCT02240628|The University of Texas Health Science Center at Houston|Dr. Samia Khalil|713-500-6242|Samia.N.Khalil@uth.tmc.edu|
304307|NCT02240654|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
304308|NCT02240667|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
304309|NCT02240680|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
304310|NCT02240693|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
304311|NCT02240706|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
304312|NCT02240810|Boston Scientific|Director, Clinical Trials|508-683-6678|peter.maurer@bsci.com|
304313|NCT02241486|Loyola University Medical Center|Dr. Joseph R. Holtman|7082168563|jholtman@luc.edu|
304314|NCT02241512|UT Southwestern|Dr. David Troendle|214456-8000|david.troendle@utsouthwestern.edu|
304315|NCT02241655|Washington University|Dr. Michael Avidan, MBBCh|314-332-7265|avidanm@wustl.edu|
304316|NCT02241720|Huntsman Cancer Institute|Kimberlee Taylor|801-213-5673|Kimberlee.Taylor@hci.utah.edu|
304317|NCT02241733|Edward Hines Jr., VA Hospital|Eileen Collins RN, PhD, Research Nurse Scientist|312-413-5621|ecollins@uic.edu|
304318|NCT02241785|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
304319|NCT02241889|Oregon Health and Science University|Dr. Jessica Castle|503-494-7072|castleje@ohsu.edu|
304320|NCT02241967|Ralph H. Johnson VA Medical Center|Jeffrey Borckardt, Ph.D|843-792-3295|Jeffrey.Borckardt@va.gov|
304321|NCT02242019|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
304322|NCT02242045|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
304323|NCT02242201|Mayo Clinic|Dr. Rebecca L. Johnson|507-266-2049|Johnson.Rebecca1@mayo.edu|
304324|NCT02242305|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
304325|NCT02242487|Acorda Therapeutics|Dr. Charles Oh, Senior Vice President - Clinical Development|914-326-5455|coh@acorda.com|
304326|NCT02242630|Keesler Medical Center|Matthew B. Carroll|228-376-3629|matthew.carroll.1@us.af.mil|
304327|NCT02242643|GlaxoSmithKline|GSK Response Center|866-435-7343||
304328|NCT02242903|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
304329|NCT02242942|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
304330|NCT02242981|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
304331|NCT02242994|Children's National|Dr. Axel Krieger|2024761284|akrieger@childrensnational.org|
304332|NCT02243007|Massachusetts General Hospital|David P. Ryan, MD|6177240245|dpryan@mgh.harvard.edu|
304333|NCT02243020|MicroTransponder Inc.|VP Clinical Affairs|5123714160|brent@microtransponder.com|
304334|NCT02243046|Global Research Consultants|Dr. Franklin Garcia-Godoy|954-888-9102|fgarciagodoy@gmail.com|
304335|NCT02243176|ASTRAZENECA INVESTMENT (CHINA) CO., LTD.|Xia, Zhang|+86 21 6030 2288|Xia.Zhang@astrazeneca.com|2035
304336|NCT02243202|Janssen Research & Development, LLC|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
304337|NCT02243280|AbbVie|Global Medical Services|800-633-9110||
304338|NCT02243293|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
304339|NCT02243371|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
304340|NCT02243527|University of British Columbia|Dr. Jordan A. Guenette|604.682.2344|Jordan.guenette@hli.ubc.ca|62129
304341|NCT02243579|Fred Hutchinson Cancer Research Center|Asa Davis|206-667-5300|akdavis@fredhutch.org|
304342|NCT02243605|Institut Bergonie|Pr Italiano Antoine, Department of Medical Oncology|0524071947|a.italiano@bordeaux.unicancer.fr|
293411|NCT01487265|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
293412|NCT01487525|University of Iowa|Dr. Neil Segal|3193358204|segal-research@uiowa.edu|
293413|NCT01487577|Children's Hospital of Pittsburgh of UPMC|Randy M. Windreich, MD|412-692-5225|randy.windreich@chp.edu|
271658|NCT00255190|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
293414|NCT01487668|Department of Veterans Affairs, VA Ann Arbor Healthcare System|Amy M. Kilbourne, PhD, MPH|734-845-3452|amy.kilbourne@va.gov|
293415|NCT01487863|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
304343|NCT02243696|BIOTRONIK, Inc.|Clinical Studies Engineer Manager|1-800-547-0394|crystal.miller@biotronik.com|
304344|NCT02243865|Chordate|Dr Jan-Åke Åkesson|+46 8 40015586|info@chordate.com|
304345|NCT02243943|LUMC|Prof Dr A. Dahan|+31 71 526 2301|a.dahan@lumc.nl|
304346|NCT02244424|Michigan State University, College of Nursing|Dr. Mildred A. Horodynski|(517) 355-6744|millie@msu.edu; silkk@msu.edu|
304347|NCT02244580|Biontech Diagnostics GmbH|Dr. Michael Oed|+49 6131/ 6358030|michael.oed@theracode.de|
304348|NCT02244619|Kettering Health Network|Skip Hickman, RPH|(937) 762-1339|skip.hickman@ketteringhealth.org|
313955|NCT03228433|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313956|NCT03228836|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
313957|NCT03228914|The University of Texas Health Science Center at Houston|William C. Yao, MD|713-500-5410|william.c.yao@uth.tmc.edu|
313958|NCT03229109|Maale Carmel Mental Health Center|Anatoly Kreinin|(+972) -4-8559315|kranata@gmail.com|
313959|NCT03229252|Spyryx Biosciences|Dr. Rob Tarran|919-966-7052|rtarran@spyryxbio.com|
313960|NCT03229486|Pusan National University Yangsan Hospital|Professor|0553602756|anesktk@pusan.ac.kr|
313961|NCT03229759|Becton Dickinson|Erin Zook|224-358-5019|erin.zook@bd.com|
313962|NCT03230175|TissueTech, Inc.|Nick McCoy, Vice President Clinical Operations|7867340023|nmccoy@tissuetechinc.com|
313963|NCT03230864|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
313964|NCT03231228|B. Braun Medical Inc.|Diana Valencia MD|610-596-2875|diana.valencia@bbraunusa.com|
313965|NCT03231345|University Medical Center of Southern Nevada|Dr. Zitek|702-383-7885|zitek10@gmail.com|
313966|NCT03231371|University of Michigan|Bryan Goldstein||Bryan.Goldstein@cchmc.org|
313967|NCT03231709|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313968|NCT03231800|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
313969|NCT03231917|White River Junction VAMC|Dr Joseph Anderson|8022959363|joseph.anderson@dartmouth.edu|
313970|NCT03231943|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313971|NCT03231969|Faes Farma|Nieves Fernández, MD, PhD|+34 94 481 83 00|nfernandez@faes.es|
313972|NCT03232281|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
313973|NCT03232333|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
313974|NCT03232567|Altimmune|Stephanie Holland, Clinical Project Manager|240-654-1450|sholland@altimmune.com|40
313975|NCT03232580|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
313976|NCT03232645|Boston Scientific|Clinical Trial Manager|00393421994999|alberto.belligoli@bsci.com|
313977|NCT03232749|University of Florida|MaryBeth Horodyski, Ed.D., ATC, LAT, FNATA|352-273-7074|horodmb@ortho.ufl.edu|
313978|NCT03232827|UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR|Dr. Theodore Wagener|405-271-4407|theodore-wagener@ouhsc.edu|50486
313979|NCT03232983|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
313980|NCT03233009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313981|NCT03233217|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
313982|NCT03233230|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
313983|NCT03233308|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
313984|NCT03233438|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
313985|NCT03233529|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
313986|NCT03233737|University of Pennsylvania, School of Dental Medicine|Elliot V Hersh, DMD, Ph.D., Director Clinical Pharmacology Research|215-898-9686|evhersh@pobox.upenn.edu|
313987|NCT03234036|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313988|NCT03234374|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
313989|NCT03234465|Oragenics, Inc.|Dr. Alan Jolyn|+ 1 813-286-7900|info@oragenics.com|
313990|NCT03234608|Portland State University|Dr. Christina Nicolaidis|503-725-9603|nicol22@pdx.edu|
313991|NCT03235050|AstraZeneca|AstraZenenca Information Center|1-877-240-9479|information.center@astrazeneca.com|
313992|NCT03235089|CooperVision, Inc|Lee Hall, BSc, PhD, MCOptom, FBCLA|925 251 6684|lhall@coopervision.com|
313993|NCT03235115|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
313994|NCT03235154|Community Research Initiative of New England|Amy E. Colson, MD|6175021700|acolson@crine.org|
313995|NCT03235180|Mayo Clinic|Shigao Chen, Ph.D.|507-284-3703|Chen.Shigao@mayo.edu|
313996|NCT03235284|Federal University of Bahia - FUBA|Dr.Pietro Araújo|71992520519|pietro.araujo@ufba.br|
313997|NCT03235349|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
313998|NCT03235414|Cincinnati Children's Hospital Medical Center; Department of Radiology|Dr. Andrew Trout|513-803-3004|andrew.trout@cchmc.org|
313999|NCT03235479|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
314000|NCT03235726|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314001|NCT03235817|Anesthesiology|Dr. Yvon Bryan, MD, Associate Professor|336-716-2329|ybryan@wakehealth.edu|
314002|NCT03236168|London School of Hygiene and Tropical Medicine|Dr Michael Marks|02079272566|michael.marks@lshtm.ac.uk|
314003|NCT03236246|Keryx|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
314004|NCT03236311|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
271659|NCT00255346|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD/Department Chair|713-792-7026|hkantarjian@mdanderson.org|
293416|NCT01487954|Case Comprehensive Cancer Center AND Summa Health System|Dr. Charles A. Kunos, MD, PhD|(330) 375-3557|kunosc@summahealth.org|
293417|NCT01488019|Mylan UK|Dik Ng, PhD, Director Clinical Science|+44 1304626895|dik.ng@mylan.co.uk|
293418|NCT01488071|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
293419|NCT01488097|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|475-230-2596|clinicaltrials@alexion.com|
293420|NCT01488188|International Vaccine Institute|Dr. Jae Seung Yang|82-2-881-1198|jsyang@ivi.int|
293421|NCT01488279|Frist Clinic Endocrinology|Dr. Annis Marney|615-403-8398|annis.marney@hcahealthcare.com|
293422|NCT01488318|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|414-647-5554|stadtermanbm@upmc.edu|
293423|NCT01488370|Loma Linda University Department of Anesthesiology|Elizabeth Ghazal, MD|909-558-4475|EGhazal@llu.edu|
271660|NCT00255684|Wake Forest|Gordon L. Phillips|604.875.4111|gophilli@wakehealth.edu|67806
293424|NCT01488409|Massachusetts General Hospital|Steven K. Grinspoon|617-724-9109|sgrinspoon@partners.org|
304349|NCT02244840|Seoul National University Hospital|Professor|82-2-2072-2901|kjparkmd@plaza.snu.ac.kr|
304350|NCT02244918|University of Kansas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
304351|NCT02244957|UCSD|Dillon Gilbertson|8582452155|dcgilbertson@health.ucsd.edu|
304352|NCT02244996|Hong Kong Polytechnic University|Dr. Henry Chan|85227667937|henryhl.chan@polyu.edu.hk|
304353|NCT02245217|Huntsman Cancer Institute|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
304354|NCT02245360|Abbott|Dmitri Kazei MD, PhD|+31 294477008|dmitri.kazei@abbott.com|
304355|NCT02245412|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
271661|NCT00255723|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
304356|NCT02245516|Kala Pharmaceuticals Inc|VP, Clinical Development||results004@kalarx.com|
304357|NCT02245568|TauRx Therapeutics Ltd|Dr. Diane Downie|+44 1224440905|info@taurx.com|
304358|NCT02245620|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
304359|NCT02245737|AstraZeneca|AstraZeneca Information Center|1-877-240-9479|information.center@astrazeneca.com|
304360|NCT02245815|Instituto Mexicano del Seguro Social|Dra. Guadalupe Gómez Rodríguez|477 75 23 166|lupitaneonato@gmail.com|
304361|NCT02246010|American University of Beirut|Dr. Mona Nabulsi|9611350000|mn04@aub.edu.lb|5523
304362|NCT02246062|Faculdade de ciências médicas da Santa Casa de São Paulo|Dr Débora de Oliveira Cumino|+55 11 33617333|comissaocientifica@fcmsantacasasp.edu.br|
304363|NCT02246166|GlaxoSmithKline|GSK Response Center|866-435-7343||
304364|NCT02246218|Horizon Therapeutics, LLC|Colleen Canavan, Director|866-479-6742|clinicaltrials@horizonpharma.com|
304365|NCT02246309|Center for Human Reproduction|Dr. David Barad, Director of Clinical Research|2129944400|dbarad@theCHR.com|212
304366|NCT02246413|Univeristy of Illinois, Chicago|Nan Lv, PhD, Research Scientist|312-802-1072|lvn2017@uic.edu|
304367|NCT02246439|RedHill Biopharma Ltd.|Dr. Terry Plasse|+972-(0)3-541-3131|terry@redhillbio.com|
304368|NCT02246478|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
304369|NCT02246582|Medtronic Diabtes|Smita Barua, Clinical Trial Manager|818.576.5534|smita.barua@medtronic.com|
304370|NCT02246608|Kettering Health Network|Manager, Research Operation and Regulatory Compliance|937-395-8367|innovationcenter@ketteringhealth.org|
304371|NCT02246647|Mayo Clinic|Madhusudan Grover, MBBS|507-253-5384|Grover.Madhusudan@mayo.edu|
304372|NCT02246660|Northwestern University|Dr. Mary McDermott|312-503-6419|mdm608@northwestern.edu|
304373|NCT02246673|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
304374|NCT02246764|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
304375|NCT02246777|Alcon, A Novartis Division|Associate, Medical Group 1, Japan|1-888-451-3937|alcon.medinfo@alcon.com|
304376|NCT02246998|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
304377|NCT02247011|Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital,Chinese Academy of Medical Science|Dr. Weibo Xia|86-10-6915-5076|xiaweibo@medmail.com.cn|
304378|NCT02247063|University of Michigan|Thiago Nascimento|734-615-9390|Nasci@umich.edu|
304379|NCT02247193|The University of Texas Health Science Center at Houston|Matthew R. Greives, MD|713-500-7275|Matthew.R.Greives@uth.tmc.edu|
304380|NCT02247245|University of Leeds|Dr Haqeel Jamil|0113 343 3241|haqeel.jamil@nhs.net|
304381|NCT02247336|William S Middleton Memorial Veterans Hospital|Corrine Voils, PhD|608-256-1901|corrine.voils@va.gov|12208
304382|NCT02247401|AbbVie|Global Medical Services|800-633-9110||
304383|NCT02247440|Institut de Recherche pour le Developpement|Gonzague Jourdain|+66818830065|Gonzague.Jourdain@ird.fr|
304384|NCT02247466|Department of Anaesthesiology, Herlev Hospital, University of Copenhagen|Roar Borregaard Medici, MD, Research Assistant|+4526390068|roar.borregaard.medici.01@regionh.dk|
304385|NCT02247479|Hoffmann-La Roche|Medical Communications|800 821 - 8590|genentech@druginfo.com|
304386|NCT02247531|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
304387|NCT02247739|Pharming Group NV|VP Clinical Research & Medical Affairs||a.relan@pharming.com|
304388|NCT02247765|Medtronic|Michael Luna-Victoria|3034068955|michael.luna-victoria@medtronic.com|
304389|NCT02247804|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
304390|NCT02247960|University of Rochester|Jean Joseph|585-341-7795|jean_joseph@urmc.rochester.edu|
304391|NCT02248103|Faculty of Oral and Dental Medicine Cairo University|Ass. Prof. Dr. Noha Ghallab|+201005263365|noha.ghallab@dentistry.cu.edu.eg|
304392|NCT02248246|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
271662|NCT00255801|Memorial Sloan Kettering Cancer Center|Dr. David Straus|212-639-8365|strausd@mskcc.org|
271663|NCT00255840|CIPRA-SA|Dr Ian Sanne|+27 11 276 8800|isanne@witshealth.co.za|
293425|NCT01488448|Children's Hospital at Montefiore/Albert Einstein College of Medicine|Dr. Alyssa Silver|718-741-2304|alysilve@montefiore.org|
293426|NCT01488487|Div. of Hematology and Oncology, Univ. of North Carolina at Chapel Hill|Dr. Hanna Sanoff|919-966-4431|hanna_sanoff@med.unc.edu|
293427|NCT01488578|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293428|NCT01488708|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293429|NCT01488877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293430|NCT01488890|Sanofi Pasteur|Medical Director||Contact-US@sanofi.com|
293431|NCT01488994|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
293432|NCT01489020|Roxall Medicina España S.A.|Dr. M Cruz Gómez project manager of Roxall Medicina España S.A.|+34 944438000|maricruz.gomez@roxall.es|
304393|NCT02248285|BioFire Diagnostics|Director of Clinical Affairs|8017366354|kevin.bourzac@biofiredx.com|
304394|NCT02248480|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
304395|NCT02248558|UNC Project-China|Weiming Tang|+86-15920567132|weimingtangscience@gmail.com|
304396|NCT02248636|Puget Sound VA|William Banks, Associate Chief of Staff for Research|206 764-2701|william.banks4@va.gov|
304397|NCT02248649|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
304398|NCT02248662|Dana-Farber Cancer Institute|Rinaa Punglia, MD|617-582-8759|rinaa_punglia@dfci.harvard.edu|
304399|NCT02248675|VA Center of Excellence for Suicide Prevention|Wilfred R. Pigeon, PhD|(585) 393-7945|wilfred.pigeon2@va.gov|
304400|NCT02248714|6thShanghaiJiaotongU|Dr. Yuqian Bao|(021)64369181|byq522@163.com|
304401|NCT02248727|Optometry Research Group (GIO) University of Valencia|Robert Montes-Mico, O.D., PhD|34-9635-44764|robert.montes@uv.es|
304402|NCT02248766|Optometry Research Group (GIO) University of Valencia|Robert Montes-Mico, O.D., PhD|34-9635-44764|robert.montes@uv.es|
304403|NCT02248818|AstraZeneca LP|Joel Posner MD||ClinicalTrialTransparency@astrazeneca.com|
304404|NCT02248857|Northwestern University|Dr. Michael Wolf|(312) 503-5592|mswolf@northwestern.edu|
304405|NCT02248922|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
304406|NCT02248961|R-Pharm|Boris Berezhanskiy, Medical Advisor|0074959567937|berezhanskiy@rpharm.ru|2468
304407|NCT02248974|Baylor College of Medicine|Dr. Jennifer Blumenthal-Barby|(713) 798-3785|jennifer.blumenthal-barby@bcm.edu|
304408|NCT02249052|Dr. Zachary E. Gerut|Dr. Zachary E. Gerut, Sponsor/Investigator|516 295-2100|zger@optonline.net|
304409|NCT02249065|Galderma Laboratories L.P.|Dr. Jean Philippe York|817-961-5468|jp.york@galderma.com|
304410|NCT02249091|GSO mbH|Dr Anne L. Kranich|+494044195460|kranich@gsoglobal.com|
304411|NCT02249104|Galderma Laboratories L.P.|Dr. Jay Mashburn|817 961 5027|jay.mashburn@galderma.com|
304412|NCT02249143|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
304413|NCT02249182|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
304414|NCT02249585|Seoul National University Hospital|Dr Kook Hyun Lee, MD, PhD|82-2-2072-2467|leekh@snu.ac.kr|
304415|NCT02249728|Prana Biotechnology|Dr Dianne Angus|+61 393494906|info@pranabio.com|
304416|NCT02249767|Spear Pharmaceuticals|Dr. Spear|239-560-2411|spear@spearpharm.com|
304417|NCT02249793|Upenn|Dr. Carsten Skarke|215-573-0673|cskarke@pennmedicine.upenn.edu|
304418|NCT02249819|Northwell Health|Johanna Chang, Senior Research Coordinator|(516)562-3646|jchang14@northwell.edu|
304419|NCT02249832|Feinstein Institutes for Medical Research|Bruce T. Volpe, MD|(516) 562-3384|bvolpe1@northwell.edu|
304420|NCT02249949|Georgetown University|Michael J. Pishvaian, MD, PhD|202-444-2144|pishvaim@georgetown.edu|
304421|NCT02250092|University of Minnesota|Bernadette Gillick|612-626-6415|gillick@umn.edu|
304422|NCT02250183|Allegheny Health Network-West Penn Hospital Burn Center|Ariel M. Aballay, MD|412-578-1836|Ariel.Aballay@AHN.org|
304423|NCT02250274|Marshfield Clinic Research Foundation|Director of the Center for Clinical Epidemiology & Population Health|715-389-3444|belongia.edward@mcrf.mfldclin.edu|
304424|NCT02250417|The Ohio State University|Ulysses J. Magalang|614-292-6563|magalang.1@osu.edu|
304425|NCT02250443|Novartis Pharmaceutical|Study Director|862-778-8300||
304426|NCT02250521|The University of Texas Health Science Center at Houston|Carin A. Hagberg, MD|713-500-6200|Carin.A.Hagberg@uth.tmc.edu|
304427|NCT02250612|Sylentis|Clinical Trials Department||info@sylentis.com|
304428|NCT02250651|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
304429|NCT02250703|University of Mississippi Medical Center|Madhankumar Sathyamoorthy. PI|6018157066|msathyamoorthy@umc.edu|
304430|NCT02250807|Janssen R&D BE|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
304431|NCT02251236|University of California, San Diego|Scott Letendre, Principal Investigator|6195438080|sletendre@ucsd.edu|
304432|NCT02251275|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
304433|NCT02251379|Johns Hopkins University|Corinne Keet|410-955-5883|ckeet1@jhmi.edu|
304434|NCT02251496|University of Iceland|Dr. Áróra Rós Ingadóttir|8461601|aroraros@landspitali.is|
304435|NCT02251548|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
304436|NCT02251561|Alcon Japan, Ltd.|Director, Clinical & Regulatory Affairs, Division of Medical Affairs||alcon.medinfo@alcon.com|
304437|NCT02251613|Alcon Japan, Ltd.|Hironari Sakaguchi, Phase IV Clinical & Regulatory Affairs, Japan|+81 3 6899 5054|Hironari.Sakaguchi@alcon.com|
304438|NCT02251652|Icahn School of Medicine at Mount Sinai|Dr. Gary Goldenberg|212-241-9728|garygoldenbergmd@gmail.com|
304439|NCT02251717|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
304440|NCT02251743|Ohio State University|Dr. L Eugene Arnold|614-685-6701|L.Arnold@osumc.edu|
304441|NCT02251886|Herning Hospital|Finn Lauszus|+45 78434614|finlau@rm.dk|
271664|NCT00255944|University of Colorado|Dr. Sheana Bull|3037241238|sheana.bull@ucdenver.edu|303
293433|NCT01489111|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
293434|NCT01489189|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrnet@jaeb.org|
293435|NCT01489254|Synthon BV|VP Clinical Development|+3124727700|clinicaltrials@synthon.com|
293436|NCT01489358|Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr Julie E Ledgerwood||ledgerwood@mail.nih.gov|
293437|NCT01489527|H. Lee Moffitt Cancer Center and Research Institute|Anna R. Giuliano, Ph.D.|813-745-6820|anna.giuliano@moffitt.org|
293438|NCT01489579|Kaiser Permanente|Alicia Cymbala|303-972-5384|Alicia.A.Cymbala@kp.org|
293439|NCT01489670|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
293440|NCT01489826|e-Therapeutics plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
293441|NCT01489891|Hospital Universitario Infanta Cristina|Dr. Felipe de la Morena|0034659716030|felipe_de_la_morena@hotmail.com|
293442|NCT01489956|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
304442|NCT02251912|University of North Carolina at Chapel Hill|Dr. Cort Pedersen|919-923-3284|cort_pedersen@med.unc.edu|
304443|NCT02251938|Santen Inc|R&D Quality Manager|+1 415 268 9199|evelyn.chikere@santen.com|
304444|NCT02251990|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304445|NCT02252016|Merck Sharp & Dohme Corp.|Senior Vice President, Glocal Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304446|NCT02252042|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304447|NCT02252068|McLean Hospital|Dr. R. Kathryn McHugh|617-855-2000|kmchugh@mclean.harvard.edu|
304448|NCT02252081|Nashville Campus TVHS|Dr. Adriana Hung|6153274751|adriana.hung@va.goc|6731
314005|NCT03236506|University of Dundee|Professor John Dillon|01382 383017|j.f.dillon@dundee.ac.uk|
314006|NCT03236779|Head of iPhysio Research Group. Editor-in-Chief Journal of Invasive Techniques in Physical Therapy|Dr. Pablo Herrero Gallego. PT, PhD.|(+34) 646168248|pherrero@usj.es|
314007|NCT03237013|San Diego State University|Dr. Aaron Blashill|619-594-2245|ajblashill@sdsu.edu|
314008|NCT03237065|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
314009|NCT03237156|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
314010|NCT03237481|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
314011|NCT03237845|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
314012|NCT03237871|Johns Hopkins Bloomberg School of Public Health|Principal Investigator|410-955-3537|ljennin6@jhu.edu|
314013|NCT03238001|Digital Cognition Technologies|SVP, Clinical Affairs|6174331777|aholway@digitalcogtech.com|
314014|NCT03238352|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314015|NCT03238417|VA Greater Los Angeles Healthcare System|Elizabeth M. Yano, PhD, MSPH|818-891-7711|elizabeth.yano@va.gov|36031
314016|NCT03238651|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
314017|NCT03238781|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
314018|NCT03238911|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
314019|NCT03238924|Medical University of South Carolina|Dr. Julianne Flanagan|843-792-5569|Hellmuth@musc.edu|
314020|NCT03238963|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314021|NCT03239106|Washington University School of Medicine|Brian Kim, Associate Professor of Medicine|314-273-1376|briankim@wustl.edu|
314022|NCT03239470|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
314023|NCT03239483|"Fundacio Lluita Contra la Sida, Hospital Universitari Germans Trias | Pujol"|Dr. Ross D. Cranston|34-934-657-897|rdcranston@outlook.com|
314024|NCT03239496|FIDEC Corporationa|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
314025|NCT03239522|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314026|NCT03239574|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
314027|NCT03239665|Rutgers University Center for Health Outcomes, Policy, & Economics|Laura T. Pizzi, PharmD, MPH|8484456825|laura.pizzi@rutgers.edu|
314028|NCT03239873|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
314029|NCT03240081|OHSU|Dr. Martha Goetsch|503-494-3666|goetsch@ohsu.edu|
314030|NCT03240133|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
314031|NCT03240575|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314032|NCT03241030|Baylor College of Medicine|Nidhi Singh, MD|832-824-2771|nidhi.singh@bcm.edu|
314033|NCT03241342|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
314034|NCT03241368|Medtronic GIH|Amanda Wenisch, Clinical Resaerch Coordinator / Study Manager|1-206-225-4025|amanda.m.wenisch@medtronic.com|
314035|NCT03241485|University of Chicago Medicine|Richa Dhawan|773-702-1000|rdhawan@dacc.uchicago.edu|
314036|NCT03241810|Elevation oncology|VP, Clinical Operations|+1-716 371 1125|clinical@elevationoncology.com|
314037|NCT03241862|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
314038|NCT03241927|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
314039|NCT03242018|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
314040|NCT03242148|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAP.trial@fphcare.co.nz|7044
314041|NCT03242252|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
314042|NCT03242408|Lipocine, INC.|Nachiappan Chidambaram, Vice President, Product Development|8018819495|nc@lipocine.com|
314043|NCT03242434|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314044|NCT03242590|Lipocine, INC.|Nachiappan Chidambaram, Vice President, Product Development|8018819495|nc@lipocine.com|
271665|NCT00255970|RTI Biologics|Clinical Projects, Director|386-418-8888|rparkhurst@rtix.com|
271666|NCT00256126|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
271667|NCT00256204|Teva Branded Pharmaceutical Products R&D|Dennis Ahern, MS, Director|215-293-6339|dennis.ahern@tevausa.com|
271668|NCT00256217|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
271669|NCT00256243|Chao Family Comprehensive Cancer Center|Dr. Rita Mehta|(714) 456-5153|rsmehta@uci.edu|
271670|NCT00256282|University of California, Irvine|Dr. John P. Fruehauf|714-456-5153|jfruehau@uci.edu|
282437|NCT00855595|Intendis GmbH|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
282438|NCT00855738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293443|NCT01489969|Neurim Pharmaceuticals (1991) LTD|Amnon Katz|972-3-768-4906|amnonk@neurim.com|
293444|NCT01490060|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|(713) 792-7966|CR_Study_Registration@mdanderson.org|
293445|NCT01490073|University of Washington|Elizabeth Micks|206-616-4939|emicks@uw.edu|
293446|NCT01490086|Reviva Pharmaceuticals, Inc.|Marc Cantillon, M.D|408-960-2209|mcantillon@revivapharma.com|
293447|NCT01490125|Novartis|Study director|41 61 324 1111||
293448|NCT01490151|Stanford University|Dr. Bruce Buckingham, MD|408-356-0911|buckingham@stanford.edu|
304449|NCT02252133|Alcon Research, Ltd.|Senior Manager, Clinical Development, Japan|1-888-451-3937|alcon.medinfo@alcon.com|
304450|NCT02252146|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
304451|NCT02252211|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org|
304452|NCT02252354|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
304453|NCT02252406|University of Florida, Jacksonville|Gladys Velarde, MD|904-244-2060|gladys.velarde@jax.ufl.edu|
304454|NCT02252445|Keimyung university|Assistant professor|+821028862876|onidori1979@gmail.com|
304455|NCT02252536|NIAAA|Megan Ryan|3014434225|mryan1@mail.nih.gov|
304456|NCT02252562|Dartmouth-Hitchcock Medical Center|Matthew D. Koff, MD Staff Physician, Anesthesiology|(603) 650-5922|Matthew.D.Koff@hitchcock.org|
304457|NCT02252588|University of Minnesota|Christine Wendt, MD|612-624-0999|wendt005@umn.edu|
304458|NCT02252666|University of Wisconsin - Madison|Dr. Mitchell Tyler|(608) 262-5112|metyler1@wisc.edu|
304459|NCT02252718|Medical University of Warsaw|Katarzyna Wojtyniak|(+48) 223179536|wojtyniakkasia@gmail.com|
304460|NCT02252744|Western University of Health Sciences|Jasmine Wong Yumori OD FAAO|(909) 706-3886|jyumori@westernu.edu|
304461|NCT02252939|Massachusetts General Hospital|Rachel Gottlieb, Research Coordinator|617-726-1569|rgottileb3@mgh.harvard.edu|
304462|NCT02252965|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
304463|NCT02253147|Teoxane|Clinical Project Manager|+41 (0) 22 344 96 36|m.chenet@teoxane.com|
304464|NCT02253160|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer - BBT|303-232-6800|Ray.Goodrich@terumobct.com|
304465|NCT02253173|TherapeuticsMD|Sebastian Mirkin, MD, Chief Medical Officer|561-961-1900|sebastian.mirkin@therapeuticsmd.com|1952
304466|NCT02253433|Environmental Health, Baylor College of Medicine|Dr. Winifred J. Hamilton|713-798-1052|hamilton@bcm.edu|
304467|NCT02253537|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
304468|NCT02253654|Amgen Inc.|Study Director|866-572-6436||
304469|NCT02253992|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
304470|NCT02254252|Mashhad University of Medical Sciences|Pouya Nezafati|00989151578421|nezafatip871@mums.ac.ir|
304471|NCT02254265|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
304472|NCT02254278|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@gmail.com|
304473|NCT02254291|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
304474|NCT02254304|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
304475|NCT02254408|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
304476|NCT02254421|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
304477|NCT02254460|GlaxoSmithKline|GSK Response Center|866-435-7343||
304478|NCT02254473|TRIA Orthopaedic Center|Megan Reams|952-806-5329|megan.reams@tria.com|
304479|NCT02254486|Norgine Ltd|Lucy Clayton|+44-1895-826669|lclayton@norgine.com|
304480|NCT02254551|Sarah Cannon Development Innovations|Charles Davis, Sr Mgr Regulatory Strategy & Operations|615-524-4341|charles.davis2@scri-innovations.com|
304481|NCT02254681|Allina Health|Srinevas K. Reddy|612-863-8716|laura.rockwell@allina.com|
304482|NCT02254772|Stanford Univeristy Medical Center|Ronald Levy, MD, Professor of Medicine|650-725-6452|levy@stanford.edu|
304483|NCT02255032|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
304484|NCT02255097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304485|NCT02255110|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
304486|NCT02255149|University of Michigan|Dr. Hsun-Liang Chan|734-763-3325|hlchan@umich.edu|
304487|NCT02255175|UNC School of Medicine|Crystal Edler Schiller, PhD|919-966-4810|crystal_schiller@med.unc.edu|
304488|NCT02255279|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
304489|NCT02255357|new york psychiatric institute|wilfrid raby, m.d.|2129233031|wilfrid.raby@nyspi.columbia.edu|
304490|NCT02255422|Reata Pharmaceuticals, Inc.|Kris Loerwald|+1 972-865-2219|MedicalAffairs-Team@reatapharma.com|
282439|NCT00855816|VA Palo Alto Health Care System / Stanford University School of Medicine|Walton T. Roth, M.D.|650-493-5000|wtroth@stanford.edu|65243
293449|NCT01490294|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
293450|NCT01490359|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
293451|NCT01490450|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
293452|NCT01490580|NICU, CHI Créteil|Dr Xavier Durrmeyer|+33145175433|xavier.durrmeyer@chicreteil.fr|
293453|NCT01490632|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293454|NCT01490684|King Abdulaziz Medical City|Dr Hasan Al-Dorzi|966535888632|aldorzih@yahoo.com|
293455|NCT01490697|Massachusetts General Hospital|Roger K. Pitman, MD|617-726-5333|roger_pitman@hms.harvard.edu|
293456|NCT01490723|U.T. MD Anderson Cancer Center|Issa F. Khouri, M.D., Stem Cell Transplantation|(713) 745-0049|ikhouri@mdanderson.org|
293457|NCT01490788|Tonix Pharmaceuticals, Inc.|Greg Sullivan, MD||greg.sullivan@tonixpharma.com|
282440|NCT00855842|Boston University|Lynn Borgatta, MD|617-414-3440|lynn.borgatta@bmc.org|
293458|NCT01490814|Medtronic|Ralf Meyer|+49215981490|ralf.meyer@medtronic.com|
304491|NCT02255461|St. Jude Children's Research Hospital|Jie Huang|9015955750|jie.huang@stjude.org|
304492|NCT02255474|The Ohio State University|Dr. Jeffrey Walline|614-247-6840|walline.1@osu.edu|
304493|NCT02255500|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
304494|NCT02255513|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
304495|NCT02255552|Sarepta Therapeutics, Inc.|Medical Director|+1-800-690-2003|clinicaltrials@sarepta.com|
304496|NCT02255565|Dept. of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
304497|NCT02255604|Aarhus Universitets Hospital|Hans Jürgen Hoffmann|7845000|Hans.Jurgen.Hoffmann@ki.au.dk|
304498|NCT02255656|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
304499|NCT02255760|MedImmune LLC|Hasan S. Jafri, MD, Senior Director, Clinical Development|301-398-0000|jafrih@medimmune.com|
304500|NCT02255981|Escuela Neijing|Researcher|5744211000|lhgut2001@gmail.com|
304501|NCT02256072|Northwestern University Feinberg School of Medicine|Dr. Lee A. Lindquist|312-503-3916|LAL425@md.northwestern.edu|
304502|NCT02256111|Duke University|Michael Harrison, MD|919-668-4615|michael.harrison@duke.edu|
304503|NCT02256189|Lund University|Professor Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
304504|NCT02256267|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
304505|NCT02256345|UPenn|Julio Chirinos|2158235800|julio.chirinos@uphs.upenn.edu|
304506|NCT02256358|Haeundae Paik Hospital, Inje University|Kihwa Lee|82-51-797-0426|tedy333@paik.ac.kr|
304507|NCT02256384|Cincinnati Children's Hospital Medical Center|Mario Patino|513-636-4200|mario.patino@cchmc.org|
304508|NCT02256436|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304509|NCT02256488|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
304510|NCT02256540|University of Colorado Anschutz Medical Campus|Dr. Kerrie Moreau|303-724-1914|kerrie.moreau@cuanschutz.edu|
304511|NCT02256553|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304512|NCT02256839|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
304513|NCT02256891|Health Partners|Michael Walsh|(952) 831-8742|michael.walsh@tria.com|
304514|NCT02256917|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
304515|NCT02256969|Massachusetts Eye and Ear Infirmary|Assistant Professor of Ophthalmology|617-573-6060|ophthalmologyclinicalresearch@meei.harvard.edu|6060
304516|NCT02256982|Massachusetts General Hospital|Ted Hong, MD|617-726-6050|tshong1@partners.org|
304517|NCT02257099|UBMD Orthopaedics and Sports Medicine|John Marzo, MD|7168292982|jmmarzo@buffalo.edu|
304518|NCT02257177|Galecto|Professor Bertil Lindmark|+4570705210|info@galecto.com|
304519|NCT02257372|GlaxoSmithKline|GSK Response Center|866-435-7343||
304520|NCT02257385|GlaxoSmithKline|GSK Response Center|866-435-7343||
304521|NCT02257489|Acceleron Pharma, Inc.|Kenneth M. Attie, MD|617-649-9200|kattie@acceleronpharma.com|
304522|NCT02257541|Memorial Sloan Kettering Cancer Center|Dr. William Tap, MD|646-888-4163|tapw@mskcc.org|
304523|NCT02257632|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
304524|NCT02257684|Jazz Pharmaceuticals|Head of Clinical Development|650-496-3777||
304525|NCT02257957|Universidad Nacional de Colombia|Dr Marcel Y Avila|+5713165000|myavilac@unal.edu.co|15119
304526|NCT02257970|Stanford University, School of Medicine|Dr. Stanley Rockson|650-725-7571|rockson@stanford.edu|
304527|NCT02258074|Cleveland Clinic Foundation|Jennifer J. Gassman, PhD|216-444-9938|gassmaj@ccf.org|
304528|NCT02258139|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
304529|NCT02258152|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|914-326-5775|ckenney@acorda.com|
304530|NCT02258217|OhioHealth Research Institute|Anand Gupta|614-788-3868|anand.gupta@ohiohealth.com|
304531|NCT02258256|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
304532|NCT02258334|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
304533|NCT02258373|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org|
314355|NCT03294317|Medtronic CRM Clinical|Nonye Harcourt|6122421785|nonye.o.harcourt@medtronic.com|
293459|NCT01490840|Novartis|Study Director|862-778-8300||
293460|NCT01490866|SCRI Development Innovations|Charles H. Davis, RAC|615 524-4341|charles.davis2@scri-innovations.com|
304534|NCT02258412|3M Health Care Business|Clinical Research Specialist|651-736-1578|mdavid@mmm.com|
304535|NCT02258464|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
304536|NCT02258477|University of Colorado, Anschutz Health and Wellness Center|Dr. James Hill|303-724-9974|james.hill@ucdenver.edu|
304537|NCT02258529|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
282441|NCT00855868|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
282442|NCT00855894|Genentech, Inc.|Medical Communications|800 821-8590||
293461|NCT01490892|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Flemming Forsberg|215-955-4870|flemming.forsberg@jefferson.edu|
293462|NCT01490918|The Catholic University of Korea, Seoul St Mary's Hospital|Yoon Hee Choi|82-2-2258-8288|choiyh@catholic.ac.kr|
293463|NCT01490931|Univeristy of Pennsylvania School of Dental Medicine|Elliot V Hersh DMD, MS, PhD Professor of Pharmacology|215-898-9686|evhersh@pobox.upenn.edu|
293464|NCT01491022|University of Miami|Dr Corneliu Luca|3052432235|cluca@med.miami.edu|
293465|NCT01491035|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
293466|NCT01491113|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
293467|NCT01491178|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
293468|NCT01491490|GW Research Ltd.|Mr Colin Stott|+44 (0)1980 557000|cgs@gwpharm.com|
293469|NCT01491607|Emergent BioSolutions|Dr. Robert Hopkins|(301) 944-0136|hopkinsr@ebsi.com|
293470|NCT01491633|Dana-Farber Cancer Institute|Dr. Peter Hammerman|617-632-3000|phammerman@partners.org|
304538|NCT02259010|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
304539|NCT02259088|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
304540|NCT02259114|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304541|NCT02259231|Reata Pharmaceuticals, Inc.|Kris Loerwald|+1 972-865-2219|MedicalAffairs-Team@reatapharma.com|
304542|NCT02259348|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
304543|NCT02259400|"AOU G. Martino Universitary Hospital of Messina"|Dr. Vincenzo Salvo|+39 0902212132|salvovincenzo@virgilio.it|
304544|NCT02259582|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
304545|NCT02259608|Radboud UMC|Rob Arts|0031 24|rob.jw.arts@radboudumc.nl|36 67206
304546|NCT02259699|University of California, Irvine|Dr. Lari Wenzel|949-824-3926|lwenzel@uci.edu|
304547|NCT02260154|Abbott|Tatiana V. Vladimirova MD, PhD|+7 495-258-4280|tatiana.vladimirova@abbott.com|
304548|NCT02260180|Aclaris Therapeutics, Inc.|Judith Schnyder, Senior Director of Clinical Operations|1-484-329-2144|jschnyder@aclaristx.com|
314045|NCT03242759|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314046|NCT03242863|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
314047|NCT03242928|Novartis Pharma AG|Clinical Disclosure Office|613241111|Novartis.email@Novartis.com|
314048|NCT03242941|Medtronic|Lilian Kornet|+31433566710|lilian.kornet@medtronic.com|
314049|NCT03242954|Indiana University School of Nursing|Amy Knopf|206-356-9430|asknopf@iu.edu|
314050|NCT03243084|UNC Chapel Hill|Julianna Prim|919-962-5271|jhprim@email.unc.edu|
314051|NCT03243305|Evofem, Inc.|Chief Medical Officer|858 550 1900|kculwell@evofem.com|
314052|NCT03243630|Yale University|Mehmet Sofuoglu|203-932-5711|mehmet.sofuoglu@yale.edu|4809
314053|NCT03243981|Stanford University|Anne Lynn Chang, MD|650-723-6316|alschang@stanford.edu|
314054|NCT03244618|Unilever|Dr Jane Matheson|+44 (0)1516413633|jane.matheson@unilever.com|
314356|NCT03294538|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
314357|NCT03294629|Sleep Center, Taoyuan Chang Gung Memorial Hospital|Ning-Hung, Chen|+886-3-3281200|ninghung@yahoo.com.tw|2281
314358|NCT03294681|Cochlear|Nicole Neben|+4951154277220|nneben@cochlear.com|
314359|NCT03294850|AdventHealth Translational Research Institute|Dr. Karen Corbin|(407) 303-7100|Karen.Corbin@AdventHealth.com|
314360|NCT03294941|HepQuant, LLC|Elyse Handley|303-923-2109|elyse.handley@hepquant.com|
314361|NCT03295201|Marmara University|Dr. Kardelen Gencer Atalay|5324404887|kardelengencer@gmail.com|532
314362|NCT03295266|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
314363|NCT03295318|Serum Institute of India Pvt. Ltd.|Abhijeet Dharmadhikari|+91-20-26602855|abhijeet.dharmadhikari@seruminstitute.com|2855
314364|NCT03295630|Hull University Teaching Hospitals NHS Trust|Dr. Jayne Anderson|01482 875875|jayne.anderson@hey.nhs.uk|5099
314365|NCT03295721|Heron Therapeutics, Inc.|Vice President, Clinical Operations|855-251-7232|svisonneau@herontx.com|
314366|NCT03296072|GlaxoSmithKline|GSK Response Center|866-435-7343 Ext:|GSKClinicalSupportHD@gsk.com|
314367|NCT03296163|mAbxience Research SL|Susana Millan|+34917711500|susana.millan@mabxience.com|
314368|NCT03296280|South Texas Veterans Health Care System / UT Health San Antonio|Nilam Soni|210-949-9454|sonin@uthscsa.edu|
314369|NCT03296345|Valley Children's Hospital|Jonathan Bryan Cooper-Sood, MD|559-353-3000|coopersoodj@usacs.com|
314370|NCT03296527|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
314371|NCT03296566|University of British Columbia|Dr. Marette Lee|604.875.5608|Marette.Lee@vch.ca|
314372|NCT03296787|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
314373|NCT03296800|Theracos Sub, LLC|Albert Collinson|(508) 688-4221|acollinson@theracos.com|
314374|NCT03297021|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|Daniel.Katz@mountsinai.org|
314375|NCT03297112|Sidney Kimmel Cancer Center at Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
314376|NCT03297216|University of North Carolina at Chapel Hill|Joan Price, MD, MPH|919-962-4717|joan_price@med.unc.edu|
314377|NCT03297294|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
314378|NCT03297398|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
314379|NCT03297944|University of Kentucky|Marion Coe|859-257-6488|mcoe07@gmail.com|
314380|NCT03298035|The University of Texas Health Science Center at Houston|Catherine C. Beaullieu, MD|(713) 500-6044|Catherine.C.Beaullieu@uth.tmc.edu|
314381|NCT03298048|UTexas_Houston|Dr. Herbert DuPont|713-500-9366|herbert.l.dupont@uth.tmc.edu|
293471|NCT01491672|Novartis|Study Director|862-778-8300||
282443|NCT00855920|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
293472|NCT01491737|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
293473|NCT01491802|Queen's University|Kathy Webb|613-549-6666|kw2@queensu.ca|4950
293474|NCT01491841|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
293475|NCT01491854|Novartis Pharma AG|Study Director|862-778-8300|novartis.email@novartis.com|
293476|NCT01491919|Duke Clinical Research Institute|Uptal Patel, MD|919-668-4601|uptal.patel@duke.edu|
293477|NCT01491945|Endologix|Sripad Bellary, Director of Clinical Affairs|9257011628|sbellary@endologix.com|
293478|NCT01491958|The Ohio State University Comprehensive Cancer Center|Yvonne Efebera, M.D|614-293-3196|Yvonne.Efebera@osumc.edu|
293479|NCT01491984|IWK Health Centre|Dr. Ronald George|902-470-6627|rbgeorge@dal.ca|
293480|NCT01492088|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
293481|NCT01492101|Nektar|Alison Hannah, MD||AHannah@nektar.com|
304549|NCT02260258|BIDMC|Mike Donnino|6177542882|mdonnino@bidmc.harvard.edu|
304550|NCT02260388|University of Kansas Medical Center|Dr. Richard Barohn|9139459943|rbarohn@kumc.edu|
304551|NCT02260401|University of Washington|Dr. Janna Friedly|206-744-3000|friedlyj@uw.edu|
304552|NCT02260440|UPMC Hillman Cancer Center|Anuradha Krishnamurthy, MD|412-623-3283|krishnamurthya2@upmc.edu|
304553|NCT02260492|Oriel Therapeutics, a Novartis Company|Malinda Longphre PhD, Director Clinical Reserach|9193131290|mlongphre@orieltherapeutics.com|114
304554|NCT02260531|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-3800|Sara_Tolaney@dfci.harvard.edu|
304555|NCT02260622|Ottawa Hospital Research Institute|Penny Phillips|613-737-8899|pphillips@ohri.ca|
304556|NCT02260635|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
304557|NCT02260648|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
304558|NCT02260791|Fujifilm Kyowa Kirin Biologics Co., Ltd., EU Branch|Clinical Trial Information|+44 1896 668 173|Clinical-Trials@fk-b.com|
304559|NCT02260804|CELLTRION, Inc.|Dr. Sung Hyun Kim|+82-32-850-5000|contact@celltrion.com|
304560|NCT02260817|Decatur Memorial Hospital, Decatur, IL|Thomas H. Tarter, M.D., Ph.D - Director, Urologic Oncology, Cancer Care Specialists of Illinois|(217) 876-6600|ttarter@ccsci.net|
304561|NCT02260882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304562|NCT02260921|Myoscience|Director of Clinical|5109331541||
304563|NCT02260934|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
304564|NCT02260986|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
304565|NCT02261428|"Attikon General University Hospital of Athens"|Mr. Konstantinos Grigoriadis ICU Physical Therapist|00302105832489|grigoriakost@gmail.com|
304566|NCT02261467|Allergan, Inc|Tanya Brandstetter|714-246-2567|brandstetter_tanya@Allergan.com|
304567|NCT02261493|Allergan, Inc|Tanya Brandstetter|714-246-2567|brandstetter_tanya@Allergan.com|
304568|NCT02261597|Beth Israel Deaconess Medical Center, Harvard Medical School|Dr. Monika Haack|617-667-5234|mhaack@bidmc.harvard.edu|
314055|NCT03244800|MedImmune Limited|Victoria Parker|+44 747 1357152|information.center@astrazeneca.com|
314056|NCT03244865|UF Health Department of Anesthesiology|Dr. Tammy Euliano|352-514-7460|teuliano@anest.ufl.edu|
314057|NCT03244917|Hebrew SeniorLife|Susan Mitchell MD, MPH|6172813669|smitchell@hsl.harvard.edu|
314058|NCT03245372|Hospital Universitario Virgen del Rocío, Servicio Andaluz de Salud|Dr. Alejandro Domínguez-Blanco|0034660762856|aledguez@gmail.com|
314059|NCT03245398|Swiss Tropical and Public Health Institute|Dr Jennifer Keiser|+41 61 284 8218|jennifer.keiser@swisstph.ch|
314060|NCT03245463|Hospital for Special Surgery|Dr. James Wyss|2126061731|wyssj@hss.edu|
314061|NCT03245619|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314062|NCT03245723|UT Southwestern Medical Center, Dallas, Texas|Dr. Kara Goss|214-648-6868|kara.goss@utsouthwestern.edu|
314063|NCT03245736|Genmab A/S|Clinical Trial Information|70202728|clinicaltrials@genmab.com|
314064|NCT03245762|University of Florida|Jennifer Miller, MD|352-265-7337|millejl@peds.ufl.edu|
314065|NCT03246061|Relievant Medsystems|Diane Sahr, VP Clinical Affairs|(650) 368-1000|dsahr@relievant.com|
314066|NCT03246152|Cairo University|Dr. Ayman Elnahry|00201224927604|ayman_elnahri@hotmail.com|
314067|NCT03246646|CMC VA Medical Center|Steven L. Sayers|(215) 823-5196|steven.sayers@va.gov|
314068|NCT03246672|William S Middleton Memorial Veterans Hospital|Dr. Corrine Voils|608-262-9636|corrine.voils@va.gov|
314069|NCT03246724|Boston Medical Center|Marissa Fiorello, Clinical Research Manager|617-414-8848|Marissa.Fiorello@bmc.org|
314070|NCT03247322|Medical University of South Carolina|David Taber, PharmD, MS|843-792-3368|taberd@musc.edu|
314071|NCT03247517|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
314072|NCT03247530|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
314073|NCT03247543|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
314074|NCT03247556|Supernus|Joseph Hull, PhD, Associate Director Clinical Research|240-403-5324|jhull@supernus.com|
314075|NCT03247673|Celltrion|Clinical Planning Department Leader|82328505000|contact@celltrion.com|
314076|NCT03247686|Resolve Therapeutics LLC|James Posada|208 727 7010|jp@resolvebio.com|
314077|NCT03247738|University of Florida College of Medicine, Jacksonville|Dominick J. Angiolillo|9042443933|dominick.angiolillo@jax.ufl.edu|
314078|NCT03247790|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314079|NCT03247816|Shield TX (UK) Limited|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
314080|NCT03247985|Mayo Clinic|Dr. David R. Farley|507-284-7565|farley.david@mayo.edu|
314382|NCT03298113|3M Healthcare Business Group|Nancy Klinger, Clinical Manager|651 736|nmklinger@mmm.com|5825
293482|NCT01492309|UPenn|Deborah Kim, MD|6107261020|drkim@upenn.edu|
293483|NCT01492400|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
282444|NCT00855933|The Procter & Gamble Co.|Jon Witt|513-622-2963|witt.jj.2@pg.com|
282445|NCT00855959|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
282446|NCT00856024|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClincialTrialsDisclosure@merck.com|
282447|NCT00856050|Dana-Farber Cancer Institute|Dr. Suzanne George|617-632-5204|sgeorge2@partners.org|
293484|NCT01492426|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
293485|NCT01492439|Centre for Addiction and Mental Health|Dr. Sean A. Kidd|416-535-8501|sean.kidd@camh.ca|6295
293486|NCT01492582|University of Alabama at Birmingham|Dr. Wendy Landier, Deputy Director, Institute for Cancer Outcomes and Survivorship|(205) 638-2120|wlandier@peds.uab.edu|
293487|NCT01492673|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett, MD|212-639-8267|trippet1@mskcc.org|
293488|NCT01492686|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
293489|NCT01493024|ZS Pharma, Inc|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
293490|NCT01493089|Norgine Ltd|Dr. Richard Ng Kwet Shing|+441895453584|RNg@Norgine.com|
293491|NCT01493167|Helsinki University Hospital|Dr Nina Linfors|358 9 4711|nina.c.lindfors@hus.fi|
293492|NCT01493180|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
304569|NCT02261714|Targovax ASA|Chief Medical Officer|004721398810|contact@targovax.com|
304570|NCT02261727|The George Institute for Global Health|Prof Christine Jenkins|+61280524300|christine.jenkins@sydney.edu.au|
304571|NCT02261805|Lombardi Comprehensive Cancer Center|Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
304572|NCT02261818|Johns Hopkins University|Dr Jin Hui Joo|4105502282|jjoo1@jhmi.edu|410
304573|NCT02261948|Centro Cardiologoco Monzino|Piergiuseppe Agostoni|02 5800|piergiuseppe.agostoni@ccfm.it|2772
304574|NCT02261961|Central Arkansas Veterans Healthcare System|Richard Dennis|501-257-5583|richard.dennis2@va.gov|
304575|NCT02261974|Viveve, Inc.|Debbie Wilkerson, PhD, Vice President, Clinical and Medical Affairs|610-209-9980|dwilkerson@viveve.com|
304576|NCT02262039|Yale University|Dr. Sanjay Kulkarni|203-785-6501|sanjay.kulkarni@yale.edu|
304577|NCT02262078|Mayo Clinic|Barry A. Borlaug, MD||Borlaug.Barry@mayo.edu|
304578|NCT02262130|CHU de Reims|Pr Manuelle Viguier|00333 26 78 43 43|mviguier@chu-reims.fr|
304579|NCT02262260|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
304580|NCT02262364|Zimmer Biomet|Jennifer Woodell-May, PhD||jennifer.woodell-may@zimmerbiomet.com|
304581|NCT02262377|Boston Medical Center|Paula Gardiner|414-6267|Paula.GardinerMD@gmail.com|617
304582|NCT02262507|Cincinnati Childrens Hospital Sports Medicine|Dr. Gregory Myer|513-636-0249|greg.myer@cchmc.org|
304583|NCT02262728|Janssen Research & Development, a division of Janssen Pharmaceutica NV|Medical Leader Hepatitis C, GCO ED&CP||ClinicalTrialDisclosure@its.jnj.com|
304584|NCT02262754|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
304585|NCT02263014|The University of Texas (UT) MD Anderson Cancer Center|Dr. Abenaa Brewster, Professor, Clinical Cancer Prevention|713-792-7734|abrewster@mdanderson.org|
304586|NCT02263040|Mount Sinai Hospital, Toronto|Dr. Allison McGeer|416-586-3118|allison.mcgeer@sinaihealthsystem.ca|
304587|NCT02263079|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
304588|NCT02263118|Ecole Polytechnique|Dr. Jose Tomas Prieto|+50252800643|jose-tomas.prieto@polytechnique.edu|
304589|NCT02263131|The Catholic University of Korea, Seoul St. Mary's Hospital|Dr. Kang Jin Han|+82-10-4251-8375|kjhan@catholic.ac.kr|
304590|NCT02263326|Northwestern University|Babafemi Taiwo|312-695-5085|b-taiwo@northwestern.edu|
304591|NCT02263547|University of South Florida, COM Neurology|Assistant Director of Research|8139746378|aaungst@health.usf.edu|
304592|NCT02263833|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
304593|NCT02263911|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
304594|NCT02264249|Cleveland Clinic Florida|Dr. Alison Schneider|954-659-5646|schneia2@ccf.org|
304595|NCT02264353|University of California, San Diego|Atul Malhotra, MD|(858) 657-6159|amalhotra@ucsd.edu|
304596|NCT02264574|Pharmacyclics LLC, An AbbVie Company|Lori Styles|(408) 215-3770|lstyles@pcyc.com|
304597|NCT02264639|Apellis Pharmaceuticals, Inc.|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
304598|NCT02264821|CHU Brugmann|Dr Madeleine Wilwerth|003224773996|madeleine.wilwerth@chu-brugmann.be|
304599|NCT02264990|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
304600|NCT02265224|Zambon S.p.A.|Isabella Salerio, PhD|+3902665241|clinicaltrials@zambongroup.com|
304601|NCT02265237|AbbVie|Global Medical Information|800-633-9110||
304602|NCT02265341|Mayo Clinic|Mitesh J. Borad, MD|480/301-8335|Borad.Mitesh@mayo.edu|
304603|NCT02265510|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
304604|NCT02265705|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
304605|NCT02265744|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
304606|NCT02265783|Medtronic|Michael Luna-Victoria|3033052463|michael.luna-victoria@medtronic.com|
304607|NCT02265796|Malcom Randall VA Medical Center|Dr. Anthony Bavry|352-376-1611|anthony.bavry@va.gov|6325
304608|NCT02265848|Center for Clinical Research / Carolinas Pain Institute|Dr. James North MD|3367656181|jhong@ccrpain.com|
304609|NCT02265913|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
304610|NCT02265952|Regeneron Pharmaceuticals, Inc.|Clinical Trial Information|844-734-6643|clinicaltrials@regeneron.com|
304611|NCT02265965|University of California, San Francisco|Jennifer Lucero, MD|415-476-5535|jennifer.lucero@ucsf.edu|
304612|NCT02266004|University of Miami|Corneliu Luca, MD|305-243-6732|cluca@med.miami.edu|
304613|NCT02266108|UCSDMED|Elizabeth Reed, Associate Professor|5082121517|elizared7@gmail.com|
304614|NCT02266147|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
314081|NCT03248037|Cornea Research Foundation of America|Marianne Price|3178142990|mprice@cornea.org|
282448|NCT00856180|Dana-Farber Cancer Institute|Ursula A. Matulonis, MD|617-632-2334|umatulonis@partners.org|
293493|NCT01493284|St Jude Medical|Sr Clinical Scientist|4159179696|alicia.kimber@abbott.com|
293494|NCT01493414|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
304615|NCT02266225|University of Waterloo|Dr. Lora Giangregorio|519-888-4567|lora.giangregorio@uwaterloo.ca|36357
304616|NCT02266277|University of Massachusetts Medical School|Dr. Sarah Cutrona|508-856-3086|sarah.cutrona@umassmed.edu|
304617|NCT02266381|The First Affiliated Hospital of Guangzhou Medical University|Dr. Guohua Zeng|0086-20-34294163|gzgyzgh@vip.sina.com|
304618|NCT02266433|New York University School of Medicine - Division of Hand Surgery|Anthony Sapienza, MD / Assistant Professor|212 737 3301|Anthony.Sapienza@nyulangone.org|
304619|NCT02266472|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
304620|NCT02266576|Stanford University|Jan J. Vasquez|408-858-4457|jan.vasquez@stanford.edu|
304621|NCT02266706|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304622|NCT02266810|Intersect ENT|James Stambaugh (VP, Clinical Affairs)|650-641-2103|jstambaugh@intersectent.com|
304623|NCT02266875|OhioHealth|Dr. Kruti Patel, DO|614-857-7735|kruti.patel@ohiohealth.com|
304624|NCT02266888|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
304625|NCT02267083|Gem Pharmaceuticals, LLC|Elizabeth Moore, Regulatory Affairs Agent|8583532019|elizabethmoore109@comcast.net|
304626|NCT02267135|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|trialandresults.registries@novartis.com|
304627|NCT02267187|University of Pittsburgh|Patsy Simon|412-648-9207|simonpa@upmc.edu|
304628|NCT02267226|Octapharma USA|Director of Clinical Operations|201 604-1149|sylvia.werner@octapharma.com|
304629|NCT02267278|The University of Texas MD Anderson Cancer Center|Srdan Verstovsek, MD/Professor|713-745-3429|sverstov@mdanderson.org|
304630|NCT02267317|University of Texas Health San Antonio|Hanyu Liang|210-617-5300|liangh0@uthscsa.edu|15197
304631|NCT02267356|Mycovia Pharmaceuticals|Sr Vice President, Clinical Development|(919) 467-8539|info@viamet.com|
304632|NCT02267382|Mycovia Pharmaceuticals|Sr Vice President, Clinical Development|(919) 467-8539|info@mycovia.com|
304633|NCT02267447|Ottawa Hospital Research Institute|Dr. Doug Manuel|613-798-5555|dmanuel@ohri.ca|19108
304634|NCT02267538|Peking University First Hospital|Dr. Dong-Xin Wang,PHD,the director of department of Anesthesiology and Critical Care Medicine|+8613910731903|wangdongxin@hotmail.com|
304635|NCT02267577|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
304636|NCT02267603|Cancer Immunotherapy Trials Network|Alisa Claeys|206-667-7607|aclaeys@fredhutch.org|
304637|NCT02267629|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor, Director of Rodriguez Translational Therapeutics Lab|650-723-6158|cr2163@stanford.edu|
304638|NCT02267746|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
304639|NCT02267772|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD, Associate Professor|713-500-6416|jerrie.s.refuerzo@uth.tmc.edu|
304640|NCT02267811|Biolux Research, Ltd.|Dr. Peter Brawn|6046690674|p.brawn@bioluxresearch.com|
304641|NCT02267824|Shaughnessy Orthodontics|Dr. Timothy Shaughnessy|770-495-9590|staff@straightteethdoc.com|
304642|NCT02267837|Shaughnessy Orthodontics|Dr. Timothy Shaughnessy|770-495-9590|staff@straightteethdoc.com|
304643|NCT02267850|Biolux Research Ltd|Clinical Studies Manager|1-604-669-0674|d.skrenes@bioluxresearch.com|
304644|NCT02268045|mAbxience|Susana Millan|+34917711500|Susana.Millan@mabxience.com|9284
304645|NCT02268058|McMaster Children's Hospital|Dr. Tina Petrelli|905-521-2100|petrelli@hhsc.ca|75162
304646|NCT02268084|Wave Neuroscience|Meagan Kovacs, Clinical and Regulatory Affairs Manager|9492292869|meagan@waveneuro.com|
304647|NCT02268175|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mary_taplin@dfci.harvard.edu|
304648|NCT02268214|AstraZenenca|Anna Maria Langkilde|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
314082|NCT03248440|Senju USA, Inc.|Takahiro Ogawa, PhD|+1 818 719 7190|ogawataka@senju-usa.com|
314083|NCT03248492|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
314084|NCT03248882|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
314085|NCT03248947|Duke University|Dr. Li-Tzy Wu|919-889-9369|litzy.wu@duke.edu|
314086|NCT03249116|Tufts University|Dr. Megan K Mueller|508-887-4543|megan.mueller@tufts.edu|
314087|NCT03249272|Duke Cardiovascular Magnetic Resonance Center|Han Kim, MD|9196683539|han.kim@duke.edu|
314088|NCT03249454|The University of Texas Health Science Center at Houston|Radha Korupolu, MD, MS|713-797-6976|Radha.Korupolu@uth.tmc.edu|
314089|NCT03249584|MedtronicNeuro|Eric Grovender|763-514-4000|eric.a.grovender@medtronic.com|
314090|NCT03249779|Mayo Clinic|Melissa C. Lipford, M.D.|507-255-9230|Lipford.Melissa@mayo.edu|
314091|NCT03249909|Mölnlycke Health Care|Andrea Marie Picchietti|260 2583879|andrea.picchietti@molnlycke.com|
314092|NCT03249935|University of Arkansas for Medical Sciences|Jeannette Lee|501-526-6712|jylee@uams.edu|
314093|NCT03250182|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
314094|NCT03250234|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@mail.mil|
314383|NCT03298412|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
292549|NCT01433081|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
292550|NCT01433107|Novartis|Clinical Project leader|+41223633111||
292551|NCT01433159|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
292552|NCT01433172|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jhanelle Gray|813-745-3050|jhanelle.gray@moffitt.org|
292553|NCT01433250|Novartis Pharmaceuticals|Study Director|862-778-8300||
292554|NCT01433263|Novartis Pharmaceuticals|Study Director|862-778-8300||
292555|NCT01433354|Novartis Pharmaceuticals|Study Director|862--778--8300||
282449|NCT00856193|Novartis Pharmaceuticals|Study Director|862-778-8300||
304649|NCT02268396|Pearl Therapeutics Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
304650|NCT02268500|University of Minnesota|Orly Vardeny, Associate Professor of Medicine|612.467.4586|ovardeny@umn.edu|
304651|NCT02268526|Novartis Pharmaceuticals|Study Director|8627788300||
304652|NCT02268786|Illumina|Tasha Kalista|858-202-4500|tkalista@illumina.com|
304653|NCT02268812|Eisai Europe Ltd.|Eisai Medical Services|+44 (0)20 8600 1400||
304654|NCT02268851|Dana-Farber Cancer Institute|Matthew Davids, MD, MMSc|617-632-6331|matthew_davids@dfci.harvard.edu|
304655|NCT02268864|Janssen Research and Developement, Belgium|Trial Physician||ClinicalTrialDisclosure@its.jnj.com|
304656|NCT02268877|Denver Health and Hospital Authority|Dr. John Kendall|(303)602-5187|John.Kendall@dhha.org|
304657|NCT02268942|Medtronic Cardiac Rhythm and Heart Failure|Mary Jacoski|+15087390909|mary.v.jacoski@medtronic.com|
304658|NCT02268955|Maricopa Integrated Health System|Dan Quan, DO|602-344-5058|dany_quan@dmgaz.org|
304659|NCT02268994|Keryx Biopharmaceuticals, Inc.|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
304660|NCT02269098|Medstar Health Research Institute|Michelle F Magee, MD|202-877-0351|michelle.f.magee@medstar.net|
304661|NCT02269124|Massachusetts Eye and Ear|Dr. Michael S. Cohen, MD|6175733190|Michael_Cohen@MEEI.HARVARD.EDU|
304662|NCT02269163|Prometic Biotherapeutics Inc|Director, External Biologics|438-802-3497|clinical@prometic.com|
304663|NCT02269241|Exeltis|Dr. Enrico Colli, Chief Scientific Officer|+34917711500|enrico.colli@exeltis.com|
304664|NCT02269423|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304665|NCT02269475|CO RIA TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
304666|NCT02269488|MedImmune, LLC, a wholly-owned subsidiary of AstraZeneca PLC|Raburn Mallory|+1 301-398-5799|malloryr@medimmune.com|
304667|NCT02269631|Emory Unioversity|Hartman, Terry Professor, SPH Epidemiology|404-727-8713|terryl.johnson.hartman@emory.edu|
304668|NCT02269657|Children's Hospital of Philadelphia|Saba Pasha, PhD|215-590-1815|pashas@email.chop.edu|
304669|NCT02269709|University of Michigan|Frank W. DiPaola, MD|734-763-9650|dipaolaf@med.umich.edu|
304670|NCT02269787|Department of Veterans Affairs|Dr. Christine Timko, Research Career Scientist|6504935000|Christine.Timko@va.gov|23336
304671|NCT02269943|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
304672|NCT02270060|University Hospitals Connor Integrative Health Network|Samuel Rodgers-Melnick, MT-BC, music therapist|216-844-7727|Samuel.RodgersMelnick@UHhospitals.org|
304673|NCT02270242|Icahn School of Medicine at Mount Sinai|Dr. Roxana Mehran|212-659-9691|roxana.mehran@mountsinai.org|
282450|NCT00856206|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
304674|NCT02270255|McGill University Health Centre|Louis-Martin boucher|5149341934|lmboucher@yahoo.com|44454
304675|NCT02270515|University of Illinois, Chicago|Dr. Denise M. Hynes, Professor, College of Medicine|312-355-0083|dhynes@uic.edu|
304676|NCT02270645|University of Miami|Keyvan Nouri|3052433380|knouri@med.miami.edu|
304677|NCT02270671|University College Dublin|Dr Amanda Fitzgerald|+35317168541|amanda.fitzgerald@ucd.ie|
304678|NCT02270736|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
304679|NCT02270944|GlaxoSmithKline|GSK Response Center|866-435-7343||
304680|NCT02270983|Forest Research Institute, Inc., an affiliate of Allergan|Therapeutic Area Head|862-261-7000|IR-CTRegistration@allergan.com|
304681|NCT02271217|Acorda Therapeutics|Holly Roberts, Executive Medical Director|914-326-5000|hroberts@acorda.com|
304682|NCT02271386|The Children's Hospital of Philadelphia|Alexander Fiks, MD, MSCE|2674262304|fiks@email.chop.edu|
304683|NCT02271425|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
304684|NCT02271451|Cincinnati Children's Hospital|Dr. Gregory Myer|513-636-4366|gregory.myer@cchmc.org|
304685|NCT02271477|Ente Ospedaliero Cantonale|Dr. med. Andrea Saporito, Vice-Director of Anaesthesiology|091/811.89.78|andrea.saporito@eoc.ch|
304686|NCT02271529|Cook Research Incorporated|Scott Snyder, Director, Clinical Affairs|765-463-7537|SSnyder@medinst.com|
304687|NCT02271698|Duke University Health System|Dr. Stuart Alan Grant|919-681-6437|stuart.grant@duke.edu|
304688|NCT02271854|Novartis Consumer Health a GSK Consumer Healthcare company|Director Clinical Research pain category|+413635528||
304689|NCT02271880|Florida International University|Dr. William Pelham|305-348-0477|wpelham@fiu.edu|
304690|NCT02271906|UT MD Anderson Cancer Center|George Simon, MD|713-792-7734|GSimon@mdanderson.org|
304691|NCT02271945|MedImmune, LLC|Mohammed Dar|301-398-4095|information.center@astrazeneca.com|
304692|NCT02271984|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
304693|NCT02272244|Thomas Jefferson Universiy|Ronald Myers(Priniciple Investigator)|215-5034085|ronald.myers@jefferson.edu|
304694|NCT02272413|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
304695|NCT02272634|Yungjin Pharm. Co., Ltd.|Director of Clinical Trials|82-2-2041-8318|mhlee2017@yungjin.co.kr|
304696|NCT02272686|UT MD Anderson Cancer Center|Issa F. Khouri, MD, Professor, Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
304697|NCT02272725|Stanford University School of Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
304698|NCT02272777|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
304699|NCT02272790|AstraZeneca|Pejvack Motlagh, MD|+44 (0) 7384 799 850|pejvack.motlagh@astrazeneca.com|
304700|NCT02272816|Centre for Experimental Cancer Medicine, Barts Cancer Institute, QMUL|Project Lead|02078828277|bci-carpet@qmul.ac.uk|
304701|NCT02272842|Innlandet Hospital Trust|Tor Strand|+4790971086|tors@me.com|
304702|NCT02272985|University Medical Center Groningen|Dr. C.F.M. Franssen|+0031(0)50 3616161|c.f.m.franssen@umcg.nl|
304703|NCT02273037|The Hospital for Sick Children|Dr. Diego G. Bassani|+14168137654|diego.bassani@sickkids.ca|303033
282451|NCT00856232|UMDNJ|Dr. Boris Veysman|732-235-8717|veysmabo@umdnj.edu|
304704|NCT02273050|AstraZeneca|Eva Johnsson, MD, PhD|46 31 7762484|Eva.Johnsson@astrazeneca.com|
304705|NCT02273063|Neuromodulation Research Clinic|Director|401-455-6200|Linda_Carpenter_MD@Brown.edu|
304706|NCT02273115|University of Massachusetts - Baystate|Dr. Corina Schoen|4137543470|Corina.SchoenMD@baystatehealth.org|413
304707|NCT02273141|Norgine Ltd|Lucy Clayton|+44-1895-826669|LClayton@norgine.com|
304708|NCT02273167|Norgine Ltd|Lucy Clayton|+44-1895-826669|LClayton@norgine.com|
304709|NCT02273180|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
304710|NCT02273206|Clinical Directors Network|Andrea Cassells, MPH|212-382-0699|acass@cdnetwork.org|227
304711|NCT02273310|The Children's Hospital of Philadelphia/Perleman School of Medicine of The University of Pennsylvania|Lamia Barakat, Ph.D.|267-426-8135|barakat@email.chop.edu|
304712|NCT02273323|Unilever R&D Vlaardingen|Theo Mulder|+31 10 460 8315|theo.mulder@unilever.com|
304713|NCT02273596|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
304714|NCT02273726|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|064study@fibrogen.com|
304715|NCT02273739|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
304716|NCT02273908|Medical Affairs, Pfizer Japan Inc.|Study Director : Koichi Fujii, MD|81-3-5309-9370|koichi.fujii@pfizer.com|
304717|NCT02273960|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
304718|NCT02273973|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
304719|NCT02274038|University of Pennsylvania Perelman School of Medicine|Dr. Sharyn Katz, Principal Investigator|215-662-4000|sharyn.katz@pennmedicine.upenn.edu|
282452|NCT00856245|University of Kansas Cancer Center|Siddhartha Ganguly, MD|(913) 588-6030|sganguly@kumc.edu|
304720|NCT02274311|Hospital das Clinicas da Faculdade de Medicina da USP|Dr. Felipe Henning Gaia Duarte|+5511987550990|drfelipegaia@outlook.com|
304721|NCT02274493|UT MD Anderson Cancer Center|Dr. Jesse C Selber / Professor, Plastic Surgery|713-794-1297|jcselber@mdanderson.org|
304722|NCT02274558|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
304723|NCT02274649|Shepherd Center|Michael Jones, PhD, Director Research|4043507595|mike_jones@shepherd.org|
304724|NCT02274675|Universiti Teknologi Malaysia|Project Leader||cfyeong@utm.my|
304725|NCT02274688|University of Washington|Douglas Zatzick|2067446701|dzatzick@uw.edu|
304726|NCT02274766|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
304727|NCT02274792|Amgen Inc.|Study Director|866-572-6436||
304728|NCT02274844|University of Wisconsin-Madison|Susan Andreae|608-265-8195|sandreae@wisc.edu|
304729|NCT02274857|Abbott|Clinical Program Director|651-756-6717|kristin.ruffner@abbott.com|
304730|NCT02274870|Northwell Health|Director of Research, Anesthesiology|718-470-7630|odowling@northwell.edu|
304731|NCT02274948|Faculty of Medicine, University of Colombo|Prof V Pujitha Wickramasinghe|+94112688748|pujithaw@yahoo.com|170
304732|NCT02275026|Icahn School of Medicine at Mount Sinai|Dr. Joshua Mincer|(917) 922-9475|joshua.mincer@mountsinai.org|
304733|NCT02275052|GlaxoSmithKline|GSK Response Center|866-435-7343||
304734|NCT02275065|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
304735|NCT02275117|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
304736|NCT02275156|Amgen Inc.|Study Director|866-572-6436||
304737|NCT02275338|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
304738|NCT02275364|GlaxoSmithKline|GSK Response Center|866-435-7343||
304739|NCT02275611|University of North Carolina at Chapel Hill|Dr. Cort A. Pedersen|(919) 966-4447|Cort_Pedersen@med.unc.edu|
304740|NCT02275767|Univ of Texas Health Sci Ctr San Antonjio, Dept of Periodontics|Brian L. Mealey DDS, MS|210-567-3567|mealey@uthscsa.edu|
304741|NCT02275780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304742|NCT02275819|VA Boston Healthcare System|Dr. Jayashri Aragam|617-323-7700|Jayashri.Aragam@va.gov|
304743|NCT02275923|Medtronic|Jennifer Seamans, Principal Clinical Research Specialist|7635262835|jennifer.l.seamans@medtronic.com|
304744|NCT02276027|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
304745|NCT02276040|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2260|susan.odum@orthocarolina.com|
304746|NCT02276053|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
304747|NCT02276222|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
304748|NCT02276274|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
314095|NCT03250689|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314096|NCT03250845|UZ Leuven|Datamanager|+3216346880|jonas.vanham@uzleuven.be|
314097|NCT03251482|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
314098|NCT03251937|Boston Scientific|Director of Clinical Sciences|661 949 4350|roshini.jain@bsci.com|
314099|NCT03251963|University of Utah|Christopher Pannucci|801 581 2121|christopher.pannucci@hsc.utah.edu|
314100|NCT03252015|Eli Lilly and Company|Cheif Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
314101|NCT03252145|University of California, San Francisco|Betty Smoot, DPTSc, PT|(707) 494-8262|Betty.Smoot@ucsf.edu|
314102|NCT03252353|Chiasma|Asi Haviv, VP Clinical development|972-8-939-3888|Asi@chiasmapharma.com|
314103|NCT03252431|Generon/Evive Biotech|Christina Tay|1-908-540-0816|christina.tay@evivebiotech.com|
314104|NCT03252964|Savvysherpa, Inc.|Jared Jones, PhD|7635493540|JaredJones@savvysherpa.com|8116
282453|NCT00856284|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
282454|NCT00856297|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
314105|NCT03253094|SCYNEXIS|Dr. David Angulo|(201) 884 - 5471|david.angulo@scynexis.com|
314106|NCT03254108|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
282455|NCT00856323|Friends Research Institute, Inc.|Dr. Cathy Reback|323-463-1601|reback@friendsresearch.org|
304749|NCT02276482|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304750|NCT02276612|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230|GileadClinicalTrials@gilead.com|
304751|NCT02276638|Nidek|Head, Regulatory Affairs|(800) 223-9044|support@nidek.com|
304752|NCT02276807|VA Center for Integrated Healthcare|Dr. Jennifer Funderburk|315-425-4400|Jennifer.Funderburk@va.gov|54703
304753|NCT02276872|United Therapeutics|Derek Solum, PhD|919-425-8122|dsolum@unither.com|
304754|NCT02276963|Johns Hopkins University|Michael Levy|443-287-4412|mlevy@jhmi.edu|
304755|NCT02277054|Filatov Institite of Eye Diseases and Tissue Therapy of the NAMS of Ukraine|Dr. Oleksiy Buznyk|+380487181548|a_buznik@bk.ru|
304756|NCT02277093|Washington University School of Medicine|Benjamin R. Tan|314-362-9915|btan@wustl.edu|
304757|NCT02277249|University of California, Los Angeles|Clinical Instructor - Department of Obstetrics and Gynecology|3107942257|priyabatra@mednet.ucla.edu|
304758|NCT02277548|University of Pennsylvania|Dr. Erin McMenamin|251-662-2428|Erin.McMenamin@pennmedicine.upenn.edu|
304759|NCT02277626|Stanford University|Carlos Milla, MD|650-723-5193|cmilla@stanford.edu|
304760|NCT02277639|Children's Hospital of Philadelphia|Nancy Bunin, MD|215-590-2255|buninn@email.chop.edu|
304761|NCT02277665|Dartmouth-Hitchcock|Dr. Alan J. Budney|603-646-7088|alan.j.budney@dartmouth.edu|
304762|NCT02277691|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
304763|NCT02277743|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
304764|NCT02277769|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
304765|NCT02277925|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH|919-966-0014|jennifer_wu@med.unc.edu|
304766|NCT02277990|Medtronic|Daniel Lexcen, Sr. Clinical Program Manager|+17635269702|daniel.lexcen@medtronic.com|
304767|NCT02278003|Memorial Sloan Kettering Cancer Center|Dr. Eric Kelhoffer, MD|212-639-8781|kelhoffe@mskcc.org|
304768|NCT02278146|Skyline Urology|Fredrick Wolk, MD|+1 310.602.5005|fred.wolk@skyuro.com|
304769|NCT02278237|University of Chicago|Valerie G. Press, MD, MPH|773-702-5170|vpress@medicine.bsd.uchicago.edu|
304770|NCT02278263|Ko Awatea|Dr Marinus Stowers|+64 276 0044|msto062@aucklanduni.ac.nz|2219
304771|NCT02278289|Department of Physical Medicine and Rehabilitation, Taipei Tzuchi Hospital, Buddhist Tzuchi Medical Foundation, New Taipei City, Taiwan, ROC|Dr. Yi-Shiung Horng|+886-2-66289779|d97841001@ntu.edu.tw|64515
304772|NCT02278328|Children's Hospital of Philadelphia|Timothy Roberts, Professor|267 426 0307|robertstim@email.chop.edu|
304773|NCT02278341|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
304774|NCT02278354|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
304775|NCT02278367|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
304776|NCT02278471|UT southwestern|Dr. Thomas J Wang|6159361717|thomas.wang@UTsouthwestern.edu|
304777|NCT02278484|Entellus Medical|Ellen O'Malley|763-463-1598|eomalley@entellusmedical.com|952
304778|NCT02278562|VA TN Valley Healthcare System|Alp Ikizler MD|615-322-5000|alp.ikizler@vanderbilt.edu|
304779|NCT02278614|Laboratoires Théa|Director of Medical Operations|04 73 98 50 89|J.AUGER@laboratoires-thea.fr|
304780|NCT02278640|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
304781|NCT02278783|Huntsman Cancer Institute|Theresa Werner|801-587-3486|theresa.werner@hci.utah.edu|
304782|NCT02278939|University of California San Francisco, School of Nursing|Dr. Melinda Sarmiento Bender and Dr. Yoshimi Fukuoka|(415) 514-3151|melinda.bender@ucsf.edu; yoshimi.fukuoka@ucsf.edu|
304783|NCT02278952|University of California, San Francisco|Dr. John Greenland|415-476-0789|john.greenland@ucsf.edu|
304784|NCT02279043|University of California, San Francisco|Edith Fox|4152062544|edith.fox@ucsf.edu|
304785|NCT02279082|Dr. Reddy's Laboratories|Clinical Operations Director|609-282-1476|kgulbronson@promiuspharma.com|
304786|NCT02279108|CHU Saint-Etienne|Pr Céline CHAULEUR|04 77 82 86 11|celine.chauleur@chu-st-etienne.fr|+33
304787|NCT02279160|United Therapeutics|Derek Solum, PhD|919-425-8122|dsolum@unither.com|
304788|NCT02279173|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
304789|NCT02279407|AstraZeneca|Stefan Carlsson||Stefan.C.Carlsson@astrazeneca.com|
304790|NCT02279420|USGI Medical|Senior Director of Clinical Research|9493693890|samlung@usgimedical.com|
304791|NCT02279498|Anthera Pharmaceuticals|Monica Gangal|510-856-5600|info@anthera.com|
304792|NCT02279524|Galmed Research and Development, Ltd.|Medical Director|+972.3.693.8448|clinicaltrial@galmedpharma.com|
304793|NCT02279641|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
304794|NCT02279667|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
304795|NCT02279719|Sumitomo Dainippon Pharma Oncology|Matthew Hitron, MD|617-674-6800|mhitron@bostonbiomedical.com|
304796|NCT02279732|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
304797|NCT02279862|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
304798|NCT02280044|Johns Hopkins Bloomberg School of Public Health|David A Sack|443 287 8795|dsack1@jhu.edu|
304799|NCT02280096|Instituto Mexicano del Seguro Social. Unidad de Investigación Médica en Enfermedades Neurológicas.|Dr. Israel Grijalva|(01152) 5555780240|igrijalvao@yahoo.com|
304800|NCT02280122|JWGUniversity|Prof. Dr. Peter Eickholz|+49696301|eickholz@med.uni-frankfurt.de|5642
304801|NCT02280187|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
304802|NCT02280200|University of Minnesota|Ryan Mays PhD, MPH, MS|612-625-0430|rjmays@umn.edu|
304803|NCT02280226|University of Bonn|Dr. Jonas Doerner|017632817006|jonas.doerner@ukb.uni-bonn.de|
304804|NCT02280291|NYU Langone Health|Nirmal Tejwani|212 598 6599|Nirmal.Tejwani@nyulangone.org|
304805|NCT02280304|Michael E. DeBakey VA Medical Center|Dr. Mary Newsome|713-791-1414|mary.newsome@va.gov|25947
282456|NCT00856349|Medtronic Cardiac Rhythm Disease Management|Daniel Lexcen, Clinical Research Specialist|763-526-9702|daniel.lexcen@medtronic.com|
282457|NCT00856375|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
304806|NCT02280317|Valirx plc|Dr Suzanne Dilly|+44 2476796496|suzanne.dilly@valirx.com|
304807|NCT02280408|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
304808|NCT02280421|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
304809|NCT02280473|Allergan plc|Michael Robinson|1-714-246-6415|Robinson_Michael@Allergan.com|
304810|NCT02280499|Smith & Nephew|Evita Leiber, Clinical Study Manager|+41 41 766 2205|evita.leiber@smith-nephew.com|
304811|NCT02280655|Emory University|Dr. John D. Roback|404-712-1774|jroback@emory.edu|
304812|NCT02280811|National Cancer Institute|Dr. Christian Hinrichs|301-435-3027|hinrichs@nih.gov|
304813|NCT02280863|Stanford University|Dr. Bruce Buckingham, MD||buckingham@stanford.edu|
304814|NCT02281136|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Manager of Clinical Research|9147608796|Anna.Houlihan@sunpharma.com|
304815|NCT02281318|GlaxoSmithKline|GSK Response Center|866-435-7343||
304816|NCT02281344|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
304817|NCT02281357|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
304818|NCT02281409|Memorial Sloan Kettering Cancer Center|Dr. Jedd Wolchok, MD, PhD|646-888-2315|wolchokj@mskcc.org|
304819|NCT02281422|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
304820|NCT02281448|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
304821|NCT02281500|Instituto Grifols S.A.|Jordi Navarro Puerto|+34 935712200|jordi.navarro@grifols.com|
304822|NCT02281526|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
304823|NCT02281552|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
304824|NCT02281591|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
304825|NCT02281760|National Human Genome Research Institute|Gahl, William|+1 301 402 2739|gahlw@mail.nih.gov|
304826|NCT02281773|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
304827|NCT02281851|University of Birmingham|Mathew Soden|07800549318|matthewsoden33@gmail.com|
304828|NCT02282111|The Johns Hopkins Hospital|Dr. Mouen A. Khashab|410-502-0064|mkhasha1@jhmi.edu|
304829|NCT02282163|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound Programs|1-609-514-2506|Melda.Dolan@diag.bracco.com|
304830|NCT02282293|UCSF|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
304831|NCT02282514|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
304832|NCT02282527|Grifols Therapeutics Inc.|Henry Li|1-919-316-6042|henry.li@grifols.com|
304833|NCT02282605|Destiny Pharma|Director of Projects|+44 (0) 1273 704440|medinfo@destinypharma.com|
304834|NCT02282631|Institute of Health and Society, Newcastle University|Dr Samuel Ginja|+44191208|samuel.ginja@newcastle.ac.uk|4565
304835|NCT02282722|Dana-Farber Cancer Institute|Dr. Deb Schrag|617-582-8301|deb_schrag@dfci.harvard.edu|
304836|NCT02282813|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
304837|NCT02282904|NIAID|Elizabeth Kang|3014027567|ekang@niaid.nih.gov|
304838|NCT02282930|Mayo Clinic|Dr. Fernando Fervenza|507-266-1045|fervenza.fernando@mayo.edu|
304839|NCT02282982|AbbVie|Global Medical Services|800-633-9110||
304840|NCT02283268|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
304841|NCT02283294|University of South Florida|David Rose, MD|813-259-8577|drose1@usf.edu|
304842|NCT02283333|Ralph H. Johnson VA Medical Center|Dr. Ron Acierno, PI|843-364-1667|ron.acierno@va.gov|
304843|NCT02283411|Abbott Diabetes Care|Shridhara A Karinka, PhD|510-749-6393|shridhara.alva@abbott.com|
304844|NCT02283528|Emory University|Dr. Gary Francis Bouloux|404-778-4500|gfboulo@emory.edu|
304845|NCT02283658|Mayo Clinic|Gerardo Colon-Otero, M.D.|(904) 953-2000|gcolonotero@mayo.edu|
304846|NCT02283749|Brown University Oncology Research Group (BrUOG)|Kayla Rosati|14018633000|kayla_rosati@brown.edu|
304847|NCT02283762|Bayer|Therapeutic Area Head|+1 888-8422937|clinical-trials-contact@bayer.com|
304848|NCT02283788|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|francisco.rocha@bial.com|
314107|NCT03254134|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314108|NCT03254147|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314109|NCT03254459|Insys Therapeutics, Inc.|Director, Clinical Development|4805003105|gdecastro@insysrx.com|
314110|NCT03254602|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
314111|NCT03254719|Palmer Center for Chiropractic Research|Dr. Anna Walden-Cobb|563-949-0676|anna.waldencobb@palmer.edu|
314112|NCT03255187|Department of Environmental Health, School of Public Health, Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
314113|NCT03255291|Washington University School of Medicine|Erika Waters, MPH, Ph.D.|314-286-2757|waterse@wustl.edu|
314114|NCT03255382|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
314115|NCT03255655|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
314116|NCT03255733|Guided Therapy Systems|Rich Amodei, RDMS|480-649-8587|r.amodei@guidedtherapy.com|
314117|NCT03255824|Montefiore Medical Center|Dr. Patrick Nolan|718-405-8195|pnolan@montefiore.org|
314118|NCT03255902|William Beaumont Hospitals|Donna Marvicsin, Nurse Practitioner, Pediatric Endocrinology|248-568-6932|donna.marvicsin@beaumont.org|
314119|NCT03255941|FHI 360|Mario Chen|919 544 7040|mchen@fhi360.org|11399
314120|NCT03255980|Helsinn Healthcare SA|Dr. Fabio Macchi|0041919852121|fabio.macchi@helsinn.com|
314121|NCT03256136|Massachusetts General Hospital|Dr. Jessica Lin|617-724-1134|jjlin1@partners.org|
282458|NCT00856388|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
304849|NCT02283814|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
304850|NCT02283827|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
304851|NCT02283840|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
304852|NCT02284009|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
304853|NCT02284126|Columbia University Irving Medical Center|Dr. E. Sander Connolly Jr.|2123054118|esc5@cumc.columbia.edu|
304854|NCT02284165|Duke Clinical Resarch Institute|Janet Prvu Bettger, ScD|617-901-0277|janet.bettger@duke.edu|
304855|NCT02284178|University of Central Florida|Mary Lou Sole|407-823-5496|mary.sole@ucf.edu|
304856|NCT02284243|Recro Pharma|Randall Mack|484-395-2470|rmack@recropharma.com|2406
304857|NCT02284347|Medtronic Xomed|Director of Clinical Trials|904-296-9600|dl.nuventstudy@medtronic.com|
304858|NCT02284386|Pacira|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com|
304859|NCT02284399|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
304860|NCT02284464|Hospital Regional Universitario de Málaga|Dr. Domingo Hernandez|951291174|domingohernandez@gmail.com|
304861|NCT02284516|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
304862|NCT02284555|Destiny Pharma|Director of Projects|+44 (0)1273 704440|medinfo@destinypharma.com|
304863|NCT02284568|Teva Pharmaceutical Industries Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
304864|NCT02284828|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
304865|NCT02284854|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
304866|NCT02284867|Ain Shams university (AinShamsU)|Ahmed Mohammed Abass , Ass.lecturer in faculty of medicine|002-01066903903|ahmedmams@hotmail.com|
304867|NCT02284880|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
304868|NCT02284893|AstraZeneca|Katarina Fridman|+46(31)7762040|katarina.fridman@astrazeneca.com|62040
304869|NCT02285010|Mahidol University|Dr.Taniga Kiatchai|+66-2-419-7990|taniga@gmail.com|
304870|NCT02285023|Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University|Prof. Kanokvalai Kulthanan|(662)419-4333|kanokvalai.kul@mahidol.ac.th|
304871|NCT02285114|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
304872|NCT02285153|Medical University of Vienna|Bernd Jilma|+434040029180|bernd.jilma@meduniwien.ac.at|
304873|NCT02285283|The University of Texas Health Science Center at Houston|Amber U. Luong, MD, PhD|713-486-5000|Amber.U.Luong@uth.tmc.edu|
304874|NCT02285361|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282459|NCT00856414|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
304875|NCT02285634|Mayo Clinic|Dr. Tobias Kummer|507 255 4732|vanmeter.derek@mayo.edu|
304876|NCT02285777|GlaxoSmithKline|GSK Response Center|866-435-7343||
304877|NCT02285855|UT MD Anderson Cancer Center|Stephen Chun/Assistant Professor, Radiation Oncology|713- 563-9600|sgchun@mdanderson.org|
304878|NCT02285907|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
304879|NCT02285920|University of Pennsylvania|Laura M. Dember, MD|215-573-5264|ldember@pennmedicine.upenn.edu|
304880|NCT02285998|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
304881|NCT02286102|Hospital for Special Surgery|Oheneba Boachie-Adjei, MD|212 606-1723|rosst@hss.edu|
304882|NCT02286193|Group Health Research Institute|Clarissa Hsu, PhD|206-287-4276|hsu.c@ghc.org|
304883|NCT02286466|Massachusetts General Hospital Cancer Center|Joseph Greer, PhD|617-643-2143|jgreer2@mgh.harvard.edu|
304884|NCT02286518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
304885|NCT02286713|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
304886|NCT02286726|The University of Texas MD Anderson Cancer Center|Ghayas Issa C. MD./Assistant Professor|713-745-6798|GCIssa@mdanderson.org|
304887|NCT02286843|Memorial Sloan Kettering Cancer Center|Dr. Gary Ulaner, MD, PhD|212-639-7373|carrasj1@mskcc.org|
282460|NCT00856492|SWOG Statistical Center|Breast Committee Statistician|206-667-4623||
304888|NCT02286895|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
304889|NCT02286921|SKCCC at JHU|Dr. Samual Denmeade|410-955-8875|denmesa@jhmi.edu|
304890|NCT02286947|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
304891|NCT02286960|NYU Langone Health|Milan Amin|646-754-1206|Milan.Amin@nyulangone.org|
304892|NCT02287038|Ralph H. Johnson VA Medical Center|Dr. Zhewu Wang|8437897949|zhewu.wang@va.gov|
304893|NCT02287350|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
304894|NCT02287376|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
304895|NCT02287402|Japan Development Center, Pharmaceutical Development Division, Takeda Pharmaceutical Company Limited|Hitoshi Onouchi|+81-6-6204-5116|hitoshi.onouchi@takeda.com|
304896|NCT02287415|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
304897|NCT02287467|NIAID|Dr. Richard Davey|301-496-8029|rdavey@niaid.nih.gov|
304898|NCT02287584|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
304899|NCT02287610|Horizon Pharma Ireland, Ltd.|Mike Marshall, PharmD|224-383-3000|clinicaltrials@horizonpharma.com|
304900|NCT02287623|University of Minnesota|Dr. Jacob Hutchins|612-624-9990|hutc0079@umn.edu|
304901|NCT02287675|Kettering Health Network|Dr. Arash Kardan|937-395-8611|arash.kardan@ketteringhealth.org|
304902|NCT02287688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
304903|NCT02287779|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
304904|NCT02287818|TWi Biotechnology Inc.|JingYi Lee|886-2-26571788|jingyi.lee@twibiotech.com|201
304905|NCT02287883|University of California, Berkeley|Patricia Ramsay, Project Drector|(510)643-8063|pramsay@berkeley.edu|
304906|NCT02287896|LFB Biotechnologies|Clinical trial Information desk|33169825656|supportqcm@lfb.fr|
304907|NCT02287909|University of Florida|Dominick J. Angiolillo, MD, PhD|9042443378|dominick.angiolillo@jax.ufl.edu|
304908|NCT02287922|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
304909|NCT02288091|Massachusetts General Hospital|Sabrina Paganoni, MD, PhD|617-724-3914|spaganoni@mgh.harvard.edu|
304910|NCT02288156|UZ Leuven|Prof. Dr. Hellings|016336340|nkogh@uzleuven.be|
304911|NCT02288182|gwd consult · contract research|Dr. Manfred Klasser|+49 (6108) 8256520|manfred.klasser@gwd-consult.de|
304912|NCT02288273|AstraZeneca, PLL|Sergey Zhuplatov MD, PhD|215-542-3222|Sergey.Zhuplatov@astrazeneca.com|
304913|NCT02288312|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
304914|NCT02288325|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
304915|NCT02288364|Duke University Medical Center|Jay A. Baker, MD|919-684-7645|jay.baker@duke.edu|
304916|NCT02288377|FFCD|Karine Le Malicot|+ 33 3 80 39 34 79|karine.le-malicot@u-bourgogne.fr|
304917|NCT02288559|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
304918|NCT02288819|Ziekenhuis Oost-Limburg|Dr. Frederik Verbrugge|0473924199|frederik.verbrugge@zol.be|+32
304919|NCT02289079|University of MInnesota|Dr. Jacob Hutchins|6126249990|hutc0079@umn.edu|
304920|NCT02289105|Fostering Improvement in End-of-Life Decision Science Program|Dr. Scott Halpern|215-5739461|shalpern@exchange.upenn.edu|
304921|NCT02289157|UTSW Medical Center|Dr. Scott Roberts|214-648-3113|scott.roberts@utsouthwestern.edu|
304922|NCT02289222|University of Maryland Greenebaum Comprehensive Cancer Center|Ashraf Badros M.B.Ch.B|410-328-1230|Abadros@umm.edu|
304923|NCT02289352|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
304924|NCT02289417|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
304925|NCT02289456|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@celgene.com|
304926|NCT02289469|SAI Interactive|Dr. Dane Boyington|(423) 521-2309|dane@thinkingmedia.com|
304927|NCT02289690|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
304928|NCT02289729|AbbVie|Global Medical Services|800-633-9110||
304929|NCT02289742|Alcon Research, Ltd.|Global Medical Affairs, Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
304930|NCT02289755|Allena Pharmaceuticals|VP of Clinical Development|617-467-4577|akausz@allenapharma.com|314
304931|NCT02289820|MedImmune LLC|Judith Falloon, MD, FACP, FIDSA, Senior Director, Clinical Development|+1-301-398-4010|information.center@astrazeneca.com|
304932|NCT02289833|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
304933|NCT02289898|Mereo BioPharma Group Plc.|John, Lewicki, Chief Scientific Officer|+44333023300|John.Lewicki@mereobiopharma.com|
304934|NCT02289950|Eisai Inc.|Eisai Medical Information|888-274-2378|esi_oncmedinfo@eisai.com|+1
304935|NCT02289963|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
304936|NCT02289989|Rutgers Robert Wood Johnson Medical School|Amy Pappert, MD|732-235-7765|papperas@rwjms.rutgers.edu|
304937|NCT02290028|BIOTRONIK, Inc.|Senior Manager, Scientific Affairs|1-800-547-0394|crystal.miller@biotronik.com|
304938|NCT02290106|Massachusetts General Hospital|Takara Stanley, MD|6177249109|tstanley@mgh.harvard.edu|
304939|NCT02290184|University of California San Francisco|Melinda Sarmiento Bender, PhD, RN|415 502 5668|melinda.bender@ucsf.edu|
304940|NCT02290223|Kaiser NCAL Division of Research|Monique Does, Project Manager|510-891-3612|monique.does@kp.org|
304941|NCT02290340|MedImmune, LLC|M. Pamela Griffin|301-398-4095|information.center@astrazeneca.com|
304942|NCT02290405|National Jewish Health|Bryan Simmons|303-398-1850|SimmonsB@NJHealth.org|
304943|NCT02290444|University at Buffalo|Curtis Wojcik, Lab Coordinator|7163230551|cmwojcik@buffalo.edu|
304944|NCT02290509|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
304945|NCT02290574|Samsung Medical Center|Professor|82-2-3410-2612|hee.ro.park@gmail.com|
304946|NCT02290613|Thoraxklinik Heidelberg gGmbH at Heidelberg University Hospital|Prof. Dr. med. E. Grünig|+49 6221 396|ekkehard.gruenig@med.uni-heidelberg.de|8053
304947|NCT02290691|PharmaJet, Inc|Tara Miller, MS, Clinical Affairs Manager|888-900-4321|tara.miller@pharmajet.com|4163
304948|NCT02290821|Novartis Consumer Health|Clinical Research Director Pain, CH Clinical Research & Development Lead|+41225672574||
314122|NCT03256162|Trinity College Dublin|Dr Bronagh Gallagher|01 249|bgallag@tcd.ie|3200
314123|NCT03256253|New York State Psychiatric Institute|John Mariani MD|6467748181|john.mariani@nyspi.columbia.edu|
314124|NCT03256526|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
314125|NCT03256552|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
314126|NCT03256578|Leiden University Medical Center|Dr. Arjan te Pas|+31 71 5265839|a.b.te_pas@lumc.nl|
314127|NCT03256695|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
314128|NCT03256799|UAB|Steven M. Rowe|205-975-9776|smrowe@uab.edu|
314129|NCT03256851|Wayne State University|Dr. Nora Fritz|(313) 577-1096|nora.fritz@wayne.edu|
314130|NCT03256968|Universtiy of Alabama at Birmingham|Steven Rowe|205-975-9776|srowe@uabmc.edi|
314131|NCT03257189|MC10 Inc|Chief Medical Officer|8572145600|ACombs@mc10inc.com|
314132|NCT03257202|Keck Medical Center of USC|Dr. George Hatch|323-442-5860|ghatch.md@gmail.com|
314133|NCT03257358|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
314134|NCT03257371|University of Missouri|Dr. James Cook|573-882-7189|cookjl@health.missouri.edu|
314384|NCT03298841|Toyos Clinic|Melissa Toyos|6153274015|mtoyos@toyosclinic.com|
281766|NCT04187989|University of Michigan|Dr. Erin Bonar|7347647936|erinbona@med.umich.edu|
304949|NCT02290873|PAION UK Ltd|Trial Information|+49 2414453101|reg_paion@paion.com|
304950|NCT02290925|Faculty of Medicine & Allied Sciences, Rajarata University of Sri Lanka|Professor Sisira Siribaddana|+94777326940|sisira.siribaddana@gmail.com|
304951|NCT02291016|University of Tennessee Graduate School of Medicine|Clinical Trials Coordinator|865-305-7975|jferris@utmck.edu|
304952|NCT02291029|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
304953|NCT02291133|Institute of Oncology Ljubljana|Dr Gregor Serša|+38615874343|gsersa@onko-i.si|
314385|NCT03298880|University of Exeter, Royal Devon and Exeter Hospital|Dr Andrew Appelboam, Isabel FitzGerald|07515688294|andy.appelboam@nhs.net ; if223@exeter.ac.uk|
314386|NCT03298984|Sumitomo Dainippon Pharma Oncology, Inc.|Susan Smith|2104147702|Susan.smith@sdponcology.com|
314387|NCT03299049|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314388|NCT03299101|Pittsburgh VA Healthcare System, CHERP|Dr. Daniel E Hall|4123602016|daniel.hall2@va.gov|
314389|NCT03299244|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
314390|NCT03299686|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
314391|NCT03299881|Elira Therapeutics, Inc.|Stephanie Amlung, PhD, RN, Vice President, Clinical Affairs|513-236-6799|samlung@elira.com|
314392|NCT03300050|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
314393|NCT03300466|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
314394|NCT03300570|Fox Chase Cancer Center|David Weinberg, M.D., M.Sc.|215-214-1424|david.weinberg@fccc.edu|
314395|NCT03300674|Montefiore|Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
314396|NCT03300752|Columbia University School of Nursing|Dr. Maureen George|2123051175|mg3656@cumc.columbia.edu|
314397|NCT03300843|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|steven-rosenberg@nih.gov|
314398|NCT03301155|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
314399|NCT03301272|University of North Carolina at Chapel Hill|Daniel Roque, MD|919-966-8178|droque@neurology.unc.edu|
314400|NCT03301298|Promentis Pharmaceuticals|Dean Brostowin|617-300-6172|dbrostowin@promentispharma.com|
314401|NCT03301623|Cedars-Sinai Medical Center|Brennan Spiegel|310-423-6467|brennan.spiegel@cshs.org|
314402|NCT03301649|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
314403|NCT03301714|Kornber School of Dentistry|Dr. Marisol Tellez Merchan|2177071773|marisol@temple.edu|
314404|NCT03301740|University of North Carolina at Chapel Hill|Jennifer E. Flythe, MD, MPH|(919) 445-2656|jflythe@med.unc.edu|
314405|NCT03301779|Hemanext|William Iselin|7813017446|william.iselin@hemanext.com|
314406|NCT03301831|Case Western Reserve University|Valerie Boebel Toly, PhD, RN, CPNP|(216) 368-3082|vab@case.edu|
314407|NCT03301844|NTC srl|Alessandro Colombo|+39 02 4385 0490|alessandro.colombo@ntcpharma.com|
314408|NCT03302091|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314409|NCT03302234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
314410|NCT03302416|Univesity of Pittsburgh|Rajesh Narendran|412-647-5176|narendranr@upmc.edu|
314411|NCT03302559|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
314412|NCT03302741|The University of Texas Health Science Center at Houston|Sheng Li, MD, PhD|713-797-7125|sheng.li@uth.tmc.edu|
314413|NCT03302767|Institut Bergonié|Véronique GERAT-MULLER|0556337839|v.gerat-muller@bordeaux.unicancer.fr|
314414|NCT03302780|University of Texas McGovern Medical School - Houston|Sheng Li, MD, PhD|7137977125|sheng.li@uth.tmc.edu|713
314415|NCT03302793|UTHealth|Dr. Sheng Li|713-797-7125|Sheng.Li@uth.tmc.edu|
314416|NCT03302936|Icahn School of Medicine at Mount Sinai|Annacecilia Peacher-Holderied|2104887216|apeacher4@gmail.com|
314417|NCT03302975|Univeristy of British Columbia|Chris Napier|604-721-1310|chris.napier@ubc.ca|
314418|NCT03303079|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
314419|NCT03303092|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
314420|NCT03303105|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
314421|NCT03303144|Rockwell Medical|Dr Ray Pratt|248 960-9009|rpratt@rockwellmed.com|405
314422|NCT03303196|Children's Hospital of Philadelphia|Lauren Mitteer|267-426-9915|MitteerL@email.chop.edu|
314423|NCT03303404|University of Texas at Austin|Brandon Fico|512-471-8594|bfico@utexas.edu|
314424|NCT03303417|University of Nottingham|Robin Spiller|0115 823 1090|robin.spiller@nottingham.ac.uk|
314425|NCT03303521|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
314426|NCT03303794|Montefiore Medical Center|Dr.Singh Nair|7189205932|sinair@montefiore.org|
314427|NCT03303911|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
314428|NCT03303950|HCI Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
314429|NCT03303989|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|2059966086|pjfoster@uabmc.edu|
314430|NCT03304054|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
314431|NCT03304106|Cochlear Limited|Laura Chenier, Clinical Project Manager|422-325-4171|lchenier@cochlear.com|
314432|NCT03304119|Hôpital Privé Antony|V Chassaing|+33 1 46 74 37 00|vchassaing92@gmail.com|
314433|NCT03304184|University of Michigan|Elizabeth Van Tubergen|2487045640|evantub@umich.edu|
314434|NCT03304522|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
314435|NCT03304626|University of Cincinnati|Khurram Bari|513-558-2898|khurram.bari@uc.edu|
314436|NCT03304873|NYU Grossman School of Medicine|Jennifer Lighter, MD|212-263-5454|Jennifer.Lighter@nyulangone.org|
314437|NCT03305081|TulaneU|Resident of OB/GYN|858-499-2702|sjunya@tulane.edu|
314438|NCT03305159|Northwestern University Feinberg School of Medicine|Supriya Rastogi|supriya.rastogi@northwestern.e|supriya.rastogi@northwestern.edu|
304954|NCT02291237|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
304955|NCT02291289|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
304956|NCT02291302|Boston Children's Hospital|Wanda Phipatanakul, MD. MS.|617-355-6117|wanda.phipatanakul@childrens.harvard.edu|
304957|NCT02291419|Cleveland Clinic|Dr. Venu Menon|216-445-5390|menonv@ccf.org|
304958|NCT02291432|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
304959|NCT02291510|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
304960|NCT02291549|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
304961|NCT02291601|Bioscience Labs|C Beausoleil|460-782-5498|cbeausoleil@biosciencelabs.com|
304962|NCT02291614|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
304963|NCT02291679|Ironwood Pharmaceuticals, Inc.|Michael Hall, MD|(617) 621-7722||
304964|NCT02291718|Duke University Medical Center|Dr. Lynne Koweek|919-684-8111|lynne.koweek@duke.edu|
304965|NCT02291861|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
304966|NCT02291913|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
304967|NCT02292082|Hospital for Special Surgery|George Birch|2127747377|birchg@hss.edu|
304968|NCT02292186|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
304969|NCT02292212|Asahi Kasei Medical Co., Ltd.|Masaharu Aritomi, Ph.D.||aritomi.mb@om.asahi-kasei.co.jp|
304970|NCT02292433|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
304971|NCT02292446|Novaratis Pharmaceuticals|Study Director|888-669-6682|novartis.email@novartis.com|
304972|NCT02292537|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
304973|NCT02292654|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
304974|NCT02292719|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
304975|NCT02292771|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
304976|NCT02292784|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
304977|NCT02292849|Weill Cornell Medical College|Patrick Raue, Ph.D.|206-543-3807|praue@uw.edu|
304978|NCT02292927|Imperial Colege London|Colin Bicknell|02033126072|alison.deslandes@imperial.nhs.uk|
304979|NCT02292940|Northern California Kaiser Permanente, Division of Research|Mary Reed, DrPH|510-891-3808|Mary.E.Reed@kp.org|
304980|NCT02293044|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
304981|NCT02293096|"University of Colorado Denver | Anschutz"|Andrew Monte, MD, PhD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
304982|NCT02293395|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
304983|NCT02293460|LFB Biotechnologies|Clinical trial information desk|0033169827010|supportqcm@lfb.fr|
304984|NCT02293499|University of Rochester School of Nursing|Hyekyun Rhee PhD, RN, FAAN|585-276-3775|Hyekyun_Rhee@urmc.rochester.edu|
304985|NCT02293512|VA Portland Healthcare System|Erin Martz, PhD|503.220.8262|erin.martz@va.gov|56006
304986|NCT02293538|Alcon Research, Ltd.|Global Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
304987|NCT02293798|Mark Mofid, M.D.|Dr. Mark Mofid|8589099000|drmofid@drmofid.com|
304988|NCT02293837|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
304989|NCT02293863|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
304990|NCT02293902|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
304991|NCT02293993|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
304992|NCT02294019|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
304993|NCT02294058|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|AMcClain@celgene.com|
304994|NCT02294175|James A. Haley Veterans Hospital and Clinics|Dr. Linda Cowan|813-558-3932|linda.cowan@va.gov|
304995|NCT02294227|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
304996|NCT02294253|NYS Psychiatric Institute|Adam Bisaga MD|646-774-6155|adam.bisaga@nyspi.columbia.edu|
304997|NCT02294318|ResearchFMH|Dr. Efrat Aharonovich|646-774-7954|efrat.aharonovich@nyspi.columbia.edu|
304998|NCT02294396|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512|astellas.resultsdisclosure@astellas.com|
304999|NCT02294474|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
305000|NCT02294604|Shuang Ho Hospital, Taipei Medical University|Dr. Ka-Wai Tam|886-2-22490088|kelvintam@h.tmu.edu.tw|8860
305001|NCT02294630|Wayne State University|Beena G. Sood, MD, MS|313-745-5638|bsood@med.wayne.edu|
305002|NCT02294682|GlaxoSmithKline|GSK Response Center|866-435-7343||
305003|NCT02294734|GlaxoSmithKline|GSK Response Center|866-435-7343||
305004|NCT02294773|Midwest Fertility Specialists or St. Vincent Women's Hospital|Dr. Matt Will or Dr. Lauren Messinger|317-415-7528|laurenmessinger@gmail.com|
305005|NCT02294786|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
305006|NCT02295020|LSUHSC-NO -Orthopaedic Department|Dr. Vinod Dasa|(504) 412-1700|vdasa@lsuhsc.edu|
305007|NCT02295280|Saint Louis University|Dorothea Mostello, MD, Maternal Fetal Medicine Faculty|314-977-2090|mostello@slu.edu|
305008|NCT02295553|The Hospital for Sick Children, Toronto, Ontario, Canada|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
305009|NCT02295644|University at Buffalo, School of Dental Medicine, Oral Diagnostic Sciences|Dr. Willard D McCall|(716)829-3559|wdmccall@buffalo.edu|
305010|NCT02295735|Charité Universitätsmedizin Berlin, Department of Dermatology and Allergy|PD Dr. Jan Kottner|+4930450518218|jan.kottner@charite.de|
314439|NCT03305419|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314440|NCT03305575|Tufts Medical Center|Alaa Basura, MD|6176365000|abasura@tuftsmedicalcenter.org|6208
282461|NCT00856518|North Florida/South Georgia Veterans Health System|Dr. Janis Daly|352-376-1611|janis.daly@neurology.ufl.edu|5223
282462|NCT00856544|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
305011|NCT02295774|Humanitas Research Hospital & Humanitas University|Alessandro Repici MD|00390282247493|alessandro.repici@hunimed.eu|
305012|NCT02295995|Durham VA HCS|Dr. Katherine S. Hall|919-286-0411|katherine.hall@duke.edu|6734
305013|NCT02296099|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
305014|NCT02296112|Vanderbilt University Medical Center|Douglas Johnson, MD|(615) 936-8422|douglas.b.johnson@vumc.org|
305015|NCT02296125|AstraZeneca AB|Global Clinical Leader|+46 766 346712|ClinicalTrialTransparency@astrazeneca.com|
305016|NCT02296138|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
305017|NCT02296164|Helsinn Therapeutics (U.S.), Inc.|Bill Bailey|+1 732 603 2848|bill.bailey@helsinn.com|
305018|NCT02296190|Milestone Pharmaceuticals|Francis Plat _MD_Chief Medical Officer|514-336-0444|fplat@milestonepharma.com|225
305019|NCT02296242|BioMed Valley Discoveries|Dean Welsch, PhD|8163898831|dwelsch@biomed-valley.com|
305020|NCT02296320|MedImmune, LLC|Hasan S. Jafri|301-398-4431|information.center@astrazeneca.com|
305021|NCT02296346|Huntsman Cancer Institute, University of Utah|Dr. Daniel Couriel|801-213-3082|dan.couriel@hci.utah.edu|
305022|NCT02296424|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
305023|NCT02296476|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305024|NCT02296502|University of Pittsburgh|Benjamin L Handen, PhD|412-235-5445|handenbl@upmc.edu|
305025|NCT02296606|The University of Texas Southwestern Medical Center|DaiWai Olson|214-648-8946|Daiwai.Olson@UTSouthwestern.edu|
305026|NCT02296775|Dr. Reddy's Laboratories Ltd, Biologics Survey No. 47, Bachupally Village, Bachupally Mandal, Medchal Malkajgiri District Telangana, India - 500 090|Dr. Ankit Ranpura, MD (Associate Director- Clinical Development)|040 4464 4000|ankitr@drreddys.com|
305027|NCT02296840|Emory University|Roy Rajan, MD|404-778-2400|royrajan@yahoo.com|
305028|NCT02296853|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
305029|NCT02296892|PAION UK Ltd|Trial Information|+49 2414453101|reg_paion@paion.com|
305030|NCT02296931|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
305031|NCT02297100|Wake Forest University Health Sciences|Dr. Robert Evans|336-713-0320|revans@wakehealth.edu|
305032|NCT02297308|Terumo Medical Corporation|Robert Gash, Director of Clinical Affairs|732-302-4931|robert.gash@terumomedical.com|
305033|NCT02297503|Galderma|Maria Norberg|+46184891267|maria.norberg@galderma.com|
305034|NCT02297516|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
305035|NCT02297815|Children's Hospital of Philadelphia|Dr. Jeffrey Gerber|(267) 426-8775|gerberj@email.chop.edu|
305036|NCT02297841|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
305037|NCT02298023|, Seoul National University Hospital|Dr. Sun G. Chung|+82-2-2072-2560|chung60611@gmail.com|
305038|NCT02298179|GlaxoSmithKline|GSK Response Center|866-435-7343|kt144805@gsk.com|
305039|NCT02298192|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
305040|NCT02298322|Zeltiq Aesthetics, Inc. an Allergan Affiliate|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
305041|NCT02298361|OCHIN, Inc.|Jennifer E. DeVoe, MD, DPhil|503-943-2618|devoej@ohsu.edu|
305042|NCT02298491|UMaryland|Horea Rus|410-706-3170|hrus@som.umaryland.edu|
305043|NCT02298803|Diabetes Centre, Royal Prince Alfred Hospital|Dr Ted Wu|61295155888|ted.wu@sswahs.nsw.gov.au|
305044|NCT02298842|Terumo BCT|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
305045|NCT02298868|University of Virginia|Dr. Zachary Henry|434-243-2718|zhenry@virginia.edu|
305046|NCT02298933|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
305047|NCT02298946|National Cancer Institute|Dr. Tim F. Greten|301-451-4723|gretentf@mail.nih.gov|
305048|NCT02299050|University of Texas Health San Antonio|Mariam Alatrach|210-358-7220|alatrach@uthscsa.edu|
314135|NCT03257410|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
314136|NCT03257631|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
314137|NCT03257657|University of Colorado|Darcy Thompson, Associate Professor|303 724 7471|darcy.thompson@ucdenver.edu|
314138|NCT03257813|Laboratorios Sophia|Dr. Ricardo Llamas (clinical safety pharmacologist)|3001 4200|ricardo.llamas@sophia.com.mx|1059
314139|NCT03257865|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
314140|NCT03257995|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
314141|NCT03258645|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314142|NCT03258710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314143|NCT03258762|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314144|NCT03258814|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
314145|NCT03259087|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
314146|NCT03259139|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
314147|NCT03259308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
314148|NCT03259334|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
314149|NCT03259425|Huntsman Cancer Institute|Data Manager, Research Compliance Office|8015850601|compliance@hci.utah.edu|
314150|NCT03259490|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282463|NCT00856557|Jesse Brown VA Medical Center|Dr. Saul J. Weiner|3125192697|Saul.Weiner@va.gov|
282464|NCT00856583|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
282465|NCT00856609|National Institutes of Health|Dr. Jonathan Krakoff|602-200-5217|jkrakoff@mail.nih.gov|
305049|NCT02299076|VAL HEALTH, LLC|Daniel Astrachan|2033769388|dastrachan@valhealth.com|
305050|NCT02299089|Camurus AB|Clinical Trial Manager|+46 46 2876 530|Info@Camurus.com|
305051|NCT02299141|Washington University School of Medicine|Ramaswamy Govindan|314-362-5654|rgovindan@wustl.edu|
305052|NCT02299167|Dammam University|Roshdi R. Al-Metwalli|+966 50 289 3485|rmetwalli@iau.edu.sa|
305053|NCT02299258|The First People's Hospital of Yuhang District|Dr.Ding Shi|+8657189369162|shidingyuhang@163.com|
305054|NCT02299297|Columbia University Department of Dermatology Clinical Research Unit|Grace Ulerio, CCRC|212-305-6593|gu2102@cumc.columbia.edu|
305055|NCT02299336|Retina Consultants of Houston|Dr. Charles C. Wykoff|7135243434|ccwmd@houstonretina.com|
305056|NCT02299349|TriHealth Hatton Research Institute|Angela N Fellner PhD CCRP|513-862-2330|Angie_Fellner@trihealth.com|
305057|NCT02299375|GlaxoSmithKline|GSK Response Center|866-435-7343||
305058|NCT02299388|Tulane University|Dr. Tina Thethi|504-988-5044|tthethi@tulane.edu|
305059|NCT02299427|University of Alabama at Birmingham|David Schwebel|205-934-8745|schwebel@uab.edu|
305060|NCT02299479|Boston Children's Hospital|Garry Steil, PhD|617 355-6000|Garry.Steil@childrens.harvard.edu|
305061|NCT02299570|Rebiotix|Assoc. Director of Clinical Research|651-705-8778|Sarah.Mische@Ferring.com|
305062|NCT02299635|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
305063|NCT02299791|KaiserPermanente Center for Health Research|Rachel Gold|503-528-3902|rachel.gold@kpchr.org|
305064|NCT02299869|CooperVision|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
305065|NCT02300025|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
305066|NCT02300077|Department of Anesthesiology Washington University in St. Louis|Helga Komen|3148527622|komenh@anest.wustl.edu|
305067|NCT02300103|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
305068|NCT02300129|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
305069|NCT02300220|Imperial College London|Professor Jadwiga Wedzicha|02075947947|j.wedzicha@imperial.ac.uk|
305070|NCT02300259|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
305071|NCT02300285|Boston Children's Hospital|Michael SD Agus, MD|617 355-5849|michael.agus@childrens.harvard..edu|
305072|NCT02300298|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
305073|NCT02300311|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
305074|NCT02300545|Washington University School of Medicine|Brian A. Van Tine, M.D., Ph.D.|314-747-8475|bvantine@wustl.edu|
305075|NCT02300558|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
305076|NCT02300610|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jingsong Zhang|813-745-3973|jingsong.zhang@moffitt.org|
305077|NCT02300727|Aurora Health Care - Bay Area Medical Center|Dhimant Patel, MD|920-288-4123|dhimant.patel@aurora.org|
305078|NCT02300987|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
305079|NCT02301039|Sarcoma Alliance for Research Through Collaboration|Research Manager|734-930-7600|sarc@sarctrials.org|
305080|NCT02301143|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
305081|NCT02301169|Tools4Patient|Stephanie Alvarez|+32 71 14|stephanie.alvarez@tools4patient.com|02 00
305082|NCT02301299|Northwestern University|Erin Wymore|3125033243|erin.wymore@northwestern.edu|
305083|NCT02301364|Memorial Sloan Kettering Cancer Center|Christian Grommes, MD|212-639-4058|grommesc@mskcc.org|
305084|NCT02301377|University of Michigan|Dr. Aarti Shakkottai|734-764-4123|aartik@med.umich.edu|
305085|NCT02301390|Icahn School of Medicine at Mount Sinai|Betsy Ellsworth, Research Program Director|212-824-8902|betsy.ellsworth@mountsinai.org|
305086|NCT02301403|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
305087|NCT02301416|Wake Forest School of Medicine|Jamy Ard|336-716-9837|jard@wakehealth.edu|
305088|NCT02301429|Medtronic Regional Clinical Center|Clinical Study manager|0039(0)22 241371|laura.manotta@medtronic.com|
305089|NCT02301546|University of Utah|Kevin Duff|8015859983|kevin.duff@hsc.utah.edu|
305090|NCT02301624|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
305091|NCT02301793|Johns Hopkins Medical Institutions|Elliott R Haut M.D, PhD, Associate Professor of Surgery, Anesthesiology &Critical Care Medicine|410-502-3122|ehaut1@jhmi.edu|
305092|NCT02301897|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
305093|NCT02301936|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
305094|NCT02301975|GlaxoSmithKline|GSK Response Center|866-435-7343||
305095|NCT02301988|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
305096|NCT02302066|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305097|NCT02302092|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305098|NCT02302157|Lineage|Avi Ben Shabat, MD|+972-509105205|avi@cellcure.co.il|
305099|NCT02302222|Acelity|Sr Director, Global Clinical Development|2102555595|jane.hart@acelity.com|
305100|NCT02302339|Celldex Therapeutics|Head of Regulatory Affairs|844-723-9363|info@celldex.com|
305101|NCT02302365|Terumo BCT|Isobelle Galeon, MD, MPH, MSCS, Medical Monitor Clinical Safety|+1 303 542-5166|Isobelle.Galeon@Terumobct.com|
305102|NCT02302716|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
305103|NCT02302807|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
305104|NCT02302846|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Assistant Professor|713-794-1141|CR_Study_Registration@mdanderson.org|
282466|NCT00856635|Teva Pharmaceuticals, Medical Affairs|Scott Kolodny, M.D.|440-327-1811|scott.kolodny@tevapharm.com|
305105|NCT02303041|Stanford University|Anne Lynn S. Chang/ Associate Professor of Dermatology|650-723-6316|alschang@stanford.edu|
305106|NCT02303093|Octapharma Pharmazeutika Produktionsgesm.b.H.,|Dr. Bernhard Rohrbacher|+431610324182|bernhard.rohrbacher@octapharma.com|
305107|NCT02303184|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
305108|NCT02303262|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
305109|NCT02303548|Asan Medical Center|Director of Clinical Trials|8230103350|wonpia73@naver.com|
305110|NCT02303574|AstraZeneca|Bengt Larsson|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
305111|NCT02303704|Ch. Pervaiz Elahi Institute of Cardiology, Multan, Pakistan.|Dr. Muhammad Sher-i-Murtaza|0333-6107570|sherm.cpeic@gmail.com|
305112|NCT02303743|Hospital Germans Trias i Pujol|Dr. Vicente Lorenzo-Zúñiga García|+34-934978866|vlorenzo.germanstrias@gencat.cat|8443
305113|NCT02303977|Abramson Cancer Center, Penn Presbyterian Medical Center|Dr. Christine Ciunci|215-662-9801|christine.ciunci@pennmedicine.upenn.edu|
305114|NCT02303990|University of Pennsylvania|Dr. Amit Maity|215) 662-3759|maity@uphs.upenn.edu|
305115|NCT02304159|Southern California Research Center|Dr. Tarek Hassanein|619-319-3993|thassanein@livercenters.com|
305116|NCT02304380|University of North Carolina at Chapel Hill|Renée Ferrari, PhD|(919) 843-1341|rferrari@unc.edu|
305117|NCT02304406|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
305118|NCT02304432|McLean Hospital|Dr. Deborah Levy|617-855-2854|dlevy@mclean.harvard.edu|
305119|NCT02304484|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
305120|NCT02304705|University of Kentucky|Dr. Maya Guglin|859-323-4738|maya.guglin@uky.edu|
305121|NCT02304757|Tenth People's Hospital of Tongji University|Chao Ma|02125078593|mc_7419@hotmail.com|86
305122|NCT02304926|FISABIO-University Hospital Dr Peset|Dr Antonio Hernández|961622492|hernandez_antmij@gva.es|
305123|NCT02305017|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
305124|NCT02305238|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
305125|NCT02305277|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
305126|NCT02305316|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
305127|NCT02305329|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
305128|NCT02305381|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
305129|NCT02305446|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
305130|NCT02305563|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
305131|NCT02305732|Cerus|Carol Moore, Senior VP Regulatory Affairs & Quality|925-288-6361|cmoore@cerus.com|
305132|NCT02305758|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
305133|NCT02305797|Cardinal Health Regulatory Sciences|Director of Regulatory Affairs and Product Development|913.451.3955|david.rhein@cardinalhealth.com|
305134|NCT02305849|Astellas Pharma Inc.|Clinical Trial Disclosure|+81-3-3244-6500 Japanese only|Astellas.resultsdisclosure@astellas.com|
305135|NCT02305888|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
305136|NCT02306265|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
305137|NCT02306694|Oregon Health & Science University|Dr. Jayson Taylor|503-494-8716|taylojas@ohsu.edu|
305138|NCT02306759|The Brooklyn Hospital Center|Director, Emergency Medicine Clinical Research Program|718-250-6250|bsin@tbh.org|
305139|NCT02306850|Saint Louis University|John Richart, MD|314-577-8854|john.richart@health.slu.edu|
305140|NCT02306928|Aarhus University Hospital, Department of infectious diseases|Dr. Kristina Öbrink-Hansen|+45 7845 2845|krisoebr@rm.dk|
305141|NCT02307123|Tampere University Hospital|Toni Pakkanen, MD|358408227209|toni.pakkanen@icloud.com|
305142|NCT02307266|Galderma|Gaëlle Charier|+33 4 93 95 70 68|gaelle.charier@galderma.com|
305143|NCT02307318|HealthEast Care System|Amy Fehrer|651-232-5363|afehrer@healtheast.org|
305144|NCT02307370|Spectranetics, LLC now a part of Philips Image Guided Therapy Devices|Nicolas Aguirre, Senior Manager, Clinical Operations|612-297-6655|nicolas.aguirre@philips.com|
305145|NCT02307513|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
305146|NCT02307526|James J. Peters VA Medical Center|Jill M. Wecht|7185849000|jm.wecht@va.gov|3122
305147|NCT02307552|UC Irvine|Thomas Ahlering, MD|714 456-6068|tahlerin@uci.edu|
305148|NCT02307682|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
314151|NCT03259555|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
314152|NCT03259789|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
314153|NCT03260205|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
314154|NCT03260426|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
314441|NCT03305653|Children's Hospital Colorado|Dr. Calies Menard-Katcher|720-777-2318|calies.menard-katcher@childrenscolorado.org|
314442|NCT03305666|Denver Health and Hospital Authority|Dr. Fredric Pieracci|(303) 436-4029|Fredric.Pieracci@dhha.org|
314443|NCT03305731|University of Illinois at Chicago|Dr. Emily Kringle|312-996-9665|kringle@uic.edu|
314444|NCT03305770|Alcon, A Novartis Division|Sr Director Project Leadership|1-888-451-3937|alcon.medinfo@alcon.com|
314445|NCT03305809|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314446|NCT03305822|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
314447|NCT03305887|Johnson & Johnson Medical Shanghai Ltd.|Xiaolei, Wang|+86 21 33378749|xwang183@its.jnj.com|
314448|NCT03306043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314449|NCT03306199|Cardiovascular Institute of the South|Research Team Leader|(985) 873-5613|Deanna.Benoit@cardio.com|
314450|NCT03306277|AveXis, Inc|US Medical Information|833-828-3947|medinfo@avexis.com|
314451|NCT03306420|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
282467|NCT00856661|H. Lundbeck A/S|study director||LundbeckClinicalTrials@Lundbeck.com|
282468|NCT00856726|University of Alabama at Birmingham|Orlando Gutierrez|205-996-2736|ogutierrez@uabmc.edu|
305149|NCT02307838|Novartis Pharmaceuticals|Study Director|862-778-8300||
305150|NCT02307916|Massachusetts Eye and Ear|Dr. Brad Welling|617-573-4075|brad_welling@meei.harvard.edu|
305151|NCT02308007|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
305152|NCT02308020|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
305153|NCT02308033|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
305154|NCT02308046|Curatek Pharmaceuticals|Vice President|847-806-7680|info@curatek.com|
305155|NCT02308124|SNUH|Jung-Ick Byun|+8224406254|mr830611@gmail.com|
305156|NCT02308163|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
305157|NCT02308189|Ohio University|Brian Clark, PhD|740-593-2354|clarkb2@ohio.edu|
305158|NCT02308228|University of Kentucky|Douglas Long|859-323-5438|DELONG2@UKY.EDU|
282469|NCT00856739|Stanford University, Palo Alto Veterans Hospital|Dr. Thomas P. Andriacchi, Ph.D.|650-723-8024|tandriac@stanford.edu|
305159|NCT02308371|University of North Carolina|Dr. Melissa Hines|901-652-6138|mhinesthomas@gmail.com|
305160|NCT02308501|Ora|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
305161|NCT02308540|PATH|Dr. Steve Lamola|1-206-285-3500|slamola@path.org|
305162|NCT02308696|Univ. WI Madison|Amy Amessoudji|608-263-2621|amessoudji@surgery.wisc.edu|
305163|NCT02308748|U.S. Food and Drug Administration|David G Strauss, MD, PhD|301-796-6323|david.strauss@fda.hhs.gov|
305164|NCT02308787|Terumo BCT|Raymond P. Goodrich, PhD, VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|(303) 231-4357|Ray.Goodrich@terumobct.com|
305165|NCT02308839|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
305166|NCT02309099|University of North Carolina at Chapel Hill|Dr. Meredith Rooth|919-966-5251|meredith_rooth@med.unc.edu|
305167|NCT02309112|University of Oxford|Marcy McCall, Lead Researcher|+441865 289300|marcy.mccall@kellogg.ox.ac.uk|
305168|NCT02309138|University of Pittsburgh|Director of Center for Research on Health Care Data Center|412-692-2023|dcenter@pitt.edu|
305169|NCT02309294|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
305170|NCT02309359|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
305171|NCT02309372|Indiana University School of Medicine|Samir K. Gupta, MD, MS|3172747926|sgupta1@iu.edu|
305172|NCT02309411|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
305173|NCT02309489|King's College London, UK|Dr Marina Daniele|020 7836 5454|marina.daniele@kcl.ac.uk|
305174|NCT02309515|Mayo Clinic|Tait D. Shanafelt, MD|507.284.2511|shanafelt.tait@mayo.edu|
305175|NCT02309723|Tufts Medical Center|Dr.Yue Zhong, Project Director of Center for the Evaluation of Value and Risk in Health|6176361424|yzhong@tuftsmedicalcenter.org|
305176|NCT02309944|Masonic Cancer Center, University of Minnesota|Deanna GK Teoh|612-626-3111|dkteoh@umn.edu|
305177|NCT02310100|Abbott|Lori Rusch, Ph.D.|1-651-756-2668|lori.rusch@abbott.com|
305178|NCT02310126|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, O.D., M.S., F.A.A.O., Sr. Principal Research Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
305179|NCT02310568|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
305180|NCT02310581|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
305181|NCT02310646|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
305182|NCT02310672|Actelion Pharmaceuticals Ltd|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
305183|NCT02310750|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
305184|NCT02310763|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
305185|NCT02310776|Northwestern Medicine|Ellen B. Mendelson, MD, FACR, Lee F. Rogers Professor of Medical Education in Radiology, Profess|3124720436|emendels@nm.org|
305186|NCT02310789|Stanford University|Jeff Wine, PhD|650-725-2462|wine@stanford.edu|
305187|NCT02310906|Sarepta Therapeutics, Inc.|Medical Director|1-800-690-2003|clinicaltrials@sarepta.com|
305188|NCT02311153|Vanderbilt University Medical Center|Justin H. Turner, MD, PhD||justin.h.turner@vanderbilt.edu|
305189|NCT02311309|CHU de Caen|Dr Jean-Luc Hanouz|2 31 06 47 36|hanouz-jl@chu-caen.fr|33
305190|NCT02311361|National Cancer Institute|Dr. Tim Greten|240-760-6114|tim.greten@nih.gov|
305191|NCT02311478|University of Utah|Dr. Dave Turok|8015818160|david.turok@hsc.utah.edu|
305192|NCT02311881|GlaxoSmithKline|GSK Response Center|866-435-7343||
305193|NCT02311894|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
305194|NCT02311907|Mayo Clinic|Charles L. Loprinzi M.D.|507/284-1623|cloprinzi@mayo.edu|
305195|NCT02311933|Alliance for Clinical Trials in Oncology|Matthew P. Goetz, MD|: 507-284-2511|goetz.matthew@mayo.edu|
305196|NCT02311972|Duke University|Dr. Robin B. Dail|919-684-3786|robin.dail@duke.edu|
305197|NCT02312063|Kansai Electric Power Medical Research Institute|Dr. Daisuke Yabe|+81-6-6458-5821|ydaisuke-kyoto@umin.ac.jp|
305198|NCT02312154|Konkuk University|Yang Won Lee|8220305172|20130112@kuh.ac.kr|
305199|NCT02312206|Prothena Biosciences|Wendy Curlin|(650) 837-8550|clinicaltrials@prothena.com|
305200|NCT02312219|Mass General Hospital|Ahmed Tawakol, MD|617-726-0791|atawakol@mgh.harvard.edu|
305201|NCT02312310|Columbia University Medical Center|Scott A. Small, MD|212-305-1269|sas68@columbia.edu|
305202|NCT02312622|Stanford University|Joel W. Neal, MD PhD, Assistant Professor of Medicine (Oncology)|(650) 498-4696|jwneal@stanford.edu|
305203|NCT02312687|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
305204|NCT02312713|University of North Carolina at Chapel HIll|Kelli Allen|919-966-0558|kdallen@email.unc.edu|
314155|NCT03260595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282470|NCT00856778|Coloplast Corp|Clinical Trial Manager|612-302-4990|usdibe@coloplast.com|
282471|NCT00856791|Onconova Therapeutics, Inc.|Francois E. Wilhelm, MD, PhD|609 281-7086|fwilhelm@onconova.us|
305205|NCT02312726|University of New Mexico - Family Planning Research Division|Michel Paves, Research Specialist|505-272-9703|mdaliva@salud.unm.edu|
305206|NCT02312739|Division of Family Planning, University of New Mexico|Sunderjeet Kaur|Email|HSC-familyplanningresearch@salud.unm.edu|
305207|NCT02312765|University of Pennsylvania|Dr Nalaka Gooneratne|215 573 2048|ngoonera@upenn.edu|
305208|NCT02312856|CERENOVUS|Christopher Hendricks|415-656-6565|chendric@its.jnj.com|
305209|NCT02312882|Stanford University|Anthony E Oro, M.D., Ph.D.||oro@stanford.edu|
305210|NCT02312934|Vanderbilt University Medical Center|Dr. Paul A. Newhouse|(615) 327-7009|paul.newhouse@vumc.org|
305211|NCT02312986|Washington University in St. Louis|Kimberly Reske, MPH, Research Coordinator|314-747-4041|kreske@wustl.edu|
305212|NCT02313155|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305213|NCT02313233|Kaohsiung Municipal TA- TUNG Hospital|Dr. Ching- Chia Li|886-7-291-1101||
305214|NCT02313454|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
305215|NCT02313506|Arthritis Research Canada|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
305216|NCT02313558|Guanghua School of Stomatology, Sun Yat-sen University,|Dr. Hongchun Liu|0086-0-13826189071|hongchun751@sina.com|
305217|NCT02313597|Services Institute of Medical Sciences|Dr, Shabbar Hussain Changazi|923059700111|shabbarchangazi246@gmail.com|
305218|NCT02313675|University of Pittsbur|John R Fowler, MD|412-605-3245|fowlerjr@upmc.edu|
305219|NCT02313766|CaenUH|Pr Jean-Luc Hanouz|33 2 31 06 47 36|hanouz-jl@chu-caen.fr|
305220|NCT02313909|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
305221|NCT02314000|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494355|roshini.jain@bsci.com|
305222|NCT02314026|Exalenz Bioscience|Clinical trial manager|97289737513|avrahamh@exalenz.com|
305223|NCT02314052|Dicerna Pharmaceuticals|Ralf Rosskamp|617-621-8097|rrosskamp@dicerna.com|
305224|NCT02314104|St. Barnabas Medical Center|Dr. Eric Liberman|917-696-1370|eliberma@montefiore.org|
271671|NCT00256308|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
305225|NCT02314117|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
305226|NCT02314143|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
305227|NCT02314247|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
305228|NCT02314260|kasr EL alini|Dr Ahmed Kamel|0201120022332|dr.ahmed.m.kamel@gmail.com|
305229|NCT02314403|Massachusetts General Hospital|Tatsuo Kawai, MD PhD|617-726-0289|tkawai@mgh.harvard.edu|
305230|NCT02314520|Penn State Health Milton S. Hershey Medical Center Dept of Neurosurgery|Dr. J. Christopher Zacko|717-531-1279|jzacko@pennstatehealth.psu.edu|
305231|NCT02314546|Bassett Healthcare Network|David A. Ullman, MD, Senior Attending Anesthesiologist|607-547-3153|david.ullman@bassett.org|
305232|NCT02314598|Medtronic|Ilaria Marcotullio|+39 06 32814218|ilaria.marcotullio@medtronic.com|
305233|NCT02314637|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
305234|NCT02314689|University of Mississippi Medical Center|Suvankar Majumdar MD|6019845220|smajumdar@umc.edu|
305235|NCT02314728|Montefiore Medical Center|Kafui A. Demasio, MD, MPH, Maternal Fetal Medicine, Dept of Obstetrics/Gynecology and Women's Health|718-920-2767|kdemasio@montefiore.org|
305236|NCT02314780|Medical University of Vienna|Dr. Martin Andreas|+ 43 1 40400|martin.andreas@meduniwien.ac.at|69660
305237|NCT02314936|KGK Synergize Inc.|Dr. Tetyana Pelipyagina|5194389374|drtetyana@kgksynergize.com|
305238|NCT02315170|Raj K M|Raj K Maturi MD|3178171414|maturi.md@midwesteye.com|
305239|NCT02315261|Faculty of Medicine Siriraj Hospital|Dr.Mingkwan Wongyingsinn|66824197995|minkcheerful@hotmail.com|81
305240|NCT02315352|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
305241|NCT02315430|NRG Oncology|Linda Gedeon on behalf of William Brady, PhD|716-845-1169|lgedeon@gogstats.org|
305242|NCT02315534|Sumitomo Dainippon Pharma Oncology|Connor Marshall|843-364-8039|cmarshall@bostonbiomedical.com|
305243|NCT02315560|University of Pittsburgh|Dr. Heidi Stephany|412-692-7932|heidi.stephany@chp.edu|
305244|NCT02315625|National Cancer Institute|Dr. Naris Nilubol|240-760-6154|niluboln@nih.gov|
305245|NCT02315664|Arthritis Research Canada|Dr. Linda Li, Professor, University of British Columbia|604-207-4020|lli@arthritisresearch.ca|
305246|NCT02315755|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
305247|NCT02315872|Providence Health & Services|Lynette Currie|503-216-1034|lynette.currie@providence.org|
305248|NCT02315989|Linkou Chang Gung Memorial Hospital|Hong, Ji-Hong M.D.|03-3281200|jihong@cgmh.org.tw|2600
314156|NCT03260699|Department of Orthopaedic Surgery, Cleveland Clinic|Alison Klika, Research Manager|216 444-4954|klikaa@ccf.org|
314157|NCT03260790|Mayo Clinic|Avni Y. Joshi, M.D., M.S.|507-284-3165|Joshi.Avni@mayo.edu|
314158|NCT03260868|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
314160|NCT03261037|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
314161|NCT03261167|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314162|NCT03261336|Inova Schar Cancer Institute|Stephanie Van Bebber, Sr. Director Clinical Trials|5714720213|Stephanie.VanBebber@inova.org|
314163|NCT03261947|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
314164|NCT03261960|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
314452|NCT03306433|University of Colorado, SoDM|Clifton Carey|3037241046|clifton.carey@cuanschutz.edu|
271672|NCT00256451|University of Pennsylvania|David Oslin, MD|2158235894|oslin@upenn.edu|
271673|NCT00256698|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
271674|NCT00256724|Advanced Circulatory|Nathan Burkhart|651.403.5600|nburkhart@advancedcirculatory.com|
305249|NCT02316002|University of Pennsylvania (Abramson Cancer Center)|Dr. Joshua Bauml|215-662-4000|melissa.volpe@pennmedicine.upenn.edu|
305250|NCT02316171|Viralytics|Mark Grose|+1 905 593 2891|Mark.Grose@viralytics.com|
305251|NCT02316223|Icahn School of Medicine at Mount Sinai|Dr. Alex Federman|212-824-7565|alex.federman@mountsinai.org|
305252|NCT02316353|CSL Behring|Michelle Hellstern|6102907515|michelle.hellstern@cslbehring.com|
305253|NCT02316366|Nationwide Children's Hospital|Dr. Renee Quarrie, fellow|2037136871|reneepetagae@gmail.com|
305254|NCT02316470|Valneva Austria GmbH|Manager Clinical Research|+43120620|info@valneva.com|0
305255|NCT02316548|NRG Oncology|Wendy Seiferheld, M.S.|215-574-3208|seiferheldw@nrgoncology.org|
305256|NCT02316613|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
305257|NCT02316678|University of Pennsylvania|James Lewis|215-573-5137|lewisjd@upenn.edu|
305258|NCT02316717|Immuron|Neta Tobis, Clinical Director|+972549277334|neta@immuron.com|2549277334
305259|NCT02316769|Vanderbilt University|Bret Alvis|6159365836|bret.d.alvis@vanderbilt.edu|
305260|NCT02316847|SK Bio-pharmaceuticals Co, Ltd|MinJae Lee, Associate Manager||minj.lee@sk.com|
305261|NCT02317016|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
305262|NCT02317042|University of Western Australia|Prof Nigel McArdle & Prof Peter Eastwood|+61 8 9346 1706|peter.eastwood@health.wa.gov.au|
305263|NCT02317432|Disparities Research Unit, MGH|Margarita Alegria, PI|617-724-1237|malegria@mgh.harvard.edu|
305264|NCT02317510|Lutfiye NBGH|Dr. Turgut Donmez|00905347400967|surgeont73@hotmail.com|
305265|NCT02317549|Leading BioSciences|Tom Hallam, PhD, MBA|631-739-3088|tom.hallam@leadingbiosciences.com|
314453|NCT03306589|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
314454|NCT03306641|CooperVision, Inc|Lee Hall, BSc, PhD, MCOptom, FBCLA|925 251 6684|lhall@coopervision.com|
305266|NCT02317562|LFB|Clinical Information Desk|0033169827010|supportqcm@lfb.fr|
305267|NCT02317575|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
305268|NCT02317614|Western Michigan University|Dr. Anthony DeFulio|269-387-4459|anthony.defulio@wmich.edu|
305269|NCT02317627|Kadmon Corporation, LLC|Associate VP, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
305270|NCT02317692|Marquette University|Dr. Alyson Gerdes|414-288-6145|alyson.gerdes@mu.edu|
305271|NCT02317744|Yale School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
271675|NCT00256750|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
314165|NCT03261973|Massachusetts General Hospital|Grace Ha|617-643-1697|gha2@mgh.harvard.edu|
314166|NCT03261999|Foresee Pharmaceuticals Co., Ltd|John Mao|+886 2-7750-0188|john.mao@foreseepharma.com|
314167|NCT03262012|AstraZeneca|Paul M. Dorinsky, MD|1-877-240-9479|information.center@astrazeneca.com|
314168|NCT03262038|University of Michigan|Elizabeth Putnam|734-763-2435|eread@umich.edu|
314169|NCT03262233|UW-Madison|John Curtin|608-262-0387|jjcurtin@wisc.edu|
314170|NCT03262389|Mayo Clinic|Michael C. Roarke, M.D.|480-342-0988|Roarke.Michael@mayo.edu|
282472|NCT00856830|Univeristy of Alabama at Birmingham|Francisco Robert, MD, Department of Medicine, Division of Hematology and Oncology|205-934-5077|pacorobertuab@cs.com|
305272|NCT02317809|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
305273|NCT02318095|Regulatory Coordinator|Linda Kaltenbach, PhD|(919) 681-6804|Linda.Kaltenbach@duke.edu|
305274|NCT02318134|First Affiliated Hospital of Nanchang University|Dr. Ling Ding|15279196058|2495802456@qq.com|
305275|NCT02318303|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
305276|NCT02318368|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|(857) 400-0101|Clinical@aveooncology.com|
305277|NCT02318550|Lancaster General Health|Project Manager|7175447395|Tawnya.Vernon@pennmedicine.upenn.edu|
305278|NCT02318602|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
305279|NCT02318667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305280|NCT02318693|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305281|NCT02318706|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
305282|NCT02318719|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
305283|NCT02318797|University of Pittsburgh Department of Psychiatry|Charles Reynolds, MD|412-246-6414|reynoldscf@upmc.edu|
305284|NCT02318940|Universidad de Chile|Dr. Pietro Pietroboni Fuster|+56982261539|pietroboni@gmail.com|
305285|NCT02318979|Denver Research Institute|Judith Jung, DRI Executive Director|303-501-0540|Judith.Jung@dri-va.org|
305286|NCT02318992|University of Texas School of Public Health|Dr. Herbert DuPont|713 500 9366|herbert.l.dupont@uth.tmc.edu|
305287|NCT02319031|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
305288|NCT02319044|AstraZeneca LP|Jean Fan, MD, Global Clinical Lead|1-301-398-5080|jean.fan@astrazeneca.com|
305289|NCT02319148|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
314455|NCT03307005|Johns Hopkins University|Rashmi Nisha Aurora, MD, MHS|443-513-6535|rnaurora@jhmi.edu|
314456|NCT03307174|University of California San Francisco|Paul Su|415-885-7246|paul.su@Ucsf.edu|
314457|NCT03307252|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314458|NCT03307785|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314459|NCT03307837|Concentric Analgesics|Dr. John Donovan, President and Founder|415-676-8940|JOHN@CONCENTRICANALGESICS.COM|
314460|NCT03308058|University of Nebraska Medical Center|Jane Meza, Interim Associate Vice Chancellor for Global and Student Support|402-559-6825|jmeza@unmc.edu|
314461|NCT03308097|Rhode Island Hospital|Larry K. Brown, MD|(401) 793 - 8808|lkbrown@lifespan.org|
282473|NCT00856843|Braintree Laboratories, Inc.|John McGowan|781-843-2202|jmcgowan@braintreelabs.com|
314462|NCT03308669|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314463|NCT03308799|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
314464|NCT03308825|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
314465|NCT03308942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314466|NCT03308968|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
314467|NCT03309020|National Institutes of Health|Teresa Magone, MD, Principal Investigator, NEI|301-435-4562|teresa.magonedequadroscosta@nih.gov|
314468|NCT03309202|Pfizer,Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
314469|NCT03309449|SUNY Upstate Medical University|William Eggleston|315-464-8906|egglestw@upstate.edu|
314470|NCT03309605|Eloxx Pharmaceuticals|Executive Director Clinical Trials|1-781-577-5300|CTI@eloxxpharma.com|
314471|NCT03309657|University of Queensland Center for Clinical Research|Prof. Jason Roberts|+61 7 334 65032|j.roberts2@uq.edu.au|
314472|NCT03309696|University of Arkansas for Medical Sciences|Dr Mark Mennemeier|205 410 2413|msmennemeier@uams.edu|
314473|NCT03309787|Dartmouth-Hitchcock|John A. Batsis, MD|603-650-5000|john.batsis@gmail.com|
314474|NCT03309943|Duke University School of Medicine|Jason A. Oliver, Ph.D.|(919) 668-0093|Jason.A.Oliver@duke.edu|
314475|NCT03310021|Portola Pharmaceuticals|Head of Clinical Development|6502767153|ClinicalTrials@Portola.com|
314476|NCT03310268|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314477|NCT03310411|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314478|NCT03310450|Universitas Negeri Semarang|Mahalul Azam|+628122853982|mahalul.azam@mail.unnes.ac.id|
314479|NCT03310580|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director, Global Clinical Operations|(908) 947-3543|nramirez@aeriepharma.com|
314480|NCT03310723|BC Women's Hospital, Department of Anesthesia|Research Assistant|604-875-2424|james.taylor1@phsa.ca|6076
314481|NCT03310775|Kyunghee university hospital, Seoul, South Korea|Dr. Miae Oh|82-10-8929-5048|miae612@naver.com|
314482|NCT03310970|University of Iowa|Nicole Brogden, Associate Professor|319-335-8752|nicole-brogden@uiowa.ed|
314483|NCT03311230|University of Pennsylvania|Joseph Harrison|2157461249|joseph.harrison@uphs.upenn.edu|
314484|NCT03311373|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
282474|NCT00856856|Abbott Vascular International BVBA|Susan Veldhof|31653428610|susan.veldhof@av.abbott.com|
314485|NCT03311646|Medical University of South Carolina|Dr. Tracy Smith|843-792-5164|smithtra@musc.edu|
314486|NCT03311659|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314487|NCT03311724|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314488|NCT03311841|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
314489|NCT03312023|Institute of Human Virology, University of Maryland Baltimore|Dr. Joel V. Chua|1-410-706-5704|jchua@ihv.umaryland.edu|
282475|NCT00856908|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
282476|NCT00856973|Sunovion|CNS Medical Director|866-503-6357||
305290|NCT02319174|Rice 360: Institute for Global Health|Dr. Rebecca Richards-Kortum|713-348-3823|rkortum@rice.edu|
305291|NCT02319304|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
282477|NCT00856986|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
305292|NCT02319317|University of Pennsylvania|Catherine McDonald. PhD, RN|2157468355|mcdonalc@nursing.upenn.edu|
305293|NCT02319369|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
305294|NCT02319486|Zhongshan Ophthalmic Center, Sun Yat-sen University|Huasheng Yang|+862087331539|yanghs64@126.com|
305295|NCT02319525|UAB|Dr. Jasvinder Singh, Principal Investigator|2059343235|jasvinder.md@gmail.com|
305296|NCT02319642|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
305297|NCT02319668|GlaxoSmithKline|GSK Response Center|866-435-7343||
305298|NCT02319759|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
305299|NCT02319824|Fred Hutchinson Cancer Research Center|Seth Pollack|206-667-6629|spollack@fhcrc.org|
305300|NCT02319967|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-3291|chicagotrial@uic.edu|
305301|NCT02320058|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
305302|NCT02320123|UT Southwestern Medical Center|Dr. Ramona Rhodes|214-648-9012|ramona.rhodes@utsouthwestern.edu|
305303|NCT02320149|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
305304|NCT02320175|Boston Children's Hospital|Isabella Liss, Patient and Family Centered I-PASS SCORE Study Coordinator|857-218-3229|isabella.liss@childrens.harvard.edu|
305305|NCT02320214|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
305306|NCT02320227|Church & Dwight Co., Inc.|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
305307|NCT02320253|MGH Diabetes Center|Dr. Deborah J. Wexler|617-726-8767|dwexler@mgh.harvard.edu|
305308|NCT02320487|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
305309|NCT02320695|Johnson & Johnson Consumer and Personal Products Worldwide|Christopher Nunez, PhD|973-385-7984|cnunez1@its.jnj.com|
305310|NCT02320721|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
305311|NCT02320812|jCyte, Inc|Terry O'Neal, Chief Operating Officer|949-243-0688|terry.oneal@jcyte.com|
305312|NCT02320838|Universidad de Castilla-La Mancha|Dr. Juan Avendaño Coy|+34 925268800|juan.avendano@uclm.es|5014
305313|NCT02320903|Evidence-Based Practice Institute|Linda Dimeff, PhD|206-455-7934|grants@ebpi.org|
305314|NCT02321098|Galderma|Farzaneh Sidou Clinical Project Manager|04 93 95 70 51|farzaneh.sidou@galderma.com|33
305315|NCT02321111|University of Texas Health San Antonio|Laurie Che Kelly|210-617-5300|che@uthscsa.edu|14731
305316|NCT02321319|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
305317|NCT02321436|Ipsen|Medical Affairs Director, Neurology||clinical.trials@ipsen.com|
305318|NCT02321462|Ipsen Pharma|Medical Director||clinical.trials@ipsen.com|
305319|NCT02321527|The University of Texas (UT) MD Anderson Cancer Center|Dr. Basak Dogan/Diagnostic Radiology|713-792-7734|CR_Study_Registration@mdanderson.org|
305320|NCT02321748|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
305321|NCT02321800|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
305322|NCT02321930|UCLA|Veena K. Ranganath|310-825-4321|vranganath@mednet.ucla.edu|
305323|NCT02322021|Eisai Medical Information|Eisai Ltd.|+1-888-274-2378|esi_medinfo@eisai.com|
305324|NCT02322047|Veterans Affairs Puget Sound Health Care System|Tracy Simpson, PhD|206-277-3337|tracy.simpson@va.gov|
305325|NCT02322125|University of Alberta|Dr. Jaynie Yang|780-492-2894|jaynie.yang@ualberta.ca|
305326|NCT02322190|National Cancer Institute|Dr. Ronald Gress|240-760-6167|rg26g@nih.gov|
305327|NCT02322216|Alcon, a Novartis Company|Clinical Project Lead, GCRA-Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
305328|NCT02322229|Alcon, A Novartis Division|Worldwide Medical Affairs Director, GMA Retina Lucentis|1-888-451-3937|alcon.medinfo@alcon.com|
305329|NCT02322242|Sunnybrook Health Sciences Centre|Dr. Stephen Choi|4164804864|stephen.choi@sunnybrook.ca|
305330|NCT02322281|Clovis Oncology|Vi Nguyen|+1 415 915 9982|vnguyen@clovisoncology.com|
305331|NCT02322320|The Emmes Company|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
305332|NCT02322333|Clinvest Research|Jim Sly MS|4178413673|jsly@clinvest.com|
305333|NCT02322411|University of Wisconsin - Madison|Dr. Nicole Pulia|6082561901|npulia@wisc.edu|11697
305334|NCT02322528|University of Rochester|Dr. James V. Aquavella|585-276-7439|rick_barrett@urmc.rochester.edu|
305335|NCT02322710|Mylan Medical SAS|Rafik NAMANE MD.|0033146258607|rafik.namane@mylan.com|
305336|NCT02322749|AstraZeneca|Information Centre||Information.centre@astrazeneca.com|
305337|NCT02322775|AstraZeneca Research and Development|Mitchell Goldman, Global Clinical Leader Benralizumab|301 398 0323|Mitchell.Goldman@astrazeneca.com|+1
305338|NCT02322788|AstraZeneca R&D Gothenburg, SE-431 83 Mölndal, Sweden|Göran Eckerwall, MD, PhD|+46 708467664|goran.eckerwall@astrazeneca.com|
305339|NCT02322814|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
305340|NCT02322866|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
305341|NCT02322879|BIDMC|Michael Ganetsky, MD|617-754-2323|mganetsk@bidmc.harvard.edu|
305342|NCT02322892|Beth Israel Deaconess Medical Center|Dr. Lars W. Andersen|6173886343|larswiuffandersen@gmail.com|
305343|NCT02323048|University of Chicago|Dr. Harriet de Wit|773-702-3560|dewitlab@yoda.bsd.uchicago.edu|
305344|NCT02323113|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
305346|NCT02323204|University of Iowa/ University of Minnesota|Dr. Marizen R Ramirez|612-624-3143|mramirez@umn.edu|
282478|NCT00856999|Oregon Health & Sciences University|Roger Dailey, MD, FACS|503-494-3020|daileyr@ohsu.edu|
305347|NCT02323217|Imperial College London|Dr Robin J Tyacke|(0)20 7594 7096|r.tyacke@imperial.ac.uk|+44
305348|NCT02323334|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
314171|NCT03262441|Fred Hutchinson Cancer Research Center|Dr. Joshua Schiffer|(206)667-7359|jschiffe@fredhutch.org|
314172|NCT03263442|University of North Carolina - Chapel Hill|Zev Nakamura|984-974-3829|zev_nakamura@med.unc.edu|
314173|NCT03263702|Icahn School of Medicine at Mount Sinai|Sam Cammack|212-824-8931|sam.cammack@mountsinai.org|
314174|NCT03263780|Cedars-Sinai Medical Center|Timothy Daskivich, M.D.|310-423-4700|timothy.daskivich@cshs.org|
314175|NCT03264066|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
314176|NCT03264092|Texas Tech University Health Sciences Center|Dr. Antonio Mendoza Ladd|9152154678|antonio.mendoza-ladd@ttuhsc.edu|
314177|NCT03264157|Bio Products Laboratory|Head of Medical Affairs|1-844-4BPLUSA|MedInfo@bpl-us.com|
314178|NCT03264248|University of Pittsburgh|Dr. Jonathan Pearlman|412-822-3685|jlp46@pitt.edu|
314179|NCT03264456|University of Alabama at Birmingham|Samuel Galgano|2059341388|samuelgalgano@uabmc.edu|
314180|NCT03265119|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
314181|NCT03265132|Swedish Orphan Biovitrum|Kineret Clinical Program Leader|+46(8)6972000|info@sobi.com|
314182|NCT03265600|Cambridge Health Alliance|Dr. Zev Schuman-Olivier|617-591-6132|zschuman@cha.harvard.edu|
314183|NCT03265938|Icahn School of Medicine at Mount Sinai|Dr. Samuel DeMaria|(212) 241-1518|samuel.demaria@mountsinai.org|
314184|NCT03266094|Medtronic|Melody LaBeau, Director of Clinical Operations|763.526.2931|melody.a.labeau@medtronic.com|
314185|NCT03266107|Relievant Medsystems Inc.|VP Clinical Affairs|(650) 368-1000|dsahr@relievant.com|280
314186|NCT03266172|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314490|NCT03312114|University of Texas Southwestern Medical Center|Phase II trial of Concurrent Anti-PD-L1 and SAbR for Patients with Persistent or Recurrent Epithelia|(214) 645-7296|kevin.albuquerque@utsouthwestern.edu|
314491|NCT03312218|McGill University|Dr. Roland Grad|514-947-3718|roland.grad@mcgill.ca|
314492|NCT03312231|Kaiser Permanente Washington Health Research Institute|Lisa A. Jackson, MD, MPH|206-442-5216|lisa.a.jackson@kp.org|
314493|NCT03312348|Sheffield Children's NHS Trust|Dr Shammi Ramlakhan - Chief Investigator|+44 1142262331|shammi.ramlakhan@sch.nhs.uk|
314494|NCT03312517|Henry Ford Sleep Research Center|Christopher Drake, PhD|248-344-6672|cdrake1@hfhs.org|
314495|NCT03312543|Johnson & Johnson Consumer Inc.|Sidney Hornby|908-874-2756|SHornby@its.jnj.com|
314496|NCT03312595|Acera Surgical, Inc.|Chief Science Officer|844-879-2237|information@acera-surgical.com|
314497|NCT03312933|Brigham and Women's Hospital|Dr. Jeremy T. Smith|(617) 983-7295|jsmith42@bwh.harvard.edu|
314498|NCT03313037|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
314499|NCT03313050|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
314500|NCT03313076|University of North Carolina at Chapel Hill|Matt Mauck, MD, PhD|919-966-5136|matt_mauck@med.unc.edu|
314501|NCT03313310|UNC Chapel Hill, ATN Coordinating Center|Betty Rupp|919-962-6603|brupp@email.unc.edu|
314502|NCT03314233|Childrens Hospital of Philadelphia|Dr. Elizabeth Foglia|215-590-1653|foglia@email.chop.edu|
314503|NCT03314519|Mahidol University|Kasana Raksamanee|66967841010|kasana@gmail.com|
314504|NCT03314662|Seqirus|Seqirus Clinical Trial Disclosure Manager|Phone: 1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
314505|NCT03314753|Medtronic|Study Project Manager (CSM)|00491742122|petra.kremer@medtronic.com|081
314506|NCT03314857|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
314507|NCT03315104|Emergent BioSolutions|Dr. Christine Hall|204-275-4200|chall@ebsi.com|4248
314508|NCT03315208|Massachusetts General Hospital/Harvard Medical School|Dr. Kate Bentley|617-724-7741|kbentley@mgh.harvard.edu|
314509|NCT03315286|Weill Cornell Medicine|Dr. George Varghese, Principal Investigator|646-962-3376|giv9006@med.cornell.edu|
314510|NCT03315559|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314511|NCT03315572|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314512|NCT03315689|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
314513|NCT03315702|Department of Anesthesia, Xinhua hospital affiliated to Shanghai Jiaotong University School of medicine|Dr. Lai Jiang|021-25078999|jianglaimz@sina.com|
314514|NCT03315780|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
314515|NCT03315793|Shionogi|Shionogi Clinical Trial Administrator|+81-6-6209-7885|shionogiclinicaltrials-admin@shionogi.co.jp|
314516|NCT03315949|College of Medicine, The Catholic University of Korea|Dr. Tae-Geun Gweon|82 32 340 2228|gweontae@naver.com|
314517|NCT03316131|AstraZeneca RD, Gothenburg|Fredrik Erlandsson|1-877-240-9479|information.center@astrazeneca.com|
314518|NCT03316170|University of Kentucky|Dr. Jessica Burris|+1 859-257-9612|jessica.burris@uky.edu|
314519|NCT03316378|University of Iowa, Department of Physical Therapy & Rehabilitation Science|Ruth Chimenti, Assistant Professor|319-335-9791|ruth-chimenti@uiowa.edu|
314520|NCT03316547|Washington University|Roberta Pineda|314-286-1304|bobbi.pineda@chan.usc.edu|
314521|NCT03316807|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
314522|NCT03316911|University of Michigan|Michelle Munro-Kramer|734-904-4600|mlmunro@umich.edu|
314523|NCT03316976|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
270321|NCT00120406|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
270322|NCT00120523|MEDA Pharma GmbH & Co. KG|Clinical Research|+49 6172 888|clinical.research@medapharma.de|01
270323|NCT00120627|VA San Diego Healthcare System|Jill E. Bormann, PhD, RN, FAAN|858-552-8585|jill.bormann@va.gov|2378
270324|NCT00120874|NYU Langone Medical Center|Barry Reisberg|121-263-8550|barry.reisberg@nyumc.org|
270325|NCT00121134|DFCI|Dr Harold J. Burstein|617-632-3800|hal_burstein@dfci.harvard.edu|
282479|NCT00857207|Malcom Randall VAMC|Julia Kay Waid-Ebbs, Health Science Specialist|352-871-0282|Julia.Waid-Ebbs@va.gov|
282480|NCT00857220|Sunovion|CNS Medical Director|866-503-6357||
305349|NCT02323646|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
305350|NCT02323854|Medtronic|Dr. Jaime Kean|303-882-6759|Jaime.m.Kean@medtronic.com|
305351|NCT02324049|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|475-230-2596|clinicaltrials@alexion.com|
305352|NCT02324075|Stanford University|Prof. Stephen P. Luby, MD|+1-650-723-4129|sluby@stanford.edu|
305353|NCT02324153|Johns Hopkins University School of Medicine|Karin Neufeld MD MPH: PI of Trial|410-550-0197|kneufel2@jhmi.edu|
305354|NCT02324205|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
305355|NCT02324270|Teva Pharmaceuticals USA, Inc|Senior Director, Global Gx Clinical R&D- PD/CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
305356|NCT02324335|Innovation Pharmaceuticals Inc.|Arthur P. Bertolino MD, PhD, MBA|978.921.4125|abertolino@IPharmInc.com|
305357|NCT02324361|Partners Healthcare|Study Project Manager|4259856430|szan@mail.harvard.edu|
305358|NCT02324465|Vanderbilt University Medical Center|Doug Hester|6153439419|doug.hester@vanderbilt.edu|
305359|NCT02324504|Boston Children's Hospital|Dr. Michael Agus|617 355-5849|michael.agus@childrens.harvard.edu|
305360|NCT02324543|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University|Dung Le, MD|443-287-0002|dle@jhmi.edu|
314524|NCT03317002|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
314525|NCT03317288|UT Southwestern Medical Center|Dr. Yi-Ting Tzen|2146481786|Yi-Ting.Tzen@UTSouthwestern.edu|
314526|NCT03317379|New York State Psychiatric Institute|Lisa Ranzenhofer, PhD|240 671 9040|lr2840@cumc.columbia.edu|
314527|NCT03317431|Department of Anesthesia,Xinhua hospital affiliated to Shanghai Jiaotong University School of Medicine|Dr.Lai Jiang|021-25078999|jianglaimz@sina.com|
314528|NCT03317444|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
314529|NCT03318315|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-5328|kneuzil@som.umaryland.edu|
314530|NCT03318341|MUSC|Na Jin Seo, PhD|8437920084|seon@musc.edu|
314532|NCT03318783|Oregon Health and Science University|Ross Martini|4013386803|martinir@ohsu.edu|
314533|NCT03318809|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
314534|NCT03319134|UT Dallas|Clinical Trial Manager|9723337277|Sarah.McLeod@utdallas.edu|
314535|NCT03319173|Bristlecone Health, Inc.|Dr. Kelly J. Gibas|763-913-4600|kelly-gibas@bethel.edu|
314536|NCT03319212|Johnson & Johnson Vision Care, Inc.|Elizabeth Dow, OD, FAAO - Principal Research Optometrist|904-443-1061|edow1@its.jnj.com|
314537|NCT03319277|Cleveland Clinic|Emily RW Davidson, M.D.|812-272-2380|dr.emily.rose@gmail.com|
314538|NCT03319719|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
314539|NCT03319810|Sutter Institute for Medical Research|Carol Parise, PhD, Research Scientist|(916) 887-4744|PariseC@sutterhealth.org|
314540|NCT03319953|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
314541|NCT03320057|University of California San Francisco|Shelly Kaller|510-986-8945|shelly.kaller@ucsf.edu|
314542|NCT03320096|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
314543|NCT03320369|Northwestern University|Nirmala Gonsalves|312-695-4054|n-gonzalves@northwestern.edu|
314544|NCT03320564|Wake Forest Baptist Health|Shane Masters|336-716-3590|smasters@wakehealth.edu|
314545|NCT03320824|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
314546|NCT03320850|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
314547|NCT03320941|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
314548|NCT03321006|NYP Institute|Dr. Katharine Brewster|646 774 6380|Katharine.Brewster@nyspi.columbia.edu|
314549|NCT03321097|Chang Gung Memorial Hospital-Kaohsiung Medical Center, Kaohsiung, Taiwan|Jen-Wen Hung, MD|+886975056689|hung0702@cgmh.org.tw|
314550|NCT03321253|Necip Fazil City Hospital|Dr. Bunyamin Kutluksaman|903442282800|bkutluksaman@gmail.com|
314551|NCT03321396|Department of Internal Medicine, National Cheng Kung University|Dr. Xi-Zhang Lin|886-6-2353535|linxz@mail.ncku.edu.tw|6202
314552|NCT03321721|St. Louis University School of Medicine|Dr. Trevor L. Tredway|314-577-5630|trevor.tredway@health.slu.edu|
314553|NCT03322293|University of California San Francisco Dept. of Dermatology|Dr. Sarah Arron, MD, PhD|415-353-9684|sarah.arron@ucsf.edu|
314554|NCT03322423|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-904-443-3402|TKarkkai@its.jnj.com|
305361|NCT02324569|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305362|NCT02324660|Azienda Ospedaliera Universitaria di Ferrara|Gianluca Campo, PI of the study|0532237079|cmpglc@unife.it|+39
305363|NCT02324673|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
305364|NCT02324699|Icahn School of Medicine at Mount Sinai|Dr. Bruce Sands|212-241-8100|bruce.sands@mssm.edu|
305365|NCT02324842|University of Texas Health San Antonio|Eugenio Cersosimo, MD|210-358-7220|cersosimo@uthscsa.edu|
293495|NCT01493427|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
305366|NCT02324920|BIOTRONIK Italiy|Daniele Giacopelli|+39 3491712305|daniele.giacopelli@biotronik.com|
305367|NCT02324972|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|+1 604-629-9223|clinical@aqxpharma.com|
305368|NCT02325219|Janssen Pharmaceutical K.K., Japan|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
305369|NCT02325401|University of Cincinnati|Trisha Wise-Draper M.D., Ph.D., Associate Professor of Medicine, Medical Director of the UC Cancer C|(513) 558-2826|wiseth@ucmail.uc.edu|
305370|NCT02325414|Northwestern University|Dr. Thomas Schnitzer|312-503-4043|tjs@northwestern.edu|
305371|NCT02325518|Alcon, A Novartis Division|Novartis Pharma KK|1-888-451-3937|alcon.medinfo@alcon.com|
305372|NCT02325687|Hospital for Special Surgery, Anesthesiology Department|Kethy Jules-Elysee|212-606-1206|juleselyseek@hss.edu|
305373|NCT02325713|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
314555|NCT03322462|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
314556|NCT03322514|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
314557|NCT03322657|Cleveland Clinic Foundation|Dr. Ehab Farag|216 444-7550|FARAGE@ccf.org|
314558|NCT03322930|Retina Foundation of the Southwest|Dr. David Birch|214-363-3911|dbirch@retinafoundation.org|105
314559|NCT03323086|The Miriam Hospital|Dr. Michael Carey|401 793 8218|michael_carey@brown.edu|
314560|NCT03323164|Wills Eye Hospital|Dr. Daniel Lee|12159283197|daniellee@willseye.org|
314561|NCT03323307|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
314562|NCT03323723|Rinovum Subsidiary 2, LLC.|Clinical Development Manager|7242418932|hwhitelam@rinovum.com|
314563|NCT03323736|Smith+Nephew|Laura England, PhD|(650) 223-6909|laura.england@smith-nephew.com|
314564|NCT03323801|University of Washington School of Medicine|Dr. John Amory|2066161727|jamory@uw.edu|
314565|NCT03323853|University of Arkansas for Medical Sciences|Dr. Michael Wilson|501-686-5515|MPWilson@uams.edu|
314566|NCT03324451|College of Nursing,Kaohsiung Medical University|Ruey-Hsia Wang|886-3-3121101|wrhsia@kmu.edu.tw|2641
314567|NCT03324581|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
314568|NCT03324607|Duke University Medical Center|Yuh-Chin T. Huang, MD, MHS|9196843069|huang002@mc.duke.edu|
314569|NCT03325010|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
314570|NCT03325556|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-|medicalinformation@acadia-pharm.com|2897
314571|NCT03325673|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
314572|NCT03325816|Georgetown University|Chul Kim, MD|202-444-2223|Chul.Kim@gunet.georgetown.edu|
314573|NCT03325881|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
314574|NCT03325894|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
314575|NCT03326323|Inova Heart and Vascular Institute|Eric L. Sarin MD|703-776-4138|eric.sarin@inova.org|
314576|NCT03326518|Lument AB|Dr Thomas Fork|+46 705336996|thomas.fork@lumentab.com|
314577|NCT03326843|Dova Pharmaceuticals|Associate Director, Clinical Operations|919-338-7864|clinical@dova.com|
314578|NCT03326856|Eirion Therapeutics|Chief Executive Officer|(781) 935-1216|info@eirionthera.com|
314579|NCT03326895|Ethicon Endo-Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
314580|NCT03326986|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
314581|NCT03326999|Icahn School of Medicine at Mount Sinai|Dr. Christina Jeng|212-241-6426|christina.jeng@mountsinai.org|
314582|NCT03327051|Stanford University|Aida Habtezion|650-736-5555|aidah@stanford.edu|
314583|NCT03327220|Pacira CryoTech, Inc.|Kent Jones/ Sr. Director, Quality and Medical Affairs|510-933-1513|kent.jones@pacira.com|
314584|NCT03327402|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
314585|NCT03327571|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
314586|NCT03328182|Hollister Incorporated|Director Global Clinical Affairs|8476802837|stacy.haddad@hollister.com|
314587|NCT03328208|Hypnalgesics, LLC|Elvira V. Lang, MD, CEO|6177349087|drevlang@comforttalk.com|
314588|NCT03328325|University of Rochester|Angela Branche, MD, Site Principal Investigator|585-275-5871|angela_branche@urmc.rochester.edu|
314589|NCT03328624|SALSA@USC|Research Coordinator|323-442-5528|dhuyvett@usc.edu|
314590|NCT03328832|Kaohsiung Chang Gung Memorial Hospital|Dr. Wang JW|+886-7-7317123|wangjw@adm.cgmh.org.tw|8003
314591|NCT03328897|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
314592|NCT03328949|Shockwave Medical, Inc.|Beaux Alexander, Vice President of Clinical Affairs|510-279-4262 ext. 145|balexander@shockwavemedical.com|
314593|NCT03329196|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
314594|NCT03329209|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
314595|NCT03329352|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
314596|NCT03329573|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314597|NCT03329690|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
314598|NCT03329846|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
314599|NCT03329885|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|clinical.trials@bms.com|
314600|NCT03329911|Bio-Thera Solutions Ltd.|Yufeng Zhang|+86 2038251386|yfzhang@bio-thera.com|
314601|NCT03329937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314602|NCT03329989|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
314603|NCT03330002|Essential Medical, a wholly owned subsidiary of Teleflex, Inc.|Darra Bigelow, Clinical Trials Manager|610-331-7299|darra.bigelow@teleflex.com|
282481|NCT00857233|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
282482|NCT00857246|Perlmutter Cancer Center|Theresa Ryan, MD|212-731-5430|theresa.ryan@nyumc.org|
305374|NCT02325739|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
314604|NCT03330041|University of California, Davis, Department of Dermatology|Daniel Eisen, M.D.|916-734-6479|dbeisen@ucdavis.edu|
314605|NCT03330119|Main Line Health System|Dr. Norman Brest|484-476-2325|brestn@mlhs.org|
314606|NCT03330236|Yale University|Lingzhong Meng, MD|(203) 785-2198|lingzhong.meng@yale.edu|
314607|NCT03330262|Barron Associates|Principal Research Scientist|434-973-1215|barron@barronassociates.com|125
314608|NCT03330275|Johnson & Johnson Vision Care, Inc.|John Buch- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
314609|NCT03330288|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
314610|NCT03330457|Portola Pharmaceuticals|Head of Clinical Development|650-246-7000|ClinicalTrials@Portola.com|
314611|NCT03330834|Sun Yat-sen University Cancer Center|Dr.Yuxiang Ma|86 020 87343894|mayx@sysucc.org.cn|
314612|NCT03331042|Sequential Medicine Ltd|Thomas Dahl|617-818-2735|tadahl@outlook.com|
314613|NCT03331185|University of Manitoba|Dr. Jonathan Bouwer|204 898 1132|jfbouwer@gmail.com|
314614|NCT03331315|University of Tennessee - West Cancer Center|Michael Ulm|404-281-9480|mulm@westclinic.com|
314615|NCT03331666|Columbia University Irving Medical Center|Dr. Nan Wang|212-342-1761|nw30@cumc.columbia.edu|
314616|NCT03331835|LEO Pharma AS|Clinical Disclosure|(+1) 877-557-1168|disclosure@leo-pharma.com|
314617|NCT03331965|Duke University Medical Center|Dr. James Ronald|919.684.7299|james.ronald@duke.edu|
314618|NCT03332160|Tactile Medical|Heather Smith|612.800.5539|HSmith@tactilemedical.com|
314619|NCT03332212|Boehringer Ingelheim|Boehringer Ingelheim , Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314620|NCT03332459|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
314621|NCT03332628|University of Iowa|Nicole Brogden, Associate Professor|(319) 335-8752|nicole-brogden@uiowa.ed|
314622|NCT03332771|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
314623|NCT03332784|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
314624|NCT03332979|Marie Curie Palliative Care Research Department, Division of Psychiatry, University College London|Dr Kirsten Moore|020 7679 9488|kirsten.moore@ucl.ac.uk|
314625|NCT03333109|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
271676|NCT00256776|EBMT|Clinical Study Unit|+31(0)715265005|ebmtcsu@lumc.nl|
314626|NCT03333317|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
314627|NCT03333577|Cochlear|George Cire|303 885 5440|gcire@msn.com|
314628|NCT03333876|Philips Respironics|Noah Papas|4122776436|Noah.Papas@philips.com|
314629|NCT03333941|AVITA Medical|VP Clinical Research|661-367-9710|clinicaltrial@avitamedical.com|
314630|NCT03334175|UCSF|Meghana Gadgil|4153537922|meghana.gadgil@ucsf.edu|
314631|NCT03334188|"University of Colorado | School of Medicine | ACCORDS"|Dr. Larry Allen, Professor of Medicine|303-724-4713|larry.allen@cuanschutz.edu|
314632|NCT03334214|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
314633|NCT03334396|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314634|NCT03334422|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314635|NCT03334448|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
314636|NCT03334630|Medtronic|Katie Flor, Principal Clinical Research Specialist|+1 763 526 9651|katie.j.flor@medtronic.com|
314637|NCT03334695|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
314638|NCT03334721|Medical University of South Carolina|James J. Prisciandaro, Ph.D.|843-792-1433|priscian@musc.edu|
314639|NCT03334734|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
314640|NCT03334747|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
314641|NCT03334812|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
271677|NCT00256854|GlaxoSmithKline|GSK Response Center|866-435-7343||
281767|NCT04109118|Boston Medical Center and BU School of Medicine|Tae Woo Park, MD|617-414-1906|taewoo.park@bmc.org|
305375|NCT02325791|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
305376|NCT02325856|Department of Nephrology, Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan|Lim Paik-Seong|886-4-26581919|jamespslim@gmail.com|
305377|NCT02326025|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
305378|NCT02326220|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
305379|NCT02326233|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
305380|NCT02326272|Cares|UCB|+1844599|UCBCares@ucb.com|2273
305381|NCT02326298|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
305382|NCT02326363|Medical University of South Carolina|Nathaniel L Baker|843-792-5028|bakern@musc.edu|
305383|NCT02326467|Boston Children's Hospital|Celeste Chandonnet|781-216-0050|celeste.chandonnet@childrens.harvard.edu|
305384|NCT02326597|Emory University|Lakshmanan Krishnamurti, MD|4047270710|lkrishn@emory.edu|
305385|NCT02326649|UCSD|Christopher Davis|8589665855|cdavis@rchsd.org|5668
305386|NCT02326805|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
305387|NCT02326844|National Cancer Institute|Dr. Jung-Min Lee|301-443-7735|leej6@mail.nih.gov|
305388|NCT02326883|Kaiser Permanente Washington Health Research Institute|Gregory Simon, Investigator|206-287-2979|gregory.e.simon@kp.org|
305389|NCT02326974|Dana-Farber Cancer Institute|Project Manager|617-632-3500|ctopm@dfci.harvard.edu|
305390|NCT02327013|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
282483|NCT00857259|Novartis Pharmaceuticals|Study Director|862-778-8300||
314642|NCT03334825|New York City Department of Health and Mental Hygiene|Dr. Ellen Wiewel|347-396-7653|ewiewel@health.nyc.gov|
314643|NCT03334903|Brigham and Women's Hospital|Dr. Wolfgang Fitz|6177325500|wfitz@bwh.harvard.edu|
314644|NCT03335150|VASDHS|Dr. Dawn Schiehser|858-552-8585|Dawn.Schiehser@va.gov|2664
314645|NCT03335254|TesoRx Pharma, LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
314646|NCT03335566|GE Healthcare|Francois Tranquart, M.D, PhD|011-44-1494-543037|francois.tranquart@ge.com|
314647|NCT03335761|Medtronic|Mylène Champs (Sr Clinical Research Specialist)|+17635261627|mylene.champs@medtronic.com|
314648|NCT03335800|Associate Professor of Medicine, Stanford University|Minang (Mintu) Turakhia, Associate Professor of Medicine, Stanford University|(650) 493-5000|mintu@stanford.edu|
314649|NCT03336450|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
314650|NCT03336502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
314651|NCT03336645|Shire|Study Physician|1 866-842-5335|ClinicalTransparency@takeda.com|
314652|NCT03336853|AOUCareggi|Dr. Riccardo Pace|+390557945608|riccardo.pace@unifi.it|
314653|NCT03337139|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
314654|NCT03337152|PATH|Gonzalo Domingo|206-285-3500|gdomingo@path.org|
292556|NCT01433549|Alcon Research, Ltd.|R. Alan Landers, O.D., M.S., F.A.A.O.|1-888-451-3937|alcon.medinfo@alcon.com|
282484|NCT00857272|Braintree Laboratories, Inc.|John McGowan, Associate Director, Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
282485|NCT00857311|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
282486|NCT00857389|UT MD Anderson Cancer Center|Kris M Mahadeo, Associate Professor, Pediatrics - Patient Care|(713) 792-2873|kmmahadeo@mdanderson.org|
282487|NCT00857415|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
314655|NCT03337308|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
314656|NCT03337477|AstraZeneca Clinical|Study Information Center|+1 877 240 9479|information.center@astrazeneca.com|
314657|NCT03337490|Mayne Pharma LLC|Associate Director, Clinical Operations|9195737948|phoevos.hughes@maynepharma.com|
314658|NCT03337542|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
314659|NCT03338010|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314660|NCT03338023|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314661|NCT03338036|University of Western Ontario|Dr Jim Dickey, Associate Professor|519-661-2111|jdickey@uwo.ca|87834
314662|NCT03338062|IndianaU|Dr. Ryan Rhome|(317) 944-1367|rrhome@iu.edu|
314663|NCT03338296|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
314664|NCT03338400|Cleveland Clinic Florida|Dr. David Ossin|954-659-5559|ossind@ccf.org|
314665|NCT03338556|PrEP Biopharm Limited|Chief Medical Officer|8666207176|info@prepbiopharm.com|0
314666|NCT03338569|University of Minnesota|Ronald Reilkoff, MD|612-624-0999|rreilkof@umn.edu|
314667|NCT03338673|University of Michigan|Dr. Cynthia Burton|7347639259|czburton@umich.edu|
314668|NCT03338686|University of Alabama at Birmingham|Ramzi Abou-Arraj|2059344506|rva@uab.edu|
314669|NCT03338803|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314670|NCT03338816|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
314671|NCT03338855|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
314672|NCT03338894|Atlantic Children's Health/Atlantic Health Outpatient|Dr. Alycia Leiby|973--971-5676|alycia.leiby@atlantichealth.org|
314673|NCT03338998|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
314674|NCT03339206|University of North Carolina at Chapel Hill|Adam O. Goldstein|984-974-0210|adam_goldstein@med.unc.edu|
314675|NCT03339219|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
314676|NCT03339297|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
314677|NCT03339453|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314678|NCT03339570|Hospital Gregorio Maranon|Dr. Mikel Aburto|34915868000|mikelaburto@hotmail.com|7007
314679|NCT03339583|I.M. Sechenov First Moscow State Medical University|Polina Pchelina|+79036701725|polbox@mail.ru|
314680|NCT03339713|Janssen Research & Development, LLC|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
314681|NCT03339726|JNJWorldwide|Steven Sacavage, PharmD, Associate Director, Global Pain & Allergy Clinical Research|215 273-8568|ssacavag@its.jnj.com|8568
314682|NCT03339999|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
314683|NCT03340025|University of Alabama at Birmingham|Benjamin Greene, MD|205-801-7855|bjgreene@uabmc.edu|
314684|NCT03340337|Universidad Maimónides - Universidad Nacional Arturo Jauretche - Instituto Universitario de Ciencias de la Salud Fundación H.A. Barceló|Oscar Ronzio|+54-11-4905-1140|ronzio.oscar@maimonides.edu|
314685|NCT03340350|VA Nebraska-Western Iowa Health Care System|Sriram Ramaswamy, MD|402-995-4712|Sriram.Ramaswamy@va.gov|
314686|NCT03340415|CUHK|Dr Samuel Ling|35052010|samuel-kk-ling@alumni.cuhk.net|
314687|NCT03340428|Johns Hopkins University|Christopher Hoffmann|410-614-4257|choffmann@jhmi.edu|
314688|NCT03340610|Southeast Retina Center|Dr. Dennis Marcus|706650061|dmarcus@southeastretina.com|
314689|NCT03340805|The Children's Hospital of Philadelphia|Dr. Scott L. Weiss, study co-PI|215-590-5505|WeissS@email.chop.edu|
314690|NCT03340883|Chinook Therapeutics, Inc.|Chinook Therapeutics, Inc. (formerly Aduro Biotech, Inc.)|206-485-7051|clinicaltrials@chinooktx.com|
314691|NCT03340961|Dr. Reddy's Lab, INC|Dr. Srinivas Sidgiddi, Senior Director|908-458-5362|Srinivassidgiddi@drreddys.com|
314692|NCT03341273|Duke University|Ephraim L. Tsalik, MD, MHS, PhD|919-684-3114|e.t@duke.edu|
314693|NCT03341299|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
314694|NCT03341312|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
314695|NCT03341507|Iuliu Hatieganu University of Medicine and Pharmacy- Cluj Napoca Romania|Dr Ioan Florin Marchis|+40757065205|marchis.ioan@umfcluj.ro|0757065205
314696|NCT03341533|Mayo Clinic|Dr. Tatnai Burnett|507-538-5783|burnett.tatnai@mayo.edu|
314697|NCT03341546|NHS Tayside|Mark Worrall|01382632177|markworrall@nhs.net|
314698|NCT03341637|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
314699|NCT03341728|University of North Caroilina at Chapel Hill|Jason R Franz, PhD|919-966-6119|jrfranz@email.unc.edu|
314700|NCT03341910|Dr. Reddy's Laboratories, Inc|Dr. Srinivas Sidgiddi, Sr. Director, Clinical Development|609-375-9910|srinivassidgiddi@drreddys.com|
314701|NCT03341923|Alcon Japan, Ltd.|Group Manager, Vision Care|+81.3.6899.5061|alcon.medinfo@alcon.com|
314702|NCT03341975|Children's Mercy Hospitals and Clinics|Melissa Miller MD|8162343430|mmiller@cmh.edu|
314703|NCT03342053|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
314704|NCT03342404|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
314705|NCT03342469|American University|Dr. Kathleen Holton|(202) 885-3797|holton@american.edu|
314706|NCT03342560|Massachusetts General Hospital|Anthony E. Samir|6176432009|asamir@mgh.harvard.edu|
314707|NCT03342690|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
314708|NCT03342898|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
282488|NCT00857454|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282489|NCT00857493|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
314709|NCT03342963|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
314710|NCT03343067|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
314711|NCT03343080|Mayo Clinic|Dr. Troy Seelhammer|507-255-6051|seelhammer.troy@mayo.edu|
314712|NCT03343639|Chief Scientific Officer|Paul Kwon|650-486-1416|pkwon@menlotx.com|
314713|NCT03343704|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314714|NCT03344172|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
314715|NCT03344510|Perelman School of Medicine at the University of Pennsylvania|Dr. Joseph Sobanko|215.360.0909|joseph.sobanko@uphs.upenn.edu|
314716|NCT03344640|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
314717|NCT03344861|on behalf of Concordia Laboratories Inc.|Kim McDonald-Taylor|647-267-2942|kmcdonald-taylor@rogers.com|
314718|NCT03345108|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314719|NCT03345160|Johns Hopkins School of Medicine|Dr. Robert Wood|410-919-7617|RWood@JHMI.edu|
314720|NCT03345394|Federal University of Sao Paulo|Dr. André Miguel|+55 11 965884111|aqcmiguel@gmail.com|
314721|NCT03345407|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314722|NCT03345472|Medtronic Restorative Therapies Group, Spinal Cord Stimulation|Stacie Hallaway/Senior Clinical Research Specialist|763-526-3844|RS.VectorsPM@medtronic.com|
314723|NCT03345914|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
314724|NCT03345979|Alkermes, Inc|Eva Stroynowski|7816097000|eva.stroynowski@alkermes.com|
314725|NCT03346057|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
314726|NCT03346070|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
314727|NCT03346161|Washington University School of Medicine|Mary C. Politi, Ph.D.|314-747-1967|mpoliti@wustl.edu|
314728|NCT03346759|University of Michigan|Jason Bell, MD|7342323897|jasonbel@med.umich.edu|
314729|NCT03346850|The University of Texas Health Science Center at Houston|Raymond Parlar-Chun, MD|713-500-5666|Raymond.L.Chun@uth.tmc.edu|
314730|NCT03346902|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|9493796569
314731|NCT03347188|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
314732|NCT03347279|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
314733|NCT03347695|Fujian Medical University Union Hospital|Dr. Liangwan Chen|861335825333|chenliangwan@tom.com|
314734|NCT03348683|Icahn School of Medicine at Mount Sinai|Dr. Catherine A Bigelow|651-206-9069|cassie.bigelow@gmail.com|
314735|NCT03349034|Icahn School of Medicine at Mount Sinai|Dr. Brett Miles|(212) 241-9410|brett.miles@mountsinai.org|
314736|NCT03349060|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
314737|NCT03349099|Cleveland Clinic|Manoj Monga MD|216-445-8678|mongam@ccf.org|
314738|NCT03349333|Mundipharma(China) Co.,Ltd|clinical study manager|8610-65636856|guodong.lu@mundipharma.com.cn|
314739|NCT03349437|Philips|Biostatistician|412-542-3651|jeff.jasko@philips.com|
314740|NCT03349515|Medical University of South Carolina|Dr. Michelle Rovner|843-792-2322|rovner@musc.edu|
314741|NCT03349567|Iowa City VA Health Care System|Daniel Livorsi|319-688-3871|daniel-livorsi@uiowa.edu|
314742|NCT03349632|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
314743|NCT03349710|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
314744|NCT03349892|University of California, Los Angeles|Robert K. Chin, MD, PhD , Assistant Clinical Professor|(310) 825-9771|rkchin@mednet.ucla.edu|
314745|NCT03350217|Indiana University|Clinical Research Specialist|317-948-0724|rlahr@iu.edu|
314746|NCT03350256|Abbott|Filippo Agnesi|+19725264860|filippo.agnesi@abbott.com|
314747|NCT03350542|Boston Scientific|Patricia O'Mara|518-744-0046|patricia.omara@bsci.com|
314748|NCT03350672|Philadelphia FIGHT Community Health Centers|Linden Lalley-Chareczko|2155258695|lchareczko@fight.org|
314749|NCT03350724|The University of Texas Health Science Center at Houston|Jennifer James, DMD, MS|713-486-4383|Jennifer.D.James@uth.tmc.edu|
314750|NCT03350919|University of Rochester|Steven E. Feldon, MD|585-273-1050|Steven_Feldon@urmc.rochester.edu|
314751|NCT03351101|Bausch Health|Study Director|+1 (585) 338-6399|Robert.Steffen@bausch.com|
314752|NCT03351114|Duke University|Dr. Adela R. Cardones|9196843110|adela.cardones@duke.edu|
314753|NCT03351231|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
314754|NCT03351335|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
282490|NCT00857506|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
282491|NCT00857532|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
314755|NCT03351478|Lexicon Pharmaceuticals, Inc|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
314756|NCT03351608|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
314757|NCT03351699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
314758|NCT03351738|MedImmune, LLC|Richard George|+1-301-398-5681|information.center@astrazeneca.com|
314759|NCT03351933|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
314760|NCT03352245|Yale University|Dr. Brett Bade|203 785 6670|Brett.bade@yale.edu|
314761|NCT03352323|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
314762|NCT03352414|University of California, San Diego|Raymond Diep, Clinical Research Coordinator|(858) 822-5352|rhdiep@health.ucsd.edu|
314763|NCT03352453|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
314764|NCT03352609|MUSC|Dr Friedrich|843-792-9888|friedric@musc.edu|
314765|NCT03352713|Center for Technology and Behavioral Health, Dartmouth Geisel School of Medicine|Dr. Shea Lemley|603-646-7040|behavior.change@dartmouth.edu|
314766|NCT03353220|Columbia University|Sharon Wardlaw, MD|212-305-3725|sw22@cumc.columbia.edu|
314767|NCT03353246|Duke University Medical Center|Michael Haglund, M.D., Ph.D.|919-684-6936|haglu001@mc.duke.edu|
314768|NCT03353740|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|thomas.hope@ucsf.edu|
314769|NCT03353753|Deciphera Pharmaceuticals, LLC|INVICTUS Clinical Team|7812096400|clinicaltrials@deciphera.com|
314770|NCT03354325|University of Utah|Eric Coon|801-662-3645|Eric.Coon@hsc.utah.edu|
314771|NCT03354429|Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
314772|NCT03354598|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
314773|NCT03354637|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
314774|NCT03354663|Abbott|Steven Madej|651-756-2230|steven.madej@abbott.com|
314775|NCT03354754|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
314776|NCT03355326|Indiana University, School of Medicine|Dr. Alan Ladd, Principle Investigator|317-274-4606|aladd@iupui.edu|
314777|NCT03355742|Clinical Affairs, Abbott Vascular|Siok Hwee Tan, PhD, Principal Clinical Research Scientist|+1 408-845-3581|siokhwee.tan@abbott.com|
314778|NCT03355820|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314779|NCT03356145|Stanford University|Clinical Research Manager|6507247826|gynresearch@stanford.edu|
314780|NCT03356977|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
314781|NCT03357341|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314782|NCT03357393|Region Östergötland|Lena Nilsson|+46 10 103 00 00|lena.nilsson@regionostergotland.se|1838
314783|NCT03357471|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
314784|NCT03357614|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
314785|NCT03357731|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
314786|NCT03358147|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
314787|NCT03358238|University of Wisconsin-Madison|Amy Cochran|608-262-0772|cochran4@wisc.edu|
314788|NCT03358251|Prudentix Ltd.|Head of QA/RA|+972-72-394-22-24|tsipi@prudentix.com|
314789|NCT03358290|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
314790|NCT03358329|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
314791|NCT03358355|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
314792|NCT03358407|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314793|NCT03358472|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
314794|NCT03358576|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
314795|NCT03359395|Wake Forest Health Science|T. Quinn McCutchen, MD|336.716.4498|tmccutch@wakehealth.edu|
314796|NCT03359473|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314797|NCT03359590|Profil Institut für Stoffwechselforschung GmbH|Dr. Christoph Kapitza|+49 2131 4018|christoph.kapitza@profil.com|157
314798|NCT03359629|Maale Carmel Mental Health Center|Anatoly Kreinin|(+972) -4-8559315|kranata@gmail.com|
314799|NCT03359850|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314800|NCT03359889|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314801|NCT03360071|John Hopkins University School of Medicine|Jody Tversky, MD|410-550-2300|hoddin1@jhmi.edu|
314802|NCT03360110|CooperVision|Myhanh Nguyen, OD, Manager of Clinical Research|19257306716|MNguyen@coopervision.com|
314803|NCT03360344|Loma Linda University|Donnamarie Krause|7347642243|donnamarie.krause@gmail.com|
314804|NCT03360747|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
314805|NCT03361137|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
314806|NCT03361176|Maryland Laser Skin and Vein|Robert A. Weiss, MD|4106662839|cmyers@mdlsv.com|
314807|NCT03361293|University of Minnesota|Jeffrey Wozniak, PhD, LP|612-273-9741|jwozniak@umn.edu|
314808|NCT03361423|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|+972723909755|daganh@theranica.com|
314809|NCT03361605|University of Michigan|Amy McKinney|734-647-8129|adrongo@med.umich.edu|
314810|NCT03361917|Indiana University|Rachel Lahr|3179480724|rlahr@iu.edu|
314811|NCT03362879|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
314812|NCT03362944|Frohlich Lab - University of North Carolina at Chapel HIll|Trevor McPherson|919-966-4755|trevor_mcpherson@med.unc.edu|
282492|NCT00857545|NRG Oncology|Linda Gedeon for Wei Deng PhD|716-845-1169|lgedeon@gogstats.org|
314813|NCT03362957|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
314814|NCT03363321|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
314815|NCT03363776|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
314816|NCT03363854|LEO Pharma A/S|Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
314817|NCT03363906|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314818|NCT03364023|Medtronic Neurovascular Clinical Affairs|Medtronic Neurovascular Clinical Affairs|9498373700|rs.nvclinicalprospr-sea@medtronic.com|
314819|NCT03364036|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
314820|NCT03364049|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
314821|NCT03364192|VA Center for Integrated Healthcare|Emily M. Johnson, Ph.D., PI|315-425-4400|Emily.Johnson1@va.gov|53487
314822|NCT03364309|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314823|NCT03364335|NuSirt Biopharma|Barbara Cannon|6156567898|BCannon@nusirt.com|
314824|NCT03364608|Pearl Therapeutics, Inc, a Member of the AstraZeneca Group|Colin Reisner, MD FCCP, FAAAAI|9739750321|Colin.Reisner@astrazeneca.com|
314825|NCT03364673|Dana-Farber Cancer Institute|Alexi Wright, MD, MPH|617-632-2334|alexi_wright@dfci.harvard.edu|
314826|NCT03364738|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
314827|NCT03364751|Philip Morris Products S.A.|Christelle Haziza, Director Clinical Science & Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
314828|NCT03365011|Washington University School of Medicine in St. Louis|Jay F. Piccirillo, MD, FACS|(314) 362-8641|piccirij@wustl.edu|
314829|NCT03365154|Libra Medical|Phil Zhang, MD|6692039308|pzhang@libramed.com|
314830|NCT03365778|Wills Eye Hospital|Clinical Research Coordinator|215-928-3213|jtran@willseye.org|
314831|NCT03365934|JNJWorldwide|Amisha Parikh-Das|973-255-8701|aparikh1@its.jnj.com|
314832|NCT03366207|Iterum Therapeutics|Senior Director, Clinical Development|18606614035|saronin@iterumtx.com|
314833|NCT03366298|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
314834|NCT03366428|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
314835|NCT03367793|Ohio State University College of Optometry|Dr. Heather Anderson, Study PI|614-247-5825|anderson.3881@osu.edu|
314836|NCT03368053|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
314837|NCT03368170|Integrative Research Laboratories AB|Joakim Tedroff/Chief Medical Officer|+ 46 707 601691|joakim.tedroff@irlab.se|
314838|NCT03368235|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
314839|NCT03368807|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314840|NCT03368859|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
314841|NCT03368898|bakirkoy dr sadi konuk training and research hospital|İsmail Alay|+905462375638|dr_ismailalay@hotmail.com|
314842|NCT03368937|University of Virginia|Sue Brown|434-982-0206|sab2f@virginia.edu|
282493|NCT00857584|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
314843|NCT03369158|Medacta International|Clinical Data Manager|+41 91 696 60 60|bonacina@medacta.ch|
314844|NCT03369236|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|1 855-752-2356|clinicaltrials@alexion.com|
314845|NCT03369340|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
314846|NCT03369418|UCLA|Kirsten Tillisch|1 310 208-5400|ktillisch@mednet.ucla.edu|
314847|NCT03369704|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
314848|NCT03369756|B. Braun Medical Inc.|Dr. Diana Valencia|610-596-2875|diana.valencia@bbraunusa.com|
314849|NCT03369951|Northwestern University of Feinberg School of Medicine|Richard G. Wunderink, MD|312-695-1878|r-wunderink@northwestern.edu|
314850|NCT03370042|Kamineni Institute of dental sciences|Dr. Raga Bindu|09849441800|ragha.j16@gmail.com|
314851|NCT03370289|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
314852|NCT03370302|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
314853|NCT03370419|Wayen State University|Heather Fritz|313-577-9499|heather.fritz@wayne.edu|
314854|NCT03370471|Atlanta VA Health Care System|Amy D Rodriguez, PhD|404-321-6111|amy.rodridguez@va.gov|204201
314855|NCT03370770|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314856|NCT03371355|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
314857|NCT03371381|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
314858|NCT03371459|Pearl Therapeutics, Inc, a Member of the AstraZeneca Group|Colin Reisner, MD FCCP, FAAAAI|9739750321|Colin.Reisner@astrazeneca.com|
314859|NCT03371732|Institute Bergonie|Dr. Marion Barrault Couchouron, Coordinating Investigator|0556337805|m.barrault@bordeaux.unicancer.fr|
314860|NCT03371836|KennedyKrieger|Project Director|443-923-7600|Salpekar@kennedykrieger.org|
314861|NCT03372083|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
314862|NCT03372096|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
314863|NCT03372369|University of North Carolina at Chapel Hill|Seri Link Anderson, PhD|919-619-0433|seri.link.a@gmail.com|
314864|NCT03372382|McGovern Medical School, University of Texas, Health Science Center at Houston|Dr Jenifer Dinis, MD|713 500 6421|jenifer.dinis@uth.tmc.edu|
314865|NCT03372434|Johnson & Johnson Surgical Vision|Eugenia Thomas, OD|+1 657 2903260|EThoma39@its.jnj.com|
314866|NCT03372551|Coopervision|Myhanh Nguyen, Sr. Optometrist|925-730-6716|mnguyen@coopervision.com|
314867|NCT03372603|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314868|NCT03372928|US Army Research Institute of Environmental Medicine|Jess Gwin|508-206-2300|jessica.a.gwin.ctr@mail.mil|
314869|NCT03373006|HALO Diagnostics|Chief Research Officer|760-766-2047|bernadette@halodx.com|
314870|NCT03373162|University of California, Irvine|Dr. Craig Stark, Professor|949-824-4201|cestark@uci.edu|
314871|NCT03373240|Yale University|Dr. Arielle Baskin-Sommers|203-432-9257|arielle.baskin-sommers@yale.edu|
314872|NCT03373383|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
314873|NCT03373591|Montefiore Medical Center|Diego Camacho, MD|718-920-4800|dicamach@montefiore.org|
314874|NCT03373890|SeattleChildrens|Kristie Bjornson, PT, PhD|206-884-2066|kristie.bjornson@seattlechildrens.org|
314875|NCT03374176|Centro Universitario de Tonalá, Universidad de Guadalajara|Dr. Arieh Roldán Mercado Sesma|+52 (33) 20 00 23 00|arieh.mercado@academicos.udg.mx|6400
314876|NCT03374189|St. Vincent's Hospital|Dr. Hee Youn Kim|82-31-249-7473|khyoun10589@gmail.com|
314877|NCT03374358|Helsinki University Hospital|Dr Jussi Sutinen|+358407480437|jussi.sutinen@hus.fi|
314878|NCT03374488|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
314879|NCT03374683|University of British Columbia|Dr. Mariana Brussoni|604-875-3712|mbrussoni@bcchr.ubc.ca|
314880|NCT03374995|Wake Forest University Health Sciences|Principal investigator|336-716-5440|kwinkfie@wakehealth.edu|
314881|NCT03375294|Palo Alto Veterans Affairs|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
314882|NCT03376061|Population Health Research Institute|Research assistant|19055212100|Austin.Browne@phri.ca|40582
314883|NCT03376256|University of Miami|Dr. Ralf Gebhard|3055858365|rgebhard@med.miami.edu|
314884|NCT03376295|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314885|NCT03376321|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
314886|NCT03376516|Octapharma AG|Sylvia Werner|604-1149|sylvia.werner@octapharma.com|+1 (201)
314887|NCT03377127|Beaumont Health|Dr. Alexandra Halalau|2485513481|alexandra.halalau@beaumont.org|
314888|NCT03377244|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
314889|NCT03377556|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
314890|NCT03377634|Wake Forest University School of Medicine|Amber Brooks, MD|336-716-4498|akbrooks@wakehealth.edu|
314891|NCT03378076|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
314892|NCT03378635|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
314893|NCT03378921|Department of Gastrointestinal surgery, Helsinki University Hospital|Dr. Essi Karjalainen|+358504621853|essi.karjalainen@hus.fi|
314894|NCT03378973|Hospital for Special Surgery|Ronald Emerson, MD|2127742742|emersonr@hss.edu|
314895|NCT03379259|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
314896|NCT03379376|Wake Forest University Health Sciences|Meg O'Mara - Study Coordinator|336-716-5440|megreen@wakehealth.edu|
314897|NCT03379506|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
314898|NCT03379545|NYU Langone Health|Joseph Zuckerman, MD|212-598-6674|Joseph.Zuckerman@nyulangone.org|
314899|NCT03379662|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
314900|NCT03379740|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
314901|NCT03379753|TriHealth Inc.|Rachel Pauls, MD|513-463-4300|Rachel_Pauls@trihealth.com|
314902|NCT03380000|Penn State University|David N. Proctor|8145715234|dnp3@psu.edu|
314903|NCT03380026|Rochester Skin Lymphoma Medical Group|Clinical Research Coordinator|(585)364-1188|scarroll@roclymphoma.com|
314904|NCT03380091|University of California, San Francisco|Heather Huddleston|(415) 353-3040|Heather.Huddleston@ucsf.edu|
314905|NCT03380390|Aclaris Therapeutics|Dr. David Gordon|484-540-6273|dgordon@aclaristx.com|
314906|NCT03380429|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314907|NCT03380572|Imperial College London|Mr R Aggarwal|02033126840|r.aggarwal@ic.ac.uk|
314908|NCT03380624|The Ohio State University College of Optometry|Jennifer Fogt|614-292-2020|fogt.78@osu.edu|
314909|NCT03380780|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
314910|NCT03380845|MGH|Dr. Sandeep Saluja|6466621084|sandeep.s.saluja@gmail.com|
271678|NCT00256867|GlaxoSmithKline|GSK Response Center|866-435-7343||
314911|NCT03381196|Janssen Research & Development, LLC|Senior Director Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
282494|NCT00857623|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
314912|NCT03381248|Avanos Medical|David Curd|470-448-5178|david.curd@avanos.com|
314913|NCT03381339|Marquette Univeristy|Associate Dean|4142885944|andrew.dentino@marquette.edu|
314914|NCT03381742|Department of Cardiology, the First Affiliated Hospital, Harbin Medical University, Harbin, China|Dr. Yue Li|86-451-85555673|ly99ly@vip.163.com|
314915|NCT03381989|National Heart Lung and Blood Institute|Lederman, Robert|+1 301 402 6769|lederman@nih.gov|
314916|NCT03382262|Flexion Therapeutics|Scott Kelley MD, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
314917|NCT03382418|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
314918|NCT03382509|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314919|NCT03382665|Zimmer Biomet|Fabrizio Lucchini, Clinical Jr.Project Lead|0041798575924|Fabrizio.Lucchini@zimmerbiomet.com|
314920|NCT03382821|University of Utah, Department of Physical Medicine and Rehabilitation|Shellie Cunningham|801-587-5488|shellie.cunningham@hsc.utah.edu|
314921|NCT03382847|NYU LANGONE TRANSPLANT INSTITUTE|Dr. Bonnie Lonze|2122638365|Bonnie.Lonze@nyumc.org|
314922|NCT03382899|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|www.ClinicalTrials.gov@lilly.com|
314923|NCT03382912|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314924|NCT03383146|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
314925|NCT03383198|Prisma Health|Dr. William R. Hand|864.522.3707|William.Hand@prismahealth.org|
314926|NCT03383523|Drugs for Neglected Diseases Initiative|Jean Yves Gillon|+41229069232|jygillon@dndi.org|
314927|NCT03383588|Montefiore Medical Center|Dr Catherine Igel|718-405-8200|cigel@montefiore.org|
314928|NCT03383614|DNDi|Jean Yves Gillon|+41.22.906.92.32|jygillon@dndi.org|
314929|NCT03383627|Northwell Health|Lubaina Presswala, DO|516-708-2540|lpresswala@northwell.edu|
314930|NCT03383692|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
314931|NCT03383757|GE Healthcare|Clinical Affairs Project Manager|262-443-7008|stephanie.karwedsky@ge.com|
314932|NCT03383783|Oral Health Research Institute|Domenick T Zero, DDS, MS|317-274-8822|dzero@iu.edu|
314933|NCT03383887|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
314934|NCT03384173|University of Wisconsin, Madison|Matthew Harer|608-417-6236|mwharer@wisc.edu|
314935|NCT03384316|National Cancer Institute|Dr. Julius Y. Strauss|240-858-3999|straussjy@nci.nih.gov|
314936|NCT03384329|Institute of Physiology and Basic Medicine|Dr. Lyubomir Aftanas|+7-913-912-2228|liaftanas@gmail.com|
314937|NCT03384693|University of California, San Francisco|Dr. Christine Higham|415-476-2188|christine.higham@ucsf.edu|
314938|NCT03384745|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
314939|NCT03384940|Daiichi Sanyko, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
314940|NCT03384953|Osher Center for Integrative Medicine|Dr. Lindsey C. McKernan|615-320-7770|lindsey.mckernan@vumc.org|
314941|NCT03384966|Idorsia Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
314942|NCT03386032|The Procter & Gamble Company|Laurie Moulton, M.S., Statistical Group Scientist|+1-513-544-3636|moulton.lt@pg.com|
314943|NCT03386110|Hunter College|Tyrel J. Starks|212-206-7919|tstarks@hunter.cuny.edu|
314944|NCT03386344|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
314945|NCT03386435|Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea|Jun-Gol Song, MD, PhD|+82-2-3010-3869|jungol.song@amc.seoul.kr|
314946|NCT03386448|The Taub Group|Neal Taub MD|7044429805|nealtaub@gmail.com|
314947|NCT03386474|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
314948|NCT03386994|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314949|NCT03387020|St. Jude Children's Research Hospital|Dr. Arzu Onar-Thomas|901-595-5499|arzu.onar@stjude.org|
314950|NCT03387033|Duke University|Nirmish Shah, MD|919-668-5178|nirmish.shah@duke.edu|
314951|NCT03387046|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
314952|NCT03387267|Nestlé Health Science|Kemuel Reyes|(908) 333-9379|Kemuel.Reyes@us.nestle.com|
314953|NCT03387319|Emory University|Kimberly R Jacob Arriola, PhD, MPH|404-727-2600|kjacoba@emory.edu|
314954|NCT03387462|Bridge HIV, San Francisco Department of Public Health|Dr. Susan Buchbinder|628-217-7479|susan.buchbinder@sfdph.org|
282495|NCT00857649|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
282496|NCT00857714|IndianaU|Sunil Badve, MD|317-491-6417|sbadve@iupui.edu|
314955|NCT03387683|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
314956|NCT03388008|Washington University in St. Louis|Ramsey Hachem, MD|(314) 454-7953|Rhachem@wustl.edu|
314957|NCT03388164|Laureate Institute for Brain Research|Teresa Victor|918-502-5108|tvictor@laureateinstitute.org|
314958|NCT03388268|Washington University in St. Louis|Kimberly Reske, MPH, Research Coordinator|314-747-4041|kreske@wustl.edu|
314959|NCT03388294|University of North Carolina at Chapel Hill|Linda R. Watson, EdD|919-966-1007|lwatson@med.unc.edu|
314960|NCT03388645|National Institute of Allergy and Infectious Diseases|Lesia Dropulic|+1 301 496 7675|dropulicl@niaid.nih.gov|
314961|NCT03389308|Castle Creek Pharmaceuticals|Mary C. Spellman, MD|312-847-1291|mspellman@castlecreekpharma.com|
314962|NCT03389555|Beth Israel Deaconness Medical Center Emergency Department|Michae Donnino|(617) 754-2882|mdonnino@bidmc.harvard.edu|
314963|NCT03389854|Mayo Clinic|Dr. Landon Trost|507-284-3728|Trost.Landon@mayo.edu|
314964|NCT03389893|DAIT/NIAID|Director, Clinical Research Operations Program|240-669-5064|DAITClinicalTrialsGov@niaid.nih.gov|
314965|NCT03390101|BIOCAD|Nikiforova Aleksandra|+7(812) 380 49 33|nikiforovaan@biocad.ru|6254
314966|NCT03390114|Indiana University School of Medicine|Samir K. Gupta, MD, MS|3172747926|sgupta1@iu.edu|
314967|NCT03390166|Mahidol|Punnee Pitisuttithum|6626435599|punnee.pit@mahidol.ac.th|
314968|NCT03390257|SF Otolaryngology|Dr. Jacob Johnson|4153625443|jjohnson@sfotomed.com|
314969|NCT03390426|Duke University Medical Center|William Michael Bullock, MD, PhD|919-681-6437|william.bullock@duke.edu|
314970|NCT03390842|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
314971|NCT03390907|Penn State Milton S. Hershey Medical Center|Dr. John Levenick|717-531-3834|jlevenick@pennstatehealth.psu.edu|
314972|NCT03391115|University of Colorado, College of Nursing|Heather Coats, PhD, APRN-BC, PI|303-724-3740|heather.coats@cuanschutz.edu|
314973|NCT03391765|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
314974|NCT03391986|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@columbia.edu|
314975|NCT03392168|Arcutis|Study Inquiry|650-847-4115|studyinquiry@arcutis.com|5
314976|NCT03392194|Brigham and Women's Hospital|Dr. Susan Redline|617-732-5859|SREDLINE@BWH.HARVARD.EDU|
314977|NCT03392532|Alcon, A Novartis Division|CDMA Project Lead, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
314978|NCT03392935|University of Utah Dermatology|Dr. Karen Stolman, Assistant Professor, Dermatology|8015816465|ks@checkmateproductions.com|
314979|NCT03392974|BioMarin Pharmaceutical Inc.|Medical Manager, Clinical Science|415-996-2917|divya.reddy@bmrn.com|
314980|NCT03393000|Diffusion Pharmaceuticals Inc|Vice President of Clinical Operations|434-220-0718|clinicaltrials@diffusionpharma.com|
314981|NCT03393208|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
314982|NCT03393494|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
314983|NCT03393754|VBI Vaccines, Inc.|Vlad Popovic|416-418-4713|vpopovic@vbivaccines.com|
314984|NCT03393806|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314985|NCT03394391|Babcock University|Dr. Olumide ABIODUN|07038569725|olumiabiodun@gmail.com|7038569725
314986|NCT03394508|Karolinska Institutet|Jon Konradsen|+46704242058|jon.konradsen@ki.se|
314987|NCT03394768|Changi General Hospital|Serene Yeow, Senior Executive, Clinical Trials and Research Unit|+6581258267|serene_yeow@cgh.com.sg|+656426781
314988|NCT03394885|Duke Cancer Center|Dr. Angeles Alvarez Secord|919-684-3765|angeles.secord@duke.edu|
314989|NCT03394924|Enanta Pharmaceuticals, Inc.|Nathalie Adda|+1 6176070705|nadda@enanta.com|
314990|NCT03395353|Shionogi|Corporate Communications Department|+81-6-6209-7885|shionogiclintrials-admin@shionogi.co.jp|
314991|NCT03395808|Avenue Therapeutics|Micheal Ryan, VP Clinical|781-652-4514|mryan@avenuetx.com|
314992|NCT03395886|Zhongshan Hospital, Fundan university|Mr Zhe Luo|64041990|ec@zs-hospital.sh.cn|
314993|NCT03395990|Duke University Medical Center|Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
314994|NCT03396432|Children Hospital of Philadelphia|Dr. John Fiadjoe, PI|267-426-2961|fiadjoej@email.chop.edu|
314995|NCT03396835|Masimo Corporation|Tala Harake|949-297-7137|studies@masimo.com|
314996|NCT03396913|Lumenis|Yair Manor, Clinical Director|+972-52-3763416|yair.manor@lumenis.com|
314997|NCT03396952|University of California, San Francisco|Dr. Adil Daud, MD|(415) 353-7392|Adil.Daud@ucsf.edu|
314998|NCT03397121|The Medicines Company|Vice President - Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
314999|NCT03397394|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
315000|NCT03397771|Ixaltis|Chief Development Officer|33457260076|svanberg@ixaltis.com|
315001|NCT03398213|Bnai Zion Medical Center|Prof. Elad Schiff|972-506267243|elad.schiff@b-zion.org.il|
315002|NCT03398265|University of Washington|Dr. Caleb Banta-Green|206-543-0937|calebbg@uw.edu|
315003|NCT03398278|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
315004|NCT03398330|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
315005|NCT03398356|Wroclaw Medical University|Dr Edyta Sutkowska|+48/503077016|edytasutkowska@yahoo.com|
315006|NCT03398421|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315007|NCT03398798|University of North Carolina at Chapel Hill|Christian Piers, DDS, MS, MFA|(828) 433-1242|christian.piers@gmail.com|
315008|NCT03398928|Bnai Zion Medical Center|Prof. Elad Schiff|972-506267243|elad.schiff@b-zion.org.il|
315009|NCT03399370|The Medicines Company|Vice-President, Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
315010|NCT03399786|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
315011|NCT03400033|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315012|NCT03400163|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
282497|NCT00857727|Mount Sinai St. Luke's|Dr. Jinu Kim|212-523-6121|JiKim@chpnet.org|
282498|NCT00857766|GlaxoSmithKline|GSK Response Center|866-435-7343||
282499|NCT00857792|The University of Chicago Medical Center|Victor Mor-Avi|773-702-7780|vmoravi@bsd.uchicago.edu|
315013|NCT03400449|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
315014|NCT03400475|University of Iowa|Dr. Ahmed Mahrous|3193336517|ahmedmohamed-mahrous@uiowa.edu|
315015|NCT03400579|University of North Carolina at Chapel Hill|Mehul Patel, PhD|919-843-7307|mehul_patel@med.unc.edu|
315016|NCT03400748|Spiration, Inc.|Lauri DeVore|425-636-5464|lauri.devore@olympus.com|
315017|NCT03400787|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
315018|NCT03400800|Novartis|Vice-President, Regulatory Operations|973-985-0597|frank.bosley@novartis.com|
315019|NCT03400852|Mallinckrodt|Medical Information Call Center|1-800-844-2830|MedInfo@mnk.com|
315020|NCT03400956|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
315021|NCT03401229|AstraZeneca|Maria Jison, MD Global Clinical Head, FASENRA, Late-stage R&I|+13013980340|Maria.Jison@astrazeneca.com|
315022|NCT03401450|NYU Langone|Dr. Prianka Desai|212-263-5072|prianka.desai@nyulangone.org|
315023|NCT03401671|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
315024|NCT03402126|Medtronic Inc|Joy Aso, Clinical Research Specialist|4015454454|joy.a.aso@medtronic.com|
315025|NCT03402243|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
315026|NCT03402386|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
315027|NCT03402555|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
315028|NCT03402659|EIP Pharma|Jennifer Conway, Associate Director of Clinical Development|(617) 744-4400|jconway@eippharma.com|
315029|NCT03402750|University of Miami|Brian McCabe|305-248-1530|bmccabe@miami.edu|
315030|NCT03402893|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
315031|NCT03402932|Western Michigan University|Jing Shen|2693878067|jing.shen@wmich.edu|
315032|NCT03403036|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|212-241-9728|mark.lebwohl@mountsinai.org|
315033|NCT03403192|Wake Forest Health Science|Benjamin Morris, MD|336.716.6533|bmorris@wakehealth.edu|
315034|NCT03403231|VA Center for Clinical Management Research|Bradley Youles, Project Manager|734-845-5055|Bradley.Youles@va.gov|
315035|NCT03403374|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
315036|NCT03403400|Advent Health|Amie Jasper|407-303-8626|amiemarie.jasper@adventhealth.com|42
315037|NCT03403413|Loui9s Stokes Cleveland VAMC|Dr. Stephen Selkirk|440-552-0493|stephen.selkirk@va.gov|
315038|NCT03403426|Reflow Medical|Isa Rizk|9494810399|info@reflowmedical.com|
315039|NCT03403491|patientMpower Ltd|Chief Scientific Officer|+353872599131|colin@patientmpower.com|
315040|NCT03403504|Mundipharma(China) Pharmaceutical. Co. Ltd|Rongna. A|86 10 65636885|rongna.a@mundipharma.com.cn|
315041|NCT03403517|Rigshospitalet|Kristin steinthorsdottir|004531666112|kjs@dadlnet.dk|
315042|NCT03403712|Helsinn SA|Head of Clinical Development|+41 91 985 2121|info-HHC@helsinn.com|
315043|NCT03403725|Menarini Ricerche SPA|Corporate Director of Clinical Sciences|+39 055 56809933|acapriati@menarini-ricerche.it|
315044|NCT03403751|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1-919-219-6377|wayned@atoxbio.com|
315045|NCT03404167|DynPort Vaccine Company LLC, a GDIT Company|George A. Saviolakis, MD, PhD, Medical Director|1-240-651-8116|George.Saviolakis@gdit.com|
315046|NCT03404206|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
315047|NCT03404219|Boston University|Dr. Daniel Fulford|(617) 358-6723|dfulford@bu.edu|
315048|NCT03404375|UTMB Galveston|Antonio Saad|4097721571|afsaad@utmb.edu|
315049|NCT03404401|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
315050|NCT03404609|Stanford University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
315051|NCT03404648|Mayo Clinic|Dr. Ming Yang|480-342-0988|Yang.Ming@mayo.edu|
315052|NCT03404674|PATH|Rahsan Erdem|202-540-4546|rerdem@path.org|
315053|NCT03404843|Colorado State University|Frank Dinenno|970-491-3203|frank.dinenno@colostate.edu|
315054|NCT03405259|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
282500|NCT00857818|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
282501|NCT00857857|GlaxoSmithKline|GSK Response Center|866-435-7343||
282502|NCT00857896|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282503|NCT00857948|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
282504|NCT00857961|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282505|NCT00858013|Ajou University|Kwan Woo Lee|82-31-219-4526|lkw65@ajou.ac.kr|
282506|NCT00858117|Northwestern University|Olga Frankfurt, MD|312 695 6180|o-frankfurt@northwestern.edu|
282507|NCT00858130|University of North Carolina at Chapel Hill|Dr. Stephan Moll, Professor of Hemology/Oncology|919-966-3311|stephan_moll@med.unc.edu|
282508|NCT00858143|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
282509|NCT00858208|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
305391|NCT02327052|Hospital São Rafael|Dr. Milena Botelho Pereira Soares|+557132816455|milenabpsoares@gmail.com|
305392|NCT02327117|Isfahan University of Medical Sciences|Amin Nemati|00989131009918|nemati@med.mui.ac.ir|
315055|NCT03405363|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
305393|NCT02327130|Isomark, LLC|Dr. Daniel Butz, Chief Scientific Officer|(608) 561-1895|daniel.butz@isomark.com|
305394|NCT02327143|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
305395|NCT02327169|Takeda|Takeda Study Registration Call Center|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
305396|NCT02327260|University of Missouri, Kansas City|Dr. Kym Bennett|816-235-6370|bennettkk@umkc.edu|
305397|NCT02327325|Health Services Research & Development, Durham VA Healthcare System|Kelli Allen, PhD|919-286-0411|kelli.allen@va.gov|7090
305398|NCT02327351|National Research Center for Pediatric Hematology , Moscow, Russian Federation|Balashov Dmitriy, head of HSCT department|84956647078|Dmitriy.Balashov@fccho-moscow.ru|6534
305399|NCT02327429|University of Alberta|Catherine Chan|780-492-9939|cbchan@ualberta.ca|
305400|NCT02327741|shiraz university of medical sciences|Professor|009836250352|kojurij@yahoo.com|
315056|NCT03405818|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315057|NCT03405935|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
315058|NCT03406260|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
315059|NCT03406325|Hong Kong Sanatorium & Hospital|Prof. Tak Hong Lee|28358430|TakHong.Lee@hksh.com|
315060|NCT03406377|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
315061|NCT03406962|Magenta Therapeutics|Medical Director|(857) 242-0170|clinicaltrials@magentatx.com|
315062|NCT03407053|NIDDK|Kevin Hall, PhD|301-402-8248|kevin.hall@nih.gov|
315063|NCT03407118|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
315064|NCT03407170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315065|NCT03407313|Recros Medica|Head of Clinical Development|925-223-8581|clinical@recrosmedica.com|
315066|NCT03407430|University of North Carolina Medical Center|Dr. Benyam Muluneh|919-966-3213|benyam.muluneh@unchealth.unc.edu|
315067|NCT03407482|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
315068|NCT03407612|Jameson Crane Sports Medicine Institute|Maria Munsch|614-293-3600|maria.munsch@osumc.edu|
315069|NCT03407625|University of Texas Southwestern Medical Center|Emily Adhikari, MD|214-648-7825|emily.adhikari@utsouthwestern.edu|
315070|NCT03407651|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
315071|NCT03408171|Geisinger Medical Center|David L. Diehl, MD|570-214-2411|dldiehl@geisinger.edu|
315072|NCT03408392|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315073|NCT03408483|UAB|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
315074|NCT03408639|CinnaGen Co.|Dr. Nassim Anjidani|00989125477964|Anjidani.N@orchidpharmed.com|
315075|NCT03408730|VBI Vaccines, Inc.|Vlad Popovic|416-418-4713|vpopovic@vbivaccines.com|
315076|NCT03408808|NHS Grampian|Miss Katharine Hamlin|0845 456 6000|katharine.hamlin@nhs.scot|56755
315077|NCT03409107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315078|NCT03409731|Abbott medical device|Hajime Kusano|+1 408-845-1626|hajime.kusano@abbott.com|
315079|NCT03409796|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
315080|NCT03410056|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
315081|NCT03410628|electroCore Inc.|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
315082|NCT03410797|University of Pittsburgh|Jacqueline Gartner-Schmidt|412-232-8970|jgs@pitt.edu|
315083|NCT03410862|Cleveland Clinic|Jeff Negrey Study Coordinator|2166365504|negreyj2@ccf.org|
315084|NCT03410914|Sunnybrook Health Sciences Centre|Dr. Paul Karanicolas|4164806100|paul.karanicolas@sunnybrook.ca|4774
315085|NCT03410953|UICEC, Complejo Asistencial Universitario de Salamanca - Instituto de Investigación Biomédica de Salamanca (IBSAL), Plataforma SCReN, Salamanca, Spain|Ricardo López-Pérez, PhD. Study Coordinator and Manager of Clinical Trial|923 291100|ricardo.lopez@scren.es|55779
315086|NCT03411902|Wake Forest School of Medicine|Kristen Beavers|336-758-5855|beaverkm@wfu.edu|
315087|NCT03412019|Tufts Medical Center|Dan Drzymalski, MD|617 636 4526|ddrzymalski@tuftsmedicalcenter.org|
315088|NCT03412084|University of Wisconsin - Madison|Dr. Kelli F Koltyn|608-263-6746|kelli.koltyn@wisc.edu|
315089|NCT03412734|TriHealth Inc.|Catrina Crisp, MD MSc|513-463-4300|Catrina_Crisp@trihealth.com|
315090|NCT03412929|Medline Industries, Inc|Stephanie Martynenko|2242163822|smartynenko@medline.com|
315091|NCT03413618|Pirogov Russian National Research Medical University|Dr. Kirill Lobastov|+7-985-211-63-31|lobastov_kv@hotmail.com|
315092|NCT03414047|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
282510|NCT00858234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315093|NCT03414359|UAMS|Nadir El Sharawi|5016866114|nelsharawi@uams.edu|
315094|NCT03415152|Abbott Laboratories|Irina Solnyshkina|+7 (495) 258-42 80|irina.solnyshkina@abbott.com|
315095|NCT03415178|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
315096|NCT03415243|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315097|NCT03415581|New York State Psychiatric Institute|Jermaine Jones PhD|6467746113|jermaine.jones@nyspi.columbia.edu|
315098|NCT03416127|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
315099|NCT03416621|Duke Cancer Institute|Dr. Kathryn I Pollak|919-681-4757|kathryn.pollak@duke.edu|
315100|NCT03416946|Orthopaedic Innovation Centre|Trevor Gascoyne|204-926-1235|tgascoyne@orthoinno.com|
315101|NCT03416985|University of California Los Angeles|Joan Pi Anfruns, DMD|310-825-0834|jpianfruns@dentistry.ucla.edu|
315102|NCT03417024|GE Healthcare|Sr. Clinical Affairs Project Manager|2624095722|kevin.r.siewert@ge.com|
315103|NCT03417141|Mayo Clinic|Jason C. Sluzevich, M.D.|904-953-6192|Sluzevich.Jason@mayo.edu|
315104|NCT03417219|VA Palo Alto Health Care System|Dr. Blake Scanlon|6504935000|blake.scanlon@va.gov|65316
315105|NCT03417466|Medtronic Minimed|Fen Peng, Biostatistician|8185763253|fen.peng@medtronic.com|
315106|NCT03417505|Tangible Science|Dr. Kelly Mabry|650-241-1045|kelly@tangiblescience.com|108
315107|NCT03417557|CooperVision|Myhanh Nguyen, Sr. Optometrist|19257306716|MNguyen@coopervision.com|
315108|NCT03417713|Hamilton General Hospital|Dr. Theodore Rapanos|905-521-2100|rapanost@mcmaster.ca|44652
315109|NCT03417739|Dana Farber Cancer Institute|Elizabeth Buchbinder, MD|617-632-5055|Elizabeth_buchbinder@dfci.harvard.edu|
315110|NCT03417752|VA Center of Excellence for Suicide Prevention|Elizabeth Karras, PhD|585-393-7285|elizabeth.karras-pilato@va.gov|
315111|NCT03417778|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
315112|NCT03417804|Centro Hospitalar do Porto|Dr. Simão Esteves|+351222077549|simao.esteves@me.com|
315113|NCT03417830|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315114|NCT03418051|University of North Carolina at Chapel Hill|Erik Wikstrom|9199622260|wikstrom@unc.edu|
315115|NCT03418064|CooperVision|Jose A. Vega, O.D., MSc., FAAO|19256213761|jvega2@coopervision.com|
315116|NCT03418324|Cedars-Sinai Medical Center|Edwin Posadas, MD|310-423-7600|Edwin.Posadas@cshs.org|
315117|NCT03418376|Hasselt University|Dr. Charly Keytsman|+32477611122|charly.keytsman@uhasselt.be|
315118|NCT03418545|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
315119|NCT03418571|Ablynx NV|Medical Monitor|+32 9 262 00 00|clinicaltrials@ablynx.com|
315120|NCT03418662|Indiana University|Rachel Lahr|317-948-0724|rlahr@iu.edu|
315121|NCT03418714|Johns Hopkins University|Frederick Barrett|4105509777|fbarret2@jhmi.edu|
315122|NCT03419078|Imperial College Healthcare NHS Trust|Julie Beckerson|02033131922|julie.beckerson@nhs.net|
315123|NCT03419403|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
315124|NCT03419533|The University of Adelaide|Prof. Helen Marshall|8161 8115|helen.marshall@adelaide.edu.au|
315125|NCT03419598|University of Bath|Professor Richie Gill|01225 383627|r.gill@bath.ac.uk|
315126|NCT03419780|University of Pennsylvania|Dr Rebecca Hamm|215-662-6913|rebecca.feldmanhamm@pennmedicine.upenn.edu|
315127|NCT03419962|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
315128|NCT03420300|National Taiwan University Hospital|Dr. Chen-Hua Liu|+886-223123456|jacque_liu@mail2000.com.tw|63572
315129|NCT03420625|Karolinska University Hospital|Dr. Paul Ackermann|+46 8 517 700 00|paul.ackermann@sll.se|717 34
315130|NCT03421197|Dr Reddy's Laboratories|Srinivas Sidgiddi, Sr Director, Clinical Development|609-375-9910|srinivassidgiddi@drreddys.com|
315131|NCT03421210|Duke University|Anthony DeVito, MD|919-684-1377|anthony.devito@duke.edu|
315132|NCT03421379|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
315133|NCT03421431|Enanta Pharmaceuticals|Kristin Sanderson|617-607-0775|ksanderson@enanta.com|
315134|NCT03421730|Vectura Limited|Gary Burgess, MD|+44 (0)1249 667700|clinical.enquiries@vectura.com|
315135|NCT03421886|University of Alabama at Birmingham|Chung How Kau, chair and professor|(205) 934-2782|ckau@uab.edu|
315136|NCT03422159|Community Medical Center Department of Critical Care, Department of Nephrology|Jose Iglesias, DO|732-557-8070|jiglesias23@gmail.com|
315137|NCT03422172|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315138|NCT03422250|IRCCS Centro San Giovanni di Dio Fatebenefratelli|Michela Pievani|+39 030 35011|mpievani@fatebenefratelli.eu|
315139|NCT03423082|University of Pittsburgh|Nghi C. Nguyen, MD, PhD|412-647-0104|nguyennc@upmc.edu|
315140|NCT03423173|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
315141|NCT03423186|Swedish Orphan Biovitrum AB|Anders Bröijersén, Medical Director|+46 8 697 20 00|anders.broijersen@sobi.com|
315142|NCT03423238|Wake Forest School of Medicine|Tina Brinkley|336-713-8534|tbrinkle@wakehealth.edu|
315143|NCT03423641|Kaiser Permanente|Elizabeth McGlynn, Ph.D.|6265643807|Elizabeth.A.Mcglynn@kp.org|
315144|NCT03424044|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
315145|NCT03424187|Imperial College London|Gary Frost|+44 20 7594 0959|g.frost@imperial.ac.uk|
315146|NCT03424239|Massachusetts General Hospital|Dr. Elaine Yu|617-643-6353|ewyu@mgh.harvard.edu|
315147|NCT03424265|University of Arkansas for Medical Sciences|Scott Schutzler, R.N.|501-526-5734|seschutzler@uams.edu|
315148|NCT03424681|Mind Research Network|Dr. Claire Wilcox|5052725028|cwilcox@mrn.org|
315149|NCT03425019|The University of Texas Health Science Center at Houston|Hyochol Ahn|(713) 500-2179|hahn@fsu.edu|
315150|NCT03425097|Stanford University|Thomas A Zikos, MD|(408) 426-5599|zikosta@stanford.edu|
315151|NCT03425188|Respicardia, Inc.|Tim Meyer, VP Clinical Affairs|952-540-4479|tmeyer@respicardia.com|
315152|NCT03425253|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
282511|NCT00858247|Mayo Clinic|Seema Kumar, MD|507-284-3300|kumar.seema@mayo.edu|
282512|NCT00858364|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
282513|NCT00858390|The University of Texas Health Science Center at Houston|G Hergenroeder, Principal Investigator|7135006130|Georgene.W.Hergenroeder@uth.tmc.edu|
282514|NCT00858403|H. Lee Moffitt Cancer Center and Research Institute|Eric Haura, M.D., via Moffitt Cancer Center|813-745-6827|eric.haura@moffitt.org|
282515|NCT00858442|coaniquem|M Beatriz Quezada.MD|56-2-28734077|investigacion@coaniquem.cl|
282516|NCT00858468|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
282517|NCT00858494|University of Washington|James A Taylor|206-616-1206|uncjat@uw.edu|
282518|NCT00858507|Providence VA Medical Center|Thomas O'Toole, MD|4012737100|thomas.otoole@va.gov|
315153|NCT03425396|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
315154|NCT03426228|Fakih IVF|Dr. Ayla Coussa|+971501403866|A.coussa@warwick.ac.uk|
282519|NCT00858637|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
282520|NCT00858689|FRAXA Research Foundation|Michael R. Tranfaglia MD|978-462-1990|info@fraxa.org|
282521|NCT00858780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282522|NCT00858832|USF Health Department of Obstetrics and Gynecology|Patrick Teefey MD|813-259-8680|ObGynClinicalResearch@health.usf.edu|
282523|NCT00858845|University of California, Los Angeles (UCLA)|Dr. Holly R. Middlekauff|310-206-6672|hmiddlekauff@mednet.ucla.edu|
282524|NCT00858858|VA|Stuart Spechler|214-857-1603|Stuart.Spechler@va.gov|
315155|NCT03426267|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
282525|NCT00858962|Yale University AIDS Program|R. Douglas Bruce, MD, MA|(203) 737-6133|robert.bruce@yale.edu|
282526|NCT00858988|Washington University School of Medicine in St. Louis|Dr. Mark Manary|314 454-2178|manary@kids.wustl.edu|
282527|NCT00859014|University of Texas Health Science Center|Dr. Sean I. Savitz, Professor and Director of Stroke|713.500.7083|sean.i.savitz@uth.tmc.edu|
282528|NCT00859027|University of Connecticut Health Center|Pamela Taxel MD|860-679-4743|taxel@nso.uchc.edu|
315156|NCT03426345|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
315157|NCT03426436|North Shore University Hospital|Director of Clinical Research for Emergency Medicine|(516) 562-1513|TLi2@northwell.edu|
315158|NCT03426566|Wroclaw Medical University|Dr Sutkowska Edyta|0048503077016|edytasutkowska@yahoo.com|
315159|NCT03426631|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
315160|NCT03426787|Washington University in St. Louis School of Medicine|Dr. Mary C Politi|3147471967|mpoliti@wustl.edu|
315161|NCT03426995|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315162|NCT03427073|Almac Discovery|Professor Richard Kennedy, Medical Director|+44 28 3833 2200|richard.kennedy@almacgroup.com|
315163|NCT03427177|Fox Chase Cancer Center|Dr. Linda Fleisher|215-214-3757|Linda.Fleisher@fccc.edu|
315164|NCT03427268|Pharmamar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology, Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
315165|NCT03427619|University of Iowa|Dr. Richard Smith|319-356-2177|richard-smith@uiowa.edu|
315166|NCT03427892|UTexasSouthwestern|Dr. E. Sherwood Brown|(214) 645-6950|Sherwood.Brown@UTSouthwestern.edu|
315167|NCT03427931|University of Virginia|Sue Brown, MD|4349820602|sab2f@virginia.edu|
315168|NCT03428100|Eli Lilly and Company|Chief Medical Officer|800-459-5979|ClinicalTrials.gov@lilly.com|
315169|NCT03428152|Derince Training and Research Hospital|Dr|+905336515650|handegrbz@gmail.com|
315170|NCT03428230|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
315171|NCT03428360|Aquestive Therapeutics|Clinical Project Manager|9089411896|cbuan@aquestive.com|
315172|NCT03428750|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
315173|NCT03428815|University of Pittsburgh|Dr. Goeran Fiedler|14126246475|gfiedler@pitt.edu|
315174|NCT03428997|Johnson & Johnson Consumer Inc.|Heather Smith|(908) 874-1235|HSmith21@its.jnj.com|
315175|NCT03429270|Laborie|Stephanie Gallone, Clinical Research Manager|9056121170|sgallone@laborie.com|1755
315176|NCT03429348|University of Arizona|Jeff Burgess, MD., MS, MPH, Assoc Dean of Research|520-626-4918|jburgess@email.arizona.edu|
315177|NCT03429556|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
315178|NCT03430050|MUSC|Dr. Sherman|843-792-8174|shermanb@musc.edu|
315179|NCT03430206|Stanford University|Thomas Caruso, MD, MEd|(626) 275-0341|tjcaruso@stanford.edu|
315180|NCT03430245|Candela Corporation|Director of Clinical Marketing|+1 949.246.7983|doranr@candelamedical.com|
315181|NCT03430349|University of Antwerp|Pierre Van Damme, MD, PhD|+32 3 265 21 30|pierre.vandamme@uantwerpen.be|
315182|NCT03430856|Biocon Research limited|Dr. Subramanian L|080-28082808|subramanian.l101@biocon.com|1323
315183|NCT03430986|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
315184|NCT03431012|KCL|Dr D D'Antoni||donatella.d'antoni@kcl.ac.uk|
315185|NCT03431337|Albany Medical College|Dr. Paul Sorum|518-262-7500|sorump@amc.edu|
315186|NCT03431441|Johnson & Johnson Vision Care|Meredith Bishop OD, MS, FAAO|904-443-1396|mbishop4@its.jnj.com|
315187|NCT03431857|Zimmer Biomet|Emilie Rohmer, Clinical Ops manager|+41588548210|emilie.rohmer@zimmerbiomet.com|
315188|NCT03432390|Anesthesiology Unit, Teaching Hospital of the Federal University of Pernambuco, Recife, Pernambuco, Brazil|Dr. Jayme Marques dos Santos Neto|5581996212977|jaymemed@yahoo.com.br|
315189|NCT03432533|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
315190|NCT03432858|WellSpan Health|Clinical Research Associate|(717) 851-7634|cbush@wellspan.org|
315191|NCT03433482|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315192|NCT03433677|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
315193|NCT03433703|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
315194|NCT03433755|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
315195|NCT03433794|Old Dominion University|Dr. Abby Braitman|757-683-3708|abraitma@odu.edu|
315196|NCT03434119|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
315197|NCT03434249|SOFAR S.p.A|LAURA PATRUCCO|+390202 909 362291|laura.patrucco@sofarfarm.it|
315198|NCT03434457|Douglas Mental Health University Institute|Dr Patricia Pelufo Silveira|1514-761-6131|patricia.silveira@mcgill.ca|3928
315199|NCT03434834|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
315200|NCT03434977|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
315201|NCT03435055|University of Michigan|Richard Harris|734-998-6996|reharris@umich.edu|
315202|NCT03435081|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
315203|NCT03435185|University of Health Sciences Dr. Lütfi Kırdar Kartal Training and Research Hospital|Dr. Cem Bölük|+902164413900|cem.boluk@sbu.edu.tr|
315204|NCT03435211|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
282529|NCT00859040|Dana-Farber Cancer Institute / Brigham & Women's Hospital|Patrick Y. Wen, MD|617-632-2166|pwen@partners.org|
315205|NCT03435224|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
282530|NCT00859053|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
315206|NCT03435497|RAND Corporation|Laura Bogart, PhD|3103930411|lbogart@rand.org|7281
315207|NCT03435562|Virginia Commonwealth University|Alison Breland|804 628 2300|abbrelan@vcu.edu|
315208|NCT03435614|MUHC-RIMUHC|Marc Perreault|514-343-6111|marc.perreault@umontreal.ca|3788
315209|NCT03435692|Seattle Children's Hospital|David E. Liston, MD, MPH|206-987-3996|david.liston@seattlechildrens.org|
315210|NCT03435783|Brown University School of Public Health|Tyler Wray|401-863-6659|tyler_wray@brown.edu|
315211|NCT03436082|Yale School of Medicine|Joseph Ross, MD, MHS|203-785-2987|joseph.ross@yale.edu|
315212|NCT03436147|bakirkoy dr sadi konuk training and research hospital|Ismail Alay|+905462375638|dr_ismailalay@hotmail.com|
315213|NCT03436420|Emory University|Miriam Vos, MD|404-727-9930|mvos@emory.edu|
315214|NCT03436732|National Cancer Institute|Dr. Raffit Hassan|240-760-6322|rh276q@nih.gov|
315215|NCT03436810|Mahidol University|Sunee Bovonsunthonchai|024415450|sunee.bov@mahidol.edu|
315216|NCT03437031|Cedars Sinai|Melissa Wong, MD MHDS|310-423-0895|wongmsx@cshs.org|
315217|NCT03437044|University of Florida|Dominick J. Angiolillo, MD, PhD|9042443378|dominick.angiolillo@jax.ufl.edu|
315218|NCT03437265|Norgine|Lucy Clayton|+441895826669|LClayton@norgine.com|
315219|NCT03437278|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
315220|NCT03437447|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
315221|NCT03437512|University of Michigan|Emily O. Garnett, PhD, CCC-SLP|734-232-3371|emilyog@med.umich.edu|
315222|NCT03437564|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
315223|NCT03437577|University of Minnesota|Susan Marino|612-624-2964|marin007@umn.edu|
315224|NCT03437733|Biosense Webster, Inc.|Franchise Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
315225|NCT03437863|Department of Digital Health Research (previously Center for Shared Decision Making and Collaborative Care Research)|Head of Research and Development|+47 23 03 31 67|elin.borosund@rr-research.no|
315226|NCT03438006|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315227|NCT03438045|NYU Grossman School of Medicine|Mary E. Northridge, PhD, MPH, Director of Dental Research|(347) 377-4342|Mary.Northridge@nyulangone.org|
315228|NCT03438266|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
271679|NCT00256984|Ethicon Endo-Surgery|Susan Knippenberg, Clinical Scientist|513 337-3452|sknippen@its.jnj.com|
315229|NCT03438383|Department of Vascular Surgery, Korgialeneio-Benakeio Hellenic Red Cross Hospital, Athens, Greece|Dr. Konstantinos Roditis, Study Chair|+306976686951|roditis.k@gmail.com|
315230|NCT03438396|Genmab A/S|Ibrahima Soumaoro|+1 609 430 2481|clinicaltrials@genmab.com|
315231|NCT03438539|University of Kentucky|Craig Rush, Ph.D.|859-257-5388|crush2@uky.edu|
315232|NCT03438578|St Olavs Hospital|Erlend Johan Skraastad|0047 79829184|Erlend.Johan.Skraastad@stolav.no|
315233|NCT03439072|Xeris Pharmaceuticals, Inc.|Martin J. Cummins|312-736-1624|mcummins@xerispharma.com|
315234|NCT03439124|Basilea Pharmaceutica International Ltd.|Project Physician|+41616061111|kamal.hamed@basilea.com|
315235|NCT03439137|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
315236|NCT03439189|Exalenz Bioscience|Clinical trial manager|00 972 546605412|avrahamh@exalenz.com|
315237|NCT03440229|University of Pennsylvania|Dr. James D. Lewis|215-573-5137|james.lewis@pennmedicine.upenn.edu|
315238|NCT03440320|Colorado State University|Dr Arlene Schmid|970-491-7562|arlene.schmid@colostate.edu|
315239|NCT03440411|Fondazione EMN Italy Onlus|Fondazione EMN Italy Onlus|+39 011 0243236|clinicaltrialoffice@emnitaly.org|
315240|NCT03440424|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
315241|NCT03440619|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
315242|NCT03440723|Elm Tree Medical Inc.|CEO|2158050862|evamartin@elmtreemedical.com|
315243|NCT03440918|Vanderbilt University Medical Center|Dr. Sophie Katz|615-343-6190|sophie.e.katz@vumc.org|
315244|NCT03440944|Boston University School of Medicine|Joseph Pare, MD|6174144925|Joseph.pare@bmc.org|
315245|NCT03441178|Ethicon Endo-Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
315246|NCT03441269|Maimonides Medical Center|Sergey Motov, MD|718-283-8693|alikourezos@maimonidesmed.org|
315247|NCT03441581|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
315248|NCT03441594|Pennington Biomedical Research Center|Candice A. Myers|12257632849|candice.myers@pbrc.edu|
315249|NCT03441633|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315250|NCT03441789|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
315251|NCT03441984|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315252|NCT03442036|University of California San Diego|John J. Finneran IV, MD|4083073004|jfinneran@ucsd.edu|
315253|NCT03442296|Johns Hopkins University School of Medicine|Dr. Carrie Nieman|410-502-6965|cnieman1@jhmi.edu|
315254|NCT03442569|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
282531|NCT00859131|Medical University of South Carolina|Kenneth Chavin, MD, PhD|843-792-3368|chavinkd@musc.edu|
305401|NCT02328027|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
305402|NCT02328040|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
305403|NCT02328105|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
305404|NCT02328326|VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion|Dr. Ann-Marie Rosland|4123602259|Ann-Marie.rosland@va.gov|
305405|NCT02328404|Hayat Pharmaceutical industries|DR. ALA' ABU RUQA'A|00962 6 4162607|tbd@hayatpharma.com|225
315255|NCT03442595|MedStar Health|Dr Michelle F Magee, Director MedStar Diabetes Institute|202-877-2383|michelle.f.magee@medstar.net|
315256|NCT03442699|Hartford Hospital/Institute of Living|David Tolin, Ph.D.|860-545-7685|david.tolin@hhchealth.org|
315257|NCT03442725|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
315258|NCT03442777|Belgian Healthcare Knowledge Centre|Jillian Harrison|+32 2 287 33 89|jillian.harrison@kce.fgov.be|
315259|NCT03442829|Bournemouth University|Prof. Katherine Appleton|01202965985|k.appleton@bournemouth.ac.uk|
315260|NCT03442868|Texas Woman's University|Hui-Ting Goh|2146897723|HGoh1@twu.edu|
315261|NCT03442933|Universidad Europea de Madrid|Gerson Garrosa Martín|+34 663 294 774|g.garrosa@gmail.com|0034
315262|NCT03443024|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
315263|NCT03443063|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
315264|NCT03443414|Verona Pharma|Brian Maurer, Senior Clinical Operations Director|(914) 767-5037|brian.maurer@veronapharma.com|
315265|NCT03443427|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315266|NCT03443713|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
315267|NCT03444090|Evergreen General Hospital, Taoyuan, Taiwan|Dr. Chi-Liang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|1510
315268|NCT03444155|Otto Loewi Research Center, Chair of Physiological Medicine, Medical University of Graz, Austria|Dr. Willibald Wonisch|00436505299540|willibald.wonisch@medunigraz.at|
315269|NCT03444584|MedImmune, LLC|Armando Flor|+1-301-398-1955|information.center@astrazeneca.com|
315270|NCT03444766|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
315271|NCT03444961|Cleveland Clinic|Dr. Aleksandra Rachitskaya|216-445-9519|rachita@ccf.org|
315272|NCT03445065|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
315273|NCT03445156|The Ohio State University|Dr. Brad Bushman|614-688-8779|bushman.20@osu.edu|
315274|NCT03445195|Entasis Therapeutics|Chief Medical Officer|781-810-8940|Enquiries@entasistx.com|
315275|NCT03445390|Stanford University|Dr. Mark Burbridge|(650) 353-8484|markburb@stanford.edu|
315276|NCT03445793|National Jewish Health|Jennifer Taylor-Cousar, Principal Investigator|3032702764|taylorcousarj@njhealth.org|
315277|NCT03446053|Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
315278|NCT03446690|University of Alabama at Birmingham|Chung How Kau|205-934-1289|ckau@uab.edu|
315279|NCT03446781|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
315280|NCT03446846|Minerva Neurosciences, Inc.|Head of Research & Development|617.600.7375|jsaoud@minervaneurosciences.com|
315281|NCT03446885|Florida International University|Gregory A. Fabiano, Ph.D.|716-359-7823|gfabiano@fiu.edu|
315282|NCT03447015|Mutah University|Dr Reham Khresheh|0791425992|rehamkh@mutah.edu.jo|
315283|NCT03447249|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
315284|NCT03447314|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315285|NCT03447353|National Advanced Driving Simulator, University of Iowa|Timothy Brown|3193354785|timothy-l-brown@uiowa.edu|
315286|NCT03447730|Synlogic|Andrew Marsh, Head Clinical Operations|617-401-9975|andrew.marsh@synlogictx.com|9135
315287|NCT03447821|Cosmo Technologies Ltd.|Richard Jones|+353 18170370|RJones@cosmopharma.com|
315288|NCT03448068|Mayo Clinic|Dr. Andrew W. Gorlin|480-342-2446|Gorlin.Andrew@mayo.edu|
315289|NCT03448224|University of Kentucky|Dr. Jerod Stapleton|859.562.2802|jerod.stapleton@uky.edu|
315290|NCT03448406|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
315291|NCT03448419|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
315292|NCT03448536|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
315293|NCT03449030|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
315294|NCT03449134|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315295|NCT03449147|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|18006726372|ClinicalTrialsDisclosure@merck.com|
305406|NCT02328547|Montefiore Medical Center|Dr. Olga C. Aroniadis, PI|718-920-4846|oaroniad@montefiore.org|
305407|NCT02328755|University of Michigan|John Magenau|734 936-8785|johnmage@med.umich.edu|
305408|NCT02328807|H. Lee Moffitt Cancer Center and Research Institute|Dr. Julio M. Pow-Sang|813-745-2226|julio.powsang@moffitt.org|
305409|NCT02328937|Johnson & Johnson Vision Care Inc.|Tawnya Wilson - PRINCIPAL RESEARCH OPTOMETRIST|+1 904 443-1834|TWilson@ITS.JNJ.com|
305410|NCT02329015|Long Island University|Marshall Hagins PhD, PT|3478048512|mhagins@liu.edu|
305411|NCT02329223|Novartis|Study Director|862-778-8300||
305412|NCT02329431|UNC Chapel Hill|Kathleen Thomas|919-966-3387|kathleen_thomas@unc.edu|
305413|NCT02329587|Butler Hospital|Sarah Garnaat|401-455-6659|sgarnaat@butler.og|
305414|NCT02329600|Faculty of Oral and Dental Medicine Cairo University|Dr. Noha Ayman Ghallab|+201005263365|noha.ghallab@dentistry.cu.edu.eg|
305415|NCT02329730|Shanghai Public Health Clinical Center|Shuihua Lu|021-37990333|tubercle@gmail.com|2582
305416|NCT02329743|Auven Therapeutics|S Weiss|201 486-0396|sid.weiss@auventx.com|
305417|NCT02329964|Korea University Anam Hospital|Seolju Park|+82-10-6314-6013|gursla2@naver.com|
282532|NCT00859222|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|617-632-2166|Patrick_Wen@dfci.harvard.edu|
282533|NCT00859313|AcelRx Pharmaceuticals, Inc.|Dr. Pamela Palmer|650-216-3504|ppalmer@acelrx.com|
315296|NCT03449342|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
315297|NCT03449433|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
315298|NCT03449446|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
315299|NCT03449758|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
315300|NCT03449979|University of North Carolina at Chapel Hill|Justin Riddle, PhD|6617131602|justin_riddle@med.unc.edu|
315301|NCT03450070|Johnson & Johnson Consumer Inc.|Heather Smith|908-874-1235|HSmith21@its.jnj.com|
315302|NCT03450083|Johns Hopkins University School of Medicine|Jody Tversky, MD|410-550-8017|hoddin1@jhmi.edu|
315303|NCT03450369|Naked Biome|Emma Taylor, MD CEO|626-260-1230|emma.t@nakedbiome.com|
315304|NCT03450915|BiondVax Pharmaceuticals ltd.|Chief Scientific Officer & Clinical Management|+97289302529|benyedidia@BiondVax.com|5103
315305|NCT03451071|University of Alabama at Birmingham|Haller Smith|205-934-4986|hjsmith@uabmc.edu|
315306|NCT03451084|ASLAN Pharmaceuticals|Study Director|+65 6222 4235|contact@aslanpharma.com|
315307|NCT03451721|Zhongshan Hospital|Dr Yangang Su|+86 13788905096|suyangang111@163.com|
315308|NCT03451773|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|rudloffu@mail.nih.gov|
315309|NCT03452033|D. Western Therapeutics Institute|Shigenobu Nakazora|+81-52-218-8785|shinakazora@dwti.co.jp|
315310|NCT03452176|Massachusetts General Hospital|Dr. Michael Levy|617-726-0412|mlevy11@mgh.harvard.edu|
315311|NCT03452189|NYU Langone Health|Dr. Jerome Lowenstein|+1 212 263 5635|Jerome.Lowenstein@nyulangone.org|
315312|NCT03452371|Boston Medical Center/ Boston University Schools of Medicine and Public Health|Karen Lasser|617-414-6688|karen.lasser@bmc.org|
315313|NCT03452527|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
315314|NCT03452943|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
315315|NCT03453060|Aronora, Inc.|Norah G. Verbout, Senior Scientist and Project Manager|503-964-0250|norah.verbout@aronorabio.com|
315316|NCT03453151|Duke University|Marat Fudim|(919) 681-5816|marat.fudim@duke.edu|
315317|NCT03453515|North Carolina State University|Dr. Laura Widman|919-513-2546|lmwidman@ncsu.edu|
315318|NCT03454048|Radboud university medical center|Prof. dr. Teun Bousema|+3124 3614306|teun.bousema@radboudumc.nl|
315319|NCT03454412|International Clinic of Rehabilitation|Oleh Kachmar|+380324765200|okachmar@ic.reha.lviv.ua|
315320|NCT03454581|Federal University of Rio Grande do Sul|PhD Manoela Domingues Martins|55-51-33085011|manomartins@gmail.com|
315321|NCT03455218|Medical College of Wisconsin|Robert Niebler, MD|4142663360|rniebler@mcw.edu|
315322|NCT03455491|PHARMENTERPRISES LLC|CEO Vladimir Nebolsin|+7 (985) 728-75-72|ph@pharmenterprises.ru|
315323|NCT03455543|Regenesis Biomedical|Heather Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
315324|NCT03456245|Harvard TH Chan School of Public Health|Dr. David Bloom|6174320650|dbloom@hsph.harvard.edu|
315325|NCT03456427|GE Healthcare|Beth Heckel|1-262-312-7269|beth.heckel@med.ge.com|
315326|NCT03456700|Mayo Clinic|Aminah Jatoi MD|507/284-2511|Jatoi.Aminah@mayo.edu|
315327|NCT03456856|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
315328|NCT03456960|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
315329|NCT03457103|NYU Langone|Dr. Anna Norweg|646-501-7777|AnnaMaria.Norweg@nyulangone.org|
315330|NCT03457116|NYU Langone Health|Judy Lee, MD|(646) 501-7906|Judy.Lee@nyulangone.org|
315331|NCT03457636|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
315332|NCT03457727|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315333|NCT03457909|Department of Gastroenterology|Changhai Hospital|86-21-31161004|liaozhuan@smmu.edu.cn|86-21-6549
315334|NCT03458702|Texas Tech University|Dr. Jacalyn McComb|806-834-6306|jacalyn.mccomb@ttu.edu|
315335|NCT03458871|The University of Texas Health Science Center at Houston|Dr. Argyrios Stampas|713-797-5938|argyrios.stampas@uth.tmc.edu|
315336|NCT03459040|Icahn School of Medicine at Mount Sinai|Dr. John Levine|212-241-6021|john.levine@mssm.edu|
315337|NCT03459131|Alcon, A Novartis Division|Sr Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
315338|NCT03459196|Johnson and Johnson Medical NV/SA|Nathalie Macours / Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
315339|NCT03459612|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
315340|NCT03459794|University of Georgia|Dr Adrian Wolstenholme|706 542 2404|adrianw@uga.edu|
315341|NCT03460587|UCLA|Steven C. Cramer, MD|424-522-7273|sccramer@mednet.ucla.edu|
315342|NCT03460652|KemPharm|Gerald Orehostky|321-250-3699|gorehostky@kempharm.com|
315343|NCT03460899|Medical University of Graz|Assoc.-Prof. Harald Sourij, MD|0043 316 385|ha.sourij@medunigraz.at|81310
315344|NCT03460990|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
315345|NCT03461146|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
315346|NCT03461289|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
315347|NCT03461757|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
315348|NCT03461965|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Margaret Mann, MD|1-800-641-2422|CTUReferral@uhhospitals.org|
315349|NCT03462082|University of Rochester|Karlo J Lizarraga, MD, MS / Assistant Professor of Neurology|585-341-7500|karlo.lizarraga@gmail.com|
315350|NCT03462576|Exalenz Bioscience|Avrahm Hershkowitz/ Clinical Trial Manager|972-8-9737513|avrahamh@exalenz.com|
282534|NCT00859339|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
315351|NCT03462680|Charlie Norwood VAMC|Dr. Chandramohan Wakade|706-733-0188|chandramohan.wakade@va.gov|2379
282535|NCT00859456|Columbia University|Robert Taub, MD||rntaubipod@gmail.com|
282536|NCT00859469|Columbia University|Joshua Leinwand|212-305-4076|jcl2125@columbia.edu|
315352|NCT03462745|American University of Beirut Medical Center|Dr. Roland Kaddoum|01350000|rk16@aub.edu.lb|6704
315353|NCT03462927|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
315354|NCT03463031|Glenmark Pharmaceuticals Ltd|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
271680|NCT00256997|Janssen Inc. Toronto, Ontario, Canada|Director Medical Affairs - CNS|+1-416-382-5094||
282537|NCT00859495|Columbia University|Robert Taub, MD||rntaubipod@gmail.com|
282538|NCT00859508|Synthes USA HQ, Inc.|Heidi Hausner, Clinical Research Manager|610-719-5707|hausner.heidi@synthes.com|
315355|NCT03463161|University of Chicago|Theodore Karrison, PhD|(773) 702-9326|tkarrison@health.bsd.uchicago.edu|
315356|NCT03463512|Abbott|Suntje Sander|+495116750|suntje.sander@abbott.com|3254
305418|NCT02330055|Beth Israel Deaconess Medical Center|Dr. Matthias Eikermann|6176673364|meikerma@bidmc.harvard.edu|
305419|NCT02330081|Terumo BCT|Beth Crump|+1 303 231-4606|beth.crump@terumobct.com|
305420|NCT02330094|Mayo Clinic|Dr. William D. Freeman|904-953-7103|freeman.william1@mayo.edu|
305421|NCT02330172|Seoul national university Bundang Hospital|Eunsu Choi|821032990658|potterydoll@hanmail.net|
305422|NCT02330276|Va San Diego Healthcare System|Robert R. Henry, MD|8585528585|rrhenry@outlook.com|3648
305423|NCT02330341|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
305424|NCT02330523|The McGuire Institute|E. Todd Scheyer DDS, MS|713-783-544|etsperio@swbell.net|
292557|NCT01433731|TetraLogic Pharmaceuticals|Vice President, Clinical Research|610-889-9900|jeffrey.skolnik@tetralogicpharma.com|
305425|NCT02330549|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
315357|NCT03463889|University of California, San Francisco|Dr. Robert Flavell, MD PhD|877-827-3222|Robert.Flavell@ucsf.edu|
315358|NCT03463915|University of Louisville|Sean Francis|502-561-7260|Sean.francis@louisville.edu|
315359|NCT03463941|Duke School of Nursing|Cherie Conley|2166597128|cherie.conley@duke.edu|
315360|NCT03464383|Wake Forest University School of Medicine|Heidi M. Munger Clary, MD, MPH Associate Professor of Neurology|336-716-7110|hmungerc@wakehealth.edu|
315361|NCT03464422|Yale University|Dr. John Pachankis|6463444060|john.pachankis@yale.edu|
315362|NCT03465436|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
315363|NCT03465709|Apellis Pharmaceuticals. Inc.|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
315364|NCT03465722|Blueprint Medicines|Medical Information Call Center|1-888-258-7768|medinfo@blueprintmedicines.com|
315365|NCT03465878|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
315366|NCT03465904|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|info@cefaly.com|
315367|NCT03466047|Imperial College London|Carel le Roux|7970719453|c.leroux@imperial.ac.uk|
315368|NCT03466060|Johnson & Johnson Vision Care Inc.|Meredith Bishop, OD, MS, FAAO- Senior Principal Research Optometrist|904-443-1396|MBishop4@its.jnj.com|
315369|NCT03466073|BioAegis Therapeutics Inc.|Mark DiNubile MD|609-706-5866|mdinubile@bioaegistx.com|
315370|NCT03466086|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO|904-443-1396|MBishop4@its.jnj.com|
315371|NCT03466099|KalVista Pharmaceuticals|Director Clinical|857-999-0075|clinicalinfo@kalvista.com|
315372|NCT03466918|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
315373|NCT03467048|Cleveland Clinic|Dr. Kurt Ruetzler|216-445-8105|ruetzlk@ccf.org|
315374|NCT03467217|Johns Hopkins Bloomberg School of Public Health|Laura Wilson|410-955-0719|lwilson9@jhu.edu|
315375|NCT03467412|Follicum AB|CEO Jan Alenfall|+46 (0)70 931 51 15|jan.alenfall@follicum.com|
315376|NCT03467425|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315377|NCT03467477|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
315378|NCT03467685|UPMC Dermatology|Dr. Rashek Kazi|5167105208|kazir@upmc.edu|
315379|NCT03467763|Memorial Sloan Kettering Cancer Center|Dr. James Flory|6468883790|floryj@mskcc.org|
315380|NCT03467945|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
315381|NCT03467971|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
315382|NCT03468075|University of Iowa, Holden Comprehensive Cancer Center|Clinical Assistant Professor|319-384-9497|varun-monga@uiowa.edu|
315383|NCT03468179|Vanderbilt University|Sean S. Davies|6153225049|sean.davies@vanderbilt.edu|
315384|NCT03468543|Lyndra|Andrew Bellinger, MD, PhD|857-302-7878|abellinger@lyndra.com|
315385|NCT03468816|Åby vårdcentral, County council of Östergötland|Dr. Fredrik Iredahl|010-103 00 00|fredrik.iredahl@liu.se|
315386|NCT03468855|Aclaris Therapeutics, Inc.|David Gordon|484-540-6296|Clintrials@aclaristx.com|
315387|NCT03468920|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
315388|NCT03468933|Tulane University|Dr. Fayez Kheir|504-988-3541|fkheir@tulane.edu|
315389|NCT03469336|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315390|NCT03469349|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
315391|NCT03470012|cyberDERM|Danielle Fendrick|610-325-0881|dfendrick@cyberderm-inc.com|
315392|NCT03470194|U Mass Memorial|Dr Danielle Taylor|508-334-9840|danielle.taylor@umassmemorial.org|
315393|NCT03470493|ResMed|Adam Benjafield|+61 466 634 609|adam.benjafield@resmed.com|
315394|NCT03470545|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
315395|NCT03470740|Chang Gung University of Science and Technology|Su-Hui Chen|886-3-2118999|sophee@mail.cgust.edu.tw|3216
315396|NCT03471065|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
315397|NCT03471078|Dova|VP of Global Drug Development|9193387864|clinical@dova.com|
315398|NCT03471832|CooperVision|Jose A.Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
315399|NCT03471871|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
315400|NCT03471975|Ajou University School of Medicine|Jihoon Hwang|+821093103304|kironojh@gmail.com|
315401|NCT03472014|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
315402|NCT03472287|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman/Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
315403|NCT03472326|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
315404|NCT03472469|The University of Texas Health Science Center at Houston|John A. Harvin, MD|(713) 500-7244|John.Harvin@uth.tmc.edu|
315405|NCT03472521|Stanford University|Dr. Pamela Flood, MD, MA|201-370-3933|pflood@stanford.edu|
315406|NCT03472534|Castle Creek Pharmaceuticals|Dr. Mary Spellman/Chief Medical Officer|862-286-0400|mspellman@castlecreekpharma.com|
315407|NCT03472547|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman; Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
305426|NCT02330588|Department of Pediatrics, University of Alberta|Dr. Geoff Ball|780-248-5490|gdball@ualberta.ca|
305427|NCT02330627|University of California, San Diego|Dr. Charles Taylor|8585349446|c1taylor@ucsd.edu|
305428|NCT02330978|University São Paulo|Jayter Silva de Paula, MD, PhD|55 16 3602-2499|jspaula@fmrp.usp.br|
305429|NCT02331095|The Ohio State University|Dr. Tzu-Fei Wang|614-366-8366|tzufeiwang@gmail.com|
305430|NCT02331108|Albert Einstein Healthcare Network|Jonathan Roth, M.D.|2154567979|rothj@einstein.edu|
315408|NCT03472885|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
282539|NCT00859547|ZymoGenetics|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
282540|NCT00859573|University of Arkansas for Medical Sciences|Michael J. Mancino, M.D.|501-526-8442|mjmancino@uams.edu|
305431|NCT02331368|University of Michigan Comprehensive Cancer Center|Dr. Attaphol Pawarode, M.D.|734-936-8785|pawarode@umich.edu|
305432|NCT02331394|Jewish General Hospita;|Goulnar Kasymjanova|514-340-8222|gkasymja@jgh.mcgill.ca|24312
305433|NCT02331407|Columbia University|Dr. Tomoko Kitago|212-305-8389|tk2229@columbia.edu|
305434|NCT02331446|Federal Universisty of Pelotas|Msc. Matheus Pintanel Freitas||matheus.pintanel@hotmail.com|
315409|NCT03473171|The University of Texas Health Science Center at Houston|James M. Stark, MD|713-500-5650|James.M.Stark@uth.tmc.edu|
315410|NCT03473184|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman; Chief Medical Officer|862 286 0400|mspellman@castlecreekpharma.com|
315411|NCT03473197|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman|862 286 0400|mspellman@castlecreekpharma.com|
315412|NCT03473236|GB002, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|R. Aranda M.D. / Senior Vice President of Clinical Development|(858) 684-1300|raranda@gossamerbio.com|
315413|NCT03473301|Duke University|Jesse D. Troy, PhD, MPH|919-668-1102|cordbloodtherapyinfo@dm.duke.edu|
315414|NCT03473665|Columbia University|Runsheng Wang|212-305-4308|rw2646@cumc.columbia.edu|
315415|NCT03473808|Medical University of South Carolina|Amanda Vatinno|8437924840|vatinno@musc.edu|
315416|NCT03473886|Massachusetts General Hospital|Rachel A. Millstein|617-724-2047|RAMILLSTEIN@mgh.harvard.edu|
315417|NCT03474081|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315418|NCT03474172|Guangdong Provincial Hospital of Chinese Medicine|Director of department of Clinical Epidemiology|+862081887233|darongwu@163.com|35842
315419|NCT03474406|Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University.|Asist. Prof. Suratsawadee Wangnamthip|6624197842|suratsawadee.wan@mahidol.ac.th|
315420|NCT03474874|NeXtGen Biologics Inc|Dayna Healy|352-215-9961|Dhealy@nextgenbiologics.com|
315421|NCT03475056|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD/IND Medical Officer|301-451-8715|martin.gaudinski@nih.gov|
315422|NCT03475316|Albert Einstein College of Medicine|Dr. Joe Verghese|718-430-3877|joe.verghese@einsteinmed.org|
315423|NCT03475875|Johnson & Johnson Vision|John Buch - Senior Principal Research Optometrist|904-443-1707|JBUCH@its.jnj.com|
315424|NCT03475992|MVG Industries|Luc Duchesne|0033169298156|luc.duchesne@mvg-world.com|
315425|NCT03476135|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
315426|NCT03476278|Derince Eğitim Ve Araştırma Hastanesi|Dr. Hande Aytuluk|5336515650|handegrbz@gmail.com|
315427|NCT03476798|Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
315428|NCT03476850|Medical University of South Carolina|Eric Bolin, MD|8437921869|bolin@musc.edu|
315429|NCT03477006|University of Pittsburgh|Jason Sperry|4128028270|sperryjl@upmc.edu|
315430|NCT03477279|University of North Carolina at Chapel Hill|Nora Rosenberg, PhD, MSPH|919-843-6580|nora_rosenberg@unc.edu|
315431|NCT03477838|Virginia Commonwealth University|Evan Sisson, PharmD|804-828-8076|emsisson@vcu.edu|
315432|NCT03478163|Cedars Sinai|Melissa Wong, MD MHDS|310-423-0895|wongmsx@cshs.org|
315433|NCT03478254|Ciudad Real University Hospital. Castilla La Mancha Health Service.|Angela M. Seco Segura RN, Endocrinology and Nutrition Department.|926278000|amsese@live.com|79510
315434|NCT03478371|Procter & Gamble Co|Jan Streicher-Scott, PhD, RPh|513-634-5584|streicherscott.jl@pg.com|
315435|NCT03478644|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315436|NCT03478657|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315437|NCT03478683|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315438|NCT03478696|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315439|NCT03478787|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
315440|NCT03478891|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
315441|NCT03478904|National Cancer Institute|William D. Figg, Pharm.D.|240-760-6179|figgw@mail.nih.gov|
315442|NCT03478930|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
315443|NCT03478969|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
315444|NCT03478982|Cares|UCB|+1 844 599|UCBCares@ucb.com|2273
315445|NCT03479216|Derince Training and Research Hospital|Dr. Hande Aytuluk|00905336515650|handegrbz@gmail.com|
315446|NCT03479944|Alcon Japan Ltd.|Group Manager, Surgical, Alcon Japan|03-6899-5061|alcon.medinfo@alcon.com|
315447|NCT03480009|University of Pittsburgh|Principal Investigator, MD MPH|412-641-5496|fpr@upmc.edu|
315448|NCT03480022|Woman's Hospital|Director of Research|12252315278|karen.elkind-hirsch@womans.org|
315449|NCT03480048|Michigan State University|Jean Kerver, PhD, MSc, RD, Assistant Professor|231-392-8227|jkerver@epi.msu.edu|
305435|NCT02331589|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
315450|NCT03480152|National Cancer Institute|Dr. Steven Rosenberg|240-858.3080|steven-rosenberg@nih.gov|
315451|NCT03480243|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
315452|NCT03480425|University of Saskatchewan|Dr. William P. McKay|306 250 5344|bill.mckay@usask.ca|
315453|NCT03480685|Avinger, Inc.|Thomas Lawson, PhD|650-241-7030|tlawson@avinger.com|
315454|NCT03480750|National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University|Dr. Yu-Fang Huang|886 6 2353535|yufangh@mail.ncku.edu.tw|5221
305436|NCT02331680|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366||
305437|NCT02331940|University of Crete|Director of Clinical Trials|2810394824|izolthi@gmail.com|0030
282541|NCT00859586|NIH NHLBI|Dr. Minoo Battiwalla|301-827-0939|battiwam@nhlbi.nih.gov|
315455|NCT03480763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315456|NCT03480802|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315457|NCT03480841|University of North Carolina at Chapel Hill|Dr. Linda Beeber|(919) 966-8148|beeber@email.unc.edu|
315458|NCT03480919|Hospital for Special Surgery|Jonathan Kirschner|6467146327|kirschnerj@hss.edu|
315459|NCT03480932|Johns Hopkins Bloomberg School of Public Health|Dr. Shruti Mehta|4432873837|smehta@jhu.edu|
315460|NCT03481270|Stanford University|Marcella Alsan, Associate Professor of Medicine|(650) 721-1352|malsan@stanford.edu|
315461|NCT03481309|University of North Carolina at Chapel Hill|Dr. Sangtae Ahn|9195233127|sangtae_ahn@med.unc.edu|
315462|NCT03481595|Cleveland Clinic Florida|Carlos Higuera|9546595430|higuerc@ccf.org|
315463|NCT03481725|University of California San Diego|Brian M. Ilfeld, MD, MS|(858) 822-0776|m1medeiros@health.ucsd.edu|
315464|NCT03481816|National Cancer Institute|Dr. Marijo Bilusic|240-760-6064|marijo.bilusic@nih.gov|
315465|NCT03482011|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
315466|NCT03482453|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
315467|NCT03482583|University of Florida|Dr. Ramzi Salloum, Assistant Professor|352-294-4997|rsalloum@ufl.edu|3522944994
315468|NCT03482635|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
315469|NCT03482713|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-80-672-6372|ClinicalTrialsDisclosure@merck.com|
315470|NCT03482882|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
315471|NCT03482973|Beth Israel Deaconess Medical Center|Dr. Balachundhar Subramaniam|6176320706|bsubrama@bidmc.harvard.edu|0706
315472|NCT03483506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
315473|NCT03483623|David Grant Medical Center, Clinical Investigation Facility, Travis AFB, CA|Lt Col Laurie Migliore|707-423-7280|laurie.a.migliore.mil@mail.mil|
315474|NCT03483675|FHCRC|Kate Chilson|206-667-6069|kchilson@fredhutch.org|
315475|NCT03483896|University of Southern California|Prof. Kyle Konis, Ph.D|(213) 740-2723|kkonis@usc.edu|
315476|NCT03483935|University of Dundee|Prof Charlotte Proby|+44 1382 383289|c.proby@dundee.ac.uk|
315477|NCT03483961|Emergent BioSolutions|Sharmila Rajendran|650-486-0244|rajendras@ebsi.com|
315478|NCT03484273|University of Calgary|Dr. Satish R. Raj|403-210-6152|satish.raj@ucalgary.ca|
315479|NCT03484429|Central Virginia Veterans Affairs Health Care System|Dr. Denise Lester|804-675-5000|denise.lester@va.gov|
315480|NCT03485222|Icahn School of Medicine at Mount Sinai|Dr. Juan Badimon|(212) 241-8484|juan.badimon@mssm.edu|
315481|NCT03485495|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
315482|NCT03485911|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
315483|NCT03485950|UT MD Anderson Cancer Center|Issam Raad,MD - Chair, Infectious Diseases|(713) 792-7943|iraad@mdanderson.org|
315484|NCT03485976|Oregon Health & Science University, Department of Dermatology|Teri Greiling, MD, PhD|503-494-8452|PRPStudy@ohsu.edu|
315485|NCT03486392|Janssen Research & Development, LLC|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
315486|NCT03486834|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315487|NCT03486990|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
315488|NCT03487276|InflaRx N.V.|Dr. Korinna Pilz, MD, MSc|+49 89 414 189 78 00|Korinna.Pilz@InflaRx.de|
315489|NCT03487445|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
315490|NCT03487549|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
315491|NCT03487588|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
315492|NCT03487718|University of Kentucky|Ridge Preservation with Leukocyte Platelet Rich Fibrin: A Clinical, Radiographic, and Histomorphomet|8593236193|firasayafi@uky.edu|
315493|NCT03487848|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
315494|NCT03488108|Mayo Clinic|Alison J. Bruce, M.B., Ch.B|904-953-6412|Bruce.Alison@mayo.edu|
315495|NCT03488225|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD./ Professor|713-792-4764|ejabbour@mdanderson.org|
315496|NCT03488238|Masimo Corporation|Cristina Johnson|949-297-7000|clincalresearchdept@masimo.com|
315497|NCT03488849|InnoVital Systems|Chief Medical Officer|2022862328|amit@innovitalsystems.com|
315498|NCT03488927|University of Nebraska-Lincoln|Katie Edwards|402-472-2223|katie.edwards@unl.edu|
315499|NCT03489304|Perelman School of Medicine|Dr. Matthew Kayser|215 898 8298|kayser@pennmedicine.upenn.edu|
315500|NCT03489343|Symphogen AS|Medical Director|0045 45265050|info@symphogen.com|
315501|NCT03489369|Symphogen AS|Medical Director|004545265050|info@symphogen.com|
315502|NCT03489551|University of Iowa|Michelle Weckmann|319-384-7538|michelle-weckmann@uiowa.edu|
315503|NCT03489720|Vanderbilt University Medical Center|Dr. Uma Shastri|615-936-3198|uma.shastri@vumc.org|
315504|NCT03489850|University of California Los Angeles|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
315505|NCT03489863|University of Florida College of Medicine Jacksonville|Dominick J. Angiolillo|9042443378|dominick.angiolillo@jax.ufl.edu|
315506|NCT03489941|Bausch & Lomb|Heleen DeCory|(585) 338-8161|heleen.decory@bausch.com|
315507|NCT03490032|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
315508|NCT03490110|Veterans Affairs|Dr. Anthony Chen|925-372-2530|anthony.chen@va.gov|
315509|NCT03490942|Xeris Pharmaceuticals|B J. Witkin|919-412-6483|bwitkin@xerispharma.com|
315510|NCT03490981|VA Center for Integrated Healthcare|Dr. Gregory P. Beehler, Associate Director of Research|716-862-7934|gregory.beehler@va.gov|
315511|NCT03491150|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
282542|NCT00859638|McMaster University|Dr. Julie Richardson|(905) 525-9140|jrichard@mcmaster.ca|27811
282543|NCT00859651|Columbia University|Katherine Crew, MD|212-305-1732|kd59@cumc.columbia.edu|
315512|NCT03491228|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315513|NCT03491553|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
315514|NCT03491800|University of North Carolina at Chapel Hill|Crystal Wiley Cené, MD, MPH, FAHA|919-445-6783|crystal_cene@med.unc.edu|
315515|NCT03491891|First Hospital of Jilin University|Xiang Wang|+86-13504321434|jdwxiang123@126.com|
315516|NCT03491917|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
315517|NCT03492099|Johns Hopkins University School of Medicine|Dr. Sophie Lanzkron|4105028642|slanzkr@jhmi.edu|
315518|NCT03492281|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
315519|NCT03492398|Seoul National University Hospital|Inseung Jeon|82-2-2072-1920|isjeon0127@snu.ac.kr|
315520|NCT03492554|Apple|Health Technology Clinical Operations|1-866-905-5303|htclinicalquestions@apple.com|
315521|NCT03493386|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315522|NCT03493542|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315523|NCT03493607|Icahn School of Medicine at Mount Sinai|Christina Layton|212-241-6231|christina.layton@mssm.edu|
315524|NCT03493698|Spring Bank Pharmaceuticals, Inc.|Don Mitchell, Vice President, Operations & Corporate Development|(508) 689-9737|dmitchell@springbankpharm.com|
315525|NCT03493815|The Pennsylvania State Univ College of Medicine, The Milton S. Hershey Medical Center|Stephanie Estes, M.D.|717-531-8478|sestes@pennstatehealth.psu.edu|
315526|NCT03493828|New York Methodist Hospital|Dr Joel Yarmush|(718) 780-3279|joelyarmush@gmail.com|
315527|NCT03494725|DuPont Nutrition and Biosciences|Elaine Patterson, Ph. D.|+358-40-4827-626|elaine.patterson@dupont.com|
315528|NCT03494816|University of Cambridge|Prof Grant Stewart|01223 256211|gds35@cam.ac.uk|
315529|NCT03494985|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315530|NCT03495102|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
315531|NCT03495648|University of Kentucky|Ann Koempel|(859) 257-3800|ann.koempel@uky.edu|
315532|NCT03495817|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
315533|NCT03495856|University of North Carolina School of Medicine|Carrie Brintz|919-445-6109|carrie_brintz@med.unc.edu|
315534|NCT03495869|Virginia Commonwealth University|Lori Keyser-Marcus, PhD|(804) 828-4164|lori.keysermarcus@vcuhealth.org|
315535|NCT03495908|The University of Texas Southwestern Medical Center|Dr Pablo F Mora|469-585-0000|pf_mora@yahoo.com|
315536|NCT03496220|Angulus|Dr. Perry Dubin|‪(917) 426-5911‬|perry@angulus.us|
315537|NCT03496298|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
315538|NCT03496324|Reckitt Benckiser Healthcare (UK) Ltd|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
315539|NCT03496428|Implantology Institute|Prof. Dr. Duarte Marques|+351217 210 980|d.marques@institutoimplantologia.com|
315540|NCT03496467|Mati Therapeutics|Deepank Utkhede|6046379717|dutkhede@matitherapeutics.com|
315541|NCT03496545|Weill Cornell Medicine|Judy Ch'ang, MD|(212) 746-2596|jhc9010@med.cornell.edu|
315542|NCT03496701|CooperVision, Inc|Jose A. Vega|925-640-2964|javega2@coopervision.com|
315543|NCT03496974|XBiotech|Ashley Otero, Corporate and Clinical Relations Manager|512-386-2930|aotero@xbiotech.com|
315544|NCT03496987|Yale University School of Medicine|Jonathan Puchalski, MD|2037375699|jonathan.puchalski@yale.edu|
315545|NCT03497026|Auris Health|Scott Rehage|925 6832590|srehage@its.jnj.com|
315546|NCT03497039|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315547|NCT03497130|Department of Dermatology at Johns Hopkins University|Dr. Anna Chien|410-502-7546|achien3@jhmi.edu|
315548|NCT03497429|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
315549|NCT03497585|Pennine Acute NHS Trust|Dr Deborah Antcliff|0161 7242168|Deborah.Antcliff@pat.nhs.uk|
315550|NCT03497845|BARDA|Silvija Tresnjak-Smith, Regulatory Operations Branch Chief, Regulatory and Quality Affairs Division|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
315551|NCT03498196|Baylor College of Medicine|Jennifer M. Taylor, MD, MPH|713-797-7670|Jennifer.Taylor@bcm.edu|
315552|NCT03498287|Pressure Profile Systems|Clinical Trials Manager|310.641.8100|research@wrist-aid.com|
315553|NCT03498300|Faculty of Medicine Siriraj Hospital, Mahidol University|Dr. Nalat Sompagdee|+6687-008-7100|pear_nalat@hotmail.com|
315554|NCT03498560|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
305438|NCT02331992|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 9 5740123|cpaptrial@fphcare.co.nz|
305439|NCT02332239|Department of Emergency Medicine, Alpert Medical School, Brown University|Megan L. Ranney, MD, MPH, FACEP|401-444-2557|megan_ranney@brown.edu|
305440|NCT02332291|Vanderbilt University Medical Center|Warren D. Taylor, MD, MHSc|615-322-1073|warren.d.taylor@vumc.org|
305441|NCT02332707|Merck Sharp & Dohme Corp.|Senior VIce President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305442|NCT02332720|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282544|NCT00859833|Univesity of Utah|Sheldon Litwin|801-581-7715|sheldon.litwin@hsc.utah.edu|
315555|NCT03499028|Cleveland Clinic|Anabelle Visperas|216-444-2416|vispera@ccf.org|
315556|NCT03499067|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
315557|NCT03499353|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315558|NCT03499873|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
282545|NCT00859898|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
315559|NCT03500094|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
315560|NCT03500198|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|+1 714 247- 8628|djanaki1@its.jnj.com|
315561|NCT03500211|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
315562|NCT03500224|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
315563|NCT03500289|Johns Hopkins University|Dr. Bardia Nourbakhsh|4106141522|bnourba1@jhmi.edu|
315564|NCT03500302|Johns Hopkins University|Allison Hays|443-287-6827|ahays2@jhmi.edu|
315565|NCT03500419|Mayo Clinic|Matthew (Matt) J. Ziegelmann, M.D.|507-266-3982|Ziegelmann.Matthew@mayo.edu|
315566|NCT03500679|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
315567|NCT03500692|Abbott|Sripad Bellary|6503531726|sripad.bellary@abbott.com|
315568|NCT03501043|MossRehab|Stella Lee|215-663-6665|leest@einstein.edu|6665
315569|NCT03501069|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
315570|NCT03501264|University of Pittsburgh, Graduate School of Public Health|James Egan|412-624-2255|jee48@pitt.edu|
315571|NCT03501277|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
315572|NCT03501550|Cocrystal Pharma Inc|Luz Pascual|9083611678|lpascual@cocrystalpharma.com|
315573|NCT03501693|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
315574|NCT03502070|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
315575|NCT03502265|University of Southern California|Beth Smith|323-361-4670|beth.smith@usc.edu|
315576|NCT03502616|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315577|NCT03502681|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-921-2050|jsmith@hoosiercancer.org|
315578|NCT03502798|Duke University|Dr. Adam Wax|919-660-5143|a.wax@duke.edu|
315579|NCT03502915|University of North Carolina at Chapel Hill|Kathleen A. Smith, MD|9199665136|ksmith@aims.unc.edu|
315580|NCT03502941|University of Arkansas for Medical Sciences|David D.Church, Ph.D.|5015265709|dchurch@uams.edu|
315581|NCT03503162|Motus GI|Director of Clinical Operations|954-541-8000|anniec@motusgi.com|
315582|NCT03503188|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
315583|NCT03503292|Mayo Clinic|Yvette N. Martin McGrew, M.D., Ph.D.|507-255-7481|martin.yvette@mayo.edu|
315584|NCT03503565|KYUNG HEE UNIVERSITY HOSPITAL AT GANGDONG|Dr Hyungseok Seo|+821029306885|seohyungseok@gmail.com|
315585|NCT03503578|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
315586|NCT03504189|Nuvo Group|VP Clinical|+972-3-6242266|adar.shani@nuvocares.com|1630
315587|NCT03504839|The Ohio State University Medical Center|Clinical Research Coordinator - Adrianne Miller|614-688-8252|adrianne.miller3@osumc.edu|
315588|NCT03504852|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
315589|NCT03504917|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: WN39434|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
315590|NCT03505021|Orion Corporation|Director, Clinical Operations|358104261|clinicaltrials@orionpharma.com|
315591|NCT03505190|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
315592|NCT03505593|ENvizion Medical|Clinical Director|+972-72-2288240|anath@envizionmed.com|
315593|NCT03505749|VA Portland Health Care System|Dr. Vanessa Somohano, Postdoctoral Research Fellow|503-220-8262|vanessa.somohano@va.gov|
315594|NCT03506295|Vanderbilt University Medical Center|Dr. Fabien Maldonado|615-322-3412|fabien.maldonado@vumc.org|
315595|NCT03506347|Mayo Clinic|Dr. Mark Spangehl|480-342-2948|Spangehl.Mark@mayo.edu|
315596|NCT03506386|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
315597|NCT03506425|Duke University|Richard Bedlack, M.D., Ph.D.|919-668-2839|richard.bedlack@duke.edu|
315598|NCT03506477|Icahn School of Medicine at Mount Sinai|Ingrid Sanabria-Gonzalez|212-523-3812|ingrid.sanabria@mountsinai.org|
315599|NCT03506724|Icahn School of Medicine at Mount Sinai|Dr. Dyese Taylor|973-926-5508|Dyesetaylor@gmail.com|
315600|NCT03507036|UT Southwestern|Jennifer Barillas|214-645-8907|jennifer.barillas@utsouthwestern.edu|
315601|NCT03507569|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
315602|NCT03508050|Institut universitaire de cardiologie et de pneumologie de Québec|Dr Jean S. Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|
315603|NCT03508609|Caladrius Biosciences, Inc.|William Sietsema|9495352391|bsietsema@caladrius.com|
315604|NCT03508661|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
315605|NCT03508687|University of Michigan|Dr. Elif Oral|734-615-7271|eliforal@med.umich.edu|
315606|NCT03508830|University of California, San Francisco|Dr. Greg J. Haro|415-353-7502|greg.haro@ucsf.edu|
315607|NCT03508843|University of Alabama at Birmingham|Dr David Schwebel|1-205-934-8745|schwebel@uab.edu|
315608|NCT03509350|Emory University|Jon Sevransky MD, MHS|404-778-5734|jonathan.sevransky@emoryhealthcare.org|
315609|NCT03509675|University of Washington|Stuart Taylor|206-221-3772|stuartt@uw.edu|
282546|NCT00859937|University of Chicago Comprehensive Cancer Center|Dr. Stuart Wong|773-702-9311|swong@mcw.edu|
315610|NCT03509766|Johns Hopkins School of Medicine|Jody Tversky|410-550-5949|jodytversky@jhmi.edu|
315611|NCT03509883|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
282547|NCT00859950|Weill Cornell Medical College|Dr. Ana Krieger|646-962-7378|ack2003@med.cornell.edu|
282548|NCT00859976|Zimmer Biomet|Clinical Project Lead||Maggie.Shen@zimmerbiomet.com|
315612|NCT03509948|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
315613|NCT03509974|Cochlear|George Cire|+13038855440|gcire@cochlear.com|
315614|NCT03510182|University of Michigan|Carol Persad|734-615-8112|cpersad@umich.edu|
315615|NCT03510195|Universiti Putra Malaysia|Dr. Aneesa Abdul Rashid|03-86092956|aneesa@upm.edu.my|
305443|NCT02332798|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
315616|NCT03510273|PATH|Dr. Silvia de Sanjose|2062853500|sdesanjose@path.org|
315617|NCT03510455|National Institute of Dental and Craniofacial Research|Rachel I. Gafni|301-594-9924|gafnir@mail.nih.gov|
315618|NCT03510481|NIAID/LMIV|Dr. Patrick Duffy|301-761-5089|patrick.duffy@nih.gov|
305444|NCT02332824|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
315619|NCT03510663|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
315620|NCT03510715|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
315621|NCT03510910|NYU Langone Health|Thomas Youm, MD|212-348-3636|Thomas.Youm@nyulangone.org|
305445|NCT02332863|University of Colorado - Anschutz Medical Campus|Dr. Sachin Wani|720-848-2786|sachin.wani@cuanschutz.edu|
315622|NCT03511001|California State University San Marcos|Dr. Kim Pulvers|760 750 4127|kpulvers@csusm.edu|
315623|NCT03511053|Dallas VA Medical Center|Dr. Thiru M. Annaswamy, Staff Physician, PM&R Service|2148570273|thiru.annaswamy@va.gov|
315624|NCT03511105|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315625|NCT03511326|Galderma R&D SNC|CTA Coordinator|+33 0493 95 70 85|cta.coordinator@galderma.com|
315626|NCT03511378|Lupin Ltd. (Lupin Research Park), Pune, India|Dr. Chirag Shah, Director|91-20-67917368|chiragshah@lupin.com|
315627|NCT03511521|Northwestern University Feinberg School of Medicine|Dr. Mark Molitch, Principal Investigator|3125034130|molitch@northwestern.edu|
315628|NCT03511638|Bausch & Lomb|Study Director|510-259-5284|aloncaric@bauschhealth.com|
315629|NCT03511937|University of North Carolina at Chapel Hill|Anna Grummon, PhD|(617) 495-2021|agrummon@hsph.harvard.edu|
315630|NCT03512028|Washington University School of Medicine|Catherine Lang|314-286-1945|langc@wustl.edu|
315631|NCT03512041|Washington University School of Medicine|Catherine E Lang|314-286-1945|langc@wustl.edu|
315632|NCT03512067|Brigham and Women's Hospital|Dr. Gyorgy Frendl|617-732-5910|gfrendl@bwh.harvard.edu|
315633|NCT03512288|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315634|NCT03512353|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
315635|NCT03512457|Northwestern University|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
315636|NCT03513588|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315637|NCT03513757|Medical College of Wisconsin|Susan Taylor MD|414-266-3560|sutaylor@mcw.edu|
315638|NCT03513848|University of California, Irvine|Alyson Zalta|949-824-3409|azalta@uci.edu|
315639|NCT03514277|Reconstructive Orthopedics|Robert Greenleaf|609-267-9400|bob.greenleaf1@gmail.com|
315640|NCT03514420|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
315641|NCT03514641|Theracos Sub, LLC|Albert Collinson|(508) 688-4221|acollinson@theracos.com|
315642|NCT03514966|Department of Gastroenterology|Changhai Hospital|86-21-31161004|liaozhuan@smmu.edu.cn|86-21-6549
315643|NCT03515681|Columbia University|Steven J. Shea, MD|212-305-6355|ss35@cumc.columbia.edu|
315644|NCT03515824|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315645|NCT03515941|Baylor College of Medicine|Eunji Jo|713-798-4923|ejo@bcm.edu|
315646|NCT03516227|National Defense Medical Center, Taiwan|Dr. Yu-Ju Chen|886-287923100|judychen37@gmail.com|18762
315647|NCT03517436|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@Edwards.com|
315648|NCT03517566|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
315649|NCT03518008|Alcon Research|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
315650|NCT03518125|BARDA|Susan Hollingsworth/Regulatory Operations Specialist|202-691-2040|Susan.Hollingsworth@hhs.gov|
315651|NCT03518658|CRHF Clinical|Keith Holloman|763-526-1545|keith.holloman@medtronic.com|
315652|NCT03518840|Loyola University Chicago|Colleen Fitzgerald, M.D., M.S.|708-216-3380|CFITZGERALD@lumc.edu|
315653|NCT03519087|The Ohio State University|Dr. Stephanie Di Stasi|614-685-9779|stephanie.distasi@osumc.edu|
315654|NCT03519204|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
305446|NCT02332876|University of San Diego, California|Dr. Sheri Hartman|8585349235|sjhartman@ucsd.edu|
305447|NCT02332889|University of Louisville|Nancy Alsip|5028522905|nancy.alsip@louisville.edu|502
305448|NCT02332902|The University of Texas Health Science Center at Houston|Dr. Mary Kay Koenig||Mary.K.Koenig@uth.tmc.edu|
314187|NCT03266419|Asan Medical Center|Dr. Byung-Moon Choi|82-2-3010-1704|byungmoonchoi7@gmail.com|
314188|NCT03266588|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
314189|NCT03267212|Harvard Medical School|Dr J. Andrew Taylor|6177585503|jandrew_taylor@hms.harvard.edu|
314190|NCT03267264|Becton Dickinson|Michael Gibney|201-847-6170|michael_gibney@bd.com|
314191|NCT03267511|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314192|NCT03267576|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
314193|NCT03267940|Halozyme Therapeutics|VP, Medical, Regulatory and Drug Safety|858-794-8889|medinfo@halozyme.com|
282549|NCT00860015|Columbia University|Rober Taub, MD - Vivian and Seymour Milstein Family Prof. of Clinical Medicine||rntaubipod@gmail.com|
305449|NCT02332915|University of Utah|Julie Wambaugh|8015846164|julie.wambaugh@health.utah.edu|
315655|NCT03519243|BIOCAD|Linkova Iuliia|+7 (495) 992 66 28|linkova@biocad.ru|930
315656|NCT03519282|CooperVision|Myhanh Nguyen, Sr. Optometrist|925-730-6716|MNguyen@coopervision.com|
315657|NCT03519516|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
315658|NCT03519854|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315659|NCT03519867|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315660|NCT03519919|CooperVision.Inc|Jose A. Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
315661|NCT03519932|CooperVision Inc.|Jose A.Vega OD, MSc., FAAO|9256213761|javega@coopervision.com|
315662|NCT03520283|Wake Forest University Health Sciences|Study coordinator|336-716-9055|megreen@wakehealth.edu|
315663|NCT03520348|Laboratorios Sophia|Ricardo Alonso Llamas Velázquez (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
315664|NCT03520387|VA Puget Sound Health Care System Seattle Division, Seattle, WA|Pradeep Suri, MD|206-764-2673|Pradeep.Suri@va.gov|
315665|NCT03520400|VA Palo Alto Health Care System|Dr. Jonathan Myers|6504503440|Drj993@aol.com|
315666|NCT03520920|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
315667|NCT03520959|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315668|NCT03520998|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
315669|NCT03521089|Mayo Clinic|Dr. Yonas Geda|480-301-6934|geda.yonas@mayo.edu|
315670|NCT03521115|PIRE|Dr. Brenda A. Miller|5105205889|BMiller@prev.org|
315671|NCT03521141|Vanderbilt University Medical Center|Stephen King|615-875-9394|stephen.king@vumc.org|
315672|NCT03521193|Centro Cardiologico Monzino, IRCCS|Clinical Trials' Office Chief|+390258002|alessandra.terragni@ccfm.it|675
315673|NCT03521479|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
315674|NCT03521505|Chang-Gung Memorial Hospital|Dr Ting-Yu Lin|886 3281200|yuebaoyuebao@gmail.com|8467
315675|NCT03521635|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
315676|NCT03521791|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
315677|NCT03521817|Pennington Biomedical Research Center|John W Apolzan|225-763-2827|john.apolzan@pbrc.edu|
315678|NCT03522350|Weill Cornell Medical College|Nikica Zaninovic, PhD|212-746-5790|nizanin@med.cornell.edu|
315679|NCT03522441|Catawba|Zaidoon A. Al-Zubaidy|1-980-242-3977|Zaidoon@catawbaresearch.com|
315680|NCT03522506|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
315681|NCT03522675|NeXtGen Biologics, Inc|Dayna Healy|352-215-9961|Dhealy@nextgenbiologics.com|
315682|NCT03522948|Boston University|Tibor Palfai|617-353-9345|palfai@bu.edu|
315683|NCT03523715|University of Southern California|Begum Ozel, MD|562-657-2961|ozel@usc.edu|
315684|NCT03523871|NYU Langone Health|Luis Angel, MD|646-501-0119|Luis.Angel@nyulangone.org|
315685|NCT03523988|University of Washington|Lead Investigator|4254668544|akeith@uw.edu|
315686|NCT03524157|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
315687|NCT03524339|Cleveland Clinic|Graham Chapman|440-312-2229|gchapman5@gmail.com|
315688|NCT03525119|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
315689|NCT03525210|KU Leuven / UZ Leuven|Head of Leuven University Vaccinology Center|+32 16 321 078|luvac@kuleuven.be|
315690|NCT03525444|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
315691|NCT03525548|Vertex Pharmaceuticals Incorporated|Medical Monitor|617 341 6777|medicalinfo@vrtx.com|
315692|NCT03525678|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315693|NCT03525834|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
315694|NCT03526055|Ohio Pain Clinic|Dr. Amol Soin|937-434-2226|drsoin@ohiopainclinic.com|
315695|NCT03526458|University of Wisconsin, School of Medicine and Public Health, Department of Urology|Shuang Li|6082638336|lis@urology.wisc.edu|
315696|NCT03526861|LEO Pharma A/S|Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
315697|NCT03527160|Cincinnati Children's Hospital Medical Center|Dr. Stuart Goldstein|513-636-2209|stuart.goldstein@cchmc.org|
315698|NCT03527173|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315699|NCT03527550|McLean Hospital|Dr. Andrew Peckham|617-855-2946|adpeckham@mclean.harvard.edu|
315700|NCT03527745|Swiss Tropical and Public Health Institute|Jennifer Keiser, PhD|+41 (61) 284 8218|jennifer.keiser@swisstph.ch|
315701|NCT03527966|Virtua Health Inc.|Jillian Hoopes|856-761-3904|jhoopes@virtua.org|
315702|NCT03528174|Oregon Health and Science University|Jessica Castle MD|503-494-7072|castleje@ohsu.edu|
315703|NCT03528369|Vizuri Health Sciences|Vice President Clinical Operations|919-397-4782|twarneke@vizuriusa.com|
315704|NCT03528512|William Beaumont Hospitals|Dr. Margaret Menoch|2489897289|margaret.menoch@beaumont.edu|
315705|NCT03528551|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
315706|NCT03528577|SPIL|Clinical Trials|912266455645|clinical.trials@sparcmail.com|
305450|NCT02333045|Emory University|Anandi Sheth, MD|404-616-6240|ansheth@emory.edu|
305451|NCT02333071|AMAG Pharmaceuticals|Medical Information|1-877-411-2510|amag@druginfo.com|
305452|NCT02333331|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
305453|NCT02333383|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
305454|NCT02333487|H. LUndbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
315707|NCT03529162|Saint Louis University|Sarah Dawson, Research Nurse|314-977-4106|sarah.dawson@health.slu.edu|
282550|NCT00860028|Yale School of Medicine|Dr. Stephanie O'Malley|203-974-7590|stephanie.omalley@yale.edu|
315708|NCT03529409|University of Maryland, College Park|Dr. Jessica Magidson|301-405-5095|jmagidso@umd.edu|
315709|NCT03529461|Bristol Hospital|Makram Gedeon, MD|8605853339|mgedeon@bristolhospital.org|
315710|NCT03529773|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315711|NCT03530098|Stanford University|Safwan S Halabi, MD|(650) 721-2850|safwan.halabi@stanford.edu|
315712|NCT03530345|Grünenthal GmbH|Director Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
315713|NCT03530631|University of Alabama, Birmingham|Karen Cropsey|(205) 975-7809|kcropsey@uabmc.edu|
315714|NCT03530917|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
315715|NCT03530995|Kadmon Corporation|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|833-900-5366|olivier.schueller@kadmon.com|
315716|NCT03531710|United Neuroscience|Medical Director|+1 (972) 809-0481|info@unitedneuroscience.com|
315717|NCT03531840|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|raffit_hassan@nih.gov|
315718|NCT03531905|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
315719|NCT03532009|Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
315720|NCT03532048|Baylor College of Medicine|Teresia O'Connor|7137986782|teresiao@bcm.edu|
315721|NCT03532308|Yale University School of Medicine|Michael S. Leapman, MD|(203) 785-2815|michael.leapman@yale.edu|
315722|NCT03532776|Dermax|Chauvel Virginie|+32 488 07 04 18|chauvelvirginie07@gmail.com|
315723|NCT03533036|UCLA|Dr. Aparna Sridhar, Associate Clinical Professor|3107947274|asridhar@mednet.ucla.edu|
315724|NCT03533114|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
315725|NCT03533244|Allgenesis Biotherapeutics|Tan Nguyen|+886-2-8787-1232|tan.nguyen@allgenesis.com|
315726|NCT03533374|Aarhus University Hospital|Professor Sandor Beniczky|+4526981536|sbz@filadelfia.dk|
315727|NCT03533608|Center for Clinical Managment Research|Dr. Rebecca Sripada|734-222-7432|rebecca.sripada@va.gov|
315728|NCT03533829|Duke Vaccine and Trials Unit|Kristen Gunnell|9196848891|kristen.gunnell@duke.edu|
315729|NCT03534427|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
315730|NCT03534986|International Biophysics Corporation|VP of Engineering and Quality|512-814-0046|quailty@biophysicscorp.com|
315731|NCT03535194|Eli Lilly and Company|Chief Medical Officer|8005455979|ClinicalTrials.gov@lilly.com|
315732|NCT03535571|KGK Science Inc.|Dr. Mal Evans|519-438-9374|mevans@kgkscience.com|
315733|NCT03535649|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
315734|NCT03535844|National University of Singapore|Dr. Kim Jung Eun|+6565161136|fstkje@nus.edu.sg|
315735|NCT03535974|Fundatia Bio-Forum|Dr. Felician Stancioiu|+40727500402|felicians11@gmail.com|
315736|NCT03536663|Fresenius Medical Care North America|Senior Director of Statistics and Data Management|781-699-4203|ChiangHong.Ho@fmc-na.com|
315737|NCT03536702|MS Hershey Medical Center|Monika Joshi, MD, MRCP|717-531-8678|muj14@psu.edu|
315738|NCT03536819|Inmode Ltd|Maria Shusterman, Clinical Director|9057070975|maria.shusterman@inmodemd.com|
315739|NCT03536923|Renovia, Inc|Chief Medical Officer, Dr. Samantha Pulliam|866-735-8424|sjpulliam@renoviainc.com|
315740|NCT03536949|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|908-809-1423|mvelasco@osmotica.com|
315741|NCT03537014|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
315742|NCT03537092|University Of Pittsburgh|Leslie Meyn, PhD|412-641-4233|meynla@mwri.magee.edu|
315743|NCT03537261|Massachusetts General Hospital Lurie Center|Lisa Nowinski, PhD|781-860-1700|lnowinski@mgh.harvard.edu|
315744|NCT03537274|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315745|NCT03537404|R-Pharm|Emiliya Krasavina, Medical Adviser|0074959567937|krasavina@rpharm.ru|
315746|NCT03537651|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
315747|NCT03537664|University of Sao Paulo|Dr. Ericka Pinheiro|551126488293|erickapinheiro@usp.br|
315748|NCT03538431|Massachusetts General Hospital|Dr. Joseph Biederman|6177261743|biederman@helix.mgh.harvard.edu|
315749|NCT03538678|University of Pittsburgh|Kar-Hai Chu|412-692-2578|chuk@pitt.edu|
315750|NCT03538743|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315751|NCT03538795|University of Alabama of Birmingham|Gitendra Uswatte|205-975-5089|guswatte@uab.edu|
315752|NCT03538808|University of Alabama at Birmingham|Samantha Schiavon|9515509388|sschiavon@uabmc.edu|
315753|NCT03539211|ChristianaCare|Brian Catania|302-838-4700|bcatania@christianacare.org|
315754|NCT03539432|The Mind Research Network|Dr. Eric Claus|5055151556|eclaus@mrn.org|
282551|NCT00860067|MedImmune LLC, an affiliate of AstraZeneca AB|Judith Falloon, MD/ Sr. Dir. Clinical Development|301-398-0000|falloonj@medimmune.com|
315755|NCT03539484|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
282552|NCT00860171|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
315756|NCT03539549|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
315757|NCT03540030|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
315758|NCT03540134|University of Virginia|Dr. Jeff Elias|(434) 924-0451|FUSbrain@virginia.edu|
315759|NCT03540147|University of Texas at Austin|Hirofumi Tanaka|5122324801|htanaka@austin.utexas.edu|
315760|NCT03540160|Menlo Therapeutics, Inc.|Iain Stuart, PhD|1-800-775-7936|Iain.Stuart@foamix.com|
315761|NCT03541044|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315762|NCT03541356|Impel NeuroPharma|Karen Craig, PhD (Medical Writer)|206-568-1466|kcraig@impelnp.com|
282553|NCT00860262|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
315763|NCT03541941|Cleveland Clinic Foundation|Dr. Michael Rosen|216-445-3441|rosenm@ccf.org|
315764|NCT03541980|Newark Beth Israel Medical Center|Dr Cena Tejani|973 926 7337|ctejani5@gmail.com|
315765|NCT03542019|University of Jordan|Dr. Ahmad El-Ma'aita|+9626535 5000|a.maaita@ju.edu.jo|
315766|NCT03542266|Weill Cornell Medical College|Jia Ruan, MD, PhD|646-962-2064|jruan@med.cornell.edu|
315767|NCT03542305|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315768|NCT03542474|Northwestern University|Dr. Daniel Corcos|312-908-6792|daniel.corcos@northwestern.edu|
315769|NCT03543085|China Medical University Hospital (in Taiwan)|Dr. Yeong-Ray Wen (Department of Anaesthesia)|+886 4 2205-2121|yray.wen@gmail.com|
315770|NCT03543137|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315771|NCT03543176|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315772|NCT03543878|Georgia Institute of Technology|Annabelle C. Singer, PhD|510-501-9659|asinger@gatech.edu|
315773|NCT03544216|Marshall B. Ketchum University (The Ohio State University during study data collection)|Erin Rueff, OD, PhD|7654145644|em.rueff@gmail.com|
315774|NCT03544307|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3774|song-youngpark@unomaha.edu|
315775|NCT03544333|University Hospital of Psychiatry Zurich, Switzerland|Stephanie Homan, PhD|0041 44 384|stephanie.homan@bli.uzh.ch|28 02
315776|NCT03544879|UC San Diego|Dr. Erik Groessl|858-642-6347|egroessl@ucsd.edu|
315777|NCT03545165|Weill Cornell Medicine|Scott Tagawa MD, Principal Investigator|646-962-2072|guonc@med.cornell.edu|
282554|NCT00860314|University Hospital Hamburg-Eppendorf, Heart Center|Tim Risius, MD|+49-40-42803|risius@uke.uni-hamburg.de|4142
315778|NCT03545412|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
315779|NCT03545503|New Hanover Regional Medical Center|William F. Powers, IV, MD, FACS|910-667-9232|william.powers@nhrmc.org|
315780|NCT03545893|University of Pennsylvania|Arden McAllister, Research Program Manager|215-662-3532|arden.mcallister@pennmedicine.upenn.edu|
315781|NCT03545984|Cleveland Clinic|Dr. Maged Argalious|+12164452064|ARGALIM@ccf.org|
315782|NCT03546192|Sanofi Pasteur Inc.|Medical Director|800-633-1610 ext 1#|RegistryContactUs@sanofipasteur.com|
315783|NCT03546270|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
315784|NCT03546491|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
315785|NCT03546621|Hepatera LLC|Dr.Alexander Alexandrov|+7 (495) 726-52-53|alexandrov@myr-pharma.com|42-03
315786|NCT03546647|University of Houston|Kathryn Richdale OD, PhD|713-743-1974|richdale@central.uh.edu|
315787|NCT03546816|Menlo Therapeutics Inc.|Iain Stuart, PhD|1- 800-775-7936|Iain.Stuart@foamix.com|
315788|NCT03546842|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315789|NCT03547154|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315790|NCT03547167|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315791|NCT03547531|Prince of Songkla University|istiyanti Hapsari|+66980493996|istiyantihapsari@gmail.com|
315792|NCT03547583|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
315793|NCT03547635|Integra LifeSciences|Jessica Knowlton, Sr Mgr, Clinical Research & PMCF Strategy|609-325-0111|jessica.knowlton@integralife.com|
315794|NCT03547687|Oregon Health Science University|Dr. Julia Durrant|503-494-0353|durrantj@ohsu.edu|
315795|NCT03548337|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315796|NCT03548935|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
315797|NCT03549117|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315798|NCT03549130|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315799|NCT03549234|University of California San Diego|Matthew Swisher, MD|415-314-4099|matthew.swisher@gmail.com|
315800|NCT03549338|Symphogen A/S|Vice President, Global Oncology|+45 8838 2600|info@symphogen.com|
315801|NCT03549429|Tufts Medical Center|Dr. Dan Drzymalski|‪617-913-8168|ddrzymalski@tuftsmedicalcenter.org|
315802|NCT03549598|Mayo Clinic|John P. Bois, M.D.|507-284-3545|Bois.John@mayo.edu|
315803|NCT03550066|Kaiser Permanente Northern California|Dr. Susan D. Brown|5108913544|susan.d.brown@kp.org|
315804|NCT03550209|Nationwide Children's Hospital|Dr. Sarah Keim|1-800-792-8401|sarah.keim@nationwidechildrens.org|52849
315805|NCT03550313|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315806|NCT03550378|MedImmune, LLC|Lars Hansen|+1 301 398 4563|information.center@astrazeneca.com|
315807|NCT03550989|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
315808|NCT03551730|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
282555|NCT00860379|Shriners Hospitlas for Children|Maggie Dylewski Begis|617-872-8567|mdylewski@shrinenet.org|
315809|NCT03551743|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
315810|NCT03551821|Aclaris Therapeutics|Executive Director Clinical Operations|4843247933|jschnyder@aclaristx.com|
315811|NCT03552198|KCL|Dr D D'Antoni||donatella.d'antoni@kcl.ac.uk|
315812|NCT03552289|Cook Research Incorporated|Alan Saunders|765-463-7537|Alan.Saunders@CookMedical.com|
315813|NCT03552523|MGH Diabetes Research Center|Courtney Balliro|617-726-1242|cballiro@partners.org|
315814|NCT03552536|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315815|NCT03552549|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315816|NCT03552757|Novo Nordisk A/S|Clinical Transparency Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
315817|NCT03553758|Massachusetts General Hospital DACCPM|Dr. Oluwaseun Johnson-Akeju|617-724-7200|oluwaseun.akeju@mgh.harvard.edu|
315818|NCT03553823|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
315819|NCT03553940|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
315820|NCT03554005|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315821|NCT03554018|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
292558|NCT01433913|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
315822|NCT03554486|Stanford|Bruce Buckingham|6508040476|buckingham@stanford.edu|
315823|NCT03554629|Clinical Research Program Manager|Kathleen H. Niebel RN BSN BSME|978-549-9325|kathleen.h.niebel@gmail.com|
315824|NCT03554746|National Yang Ming University|Dr. Yi-Fen Shih|+886-2-28267340|yfshih@ym.edu.tw|
315825|NCT03554772|Dr Reddy's Laboratories, Inc.|Srinivas Shenoy B.|6099550249|srinivasshenoyb@drreddys.com|
315826|NCT03554954|National University of Singapore|Dr. Kim Jung Eun|65161136|fstkje@nus.edu.sg|+65
315827|NCT03555266|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
315828|NCT03555305|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
315829|NCT03555435|National Center for PTSD|Eve Carlson|6504935000|eve.carlson@va.gov|24058
315830|NCT03555565|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
315831|NCT03555890|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315832|NCT03556579|Johnson & Johnson Vision Care Inc.|John Buch, O.D. F.A.A.O - Senior Principal Research Optometrist|904-443-1707|JBUCH@its.jnj.com|
315833|NCT03556761|University of Pennsylvania|Dr Lisa Levine|215-662-6913|lisa.levine@pennmedicine.upenn.edu|
315834|NCT03556891|Valencia Technologies|Jackie Dister|7604294787|jdister@valenciatechnologies.com|
315835|NCT03557034|Cleveland Clinic|Khaldoun Tarakji, MD, MPH|216-445-9225|TARAKJK@ccf.org|
315836|NCT03557086|Massachusetts General Hospital|Dr. Nneka Ufere|617-643-3408|nneka.ufere@mgh.harvard.edu|
315837|NCT03557125|Medical University of South Carolina|Sylvia Wilson, MD|843-792-2322|wilsonsh@musc.edu|
315838|NCT03557333|Impel NeuroPharma|Karen Craig, PhD (Medical Writer)|206-568-1466|kcraig@impelnp.com|
315839|NCT03557372|Dana Farber Cancer Institute|Dr. Shyam Tanguturi|617-632-0000|stanguturi@partners.org|
315840|NCT03557476|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
315841|NCT03557658|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
315842|NCT03557775|Medical University of South Carolina|Dr. Heather Shaw Bonilha|843-792-2527|bonilhah@musc.edu|
315843|NCT03557801|Vanderbilt University Medical Center|Dr. Lucy Spalluto|615 343 1187|lucy.b.spalluto@vumc.org|
315844|NCT03557931|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
315845|NCT03558061|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
315846|NCT03558074|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
315847|NCT03558230|Medical University of South Carolina|Dr. Na Jin Seo|843-792-0084|seon@musc.edu|
315848|NCT03558516|Department of Anesthesiology, Faculty of medicine, Siriaj hospital, Mahidol University|Assoc. Prof. Manee Raksakietisak|+66814880620|manee95@hotmail.com|
315849|NCT03558555|Icahn School of Medicine at Mount Sinai|Dr. Alopi Patel|(212) 523-6357|Alopi.patel@mountsinai.org|
315850|NCT03558672|Tactile Medical|Director of Clinical Research|612.540.5267|astone@tactilemedical.com|
315851|NCT03558997|Regeneron Pharmaceuticals, Inc|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
315852|NCT03559062|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
315853|NCT03559179|HealthPartners Institute|Dr. Rebecca C Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
315854|NCT03559205|Keele University|Jonathan Hill|01782 733900|j.hill@keele.ac.uk|
292559|NCT01433978|Eisai Call Center|Eisai Inc.|888-422-4743||
292560|NCT01433991|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
315855|NCT03559218|KeraNetics|Ryan Clohessy, PhD|4102513940|rclohessy@keranetics.com|
315856|NCT03559257|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
315857|NCT03559517|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
315858|NCT03559530|Unversidade de Sao Paulo|Dr Priscila Rosalba Domingos de Oliveira|551126616900|priscila.rosalba@hc.fm.usp.br|
315859|NCT03559829|Associate Professor of Neurology and Neurological Sciences|Maarten G. Lansberg, MD PhD|(650) 723-4448|lansberg@stanford.edu|
315860|NCT03559933|Stimdia Medical, Inc.|Tim Miller|612.940.3454|tmiller@stimdia.com|
315861|NCT03560102|Kantonsspital Winterthur|Christoph A Binkert (Sponsor-Investigator)|+41 52 266 2602|christoph.binkert@ksw.ch|
315862|NCT03560128|Indiana University|Study Coordinator|317-948-0724|rlahr@iu.edu|
315863|NCT03560141|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
315864|NCT03560245|Neurotropebioscience, Inc|Alan J. Tuchman, MD, Acting Chief Medical Officer|973-242-0005|atuchman@neurotrope.com|
315865|NCT03560518|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
315866|NCT03560739|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
315867|NCT03560869|University of Delaware|William B. Farquhar|302-831-6178|wbf@udel.edu|
315868|NCT03560986|Grünenthal GmbH|Director Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
315869|NCT03561090|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
271681|NCT00257010|Janssen-Ortho LLC|Vice President, Medical Affairs||ClinicalTrialDisclosure@its.jnj.com|
315870|NCT03561883|Ironwood Pharmaceuticals, Inc.|Ironwood Study Chair|(617) 621-7722|Info@ironwoodpharma.com|
315871|NCT03562117|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315872|NCT03562377|LEO Pharma A/S|Disclosure|+45|disclosure@leo-pharma.com|44945888
315873|NCT03562481|University of North Carolina at Chapel Hill|Jessica Lee, DDS, MPH, PhD|9195373955|jessica_lee@unc.edu|
315874|NCT03562559|Vancouver General Hospital|Marcus Tholin|604-875-4111|marcus.tholin@vch.ca|
315875|NCT03562663|Moss Rehabilitation Research Institute|Dylan Edwards|(215) 663-6411|EdwardDy@einstein.edu|
315876|NCT03562988|Church & Dwight Co., Inc|Dr. Annahita Ghassemi, PhD|609-806-1200|annahita.ghassemi@churchdwight.com|
315877|NCT03563027|Crescenz Veterans Affairs Medical Center|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
315878|NCT03563183|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315879|NCT03563209|İzmir Katip Çelebi University, Faculty of Medicine|ilker şengül|05337333698|ilkrsngl@gmail.com|
315880|NCT03563313|University of Virginia|Sue Brown, MD|434-962-0602|sab2f@virginia.edu|
315881|NCT03563716|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
315882|NCT03564444|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
315883|NCT03564886|University of Missouri, Department of Orthopaedics|Lasun Oladeji, MD|573-884-7796|OladejiL@health.missouri.edu|
315884|NCT03565068|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315885|NCT03565211|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
315886|NCT03565315|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
315887|NCT03565666|Mass. General Hospital|Dr. Steven J. Russell|617-726-8722|sjrussell@mgh.harvard.edu|
315888|NCT03565679|Medline Industries, Inc|Kara Cassady|847-643-3809|kcassady@medline.com|
315889|NCT03565874|Department of Child and Adolescent Psychiatry, University Hospital of Lausanne|Dr. Sébastien Urben|+41 21 314 7492|sebastien.urben@chuv.ch|
315890|NCT03565887|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|908-809-1423|mvelasco@osmotica.com|
315891|NCT03566238|Albireo AB|Patrick Horn, MD, PhD|+1 (857) 378- 2035|medinfo@albireopharma.com|
315892|NCT03566485|Vanderbilt-Ingram Cancer Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
315893|NCT03566550|University of Nottingham|Professor Alan Smyth|01158230612|alan.smyth@nottingham.ac.uk|
315894|NCT03566680|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
315895|NCT03566810|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
315896|NCT03566823|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
315897|NCT03566979|Johnson & Johnson Worldwide|Steven Sacavage, Associate Director Clinical Research|215-273-8568|SSacavag@its.jnj.com|
315898|NCT03567005|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
315899|NCT03567252|University of Kentucky|Ann Koempel|(859) 257-3800|ann.koempel@uky.edu|
315900|NCT03567291|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
315901|NCT03567382|University of North Carolina at Chapel Hill|Peyton Thompson, MD, MSCR|919-445-0854|peyton_thompson@med.unc.edu|
315902|NCT03567616|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
315903|NCT03567980|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
315904|NCT03568500|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
315905|NCT03568539|Innovent Biologics (Suzhou) Co., Ltd.|YiBo|+8613382419112|jessica.yi@innoventbio.com|
315906|NCT03568942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315907|NCT03569020|Beth Israel Deaconess Medical Center|Dr. Stephen Juraschek|617-754-1416|sjurasch@bidmc.harvard.edu|
315908|NCT03569033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
315909|NCT03569098|Ipsen Pharma|Medical Director|see email|clinical.trials@ipsen.com|
315910|NCT03569202|Finnsusp Ltd.|Dr. Jarmo Laihia, Manager of Clinical & Formulation Development|358 50 377 1212|jarmo.laihia@piiloset.fi|
292561|NCT01434030|University of Virginia|Boris P Kovatchev, Ph.D.|434-924-5592|bpk2u@virginia.edu|
315911|NCT03569371|Incyte Corporation|Incyte Corporation Call Center, Study Director|1-855-463-3463|medinfo@incyte.com|
315912|NCT03569397|University of Alabama at Birmingham|Adam Sturdivant, MPH|205-934-4042|Adamsturdivant@uabmc.edu|
315913|NCT03569618|University of California, San Francisco|Riley Bove, MD MSc|415.502.7209|riley.bove@ucsf.edu|
315914|NCT03569748|University of Catania|Maria Signorelli|095.378.2636/794|maria.signorelli@unict.it|
315915|NCT03570047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315916|NCT03570255|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
315917|NCT03570476|University of Washington|Dr. Bruce Montgomery, PI|206-598-0860|rbmontgo@uw.edu|
315918|NCT03570554|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
315919|NCT03570658|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
315920|NCT03570697|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
315921|NCT03571256|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
315922|NCT03571516|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
315923|NCT03571555|Royal Holloway University of London|Dr. Michael Evangeli|00447801543681|michael.evangeli@rhul.ac.uk|
315924|NCT03571607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315925|NCT03571672|Lantheus Medical Imaging, Inc|Istvan Molnar|978-671-8686|istvan.molnar@lantheus.com|
315926|NCT03571724|22nd Century Group, Inc.|Karen E. Delaney|716-270-1523|kdelaney@xxiicentury.com|
315927|NCT03572062|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315928|NCT03572218|Perelman School of Medicine at the University of Pennsylvania|Dr. Rebecca Pearl|215-746-5129|rpearl@pennmedicine.upenn.edu|
315929|NCT03572478|University of Chicago|Walter STadler|773-702-4150|wstadler@medicine.bsd.uchicago.edu|
315930|NCT03572972|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315931|NCT03573206|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|650-207-0563|Terry_Alverson@cardivamedical.com|
315932|NCT03573323|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
315933|NCT03573505|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
315934|NCT03573804|Dartmouth-Hitchcock|Timothy B Rooney, MD, PI|603-650-5000|timothy.b.rooney@hitchcock.org|
315935|NCT03573830|BC Children's Hospital Research Institute|Dr. Mariana Brussoni|(604) 875-3712|mbrussoni@bcchr.ubc.ca|
315936|NCT03573908|Ironwood Pharmaceuticals, Inc.|Vanessa Chong|(617) 374-3923|vchong@ironwoodpharma.com|
315937|NCT03574181|Boston Medial Center|Dr. Eric Devine|617-638-7888|eric.devine@bmc.org|
315938|NCT03574441|Augusta University|Efrain Riveros Perez|7067217361|eriverosperez@augusta.edu|
315939|NCT03574753|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
315940|NCT03574818|Montefiore Medical Center|Balazs Halmos|7184058404|bahalmos@montefiore.org|
315941|NCT03575702|R-Pharm|Georgiy Sharvadze, Medical Advisor|0074959567937|sharvadze@rpharm.ru|1175
315942|NCT03575754|London Health Sciences Centre|Dr. Derek Cool|519-685-8500|derek.cool@lhsc.on.ca|54965
315943|NCT03575806|Tsinghua University|Statistician of Clinical Trials||majunfan2@sina.com|
315944|NCT03575871|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
315945|NCT03575962|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315946|NCT03575975|Georgia Institute of Technology|Dr. Young-Hui Chang|404-894-9993|yh.chang@ap.gatech.edu|
315947|NCT03576066|Assembly Biosciences|Linda Bahr, Sr. Director, Clinical Operations|415-521-3808|clinicaltrials@assemblybio.com|
315948|NCT03576118|Ajou University Hospital|Dr. Jong Yeop Kim|+82312195574|kjyeop@ajou.ac.kr|
315949|NCT03576183|Valneva Austria GmbH|Head Global Medical Affairs|20620|info@valneva.com|0
315950|NCT03576716|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
315951|NCT03576768|Medical University of South Carolina|Colleen Hanlon, PhD|843-792-9888|hanlon@musc.edu|
315952|NCT03577171|Assembly Biosciences|Linda Baher, Sr. Director, Clinical Operations|415-521-3808|clinicaltrials@assemblybio.com|
315953|NCT03577275|NorthSea Therapeutics BV|Dr Patrick Round|+44(0)7979502770|patrick.round@northseatherapeutics.com|
315954|NCT03577730|University of Michigan|Phillip Vlisides|734-936-4280|pvliside@umich.edu|
282556|NCT00860405|Fresenius Kabi Aktiengesellschaft, Else-Kröner-Str. 1, 61352 Bad Homburg, Germany|Professor Dr. Martin Westphal, Chief Medical Officer|+49 6172 686 7280|martin.westphal@fresenius-kabi.com|
315955|NCT03578146|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
315956|NCT03578549|Univeristy of Michigan|Dr. Darya Dabiri|4198821017|daryad@umich.edu|
315957|NCT03578926|CooperVision Inc.|Jose A. Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
315958|NCT03579290|Yale University|Theresa Babuscio Data Manager|203-737-5430|theresa.babuscio@yale.edu|
315959|NCT03579433|Alcon Research, LLC|Sr. CDMA Project Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
315960|NCT03579719|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
315961|NCT03579940|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
315962|NCT03580343|Washington University in St. Louis|Lynn Hassman, Assistant Professor and Study PI|3142730341|lhassman@wustl.edu|
315963|NCT03581084|UCSF Airway Clinical Research Center|Ariana Lowman|14155141539|ariana.baum@ucsf.edu|
315964|NCT03581097|Ospedale Regionale di Bellinzona e Valli (ORBV)|Dr. med. Andrea Saporito, Vice-Chair Department of Anesthesia|091/811.91.11|andrea.saporito@eoc.ch|
315965|NCT03581474|Ambu A/S|Anna Charlotte Lundgaard|+4529643748|aclu@ambu.com|
315966|NCT03581825|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
315967|NCT03582215|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.strauss@fda.hhs.gov|
315968|NCT03582553|Pennington Biomedical Research Center|Dr. Candida Rebello|225-763-3159|Candida.Rebello@pbrc.edu|
315969|NCT03582813|Center on Mental Health Services Research and Policy, University of Illinois at Chicago, Department of Psychiatry|Dr. Judith A. Cook, Director|312-355-3921|jcook@uic.edu|
315970|NCT03582826|MEBO Research|Maria De la Torre, Executive Director|786 228-6880|maria.delatorre@meboresearch.org|
315971|NCT03582943|Washington University School of Medicine|Dr. Catherine Lang|314-286-1945|langc@wustl.edu|
315972|NCT03583372|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
315973|NCT03583385|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
315974|NCT03583450|University of California, San Francisco|Dr. Jina Sinskey|857-998-0137|jina.sinskey@ucsf.edu|
315975|NCT03583606|Cincinnati Children's Hospital|Paul Spearman, MD|513-636-4509|paul.spearman@cchmc.org|
315976|NCT03584009|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
315977|NCT03584100|Stanford University|Jeffrey Yao|650-723-5643|jyao@stanford.edu|
315978|NCT03585244|Foundation for Prader-Willi Research|Theresa Strong, PhD - Director of Research Programs|888-322-5487|theresa.strong@fpwr.org|702
315979|NCT03585296|Aclaris Therapeutics|Executive Director Clinical Operations|4843242144|jschnyder@aclaristx.com|
315980|NCT03585504|Medical University of South Carolina|Dr. Angela Dempsey|843-762-4500|dempsear@musc.edu|
315981|NCT03585543|Medical University of South Carolina College of Nursing|Shannon Phillips, PhD, RN, Associate Professor|843-792-9379|phillipss@musc.edu|
315982|NCT03585712|HRA Pharma|Agnes Hemon|0140337092|a.hemon@hra-pharma.com|
315983|NCT03585790|IU School of Optometry|Pete Kollbaum|812-856-0108|kollbaum@iu.edu|
315984|NCT03585959|Medtronic|Katie Bayliss|(763) 647-5547|katie.j.bayliss@medtronic.com|
315985|NCT03586167|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
315986|NCT03586544|The Ohio State University|Dharini Bhammar|614-866-9467|dharini.bhammar@osumc.edu|
315987|NCT03586583|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
315988|NCT03586648|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
315989|NCT03586726|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
315990|NCT03586830|Janssen Research & Development, LLC|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
315991|NCT03587207|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315992|NCT03587428|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
315993|NCT03587974|UCaliforniaDavis|Dr. Ladson Hinton|9167343485|lwhinton@ucdavis.edu|
315994|NCT03588572|Guangzhou General Hospital of Guangzhou Military Command|Dr.Yan Liu|0086-02088654756|yanliu@139.com|0086
315995|NCT03588741|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
315996|NCT03588806|University of Pittsburgh|Dr. Ajay D. Wasan|4126658030|wasanad@upmc.edu|
315997|NCT03588910|Montefiore Medical Center|Dr. Kari Plewniak|718-920-5157|kplewnia@montefiore.org|
315998|NCT03589469|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
315999|NCT03589807|Emory Children's Center|Evan J. Anderson, MD|404-727-5642|evanderson@emory.edu|
316000|NCT03589885|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
316001|NCT03590613|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
316002|NCT03591068|Optinose|Jennifer Carothers|908-432-3061|jennifer.carothers@optinose.com|
316003|NCT03591146|Taiwan Liposome Company|Cynthia Lin|+886 2 2655 7377|cynthia_lin@tlcbio.com|
316004|NCT03591406|Vifor (International) Inc.|VIT-IRON-2011-004 Clinical Study Team|+41 58 851 80 00|VIT-IRON-2011-004.study@viforpharma.com|
316005|NCT03592121|Applied Biology, Inc.|Dr. Andy Goren|(949) 387-4526|andyg@appliedbiology.com|
316006|NCT03592745|Feinstein Institutes for Medical Research at Northwell Health|Senior Research Coordinator|5165623646|jchang14@northwell.edu|
316007|NCT03593200|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
316008|NCT03593538|Perelman School of Medicine at the University of Pennsylvania|Dr. Rebecca Ashare|2157465789|rlashare@pennmedicine.upenn.edu|
316009|NCT03593681|Boston Scientific|Clinical Trial Project Manager|612-209-9532|blake.hedstrom@bsci.com|
316010|NCT03593876|University of Pittsburgh|Dr. Elizabeth Skidmore|(412) 383-6617|skidmore@pitt.edu|
282557|NCT00860457|Lombardi Comprehensive Cancer Center, Georgetown University Hospital|Dr. Bruce D. Cheson|202-444-7932|bdc4@georgetown.edu|
316011|NCT03593902|Northwestern University|Kathleen Quigley|312-695-8192|kathleen.quigley@nm.org|
282558|NCT00860470|JHSPH|Keith P. West, Jr.|4109552061|kwest@jhsph.edu|
282559|NCT00860535|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282560|NCT00860574|Fred Hutch/University of Washington Cancer Consortium|Joachim Deeg|206.667.5985|jdeeg@fredhutch.org|
282561|NCT00860743|Wayne State University and John D. Dingell VA Medical Center|Jason H. Mateika|313-576-4481|jmateika@med.wayne.edu|
305455|NCT02333630|Nationwide Children's Hospital|David Stukus, MD|614 722-4808|david.stukus@nationwidechildrens.org|
305456|NCT02334059|Penn State Health Anesthesiology and Perioperative Medicine|Sanjib D Adhikary|717-531-6597|sadhikary1@pennstatehealth.psu.edu|
305457|NCT02334215|Friends Research Institute|Robert P. Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
305458|NCT02334267|Frenova Renal Research|Brigid Flanagan, MS, RN, CCRC|781-699-2970|Brigid.Flanagan@frenovarenalresearch.com|
316012|NCT03594045|Massachusetts General Hospital|Dr. Rachel Rosovsky|617-724-4000|RPROSOVSKY@mgh.harvard.edu|
305459|NCT02334306|MedImmune, LLC|Gabor Illei|+1 240 558 0038 118|information.center@astrazenea.com|
305460|NCT02334358|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
316013|NCT03594071|Smith+Nephew, Inc.|Kirsten Wall|720-338-9460|Kirsten.wall@smith-nephew.com|
305461|NCT02334384|Eastern Virginia Medical School|Kenji Cunnion|7574465125|cunniokm@evms.edu|
305462|NCT02334423|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
305463|NCT02334436|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
305464|NCT02334527|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
305465|NCT02334683|Icahn School of Medicine at Mount Sinai|David Simpson, M.D.|(212) 241-8748|david.simpson@mssm.edu|
305466|NCT02334748|Novartis Pharma AG|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
305467|NCT02334787|Otsuka Pharmaceutical Co., LTD.|Study Director, Department of Clinical Management|+81-3-6361-7366||
305468|NCT02334800|Pfizer Inc.|Pfizer ClinicalTrail.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
305469|NCT02334813|University Hospital Essen, Germany|Prof. Dr. Ulrich Dührsen|+49 201 723|ulrich.duehrsen@uk-essen.de|2417
316014|NCT03594227|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
305470|NCT02334982|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
305471|NCT02335125|University of Washington Harborview Medical Center|Douglas Zatzick, MD|(206) 744-6701|dzatzick@uw.edu|
305472|NCT02335216|St. Jude Medical|Roni Diaz|+19723098601|rdiaz@sjm.com|
316015|NCT03594500|VA NY Harbor Healthcare System|Dr. Joshua Chodosh|212-686-7500|joshua.chodosh@va.gov|5043
316016|NCT03595176|Shockwave Medical|Randee Randoll|408.577.7856|rrandoll@shockwavemedical.com|
316017|NCT03595215|TheraNova|Clinical Research Associate|415-926-8616|akrajcevska@theranova.com|
316018|NCT03595280|Georgetown University|Darren Mays|2026878937|dmm239@georgetown.edu|
316019|NCT03595449|Mayo Clinic|Shari A. Ochoa, M.D.|480-301-6479|Ochoa.Shari@mayo.edu|
316020|NCT03595579|Axsome Therapeutics, Inc.|Amanda Jones, PharmD, Senior Vice President of Clinical Development|212-332-3223|ajones@axsome.com|
316021|NCT03595618|Galapagos NV|Galapagos Medical Information|+32 15342900|medicalinfo@glpg.com|
316022|NCT03595904|Icahn School of Medicine at Mount Sinai|Dr. Sarah Miller|212-824-7783|Sarah.Miller@mssm.edu|
316023|NCT03596151|Antiviral Research Center, University of California, San Diego|Sheldon Morris, MD, MPH|619-543-4761|shmorris@ucsd.edu|
316024|NCT03596177|MedImmune, LLC|Victoria Parker|+44 747 1357172|information.center@astrazeneca.com|
316025|NCT03596723|Kala Pharmaceuticals, Inc|VP Clinical Development|781-996-5252|Results010@kalarx.com|
316026|NCT03597009|University of North Carolina Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
316027|NCT03597022|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
316028|NCT03597061|University of Cincinnati|Cathleen Stough, Ph.D.|513-556-5589|odarcc@ucmail.uc.edu|
316029|NCT03597139|Aurinia Pharmaceuticals|Mary Palmen|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
316030|NCT03597178|Johnson & Johnson|Brian Pall OD, MS, FAAO- Director of Clinical Sciences|9044431290|BPALL@its.jnj.com|
316031|NCT03597347|Savara Inc|Dhaval Desai, VP Head of Clinical Development|+1 302-442-2309|dhaval.desai@savarapharma.com|
316032|NCT03597529|Director, Child and Adolescent Headache Program, UCSF Benioff Children's Hospitals|Dr. Amy A. Gelfand|415-502-1914|Amy.Gelfand@ucsf.edu|
316033|NCT03597789|University of North Carolina at Chapel Hill|Deborah Jones, PhD|919-962-5082|djjones@email.unc.edu|
316034|NCT03598647|The Miriam Hospital|Jessica Unick, PD (Principal Investigator)|401-793-8966|junick@lifespan.org|
316035|NCT03599089|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
316036|NCT03599193|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
316037|NCT03599271|Intersect ENT|Andrew Campbell PhD, MPH Clinical Affairs Director|6506412100|acampbell@intersectent.com|
316038|NCT03599349|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 865|clinicaltrials@merz.com|
316039|NCT03599362|NYU Langone Health|Fraustina Hsu|6467547124|Fraustina.Hsu@nyulangone.org|
316040|NCT03599687|Yorkshire Ambulance Service NHS Trust|Richard Pilbery|+447463734823|r.pilbery@nhs.net|
316041|NCT03599986|DataClin|Medical Writer|(+2) 01001566602|mariam.abdalla@dataclin.com|
316042|NCT03600142|University of Utah|Dr. Melissa Watt|8015817201|melissa.watt@hsc.utah.edu|
316043|NCT03600194|Philips|Jeff Jasko|412-542-3836|jeff.jasko@philips.com|
316044|NCT03600376|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201-326-5300|medinfo@eagleus.com|
316045|NCT03600428|Vanderbilt University Medical Center|C. Buddy Creech, MD, MPH|6153430332|buddy.creech@vumc.org|
305473|NCT02335229|St. Jude Medical|Jennifer Duggan|+32(0)27746827|jduggan@sjm.com|
282562|NCT00860795|University of Washington|James A Taylor, MD|206-616-1206|uncjat@u.washington.edu|
282563|NCT00860847|Los Angeles Biomedical Research Inst.|Dr Matthew Budoff|310-222-4107|mbudoff@labiomed.org|
282564|NCT00860938|University Hospital Basel, Switzerland|Jörg D. Leuppi, MD PhD, principle investigator|+41-61-2654294|jleuppi@uhbs.ch|
282565|NCT00860951|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
282566|NCT00861146|Yale University School of Medicine|Ned L. Cooney, PhD|860-594-6339|ned.cooney@yale.edu|
316046|NCT03601052|Viridian Therapeutics (formerly miRagen Therapeutics)|Regulatory Affairs|720-722-5917|clinicaltrials@viridiantherapeutics.com|
316047|NCT03601117|Stanford University|Dr Nolan Williams|(650) 723-1147|nolanw@stanford.edu|
316048|NCT03601715|Federal University of Santa Catarina|Inaihá Benincá|(+55 48) 3721-6255|inaiha.b@gmail.com|
316049|NCT03602053|PATH|Dr Niraj Rathi, MD; Senior Medical Officer|+91 11 4064 0000|nrathi@path.org|
316050|NCT03602339|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
316051|NCT03602482|Pennsylvania State University College of Medicine|Dr. Amanda J. Miller|7175317676|aross1@pennstatehealth.psu.edu|
316052|NCT03603028|UAB|David A. Brown|205-975-2788|dbrownpt@uab.edu|
316053|NCT03603106|Guerbet|Jing Hao, MD|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
316054|NCT03603652|ETHICON|Erin Meyers|937-681-0322|eprifog1@its.jnj.com|
282567|NCT00861198|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
282568|NCT00861263|University of FLorida|Dr. Peter Draganov MD|352-273-9472|peter.draganov@medicine.ufl.edu|
282569|NCT00861341|University of Rochester, Wilmot Cancer Center|Charles Francis, MD|585-275-3761|Charles_Francis@urmc.rochester.edu|
282570|NCT00861380|GlaxoSmithKline|GSK Response Center|866-435-7343||
282571|NCT00861471|New York University Cancer Institute|Anna Ferrari, MD|212-731-5389|anna.ferrari@nyumc.org|
316055|NCT03604263|Medtronic CRHF|Krestyn Thomas|6123236613|krestyn.j.thomas@medtronic.com|
316056|NCT03604341|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
316057|NCT03604497|University of Alabama at Birmingham|Dr David Schwebel|2059348745|schwebel@uab.edu|
316058|NCT03604523|UMass Medical School|Dr. David Cave|508-856-8399|david.cave@umassmemorial.org|
316059|NCT03604705|Amplyx Pharmaceuticals|Chief Medical Officer|8588427854|mhodges@amplyx.com|
316060|NCT03605212|Menarini Group|Angela Capriati, MD PhD - Corporate Director Clinical Sciences|+39 055 5680|acapriati@menarini-ricerche.it|9990
316061|NCT03605680|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
316062|NCT03605693|Center for Behavioral Cardiovascular Health, Columbia University Irving Medical Center|Dr. Ian Kronish|212-342-1335|ik2293@columbia.edu|
316063|NCT03605745|Boston Scientific|Kaitlyn Rainbow, Clinical Research Associate|952-930-6627|kat.rainbow@bsci.com|
316064|NCT03605836|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
316065|NCT03605914|The University of Texas Health Science Center at Houston|Martin J. Citardi, MD, Professor and Chair, Department of Otorhinolaryngology|(713) 500-5410|Martin.J.Citardi@uth.tmc.edu|
316066|NCT03606187|SGX Medical|VP of Clinical Affairs|6613108409|wpark@sgxmedical.com|
316067|NCT03606343|Cincinnati Children's Hospital Medical Center|Leanne Tamm, Principal Investigator|513-803-3176|leanne.tamm@cchmc.org|
316068|NCT03606460|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
316069|NCT03607487|Incyte Corporation|Incyte Corporation Call Center|1-855-463-3463|medinfo@incyte.com|
316070|NCT03607539|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
316071|NCT03607682|Vanderbilt University Medical Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
316072|NCT03607695|University of Washington|Valerie E. Kelly, PT, PhD|206-598-5350|vekelly@uw.edu|
316073|NCT03607994|Wake Forest Baptist Health|Catherine Tegeler - Project Manager|336-716-9341|categele@wakehealth.edu|
316074|NCT03608488|SultanAbdulhamid|Tugba OZsoy-Unubol|+905074583382|tugbaozsoyy@gmail.com|
316075|NCT03608774|University of Washington|Julia C. Dombrowski, MD, MPH|206-744-5640|jdombrow@uw.edu|
316076|NCT03608839|State University of Campinas (UNICAMP)|Dr Rodrigo Pessoa Cavalcanti Lira|551935217396|alayf@hotmail.com|7396
316077|NCT03609619|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
316078|NCT03609658|Wake Forest School of Medicine|Jennifer Gabbard, M.D.|336-716-8028|jgabbard@wakehealth.edu|
316079|NCT03610048|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
316080|NCT03610165|Cleveland Clinic Foundation|Dr. Kamal Maheshwari|216-4454311|maheshk@ccf.org|
316081|NCT03610269|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
316082|NCT03610399|Acre Health State Secretariat|Suiane Negreiros|55 68 9983 1266|omsvalle@hotmail.com|
316083|NCT03610464|Tris Pharma, Inc.|Antonio Pardo MD|16107502210|apardo@trispharma.com|
316084|NCT03610581|Janssen Vaccines & Prevention B.V|Clinical Franchise Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
316085|NCT03610633|Medical University of South Carolina|Laura Lohnes|843-792-7709|lohnes@musc.edu|
316086|NCT03611062|University of Massachusetts Lowell|Dr. Jiabin Shen|978-934-3965|jiabin_shen@uml.edu|
316087|NCT03611075|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
316088|NCT03611582|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
316089|NCT03611777|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316090|NCT03611829|McGill University|Mallory Frayn, PhD (c)|514-398-1399|mallory.frayn@mail.mcgill.ca|
316091|NCT03612856|Aronora, Inc.|Christina U. Lorentz|503-964-0250|christina.lorentz@aronorabio.com|
316092|NCT03613129|Bateman Horne Center|Lucinda Bateman, MD|(801) 359-7400|LBateman@batemanhornecenter.org|
316093|NCT03613454|University of Alabama at Birmingham|Dr. AJ Gunn|205-975-4850|agunn@uabmc.edu|
316094|NCT03613493|University of Miami|Dr. Susan Morgan|7654094919|semorgan@miami.edu|
316095|NCT03613649|DynPort Vaccine Company LLC, a GDIT Company|George A. Saviolakis, MD, PhD, Medical Director|1-240-651-8116|George.Saviolakis@gdit.com|
316096|NCT03613818|Boise State Universtiy|Dr. Diana Doumas|2084261219|dianadoumas@boisestate.edu|
316097|NCT03614078|PRCL Research Inc|Caroline Fortier|1-514-708-4417|caroline.fortier@prclresearch.com|
316098|NCT03614130|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
316099|NCT03614156|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
316100|NCT03614416|Bioserenity|Eléonore CAILLET|01 57 27 40 00.|eleonore.caillet@bioserenity.com|
316101|NCT03614975|University of Pittsburgh, Department of Family Medicine|Richard Zimmerman, MD|412-383-2354|zimmrk@upmc.edu|
316102|NCT03615001|Laborie|Stephanie Gallone, Clinical Research Manager|9056121170|sgallone@laborie.com|1755
316103|NCT03615066|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
316104|NCT03615079|University of Pennsylvania|Michael Mullen|215-662-3339|Michael.Mullen@Pennmedicine.Upenn.Edu|
316105|NCT03615183|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
316106|NCT03615404|Duke University Medical Center|Principal Investigator|919-684-0000|pedsneuronc@duke.edu|
282572|NCT00861601|GlaxoSmithKline|GSK Response Center|866-435-7343||
282573|NCT00861614|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
316107|NCT03615482|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
316108|NCT03615534|Al-Kindy College of Medicine, ////university of Baghdad|Lewai Sharki Abdulaziz|750 659 0024|lewaisharki@kmc.uobaghdad.edu.iq|+964
316109|NCT03615807|Balgrist University Hospital|Professor Ilker UCKAY|+41 44 386 37 05|ilker.uckay@balgrist.ch|
316110|NCT03615911|University Medical Center Hamburg-Eppendorf|Prof. Marylyn M. Addo|+49 40 7410|m.addo@uke.de|51102
316111|NCT03615924|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
316112|NCT03616106|University of Colorado College of Nursing|Samantha Stonbraker, Assistant Professor|720-880-8194|Samantha.Stonbraker@Cuanschutz.edu|
316113|NCT03616171|Emory University|Ashley Coombe, PhD|404-712-9313|ashley.coombe@emory.edu|
316114|NCT03616600|Hong Kong Polytechnic University|Dr. Henry Chan|+85227667937|henryhl.chan@polyu.edu.hk|
316115|NCT03616899|Kala Pharmaceuticals, Inc|VP, Clinical Development|(781) 996-5252|Results011@kalarx.com|
316116|NCT03616977|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
316117|NCT03617419|GE Healthcare|Sr. Clinical Affairs Project Manager|2624095722|kevin.r.siewert@ge.com|
316118|NCT03617523|Sanofi Pasteur Inc.|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
316119|NCT03617588|Theragnostics Ltd|Director of Clinical Operations|+44 330 606 7437|archie.hale@theragnostics.com|
316120|NCT03617770|University of Illinois at Chicago|Dr. Pamela Martyn-Nemeth|3129967903|pmartyn@uic.edu|
316121|NCT03617861|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
316122|NCT03617913|Mayo Clinic|Parminder Singh, MD|5072555123|Singh.Parminder@mayo.edu|
316123|NCT03618017|University of Michigan Rogel Cancer Center|Lauren Wallner, Ph.D.|734-232-0788|lwallner@med.umich.edu|
316124|NCT03618030|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|Sailaja.Bhaskar@ImbriumThera.com|
316125|NCT03618147|Kuwait Society of Allergy & Clinical Immunology|Kuwait Society of Allergy & Clinical Immunology|0096524636478|walherz@hsc.edu.kw|
316126|NCT03618420|University of Colorado School of Medicine|Petter Bjornstad, M.D., Assistant Professor of Pediatrics and Medicine|7207774659|petter.bjornstad@childrenscolorado.org|
316127|NCT03618628|Washington University School of Medicine|Dr. Mary Hastings|3142861433|hastingsmk@wustl.edu|
316128|NCT03618641|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
316129|NCT03618823|UPMC Children's Hospital of Pittsbugh|Senior Research Associate|1412-692-9879|nelsonjl2@upmc.edu|
316130|NCT03619135|University of Iowa College of Dentistry|Dr. Kyle Stein|319-384-5105|kyle-stein@uiowa.edu|
316131|NCT03619590|GlaxoSmithKline|GSK Response Center|866-435-7343|sk994601@gsk.com|
316132|NCT03619811|UCSD|Clinical Research Coordinator|858-246-5236|mgreytak@ucsd.edu|
316133|NCT03619837|University of Southern California|Norah Terrault|323-442-5100|terrault@usc.edu|
316134|NCT03619889|Universidad Complutense de Madrid|Dra. Gema Serrano-Hernanz|669332986|gema.serrano.hernanz@gmail.com, gemase01@ucm.es|
316135|NCT03620162|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
316136|NCT03620383|Oregon Health & Science University|Ramsey Al-Hakim, MD|503-494-7660|alhakim@ohsu.edu|
316137|NCT03620708|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
316138|NCT03620890|The University of Texas Health Science Center at Houston|Michal Fishel Bartal, MD, Assistant Professor|713-500-6421|Michal.F.Bartal@uth.tmc.edu|
316139|NCT03621085|University of Texas Southwestern Medical Center|Dr. Craig Crandall|2143454623|craigcrandall@texashealth.org|
316140|NCT03621189|Chang Gung Memorial Hospital|Dr. Hsing Chang Ni|886975365663|alanni0918@yahoo.com.tw|
316141|NCT03621202|Saranas, Inc.|Zaffer Syed|833-375-9273|zaffer@saranas.com|
316142|NCT03621787|co-PI|Kathleen Sienko|734647249|sienko@umich.edu|
316143|NCT03621878|imam abdulrahman bin faisal university|Mohammed Alghamdi|+966556852888|mohdg.ios@gmail.com|
316144|NCT03622112|AstraZeneca AB|Global Clinical Lead|301-398-5799|ClinicalTrialTransparency@astrazeneca.com|
316145|NCT03622619|Eye Research Group, SOVS, UNSW Sydney|Dr Jacqueline Tan|02 9385 6551|jacqueline.tan@unsw.edu.au|
316146|NCT03623035|Wake Forest Baptist Health|Christopher Edwards|3367168222|chedward@wakehealth.edu|
316147|NCT03623334|UT Southwestern Medical Center|Sarah Hardee|214-648-1836|sarah.hardee@utsouthwestern.edu|
316148|NCT03623698|Imperial College London|Mrs. Natalia Galaz Souza|07751842851|natalia.galaz-souza16@imperial.ac.uk|
316149|NCT03624192|AVITA Medical|VP, Clinical Research|661-367-9170|USClinicalTrials@avitamedical.com|
316150|NCT03624504|Medtronic (Shanghai) Management Co., Ltd.|Weifan Sun, Clinical Study Manager|021-20325267|weifan.sun@medtronic.com|86
316151|NCT03624920|Theranexus|Chief Medical Officer|+33680026779|werner.rein@theranexus.fr|
316152|NCT03624946|Emergent BioSolutions Canada Inc.|Jason Richardson, Senior Scientist, Clinical Research|204-275-4266|jrichardson@ebsi.com|
316153|NCT03624972|Fox Chase Cancer Center|Dr. Jennifer Reese, Associate Professor|215-214-3223|Jennifer.Reese@fccc.edu|
316154|NCT03626415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316155|NCT03626623|Integra LifeSciences|Allison Matthews|(443) 766-3869|allison.matthews@integralife.com|
316156|NCT03626714|Auritec|Sarjan Shah|9092109715|sshah@auritecpharma.com|
316157|NCT03627065|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
316158|NCT03627195|Sunovion Pharmaceuticals, Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
316159|NCT03627299|Johns Hopkins University|Christine Durand, MD|410-955-5684|ChristineDurand@jhmi.edu|
316160|NCT03627416|Jagiellonian University Medical College|Dr. Jakub Antczak|+48 795 421 153|jantczak@uj.edu.pl|
316161|NCT03627494|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
316162|NCT03627767|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316163|NCT03627832|University of Missouri|Dr. Mary Beth Miller|573-882-1813|millmary@health.missouri.edu|
316164|NCT03628417|Szeged University|Principal Investigator, Assistant Professor|+36-62-545-259|kis.erika.gabriella@med.u-szeged.hu|
316165|NCT03628456|International Biophysics Corporation|VP of Engineering and Quality|512-804-0046|quality@biophysicscorp.com|
316166|NCT03628508|The Hong Kong Polytechnic University|Dr Amy Fu|8522766 6726|amy.fu@polyu.edu.hk|
316167|NCT03628599|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
316168|NCT03628885|Indiana University|Dr. Gregory Zimet|3172748812|gzimet@iu.edu|
316169|NCT03628898|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
316170|NCT03628924|Janssen Research & Development, LLC|Product development portfolio leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
316171|NCT03629028|Principal investigator of the research|Şafak Yılmaz Baran, MD|+903224586868|safakyilmazbaran@gmail.com|
316172|NCT03629041|Innoture Ltd|Jemma Burridge, Clinical Project Manager|+44 (0)7799 902476|jburridge@innoture.co|
316173|NCT03629054|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316174|NCT03629184|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
316175|NCT03629249|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
316176|NCT03629535|NYU Langone Health|Greta Piper, MD|212-263-4778|Greta.Piper@nyulangone.org|
316177|NCT03629886|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
316178|NCT03629925|Innovent Biologics (Suzhou) Co., Ltd|YiBo|+86 13382419112|jessica.yi@innoventbio.com|
316179|NCT03630016|Owlet Baby Care, Inc.|Madison Kenley, CCRP, BS|801-552-8383|mkenley@owletcare.com|
316180|NCT03630185|The University of Texas Health Science Center at Houston|Stuart A Harlin, MD|713-486-5131|Stuart.A.Harlin@uth.tmc.edu|
316181|NCT03630198|Vanderbilt Univeristy Medical center|Dr. Brian Drolet|615-322-2918|brian.c.drolet@vumc.org|
316182|NCT03630302|Abbott neuromodulation|Erika Ross|972-526-8207|erika.ross@abbott.com|
316183|NCT03630679|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
316184|NCT03631355|NYU Langone Health Orthopedic Hospital|Dr. Michael J. Alaia|6465017223|michael.alaia@nyulangone.org|
316185|NCT03631433|OSU|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
316186|NCT03631732|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
316187|NCT03631927|Tata Memorial Hospital|Dr. Jigeeshu Divatia|+919869077435|jdivatia@yahoo.com|
316188|NCT03632083|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
316189|NCT03632109|University of Washington|Dr. Lindley Barbee, Principal Investigator|206.744.2595|lbarbee@u.washington.edu|
316190|NCT03632954|Integra LifeSciences|Allison Matthews|(443) 766-3869|allison.matthews@integralife.com|
316191|NCT03633084|Ribomic USA|Yusuf Ali, Ph.D.|(707) 287-4313|yusuf.ali@ribomic.com|
316192|NCT03633331|City of Hope Comprehensive Cancer Center|Mina S. Sedrak MD, MS|626-218-4173|msedrak@coh.org|
316193|NCT03633344|Omnifarma Kyiv LLC|Oleg Kurchenko|+380503319653|Kurchenko@omnifarma.kiev.ua|
316194|NCT03633448|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
316195|NCT03633487|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
316196|NCT03633526|Vertex Pharmaceuticals Incorporated|Medical Monitor|+1 617 341 6777|medicalinfo@vrtx.com|
316197|NCT03633825|Harvard University|Principal Investigator|617-496-4484|jaroszewski@fas.harvard.edu|
316198|NCT03633903|Laureate Institute for Brain Research|Namik Kirlic, PhD|918-502-5747|nkirlic@laureateinstitute.org|
316199|NCT03633929|Biomedical Development Corporation|Gregg Siegel|2108638053|gsiegel@biodevcorp.com|
316200|NCT03634085|Venn Life Sciences|Simone van Broekhoven / Clinical Trial Manager|+310765480625|simone.vanbroekhoven@vennlife.com|
316201|NCT03634306|Mercy Hospital St. Louis|David Levine, MD|314-251-7650|David.Levine@Mercy.net|
316202|NCT03634579|Emory University|Sherif Nour|404-778-3800|sherif.nour@emoryhealthcare.org|
316203|NCT03634800|Weill Cornell Medicine|Dr. Himanshu Nagar|212-746-3704|hnagar@med.cornell.edu|
316204|NCT03634813|Yale School of Medicine|Robert B. Schonberger, Director of Clinical Scientist Track Program|203-785-3941|robert.schonberger@yale.edu|
316205|NCT03635086|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
316206|NCT03635320|Johnson & Johnson Medical (Shanghai) Ltd.|Jie, Zhou|+86 18600551010|JZHOU138@its.jnj.com|
316207|NCT03635424|Medtronic Coronary and Structural Heart Clinical|Hatice Bilgic Lim, PhD; Principal Clinical Research Specialist|763-526-1018|hatice.bilgic.lim@medtronic.com|
316208|NCT03635775|University of Wisconsin Madison|Bernadette Gillick|612-625-3645|bgillick@wisc.edu|
316209|NCT03635957|Horizon Therapeutics Ireland DAC|Paul Peloso, MD|866-479-6742|clinicaltrials@horizontherapeutics.com|
316210|NCT03636061|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
316211|NCT03636386|Universidad Andrés Bello|Professor Hernán Andrés de la Barra Ortiz|+56984706322|quiropraxiayequilibrio@gmail.com|
316212|NCT03636893|RUIJIN HOSPITAL|Dr BIRENDRA KUMAR SAH|0086-64370045|rjsurgeon@hotmail.com|671302
316213|NCT03637296|New York State Psychiatric Institute|Thomas Smith, MD|(646)774-8442|thomas.smith@nyspi.columbia.edu|
282574|NCT00861692|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
316214|NCT03637348|Cornea Research Foundation of America|Marianne Price, PhD|3178142990|mprice@cornea.org|
316215|NCT03637517|Medicines for Malaria Venture|Stephan Chalon, MD|+41 22 555 0369|chalons@mmv.org|
316216|NCT03637699|Brigham and Women's Hospital|Bonnie Glanz, PhD|617-525-6574|bglanz@bwh.harvard.edu|
316217|NCT03637842|New York State Psychiatric Institute|Christina Brezing, MD|6467748181|christina.brezing@nyspi.columbia.edu|
316218|NCT03638011|Maimonides Medical Center|Dr Dennis Feierman|718-283-6000|dfeierman@maimonidesmed.org|7703
316219|NCT03638323|Groupe Hospitalier de la Rochelle Ré Aunis|Marie-Laure Vignaud, neuropsychologist|+33 (0)5 46 45 63 70|marie-laure.vignaud@ght-atlantique17.fr|
316220|NCT03638622|Massachusetts General Hospital, Boston|Tayyaba Hasan|617-726-6996|thasan@mgh.harvard.edu|
316221|NCT03638635|Inova Health System|Erica Emery|703-776-7615|erica.emery@inova.org|
316222|NCT03638908|UTSouthwestern medical center|Kelly Chin, MD|2146456493|kelly.chin@utsouthwestern.edu|
316223|NCT03639311|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
316224|NCT03639675|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
316225|NCT03639766|University of Central Florida|Dr. David Weinstein|(407)266-4900|david.weinstein@ucf.edu|
316226|NCT03639779|University of Central Florida College of Medicine|Dr. David Weinstein|(407)266-4900|david.weinstein@ucf.edu|
316227|NCT03639857|University of Central Florida College of Medicine|Dr. David Weinstein|407-266-4900|david.weinstein@ucf.edu|
316228|NCT03639987|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
316229|NCT03640052|Brigham and Women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
316230|NCT03640507|Beth Israel Deaconess Medical Center|Cassandra R. Duffy, MD, MPH|617-667-2636|cduffy3@bidmc.harvard.edu|
316231|NCT03640559|Pharmasyntez|Mikhail Shurygin|+7 3952 550 355|m.shurygin@pharmasyntez.com|189
316232|NCT03640832|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
316233|NCT03641508|University of Iowa|Dr. Ericka Lawler|3193563943|ericka-lawler@uiowa.edu|
316234|NCT03641716|University of Pittsburgh|Dr. Angela Caldwell|412-383-7231|arl78@pitt.edu|
316235|NCT03642262|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
316236|NCT03642457|Icahn School of Medicine at Mount Sinai|Poonam Pai|347-569-4816|poonam.paibantwalhebbalasankatte@mountsinai.org|
316237|NCT03642717|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316238|NCT03642873|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
316239|NCT03643432|Oxford University Hospitals NHS FT|Jon Room|01865737526|jonathan.room@ouh.nhs.uk|
316240|NCT03643575|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
316241|NCT03643692|Imperial College London|Nick Oliver|02033111093|nick.oliver@imperial.ac.uk|
316242|NCT03643952|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
316243|NCT03644095|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
316244|NCT03644108|Reckitt Benckiser, Inc|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
316245|NCT03644173|Hackensack meridian Health|Manager, Investigator Initiated Research Program|5519961244|Elli.GournaPaleoudis@hmhn.org|
316246|NCT03644212|Maimonides Medical Center|Sara Meeder|7182837253|smeeder@maimonidesmed.org|
316247|NCT03645421|AstraZeneca|Global Clinical Lead|+13028851180|ClinicalTrialTransparency@astrazeneca.com|
316248|NCT03645434|AstraZeneca AB|AstraZeneca AB|1-877-400-4656|clinicaltrialtransparency@astrazeneca.com|
316249|NCT03645785|Albany Medical Center|Vikas Bhatt|5182623341|bhattv@amc.edu|
316250|NCT03645811|University of Health Science|Dr. Demet İnangil|+905303021160|demet.inangil@sbu.edu.tr|
316251|NCT03645954|Lithuanian Univrsity of Health Sciences|Principal Investigator Inna Jaremko|+37064857386|inna.jaremko@kaunoklinikos.lt|
316252|NCT03646305|York University|Keisha C. Gobin, MA|416-736-2100|kgobin@yorku.ca|33153
316253|NCT03646656|Department of Veterans Administration|Dr. Karen Goldstein|919.826.0411|karen.goldstein@va.gov|1707764
316254|NCT03647033|National University Hospital|Dr. David Chen|+6594550281|david_chen@nuhs.edu.sg|
316255|NCT03647046|University of Rochester|Study Coordinator|(585) 276-6922|keratoconusstudy@gmail.com|
316256|NCT03647267|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
316257|NCT03647475|Medtronic Coronary/Renal Denervation (C/RDN)|Cecile Mahoney, Sr. Clinical Research Specialist|763-505-1057|cecile.c.mahoney@medtronic.com|
316258|NCT03647709|St Elizabeth Medical Center|Dr Andrew Wickline|315-735-4496|awickline23@gmail.com|
316259|NCT03648853|UCalifornia San Francisco|Pekka Talke|415 306 3602|pekka.talke@ucsf.edu|
316260|NCT03648879|National Cancer Institute|Dr. Jeremy L. Davis|240-760-6229|jeremy.davis@nih.gov|
316261|NCT03649412|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
316262|NCT03649477|Levo Therapeutics|Vice President of Clinical Development|1-847-901-9260|contactus@levotx.com|
316263|NCT03649646|Boryung Pharm. CO., LTD|Myung Sook Hong|82-2-708-8238|mshong@boryung.co.kr|
316264|NCT03649750|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
316265|NCT03649815|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
316266|NCT03649867|NHS Tayside - Dundee Adult Psychological Therapies Service|Dr Lucie Bartoskova|00441382346556|lucie.bartoskova@nhs.net|
316267|NCT03649932|University of Texas Medical Branch|Dr. Sunil Jain|4097722815|amnahqasim@gmail.com|
316268|NCT03650192|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
316269|NCT03650387|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|Aesthetic.Trials@merz.com|
316270|NCT03650400|Novartis Pharmaceuticals|Study Director|882 778 8300|Novartis.email@Novartis.com|
316271|NCT03650452|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
316272|NCT03650842|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-5817|Joseph.Tobias@nationwidechildrens.org|
316273|NCT03651479|Eastern Mediterranean University|Asst. Prof. Dr. Gozde Iyigun|+903926303011|gozde.iyigun@emu.edu.tr|
316274|NCT03651856|Medical University of SC|Dr. Gonzalo Revuelta|843-792-7262|revuelta@musc.edu|
316275|NCT03652610|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
316276|NCT03652662|MUSC|Sarah Miller, PhD, RN|8427921692|millesar@musc.edu|
316277|NCT03652675|Columbia University / New York State Psychiatric Institute|Jennifer C Elliott, PhD|646 774 7953|jce2130@cumc.columbia.edu|
316278|NCT03652818|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
316279|NCT03653026|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
316280|NCT03653208|ImmuneMed Inc.|Byoungok Ahn|+82-2-527-8391|ahnbo@immunemed.co.kr|
316281|NCT03653351|Washington University in Saint Louis|Eric Lenze MD|314-362-5154|lenzee@wustl.edu|
316282|NCT03653416|Icahn School of Medicine at Mount Sinai|Poonam Pai B. H|347-569-4816|poonam.paibantwalhebbalasankatte@mountsinai.org|
316283|NCT03653429|Icahn School of Medicine at Mount Sinai|Poonam Pai B. H|212-523-4000|poonam.paibantwalhebbalasankatte@mountsinai.org|
316284|NCT03654326|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
316285|NCT03654417|Duke University|Dr. Laura Havrilesky|(919) 684-0188|laura.havrilesky@duke.edu|
316286|NCT03654560|United Health Products, Inc.|Gerard Abate, MD Chief Medical Officer|(386) 627-1598|G.Abate@unitedhealthproductsinc.com|
316287|NCT03655054|Valencia Technologies|Jacqueline Dister|7604294787|jdister@valenciatechnologies.com|
316288|NCT03655080|Washington University School of Medicine|Hiram A. Gay, M.D.|314-362-8516|hiramgay@wustl.edu|
316289|NCT03655106|William Beaumont Hospitals|Amit Bahl, MD|2488982245|amit.bahl@beaumont.edu|
316290|NCT03655301|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
316291|NCT03655405|a. Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland|Dr Anne Niquille|+41213144845|anne.niquille@unisante.ch|
316292|NCT03655444|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
316293|NCT03655951|innovation Research & Training|Dr. Tracy Scull|919-493--7700|tscull@irtinc.us|118
316294|NCT03656939|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316295|NCT03657095|Lung Biotechnology PBC Study Director|Lung Biotechnology PBC|301-608-9292|info@lungbiotechnology.com|
316296|NCT03657134|NYU Langone Health|Lior Jankelson, MD, PhD|212-263-7149|Lior.Jankelson@nyulangone.org|
316297|NCT03657264|Guerbet|Jing Hao, MD|+33145915000|jing.hao@guerbet.com|
316298|NCT03657277|University of Iowa|Nicole Brogden|3193358752|nicole-brogden@uiowa.edu|
316299|NCT03657407|University of Maryland Medical Center|Anna Reinert, MD|6029089960|anna.reinert@gmail.com|
316300|NCT03658811|Toyos Clinic|Dillon O'Brien|6153274015|dobrien@toyosclinic.com|6
316301|NCT03658876|Imperial Healthcare NHS Trust|Dr Damien Ashby||d.ashby@imperial.ac.uk|
316302|NCT03658889|ChugaiPF|Isabelle Idier, Rheumatology Medical Leader|+33 (0) 1 56 37 44 89|idier@chugai-pharm.fr|
316303|NCT03660241|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316304|NCT03660787|Pharmasyntez|Mikhail Shurygin|+7 3952 550 355|m.shurygin@pharmasyntez.com|1150
316305|NCT03660839|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
316306|NCT03661346|University of Texas Medical Branch - Galveston|Dr. Mohamad Chaaban|281-338-0829|mrchaaba@UTMB.EDU|
316307|NCT03661541|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
316308|NCT03661697|University of Miami|Lisa D Grunebaum MD|3052433223|lgrunebaum@med.miami.edu|
316309|NCT03661762|Norfolk and Norwich University Hospitals NHS Foundation Trust|Mr John Phillips|: +44 1603 593054|john.phillips@mac.com|
316310|NCT03661814|Icahn School of Medicine at Mount Sinai|Dr. Joel Bauer|914-715-4242|jjb.msh@gmail.com|
316311|NCT03661983|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
316312|NCT03662074|Wake Forest Baptist Comprehensive Cancer Center|Study Nurse|336-716-0230|saverill@wakehealth.edu|
316313|NCT03662139|Department of PM&R, Marmara University School of Medicine|Naime Evrim Karadag-Saygi, Prof. Dr.|00902166570606|evrimkaradag4@hotmail.com|1628
282575|NCT00861744|GlaxoSmithKline|GSK Response Center|866-435-7343||
282576|NCT00861757|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
316314|NCT03662282|University of South Florida|Thao Ho|813-844-3437|tho1@usf.edu|
316315|NCT03662334|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
316316|NCT03662360|Clinica Luganese Moncucco|Dr. Med. Pio Fontana|0041919608712|pioeugenio.fontana@moncucco.ch|
316317|NCT03662750|Imperial College London|Prof Roland Veltkamp|020 3311 7296|r.veltkamp@imperial.ac.uk|
316318|NCT03662789|Oslo University Hospital|Dr. Lars Gullestad|0047 97644772|lars.gullestad@medisin.uio.no|
316319|NCT03662997|Molnlycke Health Care|David Pham|678-231-9655|david.pham@molnlycke.com|
316320|NCT03663101|Ipsen Innovation SAS|Medical Director|see email|clinical.trials@ipsen.com|
316321|NCT03663179|University of Pennsylvania|Leah Bernardo|2157467162|lleah@pennmedicine.upenn.edu|
316322|NCT03663231|University of Rochester|Ralph Saunders|585-275-1141|ralph_saunders@urmc.rochester.edu|
316323|NCT03663283|Mayo Clinic|Steven J. Hattrup, M.D.|480-301-8519|hattrup.steven@mayo.edu|
316324|NCT03663569|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316325|NCT03663582|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
316326|NCT03663816|University of Florica|Sharareh Sharififar|352-273-7410|sharareh75@phhp.ufl.edu|
282577|NCT00861913|Karmanos Cancer Institute, Wayne State University|Amy M. Weise, D. O.|313-576-8952||
282578|NCT00862082|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
282579|NCT00862121|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
282580|NCT00862134|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
305474|NCT02335294|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
305475|NCT02335346|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
305476|NCT02335450|Oakland University|Beth Black|248-364-8694|bblack@oakland.edu|
305477|NCT02335489|St. Jude Medical|Roni Diaz|+1 972 309 8601|rdiaz@sjm.com|
305478|NCT02335502|St. Jude Medical|Roni Diaz|+19723098601|RDiaz@sjm.com|
305479|NCT02335658|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
305480|NCT02335710|University of Tennessee|Richard D. Komistek, Ph. D.|8659742093|rkomiste@utk.edu|
305481|NCT02335905|Baylor College of Medicine|Sheldon L. Kaplan|832-824-4330|skaplan@bcm.edu|
305482|NCT02335983|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
305483|NCT02336074|Imperial College London|Professor Sarah Fidler|004420331|s.fidler@imperial.ac.uk|26790
305484|NCT02336165|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@lcr.org|
305485|NCT02336178|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
305486|NCT02336282|St. Jude Children's Research Hospital|Kevin Krull, PhD|(901) 595-5891|kevin.krull@stjude.org|
305487|NCT02336360|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
305488|NCT02336373|Baylor College of Medicine|Vivien Sheehan, MD, PhD|(832) 824-4459|vxsheeha@txch.org|
305489|NCT02336438|Bassett Healthcare Network|Dr. Amy Freeth|607-547-3273|amy.freeth@bassett.org|
305490|NCT02336451|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
305491|NCT02336555|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305492|NCT02336594|Study Information Center AstraZeneca|Jesse Hall, MD|+1 877-240-9479|information.center@astrazeneca.com|
305493|NCT02336607|Astrazeneca|BP of Astrazeneca|+86 21 60302288|aztrial_results_posting@astrazeneca.com|
305494|NCT02336737|Endomag|Clinical Develoment Director|+44 7851 247439|mwomack@endomag.com|
305495|NCT02336815|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
305496|NCT02336958|Helios Kliniken Schwerin|Dr. med. Ronald Seidel|0049 (0)385 5204251|ronald.seidel@helios-kliniken.de|
305497|NCT02337062|Acacia Pharma Ltd|Dr Gabriel Fox|44-(0)1223-919764|GabrielFox@acaciapharma.com|
305498|NCT02337218|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
305499|NCT02337361|Public Health Institute/Alcohol Research Group|Madhabika B. Nayak|510-898-5849|mnayak@arg.org|
305500|NCT02337387|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
305501|NCT02337465|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Ping Xia|1-866-223-8100|TaussigResearch@ccf.org|
305502|NCT02337478|Wake Forest University Health Sciences|Timothy Pardee, MD, Ph.D.|336-716-5440|tpardee@wakehealth.edu|
305503|NCT02337491|Dana-Farber Cancer Institute|David A. Reardon, MD|617-632-2166|dreardon3@partners.org|
305504|NCT02337517|HCI Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
305505|NCT02337530|Canadian Cancer Trials Group|Lesely Seymour|6135336430|lseymour@ctg.queensu.ca|
305506|NCT02337725|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305507|NCT02337738|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305508|NCT02337751|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305509|NCT02337764|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305510|NCT02337907|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
305511|NCT02337933|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
305512|NCT02337946|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305513|NCT02337959|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
305514|NCT02338076|Rockefeller University|Dr. Emma Guttman|212-327-8333|skhattri@rockefeller.edu|
305515|NCT02338154|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
282581|NCT00862186|Seattle Children's Hospital|Catherine Fiona Macpherson, PhD|206-987-2032|catherine.macpherson@seattlechildrens.org|
316327|NCT03664193|Weill Cornell Medicine|Josephine Kang|212-746-3607|jok9106@med.cornell.edu|
316328|NCT03664544|Mitsubishi Tanabe Pharma Europe Ltd|General Information|Please e-mail|regulatory@mt-pharma-eu.com|
316329|NCT03665155|Memorial Sloan Kettering Cancer Center|Jason Lewis, PhD|314-276-1830|lewisj2@mskcc.org|
316330|NCT03666026|UCLA|Principal Investigator|(310) 206-6328|pszilagyi@mednet.ucla.edu|
316331|NCT03666663|UCSF|Dr.Nina Riggins|7028064831|Nina.Riggins7@gmail.com|
282582|NCT00862277|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
316332|NCT03666858|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
316333|NCT03667053|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
316334|NCT03667547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
316335|NCT03668600|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
316336|NCT03668613|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
316337|NCT03669081|University of Utah|Eryberto Martinez|801-581-2563|eddie.martinez@utah.edu|
316338|NCT03669354|Southern California University Of Health Sciences|Anupama Kizhakkeveettil|(562) 475-5158|anu@scuhs.edu|
316339|NCT03669549|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
316340|NCT03669861|Massachusetts General Hospital|DRAI Director of Clinical Trials|6176920668|JHSTONE@mgh.harvard.edu|
282583|NCT00862446|Vanderbilt University Medical Center|William Walsh|615-322-3476|bill.walsh@vumc.org|
316341|NCT03670017|Washington University School of Medicine|Grant Bochicchio, Harry Edison Professor of Surgery, Chief of Acute and Critical Care Surgery|314-362-9347|gbochicchio@wustl.edu|
316342|NCT03670030|Ochsner Medical Center|Robert Ramirez, DO|504-464-8500|awendt@ochsner.org|
316343|NCT03670160|University of Tennessee Medical Center|Janet Parkey, Director - Research Compliance|865-305-6194|jparkey@utmck.edu|
316344|NCT03670264|Children's Hospital of Philadelphia|Dr. Brian Jenssen|215-554-4390|jenssenb@chop.edu|
316345|NCT03670537|Auerbach Hematology and Oncology|Michael Auerbach|4107804050|mauerbachmd@abhemonc.com|
316346|NCT03670641|University of Pittsburgh Medical Center (UPMC)|David Rometo, MD|412-586-9700|rometoda@upmc.edu|
316347|NCT03670810|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
316348|NCT03672006|Medical College of Wisconsin|Dr. Shelia Hanson|414-266-3728|shanson@mcw.edu|
282584|NCT00862459|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
316349|NCT03672032|University of Iowa Hospitals and Clinics|Dr. Henning Gerke|319-384-6582|henning-gerke@uiowa.edu|
316350|NCT03672097|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
316351|NCT03672370|Zimmer Biomet|Clinical Project Lead, Sandra Rosser|+41 (0)58 854 84 09|sandra.rosser@zimmerbiomet.com|
316352|NCT03672396|University of North Carolina at Chapel Hill|Erik Hanson, PhD|19199620816|edhanson@email.unc.edu|
316353|NCT03673670|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|9147675037
316354|NCT03674177|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
282585|NCT00862537|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303 795-3222|abraswell@pico-tesla.com|
282586|NCT00862563|Department of Psychiatry, Boston Univ School of Medicine|Dr. Domenic A Ciraulo, Professor|617-414-1990|dciraulo@bu.edu|
316355|NCT03674281|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
316356|NCT03674970|Penn State College of Medicine|Patricia Sue Grigson|717-531-5772|pgrigsonkennedy@pennstatehealth.psu.edu|
316357|NCT03675451|Weill Cornell Medicine|Junaid Niaz|212.746.5793|mjn3001@med.cornell.edu|
316358|NCT03675581|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316359|NCT03675685|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
316360|NCT03675776|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
316361|NCT03676270|Institut Bergonié|Pr Antoine Italiano|335 56333333|a.italiano@bordeaux.unicancer.fr|
316362|NCT03676634|California Department of Public Health|Stephen S. Arnon, M.D., M.P.H., Chief, Infant Botulism Treatment and Prevention Program|510-231-7600|Stephen.Arnon@cdph.ca.gov|
316363|NCT03676725|AlkaliDx|Lynn Feldman|16178791670|lynn@alkalidx.com|
316364|NCT03676803|UCLA Center for Human Nutrition|Zhaoping Li, MD, PhD|310-206-1987|zli@medent.ucla.edu|
316365|NCT03676972|Peking University Third Hospital|Dr. Lulin Ma|13701010872|malulin@medmail.com.cn|+86
316366|NCT03677089|Massachusetts General Hospital - Clinical Coordinating Center|Dr. Karen Kuhlthau|617-724-2842|KKUHLTHAU@PARTNERS.ORG|
316367|NCT03677245|University of Mississippi Medical Center|Dr. Meredith Flowers|662-386-5926|mmflowers@umc.edu|
316368|NCT03677375|Masimo|Tala Harake|9492977000|studies@masimo.com|
316369|NCT03677401|Menlo Therapeutics, Inc.|Iain Stuart|1-800-775-7936|Iain.Stuart@foamix.com|
316370|NCT03677869|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
316371|NCT03678103|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
316372|NCT03678285|University of Wyoming|Dr. Evan Johnson|307-766-5282|ejohns54@uwyo.edu|
316373|NCT03678311|Cleveland Clinic|Dr. Reena Mehra|216-444-2165|mehrar@ccf.org|
316374|NCT03678870|Vanderbilt University Medical Center|Sarah Osmundson, Assistant Professor of Obstetrics and Gynecology|(615) 343-7869‬|sarah.osmundson@vumc.org|
316375|NCT03679494|Taipei MU|MS. Po-Yao Chiu|+886-2-27361661|m437106006@tmu.edu.tw|6311
316376|NCT03679741|Johnson & Johnson Vision Care|John Buch, O.D., M.S. Sr. Prinicpal Research Optometrist|904 443-1707|JBUCH@its.jnj.com|
316377|NCT03679975|Aquestive Therapeutics|Gary Slatko, Chief Medical Officer|908-941-7050|clinicaltrials@aquestive.com|
316378|NCT03680105|Reven Pharmaceuticals|Head, Global Clinical Affairs|13036691336|kristina.cabala@reven.com|
316379|NCT03680521|Mirati Therapeutics|Sr. Clinical Operations Trial Manager|858-332-3540|hallinm@mirati.com|
316380|NCT03680742|Cerus Endovascular|Lori E Adels, Ph.D.|510-651-4000|lori.adels@cerusendo.com|109
316381|NCT03681093|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
316382|NCT03681119|NYU Langone Health|Abraham Brody, PhD, RN, FAAN|212-992-7341|Abraham.Brody@nyulangone.org|
316383|NCT03681353|Duke University Medical Center|Angela Kirby, MS|919-286-0411|angela.kirby@duke.edu|175526
316384|NCT03681405|Wake Forest Baptist Comprehensive Cancer Center|Meg O'Mara|336-716-9055|megreen@wakehealth.edu|
316385|NCT03681808|Bausch & Lomb|Study Director|585-338-6399|Robert.Steffen@bausch.com|
316386|NCT03681886|Alcon, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
316387|NCT03681951|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
316388|NCT03682107|Cincinnati Children's Hospital|Dr. Grant Paulsen|513-636-4578|Grant.Paulsen@cchmc.org|
316389|NCT03682120|St Louis University School of Medicine|Sharon Frey, MD|314-997-5500|sharon.frey@health.slu.edu|
316390|NCT03682302|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
316391|NCT03682705|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
316392|NCT03682809|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
316393|NCT03682965|Pharma Initiatives|Mark Shapiro|9193063675|mshapiro@pharmainitiatives.com|
316394|NCT03683576|GB001, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|Gossamer Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
316395|NCT03683719|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
316396|NCT03683758|Mountain Health and Performance|Dr. Matthew Wentzell|6043566986|drwentzell@mountainhp.ca|
316397|NCT03683901|MetroHealth Rehabilitation Institute|Dr. Victoria Whitehair|216-778-4414|vwhitehair@metrohealth.org|
316398|NCT03684044|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
316399|NCT03684265|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316400|NCT03684642|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
316401|NCT03684928|CooperVision,Inc.|Jose A. Vega, O.D., MSc., FAAO|925 621 3761|javega@coopervision.com|
316402|NCT03685344|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|
316403|NCT03685396|Azienda Ospedaliera San Paolo - Università degli Studi di Milano|Dr.Fulvio Gatti|3396441920|fudy@libero.it|
316404|NCT03685643|University of Hong Kong|Dr Wong Chi Wai William|(852) 2518-5650|wongwcw@hku.hk|
316405|NCT03685968|The University of Texas Health Science Center at Houston (UTHealth)|Elizabeth M. Gendel|+1 (713) 500-3587|Elizabeth.M.Gendel@uth.tmc.edu|
316406|NCT03686033|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
316407|NCT03686176|Johns Hopkins University|Therese Canares|4109964711|tcanare1@jhmi.edu|
316408|NCT03687125|Mundipharma Research Limited|Terry Nichols|(0044)1223424444|terry.nichols@mundipharma-rd.eu|
316409|NCT03687372|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
316410|NCT03687450|Brigham and Women's Hospital|Julia Loewenthal, MD|6177325500|jloewenthal@bwh.harvard.edu|
316411|NCT03687684|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
282587|NCT00862641|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
282588|NCT00862654|Galderma|Farzi Sidou, Clinical Project Manager|+33 4 93 95 70 51|farzaneh.sidou@galderma.com|
282589|NCT00862719|IndianaU|Dr. Sherif Farag|317-944-0920|ssfarag@iu.edu|
305516|NCT02338193|Woman's Hospital|Dr Karen Elkind-Hirsch, Director of Research|225 231-5278|karen.elkind-hirsch@womans.org|
316412|NCT03687736|Q-Med AB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
316413|NCT03687827|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
316414|NCT03687970|Washington University|Simon Haroutounian, PhD. Assistant Professor,|314-286-1715|simon.haroutounian@wustl.edu|
316415|NCT03688282|TheraNova|Vice President of Research and Development|415-926-8616|clinicalstudy@theranova.com|
316416|NCT03688542|Community Pharmacy, Center for Primary Care and Public Health (Unisanté), University of Lausanne, Switzerland|Dr Anne Niquille|+41213144845|anne.niquille@unisante.ch|
316417|NCT03688620|GlaxoSmithKline|Enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccines|877-379-3718|GSKClinicalSupportHD@gsk.com|
316418|NCT03688685|Cadent Therapeutics (A Novartis Company)|Cadent Therapeutics (A Novartis Company)|1-888-669-6682|Novartis.email@novartis.com|
316419|NCT03688711|Zealand Pharma A/S|Dr Kim Mark Knudsen|+4550603780|KMKnudsen@zealandpharma.com|
316420|NCT03688880|Grünenthal GmbH|Grünenthal Clinical-Trials Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
316421|NCT03689452|Icahn School of Medicine at Mount Sinai|Dr. Danielle P. Dubin|212-731-3311|DPDubin121@gmail.com|
316422|NCT03689504|Wuqu' Kawoq|Peter Rohloff, Chief Medical Officer|011-502-4958-1253|peter@wuqukawoq.org|
316423|NCT03690375|Siperstein Dermatology Group|founder/physician|5613647774|info@sipderm.com|
316424|NCT03691779|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
316425|NCT03691831|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
316426|NCT03691844|Amzell B.V.|Clinical Trial Manager|+41614864000|amzell-disclosure@amzell.com|
316427|NCT03691948|Medical University of South Carolina|Jenna L. McCauley, PhD, Assistant Professor of Psychiatry|8437923922|mccaule@musc.edu|
316428|NCT03692676|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316429|NCT03693625|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
316430|NCT03693742|BC Cancer - Vancouver|Study Manager|(604) 877-6000,|hsaprunoff@bccancer.bc.ca|
316431|NCT03693937|Sensus Healthcare|Isabelle Raymond|561-922-5808|iraymond@sensushealthcare.com|
316432|NCT03693950|BIOCAD|Yulia Linkova Medical Director|+7 (495) 992 66 28 ext. 930|linkova@biocad.ru|
316433|NCT03693989|Laboratorios Sophia|Dr. Ricardo Llamas (clinical safety pharmacologist)|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
316434|NCT03694197|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
316435|NCT03694210|Interscope, Inc.|Alexis James Global Director of Clinical Affairs|508-847-9478|alexis.james@interscopemed.com|
316436|NCT03694275|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
316437|NCT03694548|Emory University|Dr. Nitya Bakshi|404-727-3149|nitya.bakshi@emory.edu|
316438|NCT03694613|Fundacion Santa Fe, Bogotá, Colombia|Dr. Sergio Lerma|+57 3017752726|serlerma@gmail.com|
316439|NCT03694925|Cleveland Clinic Arthroplasty Research Group|Alison Klika|4123017914|klikaa@ccf.org|
316440|NCT03695094|Cares|UCB|+1844 599|clinicaltrials@ucb.com|2273
316441|NCT03695367|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
316442|NCT03695393|Boston Medical Center and BU School of Medicine|Karsten Lunze, MD|617-638-6933|lunze@bu.edu|
316443|NCT03695913|University of Michigan|Spring Stonebraker|734-649-0219|sprstone@med.umich.edu|
316444|NCT03696108|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305517|NCT02338336|Norwarta|Peggy Hagerty|267-240-4010|hagertymws@comcast.net|
305518|NCT02338362|Department of Ophthalmology and Vision Sciences, University of Toronto, Toronto, Ontario, Canada|Dr. Graham Trope|1-416-603-5117|graham.trope@uhn.ca|
305519|NCT02338492|IlluminOss Medical Inc.|Gene DiPoto|401-714-0008|gdipoto@illuminoss.com|202
305520|NCT02338713|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305521|NCT02338843|La Jolla Pharmaceutical Company|George Tidmarsh, MD, PhD|858-207-4264|gtidmarsh@ljpc.com|
305522|NCT02338882|University of Plymouth|Dr Phillip Buckhurst|01752 588884|phillip.buckhurst@plymouth.ac.uk|
305523|NCT02338960|AMAG Pharmaceuticals|Medical Information|1-877-411-2510||
305524|NCT02338973|National Institutes of Health|Wadih Zein, MD, Principal Investigator, NEI|301-496-8118|zeinw@nei.nih.gov|
305525|NCT02338999|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Kaplan, Mariana|+1 301 496 0517|mariana.kaplan@nih.gov|
305526|NCT02339038|NIH Clinical Center|Masur, Henry|+1 301 496 9320|HMasur@cc.nih.gov|
305527|NCT02339155|GlaxoSmithKline|GSK Response Center|866-435-7343||
305528|NCT02339246|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
305529|NCT02339285|University of North Carolina at Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
305530|NCT02339389|Brigham and Women's Hospital|Bhavani Kodali|6175258449|bkodali@partners.org|
305531|NCT02339415|Hennepin Healthcare Research Institute|Jason Baker|612-873-2705|baker@umn.edu|
305532|NCT02339506|Brigham and Women's Hospital|Dr. Gail Kurr Adler|(617) 732-8742|gadler@bwh.harvard.edu|
305533|NCT02339545|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
305534|NCT02339558|Prince of Wales Hospital|Brigette B.Y. Ma|(852) 26321042|brigette@clo.cuhk.edu.hk|
305535|NCT02339584|Enter Alcon, A Novartis Division|Clinical Scientific Associate Director, GCRA, GDD|1-888-451-3937|alcon.medinfo@alcon.com|
305536|NCT02339831|Brigham and Women's Hospital|Wolfgang Fitz MD|617-732-9500|wfitz@partners.org|
282590|NCT00862745|University of California, San Francisco|Dr. Jeanette Brown|415-353-9751|brownj@obgyn.ucsf.edu|
282591|NCT00862784|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282592|NCT00862810|Duke University Health System|Emmanuel Walter MD, MPH|919-620-5346|walte002@mc.duke.edu|
282593|NCT00862823|University of Alabama at Birmingham|Jennifer King|205-934-2696|jenking@uab.edu|
282594|NCT00862836|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
282595|NCT00862849|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
282596|NCT00862940|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
282597|NCT00862979|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
316445|NCT03696342|Medical Affairs Operations Chief|Dr. Alejandra Sanchez-Rios|33 3001 4200|alejandra.sanchez@sophia.com.mx|1190
316446|NCT03696576|Emory University|Sandeep Shelly|404-686-4206|SSHELLY@emory.edu|
316447|NCT03696589|Teachers College, Columbia University|Lori Quinn|212-678-3424|lq2165@tc.columbia.edu|
316448|NCT03696758|UT Southwestern, Dallas, Texas|Dr. Kara Goss|214-648-6868|kara.goss@utsouthwestern.edu|
316449|NCT03697083|University of Pennsylvania|Katherine K. Milkman Ph.D.|215-573-9646|kmilkman@wharton.upenn.edu|
316450|NCT03697122|Duke University|Negmeldeen Mamoun, M.D.|919-681-3551|negmeldeen.mamoun@duke.edu|
316451|NCT03697252|Karuna Therapeutics, Inc.|Stephen Brannan|857-449-2234|sbrannan@karunatx.com|
316452|NCT03697460|Mayo Clinic|Aaron R. Mangold, M.D.|480-301-6479|Mangold.Aaron@mayo.edu|
316453|NCT03697993|Vaccine Treatment Evaluation Unit (VTEU)|Nadine Rouphael, MD, MSc|(404) 822-1411|nroupha@emory.edu|
316454|NCT03698279|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
282598|NCT00862992|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
305537|NCT02339909|Imperial College London|Colin Bicknell|02078866666|colin.bicknell@imperial.ac.uk|6072
305538|NCT02340000|Albany Medical College|Paul Sorum, MD|5182627500|sorump@mail.amc.edu|
305539|NCT02340078|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
305540|NCT02340091|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
305541|NCT02340104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
305542|NCT02340156|SynerGene Therapeutics, Inc.|Senior Consultant|301-706-1509|clinicaltrial@synergeneus.com|
305543|NCT02340299|Charité - Universitätsmedizin Berlin|PD Dr. Christoph Czernik, principal investigator|+49 30 450|christoph.czernik@charite.de|566122
305544|NCT02340338|Biomedizinische Forschungsgesellschaft mbH|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
305545|NCT02340520|UConn Health|Nausherwan Burki, MD||nburki@uchc.edu|
305546|NCT02340663|University of Michigan|Dr. Geoffrey Gerstner|734-763-7717|geger@umich.edu|
282599|NCT00863057|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
282600|NCT00863109|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
316455|NCT03698331|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
316456|NCT03698591|Duke University|Dr. Kevin LaBar, PhD.|(919)668-2424|klabar@duke.edu|
316457|NCT03699124|Bavarian Nordic A/S|Bavarian Nordic Call Center|1-844-422-8274|medical.information_us@bavarian-nordic.com|
316458|NCT03700320|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
316459|NCT03700372|FARAPULSE, Inc.|Christopher (Kit) Schneider Sr. Director of Clinical & Pre-Clinical Engineering|617-686-7661|cschneider@farapulse.com|
316460|NCT03700385|FARAPULSE, Inc.|Christopher (Kit) Schneider Sr. Director of Clinical & Pre-Clinical Engineering|617-686-7661|kschneider@farapulse.com|
316461|NCT03700671|University of Central Lancashire|Stefan Birkett Lecturer in Exercise Science|01772 893325|sbirkett4@uclan.ac.uk|
316462|NCT03700736|University of Connecticut|Dr. Molly Waring|860-486-1446|molly.waring@uconn.edu|
316463|NCT03700892|University of North Carolina at Chapel Hill, Center for Environmental Medicine Asthma and Lung Biology|Assistant Director of Clinical Research|919 966-5638|robinet@med.unc.edu|
316464|NCT03701061|Emory University|Nadine Rouphael|404-712-1435|nroupha@emory.edu|
316465|NCT03701074|University of South Alabama|Ramachandra Bhat|2514151055|rbhat@health.southalabama.edu; rambhat79@gmail.com|
316466|NCT03702010|Hospital Universitario de Salamanca|Dr. Francisco José Sánchez Montero|923291100|fjsmontero@saludcastillayleon.es|
316467|NCT03702166|UT Health San Antonio|John Moring, PhD|(210) 562-6716|moringj@uthscsa.edu|
316468|NCT03702608|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
316469|NCT03703336|POLYVAC|Nguyen Thuy Huong, Ph.D, Vice Director|+84 912514309|huong72us@yahoo.com|
316470|NCT03703466|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
316471|NCT03703817|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316472|NCT03704194|Washington university in St.louis|Brittany Minor|314-273-4118|bminor@wustl.edu|
316473|NCT03704376|The University of Texas Health Science Center at Houston|Lane Bailey, PhD, PT|713-704-6794|lane.bailey@uth.tmc.edu|
316474|NCT03704467|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
316475|NCT03705273|Vanderbilt University School of Medicine|Donald H. Arnold, MD, MPH|16155790516|don.arnold@vumc.org|
316476|NCT03705481|Corindus, Inc.|John Van Vleet, VP Clinical and Regulatory Affairs|260-615-8892|john.vanvleet@corindus.com|
316477|NCT03705494|The University of Hong Kong|Dr Kris LOK|39176690|krislok@hku.hk|
316478|NCT03705793|Washington University in St. Louis|Pawina JIramongkolchai, MD|314-362-5296|pawina@wustl.edu|
316479|NCT03706040|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
316480|NCT03706313|Duke University|Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
316481|NCT03706456|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
316482|NCT03706469|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
316483|NCT03707041|Medicines for Malaria Venture|Andrew Slade|+41 22 555 0415|sladea@mmv.org|
316484|NCT03707522|University of Nevada, Reno|Martha Zimmermann|7756368067|mzimmermann@nevada.unr.edu|
316485|NCT03707587|National Cancer Institute|Dr. Scott Norberg|301-275-9668|scott.norberg@nih.gov|
316486|NCT03707821|Johnson & Johnson VIsion|John Buch OD, MS, FAAO Sr. Principal Research Optometrist|9044431707|JBUCH@its.jnj.com|
316487|NCT03707912|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
316488|NCT03708211|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
316489|NCT03708367|Johnson & Johnson Surgical Vision|Sanjeev Kasthurirangan, PhD|+1 408 5335282|skasthur@ITS.JNJ.com|
316490|NCT03708393|Seno Medical|Shaan Schaeffer VP of Clinical Operations|610-698-3259|sschaeffer@senomedical.com|
316491|NCT03708562|Becton Dickinson (BPV)|Courtney Rothwell|480-350-6037|courtney.rothwell@bd.com|
316492|NCT03708744|Zosano Pharma Corporation|Dr. Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
316493|NCT03708770|Becton Dickinson (BPV)|Courtney Rothwell|480.350.6037|courtney.rothwell@bd.com|
316494|NCT03709602|Duke University|Dr. Lisa Mansfield|919-681-9198|lisa.mansfield@duke.edu|
316495|NCT03709654|Naked Biome|Emma Taylor, MD CEO|626-260-1230|emma.t@nakedbiome.com|
316496|NCT03709810|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
316497|NCT03709823|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
316498|NCT03710083|Medtronic Minimed|Vivian Chen, Statistician|8185763309|vivian.chen@medtronic.com|
316499|NCT03710161|University of Nebraska Medical Center|Dr. Laura Graeff-Armas|402-559-6310|laura.armas@unmc.edu|
316500|NCT03710187|University of Tennessee Medical Center|Pharm D, Pharmacist Specialist, Critical Care|865-305-9134|swinters@utmck.edu|
316501|NCT03710577|Univerisity of Wisconsin-Madison|Dr. Kelli Koltyn|608-262-4234|koltyn@education.wisc.edu|
316502|NCT03710590|Virginia Commonwealth University|Dr. Alison Breland|804 628 2300|abbrelan@vcu.edu|
316503|NCT03710889|Radius Health, Inc.|Associate Director, Clinical Operations|(617) 551-4000|info@radiuspharm.com|
316504|NCT03711396|University of Colorado School of Medicine|Dr. Hillary D. Lum|303-724-1911|hillary.lum@cuanschutz.edu|
316505|NCT03711578|Rhizen Pharmaceuticals|Prajak Barde MD|+41325800175|pjb@rhizen.com|
316506|NCT03712189|Children's Hospital Los Angeles|Dr Todd P Chang|13233612109|tochang@chla.usc.edu|
316507|NCT03712280|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
316508|NCT03712449|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
316509|NCT03712852|Università degli studi G. D'ANNUNZIO|Prof. Michele Paolantonio|3395204073|mpaolantonio@unich.it|
316510|NCT03712917|Ataturk University|Mustafa Ceylan|+905062773216|drmuson16@hotmail.com|
282601|NCT00863122|Johns Hopkins School of Medicine|Jaishri Blakeley|410-955-6827|jblakel3@jhmi.edu|
282602|NCT00863265|Washington University School of Medicine|Richard E. Ostlund MD|314-362-3516|rostlund@wustl.edu|
282603|NCT00863304|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282604|NCT00863317|Richmond Emergency Physicians Inc|Frank Petruzella|773 447-2489|fpetruzella@gmail.com|
282605|NCT00863343|Meso Scale Diagnostics, LLC.|Dennis Mertz, Director Regulatory and Clinical Affairs|240 631-2522|dmertz@mesoscale.com|2809
316511|NCT03712930|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
316512|NCT03713398|University of North Carolina at Chapel Hill|Amy Wilson, PhD|919-962-3598|amyblank@email.unc.edu|
316513|NCT03714022|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
316514|NCT03714256|Permobil|Vice President of Research and Innovation|+46703836763|karin.leire@permobil.com|
316515|NCT03714659|New Jersey Regenerative Institute|Dr. Gerard Malanga|9739988301|gmalangamd@hotmail.com|
316516|NCT03714672|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
316517|NCT03714919|Nationwide Children's Hospital|Arlyne Thung, MD|614-722-4200|Arlyne.Thung@nationwidechildrens.org|
316518|NCT03715426|University of Michigan|Michelle Munro-Kramer|734-904-4600|mlmunro@umich.edu|
316519|NCT03715452|Osprey Medical, Inc.|Vice President of Clinical Affairs|952.955.8236|kknish@ospreymed.com|
316520|NCT03715530|University of Iowa|Dr. Mark Santillan|319-356-3180|mark-santillan@uiowa.edu|
316521|NCT03715803|Universidad de Buenos Aires|Dr. Agustín Sampietro|+5491158336327|asampietro@live.com.ar|
316522|NCT03716024|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
271682|NCT00257166|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316523|NCT03716050|Wake Forest Baptist Health|Ivo Pestana|336-716-4171|ipestana@wakehealth.edu|
316524|NCT03716076|BC Women's Hospital|Dr. Anthony Chau|604-875-2158|anton.chau@ubc.ca|
316525|NCT03717012|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316526|NCT03717051|University of Hong Kong|Dr. Derek Cheung|39176652|derekcheung@hku.hk|
316527|NCT03717064|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
316528|NCT03717155|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
316529|NCT03717506|Gage Development Company|Gage Development Clinical Trials|1-847-999-0600|clinicalinfo@capstonedevservices.com|
316530|NCT03718000|University of Georgia|Dr. Jamie Cooper, Associate Professor|706-542-4903|jamie.cooper@uga.edu|
316531|NCT03718871|Weill Cornell Medicine|Dr. Radhika Sundararajan|(646) 962-4654|ras9199@med.cornell.edu|
316532|NCT03719300|Anchiano Therapeutics, Israel Ltd.1 Kendall Square, Building 1400, Suite 105 Cambridge, MA 02139|David Kerstein, M.D.,Chief Medical Officer|857-259-4626|David.Kerstein@anchiano.com|
316533|NCT03719378|Colorado Joint Replacement|Rose Johnson, CCRP Research Lead|3032602940|roseannjohnson@centura.org|
316534|NCT03719586|NIAID/NIH|Dr. Richard T. Davey, Jr., M.D., U.S. study PI|301-496-8029|rdavey@niaid.nih.gov|
316535|NCT03719612|Lantheus Medical Imaging, Inc|Istvan Molnar|978-671-8686|istvan.molnar@lantheus.com|
316536|NCT03719677|Wayne State University|Heather Fritz|313-664-2627|Heather.fritz@wayne.edu|
316537|NCT03719885|Penn Medicine|Research Coordinator|215-662-9393|jonathan.lilley@pennmedicine.upenn.edu|
316538|NCT03720119|Sofar|Dr Laura Patrucco|+39 02909362|laura.patrucco@sofarfarm.it|1
316539|NCT03720470|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316540|NCT03720652|University of North Carolina at Chapel Hill|Philip D. Sloane, MD, MPH|+1 (919) 966-4439|philip_sloane@med.unc.edu|
316541|NCT03720847|University of North Carolina at Chapel Hill|Tory Eisenlohr-Moul|859-317-0503|moul@med.unc.edu|
282606|NCT00863356|HemCon Medical Technologies|V.P., Clinical Affairs|971.223.4904|jody.oyama@hemcon.com|
305547|NCT02340715|Medical College of Wisconsin|Ergun Ahunbay|4148057898|eahunbay@mcw.edu|
305548|NCT02340767|National Dental PBRN|Dr. Sonia Makhija|2059965298|smakhija@uab.edu|
314194|NCT03268343|Achieve Life Sciences|Daniel Cain, Senior Director Clinical Research|425.686.1546|dcain@achievelifesciences.com|
314195|NCT03268590|Case Western Reserve University|Michael John Decker, PhD|216-368-2467|mjd6@case.edu|
314196|NCT03268746|Alcon Research|Clinical/Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
314197|NCT03268941|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
314198|NCT03269435|Montefiore|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
314199|NCT03269552|University of Washington|Dr. Stephen Smith|206-606-6546|ssmith50@seattlecca.org|
314200|NCT03270085|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
314201|NCT03270332|University of Miami|Dr. Adam Wanner|3053010563|awanner@miami.edu|
314202|NCT03270436|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
314203|NCT03270514|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Kathirvel Subramaniam, MD, MPH, FASE|724-799-5852|subramaniamk@upmc.edu|
314204|NCT03270644|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314205|NCT03270657|Duke University|Dr. Dennis Turner|919-684-7777|dennis.turner@duke.edu|
314206|NCT03270943|University of North Carolina at Chapel Hill|Christine Lathren, MD, MPH|919-966-8586|lathren@email.unc.edu|
314207|NCT03271307|University of California Los Angeles|Dr. Kathryn Dovel|7143303416|KDovel@mednet.ucla.edu|
314208|NCT03271424|University of North Carolina Chapel Hill|Dr. Audrey Pettifor|919-966-7439|apettif@email.unc.edu|
314209|NCT03271528|Boston Medical Center|Dr. Eric Devine|617-638-7888|eric.devine@bmc.org|
314210|NCT03272139|Department of Anesthesiology, Critical Care & Pain Management|Dr. David Kim|212-606-1206|kimd@hss.edu|
314211|NCT03273153|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
282607|NCT00863434|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
282608|NCT00863551|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
282609|NCT00863655|Novartis Pharmaceuticals|Study Director|862-778-8300||
282610|NCT00863681|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
282611|NCT00863707|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
282612|NCT00863746|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
316542|NCT03720938|Abant Izzet Baysal University|Dr. Halil Ibrahim Atasoy|90 532 599 89 53|halilibrahimatasoy@gmail.com|
316543|NCT03721172|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
316544|NCT03721549|WCCT Global|Erin Flynn, Associate Director of Regulatory Affairs|7207713080|erin.flynn@wcct.com|
316545|NCT03722030|University of Wisconsin - Madison|Dr. Lisa Cadmus-Bertram|608-262-1167|lisa.bertram@wisc.edu|
316546|NCT03722238|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316547|NCT03722264|Virginia Commonwealth University|Eser Tufekci, DDS, PhD|804-828-9326|etufekci@vcu.edu|
316548|NCT03722446|University of Michigan - Department of Anesthesiology|Dr. Carlo Pancaro|617-435-5403|cpancaro@med.umich.edu|
316549|NCT03722524|AO Servier|Natalya LOGUNOVA|+7 495 9370700|Natalya.LOGUNOVA@servier.com|
316550|NCT03722576|Mayo Clinic|Elizabeth J. Carey, M.D.|480-342-1094|Carey.Elizabeth@mayo.edu|
316551|NCT03722784|CooperVision, Inc.|Martine Robie|9256604477|mrobie@coopervision.com|
316552|NCT03723915|Northwestern University, Feinberg School of Medicine|Devalingam Mahalingam MD, PhD Associate Professor, Division of Hematology and Oncology|312-695-6929|mahalingam@nm.org|
316553|NCT03724812|Abbott|Angelic Roach|+1 651 756 3379|angelic.roach@abbott.com|
316554|NCT03725982|Institute of Occupational and Social Medicine and Health Services Research|Tessy Luger|004970712984364|Tessy.Luger@med.uni-tuebingen.de|
282613|NCT00863772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282614|NCT00863798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316555|NCT03727841|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|mark.gilbert@nih.gov|
316556|NCT03736967|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
316557|NCT03739840|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
316558|NCT03739983|University of Wisconsin Carbone Cancer Center|Ryan Spencer, MD, MS|608-265-1700|rjspencer2@wisc.edu|
316559|NCT03746002|University of Maryland School of Pharmacy|Brent Reed|410-706-1452|breed@rx.umaryland.edu|
316560|NCT03748771|University of California San Diego|Dr. Rakesh Bhattacharjee|858-966-5846|rlbhattacharjee@ucsd.edu|
316561|NCT03752177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
316562|NCT03753763|Zambon S.p.A.|Director of Clinical Trial - Charlotte Keywood, MD|+39 02 665241|charlotte.keywood@zambongroup.com|
316563|NCT03756571|Seattle Children's Research Institute|Kristie Bjornson, PT, PhD|206-884-2066|Kristie.bjornson@seattlechildrens.org|
316564|NCT03761537|LEO Pharma A/S|Disclosure|44 94 58 88|disclosure@leo-pharma.com|+45
316565|NCT03763877|Poxel|Director, Medical Operations|+33 (0)4 37 37 20 10|carole.thang@poxelpharma.com|
316566|NCT03764007|University of California, San Francisco|Dr. Thomas A. Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|
316567|NCT03772587|Momenta Pharmaceuticals, Inc.|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
282615|NCT00863928|Virginia Mason Medical Center|Kathryn Dahl, RN|206-341-0578|kathryn.dahl@vmmc.org|
316568|NCT03789292|Celltrion Inc.|JiWoong Lim|032-850-5806|jiwoong.lim@celltrion.com|
316569|NCT03799289|The Miriam Hospital|Jessica Unick, PD (Principal Investigator)|401-793-8966|junick@lifespan.org|
316570|NCT03801408|University of Arkansas for Medical Sciences|Sara Jones, Principal Investigator|501-526-7846|sljones@uams.edu|
316571|NCT03805438|Duke University|Riley Landreth, DO|919-684-8111|riley.landreth@duke.edu|
316572|NCT03808948|Charité - Universitätsmedizin Berlin|Prof. Dr. med. Kai Schmidt-Ott|+4930450614671|Kai.schmidt-ott@charite.de|
316573|NCT03810053|University of Arkansas for Medical Sciences|Matthew Henry|5016868274|mhenry3@uams.edu|
316574|NCT03812224|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
316575|NCT03817528|New York State Psychiatric Institute|Marlene Carlson, MPH|646-774-5340|marlene.carlson@nyspi.columbia.edu|
316576|NCT03817580|Eurofins EVIC|Commercial Manager|40 213357090|luciachirita@eurofins.com|
316577|NCT03828422|University Medical Centre Ljubljana|dr. Aleš Blinc, MD, PhD|+38615227124|ales.blinc@kclj.si|
316578|NCT03829228|USANA Health Science|Dr. Junqiang Tian|8019547462|jeremy.tian@usanainc.com|
316579|NCT03829618|Penn State Hershey Medical Center|Zoulfira Nisnevitch-Savarese, M.D.|717-531-6597|znisnevitchsavarese@pennstatehealth.psu.edu|
316580|NCT03830333|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
316581|NCT03831880|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316582|NCT03831945|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
316583|NCT03835728|UT Southwestern, Dept of Neurology|Dr. Steven Vernino|214-645-8800|steven.vernino@utsouthwestern.edu|
316584|NCT03840174|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
316585|NCT03848910|Hearing CRC Melbourne|Professor Robert Cowan|+61 3 9035 5347|r.cowan@unimelb.edu.au|
316586|NCT03852524|Ohio State University|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
316587|NCT03857841|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
316588|NCT03861780|Bioscience Laboratories|Principal Investigator II/Training Coordinator|(406) 587-5735|cduley@biosciencelabs.com|110
316589|NCT03862625|Istanbul University|Dr. Merve Damla Korkmaz|+905556297264|mervedml@gmail.com|
316590|NCT03862755|Shanghai Pulmonary Hospital|Dr. Lei Shen|86-21-65115006|sh_leisen@126.com|2054
316591|NCT03869541|Imperial College London|Huw Woodbridge|+44 (0)20 7594 3192|h.woodbridge@imperial.ac.uk|
316592|NCT03877224|Astrazeneca|Łyżwa, Dawid|+48 882 345 259|dawid.lyzwa@astrazeneca.com|
316593|NCT03880565|University of Minnesota|Demetri Yannopoulos, MD|612-626-2935|yanno001@umn.edu|
316594|NCT03883607|Genfit SA|Clinical Head|+33320164000|clinicaltrial@genfit.com|
316595|NCT03885596|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
316596|NCT03885661|University of Pennsylvania|John Millar, PhD|215-898-0638|jsmillar@pennmedicine.upenn.edu|
270326|NCT00121173|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|ctrimbl@jhmi.edu|
270327|NCT00121186|SWOG Statistical Center|Study Statistician|206-667-4623||
270328|NCT00121199|SWOG Statistical Center|Study Statistician|206-667-4623||
270329|NCT00121225|Princess Margaret Cancer Centre|Dr. David Hogg|416-946-4501|david.hogg@uhn.ca|4521
270330|NCT00121238|University of Michigan Comprehensive Cancer Center|Maha Hussain, M.D.|(734)936-8906|mahahuss@med.umich.edu|
270331|NCT00121251|Weill Cornell Medical College|Cooperative Group Program Manager|646-962-9377|has7003@med.cornell.edu|
270332|NCT00121472|Thoratec Corporation|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|(781) 852-8334|psood@thoratec.com|
270333|NCT00121485|Thoratec Corporation|Poornima Sood, MD, MBA, Sr. Director, Clinical Affairs|781 852 8334|psood@thoratec.com|
270334|NCT00121641|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
270335|NCT00121667|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
270336|NCT00121719|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
270337|NCT00121810|Hoffmann-La Roche|Medical Communications|800-821-8590||
270338|NCT00121836|Hoffmann-LaRoche|Medical Communications|800-821-8590||
270339|NCT00121992|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
271683|NCT00257192|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
282616|NCT00864032|University of California Davis Comprehensive Cancer Center|Dr. Robert J. Canter|916-734-5907|robert.canter@ucdmc.ucdavis.edu|
316597|NCT03886493|Johns Hopkins University School of Medicine|Kenneth Pienta, M.D.|410-502-3137|kpienta1@jhmi.edu|
316598|NCT03888235|University of British Columbia Department of Family Practice|Dr. Helene Bertrand|7782277776|dr.hbertrand@gmail.com|
316599|NCT03889158|University of Illinois at Chicago|Dr. Elizabeth Lefferts|312-996-9607|eschro7@uic.edu|
316600|NCT03890419|Duke University|Padma Gulur|919-681-4660|padma.gulur@duke.edu|
316601|NCT03897348|University of California, San Francisco/San Francisco VA Health Care System|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
316602|NCT03900416|Lawrence University|Dr. Lori Hilt|920-832-7050|lori.m.hilt@lawrence.edu|
316603|NCT03905863|Serena Group Inc|Dr Thomas Serena|671-945-5225|serena@serenagroups.com|
282617|NCT00864084|The University of Manitoba|Ms Elizabeth Harvey|204-977-5656|harveye@cc.umanitoba.ca|
316604|NCT03907033|Mayo Clinic|Dr. Johnny Yi|480-342-0612|Yi.Johnny@mayo.edu|
316605|NCT03909178|Massachusetts General Hospital|Dr. Scott Martin|(617) 726-7500|sdmartin@partners.org|
316606|NCT03909971|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316607|NCT03920215|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
316608|NCT03921151|Virginia Commonwealth University|Liangsuo Ma, PhD|(804) 828-2871|liangsuo.ma@vcuhealth.org|
316609|NCT03926039|National Taipei University of Nursing and Health Sciences|Director of Nursing Department|886-2-28712121|tsaejyy@ntunhs.edu.tw|3100
316610|NCT03927911|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
316611|NCT03937570|Division of Cardiac Surgery, Department of Surgery - University of Verona|Marzia Lilliu, MD, PhD|+39 3281383539|marzialilliu@gmail.com|
316612|NCT03938857|Duke University|Mara L. Becker, MD, MSCE|919-613-1942|mara.becker@duke.edu|
316613|NCT03941912|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
316614|NCT03945981|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
316615|NCT03950167|UFUK UNIVERSITY|DR MÜGE KESKİN|+905333522090|mugekeskin1@hotmail.com|
316616|NCT03950674|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
316617|NCT03954834|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
316618|NCT03958071|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316619|NCT03961529|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
316620|NCT03968159|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
316621|NCT03968965|Hospital for Special Surgery|Celeste Abjornson|2127742126|AbjornsonC@HSS.edu|
316622|NCT03970824|CELLTRION, Inc.|SungHyun Kim|+82 32 850 5778|SungHyun.Kim@celltrion.com|
316623|NCT03978403|Zosano Pharma Corporation|Dr. Don Kellerman, Sr. VP, Clinical Development and Medical Affairs|+1 (510) 745-4004|dkellerman@zosanopharma.com|
316624|NCT03979807|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316625|NCT03980470|University Hospital Zurich|Dr Ronny R. Buechel|+41442551059|ronny.buechel@usz.ch|
316626|NCT03982069|University of Pittsburgh|Dr. Katherine Williams|412-383-1979|kvw3@pitt.edu|
316627|NCT03984812|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
316628|NCT03985813|University of Pittsburgh|Oliver Lindhiem|4122465909|lindhiemoj@upmc.edu|
316629|NCT03998163|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
316630|NCT04000373|Cleveland Clinic Neurological Institute Mellen Center|Research Nurse Coordinator|216-445-5877|stoughd@ccf.org|
316631|NCT04001517|EIP Pharma|Dr. John Alam|6176698426|johnjalam@gmail.com|
316632|NCT04005859|Atrium Health|Dr. Kevin Kasten|704-355-1813|kevin.kasten@atriumhealth.org|
316633|NCT04006171|Near East University|Dr.Ali Cenk Ozay|00905428583248|dr.alicenk@hotmail.com|
316634|NCT04011436|Universidad Nacional de Colombia|Pt. Luisa Prieto|+57 3202082723|lfprietog@unal.edu.co|
316635|NCT04011592|The University of Texas Health Science Center at Houston|Sudhakar Selvaraj, MD, PhD, Assistant Professor|713-486-2837|Sudhakar.Selvaraj@uth.tmc.edu|
316636|NCT04013529|Corporal Michael J. Crescenz VA Medical Center|Manik Chhabra|(215) 823-5800|manik.chhabra@va.gov|
316637|NCT04016324|Medtronic|Rianna Rapson (Prin. Clinical Research Specialist)|763-526-2170|rianna.k.rapson@medtronic.com|
316638|NCT04017910|Sonavex|Katy Feeny|443-862-2024|kfeeny@sonavex.com|
316639|NCT04018066|Rutgers, The State University of New Jersey|Dr. Diana Roopchand, Study Investigator|8489320248|roopchand@sebs.rutgers.edu|
316640|NCT04018794|University of California, San Francisco|Dr. Melissa Dvorsky|4154767167|melissa.dvorsky@ucsf.edu|
282618|NCT00864097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316641|NCT04032327|Walter Reed National Military Medical Center|Katherine L Dengler, MD|301-400-2468|katherine.l.dengler.mil@mail.mil|
316642|NCT04033640|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
316643|NCT04036292|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
316644|NCT04041440|Customized Learning Exercises for Aural Rehabilitation|Chief Operating Officer|314 399-9943|chris@amptify.com|
316645|NCT04041570|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD/IND Medical Officer|301-451-8715|martin.gaudinski@nih.gov|
316646|NCT04043143|"University of Colorado Denver | Anschutz"|Karsten Bartels, MD, PhD, MBA|303-724-1111|karsten.bartels@cuanschutz.edu|
316647|NCT04049123|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@llilly.com|
316648|NCT04051463|Cornea Research Foundation of America|Marianne Price|317-814-2990|mprice@cornea.org|
316649|NCT04052204|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials_gov_Inquiries@pfizer.com|
316650|NCT04054661|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
293496|NCT01493531|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
293497|NCT01493557|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316651|NCT04067011|Emergent Biosolutions|Bojan Drobic, Director, Clinical Research|+1 (204) 275-4196|bdrobic@ebsi.com|
316652|NCT04072159|Arizona State University, College of Health Solutions|Dr. Alexis Koskan (Assistant Professor)|602-827-2792|alexis.koskan@asu.edu|
316653|NCT04085341|Graybug Vision|Director, Global Clinical Development Operations|5622098872|bpatel@graybug.vision|
316654|NCT04094870|University of North Carolina at Chapel Hill|Elizabeth Stringer, MD, MSc|919-966-1601|elizabeth_stringer@med.unc.edu|
293498|NCT01493596|Catalyst Pharmaceutical Partners, Inc.|Douglas Winship, Vice President of Regulatory Operations|305 529-2522|dwinship@catalystpharma.com|12
316655|NCT04096482|Emory University|Joshua M Levy|(404) 778-3381|joshua.levy2@emory.edu|
316656|NCT04098172|First Affiliated Hospital of Xi 'an Jiaotong University|Dr. Ning Guo|13991229101|drnguo@gmail.com|+86
316657|NCT04103515|University of Tennessee|Dr. Michael LaCour|8659742093|mlacour@utk.edu|
316658|NCT04111276|University of Tennessee|Dr. Michael LaCour|865-974-7684|mlacour@utk.edu|
316659|NCT04123405|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
316660|NCT04128527|Ambu|Signe Toräng|31267089|sito@ambu.com|
316661|NCT04132973|The University of Sheffield|Elaine Clarke|01142226533|e.n.clarke@shef.ac.uk|
316662|NCT04133415|Washington University School of Medicine|Matthew Spraker, M.D., Ph.D.|314-362-8567|mspraker@wustl.edu|
316663|NCT04138758|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316664|NCT04147715|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
316665|NCT04150068|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
293499|NCT01493687|Galderma R&D, LLC|Clinical Science Director|609-409-7701||
316666|NCT04154605|Stryker|Robyn Schacherer, Manager Clinical Affairs|763-463-7054|robyn.schacherer@stryker.com|
316667|NCT04160091|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
316668|NCT04160260|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
316669|NCT04164758|Acadia Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261|medicalinformation@acadia-pharm.com|2897
316670|NCT04165031|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
316671|NCT04166032|Cleveland Clinic|Kimberly Jenkins, Research Administrator|216-445-4791|jenkink@ccf.org|
316672|NCT04171414|Celltrion Inc.|JiWoong Lim|032-850-5806|jiwoong.lim@celltrion.com|
316673|NCT04175808|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
316674|NCT04178720|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
316675|NCT04184297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316676|NCT04189848|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
316677|NCT04210232|Johnson & Johnson Surgical Vision|Eugenia K. Thomas|+1 657 2903260|EThoma39@its.jnj.com|
316678|NCT04211909|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
316679|NCT04218110|Eurofins EVIC|Commercial Manager|+40 213357090|luciachirita@eurofins.com|
316680|NCT04222725|Tarsier Pharma|Zohar Milman|+972-50-8371319|Zohar Milman <zohar@Tarsierpharma.com>|
316681|NCT04223843|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316682|NCT04229303|Zambon SpA|Arnd Mueller, MD|+39 02 665241|clinicaltrials@zambongroup.com|
316683|NCT04231825|University of California San Francisco|Dr. Theodore Zanto|415-502-7322|theodore.zanto@ucsf.edu|
316684|NCT04243421|Medical University of Białystok|Małgorzata Pietruska|+48606461092|mpietruska@wp.pl|
316685|NCT04244084|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
316686|NCT04256603|MetroHealth|c. kim|216 778 7800|ckim3@metrohealth.com|
316687|NCT04258995|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316688|NCT04280445|Trent Doctorate in Clinical Psychology Programme, University of Nottingham, UK|Dr Daniell De Boos|+44 (0)115 84 67523|danielle.deboos@nottingham.ac.uk|
316689|NCT04285489|Integra LifeSciences (Shanghai) Co., Ltd.|Dr. Hua Tang|0086 21 63179772|hua.tang@integralife.com|8029
316690|NCT04290494|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316691|NCT04303156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
316692|NCT04317040|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
316693|NCT04317313|Second Affiliated Hospital, School of Medicine, Zhejiang University|Dr. Xiaohui Zhang|+86-571-87767188|zhanghui4127@zju.edu.cn|
293500|NCT01493778|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
316694|NCT04319159|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32|ameluz@biofrontera.com|66
316695|NCT04321239|University of Michigan|Mary Janevic|734 647 3194|mjanevic@umich.edu|
316696|NCT04323852|Shahid Beheshti Medical School|Dr. ََAfshin Zarghi|021-22439781|Mpajouhesh@sbmu.ac.ir|
316697|NCT04327843|Case Western Reserve University|Kaylee Sarna|(216) 368-3577|kns17@case.edu|
316698|NCT04331899|Stanford University|Dr. Prasanna Jagannathan, MD|1-650-724-5343|prasj@stanford.edu|
316699|NCT04334148|Duke University|Dr. Susanna Naggie|919-684-2584|susanna.naggie@duke.edu|
316700|NCT04343287|BRIM Biotechnology, Inc.|Erin Chang, Vice President of Portfolio Management Department|0226598779|erin.chang@brimbiotech.com|119
316701|NCT04347954|Stanford University|Jayakar Nayak, MD, PhD|(650) 723-5281|jnayak@stanford.edu|
316702|NCT04349098|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
316703|NCT04353037|UnitedHealth Group R&D / Optum Labs|Mike Lahm, Director Data Science|302-379-0209|MichaelLahm@uhg.com|
316704|NCT04355117|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
316705|NCT04355767|Stanford University|Kevin Schulman, MD|(650) 724-0543|kevin.schulman@stanford.edu|
316706|NCT04356573|UAMS|Robert Wolfe|501-526-5708|rrwolfe2@uams.edu|
316707|NCT04357379|Medical University of South Carolina|Dr. Tracy Smith|8437925164|smithtra@musc.edu|
293501|NCT01493947|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
305549|NCT02340780|Canadian Cancer Trials Group|Bingshu Chen|613-533-2430|bchen@ctg.queensu.ca|
305550|NCT02340806|Northwestern University|Elizabeth Lange, MD|312-472-3585|elizabeth.lange@northwestern.edu|
305551|NCT02340819|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
305552|NCT02340949|MFAR Clinical Research|Pau Doñate Macian|0034934344412|investigacion@mfar.net|
316708|NCT04358068|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
316709|NCT04366349|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
316710|NCT04369885|University of North Carolina at Chapel Hill|Michael B Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
316711|NCT04373421|Tekirdag Namik Kemal University|Dr. Volkan Kaplan|+90282250000|dr.volkankaplan61@gmail.com|6307
316712|NCT04381728|WOMED|Pauline Chirouze|0785225561|pauline@womedtech.com|+33
316713|NCT04382053|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@novartis.com|
316714|NCT04388826|Veru|Gary Barnette PhD CSO|9194263611|gbarnette@verupharma.com|
316715|NCT04394845|Hoffmann-La Roche|Medical Communications|800 821-8590|global-roche-genentech-trials@gene.com|
316716|NCT04398732|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316717|NCT04401293|System Director - Anticoagulation and Clinical Thrombosis Services Northwell Health at Lenox Hill Hospital Affiliation: Northwell Health|Alex Spyropoulos, MD|(212) 434-6776|aspyropoul@northwell.edu|
316718|NCT04411628|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
316719|NCT04418947|University of Pennsylvania|Dr. Anne Cappola|2155735359|acappola@pennmedicine.upenn.edu|
316720|NCT04420273|Northwestern University Feinberg School of Medicine|Dr. June Robinson|3129433703|june-robinson@northwestern.edu|
316721|NCT04420572|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
316722|NCT04428411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316723|NCT04435184|Johns Hopkins University - Baltimore, MD|Dr. Charles Lowenstein|4105020391|clowens1@jhmi.edu|
316724|NCT04476784|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
316725|NCT04484207|New York State Psychiatric Institute|Yuval Y. Neria|646-774-8092|ny126@cumc.columbia.edu|
316726|NCT04485455|University of North Carolina at Chapel Hill|Shahzad Ali, MD|984-974-0033|shali@med.unc.edu|
316727|NCT04492475|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
316728|NCT04495283|Nevakar, Inc.|Eric Lang, MD|(908) 367-7400|Clinicaltrials@nevakar.com|
305553|NCT02340962|TaiGen Biotechnology Co., Ltd.|Li-Wen Chang|+886-2-8177-7020|lwchang@taigenbiotech.com|1227
305554|NCT02340975|MedImmune, LLC|Shahram Rahimian|+1-800-236-9933|information.center@astrazeneca.com|
305555|NCT02341144|Johns Hopkins All Children's Hospital|Nicole Chandler|7277674170|nicole.chandler@jhmi.edu|727
305556|NCT02341417|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
305557|NCT02341456|AstraZeneca|Lone Ottesen|1-877-240-9479|ClinicalTrialTransparency@astrazeneca.com|
305558|NCT02341482|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
305559|NCT02341599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305560|NCT02341859|Coopervision Japan|Taku Muraoka, OD, Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
305561|NCT02342015|University of Padova|Marcello Rattazzi|+300498211867|marcello.rattazzi@unipd.it|
305562|NCT02342171|Institute of Tropical Medicine|Prof. Dr. Johan van Griensven|+3232476426|jvangriensven@itg.be|
305563|NCT02342197|Kasr El-Aini Hospital|Nawara Mohamed|0223654060|nawaram@kasrelaini.edu.eg|002
305564|NCT02342223|VA Northern California Health Care System|Jared Jagdeo, MD, MS|917-837-9796|jrjagdeo@gmail.com|
305565|NCT02342288|West Virginia University|Dr. Sanford Emery|304-293-1170|semery@hsc.wvu.edu|
305566|NCT02342314|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
305567|NCT02342327|University of Minnesota|Michael Kotlyar|612-625-1160|kotly001@umn.edu|
305568|NCT02342379|University of Texas Health San Antonio|Andrew Brenner, MD, PhD|210-450-5936|brennera@uthscsa.edu|
305569|NCT02342418|University of Michigan|Manjunath Pai, Associate Professor|7346470006|amitpai@med.umich.edu|
305570|NCT02342535|Northwestern University|Dr. Namratha Kandula|312-503-6470|nkandula@nm.org|
305571|NCT02342548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
305572|NCT02342561|The Orthopaedic Research Unit, Department of Orthopaedic Surgery and Trauma, Odense University Hospital, Denmark|Nikolaj Milandt, Undergraduate researcher|26616611|nikolaj.rongsted.milandt@rsyd.dk|0045
305573|NCT02342639|University of Kansas Medical Center|Dr. Jason Stubbs|9135886074|jstubbs@kumc.edu|
305574|NCT02342678|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
305575|NCT02342704|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
305576|NCT02342743|CEFALY Technology|Clinical Trials Department director|+3243676722|info@cefaly.com|
305577|NCT02342886|TB Alliance|Leandra Lombard, Director, Clinical Operations|+27 87 700 3900|Leandra.Lombard@tballiance.org|
305578|NCT02343003|Halyard Health|David Curd|470-448-5178|david.curd@hyh.com|
314212|NCT03273166|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
314213|NCT03273257|Papworth Hospital NHS Foundation Trust|David Jenkins, MD; Principal Investigator and ICA Board member|+44 1223 638000|david.jenkins1@nhs.net|
314214|NCT03273270|Medical University of South Carolina|Gonzalo Revuelta|7927262|revuelta@musc.edu|
314215|NCT03273283|Hospital Clínic de Barcelona|Pol Bruguera Soler|628162567|pbruguer@clinic.cat|
314216|NCT03273387|Department of Cardiology and Vascular Medicine, Universitas Indonesia|dr. Bambang WIdyantoro, FIHA, PhD|+628128164299|bambang_ui@yahoo.com|
314217|NCT03273426|Seoul National University Hospital|Dr. Wonshik Han|+82-2-2072-1958|hanw@snu.ac.kr|
293502|NCT01493960|Index Pharmaceuticals|Dr Thomas Knittel|0046 8 508 847 31|thomas.knittel@indexpharma.com|
293503|NCT01494038|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
293504|NCT01494051|Oregon Health & Science University|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
293505|NCT01494298|Mercer University College of Pharmacy|Gina Ryan Clinical Professor|678.547.6222|ryan_gj@mercer.edu|
293506|NCT01494350|Institut Pasteur of Tunis|Afif Ben Salah, MD, PhD|011-216-71-792-429|afif.bensalah@pasteur.rns.tn|
293507|NCT01494467|Galderma R&D, LLC|Clinical Science Director|609-409-7701||
293508|NCT01494506|Merrimack Pharmaceuticals, Inc.|Dr. Eliel Bayever|6174411000|EBayever@merrimack.com|7676
293509|NCT01494532|GlaxoSmithKline|GSK Response Center|866-435-7343||
293510|NCT01494545|Alcon Research, Ltd|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
305579|NCT02343081|FLENI- mrc (FLENI Multi-specialty Research Center)|Dr. Alejandro Muggeri (Principal Investigator)|54-11-5777 3200|alemuggeri@hotmail.com.ar|2020
305580|NCT02343276|Instituto de Cardiologia de Santa Catarina|Roberto Léo da Silva|55 48 32719077|robertoleo@hotmail.com|
305581|NCT02343380|University of Turin|Dr Simona Bo|0039116335543|simona.bo@unito.it|5541
305582|NCT02343406|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
305583|NCT02343458|Pearl Therapeutics Inc.|Pearl Therapeutics Inc.|650-305-2600|creisner@pearltherapeutics.com|
305584|NCT02343549|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
305585|NCT02343575|Stanford University|Yelizaveta Sher, MD|650-736-0459|ysher@stanford.edu|
305586|NCT02343627|Taro Pharmaceuticals U.S.A. Inc|Senior Director, Clinical|+1 914-345-900|Natalie.Yantovskiy@Taro.com|
305587|NCT02343939|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
305588|NCT02344004|Insmed Inc|Kevin Mange (Senior Vice President, Clinical Development & Medical Affairs, ALIS)|908-947-2651|kevin.mange@insmed.com|
305589|NCT02344173|Abbott|Principal Clinical Research Scientist|6517564067|eric.grovender@abbott.com|
305590|NCT02344225|SUNY Downstate Medical Center|Jacob V. Aranda, MD, PhD, FRCPC, Principal Investigator|718-270-1912|jaranda@downstate.edu|
316729|NCT04497948|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
305591|NCT02344238|Medical University of South Carolina|Dr. Aimee McRae-Clark||mcraeal@musc.edu|
305592|NCT02344251|MUSC|Dr. Aimee McRae-Clark||mcraeal@musc.edu|
305593|NCT02344316|UCSF Pediatric Headache Program|Amy Gelfand, MD|415-885-7832|Amy.Gelfand@ucsf.edu|
305594|NCT02344342|University of Michgan Health Systems|Todd Koelling, MD|734-936-5265|tkoellin@med.umich.edu|
305595|NCT02344407|Division of Biostatistics, University of Minnesota|Greg Grandits|612-626-9033|grand001@umn.edu|
305596|NCT02344576|University of Colorado School of Medicine|Dr. Larry Allen, Principal Investigator|303-724-4713|larry.allen@ucdenver.edu|
305597|NCT02344628|London School of Hygiene and Tropical Medicine|Dr Michael Marks|+447984643424|michael.marks@lshtm.ac.uk|
305598|NCT02344745|Keck School of Medicine|Begum Ozel, M.D.|323-226-3416|ozel@usc.edu|
305599|NCT02345031|Autifony Therapeutics Ltd|Clinical Project Manager|+44 1438 906860|info@autifony.com|
305600|NCT02345070|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
305601|NCT02345161|GlaxoSmithKline|GSK Response Center|866-435-7343||
305602|NCT02345226|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
305603|NCT02345252|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
305604|NCT02345330|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
305605|NCT02345434|Columbia University|Adam Sacarny|212 305 7084|ajs2102@columbia.edu|
305606|NCT02345486|Vanderbilt University Medical Center|Dr. Matthew Semler|615-322-3412|matthew.w.semler@vumc.org|
305607|NCT02345512|National Health Service Greater Glasgow & Clyde|Ms Jennifer Crockett|0141 276 4900|jennifer.crockett@ggc.scot.nhs.uk|4912
305608|NCT02345642|Hospital for Special Surgery|Dr. Geoffrey Westrich|212-606-1510|ortizp@hss.edu|
305609|NCT02345720|Johnson & Johnson Vision Care Inc.|Tom Karkkainen, OD, MS, FAAO|904-443-3500|TKarkkai@its.jnj.com|3402
305610|NCT02345811|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
305611|NCT02345889|Indiana University|Rachel Lahr|3179480724|rlahr@iu.edu|
316730|NCT04501640|Astellas Pharma China, Inc.|Clinical Trial Disclosure|+86-(0)10-85216666|astellas.resultsdisclosure@astellas.com|
316731|NCT04501952|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
316732|NCT04504032|Gates MRI|Study Director|+1 857 702 2108|clinical.trials@gatesmri.org|
316733|NCT04507763|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316734|NCT04507867|Universidad Anáhuac México Norte|Dr. Fernando Leal Martínez|+52 5521094339|ferman5@hotmail.com|
305612|NCT02346136|MGH Biostatistics|Eric Macklin, PhD|617-724-9828|emacklin@mgh.harvard.edu|
305613|NCT02346240|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
305614|NCT02346370|Halozyme, Inc.|Halozyme Study Information|1-844-855-4256|medinfo@halozyme.com|
305615|NCT02346383|CCAMP|J Kelby Hutcheson MD|8642956399|khutchesonmd@carolinapain.com|
305616|NCT02346461|National Human Genome Research Institute|Carrillo, Nuria|+1 301 402 2324|nuria.carrillo@nih.gov|
305617|NCT02346643|St. Jude Medical|Roni Diaz|+1 972 309 8601|RDiaz@sjm.com|
305618|NCT02346708|University of Colorado Denver - Anschutz Medical Campus|Isabelle Buard, PhD|(303)724-5973|Isabelle.Buard@cuanschutz.edu|
305619|NCT02346721|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
305620|NCT02346903|Bassett Healthcare Network Research Institute|Melissa B Scribani|6075477635|melissa.scribani@bassett.org|
305621|NCT02346916|Bassett Healthcare Network Research Institute|Melissa B Scribani|6075477635|melissa.scribani@bassett.org|
293511|NCT01494584|GlaxoSmithKline|GSK Response Center|866-435-7343||
316735|NCT04525079|Celltrion Inc|JiWoong Lim|82-32-850-5806|jiwoong.lim@celltrion.com|
316736|NCT04527978|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
316737|NCT04528017|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
316738|NCT04529109|Johnson & Johnson Vision Care|Meredith Bishop, OD, MS, FAAO-Sr. Principal Research Optometrist|904-443-1783|mbishop4@its.jnj.com|
316739|NCT04536571|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
316740|NCT04537234|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
316741|NCT04544787|University of Antwerp|Pierre Van Damme, MD, PhD|+32 3 265 21 30|pierre.vandamme@uantwerpen.be|
316742|NCT04555031|Bausch & Lomb|Study Director|5853386399|robert.steffen@bausch.com|
316743|NCT04559282|Cochlear|Therese Agat|+46766498562|tagat@cochlear.com|
316744|NCT04573972|Carnegie Mellon University|Gretchen Chapman, PhD|4122687380|gchapman@andrew.cmu.edu|
316745|NCT04574297|Changhai Hospital|Dr. Zhuan Liao|86-21-31161004|liaozhuan@smmu.edu.cn|
316746|NCT04580290|Xiros Ltd|Tracey Oxley|07810337555|Tracey.Oxley@xiros.co.uk|
316747|NCT04601103|3M Health Care Business Group|Brenda Coalwell, Clinical Affairs Manager|16517362456|bccoalwell1@mmm.com|
316748|NCT04617574|Holyoke Medical Center Weight Management Program|Bariatric Clinical Administrator|(413) 535 - 4759|davidson_elana@holyokehealth.com|
316749|NCT04658797|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
316750|NCT04664855|Montana State University|Dr. Lauren Davis|8287736328|lauren.davis6@montana.edu|
316751|NCT04701658|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
316752|NCT04706416|Valley Baptist Medical Center|Dr. Ameer Hassan|973-303-8146|ameerehassan@gmail.com|
316753|NCT04709484|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
316754|NCT04717323|Altec Inc.|Dr. Paola Contessa|5085458236|pcontessa@altecresearch.com|
282619|NCT00864123|University of South Florida|Eric Storch, Ph.D.|727-767-8230|estorch@health.usf.edu|
293512|NCT01494610|GlaxoSmithKline|GSK Response Center|866-435-7343||
293513|NCT01494649|GlaxoSmithKline|GSK Response Center|866-435-7343||
293514|NCT01494753|Laboratoires Théa|Dr Pascale Pouliquen - Medical Director|33 473 981 436|p.pouliquen@laboratoires-thea.fr|
293515|NCT01494818|Alcon Research, Ltd.|Renee Garofalo, OD, FAAO|1-888-451-3937|alcon.medinfo@alcon.com|
293516|NCT01494922|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293517|NCT01494987|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
293518|NCT01495000|GlaxoSmithKline|GSK Response Center|866-435-7343||
293519|NCT01495221|Vitreous Retina Macula Consulatants of New York|Jason S. Slakter, MD|212-861-9797|mail@vrmny.com|
316755|NCT04727749|University of Saskatchewan|Dr. Colleen Dell|306-966-5912|Colleen.Dell@usask.ca|
316756|NCT04777214|University of Pennsylvania|Samuel Cason|215-573-4336|sacason@pennmedicine.upenn.edu|
316757|NCT04854707|IVFarma LLC|General Manager|+74996455342|info@ivfarma.ru|
316758|NCT04898166|Jinnah postgraduate medical centre|Syeda Mahanum Ali|03033901112|mahanumsyed8@gmail.com|
316759|NCT04926233|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316760|NCT04943159|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
316761|NCT04947436|University of Texas Health San Antonio|Dr. Donna Gardner|210-450-8479|dgardner62001@gmail.com|
316762|NCT05002972|University of Kentucky|Dawn Brewer|859-257-1661|dawn.brewer@uky.edu|
316763|NCT05002985|University of Kentucky|Dawn Brewer|859-257-1661|dawn.brewer@uky.edu|
316764|NCT04512482|Indiana University School of Dentistry, Department of Orthodontics|Kelton T. Stewart, Department Chair|317-278-1087|keltstew@iu.edu|
316765|NCT04499599|L-Nutra, Inc.|Dr. Min Wei|323.791.2426|mwei@l-nutra.com|
316766|NCT04525157|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
316767|NCT04523831|Dhaka Medical College|Dr. Reaz Mahmud, Principal investigator|01912270803|reazdmc22@yahoo.com|+88
316768|NCT04521777|UT MD Anderson Cancer Center|An T Ngo-Huang, Assistant Professor, Rehabilitation Medicine|(713) 745-2327|ango2@mdanderson.org|
316769|NCT04512703|ZOLL Medical Corporation|Mike Osz|4129683333|mosz@zoll.com|14104
316770|NCT04511520|National medical research center for therapy and preventive medicine|Dr. Maria Makhinova|+79104803524|longtimeaftertomorrow@gmail.com|
316771|NCT04507776|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316772|NCT04502979|University of North Carolina at Chapel Hill|Eric A Hodges, PhD, FNC-BC, FAAN|919-966-0534|eahodges@email.unc.edu|
305622|NCT02347072|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-350-2600|creisner@pearltherapeutics.com|
316773|NCT04502056|JPAL North America|Tristan Loisel|6307476739|tloisel@povertyactionlab.org|
316774|NCT04498403|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316775|NCT04495374|Universidade Federal de Alfenas|Profa. Dra. Larissa Helena Lobos Torres Pacheco|3537011805|larissa.torres@unifal-mg.edu.br|55
316776|NCT04495712|VA Portland Health Care System|Merritt Raitt MD|503-220-8262|merritt.raitt@va.gov|57571
316777|NCT04492397|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|JVega2@coopervision.com|
316778|NCT04491994|Pak Emirates Military Hospital (PEMH) Rawalpindi|Sultan Mehmood Kamran|+923008501100|sultanmajoka79@hotmail.com|
316779|NCT04491240|MC Dinasty|Tyumina Olga|+78462039808|centr123@bk.ru|201
316780|NCT04490863|Masimo Corporation|Vikram Ramakanth|949-297-7000|ClinicalResearchDept@masimo.com|
316781|NCT04490499|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
316782|NCT04490239|University of Mississippi|Dr. Joshua Sharp|662-915-1758|jsharp@olemiss.edu|
316783|NCT04486235|Corporal Michael J. Crescenz VA Medical Center|Jocelyn Remmert, PhD|215-823-5800|jocelyn.remmert@va.gov|
316784|NCT04483011|Bioenergy Life Science, Inc.|Alex Xue, Chief Technology Officer|763-746-0032|alex.xue@bioenergyls.com|3924
316785|NCT04475588|Biocon Biologics India Limited|Dr. Subramanian Loganathan|0802808|subramanian.l101@biocon.com|5466
316786|NCT04474496|University of Arkansas for Medical Sciences|Dr. Pearl A. McElfish|479-713-8680|pamcelfish@uams.edu|
316787|NCT04448210|innovation Research & Training|Dr. Alison Parker|919-493-7700|aparker@irtinc.us|
316788|NCT04474405|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
316789|NCT04470375|University of South Dakota|Dr. Kory Zimney|16056586373|kory.zimney@usd.edu|
316790|NCT04468347|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
316791|NCT04467424|University Hospital of Split|Dr. Ana Nevescanin Biliskov, pediatric anesthesiologist|00385912508001|anevescanin@gmail.com|
316792|NCT04465422|Taipei City Hospital|Shu Chun Lee|+886 2 27263141|A1057@tpech.gov.tw|1004
316793|NCT04463004|Virginia Commonwealth University|Antonio Abbate, MD, PhD|804-628-1215|antonio.abbate@vcuhealth.org|
316794|NCT04463069|Hong Kong Baptist University|Dr. Yang Gao|+852 3411 3082|gaoyang@hkbu.edu.hk|
316795|NCT04448561|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
316796|NCT04462731|University of Pennsylvania|Ya-Hsin Yu|215-898-4927|yayu@upenn.edu|
305623|NCT02347085|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
305624|NCT02347098|VA North Texas Health Care System, Dallas, TX and University of Texas Southwestern Medical Center|Dr. Subhash Banerjee|214-857-1608|Subhash.Banerjee@va.gov, Subhash.Banerjee@UTSouthwestern.edu|
305625|NCT02347124|Kaiser Permanente Washington Health Research Institute|Dr. Jennifer McClure|206-287-2737|mcclure.j@ghc.org|
305626|NCT02347176|MedImmune, LLC|Rene van der Merwe|301-398-4095|information.center@astrazeneca.com|
305627|NCT02347189|Medtronic|Megan Mueller, Clinical Research Manager|612-916-4771|megan.d.mueller@medtronic.com|
305628|NCT02347332|Institut de Recherche Pierre Fabre, Toulouse France|Zahida Issiakhem, Clinical Development Physician|+33 5 34 50 61 71|zahida.issiakhem@pierre-fabre.com|
305629|NCT02347345|Aaron Diamond AIDS Research Center|Martin Markowitz MD|212-448-5020|mmarkowitz@adarc.org|
293520|NCT01495286|University of Arkansas|Anita Mitchell PhD, coinvestigator|501-686-7021|AMitchell@uams.edu|
293521|NCT01495481|University of Pittsburgh|Dr. Gaurav Arora|412-692-6054|gaurav.arora@chp.edu|
293522|NCT01495572|National Cancer Institute|Udai Kammula M.D.|301-435-8606|kammulau@mail.nih.gov|
305630|NCT02347410|Spineology|Rose Griffith, Sr. Director, Clinical Affairs|6512568503|Rgriffith@spineology.com|
316797|NCT04459585|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
316798|NCT04458818|Combined Military Hospital Kharian, Punjab Pakistan|Dr Muhammad Noman Karim|+923313358884|f9noman@gmail.com|
316799|NCT04456634|Medicines for Malaria Venture (MMV)|Jacques Herve|+41 79 370 40 63|hervej@mmv.org|
316800|NCT04454138|Prism Eye Institute|Ronaldo Santiago|905-456-3937|ronaldo.santiago@prismeye.ca|267
316801|NCT04452435|Vicore Pharma|Carl-Johan Dalsgaard|+46 70 975 98 63|carl-johan.dalsgaard@vicorepharma.com|
316802|NCT04451707|Groupe Hospitalier La Rochelle Ré Aunis|Dr Florence Hoefler|+330546455050|florence.hoefler@ch-troyes.fr|
316803|NCT04449263|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256402964|javega2@coopervision.com|
316804|NCT04450381|Masimo Corporation|Vikram Ramakanth|949-297-7000|clincalresearchdept@masimo.com|
316805|NCT04449341|Carl R Darnall Army Medical Center|Matthew Perdue|(254) 553-4653|matthewperdue94@gmail.com|
316806|NCT04441255|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
316807|NCT04440449|University of Texas Health San Antonio|Rozmin Jiwani|210-450-8498|jiwani@uthscsa.edu|
316808|NCT04439214|ECOG-ACRIN Cancer Research Group|Study Statistician|16176323012|eatrials@jimmy.harvard.edu|
316809|NCT04439240|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
316810|NCT04438785|Grupo Hospitalario Quironsalud|Francisco Jesus Gonzalez|0034645014593|fgonzasan@gmail.com|
316811|NCT04431908|Yale School of Medicine|Dr. R. Peter Manes|(203) 785-5430|rpeter.manes@yale.edu|
316812|NCT04413929|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
316813|NCT04430634|Nerudia|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
316814|NCT04429932|Nerudia Ltd|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
316815|NCT04428502|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316816|NCT04428424|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316817|NCT04428359|BP Koirala Institute of Health Sciences|Dr. Bibisha Baaniya|9841744777|cul.bibisha@gmail.com|+977
316818|NCT04410159|UNIVERSITI SAINS ISLAM MALAYSIA|NURUL AZMAWATI MOHAMED|+603 42892400|drnurul@usim.edu.my|2417
316819|NCT04425850|Eurnekian Public Hospital|Dr. Héctor Carvallo|54144800949|hymcarvallo@hotmail.com|
316820|NCT04425863|Eurnekian Public Hospital|Dr. Héctor Carvallo|54144800949|hymcarvallo@hotmail.com|
316821|NCT04425746|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
316822|NCT04422561|Zagazig University|Dr. Waheed Shouman|+201114812048|shouman66@gmail.com|
316823|NCT04421404|UCSF|Dr. Annie Luetkemeyer|415-476-4082|annie.luetkemeyer@ucsf.edu|130
316824|NCT04419311|Aksaray University Training and Research Hospital|Dr. Erdem Aras Sezgin|+905057777697|sezginmd@hotmail.com|
281768|NCT04045132|The Children's Hospital of Philadelphia|Dr. James Guevara|2155901130|guevara@chop.edu|
305631|NCT02347488|UCLA Department of Anesthesiology|Nir Nahum Hoftman, MD|310-267-8679|nhoftman@mednet.ucla.edu|
305632|NCT02347605|University of Minnesota|Michael Kotlyar|612-251-8780|kotly001@umn.edu|
305633|NCT02347631|UT Southwestern Medical Center|Danielle Robertson|214-648-3416|danielle.robertson@utsouthwestern.edu|
305634|NCT02347657|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
305635|NCT02347761|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
305636|NCT02347774|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
305637|NCT02347787|University of Pennsylvania School of Medicine|Lindsey Norton|215-573-9961|lindsey.turr@uphs.upenn.edu|
305638|NCT02347813|University of Rochester|Alice Pentland, MD|585-275-1998|alice_pentland@urmc.rochester.edu|
305639|NCT02347917|Sumitomo Dainippon Pharmaceutical|Clinical Research (Oncology)|e-mail only|cc@ds-pharma.co.jp|
305640|NCT02348008|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-921-2050|jsmith@hoosiercancer.org|
305641|NCT02348203|University of Arizona|Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
305642|NCT02348216|Kite, A Gilead Company|Medical Information|844-454-5483 (1-844-454-KITE)|medinfo@kitepharma.com|
305643|NCT02348385|Yale|Kelly Cosgrove|203-737-6969|kelly.cosgrove@yale.edu|
305644|NCT02348489|Astex Pharmaceuticals, Inc.|Dr. Harold Keer|925-560-2913|harold.keer@astx.com|
305645|NCT02348593|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
305646|NCT02348606|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
305647|NCT02348619|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
305648|NCT02348632|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
314218|NCT03273543|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
314219|NCT03273673|Virginia Tech|Dr. Robin Queen|(540) 231-3134|rmqueen@vt.edu|
314220|NCT03273946|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314221|NCT03274076|University of Michigan|Dinesh Khanna|734-763-7182|khannad@med.umich.edu|
314222|NCT03274440|Columbia University/New York State Psychiatric Institute|Dr. Reilly Kayser|6467748118|reilly.kayser@nyspi.columbia.edu|
314223|NCT03274453|New York University School of Medicine|Kirsten Boenigk|212 598 6085|Kirsten.Boenigk@nyumc.org|
314224|NCT03274466|"KCI | 3M"|Director of Clinical Research|(210) 515-4060|actate@mmm.com|
316825|NCT04415489|University of North Carolina at Chapel Hill|Sarah Moustafa, MD|919-908-0000|sarah_moustafa@med.unc.edu|
293523|NCT01495585|National Insitute of DIabetes and Digestive and Kidney Diseases|Dr. Theo Heller|301-402-7147|hellert@mail.nih.gov|
293524|NCT01495689|Ottawa Hospital Research Institute|Smita Pakhale|613-737-8899|spakhale@ohri.ca|79428
293525|NCT01495702|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
316826|NCT04411667|Sharp HealthCare|Matthew Geriak, PharmD / Research Pharmacist|8589393717|matthew.geriak@sharp.com|
316827|NCT04409886|Maimonides Medical Center|Gene Sobol|718-283-6000|gsobol@maimonidesmed.org|
316828|NCT04407507|Investigacion Biomedica para el Desarrollo de Fármacos S.A. de C.V|Carmen de la Rocha|523320028697|carmen.delarocha@investigacionbiomedica.com.mx|306
316829|NCT04406194|Farmagen|Aydin Erenmemisoglu|+90 532 551 0082|a.erenmemisoglu@farmagenarge.com|
316830|NCT04404907|Northwestern University|Dr. June Robinson|312-503-5941|june-robinson@northwestern.edu|
316831|NCT04404010|Precision OS Technology|Dr. Danny P Goel|604-345-0401|danny@precisionostech.com|
316832|NCT04403399|U of Michigan|Dr. Cathie Spino, Research Professor of Biostatistics|7346155469|spino@umich.edu|
316833|NCT04402970|University of Missouri|Dr. Zach Holliday|5738829072|hollidayz@health.missouri.edu|
316834|NCT04403113|Marmara University|Assoc. Prof Gonul Acar|5323778878|gonulacar34@gmail.com|+90
316835|NCT04401202|King Abdulaziz University|Dr. Abdulrahman Koshak|0543292333|aekoshak@kau.edu.sa|
316836|NCT04401579|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
316837|NCT04400682|Farmagen|Aydin Erenmemisoglu|+90 532 551 0082|a.erenmemisoglu@farmagenarge.com|
316838|NCT04399161|JSS Dental College & Hospital, JSS Academy of Higher Education & Research|Dr. Krupa NC|8105064056|kripa_555@yahoo.com|+91
316839|NCT04399980|Cleveland Clinic|Paul C. Cremer, MD|216-444-6765|cremerp@ccf.org|
316840|NCT04399122|Joint Warfighter Refractive Surgery Center, Wilford Hall Ambulatory Surgical Center|Dr. Jose E. Capo-Aponte|(210) 292-2554|Jose.E.CapoAponte.ctr@mail.mil|
316841|NCT04397445|U.S. Food and Drug Administration|David Strauss, MD, PhD|301-796-6323|David.Strauss@fda.hhs.gov|
316842|NCT04397094|Faculty of Dentistry Ain Shams University|Dr. Mariem Wassel|+2 0064871416|mariem.wassel@dent.asu.edu.eg|
316843|NCT04396639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316844|NCT04396665|University of Oviedo|Vicerrectorado de investigación|+34985104190|viceinvestigacion@uniovi.es|
316845|NCT04393493|hospital civil de guadalajara|Dr Jonathan Chavez Iñiguez|3313299609|jonarchi_10@hotmail.com|
316846|NCT04392362|University of Pretoria|Dr. Amanda Makhubela|0722746091|neurosurgeon76@gmail.com|
316847|NCT04392141|Kermanshah University of Medical Sciences|Prof. Ali Mostafaie|+989188302044|amostafaie@kums.ac.ir|
316848|NCT04392219|Ridgeback Biotherapeutics|Dr. Wendy Painter|786-687-2495|EIDD2801@ridgebackbio.com|
316849|NCT04391842|Medical Pain Consultants|Dr. Ralph Ortiz|(607) 844-9979|drortizmpc@gmail.com|
316850|NCT04390022|Barcelona Institute for Global Health|Carlos Chaccour|0034666293112|carlos.chaccour@isglobal.org|
316851|NCT04386902|Neurosteer|Nathan Intrator, Prof.|+1 (401) 837-0351|nathan@neurosteer.com|
316852|NCT04385238|Harvard T.H. Chan School of Public Health|Sonia Hernandez-Diaz|6174323942|shernan@hsph.harvard.edu|
316853|NCT04384523|Wuhan Healthgen Biotechnology Corp.|Daichang Yang|18602708398|dyang@oryzogen.com|
316854|NCT04383665|Keck School of Medicine of University of Southern California|Dr Darrin Lee|(323) 442-5720|darrinjl@usc.edu|
293526|NCT01495793|UCB Pharma|UCB Clinical Trial Call Center|+1877-822||9493
293527|NCT01495819|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
305649|NCT02348658|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
305650|NCT02348684|Medical College of Wisconsin|Dr. Carmen Bergom|414-805-4365|cbergom@mcw.edu|
316855|NCT04383132|Şehit Prof. Dr. İlhan Varank Eğitim Ve Araştırma Hastanesi|Dr. Beslen Göksoy|05349530112|beslengoksoy@gmail.com|
316856|NCT04382066|PharmaMar, S.A.|Clinical Development Virology Business Unit PharmaMar|+34 91 846 60 00|clinicaltrials@pharmamar.com|
316857|NCT04381481|University of North Carolina at Chapel Hill|Marissa Hall, PhD|919-962-5907|mghall@unc.edu|
316858|NCT04380688|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
316859|NCT04376060|Saint Joseph University|Dr Sarah Khalil|0096170322739|sarahfkhalil2@gmail.com|
316860|NCT04374500|Umeå University, Umeå, Sweden|Stefan Söderberg|+46 70 319 38 03|stefan.soderberg@umu.se|
316861|NCT04372186|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genetech@druginfo.com|
316862|NCT04371419|Massachusetts Institute of Technology|Pierre-Luc Vautrey|(617) 258-7013|vautrey@mit.edu|
316863|NCT04370834|National Cancer Institute|Dr. Richard Little, Principal Investigator|240-276-6093|littler@mail.nih.gov|
316864|NCT04370548|Dare Bioscience, Inc.|VP, Clinical Operations|858-926-7655|nzack@darebioscience.com|109
316865|NCT04370028|OOO NPF Materia Medica Holding|Mikhail Putilovskiy, MD, PhD|+74952761575|PutilovskiyMA@materiamedica.ru|302
316866|NCT04368429|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
316867|NCT04363736|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
316868|NCT04366583|Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan|Dr. Huay-Min Wang|+886-7-3422121|hmwang@vghks.gov.tw|2075
316869|NCT04365699|NYU Langone Health|Stuart Katz, MD|212-263-3946|Stuart.Katz@nyulangone.org|
316870|NCT04365153|Cleveland Clinic|Paul C. Cremer, MD|216-444-6765|cremerp@ccf.org|
316871|NCT04363879|AtriumHealth|Dr. Brad Hurst, Director of Assisted Reproduction Program|7043553153|Brad.Hurst@@atriumhealth.org|
316872|NCT04362137|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
316873|NCT04359771|faculty of medicine, Cairo University|Dr. Ahmed Abdelbaki|00201066642728|a.abdelbaki@kasralainy.edu.eg|
316874|NCT04358991|University of Pittsburgh|Dr. Ryan Shields, Associate Professor of Medicine|412-864-3745|shieldsrk@upmc.edu|
316875|NCT04358081|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
316876|NCT04356937|Massachusetts General Hospital|DRAI Director of Clinical Trials|617-726-7938|JHSTONE@mgh.harvard.edu|
316877|NCT04355663|Third Faculty of Medicine, Charles University|PhDr. Kamila Řasová, Ph.D.|+420604511416|kamila.rasova@gmail.com|
316878|NCT04354870|NYU Langone Health - Bellevue Hospital|H. Michael Belmont, MD|646-501-7400|Michael.Belmont@nyulangone.org|
316879|NCT04350307|Yale University|Dr. Robin Raju|203-688-8800|robin.raju@yale.edu|
316880|NCT04352660|UCSD Shiley Eye Institute|Dr. Jiun Do|8585346290|jiundo@ucsd.edu|
316881|NCT04350788|UNC-CH School of Nursing|Biostatistician|919-966-7181|peiran@live.unc.edu|
316882|NCT04349917|University of North Carolina at Chapel Hill|Jessica R. Cohen, PhD|(919) 843-3753|jrcohen@unc.edu|
316883|NCT04348851|North Florida/South Georgia Veterans Health System|Dr. Constance Uphold|352-548-6000|connie.uphold@va.gov|106893
316884|NCT04348357|Texas Tech University Health and Science Center El Paso|Dr Steven Radtke|2177254940|dr.radtke@gmail.com|
316885|NCT04346199|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
316886|NCT04345653|JFK University Medical Center - Hackensack Meridian Health|Dr. Jawad Kirmani|7327745805|jawad.kirmani@hmhn.org|
316887|NCT04343261|Saint Francis Hospital and Medical Center|Latha Dulipsingh, MD|860-714-4402|Latha.Dulipsingh@trinityhealthofne.org|
316888|NCT04343222|University of Wisconsin - Madison|Maxwell Wingelaar|231-233-6051|mwingelaar@uwhealth.org|
316889|NCT04343092|College of Medicine-University of Baghdad|Faiq I. Gorial|009647801730696|faiqig@gmail.com|
316890|NCT04342663|Washington University School of Medicine|Dr. Eric Lenze|314-362-5154|lenzee@wustl.edu|
316891|NCT04342897|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
316892|NCT04342130|University of Rochester|Paul Geha|203-752-8256|paul_geha@urmc.rochester.edu|
316893|NCT04340557|Sharp HealthCare|Matthew Geriak, PharmD|858-939-3717|matthew.geriak@sharp.com|
316894|NCT04339972|Medical University of South Carolina|Dr. Mark George or Dr. Bashar Badran|843-792-6076|georgem@musc.edu|
316895|NCT04339296|Health Systems Evaluation & Evidence - Alberta Health Services|Research and Evaluation Coordinator|4036489255|armghan.ahmad@albertahealthservices.ca|
316896|NCT04338009|University of Pennsylvania|Dr. Jordana Cohen|215-662-4000|jco@pennmedicine.upenn.edu|
316897|NCT04338074|University of Alabama at Birmingham|Dr. Timothy J Ness|205-975-9643|tness@uabmc.edu|
316898|NCT04337138|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316899|NCT04336475|Cukurova University|Dr Nihan Cuzdan, MD, principal investigator|05052706846|nihancuzdan@hotmail.com|
316900|NCT04335929|Lamar University|Dr. Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 812 9443|vmanchaiah@lamar.edu|
293528|NCT01495858|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
305651|NCT02348723|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
305652|NCT02348775|Baylor College of Medicine|R. V. Sekhar M.D.|713-798-3908|rsekhar@bcm.edu|
305653|NCT02348840|Emory University|Gari D. Clifford, DPhil|404-727-0229|gari.clifford@emory.edu|
305654|NCT02348918|Allegro Ophthalmics, LLC|Director of Clinical Research|949-940-8130|info@allegroeye.com|
305655|NCT02349048|Janssen R&D BE|Associate Director, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
305656|NCT02349061|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
305657|NCT02349152|University of Pittsburgh|Dr. Kathirvel Subramaniam, MD, MPH|412-647-5635|subramaniamk@upmc.edu|
305658|NCT02349178|Medical College of Wisconsin|Michael J Burke, MD|414-955-4170|mmburke@mcw.edu|
293529|NCT01495923|The Johns Hopkins Hospital|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
316901|NCT04335812|Lamar University|Dr. Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 812 9443|vmanchaiah@lamar.edu|
316902|NCT04335136|APEIRON Biologics AG|Dr. Romana Gugenberger|+4366488506236|romana.gugenberger@apeiron-biologics.com|
316903|NCT04335552|Duke University|Jason Stout, MD, MHS|919-668-0826|jason.stout@dm.duke.edu|
316904|NCT04334876|Indiana University|Courtney Rowan|317-944-7065|coujohns@iu.edu|
316905|NCT04334681|prinipal investigator|Dr. Alpaslan Şahin|0332310500|drasahin@gmail.com|50510
316906|NCT04333225|Baylor Scott & White Research Institute|Peter A. McCullough, MD, MPH|2148412000|peteramccullough@gmail.com|
282620|NCT00864253|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
316907|NCT04333199|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
316908|NCT04332991|Mass General Hopsital (PETAL Network Coordinating Center)|B.Taylor Thompson, MD|617-726-8854|TTHOMPSON1@mgh.harvard.edu|
316909|NCT04332614|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
316910|NCT04322968|VA Ann Arbor Healthcare System|Dr. Alisher Dadabayev, Pain POC|734-222-7639|Alisher.Dadabayev@VA.GOV|
316911|NCT04332419|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Ram Gurajala, MD|1-866-223-8100|TaussigResearch@ccf.org|
316912|NCT04332081|NYU Langone|David Lee|212-263-3293|David.lee@nyulanogne.org|
316913|NCT04332107|University of California, San Francisco FI Proctor Foundation|Dr. Thomas Lietman, Director of the UCSF FI Proctor Foundation|415-476-1442|tom.lietman@ucsf.edu|
316914|NCT04323592|University of Trieste|Prof. Marco Confalonieri|+393356895168|mconfalonieri@units.it|4667
316915|NCT04326842|The First Affiliated Hospital of Harbin Medical University|Dr. Hong Zhang|+86 0451-85553952|2315186458@qq.com|
316916|NCT04325542|Medical Mission Institute|Dr Christa Kasang||christa.kasang@medmissio.de|
316917|NCT04329923|UPenn|Amelia Anderson|215-509-5690|amelia.anderson@pennmedicine.upenn.edu|
316918|NCT04328467|University of Minnesota|Radha Rajasingham, MD|612-626-8171|radha@umn.edu|
316919|NCT04327388|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
316920|NCT04322526|University of Pittsburgh|Dr. Marta Pecina|734-945-2473|pecinam@upmc.edu|
316921|NCT04322500|University of Molise|Prof. Ciro Costagliola|+39 0874 404861/ 0874 404896|ciro.costagliola@unimol.it|
316922|NCT04322682|Montreal Heart Institute|Dr. Jean-Claude Tardif (Principle Investigator)|514 376-3330|jean-claude.tardif@icm-mhi.org|3612
316923|NCT04321980|Orpheris, Inc.|Jeffrey L Cleland, PhD, Executive Chair|650-505-5048|cleland@orpheris.com|
316924|NCT04322396|Gentofte Hospital|Prof. Jens-Ulrik Stæhr Jensen, MD PHD|+4538673057|jens.ulrik.jensen@regionh.dk|
316925|NCT04320823|Haemonetics Corporation|Jan Hartmann, MD, Vice President of Medical Affairs and Clinical Development|(781) 348 7396|Jan.Hartmann@haemonetics.com|
316926|NCT04320615|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
316927|NCT04318535|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
316928|NCT04316260|Medical University of South Carolina|Noelle Natale|843-876-2426|natalen@musc.edu|
316929|NCT04314037|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
316930|NCT04315298|Regeneron Pharmaceuticals, Inc.|Clinical Trials Adminstrator|844-734-6643|clinicaltrials@regeneron.com|
316931|NCT04313647|Ruijin Hospital , Shanghai Jiao Tong University School of Medicine|Dr. Qu|(+86)2164370045|jmqu0906@163.com|
316932|NCT04310085|Medicines for Malaria Venture|Dr Stephan Chalon|+41 22 555 0379|chalons@mmv.org|
316933|NCT04309617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316934|NCT04308239|Virginia Tech|Michael Madigan|(540) 231-3543|mlm@vt.edu|
316935|NCT04308668|University of Minnesota|David Boulware, MD, MPH|6125552020|covid19@umn.edu|
316936|NCT04307940|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
316937|NCT04302545|King Edward Medical University, Lahore, Pakistan|Shazia Saaqib|+92-3214708583|shaziasaaqib@gmail.com|
316938|NCT04297631|Washington University|Venessa Riegler|3143621721|rieglerv@wustl.edu|
316939|NCT04297241|Cincinnati Children's Hospital|Mary Banks|513-636-2147|mary.banks@cchmc.org|
316940|NCT04296448|Johns Hopkins University Department o Peidaitrics Division of Pediatric Emergency Medicne|Dr. Therese Canares|(410) 955-6146‬|therese.canares@jhmi.edu|
316941|NCT04296227|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
316942|NCT04295356|CELLTRION, Inc.|Sung Hyun Kim, Head of Clinical Planning Department|+82 32 850 5778|SungHyun.Kim@celltrion.com|
316943|NCT04292639|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
316944|NCT04292535|Michigan State University|Matthew B. Pontifex|517-432-5105|pontifex@msu.edu|
316945|NCT04292171|University of Nevada Las Vegas School of Medicine|Adam V. Levy MD|702-671-2300|adam.levy@unlv.edu|
316946|NCT04292899|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
316947|NCT04292730|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
316948|NCT04290676|EyePoint Pharmaceuticals|Dario Paggiarino, MD|(617) 610-3411|dpaggiarino@eyepointpharma.com|
316949|NCT04290039|BARDA|Brenda Wolling, Regulatory SME|(202) 692-4763|Brenda.Wolling@hhs.gov|
316950|NCT04289623|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
316951|NCT04276207|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
316952|NCT04289714|Royal Brompton Hospital|Sukeshi Makhecha|0207-3528121|s.makhecha@rbht.nhs.uk|4375
316953|NCT04288752|J3 Bioscience, Inc|R. Tyler McCabe, Ph.D.|801-550-9956|tmccabe@j3bio.com|
316954|NCT04280705|NIAID|John Beigel, MD|3014519881|jbeigel@niaid.nih.gov|
282621|NCT00864383|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|Dan.Everitt@tballiance.org|
293530|NCT01495975|MGH Diabetes Center|Nancy Wei, MD|617-724-7597|ncwei@mgh.partners.org|
293531|NCT01496066|RxSight, Inc.|Maureen O'Connell Vice President, Regulator and Clinical Affairs|978-207-12415|moconnell@rxsight.com|
293532|NCT01496131|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
316955|NCT04287517|Istanbul University Faculty of Medicine Sports Medicine Department|Dr. Sergen Devran, Residency in Istanbul University Sports Medicine Department|00905377782594|sergendevran@gmail.com|
316956|NCT04287036|Johnson & Johnson Vision Care|Meredith Bishop OD, MS, FAAO|1-800-843-2020|mbishop4@its.jnj.com|
316957|NCT04286412|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
316958|NCT04285411|Vital USA Inc.|Mark H Khachaturian, PhD|+1(561)282-6074|mark.khachaturian@vvvital.com|
316959|NCT04284930|Cleveland Clinic|Risal Djohan|216 312-6146|djohanr@ccf.org|
316960|NCT04283773|Assiut Univercity|Demonstrator at pathology department|00201033986747|omar011523@med.au.edu.eg|
316961|NCT04281901|Department of Otorhinolaryngology and Cervicofacial Surgery, University Medical Centre Ljubljana, Ljubljana, Slovenia. Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.|Domen Vozel, M.D., Saba Battelino, M.D., PhD.|+386 (0)1 522 83 07|domen.vozel@kclj.si|
316962|NCT04280653|Mati Therapeutics Inc.|Deepank Utkhede|778-991-3301|dutkhede@matitherapeutics.com|
316963|NCT04277936|Vanderbilt University Medical Center|Stephan Heckers|6159222665|stephan.heckers@vumc.org|
316964|NCT04275336|Children's Hospital of Fudan University|Ms.Yu Zhuowen|18017591126|yzw100@126.com|
316965|NCT04272775|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
316966|NCT04271020|NeoTract, Inc.|Emily Friedland, Director, Global Clinical Affairs|1-610-331-7299|emily.friedland@teleflex.com|
316967|NCT04274075|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
316968|NCT04271605|National Taiwan University BioMedical Park Hospital Chu-Tung Campus|Chirn-Bin Chang|0972654906|G03776@hch.gov.tw|
316969|NCT04271761|Cochlear|Ruth English|0386633105|REnglish@cochlear.com|3105
316970|NCT04268316|Stanford University|Margot Paul|415-625-3127|mdpaul@stanford.edu|
316971|NCT04269629|Department of Dermatology and Venerology|Assoz.-Prof. Dr. Gunter Sturm|+4331638580318|gunter.sturm@medunigraz.at|
316972|NCT04267575|Jerome Canady Research Institute for Advanced Biological and Technological Sciences|Jerome Canady, M.D.|301-270-0147|drjcanady@gwu.edu|
316973|NCT04267770|Imperial College London|Nick Oliver|+44 20 7594 1796|nick.oliver@imperial.ac.uk|
316974|NCT04266925|University of Alabama at Birmingham|Dr David Schwebel,|205-934-4068|schwebel@uab.edu|
316975|NCT04263142|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
316976|NCT04256785|Universidad de Granada|Dr. Elena Pita Calandre|+34 958246291|epita@ugr.es|
316977|NCT04252092|Eksen Sağlık ve Rehabilitasyon|PT,Cansu Hayıroğlu|+905378405948|cansu5309@gmail.com|
316978|NCT04251884|Ospedale Regionale di Lugano|Dr. Francesco Mongelli|+41764706297|francesco.mongelli@mail.com|
316979|NCT04250987|Coloplast|Vice President, Medical Affairs|+45 4911 1111|clinical-studies@coloplast.com|
316980|NCT04249336|Dow University of Health Sciences|Syed Jaffar Abbas Zaidi|00923412481371|jaffar.zaidi@duhs.edu.pk|
316981|NCT04249310|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
316982|NCT04247581|Apple|Health Tech Clinical Operations|866-905-5303|htclinicalquestions@apple.com|
316983|NCT04247061|Boston University|Director of Center for Behavioral Science Research|6173583358|belindab@bu.edu|
316984|NCT04245202|Ege University Medical Faculty Hospital|Dr. Aykut Eşki|05303009760|aykuteski1984@gmail.com|
316985|NCT04243369|Philips|T.J. Battisti|(425) 205-3515|t.j.battisti@philips.com|
316986|NCT04241146|Children's Hospital of Nevada at UMC|Prashant Jha|702-383-2420|prashant.jha@umcsn.com|
316987|NCT04240678|UC Davis Medical Center|Eric Chak|916-734-3751|echak@ucdavis.edu|
316988|NCT04238650|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
316989|NCT04238663|mAbxience Research SL|Susana Millan|+34917711500|susana.millan@mabxience.com|
316990|NCT04235582|Aurora Health Care|Mindy Waite, Behavioral Health Research Scientist|414-773-4323|mindy.waite@aah.org|
316991|NCT04203225|Harbor-UCLA Medical Center|Kelly D. Young, MD|424-306-5431|kyoung3@dhs.lacounty.gov|
316992|NCT04234672|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
316993|NCT04223635|Daiichi Sanyko, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
316994|NCT04214951|Peking University People's Hospital|Dr. Xiaohui Zhang, Director of Clinical Trials|86-10-88324577|zhangxh@bjmu.edu.cn|
316995|NCT04234425|Montana State University|Dr. Lauren Davis|8287736328|lauren.davis6@montana.edu|
316996|NCT04232137|Vanderbilt University Medical Center|Dr. Tobias Limperg|(615) 343-6710|tobias.limperg@vumc.org|
293533|NCT01496157|Johns Hopkins University|Steven Rowe, M.D, Ph.D|4105021520|srowe8@jhmi.edu|
316997|NCT04222699|VA Maryland Healthcare System|Dr. Mary-Claire Roghmann|410 706 0062|mroghmann@som.umaryland.edu|
316998|NCT04208698|CinDome Pharma, Inc.|Director of Clinical Trials|844-531-1834|info@cinrx.com|
316999|NCT04206293|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
317000|NCT04228302|EicOsis|Dr. William Schmidt|650-438-3018|wkschmidt@eicosis.com|
317001|NCT04227119|Emory University|Anand Shah, MD|404-712-4063|anand.d.shah@emory.edu|
317002|NCT04224753|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
317003|NCT04218799|University of Maryland School of Medicine|Dr. Mary-Claire Roghmann|410 706 0062|mroghmann@som.umaryland.edu|
317004|NCT04204057|Rhizen Pharmaceuticals|Prajak Barde MD|+41325800175|pjb@rhizen.com|
317005|NCT04195594|TRCGEN+ (managed by Trans Russian Co)|Nikolaos Tzenios|+447583902071|Nicolas@trccolleges.com|
317006|NCT04223687|University of North Carolina at Chapel Hill|Marissa Hall, PhD|(919) 445-1310|mghall@unc.edu|
317007|NCT04223232|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33 1 80 40 14 40|frederic.sedel@medday-pharma.com|
317008|NCT04189224|Johnson & Johnson Vision Care, Inc.|Thomas R Karkkainen.|1-800-843-2020|tkarkkai@its.jnj.com|
293534|NCT01496183|The State University of New York at Buffalo|Dr. Elsa Daurignac, Research Assistant Professor|716-898-4540|ecd3@buffalo.edu|
293535|NCT01496248|Krea University College of Medicine|Young-Hoon Ko|+82-31-412-5140|korean@chol.com|
293536|NCT01496274|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
305659|NCT02349295|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317009|NCT04214600|Cairo University|Dr. Nadine Mansour|(+2)01001482455- 01001465719|lotfynadine@gmail.com|
317010|NCT04202497|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
317011|NCT04214080|Marmara University|Assoc. Prof Aysel Yıldız Ozer|5334674433|aysel.yildiz@marmara.edu.tr|+90
317012|NCT04209530|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
317013|NCT04209335|University of Salford|ISOMETRIC CORE MUSCLE ENDURANCE IN HEALTHY ACTIVE AND NON-ACTIVE WORKING AGE POPULATIONS|07488550768|H.Holmberg@edu.salford.ac.uk|
317014|NCT04207333|University of North Carolina at Chapel Hill|Lee Stoner, PhD, MPH|919-962-0534|stonerl@unc.edu|
317015|NCT04207840|Amphastar Pharmaceuticals, Inc.|Amphastar Pharmaceuticals, Inc.|(909) 980-9484|info@amphastar.com|
317016|NCT04206800|Boston IVF|Kristin Rooney|781-434-6470|krooney@bostonivf.com|
317017|NCT04205669|CERMEL|Julian Matthewman|00241 07-98-91-91|julianmatthewman@gmail.com|
317018|NCT04198948|University of Sarajevo|Associate Professor Tanja Dujic, PhD|+38733586194|tanja.dujic@ffsa.unsa.ba|
317019|NCT04206384|CAO Group|VP, Quality & Regulatory|801-256-9282|info@caogroup.com|
317020|NCT04204200|Centre Hospitalier de Ham|Dr. Jean-Francois Cazeneuve, Surgeon|06 62 29 24 51|jfc.laon@gmail.com|0033
317021|NCT04196907|Masimo Corporation|Vikram Ramakanth|949-297-7000|clinicalresearchdept@masimo.com|
317022|NCT04195893|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
317023|NCT04195880|Providence VAMC|Vincent Mor, Principal Investigator|4012737100|vincent_mor@brown.edu|6259
317024|NCT04195581|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|925-621-3761|JVega2@coopervision.com|
317025|NCT04194151|Hospital Central de la Defensa Gomez Ulla|Dr. Paula Agostina VULLO|+34681054151|agosvullo@hotmail.com|
317026|NCT04194008|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical & Regulatory Affairs|0542220121|daganh@theranica.com|
317027|NCT04191668|Ectosense|Frederik Massie|+1 786 305 8547|frederik.massie@ectosense.com|
317028|NCT04189081|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
317029|NCT04186780|Universidade de Sorocaba|Dr. Luciane Cruz Lopes|+ 55 15 2101-7104|luciane.lopes@prof.uniso.br|
317030|NCT04186806|3M Health Care|Elaine Egging/Project Manger|651-737-0263|eegging@mmm.com|
317031|NCT04186481|Smith+Nephew, Inc.|Alison Walker, Regional Operation Manager ANZ|+61 466 322 200|Alison.walker@smith-nephew.com|
317032|NCT04184999|SR Cornea Consultants|Dr. Sanjay Rao|8476685498|sanjaynraomd@gmail.com|
317033|NCT04184271|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
317034|NCT04183231|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|206-2516831|drmilgrom@silverarrest.com|
317035|NCT04182958|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
317036|NCT04179838|Northwestern University|Thorsten Kahnt|3125032896|thorsten.kahnt@northwestern.edu|
317037|NCT04179461|Cincinnati Children's Hospital Medical Center|Theresa Guilbert, MD, MS|(513) 636-6771|Theresa.Guilbert@cchmc.org|
317038|NCT04179474|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
317039|NCT04178590|Department of Periodontology and Oral Medicine, School of Dental Medicine, University of Belgrade|Dr Mila Vuckovic|+381637060694|jovanovic.dr.mila@gmail.com|
317040|NCT04177862|University of Minnesota|Dr. Jonah Pearson|218-280-8348|pears731@umn.edu|1
317041|NCT04176406|Duke University|Dr. Lawrence G. Appelbaum|919-613-7664|greg@duke.edu|
317042|NCT04175262|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317043|NCT04171102|University of Cagliari|Prof. Dr. Giuseppe Amato|337963197|amatomed@gmail.com|
317044|NCT04174638|Akdeniz University|Dr Sefika Tugba Yangoz|+905058039716|tugbayangoz@gmail.com|
305660|NCT02349360|University of Florida|Wendy Dahl Associate Professor|3522943707|wdahl@ufl.edu|
305661|NCT02349412|Massachusetts General Hospital Cancer Center|Jennifer Temel, MD|(617) 724-0453|jtemel@partners.org|
305662|NCT02349425|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305663|NCT02349438|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST|904-443-3449|CColesb@ITS.JNJ.com|
305664|NCT02349451|AbbVie|Global Medical Services|800-633-9110||
305665|NCT02349477|Medical University of South Carolina|Dr. Michaela Hoffman|8437927758|HoffmaMi@musc.edu|
305666|NCT02349542|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2260|susan.odum@orthocarolina.com|
305667|NCT02349633|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
305668|NCT02349646|St. Jude Medical|Jennifer Duggan|+32(0)27746827|jduggan@sjm.com|
305669|NCT02349685|SeoulNUBH|Nayoung Kim|+ 82-31-787-7008|nayoungkim49@empas.com|
305670|NCT02349711|Food Science and Human Nutrition Department, University of Florida|Dr. Bobbi Langkamp-Henken|352-294-3721|henken@ufl.edu|
305671|NCT02349789|Kennedy Krieger Institute|Anthony Gonzalez|4439080074|gonzalezan@kennedykrieger.org|
305672|NCT02350127|San Francisco VA|Dr. Deborah Barnes, PI|415-221-4810|deborah.barnes4@va.gov|24221
305673|NCT02350309|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
305674|NCT02350478|Medical University of Graz|Assoz.-Prof. Dr. Harald Sourij|+43316385|ha.sourij@medunigraz.at|81310
305675|NCT02350569|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
305676|NCT02350647|Hawkins Foundation|Kyle Adams, Research Coordinator|864-454-7458|kyle.adams@hawkinsfoundation.com|
305677|NCT02350660|University of Virginia|Department of Medicine and Pediatrics|434.924.0000|spc7w@virginia.edu|
293537|NCT01496287|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
293538|NCT01496313|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
293539|NCT01496352|Dr. Reddy's Laboratories, Inc.|Kent Allenby, MD, VP, Drug Development|609-375-9855|kallenby@drreddys.com|
293540|NCT01496365|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
317045|NCT04174313|Hospital El Cruce|Nestor Pistillo|054 1142109000|npistillo@yahoo.com.ar|5636
293541|NCT01496430|Takeda|Medical Director; Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
293542|NCT01496456|UMichigan|Dr. Mathilde C Peters||mcpete@umich.edu|
317046|NCT04173429|Qilu Hospital of Shandong University|Professor Gao Yanjing|18560086087|gaoyanjing@sdu.edu.cn|
293543|NCT01496469|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
293544|NCT01496612|NIH/NINDS|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
293545|NCT01496807|H. Lee Moffitt Cancer Center and Research Institute|Dr. Andrew Brohl|813-745-3242|andrew.brohl@moffitt.org|
293546|NCT01496846|University of Michigan|Dr Tatiana Botero, Director of Postgraduate Program in Endodontics|734-936-2526|tbotero@umich.edu|
305678|NCT02350816|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
305679|NCT02350881|Casa di Cura VIlla Berica|Dr Stefano Fieschi||stefanofieschi@gmail.com|
305680|NCT02350998|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
305681|NCT02351037|Pharmacyclics|Priyanka Mandava, Director of Clinical Operations|408-215-3776|psingh@pcyc.com|
317047|NCT04173741|Hacettepe University|Dr. Asli Melek|+905376636789|aslimelek121@gmail.com|
317048|NCT04169061|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
317049|NCT04157738|Emory University|Dr. Eric Felner|404-727-7651|efelner@emory.edu|
317050|NCT04156646|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
317051|NCT04170686|University of Pennsylvania|Dr. Melissa G. Hunt|610-529-8055|mhunt@psych.upenn.edu|
317052|NCT04169113|Northwestern University|Melissa Shauver; Research Project Manager|3124726024|melissa.shauver1@nm.org|
317053|NCT04160975|Harvard University|Dr. Marcella Alsan|617-496-1770|marcella_alsan@hks.harvard.edu|
270340|NCT00122109|VA Pacific Islands Healthcare System|Leslie A. Morland, PsyD, Principal Investigator|(808) 566-1934|leslie.morland@va.gov|
270341|NCT00122135|Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), MEDVAMC, Houston, TX|Dr. Ursula Braun|832 687 1645|ubraun@bcm.edu; ursula.braun@va.gov|
270342|NCT00122187|VAHSRD|Linda Humphrey|503-220-8262|linda.humphrey@va.gov|57176
270343|NCT00122278|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
270344|NCT00122317|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
270345|NCT00122369|Beth Israel Deaconess Medical Center (at time of study); now Hypnalgesics, LLC|Elvira V. Lang, MD|978 404 9724|elang@bidmc.harvard.edu|
270346|NCT00122382|Bristol-Myers Squibb|Study Director||Clinical.Trials@bms.com|
270347|NCT00122447|Emory University School of Medicine|Mary Rhee, M.D.|404-778-1660|mrhee@emory.edu|
270348|NCT00122460|Merck Serono|Inmaculada Ollero/Clinical Trial Manager|+34935655433|iollero@merck.es|
270349|NCT00122681|GlaxoSmithKline|GSK Response Center|866-435-7343||
270350|NCT00122954|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
305682|NCT02351115|Engage Therapeutics, Inc|Chief Medical Officer||studydirector@engagetherapeutics.com|
270351|NCT00122980|Baylor College of Medicine|Russell E. Ware, MD, PhD, Director, Texas Children's Hematology Center|(832) 824-1368|reware@bcm.edu|
270352|NCT00123110|University of Pennsylvania, School of Medicine|Anne R. Cappola, M.D., ScM|(215) 573-5359|ACappola@mail.med.upenn.edu|
270353|NCT00123123|University at Buffalo|Frank A. Scannapieco|716-829-3373|fas1@buffalo.edu|
270354|NCT00123162|MS Hershey Medical Center|Richard S Legro MD|717-531-8478|rsl1@psu.edu|
270355|NCT00123409|Philadelphia VAMC|David Oslin|2158235894|dave.oslin@upenn.edu|
270356|NCT00123422|Edward Hines Jr. ,VA Hospital|Eileen Collins|708-202-3525|eileen.collins@va.gov|
270357|NCT00123474|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
293547|NCT01496885|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
305683|NCT02351167|Washington University School of Medicine|Li-Shiun Chen, M.D.|314-362-3932|li-shiun@wustl.edu|
305684|NCT02351258|Johns Hopkins University|Dr. Aaron Milstone|443-287-8932|amilsto1@jhmi.edu|
305685|NCT02351271|Ziemer Ophthalmic Systems AG|Sarah Moyle|970 308 9199|sarah.moyle@ziemergroup.com|
305686|NCT02351349|MUHC|Sameena Iqbal|5146302225|sameena.iqbal@mcgill.ca|1841
305687|NCT02351505|The Ohio State University Comprehensive Cancer Center|Erin Bertino, MD|614-293-8054|Erin.Bertino@osumc.edu|
305688|NCT02351700|Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center|Andrew S. Little, MD|602-406-3181|neuropub@dignityhealth.org|
305689|NCT02351739|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
305690|NCT02351817|Coloplast A/S|Medical Director|+45 4911 1395|dkbir@coloplast.com|
305691|NCT02351934|Mayo Clinic|Ilya Danelich, Pharm.D., R.Ph.|507-255-5732|Danelich.Ilya@mayo.edu|
305692|NCT02351960|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305693|NCT02352090|Helsinki University Central Hospital|Oskari Heikinheimo|+358 50 4271533|oskari.heikinheimo@helsinki.fi|
305694|NCT02352259|Institute of Oncology Ljubljana|Dr Gregor Serša|+38615874343|gsersa@onko-i.si|
305695|NCT02352298|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|303-724-6761|satish.garg@ucdenver.edu|
305696|NCT02352363|Acorda Therapeutics|Charles Oh|914-326-5455|coh@acorda.com|
305697|NCT02352493|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|866.330.0326|Clinicaltrials@alnylam.com|
317054|NCT04153409|Lateral Pharma Pty Ltd|Mr David Kenley|+61400151490|dk@lateral-pharma.com|
293548|NCT01497067|Alcon Research|Sr. Clinical Trial Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
305698|NCT02352779|University of Rochester Medical Center|Luke J. Peppone, PhD, MPH. Assistant Professor|585-275-7827|Luke_Peppone@urmc.rochester.edu|
317055|NCT04151628|Shockwave Medical Inc|Randee Randoll, Director Clinical Affairs|1-408-577-7856|rrandoll@shockwavemedical.com|
317056|NCT04167189|PhenoSolve|Lynn Feldman|617-879-1670|lynn@phenosolve.com|
317057|NCT04162795|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
317058|NCT04161807|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical @Regulatory Affairs|0542220121|daganh@theranica.com|
317059|NCT04161144|Medical University of South Carolina|Dr. Michael Saladin|8437925306|saladinm@musc.edu|
317060|NCT04161131|Stanford University|Molly Tanenbaum|650-725-3955|mollyt@stanford.edu|
317061|NCT04161079|Medtentia International Ltd Oy|Olli Keränen / Chief Executive Officer|+358 50 3567090|ok@medtentia.com|
317062|NCT04158466|Bausch Health|Study Director|(585) 338-6399|robert.steffen@bausch.com|
317063|NCT04152083|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
317064|NCT04155567|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
317065|NCT04155047|Sunovion Respiratory Development Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
317066|NCT04152642|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
317067|NCT04150861|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
317068|NCT04150250|PATH|Gwen Ambler|206-285-3500|gambler@path.org|
317069|NCT04149925|Lexington Medical Inc.|Annette Dunn|480-313-8505|annette@lexington-med.com|
317070|NCT04150224|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
317071|NCT04149405|OndokusMU|Feyza Otan Özden|+905322535106|feyza_otan@yahoo.com|
317072|NCT04144088|Chung Shan Medical University Hospital|Dr. Cheng Chung Wei|+886-4-24739595|wei3228@gmail.com|34718
317073|NCT04149353|North Carolina State University|David Lalush|919-513-7671|dslalush@ncsu.edu|
317074|NCT04148651|Candela Corporation|Medical Director|+1 949.599.7657|konikap@candelamedical.com|
317075|NCT04137783|Children's Hospital of Chongqing Medical University|Dr. Jianhui Wang|13678428167|wangjh@cqmu.edu.cn|
317076|NCT04136444|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
317077|NCT04124536|University of North Carolina at Chapel Hill|Benjamin Chi, MD, MSc|919-445-4174|bchi@med.unc.edu|
317078|NCT04147611|University of Miami|Dr. Hillary Snapp|305-243-4611|hsnapp@med.miami.edu|
317079|NCT04147442|Bernafon AG|Dr Barbara Simon|+41 31 998 1515|bsim@bernafon.com|1684
317080|NCT04147455|Emory University|Dr. Kathryn Yount|404-727-8511|kyount@emory.edu|
317081|NCT04146272|Bernafon AG|Barbara Simon|+41 31 998 15 15|bsim@bernafon.com|1664
317082|NCT04143945|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
317083|NCT04143373|Tehran UMS|Dr. Nariman Nikparto|+989124969058|n-nikparto@razi.tums.ac.ir|
305699|NCT02352831|Washington University School of Medicine|Andrea Wang-Gillam, M.D., Ph.D.|314-362-5740|awang-gillam@wustl.edu|
317084|NCT04142216|Demiroglu bilim University|Assistant Professor Nurten Ozen|+905334509382|ozenurten@yahoo.com.tr|
317085|NCT04141930|University of Washington|Research Coordinator|2066165859|jheimo@uw.edu|
317086|NCT04142450|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
317087|NCT04142242|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
317088|NCT04140890|Wayne State University|Dr. Yi-Ling Hu|3142039991|ha1124@wayne.edu|
317089|NCT04139018|Washington University School of Medicine Department of Otolaryngology - Head and Neck Surgery|Jay Piccirillo, M.D., Vice Chair for Research|314-362-8641|piccirij@wustl.edu|
317090|NCT04138810|University of Pennsylvania, Department of Urogynecology|Dr. Lily Arya|215-662-4147|larya@pennmedicine.upenn.edu|
317091|NCT04131556|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
317092|NCT04126174|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
317093|NCT04134429|insel Gruppe AG|Dr. med. Christa König|+41 31 632 21 11|christa.koenig@insel.ch|
317094|NCT04130425|Mayo Clinic|Stephanie Kannas, OTR/L, OTD, CHT|507-284-8841|kannas.stephanie@mayo.edu|
305700|NCT02352844|Washington University School of Medicine|Saiama Waqar, M.D.|314-362-5737|saiamawaqar@wustl.edu|
317095|NCT04138498|Cingulate Therapeutics|VP of Clinical Operations and Regulatory Affairs|913-942-2304|hmitzel@cingulatetherapeutics.com|
317096|NCT04138043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317097|NCT04137627|Universitas Indonesia|Dr. dr. Diani Kartini, Sp.B-K(Onk)|+628122684919|d.kartini@gmail.com|
317098|NCT04136145|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317099|NCT04132336|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
317100|NCT04131517|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
317101|NCT04128293|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317102|NCT04126343|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
317103|NCT04126187|Gainesville Eye Associates|Clayton Blehm, MD|17705324444|claytonblehm@gmail.com|
317104|NCT04124952|SightTrust Eye Institute|Andrew Shatz, MD|877.878.7890|ashatz@sighttrust.com|
317105|NCT04123665|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317106|NCT04122534|Montana State University|Dr. Kelly E. Knight|303-819-6997|kelly.knight3@montana.edu|
317107|NCT04121078|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
317108|NCT04117607|ICON CRU|Dr. Dennis Ruff, Senior Medical Director|210-283-4572|Dennis.Ruff@iconplc.com|
317109|NCT04116684|Cleveland Clinic|Venu Menon, M. D.|216-445-5390|menonv@ccf.org|
317110|NCT04096365|AtaCor Medical, Inc.|Alan Marcovecchio, Vice President, Clinical Affairs|949 391 2252|alan@atacor.com|
317111|NCT04080297|Chief Exceutive Officer|Rob Crombie|+61 3 9657 0731|rcrombie@queoncology.com|
317112|NCT04115358|Marmara University|Prof. Dr. Ali Mentes|+90 2164140545|alimentes@gmail.com|
293549|NCT01497197|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
317113|NCT04114058|Cedar Sinai -Kerlan Jobe|Dr. Michael Banffy|(310) 665-7200|Michael.Banffy@cskerlanjobe.org|
317114|NCT04113785|University of Tennessee|Richard Komistek, Principal Investigator|8659742093|rkomiste@utk.edu|
317115|NCT04113694|Medtronic Diabetes|Emma Pham, MSHS (Clinical Study Manager)|818 576 4878|emma.pham@medtronic.com|
317116|NCT04112160|UT Southwestern Dept of Urology|Dr. Brett Johnson|214-645-3526|brett.johnson@utsouthwestern.edu|
317117|NCT04112069|Mass. General Hospital|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
317118|NCT04109703|Soovu Labs|Charles Chabal, MD|206-579-4910|Chuck@Soovu.com|
317119|NCT04109443|Boston University School of Public Health|Kimberly M Nelson, PhD|617-358-1482|knel@bu.edu|
317120|NCT04109222|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
317121|NCT04107493|ResMed|maureen crocker|+1 8588366653|maureen.crocker@resmed.com|
317122|NCT04106817|WCCT Global|Associate Director of Regulatory Affairs|7207713080|erin.flynn@wcct.com|
317123|NCT04105972|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
293550|NCT01497262|Novartis Pharmaceuticals|Study director|862-778-8300||
317124|NCT04105218|University of Colorado Anschutz Medical Campus|Clinical Research Support Center|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
317125|NCT04102956|Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, China.|Xiaoyun Liu PhD|+8613191887318|audrey-l@163.com|
317126|NCT04102540|University of Colorado College of Nursing|Dr. Samantha Stonbraker|3037248281|Samantha.Stonbraker@CUAnschutz.edu|
317127|NCT04102345|HealthPartners Neuroscience Research|Bhavani Kashyap, MBBS, PhD|651-495-6358|bhavani.x.kashyap@healthpartners.com|
317128|NCT04092907|Harbour Biomed|Nina Shen|18251811067|nina.shen@harbourbiomed.com|
317129|NCT04089982|Duke University|James M. Davis, MD|919-668-5055|james.m.davis@duke.edu|
317130|NCT04086433|Regulatory Mark|Alison Sathe|5133047971|alison@regulatorymark.com|
317131|NCT04086407|Sleep Systems|Director of Operations|978-835-7036|e.lyons@sleepsystems-llc.com|
317132|NCT04099277|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317133|NCT04098809|Benaroya Research Institute at Virginia Mason|Dr. Andrew Stamm|206-223-6772|Andrew.Stamm@virginiamason.org|
317134|NCT04098575|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
317135|NCT04098458|Medical University of South Carolina|Evan M. Graboyes, MD, MPH (principal investigator)|843-792-0719|graboyes@musc.edu|
317136|NCT04095286|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317137|NCT04094883|University of North Carolina at Chapel Hill|Joseph Duncan, MD, PhD|919-966-2536|joseph_duncan@med.unc.edu|
317138|NCT04091659|University of Pennsylvania|Nicholas A. Giordano, PhD RN|(215) 898-8281|ngio@upen.edu|
317139|NCT04091061|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317140|NCT04090242|Becton Dickinson|Edward Mahoney|978-901-7248|Edward.Mahoney@bd.com|
317141|NCT04089761|Theranica Bio-Electronics Ltd|Dr Dagan Harris. VP Clinical and Regulatory Affairs|+972723909755|daganh@theranica.com|
317142|NCT04079803|Cassava Sciences, Inc.|Nadav Friedmann, PhD, MD, Chief Medical Officer|512-501-1900|nfriedmann@cassavasciences.com|
317143|NCT04087343|The University of Texas Health Science Center at Houston|Jessica Lee, MD, MS, Assistant Professor|713-500-5457|Jessica.Lee@uth.tmc.edu|
317144|NCT04087122|Valley Health|Rebekah Smith, RN, BSN|540-536-5547|rsmith3@valleyhealthlink.com|
317145|NCT04084769|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
317146|NCT04086576|University of Pennsylvania|Jessie Hemmons|215-746-8255|jhemmons@pennmedicine.upenn.edu|
317147|NCT04086641|University of Washington|Conrad Slater|5409318478|conslate13@gmail.com|
317148|NCT04080882|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
317149|NCT04086472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
317150|NCT04085289|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317151|NCT04084015|Massachusetts General Hospital|Dr. David D'Alessandro|617-726-8841|DADALESSANDRO@MGH.HARVARD.EDU|
317152|NCT04082663|Washington University School of Medicine|Dr. Gammon Earhart|314-286-1407|earhartg@wustl.edu|
317153|NCT04084028|University of Vermont Department of Nutrition and Food Sciences|Mattie Alpaugh|8026569526|malpaugh@uvm.edu|
317154|NCT04082819|SE Health|SE Research Centre||research@sehc.com|
293551|NCT01497275|Duke University Medical Center|Anne Beaven, MD|919-668-1211|anne.beaven@duke.edu|
293552|NCT01497366|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
293553|NCT01497496|Moffitt Cancer Center|Celeste Bello, MD|813-745-8623|Celeste.Bello@moffitt.org|
293554|NCT01497613|University of Miami Miller School of Medicine|Dr. Sara J. Czaja|305-355-9068|sczaja@med.miami.edu|
305701|NCT02352922|Center for Advanced Gynecology, PLLC|Dr. Kenneth I Barron|5088876896|kenneth.barron.md@gmail.com|
305702|NCT02352974|4Pharma AB|Åsa Carlsheimer|+4672244516|asa.carlsheimer@4pharma.com|
305703|NCT02353091|UCL Ear Institute|Mr Georgios Stavrinos|07856067517|georgios.stavrinos.13@ucl.ac.uk|
305704|NCT02353169|British Columbia Children's Hospital Research Institute|Simon D. Whyte|604-875-2711|swhyte@cw.bc.ca|
305705|NCT02353299|Sleep Disorders and Research Center Henry Ford Hospital|Christopher L Drake|248-344-6672|cdrake1@hfhs.org|
317155|NCT04081961|Kazakhstan Academy of Preventive Medicine|Baurzhan Zhussupov|87774822171|baurzhan.zhussupov@gmail.com|
317156|NCT04081610|Laboratorios Sophia|Dr. Alejandra Sanchez-Rios|+52 (33) 3001 4200|alejandra.sanchez@sophia.com.mx|1190
317157|NCT04081324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317158|NCT04079790|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317159|NCT04079127|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
317160|NCT04076787|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317161|NCT04075812|The Ohio State University|Marcia Bockbrader MD PhD|6142933127|bockbrader.13@osu.edu|
317162|NCT04075409|Cares|UCB|+1844599|UCBCares@ucb.com|2273
317163|NCT04074941|Marcus Institute, Hebrew SeniorLife|Shivani Sahni, PhD|6179715382|shivanisahni@hsl.harvard.edu|
317164|NCT04073823|Tactile Medical|Andrea Stone|612.540.5267|astone@tactilemedical.com|
317165|NCT04073407|Axcella Health, Inc|Margaret Koziel, MD|8573202200|clinicaltrials@axcellahealth.com|
317166|NCT04073368|Axcella Health, Inc|Margaret Koziel, MD|8573202200|clinicaltrials@axcellahealth.com|
317167|NCT04073186|Johnson & Johnson Vision Care|Thomas Karkkainen- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
317168|NCT04072237|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
317169|NCT04063371|The Ohio State University|Dr. Douglas Scharre|614-293-4969|Doug.Scharre@osumc.edu|
317170|NCT04042324|Rockwell Medical, Inc|Raymond Pratt, MD|248 960 9009|rpratt@rockwellmed.com|405
317171|NCT04071392|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
317172|NCT04071301|Essity Hygiene and Health|Fredrik Agholme, Clinical Trials Manager, Clinical Affairs|+46 73 0323634|Fredrik.AGHOLME@essity.com|
317173|NCT04071158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317174|NCT04070287|Saint Louis University|Dr. Juliet Iwelunmor|2405280123|juliet.iwelunmor@slu.edu|
317175|NCT04069715|KGK Science Inc.|Malkanthi Evans (Ph.D.), Chief Scientific officer|5194389374|mevans@kgkscience.com|239
317176|NCT04050722|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317177|NCT04069221|Medicines for Malaria Venture|Dr Myriam El Gaaloul, PharmD|+41 22 555 0377|elgaaloulm@mmv.org|
317178|NCT04067141|CooperVision, Inc.|Jose A. Vega, O.D., MSC., FAAO|9256213761|javega@coopervision.com|
317179|NCT04049578|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
317180|NCT04067401|University of Rochester Medical Center, Psychiatry Dept|Dr. Peter Wyman|5852733372|peter_wyman@urmc.rochester.edu|
317181|NCT04067050|CooperVision, Inc|Jose A. Vega|925-640-2964|javega2@coopervision.com|
317182|NCT04066647|Cedars Sinai Medical Center|Kacey Haptonstall|424-315-4489|kacey.haptonstall@cshs.org|
317183|NCT04066426|Tekirdag Namik Kemal University|Dr. Volkan Kaplan|+90282250000|dr.volkankaplan61@gmail.com|6307
317184|NCT04061694|Folktandvården Skåne AB|Björn Gjelvold|+46709467870|bjorn.gjelvold@gmail.com|
317185|NCT04060654|Indivior Inc|Sunita Shinde|804 379-1090|sunita.shinde@indivior.com|
317186|NCT04059250|University of California San Francisco|Dr. Peter Rechmann|4155143225|Peter.Rechmann@ucsf.edu|
293555|NCT01497665|Angiochem Inc.|Betty Lawrence, Vice President, Development|514-788-7800|blawrence@angiochem.com|205
293556|NCT01497756|uNewMexico|Mark Hauswald MD|505-269-6699|markhauswald@gmail.com|
305706|NCT02353442|São Carlos Fedetal University|Dayana Rosa|+55 16 33066695|dad_rosa@hotmail.com|
305707|NCT02353754|Pacira Pharmaceuticals Inc.|James B. Jones, MD, PharmD|(973) 254-3560|jim.jones@pacira.com|
305708|NCT02353780|University of Pittsburgh|Larry Moreland, MD|412-648-4098|lwm5@pitt.edu|
305709|NCT02353806|University of Texas Southwestern Medical Center|Jamie Morgan, MD|214-645-3838|jamie.morgan@utsouthwestern.edu|2147665011
305710|NCT02353832|University of Texas Southwestern|Michael Folkert, M.D., Ph.D.|214-645-8525|Michael.Folkert@utsouthwestern.edu|
305711|NCT02353871|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
305712|NCT02354092|Oregon Health & Science University|Ob/Gyn Regulatory Specialist, Women's Health Research Unit|503-494-3666|whru@ohsu.edu|
305713|NCT02354144|Division of Cancer Epidemiology, Department of Oncology, McGill University|Dr. Eduardo Franco|514-398-6032|eduardo.franco@mcgill.ca|
305714|NCT02354222|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
305715|NCT02354235|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
305716|NCT02354339|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uice@prodigy.net.mx|34212
305717|NCT02354352|Ohio State University|Dr. Subha Raman|614-293-8963|raman.1@osu.edu|
305718|NCT02354378|Boston Children's Hospital|Keira Mason, MD|6173552339|keira.mason@childrens.harvard.edu|
305719|NCT02354417|Fate Therapeutics, Inc.|Chris Storgard, Chief Medical Officer|866-875-1833|chris.storgard@fatetherapeutics.com|
317187|NCT04058353|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
293557|NCT01497808|University of Pennsylvania|Dr. Amit Maity|(215) 615-6767|maity@uphs.upenn.edu|
293558|NCT01497860|Children's National Medical Center|Associate Professor|2024765046|ehwang@childrensnational.org|
317188|NCT04057248|Diabetes and Endocrinology Consultants of Pennsylvania, LLC (Decpa LLC)|Dr. Alan Schorr|2157501691|abs@sugardoc.com|
317189|NCT04055519|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
317190|NCT04055675|Kendall Regional Medical Center|Dr. Tony Zitek|305-480-6602|zitek10@gmail.com|
317191|NCT04054765|play4REAL XR Lab at the Yale School of Medicine|Dr. Kimberly Hieftje|2037872402|kimberly.hieftje@yale.edu|
317192|NCT04054011|UCSD Dermatology|Joyce Yuan, MD|(858) 657-8322|joyce.yuan2@ucsf.edu|
317193|NCT04059094|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
317194|NCT04051684|Montefiore Medical Center|Dr. Karina Gritsenko|718-920-7246|kgritsen@montefiore.org|
317195|NCT04046341|Children's Hospital of Philadelphia|Marsha Wallace|2155900119|wallacem@chop.edu|
317196|NCT04045964|The University of Texas Health Science Center at Houston|Angela Stotts, PhD|(713) 500-7590|Angela.L.Stotts@uth.tmc.edu|
317197|NCT04043416|The University of Ottawa|Katherine Reilly|613-562-5800|kreilly@uottawa.ca|8238
317198|NCT04057768|Venus Concept|Clinical Research Manager|888-907-0115|rmays@venusconcept.com|
317199|NCT04052542|University of Pittsburgh School of Medicine|Timothy D Girard, MD, MSCI|(412) 383-0582|timothy.girard@pitt.edu|
317200|NCT04054193|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
317201|NCT04050618|CooperVision, Inc.|Jose A. Vega, O.D., MSc, FAAO|925-621-3761|javega@coopervision.com|
317202|NCT04053465|University at Buffalo|Dr. Riana Pryor|7168295456|rpryor@buffalo.edu|
317203|NCT04053270|CLINUVEL PHARMACEUTICAL LIMITED|Dr. Dennis Wright|+ 61 3 9660 4900|mail@clinuvel.com|
317204|NCT04049552|UT Health San Antonio|Dean L Kellogg Jr.|210-617-5311|kelloggd@uthscsa.edu|
317205|NCT04053023|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317206|NCT04051710|Aurobindo Pharma|Dr. Joseph Marialouis|9196150585|jmarialouis@aurobindousa.com|4013
317207|NCT04050865|Ocular Therapeutix|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
317208|NCT04050605|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
317209|NCT04050371|UCSF|Robert Grant|415-323-6658|robert.grant@ucsf.edu|
317210|NCT04048460|University of South Florida Department of Communication Sciences & Disorders|Michelle Arnold, AuD, PhD, CCC-A Assistant Professor|(813) 974-1262|mlarnold@usf.edu|
317211|NCT04048681|Beth Israel Deaconess Medical Center|Dr. Olivia Farr|6176678636|ofarr@bidmc.harvard.edu|
317212|NCT04046250|Tosk, Inc.|William Garland, PhD|408.348.5164|wgarland@tosk.com|
317213|NCT04047342|Geisinger Clinic|Amir Goren|5702144395|agoren@geisinger.edu|
317214|NCT04044352|University of Maryland School of Medicine|Kathleen M. Neuzil, MD, MPH|410-706-4946|kneuzil@som.umaryland.edu|
317215|NCT04043728|Rush University Medical Center|Dr. Amanda Mathew|13125631273|amanda_mathew@rush.edu|
317216|NCT04041453|Universidad Nacional de Salta|Alejandro J Krolewiecki|+54 911 3183-8673|alekrol@hotmail.com|
317217|NCT04041414|University of Southern California|Jeremy Goldbach, PhD, LMSW|(213) 821-6460|goldbach@usc.edu|
317218|NCT04041219|Mayo Clinic|Heather P. May, Pharm.D.|507-266-7405|May.Heather@mayo.edu|
317219|NCT04041700|Cochlear|Johan Blechert|+46766498632|jblechert@cochlear.com|
317220|NCT04040933|Johnson & Johnson Consumer Inc. (J&JCI)|Robin Mathew|908-904-5034|rmathew1@its.jnj.com|
317221|NCT04039867|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
317222|NCT04039412|Zagazig University-Faculty of Human Medicine|Dr. Ayman Fathy Elsayed|+201125020593|aymanf28@yahoo.com|
317223|NCT04035161|Becton Dickinson|Erin Zook, PhD|224-358-5019|erin.zook@bd.com|
317224|NCT04029519|Prollenium Medical Technologies|Director Clinical Affairs|1-905-508-1469|, clinicaltrials@prolleniumus.com|
317225|NCT04024228|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
317226|NCT04039919|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
317227|NCT04037969|Centre for Ocular Research and Education|Jill Woods|5198884567|jwoods@uwaterloo.ca|36743
317228|NCT04037865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
317229|NCT04037748|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
317230|NCT04036838|ARJ Medical, Inc.|President|813-855-1557|info@gulfcoastscientific.com|
317231|NCT04034121|Elixir Medical|Candace Elek, Executive Vice President, Clinical Research|408-636-2020|celek@elixirmedical.com|
317232|NCT04027686|UCLA Periodontics and Implant Surgery|Dr Perry Klokkevold|3108251927|pklokkevold@dentistry.ucla.edu|
317233|NCT04022694|University of Pennsylvania|Deputy Director of PEACH Lab|2158987093|thepeachlab@gmail.com|
317234|NCT04036110|University of North Carolina at Chapel Hill|Jia-Rong Wu, PhD, RN|859-323-4712|jiarong.wu2@uky.edu|
317235|NCT04035694|innovation Research & Training|Dr. Tracy Scull|(919) 493-7700|tscull@irtinc.us|
317236|NCT04035577|Northwestern University|Dr. Emily Lattie|3125033741|emily.lattie@northwestern.edu|
317237|NCT04035564|"Hospital del Niño de Saltillo Dr. Federico Gomez Santos"|Carlos Sanchez|+528441757244|sanchez.carlos8516@gmail.com|
317238|NCT04032977|Prollenium Medical Technologies|Director Clinical Affairs|1-905-508-1469|clinicaltrials@prolleniumus.com|
317239|NCT04032652|NorthShore University HealthSystem|Asst Director Research Compliance|2243647975|rpulido@northshore.org|
317240|NCT04024501|AstraZeneca|AstraZeneca information Centre|1-877-240-9479|information.center@astrazeneca.com|
317241|NCT04032613|University of North Carolina at Chapel Hill|Jennifer E. Flythe, MD, MPH|919-445-2656|jflythe@med.unc.edu|
317242|NCT04032171|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
317243|NCT04032158|Merck Healthcare KGaA, Darmstadt Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@merckgroup.com|
317244|NCT04031404|University of North Carolina at Chapel Hill|Rachel B. Force, PhD|9199669929|rachel_force@med.unc.edu|
293559|NCT01497899|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
317245|NCT04031885|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
293560|NCT01497938|Medtronic|Thomas Troub|(818) 576-3142|thomas.troub@medtronic.com|
317246|NCT04018924|Emoled|Duccio Rossi Degl'Innocenti|+39 0550751981|d.rossi@emoled.com|
317247|NCT04015440|Walter Reed Army Institute of Research|Jeffrey M Osgood, Ph.D. Associate Director of Military Psychiatry Branch|301-319-7475|jeffrey.m.osgood.mil@mail.mil|
317248|NCT04030104|Seno Medical Instruments, Inc.|Vice President of Clinical Operations|210-615-6501|sschaeffer@senomedical.com|
317249|NCT04029961|Medical College of Wisconsin|John LaDisa|414-288-6739|jladisa@mcw.edu|
317250|NCT04025684|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317251|NCT04019054|UCLA Psychiatry|Dr. Michael K. Leuchter|3108906943|mkleuchter@mednet.ucla.edu|
317252|NCT04029545|Prollenium Medical Technologies|Director Clinical Affairs|19055081469|clinicaltrials@prolleniumus.com|
317253|NCT04029584|University of California, San Francisco|Leslie Benet, PhD|(415) 476-3853|leslie.benet@ucsf.edu|
317254|NCT04029311|Tohoku University|Dr. Yasue Tanaka|+81227178396|yasue.tanaka.b3@tohoku.ac.jp|
293561|NCT01498068|Janssen Belgium|Compound Development Team Leader|32 14 64 13 70||
317255|NCT04028960|HealthPartners Institute dba International Diabetes Center|Anders Carlson, MD|952-993-1927|Anders.L.Carlson@HealthPartners.Com|
317256|NCT04026399|Medical University of South Carolina|Na Jin Seo|8437920084|seon@musc.edu|
317257|NCT04023578|Ossur Iceland ehf|Kristleifur Kristleifsson|6641112|kkristjansson@ossur.com|+354
317258|NCT04023695|Vanderbilt University|Brian Drolet, MD|(615) 322-2350|brian.c.drolet@vumc.org|
317259|NCT04018664|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
317260|NCT04016259|The University of Texas Health Science Center at Houston|"Hyochol Brian Ahn, PhD, RN, MSN, Associate Professor"|713-500-2179|Hyochol.Ahn@uth.tmc.edu|
317261|NCT04016077|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317262|NCT04027803|BIOCAD|Morozova Maria|+7 (495) 992 66 28|morozovama@biocad.ru|8436
317263|NCT04016311|The University of Texas at Austin, School of Nursing|Gayle M. Timmerman PhD, Professor|5124719087|gtimmerman@mail.utexas.edu|
317264|NCT04027439|Verona Pharma|Verona Pharma|+44 (0)203 283 4200|info@veronapharma.com|
317265|NCT04027218|University|Ms. Leticia Carmen Simón López|+34 680721340|leticia.simon25@gmail.com|
317266|NCT04026750|High Point Clinical Trials Center|Melanie Fein, MD|1-336-841-0700|mfein@highpointctc.com|2530
317267|NCT04026308|UAMS|Michael Wilson|501-686-8729|MPWilson@uams.edu|
282622|NCT00864513|Georgetown University|Dr. Jimmy Hwang|202-444-2198|jh96@gunet.georgetown.edu|
317268|NCT04023682|University of Iowa Hospitals and Clinics|Sundara Reddy, MBBS|(319) 356-2108|sundarareddy-durgempuditripura@uiowa.edu|
317269|NCT04021771|Thomas Jefferson University|Dr. Kristin Rising|215-503-5507|Kristin.Rising@jefferson.edu|
317270|NCT04019626|Nerudia Ltd|Paul Morris|+44 7508 708 917|paul.morris@nerudia.com|
317271|NCT04023994|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
317272|NCT04022668|Yeditepe University|Emre Aslanger|0216578000|mr_aslanger@hotmail.com|4240
317273|NCT04020822|Medtronic Diabetes|Kusal Ahangama, Clinical Study Manager|+18185765023|kusal.c.ahangama@medtronic.com|
317274|NCT04019990|Hacetepe University|Ceyda Sofuoğlu M.Sc.|+905338557742|ceyda_sofuoglu@hotmail.com|
317275|NCT04017611|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
317276|NCT04015232|Lambda Therapeutic Research Ltd.|Dr. Adarsh Kumar Garg, M.B.B.S. Principal Investigator|+91-79-40202020|adarshgarg@lambda-cro.com|
317277|NCT04016623|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
317278|NCT04013737|Health Protection Research Unit in HCAI and AMR, Imperial College London|Head of Operations|020 3313 2732|head.ops@imperial.ac.uk|
317279|NCT04014062|Lambda Therapeutic Research Ltd.|Dr. Anshul Attrey, M.D. Principal Investigator|+91-79-40202020|anshulattrey@lambda-cro.com|
317280|NCT04013789|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
317281|NCT04012970|Edinburgh Napier Univerisity|Rebecca Hamilton, PhD student|0131 455|rebeccaisabel.hamilton@napier.ac.uk|2350
317282|NCT04013191|Cares|UCB|+1844 599|clinicaltrials@ucb.com|2273
317283|NCT04011631|SMART Clinical Products|Ellie Coumans|+31 (0)6 53 82 70 16|e.coumans@smartclinicalproducts.com|
317284|NCT04011735|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
317285|NCT04010695|PATH|Pooja Bansil|206 302 4920|pbansil@path.org|
317286|NCT04009577|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
317287|NCT04007159|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317288|NCT04007107|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
317289|NCT04006795|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317290|NCT04005885|CooperVision. Inc|Jose A. Vega, O.D., MSc., FAAO|925 621 3761|javega@coopervision.com|
317291|NCT04000815|Dr.Ali Cenk Ozay|Dr.Ali Cenk Ozay|00905428583248|dr.alicenk@hotmail.com|
317292|NCT03999944|FRESCA Medical|Vice President, RA/CA/QA|949-542-3535|mlmooney@frescamed.com|
317293|NCT03995680|Swiss Tropical and Public Health Institute|Dr. Jennifer Keiser|+41612848218|jennifer.keiser@swisstph.ch|
317294|NCT04006366|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, PhD|2158982823|kca@pennmedicine.upenn.edu|
317295|NCT04006145|Albireo AB|Patrick Horn, MD, PhD|+1 (857) 378- 2035|medinfo@albireopharma.com|
317296|NCT04005755|AFT Pharmaceuticals|Jennifer Zhang -Project Leader|+ 64 9 488 0232|jenniferz@aftpharm.com|710
317297|NCT04005586|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
317298|NCT04005404|Helios Center for Research and Innovation|Director Prof. Dr. Petra Thürmann|0049 (0)202 896-1851|petra.thuermann@helios-gesundheit.de|
317299|NCT03993288|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
270358|NCT00123487|Bristol-Myers Squibb|: Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
270359|NCT00123604|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
270360|NCT00123630|University of Utah|Dr. John Fang|801-581-7802|john.fang@hsc.utah.edu|
270361|NCT00123643|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
270362|NCT00123682|VA New York Harbor Healthcare System|Dr. Scott Sherman, PI|212-686-7500|scott.sherman@va.gov|7386
270363|NCT00123734|AGEN Biomedical Ltd|Dr Michael Gerometta|+61 408 885 416|mgerometta@agenix.com|
270364|NCT00123955|Wake Forest Baptist Health|Dr. Dalane Kitzman|336-716-3274|dkitzman@wakehealth.edu|
270365|NCT00124020|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
270366|NCT00124072|CTSU, University of Oxford|CTSU Reception|01865 743743|secretary@ctsu.ox.ac.uk|
270367|NCT00124176|Children's Hospital of Philadelphia|Joseph Zorc, MD|215-590-1944|zorc@email.chop.edu|
270368|NCT00124449|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
282623|NCT00864539|National Nutrition and Food Technology Research Institute|Dr. Tirang R. Neyestani|(+9821)22376471|neytr@yahoo.com|
282624|NCT00864682|Virginia Mason Medical Center|Joseph M. Neal, MD|206-223-6980|anejmn@vmmc.org|
293562|NCT01498120|UCB BIOSCIENCES GmbH|Clinical Trial Registries and Results Disclosure|40789+49 2173 48|clinicaltrials@ucb.com|15 15
317300|NCT03990298|Hospital of the University of Pennsylvania, Dept of Otorhinolaryngology, Head & Neck Surgery|Erica Thaler, MD|215-662-4533|erica.thaler@pennmedicine.upenn.edu|
305720|NCT02354443|Fate Therapeutics, Inc.|Chris Storgard, Chief Medical Officer|866-875-1833|chris.storgard@fatetherapeutics.com|
317301|NCT03988647|Stanford University|Susan J Knox, Associate Professor of Radiation Oncology|650-725-2720|sknox@stanford.edu|
317302|NCT03979872|University of Utah|Dr. Yelena Wu|801-213-5653|yelena@utah.edu|
317303|NCT03978832|Indivior Inc|PERSERIS Medicines Development Lead and Head Global Clinical Operations and Development|804 379-1090|regan.fong@indivior.com|
317304|NCT04005391|University of Colorado|Margo Harrison|19176555178|margo.harrison@cuanschutz.edu|
317305|NCT04004481|University hospital Osijek|Nenad Neskovic|+385996787250|nneskov@gmail.com|
317306|NCT04004260|Lamar University|Vinaya Manchaiah, Jo Mayo Endowed Professor|(409) 821 9443|vmanchaiah@lamar.edu|
317307|NCT03997851|University of Miami|Leigh Nattkemper|3055889734|Lxn202@med.miami.edu|
317308|NCT03991715|University of North Carolina at Chapel Hill|Kelly Evenson, PhD|(919) 966-1967|kelly_evenson@unc.edu|
317309|NCT03990415|University of Missouri|Dr. Dana Duren|(573) 884-7023|durendl@health.missouri.edu|
317310|NCT04002960|Masimo|Chelsea Frank|949-297-7000|studies@masimo.com|
317311|NCT04002973|Masimo|Chelsea Frank|(949) 297-7000|studies@masimo.com|
317312|NCT04002648|IRCCSSRaffaele|Prof. Michele De Bonis|+390226437102|debonis.michele@hsr.it|
317313|NCT03993210|DFCI|Clare Tempany|617-732-7858|ctempany@bwh.harvard.edu|
317314|NCT03992014|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317315|NCT03990649|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
317316|NCT04002791|Apex Heart Institute|Chairman|011 91 9824030576|theheartworld@gmail.com|
271684|NCT00257309|Centro Nacional de Investigaciones Cardiovasculares|Héctor Bueno|(+34) 914 531 200|hbueno@cnic.es|4110
317317|NCT04000581|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
317318|NCT03996694|BioDelivery Sciences|Todd Kunkel, PharmD Director, Scientific Communications|913-940-1789|tkunkel@bdsi.com|
317319|NCT03988907|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
317320|NCT03988088|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317321|NCT03980522|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
317322|NCT03999684|Dana-Farber Cancer Institute|Dr. Glenn Hanna|6176323090|glenn_hanna@dfci.harvard.edu|
317323|NCT03995784|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
317324|NCT03993392|Indivior, Inc|Global Director, Clinical Development|804-379-1090|Robert.Dobbins@Indivior.com|
317325|NCT03989427|Melaka-Manipal Medical College|Dr. Rajesh Hosadurga|+6062896662|rajesh.hosadurga@manipal.edu.my|3823
317326|NCT03981822|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
317327|NCT03992482|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
317328|NCT03993119|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
317329|NCT03991494|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
317330|NCT03989570|Minia university|Dr. Hassan Elshorbagy|1204427271|Hassan.Hetta@mu.edu.eg|0020
317331|NCT03988803|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
317332|NCT03987932|University of South Carolina|Christine Pellegrini|803-777-0911|pellegca@mailbox.sc.edu|
317333|NCT03987191|University of Colorado Anschutz Medical Campus|Dr. Viral Shah, Principal Investigator|303-724-8186|viral.shah@cuanschutz.edu|
317334|NCT03988842|Cedars-Sinai Medical Center|Victor Tapson|919-971-6441|Victor.Tapson@cshs.org|
317335|NCT03981861|ChildrensMHC|Tania Burgert|203 676 4545|tsburgert@cmh.edu|
317336|NCT03974334|University of Massachusetts Medical School|Dr. Paula Gardiner|7744416716|paula.gardiner@umassmed.edu|
317337|NCT03988426|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
317338|NCT03988374|Church & Dwight Co., Inc|Dr. Annahita Ghassemi, PhD|6098061200|annhita.ghassemi@churchdwight.com|
317339|NCT03987074|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
317340|NCT03977935|Changhai Hospital|Investigator of Clinical Trials|15021569528|1372971347@qq.com|
317341|NCT03988049|University of Utah Dermatology|Dr. David Smart, Assistant Professor, Dermatology|8015816465|david.smart@hsc.utah.edu|
317342|NCT03979820|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
317343|NCT03972137|Rutgers, The State University of New Jersey|Dr. Teresa Leyro|848-445-2090|tml124@psych.rutgers.edu|
317344|NCT03970395|Azienda Ospedaliera Città della Salute e della scienza di Torino _ Italy|Dr Claudio G Priolo|0039 3471403064|claudiog.priolo@gmail.com|
317345|NCT03987620|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
317346|NCT03983317|TheraNova, LLC|Vice President of Research and Development|415-926-8616|clinicalstudy@theranova.com|
317347|NCT03985657|Johns Hopkins University|Mudiaga Sowho|4105506264|msowho1@jhmi.edu|
317348|NCT03981939|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
317349|NCT03973905|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
293563|NCT01498185|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
293564|NCT01498289|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
293565|NCT01498419|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|Dan.Everitt@tballiance.org|
293566|NCT01498445|The University of Texas MD Anderson Cancer Center|Jorge Cortes MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
317350|NCT03984838|ViiV Healthcare|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
293567|NCT01498458|University Hospital Heidelberg|Dr. Andreas Schneeweiss|+49 (0)6221 56 36051|andreas.schneeweiss@med.uni-heidelberg.de|
293568|NCT01498549|Yale University|Dr. Mehmet Sofuoglu, Professor of Psychiatry; Director of VA New England Mental Illness Research, Ed|(203) 937-4809|mehmet.sofuoglu@yale.edu|
293569|NCT01498575|The Children's Hospital of Philadelphia|Dennis Durbin, MD, MSCE|215-590-7331|DURBIND@EMAIL.CHOP.EDU|
293570|NCT01498588|Emory University|Keerthi Gogineni, MD, MSHP|404-778-1801|keerthi.gogineni@emory.edu|
293571|NCT01498601|Fraser Health|Trudy Robertson RN, MSN, CNN(c)|604-520-4715|Trudy.Robertson@fraserhealth.ca|
293572|NCT01498640|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
317351|NCT03983941|Nationwide Children's Hospital|Julie Rice-Weimer, RN|614-355-3142|julie.rice-weimer@nationwidechildren.org|
317352|NCT03976752|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
317353|NCT03984825|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317354|NCT03971721|The Ohio State University|Dr. Ulysses Magalang|(614) 293-4925|Ulysses.Magalang@osumc.edu|
293573|NCT01498653|GlaxoSmithKline|GSK Response Center|866-435-7343||
293574|NCT01498679|GlaxoSmithKline|GSK Response Center|866-435-7343||
305721|NCT02354482|University of Kentucky|Jessica Clouser|8593230284|jess.clouser@uky.edu|
305722|NCT02354508|Novartis Pharmaceuticals|Study Director|826-778-8300|novartis.email@novartis.com|
305723|NCT02354534|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|CervixDoctor@jhmi.edu|
305724|NCT02354586|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
305725|NCT02354599|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305726|NCT02354690|National Center for Cancer Immune Therapy|Inge Marie Svane|0045386889339|inge.marie.svane@regionh.dk|
305727|NCT02354781|Nationwide Children's Hospital|Dr. Jerry Mendell|1-614-722-4877|Jerry.Mendell@nationwidechildrens.org|
305728|NCT02354833|West Virginia University|Dr. Manuel C. Vallejo, Chair of Department of Anesthesiology|304-598-4929|mvallejo@wvumediciane.org|
305729|NCT02354859|University of Washington|Christopher H. Goss, Professor of Medicine and Pediatrics|206-543-3166|goss@uw.edu|
293575|NCT01498692|Boston Scientific|Ruth M. Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
293576|NCT01498744|Ann and Robert H. Lurie Children's Hospital of Chicago|Katherine A Barsness|3122274210|kbarsness@luriechildrens.org|
317355|NCT03982433|Boston University|Tibor Palfai, PhD|6173539345|palfai@bu.edu|
317356|NCT03979677|Vanderbilt University Medical Center|Richard A. Roberts, Ph.D.|6153227384|richard.a.roberts@vanderbilt.edu|
317357|NCT03976466|ISSEMyM Instituto de Seguridad Social del Estado de Mexico y Municipios|Julio Carlos Vélez de Lachica, Head of the orthopedics department at Regional Hospital Tlalnepantla|5526269200|activeknee@gmail.com|2100
317358|NCT03979638|Bellus Health Inc|Senior Director Clinical Development|833-703-0708|lharvey@bellushealth.com|
317359|NCT03979274|Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
317360|NCT03979066|Columbia University|Gulam Manji, MD, PhD|212-305-0592|gam2140@columbia.edu|
317361|NCT03977727|Texas Diabetes & Endocrinology|Thomas Blevins, MD|512-334-3505|blevins@texasdiabetes.com|1
317362|NCT03977155|Boston Pharmaceuticals, Inc.|Craig Basson|(617) 655-9681|clinicaltrials@bostonpharmaceuticals.com|
317363|NCT03974802|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
317364|NCT03970733|Valneva Austria GmbH|Director Clinical Strategy|+43120620|office@valneva.com|0
317365|NCT03968978|AstraZeneca|Global Clinical Head|+1 877-240-9479|information.center@astrazeneca.com|
317366|NCT03968848|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
317367|NCT03967444|Galderma Research & Development, Aesthetics|Director of Clinical Operations|817-961-5655|aestheticclinicaltrials@galderma.com|
317368|NCT03966924|Recros Medica|Head of Clinical Development|925-223-8581|clinical@recrosmedica.com|
317369|NCT03966911|Medtronic Diabetes|Robin Mottackel|8185764886|robin.e.mottackel@medtronic.com|
317370|NCT03966365|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
317371|NCT03965403|Spaulding Rehabilitation Hospital|Paolo Bonato, PhD|6179526319|pbonato@partners.org|
317372|NCT03965754|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
317373|NCT03965533|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317374|NCT03965351|Cincinnati Children's Hospital Medical Center|Mary Banks|513-636-2147|mary.banks@cchmc.org|
317375|NCT03964220|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
317376|NCT03958955|LEO Pharma A/S|Clinical Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
317377|NCT03965052|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
317378|NCT03965039|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
317379|NCT03963401|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317380|NCT03962634|Virginia Commonwealth University|Parthasarathy Madurantakam|804-828-4953|madurantakap@vcu.edu|
317381|NCT03962790|Johnson & Johnson Vision Care|Brian Pall, Director Clinical Science, Vision Care|1-800-843-2020|bpall@its.jnj.com|
317382|NCT03956225|Alcon Research, LLC|Sr. CDMA Project Lead, Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
317383|NCT03951610|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
317384|NCT03958149|Imperial College Healthcare NHS Trust|Key investigator|02033121077|annabellelee@nhs.net|
317385|NCT03953183|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
317386|NCT03949335|Johnson & Johnson Surgical Vision|Eugenia Thomas, OD|+1 657 2903260|ethoma39@its.jnj.com|
317387|NCT03962738|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317388|NCT03962101|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
317389|NCT03959137|MSD Belgium|Stephanie Coulon|0032 485 461 467|stephanie.coulon@merck.com|
317390|NCT03946124|University of Pennsylvania|Dr. Lily Arya|215-662-3230|larya@pennmedicine.upenn.edu|
317391|NCT03961308|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
317392|NCT03961295|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
317393|NCT03960957|QMedAB|Clinical Project Manager|8179615000|aestheticclinicaltrials@galderma.com|
317394|NCT03956862|GB001, Inc., a wholly owned subsidiary of Gossamer Bio, Inc.|GB001, Inc. Study Director|1-866-668-4083|ClinicalTrials@gossamerbio.com|
317395|NCT03954444|Teva Pharmaceuticals Development Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
317396|NCT03953820|Aquestive Therapeutics|Denis Scheper, Director of Portfolio Management and Clinical Operations|(908)941-1887|denis.scheper@aquestive.com|
317397|NCT03951766|Massachusetts General Hospital, Psychiatry Department|Dr. Bettina Hoeppner|6176431988|bhoeppner@mgh.harvard.edu|
317398|NCT03961100|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
317399|NCT03950856|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
317400|NCT03947983|The University of Texas Austin|Kavita Radhakrishnan|5124717936|kradhakrishnan@mail.nur.utexas.edu|
317401|NCT03960658|Minneapolis VA Health Care System|Dr. Paulo R. Shiroma|612-467-2264|paulo.shiroma@va.gov|
317402|NCT03959332|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
317403|NCT03959189|Expansion Therapeutics, Inc.|Chief Medical Officer|858-764-4290|info@expansionrx.com|
317404|NCT03956550|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
317405|NCT03954158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317406|NCT03958656|National Cancer Institute|Dr. James N. Kochendefer|240-760-6062|kochendj@mail.nih.gov|
317407|NCT03955133|Swansea University|Professor Sue Jordan|+44 (0) 1792518541|s.e.jordan@swansea.ac.uk|
317408|NCT03954626|Novartis Pharmaceuticals|Study Director|862 778 8300|Novartis.email@Novartis.com|
317409|NCT03954743|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
293577|NCT01498822|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
305730|NCT02354924|Mackay Memorial Hospital_Taipei|Dr. Huey-Chuan Cheng|886-2-25433535|hccheng@ms2.mmh.org.tw|
317410|NCT03951805|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
317411|NCT03944785|Supernus Pharmacueticals|Gianpiera Ceresoli-Borroni|301-838-2521|gceresoliborroni@supernus.com|
317412|NCT03950622|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305731|NCT02354976|AstraZeneca|Torbjörn Lundström|46 317064100|Torbjorn.lundstrom@astrazeneca.com|
317413|NCT03949621|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
317414|NCT03949244|Icahn School of Medicine at Mount Sinai|Harriet Lloyd|212-979-4672|hlloyd@nyee.edu|
317415|NCT03948581|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
317416|NCT03948386|Thomas Jefferson University|Eric S Schwenk, MD|215-955-6161|eric.schwenk@jefferson.edu|
317417|NCT03948334|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
317418|NCT03946059|University of California San Diego|Dr. Jyoti Mishra|8582322855|jymishra@ucsd.edu|
317419|NCT03944707|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
317420|NCT03944668|HealthPartners Neuroscience Research|Amanda Herrmann, PhD|651-495-6356|amanda.a.herrmann@healthpartners.com|
317421|NCT03943160|Cardiovascular Systems Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
317422|NCT03943095|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317423|NCT03943290|Acceleron Pharma Inc.|SVP Regulatory Affairs|617-649-9200|jdesiderio@acceleronpharma.com|
317424|NCT03942042|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317425|NCT03938337|O'Neal Comprehensive Cancer Center at University of Alabama at Birmingham|Eddy S. Yang|12059960780|eyang@uab.edu|
317426|NCT03923530|NF South Ga VAMC|Dr. Anthony Bavry|352-548-4726|anthony.bavry@va.gov|
317427|NCT03914417|Icahn School of Medicine at Mount Sinai|Dr. Sharon Rose|212-241-3288|sharone.rose@gmail.com|
317428|NCT03913377|Johnson & Johnson Vision Care|Elizabeth Dow, PRINCIPAL RESEARCH OPTOMETRIST|+1800-843-2020|edow1@its.jnj.com|
317429|NCT03937791|National Cancer Institute|Scott Norberg, D.O.|301-275-9668|scott.norberg@mail.nih.gov|
317430|NCT03937778|National Center for Complementary and Integrative Health|Chesler, Alexander|+1 301 594 1049|alexander.chesler@nih.gov|
317431|NCT03937479|Verona Pharma Plc|Nancy Herje|+1 646-951-0961|nancy.herje@veronapharma.com|
317432|NCT03936387|BOSTON CHILDREN'S HOSPITAL|ROLAND BRUSSEAU MD|6173557737|roland.brusseau@childrens.harvard.edu|
317433|NCT03935399|Wake Forest Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
317434|NCT03936608|The University of Kansas|Amit Noheria|9135889757|amit.noheria@gmail.com|
317435|NCT03936244|Hospital Universitario Fuenlabrada|Dr. Hugo Otaola Arca|+56 9 4108 9452|hugotaolarca@hotmail.com|
317436|NCT03935126|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
317437|NCT03928327|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
317438|NCT03933462|Philips|Sara Garbin|724-787-8550|sara.garbin@philips.com|
317439|NCT03933774|St. Vincent's Hospital|Dr. Jung Min Bae|82-31-881-8982|jminbae@gmail.com|
317440|NCT03931330|Medical College of Wisconsin|Gisela Chelimsky, MD|414-266-3690|gchelimsky@mcw.edu|
317441|NCT03918811|Hospitalsantojanni|Professor Mauro Andreu|+541168788298|mfandreu@gmail.com|
317442|NCT03912259|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
317443|NCT03933618|Albany Medical Center|Dr. Charles Welliver|518-262-3341|wellivr@amc.edu|
317444|NCT03931785|Ironwood Pharmaceuticals, Inc.|Wilmin Bartolini, Ph.D.|617.621.8314|wbartolini@ironwoodpharma.com|
317445|NCT03930641|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
317446|NCT03927846|Wake Forest Health Sciences|Dennis Ang, Primary Investigator|336-705-8701|dang@wakehealth.edu|
317447|NCT03927105|Hoosier Cancer Research Network|Adelai Neal|317-921-2053|aneal@hoosiercancer.org|
317448|NCT03923933|Head of Nephrology Hospital General de México|Rafael Vadez-Ortiz M.D. PhD|+52 2789-2000|rafavaldez@gmail.com|1253
317449|NCT03909295|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
317450|NCT03908970|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
317451|NCT03897179|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
317452|NCT03930264|Nova Laboratories Limited|Dr Hussain Mulla|+44 (0)116 223 0100|hussain.mulla@novalabs.co.uk|
317453|NCT03929367|Wake Forest Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
317454|NCT03928522|Washington University|Venessa Riegler|314-362-1721|rieglerv@wustl.edu|
293578|NCT01498887|Novartis Pharmaceuticals|Study Director|862-778-8300||
305732|NCT02355028|Alcon, A Novartis Division|Clinical Scientist, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
305733|NCT02355067|Children's Hospital of Philadelphia|Dr. James Guevara|215-590-1130|guevara@email.chop.edu|
305734|NCT02355158|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
305735|NCT02355210|University of Nebraska-Lincoln|Heather Rasmussen, Assistant Professor|402-472-1373|hrasmussen2@unl.edu|
293579|NCT01498952|MedImmune LLC|Mohammed Dar|+301-398-0000|information.center@astrazeneca.com|
293580|NCT01498978|OHSU Knight Cancer Institute|Kristi Eilers|503-494-2897|eilersk@ohsu.edu|
293581|NCT01499043|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
305736|NCT02355275|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@gmail.com|838
317455|NCT03910439|National Cancer Institute|Dr. Mark Roschewski|240-760-6183|mark.roschewski@nih.gov|
317456|NCT03907241|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
317457|NCT03927950|Department of Psychiatry, University of Tartu|Eduard Maron|+3727318812|eduard.maron@kliinikum.ee|
317458|NCT03927781|University of Missouri|Dr Katie Murray|573-884-8768|murraykat@health.missouri.edu|
317459|NCT03927209|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
317460|NCT03920670|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
317461|NCT03919422|Department of Anesthesiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital|Dr. Junfen Zhang, director of the clinical trial|+8618930173689|zhangjunfeng@sjtu.edu.cn|
317462|NCT03907579|Dartmouth-Hitchcock Norris Cotton Cancer Center|Director of Community Education and Prevention|603-653-9960|nccc.community.outreach@dartmouth.edu|
317463|NCT03905811|University of Iowa|Jordan Schultz|3193849388|jordan-schultz@uiowa.edu|
317464|NCT03898063|University of Miami|Nick Carcioppolo|3052845633|n.carcioppolo@miami.edu|
317465|NCT03895307|SultanAbdulhamid|Adem Erbirol|+905426608788|aerbirol@hotmail.com|
317466|NCT03926208|Rush University Medical Center|Dr. Daniel D. Bohl|414.640.7245|danielbohl@gmail.com|
317467|NCT03926065|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
317468|NCT03909100|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
317469|NCT03905642|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
317470|NCT03892889|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
317471|NCT03921723|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317472|NCT03921190|University of Jordan|Dr. Ahmad El-Ma'aita|+9625355000|a.maaita@ju.edu.jo|
317473|NCT03920865|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
317474|NCT03918239|Shire|Study Director|+1 866-842-5335|ClinicalTransparency@takeda.com|
317475|NCT03917823|University of California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@health.ucsd.edu|
317476|NCT03911752|University of A Coruña|Thais Pousada García|+34 981 167 000|thais.pousada.garcia@udc.es|5870
317477|NCT03902613|Columbia University Irving Medical Center|Dr. Martin Lan|646 774 7610|martin.lan@nyspi.columbia.edu|
317478|NCT03902574|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
317479|NCT03914950|Medical University of Graz, Department of Radiology, Division of Nuclear Medicine|Dr. Susanne Stanzel|+43-316-385-81789|susanne.stanzel@medunigraz.at|
317480|NCT03911843|Azienda Ospedaliero-Universitaria di Novara, Italy|Dr. Francesco Cadario, Head of the Pediatric Diabetology service|+39 347 226 6507|francesco.cadario@gmail.com|
317481|NCT03896633|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
317482|NCT03894813|Peking University Shenzhen Hospital|Prof. Shangrong Fan|86-0755-83923333|fanshangrong@163.com|
317483|NCT03911960|Hennepin Healthcare|Sandra Japuntich|6128736856|sandra.japuntich@hcmed.org|
317484|NCT03907072|WAVE Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
317485|NCT03906448|University of Florida|David Tran, MD, PhD|352-273-9000|david.tran@neurosurgery.ufl.edu|
317486|NCT03911401|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
317487|NCT03909763|Peking University People's Hospital|Dr. Xiaohui Zhang, Director of Clinical Trials|86-10-88324577|zhangxh@bjmu.edu.cn|
317488|NCT03909009|Izmir Katip Çelebi University, Faculty of Medicine|Doç.Dr. Ayhan AŞKIN|00902322444444|ayhanaskin@hotmail.com|1529
317489|NCT03906968|MUSC|Dr. Zachary M. Soler|(843) 792-3531|solerz@musc.edu|
317490|NCT03904420|Cochlear Limited|Laura Chenier|+14423254171|lchenier@cochlear.com|
317491|NCT03903822|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317492|NCT03905096|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
317493|NCT03899064|MC2 Therapeutics|Birgitte Vestbjerg|+44 2077 2575|bve@mc2therapeutics.com|
317494|NCT03894969|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317495|NCT03903159|University of Minnesota|Amy Krentzman|612-625-2312|akrentzm@umn.edu|
317496|NCT03902392|University of Bari|Thea TM Magrone, BD|+39 080 5478584|thea.magrone@uniba.it|
317497|NCT03901105|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
317498|NCT03895853|UT MD Anderson Cancer Center|Joseph L. Nates, Professor, Critical Care& RespiratoryCare|(713) 792-5040|jlnates@mdanderson.org|
317499|NCT03901313|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
317500|NCT03901092|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
317501|NCT03895034|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
293582|NCT01499082|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
305737|NCT02355665|JNJWorldwide|Andrew Myers, MD, Director, Clinical Research|(215) 273-8421 USA EST|AMyers3@its.jnj.com|
305738|NCT02355691|UNC Orthopaedics|Scott Eskildsen, MD|(919) 966-9166|seskilds@unch.unc.edu|
305739|NCT02355743|BloodCenter of Wisconsin, Medical College of Wisconsin|Lynn Malec|414-257-2424|lynn.malec@bcw.edu|
305740|NCT02355821|RGNKC|Ekaterina Dudinskaya, head of age-related metabolic and endocrine disorders laboratory|+79031914690|katharina.gin@gmail.com|
305741|NCT02355886|University of Washington|George Schade|2065986190|grschade@uw.edu|
293583|NCT01499095|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
317502|NCT03900728|Columbia University Irving Medical Center|Carolyn Westhoff, MD|2123057070|clw3@cumc.columbia.edu|
317503|NCT03900299|Alexandria university|DR. mostafa elsayed|560566541|m_elsayed2009@yahoo.com|+966
317504|NCT03898349|VA|Vera Yakovchenko|7816873374|vera.yakovchenko@va.gov|
317505|NCT03897634|Northwestern University|Kendra Marks|847-467-0897|kendra.marks@northwestern.edu|
317506|NCT03895372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317507|NCT03896022|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@cumc.columbia.edu|
317508|NCT03891862|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
317509|NCT03894449|University of Veterinary & Animal Sciences, Lahore, Pakistan|Dr. Waqas Ahmed|0092-42-99211449|waqas.niaz@uvas.edu.pk|296
317510|NCT03892564|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
317511|NCT03892707|Woerwag Pharma LLC|Anna Shagako, Clinical Trials Manager/ Authorized Person of Pharmacovigilance|+7 (495) 382 85 56|anna.shagako@woerwagpharma.ru|
317512|NCT03892460|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
317513|NCT03891641|University of North Carolina at Chapel Hill|Jason R Franz, PhD|919-966-6119|jrfranz@email.unc.edu|
317514|NCT03890367|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
317515|NCT03889704|University of Pittsburgh|Dr. Edward Burton|4126924670|eab25@pitt.edu|
317516|NCT03889444|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
317517|NCT03888755|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
317518|NCT03888391|University of California, Los Angeles|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
317519|NCT03888482|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
317520|NCT03888274|Tivic Health Systems|Blake Gurfein|5615737652|blake.gurfein@tivichealth.com|
317521|NCT03888365|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292|info@lungbiotechnology.com|
317522|NCT03888469|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
317523|NCT03887442|TTCC Grupo Español de Tratamiento de Tumores de Cabeza y Cuello|Carmen Montalbán, Manager|+34676154172|ttccmanager@yahoo.com|
317524|NCT03887286|University of Miami|Mary Sokoloski|305 585-6683|msokoloski@med.miami.edu|
317525|NCT03881007|Institute of Tropical Medicine Antwerp|Dr. Chris Kenyon|+32(0)32470786|ckenyon@itg.be|
317526|NCT03878602|Ospedale Buon Consiglio Fatebenefratelli|Dr.Giuseppe De Bernardo|3357441303|pinodebtin@gmail.com|+39
317527|NCT03875118|National Taipei University of Nursing Health and Sciences|Director of Nursing Department|886-2-28227101|tsaejyy@ntunhs.edu.tw|3118
317528|NCT03873987|Melinta Therapeutics, Inc.|Vice President Clinical Operations|9086171319|kfusaro@melinta.com|
317529|NCT03870893|Samsung Medical Center|Jeong-Yi Kwon|+821045911039|jeongyi.kwon@samsung.com|
317530|NCT03887299|University of Texas Medical Branch Galveston|Antonio F Saad|4097476646|afsaad@utmb.edu|
317531|NCT03878758|Becton Dickinson|Michael Gibney|201-847-6170|michael.gibney@bd.com|
317532|NCT03849300|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
317533|NCT03887429|Promentis Pharmaceuticals|Chad Beyer|(414) 238 2992|cbeyer@promentispharma.com|
317534|NCT03886701|Thomas Jefferson University|Dr. Walter K. Kraft|215 955-9077|walter.kraft@jefferson.edu|
317535|NCT03883113|Vaccitech Ltd.|Tom Evans, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
317536|NCT03880227|The University of Texas at Dallas|Hans Klein|8304562444|hans.klein@utdallas.edu|
317537|NCT03876743|Northwestern University|Melissa Shauver; Research Project Manager|3124726024|melissa.shauver1@nm.org|
317538|NCT03885934|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
317539|NCT03885726|Vapotherm, Inc.|George C. Dungan, II|(267)347-3305|gdungan@vtherm.com|
317540|NCT03885154|University of Kentucky|Kimberly Jones, MD|859-218-5011|kimberly.jones@uky.edu|
317541|NCT03883386|University of Michigan Medical School|Professor Kelly Walkovich|734-647-2893|kwalkovi@med.umich.edu|
317542|NCT03882528|Walter Reed Army Institute of Research|Dr. James Moon, Principal Investigator|301-319-9176|James.e.moon.mil@mail.mil|
317543|NCT03882801|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
317544|NCT03882424|Zhejiang Teruisi Pharmaceutical Inc.|Yilin Li, Medical Director|13601247168|yilin.li@teruisipharm.com|
317545|NCT03881163|Zambon S.p.A|Valentina Vaja|+390266524497|Valentina.Vaja@ZambonGroup.com|
317546|NCT03881670|IU School of Optometry|Pete Kollbaum|812-856-0108|kollbaum@iu.edu|
317547|NCT03880266|Dermira, Inc|Jordan Adajar|650-421-2919|jordan.adajar@dermira.com|
317548|NCT03875664|Atrium Health|Dr. Sarah Evans|704-304-1660|sarah.evans@atriumhealth.org|
293584|NCT01499134|Thomas Jefferson University|Danielle Duffy MD|215 955 5050|Danielle.Duffy@jefferson.edu|
317549|NCT03856320|William S. Middleton VA Hospital|Dr. Luke Funk|608-256-1901|Luke.Funk@va.gov|17899
317550|NCT03848871|Skin Sciences, PLLC|Maureen McAllister|5024519000|mmdermresearch@yahoo.com|
317551|NCT03880474|Vaccitech Ltd.|Tom Evans, MD|+44 01865 591 445|enquiries@vaccitech.co.uk|
317552|NCT03878160|Massachusetts General Hospital|Dr. Christina Luberto|617-643-9453|cluberto@mgh.harvard.edu|
317553|NCT03864627|Galapagos NV|Galapagos Medical Information|+32 15 342900|medicalinfo@glpg.com|
317554|NCT03861000|National Institute of Mental Health|Dr Robert Innis|+1 301 693 2979|innisr@mail.nih.gov|
305742|NCT02355977|Zhejiang University|Dr. Ying Wang|86-571-87217437|wyi1006@sina.com|
305743|NCT02356003|University of Calgary|Frank MacMaster|403-955-2784|fmacmast@ucalgary.ca|
305744|NCT02356107|University of Utah|Brent Kious, MD, PhD|(801) 581-4888|Brent.Kious@hsc.utah.edu|
293585|NCT01499147|University of Illinois Cancer Center|Damiano Rondelli, MD|312-996-6179|drond@uic.edu|
293586|NCT01499173|University of Michigan, Neurology|Dr. Lesli Skolarus|734-936-9075|lerusche@umich.edu|
293587|NCT01499199|GlaxoSmithKline|GSK Response Center|866-435-7343||
317555|NCT03848403|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317556|NCT03847233|Boston Scientific Japan K.K.|Yoko Takizawa/Clinical Project Manager|+81-3-6853-7500|Yoko.Takizawa@bsci.com|
317557|NCT03879603|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Julie E. Ledgerwood, DO (Study Chair)|301-594-8502|ledgerwood@mail.nih.gov|
317558|NCT03878745|Becton Dickinson|Michael Gibney|201-847-6170|Michael.gibney@bd.com|
317559|NCT03848221|The University of Alabama at Birmingham|Dr. Andrew Pucker|920-579-2900|apucker@uab.edu|
317560|NCT03878108|NIDDK|Kevin Hall, PhD|301-402-8248|kevin.hall@nih.gov|
317561|NCT03877432|Taipei Medical University|Dr. Chih-Wei Peng|886-2-27361661|cwpeng@tmu.edu.tw|3070
317562|NCT03877237|Astrazeneca|Łyżwa, Dawid|+48 882 345 259|dawid.lyzwa@astrazeneca.com|
317563|NCT03866434|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
317564|NCT03863210|University of Split School of Medicine|Dr. Slavica Jurić Petričević||slavica.juric01@gmail.com|
317565|NCT03859323|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
317566|NCT03867838|Stanford University|Cole Simpson|4049077708|cole.simpson@stanford.edu|
317567|NCT03855059|University of Arizona/Deptartment of Anesthesiology|Peter Lichtenthal, MD|5206267221|plich@arizona.edu|
317568|NCT03852537|Mayo Clinic|Hemang Yadav, MBBS, MS|507-266-3958|Yadav.Hemang@mayo.edu|
317569|NCT03875859|Stanford University|Kavita Yang Sarin|650-804-2899|ksarin@stanford.edu|
317570|NCT03875508|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
317571|NCT03869333|PATH|Rahsan Erdem|+1 202 540 4546|rerdem@path.org|
317572|NCT03864900|National Taipei University of Nursing and Health Sciences|Director of Nursing Department|886-2-28712121|tsaejyy@ntunhs.edu.tw|3100
317573|NCT03863795|National Cancer Institute|Annette Kaufman|301-467-8521|kaufmana@mail.nih.gov|
317574|NCT03875482|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
317575|NCT03874377|Children's National Medical Center|Dr. Sarah Hornack|202-895-3860|shornack@childrensnational.org|
317576|NCT03863496|Ilizarov centre|Sergey Raybukh|+79226716007|rso_@mail.ru|
317577|NCT03874013|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
317578|NCT03873116|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
317579|NCT03872843|Wake Forest|Dr. Jorge Gutierrez|336-716-2011|jgutierrez@wakehealth.edu|
317580|NCT03870997|Evidation Health|Executive Director, Digital Health Outcomes|650-389-9550|results@evidation.com|
317581|NCT03869684|Senju Pharmaceutical Co. Ltd.|Director, Clinical Development|+81 078 777 1018|senju-clinicaltrials@senju.co.jp|
317582|NCT03861338|New York State Psychiatric Institute|John Mariani MD|6467748181|john.mariani@nyspi.columbia.edu|
317583|NCT03858335|Samsung Medical Center|Jeong-Yi Kwon|+821045911039|jeongyi.kwon@samsung.com|
317584|NCT03857243|UTSW|Timea Hodics, M.D.|(240)-423-2741|Timea.Hodics@UTSouthwestern.edu|
317585|NCT03851744|USARIEM|Dr. Lee Margolis|508-206-2335|lee.m.margolis.civ@mail.mil|
317586|NCT03849937|University of Kansas School of Nursing|Kristine Williams, RN, PhD, FNP-BC, FGSA, FAAN, E. Jean Hill Professor|913 588 1673|kwilliams1@kumc.edu|
317587|NCT03848416|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317588|NCT03847987|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
317589|NCT03854253|Tyumen Cardiology Research Center, Tomsk National Research Medical Center, Russian Academy of Science, Tomsk, Russia|Dr. Stanislav Sapozhnikov|+79091919191|stas_ss@bk.ru|
317590|NCT03870737|University of California, Los Angeles|James J. McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
317591|NCT03860181|Medical University of South Carolina|Josef Eichinger, MD|843-876-0111|eichinge@musc.edu|
317592|NCT03856944|Gainesville Eye Associates|Clayton Blehm, MD|770-532-4444|claytonblehm@gmail.com|
317593|NCT03853551|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|8772409479
317594|NCT03870555|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
317595|NCT03861845|Florida International University|Dr. Jaclyn Schwartz|305-348-3106|jschwart@fiu.edu|
317596|NCT03851094|ResMed|Clinical Research Team|800-424-0737|clinicaltrials@resmed.com.au|
317597|NCT03869450|Q-Med AB|Clinical Project Manager|+4618 474 9000|reception.seupp@galderma.com|
317598|NCT03868631|Point Loma Nazarene University|Dr. Heidi Lynch|619-806-3306|hlynch@pointloma.edu|
293588|NCT01499277|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
317599|NCT03865953|Lateral Pharma Pty Ltd|Mr David Kenley|+61 (0)400 151 490|dk@lateral-pharma.com|
317600|NCT03865381|Verily Life Sciences|Head of Clinical Science|(650) 253-0000|info@verily.com|
317601|NCT03865446|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317602|NCT03862027|University of North Carolina at Chapel Hill|Amanda Kovacich, MD|919-966-2532|amanda.kovacich@unchealth.unc.edu|
317603|NCT03859960|Fatih Sultan Mehmet Education and Research Hospital|MD. Arzu Atici|+905335621208|arzususinatici@gmail.com|
317604|NCT03868059|Lipocine|Shadi Mehraban|801-994-7383|sm@lipocine.com|2191
317605|NCT03850444|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
317606|NCT03868254|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
317607|NCT03865407|Virginia Commonwealth University|Cristin Kaspar, MD|804-628-3866|cristin.kaspar@vcuhealth.org|
317608|NCT03857230|IVFarma LLC|General Manager|+7(499)6455342|info@ivfarma.ru|1
270369|NCT00124462|Boston Univeristy|ClinicalTrials.gov Administrator|617 638 8862|damusk@bu.edu|617
317609|NCT03865329|Mayo Clinic|Dr. Roberto Benzo|(507) 284-0561|Benzo.Roberto@mayo.edu|
317610|NCT03864653|Friends Research Institute, Inc.|Jesse B. Fletcher, Ph.D. [Research Scientist]|(323) 463-1601|jfletcher@friendsresearch.org|126
293589|NCT01499290|AstraZeneca|Paul Newell, Medical Science Director|+44 1625 515727|paul.newell@astrazeneca.com|
317611|NCT03862482|Université de Montréal|Dr. Aldo Joseph Camarda|514-343-7124|aj.camarda@umontreal.ca|
293590|NCT01499303|AstraZeneca|Bernadette Weidman|800-456-3669|ClinicalTrialTransparency@astrazeneca.com|
293591|NCT01499355|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
293592|NCT01499368|Boryung Pharmaceuticals|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
293593|NCT01499498|Imperial College London|Dr Borja Mora Peris|020 3312 6789|b.mora-peris@imperial.ac.uk|
317612|NCT03853213|Columbia University Irving Medical Center|Dr. Jeffrey Birk|212-342-5503|jlb2287@cumc.columbia.edu|
293594|NCT01499511|Imperial College London|Professor Peter Sever|02075941100|p.sever@imperial.ac.uk|
293595|NCT01499576|Konyang University Hospital|Dr. Kyung Ho SONG, Assistnat Professor of Konyang University||postit2@daum.net, postit@kyuh.ac.kr|
305745|NCT02356198|Mayo Clinic|Dr. Dorin T. Colibaseanu, MD|904-953-2596|colibaseanu.dorin@mayo.edu|
305746|NCT02356211|TVHS GRECC, Nashville TN|James S. Powers MD, Clinical Associate Director, GRECC|615-873-8032|james.powers2@va.gov|
305747|NCT02356471|Wake Forest University Health Sciences|Dr. Clancy Clark|336-716-7207|cjclark@wakehealth.edu|
305748|NCT02356484|Lausanne University Hospital|Pr. Nicolas Demartines|0041213142424|demartines@chuv.ch|
314225|NCT03274518|University of São Paulo|Dr. Bruno Caldin da Silva|+5511997620521|bruno.caldin@hc.fm.usp.br|
314226|NCT03274804|Universitätsklinikum Heidelberg, NCT|Dr. Georg Martin Haag|+49 (0) 6221 56 3|GeorgMartin.Haag@med.uni-heidelberg.de|7630
314227|NCT03274856|GLWL Research Inc|Caroline Fortier|1.514.708.4417|caroline.fortier@glwlresearch.com|
314228|NCT03274986|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
314229|NCT03274999|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
314230|NCT03275246|Zimmer Biomet|Oliver Schaetti|0041588548901|oliver.schaetti@zimmerbiomet.com|
314231|NCT03275389|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314232|NCT03275623|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD|(713) 500-6416|Jerrie.S.Refuerzo@uth.tmc.edu|
314233|NCT03275766|University of Bern, University Hospital of Psychiatry, Bern|Prof. Sebastian Walther|+41 632 8979|sebastian.walther@upd.unibe.ch|
314234|NCT03275870|Beth Israel Lahey Health|Dr. Elena Gonzalez Brant, PI|6173191221|emgbrant@gmail.com|
314235|NCT03276026|Jefferson|Dr. Adam Thaler|215-901-0749|thaler.adam@gmail.com|
314236|NCT03276078|AstraZeneca PLC|Dr Sami Daoud|1-877-240-9479|Information.centre@astrazeneca.com|
314237|NCT03276494|Ohio State University|Thomas Lawson|614-366-7312|thomas.lawson@osumc.edu|
314238|NCT03276637|Baylor College of Medicine|Jill Robinson|7137985848|jill.robinson@bcm.edu|
314239|NCT03276871|Cleveland Clinic|Aldo Fafaj|2162195943|fafaja@ccf.org|
314240|NCT03276975|Duke University Medical Center|Timothy J. Amrhein, MD|9196841909|timothy.amrhein@duke.edu|
314241|NCT03277274|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
314242|NCT03277352|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
314243|NCT03277378|Abbott|Robyn Capobianco, PhD|+1 512 286 4274|robyn.capobianco@abbott.com|
314244|NCT03277794|Centre for Addiction and Mental Health|Dr. Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
317613|NCT03847610|Imperial College London|Richard Wilson|02033132732|richard.wilson@imperial.ac.uk|
314245|NCT03277846|University of Pennsylvania|Michael Perlis|215-746-3577|mperlis@upenn.edu|
314246|NCT03278028|Aclaris Therapeutics|Executive Director, Clinical Operations|+1(484) 329-2144|jschnyder@aclaristx.com|
314247|NCT03278067|GlaxoSmithKline|GSK Response Center|866-435-7343|emily.p.lu@gsk.com|
314248|NCT03278106|Mayo Clinic|Amit Mahipal MBBS|+1 (507) 293-0487|Mahipal.amit@mayo.edu|
314249|NCT03278223|Visioncare Research Ltd.|Mr Thomas Boyes, Clinical Project Manager|+441252 718719|t.boyes@visioncare.co.uk|223
314250|NCT03278613|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
314251|NCT03278886|Boston Medical Center|Dr. Jeffrey Samet|617-414-7444|jsamet@bu.edu|
314252|NCT03279237|Massachusetts General Hospital|Dr. Theodore Hong|(617) 726-2000|TSHONG1@mgh.harvard.edu|
314253|NCT03279458|University of Mississippi Medical Center|Dr. Madhankumar Sathyamoorthy, Principal Investigator|6018157066|msathyamoorthy@umc.edu|
314254|NCT03279731|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, PhD|2158982823|kca@pennmedicine.upenn.edu|
317614|NCT03850093|faculty of medicine- Zagazig university|assistant professor Abeer M. Elnakera|00201005720754|nakera35@hotmail.com|
317615|NCT03848208|Achieve Life Sciences|Daniel Cain, Vice President, Clinical Research|425.686.1546|dcain@achievelifesciences.com|
317616|NCT03847389|Hill Dermaceuticals, Inc.|Rosario G Ramirez, MD|4073231887|nini.ramirez@hillderm.com|
317617|NCT03862040|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
317618|NCT03861936|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
317619|NCT03859739|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
317620|NCT03857750|Rigshospitalet|Dr. Matias Vested|+4524464955|matiasvested@gmail.com|
317621|NCT03856255|NYU Langone Health|Mark Pochapin, MD|212-263-9177|Mark.Pochapin@nyulangone.org|
317622|NCT03850509|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
317623|NCT03860753|The University of Texas Health Science Center at Houston|Jin Ho Yoon, PhD|713-486-2800|jin.ho.yoon@uth.tmc.edu|
317624|NCT03848455|Zhujiang Hospital of Southern Medical University|Xiaoya Gao|18680282869|4356975@qq.com|
317625|NCT03858894|Santen Inc|R&D Quality Manager|415 268 9199|evelyn.chikere@santen.com|
317626|NCT03856164|University of Texas Southwestern|Dr. Olutoyosi Ogunkua|2145578873|olutoyosi.ogunkua@utsouthwestern.edu|
317627|NCT03850275|Clarkson University|Ali Boolani|3152681663|aboolani@clarkson.edu|
317628|NCT03851016|University of Houston|Dr. Theresa C. Chrisman|713-447-3334|tkchrisman@comcast.net|
293596|NCT01499654|Northwestern University|Edwin Wu, MD|847-535-7270|ed-wu@northwestern.edu|
293597|NCT01499667|Novartis Pharnaceuticals|Study Director|862-778-8300||
293598|NCT01499810|Research Institute of Cradiology, Siberian Branch of Russian Academy of Sciences|Dr. Stanislav Pekarskiy|+73822558122|pekarski@cardio-tomsk.ru|
293599|NCT01499849|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|781.257.2536|mhuber@tesarobio.com|
293600|NCT01499862|Department of Physical Therapy and Rehabilitation, University of California San Francisco|Dr. Nancy N. Byl|415-514-4816|byln@ptrehab.ucsf.edu|
293601|NCT01499940|West Virginia Universtiy|Gerald Higa, PharmD|(304) 293-1461|ghiga@hsc.wvu.edu|
293602|NCT01500031|Boston Scientific|Director Clinical Trials|708-771-4737|Pamela.Grady@bsci.com|
317629|NCT03850496|Imperial College London|Dr Tristan Lane, Clinical Lecturer|02033117317|tristan.lane@imperial.ac.uk|
317630|NCT03848949|Rush University Medical Center|Dr. Daniel D. Bohl|414.640.7245|danielbohl@gmail.com|
317631|NCT03849690|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
317632|NCT03845933|Evergreen General Hospital|Dr Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
317633|NCT03844945|Aerie Pharmaceuticals Ireland Limited, Japan Branch|Clinical Research, Japan|+81-3-6860-8410|JapanCS208@aeriepharma.com|
317634|NCT03844321|Massachusetts General Hospital|Andrew Nierenberg|617-512-2641|anierenberg@mgh.harvard.edu|
317635|NCT03843632|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
317636|NCT03840811|University of North Carolina at Chapel Hill|Marcia M. Hobbs, PhD|(919) 843-6893|mmhobbs@med.unc.edu|
317637|NCT03837028|bakirkoy dr sadi konuk training and research hospital|Ismail Alay|+905462375638|dr_ismailalay@hotmail.com|
317638|NCT03825939|NYU Langone|Dr. Jan Koenig|516-678-2232|Jan.Koenig@nyulangone.org|
317639|NCT03817775|• Department of Anaesthesia and Intensive Care, American Hospital of Paris|Dr Gilles BOCCARA|+33 1 46 41 25 25|gilles.boccara@ahparis.org|
317640|NCT03843372|Sleep Center, Chang Gung Memorial Hospital, Keelung, Taiwan|Dr. Chung-Chieh Yu|886+22432-9292|terminatorchieh@yahoo.com.tw|2658
317641|NCT03841331|Menlo Therapeutics, Inc.|Iain Stuart|1-800-775-7936|Iain.Stuart@foamix.com|
317642|NCT03840278|Massachusetts General Hospital Diabetes Research Center|Courtney A Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
317643|NCT03840135|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|+7(495) 730-75-45|DodonovNS@petrovax.ru|125
317644|NCT03839641|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
317645|NCT03839212|University of Miami|Daniel E. Jimenez, Ph.D., Associate Professor|3052432776|dej18@miami.edu|
317646|NCT03839355|Mayo Clinic|Dr. Malini Madhavan|507-255-4152|Madhavan.Malini@mayo.edu|
317647|NCT03838874|Mayo Clinic|Dr. Matthew Abdel|507-538-1296|Abdel.Matthew@mayo.edu|
317648|NCT03838731|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
317649|NCT03838198|University of Michigan|Ewa Czyz|734-764-9466|ewac@umich.edu|
317650|NCT03831451|University of Michigan|Dr. Lesli Skolarus|734-936-9075|lerusche@umich.edu|
317651|NCT03822078|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
317652|NCT03815240|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
317653|NCT03836859|Dompè|Flavio Mantelli, MD, PhD|+39 513831|info@dompe.com|
317654|NCT03835078|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
270370|NCT00124514|cincinnatichildrens|Hermine Brunner|5136367982|hermine.brunner@cchmc.org|
293603|NCT01500057|Brooklyn Urology Research Group|Ivan Grunberger, M.D. Medical Director|718-230-7788|ivg9002@nyp.org|
293604|NCT01500083|Lundbeck Canada Inc.|Lundbeck Canada Inc.|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
305749|NCT02356562|AbbVie|Global Medical Services|800-633-9110||
317655|NCT03834025|University of North Carolina at Chapel Hill|Marisa Domino, PhD|919-966-3891|domino@unc.edu|
317656|NCT03836677|AstraZeneca AB|AstraZeneca AB|1-877-240-9479|information.center@astrazeneca.com|
317657|NCT03836989|Oregon Health and Science University|Dr. Myriam Loyo|503-494-8510|loyo@ohsu.edu|
317658|NCT03827564|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
317659|NCT03824236|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317660|NCT03811951|University of Illinois at Chicago - College of Pharmacy|Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
317661|NCT03810235|School of Medicine and Public Health University of Wisconsin-Madison|Kathleen M. Antony, M.D, M.S.C.I|608-417-6099|kantony@wisc.edu|
317662|NCT03806556|University of Pittsburgh Medical Center|Meghan McCormick, MD MS|412-692-6938|meghan.mccormick3@chp.edu|
317663|NCT03836664|University of Kansas Medical Center|Dr Dipika Aggarwal, Clinical Assistant Professor|9139459926|daggarwal@kumc.edu|
317664|NCT03832738|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
317665|NCT03823391|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
317666|NCT03820258|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
317667|NCT03819491|Consult Med Iasi|Dr. Delia Reurean-Pintilei|+40232233387|drdeliapintilei@gmail.com|
317668|NCT03808298|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
317669|NCT03836729|ViiV Healthcare|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
317670|NCT03835975|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317671|NCT03821259|University of Edinburgh/NHS Tayside|Klaudia Suchorab|+44 1738 621151|klaudia.suchorab@nhs.net|
317672|NCT03803085|Brandeis University|Yujun Liu|781-736-3300|lyujun@brandeis.edu|
317673|NCT03801473|Sultan Abdulhamid Han Training and Research Hospital|Tugba Ozsoy|+902165422020|tugbaozsoyy@gmail.com|3876
317674|NCT03834168|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Dr. Pankaj Arora|2059754720|parora@uabmc.edu|
317675|NCT03828149|Novus Therapeutics|Clinical Director|949-679-1110|study001@novustherapeutics.com|
317676|NCT03835221|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
317677|NCT03819634|Stanford|Bruce Buckingham|6508040476|buckingham@stanford.edu|
317678|NCT03812679|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
317679|NCT03809052|Galecto BIotech|Dr Bertil Lindmark, Chief Medical Officer|+45 70 70 52 10|info@galecto.com|
317680|NCT03801148|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
317681|NCT03832907|Emory University|Dr. Umpierrez|404-778-1665|geumpie@emory.edu|
317682|NCT03832322|Evergreen General Hospital, Taiwan|Dr. Chi-Liang Cheng|0919768058|chiliang.cheng@gmail.com|
317683|NCT03832387|HOSPITAL GENERAL UNIVERSITARIO DE CASTELLÓN|Dr. ALBERTO BELENGUER MUNCHARAZ|96472500|belengueralberto8@gmail.com|
317684|NCT03831971|Clinical Center|Masur, Henry|+1 301 496 9320|hmasur@cc.nih.gov|
317685|NCT03831854|Cleveland Clinic|Dr Kamal Maheshwari|216-318-7235|maheshk@ccf.org|
317686|NCT03807739|Genentech, Inc|Medical Communications|1-800-821-8590|genentech@druginfo.com|
317687|NCT03831282|Masimo|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
317688|NCT03824912|Encube Ethicals Pvt Ltd|Dr. Lalatendu Panigrahi, Chief Scientific Officer|+91-22-6264-7002|lalatendu.p@encubeethicals.com|
317689|NCT03822884|Biosidus S.A.|Clinical Trial Manager - Dr. Roberto A. Diez|+5411 4909 8000|r.diez@biosidus.com.ar|
317690|NCT03816709|North Dakota State University|Kara Gange, Associate Professor|701-231-5777|kara.gange@ndsu.edu|
317691|NCT03810014|Duke University|Wendy P O'Meara, PhD|919-681-7711|wpo@duke.edu|
317692|NCT03806270|Yeditepe U|Dr. Ferda F. Kartufan|+902165784000|ferdasozer@gmail.com|4754
317693|NCT03830892|Virginia Commonwealth University|Dr. Andrew J. Barnes|804-827-4361|abarnes3@vcu.edu|
317694|NCT03830307|University of Pittsburgh|Dr. Grace Lim|412-641-4260|limkg2@upmc.edu|
317695|NCT03825042|A.Menarini Industrie Farmaceutiche Riunite Srl|Director of Clinical Operations|0039 055 5680459|pfabrizzi@menarini.it|
317696|NCT03823378|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
317697|NCT03831191|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317698|NCT03830281|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317699|NCT03828734|University of North Carolina at Chapel Hill|Justin Riddle, PhD|919-966-4755|justin_riddle@med.unc.edu|
317700|NCT03827395|Emory University|Evan J. Anderson, MD|404-727-1746|evanderson@emory.edu|
317701|NCT03819218|MC2 Therapeutics|Irene Sandholdt|+45 2015 7033|isa@mc2therapeutics.com|
317702|NCT03818815|Novus Therapeutics|Clinical Director|949-679-1110|study006@novustherapeutics.com|
317703|NCT03828487|Masimo Corporation|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
317704|NCT03828617|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317705|NCT03828539|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
317706|NCT03824704|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
305750|NCT02356575|Memorial Sloan Kettering Cancer Center|Dr. Jun Mao, MD, MSCE|646-888-0866|maoj@mskcc.org|
305751|NCT02356588|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
305752|NCT02356692|CooperVision|Donald Siegel, OD|602 485 3414|dsiegel@coopervision.com|
305753|NCT02356705|Bassett Healthcare|Dr. David Ullman|585-750-7510|doccfi@hotmail.com|
305754|NCT02356783|Hospital for Special Surgery|Robert Griffin, MD, PhD|212-774-2944|griffinr@hss.edu|
305755|NCT02356887|Toronto western Hospital/UHN|Emad Al Azazi|416-603-5800|emad.alazazi@uhnresearch.ca|6237
317707|NCT03823937|Sultan.abdulhamid|Tugbaozsoy|+905074583382|tugbaozsoyy@gmail.com|
293605|NCT01500096|Johns Hokpins University|Adriana Andrade|410-955-7287|aandrade@jhmi.edu|
293606|NCT01500135|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
293607|NCT01500187|University of Health Science Center|Franklin Garcia-Godoy DDDS, MS PhD||fgarciagodoy@gmail.com|
293608|NCT01500200|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
293609|NCT01500213|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|862.228.2483|mhuber@tesarobio.com|
293610|NCT01500226|Tesaro|Martin Huber, M.D., Senior Vice President and Chief Medical Officer|781-257-2536|mhuber@tesarobio.com|
293611|NCT01500252|UAlberta|Dr. Lauren Beaupre|780-407-3945|lauren.beaupre@albertahealthservices.ca|
293612|NCT01500278|Cares|UCB|+1877 822||9493
293613|NCT01500317|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
317708|NCT03817879|Ambu A/S|Anna Charlotte Lundgaard|+4529643748|aclu@ambu.com|
317709|NCT03811834|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
317710|NCT03806127|Urovant Sciences|Information, Clinical Trial Results|949-226-6029|info@urovant.com|
317711|NCT03827473|Huntsman Cancer Institute Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
317712|NCT03826914|University of Manitoba|Dr. Semone Myrie|(204) 474-7290|semone.myrie@umanitoba.ca|
271685|NCT00257322|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
317713|NCT03812328|Tetherex Pharmaceuticals|Jonathan Stocker, Ph.D.|855-222-0722|jstocker@tetherex.com|
317714|NCT03808688|Aerie Pharmaceuticals|VP, Medical Affairs|949-246-8731|jmwilliams@aeriepharma.com|
317715|NCT03811093|Vidantis Technologies, Inc|Thomas A. Namynanik - Consultant to invisa-RED Technologies|404 915-5938|andyn997@vidantis.com|
317716|NCT03822182|AHNI Orthopedics|Brian Badman|3178328800|bbadman@gmail.com|
317717|NCT03822416|University of Minnesota|Harry Lando, PhD|612-624-1877|lando001@umn.edu|
317718|NCT03809104|Ci-Shan Hospital, Health and Welfare of Minister, Taiwan|Ms. Chia-Yu Wei|+886-7-6615523|ivywei@chis.mohw.gov.tw|1729
317719|NCT03807089|Massachusetts General Hospital|Dr. Norman Nishioka|617-726-4422|nnishioka@partners.org|
317720|NCT03806231|Intermountain Healthcare|Molly Adams, Clinical Research Project Coordinator|(801)507-7030|molly.adams@imail.org|
317721|NCT03804710|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317722|NCT03822377|Cardiology Clinic, Sassari University Hospital, Sassari, Italy|Prof. Guido Parodi|0039|parodiguido@gmail.com|792830626
317723|NCT03820388|University of California Davis|Dr. Hong Liu|916-734-5031|hualiu@ucdavis.edu|
317724|NCT03816696|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317725|NCT03821064|Medical University of South Carolina|Evan Graboyes (PI)|843-792-0719|graboyes@musc.edu|
317726|NCT03820544|Sidney Kimmel Cancer Center at Thomas Jefferson University|Thomas Kowalski, MD|215-955-9396|Thomas.Kowalski@jefferson.edu|
317727|NCT03820024|UNC Lineberger|Leslie Clark|919-966-5996|leslie_Clark@med.unc.edu|
317728|NCT03807544|Theranova|Director of Clinical Trials|14159268616|clindquist@theranova.com|
317729|NCT03809182|Pontificia Universidad Católica de Chile|Mauricio Ibacache MD|+56984421425|mibacach@med.puc.cl|
317730|NCT03816761|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
317731|NCT03801044|Sisli Hamidiye Etfal Training and Research Hospital|Mustafa Sevinc|00905309291239|musevinc@hotmail.com|
317732|NCT03805672|Oregon Health & Science University|Samantha Underwood|503-494-8481|underwos@ohsu.edu|
317733|NCT03808493|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
317734|NCT03815292|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
317735|NCT03812510|Aclaris Therapeutics, Inc.|Aclaris Clinical Operations|1-833-225-2747|clinicaloperations@aclaristx.com|
317736|NCT03802994|Ralph H. Johnson VA Medical Center|ACOS/R, R. Amanda C. LaRue|843-789-6707|Rutha.LaRue@va.gov|
317737|NCT03810183|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
317738|NCT03809910|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317739|NCT03806790|LEO Pharma A/S|Clinical disclosure|+4544945888|disclosure@leo-pharma.com|
317740|NCT03809611|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
317741|NCT03807245|MinervaX ApS|Dr Per Fischer|+45 20 25 20 38|pbf@minervax.com|
317742|NCT03805971|Centre hospitalier universitaire de Liège|Dr Olivier Bonhomme|003243667881|obonhomme@chuliege.be|
317743|NCT03802916|Chiesi Canada Corp.|Fernando Tricta, MD|1-416-558-6342|ftricta@chiesi.com|
317744|NCT03809039|Mitsubishi Tanabe Pharma Europe Ltd|Clinical Trials, Information Desk|Please e-mail|regulatory@mt-pharma-eu.com|
317745|NCT03807700|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317746|NCT03804918|Imperial College London|Dr Gehan Soosaipillai|+44 20 3312 6666|gsoosaip@ic.ac.uk|7651
317747|NCT03805386|Mayo Clinic Arizona|Principal Investigator, Dr Johnny Yi|14803420612|yi.johnny@mayo.edu|
317748|NCT03803475|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|
317749|NCT03802227|Nektar Therapeutics|Study Director|415-482-5416|medicalaffairs@nektar.com|
317750|NCT03802864|Weill Cornell Medicine|Russell Hayden|2127465566|rph9002@med.cornell.edu|
317751|NCT03801265|University of Pittsburgh|Sharad Khetarpal, MD|4126235020|khetarpalsk@upmc.edu|
317752|NCT03802344|MC2 Therapeutics|Irene Sandholdt|+45 2015 7033|isa@mc2therapeutics.com|
317753|NCT03801928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317754|NCT03800173|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
293614|NCT01500382|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293615|NCT01500434|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
317755|NCT03799783|University Hospital Padova|Angela Amigoni, MD|339 8333765|Angela.amigoni@aopd.veneto.it|++39
293616|NCT01500525|Capital Institute of Pediatrics|Ling Cao，MD,Pulmonologist, Professor|86-13910610319|caoling9919@163.com|
293617|NCT01500629|Johnson & Johnson Consumer and Personal Products Worldwide|Daniel Qi, MD, PhD, Director, Clinical Research|973 385-2260|dqi6@its.jnj.com|
293618|NCT01500694|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
293619|NCT01500720|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
293620|NCT01500746|Northwestern University|Dr. Elliot Hirsch|312-695-6022|elliot-hirsch@md.northwestern.edu|
317756|NCT03800030|University of North Carolina at Chapel Hill|Justin Riddle, PhD|6617131602|justin_riddle@med.unc.edu|
317757|NCT03799211|NYU Langone Health|Mia Minen, MD, MPH|212-263-7744|Mia.Minen@nyulangone.org|
317758|NCT03798717|University of Portsmouth|Dr. Ant Shepherd|02392845289|ant.shepherd@port.ac.uk|
317759|NCT03798483|Oxford University hospital foundation trust|Colin Forde|+441865221540|Colin.Forde@ouh.nhs.uk|
317760|NCT03798366|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
317761|NCT03799952|University of New Brunswick|Dr. Danielle Bouchard|1 (506) 443-3908|danielle.bouchard@unb.ca|
317762|NCT03797872|University of Oxford|Professor Laura Coates|+447870257823|laura.coates@ndorms.ox.ac.uk|
317763|NCT03799614|Virginia Commonwealth University|Dr. Ingrid Pretzer-Aboff|804-828-3340|iaboff@vcu.edu|
317764|NCT03799484|The University of Texas Health Science Center at Houston|Karina Richani-Reverol, MD|(713) 559-5200|Karina.RichaniReverol@uth.tmc.edu|
317765|NCT03796728|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
317766|NCT03797144|Medtronic|Clinical Research Specialist|+39 3450225929|francesca.molineris@medtronic.com|
317767|NCT03782571|Johnson & Johnson Vision Care, Inc.|Thomas R. Karkkainen, OD, MS, FAAO|904 443-3402|TKarkkai@its.jnj.com|2126
317768|NCT03796260|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
317769|NCT03796039|University of New Brunswick|Dr. Danielle Bouchard|(506) 443-3908|dboucha1@unb.ca|
317770|NCT03783780|Masimo|Tala Harake|1-949-297-7100|studies@masimo.com|
317771|NCT03780959|Amgen Inc.|Study Director|866-572-6436||
317772|NCT03796182|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
317773|NCT03796013|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
317774|NCT03796676|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317775|NCT03795753|Emory University|Dr. Nancy Collop|404-712-7533|nancy.collop@emory.edu|
317776|NCT03792477|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
317777|NCT03783962|University of Vermont Department of Nutrition and Food Sciences|Mattie Alpaugh|8026569526|malpaugh@uvm.edu|
317778|NCT03782272|PATH|Gwen Ambler, Clinical Research Officer|+1-206-285-3500|gambler@path.org|
317779|NCT03779724|Aksaray University Training and Research Hospital|The principal investigator|905555289493|mlk.aykut@gmail.com|
317780|NCT03775915|University of Oxford|Dr Melanie Fleming, Research Associate|+441865611461|melanie.fleming@ndcn.ox.ac.uk|
317781|NCT03794752|UT Southwestern Medical Center|Peter Chen|12146283837|peter.chen@utsouthwestern.edu|
317782|NCT03794024|Cleveland Clinic|Robert Bolash|216-444-3134|bolashr@ccf.org|
317783|NCT03793751|Tata Main Hospital, Tata Steel|Dr.Deb Sanjay Nag|+91-9431166582|debsanjay@gmail.com|
317784|NCT03793556|Sofar Spa|Dr Francesca Baldan|0039 02 909362|francesca.baldan@sofarfarm.it|1
317785|NCT03785548|TriHealth Inc.|Tiffanie Tam, Md|513-463-4300|Tiffanie_Tam@trihealth.com|
317786|NCT03782701|Bascom Palmer Eye Institute|Dr. Wendy Lee|(305) 243-2020|wlee@med.miami.edu|
317787|NCT03773133|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
317788|NCT03792737|Johnson & Johnson Medical Shanghai Ltd.|Xiaolei, Wang|+86 21 33378749|xwang183@its.jnj.com|
317789|NCT03792672|Takeda|Medical Director|1-877-825-3327|medicalinformation@tpna.com|
317790|NCT03786744|Samara Medical Center Dinasty|Volchkov Stanislav|+78469564455|quality@cordbank.ru|
317791|NCT03782181|University of Balearic Islands|José Mingorance|+34677602465|josea.mingorance@uib.es|
317792|NCT03792191|Mansoura University|Dr. Mohamed Mohamed Tawfik|1001183400|m2tawfik@mans.edu.eg|0020
317793|NCT03791489|Stryker ENT|Pr. Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
317794|NCT03790865|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
317795|NCT03784300|Cassava Sciences|Michael R Marsman, PharmD|5125822173|mmarsman@cassavasciences.com|
317796|NCT03790878|Duke University|Katherine (Kibby) McMahon|917-880-1551|Kibby.McMahon@duke.edu|
317797|NCT03789474|ALL INDIA INSTITUTE OF MEDICAL SCIENCES,RISHIKESH,UTTARAKHAND,INDIA.|Dr M KESARI|7093005219|kesyellow@yahoo.com|
317798|NCT03789175|NHLBI, NIH|Dr. Paul Hwang|3014353068|hwangp@mail.nih.gov|
317799|NCT03787615|The Pennsylvania State University|Dr. David Conroy|814-863-3451|conroy@psu.edu|
317800|NCT03786718|Vanderbilt University Medical Center|William Martinez, MD|(615) 936-1010|william.martinez@vumc.org|
317801|NCT03784963|The University of Chicago|Dr. Ann Nguyen, MD|773-702-9396|anguyen3@medicine.bsd.uchicago.edu|
317802|NCT03771274|Carolina Eyecare Physicians, LLC|Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
317803|NCT03787472|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
317804|NCT03787212|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan, OD - Principal Research Optometrist|904 443 3449|CColesb@its.jnj.com|
317805|NCT03784001|University of California, Los Angeles|Tanera van Diggelen|4086231219|tvandiggelen@gmail.com|
293621|NCT01500759|ResMed Germany Inc|Medical Affairs CRS|089990100|ClinicalResearch&Strategy@ResMed.com|
317806|NCT03784898|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
317807|NCT03783702|Stanford University School of Medicine|Noel Ayoub|3109407055|nfa@stanford.edu|
293622|NCT01501110|Hospital de Clínicas de Porto Alegre|Josi Vidart|+55 51 98472520|josividart@gmail.com|
293623|NCT01501162|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
293624|NCT01501929|University of Texas Southwestern|Wanpen Vongpatanasin|2146482103|Wanpen.Vongpatanasin@UTSouthwestern.edu|
317808|NCT03781479|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|3054203200|gingenito@catalystpharma.com|
317809|NCT03781037|Florida International University|Dr. Jeremy Pettit|305-348-1671|jpettit@fiu.edu|
317810|NCT03784079|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
317811|NCT03783039|ETHICON, Inc|Patricia Schleckser|01 908 218 2244|PSchleck@its.jnj.com|
317812|NCT03783130|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
317813|NCT03776175|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317814|NCT03771963|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
317815|NCT03771352|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
317816|NCT03773796|Medical University of Innsbruck|Prof. Klaus Seppi|004351250481553|klaus.seppi@tirol-kliniken.at|
317817|NCT03782233|The First Affiliated Hospital of Nanjing Medical University|Dr. He Huang|13852476684|hh19871117@126.com|
317818|NCT03781375|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
317819|NCT03781336|National Institutes of Health|Psychologist|3014027360|amelir@mail.nih.gov|
317820|NCT03780400|University of North Carolina at Chapel Hill|Kelli D. Allen, PhD|919-966-0558|kdallen@email.unc.edu|
317821|NCT03779997|University of Washington|Judith I. Tsui|206-744-1835|tsuij@uw.edu|
317822|NCT03779503|CooperVision. Inc|Jose A. Vega, O.D, MSc., FAAO|9256213761|javega@coopervision.com|
317823|NCT03780010|TRACON Pharmaceuticals Inc|Medical Monitor|8585500780|clinicaltrials@traconpharma.com|
317824|NCT03778190|Kendall Regional Medical Center|Dr. Tony Zitek|305-480-6602|zitek10@gmail.com|
317825|NCT03777059|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
317826|NCT03772522|MAP Centre for Urban Health Solutions, Unity Health Toronto|Dr. Naomi Thulien|647-460-0781|ThulienN@mcmaster.ca|
317827|NCT03772327|Weill Cornell Medicine|Dr. Grant Ellsworth|212-746-7204|gre9006@med.cornell.edu|
317828|NCT03777865|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317829|NCT03774576|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
317830|NCT03776539|Eloxx Pharmaceuticals|Executive Director Clinical Trials|1-781-577-5300|CTI@eloxxpharma.com|
317831|NCT03772041|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
317832|NCT03775681|UT MD Anderson Cancer Center|Katherine Hagan, Associate Professor, Anesthesiology & PeriOper Med|(713) 794-5945|khagan@mdanderson.org|
317833|NCT03774823|Venus Concept Ltd.|Director, Clinical Affairs|888-907-0115|mgronski@venusconcept.com|
317834|NCT03774745|University of California, Davis|Dr. Mitchell Creinin|916-734-6670|mdcreinin@ucdavis.edu|
317835|NCT03774433|Dartmouth College|Dr. Lisa Marsch|603-646-7092|Lisa.A.Marsch@dartmouth.edu|
317836|NCT03771560|UCSF|Dr. Robert Hendren|415-502-3500|STAR@ucsf.edu|
317837|NCT03770091|UPMC|John Fowler|412-605-3245|fowlerjr@upmc.edu|
317838|NCT03769896|Medical University of Innsbruck|Prof. Klaus Seppi|004351250481553|klaus.seppi@tirol-kliniken.at|
317839|NCT03769649|InMode|Maria Shusterman|855.411.2639|marias@inmodemd.com|
271686|NCT00257556|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
317840|NCT03769207|Stanford University|Marco Perez, Associate Professor of Medicine|(650) 723-9363|mvperez@stanford.edu|
317841|NCT03768856|Cleveland Clinic, Case Comprehensive Cancer Center|Dr Shlomo Koyfman|1-800-223-2273|TaussigResearch@ccf.org|
317842|NCT03768726|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
317843|NCT03768206|University of South Carolina|Christine Pellegrini|803-777-0911|pellegca@mailbox.sc.edu|
317844|NCT03767894|Columbia University|Dr. Joel Stein|(212) 305-4818|js1165@columbia.edu|
317845|NCT03767738|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
317846|NCT03767153|Venus Concept|Clinical Research Manager|888-907-0115|rmays@venusconcept.com|
317847|NCT03767062|Ataturk University|Mustafa Ceylan|+905062773216|drmuson16@hotmail.com|
317848|NCT03766646|University Hospital Southampton|Dr Patrick Butler|81205662|patrick.butler@uhs.nhs.uk|+44 (0)23
317849|NCT03766373|Novus Therapeutics|Clinical Director|949-679-1110|study004@novustherapeutics.com|
317850|NCT03766165|Johns Hopkins University; Indiana University|Dr. Larissa Jennings Mayo-Wilson|1-812-856-0902|ljmayowi@iu.edu|
317851|NCT03765996|Dr. İsmail Atabek Physiotherapy and Rehabilitation Center|Ertan Şahinoğlu|+90 532 647 86 53|ertan.sahinoglu@hotmail.com|
317852|NCT03765762|Alkahest, Inc.|Head of Communications|(650) 801-0474|info@alkahest.com|
317853|NCT03765502|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317854|NCT03765164|QURE Healthcare|Director of Clinical Trials|415-321-3388|qureadmin@qurehealthcare.com|
293625|NCT01502033|Mayo Clinic|Dr. Paul Croarkin|(507) 293-2557|croarkin.paul@mayo.edu|
293626|NCT01502072|UT MD Anderson Cancer Center|Roy F. Chemaly, MD,MPH- Professor, Infectious Diseases|(713) 745-1116|rfchemaly@mdanderson.org|
317855|NCT03765138|Columbia University Medical Center/New York State Psychiatric Institute|Dr. Yuval Neria|646-774-8092|Yuval.Neria@nyspi.columbia.edu|
317856|NCT03764449|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
317857|NCT03763929|Diffusion Pharmaceuticals Inc|Clinical Operations|434-220-0718|clinicaltrials@diffusionpharma.com|
317858|NCT03763747|OrbusNeich|Stephen M. Rowland, PhD - Vice-President, Research and Development|954-730-0711|srowland@orbusneich.com|
317859|NCT03763175|MAST Program|Director of Clinical Trials|(310) 423-0617|GroupMedicineMAST@cshs.org|
317860|NCT03763058|Centre d'Evaluation et Traitement de la Douleur|Dr Guilhem Parlongue|00262262912037|guilhem_parlongue@hotmail.com|
317861|NCT03762993|Purdue University|Preeti Sivasankar|765-494-3788|preeti@purdue.edu|
317862|NCT03762681|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
317863|NCT03762668|Alcon Research, LLC|Sr. CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
317864|NCT03762616|Exact Imaging|Dr. Brian Wodlinger|6475279032|bwodlinger@exactimaging.com|
317865|NCT03762213|Arkansas Children's Hospital|Dr. Saumya V Joshi|501-364-4619|svjoshi@uams.edu|
317866|NCT03762200|ETHICON, Inc|Patricia Schleckser|01 908 218 2244|PSchleck@its.jnj.com|
317867|NCT03761368|Medical University of Łódź|Karolina Stokfisz|+48422014260|stokfisz.karolina@gmail.com|
317868|NCT03761147|Hebrew Univeristy|Anna Shaphir|+972 50 716 7309|shaphira@hadassah.org.il|
317869|NCT03760913|OliPass Corporation|OliPass Call Center|82-2-6488-2200|clinicaltrials.inquiries@olipass.com|
317870|NCT03760796|Johns Hopkins University School of Medicine|Dr. Seth Martin|(610) 331 - 3842|smart100@jhmi.edu|
317871|NCT03760640|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317872|NCT03760510|Vanderbilt University Medical Center|Janna Landsperger|6153223412|janna.landsperger@vumc.org|
317873|NCT03760250|University of Pennsylvania|Jenny Wei|2153165151|jenny.wei@pennmedicine.upenn.edu|
317874|NCT03759600|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
317875|NCT03759340|Aclaris Therapeutics, Inc.|Marco Cardillo, Clinical Trial Manager|484-540-6299|mcardillo@aclaristx.com|
317876|NCT03758716|Oneness Biotech Co., Ltd.|NienYi Chen PhD|+886 2 2655 8687|nienyichen@onenessbio.com.tw|613
317877|NCT03758365|MC2 Therapeutics|Birgitte Vestbjerg|+45 2077 2575|bve@mc2therapeutics.com|
317878|NCT03758157|Wello, Inc.|Alan C. Heller|469-522-5200|allen.heller@welloinc.com|
317879|NCT03757988|University of North Carolina at Chapel Hill|Tonya Elliott|919-966-3915|tonya_elliott@med.unc.edu|
317880|NCT03757312|Nationwide Children's Hospital|Marco Corridore, MD|614-722-4200|Marco.Corridore@nationwidechildrens.org|
317881|NCT03757234|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
317882|NCT03757039|Alcon Research, LLC|Sr. CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
317883|NCT03756883|Teva Pharmaceuticals, USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
317884|NCT03756506|Prevent-Plus|Jeff Elbl|314-606-5046|jeff.elbl@prevent-plus.com|
317885|NCT03756285|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
317886|NCT03756129|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
317887|NCT03756038|University of Pittsburgh|Dr. Maria Pacella|412-647-3183|pacellam@upmc.edu|
317888|NCT03756012|Ohio Pain Clinic|Dr. Amol Soin|937-434-2226|drsoin@ohiopainclinic.com|
317889|NCT03755882|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO- Director of clinical Sciences|904 443-1290|BPALL@its.jnj.com|
317890|NCT03755661|Boston University|LaNeia Thomas|617-358-6346|laneia@bu.edu|
317891|NCT03754582|Eisai Co., Ltd.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
317892|NCT03754556|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
317893|NCT03753113|Tabriz University of Medical Sciences|Dr. Farid Masoud|+989036859062|faridmasoud@gmail.com|
317894|NCT03752567|Farmacia La Regina|Dr. Raffaele La Regina|+393389066138|raffaele.laregina@gmail.com|
317895|NCT03752528|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Dobbins@Indivior.com|
317896|NCT03752151|Medtronic, Plc|Dana Wigert, Sr Prin Clinical Research Specialist|+17635262802|dana.wigert@medtronic.com|
305756|NCT02356900|Duke University Medical School|Richard Moon, MD|919-684-6726|richard.moon@duke.edu|
317897|NCT03751657|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1)866-867-7178|clinicaltrials@novonordisk.com|
317898|NCT03751280|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
317899|NCT03751020|Yale University School of Public Health (Social and Behavioral Sciences)|Dr. John Pachankis|(203) 785-3710|john.pachankis@yale.edu|
317900|NCT03750955|University of Washington|Dr. Diane Daubert|206-685-3766|ddaubert@uw.edu|
293627|NCT01502228|IndianaU|Dr. Theodore Logan|(317) 948-7449|tlogan@iu.edu|
305757|NCT02357043|Remington-Davis Inc.|Dr. Ian Baird|6144872560|hbaird@remdavis.com|
305758|NCT02357134|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
305759|NCT02357147|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
305760|NCT02357173|Medical University of South Carolina|Dr. Matthew Carpenter|843-876-2436|carpente@musc.edu|
305761|NCT02357264|Maimonides Medical Center|Eitan Dickman, MD|718-283-6057|edickman@maimonidesmed.org|
305762|NCT02357290|Massachusetts General Hospital|Dr. Janet Wozniak|617-724-5600|jwozniak@partners.org|
317901|NCT03750695|Duke University|Dr. William Todd Cade|919-660-9825|todd.cade@duke.edu|
293628|NCT01502293|OncoSec Medical Incorporated|Kellie Malloy, Chief Clinical Development Officer|858-375-9989|kmalloy@oncosec.com|
293629|NCT01502306|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
317902|NCT03748992|Medical University of South Carolina|Patrick Flume, MD|843-792-3167|flumepa@musc.edu|
293630|NCT01502332|USaoPaulo|Dr Alcino Costa Leme|55 11 989044014|costaleme@uol.com.br|
293631|NCT01502410|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
293632|NCT01502423|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
317903|NCT03748979|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
317904|NCT03748758|Novus Therapeutics|Clinical Director|949-679-1110|study002@novustherapeutics.com|
317905|NCT03748706|Cassava Sciences|Lindsay Burns, SVP of Neuroscience|512-501-2484|lburns@cassavasciences.com|
317906|NCT03748264|Philips|Jeff Jasko|4125423651|Jeff.Jasko@philips.com|
317907|NCT03747497|MicuRx Pharmaceuticals, Inc.|Study Director|510-782-2022|info@micrux.com|
317908|NCT03746405|Duke University|Dr Lysianne Beynel|919-681-1157|lysianne.beynel@duke.edu|
317909|NCT03745937|MedImmune, LLC|Lars Hansen|+1 301 398 4563|information.center@astrazeneca.com|
317910|NCT03745222|Celgene Corporation|Anne McClain|908-673-9100|ClinicalTrialDisclosure@Celgene.com|
317911|NCT03745092|Xuanwu Hospital, Capital Medical University|Pro. Ran Meng|+86-10-83199280|ranmeng2011@pku.org.cn|
317912|NCT03744780|McGill University|Mallory Frayn, PhD(c)||mallory.frayn@mail.mcgill.ca|
317913|NCT03743311|AO Servier|Olga Linnik|+7 495 9370700|olga.linnik@servier.com|
317914|NCT03743038|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
317915|NCT03742973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317916|NCT03742440|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
317917|NCT03742427|Marmara University|Sinan KARACABEY|+902166254545|karacabeysinan@gmail.com|
317918|NCT03742271|Johnson & Johnson Vision Care Inc.|John Buch OD F.A.A.O- Sr. Principal Research Optometrist|+1 904 443-1707|JBUCH@its.jnj.com|
317919|NCT03742154|MUSC|Lisa Coles Program Coordinator|843-876-2291|colesl@musc.edu|
317920|NCT03741725|University of North Carolina, Project-China|Dr. Weiming Tang|+86-15920567132|weiming_tang@med.unc.edu|
317921|NCT03741088|HistoSonics, Inc.|Clinical Affairs Manager|651.398.7586|christine.sullivan@histosonics.com|
293633|NCT01502631|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
317922|NCT03741062|University of Manitoba|Dr. Brian Wiens|613-809-4501|wiensb3@myumanitoba.ca|
317923|NCT03740659|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
317924|NCT03740152|Massachusetts General Hospital|Dr. Paolo Cassano, M.D.|617-643-9622|pcassano@mgh.harvard.edu|
317925|NCT03739866|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
317926|NCT03739684|Lantheus Medical Imaging / Progenics Pharmaceuticals|David Myl|914-582-1120|david.myl@lantheus.com|
317927|NCT03739528|NTC srl|Alessandro Colombo|+390243850490|alessandro.colombo@ntcpharma.com|
317928|NCT03739242|A. Menarini Industrie Farmaceutiche Riunite SrL|Dr Paolo Fabrizzi Clinical Operation Director|+39 055 5680459|pfabrizzi@menarini.it|
317929|NCT03738865|Xeris Pharmaceuticals, Inc.|Chelsea Boundy|312-517-1466|cboundy@xerispharma.com|
317930|NCT03738826|Duke University|Kai Sun, M.D.|919-681-7417|kai.sun@duke.edu|
317931|NCT03738475|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
293634|NCT01502644|Brigham and Women's Hospital|Ajay D. Wasan, M.D., M.Sc.||awasan@partners.org|
317932|NCT03738241|Baylor College of Medicine|Hana El Sahly, MD, FIDSA|713-798-2058|hana.elsahly@bcm.edu|
317933|NCT03738163|Mölnlycke Health Care|Sabrina Chowdhury|+44 (0)7769 907654|sabrina.chowdhury@molnlycke.com|
317934|NCT03738020|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
317935|NCT03736928|QMedAB|Clinical Project Manager|(817) 961-5000|aestheticclinicaltrials@galderma.com|
317936|NCT03736785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317937|NCT03736031|Texas Tech University Health Sciences Center at El Paso|Associate Director of Ob/Gyn Research|915-215-5103|elp-obgynresearch@ttuhsc.edu|
317938|NCT03735862|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
293635|NCT01502709|University of North Carolina|Dr Asma Khan|919 537 3389|asma_khan@dentistry.unc.edu|
317939|NCT03734991|SCYNEXIS|Dr. David Angulo|(201) 884-5471|david.angulo@scynexis.com|
317940|NCT03734822|Nationwide Children's Hospital|Anne May, MD|614-722-4766|Anne.May@nationwidechildrens.org|
317941|NCT03734601|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)|650-723-0822|rlowsky@stanford.edu|
317942|NCT03733899|Johnson & Johnson Vision Care, Inc.|Thomas Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist|904-443-3402|TKarkkai@its.jnj.com|
317943|NCT03733483|University of Colorado, Anschutz Medical Campus|Christine Swanson, MD, MCR, Assistant Professor|(303)724-0073|christine.swanson@cuanschutz.edu|
317944|NCT03733470|University of Iowa|Eric Hoffman, PhD|319-365-1381|eric-hoffman@uiowa.edu|
317945|NCT03733301|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317946|NCT03732638|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
317947|NCT03732248|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
317948|NCT03731182|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
317949|NCT03730961|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
317950|NCT03730116|Sevier|Mrdical manager - Yuriy Burtsev|8-495-93707-00|Yuriy.Burtsev@servier.com|1389
317951|NCT03730103|The Cleveland Clinic|Lynn Borzi, Research Administrator|216-445-3158|borzil@ccf.org|
317952|NCT03729960|Danone Asia Pacific Holdings|Digital Project Manager|82281172|jill.wong@danone.com|
317953|NCT03729024|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
293636|NCT01502761|University of Southern California|Dr. William J Mack|323 442 7512|william.mack@med.usc.edu|
293637|NCT01502787|University of Texas Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|wanpen.vongpatanasin@utsouthwestern.edu|
317954|NCT03728790|Columbia University|Dr. Leslie Moroz|646-532-8208|lm3000@cumc.columbia.edu|
293638|NCT01502813|University of Utah, Diagnostic Neuroimaging Lab|Deborah Yurgelun-Todd, Ph.D.|801-587-1538|Deborah.Yurgelun-Todd@hsc.utah.edu|
293639|NCT01502956|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
317955|NCT03728348|Exact Sciences|Alexandra Massoud, Sr. Director of Clinical Affairs|608.284.5700|clinicaltrials@exactsciences.com|
293640|NCT01503021|Rockwell Medical, Inc|Senior Director, Clinical Research|248-960-9009|rd@rockwellmed.com|
293641|NCT01503164|Johns Hopkins University|Naresh Punjabi|410-550-6384|npunjabi@jhmi.edu|
293642|NCT01503229|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
293643|NCT01503333|Michigan State University College of Nursing|Dr. Lorraine Robbins|517-353-3011|Lorraine.Robbins@hc.msu.edu|
293644|NCT01503749|Seoul National University Hospital|Pf. Jung-Hwan Yoon|82-2-2072-2228|yoonjh@snu.ac.kr|
293645|NCT01504204|Wake Forest University Health Sciences|Irma M Richardsom, MHA|336-716-2903|irichard@wakehealth.edu|
305763|NCT02357342|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
317956|NCT03728140|Reproductive medcine of Jinan central hospatil|Dr. bin wu|+86 053185695203|wb0538@163.com|
317957|NCT03727854|Seoul National University Hospital|Professor|82-2-2072-2217|ymchomd@snu.ac.kr|
317958|NCT03727425|Auris Health, Inc.|Scott Rehage|9256832590|scott.rehage@aurishealth.com|
317959|NCT03727347|Aerin Medical, Inc.|Anais Laborde|(650) 518-9624|alaborde@aerinmedical.com|
317960|NCT03726996|Yale University|Yong-Hui Jiang, MD, PhD|203-785-2660|yong-hui.jiang@yale.edu|
317961|NCT03726164|University College London|Prof Derek Hausenloy|+6584053767|d.hausenloy@ucl.ac.uk|
317962|NCT03725852|Galapagos NV|Galapagos Medical Information|+32 15 342 900|medicalinfo@glpg.com|
317963|NCT03725722|LEO Pharma A/S|Clinical disclosure|+45 4494 5888|disclosure@leo-pharma.com|
317964|NCT03725098|Biom'up|William Spotnitz, MD, MBA|351-514-5009|w.spotnitz@biomup.com|
317965|NCT03725085|Reckitt Benckiser Inc.|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
317966|NCT03725033|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
305764|NCT02357368|Emory University|Lisa Haddad, MD|404-778-1385|lisa.haddad@emory.edu|
305765|NCT02357394|University of Kansas Health System, Dept of OBGYN|Dr. Gene Lee|9135886201|glee@kumc.edu|
317967|NCT03724981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
317968|NCT03724968|Vanderbilt University Medical Center|Teresa Melton|6159367423|teresa.melton@vumc.org|
317969|NCT03724877|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
317970|NCT03724253|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
317971|NCT03723980|Dow University of Health Sciences|Dr. Juzer Shabbir Saifee|92-333-2352134|dr.juzer.shabbir@gmail.com|
317972|NCT03723603|Medline Industries, Inc|Stephanie Martynenko|2242163822|smartynenko@medline.com|
317973|NCT03723447|Cedars-Sinai|Dr Karen Zaghiyan|(310) 289-9224|kzaghiyan@yahoo.com|
317974|NCT03723070|Boston Scientific|Clinical Trial Manager|+32 470 991143|nele.cielen@bsci.com|
317975|NCT03720210|Mayo Clinic|Marius N. Stan, M.D.|507-266-3769|Stan.Marius@mayo.edu|
317976|NCT03718455|Mayo Clinic|Genevieve A. Woodard, M.D., Ph.D.|507-538-3945|Woodard.Genevieve@mayo.edu|
317977|NCT03718143|NYU Langone Health - PCC CTO|Rachael Keller, Sr. Regulatory Specialist|929-455-2453|Rachael.Keller@nyulangone.org|
317978|NCT03709576|Penn State Cancer Institute|Michelle Stojanovic|7175310003|mstojanovic1@pennstatehealth.psu.edu|287412
317979|NCT03704636|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
317980|NCT03703791|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
317981|NCT03701295|Johns Hopkins University|ETCTN Grants Administrative Manager|410-955-4044|jmurra33@jhmi.edu|
317982|NCT03697551|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
317983|NCT03694821|UConn Health|Director of Outcomes, Research & Quality|860-679-4932|mcote@uchc.edu|
317984|NCT03686969|CRMG|Mikaela Raymond|866-337-1868|ctgov@cllinicalresearchmgt.com|
317985|NCT03682367|UC Davis Health|Arnaud Bewley|9167342704|abewley@ucdavis.edu|
317986|NCT03680911|University of Miami|Roy R. Casiano, MD|305-243-5290|rcasiano@med.miami.edu|
317987|NCT03656692|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
317988|NCT03648983|Montefiore Medical Center|Lisa Wiechmann||lwiechma@montefiore.org|
317989|NCT03643159|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
317990|NCT03632655|Weill Cornell Medicine|Dr. Jim C. Hu|(646) 962-9600|jch9011@med.cornell.edu|
317991|NCT03630120|Moffitt Cancer Center|Christine Chung, MD|813-745-5061|Christine.Chung@moffitt.org|
317992|NCT03621657|University of Wisconsin-Madison|Dr. Nasia Safdar|608-263-1545|ns2@medicine.wisc.edu|
317993|NCT03615508|Denver Health|Dr. Ifantides|303-602-0156|cristos.ifantides@dhha.org|
317994|NCT03615144|Memorial Sloan Kettering Cancer Center|Maria Cancio, MD|212-639-7196|canciom@mskcc.org|
317995|NCT03605303|Johnson & Johnson Vision Care Inc.|Brian Pall OD, MS, FAAO - Director of Clinical Sciences|9044431290|BPALL@its.jnj.com|
317996|NCT03600740|Mayo Clinic|Erik H. Middlebrooks, M.D.|904-953-6696|Middlebrooks.Erik@mayo.edu|
317997|NCT03598140|UTexas Southwestern|Dr. Joshua Gaston|817-637-8043|drgaston@outlook.com|
317998|NCT03598036|Aurinia Pharmaceuticals Inc.|Clinical Trial Support|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
293646|NCT01504412|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|+81 362251111 (M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
305766|NCT02357420|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
305767|NCT02357459|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
305768|NCT02357485|UCLA Medical Center|Peter Fodor, MD|3102039818|pbfodor@centurysurgery.com|
305769|NCT02357576|University of Michigan|Meghan Arnold|734-936-8978|meghanar@umich.edu|
317999|NCT03591458|University of Utah|Scott Low|801-585-1380|scott.low@hsc.utah.edu|
318000|NCT03590743|Mayo Clinic|Robert D. McBane, II M.D.|507-266-3964|mcbane.robert@mayo.edu|
318001|NCT03580382|NYU Langone Health - PCC CTO|Rachael Keller, Sr. Regulatory Specialist|929-455-2453|Rachael.Keller@nyulangone.org|
293647|NCT01504477|Georgetown University|Michael Pishvaian|202-444-2223|pishvaim@georgetown.edu|
293648|NCT01504672|Umeå University|Dr. Maria Gustafsson|0046703978717|maria.gustafsson@umu.se|
305770|NCT02357706|Charite Department of Sleepmedizin|Prof Dr med Ingo Fietze|+49 30 450 513 122|ingo.fietze@charite.de|
318002|NCT03572634|Sr. Director Drug Development/Clinical Operations|Susan Smith|210-414-7702|s.smith@toleropharma.com|
318003|NCT03571646|Medtronic|Geraldine Kelly|+353 879840223|geraldine.kelly@medtronic.com|
318004|NCT03565328|National Heart Lung and Blood Institute (NHLBI)|Michael Sack, M.D. Principal Investigator, NIH, NHLBI|301.402.9259|sackm@nhlbi.nih.gov|
318005|NCT03544242|University of Alabama at Birmingham|Adam Sturdivant, MPH|205-934-4042|Adamsturdivant@uabmc.edu|
318006|NCT03543358|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
318007|NCT03538015|University of Utah|Dr. Owen Chan|801-581-7755|ochan@u2m2.utah.edu|
318008|NCT03534362|Saint Louis University|Joe D Brunworth, MD|314-577-8884|joe.brunworth@health.slu.edu|
318009|NCT03509207|Medical University of Graz|Prof. Edgar Petru|0043 31638581082|edgar.petru@medunigraz.at|
318010|NCT03505372|Beth Israel Deaconess Medical Center|Dr Jordana Phillips|617 667 1630|jphilli2@bidmc.harvard.edu|
318011|NCT03500406|Mayo Clinic|Dr. Landon Trost|507-284-3728|Trost.Landon@mayo.edu|
318012|NCT03500341|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
318013|NCT03500159|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|604-629-9223|clinical@aqxpharma.com|
318014|NCT03490916|UMass Medical School|Principal Investigator|4136279111|vincent.kan08@gmail.com|
318015|NCT03483051|University of Pennsylvania|Dr. Julio Chirinos|215-200-7779|juliochi@pennmedicine.upenn.edu|
318016|NCT03477903|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
318017|NCT03469258|Beth Israel Deaconess Medical Center|A. James Moser, MD|(617) 632-1032|ajmoser@bidmc.harvard.edu|
318018|NCT03466658|Penn State Health|Dr. Hyunmin Kim|717-531-4826|hkim2@pennstatehealth.psu.edu|
318019|NCT03465891|Memorial Sloan Kettering Cancer Center|Dr. Lia Palomba|646-608-3711|palombam@mskcc.org|
318020|NCT03465735|Mayo Clinic|Waldemar E. Wysokinski, M.D., Ph.D.|507-266-6717|Wysokinski.Waldemar@mayo.edu|
318021|NCT03461705|Columbia University|Ajay Kirtane, MD, SM|212-305-7060|akirtane@columbia.edu|
318022|NCT03457818|Columbia University|Dr. Mishaela Rubin|2019528237|mrr6@cumc.columbia.edu|
318023|NCT03455556|Mayo Clinic|Alex A Adjei, MD, PhD|(507) 284-2511|Adjei.Alex@mayo.edu|
318024|NCT03447639|Beaumont Hospital|Director of Urology Research|248.551.0804|Deborah.Hasenau@Beaumont.org|
318025|NCT03429712|Duke University Medical Center|Daniele Marin|919-684-2711|daniele.marin@duke.edu|
318026|NCT03426137|University of Maryland School of Nursing|Research Coordinator|410-706-5975|NRSCollocaLab@umaryland.edu|
318027|NCT03425799|Exela Pharma Sciences|Aruna Koganti, VP Clinical Programs|828-758-5474|akoganti@exela.us|
318028|NCT03423654|VA|April Maa|4043216111|april.maa2@va.gov|206817
318029|NCT03387059|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
318030|NCT03382925|University of Utah, Department of Physical Medicine and Rehabilitation|Shellie Cunnungham|801-587-5488|shellie.cunningham@hsc.utah.edu|
318031|NCT03379233|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
318032|NCT03370536|Icahn School of Medicine at Mount Sinai|Dr. Vivek Reddy|(212) 241-7114|vivek.reddy@mountsinai.org|
318033|NCT03363633|Duke University Medical Center|Ellen D. Dillavou, MD, FACS||ellen.dillavou@duke.edu|
318034|NCT03361228|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
318035|NCT03360903|University of Chicago|Aaron Fox|(773) 702-0021|aaronfox@uchicago.edu|
318036|NCT03359174|Yale Univeristy|Clinical Research Coordinator|203 737 6839|laura.cusack@yale.edu|
318037|NCT03352882|University of Pennsylvania|Kimberly A. Forde, MD, PhD - Principal Investigator|(215) 349-8222|kforde@pennmedicine.upenn.edu|
318038|NCT03348904|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
318039|NCT03345901|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
318040|NCT03344562|University of Texas Southwestern Medical Center|Dr. Amy Mathews - ASSISTANT PROFESSOR|214/645-1719|Amy.Mathews@UTSouthwestern.edu|
318041|NCT03342638|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
318042|NCT03342157|Advocate Aurora Health|Dr. Bradley Gose|414-385-2590|bradley.gose@aah.org|
318043|NCT03339401|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
318044|NCT03339245|The Rockefeller University|Dr. Peter R Holt|212-327-7706|holtp@rockefeller.edu|
318045|NCT03333746|The Ohio State University Comprehensive Cancer Center|Dr. Yvonne Efebera|614-293-7243|Yvonne.Efebera@osumc.edu|1278
318046|NCT03329404|Terumo Blood and Cell Technologies|Robert Cortes, Jr. MD|+1.303.231.4353|Robert.Cortes@terumobct.com|
318047|NCT03326869|Eye Center of N Florida|Christina Menck|8507843937|eyenerdgyrl1@gmail.com|1124
318048|NCT03325114|University of Rochester|Carrie Dykes|15852750736|carrie_dykes@urmc.rochester.edu|
318049|NCT03319407|Mayo Clinic|Robert L. McClain, M.D.|904-956-1728|Mcclain.Robert@mayo.edu|
318050|NCT03316105|Mayo Clinic|Michael Camilleri, M.D.|507-284-2687|camilleri.michael@mayo.edu|
318051|NCT03305055|Johns Hopkins University|James A. Fauerbach|410-550-0890|jfauerb1@jhmi.edu|
318052|NCT03303469|The University of Alabama at Birmingham|Janis O'Malley|205-934-6504|jomalley@uabmc.edu|
318053|NCT03302247|Fox Chase Cancer Center|Martin Edelman|215-728-5682|Martin.Edelman@fccc.edu|
318054|NCT03300024|Johns Hopkins University|Thomas Reifsnyder|410-955-7518|treifsn1@jhmi.edu|
293649|NCT01504711|Barbara Ann Karmanos Cancer Institute|Dr. Philip A. Philip, M.D., Ph.D., F.R.C.P|(313)576-8624|philipp@karmanos.org|
293650|NCT01504841|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
293651|NCT01504854|Alzheimer's Disease Cooperative Study|Michael Rafii, MD, PhD|858-846-1300|mrafii@ucsd.edu|
318055|NCT03283709|University of Kentucky|Hiroko Nagaoka|859-257-2101|h.nagaoka@uky.edu|
270371|NCT00124579|SWOG|Robert Z. Orlowski, MD, PhD|(713) 792-2860|rorlowsk@mdanderson.org|
270372|NCT00124618|Mayo Clinic|Aminah Jatoi, M.D.|507/538-0268|jatoi.aminah@mayo.edu|
270373|NCT00124657|St. Jude Children's Research Hospital|Alberto Broniscer, MD|866-966-5934|info@stjude.org|
270374|NCT00124709|Novartis Pharmaceuticals|Study Director|862-778-8300||
270375|NCT00124735|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
270376|NCT00124748|Novartis Pharmaceuticals|Study Director|862-778-8300||
270377|NCT00124917|National Cancer Institute|Dr. Deborah Citrin|301-496-5457|Debra_Citrin@nih.gov|
271687|NCT00257608|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
271688|NCT00257660|Ipsen|Senior Director, Medical Development, Neurology||clinical.trials@ipsen.com|
271689|NCT00257686|Kowa Research Institute|Bill Arana|9194331600|barana@kowaus.com|
271690|NCT00257725|New York State Psychiatric Institute|Laurence Greenhill, MD|212-543-5340|GREENHIL@nyspi.columbia.edu|
271691|NCT00257894|Veterans Affairs Medical Center (VAMC), Providence|Damaris J. Rohsenow, Ph.D.|401-863-6648|damaris.rohsenow@va.gov|
271692|NCT00257920|Abbott|Medical Information Specialist|1-800-633-9110||
271693|NCT00257933|The Children's Hospital of Philadelphia|Joseph Zorc, MD|215-590-1944|zorc@email.chop.edu|
271694|NCT00258011|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
271695|NCT00258128|Joslin Diabetes Center|Allison B. Goldfine, MD|617-309-2400|allison.goldfine@joslin.harvard.edu|
271696|NCT00258154|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
271697|NCT00258180|Johns Hopkins School of Medicine|Maria Oliva-Hemker MD|410-955-8769|moliva@jhmi.edu|
271698|NCT00258206|Johns Hopkins University|Dr. Carol Ann Huff|410-955-8842|chuff1@jhmi.edu|
271699|NCT00258310|Barbara Ann Karmanos Institute|George Yoo, M.D.|(313) 576-9782|yoog@karmanos.org|
271700|NCT00258349|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
271701|NCT00258362|Masonic Cancer Center, University of Minnesota|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
271702|NCT00258440|Oregon Health and Science Univeristy|Joseph Bubalo|503-494-8007|bubaloj@ohsu.edu|
271703|NCT00258674|Baylor Research Institute|Baylor Research Institute|214-820-9991|Elizabeth.Cothran@baylorhealth.edu|
271704|NCT00258817|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
271705|NCT00258830|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
271706|NCT00258856|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
271707|NCT00258882|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
271708|NCT00258895|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
271709|NCT00258908|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
271710|NCT00258960|Spanish Breast Cancer Research Group|Cesar Rodriguez Martin|+34 916 592 870|crmartin@geicam.org|1127
271711|NCT00259012|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
271712|NCT00259090|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
271713|NCT00259272|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293652|NCT01504867|Mayo Clinic|Dr. Daryl J. Kor|507-284-7678|Kor.Daryl@mayo.edu|
305771|NCT02357758|London Health Sciences Centre|Dr. Sumit Dave|519.685.8439|Sumit.Dave@lhsc.on.ca|
271714|NCT00259285|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
305772|NCT02357810|Northwestern University|Mary Mulcahy, MD|312-695-0990|Mary.Mulcahy@nm.org|
305773|NCT02357836|UT Southwestern Medical Center|Dr. David Gerber|214-648-4180|David.Gerber@UTSouthwestern.edu|
305774|NCT02357901|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
305775|NCT02357940|Johnson & Johnson Consumer Inc.|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
305776|NCT02357979|University of California at San Francisco|Dr. Peter Rechmann|415 514 3225|Peter.Rechmann@ucsf.edu|
318056|NCT03277183|NFSGVA|Dr. Mark Segal|3523761611|mark.segal@va.gov|104496
318057|NCT03269968|MedStar Health Reseach Institute|Rachael Overcash|202-877-6093|rachael.overcash@medstar.net|
318058|NCT03248141|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
318059|NCT03263806|Beaumont Hospitals|Korana Stakich-Alpirez|248 898 0315|Korana.Stakich-Alpirez@beaumont.org|
318060|NCT03261531|Mayo Clinic|Michael Camilleri, M.D.|507-284-2687|camilleri.michael@mayo.edu|
318061|NCT03251326|New York State Psychiatric Institute|Margaret Haney, Ph.D.|646-774-6129|meg.haney@nyspi.columbia.edu|
293653|NCT01504958|Beth Israel Deaconess Medical Center|Alvaro Pascual-Leone, M.D., Ph.D.|617-667-0203|apleone@bidmc.harvard.edu|
305777|NCT02358031|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305778|NCT02358044|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305779|NCT02358135|Keck School of Medicine of University of Southern California|April W. Armstrong, MD, MPH; Associate Dean of Clinical Research|323-865-3871|april.armstrong@med.usc.edu|
318062|NCT03219372|Cedars Sinai Medical Center|Shehnaz K. Hussain, PhD, ScM|310-429-9859|Shehnaz.Hussain@cshs.org|
318063|NCT03217175|MGH Diabetes Research Center|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
318064|NCT03231397|Washington University School of Medicine|Dr. Sean J. English|(314) 362-5707|sjenglish@wustl.edu|
318065|NCT03232892|University of California, San Francisco|Dr. Collin Blakely, MD PhD.|(415) 502-6959|Collin.Blakely@ucsf.edu|
318066|NCT03223662|National Cancer Institute|Caryn Steakley|240-858-3749|steaklec@nih.gov|
271715|NCT00259298|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
305780|NCT02358343|Center for Biomedical Statistics, University of Washington|Tessa Rue, Biostatistician|206-543-4246|ruet@uw.edu|
271716|NCT00259610|University of Alabama at Birmingham|Dr. Jeffrey R. Curtis,|205-934-7733|jcurtis@uab.edu|
293654|NCT01504971|ChinaPLAGH|Dr. Weifeng Wang|0086-13911952018|wangwf301@hotmail.com|
293655|NCT01504997|Shizuoka Cancer Center|Doctor Masanori Tokunaga|81-55098908777|m.tokunaga@scchr.jp|
305781|NCT02358369|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
293656|NCT01505010|University of Leuven|Dr. Jan A. Staessen|+32 16 34 7104|jan.staessen@med.kuleuven.be|
293657|NCT01505062|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
293658|NCT01505114|Fred Hutchinson cancer Research center|Chunyuan Wu|206-667-5567|cwu@scharp.org|
293659|NCT01505166|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
293660|NCT01505179|UCSD MED CLINICAL TRIALS|Denise Barnard, MD|858 246-2996|dbarnard@ucsd.edu|
293661|NCT01505374|Hospital for Special Surgery|Stavros G. Memtsoudis, MD, PhD|212-606-1206|memtsoudiss@hss.edu|
293662|NCT01505387|Analyze & Realize|Felix Alt|+49 30 40008100|Falt@a-r.com|
318067|NCT03212144|Columbia University|Dr. Richard Sloan|6467748947|rps7@columbia.edu|
318068|NCT03218163|SKCCC|Dr. Philip Imus|4109558873|pimus1@jhmi.edu|
318069|NCT03172520|Mayo Clinic|Eric J. Moore, M.D.|507-284-3853|Moore.Eric@mayo.edu|
293663|NCT01505465|HSS|Dr. Memtsoudis|(212) 606-1000|MemtsoudisS@hss.edu|
318070|NCT03204539|UC Davis|Dr. Jonathan Ducore|916-734-3461|jmducore@ucdavis.edu|
318071|NCT03206216|Stanford University Medical Center|Seema Nagpal, MD|650-725-8630|snagpal@stanford.edu|
318072|NCT03195660|ResMed|Adam Benjafield|+61 466 634 609|adam.benjafield@resmed.com|
318073|NCT03195465|Loma Linda University School of Allied Health Professions|Amy Sadek, PhD Rehabilitation Science|951-212-2104|asadek@llu.edu|
318074|NCT03166618|Allergan Sales LLC|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
318075|NCT03169530|Beth Israel Deaconess Medical Center|Kenneth Mukamal, MD, MPH|617 754-1401|kmukamal@bidmc.harvard.edu|
318076|NCT03189433|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201-326-5300|medinfo@eagleus.com|
318077|NCT03151226|Wake Forest School of Medicine|Dr. Peter H. Pan|336-718-8278|ppan@wakehealth.edu|
318078|NCT03165747|Emory University|Roberto Pacifici, MD|404-712-8420|roberto.pacifici@emory.edu|
318079|NCT03168906|Tufts Medical Center|Jaime Chisholm|617-636-5409|jchisholm1@tuftsmedicalcenter.org|
318080|NCT03178201|Columbia University|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
318081|NCT03172026|University of California Los Angeles|Dr. Bruce H. Dobkin|310-206-6500|BDobkin@mednet.ucla.edu|
318082|NCT03152526|Miltenyi Biotec|Clinical Project Manager|617-218-0055|lorenb@miltenyibiotec.com|
318083|NCT03161964|University of Utah|Dr. Anu Sharma|(801) 581-7761|Anu.Sharma@hsc.utah.edu|
318084|NCT03150160|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
318085|NCT03137225|Virginia Commonwealth University|Henry J. Rozycki, MD|8048289602|henry.rozycki@vcuhealth.org|
318086|NCT03123393|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
318087|NCT03123328|Masimo Corporation|Director, Clinical Research|949-297-7416|clinicalresearchdept@masimo.com|
318088|NCT03119662|GE Healthcare|Francois Tranquart, M.D., Ph.D.|00-44-1494-543037|francois.tranquart@ge.com|
318089|NCT03109418|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
318090|NCT03120676|Memorial Sloan Kettering Cancer Center|Dr. Anas Younes, MD|212-639-5059|younesa@mskcc.org|
318091|NCT03109873|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Adam Luginbuhl|215-240-0748|adam.luginbuhl@jefferson.ed|
318092|NCT03100617|UCaliforniaDavis|Dr. Ladson Hinton|9167343485|lwhinton@ucdavis.edu|
318093|NCT03115853|Vanderbilt University Medical Center|James Muldowney, MD|615-936-1720|james.muldowney@vanderbilt.edu|
318094|NCT03113071|Fox Chase Cancer Center|Dr. Henry Fung|215-728-2674|Henry.Fung@tuhs.temple.edu|
318095|NCT03110900|University of Arkansas for Medical Sciences|Michael Wilson, M.D.|(501) 686-5515|mpwilso1@outlook.com|
318096|NCT03078868|University of Chicago|Shirley Rodriguez|773-834-4337|srodrigu@surgery.bsd.uchicago.edu|
318097|NCT03078270|George Washington University|Daniel Lieberman, M.D.|202-741-2899|dlieberman@mfa.gwu.edu|
318098|NCT03065933|McLean Hospital|Elizabeth S. Liebson, M.D.|617-855-2284|eliebson@partners.org|
318099|NCT03070002|Northwestern University|MASSIMO CRISTOFANILLI, MD|312-503-1114|massimo.cristofanilli@nm.org|
318100|NCT03058705|University of Rochester|Edward Messing, MD|585-275-0998|edward_messing@urmc.rochester.edu|
318101|NCT03061279|Stanford University|Derek Amanatullah, MD, PhD|650-723-2257|dfa@stanford.edu|
318102|NCT03040323|Indiana University Department of Radiology|Jordan Swensson ,MD|317-944-1831|jswensso@iupui.edu|
318103|NCT03053518|NYU Langone Health|Mary Sevick, MD|646-501-2621|Mary.Sevick@nyulangone.org|
318104|NCT03050398|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
318105|NCT03042780|H Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, MD|813-745-7257|Jonathan.Strosberg@moffitt.org|
318106|NCT03053960|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Lionel Gold|215-955-6215|Lionel.Gold@jefferson.edu|
318107|NCT03036735|Steward Health Care|Dr Peter Catalano|617-789-5004|peter.catalano@steward.org|5004
318108|NCT03029832|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
318109|NCT03020446|University of Toledo|Munier Nazzal, MD|419-383-3576|Munier.Nazzal@utoledo.edu|
318110|NCT03031340|Montefiore Medical Center|Dr.Singh Nair|7189205932|sinair@montefiore.org|
318111|NCT03017040|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
318112|NCT03007719|University of California, San Francisco|Dr. Lawrence Fong|(415) 353-2051|Lawrence.Fong@ucsf.edu|
318113|NCT03010423|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
318114|NCT02985801|Mayo Clinic|Dr. Massimo Raimondo|904-953-6982|Raimondo.Massimo@mayo.edu|
318115|NCT02991430|Scion NeuroStim, LLC|Dr. Robert Black|(919) 260-5528|rblack@scionneurostim.com|
318116|NCT02995967|UAB|Joseph Malek|2059965466|jmalek@uabmc.edu|
318117|NCT02994251|Yale University|Dr. Todd Schlachter|203-785-5885|todd.schlachter@yale.edu|
293664|NCT01505491|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
318118|NCT02978885|Columbia University|Gebhard Wagener, MD|212-305-6494|gw72@cumc.columbia.edu|
318119|NCT02978833|Hospital for Special Surgery|Jennifer Cheng|6467146870|chengj@hss.edu|
293665|NCT01505530|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
305782|NCT02358473|Kyowa Kirin Pharmaceutical Development, Inc.|Regional_Program Lead|1-609-919-1000|clinical.info@kyowa-kirin-pharma.com|
305783|NCT02358603|Department of Cardiology, Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine|Dr. Zhao, Jianrong||drzjr@126.com|
318120|NCT02971839|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
318121|NCT02985840|OhioHealth Research Institutute|Chelsea Blessing, PhD|(513) 461-1772|chelsea.blessing@ohiohealth.com|
318122|NCT02966223|Indiana University|Mark Tann, MD|317- 948-8782|matann@iupui.edu|
318123|NCT02965846|Allergan, Inc.|Therapeutic Area Head|877-277-8566|clinicaltrials@allergan.com|
318124|NCT02974803|Canadian Cancer Trials Group|Lesely Seymour|6135336430|lseymour@ctg.queensu.ca|
318125|NCT02974686|Washington University|Dr. R. Delos Santos|314-362-8351|delossantos@wustl.edu|
318126|NCT02956005|MedStar Georgetown Transplant Institute|Alexander Gilbert|202-444-0621|Alexander.J.Gilbert@gunet.georgetown.edu|
318127|NCT02966184|Norton Healthcare|Tristan Murray, PharmD|5026295571|tristan.murray@nortonhealthcare.org|
318128|NCT02940223|UT MD Anderson Cancer Center|Sriram Yennu,Professor, MD- Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
318129|NCT02954159|Medical College Of Wisconsin|Andres Yarur, MD; Principal Investigator|414-955-6858|ayarur@mcw.edu|
318130|NCT02954952|Masimo Corporation|Director of Clinical Research|949-297-7416|clinicalresearchdept@masimo.com|
318131|NCT02950896|Washington University School of Medicine|Heather McKenzie|3142862628|heather.mckenzie@wustl.edu|
318132|NCT02947022|UNC Chapel Hill, Department of Radiology|Clinical Research Manager|919-966-4997|rad_research@med.unc.edu|
318133|NCT02936999|Inova Health Services|Regulatory Research Coordinator|(571) 472-0239|elizabeth.gebregeorgis@inova.org|
318134|NCT02950480|University of California, San Francisco|Dr. Pamela Munster|(415) 885-7810|pamela.munster@ucsf.edu|
318135|NCT02949947|UT MD Anderson Cancer Center|Saroj Vadhan,Clinical Professor, Cytokine & Supportive Oncology|(713) 792-7966|svadhanr@mdanderson.org|
318136|NCT02947100|Nemours/AI duPont Hospital|Dr Robin Miller|302-651-5500|rmiller@nemours.org|
318137|NCT02936206|Icahn School of Medicine at Mount Sinai|Dr. Amy Tiersten|212-241-3300|amy.tiersten@mssm.edu|
318138|NCT02934932|Duke University|Dr. Steven Szabo|919-681-8742|steven.szabo@duke.edu|
318139|NCT02908516|Yale School of Medicine, Department of Orthopaedics and Rehabilitation|Dr. Michael P. Leslie|(203) 737-6358|michael.leslie@yale.edu|
318140|NCT02923830|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
318141|NCT02920450|University of Florida Heath Cancer Center|Protocol Development Manager|352-273-8128|clh1230@ufl.edu|
318142|NCT02920177|University of Michigan|Jordyn Sessel|734-615-0934|jsessel@med.umich.edu|
318143|NCT02926638|SWOG|Lung Committee Statistician|2066677733|kmini@fredhutch.org|
318144|NCT02920242|Novartis Pharmaceuticals|Study Director|862-778-1873|novartisemail@novartis.com|
318145|NCT02900781|Texas Tech University Health Sciences Center|Nancy Swinford CCRC|8067432569|nancy.swinford@ttuhsc.edu|
318146|NCT02892500|Sanford Health|Christie Ellison|605-312-6030|christie.ellison@sanfordhealth.org|
318147|NCT02904356|Baylor College of Medicine|Sameer Sheth, MD, PhD|713-798-4696|sasheth@bcm.edu|
318148|NCT02899728|Dana- Farber Cancer Institute|Jacob Sands, MD|617-632-6049|Jacob_Sands@DFCI.HARVARD.EDU|
318149|NCT02875067|NYU Langone Health|Catherine Diefenbach, MD|212-731-5670|Catherine.Diefenbach@nyulangone.org|
318150|NCT02877732|Stanford Concussion and Brain Performance Center/ Stanford Emergency Medicine|Dr. Jamshid Ghajar|(650) 725-5562|jghajar@stanford.edu|
318151|NCT02860169|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
318152|NCT02865395|George Washington University|Dr. Patrick Mufarrij|2027154000|pmufarrij@gmail.com|
318153|NCT02868892|WRMC|Jessica L. Coats|6233417220|jessica.coats@ctca-hope.com|
318154|NCT02865083|Saint Louis University|Jennifer Goldkamp, MD|314-977-2574|jgolka2@slu.edu|
305784|NCT02358668|The Chinese University of Hong Kong|Dr Andrea Luk|852-26324276|andrealuk@cuhk.edu.hk|
305785|NCT02358863|Lombardi Comprehensive Cancer Center (LCCC)|John Marshall, MD|202-444-7064|marshalj@georgetown.edu|
305786|NCT02358876|Great Lakes NeuroTechnologies Inc|Biomedical Research Manager|2163615410|dheldman@glneurotech.com|
305787|NCT02358889|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
293666|NCT01505608|NMTRC|Giselle Sholler, MD|6162670335|genevieve.bergendahl@helendevoschildrens.org|
293667|NCT01505634|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293668|NCT01505647|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293669|NCT01505673|University of Texas Southwestern Medical Center at Dallas|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
293670|NCT01505764|Department of Veterans Affairs|Jose M Garcia MD, PhD, Clinician Investigator|206-7642984|jose.garcia@va.gov|
293671|NCT01505868|UT MD Anderson Cancer Center|Paul Corn, MD PHD- Chair Ad Interim, Genitourinary Medical Oncology|(713) 563-7208|pcorn@mdanderson.org|
293672|NCT01505881|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
293673|NCT01505933|Penn State Health Milton S. Hershey Medical Center|Dr. Uma R Parekh, MBBS, DNB, FRCA, FFARCSI|717531-4264|uparekh@pennstatehealth.psu.edu|
293674|NCT01506193|GlaxoSmithKline|GSK Response Center|866-435-7343||
305788|NCT02359006|Yale University|Dr. Mehmet Sofuoglu|203-932-5711|mehmet.sofuoglu@yale.edu|4809
318155|NCT02865122|Elgan Pharma Ltd.|Miki Olshansky, Chief Executive Officer|972-4-6098600|Miki@elganpharma.com|
318156|NCT02865915|Millendo Therapeutics US, Inc.|Director of Clinical Operations|734-845-9000|millendo@millendo.com|
318157|NCT02855411|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
318158|NCT02826161|Sumitomo Dainippon Pharma Oncology|Matthew Hitron, MD|617-674-6800|mhitron@bostonbiomedical.com|
318159|NCT02828124|Bristol Myers-Squibb|Phase 1/2 Study of BMS-986183 in Subjects with Advanced Hepatocellular Carcinoma|Please email|Clinical.Trials@bms.com|
318160|NCT02826551|Cedars-Sinai|Josh Page|3104233198|josh.page@cshs.org|
318161|NCT02825043|University of Oklahoma Health Sciences Center Dept. of Medicine|Clinical Trials Manager|(405)271-6651|research@ouhsc.edu|
318162|NCT02819804|Northwestern University|Shira Dinner, MD|312-695-6180|shira.dinner@nm.org|
318163|NCT02809118|Auris Medical|RAM|0041 61 201 13|ra@aurismedical.com|50
318164|NCT02818946|Duke University|Sujata Ghate, MD|919-684-2711|sujata.ghate@duke.edu|
318165|NCT02819908|Eye Center of N Florida|Christina Menck|8507843937|eyenerdgyrl1@gmail.com|1124
318166|NCT02808390|PPM Services|Salvatore Bellinvia|+41916961710|sbellinvia@ppmservices.ch|
318167|NCT02806960|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
318168|NCT02815397|Northwestern University|Dr. R Karmali|312-695-6832|reem.karmali@northwestern.edu|
318169|NCT02802592|Johns Hopkins University School of Medicine|Dr. Kenneth Horvath|301-896-3100||
318170|NCT02774148|Spectrum Health|Andrea Mantel|616-486-2051|andrea.mantel@spectrumhealth.org|
318171|NCT02773576|Braeburn Inc|Christine Kampf|6104678728|ckampf@braeburnrx.com|
318172|NCT02730793|Virginia Commonwealth University|Bruce K. Rubin MEngr, MD, MBA, FRCPC|804 828 9604|bruce.rubin@vcuhealth.org|
318173|NCT02744352|University of Pennsylvania|Anmol Madaan, Clinical Research Coordinator|2156623778|Anmol.Madaan@Pennmedicine.Upenn.edu|
318174|NCT02760602|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
318175|NCT02757521|Washington University|Ben J Palanca, MD PhD MSC|314-286-0132|palancab@wustl.edu|
318176|NCT02758132|University of Hawaii Cancer Center|Stacy Mercado|8084404561|smercado@cc.hawaii.edu|
318177|NCT02757547|Philips|Pat Olsen|(303) 475-3417|pat.olsen@philips.com|
318178|NCT02757053|Heartland Regional Medical Center dba Mosaic Life Care|Clinical Research Development Manager|816 271 7937|Linda.Schumacher@mymlc.com|
318179|NCT02734940|Virginia Commonwealth University|Dr. Jessica Potter|(804) 828-2755|jessica.potter@vcuhealth.org|
318180|NCT02749617|Hematology Research Program (HRP)|Director of HRP|6048754111|alee14@bccancer.bc.ca|22958
318181|NCT02749227|Columbia University|Pamela U. Freda, MD|212-305-2254|puf1@cumc.columbia.edu|
318182|NCT02745210|Loma LInda University Medical Center|Brenda Bartnik Olson|1-909-558-4000|BBartnik@llu.edu|85216
318183|NCT02725671|Johns Hopkins University|Dr. Armin Zadeh|4105020549|arminzadeh@jhu.edu|
318184|NCT02746263|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
318185|NCT02721277|University of Florida|Josef Neu, MD|352-273-8985|neuj@peds.ufl.edu|
318186|NCT02732327|Allergan|David Melnick, MD|201-427-8554|Melnick_David@Allergan.com|
318187|NCT02726399|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
318188|NCT02720510|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
318189|NCT02715765|University of Minnesota|Kelvin Lim|612-273-9803|kolim@umn.edu|
318190|NCT02717949|UT Southwestern Medical Center|Mamta K.Jain, MD|214-648-9914|mamta.jain@utsouthwestern.edu|
318191|NCT02717130|Thriving Mind South Florida|John W. Newcomer, M.D., President & CEO|305-860-0653|jnewcomer@thrivingmind.org|
318192|NCT02685202|University of North Carolina at Chapel Hill|Anne E. Sanders, PhD|919-537-3275|anne_sanders@unc.edu|
318193|NCT02709083|Emory University|William Blum, MD|404-778-1900|william.g.blum@emory.edu|
318194|NCT02693171|United Therapeutics Corp.|Odette Jordan, MD, PMP|919-425-5606|ojordan@unither.com|
318195|NCT02696226|Cleveland Clinic|Dr. Douglas Johnston|216-444-5613|JOHNSTD3@ccf.org|
318196|NCT02693743|University of Arkansas for Medical Sciences|Favrin Smith|1 (501) 526-8488|SmithFavrinM@uams.edu|
318197|NCT02706691|University of Chicago Comprehensive Cancer Center|Technical Director|773-702-0819|pccc_regulatory@bsd.uchicago.edu|
318198|NCT02708849|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
318199|NCT02693717|UT MD Anderson Cancer Center|Jianjun Gao, MD PHD, Associate Professor, Genitourinary Medical Oncology|(713) 563-4195|jgao1@mdanderson.org|
318200|NCT02694757|11 Health|Michael Seres|+16572660570|michael@11health.com|
318201|NCT02693002|University of Kentucky|Dr. Gretchen Wells, PI||gretchen.wells@uky.edu|
318202|NCT02689518|University of California San Diego|Professor Michael Goldbaum|858 534 3516|mgoldbaum@ucsd.edu|
293675|NCT01506271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293676|NCT01506323|VA San Diego Healthcare System|Dr. Jill E. Bormann|858-552-8585|jill.bormann@va.gov|x2378
293677|NCT01506362|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|135
293678|NCT01506453|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|(901) 595-4034|doralina.anghelescu@stjude.org|
318203|NCT02687165|New York State Psychiatric Institute|Alla Landa PhD|6467746717|AL2898@cumc.columbia.edu|
318204|NCT02679560|UC Davis|Dr. Ian Brown|(916)734-1279|iebrown@ucdavis.edu|
318205|NCT02679066|Johns Hopkins Bayview|Erik Hasenboehler MD|4105504190|ehasenb1@jhmi.edu|
318206|NCT02673684|Defense and Veterans Center for Integrative Pain Management|Mary McDuffie|301-400-4242|mmcduffie@dvcipm.org|
318207|NCT02674204|Cedars-Sinai Medical Center|Marc Goodman, PhD|310-423-6188|Marc.Goodman@cshs.org|
318208|NCT02665221|MS Comprehensive Care Center NYU Langone Health|Shannon Haas|646 501 7504|Shannon.Haas@nyumc.org|
318209|NCT02672033|Jonsson Comprehensieve Cancer Center|Dr. Percy Lee|310 825-9771|percylee@mednet.ucla.edu|
318210|NCT02671461|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
318211|NCT02671136|Loma Linda University Health|Ahmed Khocht|909 558 4000|akhocht@llu.edu|
318212|NCT02663752|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
318213|NCT02658357|Braeburn|Christine Kampf|6104678728|ckampf@braeburnrx.com|
318214|NCT02665988|Houston Methodist Hospital|Dr. Alok Madan|832-930-1662|amadan@houstonmethodist.org|
318215|NCT02660528|Brigham and Women's Hospital|Dr. Jessica Harder|617-525-7919|jaharder@bwh.harvard.edu|
318216|NCT02658877|NYU Langone Health|Joan Reibman|212 263 6479|Joan.Reibman@nyulangone.org|
318217|NCT02654782|Mayo Clinic|Dr. William C. Oliver, Jr.|507-255-4240|oliver.william@mayo.edu|
318218|NCT02656199|Albert Einstein Healthcare Network|Roberta Costello; Research Compliance|215-456-7225|bcostell@einstein.edu|
318219|NCT02654639|Levine Cancer Institute-Concord|Mohamed Salem, MD|704-403-1370|mohamed.salem@lcic.edu|
318220|NCT02653495|Rockefeller University|Dr. Ursula Andreo|212-327-7894|uandreo@gmail.com|
318221|NCT02640573|Baylor College of Medicine|Vivien Sheehan|832 824 4459|vsheehan@bcm.edu|
318222|NCT02639390|Department of Veterans Affairs|Peter Lum|12023195181|lum@cua.edu|
318223|NCT02634606|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|x61987
318224|NCT02634827|Mayo Clinic|Aref Al-Kali, MD|507-538-0871|AlKali.Aref@mayo.edu|
318225|NCT02636283|University of Minnesota|Otto Sanchez|615-833-9867'|sanc0050@umn.edu|
318226|NCT02638129|Orexigen Therapeutics, Inc.|Global Head of Development|858-875-8600|MedInfo@Orexigen.com|
318227|NCT02615990|University of Kentucky|Lisa Fryman|859 323 2060|lisa.fryman@uky.edu|
318228|NCT02640677|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
318229|NCT02633540|Fox Chase Cancer Center|Dr. Thomas Galloway|215-728-5536|Thomas.Galloway@fccc.edu|
318230|NCT02623959|UT MD Anderson Cancer Center|Ost,David,M.D. / DOST@MDANDERSON.ORG|713-745-8775|DOst@mdanderson.org|
318231|NCT02631148|Brigham and Women's Hosptial|Dr. Ciaran McMullan|617 732 5500|mcmullcj@gmail.com|
318232|NCT02630472|UPenn|Nithin D. Adappa, Principal Investigator|215-662-2360|Nithin.Adappa@uphs.upenn.edu|
318233|NCT02626520|Essentia Health|Dr. Bret Friday|218-786-3625|bret.friday@essentiahealth.org|
318234|NCT02614898|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|475-230-2596|clinicaltrials@alexion.com|
318235|NCT02622828|University of Manitoba|Dr. Jacquie Ripat|204-789-3303|jacquie.ripat@umanitoba.ca|
318236|NCT02624739|ResMed|Paul Phillips|01 906 8861|paul.phillips@resmed.com|
318237|NCT02608905|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
318238|NCT02619812|Mayo Clinic|Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
318239|NCT02612285|Esanex Inc|Eric Orlemans PhD||eorlemans@esanexpharma.com|
318240|NCT02614586|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
318241|NCT02606279|Wake Forest University Health Sciences|Katherine Schafer, Assistant Professor Internal Medicine|13367166342|kschafer@wakehealth.edu|336
318242|NCT02605824|UCSF Airway Clinical Research Center|Fahy Research Manager|415-514-1539|ariana.baum@ucsf.edu|
318243|NCT02598622|Indiana University|Dr. Chie Schin-Shih|317-944-8784|shih2@iu.edu|
318244|NCT02589145|UT MD Anderson Cancer Center|Dr. Yago Nieto/Professor, Stem Cell Transplantation|713-792-2466|ynieto@mdanderson.org|
318245|NCT02582749|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317.921.2050|jsmith@hoosiercancer.org|
318246|NCT02590068|The Rockefeller University|Dr. Aileen O'Connell, Laboratory Manager|212-327-7047|aoconnell@rockefeller.edu|
318247|NCT02593682|University of California, San Francisco|Dr. Andrew Goddard|(317) 274-3960|agoddard@fresno.ucsf.edu|
318248|NCT02587650|University of California, San Francisco|Dr. Adil Daud|(415) 353-7392|Adil.Daud@ucsf.edu|
318249|NCT02569957|Sidney Kimmel Cancer Center at Thomas Jefferson University|Russell Schilder|215-503-3057|russell.schilder@jefferson.edu|
293679|NCT01506479|University of Pittsburgh|Dr. Charity G. Moore|412-383-6630|cgp22@pitt.edu|
318250|NCT02568007|Medical College of Wisconsin|Praveen Goday|4142663690|pgoday@mcw.edu|
318251|NCT02575365|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
318252|NCT02549755|Indiana University School of Medicine|Justin Sims, M.D.|317 948-6340|simsjb@iupui.edu|
293680|NCT01506596|Vector Oncology LLC|Dr. Mark Walker, VP of Scientific Affairs|901-435-5570|mwalker@vectoroncology.com|
318253|NCT02547129|Mayo Clinic|Dr. Michael J. Taunton|507-284-7692|Taunton.Michael@mayo.edu|
318254|NCT02528097|NYU Langone Medical Center|The Office of Clinical Trials|646.754.7431|clinicaltrials@nyumc.org|
293681|NCT01506609|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
293682|NCT01506726|Duke University Medical Center|Harvey J. Cohen, MD|919-660-7502|harvey.cohen@dm.duke.edu|
293683|NCT01506882|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
318255|NCT02549716|Milton S. Hershey Medical Center|Sprague W. Hazard III, M.D.|717-531-0003|shazard@pennstatehealth.psu.edu|311253
318256|NCT02540434|Weill Cornell Medicine|Michele Steinkamp|2127462953|mls9004@med.cornell.edu|
318257|NCT02531308|Northwestern University|Dr. R Karmali|312-695-0686|reem.karmali@northwestern.edu|
318258|NCT02533531|LifeWatch Services, Inc.|Paul Hanneman|1 847 720 2231|Phanneman@gobio.com|
318259|NCT02534038|Avanir Pharmaceuticals, Inc.|Sanjay Dubé, M.D.|949-389-6700|sdube@avanir.com|
318260|NCT02520726|University of Utah|Brent Kious, MD|801-585-1418|brent.kious@hsc.utah.edu|
318261|NCT02520297|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
318262|NCT02519712|Memorial Sloan Kettering Cancer Center|Brian Shaffer, MD|212-639-2212|shaffeb1@mskcc.org|
318263|NCT02518750|St. Jude Children's Research Hospital|Sima Jeha, MD|901-595-3901|sima.jeha@stjude.org|
318264|NCT02516228|Philips|Sr. Clinical Operations Manager|3034753417|pat.olsen@philips.com|
318265|NCT02515851|University Louisville|Nancy Alsip|502-852-2610|nlalsi01@exchange.louisville.edu|
318266|NCT02506985|University of Kentucky|Susan Smyth|859-323-2274|susansmyth@uky.edu|
318267|NCT02514252|UT MD Anderson Cancer Center|Suresh K. Reddy, MD/Professor, Palliative Care Med|(713) 794-5362|sreddy@mdanderson.org|
318268|NCT02501759|OHSU Knight Cancer Institute|Fegus Coakley|503-494-2333|coakleyf@ohsu.edu|
318269|NCT02487277|University of California, San Francisco|Dr. Andrew Ko|(415) 353-7286|Andrew.Ko@ucsf.edu|
318270|NCT02506101|Johns Hopkins Medicine|Dr. Ginette Okoye|410-502-7546|CTReP@jhmi.edu|
318271|NCT02499887|UBMD Emergency Medicine|Heather Lindstrom|716-898-4564|hlindstrom@ecmc.edu|
318272|NCT02504099|AbbVie|Global Medical Services|800-633-9110||
318273|NCT02500901|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
318274|NCT02483533|Neothetics|Director of Clinical Trials|8585501900||
318275|NCT02496039|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
318276|NCT02492295|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Department|215-456-2313|MOHIUDDK@EISNTEIN.EDU|
318277|NCT02494206|Memorial Sloan Kettering Cancer Center|Dr. Babak Mehrara MD|212-639-3099|mehrarab@mskcc.org|
318278|NCT02473445|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224- 383-3000|clinicaltrials@horizonpharma.com|
305789|NCT02359019|Barbara Ann Karmanos Cancer Institute|Dr. Ammar Sukari|313-576-8778|sukaria@karamanos.org|
318279|NCT02491411|SKCCC at JHU|Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
318280|NCT02476994|Baxter Healthcare|Clinical Trials Disclosure Group||joe_archer@baxter.com|
318281|NCT02473523|St. Jude Children's Research Hospital|Kirsten Ness, PT, PhD|901-595-5157|kiri.ness@stjude.org|
318282|NCT02468583|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
318283|NCT02450591|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-888-4274|YuH@mskcc.org|
318284|NCT02472639|Cedars Sinai Medical Center|Karen Zaghiyan, MD|310-289-9224|kzaghiyan@yahoo.com|
318285|NCT02469415|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Assistant Professor|713-794-1141|CR_Study_Registration@mdanderson.org|
318286|NCT02461550|Memorial Sloan Kettering Cancer Center|Dr. Stephen Solomon|212-639-5012|solomons@mskcc.org|
318287|NCT02461355|Burke Neurological Institute|Tomoko Kitago, MD|914-368-3169|tok7002@med.cornell.edu|
318288|NCT02452359|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
318289|NCT02434146|University of Wisconsin Carbone Cancer Center|Margo L Hoover-Regan|608-263-6200|mhooverregan@pediatrics.wisc.edu|
318290|NCT02452398|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
318291|NCT02447887|Fox Chase Cancer Center|Dr. Daniel M. Geynisman|215-728-3889|daniel.geynisman@fccc.edu|
318292|NCT02431494|Nova Southeastern University|Sue Breno|9542621447|sb1382@nova.edu|
318293|NCT02439970|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
318294|NCT02439957|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
318295|NCT02441036|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
318296|NCT02436265|Indiana University|Aali shah MD|317-944-9981|ashah9@iuhealth.org|
318297|NCT02429583|The Rockefeller University|Aileen O'Connell, Laboratory Manager|212-327-7047|aoconnell@rockefeller.edu|
318298|NCT02417870|Brigham and Women's Hospital|Anil Chandraker|617-732-7412|achandraker@bwh.harvard.edu|
318299|NCT02430532|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
318300|NCT02428231|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
318301|NCT02424565|GlaxoSmithKline|GSK Response Center|866-435-7343||
318302|NCT02413047|Indiana University|Dr. Matthew Bohm, DO (Principal Investigator)|3179485136|mbohm@iu.edu|
318303|NCT02414698|Montefiore Medical Center|Sayed E Wahezi, MD|7189207246|swahezi@montefiore.org|
318304|NCT02422303|University of Texas Health Science Center San Antonio|Bonnie Gillis|210-567-4500|gillis@uthscsa.edu|
318305|NCT02415166|LaurateInstitute|Jonathan Savitz|918 502 5104|jsavitz@laureateinstitute.org|
293684|NCT01506908|GlaxoSmithKline|GSK Response Center|866-435-7343||
318306|NCT02414152|Northwell Health|Dr. Andrea Vambutas|718-470-7550|avambuta@northwell.edu|
318307|NCT02410551|UT MD Anderson Cancer Center|Popat,Uday,M.D. / Stem Cell Transplantation|713-792-8750|upopat@mdanderson.org|
318308|NCT02411643|Northwestern University|Stephanie Rangel|3125035942|stephanie.rangel@northwestern.edu|
318309|NCT02410954|University of California, San Francisco|Andrew Krystal, MD|(415) 476-7702|andrew.krystal@ucsf.edu|
293685|NCT01506947|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
293686|NCT01506960|Massachusetts General Hospital|Iris McNulty|617 726 2612|imcnulty@partners.org|
305790|NCT02359045|AstraZeneca AB|Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
305791|NCT02359058|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
318310|NCT02410577|Memorial Sloan Kettering Cancer Center|Dr. Joseph Osborne, MD, PhD|212-639-7788|osbornej@mskcc.org|
318311|NCT02409355|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
318312|NCT02403154|Indiana University|Krista Brown, Clinical Research Coordinator|317-963-1944|brownkm@indiana.edu|
318313|NCT02404545|Baptist Health South Florida - Miami Cancer Institute|Murugesan Manoharan MD, FRCS (Eng), FRACS (Urol)|305-595-2141|mmanoharan@baptisthealth.net|
318314|NCT02392377|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr Jennifer Eads|(216) 844-6031|jennifer.eads@uhhospitals.org|
318315|NCT02399111|Northwell Health System|Dr. Kambhampaty Krishnasastry|516-233-3643|kkrishna@northwell.edu|
305792|NCT02359110|Penn State Milton S. Hershey Medical Center|Timothy Deimling, M.D.|717-531-3503|tdeimling@pennstatehealth.psu.edu|
318316|NCT02402036|Levine Cancer Institute-Concord|Mohamed Salem, MD|704-403-1370|mohamed.salem@lcic.edu|
318317|NCT02394665|University of Miami|Fazilat Ishkanian MD, PhD|305-243-4200|f.ishkanian@med.miami.edu|
318318|NCT02389712|Mayo Clinic|Mark A. Frye, M.D.|507-255-7164|MFrye@mayo.edu|
318319|NCT02390362|The Research Institute at Nationwide Children's Hospital|William E. Smoyer, MD.|6147222683|william.smoyer@nationwidechildrens.org|
318320|NCT02388776|Weill Cornell Medicine|Christine Lennon, M.D.|212-746-2621|chl9083@med.cornell.edu|
318321|NCT02383433|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Davendra Sohal|+1 216-444-8258|sohald@ccf.org|
318322|NCT02382588|Northwestern Universtiy|Dr. Robert Feder|3126958150|r-feder@northwestern.edu|
318323|NCT02381626|Memorial Sloan Kettering Cancer Center|Dr. Jennifer Leng, MD, MPH|646-888-8057|lengj@mskcc.org|
318324|NCT02379390|Sanofi|Trial Transparency Team|800-633-1610|Us@sanofipasteur.com|1
318325|NCT02373865|GWT-TUD GmbH, Study center Prof. Hanefeld|Prof. Dr. Markolf Hanefeld|+49 351 44005|Markolf.Hanefeld@gwtonline.de|82
318326|NCT02365688|Duke University Medical Center, Department of Anesthesiology|Timothy Miller MB ChB, FRCA|(+1) 919 6819660|timothy.miller2@duke.edu|
318327|NCT02361580|Massachusetts Generla Hospital|Taylor Pong, Research Coordinator||tpong1@partners.org|
318328|NCT02369744|Albert Einstein Medical Center|Kamran Mohiuddin; Director ED Clinical Research|2154562313|MOHIUDDK@EISNTEIN.EDU|
318329|NCT02379585|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
318330|NCT02370888|Univeristy of Florida Health Cancer Center|Archana Narasanna, Project Manager|(352) 273-6772|PMO@cancer.ufl.edu|
318331|NCT02367170|University of Florida|PhD in exercise physiology|352 2736105|UFCT-gov@ufl.edu|
318332|NCT02376933|University of Arizona Cancer Center|Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
318333|NCT02365233|University of Texas Medical Branch|Nicola Abate, MD - Professor and Director of Endocrinology Division|409 772 1922|niabate@utmb.edu|
318334|NCT02347943|Acclarent, Inc|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
318335|NCT02365207|University of Texas Health San Antonio|Robert Svatek|210-567-5676|svatek@uthscsa.edu|
318336|NCT02360111|Memorial Sloan Kettering Cancer Center|Dr. Ann Jakubowski, Ph.D., MD|212-639-5013|jakubowa@mskcc.org|
318337|NCT02353468|University of Colorado|Choon-kee Lee, MD|7208489252||
318338|NCT02360059|The University of Texas (UT) MD Anderson Cancer Center|Dr. David L. Ramirez, Assistant Professor, Breast Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
318339|NCT02350777|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari, MD|212-639-5987|tamarir@mskcc.org|
318340|NCT02345460|Case Comprehensive Cancer Center|Dr. Davendra Sohal|216-444-8258|sohald@ccf.org|
318341|NCT02346877|Amgen Inc.|Study Director|866-572-6436||
318342|NCT02351063|Alere, Inc.|William Arnold, PhD|8588053177|william.arnold@alere.com|
318343|NCT02345772|CTCA|Jessica L. Coats, RN|6232073899|jessica.coats@ctca-hope.com|
318344|NCT02340728|Memorial Sloan Kettering Cancer Center|Mark Schattner, MD|212-639-3148|schattnm@mskcc.org|
318345|NCT02353572|University of Colorado|Choon-kee Lee, MD|7208489252||
318346|NCT02345369|Bassett Medical Center|clinical research nurse supervisor|6075476965|jennifer.victory@bassett.org|
318347|NCT02343263|Indiana University|Bruce H. Matt, MD, MSc|3172781215|bmatt@iupui.edu|
318348|NCT02343159|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
318349|NCT02341495|Loyola University Medical Center|Dr. Elizabeth Henry|708-327-3153|ehenry@lumc.edu|
318350|NCT02336425|Novartis Pharmaceuticals|Study Director|862-778-8300||
318351|NCT02336763|UCLA|Mitchell Kamrava, MD|310-825-9775|mkamrava@mednet.ucla.edu|
318352|NCT02320825|Memorial Sloan Kettering Cancer Center|Dr. Ilya Laufer, MD|212-639-2368|lauferi@mskcc.org|
318353|NCT02319005|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
318354|NCT02318901|WRMC|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
270378|NCT00124943|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
270379|NCT00124982|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
270380|NCT00125034|Merck Serono|Inmaculada Ollero/Clinical Trial Manager|+34935655433|iollero@merck.es|
293687|NCT01507051|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
293688|NCT01507090|Children's Mercy Hospital|Principal Investigator|816-234-3059|srahman@cmh.edu|
318355|NCT02317276|UCSF Dermatology|Sarah Arron, MD, PhD|415-353-9684|Sarah.Arron@ucsf.edu|
318356|NCT02307188|Columbia University Medical Center|Abgelo Biviano|212-305-7646|ab542@columbia.edu|
318357|NCT02308475|Medical University of South Carolina|Brian Jacobs - Program Assistant|843-876-4922|jacobsbr@musc.edu|
318358|NCT02308735|University of Oklahoma Health Sciences Center|Douglas Dannaway|405-271-5215|douglas-dannaway@ouhsc.edu|42048
318359|NCT02299206|Northwestern University|Dermatology CTU|312-503-5944|NUdermatologyCTU@northwestern.edu|
318360|NCT02302859|The University of Texas (UT) MD Anderson Cancer Center|Dr. Lorna McNeill, MPH,PHD/ Chair, Health Disparities Research|713- 563-1103|lmcneill@mdanderson.org|
293689|NCT01507103|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
293690|NCT01507155|Genomind|Dr. Rachel Scott|267-989-3435|rscott@genomind.com|
318361|NCT02299934|University of Colorado, Denver|Dr. Samuel Chang|720-848-1875|SAMUEL.CHANG@UCDENVER.EDU|
318362|NCT02297230|New York University School of Medicine|Sylvia Formenti|646.962.4073|lao2003@med.cornell.edu|
318363|NCT02294981|UCSF Psoriasis and Skin Treatment Center|Tina Bhutani|4159147618|psoriasis@ucsf.edu|
318364|NCT02284906|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
318365|NCT02287025|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
318366|NCT02282332|MedStar Health Research Institute|Scientific Center Adminstrator|(301) 560-7300|Research@medstar.net|
318367|NCT02287636|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
318368|NCT02276560|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
318369|NCT02280252|NYU Langone Health|Dr. Nelly Huppert|(212) 731-5003|Nelly.Huppert@nyulangone.org|
318370|NCT02284373|New York University Langone Medical Center|Todd Berland, MD|212 263 5060|todd.berland@nyumc.org|
318371|NCT02285270|University of Pennsylvania|Daniel Pryma|215-349-5272|daniel.pryma@uphs.upenn.edu|
318372|NCT02275481|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
318373|NCT02266914|The Ohio State University Wexner Medical Center|Tamara McMath, MPH|614-293-8082|tamara.mcmath@osumc.edu|
318374|NCT02273752|Emory University|R. Donald Harvey, PharmD|404-778-1900|donald.harvey@emory.edu|
318375|NCT02270684|University of Southern California|Dr Christopher Powers|3234422900|powers@usc.edu|
318376|NCT02262000|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
318377|NCT02271594|BD|Dr. Ken Strauss|32475380454|kenneth.strauss@bd.com|
318378|NCT02263365|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
318379|NCT02266797|NYU Langone Medical Center|Michael Gerling|(718) 630-8600|Michael.Gerling@nyumc.org|
318380|NCT02249377|New York Langone Health|Eric Strauss, MD|646 501 7223|Eric.Strauss@nyumc.org|
318381|NCT02253394|Brigham and Women's Hospital|Dr. Bradley Maron|617-525-4857|bmaron@bwh.harvard.edu|
318382|NCT02241551|University of Pittsburgh Cancer Institute|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
318383|NCT02246114|The Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
318384|NCT02232880|Vanderbilt University|David Harrison||david.g.harrison@Vanderbilt.Edu|
318385|NCT02248740|Virginia Commonwealth Univeristy|Dr. Malcolm Sydnor|(804) 828-0534|malcolm.sydnor@vcuhealth.org|
318386|NCT02239627|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
318387|NCT02244944|University of Kentucky|Gregory Graf|8592574749|Gregory.Graf@uky.edu|
318388|NCT02241187|Memorial Sloan Kettering Cancer Center|Dr. Kenneth Yu, MD|646-888-4188|YuK1@mskcc.org|
318389|NCT02239926|Mayo Clinic|Dr. Yuri Saito Loftus|507-255-3680|saito.yuri@mayo.edu|
318390|NCT02231892|National Institute on Drug Abuse|Dr. Elliott Stein|443-740-2650|estein@mail.nih.gov|
318391|NCT02241343|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
318392|NCT02242578|The University of Texas at Austin|Robert J Buchanan, MD|512-324-7991|robertbuchanan@utexas.edu|
318393|NCT02234011|McLean Hospital, Biological Psychiatry Laboratory|Dr. Brian Brennan, MD|617-855-2911|bbrennan@partners.org|
318394|NCT02236546|Vanderbilt-Ingram Cancer Center|Dr. Tom Yankeelov||thomas.yankeelov@utexas.edu|
318395|NCT02234687|New York University School of Medicine|Charles Marmar, MD|646 754 4855|Charles.Marmar@nyumc.org|
318396|NCT02224599|Kiromic|CMO and Head of Clinical Operations|(832) 968-4888|sdahlbeck@kiromic.com|
271717|NCT00259649|University of Pittsburgh|Dawn marcus|412-953-4797|marcusd@upmc.edu|
318397|NCT02201472|Cincinnati Children's Hospital|Dr. Stephanie Merhar|513-803-5180|stephanie.merhar@cchmc.org|
318398|NCT02202044|University of Colorado|Tracey MacDermott|303-724-2757|Tracey.MacDermott@ucdenver.edu|
318399|NCT02192775|University of Arkansas for Medical Sciences|Brittany Lehman|501-686-8274|blehman@uams.edu|
318400|NCT02200328|Cleveland Clinic Florida|Dr.Alison Schneider|9546595646|schneia2@ccf.org|
318401|NCT02200042|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
318402|NCT02181790|Icahn School of Medicine at Mount Sinai|Dr Mark Lebwohl|2122413288|giselle.singer@mssm.edu|
318403|NCT02198833|Baylor College of Medcine|Rabih Darouiche, MD|713-794-8858|rabihd@bcm.edu|
318404|NCT02175628|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|9199664997|rad_research@med.unc.edu|
318405|NCT02177266|Mayo Clinic|Dr. Jae K. Oh|507-284-6055|oh.jae@mayo.edu|
318406|NCT02184520|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|
318407|NCT02170298|UC Davis|Julie B Schweitzer|916-703-0294|jschweitzer@UCDAVIS.EDU|
318408|NCT02177773|Unviersity of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|thomas.hope@ucsf.edu|22648
318409|NCT02162979|Loma Linda University|Tonya Hamilton, reszearch Compliance Auditor|909-558-4908|thamilton@llu.edu|
318410|NCT02169830|Saint Louis University|Dr. Anthony A Mikulec|314-977-8884|anthony.mikulec@health.slu.edu|
318411|NCT02163187|Memorial Sloan Kettering Cancer Center|Dr. Martin Weister, MD|212-639-6698|weiser1@mskcc.org|
318412|NCT02161016|RTI Surgical|Robin Waite|386-418-8888|rwaite@rtix.com|
318413|NCT02159040|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
318414|NCT02168270|University of Nebraska Medical Center|Dr. Nicole Shonka|402-559-5166|nshonka@unmc.edu|
318415|NCT02157116|Duke University|Richard Riedel, MD|919-681-6932|richard.riedel@duke.edu|
318416|NCT02154087|Smith & Nephew, Inc|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
318417|NCT02152670|Yale University|Gustavo Angarita, MD, Assistant Professor of Clinical Psychiatry|(203) 974-7536|gustavo.angarita@yale.edu|
293691|NCT01507181|Mood and Anxiety Disorders Program, Department of Psychiatry, Icahn School of Medicine at Mount Sinai|Dr. J. W. Murrough|212-241-7574|james.murrough@mssm.edu|
318418|NCT02152566|Fisher & Paykel Healthcare|Dr Rachel Vicars|09 574 0123|rachel.vicars@fphcare.co.nz|7759
318419|NCT02137096|University of Florida|John Fort, MD|352-273-9120|john.fort@ufl.edu|
318420|NCT02147834|North Florida South Georigai Veteran Health System|Anthony A Bavry, M.D.|352-548-6000|anthony.bavry@va.gov|104726
318421|NCT02145390|University of Miami|Adrian Ishkanian MD|305-243-4200|aishkanian@miami.edu|
318422|NCT02132884|Fox Chase Cancer Center|Dr. Hossein Borghaei|215-2141515|Hossein.Borghaei@fccc.edu|
318423|NCT02144155|UCSD|David Feifel||dfeifel@kadimanp.com|
318424|NCT02140788|Duke University Health System|Joseph P. McEvoy|919-819-9295|JMCEVOY@gru.edu|
318425|NCT02150863|Massachusetts General Hospital|Elizabeth Morehouse, Clinical Research Coordinator|617-724-2168|emorehouse@partners.org|
318426|NCT02145169|Albert Einstein Medical Center|Kamran Mohiuddin. Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EISNTEIN.EDU|
318427|NCT02130622|Dartmouth-Hitchcock|Gastroenterology Research Team Lead|603-653-9033|Jessica.I.Chevalier@hitchcock.org|
318428|NCT02133534|Duke University Medical Center|Research Practice Manager|919 681 6819|bixby001@duke.edu|
318429|NCT02134912|SWOG|Melanoma Statistician|2066674623|jmoon@fredhutch.org|
318430|NCT02131155|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
318431|NCT02117050|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
318432|NCT02110069|Boston Children's Hospital|Dr. Denise M. Adans|617-919-6407|adamsdm@chop.edu|
318433|NCT02110277|UConn Health|Dr.Molly Brewer|860-679-2100||
318434|NCT02109809|Wake Forest University Health Sciences|Dr. Gordon Phillips|336-716-0659|gophilli@wakehealth.edu|
318435|NCT02105116|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
318436|NCT02099318|University Hospitals Cleveland Medical Center|Valerie Cwiklinski Clinical Research Nurse|216-983-5144|valerie.cwiklinski1@uhhospitals.org|
318437|NCT02099344|Kaiser Permanente NW|Earl Schuman, MD|503-331-6017|kathleen.ann.arnold@kpchr.org|
318438|NCT02094352|HSS|Dr. Richman|212.517.4481|RichmanD@HSS.EDU|
318439|NCT02096042|The University of Texas (UT) MD Anderson Cancer Center|Nitin Jain, MD/Assistant Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
318440|NCT02088957|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
318441|NCT02093689|Omeros Corporation|Medical Monitor|206-676-5000|info@omeros.com|
318442|NCT02091752|Novartis|Study Director|862-778-8300||
318443|NCT02068547|Washington University St. Louis|Wilson Z. Ray, MD|314-362-9959|rayz@wustl.edu|
318444|NCT02075411|Children's Hospital of Philadelphia|Harshad Gurnaney, MBBS, MPH|215-590-1858|gurnaney@email.chop.edu|
318445|NCT02074904|UPENN|Timothy Pond, MPH|215-746-1959|timpond@pennmedicine.upenn.edu|
318446|NCT02084147|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
318447|NCT02081183|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
318448|NCT02067611|Techfields|Dr. Chongxi Yu|571 276 5371|chongxiyu@hotmail.com|
318449|NCT02067104|University of Arizona|Amy Selegue|520-626-0301|aselegue@email.arizona.edu|
318450|NCT02075021|NYU Clinical Cancer Center|Amitabha Mazumder, MD|(212) 731-5757|Amitabha.Mazumder@nyumc.org|
318451|NCT02057874|Vanderbilt University Medical Center|Professor of Surgery and Cancer Biology|615-936-2956|lee.gorden@vanderbilt.edu|
318452|NCT02057237|Princess Margaret Cancer Centre|Dr. Anthony Joshua|416-946-4501|anthony.joshua@uhn.ca|2520
318453|NCT02047747|University of California, San Diego|David Piccioni M.D., Ph.D.|(858) 822-6346|dpiccioni@ucsd.edu|
318454|NCT02058537|Temple University Hospital|Ron Schey|215-540-0120|Ron.schey@tuhs.temple.edu|
271718|NCT00259740|Amgen Inc.|Study Director|866-572-6436||
293692|NCT01507220|The Ohio State University|Sergio Bergese, MD|(614) 293-9027|bergese.1@osu.edu|
314255|NCT03280108|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
318455|NCT02057276|Cincinnati Children's Hospital Medical Center|Steve Wu, MD|513-636-4222|steve.wu@cchmc.org|
318456|NCT02038153|Montefiore|Dr. Ira Braunschweig|718 920-4826|ibraunsc@montefiore.org|
318457|NCT02054910|University of Alabama at Birmingham|Jaypal Ramesh|205-975-9564|jramesh@uab.edu|
318458|NCT02044302|Yale Center for Clinical Investigations|Katisha Brown CPC|(203) 737-7495|katisha.brown@yale.edu|
318459|NCT02046226|Halyard Health, Inc.|David T Curd|470-448-5178|david.curd@hyh.com|
318460|NCT02044848|Novartis Pharmaceuticals|Study Director|862-778-8300||
318461|NCT02042950|UT MD Anderson Cancer Center|Dr. Hun Ju Lee/ Assistant Professor, Lymphoma/Myeloma|(713) 794-1829|hunlee@mdanderson.org|
318462|NCT02048904|University of Missouri|Principal Investigator|573-882-2273 lastrag@healt|lastrag@health.missouri.edu|
318463|NCT02044822|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
318464|NCT02042924|Masonic Cancer Center, University of Minnesota|Dr. Susanta Hui|626-218-0556|shui@coh.org|
318465|NCT02043860|UIC Cancer Center Clinical Trials Office|Annette Kinsella, RN, CCRC, QA Education Specialist|312-996-5931|annettek@uic.edu|
318466|NCT02017522|University of Michigan|Venkatesh Murthy, MD||vlmurthy@umich.edu|
318467|NCT02030015|University of Minnesota|Jeanine Jarnes, PharmD|612-626-5131|utzx0002@umn.edu|
318468|NCT02015663|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
318469|NCT02029846|Johns Hopkins University|Dr. Hsin-Chieh Yeh|410-614-4316|hyeh1@jhmi.edu|
318470|NCT02027272|University of Mississippi Medical Center|James N. Martin, Jr.|601-984-5358|jnmartin@umc.edu|
318471|NCT02012608|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
318472|NCT02017379|Texas Tech University Health Sciences Center at El Paso|Research Compliance Officer|915-215-4814|jackie.roberts@ttuhsc.edu|
318473|NCT02011542|University of Utah, Dept. of Gastroenterology|Dr. Ashok Tuteja|801-581-5679|ashok.tuteja@hsc.utah.edu|
318474|NCT02008370|Maimonides Medical Center|Dr G Trunfio|718-283-6000|gtrunfio@maimonidesmed.org|
318475|NCT02009982|Emory University|Dr. David De Lurgio|404-251-1481|ddelurg@emory.edu|
318476|NCT02013414|Emory University|Baowei Fei, PhD|972-883-7239|bfei@utdallas.edu|
318477|NCT02005445|VA Boston Healthcare System|Dr. Daniel Gottlieb|857-203-6375|daniel.gottlieb@va.gov|
318478|NCT02020837|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|BScanlan@uams.edu|
318479|NCT02015910|Georgetown University Medical Center|Paul J. Kim, DPM, Director of Research|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
318480|NCT02006927|William Beaumont Hospitals|Deborah Hasenau, RN|248 551-0804|deborah.hasenau@beaumont.org|
318481|NCT01996982|Ascension Seton|Research Enterprise Staff|512-3247991|ra@seton.org|
318482|NCT02006407|University of Michigan Comprehensive Cancer Center|Dr. Carl Johannes Koschmann, M.D.|734-647-2893|ckoschma@umich.edu|
318483|NCT01986751|University of Alabama Birmingham|Dr. Promil Kukreja|205-996-7025|pkukreja@uabmc.edu|
318484|NCT01996410|OhioHealth|John Elliott|614-566-3643|John.Elliott@ohiohealth.com|
318485|NCT01996852|Case Comprehensive Cancer Center|Dr. Amy Zhang|+1 216-368-0968|amy.zhang@case.edu|
318486|NCT01997567|Rush University Medical Center Department of Anesthesiology|Sandeep Amin, M.D|312-942-6449|Sandeep_Amin@rush.edu|
318487|NCT01977729|Yale University|Dr. Wendy Silverman|(203) 737-7053|wendy.silverman@yale.edu|
318488|NCT01973062|Case Comprehensive Cancer Center|Manmeet Ahluwalia, MD|216-444-6145|ahluwam@ccf.org|
318489|NCT01982253|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@takeda.com|
318490|NCT01984268|Dartmouth-Hitchcock Medical Center|Director, Office of Research Operations|(603) 650-6340|Barbara.A.Moskalenko@hitchcock.org|
318491|NCT01974284|Yale University School of Medicine|Dr. Glenda Callendar|203-737-2036|glenda.callender@yale.edu|
271719|NCT00259857|Medical University of South Carolina|Deborah A Bowlby, MD, Asst.Professor, Pedeiatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
318492|NCT01971853|"University of Colorado Denver | Anschutz"|Director, Clinical Research Administration||clinicalresearchsupportcenter@ucdenver.edu|
318493|NCT01980875|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
318494|NCT01982383|Medical Faculty Associates|Nicole Swanson|202-741-2437|nswanson@mfa.gwu.edu|
318495|NCT01980342|Johns Hopkins University School of Medicine|Jenny Robinson, MD MP FACOG|4105500337|mailto:jrobin87@jhmi.edu|
318496|NCT01978535|Mayo Clinic|Dr. Amie Jones|507-284-6063|Jones.Amie@mayo.edu|
318497|NCT01974635|AMES Technology Inc.|Paul Cordo|15039706129|pcordo@amesdevices.com|
318498|NCT01975467|Sonoma Orthopedics|Rick Epstein|8479872516|repstein@sonomaorthopedics.com|
318499|NCT01970462|Ohio State University|Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
318500|NCT01969565|Emory University|Jonathan Kaufman, MD|404-778-1900|jlkaufm@emory.edu|
318501|NCT01968226|Cleveland Clinic|Dr. Balaji Tamarappoo|216-444-6765|tamarab@ccf.org|
318502|NCT01965782|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
318503|NCT01962675|Shepherd Center|Edelle Field-Fote|404-603-4274|edelle_field-fote@shepherd.org|
318504|NCT01962974|Janssen Pharmaceuticals|STRATEGIC LEAD||ClinicalTrialDisclosure@its.jnj.com|
318505|NCT01954160|Duke Clinical Research Institute|Kathy Moore|919-668-8065|kathy.moore@dm.duke.edu|
318506|NCT01951378|Seton Family of Hospital|Director Pediatric Fellowship|512-324-9999|a.a@abc.com|
318507|NCT01941615|Boehringer Ingelheim|Boehringer Ingelheim Call Center|+1 800 243 0127|clintriage.rdg@boehringer-ingelheim.com|
314256|NCT03280121|Daniel and Daniel Consulting, LLC|Cynthia Harris, Director of Clinical Trials|775-392-2975|cindy@clinregconsult.com|
314257|NCT03280264|Kyowa Kirin Co., Ltd.|Research & Development Planning Department, Research & Development Division|+81-3-5205-7200|clinical.info.jp@kyowakirin.com|
314258|NCT03280381|PATH|Dr. Patricia S. Coffey|206-302-4704|pcoffey@path.org|
314259|NCT03280537|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
314260|NCT03280550|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
293693|NCT01507246|Atlanta Colon and Rectal Surgery|Stephen Cohen, MD|770-997-1975|klong@atlantacolon.com|
293694|NCT01507298|Imperial College London|Dr. Richard Mark Kwasnicki|07851759471|rmk107@ic.ac.uk|
318508|NCT01946542|Duke University Medical Center|William Kraus|919-684-2063|william.kraus@duke.edu|
293695|NCT01507350|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
293696|NCT01507493|Huazhong University of Science&Technology|Xianwei Zhang|13037154560|znpain@sina.com|
293697|NCT01507662|University of Iowa|Dr. Fredric Wolinsky|(319) 384-3821|fredric-wolinsky@uiowa.edu|
271720|NCT00260065|Eisai Inc.|Eisai Call Center|888-422-4743||
293698|NCT01507688|VA HSRD PRIS-M QUERI and CHIC HSRD Centers|Teresa Damush Ph.D.|317-988-4277|Teresa.Damush@va.gov|
293699|NCT01507779|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
293700|NCT01507831|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
293701|NCT01507896|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
305793|NCT02359305|Nationwide Children's Hospital - Dept. of Anesthesiology & Pain Medicine|Dr. Arlyne Thung|614-722-4200|Arlyne.Thung@nationwidechildrens.org|
305794|NCT02359435|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
305795|NCT02359552|Cleveland Clinic Lou Ruvo Center for Brain Health|Dr. Aaron Ritter|702-483-6049|rittera@ccf.org|
305796|NCT02359851|Vanderbilt-Ingram Cancer Center|Principal Investigator|615-936-7423|douglas.b.johnson@vanderbilt.edu|
305797|NCT02359877|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
305798|NCT02359890|Biosense Webster|Robert Stagg|(800) 729-9010|RStagg@its.jnj.com|
305799|NCT02359903|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
305800|NCT02359916|Rush University Medical Center|Brad Appelhans, PhD (PI)|312-942-3477|brad_appelhans@rush.edu|
305801|NCT02359955|Shanghai No. 9 People's Hospital|Dr. Haixin Qian|13501961651|drqian8167@126.com|
318509|NCT01937507|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
305802|NCT02360085|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
305803|NCT02360098|TORONTO WESTERN HOSPITAL/UHN|Emad Al Azazi|416-603-5800|emad.alazazi@uhnresearch.ca|6237
305804|NCT02360124|University of Hong Kong|Prof. E.C.M. Lo|852-2859 0292|edward-lo@hku.hk|
305805|NCT02360215|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
305806|NCT02360228|University of North Carolina at Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
305807|NCT02360280|Minneapolis VA Medical Center|Paulo R. Shiroma|612-467-2264|paulo.shiroma@va.gov|
305808|NCT02360293|VA ORD|Laura Damschroder|734-845-3603|laura.damschroder@va.gov|
305809|NCT02360319|Vanguard Research Group|Patrica Marcy|3474398035|pmarcy@northwell.edu|
305810|NCT02360371|Johns Hopkins University School of Medicine|Dr. Kelly Dunn, Ph.D., MBA|410-550-2254|kdunn9@jhmi.edu|
305811|NCT02360397|Brigham and Women's Cardiovascular Associates at Kent Hospital|Chester M. Hedgepeth, MD, PhD|(401) 737-7010|chedgepeth@kentri.org|32880
305812|NCT02360475|GlaxoSmithKline|GSK Response Center|866-435-7343||
305813|NCT02360488|UCLA|Steve Cramer|424-522-7273|sccramer@mednet.ucla.edu|
305814|NCT02360605|LSUShreveport|Dr. Connie Arnold|318-675-4324|carnol@lsuhsc.edu|
305815|NCT02360631|University of Kansas Medical Center|Lisa Sanderson Cox|913-588-2643|lcox@kumc.edu|
305816|NCT02360774|Beth Israel Deaconess Medical Center|Jody Dushay|6176671996|jdushay@bidmc.harvard.edu|
318510|NCT01944059|University Cincinnati Physicians Company|Vincent Martin, MD|513-558-7581|vincent.martin@uc.edu|
318511|NCT01935947|Johns Hopkins University|Gary Rosner|410-955-4884|grosner1@jhmi.edu|
318512|NCT01939223|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
318513|NCT01938716|UT MD Anderson Cancer Center|Dr. Gauri R Varadhachary,Professor, GI Medical Oncology|713-792-2828|gvaradha@mdanderson.org|
318514|NCT01936974|CTCA|Jessica Coats, RN|6232073899|jessica.coats@ctca-hope.com|
318515|NCT01938833|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Maysa Abu-Khalaf|215 503-4685|maysa.abu-khalaf@jefferson.edu|
318516|NCT01934647|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
318517|NCT01934504|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
318518|NCT01928082|The University of Chicago|Murray J. Favus|(773) 702-6138|mfavus@medicine.bsd.uchicago.edu|
318519|NCT01928615|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
318520|NCT01911793|Cedars Sinai Medical Center|Phillip Fleshner, MD|310-289-9224|pfleshner@aol.com|
318521|NCT01912404|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
318522|NCT01910389|New England Research Institutes|Brian Harty|617-972-3224|bhartY@neriscience.com|
318523|NCT01921114|AngioDynamics|Alicia Conway|774-249-8707|aconway@angiodynamics.com|
318524|NCT01916590|UColorado|Colleen Dingmann R.N. Ph.D.|303-724-7494|colleen.dingmann@ucdenver.edu|
318525|NCT01913327|University of California San Francisco|Michael Minzenberg|5104122199|MMinzenberg@mednet.ucla.edu|
318526|NCT01902888|W.L. Gore and Associates, Inc.|Arthur Scott / Clinical Study Manager|623.208.3365|artscott@wlgore.com|
318527|NCT01901224|Brigham and Women's Hospital|Mark A. Creager, MD|603-650-8283|mark.a.creager@hitchcock.org|
318528|NCT01910441|Novartis|Study Director|862-778-8200||
318529|NCT01902966|UT MD Anderson Cancer Center|Lois M. Ramondetta, MD, Professor, Gynecologic Oncology & Reproductive Medicine|713-745-0307|lramonde@mdanderson.org|
318530|NCT01901679|The Rockefeller University|Dr. Peter R Holt|212-327-7706|holtp@rockefeller.edu|
293702|NCT01507987|Abbott|Grant Kim, Program Director - Traditional Cardiac Rhythm Management|818-493-3147|grant.kim1@abbott.com|
305817|NCT02360995|Loma Linda University School of Dentistry|Yiming Li, DDS|909-558-8069|yli@llu.edu|
305818|NCT02361216|LEO Pharma A/S|Clinical Trial Disclosure Manager||disclosure@leo-pharma.com|
293703|NCT01508013|East Tennessee State University|Dr. Joel Hillhouse|423-439-4332|hillhous@etsu.edu|
293704|NCT01508052|Gachon University|Dr.Kwak|82324603400|hyun615@gilhospital.com|
318531|NCT01900730|UT MD Anderson Cancer Center|Dr. Wendy Woodward, PHD/ Professor, Radiation Oncology Department|713-563-8481|wwoodward@mdanderson.org|
318532|NCT01877564|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|BScanlan@uams.edu|
318533|NCT01890694|NYU Langone Medical Center|Office of Clinical Trials|646-754-7431|clinicaltrials@nyumc.org|
318534|NCT01900626|University of Wisconsin School of Medicine and Public Health|Benjamin J. Walker, MD|608/262-8858|bjwalker2@wisc.edu|
318535|NCT01890577|Amgen Inc.|Study Director|866-572-6436||
318536|NCT01895959|University of California, San Francisco|Xiaojuan Li, PhD|415-353-4909|Xiaojuan.li@ucsf.edu|
318537|NCT01889420|University of New Mexico|Dulcinea Quintana, MD|505-272-4661|dcandelaria@salud.unm.edu|
318538|NCT01884077|Washington University School of Medicine - Dept of Orthopaedic Surgery|Dr. Aaron Chamberlain|314-362-9283|chamberlaina@wudosis.wustl.edu|
318539|NCT01881984|University of Pittsburgh|Dr. Gerard Vockley|412-692-7746|gerard.vockley@chp.edu|
318540|NCT01893359|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
318541|NCT01883908|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
318542|NCT01887288|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
318543|NCT01868139|University of Maryland School of Medicine|Dr. Bruce Greenwald|4103288731|bgreenwa@medicine.umaryland.edu|
318544|NCT01881932|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
318545|NCT01878786|MedStar Georgetown Transplant Institute|Dr. Matthew Cooper|202-444-0753|Matthew.Cooper@gunet.georgetown.edu|
318546|NCT01877343|University of Florida|Dr. Curt DeGroff|352-273-7770|degroffc@peds.ufl.edu|
318547|NCT01861717|JOHN WAYNE CANCER INSTITUTE|Dr. Daniel Kelly|310-582-7450|Daniel.Kelly2@providence.org|
305819|NCT02361307|Mahidol University|Piyapat Dajpratham|6624197508|piyapat.daj@mahidol.ac.th|
270381|NCT00125138|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
270382|NCT00125164|Ipsen|Medical Director, Pediatric Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
270383|NCT00125190|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
270384|NCT00125242|VA Salt Lake City Health Care System|Dr. Julie Wambaugh|801-582-1565|julie.wambaugh@health.utah.edu|1363
270385|NCT00125359|Dartmouth-Hitchcock Medical Center|Konstantin Dragnev, MD|603-650-6344|Konstantin.H.Dragnev@Hitchcock.org|
270386|NCT00125372|Dartmouth-Hitchcock Medical Center|Konstantin Dragnev, MD|603-650-6344|Konstantin.H.Dragnev@hitchcock.org|
270387|NCT00125515|New York Psychiatric Institute|Dr Adam Bisaga|212-543-6542|bisagaa@nyspi.columbia.edu|
270388|NCT00125528|Northwestern Universiyt|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
270389|NCT00125593|Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford|Professor Colin Baigent|+44 1865 743743|colin.baigent@ctsu.ox.ac.uk|
270390|NCT00125619|VA Brain Rehabilitation Research Center|Dr. Carolynn Patten|352.376.1611|patten@phhp.ufl.edu|4160
270391|NCT00125658|VA Brain Rehabilitation Research Center|Dr. Carolynn Patten|352.376.1611|carolynn.patten@va.gov|4160
270392|NCT00125762|BIDMC|Nezam Afdhal|6176321118|nafdhal@bidmc.harvard.edu|
270393|NCT00125788|Emmaus Medical, Inc.|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
270394|NCT00125853|Imperial College London|Professor Neil Poulter|+44 2075943445|n.poulter@imperial.ac.uk|
270395|NCT00125931|McLean Hospital|Beth Murphy, MD PhD|617-855-2297|BMurphy5@partners.org|
270396|NCT00125957|McLean Hospital|Dr. Beth Murphy|617-855-2000|bmurphy5@partners.org|2297
270397|NCT00126113|National Center for Rehabilitative Auditory Research|Gabrielle Saunder Ph.D.|503-220-8262|gabrielle.saunders@va.gov|56210
270398|NCT00126126|Miami VAHS & University of Miami, Department of PT|Robert Gailey, PhD, PT|305-284-4535|rgailey@miami.edu|
270399|NCT00126191|DFCI|Ann LaCasce, MD|617-632-5959|ALACASCE@PARTNERS.ORG|
270400|NCT00126425|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
270401|NCT00126438|GE Healthcare|Jose Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
270402|NCT00126490|H. Lee Moffitt Cancer Center and Research Institute|Mayer Fishman, M.D., Ph.D.|813-745-8311|mayer.fishman@moffitt.org|
270403|NCT00126503|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
270404|NCT00126555|University of Texas MD Anderson Cancer Center|Randal S. Weber, MD / Head & Neck Surgery|7137927734|rsweber@mdanderson.org|
271721|NCT00260195|RAND Corporation|Lisa Jaycox|703-344-8236|jaycox@rand.org|5118
293705|NCT01508117|University of Cincinnati|Alison Kastl|513-584-0436|kastla@ucmail.uc.edu|
318548|NCT01866709|ZS Pharma, Inc|Henrik Rasmussen, MD, PhD|443-699-5230|hrasmussen@zspharma.com|
293706|NCT01508130|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
318549|NCT01860040|Western Regional Medical Center|Director of Clinical Research|6232073000|jessica.coats@ctca-hope.com|
318550|NCT01869478|Mayo Clinic|Kevin M. Barrett, MD|904-953-9740|Barrett.Kevin@mayo.edu|
318551|NCT01851174|CTCA|Jessica L. Coats|6232073899|jessica.coats@ctca-hope.com|
318552|NCT01846182|Central Texas Veterans Health Care System|Charles J. Foulks, M.D., ACOS/R|254 743 2643|Charles.Foulks@va.gov|
318553|NCT01844206|Columbia University|Dr. Allison Lee|305-582-6077|al3196@cumc.columbia.edu|
318554|NCT01856322|National Cancer Institute|Dr. Marybeth Hughes|301-594-9341|hughesm@mail.nih.gov|
292562|NCT01434121|Virginia Commonweath University|Alpha A. Fowler, III, MD|804-628-5710|afowler@mcvh-vcu.edu|
292563|NCT01434186|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
292564|NCT01434290|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
293707|NCT01508169|Hospital de Clinicas da Universidade Estadual de Campinas (Unicamp)|Cecilia de Morais Barbosa|+55-19-35217113|cecimbarbosa@gmail.com|
293708|NCT01508325|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
305820|NCT02361476|Rigshospitalet|Mogens Ydemann, MD|+45 35455620|mogens@ydemann.dk|
305821|NCT02361736|Tianjin Medical University General Hospital|Dr. Yuanyuan Zhang|13821685913|doctorkelly@126.com|
318555|NCT01853176|Emory University|Albert Losken MD|404-686-8143|alosken@emory.edu|
318556|NCT01857271|Albert Einstein Cancer Center|Dr. Haiying Cheng|718-405-8404|hcheng@montefiore.org|
318557|NCT01856361|Weill Cornell Medical College|Peter N Schlegel, MD|2127465491|pnschleg@med.cornell.edu|
318558|NCT01853982|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
318559|NCT01841931|Maimonides Medical Center|Director of Research, Department of Psychiatry|718-283-7162|tjacob@maimonidesmed.org|
318560|NCT01836809|Virginia Commonwealth University|Keyur Shah, MD|804-828-4571|kshah@mcvh-vcu.edu|
318561|NCT01831596|KCI|VP, Global Clinical Development|210-255-5595|jkhart@mmm.com|
318562|NCT01834144|University of Manitoba|Dr. Jonathan McGavock|204-480-1359|jmcgavock@chrim.ca|
318563|NCT01821963|University of Texas (UT) MD Anderson Cancer Center|Harrys A. Torres, MD/Assistant Professor, Infectious Diseases|(713) 792-6503|htorres@mdanderson.org|
318564|NCT01821898|Baylor College of Medicine/Texas Children's Hospital|Carla M. Davis, MD|832-824-1319|carlad@bcm.edu|
318565|NCT01814722|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
318566|NCT01830790|Duke University|Sharon Fekrat: Associate Professor of Ophthalmology|(919) 681-0341|Sharon.Fekrat@dm.duke.edu|
318567|NCT01829477|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
318568|NCT01803711|UConn Health Center|Jayesh Kamath MD PhD|8606796727|jkamath@uchc.edu|
318569|NCT01821859|Oregon Health and Science University|Tanja Pejovic|503-494-5125|pejovict@ohsu.edu|
318570|NCT01808950|Galderma Spirig|Dr. Francine Santoro|+41623878720|francine.santoro@galderma.com|
318571|NCT01806051|Children's Hospital Los Angeles|Linda Randolph, M.D.|323-361-2178|lrandolph@chla.usc.edu|
318572|NCT01808794|Tufts University|Associate Vice Provost for Research Administration & Development|617-627-7000|tss@tufts.edu|
318573|NCT01809899|Georgetown University Medical Center|Mary Ann Dutton|2026871997|mad27@georgetown.edu|
318574|NCT01810302|University of Florida|Dr. Spiros Blackburn|(352) 273-9000|spiros.blackburn@neurosurgery.ufl.edu|
318575|NCT01806961|Sipirig AG|Dr. Francine Santoro|+41 62 387 87 87|francine.santoro@galderma.com|87 20
318576|NCT01804166|Janssen Scientific Affairs, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
318577|NCT01783015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
318578|NCT01800162|University of Pennsylvania|Dr. Kurt Barnhart|215-662-2974|KBarnhart@uphs.upenn.edu|
318579|NCT01794936|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
318580|NCT01797380|Duke University Health Systems|Harold Goforth, M.D.|216-636-3999|goforth@ccf.org|
318581|NCT01781026|Yale University|Harriet Kluger||Harriet.Kluger@yale.edu|
318582|NCT01788475|Lahey Medical Center|Christine Gould PAC, MS|9785384412|christine.gould@lahey.org|
318583|NCT01784991|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EINSTEIN.EDU|
318584|NCT01777854|UH|Carissa Wentland DO|320-392-4737|carissa.wentland@gmail.com|
318585|NCT01760993|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
318586|NCT01772719|University of Louisville, James Graham Brown Cancer Center|James Graham Brown Cancer Center, Clinical Trials|502-562-3429|ctobcc@louisville.edu|
318587|NCT01764997|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
318588|NCT01760941|Virginia Commonwealth University/Massey Cancer Center|Drew Moghanaki, MD, MPH|804-765-5850|Drew.moghanaki@vcuhealth.org|
318589|NCT01769443|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
318590|NCT01760889|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
318591|NCT01749826|Stanford University School of Medicine Department of Anesthesiology|Dr. Larry F. Chu|6507236632|lchu@stanford.edu|
318592|NCT01756586|University of Chicago|TARIQ MALIK|773-834 3643|tmalik@dacc.uchicago.edu|
318593|NCT01754987|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
318594|NCT01756560|University of Chicago|TARIQ MALIK|773-8342643|tmalik@dacc.uchicago.edu|
318595|NCT01756573|University of Chicago|TARIQ MALIK|773-8342643|tmalik@dacc.uchicago.edu|
318596|NCT01745913|Weill Cornell Medical College|Koen van Besien, MD|2127462646|kov9001@med.cornell.edu|
318597|NCT01752023|SKCCC at Johns Hopkins|Ronan Kelly, MD|443-287-0005|rkelly25@jhmi.edu|
318598|NCT01740154|Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
318599|NCT01748890|Massachusetts General Hospital|Anthony E. Samir|6178523241|asamir@partners.org|
318600|NCT01748162|University of Michigan|Dr. David J. Brown||davidjb@med.umich.edu|
318601|NCT01738698|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
271722|NCT00260208|Novartis Pharmaceuticals|Study coordinator|862-778-8300||
293709|NCT01508455|Hospira|Dr. Marcelo Garcia da Rocha|224-212-4424|marcelo.rocha@hospira.com|
293710|NCT01508650|Wake Forest School of Medicine|Dr. Dalane Kitzman|336-716-2227|dkitzman@wakehealth.edu|
293711|NCT01508676|Massachusetts General Hospital|Dr. Jianren Mao|6177246102|mghpainresearch@partners.org|
293712|NCT01508702|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
293713|NCT01508832|University of California San Francisco|Ronald D Miller, MD|415 476-9034|millerr@anesthesia.ucsf.edu|
293714|NCT01508910|Baxalta US Inc.|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com|
318602|NCT01732926|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
318603|NCT01727167|Duke University Medical Center|John J. Freiberger, M.D.|919-684-6726|john.freiberger@duke.edu|
318604|NCT01732913|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
318605|NCT01732211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
318606|NCT01716052|UTHSCSA @CTRC|Dr. Kenneth Kist|210-450-5600|KIST@UTHSCSA.EDU|
318607|NCT01718444|UIC|Albert Asante, MD MPH|3123552634|akdasante@yahoo.com|
318608|NCT01712854|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
318609|NCT01717482|Mayo Clinic|Dennis Wigle, M.D., Ph.D.|507-284-8462|Wigle.Dennis@mayo.edu|
318610|NCT01702896|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
318611|NCT01709136|Children's Hospital of Pittsburgh|Dr. Rakesh Sindhi, MD|412-692-6110|rakesh.sindhi@chp.edu|
318612|NCT01708057|AstraZeneca|Carin Jorup||aztrial_results_posting@astrazeneca.com|
318613|NCT01697332|Brigham and Women's Hospital|Samuel Patz|6172780616|patz@bwh.harvard.edu|
318614|NCT01693367|AO Foundation|Clinical Operations Manager of Clinical Investigation and Documentation|0041 44 200 24 67|andreas.faeh@aofoundation.org|
318615|NCT01705106|University of Chicago|Manish R. Sharma, MD|773-834-0312|msharma@bsd.uchicago.edu|
318616|NCT01702909|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
318617|NCT01701622|University of Mississippi Medical Center|Debbie Minor|601-984-6888|DMinor@umc.edu|
318618|NCT01697800|Johns Hopkins Medicine|Zubair Khan|410-955-3157|zkhan@jhmi.edu|
318619|NCT01700348|Philips Oral Healthcare, Inc|Marcia Delaurenti, Clinical Project Manager|425-908-1212|marcia.delaurenti@philips.com|
318620|NCT01693484|LSU Health Science Center Shreveport|Dr Todd Jaeblon|318 675 6180|tjaebl@lsuhsc.edu|419
318621|NCT01693653|NYU Langone Medical Center, Center for Musculoskeletal Care|Yusuf Yazici|646-501-7400|yusuf.yazici@nyumc.org|
318622|NCT01692691|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
318623|NCT01691079|University of California, San Francisco|Mona Luke-Zeitoun, MD||lukezeitounm@peds.ucsf.edu|
318624|NCT01690910|St. Joseph Mercy Hospital|Amy Burghardt|734-712-2027|amy.burghardt@stjoeshealth.org|
318625|NCT01689974|New York University School of Medicine|Sylvia Formenti, MD|646.962.4073|formenti@med.cornell.edu|
318626|NCT01676961|NYU Clinical Cancer Center|Amitabha Mazumder, MD|(212) 731-5757|Amitabha.Mazumder@nyumc.org|
318627|NCT01681589|NYU Langone Health|Prin Amorapanth, MD, PhD|212-263-6037|Prin.Amoropanth@nyulangone.org|
318628|NCT01681745|Pacira Cryotech, Inc.|Kent Jones/ Sr. Director Quality and Medical Affairs|(510)933-1513|kent.jones@pacira.com|
318629|NCT01682928|Mednax|Ana Braescu|480-969-5999|ana_braescu@mednax.com|
318630|NCT01668940|The Hospital for Sick Children|Dr Shinya Ito, Principal Investigator|4168135776|shinya.ito@sickkids.ca|205776
318631|NCT01663285|University of Michigan Comprehensive Cancer Center|Dr. Ajjai Alva|734-647-8921|ajjai@umich.edu|
318632|NCT01683864|University Clinic of Tübingen|Prof. Alfred Königsrainer|0049 7071 2983290|silvia.wagner@med.uni-tuebingen.de|
318633|NCT01675011|Boston Scientific|Anastasia Becker - Director of Clinical Trials|763-494-2170|Ana.Becker@bsci.com|
318634|NCT01673425|VA National Center for Occupational Health & Infection Control|Lewis Radonovich|352-376-1611|Lewis.radonovich@va.gov|4988
318635|NCT01673061|Albert Einstein Medical Center|Kamran Mohiuddin, Director Clinical Research Emergency Medicine|2154562313|mohiuddk@einstein.edu|
318636|NCT01675960|Children's of Minnesota|Scott Schwantes|(612)813-7888|sschwantes@gillettechildrens.com|
318637|NCT01668147|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
318638|NCT01676701|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
318639|NCT01669148|Massachusetts General Hospital|Thomas J. Brady, MD|6177268294|tbrady@mgh.harvard.edu|
293715|NCT01508936|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
318640|NCT01662102|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
318641|NCT01659554|Columbia University Medical Center|Reena M. Vattakalam, CCRP|212-342-6895|rmv2110@cumc.columbia.edu|
318642|NCT01658813|Western Regional Medical Center|Jessica L. Coats|623-207-3899|jessica.coats@ctca-hope.com|
318643|NCT01648296|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
318644|NCT01649505|Oregon Health and Science University|Dr. Juliana Hansen|503-494-4834|hansenju@ohsu.edu|
318645|NCT01642732|University of Michigan Hospital|Dr. Daniel Hamstra, Associate Professor of Radiation Oncology|734-936-4300|dhamm@umich.edu|
318646|NCT01645709|CaloSyn Pharma Inc.|Stephen Snowdy, PhD|404-863-8892|ssnowdy@ansleyvc.com|
318647|NCT01648270|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
318648|NCT01643525|Johns Hopkins University|Dr. Paul Nyquist||pnyquis1@jhmi.edu|
318649|NCT01641601|UCSF|Kirsten Salmeen|628-213-5314|kesalmeen@gmail.com|
318650|NCT01633814|University of Missouri|Principal Investigator|573-884-5220|fadelp@health.missouri.edu|
318651|NCT01636466|Emory University|Dr. Ashtar Chami|404-712-7735|ashtar.chami@emory.edu|
318652|NCT01629329|EINSTEIN MEDICAL CENTER|Kamran Mohiuddin, Director Clinical Research Emergency Department|2154562313|MOHIUDDK@EINSTEIN.EDU|
318653|NCT01627899|LifeScan Scotland|Mike Grady|+44 01463 721000|MGRADY@its.jnj.com|
318654|NCT01632020|University of Arkansas for Medical Sciences|Daisy Wade|5016868274|dewade@uams.edu|
293716|NCT01509040|University of Washington Harborview Center for Pre Hospital Emergency Care|Dr. Graham Nichol|206-521-1728|nichol@uw.edu|
293717|NCT01509079|HealthPartnersInstitute|Dr. Alice Shapiro|952-993-1704|shapia@parknicollet.com|
318655|NCT01602471|Certus International, Inc.|Edward M. Aten, M.D.|603.627.1212|eaten@certusintl.com|
318656|NCT01619800|Icahn School of Medicine at Mount Sinai|Vivek Reddy|212-241-7114|vivek.reddy@mountsinai.org|
318657|NCT01608906|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
318658|NCT01621737|UCSD|David Feifel|(858) 412-4130|dfeifel@kadimanp.com|
318659|NCT01614067|University of California, San Francisco|Mitchell Rosen, MD|415-353-7475||
318660|NCT01607320|Greenville Health System|Bruce Lessey|864-455-1600|blessey@ghs.org|
318661|NCT01605019|Houston Methodist Research Institute|Raquel R Bunge|713-441-3912|rrbunge2@houstonmethodist.org|
318662|NCT01609231|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
318663|NCT01602198|Cleveland Clinic|Stephen Rao|216-444-1025|raos2@ccf.org|
318664|NCT01606150|Georgetown University NICU|Judith Palafoutas, Research Director|202 444 8756|jxp11@gunet.georgetown.edu|
318665|NCT01603043|Alcon Research, Ltd.|Yamini Patel, PhD, Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
318666|NCT01605370|Mayo Clinic|Marek Belohlavek, M.D., Ph.D.|408-301-6694|belohlavek.marek@mayo.edu|
293718|NCT01509105|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
318667|NCT01605617|Mayo Clinic|Dr. Jeffrey L. Cornella|480-342-2867|cornella.jeffrey@mayo.edu|
318668|NCT01606709|UConnHealth|Lawrence Engmann|8605258283|lengmann@uchc.edu|
318669|NCT01603121|Eastern Virginia Medical School|Dr. David Lieb, Principal Investigator|7574465910|liebdc@evms.edu|
318670|NCT01602016|University of Arkansas for Medical Sciences|Tracy Gatlin|501-686-6803|tlgatlin@uams.edu|
318671|NCT01603394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
318672|NCT01592383|University of Chicago|Hedy Kindler|7737020360|hkindler@medicine.bsd.uchicago.edu|
318673|NCT01598025|Memorial Sloan Kettering Cancer Center|Dr. Richard O'Reilly, MD|646-888-2157|oreillyr@mskcc.org|
318674|NCT01587963|Rutgers RWJMS|Vincente Gracias|732-235-7920|graciavh@rwjms.rutgers.edu|
318675|NCT01591096|SeattleChildrens|Catherine Amlie-Lefond MD|206-987-2078|calefond@seattlechildrens.org|
318676|NCT01591954|Department of Biomedical Engineering, Johns Hopkins University|Jeffrey H. Siewerdsen, PhD / Professor of Biomedical Engineering|443-287-6269|jeff.siewerdsen@jhu.edu|
318677|NCT01589926|Children's Hospital at Montefiore|Kerry Morrone, MD, Asst Prof of Pediatrics|718-741-2342|kmorrone@montefiore.org|
318678|NCT01576575|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
318679|NCT01590394|Mayo Clinic|Christopher J. Gostout|507-284-7647|gostout.christopher@mayo.edu|
318680|NCT01577628|Innovaderm Research|Dr Robert Bissonnette|514-521-4285|rbissonnette@innovaderm.ca|
318681|NCT01582100|Northwestern University|Christine Ebert Nelson|3126954513|c-ebert@northwestern.edu|
318682|NCT01583647|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
318683|NCT01575028|Nationwide Children's Hospital|Tarun Bhalla|(614) 722-4200|Tarun.Bhalla@NationwideChildrens.org|
318684|NCT01578785|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
318685|NCT01576549|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271723|NCT00260429|Auxilium Pharmaceuticals, Inc.|Greg Kaufman, MD; Senior Director of Clinical Development|484 321 5900|gkaufman@auxilium.com|5920
318686|NCT01570634|Salient Pharmaceuticals Incorporated|Richard scruggs|7135899859|rscruggs@salientpharmaceuticals.com|
318687|NCT01566370|Yale/VA Connecticut Healthcare system|Albert Arias|2039325711|albert.arias@va.gov|8155
318688|NCT01561989|Roswell Park Cancer Institute|Dr. Martin Mahoney|716-845-2300|martin.mahoney@roswellpark.org|
318689|NCT01564732|Duke University Medical Center|Dana Portenier, M.D.|919-470-7031|dana.portenier@duke.edu|
318690|NCT01560507|Duke University Medical Center|Dr. Jed Rose|919-668-5055|jed.rose@duke.edu|
318691|NCT01557881|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
318692|NCT01555489|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
318693|NCT01549977|Takeda|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
318694|NCT01558492|Weill Cornell Medicine|Himisha Beltran, MD|646-962-2072|hip9004@med.cornell.edu|
318695|NCT01550562|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
318696|NCT01561495|AbramsonCC Radiation Oncolocy|Susan Prendergast, RN|215-662-4267|susan.prendergast@pennmedicine.upenn.edu|
318697|NCT01555073|Northwestern University, Feinberg School of Medicine|Antoun Nader, MD|312-695-3045|a-nader2@northwestern.edu|
318698|NCT01551082|Alliance of Cardiac Vascular and Thoracic Surgeons|Jeremy Smith RN|4236245200|jsmith@actvsurgeons.com|
318699|NCT01556009|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
293719|NCT01509183|Propeller Health|Research Team at Propeller Health|9545369563|leanne.kaye@propellerhealth.com|
293720|NCT01509404|Medical University of South Carolina|James Fleming|843-792-0312|fleminj@musc.edu|
305822|NCT02361762|Boston Children's Hospital|Dr. Susan Faja|617-919-4108|susan.faja@childrens.harvard.edu|
318700|NCT01550510|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Daniel Monti|215 955-2221|daniel.monti@jefferson.edu|
318701|NCT01541397|The University of Texas Health Science Center at Houston|Heather Saavedra|713-500-7098|Heather.Saavedra@uth.tmc.edu|
318702|NCT01546207|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y. Reddy|212-241-7114|vivek.reddy@mountsinai.org|
318703|NCT01553240|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
318704|NCT01547728|Mayo Clinic Rochester|Dr. William Oliver|507-255-4240|oliver.william@mayo.edu|
318705|NCT01548651|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
318706|NCT01545648|University of California, San Francisco|Hope Rugo, MD|877-827-3222|cancertrials@ucsf.edu|
318707|NCT01546883|University of Utah|Clinical Research Manager|8015873889|christina.pacchia@hsc.utah.edu|
318708|NCT01545518|Emory University|Dr. Charles M. Epstein|404-778-3633|cepstei@emory.edu|
318709|NCT01536015|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
318710|NCT01539590|Yale University Medical Center|Dr. Joesph Brennan|(203) 483-8300|Brennan.Joesph@yale.edu|
318711|NCT01539811|Greenville Health System|Dr. David Cull|8644548295|dcull@ghs.org|
318712|NCT01534676|Columbia University Medical Center|Eldad Hod, MD|212-342-5648|eh2217@cumc.columbia.edu|
318713|NCT01533753|University of Wisconsin Carbone Cancer Center|Dr. Justine Bruce|608-263-7107|jybruce@medicine.wisc.edu|
318714|NCT01534143|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kahdimi, M.D.|(313) 576-8022|zalkadh@emory.edu|
318715|NCT01530880|Columbia University|Michael Schmidt|212-305-8745|mjs2134@columbia.edu|
318716|NCT01530087|Hollister Incorporated|Director, Global Clinical Affairs|847.918.3467|Stacy.Haddad@hollister.com|
318717|NCT01527942|ST. FRANCIS HOSPITAL AND MEDICAL CENTER|Ioannis Raftopoulos, MD||IRaftopo@stfranciscare.org|
318718|NCT01521143|Prima BioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
318719|NCT01532635|Thomas Jefferson University|Neal Flomenberg, MD|215-955-8874|Neal.Flomenberg@jefferson.edu|
318720|NCT01531387|St. Jude Children's Research Hospital|James M. Boyett, PhD|901-595-4986|james.boyett@stjude.org|
318721|NCT01532362|Jonsson Comprehensive Cancer Center: University of California at Los Angeles|Dr. Jay Moon Lee|(310) 794-7333|jaymoonlee@mednet.ucla.edu|
318722|NCT01527292|University of Louisville, James Graham Brown Cancer Center|Dr. Shiao Woo|502-561-2700|sywoo001@exchange.louisville.edu|
318723|NCT01525745|Beth Israel Deaconess Medical Center|Anand Mahadevan, MD|617-667-2345|amahadev@bidmc.harvard.edu|
318724|NCT01528696|University of Michigan|Mark Chames|734 764-1406|mchames@med.umich.edu|
318725|NCT01526408|House Institute Foundation|Mahta Marefat|(213) 770-1808|mmarefat@hifla.org|
318726|NCT01528293|Georgetown University Medical Center|Paul J. Kim, DPM, Director of Research, MGUH Center for Wound Healing and HBOT|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
318727|NCT01525927|North Shore LIJ Cancer Institute|Jeffrey Revello Sr. Administrative Manager|516 734 7629|jrevello@nshs.edu|
318728|NCT01520714|The Heart Hospital Baylor Plano|Research Manager|469-814-4712|natalie.settele@baylorhealth.edu|
318729|NCT01507233|University of Miama/Jackson Memorial Hospital|Keith Candiotti, MD|305-585-5332|info@jhsmiami.org|
318730|NCT01516034|Dr David Friedman Laser & Skin Center|David J. Friedman, Principal Investigator|+972-2-5635673|drfriedmanlaser@gmail.com|
318731|NCT01500772|Debiopharm International S.A.|Vice President, Clinical Research and Development|4121 321 01 11|info-international@debiopharm.com|
318732|NCT01517763|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAPtrial@fphcare.co.nz|
318733|NCT01507584|ucsdmed|Eunice Williams-Steppe|8588221133|emwilliamssteppe@ucsd.edu|
318734|NCT01510756|University of California, San Diego|Thomas Kipps, MD|(858) 534-5400|tkipps@ucsd.edu|
318735|NCT01511081|UT MD Anderson Cancer Center|Joe Chang, MD/Professor, Radiation Oncology Department|713-792-7734|CR_Study_Registration@mdanderson.org|
318736|NCT01500109|Loma Linda University|Chelan Nour, MD|909-558-8493|cnour@llu.edu|
318737|NCT01509053|Otsuka Pharmaceutical Development & Commercialization, Inc.|Medical Affairs|800-562-3974||
318738|NCT01495988|The Emmes Corporation|Damon Collie|301-251-1161|dcollie@emmes.com|
318739|NCT01498991|AMES Technology Inc.|Paul Cordo|15039706129|pcordo@amesdevices.com|
318740|NCT01497171|Mayo Clinic|Dr. Emanuel C. Trabuco|507-284-7519|trabuco.emanuel@mayo.edu|
318741|NCT01483872|UCSD|Saima Aslam|858 657 7463|saslam@ucsd.edu|
318742|NCT01487499|University of Florida|Michael A. Jantz, MD|352-273-8737|michael.jantz@medicine.ufl.edu|
318743|NCT01478113|Massachusetts General Hospital|Maren Nyer|617-643-4897|mnyer@partners.org|
318744|NCT01483209|Duke University Medical Center|Dr. Cynthia Shortell|919-681-2223|cynthia.shortell@duke.edu|
318745|NCT01484314|Brigham and Womens Hospital/ Dana Farber Cancer Institute|Dr. Nancy Berliner|617-732-5840|nberliner@parnes.org|
318746|NCT01482598|Abbott|Alessandra Denaro, Sr. Director Clinical Site Management||alessandra.denaro@abbott.com|
318747|NCT01479010|Virginia Commonwealth University|Benjamin Van Tassell, PharmD|8048284583|bvantassell@vcu.edu|
318748|NCT01482325|GE Healthcare|Global Research Manager|414 721 2423|Jeffrey.Conner@ge.com|
318749|NCT01477177|Mayo Clinic|Herbert C. Wolfsen, M.D.|904-953-6319|Wolfsen.Herbert@mayo.edu|
318750|NCT01473732|Montefiore Medical Center|Dr. Enver Akalin, Medical Director Kidney Transplant|718-920-4815|eakalin@montefiore.org|
318751|NCT01472692|UCSD|Department of Medicine|(858) 552-8585||
318752|NCT01465230|Yale University|Dr. Terri Parker|203-737-5312|terri.parker@yale.edu|
318753|NCT01464723|University of California San Diego Shiley Eye Center|Dr. Stuart Brown|(858) 822-2585858-246-0814|sibrown@ucsd.edu|
293721|NCT01509547|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
293722|NCT01509586|Medical University of South Carolina|Dr. Matthew J. Carpenter|843-876-2436|carpente@musc.edu|
293723|NCT01509612|Medical University of Vienna|Michael Frass, MD|+436645453040|office@ordination-frass.at|
293724|NCT01509625|Hospital Clínico San Cecilio Granada|Dr Isabel Blancas|+34 958023498|blancaslb@hotmail.com|
318754|NCT01446250|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
293725|NCT01509638|Cleveland Clinic Florida|Marylise Boutrous, MD|954-659-5000|canedoj@ccf.org|
293726|NCT01509664|New York Obesity Nutrition Research Center|Dr Allan Geliebter|212-523-4184|ag58@columbia.edu|
318755|NCT01463293|Fonterra Research Centre|Dr James Dekker|+64 6 350 6323|james.dekker@fonterra.com|
318756|NCT01457053|University of Cincinnati Medical Center|Dr. Myron C. Gerson/Professor of Medicine|5135583074|myron.gerson@uc.edu|
318757|NCT01451723|Louisiana Health Sciences Center-New Orleans|Jesus Lovera MD|50-903 9302|jlover@lsuhsc.edu|
318758|NCT01452854|UCSF|Dr. Mitchell Rosen|415-353-7394|thomas.remble@ucsfmedctr.org|
318759|NCT01440517|GE Healthcare|Arnold Jacobson, M.D.|1-609-514-6325|Arnold.Jacobson@ge.com|
318760|NCT01440595|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
318761|NCT01446796|Duke University Medical Center|Michel Khouri, MD|919 684 8111|michel.khouri@duke.edu|
318762|NCT01443923|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
318763|NCT01439347|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@appirx.com|
318764|NCT01440452|Johns Hopkins Hospital|Daniel Becker|4108284629|db@inirehab.com|
318765|NCT01433471|NYU Langone Medical Center|Martin Wolff|(646) 329-7259|martin.wolff@nyumc.org|
318766|NCT01436084|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Professor, Leukemia|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
318767|NCT01434511|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
318768|NCT01426555|VA Boston Healthcare System|Dr. Antonio Lazzari|857-364-6381|antonio.lazzari@va.gov|
318769|NCT01434745|Washington State University|Dr. jean-Baptiste Roullet|5093587666|j.roullet@wsu.edu|
318770|NCT01415986|Roswell Park Cancer Institute|Gal Shafirstein, D.Sc.|716-845-4025|Gal.Shafirstein@RoswellPark.org|
318771|NCT01410799|University of Pennsylvania|Dr. Anne Cappola|215-573-5359|acappola@upenn.edu|
318772|NCT01426113|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
318773|NCT01426516|Genomind|Dr. Rachel Scott|267-989-3435|rscott@genomind.com|
318774|NCT01420965|Georgetown University|Dr. Samir Khleif|(202) 687-0100|snk48@georgetown.edu|
318775|NCT01417377|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
318776|NCT01416272|Bausch & Lomb / Valeant Pharmaceuticals|Robert Steffen, OD, MS|585-338-6399|robert.steffen@bausch.com|
318777|NCT01414166|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
318778|NCT01406860|University of Iowa Hospitals and Clinics|Brett Faine|3193108067|brett-faine@uiowa.edu|
318779|NCT01401049|NYU School of Medicine|Mitchell Lee, MD|212.263.5071|mitchell.lee@nyumc.org|
318780|NCT01408641|FDA|Bernard Fischer, M.D.|240-402-4511|Bernard.Fischer@fda.hhs.gov|
318781|NCT01409031|University of Colorado, Denver|John Kinsella, MD|303-724-2853|John.Kinsella@ucdenver.edu|
318782|NCT01402531|UCSD|Department of Surgery|(858) 657-5291||
318783|NCT01394926|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6820|Paulsherwin@ge.com|
293727|NCT01509677|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
318784|NCT01383681|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
318785|NCT01403194|Mayo Clinic|Dr. Seema Kumar|507-538-2724|kumar.seema@mayo.edu|
318786|NCT01397552|Upstate Medical University|William Lavelle|315-464-4472|lavellew@upstate.edu|
318787|NCT01392170|University of Texas (UT) MD Anderson Cancer Center|Alfonso Quintas-Cardama, MD/Professor, Leukemia|713-745-4009|CR_Study_Registration@mdanderson.org|
318788|NCT01389817|Medical College of Wisconsin|Harry T. Whelan M.D.|414-266-3466|hwhelan@mcw.edu|
318789|NCT01397695|UCSD|Research Compliance and Integrity|(858) 822-4939|ctgov@ucsd.edu|
318790|NCT01390181|Grand Traverse Heart Associates|Anna Booher|231 935-5800|annabooher3@gmail.com|
318791|NCT01385033|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
318792|NCT01394211|University of Arizona Cancer Center|Program Coordinator|5206260301|aselegue@email.arizona.edu|
318793|NCT01388920|Theratechnologies|Senior Medical Advisor|514-336-7800|jmamputu@theratech.com|
318794|NCT01377441|NYU School of Medicine|Lisa Doan, MD|212.263.5072|lisa.doan@nyumc.org|
318795|NCT01383447|Johns Hopkins Sidney Kimmel Cancer Center|Dr. Patrick Brown|410-614-4915|pbrown2@jhmi.edu|
318796|NCT01372618|NYU Langone|David Kleinberg|646 501 7504|david.kleinberg@nyumc.org|
318797|NCT01385280|University of Arizona Cancer Center|Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
318798|NCT01379274|Rush University Medical Center|Dr. Jamile Shammo|312-CANCER-1|jamile_shammo@rush.edu|
318799|NCT01379469|Washington University School of Medicine|David Rudnick MD, PhD- Associate Professor|314-286-2832|rudnick_d@wustl.edu|
318800|NCT01369641|Thomas Jefferson University|David Cognetti, MD|215-955-6670|David.Cognetti@jefferson.edu|
318801|NCT01365156|UT MD Anderson Cancer Center|Michael Frumovitz,Professor, Gyn Onc & Reproductive Med|(713) 792-9599|mfrumovitz@mdanderson.org|
318802|NCT01359254|The University of Chicago Medicine|Andrew Artz, MD, MS|(773) 834-8980|aartz@medicine.bsd.uchicago.edu|
318803|NCT01347632|CONRAD|Andrea Thurman|757-446-7444|thurmaar@evms.edu|
271724|NCT00260533|University of California San Diego|Murray B. Stein MD, MPH|858-534-6400|mstein@ucsd.edu|
318804|NCT01356667|UCLA, Integrated Substance Abuse Programs|Dr. Daniel Dickerson|562-277-0310|daniel.dickerson@ucla.edu|
318805|NCT01354951|Memorial Sloan Kettering Cancer Center|Dr. Michael Zelefsky, MD|212-639-6802|zelefskm@mskcc.org|
318806|NCT01350232|Thomas Jefferson University|Joanne Filicko-O'Hara, MD|215-955-8874|jef001@jefferson.edu|
293728|NCT01509807|University of South Florida|Jorge Marcet, MD|813-844-4545|jmarcet@health.usf.edu|
293729|NCT01509846|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
318807|NCT01350583|H. Lee Moffitt Cancer Center and Research Institute|Robert J. Gillies, Ph.D. - Principal Investigator|813-745-8355|robert.gillies@moffitt.org|
318808|NCT01352416|William Beaumont Hospital|Ilana Kutinsky, DO|248-267-5050|ikutinsky@beaumont.edu|
318809|NCT01350258|Thomas Jefferson University|Dolores Grosso, CRNP, DNP|215-955-8874|Dolores.Grosso@jefferson.edu|
318810|NCT01349595|Mayo Clinic|Dr. Mark Stegall|507-266-2812|Stegall.Mark@mayo.edu|
318811|NCT01337609|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-2513|mfava@partners.org|
318812|NCT01347840|Ethicon Endo-Surgery, Inc.|Amy Mahanes|513-337-8366|amahanes@its.jnj.com|
293730|NCT01509872|Queen's University Belfast|Dr Paul O'Callaghan|+44 7501 43 46 32|pocallaghan02@qub.ac.uk|
318813|NCT01340573|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
318814|NCT01335997|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
318815|NCT01340885|Oregon Health & Science University|Diana Dimitrova|503-494-7269|dimitrov@ohsu.edu|
318816|NCT01341587|University of Maryland Baltimore|Charlene C. Quinn|4107062406|cquinn@som.umaryland.edu|
318817|NCT01334606|BD Medical - Diabetes Care|Laurence J. Hirsch. Medical Director|201-847-6513|laurence_hirsch@bd.com|
318818|NCT01326923|LSU Health Shreveport|J.K. Miller|318 8131406|jmil12@lsuhsc.edu|
318819|NCT01332799|University of Iowa|Dr. Roberto Kalil|319-355-6564|roberto-kalil@uiowa.edu|
318820|NCT01329549|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
318821|NCT01326845|Novartis Pharmaceuticals|Study Director|862-778-8300||
318822|NCT01329341|James A Haley Veterans Hospital|Stephanie McGovern|813-558-3964|stephanie.mcgovern@va.gov|
293731|NCT01509950|Stanford University|Research Operations Manager|6507255720|agirsen@stanford.edu|
318823|NCT01319760|Columbia Presbytarian Hospital, NY|Dr. Ajay Kirtane|212-305-7060|akirtane@columbia.edu|
318824|NCT01320683|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
318825|NCT01313273|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
318826|NCT01321008|University of Texas MD Anderson Cancer Center|Bouthaina Dabaja, MD / Associate Professor, Radiation Oncology|713-563-2300|CR_Study_Registration@mdanderson.org|
318827|NCT01310803|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
318828|NCT01309581|Mount Sinai School of Medicine|James Murrough|212 241 7574|James.Murrough@mssm.edu|
318829|NCT01315873|New York University School of Medicine|Michael Grossbard, MD|646 501 9305|Michael.Grossbard@nyumc.org|
318830|NCT01313923|UC Irvine Dermatology Research Center|Sergei A. Grando, MD, PhD, DSc|9498242713|sgrando@uci.edu|
318831|NCT01321697|University of Arkansas for Medical Sciences|Sandy Annis|5016868274|amannis@uams.edu|
318832|NCT01312428|Stryker Orthopedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
318833|NCT01313416|Georgetown University|Dr. Samir Khleif|(202) 687-0100|snk48@georgetown.edu|
318834|NCT01303003|Steward St. Elizabeth's Medical Center|Meghan Cashman, IRB Manager|617-789-2804|meghan.cashman@steward.org|2804
318835|NCT01302444|Rhode Island Hospital|James R Klinger, MD||jklinger@lifespan.org|
318836|NCT01301963|CCCC|Hien Duong, MD|216-445-5531|duongh@ccf.org|
293732|NCT01510028|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
318837|NCT01298921|Geisinger Health System|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
318838|NCT01292070|Tunitas Therapeutics|Nolan Sigal, MD, PhD, CEO, Tunitas Therapeutics|(650) 887-4747|nsigal@tunitastherapeutics.com|
318839|NCT01292265|UCB, Inc.|Study Director|+1 887 822 9493||
318840|NCT01290822|Columbia University|Henry M. Spotnitz, MD|(212) 305-6191|hms2@columbia.edu|
318841|NCT01290718|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
318842|NCT01293123|University of California, San Diego|Scott Letendre, Principal Investigator|6195438080|sletendre@ucsd.edu|
318843|NCT01294046|Cleveland Clinic|Kathryn O'Connor||oconnok@ccf.org|
318844|NCT01280643|Fox Chase Cancer Center|Dr. Crystal Denlinger|215-214-1676|crystal.denlinger@fccc.edu|
318845|NCT01281124|The Ohio State University Comprehensive Cancer Center|Greg Otterson|614-293-2887|Greg.Otterson@osumc.edu|
318846|NCT01272141|Emory University School of Medicine|William Read, MD|1-888-946-7447|william.l.read@emory.edu|
271725|NCT00260689|NHLBI, NIH|Danielle Townsley MD|301-402-3477|townsleydm@nhlbi.nih.gov|
318847|NCT01282216|Johns Hopkins University|Rich Ambinder, MD|4109558839|rambind1@jhmi.edu|
305823|NCT02362048|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
318848|NCT01284491|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
318849|NCT01284504|Stanford University|Anthony Doufas, MD, PhD|1-650-498-7699|agdoufas@stanford.edu|
318850|NCT01269034|Albert Einstein College of Medicine|Roger Hicks, Administrative Director for Research - Department of Pediatrics|718-920-7386|roger.hicks@einsteinmed.org|
318851|NCT01274533|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
318852|NCT01279616|Nationwide Children's Hospital|Kristy Ott|614-722-6313|kristy.ott@nationwidechildrens.org|
318853|NCT01276054|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|victoria.soto@med.usc.edu|
318854|NCT01264965|University of Chicago|Theodore Karrison|773-702-9326|karr@health.bsd.uchicago.edu|
305824|NCT02362191|University of North Carolina at Chapel Hill|David Rubinow, MD|919-445-0220|drubinow@med.unc.edu|
293733|NCT01510145|Alcon Research, Ltd|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
293734|NCT01510158|Ardea Biosciences, MD|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
318855|NCT01266824|Children's Hospital of Philadelphia|Dr. Amy Cohen|215-590-1000|cohenam@email.chop.edu|
293735|NCT01510327|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
293736|NCT01510379|The Ohio State University|Kyle A. Perry, MD|614-293-5815|kyle.perry@osumc.edu|
293737|NCT01510457|Rehabilitation Institute of Chicago Center for Pain Studies|Dr. R. Norman Harden|312.238.5654|centerforpainstudies@ric.org|
293738|NCT01510652|Institute of Cardiology, Univ. of Bologna, Bologna, Italy|Prof. Giuseppe Boriani||giuseppe.boriani@unibo.it|
293739|NCT01510704|Acacia Pharma Ltd|Dr Gabriel Fox||gabrielfox@acaciapharma.com|
293740|NCT01510717|Alcon Research, Ltd.|Magda Michna, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
318856|NCT01264835|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
318857|NCT01274429|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
318858|NCT01273064|Conatus Pharmaceuticals Inc.|MiRa Huyghe, Vice President, Clinical Development|(858) 457-7227|mhuyghe@conatuspharma.com|
318859|NCT01274559|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
318860|NCT01270581|Mount Sinai School of Medicine|Dr. Andrea Weintraub|212-241-6186|andrea.weintraub@mssm.edu|
318861|NCT01269749|University of Florida|Dr Scott Rivkees|352-273-9001|srivkees@ufl.edu|
318862|NCT01270919|Stryker Orthopedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
318863|NCT01262339|University of Wisconsin- Madison|Dermatology Clinical Trials Administrator|608-287-2640|dbock@dermatology.wisc.edu|
318864|NCT01267825|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
318865|NCT01264679|AMAG Pharmaceuticals, Inc.|Medical Information|+1-877-411-2510|amag@druginfo.com|
318866|NCT01259284|UT MD Anderson Cancer Center|Ara Vaporciyan, MD, BS / Professor||CR_Study_Registration@mdanderson.org|
318867|NCT01249157|Memorial Sloan Kettering|Dr. Maxine Jochelson|646-888-4507|JochelsM@mskcc.org|
318868|NCT01263028|Kaiser Permanente|John J. Sim, MD||john.j.sim@kp.org|
318869|NCT01256281|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Glassberg|(212) 824-8056|jeffrey.glassberg@mountsinai.org|
318870|NCT01253668|Merck|Dr. Stephen Keefe|215-220-9693|stephen.keefe@merck.com|
318871|NCT01259024|Washington University|Patricia Nieters, RN, BSN, Clinical Research Specialist|314-362-3371|nietersp@wustl.edu|
318872|NCT01251952|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kadhimi, M.D.|(313) 576-8022|alkadhiz@karmanos.org|
318873|NCT01251120|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
318874|NCT01248130|Massachusetts General Hospital|Gagan Joshi, MD|617-726-4651|lkfeinberg@mgh.harvard.edu|
318875|NCT01243892|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
318876|NCT01246011|Massachusetts General Hospital|Anne Philip, Data Manager|617 726 0423|alphilip@partners.org|
318877|NCT01242020|Associate Dean for Clinical and Translational Research, College of Physicians and Surgeons|Muredach P. Reilly, MBBCh, MSCE|212-305-9453|mpr2144@cumc.columbia.edu|
318878|NCT01244620|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
318879|NCT01240304|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
318880|NCT01241279|Valeant Pharmaceuticals/Bausch & Lomb|Johnson Varughese|908-927-1162|Johnson.Varughese@valeant.com|
318881|NCT01230788|Emory University|Dr. Todd Cooper|404-785-3000|tmcoope@emory.edu|
318882|NCT01239680|Truman Medical Center|Charles W. Van Way, III, M.D.|816.235.2553|vanwayc@umkc.edu|
318883|NCT01237613|Orthopedic Foot and Ankle Center|Terrence M. Philbin, DO|614-895-8747|ofacresearch@orthofootankle.com|111
318884|NCT01234103|University of California, San Francisco|Cherrie B. Boyer, PhD|4154762184|Cherrie.Boyer@ucsf.edu|
318885|NCT01231750|University of Cincinnati|Dr. Faisal Khan|513-558-4272|faisal.khan@uc.edu|
318886|NCT01230307|University of Michigan|Barry Bleske|734-763-3232|bbleske@umich.edu|
318887|NCT01230489|University of Missouri-Columbia|Harold Moore|5738824433|mooreh@health.missouri.edu|
318888|NCT01222871|SEMC|Dr. Peter catalano|1-617-789-5004|peter.catalano@steward.org|
318889|NCT01219673|University of Texas (UT) MD Anderson Cancer Center|Dr. David Rosenthal Professor, Radiation Oncology Department|713-792-7734|CR_Study_Registration@mdanderson.org|
318890|NCT01223001|The Rehabilitation Hospital of Indiana|Dr. Lance Trexler|(317)879-8940|lance.trexler@rhin.com|
318891|NCT01217060|UT MD Anderson Cancer Center|Steven H. Lin, Associate Professor, Radiation Oncology Department|(713) 563-8490|shlin@mdanderson.org|
318892|NCT01217047|Kennedy Krieger Institute|Daniel Becker, M.D.|888-923-9222|dbecke13@jhu.edu|
318893|NCT01206101|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
318894|NCT01216631|University of Leeds|Professor Philip Conaghan|+44 113 3924884|p.conaghan@leeds.ac.uk|
318895|NCT01211756|UCSD|David Feifel||dfeifel@kadimanp.com|
318896|NCT01209520|University of Miami|Ikechukwu Akunyili MD|305-243-6626|IAkunyili@med.miami.edu|
318897|NCT01207726|SKCCC|Charlie Rudin, MD|646.888.4527|rudinc@mskcc.org|
318898|NCT01206296|MedStar Health Research Institute|Director of Clinical Trials|301-560-7300|Research@MedStar.Net|
318899|NCT01207102|Duke University Medical Center|Dr Kimberly Blackwell|919-6681748|black034@mc.duke.edu|
318900|NCT01213329|Northwestern University|Dr. Lorenzo Gallon|312-695-8900|l-gallon@northwestern.edu|
318901|NCT01202110|Cedars-Sinai|Leah Silbert|310 423-3783|Leah.Silbert@cshs.org|
318902|NCT01206439|University of Cincinnati|Jack Rubinstein|513-558-3062|rubinsjk@ucmail.uc.edu|
318903|NCT01204788|University of Texas (UT) MD Anderson Cancer Center|Emil Freireich, MD, Professor, Department of Medical Education|713-745-2723|CR_Study_Registration@mdanderson.org|
293741|NCT01510769|Ardea Biosciences, Inc.|Maple Fung, MD|1-858-652-6671|mfung@ardeabio.com|
293742|NCT01510834|Pacific Health Research and Education Institute|Laurel King, PhD|808-564-5711|laurel.king@va.gov|
293743|NCT01510912|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
305825|NCT02362269|University of Wisconsin|Dr. Corinne D. Engleman|(608) 265-5491|cengelman@wisc.edu|
318904|NCT01200602|Mayo Clinic|Vilmarie Rodriguez, MD|507-284-2695|rodriguez.vilmarie@mayo.edu|
318905|NCT01198548|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
318906|NCT01194908|Emory University School of Medicine|Ruth O'Regan, MD|404-778-4824|roregan@emory.edu|
318907|NCT01194856|Cleveland Clinic|Marisa Tungsiripat|2164442037|tungsim@ccf.org|
318908|NCT01194427|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
318909|NCT01193556|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
318910|NCT01189435|Memorial Sloan Kettering Cancer Center|Dr. Gregory Riely|646-888-4199|rielyg@mskcc.org|
318911|NCT01193530|The University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO/Associate Professor, Palliative Care Medicine|713-792-6085|rdev@mdanderson.org|
318912|NCT01182610|Accelerated Community Oncology Research Network, Inc.|Vice Presidnet of Scientific Affairs||mwalker@acorncro.com|
318913|NCT01189071|University of Missouri-Columbia|Dr. Mark Wakefield|573-882-0496|wakefieldmr@health.nissouri.edu|
318914|NCT01183416|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
318915|NCT01184456|AIDS Healthcare Foundation - Public Health Division|Adam Sukhija-Cohen|(323) 436-8900|adam.cohen@aidshealth.org|
318916|NCT01183221|Icahn School of Medicine at Mount Sinai|Dr. Alexander Kolevzon|(212) 659-8762|alexander.kolevzon@mssm.edu|
318917|NCT01189227|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
318918|NCT01190306|Topcon Medical Systems|Robert Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
318919|NCT01179737|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
318920|NCT01183468|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
318921|NCT01181921|Jan-Cil Spain|COUNTRY MEDICAL DIRECTOR|+34 91 7228043||
318922|NCT01188798|St. Jude Children's Research Hospital|Asha Pillai, MD|1-866-278-5833|info@stjude.org|
318923|NCT01174368|The Rogosin Institute|Angelica Nazarian|212-746-1551||
318924|NCT01183897|Memorial Sloan Kettering Cancer Center|Brian Kushner MD|212-639-6793|kushnerb@mskcc.org|
318925|NCT01183884|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
318926|NCT01183429|Memorial Sloan Kettering Cancer Center|Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
318927|NCT01166178|Novartis|Study Director|41 61 324 1111||
318928|NCT01176513|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|Paul.Gordon@ge.com|
318929|NCT01165450|University of Maryland School of Medicine|Bennie H. Jeng, MD, MS|667-214-1111|bjeng@som.umaryland.edu|
318930|NCT01179399|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
318931|NCT01169753|University of Texas (UT) MD Anderson Cancer Center|Carmen Escalante, MD / Chair, General Internal Medicine||CR_Study_Registration@mdanderson.org|
318932|NCT01171534|University of Missouri, Department of Orthopaedic Surgery|Gregory J. Della Rocca, MD, PhD, FACS|573-882-6562|dellaroccag@health.missouri.edu|
318933|NCT01169610|Mayo Clinic|Mark A. Frye, MD|507-255-9391|mfrye@mayo.edu|
318934|NCT01155388|AMAG Pharmaceuticals, Inc.|Medical Information|+1-877-411-2510|amag@druginfo.com|
318935|NCT01163084|UT MD Anderson Cancer Center|Logothetis, Christopher, M.D. / Genitourinary Medical Oncology|7137922830|clogothe@mdanderson.org|
318936|NCT01166724|Cleveland Clinic|Dr. Stuart Flechner|216 445-5772|FLECHNS@ccf.org|
318937|NCT01155375|AMAG Pharmaceuticals, Inc.|Medical Information|+1-877-411-2510|amag@druginfo.com|
318938|NCT01162382|Washington University School of Medicine|Kathy Pierce|314-362-5626|jenkerson_m@wustl.edu|
318939|NCT01157533|The University of Texas (UT) MD Anderson Cancer Center|Ara Vaporciyan, MD, BS/ Professor||CR_Study_Registration@mdanderson.org|
318940|NCT01162304|University of Rochester|Joel Kent, MD|585-273-2972|joel_kent@urmc.rochester.edu|
318941|NCT01151904|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
318942|NCT01155518|suny buffalo|sandeep dhindsa||sandhindsa@yahoo.com|
318943|NCT01150409|The Cleveland Clinic Foundation|Jorge Guzman MD|216-445-5765|guzmanj@ccf.org|
318944|NCT01151553|Emory University|Dr. Heather Bloom|404-321-6111|heather.bloom@emory.edu|6391
318945|NCT01148056|Mass General Hospital Cancer Center|Maria Kempner|508.533.4132|mkempner@partners.org|
318946|NCT01147393|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
318947|NCT01147042|NIH CC|Dr. John Gallin|301-827-5428|jgallin@cc.nih.gov|
318948|NCT01147536|Agenus Inc.|Agenus, Inc. Clinical Trial Information|781-674-4265|clinicaltrialinfo@Agenusbio.com|
318949|NCT01139996|Memorial University Medical Center|Imran Siddiqui, MD|912-350-8707|research2@memorialhealth.com|
318950|NCT01133288|Kennedy Krieger Institute|Eric Levey, M.D.|443-923-9148|levey@kennedykrieger.org|
318951|NCT01142128|University of Florida|Phillip Toskes, M.D.|352-273-9493|phillip.toskes@medicine.ufl.edu|
318952|NCT01131884|University of Rochester|K.Rao Poduri, M.D., Chair of Physical Medicine & Rehab|585-275-6978|kr_poduri@urmc.rochester.edu|
293744|NCT01511016|Baylor College of Medicine|Leanne Scott, PhD, Director of Sponsored Programs|713-798-6978|lbscott@bcm.edu|
293745|NCT01511055|Mayo Clinic|Sean C. Dowdy, M.D.|507-266-0225|Dowdy.Sean@mayo.edu|
293746|NCT01511068|Cincinnati Children's Hospital Medical Center|Dr. Bruce Trapnell|513636-6361|Bruce.Trapnell@cchmc.org|
293747|NCT01511107|Children's Hospital of Pittsburgh of UPMC|Dr. Alejandro Hoberman|412-692-5249|hobermana@upmc.edu|
318953|NCT01128114|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
318954|NCT01126879|Northwestern University|William Catalona, MD|312-695-1301|WCatalona@nm.org|
293748|NCT01511250|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305826|NCT02362282|North Florida/South Georgia Gainesville VA Medical Center|Janis J Daly, Ph.D., Director Brain Rehabilitation Research Center|352-548-6000|Janis.Daly@va.gov|6603
318955|NCT01136811|University of Chicago|Shirley Rodriguez|773-834-4337|srodrigu@surgery.bsd.uchicago.edu|
318956|NCT01139294|Vanderbilt University Medical Center|Thomas Abramo, MD||tjabramo@uams.edu|
318957|NCT01139125|Georgia Regents University|Peter F. Buckley, MD|706-721-2231|PBuckley@gru.edu|
318958|NCT01136668|Hospital for Sick Children|Dr. Jason Hayes|416-813-7445|jason.hayes@sickkids.ca|
318959|NCT01133639|Mount Auburn|Emily Cook|(617) 354-3131|ecook@mah.harvard.edu|
318960|NCT01131455|ColumbiaOG|Vicki L Jones, Research Coordinator|573-443-2402|v.jones@columbiaorthogroup.com|4391
318961|NCT01126801|Brigham & Women's Hospital|Dr. Hadine Joffe|617-732-4906|hjoffe@partners.org|
318962|NCT01123850|Zimmer|Laura Herdrich|952-830-6224|laura.herdrich@zimmer.com|
318963|NCT01126957|University of Missouri-Columbia|Dr. David Henry|573/884-2582|henryda@missouri.edu|
318964|NCT01127503|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
318965|NCT01122511|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
318966|NCT01118013|Blood and Marrow Transplant Group of Georgia|Asad Bashey, MD, PhD||abashey@bmtga.com|
318967|NCT01122381|Vetarans Administration Pittsburgh Healthcare System|Kathy Gardner MD|(412) 360-6185|kathy.gardner@va.gov|
318968|NCT01116232|Barbara Ann Karmanos Cancer Institute|Zaid Al-Kadhimi, M.D.|404-778-5984|zalkadh@emory.edu|
318969|NCT01110174|PI has left the institution, all efforts to locate PI have been exhausted.|PI has left the institution, all efforts to locate PI have been exhausted.||steve.martinez@ucdmc.ucdavis.edu|
318970|NCT01115699|Mayo Clinic|Michelle Skime, Supervisor - Senior Clinical Research Coordinator|507-255-0501|skime.michelle@mayo.edu|
318971|NCT01108666|University of Pennsylvania|Dr. Abigail Berman|215-615-3659|Abigail.Berman@uphs.upenn.edu|
318972|NCT01115244|Vanderbilt University Medical Center|Mary Beth Cole|(615) 322-6485||
318973|NCT01108523|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
318974|NCT01107795|University of Alabama at Birmingham|Dr. Kirk Withrow|(205) 801-7874|kwithrow@uabmc.edu|
318975|NCT01106534|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
318976|NCT01104116|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
318977|NCT01100658|Masonic Cancer Center, University of Minnesota|Alicia Kunin-Batson|612-624-6931|kunin003@umn.edu|
318978|NCT01103180|University of Chicago|Dr. Emil Coccaro|773-834-4083|ecoccaro@yoda.bsd.uchicago.edu|
318979|NCT01090141|Unknown|Tawanda Gumbo||Unknown@utsouthwestern.edu|
318980|NCT01102140|University of Michigan|Dr. Jennifer Cowger|7345464911|jennifercowger@gmail.com|
318981|NCT01095250|Novartis Pharmaceuticals|Study Director|862-778-8300||
318982|NCT01094561|Columbia University|Elizabeth Hecht, MD|(212)305-6510|eh2560@cumc.columbia.edu|
318983|NCT01093846|Novartis Pharmaceuticals|Study Director|862-778-8300||
318984|NCT01078844|Johns Hopkins University School of Medicine|Eric Samstad, MD|410-550-0171|esamsta1@jhmi.edu|
318985|NCT01081886|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
318986|NCT01085643|Cedars-Sinai Medical Center|Edy Soffer, MD|(310) 423-6143|edy.soffer@cshs.org|
318987|NCT01083472|LifeCell|Sandra VanGuldener|310612504695|svanguldener@lifecell.com|
318988|NCT01080768|Novartis Pharmaceuticals|Study Director|862-778-8300||
318989|NCT01079598|Medtronic|Stephanie Brucato, Principal Clinical Research Specialist|508-261-8000|stephanie.m.brucato@medtronic.com|
318990|NCT01074502|UNC Chapel Hill|Aida Lugo-Somolinos MD-PI|919-843-9447|alugosom@med.unc.edu|
318991|NCT01074437|Seattle childrens research institute|Jonathan Perkins, Prinicipal Investigator|206-987-1927|jonathan.perkins@seattlechildrens.org|
318992|NCT01069861|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
318993|NCT01072526|University of Missouri|Lenworth Johnson, MD|573-882-8473|JohnsonLN@health.missouri.edu|
318994|NCT01071993|University of Oklahoma|Mazen Abu-Fadel, MD|405-271-4742|mazen-abufadel@ouhsc.edu|
318995|NCT01065051|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
318996|NCT01069120|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
318997|NCT01066637|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
318998|NCT01058642|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
318999|NCT01065818|Columbia University|K.S. Clifford Chao, MD|212-305-9987|ksc2119@cumc.columbia.edu|
319000|NCT01051921|Conatus Pharmaceuticals Inc.|Vice President, Clinical Development|(858) 457- 7227|MHuyghe@conatuspharma.com|
319001|NCT01048125|University of Missouri-Columbia|Dr. Anand Chockalingam|573/882-2296|chockalingama@health.missouri.edu|
319002|NCT01056315|Grünenthal|Study Director|+49 (0)-241-569-3223|clinical-trials@grunenthal.com|
319003|NCT01058369|Universitätsklinikum Erlangen, Medizinische Klinik 5|Prof. Dr. med. Stefan Krause||stefan.krause@uk-erlangen.de|
319004|NCT01048723|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Zager, M.D.|813-745-1085|jonathan.zager@moffitt.org|
319005|NCT01053221|University of Wisconsin-Madison|William Burlingham, PhD|6082630119|burlingham@surgery.wisc.edu|
319006|NCT01038752|Optimum Therapeutics|Dr. M. Guillaume Wientjes||gwientjes@optimumtx.com|
319007|NCT01050218|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
319008|NCT01045694|University of Missouri-Columbia|Stephen Colbert|573-882-2275|colberts@health.missouri.edu|
319009|NCT01035944|HemCon Medical Technolgoies|Dr. Jody Oyama|503.245.0459|jody.oyama@hemcon.com|
271726|NCT00260832|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
293749|NCT01511315|UCSF Psoriasis Center|Mio Nakamura, MD|4154764701|mio.nakamura@ucsf.edu|
319010|NCT01031628|SARC|Research Project Manager|(734) 930-7600|sarc@sarctrials.org|
319011|NCT01030757|University of New Mexico|Ben Liem, MD|505-272-0086|bliem@salud.unm.edu|
319012|NCT01035073|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
319013|NCT01031550|UMDNJ|Yuriy Gubenko, MD|973 972-5007|yuriygubenko@yahoo.com|
319014|NCT01030198|Cynosure, Inc.|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
319015|NCT01028300|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
319016|NCT01025271|University of Pittsburgh|Karin Byers, MD|412-648-6553|dlp5@pitt.edu|
319017|NCT01022398|Creighton University|Cardiology Research Manager|402-280-4566|tammyburns@creighton.edu|
319018|NCT01019980|Novartis Pharmaceuticals|Study Director|862-778-8300||
319019|NCT01025492|University of Utah|Scott Low|801-585-1380|scott.low@hsc.utah.edu|
319020|NCT01017263|Duke UMC|Scott Kollins, PhD|9196810014|scott.kollins@dm.duke.edu|
319021|NCT01020903|Staten Island University Hospital|Michael Silverberg/Principal Investigator|718-226-6629|msilverberg@siuh.edu|
319022|NCT01023620|UT Southwestern Medical Center|Dr. Michael Limerick|214-590-0611|Michael.Limerick@UTSouthwestern.edu|
319023|NCT01018810|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
319024|NCT01016561|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
319025|NCT01016847|Duke Asthma Allergy and Airway Center|Monica Kraft, M.D.|9194790719|denise.beaver@dm.duke.edu|
319026|NCT01014767|Tufts Medical Center|Research Administration|617-636-1142|mcoughlin@tuftsmedicalcenter.org|
319027|NCT01013701|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
319028|NCT01012414|Thomas Jefferson University|David Whellan MD|215 955 5050|david.whellan@jefferson.edu|
319029|NCT01011634|UCSF|Karen Meckstroth, MD|415 206-8713|meckstrothk@obgyn.ucsf.edu|
319030|NCT01009931|Rutgers Cancer Institute of New Jersey|Tatiana Zelinskaya|(732) 235-9837|zelinsta@cinj.rutgers.edu|
319031|NCT01001390|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|866-966-5934|info@stjude.org|
319032|NCT01006018|Emory University|Mary Rhee, M.D.|404-778-1666|mrhee@emory.edu|
319033|NCT01004510|Rochester General Hospital|Todd Sheppard, MD|585-922-4409|todd.sheppard@rochestergeneral.org|
319034|NCT01005914|Oregon Health & Science University|Dr. Brandon Hayes-Lattin|503-494-1551|hayeslat@ohsu.edu|
319035|NCT00996333|Columbia University|Paul Oberstein|212-305-0592|po2178@cumc.columbia.edu|
319036|NCT00998738|Mayo Clinic|Dr. Charles Loprinzi|507-266-6247|cloprinzi@mayo.edu|
319037|NCT00996502|Columbia University|CU PRS Administrator|212-342-1643|ClinicalTrialsGov@cumc.columbia.edu|
319038|NCT00997386|University of Arizona Cancer Center|Program Coordinator|52-626-0301|aselegue@email.arizona.edu|
319039|NCT00985738|University of Colorado Hospital|Dr. Al Baha Barqawi|303-724-2722|AL.BARQAWI@UCDENVER.EDU|
319040|NCT00986999|University of Hawaii|Cecilia M. Shikuma M.D.|808 692-1328|shikuma@hawaii.edu|
319041|NCT00989937|UCSD|David Feifel||dfeifel@kadimanp.com|
319042|NCT00986947|Johns Hopkins University School of Medicine|Andrew Singer, MD|410-550-6484|registerclinicaltrials@jhmi.edu|
319043|NCT00982995|University of Michgan Comprehensive Cancer Center|Susan Urba|734-615-4762|surba@umich.edu|
319044|NCT00984490|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
319045|NCT00986310|University of California, Davis|Lisa Bateman, MD, FRCPC||lb2863@cumc.columbia.edu|
319046|NCT00978874|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
319047|NCT00983645|Loma Linda University Medical Center Transplantation Institute|Dr. Pedro Baron|909-558-3636|pbaron@llu.edu|36792
319048|NCT00979147|Minneapolis VAMC|Terence Gioe M.D.|612-467-1780|tjgioe@gmail.com|
319049|NCT00967447|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
319050|NCT00970606|Vanderbilt University Medical Center|Gordon R. Bernard, MD, Associate Vice Chancellor for Research|615-343-0077|gordon.bernard@vanderbilt.edu|
319051|NCT00979550|University of Kentucky Healthcare|Henry C. Vasconez, MD|8593236328|betsy.fink@uky.edu|
293750|NCT01511419|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
319052|NCT00966992|Washington University School of Medicine|Perry Grigsby, M.D.|314-362-8502|pgrigsby@radonc.wustl.edu|
319053|NCT00981370|Childrens Hospital Los Angeles|Thomas Coates, MD|323-361-2352|tcoates@chla.usc.edu|
293751|NCT01511445|Amedica Corporation|Sonny Bal, MD|(573) 808-4512|SBal@amedica.com|
319054|NCT00975611|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
293752|NCT01511536|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
293753|NCT01511640|University of Kentucky College of Medicine|Joshua Lile, Ph.D., Professor|8593236034|jalile2@uky.edu|
293754|NCT01511809|Ospedale San Raffaele|Dr. Antonella Castagna|00390226437934|castagna.antonella1@hsr.it|
293755|NCT01511939|Arthritis Treatment Center|Manager, Clinical Research Department|301-624-1168|tgillis@arthritistreatmentcenter.com|
305827|NCT02362321|CHU de Québec|Principal Investigator|418-649-0252|michel.prudhomme.chuq@gmail.com|
319055|NCT00978419|Vanderbilt University Medical Center|Burn Unit Director|(615) 322-4590||
319056|NCT00973856|Cleveland Clinic Akron General|Eliot Mostow, MD||emostow@akronderm.com|
319057|NCT00979810|Memorial Sloan Kettering Cancer Center|Michelle Bradbury, MD, PhD|646-888-3373|bradburm@mskcc.org|
319058|NCT00974922|UCHC|Dr. William White|860-679-2104|wwhite@uchc.edu|
319059|NCT00976339|Columbia University|Dr. Katherine Crew|212-305-1732|kd59@cumc.columbia.edu|
319060|NCT00965146|Stryker Orthopaedics®|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
319061|NCT00972023|Barbara Ann Karmanos Cancer Institute|Elaina Gartner|800-527-6266|egartner@seagen.com|
319062|NCT00970736|University of Florida|Karen Hegland|352 359-1830|kwheeler@ufl.edu|
319063|NCT00957827|University of Pennsylvania|Eric Granquist|215 880-7568|eric.granquist@uphs.upenn.edu|
319064|NCT00953329|DukeUMC|Shirley Blalock|919-668-0999|shirley.blalock@duke.edu|
319065|NCT00965055|UCSD|Ori Ben-Yehuda|9179697273|obenyehuda@ucsd.edu|
319066|NCT00962429|Oregon Health and Science University|Diana Dimitrova|503-494-7269|dimitrov@ohsu.edu|
319067|NCT00958893|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
319068|NCT00966654|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
319069|NCT00960154|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
319070|NCT00960752|UT MD Anderson Cancer Center|Michael Davis, PHD., Chair, Melanoma Medical Oncology|713-792-3454|mdavies@mdanderson.org|
319071|NCT00958347|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|ellen.axelson@stryker.com|
319072|NCT00954187|Loma Linda University|Julio Narvaez, MD|9095589408|thamilton@llu.edu|
319073|NCT00953615|Mayo Clinic|Keith D. Lindor, M.D.|507-284-2969|lindor.keith@mayo.edu|
319074|NCT00947284|UCaliforniaSF|Jon Levine MD, PhD|415-476-5108|jon.levine@ucsf.edu|
319075|NCT00957034|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
319076|NCT00949988|UCSD Moores Cancer Center|Kimberly Aguilar, Clinical Trials Manager|858-534-5201|k1aguilar@ucsd.edu|
319077|NCT00948194|University of Colorado Denver|Nick Naughton|303-724-0833|nick.naughton@cuanschutz.edu|
319078|NCT00946985|Ortho-McNeil Janssen Scientific Affairs, LLC|Clinical Project Scientist|609-730-3229||
319079|NCT00950183|OrthoCarolina|Dr. Robert B. Anderonson|704-323-2000|robert.anderson@orthocarolina.com|
319080|NCT00950690|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
319081|NCT00944229|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
319082|NCT00941928|University of Texas MD Anderson Cancer Center|Anna Franklin, MD, Assistant Professor|713-792-3497|rnjackso@mdanderson.org|
319083|NCT00949403|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
319084|NCT00947791|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-6539|james.murrough@mssm.edu|
319085|NCT00947011|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
319086|NCT00943605|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
319087|NCT00942409|University of California, San Diego|Januario E Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
319088|NCT00936585|National Institute of Allergy and Infectious Diseases|Michael Yao, MD|301-594-0593|yaomic@niaid.nih.gov|
319089|NCT00936598|University of Pittsburgh|Professor|412-623-5965|bovbjergdh@upmc.edu|
319090|NCT00920309|Yale University School of Medicine|Dr. Neera Dahl|203-785-4184|neera.dahl@yale.edu|
319091|NCT00935649|PathoLase|David M Harris, PhD, Research Director|510-502-3345|bmcinc@comcast.net|
319092|NCT00934791|Mayo Clinic|Dr. Patrick G. Dean|507-266-6953|dean.patrick2@mayo.edu|
319093|NCT00932152|University of Pittsburgh|Ahmad Tarhini, MD|(412) 648-6578|tarhiniaa@upmc.edu|
319094|NCT00928499|University of California, Irvine|Karen Noblett, MD|714-456-8564|knoblett@uci.edu|
319095|NCT00924807|St. Luke's Roosevelt Hospital Center|Seth Cohen, MD|212-523-7289|secohen@chpnet.org|
319096|NCT00930787|LifeCell|Dr Michael Franz|908094701100|mfranz@lifecell.com|
319097|NCT00929474|St. Jude Medical|Manager of Clinical Studies|818-493-2522|klee3@sjm.com|
319098|NCT00925548|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
319099|NCT00926575|Soligenix, Inc.|Dhara Patel, Clinical Coordinator|609-538-8200|dpatel@soligenix.com|
319100|NCT00911053|Oregon Health and Science University|OHSU IRB|5034948849|irb@ohsu.edu|
319101|NCT00918463|Weill Cornell Medicine|Dr. Peter Martin||pem9019@med.cornell.edu|
319102|NCT00913692|National Institute of Allergy and Infectious Diseases, Laboratory of Infectious Diseases|Jeffrey I. Cohen, MD|(301) 496-5265|jcohen@niaid.nih.gov|
319103|NCT00918645|University of California, Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
319104|NCT00907218|MassGH|Dr. Timothy Wilens|617-724-5226|twilens@partners.org|
319105|NCT00895284|Mayo Clinic|Dr. Rosanne Kho|408-301-5811|kho.rosanne@mayo.edu|
319106|NCT00897910|Barbara Ann Karmanos Cancer Institute|Zaid S. Al-Kadhimi, M.D.|313-576-8022|alkadhiz@karmanos.org|
319107|NCT00901303|Weill Cornell Medicine|Dr. Peter Martin||pem9019@med.cornell.edu|
319108|NCT00906035|Upenn|Emile Mohler, MD|215-573-6606|Emile.Mohler@uphs.upenn.edu|
293756|NCT01511978|Jacobus Pharmaceutical Company, Inc.|Dr. Kathy Aleš, Medical Director|6099217447|kathy.ales@jacobus-pharmaceutical.com|231
293757|NCT01512108|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
293758|NCT01512160|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293759|NCT01512225|Sunnybrook Research Institute|Dr. Elizabeth Asztalos|416-480-6100,|elizabeth.asztalos@sunnybrook.ca|87791
293760|NCT01512251|University of California, San Francisco|Alain Algazi|(415) 353-7552|alain.algazi@ucsf.edu|
293761|NCT01512264|Universtiy of Alabama at Birmingham|Dr. Jerzy P. Szaflarski|205.975.5587|jszaflarski@uabmc.edu|
293762|NCT01512368|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Dr. Daniel Cuevas-Ramos|525554870900|shiverqks@hotmail.com|2407
293763|NCT01512446|Ruhr-Universität Bochum|Johannes Pfeilschifter, MD||Johannes.Pfeilschifter@rub.de|
293764|NCT01512667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305828|NCT02362360|Coloplast|Head of Clinical Operations|0045 49111990|dkcfv@coloplast.com|
305829|NCT02362373|Columbia University|Anne Davis, MD|212-305-4951|ard4@cumc.columbia.edu|
305830|NCT02362412|Astellas Pharma Inc.|Vice-President, Japan-Asia Clinical Development Administration||Astellas.resultsdisclosure@astellas.com|
305831|NCT02362425|National Institute of Nursing|Katherine Meileur Chief, Neuromuscular Symptoms Unit|301-435-1503|meilleurk@mail.nih.gov|
305832|NCT02362503|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
305833|NCT02362594|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
319109|NCT00904423|Stanford Cancer Institute, Stanford University|Mark D Pegram, MD|650-723-5801|mpegram@stanford.edu|
319110|NCT00903396|Mayo Clinic|Michele Halyard, M.D.|4803014567|mhalyard@mayo.edu|
319111|NCT00894790|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319112|NCT00902668|Virginia Commonwealth University|Laurie W. Cuttino, MD|804-828-7232|LCuttino@mcvh-vcu.edu|
319113|NCT00881205|Novartis Pharmaceuticals|Study Director|862-778-8300||
319114|NCT00896025|University of Texas Southwestern Medical Center|William M. Lee, MD|214-645-6111|william.lee@utsouthwestern.edu|
319115|NCT00903006|University of Texas MD Anderson Cancer Center|Ana Gonzalez-Angulo, MD / Associate Professor, Breast Medical Oncology|713-792-2817|CR_Study_Registration@mdanderson.org|
319116|NCT00904189|University of Rochester Medical Center|Steven Swarts|5852755623|christine_huggins@urmc.rochester.edu|
319117|NCT00887315|Department of Health Studies, University of Chicago|Dr. Sang Mee Lee|773-834-6765|slee@health.bsd.uchicago.edu|
319118|NCT00891904|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
319119|NCT00881608|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
319120|NCT00889421|Oregon Health & Science University|Dr. Eric Suhler|503-494-5023|suhlere@ohsu.edu|
319121|NCT00875394|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
319122|NCT00882310|Columbia University|Paul Oberstein, MD|212-305-0592|po2178@cumc.columbia.edu|
293765|NCT01512693|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293766|NCT01512745|Fudan University Shanghai Cancer Center, Shanghai; PLA Cancer Centre, The 81 Hospital of PLA, Nangjing|Co-Director of Clinical Trials|021-64433755|fudanlijin@163.com,qinsk@csco.org.cn|
319123|NCT00880542|University of Calicornia Los Angeles (UCLA)|William Tap, MD|888-798-0719|wtap@mednet.ucla.edu|
319124|NCT00879619|University of California, Irvine|Nicole Macaranas, Clinical Research Specialist|714-456-6550|nicole.macaranas@uci.edu|
319125|NCT00874939|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
319126|NCT00878605|VA Greater Los Angeles Healthcare System|Dr. Zhaoping Li, Section Chief|310-268-3528|zhaoping.li@va.gov|
319127|NCT00877071|University of Pittsburgh Medical Center|Dr. David Geller|412-692-2001|gellerda@upmc.edu|
319128|NCT00878969|Vanderbilt University|T. Alp Ikizler, MD|615-343-6104|alp.ikizler@vanderbilt.edu|
319129|NCT00865514|University of Florida|Dr. Peter W. Stacpoole|(352) 273-9023|pws@ufl.edu|
319130|NCT00869414|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
319131|NCT00863512|Duke University Medical Center|David Harpole, M.D.||david.harpole@duke.edu|
319132|NCT00868998|Columbia University|Robert Fine|212-305-1168|rlf20@columbia.edu|
319133|NCT00869258|Columbia University|Robert Fine, MD|212-305-1168|rlf20@columbia.edu|
319134|NCT00863330|Aurora Health Care|IIR regulatory specialist|414-219-7886|jackie.blundon@aurora.org|
319135|NCT00853229|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
319136|NCT00860249|Northwestern University, Department of General Internal Medicine|Kenzie A. Cameron, PhD, MPH|312-503-3910|K-Cameron@northwestern.edu|
319137|NCT00860158|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
319138|NCT00853567|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
319139|NCT00849524|University of California, San Diego|Januario Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
319140|NCT00843986|Astellas Pharma Global Development|Medical Director||clinicaltrials@us.astellas.com|
319141|NCT00851682|Washington University|Robert Grubb, III|314 454-7185|grubbr@wudosis.wustl.edu|
319142|NCT00852124|UMARYLAND|Alessio Fasano|617-726-1450|afasano@partners.org|
319143|NCT00850421|Park Nicollet Institute|Park Nicollet Institute|952-993-3123||
319144|NCT00851747|Loyola Medical Center|Rebecca Tung, MD|(708) 216-4962|rtung@loyolamedical.org|
319145|NCT00852241|Loyola Medicine|Rebecca Tung, MD|(708) 216-4962|rtung@loyolamedicine.org|
319146|NCT00851552|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
319147|NCT00850720|Children's Healthcare of Atlanta|Kiran Hebbar, MBBS|404-785-1600|kiran.hebbar@choa.org|
319148|NCT00845845|The University of Illinois Chicago|Scott Cotler, M.D. Professor of Medicine|708-216-3789|scotler@lumc.edu|
319149|NCT00851591|Texas Tech University Health Sciences Center|Thomas Hale, PhD.|806-354-5528|thomas.hale@ttuhsc.edu|
319150|NCT00847509|Certus International, Inc.|Edward M. Aten, M.D.|603.627.1212|eaten@certusintl.com|
319151|NCT00843310|NYU Cancer Institute|Hearn J. Cho, MD|212-263-9274|hearn.jay.cho@med.nyu.edu|
319152|NCT00847002|Tactile Systems Technology, Inc|Sunday Hoy, Director of Clinical Research|612.355.5100||
319153|NCT00845702|Guerbet|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
319154|NCT00843830|University of Michigan Comprehensive Cancer Center|Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
293767|NCT01512758|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
293768|NCT01512797|Columbia University Medical Center|Dr. Blandine Laferrere|212-851-5562|bbl14@columbia.edu|
293769|NCT01512849|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
293770|NCT01512979|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
319155|NCT00835679|Vanderbilt-Ingram Cancer Center|Emily Chan, MD|615-343-4677|emily.chan@vanderbilt.edu|
319156|NCT00841035|University of Alabama at Birmingham|Research Nurse Supervisor of Clinical trials|(205)975-0450|jhrichardson@uabmc.edu|
319157|NCT00832520|UNM Comprehensive Cancer Center|Valerie Parks, RN|505-925-0390|vparks@salud.unm.edu|
319158|NCT00833859|H. Lee Moffitt Cancer Center and Research Institute|Gregory Springett, M.D., Ph.D., via Moffitt Cancer Center|813-745-6898|gregory.springett@moffitt.org|
293771|NCT01513122|The Kirby Institute|Prof Sean Emery|+61293850900|semery@kirby.unsw.edu.au|
319159|NCT00843050|Piramal Healthcare Limited|Dr. Alan Hatfield|02230275000|alan.hatfield@piramal.com|5002
319160|NCT00840827|Weill Cornell Medicine|Clinical Trials Administrator|212-746-0284|ray2013@med.cornell.edu|
319161|NCT00835328|The Children's Hospital of Philadelphia|Diva D. Deleon, MD,MSCE|215-590-3420|deleon@email.chop.edu|
319162|NCT00832572|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
319163|NCT00832624|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
319164|NCT00832299|Beth Israel Medical Center|Peter Kozuch, MD||pkozuch@chpnet.org|
319165|NCT00836355|New York University Langone Medical Center|Saran Jonas|212 263 7591|Saran.Jonas@nyumc.org|
319166|NCT00832598|Memorial Sloan Kettering Cancer Center|Dr. Ronald Blasburg, MD|646-888-2211|blasberr@mskcc.org|
319167|NCT00816777|Generic Devices Consulting, Inc|John Greenbaum|772-353-5301|genericd@bellsouth.net|
319168|NCT00823095|Loma Linda University Medical Center|Deborah Dodge|(909) 558-4000|ddodge@llu.edu|48500
319169|NCT00827567|Penn State|Allan Lipton, MD|717-531-5960|alipton@psu.edu|
319170|NCT00815633|Icahn School of Medicine at Mount Sinai|Dr. Joshua Zeichner||joshzeichner@gmail.com|
319171|NCT00814983|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|Mitchell.Horwitz@duke.edu|
319172|NCT00825227|Cephalon, Inc.|Vice President, Clinical Research|1-800-896-5855||
319173|NCT00819832|UT MD Anderson Cancer Center|Dawid Schellingerhout, MD/Asst. Professor||CR_Study_Registration@mdanderson.org|
319174|NCT00822679|University of Arizona|Sairam Parthasarathy|5206266109|sparthasarathy@deptofmed.arizona.edu|
319175|NCT00814892|Mayo Clinic|Dr. Manish Kohli|507-284-2511|kohli.manish@mayo.edu|
319176|NCT00809458|UNM Cancer Center|Richard Lauer, MD|505-925-0390|rlauer@salud.unm.edu|
319177|NCT00802659|Washington University School of Medicine|Jeffrey Bradley, M.D.|314-362-8525|jbradley@radonc.wustl.edu|
319178|NCT00807365|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|4105506484|registerclinicaltrials@jhmi.edu|
319179|NCT00814333|University of Kansas Medical Center|Kevin Sykes, PhD|913-588-7154|ksykes@kumc.edu|
319180|NCT00808080|UC San Diego Moores Cancer Center|Dr. Thomas Lane, Stem Cell Lab Director|858-822-5364|jreiner@Ucsd.edu|
319181|NCT00802893|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
319182|NCT00809341|Johns Hopkins Sidney Kimmel Cancer Center|Dr. Lode Swinnen|410-955-8603|lswinne1@jhmi.edu|
319183|NCT00804349|Albert Einstein Healthcare Network|Roberta Costello; Research Compliance|215-456-7225|bcostell@einstein.edu|
319184|NCT00803283|Janssen Taiwan|Medical Advisor|886-2-23762158||
319185|NCT00811590|Huntsman Cancer Institute|Dr. Randall Burt|801-585-3281|randall.burt@hci.utah.edu|
319186|NCT00808899|St. Jude Children's Research Hospital|Wayne L. Furman|1-866-278-5833|info@stjude.org|
319187|NCT00808769|The Procter & Gamble Company|John Mcrorie, PhD, FACG, AGAF|513-622-1423|mcrorie.jw@pg.com|
319188|NCT00803179|UMass Medical School|Michael Stalvey, MD, Principal Investigator|508-856-4280|mstalvey@peds.uab.edu|
319189|NCT00801931|Columbia University|Prakash Satwani, MD|212-305-0223|ps2087@cumc.columbia.edu|
319190|NCT00793520|Forest Research Institute|Allan Spera|201-427-8399|allan.spera@frx.com|
319191|NCT00795236|Oregon Health & Science University|Alfred Lewy|(503) 494-7746|lewy@ohsu.edu|
319192|NCT00799773|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
319193|NCT00790452|UT MD Anderson Cancer Center|Victor A Levin, MD, BS / Professor||CR_Study_Registration@mdanderson.org|
319194|NCT00795665|University of California Davis|Analyst|916-734-8053|nlogihara@ucdavis.eduu|
319195|NCT00787917|Novartis Pharmaceuticals|Study Director|862 778-8300||
319196|NCT00798590|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
319197|NCT00796510|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319198|NCT00796861|Penn State Health|Dr. Leah Cream|717-531-8870|lcream@pennstatehealth.psu.edu|
319199|NCT00791076|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
319200|NCT00790478|University of Tennessee|Paul Terry|(865) 305-9341|pterry@utmck.edu|
319201|NCT00796107|Hoffmann-La Roche, Ltd.|Study Director|888-662-6728 (U.S.)|global-roche-genentech-trials@gene.com|
319202|NCT00791336|The University of Iowa|John M. Buatti, M.D., Chair, Department of Radiation Oncology|319-356-2699|john-buatti@uiowa.edu|
319203|NCT00786682|Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
319204|NCT00787124|Duke University Medical Center|Brian Smith|9196688951|brian.smith@duke.edu|
319205|NCT00785356|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
319206|NCT00782483|University of Arkansas for Medical Sciences/Arkansas Children's Hospital|Dr. Gal Shafirstein|501-364-7546|jboswell@uams.edu|
293772|NCT01513148|Shenandoah University|Dr. Todd Telemeco|540-545-7398|ttelemec@su.edu|
293773|NCT01513239|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305834|NCT02362646|Icahn School of Medicine at Mount Sinai|Annetine Gelijns, PhD|212-659-9567|annetine.gelijns@mssm.edu|
319207|NCT00791843|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
319208|NCT00784043|MED-EL Corporation|Jennifer Bulls|1-888-633-3524|research.us@medel.com|
319209|NCT00787618|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
319210|NCT00774306|Thomas Jefferson University|Dr. Scott Mintzer|215-955-1222|scott.mintzer@jefferson.edu|
319211|NCT00771602|UT MD Anderson Cancer Center|Stefan Faderl, MD / Professor|713-745-4613||
319212|NCT00779038|Janssen-Cilag Belgium|Study Responsible Physician|003214649584||
319213|NCT00780455|Bayer Healthcare AG|Medical Affiars Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
271727|NCT00260962|Ottawa Hospital Research Institute|Dr. Hany Bissada|613-798-5555|hbissada@ottawahospital.on.ca|78042
270405|NCT00126568|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Panayiotis Savvides|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
270406|NCT00126581|Dana-Farber Cancer Institute|Pasi Janne, MD, PhD||pjanne@partners.org|
270407|NCT00126594|University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
270408|NCT00126737|Edward Hines, Jr. VA Hospital|Elly Budiman-Mak, MS MPH MD|708-202-2414|elly.mak@va.gov|
270409|NCT00126750|VA Bedford CHOIR|Dr. Thomas Houston II|781-687-2884|thomas.houston2@va.gov|
270410|NCT00127036|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-2069|jonathan.strosberg@moffitt.org|
270411|NCT00127062|Imperial College London|Professor Fan Chung|+44 (0)20 7594 7954|f.chung@imperial.ac.uk|
270412|NCT00127101|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
270413|NCT00127166|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270414|NCT00127192|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
270415|NCT00127205|SWOG Statistics & Data Management Center|SWOG statistician|2066674263|jmiao@fredhutch.org|
270416|NCT00127218|The Johns Hopkins Hospital, Department of Medicine, Division of Cardiology|Dr. Joao AC Lima|410-614-1284|jlima@jhmi.edu|
270417|NCT00127231|Johns Hopkins University School of Medicine|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
270418|NCT00127413|VA Boston Healthcare System|John D. Otis|8573645740|john.otis@va.gov|
270419|NCT00127439|University of Louisville|Andrea L. Behrman, PhD, PT|502-582-7451|andreabehrman@catholichealth.net|
270420|NCT00127530|Acorda Therapeutics, Inc.|Andrew Blight, Chief Scientific Officer|914-347-4300|ablight@acorda.com|102
270421|NCT00127608|GlaxoSmithKline|GSK Response Center|866-435-7343||
270422|NCT00127660|University of Minnesota|Lisa Harnack, DrPH|612-626-9398|harna001@umn.edu|
270423|NCT00127712|Purdue University|James E. Tisdale|317-613-2315|jtisdale@iupui.edu|306
270424|NCT00127790|Universityy of Rochester|Wilfred Pigeon, PhD|(585) 275-3374|wilfred_pigeon@urmc.rochester.edu|
293774|NCT01513291|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293775|NCT01513317|Janssen Research & Development|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
319214|NCT00776100|Mayo Clinic|Steven E. Schild, M.D.|507-538-1760|sschild@mayo.edu|
293776|NCT01513330|Coloplast A/S|Director of Clinical Trials|+45 4911 3595|dkbir@coloplast.com|
293777|NCT01513447|Northwestern University Feinberg School of Medicine|Cynthia A. Wong, M.D.|312-472-3585|c-wong2@northwestern.edu|
293778|NCT01513460|Novartis Pharmaceuticals|Study Director|862-778-8300||
293779|NCT01513473|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
319215|NCT00771316|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
319216|NCT00780481|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
319217|NCT00769652|Rutgers Cancer Institute of New Jersey|Dr. Elizabeth Poplin, MD (sub-investigator)|732-235-8675|poplinea@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
319218|NCT00768040|Novartis Pharmaceuticals|Study Director|862-778-8300||
319219|NCT00776555|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
319220|NCT00775190|Beaumont Health System|Evie Russell, RN|248-898-5388|Evie.Russell@beaumont.org|
319221|NCT00755261|SKCCC, Johns Hopkins University|Christian Meyer, M.D., Ph.D.|4105025940|cmeyer13@jhmi.edu|
319222|NCT00762723|Zimmer|Laura Herdrich|952-830-6224|laura.herdrich@zimmer.com|
319223|NCT00770965|Novartis|Study Director|862-778-8300||
319224|NCT00769002|Hackensack University Medical Center|Dr. David Schwartz|551-996-2000|DSchwartz@hackensackumc.org|
319225|NCT00766636|University of Texas MD Anderson Cancer Center|Jason B. Fleming, MD / Surgical Oncology|713-563-2300|CR_Study_Registration@mdanderson.org|
319226|NCT00768248|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
319227|NCT00765765|Cancer Institute of New Jersey|Dr. Vassiliki Karantza|732-235-8675|karantva@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
319228|NCT00764699|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
319229|NCT00759577|New York University|Dr. Victor Nitti|646 825 6300|Victor.Nitti@NYUMC.org|
319230|NCT00763009|UCHC|Michael Azrin|8606793343|azrin@uchc.edu|
319231|NCT00761176|Regenesis Biomedical, Inc.|VP of Clinical Research and Regulatory|602-309-2118|mark.davis@regenesisbio.com|
319232|NCT00749476|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
319233|NCT00760461|Yale University|Anish A Sheth M.D|203-785-4576|anish.sheth@yale.edu|
319234|NCT00749658|University of Minnesota|Marc Mooney PhD||moon0078@umn.edu|
319235|NCT00754793|University of Washington|Dr. Greg E. Davis, MD MPH|206-543-5230|gedavis@uw.edu|
319236|NCT00754052|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
319237|NCT00750555|Geisinger|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
293780|NCT01513538|Medtronic|Céline This|33 6 89 71 90 67|celine.this@medtronic.com|
319238|NCT00754767|HealthPartnersInstitute|Dr. Alice Shapiro|952-993-1704|shapia@parknicollet.com|
319239|NCT00750204|Johns Hopkins University School of Medicine|Roy Brower, M.D.|1 (410) 614-6292|rbrower@jhmi.edu|
319240|NCT00748579|Cytokinetics, Inc.|Medical Director|(650) 624-3011||
319241|NCT00748085|CSA Medical|Ann Murphy Legg, Director of Clinical Research|781-538-4732|alegg@csamedical.com|
319242|NCT00752986|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
319243|NCT00751335|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAP.trial@fphcare.co.nz|7044
319244|NCT00746239|Penn State Hershey Medical Center|Ravi Singareddy|717-531-0040|rsingare@gmail.com|
319245|NCT00754013|Eisai inc.|Eisai Medical Services|1-888-422-4743||
319246|NCT00735553|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
319247|NCT00751933|Haukeland University Hospital|Gunnar Nysæter or Solomon Tefera or Jan Hatlebakk|+47 55972900|jhat@helse-bergen.no|
319248|NCT00747916|Titus Regional Medical Center|Dr. Gordon Downie|903-572-9050|downieg@trhta.net|
319249|NCT00745030|Northwestern University|Angelica Marconi|312-503-1999|a-marconi@northwestern.edu|
319250|NCT00747461|CSA Medical|Ann Murphy Legg, Director of Clinical Research|781-538-4732|alegg@csamedical.com|
319251|NCT00746018|Memorial Sloan Kettering Cancer Center|Nadeem Abu-Rustum, M.D.|212-639-7051|abu-rusn@mskcc.org|
319252|NCT00746603|Weill Cornell Medicine|Jennifer Levine, MD|212-305-9770|jel9022@med.cornell.edu|
319253|NCT00736385|Duke University Medical Center|Christopher Kigongo|919-668-6579|christopher.kigongo@duke.edu|
319254|NCT00738972|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305835|NCT02362672|Nektar Therapeutics|Medical Affairs||StudyInquiry@nektar.com|
293781|NCT01513551|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293782|NCT01513590|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
319255|NCT00743197|Northwestern University|Dr. Martha Gulati, Principal Investigator|312-695-4965|mgulati@nmh.org|
305836|NCT02362724|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
319256|NCT00739063|UT MD Anderson Cancer Center|Ana Gonzalez-Angulo, MD, MS / Associate Professor||CR_Study_Registration@mdanderson.org|
319257|NCT00740597|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
319258|NCT00737594|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
319259|NCT00737282|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
319260|NCT00739882|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49 6151 72 5200|service@merckgroup.com|
319261|NCT00739024|Swedish Headache Center|Pat Barrodale, RN|206-215-3502|pat.barrodale@swedish.org|
319262|NCT00731770|Penn State University|Erin Banta|717-531-6525|ebanta@hmc.psu.edu|1
319263|NCT00735254|Arizona Dermatology and Cosmetic|Edward Galiczynski, MD|(602) 277-1449|egaliczynski@arizonaderm.com|
319264|NCT00729365|Northwestern University Feinberg School of Medicine|Mark E. Molitch|312 503-4130|molitch@northwestern.edu|
319265|NCT00732680|Mayo Clinic|Rizwan Siwani, MBBS|507-284-9155|siwani.rizwan@mayo.edu|
319266|NCT00726180|Universtiy of Michigan|Anne F. Schott, MD|734-936-6000|aschott@umich.edu|
319267|NCT00724282|University of Chicago|Andrea Eiring|773-702-3657|aeiring@bsd.uchicago.edu|
319268|NCT00730886|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
319269|NCT00728845|Cancer Institute of New Jersey|Dr. Joseph Aisner|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
319270|NCT00726830|University of Texas MD Anderson Cancer Center|Michael J. Fisch, MPH/Clinical Professor, General Oncology|(713) 563-9905|mfisch@mdanderson.org|
319271|NCT00726037|Northwestern Medicine Regional Medical Group|Margret Shoup|630-352-5450|MSHOUP@lumc.edu|
319272|NCT00729560|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
319273|NCT00716807|UCSF|Jon Levine MD, PhD|415-476-5108|jon.levine@ucsf.edu|
319274|NCT00714948|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
319275|NCT00720343|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
319276|NCT00719914|Brigham and Women's Hospital|C. Michael Gibson, MS, MD|617-632-7753|mgibson@perfuse.org|
319277|NCT00718640|Janssen Inc., Canada|Director, Medical Affairs Oncology|416-382-5078||
319278|NCT00720083|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.com|
319279|NCT00717275|University of Florida|Dr. Erin M. Dunbar|352-273-9000|edunbar@neurosurgery.ufl.edu|
319280|NCT00708734|Tampa VA Hospital|Tatjana Bulat|8135583932|tatjana.bulat@va.gov|
319281|NCT00711087|Baylor College of Medicine|Christopher P. Smith, MD, MBA, MSS|713-798-7498|cps@bcm.edu|
319282|NCT00706797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
319283|NCT00713596|Mayo Clinic|Dr. Oren Friedman|507-538-1392||
319284|NCT00703885|UCSD|Murray B. Stein MD, MPH|858-534-6451|mstein@ucsd.edu|
319285|NCT00703092|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
319286|NCT00713258|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
319287|NCT00706329|Children's Hospital Boston and South Shore Hospital|Dr. Neil Feins|6173556915||
319288|NCT00707434|UT MD Anderson Cancer Center|Clinical Research Operations, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
319289|NCT00707161|Huntsman Cancer Institute|Dennis Shrieve, MD|801-581-8793|dennis.shrieve@hci.utah.edu|
319290|NCT00704496|milton s hershey medical center|timothy craig,|717-531-6525|tcraig@psu.edu|1
319291|NCT00708916|New York University School of Medicine|Andrew Franks, MD, Principal Investigator|212-263-5244|andrew.franks@nyumc.org|
319292|NCT00700778|Fox Chase Cancer Center|Dr. Jose Russo|215-728-4782|Jose.Russo@fccc.edu|
319293|NCT00699842|Thomas Jefferson University|Emmanuel Besa, MD|215-955-8874|Emmanuel.Besa@jefferson.edu|
319294|NCT00702962|MSHERSHEY MC|Dr. C. Belani|717-531-1078|cbelani@psu.edu|
319295|NCT00703534|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
319296|NCT00698009|UT MD Anderson Cancer Center|Eugenie S Kleinerman,MD/Professor, Pediatrics - Research|(713) 497-6226|ekleiner@mdanderson.org|
319297|NCT00703339|Lung Rx|Rosa Negro-Vilar|240-821-1881|rnegrovilar@lungrx.com|
319298|NCT00691444|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
319299|NCT00702702|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
319300|NCT00693628|Department of Orthopedic Surgery & Rehabilitation, Orthotics and Prosthetics Division|Jonathan Day||jonathan-day@ouhsc.edu|
319301|NCT00699413|USC|Michael Goran|323.442.3027|goran@usc.edu|
319302|NCT00691652|OHSU Knight Cancer Institute|Dr. Craig Okada|503-494-1080|Okadac@ohsu.edu|
293783|NCT01513759|EKOS Corporation|David Hahn|4254153100|David.Hahn@btgplc.com|
319303|NCT00686972|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
319304|NCT00693017|Eisai Inc|Antonio Laurenza, MD, Executive Director|1 201 949-4157|antonio_laurenza@eisai.com|
319305|NCT00691574|Oregon Health & Science University|Alfred Lewy, MD, PhD|(503) 494-7746|lewy@ohsu.edu|
293784|NCT01513902|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319306|NCT00692094|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
319307|NCT00689884|Dartmouth-Hitchcock Medical Center|John M. Hill, MD - Principal Investigator|603-650-4628|john.m.hill@hitchcock.org|
319308|NCT00692003|Eisai Inc|Antonio Laurenza, MD, Executive Director|1 201 949-4157|antonio_laurenza@eisai.com|
319309|NCT00678288|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
319310|NCT00676026|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
319311|NCT00689052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
319312|NCT00678574|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
319313|NCT00683917|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
319314|NCT00688935|Oregon Health and Science University|OHSU Integrity Department|1-877-733-8313|irb@ohsu.edu|
319315|NCT00685880|Mayo Clinic|Dr. Jeffrey S. Brault|507-284-1643|brault.jeffrey@mayo.edu|
319316|NCT00686036|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
319317|NCT00681044|Boston Medical Center|Dr. Vaishali Sanchorawala, Director of Stem Cell Transplant Program|617-637-7017|vaishali.sanchorawala@bmc.org|
319318|NCT00676455|Lahey Clinic|Christopher Wald, MD|781-744-8710|Christopher.Wald@lahey.org|
319319|NCT00684255|New York Medical College|Dr. Mitchell S. Cairo|914-594-3650|mitchell_cairo@nymc.edu|
319320|NCT00683787|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
319321|NCT00679926|Oklahoma State University Center for Health Sciences|Johnny Stephens|918-382-3527|johnny.stephens@okstate.edu|
319322|NCT00678041|University of Pittsburgh, UPP13 WH Uro Gynecology - Cor|Gary Sutkin, MD|412--641-1440|gsutkin@mail.magee.edu|
319323|NCT00680316|Genentech, Inc.|Medical Communications|800-821-8590||
319324|NCT00681629|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
319325|NCT00669461|University of Arkansas for Medical Sciences|Muhannad Heif, MD|5016500215|mmheif@gmail.com|
319326|NCT00671606|UT MD Anderson Cancer Center|Dr. Michael Frumovitz, ND/Assistant Professor||tjohnsto@mdanderson.org|
319327|NCT00673309|University of Texas Medical Branch|David Herndon, MD|409-770-6731|dherndon@utmb.edu|
319328|NCT00672178|Duke University Medical Center|John Kirkpatrick, MD, PhD|919 668-7342|kirkp001@mc.duke.edu|
319329|NCT00673595|Mayo Clinic|Dr. John H. Eisenach|507-266-8715|eisenach.john@mayo.edu|
319330|NCT00673361|Duke University Medical Center|Michael A Morse, M.D.|919-681-3480|morse004@mc.duke.edu|
319331|NCT00670631|University of Iowa|Guido Tricot, MD, PhD||guido-tricot@uiowa.edu|
319332|NCT00668785|West Coast Retina Medical Group, Inc.|J. Michael Jumper, MD|415-972-4600|jmjumper@westcoastretina.com|
319333|NCT00673179|UT MD Anderson Cancer Center|Peter M. Anderson, MD, PHD / Professor||CR_Study_Registration@mdanderson.org|
319334|NCT00668265|Beth Israel Medical Center|Igor Galynker, MD|212 420 4535|igalynke@chpnet.org|
319335|NCT00660348|Sidney Kimmel Comprehensive Cancer Center|Michael Erdek, MD|410-502-7388|merdek1@jhmi.edu|
319336|NCT00664066|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
319337|NCT00667017|University of Texas Southwestern Medical Center|Larry Andeson, MD|214-648-7097||
319338|NCT00665444|University of Pittsburgh|Holly Swartz, MD|412-246-5588|swartzha@upmc.edu|
319339|NCT00656916|UT MD Anderson Cancer Center|Lara Bashoura, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
319340|NCT00660595|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
319341|NCT00661466|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
319342|NCT00646282|Emory University|Dr. Antonio Guasch|404-727-2522|aguasch@emory.edu|
319343|NCT00657553|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-569-6990|pettynathanm@uams.edu|2461
319344|NCT00655057|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
319345|NCT00648895|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
293785|NCT01513967|Regenera Pharma Ltd|Dr Konstatin Adamsky|+972 8 9316306|kostia@Regenerapharma.com|
319346|NCT00647426|Abramson Cancer Center|Tracey Evans MD|215 614 0861|Christine.Bonney@UPHS.upenn.edu|
319347|NCT00645567|James A Haley VA, Tampa|John Lloyd|813-624-8986|john.lloyd2@va.gov|
319348|NCT00637806|Endo Pharmaceuticals Inc.|M. Todd Kirby, PhD|(484) 216-6491|kirby.todd@endo.com|
319349|NCT00652457|University of California, San Diego|Jody Corey-Bloom, MD, PhD|858-249-0574|jcoreybloom@ucsd.edu|
319350|NCT00642603|Genentech, Inc.|Medical Communications|800-821-8590||
319351|NCT00629798|Memorial Sloan Kettering Cancer Center|Dr. Roni Tamari, MD|646-608-3738|tamarir@mskcc.org|
319352|NCT00645359|University of Michigan Comprehensive Cancer Center|Dr. Daniel Lebovic, M.D.|734-936-5310|dlebovic@umich.edu|
319353|NCT00637728|Endo Pharmaceuticals Inc.|M. Todd Kirby, PhD|(484) 216-6491|kirby.todd@endo.com|
319354|NCT00639626|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
293786|NCT01514136|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1990|dkbir@coloplast.com|
293787|NCT01514149|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
319355|NCT00634582|Comprehensive Cancer Center of Wake Forest Univeresity|Gary Schwartz, PhD|336-716-7446|gschwart@wakehealth.edu|
319356|NCT00641108|University of Pennsylvania|Tyrone Quarterman|215-349-5537|tyroneq@upenn.edu|
319357|NCT00642382|Cartiva, Inc|Director Clinical Operations|770-754-3805|rtownsend@cartiva.net|
319358|NCT00637416|University of Kansas Medical Center|Director, ENT Clinical Research|(913) 588-7154|ksykes@kumc.edu|
319359|NCT00635167|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Edouard Trabulsi|215-955-1000|edouard.trabulsi@jefferson.edu|
319360|NCT00637312|Orthofix|Ruba Sarris|214-937-2256|rubasarris@orthofix.com|
319361|NCT00638222|The University of Toledo, HSC|Christopher Cooper, MD|419.383.6030|christopher.cooper@utoledo.edu|
319362|NCT00634322|BTG International (Protherics)|VP Clinical Development, BTG International|610-943-3632|janet.rush@btgplc.com|
319363|NCT00633087|Rutgers Cancer Institute of New Jersey|Dr. Robert DiPaola, MD|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
319364|NCT00631137|Johns Hopkins|Jaishri Blakeley|410-955-8837|jblakel3@jhmi.edu|
319365|NCT00634972|University of South Alabama|Fabien Eyal, MD|251-415-1055|feyal@health.southalabama.edu|
319366|NCT00633061|Univesity of Oklahoma College of Medicine|Janna Journeycake, MD||janna-journeycake@ouhsc.edu|
319367|NCT00626444|Thomas Jefferson University|Daniel Monti, MD|215-955-4410|Daniel.Monti@jefferson.edu|
319368|NCT00630292|University of North Carolina|William Irvin, Jr. MD / Co-Principal Investigator|919-966-6735|william_irvin@med.unc.edu|
319369|NCT00634010|The University of Texas (UT) MD Anderson Cancer Center|Eduardo Bruera, MD, Chair, Palliative Care Medicine||CR_Study_Registration@mdanderson.org|
319370|NCT00630487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
319371|NCT00629850|Texas State Respiratory Care Department|Chris Russian, Associate Professor|512-245-3794|cr23@txstate.edu|
319372|NCT00623974|UT MD Anderson Cancer Center|Mimi Hu, MD / Professor||CR_Study_Registration@mdanderson.org|
319373|NCT00624650|OHSU|Samantha Ruimy|5034940724|ruimy@ohsu.edu|
319374|NCT00626561|University of Texas MD Anderson Cancer Center|Michael M. Frumovitz, MD / Professor, Gynecologic Oncology|713-792-9599|CR_Study_Registration@mdanderson.org|
319375|NCT00613730|Amgen Inc.|Study Director|866-572-6436||
319376|NCT00625586|MacroGenics, Inc.|Sr. Director of Clinical Operations|650 624 2676|baughmanj@macrogenics.com|
319377|NCT00625703|University of Texas Southwestern Medical Center|Lus Stella Muniz, MD|214-648-3111|irb@utsouthwestern.edu|
319378|NCT00625742|University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO/Associate Professor, Palliative Care Med||CR_Study_Registration@mdanderson.org|
319379|NCT00619242|The University of Chicago|Ezra Cohen, MD|773/702-4137|ecohen@medicine.bsd.uchicago.edu|
319380|NCT00619151|Sorin Group USA, Inc.|Barbara Mathews Director Clinical and Medical Affairs|512-435-3602|Barbara.mathews@sorin.com|
319381|NCT00622167|Massachusetts General Hospital|Iris McNulty, RN|617 726 2612|imcnulty@partners.org|
319382|NCT00616577|Loma Linda University|Charles Lee, MD|909-558-9408|thamilton@llu.edu|
319383|NCT00616759|Loma Linda University|Ronald L. Warnell, M.D.|909-558-9551|rwarnell@llu.edu|
319384|NCT00616642|University of California Los Angeles|Anthony Heaney, M.D. Ph.D|310 267 4980|aheaney@mednet.ucla.edu|
319385|NCT00619515|Case Comprehensive Cancer Center|Dr. Lee Ponsky|216-844-4831|lee.ponsky@uhhospitals.org|
319386|NCT00616343|Loma Linda University|Dr. David Swope|909-558-4908|Thamilton@llu.edu|
293788|NCT01514162|St Jude Medical|Jennifer Johnson|6517566803|jjohnson101@sjm.com|
319387|NCT00612677|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D., via Moffitt Cancer Center|813-745-3050|alberto.chiappori@moffitt.org|
319388|NCT00616603|Loma Linda University Department of Anesthesiology|Patricia Moore, CCRP|909-558-8493|pamoore@llu.edu|
319389|NCT00613886|University of California, Irvine|Chris Nishi Clinical Trials Coordinator|949-824-3238|cnishi@uci.edu|
319390|NCT00610467|University of California Irvine|Professor|949-824-6001|msu@uci.edu|
319391|NCT00610558|University of California, Irvine|Dr. Lydia Su|(949) 824-4925|msu@uci.edu|
319392|NCT00610532|The Ohio State University|Dr. Jim McAuley|614-292-9713|mcauley.5@osu.edu|
319393|NCT00609765|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-2069|jonathan.strosberg@moffitt.org|
319394|NCT00608465|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
319395|NCT00608777|DermResearch, PLLC|Leon Kircik, M.D.|502-5451-9000|wedoderm@yahoo.com|
319396|NCT00601848|University of Pennsylvania|Keith A Cengel, MD, PhD|(215) 615-5312|cengel@pennmedicine.upenn.edu|
319397|NCT00607477|University of Chicago|Michael Maitland, MD, PhD|773-702-4400|mmaitlan@medicine.bsd.uchicago.edu|
319398|NCT00595920|Opexa Therapeutics, Inc.|Kenny Frazier, VP of Clinical Development and Regulatory Affairs|281-775-0660|kfrazier@opexatherapeutics.com|
293789|NCT01514201|St. Jude Children's Research Hospital|Catherine Billups|901-595-3709|catherine.billups@stjude.org|
293790|NCT01514240|Biometrics Department, Science Affairs Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
319399|NCT00596947|Hospital of the University of Pennsylvania|Jennifer Trofe-Clark, Clinical Transplant Research Pharmacist|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu|
319400|NCT00584012|Holden Comprehensive Cancer Center|Cena Jones-Bitterman|319-353-4596|cena-jones@uiowa.edu|
319401|NCT00599131|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden|734-936-0453|fworden@umich.edu|
319402|NCT00597909|Horizon Pharma plc|Bruce Scharschmidt, MD||bscharschmidt@horizonpharma.com|
319403|NCT00593320|Washington University School of Medicine|Jeffrey Bradley, M.D.|314-362-8502|jbradley@radonc.wustl.edu|
319404|NCT00589550|The Ohio State University Comprehensive Cancer Center|Thomas Olencki, DO|614-293-2886|Thomas.Olencki@osumc.edu|
319405|NCT00577772|Mayo Clinic|Dr. John K. DiBaise|480-301-6990|dibaise.john@mayo.edu|
319406|NCT00592007|UC San Diego, Moores Cancer Center|Lyudmila Bazhenova, MD|858 822 6189|lbazhenova@ucsd.edu|
319407|NCT00595582|LSU Health Sciences Center, Shreveport LA|Dr. James Patterson/Professor|318-813-2070|jpatte@lsuhsc.edu|
319408|NCT00588146|Mayo Clinic|Karen L. Swanson, D.O.|507-255-3214|swanson.karen@mayo.edu|
319409|NCT00586209|Emmaus Medical, Inc.|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
319410|NCT00590538|The Children's Hospital of Philadelphia|Ronald Rubenstein, MD, PhD|1-215-590-1281|rubensteinr@email.chop.edu|
319411|NCT00583115|Indiana University|Ronald Mark Payne MD|317-278-6329|rpayne@iu.edu|
319412|NCT00582712|University of Wisconsin Carbone Cancer Center|Director of Clinical Research|608-265-0540|clinicalresearch@surgery.wisc.edu|
319413|NCT00586716|Loma Linda University Medical Center|Dr. Pedro Baron|909-558-6792|PBaron@llu.edu|
319414|NCT00583466|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|410-550-6484|registerclinicaltrials@jhmi.edu|
319415|NCT00588471|Mayo Clinic|Dr. Amir Lerman|507-255-7760|lerman.amir@mayo.edu|
319416|NCT00587795|Mayo Clinic|Dr. David Dennison|507-284-7405|Dennison.David@mayo.edu|
319417|NCT00590135|Cleveland Clinic|Brian Griffin MD|216-444-6812|Griffib@ccf.org|
319418|NCT00582036|University of Oklahoma Health Sciences Center|George Selby, MD|405-271-4022|george-selby@ouhsc.edu|
319419|NCT00585585|University of Cincinnati|Erik Nelson, MD|513-558-5115|erik.nelson@uc.edu|
319420|NCT00585221|Huntsman Cancer Institute|Director of Clinical Trials|801-213-4241|candace.larson@hci.utah.edu|
319421|NCT00581113|Virginia Commonwealth University|Martha D. Wellons|804-628-1939|mwellons@vcu.edu|
319422|NCT00579254|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
319423|NCT00587223|Organogenesis Inc.|Director of Clinical Operations||kgiovino@organo.com|
319424|NCT00585611|UW-Madison at time of study|Nancy Sweitzer||nancysweitzer@shc.arizona.edu|
319425|NCT00572260|Duke University Health System|Yong Choi, Clinical Research Coordinator|919-684-7584|yong.choi@duke.edu|
319426|NCT00571194|Arkansas Children's Hospital|Dr. Eileen Ellis|501-364-1847|elliseileenn@uams.edu|
319427|NCT00584935|UAB Department of Dermatology|Wendy Cantrell, CRNP|205-502-9960|wcantrell@uabmc.edu|
319428|NCT00577395|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
319429|NCT00573391|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
319430|NCT00570258|University of Arkansas for Medical Sciences|Beth Scanlan|501-686-8274|bscanlan@uams.edu|
319431|NCT00568802|Stanford University|Principal Investigator||clinicaltrials-gov@lists.stanford.edu|
319432|NCT00576524|Children's Hospital of Philadelphia|Marsha Wallace|(215) 590-0119|wallacem@email.chop.edu|
319433|NCT00568698|Stanford University|Principal Investigator||clinicaltrials-gov@lists.stanford.edu|
319434|NCT00574080|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|PettyNathanM@uams.edu|2461
319435|NCT00558558|UT MD Anderson Cancer Center|Ying Guo, MD - Associate Professor|713-745-2327|jaallo@mdanderson.org|
319436|NCT00577356|Virginia Mason Medical Center|Jacqueline Vuky, MD|(206) 223-6193|Jacqueline.Vuky@vmmc.org|32246
319437|NCT00573937|Mayo Clinic|Donald Northfelt, MD|480-301-8335|northfelt.donald@mayo.edu|
319438|NCT00577317|NRG Oncology|Linda Gedeon for Helen Huang, MS.|716-845-1169|Linda.gedeon@roswellpark.org|
319439|NCT00571922|NYU Langone Medical Center|The Office of Clinical Trials|212.263.4210|clinicaltrials@nyumc.org|
319440|NCT00569868|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|5015266990|pettynathanm@uams.edu|2461
319441|NCT00573157|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
319442|NCT00570531|University of Michigan Comprehensive Cancer Center|Susan Urba, M.D.|734-615-4762|surba@umich.edu|
319443|NCT00566462|Eisai Call Center|Eisai Inc.|888-422-4743||
319444|NCT00561912|UT MD Anderson Cancer Center|Ana M. Aparicio, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
319445|NCT00561795|GlaxoSmithKline|GSK Response Center|866-435-7343||
319446|NCT00564876|Duke University Medical Center|Neal Ready, MD|919-668-6688|neal.ready@duke.edu|
319447|NCT00558870|University of Texas (UT) MD Anderson Cancer Center|Sriram Yennurajalingam, Palliative Care & Rehabilitation Medicine||CR_Study_Registration@mdanderson.org|
319448|NCT00559897|Barbara Ann Karmanos Cancer Institute|Dr. Shirish Gadgeel|313-576-8753|gadgeels@karmanos.org|
319449|NCT00556400|NICHD|Dr. Pamela Stratton|301 496-9079|strattop@mail.nih.gov|
319450|NCT00556075|Repros Therapeutics Inc.|Jennifer L. Wike|2817193402|jwike@reprosrx.com|
319451|NCT00556166|Columbia University|Dennis Fowler|212-305-9914|dlf91@columbia.edu|
319452|NCT00521924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
319453|NCT00548886|Emory University|Dr. Peter Seth Fischbach|404-256-2593|pfischb@emory.edu|
319454|NCT00547456|North Shore LIJ Health System|Rubin Cohen, MD|516-465-5400|rocohen@nshs.edu|
293791|NCT01514279|School of Medicine, Case Western Reserve University|Dr. Elaine Borawski, PhD|216)368-1024|exb11@case.edu|
319455|NCT00539838|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
319456|NCT00549328|GlaxoSmithKline|GSK Response Center|866-435-7343||
319457|NCT00548327|Clinical Brain Disoders Branch-National Institute of Mental Health (NIMH)-National Institute of Health (NIH)|Jose A. Apud MD, PhD|301 5946561|apudj@mail.nih.gov|
319458|NCT00542542|University of Texas MD Anderson Cancer Center|Dr. Farzin Goravanchi, Professor, Anesthesiology & Perioperative Medicine|713-563-5613|CR_Study_Registration@mdanderson.org|
319459|NCT00545506|Dep. Anesthesia And Intensive Care|Helmut Hager|+43 1 40400 4102|helmut.hager@meduniwien.ac.at|
319460|NCT00547300|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
319461|NCT00539617|University of California, San Francisco|W. Michael Korn, MD|415-502-2844|michael.korn@ucsf.edu|
293792|NCT01514292|Dexcom, Inc|Andy Balo, SVP, Regulatory, Clinical and Biometrics|8582000200|abalo@dexcom.com|
319462|NCT00546455|UCSD|MARIO CHOJKIER|858-552-8585|mchojkier@gmail.com|7283
319463|NCT00538980|Weill Cornell Medicine|Richard T. Silver, MD|646-962-2273|rtsilve@med.cornell.edu|
319464|NCT00540969|Mayo Clinic|Matthew Callstrom, M.D., Ph.D.|5072664532|callstrom.matthew@mayo.edu|
319465|NCT00535262|Depression Evaluation Service, New York State Psychiatric Institute|Deborah A. Deliyannides, M.D. Research Psychiatrist|(212) 543-5734|deliiyan@nyspi.columbia.edu|
319466|NCT00529464|UT MD Anderson Cancer Center|Helen E. Rhodes, MD / Assistant Professor|713-792-2933|CR_Study_Registration@mdanderson.org|
319467|NCT00537199|UT MD Anderson Cancer Center|Mark Chambers, MS, DMD / Professor|713-792-6510||
319468|NCT00537446|Columbia University Irving Medical Center|Robert Basner, MD||rcb42@cumc.columbia.edu|
319469|NCT00536978|UT MD Anderson Cancer Center|Issa F. Khouri, MD / Professor, Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
319470|NCT00524485|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
319471|NCT00533351|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
319472|NCT00529282|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clincal Team Lead|908 927-3785||
319473|NCT00524134|Columbia University|CU PRS Administrator|212-342-1643|crchelp@columbia.edu|
319474|NCT00527748|University of Missouri|Dr. Saul G Trevino|573/884-8840|trevinos@health.missouri.edu|
319475|NCT00517699|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
319476|NCT00528775|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
319477|NCT00528437|NYU Langone|Dr. Sharon Gardner|212-263-9913|Sharon.Gardner@nyulangone.org|
319478|NCT00524511|UMass Memorial Medical Center|Dawn Tasillo, MD|5083346255|tasillod@ummhc.org|
319479|NCT00517075|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
319480|NCT00527982|UT MD Anderson Cancer Center|Waun K. Hong, MD/Professor||CR_Study_Registration@mdanderson.org|
319481|NCT00524459|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
319482|NCT00517361|The University of Chicago|Dr. Rita Nanda|773-834-2756|rnanda@medicine.bsd.uchicago.edu|
319483|NCT00523939|Duke University Medical Center|Dr. David Rizzieri|919-668-1040|rizzi003@mc.duke.edu|
319484|NCT00522457|Fresenius Biotech North America|Manager of Regulatory Affairs|781-699-4652|bao.le@fresenius-biotech.com|
319485|NCT00526331|UT MD Anderson Cancer Center|Gabriel Mena, MD / Professor||CR_Study_Registration@mdanderson.org|
319486|NCT00519090|Novartis Pharmaceuticals|Study Director|862-778-8300||
319487|NCT00524394|University of Texas Health Science Center|James Murphy, PhD|713-500-5714|james.r.murphy@uth.tmc.edu|
319488|NCT00523809|UT MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
319489|NCT00522301|Memorial Sloan Kettering Cancer Center|Dr. William Tew|646-888-4220|teww@mskcc.org|
319490|NCT00517192|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
319491|NCT00504985|UT MD Anderson Cancer Center|Xin Shelley Wang, MD, MPH / Associate Professor|713-745-3504||
319492|NCT00503581|NRG Oncology|Linda Gedeon for James Kauderer|716-845-1169|linda.gedeon@roswellpark.org|
319493|NCT00509600|UT MD Anderson Cancer Center|Robert J. Wells, MD / Professor|713-792-6620||
319494|NCT00515112|The University of Chicago|Dr. Walter Stadler|773-702-4400|wstadler@medicine.bsd.uchicago.edu|
319495|NCT00508872|UT MD Anderson Cancer Center|Eddie Abdalla, MD/Assistant Professor|713-792-6940||
319496|NCT00514813|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
319497|NCT00506064|UT MD Anderson Cancer Center|Una Srejic, MD / Professor|713-792-6914|CR_Study_Registration@mdanderson.org|
319498|NCT00503880|University of Nebraska Medical Center|Lori Maness-Harris, MD|402-559-3848|lmaness@unmc.edu|
270425|NCT00127803|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
293793|NCT01514318|DJO Surgical|Dr. Jane M. Jacob|512-834-6323|jane.jacob@djoglobal.com|
293794|NCT01514357|Mayo Clinic|Dr. John C. Burnett|507-284-7932|burnett.john@mayo.edu|
293795|NCT01514370|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
293796|NCT01514383|Medline Industries, Inc|Ed Drower, Clinical Project Director|847-643-3874|edrower@medline.com|
319499|NCT00511329|Nationwide Children's Hospital|Julie Rice, RN|6143553142|julie.rice@nationwidechildrens.org|
319500|NCT00501228|U.T. M.D. Anderson Cancer Center|Martin Korbling, MD / Professor|713-745-3219||
319501|NCT00496782|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
319502|NCT00506909|UCSD|David Feifel||dfeifel@kadimanp.com|
319503|NCT00487578|Clinvest|M.E. Beach|(417) 841-3618|mbeach@clinvest.com|
319504|NCT00503009|GlaxoSmithKline|GSK Response Center|866-435-7343||
319505|NCT00500045|Palo Alto Medical Foundation|Renee Kaneshiro|650-853-4744|kaneshr@pamf.org|
319506|NCT00499590|OPKO Health, Inc.|Jane Hsiao, PhD, MBA|305-575-6004|jhsiao@opko.com|
319507|NCT00501345|UT MD Anderson Cancer Center|Jean-Bernard Durand, MD / Professor||CR_Study_Registration@mdanderson.org|
319508|NCT00496756|University of Nebraska Medical Center|Ralph Hauke, MD|402-354-8124|rhauke@nebraskacancer.com|
319509|NCT00495716|University of Washington Virology Research Clinic|Clinic Director|206-520-4340|vrc@uw.edu|
319510|NCT00500890|UT MD Anderson Cancer Center|Dr. Richard Gorlick, MD/Division Head, Pediatrics Administration|713- 563-2516|rgorlick@mdanderson.org|
319511|NCT00503841|Barbara Ann Karmanos Cancer Institute|Dr. Elaina Gartner|313-576-8724|egartner@seagen.com|
319512|NCT00493025|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Rosalyn Juergens, MD.|410-908-7829|rjuerge1@jhmi.edu|
319513|NCT00491400|Boston University|Joseph A. Vita, MD|617-638-8700|jvita@bu.edu|
319514|NCT00490776|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
319515|NCT00487162|UMDNJ-NJMS|J. Jeffrey Freda, MD, MBA|973 972-5007|jjfreda@umdnj.edu|
319516|NCT00487981|Boston Scientific|Lyn M. Pimentel, M.B.A.|(661) 949-4174|Lyn.Pimentel@bsci.com|
319517|NCT00491387|University of Cincinnati|Myron Gerson MD|5135583974|myron.gerson@uc.edu|
319518|NCT00475332|University of Florida|Bridget Fitzgerald, Clinical trials coordinator|(352) 265-0680|fitzgb@shands.ufl.edu|87829
293797|NCT01514396|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
305837|NCT02362789|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
319519|NCT00483119|NYU School of Medicine|Elise Kelman, Associate Director of Research Administration|2122639073|elise.kelman@nyumc.org|
319520|NCT00487461|University of Illinois at Chicago|Ali Alaraj, MD|312-996-4842|alaraj@uic.edu|
319521|NCT00484718|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319522|NCT00477230|CardioFocus, Inc.|Burke T. Barrett, Study Director|508 658-7200|bbarrett@cardiofocus.com|
319523|NCT00470067|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
319524|NCT00476827|Duke University|Kimberly Blackwell, MD|919-668-1748|kimberly.blackwell@duke.edu|
319525|NCT00475657|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
319526|NCT00472082|Emory University|Kenneth A. Newell, MD, PhD|404-727-2489|kanewel@emory.edu|
319527|NCT00478062|Johns Hopkins Sidney Kimmel Cancer Center|Yvette Kasamon|4109135018|ykasamon@jhmi.edu|
319528|NCT00470574|Memorial Sloan Kettering Cancer Center|Teresa Gilewski, MD|(212) 639-2000|gilewskt@mskcc.org|
319529|NCT00467753|UMDNJ|Sherie Novotny, MD|(732) @35-4119|novotnsl@rutgers.edu|
319530|NCT00456612|Beth Israel Deaconess Medical Center|Anand Mahadevan, MD|617-667-2345|amahadev@bidmc.harvard.edu|
319531|NCT00469612|The Ohio State University|Dr. Don Mutti|614-247-7057|mutti.2@osu.edu|
319532|NCT00461812|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
319533|NCT00459121|Barbara Ann Karmanos Cancer Institute|Shirish Gadgeel, M.D.|313-576-8753|sgadgeel@med.umich.edu|
319534|NCT00461682|GlaxoSmithKline|GSK Response Center|866-435-7343||
319535|NCT00462904|University of Texas Southwestern Medical Center|Joseph Minei|214-648-3917|joseph.minei@utsouthwestern.edu|
319536|NCT00450333|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
319537|NCT00455143|Icahn School of Medicine at Mount Sinai|Department of Anesthesiology|212-241-7473||
319538|NCT00456989|University of Louisville, James Graham Brown Cancer Center|University of Louisville, James Graham Brown Cancer Center Clinical Trials|502-562-3429|ctobcc@louisville.edu|
319539|NCT00448682|University of Miami Sylvester Comprehensive Cancer Center|Bach Ardalan MD|305-243-6608|bardalan@med.miami.edu|
319540|NCT00454571|The University of Chicago|Walter M. Stadler, MD|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu|
319541|NCT00452361|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
319542|NCT00443040|Tioga Pharmaceuticals|Dr. Allen Mangel, Chief Medical Officer|919-485-5668|mangel@tiogapharma.com|
319543|NCT00447421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
319544|NCT00441272|National Institute of Allergy and Infectious Diseases|Colleen Hadigan, MD, MPH|301-594-5754|hadiganc@niaid.nih.gov|
319545|NCT00437398|Mayo Clinic|Dr. Yogish Kudva|507-284-3964|kudva.yogish@mayo.edu|
305838|NCT02363010|Drexel University|Dr. Meghan Butryn|215-553-7108|mlb34@drexel.edu|
319546|NCT00440271|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
293798|NCT01514422|Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai|Dr. Dan V. Iosifescu|212-241-4480|dan.iosifescu@mssm.edu|
293799|NCT01514448|Novartis Pharmaceuticals|Study Director|862-778-8300||
293800|NCT01514461|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
293801|NCT01514513|Tec Laboratories, Inc.|Wendy Langley|5419264577|wendy@teclabsinc.com|338
319547|NCT00442260|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
319548|NCT00429026|U.T. M.D. Anderson Cancer Center|Naoto Ueno, MD, PhD / Associate Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
319549|NCT00428207|Joslin Diabetes Center|Howard Wolpert, MD|6173092665|howard.wolpert@joslin.harvard.edu|
319550|NCT00439569|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
319551|NCT00422669|Medtronic, Inc.|Optimize RV Trial Leader|1-800-328-2518|medtroniccrmtrials@medtronic.com|
319552|NCT00432445|University of Texas (UT) MD Anderson Cancer Center|Dan Gombos, MD/Professor, Ophthalmology|713-792-6920|CR_Study_Registration@mdanderson.org|
319553|NCT00434590|Novartis Pharmaceuticals|Study Director|862-778-8300||
319554|NCT00424645|UT MD Anderson Cancer Center|Saroj Vadhan, MD||CR_Study_Registration@mdanderson.org|
270426|NCT00127842|Amgen Inc.|Study Director|866-572-6436||
293802|NCT01514630|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
293803|NCT01514682|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
319555|NCT00430027|University of Colorado, Denver|Dr. Tracey Schefter|720-848-0100|Tracey.Schefter@ucdenver.edu|
293804|NCT01514734|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
293805|NCT01514760|University of Arkansas for Medical Sciences|Dr. Tamara T. Perry|501-364-3264|perrytamarat@uams.edu|43264
293806|NCT01514786|UMichigan|Dr. Masahito Jimbo|734-998-7120|mjimbo@med.umich.edu|
305839|NCT02363270|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
305840|NCT02363283|UT MD Anderson Cancer Center|Dr. Sapna Pradyuman Patel,MD/ Melanoma Medical Oncology|713-792-2921|SPPatel@mdanderson.org|
305841|NCT02363322|NIAID/LIR|Dr. Richard T. Davey, Jr.|301-496-8029|rdavey@niaid.nih.gov|
305842|NCT02363439|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
305843|NCT02363478|"Academic Department of Gastroenterology, LAIKON General Hospital"|Dr. George P. Karamanolis|+30.213.2061307|georgekaramanolis@yahoo.co.uk|
305844|NCT02363621|Sierra Eye Associates|Dr. Arshad Khanani|775-329-0286|Arshad.Khanani@gmail.com|
305845|NCT02363686|University of Colorado|Carrie Higgins|7205603037|carrie.higgins@cuanschutz.edu|
305846|NCT02363738|University Health Network|Dr. Roger McIntyre|416-603-5279|roger.mcintyre@uhn.ca|
305847|NCT02363803|Washington University in St. Louis|Dr. Simon Haroutounian|3143622628|sharout@wustl.edu|
305848|NCT02363907|Dexcom|Eileen Casal, RN, MSN|8588759774|ecasal@dexcom.com|
314261|NCT03280615|Institute of Nutrition and Food Technology University of Chile|Dr. Francisco Perez Bravo, Director|+5629781411|fperez@inta.uchile.cl|
314262|NCT03281200|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314263|NCT03281304|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
314264|NCT03281538|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
314265|NCT03281577|Takeda|Medical Director|+1-877-825-3327|takedadisclosures@takeda.com|
314266|NCT03281668|University of North Carolina at Chapel Hill/Thurston Arthritis Research Center|Yvonne Golightly, PhD|919-966-0566|golight@email.unc.edu|
314267|NCT03281876|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314268|NCT03282071|The University of Hong Kong|Dr. Yuying Sun|(852)39179144|gyysun@hku.hk|
314269|NCT03282227|Zosano Pharma Corporation|Donald Kellerman, PharmD, Sr. VP, Clin Dev and Med Affairs|(510) 745-4004|dkellerman@zosanopharma.com|
314270|NCT03282240|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
314271|NCT03282357|Merz Pharmaceuticals GmbH.|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
314272|NCT03282591|Menlo Therapeutics Inc.|Anna Gururajan|(650) 486-1416|agururajan@menlotx.com|
314273|NCT03282682|Comenius University in Bratislava|Doc. Mgr. Milan Sedliak, PhD.|+421918340671|milan.sedliak@uniba.sk|
319556|NCT00429858|University of California, San Francisco|Dr. Andrew Ko, MD|(415) 353-7286|Andrew.Ko@ucsf.edu|
314274|NCT03283098|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
319557|NCT00425438|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
319558|NCT00421954|New York State Psychiatric Institute|Linda Sherman|(646) 774-7158|lsherma@nyspi.columbia.edu|
319559|NCT00422942|Hoffmann-LaRoche|Medical Communications Organization|800-821-8590|genentech@druginfo.com|
319560|NCT00409344|Massachusetts General Hospital|Ulrich Schmidt, MD PhD|617-724-6490|uschmidt@partners.org|
293807|NCT01514864|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
319561|NCT00414453|University of Rochester|Robert H Dworkin|275-8214|robert_dworkin@urmc.rochester.edu|
319562|NCT00417248|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
319563|NCT00418145|Icahn School of Medicine at Mount Sinai|Dr. Fred Lublin|212-241-6854|fred.lublin@mssm.edu|
319564|NCT00418301|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
319565|NCT00409331|UT MD Anderson Cancer Center|Mark Chambers, DMD / Associate Professor|713-745-2672||
319566|NCT00392860|Human Engineering Research Laboratories|Michael L Boninger|412-822-3700|boninger@upmc.edu|
319567|NCT00391430|NYU Langone|Marylene Cloitre|2122632471|marylene.cloitre@nyulangone.org|
319568|NCT00399841|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
319569|NCT00387673|Miami VA Healthcare System|Kristina Beekhuizen|305-575-7000|Kristina.Beekhuizen@va.gov|
319570|NCT00386724|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
319571|NCT00387244|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
319572|NCT00384293|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
319573|NCT00383630|Columbia University|Yoshifumi Naka, MD, PhD|(212) 305-0828|yn33@columbia.edu|
319574|NCT00374543|Massachusetts General Hospital|Naomi M. Simon, M.D., M.Sc.|(617) 726-7913|nsimon@partners.org|
319575|NCT00377455|Georgetown University|Dr. Virginia Steen|202-444-6200|steenv@georgetown.edu|
319576|NCT00371462|Edward Hines Jr., VA Hospital|Associate Chief of Staff for Research|708-202-5689|eileen.collins@va.gov|
319577|NCT00369265|Philadelphia ENT Associates|Robert T. Sataloff, M.D., D.M.A., FACS|215-545-3322|rtsataloff@phillyent.com|
319578|NCT00370695|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
319579|NCT00364689|University of Miami|Clinical Trial Disclosure Manager|305-243-0494|y.p.davis@med.miami.edu|
319580|NCT00352118|Masonic Cancer Center, University of Minnesota|Frank Ondrey, M.D.|612-625-3200|ondre002@umn.edu|
319581|NCT00368654|Kaiser Permanente (Current), UC Davis (Previous)|Chai Sue Lee||lam.nguyen@ucdmc.ucdavis.edu|
319582|NCT00356421|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
319583|NCT00350623|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
319584|NCT00356187|Denver Health and Hospital Authority|Elizabeth Kingsley, Senior Grants Analyst|3036027061|elizabeth.kingsley@dhha.org|
319585|NCT00353275|UT Health Science Center at Houston|Dr. Lillian S. Kao|713-566-5095|Lillian.S.Kao@uth.tmc.edu|
319586|NCT00350844|Ann and Robert H. Lurie Children's Hospital of Chicago|Dr. Robert I. Liem|312-227-4842|Rliem@luriechildrens.org|
319587|NCT00348556|Mayo Clinic|Dr. Horng Chen|507-284-8846|chen.horng@mayo.edu|
319588|NCT00319839|University of California, Irvine|Chao Family Comprehensive Cancer Center|(877) 827-8839|UCstudy@uci.edu|
319589|NCT00344019|BIDMC|Director of Clinical Trials|6176678800|dcutlip@bidmc.harvard.edu|
319590|NCT00338455|Scios R&D, Inc.|Sr. Director Clinical Leader|650 564-5084||
319591|NCT00329108|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
319592|NCT00325572|Milton S. Hershey Medical Center|Jeanette C. Ramer MD|717 531-8414|jramer2@hmc.psu.edu|
319593|NCT00333762|VA Pittsburgh Healthcare System|Dana Sinciline|412-822-3683|dana.sinciline@va.gov|
319594|NCT00333229|Novartis Pharmaceuticals|Study Director|862-778-8300||
319595|NCT00322855|University of New Mexico|Christine M. Gan, Ph.D|5059250387|cgan@salud.unm.edu|
305849|NCT02363933|Duke University Medical Center|Katherine Peters, MD, PhD|9196846173|katherine.peters@duke.edu|
319596|NCT00323635|Brigham and Women's Hospital|Quentin Regestein|617-732-4497|qregestein@partners.org|
319597|NCT00329732|Thomas Jefferson University|Kathleen Bradley|215-955-2025|Kathleen.Bradley@jefferson.edu|
319598|NCT00320931|University of Maryland, Baltimore|Vasken Dilsizian, MD|410-328-6890|vdilsizian@umm.edu|
319599|NCT00314353|NSABP Foundation, Inc.|Diana Gosik|412-330-4692|diana.gosik@nsabp.org|
319600|NCT00314093|University of Texas Southwestern Medical Center|Dr. Ellen Vitetta|214-648-1200|ELLEN.VITETTA@UTSouthwestern.edu|
319601|NCT00314327|NSLIJ|Delbert Robinson, M.D.|718-470-8195|Drobinson@nshs.edu|
319602|NCT00308113|University of Pittsburgh|Dr. Paula R. Clemens|412-648-9762|pclemens@pitt.edu|
319603|NCT00305643|UT MD Anderson Cancer Center|Scott Kopetz, MD, PHD / Assistant Professor||CR_Study_Registration@mdanderson.org|
319604|NCT00298740|Johns Hopkins University|Johns Hopkins ClinicalTrials.gov Program|410-550-6484|registerclinicaltrials@jhmi.edu|
319605|NCT00301080|Northwestern University|Clinical Research Office|312-695-1301|cancertrials@northwestern.edu|
319606|NCT00299195|Memorial Sloan Kettering Cancer Center|Dr. Jay Boyle, MD|212-639-2906|boylej@mskcc.org|
319607|NCT00290407|James Graham Brown Cancer Center|Roger H Herzig, MD|502/396-3119|rhherz01@louisville.edu|
319608|NCT00295490|University of Southampton|Dr Sarah Brien|07870642667|sbb@southampton.ac.uk|
319609|NCT00268463|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
319610|NCT00271102|Geisinger|Office of Research Compliance|570-214-9628|orc@geisinger.edu|
319611|NCT00276419|Mayo Clinic|Dr. Robin L. Smith|507-284-1210|smith.robin@mayo.edu|
319612|NCT00279409|USSF|Laurence Greenhill||larrylgreenhill@gmail.com|
319613|NCT00281879|OHSU Knight Cancer Institute|Dr. Richard Maziarz|503-494-1551|maziarzr@ohsu.edu|
293808|NCT01515046|The University of Iowa|Joseph J. Cullen, MD, FACS|319-353-8297|joseph-cullen@uiowa.edu|
319614|NCT00271947|Northwestern University|Dr Richard Burt|312-908-0059|rburt@northwestern.edu|
319615|NCT00271011|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski|734-615-3969|zalupski@umich.edu|
319616|NCT00253981|William Beaumont Army Medical Center|COL Richard Petri, Chief Integrative Pain Management|915-742-3245|richard.petri@amedd.army.mil|
319617|NCT00252174|McLean Hospital at time of study|John H. Halpern, M.D.|6179065063|jhalpern@recoverycoa.com|
319618|NCT00256295|University of California, Irvine|Nicole Macaranas|714-456-6550|nicole.macaranas@uci.edu|
319619|NCT00245128|OHSU Knight Cancer Institute|Dr. Michael Mauro|503-494-1080|maurom@ohsu.edu|
319620|NCT00268450|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
319621|NCT00239720|University of Chicago|Marcus Clark, MD|773-702-0202|mclark@medicine.bsd.uchicago.edu|
319622|NCT00250718|University of New Mexico|Dulcinea Quintana, MD|505-272-4661|dcandelaria@salud.unm.edu|
319623|NCT00244010|St. Jude Children's Research Hospital|Kimberly Kasow, DO|901-595-3300|kimberly_kasow@med.unc.edu|
319624|NCT00218036|The University of Texas Health Science Center at Houston|Joy M Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
319625|NCT00240227|VA Puget Sound Health Care System|Andrew J. Saxon, M.D.|206-764-2782|andrew.saxon@va.gov|
319626|NCT00205868|Boston Scientific|Director, Clinical Research Sciences|6619494350|roshini.jain@bsci.com|
319627|NCT00206375|Texas Children's Hospital, Baylor College of Medicine|Dr. MJ Redondo (designated by the institution to enter results)|832-822-1019|redondo@bcm.edu|
319628|NCT00229931|Dean McGee Eye Institute|Robert E. Leonard, II, MD|405-271-6307|sonny-icks@dmei.org|
319629|NCT00209131|Emory University|Dr. Kenneth Ogan|404-778-4898|kogan@emory.edu|
319630|NCT00233090|Icahn School of Medicine at Mount Sinai|Wayne A Gordon, PhD|212-659-9372|wayne.gordon@mssm.edu|
319631|NCT00214149|UW Hospital and Clinics|Diana Trask, research coordinator for study|608-263-9528|trask@humonc.wisc.edu|
319632|NCT00205049|University of Wisconsin|Research Program Manager - Kelly Richie|608-262-5404|kr2@medicine.wisc.edu|
319633|NCT00209027|Emory University|Erica Duncan|404-321-6111|erica.duncan@va.gov|7532
319634|NCT00182637|UC Irvine|Dr. Lauren Pinter-Brown|(714) 456-5153|lpinterb@uci.edu|
319635|NCT00176488|Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
319636|NCT00179127|Vanderbilt University Medical Center|Sheila McMorrow|615-343-8332||
319637|NCT00183963|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|Victoria.Soto@med.usc.edu|
319638|NCT00178477|University of Rochester Medical Center|Walter O'Dell, Ph.D.|585-275-9996|walter_odell@urmc.rochester.edu|
319639|NCT00162773|Johns Hopkins University School of Medicine|Clinical Trials Program JHU ICTR|410-550-6484|registerclinicaltrials@jhmi.edu|
319640|NCT00176631|Rutgers Cancer Institute of New Jersey|Dr. Robert DiPaola, MD|732-235-8675|dipaolrs@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
319641|NCT00176501|Rutgers Cancer Institute of New Jersey|Dr. Roger Strair, MD, PhD|732-235-8675|strairrk@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
319642|NCT00177970|UPittsburgh|Dr. George Arnold|4126212334|arnoldgl@upmc.edu|
319643|NCT00177866|University of Pittseburgh|George Arnold, MD|412 621-2334|Arnoldgl@upmc.edu|
319644|NCT00147238|UT MD Anderson Cancer Center|Haesun Choi, MD / Professor|713-745-4693||
319645|NCT00165503|Brigham and Women's Hospital|Dr. David Sugarbaker|617-732-5004|dsugarbaker@partners.org|
319646|NCT00160563|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
319647|NCT00142519|Memorial Sloan Kettering Cancer Center|Dr. Natalia Moryl, MD|646-888-2681|moryln@mskcc.org|
319648|NCT00145704|Upstate Orthopedics|Timothy A. Damron|315-464-8602|damront@upstate.edu|
319649|NCT00138073|Massachusetts General Hospital|Jaime Chang|617-726-9069|jchang4@partners.org|
319650|NCT00113386|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
319651|NCT00138151|Rutgers Cancer Institute of New Jersey|Lorna Rodriguez, MD, PhD|732-235-8675|rodriglo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
319652|NCT00129974|Tufts Medical Center|Research Administration||mcoughlin@tuftsmedicalcenter.org|
319653|NCT00126659|UT MD Anderson Cancer Center|Eric Jonasch, MD / Associate Professor||caperez@mdanderson.org|
319654|NCT00133679|University of California, San Francisco|Roberta Keller, MD|(415) 476-1888|roberta.keller@ucsf.edu|
293809|NCT01515072|Rutgers-New Jersey Medical School|Baburao Koneru, MD, MPH|(973) 972-9599|koneruba@njms.rutgers.edu|
293810|NCT01515176|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-293-3507|Jeffrey.Jones@osumc.edu|
293811|NCT01515189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
293812|NCT01515306|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293813|NCT01515319|Imperial College London|Dr Tricia Tan|020 838 38038|t.tan@imperial.ac.uk|
319655|NCT00125268|Mayo Clinic|Dr. Matthew A. Butters|480-301-7745|butters.matthew@mayo.edu|
319656|NCT00113399|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
319657|NCT00118053|Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-8675|toppmede@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
319658|NCT00107614|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
319659|NCT00107315|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
319660|NCT00108433|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319661|NCT00113919|University of Arkansas for Medical Sciences|Nathan Petty|501-837-3894|pettynathanm@uams.edu|
319662|NCT00108342|Department of Veterans Affairs - VAGLA|Nina G. Schneider, Ph.D., Principle Investigator|310-268-3059|ngs@ucla.edu|
319663|NCT00100828|SKCCC at Johns Hopkins|Arlene Forastiere|410-955-9818|af@jhmi.edu|
319664|NCT00104728|H. Lee Moffitt Cancer Center and Research Institute|Dr. Eric Haura|813-745-6826|eric.haura@moffitt.org|
319665|NCT00089414|Behavioral Endocrinology Branch/National Institute of Mental Health/NIH|Pedro E. Martinez, M.D., Principal Investigator|301-402-0615|martinep@mail.nih.gov|
319666|NCT00083915|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
319667|NCT00090870|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
319668|NCT00088972|SWOG|Study Statistician|206-667-4623||
319669|NCT00088829|Georgetown University Medical Center|Claudine Isaacs, MD|202-444-3677|isaacsc@georgetown.edu|
319670|NCT00089128|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
319671|NCT00075608|Boston Medical Center|Principal Investigator|617-638-8261|sfenness@bu.edu|
319672|NCT00074724|MedStar Health Research Institute|Scientific Center Administrator|301-560-7300|Research@medstar.net|
319673|NCT00085631|Duke University Medical Center|Dr Mark Dewhirst|919 6683726|joan.cahill@dm.duke.edu|
319674|NCT00062751|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
319675|NCT00066807|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
319676|NCT00058188|Northwestern University|Clinical Trials Office|312-695-1301||
319677|NCT00014560|Dartmouth Hitchcock|Dr. Pamela Ely|603-653-9071||
319678|NCT00038142|The University of Texas (UT) MD Anderson Cancer Center|Dr. Eugenie S. Kleinerman, Professor, Pediatrics - Research|713-792-8110|ekleiner@mdanderson.org|
319679|NCT00020722|Barbara Ann Karmanos Cancer Institute|Lawrence G. Lum, M.D., D.Sc|(313) 576-8326|luml@karmanos.org|
319680|NCT00002975|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
319681|NCT00006478|University of Nebraska Medical Center Division of Oncology/Hematology|Bryan Ludwig, Regulatory Coordinator|402-559-8071|bmludwig@unmc.edu|
319682|NCT00019747|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
319683|NCT00006916|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
319684|NCT00003726|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|james.r.rigas@hitchcock.org|
319685|NCT04051996|Yale University|Dr. Amer Zeidan|(203) 200-4363|amer.zeidan@yale.edu|
319686|NCT02970799|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
319687|NCT02385292|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
319688|NCT02126878|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
319689|NCT02221817|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
319690|NCT02595996|Columbia University Irving Medical Center|June K. Wu, MD|212-342-3704|jw92@cumc.columbia.edu|
319691|NCT03879044|The Ohio State University Wexner Medical Center|Dr. Ulysses Magalang|614-292- 4307|Ulysses.Magalang@osumc.edu|
319692|NCT03198156|The Ohio State University Wexner Medical Center|Dr. Ulysses Magalang|614-292- 4307|Ulysses.Magalang@osumc.edu|
319693|NCT02009384|University of Louisville|Jason Chesney|502-562-3429||
319694|NCT04558125|Cedars-Sinai Medical Center|Victor Tapson, MD|919-971-6441|Victor.Tapson@cshs.org|
319695|NCT02401308|St. Joseph's Hospital and Medical Center|Lisa Arnold - Operations Manager Neurosurgery Clinical Research|602-406-9593|lisa.arnold@dignityhealth.org|
319696|NCT04381988|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@MSKCC.ORG|
319697|NCT00521885|Lehigh Valley Health Network|Leslie Baga, Director of Research|610 402 1285|Leslie.Baga@lvhn.org|
319698|NCT02376946|TuftsU|Dr. Archana Viswanath|617-636-3578|Archana.Viswanath@tufts.edu|
319699|NCT01780636|UC Irvine|Karen Noblett|714-456-6807|knoblett@uci.edu|
319700|NCT00479167|Rush University Medical Center|Stephanie Gregory, MD|312-942-5982|stephanie_gregory@rush.edu|
319701|NCT03998189|Wake Forest Baptist Comprehensive Cancer Center|Study Coordinator|336-713-4550|aohlmans@wakehealth.edu|
319702|NCT02212574|Johns Hopkins University|Dr. Kenneth Cohen|(410) 614-5055|kcohen@jhmi.edu|
319703|NCT04422210|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
319704|NCT04298918|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
319705|NCT01996371|OhioU|Shelby Miracle|614-366-1648|shelby.miracle@osumc.edu|
319706|NCT01561378|Montefiore Medical Center|Daniel Ceusters|718-920-2956|dceuster@montefiore.org|
293814|NCT01515345|Kaiser Franz Josef Hospital|Univ.Prof. Dr Günter Christ|+43160191|guenter.christ@wienkav.at|2508
293815|NCT01515410|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
305850|NCT02363946|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|6263043400||
319707|NCT00955929|Memorial Sloan Kettering Cancer Center|John Mulhall, MD|646-888-6024|mulhalj1@mskcc.org|
319708|NCT00402883|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
319709|NCT03482505|Masimo|Cristina Johnson|949-297-7000|clinicalresearchdept@masimo.com|
319710|NCT02934503|NYU Langone|Dr. Joshua Sabari|212-731-6363|Joshua.Sabari@nyulangone.org|
319711|NCT02137252|Dana-Farber Cancer Institute/Brigham and Women's Hospital|Fremonta Meyer, MD||flmeyer@partners.org|
319712|NCT03863522|Johns Hopkins University|Dr. Sara Sukumar|4106142479|saras@jhmi.edu|
319713|NCT01294670|Memorial Sloan Kettering Cancer Center|Tanya Trippett, MD|1-833-MSK-KIDS|trippet@mskcc.org|
319714|NCT03095287|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
319715|NCT03236662|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
319716|NCT02930122|University of Kentucky|Dr. Cale Jacobs|859-218-3065|cale.jacobs@uky.edu|
319717|NCT01444209|University of Texas Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|robert.timmerman@utsouthwestern.edu|
319718|NCT00893516|Emergent Biosolutions|Caryl Iledan, Clinical Research Specialist|2042754169|iledanc@ebsi.com|
319719|NCT04267380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319720|NCT04144166|North Shore University Hospital|Director of Clinical Research for Emergency Medicine|(516) 562-1513|TLi2@northwell.edu|
319721|NCT04090164|Mansoura University|Osama Hussein|00201099815110|osamahussein@mans.edu.eg|
319722|NCT04047121|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319723|NCT04036799|Hospital for Sick Children|Seema Mital, Staff Cardiologist|416-813-7418|seema.mital@sickkids.ca|
319724|NCT04018001|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319725|NCT04017754|Aalborg University Hospital, Gynecologic and Obstetric department|Caroline Nørgaard-Pedersen|+45 41120267|carolinenp94@gmail.com|
319726|NCT04010370|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
319727|NCT03997825|Relievant Medsystems|Diane Sahr, VP of Clinical Research|(650) 368-1000|dsahr@relievant.com|
319728|NCT03975790|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319729|NCT03979079|Institut Bergonié|Dr Carine Bellera|33 0 5 56 33 04 95|c.bellera@bordeaux.unicancer.fr|
319730|NCT03895632|Medical Physics & Clinical Engineering, Royal Liverpool Hospital|Dr. Tristan Payne|0151 7064225|tristan.payne@nhs.net|
319731|NCT03859622|Karl Landsteiner Institute of General Medicine|Dr.med.Gustav Kamenski|+4322832226|kamenski@aon.at|
319732|NCT03764813|Fondazione Policlinico Gemelli IRCCS|luciana teofilili medical director of the UNICATT cord blood bank|39 06 30154180|luciana.teofili@unicatt.it|
293816|NCT01515423|Janssen Research & Development, LLC|Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
293817|NCT01515475|Jaeb Center for Health Research|Ray Kraker M.S.P.H.|813-975-8690|rkraker@jaeb.org|
293818|NCT01515488|Maricopa Integrated Health System|Madhumita Sinha, MD, MHSM|602-344-5404|madhumita_sinha@dmgaz.org|
293819|NCT01515540|Northwestern University|Javeria Ali Hashmi|3125037991|j-hashmi@northwestern.edu|
293820|NCT01515566|University of Texas MD Anderson Cancer Center|David Hui, MD, MSc, FRCPC / Asst. Professor, Palliative Care and Rehabilitation Medicine|713-792-6085|CR_Study_Registration@mdanderson.org|
293821|NCT01515657|PLx Pharma|Ronald Zimmerman|1-713-842-1249|ron.zimmerman@plxpharma.com|205
293822|NCT01515696|Medical University of Vienna|Nadja Haiden M.D.|+431404003232|nadja.haiden@meduniwien.ac.at|
293823|NCT01515748|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
293824|NCT01515865|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
293825|NCT01515891|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
319733|NCT00078806|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
319734|NCT00162370|Lantheus Medical Imaging|Director, Clinical Operations|978-671-8118|Sandra.Monte@lantheus.com|
319735|NCT00204737|University of Wisconsin - Madison|Catherine Johnson|608-280-7084|catherine.johnson2@va.gov|
319736|NCT00214500|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
319737|NCT00278343|Juarvinski Cancer Centre|Dr. Hal Hirte|905-387-9495|hirteh@hhsc.ca|
319738|NCT00283959|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
319739|NCT00290758|NorthwesternU|Seema Khan, MD|312-695-0288|skhan@nmh.org|
319740|NCT00310388|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
319741|NCT00345358|GlaxoSmithKline|GSK Response Center|866-435-7343||
319742|NCT00372229|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
319743|NCT00383708|Ipsen|Medical Director, Endocrinology||clinical.trials@ipsen.com|
293826|NCT01515943|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
319744|NCT00413699|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319745|NCT00435227|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
319747|NCT00442546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
319748|NCT00545129|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319750|NCT00554606|Novartis|Study Director|+41613241111|Novartis.email@novartis.com|
319752|NCT00565461|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
319754|NCT00586924|MedImmune, LLC|Nai Shun Yao, MD|1-301-398-5936|information.center@astrazenea.com|
319756|NCT00641537|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
319757|NCT00655824|GlaxoSmithKline|GSK Response Center|866-435-7343||
319758|NCT00663052|Wyeth, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319759|NCT00686374|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
319760|NCT00698828|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
293827|NCT01515956|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|PSlasor@bmrn.com|
319761|NCT00712933|GlaxoSmithKline|GSK Response Center|866-435-7343||
319762|NCT00725985|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
319763|NCT00799266|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
319764|NCT00810446|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319765|NCT00844480|Northwestern University|Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
319766|NCT00864474|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319767|NCT00873366|Mayo Clinic|Dr. Matthew P. Goetz|507-284-2511|goetz.matthew@mayo.edu|
319768|NCT00923247|National Cancer Institute|Dr. Ravi Madan|301-480-7168|madanr@mail.nih.gov|
319769|NCT00928226|Stanford University|Scott Soltys, Associate Professor of Radiation Oncology|65072441569|sgsoltys@stanford.edu|
319771|NCT00940498|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319772|NCT01009294|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
319773|NCT01049035|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
319774|NCT01053637|BAYLOR COLLEGE OF MEDICINE|Corrie E. Chumpitazi|832 824-1353|corriec@bcm.edu|
319775|NCT01072175|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
319776|NCT01087203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319778|NCT01108055|Stanford University|Sandy Srinivas, MD|650 498 6000|sandysri@stanford.edu|
319780|NCT01136967|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
319781|NCT01136980|EndoGastric Solutions|Adrain Lobontiu|+16504749259|alobontiu@endogastricsolutions.com|
319783|NCT01174563|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
319784|NCT01190202|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
319785|NCT01200862|Mereo BioPharma|Dr. Jackie Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
319786|NCT01225341|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
319787|NCT01235962|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
319788|NCT01239368|National Cancer Institute|Dr. Steven Pavletic|301-402-4899|steven_pavletic@nih.gov|
319789|NCT01266031|National Cancer Institute|Dr. Mark Gilbert|301-402-6383|gilbertmr@mail.nih.gov|
319790|NCT01287741|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
319791|NCT01304316|University of Pennsylvania|Dr. Elliot V. Hersh|215-898-9686|evhersh@pobox.upenn.edu|
319792|NCT01313689|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
319794|NCT01318993|GlaxoSmithKline|GSK Response Center|866-435-7343||
270427|NCT00127855|GlaxoSmithKline|GSK Response Center|866-435-7343||
293828|NCT01515995|UT Southwestern Medical Center|Mohamed Badawy, MD|2144567106|mohamed.badawy@utsouthwestern.edu|
305851|NCT02363959|Duke University|Scott Shofer MD, PhD|919-668-2402|scott.shofer@duke.edu|
319746|NCT00436826|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
319749|NCT00548093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319751|NCT00555009|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
319753|NCT00566995|National Cancer Institute|Dr. W. Marston Linehan|301-496-6353|linehanm@mail.nih.gov|
319755|NCT00588861|Biomet Manufacturing|Nick Higdon, Clinical Research Specialist|1-800-348-9500|nicholas.higdon@biomet.com|3047
319770|NCT00930722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319777|NCT01088815|Johns Hopkins SKCCC|Dr. Ana De Jesus Acosta|443-287-0411|adejesu1@jhmi.edu|7-0411
319779|NCT01111019|Merck Healthcare, a business of Merck KGaA|Merck KGaA Communication Center|+49 6151 72 5200|service@merckgroup.com|
319782|NCT01140451|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
319793|NCT01315353|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
319795|NCT01335685|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
319796|NCT01336621|GlaxoSmithKline|GSK Response Center|866-435-7343||
305852|NCT02363972|Avenu Medical|Gene Reu EVP and General Manager|9492762483|greu@avenumedical.com|
293829|NCT01516008|Janssen Research & Development, L.L.C.|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
293830|NCT01516268|Tehran University of Medical Sciences|Dr. Laleh Eslamian|0098218490|leslamian@tums.ac.ir|2415
293831|NCT01516424|Shang Hai Mental health center|Dr.HuafangLi|13641625395|lhlh_5@163.com|
319797|NCT04391036|University of Pittsburgh Medical School|Dr. Leslie Meyn|412-641-4233|meynla@mwri.magee.edu|
319801|NCT03160521|Laboratorios Farmacéuticos Rovi, S.A.|Director of Medical Department|91 375 62 30|departamento.medico@rovi.es|
319802|NCT03143816|Barbara Davis Center for Diabetes, University of Colorado|Satish Garg MD|3037246713|satish.garg@ucdenver.edu|
319803|NCT03078192|Duke University Medical Center|Bastiaan Driehuys|919-684-7786|bastiaan.driehuys@duke.edu|
319804|NCT02959944|Pharmacyclics, LLC|Justin Wahlstrom MD|669-215-7210|jwahlstrom@pcyc.com|
319805|NCT02903823|Vanderbilt University Medical Center|Peter Konrad, MD PhD - PI|6153439822|peter.konrad@vumc.org|
319806|NCT02666183|Case Western Reserve University|Sara L. Douglas, PhD, RN, Professor FPB School of Nursing|216-368-0702|sld4@case.edu|
319807|NCT01547117|Vanderbilt University Medical Center|Alfredo Gamboa, MD|6158751003|alfredo.gamboa@vumc.org|
319808|NCT01431508|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
319809|NCT00871351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
319810|NCT00832455|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
319811|NCT00812006|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
319812|NCT00739050|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
319813|NCT00687531|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
319814|NCT00654628|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
319815|NCT00604812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
319816|NCT00536380|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
319817|NCT00521599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
319818|NCT00496834|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
319819|NCT00442897|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
319820|NCT00423579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
319821|NCT00394355|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
319822|NCT00359216|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
319823|NCT00166504|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
319824|NCT01345240|GlaxoSmithKline|GSK Response Center|866-435-7343||
319825|NCT01371305|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
319826|NCT01376323|GlaxoSmithKline|GSK Response Center|866-435-7343||
319827|NCT01386658|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
319828|NCT01386684|AbbVie|Global Medical Services|800-633-9110||
319829|NCT01403948|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
319830|NCT01404312|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
319831|NCT01425008|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
319832|NCT01470326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319833|NCT01480180|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
319834|NCT01504438|Duke University|James Nunley II, M.D.|919-684-4033|james.nunley@duke.edu|
319835|NCT01545050|CSL behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
319836|NCT01550302|University of Washington|Srdjan Jelacic|(206) 598-3777|sjelacic@uw.edu|
319837|NCT01555021|Massachusetts General Hospital, Boston, MA|John D. Matthews, M.D., M.Sc.|617-643-9095|jmatthews@partners.org|
319838|NCT01561430|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
319839|NCT01580813|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
319840|NCT01595009|Novartis Pharmaceuticals|Study Director|862-778-1873||
319841|NCT01620944|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
319842|NCT01627561|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
319844|NCT01652534|Northwestern University|Dr. Tanya Simuni|312-503-2970|tsimuni@nm.org|
319845|NCT01701583|University of Colorado|Jenny Stitt|303-724-7205|jenny.stitt@ucdenver.edu|
319846|NCT01714817|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
319847|NCT01755689|GlaxoSmithKline|GSK Response Center|866-435-7343||
319848|NCT01762761|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
270428|NCT00127933|Hoffman-LaRoche|Medical Communications|800-821-8590||
270429|NCT00128102|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270430|NCT00128180|UNewMexico|Gregory Mertz, MD|5059808601|gmertz@salud.unm.edu|
293832|NCT01516437|GlaxoSmithKline|GSK Response Center|866-435-7343||
293833|NCT01516632|Center for Innovative Public Health Reserch|Dr. Michele Ybarra|(877) 302-6858|michele@innovativepublichealth.org|1-801#
293834|NCT01516684|Wake Forest University Health Sciences|Thomas McLean|336-716-5440|tmclean@wakehealth.edu|
319798|NCT04170296|Endo Pharmaceuticals|David Hernandez, MD|800-462-3636|clinicaltrials@endo.com|
319799|NCT04039217|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
319800|NCT03998046|Northwestern University|Ronald Ackermann, MD, MPH|(312)-503-3232|r.ackermann@northwestern.edu|
319843|NCT01629511|UT MD Anderson Cancer Center|Dr. Chitra Hosing|713-792-8750|cmhosing@mdanderson.org|
319849|NCT01763788|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
319850|NCT01774370|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
271728|NCT00261040|The Ottawa Hospital - Ottawa Hospital Research Institute|Dr Paul Kim|613-737-8920|pkim@toh.ca|
293835|NCT01516736|Sandoz|Strategic Planning, Biopharmaceutical Clinical Development|+49 (0) 8024 476 - 0|biopharma.clinicaltrials@sandoz.com|
305853|NCT02363998|US WorldMeds|Medical Affairs||medinfo@usworldmeds.com|
305854|NCT02364037|Washington University School of Medicine|Rachel Paul|3147478176|paulr@wustl.edu|
319851|NCT01777295|GlaxoSmithKline|GSK Response Center|866-435-7343||
319852|NCT01787552|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
319853|NCT01807117|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Raj Paspulati|1-800-641-2422|Raj.Paspulati@UHhospitals.org|
319855|NCT01814826|Takeda|Medical director|+1-877-825-3327|trialdisclosures@takeda.com|
319856|NCT01829711|MedImmune, LLC|Priti Patel|+1-650-264-9079|information.center@astrazeneca.com|
319857|NCT01846273|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
319858|NCT01875185|Johns Hopkins University School of Medicine|RhondaLyn McLean|(215) 662-4949|rhondalyn.mclean@uphs.upenn.edu|
292565|NCT01434342|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
292566|NCT01434472|Fred Hutchinson Cancer Research Center|Dr. Ajay Gopal|206-606-2037|agopal@uw.edu|
292567|NCT01434641|St. Luke's-Roosevelt Hospital|E. Gordon DePuey, M.D.|212-523-3400|edepuey@chpnet.org|
292568|NCT01434654|St Vincent's Hospital, Sydney|Prof. Bruce Brew|+61 2 8382 1111|b.brew@unsw.edu.au|4100
319854|NCT01808261|GlaxoSmithKline|GSK Response Center|866-435-7343||
293836|NCT01516749|University of California, San Francisco|Kieron S. Leslie, MD|415-206-4777|lesliek@derm.ucsf.edu|
293837|NCT01516879|Amgen Inc.|Study Director|866-572-6436||
293838|NCT01516892|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
319859|NCT01887743|Children's Mercy Kansas City|Valentina Shakhnovich, MD|816-302-3068|vshakhnovich@cmh.edu|
282625|NCT00864708|NF/SG VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|(352) 376-1611|janis.daly@neurology.ufl.edu|5223
282626|NCT00864721|Ocala Oncology, Ocala, FL, USA|Dr. Craig Reynolds|352-732-4032|Craig.Reynolds@USOncology.com|
293839|NCT01516957|Bausch Health|Director of Clinical Trials|310-770-7750|anya.loncaric@bauschhealth.com|
319860|NCT01891643|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
293840|NCT01516970|Janssen-Cilag GmbH|Medical Leader, Medical Department||ClinicalTrialDisclosure@its.jnj.com|
293841|NCT01517074|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
293842|NCT01517178|Bispebjerg Hospital|Tonny Karlsmark||tkar0002@bbh.regionh.dk|
293843|NCT01517282|MorphoSys|Roman Korolkiewicz|+49 89 89927 208|roman.korolkiewicz@morphosys.com|
293844|NCT01517295|International Clinical Research Institute|Srinivas Nalamachu|913.317.5300|nalamachu@yahoo.com|
319861|NCT01900691|Cook Research Incorporated|Alan Saunders, MDR, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
319862|NCT01901432|ITALFARMACO S.p.A.|Medical Expert|+39 026443 258|p.bettica@italfarmaco.com|
319863|NCT01904279|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
319864|NCT01915498|Celgene Corporation|Anne McClain, Senior Manager|908-673-9100|ClinicalTrialDisclosure@Celgene.com|
319869|NCT01931098|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|mark.gilbert@nih.gov|
319870|NCT01945021|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319871|NCT01956669|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
319872|NCT01967823|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@mail.nih.gov|
319873|NCT01989676|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319875|NCT02001974|Dompé Farmaceutici|Pieradelchi Ruffini, MD|+39 (0)2 583831|info@dompe.it|
319876|NCT02014558|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
319878|NCT02024555|Vanderbilt University Medical Center|Wonder Drake, MD|(615) 322-2035|wonder.drake@vumc.org|
319879|NCT02034123|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
319880|NCT02040584|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
319881|NCT02045797|GlaxoSmithKline|GSK Response Center|866-435-7343||
319882|NCT02049710|Carnegie Mellon University, Social and Decision Sciences|Mandy Lanyon, Research Associate II|4122683249|mandy@cmu.edu|
319883|NCT02055547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
319884|NCT02064387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
319885|NCT02076178|GlaxoSmithKline|GSK Response Center|866-435-7343||
319886|NCT02079766|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
319888|NCT02087189|BIOTRONIK SE & Co. KG|Mathias Freudigmann, Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|1248
319889|NCT02112916|Children's Oncology Group|Results Reporting Coordinator|16264470064|resultsreportingcoordinator@childrensoncologygroup.org|
319891|NCT02134717|University of Pittsburgh|Kevin Gibson MD|412-624-7095|gibsonkf@upmc.edu|
319892|NCT02135029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319894|NCT02148133|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
319895|NCT02151383|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
319896|NCT02165215|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
319897|NCT02180217|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
319898|NCT02186457|Indiana University School of Medicine|Dr. Michael House|3179440113|michouse@iupui.edu|
319899|NCT02193867|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
319900|NCT02215096|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
319901|NCT02218697|GlaxoSmithKline|GSK Response Center|866-435-7343||
319903|NCT02224456|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
319904|NCT02231762|Ipsen|Medical Director||clinical.trials@ipsen.com|
319905|NCT02234843|Therapeutic Area Head|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
319906|NCT02243306|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
319907|NCT02246621|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
319908|NCT02257918|Louisiana State University Health Sciences Center|Stephanie N. Taylor, MD|(504) 658-2622|staylo2@lsuhsc.edu|
319910|NCT02290431|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
319911|NCT02314923|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
319912|NCT04821362|Ege University|Dr. Sercan Yalçınlı|+90 505 537 41 01|sercan.yalcinli@ege.edu.tr|
319913|NCT04524507|University of North Carolina at Chapel Hill|Luther Bartelt, MD|919-966-2537|barteltl@ad.unc.edu|
319914|NCT04382924|Algernon Pharmaceuticals|Dr. Christopher Bryan|2045572308|cbryan@algernonpharmaceuticals.com|
319915|NCT04166214|NYU Langone Health - Hansjörg Wyss Department of Plastic Surgery|Mary E. Northridge, PhD, MPH, Director of Dental Research|347-377-4342|Mary.Northridge@nyulangone.org|
319916|NCT03947788|NorthShore University HealthSystem|Emily White VanGompel|224-364-7300|ewhitevangompel@northshore.org|
319917|NCT03842436|Brigham and Women's Hospital|Peter R. Chai, MD, MMS|617-732-5640|pchai@bwh.harvard.edu|
319918|NCT03646162|Veru|Gary Barnette PhD CSO|9194263611|gbarnette@verupharma.com|
319919|NCT03462030|Johns Hopkins University|Dr. Robert Wood|410-955-5883|rwood@jhmi.edu|
319920|NCT03446768|University of California, San Diego, La Jolla, CA|Carl Stepnowsky, PhD|858-642-1240|cstepnowsky@health.ucsd.edu|
319921|NCT03405714|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
293845|NCT01517373|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319865|NCT01917318|University of Colorado|Michael H. Allen, M.D.|(303) 724-3300|Michael.Allen@ucdenver.edu|
319874|NCT01992653|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
319877|NCT02015455|University of Washington|Dr. Sandra K Johnston, PhD, RN Executive Administrative Director- CLEAR Center|206-221-7444|stonesk@uw.edu|
319887|NCT02081391|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|Clinical-Trials@grunenthal.com|3223
319890|NCT02114697|Emory University|John Oshinski PhD|404-727-5894|jnoshin@emory.edu|
319893|NCT02137239|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
319902|NCT02221037|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
319909|NCT02258542|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
319922|NCT03348514|University of Kansas Medical Center|Dr. John A Taylor III|913-588-8170|Jtaylor27@kumc.edu|
319923|NCT03253393|University of New South Wales|Dr Jacqueline Tan|+612 9385 6551|jacqueline.tan@unsw.edu.au|
319924|NCT03188822|UR Medicine Otolaryngology|Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
319925|NCT03128671|University of Miami|Cindy Munro|305-284-2107|cmunro@miami.edu|
319926|NCT03111732|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
319927|NCT03065244|Dept. of Pediatrics UCSD School of Medicine|Dr. Jane Burns|858-246-0155|jcburns@health.ucsd.edu|
282627|NCT00864851|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
319928|NCT02879305|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
319929|NCT02816736|Duke Clinical Research Institute|Kevin J. Anstrom, Ph.D., Director of Biostatistics|919-668-8902|kevin.anstrom@duke.edu|
319930|NCT02787850|Zeltiq Aesthetics|Kerrie Jiang, Sr. Director of Clinical, Regulatory and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
319931|NCT02713373|Roswell Park Comprehensive Cancer Center|Katy Wang|716-845-1300|Chong.Wang@RoswellPark.org|
319932|NCT02676284|Zambon S.A.U.|Antonio Esteras, MD|+34 93 544 64 00|antonio.esteras@zambongroup.com|
319933|NCT02632409|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
319934|NCT02516241|AstraZeneca|Medical Science Director|1-877-240-9479|information.center@astrazeneca.com|
282628|NCT00864916|Indiana University School of Medicine|Samir K. Gupta, MD|317-274-7926|sgupta1@iu.edu|
282629|NCT00865020|Novartis Pharmaceuticals|Study Director|862-778-8300||
282630|NCT00865046|VA Pittsburgh Healthcare System|Dr. Debra K. Weiner|412-360-2920|debra.weiner@va.gov|
282631|NCT00865098|Merck Serono Co., Ltd, Tokyo, Japan|Masataka Ota|+81 0 3 6853 8611||
293846|NCT01517412|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
319866|NCT01921218|Emory University|Idelberto R. Badell, MD|404-712-6562|ibadell@emory.edu|
319935|NCT02431702|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
319936|NCT02368002|University of Minnesota|Nancy Sherwood|612-625-4567|sherw005@umn.edu|
319937|NCT02200770|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
319938|NCT02136069|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
319939|NCT02086552|Mayo Clinic|Francis K Buadi, MD|507/284-2511|Kumar.Shaji@mayo.edu|
319940|NCT01839396|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494355|roshini.jain@bsci.com|
319941|NCT01517659|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
319942|NCT01209767|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
319943|NCT01186848|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
319944|NCT01040624|University of Florida Health Proton Therapy Institute|Nancy P. Mendenhall, MD|904-588-1000|rtoton@floridaproton.org|
319945|NCT01024608|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
319946|NCT00988247|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
319947|NCT00838981|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
319948|NCT00730639|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
319949|NCT00693238|University of Florida|Randal Henderson, MD, MBA|904-588-1800|rhenderson@floridaproton.org|
319950|NCT00363038|Northwestern University Department of Dermatology|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
319951|NCT04834362|National Institute of Neurosciences and Hospital, Dhaka|Dr. Mashfiqul Hasan|+8801816268746|mashfiqul.hasan@nins.gov.bd|
319952|NCT04681482|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319953|NCT04611789|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
319954|NCT04540952|Atrium Health|Dr. Paul Marshburn|704-619-2537|Paul.Marshburn@atriumhealth.org|
319955|NCT04537910|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
319956|NCT04441931|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
319957|NCT04355728|University of Miami|Camillo Ricordi|305-243-6913|ricordi@miami.edu|
319958|NCT04344535|Stony Brook University|Elliott Bennett-Guerrero|6314446026|elliott.bennett-guerrero@stonybrookmedicine.edu|
319959|NCT04254809|Southeast Louisiana Veterans Health Care System|Joseph Boffa, PhD|504-507-2000|joseph.boffa@va.gov|67372
319960|NCT04230122|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
319961|NCT04110366|Imperial College London|Dr Ryan Thwaites|(0044) 0203 3125730|r.thwaites@imperial.ac.uk|
319962|NCT04086693|Beaumont Health|Amit Bahl, MD|248-551-1792|Amit.Bahl@beaumont.edu|
319963|NCT04033068|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
319964|NCT03561597|KKWCH|Dr Chew Chu Shan Elaine|63946042|elaine.chew.c.s@singhealth.com.sg|
319965|NCT03446573|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
319966|NCT03402607|Duke University Health System|Linda Kaltenbach|919-681-6804|Linda.Kaltenbach@duke.edu|
319967|NCT03350984|University of Guanajuato|Dra. Paulina Crespo Morfin|+52 4431300112|pb.crespomorfin@outlook.es|
319968|NCT03277261|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
319969|NCT03277248|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
319970|NCT03179462|University of Arkansas for Medical Sciences|David D.Church, Ph.D.|5015265709|dchurch@uams.edu|
319971|NCT03099707|Brigham and Women's Hospital|Ingrid T. Katz|617-525-8194|ikatz2@bwh.harvard.edu|
319867|NCT01923168|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
319972|NCT03064763|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
319973|NCT03036267|Columbia University School of Nursing|Dr. Maureen George|2123051175|mg3656@cumc.columbia.edu|
319974|NCT02941146|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
319975|NCT02928224|Pfizer|Study Director|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
319976|NCT02922985|University of Texas Medical Branch|Emily Hadley|4022028626|ehadley15@gmail.com|
319977|NCT02906033|Helsinki University Hospital|MNSc Maria Pulkkinen|+358 50 427 2678|maria.pulkkinen@hus.fi|
270431|NCT00128193|Colorado State University, Department of Microbiology, Immunology and Pathology|Patrick J. Brennan, Ph.D.|970-491-6700|patrick.brennan@colostate.edu|
270432|NCT00128206|University of California, San Francisco|Mary White|415-476-5213|mary.white@nursing.ucsf.edu|
270433|NCT00128219|University of Pittsburgh School of Medicine|Sharon Hillier, Ph.D.|412-641-6435|hillsl@mwri.magee.edu|
270434|NCT00128401|National Institute of Mental Health|Cameron, Jennifer Ann|+1 301 402 9356|cameronj@mail.nih.gov|
270435|NCT00128492|Gilead Sciences, Inc.|Mark Bresnik, Director of Clinical Research|650-522-5934|Mark.Bresnik@gilead.com|
270436|NCT00128661|GlaxoSmithKline|GSK Response Center|866-435-7343||
270437|NCT00128713|New England Research Institutes|Susan Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
270438|NCT00128830|Tibotec Pharmaceuticals|Trial Physician|+32-14-607-767||
270439|NCT00128921|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
270440|NCT00129116|GlaxoSmithKline|GSK Response Center|866-435-7343||
270441|NCT00129129|GlaxoSmithKline|GSK Response Center|866-435-7343||
270442|NCT00129220|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
270443|NCT00129246|Associate Professor of Psychiatry and Program Director, Smoking Cessation Service at Smilow Cancer Hospital at Yale-New Haven|Benjamin A. Toll, PhD|(203) 974 5767|benjamin.toll@yale.edu|
270444|NCT00129259|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
270445|NCT00129272|The University of Tennessee|Uma Rao, MD|615-794-3351|urao@utk.edu|
270446|NCT00129285|University of Pennsylvania Treatment Research Center|Kyle Kampman|215-746-2764|kampman@mail.med.upenn.edu|
270447|NCT00129311|Yale Unviersity|Dr. Andrea Weinberger|203-974-7598|andrea.weinberger@yale.edu|
270448|NCT00129376|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
270449|NCT00129389|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
270450|NCT00129441|University of Pittsburgh|David A. Lewis, MD|(412) 246-6010|lewisda@upmc.edu|
270451|NCT00129467|Portland Veterans Affairs Medical Center|Dr. Linda Ganzini|(503) 220-8262|linda.ganzini@va.gov|56492
270452|NCT00129480|Portland VA Medical Center|Steven K. Dobscha MD|503-220-8262|steven.dobscha@va.gov|52207
270453|NCT00129545|Boston Scientific|Watchman Trial Manager|1-800-227-3422||
270454|NCT00129623|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
270455|NCT00129649|Imperial College London|Prof Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
270456|NCT00129701|Imperial College London|Prof Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
270457|NCT00129727|Massachusetts General Hospital|Richard T Penson MD MRCP|617-726-5867|rpenson@partners.org|
270458|NCT00129740|The University of Texas MD Anderson Cancer Center|Cortes,Jorge E, MD./Professor|713-794-5783|jcortes@mdanderson.org|
270459|NCT00129766|MedImmune|M. Pamela Griffin, Sr. Director, Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
270460|NCT00129935|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
270461|NCT00129961|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
270462|NCT00129987|Imperial College London|Martyn R Patridge|+44 (0)20 7594 7959|m.patridge@imperial.ac.uk|
293847|NCT01517529|University of Cincinnati|Dr. Mohamed Tarek M Shata|(513) 558-6110|mohamed.shata@uc.edu|
293848|NCT01517750|HELIOS-Klinik Ambrock|Dr Georg Nilius|+492331-9742005|klinik-ambrock.pneumo@t-online.de|
319868|NCT01923480|Baxter Healthcare|Aparna Valluru, Clinical Project Manager|224.270.6063|Aparna_Valluru@baxter.com|
319978|NCT02837783|Ironwood Pharmaceuticals, Inc.|Lara Lane|(617) 621-7722|llane@ironwoodpharma.com|
319979|NCT02786537|UF Hepatology Research at CTRB|Lauren Morelli|352-273-9508|lauren.morelli@medicine.ufl.edu|
319980|NCT02740231|Bone Therapeutics|Dr Olivier Godeaux Medical Officer|+32 71 12 10 00|jta.koa1@bonetherapeutics.com|
319981|NCT02710084|Icahn School of Medicine at Mount Sinai|Alexander Kolevzon, MD|212-659-9134|alexander.kolevzon@mssm.edu|
319982|NCT02660034|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
319983|NCT02640625|Oslo University Hospital|Dr. Dag Henrik Reikvam|+4722119881|dagrei@ous-hf.no|
319984|NCT02561962|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
319985|NCT02519348|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
319986|NCT02500589|Durahm VA Health Care System|Jennifer Gierisch|919-286-0411|jennifer.gierisch@va.gov; j.gierisch@duke.edu|176936
319987|NCT02474329|Radboudumc|Marjan Meinders|+00000000|Marjan.Meinders@radboudumc.nl|
319988|NCT02471339|National Cancer Institute|Staci M. Peron, Ph.D.|240-760-6025|martins@mail.nih.gov|
319989|NCT02384993|University of Wisconsin - Madison|Ozioma C. Okonkwo|(608) 265-4479|ozioma@medicine.wisc.edu|
314275|NCT03283319|BARDA|Silvija Tresnjak-Smith|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
314276|NCT03283436|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
314277|NCT03283553|Johns Hopkins University|Research Program Manager|410-614-7910|dechava1@jhu.edu|
314278|NCT03283696|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
314279|NCT03283787|Integra LifeSciences|Allison Matthews|443-766-3869|allison.matthews@integralife.com|
314280|NCT03284229|Spectranetics Corporation|Spectranetics Corporation|719-447-2211|Ami.Sood@philips.com|
293849|NCT01517867|Johns Hopkins University|Deborah Gross|410-614-5311|debgross@jhu.edu|
293850|NCT01517893|University of Massachusetts Medical School|John E. Harris, MD, PhD|508-856-1982|john.harris@umassmed.edu|
319990|NCT01976273|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
319991|NCT01722929|Northwestern University|Murad Alam, MD|312-695-4761|m-alam@northwestern.edu|
319992|NCT01500733|National Heart Lung and Blood Institute|Ahn, Inhye|+1 301 827 1203|inhye.ahn@nih.gov|
319993|NCT01388491|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
319994|NCT01373151|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
319995|NCT01328587|National Heart Lung and Blood Institute|Dunbar, Cynthia|+1 301 827 1164|dunbarc@nhlbi.nih.gov|
319996|NCT01285947|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
319997|NCT01281644|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
319998|NCT01274611|Northwestern University|Dr. Murad Alam|312-695-4761|m-alam@northwestern.edu|
319999|NCT00960297|Study Chair|David R. Spigel, M.D.|1-877-MY-1-SCRI|David.Spigel@scresearch.net|
320000|NCT00910650|University of California at Los Angeles, Jonsson Comprehensive Cancer Center|Ignacio Baselga|310 206-2090|ibaselga@mednet.ucla.edu|
320001|NCT00793169|Northwestern University|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
320002|NCT00703326|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
320003|NCT00602667|St. Jude Children's Research Hospital|Amar Gajjar, MD|866-278-5833|amar.gajjar@stjude.org|
320004|NCT00535990|UCSD|Dr. Jonathan Li|6618603471|jzl023@health.ucsd.edu|
320005|NCT00472186|Dupage Chidlren's ENT & Allergy|Manali Amin, MD|630-785-0367|manali.amin@gmail.com|
320006|NCT03996876|University of California, San Francisco|Aoife O'Donovan, Associate Professor of Psychiatry|4152214810|aoife.odonovan@ucsf.edu|x24959
320016|NCT02880540|Children's National Hospital|Janelle Vaughns MD|202-476-2025|jvaughns@childrensnational.org|4165
320017|NCT02740972|NS Pharma, Inc.|Medical Affairs|(201) 986-3860|trialinfo@nspharma.com|
320018|NCT02662985|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
320019|NCT02606461|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
320020|NCT02536339|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
320021|NCT02514083|National Heart Lung and Blood Institute (NHLBI)|Inhye Ahn, M.D.|301-827-1203|inhye.ahn@nih.gov|
320022|NCT02323295|Massachusetts General Hospital|Dr. Joseph Schwab|617-643-0547|JHSCHWAB@PARTNERS.ORG|
320023|NCT02180724|Acerta Pharma, LLC, A Member of the AstraZeneca Group|Priti Patel, VP Clinical Development Heme|650-379-3000|p.patel@acerta-pharma.com|
320024|NCT02108964|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
320025|NCT02050308|The University of Kansas Medical Center|Dr. Won S. Choi|(913) 588-4742|wchoi@kumc.edu|
320026|NCT02036970|Reata Pharmaceuticals, Inc.|Kris Loerwald|+1 972-865-2219|MedicalAffairs-Team@reatapharma.com|
320027|NCT01958021|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
320028|NCT01941719|TUSPM|Dr. Jinsup Song|2157775872|jsong@temple.edu|
320029|NCT01828099|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
320030|NCT01593254|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
320031|NCT01578967|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
320032|NCT01186003|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
320033|NCT00943618|UT MD Anderson Cancer Center|Paul M. Cinciripini, BS,MS,PHD/Chair, Behavioral Science|(713) 745-1868|pcinciri@mdanderson.org|
320034|NCT00529763|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
320035|NCT03938272|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
320036|NCT03641339|National Institutes of Health|Matthew J. Memoli, MD, MS|301-443-5971|memolim@niaid.nih.gov|
320037|NCT03625466|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
305855|NCT02364076|Georgetown University Medical Center -Lomabardi Comprehensive Cancer Center|Dr Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
293851|NCT01517984|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
320038|NCT03476239|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
293852|NCT01518153|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-8750|CR_Study_Registration@mdanderson.org|
293853|NCT01518192|Department of Infectious Diseases, University Medical Center Ljubljana|Franc Strle|+386 1 522 2610|franc.strle@kclj.si|
293854|NCT01518244|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
320007|NCT03589976|NYU Langone Health|Jose-Alberto Palma, MD, PhD|212-263-7225|JoseAlberto.PalmaCarazo@nyulangone.org|
320008|NCT03517449|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
320009|NCT03490227|Pennington Biomedical Research Center|Dr. Leanne Redman|225-763-0947|leanne.redman@pbrc.edu|
320010|NCT03401190|CalciMedica, Inc.|Sudarshan Hebbar, MD|816-838-7105|sudarshan@calcimedica.com|
320011|NCT03392753|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
320012|NCT03212963|Sun Pharma Advanced Research Company Ltd.|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
320013|NCT03135262|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: BH39147|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
320014|NCT03104075|The Jackson Laboratory|Dr. Jacques Banchereau|860-837-2443|jacques.banchereau@jax.org|
320015|NCT03038087|SENSE Diagnostics, Inc.|Joe Korfhagen|844-373-6730|jkorfhagen@senseneuro.com|
320039|NCT03427411|National Cancer Institute|Dr. Julius Strauss|240-858-3999|julius.strauss@nih.gov|
293855|NCT01518257|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
293856|NCT01518270|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
293857|NCT01518309|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
320040|NCT03317795|Mayo Clinic|Dr. Shannon K. Laughlin-Tommaso|507-538-5783|LaughlinTommaso.Shannon@mayo.edu|
320041|NCT03287245|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
320042|NCT03165916|GI Clinical Research Enterprise|Tina Higginbotham|615-322-4643|tina.higginbotham@vumc.org|
320043|NCT03092219|Teoxane SA|Clinical Project Manager|+41(0) 22 344 96 36|m.chenet@teoxane.com|
320044|NCT03033069|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
293858|NCT01518322|Aerocrine, Inc.|Nancy Herje|919-449-8873|Nancy.Herje@aerocrine.com|
271729|NCT00261443|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
305856|NCT02364180|The University of Toledo|Shashi Bhatt, MD|419-383-3556|Shashi.Bhatt@utoledo.edu|
293859|NCT01518374|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
293860|NCT01518530|Hillel Yaffe Medical Center|Dr. Yaron River|972-523-756-446|yaronr@hy.health.gov.il|
305857|NCT02364271|Chinese University of Hong Kong|Professor Timothy Rainer|00 852 2632 1034|thrainer@cuhk.edu.hk|
305858|NCT02364336|NIDDK|Dr. Marc Ghany|301-402-5115|mg228m@nih.gov|
320045|NCT02956434|VA Boston Healthcare System|Dr. Johanna Thompson-Hollands|857-364-2311|johanna.thompson-hollands@va.gov|
320046|NCT02663622|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
320047|NCT02609503|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
320048|NCT02587598|Call Center|Incyte Corporation|1-855-463-3463|medinfo@incyte.com|
320049|NCT02485574|Chung-Ang University hospital|Kwang-Sup Song|+82-1037616503|ksong70@cau.ac.kr|
320050|NCT02214160|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
320051|NCT02032823|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
320052|NCT01899261|Montefiore Medical Center and Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nohri@montefiore.org|
320053|NCT01612351|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
320054|NCT01595503|University of Michigan|stephan taylor|7349364955|sftaylor@umich.edu|
320055|NCT01460160|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
320056|NCT01413399|Mecklenburg EMS Agency|Jonathan R Studnek PhD|7049436046|jonst@medic911.com|
320057|NCT01170702|Northwestern University Feinberg School of Medicine|Edward Yaghmour|312-695-0693|edward.yaghmour@nm.org|
320058|NCT01018563|Eisai Medical Information|Eisai Medical Information|888 422 4743|esi_medinfo@eisai.com|
271730|NCT00261495|Janssen Pharmaceutica NV|EMEA Medical Affairs Director Analgesia|+49 4107 312356|kpappert@its.jnj.com|
320059|NCT00805961|Sarah Cannon Research Institute|John D. Hainsworth, MD.|877-691-7274|ASKSARAH@scresearch.net|
320060|NCT04056182|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frances.levin@nyspi.columbia.edu|
320061|NCT03954106|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
320062|NCT03921424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
320063|NCT03598777|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
320064|NCT03406078|AstraZeneca|Global Clinical Head|+1 302 885 1180|information.center@astrazeneca.com|
320065|NCT03397589|University of Illinois Chicago|Molly A Martin, MD|312-996-2363|mollyma@uic.edu|
320066|NCT03368066|University of Virginia|Dr. Brian Wentworth|9739436781|bw8xz@hscmail.mcc.virginia.edu|
320067|NCT03345342|Janssen Research & Development, LLC|Compound Development Team Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
320068|NCT03265145|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
320069|NCT03218995|Sarepta Therapeutics, Inc.|Medical Director|800-690-2003|clinicaltrials@sarepta.com|
320070|NCT03197935|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
320071|NCT03030222|Saint Luke's Hospital of Kansas City|Study Manager|816-932-9858|EMBRACE-HF@saint-lukes.org|
320072|NCT02880241|Medicines for Malaria Venture (MMV)|Dr Stephan Duparc, Chief Medical Officer|+41 22 555 0351|duparcs@mmv.org|
320073|NCT02832687|CHRISTUS St. Vincent Regional Medical Center|Dr. Michal Gajewski, DO|(505) 913-3361|Michal.Gajewski@stvin.org|
320074|NCT02568449|Karmanos Cancer Instiute|Dr. Dipesh Uprety|313-576-8722|upretyd@karmanos.org|
320075|NCT02499900|Teva Pharmaceutical Industries Ltd.|Director, Clinical Research|+01 215-591-3000|USMedInfo@tevapharm.com|
320076|NCT02481986|University of Illinois Chicago|Molly A Martin, MD|312-996-2363|mollyma@uic.edu|
320077|NCT02394548|Massachusetts General Hospital|Dr. Henning Willers|617-726-5184|hwillers@mgh.harvard.edu|
320078|NCT02269917|Janssen Research & Development|Medical Officer|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
320079|NCT02225366|UT MD Anderson Cancer Center|Dr. Rodabe Amaria,MD, Associate Professor, Melanoma Medical Oncology|(713) 792-2921|rnamaria@mdanderson.org|
320080|NCT02021773|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
320081|NCT01530997|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
320082|NCT01109004|The Emmes Corporation|Adam Mendizabal, PhD||amendizabal@emmes.com|
320083|NCT01067521|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|001-215-591-3000|info.era-clinical@teva.de|
270463|NCT00130039|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
270464|NCT00130117|BIDMC|Christos Mantzoros|6176678630|cmantzor@bidmc.harvard.edu|
270465|NCT00130208|Keryx Biopharmaceuticals|Medical Information|1-844-44-KERYX|medicalinfo@keryx.com|
270466|NCT00130247|Case Western Reserve University, Tuberculosis Research Unit|John L. Johnson, M.D., Principal Investigator|(216) 368-1949|jlj@case.edu|
270467|NCT00130286|Weill Cornell Medical College|Dr. Marshall J. Glesby|212-746-4177|mag2005@med.cornell.edu|
270468|NCT00130442|Progen Pharmaceuticals Ltd|Director of Regulatory Affairs and Clinical Development|+61 (0)7 38423333|darrynb@progen-pharma.com|
270469|NCT00130520|Arizona Cancer Center, University of Arizona|Setsuko K. Chambers, M.D.|520-626-0950|schambers@azcc.arizona.edu|
270470|NCT00130533|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
270471|NCT00130637|National Eye Institute, NIH|H. Nida Sen, MD, MHS|301-435-5139|senh@nei.nih.gov|
270472|NCT00130689|Dana-Farber Cancer Institute|Jennifer Ang Chan, MD, MPH|617-632-6315|jennifer_chan@dfci.harvard.edu|
270473|NCT00130728|Genentech, Inc.|Medical Communications Specialist|800-821-8590|genentech@druginfo.com|
270474|NCT00130780|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris, Attending|+1646-888-4205|krism@mskcc.org|
270475|NCT00130793|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270476|NCT00130832|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270477|NCT00130923|Psychopharmacology Research Group|Dr. Mary Brunette|603-271-5747|mary.f.brunette@hitchcock.org|
271731|NCT00261716|VAGLAHS at West Los Angeles|Shirley M. Glynn. Ph.D.|310-268-3939|sglynn@ucla.edu|
271732|NCT00261833|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
271733|NCT00261846|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271734|NCT00261950|Amgen Inc.|Study Director|866-572-6436||
271735|NCT00262002|Novartis Vaccine and Diagnostics S.r.l|Posting Director||RegistryContactVaccineUS@novartis.com|
271736|NCT00262028|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
271737|NCT00262041|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
271738|NCT00262067|Genentech, Inc.|Medical Communications|800 821-8590||
271739|NCT00262080|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
271740|NCT00262119|Medtronic|Senior Clinical Research Manager|0039-0632814225|andrea.grammatico@medtronic.com|
271741|NCT00262223|The City College of New York|Denise A. Hien, Ph.D.|(212) 650-5666|dhien@ccny.cuny.edu|
271742|NCT00262301|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
271743|NCT00262314|EMD Serono, Inc.|Fernando Dangond, M.D., Medical Responsible|+1 781 681 2348||
271744|NCT00262509|Atlanta VA Rehabilitation R&D Center of Excellence|David A. Ross|404-321-6111|ross0128@bellsouth.net|6817
271745|NCT00262522|Abbott|Global Medical Services|800-633-9110||
271746|NCT00262600|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
271747|NCT00262639|Medical University of South Carolina|Raymond F. Anton, M.D.|843-792-1226|antonr@musc.edu|
293861|NCT01518699|Dr. Reddy's Laboratories Inc.|Dr Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
293862|NCT01518868|Bausch Health|Study Director||robert.steffen@bausch.com|
320084|NCT01047319|Teva Pharmaceutical Industries, Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
320085|NCT00988052|Teva Pharmaceutical Industries, Ltd|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
320086|NCT00861705|Warren Alpert Medical School of Brown University, Department of Medicine|William M. Sikov, M.D.|401-793-7151|wsikov@lifespan.org|
293863|NCT01518946|Shire|Study Director|+1 866-842-5335|ClinicalTransparency@shire.com|
293864|NCT01518972|VA Puget Sound Health Care System|Tracy L. Simpson, Ph.D.|206-277-3337|tracy.simpson@va.gov|
293865|NCT01519063|Yale University|Dana Cavallo, Assistant Professor|203974-7607|dana.cavallo@yale.edu|
320087|NCT04689932|Rockwell Medical|Raymond D Pratt, MD|2489609009|rpratt@rockwellmed.com|
320088|NCT04635579|University of Washington|Dr Scott Telfer|2062292022|telfers@uw.edu|
320089|NCT04553406|SperoTherapeutics|Dr. Jon Bruss|(+1) 269-352-3766|jbruss@sperotherapeutics.com|
320090|NCT04325906|Rush University|Jie Li, PI|3125634643|jie_li@rush.edu|
320091|NCT04056299|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
320092|NCT04046939|Knopp Biosciences|Vice President, Clinical and Translational Medicine|4124881776|calman@knoppbio.com|
320093|NCT03792750|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
320094|NCT03739593|Aerie Pharmaceuticals, Inc|Kevin Kerr, Director of Clinical Development|(949) 526-8701|kkerr@aeriepharma.com|
320095|NCT03739138|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
320096|NCT03688555|Idorsia Pharmaceuticals Ltd|Clinical Trials Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
320097|NCT03518086|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
320098|NCT03468309|VA Puget Sound Health Care System|Dr. Amanda E. Wood; Clinical Research Psychologist, VA PSHCS|253-583-1652|amanda.wood@va.gov|71652
320099|NCT03367910|Washington University in St. Louis School of Medicine|Kimberly Reske, Research Coordinator|3147474041|kreske@wustl.edu|
320100|NCT03347123|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
320101|NCT03318523|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
320102|NCT03260894|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
320103|NCT03125902|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
320104|NCT02906020|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
320105|NCT02899299|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
320106|NCT02891226|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
320107|NCT02829918|Moffitt Cancer Center|Richard D. Kim, MD|813-745-1277|Richard.Kim@Moffitt.org|
320108|NCT02703480|Tufts University School of Dental Medicine|Associate Professor|6176366659|yumi.ogata@tufts.edu|
320109|NCT02549092|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
320110|NCT02506465|Medi-Tate / Olympus|Sivan Baker|+97247701839|sivan.baker@olympus.com|
320111|NCT02323126|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
320112|NCT01902290|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
320113|NCT01619085|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
320114|NCT01126749|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
320115|NCT01111110|University of Florida|Dr.Sreekala Prabhakaran. Clinical Assistant Professor Pediatrics|352-273-8381|sprabhakaran@peds.ufl.edu|
320116|NCT01059448|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
320117|NCT01032603|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
320118|NCT00821587|University of Florida|Roberto J. Firpi-Morell, MD|352-273-9500|firpirj@medicine.ufl.edu|9466
320119|NCT00585195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
320120|NCT00278915|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
282632|NCT00865124|Brigham and Women's Hospital|Gail K. Adler|617-732-5661|gadler@partners.org|
282633|NCT00865189|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
282634|NCT00865202|University of Colorado|Thomas Robinson MD|303-724-2728|thomas.robinson@ucdenver.edu|
293866|NCT01519089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293867|NCT01519167|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
305859|NCT02364388|Seno Medical Instruments, Inc|Shaan Schaeffer, VP Clinical Operations|2106156501|sschaeffer@senomedical.com|
293868|NCT01519206|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
305860|NCT02364570|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
270478|NCT00131248|UT Houston Medical School|Kathleen A. Kennedy, MD, MPH|713 500-6708|kathleen.a.kennedy@uth.tmc.edu|
270479|NCT00131352|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
270480|NCT00131365|InSightec|Nadir Alikacem|214.630.2000|nadira@insightec.com|
270481|NCT00131378|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@partners.org|
270482|NCT00131456|Columbia University|Dr. Frances R. Levin|212-543-5896|frl2@columbia.edu|
270483|NCT00131469|OHSU|Eric Orwoll|15034940225|orwoll@ohsu.edu|
270484|NCT00131508|St Jude Children's Research Hospital|Winfred Wang|1-866-278-5833|info@stjude.org|
293869|NCT01519245|University of Saskatchewan|Dr. Kelsey Brose, Primary Investigator|306-655-1483|kelsey.brose@saskcancer.ca|
293870|NCT01519271|University of Pennsylvania|Daniel Weintraub, MD|215-349-8207|Daniel.Weintraub@UPHS.UPENN.EDU|
293871|NCT01519284|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
293872|NCT01519323|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
293873|NCT01519414|The Ohio State University Comprehensive Cancer Center|Paul Monk, MD|(614) 293-6196|Paul.Monk@osumc.edu|
293874|NCT01519427|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
293875|NCT01519453|Johns Hopkins School of Medicine|Dr. Michelle Eakin|410-550-0487|meakin1@jhmi.edu|
293876|NCT01519466|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
305861|NCT02364700|New York University|Grace Kim PhD, OTR/L|121-998-5846|gjk207@nyu.edu|
305862|NCT02364778|Icahn School Of Medicine at Mount Sinai|Dr. Annapoorna Kini||annapoorna.kini@mountsinai.org|
305863|NCT02364947|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
305864|NCT02364999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
305865|NCT02365064|Sleep and Human Health Institute|Dr. Barry Krakow|(505) 9987204|bkrakow@sleeptreatment.com|
305866|NCT02365285|Vanderbilt University Medical Center|Cyndya Shibao, MD|615-322-2318|cyndya.shibao@vumc.org|
305867|NCT02365298|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan|904-443-3449|CColesb@ITS.JNJ.com|
305868|NCT02365480|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
305869|NCT02365506|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
305870|NCT02365519|Alcon, A Novartis Division|Ophthalmology & Medical Lead, Translational Medicine, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
305871|NCT02365558|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
305872|NCT02365584|Ipsen SpA|Medical Director|see email|clinical.trials@ipsen.com|
305873|NCT02365636|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
293877|NCT01519518|Liverpool Heart and Chest Hospital|Dr Rod Stables|01512281616|rod.stables@lhch.nhs.uk|1489
293878|NCT01519570|The Ohio State University College of Pharmacy|Stuart Beatty|6146888466|beatty.52@osu.edu|
293879|NCT01519635|Service of Nephrology, Centre Hospitalier Universitaire Vaudois, Lausanne|Prof Michel Burnier|+41 21 314 11 54|michel.burnier@chuv.ch|
293880|NCT01519648|National Hematological Society|Professor Galina A Klyasova|+7(495)6125181|klyasova.g@blood.ru|
293881|NCT01519661|Novartis Pharmaceuticals|Study Director|862-778-8300||
293882|NCT01519674|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
293883|NCT01519700|Sandoz|Dr. Roumen Nakov, Global Programme Medical Director|+49 8024 4764704|roumen.nakov@sandoz.com|
293884|NCT01519713|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
293885|NCT01519765|Stanford University|Dr. Linh Tran|925-642-2241|lltran20@gmail.com|
293886|NCT01519778|Cubist Pharmaceuticals|Carisa De Anda, Phd, Vice President Clinical Research|8583522639|carisa.deanda@cubist.com|
293887|NCT01519791|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
293888|NCT01519817|National Cancer Institute|Dr. James Gulley|301-480-8870|gulleyj@mail.nih.gov|
293889|NCT01519869|University of Kentucky|Rachel Miller|859-323-2169|raware00@uky.edu|
293890|NCT01519882|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
293891|NCT01519921|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
293892|NCT01519934|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
293893|NCT01519947|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
293894|NCT01520038|University of Pennsylvania|John Christodouleas, MD|215-662-6568|christojo@uphs.upenn.edu|
293895|NCT01520207|Brigham and Women's Hosptial|Dr. Finnian Mc Causland|6177326432|fmccausland@partners.org|
293896|NCT01520324|Cosmo Pharmaceuticals NV|Dr. Richard Jones|+353 18170370|RJones@cosmopharma.com|
293897|NCT01520363|Hugo W. Moser Research Institute at Kennedy Krieger , Inc.|Dr. Sakkubai Naidu|443 923 2778|naidu@kennedykrieger.org|
293898|NCT01520402|Mount Sinai School of Medicine|Dr. Daniella Kadian-Dodov|(212) 241-9454|daniella.kadian-dodov@mssm.edu|
293899|NCT01520454|Beth Israel Deaconess Medical Center|Dr. Christos Manztoros|617-667-8630|cmantzor@bidmc.harvard.edu|
293900|NCT01520506|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
293901|NCT01520519|The University of Texas MD Anderson Cancer Center|Jan Burger MD./Professor|713-563-1487|jaburger@mdanderson.org|
293902|NCT01520532|Medtronic AF Solutions|Jay Kelley, Director of Clinical Research|+1.760.827.0076|jay.l.kelley@medtronic.com|
293903|NCT01520558|Coronado Biosciences|Vice President, Clinical Operations|7816524516|nsilver@coronadobio.com|
293904|NCT01520688|Allegheny Health Network|Deborah Gentile, MD|412-359-4099|dgentile@ahn.org|
293905|NCT01520727|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
293906|NCT01520870|MFAR Clinical Research|Pau Doñate||investigacion@mfar.net|
293907|NCT01520909|GlaxoSmithKline|GSK Response Center|866-435-7343||
293908|NCT01520922|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
293909|NCT01520987|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
293910|NCT01521026|UCSD|Elizabeth Twamley, PhD|6195436684|etwamley@ucsd.edu|
293911|NCT01521117|Oregon Health & Science University|Amie Hiller, MD|503 721 1091|peterami@ohsu.edu|
293912|NCT01521260|University Medical Center Groningen - Center for dentistry and oral hygiene|Y.C.M. de Waal|+31 50-3639051|y.c.m.de.waal@umcg.nl|
293913|NCT01521364|University of Groningen, University Medical Center Groningen|Dr. J.W.C. Alffenaar|+31-50-3614070|j.w.c.alffenaar@umcg.nl|40378
293914|NCT01521494|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
293915|NCT01521507|TearScience, Inc.|Study Director|919-467-4007|cstevens@tearscience.com|
293916|NCT01521546|The Ohio State University|Subha V. Raman, MD|(614)293-8963|raman.1@osu.edu|
293917|NCT01521559|Regeneron|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
293918|NCT01521780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293919|NCT01521845|Shaheed Beheshti Medical University|Dr.Jamshid Salamzadeh|00982188662334|j.salamzadeh@yahoo.com|
293920|NCT01521871|Oslo University Hospital, Rikshospitalet|Dr. Ole Øyen|+4723070000|ooyen@ous-hf.no|
293921|NCT01521884|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293922|NCT01521897|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293923|NCT01521923|UCB Cares|UCB (Study Director)|+1 887 822 9493||
293924|NCT01521949|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
293925|NCT01522131|The University of Texas Health Science Center at Houston|Rosemary Thomas, DMD, MS|713-486-4074|rosemary.thomas@uth.tmc.edu|
293926|NCT01522235|Beth Israel Deaconess Medical Center|Dr. Roy Freeman|6176328454|rfreeman@bidmc.harvard.edu|
293927|NCT01522248|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
293928|NCT01522339|Cincinnati Children's Hospital Medical Center|Jean Tkach|513-636-7166|jean.tkach@cchmc.org|
293929|NCT01522391|Pergamum AB|Margit Mahlapuu PhD, Assoc. Prof. in Molecular Medicine|+46 70 631 01 09|margit.mahlapuu@pergamum.com|
293930|NCT01522404|Emory University|Allan I. Levey, MD, PhD|404-727-7220|alevey@emory.edu|
293931|NCT01522417|Medicure|Kyle Brown|204-594-3411|kbrown@medicure.com|
293932|NCT01522443|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
293933|NCT01522456|Galderma Laboratories, L.P.|Elizabeth M. Nieman, Associate Medical Information Specialist|817-961-5130|elizabeth.nieman@galderma.com|
293934|NCT01522651|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
293935|NCT01522703|Johns Hopkins University School of Medicine|Elizabeth Matsui, MD MHS|410-502-3858|ematsui@jhmi.edu|
293936|NCT01522755|Medtronic|Foudali Latifa|+33 631992144|latifa.foudali@medtronic.com|
293937|NCT01522924|University of Louisville|Dr. Jacqueline Singleton|502-852-2611|jasing02@louisville.edu|
293938|NCT01522937|University of Michigan Comprehensive Cancer Center|Dr. Kyle Cuneo, M.D.|734-936-4300|kcuneo@umich.edu|
293939|NCT01522950|University of Minnesota|Jay N. Cohn, M.D., Professor of Medicine|612.625.5646|cohnx001@umn.edu|
293940|NCT01522963|University of Minnesota|Michael Kotlyar|6126251160|kotly001@umn.edu|
293941|NCT01523275|University of California, San Francisco|Jolie Chang|415-353-2203|jolie.chang@ucsf.edu|
293942|NCT01523301|UCB|Study Director|+1877 822 9493||
293943|NCT01523366|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com|
293944|NCT01523392|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9933|ClinicalTrialTransparency@astrazeneca.com|
293945|NCT01523457|Yale University|Jill Lacy|+1 (203) 737-1600|jill.lacy@yale.edu|
293946|NCT01523496|University Hospitals Cleveland Medical Center|Dr Grace McComsey|216-844-2739|Grace.McComsey@UHhospitals.org|
293947|NCT01523587|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
293948|NCT01523613|University of Michigan|Dr. Mathilde Peters||mcpete@umich.edu|
305874|NCT02365714|Medstar Georgetown University Hospital|Sonali Rudra, M.D.|202-444-3320|sonali.rudra@gunet.georgetown.edu|
305875|NCT02365870|Johns Hopkins University School of Medicine|Dr. Gregory Pontone|(410) 502 - 0477|gpontone@jhmi.edu|
305876|NCT02365961|Hawkins Foundation|Hawkins Foundation Research Coordinator|864 454 7458|info@hawkinsfoundation.com|
305877|NCT02366091|Johns Hopkins Hospital|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
305878|NCT02366130|UT MD Anderson Cancer Center|Dr. Naoto T Ueno, Professor, Breast Medical Oncology|(713) 792-8754|nueno@mdanderson.org|
305879|NCT02366143|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
305880|NCT02366195|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
305881|NCT02366312|NYU College of Dentistry|Dr. Brian Schmidt|212-998-8900|brianl.schmidt@nyu.edu|
305882|NCT02366338|Mugla Sitki Kocman University|Ozcan Basaran|+902522120724|basaran_ozcan@yahoo.com|
305883|NCT02366403|War Related Illness and Injury Study Center, VA Palo Alto Healthcare System|Peter Bayley, PhD|650 493-5000|peter.bayley@va.gov|68653
305884|NCT02366468|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
305885|NCT02366611|University of Michigan, School of Dentistry|Alexandre DaSilva|7346153807|adasilva@umich.edu|
305886|NCT02366637|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
305887|NCT02366663|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|82405
305888|NCT02366689|Farid Ayad|Dr. Farid Ayad|416-473-1189|ayad.farid@gmail.com|
305889|NCT02366767|Stanford School of Medicine|Bruce Buckingham|650-725-9549|buckingham@stanford.edu|
305890|NCT02366845|University of Colorado|Dr. Marc Moss|303-724-6080|marc.moss@cuanschutz.edu|
305891|NCT02366871|University of Colorado, Anschutz Medical Campus|Dr. Saketh Guntupalli|303-724-2033|saketh.guntupalli@cuanschutz.edu|
305892|NCT02366910|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
305893|NCT02366923|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
305894|NCT02366936|Duke University Health System|Dr. William Malcolm|919-681-4913|william.malcolm@duke.edu|
305895|NCT02367014|Stealth BioTherapeutics Inc.|Jim Carr PharmD Chief Clinical Development Officer|617-600-6888|jim.carr@stealthbt.com|
305896|NCT02367066|AstraZeneca|Dr. Stanko Skrtic, MD, PhD||ClinicalTrialTransparency@astrazeneca.com|
305897|NCT02367131|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
305898|NCT02367352|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305899|NCT02367391|Penn State College of Medicine|Project Coordinator|7175310003|jyingst@phs.psu.edu|289511
305900|NCT02367430|Columbia University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
305901|NCT02367521|Johns Hopkins University School of Medicine|Vani Rao, MD|4105502288|vrao@jhmi.edu|
305902|NCT02367599|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
305903|NCT02367716|Cardiac Rhythm Management, Abbott Medical Devices|Clay Cohorn, Clinical Program Director|+19723098087|clay.cohorn@abbott.com|
305904|NCT02367729|Medical College of Wisconsin|Dr. Katja Kovacic|4142663915|kkovacic@mcw.edu|
305905|NCT02367781|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
305906|NCT02367794|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
305907|NCT02367820|Nektar Therapeutics|Medical Affairs|855-482-8676|StudyInquiry@nektar.com|
305908|NCT02367833|Penn State University|Dr. Mary Jane De Souza|8148630045|mjd34@psu.edu|
305909|NCT02367859|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
305910|NCT02367872|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305911|NCT02367885|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
293949|NCT01523704|Fujita Health University School of Medicine|Eiichi Watanabe, MD, PhD|+81-562-93-2312|enwatan@fujita-hu.ac.jp|
293950|NCT01523743|Hopital Raymond poincare|Pref. Emmanuel Chartier-kastler|+33 1 42 17 71 29|emmanuel.chartier-kastler@psl.aphp.fr|
293951|NCT01523756|Coloplast A7S|Marianne Raff|+45 4911 2562|dkmr@oloplast.com|
293952|NCT01523782|ERYTECH Pharma|Denise Tilton, Global Head Clinical Operations & Program Management|+1 857-706-1587|dtilton@erytech.com|
293953|NCT01523808|Erytech Pharmaceuticals|Director of Clinical Trials|+33 4 78 74 44 38|contact@erytech.com|
293954|NCT01523821|Fred Hutchinson Cancer Research Center|H. Joachim Deeg, MD|206-667-5985|jdeeg@fredhutch.org|
293955|NCT01523834|Azienda Sanitaria Universitaria Integrata di Udine (A.S.U.I. Udine) - SOC Clinica Ematologica|Dr. Francesco Zaja, Co-Investigator of the Study|+39 0432559604|francesco.zaja@asuiud.sanita.fvg.it|
293956|NCT01523873|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 51 84|corinne.dubourdieu@guerbet-group.com|
293957|NCT01523886|Herlev Hospital|Mona R Gätke, MD, PH.D.|004538662420|mona.gatke@regionh.dk|
282635|NCT00865280|Paratek Pharmaceuticals, Inc.|Paratek Medical Information|1-833-727-2835|medinfo@paratekpharma.com|
293958|NCT01523899|University of California-Davis|Larissa May, MD|9167345000|lsmay@ucdavis.edu|
293959|NCT01523964|DART Therapeutics|Chief Operating Officer|415-341-5783|egoldstein@dartrx.com|
293960|NCT01524133|Atlanta VAMC|Sheila Rauch|404-321-6111|sheila.rauch@va.gov|3122
293961|NCT01524198|King Saud University|Dr. Abdullah Alangari|966506287276|alangari100@gmail.com|
293962|NCT01524224|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293963|NCT01524289|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
293964|NCT01524302|Michigan State University|Dr. Gary E. Stein|517-353-5126|steing@msu.edu|
293965|NCT01524627|UPenn|Teresa R. Franklin, Ph.D.|215-746-1883|teresafr@mail.med.upenn.edu|
293966|NCT01524679|IZKS of the University Medical Center of the Johannes Gutenberg University Mainz|Christian Ruckes|+49 6131 17|ruckes@izks-mainz.de|9919
293967|NCT01524692|University of Virginia|Dr. Patrick Dillon|4349821495|pmd5b@virginia.edu|
293968|NCT01524770|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
293969|NCT01524783|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
293970|NCT01524796|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
293971|NCT01524887|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
293972|NCT01524900|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
293973|NCT01524913|Emory University|Gary Bouloux, MD, DDS|404-778-4500|gfboulo@emory.edu|
293974|NCT01524978|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
293975|NCT01524991|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
293976|NCT01525082|Stanford University|Shaheen Shagufta, Clinical Assistant Professor|650-725-6454|sshaheen@stanford.edu|
293977|NCT01525173|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
293978|NCT01525225|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
293979|NCT01525238|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
293980|NCT01525329|Cleveland Clinic|Dr. Edward Maytin|216-445-6676|maytine@ccf.org|
293981|NCT01525407|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|2066672827|mmielcar@fredhutch.org|
293982|NCT01525420|Fred Hutchinson Cancer Research Center|Jonathan B. Bricker, Ph.D.||jbricker@fhcrc.org|
293983|NCT01525550|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293984|NCT01525563|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
293985|NCT01525589|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
293986|NCT01525602|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
293987|NCT01525615|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
293988|NCT01525628|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
293989|NCT01525641|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
293990|NCT01525667|Pluristem Ltd.|Dr.Esther Lukasiewicz Hagai|+972-972-74-710-8600|estherl@Pluristem.com|694
293991|NCT01525849|Entellus Medical|Ellen O'Malley|763-463-1598|eomalley@entellusmedical.com|
293992|NCT01525862|Stryker ENT|Principal Clinical Research & Publications Manager|764-463-1598|ellen.omalley@stryker.com|
293993|NCT01525875|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|212-241-9728|mark.lebwohl@mountsinai.org|
293994|NCT01526057|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
293995|NCT01526148|University Hospitals Cleveland Medical Center|Keming Gao, MD, PhD|216-844-2865|keming.gao@UHhospitals.org|
293996|NCT01526213|UNC-Chapel Hill|Mary F. Paine, RPh, PhD|919-966-9984|mpaine@unc.edu|
293997|NCT01526343|Washington University School of Medicine|Jennifer Bell, Manager of Clinical Trials|314-747-6969|jennifer.bell@wustl.edu|
293998|NCT01526356|The University of Texas Health Science Center at Houston|Mary Kay Koenig, MD|713-500-7142|mary.k.koenig@uth.tmc.edu|
293999|NCT01526538|Johns Hopkins University|Matthew Johnson Ph.D.|4105500056|mwj@jhu.edu|
294000|NCT01526551|University of Kentucky College of Public Health|Dr. Robin Vanderpool|859-218-2102|robin@kcr.uky.edu|
294001|NCT01526577|LG Life Sciences|Dong Yeop Shin|82 2 6924 3114|dongyeopshin@lgls.com|
294002|NCT01526629|Medtronic|Latifa Foudali|0155381700|latifa.foudali@medtronic.com|
294003|NCT01526733|Halozyme Therapeutics, Inc|Vice President, Endocrinology Clinical Development|858-794-8889||
294004|NCT01526785|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
294005|NCT01526889|Novartis Pharmaceuticals|Study Director|+1 862-778-8300|Novartis.email@novartis.com|
294006|NCT01526902|Indiana University|Pete Kollbaum, OD, PhD, FAAO, FBCLA, Principal Investigator|812-856-0108|kollbaum@indiana.edu|
294007|NCT01526928|Clovis Oncology|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
294008|NCT01527006|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
294009|NCT01527045|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|(206) 667-2827|mmielcar@fredhutch.org|
294010|NCT01527110|GlaxoSmithKline|GSK Response Center|866-435-7343||
294011|NCT01527149|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
294012|NCT01527162|Seattle Children's Research Institute|Kristie Bjornson, PhD, PT|206 884-2066|kristie.bjornson@seattlechildrens.org|
294013|NCT01527357|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
294014|NCT01527370|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294015|NCT01527383|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294016|NCT01527487|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
294017|NCT01527500|Novartis Pharmaceuticals|Study Director|862-778-8300||
294018|NCT01527513|BIAL - Portela & Cª SA|Director R&D|+351-229866100|clinical.trials@bial.com|
294019|NCT01527682|ASST Spedali Civili di Brescia|Prof. Luciano Quaranta|+39 030 3995|luciano.quaranta@unibs.it|847
294020|NCT01528033|Witten/Herdecke University|Dörthe Seidel|00492219895731|Doerthe.Seidel@uni-wh.de|
294021|NCT01528072|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
294022|NCT01528124|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294023|NCT01528150|St. Jude Medical|Director Clinical Studies|+1 818 493 3648|aoza@sjm.com|
294024|NCT01528215|DENTSPLY Implants|Manager Global Clinical Affairs|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
294025|NCT01528228|A.T. Still University|Corey Luebbering|660.626.2147|coreyluebbering@atsu.edu|
294026|NCT01528254|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
294027|NCT01528319|Johnson & Johnson K.K. Medical Company|Department Chief, Clinical Development & PMS|+81-3-4411-6789|yikeda5@its.jnj.com|
294028|NCT01528332|Philips Consumer Lifestyle|Dr. Elke Naujokat|+31 (0) 631974213|elke.naujokat@philips.com|
294029|NCT01528345|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
294030|NCT01528592|Northwestern University|Darren Gitelman, MD|312-908-8266|d-gitelman@northwestern.edu|
294031|NCT01528605|Peking University|Xiaoming Lin|010-82805336|linbjmu@bjmu.edu.cn|
294032|NCT01528709|Lynn Heart and Vascular Institute, Boca Raton Regional Hospital|Dr. Alexander Kulik|5619556300|alex_kulik@yahoo.com|
294033|NCT01528735|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
294034|NCT01528787|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
294035|NCT01528878|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
294036|NCT01528891|Children's Hospital of Pittsburgh of UPMC|Peter J. Davis, MD|4126925260|davispj@anes.upmc.edu|
294037|NCT01528969|Kuwait University, Faculty of Dentistry|Prof. Eino Honkala|+965 65638938|eino.honkala@hsc.edu.kw|
294038|NCT01529034|Proximagen, LLC|David Sequeira|952-658-7438|dsequeira@proximagen.com|
294039|NCT01529060|Baylor|Alyssa Tran, BS|832-822-4264|alyssat@bcm.edu|
294040|NCT01529112|Eisai Call Center|Eisai Inc.|888-422-4743||
294041|NCT01529203|Galderma|Clinical Project Manager|(33) 4 92 38 67 33|may.ma@galderma.com|
294042|NCT01529268|Johns Hopkins Data Coordinating Center|Laura Wilson|410-955-0719|lwilson9@jhu.edu|
305912|NCT02367911|Therapeutics, Inc.|Clinical Research Director|858-571-1800|projectmanager@therapeuticsinc.com|
305913|NCT02368093|Taichung Veterans General Hospital|Der-Yuan Chen|884-4-23592525|dychen@vghtc.gov.tw|3354
305914|NCT02368210|Therapeutics, Inc.|Clinical Research Director|858-571-1800|projectmanager@therapeuticsinc.com|
305915|NCT02368314|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
305916|NCT02368431|VA Connecticut Healthcare System West Haven Campus, West Haven, CT|Dr Albert Arias|804-828-5793|albert.arias@vcuhealth.org|
305917|NCT02368457|Oral and Maxillofacial Surgeon|Dr. Miriam Martos|+34932746179|miryam.martos@gmail.com|
305918|NCT02368691|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
305919|NCT02369068|Beaumont Hospital, Royal Oak|Deborah Hasenau RN, Director, Urology Research|248-551-0804|Deborah.Hasenau@Beaumont.org|
305920|NCT02369159|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
305921|NCT02369172|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
305922|NCT02369211|Brigham and Women's Hospital|James Webber|(617) 732-6877|jwebber1@partners.org|
305923|NCT02369341|GlaxoSmithKline|GSK Response Center|866-435-7343||
305924|NCT02369484|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser, Lead Trial Activities|+41 31 511 94 18|Heidi.Roschitzki@etop-eu.org|
305925|NCT02369510|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|Daniel.Katz@MountSinai.org|
294043|NCT01529346|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294044|NCT01529385|Center for Lower Extremity Ambulatory Research|Ryan Crews, Clinical Scientist|847-578-8437|ryan.crews@rosalindfranklin.edu|
294045|NCT01529450|Stanford University|Anne Chang, MD|(650) 721 7151|alschang@stanford.edu|
294046|NCT01529502|Massachusetts General Hospital|Dr. Lorenzo Berra|617 724 1901|LBERRA@MGH.HARVARD.EDU|
294047|NCT01529515|Janssen Research & Development, LLC|Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
294048|NCT01529606|UTHSC|Professor|901-448-2369|lhong2@uthsc.edu|
305926|NCT02369796|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305927|NCT02369835|Stanford University|Beth Beadle|650-723-6194|bbeadle@stanford.edu|
305928|NCT02369848|Shockwave Medical, Inc.|Gheda Sahyun, Director of Clinical Affairs|510-624-9073|gsahyun@shockwavemedical.com|
305929|NCT02369874|AstraZeneca|Nassim Morsli|+44 7384 520046|nassim.morsli@astrazeneca.com|
305930|NCT02369900|Beth Israel Deaconess Medical Center|Michael N. Cocchi MD|617-754-2388|mcocchi@bidmc.harvard.edu|
305931|NCT02370004|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
305932|NCT02370043|Kaneq Bioscience Limited|Dr. Gosse Bruinsma|1-613-800-0955|gosse.bruinsma@kaneqbioscience.ca|
305933|NCT02370056|Cleveland Clinic|Dr. Emre Gorgun|216 444-1244|GORGUNE@ccf.org|
305934|NCT02370095|University of North Carolina at Chapel Hill|Wayne H Anderson, PhD|919-445-0351|wayne_anderson@med.unc.edu|
305935|NCT02370121|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
305936|NCT02370160|Masonic Cancer Center at University of Minnesota|Dr. Veronika Bachanova|612-625-8287|pham0179@umn.edu|
305937|NCT02370238|Dompé Farmaceutici SpA|Dr Pier Adelchi Ruffini, MD|+39 02 583831|info@dompe.it|
305938|NCT02370251|University of Oklahoma|Kimberly Ernst, MD|405-271-5215|kimberly-ernst@ouhsc.edu|42039
305939|NCT02370368|The University of the West Indies, Mona|Dr. Sharmella Roopchand-Martin|876-927-2235|sharmella.roopchandmartin@uwimona.edu.jm|
305940|NCT02370394|Butler Hospital/Women and Infants Hospital|Caron Zlotnick, Ph.D.|(401) 455-6529|CZlotnick@Butler.org|
305941|NCT02370407|Johns Hopkins University|Dr. Lauren Thomaier|410-955-6710|lthomai1@jhmi.edu|
305942|NCT02370420|Universidad Autonoma de Nuevo Leon|Felix Vilchez Cavazos|811 049 80 70|vilchez.doctor@hotmail.com|
305943|NCT02370498|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305944|NCT02370511|Mayo Clinic|Dr. Mayra Guerrero|507-255-1267|Guerrero.Mayra@mayo.edu|
305945|NCT02370537|AstraZeneca AB|Stefan Carlsson||Stefan.C.Carlsson@astrazeneca.com|
305946|NCT02370602|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
305947|NCT02370615|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305948|NCT02370641|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|
314281|NCT03284359|University of Pennsylvania|Dr. Katherine Courtright|267-978-5083|Katherine.Courtright@pennmedicine.upenn.edu|
314282|NCT03284398|Fresenius Kabi Deutschland, GmbH|Prof. Dr. med. Martin Westphal|+49 6172 686-7348|martin.westphal@fresenius-kabi.com|
314283|NCT03284411|Medtronic|SCS Dosing Clinical Research Study Team|800-633-8766|rs.scsdosing@medtronic.com|
314284|NCT03284424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
314285|NCT03284710|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
314286|NCT03285061|Brigham & Women's Hospital|Dr. Christopher Chiodo|617-983-7363|cchiodo@bwh.harvard.edu|
314287|NCT03285113|China Medical University Hospital (in Taiwan)|Dr. Yeong-Ray Wen (Department of Anaesthesia)|+886 4 2205-2121|yray.wen@gmail.com|
314288|NCT03285295|Abbott Laboratories|George Chen (Associate Director Clinical Affairs)|224-668-9185|george.chen@abbott.com|
314289|NCT03285308|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
314290|NCT03285373|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
314291|NCT03285477|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
314292|NCT03285490|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
314293|NCT03285529|Cleveland Clinic|Viktor Krebs|216-444-2600|krebsv@ccf.org|
314294|NCT03285542|Cleveland Clinic|Viktor Krebs|216-445-3843|krebsv@ccf.org|
314295|NCT03285555|Cleveland Clinic|Viktor Krebs|216-444-2600|krebsv@ccf.org|
314296|NCT03285594|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
314297|NCT03285646|Regeneron Pharmaceuticals, Inc.|Study Director|844-734-6643|clinicaltrials@regeneron.com|
314298|NCT03285711|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
314299|NCT03285724|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
314300|NCT03285958|University of Michigan|Dr. Mary Janevic|734 647 3194|mjanevic@umich.edu|
314301|NCT03285984|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
314302|NCT03286218|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
314303|NCT03286283|Apyx Medical (formerly Bovie Medical Corporation)|Shawn Roman/Vice President of Research and Development|1-727-384-2323|shawn.roman@apyxmedical.com|
314304|NCT03286400|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
314305|NCT03286465|The University of Texas Health Science Center at Houston|Javier Barreda Garcia, MD|713-500-6838|Javier.BarredaGarcia@uth.tmc.edu|
294049|NCT01529632|Novartis Pharmaceuticals|Study Director|862-778-8300||
294050|NCT01529645|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
294051|NCT01529749|Hospital Clínic|FELIPE GARCIA ALCAIDE|34619175783|FGARCIA@clinic.cat|
294052|NCT01529827|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
294053|NCT01530178|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
294054|NCT01530243|Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences|Yousef Rezaei|+989126231864|yousefrezaei1986@gmail.com|
294055|NCT01530256|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
294056|NCT01530334|SPARC CONSULTING SRL|Claudio Iannacone|+39 0243119667|info@sparcconsulting.com|
294057|NCT01530399|TMC|Peter Villiger|+19732906340|peter.villiger@themedco.com|
294058|NCT01530464|Duke University Medical Center|Dr. Thies Schroeder|919 681 4721|thies.schroeder@duke.edu|
294059|NCT01530477|GE Healthcare|Yi Xia|1 (608) 221-1551|Yi.Xia@ge.com|500-3045
294060|NCT01531153|Yale University|Dr. Mehmet Sofuoglu, Professor of Psychiatry; Director of VA New England Mental Illness Research, Ed|(203) 937-4809|mehmet.sofuoglu@yale.edu|
294061|NCT01531205|H. Lee Moffitt Cancer Center and Research Institute|Julio Pow-Sang, M.D.|813-745-2226|julio.powsang@moffitt.org|
294062|NCT01531335|Pontificia Universidad Javeriana|Dr Saul Rugeles|5715946161|rujeles@javeriana.edu.co|2240
294063|NCT01531374|Medtronic, Inc.|Hatice Bilgic Lim||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
294064|NCT01531439|Children's Mercy Hospital|Dr Ben Pieters|816-234-3464|bjpieters@cmh.edu|
294065|NCT01531673|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
294066|NCT01531725|ZNA Middelheim Department Interventional Cardiology, Antwerpen, Belgium|Paul Vermeersch, MD, PhD|+32 3 280 3211|paul.vermeersch@zna.be|
294067|NCT01531738|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
294068|NCT01531803|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
294069|NCT01531894|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
294070|NCT01531959|Beth Israel Deaconess Medical Center|Matthias Eikermann|6176327034|meikerma@bidmc.harvard.edu|
294071|NCT01531998|University of Texas (UT) MD Anderson Cancer Center|Jatin J. Shah, MD/Associate Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
294072|NCT01532089|Duke University|Thomas E. Stinchcombe, M.D.|507/284-4565|thomas.stinchcombe@duke.edu|
294073|NCT01532128|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
294074|NCT01532141|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
294075|NCT01532349|Johns Hopkins University|Dr. Meredith Atkinson|410-955-2467|matkins3@jhmi.edu|
294076|NCT01532388|Karolinska Institutet|Dr Kristina Sinadinovic|+46812345735|kristina.sinadinovic@ki.se|
294077|NCT01532414|Repros Therapeutics Inc.|Jennifer L Wike, Director of Regulatory Affairs|281-719-3402|jwike@reprosrx.com|
294078|NCT01532453|Galderma Spirig|Dr. Francine Santoro|+41 62 387 87 87|Francine.santoro@galderma.com|87 20
294079|NCT01532570|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
294080|NCT01532648|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
294081|NCT01532687|OHSU Knight Cancer Institute|Dr. Christopher Ryan|503-494-9000|ryanc@ohsu.edu|
294082|NCT01532700|University Health Network|Dr. Christine Chen|416-946-2827|Christine.Chen@uhn.ca|
294083|NCT01532817|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
294084|NCT01532830|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
294085|NCT01532869|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
294086|NCT01532908|MassBiologics|Director of Clinical Affairs|617-474-3000|Mblclinicaldirector@Umassmed.edu|
294087|NCT01532921|Medtronic, Bakken Research Center Coronary and Structural Heart Disease Management (CSH), Endepolsdomein 5, 6229 GW Maastricht, The Netherlands|Ber Kleijnen|+3143356 6566|ber.kleijnen@medtronic.com|
294088|NCT01532934|University of Rochester|Marc T. Swogger, Ph.D.|585-275-7418|marc_swogger@urmc.rochester.edu|
294089|NCT01532973|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
305949|NCT02370667|McMaster University|Dr. Monica Maly|905-525-9140|mmaly@mcmaster.ca|27823
305950|NCT02370693|Northwestern University|Manu Jain, MD|312-503-4242|m-jain@northwestern.edu|
305951|NCT02370784|University of Pittsburgh School of Medicine|Robyn T. Domsic, MD MPH|412-383-8000|rtd4@pitt.edu|
305952|NCT02370810|Anglia Ruskin Univeristy|Eldre Beukes|1223698847|eldre.beukes@anglia.ac.uk|2847
305953|NCT02370914|Stanford University|Dr. Paul Auerbach|(650) 725-9445|auerbach@stanford.edu|
305954|NCT02371187|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
305955|NCT02371252|Mahidol University|Dr. Aasis Unnanuntana|+66836871159|uaasis@gmail.com|
305956|NCT02371356|Kaiser Permanente Division of Research|De-Kun Li, MD, PhD|510.891.3749|De-Kun.Li@kp.org|
305957|NCT02371369|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
305958|NCT02371395|CDC|Alexandre Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
305959|NCT02371616|GlaxoSmithKline|GSK Response Center|866-435-7343||
305960|NCT02371629|Novartis Pharmaceuticals|Study Director|862-778-8300||
305961|NCT02371668|National Institute of Allergy and Infectious Diseases|Memoli, Matthew|+1 301 443 5971|mm982v@nih.gov|
305962|NCT02371746|Envisia Therapeutics, Inc.|Kristin Blackwell, Consultant, Regulatory Affairs & Quality Assurance|919-219-6448|kristin.blackwell@envtx.com|
305963|NCT02371759|University of Belgrade, Faculty of Dental Medicine|DDS PhD Professor Dragica Stojic, DDS PhD Professor Bozidar Brkovic, DDS PhD Marija Milic|+ 381 11 2685 280|brkovic73@yahoo.com|244
305964|NCT02371785|Corindus Vascular Robotics|Vice President, Clinical and Regulatory Affairs|260-615-8892|john.vanvleet@corindus.com|
294090|NCT01532986|VA Greater Los Angeles Healthcare System|Eric M Cheng|3102067671|echeng@mednet.ucla.edu|
294091|NCT01532999|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|lori.davis@va.gov|
294092|NCT01533038|NeoTract|Director of Clinical Affairs|925-401-0641|ehergenreter@neotract.com|
294093|NCT01533077|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
294094|NCT01533116|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
294095|NCT01533181|H. Lee Moffitt Cancer Center and Research Institute|Dr. Alberto Chiappori|813-745-2158|alberto.chiappori@moffitt.org|
294096|NCT01533207|NRG Oncology|Linda Gedeon on behalf of Danielle Enserro, PhD|716-845-1169|linda.gedeon@roswellpark.org|
294097|NCT01533246|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
294098|NCT01533259|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
294099|NCT01533428|Astellas Pharma Global Development|Medical Science Director, Global Medical Science|+31(0)715454002|Astellas.resultsdisclosure@astellas.com|
294100|NCT01533493|Massachusetts General Hospital|Joseph Biederman|617-724-1743|jbiederman@partners.org|
294101|NCT01533597|Soonchunhyang Bucheon Hospital|Dr. Kwang-Woo Lee|+82 32 621 5465|urolkw@schmc.ac.kr|
294102|NCT01533688|UOklahoma|Dr. Mohammad Madhoun|405-456-326-|mohammad-madhoun@ouhsc.edu|
294103|NCT01533922|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
294104|NCT01533935|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
294105|NCT01533948|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
294106|NCT01533974|Fred Hutchinson Cancer Research Center|Jonathan B. Bricker, Ph.D.|206-667-5074|jbricker@fredhutch.org|
294107|NCT01534013|Imperial College London|Prof Nick Oliver|02075942433|nick.oliver@imperial.ac.uk|
294108|NCT01534052|Astellas Pharma Europe B.V. (APEB)|Clinical Trial Disclosure|800-888-7704 Ext:5473|astellas.resultsdisclosure@astellas.com|
294109|NCT01534078|Massachusetts General Hospital|Jeremy Abramson, MD|617-724-4000|JABRAMSON@mgh.harvard.edu|
294110|NCT01534182|Novartis|Study Director|+1 (862) 778-8300||
294111|NCT01534195|Ora|Keith Lane|9786896500|klane@oraclinical.com|
294112|NCT01534208|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
294113|NCT01534260|IndianaU|Dr. Hamid Sayar|(317) 948-7576|ssayar@iu.edu|
294114|NCT01534273|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294115|NCT01534351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294116|NCT01534416|Icahn School of Medicine at Mount Sinai|Dr. Rachel L. Barr Grzesh|212-241-2995|rachel.barr@mssm.edu|
294117|NCT01534520|UPittsburgh|Dionne Best|412-641-5496|dbest@upmc.edu|
294118|NCT01534533|Peking University|Dr. Zhiyong Zou|+8610-13581525193|harveyzou2002@bjmu.edu.cn|
294119|NCT01534637|Comprehensive Cancer Center of Wake Forest University|James Lovato, MS|336-713-4172|jlovato@wakehealth.edu|
294120|NCT01534663|University Hospital Jena|Christian Schulze, MD, PhD|03641-9 32 41 04|christian.schulze@med.uni-jena.de|
294121|NCT01534689|Regulatory Insight, Inc.|Clinical Consultant|6157129743|elvira@reginsight.com|
294122|NCT01534897|Massachusetts General Hospital Cancer Center|Dr. Lori J. Wirth|617 724 4000|lwirth@mgh.harvard.edu|
294123|NCT01534910|Los Angeles Biomedical Research Institute|Dr Matthew Budoff|310-222-4107|mbudoff@labiomed.org|
294124|NCT01534962|Menarini Ricerche S.p.A|Angela Capriati MD PhD, Head of Corporate Clinical Research|00390555680|acapriati@menarini-ricerche.it|9933
294125|NCT01534975|Los Angeles Biomedical Research Institute|Matthew Budoff|3102224107|mbudoff@labiomed.org|310
294126|NCT01535001|Aalborg University Hospital|Dr. Søren T. Skou|+4523708640|sots@rn.dk|
294127|NCT01535014|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
294128|NCT01535040|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
294129|NCT01535053|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD.|716-845-1169|lgedeon@gogstats.org|
294130|NCT01535118|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294131|NCT01535222|The Medicines Company|Andreas van de Locht|+4989244180862|andreas.locht@themedco.com|
294132|NCT01535235|Medical College of Wisconsin|Dr. Leslie Cockerham|414-805-0738|lcockerham@mcw.edu|
294133|NCT01535261|Novartis|Study Director|862-778-8300||
294134|NCT01535287|University of Iowa|Martin Mueller|3193562633|martin-mueller@uiowa.edu|
294135|NCT01535326|Dalin Tzu Chi Hospital|Dr. Yu-Hsi Hsieh|88652648000|hsieh.yuhsi@msa.hinet.net|5241
294136|NCT01535365|Stony Brook U|Adam Singer|631-444-7856|adam.singer@stonybrook.edu|
294137|NCT01535443|Laboratorios Sophia, SA de CV|Baiza-Duran Leopoldo, Medial Director|+52 (33)30014200|lbaiza@sophia.com.mx|
294138|NCT01535560|Alcon Research, Ltd.|Sally Schieb, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
305965|NCT02371850|University of Maryland School of Pharmacy|Audra Stinchcomb, PharmD|410-706-2646|astinchc@rx.umaryland.edu|
305966|NCT02371876|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
305967|NCT02371980|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305968|NCT02372006|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
305969|NCT02372058|Albert Einstein Medical Center located in Philadelphia, Pennsylvania, USA|Dr. David L. Schutzman|215-456-6698|schutzmand@einstein.edu|
305970|NCT02372071|Hadassah Hospital located in Jerusalem, Israel|PROF. BAR-OZ BENJAMIN|02-6774919|baroz@hadassah.org.il|
294139|NCT01535573|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD, Professor and Director of Center For Neurobehavioral Research On Addictions||Joy.M.Schmitz@uth.tmc.edu|
294140|NCT01535599|Alcon Research, Ltd.|Sally Scheib, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
294141|NCT01535638|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
294142|NCT01535664|Acorda Therapeutics, Inc.|Gustavo Suarez, MD|(914) 326-5394|gsuarez@acorda.com|
294143|NCT01535729|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
294144|NCT01535924|The Ohio State University|Dr. Beth Christian|614-293-7807|Beth.Christian@osumc.edu|
282636|NCT00865306|Massachusetts General Hospital|Dina R. Hirshfeld-Becker, PhD|617-503-1408|dhirshfeld@partners.org|
282637|NCT00865345|Medtronic|Scott Lee M.D.|818-576-4204|scott.w.lee@medtronic.com|
294145|NCT01535937|NYSPI|Elias Dakwar, MD|646.774.8728|elias.dakwar@nyspi.columbia.edu|
294146|NCT01535976|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
294147|NCT01536067|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
294148|NCT01536093|Seoul National University College of Medicine|Dr. Juyoung Lee|82-31-787-7301|lamb4122@snu.ac.kr|
305971|NCT02372097|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
305972|NCT02372136|Gerber Foundation, UT Southwestern Med Ctr, Children's Medical Center|National Grant Gerber Foundation) (LPB); George L. MacGregor Professorship (CRR); National Children'|214-648-3903|luc.brion@utsouthwestern.edu|
305973|NCT02372253|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Anath Shalev, MD|205-996-4777|shalev@uab.edu|
305974|NCT02372344|AstraZeneca Pharmaceuticals|Stefan C Carlsson, MD, PhD, Global Clinical Lead|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
305975|NCT02372383|UColorado|Dr. Stacey Martiniano|7207776181|stacey.martiniano@childrenscolorado.org|
305976|NCT02372396|Veterans Medical Research Foundation|Dr. Ariel Lang|858-552-8585|ajlang@ucsd.edu|5359
305977|NCT02372682|Saint Louis University|Anna Hardy, Research Nurse Coordinator|314-268-5785|anna.hardy@health.slu.edu|
305978|NCT02372799|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
305979|NCT02373098|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email.@novartis.com|
305980|NCT02373124|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
305981|NCT02373137|Kaiser Permanente / University of California, San Francisco|Dr. Jennifer Rose-Nussbaumer|650-299-2111|Jennifer.Rose-Nussbaumer@kp.org|
305982|NCT02373202|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
305983|NCT02373371|CHU de Limoges|Project Manager|0555058616|abdeslam.bentaleb@chu-limoges.fr|+33
305984|NCT02373813|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
305985|NCT02373852|Gardia Medical Ltd|Dr Vardit Segal|972-52-4579178|vardit@gardiamedical.com|
305986|NCT02374060|Johns Hopkins University|Elizabeth Sugar, PhD|(410) 614-7837|esugar2@jhu.edu|
305987|NCT02374099|Celgene Corporation|Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
305988|NCT02374138|Children's Research Institute|Stephen Teach, MD, MPH|202 476 5134|steach@childrensnational.org|
305989|NCT02374164|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
305990|NCT02374255|Icahn School of Medicine at Mount Sinai|Radhi Yagnik|212-659-5933|radhi.yagnik@mountsinai.org|
305991|NCT02374307|OsloMet - Oslo Metropolitan University|Maria Bjerk|+4767236683|maria.bjerk@oslomet.no|
305992|NCT02374346|Attikon Hospital|P. Matsota|00302105831000|matsota@yahoo.gr|
305993|NCT02374398|Eastern Maine Medical Center|Dr. Alexandru Seviciu|207-973-5918|aseviciu@emhs.org|
305994|NCT02374463|Baltimore VA Medical Center|Leslie Katzel, MD, PhD|410-605-7248|leslie.katzel@va.gov|
305995|NCT02374593|Riley Hospital for Children|Dr. Erica Eugster|317 944-3889|eeugster@iu.edu|
305996|NCT02374671|Refocus Group, Inc.|Director of Regulatory & Quality|214-368-0200|lstewart@refocus-group.com|431
305997|NCT02374918|University of Arizona|"Dr. William Scott Killgore"|(520) 621-0605|killgore@psychiatry.arizona.edu|
305998|NCT02374957|Wake Forest University Health Sciences|Dr. Matthew Edwards|336-716-9343|medwards@wakehealth.edu|
305999|NCT02375347|University of Florida|Volker Mai, PhD, MPH|3522739398|vmai@epi.ufl.edu|
306000|NCT02375373|University of Florida|Volker Mai, PhD, MPH|352-273-9398|vmai@epi.ufl.edu|
306001|NCT02375698|UCT|Dr. Rodney Dawson|27214066850|rodney.dawson@uct.ac.za|
306002|NCT02375724|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
306003|NCT02375971|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
306004|NCT02375984|Saint John's Cancer Institute (formerly John Wayne Cancer Institute)|Lisa van Kreuningen|3105827053|lisa.vankreuningen@providence.org|
306005|NCT02376010|Lundquist Institute|Matthew Budoff|3102224107|mbudoff@lundquist.org|
306006|NCT02376166|Icahn School of Medicine at Mount Sinai|Dr. Matthew D. Galsky|(212) 659-5599|matthew.galsky@mssm.edu|
292569|NCT01434667|Brigham and Women's Hospital|Kurt Christensen, PhD|(617) 264-5883|kchristensen@bwh.harvard.edu|
292570|NCT01434680|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
292571|NCT01434693|Coronado Biosciences|Vice President Clinical Operations|781.652.4516|nsilver@coronadobio.com|
292572|NCT01434810|Minnesota Medical Research Foundation and University of Minnesota|Tina M. Slusher|612-624-4586|tslusher@umn.edu|
292573|NCT01434823|University of Pennsylvania|Dr. Meeta P. Kerlin|215.614.0627|meeta.prasad@uphs.upenn.edu|
292574|NCT01435018|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
294149|NCT01536119|University of Toronto|Jennifer Abbass Dick||jennifer.abbass@mail.utoronto.ca|
294150|NCT01536145|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294151|NCT01536171|University of Florida|Dr. Heather K. Vincent, PhD|352-273-7410|vincehk@ortho.ufl.edu|
294152|NCT01536184|Child Development Clinic SSCY Centre|Dr. Ana Hanlon-Dearman|204-258-6628|ahdearman@hsc.mb.ca|
294153|NCT01536197|University of Illinois at Urbana Champaign|M. Yanina Pepino|217-300-2374|ypepino@illinois.edu|
294154|NCT01536262|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
294155|NCT01536366|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|jose.rocha@bial.com|
294156|NCT01536379|GlaxoSmithKline|GSK Response Center|866-435-7343||
294157|NCT01536392|UT MD Anderson Cancer Center|Michael Frumovitz, Professor, Gyn Onc & Reproductive Med|(713) 792-9599|mfrumovitz@mdanderson.org|
294158|NCT01536405|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294159|NCT01536418|GlaxoSmithKline|GSK Response Center|866-435-7343||
294160|NCT01536496|Denver Health Medical Center|Ernest E. Moore|303.602.1817|Ernest.Moore@dhha.org|
294161|NCT01536535|Connecticut Childrens|Dr. Jeffrey Hyams|8605459532|jhyams@connecticutchildrens.org|
294162|NCT01536561|GlaxoSmithKline|GSK Response Center|866-435-7343||
294163|NCT01536574|GlaxoSmithKline|GSK Response Center|866-435-7343||
294164|NCT01536587|GlaxoSmithKline|GSK Response Center|866-435-7343||
294165|NCT01536704|GlaxoSmithKline|GSK Response Center|866-435-7343||
294166|NCT01536795|Institut Pasteur, Tunisia|Afif Ben Salah, MD|011-216-71-792-429|afif.bensalah@pateur.rns.tn|
294167|NCT01536860|RSSL|Rungano Munyuki|+44 118 918 4166|rungano.munyuki@rssl.com|
294168|NCT01536886|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
306007|NCT02376179|Nationwide Children's Hospital|Kris Jatana, MD|614-722-6032|Kris.Jatana@nationwidechildrens.org|
306008|NCT02376257|Boston UCRC|Michael Otto, PhD|617-353-9610|mwotto@bu.edu|
306009|NCT02376283|The Royal Wolverhampton NHS Trust|Prof James Cotton|01902307999|jamescotton@nhs.net|
306010|NCT02376361|Albany Medical College|Loay Salman, MD|518-262-5176|SalmanL@amc.edu|
306011|NCT02376530|SUNYBuffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
306012|NCT02376790|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
306013|NCT02376998|University Magna Graecia of Catanzaro|Prof. Raffaele Serra|+3909613647380|rserra@unicz.it|
306014|NCT02377063|UCLA Center for Human Nutrition|Zhaoping Li, MD, PhD - Principal Investigator|310-206-1987|zli@mednet.ucla.edu|
306015|NCT02377349|GlaxoSmithKline|GSK Response Center|866-435-7343|en736091@gsk.com|
306016|NCT02377362|GLWL Research Inc|Study Director||choruspharma@lists.lilly.com|
306017|NCT02377427|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
306018|NCT02377466|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
306019|NCT02377674|Xeltis|Eliane Schutte, CEO|+31 40 751 7614|clinical@xeltis.com|
306020|NCT02377700|Xeltis|Eliane Schutte, CEO|+31 40 751 7614|clinical@xeltis.com|
306021|NCT02377752|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
294169|NCT01536938|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
294170|NCT01536951|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294171|NCT01537029|TTUHSC|Ronald Hall|2143589009|ronald.hall@ttuhsc.edu|
294172|NCT01537042|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
294173|NCT01537068|NYSPI|David Hellerstein MD|646-774-8000|desdesk@nyspi.columbia.edu|
314306|NCT03286543|SPR Therapeutics|Clinical Affairs|216-378-9106|support@sprtherapeutics.com|
314307|NCT03286751|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
314308|NCT03286829|Saniona A/S|Dr.Kim Krogsgaard, MD, DMSc, CMO|+45 20 14 83 84|kim.krogsgaard@saniona.com|
314309|NCT03287089|Atrium Health|Dina Bastawros, MD|336-718-1970|dina.bastawros@gmail.com|
314310|NCT03287219|Cosmo Technologies Ltd|R&D Manager||rjones@cosmopharma.com|
314311|NCT03287310|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
314312|NCT03287622|University of Michigan|Dr. Terri Voepel-Lewis|734-646-6803|terriv@umich.edu|
294174|NCT01537081|Reckitt Benckiser LLC|Gail Solomon,MS; Director Clinical Development|973-404-2752|gail.solomon@rb.com|
294175|NCT01537120|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294176|NCT01537133|Penn State University|David Mauger|717-531-7178|dtm5@psu.edu|
294177|NCT01537185|Comprehensive Clinical Development Northwest|Dr. Royce Morrison|206 285 3500|ckeech@path.org|
294178|NCT01537198|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
294179|NCT01537211|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
294180|NCT01537302|Austin Heart|Matthew Selmon, MD|512-788-2692|matthew.selmon@hcahealthcare.com|
294181|NCT01537315|University of Arkansas for Medical Sciences|Dumitru Rotaru, MD, PI|501/526-6919|drotaru@uams.edu|
294182|NCT01537367|Division of HIV/AIDS (Epidemiology Branch), National Center for HIV/Hepatitis/STD/Tuberculosis Prevention, Centers for Disease Control and Prevention|Lytt I. Gardner, Ph.D., CDC Project Officer|(404) 639-6163|lig0@cdc.gov|
294183|NCT01537393|CaseWestern|Dr. Jonathan Lass|2168448368|Jonathan.Lass@UHhospitals.org|
294184|NCT01537419|Center for Family Intervention Science, Drexel University|Guy Diamond, Ph.D.|215-571-3420|gd342@drexel.edu|
294185|NCT01537432|Novartis Pharmaceuticals|Study Director|862-778-8300||
294186|NCT01537549|Weill Cornell Medicine|Dr. Claire Henchcliffe|2127462584|clh2007@med.cornell.edu|
294187|NCT01537666|Savara Inc.|Taneli Jouhikainen, MD, MBA; Chief Operating Officer|(888) 302-4876|info@savarapharma.com|
294188|NCT01537783|Brigham and Women's Hospital|Scott Weiner, MD, MPH|617-732-5640|sweiner@bwh.harvard.edu|
294189|NCT01537835|Denver Health and Hospital Authority|Marisha Burden, MD|303-602-5011|Marisha.Burden@dhha.org|
294190|NCT01537887|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294191|NCT01537900|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294192|NCT01537926|UTHealth Science Center at Houston|Dr. Ali J. Marian|713-500-2310|Ali.J.marian@uth.tmc.edu|
294193|NCT01538199|Massachusetts General Hospital|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
294194|NCT01538472|University of Texas (UT) MD Anderson Cancer Center|Issa Khouri, MD / Professor, Stem Cell Transplant|713-745-2803|CR_Study_Registration@mdanderson.org|
294195|NCT01538615|University of Minnesota School of Nursing|Dr. Jayne A. Fulkerson|612-624-4823|fulke001@umn.edu|
294196|NCT01538628|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
294197|NCT01538719|Boston University School of Medicine|Eric A Stratton, Sr. Clinical Research Manager|6174142507|eas@bu.edu|
294198|NCT01538745|SAUSHEC|Josh Miller|210-916-7111|joshmillersr@gmail.com|
294199|NCT01538862|Vanderbilt University|Haydar Frangoul, MD, MS|615-342-7339|Haydar.Frangoul@hcahealthcare.com|
294200|NCT01539070|Instituto Mexicano del Seguro Social|MPH. Gloria Oliva Martínez Andrade|5556059862|gloria_olivam@hotmail.com|21075
306022|NCT02377817|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
306023|NCT02377921|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
306024|NCT02377947|Abbott|Dr. Shubhangi Desai|+91 22 7175 7408|shubhangi.desai@abbott.com|
306025|NCT02377986|Columbia University|Dr. Carolyn Rodriguez|650-723-6158|cr2163@stanford.edu|
306026|NCT02378025|Veterans Affairs Palo Alto Healthcare System|Dr. Peter Bayley|650 493-5000|peter.bayley@va.gov|
306027|NCT02378038|Sierra Oncology|Corporate Affairs||info@sierraoncology.com|
306028|NCT02378207|Desmond Tutu HIV Foundation, Cape Town, South Africa|Dr. Linda-Gail Bekker|+27214066959|linda-gail.bekker@hiv-research.org.za|
306029|NCT02378220|Harding University College of Pharmacy / Unity Health - White County Medical Center, Searcy, Arkansas, USA|Lindsay Elliott|5012794800|lselliott@harding.edu|
306030|NCT02378402|Department of Radiology, Chang Gung Memorial Hospital|Gigin Lin, MD, PhD|886-3-3281200|giginlin@cgmh.org.tw|2575
306031|NCT02378480|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
306032|NCT02378506|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
306033|NCT02378662|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
306034|NCT02378714|Northwestern University|Dr. Brian Hitsman|312-504-5834|b-hitsman@northwestern.edu|
306035|NCT02378753|Centers for Disease Control and Prevention|Dr. Barbara Mahon|404-718-1157|bdm3@cdc.gov|
306036|NCT02378844|electroCore INC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
306037|NCT02378883|Medtronic Neurovascular|Darren Lacour, Sr. Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
306038|NCT02378935|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
306039|NCT02378961|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
306040|NCT02379052|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
306041|NCT02379078|St. Michael's Hospital (Unity Health Toronto)|Dr. Catherine Yu|(416) 360-4000|catherine.yu@unityhealth.to|
306042|NCT02379091|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306043|NCT02379117|UNottingham|Dr Gordon Moran|44 [0]115 9249924|Gordon.Moran@nottingham.ac.uk|70608
306044|NCT02379195|Center for Cancer Immune Therapy, Herlev Hospital|Dr. Inge Marie Svane|38683868|inge.marie.svane@regionh.dk|
306045|NCT02379221|Travis AFB OMFS Clinic|Dr. Jason May|707-423-7085|jason.may.11@us.af.mil|
306046|NCT02379247|University of Kansas Medical Center|Dr. Priyanka Sharma|9135886079|psharma2@kumc.edu|
306047|NCT02379273|Cochlear Americas|Aaron J Parkinson, PhD, Principal Clinical Project Manager|3035242563|aparkinson@cochlear.com|
306048|NCT02379442|NHLBI, NIH|Sawa Ito, MD|301-326-5233|itos3@upmc.edu|
314313|NCT03287635|Toyos Clinic|Dr.|9137064408|mtoyos@toyosclinic.com|
294201|NCT01539083|Janssen R&D|Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
294202|NCT01539135|Tulane University Hospital and Clinics|Dr. Sabrina Bent|5049887137|sabrina.bent@hcahealthcare.com|
294203|NCT01539239|Ivantis|Richard Hope|949-333-1310|rhope@ivantisinc.com|
294204|NCT01539291|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
294205|NCT01539317|Oregon Health and Science University|Dr. Martha Goetsch|503-494-3666|whru@ohsu.edu|
294206|NCT01539512|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
294207|NCT01539525|Yale University School of Medicine|Kimberly A Yonkers|203-764-6621|kimberly.yonkers@yale.edu|
294208|NCT01539538|AcelRx|Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
294209|NCT01539642|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
294210|NCT01539694|Bausch Health|Study Director||robert.steffen@bausch.com|
294211|NCT01539759|University of North Carolina|Erika Levi, MD and Gretchen Stuart, MD|(919) 843-5633|Erika.Levi@gmail.com|
294212|NCT01539837|Imperial College London|David Dexter|+44 (0)20 7594 6665|d.dexter@imperial.ac.uk|
294213|NCT01539863|Karolinska Institutet|Ass professor Iben Axén|+46704400618|iben.axen@ki.se|
294214|NCT01539980|Faculty of Pharmaceutical Sciences, Chulalongkorn University|Professor Pornanong Aramwit, Pharm.D., Ph.D.|+66899217255|aramwit@gmail.com|
294215|NCT01540045|Instituto Nacional de Cancerología de México|Dr. Oscar Arrieta|5628-0400|ogarrieta@gmail.com|832
294216|NCT01540071|Io Therapeutics, Inc.|Martin E. Sanders, M.D.|(650) 219-5973|msanders@io-therapeutics.com|
294217|NCT01540162|National Medical University Odessa|Prof. Mykola L. Aryayev, MD & PhD|+380 48 740 5249|nataly_kononenko@ukr.net|
294218|NCT01540266|University Hospital Basel|Dr. med. Roland Bingisser|+41 61 265 58 30|roland.bingisser@usb.ch|
294219|NCT01540370|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
294220|NCT01540409|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
294221|NCT01540474|Walter Reed Institute of Research|Jason W. Bennett|3013199477|jason.w.bennett.mil@mail.mil|
294222|NCT01540487|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
294223|NCT01540513|University of Wisconsin Carbone Cancer Center|Dr. Lance Hall|608-263-5585|lhall@uwhealth.org|
294224|NCT01540565|NRG Oncology|Christopher Purdy on behalf of Mike Sill|(716)845-1300|purdyc@nrgoncology.org|2296
294225|NCT01540773|Pennington Biomedical Research Center|Dr. Frank Greenway, Chief of Outpatient Clinic|225-763-2578|Frank.Greenway@pbrc.edu|
294226|NCT01540825|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
294227|NCT01540838|University of Helsinki, Children´s Hospital, Helsinki University Hospital|Dr. Okko Savonius, PhD candidate|+358456731185|okko.savonius@helsinki.fi|
306049|NCT02379637|Novartis|Dr Marianna Armogida Director Clinical Research Innovation|+41223635182|marianna.armogida@novartis.com|
306050|NCT02379728|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
306051|NCT02379858|Medical College of Wisconsin|Matthew Goldblatt, MD|414-955-5751|mgoldbla@mcw.edu|
306052|NCT02379923|Asahi Intecc USA, Inc.|Robert Ricker|408.429.3749|robertr@asahi-intecc.com|
306053|NCT02380183|Montefiore Medical Center|Dr. Amaresh Vydynathan|718-920-4316|avydynathan@montefiore.org|
306054|NCT02380248|Alcon, A Novartis Division|Clinical Scientific Associate Director, GCRA-GDD|1-888-451-3937|alcon.medinfo@alcon.com|
306055|NCT02380261|Alcon, a Novartis company|Dir Clinical Operations - LACAR, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
306056|NCT02380287|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
306057|NCT02380612|AVITA Medical|VP Clinical Research|661-367-9170|clinicaltrial@avitamedical.com|
306058|NCT02380677|NewLink Genetics Corporation|Manager, Clinical Operations|515-598-5020|csmith@linkp.com|2624
306059|NCT02380690|VA ORD|Robert O'Brien|2024435741|Robert.O'Brien2@va.gov|
306060|NCT02380703|Baylor College of Medicine|Mark Kunik, MD, MPH, Primary Investigator|713-794-8639|mkunik@bcm.edu|
306061|NCT02380742|Loyola University|Brendan Martin, Biostatistician|708-216-8051|bmartin5@luc.edu|
306062|NCT02380859|Dartmouth-Hitchcock Medical Center|Stephen L. Lee, MD PhD|603-650-5104|stephen.l.lee@hitchcock.org|
306063|NCT02381015|Wake Forest University Health Sciences|Dr. Aubrey R. Turner|336-918-3585|aubreyturner@gmail.com|
306064|NCT02381288|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306065|NCT02381392|Harbor-UCLA Medical Center|Kelly D. Young, MD|310-222-3506|kyoung@emedharbor.edu|
306066|NCT02381418|Abbott|Global Clinical Director|+31294477184|serge.vandewitte@abbott.com|
306067|NCT02381652|Anika|Carol Pekar, VP Clinical Affairs|781.457.9218|cpekar@anikatherapeutics.com|
306068|NCT02381678|Guangdong General Hospital|Dr. Huiming Guo (Chief in Cardiac Surgical Department)|86-13609089789|guohuiming@vip.tom.com|
306069|NCT02381795|Clinvest Research|Clinical Data Manager|417-883-7889|jsly@clinvest.com|
306070|NCT02382016|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
306071|NCT02382133|Barnes-Jewish Hospital|Dr. Marilyn Schallom|314-286-0835|marilyn.schallom@bjc.org|
306072|NCT02382276|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
306073|NCT02382640|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306074|NCT02382705|University of British Columbia|Dr. Robert Enns|604 688 6332|cgalorport@gmail.com|
306075|NCT02382744|Department of Anesthesia, St. Paul's Hospital/Providence Health Care|Dr. Stephan Schwarz, Director of Research|(604) 806-8337|stephan.schwarz@ubc.ca|
306076|NCT02382796|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
306077|NCT02382848|Penn State University College of Medicine|Dr. Fauzia Mahr|717 531-8133|fmahr@pennstatehealth.psu.edu|
294228|NCT01540851|Brigham and Women's Hospital|Elena Losina, PhD|617-732-6928|elosina@partners.org|
294229|NCT01540981|UNMC|Joyce Black|(402) 559-6573|jblack@unmc.edu|
294230|NCT01541215|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
294231|NCT01541254|MicroVention, Inc.|Mary Schmitz|714-247-8025|mary.schmitz@microvention.com|
294232|NCT01541358|David Geffen School of Medicine at UCLA|Andrew Quon, MD|310-983-1419|AQuon@mednet.ucla.edu|
294233|NCT01541371|CDMA, Beijing|Therapeutic Area Manager|00861058218352||
294234|NCT01541384|University of Pennsylvania|Dr. Peter Reese|215-898-6086|peter.reese@uphs.upenn.edu|
294235|NCT01541553|LEO Pharma A/S|Clinical trial disclosure|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
294236|NCT01541644|University of Maryland Baltimore Greenebaum Cancer Center|Emily Parks|410-328-7340|eparks@umm.edu|
294237|NCT01541735|Instituto Mexicano del Seguro Social|PhD. Manuel González Ortiz|33 36176000|uiec@prodigy.net.mx|31494
294238|NCT01541748|Coloplast|Cathy Bartz|612-834-3127|uscmba@coloplast.com|
294239|NCT01541826|University of Wisconsin-Madison, Department of Food Science|Dr. Bradley Bolling|608-890-0212|bwbolling@wisc.edu|
294240|NCT01541865|Boston Scientific|Angela Schutt, Clinical Trial Manager|763-494-2166|angela.schutt@bsci.com|
294241|NCT01541891|Laboratorios Sophia, SA de CV|Baiza-Duran Leopoldo, Medical Director|+52 (33)30014200|leopoldo.baiza@sophia.com.mx|
294242|NCT01541917|Children's Mercy Hospital|Mark Connelly, PhD (Principal Investigator)|816-234-3000|mconnelly1@cmh.edu|3193
294243|NCT01541930|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
294244|NCT01541969|University of Nottingham|Professor Deborah Hall, Professor of Hearing Sciences|+44 (0) 115 823 2600|deborah.hall@nottingham.ac.uk|
294245|NCT01542034|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
294246|NCT01542125|Alberta Health Services|Research Coordinator|780-492-2398|manu.saraswat@albertahealthservices.ca|
294247|NCT01542229|Charleston VAMC|Dr. Anouk L. Grubaugh|843-789-5853|grubaugh@musc.edu|
294248|NCT01542255|Dartmouth-Hitchcock|Marc Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
306078|NCT02382913|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
306079|NCT02382939|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
306080|NCT02382991|OTTOBOCK FRANCE|Aurélie LACROIX|0033 (0)7 86 29 52 03|market.access@ottobock.fr|
306081|NCT02383017|Onnit Labs|Vince Kreipke|3176954359|Vkreipke@onnit.com|
306082|NCT02383043|University of Kentucky|Joshua A. Lile, Ph.D.|859-420-0503|jalile2@uky.edu|
306083|NCT02383056|University of Miami|Dr. Keyvan Nouri|305-243-3380|Knouri@med.miami.edu|
306084|NCT02383173|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
306085|NCT02383355|Radboudumc|Wouter van der Heijden|0031 24 3616980|wouter.vanderheijden@radboudumc.nl|
306086|NCT02383420|Carestream Health, Inc.|Susan Pate, Senior Clinical Affairs Manager|585-627-6557|susan.pate@carestream.com|
306087|NCT02383472|Boston Children's Hospital|Dr. William Meehan|781-216-1328|William.Meehan@childrens.harvard.edu|
306088|NCT02383576|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
306089|NCT02383589|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
306090|NCT02383667|The University of Toledo|Saima Karim, DO|419-383-3697|Saima.Karim@utoledo.edu|
306091|NCT02383706|Duke University Medical Center|Dr Jennifer Dominguez|(919) 668-2024|jennifer.dominguez@dm.duke.edu|
306092|NCT02383719|Convergent Engineering|Study Coordinator|3523784899|carl@conveng.com|113
306093|NCT02383758|Emory University|Dr. Nathan Call||nathan.call@choa.org|
306094|NCT02383862|Regenstrief Institute|Research Coordintor|317-274-9288|tltalib@regenstrief.org|
306095|NCT02383940|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
306096|NCT02383966|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
306097|NCT02384044|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
306098|NCT02384070|Odessa Heart Institute / Permian Research Foundation|Fernando Boccalandro MD FACC FSCAI|432-3373117|Fboccalandro@echd.org|
306099|NCT02384096|Boston Scientific Neuromodulation|Director, Clinical Sciences and Scientific Communication||Roshini.Jain@bsci.com|
306100|NCT02384200|UCSD Medical Center|Paul Zupkas, Ph.D.|6195432628|pzupkas@ucsd.edu|
306101|NCT02384382|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
306102|NCT02384395|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-6712|cynthia_gay@med.unc.edu|
306103|NCT02384460|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
306104|NCT02384538|AbbVie|Global Medical Services|800-633-9110||
306105|NCT02384941|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
306106|NCT02385084|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
306107|NCT02385097|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
306108|NCT02385240|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
306109|NCT02385318|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
306110|NCT02385526|Cyberonics, Inc.|Peter Sears, Clinical Project Manager|(281) 228-7597|peter.sears@cyberonics.com|
306111|NCT02385669|University of Virginia|Craig L. Slingluff, Jr. MD|434-924-9311|cls8h@virginia.edu|
306112|NCT02385708|Vanderbilt University Medical Center|Steven Klintworth|615-936-3298|steven.klintworth@vumc.org|
306113|NCT02385721|Boryung Pharmaceutical Co., Ltd|Myung Sook Hong|82-2-708-8238|mshong@boryung.co.kr|
306114|NCT02385799|UC Davis MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
306115|NCT02386098|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
294249|NCT01542307|Massachusetts General Hospital|Aneesh Singhal, MD|6177268459|asinghal@partners.org|4
294250|NCT01542372|Massachusetts|Dr. Devon Hinton|617-620-4522|DHINTON1@mgh.harvard.edu|
294251|NCT01542398|Queen's University, Belfast|Dr Paul O'Callaghan|+44 7501 43 46 32|pocallaghan02@qub.ac.uk|
294252|NCT01542502|Virginia Commonwealth University|Antonio Abbate|804-828-0513|aabbate@vcu.edu|
306116|NCT02386189|Iowa City VA Health Care System|Dr. Carolyn Turvey|319 358 9501|carolyn.turvey@va.gov|7714
306117|NCT02386319|Herlev Hospital|Dr. Anders Gram-Hanssen|004526225318|anders.gram-hanssen@regionh.dk|
306118|NCT02386345|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
306119|NCT02386605|Greater Los Angeles VA Healthcare System|Dr. Felice Reddy|3104783711|felice.reddy@gmail.com|
306120|NCT02386995|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
306121|NCT02387008|University of North Carolina at Chapel Hill|Gidgetta Kang|919-537-3968|gidget_jenkins@unc.edu|
306122|NCT02387164|Skåne University Hospital|Helena Elding Larsson|+4640337676|helena.larsson@med.lu.se|
306123|NCT02387216|Elevation oncology|VP, Clinical Operations|+1-716 371 1125|clinical@elevationoncology.com|
306124|NCT02387268|M.C.Carmel|Dr.Kobie Dickstein|048250055|kobiedi@clalit.org.il|
306125|NCT02387294|Fluart Innovative Vaccines Ltd|Zsolt Németh|+3620|info@fluart.hu|4197020
306126|NCT02387359|Synergy Pharmaceuticals Inc.|VP Regulatory Affairs & Clinical QA|646-675-7283|ejaeger@synergypharma.com|
306127|NCT02387372|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281769|NCT03846219|Immunic AG|Andreas Muehler, MD|+4917678738359|andreas.muehler@imux.com|
294253|NCT01542528|Yale University|Dr. James Leckman|203-785-5880|james.leckman@yale.edu|
294254|NCT01542541|BIDMC|Dr Alan Moss|6176673197|amoss@bidmc.harvard.edu|
294255|NCT01542632|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
294256|NCT01542645|NorthShore University HealthSystem|Glenn Murphy, MD|847-570-2760|dgmurphy2@yahoo.com|
281770|NCT03758404|MeiraGTx|Program Manager|020 3866 4320|CNGA3@meiragtx.com|
294257|NCT01542684|The University of Texas MD Anderson Cancer Center|Zeev Estrov, MD/Professor|713-794-1675|eharriso@mdanderson.org|
294258|NCT01542788|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
294259|NCT01542957|Universitat de Barcelona|Prof. Guillem Feixas|0034 933125100|gfeixas@ub.edu|
294260|NCT01543074|Institute of Biosciences and Technology, Texas A&M Health Science Center, Houston TX|Rod Dashwood|7136777806|rdashwood@ibt.tamhsc.edu|
294261|NCT01543087|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294262|NCT01543152|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
294263|NCT01543178|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
294264|NCT01543204|Amgen Inc.|Study Director|866-572-6436||
294265|NCT01543490|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
294266|NCT01543503|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
294267|NCT01543568|Retina Consultants of Houston|David Brown, MD|713-524-3434|dmbmd@houstonretina.com|
294268|NCT01543581|Loma Linda University Health, Department of Dermatology|Dr. Abel Torres, PI|(909) 558-2055|atorres@llu.edu|
294269|NCT01543607|Mass. General Hospital|William R. Brugge|617-724-0578|wbrugge@partners.org|
294270|NCT01543685|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
294271|NCT01543776|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
294272|NCT01543828|Novartis Pharmaceuticals|Study Director|862-778-8300||
294273|NCT01543958|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
294274|NCT01544023|University of Rostock, Klinikum Südstadt der Hansestadt Rostock, Frauenklinik|Dr. Max Dieterich|+4938144016145|max.dieterich@uni-rostock.de|
294275|NCT01544062|University of Washington|Srdjan Jelacic, MD|(206) 598-3777|sjelacic@uw.edu|
294276|NCT01544088|VA Boston Healthcare System|Denise Sloan, Ph.D.|(857) 364-6333|denise.sloan@va.gov|
294277|NCT01544114|Horizon Pharma, Inc.|Julie Ball, Executive Director of Clinical Development & Operations||clinicaltrials@horizonpharma.com|
294278|NCT01544153|Truth Initiative|Amanda L. Graham, PhD|202-454-5938|agraham@truthinitiative.org|
294279|NCT01544166|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
306128|NCT02387476|FRESCA Medical|Robert Lahaderne|949-542-3535|rlahaderne@frescamed.com|
306129|NCT02387502|Govt. Medical College, Haldwani.|Dr. Geeta Bhandari|8958267145|bhandari_geetantl@rediff.com|
306130|NCT02387554|Bundang Seoul National University Hospital|Principal Investigator||mekka@snu.ac.kr|
306131|NCT02387580|Medicines for Malaria Venture (MMV)|Fiona Macintyre PhD|+41 22 555 0319|Macintyref@mv.org|
306132|NCT02387710|Brigham and women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
306133|NCT02387749|Cairo university, faculty of medicine|Dina Mohammed Riad Ebrahim Abdelmagid|+201112052600|drdina_m@hotmail.com|
306134|NCT02387762|Acerta Pharma|Ahmed Hamdy, MD, VP of Early Development|650-591-2800|a.hamdy@acerta-pharma.com|145
306135|NCT02387801|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
306136|NCT02387814|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
306137|NCT02387840|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Deborah Runkin Gold|1-800-641-2422|CTUReferral@UHhospitals.org|
306138|NCT02387853|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
306139|NCT02387957|Ophthotech Corp.|Denise Teuber|646-753-8461|denise.teuber@ophthotech.com|
306140|NCT02387970|Columbia University|Panos N. Papapanou, DDS, PhD|(212) 342-3008|pp192@cumc.columbia.edu|
306141|NCT02387983|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
306142|NCT02387996|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
306143|NCT02388074|bioAffinity Technologies Inc.|Bijal Karia, PhD Director of Research|2107485287|bk@bioaffinitytech.com|
306144|NCT02388165|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
306145|NCT02388191|Planned Parenthood League of Massachusetts|Principal Investigator|6176298603|jfortin@pplm.org|
306146|NCT02388269|electroCore LLC|Clinical Affairs Department electroCore LLC|+1 973 355 6683|clinical@electrocorellc.com|
306147|NCT02388295|AstraZeneca Pharmaceuticals LP|Jamie Mullen MD||Clinicaltrialtransparency@astrazeneca.net|
306148|NCT02388321|Maimonides Medical Center|Sergey Motov, MD (Prinicipal Investigator)|718-283-8693|smotov@maimonidesmed.org|
314314|NCT03287674|National Center for Cancer Immune Therapy, Herlev Hospital|Anders Kverneland, MD|38686467|anders.kverneland@regionh.dk|
314315|NCT03287791|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
314316|NCT03287804|Autolus Ltd|Clinical Project Manager|+44 1483 920748|clinicaltrials@autolus.com|
314317|NCT03287843|Ege University Hospital|Erhan Akgun,MD, Proffessor|+902323905050|z.erhan.akgun@ege.edu.tr|
314318|NCT03287869|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
314319|NCT03288714|Wave Neuroscience|Meagan Kovacs, Clinical and Regulatory Affairs Manager|9492292869|meagan@waveneuro.com|
314320|NCT03288779|DukeUMC|Steven T Szabo|3524540101|steven.szabo@duke.edu|3524540101
314321|NCT03288987|Aryogen|Dr. Nasim Anjidani (Director of Medical- Clinical Trials)|009809125477964|anjidani.n@orchidpharmed.com|
294280|NCT01544179|AstraZeneca|Haiyi Jiang/Asia Medical Director|+86 21 60302408|haiyi.jiang@astrazeneca.com|
294281|NCT01544309|Department of Cardiovascular Medicine, Faculty of Life Sciences, Kumamoto University|Hisao Ogawa, Ph.D; Study Chair|+ 81 963735175|ogawah@kumamoto-u.ac.jp|
294282|NCT01544335|Massachusetts General Hospital|Associate Director, Lymphedema Research Program|6177240127|cbrunelle@mgh.harvard.edu|
294283|NCT01544348|MedImmune|Claire Birrell, Senior Clinical Scientist|301-398-0000|birrellc@medimmune.com|
294284|NCT01544361|MedImmune, LLC.|Joseph M. Parker, Director, Clinical Development|301-398-0000|parkerj@medimmune.com|
294285|NCT01544478|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294286|NCT01544491|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
294287|NCT01544582|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294288|NCT01544595|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
294289|NCT01544920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294290|NCT01544998|Mayo Clinic|Horng Chen, MD, Professor of Medicine|507-284-8846|chen.horng@mayo.edu|
294291|NCT01545076|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
294292|NCT01545141|Roswell Park Cancer Institute|Kris Attwood|716-845-2300|Kristopher.attwood@roswellpark.org|
294293|NCT01545193|NorthShore University HealthSystem|Glenn S. Murphy,MD|847-570-2760|dgmurphy2@yahoo.com|
294294|NCT01545232|University of Texas Health Science Center - Houston|John Holcomb, M.D.|713-500-5493|John.Holcomb@uth.tmc.edu|
294295|NCT01545336|University of Pennsylvania|Dr. Steven M. Kawut|215-573-0258|kawut@upenn.edu|
294296|NCT01545375|GlaxoSmithKline|GSK Response Center|866-435-7343||
294297|NCT01545388|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294298|NCT01545583|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294299|NCT01545700|NorthShore University HealthSystem|Glenn S. Murphy, MD|847-570-2760|dgmurphy2@yahoo.com|
294300|NCT01545765|Galderma|Farzaneh Sidou Clinical Project Manager)|00.33.4.93.95.70.70|farzaneh.sidou@galderma.com|
294301|NCT01545817|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
294302|NCT01545843|University of Michigan|Dr. J. Todd Arnedt|734-764-1234|tarnedt@med.umich.edu|
294303|NCT01545934|Cal Poly|Suzanne Phelan|805-756-2087|sphelan@calpoly.edu|
294304|NCT01546038|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294305|NCT01546142|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
294306|NCT01546155|Massachusetts General Hospital|Dr. Jian Kong|617-726-7893|JKONG2@mgh.harvard.edu|
306149|NCT02388347|MedImmune LLC|Rene van der Merwe||information.center@astrazeneca.com|
306150|NCT02388386|Scripps Clinic Medical Group|Sanjeev Bhavanni MD|6196601842|bhavnani.sanjeev@scrippshealth.org|
306151|NCT02388568|The University of Pennsylvania's Center for Weight and Eating Disorders|Dr. Jena Shaw Tronieri|215-746-5045|jena.tronieri@pennmedicine.upenn.edu|
306152|NCT02388633|OregonHSU|Jonathan Lindner, MD|5034949191|lindnerj@ohsu.edu|
306153|NCT02388646|OrthoIndy|Dr. Frank Kolisek|3178845160|fkolisek@orthoindy.com|
306154|NCT02388724|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306155|NCT02388737|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
306156|NCT02388763|Alcon, A Novartis Division|GMA Franchise Head - Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
306157|NCT02388815|Abbott Diabetes Care|Jolyon Bugler, Snr Director Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
306158|NCT02388880|Advanced Circulatory Systems|Clinical Research Associate|651.403.5600|nburkhart@advancedcirculatory.com|
306159|NCT02388906|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
306160|NCT02388932|Cleveland Clinic, Case Comprehensive Cancer Center|Shlomo Koyfman, MD|216-444-7552|koyfmas@ccf.org|
306161|NCT02388997|University of Virginia|Peter W. Heymann|434-982-3654|pwh5a@virginia.edu|
306162|NCT02389088|University of California, San Diego|Dr. R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
306163|NCT02389101|Turku Univesrity Hospital, Turku, Finland|Heikki Minn, MD|+35823130000|heikki.minn@utu.fi|30149
306164|NCT02389361|ASTES|Dr. DEFLANDRE Eric|0032477764241|eric.deflandre@gmail.com|
306165|NCT02389374|Menzies School of Health Research|Benedikt Ley|889468643|benedikt.ley@menzies.edu.au|
306166|NCT02389452|Sanofi|Trial Transparency Team||Contact --US@Sanofi.com|
306167|NCT02389621|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
306168|NCT02389725|Mayo Clinic|Dr. Tobias Kummer|507-255-4399|kummer.tobias@mayo.edu|
306169|NCT02389738|Johns Hopkins/NIH|Principal Investigator|4109558837|sjacks78@jhmi.edu|
306170|NCT02389764|UT MD Anderson Cancer Center|Ueno,Naoto,M.D., PH.D. / Breast Medical Oncology|713-792-2817|nueno@mdanderson.org|
306171|NCT02389816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306172|NCT02389829|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
306173|NCT02389881|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306174|NCT02389894|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
306175|NCT02389946|BIOTRONIK, Inc|Amy Culley, Director of Vascular Intervention Clinical Studies|503-451-8034|amy.culley@biotronik.com|
306176|NCT02389959|Stanford University|Peter H. Hwang, MD|(650) 723-5281|hwangph@stanford.edu|
306177|NCT02389998|Boston Children's Hospital|Dr Samuel Nurko|6173556055|samuel.nurko@childrens.harvard.edu|
294307|NCT01546168|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
294308|NCT01546194|NorthShore University HealthSystem|Glenn Murphy|847-570-2760|dgmurphy2@yahoo.com|
294309|NCT01546285|GE Healthcare|Jeffrey Conner - Global Research Manager|414.721.2423|Jeffrey.Conner@ge.com|
294310|NCT01546402|Post Graduate Institute of Medical Education and Research|Aniruddha Agarwal|+911722756111|aniruddha9@gmail.com|
294311|NCT01546454|University of Arizona|Dr. Randy Bogan|520-621-1487|boganr@email.arizona.edu|
294312|NCT01546519|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
294313|NCT01546623|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
294314|NCT01546636|NorthShore University HealthSystem|Glenn Murphy, MD, Director of Clinical Research|847-570-2760|gmurphy@northshore.org|
294315|NCT01546649|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
294316|NCT01546675|Department of Veterans Affairs|Linda Resnik, PT, PhD|401-273-7100|linda.resnik@va.gov|2368
294317|NCT01546688|Eisai Call Center|Eisai Inc.|888-422-4743||
294318|NCT01546857|Rutgers-New Jersey Medical School|Jean Daniel Eloy|9739721470|eloyje@njms.rutgers.edu|973
294319|NCT01546922|University Medical Center Groningen|A. P. van Beek, MD PhD|00315036110388|a.p.van.beek@umcg.nl|
294320|NCT01547000|University of South Florida|Tanya K. Murphy, MD, MS|813-974-2201|tmurphy@health.usf.edu|
294321|NCT01547130|Wyckoff Heights Medical Center|Dr Vijaypal Arya|718-326-0400|varyamd@yahoo.com|
294322|NCT01547247|Digestive Diseases Center, Vítkovice Hospital, Ostrava, Czech Republic|Přemysl Falt MD|+420602689561|faltprem@centrum.cz|
294323|NCT01547286|Massachusetts General Hospital|Dr. Robert Scott Harris, MD|617-726-9429|rsharris@mgh.harvard.edu|
294324|NCT01547299|Medivation, Inc.|William Novotny, MD, Sr. Director, Clinical Development|415- 983-3066|william.novotny@medivation.com|
294325|NCT01547390|University of South Florida|Dr. Anthony Odibo|813-259-0828|aodibo@health.usf.edu|
294326|NCT01547598|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
294327|NCT01547715|Novartis Vaccines and Diagnostics SRL|Posting Director||RegistryContactVaccinesUS@novartis.com|
294328|NCT01547780|National Institute of Mental Health|Robert Innis|+1 301 594 1368|innisr@mail.nih.gov|
294329|NCT01547806|National Cancer Institute|Dr. Jennifer Kanakry|301-451-3787|kanakryja@nih.gov|
294330|NCT01548040|Theragen Inc.|Richard Pearce|901 634 0544|richard.pearce@theragen.com|
294331|NCT01548287|AstraZeneca Pharmaceuticals LP, Neuroscience iMed|Joel Posener, MD||clinicaltrialtransparency@astrazeneca.net|
294332|NCT01548339|University Hospital Lausanne|Prof. N. Demartines||demartines@chuv.ch|
294333|NCT01548404|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
294334|NCT01548417|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
294335|NCT01548573|University of Iowa|Guido Tricot, MD, PhD|319-356-3425|guido-tricot@uiowa.edu|
294336|NCT01548599|University of California, San Francisco|Sheri Weiser|(415) 314-0665|Sheri.Weiser@ucsf.edu|
306178|NCT02390050|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
306179|NCT02390076|Minneapolis VA Health Care System|Seth Disner|3105605990|disne014@umn.edu|
306180|NCT02390167|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
306181|NCT02390219|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
306182|NCT02390557|Massachusetts General Hospital, Mongan Institute for Health Policy|Lisa I. Iezzoni, MD, MSc|6176430657|liezzoni@mgh.harvard.edu|
306183|NCT02390791|Cincinnati Children's|Dr. William B. Brinkman|513-636-2576|bill.brinkman@cchmc.org|
306184|NCT02390908|Hunter College|Dr. Tyrel J. Starks|212-772-5550|tstarks@hunter.cuny.edu|
306185|NCT02391038|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306186|NCT02391116|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
306187|NCT02391311|UAB|Pariya L Fazeli, PhD|205-996-0330|plfazeli@uab.edu|
306188|NCT02391337|University of Birmingham|Prof. Dipak Kotecha|+44 (0) 7974 115676|d.kotecha@bham.ac.uk|
306189|NCT02391350|University of Utah|Dr. Julie Fritz|8015872237|julie.fritz@utah.edu|
306190|NCT02391363|Baylor College of Medicine|Melinda A. Stanley, PhD|713-794-8841|mstanley@bcm.edu|
306191|NCT02391545|Verastem, Inc.|Gloria Patrick|17814691594|gpatrick@verastem.com|
306192|NCT02391584|Entellus Medical|Clinical Affairs Manager|7634631595|rschacherer@entellusmedical.com|
306193|NCT02391701|Hospital Clínico Universitario de Santiago|Dr. María del Mar Calvo Malvar|34 981950395|mariadelmar.calvo.malvar@sergas.es|
306194|NCT02391714|Division of Family Planning, University of New Mexico|Sunderjeet Kaur|Email|skaur@salud.unm.edu|
306195|NCT02391948|University of Washington|Sarah Westcott McCoy PT, PhD, FAPTA|206-616-8601|westcs@uw.edu|
306196|NCT02391961|Louis Stokes VAMC|Alessandro Serra|2167913800|Alessandro.Serra@va.gov|
306197|NCT02391987|Mayo Clinic|Charles J. Bruce|904-953-7227|bruce.charles@mayo.edu|
306198|NCT02392000|Edith Nourse Rogers Memorial VA Hospital|Karen S. Quigley|781-687-2273|karen.quigley@va.gov|
306199|NCT02392104|William S. Middleton Memorial Veterans Hospital|Andrea Porter, PharmD|608-890-0742|andrea.porter@wisc.edu|
306200|NCT02392195|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
306201|NCT02392208|University of Michigan|Dr. Bruce A. Mueller|734-763-6629|muellerb@med.umich.edu|
294337|NCT01548638|University of Pennsylvania Perelman School of Medicine|Dr. Rebecca Ashare|2157465789|rlashare@mail.med.upenn.edu|
294338|NCT01548690|University of Texas Southwestern Medical Center|William M. Lee, MD|(214) 645-6110|William.Lee@UTSouthwestern.edu|
306202|NCT02392234|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
294339|NCT01548742|Minneapolis VA Medical Center|Kelvin O. Lim, MD (Principal Investigator)|612-467-3323|kolim@umn.edu|
294340|NCT01548768|Columbia University Irving Medical Center|Dr. Joan Bathon, MD|212-305-6327|jmb2311@cumc.columbia.edu|
294341|NCT01548833|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
294342|NCT01548885|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
294343|NCT01549002|ColumbiaU|Dr. Daniel Fenster|212-305-9825|dbf2114@columbia.edu|
294344|NCT01549041|DukeUMC|Joseph P McEvoy, MD|9198199295|JPMCEVOY@DUKE.EDU|
294345|NCT01549223|Brigham and Women's Hospital|Lawrence Tsen, MD|617-732-8216|ltsen@partners.org|
294346|NCT01549275|Kaohsiung Medical University Hospital|Dr. Zu-Yau LIn|886-7-323-4553|linzuyau@yahoo.com.tw|
294347|NCT01549314|Massachusetts General Hospital Endocrine Unit|Dr. Melissa Putman|857-218-5017|msputman@partners.org|
294348|NCT01549340|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
306203|NCT02392247|Virginia Commonwealth University|Dr.Bruce Spiess, Principal Investigator|804-828-2267|bruce.spiess@vcuhealth.org|
306204|NCT02392286|Yale|Dr. Loren Laine|203-785-7312|loren.laine@yale.edu|
306205|NCT02392351|Boston Scientific|Clinical Trial Manager|970-294-4082|nicole.kilburn@bsci.com|
306206|NCT02392403|Cochlear|Chris James|+33 534 638 584|cjames@cochlear.com|
306207|NCT02392481|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
306208|NCT02392494|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
306209|NCT02392507|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
306210|NCT02392559|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
306211|NCT02392611|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
306212|NCT02392624|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
306213|NCT02392767|Dr. Loges + Co. GmbH|Dr. Birgit Goyvaerts|0049-4171-707182|goyvaerts@loges.de|
306214|NCT02392806|Saint Louis University|Noah Hillman|3145779292|noah.hillman@health.slu.edu|
306215|NCT02393209|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306216|NCT02393339|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+972507410935|fuxavia@gmail.com|
306217|NCT02393378|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306218|NCT02393417|Nielsen BioSciences Inc.|David Burney, PhD, MBA|858-571-2726|david@nielsenbio.com|
306219|NCT02393547|Mayo Clinic|Ryan T. Hurt, MD|507-266-1944|nicotineresearch@mayo.edu|
306220|NCT02393677|Govt. Medical College, Haldwani.|Dr. Bikramjit Das|(05946)-228393|bikramjit_81@rediff.com|
306221|NCT02393690|Academic and Community Cancer Research United (ACCRU)|Alan Ho, M.D.|212-639-7202|hoa@mskcc.org|
281771|NCT03698708|Nemours Children's Health|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
294349|NCT01549392|London Health Sciences Hospital|Barbara Fisher|519-685-8650|barbara.fisher@lhsc.on.ca|
294350|NCT01549405|Ministry of health Diskapi Yıldirim Beyazit Training and Research Hospital|Dr Derya Özkan|00903125962553|derya_z@yahoo.com|
294351|NCT01549587|Procter & Gamble|Clinical Trial Manager|5136225362|combs.cs@pg.com|
294352|NCT01549613|University of Cincinnati, Dept. of Emergency Medicine|George J. Shaw, MD, PhD|513-558-8098|shawge@ucmail.uc.edu|
294353|NCT01549652|Stanford University School of Medicine Department of Anesthesiology|Dr. Larry F. Chu|6507236632|lchu@stanford.edu|
294354|NCT01549860|VP Medical Affairs|Pamela Unger|(952) 224-8755|punger@celleration.com|
294355|NCT01549873|Nationwide Children's Hospital|David Martin, MD|614-722-4200|David.Martin@nationwidechildrens.org|
294356|NCT01549886|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
294357|NCT01549925|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
294358|NCT01549951|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
294359|NCT01549964|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
294360|NCT01550224|Stanford University Medical Center|Steven Edward Coutre, MD; Professor of Medicine (Hematology)|650-725-4040|coutre@stanford.edu|
294361|NCT01550289|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
294362|NCT01550341|Yale University|Dr. Frederick Altice, Principal Investigator|203-737-2883|frederick.altice@yale.edu|
294363|NCT01550367|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
294364|NCT01550471|Allegheny Health Network|Deborah Gentile, Principal Investigator|412-359-4099|dgentile@wpahs.org|
294365|NCT01550549|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
294366|NCT01550705|University of Utah|John D. Phillips, Ph.D.|801-581-6650|john.phillips@hsc.utah.edu|
294367|NCT01550731|Veterans Administration|Dr. Rebecca Sudore|(415) 221-4810|Rebecca.Sudore@va.gov|23475
294368|NCT01550744|Janssen Biotech, Inc|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
294369|NCT01550757|US Department of Veterans Affairs|Thomas O'Toole, MD|(401) 273-7100|thomas.otoole@va.gov|6359
294370|NCT01550809|Departamento de Endocrinología y Nutrición, Hospital Clínico Universitario de Valencia, Universitat de València, Valencia, Spain|Francisco Javier Ampudia Blasco|+34 96 3862665|Francisco.J.Ampudia@uv.es|
294371|NCT01550952|Hospital for Special Surgery|Dr. Jacques YaDeau|2127742224|yadeauj@hss.edu|
294372|NCT01550965|AbbVie|Global Medical Information|800-633-9110||
294373|NCT01551030|Memorial Sloan Kettering Cancer Center|Dean Bajorin, MD|646-888-4700|bajorind@MSKCC.ORG|
294374|NCT01551056|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
294375|NCT01551095|Johns Hopkins University|Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
294376|NCT01551173|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
294377|NCT01551186|Washington University School of Medicine, St. Louis, Missouri|Dr. Erik Dubberke, MD, MSPH|314-454-8354|edubberk@wustl.edu|
294378|NCT01551199|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 791-1414|ellen.teng@va.gov|25513
294379|NCT01551212|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
294380|NCT01551264|Washington University School of Medicine|Matthew Dobbs MD|561-844-5255|mdobbs@paleyinstitute.org|
294381|NCT01551303|Massachusetts General Hospital|Dr. Elizabeth Hoge|617-724-0859|ehoge@partners.org|
294382|NCT01551355|Icahn School of Medicine at Mount Sinai|Dr. Valentin Fuster|212-241-3852|valentin.fuster@mssm.edu|
294383|NCT01551420|Providence VA Medical Center|Linda Resnik, Research Career Scientist|401-273-7100|Linda.Resnik@va.gov|2368
294384|NCT01551550|TissueTech|Medical Affairs|(888) 296-8858|info@tissuetech.com|
294385|NCT01551693|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
294386|NCT01551745|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
294387|NCT01551758|GlaxoSmithKline|GSK Response Center|866-435-7343||
294388|NCT01551888|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
294389|NCT01551979|Beth Israel Deaconess Medical Center|Mark Halko|6176670367|mhalko@bidmc.harvard.edu|
294390|NCT01552057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294391|NCT01552213|Stanford University, School of Medicine|Anna Girsen, Research Operations Manager|(650) 725-5720|agirsen@stanford.edu|
294392|NCT01552343|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
294393|NCT01552369|University of Pittsburgh - Medicine - Infectious Diseases|Nina Singh, MD|412-360-1688|nis5@pitt.edu|
294394|NCT01552408|Retina Consultants of Houston|David M. Brown, MD|713-524-3434|dmbmd@houstonretina.com|
294395|NCT01552603|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
294396|NCT01552681|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
294397|NCT01552694|Washington University School of Medicine|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
294398|NCT01552772|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
294399|NCT01552876|Johnson & Johnson Vision Care|Katherine Osborn OD, MS FAAO|1 904 443-1032|kosborn@its.jnj.com|
294400|NCT01552889|Washington University School of Medicine|Dr. Robert Carney|314-286-1313|carneyr@wustl.edu|
294401|NCT01552902|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
294402|NCT01552915|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
281772|NCT03608696|Thomas Jefferson University|Walter Kraft|2159559077|walter.kraft@jefferson.edu|
294403|NCT01552928|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
294404|NCT01552954|Department of Internal Medicine, Seoul National University Bundang Hospital|Ho Jun Chin|+82-10-7360-7025|mednep@snubh.org|
294405|NCT01553058|University of Pennsylvania|Suzette Baez VanderBeek, MPH|215-662-3514|suzettev@upenn.edu|
294406|NCT01553084|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
294407|NCT01553136|Yale University|Stephanie Samples O'Malley, PhD, Professor of Psychiatry|(203) 974-7590|stephanie.omalley@yale.edu|
294408|NCT01553188|National Cancer Institute|Dr. Ravi Madan|301-480-7168|madanr@mail.nih.gov|
294409|NCT01553201|National Institute of Neurological Disorders & Stroke|Barbara Karp, MD|301-496-0150|karpb@ninds.nih.gov|
294410|NCT01553279|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294411|NCT01553292|University of Manitoba|Dr Yahya Al Ethawi|0012049634721|yalethawi@hsc.mb.ca|
294412|NCT01553318|Wake Forest Baptist|dennis ang|336-716-4209|dang@wakehealth.edu|
294413|NCT01553539|Wake Forest University Health Sciences|Dr. William J. Petty|336-716-3313|wpetty@wakehealth.edu|
294414|NCT01553591|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
294415|NCT01553708|Faculty of Pharmaceutical Sciences, Chulalongkorn University|Associate Prof. Pornanong Aramwit, Pharm.D., Ph.D.|+66-02-218-8409|paramwit@gmail.com|
294416|NCT01553747|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
294417|NCT01553851|Washington University School of Medicine|Dr. Douglas Atkins|314-747-8475|datkins@dom.wustl.edu|
294418|NCT01553916|Washington University School of Medicine|Clifford Robinson, M.D.|314-362-4653|clifford.robinson@wustl.edu|
294419|NCT01554176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294420|NCT01554241|University of California, San Francisco|Janice B.Schwartz, M.D., Professor of Medicine|(415) 406-1573|janice.schwartz@ucsf.edu|
294421|NCT01554371|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
294422|NCT01554488|William S. Middleton Memorial VA Hospital|Mihaela Teodorescu, MD-Principle Investigator|(608)2561901|mt3@medicine.wisc.edu|11080
294423|NCT01554514|Washington University|Dr. Elaine Majerus|314-362-8866|emajerus@wustl.edu|
294424|NCT01554527|University of Michigan|Dr. Ronald Chervin|734-647-9064|chervin@med.umich.edu|
294425|NCT01554579|Afferent Pharmaceuticals|Clinical Development|650-286-1276|info@afferentpharma.com|
294426|NCT01554618|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
294427|NCT01554683|Beth Israel Deaconess Medical Center|Dr. Daniel Press|617-667-4074|dpress@bidmc.harvard.edu|
294428|NCT01554891|Geisel School of Medicine at Dartmouth|Laura A. Flashman, Ph.D.|6036505824|flashman@dartmouth.edu|
294429|NCT01554904|University of Florida|Richard B Berry, M.D. Principal Investigator|3522621575|Richard.Berry@medicine.ufl.edu|
294430|NCT01554982|Keryx|Lisa Loram|919-434-6195|lisa.loram@keryx.com|
294431|NCT01555125|Novartis Pharmaceutical|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
294432|NCT01555138|Novartis Pharmaceuticals|Study Director|862-778-8300||
294433|NCT01555151|Novartis Pharmaceuticals|Clinical Disclosure Office|+1(862)778-8300||
294434|NCT01555164|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
294435|NCT01555463|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
294436|NCT01555541|University of California, San Francisco|Charalambos Andreadis, MD, MSCE, Associate Professor of Clinical Medicine|877-827-3222|cancertrials@ucsf.edu|
294437|NCT01555567|University of Michigan|Riann Palmieri-Smith|7346153154|riannp@umich.edu|
294438|NCT01555671|Prof.Dr.Cemil Tascioglu City Hospital|Orhan SAHIN|+90 532 240 00 12|drorhansahin@gmail.com|
294439|NCT01555697|UC San Diego|Neal Swerdlow, M.D., Ph.D.|619-543-6270|nswerdlow@health.ucsd.edu|
294440|NCT01555762|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
294441|NCT01555931|University of North Carolina School of Medicine|Dr. Gretchen Stuart|919-962-4880|gstuart@med.unc.edu|
306222|NCT02393755|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
306223|NCT02393950|Orion Corporation|Clinical Trials Information Desk|+358104261|clinicaltrials@orionpharma.com|
306224|NCT02394275|St. Joseph's Healthcare Hamilton, ON|Dr. Marek Smieja|905 521 6021|smiejam@mcmaster.ca|
306225|NCT02394340|Bausch Health Americas, Inc.|Director of Clinical Operations||aloncaric@bauschhealth.com|
306226|NCT02394457|Naval Medical Center San Diego|Steven Hanling, MD|619-532-8954|steven.r.hanling@mail.mil|
306227|NCT02394561|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
306228|NCT02394600|Kingston General Hospital|Dr. Anne Ellis|613-548-2336|ellisa@kgh.kari.net|
306229|NCT02394730|University of New South Wales|Sean Emery, Chief Principal Investigator|+61 2 9385 0897|s.emery@unsw.edu.au|
306230|NCT02394756|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan- PRINCIPAL RESEARCH OPTOMETRIST|1 904 443 3449|CColesb@ITS.JNJ.com|
306231|NCT02394769|Massachusetts General Hospital|Andrew T. Chan, MD, MPH|(617) 726-3212|achan@partners.org|
306232|NCT02394808|Johnson & Johnson Vision Care Inc.|Tawnya Wilson O.D. SR. MANAGER GLOBAL CLINICAL SALES EDU|443-1834|TWilson@ITS.JNJ.com|
306233|NCT02394912|Volcano|VP Clinical Trials|858-720-8731|jonathan.batiller@philips.com|
306234|NCT02394925|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO Sr. Principal Research Optometrist|904 443-3402|TKarkkai@its.jnj.com|
306235|NCT02394951|Washington University in Saint Louis|Dr. Simon Haroutounian|3143622628|sharout@wustl.edu|
306236|NCT02395042|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
306237|NCT02395055|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
306238|NCT02395081|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|617-525-8264|jr33@partners.org|
306239|NCT02395133|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
294442|NCT01555957|University of Rochester|Sanjiv Amin|585-273-2696|sanjiv_amin@urmc.rochester.edu|
294443|NCT01555983|UC Davis (currently at UC San Diego)|Barth Wilsey MD|916-402-2270|bwilsey@ucsd.edu|
294444|NCT01556061|University of Texas at Houston Medical School/ Dept. of Anesthesiology|Dr. Davide Cattano MD PhD|713-500-6235|davide.cattano@uth.tmc.edu|
294445|NCT01556100|Chang Gung Memorial Hospital|Dr. kun-Ju Lin|033281200|lin4857@adm.cgmh.org.tw|2632
294446|NCT01556165|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
294447|NCT01556204|Cleveland Clinic|Tommaso Falcone, M.D.|216-444-1752|falcont@ccf.org|
294448|NCT01556347|Tim Icenogle MD PLLC|Timothy B Icenogle MD|509-220-1900|timicenogle@comcast.net|
306240|NCT02395172|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
306241|NCT02395185|Shriners Hospital for Children|Rebecca Davis|859-268-5705|rfdavis@shrinenet.org|
306242|NCT02395302|Tactile Medical|Clinical Research Manager|(612)355-5123|mbroich@tactilemedical.com|
306243|NCT02395471|Medtronic MITG Gastrointestinal & Hepatology|Dr.Jaime Kean|303-882-6759|Jaime.M.Kean@medtronic.com|
306244|NCT02395536|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|7635268168|lindsay.k.werder@medtronic.com|
306245|NCT02395627|University of California, San Francisco|Dr. Pamela Munster, MD|(415) 502-3598|Pamela.Munster@ucsf.edu|
306246|NCT02395653|The Medicines Company|Global Health Science Center|1-888-977-6326|medical.information@themedco.com|
306247|NCT02395692|ABTC|Sr. Research Program Manager|410-955-8837|ABTC@jhmi.edu|
306248|NCT02395822|University of Minnesota Masonic Cancer Center|Yumna Akhtar - Ct.gov Manager|612-624-6313|akhta012@umn.edu|
281773|NCT03606668|NYU Langone Health|Leigh Charvet, PhD|(929) 455-5141|Leigh.Charvet@nyulangone.org|
294449|NCT01556425|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
294450|NCT01556438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294451|NCT01556451|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294452|NCT01556581|Madigan Army Medical Center|Dr. Dan Rhon|253-968-0780|daniel.i.rhon.ctr@mail.mil|
294453|NCT01556594|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294454|NCT01556633|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
294455|NCT01556724|University of Pittsburgh|Susan Sandusky|412-383-1036|sis127@pitt.edu|
294456|NCT01556763|EnVivo Pharmaceuticals, Inc.|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|617-225-4264|mgawryl@envivopharma.com|
294457|NCT01556906|Aegerion Pharmaceutical|Chief Medical Officer|617-500-7867||
294458|NCT01556932|Virginia Commonwealth University/ Hospice & Pallative Medicine|Devon S. Flecher, MD|804-828-9723|dsfletcher@mcvh-vcu.edu|
294459|NCT01556997|Symplmed Pharmaceuticals LLC|Jeff Feldstein, Sr. Vice President and CMO|888-552-9769|feldstein@symplmed.com|
294460|NCT01557166|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
294461|NCT01557244|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294462|NCT01557283|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294463|NCT01557322|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294464|NCT01557348|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
294465|NCT01557400|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
294466|NCT01557452|Italfarmaco SpA|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
294467|NCT01557504|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294468|NCT01557517|National Cancer Institute|Dr. Steven Pavletic|301-402-4899|steven_pavletic@nih.gov|
294469|NCT01557569|UAMS|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
294470|NCT01557582|VentriPoint, Inc.|Jim bodtke, Vice President Clinical Affairs and Development|206-283-0221|jbodtke@ventripoint.com|
294471|NCT01557595|UAB|Dr. Rachel Fargason|205-934-5151|rfargason@uab.edu|
294472|NCT01557699|SERUM INSTITUTE OF INDIA LIMITED|Dr Prasad Kulkarni|+912026602384|drpsk@seruminstitute.com|
294473|NCT01557751|University of Pittsburgh Medical Center (UPMC)|Dr. Jacques Chelly, MD, PHD MBA|412-623-6382|chelje@anes.upmc.edu|
294474|NCT01557790|University of Pennsylvania|Justin E. Bekelman, MD|(215)662-7292|bekelman@xrt.upenn.edu|
294475|NCT01557842|Biosense Webster, Inc.|Karen Cropper, Manager, Clinical Operations|(800) 729-9010|Kcropper@its.jnj.com|8607
294476|NCT01557868|American Orthopaedic Society for Sports Medicine|Dr. Barton Mann|847-292-4900|bart@aossm.org|
294477|NCT01557894|Babes-Bolyai University|Bogdan Tudor Tulbure|+40745753061|btulbure@gmail.com|
294478|NCT01557920|Massachusetts General Hospital|Dr. Matthias Eikermann|6176434408|meikermann@partners.org|
294479|NCT01557946|McLean Hospital, Biological Psychiatry Laboratory|Dr. Brian Brennan, MD|617-855-2911|bbrennan@partners.org|
294480|NCT01557959|Wake Forest Baptist Health|Dr. William J. Petty|336-716-3313|wpetty@wakehealth.edu|
294481|NCT01558063|Columbia University|J. John Mann, MD|646-774-7553|jjm@columbia.edu|
294482|NCT01558089|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
294483|NCT01558128|Weill Cornell Medicine, Department of Anesthesiology|Michele Steinkamp, Research Nurse Specialist|212-746-2953|mls9004@med.cornell.edu|
294484|NCT01558271|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294485|NCT01558297|Yale Medical School|Dr. Rachel Barnes|2037856395|rachel.barnes@yale.edu|
294486|NCT01558596|Minneapolis VA Medical Center|Santiago Garcia, MD|6124673670|santiago.garcia@va.gov|
294487|NCT01558635|Medtronic, Bakken Research Center, Coronary and Structural Heart Disease Management (CSH), Endepolsdomein 5, 6229 GW Maastricht, The Netherlands|Ber Kleijnen, Sr Clinical Research Manager|+31653227763|ber.kleijnen@medtronic.com|
294488|NCT01558661|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
294489|NCT01558674|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294490|NCT01558700|Northwestern University|Apkar Vania Apkarian|(312) 503-0404|a-apkarian@northwestern.edu|
294491|NCT01558739|Novartis Pharmaceuticals|Study Director|862-778-8300||
294492|NCT01558752|The Ottawa Hospital Research Institute|Dr Paul Beaule|613-737-8899|pbeaule@toh.ca|73265
294493|NCT01558791|National Center for PTSD|Dr. Jessica Hamblen, PI|802-296-5132|Jessica.Hamblen@va.gov|5389
306249|NCT02395978|BioLite, Inc.|Hsien-Ming Wu|+886-6579631|sonnywu@bioliteinc.com|
306250|NCT02395991|Seoul National University Hospital|Professor Jeong Min Lee|82-2-2072-3154|jmsh@snu.ac.kr|
306251|NCT02396147|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306252|NCT02396160|University of Queensland|Dr Niikee Schoendorfer|0413122076|n.schoendorfer@uq.edu.au|
306253|NCT02396212|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
306254|NCT02396251|Galderma|Reception|+46184749000|reception.seupp@galderma.com|
306255|NCT02396316|Bayer|Therapeutic Area Head||clinical-trials-contact@bayer.com|
306256|NCT02396381|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
306257|NCT02396420|South Florida Medical Imaging|Cynthia Toot ARNP|954-267-6626|cynthia.toot@holy-cross.com|
294494|NCT01559012|Città della Salute e della Scienza Ospedale Sant'Anna. Servizio di Medicina Interna|Dr. Aldo Maina M.D. Obstetric Medicine|0039011313|amaina@cittadellasalute.to.it|5735
294495|NCT01559064|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
306258|NCT02396511|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
306259|NCT02396537|University of Alabama at Birmingham|Dr. Christopher Pruitt|2056389587|cpruitt@peds.uab.edu|
306260|NCT02396732|University of Miami|Kenneth Proctor|305-585-1178|kproctor@med.miami.edu|
306261|NCT02396745|Allegheny Singer Research Institute|Mara Yerk, Administrative Director|412-389-3059|mara.yerk@ahn.org|
306262|NCT02396758|Boston Scientific|Nancy O'Connell|763-494-2706|nancy.oconnell@bsci.com|
306263|NCT02396849|Indiana University|Christina Tiller|317-044-4522|ctiller@iu.edu|
306264|NCT02396953|Ipsen|Medical Director|Use email address below|clinical.trials@ipsen.com|
306265|NCT02397057|American Regent, Inc|Mark A. Falone, MD MPH|6317723544|mfalone@americanregent.com|61844
306266|NCT02397096|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
306267|NCT02397122|Kirikkale University|Dr. H. Gencay Keceli|+905326714377|monsieur_gencay@yahoo.com|
306268|NCT02397265|Imperial College London|Nick Oliver|020 7594 2460|nick.oliver@imperial.ac.uk|
306269|NCT02397278|Stanford University|Michael Fadell II|3037241111|mfadell@stanford.edu|
306270|NCT02397291|"University of Colorado Denver | Anschutz"|Henry Galan|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
306271|NCT02397408|University of California, Los Angeles|Albert J. Chang, MD, PhD|(310) 82509771|ajchang@mednet.ucla.edu|
306272|NCT02397447|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
306273|NCT02397460|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
306274|NCT02397473|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
306275|NCT02397564|University of Louisville|W. James Tidwell|5025831749|wjamestidwell@gmail.com|
306276|NCT02397655|Xuanwu hospital, Capital medical university|Dr. Yang Hua|86-10-83198923|dryanghua99@163.com|
306277|NCT02397694|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
306278|NCT02397707|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
306279|NCT02397785|Cleveland Clinic Foundation|Erica Magelky, Principal Investigator|713-628-5357|magelke@ccf.org|
306280|NCT02397837|Brigham and Women's Hospital|Dr. Katherine Burdick|617-732-5789|kburdick1@bwh.harvard.edu|
306281|NCT02397889|Icahn School of Medicine at Mount Sinai|Adriana Feder|212-659-9279|adriana.feder@mssm.edu|
306282|NCT02397915|GlaxoSmithKline|GSK Response Center|866-435-7343||
306283|NCT02397954|Ophthotech Corp|Keith Westby||Keith.Westby@ophthotech.com|
306284|NCT02398188|Neothetics, Inc.|Neothetics Clinical|858-550-1900||
306285|NCT02398227|University of Akron|Dawn M Johnson, Ph.d|3309722505|johnsod@uakron.edu|
306286|NCT02398409|VHA|Dr. Virginia (Daggett) Wilder|307-675-3659|virginia.wilder@va.gov|
306287|NCT02399085|MorphoSys AG|Dr. Sumeet Ambarkhane, Director, Clinical Program Leader|+49 89 89927 26841|Sumeet.Ambarkhane@morphosys.com|
306288|NCT02399163|GlaxoSmithKline|GSK Response Center|866-435-7343||
306289|NCT02399228|University of Texas Health Science Center at San Antonio|Dr. Ying Li, M.D., Ph.D.|210-450-1719|liy8@uthscsa.edu|
306290|NCT02399254|Saint Francis Hospital and Medical Center|Richard ZuWallack, MD|860-714-4055|RZuWalla@TrinityHealthOfNE.org|
306291|NCT02399345|AbbVie|Global Medical Information|800-633-9110||
306292|NCT02399475|University of Pennsylvania|Dr. Anne Cappola|2155375359|acappola@pennmedicine.upenn.edu|
306293|NCT02399917|The University of Texas MD Anderson Cancer Center|Naval Daver, MD./Associate Professor|713-794-4392|NDaver@mdanderson.org|
306294|NCT02400073|ResMed|Senior Manager, Medical Affairs|+61 8884 1123|alison.wimms@resmed.com|
306295|NCT02400307|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
306296|NCT02400333|AstraZeneca AB|Brilinta Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
306297|NCT02400346|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
306298|NCT02400437|Dana-Farber Cancer Institute|Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
306299|NCT02400463|University of Michigan Rogel Cancer Center|Ryan Wilcox|734-615-1482|rywilcox@umich.edu|
306300|NCT02400580|University of Pittsburgh Medical Center|Dr. Noah Rindos|(412) 641-8769|rindosnb@upmc.edu|
306301|NCT02400710|Center for Integrated Healthcare, Syracuse Veterans Affairs Medical Center|Kyle Possemato, Ph.D.|315-425-4400|kyle.possmato@va.gov|53551
306302|NCT02400736|Tuscaloosa VA Medical Center|Lori L. Davis, M.D.|205-554-2000|Lori.Davis@va.gov|1-3819
306303|NCT02400749|Innovaderm Research Inc.|Dr Robert Bissonnette|514-521-4285|rbissonnette@innovaderm.ca|
306304|NCT02400905|Veryan Medical|Nick Yeo|+44 1403 258984|nick.yeo@veryanmed.com|
306305|NCT02400996|Sir Ganga Ram Hospital, New Delhi, India|Md Tanveer Adil|0091-9830154566|tanveer.cmc@gmail.com|
306306|NCT02401022|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
306307|NCT02401048|Pharmacyclics|Emily Liu|(669) 224-1899|aliu@pcyc.com|
306308|NCT02401230|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
306309|NCT02401256|Indiana University School of Medicine|Dr. Zeruesenay Desta|3172742823|zdesta@iu.edu|
306310|NCT02401412|Hollister Incorporated|Stacy Haddad, Global Clinical Affairs Director|847-680-2837|stacy.haddad@hollister.com|
306311|NCT02401464|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306312|NCT02401529|King Fahd General Hospital|Dr Faris Ahmed Bahammam|00966554699544|dr_farisbahammam@yahoo.com|
294496|NCT01559090|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
294497|NCT01559116|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
294498|NCT01559129|Celgene Corporation|Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
294499|NCT01559259|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294500|NCT01559311|St. Jude Medical (Hong Kong) Ltd|Clinical Project Leader Asia|29967605|lyim@sjm.com|
294501|NCT01559389|Loyola University Medical Center|Elizabeth Mueller, MD|708-216-2180|emuelle@lumc.edu|
294502|NCT01559454|University at Buffalo|Dr. Ricahrd Blondell|716-816-7237|blondell@buffalo.edu|
294503|NCT01559506|Nimbic Systems|Sean Self|281-565-5715|self@nimbicsystems.com|
294504|NCT01559649|Michael E. DeBakey VA Medical Center|Stephanie Daniels|713-743-2570|skdaniels@uh.edu|
294505|NCT01559675|Cedars Sinai Medical Center|Dr. Phillip Fleshner|310-289-9224|pfleshner@aol.com|
294506|NCT01559844|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
294507|NCT01559857|Stanford University|Dr. Natalie Rasgon|6507249694|natalie.rasgon@stanford.edu|
294508|NCT01559922|Suneva Medical, Inc.|Suneva Medical,Inc.||Acne.ScarInfo@sunevamedical.com|
294509|NCT01559935|Weill Cornell Medicine|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
294510|NCT01559948|Texas Woman's University|Dr. Kelli Brizzolara|214-689-7722|kbrizzolara@twu.edu|
294511|NCT01560143|University of Michigan|Manjunath Pai|7346473466|amitpai@med.umich.edu|
294512|NCT01560234|AstraZeneca R&D|Ajay Aggarwal||ClinicalTrialTransparency@astrazeneca.com|
294513|NCT01560260|Sarcoma Alliance for Research through Collaboration (SARC)|Kristen Nuyen, Research Project Manager|734-930-7600|sarc@sarctrials.org|
294514|NCT01560286|BioMarin Pharmaceutical Inc|Sr. Medical Director, Clinical Science|415-475-5854|Ari.Gershman@bmrn.com|
294515|NCT01560377|Novadaq Technologies, Inc.|Alicia Wilton|1.905.629.3822|awilton@novadaq.com|209
294516|NCT01560403|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
294517|NCT01560416|Dana-Farber Cancer Institute|Nancy Lin|617-632-2335|Nancy_Lin@dfci.harvard.edu|
294518|NCT01560429|Queen's University|Dr. Vidur Shyam|(613) 548-7827|shyamv@kgh.kari.net|
294519|NCT01560624|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
294520|NCT01560780|VA North Texas Healthcare System|Shuaib Abdullah|214-857-1458|shuaib.abdullah@va.gov|
294521|NCT01560819|Helen DeVos Children's Hospital of Spectrum Health Hospitals|Dr. Sachin Kunde|616-267-2100|sachin.kunde@helendevoschildrens.org|
294522|NCT01560871|Texas Woman's University|Dr. Suh-Jen Lin|214-689-7718|slin@twu.edu|
294523|NCT01560923|Masonic Cancer Center, University of Minnesota|Dr.Gautam Jha|612-624-5373|jhaxx014@umn.edu|
294524|NCT01560949|UT MD Anderson Cancer Center|Dr. Gauri R Varadhachary,Professor, GI Medical Oncology|(713) 792-2828|gvaradha@mdanderson.org|
306313|NCT02401542|Rainier Therapeutics|Chief Medical Officer|510-878-2486|Sabella@RainierRx.com|
306314|NCT02401555|Bio-Rad Laboratories|David Bhend|425 498 1758|david_bhend@bio-rad.com|
306315|NCT02401672|Medical University of South Carolina|Xingbao Li, MD|843-792-5729|lixi@musc.edu|
306316|NCT02401867|Fenway Community Health|Sari Reisner, ScD|617-927-6017|sari.reisner@childrens.harvard.edu|
306317|NCT02402062|MFAR Clinical Research|Federico Nepote|0034934344412|investigacion@mfar.net|102
306318|NCT02402127|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
306319|NCT02402153|UNEEG medical A/S|Clinical Manager|+45 41414244|lybl@UNEEG.com|
306320|NCT02402166|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
306321|NCT02402218|Johns Hopkins School of Medicine|Dr. Mark Sulkowski|443-997-1900|msulkowski@jhmi.edu|
294525|NCT01560975|NYEE|Dr. Robert Ritch|+1 212 477 7540|ritchmd@earthlink.net|
294526|NCT01560988|Brigham and Women's Hospital|Dr. Joshua Boyce|617-525-1261|jboyce@partners.org|
294527|NCT01561053|Grifols|AMBAR clinical manager|+34 935712200|AMBARclinical@grifols.com|
294528|NCT01561079|Johns Hopkins University School of Medicine|Dr. Lauren M Jansson|410-550-5438|ljansson@jhmi.edu|
294529|NCT01561300|Unilever R&D Vlaardingen|Dr Theo Mulder|+31 10 460 8315|theo.mulder@unilever.com|
294530|NCT01561313|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
294531|NCT01561469|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294532|NCT01561560|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
294533|NCT01561703|University of Missouri - Department of Otolaryngology - Head and Neck Surgery|Research Coordinator|5738822549|schneiderri@health.missouri.edu|
294534|NCT01561716|University of Rochester|Dr. Isabel D Fernandez|585-275-9554|Diana_Fernandez@URMC.Rochester.edu|
294535|NCT01561755|Icahn School of Medicine at Mount Sinai|Dr. David Simpson|212-241-8748|david.simpson@mssm.edu|
294536|NCT01561833|Yale University School of Medicine|Francine Foss MD|2037375312|francine.foss@yale.edu|
294537|NCT01561898|Janssen Pharm KK Japan|Medical Director|03-4411-5067||
294538|NCT01561963|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
294539|NCT01561976|GlaxoSmithKline|GSK Response Center|866-435-7343||
294540|NCT01562028|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|belief@etop-eu.org|
294541|NCT01562041|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
294542|NCT01562132|Yale University|Dr. Ana-Claire Meyer|203-737-8372|ana-claire.meyer@yale.edu|
294543|NCT01562275|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
294544|NCT01562314|GW Research Ltd|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
294545|NCT01562327|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
294546|NCT01562379|Johns Hopkins Bloomberg School of Public Health|Parul Christian|1-410-955-1188|pchrist1@jhu.edu|
294547|NCT01562444|GlaxoSmithKline|GSK Response Center|866-435-7343||
294548|NCT01562548|GlaxoSmithKline|GSK Response Center|866-435-7343||
306322|NCT02402296|Al-Azhar University- Faculty of dental medicine (Girls branch)|Professor Hala Helmi Hazzaa|00201014129297|hala.hazzaa@yahoo.com|
306323|NCT02402322|Universitat Autonoma de Barcelona|Dr. Pablo Oromendia|+34 665175467|p.oromendia@gmail.com|
306324|NCT02402452|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
306325|NCT02402764|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hyo Sook Han|813-745-8960|hyo.han@moffitt.org|
306326|NCT02402881|The Johns Hopkins University|Elliott R Haut, MD PhD|410-502-3122|ehaut1@jhmi.edu|
306327|NCT02402907|Icahn School of Medicine at Mount Sinai|Dr. Joanne Stone|212-241-5681|joanne.stone@mssm.edu|
306328|NCT02402933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
306329|NCT02403180|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
306330|NCT02403206|Alcon, A Novartis Division|Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
306331|NCT02403271|Pharmacyclics LLC, An AbbVie Company|Thorsten Graef|(408) 215-3127|tgraef@pcyc.com|
306332|NCT02403479|St. Joseph's Healthcare London|Dr. Leigh Sowerby|519-646-6143|leigh.sowerby@sjhc.london.on.ca|
306333|NCT02403622|Microbiome Health Research Institute|Majdi Osman, MD, MPH|6175752201|mosman@openbiome.org|
306334|NCT02403635|Clinical Development Dept.|Maruho Co.,Ltd. Kyoto R&D Center|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
306335|NCT02403674|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
306336|NCT02403778|Univesity Colorado Ansshutz Medical Campus|Martin McCarter|303-724-2728|martin.mccarter@ucdenver.edu|
306337|NCT02403817|University of California, San Diego|Jeanne Townsend, PhD, Professor of Neurosciences|858-246-1931|jtownsend@ucsd.edu|
306338|NCT02403830|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
306339|NCT02403895|AstraZeneca|Medical Science Director||clinicaltrialtransparency@astrazeneca.com|
306340|NCT02403986|Q-Med AB|Cecilia Skoglund, Manager Study strategy and publications|46 18 474 9000|cecilia.skoglund@galderma.com|
306341|NCT02403999|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
306342|NCT02404025|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
306343|NCT02404103|University Louisville|Nemr Eid, MD|502-852-3772|n.eid@louisville.edu|
306344|NCT02404168|University of Maryland|James Polli|410-706-8292|jpolli@rx.umaryland.edu|
306345|NCT02404220|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
306346|NCT02404285|Next Science|Matt Myntti PHD, President|9046474161|mmyntti@nextscience.org|
306347|NCT02404311|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
306348|NCT02404350|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|Novartis.email@novartis.com|
294549|NCT01562613|Abbott|Taco Baardman||taco.baardman@abbott.com|
294550|NCT01562678|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|617-667- 8630|cmantzor@bidmc.harvard.edu|
294551|NCT01562743|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-6361-7366||
294552|NCT01562756|Palmer College of Chiropractic|Ting Xia, PhD (Principal Investigator)|563-884-5161|Ting.Xia@palmer.edu|
294553|NCT01562782|The Rogosin Institute|Lisa Hudgins, M.D.|646-317-0805|lih2013@nyp.org|
294554|NCT01562873|Dana-Farber Cancer Institute|Nancy Lin, MD|617.632.2335|Nancy_Lin@dfci.harvard.edu|
294555|NCT01562886|Imperial College London|Dr Borja Mora Peris|020 3312 6789|b.mora-peris@imperial.ac.uk|
294556|NCT01563003|University of South Florida|Eric Storch, Ph.D.|727-767-8230|estorch@health.usf.edu|
294557|NCT01563029|GlaxoSmithKline|GSK Response Center|866-435-7343||
294558|NCT01563055|GlaxoSmithKline|GSK Response Center|866-435-7343||
294559|NCT01563081|GlaxoSmithKline|GSK Response Center|866-435-7343||
294560|NCT01563172|GlaxoSmithKline|GSK Response Center|866-435-7343||
294561|NCT01563185|Horizon Pharma|Julie Ball, Senior Director of Clinical Development & Operations|224-383-3059|jball@horizonpharma.com|
294562|NCT01563198|Hypnalgesics, LLC d/b/a Comfort Talk|Elvira V. Lang, MD (PI of SBIR grant)|617 734 9087|drevlang@gmail.com|
294563|NCT01563237|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
294564|NCT01563354|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
294565|NCT01563406|Rush University Medical Center|Mary Hayden, MD|3129428727|mhayden@rush.edu|
294566|NCT01563536|AbbVie|Global Medical Services|800-633-9110||
306349|NCT02404389|Novartis Pharmaceuticals|Study Director|862-778-8300||
306350|NCT02404441|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
306351|NCT02404493|Johnson & Johnson Consumer, Inc|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
306352|NCT02404532|Otsuka Pharmaceutical Development & Commercialization, Inc|Tim Peters-Strickland|800 562-3974||
306353|NCT02404610|Hennepin Healthcare|Audrey Hendrickson|6128739528|audrey.hendrickson@hcmed.org|
306354|NCT02404649|Harvard School of Dental Medicine|Dr. Kevin Guze|6177210707|kevin_guze@hsdm.harvard.edu|
306355|NCT02404792|University of Colorado|Kristine Erlandson (PI)|303-724-4941|kristine.erlandson@ucdenver.edu|
306356|NCT02404805|University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences|Dr. Jennifer Kiser|(303) 724-6131|jennifer.kiser@ucdenver.edu|
306357|NCT02405091|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
306358|NCT02405195|Västra Götalandsregionen|Lukas Lannemyr|46313428860|lukas.lannemyr@vgregion.se|
306359|NCT02405325|UCSD|Loki Natarajan|8588224763|lnatarajan@ucsd.edu|
306360|NCT02405390|Nicklaus Children's Hospital|Jose M. Vargas Loayza, M.D.|786-624-3588|jose.vargas-loayza@mch.com|
306361|NCT02405429|University of Iowa|Edward F. Bell, MD|319-356-4006|edward-bell@uiowa.edu|
306362|NCT02405442|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
306363|NCT02405780|Fujifilm Kyowa Kirin Biologics Co., Ltd., EU Branch|Clinical Trial Information|0044 1896 668 173|Clinical-Trials@fk-b.com|
306364|NCT02405962|The Hong Kong Polytechnic University|Dr. Yim Wah Mak|(852) 2766-6421|yw.mak@polyu.edu.hk|
306365|NCT02406027|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
306366|NCT02406248|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00|kontakt@astrazeneca.com|
306367|NCT02406261|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
306368|NCT02406443|Renal Physiology Laboratory|University Health Network|416-340-4800|vesta.lai@uhn.ca|8508
306369|NCT02406495|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
306370|NCT02406573|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
306371|NCT02406586|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
306372|NCT02406612|Essential Medical|Sam Nardone|6105571009|sam@essmedclosure.com|
306373|NCT02406651|Generon/Evive Biotech|Christina Tay|1-908-540-0816|christina.tay@evivebiotech.com|
306374|NCT02406677|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD, VP, CVMD TA|302-886-5526|Naeem.Khan@astrazeneca.com|
306375|NCT02406742|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
294567|NCT01563913|VA Portland Health Care System|Kathryn Chung, MD|5037211091|Kathryn.Chung@va.gov|
294568|NCT01563978|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44-1625-512415|dave.goldstraw@astrazeneca.com|
294569|NCT01564277|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
294570|NCT01564394|Huntsman Cancer Institute, University of Utah|Anita Y. Kinney, PhD|801-585-1151|anita.kinney@hci.utah.edu|
294571|NCT01564407|University of Pittsburgh|Amy Steele, RN, MSN, CCRC|412-641-3728|steeleam@upmc.edu|
294572|NCT01564459|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294573|NCT01564485|University of California, Irvine|Ashwini Erande, Clinical Coordinator|714 456 7025|aerande@uci.edu|
294574|NCT01564628|Acarix A/S|Claus Christensen|+45 29724411|dkcbc@acarix.com|
294575|NCT01564654|ConforMIS|Marc Quartulli, VP Clinical Affairs|781-345-9191|marc.quartulli@conformis.com|
294576|NCT01564693|SAPIENZA UNIVERSITY OF ROME|PROF. ALESSANDRO LAVIANO|+390649973902|alessandro.laviano@uniroma1.it|
294577|NCT01564706|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
294578|NCT01564758|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294579|NCT01564784|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294580|NCT01564862|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
294581|NCT01564914|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
294582|NCT01564953|Aarhus University Hospital|Dr. Sarah Hashim Ali Hussein|0045 42660308|sarsuri@hotmail.com|
294583|NCT01565083|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
294584|NCT01565148|University of Nebraska|Quan Dong Nguyen|4025592020|quan.nguyen@unmc.edu|
294585|NCT01565291|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
294586|NCT01565330|Avid Radiopharmaceuticals|Chief Medical Officer|215-290-0700|clinicaloperations@avidrp.com|
294587|NCT01565343|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
294588|NCT01565356|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
294589|NCT01565369|Avid Radiopharmaceuticals|Chief Medical Officer|215-798-0700|clinicaloperations@avidrp.com|
294590|NCT01565382|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
294591|NCT01565499|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
294592|NCT01565538|Sun Yat-sen University Cancer Center|Dr. Si-Yu Wang|020-87343439|wsysums@163.net|
306376|NCT02406859|James J. Peters VAMC|Dr. Mark Korsten|718-741-4675|mark.korsten@va.gov|6753
306377|NCT02406885|The Johns Hopkins University School of Medicine|Dr. Brent Petty|410-955-8181|bpg@jhmi.edu|
306378|NCT02406937|Sprim (Shanghai) Consulting Co., Ltd.|Dr. Charlie Zhang|+86 (21) 51097272|charlie.zhang@sprim.cn|
306379|NCT02407041|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
306380|NCT02407054|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
306381|NCT02407132|University of Arkansas for Medical Sciences|Dr. Pearl McElfish|479-713-8680|pamcelfish@uams.edu|
306382|NCT02407223|Janssen Research & Development, LLC|Scientific Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
306383|NCT02407249|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
306384|NCT02407457|Endologix, Inc.|Sharone Trifskin|949-599-8860|strifskin@endologix.com|
306385|NCT02407704|University of Pittsburgh|Dr. Kirk Erickson|412-624-4533|kiericks@pitt.edu|
306386|NCT02407756|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
306387|NCT02407990|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
306388|NCT02408016|FHCRC|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
306389|NCT02408068|Simbec Research Ltd|Dr G Sharma|0800 691995|contact@simbec.com|
306390|NCT02408120|Emory University|Dr. Priyathama Vellanki|404-251-8957|priyathama.vellanki@emory.edu|
306391|NCT02408198|King's College London|Dr Amy Hardy|0207 848 0033|amy.hardy@kcl.ac.uk|
306392|NCT02408263|HSS|Dr. Gungor|212.606.1206|GungorS@hss.edu|
306393|NCT02408315|Indiana University School of Medicine|Dr. David M. Haas|317-880-3949|dahaas@iu.edu|
306394|NCT02408445|University of Colorado|Dr. Shanlee Davis|720-777-6073|shanlee.davis@childrenscolorado.org|
306395|NCT02408484|Octapharma|Sigurd Knaub|55 451 21 41|sigurd.knaub@octapharma.com|+41 (0)
306396|NCT02408523|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
306397|NCT02408692|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|whru@ohsu.edu|
306398|NCT02408796|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
306399|NCT02408965|UCSF|Jennifer Kerns|4152068715|Jennifer.kerns@ucsf.edu|
306400|NCT02409277|University of Utah|Flory Nkoy|801-662-3660|flory.nkoy@hsc.utah.edu|
306401|NCT02409329|Vanderbilt University Medical Center|Lindsay S. Mayberry, PhD, MS|615-875-5821|lindsay.mayberry@vumc.org|
306402|NCT02409459|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610.650.4200|mfalone@luitpold.com|844
281774|NCT03575897|University of Alabama at Birmingham|Dr. Ariel Salas|205-934-4680|asalas@peds.uab.edu|
306403|NCT02409667|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
306404|NCT02409680|RTI International|Elizabeth McClure|919-316-3773|mcclure@rti.org|
306405|NCT02409719|Universidad Autonoma de Nuevo Leon|FELIX VILCHEZ CAVAZOS|8183476698|vilchez.doctor@gmail.com|
306406|NCT02409732|Dartmouth-Hitchcock Medical Center|Dr. Michael Shane Chapman Section Chief of Dermatology|603-650-3106|Michael.Shane.Chapman@hitchcock.org|
306407|NCT02409784|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
306408|NCT02409914|USherbrooke|Stephen Cunnane|1-819-780-2220|Stephen.Cunnane@USherbrooke.ca|45670
306409|NCT02409927|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
306410|NCT02410018|IMBiotechnologies Ltd|President|780-945-6609|mstewart@tbwifi.ca|
294593|NCT01565551|University of California, San Francisco|Geoffrey Manley, MD, PhD|415-206-8300|manleyg@neurosurg.ucsf.edu|
294594|NCT01565564|Tianjin Medical University|Dr. Xilin Yang|+86 22 83336727|yangxilin@tijmu.edu.cn|
294595|NCT01565616|Emory University|Lakshmanan Krishnamurti, MD||lakshmanan.krishnamurti@emory.edu|
294596|NCT01565642|University of North Carolina at Chapel Hill|Laura C. Hanson, MD, MPH|919-843-4096|lhanson@med.unc.edu|
294597|NCT01565668|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
294598|NCT01565694|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|310715455050|astellas.resultsdisclosure@astellas.com|
294599|NCT01565707|Astellas Pharma Europe B.V.|Medical Director, Medical Science - Urology||Astellas.resultsdisclosure@astellas.com|
294600|NCT01565850|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
294601|NCT01565889|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
294602|NCT01565902|Novartis Pharmaceuticals|Study Director|862-778-8300||
294603|NCT01565928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294604|NCT01565941|Boston Children's Hospital|Dr. Michael Agus|617-355-5849|michael.agus@childrens.harvard.edu|
294605|NCT01565980|Michigan State University College of Nursing|Rebecca H. Lehto, PhD, Assistant Professor|517-353-4757|rebecca.lehto@hc.msu.edu|
294606|NCT01565993|Hospital Universitario Severo Ochoa|Dra Elvira Quintanilla|34 914818000|elviramquintanilla@hotmail.com|8326
294607|NCT01566084|University of Colorado Denver|Dr. Kristen Jablonski|303-724-4842|KRISTEN.NOWAK@UCDENVER.EDU|
294608|NCT01566162|Sunovion|Medical Director CNS Clinical Trials|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
294609|NCT01566214|Iowa City VA Health Care System|Mark Vander Weg|319-338-0581|mark.vanderweg@va.gov|7717
294610|NCT01566331|University of Padua|Dr. Erich Cosmi|+393398146745|ecosmi@hotmail.com|
294611|NCT01566409|Pediatric Department, Hospital Lillebaelt, Kolding|Dr. Line Modin|0045 61386349|line.modin@rsyd.dk|
294612|NCT01566435|Washington University School of Medicine|Douglas Adkins, M.D.|314-747-7402|dadkins@wustl.edu|
281775|NCT03441477|NIDEK Inc.|Todd Milholland|(800) 223-9044|todd_milholland@nidek.com|
294613|NCT01566448|West Virginia University Hospitals|Aaron Cumpston|304-598-4000|cumpstona@wvumedicine.org|73350
294614|NCT01566461|Medtronic Endovascular Therapies|Arslan Malik, Sr. Clinical Research Manager||arslan.malik@medtronic.com|
294615|NCT01566500|Columbia University|Marie Chesaniuk|212-854-0127|mc3333@columbia.edu|
294616|NCT01566526|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
294617|NCT01566539|Emory University|Dr. James Rilling|404-727-3062|jrillin@emory.edu|
294618|NCT01566604|Novartis|Study Director|862-778-8300||
294619|NCT01566630|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
294620|NCT01566682|ProLung|Michael Garff, Chief Operating Officer|8012049625|mag@prolunginc.com|
294621|NCT01566721|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
294622|NCT01566773|Pearl Therapeutics Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
294623|NCT01566838|Cardiac, Vascular, and Thoracic Surgery Associates|Sandeep Khandhar, MD|703-280-5858|SKhandhar@CVTSA.com|
294624|NCT01566981|Department of family medicine, Medical Faculty in Ljubljana|Dr. Rade Iljaž|'386 31 300- 381|radeiljaz@gmail.com|
294625|NCT01567020|VA Portland Health Care System|Dr. Frederick Gallun|5032208262|Frederick.Gallun@va.gov|57472
294626|NCT01567085|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc. (Sponsor)||clinicaltrials@alexion.com|
294627|NCT01567150|Hollister Incorporated|Director, Global Clinical Affairs|8479183996|ginger.salvadalena@hollister.com|
294628|NCT01567163|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294629|NCT01567306|Roxall Medicina España S.A.|Dr. M Cruz Gómez project manager of Roxall Medicina España S.A.|+34 944438000|maricruz.gomez@roxall.es|
294630|NCT01567371|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
294631|NCT01567462|Emory University|Dr. Kenneth Ogan|404-778-3038|kogan@emory.edu|
294632|NCT01567527|Otsuka Pharmaceutical Development & Commercialization, Inc.|Joan Amatniek, Senior Director, Global Clinical Development|(609) 512-4464|joan.amatniek@otsuka-us.com|
294633|NCT01567826|Icahn School of Medicine at Mount Sinai|Dr. Pedro R. Moreno||pedro.moreno@mountsinai.org|
294634|NCT01567839|The Ohio State University, Division of Endodontics|Dr. John Nusstein|614-292-9412|nusstein.1@osu.edu|
294635|NCT01567852|University of NewMexico|Dr. Tony Yen|505-272-2610|tyen@salud.unm.edu|
294636|NCT01567865|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
294637|NCT01567891|Adaptimmune|Clinical Trials Management|215-825-9302|clinicaltrials@adaptimmune.com|6302
294638|NCT01567943|Washington State University|Michael McDonell|509 368-6967|mmcdonell@wsu.edu|
294639|NCT01568008|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
294640|NCT01568021|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
294641|NCT01568034|BIAL - Portela & Cª S.A.|Head of Clinical Research|+351-229866100|clinical.trials@bial.com|
294642|NCT01568047|BIAL - Portela & Cª S.A.|Head of Clinical Research|+351-229866100|clinical.trials@bial.com|
294643|NCT01568073|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
294644|NCT01568112|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
294645|NCT01568255|Cedars Sinai|Margo Minissian, PhD|310-423-5195|Margo.Minissian@cshs.org|
294646|NCT01568320|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
294647|NCT01568424|St. Jude Medical|Poornima Sood|+1.781.852.8334|psood@sjm.com|
294648|NCT01568528|Emory University|Dr. Erica Duncan|404-321-6111|eduncan@emory.edu|
294649|NCT01568593|Laboratoires Thea|Dr Pascale POULIQUEN|0473981436|p.pouliquen@laboratoires-thea.fr|
294650|NCT01568606|Ahmanson-UCLA Cardiomyopathy Center|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
294651|NCT01568827|The Ohio State University|Dr. Joseph Kitzmiller|6142928438|joseph.kitzmiller@osumc.edu|
294652|NCT01568866|Amgen Inc.|Study Director|866-572-6436||
294653|NCT01568892|GlaxoSmithKline|GSK Response Center|866-435-7343||
294654|NCT01568905|University of Minnesota Tobacco Research Programs|Dorohty Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
294655|NCT01568944|Dental College of Georgia|chairman|706-7212442|chcutler@augusta.edu|
294656|NCT01569022|VA Western New York|Ali El Solh|716-862-6525|ali.el-solh@va.gov|
294657|NCT01569074|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
294658|NCT01569087|Biocad|Roman Ivanov, Director of Clinical Trials|+7 (812) 380 49 33|ivanov@biocad.ru|950
294659|NCT01569126|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294660|NCT01569152|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinialTrialsDisclosure@merck.com|
294661|NCT01569191|Aston University|Prof James Wolffsohn|+44(0)1212044140|j.s.w.wolffsohn@aston.ac.uk|
294662|NCT01569295|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|ClinicalTrialDisclosures@gilead.com|
294663|NCT01569438|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294664|NCT01569451|University of Colorado|Stefan Sillau|303-724-8657|stefan.sillau@ucdenver.edu|
294665|NCT01569464|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
294666|NCT01569529|University of Illinois at Chicago, Institute for Health Research and Policy|Dr. Robin Mermelstein|312 996-1469|robinm@uic.edu|
294667|NCT01569568|Children's National Medical Center|Dr. Andrea Gropman|202-476-2120|agropman@childrensnational.org|
294668|NCT01569594|Aziyo Biolgics, Inc.|Clinical Director|510-730-7973|clinical@aziyo.com|
294669|NCT01569607|Emory University|Dr. Cathrin Buetefisch|404-712-5507|cathrin.buetefisch@emory.edu|
294670|NCT01569737|HRA Pharma|Christine Adelbrecht, Clinical Trial Coordinator|+33 1 40 33 32 74|c.adelbrecht@hra-pharma.com|
294671|NCT01569763|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|Eugenes@minervasurgical.com|
294672|NCT01569815|Novartis Pharmaceuticals|Study Director|862-778-8300||
294673|NCT01569828|Novartis Pharmaceuticals|Study Director|862-778-8300||
294674|NCT01569841|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
294675|NCT01570036|Cancer Insight|Program Director, Karen Arrington, RN, BSN|210-243-5711|karrington@cancerinsight.com|
294676|NCT01570192|University of Florida, Department of Medicine|Dr. George L. Drusano|407-313-7060|gdrusano@ufl.edu|
294677|NCT01570244|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
294678|NCT01570283|Center for Cell and Gene Therapy|Dr. Helen Heslop|832-824-4662|heheslop@txch.org|
294679|NCT01570309|Jacobi Medical Center|Dr Seth I Sokol|718-918-5735|seth.sokol@nbhn.net|
294680|NCT01570348|FHCRC|Dr. George Georges|(206) 667-6886|ggeorges@fredhutch.org|
294681|NCT01570361|Johnson & Johnson Medical N.V., Biosense Webster|Liesbeth Vanderlinden|+32 (0) 2 746 3446|lvanderl@its.jnj.com|
294682|NCT01570387|Boston Medical Center|Vaishali Sanchorawala|617-638-7017|vaishali.sanchorawala@bmc.org|
294683|NCT01570491|Cleveland Clinic|Daniel Sessler, MD|2164444900|sessled@ccf.org|
294684|NCT01570686|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
294685|NCT01570751|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
294686|NCT01570829|MATERIA MEDICA HOLDING|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
294687|NCT01570868|The University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
294688|NCT01571232|Retina Macula Institute|Ron P. Gallemore M.D., Ph.D.|310-944-9393|rongallemoremd@gmail.com|
306411|NCT02410161|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
306412|NCT02410200|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
306413|NCT02410213|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@lpicrd.com|811
306414|NCT02410252|Partners Connected Health Innovations|Amanda Centi|6177242158|acenti@partners.org|
306415|NCT02410278|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
306416|NCT02410291|Sunnybrook Health Sciences Centre|Krista Dawdy, Clinical Educator|416 480 6104|krista.dawdy@sunnybrook.ca|
306417|NCT02410382|University of Arizona|Dr. Sun K. Yi|(520) 694-7236|sunkyi@email.arizona.edu|
294689|NCT01571284|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
294690|NCT01571362|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294691|NCT01571427|Oregon Health & Science University|Dr. Hiroko Dodge|(503) 494-6695|dodgeh@ohsu.edu|
294692|NCT01571453|Study Director|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
294693|NCT01571557|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
294694|NCT01571596|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
294695|NCT01572038|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
294696|NCT01572298|UTHSCSA Periodontics|Dr. Brian Mealey|210-567-3589|mealey@uthscsa.edu|
294697|NCT01572389|Department of Veteran Affairs|Aanand, Naik, MD|713-794-8541|anaik@bcm.edu|
294698|NCT01572428|Indiana University|Rachel Lahr|317-948-0724|rlahr@iu.edu|
294699|NCT01572727|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
294700|NCT01572740|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
294701|NCT01572792|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
294702|NCT01572844|GW Medical Faculty Associates|Alison Ehrlich, MD, Chair of Department of Dermatology|202-741-2625|aehrlich@mfa.gwu.edu|
294703|NCT01572909|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
294704|NCT01572922|St. Jude Children's Research Hospital|Jane Hankins, MD|866-278-5833|Jane.Hankins@stjude.org|
294705|NCT01572948|University of Alabama at Birmingham, Division of Pulmonary, Allergy, and Critical Care Medicine|J. Michael Wells, M.D.|205-934-6047|jmwells@uab.edu|
294706|NCT01573000|GlaxoSmithKline|GSK Response Center|866-435-7343||
294707|NCT01573052|VA Salt Lake City Medical Center|Dr. Christopher Stock|801-582-1565|christopher.stock@va.gov|1172
294708|NCT01573169|Stroke Unit and Division of Internal and Cardiovascular Medicine University of Perugia, Santa Maria della Misericordia Hospital|Dr. Maurizio Paciaroni|+390755786424|maurizio.paciaroni@unipg.it|
294709|NCT01573260|McGill University|Dr.Ronald B Postuma|514-934-8026|ron.postuma@mcgill.ca|
294710|NCT01573273|MUSC|Lisa Nunn|843-792-0476|jenkinli@musc.edu|
294711|NCT01573325|Northwestern Memorial Hospital|Rebecca Duke DNP, MSN, NP-BC Transplant Surgery Nurse Practitioner|3126951686|rduke@nmh.org|
294712|NCT01573442|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-4565|cloprinzi@mayo.edu|
294713|NCT01573533|Mayo Clinic|Fernando C. Fervenza, M.D., Ph.D.|507-266-1045|Fervenza.Fernando@mayo.edu|
294714|NCT01573572|Bausch Health|Study Manager|908-242-8287|sandra.narain@bauschhealth.com|
294715|NCT01573624|GlaxoSmithKline|GSK Response Center|866-435-7343||
294716|NCT01573702|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
294717|NCT01573767|GlaxoSmithKline|GSK Response Center|866-435-7343||
294718|NCT01573910|Alcon Research, Ltd.|Firoz Vohra, Project Head, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
294719|NCT01573949|University of California Los Angeles|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
294720|NCT01574079|University of Mississippi Medical Center|Principle investigator|601-984-6369|lbarnes@umc.edu|
294721|NCT01574105|Saskatoon Health Region|Mark Rosin|306-655-2128|mark.rosin@sasktoonhealthregion.ca|
294722|NCT01574144|Medtronic, Inc|Amy Lautenbach|7633609163|amy.a.lautenbach@medtronic.com@medtronic.com|
294723|NCT01574157|VA Salt Lake City Healthcare System|Dr. Kalani Raphael, Principal Investigator|801-582-1565|kalani.raphael@va.gov|1794
294724|NCT01574183|MUSC|Aimee McRae-Clark, PharmD|843-792-5216|mcraeal@musc.edu|
294725|NCT01574248|Vanderbilt University Medical Center|Nancy J. Brown, M.D.|6153438701|nancy.j.brown@vanderbilt.edu|
294726|NCT01574287|Emory University|Schuster, David|404-712-4859|dschust@emory.edu|
294727|NCT01574326|Genzyme Corporation|Trial Transparency Team||Contact-US@sanofi.com|
281776|NCT03343626|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
294728|NCT01574352|USouthernDenmark|professor Lars Bo Andersen|+45 60114380|lars.bo.andersen@hvl.no|
294729|NCT01574612|Meda Pharmaceutical|David Ginsberg, DO|732 564 2200|ginsberg.david@gmail.com|
294730|NCT01574651|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
294731|NCT01574703|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294732|NCT01574716|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
294733|NCT01574807|Division of Endodontics|Dr. John Nusstein|614-292-3596|nusstein.1@osu.ed|
294734|NCT01575054|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
294735|NCT01575080|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
294736|NCT01575106|Massachusetts General Hospital|Jian Kong|617-726-7893|JKONG2@mgh.harvard.edu|
294737|NCT01575197|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
294738|NCT01575275|Cleveland Clinic|Dr. Michael Vogelbaum|2164448564|vogelbm@ccf.org|
294739|NCT01575522|Dana-Farber Cancer Institute|Sara M. Tolaney, MD, MPH|617.632.5743|Sara_Tolaney@dfci.harvard.edu|
294740|NCT01575561|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
294741|NCT01575756|Octapharma USA|Director of Clinical Operations|201 604-1149|sylvia.werner@octapharma.com|
294742|NCT01575769|Hoffmann-LaRoche or Genentech, Inc|Medical Communications|800 821-8590|genentech@druginfo.com|
294743|NCT01575808|Toyko Jikei University Hospital|Dr. Takao Ohki|81-090-2478-8304|takohki@msn.com|
294744|NCT01575834|Amgen Inc.|Study Director|866-572-6436||
294745|NCT01575860|Abramson Cancer Center of the University of Pennsylvania|Jakub Svoboda, MD. Study Principal Investigator|855-216-0098|PennCancerTrials@emergingmed.com|
294746|NCT01575873|Amgen Inc.|Study Director|866-572-6436||
294747|NCT01575899|Buddhist Tzu Chi General Hospital|Dr. Ming-Cheh, Chen|+886-910-521003|MingCheh_chen@tzuchi.com.tw|
294748|NCT01575912|Centre Hospitalier Esquirol|Dr Murielle Girard|0033555431028|murielle.girard@ch-esquirol-limoges.fr|
306418|NCT02410629|University of California Irvine|Dr An Do|(714) 456-2332|and@uci.edu|
306419|NCT02410707|Einstein Healthcare Network|Joseph Herres, DO, Director of Research|215-456-6666|herresjo@einstein.edu|
306420|NCT02410772|Centers for Disease Control and Prevention|Dr. Ekaterina Kurbatova, MD, PhD, MPH|4046392017|ies3@cdc.gov|
306421|NCT02410798|Synapse Biomedical|Anthony Ignagni|440-774-2488|aignagni@synapsebiomedical.com|110
306422|NCT02410811|Cincinnati Children's Hospital Medical Center|Dr. Charles T. Quinn|5138033086|charles.quinn@cchmc.org|
306423|NCT02410824|CooperVision Inc.|Sr. Manager Clinical Research|925-730-6754|pchamberlain@coopervision.com|
306424|NCT02410837|Medtronic|Jennifer Wolvers|763-258-9405|Jennifer.Wolvers@Medtronic.com|
306425|NCT02410967|Florida International University|Dr. Jeremy Pettit|305-348-1671|jpettit@fiu.edu|
306426|NCT02411084|ADIENNE S.A|Renata Palmieri|+41.91.210.47.22|renata.palmieri@adienne.com|
306427|NCT02411110|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
306428|NCT02411201|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
306429|NCT02411292|Division of Plastic Surgery, University of Utah|Dr. Christopher J. Pannucci, M.D., M.S.|801-581-7719|christopher.pannucci@hsc.utah.edu|
306430|NCT02411396|Johns Hopkins University School of Medicine|Sophie Lanzkron, MD, MHS, Associate Professor of Medicine and Oncology|410-502-8642|slanzkr@jhmi.edu|
306431|NCT02411448|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
306432|NCT02411461|Vanderbilt University Medical Center|Ashley Shoemaker, Principal Investigator|6153438116|ashley.h.shoemaker@vanderbilt.edu|
306433|NCT02411539|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
306434|NCT02411565|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hye Sook Chon|813-745-7205|hyesook.chon@moffitt.org|
306435|NCT02411578|Jaeb Center for Health Research|Stephanie DuBose|813-975-8690|t1dstats2@jaeb.org|
306436|NCT02411591|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
306437|NCT02411747|Copenhagen Academy for Medical Education and Simulation, Rigshospitalet, Copenhagen University Hospital|Dr. Sarah Bube, director of the CYSTOSIM project|+4561339183|sarahbube@gmail.com|
306438|NCT02411916|Queens Hospital Center|Dr. Aleksandr Fuks|718 883-4035|fuksal@nychhc.org|
306439|NCT02411929|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
306440|NCT02412098|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
306441|NCT02412111|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
306442|NCT02412228|Brown University Oncology Research Group|John Reagan, MD|401-863-3000|BrUOG@Brown.edu|
306443|NCT02412306|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
306444|NCT02412371|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
306445|NCT02412436|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
306446|NCT02412488|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|7635268168|lindsay.k.werder@medtronic.com|
306447|NCT02412501|Medtronic Coronary/Structural Heart|Beth Moe, Clinical Study Manager|763-526-1184|beth.moe@medtronic.com|
306448|NCT02412631|Mayo Clinic|Dr. Ryan Hurt|(507) 284-2511|gimresearchstudies@mayo.edu|
294749|NCT01576003|Cincinnati Children's Hospital Medical Center|Conrad R. Cole, MD|513-636-6155|conrad.cole@cchmc.org|
294750|NCT01576016|Abbott|Grant Kim, Program Director - Traditional Cardiac Rhythm Management|818-493-3147|grant.kim1@abbott.com|
294751|NCT01576042|Duke Clinical Research Institute|Sana M. Al-Khatib, MD, MHS|919-668-8649|sana.alkhatib@dm.duke.edu|
306449|NCT02412644|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
306450|NCT02412657|MaisonneuveRH|Dr Veronique Brulotte|(514)252-3400|veronique.brulotte@umontreal.ca|
306451|NCT02412722|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306452|NCT02412761|The University of Texas Health Science Center at Houston|Joyce P. Samuel, MD, MS|(713) 500-5670|Joyce.P.Samuel@uth.tmc.edu|
306453|NCT02412852|TheraVasc Inc.|Tony Giordano|3183493851|tgiordano@theravasc.com|
306454|NCT02412878|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
306455|NCT02412956|The George Washington University|Dr. Lorien Abroms||lorien@gwu.edu|
306456|NCT02412982|UC Health - University of Cincinnati Medical Center|Molly Droege, PharmD|513-584-2126|molly.droege@uchealth.com|
306457|NCT02413008|ITF Research Pharma SLU|Concepción Nieto Magro|0034916572323|concepcion@itfsp.com|
306458|NCT02413034|Hospital del Mar|Daniel Pérez-Prieto|0034932483196|dperezprieto@hospitaldelmar.cat|
306459|NCT02413151|University of Lisbon|Maria Helena Santa-Clara Pombo Rodrigues|00351917377277|santaclara@fmh.ulisboa.pt|
306460|NCT02413190|Kennedy Krieger Institute|Dr. Kathryn Wagner|443-923-9525|wagnerk@kennedykrieger.org|
306461|NCT02413203|Univesrity of Pennsylvania|Garret A. FitzGerald|215-898-1185|garret@upenn.edu|
306462|NCT02413229|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
306463|NCT02413255|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306464|NCT02413294|University of Michigan|Dr. Amanda Leggett|734-232-0538|leggetta@med.umich.edu|
306465|NCT02413320|University of Kansas Medical Center|Dr. Priyanka Sharma|913-588-6029|psharma2@kumc.edu|
306466|NCT02413333|Alcon Research, Ltd.|Global Medical Affairs Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
306467|NCT02413346|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
306468|NCT02413372|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
306469|NCT02413398|Global Clinical Leader-Dapagliflozin AstraZeneca|Anna Maria Langkilde, MD PhD|Tel: + 46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
306470|NCT02413463|Faculty of Medicine, Cairo University|Ahmed Awadein, MD|201223911743|ahmedawadein@yahoo.com|
306471|NCT02413489|Janssen Research & Development, LLC|Study Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
306472|NCT02413580|Grifols Therapeutics LLC|Rhonda Griffin|9193166693|Rhonda.Griffin@grifols.com|
306473|NCT02413593|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
306474|NCT02413684|Duke Asthma, Airway and Allergy Center|Njira Lugogo|919-613-5707|njira.lugogo@duke.edu|
306475|NCT02413879|Prescient Surgical|Director of Clinical|6504895025|lclaude@prescientsurgical.com|
306476|NCT02413918|University of Texas HEalth Science Center San Antonio|Charles Bowden, MD|210-567-5405|BowdenC@uthscsa.edu|
306477|NCT02413996|IRCCS Istituto Ortopedico Galeazzi, Milano|Davide Tornese|0266214046|davidzai@tin.it|
306478|NCT02414204|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Timmy Lee|205-934-3589|txlee@uab.edu|
306479|NCT02414243|Laboratorios Ordesa|Roser De Castellar|+34 902105243|Roser.DeCastellar@ordesa.es|
306480|NCT02414633|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
306481|NCT02414828|Aeras|Ann Ginsberg, Chief Medical Officer|301-547-2912|aginsberg@aeras.org|
306482|NCT02414841|Proteon Therapeutics, Inc|Steven Burke, MD|781-890-0102|Clinical@ProteonTx.com|
306483|NCT02414854|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
306484|NCT02414932|Trinity College Dublin|Dr Martha Finnegan|0035312493385|mfinneg@tcd.ie|
306485|NCT02414958|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
306486|NCT02415127|Horizon Pharma Ireland, Ltd. Dublin, Ireland|Julie Ball, Executive Director Clinical Development & Operations||clinicaltrials@horizonpharma.com|
306487|NCT02415244|University of Iowa Hosptials and Clinics|Kenichi Ueda|3193562633|kenichi-ueda@uiowa.edu|
306488|NCT02415400|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
306489|NCT02415439|ReveraGen BioPharma, Inc.|Eric P. Hoffman, PhD|301-962-1578|eric.hoffman@reveragen.com|
306490|NCT02415556|Beth Israel Deaconess Medical Center (BIDMC)|Dr. Vera Novak, Principal Investigator|6176328680|vnovak@bidmc.harvard.edu|
306491|NCT02415595|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
306492|NCT02415608|Stanford University Medical Center|Jason Robert Gotlib, MD; Professor of Medicine (Hematology)|650-498-6000|C.Langford@stanford.edu|
306493|NCT02415842|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
306494|NCT02415855|University of Alberta|Dr. Kenneth Butcher|780-407-4366|ken.butcher@ualberta.ca|
306495|NCT02415959|Abbott|Suntje Sander-Struckmeier|+49 (0) 511 6750 3254|suntje.sander@abbott.com|
306496|NCT02415998|University of Iowa|Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|
306497|NCT02416102|University of Miami|Matthias Salathe, MD|913-588-6000|msalathe@kumc.edu|
306498|NCT02416180|GlaxoSmithKline|GSK Response Center|866-435-7343||
306499|NCT02416193|Loyola University Chicago|Mary Byrn, R.N., Ph.D.|(773) 508-8973|mbyrn@luc.edu|
306500|NCT02416453|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
306501|NCT02416622|AGTC|Dr. Matt Feinsod|386-462-2204|mfeinsod@agtc.com|7202
306502|NCT02416713|University of Pennsylvania|Dr. M. Kit Delgado|215-746-8256|Mucio.Delgado@uphs.upenn.edu|
294752|NCT01576055|W.L. Gore & Associates|Thomas Sabin|928-864-3153|tsabin@wlgore.com|
294753|NCT01576120|Given Imaging|"Ravit Peled | Clinical Trials Manager"|+972 (4) 909-7894|Ravit.peled@covidien.com|7894
294754|NCT01576146|Amgen, Inc|Study Director|866-572-6436||
294755|NCT01576159|Middle East Technical University|Ozgur Celik PhD.|+903122104016|ozgur@udel.edu|3663
294756|NCT01576172|University of Chicago|Theodore Karrison, PhD|(773) 702-9326|tkarrison@health.bsd.uchicago.edu|
294757|NCT01576276|Massachusetts General Hospital|Dr. Jian Kong|617-726-7893|jkong2@mgh.harvard.edu|
294758|NCT01576341|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
294759|NCT01576367|Novartis Pharmaceuticals|Study Director|862-778-8300||
294760|NCT01576406|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294761|NCT01576471|Coronado Biosciences|Vice President, Clinical Operations|7816524516|nsilver@coronadobio.com|
294762|NCT01576484|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
294763|NCT01576523|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
294764|NCT01576536|Vanderbilt University Medical Center|Dr. C. M. Stein|615-936-3420|mike.stein@vanderbilt.edu|
294765|NCT01576588|Vilnius University Hospital Santaros Klinikos|Regina Pileckyte, investigator|+370 5 2501384|regina.pileckyte@santa.lt|
294766|NCT01576705|Institut Jérôme Lejeune|Dr Clotilde Mircher|00 33 1 56 58 63 00|clotilde.mircher@institutlejeune.org|
294767|NCT01576718|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
294768|NCT01576783|Nationwide Children's Hospital|Dr. Sarah Keim|614-722-3177|Sarah.Keim@nationwidechildrens.org|
294769|NCT01576809|Novartis Consumer Health|Clinical project Leader|41223633111||
294770|NCT01576874|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
294771|NCT01576939|Stanford University|Quynh Le|650-725-0203|qle@stanford.edu|
294772|NCT01576952|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
294773|NCT01577108|China Medical University Hospital|Ming Ho, MD|886422052121|mi.ho@msa.hinet.net|2063
294774|NCT01577160|Janssen Research & Development|Medical Director|886 2 23762155||
294775|NCT01577186|Janssen Research & Development|Medical Director|886 2 23762155||
294776|NCT01577238|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
294777|NCT01577329|University of Michigan|Roxane Raffin Chan|7344780170|roxchan@comcast.net|734
294778|NCT01577381|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
294779|NCT01577537|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
294780|NCT01577706|McLean Hospital|Dr. J. Eric Jensen|617-855-3366|ejensen@mclean.harvard.edu|
294781|NCT01577732|GlaxoSmithKline|GSK Response Center|866-435-7343||
294782|NCT01577745|MedImmune, LLC|Mohammed Dar|301-398-1008|information.center@astrazeneca.com|
294783|NCT01577758|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
294784|NCT01577966|UAB|Burt Nabors, MD|205-934-2424|bnabors@uabmc.edu|
294785|NCT01578031|University of Pennsylvania|Samuel T. Kuna, MD|215-823-4400|skuna@mail.med.upenn.edu|
294786|NCT01578044|VA Eastern Colorado Health Care System|P. Michael Ho|720-857-2115|michael.ho@va.gov|
294787|NCT01578187|Syneron Beauty|Doran Rozen, Director of Clinical Affairs|+972-54-7800260|Doran.Rozen@syneron.com|
294788|NCT01578239|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
294789|NCT01578278|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
294790|NCT01578317|NIH|John Tsang|301-496-0304|tsangjs@mail.nih.gov|
294791|NCT01578330|Novartis|Study Director|862-778-8300|trialandresults.registries@novartis.com|
294792|NCT01578486|UMass Medical School|Xiaoduo Fan, MD, MPH|508-856-3881|xiaoduo.fan@umassmed.edu|
294793|NCT01578499|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
294794|NCT01578551|Johns Hopkins University|David Ettinger, MD|410-955-8847|ettinda@Jhmi.edu|
294795|NCT01578577|Northwestern University|Dr. Stephen Persell|312-503-6464|spersell@nm.org|
294796|NCT01578707|Pharmacyclics, LLC|Anita Szoke|(669) 215-7235|aszoke@pcyc.com|
294797|NCT01578772|UCLA|Dr. Jordan Lake|310-557-2273|jlake@mednet.ucla.edu|
294798|NCT01578850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
306503|NCT02416791|Neurostimulation Laboratory, Hospital das Clínicas/São Paulo University, Brazil|Professor Adriana Bastos Conforto|+55 11 2661-7955|adriana.conforto@hc.fm.usp.br|
306504|NCT02416908|Washington University School of Medicine|Geoffrey Uy, M.D.|314-747-8439|guy@wustl.edu|
306505|NCT02416934|West Virginia University Department of Orthopaedics|Dr. Sanford Emery|304-293-1170|semery@hsc.wvu.edu|
306506|NCT02416973|Regenesis Biomedical Inc.|Heather Vander Ploeg|602-428-7041|Heather.VanderPloeg@regenesisbio.com|
306507|NCT02417064|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
306508|NCT02417129|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
306509|NCT02417233|University of California San Francisco|Dr. Sheri Lippman|415-476-6319|sheri.lippman@ucsf.edu|
294799|NCT01578902|Sunnybrook Research Institute|Dr Andrew Loblaw, Director GU Radiation Trials|4164804806|andrew.loblaw@sunnybrook.ca|
294800|NCT01578980|University of Virginia|Boris Kovatchev, PhD|434-924-5592|bpk2u@virginia.edu|
294801|NCT01578993|Semprus BioSciences|Ulla Wallin, Director of Clinical Research|1-617-577-2205|ulla.wallin@semprusbio.com|
294802|NCT01579006|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
294803|NCT01579045|Vistakon/Johnson & Johnson Vision Care|Katherine Osborn Lorenz, OD MS|904-443-3123|kosborn@its.jnj.com|
294804|NCT01579084|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
294805|NCT01579162|HepQuant, LLC|Elyse Handley|303-923-2109|elyse.handley@hepquant.com|
294806|NCT01579214|Massachusetts General Hospital|Dr. Mark Siedner|617-726-4686|msiedner@mgh.harvard.edu|917
294807|NCT01579305|Allergan, Inc.|Medical Monitor|805 961 5000|devicetrials@allergan.com|
294808|NCT01579318|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
294809|NCT01579474|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
294810|NCT01579513|Medical University of South Carolina|Eric Graham, MD|843-792-9570|grahamem@musc.edu|
294811|NCT01579565|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
294812|NCT01579578|AstraZeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
294813|NCT01579669|Portland State University|Christina Nicolaidis, MD, MPH|5037259603|nicol22@pdx.edu|
294814|NCT01579747|Univeristy of New Mexico|Nicholas Lam|505 272 2610|nlam@salud.unm.edu|
294815|NCT01579812|UPMC Hillman Cancer Center|Dr. Ronald Buckanovich, MD, PhD|412-641-4721|buckanovichrj@mwri.magee.edu|
294816|NCT01579916|MedImmune, LLC|Raburn Mallory, MD/Senior Director Clinical Development|301-398-0000|malloryr@medimmune.com|
294817|NCT01580020|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
294818|NCT01580072|Landeskrankenanstalten-Betriebsgesellschaft|Dr. Hannes Steinberger|+4346355212 50303|hannes.steinberger@kabeg.at|
294819|NCT01580098|Landeskrankenanstalten-Betriebsgesellschaft|Dr. Hannes Steinberger|+4346355212 50303|hannes.steinberger@kabeg.at|
294820|NCT01580293|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
294821|NCT01580306|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
294822|NCT01580410|Wake Forest University Health Sciences|Dr. Edward Levine|336-716-2763|elevine@wakehealth.edu|
294823|NCT01580423|Dartmouth-Hitchcock Medical Center|Donald A. Mahler|603 650-5533|Donald.a.mahler@hitchcock.org|
294824|NCT01580488|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
294825|NCT01580592|Charité - University of Berlin; Dpt. of Dermatology and Allergy|Professor Dr. Martin Metz|+49 30 450 518 159|martin.metz@charite.de|
294826|NCT01580618|Kaiser Permanente|Hyo-Chun Yoon, MD, PHD|8084327342|Hyo-Chun.Yoon@nsmtp.kp.org|
294827|NCT01580670|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
294828|NCT01580904|Universidade Estadual da Paraíba|Impacto da Atenção Farmacêutica em pacientes diabéticos (IPCD)|558387010977|patriciatrindad@yahoo.com.br|
294829|NCT01580969|Huntsman Cancer Institute|Josiah Hawks|801-585-0601|Josiah.Hawks@hci.utah.edu|
294830|NCT01580995|VAORD|Mary Jane Burton|6013624471|mary.burton2@va.gov|
294831|NCT01581008|VA Eastern Colorado Health Care System|David Bekelman, MD, MPH|720-857-5088|david.bekelman@va.gov|
294832|NCT01581021|University of Mississippi Medical Center|Dr. Lawrence Haber|601-984-6525|lhaber@umc.edu|
294833|NCT01581281|Cincinnati Children's Hospital Medical Center|Scott Powers, PhD|513-636-8106|scott.powers@cchmc.org|
294834|NCT01581307|H. Lee Moffitt Cancer Center and Research Institute|Dr. Sarah Hoffe|813-745-4380|sarah.hoffe@moffitt.org|
294835|NCT01581437|Virginia CU|Kenneth Ellenbogen|804-828-7565|kellenbogen@mcvh-vcu.edu|
294836|NCT01581541|Stanford University School of Medicine|Dr. Shivaani Kummar|650-724-9084|skummar@stanford.edu|
294837|NCT01581593|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
294838|NCT01581619|Massachusetts General Hospital|Alphonse Taghian, MD, PhD|617-726-7559|ATAGHIAN@mgh.harvard.edu|
294839|NCT01581658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
294840|NCT01581684|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
294841|NCT01581710|CHA UNIVERSITY|Dr. HAN, MAN YONG|82-31-780-6262|drmesh@gmail.com|
306510|NCT02417246|UF|Dr. Larisa H Cavallari|352-273-8245|lcavallari@cop.ufl.edu|
306511|NCT02417376|GCD Indore|Dr Divya Singh Hada|+918720898289|dr_dshada@yahoo.com|
306512|NCT02417441|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
306513|NCT02417532|The Chris Moody Centre|Nick Birch|+44 1604 215440|nickbirch@doctors.org.uk|
306514|NCT02417753|National Cancer Institute|Dr. Tim Greten|301-451-4723|gretentf@nih.gov|
306515|NCT02417831|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
306516|NCT02417844|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
306517|NCT02417935|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
306518|NCT02417961|AstraZeneca|Mitchell Goldman, Global Clinical Lead Benralizumab|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
306519|NCT02418000|Spirita Oncology, LLC|Chief Development Officer|+1 (713) 898-8965|linda.paradiso@spiritaoncology.com|
306520|NCT02418026|Groupe Hospitalier de la Rochelle Ré Aunis|Mrs Sandrine Delavaux|+33 5 46 45 50 50|saniade@msn.com|
306521|NCT02418156|Aziyo Biolgics, Inc.|Clinical Director|470-514-4085|clinical@aziyo.com|
306522|NCT02418182|University of Alabama at Birmingham|Deidre Gunn, Assistant Professor|205-934-1030|ddowns@uabmc.edu|
306523|NCT02418234|Hangzhou first people's hospital|Prof. Shenglin Ma|086057156007664|mashenglin@medmail.com.cn|
306524|NCT02418312|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
306525|NCT02418455|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
306526|NCT02418468|Novartis Pharmaceuticals|Study Director|862-778-8300||
306527|NCT02418546|Massachusetts General Hospital|Dr. Anne-Marie Wills|6177265532|awills@mgh.harvard.edu|
306528|NCT02418585|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
306529|NCT02418676|State University of Maringá - Paraná - Brazil|Dra. Graciette Matioli|55 44 3011-3868|gmatioli@uem.br|
306530|NCT02418754|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844-734-6643|clinicaltrials@regeneron.com|
294842|NCT01581931|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
294843|NCT01581970|Masonic Cancer Center, University of Minnesota|Dr. Gautam Jha|612-624-5373|jhaxx014@umn.edu|
294844|NCT01582009|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
294845|NCT01582061|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
294846|NCT01582139|University of Virginia|Marc D Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
294847|NCT01582152|The University of Texas (UT) MD Anderson Cancer Center|Dr. Alfred Yung, Clinical Professor, Neuro-Oncology|713-792-7734|wyung@mdanderson.org|
294848|NCT01582178|Vitkovice Hospital|Premysl Falt, MD|+420595633|faltprem@centrum.cz|205
306531|NCT02418819|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
306532|NCT02418845|Lupin Pharmaceuticals Inc|Gregory Kaufman, MD|908.603.6062|gregorykaufman@lupin.com|
306533|NCT02418910|Biomedical Development Corporation|Gregg Siegel|2108638053|gsiegel@biodevcorp.com|
306534|NCT02418949|Shirley Ryan AbilityLab|Alexander Barry|3122381435|abarry@sralab.org|
306535|NCT02419001|Synthetic Biologics Inc.|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
306536|NCT02419313|Yale-Department of Neurology|Bahman Jabbari M.D , Professor Emeritus- Neurology|914-482-8542|bahman.jabbari@yale.edu|
306537|NCT02419469|UT MD Anderson Cancer Center|Rytting,Michael E.,M.D. / PEDIATRICS|713-792-7734|CR_Study_Registration@mdanderson.org|
306538|NCT02419508|Alcon, A Novartis Division|Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
306539|NCT02419521|Medtronic Coronary Structual Heart|Beth Moe, Clinical Study Manager||beth.moe@medtronic.com|
306540|NCT02419547|Brigham and Women's Hospital|Douglas Shook, MD, Chief, Divison of Cardiac Anesthesia|617-732-8219|dshook@bwh.harvard.edu|
294849|NCT01582243|Novartis Pharmaceuticals|Study Director|862-778-8300||
294850|NCT01582282|Procter and Gamble|John McRorie, PhD|513-622-1423|mcrorie.jw@pg.com|
294851|NCT01582308|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294852|NCT01582451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294853|NCT01582477|St. Elizabeth's Medical Center|Andrew Sternlicht, MD|617-789-2777|andrew.sternlicht@steward.org|
294854|NCT01582490|Pacira Pharmaceuticals, Inc.|Erol Onel, MD|858-625-2424|erol.onel@pacira.com|
294855|NCT01582789|CooperVision, US|Don Siegel, OD|623-544-3877|dsiegel@coopervision.com|
294856|NCT01582854|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
294857|NCT01582880|Massachusetts Eye and Ear Infirmary|Dr. Joseph Ciolino, MD|617-573-4437|joseph_ciolino@meei.harvard.edu|
294858|NCT01582945|Massachusetts General Hospital|Dr. Cristina Cusin|6177266421|ccusin@mgh.harvard.edu|
294859|NCT01582971|Michigan State University|Dr. Gwen Wyatt|517-432-5511|gwyatt@msu.edu|
294860|NCT01583101|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
294861|NCT01583166|UMass Worcester|Michael Flynn, MD|508-334-9840|michael.flynn@umassmemorial.org|
294862|NCT01583179|University of Wisconsin-Madison|Melanie Donnelly|720-848-0000|melanie.donnelly@ucdenver.edu|
294863|NCT01583218|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
294864|NCT01583296|Ferkauf Graduate School of Psychology, Yeshiva University|Jonathan M. Feldman|6465924508|jonathan.feldman@einstein.yu.edu|
294865|NCT01583374|Celgene Corporation|Anne McClain, Senior Study Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
294866|NCT01583452|ITESM - Pediatrics Division|Gabriela López Jaimez|+527211476044|gabylopez7@gmail.com|
294867|NCT01583530|GlaxoSmithKline|GSK Response Center|866-435-7343||
294868|NCT01583543|Massachusetts General Hospital|Dr. Edwin Choy|617-724-4000|echoy@mgh.harvard.edu|
306541|NCT02419573|Unviersity of Texas Health Science Center at Houston|Henry E. Wang, MD, MS|713-500-7878|henry.e.wang@uth.tmc.edu|
306542|NCT02419612|AstraZeneca|Global Clinical Lead|+1 877-240-9479|information.center@astrazeneca.com|
306543|NCT02419690|Denver Health & Hospital Authority|Deborah Rinehart|303-602-2743|deborah.rinehart@dhha.org|
306544|NCT02419755|St. Jude Children's Research Hospital|Tanja A. Gruber, MD, PhD|901-595-2252|tanja.gruber@stjude.org|
306545|NCT02419807|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Stephen Grobmyer|1-866-223-8100|TaussigResearch@ccf.org|
306546|NCT02419924|Mayo Clinic|Dr. Amy Foxx-Orenstein|480-301-6990|foxx-orenstein.amy@mayo.edu|
306547|NCT02419937|United States Air Force|Dr. Matthew B. Carroll|228-376-3829|mcar100210@yahoo.com|
306548|NCT02420015|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|175526
294869|NCT01583686|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@nci.nih.gov|
294870|NCT01583868|Bausch Health|Study Director||robert.steffen@bausch.com|
294871|NCT01583894|Boston Scientific Corporation|Nitzan Mekel-Bobrov, Director of Scientific Communications|6619494537|nitzan.mekel-bobrov@bsci.com|
294872|NCT01583985|Minneapolis VA Health Care System|Erin Krebs, MD|612-725-2000|erin.krebs@va.gov|
294873|NCT01584024|University of Michigan|Dr. Mathilde Peters (PI)|734-925-2750|mcpete@umich.edu|
294874|NCT01584232|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294875|NCT01584388|MGH Rheumatology|John H Stone|617-726-7938|jhstone@partners.org|
294876|NCT01584440|Avanir Pharmaceuticals, Inc.|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
294877|NCT01584479|University of Michigan|William Giannobile, Principal Investigator|734-764-1562|wgiannob@umich.edu|
294878|NCT01584518|Creighton University|Dr Anjan Talukdar|402-280-3586|talukdar.anjan@gmail.com|
294879|NCT01584544|Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College|Dr. Jing Jin|8601087788122|jingjin1025@163.com|
294880|NCT01584609|Penumbra, Inc.|Michaella Corso|(510) 748-3200|mcorso@penumbrainc.com|
294881|NCT01584648|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
294882|NCT01584843|GlaxoSmithKline|GSK Response Center|866-435-7343||
294883|NCT01585025|Imperial College London|Prof Julian Walters|+442033132361|julian.walters@imperial.ac.uk|
294884|NCT01585038|Indiana University School of Medicine|Samir K Gupta, Md, MS|317-274-7926|sgupta1@iu.edu|
294885|NCT01585129|WashingtonU|Dr. Anthony Shanks|3179448182|ashanks@iupui.edu|
294886|NCT01585155|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
294887|NCT01585168|Yale University|Dr. Godfrey Pearlson|(860) 545-7757|Godfrey.Pearlson@hhchealth.org|
294888|NCT01585194|MD Anderson Cancer Center|Dr. Sapna P. Patel/Associate Professor, Melanoma Medical Oncology|713-792-2921|sppatel@mdanderson.org|
294889|NCT01585207|Icahn School of Medicine at Mount Sinai|Dr. Barbara J. Coffey|212-659-1663|Barbara.coffey@mssm.edu|
294890|NCT01585246|Michigan State University|Dr. Gwen Wyatt|517-884-4630|gwyatt@msu.edu|
306549|NCT02420041|Naval Medical Center San Diego|LCDR Ian M Fowler, MD|619-532-8954|ian.m.fowler.mil@mail.mil|
306550|NCT02420093|University of Michigan Health System|Patricia Connors, PT, DScPT, OMPT|734-763-6464|pattyconnors219@gmail.com|
306551|NCT02420210|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
306552|NCT02420223|Medical College of Wisconsin|Dr. Jennifer Knight|866-680-0505|jknight@mcw.edu|
306553|NCT02420262|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
306554|NCT02420327|University of Maryland School of Medicine|Dr. Britta Hahn|410-402-6112|bhahn@som.umaryland.edu|
306555|NCT02420353|Hopsital For Special Surgery and University of Michigan|Dr. Christopher Mendias|212-249-2373|mendiasc@hss.edu|
306556|NCT02420379|Sarepta Therapeutics, Inc.|Medical Director|+1-888-727-3782|clinicaltrials@sarepta.com|
306557|NCT02420639|Department of Anesthesiology & Intensive Care Medicine, Dnipropetrovsk Medical Academy|Alexander Tsarev|+38 057 701 52 00|tsarev03@rambler.ru|
306558|NCT02420691|UT MD Anderson Cancer Center|Arvind Dasari,MBBS|713-792-2828|adasari@mdanderson.org|
306559|NCT02420873|The University of Texas MD Anderson Cancer Center|Naval Daver, MD/ Associate Professor|713-794-4392|ndaver@mdanderson.org|
306560|NCT02420951|Brigham and Women's Hospital|Dr. Wolfgang Fitz|6177329501|wfitz@partners.org|
306561|NCT02421055|Imperial College London|Dr Nicholas Penney|020 7589 5111|n.penney@imperial.ac.uk|
306562|NCT02421094|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
306563|NCT02421120|Hartford Hospital|Dr. Joseph L. Kuti, PharmD|860-972-3612|joseph.kuti@hhchealth.org|
306564|NCT02421146|Psychiatry Research, The Zucker Hillside Hospital|Andrea Joanlanne|7184708898|ajoanlanne@northwell.edu|
306565|NCT02421172|Novartis Pharmaceuticals|Study Director|8627788300||
306566|NCT02421211|Janssen Research & Development|Trial Physician, Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
306567|NCT02421224|University of California, San Francisco|Dr. Justin S. White|415-476-8045|justin.white@ucsf.edu|
306568|NCT02421354|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD. Professor|713-745-3429|sverstov@mdanderson.org|
306569|NCT02421419|Penn State Milton S. Hershey Medical Center|Kenneth Taylor, M.D.|(717) 531-5638|ktaylor2@pennstatehealth.psu.edu|
306570|NCT02421510|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
306571|NCT02421588|Pharma Mar S.A.|Pharma Mar S.A.|0034918466000|clinicaltrials@pharmamar.com|
306572|NCT02421601|Seikagaku Corporation|Clinical Development Department|(81)3-5220-8948|kyoichi.osano@seikagaku.co.jp|
306573|NCT02421666|Center for Asian Health, Lewis Katz School of Medicine, Temple University|Dr. Grace X. Ma|2157078823|grace.ma@temple.edu|
306574|NCT02421757|University of Maryland School of Medicine|Dr. Peter Rock|410-328-6933|prock@som.umaryland.edu|
306575|NCT02421887|NICHD|Esther Eisenberg, NICHD Project Scientist|301-496-6516|esther.eisenberg@nih.gov|
306576|NCT02421952|Baylor College of Medicine|Dr. Mary Felberg|832-824-5800|mafelber@texaschildrens.org|
306577|NCT02422186|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
306578|NCT02422264|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
294891|NCT01585272|Novartis Pharmaceutical|Study Director|862-778-8300||
294892|NCT01585298|Novartis Pharmaceuticals|Study Director|862-778-8300||
294893|NCT01585324|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
294894|NCT01585428|National Cancer Institute|D. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
294895|NCT01585441|National Eye Institute|Emily Chew, MD|301-496-6583|emily.chew@nih.gov|
294896|NCT01585558|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
294897|NCT01585584|University of Calgary|Dr. Samuel Lee|403-220-8457|samlee@ucalgary.ca|
294898|NCT01585597|Emory University|Christopher Horn|404 387 7320|cmhorn@emory.edu|
294899|NCT01585766|MedImmune|Armando Flor, MD, Director, Clinical Development|301-398-1955|information.center@astrazeneca.com|
294900|NCT01585779|Medtronic Coronary and Structural Heart|Shari Benoit|(763) 514-4000|shari.g.benoit@medtronic.com|9749
294901|NCT01585831|University of Colorado Denver|Nicole Tartaglia, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
294902|NCT01585961|Biosense Webster|Ellen Harris, Project Manager, Clinical Operations|909-839-7376|eharris8@its.jnj.com|
294903|NCT01585987|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
294904|NCT01586026|Bard Access Systems, Inc.|Christopher DiMatteo|801-522-5000|chris.dimatteo@crbard.com|
294905|NCT01586039|Brigham and Women's Hospital|Dr. Steven W. Lockley|617-732-4977|slockley@hms.harvard.edu|
294906|NCT01586091|University of Charité Berlin; Dpt. of Dermatology and Allergy|Professor Marcus Maurer|+49 30 450 518 043|marcus.maurer@charite.de|
294907|NCT01586156|Cleveland Clinic|Dr. Serpil Erzurum|216-445-6624|erzurus@ccf.org|
294908|NCT01586195|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
306579|NCT02422290|New York State Psychiatric Institute|Pablo H. Goldberg, MD|646-774-6318|Pablo.Goldberg@nyspi.columbia.edu|
306580|NCT02422446|Brigham and Women's Hospital|Dr. Luc Djousse|617-525-7591|Ldjousse@rics.bwh.harvard.edu|
306581|NCT02422511|Baylor College of Medicine|Jill Robinson|7137985848|jill.robinson@bcm.edu|
306582|NCT02422940|Acorda Therapeutics|Holy Roberts, Executive Medical Director - Medical Affairs|914-326-5224|hroberts@acorda.com|
306583|NCT02423109|CooperVision|Myhanh Nguyen, OD|9257306716|mnguyen@coopervision.com|
306584|NCT02423122|EIP Pharma|John Alam||jalam@eippharma.com|
306585|NCT02423200|EIP Pharma|John Alam|617-945-0794|jalam@eippharma.com|
306586|NCT02423291|"Institute of Hematology L. e A. Seràgnoli, AOU Policlinico S.Orsola-Malpighi Via Massarenti, 9 - 40138 Bologna Italy"|MD Vittorio Stefoni|+39 0512143680|vittorio.stefoni2@unibo.it|
306587|NCT02423317|Govt. Medical College, Haldwani.|Dr. Bikramjit Das|8937963828|bikramjit.anesth@gmail.com|
306588|NCT02423343|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
306589|NCT02423408|Tonix Pharmaceuticals|Judith Gendreau, Senior Medical Director|858-433-5574|judy.gendreau@tonixpharma.com|
306590|NCT02423447|Stanford University|Carlos Milla, MD|650-723-5193|cmilla@stanford.edu|
306591|NCT02423577|President and Chief Scientific Officer|Russell Wilson, PhD|504-896-2789|rbw@autoimmune.com|
306592|NCT02423798|Medtronic Minimed|Odile O'Sullivan, Clinical Trial Manager|8184763319|odile.osullivan@medtronic.com|
306593|NCT02423980|Xeris Pharmaceuticals, Inc.|Martin Cummins, VP Drug Development|512-498-2675|mcummins@xerispharma.com|
306594|NCT02423993|Endocrinology Research Centre, Moscow|Dr. Lyudmila Ibragimova|+7 9266180811|doc_mila@mail.ru|
306595|NCT02424097|UCSF - School of Dentistry|Dr. Peter Rechmann|415 514 3225|Peter.Rechmann@ucsf.edu|
306596|NCT02424149|Hartford Hospital|Katie Propst, MD|860-972-4338|katie.propst@hhchealth.org|
306597|NCT02424175|Brigham and Women's Hospital|Dr. Jessica Allegretti|6177325500|jallegretti@bwh.harvard.edu|
306598|NCT02424253|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
306599|NCT02424344|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
306600|NCT02424357|University of Miami|Hilda Capo|305-326-6555|hcapo@med.miami.edu|
306601|NCT02424383|Becton Dickinson|Sharon Christensen|612-757-0750|Sharon.Christensen@bd.com|
306602|NCT02424526|Sacramento State|Katrin Mattern-Baxter, PT, DPT|19162785766|kbaxter@csus.edu|
306603|NCT02424539|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
306604|NCT02424578|Iroko Pharmaceuticals|SVP Medical Affairs, Pharmacovigilance and Medical Information|2675463003|eoimagosie@iroko.com|3182
306605|NCT02424591|NYU School of Medicine|John Ard, MD|212.263.5072|john.ard@nyumc.org|
306606|NCT02424630|Chuncheon Sacred Heart Hospital|Dr Jung-Taek Hwang|82 33 240 5197|drakehjt@hanmail.net|
306607|NCT02424734|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
306608|NCT02424799|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
306609|NCT02424968|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)|650-723-0822|rlowsky@stanford.edu|
306610|NCT02425098|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306611|NCT02425111|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306612|NCT02425306|University of Virginia|Craig Slingluff, MD, Professor of Surgery|434-924-9311|cls8h@virginia.edu|
306613|NCT02425449|The University of Toledo|Shashi Bhatt, MD|419-383-3556|Shashi.Bhatt@utoledo.edu|
306614|NCT02425826|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-800-260-1599|ClinicalTrialDisclosure@celgene.com|
294909|NCT01586312|Instituto de Biología y Genética Molecular (IBGM)|Professor Javier Garcia-Sancho|34 983 423 084|jgsancho@ibgm.uva.es|
294910|NCT01586338|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
294911|NCT01586364|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
294912|NCT01586624|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
294913|NCT01586741|Karolinska University Hospital|D. Peter Emanuelsson|+46851770000|peter.emanuelsson@sll.se|
294914|NCT01586806|Hospital for Special Surgery|Dr. Mary Chisholm|2126061206|chisholmm@hss.edu|
294915|NCT01586819|Loyola University Chicago|Rebecca Tung, M.D.|708-216-8000|rtung@lumc.edu|
294916|NCT01586871|University of Minnesota|Aaron Kelly PhD|612-626-3492|kelly105@umn.edu|
294917|NCT01586897|Massachusetts General Hospital|Steven J. Atlas, Director of Massachusetts General Primary Care Practice Based Research Network|617-724-4736|satlas@partners.org|
294918|NCT01586910|Medtronic, Inc.|Peggy Yunker|763-514-4000|surtavi@medtronic.com|
294919|NCT01586962|Novartis|Clinical Project Leader|+41223633111||
294920|NCT01586975|Northwestern University|Northwestern University|312.503.4394|r-bernstein@northwestern.edu|
294921|NCT01587001|National Jewish Health|Nabeel Hamzeh|303-270-2613|hamzehn@njhealth.org|
294922|NCT01587014|Medical Center of the Rockies|Dr. Julie Dunn|970-624-1680|julie.dunn@uchealth.org|
294923|NCT01587027|Medical Center of the Rockies|Gary Luckasen, M.D.|(970)624-1686|gary.luckasen@uchealth.org|
294924|NCT01587040|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
294925|NCT01587079|Pearl Therapeutics, Inc|Colin Resiner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
294926|NCT01587105|Seattle Children's Hospital|Rita Mangione-Smith, MD, MPH|2068848242|Rita.Mangione-Smith@seattlechildrens.org|
294927|NCT01587118|Tuscaloosa Research and Education Advancement Corp|Sandra Creel|205-554-2000|sandra.creel@va.gov|1-2840
306615|NCT02425891|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
306616|NCT02425956|GE Healthcare|Research Manager|262-521-6819|Sandhya.Parameswaran@med.ge.com|
306617|NCT02426086|Geron Corp.|Study Director|650-473-7700|myf2001-info@geron.com|
306618|NCT02426138|University of North Carolina at Chapel Hill|Dr. Seth A. Berkowitz|919-966-2276|seth__berkowitz@med.unc.edu|
306619|NCT02426476|Columbia VA Health Care System, Virginia Commonwealth University, University of South Carolina|James Burch, MS, PhD, Professor|803-404-1552|burch@mailbox.sc.edu|
306620|NCT02426541|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
306621|NCT02426580|The Nephrology Department, the Chengdu Second Affiliated Hospital of Chongqing Medical University, the Third Peoples's Hospital of Chengdu|Dr. Gong Rong, Dr. Han Tianzhao, Dr. Leonard Stern|+86 028-61318708|gongr2006@sina.com|
306622|NCT02426658|Wake Forest University Health Sciences|Study Nurse|336-716-2121|saverill@wakehealth.edu|
306623|NCT02426749|University of Manitoba|Dr Zahra Moussavi|204 474 7023|Zahra.Moussavi@umanitoba.ca|
306624|NCT02426918|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
306625|NCT02427100|The University of Oklahoma Health Sciences Center|Dr. Darla Kendzor, Associate Professor|(405) 271-8001|Darla-Kendzor@ouhsc.edu|50478
271748|NCT00262730|Adult Brain Tumor Consortium Central Office- Johns Hopkins|Director of Adult Brain Tumor Consortium|410-955-3657|jfisher@jhmi.edu|
306626|NCT02427399|Fenway Health|Dr. Jennifer Potter|617-416-0986|jpotter@bidmc.harvard.edu|
306627|NCT02427477|Johnson & Johnson Vision Care Inc.|John R. Buch, O.D., M.S., F.A.A.O.|904-443-3500|JBUCH@its.jnj.com|1707
306628|NCT02427607|Eisai Co., Ltd.|Hidetaka Hiramatsu|+81-3-3817-5245|esi_medinfo@eisai.com|
306629|NCT02427646|LHSC|Dr. Mandar Jog|519-685-8500|mandar.jog@lhsc.on.ca|76708
306630|NCT02427672|Nanyang Technological University|Dr. Olivia Choy|(65)65921522|oliviachoy@ntu.edu.sg|
306631|NCT02427737|Hypnalgesics, LLC d/b/a Comfort Talk|Elvira V. Lang, MD (PI of SBIR grant sponsoring site-PIs); CEO|617 734 9087|drevlang@ComfortTalk.com|
306632|NCT02427750|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
306633|NCT02427802|Innocoll|Lesley Russell, MBChB, MRCP, Chief Medical Officer|484-406-5206|lrussell@innocoll.com|
306634|NCT02427841|OHSUKCI|Dr. Gina Vaccaro|503-216-6300|vaccarog@ohsu.edu|
306635|NCT02427958|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306636|NCT02427984|Medical technology laboratory, Rizzoli Orthopaedic Institute|Susanna Stea|00390516366861|stea@tecno.ior.it|
306637|NCT02428192|DFCI|Dr. Suzanne George|617-632-5204|Suzanne_George@dfci.harvard.edu|
306638|NCT02428296|Children's National Medical Center|Dr. Kim Keppler-Noreuil|2024766287|kkepplerno@childrensnational.org|
306639|NCT02428309|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
306640|NCT02428413|Teleflex|Thomas Philbeck, PhD, MBA, Senior Director of Global Research and Scientific Services|210-581-7778|thomas.philbeck@teleflex.com|
306641|NCT02428478|Brigham and Women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
306642|NCT02428595|Pelvalon|Clinical Management|650-276-0130|steve@pelvalon.com|
306643|NCT02428608|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
306644|NCT02428699|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
306645|NCT02428855|Massachusetts General Hospital|Dr. Bruce Giantonio|617-724-4000|BGIANTONIO@mgh.harvard.edu|
306646|NCT02429115|Penn State College of Medicine - Penn State Health|Nasrollah Ghahramani|7175318156|nghahramani@pennstatehealth.psu.edu|
306647|NCT02429258|AstraZeneca, PLL|Sergey Zhuplatov MD, PhD|215-542-3222|sergey.zhuplatov@astrazeneca.com|
306648|NCT02429310|Imperial College London|Professor Alun Davies|02033117320|a.h.davies@imperial.ac.uk|
294928|NCT01587274|Montefiore Health|Benjamin W. Friedman, MD|7189206626|befriedm@montefiore.org|
294929|NCT01587651|Daiichi Sankyo Medical Affairs|Fred Lipkin|973-944-2216|flipkin@dsi.com|
294930|NCT01587703|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
294931|NCT01587885|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294932|NCT01587898|GlaxoSmithKline|GSK Response Center|866-435-7343||
294933|NCT01587924|GlaxoSmithKline|GSK Response Center|866-435-7343||
294934|NCT01587950|GlaxoSmithKline|GSK Response Center|866-435-7343||
294935|NCT01587989|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
294936|NCT01588106|GWT-TUD GmbH|Dr. Carsta Köhler|+49 (0) 351 25933 100|contact@gwtonline.de|
294937|NCT01588158|Massachusetts General Hospital|Neal Chen, MD||nchen1@partners.org|
294938|NCT01588184|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
294939|NCT01588197|Medical University of South Carolina|Dr. Jeffrey J. Borckardt|8437923295|borckard@musc.edu|
294940|NCT01588236|Jiangsu Kanion Pharmaceutical Co. Ltd|Xiaoming Song, MD|+0086-025-87181862|sxm0903@kanion.com|
294941|NCT01588353|XIA Project, Pharmaceuticals Sales Division, Asahi Kasei Pharma Corporation|Norihiro Tateishi, Manager|+81-3-3296-3641|xia_project@om.asahi-kasei.co.jp|
294942|NCT01588366|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
294943|NCT01588405|United Therapeutics|Nicole Leedom|919-425-5870|nleedom@unither.com|
294944|NCT01588418|University of Texas Health Science Center at San Antonio|Dr. Ralph DeFronzo|210-567-6691|defronzo@uthscsa.edu|
294945|NCT01588444|UT Health Sci Ctr San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
294946|NCT01588457|UT Health San Antonio|Charles Bowden, MD|2105675393|bowdenc@uthscsa.edu|
306649|NCT02429427|Imperial College London|Prof Charles Coombes|+44 20 7594 2135|c.coombes@imperial.ac.uk|
306650|NCT02429778|VA Palo Alto Health Care System|Christine Gould, PhD|650-493-5000|Christine.Gould@va.gov|68899
306651|NCT02429856|UAlberta|Director of NACTRC|780-407-8007|ron.welch@ahs.ca|
306652|NCT02429869|University of California, San Francisco|Rodney Rogers|415-514-6454|Rodney.Rogers@ucsf.edu|
306653|NCT02429934|University of California at Los Angeles|Dr. Bevra Hahn|8184869745|bhahn@mednet.ucla.edu|8184869745
306654|NCT02430090|Ankara Numune Training and Research Hospital|Dr. Müge Çakırca|+905054433177|mugeturkoglu81@hotmail.com|
306655|NCT02430311|Astrazeneca|Gershon Locker|+1 773 868 0184|Gershon.Locker@astrazeneca.com|
306656|NCT02430337|Georgia State University|Shannon Self Brown, PhD|404-413-1283|sselfbrown@gsu.edu|
306657|NCT02430389|Northwester University|Laura B. Hemmer, M.D.|312-695-0061|l-hemmer@northwestern.edu|
306658|NCT02430480|National Cancer Institute|Dr. William Dahut|240-760-6070|dahutw@mail.nih.gov|
306659|NCT02430818|Washington University School of Medicine|Evan Schwarz|3147473690|schwarze@wustl.edu|
306660|NCT02430870|Takeda|Medical Director Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
306661|NCT02431052|Eli Lilly and Company.|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
306662|NCT02431260|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
306663|NCT02431273|Auritec Pharmaceuticals|Sarjan Shah|909-210-9715|sshah@auritecpharma.com|
306664|NCT02431299|Indiana University Purdue University Indianapolis|Dr. Alan B. McGuire|3179882725|abmcguir@iupui.edu|
306665|NCT02431364|Karyopharm Therapeutics Inc|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
306666|NCT02431455|Lahey Hospital and Medical Center|Haddon Pantel|3013566674|Haddon.Pantel@Lahey.org|
306667|NCT02431468|Neurotrope BioScience, Inc.|David Crockford, Vice President, Regulatory Affairs|(973)242-0005|dcrockford@neurotropebioscience.com|
306668|NCT02431533|Pharmabiotix, Inc|Mark Cobb|214-327-4712|cobbcoinc@aol.com|
306669|NCT02431559|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@lcr.org|
306670|NCT02431572|Massachusetts General Hospital|Dr. Elizabeth Gerstner|617-724-8770|EGERSTNER@mgh.harvard.edu|
306671|NCT02431598|Duke University Medical Center|Dr. Mustafa Bashir|919-684-8111|mustafa.bashir@duke.edu|
306672|NCT02431637|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 0369|moehrlej@mmv.org|
306673|NCT02431650|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 0369|moehrlej@mmv.org|
306674|NCT02431676|Johns Hopkins University|Dr. Jessica Yeh|410-614-4316|hyeh1@jhmi.edu|
306675|NCT02431741|Faculty Hospital Kralovske Czech Republic|Prof. Dr. Petr Arenberger|+420 267 16 11 11|avemedica@email.cz|
306676|NCT02431754|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
306677|NCT02431793|Northwestern University|Dr. Danielle McCarthy|312-926-7532|d-mccarthy2@northwestern.edu|
306678|NCT02431806|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
306679|NCT02432040|University of the Philippines - Philippine General Hospital Section of Dermatology|Dr. Sharlene Chua|2418118|sharlene_chua@yahoo.com|
306680|NCT02432105|Alcon, A Novartis Division|Clinical Scientific Director, GCRA - Global Clinical Development|1-888-451-3937|alcon.medinfo@alcon.com|
306681|NCT02432144|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
306682|NCT02432183|KU Leuven|Dominique MA Bullens|3216341338|dominique.bullens@kuleuven.be|
271749|NCT00262743|Mayo Clinic|Dr. Tait Shanafelt||shanafelt.tait@mayo.edu|
294947|NCT01588470|UT Health Science, San Antonio|Dr. Muhammad Abdul-Ghani, MD|210-567-6691|abdulghani@uthscsa.edu|
294948|NCT01588496|Amgen Inc.|Study Director|866-572-6436||
306683|NCT02432235|ADC Therapeutics SA|Clinical Trials Information|954-903-7994|clinical.trials@adctherapeutics.com|954
306684|NCT02432274|Eisai Ltd.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
306685|NCT02432287|Albert Einstein College of Medicine|Erika Brutsaert|7188397961|erika.brutsaert@einstein.yu.edu|
306686|NCT02432300|EmotEd, LLC|Dawn Neumann|716-713-5048|dneumann73@gmail.com|
306687|NCT02432456|Medical College of Wisconsin|Thomas Carver|414-955-1733|tcarver@mcw.edu|
306688|NCT02432703|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
306689|NCT02432716|HealthPartners Neuroscience Research|Clinical Trial Manager|651-495-6363|maria.x.pyle@healthpartners.com|
306690|NCT02432729|Philip Morris Products S.A.|Christelle Haziza, Director Health Science and Biostatistics|+41 58 242 11 11|christelle.haziza@pmi.com|
306691|NCT02432742|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
306692|NCT02433080|University College London|Dr Anne Lanceley|+442076796807|a.lanceley@ucl.ac.uk|
306693|NCT02433288|AstraZeneca|Traxler, Barry M|+1 301 398 0657|barry.traxler@astrazeneca.com|
306694|NCT02433340|AbbVie|Global Medical Services|800-633-9110||
306695|NCT02433366|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
306696|NCT02433379|Boston Scientific|Paji Vitoff, Manager, Clinical Trials|651-582-5415|Paji.Vitoff@bsci.com|
306697|NCT02433483|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
306698|NCT02433496|University of Wisconsin - Madison|Andrew Quanbeck|6082627385|arquanbe@wisc.edu|
306699|NCT02433613|Medtronic GmbH|Dr. Ralf Meyer|01755810431|ralf.meyer@medtronic.com|
306700|NCT02433665|Duke University Medical Center|Dr. Daniele Marin|919.684.7709|daniele.marin@duke.edu|
306701|NCT02433678|University at Buffalo|Dr. Paresh Dandona|716-535-1850|dandona@buffalo.edu|
306702|NCT02433834|Pearl Therapeutics, Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
306703|NCT02433977|University of Pittsburgh|Stacy Gelhaus Wendell|412-648-1351|gstacy@pitt.edu|
306704|NCT02434081|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser|+41 31 511 94 18|NICOLAS@etop-eu.org|
306705|NCT02434328|Novartis Pharmaceuticals|Study Director|1-862-778-8300|novartis.email@novartis.com|
306706|NCT02434471|Duke University|Mustafa R. Bashir, M.D.|919-684-7366|mustafa.bashir@duke.edu|
306707|NCT02434497|AstraZeneca Plc|Robin Mukherjee|+46317761000|robin.mukherjee@astrazeneca.com|
306708|NCT02434523|Boston Medical Center|Dr. Jacob Pieter Noordzij|617-638-8124|Pieter.Noordzij@bmc.org|
306709|NCT02434770|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
306710|NCT02434939|Makerere University ,College of Health Sciences, Department of Anesthesia and Critical care|Dr.Lubega Felix Anthony|+256777756571|falubega@chs.mak.ac.ug|
306711|NCT02435069|Nemours Children's Clinic|Kimberly S. Jarczyk, PhD, C-PNP|9044611730|jarczykks@gmail.com|
306712|NCT02435147|HealthEast Care System|Amy Fehrer|651-232-5363|afehrer@healtheast.org|
306713|NCT02435277|NuSirt Biopharma|Barbara Cannon|615-656-7898|BCannon@nusirt.com|
306714|NCT02435381|Baylor College of Medicine|Christopher D. Verrico Ph.D.|713-791-1414|Cverrico@bcm.edu|26020
306715|NCT02435511|University of Chicago|Dr. Stacy Lindau|7738348986|slindau@bsd.uchicago.edu|
306716|NCT02435524|London School of Hygiene & Tropical Medicine|Dr Veronique Filippi|+44 (0)20 7927 2874|veronique.filippi@lshtm.ac.uk|
306717|NCT02435680|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
306718|NCT02435706|Columbia University College of Dental Medicine|Elena Sanz Miralles, DDS, PhD|212-342-3008|ecs2181@cumc.columbia.edu|
306719|NCT02435836|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
306720|NCT02435849|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
306721|NCT02435901|Northwell Health System Cohen Children's Medical Center of NY|Indira Sahdev, MD|7184703460|isahdev@northwell.edu|
306722|NCT02435914|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
306723|NCT02435966|Physios & Universidad Europea de Madrid|Gracia M. Gallego, M.Sc.|+34 609036607|gracia.maria.gallego@gmail.com|
306724|NCT02435992|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
282638|NCT00865566|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
306725|NCT02436005|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
294949|NCT01588509|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
294950|NCT01588548|AstraZeneca|Karen Keating|+1 781 839 4182|karen.keating@astrazeneca.com|
294951|NCT01588561|McLean Hospital|Scott Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
294952|NCT01588821|Massachusetts General Hospital|Rebecca Suk Heist, MD|617-724-4000|rheist@partners.org|
294953|NCT01588951|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Margaret Showel, MD|410-614-0675|mshowel1@jhmi.edu|
294954|NCT01588990|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
294955|NCT01589094|Memorial Sloan Kettering Cancer Center|Dean Bajorin, MD|646-888-4700|bajorind@mskcc.org|
282639|NCT00865709|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
294956|NCT01589185|Aridis Pharmaceuticals, Inc.|Lynne Deans, M.T.|408-385-1742|deansl@aridispharma.com|
294957|NCT01589237|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
306726|NCT02436031|Brigham and Women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
306727|NCT02436135|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
306728|NCT02436200|Imperial College London|Professor Alun Davies, Professor of Vascular Surgery|+44 (0)20 3311 7309|a.h.davies@imperial.ac.uk|
306729|NCT02436239|Allergan|Armin Szegedi, MD, PhD, Vice President CNS Clinical Development|714-246-4500|IR-CTRegistration@allergan.com|
306730|NCT02436304|Alcon, A Novartis Division|Clinical Scientific Director, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
306731|NCT02436330|University of Illinois College of Medicine at Peoria|Dr. Amy L. Christison|309-624-9188|alc@uic.edu|
306732|NCT02436356|Vanderbilt University Medical Center|Jeffry S. Nyman, Ph.D.|615-936-6296|jeffry.s.nyman@vumc.org|
306733|NCT02436408|University of Michigan Rogel Cancer Center|Cagri Besirli, MD, PhD|734-232-8404|cbesirli@med.umich.edu|
306734|NCT02436577|AstraZeneca AB|Brilinta Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
306735|NCT02436668|Pharmacyclics, An AbbVie Company|George Cole|(408) 990-7340|gcole@pcyc.com|
306736|NCT02436681|Miromatrix|Head of Clinical Affairs|952.942-6000|mmacenski@miromatrix.com|
306737|NCT02436759|RVL Pharmaceuticals, Inc.|Senior Director of Clinical Operations|9088091423|mvelasco@osmotica.com|
306738|NCT02436811|Universidade Federal do Paraná|Dr Luciana Reichert Assunção Zanon|554133604025|lurassuncao@yahoo.com.br|
306739|NCT02436876|Microbion Corporation|Brett Baker, President and Chief Innovation Officer|4065991190|bbaker@microbioncorp.com|
306740|NCT02436889|University of California, San Francisco|Alison Huang, MD|415-514-8697|alison.huang@ucsf.edu|
306741|NCT02436915|Institute for Aging Research, Hebrew SeniorLife|Brad Manor|617-971-5332|bradmanor@hsl.harvard.edu|
306742|NCT02437084|Stanford University School of Medicine|Dr Joshua W. Knowles, MD, PhD; Assistant Professor, Cardiovascular Medicine|650-723-1431|knowlej@stanford.edu|
306743|NCT02437162|Johnson&Johnson|SENIOR DIRECTOR CLINICAL DEVELOPMENT|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
306744|NCT02437188|Baylor College of Medicine|Dr. Lilian Dindo, Assistant Professor|713-440-4637|lilian.dindo@bcm.edu|
306745|NCT02437253|Los Angeles Biomedical Research Institute at Harbor-UCLA|Dr. Lynda Polgreen (PI)|310-222-1961|lpolgreen@labiomed.org|
306746|NCT02437305|Northwestern Univeristy|Dr. Roopal Kundu|312-926-4926|rkundu@nm.org|
306747|NCT02437344|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
306748|NCT02437383|University of North Carolina at Chapel Hill|Dr. Inna E. Tchivileva|1 919 537 3291|inna_tchivileva@unc.edu|
294958|NCT01589263|Baylor College of Medicine|Christopher Smith|713-798-4001|cps@bcm.edu|
294959|NCT01589302|The Ohio State University Comprehensive Cancer Center|Kami Maddocks, MD|614-293-3507|Kami.Maddocks@osumc.edu|
294960|NCT01589315|Medical University of South Carolina|Mark S. George, MD|1843876 5142|georgem@musc.edu|
294961|NCT01589445|Ministry of Science and Technology, Government of the People's Republic of Bangladesh|Dr. Masuma Parvin|88 01819141258|acmasuma@gmail.com|
294962|NCT01589484|University of Sao Paulo Medical School|Dr. Fabio Torricelli|+55 11 94308951|fabio_torri@yahoo.com.br|
294963|NCT01589497|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
294964|NCT01589510|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
294965|NCT01589601|Duke University Medical Center|Joseph G. Rogers, MD|919-681-1370|joseph.rogers@duke.edu|
294966|NCT01589653|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
306749|NCT02437409|phenox GmbH|Clinical Affairs|+49 (0)234 36 919|ARTESp@phenox.info|0
306750|NCT02437487|Seres Therapeutics|Dr. Michele Trucksis, Chief Medical Officer|(617) 945-9626|mtrucksis@serestherapeutics.com|
306751|NCT02437513|Protip Medical|Linda Nicolini CEO|0033388103068|l.nicolini@protipmedical.com|
306752|NCT02437669|Columbia University College of Physicians and Surgeons|Daniel S. Tsze, MD, MPH|212-305-9825|dst2141@columbia.edu|
306753|NCT02437864|University of New Mexico Health Sciences Center (HSC)|Dr. Codruta Soneru|5052722610|csoneru@salud.unm.edu|
306754|NCT02437890|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
306755|NCT02437903|Baumann Cosmetic and Research Institute|Leslie Baumann, MD|(305) 531-5788|studies@derm.net|
306756|NCT02438137|UMichigan|Tiffany Braley, M.D., M.S.|734-232-1147|tbraley@med.umich.edu|
306757|NCT02438280|University of Washington|Dr. Greg Huang, Professor and Chair of Orthodontics|(206) 616-6996|ghuang@uw.edu|
282640|NCT00865904|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
306758|NCT02438371|The University of Texas Health Science Center at Houston|Jerrie S. Refuerzo, MD|(713) 500-6416|Jerrie.S.Refuerzo@uth.tmc.edu|
306759|NCT02438384|Department of Emergency Medicine, UNC School of Medicine|Tim Platts-Mills, MD|559-240-6073|tim_platts-mills@med.unc.edu|
306760|NCT02438423|Georgia Tech|Mark Prausnitz, PhD|404-894-5135|prausnitz@gatech.edu|
306761|NCT02438475|Medstar Health Research Institute|Megan Rowland|202-877-2959|megan.e.rowland@medstar.net|
306762|NCT02438540|Nanjing university of TCM|Dr. Amir Firouzjaei|+989125397047|amirfi@yahoo.com|
306763|NCT02438722|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
306764|NCT02438787|Janssen Research & Development, LLC|Scientific Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
306765|NCT02438813|Allergan, Inc|Medical Director/ Epidemiologist|714-246-4500|clinicaltrials@allergan.com|
306766|NCT02438826|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
306767|NCT02439138|Dana-Farber Cancer Institute|Jorge J. Castillo|617-632-6045|jorgej_castillo@dfci.harvard.edu|
306768|NCT02439164|Beijing Tiantan Hospital|Dr. Nan Lin|861067096658|linnan127@163.com|
306769|NCT02439281|U Pittsbutgh, UPMC Children's Hospital|Mihaela Visoiu|4126925260|visoium@upmc.edu|
306770|NCT02439320|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
306771|NCT02439710|Institute for Policy Advancement Ltd|Mark W Skinner|+1-202-253-8342|mskinnerdc@gmail.com|
306772|NCT02439749|Medtronic|Pamela McKenna, Sr. Principal Clinical Research Specialist|(773) 597-5241|pamela.m.mckenna@medtronic.com|
306773|NCT02439814|Medical University of South Carolina|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
306774|NCT02439879|Universidad Popular Autonoma del Estado de Puebla|Dr. Hector Garcia Alcala|+522222299400|hector.garcia@upaep.mx|7466
306775|NCT02440022|Becton Dickinson (BD)|Heidi Ronhovde|480-597-8579|Heidi.Ronhovde@bd.com|
306776|NCT02440139|Virginia Tech|Dr. ShihChung Benedict Lo|301-9215754|benlo@vt.edu|
306777|NCT02440178|seoul national university|Pf. Youngil Koh|82-2-2072-7217|go01@snu.ac.kr|
306778|NCT02440204|Severance|Dr. Jae Chul Koh|82-010-8702-3931|jaykoh82@gmail.com|
306779|NCT02440308|Stanford Healthcare|Dr. Andrei Iagaru, Chief of the Division of Nuclear Medicine and Molecular Imaging|650-725-4711|aiagaru@stanford.edu|
306780|NCT02440334|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. John Eisenbrey|(215) 503-5188|john.eisenbrey@jefferson.edu|
306781|NCT02440425|Moffitt Cancer Center|Robert M. Wenham, MD, MS, FACOG, FACS|813-745-5739|Robert.Wenham@moffitt.org|
306782|NCT02440451|University of Coimbra|Prof. Dr. Miguel Castelo-Branco|+351239790000|mcbranco@fmed.uc.pt|
306783|NCT02440568|University of Illinois at Chicago|Dr. John Quigley|312-413-1300|seanq@uic.edu|
306784|NCT02440594|University of Pennsylvania|Shahrzad Mavandadi|215-823-5211|shahrzad.mavandadi@va.gov|
306785|NCT02440633|Otsuka Pharmaceutical Co., Ltd.|Study Director, Yoshitaka Kotobuki, Mr|+81-3-6361-7366||
306786|NCT02440659|Arbor Research Collaborative for Health|Francesca Tentori|734-665-4108|christina.pustulka@arborresearch.org|
294967|NCT01589770|Vanderbilt University Medical Center|Dr. C. M. Stein|615-936-3420|michael.stein@vanderbilt.edu|
282641|NCT00865969|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
294968|NCT01589822|Ethicon|Director of Clinical Development|1 908 218-2492|JBatill2@its.jnj.com|
294969|NCT01589978|Boston Scientific|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
306787|NCT02440789|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
306788|NCT02441062|University of Iowa, Holden Comprehensive Cancer Center|M.Sue O'Dorisio|(319) 335-7234|sue-odorisio@uiowa.edu|
294970|NCT01590017|AMC Statistical Center|Jeannette Lee, PhD.|501-526-6712|jylee@uams.edu|
306789|NCT02441114|Seoul National University Hospital|Clinical Pharmacology and Therapeutics|82-2-2072-4081|rheesjin@gmail.com|
306790|NCT02441179|Teleton Institute|Dr. Angela Navarrete-Opazo|+56 0226772075|angelaandrean@gmail.com|
306791|NCT02441218|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
306792|NCT02441283|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
294971|NCT01590082|The University of Texas (UT) MD Anderson Cancer Center|Sapna P. Patel, Associate Professor, Melanoma Medical Oncology|(713) 792-2921|sppatel@mdanderson.org|
294972|NCT01590212|University of Glasgow|Prof. Phil Wilson|+44 (0)1463 255892|p.wilson@abdn.ac.uk|
306793|NCT02441309|University of Oxford|Joint Research Office|+441865572245|ctrg@admin.ox.ac.uk|
294973|NCT01590238|New York Eye & Ear Infirmary|Anthony P Sclafani, MD|212-979-4200|asclafani@nyee.edu|
294974|NCT01590264|Washington University in Saint Louis|Dr. Jay F. Piccirillo|314-362-8641|piccirilloj@ent.wustl.edu|
306794|NCT02441517|Astellas Pharma Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
306795|NCT02441946|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
306796|NCT02442206|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
306797|NCT02442271|AbbVie|Global Medical Services|800 633-9110||
306798|NCT02442284|AbbVie|Global Medical Services|800-633-9110||
306799|NCT02442310|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
306800|NCT02442336|Fox Chase Cancer Center|Carolyn Fang|215-728-4062|carolyn.fang@fccc.edu|
306801|NCT02442622|NYU Langone Health|Steve Vanlew, PhD|646-501-7707|Steve.Vanlew@nyulangone.org|
306802|NCT02442687|Duke University|Dr. Manal F. Abdelmalek|919-684-8356|manal.abdelmalek@duke.edu|
294975|NCT01590433|Beth Israel Deaconess Medical Center|Jody Dushay|617-667-9344|jdushay@bidmc.harvard.edu|
294976|NCT01590550|Loma Linda University|Rita Sheth, MD|909-558-8242|rsheth@llu.edu|
294977|NCT01590563|Synexus Hungary|Dr. Beata Szoczei, MD|+36 1 436 7330||
294978|NCT01590758|Dipexium Pharmaceuticals, Inc|Robert J DeLuccia|+19145226503|delucciarj@gmail.com|
294979|NCT01590771|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294980|NCT01590797|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
294981|NCT01590810|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
294982|NCT01590875|Medical College of Wisconsin|Marcie Berger, MD|414-955-6806|mgberger@mcw.edu|
294983|NCT01590888|Prana Biotechnology|Dr Caroline Herd|+61393494906|info@pranabio.com|
270485|NCT00131573|Boston Scientific|Director of Clinical Operations|866-360-4747|valerie.lucero-cimmarusti@bsci.com|
270486|NCT00131664|Dr. Anatoly Langer, Chair CHRC, Canadian Heart Research Centre|Dr. Robert Josse|416-977-8010|langera@chrc.net|
270487|NCT00131677|Centers for Disease Control and Prevention (CDC)|Taraz Samandari|404-639-1676|tts0@cdc.gov|
270488|NCT00131885|University of Utah|Patricia Murphy, DrPH|801-793-5729|patricia.murphy@nurs.utah.edu|
270489|NCT00131911|Mayo Clinic Cancer Center|Timothy J. Hobday M.D.||Hobday.timothy@mayo.edu|
270490|NCT00131937|ECOG Statistical Office|Study Statistician|617-632-3012||
270491|NCT00132002|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
270492|NCT00132028|SWOG Statistical Center|Study Statistician|206-667-4623||
270493|NCT00132041|American College of Radiology Imaging Network|Donna Harfeil, Director of Protocol Management|215-717-2765|Donna Hartfeil <dhartfeil@acr.org>|
270494|NCT00132132|SEMC|Dr. Shirley Gonzalez|617-926-0114|shirley.gonzalez@steward.org|
270495|NCT00132301|VA Puget Sound Health Care System|Dr. Bruce Montgomery|206-277-6878|Robert.Montgomery@va.gov|
270496|NCT00132314|VA New England Mental Illness, Research, Education and Clinical Center|Robert Rosenheck, MD|(203) 932-5711|Robert.Rosenheck@va.gov|3723
270497|NCT00132496|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
270498|NCT00132678|Johnson & Johnson Pharmaceutical Research and Development|Director of Clinical Research|609 730-4576||
270499|NCT00132691|Center for Presventive Ophthalmology and Biostatistics, Department of Ophthalmology, University of Pennsylvania|John H. Kempen, MD, PhD, MUST Trial Vice-Chairman|215-615-1500|john.kempen@uphs.upenn.edu|
270500|NCT00132730|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270501|NCT00132769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270502|NCT00132808|Novartis Pharmaceuticals|Study Director|862-778-8300||
270503|NCT00132873|Jazz Pharmaceuticals, Inc.|Mortimer Mamelak, MD|650 496 3777|roman.skowronski@jazzpharma.com|
270504|NCT00132964|Hospital for Sick Children|Kathy Boutis|4168138982|kathy.boutis@sickkids.ca|
270505|NCT00133575|Brigham and Women's Hospital|Lindsey R. Baden, M.D.|617-732-6801|LBaden@partners.org|
270506|NCT00133705|University of Rochester|Dr. Kevin Fiscella|585-271-1206|kevin_fiscella@urmc.rochester.edu|205
270507|NCT00133809|Emory University|Nicole Turgeon MD|404-727-3257|nturgeo@emory.edu|
306803|NCT02442700|Ramathibodi Hospital, Mahidol University|Asita Wongprikorn, MD|664236949|wongprikorn@yahoo.com|
306804|NCT02442804|Brown University|John Bellone, Ph.D.|4012737100|john_bellone@brown.edu|6168
306805|NCT02442830|UMass Medical School|Principal Investigator|(774) 442-4098|David.Cave@umassmemorial.org|
306806|NCT02442856|University of Pennsylvania|Michael Mullen|215-662-3339|mmullen@pennmedicine.upenn.edu|
294984|NCT01590979|Staten Island University Hospital, Northwell Health|Soad Bekheit, MD|718-226-6629|msills@northwell.edu|
294985|NCT01591005|University Hospital Ostrava|Prof. David Skoloudik, MD, Ph.D.|+420597375613|skoloudik@hotmail.com|
294986|NCT01591018|University Hospital Ostrava|David Skoloudik|00420597375630|skoloudik@hotmail.com|
270508|NCT00133952|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
270509|NCT00133978|Clinical Evaluation Research Unit|Dr. Daren Heyland|613-549-6666|dkh2@queensu.ca|4847
294987|NCT01591044|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
294988|NCT01591161|Bausch Health|Study Director||susan.harris@bauschhealth.com|
294989|NCT01591317|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294990|NCT01591330|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
294991|NCT01591382|Brigham and Women's Hospital|Dr. Srdjan S. Nedeljkovic||snedeljkovic@partners.org|
282642|NCT00866034|UMC Utrecht|Ouijdane Hamdine, MD|+31-88-7557524|O.Hamdine@umcutrecht.nl|
294992|NCT01591408|NavalMCSD|Julie Onton|619-553-6228|julie.a.onton.ctr@mail.mil|
282643|NCT00866047|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
294993|NCT01591460|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
294994|NCT01591499|CooperVision|Caroline Bonneville and Sandrine Cheneau, Study Managers|+33609202762|caroline.bonneville@coopervision-fr.com|
294995|NCT01591616|Virginia Commonwealth University, School of Dentistry|Tegwyn H. Brickhouse, DDS, PhD|(804) 827-2699|thbrickhouse@vcu.edu|
270510|NCT00133991|Johns Hopkins University|Yvette Kasamon, MD||ykasamon@jhmi.edu|
282644|NCT00866177|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
294996|NCT01591655|Bausch Health|Study Director||susan.harris@bauschhealth.com|
294997|NCT01591681|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D.|813-975-8690|jdrfapp2@jaeb.org|
294998|NCT01591733|Massachusetts General Hospital|Dr. Theodore Hong|617-726-6050|TSHONG1@mgh.harvard.edu|
294999|NCT01591746|Mayo Clinic|Dr. Valerie Lemaine, MD, MPH|507-284-2736|lemaine.valerie17@gmail.com|
295000|NCT01591785|Icahn School of Medicine at Mount Sinai|Gary Goldenberg, MD|212-241-6500|garygoldenbergmd@gmail.com|
295001|NCT01591837|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
295002|NCT01591863|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
306807|NCT02442869|University of Nevada, Reno|Dr. Jacqueline Pistorello|775-784-4648|pistorel@unr.edu|
306808|NCT02443103|IndianaU|Dr. Kathy Miller|317-948-3855|kathmill@iu.edu|
306809|NCT02443155|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
306810|NCT02443298|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
306811|NCT02443337|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
295003|NCT01592006|University of Chicago Medical Center|Dr. Helen S. Te|773-702-2395|hte@medicine.bsd.uchicago.edu|
306812|NCT02443402|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
295004|NCT01592045|United Therapeutics Corporation|Allison Lim|919-425-8799|alim@unither.com|
295005|NCT01592071|University of Miami|Dr. John Lewis|(305) 243-6227|jelewis@miami.edu|
295006|NCT01592240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295007|NCT01592292|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
295008|NCT01592344|Bioness|Charlene Myers, Contractor|9499101655|cahanderson@msn.com|
295009|NCT01592396|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
295010|NCT01592409|Centre for Addiction and Mental Health|Dr. Robert Mann, Senior Scientist|416-535-8501|robert.mann@camh.ca|34496
295011|NCT01592435|Carestream Health, Inc.|Susan Pate, MS, RN, RAC, Senior Manager, Clinical Affairs|585-627-6557|susan.pate@carestream.com|
295012|NCT01592500|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
306813|NCT02443519|Yeshiva University & Albert Einstein College of Medicine|Dr. Elizabeth Seng|646-592-4368|elizabeth.seng@yu.edu|
306814|NCT02443571|Blue Earth Diagnostics Ltd.|Chief Medical Officer|+44 (0) 1865 784 186|contact@blueearthdx.com|
306815|NCT02443688|Celtaxsys, Inc.|Director, Clincal Operations|4702060153|sbirnbaum@celtaxsys.com|123
306816|NCT02443740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
306817|NCT02443792|U of Cape Town|Dr. Justin Shenje|0027788938497|justintshenje@gmail.com|
306818|NCT02443805|Stallergenes Greer|Martine Le Gall, Director of Clinical Development|+33 1 55 59 25 56|martine.legall@stallergenesgreer.com|
306819|NCT02443883|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
306820|NCT02444143|University of Illinois at Chicago|Dr. Patricia West-Thielke|312-996-5695|pwest@uic.edu|
306821|NCT02444182|Kuwait University - Faculty of Dentistry|Dr. Abrar Alanzi|24636812|aalanzi@hsc.edu.kw|
306822|NCT02444234|University of Southern California|Paul M Beringer, Pharm.D.|323-442-1402|beringer@usc.edu|
306823|NCT02444533|Mayo Clinic|Dr. Daniel Price|507-293-4395|Price.Daniel@mayo.edu|
306824|NCT02444663|University of Oxford|Thomas Hamilton, Clinical Research Fellow|01865227696|thomas.hamilton@ndorms.ox.ac.uk|
306825|NCT02444715|Luxembourg Institute of Science and Technology|Dr. Lübomira Spassova|+352 275 888 1|lubomira.spassova@list.lu|
306826|NCT02444793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
306827|NCT02444936|Cleveland VA|Dr. David Canaday|216-368-8901|dxc44@case.edu|
306828|NCT02444988|Vanderbilt University Medical Center|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
306829|NCT02445014|Mass General Hospital|Gary Tearney, MD|617-724-2979|gtearney@partners.org|
306830|NCT02445027|Massachusetts General Hospital|Anna Gao RN.|617-643-6092|tearneylabtrials@partners.org|
306831|NCT02445196|Stanford University|Dr. C. Barr Taylor|415-987-1810|btaylor@stanford.edu|
306832|NCT02445287|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
306833|NCT02445326|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
306834|NCT02445573|Guang'anmen hospital of China Academy of Chinese Medical Sciences|Dr. Huanfang Xu|+86 10 8800 1124|huanfang_xu@126.com|
282645|NCT00866281|Novartis Pharmaceuticals|Study Director|862-778-8300||
295013|NCT01592695|University of Iowa|Mark Vander Weg, PhD|319-338-0581|mark-vanderweg@uiowa.edu|7717
295014|NCT01592708|UNC Chapel Hill|Dr. Jay Anderson, PI|919-966-5136|janderson@aims.unc.edu|
295015|NCT01592747|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
295016|NCT01592760|Universtiy of Wisconsin School of Medicine and Public Health|Richard E. Galgon, MD, MS|608-263-8100|galgon@wisc.edu|
295017|NCT01592773|Forest Research Institute|Joel Trugman, MD|201-427-8681|Joel.Trugman@frx.com|
295018|NCT01592786|Forest Research Institute|Joel Trugman, MD|201-427-8000|Joel.Trugman@frx.com|8681
295019|NCT01592799|GlaxoSmithKline|GSK Response Center|866-435-7343||
295020|NCT01592851|GlaxoSmithKline|GSK Response Center|866-435-7343||
295021|NCT01592864|GlaxoSmithKline|GSK Response Center|866-435-7343||
295022|NCT01593020|UT MD Anderson Cancer Center|Dr. Valero Vicente, Professor, Breast Medical Oncology|(713) 563-0751|vvalero@mdanderson.org|
306835|NCT02445586|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
306836|NCT02445625|University of Coimbra|Prof. Dr. Miguel Castelo-Branco|+351239790000|mcbranco@fmed.uc.pt|
270511|NCT00134004|Johns Hopkins University|Dr. Ephraim Fuchs|410-419-6479|fuchsep@jhmi.edu|
270512|NCT00134017|Johns Hopkins University|Leo Luznik, MD|4105027732|luznile@jhmi.edu|
270513|NCT00134043|The Ohio State University Comprehensive Cancer Center|Manisha Shah, MD|614-293-8629|manisha.shah@osumc.edu|
270514|NCT00134056|University of Southern California Norris Comprehensive Cancer Center|Dr. David I Quinn|3238653956|diquinn@med.usc.edu|
270515|NCT00134082|Johns Hopkins University|Richard Ambinder, MD|4109558839|rambind1@jhmi.edu|
270516|NCT00134381|UMDNJ-Robert Wood Johnson Medical School|Dr M Magliocco||maglioma@yahoo.com|
270517|NCT00134563|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
270518|NCT00134719|GlaxoSmithKline|GSK Response Center|866-435-7343||
270519|NCT00134784|Institute for Neurodegenerative Disorders|Principal Investigator|203 401 4300|kmarek@indd.org|
295023|NCT01593215|RegionSkane|Anders Rosengren|+4640391169|anders.rosengren@med.lu.se|
295024|NCT01593592|Tropical Medicine Departement, Faculty of Medicine, Zagazig University, Egypt|Dr Mohamed Emara|+2 0100 272 4482|emara_20007@yahoo.com|
306837|NCT02445755|Stanford University School of Medicine|Vinod K. Bhutani, MD|(650) 723-5711|bhutani@stanford.edu|
306838|NCT02445794|Retrotope, Inc|Frederic Heerinckx/VP Clinical Operations|650-437-0700|frederic@retrotope.com|109
306839|NCT02445807|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
306840|NCT02445859|The Universit yof Leeds|Andrew Kirby|0044 113 3923989|a.kirby@leeds.ac.uk|
306841|NCT02445911|Kaneq Bioscience Limited|Dr. Gosse Bruinsma|1-613-800-0955|gosse.bruinsma@kaneqbioscience.ca|
295025|NCT01593670|Masonic Cancer Center, University of Minnesota|Dr. Erica Warlick|612-625-5467|ewarlick@umn.edu|
295026|NCT01593696|National Cancer Institute|Dr. Nirali N. Shah|240-760-6199|shahnn@nih.gov|
295027|NCT01593722|Laboratory of Parasitic Diseases, NIAID, NIH|Dr. Amy Klion|301-435-8903|aklion@niaid.nih.gov|
295028|NCT01593748|MUSC|Cameron Coggins|843-792-4743|cogginca@musc.edu|
295029|NCT01593787|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
295030|NCT01593852|Catharina Hospital Eindhoven|Lukas Dekker, MD, PhD|+31 40 239 7000|lukas.dekker@catharina_ziekenhuis.nl|
295031|NCT01593917|Abbott Medical Devices, Structural Heart Divison|Clinical Scientist, Tissue Heart Valves|+1 651-756-2320|Roland.MaudeGriffin@Abbott.com|
295032|NCT01594125|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
306842|NCT02445963|Walter Reed Army Institute of Research (WRAIR) Clinical Trials Center (CTC)|Christopher Duplessis, MD|301-319-9047|Christopher.a.duplessis.mil@mail.mil|
306843|NCT02446015|Alcon, A Novartis Division|WW Medical Affairs Director, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
306844|NCT02446171|AstraZeneca AB|Ian Wogan|+1 301 398 0670|ClinicalTrialTransparency@astrazeneca.com|
306845|NCT02446223|Cosmetic Laser Dermatology/West Dermatology Research|Clinical Research Coordinator|858 657 1004|IGuiha@CLderm.com|
306846|NCT02446314|The University of Reading|Prof Claire Williams|0118 378 7540|claire.williams@reading.ac.uk|
306847|NCT02446418|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
306848|NCT02446483|GlaxoSmithKline|GSK Response Center|866-435-7343||
295033|NCT01594281|Novartis Pharmaceuticals|Study Director|1-862-778-8300|Novartis.email@novartis.com|
295034|NCT01594294|Alcon Research, Ltd.|Renee Garofalo, OD, FAAO|1-888-451-3937|alcon.medinfo@alcon.com|
295035|NCT01594333|Brigham & Women's Hospital|Dr. Paul Ridker and Dr. Robert Glynn|617-732-4965|pridker@bwh.harvard.edu|
295036|NCT01594385|St. Luke's University Health Network|Stanislaw P. Stawicki, M.D.|484-526-4426|stanislaw.stawicki@sluhn.org|
295037|NCT01594411|CardioDx, Inc.|EJ Fernandez, MD, CCRP - Sr. Manager Clinical Affairs|650-383-3350|jkuo@cardiodx.com|
282646|NCT00866294|GlaxoSmithKline|GSK Response Center|866-435-7343||
295038|NCT01594424|Cedars-Sinai Medical Center, Comprehensive Transplant Center|Jua Choi, PharmD|310-248-8186|jua.choi@cshs.org|
295039|NCT01594476|Oregon Health & Science University|Dr. Maureen Baldwin, MD MPH|(503) 494-9762|schaum@ohsu.edu|
306849|NCT02446496|GlaxoSmithKline|GSK Response Center|866-435-7343||
282647|NCT00866307|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
306850|NCT02446613|GlaxoSmithKline|GSK Response Center|866-435-7343||
306851|NCT02446691|GlaxoSmithKline|GSK Response Center|866-435-7343|sss42438@gsk.com|
306852|NCT02446717|AbbVie|Global Medical Services|800-633-9110||
306853|NCT02446743|GlaxoSmithKline|GSK Response Center|866-435-7343||
306854|NCT02446769|Philips|Chuck Cain|412-542-3605|chuck.cain@philips.com|
306855|NCT02446847|The Rockefeller University|Dr. Marina Caskey, Associate Professor of Clinical Investigation|212-327-7396|mcaskey@rockefeller.edu|
306856|NCT02446886|Weill Cornell Medicine|Research Coordinator|6469625736|liz4005@med.cornell.edu|
306857|NCT02446899|AstraZeneca AB|Global Clinical Lead|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
306858|NCT02446912|AstraZeneca AB|Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
295040|NCT01594515|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282648|NCT00866320|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
295041|NCT01594528|Centre Hospitalier Esquirol|Dr Murielle Girard|0033555431028|murielle.girard@ch-esquirol-limoges.fr|
295042|NCT01594749|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292575|NCT01435031|Abbott Vascular|Jennifer M Jones-McMeans, PhD (Associate Director Clinical Research)|408-845-1459|jennifer.jones@av.abbott.com|
306859|NCT02446990|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
306860|NCT02447003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
306861|NCT02447029|Stanford University|Klaira Lerma, MPH|(650) 721-1562|klairalerma@stanford.edu|
306862|NCT02447081|Abbott|Ryan Gage, Senior Scientist|651 756 3334|Ryan.Gage@abbott.com|
306863|NCT02447172|Innocoll|Charlene A. Tucker MS, Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
292576|NCT01435122|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jonathan R. Strosberg|813-745-3636|jonathan.strosberg@moffitt.org|
292577|NCT01435174|University of Michigan College of Pharmacy|Bruce A. Mueller|7346154578|muellerb@umich.edu|
292578|NCT01435265|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-7740|sfeldman@wakehealth.edu|
292579|NCT01435304|Maine Medical Center|Dr. Robert S Kramer|207-662-1486|Kramer@mmc.com|
295043|NCT01594762|Dipexium Pharmaceuticals, Inc|Robert J DeLuccia|+19145226503|delucciarj@gmail.com|
295044|NCT01594827|Johns Hopkins Unviversity School of Medicine|Dr. Mark Jennings|410-502-7044|mjenni15@jhmi.edu|
295045|NCT01594853|Kennedy Krieger Institute|Kathleen Zackowski|443-923-2716|zackowski@kennedykrieger.org|
295046|NCT01594931|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
295047|NCT01594970|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
295048|NCT01595282|PPLM|Principal Investigator|617-616-1600||
306864|NCT02447250|OHSU|Cindy McEvoy, MD|5034940223|mcevoyc@ohsu.edu|
306865|NCT02447302|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
306866|NCT02447328|AstraZeneca Korea|Karin Otter, MD, PhD|+82 2 2188 0968|Karin.Otter@astrazeneca.com|
306867|NCT02447432|GlaxoSmithKline|GSK Response Center|866-435-7343||
306868|NCT02447458|Takeda|Takeda Study Registration Call Center|+1-877-825-3327|medicalinformation@tpna.com|
306869|NCT02447497|3M|Nancy Klinger|651 491 9433|nmklinger@mmm.com|
306870|NCT02447575|Baylor College of Medicine|Dr. Nicola Hanania|(713) 873-3454|hanania@bcm.edu|
306871|NCT02447718|IWK Health Centre|Dr. Karina Top|902-470-6343|karina.top@dal.ca|
306872|NCT02447744|MGH|Dr. Sara Lazar|617-724-7108|slazar@mgh.harvard.edu|
306873|NCT02447848|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
295049|NCT01595386|University of Alabama at Birmingham, Pediatric Cardiac Critical Care|Jeffrey Alten, M.D., Director of Clinical and Translational Research Department|205-975-3123|jalten@peds.uab.edu|
295050|NCT01595438|AstraZeneca/ PPD|Gayan Makumburage|9105588682|gayan.makumburage@ppdi.com|
295051|NCT01595516|University of Colorado|Dr. Christopher DeSouza|303-492-2988|desouzac@colorado.edu|
295052|NCT01595529|Westat|Dr. Elizabeth Rowley|(919) 941-8325|ElizabethRowley@westat.com|
295053|NCT01595646|Wake Forest School of Medicine|Suzanne Craft, PhD|3366-713-8830|suzcraft@wakehealth.edu|
295054|NCT01595854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
295055|NCT01596062|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
306874|NCT02447926|Northwestern University|Dr. Josh Levitsky|312-695-4837|j-levitsky@northwestern.edu|
306875|NCT02447952|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
306876|NCT02447991|Mayo Clnic|Jeffrey Staab, MD|507-293-9438|staab.jeffrey@mayo.edu|
295056|NCT01596088|Kissei Pharmaceutical Co., Ltd|Clinical Development Division||rinsyousiken@pharm.kissei.co.jp|
295057|NCT01596127|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Associate Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
295058|NCT01596231|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
295059|NCT01596283|Memorial Sloan Kettering Cancer Center|Dr. Mary Fischer MD|212-639-6745|fischerm@mskcc.org|
295060|NCT01596335|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
295061|NCT01596504|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
295062|NCT01596582|Boston Medical Center|Paul C. Schroy III, MD, MPH|671-638-8335|paul.schroy@bmc.org|
295063|NCT01596595|Boston Scientific|Paji Vitoff, Manager, Clinical Trials|651-582-5415|Paji.Vitoff@bsci.com|
306877|NCT02448043|Department of Ophthalmology, Northwestern University Feinberg School of Medicine|Dr. David J. Palmer|3126958150|dpalmermd@comcast.net|
306878|NCT02448303|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
306879|NCT02448368|Ardea Biosciences, Inc.|Jesse Hall, MD|(858) 652-6672|JHall@ardeabio.com|
306880|NCT02448446|South Coast Retina Center|Dr. Julie Gasperini|5629847024|jgasperini@gmail.com|
295064|NCT01596699|University of California, San Francisco|Dr. Christopher Dvorak, MD|(415) 476-0554|Christopher.Dvorak@ucsf.edu|
295065|NCT01596751|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7070|Hope.Rugo@ucsf.edu|
295066|NCT01596842|Dong-A University|Professor|82-51-240-2811|anws@dau.ac.kr|
295067|NCT01596972|Planned Parenthood League of Massachusetts|Director of Clinical Research and Training|617.616.1600|agoldberg@pplm.org|
295068|NCT01597050|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
295069|NCT01597128|University of Kentucky Medical Center|J. Scott Roth, M.D.|859-323-6346|arockich@uky.edu|246
295070|NCT01597141|Maine Medical Center Research Institute|William R. McFarlane, M.D.|207-662-4348|mcfarw@mmc.org|
295071|NCT01597193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295072|NCT01597245|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295073|NCT01597258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295074|NCT01597375|Brigham and Women's Hospital|Tanya Laidlaw|617-525-1034|tlaidlaw@bwh.harvard.edu|
295075|NCT01597440|Children's National Health System|Dr. Mendel Tuchman||mtuchman@childrensnational.org|
295076|NCT01597479|Hospital de la Santa Creu i Sant Pau|Dra. Mireia Rodriguez Prieto|677896054|mrodriguezpr@santpau.cat|
295077|NCT01597492|GlaxoSmithKline|GSK Response Center|866-435-7343||
295078|NCT01597505|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295079|NCT01597557|University at Buffalo|Dr. Anne Curtis|716-859-4828|abcurtis@buffalo.edu|
295080|NCT01597596|Sanofi|Trial Transparency Team||Contact -US@sanofi.com|
295081|NCT01597622|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
295082|NCT01597635|GlaxoSmithKline|GSK Response Center|866-435-7343||
295083|NCT01597687|GlaxoSmithKline|GSK Response Center|866-435-7343||
306881|NCT02448537|Massachusetts General Hospital|Gregory Cote, M.D., Ph.D|617-724-4000|gcote@partners.org|
306882|NCT02448563|Boston Medical Center|Ashley McCarthy, Clinical Research Manager|617-638-5906|ashley.mccarthy@bmc.org|
306883|NCT02448641|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
306884|NCT02448654|Yale University|Elise E. DeVito, Ph.D./ Associate Research Scientist|203-737-4882|elise.devito@yale.edu|
306885|NCT02448706|Northwestern University|Pamela Souza|8474912433|p-souza@northwestern.edu|
306886|NCT02448719|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
306887|NCT02448771|Dana-Farber Cancer Institute|Rinath Jeselsohn|617.632.6887|rinath_jeselsohn@dfci.harvard.edu|
306888|NCT02448810|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
295084|NCT01597791|Northwestern University|Paul Fitzgerald|312-695-1064|p-fitzgerald2@northwestern.eud|
306889|NCT02448862|Gangnam Severance hospital, Seoul, Korea|Dr. Jae Chul Koh, MD|82-01087023931|aneskoh@yuhs.ac|
295085|NCT01597843|Clement J Zablocki VA Medical Center|Jeff Whittle, MD, MPH|414-384-2000|jeffrey.whittle@va.gov|46444
295086|NCT01597856|VA Connecticut/ Yale University|Christina Lazar|203-932-5711|Christina.Lazar@Yale.edu|4833
295087|NCT01597908|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
295088|NCT01597973|University of Michigan|Jolene Daniel|732 235-7713|jd1557@rwjms.rutgers.edu|
295089|NCT01598064|National Cheng Kung University Hospital|Dr. Po Lin Chen|886-2353535|n939492@mail.hosp.ncku.edu.tw|4733
295090|NCT01598090|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
295091|NCT01598129|Oncos Therapeutics|Director, Clinical Operations||info@oncos.com|
295092|NCT01598194|UT MD Anderson Cancer Center|Weston,Brian,MD / Gastroenterology Hepatology & Nutrition|713-792-7734|BWESTON@MDANDERSON.ORG|
295093|NCT01598207|Temple University|Dr. Ron Schey|215-707-9900|Ron.schey@tuhs.temple.edu|
295094|NCT01598298|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
306890|NCT02448875|Alcon Research|Senior Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
306891|NCT02448914|LobSor Pharmaceutical AB|Roger Bolsöy, CEO|+46 (0) 72 222 44 08|roger.bolsoy@lsmgroup.se|
306892|NCT02449018|Novartis Pharmaceuticals|Study Director|8627781873||
306893|NCT02449044|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
306894|NCT02449174|University of Texas School of Public Health|Dr. Herbert DuPont|713 500 9366|herbert.l.dupont@uth.tmc.edu|
306895|NCT02449291|Acacia Pharma Ltd|Gabriel Fox|01-223919764|gabrielfox@acaciapharma.com|
306896|NCT02449356|Xiangya Hospital|Jiali Shao|+8684327413|zwyfeng@163.com|
306897|NCT02449434|King's College London|Prof David Bartlett|02071887462|david.bartlett@kcl.ac.uk|
306898|NCT02449473|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
306899|NCT02449798|Bard Access Systems, Inc.|Gina Gilbert, BSN, RN|407-489-0935|Gina.Gilbert@crbard.com|
306900|NCT02449889|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
306901|NCT02449902|TherapeuticsMD|Shelli Graham, PhD|561-961-1900|Shelli.Graham@TherapeuticsMD.com|
306902|NCT02449915|TriHealth Inc.|Jennifer Yeung, DO|513-463-4300|Jennifer_Yeung@trihealth.com|
306903|NCT02450383|University of Iowa|Gustavo Avila-Ortiz|3193357241|gustavo-avila@uiowa.edu|
306904|NCT02450487|Bauru School of Dentistry University of Sao Paulo|Dr. Adriana Calvo|+551432358200|birinjela@yahoo.com.br|
306905|NCT02450526|Ipsen|Medical Director||clinical.trials@ipsen.com|
306906|NCT02450539|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
306907|NCT02450552|Massachusetts General Hospital - Neurological Clinical Research Institute|Protocol Investigator|617-726-2000|Brian.Wainger@MGH.HARVARD.EDU|
306908|NCT02450578|Medicines for Malaria Venture|Jörg Möhrle|+41 22 555 0330|moehrlej@mmv.org|
306909|NCT02450747|Johnson & Johnson Vision Care Inc.|Tom Karkkainen O.D., M.S., F.A.A.O- Sr. Research Principal Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
306910|NCT02450799|Alcon, A Novartis Division|Phase IV, Clinical and Regulatory Affairs, Alcon Japan|1-888-451-3937|alcon.medinfo@alcon.com|
306911|NCT02450903|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
306912|NCT02451007|Pharma Mar, S.A.|Clinical Development Department of PharmaMar's Oncology Business Unit|+34 91 846 60 00|clinicaltrials@pharmamar.com|
306913|NCT02451124|Case Comprehensive Cancer Center|Amitabh Chak|2168443217|axc22@cwru.edu|
306914|NCT02451137|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
295095|NCT01598311|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295096|NCT01598350|University of Puget Sound|Julia Looper, PT PhD|253 879 2895|jlooper@pugetsound.edu|
295097|NCT01598428|Shandong University|Dr.Yang Gao|0086-543-89268587|pinkapples@126.com|
295098|NCT01598506|Emory University|Dr. Grant Lynde|404-778-3900|glynde@emory.edu|
295099|NCT01598532|Spaulding Rehabilitation Hospital|Ross D. Zafonte, DO|617-952-5227|rzafonte@partners.org|
295100|NCT01598545|Emory University|Dr. Grant Lynde|404-778-3900|glynde@emory.edu|
295101|NCT01598610|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
295102|NCT01598662|University Louisville|Nancy Alsip|502-852-2905|nancy.alsip@louisville.edu|
306915|NCT02451150|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
270520|NCT00134901|New York State Psychiatric Institute|Dr Adam Bisaga|(646) 774-6155|bisagaa@nyspi.columbia.edu|
270521|NCT00135200|University of Michigan Comprehensive Cancer Center|Dr. Mark Kaminski, M.D.|(734) 936-5310|mkaminsk@umich.edu|
270522|NCT00135226|Nuffield Department of Population Health|Prof Jane Armitage|+44 (0)1865 743743|ascend@ndph.ox.ac.uk|
295103|NCT01598701|University of Texas Health Science Center at Houston|Carlos Artime, MD|713-500-6200|Carlos.Artime@uth.tmc.edu|
270523|NCT00135330|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
295104|NCT01598740|Sorbent Therapeutics, Inc.|Howard Dittrich, MD|858-405-1429|hdittrich@sorbent.com|
306916|NCT02451202|Department of Anesthesiology, King Chulalongkorn Memorial Hospital|Dr. Prok Laosuwan|+66 2256 4295|plaospir@yahoo.com|
306917|NCT02451358|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
306918|NCT02451488|Mayo Clinic|Dr. James Jakub|507-284-3629|Jakub.James@mayo.edu|
306919|NCT02451514|GlaxoSmithKline|GSK Response Center|866-435-7343||
295105|NCT01598753|University of Washington|Dennis C. Turk, Ph.D.|(206)616-2626|turkdc@uw.edu|
295106|NCT01598779|University of Buenos Aires|Dr. Laura Fleider|541159508000|laurafleider@hotmail.com|8582
295107|NCT01598831|Asahi Kasei Pharma America Corp.|Director of Clinical Operations|(781) 419-1919|pallton@akpamerica.com|
295108|NCT01598896|Beth Israel Deaconess Medical Center|Dr. Kevin Hill|617-667-1504|khill1@bidmc.harvard.edu|
295109|NCT01598922|McLean Hospital|Dr.Isabelle Rosso|6178552607|irosso@partners.org|
295110|NCT01598987|Novartis Pharmaceuticals|Study Director|862-778-8300||
295111|NCT01599104|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
295112|NCT01599234|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
295113|NCT01599286|Children's National Hospital|Robert McCarter|202-476-3140|RMcCarte@childrensnational.org|
295114|NCT01599325|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
295115|NCT01599585|National Center for Telehealth and Technology|Larry D. Pruitt, PhD|253-968-2946|larry.d.pruitt21.civ@mail.mil|
295116|NCT01599637|Novartis Pharmaceuticals|Study Director|862-778-8300||
295117|NCT01599650|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
295118|NCT01599741|Philips|Thijs Grunhagen|+31 6 11645166|thijs.grunhagen@philips.com|
295119|NCT01599754|SFJ Pharmaceuticals|Stewart Hallett|19252011003|stewart.hallett@sfj-pharma.com|
295120|NCT01599793|University of Chicago|Russell Szmulewitz, MD|773-702-7609|rszmulew@medicine.bsd.uchicago.edu|
295121|NCT01599806|AstraZeneca/ PPD|Gayan Makumburage|9105588682|gayan.makumburage@ppdi.com|
306920|NCT02451670|HealthPartnersInstitute|Rebecca Rossom|952-883-5466|Rebecca.C.Rossom@HealthPartners.com|
306921|NCT02451696|NYU Langone|Dr. Orrin Devinsky|646-558-0800|od4@nyu.edu|
306922|NCT02451839|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
306923|NCT02451917|Endocrinology Division, University of São Paulo Medical School,|Marcia Silva Queiroz, MD, PhD|+ 5511 26616293|marcia.queiroz@hc.fm.usp.br|
306924|NCT02451930|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
306925|NCT02451943|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
306926|NCT02451995|Imperial College Healthcare|Dr Vishal Luther|07828913612|v.luther14@imperial.ac.uk|
306927|NCT02452034|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295122|NCT01599832|University of Chicago Comprehensive Cancer Center|Walter Stadler|(773) 702-4150|wstadler@medicine.bsd.uchicago.edu|
295123|NCT01600014|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
295124|NCT01600053|University of California, San Diego|Thomas Kipps, MD|(858) 534-5400|tkipps@ucsd.edu|
295125|NCT01600092|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295126|NCT01600105|Icahn School of Medicine at Mount Sinai|Dr. Bachir Taouli|212-824-8475|bachir.taouli@mountsinai.org|
295127|NCT01600170|University of Pennsylvania School of Medicine|Ronald G Collman|215-898-0913|collmanr@pennmedicine.upenn.edu|
295128|NCT01600222|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
295129|NCT01600287|Postgraduate Institute of Medical Education and Research|Dr G D Puri|00919914209509|gdpuri007@hotmail.com|
295130|NCT01600326|University of Michigan|Jon Jacobson|734 936-4365|jjacobsn@umich.edu|
295131|NCT01600482|Vasorum Ltd|Dr James Coleman|00 353 1 4035460|jcoleman@vasorum.ie|
295132|NCT01600495|University of São Paulo.|Prof. Alessandra Cristina Marcolin|Tel.: (16) 36022587|dralemar@uol.com.br|55 +
295133|NCT01600586|Vanderbilt University|Olena Chorna|850-508-5571|olena.chorna@vanderbilt.edu|
306928|NCT02452047|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
306929|NCT02452060|NYU Langone Medical Center|Jing Wang|212-460-0176|jing.wang@nyulangone.org|
306930|NCT02452190|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
306931|NCT02452320|Weill Cornell Medicine|Farrell Cooke, Senior Research Assistant|212-746-2774|fac2010@med.cornell.edu|
306932|NCT02452346|Weill Cornell Medicine|Dr. Sangmin Lee, MD|646-962-2700|sal9053@med.cornell.edu|
282649|NCT00866333|Syndax Pharmaceuticals, Inc.|Michael L. Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
282650|NCT00866359|Celgene Corporation|Anne McClain|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
295134|NCT01600638|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
295135|NCT01600677|UPittsburgh|Steven M. Handler, MD, PhD|412-864-1878|handler@pitt.edu|
295136|NCT01600703|University Health Network|Dr. Gary Lewis|416-340-4270|gary.lewis@uhn.ca|
295137|NCT01600716|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
295138|NCT01600729|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
282651|NCT00866606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270524|NCT00135356|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
270525|NCT00135512|GlaxoSmithKline|GSK Response Center|866-435-7343||
270526|NCT00135694|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
270527|NCT00135707|Dept of Obstetrics and Gynecology, University of Pittsburgh|Dr. James Roberts|412-641-1427|RSIJMR@mwri.magee.edu|
270528|NCT00135798|University Colorado, Denver|Gregory T. Everson, M.D., Director of Hepatology|720-848-2245|greg.everson@UCDenver.edu|
270529|NCT00136084|St. Jude Children's Research Hospital|Jeffrey Rubnitz, M.D|1-866-278-5833|info@stjude.org|
270530|NCT00136214|BIDMC|Nezam Afdhal|617632118|nafdhal@bidmc.harvard.edu|
270531|NCT00136318|Kliniken Essen-Mitte, Department of Psychiatry|Professor Dr. Martin Schaefer|+49201-17430001|m.schaefer@kliniken-essen-mitte.de|
270532|NCT00136357|The Center for Mind-Body Medicine|Dr. James Gordon|202-966-7338|jgordon@cmbm.ort|
270533|NCT00136604|GlaxoSmithKline|GSK Response Center|866-435-7343||
270534|NCT00136695|Massachusetts General Hospital|Dr. Benjamin Leder|617-726-6723|bzleder@partners.org|
270535|NCT00136760|Brown University|Jennifer Tidey, Ph.D.|401-863-6418|Jennifer_Tidey@brown.edu|
270536|NCT00136812|Stanord University|Judith Prochaska, PhD, MPH; Associate Professor|650-724-3608|JPro@stanford.edu|
270537|NCT00136838|New York State Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|bisagaa@nyspi.columbia.edu|
270538|NCT00136916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
282652|NCT00866619|GlaxoSmithKline|GSK Response Center|866-435-7343||
282653|NCT00866658|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
282654|NCT00866697|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
282655|NCT00866723|Dana-Farber Cancer Institute|Panagiotis Konstantinopoulos|(617) 632-5269|panagiotisa_konstantinopoulos@dfci.harvard.edu|
282656|NCT00866749|The University of Texas MD Anderson Cancer Center|Michael Andreeff MD./Professor|713-792-7261|mandreeff@mdanderson.org|
282657|NCT00866775|Sunovion Phamaceuticals Inc.|Eslicarbazepine acetate Medical Director|866-503-7813|clinicaltrialsdisclosure@sunovion.com|
295139|NCT01600885|Yale University|John Krystal, MD|203-785-6396|john.krystal@yale.edu|
295140|NCT01600950|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295141|NCT01601067|VA San Diego|Sonya Norman, PhD|858-552-8585|sonya.norman@va.gov|
295142|NCT01601132|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
295143|NCT01601236|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
295144|NCT01601431|Baylor College of Medicine|Mohamed Othman, M.D.|713 798 0947|mohamed.othman@bcm.edu|
295145|NCT01601470|Novartis Pharmaceuticals|Study Director|862-778-8300||
306933|NCT02452424|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
295146|NCT01601496|Getinge Group|Elizabeth Bulger|603 880 1433 ext 5368|Elizabeth.Bulger@getinge.com|
306934|NCT02452463|Roswell Park|CTRP/CT.gov Registry Coordnator|716-845-1073|KIM.BROSIUS@ROSWELLPARK.ORG|
295147|NCT01601535|New Approaches to Neuroblastoma Therapy|NANT Medical Director|323-361-5687|nantops@chla.usc.edu|
306935|NCT02452476|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+39 0521 2791|clinicaltrials_info@chiesi.com|
306936|NCT02452528|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
306937|NCT02452762|Children's Hospital of Eastern Ontario|James Dayre McNally, Principal Investigator and Pediatric Intensivist|613-737-7600|dmcnally@cheo.on.ca|3553
306938|NCT02452866|Symbiomix Therapeutics|VP Clinical Operations|609-722-7250|nadetoro@symbiomix.com|112
306939|NCT02452892|Tal Medical|Dr. Atul Pande, MD, Chief Medical Officer||apande@talmedical.com|
306940|NCT02452931|Tolmar, Inc.|Vice President of Clinical Development|970-212-4500|info@tolmar.com|
306941|NCT02452944|Department of Anesthesiology, Gachon University Gil Hospital|Mi Geum Lee|82-32-460-3637|mikeum2@gilhospital.com|
295148|NCT01601626|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
306942|NCT02453048|ILIAD Biotechnologies|Ken Solovay|9543360777|ken@iliadbio.com|
306943|NCT02453113|UC Irvine|Kristen Kelly|949 824 5515|kmkelly@uci.edu|
306944|NCT02453191|University of Iowa|Varun Monga, MD|319-384-9497|varun-monga@uiowa.edu|
295149|NCT01601652|UC Davis|Arthur J de Lorimier, Director of Pediatric Gastroenterology|916-734-3112|adelorimier@ucdavis.edu|
295150|NCT01601691|Oulu University Hospital|Dr. Markku Vaarala|+3588315|markku.h.vaarala@ppshp.fi|2840
295151|NCT01601704|Orexigen Therapeutics, Inc.|Global Head of Development|858-875-8600|MedInfo@Orexigen.com|
295152|NCT01601782|University of Michigan|Jon Jacobson, MD|734-936-4365|jjacobsn@umich.edu|
295153|NCT01601821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295154|NCT01601847|Case Western Reserve University|Dr. Anna Maria Hibbs|216-844-3387|annamaria.hibbs@cwru.edu|
295155|NCT01601860|University of São Paulo|Dra. Alessandra Cristina Marcolin|+55(16)36022813|dralemar@uol.com.br|
306945|NCT02453256|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
295156|NCT01601873|The University of Texas Health Science Center at Houston|Kristofer Charlton-Ouw, MD|(713) 486-5117|Kristofer.CharltonOuw@uth.tmc.edu|
295157|NCT01601977|GSTT|Gill Arbane, Clinical trials coordinator|02071888070|gill.arbane@gstt.nhs.uk|
306946|NCT02453282|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
306947|NCT02453321|University of Pittsburgh Medical Center|Kevin King, DO - Clinical Asst. Professor|412 748-5589|kingkk@upmc.edu|
306948|NCT02453334|American Regent, Inc|Mark A. Falone, MD MPH|631-772-3544|mfalone@americanregent.com|61844
295158|NCT01602068|Eyegate Pharmaceuticals, Inc.|Lisa Brandano|781-398-3806|lbrandano@eyegatepharma.com|
295159|NCT01602120|Hoffmann-La Roche|Medical Communications|800 821 - 8590|genentech@druginfo.com|
295160|NCT01602172|VA Pittsburgh Healthcare System|Lauren M. Broyles, PhD, RN|412-360-2269|Lauren.Broyles@va.gov|
295161|NCT01602224|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295162|NCT01602315|Novartis Pharmaceuticals|Study Director|862-778-8300||
295163|NCT01602341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295164|NCT01602380|AstraZeneca|Global Clinical Lead||ClinicalTrialTransparency@astrazeneca.com|
295165|NCT01602419|Octapharma AG|Sigurd Knaub/SVP CR&D Haematology|+41 55 4512141|Sigurd.Knaub@octapharma.com|
295166|NCT01602484|Brigham and Women's Hospital|Dr. Eric Bluman|6179837363|ebluman@partners.org|
295167|NCT01602510|GlaxoSmithKline|GSK Response Center|866-435-7343||
270539|NCT00136955|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270540|NCT00137046|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
295168|NCT01602549|GlaxoSmithKline|GSK Response Center|866-435-7343||
270541|NCT00137111|St. Jude Children's Research Hospital|Ching-Hon Pui|1-866-278-5833|info@stjude.org|
270542|NCT00137267|Bedford VA Medical Center|Dr. David Smelson|781-687-2845|david.smelson@va.gov|
270543|NCT00137280|Greater Los Angeles Veterans Healthcare Center|Dr. Alexander S. Young|310-268-3416|alexander.young@va.gov|
270544|NCT00137423|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270545|NCT00137436|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270546|NCT00137449|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270547|NCT00137631|Department of Human Development, State University of New York at Binghamton|Leo Wilton, PhD|607-777-9215|lwilton@binghamton.edu|
270548|NCT00137839|Dana-Farber Cancer Institute|David Jackman, MD|617-632-6049|DJACKMAN@PARTNERS.ORG|
270549|NCT00137969|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
270550|NCT00138034|Radboud University Medical Center Nijmegen|Professor Doctor F.W.A. Verheugt|+31(0)24-3614533|f.verheugt@cardio.umcn.nl|
295169|NCT01602562|GlaxoSmithKline|GSK Response Center|866-435-7343||
295170|NCT01602614|University of Alabama at Birmingham|David Kimberlin, MD|205 934-2424|Dkimberlin@peds.uab.edu|
306949|NCT02453347|Audie L. Murphy Veterans Administration Hospital|Dr. Carlos Jaramillo|210-617-5300|jaramilloc3@uthscsa.edu|15773
306950|NCT02453360|University of Wisconsin School of Medicine|Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
306951|NCT02453386|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|914-326-5775|ckenney@acorda.com|
306952|NCT02453555|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
306953|NCT02453581|Qeensland Institute of Medical Research|Dr James McCarthy|+61 7 3845 3796|James.McCarthy@qimr.edu.au|
306954|NCT02453672|Samsung Bioepis|Director of Clinical Development|+82 31 8061 4534|sbregistry@samsung.com|
306955|NCT02453685|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
306956|NCT02453711|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
306957|NCT02453750|SickKids|Dr Theo Moraes|416 813 2196|theo.moraes@sickkids.ca|
306958|NCT02453841|Nationwide Children's Hospital|Richard Cartabuke, MD|614-722-4200|Richard.Cartabuke@nationwidechildrens.org|
306959|NCT02454075|Trio Medicines|Dr Malcolm Boyce|020 8961 4130|mboyce@hmrlondon.com|
306960|NCT02454101|AinShamsU|ahmed kotb|0100868199|ahmedmkotp@hotmail.com|+2
306961|NCT02454127|Tufts Medical Center|Michael Dansinger, MD|617-636-5000|mdansinger@tuftsmedicalcenter.org|
306962|NCT02454153|Johns Hopkins University|Naresh M. Punjabi|410-550-6487|npunjabi@jhmi.edu|
295171|NCT01602679|University of Virginia Center for Research in Reproduction|Dr. Christopher R. McCartney|4342430329|cm2hq@virginia.edu|
295172|NCT01602692|University of Wisconsin - Madison|Dr. Venkat Rao|(608) 263-1223|rao@surgery.wisc.edu|
295173|NCT01602731|VA Loma Linda Healthcare System|Dr. Helme Silvet, cardiologist|9095836097|helme.silvet@va.gov|
295174|NCT01602744|Tel Aviv University|Dvora Frankenthal|0097235326835|shai_f@zahav.net.il|
295175|NCT01602965|Istituto Ortopedico Rizzoli|Mariela Terrafino|0516366694|cristiana.forni@ior.it|0039
295176|NCT01603056|ALK-Abelló A/S|Vivian Wang, Sr. Medical Affairs Manager|86 - 10 5166 8198|Vivian.Wang@alk.net|
295177|NCT01603082|AstraZeneca|Tomas LG Andersson, MD, PhD|1-800-236-9393|ClinicalTrialTransparency@astrazeneca.com|
295178|NCT01603277|KaloBios Pharmaceuticals Inc.|Nestor Molfino, MD|650-243-3100|nmolfino@kalobios.com|
295179|NCT01603355|Oregon Health & Science University|Dr. Eric Suhler|503-494-5023|suhlere@ohsu.edu|
295180|NCT01603368|University of Linköping|Thomas Abrahamsson, MD PhD|+46.10.1030000|thomas.abrahamsson@liu.se|
295181|NCT01603420|The Proton Collaborative Group|Corey Woods|630-836-8668|cwoods@pcgresearch.org|
295182|NCT01603459|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
271750|NCT00262821|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
295183|NCT01603602|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@Allergan.com|
295184|NCT01603615|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
306963|NCT02454179|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
306964|NCT02454283|Laguna Pharmaceuticals|Chief Medical Officer|858-405-1429|hdittrich@imager.com|
306965|NCT02454296|University of Hawaii|Reni Soon, MD|808-203-6548|rsoon@hawaii.edu|
306966|NCT02454478|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
306967|NCT02454530|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
306968|NCT02454608|Massachusetts Eye and Ear Infirmary|Benjamin Bleier|(617) 573-6966|Benjamin_Bleier@MEEI.HARVARD.EDU|
306969|NCT02454959|Pearl Therapeutics, Inc.|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
306970|NCT02454972|Pharma Mar S.A.|Clinical Development, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
306971|NCT02455050|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
306972|NCT02455076|Emory University|Guillermo Umpierrez|(404)778-1665|geumpie@emory.edu|
306973|NCT02455167|"University of Colorado Denver | Anschutz"|Amanda Wieland, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
306974|NCT02455336|James J. Peters VA Medical Center|Michael F. La Fountaine, EdD, ATC, FACSM|718-584-9000|michael.lafountaine@va.gov|3121
306975|NCT02455388|Virginia Tech|Dr. Brenda Davy|540-231-6784|bdavy@vt.edu|
306976|NCT02455453|Washington University School of Medicine|Farrokh Dehdashti, M.D.|314-747-1604|dehdashtif@wustl.edu|
306977|NCT02455518|Albany Medical College|Dr. Andrew Chang|2125555555|achang3@yahoo.com|
306978|NCT02455557|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
295185|NCT01603628|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
295186|NCT01603641|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
295187|NCT01603875|Queen Saovabha Memorial Institute|Dr. Terapong Tantawichien|66225201614|terapong_tantawichien@hotmail.com|125
295188|NCT01603940|Hospital Universitario Pedro Ernesto (UERJ)|Ronaldo Altenburg Gismondi, MD, PhD|+5521996092383|ronaldogismondi@gmail.com|
295189|NCT01604109|ThammasatU|Thanya Sitthisettapong|6629869213|thanyasang@yahoo.com|7150
295190|NCT01604122|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295191|NCT01604265|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
295192|NCT01604278|Novartis Pharmaceuticals|Study Director|862-778-8300||
295193|NCT01604291|Hoffmann-La Roche|Medical Communications|800-821-8590|Genentech@druginfo.com|
306979|NCT02456103|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
306980|NCT02456636|University of Kansas Medical Center|Christie Befort, PhD|913 588-3338|cbefort@kumc.edu|
306981|NCT02456662|University of Rochester|Sarah Betstadt, MD, MPH|585-276-5367|sarah_betstadt@urmc.rochester.edu|
306982|NCT02456727|Albert Einstein College of Medicine|Diane McKee|718-430-2952|Diane.Mckee@einstein.yu.edu|
306983|NCT02456740|Amgen Inc.|Study Director|866-572-6436||
306984|NCT02456896|AIIMS, Bhubaneswar, India|Dr. Rituparna Maiti|9438884191|rituparnamaiti@gmail.com|
295194|NCT01604343|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
306985|NCT02456909|Medical College of Wisconsin|Keri R. Hainsworth, PhD|414-266-6306|khainswo@mcw.edu|
295195|NCT01604408|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295196|NCT01604772|Memorial Sloan Kettering Cancer Center|Alan Ho, M.D.||hoa@mskcc.org|
295197|NCT01604785|Oregon Health & Science University|David Sheridan|503 494-8311|sheridda@ohsu.edu|
295198|NCT01604824|Regeneron Pharmaceuticals|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
295199|NCT01604850|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
295200|NCT01604941|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
295201|NCT01605032|Albert Einstein College of Medicine/Montefiore Medical Center|Ira Braunschweig, MD|718-920-4057|IBRAUNSC@montefiore.org|
295202|NCT01605071|University of Colorado Denver, Anschutz Medical Campus|Kimberly Cox-York||KIMBERLY.COX-YORK@CUANSCHUTZ.EDU|
295203|NCT01605097|BC Cancer|Dr Juanita Crook|250 712 3958|jcrook@bccancer.bc.ca|
270551|NCT00138125|University of California at Los Angeles|Richard J. Pietras, M.D. Ph.D|310 825 9769|rpietras@ucla.edu|
270552|NCT00138203|University of Wisconsin Carbone Cancer Center|Dr. Anne Traynor|(608) 262-8158|amt@medicine.wisc.edu|
270553|NCT00138294|Baylor College of Medicine|Pedro A Piedra, MD|713-798-5240|ppiedra@bcm.edu|
270554|NCT00138424|Collaborative Antiviral Study Group|Penelope Jester, BSN,MPH,CCRC|(205) 877-975-7280|PJester@peds.uab.edu|
270555|NCT00138645|Pennington Biomedical Research Center|Corby K. Martin, Ph.D.; Assistant Professor|225-763-2585|martinck@pbrc.edu|
270556|NCT00138658|OncoGenex Pharmaceuticals|Dr. Patricia Stewart, Vice President Medical Affairs|425-686-1500|psstewartmd@oncogenex.com|
270557|NCT00138671|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270558|NCT00139399|Imperial College London|Dr Carolyn Webb|03301288860|c.webb@imperial.ac.uk|
270559|NCT00139477|Nemours Children's Clinic|Dr. Nelly Mauras, Chief, Division of Endocrinology|904-697-3674|nmauras@nemours.org|
270560|NCT00139659|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
306986|NCT02457065|Dartmouth-Hitchcock Medical Center|Michael S Chapman, MD|(603) 650-5000|Michael.Shane.Chapman@hitchcock.org|
306987|NCT02457182|University of New Mexico|Gregg Kanter, MD|818-599-3456|greggkanter@gmail.com|
306988|NCT02457195|The Pennsylvania State University College of Medicine|Dr. Piotr Janicki|7175315680|pjanicki@pennstatehealth.psu.edu|
306989|NCT02457247|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
306990|NCT02457260|University of Pittsburgh|Daniel E. Forman - Chief of a section of Geriatrics Cardiology|412-864-2507|formand@pitt.edu|
306991|NCT02457325|University of Sao Paulo / Bauru School of Dentistry|Carlos Ferreira Santos|+551432358200|cfsantos@fob.usp.br|
295204|NCT01605136|Clinuvel Inc.|Dr. Dennis Wright|646 527 7310|Dennis.Wright@clinuvel.com|170
295205|NCT01605227|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
295206|NCT01605292|Long Beach VA Medical Center|Arnold Seto, MD, MPA|(562) 826-8000|arnold.seto@va.gov|5486
295207|NCT01605396|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295208|NCT01605435|University of Pennsylvania|Dr. Anne Cappola, PI|215-573-5359|acappola@mail.med.upenn.edu|
295209|NCT01605461|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
295210|NCT01605539|Icahn School of Medicine at Mount Sinai|Yasmin Hurd, PhD|212-824-9314|yasmin.hurd@mssm.edu|
295211|NCT01605552|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, Ph.D.|(317) 274-6761|jstew@iupui.edu|
295212|NCT01605669|Naval Medical Center San Deigo|LCDR William Bennett MD FACC|619-532-7400|william.bennett5@med.navy.mil|
295213|NCT01605799|San Francisco VA Medical Center|Dr. Shira Maguen|415-221-4810|shira.maguen@va.gov|22511
306992|NCT02457403|The Ohio State University|A James Hanje|614 293 6255|james.hanje@osumc.edu|
306993|NCT02457520|SPIL|Clinical Trials|912266455645|Clinical.Trials@sparcmail.com|
306994|NCT02457546|Ethicon, Inc.|Richard Kocharian, MD, PhD|1-908-218-2013|rkochar1@its.jnj.com|
306995|NCT02457611|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
306996|NCT02457637|Renji Hospital, Shanghai Jiao Tong University School of Medical|Professor Hai Li , Director of Clinical Trials|+86-13818525494|haili＿17@126.cpm|
306997|NCT02457728|St John of God Hospital Vienna|Bernhard Dauser, MD, PhD|+4321121|b.dauser@hotmail.com|5098
306998|NCT02457793|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
306999|NCT02457819|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
307000|NCT02457897|NIDDK|Dr. Rebecca Brown|301-594-0609|Rebecca.Brown@NIH.gov|
307001|NCT02458092|US Army Medical Research Unit - Kenya|Nekoye Otsyula|254-722-239-828|notsyula@wrp-ksm.org|
307002|NCT02458235|University of California, San Francisco|Dr. Christopher Dvorak, MD|(415) 476-0554|Christopher.Dvorak@ucsf.edu|
307003|NCT02458287|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
307004|NCT02458352|University Hospital Zurich|Dr. Ronny Buechel|0041442551059|ronny.buechel@usz.ch|
307005|NCT02458365|Pro-Change Behavior Systems, Inc.|Deborah Levesque, Ph.D.|(401) 360-2975|dlevesque@prochange.com|
307006|NCT02458469|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
307007|NCT02458638|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
307008|NCT02458690|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, PhD., Principal Investigator|317-274-6761|jstew@iupui.edu|
307009|NCT02458768|LG Life Sciences|Jonghee Jin|82-2-6924-3122|jonghee@lgls.com|
295214|NCT01605825|Acorda Therapeutics, Inc.|Study Director|914-347-4300||
295215|NCT01605877|Alcon Japan, Ltd.|Hiroshi Kodama, Group Manager|81-3-6899-5000||
295216|NCT01605890|Hopital Bichat-Claude Bernard, AP-HP, Paris, France|Pr Sophie Matheron|+33140257883|sophie.matheron@aphp.fr|
295217|NCT01605903|Massachusetts Eye and Ear Infirmar|Gillian Diercks, MD, MPH|617-573-3190|gillian_diercks@meei.harvard.edu|
295218|NCT01605916|Biometrics Department, Science Affairs Division, R&D, Astrazeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
295219|NCT01605942|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
295220|NCT01606007|AstraZeneca Pharmaceuticals|Boaz Hirshberg||ClinicalTrialTransparency@astrazeneca.com|
295221|NCT01606124|Mayo Clinic|Frank A. Sinicrope, M.D.|507-284-2511|sinicrope.frank@mayo.edu|
307010|NCT02459093|Stony Brook Medicine|Dr David Garry|631-444-7650|david.garry@stonybrookmedicine.edu|
307011|NCT02459119|Dana Farber Cancer Institute|Dr. Guru Sonpavde, MD|617-632-2429|gsonpavde@gmail.com|
307012|NCT02459197|Tools4Patient|Chief Scientific Officer|+32 71 91|alvaro.pereira@tools4patient.com|94 00
307013|NCT02459262|MinervaX ApS|Per Fisher DPhil|+45 20 25 20 38|pbf@minervax.com|
307014|NCT02459275|University of Miami|Dr. D. Dante Yeh|305-585-1822|dxy154@med.miami.edu|
307015|NCT02459418|Fertility Biotech AG|Executive VP of Regulatory Affairs||maria.vazquez@fertilitybiotech.com|
307016|NCT02459587|Veterans Health Administration|Dr. Mark Ilgen|7349366266|mark.ilgen@va.gov|
307017|NCT02459665|University of Liverpool|Prof. Janneke van de Wijgert, Chief Investigator|+447557195108|j.vandewijgert@liverpool.ac.uk|
307018|NCT02459795|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
271751|NCT00262834|SKCCC|Vered Stearns|4432876489|vstearn1@jhmi.edu|
271752|NCT00262847|Gynecologic Oncology Group (GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
307019|NCT02459899|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
295222|NCT01606137|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
295223|NCT01606176|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
295224|NCT01606189|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
295225|NCT01606202|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
295226|NCT01606228|Janssen China|Medical Affairs Director, CNS, Asia Pacific|8610 5821 8766||
295227|NCT01606254|Janssen Pharm KK Japan|Medical Director|81-3-4411||5509
295228|NCT01606306|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.573.0336|dmauger@psu.edu|
295229|NCT01606319|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.573.0336|dmauger@psu.edu|
295230|NCT01606670|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
307020|NCT02459951|Albert Einstein Healthcare Network|Nathaniel Mayer MD|215 663 6681|nmayer@einstein.edu|
307021|NCT02459964|UT MD Anderson Cancer Center|Sai-Ching J. Yeung, MD, Professor, Emergency Medicine|(713) 745-9911|syeung@mdanderson.org|
307022|NCT02460172|ZipLine Medical|Wendy Winters, Clinical Project Manager|408-506-1866|wwinters0@gmail.com|
307023|NCT02460198|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307024|NCT02460263|Outset Medical, Inc|Clinical Operations|(669) 231-8200|clinical@outsetmedical.com|
307025|NCT02460380|Maimonides Medical Center|Mohamad Irani|3472862167|mohamad.irani@hotmail.com|
307026|NCT02460458|Hematology and Transfusion Medicine, L. Sacco University Hospital Department of Clinical & Community Sciences, University of Milan, Via Pace, 9 20122 Milan, Italy|Prof. Augusto B. Federici|+39-0250319895|augusto.federici@unimi.it|
307027|NCT02460562|Faculty of Dentistry, Thammasat University|Dr. Kritirat Kiatsirirote|662-9869213-5|kkritirat@yahoo.com|7150
307028|NCT02460575|Tulane University|Dr. Richard Oberhelman|504-988-2511|oberhel@tulane.edu|
295231|NCT01606735|Icon Bioscience, Inc|Wendy Murahashi, MD|6503694049|wendymurahashi@iconbioscience.com|
295232|NCT01606748|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295233|NCT01606761|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
295234|NCT01606787|Memorial Sloan Kettering Cancer Center|Dr. Jonathan Coleman, MD|646-422-4432|colemanj@mskcc.org|
307029|NCT02460666|University of California, Los Angeles|Helen Lavretsky, MD|(310) 794-4619|HLavretsky@mednet.ucla.edu|
307030|NCT02460679|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
307031|NCT02460822|University of Michigan|Dr. Lawrence C. An|734-763-6099|lcan@med.umich.edu|
307032|NCT02460978|AstraZeneca|Anna Maria Langkilde|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
307033|NCT02460991|Boston Scientific|Kristi Winterfeldt|763-494-1165|kristi.winterfeldt@bsci.com|
271753|NCT00262860|University of Rochester|Jonathan W. Friedberg|585-273-4150|jonathan_friedberg@urmc.rochester.edu|
271754|NCT00262873|University of Rochester|Jane Liesveld, M.D.|585-275-4099|Jane_Liesveld@urmc.rochester.edu|
271755|NCT00262925|ECOG Statistical Office|Study Statistician|617-632-3012||
271756|NCT00262951|University of Minnesota, Masonic Cancer Center|Edward Greeno, M.D.|612-626-6418|green049@umn.edu|
271757|NCT00262964|Washington University School of Medicine|Elisa Fabbrini, MD|314-362-8156|efabbrini@dom.wustl.edu|
271758|NCT00263211|Department of Medicine Div. of Oncology, Washington University School of Medicine St. Louis MO|Katherine Weilbacher, M.D,|Fax: 314-454-8973|kweiblac@dom.wustl.edu|
271759|NCT00263328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271760|NCT00263562|Baylor College of Medicine|Andrea T. Cruz, MD, MPh|832-824-5582|acruz@bcm.edu|
271761|NCT00263575|Strakan Pharmaceuticals Ltd|Fiona Miller|01896 66868|fiona.miller@prostrakan.com|
271762|NCT00263588|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
271763|NCT00263666|GlaxoSmithKline|GSK Response Center|866-435-7343||
271764|NCT00263757|Mayo Clinic|Dr. Sean M. Caples|507-293-1031|Caples.Sean@mayo.edu|
271765|NCT00263887|Talecris Biotherapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
271766|NCT00264004|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
271767|NCT00264238|Stanford University School of Medicine, Dept of Psychiatry|Dr John Barry, Professor|(650) 725-5588|jbarry@stanford.edu|
271768|NCT00264290|University of California, San Francisco|Peter W. Hunt, M.D.|415-476-4082|phunt@php.ucsf.edu|345
271769|NCT00264303|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
271770|NCT00264381|University of Oklahoma Health Sciences Center|Suman Rathbun MD,MS|405271-4742|suman-rathbun@ouhsc.edu|44773
271771|NCT00264498|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
271772|NCT00264537|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
271773|NCT00264550|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
295235|NCT01606800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295236|NCT01606852|University of Minnesota|Craig Weinert MD|612-624-0999|weine006@umn.edu|
307034|NCT02461134|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
295237|NCT01607073|Gillette Children's Specialty Healthcare|Beverly Wical, MD|(651) 229-3870|BWical@gillettechildrens.com|
295238|NCT01607112|GlaxoSmithKline|GSK Response Center|866-435-7343||
295239|NCT01607203|AZ JAN PALFIJN|dr.Decleer Wim|+32 9 325 92 20|wim.decleer@janpalfijngent.be|092248851
295240|NCT01607255|VA Northern California Healthcare Systems - Mather|Joseph W. Leung, MD, Chief of Gastroenterology|916-366-5339|Joseph.Leung2@va.gov|
295241|NCT01607346|GlaxoSmithKline|GSK Response Center|866-435-7343||
295242|NCT01607398|GlaxoSmithKline|GSK Response Center|866-435-7343||
307035|NCT02461160|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
307036|NCT02461290|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
307037|NCT02461433|Johns Hopkins University|Mahmoud Malas|410-550-4546|bmalas1@jhmi.edu|
307038|NCT02461563|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307039|NCT02461589|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
307040|NCT02461628|Duke University|Wendy O'Meara, PhD|16099103091|wpo@duke.edu|
270561|NCT00139737|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307041|NCT02461693|University of Alabama at Birmingham|Dr. David Allison, PI|205-975-9169|dallison@uab.edu|
270562|NCT00139776|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270563|NCT00139997|Yale University|Paul Desan, MD, PhD|203 785 2618|paul.desan@yale.edu|
270564|NCT00140140|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
270565|NCT00140205|BIDMC|Dr. Christos mantzoros|6176671656|cmantzor@bidmc.harvard.edu|
270566|NCT00140231|BIDMC|Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
270567|NCT00140244|BIDMC|Dr. Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
270568|NCT00140413|Children's Hospital Los Angeles|Dr. Mark Borchert|323-361-6219|mborchert@chla.usc.edu|
270569|NCT00140426|University of Colorado School of Medicine, Childrens Hospital Colorado|Jennifer Hagman MD|720-777-2539|jennifer.hagman@childrenscolorado.org|
270570|NCT00140556|Duke University Medical Center, Dept Radiation Oncology|David Brizel, MD|919 668-5637|david.brizel@duke.edu|
270571|NCT00140621|Sanofi|Trial Transparency Team||Contact-US@Sanofi.com|
270572|NCT00140842|Massachusetts General Hospital|Madhu Misra, MD|617-724-5602|mmisra@partners.org|
270573|NCT00140855|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
270574|NCT00141037|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
270575|NCT00141102|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270576|NCT00141115|New York State Psychiatric Institute|John J. Mariani|2125435987|jm2330@columbia.edu|
270577|NCT00141219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
271774|NCT00264576|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
271775|NCT00264641|Hypoglycaemia Research Group|Prof. Birger Thorsteinsson|+4548294829|Birger.Thorsteinsson@regionh.dk|
307042|NCT02461745|Southern California Permanente Medical Group|Division of Clinical Trials Research|(626) 564-5667|clinical.trials@kp.org|
271776|NCT00264797|Univ of Colorado Denver; Univ of Cincinnati|Dr. Paula Riggs; Dr. Theresa Winhusen|303-724-2235; 513-487-7800|paula.riggs@ucdenver.edu; winhusen@carc.uc.edu|
271777|NCT00264810|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
281777|NCT03088930|University of Colorado Cancer Center|Dr. Tejas Patil|7208489264|tajas.patil@cuanschutz.edu|
281778|NCT02960204|Histogen Inc.|Mark Hubka, Executive Director, Medical Affairs|858-526-3109|mhubka@histogen.com|
281779|NCT02856269|University Hospitals Cleveland Medical Center|Dr. Grace McComsey|216-8442739|Grace.McComsey@UHhospitals.org|
281780|NCT02807363|Enteris Biopharma Inc.|Paul Shields, Ph.D|9734533520|pshields@enterisbiopharma.com|
281781|NCT02756403|MedStar Washington Hospital Center|Principal Investigator|202-877-7479|peggy.ye@medstar.net|
281782|NCT02751502|NYU Langone Health|Renat Sukhov, MD|347-377-5138|Renat.Sukhov@nyulangone.org|
281783|NCT02487797|Northwestern University, Yale University|Dr. Moeun Son|475-414-5328|moeun.son@yale.edu|
281784|NCT02348359|Brace Pharma Capital|Vice President, Clinical and Regulatory|240-403-7153|info@Tyrogenex.com|
295243|NCT01607411|GlaxoSmithKline|GSK Response Center|866-435-7343||
295244|NCT01607450|Indiana University|Kieren J Mather MD FRCPC|317-278-7826|kmather@iu.edu|
295245|NCT01607476|Mayo Clinic|Dr. Val Lowe|507-255-3616|vlowe@mayo.edu|
295246|NCT01607554|University of New Mexico Comprehensive Cancer Center|Valerie Parks, RN|505-925-0390|vparks@salud.unm.edu|
295247|NCT01607593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295248|NCT01607645|FHCRC|Derek L. Stirewalt|2066675386|dstirewa@fhcrc.org|
307043|NCT02461758|University of Wisconsin School of Medicine and Public Health|FREDDY CALDERA, ASST PROFESSOR , GASTROENTEROLOGY|(608) 263-1995|fcaldera@medicine.wisc.edu|
307044|NCT02461771|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
307045|NCT02461966|Tanta university|Sherief Abd-Elsalam|00201095159522|sherif_tropical@yahoo.com|
307046|NCT02461992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307047|NCT02462057|Kaiser Permanente Northern California Division of Research|Anjali Gopalan|510-891-3458|Anjali.Gopalan@kp.org|
307048|NCT02462070|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
295249|NCT01607658|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Chief Scientific Officer|1-416-679-0776|nbryson@aceruspharma.com|
295250|NCT01607853|Leo Pharma A/S|Clinical Trial Disclosure Manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
295251|NCT01607892|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
295252|NCT01607905|Karyopharm Therapeutics Inc|Jatin Shah|(617) 658-0600|jshah@karyopharm.com|
295253|NCT01607957|Taiho Oncology, Inc.|Clinical Development Head|609 750 5300||
295254|NCT01608061|Functional Neuromodulation|Todd Langevin|7636071214|todd@fxneuromod.com|
295255|NCT01608087|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
295256|NCT01608100|Abbott Diagnostics Division|Karla Grasso, Clinical Research Manager|1 224-667-5602|karla.grasso@abbott.com|
295257|NCT01608295|UCLA|Helen Lavretsky, M.D.|310-794-4619|hlavretsky@mednet.ucla.edu|
307049|NCT02462083|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
307050|NCT02462122|Bausch Health|Study Director||anyaloncaric@bauschhealth.com|
307051|NCT02462148|Wake Forest Baptist Health|Dr. Jimmy Turner|3368064498|jturner@wakehealth.edu|
307052|NCT02462291|University of Verona|Massimo Venturelli - PI|+39 02503 14648|massimo.venturelli@univr.it|
307053|NCT02462382|Orlando Orthopaedic Center|Randy Schwartzberg, MD|407-254-2500|orlandosportsdoc@yahoo.com|
307054|NCT02462473|Janssen R&D US|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
271778|NCT00264849|Novartis Pharmaceuticals|Study Director|862-778-8300||
271779|NCT00264875|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
271780|NCT00265083|Centocor Research and Development, Inc.|Director, Clinical Research|1-800-457-6399||
271781|NCT00265096|Centocor Research and Development, Inc.|Director, Clinical Research|1-800-457-6399||
271782|NCT00265109|Weill Cornell Medicine|Katharine A. Phillips MD|646-962-2820|kap9161@med.cornell.edu|
271783|NCT00265122|Centocor Research & Development, Inc.|Sr. Dir. Clinical Research|1-800-457-6399||
271784|NCT00265148|GlaxoSmithKline|GSK Response Center|866-435-7343||
271785|NCT00265200|James Graham Brown Cancer Center, University of Louisville|Goetz H Kloecker, MD|502-562-4358|ghkloe01@louisville.edu|
295258|NCT01608308|The University of Texas Health Science Center at Houston|Davide Cattano|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
295259|NCT01608321|VA Palo Alto Health Care System|Director, WRIISC|650-493-5000|wes.ashford@va.gov|
295260|NCT01608490|Boston Scientific|Kristi Winterfeldt|+1 763-494-1165|Kristi.Winterfeldt@bsci.com|
295261|NCT01608659|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
295262|NCT01608672|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
295263|NCT01608724|Astrazeneca Investment (China) Co., Ltd.|Anya Huang, Brand Physician|+86 21 6030 2032|anya.huang@astrazeneca.com|
295264|NCT01608815|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
295265|NCT01608971|Heart and Diabetes Center NRW|Andreas Koster|0043 5731 3284|akoster@hdz-nrw.de|
307055|NCT02462486|Allergan, Inc|Clinical Trials Registry Team|1-800-347-4500|IR-CTRegistration@allergan.com|
307056|NCT02462720|BTG International Inc.|Lynn Allen|425-410-3152|lynn.allen@btgplc.com|
307057|NCT02462759|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
307058|NCT02462928|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
307059|NCT02462967|Galectin Therapeutics|Vice President of Regulatory Affairs|678-620-3186|horton@galectintherapeutics.com|
307060|NCT02463032|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
307061|NCT02463071|AstraZeneca|Torbjorn Lundstrom, MD, PhD|+46 31 706 4100|torbjorn.lundstrom@astrazeneca.com|
307062|NCT02463097|Medtronic Minimed|Thomas Thoub|8185763142|thomas.troub@medtronic.com|
307063|NCT02463227|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s3.com|
307064|NCT02463331|Clinic Hospital of University of Sao Paulo|Lydia Teófilo de Moraes Falcão|55-81-996486935|lydiatmf@yahoo.com.br|81
270578|NCT00141271|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270579|NCT00141297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295266|NCT01609010|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
295267|NCT01609023|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
295268|NCT01609062|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
295269|NCT01609218|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295270|NCT01609257|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
295271|NCT01609296|Medtronic|Kristel Wittebols Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
295272|NCT01609348|Johns Hopkins University|Paul Rosenberg, MD|410-550-9883|prosenb9@jhmi.edu|
295273|NCT01609478|Novartis Pharmaceuticals|Clinical Disclosure Office|+1(862)778-8300||
295274|NCT01609543|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
295275|NCT01609556|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
295276|NCT01609582|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
307065|NCT02463357|University of Colorado Denver|Robert Roach||clinicalresearchsupportcenter@ucdenver.edu|
307066|NCT02463409|Vanderbilt University Medical Center|Dr. Ashley Shoemaker|615-343-8816|ashley.h.shoemaker@vanderbilt.edu|615
307067|NCT02463487|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
270580|NCT00141453|Daiichi Sankyo, Inc|Howard Kessler|732-590-5032|hmkessler@dsi.com|
295277|NCT01609933|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
295278|NCT01610011|McLean Hospital|Marc J. Kaufman, Ph.D., Principal Investigator|617-855-3469|kaufman@mclean.harvard.edu|
295279|NCT01610037|Novartis Pharmaceuticals|Study Director|862-778-8300||
295280|NCT01610063|Mayo Clinic|Dr. Daniel K. Hall-Flavin|507-255-4151|flavin.daniel@mayo.edu|
295281|NCT01610076|Mayo Clinic|Kianoush Kashani; Principal Investigator|5072667093|kashani.kianoush@mayo.edu|
295282|NCT01610154|Fuwai Hospital|Dr. Hui Wang|86-010-88396587|wh_endo@163.com|
295283|NCT01610167|Salus Research, Inc.|Jeffery L. Milleman, DDS, MPA|(260) 755-1099||
307068|NCT02463799|Johns Hopkins University|Emmanuel Antonarakis, MD|410-502-8341|eantona1@jhmi.edu|
307069|NCT02464033|Linkoeping University|Johnny Ludvigsson, MD, PhD, Prof Linkoeping University|+46 13 28 68 54|Johnny.Ludvigsson@liu.se|
307070|NCT02464059|University of North Carolina at Chapel Hill|Michael Bradley Drummond, MD|919-966-7054|brad_drummond@med.unc.edu|
295284|NCT01610206|University of Virginia|Linda Duska, MD|434-982-1719|lrd5d@virginia.edu|
295285|NCT01610271|Baylor College of Medicine|Rabih Darouiche, MD|713.799.5088|sdself@gmail.com|
295286|NCT01610284|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
295287|NCT01610297|Novartis|Study Director|862-778-8300||
295288|NCT01610336|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
295289|NCT01610414|GlaxoSmithKline|GSK Response Center|866-435-7343||
295290|NCT01610427|GlaxoSmithKline|GSK Response Center|866-435-7343||
295291|NCT01610453|Stavanger UH|Professor Torbjørn Moe Eggebø|+4792699433|tme@lyse.net|
295292|NCT01610492|GlaxoSmithKline|GSK Response Center|866-435-7343||
307071|NCT02464163|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
307072|NCT02464176|Wake Forest Baptist Medical Center|Dr. James D. Turner|3367164998|jturner@wakehealth.edu|
307073|NCT02464449|Ann Arbor VA Healthcare System|Dr. John Piette, PhD|734-845-3626|jpiette@umich.edu|
307074|NCT02464540|Federal University of Pelotas|Dr Noéli Boscato|5553999530000|noeliboscato@gmail.com|
307075|NCT02464657|The University of Texas MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani, MD/Professor|(713)745-0394|fravandi@mdanderson.org|
307076|NCT02464917|Memorial Health Systems|Michael Nageotte, MD|562-933-2748|mnageotte@memorialcare.org|
307077|NCT02465034|Emory University|Dr. Michael Borich|404-712-0612|michael.borich@emory.edu|
307078|NCT02465073|Southwest Regional Wound Care Center|Randall Wolcott|806-793-8869|randy@randallwolcott.com|
307079|NCT02465099|Ethicon Inc|Jason Waggoner|(513) 337-8130|jwaggon1@its.jnj.com|
307080|NCT02465203|Novartis|Study Director|+41613241111||
307081|NCT02465216|IDRI|Dr. Corey Casper|2063810883|corey.casper@idri.org|
307082|NCT02465372|Wake Forest University Health Sciences|Dr. Justin Moore|336-716-3702|jusmoore@wakehealth.edu|
307083|NCT02465437|Corbus Pharmaceuticals, Inc.|John Skutnik, MS|781-562-9853|jskutnik@corbuspharma.com|
307084|NCT02465450|Corbus Pharmaceuticals|Ajay Aggarwal, MD|781-250-9176|aaggarwal@corbuspharma.com|
307085|NCT02465463|Emory|Dr. Tanvi Dhere|404-686-1000|tdhere@emory.edu|
307086|NCT02465489|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
307087|NCT02465515|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
307088|NCT02465528|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
271786|NCT00265239|Kumamoto University|Dr. Kenichi Tsujita|+81-96-373-5175|tsujita@kumamoto-u.ac.jp|
270581|NCT00141518|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
270582|NCT00141726|University of Michgan Comprehensive Cancer Center|Gregory Yanik, M.D.|734-936-8785|gyanik@umich.edu|
270583|NCT00141739|Blood and Marrow Transplant Program, University of Michigan|Dr. John E. Levine|734-936-8456|jelevine@med.umich.edu|
270584|NCT00141765|University of Michigan Cancer Center|Dr. John E. Levine, MD|734-936-8456|jelevine@umich.edu|
270585|NCT00141778|Vanderbilt University School of Medicine|Dr. Mias Pretorius|16153430665|mias.pretorius@vanderbilt.edu|
270586|NCT00141817|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270587|NCT00141921|Amgen Inc.|Study Director|866-572-6436||
270588|NCT00142116|Dana Farber Cancer Institute|Steven P. Treon MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
270589|NCT00142168|DFCI|Steven P. Treon MD PhD|617 632 2681|steven_treon@dfci.harvard.edu|
270590|NCT00142298|Novartis Pharmaceuticals|Study Director|862-778-8300||
270591|NCT00142415|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org|
270592|NCT00142454|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@lcr.org|
282658|NCT00866788|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
295293|NCT01610557|National Eye Institute (NEI) at National Institutes of Health (NIH)|Henry E Wiley, MD, Principal Investigator|(301) 451-4260|wileyhe@mail.nih.gov|
307089|NCT02465567|Pearl Therapeutics Inc|Pearl Therapeutics Inc|1-877-240-9479|information.center@astrazeneca.com|
295294|NCT01610570|National Cancer Institute|Dr. Brigitte Widemann|301-496-7387|widemanb@mail.nih.gov|
295295|NCT01610596|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
295296|NCT01610687|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
295297|NCT01610700|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
295298|NCT01610713|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
295299|NCT01610752|Pennington Biomedical Research Center|Dr. Leanne M. Redman|2257630947|leanne.redman@pbrc.edu|
295300|NCT01610791|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
295301|NCT01611090|Janssen Research & Development, LLC|Medical Director Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
295302|NCT01611155|Mayo Clinic|Charles L. Loprinzi, MD|507-284-3731|cloprinzi@mayo.edu|
295303|NCT01611194|Intermountain Healthcare|Lindell Weaver, MD, FACP, UHM|801-408-3623|lindell.weaver@imail.org|
295304|NCT01611259|AGMT|Public contact Daniela Wolkersdorfer|00436626404411|d.wolkersdorfer@agmt.at|
295305|NCT01611298|Baylor College of Medicine|Dr. Robert A. Krance|832-824-4661|rakrance@txch.org|
295306|NCT01611454|Baptist Health South Florida|Raul Herrera, MD. Director Miami Cardiac and Vascular Institute|786-596-3505|raulh@baptisthealth.net|
295307|NCT01611558|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
295308|NCT01611571|Columbia University Medical Center|Marcella Walker MD|212-342-5351|mad2037@columbia.edu|
295309|NCT01611662|Fox Chase Cancer Center|Elizabeth Plimack, MD|215-728-3889|Elizabath.Plimack@fccc.edu|
295310|NCT01611779|Siesta Medical, Inc.|Michael Kolber|408-320-9424|mkolber@siestamedical.com|
295311|NCT01611792|University of Vermont Medical Center, Burlington, VT|Dr. Sharon M. Henry|802 847-6733|Sharon.Henry@uvm.edu|
295312|NCT01611857|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
295313|NCT01611935|University of Pennsylvania|Dr. Carrie Sims|215-588-5154|carrie.sims@uphs.upenn.edu|
295314|NCT01611948|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
295315|NCT01611974|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
295316|NCT01612000|Protein Sciences Corproation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
295317|NCT01612156|University of Southern California|Begum Ozel, MD|323-441-9589|ozel@usc.edu|
295318|NCT01612221|Huntsman Cancer Institute|Kimberlee Taylor|801-213-5673|Kimberlee.Taylor@hci.utah.edu|
307090|NCT02465632|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
270593|NCT00142506|MEMORIAL SLOAN KETTERING CANCER CENTER|MICHAEL J ZELEFSKY|+1212-639-6802|zelefskm@MSKCC.ORG|
270594|NCT00142597|University of Michigan|Richard E. Harris|734-998-6996|reharris@med.umich.edu|
270595|NCT00142792|MetroHealth Medical Center|Richard WIlson, MD|216-957-3559|rwilson@metrohealth.org|
270596|NCT00142818|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
270597|NCT00142909|Yale University School of Medicine|Rajita Sinha, Ph.D|203-737-5805|rajita.sinha@yale.edu|
270598|NCT00142935|The Miriam Hospital/Brown University|Josiah D. Rich, MD, MPH|401-793-4770|jrich@lifespan.org|
270599|NCT00143247|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270600|NCT00143312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270601|NCT00143390|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270602|NCT00143403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270603|NCT00143455|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270604|NCT00143507|Institut de Recherches Internationales Servier (I.R.I.S.)|Therapeutic Innovation Pole|+33155724366|clinicaltrials@servier.com|
270605|NCT00143598|Centre for Clinical Epidemiology, Jewish General Hospital|Dr. Susan R Kahn|514-340-8222|susan.kahn@mcgill.ca|7587
270606|NCT00143819|UMDNJ-Robert Wood Johnson Medical School|Dr M Magliocco||maglioma@yahoo.com|
270607|NCT00143845|University of Michigan Comprehensive Cancer Center|Dr. John Levine, M.D.|734-936-8456|jelevine@umich.edu|
270608|NCT00144027|Central Arkansas Veterans Healthcare System|Jeff Pyne|501-257-1083|jeffrey.pyne@va.gov|
270609|NCT00144170|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
270610|NCT00144300|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
270611|NCT00144339|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
270612|NCT00144391|Charles R. Drew University of Medicine and Science|Dr. Theodore Friedman|310-668-5197|theodorefriedman@cdrewu.edu|
270613|NCT00144781|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
270614|NCT00144963|Talon Therapeutics|VP, Regulatory Affairs|650-228-5066|ttarlow@talontx.com|
270615|NCT00145041|Talon Therapeutics|Chief Medical Officer|650-588-6404|info@talontx.com|
295319|NCT01612494|Washington University School of Medicine|Dr. Angela Lumba-Brown|314-362-4325|lumba_a@kids.wustl.edu|
295320|NCT01612546|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
295321|NCT01612676|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
295322|NCT01612702|Joint Reconstruction Center, Seoul National University Bundang Hospital|Dr. TK Kim|82-31-787-7196|osktk@snubh.org|7200
295323|NCT01612767|BIOTRONIK|Amy Culley, Director of Vascular Intervention|503-451-8034|amy.culley@biotronik.com|
295324|NCT01612780|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
295325|NCT01612793|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
295326|NCT01612858|Tufts Medical Center|Rakhi Kohli MD MS|617-636-4709|rkohli@tuftsmedicalcenter.org|
295327|NCT01612884|Indiana University School of Medicine|Rolf Kreutz, MD|3179620500|rkreutz@iu.edu|
295328|NCT01613014|NIAAA|Megan Ryan, Clinical Program Director|3014434225|mryan1@mail.nih.gov|
307091|NCT02465866|Charleston Laboratories, Inc|Chief Commercial Officer|561-748-2007|cliregulatory@charlestonlabs.com|
307092|NCT02465931|RTI International|Dr. Don Bailey|(919) 541-6488|dbailey@rti.org|
295329|NCT01613027|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
307093|NCT02466009|University of Rochester|Aram Hezel|585-275-5823|Aram_Hezel@urmc.rochester.edu|
295330|NCT01613118|Travere Therapeutics, Inc.|Noah Rosenberg, MD|1-646-564-3680|noah.rosenberg@travere.com|
295331|NCT01613131|University of Colorado Denver|Chanel Mansfield|303-724-6501|chanel.mansfield@ucdenver.edu|
295332|NCT01613222|GEHealthcare|Jeffrey Conner|414-477-8374|Jeffrey.Conner@ge.com|
295333|NCT01613248|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
295334|NCT01613313|GerutZ|Dr. Zachary E.Gerut|516 295-2100|Drgerut@drgerut.com|
295335|NCT01613326|Novartis Pharmaceuticals|Study Director|4 161 324 1111||
295336|NCT01613339|Orebro county council|Dr. Anette Forsberg|+46-19-602 5788|anette.forsberg@orebroll.se|
295337|NCT01613378|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
295338|NCT01613417|Executive Director, MRI|Gianpaolo Pirovano, MD|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
295339|NCT01613599|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
307094|NCT02466087|University of Vermont|Emily Tarleton, MS, RD|802-847-4730|emily.tarleton@uvm.edu|
307095|NCT02466126|Department of Veterans Affairs, Micheal E. DeBakey VAMC|Dr. Jeffrey Cully|713-794-8526|Jeffrey.Cully@va.gov|
307096|NCT02466230|Weill Cornell Medical College|Marc Dubin, M.D.|(212) 746-5817|mrd9035@med.cornell.edu|
307097|NCT02466386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
307098|NCT02466399|Peregrine Ophthalmic Pte Ltd|Chief Operating Officer|65 97914382|jchua@peregrineop.com|
295340|NCT01613716|Cleveland Clinic Foundation|Sunil K. Srivastava, MD|216-636-2286|srivass2@ccf.org|
295341|NCT01613768|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
270616|NCT00145119|Medtronic Bakken Research Center|Director CRDM|+31 43 3566||566
295342|NCT01614093|Morgan State University|Kimberly R. Warren, Ph.D.|443-885-3492|kimberly.warren@gmail.com|
295343|NCT01614210|Huntsman Cancer Institute|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
295344|NCT01614249|University of Nairobi|Mrs. Rose Okoyo Opiyo|+254 020 2726300|roseopiyo@uonbi.ac.ke|43481
295345|NCT01614392|Jean Mayer USDA HNRCA, Tufts University|Dr. Roger Fielding|6175563083|Roger.Fielding@tufts.edu|
295346|NCT01614457|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
295347|NCT01614470|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
295348|NCT01614509|Yeungnam University College of Medicine|Dr. Min Sagong|82-53-620-4191|msagong@ynu.ac.kr|
307099|NCT02466412|Philip Morris Products S.A.|Steffen Fredersdorf|+41 (58) 242 2182|Steffen.Fredersdorf@pmi.com|
307100|NCT02466425|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
307101|NCT02466516|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
307102|NCT02466555|University Hospitals Connor Integrative Health Network|Samuel Rodgers-Melnick, MT-BC, music therapist|216-844-7727|Samuel.RodgersMelnick@UHhospitals.org|
307103|NCT02466646|Marmara University Faculty of Dentistry, Department of Periodontology|Prof. Dr. Basak Dogan|00905332621170|basak.sdogan@gmail.com|
307104|NCT02466659|Indiana University|Daniel Neely|3172741214|deneely@iupui.edu|
307105|NCT02466958|UCLA|Helen Lavretsky, MD|310-794-4619|HLavretsky@mednet.ucla.edu|
307106|NCT02467075|University of Michigan, Department of Radiology|Matthew Davenport, MD|734-232-2095|matdaven@med.umich.edu|
307107|NCT02467166|University of California, San Diego Health System|Gregory K. Feld, MD, Director CCEP|(858) 246-2972|gfeld@health.ucsd.edu|
307108|NCT02467179|University of California San Diego|Dr. Gregory Feld|(858) 246-2972|gfeld@ucsd.edu|
307109|NCT02467192|Hopitaux Universitaires de Geneve|Dr Jerome Stirnemann|+41223729101|jerome.stirnemann@hcuge.ch|
307110|NCT02467387|CardioCell, LLC|Sergey Sikora, President and CEO|760-315-0861|SSIKORA@STEMCARDIOCELL.COM|
270617|NCT00145145|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
270618|NCT00145249|University of Alabama at Birmingham|Peter G. Pappas, MD|205-934-9951|pappas@uab.edu|
270619|NCT00145327|Novartis Pharmaceuticals|Study Director|862-778-8300||
270620|NCT00145418|Oncology Specialists, S.C.|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
270621|NCT00145574|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
270622|NCT00145587|St. Jude Children's Research Hospital|Kimberly Kasow, DO|901-595-3300|kimberly_kasow@med.unc.edu|
270623|NCT00145600|St. Jude Children's Research Hospital|Monika Metzger, MD|1-866-278-5833|info@stjude.org|
270624|NCT00145626|St. Jude Children's Research Hospital|Brandon Triplett, MD|866-278-5833|referralinfo@stjude.org|
270625|NCT00145795|The University of Chicago Department of Health Studies, Section of Infectious Diseases and Global Health|Dr. David Pitrak|(773) 702-2710|dpitrak@medicine.bsd.uchicago.edu|
270626|NCT00145977|The University of Chicago|Tamara Vokes, MD|773-702-1465|tvokes@medicine.bsd.uchicago.edu|
270627|NCT00146172|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
270628|NCT00146328|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
270629|NCT00146640|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
270630|NCT00146757|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
270631|NCT00146770|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
270632|NCT00146848|Clinical Affairs|Kira Stolen|1 800 CARDIAC|cshd@bsci.com|
270633|NCT00147017|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
270634|NCT00147030|National Perinatal Epidemiology Unit, University of Oxford|Director of NPEU Clinical Trials Unit|01865 289700|ctu@npeu.ox.ac.uk|89728
270635|NCT00147043|Imperial College London|Professor Nagy Habib|+442033138574|nagy.habib@imperial.ac.uk|
270636|NCT00147069|Imperial College London|Professor Louise Donnelly|+44 (0)20 7594 7895|l.donnelly@imperial.ac.uk|
307111|NCT02467465|Universidad Complutense de Madrid|Miguel Suárez Varela|+34913941518|misuarezvarela@gmail.com|
270637|NCT00147082|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
270638|NCT00147199|United Therapeutics|Inhaled Treprostinil Program Head|919-485-8350|clinicalrecordsmanagement@unither.com|
270639|NCT00147212|MGH Cancer Center|M. Dror Michaelson, MD PhD|6177261594|dmichaelson1@partners.org|
295349|NCT01614574|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
295350|NCT01614600|Alcon Research, Ltd.|Jami Kern, MBA, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
295351|NCT01614613|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
295352|NCT01614743|DeNova Research|Steven H Dayan, MD|312-335-2070|sdayan@drdayan.com|
295353|NCT01614769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295354|NCT01614795|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
295355|NCT01614821|Dana-Farber Cancer Institute|Dr. Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
295356|NCT01614847|Northeastern State University Oklahoma College of Optometry|Thomas O. Salmon, OD, PhD, Professor|918-444-4011|salmonto@nsuok.edu|
295357|NCT01614886|Novartis Pharmaceuticals|Study Director|862-778-8300||
307112|NCT02467491|University of Florida|Dr. Vincenzo Valiani|352-2835906|vincio86@gmail.com; v.valiani@ufl.edu|
307113|NCT02467504|Peking university People's Hospital|Prof. Zhanguo Li|+86-13810001444|13810001444@163.com|
307114|NCT02467621|Copenhagen University Hospital Rigshospitalet, Dept. of Intensive Care 4131|Dr. Morten Hylander Møller|22555343|mortenhylander@gmail.com|+45
307115|NCT02467777|Fox Valley Orthopaedic Institute|Vishal Mehta|6305841400|vmehta@fvortho.com|
307116|NCT02467842|SK bioscience|Hayoung Lee|+82-2-2008-2552|haylee@sk.com|
271787|NCT00265317|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
271788|NCT00265330|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
295358|NCT01614899|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
295359|NCT01614912|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
295360|NCT01614925|Straumann|Michel Mallaun||michel.mallaun@straumann.com|
295361|NCT01615120|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
307117|NCT02468154|Istituto Ortopedico Rizzoli|Luisa Veronesi|0516366694|cristiana.forni@ior.it|0039
307118|NCT02468193|Novartis PharmaCeuticals|Study Director|862-778-8300|novartis.email@novartis.com|
307119|NCT02468414|Aevi Genomic Medicine|Garry A. Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
307120|NCT02468557|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
307121|NCT02468570|BioMarin Pharmaceutical Inc.|Karen Gu/Director, BioStatistics|650-829-4017|kgu@bmrn.com|
307122|NCT02468648|NIDDK|Marc Ghany, MD, MHSc|301-402-5115|marcg@intra.niddk.nih.gov|
307123|NCT02468674|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
307124|NCT02468700|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
295362|NCT01615198|Novartis|Study Director|862-778-8300||
307125|NCT02468804|University of Colorado Denver|Isabelle Buard, PhD|(303)472-5973|Isabelle.Buard@cuanschutz.edu|
295363|NCT01615263|Institut universitaire de cardiologie et de pneumologie de Québec, Laval University|Dr Jean S. Bussières, anesthesiologist, director of research|418 656-4870|jbuss@criucpq.ulaval.ca|
295364|NCT01615328|Seoul National University Bundang Hospital|Jin-Sup Yeom|82-31-787-7190|highcervical@gmail.com|
295365|NCT01615367|Massachusetts General Hospital|Dr. Louisa Sylvia|617-643-4804|lsylvia2@partners.org|
295366|NCT01615484|University of North Carolina at Chapel Hill|Thomas Egan, MD, MSc, FACS|919-966-3381|thomas_egan@med.unc.edu|
295367|NCT01615731|Stanford University|Dr. Kate Shaw|(650) 725-5986|kateshaw@stanford.edu|
295368|NCT01615809|Fundaciò per la Recerca i la Docencia sant Joan de Deu|Rosa Maria morales Palau|936009751|rmorales@fsjd.org|
307126|NCT02468830|CHU de Quebec-Universite Laval|Dr Stephane Bolduc||Stephane.Bolduc@fmed.ulaval.ca|
270640|NCT00147225|University of Texas MD Anderson Cancer Center|Dr. Saroj Vadhan-Raj|713-792-7966|svadhanr@mdanderson.org|
270641|NCT00147251|MedStar Research Institute|Barbara V Howard|301-560-7305|barbara.v.howard@medstar.net|
270642|NCT00147316|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
270643|NCT00147446|Northwestern University|David C. Mohr|312-503-3128|m.lisetteluistro@northwestern.edu|
270644|NCT00147498|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270645|NCT00147537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270646|NCT00147745|Daiichi Sankyo, Inc|John Raia, Senior Director, Professional Affairs|(973) 944-2683|jraia@dsi.com|
270647|NCT00147823|SUNY Upstate Medical University|Timothy A. Damron, MD|315-464-8604|damront@upstate.edu|
270648|NCT00147966|UCSD|Arthur Kavanaugh|858-657-7040|akavanaugh@ucsd.edu|
270649|NCT00148109|University of Michigan Comprehensive Cancer Center|Dr. Rashmi Chugh|(734) 936-5710|rashmim@umich.edu|
270650|NCT00148122|University of Michigan Comprehensive Cancer Center|Dr. Francis Worden|734-936-0453|fworden@umich.edu|
270651|NCT00148317|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
270652|NCT00148343|Case Western Reserve University/MetroHealth Medcial Center|Lynne Sheffler, MD|216-957-3570|lsheffler@metrohealth.org|73556
270653|NCT00148668|Dana-Farber Cancer Institute|Dr Eric Winer|617-632-2335|eric_winer@dfci.harvard.edu|
270654|NCT00148733|University of Bergen|Tor A Strand|90971086|tor.strand@cih.uib.no|
270655|NCT00148759|Emory University|Ighovwerha Ofotokun, MD, MSc|404-616-0659|iofotok@emory.edu|
270656|NCT00148798|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
270657|NCT00148941|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
270658|NCT00148954|Boston Scientific|Greg Voss, Clinical Director|651-581-3068|gregory.voss@bsci.com|
270659|NCT00149214|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
270660|NCT00149227|Department of Cardiology, Kyoto Prefectural University of Medicine|Prof. Hiroaki Matsubara|+81-75-251-5511|matsubah@koto.kpu-m.ac.jp|
270661|NCT00149396|Medigene|Associate Director Regulatory Affairs|858-586-2252|p.larson@medigeneusa.com|
270662|NCT00149630|Baylor College of Medicine|Thomas R. Kosten, M.D.|(713) 794-7032|kosten@bcm.edu|
270663|NCT00149643|University of Pittsburgh|Jack R. Cornelius, M.D.|412-246-6906|corneliusjr@upmc.edu|
270664|NCT00149669|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
270665|NCT00149734|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
270666|NCT00149747|Stanford Prevention Research Center|Abby C. King|6507252826|king@stanford.edu|
270667|NCT00149799|Rhode Island Hospital|Katharine A. Phillips, MD|401-444-1646|katharine_phillips@brown.edu|
270668|NCT00149825|Stanford University, School of Medicine|Rachel Manber, PhD|650-724-2377|Rmanber@stanford.edu|
270669|NCT00149838|MUSC|Mark S. George, MD, Professor|8438700368|georgem@musc.edu|
270670|NCT00149890|Novartis Pharmaceuticals|Study Director|862-778-8300||
270671|NCT00149994|Novartis Pharmaceuticals|Study Director|862-778-8300||
270672|NCT00150345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270673|NCT00150462|Amgen, Inc.|Study Director|866-572-6436||
270674|NCT00150592|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
270675|NCT00150618|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
270676|NCT00150800|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
270677|NCT00150813|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
271789|NCT00265382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
271790|NCT00265395|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
271791|NCT00265473|Schulze Diabetes Institute, University of Minnesota|Melena D. Bellin, MD|612-625-4686|bell0130@umn.edu|
295369|NCT01615822|Medicines for Malaria Venture|Fiona Macintyre, PhD|+41 22 555 0319|macintyref@mmv.org|
307127|NCT02468934|SPR Therapeautics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
307128|NCT02469038|University of Chicago|Melanie Norstrom|773-702-1991|mnorstrom@medicine.bsd.uchicago.edu|
307129|NCT02469064|Universidad del Valle|Dr Lina Marcela Sandoval Moreno|316 478 0808|linamarce48@gmail.com|
307130|NCT02469077|Vanderbilt University Medical Center|Stephen Bruehl, Ph.D.|615-936-1821|stephen.bruehl@vumc.org|
307131|NCT02469090|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
307132|NCT02469116|Washington University School of Medicine|David G. Mutch, M.D.|314-362-3181|mutchd@wustl.edu|
307133|NCT02469168|Walter Reed National Military Medical Center|Jody Richardson, MSN, RN|301-295-7798|jody.richardson.ctr@usuhs.edu|
307134|NCT02469246|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
307135|NCT02469298|GlaxoSmithKline|GSK Response Center|866-435-7343||
307136|NCT02469389|VISN 5 MIRECC|Dr. Melanie Bennett|(410) 637-1850|Melanie.Bennett@va.gov|
307137|NCT02469597|Northwell Health- Cohen Children's Medical Center|Dr. Kristy Williamson|718-470-7640|kwilliam12@nshs.edu|
307138|NCT02469610|CarmelMC|Dr LEVY FABER Dan|97248250289|DANLf@clalit.org.il|
307139|NCT02469623|Acutus Medical, Inc.|Steve McQuillan, Sr. Vice President Regulatory, Clinical, & Quality Assurance|442232608-|steven.mcquillan@acutus.com|
307140|NCT02469701|Brown University Oncology Research Group|Kristen M. Mitchell, CCRP|4018633000|kristen_mitchell@brown.edu|
307141|NCT02469714|Illinois Institute of Technology|Patrick Corrigan|(312)567-6751|corrigan@iit.edu|
307142|NCT02469857|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1-919-219-6377|wayned@atoxbio.com|
295370|NCT01615939|Northwestern University, Feinberg School of Medicine|Antoun Nader|312-695-3045|a-nader2@northwestern.edu|
295371|NCT01616056|FHCRC|Stephanie J. Lee MD MPH|206-667-6190|sjlee@fhcrc.org|
295372|NCT01616082|Translational Research Institute for Metabolism and Diabetes|Dr. Steven R. Smith|407-303-7115|steven.r.smith.md@flhosp.org|
295373|NCT01616160|Massachusetts General Hospital|Daniel L. Hamilos, M.D.|617-726-5090|dhamilos@partners.org|
295374|NCT01616173|Northwestern University, Feinberg School of Medicine|Rohit Rahangdale MD|312-695-3045|ryrahangdale@hotmail.com|
295375|NCT01616459|GlaxoSmithKline|GSK Response Center|866-435-7343||
295376|NCT01616563|Metabolic Syndrome Canada|Rupinder Dhaliwal|613 484 3830|rupinder.dhaliwal@metsc.ca|
295377|NCT01616576|Advanced Bionics, LLC|Cedric Navarro, Vice President of Regulatory/Clinical Affairs and Quality|(661) 362-1963|Clinical.Research@advancedbionics.com|
295378|NCT01616654|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
295379|NCT01616693|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
307143|NCT02469870|Trifoia|Dr. Jordan Pennefather|1-877-874-3642|jordanp@trifoia.com|
307144|NCT02469896|Barrow Neurological Institute|Shafeeq Ladha, MD|602-406-8989|Shafeeq.Ladha@Barrowneuro.org|
307145|NCT02469961|Maimonides Medical Center|Piyush Gupta, Director of clinical affairs|718-283-7189|pgupta@maimonidesmed.org|
307146|NCT02470091|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
307147|NCT02470234|Rhodes Pharmaceuticals L.P.|Dr. Akwete Adjei|401-262-9408|akwete.adjei@rhodespharma.com|
307148|NCT02470312|Abbott|Kristin Ruffner, Clinical Program Director|+1 651 756 6717|Kristin.Ruffner@abbott.com|
270678|NCT00150969|University Health Network|Dr. Angela M Cheung|416-340-4841|jscher@uhnresearch.ca|
295380|NCT01616771|Seoul National University Hospital|Jin-Tae Kim|82-10-6260-8490|jintae73@gmail.com|
295381|NCT01616953|University of Michigan|Dr. Darnell Kaigler|734-615-4023|dkaigler@umich.edu|
295382|NCT01617005|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
295383|NCT01617070|USC/Keck School of Medicine|Shoji Yano|323-226-3816|syano@usc.edu|
295384|NCT01617083|University of South Florida Rothman Center|Study Coordinator|7277678393|ebrenna1@health.usf.edu|
295385|NCT01617148|Cleveland Clinic Foundation|Dr. Rishi Singh|330-888-4000|singhr@ccf.org|
295386|NCT01617369|University of North Carolina Chapel Hill|Dr. Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
295387|NCT01617421|Clinical Center|Middleton, Kimberly|+1 301 496 9083|middletonk@mail.nih.gov|
295388|NCT01617434|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
295389|NCT01617447|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
307149|NCT02470390|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
307150|NCT02470403|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
307151|NCT02470429|Alcon, A Novartis Division|WW Medical Affairs Director, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
307152|NCT02470494|Earlens Corporation|Dr. Suzanne Levy, Director of Clinical Research|650-739-4447|Suzanne.Levy@Earlens.com|
307153|NCT02470585|AbbVie|Global Medical Services|1-800-633-9110|abbvieclinicaltrials@abbvie.com|
307154|NCT02470741|University of California, San Francisco|Lisa Abinanti, Project Director|415-353-9978|lisa.abinanti@ucsf.edu|
307155|NCT02470754|UCSF|Natalie Nardone|415-514-1450|natalie.nardone@ucsf.edu|
307156|NCT02470806|Smith & Nephew, Inc.|Natasha Schappell, CCRP|817-302-3949|natasha.schappell@smith-nephew.com|
270679|NCT00151281|Weill Cornell Medical College|Dr. Jia Ruan|646-962-2068|jruan@med.cornell.edu|
270680|NCT00151320|Weill Cornell Medicine|John Leonard, MD|646.962.2064|amr2017@med.cornell.edu|
270681|NCT00151372|Weill Cornell Medical College|George S. Alexopoulos, M.D.|914-997-5767|gsalexop@med.cornell.edu|
270682|NCT00151411|Penn State Hershey|Sandy Eyer|717-531-1540|seyer@hmc.psu.edu|
270683|NCT00151476|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270684|NCT00151775|Daiichi Sankyo|Howard Kessler, Senior Director Regulatory Operations|732-590-5032|hmkessler@dsi.com|
270685|NCT00151814|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
270686|NCT00151892|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
270687|NCT00151996|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
270688|NCT00152009|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
270689|NCT00152464|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
270690|NCT00152516|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
270691|NCT00152763|University Health Network, Toronto General Hospital|Dr. Jane Irvine|(416) 736-5115|jirvine@yorku.ca|22444
270692|NCT00152971|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
295390|NCT01617460|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
307157|NCT02470910|DFCI/BWH|Anthony D'Amico|8572151489|adamico@bwh.harvard.edu|
295391|NCT01617577|University of South Florida|Professor Juan Sanchez-Ramos|813-974-5841|jsramos@health.usf.edu|
295392|NCT01617603|Medical School, Michael White Diabetes Centre, 220-236, Anlaby Road,|Prof. Stephen Atkin, Principal Investigator|+44(0)1482 675312|Stephen.Atkin@hyms.ac.uk|
295393|NCT01617629|PrimaBioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
295394|NCT01617655|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
295395|NCT01617668|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
295396|NCT01617681|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
295397|NCT01617967|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|1-877-256-9526|medinfo@alnylam.com|
295398|NCT01618019|Hanyang University|Dr. Yongsoon Park|82-2-2220-1205|yongsoon@hanyang.ac.kr|
295399|NCT01618162|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
307158|NCT02470949|University of Florida|Michelle Cardel, PhD, RD|(352) 273-9703|mcardel@ufl.edu|
307159|NCT02471014|University of Florida|Mathew Sebastian, PhD|8644901978|mathewsebastian@ufl.edu|
307160|NCT02471183|Actelion Pharmaceuticals Ltd|Global Post approval studies Director||lperchen@its.jnj.com|
282659|NCT00866814|C.R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
282660|NCT00866879|Northwestern University|Lorenzo Gallon, MD|3126954457|l-gallon@northwestern.edu|
295400|NCT01618214|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
295401|NCT01618227|Massachusetts General Hospital|Neal Chen|617-726-4700|nchen1@partners.org|
295402|NCT01618240|Massachusetts General Hospital|Hooman Mirzakhani|617-291-9779|hmirzakhani@partners.org|
295403|NCT01618266|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
295404|NCT01618305|Westat|Lauren Laimon, Project Manager|240-453-2987|laurenlaimon@westat.com|
295405|NCT01618344|Hunstman Cancer Institute|Dr. Yelena Wu|801-213-5653|yelena.wu@utah.edu|
295406|NCT01618422|Chinese University of Hong Kong|Prof David SC Hui|2632 3134|dschui@cuhk.edu.hk|
295407|NCT01618669|Astellas Pharma Global Development, Inc. (APGD)|Senior Medical Director, Medical Affairs||Astellas.resultsdisclosure@astellas.com|
295408|NCT01618695|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
295409|NCT01618708|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
307161|NCT02471313|National Institutes of Health Clinical Center|Dr. Elliot Levy, Staff Clinician, Radiology & Imaging Sciences|301-402-5368|levyeb@cc.nih.gov|
307162|NCT02471326|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
307163|NCT02471404|AstraZeneca|Eva Johnsson, MD, PhD|+46 (0)31776 24 84|ClinicalTrialTransparency@astrazeneca.com|
307164|NCT02471521|Seoul National University Hospital|Jin-Tae Kim|82-2-2072-3661|jintae73@gmail.com|
307165|NCT02471586|Abbott|Kristina M Gibbens, Senior Clinical Project Manager|+1 651-756-3859|Kristina.gibbens@abbott.com|
295410|NCT01618838|Georgetown University Hospital|Dr. Sean Collins|202-444-3062|spc9@gunet.georgetown.edu|
307166|NCT02471612|Tata Main Hospital|Dr.Deb Sanjay Nag|+91-7763807101|debsanjay@gmail.com|
295411|NCT01618864|Iluminage|Director of Clinical Affairs|+972 547 800 260|doranr@iluminagebeauty.com|
295412|NCT01618916|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295413|NCT01618942|Huazhong University of Science&Technology|Xianwei Zhang|027 83662853|ourpain@163.com|
295414|NCT01618955|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President-Clinical Development|609-359-3020|jjaffe@antarespharma.com|324
295415|NCT01618968|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President Clinical Development|609-359-3020|jjaffe@antarespharma.com|324
295416|NCT01619059|AstraZeneca Pharmaceuticals|Eva Johnsson, Clinical Science Lead|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762484
307167|NCT02471651|California Retina Consultants|Dr. Gabriel Gordon|8059631648|gabe@californiaretina.com|3034
307168|NCT02471716|FivePrime Theraputics|Medical|415-365-5600|nick.mahasuwan@fiveprime.com|
307169|NCT02471755|Guang'anmen Hospital of China Academy of Chinese Medical Sciences|Dr.Xiaoxu Liu|+86 10 8800 1124|liuxiaoxu_lxx@163.com|
307170|NCT02472145|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
307171|NCT02472223|Washington University School of Medicine|Mae Gordon|3143623716|gordon.mae@wustl.edu|
270693|NCT00153062|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
270694|NCT00153101|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
270695|NCT00153166|Brigham and Women's Hospital|Mark Creager|617-732-5267|mcreager@partners.org|
270696|NCT00153179|Brigham and Women's Hospital|Mark A. Creager|603-650-8283|Mark.A.Creager@hitchcock.org|
270697|NCT00153803|Dartmouth-Hitchcock Medical Center|Clinical Research Office||Cancer.Research.Nurse@Dartmouth.edu|
270698|NCT00153816|Geisel School of Medicine at Dartmouth|Leila A. Mott, Statistical Analyst|603-650-3447|Leila.A.Mott@Dartmouth.EDU|
270699|NCT00153842|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|Cancer.Research.Nurse@Dartmouth.edu|
270700|NCT00153920|Dana-Farber Cancer Institute|Paul G. Richardson|617.632.2104|Paul_Richardson@dfci.harvard.edu|
270701|NCT00153985|Dana-Farber Cancer Institute|Catherine Wu, MD|617-632-5943|cwu@partners.org|
270702|NCT00154063|Eisai Call Center|Eisai Inc.|888-422-4743||
270703|NCT00154102|Merck Serono|Monika Foerster/Clinical Trial Leader|+496151729517|monika.foerster@merck.de|
270704|NCT00154284|Novartis Pharmaceuticals|Study Director|862-778-8300||
270705|NCT00154297|Novartis Pharmaceuticals|Study Director|862-778-8300||
270706|NCT00154310|Novartis Pharmaceuticals|Study Director|862-778-8300||
270707|NCT00154375|Novartis Pharmaceuticals|Study Director|862-778-8300||
270708|NCT00154466|National Taiwan University Hospital|Dr. Bai-Chin Lee|0223123456|lebai@ntu.edu.tw|63352
270709|NCT00156013|Oncology Specialists|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
270710|NCT00156247|UMDNJ-Robert Wood Johnson Medical School|Melissa Magliocco, MD|(732) 235-5735|maglioma@umdnj.edu|
270711|NCT00156390|University of Pittsburgh|Dr. Samir Saba|412-802-3372|sabas@upmc.edu|
270712|NCT00156533|University of Rochester|Wilfred Pigeon|585 275-3374|wilfred_pigeon@urmc.rochester.edu|
270713|NCT00156715|Dartmouth Medical School|Christopher OKeefe, M.A|603-271-5287|chris.okeefe@hitchcock.org|
270714|NCT00156819|Johns Hopkins Center for Clinical Trials|Razan Yasin|443-287-5796|ryasin1@jhu.edu|
270715|NCT00156910|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
270716|NCT00156923|Alkermes, Inc.|Bernard L. Silverman / VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
270717|NCT00156936|Alkermes, Inc.|Bernard L. Silverman / VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
270718|NCT00157014|Astellas Pharma Canada, Inc|Associate Director, Scientific Affairs||clinicaltrials@us.astellas.com|
271792|NCT00265512|VA Center for Innovation to Implementation|Todd Wagner|6504935000|todd.wagner@va.gov|22048
271793|NCT00265538|Iowa City VA Health Care System|Dr. Peter Kaboli|319-338-0581|Peter.kaboli@va.gov|
295418|NCT01619410|University of Pennsylvania|Michael Z. David/Assistant Professor|215-662-6932|michdav@pennmedicine.upenn.edu|
295419|NCT01619423|PledPharma AB|Stefan Carlsson, MD, PhD, Chief Medical Officer|+46 8 679 72 10|stefan.carlsson@pledpharma.se|
295420|NCT01619579|VA Medical Center & UCSD Center for Pain Medicine|Tobias Moeller-Bertram, MD|858-552-8585|tmoellerbertram@ucsd.edu|3123
295421|NCT01619774|University of Texas (UT) MD Anderson Cancer Center|Michael Davies, Associate Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
295422|NCT01619787|SUNYBuffalo|Leonard H. Epstein|716-829-3400|ckk@buffalo.edu|
295423|NCT01619839|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
295424|NCT01619852|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
295425|NCT01619865|University of Iowa Holden Comprehensive Cancer Center|Sue O'Dorisio, MD, PhD|319-356-7873|sue-odorisio@uiowa.edu|
295426|NCT01619878|Novartis Pharmaceuticals|Study Director|862-778-8300||
295427|NCT01619982|Stanford University|Chandra Ramamoothy|650-723-5728|chandrar@stanford.edu|
295428|NCT01620047|Gulf-to-Bay Anesthesiology Associates LLC|Director of Research|813-844-4413|rkarlnoski@fgtba.com|
295429|NCT01620060|Sunovion|Medical Director, CNS|1-866-503-6351||
307172|NCT02472262|Washington University School of Medicine in St. Louis|Mark Manary|3144542178|manarymj@wustl.edu|
307173|NCT02472314|Wayne State University School of Medicine and Cleveland Clinic Florida|Vani J. Sabesan, MD|131375138489|sabes001@gmail.com|
307174|NCT02472353|Avera|Stacy Kehoe|605.322.3082|Stacy.Kehoe@avera.org|
307175|NCT02472366|Hopital Lariboisiere|Professor Pascale Massin|0149 95 24 74|pascale.massin@lrb.aphp.FR|
307176|NCT02472405|University of Miami|Keyvan Nouri MD|305-243-3380|KNouri@med.miami.edu|
307177|NCT02472457|The Children's Hospital of Philadelphia|Ronen Stein, MD|215-590-7801|ibdresearch@email.chop.edu|
307178|NCT02472522|Tata Main Hospital, Jamshedpur, India|Specialist, Anaesthesia & Critical Care|91-9431166582|debsanjay@gmail.com|
307179|NCT02472652|Thomas D Gazda MD PC|Thomas D Gazda MD|480 518 6299|goodgazda@yahoo.com|
307180|NCT02472730|Baylor College of Medicine|Dr. Kalpesh K. Patel|7137980947|kalpeshp@bcm.edu|
307181|NCT02472756|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
307182|NCT02472795|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 1977|clinical-trials-disclosure@idorsia.com|
295430|NCT01620086|University of Arkansas for Medical Sciences|Erik Messias, MD|501-526-8142|emessias@uams.edu|
295431|NCT01620138|Universidade Federal do Rio de Janeiro|Monica Gadelha|+552139382323|mgadelha@hucff.ufrj.br|
295432|NCT01620177|National Advanced Driving Simulator|Dr. Timothy L. Brown, Co-PI|319-335-4785|timothy-l-brown@uiowa.edu|
295433|NCT01620190|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
295434|NCT01620216|OHSU|Dr. Stephen Spurgeon|5034948950|spurgeos@ohsu.edu|
295435|NCT01620255|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
295436|NCT01620489|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
295437|NCT01620528|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
295438|NCT01620567|Tufts University|Elizabeth J. Johnson, PhD|617.556.3204|elizabeth.johnson@tufts.edu|
295439|NCT01620593|UT Health San Antonio Cancer Center|Sukeshi Arora, MD|210-450-1015|aroras@uthscsa.edu|
295440|NCT01620658|Baptist Health South Florida|Raul Herrera, MD. Director Miami Cardiac and Vascular Institute, Research and Outcomes|786-596-3505|raulh@baptisthealth.net|
295441|NCT01620762|Circassia Ltd|VP Clinical Operations|+44 1865 405560||
295442|NCT01620983|Virginia Commonwealth University|Dr. Daniel L. Riddle|804-828-0234|dlriddle@vcu.edu|
295443|NCT01621009|University of Wisconsin Center for Tobacco Research and Intervention|Timothy Baker, PhD, Director of Research|(608) 262-7568|tbb@ctri.wisc.edu|
295444|NCT01621126|Massachusetts General Hospital|Dr. Jon J.P. Warner, Chief of Shoulder Service MGH, Harvard Professor of Orthopaedics.|617-724-3140|jwarner@mgh.harvard.edu|
295445|NCT01621178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295446|NCT01621191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295447|NCT01621230|UTexasSouthwestern|Margaret Craig, MD|2142638919|maggieanes@gmail.com|
295448|NCT01621477|St. Jude Children's Research Hospital|Brandon M. Triplett, MD|901-595-2766|brandon.triplett@stjude.org|
307183|NCT02472847|University of Illinois at Chicago|Dr. K. Luan Phan|312-355-5954|klphan@psych.uic.edu|
307184|NCT02472886|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
307185|NCT02472977|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Clinical.Trials@bms.com|Clinical.Trials@bms.com|
307186|NCT02473250|Columbia University Irving Medical Center|Martin Lan MD PhD|646 774 7610|martin.lan@nyspi.columbia.edu|
307187|NCT02473289|Janssen Research & Development, LLC|ASSOCIATE DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
307188|NCT02473367|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307189|NCT02473393|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
307190|NCT02473471|Jordanian University of science and Technology|Dr.Amal Alkebsi|00966552358684|amalkibsi@gmail.com,aalkebsi13@den.just.edu.jo|
307191|NCT02473510|MedImmune, LLC|Ashwin Swami, MD|+1 301 398 5000|information.center@astrazeneca.com|
307192|NCT02473614|University of California at Irvine|Dr. Kelli Sharp|9495107968|ksharp@uci.edu|
307193|NCT02473640|Synthetic Biologics Inc.|Michael Kaleko, M.D.|(240) 238-3862|mkaleko@syntheticbiologics.com|
307194|NCT02473718|University of Texas Southwestern Medical Center|Catherine Chen|214-648-9095|catherine.chen@utsouthwestern.edu|
307195|NCT02473783|Tri-Service General Hospital, National Defense Medical center|Dr. Chin-bin Yeh|886-2-87923311|chinbinyeh@gmail.com|17387
307196|NCT02473913|University of Chicago|Stephanie Valle|773-834-3778|svalle@yoda.bsd.uchicago.edu|
307197|NCT02473952|Grifols Therapeutics, LLC|Rhonda Griffin, BSN|919-316-6693|Rhonda.Griffin@Grifols.com|
307198|NCT02473965|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
307199|NCT02473991|ain shams university maternity hospital|prof Dr khaled ebrahim abdalla|00201023220701|drkhaled_abdallah@med.asu.edu.eg|
307200|NCT02474069|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
307201|NCT02474082|Novartis Pharmaceuticals|Study Director|862 -778- 8300||
307202|NCT02474199|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
307203|NCT02474355|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
307204|NCT02474407|SK Bio-pharmaceuticals Co, Ltd|Lee Min Jae, Associate Manager||minj.lee@sk.com|
307205|NCT02474498|Piracicaba Dental School - University of Campinas|Prof.Dr. Enilson Antonio Sallum|+55 19 2106-5301|easallum@fop.unicamp.br|
307206|NCT02474589|SIGA Technologies|Dennis E Hruby, PhD, Chief Scientific Officer|541-753-2000|dhruby@siga.com|
307207|NCT02474901|University of Colorado|Adriana Weinberg, MD|3037244480|adriana.weinberg@ucdenver.edu|
307208|NCT02475031|Indiana University School of Medicine - Anesthesia Division|Dr. Yar Yeap|317-274-0275|yyeap@iupui.edu|
307209|NCT02475070|Lund University|Dr Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
307210|NCT02475265|Massachusetts General Hospital|Dr. Pouneh Fazeli|617-726-3870|pkfazeli@partners.org|
307211|NCT02475278|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
307212|NCT02475369|BIDMC|Caitlin Barrett|617-667-8266|cbarret5@bidmc.harvard.edu|
307213|NCT02475395|Sandstone Diagnostics|Cheif Science Officer|9253157246|gsommer@sandstonedx.com|925
307214|NCT02475564|Hospital de Clínicas de Porto Alegre, RS|Dr. Ricardo Francalacci Savaris|+55 51 33598653|rsavaris@hcpa.edu.br|
307215|NCT02475629|TaiMed Biologics USA Corp.|Manager - Clinical Services|(949) 331-3225|bbell@taimedbio.com|
307216|NCT02475655|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
307217|NCT02475733|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307218|NCT02475837|Stanford University|Ken Mahaffey MD|650.723.3096|kmahaf@stanford.edu|
307219|NCT02475850|Yale University|Erich Greene PhD|203-737-3636|erich.greene@yale.edu|
307220|NCT02475954|Rutgers - Robert Wood Johnson Medical School|Roseanne D. Dobkin|732-235-4051|dobkinro@rutgers.edu|
295449|NCT01621490|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
295450|NCT01621542|Sunovion Pharmaceuticals Inc.|WT2725 Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
295451|NCT01621633|Novartis Pharmaceuticals|Study Director|862-778-8300||
295452|NCT01621672|University of Arkansas for Medical Sciences|Bart Barlogie|526-6990|barlogiebart@uams.edu|2420
295453|NCT01621776|University of Florida|Janet Silverstein, MD|352-334-1390|silvejh@peds.ufl.edu|
295454|NCT01621802|GlaxoSmithKline|GSK Response Center|866-435-7343||
295455|NCT01621880|Sun Yat-sen Memorial Hospital, Sun Yat-sen University|Yamei Tang|08613556001992|yameitang@hotmail.com|
295456|NCT01622010|St. Boniface Hospital|Kelly Codispodi BMR PT|204-237-2138|kcodispodi@sbgh.mb.ca|
295457|NCT01622231|GlaxoSmithKline|GSK Response Center|866-435-7343||
307221|NCT02475980|University of New Mexico Health Sciences Center|Nancy Sokkary, MD|email|HSC-FamilyPlanningResearch@salud.unm.edu|
307222|NCT02476006|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
307223|NCT02476032|University of Minnesota|Patricia Lenton Director of Oral Health Research Clinic||lento001@umn.edu|
307224|NCT02476175|CHU de Quebec-Universite Laval|Dr Stephane Bolduc||Stephane.Bolduc@fmed.ulaval.ca|
307225|NCT02476201|Abbott Medical|Pilar Santamaria|+34 917 278 964|pilar.santamaria@abbott.com|
307226|NCT02476357|Lausanne University Hospita! and University of Lausanne|Prof. Dr Med. Maurice MATTER|795561071|maurice.matter@chuv.ch|0041
307227|NCT02476422|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
307228|NCT02476448|Cleveland Clinic Florida|Dr. Eric Hurtado|954-659-5559|hurtade@ccf.org|
307229|NCT02476565|Vanderbilt University Medical Center|Antonio Hernandez, MD|615 322-4650|antonio.hernandez@vanderbilt.edu|
307230|NCT02476578|CLALIT HEALTH SERVICES|Dr. Nir Tsabar|+97246049512|NIR.TSABAR@CLALIT.ORG.IL|
307231|NCT02476617|AbbVie|Global Medical Services|800-633-9110||
307232|NCT02476890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307233|NCT02477020|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
307234|NCT02477111|Cordis, A Cardinal Health Company|Katherine Braun, Clinical Project Manager|602-622-9133|katherine.braun@cardinalhealth.com|
307235|NCT02477215|Medical College of Wisconsin|Parameswaran Hari|414-805-4600|phari@mcw.edu|
307236|NCT02477319|Seattle Children's Hospital|Umer Khan (Principal Biostatistician)|206-884-7516|umer.khan@seattlechildrens.org|
307237|NCT02477332|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
307238|NCT02477423|Neonatology, Department of Pediatrics, University of Chicago|Dr. Christina S. Kim|773-702-6210|christinakim13@gmail.com|
307239|NCT02477527|Midtown Medical Center|Edward W Braun, MD|8139353221|Dr.Braun@DrEdwardBraun.com|
307240|NCT02477553|Indiana University|Peter H. Schwartz, M.D., Ph.D.|317-278-4037|phschwar@iu.edu|
307241|NCT02477605|Alcon, A Novartis Division|Brand Lead, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
307242|NCT02477670|Avanir Pharmaceuticals, Inc.|Sanjay Dubé, M.D.|949-389-6700|SDube@avanir.com|
307243|NCT02477709|Afferent Pharmaceuticals, Inc.|Chief Medical Officer|650-286-1276|info@afferentpharma.com|
307244|NCT02477800|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
307245|NCT02477839|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
307246|NCT02478164|Dana-Farber Cancer Institute|Eudocia Q. Lee, MD, MPH|617-632-2166|eqlee@partners.org|
307247|NCT02478359|Kaiser Permanente|Huong Q2 Nguyen, Research Scientist|626-564-3935|huong.q2.nguyen@kp.org|
307248|NCT02478372|Golden Jubilee National Hospital|David McDonald|07914861078|david.mcdonald@nhs.net|
295458|NCT01622257|Assistant professor of Obstetrics & Gynecology, Ain-shams faculty of medicine|Dr. Moustafa Ibrahim|00201001955996|mi_monem@yahoo.com|
295459|NCT01622296|UCSF School of Dentistry|Dr. Susan Parveen Tavana|415-476-1891|susan.tavana@ucsf.edu|
295460|NCT01622348|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
295461|NCT01622543|The Ottawa Hospital - Cancer Centre|Dr. Derek Jonker|613-737-7700|djonker@ottawahospital.on.ca|70170
295462|NCT01622569|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
295463|NCT01622660|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
295464|NCT01622673|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295465|NCT01622699|Isala|Dr J Bekhof|0384247492|j.bekhof@isala.nl|+31
295466|NCT01623037|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulaory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
295467|NCT01623050|SinuSys Corporation|Janie Mandrusov, Director of Pre-Clinical and Clinical Development|4084104411|emandrusov@sinusys.com|
295468|NCT01623115|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
295469|NCT01623154|Otsuka America Pharmaceutical, Inc|Tao Wang, PhD|240-683-3213|Tao.Wang@otsuka-us.com|
295470|NCT01623167|National Heart Lung and Blood Institute (NHLBI)|Neal S. Young, M.D, NIH Principal Investigator|301-496-5093|youngns@nhlbi.nih.gov|
295471|NCT01623271|Massachusetts General Hospital|Jianren Mao, MD, PhD|617-724-6102|jmao@mgh.harvard.edu|
295472|NCT01623310|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
295473|NCT01623323|OptiNose|Jennifer Carothers|908-432-3061|jennifer.carothers@optinose.com|
295474|NCT01623466|Agile Therapeutics|Lisa Flood|609-683-1880|lflood@agiletherapeutics.com|
295475|NCT01623479|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
307249|NCT02478398|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307250|NCT02478463|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
307251|NCT02478489|Boston University School of Public Health and School of Medicine|Richard Saitz, MD MPH|(617) 358-1343|rsaitz@bu.edu|
307252|NCT02478580|University Of Texas Southwestern Medical Center|Dr. Enas Kandil|214-590-8509|Enas.Kandil@UTSouthwestern.edu|
307253|NCT02478632|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
307254|NCT02478671|Terumo Medical Corporation|Robert Gash, Director of Clinical Affairs|732-302-4931|robert.gash@terumomedical.com|
307255|NCT02479139|Allergan, Inc|Therapeutic Area Head,|1-877-277-8566|IR-CTRegistration@allergan.com|
307256|NCT02479412|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
307257|NCT02479763|Montreal General Hospital|Dr. De QH Tran|514-934-1934|de_tran@hotmail.com|43261
307258|NCT02479802|Grifols Bioscience Industrial Group|Miquel Barcelo, PhD|+34 935.712.368|Miquel.Barcelo@Grifols.com|
307259|NCT02479880|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
307260|NCT02480010|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
307261|NCT02480114|Vanderbilt University Medical Center|Derek Smith, DDS, PhD|6159367423|derek.k.smith@vumc.org|
307262|NCT02480153|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307263|NCT02480166|Stanford University Medical Center|Mindie H. Nguyen, MD, MAS|650-4985691|mindiehn@stanford.edu|
307264|NCT02480439|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
307265|NCT02480582|University of Leeds|Dr Graham Finlayson|0113 343 7601|g.s.finlayson@leeds.ac.uk|
307266|NCT02480621|Department of Orthopaedic Surgery, NYU Langone Orthopaedic Hospital|Dr. Adam Driesman|2033315938|Adam.Driesman@nyumc.org|
295476|NCT01623531|Department of Anesthesia, Dalhousie University, Halifax, Canada|Dr. Myron Kwapisz|+1 902 473 4326|myron.kwapisz@nshealth.ca|
295477|NCT01623596|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
295478|NCT01623739|UTHSCSA Periodontics|Guy Huynh-Ba|2105673569|huynhba@uthscsa.edu|
295479|NCT01623752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295480|NCT01623830|Emory University|Barbara Rothbaum|404-712-8866|brothba@emory.edu|
295481|NCT01623869|Memorial Sloan-Kettering Cancer Center|Sandra Pierina D'Angelo, M.D.||dangelos@mskcc.org|
295482|NCT01624090|National Cancer Institute|Dr. David S. Schrump|240-858-7000|schrumpd@nih.gov|
295483|NCT01624142|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
295484|NCT01624168|Appalachian State University|Dr. Karen Caldwell, Professor|828-262-6045|caldwellkaren@appstate.edu|
295485|NCT01624194|Stanford University|Antonio Y. Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
295486|NCT01624233|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
295487|NCT01624259|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295488|NCT01624350|Medtronic|Medtronic (Sponsor)|508.452.4095|michelle.v.disalvo@medtronic.com|
295489|NCT01624363|Indiana Universtiy Schol of Medicine|John DeWitt, MD, Director, Endoscopic Ultrasound|317-944-1113|jodewitt@iu.edu|
295490|NCT01624467|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295491|NCT01624506|Ethicon|Janet DeMarchi|612-867-8727|jdemarch@its.jnj.com|
295492|NCT01624662|OptiNose|Vice President Global Clinical Operations & Outsourcing|267-364-3508|jennifer.carothers@optinose.com|
295493|NCT01624870|Medtronic Bakken Research Center|Maarten Hollander|+31620534428|maarten.hollander@medtronic.com|
295494|NCT01624740|Boston Scientific|Nitzan Mekel-Bobrov, PhD|661-949-4537|Nitzan.Mekel-Bobrov@bsci.com|
295495|NCT01624948|UCSF|Allison Webber MD|415 353 8382|allison.webber2@ucsf.edu|
307267|NCT02480712|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
307268|NCT02480764|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
295496|NCT01624974|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295497|NCT01625000|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
282661|NCT00866905|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
295498|NCT01625013|University of California, San Francisco|Anthony Luke, MD|4155146120|Anthony.Luke@ucsf.edu|
295499|NCT01625091|Unversity of Florida|Dr. Robert Cook|352-273-5869|cookrl@ufl.edu|
295500|NCT01625104|University of Michigan|Eva Kline-Rogers MS, RN|734 9985909|evakline@med.umich.edu|
295501|NCT01625169|USC|LaShonda Spencer|323 226-6437|lspencer@usc.edu|
295502|NCT01625182|Novartis Pharmaceuticals|Study Director|862-778-8300||
295503|NCT01625221|Torax Medical, Inc.|VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
295504|NCT01625338|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
295505|NCT01625377|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
295506|NCT01625416|University of Washington|Dr. Douglas Zatzick|2067446701|dzatzick@uw.edu|
295507|NCT01625455|VANDERBILT UNIVERSITY MEDICAL CENTER|Nancy J. Brown, M.D., Principal Investigator|6153438701|nancy.j.brown@vanderbilt.edu|
295508|NCT01625507|University of Alberta|Dr. Catherine Chan|780-492-9939|cbchan@ualberta.ca|
295509|NCT01625689|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
295510|NCT01625845|Indiana University-Purdue University Indianapolis (IUPUI)|Jesse C. Stewart, Ph.D.|(317) 274-6761|jstew@iupui.edu|
295511|NCT01625897|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
295512|NCT01625910|University of Minnesota, Department of Family Medicine and Community Health|Steven D. Stovitz, MD, MS|612-310-2344|sstovitz@umphysicians.umn.edu|
295513|NCT01625923|University of Michigan|Allen Lee|734-936-9454|allenlee@umich.edu|
307269|NCT02480920|Department of Cardiology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey|Volkan Emren||vemren@hotmail.com|
307270|NCT02480998|The catholic university of Korea, Seoul ST. Marry's Hospital|Dr.Dong-suck Lim, CI|+82-2-2258-7327||
307271|NCT02481050|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
307272|NCT02481141|SBI Pharmaceuticals Co, Ltd.|Dr. Riyadh Rehani, President of MENA Region|+973 66394100|rrehani@sbigroup.co.jp|
307273|NCT02481206|Zoll|Director of Clinical Affairs|724-968-3333|mosz@zoll.com|
307274|NCT02481219|Given Imaging (a Medtronic company)|Liron Bar Yaakov|+97249097946|liron.bar-yaakov@covidien.com|
307275|NCT02481258|Mayo Clinic|Jordan D. Miller, Ph.D.|507-293-0813|Miller.Jordan@mayo.edu|
307276|NCT02481297|The University of Texas MD Anderson Cancer Center|Dr. Nitin Jain/Associate Professor|713-745-6080|njain@mdanderson.org|
307277|NCT02481375|University of British Columbia|Crystal Karakochuk|604 822 0421|crystal.karakochuk@ubc.ca|
307278|NCT02481440|The Third Affiliated Hospital of Sun Yat-sen University|Li-Min Rong M.D., Director of Clinical Trials|862085252900|ronglimin@21cn.com, ronglm@mail.sysu.edu.cn|
307279|NCT02481505|Sintetica SA, via Penate 5 Mendrisio|Elisabetta Donati Clinical Project Leader|+41.91.640.42.50|edonati@sintetica.com|
307280|NCT02481557|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
307281|NCT02481596|Vanderbilt University Medical Center|Lindsay S. Mayberry, PhD, MS|615-875-5821|lindsay.mayberry@vumc.org|
307282|NCT02481713|VA Connecticut Healthcare System|Joanna Fiszdon, PhD|2039325711|joanna.fiszdon@va.gov|2231
307283|NCT02481869|University of Missouri|Dr. James Cook|5738827615|cookjl@health.missouri.edu|
307284|NCT02481934|Hospital universitario 12 de octubre|Alejandra Leivas PhD|+34917792612|alejandraleial@gmail.com|4612
307285|NCT02481947|Braintree Laboratories, Inc.|Vice President, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
307286|NCT02482025|VA Greater Los Angeles Healthcare System|Steven R. Simon, MD|310.268.3132|steven.simon2@va.gov|
307287|NCT02482129|Alcon, A Novartis Division|Ophthalmology & Medical Lead, Translational Medicine, NIBR|1-888-451-3937|alcon.medinfo@alcon.com|
307288|NCT02482233|Royal Columbian Hospital / University of British Columbia|Dr. Susan Ming Lee|604-520-4253|susanlee.anesthesia@gmail.com|
307289|NCT02482298|AstraZeneca|Brilinta Global Clinical Leader|+46 31 776 10 00||
307290|NCT02482428|Novartis Pharmaceuticals|Study Director|862-778-8300||
307291|NCT02482571|University of Minnesota|Silvia Mangia, PhD|6126254920|mangia@umn.edu|
307292|NCT02482610|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
307293|NCT02482675|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
307294|NCT02482805|University of Texas at Austin|Michelle Davis|214-470-1371|michelledavis@utexas.edu|
307295|NCT02482870|Recep Tayyip Erdogan University School of Medicine|Dr. Başar Erdivanlı|+904642130491|berdivanli@gmail.com|2128
307296|NCT02482935|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
307297|NCT02483000|Fred Hutchinson Cancer Research Center|Dr. Ajay Gopal|206-606-2037|agopal@uw.edu|
307298|NCT02483416|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
307299|NCT02483520|University of Kansas School of Nursing|Kristine Williams, RN, PhD, FNP-BC, FGSA, FAAN, E. Jean Hill Professor|913 588-1673|Kwilliams1@kumc.edu|
307300|NCT02483572|University of Nebraska Medical Center|Wayne Fisher|4025598863|wfisher@unmc.edu|
295514|NCT01625988|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
307301|NCT02483585|Amgen Inc.|Study Director|866-572-6436||
307302|NCT02483611|University of Sao Paulo|Dra Waynice Neiva de Paula Garcia|551636021000|waynicegarcia@gmail.com|2211
307303|NCT02483676|Baltimore VA Medical Center VA Maryland Health Care System|Dr. Steven Kittner|410-706-0414|skittner@som.umaryland.edu|
307304|NCT02483975|GlaxoSmithKline|GSK Response Center|866-435-7343||
307305|NCT02484092|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307306|NCT02484222|the Children's Hospital of Fudan University|Dr.Wang Xuan|18017591058|18017591058@163.com|
307307|NCT02484443|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
307308|NCT02484547|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
307309|NCT02484651|Universidade Aberta, Mathematics Section|Prof. Catarina S Nunes|+351 300 001 705|cnunes@bio-mathematics.org|
307310|NCT02484690|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
307311|NCT02484729|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
307312|NCT02484807|Centre for pulmonary hypertension of the Thoraxclinic at the University Hospital Heidelberg|Professor Dr. med. Ekkehard Grünig|+4962213968053|ekkehard.gruenig@med.uni-heidelberg.de|
307313|NCT02484859|Recep Tayyip Erdoğan Üniversitesi|Dr. Başar Erdivanlı|04642130491|berdivanli@gmail.com|2128
307314|NCT02484898|Medtronic CRHF|Medtronic SEEQ Performance Clinical Trial Leader|1-800-328-2518|medtronicCRMtrials@medtronic.com|
281785|NCT02344108|Mass General Brigham|Matthew E Stenerson, MS, Clinical Research Project Manager|7155721100|matthew_stenerson@meei.harvard.edu|
295515|NCT01626079|Abbott|Sripad Bellary|4088458114|sripad.bellary@abbott.com|
295516|NCT01626092|Masonic Cancer Center, University of Minnesota|Weston P Miller, MD|612-626-2778|mill4991@umn.edu|
295517|NCT01626118|Iroko Pharmaceuticals, LLC|Daniel Solorio|267-546-3150|dsolorio@iroko.com|
295518|NCT01626352|Sarah Cannon Research Institute|Charles H. Davis|615-524-4341|charles.davis2@scri-innovations.com|
295519|NCT01626391|TauRx Therapeutics Ltd|Dr. Jiri Hardlund|+44 (0)1224438550|JHH@taurx.com|
295520|NCT01626456|Alkermes, Inc.|ARISTADA Medical Information|866-274-7823|usmedinfo@alkermes.com|
295521|NCT01626495|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
295522|NCT01626664|Kyowa Kirin Inc|Fiona Herr, Associate Director, Medical Communications|1 (908) 234-1096|medinfo-US@kyowakirin.com|
295523|NCT01626690|University of Wisconsin School of Medicine and Public Health|Dr. Kristopher Schroeder, MD|608-263-8100|kmschro1@wisc.edu|
295524|NCT01626820|GlaxoSmithKline|GSK Response Center|866-435-7343||
295525|NCT01626859|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
295526|NCT01626872|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
295527|NCT01626885|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
270719|NCT00157157|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
270720|NCT00157196|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
270721|NCT00157209|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
270722|NCT00157248|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
270723|NCT00157573|MGH DF/HCC|Richard T Penson MD MCCP|617-726-8566|rpenson@partners.org|
270724|NCT00157755|Medtronic Neuromodulation|Clinical Program Manager|763-526-8172|medtronicneurotrials@medtronic.com|
270725|NCT00157820|Hospital General Universitario de Valencia, Spain|Dr.A.Quesada||aquesadad@secardiologia.es|
270726|NCT00157950|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270727|NCT00158054|Columbia University Medical Center|Karina W Davidson, PhD|212-342-4493|kd2124@cumc.columbia.edu|
270728|NCT00158184|Substance Use Research Center|Dr. Sandra D. Comer|212-543-5981|sdc10@columbia.edu|
270729|NCT00158197|Friends Research Institute|Joy Chudzynski|323-333-8122|joychud@ucla.edu|
270730|NCT00158223|Icahn School of Medicine at Mount Sinai|Dr. Joseph I. Friedman|631-761-3607|joseph.friedman@mssm.edu|
270731|NCT00158249|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
270732|NCT00158262|Massachusetts General Hospital|Roger K. Pitman, M.D.|617-726-5333|roger_pitman@hms.harvard.edu|
270733|NCT00158379|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
270734|NCT00158600|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
270735|NCT00158743|BTG International Inc|Suzanne Ward Pharm D|610-278-1660|suzanne.ward@btgplc.com|
270736|NCT00158756|GlaxoSmithKline|GSK Response Center|866-435-7343||
270737|NCT00158860|GlaxoSmithKline|GSK Response Center|866-435-7343||
270738|NCT00158925|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
270739|NCT00159250|Imperial College London|Francesco Muntoni|+44 02075941872|f.muntoni@ucl.ac.uk|
270740|NCT00159263|Imperial College London|Peter Barnes|+44 (0)20 7594 7959|p.j.barnes@imperial.ac.uk|
270741|NCT00159419|Indiana University School of Medicine|Dr. Linda DiMeglio|317-944-3889||
270742|NCT00159432|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist|323-226-6384|victoria.soto@med.usc.edu|
270743|NCT00159822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270744|NCT00159861|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270745|NCT00159874|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270746|NCT00159913|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270747|NCT00159965|Rhode Island Hospital|W. Curt LaFrance, Jr., MD, MPH|401-444-3534|William_LaFrance_Jr@Brown.edu|
270748|NCT00160199|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32(0)2 509 69 77|sven.voet@solvay.com|
270749|NCT00160251|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
270750|NCT00160524|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
270751|NCT00160615|Cares|UCB|+1844 599||2273
270752|NCT00160641|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
270753|NCT00160654|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
270754|NCT00160667|Cares|UCB|+1844599|UCBCares@ucb.com|2273
270755|NCT00160680|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
270756|NCT00160693|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
270757|NCT00160706|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
270758|NCT00161213|UMDNJ|Dr. Susan Goodin (Deputy Director, Associate Director for Clinical Science)|732-235-6783|goodin@umdnj.edu|
270759|NCT00161382|The University of Texas Health Science Center at Houston (UTHealth) School of Public Health|Dr. Susan R. Tortolero|713-500-9634|Susan.Tortolero@uth.tmc.edu|
270760|NCT00161473|VA Puget Sound Healthcare System|Lucy Y. Wang, M.D.|206-277-5089|wanglucy@u.washington.edu|
270761|NCT00161616|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
295528|NCT01626989|Philips|Jeremy Powers|412-542-3669|jeremy.powers@philips.com|
307315|NCT02484911|First Affiliated Hospital of Harbin Medical University|Dr.Zhang|85555068|daxinmay@126.com|
307316|NCT02485158|University of Chicago|Dr. Harriet de Wit|773-702-1537|hdew@uchicago.edu|
307317|NCT02485301|GlaxoSmithKline|GSK Response Center|866-435-7343||
307318|NCT02485353|IndianaU|Hamid Sayar, MD|317-948-7576|ssayar@iu.edu|
307319|NCT02485483|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
307320|NCT02485561|Washington University in St. Louis|Amy McQueen|3142862016|amcqueen@wustl.edu|
307321|NCT02485704|ParaPRO, LLC|Kerry W. Mettert, MBA, MT(ASCP)|317-810-6205|kerrym@parapro.com|
307322|NCT02485717|ParaPRO, LLC|Kerry W. Mettert, MBA, MT(ASCP)|317-810-6205|kerrym@parapro.com|
307323|NCT02485834|Weill Medical College of Cornell University|Manish A. Shah MD|646-962-6200|mas9313@med.cornell.edu|
307324|NCT02485912|University of Oxford|Adrian V Hill, DPhil FRCP||vaccinetrials@ndm.ox.ac.uk|
307325|NCT02485925|Biosense Webster, Inc.|Kendra McInnis|949-450-7783|kmcinnis@its.jnj.com|
270762|NCT00162032|Lantheus Medical Imaging|Cesare Orlandi, MD, Chief Medical Officer|978-671-8686|Cesare.Orlandi@lantheus.com|
295529|NCT01627002|ProtAffin Biotechnologie AG|ProtAffin Biotechnologie AG||office@protaffin.com|
295530|NCT01627067|UT MD Anderson Cancer Center|Dr. Vicente Valero, MD/ Professor, Breast Medical Oncology|713- 563-0751|vvalero@mdanderson.org|
295531|NCT01627249|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrstat2@jaeb.org|
295532|NCT01627288|Duke University Health System|Jennifer Mewshaw, MS RN|(919) 668-5211|Jennifer.Mewshaw@duke.edu|
295533|NCT01627327|GlaxoSmithKline|GSK Response Center|866-435-7343||
307326|NCT02485964|University of Arkansas for Medical Sciences|Beth Scanlan|5016868274|bscanlan@uams.edu|
295534|NCT01627340|GlaxoSmithKline|GSK Response Center|866-435-7343||
295535|NCT01627574|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-5562|lmurphy@uri.edu|
295536|NCT01627691|Boston Scientific|Anne Cornaille|+33608863659|anne.cornaille@bsci.com|
295537|NCT01627782|Janssen Research & Development, LLC|Senior Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
295538|NCT01627860|Janssen-Cilag Taiwan|Medical Director|886 2 23762155||
295539|NCT01628016|Hunan Normal University|Dr. Wenhui Yang|+86 731 8873076|yangwh110@163.com|
295540|NCT01628042|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295541|NCT01628107|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295542|NCT01628120|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295543|NCT01628159|BD|Director of Clinical Affairs|763-445-2385|anna.lovas@bd.com|
307327|NCT02486016|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchomb (PI)|410-706-2646|astinchc@rx.umaryland.edu|
307328|NCT02486211|University of Pittsburgh|Dr. Jon Rittenberger|4126479489|rittjc@upmc.edu|
307329|NCT02486263|Nationwide Children's Hospital|Dr. Sudarshan Jadcherla|614-355-6643|sudarshan.jadcherla@nationwidechildrens.org|
270763|NCT00162097|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
270764|NCT00162123|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
295544|NCT01628198|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
295545|NCT01628250|Ruijin Hospital, Shanghai Jiao Tong University School of Medicine|Dr. Bo Feng|021-64458887|fengbo2022@163.com|
270765|NCT00162136|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
295546|NCT01628367|University of Michigan|Dr. Hom-Lay Wang|734-647-6175|homlay@umich.edu|
295547|NCT01628393|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
295548|NCT01628510|Washington University|Roberta Pineda|314-286-1304|pineda_r@kids.wustl.edu|
307330|NCT02486302|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307331|NCT02486328|Ufuk University Faculty of Medicine|Dr Perihan Ekmekçi|+903122044000|erdogduperi@gmail.com|
307332|NCT02486406|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
307333|NCT02486588|Kaiser Permanente Northern California Division of Research|Anjali Gopalan|510-891-3458|Anjali.Gopalan@kp.org|
307334|NCT02486627|Achaogen, Inc.|Clinical Trials Registration Group||clinical-trials@achaogen.com|
307335|NCT02486653|University of Wisconsin - Madison|Dr. Evie Carchman, MD|608-263-2521|carchman@surgery.wisc.edu|
307336|NCT02486692|Ralph H. Johnson VAMC|Anouk Grubaugh|843-532-6672|grubaugh@musc.edu|
307337|NCT02486757|Massachusetts General Hospital|Dr. Natalie Shaw||natalie.shaw@nih.gov|
307338|NCT02486796|Midwestern Regional Medical Center, Inc.|Director of ClinicalResearch|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
307339|NCT02486939|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
307340|NCT02486952|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
307341|NCT02487030|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
270766|NCT00162266|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
270767|NCT00162981|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
270768|NCT00163020|Obstetrix Medical Group, Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@pediatrix.com|
270769|NCT00163189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270770|NCT00163215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270771|NCT00163293|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
270772|NCT00163657|Baylor University Medical Center|Goran Klintmalm, MD Director|214-820-2050|michelle.acker@baylorhealth.edu|
270773|NCT00165646|Eisai Co.,Ltd. Eisai Product Creation Systems|Nobuyuki Sugisaki, Study Director|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp|
270774|NCT00165672|Eisai Co.,Ltd. Eisai Product Creation Systems|Nobuyuki Sugisaki, Study Director|+81-3-3817-3908|n-sugisaki@hhc.eisai.co.jp|
270775|NCT00165698|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affaires|81-3-3817-3914||
270776|NCT00165776|Eisai Co., Ltd.|Hiroki Shimizu, Study Director|+81-3-3817-5245||
270777|NCT00165789|Eisai Call Center|Eisai Inc.|888-422-4743||
271794|NCT00265564|Office of Mental Health Operation, Veterans Health Administration|Jodie Trafton, Director Program Evaluation and Resource Center|650-493-5000|Jodie.Trafton@va.gov|22474
271795|NCT00265616|CHUV Lausanne|Dr Andrea O. Rossetti|+41 21 314 1190|andrea.rosseti@chuv.ch|
271796|NCT00265759|Baylor College of Medicine|Matthew J. Ellis, MB, BChir, BSc., PhD, FRCP|713 798-1999|Matthew.Ellis@bcm.edu|
271797|NCT00265785|SWOG Statistical Center|Study Statistician|206-667-4623||
271798|NCT00265798|University of Chicago|Dr. Hedy L. Kindler|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
271799|NCT00265850|Alliance for Clinical Trials in Oncology|Alan Venook, M.D.||Venook@cc.ucsf.edu|
271800|NCT00265889|Case Comprehensive Cancer Center|Brian Bowell, MD|216-444-6922|bolwelb@ccf.org|
271801|NCT00265941|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
271802|NCT00265980|Professor of Pediatrics and Medicine at the Columbia University|Michael Rosenbaum, MD|212-305-9949|mr475@cumc.columbia.edu|
271803|NCT00266032|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
271804|NCT00266110|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
271805|NCT00266227|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
307342|NCT02487056|Cardiovascular Academy Society|Dr. Mehdi Zoghi|3904001|mehdi_zoghi@hotmail.com|
307343|NCT02487199|AbbVie|Global Medical Services|800-633-9110||
295549|NCT01628523|Washington University in St. Louis|Brian M Fuller|3147475368|fullerb@wusm.wustl.edu|
295550|NCT01628549|Allergan|Thearpeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
295551|NCT01628588|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
295552|NCT01628601|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
295553|NCT01628614|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
295554|NCT01628692|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
295555|NCT01628718|Massachusetts Veterans Epidemiological Research and Information Center|Brett T. Litz, PhD|617-584-9314|litzb@bu.edu|
295556|NCT01628848|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6131-7366||
295557|NCT01628874|Children's Hospital Colorado|Dr. Ryan Caltagirone|303-521-8563|ryan.caltagirone@childrenscolorado.org|
295558|NCT01628913|Novartis Pharmaceuticals|Study Director|862-778-8300||
307344|NCT02487225|Mayo Clinic|Dr. Santhi Swaroop Vege|507-284-7474|Vege.Santhi@mayo.edu|
307345|NCT02487303|Medical University of South Carolina|Sylvia Wilson|8437921414|wilsosh@musc.edu|
307346|NCT02487446|Novartis Pharmaceuticals|Study Director|862-778-1873||
307347|NCT02487472|GlaxoSmithKline|GSK Response Center|866-435-7343|lzr30020@gsk.com|
307348|NCT02487485|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
295559|NCT01628926|Otsuka Pharmaceutical Co, Lts.|Director of Clinical Research and Development|+81-3-6361-7366||
295560|NCT01628965|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
295561|NCT01629134|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
295562|NCT01629290|University of Michigan School of Dentistry|Danika Downey, DDS|330-877-8783|danika.downey@gmail.com|
295563|NCT01629381|University of Padua|Dr. Giuseppe Camporese|049 8212882|giuseppe.camporese@aopd.veneto.it|+39
295564|NCT01629563|PregLem|Dr Pablo Arriagada|0041228840355|info@preglem.com|
295565|NCT01629589|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
295566|NCT01629615|SOLTI|Scientific Manager|(+34) 93 343 63 02|pamela.celiz@gruposolti.org|
295567|NCT01629667|MedImmune, LLC|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
295568|NCT01629693|Alcon Research, Ltd.|Jessie Lemp, GMA Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
295569|NCT01629706|Alcon Research, Ltd.|Alan Landers, Project Head, Vision Care R&D|1-888-451-3937|alcon.medinfo@alcon.com|
307349|NCT02487498|Novartis Pharmaceuticals|Study Director|862-778-1873||
307350|NCT02487563|Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University|Yaqiong Tang|+86 18896588075|tangyaqiong@suda.edu.cn|
307351|NCT02487771|University of Kansas Medical Center|Susan Carlson, PhD|(913) 588-5359|SCARLSON@kumc.edu|
307352|NCT02487810|Fostering Improvement in End-of-Life Decision Science (FIELDS) Program|Beth Cooney, Assistant Director of FIELDS Program|215-573-9461|elcooney@exchange.upenn.edu|
307353|NCT02487966|Spaulding Rehabilitation Hospital|Dr. Felipe Fregni|6179526158|fregni.felipe@mgh.harvard.edu|
307354|NCT02488005|Icahn School of Medicine at Mount Sinai|Becky Phan|212-824-7785|becky.phan@mssm.edu|
307355|NCT02488018|Addis Ababa University [Office telephone +251011-655-1927]|Abera Belay (PhD Candidate)|Mobile +251911840655|ab.berabelay@gmail.com|
307356|NCT02488070|Stanford University|Andrei Iagaru, MD|650-725-4711|aiagaru@stanford.edu|
307357|NCT02488109|University of California, San Francisco, Department of Pediatrics|Andrea Garber, PhD, RD|415-514-2180|andrea.garber@ucsf.edu|
295570|NCT01629771|Northwestern University|Clinical Trials Unit Coordinator|312-695-6829|j-bae@northwestern.edu|
295571|NCT01629784|Northwestern University|Hae Bae, CRCC|312-695-6829|j-bae@northwestern.edu|
295572|NCT01629797|Northwestern University|Hae Bae|312-695-6829|j-bae@northwestern.edu|
295573|NCT01629823|ALA-ACRC|Janet T Holbrook, PhD, MPH|443-287-3170|jholbro1@jhu.edu|
295574|NCT01629862|University of Pittsburgh|Sanjay Patel|412-692-2035|patelsr2@upmc.edu|
295575|NCT01629953|VA North Texas Health Care System|James LePage, Ph.D. Chief Research and Development|214-857-0240|james.lepage@va.gov|
295576|NCT01629966|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
295577|NCT01630109|Genesys Regional Medical Center Office of Research|Dr. Steven Brooks|8106067722|Steven.Brooks@genesys.org|
295578|NCT01630135|GlaxoSmithKline|GSK Response Center|866-435-7343||
307358|NCT02488239|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
307359|NCT02488317|Arbor Research Collaborative for Health|Dr. Francesca Tentori|7346654108|francesca.tentori@arborresearch.org|
307360|NCT02488330|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
307361|NCT02488681|Medtronic|Micra CA Study Manager|800-328-2518|rs.micracontinuedaccess@medtronic.com|
271806|NCT00266279|University of Louisville, James Graham Brown Cancer Center|University of Louisville, James Graham Brown Cancer Center Clinical Trials|502-562-3429|bcccto@louisville.edu|
307362|NCT02488824|VAORD|Dr John Handrakis|(718) 584-9000|John.Handrakis@va.gov|5439
270778|NCT00165841|Eisai Medical Research Inc.|Yufang Lu, Study Director|201-403-2500||
270779|NCT00165958|Emory University|Dr. Suephy Chen|4047783084|schen2@emory.edu|
270780|NCT00165984|Emory University|Paul Kirshbom|404-785-6330|pkirshb@emory.edu|
270781|NCT00166036|Emory University|Arshed A Quyyumi, MD|404 712 2741|aquyyum@emory.edu|
270782|NCT00166114|University of Miami School of Medicine|Dominique Musselman, MD, MSCR|404-723-8361|dmusselman@med.miami.edu|
270783|NCT00166166|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
270784|NCT00166205|Worldwide Clinical Operations|Sheryl Helsinger, Director|513-337-3079|shelsing@its.jnj.com|
270785|NCT00166296|Hospital Universitari Germans Trias i Pujol, Autonomous University of Barcelona|Crisanto Diez-Quevedo|+34934978814|cdiezquevedo.germanstrias@gencat.cat|
270786|NCT00166361|Mayo Clinic|Dr. Lance A. Mynderse|507-284-1250|mynderse.lance@mayo.edu|
307363|NCT02488915|Neuravi Ltd|Mairsíl Claffey|0035391394123|mclaffey@neuravi.com|
270787|NCT00166439|Mayo Clinic|Patrick B. Johnston, M.D., Ph.D.|507/284-5362|johnston.patrick@mayo.edu|
270788|NCT00166517|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270789|NCT00166712|Comprehensive Transplant Center, Northwestern University|Joseph Leventhal, MD, PhD, Associate Professor|(312) 695-1703|jleventh@nmh.org|
270790|NCT00167102|University of Minnesota|Dr. Maria Hordinsky|612-624-5721|hordi001@umn.edu|
270791|NCT00167180|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-625-7409|mille011@umn.edu|
270792|NCT00167206|Masonic Cancer Center, University of Minnesota|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
270793|NCT00167245|University of Pennsylvania|Dr. Kyle Kampman|2152223200|kampman@mail.med.upenn.edu|109
270794|NCT00167310|UPittsburgh|Dr. Jeffrey K. Yao, Research Professor|412-360-6781|jkyao@pitt.edu|
295579|NCT01630200|Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology|Dr. Matthias Urban|+43(0)6508125980|matthias.urban1@gmx.net|
295580|NCT01630616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295581|NCT01630694|University of Rochester|Jacek Wojtczak|585-273-2972|jacek_wojtczak@urmc.rochester.edu|
295582|NCT01630811|Sutter Medical Group, Neurology|Michael Chez, MD|(916) 454-6667|ChezM@sutterhealth.org|
295583|NCT01630889|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|059study@fibrogen.com|
295584|NCT01631071|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
295585|NCT01631110|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
295586|NCT01631149|Leiden University Medical center|Dr. Albert Dahan|3171 526 2301|a.dahan@lumc.nl|
295587|NCT01631188|Rutgers University|Enrique Pantin, MD|7328900640|pantinej@rwmjs.rutgers.edu|
295588|NCT01631214|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
295589|NCT01631227|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
307364|NCT02488980|Penn State Hershey Infectious Diseases|Jose Stoute, MD|800-243-1455|noemail@no.com|
295590|NCT01631331|Stanford University|Dr. Gina Kwon|650-724-3859|gkwon@stanford.edu|
295591|NCT01631435|Given Imaging- Covidien|Ravit Peled , Clinical trials manager|+972 (4) 909-7894|Ravit.peled@covidien.com|7894
295592|NCT01631474|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
295593|NCT01631552|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
295594|NCT01631630|National Institute on Alcohol Abuse and Alcoholism|Diazgranados, Nancy|+1 301 435 9386|nancy.diazgranados@nih.gov|
295595|NCT01631656|WakeForest University Health Sciences|Dr Amy McMichael|336-716-3775|amcmicha@wakehealth.edu|
295596|NCT01631682|Massachusetts General Hospital|Scott P. Orr, Ph.D.|617-643-7269|scott_orr@hms.harvard.edu|
295597|NCT01631747|Northwestern University|Mary J. Kwasny|312-503-2294|m-kwasny@northwestern.edu|
295598|NCT01631812|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
295599|NCT01631825|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
307365|NCT02489045|Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
307366|NCT02489110|Photozig, Inc.|Bruno Kajiyama|6506947595|info@photozig.com|
307367|NCT02489123|University of Washington|Ajay K. Gopal, MD|206-606-2037|agopal@uw.edu|
307368|NCT02489227|Coherus BioSciences, Inc.|Barbara K. Finck, MD|650-649-3530|bfinck@coherus.com|
307369|NCT02489279|Think Now, Inc.|Dr. Gregory V. Simpson|4156016522|greg@think-now.com|
307370|NCT02489344|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
295600|NCT01631864|Novartis Pharmaceuticals|Study Director|862-778-8300||
307371|NCT02489357|Johns Hopkins University/Sidney Kimmel Cancer Center|Emmanuel Antonarakis, MD|410-502-7528|eantona1@jhmi.edu|
295601|NCT01631929|HOSPITAL GENERAL DE NIÑOS PEDRO DE ELIZALDE|Ferreira Juan Pablo MD|+5491136085959|ferreirajuanpablo@hotmail.com|
295602|NCT01632150|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
295603|NCT01632202|Weill Cornell Medicine|Sr. Research Compliance Specialist|646-962-4065|lao2003@med.cornell.edu|
295604|NCT01632215|Federal University of São Paulo|Dr. Rioko K. Sakata|055 11 5084 7463|riokoks.dcir@epm.br|
295605|NCT01632241|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
295606|NCT01632267|AssureRx|Joel Winner, MD|513-234-0510|jwinner@assurerxhealth.com|
295607|NCT01632280|Beth Israel Deaconess Medical Center|Dr. Miguel Alonso-Alonso|617-667-0240|malonso@bidmc.harvard.edu|
270795|NCT00167388|University of Pittsburgh|Dr. Toby Yanowitz|412-641-4111|yanotd@mail.magee.edu|
270796|NCT00167414|University of Rochester|Hong Zhang|585-341-6750|hong_zhang@urmc.rochester.edu|
270797|NCT00167544|Nationwide Children's Hospital Clinical Research Institute|Dr. Nehal Parikh|614-355-6657|nehal.parikh@nationwidechildrens.org|
270798|NCT00167661|University of Wisconsin - Madison|Dr. Sharon Bartosh|(608) 265-6020|smbartosh@wisc.edu|
270799|NCT00167778|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|Glenn K. Klute, PhD|206-277-6724|Glenn.Klute@va.gov|
270800|NCT00167934|Washington University School of Medicine|Michael Yingling|573-579-1412|yinglingm@wustl.edu|
295608|NCT01632306|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295609|NCT01632345|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307372|NCT02489500|Boston Medical Center|Vaishali Sanchorawala, MD|6176388261|sfenness@bu.edu|
307373|NCT02489630|Virginia Tech SOM / Carilion Clinic (prior)|Dr Karen J Bowers, co-PI|678-591-7280|bowerskj@gmail.com|
307374|NCT02489734|Children's Hospital of Fudan University|Dr. Xuan Wang|021-18017591058|13818318679@139.com|
307375|NCT02489773|Asahi Kasei Pharma Corporation|Takuji Kohzuma PhD|+81-3-3296-3617|kouzuma.tb@om.asahi-kasei.co.jp|
307376|NCT02489799|The Johns Hopkins University School of Medicine|Rebecca Aslakson, M.D., Ph.D.|410-955-9082|raslaks1@jhmi.edu|
307377|NCT02489968|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
307378|NCT02489981|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
307379|NCT02490293|SeoulStmary's hospital|Tae-ho Hong|010-5206-5266|gshth@catholic.ac.kr|
307380|NCT02490371|QEHHongKong|Dr. Helen LUK|852-9208 5366|clkyz02@ha.org.hk|
307381|NCT02490475|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
307382|NCT02490631|Vanderbilt University Medical Center|Elizabeth Card|615-875-4611|elizabeth.b.card@vumc.org|
307383|NCT02490670|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
307384|NCT02490878|MD Anderson Cancer Center|Caroline Chung, MD|(713) 745-5422|cchung3@mdanderson.org|
307385|NCT02491073|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351||
307386|NCT02491359|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
307387|NCT02491437|Abbott|Erik van Leeuwen MSc, PMP|+31294479241|erik.vanleeuwen@abbott.com|
307388|NCT02491463|GlaxoSmithKline|GSK Response Center|866-435-7343||
307389|NCT02491671|Hospital Universitario de Salamanca|Dr. Marcelo Jiménez|923291100|mfjl@usal.es|
271807|NCT00266409|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
271808|NCT00266630|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271809|NCT00266656|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271810|NCT00266695|Chromaderm|info@chroma-derm.com|info@chroma-derm.com||
295610|NCT01632423|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
307390|NCT02491684|AstraZeneca|Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
295611|NCT01632566|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295612|NCT01632579|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295613|NCT01632683|Oregon Health & Science University|Michael Aziz, MD|503-494-5581|azizm@ohsu.edu|
295614|NCT01632709|Rehabilitation Institute of Chicago|Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
295615|NCT01632735|Azusa Pacific University|Dr. Rachel Gonzales Castaneda|6268156000|rcastaneda@apu.edu|2744
295616|NCT01632800|Weinberg Medical Physics LLC|Irving Weinberg MD PhD|3013467944|inweinberg@gmail.com|
295617|NCT01632878|Mylan|Patrick Aubonnet / Medical Director||patrick.aubonnet@mylan.com|
295618|NCT01632891|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
295619|NCT01632904|Incyte Corporation|Study Director|855 463-3463||
295620|NCT01632995|Bridge HIV, San Francisco Department of Public Health|Dr. Albert Liu, Clinical Research Director|415-437-7408|albert.liu@sfdph.org|
295621|NCT01633060|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
295622|NCT01633112|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
295623|NCT01633320|Edouard Herriot hôspital Anaesthesia and intensive care|Dr Emmanuel Boselli|+334711689|emmanuel.boselli@chu-lyon.fr|
295624|NCT01633398|National University Health System, Singapore|Carolyn Lam|(65)67048965|carolyn.lam@duke-nus.edu.sg|
295625|NCT01633788|Allergan plc|Ronald Bradford|1-714-846-5486|Bradford_Ron@allergan.com|
295626|NCT01633827|Brigham and Women's Hospital|David Andrew Wellman|617-732-8483|awellman@rics.bwh.harvard.edu|
295627|NCT01633853|Peking University Internetional Hospital|Dr. Zhang Dongliang|+86-10-69006561|zhangdongliang@pkuih.edu.cn|
295628|NCT01633892|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
295629|NCT01633944|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
307391|NCT02491788|Stanford University|Dr. Jamie Zeitzer|16504935000|jzeitzer@stanford.edu|
307392|NCT02491892|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
307393|NCT02491944|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
307394|NCT02492100|Massachusetts General Hospital|Areej El-Jawahri|248-763-3912|ael-jawahri@partners.org|
307395|NCT02492165|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
270801|NCT00168038|CSL Behring|Clinical Trial Disclosure Manager||clinicaltrials@cslbehring.com|
270802|NCT00168064|Yaupon Therapeutics|H. Jeffrey Wilkins, MD|4843247935|hjwilkins@yaupontherapeutics.com|935
270803|NCT00168103|CSL Behring|Clinical Program Director|Use email contact|clinicaltrials@cslbehring.com|
270804|NCT00168298|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
270805|NCT00168311|Monash Alfred Psychiatry Research Centre|Professor Paul Fitzgerald|+61 3 9076 6564|p.fitzgerald@alfred.org.au|
270806|NCT00168324|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
270807|NCT00168337|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
270808|NCT00168389|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
270809|NCT00168428|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
270810|NCT00168454|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
270811|NCT00168805|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
270812|NCT00168818|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
270813|NCT00168831|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
270814|NCT00168844|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
270815|NCT00169104|Dartmouth-Hitchcock Medical Center / Norris Cotton Cancer Center|Gary N. Schwartz MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
270816|NCT00169442|GlaxoSmithKline|GSK Response Center|866-435-7343||
270817|NCT00170157|Mayo Clinic|Eugene D. Kwon||kwon.eugene@mayo.edu|
270818|NCT00170625|Charite Campus Vichow Klinikum|Prof. Dr. Jalid Sehouli|+49 30-450564052|jalid.sehouli@charite.de|
270819|NCT00170846|Novartis Pharmaceuticals|Study director|862-778-8300||
270820|NCT00170950|Novartis Pharmaceuticals|Study Director|862 778-8300||
270821|NCT00171054|Novartis Pharmaceuticals|Study Director|862-778-8300||
270822|NCT00171158|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
271811|NCT00266708|Montefiore Medical Center|Maria Coco, MD|718-920-4136|mcoco@montefiore.org|
271812|NCT00266799|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
271813|NCT00266812|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
271814|NCT00266825|University of Kansas Medical Center|Dr. Susan Carlson|913-588-5359|SCARLSON@kumc.edu|
295630|NCT01634048|Imperial College|Professor Gary Frost|+44 20 7594 0959|g.frost@imperial.ac.uk|
295631|NCT01634100|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
295632|NCT01634113|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
295633|NCT01634139|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
295634|NCT01634152|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
295635|NCT01634165|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295636|NCT01634178|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
295637|NCT01634191|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
295638|NCT01634243|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
295639|NCT01634256|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Sang-Wook Kim, MD|82-63-276-8284|clickm@jbnu.ac.kr|
295640|NCT01634269|Medttronic|Hiroko Ookubo|81367760811|hiroko.ookubo@medtronic.com|
295641|NCT01634360|Eisai Call Center|Eisai Inc.|888-422-4743||
295642|NCT01634555|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
295643|NCT01634620|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA|919-449-8873|Nancy.Herje@aerocrine.com|
295644|NCT01634659|Alcon Research, Ltd.|Jami Kern, MBA, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
295645|NCT01634854|Vanderbilt University Medical Center|Angela Wilson-Liverman CNM||angela.wilson-liverman@vanderbilt.edu|
295646|NCT01635062|Brigham and Women's Hospital|Dr. Anand Vaidya (Asst Professor of Medicine)|6175258285|avaidya1@partners.org|617
295647|NCT01635101|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
295648|NCT01635153|Dartmouth-Hitchcock|Dr C Fordham von Reyn|6036507167|fvr@dartmouth.edu|
307396|NCT02492451|Zeynep Kamil Research and Teaching Hospital|Selcuk Selcuk|+905321630488|md_sel@hotmail.com|
307397|NCT02492750|Mayo Clinic|John A Lust MD PhD|507/284-2511|lustj@mayo.edu|
307398|NCT02492763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307399|NCT02492802|University Medical Center Groningen|Jan-Willem Alffenaar, PhD|+31503614035|j.w.c.alffenaar@umcg.nl|
307400|NCT02492841|UNIVERSIDAD DE LOS ANDES|Dra. CLAUDIA BRIZUELA CORDERO|562226181166|clau@cibrizuela.com|
307401|NCT02492854|Boston Medical Center|Jeffrey Siracuse, MD|617-638-8488|Jeffrey.Siracuse@bmc.org|
271815|NCT00266851|Wisconsin Resaerch & Education Network|Dr. David Hahn|608-234-3212|dlhahn@wisc.edu|
271816|NCT00266864|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|5428
307402|NCT02492880|Boston Scientific|Director of Clincial Sciences|855-213-9890|BSNClinicalTrials@bsci.com|
295649|NCT01635218|Hospital Juárez de México|Dr. Emma del Carmen Macías-Cortés|+52 55 5747 7605|ecmc2008@hotmail.es|
295650|NCT01635244|University of Michigan|David Bach, MD|734-615-4907|dbach@med.umich.edu|
295651|NCT01635283|Jonsson Comprehensieve Cancer Center|Dr. Robert Prins|310-825-7647|rprins@mednet.ucla.edu|
295652|NCT01635439|NWAFH|Ahmed Abdelaziz|0096644411088|webmaster@nwafh.med.sa|
295653|NCT01635504|University of British Columbia|Dr. Shannon Humphrey|(604) 714-0222|shannon@carruthers-humphrey.com|
295654|NCT01635764|AbbVie|Global Medical Services|800-633-9110||
295655|NCT01635855|Merz Pharmaceuticals North America|Merz Pharmaceuticals North America|800-334-0514|clinicaltrials@merzusa.com|
295656|NCT01635881|Boston Scientific|Andrey Nersesov, Clinical Trial Manager|1-508-683-4988|Andrey.Nersesov@bsci.com|
307403|NCT02492958|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307404|NCT02492984|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307405|NCT02492997|Venus Concept Ltd.|Dr. Yoni Iger|888-907-0115|yoni@venusconcpet.com|
307406|NCT02493036|Synthetic Biologics Inc|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
307407|NCT02493062|St. Louis Fetal Care Institute|Dr. Laura Vricella|3146784488|fetalcare@ssmhealth.com|
307408|NCT02493088|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Jérôme SAINT-MARTIN, study director|+33 5 46 45 66 03|jerome.saint-martin@ch-larochelle.fr|
270823|NCT00171210|Novartis Pharmaceuticals|Study Director|862-778-8300||
270824|NCT00171223|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
270825|NCT00171249|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
270826|NCT00171301|Novartis Pharmaceuticals|Study Director|862-778-8300||
270827|NCT00171314|Novartis Pharamaceuticals|Novartis Pharmaceuticals|862-778-8300||
270828|NCT00171340|Novartis Pharmaceuticals|Study Director|862- 778 8300||
270829|NCT00171704|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
270830|NCT00171730|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
270831|NCT00171834|Novartis Pharmaceuticals|Study Director|862-778-8300||
270832|NCT00171873|KKS Marburg|Carmen Schade-Brittinger|0049-6421-2866458|carmen.brittinger@kks.uni-marburg.de|
270833|NCT00171925|Novartis Pharmaceuticals|Study Director|862-778-8300||
270834|NCT00171951|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
270835|NCT00172042|Novartis Pharmaceuticals|Study Director|862-778-8300||
270836|NCT00172185|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
270837|NCT00174187|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270838|NCT00174252|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270839|NCT00174291|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270840|NCT00174382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270841|NCT00174447|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270842|NCT00174460|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270843|NCT00174785|sanofi-aventis|International Clinical Development (ICD), Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
270844|NCT00174915|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
270845|NCT00174941|Takeda Global Research & Development Center, Inc.|Sr VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
270846|NCT00174954|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
270847|NCT00174967|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
270848|NCT00175006|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
270849|NCT00175019|Takeda Global Research & Development Center, Inc.|Senior Vice President, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
270850|NCT00175825|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
270851|NCT00175877|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
270852|NCT00175916|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
270853|NCT00176202|University of Illinois at Chicago|Dr Mani Pavuluri|3124130064|mpavuluri@psych.uic.edu|
270854|NCT00176228|Uillinois|Dr. Mani Pavuluri|312 4130064|mpavuluri@psych.uic.edu|
270855|NCT00176254|University of Kentucky|Dr. Emily Van Meter/Assistant Professor, Division of Cancer Biostatistics|859-323-3076|emily.vanmeter@uky.edu|
270856|NCT00176306|University of Kentucky|Aaron Cook|8593239258|amcook0@email.uky.edu|
270857|NCT00176423|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
270858|NCT00176436|Maryland Psychiatric Research Center|M. Patricia Ball, R.N., C.,M.S.|410-402-7663|pball@mprc.umaryland.edu|
271817|NCT00266877|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
295657|NCT01635920|Alcon Research, Ltd.|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
295658|NCT01635933|Alcon Research, Ltd.|Sharon Holden Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
295659|NCT01635998|Icahn School of Medicine at Mount Sinai|Sam Cammack|(212) 824-8931|sam.cammack@mountsinai.org|
295660|NCT01636063|Baystate Medical Center|David R Kattan|413-794-5256|davidrkattan@gmail.com|
295661|NCT01636076|Novartis Pharmaceuticals|Study Director|862-778-8300||
295662|NCT01636102|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
295663|NCT01636206|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
295664|NCT01636258|The Cleveland Clinic|Adam M. Bernstein MD|216-448-8538|bernsta2@ccf.org|
295665|NCT01636284|Sillajen Biotherapeutics Inc.|Kyoung Soo Ha, Head of Clinical Development|+1-415-281-8886|ksha@kr.sillajen.com|
307409|NCT02493127|Massachusetts General Hospital|Taylor Pong, Research Coordinator|617-726-1569|tpong1@partners.org|
270859|NCT00176462|Rutgers Cancer Institute of New Jersey|Richard Drachtman, MD|732-235-8675|drachtri@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu|
270860|NCT00176592|Rutgers New Jersey Medical School|Stuart Cook, MD|973-972-2550|cooksd@njms.rutgers.edu|
270861|NCT00176605|Rutgers Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
270862|NCT00176644|Cancer Institute of New Jersey|Dr. Mark Stein|732-235-8675|steinmn@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
270863|NCT00176800|University of Michigan Comprehensive Cancer Center|Dr. Susan Urba, M.D.|734-615-4762|surba@umich.edu|
270864|NCT00176826|University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
270865|NCT00176839|University of Minnesota Masonic Cancer Center|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
270866|NCT00176852|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
270867|NCT00176865|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-2778|smith719@umn.edu|
270868|NCT00176878|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
270869|NCT00176891|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|(612) 626-2313|orcha001@umn.edu|
270870|NCT00176904|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
270871|NCT00176917|Masonic Cancer Center, University of Minnesota|Paul J. Orchard, M.D.|612-626-2313|orcha001@umn.edu|
270872|NCT00176930|Masonic Cancer Center, University of Minnesota|Dr. Daniel J.Weisdorf, M.D|612 624-3101|weisd001@umn.edu|
270873|NCT00177047|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
270874|NCT00177164|UPMC|K.N. Roy Chengappa|412-246-5006|chengappakn@upmc.edu|
270875|NCT00177216|University of Pittsburgh|Jean Miewald|412-246-6406|miewaldjm@upmc.edu|
270876|NCT00177255|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
270877|NCT00177294|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
271818|NCT00267007|Centocor Ortho Biotech Services, LLC (COBS)|Vice President|215 325 4464||
271819|NCT00267020|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271820|NCT00267046|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor|713-792-7966|xzhou@mdanderson.org|
271821|NCT00267059|The University of Texas M. D. Anderson Cancer Center|Alessandra Ferrajoli, MD, BS / Associate Professor|713-792-2063|eharriso@mdanderson.org|
271822|NCT00267085|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
271823|NCT00267098|Medtronic CRDM Clinical|BLOCK HF Clinical Trial Leader|763-526-2729|medtroniccrmtrials@medtronic.com|
271824|NCT00267111|Mount Sinai Hospital|Dr. Vibhuti Shah|416-586-4816|vshah@mtsinai.on.ca|
271825|NCT00267150|Novartis Pharmaceuticals|Study Director|862-778-8300||
271826|NCT00267189|Novartis Pharmaceuticals|Study Director|862-778-8300||
271827|NCT00267202|Novartis Pharmaceuticals|Clinical Director|862-778-1768|maria.figliomeni@novartis.com|
295666|NCT01636297|Cleveland Clinic|Dr. Jay Alberts|216-445-3222|albertj@ccf.org|
295667|NCT01636362|Molnlycke Health Care AB|Joan Wilson|706 504 8997|joan.wilson@molnlycke.com|
295668|NCT01636414|OrthoCarolina Research Institute|Senior Research Scientist|704-323-2265|susan.odum@orthocarolina.com|
295669|NCT01636453|Penumbra, Inc.|Michaella Corso|(510) 748-3200||
295670|NCT01636661|University of Minnesota|Dr. Bernadette Gillick|612.626.6415|brown029@umn.edu|
295671|NCT01636687|Novartis Pharmaceuticals|Study Director|+1-862-778-8300|Novartis.email@novartis.com|
295672|NCT01636713|GlaxoSmithKline|GSK Response Center|866-435-7343||
295673|NCT01636765|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
295674|NCT01636778|GlaxoSmithKline|GSK Response Center|866-435-7343||
295675|NCT01636882|Viralytics Ltd|Mark Grose|1 647 821 7673|mark.grose@viralytics.com|
307410|NCT02493257|The University of Texas Health Science Center at Houston|Dr. Amber U. Luong, Associate Professor and Director of Research|(713) 500-5410|Amber.U.Luong@uth.tmc.edu|
307411|NCT02493361|University of California, San Francisco|Dr. Katy Tsai|(415) 402-5483|katy.tsai@ucsf.edu|
307412|NCT02493452|Synergy Pharmaceuticals Inc.|VP Regulatory Affairs & Clinical QA|646-675-7283|ejaeger@synergypharma.com|
307413|NCT02493517|Ipsen|Medical Director, Oncology||clinical.trials@ipsen.com|
295676|NCT01636934|UT MD Anderson Cancer Center|Zhongxing Liao, MD/ Professor, Radiation Oncology Department|(713) 563-2300|zliao@mdanderson.org|
295677|NCT01636947|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295678|NCT01636960|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295679|NCT01636986|Alcon Research, Ltd.|Jami Kern, PhD|1-888-452-3937|alcon.medinfo@alcon.com|
295680|NCT01637077|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-1623|loprinzi.charles@mayo.edu|
295681|NCT01637090|Boston Medical Center|Adam Lerner, MD|617-638-8265|adam.lerner@bmc.org|
295682|NCT01637142|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295683|NCT01637246|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
295684|NCT01637272|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
295685|NCT01637402|University of California, San Francisco|Dr. Terry Friedlander, MD|415-514-6380|Terence.Friedlander@ucsf.edu|
307414|NCT02493608|Texas Tech Health Sciences Center|Chadley Copeland|8067434752|chadley.copeland@ttuhsc.edu|
307415|NCT02493621|MUSC|Sylvia Wilson|8437922322|wilsosh@musc.edu|
270878|NCT00177307|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
270879|NCT00177671|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
270880|NCT00178126|University of PIttsburgh|David Brienza|(412) 624-6383|DBrienza@pitt.edu|
270881|NCT00178178|University of Rochester|Dr. Robert Bronstein|585-275-1024|robert_bronstein@urmc.rochester.edu|
270882|NCT00178191|University of Rochester|Michael Flynn|585-273-3232|Michaelk_flynn@urmc.rochester.edu|
270883|NCT00178256|University of Rochester|Yuhchyau Chen MD, PhD|585-275-5575|yuhchyau_chen@urmc.rochester.edu|
270884|NCT00178399|University of Rochester|Michael Milano|585-273-4096|michael_milano@urmc.rochester.edu|
270885|NCT00178464|St. Christopher's Hospital for Children|Dr. Norma B. Lerner|215 427-5261|norma.lerner@drexelmed.edu|
295686|NCT01637584|UPittsburgh|Dr. Anne Germain|4123832150|germax@upmc.edu|
295687|NCT01637623|University of Wisconsin School of Pharmacy|John M. Dopp|608-265-9352|john.dopp@wisc.edu|
295688|NCT01637870|University of Iowa Hospitals and Clinics|Abbey Hardy-Fairbanks, MD|319-356-2291|abbey-hardy-fairbanks@uiowa.edu|
295689|NCT01637922|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
295690|NCT01637935|Takeda|Head, Pharmacoepidemiology|+1-877-825-3327|trialdisclosures@takeda.com|
295691|NCT01637961|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
295692|NCT01638000|Astellas Pharma Europe Ltd|Medical Director||Astellas.resultsdisclosure@astellas.com|
295693|NCT01638013|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
295694|NCT01638052|Ann & Robert H. Lurie Children's Hospital of Chicago|Santhanam Suresh, MD|312-227-5147|SSuresh@luriechildrens.org|
307416|NCT02493660|OrthoSpace Ltd.|Heather Neill, VP Clinical Operations|615-483-7438|heather.neill@stryker.com|
307417|NCT02493712|Holy Stone Healthcare Co., Ltd|YUCHIH, Chen|886287975966|ivychen@hshc.com.tw|272
307418|NCT02493764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307419|NCT02493777|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
307420|NCT02493855|AbbVie|Global Medical Services|800-633-9110||
307421|NCT02493868|Janssen Research & Development, LLC|Senior Director, Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
307422|NCT02493946|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
295695|NCT01638312|Kaohsiung Medical University Chung-Ho Memorial Hospital|JihJin Tsai, MD|886-7-3121101|jijits@cc.kmu.edu.tw|6358
295696|NCT01638390|Carl Zeiss Meditec, Inc.|Todd Otani, Senior Clinical Research Scientist|925-557-4513|todd.otani@zeiss.com|
295697|NCT01638416|Australian and New Zealand Intensive Care Research Centre|Dr. Cooper|+61 3 9903 0071|anzicrc@monash.edu|30071
295698|NCT01638429|Cedars-Sinai Medical Center|Dr Ruchi Mathur|310-423-4774|Ruchi.Mathur@cshs.org|
295699|NCT01638468|Boston Scientific|Angela Schutt|763-494-2166|angela.schutt@bsci.com|
295700|NCT01638507|Medtronic, Coronary Clinical Affairs|Lisa Bousquette, Clinical Research Director|(707) 591-2967|lisa.r.bousquette@medtronic.com|
295701|NCT01638546|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
295702|NCT01638559|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
295703|NCT01638819|Sutter Health|Michael Chez, MD|(916) 773-8711|ChezM@sutterhealth.org|
271828|NCT00267293|Penn State Children's Hospital|Ian M Paul, MD, MSc|717-531-5656|ipaul@hmc.psu.edu|
271829|NCT00267488|GlaxoSmithKline|GSK Response Center|866-435-7343||
271830|NCT00267631|Maimonides Medical Center|Dr. Estevan Garcia, MD; Principal Investigator|718-283-6352|EsGarcia@maimonidesmed.org|
271831|NCT00267644|Maimonides Medical Center|Dr. Eitan Dickman, MD; Principal Investigator|718-283-6057|edickman@maimonidesmed.org|
271832|NCT00267670|Northwestern University|Mary E. Rinella, MD|312-503-4592|m-rinella@northwestern.edu|
271833|NCT00267696|The Ohio State University Comprehensive Cancer Center|Larry Copeland, MD|614-293-8697|Larry.Copeland@osumc.edu|
282662|NCT00866918|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
295704|NCT01639001|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295705|NCT01639040|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
295706|NCT01639144|Center for Research & Grants, Baptist Health South Florida|Gary M. Kiebzak, Ph.D., Co-investigator and Clinical Research Administrator|786-268-6224|garyk@baptisthealth.net|
282663|NCT00867009|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
307423|NCT02494076|University Colorado School of Medicine, Chidren's Hospital Colorado|Nidhya Navanandan, MD|847-636-0817|nidhya.navanandan@childrenscolorado.org|
307424|NCT02494102|Penn State Health Milton S. Hershey Medical Center|Zyad J. Carr, M.D., FASA|717-531-8521|zcarr@pennstatehealth.psu.edu|
307425|NCT02494180|Kwong Wah Hospital|Dr SF Lai|85223322311|lsf087@ha.org.hk|
307426|NCT02494297|Center for Epidemiology and Health Research, Germany|Dr. Klaas Heinemann|0049 (0) 30 945 101 20|k.heinemann@zeg-berlin.de|
307427|NCT02494323|Bet-Loewenstein|Dr.Yaron Sacher|97297709918|ysacher@clalit.org.il|
270886|NCT00178503|University of Texas Medical School at Houston|Deborah A. Pearson, Ph.D.|713-486-2588|Deborah.A.Pearson@uth.tmc.edu|
270887|NCT00178633|University of Texas Medical School at Houston|Heinrich Taegtmeyer, MD, DPhil, Principal Investigator|713 500-6569|heinrich.taegtmeyer@uth.tmc.edu|
270888|NCT00178646|UTHealth|Gerard E. Francisco|7137975246|Gerard.E.Francisco@uth.tmc.edu|
270889|NCT00178685|University of Rochester|Dr. Geoffrey Williams|585-530-2050|geoffrey_williams@urmc.rochester.edu|
270890|NCT00178711|University of Texas Health Science Center|Guy L Clifton|2024224824|guy@guyclifton.com|
270891|NCT00178841|Vanderbilt University Dermatology|John Zic, MD|615-322-6485|john.zic@vanderbilt.edu|
270892|NCT00178919|Vanderbilt University|Italo Biaggioni|615-343-6499|italo.biaggioni@vanderbilt.edu|
270893|NCT00179010|Vanderbilt University|Italo Biaggioni, MD., Professor of Medicine and Pharmacology|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
270894|NCT00179309|National Cancer Institute, National Institutes of Health|Dr. James Gulley, M.D., Ph.D.|301-435-2956|gulleyj@mail.nih.gov|
270895|NCT00179413|BIDMC|Dr. Nezam Afdhal|617632118|nafdhal@bidmc.harvard.edu|
270896|NCT00179478|University of California San Diego|Revere P Kinkel MD (PI)|619-543-5295|rkinkel@ucsd.edu|
270897|NCT00179517|Beth Israel Deaconess Medical Center|Andrew G Herzog MD,MSc|781-431-0277|aherzog@bidmc.harvard.edu|
270898|NCT00179621|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
270899|NCT00179647|Celgene Corporation|Robert D. Knight, M.D.|908-673-9749|rknight@celgene.com|
270900|NCT00179660|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
270901|NCT00179673|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com|
270902|NCT00179777|University of Helsinki|Professor Mikael Knip|+3582941 25222|mikael.knip@helsinki.fi|
270903|NCT00179959|Children's Memorial Hospital|Amy Paller, MD|312-695-6829|apaller@nmff.org|
270904|NCT00179998|Nationwide Children's Hospital|Dr. Robert Castile|614-355-6670|robert.castile@nationwidechildrens.org|
270905|NCT00180271|Boston Scientific|Jill Leigh|800 227 3422|jill.leigh@bsci.com|
270906|NCT00180297|Boston Scientific|Elisabeth Mouton - Clinical Trial Manager|+33 1 39 30 11 90|elisabeth.mouton@bsci.com|
270907|NCT00180323|Rigshospitalet, Copenhagen Unviversity Hospital, Denmark|Dr. Jesper Hastrup Svendsen||jesper.hastrup.svendsen@rh.regionh.dk|
270908|NCT00180479|Abbott Vascular|Ellen Travis, Clinical Science|408-845-1512|Ellen.Travis@av.abbott.com|
270909|NCT00180661|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
270910|NCT00180674|Imperial College London|Prof Mark Thursz|+44 (0)20 3312 1903|m.thursz@imperial.ac.uk|
270911|NCT00180687|Imperial College London|Dr. Nawar Alkhamesi|442033121110|n.alkhamesi@imperial.ac.uk|
270912|NCT00180713|Imperial College London|Professor Martin R Wilkins|+44 (0)20 8383 2049|m.wilkins@imperial.ac.uk|
270913|NCT00181155|Johns Hopkins University|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
270914|NCT00181168|Johns Hopkins Univ|Paul W. Ladenson, MD, Professor and PI|4109553663|ladenson@jhmi.edu|
270915|NCT00181207|Johns Hopkins University|Gregory Diette|410-955-3497|gdiette@jhmi.edu|
270916|NCT00181285|University of Illinois at Chicago|Jerry A. Krishnan|312-413-0637|jakris@uic.edu|
270917|NCT00181363|Maastro Radiation Oncology|J. Buijsen,|+31 (0)88-44-55-666|jeroen.buijsen@maastro.nl|
270918|NCT00181610|Massachusetts General Hospital|Corrine Welt, MD|617-726-8437|cwelt@partners.org|
270919|NCT00181623|Massachusetts General Hospital|Corrine Welt, MD|617-716-8437|cwelt@partners.org|
295707|NCT01639157|University of Kentucky|William W. Stoops, Ph.D.|859-257-5388|william.stoops@uky.edu|
295708|NCT01639222|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
295709|NCT01639339|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
295710|NCT01639352|University of Miami|Lynn Feun, M.D.|305-243-4909|lfeun@med.miami.edu|
295711|NCT01639443|West Los Angeles VA / Cedars-Sinai Medical Center|Jennifer Talley Soares|(310) 478-3711|jennifer.soares@va.gov|83240
295712|NCT01639469|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
295713|NCT01639495|Biosense Webster, Inc.|Robert Stagg, PhD, Manager, Clinical Franchise|(949) 450-7779|rstagg@its.jnj.com|
295714|NCT01639560|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
295715|NCT01639599|Seoul St.Mary's Hospital,|Young Eun Moon|822-2258-6163|0910momo@naver.com|
295716|NCT01639664|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Dr. Guido Bertolini|035 4535 313|guido.bertolini@marionegri.it|
271834|NCT00267748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271835|NCT00267774|Stanford University|William F. Fearon, MD|650 725-2621|wfearon@stanford.edu|
271836|NCT00267865|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|yarchoar@nih.gov|
271837|NCT00267956|Centocor Research & Development, Inc|Senior Director Clinical Research|1-800-457-6399||
271838|NCT00267969|Centocor Research & Development, Inc.|Dir. Clinical Research|1-800-457-6399||
271839|NCT00268203|GlaxoSmithKline|GSK Response Center|866-435-7343||
271840|NCT00268242|The Cleveland Clinic|Anjali S. Advani, MD|216-445-5330|advania@ccf.org|
271841|NCT00268346|Cleveland Clinic Taussig Cancer Institute|David Adelstein MD|216-444-9310|adelstd@ccf.org|
271842|NCT00268437|Mayo Clinic|Aminah Jatoi, M.D.|507/284-4918|jatoi.aminah@mayo.edu|
295717|NCT01639703|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|+33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
295718|NCT01639729|AcelRx|Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
295719|NCT01639742|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
295720|NCT01639755|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
295721|NCT01639833|Covidien|Michael Rohan|781-839-1757|Michael.Rohan@Covidien.com|
295722|NCT01639872|Psychopharmacology Research Group|Dr. Mary Brunette|603-271-5054|mary.f.brunette@hitchcock.org|
295723|NCT01640054|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
307428|NCT02494336|Johns Hopkins All Children's Hospital|Nicole Chandler, MD|7277674170|nicole.chandler@jhmi.edu|
295724|NCT01640171|Retina Vitreous Associates of Florida|Steven Cohen|7274459110|scohen@health.usf.edu|
307429|NCT02494401|University of New Mexico|Janet Poole|(505) 272-1753|JPoole@salud.unm.edu|
307430|NCT02494440|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
270920|NCT00181714|Massachusetts General Hospital|Paul Hammerness, MD|617-503-1063|phammerness@partners.org|
270921|NCT00181766|Massachusetts General Hospital|Joseph Biederman, MD|617-726-1743|jbiederman@partners.org|
270922|NCT00181844|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
270923|NCT00181883|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
270924|NCT00181961|Massachusetts General Hospital|Dr. Christina Dording|6177249457|cdording@mgh.harvard.edu|
270925|NCT00182000|Massachusetts General Hospital|Sabine Wilhelm, PhD|6177246146|swilhelm@partners.org|
270926|NCT00182078|Massachusetts General Hospital|Dr. Frederick J. Stoddard Jr., M.D.|6173714762|fstoddard@partners.org|
270927|NCT00182091|Massachusetts General Hospital|Dr. Anne Klibanski|617-726-3870||
270928|NCT00182325|Department of Family Medicine, McMaster University|Dr. Heather Waters|(905) 575-6782|watersh@mcmaster.ca|
270929|NCT00182689|SWOG Statistical Center|Study Statistician|206-667-4623||
270930|NCT00182754|Mayo Clinic|Aminah Jatoi, M.D|507-284-4918|jatoi.aminah@mayo.edu|
270931|NCT00182767|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
270932|NCT00182793|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
270933|NCT00183092|UCaliforniaSF|Michael Geschwind, MD, PhD|415-476-2901|mgeschwind@memory.ucsf.edu|
270934|NCT00183170|Boston University School of Public Health|Dr. Jonathan Howland, Professor||jhowl@bu.edu|
270935|NCT00183196|Medical University of South Carolina|Raymond F. Anton, MD|843-792-1226|antonr@musc.edu|
270936|NCT00183248|University of Miami|George W. Burke III, M.D.|(305) 355-5060|Gburke@med.miami.edu|
270937|NCT00183274|UPENN|Karl Rickels, M.D.|215-746-6417|krickels@mail.med.upenn.edu|
270938|NCT00183339|University of North Carolina|Linmarie Sikich, MD|919 966 8653|Lsikich@med.unc.edu|
270939|NCT00183391|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey H Newcorn|212-659-8705|jeffrey.newcorn@mssm.edu|
270940|NCT00183430|VA Puget Sound HCS|Murray A. Raskind, MD|206-277-3797|Murray.Raskind@va.gov|
270941|NCT00183443|Stanford University|Dr. Patricia Suppes|6504935000|tsuppes@Stanford.edu|62567
270942|NCT00183456|Johns Hopkins Bloomberg School of Public Health|Carl Latkin, PhD||clatkin@jhsph.edu|
270943|NCT00183469|University of Texas Health Science Center San Antonio|Charles L. Bowden, M.D. Clinical Professor|210 567 5405|bowdenc@uthscsa.edu|
270944|NCT00183625|Semel Institute at UCLA|Stephen R. Marder, M.D.|310-268-3647|marder@ucla.edu|
270945|NCT00183677|Massachusetts General Hospital|Dan Iosifescu, MD, MSc||diosifescu@partners.org|
270946|NCT00183729|Washington University School of Medicine|Eric Lenze|314-362-1671|lenzee@wustl.edu|
270947|NCT00183794|USC/Norris Cancer Comprehensive Cancer Center|Agustin Garcia, MD|323-865-3900|aagarcia@usc.edu|
270948|NCT00183872|USC/Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
270949|NCT00184002|USC Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
270950|NCT00184028|USC/Norris Comrpehensive Cancer Center|Barbara Gitlitz, MD|323-865-3906|Gitlitz@usc.edu|
270951|NCT00184054|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist, Clinical Investigations Support Office|323-226-6384|victoria.soto@med.usc.edu|
270952|NCT00184093|USC Norris Comprehensive Cancer Center|Victoria Soto - Project Specialist|(323) 865-0454|Victoria.Soto@med.usc.edu|
270953|NCT00184548|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
270954|NCT00184600|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
270955|NCT00184717|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
270956|NCT00185211|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
270957|NCT00185380|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
270958|NCT00185458|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
270959|NCT00185588|Stanford University|George Albert Fisher, Associate Professor of Medicine, Stanford University|650-725-9057|georgeaf@stanford.edu|
271843|NCT00268762|University of Texas Health Science Center at Houston|Andrew D. Barreto, MD|713-500-7002|andrew.d.barreto@uth.tmc.edu|
271844|NCT00268892|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
271845|NCT00268905|Eisai|Prash Krishna, Study Director|888-422-4743||
271846|NCT00268983|GlaxoSmithKline|GSK Response Center|866-435-7343||
271847|NCT00268996|GlaxoSmithKline|GSK Response Center|866-435-7343||
271848|NCT00269087|GlaxoSmithKline|GSK Response Center|866-435-7343||
271849|NCT00269113|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
271850|NCT00269152|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
295725|NCT01640184|Peking University International Hospital|Dr. Zhang Dongliang|+86-10-69006561|zhangdongliang@pkuih.edu.cn|
295726|NCT01640197|Northumbria University|Emma Wightman|(+44) 0191 2437253|emma.l.wightman@northumbria.ac.uk|
295727|NCT01640249|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295728|NCT01640288|Duke University School of Medicine, Department of Radiology|H. Cecil Charles, Ph.D.|919-684-7921|cecil.charles@duke.edu|
295729|NCT01640314|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
271851|NCT00269399|Bausch Health Americas, Inc.|Director of Clinical Operations|908-927-0873|lindsey.mathew@bauschhealth.com|
271852|NCT00269477|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
271853|NCT00269633|Thomas Jefferson University|Roseann Talarico|215 503 4743|roseann.talarico@jefferson.edu|
271854|NCT00269919|Janssen Korea Ltd., Korea|Medical CRA|+82-2-2094-4804||
271855|NCT00270205|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
295730|NCT01640327|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
295731|NCT01640340|Ohio State University Medical Center|Rachel Layman, MD|614-293-0066|Rachel.Layman@osumc.edu|
295732|NCT01640353|SI-BONE, Inc.|Daniel Cher, MD, Vice President of Clinical Affairs|650-269-5763|dcher@si-bone.com|
295733|NCT01640366|Smith & Nephew Inc|Rachael Winter, Director of Clinical Operations|+44 1482 673475|rachael.winter@smith-nephew.com|
295734|NCT01640379|Johns Hopkins University|Dr. Maria Trent|4109552910|mtrent2@jhmi.edu|
307431|NCT02494518|Cleveland Clinic|Dr. Susan Linder|(216) 445-9815|linders@ccf.org|
307432|NCT02494583|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307433|NCT02494596|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
307434|NCT02494713|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
307435|NCT02494778|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
307436|NCT02494817|University of Hawaii|Jason W. Mitchell, PhD, MPH|8082196729|jasonmit@hawaii.edu|
307437|NCT02495025|University of California Los Angeles|Principal Research Manager, Health Services Research Program|310-825-8624|lindseythompson@mednet.ucla.edu|
307438|NCT02495038|Yonsei University Wonju college of medicine|Dr. Wooyoung Park|563664250|wongulung28@gmail.com|971
307439|NCT02495103|National Cancer Institute|Dr. Ramaprasad Srinivasan|240-760-6251|ramasrin@mail.nih.gov|
307440|NCT02495168|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
307441|NCT02495233|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
307442|NCT02495259|Emory University|Dr. Igor Zhukov|404-268-1404|izhukov@live.com|
307443|NCT02495389|Loyola University Chicago|Alan Wolfe, Ph.D.|708-216-5814|awolfe@luc.edu|
307444|NCT02495454|Fondazione Italiana Linfomi ONLUS|Dr. Luigi Marcheselli - FIL statistician|059 4223873|lmarcheselli@filinf.it|
307445|NCT02495467|Richmond Pharmacology Limited|Dr Jorg Taubel|020 8664 5200|j.taubel@richmondpharmacology.com|
307446|NCT02495623|Synthetic Biologics Inc|Michael Kaleko|(240) 238-3862|mkaleko@syntheticbiologics.com|
307447|NCT02495779|University of Pittsburgh, Graduate School of Public Health|James Egan|4126242255|jee48@pitt.edu|
307448|NCT02495831|CROSS REsearch SA|Dr. Milko Radicioni|+41.91.63.00|clinic@croalliance.com|510
295735|NCT01640548|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
295736|NCT01640808|Pharmaceutical Division, Clinical Administration Dept.|Administrator of clinical trial information||ctrdinfo@kowa.co.jp|
295737|NCT01640834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295738|NCT01640873|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295739|NCT01640925|Houston Methodist Hospital|Dr. Joshua Swan|713-441-0165|jtswan@houstonmethodist.org|
295740|NCT01640951|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
295741|NCT01640964|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
295742|NCT01641042|GlaxoSmithKline|GSK Response Center|866-435-7343||
295743|NCT01641081|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
307449|NCT02495844|Cares|UCB|+1844599|UCBCares@ucb.com|2273
307450|NCT02495857|Teva Pharmaceuticals Inc. USA|Senior Director, Clinical R&D|1-888-483-8279|USMedinfo@tevapharm.com|
307451|NCT02495883|UCSD|Fatta Nahab, MD|858-822-5871|fnahab@health.ucsd.edu|
307452|NCT02495948|Alcon, A Novartis Division|Global Medical Affairs Brand Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
307453|NCT02496000|Orange County Research Center|Joel M. Neutel, M. D.|714-541-5591|jmneutel@aol.com|
307454|NCT02496091|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
307455|NCT02496221|GlaxoSmithKline|GSK Response Center|866-435-7343||
307456|NCT02496533|Midwestern Regional Medical Center, Inc.|Jessica Kapustin, RN-C||Jessica.Kapustin@CTCA-Hope.com|
295744|NCT01641120|Mandell Center for Multiple Sclerosis, Mount Sinai Rehabilitation Hospital|Lindsay Tuttle, MPH|860-714-2149|LTuttle@stfranciscare.org|
295745|NCT01641133|GlaxoSmithKline|GSK Response Center|866-435-7343||
295746|NCT01641159|University of Cincinnati College of Medicine; Department of Psychiatry|Dr. Theresa Winhusen|513-585-8227|winhust@ucmail.uc.edu|
295747|NCT01641198|Université de Montréal|Dr. Aldo-Joseph Camarda|(514) 343-7124|aj.camarda@umontreal.ca|
295748|NCT01641237|GlaxoSmithKline|GSK Response Center|866-435-7343||
307457|NCT02496702|Technical University of Denmark, Center for Playware|Jari Due Jessen|+45 45 25 39 29|jdje@elektro.dtu.dk|
307458|NCT02496767|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
307459|NCT02496884|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
307460|NCT02497001|Pearl Therapeutics Inc.|Pearl Therapeutics Inc.|1-877-240-9479|information.center@astrazeneca.com|
307461|NCT02497040|uludag university|Dr.Banu Otlar Can|+905323827044|botlar@hotmail.com|
307462|NCT02497235|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
307463|NCT02497287|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
270960|NCT00185614|Stanford University School of Medicine|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
270961|NCT00185640|Stanford University|Robert Lowsky|650-723-0822|rlowsky@stanford.edu|
270962|NCT00185679|Stanford Cancer Institute|Ginna G Laport, MD|650-723-8222|ginna.laport@stanford.edu|13911
270963|NCT00185692|Stanford University|Robert Lowsky|650-723-0822|rlowsky@stanford.edu|
270964|NCT00185731|Stanford University School of Medicine|Alice Fan, MD|650-725-6454|afan@stanford.edu|
270965|NCT00185900|Stanford University|Dr. Anna Girsen|(650) 725-5720|agirsen@stanford.edu|
270966|NCT00185965|School of Medicine, Stanford University|Ronald Levy, MD / Robert K and Helen K Summy Professor of Medicine|650-725-6452|levy@stanford.edu|
270967|NCT00186017|Stanford University School of Medicine|Dr. Terence A. Ketter, MD.|6507232507|tketter@stanford.edu|
270968|NCT00186043|Bipolar and Depression Research Program, Stanford University, School of Medicine, VA Palo Alto Health Care System|Trisha Suppes MD, PhD|6504962567|tsuppes@stanford.edu|
270969|NCT00186056|Stanford University|Brent Solvason|650-723-8331|solvason@stanford.edu|
270970|NCT00186069|Stanford University|Anna Girsen, Manager of Research Operations|(650) 725-5720|agirsen@stanford.edu|
270971|NCT00186121|Stanford University Medical Center|Melinda Telli, MD|650-724-9533|mtelli@stanford.edu|
270972|NCT00186186|Stanford University|Dr. Terence Ketter, Chief Bipolar Disorder Clinic|650-723-2515|tketter@stanford.edu|
270973|NCT00186446|Stanford University|aimee-noelle swanson|650-736-4559|aimnoe@stanford.edu|
270974|NCT00186485|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
270975|NCT00186498|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
270976|NCT00186537|Stanford University|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
270977|NCT00186628|Stanford University Medical Center|David Miklos, MD, PhD; Associate Professor of Medicine (Blood and Marrow Transplantation)|650-725-4626|dmiklos@stanford.edu|
271856|NCT00270231|University of Pennsylvania|Caryn Lerman, Ph.D.|215-746-7141|clerman@mail.med.upenn.edu|
271857|NCT00270257|Fred Hutchinson Cancer Research Center|Senior Statistical Analyst|206-667-6167|geetha@scharp.org|
271858|NCT00270296|Harvard TH Chan School of Public Health|Dr. Roger Shapiro|617-432-2334|rshapiro@hsph.harvard.edu|
271859|NCT00270634|Isotechnika Pharma Inc.|Robert Huizinga|780 487 1600|robert.huizinga@isotechnika.com|223
271860|NCT00270790|University of Maryland School of Medicine|Mohan Suntharalingam|410-328-2328|msuntha@umm.edu|
271861|NCT00270842|James A. Haley VA|Dr. Patricia A. Quigley|8135583912|patricia.quigley@va.gov|
271862|NCT00270855|Penn State Hershey Medical Center|Dr. David Gater|7175314263|dgater@hmc.psu.edu|
271863|NCT00270894|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
271864|NCT00270998|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
271865|NCT00271024|University of Chicago|Dr. Andrea King|7737026181|aking@bsdad.uchicago.edu|
271866|NCT00271154|Medtronic CRDM|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
271867|NCT00271219|Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology, Johns Hopkins University School of Medicine|Dr. Hendree Jones|919-485-2664|hjones18@jhmi.edu|
271868|NCT00271375|Atlanta VAMC|Patricia Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
271869|NCT00271505|UT MD Anderson Cancer Center|Dr. John V Heymach, PHD/ Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
295749|NCT01641367|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
295750|NCT01641380|Johns Hopkins University School of Medicine|Maria Trent, MD, MPH, Principal Investigator|443-287-8945|mtrent2@jhmi.edu|
295751|NCT01641445|Brown University|Dr. Robert Miranda|401.863.6658|Robert_Miranda_Jr@brown.edu|
295752|NCT01641471|Cleveland Clinic - Section of Adult Reconstrution|Research Program Manager|216-444-4954|klikaa@ccf.org|
295753|NCT01641640|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
295754|NCT01641653|Rutgers-New Jersey Medical School|Vasanti Tilak, MD|973 972-7477|tilakva@njms.rutgers.edu|
295755|NCT01641692|GlaxoSmithKline|GSK Response Center|866-435-7343||
295756|NCT01641809|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
295757|NCT01641822|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
295758|NCT01641835|Heidelberg Engineering GmbH|Gerhard Zinser, PhD|+4962216463|Contact@HeidelbergEngineering.com|0
307464|NCT02497391|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
307465|NCT02497404|Weill Cornell Medical College|Sebastian Mayer, MD|646-962-7950|sam2033@med.cornell.edu|
307466|NCT02497469|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
307467|NCT02497612|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
271870|NCT00271570|University of California, San Diego|Jane Burns, MD, Professor|858-246-0155|jcburns@ucsd.edu|
295759|NCT01641861|Khon Kaen University|Dr. Kemporn Kitsahawong|66-910-566-996|kkempo@kku.ac.th|
295760|NCT01641900|Massachusetts General Hospital|Dara S. Manoach, Principal Investigator|617-724-6148|dara.manoach@mgh.harvard.edu|
295761|NCT01641926|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295762|NCT01641939|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
295763|NCT01641952|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
295764|NCT01641978|Hospital Universitario de Getafe|Susana Arias Rivera|+34916839360|susana.arias@salud.madrid.org|2459
295765|NCT01641991|Division of Infectious Diseases, Cincinnati Children's Hospital Medical Center|David Bernstein, MD, MA|513-636-7625|david.bernstein@cchmc.org|
295766|NCT01642056|National Human Genome Research Institute|Gahl, William|+1 301 402 2739|gahlw@mail.nih.gov|
295767|NCT01642082|NRG Oncology|Linda Gedeon, BA, CCRP Clinical Research Coordinator|716-845-1169|lgedeon@gogstats.org|
295768|NCT01642147|Huashan Hospital Fudan University|Xiao-Yu Yang|086-021-52889999|xiaoyuyangfudan@gmail.com|7693
307468|NCT02497755|University of Washington|Dr. Amy Bauer|206.221.8385|abauer1@uw.edu|
307469|NCT02497781|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307470|NCT02497937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
307471|NCT02497976|IC Study LLC|Philip C. Bosch, MD|760 743-3135|pboschmd@gmail.com|
307472|NCT02498067|University of Chicago|Soo Young Lee|6513430045|sooyoungl@uchicago.edu|
307473|NCT02498236|University of California, Los Angeles|Dr. Stephen R. Marder|3104783711|SMarder@mednet.ucla.edu|83647
307474|NCT02498418|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
307475|NCT02498483|Columbia University|Jennifer Woo Baidal|212-342-2962|jw3286@cumc.columbia.edu|
307476|NCT02498522|AinShamsU|Dr. Ahmed kotb|1008681999|ahmedmkotp@hotmail.com|+20
307477|NCT02498652|Study Information Center AstraZeneca|Jesse Hall, MD|(877) 240-9479|information.center@astrazeneca.com|
307478|NCT02498678|Instituto da Criança do Hospital das Clínicas da Universidade de São Paulo|Dr. Ricardo Vieira Carlos|55-11-99911-6677|ricardovieirac@gmail.com|
307479|NCT02498769|Duke University Health System|Dr. Joseph P Mathew Professor of Anesthesiology and Chairman Department of Anesthesiology|919-681-6646|joseph.mathew@duke.edu|
295769|NCT01642212|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
295770|NCT01642238|Icahn School of Medicine at Mount Sinai|Dr. Juan J. Badimon|(212) 241-8484|Juan.Badimon@mssm.edu|
295771|NCT01642251|ECOG-ACRIN Cancer Research Group|Study Statistician||eatrials@jimmy.harvard.edu|
295772|NCT01642277|Loyola University Chicago, Microbiology and Immunology|Dr. Alan J. Wolfe|224-392-4002|awolfe@luc.edu|
295773|NCT01642407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295774|NCT01642485|Richmond Pharmacology Ltd|Dr Jorg Taubel|+44(0)2086645200|j.taubel@richmondpharmacology.com|
295775|NCT01642589|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
295776|NCT01642602|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
295777|NCT01642615|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
307480|NCT02498821|Bard Access Systems, Inc.|Gina Gilbert, BSN, RN|407-489-0835|Gina.Gilbert@crbard.com|
307481|NCT02498834|University of North Carolina at Chapel Hill|Betsy Sleath, PhD|(919) 962-0079|betsy_sleath@unc.edu|
307482|NCT02499029|MUSC|Sudie Back, PhD|843-792-9383|backs@musc.edu|
307483|NCT02499081|University of Arkansas for Medical Sciences|Maurizio Zangari, MD|501-686-8274|MZangari@uams.edu|
270978|NCT00186875|St. Jude Children's Research Hospital|Sima Jeha, MD|866-278-5833|info@stjude.org|
270979|NCT00186901|St. Jude Children's Research Hospital|Sue Kaste, DO|866-278-5833|referralinfo@stjude.org|
270980|NCT00187096|St. Jude Children's Research Hospital|Jeffrey Rubnitz, MD|1-866-278-5833|info@stjude.org|
270981|NCT00187135|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|866-278-5833|referralinfo@stjude.org|
270982|NCT00187200|St. Jude Medical|Ashish Oza|(818) 493-3648|aoza@sjm.com|
270983|NCT00187226|St. Jude Children's Research Hospital|Thomas E. Merchant, DO, PhD|901-595-3604|thomas.merchant@stjude.org|
270984|NCT00187278|St Jude Medical|Pascale Ducloux, Clinical Manager|+3227746709|pducloux@sjm.com|
270985|NCT00187369|Sunnybrook Health Sciences Center|Dr Jon Barrett||jon.barrett@sunnybrook.ca|
270986|NCT00187486|University of California San Francisco|Michael Prados, MD|415 353 2076|PradosM@neurosurg.ucsf.edu|
270987|NCT00187655|UCSF|Richard Castro, MD|4155144363|Rich.Castro@ucsf.edu|
270988|NCT00187681|UCSF|Kathy Giacomini, Ph.D|4154761936|Kathy.Giacomini@ucsf.edu|
270989|NCT00187720|UCSF|Kathy Giacomini, Ph.D|4154761936|Kathy.Giacomini@ucsf.edu|
270990|NCT00187876|University of Florida|Peter Indelicato, MD|352-273-7017|wernegs@ortho.ufl.edu|
270991|NCT00187889|University of Florida|Dr. Carl J. Pepine|352-273-9082|carl.pepine@medicine.ufl.edu|
270992|NCT00189098|Wilhelmina Children's Hospital, University Medical Center Utrecht|Prof. A. Schilder|0031 302504580|A.Schilder@umcutrecht.nl|
270993|NCT00189137|University of Michigan Comprehensive Cancer Center|Dr. Scott Schuetze, M.D., Ph.D.|1-800-865-1125|scotschu@umich.edu|
270994|NCT00189202|University of Michigan|Dr. Akinlolu Ojo, Professor of Medicine|734 9364890|aojo@umich.edu|
270995|NCT00189228|University of New Mexico Health Sciences Center|Dr. Mark Schuyler|5059254197|mschuyler@salud.unm.edu|
270996|NCT00189306|Graceway Pharmaceuticals|Medical Director|267-984-0400|jim.lee@gracewaypharma.com|
270997|NCT00189423|Advanced Circulatory Systems, Inc.|Director of Clinical Trials|651-403-5600|csetum@advancedcirculatory.com|
271871|NCT00271596|University of Iowa; Elks Rehab Hospital|Leigh Beglinger, PhD|319-353-4489|leigh-beglinger@elksrehab.org|
271872|NCT00271609|National Cancer Institute, National Institutes of Health|Teri Kreisl, M.D.|301-402-3423|kreislt@mail.nih.gov|
271873|NCT00271739|Columbia University|Walter Palmas, M.D.|212-305-3163|wp56@columbia.edu|
271874|NCT00271856|UCSF Osher Center for Integrative Medicine|Patricia Moran, PhD|415.353.9745|moranp@ocim.ucsf.edu|
271875|NCT00272038|Oncology Specialists, S.C.|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD, FACP (PI)|847-268-8200|shallmeyer@oncmed.net|
295778|NCT01642914|Forest Research Institute|Steven Shiff, Executive Director, Clinical Development|201-427-8000|Steven.Shiff@actavis.com|8077
295779|NCT01643044|Wayne State University|Steven Ondersma, PhD|313-444-9797|sondersm@med.wayne.edu|
295780|NCT01643213|Boston Scientific|Clinical Research Information|855-213-9890|BSNClinicalTrials@bsci.com|
295781|NCT01643382|University of California, San Francisco|Justin Parekh, MD, MAS|415-595-3707|justin.parekh@ucsfmedctr.org|
295782|NCT01643408|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
295783|NCT01643473|NYU School of Medicine|Antoinette Schoenthaler|212-263-4205|antoinette.schoenthaler@nyumc.org|
295784|NCT01643616|HELIOS-Kliniken Schwerin, Germany|Dr. Ronald Seidel|0049 385 5204251|ronald.seidel@helios-kliniken.de|
295785|NCT01643668|Massachusetts General Hospital|Yi-Bin Chen, MD|617-726-0187|YCHEN6@PARTNERS.ORG|
295786|NCT01643707|Medtronic|Sr Clinical Research Program Manager|+1 (651) 308 3608|jennifer.tinsley@medtronic.com|
295787|NCT01643772|Mundipharma (China) Pharmaceutical Co.Ltd|Ms. Dan Zhu, Clinical operation and quality lead of the study|+8610 6563 6891|dan.zhu@mundipharma.com.cn|
307484|NCT02499120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307485|NCT02499146|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307486|NCT02499159|Inova Health System|Devon Collins|703-776-4096|Devon.Collins@inova.org|
307487|NCT02499172|Johns Hopkins Bloomberg School of Public Health|Dr. Mohammad Ali|410-502-3154|mali25@jhu.edu|
307488|NCT02499263|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
307489|NCT02499380|PneumRx|Jörg Rennecke|+49 211 5422750|medical.services@btgplc.com|
307490|NCT02499406|VACHS|Investigator|203 932 5711|suzanne.decker@va.gov|
307491|NCT02499497|Brigham and Women's hospital|Dr. Shalender Bhasin, Principal Investigator|617 525 9150|sbhasin@bwh.harvard.edu|
307492|NCT02499575|Orthopedic Foot and Ankle Center|Dr. Christopher Hyer|614-895-8747|hyerofac@gmail.com|
307493|NCT02499692|The General Hospital of ShenYang Military|Dr Hanyaling|02428851876|hanyl@medmail.com.cn|
307494|NCT02499770|G1 Therapeutics|Chandra Lovejoy|001 9192991250|clovejoy@g1therapeutics.com|
295788|NCT01643798|Medical University of South Carolina|Joseph Taylor|8437295729|taylorjj@musc.edu|
295789|NCT01643850|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
295790|NCT01643876|Université de Montréal|Dr. Elham Emami|5143436111|elham.emami@umontreal.ca|6053
295791|NCT01643902|Johns Hopkins University School of Medicine|Victor C. Urrutia|410-955-2228|vurruti1@jhmi.edu|
295792|NCT01643928|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295793|NCT01644058|Université de Montréal|Elham Emami, DDS, MSc, PhD|514-343-6111|elham.emami@umontreal.ca|6053
295794|NCT01644149|PharmaJet, Inc.|Marilyn Dysart, Clinical Affairs Manager|720-214-9399|marilyn.dysart@pharmajet.com|
295795|NCT01644175|Sanofi|Trial Transparency Team||Contact -US@sanofi.com|
295796|NCT01644188|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
295797|NCT01644240|Theravance Biopharma US, Inc.|Dr. Brett Haumann, SVP, Clinical Development|650-808-6000|BHaumann@theravance.com|
307495|NCT02499783|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
307496|NCT02499952|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
307497|NCT02500043|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
307498|NCT02500056|Tartu University Hospital|Ceith Nikkolo|+37253319082|ceith.nikkolo@kliinikum.ee|
307499|NCT02500368|CooperVision Inc.|Sr. Manager Clinical Research|(925) 730-6754|PChamberlain@coopervision.com|
307500|NCT02500537|Medtronic|Michelle DiSalvo|774.284.6089|michelle.v.disalvo@medtronic.com|
307501|NCT02500550|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@kiadis.com|
307502|NCT02500602|Medical University of South Carolina|Sudie Back|843-792-9383|backs@musc.edu|
307503|NCT02500628|Woodinville Psychiatric Associates|Jon Berner MD PhD|425-481-0429|jonbernermd@gmail.com|
307504|NCT02500641|A. Menarini Industrie Farmaceutiche Riunite SrL|Post-Registration Clinical Trial Responsible|+39 055 5680459|pfabrizzi@menarini.it|
295798|NCT01644292|University of Manitoba|Ed Giesbrecht|204-977-5630|Ed.Giesbrecht@med.umanitoba.ca|
295799|NCT01644331|Duke Clinical Research Institute|G. Michael Felker, MD|919-668-8919|Michael.Felker@duke.edu|
307505|NCT02500706|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
307506|NCT02500719|University of Arkansas for Medical Sciences|Dr. Keith A. Bush|501.526.8347|kabush@uams.edu|
307507|NCT02500732|University of Calgary|Dr. Satish R Raj|403-210-6152|satish.raj@ucalgary.ca|
307508|NCT02500758|Universidad Complutense de Madrid|Dr. Ricardo Becerro de Bengoa Vallejo|914590409|ribebeva@enf.ucm.es|
307509|NCT02500836|STATKING Clinical Services|Lori Christman, PhD|513-858-2989|lori@statkingclinical.com|317
307510|NCT02500979|AstraZeneca|Dr. Peter Ohman|+1 (301) 398-0120|Peter.Ohman@astrazeneca.com|
307511|NCT02501135|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
307512|NCT02501161|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
307513|NCT02501265|Duke University School of Medicine|Dr. James Davis|919-668-5055|james.m.davis@duke.edu|
307514|NCT02501473|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307515|NCT02501538|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
307516|NCT02501590|Head of The Pediatric Neurology and Developmental Unit|Aviva Mimouni-Bloch|97297709048|abloch@clalit.org.il|
307517|NCT02501629|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
307518|NCT02501642|James A. Haley VA|Tracy Kretzmer, Ph.D.|813-972-2000|tracy.kretzmer@va.gov|5729
307519|NCT02501811|University of Texas-Houston School of Public Health|Shelly Sayre, M.P.H. Project Manager|713-500-9529|Shelly.L.Sayre@uth.tmc.edu|
307520|NCT02501902|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
307521|NCT02501928|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307522|NCT02502019|Biom'Up|Dr. William Spotnitz, Chief Medical Officer|352-514-5009|wspotnitz@gmail.com|
307523|NCT02502097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270998|NCT00189436|Allegheny Singer Research Institute, WPAHS|David Skoner, MD|412-359-4099|dskoner@hsc.wvu.edu|
270999|NCT00189462|West Penn Allegheny Health System|David Skoner, MD|4123594099|dskoner@wpahs.org|
271000|NCT00189475|Allegheny Singer Research Institute, WPAHS|David Skoner, MD|4123594099|dskoner@wpahs.org|
271001|NCT00189488|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
271002|NCT00189540|AnGes|Director of Clinical Operations|240-780-9031|information@anges-mg.com|
271003|NCT00190671|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271004|NCT00190684|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271005|NCT00190749|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271006|NCT00190775|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271007|NCT00190983|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271008|NCT00191100|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271009|NCT00191113|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271010|NCT00191139|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271011|NCT00191152|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271012|NCT00191165|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271013|NCT00191191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271014|NCT00191269|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
295800|NCT01644396|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
295801|NCT01644474|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
295802|NCT01644500|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295803|NCT01644565|Enteric Diseases Department, Naval Medical Research Center|Ramiro L. Gutierrez, MD, MPH|301-319-3193|ramiro.gutierrez@med.navy.mil|
295804|NCT01644617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295805|NCT01644643|AstraZeneca-PPD|Yunxia Lu|910-558-4197|Yunxia.Lu@ppdi.com|
295806|NCT01644695|Institute For Advanced Reconstruction|Dr. Andrew Elkwood, MD|732-741-0970|aelkwood@hotmail.com|
295807|NCT01644734|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
295808|NCT01644890|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
295809|NCT01645059|Hospital San Pedro Alcántara|Dr. Santiago González Santiago||santidatvs@hotmail.com|
307524|NCT02502149|Bioverativ|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
307525|NCT02502461|Dept. of Anesthesia, University of Saskatchewan|Dr. William P. McKay|306 655 1202|bill.mckay@usask.ca|
307526|NCT02502487|West China Hospital, Department of Anesthesiology|Dr. Guizhi Du, Associate professor|+86 18980602213|du_guizhi@yahoo.com|
307527|NCT02502526|Alcon, A Novartis Division|Dir Surg Instrumentation, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
307528|NCT02502734|GlaxoSmithKline|GSK Response Center|866-435-7343||
307529|NCT02502864|H. Lee Moffitt Cancer Center and Research Institute|Christine M. Walko, Pharm.D., BCOP|813-745-1519|christine.walko@moffitt.org|
307530|NCT02503085|Reckitt Benckiser Healthcare (UK) Ltd.|Clinical Research Director|+441482 326151||
307531|NCT02503202|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295810|NCT01645098|Nationwide Children's Hospital|Marco Corridore, MD|614-722-4200|Marco.Corridore@nationwidechildrens.org|
295811|NCT01645111|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
295812|NCT01645176|Stanford University School of Medicine|Mark C. Genovese|650-498-4528|genovese@stanford.edu|
295813|NCT01645280|Janssen Pharmaceuticals|Senior Director Clin Development||ClinicalTrialDisclosure@its.jnj.com|
295814|NCT01645306|advanceCOR GmbH|Prof. Dr. Götz Münch, CRP & CEO|+4989200020410|muench@advancecor.com|
295815|NCT01645735|Cerexa, Inc|Medical Monitor|(510) 285-9200||
295816|NCT01645930|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
295817|NCT01646021|Janssen-Cilag International NV|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
295818|NCT01646073|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
295819|NCT01646125|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
307532|NCT02503215|Nephrology Division, University of São Paulo|Dr Bruno Caldin da Silva|5511997620521|brunocaldin@hotmail.com|
307533|NCT02503254|Philip Morris Products S.A.|Cam Tuan Tran|+41 (58) 242 2620|CamTuan.Tran@pmi.com|
307534|NCT02503332|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
307535|NCT02503410|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
307536|NCT02503501|HealthPartners Neuroscience Research|Clinical Research Manager|651-495-6363|aleta.l.svitak@healthpartners.com|
307537|NCT02503540|Cole Eye Institute Cleveland Clinic Foundation|Dr.Justis P. Ehlers|2166360183|ehlersj@ccf.org|
307538|NCT02503735|Massachusetts General Hospital|Dr. Meghan Sise|617-726-5050|MSise@partners.org|
307539|NCT02503787|Medtronic Implantable Therapies|Helen Berrier|1-800-633-8766|medtronicneurotrials@medtronic.com|
307540|NCT02503852|Kerastem|Eric Daniels, M.D., Chief Medical Officer|858.348.8050|edaniels@puregraft.com|
295820|NCT01646138|National Institute of Allergy and Infectious Diseases|Matthew J. Memoli|+1 301 443 5971|memolim@niaid.nih.gov|
295821|NCT01646151|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
295822|NCT01646177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
295823|NCT01646203|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
295824|NCT01646216|Kennedy Krieger Institute|Anthony Gonzalez|4439080074|gonzalezan@kennedykrieger.org|
295825|NCT01646255|UCB|Study Director|+1877 822||9493
295826|NCT01646268|UCB Clinical Trial Call Center|Study Director|+1 844-599-2279||
295827|NCT01646320|AstraZeneca Pharmaceuticals|Eva Johnsson, Clinical Science Lead|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
295828|NCT01646346|Yale University|Dr. Suzanne Evans, MD, MPH|(203) 785-5175|suzanne.evans@yale.edu|
295829|NCT01646385|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295830|NCT01646398|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307541|NCT02503865|Republican Scientific Center for Emergency care at Nazarbayev University|Dr. Kuat Oshakbayev|+77013999141|okp.kuat@mail.ru|
307542|NCT02503982|Schneider Children's Medical Center of Israel|Dr. Liat Ashkenazi-Hoffnung|972-3-9253681|LiatA3@clalit.org.il|
307543|NCT02504073|Kantonsspital Baselland Standort Bruderholz|Alexandra Bellwald|0041797429755|alexandra.bellwald@ksbl.ch|
307544|NCT02504216|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
307545|NCT02504268|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
307546|NCT02504294|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|1--800--718--1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
271015|NCT00191282|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271016|NCT00191308|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271017|NCT00191334|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271018|NCT00191386|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271019|NCT00191451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271020|NCT00191477|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271021|NCT00191646|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271022|NCT00191724|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271023|NCT00191789|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271024|NCT00191815|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271025|NCT00191854|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271026|NCT00191906|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271027|NCT00191945|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271028|NCT00191984|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271029|NCT00192023|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271030|NCT00192036|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271031|NCT00192075|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271032|NCT00192114|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271033|NCT00192296|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
271034|NCT00192504|MedImmune, LLC|Genevieve A. Losonsky, MD/VP Clinical Development|301-398-0000|losonskyG@medimmune.com|
271035|NCT00192647|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
271036|NCT00193037|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
271037|NCT00193050|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSarah@scresearch.net|
271038|NCT00193063|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
271039|NCT00193128|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
271040|NCT00193180|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
271041|NCT00193206|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
295831|NCT01646645|Memorial Sloan Kettering Cancer Center|Dr. Susan Prockop|212-639-6715|prockops@mskcc.org|
295832|NCT01646671|Novartis Pharmaceuticals|Study Director|+1-862-778-8300||
295833|NCT01646762|Mayo Clinic|Dr. Rafael Fonseca|480-301-4280|fonseca.rafael@mayo.edu|
295834|NCT01646814|PLxPharma|Regulatory Affairs Director|17138421249|regaffairs@plxpharma.com|
295835|NCT01646827|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
295836|NCT01647217|Tissuetech Inc|Hosam El Sheha, MD, PhD|305-274-1299|hsheha@tissuetechinc.com|
295837|NCT01647282|UNMC College of Dentistry|Dr. Amy C. Killeen|402-202-7848|akilleen@unmc.edu|
295838|NCT01647438|Northwestern University|Dr. Namratha Kandula, Principal Investigator|312-503-6470|nkandula@nm.org|
307547|NCT02504320|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
307548|NCT02504424|AirXpanders|Director of Clinical Affairs|650-390-9000|kkelley@airxpanders.com|
295839|NCT01647464|OHSU|Jonathan Lindner|5034948750|lindnerj@ohsu.edu|
295840|NCT01647516|Celgene Corporation|Anne McClain, Senior Manager|908-673-9100|ClinicalTrialDisclosure@Celgene.com|
295841|NCT01647542|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
295842|NCT01647581|VA|Linda Feagins|214-587-1603|linda.feagins@austin.utexas.edu|
295843|NCT01647711|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
295844|NCT01647737|Georgia Regents University|Dr. Scot DeRossi, Chairman of the ORal Medicine & Diagnostic Sciences Department|706-721-2607|Sderossi@gru.edu|
295845|NCT01647945|Stanford University|Dr. Edda Spiekerkoetter|650-724-1493|eddas@stanford.edu|
295846|NCT01647958|EndoGastric Solutions|Adrian Lobontiu|650-474-9259|alobontiu@endogastricsolutions.com|
295847|NCT01648101|GlaxoSmithKline|GSK Response Center|866-435-7343||
295848|NCT01648140|GlaxoSmithKline|GSK Response Center|866-435-7343||
307549|NCT02504502|Geisinger Health System|Alanna Kulchak Rahm, PhD|570-214-5093|akrahm@geisinger.edu|
307550|NCT02504541|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
307551|NCT02504554|Arizona State University|James Adams|480 965 3316|jim.adams@asu.edu|
307552|NCT02504619|Gamida Cell|Kelly Myers|026595631|kelly@gamida-cell.com|
307553|NCT02504645|ImmuPharma|CEO|+33 6 18 22 16 50|robert.zimmer@immupharma.com|
307554|NCT02504671|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
307555|NCT02504723|Kaohsiung Veterans General Hospital|Dr. Wen-Chi Chen|886-7-3422121|wcchen@vghks.gov.tw|2139
307556|NCT02504775|GlaxoSmithKline|GSK Response Center|866-435-7343||
307557|NCT02504827|University of Southern California|Paul Beringer|323-442-1402|beringer@usc.edu|
271876|NCT00272168|VA Central Office|Wendy Tenhula, Ph.D.|202-461-4167|Wendy.Tenhula@va.gov|
271877|NCT00272311|Florida Atlantic University|Charles H. Hennekens, M.D.||chenneke@fau.edu|
281786|NCT02285062|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
281787|NCT02264977|W.L. Gore & Associates|Jennifer Gorman|928-863-8483|jgorman@wlgore.com|
292580|NCT01435356|EAU Research Foundation|Wim P.J. Witjes, MD, PhD Scientific and Clinical Research Director|+31 26 389 0677|w.witjes@uroweb.org|
307558|NCT02504892|National Cancer Institute|Dr. Ramaprasad Srinivasan|301-451-2298|srinivasanr@mail.nih.gov|
307559|NCT02504931|UT Health San Antonio|Dr. John Roache|210-562-5406|roache@uthscsa.edu|
295849|NCT01648166|University of Kentucky|Dr. Susanne Arnold|8592579568|smarno0@uky.edu|
295850|NCT01648283|Washington University School of Medicine|Evan D. Kharasch, MD, PhD|314-362-8796|kharasch@wustl.edu|
295851|NCT01648322|Generon (shanghai) corporation|Chief Medical Officer|8621-61760866|tangt@generonbiomed.com|
295852|NCT01648348|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-1370|galanis.evanthia@mayo.edu|
295853|NCT01648452|National Eye Institute|Paul A Sieving, MD, PhD|301-496-2234|ps261o@nih.gov|
295854|NCT01648491|Beaumont Hospital - Royal Oak|Kenneth Peters MD|248-551-0387|Kenneth.Peters@Beaumont.org|
295855|NCT01648530|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
295856|NCT01648582|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295857|NCT01648699|Janssen Philippines|Medical Affairs Manager|+632-8248935||
271042|NCT00193258|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
271043|NCT00193375|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
271044|NCT00193414|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
271045|NCT00193427|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
271046|NCT00193453|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|askSarah@scresearch.net|
271047|NCT00193479|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
271048|NCT00193492|Sarah Cannon Research Institute|John Hainsworth MD|1-877-691-7274|asksarah@scresearch.net|
271049|NCT00193596|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
271050|NCT00193609|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
271051|NCT00194012|Johns Hopkins University School of Medicine|Robert Findling, MD, MBA, Director, Child and Adolescent Psychiatry|410-614-3225|rfindli1@jhmi.edu|
271052|NCT00194025|Case Western Reserve University and Unversity Hospitals Case Medical Center|Martha Sajatovic MD|216-844-2808|martha.sajatovic@uhhospitals.org|
271053|NCT00194077|Johns Hopkins University School of Medicine|Robert Findling, MD,MBA Director, Child and Adolescent Psychiatry|410-614-3225|rfindli1@jhmi.edu|
295858|NCT01648764|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295859|NCT01648790|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
307560|NCT02505217|University of Vermont|David J Schneider, MD|802-656-8955|david.schneider@uvm.edu|
307561|NCT02505269|Massachusetts General Hospital|Dr. Jeremy Abramson|617-724-4000|JABRAMSON@mgh.harvard.edu|
307562|NCT02505334|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
307563|NCT02505542|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
307564|NCT02505867|The Ohio State Unveristy|Rami Khayat|6142477717|rami.khayat@osumc.edu|
307565|NCT02505919|PROCEPT BioRobotics Corporation|Angela Lee|6502327215|a.lee@procept-biorobotics.com|
307566|NCT02505945|Torax Medical|Adam Ahlstrom|651-361-8900|aahlstro@its.jnj.com|
307567|NCT02506036|Johns Hopkins University School of Medicine|Dr. Argye Hillis|410-614-2381|argye@jhmi.edu|
307568|NCT02506114|University of California, San Francisco|Dr. Lawrence Fong, MD|(415) 514-3160|Lawrence.Fong@ucsf.edu|
307569|NCT02506257|AMC Amsterdam|Dr. IJE van Der Muelen|020 - 566 9111|TtT@amc.uva.nl|
307570|NCT02506309|Brno University Hospital|dr. Martin Huser|+420532233843|huser.martin@fnbrno.cz|
307571|NCT02506634|FirstSunYetSen|Dr. Niandi Tan|+86 15989117039|tanniandi@126.com|
307572|NCT02506660|Hospital of Special Surgery|Dr. Richard Kahn|212-774-7274|KahnR@HSS.EDU|
307573|NCT02506673|Hospital for Special Surgey|Danya DeMeo, Research Assistant|2127742678|demeod@hss.edu|
307574|NCT02506816|Medica Scientia Innovation Research (MedSIR)|Director of Operations|0034 932 214 135|alicia.garcia@medsir.org|
307575|NCT02506868|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
271878|NCT00272337|Florida Atlantic University|Charles H. Hennekens, M.D.||chenneke@fau.edu|
271879|NCT00272779|Bristol-Myers Squibb|BMS Study Director||ClinicalTrials@bms.com|
271880|NCT00272792|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
307576|NCT02506881|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
307577|NCT02507011|University of Minnesota|Thenappan Thenappan, MD|612-625-2191|cvheart@umn.edu|
295860|NCT01648920|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA. Director, Clinical Development and Medical Affairs|919-449-8873|nancy.herje@aerocrine.com|
295861|NCT01648959|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
295862|NCT01649180|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
295863|NCT01649232|Spanish Neurometrics Foundation|Dr. Moises Aguilar-Domingo, Chairman of Spanish Neurometrics Foundation|+34 634548720|moises.aguilar@gmail.com|
295864|NCT01649271|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
295865|NCT01649297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
295866|NCT01649362|Centre Hospitalier de Luxembourg|Dr Manon Bache|+352 4411 3157|manon.bache@hotmail.com|
295867|NCT01649375|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
307578|NCT02507219|Laureate Institute for Brain Research|Dr. Martin Paulus|918-502-5120|mpaulus@laureateinstitute.org|
307579|NCT02507297|University of Michigan|Leslie Swanson|734-764-2242|lmswan@umich.edu|
307580|NCT02507349|UPMC Center for High-Value Health Care|Kelly Williams, Program Administrator|412-454-1198|Williamsk17@upmc.edu|
307581|NCT02507375|Hoffmann-La Roche|Medical Communications|800-821-8590||
307582|NCT02507388|Alcon, A Novartis Division|Global Program Clinical Head, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
307583|NCT02507752|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
307584|NCT02508077|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
307585|NCT02508103|University of North Carolina at Chapel Hill|Dr. Susan Girdler|919-966-2179|susan_girdler@med.unc.edu|
307586|NCT02508116|University of Pennsylvania School of Medicine|Sony Tuteja, PharmD, MS|215-573-7834|sonyt@pennmedicine.upenn.edu|
307587|NCT02508194|MedImmune, LLC|Judith Falloon, MD|301-398-0000|clinicaltrialenquiries@medimmune.com|
307588|NCT02508207|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
307589|NCT02508259|University of California, San Diego School of Medicine|Dr. Robert K. Naviaux, MD, PhD|619-543-2904|naviaux@ucsd.edu|
292581|NCT01435382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295868|NCT01649427|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
295869|NCT01649557|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
295870|NCT01649596|Genesys Regional Medical Center|Surgeon|810-606-6500|twasfie@gmail.com|
295871|NCT01649609|Columbia University Medical Center|Sumit Mohan, MD|2123053273|sm2206@cumc.columbia.edu|
295872|NCT01649765|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
295873|NCT01649791|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
295874|NCT01649804|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
295875|NCT01649856|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
307590|NCT02508389|Galera Therapeutics, Inc.|Kara Terry|610-725-1500|kterry@galeratx.com|
307591|NCT02508428|Anderson Orthopaedic Research Institute|C. Anderson Engh, Jr., MD|703-619-4411|research@aori.org|
307592|NCT02508480|Boston University|Dr. Zlatka Russinova|617-353-3549|zlatka@bu.edu|
307593|NCT02508532|Blueprint Medicines|Medical Information|1-888-258-7768|medinfo@blueprintmedicines.com|
307594|NCT02508636|University of California, San Francisco|Dr. Hao Nguyen|(415) 514-5541|Hao.Nguyen@ucsf.edu|
307595|NCT02508649|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DK0-Disclosure@ferring.com|
307596|NCT02508701|Purdue University|Stewart Chang Alexander|765-427-9860|alexan90@purdue.edu|
307597|NCT02508935|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
271054|NCT00194116|Univeristy Hospitals Case Medical Center|Dr. Keming Gao|216-844-2865|Keming.Gao@uhhospitals.org|
271055|NCT00194129|UHCMC Mood Disorders Program|David Kemp, MD|216-844-2865|David.Kemp@UHhospitals.org|
271056|NCT00194532|University Of Washington|Ann Stapleton, MD|206-616-4121|stapl@uw.edu|
271057|NCT00194610|University of Washington|Claire Yang, MD|206-744-6384|cyang@uw.edu|
271058|NCT00194675|VA Puget Sound Health Care System|Alvin M. Matsumoto, MD|(206) 764-2760|alvin.matsumoto@med.va.gov|
271059|NCT00194779|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
271060|NCT00194792|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
271061|NCT00194896|University of Washington|Jerry P. Palmer, MD|206-764-2495|jpp@u.washington.edu|
271062|NCT00194987|Weill MC|Dr James Bussel|917-291-5091|jbussel@med.cornell.edu|
271063|NCT00195013|Weill Cornell Medicine|Linda Vahdat, MD|646-962-9888|ltv2001@med.cornell.edu|
271064|NCT00195039|Weill Cornell Medicine|Scott Tagawa, MD||guonc@med.cornell.edu|
271065|NCT00195260|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271066|NCT00195273|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
271067|NCT00195338|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271068|NCT00195351|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
271069|NCT00195403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271070|NCT00195429|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
271071|NCT00195442|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271072|NCT00195494|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
271073|NCT00195507|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
271074|NCT00195624|National Heart Lung and Blood Institute|Young, Neal|+1 301 496 5093|youngns@mail.nih.gov|
271075|NCT00195650|Abbott|Global Medical Services|800-633-9110||
271076|NCT00195663|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
295876|NCT01649869|University of Alabama at Birmingham|David Kimberlin, MD|(205) 638-2530|DKimberlin@peds.uab.edu|
307598|NCT02509026|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295877|NCT01649947|Rutgers Cancer Institute of New Jersey|Joseph Aisner, MD|732-235-7401|aisnerjo@cinj.rutgers.edu|
295878|NCT01650194|Astellas Pharma Global Development, Inc. (APGD)|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
295879|NCT01650246|Ardea Biosciences, Inc.|Maple Fung, MD|1-858-652-6721|mfung@ardeabio.com|
295880|NCT01650259|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
295881|NCT01650285|BrUOG|Dr. Anthony Mega|4018633000|kayla_rosati@brown.edu|
295882|NCT01650298|ABBOTT|Grant Kim|818-493-3147|gkim@sjm.com|
295883|NCT01650324|Taipei Medical University - Wanfang Hospital|Dr. Yi-Jen Chen|886-2-2930-7930|yjchen@tmu.edu.tw|2543
295884|NCT01650350|Brown University Oncology Research Group|Maria Constantinou, MD|401-863-3000|Kayla_rosati@brown.edu|
295885|NCT01650402|UConn Health|William White, MD|860-679-4556|wwhite@uchc.edu|
295886|NCT01650519|Cumberland Pharmaceutical Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
307599|NCT02509065|Massachusetts General Hospital|Courtney A Balliro|617-726-1242|cballiro@partners.org|
307600|NCT02509078|Mass General Hospital (PETAL Clinical Coordinating Center)|Katie Oldmixon|617-726-4777|coldmixon@mgh.harvard.edu|
307601|NCT02509117|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
307602|NCT02509156|University of Texas-Houston School of Public Health|Shelly Sayre, M.P.H. Project Manager|713-500-9529|Shelly.L.Sayre@uth.tmc.edu|
307603|NCT02509481|Colorado State University|Dr. Brian D. Foy, Professor|970-491-3470|Brian.Foy@colostate.edu|
307604|NCT02509585|Cardinal Health|LaTosha Eligon|913-661-3896|latosha.eligon@cardinalhealth.com|
307605|NCT02509624|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
307606|NCT02509767|Planned Parenthood Federation of America|Julia Kohn|2122614636|julia.kohn@ppfa.org|
307607|NCT02509936|"Wuqu' Kawoq | Maya Health Alliance"|Dr Peter Rohloff|6174473034|peter@wuqukawoq.org|
307608|NCT02510001|University of Oxford Clinical Trials and Research Governance (CTRG)|Heather House|01865 572245|heather.house@admin.ox.ac.uk|
307609|NCT02510014|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Bauer@Indivior.com|
307610|NCT02510144|University of Maryland Baltimore|Dr. Mohit Gilotra|(301) 502-4102|mgilotra@som.umaryland.edu|
307611|NCT02510664|Baylor College of Medicine|Marisa Hilliard PhD, Principal Investigator|832-824-7209|marisa.hilliard@bcm.edu|
307612|NCT02510794|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
307613|NCT02510820|CooperVision|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
307614|NCT02511184|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307615|NCT02511236|University of Miami Miller School of Medicine|David J. Lee|305-243-9680|dlee@med.miami.edu|
295887|NCT01650545|University of Maryland|Aldo Tullio Iacono|410 328 4351|aiacono@umm.edu|
295888|NCT01650558|University of Maryland School of Medicine|Miriam K. Laufer, M.D., M.P.H.|410-706-5333|mlaufer@som.umaryland.edu|
295889|NCT01650584|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
295890|NCT01650636|University of Miami|Dr. Michael Antoni|305-284-5466|mantoni@miami.edu|
295891|NCT01650779|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
295892|NCT01650805|ARIAD Pharmaceuticals, Inc.|Maureen Conlan, Senior Medical Director|1-617-621-2316|Maureen.Conlan@ariad.com|
295893|NCT01650831|Exalenz.Bioscience Ltd.|Avraham Hershkowitz, Clinical Trials Manager|+972-8-9737513|avrahamh@exalenz.com|
295894|NCT01650844|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
295895|NCT01651000|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
295896|NCT01651039|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|212-241-7873|ajai.chari@mountsinai.org|
307616|NCT02511379|Alcon, A Novartis Division|Study Director Med Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
307617|NCT02511431|NIDDK|Christopher Koh, MD|301-443-9402|christopher.koh@nih.gov|
307618|NCT02511535|Med Uni Wien, Institut für Spezifische Prophylaxe und Tropenmedizin|Erika Garner-Spitzer, PhD|0043 1 40160|erika.garner-spitzer@meduniwien.ac.at|38255
307619|NCT02511561|Otonomy|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
307620|NCT02511587|Medical University of Vienna|Univ.-Prof. Dr. Ursula Wiedermann|0043 1 40160 38291|ursula.wiedermann@meduniwien.ac.at|
307621|NCT02511678|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
307622|NCT02511717|Lawson Health Institute|Dr Blayne Welk|5196466000|lawson@lawsonsresearch.com|
307623|NCT02511730|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
295897|NCT01651052|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, Surgical Structural Heart|949-250-2500|mary_edwards@edwards.com|1536
295898|NCT01651078|Monteris Medical|Nissa Mollema (Clinical Operations Manager)|763-253-4710|nmollema@monteris.com|
295899|NCT01651104|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
295900|NCT01651117|Corporal Michael J. Crescenz VA Medical Center|Judith A. Long, MD|215-898-4311|judith.long@va.gov|
307624|NCT02511782|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-4762|Pooja.Khandelwal@cchmc.org|
307625|NCT02512042|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
307626|NCT02512068|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
307627|NCT02512094|Faculty of Medicine Siriraj Hospital, Mahidol University|Panai Laohaprasitiporn||panailao@gmail.com|
307628|NCT02512224|The University of Tokyo Hospital|Dr. Sumito Ogawa|+81-3-5800-8830|suogawa-tky@umin.ac.jp|
307629|NCT02512276|Brigham and Women's Hospital|Niteesh K. Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
307630|NCT02512302|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
307631|NCT02512393|The University of Texas Health Science Center at Houston|Hyochol Ahn, PhD, ARNP|713-500-2179|Hyochol.Ahn@uth.tmc.edu|
307632|NCT02512419|Brown University|Dr. Bess Marcus|401-863-9858|bess_marcus@brown.edu|
307633|NCT02512575|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
307634|NCT02512679|Children's Hospital Los Angeles|Neena Kapoor, M.D.|343-361-2434|nkapoor@chla.usc.edu|
307635|NCT02512783|Children's Hospitals and Clinics of Minnesota|Angela Doucette|6128137144|angela.doucette@childrensmn.org|
307636|NCT02512809|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|joseph.tobias@nationwidechildrens.org|
307637|NCT02512861|Children's Hospitals and Clinics of Minnesota|Mark Lo Galbo, MPH, CCRP|(612)-813-7828|mark.logalbo@childrensmn.org|
307638|NCT02512874|Mayo Clinic|Dr. Cassie C. Kennedy|507-266-3958|kennedy.cassie@mayo.edu|
307639|NCT02512900|MedImmune, LLC|Rene van der Merwe, Senior Director, Clinical Development, Respiratory, and Inflammation|301-398-0000||
271077|NCT00195676|Abbott|Global Medical Services|800-633-9110||
271881|NCT00272844|Boston Children's Hospital|Dr. Mira Irons|617-355-2449|mira.irons@childrens.harvard.edu|
271882|NCT00272961|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271883|NCT00272987|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
295901|NCT01651195|Helsinki University Central Hospital|Prof. Anne Pitkäranta|+358406430511|anne.pitkaranta@hus.fi|
295902|NCT01651208|University of Miami|Ana M. Palacio|3052439754|apalacio2@med.miami.edu|
295903|NCT01651260|Hollister Incorporated|Malford Cullum|847-918-3975|malford.cullum@Hollister.com|
295904|NCT01651351|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
295905|NCT01651442|National Jewish Health|Bryan Simmons|303-398-1850|simmonsb@njhealth.org|
295906|NCT01651780|The Medicines Company|Global Health Science Center|800-388-1183||
295907|NCT01651793|University of Georgia|Dr. Patrick J. O'Connor|706-542-4382|poconnor@uga.edu|
295908|NCT01651806|Rush University Medical Center|Brett Levine, MD|708.236.2664|levine.research@rushortho.com|
295909|NCT01651936|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinialTrialsDisclosure@merck.com|
307640|NCT02512965|Canadian Cancer Trials Group|Dr. Keyue Ding|16135336430|kding@ctg.queensu.ca|77705
307641|NCT02513095|Eagle Pharmaceuticals, Inc.|Chief Medical Officer|201 326 5300|medinfo@eagleus.com|
307642|NCT02513121|University of California, San Diego|Dr. Jeffrey Schwimmer|858-966-8907|jschwimmer@ucsd.edu|
307643|NCT02513160|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
307644|NCT02513212|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
307645|NCT02513446|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
307646|NCT02513459|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
307647|NCT02513472|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
307648|NCT02513498|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
295910|NCT01651949|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295911|NCT01652001|University of Granada|Dr. Gómez-Moreno|+34000000000|ggomez@ugr.es|
295912|NCT01652040|Hunter Holmes McGuire VA Medical Center|Ashraf S. Gorgey|8046755000|ashraf.gorgey@va.gov|3386
295913|NCT01652287|Georgetown University Medical Center, Department of Family Medicine|Director of Research Programs|202-687-1600|FamilyMedResearch@georgetown.edu|
295914|NCT01652469|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki-Voser, Lead Trial Activities|+41 31 511 94 18|Heidi.Roschitzki@etop-eu.org|
295915|NCT01652495|Istituto Ortopedico Rizzoli|Milva Battaglia, Director of Clinical Trials|0516366026|milva.battaglia@ior.it|0039
295916|NCT01652573|Yale School of Medicine|Dr. Karl Insogna|203-737-2871|karl.insogna@yale.edu|
295917|NCT01652664|Alcon Research, Ltd.|Subha Venkataraman, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
295918|NCT01652690|Amgen Inc.|Study Director|866-572-6436||
307649|NCT02513550|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
307650|NCT02513641|Pennington Biomedical Research Center|Dr. Eric Ravussin|225-763-3186|eric.ravussin@pbrc.edu|
307651|NCT02513719|Abbott Vascular|Kusano Hajime|408-645-1626|hajime.kusano@av.abbott.com|
307652|NCT02513732|Abbott|Hajime Kusano, Senior Adviser Clinical|+1 4088451626|hajime.kusano@abbott.com|
307653|NCT02513745|Carolina Eyecare Physicians, LLC|Helga P. Sandoval, MD, MSCR. Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
307654|NCT02513771|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
307655|NCT02513823|Texas Woman's University|Carolyn Moore|713-794-2377|cmoore8@twu.edu|
307656|NCT02513940|Indiana University|Dr. James E Tisdale|317-880-5418|jtisdale@iu.edu|
295919|NCT01652703|Amgen Inc.|Study Director|866-572-6436||
295920|NCT01652716|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
295921|NCT01652729|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
295922|NCT01652872|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
295923|NCT01652885|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
295924|NCT01652976|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
295925|NCT01653028|Memorial Sloan Kettering Cancer Center|Mark Andrew Dickson M.D.|6468884164|dicksonm@mskcc.org|
295926|NCT01653132|Beth Israel Deaconess Medical center|Dr. Pushpa Narayanaswami|617-667-8130|pnarayan@bidmc.harvard.edu|
295927|NCT01653158|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307657|NCT02514044|University of Texas Health Science Center at Houston (UTHealth)|Dr. Gerard E. Francisco, Chairman and Professor, Physical Medicine and Rehabilitation|713.797.5246|gerard.e.francisco@uth.tmc.edu|
307658|NCT02514070|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301-402-0521|mamar@nhlbi.nih.gov|
307659|NCT02514122|University of Saskatchewan|Dr. William P. McKay|1 306 655 1202|bill.mckay@usask.ca|
307660|NCT02514174|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
307661|NCT02514473|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
307662|NCT02514551|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
307663|NCT02514577|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
307664|NCT02514746|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
307665|NCT02514772|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
307666|NCT02514824|Dana-Farber Cancer Institute|Robert Haddad, MD|617.632.3090|Robert_Haddad@dfci.harvard.edu|
307667|NCT02514889|UCLA Fielding School of Public Health, 650 Charles Young Drive, Los Angeles, CA 90095|William J. McCarthy, Ph.D., Professor|310-794-7587|wmccarth@ucla.edu|
307668|NCT02515045|Carolina Eyecare Physicians, LLC|Helga P. Sandoval, MD, MSCR. Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
307669|NCT02515058|UT Health Science Center at San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
307670|NCT02515097|Bausch Health Americas, Inc.|Director of Clinical Operations|1-510-259-5284|aloncaric@bauschhealth.com|
307671|NCT02515253|University of Portsmouth|Dr Emma Sharland||emma.sharland@port.ac.uk|
307672|NCT02515279|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
307673|NCT02515305|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
307674|NCT02515331|Novartis Pharmaceuticals|Study Director|862-778-8300|novartisemail@novartis.com|
307675|NCT02515630|Sierra Oncology, Inc.|Dr. Barbara Klencke|1-604-558-6536|bklencke@sierraoncology.com|
271078|NCT00195702|Abbott|Global Medical Services|800-633-9110||
271079|NCT00195715|Abbott|Global Medical Services|1-800-633-9110||
271080|NCT00195819|Abbott|Global Medical Services|800-633-9110||
271081|NCT00196105|Cook|Scott Snyder|765-463-7537|ssnyder@medinst.com|
271082|NCT00196196|Codman & Shurtleff, Inc.|Jandira Ramos, MPH|508-828-3127|jramos8@its.jnj.com|
271083|NCT00196313|Duramed Research|Duramed Research Protocol Chair|215-293-7279|role_medical_affairs@tevapharm.com|
271084|NCT00196326|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000||
271085|NCT00196716|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
295928|NCT01653210|Univerisity of Virginia|Sue Brown, MD||sab2f@virginia.edu|
295929|NCT01653262|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
295930|NCT01653288|Children's Hospital of Philadelphia|Dr. Nancy Kassam-Adams|2155903118|adamsn@email.chop.edu|
295931|NCT01653327|Dartmouth-Hitchcock Medical Center|Dr. Thomas Davis|1-603-650-8626|Thomas.H.Davis@hitchcock.org|
295932|NCT01653405|Rand Corporation|Dr. Adam Rose|617-338-2059|arose@rand.org|8672
295933|NCT01653418|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
295934|NCT01653509|GlaxoSmithKline|GSK Response Center|866-435-7343||
295935|NCT01653587|Santa Casa de Marília|Dr. Pedro Beraldo de Andrade|+551434025561|pedroberaldo@gmail.com|
295936|NCT01653704|The Ottawa Hospital|Dr. Sylvain Boet|6137985555|sboet@toh.on.ca|14775
307676|NCT02515656|Laboratoire Innotech International|Director of Medical Affairs|+33 (0)1 46 15 29 00||
307677|NCT02515669|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
307678|NCT02515825|AUM Cardiovascular|Marie Johnson, PhD|612.799.2511|mariej@aumcv.com|
307679|NCT02515890|University of Pittsburgh|Keith M. Vogt, MD., PhD.|412-999-8570|vogtkm@upmc.edu|
307680|NCT02515942|Alcon, A Novartis Division|WW Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
307681|NCT02515994|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D., F.A.A.O. Principle Research Optometrist|904-443-1474|KCANAVA2@its.jnj.com|
307682|NCT02516046|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
307683|NCT02516098|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
307684|NCT02516150|Massachusetts General Hospital|Courtney Balliro|617-726-1242|cballiro@partners.org|
307685|NCT02516163|Stryker SP|Holly Solomon|+61 2 9467 1072|Holly.Solomon@stryker.com|
307686|NCT02516202|Fred Hutchinson Cancer Research Center|Dr. Katherine A. Guthrie|2066675595|kguthrie@fredhutch.org|
307687|NCT02516306|Encore Vision, Inc|Jerry M. Stein, Ph.D.|817-292-6963|summercreekc@gmail.com|
307688|NCT02516332|Duke University|Patrick Smith, Ph.D.|919-681-3006|patrick.j.smith@duke.edu|
307689|NCT02516410|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
307690|NCT02516579|Addmedica|Medical director|+33172690186|corinne.duguet@addmedica.com|
307691|NCT02516592|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
307692|NCT02516605|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
271884|NCT00273052|GlaxoSmithKline|GSK Response Center|866-435-7343||
307693|NCT02516982|Imperial College London|Dr Josip Car|+44(0)2075940799|josip.car@imperial.ac.uk|
295937|NCT01653743|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
307694|NCT02517021|Helsinn Healthcare SA|Dr. Ruben Giorgino|+41 91 985 2121|ruben.giorgino@helsinn.com|
295938|NCT01653782|Karolinska Institute|Dr. Irene Jensen|+46852483218|irene.jensen@ki.se|
295939|NCT01653847|Northwestern University|Lorenzo Gallon, MD|312-695-4457|l-gallon@northwestern.edu|
295940|NCT01653912|Novartis Pharma AG|Study Director|+41 613241111||
295941|NCT01653964|Mayo Clinic|Dr. Carrie Hruska|5072663991|hruska.carrie@mayo.edu|
295942|NCT01654068|University of Kentucky|Ronal McGarry|859-323-6486|rcmcga2@email.uky.edu|
295943|NCT01654107|Rutgers Robert Wood Johnson Medical School|Marc L. Steinberg, Ph.D.|7322354341|marc.steinberg@rutgers.edu|
295944|NCT01654224|University of Pittsburgh|David Nace, MD, MPH|412 692-2366|naceda@upmc.edu|
295945|NCT01654250|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307695|NCT02517047|Boston Children's Hospital|Dr. Wanda Phipatanakul|6173556117|wanda.phipatanakul@childrens.harvard.edu|
307696|NCT02517268|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Harish Lavu|215-955-6888|Harish.Lavu@jefferson.edu|
307697|NCT02517463|The University of Hong Kong|Dr. Raymond Li|+852 22553914|raymondli@hku.hk|
307698|NCT02517515|AbbVie|Global Medical Services|800-633-9110||
307699|NCT02517528|AbbVie|Global Medical Services|800-633-9110||
307700|NCT02517541|Scientific and Regulatory affairs|Zenia M Størling|+45 49111869|dkzenst@coloplast.com|
307701|NCT02517567|Alcon, A Novartis Division|Sr Global Brand Medical Affairs Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
307702|NCT02517580|Lebanese American University|Dr. Sola Aoun Bahous|+961-1-200-800|sola.bahous@lau.edu.lb|
295946|NCT01654263|Group Health Research Institute|Lisa A. Jackson, MD, MPH|206-442-5216|Jackson.L@ghc.org|
307703|NCT02517658|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
295947|NCT01654276|University of Texas Southwestern Medical Center|Naim Maalouf. MD|214-648-2954|naim.maalouf@utsouthwestern.edu|
295948|NCT01654289|University of Wisconsin|Bruce Barrett MD PhD|608-263-2220|bruce.barrett@fammed.wisc.edu|
307704|NCT02517866|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
307705|NCT02517905|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
307706|NCT02517996|Johns Hopkins University School of Medicine|Dr. Tola Fashokun|410-464-6641|bunmi_omo@hotmail.com|
307707|NCT02518048|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
307708|NCT02518113|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
307709|NCT02518191|Shanghai 6th People's Hospital Affiliated to Shanghai Jiao Tong University|Dr. ZONG|86 (21) 24058549|tigerzong@msn.com|
307710|NCT02518230|Children's Mercy Hospital|Winston Manimtim|816-234-3000|wmmanimtim@cmh.edu|
307711|NCT02518464|Columbia University Medical Center|Robert Sommer, MD|212-305-7060|rs2463@cumc.columbia.edu|
307712|NCT02518490|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
307713|NCT02518620|Ablynx NV|Medical Monitor|+32 (0)9 262 00 00|clinicaltrials@ablynx.com|
307714|NCT02518685|BAROnova, Inc|Lian Cunningham, MD, PhD|650.638.9796|lcunningham@baronova.com|22
271086|NCT00196937|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
307715|NCT02518919|Children's Hospital of Michigan|Dr. Nirupama Kannikeswaran, Associate Professor of Pediatrics and Emergency Medicine|313-745-5260|nkannike@dmc.org|
271087|NCT00196976|GlaxoSmithKline|GSK Response Center|866-435-7343||
271088|NCT00197002|GlaxoSmithKline|GSK Response Center|866-435-7343||
271089|NCT00197015|GlaxoSmithKline|GSK Response Center|866-435-7343||
271090|NCT00197028|GlaxoSmithKline|GSK Response Center|866-435-7343||
271091|NCT00197054|Kombewa Clinic, US Army Medical Research Unit, Kisumo Kenya|LTC Mark Polhemus MD, MC|877-379-3788|GSKClinicalSupportHD@gsk.com|
271092|NCT00197106|GlaxoSmithKline|GSK Response Center|866-435-7343||
271093|NCT00197119|GlaxoSmithKline|GSK Response Center|866-435-7343||
271094|NCT00197145|ViiV Healthcare|GSK Response Center|866-435-7343||
271095|NCT00197184|GlaxoSmithKline|GSK Response Center|866-435-7343||
271096|NCT00197236|GlaxoSmithKline|GSK Response Center|866-435-7343||
271097|NCT00197392|Codman & Shurtleff, Inc|J. Thomas Megerian, MD|508.880.8274|jmegeri1@its.jnj.com|
271098|NCT00197496|University of Waterloo|Dr. Lora Giangregorio|5198884567|lmgiangr@uwaterloo.ca|36357
271099|NCT00198029|Hospital for Special Surgery|Dr. Lisa Mandl|212-774-2555|MandlL@hss.edu|
271100|NCT00198042|Hospital for Special Surgery|Scott Rodeo, MD|212-606-1000|rodeos@hss.edu|
271101|NCT00198081|Indiana University|Christian M. Schmidt, MD|317-278-8349|maxschmi@iupui.edu|
271102|NCT00198107|Indiana University|Christopher J. McDougle, MD|781-860-1783|cmcdougle@partners.org|
271103|NCT00198133|IndianaU|Patrick J. Loehrer, Sr., M.D.|(317)944-0920|ploehrer@iu.edu|
307716|NCT02518971|Michigan Medicine|Andrew Urquhart|734-936-6636|andrewu@med.umich.edu|
271104|NCT00198822|Center for Human Nutrition, Department of International Health, Johns Hopkins Bloomberg School of Public Health|Prof. Keith P West, Jr., Principal Investigator|410-955-2061|kwest@jhsph.edu|
271105|NCT00199381|Kyowa Hakko Kirin Pharma, Inc.|Director of Clinical Trials|609-919-1100|mcantillon@kyowa-kirin-pharma.com|
271106|NCT00199797|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
271107|NCT00199836|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
295949|NCT01654302|Northwestern University|Julia Marks, CRC|312-503-1215|julia.marks@northwestern.edu|
295950|NCT01654380|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
295951|NCT01654445|University of Calgary, Department of Clinical Neurosciences|Shelagh B Coutts and Michael D Hill|4039448065|michael.hill@ucalgary.ca|
295952|NCT01654523|University of Michigan|Joseph Himle - Professor|7343303258|himlej@umich.edu|
295953|NCT01654536|Sunovion|Respiratory Medical Director|1-866-503-6351||
295954|NCT01654549|Tehran University of Medical Sciences|Dr Raika Jamali|982163120000|jamalira@tums.ac.ir|411
295955|NCT01654601|The Catholic university of Korea|Won-myung Bahk. M.D. PhD.|82-2-3779-1051|wmbahk@catholic.ac.kr|
295956|NCT01654666|XuanWu Hospital, Capital Medical University|Xunming Ji, M.D.,Ph.D|8683198127|jixunming@vip.163.com|
295957|NCT01654796|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-2513|MFAVA@mgh.harvard.edu|
307717|NCT02518997|Stanford University|Melissa Scala|650-723-5711|mscala@stanford.edu|
307718|NCT02519023|University of Minnesota|Dr. Jacob Hutchins|6122505535|hutc0079@umn.edu|
307719|NCT02519036|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
307720|NCT02519231|University of Washington|Dr. Emily Godfrey|206.685.4895|godfreye@uw.edu|
307721|NCT02519244|The University of Texas Health Science Center at Houston|Shuo-Hsiu Chang, PT, PhD|713-799-7016|shuo-hsiu.chang@uth.tmc.edu|
307722|NCT02519387|Mundipharma Pharmaceuticals Sdn Bhd|Elayne Chan|+60 122162170|Elayne.Chan@mundipharma.com.my|
307723|NCT02519491|University of Ottawa Heart Institute|Dr. Benjamin Hibbert, Cardiologist|613-696-7000|bhibbert@ottawaheart.ca|
307724|NCT02519504|Emory University|Judith Fridovich-Keil, PhD|404-727-3924|jfridov@emory.edu|
307725|NCT02519595|Children's Hospital of Michigan|Nirupama Kannikeswaran|313-745-5260|nkannike@dmc.org|
307726|NCT02519621|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
295958|NCT01654861|Eastern Regional Medical Center|Eiko Klimant, MD|215-537-7400|eiko.klimant@ctca-hope.com|
295959|NCT01654887|Icahn School of Medicine at Mount Sinai|Dr. James Tsung|212-241-6272|james.tsung@mountsinai.org|
295960|NCT01655043|Northwestern University|Dr. James Carr|(312)926-2270|jcarr@northwestern.edu|
295961|NCT01655069|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 71 5455 050|Astellas.resultsdisclosure@astellas.com|
295962|NCT01655329|Georgetown University Medical Center|Matthew T. Freedman|4105429680|MTFreedman@verizon.net|
295963|NCT01655381|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
295964|NCT01655498|Pelvalon|Director of Clinical|650-276-0130||
295965|NCT01655563|Hospital for Sick Children|Dr. Seema Mital|416-813-7418|seema.mital@sickkids.ca|207418
295966|NCT01655693|ONXEO|Olivier De Beaumont; Chief Medical Officer|+33 (0) 1 45 58 95 33|o.debeaumont@onxeo.com|
307727|NCT02519842|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307728|NCT02519855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307729|NCT02520011|Sumitomo Dainippon Pharma Oncology, Inc.|Susan Smith|+1-210-414-7702|Susan.smith@sdponcology.com|
307730|NCT02520089|Universidad Autonoma de Nuevo Leon|Dr. Carlos Alberto Acosta-Olivo|+528183476698|dr.carlosacosta@gmail.com|
307731|NCT02520284|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
307732|NCT02520310|Abbott Structural Heart|Sripad Bellary|650-353-1726|sripad.bellary@abbott.com|
307733|NCT02520388|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
307734|NCT02520414|Boston Scientific|Meaghan Wilk Clinical Project Manager|5086834113|meaghan.wilk@bsci.com|
295967|NCT01655719|University of Michigan|Tim Muth|734-615-8914|tmuth@med.umich.edu|
295968|NCT01655823|Wex Pharmaceuticals|Mehran Kavoosi|6046767900|mehrank@wexpharma.com|
295969|NCT01655901|CHEO Research Institute|Dr. Jean-Philippe Chaput|613-737-7600|jpchaput@cheo.on.ca|3683
295970|NCT01656031|Comprehensive Cancer Center of Wake Forest University|Dr. Bayard Powell|336-716-7970|bpowell@wakehealth.edu|
295971|NCT01656161|Debiopharm International|Eija Lundstrom, Medical Director|+41 21 321 06 03|eija.lundstrom@debiopharm.com|
295972|NCT01656187|UT Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|sherwood.brown@utsouthwestern.edu|
295973|NCT01656200|University of Liverpool|Dr Lance Turtle|+44 151 795 9626|lance.turtle@liverpool.ac.uk|
295974|NCT01656252|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
295975|NCT01656304|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
307735|NCT02520518|COLORADO STATE UNIVERSITY|Manager of Research Operations|970-491-2242|Laurie.Biela@colostate.edu|
307736|NCT02520531|Stryker|Britta von den Brincken, Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
307737|NCT02521181|Cleveland Clinic Foundation|Jennifer J. Gassman, PhD|(216) 444-9938|gassmaj@ccf.org|
307738|NCT02521259|Seoul National University Bundang Hospital|Dr. YEA JI LEE|+821086307701|ladydaisy82@naver.com|
307739|NCT02521376|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
307740|NCT02521766|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
307741|NCT02521792|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
307742|NCT02521870|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
307743|NCT02521948|Essential Medical, Inc|Director of Operations|610-557-1009|todd@essmedclosure.com|
307744|NCT02521974|FIDEC Corporationa|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
307745|NCT02522104|Addmedica|Medical director|+33 1 72 69 01 86|corinne.duguet@addmedica.com|
307746|NCT02522286|Palo Alto Medical Foundation Research Institute|Dr. Ming Tai-Seale|650-853-4779|Tai-SealeM@pamfri.org|
307747|NCT02522299|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
307748|NCT02522325|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
295976|NCT01656395|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295977|NCT01656408|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
295978|NCT01656460|Brown University Oncology Research Group (BrUOG)|Thomas DiPetrillo, MD|4018633000|kayla_rosati@brown.edu|
295979|NCT01656486|Carolinas Medical Center|David Iannitti, MD|704-446-2772|david.iannitti@carolinashealthcare.org|
295980|NCT01656629|Johns Hopkins University|Dr. Suzanne Jan De Beur|410-550-0100|sjandebe@jhmi.edu|
295981|NCT01656733|University of Connecticut School of Medicine|Cheryl Oncken, MD, MPH|860-679-3425|oncken@uchc.edu|
295982|NCT01656759|Rush University|Sean Kearns|708-236-2664|sean_m_kearns@rush.edu|
295983|NCT01656772|Stereotaxis, Inc.|Qun Sha M.D. (Study Director)|314-678-6143|qun.sha@stereotaxis.com|
295984|NCT01656850|Taipei Medical University|Liu, Jen-Fang|+886-3-2118999|liujenfa@mail.cgust.edu.tw|5487
295985|NCT01656889|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
307749|NCT02522377|CLEVELAND CLINIC FOUNDATION|MURAT ALTINAY, MD|2164453359|altinam@ccf.org|
282664|NCT00867035|Department of Orofacial Sciences, University of California, San Francisco|Milton Robert Wirthlin, DDS, MS|415-476-1731|m.robert.wirthlin@ucsf.edu; ddsmmr@att.net|
271108|NCT00199849|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
271109|NCT00199875|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org|
271110|NCT00199888|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
271111|NCT00199901|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|(212) 450-1546|mmacri@lcr.org|
271112|NCT00199914|Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand|Manee Rattanachaiyanont|+66-2419-4657|manee.rat@mahidol.ac.th|
271113|NCT00200057|Medtronic Neuromodulation|Chad Giese|763-377-5955|chad.giese@medtronic.com|
271114|NCT00200161|Memorial Sloan Kettering Cancer Center|Dr. Lisa Deangelis|212-639-7997|deangell@mskcc.org|
271115|NCT00200343|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
271116|NCT00200356|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
271117|NCT00200785|Silliker, Inc./Plant Bioactives Research Institute, Inc.|Larry D. Lawson|801-226-3041|larry.lawson@silliker.com|
271118|NCT00200850|UW Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
271119|NCT00200902|Laboratory of Brain, Behavior, and Pharmacology at the University of California Los Angeles|Andrew Leuchter, MD|310-825-0207|jpv@brain.ucla.edu|
271120|NCT00200967|Penn State College of Medicine|Vernon M. Chinchilli|717-531-4262|vchinchi@psu.edu|
271121|NCT00201006|University of Florida|Michael G. Perri, PhD|352 273-6214|mperri@ufl.edu|
271122|NCT00201123|NYU School of Medicine|William Rom MD|212 263-6479|William.Rom@nyumc.org|
271123|NCT00201201|University of Connecticut|Patricia J. Neafsey, PhD|860-486-0779|pjneafsey@actualmeds.com|
271124|NCT00201240|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
271125|NCT00201409|University of Michigan|Dr. Robert Hyzy|7349365201|rhyzy@umich.edu|
271126|NCT00201448|Virginia Commonwealth University|Stuart Adler|8048281807|sadler@vcu.edu|
271127|NCT00201643|Obstetrix Medical Group, Inc.|Kimberly A. Maurel, MSN, CNS|714-593-9171|kimberly_maurel@pediatrix.com|
271128|NCT00201734|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, MD|614-293-9863|tanios.bekaii-saab@osumc.edu|
271885|NCT00273182|Medtronic, Inc.|InSync Registry Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
271886|NCT00273364|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
307750|NCT02522403|Universidad Autonoma de Nuevo Leon|Carlos Acosta-Olivo|528183467798|dr.carlosacosta@gmail.com|
295986|NCT01656967|The University of Texas Health Science Center at Houston|Dr. Carin A. Hagberg|(713) 500-6240|Carin.A.Hagberg@uth.tmc.edu|
295987|NCT01657019|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
295988|NCT01657032|The Medical University of Warsaw|Hanna Szajewska, Malgorzata Pieścik-Lech|+48-22-45-23-309|hania@ipgate.pl|
295989|NCT01657162|Radius Health, Inc.|Radius Head of Clinical Operations|(617) 551-4700||
295990|NCT01657253|Laboratorios Sophia S.A. de C.V.|Leopoldo M Baiza-Duran MD, Director of Clinical Trials|52+ 33 30014200|leopoldo.baiza@sophia.com.mx|
307751|NCT02522442|Sleep Therapy & Research Center|Eric Powell, Ph.D.|(210) 614-6000|powell.eric@sleeptrc.com|
307752|NCT02522481|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound|1-609-514-2506|Melda.Dolan@diag.bracco.com|
307753|NCT02522494|Jesse Brown VA Medical Center|Howard S. Gordon, MD|(312) 569-7331|howard.gordon2@va.gov|
307754|NCT02522624|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
307755|NCT02522715|Oregon Health & Science University|Shawna Bailey, Data Manager|503-418-9104|bailesh@ohsu.edu|
307756|NCT02522728|Stryker Orthopaedics|Eric Garling, PhD Snr. Director Medical & Scientific Affairs Europe|+31 6 467 135 18|Eric.Garling@stryker.com|
307757|NCT02522767|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
307758|NCT02522780|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
307759|NCT02522845|Imperial College London|Mr Roshan Bootun|+442033117335|r.bootun@imperial.ac.uk|
307760|NCT02522884|Intact Vascular, Inc.|Joseph C. Griffin, III|4842531048|JGriffin@intactvascular.com|1043
307761|NCT02523196|University of Colorado Denver|Dr. Amanda Wieland|720-848-2291|amanda.wieland@cuanschutz.edu|
307762|NCT02523235|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
307763|NCT02523586|Oregon Health and Science University|Jeffrey Kirsch|503-494-9000|kirschje@ohsu.edu|
307764|NCT02523599|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
307765|NCT02523690|Johns Hopkins University|Dr. Dale Needham|410-287-3343|dale.needham@jhmi.edu|
307766|NCT02523924|Johns Hopkins University|Steven Rowe, MD|4105028052|srowe8@jhmi.edu|
307767|NCT02524054|Beth Israel Deaconess Medical Center|Robert Banzett, PhD|6176670572|rbanzett@bidmc.harvard.edu|
295991|NCT01657266|Laboratorios Sophia S.A. de C.V.|Leopoldo M Baiza-Duran MD, Clinical trials Director|52+ (33) 30 01 42 00|leopoldo.baiza@sophia.com.mx|
295992|NCT01657292|Birken AG|Head of pharmaceutical development|+49 7233 97490|t.zahn@birken.eu|
295993|NCT01657305|Amryt Pharma|Head of Clinical Development|+353 1 669 4606|medinfo@amrytpharma.com|
295994|NCT01657344|Lurie Children's Hospital|Elizabeth Alpern|312-227-6080|ealpern@luriechildrens.org|
295995|NCT01657370|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
295996|NCT01657461|Medtronic|Manish Gupta, Sr. Director of Medical Affairs|949 297 5494|manish.s.gupta@medtronic.com|
295997|NCT01657617|University of Kentucky|Ronald McGarry|859 323 6486|rcmcga2@email.uky.edu|
295998|NCT01657760|Harbor-UCLA Department of Psychiatry|Todd Zorick|310-781-3400|tzorick@mednet.ucla.edu|
295999|NCT01657799|AbbVie|Global Medical Services|800-633-9110||
307768|NCT02524106|University of California San Francisco|Priscilla Hsue, PI|415-206-8257|priscilla.hsue@ucsf.edu|
307769|NCT02524119|UT Southwestern Medical Center|Dr. Muhammad Beg|2146484180|Muhammad.Beg@UTSouthwestern.edu|
307770|NCT02524145|University of Texas Southwestern Medical Center|Dr. Satyam Sarma|214-345-7111|SatyamSarma2@texashealth.org|
307771|NCT02524158|VA San Diego|Dr. Erik J. Groessl|858-552-8585|erik.groessl@va.gov|6347
307772|NCT02524418|University of Florida|Dr. Peter V. Draganov MD|352-273-9472|peter.draganov@medicine.ufl.edu|
307773|NCT02524561|Brigham and Women's Hospital|Dr. Rulla Tamimi|617-525-0862|rulla.tamimi@channing.harvard.edu|
307774|NCT02524665|GlaxoSmithKline|GSK Response Center|866-435-7343||
307775|NCT02524730|Stryker|Britta von den Brincken, Sr. Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
307776|NCT02524769|Loyola University Chicago|Dr. Elizabeth Mueller|708-216-2180|EMUELLE@lumc.edu|
307777|NCT02524847|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
307778|NCT02524977|University of Cincinnati Health|VP Research UC Health|513-558-6937|christopher.lindsell@uc.edu|
307779|NCT02525055|hVIVO Services Limeted|Dr Nicolas Noulin|+442077561365|n.noulin@hvivo.com|
307780|NCT02525094|MedImmune, LLC|Rene van der Merwe|301-398-2532|information.center@astrazeneca.com|
307781|NCT02525133|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
307782|NCT02525263|CTI|Dr William S Aronstein|5135989290|baronstein@ctifacts.com|
307783|NCT02525471|Massachusetts General Hospital|Sabrina Paganoni, MD, PhD|617-724-3914|spaganoni@mgh.harvard.edu|
307784|NCT02525523|Atlantic Pharmaceuticals|Dr Chris Dunk, Director of Clinical Development|+44 1799 513391|chris.dunk@atlantichc.com|
307785|NCT02525536|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
307786|NCT02525549|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
307787|NCT02525575|Department of Veteran Affairs|Marianne Goodman, MD|718-584-9000|Marianne.Goodman@va.gov|5188
307788|NCT02525588|Stryker|Britta von den Brincken, Clinical Study Manager|+491638999202|britta.vondenbrincken@stryker.com|
307789|NCT02525627|Stryker EU Operations B.V. Herikerbergweg 110 1101 CM Amsterdam The Netherlands|Doug McGurty|+44 (0) 1635 500690|doug.mcgurty@stryker.com|
307790|NCT02525653|Memorial Sloan Kettering Cancer Center|Dr. Paul Paik, MD|646-608-3759|paikp@mskcc.org|
307791|NCT02525718|Northwestern Memorial Hospital|Dr. Mohammed Alghoul||malghoul@nm.org|
307792|NCT02525744|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
307793|NCT02525861|Baxalta|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
307794|NCT02525874|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
307795|NCT02526160|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
307796|NCT02526212|Montefiore Medical Center-Albert Einstein College of Medicine|Aaron Fox, Principal Investigator|718-920-7173|adfox@montefiore.org|
307797|NCT02526277|The Ohio State University|Ariane Park, MD|614.293.4969|Ariane.Park@osumc.edu|
307798|NCT02526290|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
307799|NCT02526524|Elcelyx Therapeutics, Inc|Chief Scientific Officer|858-876-1814|info@elcelyx.com|
307800|NCT02526550|Siriraj Hospital|Prof.Kulkanya Chokephaibulkit|662 4195695|kulkanya.cho@mahidol.ac.th|
296000|NCT01657877|GlaxoSmithKline|GSK Response Center|866-435-7343||
296001|NCT01657903|GlaxoSmithKline|GSK Response Center|866-435-7343||
296002|NCT01658020|Asan Midical Center|Principal Investigator|+82-2-3010-3136|ymoh55@amc.seoul.kr|
296003|NCT01658059|Hadassah Medical Organization|Moti Moskovitz||motim@ekmd.huji.ac.il|
296004|NCT01658072|Hospital for Special Surgery|Kethy Jules-Elysee, MD|2126061206|juleselyseek@hss.edu|
296005|NCT01658150|Icahn School of Medicine at Mount Sinia|Dr. Katherine Burdick|212-659-8841|katherine.burdick@mssm.edu|
296006|NCT01658228|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
296007|NCT01658436|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|trialandresults.registries@novartis.com|
296008|NCT01658514|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
296009|NCT01658579|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
296010|NCT01658657|UNC Chapel Hil|Anthony Viera|919-966-0758|viera@med.unc.edu|
296011|NCT01658735|University of Utah School of Medicine|Matthew A Hughes, MD, MPH|8015814800|matthew.hughes@hsc.utah.edu|
296012|NCT01658839|Alcon Research, Ltd.|Theresa Landry, Project Head, Clinical Trial Management|1-888-451-3937|alcon.medinfo@alcon.com|
296013|NCT01658904|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
296014|NCT01658943|SWOG Statistical Center|SWOG Statistician|206-667-4408||
296015|NCT01658995|Mayo Clinic|Petra M. Casey, M.D.|507-266-9873|Casey.Petra@mayo.edu|
296016|NCT01659021|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
296017|NCT01659125|Institute of Living|Gretchen J. Diefenbach|860-545-7685|gretchen.diefenbach@hhchealth.org|
296018|NCT01659255|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
307801|NCT02526654|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
296019|NCT01659268|College of Nursing at Ribeirão Preto, University of Sao Paulo|Cesar Eduardo Pedersoli|55(16)3602-3421|cesinhajardel@ig.com.br|
296020|NCT01659320|Weill Cornell Medical College|Dr. George Alexopoulos, M.D.|914-997-5767|galexopoulos@med.cornell.edu|
296021|NCT01659567|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
296022|NCT01659736|The Institute of Living|Gretchen J. Diefenbach, Ph.D|860-545-7685|Gretchen.Diefenbach@hhchealth.org|
296023|NCT01659853|Galerma Laboratories|Dr. Warren Winkelman|817-961-5494|warren.winkelman@galderma.com|
296024|NCT01659866|Northwestern University|Dr. Anthony Schaeffer|312-908-1615|ajschaeffer@northwestern.edu|
296025|NCT01659996|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
296026|NCT01660022|Medicines for Malaria Venture|Fiona Macintyre|0041 22 555 0319|macintyref@mmv.org|
296027|NCT01660191|University of Kansas Medical Center|Julie-Ann Dutton|913-588-4064|JDUTTON@kumc.edu|
282665|NCT00867087|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296028|NCT01660230|ZZ Biotech, LLC|Kent Pryor, PhD, MBA, Chief Operating Officer||kpryor@zzbiotech.com|
296029|NCT01660256|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
296030|NCT01660321|ParaPro|Director, Quality and Regulatory|317-810-6205|kerrym@parapro.com|
296031|NCT01660334|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296032|NCT01660412|UAMS|James A Ntambi|5015265062|jantambi@uams.edu|
296033|NCT01660672|University of Rochester Medical Center|Gretchen Birbeck|585-273-4265|Gretchen_Birbeck@URMC.Rochester.edu|
296034|NCT01660698|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, Principal Investigator|+41217858054|maurice.beaumont@rdls.nestle.com|
296035|NCT01660711|NorthShore University/University of Chicago|Dr Robert Marsh|847-5702112|rmarsh@northshore.org|
296036|NCT01660737|PASCOE Pharamzeutische Präparate GmbH|Jennifer Lebert|0049+(0)641-7960-955|Jennifer.lebert@pascoe.de|
296037|NCT01660763|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
296038|NCT01660802|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
296039|NCT01660815|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
307802|NCT02526667|Evic Romania|Dr. Olsavszky|40 21 335 70 90|research@evic.ro|
307803|NCT02526680|Wills Eye Hospital Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
307804|NCT02526693|Wills Eye Hospital|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
307805|NCT02527148|Stryker South Pacific|David Fulker|+61 2 9467 1072|david.fulker@stryker.com|
307806|NCT02527161|Stryker SP|David Fulker|+61 2 9467 1072|david.fulker@stryker.com|
307807|NCT02527265|MannKind Corporation|Clinical Development|844.323.7399|mapp@mannkindcorp.com|
271129|NCT00201760|The Ohio State University Comprehensive Cancer Center|Kari Kendra, MD|614-293-7956|Kari.Kendra@osumc.edu|
271130|NCT00201773|The Ohio State University Comprehensive Cancer Center|Steven Provoski, MD|614-293-8700|Stephen.Povoski@osumc.edu|
271131|NCT00201825|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, MD|614-293-6529|Tanios.Saab@osumc.edu|
271132|NCT00201838|The Ohio State Unversity Comprehensive Cancer Center|Miguel Villalona-Calero, MD|614-293-5484|Miguel.Villalona@osumc.edu|
271133|NCT00201851|International Breast Cancer Research Foundation|Richard R. Love|608-698-7881|richardibcrf@gmail.com|
271134|NCT00201864|The Ohio State University|Ewa Mrozek|614-293-7956|Ewa.Mrozek@osumc.edu|
271135|NCT00201877|The Ohio State University Comprehensive Cancer Center|Kristie Blum, MD|614-293-4519|Kristie.Blum@osumc.edu|
271136|NCT00202449|VA PSHCS|Murray Raskind, MD|206-764-2702|Murray.Raskind@va.gov|
271137|NCT00202644|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
271138|NCT00202722|Sorlandet Hospital HF|Tor Tveit|+4738073608|tor.tveit@sshf.no|
271139|NCT00202839|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
271140|NCT00202930|UPMC Children's Hospital of Pittsburgh|Jean M. Tersak, M.D.|412-692-8570|jean.tersak@chp.edu|
271141|NCT00203021|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
271142|NCT00203047|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
271143|NCT00203203|Texas Heart Institute|Emerson C. Perin, M.D., Ph.D.|832-355-9405|eperin@texasheart.org|
271144|NCT00203216|Thomas Jefferson University/Jefferson Headache Center|Dr. William Young, Principal Investigator|215-955-2243|William.B.Young@Jefferson.Edu|
271145|NCT00203229|Thomas Jefferson University|M. Alan Stiles|215-955-6215|Alan.Stiles@Jefferson.edu|
271146|NCT00203242|Thomas Jefferson University/Jefferson Headache Center|Stephen D. Silberstein-Principal Investigator|215-955-9477|Stephen.Silberstein@jefferson.edu|
271147|NCT00203268|Thomas Jefferson University|Stephen D. Silberstein, MD|215-955-2243|Stephen.Silberstein@Jefferson.edu|
271148|NCT00203294|Thomas Jefferson University|Kathleen Bradley|215-955-2025|Kathleen.Bradley@Jefferson.edu|
282666|NCT00867100|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
296040|NCT01660893|University of Maryland|Dr. Sharon M. Gordon|410-706-1656|sgordon@dental.umaryland.edu|
296041|NCT01660906|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
296042|NCT01661062|University of Michigan Comprehensive Cancer Center|Avraham Eisbruch, M.D.|734-936-4302|eisbruch@umich.edu|
296043|NCT01661088|University of Michigan Rogel Cancer Center|Mark Zalupski, M.D.|734-647-8902|zalupski@med.umich.edu|
296044|NCT01661114|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
296045|NCT01661140|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
296046|NCT01661179|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
296047|NCT01661205|AtriCure, Inc.|Vice President, Clinical Operations|513-755-4562|SZink@AtriCure.com|
296048|NCT01661270|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
307808|NCT02527343|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
307809|NCT02527421|Prosoft Clinical|Robert Babilon President|484 320 2068|b.babilon@prosoftclinical.com|
307810|NCT02527512|Boston Children's Hospital|Lauren Hutchinson, Clinical Research Manager|6179191632|lauren.hutchinson@childrens.harvard.edu|
307811|NCT02527681|Basilea Pharmaceutica International Ltd.|Project Physician|+41616061111|Kamal.Hamed@basilea.com|
307812|NCT02527694|Seoul National University Hospital|So Yeon Kong|82220724412|soyeon.kong@gmail.com|
307813|NCT02528188|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307814|NCT02528214|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
307815|NCT02528253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307816|NCT02528305|University of Striling|Dr Niels Vollaard|+441786466488|n.vollaard@stir.ac.uk|
307817|NCT02528318|Windtree Therapeutics, Inc.|Robert Segal, MD, FACP|215-488-9300|rsegal@windtreetx.com|9450
307818|NCT02528331|Duke University|Richard Weiner, MD, PhD|919-681-8742|weine002@duke.edu|
307819|NCT02528357|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
307820|NCT02528370|Hospital Galdakao-Usansolo|Dr Cristobal Esteban|0034 94 400 7000|cristobal.estebangonzalez@osakidetza.eus|7002
307821|NCT02528409|University of Chicago|Dr. Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
307822|NCT02528721|Exalenz Bioscience|VP of Clinical Affairs|972-8-9737502|melinaa@exalenz.com|
307823|NCT02528786|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
307824|NCT02528942|Thomas Jefferson University|Yevgeniy Vinogradskiy PhD|2159553605|yevgeniy.vinogradskiy@Jefferson.edu|
307825|NCT02529072|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
307826|NCT02529137|Philips Digital Pathology Solutions|Mischa Nelis, Clinical Study Director||dpsclinicaltrials@philips.com|
307827|NCT02529488|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
307828|NCT02529553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
271887|NCT00273754|University of Texas Medical School/ Houston|Samia Khalil, M.D./ Professor|713-500-6242|Samia.N.Khalil@uth.tmc.edu|
271888|NCT00273793|UTexas_SanAntonio|Dr. RJ Lamb|210-567-5480|lamb@uthscsa.edu|
296049|NCT01661283|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
296050|NCT01661595|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8707|melmoore@utmb.edu|
296051|NCT01661621|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
296052|NCT01661686|Erasmus University Medical Center|Dr. V.M.C.W. Spaander|0031 10 703 5643|v.spaander@erasmusmc.nl|
296053|NCT01661712|2Guy's and St Thomas' NHS Foundation Trust, Lane Fox Respiratory Unit/Sleep Disorders Centre, London, UK|Dr Joerg Steier|020 7188 3430|joerg.steier@gstt.nhs.uk|
296054|NCT01661764|Vanderbilt University Medical Center|Harvey J Murff|615 936 8319|harvey.j.murff@vanderbilt.edu|
296055|NCT01661790|China PLA General Hospital|Dr. Nan Du|86-13911599657|dunan05@aliyun.com|
296056|NCT01661881|Dana-Farber Cancer Institute|Philippe Armand MD, PhD|617.632.2305|Philippe_Armand@dfci.harvard.edu|
296057|NCT01661933|The Prince Charles Hospital|Dr John Croese. The Chief Investigator|+61733716164|jcroese@bigpond.com|
296058|NCT01661946|Queen's University Department of Ophthalmology|Dr. Sanjay Sharma|613-544-3400|sanjay_sharma60@hotmail.com|2227
296059|NCT01661972|Duke University Medical Center|John Strickler, M.D.|919-668-1861|john.strickler@duke.edu|
296060|NCT01662024|Brigham and Women's Hospital|Christopher C. Thompson, MD, MSc|617-525-8266|ccthompson@bwh.harvard.edu|
296061|NCT01662063|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
296062|NCT01662115|Cleveland Clinic Florida|Chief Academic Office|9546595278|weisse@ccf.org|
296063|NCT01662297|Yale University/West Haven VAMC|Dr. Albert Arias|2039325711|albert.arias@va.gov|8155
296064|NCT01662310|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
296065|NCT01662336|AbbVie (prior Sponsor Abbott)|Global Medical Services|800-633-9110||
296066|NCT01662362|Abbott|Barbara Kaesdorf, Associate Director Clinical Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
296067|NCT01662440|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
296068|NCT01662492|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
307829|NCT02529995|AstraZeneca|Global Clinical Lead, Yuri Rukazenkov|+44 1625 231825|Yuri.Rukazenkov@astrazeneca.com|
307830|NCT02530125|Northwestern University|Winter, Jane MD|312 695 4033|Jwinter@nm.org|
307831|NCT02530151|Northwestern University|Michael Terry, MD|312-472-6488|mterry@nm.org|
307832|NCT02530242|UCSF Benioff's Children's Hospital Oakland|Ashutosh Lal, MD||Ashutosh.Lal@ucsf.edu|
307833|NCT02530281|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
307834|NCT02530294|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
307835|NCT02530385|Massachusetts General Hospital Endocrine Unit|Dr. Elaine Yu|617-726-6723|ewyu@mgh.harvard.edu|
307836|NCT02530450|UT Health Science Center in San Antonio|Dr. Maria Rayas, Assistant Professor in Pediatric Endocrinology and Diabetes|210-567-5283|rayas@uthscsa.edu|
307837|NCT02530476|The University of Texas MD Anderson Cancer Center|Naval Daver, MD/Associate Professor|713-794-4392|NDaver@mdanderson.org|
307838|NCT02530515|UT MD Anderson Cancer Center|Dr. Chitra Hosing / Stem Cell Transplantation|(713) 745-3219|cmhosing@mdanderson.org|
307839|NCT02530528|MicroBioTest|Dr. MH Bashir|7039250100|muhammad.bashir@microbac.com|
307840|NCT02530541|BSL|C. Beausoleil|406-587-5735|cbeausoleil@biosciencelabs.com|
307841|NCT02530554|Evic Romania|Dr. R Olsavszky|40 21 335 70 91|evicromania@evic.ro|
307842|NCT02530619|Northwestern University, Feinberg School of Medicine|Brady L. Stein, MD|312-695-6832|bstein@nmff.org|
307843|NCT02530671|University Kiel|Dr. Sonja Sälzer|00494315972810|saelzer@konspar.uni-kiel.de|
307844|NCT02530905|Sarepta Therapeutics, Inc.|Medical Director|1-800-690-2003|clinicaltrials@sarepta.com|
307845|NCT02530970|Aziyo Biologics, Inc.|Clinical Director|470-514-4085|clinical@aziyo.com|
296069|NCT01662505|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296070|NCT01662531|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
296071|NCT01662583|Columbia University|Melissa Stockwell, MD MPH|212-342-5372|mss2112@columbia.edu|
296072|NCT01662635|Thoracic Oncology Unit. Instituto Nacional de Cancerología|Oscar Gerardo Arrieta-Rodríguez|+52 55 56280400|ogar@unam.mx|832
296073|NCT01662648|Janssen China|Regional Medical Franchis Director AP|+86 10 582 187 66||
296074|NCT01662752|St Mark's Hospital|Professor Robin Kennedy|+44(0)2082354046|robin.kennedy@nhs.net|
296075|NCT01662765|Bahcesehir University, School of Medicine|Dr. Mehmet Kaplan|+905056268899|dr.kaplan27@gmail.com|
296076|NCT01662778|Imperial College London|Dr Omar Usmani||o.usmani@imperial.ac.uk|
296077|NCT01662791|Mayo Clinic|Dr. John K. DiBaise|480-301-6990|DiBaise.John@mayo.edu|
296078|NCT01662856|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
296079|NCT01662882|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
296080|NCT01662895|Beth Israel Deaconess Medical Center|Magdy Selim, MD, PhD|617-63208913|mselim@bidmc.harvard.edu|
296081|NCT01662908|Daiichi Sankyo, Inc.|Senior Director, CVM TA Development|732-590-5000||
307846|NCT02530996|Salt Lake VAMC and University of Utah|Dr. Tracy Frech|801 213 2312|tracy.frech@hsc.utah.edu|
307847|NCT02531022|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
307848|NCT02531035|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
296082|NCT01662960|Albert Einstein Healthcare Network|Dr. Steven Jax|215-870-0196|stevenandrewjax@gmail.com|
296083|NCT01662986|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296084|NCT01662999|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
296085|NCT01663012|Stanford University School of Medicine650-|Lawrence Recht, MD, Professor of Neurology|650-725-8630|lrecht@stanford.edu|
296086|NCT01663103|University of Colorado Anschutz Medical Campus|Dr. Kristen Nowak|303-724-4842|Kristen.Nowak@ucdenver.edu|
296087|NCT01663233|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
296088|NCT01663259|University of Michigan Rogel Cancer Center|Michelle Mierzwa|734-936-7810|mmierzwa@umich.edu|
296089|NCT01663272|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-647-8902|zalupski@med.umich.edu|
296090|NCT01663363|Abbott Medical Optics|Ann Murphy, Manager, Clinical Research|619-518-4158|Ann.Murphy@abbott.org|
296091|NCT01663402|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1
296092|NCT01663506|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
296093|NCT01663532|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
296094|NCT01663623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
296095|NCT01663636|Center for Global Health, University of Colorado|Dr. Edwin J. Asturias|3037246282|edwin.asturias@ucdenver.edu|
296096|NCT01663714|GlaxoSmithKline|GSK Response Center|866-435-7343||
296097|NCT01663727|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
296098|NCT01663740|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
296099|NCT01663779|Yale School of Medicine|Kevin M. Schuster|203-785-2572|kevin.schuster@yale.edu|
296100|NCT01663857|Eli Lilly and Company|Chief Medical Officer|800-575-5979|Clinicaltrials.gov@lilly.com|
296101|NCT01663896|St. Jude Medical|Sr. Manager, Global Clinical Affairs|651-756-5585|mwagner2@sjm.com|
296102|NCT01663922|St Stephens AIDS Trust|Dr Akil Jackson|0203 315 6503|akil.jackson@chelwest.nhs.uk|
307849|NCT02531113|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email:|Clinical.Trials@bms.com|
307850|NCT02531321|University of Southern California|Dr. Nicole Bender|3234093416|nicole.bender@med.usc.edu|
307851|NCT02531373|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307852|NCT02531438|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
307853|NCT02531633|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
307854|NCT02531646|Carestream Health, Inc.|Susan Pate, RN, MS, RAC, Senior Clinical Manager|585-627-6557|susan.pate@carestream.com|
307855|NCT02531698|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307856|NCT02531802|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
271149|NCT00203307|Thomas Jefferson University/ Jefferson Headache Center|Stephen D. Silberstein, M.D.- Principal Investigator|215-955-2243|stephen.silberstein@jefferson.edu|
271150|NCT00203411|Translational Research in Oncology|Dr. Arash Naeim|310 267-6810|anaeim@mednet.ucla.edu|
271151|NCT00203424|Translational Oncology Research International|Dr. Fairooz F. Kabbinavar, Chief Medical Officer|310-824-1934|FKabbina@mednet.ucla.edu|
271152|NCT00203476|TuscaloosaREAC|Raela Williford, PharmD|(205) 554-2000|Raela.Williford@va.gov|2433
271153|NCT00203502|University of Arkansas for Medical Sciences|Dr. Issam Makhoul|5016868274|MakhoulIssam@uams.edu|
271154|NCT00203892|University of Chicago|Dr. Hedy Kindler|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
271155|NCT00203931|University of Chicago|Kristen Wroblewski|773-702-7173|kwroblewski@health.bsd.uchicago.edu|
271156|NCT00203996|The University of Chicago|David A. Ehrmann, MD|(773) 702-6138|dehrmann@medicine.bsd.uchicago.edu|
271157|NCT00204373|The University of Alabama at Birmingham|Dr. C. Mel Wilcox|205-934-6060|melw@uab.edu|
271158|NCT00204932|U Wisconsin-Madison|Dale Schoeller Principal Investigator|608-262-1082|dschoell@nutrisci.wisc.edu|
271159|NCT00205179|University of Wisconsin|Dr. Carey Gleason|608-280-7000|ceg@medicine.wisc.edu|
271160|NCT00205348|University of Wisconsin-Madison|Dr. Herbert Chen|608-263-1387|chen@surgery.wisc.edu|
271161|NCT00205374|University of Wisconsin-Madison|J. Scott McMurray, MD|608-262-7181|mcmurray@surgery.wisc.edu|
271162|NCT00205504|Virginia Commonwealth University|Kai Cheang, Principal Investigator|804-828-9698|kicheang@vcu.edu|
296103|NCT01663935|University of Wisconsin, Madison|Dr Michael Struck|608 263-6429|mcstruck@wisc.edu|
296104|NCT01663987|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296105|NCT01664039|Alcon Research, Ltd|Global Brand Lead, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
296106|NCT01664052|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
296107|NCT01664078|Cordis, a Cardinal Health Company|Brandy Maschhaupt|847 887 5744|brandy.maschhaupt@cardinalhealth.com|
296108|NCT01664091|Dana-Farber Cancer Institute|Julia Wong, MD|617-632-3591|JWONG@LROC.HARVARD.EDU|
296109|NCT01664104|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
296110|NCT01664117|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
296111|NCT01664130|Case Comprehensive Cancer Center|Kevin Stephans MD|216-445-8285|stephak@ccf.org|
296112|NCT01664247|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
296113|NCT01664494|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
296114|NCT01664533|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
296115|NCT01664559|BWH|Dr. Lynn Ngo, Lead Study Coordinator/investigator|(617)732-8798|llngo@partners.org|
296116|NCT01664624|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
296117|NCT01664741|Johns Hopkins School of Medicine|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
296118|NCT01664793|University of Pittsburgh|Richard K. Zimmerman|412-383-2355|zimmer@pitt.edu|
296119|NCT01664806|University of Colorado School of Medicine|Dr. Thomas Robinson|303-724-2728|thomas.robinson@Ucdenver.edu|
296120|NCT01664858|University of Leeds|Professor John P Greenwood|+44 (0)113 3925481|j.greenwood@leeds.ac.uk|
296121|NCT01664897|The University of Texas MD Anderson Cancer Center|Jorge Cortes MD./Professor|713-794-5783|jcortes@mdanderson.org|
307857|NCT02531867|Alexion|Medical Director|(781) 357-9900|clinicaltrials@alexion.com|
271889|NCT00273858|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296122|NCT01664923|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296123|NCT01664949|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
296124|NCT01664975|Zhengzhou University|Mingzhi Zhang|0371-66295564|mingzhi_zhang@126.com|
296125|NCT01665040|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494350|rjain@bsci.com|
296126|NCT01665053|Boston Scientific|Patricia O'Mara, Clinical Trial Manager|518-792-5673|patricia.o'mara@bsci.com|
296127|NCT01665092|Univeristy of Mississippi Medical Center|Alan Jones|601-384-5586|aejones@umc.edu|
296128|NCT01665157|National Taiwan University Hospital|Han-Mo Chiu, M.D., Ph.D.||hanmochiu@ntu.edu.tw|
296129|NCT01665170|PASCOE pharmazeutische Präparate GmbH|Dr. Gabriele Weiß|0641-7960|klinischeforschung@pascoe.de|
296130|NCT01665430|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
296131|NCT01665508|Massachusetts General Hospital|Nandita S. Scott|6177241739|nsscott@partners.org|
296132|NCT01665599|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
296133|NCT01665768|Johns Hopkins University|Douglas Gladstone, MD|4109558781|dgladst1@jhmi.edu|
296134|NCT01665807|Mount Sinai Hospital, IDERU|Brenda L. Coleman, PhD,|416-586-4800|bcoleman@mtsinai.on.ca|4538
296135|NCT01665872|Yale University|Dr. Megan Smith|2037648655|megan.smith@yale.edu|
296136|NCT01665911|Indiana University School of Dentistry|Frank Lippert|317-274-8822|flippert@iu.edu|
296137|NCT01665950|Massachusetts General Hospital, Center for Quantitative Health|Dr. Roy Perlis|617-643-6310|rperlis@partners.org|
296138|NCT01666002|Stanford University|Jean Tang MD PhD, assistant professor|650-723-6316|tangy@stanford.edu|
296139|NCT01666119|BDSI|Enoch Bortey|919 582 9050|ebortey@bdsi.com|
296140|NCT01666145|Carolinas Healthcare System|Principal Investigator|704-446-2772|john.martinie@carolinashealthcare.org|
296141|NCT01666197|Novartis Consumer Health SA|Clinical Project Leader|41223635293||
307858|NCT02531971|University of Maryland, Baltimore|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
296142|NCT01666210|Ocular Therapeutix, Inc.|Eric Ankerud|781-357-4013|eankerud@ocutx.com|
296143|NCT01666314|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
296144|NCT01666444|Vice President, Clinical Affairs|Kristi Manjarrez|206-689-2256|kmanjarrez@ventirx.com|
296145|NCT01666652|WRAIR|Robin Nielsen, RN|301-319-9063|trials.clinical@amedd.army.mil|
296146|NCT01666730|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. David Bajor|1-800-641-2422|CTUReferral@UHhospitals.org|
296147|NCT01666782|Rochester General Hospital|Saad Jamshed, MD|585-922-4020|Saad.Jamshed@rochesterregional.org|
296148|NCT01666912|UNC_ChapelHill|Amy G. Bryant, Assistant Professor|919-843-5633|amy_bryant@med.unc.edu|
307859|NCT02532010|Weill Cornell Medicine|Dr. Sangmin Lee|646-962-2700|sal9053@med.cornell.edu|
307860|NCT02532036|University of Oxford|Professor Helen McShane|+44 (0)1865 617606|helen.mcshane@ndm.ox.ac.uk|
307861|NCT02532179|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
307862|NCT02532283|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
307863|NCT02532374|Philip Morris Products S.A.|Loyse Felber Medlin|+41 (58) 242 2686|Loyse.FelberMedlin@pmi.com|
307864|NCT02532465|Nationwide Children's Hospital|Senthil Krishna, MD|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
307865|NCT02532517|Cerenovus|Christopher Hendricks|415-656-6565|CHendric@its.jnj.com|
307866|NCT02532543|University of North Carolina at Chapel Hill|Gidgetta Kang|919-537-3968|gidgetta_jenkins@unc.edu|
307867|NCT02532556|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
307868|NCT02532647|PAION UK Ltd|Trial Information||reg_paion@paion.com|
307869|NCT02532764|ProQR Therapeutics|Medical Monitor|+31 6 20 183 437|clinical@proqr.com|
307870|NCT02532855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307871|NCT02532933|University Of Denver|Kevin Shelburne|3039021249|kevin.shelburne@du.edu|
307872|NCT02532972|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736981|Daniel_Lee@meei.harvard.edu|
307873|NCT02532998|AstraZeneca AB|AZD9977 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
307874|NCT02533063|University of Wisconsin|Diane Krueger|6082656410|dckruege@wisc.edu|
271163|NCT00205660|Washington University|Michael Yingling|5735791412|yinglinm@wustl.edu|
271164|NCT00205699|Florida Atlantic University|John W. Newcomer|(561) 297-0252|jnewcomer@health.fau.edu|
271165|NCT00205712|Washington University School of Medicine|John Newcomer, MD|314-362-3153|newcomerj@wustl.edu|
271166|NCT00205777|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271167|NCT00205803|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271168|NCT00205855|Boston Scientific Corporation|Natalie Bloom Lyons|763-228-9040|lyonsn@bsci.com|
271169|NCT00205881|Advanced Bionics, LLC|Kenneth Ripley|(661) 362-4572|Kenneth.Ripley@advancedbionics.com|
271170|NCT00206076|Drexel University College of Medicine|David Reich, MD|215-762-7143|David.Reich@DrexelMed.edu|
271171|NCT00206102|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
271172|NCT00206323|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
271173|NCT00206336|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
271174|NCT00206427|Baylor Breast Cancer|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.tmc.edu|
271890|NCT00273910|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
271891|NCT00274261|NICHD|Jason Woo, MD, MPH|301-496-1662|woojj@mail.nih.gov|
307875|NCT02533089|Li Ka Shing knowledge institute|Dr. L M Puchalski Ritchie|416 864 6060|lisa.puchalskiritchie@utoronto.ca|
296149|NCT01666951|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
296150|NCT01667029|Massachusetts General Hospital|Dr. Brian Wainger|617-726-8810|Brian.Wainger@mgh.harvard.edu|
296151|NCT01667107|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
296152|NCT01667224|Clinical Trial Center for Functional Food in Chonbuk National University Hospital|Dr. Soo-Wan Chae|82-63-250-2348|soowan@jbnu.ac.kr|
296153|NCT01667250|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
296154|NCT01667406|Imperial College London|Professor Waljit Dhillo|442083833242|w.dhillo@imperial.ac.uk|
296155|NCT01667419|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
296156|NCT01667432|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
296157|NCT01667471|Hoffmann-LaRoche or Genentech, Inc|Medical Communications|800-821-8590|genentech@druginfo.com|
296158|NCT01667536|Progenics Pharmaceuticals, Inc.|Senior Director, Clinical Science Communications|914 784-1825|vdipippo@progenics.com|
296159|NCT01667549|Monell Chemical Senses Center|Julia A. Mennella, PhD; Study Principal Investigator|267-519-4880|mennella@monell.org|
296160|NCT01667562|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
296161|NCT01667679|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
296162|NCT01667731|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
282667|NCT00867113|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
296163|NCT01667796|Johns Hopkins|Ellen Mowry|4106141522|vitamindtrialms@jhmi.edu|
296164|NCT01667848|LudwigBoltzmannIOL|Dr. Bettina Klugsberger|+43 732 7806 2133|Bettina.Klugsberger@akh.linz.at|
271175|NCT00206440|Baylor College of Medicine|Mothaffar Rimawi|713 798 1999|rimawi@bcm.tmc.edu|
296165|NCT01667900|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
296166|NCT01667926|Massachusetts General Hospital|Dr. Cristina Cusin|6177263855|ccusin@mgh.harvard.edu|
296167|NCT01667978|Montefiore|Jessica Atrio|718 405 82 60|jatrio@montefiore.org|
296168|NCT01668004|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
307876|NCT02533167|Wake Forest Health Sciences|Ashley Tonidandel, MD|336-718-8278|atonidan@wakehealth.edu|
307877|NCT02533180|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
307878|NCT02533258|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307879|NCT02533375|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
307880|NCT02533401|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
307881|NCT02533427|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
307882|NCT02533453|Astrazeneca, Korea|Hyun Jung Kang / Local Study Leader|82 2 2188 0846|hyunjung.kang@astrazeneca.com|0846
307883|NCT02533466|GlaxoSmithKline|GSK Response Center|866-435-7343||
307884|NCT02533505|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
307885|NCT02533570|Seattle Genetics, Inc|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
307886|NCT02533674|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
307887|NCT02533726|Stanford University School of Medicine|Dr David Pickham|650 701 6830|dpickham@stanford.edu|
307888|NCT02533921|University of Colorado|Benzi Kluger, MD, MS, Principal Investigator|303-724-2194|Benzi.kluger@ucdenver.edu|
307889|NCT02533934|University of California San Francisco|Rodney Rogers|+14155951226|Rodney.Rogers@ucsf.edu|
307890|NCT02533999|Nemours Children's Specialty Care|Kathryn Blake, PharmD|904-697-3806|kathryn.blake@nemours.org|
282668|NCT00867139|FHCRC|Michael Boeckh MD|206 667 6706|mboeckh@fhcrc.org|
296169|NCT01668017|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
296170|NCT01668030|University of Louisville School of Nursing|Dr. Carlee Lehna, Associate Professor|502-852-3913|carlee.lehna@louisville.edu|
296171|NCT01668173|Memorial Sloan Kettering Cancer Center|Dr. Raajit Rampal|212-639-2194|RampalR@mskcc.org|
296172|NCT01668355|VA|Alexander Young|310-794-7219|alexander.young@va.gov|
296173|NCT01668537|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
296174|NCT01668589|Amgen Inc.|Study Director|866-572-6436||
296175|NCT01668602|Emory University|Trisha Kesar, PT, PhD|404-712-5803|trisha.m.kesar@emory.edu|
296176|NCT01668628|The Catholic University of Korea|Dr. Hye Eun Yoon|82-32-280-5886|berrynana@catholic.ac.kr|
296177|NCT01668654|GlaxoSmithKline|GSK Response Center|866-435-7343||
296178|NCT01668667|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
296179|NCT01668719|SWOG Statistics and Data Management Center|Myeloma Committee Statistician|2066674623|rachaels@crab.org|
296180|NCT01668784|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
296181|NCT01668797|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
296182|NCT01668836|Heart Institute (InCor), University of São Paulo Medical School|Antonio de Padua Mansur - Associate Professor|55-11-26615387|apmansur@usp.br; apmansur@yahoo.com|
296183|NCT01668966|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
296184|NCT01669096|GlaxoSmithKline|GSK Response Center|866-435-7343||
296185|NCT01669122|GlaxoSmithKline|GSK Response Center|866-435-7343||
296186|NCT01669174|Novartis Pharmaceuticals|Study Director|862-778-8300||
296187|NCT01669343|Princess Margaret Hospital|Dr. David Cescon|416-946-2000|dave.cescon@uhn.on.ca|
271176|NCT00206518|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
271177|NCT00206726|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
271892|NCT00274287|Oncology Specialists, S.C.|Chadi Nabhan, MD|847-268-8200|cnabhan@oncmed.net|
271893|NCT00274456|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
296188|NCT01669421|University of Miami|Michael Campos|305-243-3045|mcampos1@med.miami.edu|
271894|NCT00274469|AstraZeneca|Jasmine Lichfield|07585404954|jasmine.lichfield@astrazeneca.com|
271895|NCT00274625|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
271896|NCT00274651|Topotarget A/S|PRS Admnistrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
271897|NCT00274716|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
271898|NCT00274742|Amgen Inc.|Study Director|866-572-6436||
271899|NCT00274768|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Antonio Wolff|410-614-6192|awolff@jhmi.edu|
271900|NCT00274781|The Cleveland Clinic|Mikkael Sekeres, MD, MS|216-445-9353|sekerem@ccf.org|
271901|NCT00274846|Masonic Cancer Center, University of Minnesota|Jeffrey Miller, M.D.|612-625-7409|mille011@umn.edu|
271902|NCT00274924|ECOG Statistical Office|Study Statistician|617-632-3012||
271903|NCT00274937|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
271904|NCT00275002|Pediatric Brain Tumor Consortium|Dana Wallace|901-595-2617|dana.wallace@stjude.org|
271905|NCT00275028|Dana-Farber Cancer Institute|Kimberley MacNeill|617-632-2621|kmacneill@partners.org|
271906|NCT00275262|Abbott|Global Medical Services|800-633-9110||
271907|NCT00275275|University of Kansas Medical Center|Kelly E. Lyons, PhD|913-588-7159|klyons@kumc.edu|
307891|NCT02534129|ProTechSure Scientific Inc.|L. Michael Glode, MD|303-526-9031|mike.glode@ucdenver.edu|
296189|NCT01669434|University of Nebraska Medical Center|Dr. Jason Shiffermiller|402-559-7299|jshiffermiller@unmc.edu|
296190|NCT01669538|University of Pennsylvania|Rebecca Ashare|2157465789|rlashare@pennmedicine.upenn.edu|
296191|NCT01669577|University of São Paulo|Luiz Guilherme Villares da Costa, MD|5511985584737|lgvc76@yahoo.com.br|
296192|NCT01669603|University of Virginia|Ronald Turner||rbt2n@virginia.edu|
296193|NCT01669629|Vistakon|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|904 443-1032|kosborn@its.jnj.com|
296194|NCT01669642|washington university in st louis|SRI SANKAR CHINTA PI|3144544661|schinta@wustl.edu|
296195|NCT01669720|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
296196|NCT01669785|Salus Research, Inc.|Jeffery L. Milleman, DDS, MPA|260-755-1099||
296197|NCT01669798|Duke University Medical Center|Angeles Alvarez Secord|919-684-3765|secor002@mc.duke.edu|
296198|NCT01669811|Clinical Statistics & Programming Department, Clinical Science Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
296199|NCT01669863|Hannover Medical School|Dr Marius Hoeper|00495115323530|hoeper.marius@mh-hannover.de|
296200|NCT01669902|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
296201|NCT01669928|Imperial College London|Professor Neil Poulter|+44 20 7594 3446|n.poulter@imperial.ac.uk|
296202|NCT01670019|Duke University|John Beyer, M.D.|919-668-0209|john.beyer@dm.duke.edu|
296203|NCT01670045|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
296204|NCT01670097|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
296205|NCT01670110|Mayo Clinic|Marie C. Hogan, M.D., Ph.D.|507-284-3479|Hogan.Marie@mayo.edu|
296206|NCT01670188|Mayo Clinic|Dr. Alejandro Rabinstein|507-284-4741|Rabinstein.Alejandro@mayo.edu|
296207|NCT01670201|Harborview Medical Center / Seattle, Washington|Dr Nicole Gibran|206-744-3140|nicoleg@uw.edu|
296208|NCT01670279|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
296209|NCT01670292|Palmer Center for Chiropractic Research|Dr. Ting Xia|563-884-5161|ting.xia@palmer.edu|
296210|NCT01670487|Cleveland Clinic|Dr. Sharon Mace|216-445-4598|maces@ccf.org|
296211|NCT01670500|DFCI|Project Manager|617-632-2257|CTOPM@dfci.harvard.edu|
296212|NCT01670526|Hines CSPCC|Tom Sindowski|708-202-5858|tom.sindowski@va.gov|
296213|NCT01670721|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
296214|NCT01670760|3M|Terri White|651-733-0228|twhite3@mmm.com|
307892|NCT02534285|Technical University Dresden, Dept. of Anaesthesiology|Prof. Dr. Matthias Hübler|+4945814002|matthias.huebler@uniklinikum-dresden.de|
307893|NCT02534324|Faculty of Medicine, Chulalongkorn University|Dr. Khrongwong Musikatavorn|+66818390511|Khrongwong.m@chulahospital.org|
307894|NCT02534350|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
307895|NCT02534493|Pressure Profile Systems|Jae Son|3106418100|jaeson@pressureprofile.com|
307896|NCT02534883|St. Louis University|Donald Gregory Ward, MD|314-781-1505|dgreg.ward@health.slu.edu|1
307897|NCT02534896|SPARC|Dr Mudgal Kothekar|912266455645|clinical.trials@sparcmail.com|
307898|NCT02534935|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307899|NCT02535000|Serviço de Anestesiologia de Joinville|Antonio Bedin|+554734331666|abjoimailbox-ct@yahoo.com|
307900|NCT02535026|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
296215|NCT01670825|Johns Hopkins Hospital|Steven Cohen|410-955-1818|scohen40@jhmi.edu|
296216|NCT01671007|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296217|NCT01671059|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
296218|NCT01671085|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
296219|NCT01671111|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
296220|NCT01671176|Oticon Medical LLC|Ravi Sockalingam|9082023524|rsoc@oticomedical.com|
296221|NCT01671280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296222|NCT01671293|Universidad del Desarrollo|J. Carola Pérez Ewert|5623279875|janetperez@udd.cl|
296223|NCT01671319|University of Wisconsin Carbone Cancer Center|Dr. Amyé Tevaarwerk|608-262-2837|at4@medicine.wisc.edu|
296224|NCT01671332|University of Wisconsin|Anne Traynor|608-262-5092|amt@medicine.wisc.edu|
296225|NCT01671345|Jesse Brown VA Medical Center|Howard S. Gordon, MD|312-569-7331|howard.gordon2@va.gov|
296226|NCT01671423|Einstein Medical Center|Scott Goldstein|2154561836|goldstes@einstein.edu|
296227|NCT01671488|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
296228|NCT01671605|Vanderbilt University Medical Center|Valentina Kon|6153224883|valentina.kon@vanderbilt.edu|
296229|NCT01671748|Cardiff and Vale University Health Board|Dr Judith White|02920744771|judith.white3@wales.nhs.uk|
296230|NCT01671839|Merz Pharmaceuticals|Public Disclosure Manager|+49 69 1503 0|clinicaltrials@merz.com|
296231|NCT01672242|University of Maryland School of Medicine|Carl Shanholtz, MD|410.328.8141|cshanhol@som.umaryland.edu|
296232|NCT01672294|VA HSRD Durham VA Medical Center|Karen Steinhauser, PhD|9196682148|karen.steinhauser@va.gov|
296233|NCT01672658|Rehabilitation Instititute of Chicago|Arun Jayaraman, PT, PhD|312-238-2091|a-jayaraman@northwestern.edu|
296234|NCT01672710|Institute for Health and the Environment, University at Albany|David O. Carpenter MD|518-525-2660|dcarpenter@albany.edu|
296235|NCT01672723|University of California, Los Angeles|Dr. Naomi Eisenberger|310-267-5196|neisenbe@ucla.edu|
296236|NCT01672736|University Health Network - Princess Margaret Cancer Centre|Dr. Suzanne Trudel|416-946-4501|Suzanne.Trudel@uhn.ca|4566
307901|NCT02535065|Cook Research Incorporated|Manager, Biostatistics|7654637537|Alan.Saunders@CookMedical.com|321204
307902|NCT02535364|Juno Therapeutics|Dr. Nikolaus Trede|206-566-5886|Nick.Trede@junotherapeutics.com|
271178|NCT00207090|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
271179|NCT00207142|Bristol-Myers Squibb|Study Director||clinical.trials@bms.com|
271180|NCT00207714|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
271181|NCT00207727|Centocor Research & Development, Inc.|Sr. Dir. Clinical Research|1-800-457-6399||
271182|NCT00207740|Centocor Research & Development, Inc.|Director Clinical Research|1-800-457-6399||
271183|NCT00207883|Children's Healthcare of Atlanta / Emory University|Jana Stockwell, MD|404-785-1600|jana.stockwell@choa.org|
271184|NCT00208026|The Children's Hospital of Philadelphia|Albert C. Yan, M.D.|(215) 590-2158|Yana@email.chop.edu|
271185|NCT00208091|Clinical Motor Physiology Laboratory|Dr. Seth Pullman|212-305-3808|sp31@columbia.edu|
271186|NCT00208325|DePuy International|Kimberly Dwyer, Ph.D, CCRA||kdwyer2@its.jnj.com|
271187|NCT00208494|DePuy Orthopaedics, Inc.|Jennifer Hoag, MS, Project Leader, Clinical Research|574-372-7399|JHoag2@its.jnj.com|
271188|NCT00208507|DePuy Orthopaedics, Inc|Dave Whalen|574-372-7028|DWhalen@its.jnj.com|
271189|NCT00208767|Emory University School of Medicine|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
271190|NCT00208949|Emory University|Dr. Sagar Lonial|404-778-1900|SLONI01@emory.edu|
271191|NCT00208975|Emory University|Dr. Christopher Flowers|404-778-3942|crflowe@emory.edu|
271192|NCT00209092|Emory University|Dr. Amelia Zelnak|404-778-1900|amelia.zelnak@emory.edu|
271193|NCT00209170|University of Miami School of Medicine|Dominique Musselman, MD|404-723-8361|dmusselman@med.miami.edu|
296237|NCT01672788|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296238|NCT01672801|Boston IVF|Alan Penzias|781-434-6500|apenzias@bostonivf.com|
296239|NCT01672827|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6820|paulsherwin@ge.com|
296240|NCT01672853|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
296241|NCT01672866|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
296242|NCT01672879|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
296243|NCT01672892|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
296244|NCT01672957|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
296245|NCT01672970|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
296246|NCT01672983|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
296247|NCT01672996|GE Healthcare|Rubin Sheng, MD|609-514-6899|Rubin.Sheng@ge.com|
296248|NCT01673009|Indiana University|Kent Robertson MD PhD|317-944-8784|krobert@iu.edu|
307903|NCT02535416|Arrowhead Pharmaceuticals, Inc.|James Hamilton, MD|626-696-3400|jhamilton@arrowheadpharma.com|
307904|NCT02535481|UCL|EPIGRAAFT Trial team|020 7679 2000|epigraaft@gmail.com|
307905|NCT02535572|Medical University of South Carolina|Morgan Dancy|843-876-5141|maddoxm@musc.edu|
307906|NCT02535611|Mazandaran University of medical sciences|Nasim Tabrizi|+981133343015|nasimtabrizi@gmail.com|
307907|NCT02535715|University of Texas Health San Antonio|Curtis Triplitt, PharmD|210-358-7228|triplitt@uthscsa.edu|
307908|NCT02535741|Stryker European Operations BV|Doug McGurty|+44(0)1635 500690|doug.mcgurty@stryker.com|
307909|NCT02535806|Children's Mercy Hospital|Dr. Keith August|816-302-6808|kjaugust@cmh.edu|
307910|NCT02535949|Washington University School of Medicine|Dr. Philip Spinella|314-286-0858|pspinella@wustl.edu|
307911|NCT02536040|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
307912|NCT02536105|Massachusetts General Hospital|Dr. Thomas Spencer|617-724-5600|spencer@helix.mgh.harvard.edu|
307913|NCT02536196|Keystone Heart|Pauliina Margolis - CMO|813.530.8200|pauliina.margolis@keystoneheart.com|
307914|NCT02536248|Laval university|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
307915|NCT02536313|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
307916|NCT02536378|Silk Road Medical, Inc.|Ric Ruedy, Executive VP, Clinical, Regulatory and Quality Affairs|408-585-2112|ric@silkroadmed.com|
296249|NCT01673022|Indiana University School of Medicine|Research Coordinator|317-944-2654|jmvinter@iupui.edu|
296250|NCT01673113|Massachusetts General Hospital|Dr. Lilit Garibyan|617-726-6168|lgaribyan@partners.org|
296251|NCT01673126|Coma Science Group, University of Liège|Aurore Thibaut and Pr Steven Laureys|003243662362|athibaut@ulg.ac.be|
296252|NCT01673178|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296253|NCT01673191|Retinal Consultants of Arizona|Dr. Pravin Dugel|602-222-2221|PDugel@gmail.com|
296254|NCT01673256|St. Jude Medical Inc.|Kyle Brunner|651.756.3482|kbrunner02@sjm.com|
296255|NCT01673282|UCB Cares|UCB (Study Director)|+1 887 822 9493||
296256|NCT01673347|William Beaumont Hospital|Erin Baker, PhD|248-551-1816|erin.baker@beaumont.org|
296257|NCT01673373|Getinge|Sr. Clinical Trial Manager|603-864-5219|inka.vesela@getinge.com|
296258|NCT01673386|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
296259|NCT01673490|GlaxoSmithKline|GSK Response Center|866-435-7343||
296260|NCT01673568|Hvidovre Hospital University of Copenhagen|Mette W. Christoffersen|38625826|mette.willaume@gmail.com|
296261|NCT01673594|Massachusetts General Hospital|Research Regulatory Coordinator|617-726-4651|apulli@mgh.harvard.edu|
307917|NCT02536404|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
307918|NCT02536508|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
307919|NCT02536664|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
307920|NCT02536781|Khon Kaen University|Faculty of Pharmaceutical Science|+66-43-362092|lsucharat@gmail.com|
307921|NCT02536794|Northwestern University|Massimo Cristofanilli|312 503 5488|Massimo.cristofanilli@nm.org|
307922|NCT02536833|Samumed|Christopher Swearingen, PhD, VP of Clinical Outcomes and Analytics|858.926.2952|chris@samumed.com|
307923|NCT02536846|McLean Hospital|Dr. Dost Öngür|617-855-3922|dongur@partners.org|
307924|NCT02536963|Rebiscan|CEO|857-600-0982|jgshaka@rebiscan.com|
307925|NCT02536976|Struthers Parkinson's Center|Dr. Sotirios Parashos|001-952-993-5495|sotirios.parashos@parknicolet.com|
307926|NCT02537015|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
307927|NCT02537431|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
307928|NCT02537444|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
307929|NCT02537522|Johnson & Johnson Vision Care Inc.|Andrea Le, OD -Manager Global Medical Affairs|904 4431866|ale3@ITS.JNJ.com|
307930|NCT02537574|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
307931|NCT02537717|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
307932|NCT02537730|Coopervision Japan|Director Professional Services Organization|81-3-5449-6619|taku.muraoka@jp.coopervision.com|
307933|NCT02537873|Virginia Commonwealth University|F. Gerard Moeller, M.D.|804-628-7788|lmbobb@vcu.edu|
307934|NCT02537951|Erasmus MC|Joost L.M. Jongen|+31107041415|j.jongen@erasmusmc.nl|
307935|NCT02538016|Boston Children's Hospital|Alyssia Venna|617-919-6352|Alyssia.Venna@childrens.harvard.edu|
307936|NCT02538029|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
307937|NCT02538042|Duke University|Dr. F. Joseph McClernon|9196682963|joseph.mcclernon@duke.edu|
307938|NCT02538094|Johns Hopkins University SOM|Dr. Tracy Vannorsdall|4105023701|TVannor1@jhmi.edu|
307939|NCT02538107|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
307940|NCT02538341|University of Alabama at Birmingham|Dr. Jeffrey R. Curtis|205-975-2176|jrcurtis@uabmc.edu|
307941|NCT02538354|Universy Medical Center Groningen|dr. J.Z.H. von Martels|0031503616161|j.z.h.von.martels@umcg.nl|
307942|NCT02538419|Brigham and Women's Hospital|Dr. Jessie Bakker|617-732-5987|jpbakker@bwh.harvard.edu|
271194|NCT00209274|Abbott Vascular Structural Heart (formerly Evalve, Inc.)|Chithra Sangli|650-421-6994|chithra.sangli@av.abbott.com|
296262|NCT01673646|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
296263|NCT01673698|ReShape Medical|Director of Clinical Operations|94429-6680|lfong@reshapemedical.com|
296264|NCT01673802|University of Alabama at Bimringham|John V. Thomas, MD; Principal Investigator|205-996-4132|jvthomas@uabmc.edu|
296265|NCT01673828|Department of Neurology, School of Medicine, University of California, Davis|Dr. Michael Rogawski|916-734-6285|rogawski@ucdavis.edu|
296266|NCT01673854|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
296267|NCT01673867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
296268|NCT01673893|Cardiovascular Institute of the South Clinical Research Corporation|Deanna K. Benoit, LPN, CCRC|985-876-0300|deanna.benoit@cardio.com|5613
296269|NCT01673919|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
296270|NCT01673984|Ipsen|Medical Director, Uro-Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
296271|NCT01674010|Transition Therapeutics Ireland Limited|Aleksandra Pastrak,MD, PhD, VP of Clinical Development and Medical Officer|+1 416 263 1227|apastrak@transitiontherapeutics.com|
296272|NCT01674062|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
296273|NCT01674478|Wake Forest University Health Sciences|Dr. Qing Yang||qyang@wakehealth.edu|
296274|NCT01674569|Tyrogenex, Inc|Sr Vice President, Development|240-403-7153|Dan@tyrogenex.com|
296275|NCT01674621|Radius Health Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
296276|NCT01674634|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
296277|NCT01674647|Bayer HealthCare AG|Bayer HealthCare AG||clinical-trials-contact@bayerhealthcare.com|
296278|NCT01674712|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
296279|NCT01674725|AbbVie|Global Medical Information|800-633-9110||
296280|NCT01675050|University of Michigan|Ismaeel Hashemi, M.D. Principal Investigator|6169165566|ismaeel.hashemi@gmail.com|
296281|NCT01675063|Emory University|James Blum|404-778-3482|jmblum@emory.edu|
271908|NCT00275301|University of Minnesota|S. Charles Schulz, MD|612-273-9820|scs@umn.edu|
271909|NCT00275392|James H. Quillen VAMC|Courtney D. Hall, PhD|423-926-1171|courtney.hall@va.gov|7518
271910|NCT00275509|New York University Langone Transplant Institute|Robert Montgomery, MD|646-501-2418|Robert.Montgomery@nyumc.org|
271911|NCT00275561|Mayo Clinic|Jeffrey A. Alexander, MD, Assistant Professor of Medicine|507-538-2403|alexander.jeffrey14@mayo.edu|
271912|NCT00275821|Novartis Pharmaceuticals|Study Director|862-778-8300||
296282|NCT01675128|National Cancer Institute|Dr.Tim Greten|301-451-4723|gretentf@mail.nih.gov|
296283|NCT01675141|National Cancer Institute|Dr. Dickran Kazandijian|301-451-2677|kazandijiandg@nih.gov|
296284|NCT01675154|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-8295|abhimanyu.garg@utsouthwestern.edu|
296285|NCT01675167|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
296286|NCT01675297|Hanlim Pharma|Clinical Trial Unit|82-2-3489-6297|yrsong@hanlim.com|
296287|NCT01675427|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
296288|NCT01675453|Academician EN Meshalkin State Budget Research Institute of Circulation Pathology|Dr. Evgeny Fominskiy|+79139538754|evfominskiy@gmail.com|
296289|NCT01675492|Abbott Medical Optics|Director, Clinical Operations|714-247-8628|lachelle.arredondo@abbott.com|
296290|NCT01675531|Seoul ST.Mary's Hospital|Jin-Hyong Kang|82-2-2258-6043|jinkang@catholic.ac.kr|
296291|NCT01675544|Creighton University School of Medicine|Dr. Venkata M. Alla|(402) 280-4292|venkataalla@creighton.edu|
296292|NCT01675596|Edwards Lifesciences|Tenley Koepnick||tenley.koepnick@edwards.com|
296293|NCT01675622|Mundipharma (China) phamaceutical CO. LTD|Director of R&D|0086-10-65636800||
296294|NCT01675635|Mundipharma (China) pharmaceutical Co, LTD.|Ms. Dan Zhu, Clinical operation and quality lead of the study|0086-10-65636800|medical.mcpc@mundipharma.com.cn|
296295|NCT01675661|Medical University of South Carolina|Kevin Gray, MD|843-792-6330|graykm@musc.edu|
296296|NCT01675765|Aduro Biotech, Inc.|Corporate Communications|510-848-4400|press@aduro.com|
296297|NCT01675778|Jacobi Medical Center|Dr. Shujun Xia|718-918-5800|shujun.xia@nbhn.net|
296298|NCT01675830|Boston Children's Hospital|Karen Sakakeeny|617-355-6369|Karen.Sakakeeny@childrens.harvard.edu|
296299|NCT01675882|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
296300|NCT01676012|Radboudumc|Dr. Erik van der Heijden|0031243614579|Erik.vanderHeijden@radboudumc.nl|
296301|NCT01676116|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
307943|NCT02538471|Weill Cornell Medicine|Dr. Silvia Formenti|212-746-3608|formenti@med.cornell.edu|
307944|NCT02538523|Regulatory Insight, Inc.|Elvira Cawthon|6154475150|elvira@reginsight.com|
307945|NCT02538614|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
307946|NCT02538679|Cedars Sinai Medical center|Dr. Karen Zaghiyan|310-289-9224|karen.zaghiyan@cshs.org|
307947|NCT02538783|UPenn|Catherine Reale|215-746-4009|catherine.reale@uphs.upenn.edu|
307948|NCT02538900|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
296302|NCT01676220|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
296303|NCT01676298|Spartan Bioscience Inc.|Dr. Chris Harder|613-228-7756|chris.harder@spartanbio.com|778
296304|NCT01676311|Spaulding Rehabilitation Hospital|Ross Zafonte, DO|617-952-5227|rzafonte@mgh.harvard.edu|
296305|NCT01676415|NORTHWESTERN UNIVERSITY|BRUCE TAN|3126958182|CPRICE2@NM.ORG|
296306|NCT01676532|St.Michael's Hospital|Sloane Freeman|416-864-6060|freemansl@smh.ca|77042
296307|NCT01676714|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
296308|NCT01676727|Medtronic Bakken Research Center|Maarten Hollander|+31620534428|Maarten.Hollander@medtronic.com|
296309|NCT01676831|Hospital of the University of Pennsylvania|Study Coordinator|215-662-6722|deborah.leahy@uphs.upenn.edu|
296310|NCT01676896|UTexasAustin|Sharon Horner|512-471-7951|shorner@mail.nur.utexas.edu|
296311|NCT01676909|Department of Veterans Affairs, VAMHCS MIRECC|Mary Brighid Walsh|410-637-1860|marybrighid.walsh@va.gov|
296312|NCT01677182|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
296313|NCT01677195|University of Texas Health Science Center at San Antonio / University of California, Davis* current|Dr. Bradley H. Pollock, PI|(530) 752-7250|pbollock@ucdavis.edu|
296314|NCT01677286|Boston Medical Center|John Berk, MD|617-638-4494|jberk@bu.edu|
296315|NCT01677299|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
296316|NCT01677312|Center for Interventional Endoscopy, Florida Hospital|Dr. Shyam Varadarajulu, MD|407-303-2570|svaradarajulu@yahoo.com|
296317|NCT01677377|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
296318|NCT01677507|University of Michigan|Dr. Sayoko Moroi|734-763-3732|smoroi@med.umich.edu|
296319|NCT01677624|Eisai Co., Ltd.|Shin Maeda|+81-3-3817-5252||
296320|NCT01677741|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
296321|NCT01677767|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
307949|NCT02538965|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosur|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
307950|NCT02539108|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
307951|NCT02539134|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
307952|NCT02539225|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
307953|NCT02539342|Medical College of Wisconsin|Michael J Burke, MD|414-955-4170|mmburke@mcw.edu|
307954|NCT02539368|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
307955|NCT02539459|Fox Chase Cancer Center|Robert Uzzo, M.D.|215-728-3096|robert.uzzo@fccc.edu|
307956|NCT02539511|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
271195|NCT00209339|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
271196|NCT00209417|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|Paul.Gordon@ge.com|
271197|NCT00209560|Eisai Inc|Eisai Medical Services|1-888-422-4743||
271198|NCT00210106|Digestive Tumours Unit, Institut Bergonie|Pr Serge Evrard|s.evrard@brdeaux.unicancer.fr||
271199|NCT00210119|Institut Bergonie|Dr Gabriel Etienne||g.etienne@bordeaux.unicancer.fr|
271200|NCT00210184|Institut Bergonie|Pr Marianne Fonck|+33556333333||
271201|NCT00210353|International Extranodal Lymphoma Study Group (IELSG)|Prof. Emanuele Zucca MD, Scientific and Medical Director|+41 91 811 9040|ielsg@eoc.ch|
271202|NCT00210470|University of Michigan Hospital|Gregory T. Wolf||gregwolf@umich.edu|
271203|NCT00210626|Centocor Ortho Biotech Services, LLC (COBS)|Vice President Medical Affairs|215-325-4464||
271204|NCT00210639|Janssen R&D US|Director, Clinical Research|1 609 730-3158||
271205|NCT00211081|Emory University|Dr. Willam Mahle|404-785-6000|wmahle@emory.edu|
271206|NCT00211172|Kaiser Permanente Center for Heatlh Research|David H. Smith|503-335-6302|david.h.smith@kpchr.org|
271207|NCT00211185|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
271208|NCT00211237|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
271209|NCT00211510|Medtronic, Inc|John Shin, PhD, MBA|818 576 4019|john.shin@medtronic.com|
271210|NCT00211536|Sr. Clinical Research Manager|John Shin|818-576-4019|john.shin@medtronic.com|
271211|NCT00211692|VA San Diego Healthcare System|Samuel B. Ho, MD, Chief GI Section|858-552-8585|samuel.ho2@va.gov|2631
271212|NCT00211757|Montefiore Medical Center|Dr. Eric Hollander|718-920-4287|eholland@montefiore.org|
271213|NCT00211809|Icahn School of Medicine at Mount Sinai|Dr. Andrea Allen|212-241-3176|andrea.allen@mssm.edu|
271214|NCT00211887|Icahn School of Medicine at Mount Sinai|Dr. Fred D. Lublin|212-241-6854|fred.lublin@mssm.edu|
307957|NCT02539563|Wake Forest School of Medicine|Robert D'Angelo, MD|336-718-8278|rdangelo@wakehealth.edu|
271215|NCT00212134|Stanford University School of Medicine|Scott R Lambert, MD, Study Chairman|650-498-4242|lambert7@stanford.edu|
271216|NCT00212264|University of Alabama at Birmingham|Patricia S Goode, MD|2055587064|pgoode@uabmc.edu|
271217|NCT00212355|Nobelpharama|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
271218|NCT00212446|New York Downtown Hospital (hospital bankrupt/closed)|Dr. Jeffrey Karsdon||JK_MD@yahoo.com|
271219|NCT00212758|Oregon Health & Science University|Dr. Amira Al-Uzri|503-494-7327|aluzria@ohsu.edu|
271220|NCT00212888|OHRI|Dr. Jonathan B Angel|613-737-8442|JANGEL@toh.ca|
271221|NCT00213135|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
271222|NCT00213148|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
296322|NCT01677858|Amgen Inc.|Study Director|866-572-6436||
296323|NCT01677910|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
296324|NCT01677936|Louisville Metabolic and Atherosclerosis Research Center|Kathy Schmitz RN|502.515.5672|kschmitz@lmarc.com|
296325|NCT01677988|Medical University of South Carolina|Paul O'Brien, MD|843-792-4271|obrienpe@musc.edu|
296326|NCT01678131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
296327|NCT01678144|Medtentia International Ltd Oy|Olli Keränen / CEO|+358 50 3567090|ok@medtentia.com|
296328|NCT01678196|Minneapolis VA Healthcare Service Center|Christopher Erbes, PhD|612-725-2000|christopher.erbes@va.gov|2125
296329|NCT01678209|Icahn School of Medicine at Mount Sinai|Beth Krone, PhD|212-241-8014|beth.krone@mssm.edu|
296330|NCT01678313|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
296331|NCT01678443|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
296332|NCT01678560|Yale University|Meir Kryger, MD|203-815-0914|meir.kryger@yale.edu|
296333|NCT01678794|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
296334|NCT01678807|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
296335|NCT01678820|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
296336|NCT01678846|London School of Hygiene and Tropical Medicine|Dr Karen Devries|0207958 8164|Karen.Devries@lshtm.ac.uk|8164
296337|NCT01678885|Pennington Biomedical Research Center|Corby Martin, Ph.D.|225-763-2585|corby.martin@pbrc.edu|
296338|NCT01678898|Protalix Ltd|Raul Chertkoff|+972-4-9028100|raul@protalix.com|
296339|NCT01678911|Rehabilitation Institute of Chicago|Director of the Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
296340|NCT01678924|Allergan plc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
296341|NCT01678976|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
307958|NCT02539654|Alcon, A Novartis Division|Clinical Scientific Director, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
307959|NCT02539797|University of California, Los Angeles|Dr. Yuri Rassovsky|3104783711|yurir@ucla.edu|
307960|NCT02539992|Stryker European Operations BV|Dr. Eric Garling, Director Medical & Scientific Affairs Europe|+31 20 219 2660|eric.garling@stryker.com|
307961|NCT02540083|GE Healthcare|Sara Lam|1-262-548-2369|Sara.J.Lam@ge.com|
307962|NCT02540161|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
307963|NCT02540213|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
307964|NCT02540226|Hospital for Special Surgery|Dr. Kethy Jules-Elysee|212-606-1206|JulesElyseeK@HSS.EDU|
307965|NCT02540265|Recro Pharma, Inc.|Randall Mack|484-395-2470|rmack@recropharma.com|2406
307966|NCT02540291|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
307967|NCT02540356|Baxalta, now part of Shire|Clinical Trial Registries and Results Disclosure||ClinicalTrialsDisclosure@baxalta.com|
296342|NCT01679002|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
296343|NCT01679028|Tasly Pharmaceuticals, Inc.|Dr. Henry SUN|240-744-6225|henrysunusa@gmail.com|
296344|NCT01679197|University of Michigan|Dr. Elif Oral|7346157271|eliforal@med.umich.edu|
296345|NCT01679236|University of Wisconsin|James M. Davis MD, Assistant Professor, Duke University|608-217-9405|jjamesdavis@hotmail.com|
296346|NCT01679301|Philips Respironics|Chuck Cain|+1 724 7335835|chuck.cain@philips.com|
296347|NCT01679314|electroCore LLC|Annelie Andersson|+46 721 803076|annelie.andersson@electrocorellc.com|
296348|NCT01679405|University Medical Center Mainz|Prof. Dr. Markus Moehler|0049613117|Markus.Moehler@unimedizin-mainz.de|7275
307968|NCT02540447|Mansoura Faculty of Medicine|Amr Mohamed Yassen Ali Badawy|+201001497044|amryassen@hotmail.com|
307969|NCT02540538|MaastrichtUMC|Astrid ML Oude Lashof, MD, PHD|0031433876644|a.oudelashof@mumc.nl|
307970|NCT02540629|Seoul National University Hospital|Dr. Jeong Ho Park|+821035426282|timthe@gmail.com|
307971|NCT02540668|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
307972|NCT02540772|San Rafael University Hospital|Monica Triviño Mosquera|34958275700|monica.trivino@sjd.es|
307973|NCT02540850|BioChain (Beijing) Science and Technology, Inc.|Dr. Lele Song|86-10-63401580|songlele@biochainbj.com|
307974|NCT02540954|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
307975|NCT02540993|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
307976|NCT02541409|Johns Hopkins University Bloomberg School of Public Health|Dr. Shruti Mehta|443-287-3837|smehta@jhu.edu|
307977|NCT02541422|St. Luke's University Health Network|Holly Stankewicz, D.O.|610-360-2725|holly.stankewicz@gmail.com|
307978|NCT02541565|University of Washington|Dr. Stephen Smith|206-606-6546|ssmith50@seattlecca.org|
307979|NCT02541604|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
307980|NCT02541669|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
307981|NCT02541812|University of Manitoba|Dr. Mandana Modirrousta|2042372303|mmodirrousta@sbgh.mb.ca|
307982|NCT02541864|Kaohsiung Veterans General Hospital|Dr. Feng-Woei Tsay|+886-7-3422121|fwchaie@vghks.gov.tw|8233
307983|NCT02541903|UAB|Dr. Lisle Nabell, MD, Professor|(205) 934-3061|lnabell@uabmc.edu|
307984|NCT02541942|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
307985|NCT02542046|UCaliforniaSF|Dr. Benjamin Yeh|4155149318|ben.yeh@ucsf.edu|
307986|NCT02542072|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
307987|NCT02542150|"University of Colorado Denver | Anschutz"|Jody Tanabe, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
307988|NCT02542267|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
307989|NCT02542280|Ain Shams Maternity Hospital|Ahmed Bahaa|+20 1111700556|abahaa0503@yahoo.com|
307990|NCT02542397|Atrium Health/Levine Cancer Institute, Department of Cancer Biostatistics|Danielle M Boselli|12017903385|Danielle.Boselli@AtriumHealth.org|
307991|NCT02542410|BOSTON CHILDREN'S HOSPITAL|DR. AMY DIVASTA|6173556000|amy.divasta@childrens.harvard.edu|
307992|NCT02542462|Cincinnati Childrens Hospital Medical Center|Nancy Back RN MPH|513-636-2479|Nancy.Back@cchmc.org|
307993|NCT02542605|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
307994|NCT02542631|Johnson & Johnson Diabetes Companies|Brian Levy, MD-Chief Medical Officer|484 328-6128|BLevy1@its.jnj.com|
307995|NCT02542761|Mayo Clinic|Kenton Kaufman, Ph.D.|507-266-0136|Kaufman.Kenton@mayo.edu|
307996|NCT02542865|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
307997|NCT02542943|GlaxoSmithKline|GSK Response Center|866-435-7343||
307998|NCT02543203|The Ohio State University Nisonger Center|Dr. Jill Ann Hollway|614-688-3848|Jill.Hollway@osumc.edu|
307999|NCT02543294|UT MD Anderson Cancer Center|Dr. Anecita P. Fadol,PHD/Associate Professor, Department of Nursing|713-792-8397|afadol@mdanderson.org|
308000|NCT02543346|Kingston General Hospital|Dr. Anne Ellis|6135482336|ellisa@kgh.kari.net|
308001|NCT02543398|UTHSCSA Periodontics|Guy Huynh-Ba|2105673569|huynhba@uthscsa.edu|
308002|NCT02543437|Stryker Japan|Yasuyuki Inatsugu, Associate manager of clinical affairs|81 3 6894 8394|yasuyuki.inatsugu@stryker.com|
308003|NCT02543528|Johnson & Johnson Vision|Elizabeth Dow -PRINCIPAL RESEARCH OPTOMETRIST|904-443-1061|edow1@its.jnj.com|
308004|NCT02543554|Washington University in St. Louis|Brian M Fuller|3147475368|fullerb@wustl.edu|
308005|NCT02543658|First affilitated hospital of Nanchang university|Wenhua He|+8613879182642|hewenhua@ncu.edu.cn|
308006|NCT02543723|East Carolina University|Essie Torres|252-328-1818|torrese@ecu.edu|
308007|NCT02543801|Kootenai Health|Director of Research Programs|2086254223|salbritton@kh.org|
308008|NCT02543840|VA Boston Healthcare System- Center for Healthcare Organization and Implementation Research|Dr. Mark S. Bauer, MD|857-364-6380|mark.bauer@va.gov|
308009|NCT02543892|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
308010|NCT02543918|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979||
308011|NCT02544074|The Ohio State University|Douglas Scharre, MD|614-293-4969||
308012|NCT02544113|Cleveland Clinic|Dr. Bijan Eghtesad|216 444-9898|eghtesb@ccf.org|
308013|NCT02544152|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
296349|NCT01679600|Bern University of Applied Sciences|Dr. Oliver Stoller|+41344264195|oliver.stoller@bfh.ch|
296350|NCT01679613|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296351|NCT01680016|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
296352|NCT01680159|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
296353|NCT01680172|Mayo Clinic|Robert Bright, MD|480-301-4853|bright.robert@mayo.edu|
296354|NCT01680328|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
296355|NCT01680341|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
296356|NCT01680458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296357|NCT01680497|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
296358|NCT01680549|Texas Tech University Health Sciences Center|Nancy Swinford|806-743-2569|nancy.swinford@ttuhsc.edu|
296359|NCT01680640|University of Southampton|Christopher D Byrne|44 (0)23 8120 8818|cdtb@soton.ac.uk|
296360|NCT01680653|Stanford University|Dr. Bruce Buckingham|650-725-6549|bbendo@stanford.edu|
296361|NCT01680666|Stanford University|Matias Bruzoni, MD|650-723-6439|mbruzoni@stanford.edu|
296362|NCT01680783|University of Chicago|John P. Kress|7737026790|jkress@medicine.bsd.uchicago.edu|
296363|NCT01680835|Medtronic|Jennifer Seamans, M.S., Clinical Research Program Manager|763-398-7455|jennifer.l.seamans@medtronic.com|
296364|NCT01680848|Dental PBRN Japan|Director of the Dental PBRN Japan|+81-93-285-3022|info@dentalpbrn.jp|
271913|NCT00275834|Duke University Medical Center|Kishore Gadde|919-668-0208|kishore.gadde@duke.edu|
271914|NCT00276094|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
271915|NCT00276159|Masonic Cancer Center, University of Minnesota|Sarah Cooley, MD|612-625-8474|cool0023@umn.edu|
296365|NCT01680861|Miami Transplant Institute|Jeffrey Gaynor, Ph.D. biostatistician||jgaynor@med.miami.edu|
296366|NCT01680887|Perelman School of Medicine|Kyle Kampman|215 746 2764|kampman@pennmedicine.upenn.edu|
296367|NCT01680900|University of Pennsylvania|Dr. Ellen Freeman|215-662-3329|freemane@mail.med.upenn.edu|
296368|NCT01680965|Moffitt Cancer Center|Joseph Pidala, M.D., PhD|813-745-2069|Joseph.Pidala@moffitt.org|
296369|NCT01680991|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
296370|NCT01681004|SI-BONE, Inc.|Daniel Cher, Vice President of Clinical Affairs|408-207-0700|dcher@si-bone.com|
296371|NCT01681030|Ethicon, Inc|Richard Kocharian, MD, PhD|+1-908-218-2013|rkochar1@its.jnj.com|
296372|NCT01681069|Analyze & Realize GmBH|Dr Christof Jänicke|+49 30 40 00 83 23|cj@a-r.com|
296373|NCT01681095|William Beaumont Hospital|Marc P. Sakwa, M.D.|248/898-0123|marc.sakwa@beaumont.org|
296374|NCT01681121|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-970-7145|ClinicalTrialDisclosure@JazzPharma.com|
296375|NCT01681186|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
296376|NCT01681212|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
308014|NCT02544217|Khondrion B.V.|Edwin Spaans, PharmD.|+31654997700|spaans@khondrion.com|
308015|NCT02544321|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
308016|NCT02544451|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
308017|NCT02544607|Massachusetts General Hospital|Dr. Cristina Cusin|617-726-6421|ccusin@mgh.harvard.edu|
308018|NCT02544633|Mirati Therapeutics, Inc.|Vanessa Tassell, Vice President, Clinical Science|858-332-3438|tassellv@mirati.com|
308019|NCT02544763|GW Research Ltd|Medical Enquiries|+1 833 424 6724|medinfo@gwpharm.com; medinfo@greenwichbiosciences.com|
308020|NCT02544984|The University of Texas Health Science Center at Houston|Ricardo A. Mosquera, MD|(713) 500-5650|Ricardo.A.Mosquera@uth.tmc.edu|
308021|NCT02545075|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
308022|NCT02545101|Otsuka Pharmaceutical Europe Ltd.|Medical Department|+44(0)2037475000||
308023|NCT02545270|Department of Anesthesiology, Herlev and Gentofte Hospital, University of Copenhagen, Herlev Denmark|MD. G. G. Nervil||gustavnervil@gmail.com|
296377|NCT01681277|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296378|NCT01681368|National Cancer Institute|Dr. Christina Annunziata|301-402-7189|annunzic@mail.nih.gov|
296379|NCT01681433|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
296380|NCT01681472|Isofol Medical|Anders Rabbe|+46 (0)707 64 65 00|anders.rabbe@isofolmedical.com|
296381|NCT01681511|ICET, Inc.|Dr. Shantha Sarangapani|781-769-6064|Shantha@icetinc.com|
296382|NCT01681576|Novartis|Study Director|862-778-8300||
296383|NCT01681628|Thought field Therapy Foundation UK Ltd.|Dr R H Robson|+44 (0)1952550688|r.robson2@btinternet.com|
296384|NCT01681771|Linköping University, Department of social and welfare studies. Linköping University|Prof. RN Peter Johansson|+4613313685|peter.b.johansson@liu.se|
296385|NCT01681810|University of Pittsburgh|Dr. Kara Hughan|4126925173|kara.hughan@chp.edu|
296386|NCT01681836|University of Pittsburgh|Dr. Kara Hughan|412-692-5170|kara.hughan@chp.edu|
296387|NCT01681849|Emory University|Dr. J. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
296388|NCT01681992|GlaxoSmithKline|GSK Response Center|866-435-7343||
296389|NCT01682031|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
296390|NCT01682044|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
296391|NCT01682083|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
296392|NCT01682135|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
296393|NCT01682148|Ipsen|Medical Director, Neurology|clinicaltrials@ipsen.com|clinicaltrials@ipsen.com|
296394|NCT01682213|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman, MD|646-888-4162|chapmanp@mskcc.org|
296395|NCT01682460|CCLR|Research Manager|519-888-4742|cclr2@sciborg.uwaterloo.ca|
296396|NCT01682512|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308024|NCT02545322|Department of Therapeutic Radiology and Oncology, Medical University of Graz|Peter Winkler, PhD (Head of Medical Physics)|+43 316 385|peter.winkler@medunigraz.at|83193
308025|NCT02545504|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
308026|NCT02545543|Seqirus|Seqirus Clinical Trial Disclosure Lead|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
308027|NCT02545608|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
308028|NCT02545907|Leeds Institute of Clinical Trials Research|Alexandra Pitchford|0113 343 9077|medcatal@leeds.ac.uk|
308029|NCT02545933|University of Florida|Dr. Dominick Angiolillo|9042443378|dominick.angiolillo@jax.ufl.edu|
308030|NCT02546193|Mayo Clinic|VanessaTorbenson, M.D.|507-266-9873|torbenson.vanessa@mayo.edu|
308031|NCT02546323|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
308032|NCT02546362|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|info@cefaly.com|
308033|NCT02546375|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308034|NCT02546388|University of Pennslyvania|Paco Bravo, MD|1-215-220-9494|Paco.Bravo@pennmedicine.upenn.edu|
308035|NCT02546544|University of Oxford|Joint Research Office|+441865572245|ctrg@admin.ox.ac.uk|
308036|NCT02546570|National Center for PTSD|Dr. Lauren Sippel|802-295-9363|lauren.m.sippel@dartmouth.edu|6082
308037|NCT02546609|Nusirt Biopharma Inc.|Barbara Cannon|615-656-7898|BCannon@nusirt.com|
308038|NCT02546765|Beth Israel Deaconess Medical Center|Dr. Balachundhar Subramaniam|6176320706|bsubrama@bidmc.harvard.edu|6176320706
308039|NCT02546856|Servicio de Cardiologıa, Hospital Universitario Galdakao-Usansolo, OSI Barrualde-Galdakao-Osakidetza, Servicio Vasco de Salud, Galdakao, Bizkaia, Spain .BIOCRUCES, Instituto de Investigacion Sanitaria, Bizkaia, Spain|Juana Oyanguren, Nursing graduate, Master in Heart Failure, CV Pathology and Thrombosis Specialist|34 656780945|juanaoy@hotmail.com|
308040|NCT02547012|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
308041|NCT02547038|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
308042|NCT02547064|Keimyung university|Hyun-Chang Kim|+821028862876|onidori1979@gmail.com|
308043|NCT02547220|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
308044|NCT02547233|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
271223|NCT00213239|The Hospital for Sick Children, Department of Anesthesia and Pain Medicine|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
271224|NCT00213980|University of Wisconsin Carbone Cancer Center|Dr. Daniel Mulkerin|608-265-8090|dm2@medicine.wisc.edu|
271225|NCT00214019|UW Madison|Gina Crisafi|6082654554|gmc@medicine.wisc.edu|
271226|NCT00214045|University of Wisconsin School of Medicine and Public Health|Dr. Stephen Nakada|(608)263-1359|nakada@urology.wisc.edu|
296397|NCT01682538|Swedish Orphan Biovitrum|Medical Director|+4686972000|erik.brouwer@sobi.com|
296398|NCT01682603|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
296399|NCT01682642|Fertility Center AZ Jan Palfijn|dr. Wim Decleer, PI|0032 9 325 92 20|wim.decleer@janpalfijngent.be|09/2248851
296400|NCT01682681|Janssen Korea, Location: 25F, LS , Yongsan Tower, 191, Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|Clinical Research Associate, Medical affairs|82-2-2094-4837||
296401|NCT01682720|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
296402|NCT01682759|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
296403|NCT01682811|Medical College of Wisconsin|Harry T. Whelan MD, Bleser Professor of Neurology|414-266-7544|hwhelan@mcw.edu|
296404|NCT01682837|UT Southwestern Medical Center at Dallas|John Poindexter|2146486857|john.poindexter@utsouthwestern.edu|
296405|NCT01682863|Novartis Pharmaceuticals|Study Director|862-778-8300||
296406|NCT01682876|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
296407|NCT01682954|Ohio State University|Dr. Carla Miller|614-292-1391|miller.4453@osu.edu|
296408|NCT01683019|NeoSync, Inc.|Dr. Bill Phillips|949-333-2906|bill@neosync.com|
296409|NCT01683058|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
296410|NCT01683071|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
296411|NCT01683266|Sanofi|Trial Transparency Team||Contact--US@sanofi.com|
296412|NCT01683331|University of Michigan|Akinlolu Ojo|734 936-4890|aojo@umich.edu|
296413|NCT01683383|Stanford University School of Medicine|Krisa P. Van Meurs, M.D.|+1 650 723 5711|vanmeurs@stanford.edu|
296414|NCT01683409|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
296415|NCT01683422|Loma Linda University Health|Gary Yang|909 558 4000|gyang@llu.edu|88056
296416|NCT01683526|Beth Israel Medical center|Michael Silverberg|2124202377|msilverberg2@chpnet.org|
308045|NCT02547363|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
308046|NCT02547428|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
308047|NCT02547454|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
308048|NCT02547623|Icon Bioscience, Inc.|Vice President, Quality and Compliance|510-933-8381||
296417|NCT01683565|Nationwide Children's Hospital|Dr. Sarah Keim|614-722-3177|Sarah.Keim@nationwidechildrens.org|
296418|NCT01683604|HoffmannLaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
296419|NCT01683630|Unversity of Manotiba|Salah Mahmud|204-272-3139|salah.mahmud@umanitoba.ca|
296420|NCT01683812|Boston Children's Hospital|Michele DeGrazia PhD, RN, NNP-BC, FAAN|617-919-1222|Michele.DeGrazia@childrens.harvard.edu|
296421|NCT01683838|Acorda Therapeutics, Inc.|Chief Scientific Officer|914-347-4300|ablight@acorda.com|5102
296422|NCT01683994|National Cancer Institute|Dr. William Dahut|240-760-6070|william_dahut@nih.gov|
296423|NCT01684007|Alcon Research, Ltd.|Magda Michna, Expert Clinical Lead, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
296424|NCT01684020|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
296425|NCT01684033|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
296426|NCT01684046|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
296427|NCT01684202|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
296428|NCT01684215|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296429|NCT01684410|Grifols Therapeutics Inc.|Henry Li, PhD|919-316-6042|henry.li@grifols.com|
296430|NCT01684423|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
296431|NCT01684436|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
296432|NCT01684566|Camurus AB|Håkan Olsson DDS, PhD|+46 46 2863852|Hakan.Olsson@camurus.com|
296433|NCT01684592|Battelle|Dr. Victoria Coleman-Cowger|4103722748|colemancowger@battelle.org|
296434|NCT01684722|University of Washington|Ian de Boer, MD, MS|2066165403|deboer@u.washington.edu|
296435|NCT01684748|Virginia Polytechnic Institute & State University|Elaina Marinik, Ph.D.|5402318299|emarinik@vt.edu|
296436|NCT01684826|Philips|Frank Everaerts|+31630728782|frank.everaerts@philips.com|
296437|NCT01684839|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
296438|NCT01684878|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
296439|NCT01684917|Imperial College London|Professor Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
296440|NCT01684930|Victoria University|Jason D. Allen, PhD|61 3 9919 4264|jason.allen@vu.edu.au|
296441|NCT01684943|Massachusetts General Hospital|Courtney A Balliro|617-726-1242|cballiro@partners.org|
296442|NCT01685021|MorphoSys AG|Dr. Sumeet Ambarkhane, Director, Clinical Program Leader|004989899270|sumeet.ambarkhane@morphosys.com|
296443|NCT01685047|St Jude Medical|Karolien Timmermans|0032 497 51 39 21|ktimmermans@sjm.com|
296444|NCT01685060|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
296445|NCT01685073|Johns Hopkins University|Ryan Vandrey, PhD|410-550-4036|rvandrey@jhmi.edu|
296446|NCT01685138|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
296447|NCT01685203|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
296448|NCT01685216|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
308049|NCT02547649|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308050|NCT02547714|Novartis Pharmaceuticals|Study Director|862-778-8300||
308051|NCT02547766|University of Utah|Associate Director of Clinical Trials|801-581-5318|heather.thiesset@hsc.utah.edu|
308052|NCT02547779|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
308053|NCT02547922|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
308054|NCT02547935|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
308055|NCT02547974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
271227|NCT00214097|University of Wisconsin|Diana Trask|608-263-9528|trask@humonc.wisc.edu|
271228|NCT00214136|University of Wisconsin Carbone Cancer Center|Dr. Mark A. Ritter|608-263-8500|ritter@humonc.wisc.edu|
271229|NCT00214201|UW Madison|Director of Clinical Trials|608-263-2565||
271230|NCT00214383|University of Wisconsin - Madison|Alice Pulvermacher|(608) 262-8448|alice.pulvermacher@chess.wisc.edu|
271231|NCT00214422|National Cancer Institute|Dr. Kevin Camphausen|240-760-6205|camphausen@nih.gov|
271232|NCT00214461|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
271233|NCT00214487|Dr. Thomas Aller, Optometrist Inc.|Dr. Thomas Aller|650 871-1816|cptreyes@earthlink.net|
271234|NCT00214526|Boston Scientific Corporation|Mark G. Grubb|412-749-1423|Mark.Grubb@bsci.com|
271235|NCT00214539|Boston Scientific Corporation|G Mark Grubb, RN, CCRA|412-716-0717|Mark.Grubb@bsci.com|
271236|NCT00214786|Baylor University Medical Center|Dr. Marlon Levy|214-820-2050|Marlon.Levy@baylorhealth.edu|
271237|NCT00214890|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
271238|NCT00214903|Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD|+49 (0) 30 945 101 20|dinger@zeg-berlin.de|
271239|NCT00215137|Duke University Medical Center Dept of Psychiatry|Wei Zhang MD|919 684 5645|wei.zhang@duke.edu|
271240|NCT00215150|Duke University Medical Center|Wei Zhang, MD|(919) 684 5645|wei.zhang@duke.edu|
271916|NCT00276250|Emory University|Nicole Turgeon, MD|404-727-3257|nturgeo@emory.edu|
271917|NCT00276380|Ipsen|Medical Director||clinical.trials@ipsen.com|
308056|NCT02547987|Baylor College of Medicine|Mothaffar Rimawi, M.D.|713-798-1311|rimawi@bcm.edu|
271241|NCT00215540|Discovery Laboratories, Inc.|Dr. Robert Segal|215-488-9300|rsegal@discoverylabs.com|
271918|NCT00276406|Mayo Clinic|Adil E. Bharucha, MD|507-284-6439|bharucha.adil@mayo.edu|
296449|NCT01685229|Acclarent Inc.|Clinical Manager|949-453-6408|PChen126@ITS.JNJ.com|
296450|NCT01685242|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
296451|NCT01685320|Campus Bio-medico University|Prof. Massimiliano Carassiti|+39-06-225411952|m.carassiti@unicampus.it|
296452|NCT01685372|University of Colorado School of Medicine|Donna Curtis, MD, MPH|720-777-6981|donna.curtis@childrenscolorado.org|
296453|NCT01685411|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
296454|NCT01685437|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
296455|NCT01685463|Medical University of south Carolina|Dr. Xingbao Li|8437925729|lixi@musc.edu|
296456|NCT01685567|Silk Road Medical, Inc.|Linda Ruedy. Sr. Director, Clinical and Regulatory Affairs|(408) 585-2113|lruedy@silkroadmed.com|
296457|NCT01685606|Brown University Oncology Research Group (BrUOG)|Dr. Peter Quesenberry|4018633000|kayla_rosati@brown.edu|
296458|NCT01685684|Collegium Pharmaceutical|Clinical Scientist|+1.781.232.0764|clinicaltrials@collegiumpharma.com|
308057|NCT02548078|GlaxoSmithKline|GSK Response Center|866-435-7343|aal77632@gsk.com|
308058|NCT02548156|GlaxoSmithKline|GSK Response Center|866-435-7343||
308059|NCT02548312|BMJ|Dr Sara Schroter|02073836744|sschroter@bmj.com|
308060|NCT02548455|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
308061|NCT02548585|MedImmune, LLC|Philip Ambery|+44 (0) 1223 895997|information.center@astrazeneca.com|
308062|NCT02548650|University of Florida College of Medicine - Jacksonville|Dominick J Angiolillo|9042443933|dominick.angiolillo@jax.ufl.edu|
308063|NCT02548728|University of North Carolina at Chapel Hill|Cort Pedersen, MD|919-923-3284|cort_pedersen@med.unc.edu|
308064|NCT02548845|Otsuka Pharmaceutical Europe Ltd.|Medical Department|+44(0)2037475000||
308065|NCT02548910|Ottawa Hospital Research Institute|Dr. Guillaume Martel|6137378899|gumartel@toh.ca|71053
308066|NCT02548949|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308067|NCT02548962|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
308068|NCT02549014|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308069|NCT02549027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308070|NCT02549040|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308071|NCT02549196|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
308072|NCT02549209|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
296459|NCT01685697|Univeristy of Alberta|Georg Schmolzer|7807354660|georg.schmoelzer@me.com|
296460|NCT01685801|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
296461|NCT01685840|Duke University Health System|G. Michael Felker, M.D.|919-668-8919|michael.felker@duke.edu|
296462|NCT01685983|Janssen R&D BE|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
296463|NCT01685996|Johns Hopkins University School of Medicine|Dr. Annie Umbricht, M.D.|410-550-1917|annieumbricht@jhu.edu|
296464|NCT01686152|Teva Pharmaceuticals USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
296465|NCT01686165|University of Arizona Cancer Center|Daniel Persky, M.D.|520-626-8908|dpersky@uacc.arizona.edu|
296466|NCT01686373|University of South Carolina|Dr. Julius Fridriksson|1-803-777-5931|jfridrik@sc.edu|
296467|NCT01686438|Crescenz VA Medical Center|Dr. Samuel T. Kuna|215-823-4400|Samuel.Kuna@va.gov|
296468|NCT01686451|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou, 325000, China|Dr. JiFei Tang|+8615968766021|jiftang@126.com|
296469|NCT01686503|Eastern Virginia Medical School|Dr. Stephanie Troy|757-446-8999|troysb@evms.edu|
296470|NCT01686568|Mayo Clinic|Dr. Ian R. Lanza|507-255-8147|lanza.ian@mayo.edu|
296471|NCT01686581|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
308073|NCT02549287|Georgia State University|Dr. Daniel Whitaker|404-413-1282|dwhitaker@gsu.edu|
308074|NCT02549339|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
308075|NCT02549352|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
308076|NCT02549365|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
308077|NCT02549508|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 09 574 0100|CPAPtrial@fphcare.co.nz|7044
308078|NCT02549573|US WorldMeds|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
308079|NCT02549859|University of Chicago|Ms. Lani Leong, Research Coordinator|7738341688|lani@neurology.bsd.uchicago.edu|
308080|NCT02550106|Novartis Pharmaceuticals|Study Director|(862) 778-8300||
308081|NCT02550132|Université du Québec à Trois-Rivières|Dr Martin Descarreaux DC, PhD|18193765011|martin.descarreaux@uqtr.ca|3791
308082|NCT02550197|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
308083|NCT02550210|Dartmouth Hitchcock Medical Center|Dr. Richard J. Barth Jr.|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
308084|NCT02550743|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD, Principal Investigator|14018633000|kayla_rosati@brown.edu|
308085|NCT02550795|Gil hospital|Dr. Youn Yi Jo|82324603636|endless37@gilhospital.com|
296472|NCT01686633|GlaxoSmithKline|GSK Response Center|866-435-7343||
296473|NCT01686646|GlaxoSmithKline|GSK Response Center|866-435-7343||
296474|NCT01686750|Johns Hopkins University|Dr. Gregory M.Lucas|410-614-0560|glucas@jhmi.edu|
296475|NCT01686828|University of Washington|Dr. Katya Rubinow|206-7543-3470|rubinow@uw.edu|
296476|NCT01686932|Novartis|Study Director|862-778-8300||
296477|NCT01686958|Profound Medical|Mathieu Burtnyk|647-476-1350|mburtnyk@profoundmedical.com|408
296478|NCT01687036|Medical University Innsbruck, Department of Internal Medicine III, Cardiology|Markus Stühlinger, MD|+43 512 504|markus.stuehlinger@uki.at|81 320
296479|NCT01687088|Thomas Jefferson University|Michael J. Marmura, MD|215-955-2243|michael.marmura@jefferson.edu|
296480|NCT01687101|Thomas Jefferson University, Jefferson Headache Center|Stephen D Silberstein, MD|215-955-2243|bruce.smith@jefferson.edu|
296481|NCT01687114|Tufts University|Oliver Chen|617-5563128|oliver.chen@tufts.edu|
308086|NCT02550873|Promedior Inc.|Renu Gupta, MD, Chief Medical Officer|856-722-9824|rgupta@promedior.com|
308087|NCT02550938|Align Technology, Inc.|Allison Mossing, Sr. Clinical Research Associate|4084701046|amossing@aligntech.com|
308088|NCT02551055|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
308089|NCT02551094|Montreal Heart Institute|Dr. Jean-Claude Tardif (Principle Investigator)|514-376-3330|jean-claude.tardif@icm-mhi.org|3612
308090|NCT02551159|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
308091|NCT02551224|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
308092|NCT02551432|Seoul National University Hospital|Bhumsuk Keam|82+10-3231-2208|bhumsuk@snu.ac.kr|
308093|NCT02551653|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
308094|NCT02551666|Virginia Tech|Professor Michael L. Madigan, PhD|540-231-3543|mlm@vt.edu|
308095|NCT02551692|Duke University|Anthony DeVito, MD|919-684-1377|anthony.devito@duke.edu|
308096|NCT02551731|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
308097|NCT02551744|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
308098|NCT02551757|University of Washington|Dr. Sandeep Khot|206-744-3251|skhot@uw.edu|
308099|NCT02551770|GWD Consult|Dr. Manfred Klasser|+49 6108 825 65 20|manfred.klasser@gwd-consult.de|
308100|NCT02551809|United Neuroscience|Responsible Medical Officer|+(353) 1 524 0397|info@unitedneuroscience.com|
308101|NCT02551822|University of New Mexico Health Sciences Center, Department of Obstetrics & Gynecology, Division of Urogynecology|Dr. Yuko Komesu, MD|505-272-6382|YKomesu@salud.unm.edu|
308102|NCT02551874|AstraZeneca|Global Clinical Lead|+46 (0)31 7761000|ClinicalTrialTransparency@astrazeneca.com|
308103|NCT02551887|Indiana University|Dr. Gregory Zimet|317-274-8812|gzimet@iu.edu|
308104|NCT02552121|Genmab A/S|Genmab|7020 2728|clinicaltrials@genmab.com|+45
308105|NCT02552147|Vanderbilt University Medical Center|Alan Lewis, MD, PhD|(615) 936-4997|alan.s.lewis@vumc.org|
308106|NCT02552212|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
282669|NCT00867217|University of Kansas Medical Center|Dr. Bruce Kimler|(913) 588-4523|bkimler@kumc.edu|
308107|NCT02552225|Boson Medical Center|Pieter Noordzij, MD|(617) 414-1756|pieter.noordzij@bmc.org|
308108|NCT02552238|Bracco Diagnostics Inc.|Melda S. Dolan, MD, FACC, FASE, Head, Medical Affairs and Cardiac Ultrasound|1-609-514-2506|Melda.Dolan@diag.bracco.com|
296482|NCT01687166|Boston Scientific|Clinical Trial Manager|617-218-3849|weismanm@bsci.com|
296483|NCT01687179|Brigham and Women's Hospital|Elizabeth P. Henske, MD|857-307-0782|ehenske@bwh.harvard.edu|
296484|NCT01687218|Division of Infectious Diseases - UPMC|Ross D. Cranston, MD, FRCP|412-383-2054|rdc27@pitt.edu|
296485|NCT01687244|FKD Therapies Oy|David Sawutz, PhD|416-607-9515|david.sawutz@fkdtherapies.com|
296486|NCT01687257|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
296487|NCT01687270|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
296488|NCT01687283|GlaxoSmithKline|GSK Response Center|866-435-7343||
296489|NCT01687296|GlaxoSmithKline|GSK Response Center|866-435-7343||
296490|NCT01687387|Innate Pharma|Director Clinical Operations|+33043030|info@innate-pharma.fr|30
296491|NCT01687400|Washington University School of Medicine|John Welch, M.D., Ph.D.|314-362-2626|jwelch@wustl.edu|
296492|NCT01687413|Washington University School of Medicine|Jason Rich, M.D.|314-747-3742|richj@wustl.edu|
308109|NCT02552303|University of Pennsylvania|Michael Perlis|(215) 746-3577|mperlis@upenn.edu|
308110|NCT02552316|University of Pennsylvania|Junko Takeshita|215-349-5551|Junko.Takeshita@pennmedicine.upenn.edu|
308111|NCT02552355|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
308112|NCT02552368|Washington University School of Medicine - Department of Neurology|Dr. Thy Huskey|314-362-4503|huskeyt@wustl.edu|
308113|NCT02552732|Fisher and Paykel Healthcare|Dr Stanislav Tatkov|09 5740100|stanislav.tatkov@fphcare.co.nz|
308114|NCT02552810|University of Valencia|Dr. Luigi Canullo|+39 347 6201976|luigicanullo@yahoo.com|
308115|NCT02552888|Tulane School of Medicine|Dr. Jing Chen|5049886110|jchen@tulane.edu|
308116|NCT02552966|Northwestern University|Dr. John Pandolfino, Principal Investigator|3126950182|j-pandolfino@northwestern.edu|
308117|NCT02553135|University of Miami|Byron Lam , MD|305-326-6021|blam@med.miami.edu|
271242|NCT00215553|Discovery Laboratories, Inc.|Robert Segal, MD|215-488-9300|rsegal@discoverylabs.com|
271243|NCT00215644|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
271244|NCT00215657|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
271245|NCT00215683|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
271246|NCT00215787|Head and Neck Surgery Associates|Scott Phillips|317-926-1056|sphillips@hnsaonline.com|
271247|NCT00215930|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|Gerald Bepler, M.D., via Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
271248|NCT00215943|H. Lee Moffitt Cancer Center and Research Institute|Melissa Alsina, M.D.|813-745-6886|melissa.alsina@moffitt.org|
271249|NCT00216060|Hoosier Oncology Group|Christopher Sweeney, M.B., B.S.|(617) 632 4524|christopher_sweeney@dfci.harvard.edu|
271250|NCT00216086|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
271251|NCT00216099|Hoosier Cancer Research Network|Jeff Smith|317-921-2050|jsmith@hoosiercancer.org|
271252|NCT00216125|Hoosier Cancer Research Network|Georgia Gould|3176385842|ggould@hoosiercancer.org|10
271253|NCT00216203|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
271254|NCT00216320|Innovative Neurotronics|Director of Clinical Research|512-721-1922|hrogers@ininc.us|
271255|NCT00216476|Janssen Cilag European Medical Affairs|EMEA Medical Affairs Director Psychiatry|+34 91 7228043||
271256|NCT00216671|Janssen Cilag Spain|EMEA Medical Affairs Director Psychiatry|+34 91 7228043||
271257|NCT00216736|Joseph Epstein Centre for Emergency Medicine Research|Prof Anne-Maree Kelly|+61383456666|anne-maree.kelly@wh.org.au|
308118|NCT02553317|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
296493|NCT01687478|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
296494|NCT01687595|Agenus Inc.|Agenus, Inc. Clinical Trial Information|781-674-4265|clinicaltrialinfo@Agenusbio.com|
296495|NCT01687673|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|Katie.Kelley@ucsf.edu|
296496|NCT01687712|Fertility Biotech AG|Executive VP of Regulatory Affairs||maria.vazquez@fertilitybiotech.com|
296497|NCT01687790|University of Pittsburgh|Dr. Christiane Hakim|412-641-1965|chakim@magee.edu|
271919|NCT00276549|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Robert Dreicer|216-445-4623|dreicer@ccf.org|
296498|NCT01687972|Johns Hopkins Univesity School of Medicine|Janice Henderson, MD Assistant Professor|443-287-2783|jhender7@jhmi.edu|
296499|NCT01687998|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
296500|NCT01688037|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
308119|NCT02553330|Incyte Organization|Study Director|855-463-3463|medinfo@incyte.com|
308120|NCT02553395|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
308121|NCT02553421|ivWatch, LLC|Jason Naramore|855-485-2824|jason.naramore@ivwatch.com|7019
308122|NCT02553499|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308123|NCT02553512|Proteus Digital Health|Lorenzo DiCarlo MD, Vice-President of Clinical and Medical Affairs|+1 650 637 6199|ldicarlo@proteus.com|
308124|NCT02553538|Massachusetts General Hospital|Dr. Sanja Percac-Lima|617-643-6980|spercaclima@partners.org|
308125|NCT02553629|Leiden University Medical Center|Prof. Dr. A. Dahan|+31 71 526 2301|a.dahan@lumc.nl|
308126|NCT02553746|424 Army General Hospital|Georgios Kotsovolis|+306948182743|gskotsos@gmail.com|
308127|NCT02553772|Allergan, Inc|Therapeutic Area Head,|1-877-277-8566|IR-CTRegistration@allergan.com|
308128|NCT02553798|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
308129|NCT02553915|Massachusetts General Hospital|Dr David Mischoulon, Director, Depression Clinical and Research Program, MGH|617-724-5198|dmischoulon@mgh.harvard.edu|
308130|NCT02553928|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
308131|NCT02554019|Biotest AG|Dr. Peter Röttgen|+496103801|peter.roettgen@biotest.com|803
308132|NCT02554279|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
308133|NCT02554435|California State Polytechnic University, Pomona|Dr. Zakkoyya Lewis|5628819950|drkoyyalewis@gmail.com|
308134|NCT02554474|University of British Columbia|Dr. Linda Li|604-207-4020|lli@arthritisresearch.ca|
308135|NCT02554513|VASLCHCS|Dr. Shannon Mauszycki|801-582-1565|shannon.mauszycki@utah.edu|
271920|NCT00276614|David Geffen School of Medicine at UCLA|Matthew Rettig, M.D.|310-794-3565|mrettig@mednet.ucla.edu|
296501|NCT01688050|Cook Research Incorporated|Alan Saunders,MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
296502|NCT01688102|The Rockefeller University|Dr. Manish Ponda|212-327-7631|mponda@rockefeller.edu|
296503|NCT01688141|University of Leicester|Professor Nigel Brunskill|+44 116 258 8043|njb18@le.ac.uk|
296504|NCT01688310|Catholic University of Mozambique Medical School|Dr. Peter Millard|2078663503|pmillard@mac.com|
296505|NCT01688336|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
296506|NCT01688466|National cancer Institute|Dr. Steven Z. Pavletic|301-402-4899|steven_pavletic@nih.gov|
296507|NCT01688596|Penn State Milton S. Hershey Medical Center|Dr. Matthew F. Davies, M.D.|7175310003|mdavies@hmc.psu.edu|283519
296508|NCT01688609|St. Luke's International Hospital|Dr. Teruo Yamauchi|+81-3-3541-5151|tryhi@luke.ac.jp|
296509|NCT01688635|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
296510|NCT01688726|Alcon Research, Ltd.|Abayomi Ogundele, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
308136|NCT02554656|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308137|NCT02554682|Children's Hospital of Philadelphia|Dr. Carol Ford|267-426-3938|fordc@email.chop.edu|63938
308138|NCT02554721|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
308139|NCT02554760|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
308140|NCT02554786|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
308141|NCT02554799|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
308142|NCT02554877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308143|NCT02554890|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
296511|NCT01688739|Amgen Inc.|Study Director|866-572-6436||
308144|NCT02554903|Actelion Pharmaceuticals US, Inc|Medical Affairs Associate Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
308145|NCT02554929|The Hospital for Sick Children|Dr. Suneeta Monga|416-813-8954|suneeta.monga@sickkids.ca|
296512|NCT01688830|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296513|NCT01688843|Boston Scientific|Gena Kantor, MPH|1-800-227-3422|gena.kantor@bsci.com|
296514|NCT01688856|The MetroHealth System|Dr. Jayme Knutson|216-957-3557|jsk12@case.edu|
296515|NCT01688882|Novartis Pharmaceuticals|Study Director|862-778-8300||
296516|NCT01688895|Icahn School of Medicine at Mount Sinai|Dr. Hetanshi Naik|212-241-7699|hetanshi.naik@mssm.edu|
296517|NCT01688921|PharmaJet, Inc.|Tara Miller, Clinical Affairs Manager|888-900-4321|tara.miller@pharmajet.com|4163
296518|NCT01688973|City of Hope National Medical Center|Przemyslaw W. Twardowski, MD|626-256-4673|ptwardowski@coh.org|68218
296519|NCT01688999|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
296520|NCT01689155|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
296521|NCT01689207|AstraZeneca|Paul Newell, Medical Science Director|+44 1625 515727|paul.newell@astrazeneca.com|
308146|NCT02554981|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
308147|NCT02555098|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
308148|NCT02555215|Biogen|Medical Director, Overall Study Officials|866-633-4636|clinicaltrials@biogen.com|
282670|NCT00867308|Johns Hopkins University|Amy DeZern, MD|4105027208|adezern1@jhmi.edu|
282671|NCT00867321|Mayo Clinic|Steven R. Alberts, MD MPH|507/284-4918|Alberts.steven@mayo.edu|
296522|NCT01689324|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
296523|NCT01689337|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
296524|NCT01689350|School of Pharmaceutical Sciences, Sun Yat-sen University|Lingyan CHEN, Master candidate|+8615018706960|chlingy@mail2.sysu.edu.cn|
296525|NCT01689363|Amphastar Pharmaceuticals, Inc.|Gisela Sharp|(909) 980-9484|GiselaS@amphastar.com|2016
296526|NCT01689441|Brigham and Women's Hospital|David Leaf, MD, MMSc|617-732-5500|deleaf@partners.org|
296527|NCT01689519|Hoffmann-La Roche|Medical Communications|800 821-8590||
296528|NCT01689532|Janssen Pharmaceutical K.K.|Senior Manager||ClinicalTrialDisclosure@its.jnj.com|
296529|NCT01689649|Janssen-Cilag Taiwan|Medical Director|886 2 23762155||
296530|NCT01689701|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Sang-Wook Kim, MD|82-63-276-8284|clickm@jbnu.ac.kr|
296531|NCT01689779|Massachusetts General Hospital|Sadeq A. Quraishi, MD|617-726-3030|squraishi@mgh.harvard.edu|
296532|NCT01689857|Seoul National University Bundang Hospital|Dr. Chanyeong Heo|82317877222|lionheo@snu.ac.kr|
271921|NCT00276744|SKCCC|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
308149|NCT02555228|MOHH Holdings|Dr Song Mingjun|86337635|mingjun.song0950c@gmail.com|
308150|NCT02555306|Santen Inc|R&D Quality Manager|+1 415 268 9199|evelyn.chikere@santen.com|
308151|NCT02555371|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
282672|NCT00867334|George Mason University|Emanuel Petricoin|571-830-4166|epetrico@gmu.edu|
296533|NCT01690000|Aarhus University|Anne Kristine Amstrup|4578467681|anne_kristine_am@hotmail.com|
296534|NCT01690052|Indiana University School of Dentistry|Juan F. Yepes DDS, MD, MPH, MS, DrPH, Associate Professor|317-944-9601|jfyepes@iupui.edu|
296535|NCT01690117|University of Leipzig, Medical Faculty, Clinic and Policlinic for Psychiatry and Psychotherapy|Prof. Dr. Hermann-Josef Gertz|0049 (0)341 97 24420|Hermann-Josef.Gertz@medizin.uni-leipzig.de|
296536|NCT01690130|Medical University of South Carolina|TMS in Nicotine Craving|8437925729|lixi@musc.edu|
296537|NCT01690143|University of Alabama at Birmingham|Luciano J Costa, Principal Investigator|205-209-6038|ljcosta@uabmc.edu|
308152|NCT02555449|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
308153|NCT02555618|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
308154|NCT02555631|Albert Einstein College of Medicine|Dr. Elizabeth Walker|718-430-3242|elizabeth.walker@einstein.yu.edu|
308155|NCT02555683|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
308156|NCT02555722|CooperVision Inc.|Senior Manager, Clinical Research|925-730-6754|PChamberlain@coopervision.com|
308157|NCT02555878|Janssen Scientific Affairs, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
308158|NCT02555930|Imperial College London|Dr Harriet Kemp|+44 20 3315 8816|h.kemp@imperial.ac.uk|
308159|NCT02556112|711 Human Performance Wing, U.S. Air Force|Col Nicole Armitage|937-255-3784|nicole.armitage@us.af.mil|
308160|NCT02556138|Mayo Clinic|Dr. Kymberly Watt|507-266-1686|Watt.Kymberly@mayo.edu|
308161|NCT02556177|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
308162|NCT02556203|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
308163|NCT02556255|Eximo Medical|Oshrat Cohen|97286307639|oshratc@eximomedical.com|
308164|NCT02556307|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
308165|NCT02556333|National Institutes of Health, National Institute of Allergy and Infectious Diseases|Alice Pau, Pharm.D., Staff Scientist (Clinical)|301-451-3740|apau@niaid.nih.gov|
308166|NCT02556554|Regents of the University of Colorado|Sarit Polsky, MD, MPH|3037248575|sarit.polsky@ucdenver.edu|
308167|NCT02556632|University of Rochester|Julie Ryan Wolf, PhD, MPH; Associate Professor of Dermatology and Radiation Oncology|585-276-3862|julie_ryan@urmc.rochester.edu|
308168|NCT02556736|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
308169|NCT02556775|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
308170|NCT02556788|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
308171|NCT02556801|HAL Allergy|Andrey Larionov, MD, Head of Clinical Development|+31881959189|alarionov@hal-allergy.com|
308172|NCT02556918|Emory University|Dr. Guillermo Umpierrez|404-778-1665|GEUMPIE@emory.edu|
308173|NCT02557035|Helsinn Healthcare SA|Daniel Voisin|+41 91 985 2121|daniel.voisin@helsinn.com|
308174|NCT02557100|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
308175|NCT02557178|Mayo Clinic|Johanna Hoult|507-293-1989|hoult.johanna@mayo.edu|
308176|NCT02557399|GlaxoSmithKline|GSK Response Center|866-435-7343||
308177|NCT02557516|Innate Pharma|Dr. Agnes BOYER-CHAMMARD, Medical Director|+33430303030|Agnes.BOYER-CHAMMARD@innate-pharma.fr|
308178|NCT02557555|Rutgers New Jersey Medical School|Assistant Professor|4133869415|ajantoni@gmail.com|
308179|NCT02557646|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
308180|NCT02557698|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
308181|NCT02558231|Actelion Pharmaceuticals Ltd.|Principal Clinical Scientist|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
308182|NCT02558296|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
308183|NCT02558374|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
308184|NCT02558400|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
308185|NCT02558790|Massachusetts General Hospital|Craig Surman, MD|617-726-8422|csurman@partners.org|
282673|NCT00867360|Stanford University|Dr. Alan Schatzberg|650-723-6811|afschatz@stanford.edu|
308186|NCT02558829|Aeterna Zentaris|Dr. Nicola Ammer|+496942602|nammer@aezsinc.com|3472
308187|NCT02558894|AstraZeneca|Global Clinical Lead|+1 301-398-0000|ClinicalTrialTransparency@astrazeneca.com|
308188|NCT02559115|Memorial Sloan Kettering Cancer Center|Dr. Hebert A. Vargas Alvarez , MD|646-888-5410|vargasah@mskcc.org|
308189|NCT02559206|Ironwood Pharmaceuticals, Inc.|Nick Omniewski, MPH|(617) 621-8454|nomniewski@ironwoodpharma.com|
308190|NCT02559310|Nabriva Therapeutics US, Inc.|Jennifer Schranz, MD, Chief Medical Officer|610-981-2842|jennifer.schranz@nabriva.com|
308191|NCT02559414|New York University School of Medicine|Jeffrey Berger, MD|212 263 4004|Jeffrey.Berger@nyumc.org|
296538|NCT01690273|Universidade Sao Paulo|Andrea Lopes Gallinaro; Researcher|55112601|algallinaro@gmail.com|8022
296539|NCT01690299|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com|
296540|NCT01690520|Deverra Therapeutics|Chief Scientific Officer|206-519-5304|cdelaney@deverratx.com|
296541|NCT01690546|Duke University Medical Center|Paolo Mannelli, M.D|919-681-0613|paolo.mannelli@dm.duke.edu|
296542|NCT01690663|the University of Pennsylvania|Jiabin Liu, MD, PhD|215-573-8208|jiabin.liu@uphs.upenn.edu|
296543|NCT01690923|ResMed Ltd|Xueling Zhu, Clinical Consultant|61288842265|xueling.zhu@resmed.com.au|
296544|NCT01690988|Washington University School of Medicine|Dr. Michael Avidan|314-747-4155|avidanm@wustl.edu|
296545|NCT01691014|Pfizer ClinicalTrials.gov Call Center, Pfizer, Inc.|Pfizer Inc.|001 800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296546|NCT01691027|Kansas City VA Medical center|Health Scientist|816-861-4700|George.Timberlake@va.gov|52755
296547|NCT01691092|Yale University - Psychiatry Department|Irina Esterlis, Ph.D.|(203)737-6820|irina.esterlis@yale.edu|
308192|NCT02559505|University Of Rochester|Dr. Jennifer Nayak|5852767404|Jennifer_Nayak@URMC.Rochester.edu|
308193|NCT02559570|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
308194|NCT02559622|Novartis Pharmaceuticals|Study Director|862--778--8300||
308195|NCT02559687|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308196|NCT02559713|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
308197|NCT02559817|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
308198|NCT02559895|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
271258|NCT00217022|Mayo Clinic, Rochester MN|Dr. Darrell Pardi|507-538-1231|pardi.darrell@mayo.edu|
271259|NCT00217087|Mayo Clinic|Kenneth Wang MD|507-255-7495|wang.kenneth@mayo.edu|
271260|NCT00217399|Georgetown University|Dr. Claudine Isaacs|202-444-3677|isaacsc@georgetown.edu|
271261|NCT00217425|ECOG Statistical Office|Study Statistician|617-632-3012||
271262|NCT00217438|Fred Hutchinson Cancer Research Center|Dr. William Bensinger|206-667-4933|wbensing@fhcrc.org|
271263|NCT00217464|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
271264|NCT00217490|Kaiser Permanente Center for Health Research|Victor J. Stevens, PhD|503 335 6751|victor.j.stevens@kpchr.org|
271265|NCT00217581|Barbara Ann Karmanos Institute|Philip A. Philip, M.D., Ph.D., F.R.C.P|(313) 576-8746|philipp@karmanos.org|
271266|NCT00217594|NHLBI, NIH|Chris Hourigan MD|301-451-0257|hourigancs@mail.nih.gov|
271267|NCT00217620|SWOG Statistical Center|Study Statistician|206-667-4623||
271268|NCT00217672|University of California, Los Angeles|Sara Hurvitz, M.D.|310-829-5471|shurvitz@mednet.ucla.edu|
271269|NCT00217724|OHSU Knight Cancer Institute|Joseph Bublao|503-494-1054|bubaloj@ohsu.edu|
271270|NCT00217971|Columbia University|Frances R. Levin, M.D.|(212) 543-5896|frl2@columbia.edu|
271271|NCT00218023|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
271922|NCT00276861|Dept. of Oncology Johns Hopkins Singapore Intl Medical Center|Gilberto Lopes MD|656-880-2240|glopes@imc.jhmi.edu|
271923|NCT00277095|Uromedica|Sabitha R Shriram|763-694-9880|sshriram@uromedica-inc.com|216
271924|NCT00277212|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
271925|NCT00277355|Massachusetts General Hospital|Merit Cudkowicz, MD, MSc|617-726-1873|mcudkowicz@partners.org|
271926|NCT00277394|Leo Pharma|Torsten Skov, Senior Medical Advisor|+45 72263990|tosdk@leo-pharma.com|
271927|NCT00277446|Northwestern University|Lewis J. Smith|312-503-0501|ljsmith@northwestern.edu|
271928|NCT00277524|Medtronic Cardiac Rhythm Disease Management|Melinda Hoey, Clinical Research Specialist|763-526-2831|Melinda.hoey@medtronic.com|
308199|NCT02560012|The University of Texas Health Science Center, Houston|Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
308200|NCT02560025|Massachusetts General Hospital|Amir Fathi, MD|617-724-1124|AFATHI@mgh.harvard.edu|
296548|NCT01691105|Yale School of Medicine|Dr. Steven Bernstein|203-737-3574|steven.bernstein@yale.edu|
308201|NCT02560038|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
308202|NCT02560051|The University of Texas Health Science Center at Houston|Marka Lyons, Research Manager|713-500-6919|Marka.Lyons@uth.tmc.edu|
308203|NCT02560324|University of Pennsylvania|Principal Investigator|215-746-5789|rlashare@pennmedicine.upenn.edu|
308204|NCT02560389|University of Wisconsin School of Medicine and Public Health, University of Wisconsin, Madison|Josh Cisler|608-263-6100|jcisler2@wisc.edu|
308205|NCT02560493|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632869|amanda.staiano@pbrc.edu|
308206|NCT02560558|Emory University|Dr. Idelberto Badell|404-712-6562|ibadell@emory.edu|
308207|NCT02560584|Regional Hospitals & Family Health Centers|Dr. J. Stephen Jones|+1-216-442-5060|joness7@cff.org|
308208|NCT02560701|Harvard Pilgrim Health Care Institute|Dr. J. Frank Wharam|(617) 867-4948|jwharam@post.harvard.edu|
308209|NCT02560753|T3DTherapeutics|John Didsbury, PhD|9199490517|didsj919@t3dtherapeutics.com|
308210|NCT02560779|TRACON Pharmaceuticals Inc.|Charles Theuer|(858) 550-0780|ctheuer@traconpharma.com|
308211|NCT02560922|University of North Carolina at Chapel Hill|Kelli D. Allen, PhD|919-966-0558|kdallen@email.unc.edu|
308212|NCT02561000|Tufts Medical Center|Athan Kuliopulos, MD, PhD|617-636-8482|athan.kuliopulos@tufts.edu|
308213|NCT02561078|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
308214|NCT02561130|McMaster University|Natalia McInnes|905-521-2100|natalia.mcinnes@mcmaster.ca|
308215|NCT02561156|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
308216|NCT02561195|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308217|NCT02561221|Pennington Biomedical Research Center|Dr. Peter T. Katzmarzyk, Associate Executive Director of Population and Public Health Sciences|225-763-2536|doctors@pbrc.edu|
308218|NCT02561247|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
308219|NCT02561273|University of Nebraska Medical Center|Matthew Lunning, DO|402-559-7164|mlunning@unmc.edu|
308220|NCT02561338|Hua Medicine|Yi Zhang|+86-21-58869997|yzhang@huamedicine.com|3269
296549|NCT01691248|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
296550|NCT01691313|Laguna Pharmaceuticals, Inc.|Howard C. Dittrich|858-405-1429|HDittrich@lagunarx.com|
296551|NCT01691326|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
296552|NCT01691339|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
296553|NCT01691378|Rocky Mountain MIRECC|Lisa Brenner|720-723-6488|lisa.brenner@va.gov|
296554|NCT01691430|Yale University|Dr. Manisha Juthani-Mehta|(203)785-4140|manisha.juthani@yale.edu|
296555|NCT01691482|GlaxoSmithKline|GSK Response Center|866-435-7343||
296556|NCT01691508|GlaxoSmithKline|GSK Response Center|866-435-7343||
296557|NCT01691521|GlaxoSmithKline|GSK Response Center|866-435-7343||
296558|NCT01691534|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
308221|NCT02561455|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
308222|NCT02561481|Univ of Massachusetts Medical School|Andrew Zimmerman, MD|4109350488|andrew.zimmerman@umassmemorial.org|
308223|NCT02561572|Sheffield Teaching Hospitals NHS Foundation Trust|Dr Matthew Wiles|00441142712381|matthew.wiles@sth.nhs.uk|
308224|NCT02561585|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
308225|NCT02561702|University of Rochester|David Herrmann|585-275-4568|david_herrmann@urmc.rochester.edu|
308226|NCT02561806|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
308227|NCT02561832|AstraZeneca Pharmaceuticals LP|Carsten Goessl MD|+1 2404490654|Carsten.Goessl@astrazeneca.com|
308228|NCT02561897|Electrophysiology Research Foundation|Sanjeev Saksena|7323029990|eprf@aol.com|
308229|NCT02562066|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
308230|NCT02562482|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Grace Chen, Deputy Chief, Clinical Trials Program, Vaccine Research Center|240-669-2809|grace.chen@nih.gov|
308231|NCT02562521|Yale University School of Medicine|Dr. Krysten Bold|2039747603|krysten.bold@yale.edu|
308232|NCT02562755|SillaJen Biotherapeutics Inc.|Kyoung Soo Ha, Senior Medical Director|+1-415-281-8886|ksha@kr.sillajen.com|
308233|NCT02562898|University of California, San Francisco|Dr. Margaret Tempero|415-353-7528|Margaret.Tempero@ucsf.edu|
308234|NCT02562924|University of Vermont Medical Center|Dr. Daniel Gerges|8028474535|daniel.gerges@uvmhealth.org|
308235|NCT02562989|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308236|NCT02563028|Hospital for Special Surgery|Valeria Rotundo|212-774-7885|rotundov@hss.edu|
308237|NCT02563067|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
308238|NCT02563093|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
296559|NCT01691560|GlaxoSmithKline|GSK Response Center|866-435-7343||
296560|NCT01691612|Brigham & Women's Hospital|Elliot Israel, M.D.|617-732-8110|eisrael@partners.org|
296561|NCT01691690|Nationwide Children's Hospital|Dr. Arlyne Thung|(614) 722-4200|Arlyne.Thung@NationwideChildrens.org|
296562|NCT01691768|CAPRISA|Nonhlanhla Yende-Zuma|+27 31 260 4392|nonhlanhla.yende@caprisa.org|
296563|NCT01691781|Brigham and Women's Hospital|Anand Vaidya|6175258285|avaidya1@partners.org|
296564|NCT01691794|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
296565|NCT01691820|GlaxoSmithKline|GSK Response Center|866-435-7343|biliana.v.nestorova@gsk.com|
296566|NCT01691833|Carolinas Healthcare System|Dr. Rachel Seymour|704-355-2000|Rachel.Seymour@carolinas.org|
296567|NCT01691859|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
308239|NCT02563106|Synthetic Biologics|Michael Kaleko, MD|(240) 238-3862|mkaleko@syntheticbiologics.com|
308240|NCT02563496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
308241|NCT02563548|Halozyme Therapeutics|VP, Clinical Development|858-794-8889|medinfo@halozyme.com|
308242|NCT02563561|Spectrum Pharmaceuticals, Inc. Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|(949) 788-6700|shanta.chawla@sppirx.com|
308243|NCT02563808|University of Pennsylvania Hospital|Lee Fleisher|2156623738|lee.fleisher@uphs.upenn.edu|
271929|NCT00278109|Indiana University School of Medicine|Richard Zellars MD|3179444505|rzellars@iu.edu|
271930|NCT00278148|Case Comprehensive Cancer Center|Dr. Nathan Pennell|21684459281|penneln@ccf.org|
271931|NCT00278161|Johns Hopkins University|Lode Swinnen, MD|4106146398|lswinne1@jhmi.edu|
271932|NCT00278200|Johns Hopkins University|Richard Ambinder, MD, PhD|4109558839|rambind1@jhmi.edu|
271933|NCT00278395|University of Texas Health Science Center at San Antonio|Dr. John Sarantopoulos|210-450-1000|sarantopoulo@uthscsa.edu|
271934|NCT00278473|Icahn School of Medicine at Mount Sinai|Dr. Mary V. Solanto|212-241-5420|Mary.Solanto@mssm.edu|
271935|NCT00278512|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
271936|NCT00278525|Northwestern University|Dr. Richard Burt|312-908-0059|rburt@northwestern.edu|
271937|NCT00278538|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
308244|NCT02563834|Indiana University|Dr. Kieren J Mather|317-278-7826|kmather@iu.edu|
271938|NCT00278564|Northwestern University|Dr. Richard Burt|312-695-4960|rburt@northwestern.edu|
296568|NCT01691885|GlaxoSmithKline|GSK Response Center|866-435-7343||
296569|NCT01691898|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
296570|NCT01691950|Imperial College London|Mr Richard M Kwasnicki PhD MRCS|+44 (0) 20 759 48904|rmk107@ic.ac.uk|
296571|NCT01692119|ABDA, Department of Medicine|Dr. Martin Schulz|+49 30 40004-514|arzneimittel@abda.de|
296572|NCT01692197|UT MD Anderson Cancer Center|Borthakur,Gautam MD|713-563-1586|CR_Study_Registration@mdanderson.org|
296573|NCT01692275|Palmer Center for Chiropractic Research|Dr. Cyndy Long|563-884-5157|LONG_C@palmer.edu|
296574|NCT01692301|Novartis Pharmaceuticals|Study Directors|862-778-8300|trialandresults.registries@novartis.com|
296575|NCT01692340|The Ohio State University|Steven K. Clinton, MD PhD|614-293-2886|steven.clinton@osumc.edu|
296576|NCT01692496|GEIS|Clinical Trial Coordinating Investigator|912866807|secretaria@grupogeis.org|
296577|NCT01692626|West Virginia University|Mohammed Almubarak, MD, Assistant Professor|304-293-4229|malmubarak@hsc.wvu.edu|
296578|NCT01692730|University of Rochester|Scott McIntosh|585-275-0511|scott_mcintosh@urmc.rochester.edu|
308245|NCT02563860|Montefiore MC|Aleksandra Djukic|7189204378|adjukic@montefiore.org|
308246|NCT02563899|GlaxoSmithKline|GSK Response Center|866-435-7343||
308247|NCT02563990|University of Miami|Andres Missair|3055857037|amissair@miami.edu|
308248|NCT02564016|Medical University of South Carolina|Laura L Roberts MD, Assistant Professor|843 792 2322|roberll@musc.edu|
271272|NCT00218062|The University of Texas Health Science Center at Houston|Dr Joy M. Schmitz|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
271273|NCT00218257|University of Minnesota|Dr. Sheila Specker|612-273-9806|speck001@umn.edu|
271274|NCT00218296|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
271275|NCT00218335|Johns Hopkins Bloomberg School of Public Health|Carl Latkin, PhD||clatkin@jhsph.edu|
271276|NCT00218387|Medical University of SC|Robert Malcolm, MD|843-792-1901|malcomr@musc.edu|
271277|NCT00218426|University of Pennsylvania|Dr. George E Woody|215-746-7702|woodg@pennmedicine.upenn.edu|
271939|NCT00278629|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
271940|NCT00278655|Northwestern University|Dr Richard Burt|312-908-0059|rburt@northwestern.edu|
271941|NCT00278863|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
271942|NCT00278876|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
271943|NCT00278889|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
271945|NCT00278954|Bio Products Laboratory|Margaret Stratford Bobbitt|+44 20 8258 2288|Margaret.Stratford-Bobbitt@bpl.co.uk|
271946|NCT00278993|Eisai Call Center|Eisai Inc.|888-422-4743||
271947|NCT00279201|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
271948|NCT00279214|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271949|NCT00279305|Type 1 Diabetes TrialNet|Carla Greenbaum, MD||cjgreen@benaroyaresearch.org|
271950|NCT00279500|Second Sight Medical Products, Inc.|Jessy Dorn, PhD, Director, Clinical and Scientific Research|8188335089|jdorn@secondsight.com|
271951|NCT00279591|University of Arkansas for Medical Sciences|Dr. Michael Stroud|501-364-1861|StroudMichaelH@uams.edu|
271952|NCT00279708|The National Institutes of Health/ The National Heart, Lung, and Blood Institute|Joseph Fontana, MD|301-451-7740|fontanaj@nhlbi.nih.gov|
271953|NCT00279812|Institute of Food Research|Dr Charlotte Armah|01603 255 000|charlotte.armah@ifr.ac.uk|5360
271954|NCT00279916|Mayo Clinic|Dr. Laura Orvidas|507-284-3410|orvidas.laura@mayo.edu|
271955|NCT00279955|Medtronic CRDM Clinical Research|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
271956|NCT00280059|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296579|NCT01692743|University of Maryland School of Medicine|Raymond K. Cross, MD, MS, AGAF|410-706-3387|rcross@som.umaryland.edu|
296580|NCT01692756|Univerisity of Kentucky|Cale Jacobs, ATC, PhD|8592183065|Kycartilagedoc@gmail.com|
296581|NCT01692782|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
296582|NCT01692938|Stanley M. Truhlsen Eye Institute|Quan Nguyen, MD Director of the Stanley M. Truhlsen Eye Institute|402-559-4276|quan.nguyen@unmc.edu|
296583|NCT01692951|Cleveland Clinic Foundation|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
296584|NCT01692964|Rapid Pathogen Screening, Inc.|Robert Sambursky, MD|941-556-1853|rob.sambursky@lumosdiagnostics.com|
296585|NCT01693029|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|004980244760|biopharma.clinicaltrials@sandoz.com|
296586|NCT01693068|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
296587|NCT01693120|Medtronic AF Solutions|Bob Hokanson, Clinical Research Manager|763.526.2811|robert.hokanson@medtronic.com|
308249|NCT02564029|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308250|NCT02564042|GlaxoSmithKline|GSK Response Center|866-435-7343||
308251|NCT02564055|GlaxoSmithKline|GSK Response Center|866-435-7343||
296588|NCT01693185|Konkuk University Medical Center|Dr. Tae-Yop Kim, Professor of Anesthesiology|82-2-2030-5445|taeyop@gmail.com|
296589|NCT01693250|University of California San Francisco|Dr. Jyu-Lin Chen|415-502-6015|jyu-lin.chen@ucsf.edu|
296590|NCT01693523|UT MD Anderson Cancer Center|Dr. David Fogelman/ Associate Professor, GI Medical Oncology|832-710-7754|dfogelman@mdanderson.org|
296591|NCT01693562|MedImmune, LLC|Ashok Gupta|+13013981287|information.center@astrazeneca.com|
296592|NCT01693614|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
296593|NCT01693900|Beaumont Health|Randy Fayne, DO|248-898-1905|rfyane@beaumont.org|
296594|NCT01694108|Rigshospitalet|Lone Graff Stensballe, Research leader, Pediatrician, PhD|+0045 35459727|lone.graff.stensballe@regionh.dk|
296595|NCT01694121|Center on Gender Equity and Health at UCSD|Dr. Anita Raj|8588220229|anitaraj@ucsd.edu|
296596|NCT01694186|Eyepoint Pharmacueticals|Clinical Affairs|6179726204|fleonin@eyepointpharma.com|
296597|NCT01694199|Regenesis Biomedical, Inc.|Dr. Rick Isenberg|877-970-4970|isenberg@regenesisbio.com|
271957|NCT00280150|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
271958|NCT00280241|University of Pittsburgh|Michael Boyiadzis, MD|412-623-0040|boyiadzism@upmc.edu|
271959|NCT00280293|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
271960|NCT00280384|Eisai Co., Ltd.|Hiroki Shimizu, Study Director|81-3-3817-5235|h3-shimizu@hhc.eisai.co.jp|
271961|NCT00280397|Eisai Co., Ltd.|Akihiko Tsuruoka|+81-3-3817-5252||5252
271962|NCT00280566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
271963|NCT00280683|UCaliforniaDavis|Dr. Nicholas Kenyon|916-734-3564|njkenyon@ucdavis.edu|
271964|NCT00280735|UNC Lineberger Comprehensive Cancer|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
271965|NCT00280748|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
271966|NCT00280826|National Eye Institute|Robert Nussenblatt, MD, MPH|301-496-3123|drbob@intra.nei.nih.gov|
282674|NCT00867451|Cincinnati Children's Hospital Medical Center|Richard Gilman, Ph.D.|513-636-8172|richard.gilman@cchmc.org|
296598|NCT01694420|Duke University Medical Center|Mehri McKeller, MD|919-668-0242|kara.mcgee@duke.edu|
296599|NCT01694433|UCLA|Dr. Jenny Kim|310-825-5420|jekim@mednet.ucla.edu|
296600|NCT01694485|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
296601|NCT01694563|Atricure Inc.|Nfii K. Ndikintum, PhD, MBA / VP, Clinical Affairs and Biometrics|513-644-8192|NNdikintum@atricure.com|
296602|NCT01694641|Kaali Inst. IVF Center|Dr Peter Kovacs|36-1-202-2802|peterkovacs1970@hotmail.com|
296603|NCT01694667|University of California, San Francisco|Stephen Bent|415-221-4810|Stephen.Bent@ucsf.edu|3457
296604|NCT01694706|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296605|NCT01694771|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308252|NCT02564120|The University of North Carolina at Chapel Hill|Dr. Ronald Chen|984-974-0400|ronald_chen@med.unc.edu|
308253|NCT02564198|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
271278|NCT00218439|University of Minnesota College of Pharmacy|Dr. Michael Kotlyar|612-625-1160|kotly001@umn.edu|
271279|NCT00218465|Center for Addiction Medicine|Sara Carlini|617-643-1990|scarlini@partners.org|
271280|NCT00218491|Medical University of SC|Robert Malcolm, MD|843-792-1901|malcomr@musc.edu|
271281|NCT00218543|COLUMBIA UNIVERSITY|Frances R Levin, MD|212-543-5896|FRL2@COLUMBIA.EDU|
271282|NCT00218634|Mass General Hospital|Steven Safren|617 724 0817|ssafren@partners.org|
271283|NCT00219141|Novartis Pharmaceuticals|Study Director|862 778-8300||
271284|NCT00219284|Novartis Pharmaceuticals|Study Director|862-778-8300||
271285|NCT00219349|New York State Psychiatric Institute|Franklin Schneier MD|2125435368|fschneier@nyspi.columbia.edu|
271286|NCT00219544|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
271287|NCT00219557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271288|NCT00220636|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
271289|NCT00220701|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
271290|NCT00220727|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
271291|NCT00220740|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
271292|NCT00220779|Talecris Biotherapeutics|Ralph Kantor, PhD|1-800-520-2807|ralph.kantor@talecris.com|
296606|NCT01694966|Cosmo Technologies Ltd|R&D Manager|111111111|rjones@cosmopharma.com|11111
296607|NCT01695044|Progenics Pharmaceuticals, Inc.|Dr. Vincent A. DiPippo|(646) 975-2502|vdipippo@progenics.com|
296608|NCT01695135|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
296609|NCT01695239|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
296610|NCT01695291|New York State Psychiatric Institute|Kelsey Hill, Research Coordinator|646-774-5793|Kelsey.Hill@nyspi.columbia.edu|
296611|NCT01695304|Centers for Disease Control and Prevention|Ciara O'Reilly, PhD|404-639-1953|bwf1@cdc.gov|
296612|NCT01695330|Oncotherapeutics|Dr. James Berenson|310-420-9649|jberenson@berensonocology.com|
296613|NCT01695369|University of Houston, College of Optometry, TERTC|Jan Bergmanson, OD,PhD|713-743-1950|jbergmanson@uh.edu|
296614|NCT01695473|University of California, San Francisco|Dr. Won Kim, MD|877-827-3222|Won.Kim@ucsf.edu|
308254|NCT02564211|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
271967|NCT00280904|Codman & Shurtleff|J. Thomas Megerian|1-508-828-8274|jmegeri1@its.jnj.com|
271968|NCT00280917|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
271969|NCT00281021|James Graham Brown Cancer Center, University of Louisville|Dr. Goetz Kloecker|502-562-4358|ghkloe01@exchange.louisville.edu|
271970|NCT00281099|Medtronic, Inc.|MVP Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
271971|NCT00281463|Human Engineering Research Laboratories|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
271972|NCT00281528|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
271973|NCT00281580|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
271974|NCT00281632|GlaxoSmithKline|GSK Response Center|866-435-7343||
282675|NCT00867490|Novartis Pharmaceuticals|Study Director|862 778-8300||
296615|NCT01695668|University of Michigan|Dr Shahzad Mian|734-647-8397|smian@med.umich.edu|
296616|NCT01695746|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
296617|NCT01695772|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
296618|NCT01695954|NYU School of Medicine|Carlos Malvestutto, MD, MPH|212-263-3570|carlos.malvestutto@nyumc.org|
296619|NCT01695993|University of Rochester Medical Center|Joseph A. Roscoe, PhD Associate Research Professor|585 275-9962|joseph_roscoe@urmc.rochester.edu|
296620|NCT01696032|Astex Pharmaceuticals, Inc.|Dr. Harold Keer|925-719-0741|Harold.Keer@astx.com|
296621|NCT01696045|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
296622|NCT01696058|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296623|NCT01696071|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308255|NCT02564354|ProQR Therapeutics|Medical Monitor|+31 6 20 183 437|clinical@proqr.com|
308256|NCT02564432|Department of Veterans Affairs|James Peter Beck|801-231-6309|james.beck@hsc.utah.edu|
296624|NCT01696084|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|2158709177|tom.chmielewski@jazzpharma.com|
296625|NCT01696188|Sidney Kimmel Medical College at Thomas Jefferson University|Dr. Eric Schwenk|215-955-6161|Eric.Schwenk@jefferson.edu|
296626|NCT01696214|University of California San Diego|Dr. Joe Ramsdell|619-543-7241|jramsdell@ucsd.edu|
296627|NCT01696279|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
296628|NCT01696357|University of Rochester Medical Center|Hyekyun Rhee|5852763775|hyekyun_rhee@urmc.rochester.edu|
296629|NCT01696396|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
296630|NCT01696643|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
296631|NCT01696695|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
296632|NCT01696760|The Ohio State University Comprehensive Cancer Center|Joel Mayerson, MD|614-293-4420|joel.mayerson@osumc.edu|
308257|NCT02564471|SUNY Upstate Medical University|Dr. Timothy Endy|3154647692|endyt@upstate.edu|
271293|NCT00220805|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
271294|NCT00220961|University of Texas Health Science Center at San Antonio|Ralph DeFronzo, MD|210-567-6691|defronzo@uthscsa.edu|
271295|NCT00221104|Translational Research Informatics Center, Kobe, Hyogo|Director of Medical Statistics Division|+81-78-303-9108|kagimura@tri-kobe.org|
271296|NCT00221117|Toronto RI Institute|Dr. Milos Popovic|416-597-3422|milos.popovic@utoronto.ca|6305
271297|NCT00221195|Tulane University|Cindy Leissinger|504-988-5433|cleissi@tulane.edu|
271298|NCT00221299|Unversity of California Davis|Nancy E. Lane MD, Director, Center for Musculoskeletal Health|916 734-0753|nancy.lane@ucdmc.ucdavis.edu|
271299|NCT00221338|University of California San Francisco|Clinical Research Coordinator|4154769489|Christopher.Tang2@ucsf.edu|
271300|NCT00221403|Ohio State Medical Center/Nationwide Children's Hospital|Robert Kowatch, MD, PhD|(614) 355-2872|Robert.Kowatch@nationwidechildrens.org|
271301|NCT00222105|University of Kansas Medical Center|Cancer Center Clinical Trials Office|(913) 945-5059|SWILLIAM@kumc.edu|
271302|NCT00222131|Texas Tech|Jerzy Sarosiek, MD, PhD, AGAF, FACG|915-215-5255|jerzy.sarosiek@ttuhsc.edu|
271303|NCT00222729|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
271304|NCT00223080|Department of Disease Control, Ministry of Public Health|Dr. Supachai Rerks-Ngarm|66-2-590-3006|supachai@health.moph.go.th|
271305|NCT00223236|The University of Texas Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D., Professor|214-645-6950|sherwood.brown@utsouthwestern.edu|
271306|NCT00223262|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146456950|sherwood.brown@utsouthwestern.edu|
271307|NCT00223496|UTHSCSA|Dr. Charles Bowden|210-567-5479|Bowdenc@uthscsa.edu|
271308|NCT00223652|Northwestern University|David C. Mohr|312- 503-1403|d-mohr@northwestern.edu|
271309|NCT00223665|University of Washington|Celestia Higano, MD|206-606-1187|mjcampbe@seattlecca.org|
271310|NCT00223678|Vanderbilt Medical Center|Dr. Anthony Langone|615-936-1179|anthony.langone@vanderbilt.edu|
271311|NCT00223704|Vanderbilt University|Mias Pretorius, Associate Professor of Anesthesiology and Clinical Pharmacology|615-8757402|mias.pretorius@vanderbilt.edu|
271312|NCT00223795|VA Greater Los Angeles Healthcare System|Meika A. Fang, MD|310-268-4503|meika.fang@va.gov|
271313|NCT00223808|CTVHCS|Charles Burgar, MD|254/743-0085|charles.burgar1@va.gov|
271314|NCT00223821|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
271315|NCT00223977|Watson Laboratories, Inc|Gary Hoel, RPh, PhD|801-588-6641|gary.hoel@watson.com|
271316|NCT00223990|Kenya Medical Research Institute|Bernhards R. Ogutu, PhD|254-57-22942|bogutu@kisian.mimcom.net|
271317|NCT00224016|Watson Laboratories, Inc|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
271318|NCT00224029|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
271319|NCT00224042|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
271320|NCT00224055|Watson Pharmaceuticals, Inc|Naomi Dahl, PharmD Director, Clinical Affairs||Naomi.dahl@watson.com|
271321|NCT00224107|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
271322|NCT00224120|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
271323|NCT00224133|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Executive Director of Clinical Research|801-588-6641|gary.hoel@watson.com|
271324|NCT00224289|Principal Investigator|Bruce Shields, MD|203-785-6288|bruce.shields@yale.edu|
271325|NCT00224484|GlaxoSmithKline|GSK Response Center|866-435-7343||
296633|NCT01696773|The Ohio State University|Steven J. Schwartz|614-292-2934|schwartz.177@osu.edu|
308258|NCT02564497|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
308259|NCT02564718|Bayer|Therapeutic Area Head|+1-888-84-22937|clinical-trials-contact@bayer.com|
308260|NCT02564887|University of Pittsburgh|Christine Harrison, Clinical Research Coordinator|412-647-9665|harrisonta@upmc.edu|
308261|NCT02564926|Astrazeneca, Korea|EunYoung Kim / Local Study Specialist|82 2 2188 0946|EunYoung.Kim@astrazeneca.com|0946
308262|NCT02564952|GW Research Ltd|Medical Enquiries|+44 01223 238170; +18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
308263|NCT02565108|GW Research Ltd.|Medical Enquiries||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
308264|NCT02565147|The Medicines Company|Global Health Science Center|1.888.977.6326|medical.information@themedco.com|
308265|NCT02565186|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
308266|NCT02565381|Massachusetts General Hospital|Travis P. Baggett, MD, MPH (Principal Investigator)|617-643-9314|tbaggett@mgh.harvard.edu|
308267|NCT02565485|University Hospitals Cleveland Medical Center|Justin R. Lappen MD|216-844-3787|Justin.Lappen@UHhospitals.org|
308268|NCT02565511|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
308269|NCT02565576|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
296634|NCT01696877|Johns Hopkins University|Emmanuel S. Antonarakis, M.D., principal investigator|443-287-0553|eantona1@jhmi.edu|
296635|NCT01696929|Georgia Regents University|Dr. Brian Miller|706-721-4445|brmiller@gru.edu|
296636|NCT01696942|Milton S. Hershey Medical Center|Dr. David Stewart|717-531-0003|dstewart@pennstatehealth.psu.edu|
296637|NCT01696955|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
296638|NCT01696968|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
296639|NCT01696981|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
296640|NCT01696994|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
296641|NCT01697319|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
296642|NCT01697345|Creighton University|Dr. Melissa A Dahir|402-657-2847|melissadahir@creighton.edu|
308270|NCT02565615|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308271|NCT02565628|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308272|NCT02565706|William Paterson University|Jennifer Di Noia|973.720.3714|dinoiaj@wpunj.edu|
308273|NCT02565784|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
308274|NCT02565810|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
308275|NCT02565901|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
308276|NCT02565914|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
308277|NCT02566005|Mount Sinai Health Systems|Dr. Zainab Al-Ibraheemi||Zainab.Al-ibraheemi@mountsinai.org|
308278|NCT02566031|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
308279|NCT02566044|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
308280|NCT02566083|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|+1 714 247- 8628|djanaki1@its.jnj.com|
308281|NCT02566109|Wake Forest University Health Sciences|Gregory Hundley, MD|336-716-0607|ghundley@wakehealth.edu|
308282|NCT02566135|Medical College, Baroda.|Dr Aditi Amrutlal Dhimar|09825334605|dhimaraditi@yahoo.in|
308283|NCT02566239|Oregon Health & Science University|Dr. Jeffrey Kaye|503 494 6695|kaye@ohsu.edu|
308284|NCT02566265|Yale University School of Medicine|Andrew Branagan, MD|617-459-5234|andrew.branagan@yale.edu|
308285|NCT02566317|Arizona State University|Matthew Buman, PhD|602-827-2289|mbuman@asu.edu|
308286|NCT02566369|Galderma S.A.|Anne Fulton|+1 817-961-5203|anne.fulton@galderma.com|
308287|NCT02566525|University of Kentucky College of Medicine|Dr. Joseph Zwischenberger, MD|859-323-6013|jzwis2@uky.edu|
308288|NCT02566577|Emory University|Arshed A. Quyyumi|404-727-3655|aquyyum@emory.edu|
308289|NCT02566590|University of Utah|Micah Drummond|8015877764|micah.drummond@hsc.utah.edu|
308290|NCT02566759|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
308291|NCT02566785|University of Nebraska Medical Center College of Nursing|Dr. Rita McGuire|402-472-4712|rita.mcguire@unmc.edu|
308292|NCT02566889|Janssen Scientific Affairs|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
308293|NCT02566902|University of California - San Diego|Mike Gardiner, MD|8589668036|magardiner@ucsd.edu|
308294|NCT02566993|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 918466000|clinicaltrials@pharmamar.com|
308295|NCT02567188|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
308296|NCT02567227|Albert Einstein College of Medicine|Dr. Joe Verghese|718-430-3877|joe.verghese@einsteinmed.org|
308297|NCT02567266|University of Miami|Dr. Amanda Jensen-Doss|+1 (305)284-8332|ajensendoss@miami.edu|
308298|NCT02567552|IVI Barcelona|Evelin Lara Molina|+34 93 531 63 00|Evelin.Lara@ivi.es|27503
308299|NCT02567656|Rhizen Pharmaceuticals S.A.|Prajak Barde MD|+41 32 580 0113|pjb@rhizen.com|
308300|NCT02567708|GlaxoSmithKline|GSK Response Center|866-435-7343||
308301|NCT02567968|University of Chicago|Aaron Fox, PhD|7737020021|aaronfox@uchicago.edu|
308302|NCT02568046|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
308303|NCT02568072|St George's, University of London|Dr Andrew D'Silva|020 7188 7188|adsilva@nhs.net|51554
308304|NCT02568254|Johnson & Johnson Vision Care Inc.|Chantal Coles-Brennan BSc, OD, FAAOPrincipal Research Optometrist|904 443 3449|CColesb@ITS.JNJ.com|
308305|NCT02568345|Central Hospital, Irmandade da Santa Casa de Misericórdia (ISCM)|Mauro Prado da Silva|+55 11 2176 7000|comissaocientifica@fcmsantacasasp.edu.br|
308306|NCT02568384|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
308307|NCT02568397|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
308308|NCT02568475|Florida Atlantic University|Ruth M. Tappen, Principal Investigator|561-297-2613|rtappen@health.fau.edu|
296643|NCT01697358|Medtronic Restorative Therapies Group - Pain Stim|Restorative Therapies Group Clinical Trials||medtronicneurotrials@medtronic.com|
296644|NCT01697449|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
296645|NCT01697462|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
296646|NCT01697501|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
296647|NCT01697579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
296648|NCT01697592|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308309|NCT02568644|Universidade Federal de Minas Gerias|Dr. Antonio Lucio Teixeira||altexr@gmail.com|
308310|NCT02568683|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
271975|NCT00281671|Ann & Robert H. Lurie Children's Hospital of Chicago|John M. Costello, MD MPH|312 227 1551|jmcostello@luriechildrens.org|
271976|NCT00281684|GlaxoSmithKline|GSK Response Center|866-435-7343||
308311|NCT02568852|Haseki-156|Dr.Turgut Donmez|00905347400967|surgeont73@hotmail.com|
271977|NCT00281697|Genentech, Inc.|Medical Communications|800 821-8590||
308312|NCT02569086|Aarhus University Hospital, Department of infectious diseases|Dr. Kristina Öbrink-Hansen|+45|krisoebr@rm.dk|78452845
296649|NCT01697696|Novartis Pharmaceuticals|Study Director|862-778-8300||
296650|NCT01697709|NYSPI|john mariani. MD|212-923-3031|John.mariani@nyspi.columbia.edu|
296651|NCT01697748|University of South Florida|Dr Sheila Connery, Associate Professor Obstetrics and Gynecology|813-259-8542|sconnery@health.usf.edu|
296652|NCT01697956|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
296653|NCT01697969|Alcon Research, Ltd.|Danyel Crout Carr, MS, CCRA|1-888-451-3937|alcon.medinfo@alcon.com|
296654|NCT01698008|University of Nebraska Medical Center|Whitney Goldner, MD|402-559-3579|wgoldner@unmc.edu|
296655|NCT01698268|Beaumont Health|Kaveh Aslani, MD|248-898-81905|kaslani@beaumont.org|
296656|NCT01698320|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
296657|NCT01698333|Therapeutics Inc.|Clinical Research|858-571-1800|clinicalresearch@therapeuticsinc.com|
271326|NCT00224770|Johns Hopkins University|Dr. Daniel F. Hanley|(410) 614-6996|dhanley@jhmi.edu|
271327|NCT00224874|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
271328|NCT00224887|Stanford University|Dr. Donna Matheson|650-723-5895|donna.matheson@stanford.edu|
271978|NCT00281827|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
271979|NCT00281840|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Panayiotis Savvides, MD|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
271329|NCT00224952|The Children's Mercy Hospital|J. Steven Leeder Pharm D, PhD|816-234-3059|sleeder@cmh.edu|
271330|NCT00225017|Northwestern University|Robert Murphy|312-503-9000|r-murphy@northwestern.edu|
271331|NCT00225147|Pharming Technologies BV|Medical Affairs Department|+31715247400|medicalinfo@pharming.com|
271332|NCT00225212|Stanford University Medical Center|Neal Birkett, MS, RAC|650-723-6456|nbirkett@stanford.edu|
271333|NCT00225251|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
271334|NCT00225277|Takeda Global Research and Development Center Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
271335|NCT00225420|Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
271336|NCT00225498|Feinstein Institute for Medical Research, Zucker Hillside Hospital|Anil K. Malhotra, MD|718-470-8012|malhotra@lij.edu|
271337|NCT00225732|Cumberland Pharmaceuticals Inc.|Amy Rock, Ph.D.|615-255-0068|arock@cumberlandpharma.com|
271338|NCT00225758|Dartmouth-Hitchcock Medical Center|Gary N. Schwartz, MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
271339|NCT00225784|Dartmouth-Hitchcock|J. Marc Pipas, MD|603-650-9474|J.Marc.Pipas@hitchcock.org|
271340|NCT00226239|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
271341|NCT00226499|GlaxoSmithKline|GSK Response Center|866-435-7343||
271342|NCT00226577|Karmanos Cancer Institute|Gerold Bepler, M.D., Ph.D. via Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
271343|NCT00226590|Karmanos Cancer Institute (formerly at Moffitt Cancer Center)|Gerald Bepler, M.D., Ph.D., c/o Moffitt Cancer Center|813-745-4398|beplerg@karmanos.org|
271344|NCT00226655|Celtic Pharma Development Services America Inc|Director Medical Sciences|(212) 616 4016|henk-andre.kroon@dev.celticpharma.com|
271345|NCT00226811|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
271346|NCT00226941|Stanford Cancer Institute, Stanford University|George Albert Fisher, Jr, MD, PhD; Colleen Haas Chair, School of Medicine|650-723-2990|georgeaf@stanford.edu|
271347|NCT00227019|Stanford University|Heather Wakelee, MD|650-736-7221|hwakelee@stanford.edu|
271348|NCT00227266|University of Utah|Sandra Reyna, M.D.|801-581-3551|sreyna@genetics.utah.edu|
271349|NCT00227305|AstraZeneca|Seroquel Medical Science Director, MD||AZTrial_Results_Posting@astrazeneca.com|
271350|NCT00227344|Biosense Webster, Inc.|Pat Ticknor, Clinical Operations|909-839-8500|PTicknor@its.jnj.com|
271351|NCT00227370|Duke Clinical Research Institute|Scott M. Palmer, MD, MHS|919 684 0254|scott.palmer@duke.edu|
271352|NCT00227539|University of Washington|Renato G. Martins|206-288-6680|rgmart@uw.edu|
271353|NCT00227591|ECOG Statistical Office|Study Statistician|617-632-3012||
271354|NCT00227617|UCSF Helen Diller Family Comprehensive Cancer Center|Dr. Emily Bergsland|415-885-7810|Emily.Bergsland@ucsf.edu|
271355|NCT00227721|Barbara Ann Karmanos Cancer Institute|Robert Morris, M.D.|313-576-9436|rmorris@med.wayne.edu|
271356|NCT00227760|Princess Margaret Cancer Centre - University Health Network|Dr. Srikala Sridhar|416-946-2249|srikala.sridhar@uhn.ca|
271357|NCT00227877|Boston Children's Hospital - Center for Adolescent Substance Use and Addiction Research|Sion Kim Harris, PhD|857-218-4304|sion.harris@childrens.harvard.edu|
271358|NCT00227903|Yale University|Dr. Kimberly Yonkers|1-203-764-6621|Kimberly.Yonkers@yale.edu|
271359|NCT00227994|Washington University School of Medicine|Eric Lenze|314-362-1671|lenzee@wustl.edu|
296658|NCT01698463|University of Waterloo|Dr. Lora Giangregorio|(519) 888-4567|lmgiangr@uwaterloo.ca|36357
296659|NCT01698502|University of Copenhagen|Michael Lund|+45 3532 7519|michaeltl@sund.ku.dk|
296660|NCT01698528|Joslin Diabetes Center|Dr William Hsu|617-309-5803|william.hsu@joslin.harvard.edu|
296661|NCT01698554|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
296662|NCT01698684|Vivus, Inc.|Wesley W Day, PhD|650-934-5200||
271980|NCT00281918|Hoffmann-LaRoche|Medical Communications|800-821-8590||
296663|NCT01698710|Massachusetts General Hospital|Dr. William Brugge|6173083532|Brugge.William@mgh.harvard.edu|
296664|NCT01698775|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
296665|NCT01698801|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
296666|NCT01698814|Alcon Research, Ltd.|Terri Pasquine, Sr. Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
296667|NCT01698879|CETLAM|Dr. Jordi Sierra|+34 93 434 44 12|jsierra@santpau.cat|
296668|NCT01698905|Novartis|Study Director|862-778-8300|novartis.email@novartis.com|
308313|NCT02569112|Venus Concept Ltd.|Dr. Yoni Iger|8889070115|yoni@venusconcept.com|
308314|NCT02569398|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
271981|NCT00281957|SWOG Statistical Office|SWOG melanoma statistician|206-667-4408||
271982|NCT00282048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271983|NCT00282087|SARC|Research Project Manager|(734) 930-7600|sarc@sarctrials.org|
271984|NCT00282113|University of California Davis|Mark A. Underwood MD|916-734-5061|mark.underwood@ucdmc.ucdavis.edu|
271985|NCT00282152|Vanderbilt University Medical Center|David Charles, MD||david.charles@Vanderbilt.Edu|
271986|NCT00282243|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
271987|NCT00282256|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
271988|NCT00282282|Dana-Farber Cancer Institute|Vincent T. Ho, MD Associate Professor of Medicine, Harvard Medical School|(617) 632-5938|vincent_ho@dfci.harvard.edu|
271989|NCT00282295|GlaxoSmithKline|GSK Response Center|866-435-7343||
271990|NCT00282308|Genentech, Inc.|Medical Communications|800 821-8590||
271360|NCT00228384|W. L. Gore & Associates, Inc.|Chad Badorek|800/437-8181|cbadorek@wlgore.com|
271361|NCT00228423|University Of Ottawa Heart Institute|Dr. Marc Ruel||mruel@ottawaheart.ca|
271362|NCT00228553|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
271363|NCT00228566|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
271364|NCT00228813|Emory University|Kuang-Yueh Chiang, MD|404-785-0858|kchian2@emory.edu|
271365|NCT00228917|GlaxoSmithKline|GSK Response Center|866-435-7343||
271366|NCT00228943|Indiana University|Janet S. Carpenter|317-278-6093|carpentj@iupui.edu|
271367|NCT00229203|PharmaMar USA Inc|Claudia Silvia Corrado M.D.|1 212 201 6770|cscorrado@pharmamar.com|
271368|NCT00229619|NIH National Heart, Lung and Blood Institute|Adrian Wiestner MD, NHLBI|301-594-6855|wiestnera@nhlbi.nih.gov|
271369|NCT00229658|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
271370|NCT00229723|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
271371|NCT00229957|McMaster University|Dr. Julie Richardson|905-525-9140|jrichard@mcmaster.ca|27811
271372|NCT00230009|Wayne State University|Steven J. Ondersma, ,PI|313-577-6680|s.ondersma@wayne.edu|
271373|NCT00230022|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
271374|NCT00230048|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
271375|NCT00230100|McLean Hospital|Shelly F. Greenfield, MD, MPH|617-855-2241|sgreenfield@mclean.harvard.edu|
271376|NCT00230126|The Ohio State University|Miguel Villalona|614-366-5068|miguel.villalona@osumc.edu|
271377|NCT00230178|Sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
271991|NCT00282334|Dept. of Medical Research, Holstebro Hospital|Line Bille Madsen|+45 99125421|linemads@rm.dk|
271992|NCT00282347|Genentech, Inc.|Medical Communications|800-821-8590||
271993|NCT00282412|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
271994|NCT00282438|Northwestern University|Dr Richard Burt, Chief, Division of Immunotherapy, Department of Medicine|312-695-4960|rburt@northwestern.edu|
271995|NCT00282464|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
271996|NCT00282568|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
271997|NCT00282672|University of north Carolina|Nicholas Shaheen|(919) 966-7047|nshaheen@med.unc.edu|
271998|NCT00282815|University of Michigan|Devin Brown, MD|734-936-9075|devinb@umich.edu|
271999|NCT00282828|Rush University Medical Center|Mark Pollack, M.D.|312-942-5372|mark_pollack@rush.edu|
272000|NCT00282841|University of California San Diego|Thilo Hoelscher, MD|619-543-5251|thoelscher@ucsd.edu|
272001|NCT00282919|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272002|NCT00282971|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
272003|NCT00282984|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
272004|NCT00283049|sanofi-aventis|Medical Affairs study director||publicregistryUSMA@sanofi-aventis.com|
272005|NCT00283062|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
272006|NCT00283075|The Rogosin Institute|Dr. Barry H. Smith, CEO|212-746-1551|bas2005@nyp.org|
272007|NCT00283244|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
272008|NCT00283283|Walter Reed National Vaccine Healthcare Center Network|COL Renata J. M. Engler, MD|202-782-9461|renata.engler@na.amedd.army.mil|8819
296669|NCT01699022|SPARC|Dr. Shravanti Bhowmik|02266455645|shravanti.bhowmik@sparcmail.com|5626
296670|NCT01699087|Alcon, A Novartis Division|Expert Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
296671|NCT01699178|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
296672|NCT01699373|Changi General Hospital|Dr Lim Yean Chin|+65 68503831|yean_chin_lim@cgh.com.sg|
296673|NCT01699503|Indiana University|Dr. Nicole Fowler|317-274-9021|fowlern@iupui.edu|
296674|NCT01699542|Boston Scientific Corporation|Joyce Peetermans, PhD - Vice President, Global Clinical Programs|508-683-4211|Joyce.Peetermans@bsci.com|
296675|NCT01699607|Yale|Dr. Kelly Cosgrove, Ph.D.|203-737-6969|kelly.cosgrove@yale.edu|
272009|NCT00283296|Human Engineering Research Laboratories|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
272010|NCT00283387|Mayo Clinic|Dr. Dawn S. Milliner|507-284-7431|milliner.dawn@mayo.edu|
272011|NCT00283400|Baylor College of Medicine|Jose I Suarez, MD, Professor of Neurology|713-798-8472|jisuarez@bcm.edu|
272012|NCT00283439|Amgen Inc.|Study Director|866-572-6436||
272013|NCT00283504|CHILDREN'S HOSPITAL OF THE KING'S DAUGHTERS|MARIPAZ MORALES MD|7576688255|MARIPAZ.MORALES@CHKD.ORG|
272014|NCT00283595|Massachusetts General Hospital|Anne Klibanski, MD|617-726-3870|aklibanski@partners.org|
296676|NCT01699685|Novartis Pharmaceuticals|Study Director|862-778-8300||
296677|NCT01699698|Kyushu University|Dr. Taketo Matsunaga|092-642-5444|mtaketo@surg1.med.kyushu-u.ac.jp|
308315|NCT02569411|St. Michael's Hospital|Dr. Areti Angeliki Veroniki|416-360-4000|averonik@cc.uoi.gr|
308316|NCT02569437|Icahn School of Medicine at Mount Sinai|Dr. Benjamin Malkin||Benjamin.D.Malkin@kp.org|
308317|NCT02569476|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
308318|NCT02569541|Arrevus, Inc.|Carl Kraus, MD (CEO)|9193665503|ckraus@arrevus.com|
308319|NCT02569632|Children's Hospital Oakland Research Institute (CHORI)|Dan Granoff, MD (Principal Investigator)|510-428-3000|dgranoff@chori.org|7640
271378|NCT00230282|Stanford University|Steven E. Coutre, Associate Professor of Medicine|650-723-6661|coutre@stanford.edu|
271379|NCT00230737|University of Pennsylvania|Dr. Nalaka Gooneratne|2674083789|ngoonera@upenn.edu|
271380|NCT00230802|Brigham & Women's Hospital|Erik Alexander, MD|6177325666|ekalexander@partners.org|
271381|NCT00230971|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
271382|NCT00231062|Acclarent|Laura England, Manager-Clinical Affairs|650-687-4466|lenglan1@its.jnj.com|
271383|NCT00231114|Asthmatx, Inc.|Narinder S Shargill, PhD|408-419-0100||
271384|NCT00231179|Children's Hospital of Philadelphia|Jerilynn Radcliffe, PhD|215-590-7446|Radcliffe@email.chop.edu|
271385|NCT00231283|Cordis|Sidney Cohen, MD PhD, Vice President|650 614-2726|scohen7@its.jnj.com|
271386|NCT00231309|Emory University|Kuang-Yueh Chiang, MD|404-785-1441|kuang-yueh.chiang@choa.org|
271387|NCT00231413|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
271388|NCT00231465|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
271389|NCT00231478|Hoffman-LaRoche|Medical Communications|800-821-8590||
296678|NCT01699750|Alcon Research, Ltd.|Jessie Lemp, DrPH|1-888-451-3937|alcon.medinfo@alcon.com|
296679|NCT01699763|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
296680|NCT01699789|RAND Corporation|Kenneth B. Wells|310-794-3728|kwells@mednet.ucla.edu|
296681|NCT01699815|Duke University School of Nursing|Virginia C. Muckler|919-684-9307|chris.muckler@duke.edu|
271390|NCT00231777|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
271391|NCT00231816|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
271392|NCT00231842|Montefiore Medical Center|Mark Einstein, MD, MS|718-405-8082|meinstei@montefiore.org|
271393|NCT00231868|Montefiore Medical Center|Dr. Dennis Yi-Shin Kuo|718-405-8082|DYKUO@montefiore.org|
271394|NCT00231894|Nathan Kline Institute ofr Psychiatric research|Robert C. Smith MD|845-398-6531|rsmith@nki.rfmh.org|
271395|NCT00232180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271396|NCT00232479|UMiami|Judith Hurley|305-243-6698|jhurley@miami.edu|
271397|NCT00232505|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
271398|NCT00232544|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
271399|NCT00232557|VA Boston Healthcare System|Dr. David Sparrow|857-364-6407|david.sparrow@va.gov|
271400|NCT00232583|UT Southwestern Medical Center|Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
271401|NCT00232596|GlaxoSmithKline|GSK Response Center|866-435-7343||
271402|NCT00232739|Cordis|Sidney Cohen, MD PhD, Vice President|650 614-2726|scohen7@its.jnj.com|
271403|NCT00233064|MedImmune, LLC|Hasan S. Jafri, MD|301-398-0000||
271404|NCT00233103|Icahn School of Medicine at Mount Sinai|Wayne A Gordon, PhD|212-659-9372|wayne.gordon@mssm.edu|
271405|NCT00233324|University of Alabama|Waldemar A. Carlo, M.D|(205) 934-4680|wcarlo@peds.uab.edu|
271406|NCT00233363|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
271407|NCT00233389|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
271408|NCT00233402|Photocure|Yngvil Kloster Thomas|+1 2167732505|ykt@photocure.no|
271409|NCT00233454|Stanford University Medical Center|Jason R Gotlib, MD, Associate Professor of Medicine (Hematology)|650-867-2823|jason.gotlib@stanford.edu|
271410|NCT00233480|Ahmanson-UCLA Cardiomyopathy Center|Tamara B Horwich, MD|310-825-8676|thorwich@mednet.ucla.edu|
271411|NCT00233519|University of Rochester Medical Center|Richard T. Moxley, III MD|585-275-5006|RichardT_Moxley@urmc.rochester.edu|
271412|NCT00233948|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
271413|NCT00233987|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
271414|NCT00234039|SWOG Statistical Center|Study Statistician|206-667-4623||
271415|NCT00234052|Northwestern University|Clinical Trials Office|312-695-1301||
271416|NCT00234065|Department of Clinical Research and Development, Otsuka Pharmaceutical Co., Ltd.|Masahiko Abe, Director Cardiovascular Projects|+81-6-6943-7722|abems@otsuka.jp|2545
271417|NCT00234078|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
271418|NCT00234104|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
271419|NCT00234286|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
271420|NCT00234494|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
271421|NCT00234533|Ipsen|Medical Director, Pediatric Endocrinology||clinical.trials@ipsen.com|
271422|NCT00234832|Abbott|Global Medical Services|800-633-9110||
271423|NCT00234884|Abbott|Global Medical Services|1-800-633-9110||
271424|NCT00235391|Novartis Pharmaceuticals|Study Director|862-778-8300||
296682|NCT01699867|Johns Hopkins Medicine|Lisa K. Jacobs, M.D.|410-502-0880|ljacob14@jhmi.edu|
296683|NCT01700036|University of Michigan Cancer Center|Dr. Pavan Reddy, MD|734-936-8785|reddypr@umich.edu|
296684|NCT01700049|Mayo Clinic|Dr. Scott Fosko|904-953-2303|fosko.scott@mayo.edu|
296685|NCT01700140|SymBio Pharmaceuticals|Nobuyuki Koseki|+81-3-5472-1127||
296686|NCT01700179|Achillion Pharmaceuticals|Kevin Kucharski, VP of Clinical Operations|203-624-7000|Kkucharski@achillion.com|
296687|NCT01700192|Merck Sharp & Dohme Corp.|Senior Vice President, Global Corporate Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
296688|NCT01700205|Monell Chemical Senses Center|Julia A. Mennella, PhD|267-519-4880|mennella@monell.org|
296689|NCT01700335|None|Director of Clinical Trials|+81-3-5472-1127|kgoto.34@symbiopharma.com|
296690|NCT01700387|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-883-7889|rcady@banyangroupinc.com|
296691|NCT01700439|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
296692|NCT01700517|Madre Teresa´s Hospital|Dr Lucio Honorio de Carvalho Júnior|+55 31 33398000|luciohcj@gmail.com|
308320|NCT02569658|Rush University Medical Center|Yale Fillingham|3095310220|yale.fillingham@gmail.com|
272015|NCT00283686|Emory University|Dr. Arlene Chapman|(404) 712-1993|abchapm@emory.edu|
272016|NCT00283712|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
272017|NCT00283803|University of Washington|Dr. Celestia Higano, MD|206-606-1187|mjcampbe@seattlecca.org|
296693|NCT01700530|University of Missouri|John P. Thyfault, PhD|573-874-9728|thyfaultj@missouri.edu|
296694|NCT01700621|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
296695|NCT01700673|Johns Hopkins University School of Medicine, Division of Hematologic Malignancies|Jonathan Webster, MD|4106149106|jwebst17@jhmi.edu|
296696|NCT01700725|University of Wisconsin - Madison|David Rabago, MD|608-843-0850|david.rabago@fammed.wisc.edu|
296697|NCT01700816|Massachusetts General Hospital|Carlos Fernandez Robles MD|6176432410|cfernandez-robles@mgh.harvard.edu|
296698|NCT01700829|NY State Psychiatric Institute-Columbia University Medical Center|Michael Grunebaum, MD|646-774-7573|michael.grunebaum@nyspi.columbia.edu|
296699|NCT01700907|Sapporo Medical University School of Medicine|Michiaki Yamakage|+81116112111|yamakage@sapmed.ac.jp|3568
296700|NCT01700959|St. Jude Children's Research Hospital|Tara M. Brinkman, PhD|(901) 595-5683|tara.brinkman@stjude.org|
296701|NCT01700985|Therapeutics Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
271425|NCT00235443|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
308321|NCT02569710|Alios BioPharma, Inc|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
308322|NCT02569723|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
271426|NCT00235456|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
271427|NCT00235495|University of Miami|Dr. Myron D. Ginsberg|305-243-6103|MGinsberg@med.miami.edu|
271428|NCT00235547|University of Washington|Dr. Sarah Prager|415-206-8715|pragers@uw.edu|
271429|NCT00235573|University of Florida|Gail Kauwell|352-392-1991|gkauwell@ufl.edu|227
271430|NCT00235716|Dept. of Veterans Affairs Cooperative Stduies Program|Peter Guarino, PhD, Director WH-CSPCC|203-932-5711|peter.guarino@va.gov|3780
271431|NCT00235755|GlaxoSmithKline|GSK Response Center|866-435-7343||
271432|NCT00235833|Abbott|Medical Information Specialist|800-633-9110||
271433|NCT00235872|Abbott|Global Medical Services|800-633-9110||
271434|NCT00235989|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
271435|NCT00236080|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
271436|NCT00236184|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
271437|NCT00236197|Eisai Medical Research Inc.|Yufang Lu, MD, PhD, Study Director|201-403-2500||
271438|NCT00236899|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
271439|NCT00236938|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
271440|NCT00236951|Luitpold Pharmaceuticals|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
271441|NCT00236977|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
271442|NCT00237042|University of Washington|Dr. Judith Turner|206-543-3997|jturner@u.washington.edu|
271443|NCT00237185|Novartis|Study Director|862-778-8300||
271444|NCT00237458|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
271445|NCT00237666|The Medical Research Network, LLC|Dr. Michael Liebowitz|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com|
271446|NCT00237692|Center for Primary Care, HSRD COIN|Hayden B. Bosworth, PhD|919-286-0411|hayden.bosworth@va.gov|7107
271447|NCT00237718|Vanderbilt University|T. Alp Ikizler, MD||alp.ikizler@vanderbilt.edu|
271448|NCT00237744|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|(352) 376-1611|jjd17@case.edu|6603
271449|NCT00237770|James J Peters VA Medical Center|Dr. Jill M. Wecht, principal Investigator|718 584-9000|jm.wecht@va.gov|3122
271450|NCT00237796|VA San Diego Healthcare System, San Diego|Eric Granholm, PhD|858-552-8585|egranholm@ucsd.edu|7768
271451|NCT00237809|Yale University|Dr. Deepak Cyril D'Souza|203-932-5711|deepak.dsouza@yale.edu|2594
271452|NCT00238108|Brigham and Women's Hospital|Dr. Frank Scheer|617-732-7014|fscheer@rics.bwh.harvard.edu|
271453|NCT00238121|University of Chicago Comprehensive Cancer Center|Dr. Gini Fleming|773-702-6712|gfleming@medicine.bsd.uchicago.edu|
271454|NCT00238238|Meyer Cancer Center, Weill Cornell Medical College|John P Leonard, M.D.||jpleonar@med.cornell.edu|
271455|NCT00238264|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
271456|NCT00238303|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-3902|galanis.evanthia@mayo.edu|
271457|NCT00238355|OHSU Knight Cancer Institute|Dr. Lynne Strasfeld|503-494-1551|strasfel@ohsu.edu|
271458|NCT00238433|Oregon Health & Science University|Richard Maziarz, MD|503-494-6365|maziarzr@ohsu.edu|
271459|NCT00238615|Stanford University|Dr. Heather Wakelee|650-736-7221|hwakelee@stanford.edu|
271460|NCT00239005|Novartis Pharmaceuticals|Study Director|862-778-8300||
271461|NCT00239226|Medtronic BRC - Medtronic Italia SpA|Giorgio Corbucci - Sr Principal Scientist|+39 02 241371|giovanna.zucchi@medtronic.com|
271462|NCT00239356|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
271463|NCT00239577|GlaxoSmithKline|GSK Response Center|866-435-7343||
271464|NCT00239590|Imperial College London|Dr Carolyn Webb|03301288860|c.webb@imperial.ac.uk|
271465|NCT00239642|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|601-650-4200|mfalone@luitpold.com|
271466|NCT00239681|AstraZeneca|Torbjorn Lundstrom||ClinicalTrialTransparency@astrazeneca.com|
296702|NCT01701011|UMCU|Henrietta Ockhuijsen 1,*, Agnes van den Hoogen, Marinus Eijkemans , Nick Macklon, Jacky Boivin|+31307553628|h.d.l.ockhuysen@umcutrecht.nl|
296703|NCT01701024|Exec Dir Clinical Dir|Johnson Varughese|908-927-1162|johnson.varughese@valeant.com|
296704|NCT01701037|Vanderbilt-Ingram Cancer Center|Mark C. Kelley|615-936-7423|mark.kelley@vanderbilt.edu|
296705|NCT01701063|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
296706|NCT01701102|Hospital for Special Surgery|Jennifer Cheng|212-774-7377|chengj@hss.edu|
296707|NCT01701115|HSS|Dr. Daniel Maalouf|(212) 606-1000|MaaloufD@HSS.EDU|
296708|NCT01701193|University of Saskatchewan|Roger Pierson, PhD|306-884-1059|roger.pierson@usask.ca|
296709|NCT01701245|electroCore LLC|Annelie Andersson|+46 721 803076|annelie.andersson@electrocorellc.com|
296710|NCT01701258|McLean Hospital|Diego Pizzagalli, Ph.D.|617-855-4230|dap@mclean.harvard.edu|
272018|NCT00283816|University of Rochester Medical Center|Kathleen M. Hoeger, MD, MPH|585-275-7891|Kathy_Hoeger@urmc.rochester.edu|
272019|NCT00283842|Wyeth|U.S. Contact Center||clintrialresults@wyeth.com|
272020|NCT00283933|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
272021|NCT00284050|Novartis Pharmaceuticals|Study Director|862 778-8300||
272022|NCT00284089|Novartis Pharmaceuticals|Study Director|862 778-8300||
272023|NCT00284141|Sanofi|Trial Transparency Team||Contact-Us@Sanofi.com|
296711|NCT01701271|Bio Basic Europe|Prof. Fulvio Marzatico|(39) 0382 - 506390|fulviomk@unipv.it|
271467|NCT00239733|Weill Cornell|Kristen Marks|212-746-4177|markskr@med.cornell.edu|
271468|NCT00239837|University of Oregon|Dr Leslie Leve|541-346-9528|leve@uoregon.edu|
271469|NCT00239928|Pfizer, Inc.|Pfizer Clinical Trails.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
271470|NCT00240071|University of Alabama at Birmingham|Carla I Falkson|205-975-2691|cfalkson@uab.edu|
271471|NCT00240097|UAB|Dr. Francisco Robert|205-934-5077|pacorobertuab@cs.com|
271472|NCT00240110|Univeristy of Miami|Dr. Ihsan Salloum|305-243-7931|isalloum@med.miami.edu|
271473|NCT00240162|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
271474|NCT00240331|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
271475|NCT00240487|The Children's Hospital of Philadelphia|Richard Lin|2155905505|linr@email.chop.edu|
271476|NCT00240526|GlaxoSmithKline|GSK Response Center|866-435-7343||
271477|NCT00240539|GlaxoSmithKline|GSK Response Center|866-435-7343||
296712|NCT01701362|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308323|NCT02569801|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
271478|NCT00240981|Brigham & Women's Hospital|Dr. Shalender Bhasin|617-525-9150|sbhasin@partners.org|
271479|NCT00240994|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
271480|NCT00241176|NYU School of Medicine, NYU Child Study Center|Barbara J Coffey, M.D, M.S.|(212)263-3926|barbara.coffey@mssm.edu|
271481|NCT00241280|Johnson & Johnson Vision Care, Inc.|David C. Turner, Ph.D. GLOBAL PLATFORM SR DIRECTOR, R&D|904-443-3500|DTURNER2@its.jnj.com|3479
271482|NCT00241358|Washington University School of Medicine|John F. DiPersio, M.D., Ph.D.|314-454-8603|jdipersi@wustl.edu|
271483|NCT00241631|Imperial College London|Ian M Adcock|+44 (0)20 7594 7840|ian.adcock@imperial.ac.uk|
271484|NCT00241644|GlaxoSmithKline|GSK Response Center|866-435-7343||
272024|NCT00284154|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
272025|NCT00284180|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
272026|NCT00284518|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
272027|NCT00284557|Emory University|Anne L. Dunlop, MD, MPH|404-712-8520|amlang@emory.edu|
272028|NCT00284739|Kaiser Permanente|Hyo-Chun Yoon, MD,PHD|8084327342|Hyo-Chun.Yoon@nsmtp.kp.org|
272029|NCT00284934|Novartis Pharmaceuticals|Study Director|862-778-8300||
272030|NCT00285012|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
296713|NCT01701375|Johns Hopkins University|Ivana Gojo, MD|410-502-7726|Igojo1@jhmi.edu|
271485|NCT00241839|University of Florida|Mark S. Segal, MD, PhD; Assistant Professor and Chief, Division of Nephrology|352-273-8821|Mark.Segal@medicine.ufl.edu|
271486|NCT00241904|Johns Hopkins University|Dr. Jerilyn Allen|410-614-4882|jallen1@jhu.edu|
271487|NCT00241969|Cincinnati Children's Hospital Medical Center|Scott Powers, PhD|513-636-8106|scott.powers@cchmc.org|
271488|NCT00242216|The University of Texas Health Science Center at Houston|Dr. Roberto C. Arduino, Professor of Medicine|713-500-6731|roberto.c.arduino@uth.tmc.edu|
271489|NCT00242385|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
271490|NCT00242502|University of Texas MD Anderson Cancer Center|Ahmed Kaseb, MD/ Professor||MJLim@mdanderson.org|
271491|NCT00242567|Novartis Pharmaceuticals|Study Director|862-778-8300||
271492|NCT00242580|Novartis Pharmaceuticals|Study Director|862 778-8300||
271493|NCT00242619|Stanford University|Dr. Natalie Rasgon|(650) 724-6689|natalie.rasgon@stanford.edu|
271494|NCT00242632|Stanford University|Dr. Natalie Rasgon|(650) 724-6689|natalie.rasgon@stanford.edu|
271495|NCT00242658|Penn State Milton S. Hershey Medical Center|Chris Sciamanna, MD, MPH|717-531-8161|cns10@psu.edu|
271496|NCT00242684|Central Arkansas Veterans Healthcare System|Melinda Bopp, Project Coordinator|501-257-2045|melinda.bopp@va.gov|
271497|NCT00242710|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271498|NCT00243022|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Glen Stevens||steveng@ccf.org|
271499|NCT00243061|Juravinski Cancer Centre|Dr. Elaine McWhirter|905-387-9495|elaine.mcwhirter@hrcc.on.ca|67559
271500|NCT00243074|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|jmoon@fredhutch.org|
271501|NCT00243152|Boston Children's Hospital|Dr. David Borsook|617-281-7135|david.borsook@childrens.harvard.edu|
271502|NCT00243191|SARC|SARC, Chief Operating Officer|734-930-7600|sarc@sarctrials.org|
271503|NCT00243230|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
271504|NCT00243243|US Army Institute of Surgical Research|David G. Baer, PhD, Director Research|210-539-4327|david.g.baer@us.army.mil|
271505|NCT00243269|University of Rochester|Joseph Roscoe PhD|585 275-9962|joseph_roscoe@urmc.rochester.edu|
271506|NCT00243347|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
271507|NCT00243386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
271508|NCT00243412|Hoffman-LaRoche|Medical Communications|800-821-8590||
271509|NCT00243503|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271510|NCT00243659|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
271511|NCT00243841|Indiana University|Amy Miller Research Manager|317 944 1242|amym@iu.edu|
271512|NCT00243919|Duke University|Pamela W. Duncan, PT, PhD, FAHA, FAPTA|919-681-2060|pamela.duncan@duke.edu|
271513|NCT00243932|Columbia University|Petra Kaufmann, MD, MSc|(212) 342-1252|pk88@columbia.edu|
272031|NCT00285207|TigrisPharmaceuticals|Chief Medical Officer||info@tigrispharma.com|
296714|NCT01701401|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
296715|NCT01701414|Dept of Emergency Medicine, Rhode Island Hospital|Francesca Beaudoin MD, MS|401-444-2577|fbeaudoin@lifespan.org|
296716|NCT01701505|Big Grins Pediatric Dentistry|Dr. Gregory D. Evans, DDS|970-407-1020|greg@biggrinswithdrgreg.com|
296717|NCT01701973|Vanderbilt University Medical Center|Dr. Jessica Devin|6159361665|jessica.devin@vanderbilt.edu|
308324|NCT02569853|Dr. Reddy's|Director, Clinical Development|609-375-9900|ebrandschieber@drreddys.com|
308325|NCT02569892|Stanford University School of Medicine|Steven Sanislo, MD|650-723-6995|ssanislo@stanford.edu|
308326|NCT02569996|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
308327|NCT02570022|Henry Ford Hospital|Dr. Kelechi Okoroha|8324239895|krokoroha@gmail.com|
308328|NCT02570074|University of Illinois at Chicago|Keith A. Rodvold, PharmD, FCCP, FIDSA|312-996-3341|kar@uic.edu|
308329|NCT02570126|GlaxoSmithKline|GSK Response Center|866-435-7343||
282676|NCT00867503|University Of Arizona|Dr. Setsuko K Chambers|520/626-0950|schambers@azcc.arizona.edu|
308330|NCT02570139|3M Critical and Chronic Care Solutions Division|Anne Swearingen, Manager, Clinical Operations|651 736 7826|aswearingen@mmm.com|
272032|NCT00285246|Edith Nourse Rogers Memorial VA Hospital|Karen S. Quigley, Ph.D., Research Physiologist|781-687-2273|karen.quigley@va.gov|
272033|NCT00285467|Indiana University School of Medicine|Sharon Moe, MD|317-278-2868|smoe@iupui.edu|
272034|NCT00285584|NYU School of Medicine|Michael Marmor, Ph.D.|212-263-6667|michael.marmor@nyumc.org|
282677|NCT00867529|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
296718|NCT01701999|California Department of Public Health|Dr. Jessica Khouri|510-231-7600|Jessica.Khouri@cdph.ca.gov|
308331|NCT02570152|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupport@gsk.com|
308332|NCT02570165|GlaxoSmithKline|GSK Response Center|866-435-7343||
308333|NCT02570295|Swiss Federal Institute of Sport Magglingen SFISM|Dr. Thomas Wyss|+41 58 467 64 16|thomas.wyss@baspo.admin.ch|
308334|NCT02570308|Immunocore, Ltd|Study Director|484-534-5261|clinicaltrials@immunocore.com|
308335|NCT02570425|Sydney Medical School, University of Sydney & Woolcock Institute of Medical Research|Assoc Prof Sinthia Bosnic-Anticevich|+61 2 9114 0040|sinthia.bosnic-anticevich@sydney.edu.au|
308336|NCT02570711|Acerta Pharma, LLC|Priti Patel, MD, Vice President - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
308337|NCT02570750|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308338|NCT02571049|Dr. Reddy's|Director of Clinical Development|609-375-9900|cfritz@drreddys.com|
308339|NCT02571075|Womack Army Medical Center|Anthony Plunkett|910-643-2324|anthony.r.plunkett.civ@mail.mil|
271514|NCT00244101|Vermont Oxford Network|Roger F. Soll, MD|802 865 4814|roger.soll@vtmednet.org|212
271515|NCT00244140|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
272035|NCT00285649|Palmer College of Chiropractic|Ting Xia, PhD (Principal Investigator)|563-884-5161|Ting.Xia@palmer.edu|
272036|NCT00285779|Stanford University Department of Dermatology|David Fiorentino|650-723-6316|fiorentino@stanford.edu|
272037|NCT00285818|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
272038|NCT00285857|Stanford University|James M. Ford|(650) 498-6689|jmf@stanford.edu|
272039|NCT00286078|Boston Scientific|Clinical Research Information|855-213-9890|BSNClinicalTrials@bsci.com|
272040|NCT00286091|Amgen Inc.|Study Director|866-572-6436||
272041|NCT00286156|Cleveland Clinic|Dr William Braun Consultant Staff Nephrology, Cleveland Clinic|216/444/6995|braunw@ccf.org|
272042|NCT00286182|Columbia University|Mathew Maurer, MD, Professor of Medicine at the Columbia University Medical Center|212-305-9808|msm10@cumc.columbia.edu|
272043|NCT00286221|Johns Hopkins School of Medicine|Dr. Bradford Winters|4109559080|bwinter1@jh.edu|
272044|NCT00286234|Sanford School of Medicine, University of South Dakota|Dr. William Harris|16052716917|bill@omegaquant.com|2
272045|NCT00286325|Duke University Medical Center|Dr. Russell P Hall|919-684-3110|hall0009@mc.duke.edu|
272046|NCT00286429|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
272047|NCT00286442|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
272048|NCT00286455|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
272049|NCT00286468|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
272050|NCT00286494|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
272051|NCT00286728|VAHSRD|Christine Timko|650-617-2746|Christine.Timko@va.gov|
272052|NCT00286741|Durham VA Medical Center|David Edelman|919-286-6936|dedelman@duke.edu|
272053|NCT00286754|Department of Veterans Affairs|Sundar Natarajan, MD, Staff Physician|212-686-7500|Sundar.Natarajan@va.gov|3287
272054|NCT00286949|Michael E. DeBakey VA Medical Center|Laura Marsh, M.D., Principal Investigator|713-794-8907|laura.marsh2@va.gov|
272055|NCT00287053|Pennington Biomedical Reseach Center|Corby Martin, Ph.D.; Assistant Professor|225-763-2585|martinck@pbrc.edu|
272056|NCT00287079|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
272057|NCT00287118|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
282678|NCT00867568|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
282679|NCT00867659|Virginia Center for Reproductive Medicine|Dr Fady Sharara|7034377722|fsharara@vcrmed.com|
282680|NCT00867789|Children's Mercy Hospital|Dr. Joan Giovanni|8162343430|gegiovanni@cmh.edu|
282681|NCT00867815|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
282682|NCT00867932|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.||ClinicalTrials@Alexion.com|
282683|NCT00868101|Universidade de Sao Paulo|Marcos Alves Pavione|55 79 9199 9576|mapavione@hotmail.com|
282684|NCT00868140|Virginia Commonwealth University|Dr. John Nestler|(804) 828-3389|john.nestler@vcuhealth.org|
282685|NCT00868166|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
282686|NCT00868192|Washington University School of Medicine|David G. Mutch, M.D.|314-362-2181|mutchd@wudosis.wustl.edu|
271516|NCT00244374|University of California, San Francisco|Dr. Paula J. Lum|415-476-4082|plum@php.ucsf.edu|411
271517|NCT00244621|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
271518|NCT00244712|GlaxoSmithKline|GSK Response Center|866-435-7343||
271519|NCT00244725|GlaxoSmithKline|GSK Response Center|866-435-7343||
271520|NCT00244751|GlaxoSmithKline|GSK Response Center|866-435-7343||
271521|NCT00244764|GlaxoSmithKline|GSK Response Center|866-435-7343||
296719|NCT01702025|Department of Health and Exercise Science|Christopher Bell, Ph.D.|(970) 491-7522|christopher.bell@colostate.edu|
296720|NCT01702233|Biologische Heilmittel Heel|Dr Istvan Zatik|+497221501(0)|istvan.zatik@heel.com|3192
296721|NCT01702246|UCSF Benioff Children's Hospital Oakland|Dr. Carolyn Hoppe|(510)428-3193|choppe@mail.cho.org|
296722|NCT01702259|Surgeon's Inc.|Dr. Robert F. Jackson|765-662-8303|rjlipodr@comteck.com|
296723|NCT01702298|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
296724|NCT01702311|Emory University|Guillermo Umpierrez, MD|404-778-1663|geumpie@emory.edu|
296725|NCT01702363|GlaxoSmithKline|GSK Response Center|866-435-7343||
272058|NCT00287222|University of Arkansas for Medical Sciences|Sandy Annis|5016868274|amannis@uams.edu|
272059|NCT00287287|University of Kentucky|Kenneth Ain|8593236652|kenneth.ain@uky.edu|
272060|NCT00287339|UNC_ChapelHill|Dr Nicholas Shaheen|919 9667047|nshaheen@med.unc.edu|
272061|NCT00287365|University of North Carolina at Chapel Hill|David B. Peden, MD, MS|919-966-0768|dpeden@med.unc.edu|
272062|NCT00287469|Armed Forces Research Institute of Medical Services|Mrigendra P. Shrestha MD|662-644-4888|shrestham@afrims.org|
272063|NCT00287586|Brigham and Women's Hospital|Shalendar Bhasin, MD||Sbhasin@partners.org|
272064|NCT00287690|Imperial College London|Dr Carolyn Webb|+44 3301288121|c.webb@imperial.ac.uk|
272065|NCT00287716|InterMune, Inc.|Bill Bradford, MD, PhD|(415) 466-2200|bbradford@intermune.com|
272066|NCT00287729|InterMune, Inc.|Bill Bradford, MD, PhD|(415) 466-2200|bbradford@intermune.com|
272067|NCT00287872|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivan Borrello|(410) 955-4967|iborrell@jhmi.edu|
308340|NCT02571153|Pontificia UCSP|Eduardo Toshiyuki Moro||eduardo_moro@terra.com.br|
272068|NCT00287989|MSKCC|Charles M. Rudin, MD, PhD.|646-888-4527|rudinc@mskcc.org|
272069|NCT00288015|Northwestern University|Mark Agulnik, MD|312-695-6182|magulnik@nm.org|
281788|NCT01981096|Cincinnati Children's Hospital Medical Center|Susmita Kashikar-Zuck, PhD|513 636 6337|susmita.kashikar-zuck@cchmc.org|
281789|NCT01935336|U of Colorado, Division of Medical Oncology. Anschutz Medical Campus|Dr. Ross Camidge|7208480300|ross.camidge@cuanschutz.edu|
281790|NCT01712490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
281791|NCT01702805|Emeritus Professor U Pennsylvania at CHOP and Emeritus Professor McMaster University, Dept Pediatrics|Haresh Kirpalani|267-844-3233|kirpalan@mcmaster.ca|
281792|NCT01499160|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
281793|NCT01333436|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281794|NCT01307631|Dana-Farber Cancer Institute|Jennifer Curtis, MS|617-582-7183|jennifer_curtis@dfci.harvard.edu|
296726|NCT01702428|GlaxoSmithKline|GSK Response Center|866-435-7343||
296727|NCT01702454|GlaxoSmithKline|GSK Response Center|866-435-7343||
308341|NCT02571218|IRCCS Policlinico San Donato|Giuseppe Ciconte|+39 02 52 77 42 60|g.ciconte@gmail.com|
308342|NCT02571244|Federal University of Juiz de Fora/Brazil|Dr. Erica Cruvinel|55-32-99174-8855|ericacruvinel@gmail.com|
308343|NCT02571439|Maimonides Medical Center|Dr Kalpana Tyagaraj|7182836000|KTyagaraj@maimonidesmed.org|
308344|NCT02571452|San Francisco VA Healthcare System|Dr. Shira Maguen|415-221-4810|Shira.Maguen@va.gov|22511
272070|NCT00288054|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
272071|NCT00288067|University of Washington|Dr. Ajay Gopal|206-288-2035|agopal@uw.edu|
272072|NCT00288366|Northwestern University|Herbert Y Meltzer|1 312 503 0309|h-meltzer@northwestern.edu|
272073|NCT00288509|Ipsen|Senior Director, Medical Development, Neurology||clinical.trials@ipsen.com|
272074|NCT00288574|NYSPI|BT Walsh, MD|646-774-8066|edru@nyspi.columbia.edu|
272075|NCT00288587|Cleveland Clinic Foundation|Leighann Cesar, RN|216-445-6551|cesar1@ccf.org|
272076|NCT00288600|Fundação Oswaldo Cruz|Maria Elisabeth Moreira|552125541911|bebeth@iff.fiocruz.br|
272077|NCT00288626|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
281795|NCT01256086|University of Florida, Department of Pharmacotherapy and Tanslational Research, 100486 Gainesville, FL 32610|Prof. Dr. Leslie Hendeles|+1 352 279|hendeles@cop.ufl.edu|6027
281796|NCT01061151|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
281797|NCT00981058|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281798|NCT00885495|University of Cincinnati College of Medicine|Dr. Carl J. Fichtenbaum|513-584-6361|carl.fichtenbaum@uc.edu|
281799|NCT00084799|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
281800|NCT00821236|Durrie Vision|Brigette Ellis|913-491-3330|bellis@durrievision.com|7255
281801|NCT00821327|US Oncology Research, McKesson Specialty Health|Dr. Matthew D. Galsky|212-659-5412|matthew.galsky@mssm.edu|
281802|NCT00821431|ConvaTec|Kim Peters, Director of Clinical Affairs|07889841338|kim.peters@convatec.com|
281803|NCT00821509|National Institute for Health and Welfare|Tapani Hovi, Project Leader|+358 400 517299|tapani.hovi@thl.fi|
281804|NCT00821626|Infectious Disease Service, and Travel Clinic, University Hospital of Lausanne, Switzerland|Dr Serge de Vallière|+41 79 556 43 12|serge.de-valliere@unisante.ch|
281805|NCT00821678|VA HSR&D|John Fortney|206.764.2821|john.fortney@va.gov|
281806|NCT00821795|Lexington VAMC|Dennis G Karounos, MD Principal investigator|859 233-4511|dennis.karounos@va.gov|4430
281807|NCT00821821|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
271522|NCT00244855|Fred Hutchinson Cancer Research Center|Dr. David Maloney|206-667-5616|dmaloney@fredhutch.org|
271523|NCT00244881|Dana-Farber Cancer Institute|Dr Harold Burstein|617-632-3800|hburstein@partners.org|
271524|NCT00244933|Barbara Ann Karmanos Cancer Institute|Amy Weise, M.D.|313-576-8599|weisea@karmanos.org|
271525|NCT00244985|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
271526|NCT00245011|Sidney Kimmel Comprehensive Cancer Center|David M. Loeb, M.D., Ph.D., Director, Musculoskeletal Tumor Program|410.502.7247|loebda@jhmi.edu|
271527|NCT00245037|Oregon Health and Science University|Richard T. Maziarz, MD|503-494-6345|maziarzr@ohsu.edu|
271528|NCT00245050|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Vivian von Gruenigen, MD|216-844-5011|vev1@case.edu|
271529|NCT00245063|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
271530|NCT00245102|Memorial Sloan-Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
271531|NCT00245219|Carnegie Mellon University|Michael F. Scheier, PhD|412-268-3791|Scheier@cmu.edu|
271532|NCT00245466|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
271533|NCT00245518|Johns Hopkins University School of Medicine|Johns Hopkins University Clinical Trials Program|410-550-6484|registerclinicaltrials@jhmi.edu|
296728|NCT01702519|GlaxoSmithKline|GSK Response Center|866-435-7343||
296729|NCT01702532|GlaxoSmithKline|GSK Response Center|866-435-7343||
296730|NCT01702558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
296731|NCT01702571|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
296732|NCT01702844|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
296733|NCT01702961|Baylor College of Medicine|George Carrum, MD||GCarrum@houstonmethodist.org|
296734|NCT01702987|Beth Israel Deaconess Medical Center|Jim Wu|617-754-2390|jswu@bidmc.harvard.edu|
296735|NCT01703000|Boston Scientific|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
296736|NCT01703039|Brigham and Women's Hospital|Dr. Jessica Harder|617-525-7919|jaharder@bwh.harvard.edu|
296737|NCT01703065|University of Washington|Dr. Celestia Higano, MD|206-606-1152|thigano@u.washington.edu|
296738|NCT01703091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
296739|NCT01703117|Icahn School of Medicine at Mount Sinai|Dr. Ana Pereira|212-241-6984|ana.pereira@mssm.edu|
296740|NCT01703169|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
296741|NCT01703208|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
296742|NCT01703221|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308345|NCT02571634|Womack Army Medical Center|Michael Bartoszek, MD|910-907-6000|michael.w.bartoszek.mil@mail.mil|
308346|NCT02571777|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
308347|NCT02571972|Retina Service of Wills Eye Hospital, Mid Atlantic Retina|Dr. Jason Hsu|215-928-3092|jhsu@midatlanticretina.com|
308348|NCT02572076|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|0733243823|ravit@motusgi.com|203
272078|NCT00288639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
272079|NCT00288704|Regeneron Pharmaceuticals|Doug Nadler, MS Statistics|914 345 7905|clinicaltrials@regeneron.com|
272080|NCT00288860|Nationa Center for PTSD Dissemination & Training Division|Craig S. Rosen|650-493-5000|craig.rosen@va.gov|22812
272081|NCT00288886|Salem Veterans Affairs Medical Center|Steven Lash, Ph.D.|(540)982-2463|Steven.Lash@va.gov|2593
272082|NCT00288912|Durham VA HSR&D|Dr. Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
272083|NCT00289016|Amgen, Inc.|Study Director|866-572-6436||
272084|NCT00289094|DePuy Orthopaedics, Inc.|Tammy O'Dell, EMT, CCRA|574-372-7104|TOdell2@its.jnj.com|
272085|NCT00289107|DePuy Orthopaedics|Tammy O'Dell, EMT, CCRA|574-372-7104|TOdell2@its.jnj.com|
272086|NCT00289120|Emory University|Kenneth Ogan|404-778-4898|kogan@emory.edu|
272087|NCT00289133|DePuy Orthopaedics, Inc.|Clinical Portfolio Leader|574-372-7231|shimden@its.jnj.com|
272088|NCT00289185|GlaxoSmithKline|GSK Response Center|866-435-7343||
272089|NCT00289198|GlaxoSmithKline|GSK Response Center|866-435-7343||
272090|NCT00289211|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
272091|NCT00289276|Medtronic CRDM Clinical Research|CRDM Core Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
272092|NCT00289289|Medtronic CRDM Clinical|Jen Lahr||jen.lahr@medtronic.com|
272093|NCT00289315|Pennington Biomedical Research Center|Lori Steib|(225) 252-5030|Lori.Steib@pbrc.edu|
272094|NCT00289341|Rockefeller University|Mayu Frank|212-327-7443|frankm@rockefeller.edu|
272095|NCT00289458|University of Saskatchewan|Dr. Cathy M. Arnold|306 966 6588|cathy.arnold@usask.ca|
272096|NCT00289471|Durham VAMC|John W. Williams|919-286-6963|jw.williams@duke.edu|
272097|NCT00289536|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
272098|NCT00289653|Centre for Addiction and Mental Health|Dr. Peter Selby|416-535-8501|peter.selby@camh.ca|36859
272099|NCT00289718|GlaxoSmithKline|GSK Response Center|866-435-7343||
272100|NCT00289731|GlaxoSmithKline|GSK Response Center|866-435-7343||
272101|NCT00289744|GlaxoSmithKline|GSK Response Center|866-435-7343||
272102|NCT00289757|GlaxoSmithKline|GSK Response Center|866-435-7343||
272103|NCT00289770|GlaxoSmithKline|GSK Response Center|866-435-7343||
272104|NCT00289783|GlaxoSmithKline|GSK Response Center|866-435-7343||
272105|NCT00289848|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
272106|NCT00289900|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
296743|NCT01703260|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
296744|NCT01703286|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296745|NCT01703507|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Wenyin Shi|215-955-6702|Wenyin.Shi@jefferson.edu|
296746|NCT01703598|Oregon Health & Science University|Matthew Brodsky MD|503-494-9054|brodskym@ohsu.edu|
296747|NCT01703663|University of Michigan|Devin L. Brown, MD, MS|734-936-9075|devinb@umich.edu|
296748|NCT01703702|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
308349|NCT02572167|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
272107|NCT00289913|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
272108|NCT00289978|Novartis Pharmaceuticals|Study Director|862 778-8300||
308350|NCT02572388|University of Oxford|Adrian V Hill, DPhil FRCP|+44 1865 617610|adrian.hill@ndm.ox.ac.uk|
272109|NCT00289991|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
272110|NCT00290147|Naval Medical Research Center, Viral Diseases Department|Charmagne Beckett, LCDR, MC, USNR|301-295-6400|charmagne.beckett@med.navy.mil|
272111|NCT00290186|Dayton Children's Hospital|Daniel J. Lacey, MD, PhD|937-641-3080|LaceyD@childrensdayton.org|
272112|NCT00290199|UAB|Dr. Alan Tita|205-934-9616|atita@uab.edu|
272113|NCT00290238|RS Medical|Clinical Research Manager|360-891-7299||
272114|NCT00290251|NICHD, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
272115|NCT00290290|Baylor College of Medicine|Rabih Darouiche, M.D.|713-794-8858|rabihd@bcm.edu|
272116|NCT00290329|GlaxoSmithKline|GSK Response Center|866-435-7343||
272117|NCT00290342|GlaxoSmithKline|GSK Response Center|866-435-7343||
272118|NCT00290355|GlaxoSmithKline|GSK Response Center|866-435-7343||
272119|NCT00290433|The University of Texas (UT) MD Anderson Cancer Center|Christopher Flowers/Chair, Lymphoma-Myeloma|713-745-6095|crflowers@mdanderson.org|
271534|NCT00245557|McLean Hospital|Brent Forester MD|617-855-3622|bforester@mclean.harvard.edu|
271535|NCT00245583|Icahn School of Medicine at Mount Sinai|Dr. Heather Berlin|212-241-4761|heather.berlin@mssm.edu|
271536|NCT00245635|Montefiore Medical Center, Albert Einstein College of Medicine|Eric Hollander, MD|7189204287|eholland@montefiore.org|
271537|NCT00245765|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
271538|NCT00245856|University of Oklahoma Health Sciences Center|Suman Rathbun MD|4052714742|suman-rathbun@ouhsc.edu|44773
271539|NCT00246012|Centocor, Inc.|Senior Director|908-927-2116||
271540|NCT00246025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
271541|NCT00246090|Eisai Call Center|Eisai Inc.|888-422-4743||
271542|NCT00246129|imperial College Kidney & Transplant Centre|Dr Adam McLean|+44 (0) 208 383 5164|adam.mclean@imperial.nhs.uk|356164
271543|NCT00246259|Janssen Inc., Toronto, ON, Canada|Director Medical Affairs - CNS|+1-416-382-5094||
271544|NCT00246324|LSU Health Sciences Center in Shreveport Department of Neurology|Alireza Minagar, MD|318-813-1481|aminag@lsuhsc.edu|
271545|NCT00246337|Merck Sharp & Dohme Corp|Vice President of Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
271546|NCT00246376|Baylor College of Medicine|Ashok Balasubramanyam, MD, Prinicipal Investigator|713-798-8654|ashokb@bcm.edu|
272120|NCT00290472|University of Chicago Comprehensive Cancer Center|Dr. Sonali M. Smith|7738342895|smsmith@medicine.bsd.uchicago.edu|
272121|NCT00290498|U.T. MD Anderson Cancer Center|Dr. Luis E. Fayad / Lymphoma/Myeloma|7137922860|lefayad@mdanderson.org|
272122|NCT00290537|U.T. M.D. Anderson Cancer Center|Vali Papadimitrakopoulou, MD / Associate Professor|713-792-6363||
272123|NCT00290589|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
272124|NCT00290615|Duke University Medical Center|Brant Hamel|919-68-1861|brant.hamel@duke.edu|
272125|NCT00290654|Masonic Cancer Center, University of Minnesota|Todd Tuttle, M.D.|612-625-2991|tuttl005@umn.edu|
272126|NCT00290693|University of Miami Sylvester Comprehensive Cancer Center|Caio Max Rocha Lima MD|305-243-7770|crocha@med.miami.edu|
272127|NCT00290706|Northwestern University|Leo Gordon|312-695-4520|l-gordon@northwestern.edu|
271547|NCT00246441|MUSC|Dr. Sarah Book|8437925200|booksw@musc.edu|
271548|NCT00246519|University of Florida|Julie A. Johnson|352-273-6007|johnson@cop.ufl.edu|
282687|NCT00868218|University of Bergen|Professor Rebecca Jane Cox|+4755974668|rebecca.cox@uib.no|
296749|NCT01703741|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
308351|NCT02572401|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
272128|NCT00290732|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
272129|NCT00290745|Duke University and Duke Cancer Institute|Dr. E. Shelly Hwang, MD, MPH|(919) 684-6849|shelley.hwang@duke.edu|
272130|NCT00290771|Novartis Pharmaceuticals|Study Director|862 778-8300||
272131|NCT00290810|Mayo Clinic|Tait Shanafelt, M.D.||shanafelt.tait@mayo.edu|
272132|NCT00290888|Pan Am Clinic|Dr. Peter MacDonald|204-925-7480|pmacdonald@panamclinic.com|
272133|NCT00291018|DePuy Synthes Spine|Erin Prifogle|508-977-6451|eprifog1@its.jnj.com|
272134|NCT00291135|University of Kansas Medical Center Research Institute|Carol J. Fabian, M.D.|913-588-7791|cfabian@kumc.edu|
272135|NCT00291161|Houston HSRD Center of Excellence|Mark Kunik, MD, MPH|713-794-8639|kunik.marke@va.gov|
272136|NCT00291187|Vanda Pharmaceuticals Inc.|Marlene Dressman, PhD.|202-734-3462|marlene.dressman@vandapharma.com|
272137|NCT00291226|Yale University School of Medicine|Scott W. Woods, MD|203-974-7038|scott.woods@yale.edu|
272138|NCT00291317|Children's Specialized Hospital|Frank Castello|732 258 7065|fcastello@childrens-specialized.org|
272139|NCT00291330|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
272140|NCT00291343|GlaxoSmithKline|GSK Response Center|866-435-7343||
272141|NCT00291447|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
272142|NCT00291499|IBSA Institut biochimique|Project Leader|0041 58360100|rd@ibsa.ch|
296750|NCT01703819|Biologische Heilmittel Heel GmbH|Christine Frank, PhD|+49 7221 501 3188|christine.frank@heel.com|
296751|NCT01703832|Biologische Heilmittel Heel GmbH|Christine Frank, PhD|+49 7221 501 3188|christine.frank@heel.com|
296752|NCT01703845|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
267026|NCT04446429|Applied Biology|Director of Clinical Trials|+1-949-387-4526|monican@appliedbiology.com|
267027|NCT04372017|Sanford Health|Dr. Susan Hoover|605-328-8120|Susan.Hoover@sanfordhealth.org|
267032|NCT03116685|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
267033|NCT03099304|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
267034|NCT03034863|James J Peters VAMC|Marianne Goodman, MD|718-584-9000|Marianne.Goodman@va.gov|5188
267035|NCT02819050|Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center|Virender Rehan|3102221965|vrehan@labiomed.org|
267036|NCT02682901|Eastern Virginia Medical School|Henri Parson|7574467976|parsonhk@evms.edu|
267037|NCT02567825|UPMC Children's Hospital of Pittsburgh|Alejandro Hoberman, MD|412-999-3277|hobermana@upmc.edu|
267038|NCT02555657|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267039|NCT02328014|Acerta Pharma|Global Clinical Lead|1-877-240-9497|information.center@astrazeneca.com|
267040|NCT02190721|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|USMedInfo@tevapharm.com|
267041|NCT00908687|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
267042|NCT00739401|Endologix|Elisa Hebb, VP Clinical Affairs|949-598-4628|ehebb@endologix.com|
267043|NCT00651742|Taiho Oncology, Inc|Taiho Central|1-609-250-7336|clinicaltrialinfo@taihooncology.com|
267044|NCT00308516|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
267045|NCT04331366|Emory University|Jeffery Miller, MD|404-778-7200|jeffrey.miller@emory.edu|
267046|NCT04930263|National Yang Ming Chiao Tung University|Mrs Cheng-Chen Chou|28267176|chou8278@gmail.com|
267047|NCT04524598|Limbix Health|Janel Shelton-DeMagnus, Research Operations Manager|8885462495|janel@limbix.com|709
267048|NCT04321252|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
267049|NCT04285684|Ketamine Research Foundation|Philip E Wolfson, MD|415-550-1700|ketamine.research@gmail.com|
267050|NCT04176445|Hospital Moinhos de Vento|PT Douglas Neves|(51) 9.98975514|nevesfisioup@gmail.com|
267051|NCT04126213|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
272143|NCT00291551|Paracor Medical, Inc.|Michael Kolber, General Manager, VP, Regulatory Affairs|408-734-6000|info@paracor.com|
296753|NCT01703858|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296754|NCT01703988|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
296755|NCT01704079|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
296756|NCT01704196|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
296757|NCT01704261|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
296758|NCT01704287|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
296759|NCT01704456|UBC|Dr Lori Brotto|604-875-4111|lori.brotto@vch.ca|68898
272144|NCT00291577|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
272145|NCT00291642|UCB S.A.|UCB|+1844 599|UCBCares@ucb.com|2273
272146|NCT00291655|UCB Pharma|UCB Clinical trial call center|+1 877 822 9493||
272147|NCT00291668|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
272148|NCT00291694|University of Kansas Medical Center|Dr. Carol Fabian|913-588-3666|cfabian@kumc.edu|
272149|NCT00291876|GlaxoSmithKline|GSK Response Center|866-435-7343||
272150|NCT00292045|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@lcr.org|
272151|NCT00292162|NHS|Michael MacDonald|01412112000|michael.macdonald@nhs.net|
272152|NCT00292188|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
272153|NCT00292227|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
272154|NCT00292318|Greater Los Angeles VA Medical Center|Felix W. Leung, MD|818-891-7711|felix.leung@va.gov|9403
272155|NCT00292370|Ralph H. Johnson VA Medical Center|Mark Hamner, MD|843-789-7799|Mark.Hamner@va.gov|
267028|NCT04194528|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|adarke@fredhutch.org|
267029|NCT04147650|Aurinia Pharmaceuticals|Clinical Trial Support|(250) 744-2487|clinicaltrials@auriniapharma.com|
267030|NCT03907540|Kadmon Corporation|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|724-778-6170|olivier.schueller@kadmon.com|
267031|NCT03527238|University of Florida|Ali Zarrinpar|352-265-0606|ali.zarrinpar@surgery.ufl.edu|
267052|NCT03916458|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
267053|NCT03672188|Vir Biotechnology, Inc.|Study Inquiry|415-654-5281|clinicaltrials@vir.bio|
267054|NCT03637959|Mayo Clinic|Shigao Chen, Ph.D.|507-284-3703|Chen.Shigao@mayo.edu|
267055|NCT03573336|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
271549|NCT00246571|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
271550|NCT00246740|Departments of Pediatrics and Pharmacology, University of Alberta|Dr Richard Schulz|780-492-6581|richard.schulz@ualberta.ca|
271551|NCT00246753|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
271552|NCT00246805|Medtronic BRC - Medtronic Italia|Giorgio Corbucci - Sr Principal Scientist|+39 02 241371|giovanna.zucchi@medtronic.com|
271553|NCT00247273|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
271554|NCT00247377|UCI|Ninh Nguyen|714-456-8598|ninhn@uci.edu|
271555|NCT00247416|University of Kentucky Markey Cancer Center|Suzane Arnold, MD|859 323 8043|smarno0@uky.edu|
271556|NCT00247611|Center for Health, Intervention & Prevention|Dr. Jeffrey Fisher, Principal Investigator|(860) 486-4940|jeffrey.fisher@uconn.edu|
271557|NCT00247624|August Health University|Vaughn McCall|706-721-3141|wmccall@augusta.edu|
271558|NCT00247676|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
271559|NCT00247728|Progen Pharmaceuticals Ltd|Director of Regulatory Affairs and Clinical Development|+61 (0)7 38423333|darrynb@progen-pharma.com|
271560|NCT00247962|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
271561|NCT00248040|Dompé s.p.a.|Marcello Allegretti|+39 0862 338212|marcello.allegretti@dompe.it|
272156|NCT00292461|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affaires|81-3-3817-3914||
272157|NCT00292591|Medical University of South Carolina|Dr. Carol Wagner|18437922112|wagnercl@musc.edu|
272158|NCT00292942|Uniformed Services University of the Health Sciences|Louis Cantilena, Jr., MD, PhD|301-295-0016|lcantilina@usuhs.mil|
272159|NCT00292981|CSL Behring|Clinical Program Director|Use email contact|clinicaltrials@cslbehring.com|
272160|NCT00293020|BioDelivery Sciences International|Andrew Finn, Pharm.D.|919-582-9050|AFinn@bdsi.com|
272161|NCT00293033|Meda Pharmaceuticals Inc.|Larry Gever, PharmD, Director, Medical Affairs|732-564-2400|larry.gever@meda.us|
296760|NCT01704495|AstraZeneca|Medical Science Director Bengt Larsson||ClinicalTrialTransparency@astrazeneca.com|
296761|NCT01704521|University of Cincinnati|Kenneth E. Sherman, MD. PhD|513-558-3918|kenneth.sherman@uc.edu|
308352|NCT02572427|University of Arkansas for Medical Sciences|Dr Richard Whit Hall|501-680-7894|HallRichardW@uams.edu|
308353|NCT02572570|University of North Carolina at Chapel Hill|Ricardo Walter, DDS, MS|9195373596|walterr@unc.edu|
308354|NCT02572609|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308355|NCT02572752|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
267056|NCT03230916|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
272162|NCT00293059|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
272163|NCT00293202|University of California, Davis|George Kaysen MD PhD|916-734-3774|gakaysen@ucdavis.edu|
272164|NCT00293215|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@lcr.org|
272165|NCT00293241|Medtronic Bakken|Lidwien Vainer|+31 433566752|lidwien.vainer@medtronic.com|
272166|NCT00293254|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
272167|NCT00293267|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
272168|NCT00293293|Moffitt Cancer Center|Patricia L. Judson, M.D.|813-745-1600|Patricia.Judson@moffitt.org|
267057|NCT03195894|KontigoCare AB|Markku Hämäläinen, Research Director|0769 47 31 32|markku.hamalainen@kontigocare.com|
272169|NCT00293384|Barbara Ann Karmanos Cancer Institute|Muneer Abidi, M.D.|(313) 576-8713|abidim@karmanos.org|
272170|NCT00293397|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
272171|NCT00293423|University of California, Davis|Dr. Orin Bloch||obloch@ucdavis.edu|
272172|NCT00293462|University of California, San Francisco|Marylin J. Dodd, RN, PhD, FAAN|415-476-2191|Marylin.dodd@ucsf.edu|
272173|NCT00293540|International Breast Cancer Research Foundation|Richard R. Love, MD|608-698-7881|richardibcrf@gmail.com|
292582|NCT01435460|Bausch & Lomb, Incorporated|Tuyen Ong|(973) 360-6389|tuyen.ong@bausch.com|
267058|NCT03032705|Tufts University School of Dental Medicine|Dr Gerard Kugel|(617) 636-0870|Gerard.Kugel@tufts.edu|
267059|NCT02573259|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
267060|NCT02318329|Five Prime Therapeutics|Medical Lead|415-365-5600|FPA144@fiveprime.com|
267061|NCT02097420|Abbott|John Carrithers, Clinical Program Director|+1 6517564725|john.carrithers@abbott.com|
267062|NCT01602666|Children's Oncology Group|Results Reporting Coordinator|626 447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
267063|NCT01375959|Albert Einstein College of Medicine|Dr. Jill Crandall|718-430-3765|jill.crandall@einstein.yu.edu|
267064|NCT01224106|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
267065|NCT00999609|Spark Therapeutics|Clinical Director||clinicaltrials@sparktx.com|
267066|NCT00567567|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|Resultsreportingcoordinator@childrensoncologygroup.org|
267067|NCT00354835|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
267068|NCT04531241|Johnson & Johnson Vision Care, Inc.|Meredith Bishop, OD, MS, FAAO|1-800-843-2020|mbishop4@its.jnj.com|
267069|NCT04456153|UT Southwestern Medical Center|Dr. Mamta K. Jain|2140648-9914|mamta.jain@utsouthwestern.edu|
267070|NCT04351243|Kinevant Sciences, Inc. on behalf of Kinevant Sciences GmbH|Simon Lowry, MD, Chief Medical Officer|(646) 495-5368|simon.lowry@roivant.com|
267075|NCT03600714|NIDDK|Dr. Christopher Koh|301-443-9402|kohchris@mail.nih.gov|
267076|NCT03479307|Faes Farma|Nieves Fernández, MD, PhD|+34 94 481 83 00|nfernandez@faes.es|
267077|NCT03470441|Faraday Pharmaceuticals, Inc|Clinical Trials Manager|206-492-5310|info@faradaypharma.com|
267078|NCT03452397|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
267079|NCT03448939|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
267080|NCT03410108|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
267081|NCT03377803|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
267082|NCT03283371|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
267083|NCT03257254|Boston Scientific|Timothy Keo|425-599-3814|Timothy.Keo@bsci.com|
267084|NCT03084718|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
267085|NCT03069417|Massachusetts General Hospital|Dr. Christina Psaros|617.726.7458|cpsaros@mgh.harvard.edu|
267086|NCT03063164|Stanford University School of Medicine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
267087|NCT02952365|Stanford University School of Medicine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
267088|NCT02936323|Tarveda Therapeutics, Inc.|Tarveda Clinical Information Center|(617) 923-4100|clinical.information@tarvedatx.com|
267089|NCT02631837|Imelda ziekenhuis Bonheiden|Dr Jan Baekelandt|+ 32 15 505208|jan.baekelandt@imelda.be|
267090|NCT02437318|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
267091|NCT02429791|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
267092|NCT02422797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
267093|NCT02422615|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
267094|NCT02287493|University Medical Center Hamburg-Eppendorf|Dr. Christina König|+49 040 7410 -0|ch.koenig@uke.de|
292583|NCT01435512|BVARI|Dr. Casey Taft|857-364-6261|casey.taft@va.gov|
292584|NCT01435577|Grünenthal GmbH|Director of Clinical Trials|+241 569 3223||
292585|NCT01435603|Northwestern University|Research Project Manager|312-503-3359|emily.anderson1@northwestern.edu|
292586|NCT01435616|Eli Lilly and Company|Chief Medical Officer|800 545 5979||
292587|NCT01435655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296762|NCT01704599|Dept. Dermatology Wayne StateUniversity|Peter J. Aronson, MD|(313)_745-7845|paronson@med.wayne.edu|
296763|NCT01704651|Mayo Clinic|Dr. Jamie N. Bakkum-Gamez|507-266-8661|Bakkum.Jamie@mayo.edu|
296764|NCT01704755|AbbVie (prior sponsor, Abbott)|Global Medical Information|800 633-9110||
296765|NCT01704781|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
296766|NCT01704846|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296767|NCT01704976|BUAS|Slavko Rogan (Study Chair)|+41 31 848 35 56|slavko.rogan@bfh.ch|
296768|NCT01705080|Abbott|Steven Madej|651-756-2230|smadej@sjm.com|
296769|NCT01705145|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
267071|NCT04312256|Mayo Clinic|J. Ross Renew, M.D.|904-956-3328|Renew.J@mayo.edu|
296770|NCT01705236|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
296771|NCT01705288|Masonic Cancer Center at University of Minnesota|Dr. Peter Argenta|612-626-6283|argenta@umn.edu|
308356|NCT02572817|National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
308357|NCT02573012|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
308358|NCT02573155|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
308359|NCT02573181|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308360|NCT02573233|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
308361|NCT02573246|Duke University Health System|Dr. Andrada D. Neacsiu|919-684-6714|andrada.neacsiu@duke.edu|
308362|NCT02573311|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308363|NCT02573350|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
308364|NCT02573402|The University of Texas Health Science Center at Houston|Argyrios Stampas, MD|(713) 797-5007|Argyrios.Stampas@uth.tmc.edu|
308365|NCT02573467|Novartis Pharmaceuticals|Study Director|862-778-8300||
308366|NCT02573493|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-747-8475|dadkins@wustl.edu|
308367|NCT02573779|Baylor College of Medicine/Texas Children's Hospital|Dr. Amy B. Hair|832-826-1398|abhair@bcm.tmc.edu|
308368|NCT02573857|Medicines for Malaria Venture|Dr Joerg Moehrle|+41 22 555 0330|moehrlej@mmv.org|
272174|NCT00293579|Ohio State University Comprehensive Cancer Center|Anterpreet Neki|614-257-2900|Anterpreet.Neki@osumc.edu|
267072|NCT04185220|National Cancer Institute|Dr. Kevin Conlon|240-858-3570|conlonkc@mail.nih.gov|
272175|NCT00293709|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272176|NCT00293722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272177|NCT00293813|Amgen Inc.|Study Director|866-572-6436||
281808|NCT00821873|RTI Biologics|Robin Waite, Director, Clinical Projects|386-418-8888|rwaite@rtix.com|4172
281809|NCT00821886|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
281810|NCT00821951|Yale University|Dr. Roy H Decker, MD PhD|203 737-2758|roy.decker@yale.edu|
281811|NCT00821964|University of Washington|Principal Investigator||TrialTVG@medicine.washington.edu|
267073|NCT03851107|McGill University|Dr. Dana Anaby|15143984400|dana.anaby@mcgill.ca|00394
281812|NCT00822094|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|(215) 832-3750||
281813|NCT00822107|Oregon Health & Science University|Dr. David H. Ellison|5034944465|ellisond@ohsu.edu|
281814|NCT00822172|CPC Clinical Research|William Hiatt, MD, President|3038609900|william.hiatt@cpcmed.org|
281815|NCT00822185|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
281816|NCT00822237|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281817|NCT00822328|Cheng Hsin Rehabilitation Medical Center|Dr.Yi-Hsien Lin|+886-2-28264400|d49311001@ym.edu.tw|5750
267074|NCT03815175|Abbott|Lijuan Jenn Wang|01-408-8453133|Lijuan.wang1@abbott.com|
281818|NCT00822354|Northwestern University|Clinical Trials Coordinator|312-695-6829|j-bae@northwestern.edu|
281819|NCT00822510|University of Arizona College of Nursing|Terry Badger, PhD, PMHCNS-BC, FAAN|520-626-6058|tbadger@email.arizona.edu|
281820|NCT00822523|Loma Linda University|Gordon Perterson, MD|909-558-4000|gpeterson@llu.edu|
281821|NCT00822588|Astra Tech AB|Head of Clinical Research Area Health Care|+46317763000||
281822|NCT00822692|Wilford Hall Medical Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
281823|NCT00822757|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281824|NCT00822770|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PhD / Associate Professor|713-794-1628|mkonople@mdanderson.org|
281825|NCT00822900|Emergency Neurosciences, Emergency Medicine, Emory University|David W. Wright, Associate Professor, Department of Emergency Medicine, Emory University|404-778-1709|david.wright@emory.edu|
281826|NCT00822926|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
281827|NCT00823043|Vistakon|Arthur Shedden MD|904-443-1557||
281828|NCT00823069|Medicis|Mary Sanstead|480-291-5926|msanstead@medicis.com|
281829|NCT00823082|GrifolsTherapeutics Inc.|Michael Ken Woodward, BSc, M.Sc|+1 919-316-6675|michael.woodward@grifols.com|
281830|NCT00823134|ResMed Germany Inc|Oliver Munt|0899901|oliver.munt@resmed.de|00
296772|NCT01705496|Biomed valley discoveries|Dr. Michelle Zhang, Executive Director|7815339412|mzhang@biomed-valley.com|
308369|NCT02573870|GlaxoSmithKline|GSK Response Center|866-435-7343||
267095|NCT02132611|Cardiovascular Systems, Inc.|Clinical Project Manager|651-259-1600|clinicaltrials_csi@csi360.com|
267096|NCT01796197|Dana-Farber Cancer Institute|Beth Overmoyer, MD, FACP|617.632.3800|beth_overmoyer@dfci.harvard.edu|
267097|NCT01147822|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
296773|NCT01705509|Cardiovascular Institute of the South|Agostino Ingraldi, MD, FACC|337-988-1585|Agostino.Ingraldi@cardio.com|
296774|NCT01705574|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
296775|NCT01705587|University of Pittsburgh|Susan Greenspan, MD|412-692-2477|greenspn@pitt.edu|
296776|NCT01705652|The University of Texas Health Science Center at San Antonio Department of Radiation Oncology|Gregory P. Swanson, MD|210-450-1109|swansong@uthscsa.edu|
296777|NCT01705691|NSABP Foundation, Inc.|Diana Gosik|412-339-5333|diana.gosik@nsabp.org|
272178|NCT00294047|GlaxoSmithKline|GSK Response Center|866-435-7343||
272179|NCT00294060|Medtronic CRDM|P3 Study Team|800-328-2518|medtroniccrmtrials@medtronic.com|
272180|NCT00294398|CHOP|Esther Sampayo MD MPH|215-590-1944|sampayo@email.chop.edu|
272181|NCT00294515|Hoffmann-La Roche|Medical Communications|800-821-8590||
272182|NCT00294554|Johns Hopkins University School of Medicine|Laura Marsh, MD|713-794-8907|laura.marsh2@va.gov|
272183|NCT00294632|The University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Wang, Professor, Lymphoma/Myeloma|713-792-2860|miwang@mdanderson.org|
272184|NCT00294645|Medtronic CRDM|CRDM Clinical|800-328-2518|medtroniccrmtrials@medtronic.com|
272185|NCT00294658|University of Alabama at Birmingham|Dr. Gary Cutter, Professor|205-975-5048|cutter@uab.edu|
267098|NCT00328653|Santen Inc|R&D Quality Manager|415 268 9199|evelyn.chikere@santen.com|
272186|NCT00294671|Amyloidosis Center, Boston Medical Center|Dr. John L. Berk|617-638-4494|jberk@bu.edu|
272187|NCT00294684|NIDDK|Ed Doo||dooe@niddk.gov|
272188|NCT00294723|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
272189|NCT00294762|Astellas Pharma Global Development|Medical Monitor||clinicaltrials@us.astellas.com|
272190|NCT00295009|DePuy Synthes|Erin Prifogle|508-977-6451|eprifog1@its.jnj.com|
272191|NCT00295022|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
272192|NCT00295061|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
272193|NCT00295503|UT Southwestern|Jonathan Dowell|214-648-4180|jonathan.dowell@utsouthwestern.edu|
272194|NCT00295620|ABCSG|Trial Office Director|+43 1 4089230|info@abcsg.at|
272195|NCT00295633|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
272196|NCT00295750|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
272197|NCT00295854|Medicinova Inc|Richard E. Gammans PhD Chief Developing Officer|848-373-1500|gammans@medicinova.com|
272198|NCT00295867|UCSF Helen Diller Family Comprehensive Cancer Center|Hope S. Rugo|415-353-7618|hrugo@medicine.ucsf.edu|
272199|NCT00295880|Masonic Cancer Center, University of Minnesota Blood and Marrow Transplant Program|John E. Wagner, M.D.|612-626-2961|wagne002@umn.edu|
272200|NCT00295932|Memorial Sloan Kettering Cancer Center|Dr. Carol Portlock|212-639-8109|portlocc@mskcc.org|
272201|NCT00296036|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
272202|NCT00296140|Roudebush VA Medical Center|Dr. Linda Williams|317-988-2715|Linda.Williams6@va.gov|
272203|NCT00296192|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
272204|NCT00296231|University of Iowa|Tarah Colaizy||tarah-colaizy@uiowa.edu|
272205|NCT00296244|Thomas Jefferson University|Carlo Gerardo B Ramirez, MD|215-955-5909|carlo.ramirez@jefferson.edu|
272206|NCT00296296|Stanford University|Stephan Busque, MD|650-498-6189|sbsuque@stanford.edu|
272207|NCT00296322|Asan Medical Center, University of Ulsan College of Medicine|Dr. Yoon-Koo Kang|+82-2-3010-3230|ykkang@amc.seoul.kr|
272208|NCT00296335|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
272209|NCT00296374|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
272210|NCT00296400|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
272211|NCT00296491|GlaxoSmithKline|GSK Response Center|866-435-7343||
272212|NCT00296504|ViiV Healthcare|GSK Response Center|866-435-7343||
272213|NCT00296517|GlaxoSmithKline|GSK Response Center|866-435-7343||
272214|NCT00296647|UW-Center for Tobacco Research and Intervention|Stevens Smith, PhD|608-262-7563|sss@ctri.medicine.wisc.edu|
272215|NCT00296725|New York State Psychiatric Institute|Jonathan W. Stewart, M.D., Principle Investigator|646-774-8070|jws6@cumc.columbia.edu|
272216|NCT00296816|Sanofi|Trial Trans[parency Team||Contact_us@sanofi.com|
272217|NCT00297037|University of Utah|Dr. Christopher Hull|801-581-6465|christopher.hull@hsc.utah.edu|
272218|NCT00297102|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
272219|NCT00297115|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
272220|NCT00297167|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1- 800- 472- 2634||
272221|NCT00297232|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
308370|NCT02573883|Medstar Health Research Institute|Dr. Cheryl Iglesia|202-877-6526|cheryl.iglesia@medstar.net|
272222|NCT00297258|GlaxoSmithKline|GSK Response Center|866-435-7343||
272223|NCT00297427|University of Pittsburgh|Dr. Sandra Engberg|412-624-6616|sje1@pitt.edu|
272224|NCT00297479|UT MD Anderson Cancer Center|Dr. Sharon Giordano, MD/Chair, Health Svcs Research-Clinical|713-563-0020|sgiordan@mdanderson.org|
272225|NCT00297492|University of Vermont|Dr. John Hughes|802-656-9610|John.Hughes@uvm.edu|
272226|NCT00297596|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSarah@scresearch.net|
272227|NCT00297648|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
272228|NCT00297778|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
272229|NCT00297830|Columbia University|Dr. Elizabeth Shane|2123056289|es54@columbia.edu|
272230|NCT00297882|University of Yaounde 1, Cameroon|Professor Wilfred Mbacham|+237 677579180|wfmbacham@yahoo.com|
272231|NCT00298038|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
272232|NCT00298090|UTHSCSA|Jane Youngers|210-567-2340|youngers@uthscsa.edu|
272233|NCT00298155|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
296778|NCT01705717|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
296779|NCT01705730|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
296780|NCT01705964|University of Louisville|Dr. Kerry Caperell|502-629-7212|k0cape01@louisville.edu|
296781|NCT01705977|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
272234|NCT00298233|Oxford University Clinical Research Unit|Dr. Jeremy Farrar|+84 839237954|info@oucru.org|
272235|NCT00298272|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
272236|NCT00298363|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
272237|NCT00298389|Imperial College London|Professor Louise Donnelly|+442075947895|l.donnelly@imperial.ac.uk|
272238|NCT00298558|New England Research Institutes|Sharon L. Tennstedt, PhD|617-972-3362|stennstedt@neriscience.com|
272239|NCT00298610|Walter Reed Army Institute of Research|Shon A. Remich, MD|254-733-628-670|sremich@hotmail.com|
272240|NCT00298766|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
272241|NCT00298831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
272242|NCT00298896|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
272243|NCT00299000|BioMarin Pharmaceutical Inc.|Medical Information Services|800-983-4587|medinfo@bmrn.com|
272244|NCT00299104|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
267099|NCT04476251|National Cancer Institute|Scott M. Norberg D.O.|301-275-9668|scott.norberg@nih.gov|
272245|NCT00299130|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
272246|NCT00299156|The University of Texas MD Anderson Cancer Center|Hagop Kantarjian, MD /Professor|713-792-7026|eharrison@mdanderson.org|
267100|NCT03924765|Georgia Institute of Technology|Dr. Aaron Young|404-385-5306|aaron.young@me.gatech.edu|
267101|NCT03915860|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|1
267102|NCT03817606|Riverside Medical Center|Cynthia Koehn, Clinical Research Nurse|815-933-1671|ckoehn@rhc.net|
267103|NCT03795233|Boston Medical Center|Tamar Barlam, MD MSC|617 414 5190|tamar.barlam@bmc.org|
267104|NCT03786380|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
267105|NCT03769376|"University of Colorado Denver | Anschutz"|Kerri Font, DDS, MS|303-724-1111|clinicalresearchsupportcenter@ucdenver.edu|
267106|NCT03645863|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|+81-3-5960-9608 Japanese only|cti-inq-ml@ml.mt-pharma.co.jp|
267107|NCT03564145|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
267108|NCT03564119|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
267109|NCT03365635|Penn Presbyterian Medical Center|Michael R. Rudnick, MD|215-662-8738|rudnickm@uphs.upenn.edu|
267110|NCT03287050|University of Michigan|Zachery Reichert|764-3066|zreiche@med.umich.edu|
267111|NCT03223350|Henry Ford Hospital|Dr. Joseph Miller, associate research director|313-916-5419|jmiller6@hfhs.org|
267112|NCT03181828|Children's National|Dr. Nicholas Ah Mew|2025452513|nahmew@childrensnational.org|
267113|NCT03181529|Johns Hopkins University|Dr. Roland Griffiths|410-550-0034|rgriff@jhmi.edu|
267114|NCT03138096|Radboud University Medical Center|Dr. M.B.B. McCall|+31642166480|Matthew.McCall@radboudumc.nl|
267115|NCT02993107|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
267116|NCT02946931|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
267117|NCT02779556|University of Arkansas for Medical Sciences|Kristie Hadden, PhD/Associate Professor|501-993-3178|KBHADDEN@uams.edu|
267118|NCT02724774|University of Washington|Carol Rhodes, Director of Sponsored Programs|206 543-2139|carhodes@uw.edu|
308371|NCT02573948|UMR 1058 (Inserm/University of Montpellier/EFS)|NAGOT NICOLAS|+33 4 34 35 91 09|n-nagot@chu-montpellier.fr|
267119|NCT02722941|Moffitt Cancer Center|Taiga Nishihori, MD|813-745-8156|Taiga.Nishihori@moffitt.org|
267120|NCT02675751|Johnson & Johnson Surgical Vision|Sanjeev Kasthurirangan Ph.D.|+1 408-273-4081|skasthur@its.jnj.com|
267121|NCT02643381|UT-Southwestern Medical Center|Gerald Matchett|214-648-6400|gerald.matchett@utsouthwestern.edu|
267122|NCT02621424|VA Palo Alto|Jauhtai Cheng, MD, Staff Neurologist|650-493-5000|jauhtai.cheng2@va.gov|63617
267123|NCT02611960|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
272247|NCT00299182|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|713-792-7966|CR_Study_Registration@mdanderson.org|
272248|NCT00299221|Newark Beth Israel Medical Center|David Baran MD|973-926-7205|dbaran@barnabashealth.org|
272249|NCT00299416|UT-Houston Health Science Center, Department of Neurology|James C. Grotta, MD|713-500-7088|james.c.grotta@uth.tmc.edu|
272250|NCT00299494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272251|NCT00299546|Centocor Research & Development, Inc.|Associate Director Clinical Research|1-800-457-6399||
272252|NCT00299689|James Graham Brown Cancer Center, University of Louisville|Dr. Jason Chesney|502/852-3679|jaches03@exchange.louisville.edu|
272253|NCT00299702|Ortho-McNeil, Inc. N America Pharm CNS/IM|Therapeutic Area Lead|609-730-3693||
272254|NCT00299741|Massachusetts General Hospital|Dr. Dror Michaelson|617-726-1594|dmichaelson1@partners.org|
272255|NCT00299975|Hong Kong Baptist University|Prof. Zhao-xiang Bian|(852) 3411 2905|bzxiang@hkbu.edu.hk|
272256|NCT00299988|Weill Cornell Medical College|Norman Relkin, MD, PhD|212-746-9882|nrelkin@med.cornell.edu|
272257|NCT00300053|Caladrius Biosciences|William Sietsema|9495352391|bsietsema@caladrius.com|
272258|NCT00300235|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
272259|NCT00300274|Novartis Pharmaceuticals|Study Director|862-778-8300||
272260|NCT00300365|University of Pennsylvania|Dr. Richard L. Dunbar|(215) 315-3378|richard.dunbar@uphs.upenn.edu|
272261|NCT00300391|UPittsburgh|Barb Early, RN, BSN, CCRC|(412) 647-9745|earlybj@upmc.edu|
296782|NCT01706003|UT Southwestern Medical Center|Deborah I. Friedman, MD, MPH, Professor of Neurology and Neurotherapeutics and Ophthalmology|2146483517|Deborah.Friedman@utsouthwestern.edu|
296783|NCT01706081|Memorial Sloan Kettering Cancer Center|Dr. Ting Bao MD|646-888-0865|baot@mskcc.org|
296784|NCT01706146|Northwestern University|Adin-Cristian Andrei, Ph.D.|312-694-0509|Adin-Cristian.Andrei@nm.org|
296785|NCT01706159|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
296786|NCT01706198|GlaxoSmithKline|GSK Response Center|866-435-7343||
296787|NCT01706250|GlaxoSmithKline|GSK Response Center|866-435-7343||
272262|NCT00300430|Abbott|Medical Information Specialist|800-633-9110||
272263|NCT00300456|Abbott|Medical Information Specialist|800-633-9110||
272264|NCT00300469|Abbott|Medical Information Specialist|800-633-9110||
272265|NCT00300482|Abbott|Medical Information Specialist|800-633-9110||
272266|NCT00300495|Houston Methodist Hospital|Min Kim|7134415177|mpkim@houstonmethodist.org|
272267|NCT00300677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
272268|NCT00300742|UVA Center for Addiction Research and Education|Dr. Nassima Ait-Daoud|434-243-0541|uvacare@virginia.edu|
272269|NCT00300755|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
272270|NCT00300781|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
272271|NCT00300885|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
272272|NCT00301028|UT MD Anderson Cancer Center|Merrill S. Kies, MD / Professor||CR_Study_Registration@mdanderson.org|
272273|NCT00301067|Northwestern University|Clinical Trials Office|312-695-1301||
272274|NCT00301366|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
272275|NCT00301418|Feinstein Institute for Medical Research|John Boockvar, MD|212-434-3900|jboockvar@northwell.edu|
272276|NCT00301756|Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
272277|NCT00301808|Barbara Ann Karmanos Cancer Institute|Shrish Gadgeel, M.D.|(313) 576-8753|sgadgeel@med.umich.edu|
281831|NCT00823199|Bronx Psychiatric Center|Nigel Bark MD|7188625429|Nigel.Bark@omh.ny.gov|
267124|NCT02595372|IndianaU|Dr. Kathy Miller|(317) 948-3855|kathmill@iu.edu|
267125|NCT02447133|Topcon|Charles Reisman|201-599-5283|CREISMAN@topcon.com|
267126|NCT02434354|Abramson Cancer Center|Dr. Tara Mitchell|215-662-7908|tara.mitchell@pennmedicine.upenn.edu|
267127|NCT02334722|University of Florida|Kristine Wynne|352-273-9727|kristine.wynne@neurosurgery.ufl.edu|
267128|NCT02259725|USC / Norris Comprehensive Cancer Center|Victoria Soto|3238653000|soto_v@med.usc.edu|
267129|NCT01966731|Cincinnati Children's Hospital Medical Center|Russell Ware, MD, PhD|(513) 803-1108|russell.ware@cchmc.org|
267130|NCT01952288|VA Puget Sound Health Care System|Rebekah J. Rein, JD|206-764-2711|rebekah.rein@va.gov|
267131|NCT01850082|VA Boston Healthcare System|Marco Zenati, M.D.|857-203-6815|Marco.Zenati@va.gov|
267132|NCT01844518|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
267133|NCT01675479|Abbott Medical Optics|Head of Clinical Science|714-247-8613|khileman@its.jnj.com|
267134|NCT01398839|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
267135|NCT01349959|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Clinical Research Office|410-955-8866|jhcccro@jhmi.edu|
267136|NCT01193842|AIDS Malignancy Consortium|AMC Statistical Center|501-526-6712|jylee@uams.edu|
267137|NCT01168219|Washington University School of Medicine|Ravi Vij, MD||rvij@im.wustl.edu|
296788|NCT01706263|GlaxoSmithKline|GSK Response Center|866-435-7343||
281832|NCT00823212|Boston Scientific Corporation|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
281833|NCT00823264|Emory University|Dr. Brent Morgan|404-616-4403|bmorg02@emory.edu|
281834|NCT00823303|Washington University School of Medicine|Dr. Daniel W. Coyne|3143627211|dcoyne@dom.wustl.edu|
281835|NCT00823459|University of California, San Francisco|Susan Chang, MD|(415) 353-2966|jessica.carlson@ucsf.edu|
281836|NCT00823472|UMC Utrecht|Prof. dr. B.C.J.M. Fauser|+31-88-7557524|b.c.fauser@umcutrecht.nl|
281837|NCT00823615|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
281838|NCT00823719|GlaxoSmithKline|GSK Response Center|866-435-7343||
281839|NCT00823797|University of Washington|Maciej Mrugala, MD, PhD, MPH|206-543-4069|mmrugala@uw.edu|
281840|NCT00823823|Children's Hospital Boston|Dr. Donald Bae|617-355-6808|donald.bae@childrens.harvard.edu|
281841|NCT00823836|GlaxoSmithKline|GSK Response Center|866-435-7343||
281842|NCT00823901|MGH CURTIS|Alexandra B. Kimball, MD|617-726-5066|harvardskinstudies@partners.org|
281843|NCT00823966|Pfizer, Inc.|Pfizer ClinicalTraials.gov Call Center|1-800-718-1021|ClinicalTraials.govCallCenter@pfizer.com|
281844|NCT00823979|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281845|NCT00824005|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
281846|NCT00824044|Massachusetts General Hospital|Dr. Amy Farabaugh|617-726-1629|afarabaugh@partners.org|
281847|NCT00824070|Bausch & Lomb Inc|Tuyen Ong, MD|(973) 360-6389|tuyen.ong@bausch.com|
281848|NCT00824161|The University of Texas M.D. Anderson Cancer Center|Scott Kopetz, MD|713-792-2828||
282688|NCT00868231|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
282689|NCT00868296|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
282690|NCT00868309|Instituto Bioclon S.A. de C.V.|Walter Garcia|+52 (55)54883700|wgarcia@silanes.com.mx|3785
282691|NCT00868348|Aarhus University Hospital|Karen V Andersen|51263173|karenand@rm.dk|0045
282692|NCT00868374|University Hospitals Cleveland Medical Center|Dr. Keming Gao|216-844-2865|keming.gao@UHhospitals.org|
282693|NCT00868439|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
282694|NCT00868452|Sunovion|Medical Director, CNS|1-866-503-6351||
282695|NCT00868517|Department of Veterans Affairs|Michelle Kennedy Prisco|202-745-8000|michelle.prisco@va.gov|56235
296789|NCT01706328|GlaxoSmithKline|GSK Response Center|866-435-7343||
296790|NCT01706458|UWCCC|Mary Jane Staab - Program Manager|608-262-4304|mjs@medicine.wisc.edu|
296791|NCT01706497|University Hospitals Leuven (UZ Leuven) and KU Leuven|Prof Dr Geert Meyfroidt, Associate Professor|0032 16 344021|geert.meyfroidt@uzleuven.be|
308372|NCT02574078|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
267138|NCT01081262|NRG Oncology|Linda Gedeon on behalf of William Brady, PhD|716-845-1169|lgedeon@gogstats.org|
272278|NCT00301821|Mayo Clinic|Ivana N. M. Micallef, M.D.|507-284-4642|micallef.ivana@mayo.edu|
272279|NCT00301834|University of California San Francisco|Dr. Morton Cowan|4154762188|mcowan@peds.ucsf.edu|
272280|NCT00301873|Duke Comprehensive Cancer Center|Mary Lou Affronti, RN, MSN, ANP, MHSc Senior Investigator|919-684-6239|mary.affronti@duke.edu|
272281|NCT00301964|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
267139|NCT01062425|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
272282|NCT00302003|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
272283|NCT00302042|Northwestern University|Dr. Ronald T. Ackermann|3126036400|r.ackermann@northwestern.edu|
272284|NCT00302055|Northwestern University|Dr. Ronald T Ackermann|(312) 503-6400|r.ackermann@northwestern.edu|
272285|NCT00302068|DukeUMC|Dr. James Blumenthal|919-684-3969|blume003@mc.duke.edu|
272286|NCT00302081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
272287|NCT00302107|Tuscaloosa VA Medical Center|Lori Davis, MD|205-554-2000|lori.davis@va.gov|
272288|NCT00302133|University of Miami Miller School of Medicine|Ihsan Salloum, MD, MPH|305 243-7931|isalloum@med.miami.edu|
272289|NCT00302159|National Cancer Institute, national Institutes of Health|Kevin Camphausen, M.D.|301-496-5457|camphauk@mail.nih.gov|
272290|NCT00302211|Actelion Pharmaceuticals US, Inc.|Gary Palmer SVP, US Medical Affairs|650-624-6900||
267140|NCT00812708|University of California Los Angeles|Kevin M. Miller, MD|(310) 206-9951|millerpatients@jsei.ucla.edu|
272291|NCT00302328|Glostrup Hospital|Ulrik Christensen|+4538634825|bisan@regionh.dk|
272292|NCT00302458|Massachusetts General Hospital|Dr. Thomas Spencer|617-726-1731|spencer@helix.mgh.harvard.edu|
267141|NCT00792259|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
267142|NCT00741988|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
267143|NCT00563576|Columiba University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
267144|NCT00515671|IUPUI|Michelle Salyers|317-274-2904|mpsalyer@iupui.edu|
267145|NCT00455403|Wash. Univ. School of Medicine|Janet McGill, MD|314-362-8681|jmcgill@wustl.edu|
267146|NCT00238420|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
267147|NCT00085982|NIDDK|Rebecca Brown, MD|301-594-0609|brownrebecca@mail.nih.gov|
267148|NCT04328961|University of Washington|Ruanne Barnabas|206 520 3800|rbarnaba@uw.edu|
267149|NCT04128319|Xenikos|Eric van Hooren, Chief Development Officer|+31 6 109 345 84|e.vanhooren@xenikos.com|
267150|NCT03761810|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
267151|NCT03761784|Sol-Gel Technologies, Ltd.|Sol-Gel|972-8-9313433|info@sol-gel.com|
267152|NCT03541317|University of Michigan|Amy M Kilbourne|734-845-3452|amykilbo@umich.edu|
267153|NCT03457129|University of Arizona, College of Medicine Phoenix|Stephanie Marsh, MPH, CCRC|602-255-7552|slmarsh@arizona.edu|
267154|NCT03361865|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
267155|NCT03294304|Masonic Cancer Center, University of Minnesota|Dr. Konety Badrinath|612-625-1655|brkonety@umn.edu|
267156|NCT03122431|Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo|Prof Eloisa Bonfa|551130617490|eloisa.bonfa@hc.fm.usp.br|
267157|NCT02929056|Prisma Health|Dr. Thomas Oliver|864-454-8272|Tom.Oliver@prismahealth.org|
267158|NCT02896855|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
267159|NCT02871778|Parion Sciences|Karl Donn|919 313 1185|kdonn@parion.com|
267160|NCT02769000|Virginia Commonwealth University|Timothy Harris, MD|804-828-7232|timothy.harris@vcuhealth.org|
267161|NCT02756208|Institute of Human Virology|Dr. Mohammad Sajadi|410-7061779|msajadi@ihv.umaryland.edu|
267162|NCT02714218|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
267163|NCT02564263|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267164|NCT02450331|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
267165|NCT02149121|Celltrion, Inc.|SungYoung Lee|+82 32 850 6532|SungYoung.Lee@celltrion.com|
267166|NCT02066181|Memorial Sloan-Kettering Cancer Center|Mrinal Murugesan Gounder M.D.|646-888-4167|gounderm@mskcc.org|
267167|NCT01933932|AstraZeneca Research and Development|Dr Gabriella Mariani|+44 (0)1763 263801|ClinicalTrialTransparency@astrazeneca.com|
267168|NCT01927419|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
267169|NCT01889186|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
267170|NCT01850004|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
267171|NCT01849263|Washington University School of Medicine|Nancy L. Bartlett, M.D.||nbartlet@dom.wustl.edu|
267172|NCT01844505|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
267173|NCT01757535|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|clinicaltrialdisclosure@celgene.com|
267174|NCT01750281|AstraZeneca|Dr Gabriella Mariani|+44 (0)207 6048000|ClinicalTrialTransparency@astrazeneca.com|
272293|NCT00302718|VA HSR&D Center for Innovations in Quality, Effectiveness & Safety (IQuESt)|Dr. Laura A. Petersen|713-794-8623|Laura.Petersen@va.gov|
282696|NCT00868530|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296792|NCT01706536|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
296793|NCT01706549|Tampere University Hospital|MD Satu Pokkinen|+3583311611|Satu.pokkinen@pshp.fi|
296794|NCT01706575|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
296795|NCT01706588|The School of Dentistry, University of Birmingham|Prof. Thomas Dietrich|+44-121-46 65494|t.dietrich@bham.ac.uk|
272294|NCT00302731|University of Kansas Medical Center|Jeanne A Drisko, MD, CNS, FACN|913-588-6208|jdrisko@kumc.edu|
267175|NCT01510184|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|gajanan.Bhat@sppirx.com|
272295|NCT00302848|Berlin Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD, Principal Investigator|+49 30 94510145|dinger@zeg-berlin.de|
272296|NCT00302952|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
272297|NCT00303069|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@spcorp.com|
272298|NCT00303108|New York Oncology Hematology, Albany Medical Center|Dr. Rufus Collea|518-262-6696|rufus.collea@usoncology.com|
272299|NCT00303186|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272300|NCT00303316|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
272301|NCT00303329|Novartis Pharmaceuticals|Study Director|862-778-8300||
272302|NCT00303446|National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH)|Kenneth Fischbeck, M.D.|301-435-9318|kf@ninds.nih.gov|
272303|NCT00303459|Actelion Pharmaceuticals Ltd|Jonathan Tolson|+41 61 565 56 04|jonathon.tolson@actelion.com|
272304|NCT00303472|Amgen Inc.|Study Director|866-572-6436||
267176|NCT01471444|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
272305|NCT00303485|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
272306|NCT00303511|Emory University|Dr. Wendy Book|404-778-5545|wbook@emory.edu|
272307|NCT00303602|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
272308|NCT00303628|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
272309|NCT00303667|Masonic Cancer Center|Sarah Cooley, M.D.|612-626-4024|cool0023@umn.edu|
267177|NCT01238211|The Ohio State University|Guido Marcucci, M.D.||Guido.Marcucci@osumc.edu|
272310|NCT00303719|Masonic Cancer Center, University of Minnesota|Erica Warlick, MD|612-625-8942|ewarlick@umn.edu|
272311|NCT00303823|The University of Arizona|H-H. Sherry Chow, Ph.D.|520-626-3358|schow@azcc.arizona.edu|
272312|NCT00303862|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
272313|NCT00303901|Barbara Ann Karmanos Cancer Institute|Peter Littrup, M.D.|313-576-8758|littrupp@karmanos.org|
272314|NCT00303953|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623|mleblanc@fhcrc.org|
272315|NCT00303966|University of Chicago|Dr. Wendy Stock|773-834-8982|wstock@medicine.bsd.uchicago.edu|
272316|NCT00303979|Medtronic Cardiac Rhythm Disease Management|IMPROVE HF, Clinical Research Specialist||medtronicCRMtrials@medtronic.com|
272317|NCT00304031|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
272318|NCT00304070|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
272319|NCT00304083|SARC|Research Project Manager|734-930-7600|sarc@sarctrials.org|
272320|NCT00304096|University of Virginia|Kimberly Bullock, PhD and David Brenin, MD|434-924-0180|kb9d@virginia.edu|
272321|NCT00304161|University of Pennsylvania|Dr. Daniel Weintraub|215-349-8207|daniel.weintraub@uphs.upenn.edu|
272322|NCT00304187|New York State Psychiatric Institute|Dr. Michael Devlin|212-543-5748|mjd5@columbia.edu|
272323|NCT00304265|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
272324|NCT00304278|Southern Illinois University|Dr. Krishna Rao|217-545-7969|krao@siumed.edu|
272325|NCT00304356|VA Houston|Daniel Musher|713-794-7386|daniel.musher@va.gov|
272326|NCT00304512|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
272327|NCT00304707|University of Massachusetts Medical School|David Kalman, PhD|9785782371|kalmand@comcast.net|
272328|NCT00304746|McLean Hospital|Harrison G Pope Jr., M.D.|617-855-2911|hpope@mcLean.harvard.edu|
272329|NCT00304915|Central Arkansas Veterans Healthcare System|Dr. Jeff Pyne|501-257-1083|jmpyne@uams.edu|
272330|NCT00304954|NEI|Dr. Robert Nussenblatt, MD, MPH|301-496-3123|robert.nussenblatt@nih.gov|
272331|NCT00305006|Teachers College, Columbia University|Dr. Andrew Gordon|212-678-3326|ag275@columbia.edu|
272332|NCT00305058|Montefiore Medical Center|Andrew Chang, MD|718-920-6626|achang3@yahoo.com|
272333|NCT00305084|Clinical Operations|MolMed S.p.A.|0039 02212771|clinical.operations@molmed.com|
272334|NCT00305110|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7476|achang@montefiore.org|
272335|NCT00305162|The Medicines Company|Meredith Todd|+19732906088|meredith.todd@themedco.com|
272336|NCT00305227|University of Washington|Ann Stapleton, MD|206-616-4121|stapl@uw.edu|
272337|NCT00305253|University of California San Francisco (UCSF)|Suellen Miller|415 597 9394|smiller@globalhealth.ucsf.edu , suellenmiller@gmail.com|
272338|NCT00305448|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
272339|NCT00305565|Cyberonics Inc.|Mark Bunker Sr. Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
272340|NCT00305578|Indiana University|Dr. Amit Anand||aanand@iupui.edu|
272341|NCT00305604|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
272342|NCT00305682|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
272343|NCT00305695|NRG Oncology|Linda Gedeon on behalf of James Kauderer, MA, BS|716-845-1169|linda.gedeon@roswellpark.org|
272344|NCT00305760|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
272345|NCT00305773|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Steven Gore, MD||gorest@jhmi.edu|
296796|NCT01706666|Mayo Clinic Cancer Center|Craig B Reeder, MD|4803018335|Reeder.Craig@mayo.edu|
296797|NCT01706770|Foresight Regulatory Strategies, Inc.|William J. Gleason, O.D.|(978) 658-6888||151
296798|NCT01706822|Covidien|Julie Doyle|781-839-1729|Julie.Doyle@Covidien.com|
296799|NCT01706926|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
296800|NCT01706952|McGill University Health Centre|Marc A. Tewfik|+15147976673|marc.tewfik@mcgill.ca|
296801|NCT01706965|New York State Psychiatric Insititute|Marlene Carlson|646-774-8436|marlene.carlson@nyspi.columbia.edu|
296802|NCT01706978|The Ottawa Hospital Research Institute|Dr. Peter Lapner|613-737-8899|plapner@toh.ca|78377
272346|NCT00305864|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
272347|NCT00305877|ECOG Statistical Office|Study Statistician|617-632-3012||
272348|NCT00305942|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
272349|NCT00306163|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
272350|NCT00306189|Amgen Inc.|Study Director|866-572-6436||
272351|NCT00306202|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
267178|NCT00545766|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
272352|NCT00306293|GlaxoSmithKline|GSK Response Center|866-435-7343||
272353|NCT00306384|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
272354|NCT00306488|National Eye Institute|Wai Wong, MD, PhD|301-496-7566|wongw@mail.nih.gov|
272355|NCT00306527|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
272356|NCT00306592|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
272357|NCT00306670|Georgetown University|Craig M Kessler, MD|202-444-8676|kesslerc@georgetown.edu|
272358|NCT00306787|Novartis Pharmaceuticals|Study Director|862-778-8300||
272359|NCT00306852|University of Miami|Dr. Steven Gedde|305-326-6435|sgedde@med.miami.edu|
272360|NCT00306891|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
272361|NCT00306917|DePuy Orthopaedics, Inc|Barry Sisson|574-372-7156|BSisson@its.jnj.com|
272362|NCT00306995|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
272363|NCT00307034|GlaxoSmithKline|GSK Response Center|866-435-7343||
272364|NCT00307047|Abbott Vascular|Ellen Travis|408-845-1512|ellen.travis@av.abbott.com|
267179|NCT04101890|Children's Research Institute|Elena Gibson|(202) 476-6877|egibson@cnmc.org|
267180|NCT03993314|University of Alabama at Birmingham|Dr. Mark Powell|205-934-6007|mfpowell@uabmc.edu|
267190|NCT03112902|University of Colorado|Brice McConnell|303-724-3897|brice.mcconnell@cuanschutz.edu|
267191|NCT02976038|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
267192|NCT02951767|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
272365|NCT00307086|H. Lee Moffitt Cancer Center|Mellisa Alsina, MD|813-745-6886|Melissa.Alsina@moffitt.org|
267194|NCT02631070|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
267195|NCT02557139|Kadmon Corporation, LLC|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|833-900-5366|olivier.schueller@kadmon.com|
267196|NCT02513667|UT Southwestern Medical Center|Dr. Sawsan Rashdan|214-648-4180|Sawsan.Rashdan@UTSouthwestern.edu|
267197|NCT02281955|University of North Carolina at Chapel Hill|Dr. Bhisham Chera|984-974-0400|bchera@med.unc.edu|
267198|NCT02202434|Boston Scientific|Amy Maurer|508-683-6647|amy.maurer@bsci.com|
267199|NCT02108652|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
267200|NCT02097134|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
267201|NCT01727011|Centre Antoine Lacassagne|Professeur JM Hannoun-Levi|04.92.03.12.60|jean-michel.hannoun-levi@nice.unicancer.fr|
267202|NCT01564537|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
267203|NCT01230242|MaineHealth|Clinicaltrials.gov Administrator|207.396.8228|llemire@mmc.org|
267204|NCT00983437|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
267205|NCT00965757|Eisai Co., Ltd.|Kota Nagai|+81-3-3817-5238||
267206|NCT00928447|Halozyme Therapeutics|Chief Medical Officer|855-495-3639|halozyme@EVERSANA.com|
267207|NCT00893789|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
267208|NCT04349150|Massachusetts General Hospital|Daniel C. Chung, MD|6177263544|chung.daniel@mgh.harvard.edu|
267209|NCT03948698|Elizabeth Glaser Pediatric AIDS Foundation|Shirin Kakayeva|2404377929|skakayeva@pedaids.org|
272366|NCT00307125|DAIT/NIAID|Director, Clinical Research Operations Program (CROP)|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
272367|NCT00307151|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
272368|NCT00307164|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
272369|NCT00307294|University of Pittsburgh|Rita Johnson RN BSN CCRC|412-647-8571|johnsonr1@upmc.edu|
272370|NCT00307333|University of Virginia|Joseph R. Moorman, MD|434-982-3367|rm3h@virginia.edu|
272371|NCT00307437|Centocor Research & Development, Inc.|Senior Director, Compound Development Team Leader|1 215 793-7612||
272372|NCT00307489|Gilead Sciences, Inc.|Stephen J. Rossi, PharmD|650-522-4212|stephen.rossi@gilead.com|
272373|NCT00307684|Janssen-Cilag G.m.b.H.|European Medical Affairs Director Neurology|+49 2137 955258|bschaeu2@its.jnj.com|
272374|NCT00307736|Massachusetts General Hospital|Lawrence Blaszkowsky|6177244637|lblaszkowsky@partners.org|
272375|NCT00307801|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
272376|NCT00307931|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
272377|NCT00308061|University of Bamako Faculty of Medicine, Mali|Mahamadou A. Thera, MD MPH|223-222-1809|mthera@mrtcbko.org|
281849|NCT00824265|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
296803|NCT01707004|UW Carbone Cancer Center|Aric Hall|608-262-1604|achall@medicine.wisc.edu|
296804|NCT01707030|Department of Veterans Affairs|Dr. Micheal Cucciare|501-257-1068|Michael.Cucciare@va.gov|
296805|NCT01707043|Wake Forest|Steve Feldman, MD|336-716-3775|sfeldman@wakehalth.edu|
296806|NCT01707095|University of Colorado|Thomas Robinson|303-724-2728|thomas.robinson@ucdenver.edu|
272378|NCT00308074|University of Massachusetts Medical School|Dr. Jean A. Frazier|508-856-5896|ChildResearch@umassmed.edu|
272379|NCT00308087|Genzyme Corporation|Genzyme MedInfo||medinfo@genzyme.com|
272380|NCT00308139|AstraZeneca|ClinicalTrialTransparency@astrazeneca.com||ClinicalTrialTransparency@astrazeneca.com|
272381|NCT00308230|Emory University|Wendy Book|404-778-5545|wbook@emory.edu|
272382|NCT00308282|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
272383|NCT00308308|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
296807|NCT01707108|Rambam Health Care Campus|Director of Trial|+97247772983|j_horwitz@rambam.health.gov.il|
272384|NCT00308555|UCSF/San Francisco General Hospital|Dr. Donald I. Abrams|415-476-4082|dabrams@hemeonc.ucsf.edu|444
267181|NCT03874351|MJHS Institute for Innovation in Palliative Care, New York, NY|Helena Knotkova, PhD, PhilD|646-784-2262|HKnotkov@mjhs.org|
272385|NCT00308581|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
272386|NCT00308620|University of Minnesota|David Boulware|6126269546|boulw001@umn.edu|
296808|NCT01707147|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
272387|NCT00308711|Cytokine PharmaSciences, Inc.|Barbara L. Powers|610-687-1776|bpowers@cytokinepharmasciences.com|214
272388|NCT00308737|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
272389|NCT00308750|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
272390|NCT00308997|Yale University School of Medicine|Ralph Hoffman, MD|203-688-9734|Ralph.Hoffman@yale.edu|
267182|NCT03856359|Duke University Hospital|Dr. Paul V. Suhocki|919-684-7284|suhoc001@mc.duke.edu|
267183|NCT03769519|Duke|Isaretta L. Riley, MD, MPH|919-286-0411|isaretta.riley@duke.edu|
267184|NCT03745651|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
267185|NCT03745638|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
267186|NCT03715764|Region Västra Götaland, Närhälsan|PhD-student, Chan-Mei Ho-Henriksson|+46709892821|chan-mei.ho@vgregion.se|
267187|NCT03663855|NYU Langone Health|David Goldfarb, MD|(212) 263-7300|David.Goldfarb@nyulangone.org|
267188|NCT03654729|Egetis Therapeutics AB|Kristina Sjoblom Nygren|+46732344698|kristina.sjoblom@egetis.com|
267189|NCT03531112|University of North Carolina at Chapel Hill|Rachel Goode, PhD|919-962-6429|rwgoode@email.unc.edu|
267210|NCT03933449|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267211|NCT03901144|Perrigo/ACO Hud Nordic|Dr Tina Holm|+46732744113|tina.holm@perrigo.com|
267212|NCT03561701|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
272391|NCT00309140|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
272392|NCT00309166|GlaxoSmithKline|GSK Response Center|866-435-7343||
272393|NCT00309244|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
272394|NCT00309387|University of Parma|Giovanni Maraini, MD|+39 0521 238527|maraini@unipr.it|
272395|NCT00309452|Yale University|Vinod H. Srihari|2039747816|vinod.srihari@yale.edu|
272396|NCT00309465|Beaumont Health System|Tamra Dukatz, CRNA, MSN|248 992-4741 (pager)|tdukatz@beaumont.edu|
272397|NCT00309608|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
272398|NCT00309738|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
272399|NCT00309751|Kowa Research Institute Inc|Bill Arana|919 433 1600|barana@kowaus.com|
272400|NCT00309777|Kowa Research Europe, Ltd.|Neil Hounslow|01189229004|nhounslow@kowa.co.uk|
272401|NCT00309842|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612-625-3918|bruns072@umn.edu|
272402|NCT00309907|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
272403|NCT00309946|The University of Chicago|Dr. Hedy Kindler|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
272404|NCT00309959|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
272405|NCT00309985|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
272406|NCT00310037|University of California, San Francisco|Lawrence D. Kaplan, MD||lkaplan@medicine.ucsf.edu|
272407|NCT00310050|Wake Forest University Health Sciences|Dr. William Blackstock|3367136501|ablackst@wakehealth.edu|
272408|NCT00310076|Comprehensive Cancer Center of Wake Forest University|Greg Russell, MS|336-716-5449|grussell@wakehealth.edu|
272409|NCT00310310|VA San Diego Healthcare System|Carl J. Stepnowsky,PhD|858-642-1240|Carl.Stepnowsky@va.gov|
272410|NCT00310362|MInneapolis VA Health Care System|Dr. Joan Griffin|507-538-1490|griffin.joan@mayo.edu|
272411|NCT00310375|GlaxoSmithKline|GSK Response Center|866-435-7343||
272412|NCT00310401|Vanderbilt University|Lorraine B. Ware M.D.|615 322 8614|lorraine.ware@vanderbilt.edu|
272413|NCT00310427|NIH/National Institute on Alcohol Abuse and Alcoholism|Markus A. Heilig, M.D., Ph.D.|301-435-9386|mheilig@mail.nih.gov|
272414|NCT00310440|Nor Consult, LLC|Lead Clinical Research Associate|2066076861|p15@nor-consult.com|
272415|NCT00310466|ALK-Abelló A/S|Kim Simonsen, Senior Director|+4545747576||
272416|NCT00310791|Children's Hospital Boston|Dr. Catherine Gordon|401-444-4712|cgordon1@lifespan.org|
272417|NCT00310804|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
296809|NCT01707225|Virginia Commonwealth University|Rajiv Malhotra, DO|804-828-9071|rajiv.malhotra@vcuhealth.org|
272418|NCT00310817|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
272419|NCT00310856|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
272420|NCT00311155|Daiichi Sankyo Pharma Development|Sr. Director, Regulatory Operations|732-590-5032|hmkessler@dsi.com|
272421|NCT00311168|Abbott|Clay Cohorn - Director, Clinical Research|469-929-7116|clay.cohorn@abbott.com|
272422|NCT00311181|St Jude Medical|Ashish Oza|818-493-3648|aoza@sjm.com|
272423|NCT00311246|UIC|Nadera J Sweiss|312-996-5723|nsweiss@uic.edu|
272424|NCT00311311|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272425|NCT00311363|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
272426|NCT00311376|Allergan, Inc.|Therapeutic area Head|714-246-4500|clinicaltrials@allergan.com|
296810|NCT01707238|Visioncare Research Ltd.|Graeme Young|01252 718719|g.young@visioncare.co.uk|207
308373|NCT02574247|University of Illinois at Urbana-Champaign|Dr. Ian Mertes|217-300-4756|imertes@illinois.edu|
272427|NCT00311402|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
272428|NCT00311584|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
272429|NCT00311623|Duke University|Andrew Armstrong, MD ScM FACP|(919) 668-8797|andrew.armstrong@duke.edu|
267213|NCT03525808|Boston Scientific|Ornela Gjata|(508)-683-4155|Ornela.Gjata@bsci.com|
267214|NCT03461211|Horizon Pharma USA, Inc.|Roxann Becco|866-479-6742|clinicaltrials@horizontherapeutics.com|
267215|NCT03282123|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
267216|NCT03276780|University of Alabama at Birmingham, Department of Psychiatry and Behavioral Neurobiology|Dr. Karen Cropsey|205-975-4204|kcropsey@uabmc.edu|
267217|NCT03219333|Seagen Inc|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
267218|NCT03205553|University of Arkansas for Medical Sciences|Dr. Patrick Bonasso|(501) 364-2943|PCBonasso@uams.edu|
267219|NCT03104205|Dartmouth-Hitchcock|John A. Batsis|6036505000|john.a.batsis@hitchcock.org|
267220|NCT03100149|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
267221|NCT03050814|National Cancer Institute|Dr. Julius Y. Strauss|240-858-3999|julius.strauss@nih.gov|
267222|NCT02797262|University of California, Los Angeles|Research Scientist|3105917541|statue22@gmail.com|
267223|NCT02639910|MorphoSys AG|Peter Kelemen MD, PhD - Director, Clinical Program Leader|+498989927|peter.kelemen@morphosys.com|26856
267224|NCT02409368|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
267225|NCT02322593|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
267226|NCT02277119|Topcon|Charles Reisman|201-599-5283|CREISMAN@topcon.com|
267227|NCT02220894|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267228|NCT02124824|VAMC SLC|Scott Capps|8015821565|Scott.Capps@hsc.utah.edu|
267229|NCT01772004|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
267230|NCT01721759|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
267231|NCT01322971|Stanford University|Ruth Lathi||rlathi@stanford.edu|
267232|NCT01285102|Fox Chase Cancer Center|Dr. Efrat Dotan|215-214-4283|Efrat.Dotan@fccc.edu|
267233|NCT01026220|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
267234|NCT00952692|Duke University|Dr. Michael Morse|919-681-3480|morse004@mc.duke.edu|
267235|NCT00804713|USUHS|James Mancuso|301-295-3734|james.mancuso@usuhs.edu|
267236|NCT00677560|Queen Mary University of London|Dr Harpal Singh Kalsi|07872492181|h.kalsi@qmul.ac.uk|
267237|NCT00389649|Universitry of Maryland|Stephen Gottlieb, MD|4103288788|sgottlie@medicine.umaryland.edu|
267238|NCT04644328|Massachusetts Institute of Technology|Esther Duflo|617-258-7013|eduflo@mit.edu|
267239|NCT04246554|UH Cleveland Medical Center|Dr. Michael Karns|216-844-7200|srmengers@gmail.com|
267240|NCT03877926|Emergent BioSolutions Inc.|Bojan Drobic, Director, Clinical Research|204 275 4196|bdrobic@ebsi.com|
267241|NCT03862807|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
267242|NCT03857867|Stanford|Peter Tass|650-304-8849|ptass@stanford.edu|
267243|NCT03691571|The Hospital of the University of Pennsylvania|Dr. Cory M. Tschabrunn|215-614-0482|coryt@pennmedicine.upenn.edu|
267244|NCT03436199|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
267245|NCT03417102|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
267246|NCT03353233|Duke University Medical Center|W. Michael Bullock, MD, PhD|919-681-6437|william.bullock@duke.edu|
267247|NCT03250273|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
267248|NCT03217136|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267249|NCT03181542|Penn State Hershey Medical Center|Dr Priti Dalal|717-531-6597|pdalal@pennstatehealth.psu.edu|
267250|NCT02983617|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
267251|NCT02964377|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
267252|NCT02790034|Newron Pharmaceuticals S.p.A.|Ravi Anand MD, Chief Medical Officer|+41 793741364|regulatoryaffairs@newron.com|
272430|NCT00311766|RegeneRx Biopharmaceuticals, Inc.|Study Director, David R. Crockford|617-285-5588|dcrockford@regenerx.com|
272431|NCT00312195|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
272432|NCT00312208|sanofi-aventis|Medical Affairs study director||publicregistryGMA@sanofi-aventis.com|
272433|NCT00312221|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
272434|NCT00312338|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
272435|NCT00312377|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
267253|NCT02649946|BD/Bard|Heather Lam, Associate Project Manager, Clinical Affairs|(763) 390-8616|heather.lam@bd.com|
272436|NCT00312494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
272437|NCT00312572|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
272438|NCT00312663|WRAIR|James Cummings, MD|301-319-9312|james.cummings@us.army.mil|
272439|NCT00312702|Walter Reed Army Institute of Research|James F. Cummings, MD|301-319-9312|james.cummings@us.army.mil|
272440|NCT00312728|Hoffman-LaRoche|Medical Communications|800-821-8590||
296811|NCT01707290|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
272441|NCT00312845|Johnson & Johnson Pharmaceutical Research & Development|Yusri A. Elsayed, M.D., M.H.Sc., Ph.D.||YElsaye1@ITS.JNJ.COM|
272442|NCT00312858|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308374|NCT02574260|Amgen, Inc.|Study Director|866-572-6436||
267254|NCT02431247|Janssen Sciences Ireland UC|Clinical Registry Group|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
267255|NCT02395666|Beat Childhood Cancer|Dr. Giselle Sholler|6162670334|giselle.sholler@helendevoschildrens.org|
267256|NCT02345850|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
267257|NCT02343302|Johns Hopkins University|Director of Clinical Trials|410-955-7518|sleung7@jhu.edu|
267258|NCT02281084|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|908-673-9100|ClinicalTrialDisclosure@Celgene.com|
267259|NCT02053584|Wolfson Medical Center|Dr. Julio Weinstein|972-3-5028371|vainstein@wolfson.health.gov.il|
267260|NCT01962792|Pharmacyclics LLC|Thorsten Graef, Head of Clinical Development|+1 (408) 215-3127|tgraef@pcyc.com|
267261|NCT01878500|Johns Hopkins University|Dr. John P Gearhart|410-955-5358|jgearha2@jhmi.edu|
267262|NCT01464164|Feinstein Institutes for Medical Research|Adrianna Vlachos, MD|516-562-1506|avlachos@northwell.edu|
267263|NCT01318317|City of Hope|Dr. Lwaliw Popplewell|626-359-8111|lpopplewell@coh.org|
267264|NCT01111565|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
267265|NCT01092117|Endologix|Manager, Clinical Affairs|864-270-8524|nsmith@endologix.com|
267266|NCT00950989|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
267267|NCT00601900|Memorial Sloan-Kettering Cancer Center|Maura Dickler, M.D.||dicklerm@mskcc.org|
267268|NCT00489307|UT MD Anderson Cancer Center|Dr. Sriram Yennu, Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
267269|NCT00072410|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
272443|NCT00312884|Imperial College london|Professor Cowie|0207 349 7716|m.cowie@imperial.ac.uk|
272444|NCT00312897|Icahn School of Medicine at Mount Sinai|Dr. Vilma Gabbay|212-659-1661|vilma.gabbay@mssm.edu|
272445|NCT00312923|Rush University Medical Center|Barbara Swanson|312-942-8977|barbara_a_swanson@rush.edu|
272446|NCT00313014|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
272447|NCT00313144|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
272448|NCT00313170|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
272449|NCT00313209|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
272450|NCT00313300|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
272451|NCT00313313|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
272452|NCT00313443|Unité de Recherches Thérapeutiques. Service de Médecine Interne A. Hôpital Lariboisière. Paris, France|Dr Carmelo Lafuente-Lafuente|+33 1 49 95 63 37|c.lafuente@nodo3.net|
272453|NCT00313560|Sidney Kimmel Comprehensive Cancer Center|Dr. Amol Narang|410-502-3823|anarang2@jhmi.edu|
272454|NCT00313586|ECOG Statistical Office|Study Statistician|617-632-3012||
272455|NCT00313612|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
272456|NCT00313703|Montefiore Medical Center|Benjamin Friedman|718-920-6626|befriedm@montefiore.org|
272457|NCT00313716|Baylor College of Medicine|Claudia Robertson, MD|713-873-2792|claudiar@bcm.edu|
272458|NCT00313729|UCSF Neuro-Oncology|Susan Chang MD|415-353-2966|Susan.Chang@ucsf.edu|
272459|NCT00313781|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272460|NCT00313820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
272461|NCT00313846|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
272462|NCT00313911|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
272463|NCT00314106|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
272464|NCT00314132|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
272465|NCT00314145|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
272466|NCT00314236|Piramal Healthcare (Canada) Limited|Alberto Restrepo, MD, Director of Medical and Clinical Affairs|450-686-2437|alberto.restrepo@piramal.com|315
272467|NCT00314249|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|1-201-427-8218|robert.palmer@frx.com|
272468|NCT00314262|Emory University School of Medicine|Dong Shin, MD|404-778-2980|dmshin@emory.edu|
272469|NCT00314340|UC Davis Medical Center|Barth Wilsey MD|916-843-7165|blwilsey@ucdavis.edu|
272470|NCT00314366|Texas Heart Institute|Emerson C. Perin, M.D., Ph.D.|832-355-9405|eperin@texasheart.org|
272471|NCT00314574|Hoffman-LaRoche|Medical Communications|800-821-8590||
272472|NCT00314795|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
272473|NCT00314808|Duke University|Deborah H. Allen, MSN, RN, CNS, FNP-BC, AOCNP|(919) 681-4719|allen079@mc.duke.edu|
272474|NCT00314951|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
272475|NCT00315055|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
281850|NCT00824291|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272476|NCT00315120|University of North Texas Health Science Center-The Osteopathic Research Center|John C. Licciardone, DO, MS, MBA|817-735-2028|john.licciardone@unthsc.edu|
272477|NCT00315146|Wake Forest Universtiy Baptist Medical Center|Stephen Kritchevsky|336-713-8548|skritche@wakehealth.edu|
281851|NCT00824369|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281852|NCT00824382|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281853|NCT00824408|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281854|NCT00824421|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281855|NCT00824434|Boston Scientific|Ruth Starzyk, PhD|508-683-6577|ruth.starzyk@bsci.com|
281856|NCT00824460|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
281857|NCT00824473|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
281858|NCT00824512|Ipsen|Medical Director, Primary Care|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
267270|NCT05057923|DreamTec Research Limited|Keith Kwong|+85237052355|keithkwong@dreamtec.hk|
267271|NCT04632706|MedinCell S.A.|Joel Richard - Chief Development Officer|00336984590|joel.richard@medincell.com|99
267276|NCT04151290|Cognoa|Senior Director Clinical Research|4082076659|minda.seal@cognoa.com|
267283|NCT03819114|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
267284|NCT03804268|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
267285|NCT04721171|Medical College of Wisconsin|Thangam Venkatesan|262-226-9632|tvenkate22@gmail.com|
267286|NCT04435808|The University of New Mexico School of Medicine|Walter Dehority|5052725535|wdehority@salud.unm.edu|
267287|NCT04409262|Hoffmann - La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
267288|NCT04305912|CooperVision, Inc|Jose Vega, OD, MSc, FAAO|9256213761|JVega2@coopervision.com|
296812|NCT01707368|LEO Pharma GmbH|Tobias Anger, Medical Advisor|+49 610 220 1258|TANDE@leo-pharma.com|
267289|NCT04030416|seca gmbh & co. kg|Kristin Klückmann|+49(40)200000|kristin.klueckmann@seca.com|232
267290|NCT04028648|seca gmbh & co. kg|Kristin Klückmann|040200000232|kristin.klueckmann@seca.com|
267291|NCT03987919|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
267292|NCT03980145|Indiana University|Peter Altenburger|3172780703|paltenbu@iu.edu|
267293|NCT03905694|Alnylam Pharmaceuticals Inc.|Chief Medical Officer|866-330-0326|clinicaltrials@alnylam.com|
267294|NCT03861039|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
267295|NCT03759587|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
267296|NCT03730662|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
267297|NCT03681184|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
267298|NCT03538444|Medical University of South Carolina|Gregory Sahlem MD|843-792-5716|sahlem@musc.edu|
267299|NCT03410693|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
267300|NCT03369431|University College London|Susan Simmons|+44 7952961881|susan.simmons.16@ucl.ac.uk|
267301|NCT03359356|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
267302|NCT03252925|The First Affiliated Hospital of Soochow University|Yue Han|13901551669|hanyue@suda.edu.cn|
267303|NCT03185832|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
267304|NCT02963714|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
267305|NCT02959918|Selecta Biosciences, Inc.|Dr. Peter Traber|713-540-9776|ptraber@selectabiosciences.com|
267306|NCT02855944|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
267307|NCT02485691|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
267308|NCT02472964|Mylan Inc|Clinical Program Manager|412-651-9530|gail.tribble@mylan.com|
267309|NCT02178722|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
281859|NCT00824538|University of California San Francisco|Hope S Rugo|877-827-3222|clinicaltrials@ucsf.edu|
281860|NCT00824564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281861|NCT00824616|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281862|NCT00824655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281863|NCT00824720|Vistakon|Brian Schwam MD/Director Clinical Affairs & Ocular Sciences|904-443-1482||
281864|NCT00824733|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy, MD|614-293-8858|Bhuvaneswari.Ramaswamy@osumc.edu|
281865|NCT00824746|Chonnam National University Hwasun Hospital|Young-Chul Kim, MD, PhD|82-61-379-7614|kyc0923@jnu.ac.kr|
281866|NCT00824772|Inje University|Kye-Min Kim, Associate Professor, Dept of Anesthesiology & Pain Medicine|82-2-950-1168|kyemin@paik.ac.kr|
281867|NCT00824824|Massachusetts Eye and Ear Infirmary|Louis R. Pasquale, MD|617-573-4270|Louis_Pasquale@meei.harvard.edu|
296813|NCT01707381|Bausch + Lomb|Heleen DeCory, Ph.D.|(585) 338-8161|Heleen.DeCory@bausch.com|
281868|NCT00824850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281869|NCT00824993|UT MD Anderson Cancer Center|Lu,Huifang,M.D. PH.D. / General Internal Medicine|713-563-4462|HLU@MDANDERSON.ORG|
281870|NCT00825162|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
281871|NCT00825175|University of Michigan|Julia Looper|253 534 8499|jlooper@umich.edu|
281872|NCT00825266|Stanford University|Roham Zamanian|650-725-5495|roham.zamanian@stanford.edu|
282697|NCT00868608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296814|NCT01707420|University of Colorado|Thomas Notides|720-777-6005|thomas.notides@childrenscolorado.org|
272478|NCT00315302|Jaeb Center for Health Research|Raymond Kraker|813-975-8690|pedig@jaeb.org|
272479|NCT00315328|Jaeb Center for Health Research|Raymond Kraker|813-975-8690|pedig@jaeb.org|
272480|NCT00315341|University of California, Los Angeles|Walter Ling, M.D.|(310) 933-8111|lwalter@ucla.edu|
272481|NCT00315445|Purdue Pharma L.P.|Medical Director|800-733-1333||
272482|NCT00315458|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
272483|NCT00315588|University of Miami Miller School of Medicine Miami Fl|Dr. Rodolfo Alejandro|305 243 5324|ralejand@med.miami.edu|
272484|NCT00315614|University of Miami|Dr. Rodolfo Alejandro|3052435324|ralejand@med.miami.edu|
272485|NCT00315627|University of Miami Miller School of Medicine|Dr. Rodolfo Alejandro|305 243-5324|ralejand@med.miami.edu|
267272|NCT04544358|University of Illinois at Chicago|Dr. David X Marquez|312.996.1209|marquezd@uic.edu|
267273|NCT04498247|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267274|NCT04472650|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
267275|NCT04359797|Vanderbilt University Medical Center|Dr. Edward T. Qian|615-322-2386|edward.t.qian@vumc.org|
267278|NCT04038385|William Paterson University, Sociology Department|Jennifer Di Noia, PhD, Principal Investigator|19737203714|dinoiaj@wpunj.edu|
267279|NCT03978091|ARLG - Albany College of Pharmacy and Health Sciences|Thomas Lodise, PharmD, PhD|1 (518) 694-7292|Thomas.Lodise@acphs.edu|
267280|NCT03923738|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
267281|NCT03887117|Philip Morris Products S.A.|Christelle Haziza, Global Head Clinical Research and Execution|+41 58 242 11 11|ClinicalTrials.PMI@pmi.com|
267282|NCT03858634|Kiniksa Pharmaceuticals, Ltd.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
267310|NCT01258803|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
267311|NCT01104922|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor; ClinicalTrials.gov Admin|412-647-5554|stadtermanbm@upmc.edu|
267312|NCT00862251|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267313|NCT00783263|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267314|NCT00782184|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267315|NCT00635882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
267316|NCT00594620|The University of Kansas|Jeffrey Holzbeierlein, MD, FACS|913-945-8239|jholzbeierlein@kumc.edu|
267317|NCT00535405|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267318|NCT00496730|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
267319|NCT00462748|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
267320|NCT00418834|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
267321|NCT00409773|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267322|NCT00276484|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
267323|NCT00276458|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267324|NCT00271817|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
272486|NCT00315705|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
272487|NCT00315731|GlaxoSmithKline|GSK Response Center|866-435-7343||
272488|NCT00315822|Cleveland Clinic|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
272489|NCT00315939|University of Virginia|Boris Kovatchev, PhD|434-924-5592|bpk2u@virginia.edu|
272490|NCT00316004|Clinical Trial Center, University of Washington, Seattle, WA|Susanne May, PhD|206-685-1302|sjmay@uw.edu|
272491|NCT00316017|Clinical Trial Center, University of Washington, Seattle, WA|Susanne May, PhD|206-685-1302|sjmay@uw.edu|
272492|NCT00316082|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
272493|NCT00316121|Advanced Technologies and Regenerative Medicine, LLC|Manny Lazaro, Director, Clinical Affairs|508-828-2741|mlazaro@its.jnj.com|
272494|NCT00316173|GlaxoSmithKline|GSK Response Center|866-435-7343||
272495|NCT00316186|GlaxoSmithKline|GSK Response Center|866-435-7343||
272496|NCT00316199|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
272497|NCT00316225|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
272498|NCT00316264|MedImmune|Pamela Griffin|301 398 0000|clinicaltrialenquiries@medimmune.com|
272499|NCT00316277|McLean Hospital/Harvard Medical School|Roger D. Weiss, M.D.|617-855-2242|rweiss@mclean.harvard.edu|
272500|NCT00316303|Dartmouth-Hitchcock|Stanley Rosenberg, Ph.D.|603-653-0740|Stanley.d.rosenberg@dartmouth.edu|
272501|NCT00316355|Hartford Hospital|David Tolin|860-545-7685|david.tolin@hhchealth.org|
272502|NCT00316524|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
272503|NCT00316589|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
272504|NCT00316602|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
272505|NCT00316693|GlaxoSmithKline|GSK Response Center|866-435-7343||
272506|NCT00316706|GlaxoSmithKline|GSK Response Center|866-435-7343||
272507|NCT00316719|GlaxoSmithKline|GSK Response Center|866-435-7343||
272508|NCT00316862|Memorial Sloan-Kettering Cancer Center|David H. Ilson, M.D., Ph.D.||ilsond@mskcc.org|
272509|NCT00316888|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
272510|NCT00316914|Mayo Clinic|Dr. Axel Grothey|507-184-2779|grothey.axel@mayo.edu|
272511|NCT00317044|AstraZeneca|ClinicalTrialTransparency||ClinicalTrialTransparency@astrazeneca.com|
272512|NCT00317109|GlaxoSmithKline|GSK Response Center|866-435-7343||
272513|NCT00317226|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
272514|NCT00317239|Luitpold Pharmaceuticals, Inc.|Mark Falone|610-650-4200|mfalone@luitpold.com|
272515|NCT00317356|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
272516|NCT00317369|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
272517|NCT00317473|USAMRU-K|Mark A. Withers, MD PhD|+254-722-449-357|aodika@wrp-ksm.org|
272518|NCT00317603|Mass General Brigham|Beth Overmoyer|617 632 3800|Beth_Overmoyer@DFCI.HARVARD.EDU|
272519|NCT00317642|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
267325|NCT03660865|RxSight|Jeffrey Ha, Senior Director of Clinical Research|949-521-7870|jha@rxsight.com|
267326|NCT03493126|The Ohio State University|Dr. Andrew Hundley|614-293-4647|andrew.hundley@osumc.edu|
267327|NCT03420781|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
267328|NCT03316586|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|617-632-2335|Sara_Tolaney@dfci.harvard.edu|
267329|NCT03277066|Noven Pharmaceuticals, Inc.|Gunnar Klauss, MD|1-551-233-2656|gklauss@noven.com|
267330|NCT03269695|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
267331|NCT03227757|Abbott|Karine Miquel|+32 479 600 107|karine.miquel@abbott.com|
267332|NCT03222128|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@Edwards.com|
267333|NCT03142334|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267334|NCT03093701|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
267335|NCT03093246|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
267336|NCT02991599|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
267337|NCT02976129|VHsquared|Chief Medical Officer|+44 (0)1223 837650|info@vhsquared.com|
267338|NCT02970136|University of Miami|Olveen Carrasquillo|305-243-5505|ocarrasquillo@miami.edu|
267339|NCT02969928|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
267340|NCT02949297|Endologix, LLC|Manager, Clinical Affairs|864-270-8524|nsmith@endologix.com|
267341|NCT02945787|Moffitt Cancer Center|Thomas H. Brandon PhD|813 745-1750|Thomas.Brandon@moffitt.org|
267342|NCT02908685|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
267343|NCT02857426|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
267344|NCT02855125|Taiho Oncology, Inc.|Taiho Central|1-609-250-7336|clinicaltrialinfo@taihooncology.com|
267345|NCT02836236|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
267346|NCT02831764|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
267347|NCT02728752|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
267348|NCT02680587|Johns Hopkins University|Dr. Phuoc T. Tran|4106143880|ptran12@jhmi.edu|
267349|NCT02667639|Monitor CRO|Murat Özdemir|902122341260|murato@monitorcro.com|
267350|NCT02652949|Medtronic|Katrin Dias - Clinical Study Manager|707-525-0111|katrin.a.dias@medtronic.com|
267351|NCT02574455|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
267352|NCT02528500|W. L. Gore & Associates|Justine Roberts|928-864-3349|jusrober@wlgore.com|
267353|NCT02527798|Duke University|Leigh Gosnell|919-668-1280|leigh.gosnell@duke.edu|
267354|NCT02416492|SanBio, Inc.|Bijan Nejadnik M.D.; Chief Medical Officer|650-625-2205|Bijan.Nejadnik@sanbio.com|
272520|NCT00317720|UT MD Anderson Cancer Center|Dr. Francisco Esteva|713-563-0742|CR_Study_Registration@mdanderson.org|
272521|NCT00317941|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
272522|NCT00318136|Genentech, Inc.|Medical Communications|800-821-8590||
272523|NCT00318149|GlaxoSmithKline|GSK Response Center|866-435-7343||
272524|NCT00318292|Mayo Clinic|Michaele Menghini|480-301-6651|menghini.michaele@mayo.edu|
272525|NCT00318357|The University of Hull; Department of Cardiology; United Kingdom|John Cleland, Professor|Telephone: 0044 1482 624084||
272526|NCT00318370|Morphotek, Inc.|Susan Weil, MD|610-423-6182|sweil@morphotek.com|
272527|NCT00318409|San Francisco Department of Public Health|Moupali Das, MD, MPH|415-437-6204|moupali.das@sfdph.org|
272528|NCT00318461|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
272529|NCT00318474|Saint Joseph's Hospital and Medical Center|Ron Hogg, M.D.|602-406-3246|ronhogg@gmail.com|
272530|NCT00318565|Biosense Webster|Christine Liu|9098398608|cliu10@its.jnj.com|8608
272531|NCT00318591|Coloplast|Anna Karina Busch, Intl. Senior Scientific Manager|+45 49112350|dkakb@coloplast.com|
272532|NCT00318643|Halozyme Therapeutics|Chief Medical Officer|855-495-3639|halozyme@EVERSANA.com|
272533|NCT00318708|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
272534|NCT00318812|Ottawa Hospital Research Institute|Dr Deborah Zimmerman, principal investigator|613-738-8400|dzimmerman@toh.on.ca|82534
272535|NCT00318929|Virginia Commonwealth University|Alan R. Towne, MD|804-282-9869|atowne@mcvh-vcu.edu|
272536|NCT00319020|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
272537|NCT00319046|Actelion Pharmaceuticals Ltd|Cécile Luzy, MSc/Clinical Research Scientist|+ 41 61 565 6386||
272538|NCT00319098|GlaxoSmithKline|GSK Response Center|866-435-7343||
272539|NCT00319111|Actelion Pharmaceuticals Ltd|Loïc Perchenet PhD/Clinical Trial Leader|+41 61 565 6457||
272540|NCT00319254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272541|NCT00319436|Yale University School of Medicine, Department of Psychiatry and Yale Child Study Center|Nancy Suchman, Ph.D., Associate Professor|203-937-3486|nancy.suchman@yale.edu|7430
267355|NCT02324816|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
272542|NCT00319501|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272543|NCT00319553|Sanofi Pasteur Inc.|Medical Director||RegistryContactUS@sanofipasteur.com|
272544|NCT00319592|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
272545|NCT00319644|University of California, San Francisco|Julin Tang, MD|415-206-5274|tangj@anesthesia.ucsf.edu|
272546|NCT00319696|Actelion Pharmaceuticals Ltd|Andjela Kusic-Pajic, MD/Clinical Project Team Leader|+41 61 565 64 17||
296815|NCT01707472|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
272547|NCT00319735|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
272548|NCT00319748|Masonic Cancer Center, University of Minnesota|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
272549|NCT00319956|University of Kentucky Medical Center|Dr. Hubert O. Ballard|859-323-1496|hoball2@uky.edu|
272550|NCT00319982|Brigham and Women's Hospital|Carolyn Ho, MD|617-732-5685|cho@partners.org|
272551|NCT00320112|VA HSRD|Fatima Makki|734 845 3623|Fatima.Makki@va.gov|
272552|NCT00320190|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
272553|NCT00320216|Centocor Research & Development, Inc.|Senior Director Clinical Research|1-800-457-6399||
272554|NCT00320242|Beth Israel Deaconess Medical Center and Harvard Medical School|Dr. David K. Simon, Associate Professor of Neurology|617-735-3251|dsimon1@bidmc.harvard.edu|
272555|NCT00320255|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
272556|NCT00320281|Craig Hospital|Dr. Gary Maerz|303-789-8220|adannels@craighospital.org|
272557|NCT00320372|Cyberonics, Inc|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|281-228-7223|mark.bunker@cyberonics.com|
272558|NCT00320385|GlaxoSmithKline|GSK Response Center|866-435-7343||
272559|NCT00320398|GlaxoSmithKline|GSK Response Center|866-435-7343||
272560|NCT00320411|GlaxoSmithKline|GSK Response Center|866-435-7343||
272561|NCT00320424|GlaxoSmithKline|GSK Response Center|866-435-7343||
272562|NCT00320489|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
272563|NCT00320515|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
272564|NCT00320528|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
272565|NCT00320541|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
308375|NCT02574312|DePuy Ortho Joint US|Kirstin Cosgrove|800-827-7003|kcosgro1@its.jnj.com|
272566|NCT00320593|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
267356|NCT02279745|United Therapeutics Corp.|Global Medical Information|919-485-8350|clinicaltrials@unither.com|
272567|NCT00320606|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
272568|NCT00320671|Northwell|Delbert Robinson MD|718.470.8195|drobinson@nshs.edu|
272569|NCT00320710|Novartis|Study Director|862-778-8300||
272570|NCT00320749|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab, M.D.|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
272571|NCT00320788|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator||clinicaltrials@regeneron.com|
272572|NCT00320801|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333||
272573|NCT00321048|Indiana University|Richard Zellars|3179444505|rzellars@iu.edu|
272574|NCT00321269|Iowa City VA Health Care System|Carolyn Turvey|319 338 0581|Carolyn-Turvey@uiowa.edu|7714
272575|NCT00321321|Gentofte Hospital, University of Copenhagen|Dr. Kasper Aaboe|+4539978474|Kasper@dadlnet.dk|
272576|NCT00321373|GlaxoSmithKline|GSK Response Center|866-435-7343||
272577|NCT00321464|Amgen Inc.|Study Director|866-572-6436||
281873|NCT00825305|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
281874|NCT00825318|St. Luke's-Roosevelt Hospital Center|James Jones, MD|2125233530|JaJones@chpnet.org|
281875|NCT00825344|Johns Hopkins|Dr. Steven P. Cohen|410-955-1818|scohen40@jhmi.edu|
267357|NCT02112526|Acerta Pharma LLC|Study Director|1-888-292-9613|acertamc@dlss.com|
281876|NCT00825370|Department of Emergency Medicine, Albert Einstein College of Medicine|Andrew Chang, MD, MS|7189207464|achang@montefiore.org|
281877|NCT00825500|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
281878|NCT00825565|Northwestern University|Stephanie Rangel|312-503-5942|stephanie.rangel@northwestern.edu|
281879|NCT00825630|Sharon Hospital|Dr. Haim Shirin|0097239372231|haims3@clalit.org.il|
281880|NCT00825682|Sheba Medical Center|Dr Dorit Gamus|+972-3-5303956|dorit.gamus@sheba.health.gov.il|
267358|NCT02067975|Maryland Psychiatric Research Center|Sam Kane-Gerard|410-402-6120|SGerard@som.umaryland.edu|
281881|NCT00825734|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
281882|NCT00825786|University of North Carolina, Department of Anesthesiology, University of North Carolina|Priya Kumar, MD|(919) 966-5136|pkumar@aims.unc.edu,|
281883|NCT00825812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
267359|NCT02030938|Sofregen|Clinical Project Manager|4029991564|fjawed@sofregen.com|
281884|NCT00825825|Steward St. Elizabeth's Medical Center|Tara Lauriat, Ph.D.|617-789-2404|tara.lauriat@steward.org|
281885|NCT00825916|Capstone Therapeutics|Denise Lamon, Director of Regulatory Affairs|800-937-5520|dlamon@capstonethx.com|5206
281886|NCT00825994|Massachusetts General Hospital|Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
281887|NCT00826007|William Beaumont Hospital|Tamra Dukatz, CRNA, MSN|2489924741|tdukatz@beaumont.edu|
281888|NCT00826020|University of Nebraska Medical Center|Dr. David Mercer|4025596955|dmercer@unmc.edu|
267360|NCT02006147|Taiwan Liposome Company|Dr. Carl Brown|886-2-2655-7377|tlc_clinicaltrials@tlcbio.com|
267361|NCT01999179|Versiti|Dr Lisa Baumann Kreuziger|414-937-6826|lisakreuziger@versiti.org|
281889|NCT00826111|Steward St. Elizabeth's Medical Center of Boston, Inc.|Tara Lauriat, Ph.D.|617-789-2404|tara.lauriat@steward.org|
281890|NCT00826150|BioCancell Ltd.|VP Clinical|+97225486553|monique.ben-am@biocancell.com|
272578|NCT00321555|National Cancer Institute|Dr. Robert Kreitman|301-648-7375|robert_kreitman@nih.gov|
272579|NCT00321594|Department of Clinical Oncology, The Chinese University of Hong Kong|Professor Winnie Yeo|852-2632|winnieyeo@cuhk.edu.hk|2118
272580|NCT00321620|Amgen Inc.|Study Director|866-572-6436||
296816|NCT01707654|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
272581|NCT00321646|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-8313|mary_taplin@dfci.harvard.edu|
272582|NCT00321672|NeurogesX|Trudy Vanhove, VP Clinical Development|650-393-7444|tvanhove@neurogesx.com|
272583|NCT00321685|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
272584|NCT00321698|Portland VAMC|Dr. Mark Garzotto|541-728-0665|garzotto@ohsu.edu|
296817|NCT01707667|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
272585|NCT00321711|Amgen Inc.|Study Director|866-572-6436||
272586|NCT00321737|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
272587|NCT00321763|GlaxoSmithKline|GSK Response Center|866-435-7343||
272588|NCT00321789|Veterans Affairs Medical Center|Corrine I. Voils|919-286-0411|corrine.voils@va.gov|5196
272589|NCT00321828|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
272590|NCT00321854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
272591|NCT00321893|University of Texas MD Anderson|Powel H. Brown, MD, PhD/Professor of Medicine and Cancer Prevention||CR_Study_Registration@mdanderson.org|
272592|NCT00321906|The University of Chicago|Edward Garrity, MD|(773) 834-1119|egarrity@uchicago.edu|
272593|NCT00321919|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
272594|NCT00321932|Masonic Cancer Center, University of Minnesota|Linda Burns, M.D.|612-624-8144|burns023@umn.edu|
272595|NCT00321971|Duquesne University School of Nursing|Linda Garand PhD|412-396-6543|garandl@duq.edu|
272596|NCT00321984|Takeda Global Research & Development Center, Inc.|Sr. VP Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
267362|NCT01940341|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
267363|NCT01925794|CeloNova BioSciences Inc.|Mark Barakat, MD|(210) 489-4004|mbarakat@celonova.com|
267364|NCT01907360|Ironshore Pharmaceuticals and Development, Inc.|Chief Scientific Officer|13457498174|bev@ironshorepharma.com|
267365|NCT01886872|Ohio State University|Jennifer Woyach, MD|614-685-5667|jennifer.woyach@osumc.edu|
267366|NCT01856868|UC Davis Health|Dr. Craig McDonald, Professor and Chair|(916) 734-4293|cmmcdonald@ucdavis.edu|
267367|NCT01849250|The University of Texas MD Anderson Cancer Center|Powel H. Brown, MD/Chair, Clinical Cancer Prevention|713-792-7734|PHBrown@mdanderson.org|
267368|NCT01609790|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
267369|NCT01592643|Stanford University School of Medcine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
267370|NCT01441115|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
267371|NCT01295944|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|mark.gilbert@nih.gov|
267372|NCT01199302|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
267373|NCT01123707|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
267374|NCT00894244|Northwestern University|Dr. Murad Alam|(312) 695-6785|m-alam@northwestern.edu|
267375|NCT00462943|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
267376|NCT00248287|Baylor Sammons Cancer Center|Dr. Joyce O'Shaughnessy|(214) 370 -1796|Joyce.OShaughnessy@usoncology.com|
267377|NCT00182728|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
267378|NCT00105560|Massachusetts General Hospital|Dr. Nancy Tarbell, Pediatric Radiation Oncologist|617-724-1836|NTARBELL@mgh.harvard.edu|
267379|NCT00038727|George Washington University|Marinella Temprosa, PI of Coordinating Center|3018819260|ella@bsc.gwu.edu|
267380|NCT04569786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267381|NCT04409041|Washington University|Dr. Caroline Mann|(314) 996-8010|cmann@wustl.edu|
267382|NCT04129944|Unity Biotechnology, Inc.|Chief Medical Officer|650-416-1192|Clinicaltrials@unitybiotechnology.com|
267396|NCT03143829|University of Central Floroda|Victoria Loerzel|407-823-0762|victoria.loerzel@ucf.edu|
267397|NCT03099863|MetroHealth Medical Center|Dr. Jeffrey Mangel|2167784444|jmangel@metrohealth.org|
267398|NCT02963610|Fox Chase Cancer Center|Hossein Borghaei, DO, MS|215-214-4297|Hossein.Borghaei@fccc.edu|
267399|NCT02766335|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
272597|NCT00322023|Nathan Kline Institute|Dr. Daniel Javitt|845-398-6534|javitt@nki.rfmh.org|
272598|NCT00322049|U.S. Army Medical Component Armed Forces Research Institute of Medical Services|Wipa Chawachalasai|662-696-2700|wipac@afrims.org|4351
272599|NCT00322101|Fred Hutchinson Cancer Research Center|Bart Lee Scott|206-667-1990|bscott@fhcrc.org|
272600|NCT00322153|Forest Research Institute|Stephen M Graham, PhD|201-427-8156|Stephen.Graham@frx.com|
272601|NCT00322231|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
272602|NCT00322309|BUPA CSU, Boston University School of Medicine|Maryam Afshar, MD|617-414-1990|maryam.afshar@bmc.org|
272603|NCT00322335|GlaxoSmithKline|GSK Response Center|866-435-7343||
272604|NCT00322348|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
272605|NCT00322374|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
272606|NCT00322387|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
272607|NCT00322439|Amgen Inc.|Study Director|866-572-6436||
272608|NCT00322452|AstraZeneca|Gerard Lynch||AZTrial_results_posting@AstraZeneca.com|
282698|NCT00868699|Sunovion|Medical Director, CNS|1-866-503-6351||
308376|NCT02574520|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
272609|NCT00322465|University of Alabama at Birmingham|Jane R. Schwebke, MD|(205) 975-5665|schwebke@uab.edu|
272610|NCT00322491|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
272611|NCT00322556|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
272612|NCT00322621|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
296818|NCT01707693|University of Arkansas for Medical Sciences|Leanne L. Lefler, PhD, APN, RN Principal Investigator|5012961939|LeflerLeanne@uams.edu|
272613|NCT00322712|University of New Mexico|Dr. Fa Chyi Lee|505-925-0405|flee@salud.unm.edu|
272614|NCT00322777|Canadian Institute of Natural and Integrative Medicine|Dr. Badri Rickhi|403-220-0022|b.ricki@cinim.org|0
272615|NCT00322842|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
272616|NCT00322868|Case Western Reserve University|Michael W Konstan, MD|2168443267|michael.konstan@case.edu|
272617|NCT00322881|Dana-Farber Cancer Institute|Ursula A. Matulonis, MD|617-632-2334|umatulonis@partners.org|
272618|NCT00323063|Rutgers Cancer Institute of|Deborah Toppmeyer, MD|732-235-6789|toppmede@cinj.rutgers.edu|
272619|NCT00323115|Dartmouth-Hitchcock Medical Center|Dr. Camilo Fadul|603-653-6312|camilo.e.fadul@hitchcock.org|
272620|NCT00323193|VA VISN 5 Mental Illness Research, Education and Clinical Center|Richard W. Goldberg, Ph.D.|410-637-1851|richard.goldberg@va.gov|
272621|NCT00323258|Duke University Medical Center|Sara Calvert, PharmD|919-668-7540|sara.calvert@duke.edu|
272622|NCT00323271|VA Connecticut Healthcare System|Robert Kerns, PhD|203-932-5711|robert.kerns@va.gov|3841
272623|NCT00323284|Glaukos|Jeff Wells, Sr. VP, Clinical, Regulatory, and Quality Affairs|949-367-9600|jwells@glaukos.com|227
272624|NCT00323297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272625|NCT00323310|Bracco Diagnostics Inc|Usha Halemane/Executive Director|609-514-2578|usha.halemane@diag.bracco.com|
272626|NCT00323362|Rutgers Cancer Institute of New Jersey|Dr. Joseph Aisner, MD|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
272627|NCT00323414|Cleveland Clinic Foundation|Srinivasan Dasarathy MD|216-444-2766|dasaras@ccf.org|
267383|NCT03861728|University of Miami|Wendy Lee|305-326-6434|wlee@miami.edu|
267384|NCT03857542|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
267385|NCT03848832|GW Research Ltd|Medical Enquiries|1-833-424-6724|medinfo@gbio.com|
267386|NCT03688802|Oyster Point Pharma, Inc.|Jeffrey Nau|609-382-9035|jnau@oysterpointrx.com|
267387|NCT03656744|HighTide Therapeutics|Chief Medical Officer|314-791-0593|adibisceglie@hightidetx.com|
267388|NCT03510598|Zeltiq Aesthetics|Lori Brandt, Director Clinical Trial Management|925 621-7460|lori.brandt@abbvie.com|
267389|NCT03487796|Rhode Island Hospital|Larry K. Brown, MD|(401) 793-8808|lkbrown@lifespan.org|
267390|NCT03446612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
267391|NCT03436433|Duke Neurosugery|Claudia E. Pamanes, MPH, CCRP|9196680897|claudia.pamanes@duke.edu|
267392|NCT03434379|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
267393|NCT03370120|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
267394|NCT03367429|Weill Cornell Medicine|Michael O'Dell, M.D.|19175495179|mio2005@med.cornell.edu|
267395|NCT03332498|Moffitt Cancer Center|Richard D. Kim, MD|813-745-1277|Richard.Kim@moffitt.org|
267400|NCT02606136|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|FG3019-079DMDStudy@fibrogen.com|
267401|NCT02228382|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
267402|NCT02208024|University of Cincinnati Cancer Center|Jordan Kharofa, Associate Professor, Department of Radiation Oncology|(513)-584-4073|kharofjr@ucmail.uc.edu|
267403|NCT02128958|Can-Fite BioPharma|Pnina Fishman, PhD, CEO|972-3-924-1114|pnina@canfite.co.il|
267404|NCT02090998|Rutgers/RWJMS|william grubb md|7322357827|grubbwr@rwjms.rutgers.edu|
267405|NCT02051309|Yale School of Medicine|Sherry McKee PhD|2037373529|sherry.mckee@yale.edu|
267406|NCT02001623|Genmab A/S|Clinical Trial Information|70202728|clinicaltrials@genmab.com|
267407|NCT01900002|UT MD Anderson Cancer Center|Dr. Ahmed Kaseb, MD, Professor, GI Medical Oncology|(713) 792-2828|akaseb@mdanderson.org|
267408|NCT01595061|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
272628|NCT00323427|Portland VA Medical Center|Mitchel Turbin, Ph.D.|503-220-8262|bonnie.becker@va.gov|54525
272629|NCT00323453|Santa Barbara Cottage Hospital|Laura Isaacs (Research Quality Assurance & Integrity Analyst) on behalf of Dr. Kenneth Waxman (PI)|805-324-9255|lisaacs@sbch.org|
272630|NCT00323479|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
272631|NCT00323492|Gilead Sciences|Camille Aubron-Olivier|+33(0)1 42 737130|camille.aubron-olivier@gilead.com|
272632|NCT00323557|UT MD Anderson Cancer Center|Amar Safdar, MD/Professor||CR_Study_Registration@mdanderson.org|
272633|NCT00323609|Medtronic|John Tillman|408-548-6518|tillmj1@mspexcng.medtronic.com|
272634|NCT00323622|GlaxoSmithKline|GSK Response Center|866-435-7343||
272635|NCT00323739|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
272636|NCT00323869|Stanford University Medical Center|Heather A Wakelee, MD, Associate Professor of Medicine (Oncology)|650-498-6000|hwakelee@stanford.edu|
272637|NCT00323882|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
272638|NCT00323960|IRCCS Istituto Giannina Gaslini|Dr. Nicolino Ruperto|+39-010-382854|nicolaruperto@gaslini.org|
272639|NCT00324038|Napp Pharmaceutical Ltd|Dr Paul Schofield, Medical Director|01223424444|info@contact-clinical-trials.com|
272640|NCT00324116|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
272641|NCT00324155|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
272642|NCT00324168|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
272643|NCT00324233|Coloplast A/S|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
272644|NCT00324259|Washington University School of Medicine|Dr. Matthew Ellis|314-362-8866|mjellis@bcm.edu|
272645|NCT00324272|John Radcliffe Hospital|Mr. Henk Giele, Consultant Plastic & Reconstructive Surgeon|01865 231 056|henk.giele@orh.nhs.uk|
272646|NCT00324350|University of California, San Francisco|Dr. Ann Schwartz|415-514-8000|aschwartz@psg.ucsf.edu|
272647|NCT00324415|AMC|Director, AMC Statistical Center|501-526-6712|jylee@uams.edu|
272648|NCT00324649|Gilead Sciences|Pedro Ferrer|+34 91 771 2478|pedro.ferrer@gilead.com|
272649|NCT00324675|"University Hospital Carl Gustav Carus, Dresden"|Dr. Frank Pistrosch|0049 351 4400580|frank.pistrosch@uniklinikum-dresden.de|
272650|NCT00324701|Ralph H. Johnson VAMC|Leonard E. Egede, MD, MS|843-789-6670|Leonard.Egede@va.gov|
272651|NCT00324740|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
272652|NCT00324753|Center for Health Equity Research and Promotion (VAPHS)|Maria K. Mor|(412) 360-2240|maria.mor@va.gov|
272653|NCT00324857|VA|Said A. Ibrahim, MD, MPH|215 823 5800|Said.Ibrahim2@va.gov|7163
272654|NCT00324870|Johns Hopkins University|Michael Carducci, MD|410-614-6337|carducci@jhmi.edu|
272655|NCT00324896|UMDNJ - RWJMS|Matthew Menza, MD|732-235-4440|menza@umdnj.edu|
272656|NCT00324961|GlaxoSmithKline|GSK Response Center|866-435-7343||
272657|NCT00324987|SWOG Statistical Center|SWOG Statistician|206-667-4408||
272658|NCT00325039|New England Research Institutes, Inc.|Heather Litman, PhD|617 972 3297|hlitman@neriscience.com|
272659|NCT00325078|National Institute of Allergy and Infectious Diseases|De Ravin, SukSee|+1 301 496 6772|sderavin@mail.nih.gov|
272660|NCT00325130|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
296819|NCT01707992|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|info.era-clinical@teva.de|
272661|NCT00325143|GlaxoSmithKline|GSK Response Center|866-435-7343||
272662|NCT00325156|GlaxoSmithKline|GSK Response Center|866-435-7343||
267409|NCT04267276|Boehringer Ingelheim|Boehringer Ingelheim|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
272663|NCT00325195|Savient Pharmaceuticals, Inc.|Medical Director|732-418-9300||
272664|NCT00325234|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
272665|NCT00325403|United Therapeutics Corporation|Kevin Laliberte; Senior Director, Product Development|919-425-8176|klaliberte@unither.com|
272666|NCT00325416|H. Lee Moffitt Cancer Center and Research Institute|Daniel M. Sullivan, M.D.|813-745-3878|dan.sullivan@moffitt.org|
282699|NCT00868712|Walter Reed Army Medical Center, Cardiology Service|Todd C. Villines, MD|301-295-7839|todd.villines@us.army.mil|
267410|NCT04238429|Sun Yat-sen University|Dr. Hongchun Liu|86-13826189071|hongchun_liu@vip.sina.com|
267411|NCT04126083|Mayo Clinic|W. Michael Hooten, M.D.|507-266-9672|Hooten.William@mayo.edu|
267412|NCT03901300|LSU's Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632500|amanda.staiano@pbrc.edu|
267413|NCT03870880|Laboratorios Farmacéuticos Rovi, S.A.|Director of Medical Department|91 375 62 30|departamento.medico@rovi.es|
267414|NCT03744637|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267415|NCT03586050|ETHICON|Jaclyn Calia|908-218-2933|jcalia@its.jnj.com|
267416|NCT03576144|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
267417|NCT03444038|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
267418|NCT03432897|Brown Oncology Research Group|BrUOG|4018633000|BrUOG@Brown.edu|
267419|NCT03349723|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
267420|NCT03315039|Moleculin Biotech Inc|Chief Scientific Officer|862-273-1432|DPicker@moleculin.com|
267421|NCT03265665|University of Illinois at Chicago|Dr. Sharmilee Nyenhuis|3124131655|snyenhui@uic.edu|
267422|NCT03248531|Cares|UCB|+1-844-599-2273|UCBCares@ucb.com|
267423|NCT03196180|University of Arizona|Sherry Chow, PhD|520-626-3358|schow@azcc.arizona.edu|
267424|NCT02741700|VA ORD: Birmingham VA Medical Center|Dr. Jasvinder Singh|205-934-3235|jasvinder.md@gmail.com|
267425|NCT02725593|Study Information Center|Global Clinical Lead|+1-887-240-9479|information.center@astrazeneca.com|
267426|NCT02716675|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
267427|NCT02636946|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
267428|NCT02631941|Zambon S.p.A.|Isabella Salerio, PhD|+3902665241|clinicaltrials@zambongroup.com|
267429|NCT02568215|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
267430|NCT02562378|Medica Scientia Innovation Research (MEDSIR)|Scientific director|+34 93 221 41 35|trialsregister.medsir@medsir.org|
267431|NCT02528643|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
267432|NCT02527434|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
267433|NCT02416011|Moffitt Cancer Center|Dr. Thomas Bradon|(813) 745-1750|Thomas.Brandon@moffitt.org|
267434|NCT02294461|Astellas Pharma Inc|Clinical Trial Disclosure||astellas.resultsdisclosure@astellas.com|
267435|NCT02258659|University of Chicago|Dr. Everett Vokes|773-702-9306|evokes@medicine.bsd.uchicago.edu|
267436|NCT02237508|Zambon SpA|Isabella Salerio, PhD|+39 02665241|clinicaltrials@zambongroup.com|
267437|NCT02197234|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
267438|NCT02163733|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
272667|NCT00325442|United Therapeutics Corporation|Kevin Laliberte, PharmD; Senior Director, Product Development|919-425-8176|klaliberte@unither.com|
282700|NCT00868751|Tufts Medical Center|Research Administration||mcoughlin@tuftsmedicalcenter.org|
282701|NCT00868790|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
272668|NCT00325468|Amgen Inc.|Study Director|866-572-6436||
282702|NCT00868959|Sunovion|Medical Director, CNS|1-866-503-6351||
272669|NCT00325598|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8525|izoberi@radonc.wustl.edu|
272670|NCT00325754|Harbo-UCLA Research and Education Institute|Richard Casaburi|310-22-8249|casaburi@ucla.edu|
296820|NCT01708122|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center - Urology|Richard Reznichek|3102222724|RReznichek@dhs.lacounty.gov|
272671|NCT00325780|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
272672|NCT00325819|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216|jackson.L@ghc.org|
272673|NCT00325897|Denver Health Medical Center|Dr. Richard Albert|303-436-6900|ralbert@dhha.org|
272674|NCT00326001|Biotronik GmbH&Co. KG, Berlin, Germany|Dejan Danilovic|+49 9131 8924 7832|dejan.danilovic@biotronik.com|
272675|NCT00326118|GlaxoSmithKline|GSK Response Center|866-435-7343||
272676|NCT00326170|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
272677|NCT00326196|Roudebush VAMC|Masoor Kamalesh, MD|317-988-2401|masoor.kamalesh@va.gov|
281891|NCT00826176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
267439|NCT02157883|AstraZeneca|Dr Karen So||ClinicalTrialTransparency@astrazeneca.com|
281892|NCT00826202|Nathan Kline Institute|Daniel Javitt MD, PhD|845-398-6534|javitt@nki.rfmh.org|
296821|NCT01708161|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
281893|NCT00826228|Northwestern University Feinberg School of Medicine|Thomas J Schnitzer|3125032315|tjs@northwestern.edu|
267440|NCT01996449|UT Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|Wanpen.Vongpatanasin@UTSouthwestern.edu|
281894|NCT00826241|National Cancer Institute|Dr. Mark Gilbert|240-760-6023|gilbertmr@nih.gov|
281895|NCT00826267|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281896|NCT00826280|Astellas Pharma Global Development|Senior Medical Director||clinicaltrials@us.astellas.com|
281897|NCT00826449|University of Texas (UT) MD Anderson Cancer Center|Faye Johnson, Associate Professor, Thoracic/Head & Neck Med Oncology||CR_Study_Registration@mdanderson.org|
281898|NCT00826514|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281899|NCT00826540|Mayo Clinic|Dr. Axel Grothey, M.D.|(507) 284-4430|grothey.axel@mayo.edu|
281900|NCT00826618|University of Miami|Thomas A. Albini, MD|3054825006|talbini@med.miami.edu|
281901|NCT00826748|Weill Cornell Medicine|Grace Mammen|646-962-2672|gwm2004@med.cornell.edu|
281902|NCT00826800|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
281903|NCT00826943|Vanderbilt University|Douglas Tzanetos|615-942-7971|dtzanetos@hotmail.com|
281904|NCT00827073|Robert Cizik Eye Clinic|Joseph Selem, MD|713-559-5263|laurabaker@cizikeye.org|
281905|NCT00827099|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
281906|NCT00827112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281907|NCT00827242|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281908|NCT00827255|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
281909|NCT00827359|Beth Israel Deaconess Medical Center|Rupal Bhatt|6177352060|rbhatt@bidmc.harvard.edu|
281910|NCT00827372|IndianaU|Kathy Miller, MD|317-944-0920|kathmill@iupui.edu|
281911|NCT00827502|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
281912|NCT00827541|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296822|NCT01708174|Novartis Pharmaceuticals|Study Director|862-778-8300||
281913|NCT00827606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281914|NCT00827632|Columbia University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
281915|NCT00827775|University of Texas Southwestern Medical Center|Peter Van Buren|214-645-8293|peter.vanburen@utsouthwestern.edu|
296823|NCT01708187|Orthopedic Foot and Ankle Center|Gregory Berlet, MD|614-895-8747|ofacresearch@orthofootankle.com|
281916|NCT00827827|Baltimore VAMC|Frederick M. Ivey|410-375-8419|fivey@grecc.umaryland.edu|
267441|NCT01877655|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
281917|NCT00827918|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267442|NCT01802632|AstraZeneca|Senior Medical Director, Tagrisso||ClinicalTrialTransparency@astrazeneca.com|
281918|NCT00827931|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281919|NCT00827944|Derriford Hospital, Department of Surgery|Pr. Andrew KINGSNORTH|+44 175 276 3017|Andrew.Kingsnorth@phnt.swest.nhs.uk|
281920|NCT00827983|IBSA Institut biochimique|Clinical trial manager|+41583601000|barbara.cometti@ibsa.ch|
281921|NCT00828009|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
281922|NCT00828061|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
281923|NCT00828074|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
281924|NCT00828113|University of Wisconsin School of Medicine and Public Health|Douglas E. Jorenby, Ph.D.|6082627527|dej@ctri.medicine.wisc.edu|
281925|NCT00828139|SWOG Statistical Center|Lung Committee Statistician|2066674623|jmoon@fredhutch.org|
281926|NCT00828178|Johns Hopkins University School of Medicine|Dr. Michelle Petri|410-955-9114|mpetri@jhmi.edu|
267443|NCT01706705|UT MD Anderson Cancer Center|Dr. Ann Klopp / Associate Professor, Radiation Oncology|713-563-6930|aklopp@mdanderson.org|
281927|NCT00828191|IBSA Institut Biochimique SA|IBSA U.S. Agent|805 376 00 78|cejtwsxx@verizon.net|
281928|NCT00828204|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
281929|NCT00828295|Helsinn Healthcare SA|Salvatore Chessari|+41 91 985 21 21|salvatore.chessari@helsinn.com|
281930|NCT00828308|BrUOG|Anthony Mega, MD|4018633000|kayla_rosati@brown.edu|
296824|NCT01708213|TauTona Group|Ann Thomas|650-331-2461|athomas@tautonagroup.com|
272678|NCT00326209|Bausch Health Americas, Inc.|Director of Clinical Operations||lindsey.mathew@bauschhealth.com|
296825|NCT01708278|University of Michigan|Fernando Martinez|(734) 763-2540|fmartine@umich.edu|
272679|NCT00326417|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
272680|NCT00326495|National Cancer Institute|Dr. Alice Chen|240-276-6565|chenali@mail.nih.gov|
272681|NCT00326599|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|716-845-4101|alex.adjei@roswellpark.org|
272682|NCT00326612|DIvision of Pediatric Emergency Medicine|Maija Holsti, MD, MPH|801-587-7450|maija.holsti@hsc.utah.edu|
272683|NCT00326625|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
272684|NCT00326716|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
272685|NCT00326781|University of Pennsylvania|Caryn Lerman, Ph.D.|215-746-7141|clerman@mail.med.upenn.edu|
272686|NCT00326872|Mayo Clinic|Dr. Dusica Babovic-Vuksanovic||dbabovic@mayo.edu|
272687|NCT00326885|Fresenius Biotech|Manager, Regulatory Affairs|781-699-4652|bao.le@fresenius-biotech.com|
272688|NCT00326911|ImClone LLC|Chief Medical Officer||ClinicalTrials@ImClone.com|
296826|NCT01708291|University of Rochester|Sandra Jee|585-273-4657|sandra_jee@urmc.rochester.edu|
272689|NCT00326924|Ottawa Hospital Research Institute|Dean Fergusson, Senior Scientist|613-737-8480|dafergusson@ohri.ca|
272690|NCT00326950|Eisai Call Center|Eisai Inc.|888-422-4743||
272691|NCT00326963|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
272692|NCT00327015|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
272693|NCT00327171|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
272694|NCT00327340|OncoGenex Pharmaceuticals|Monica S. Krieger, PhD|425-686-1558|mkrieger@oncogenex.com|
272695|NCT00327392|Eisai Inc|Eisai Medical Services|1-888-422-4743||
272696|NCT00327444|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
296827|NCT01708317|Washington University School of Medicine|Dr. Fahd A Ahmad|314-286-0298|ahmad_f@kids.wustl.edu|
272697|NCT00327470|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272698|NCT00327717|Eisai Co., Ltd.|Takao Ishii, Asia regulatory affairs|81-3-3817-3914||
267444|NCT01625286|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
267445|NCT01609842|VHA Eastern Colorado Health Care System|Marina McCreight|720-857-2785|marina.mccreight@va.gov|
267446|NCT01341600|University of Maryland School of Medicine|Richard Horenstein M.D., Associate Professor of Medicine|410-706-0154|rhorenst@medicine.umaryland.edu|
267447|NCT01044901|The University of Chicago|Dr. Amit Patel, MD|773-702-9461|apatel2@medicine.bsd.uchicago.edu|
267448|NCT00769379|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
267449|NCT00288080|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
267450|NCT00099437|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
267451|NCT00003479|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
267452|NCT00003458|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
272699|NCT00328016|National Institute on Aging|Jessica McNeeley, Research Fellow|410-558-8110|mcneeleyj@mail.nih.gov|
272700|NCT00328042|VA San Diego|Dr. Erik Groessl|858-552-8585|erik.groessl@va.gov|
272701|NCT00328094|Beth Israel Deaconess Medical Center, Boston, MA|Dr. Balachundhar Subramaniam, MD MPH|6177542675|bsubrama@bidmc.harvard.edu|
272702|NCT00328172|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
272703|NCT00328198|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
272704|NCT00328263|Bio-K+ International Inc.|Dr. Serge Carrière|450-978-2465|scarriere@biokplus.com|
272705|NCT00328510|Thomas Jefferson University|Maria Werner-Wasik, MD|215-955-7679|Maria.Werner-Wasik@jeffersonhospital.org|
272706|NCT00328562|Thomas Jefferson University|Maria Werner-Wasik, MD|215-955-6702|Maria.Werner-Wasik@jeffersonhospital.org|
272707|NCT00328614|Thomas Jefferson University|Edouard Trabulsi, MD|215-955-1000|Edouard.Trabulsi@jefferson.edu|
272708|NCT00328627|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
272709|NCT00328770|Liver Transplant Program, University of Alberta Hospitals|Dr. Norman Kneteman|780-407-6168|norm.kneteman@albertahealthservices.ca|
272710|NCT00328783|Thomas Jefferson University|Rani Anne, MD|215-955-6045|Rani.Anne@jeffersonhospital.org|
272711|NCT00328861|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
272712|NCT00328926|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
272713|NCT00329030|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
272714|NCT00329160|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
272715|NCT00329238|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
272716|NCT00329303|Cares|UCB|+1844599|UCBCares@ucb.com|2273
272717|NCT00329407|Boston University|Ofra sarid-Segal, MD|617-414-1990|ofra.segal@bmc.org|
272718|NCT00329420|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
272719|NCT00329433|Washington University School of Medicine|Michael S. Avidan, MBBCh|314-747-4155|avidanm@wustl.edu|
272720|NCT00329524|UAMS Department of Otolaryngology|John Dornhoffer, MD|501-686-7000|dornhofferjohnl@uams.edu|
272721|NCT00329550|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
272722|NCT00329602|GlaxoSmithKline|GSK Response Center|866-435-7343||
272723|NCT00329641|SWOG Statistical Office|SWOG Melanoma Statistician|206-667-4408||
272724|NCT00329719|Mayo Clinic|Kurt A. Jaeckle, M.D.|5072842511|jaeckle.kurt@mayo.edu|
272725|NCT00329745|GlaxoSmithKline|GSK Response Center|866-435-7343||
272726|NCT00329771|Doylestown Hospital, Pennsylvania|Abraham A. Ashkenazi, M.D./Principal Investigator|215-625-2894|aashkenzai2001@yahoo.com|
272727|NCT00329784|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
272728|NCT00329797|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
272729|NCT00329836|Doylestown Hospital|Abraham Ashkenazi, M.D./ Prinicpal Investigator|215-625-2894|aashkenazi@yahoo.com|
272730|NCT00329849|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
272731|NCT00329901|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
272732|NCT00330161|University of Michigan Comprehensive Cancer Center|Erin Sargent|(734) 936-3348|esargent@umich.edu|
272733|NCT00330174|Medical University of South Carolina|Susan Sonne, PharmD, BCPP|843.792.5221|sonnesc@musc.edu|
272734|NCT00330187|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
272735|NCT00330343|JHU|Myron Yaster|9552393|myaster1@jhmi.edu|
272736|NCT00330382|University of California, Irvine|Dr. Frank Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
272737|NCT00330421|Dana-Farber Cancer Institute|Jeffrey A. Morgan, M.D.|617-632-5204|jamorgan@partners.org|
272738|NCT00330460|Amgen Inc.|Study Director|866-572-6436||
272739|NCT00330551|University of California, Los Angeles|Keith Nuechterlein, PhD|(310) 825-0036|keithn@ucla.edu|
296828|NCT01708525|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
272740|NCT00330564|UT MD Anderson Cancer Center|Quality Assurance Specialist|713-563-1602|caperez@mdanderson.org|
272741|NCT00330616|GlaxoSmithKline|GSK Response Center|866-435-7343||
272742|NCT00330668|Ipsen|Ipsen Medical Director|See email|clinical.trials@ipsen.com|
308377|NCT02574598|Instituto Nacional de Cancerología|Dr. Oscar Arrieta|(52) 55-5628-0400|ogar@unam.mx|71101
272743|NCT00330681|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
272744|NCT00330733|Phoenix VA Health Care System|Peter Reaven|602 277 5551|Peter.Reaven@va.gov|5817
272745|NCT00330759|Amgen Inc.|Study Director|866-572-6436||
272746|NCT00330863|Medical College of Georgia, Georgia Regents University|Peter F. Buckley, MD|706-721-2231|pbuckley@gru.edu|
272747|NCT00330876|Kowa Research Institute|Bill Arana|919 433 1600|barana@kowaus.com|
272748|NCT00330915|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
272749|NCT00330928|InfraReDx, Inc|Director Clinical and Regulatory|781-221-0053|pshah@infraredx.com|
272750|NCT00330967|Phoenix VA Health Care System|Charles Oh|602-277-5551|charles.oh@va.gov|1-5127
272751|NCT00331006|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-972-3048|sassmann@neriscience.com|
272752|NCT00331136|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
308378|NCT02574637|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
272753|NCT00331162|Wake Forest University Health Sciences|Dr. Alan Farney|336-716-6510|afarney@wakehealth.edu|
272754|NCT00331344|Oakland Medical Center|Andrea Harzstark, M.D.|510-752-6789|andrea.l.harzstark@kp.org|
272755|NCT00331409|Oregon Health and Science University|Christopher W. Ryan|503-494-1951|ryanc@ohsu.edu|
267453|NCT04160195|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@mail.nih.gov|
267454|NCT04152447|Massachusetts General Hospital|Dr. Marilyn Heng|617-643-0149|mheng@mgh.harvard.edu|
267455|NCT03834974|University of Connecticut|Dr. Sherry Pagoto|860-486-8979|sherry.pagoto@uconn.edu|
267456|NCT03794544|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
267457|NCT03732807|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
267459|NCT03724422|University of Louisville|Salwa Rashid|5028526964|salwa.rashid@louisville.edu|
267460|NCT04598152|The Ohio State University College of Medicine|Jay Fournier, PhD|614-293-9600|jay.fournier@osumc.edu|
267461|NCT04353271|University of South Alabama|Office of Research Complaince|2514607573|swhite@southalabama.edu|
267462|NCT04246021|King Hussein Cancer Center|Dr. Hikmat Abdel-Razeq|0096265300460|habdelrazeq@khcc.jo|1403
267463|NCT04098497|University of Wisconsin - Madison|Amy Cochran|(608) 262-0772|cochran4@wisc.edu|
267464|NCT03945825|University of Iowa Carver College of Medicine|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
267465|NCT03937141|Chinook Therapeutics, Inc.|Chinook Therapeutics, Inc. (formerly Aduro Biotech, Inc.)|206-485-7051|clinicaltrials@chinooktx.com|
267466|NCT03678402|The Ohio State University Wexner Medical Center|Dr. Tammy Moore|6142937847|tammy.moore@osumc.edu|
267467|NCT03641937|Masimo|Ahmed Alghazi|949-297-7000|studies@masimo.com|
267468|NCT03572244|University of Iowa|Dr. Chris Barwacz|3193843002|chris-barwacz@uiowa.edu|
267469|NCT03562767|Emory University|Dr. Ambar Kulshreshtha|(404) 686-2410|akulshr@emory.edu|
267470|NCT03559699|Agios Pharmaceuticals, Inc|Medical Affairs|833-228-8474|medinfo@agios.com|
267471|NCT03360396|Boston Scientific Corporation|Jessica Stockwell|612-618-1136|Jessie.Stockwell@bsci.com|
267472|NCT03333057|Novaliq GmbH|Dr. Sonja Kroesser|+49 6221 50259|info@novaliq.com|0
267473|NCT03305016|Ascendis Pharma, Inc.|Aimee D Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
267474|NCT03300336|HSRD ADAPT|S. Nicole Hastings|919-286-6936|susan.hastings@va.gov|
267475|NCT03291067|Mitsubishi Tanabe Pharma Development America, Inc.|Clinical Trials, Information Desk|Please e-mail|information@mt-pharma-us.com|
267476|NCT03271047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272756|NCT00331422|Masonic Cancer Center, University of Minnesota|Melissa Geller, MD|612-626-3111|gelle005@umn.edu|
267477|NCT03257436|BostonScientific|Sharda Mehta|6785967330|sharda.mehta@bsci.com|
267478|NCT03171480|The Ohio State University|Kara Rood, MD|440-321-0264|kara.rood@osumc.edu|
267479|NCT03158285|Janssen Research & Development, LLC|Head Rheumatology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
272757|NCT00331552|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
272758|NCT00331630|Northwestern University|Virginia Kaklamani|312-695-1301||
296829|NCT01708590|Bausch Health|Study Director|510-259-5284||
267458|NCT03731364|Concentric Analgesics|Nancy Wu|(415) 484-7921|nancy@concentricanalgesics.com|
272759|NCT00331682|Memorial Sloan-Kettering Cancer Center|Dr. Eileen O'Reilly|646-888-4182|oreillye@mskcc.org|
272760|NCT00331760|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
272761|NCT00331773|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
272762|NCT00331799|Duke University Medical Center Dept of Psychiatry|Wei Zhang MD|919 684 5645|wei.zhang@duke.edu|
272763|NCT00331864|Novartis Pharmaceuticals|Study Director|862-778-8300||
296830|NCT01708603|Bausch Health|Study Director|510-259-5284||
272764|NCT00332163|Amgen Inc.|Study Director|866-572-6436||
272765|NCT00332189|BioMarin Pharmaceutical, Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
272766|NCT00332202|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
272767|NCT00332241|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@BMS.com|
272768|NCT00332332|Amgen Inc.|Study Director|866-572-6436||
272769|NCT00332462|Novartis Pharmaceuticals|Study Director|862-778-8300||
272770|NCT00332488|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
272771|NCT00332579|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
272772|NCT00332605|University of Chicago|Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
272773|NCT00332644|University of Wisconsin|Piper, Megan E|608-265-5472|mep@ctri.medicine.wisc.edu|
272774|NCT00332696|Novartis Pharmaceuticals|Study Director|862-778-8300||
272775|NCT00332709|Novartis Pharmaceuticals|Study Director|862-778-8300||
272776|NCT00332722|Pain Management Center of Paducah|Dr. Laxmaiah Manchikanti, MD|2705548373|drlm@thepainmd.com|101
272777|NCT00332839|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300||
281931|NCT00828347|Department of Nephrology, Kumamoto University Graduate School of Medical Sciences|A study of maintenance therapy after intravenous maxacalcitol for secondary hyperparathyroidism|+81-96-373-5164|m-adachi@gpo.kumamoto-u.ac.jp|
281932|NCT00828412|Promius Pharma|Joanne Fraser|908 429-4504|joannefraser@promiuspharma.com|
281933|NCT00828451|Washington University|Aaron Hamvas, MD|314-454-6148|hamvas@kids.wustl.edu|
281934|NCT00828464|GlaxoSmithKline|GSK Response Center|866-435-7343||
281935|NCT00828516|Lynda Jackson Macmillan Centre|Dr Beverley de Valois|+44(0)1923-844456|beverley.devalois@nhs.net|
281936|NCT00828542|Sao Paulo University|Dr. Milena Bastos Brito|551636022814|milenabastos@usp.br|
281937|NCT00828568|Taro Pharmaceuticals USA|Medical Director|(914) 345-9001|medical.affairs@taro.com|6427
281938|NCT00828672|UZ Leuven|Prof. Dr. Eric Van Cutsem|+32 16 34 42 18|Eric.VanCutsem@uzleuven.be|
281939|NCT00828711|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
281940|NCT00828750|GlaxoSmithKline|GSK Response Center|866-435-7343||
267480|NCT03051217|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
267481|NCT03025542|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
267482|NCT02958319|Servicio de Reumatología del Hospital Universitario|David Vega-Morales MD|52 81 80485210|drdavidvega@yahoo.com.mx|
267483|NCT02929069|Yale University|John Pachankis, PhD|(203) 785-3710|john.pachankis@yale.edu|
267484|NCT02889809|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
267485|NCT02849587|University of California, San Diego; Center for Medicinal Cannabis Research|Thomas D. Marcotte, Phd|619-543-5044|tmarcotte@ucsd.edu|
267486|NCT02815540|Gillette Children's Specialty Healthcare|Director of Research|651-229-1745|Research@gillettechildrens.com|
267487|NCT02814708|Biomedizinische Forschung & Bio-Produkte AG|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
267488|NCT02781727|Ascendis Pharma, Inc.|Aimee D Shu, MD|+1 650 352 8389|ADS@ascendispharma.com|
267489|NCT02778204|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
267490|NCT02743364|Northwestern University|Seema A. Khan, MD|312-503-4236|s-khan2@northwestern.edu|
281941|NCT00828841|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
281942|NCT00828945|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281943|NCT00828984|Northwestern University|Dr. Seema Khan|312-503-4236|s-khan2@northwestern.edu|
281944|NCT00829010|GlaxoSmithKline|GSK Response Center|866-435-7343||
281945|NCT00829036|Atlanta VA Rehab R&D Center of Excellence|David A. Ross|404-321-6111|ross0128@bellsouth.net|6817
281946|NCT00829049|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
281947|NCT00829166|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
281948|NCT00829179|Duke University Medical Center|John S. Sundy M.D. PhD|(919) 668-2169|john.sundy@duke.edu|
282703|NCT00869024|University of Minnesota|Dr. Ganesh Raveendran|612-626-4283|ravee001@umn.edu|
282704|NCT00869050|Columbia University|Dr. Paul Oberstein|212-305-0592|po2178@cumc.columbia.edu|
282705|NCT00869089|University Hospitals Case Medical Center|Neil J. Korman, MD Principal Investigator|216-844-7164|neil.korman@UHHospitals.org|
282706|NCT00869141|Stein Eye Institute|Dr. Simon K. Law|(310)794-1477|law@jsei.ucla.edu|
282707|NCT00869167|California Pacific Medical Center|Brandon Lu, M.D., M.S.|415-923-3421|lubs@sutterhealth.org|
282708|NCT00869206|Christiana Care Health System|Andrew L. Himelstein, MD|(302) 366-1200|ahimelstein@cbg.org|
282709|NCT00869323|Masonic Cancer Center, University of Minnesota|Dr. Anne Blaes|612-626-8138|blaes004@umn.edu|
282710|NCT00869349|Brigham and Women's Hospital|Nancy A. Shadick|617-732-5266|nshadick@partners.org|
282711|NCT00869362|Massachusetts General Hospital Diabetes Center|Deborah J. Wexler MD|617-726-8722|dwexler@partners.org|
282712|NCT00869375|OUHSC|J. Emilio Exaire MD|405 271 4742|jose-exaire@ouhsc.edu|44744
282713|NCT00869401|Mayo Clinic|Nadia Laack M.D.|5072844561|laack.nadia@mayo.edu|
282714|NCT00869440|PAION UK Ltd|Trial Information||reg_paion@paion.com|
282715|NCT00869518|University of California, San Francisco|Brian S. Schwartz, MD|415-476-5767|brian.schwartz@ucsf.edu|
296831|NCT01708629|Bausch Health|Study Director|510-259-5284||
272778|NCT00333138|Novartis pharmaceuticals|Study director|862-778-8300||
272779|NCT00333177|University of California, Los Angeles|Keith H. Nuechterlein, Ph.D., Principal Investigator|(310) 825-0036|keithn@ucla.edu|
296832|NCT01708902|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
272780|NCT00333359|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
272781|NCT00333437|University of California San Francisco|Jeffrey A. Golden, MD|415-353-2935|Jeff.Golden@ucsf.edu|
272782|NCT00333606|Ernst Moritz Arndt University of Greifswald|Taras Usichenko, director of the trial|+493834865828|taras@uni-greifswald.de|
272783|NCT00333619|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 895-9311|cathy.alessi@va.gov|
272784|NCT00333710|VA Boston Healthcare System|Amy Silberbogen, Ph.D.|857-364-4707|amy.silberbogen@va.gov|
272785|NCT00333775|Hoffmann-La Roche|Medical Communications|800 821-8590||
272786|NCT00333788|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
272787|NCT00333801|Tuscaloosa VA Medical Center|Lori Davis, MD|205-554-3819|lori.davis@va.gov|
272788|NCT00333814|Allergan, Inc|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
272789|NCT00333840|Novartis Pharmaceuticals|Study Director|862-778-8300||
272790|NCT00333866|Organization: Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
272791|NCT00333879|Atlanta VA Rehab R&D Center|David Ross|404-321-6111|rosss0128@bellsouth.net|6817
272792|NCT00333970|VA Connecticut Healthcare System|Dr. Joanna Fiszdon|203-932-5711|joanna.fiszdon@va.gov|2231
272793|NCT00333983|VA Maryland Health Care System, Baltimore|Dr. Susan S. Conroy|(410) 605-7000|susan.conroy@va.gov|3213
272794|NCT00334061|Penumbra Inc|Siu Po Sit, PhD Study Coordinator|510 748 3200|siupo.sit@penumbrainc.com|221
272795|NCT00334074|Baylor University Medical Center|Dr. Edward Agura|214-818-8472|Sandyli@baylorhealth.edu|
272796|NCT00334113|VA Boston Healthcare System|Dr. DeAnna Mori|857-364-4121|deanna.mori@va.gov|
272797|NCT00334204|University of Mississippi|Tibor Fulop, M.D./Associate Professor of Medicine|601 984-5670|tfulop@umc.edu|
272798|NCT00334282|GlaxoSmithKline|GSK Response Center|866-435-7343||
272799|NCT00334295|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
272800|NCT00334542|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
272801|NCT00334633|University of Alabama at Birmingham|jane R Schwebke, MD|205-975-5665|schwebke@uab.edu|
272802|NCT00334737|University of New Mexico|Dr. Robin K Ohls|505-272-6753|rohls@salud.unm.edu|
267491|NCT02496611|University of Minnesota|Aaron Kelly PhD|6126253492|kelly105@umn.edu|
272803|NCT00334802|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
272804|NCT00334815|SWOG Statistical Center|Lung Committee Statistician|206-667-4623|jmoon@fhcrc.org|
272805|NCT00334893|Memorial Sloan-Kettering Cancer Center|Dr. Martee L. Hensley|646-888-4222|hensleym@mskcc.org|
272806|NCT00334958|Eisai Medical Services|Eisai Inc.|1-888-422-4743|esi_medinfo@eisai.com|
272807|NCT00335140|Johns Hopkins Cancer Center|Lode Swinnen, MD|(410) 955-8603|lswinne1@jhmi.edu|
272808|NCT00335153|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
267492|NCT02245308|Durham VA Health Care System|Angela Kirby|919-286-0411|angela.kirby@va.gov|175526
267493|NCT02227199|University of Washington|Dr. Ajay Gopal|26-606-2037|agopal@uw.edu|
267494|NCT02198794|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
267495|NCT02177695|SWOG Statistics and Data Management Center|Genitourinary Committee Statistician|2066674623|mplets@fredhutch.org|
267496|NCT02145403|University of Michigan Rogel Cancer Center|Attaphol Pawarode, M.D.|734-936-8785|pawarode@med.umich.edu|
267497|NCT02105636|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
267498|NCT02038946|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
267499|NCT01988571|Wake Forest NCI Community Oncology Research Program Research Base|Lead Biostatistician|336-716-0891|NCORP@wakehealth.edu|
267500|NCT01841736|UCSF Helen Diller Family Comprehensive Cancer Center|Emily Bergsland, M.D.|415-353-9888|emily.bergsland@ucsf.edu|
267501|NCT01715285|Janssen Research & Development, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
267502|NCT01398852|Topcon Medical Systems|Bob Gibson|(201) 599-5121|RGIBSON@TOPCON.COM|
267503|NCT01332266|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
267504|NCT01150890|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
267505|NCT01140867|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
267506|NCT01137773|University Louisville|Rainer Lenhardt, MD|502-228-7517|rainer.lenhardt@louisville.edu|
267507|NCT01127256|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
267508|NCT01004861|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
267509|NCT00912223|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
267510|NCT00381381|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical team manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
267511|NCT00038675|University of Texas (UT) MD Anderson Cancer Center|Hagop M Kantarjian,MD/Chair, Leukemia|(713) 792-7026|hkantarjian@mdanderson.org|
267512|NCT04957498|Stanford University School of Medicine|Dr. James Lock|(650) 723-6643|jimlock@stanford.edu|
267513|NCT04706403|UMass Chan Medical School|Dr. Kimberly Fisher|(508)8561975|Kimberly.Fisher@umassmemorial.org|
267514|NCT04389333|National Clinical Research Center for Digestive Diseases Department of Gastroenterology|Dr. Zhuan Liao|21-31161004|liaozhuan@smmu.edu.cn|+86
267515|NCT03712124|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
272809|NCT00335257|Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD|0049(0)30 945 10120|dinger@zeg-berlin.de|
272810|NCT00335283|Vanderbilt University Medical Center|Manager, Clinical Trials|615-322-4643|tina.higginbotham@vanderbilt.edu|
272811|NCT00335322|Kirby Institute|Sean Emery|9385 0900|semery@kirby.unsw.edu.au|
272812|NCT00335452|sanofi-aventis|Trial Information Transparency Team||GV-Contact-us@sanofi-aventis.com|
267516|NCT03689582|University of Michigan Rogel Cancer Center|Morand Piert, MD|734-936-5388|mpiert@med.umich.edu|
296833|NCT01708915|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
272813|NCT00335478|OHSU Knight Cancer Institute|Joseph Bubalo, PharmD, BCPS, BCOP|503-494-1080|bubaloj@ohsu.edu|
272814|NCT00335504|Mayo Clinic|Dr. Paul Limburg|507-266-9093|limburg.paul@mayo.edu|
272815|NCT00335517|University of Rochester|Glenn Rectine, MD|585-275-8780|glenn_rectine@urmc.rochester.edu|
272816|NCT00335556|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
272817|NCT00335725|IBSA instutut Biochimique SA|IBSA Clinical Research Manager|+41 58 360 1000|sd@ibsa.ch|
272818|NCT00335738|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
272819|NCT00335764|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-3657|jfisher@jhmi.edu|
272820|NCT00335829|Johns Hopkins, Interventional Radiology|Jeff Geschwind, MD|410-614-6597|jfg@jhmi.edu|
272821|NCT00335959|SWOG Statistical Center|Study Statistician|206-667-4623||
272822|NCT00335972|Cleveland Clinic|Rafi Avitsian, M.D|(216)-444-9735|avitsir@ccf.org|
272823|NCT00336024|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
272824|NCT00336232|Tufts University|Sarah Booth, PhD|617-556-3231|sarah.booth@tufts.edu|
272825|NCT00336284|Biotronik, Inc.|Justin Michalski, M.S. / Clinical Studies Engineer|503-675-2155|justin.michalski@biotronik.com|
272826|NCT00336323|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|Name/Official Title: Adam Glassman, M.S., Director|(813) 975-8690|drcrnet@jaeb.org|
272827|NCT00336479|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
272828|NCT00336492|Johnson & Johnson Pharmaceutical Research and Development|Senior Director, Clinical Research|610-240-8092||
272829|NCT00336505|Advanced Life Sciences|David Eiznhamer, PhD, Executive Vice President, Clinical Development|630-739-6744|deiznhamer@advancedlifesciences.com|
272830|NCT00336544|Advanced Life Sciences|David Eiznhamer, PhD, Executive Vice President, Clinical Development|630-739-6744|deiznhamer@advancedlifesciences.com|
272831|NCT00336583|Asan Medical Center|Cheolwon Suh|82 2 3010 3209|csuh@amc.seoul.kr|
272832|NCT00336700|UPMC CancerCenter|Herbert Zeh, MD|412-692-2852|zehxhx@upmc.edu|
267517|NCT03535740|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
272833|NCT00336817|Upittsburgh|Dr. Roberto Lopez-Solis|412-647-5173|lopezrc@upmc.edu|
272834|NCT00336856|University of Pittsburgh|Nathan Bahary, MD|412-864-7764|baharyn@upmc.edu|
272835|NCT00336895|UPittsburgh|Dr. Roberto Lopez-Solis|412-647-5173|lopezrc@upmc.edu|
272836|NCT00337077|ECOG Statistical Office|Study Statistician|617-632-3012||
272837|NCT00337103|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
272838|NCT00337129|SWOG Statistical Center|Head and Neck Committtee Statistician|(206)-667-4623||
272839|NCT00337168|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4623||
272840|NCT00337181|Thai Ministry of Public Health|Supachai Rerks-Ngarm|6629659571|supachai@health.moph.go.th|
272841|NCT00337194|The Ohio State University|Dr. Kristie Blum||kristie.blum@osumc.edu|
272842|NCT00337207|Northwestern University|Clinical Research Office Administrator|312-695-1301|cancertrials@northwestern.edu|
272843|NCT00337272|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
272844|NCT00337285|Shire Pharmaceutical Development, Inc.|Timothy Whitaker||twhitaker@shire.com|
272845|NCT00337350|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
272846|NCT00337428|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
272847|NCT00337467|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
272848|NCT00337571|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
272849|NCT00337610|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
272850|NCT00337662|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
272851|NCT00337727|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
272852|NCT00337779|Teva Pharmaceutical Industries, Ltd.|Chen Duksin, MD|972-9-863-4642|chen.duksin@teva.co.il|
272853|NCT00337818|GlaxoSmithKline|GSK Response Center|866-435-7343||
272854|NCT00337935|Centocor Ortho-Biotech LLC.|Vice President, Medical Affairs|800.457.6399||
272855|NCT00337987|Yale University School of Medicine|Francine Foss, MD|203-737-5312|francine.foss@yale.edu|
272856|NCT00338039|UT MD Anderson Cancer Center|Christopher H. Crane, MD / Professor||CR_Study_Registration@mdanderson.org|
272857|NCT00338286|Janssen Research and Development|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
272858|NCT00338598|Yale University|Elizabeth Ralevski Assistant Professor of Psychiatry|+1 203-932-5711|elizabeth.ralevski@yale.edu|4282
272859|NCT00338728|UT MD Anderson Cancer Center|Dr. Arun,Banu,M.D. / Breast Medical Oncology|713-792-2817|barun@mdanderson.org|
272860|NCT00338741|EMD Serono|Liz Gedney/Clinical Trial Leader|+781 681-2179||
272861|NCT00338806|NYSPInstitute|Dr. Helen Verdeli|212 543 5262|verdelih@nyspi.columbia.edu|
272862|NCT00338884|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272863|NCT00338949|UCSD/VA San Diego|Jonathan Meyer MD|8589640777|jmmeyer@ucsd.edu|
272864|NCT00338962|Yale University|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
272865|NCT00338988|University Texas MD Anderson Cancer Center|Melanie Thomas, MD/Assistant Professor|713-794-4869|mjlim@mdanderson.org|
282716|NCT00869557|Gilead Sciences, Inc|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
272866|NCT00339040|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
272867|NCT00339079|Brigham and Women's Hospital|Arthur J. Barsky, MD|617-732-5236|abarsky@partners.org|
272868|NCT00339144|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
272869|NCT00339183|Amgen Inc.|Study Director|866-572-6436||
296834|NCT01708941|ECOG-ACRIN Statistical Office|Study Statistician|(617) 632-3012|eatrials@jimmy.harvard.edu|
272870|NCT00339833|National Institutes of Health|Jonathan Krakoff, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|6022005217|jkrakoff@mail.nih.gov|
272871|NCT00340379|Duke University|Frederick Cassidy|919-575-7801|cassi002@mc.duke.edu|
272872|NCT00340678|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Dr. Robert Nelson|(602) 200-5205|rnelson@phx.niddk.nih.gov|
272873|NCT00340704|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
272874|NCT00340834|Novartis Pharmaceuticals|Study Director|862-778-8300||
272875|NCT00342355|National Institute of Allergy and Infectious Diseases, Dvision of Clinical Research|Michael A Polis, MD, MPH|301-496-8027|mpolis@niaid.nih.gov|
272876|NCT00342563|Yale University School of Medicine|Dr. Elizabeth Ralevski|+1 203-932-5711|elizabeth.ralevski@yale.edu|x4282
272877|NCT00342628|PDMI, NICHD, NIH|Feng-Ying (Kimi) Lin, MD, MPH|301-496-0295|link@mail.nih.gov|
281949|NCT00829244|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
281950|NCT00829283|Yale School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
267518|NCT03503318|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
281951|NCT00829296|University of Chicago|Dr. George Bakris|773-702-7936|gbakris@medicine.bsd.uchicago.edu|
281952|NCT00829387|VA Connecticut Healthcare System|Rebecca Czlapinski|203-932-5711|rebecca.czlapinski@va.gov|3357
281953|NCT00829413|Bracco Diagnostics Inc.|Maria Luigia Storto, MD Executive Director X-Ray and Ultrasound Medical Affairs|(609) 514-2200|MariaLuigia.Storto@diag.bracco.com|
281954|NCT00829439|Boston Children's Hospital|Wen-Hann Tan|617-355 6394|wen-hann.tan@childrens.harvard.edu|
281955|NCT00829621|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
281956|NCT00829738|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
267519|NCT02986789|Masimo Corporation|Cristina Johnson|949-297-7000|clinicalresearchdept@masimo.com|
281957|NCT00829829|Regeneron Pharmaceuticals, Inc. Phone:|Clinical Trial Management||clinicaltrials@regeneron.com|
281958|NCT00829933|Daiichi Sankyo.,LTD|So Yoshino, Manager|81-90-8024-0742|yoshino.so.ej@daiichisankyo.co.jp|
281959|NCT00829985|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
296835|NCT01708954|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
281960|NCT00830037|Indiana University School of Medicine & Richard L Roudebush VA Medical Center|Rajiv Agarwal, MD, FAHA, FASN, FASH|317-988-2241|ragarwal@iu.edu|
267520|NCT02974907|ReGenTree, LLC|Shinwook Kang|609-649-5505|swkang@regentreellc.com|
267521|NCT02921789|Astellas Pharma Global Development, Inc|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
267522|NCT02918500|University of Ottawa Heart Institute|Dr. Andrew Pipe|613-696-7000|apipe@ottawaheart.ca|
267523|NCT02896257|VA Puget Sound Health Care System|Dr. David Au|206-764-2504|David.Au@va.gov|
267524|NCT02774265|University of Maryland Medical Center|Dr. Bryce Haac|410-328-3495|bhaac@som.umaryland.edu|
267525|NCT02736617|Oregon Health and Sciences University, Knight Cancer Institute|Dr. Stephen E. Spurgeon, Associate Professor of Medicine|503-494-8950|spurgeos@ohsu.edu|
267526|NCT02652468|University of Madison Carbone Cancer Center|Vaishalee Kenkre|(608) 263-1699|vpkenkre@medicine.wisc.edu|
267527|NCT02579265|Fresenius Kabi Deutschland GmbH|Dr. Jean-Marc Lohse, Director Clinical Operations PN NAM & ELAMA|+49 6172 686|Jean-Marc.Lohse@fresenius-kabi.com|4911
281961|NCT00830063|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281962|NCT00830076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281963|NCT00830115|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
281964|NCT00830128|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281965|NCT00830167|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281966|NCT00830180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281967|NCT00830232|Dallas VA Medical Center|Dr. Carlos H Timaran|2148570336|carlos.timaran@va.gov|
281968|NCT00830284|Boston Children's Hospital|John Kheir|6179194712|john.kheir@childrens.harvard.edu|
281969|NCT00830310|University Hospitals Case Medical Center|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
281970|NCT00830362|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
281971|NCT00830375|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
281972|NCT00830388|University of Alabama at Birmingham|Wendy Cantrell|205-502-9960|wcantrell@uabmc.edu|
281973|NCT00830440|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3263|kwoessner@gidynamics.com|
281974|NCT00830518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
281975|NCT00830596|Palmer College of Chiropractic|Christine Goertz, DC, PhD, Principal Investigator|(563) 884-5150|christine.goertz@palmer.edu|
281976|NCT00830765|UMississippi|Dr John Morrison|601-984-5300|jmorrison@umc.edu|
281977|NCT00830791|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|(800) 672-6372|ClinicalTrialsDisclosure@merck.com|
281978|NCT00830804|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
281979|NCT00830869|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
308379|NCT02574832|Northwerstern University|Paloma Toledo, M.D.|312-472-3585|p-toledo@northwestern.edu|
272878|NCT00343044|Benaroya Research Institute at Virginia Mason|Thomas Malpass, M.D., Principal Investigator|206-223-6193|thomas.malpass@vmmc.org|
272879|NCT00343083|University of Maryland Baltimore|Ritesh Kataria|410-328-8018|rkataria@umm.edu|
272880|NCT00343252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
272881|NCT00343291|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
272882|NCT00343382|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-1623|cloprinzi@mayo.edu|
272883|NCT00343460|Heron Therapeutics|Robert Geller, M.D.|650-366-2626|rgeller@herontx.com|
272884|NCT00343512|Vanderbilt-Ingram Cancer Center|Bapsi Chak, M.D.|615-322-2555||
272885|NCT00343564|Cytokinetics,Inc.|Project Manager|650-624-2918||
272886|NCT00343642|Rush University Medical Center|Ece A Mutlu, Principal Investigator|312 942 5861|Ece_Mutlu@rush.edu|
272887|NCT00343785|Fred Hutchinson Cancer Research Center|Dr. Rainer Storb, Director Transplantation Biology|2066676839|rstrob@fredhutch.org|
272888|NCT00343863|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
272889|NCT00343889|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
272890|NCT00343915|GlaxoSmithKline|GSK Response Center|866-435-7343||
272891|NCT00344032|GlaxoSmithKline|GSK Response Center|866-435-7343||
272892|NCT00344175|Kowa Research Institute|Bill Arana|919 433-1600|barana@kowaus.com|
272893|NCT00344305|MedImmune, LLC|Raburn Mallory MD/ Sr Dir Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
272894|NCT00344318|GlaxoSmithKline|GSK Response Center|866-435-7343||
272895|NCT00344370|Kowa Research Institute|Bill Arana|919 433-1600|barana@kowaus.com|
272896|NCT00344448|National Institute of Dental and Craniofacial Research|Gabor G Illei, Md, principal Investigator|301 496-4072|illeig@mail.nih.gov|
272897|NCT00344461|University of Maryland, Institute Of Human Virology|Charles E. Davis, Jr., MD|410-706-4608|cdavis@ihv.umaryland.edu|
272898|NCT00344500|Psychiatry Department at VA Greater Los Angeles Healthcare System|Dr. Donna Ames, Principal Investigator|310-478-3037|donna.ames@va.gov|
272899|NCT00344682|UMass Medical School|Dr. Kristina Deligiannidis|508-856-5928|kristina.deligiannidis@umassmemorial.org|
267528|NCT02013167|Amgen Inc.|Study Director|866-572-6436||
267529|NCT02004522|Verastem, Inc.|Gloria Patrick|1-781-469-1594|gpatrick@verastem.com|
267530|NCT02000427|Amgen Inc.|Study Director|866-572-6436||
267531|NCT01981850|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
267532|NCT01804816|Cleveland Clinic Foundation|Dr. W.H. Wilson Tang, MD|(216) 444-2121||
267533|NCT01572207|Case Western Reserve University|Matthew Plow|216-368-8969|map208@case.edu|
267534|NCT01550315|Vanderbilt Universtiy|Alfredo Gamboa|6158751003|alfredo.gamboa@vumc.org|
267535|NCT01519960|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
267536|NCT00688376|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
267537|NCT00604201|National Heart Lung and Blood Institute|Childs, William|+1 301 451 7128|childsr@nhlbi.nih.gov|
267538|NCT00492349|University of Maryland|L. Elliot Hong, M.D.|410-402-6828|ehong@mprc.umaryland.edu|
267539|NCT00121108|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
267540|NCT00003102|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
267541|NCT04633837|American Health Network|Brian Badman|317-208-3866|bbadman@gmail.com|
267542|NCT04057937|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
267543|NCT03674112|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
267544|NCT03566732|University of Bergen|Professor Dagny F. Haugen|+4747606633|dagny.haugen@uib.no|
267545|NCT03032510|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
267546|NCT03029000|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
267547|NCT03022292|Stein Eye Institute of UCLA|Dr. David Sarraf|310-825-7836|DSarraf@ucla.edu|
267548|NCT02968602|Maryland Psychiatric Research Center|Heidi J Wehring|410-402-6854|hwehring@som.umaryland.edu|
267549|NCT02946047|Mayo Clinic|Dr. Nathan Cummins|507-284-3747|Cummins.Nathan@mayo.edu|
267550|NCT02830165|University of California at Los Angeles, David Geffin School of Medicine, Radiation Oncology|Nicholas Nickols, MD|310 825-8278|nnickols@mednet.ucla.edu|50472
267551|NCT02784704|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
267552|NCT04876274|School of Pharmacy, Taipei Medical University|Professor Hsiang-Yin Chen|(02)2736-1661|shawn@tmu.edu.tw|6175
267553|NCT04831515|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|JVega2@coopervision.com|
267554|NCT04343989|NYU Langone Health|Bonnie Lonze, MD, PhD|212-263-3865|bonnie.lonze@nyulangone.org|
267555|NCT04253834|Emory University|Dr. Jeffrey Miller|404-252-6104|jeffrey.miller@emory.edu|
267556|NCT03881059|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
267557|NCT03878277|University of Colorado School of Medicine|Petter Bjornstad, M.D., Assistant Professor of Pediatrics and Medicine|7207774659|petter.bjornstad@childrenscolorado.org|
272900|NCT00344773|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
272901|NCT00344968|Alimera Sciences, Inc.|Kathleen Billman, Senior Director of Scientific Affairs|678-572-1302|kathleen.billman@alimerasciences.com|
272902|NCT00345033|Massachusetts General Hospital|David C. Henderson|(617) 912-7800|dchenderson@partners.org|
272903|NCT00345046|Indiana University|Louis B. Cantor|317-278-2651|lcantor@iupui.edu|
272904|NCT00345176|The EMMES Corporation|Traci Clemons, PhD|301-251-1161|tclemons@emmes.com|212
272905|NCT00345254|Edith Wolf son Medical Cemter|Samuel Lurie|+972-35028329|drslurie@hotmail.com|
272906|NCT00345293|Rockefeller University|Mayu Frank, MS, ANP, Clinical Research Nurse Practitioner|212-327-7443|frankm@rockefeller.edu|
272907|NCT00345332|University of Rochester|Division of Urogynecology|585-273-3232|amy_keller@urmc.rochester.edu|
272908|NCT00345371|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
272909|NCT00345384|Baylor Research Institute|President Baylor Research Institute|214-820-3296|researchclinicaltrials@baylorhealth.edu|
272910|NCT00345397|Medical College of Wisconsin and Zablocki VAMC Milwaukee, WI|Mary F. Otterson, MD; Professor of Surgery|414-384-2000|Motterso@mcw.edu|4-1619
272911|NCT00345540|Novelos Therapeutics, Inc.|Vice President, Clinical Development|617-244-1616|hpalmin@novelos.com|
272912|NCT00345579|GlaxoSmithKline|GSK Response Center|866-435-7343||
272913|NCT00345592|S. Anna Hospital|Giovanni Luca Botto|0315851|gluca.botto@gmail.com|+39
272914|NCT00345605|Baylor College of Medicine|Dr. Sandesh Nagamani||nagamani@bcm.edu|
272915|NCT00345631|Cordis Corporation, a Johnson&Johnson company|Hans-Peter Stoll, M.D.|908-541-4770|hpstoll@its.jnj.com|
308380|NCT02574845|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
272916|NCT00345683|GlaxoSmithKline|GSK Response Center|866-435-7343||
272917|NCT00345839|Amgen Inc.|Study Director|866-572-6436||
272918|NCT00345865|Masonic Cancer Center, University of Minnesota|Dr.Veronika Bachanova|612-625-5469|bach0173@umn.edu|
272919|NCT00345878|GlaxoSmithKline|GSK Response Center|866-435-7343||
308381|NCT02574858|University of Michigan|Dr. D. Kim Turgeon|734-764-6860|kturgeon@med.umich.edu|
272920|NCT00345969|Washington University School of Medicine|Ellen F. Binder, MD|314-286-2707|ebinder@wustl.edu|
272921|NCT00346034|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
272922|NCT00346073|GlaxoSmithKline|GSK Response Center|866-435-7343||
272923|NCT00346151|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
272924|NCT00346164|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordintator@childrensoncologygroup.org|
272925|NCT00346216|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272926|NCT00346268|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272927|NCT00346333|Harvard Medical School|Eliot L. Berson, M.D.|617-573-3600|marilyn_sullivan@meei.harvard.edu|
308382|NCT02575079|Emory University|Elizabeth Stenger|404-785-1272|elizabeth.o'brien.stenger@emory.edu|
272928|NCT00346398|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
272929|NCT00346476|Desmond Tutu HIV Centre|Prof LG Bekker|+27216506966|Linda-Gail.Bekker@hiv-research.org.za|
272930|NCT00346632|Kyowa Kirin Pharmaceutical Development, Inc.|Project Leader|6099191100|clinical.info@kyowakirin.com|
272931|NCT00346697|Johns Hopkins University|Dr Todd Brown, Associate Professor of Medicine and Epidemiology|410-502-2327|tbrown27@jhmi.edu|
267558|NCT03817853|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
272932|NCT00346775|GlaxoSmithKline|GSK Response Center|866-435-7343||
272933|NCT00346905|Boston Scientific|Director, Endoscopy Clinical Affairs|1-508-333-1015||
272934|NCT00347009|GlaxoSmithKline|GSK Response Center|866-435-7343||
272935|NCT00347022|GUERBET|Corinne DUBOURDIEU|+33.1.45.91.50.00|corinne.dubourdieu@guerbet-group.com|
272936|NCT00347269|University of Washington|Peter Roy-Byrne MD Professor of Psychiatry|206-313-8504|roybyrne@u.washington.edu|
272937|NCT00347308|The New York Eye & Ear Infirmary|Anthony P. Sclafani, MD|212-979-4200|asclafani@nyee.edu|
272938|NCT00347360|GlaxoSmithKline|GSK Response Center|866-435-7343||
272939|NCT00347438|University of Chicago Medical Center|Dr. Funmi Olopade|773-702-1632|folopade@medicine.bsd.uchicago.edu|
272940|NCT00347776|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
272941|NCT00347919|GlaxoSmithKline|GSK Response Center|866-435-7343||
272942|NCT00347932|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
272943|NCT00347958|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
272944|NCT00348140|GlaxoSmithKline|GSK Response Center|866-435-7343||
272945|NCT00348205|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
272946|NCT00348283|Abbott|Medical Information Specialist|800-633-9110||
272947|NCT00348309|GlaxoSmithKline|GSK Response Center|866-435-7343||
272948|NCT00348348|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
272949|NCT00348374|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
272950|NCT00348595|Johns Hopkins University School of Medicine|Mario Eisenberger|(410) 614-3511|eisenma@jhmi.edu|
272951|NCT00348673|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272952|NCT00348686|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
272953|NCT00348790|Northwestern University|Jeffrey Raizer, MD|312-503-4724|jraizer@nmff.org|
272954|NCT00348816|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|Gregory P. Swanson, MD|210-450-1103|swansong@uthscsa.edu|
272955|NCT00348881|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
272956|NCT00348933|University of California and Rady Children's Hospital, San Diego|Lynne M. Bird, MD|858-966-5840|Lbird@rchsd.org|
272957|NCT00348946|Thomas Jefferson University|Judith L. Ross, M.D.|215-955-1648|judith.ross@jefferson.edu|
272958|NCT00349336|Hoffmann-La Roche|Medical Communications|800-821-8590||
272959|NCT00349349|GlaxoSmithKline|GSK Response Center|866-435-7343||
272960|NCT00349388|Atlantic Health System|Dr. Joel Rosh|973-971-5676|joel.rosh@atlantichealth.org|
272961|NCT00349466|Can-Fite Biopharma|Pnina Fishman, PhD|011972 3 924 1114|pnina@canfite.co.il|
272962|NCT00349622|MGH|Merit Cudkowicz|617-724-1873|mcudkowicz@partners.org|
272963|NCT00349713|University of Bamako|Mahamadou A. Thera, MD, MPH, Professor|223-20-22-81-09|mthera@icermaili.org|
272964|NCT00349752|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
272965|NCT00349778|Stanford University|Dr. Sally Arai|650-723-0822|sarai1@stanford.edu|
272966|NCT00349908|Codman & Shurtleff|J. Thomas Megerian, MD|508.828.8274|jmegerian1@its.jnj.com|
267559|NCT03450629|Sun Pharma Advanced Research Company Limited|Head, Clinical Developmnt|912266455645|clinical.trials@sparcmail.com|
272967|NCT00349921|Wake Forest University Health Sciences|Regina Curry, RN, CCRC|(336) 716-4294|recurry@wfubmc.edu|
272968|NCT00349973|University of Maryland, Baltimore|Dr. Elliot Hong, Prinicipal Investigator|410-402-6828|ehong@som.umaryland.edu|
272969|NCT00350025|Fox Chase Cancer Center|Dr. Yu-Ning Wong|215-728-3889|yu-ning.wong@fccc.edu|
296836|NCT01708967|Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea|Dr. Ki Tae Suk|+82-33-240-5826|ktsuk@hallym.ac.kr|
272970|NCT00350142|Stanford Cancer Center|Dr. Albert Koong|650-498-7703|akoong@stanford.edu|
272971|NCT00350207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296837|NCT01709032|Children's Hospital of Philadelphia|Janet Kwiatkowski, MD|215-590-3437|kwiatkowski@email.chop.edu|
272972|NCT00350220|University of Rochester Medical Center|Jill M. Cholette MD|585-275-0189|Jill_Cholette@urmc.rochester.edu|
272973|NCT00350272|Achillion Pharmaceuticals, Inc.|Kevin Kucharski, VP of Clinical Operations|203-624-7000|Kkucharski@achillion.com|
272974|NCT00350298|MassBiologics|Director of Clinical Affairs|617-474-3000|MBLClinicalDirector@umassmed.edu|
272975|NCT00350337|United States Army Medical Materiel Development Activity|Division of Regulated Activities and Compliance Director|301-619-0317|USAMRMCREGULATORYAFFAIRS@amedd.army.mil|
272976|NCT00350363|Stanford|Professor|650-723-6995|cta@stanford.edu|
267560|NCT03367403|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
272977|NCT00350402|University of Florida|Dr. Dawn Bowers|(352) 392-3450|dawnbowers@phhp.ufl.edu|
281980|NCT00830947|OrthoAccel Technologies, Inc.|Zaffer Syed, Director of Clinical & Regulatory Affairs|(832) 803-0339|zsyed@orthoaccel.com|
281981|NCT00830960|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281982|NCT00831129|University of Chicago|Dr. George Bakris|773-702-7936|bbrisky@medicine.bsd.uchicago.edu|
267561|NCT03286426|Duke Eye Center|Dr. Grace Prakalapakorn|+1 919 684 7679|grace.prakalapakorn@duke.edu|
281983|NCT00831181|Beth Israel Medical Center|Dr Peter Kozuch|212 844-8282|pkozuch@chpnet.org|
296838|NCT01709084|Janssen R&D US|Director, R&D, Medical Departement||ClinicalTrialDisclosure@its.jnj.com|
281984|NCT00831233|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
281985|NCT00831272|University of Pennsylvania|David Oslin|215 823 5894|oslin@upenn.edu|
281986|NCT00831311|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
296839|NCT01709110|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281987|NCT00831389|Medtronic Diabetes|Harry Clark|818-576-5653|bud.clark@medtronic.com|
281988|NCT00831415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
281989|NCT00831428|University of Dundee|Dr Karine Clearie|01382 496440|k.clearie@dundee.ac.uk|
281990|NCT00831441|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
281991|NCT00831480|Baylor College of Medicine|Dr. Gilad E. Amiel|713-798-4079|lhiggins@bcm.edu|
281992|NCT00831493|UT MD Anderson Cancer Center|Sunil Krishnan, MD / Associate Professor||mclemons@mdanderson.org|
296840|NCT01709149|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
281993|NCT00831675|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
296841|NCT01709162|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
296842|NCT01709227|Stanford University|David Kwiatkowski|650-721-3290|david.kwiatkowski@stanford.edu|
308383|NCT02575300|H. Lee Moffitt Cancer and Research Center|Dr. Jonathan Strosberg, MD|813-745-7257|Jonathan.Strosberg@moffitt.org|
267562|NCT03206476|Universidad de Guadalajara|Dra. Gabriela Macedo Ojeda|(+52) 3310585200|gabriela.macedo@cucs.udg.mx|33900
267563|NCT03135249|UT Southwestern Medical Center|Dr. Olaf Stuve, Principal Investigator|12146484559|olaf.stuve@utsouthwestern.edu|
267564|NCT03106779|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
267565|NCT02818582|National Institute of Allergy and Infectious Diseases|Higgs, Elizabeth|+1 301 768 3947|ehiggs@niaid.nih.gov|
267566|NCT02809677|UT Southwestern Medical Center|Dr. E. Sherwood Brown|24-645-6950|sherwood.brown@utsouthwestern.edu|
267567|NCT02728258|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD.|716-845-1169|gedeonl@nrgoncology.org|
267568|NCT02554253|Mayo Clinic|Erica Wittwer|5072559814|wittwer.erica@mayo.edu|
267569|NCT02498600|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|linda.gedeon@roswellpark.org|
267570|NCT02476916|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
267571|NCT02462876|W. L. Gore & Associates|Eric Novak|314-440-2119|enovak@wlgore.com|
267572|NCT02106195|Kadmon Corporation, LLC|Associate VP, Clinical Operations|833-900-5366|karin.herrera@kadmon.com|
267573|NCT01524536|National Institute of Allergy and Infectious Diseases|Paneez Khoury|+1 301 402 3773|khouryp@niaid.nih.gov|
267574|NCT01307046|Merch Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267575|NCT01307033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267576|NCT00942331|Memorial Sloan-Kettering Cancer Center|Jonathan Rosenberg, MD|646-422-4461|rosenbj1@mskcc.org|
267577|NCT00739674|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
267578|NCT00546754|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
267579|NCT00479713|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267580|NCT00406783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
267581|NCT00405964|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
281994|NCT00831701|Department of Urology, University Hospital Zürich, Switzerland|Räto T. Strebel|0041-44-2551111|raeto.strebel@ksgr.ch|
272978|NCT00350519|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Vice President Medical Affairs COBS|215-325-4464||
272979|NCT00350532|Wake Forest University School of Medicine|Dr. James Eisenach|336-716-4498|jimeisenach@gmail.com|
272980|NCT00350545|Stanford University|David B. Miklos|650 725-4959|dmiklos@stanford.edu|650
272981|NCT00350636|Watson Laboratories, Inc|Gary Hoel, PhD, Executive Director|801-808-8866|gary.hoel@watson.com|
272982|NCT00350727|GlaxoSmithKline|GSK Response Center|866-435-7343||
272983|NCT00350779|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclsoure@merck.com|
272984|NCT00350792|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
272985|NCT00350870|Yale University School Of Medicine Department of Psychiatry|Dr. Kathleen M. Carroll|203-937-3486|kathleen.carroll@yale.edu|7403
272986|NCT00351000|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
272987|NCT00351039|Fox Chase Cancer Center (formerly at H. Lee Moffitt Cancer Center & Research Institute)|George Simon, M.D.|215-728-2509|george.simon@fccc.edu|
272988|NCT00351273|University of South Florida|John D. Carter, M.D.|(813) 974-2681|jocarter@health.usf.edu|
267582|NCT00383721|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
272989|NCT00351299|BrighamHospital|Dr. Gerald Weinhouse|617-732-5499|gweinhouse@partners.org|
272990|NCT00351351|IU Health Methodist Hospital|James Lingeman, MD|317-962-0870|lrawlings@iuhealth.org|
272991|NCT00351377|Novartis Pharmaceuticals|Study Director|862-778-8300||
272992|NCT00351416|Massachusetts General Hospital|Janet Hall|617-877-1112|jehall@partners.org|
272993|NCT00351468|Novartis|Study Director|862-778-8300||
272994|NCT00351533|University of Vermont|Renee Stapleton, MD PhD|802-656-7975|renee.stapleton@uvm.edu|
272995|NCT00351611|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
272996|NCT00351741|USAISR|Principal Investigator|210-916-3054|kevin.chung@us.army.mil|
272997|NCT00351819|Brigham and Women's Hospital|Dr. Shehzad Basaria|617-525-9150|sbasaria@partners.org|
267583|NCT00383552|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
267584|NCT00383435|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
267585|NCT00381485|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@spcorp.com|
267586|NCT00379288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
267587|NCT00378378|Merck, Sharp & Dohme Corp.|Senior Vice Presiden, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
267588|NCT00089895|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
267589|NCT02614066|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
267590|NCT02577354|Mainstay Medical|Vice President Clinical Affairs|7637727637|diane.burnside@mainstay-medical.com|
267591|NCT02551718|University Of Washington|Dr. Percival|206-606-1320|mperciva@seattlecca.org|
267592|NCT02471807|Edwards Lifesciences|Ted Feldman, MD|949-250-2500|Feldman_Info@edwards.com|
267593|NCT02321514|Abbott|Karine Miquel, PhD|+32 479 600 107|karine.miquel@abbott.com|
267594|NCT02118610|Maryland Psychiatric Research Center|Ann Kearns, MS|4104066854|akearns@som.umaryland.edu|
267595|NCT01909570|University Hospital Virgen de las Nieves|Dr. Ana Clavero|0034958020482|anaclaverogilabert@gmail.com|
272998|NCT00351936|Massachusetts General Hospital Schizophrenia Research Program|Dr. David Henderson|(617) 912-7800|dchenderson@partners.org|
272999|NCT00352001|CCCC|Dr. Mikkael Sekeres|216-445-9353|sekerem@ccf.org|
273000|NCT00352027|S.t Jude Children's Research Hospital|Monika Metzger, MD|901-595-4974|monika.metzger@stjude.org|
273001|NCT00352053|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
273002|NCT00352105|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. David Adelstein|216-444-9310|adelstd@ccf.org|
273003|NCT00352365|SWOG|Study Statistician|206-667-4623||
273004|NCT00352417|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
273005|NCT00352612|Johns Hopkins University|Aaron Chen|4109556143|achen33@jhmi.edu|
273006|NCT00352664|UT MD Anderson Cancer Center|Eduardo Bruera, MD / Professor|713-792-6084||
273007|NCT00352690|Washington University School of Medicine|Ramaswamy Govindan, M.D.|314-362-5737|rgovinda@dom.wustl.edu|
273008|NCT00352755|Washington University School of Medicine|Dr. James Fleshman|314-747-4610|James.Fleshman@BSWHealth.org|
273009|NCT00352781|Centre for Addiction and Mental Health|Co-Investigator|416-535-8501|laurie_zawertailo@camh.net|7422
273010|NCT00352794|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD., Professor|713-745-3429|sverstov@mdanderson.org|
273011|NCT00352846|The University of Texas (UT) MD Anderson Cancer Center|Fredrick Hagemeister, MD/Professor||psanjorjo@mdanderson.org|
273012|NCT00352885|Emory University|Bobbi Woolwine|404-712-9620|bwoolwi@emory.edu|
273013|NCT00352911|VGX Pharmaceuticals, LLC|Mary Giffear, Sr. Clinical Scientist|267 440 4220|mgiffear@inovio.com|
273014|NCT00352976|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-626-2961|macmi002@umn.edu|
273015|NCT00353119|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
273016|NCT00353262|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
273017|NCT00353301|University of Colorado, Denver|Dr. Thomas Flaig|(720) 848-0655|Thomas.Flaig@ucdenver.edu|
273018|NCT00353366|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
273019|NCT00353418|Hoffmann-La Roche|Medical Communications|800-821-8590||
273020|NCT00353431|Intern Medicine Solothurn, Switzerland|Robert Thomann, MD|+41326274501|endodiab.bss@bluewin.ch|
273021|NCT00353496|Ipsen|Medical Director Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
273022|NCT00353522|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
267596|NCT01453946|Perrigo|Beatriz North|718-960-0163|beatriz.north@perrigo.com|
273023|NCT00353652|University of Texas Southwestern Medical Center|Wanpen Vongpatanasin|2146458000|wanpen.vongpatanasin@utsouthwestern.edu|
273024|NCT00353704|Baerum Hospital|Ulrich J Spreng|004798499184|ulispreng@hotmail.com|
296843|NCT01709305|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
273025|NCT00353795|NIH|David Bluemke|301 402 1854|bluemked@nih.gov|
273026|NCT00353834|Joslin Diabetes Center|Edward S. Horton, MD|6173091995|edward.horton@joslin.harvard.edu|
273027|NCT00353873|GlaxoSmithKline|GSK Response Center|866-435-7343||
273028|NCT00353977|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
273029|NCT00354029|Baerum Hospital|Ulrich J Spreng|004798499184|ulispreng@hotmail.com|
296844|NCT01709383|Georgetown University|Elizabeth H. Lacey, PhD, Study Coordinator|202-877-1124|ehl4@georgetown.edu|202
273030|NCT00354107|Children's Oncology Group|Results Reporting Coordinator|3522730558|resultsreportingcoordinator@childrensoncologygroup.org|
273031|NCT00354159|Medtronic CRDM|REDUCEhf Clinical Research Specialist|1-800-328-2518|medtronicCRMtrials@medtronic.com|62736
273032|NCT00354172|Masonic Cancer Center, University of Minnesota|Jeffrey Miller, M.D.|612-625-7409|mille011@umn.edu|
273033|NCT00354224|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
273034|NCT00354341|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
273035|NCT00354432|Wake Forest University School of Medicine|Dr. Doug Case|(336) 716-5425|dcase@wakehealth.edu|
273036|NCT00354484|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
273037|NCT00354601|Wake Forest University Health Sciences|Doug Case Biostatistician|336-716-1048|dcase@wfubmc.edu|
296845|NCT01709409|OHRI|Dr. Brigitte Lemyre|613-737-8899|blemyre@toh.on.ca|71882
273038|NCT00354614|ResMed|VP Medical Affairs|858 836 6782|ResmedScienceCenter@resmed.com.au|
273039|NCT00354640|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|4432876489|vstearn1@jhmi.edu|
273040|NCT00354679|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
273041|NCT00354744|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
273042|NCT00354770|University of Chicago|Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
282717|NCT00869609|University of Pittsburgh|Trevor J Orchard|412-383-1032|tjo@pitt.edu|
267597|NCT01444092|Perrigo|Beatriz North|718-960-0163|beatriz.north@perrigo.com|
267598|NCT01332968|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
267599|NCT01265784|La Jolla Pharmaceutical Company|Chief Development Officer|+1.617.715.3600|ljpcregulatory@ljpc.com|
267600|NCT00577577|Insmed|Insmed Medical Information|1-844-446-7633|medicalinformation@insmed.com|
267601|NCT00392327|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
267602|NCT00085202|St. Jude Children's Research Hospital|Amar Gajjar, MD|866-278-5833|info@stjude.org|
267603|NCT05007639|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|+33 (0)5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
267604|NCT04739735|Faculty of dentistry, Alexandria University, Egypt|Dr. Rodaina Helmy|00201100001193|rodaina.helmy@alexu.edu.eg|
267605|NCT04552535|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
267609|NCT04386616|Genentech, Inc.|Medical Communications|800-821-8590|genentech@druginfo.com|
267610|NCT04377711|Covis Pharma|Eric Dowrick|6108830485|edowrick@covispharma.com|
267611|NCT04347408|Queen's University Belfast|Dr Thomas Waterfield|028 9024 5133|t.waterfield@qub.ac.uk|
267612|NCT04296942|National Cancer Institute|Dr. Fatima H. Karzai|301-480-7174|fatima.karzai@nih.gov|
267613|NCT04278872|Sojournix, Inc.|Head of Regulatory Affairs|6174758469|clinicaltrials@sojournixpharma.com|
267614|NCT04213807|Anthos Therapeutics|Debra Freedholm|609-439-8246|Deb.f@anthostherapeutics.com|
267615|NCT04172467|Hematology Oncology Kaiserslautern|Prof. Hartmut Link|0631|praxis-link@kabelmail.de|3503709
267616|NCT04132804|Massachusetts General Hospital|Dr. Kyle Staller|617-726-5565|kstaller@mgh.harvard.edu|
267617|NCT03963011|Children's Mercy Hospital|Erin Opfer, DO|816-324-3273|ekopfer@cmh.edu|
267625|NCT03691727|University of Iowa|David Hasan|319-384-8669|david-hasan@uiowa.edu|
267626|NCT03689920|Boston Scientific|Director of Clinical Sciences|661-949-4350|roshini.jain@bsci.com|
267627|NCT03672227|REGENTS OF THE UNIVERSITY OF MICHIGAN|Dr. Katherine Bauer|(734)763-2546|kwbauer@umich.edu|
267628|NCT03644849|Saint Louis University|Dr. Ramona Behshad|314-977-9721|ramona.behshad@health.slu.edu|
267629|NCT03640949|Aarhus University|Lars W. Andersen|+4551781511|lwandersen@clin.au.dk|
267630|NCT03604159|NYU Langone|Dr. Joshua Lee|646-501-3552|Joshua.Lee@nyulangone.org|
267631|NCT03602885|DFCI|Andrea Enzinger, MD|617-582-7335|andrea_enzinger@dfci.harvard.edu|
267632|NCT03539601|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
267633|NCT03539458|Abbott Vascular Structural Heart|Reshma Rao, Principal Study Clinical Research Associate|651-756-2542|reshma.rao@abbott.com|
267634|NCT03532451|ECOG Stats Center|Jun Yin|3472770190|jun_yin@dfci.harvard.edu|
267635|NCT03505099|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
282718|NCT00869622|VA Boston Healthcare System|Antonio A. Lazzari, M.D., Ph.D|(857) 364-6381|Antonio.Lazzari@va.gov|
282719|NCT00869778|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
282720|NCT00869791|Impax Laboratories, Inc.|Michelle Landolfi, PhD. Sr. Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com|
282721|NCT00869947|Eastern Colorado Healthcare System|Dr. Alena Grabowski|303-492-5208|alena.grabowski@va.gov|
282722|NCT00869960|UAB|Jennifer King|205-934-2696|jenking@uab.edu|
267636|NCT03478956|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
273043|NCT00354887|UT MD Anderson Cancer Center|Robert Wolff, MD / Professor|713-792-2828|mjlim@mdanderson.org|
273044|NCT00354913|Duke University Medical Center|Dr. Annick Desjardins|919-681-1691|annick.desjardins@dm.duke.edu|
273045|NCT00354978|UT MD Anderson Cancer Center|Scott Kopetz, MD Associate Professor|713-792-2828|mjlim@mdanderson.org|
273046|NCT00355030|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273047|NCT00355056|St. Jude Medical|Director, Global Clinical Affairs|818-493-3648|aoza@sjm.com|
267606|NCT04502472|Inova Health Systems|Anne Whitney Brown, MD|7037763067|anne.brown@inova.org|
273048|NCT00355082|GlaxoSmithKline|GSK Response Center|866-435-7343||
273049|NCT00355121|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
273050|NCT00355134|Novartis Pharmaceuticals|Study Director|862-778-8300||
273051|NCT00355147|VA Stroke QUERI Center, Roudebush VAMC|Teresa Damush, Ph.D.|317-988-4277|Teresa.Damush@va.gov|
267607|NCT04495166|Medical School of the University of Sao Paulo|Daniel Fatori|5511 96162-6183|daniel.fatori@gmail.com|
273052|NCT00355199|Ospedale Papa Giovanni XXIII, Bergamo|Alessandro Rambaldi|0352673684|arambaldi@asst-pg23.it|+39
273053|NCT00355264|BioMarin Pharmaceutical Inc.|Joshua Lilienstein|651-523-0310|MEDINFO@bmrn.com|
273054|NCT00355342|GlaxoSmithKline|GSK Response Center|866-435-7343||
273055|NCT00355368|Medical Intensive care unit, University Hospital Basel|Stephan Marsch|+ 41 61 265 2525|smarsch@uhbs.ch|
273056|NCT00355394|CHOP|Dr. Nicholas Abend|215-590-1719|abend@email.chop.edu|
273057|NCT00355472|Kyowa Hakko Kirin|Project Management Department, Development Division||clinical.info@kyowa-kirin.co.jp|
273058|NCT00355615|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
267608|NCT04461483|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
273059|NCT00355706|Pain Management Center of Paducah|Laxmaiah Manchikanti, MD|2705548373|drm@asipp.org|100
273060|NCT00355784|University of Michigan, Ann Arbor, Michigan|Jeffrey F. Horowitz|734-647-1076|jeffhoro@umich.edu|
273061|NCT00355797|BIOTRONIK, Inc.|CLEAR Study CSE|503-451-8051||
273062|NCT00355914|Pain Management Center of Paducah, Paducah, KY|Laxmaiah Manchikanti, MD|2705548373|drlm@thepainmd.com|100
273063|NCT00356031|Massachusetts General Hospital|Dr. Sam S. Yoon, Principal Investigator|617 643-9475|syoon@partners.org|
273064|NCT00356057|BIOTRONIK, Inc.|Katerina de Metz, Director Clinical Studies|5036752169|katerina.demetz@biotronik.com|
273065|NCT00356122|Sanofi-Aventis|Trial Transparency Team||Contact-Us@sanofi.com|
273066|NCT00356135|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273067|NCT00356148|Marmara University School of Medicine|Prof. Bahadir M Gulluoglu|902164256565|bmgulluoglu@marmara.edu.tr|4012
267618|NCT03894501|Rutgers Robert Wood Johnson Medical School|Nina Cooperman|732-235-8569|cooperna@rwjms.rutgers.edu|
273068|NCT00356200|Tufts Medical Center|Alice B Gottlieb, MD, PhD|617 636 4802|agottlieb@tuftsmedicalcenter.org|
267619|NCT03874325|Moffit Cancer Center|Hung Khong, MD|813-745-3828|hung.khong@moffitt.org|
267620|NCT03837184|Novartis Gene Therapies EU Limited|EMEA Medical Information|+353 (1) 566-2364|medinfoemea.gtx@novartis.com|
267621|NCT03833661|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
267622|NCT03735420|National University of Natural Medicine|Ryan Bradley, ND, MPH|5035521862|rbradley@nunm.edu|
267623|NCT03721328|Nor Consult, LLC|Nor Consult|206-607-6861|regulatory@nor-consult.com|
267624|NCT03721107|4D pharma plc|Programme Development Director|+4401138950130|clinicaltrials@4dpharmaplc.com|
267637|NCT03464136|Janssen Scientific Affairs, LLC|DIRECTOR MEDICAL AFFAIRS MD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
267638|NCT03439657|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
267639|NCT03377790|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
267640|NCT03353675|Transgene|Director of Medical Affairs|+ 33 (0)3 88 27 91 00|clinical.trials@transgene.fr|
267641|NCT03294109|university of Californiia|Siamak Rahman, MD|310 2678839|sirahman@mednet.ucla.edu|
267642|NCT03268005|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
273069|NCT00356265|University of Michigan|Crystal Gadegbeku||crystal.Gadebeku@tuhs.temple.edu|
273070|NCT00356278|Emory University|Barbara O. Rothbaum, PhD, ABPP|404-712-8866|brothba@emory.edu|
273071|NCT00356304|VA New Jersey Healthcare System|Alejandro Interian, Principal Investigator|908-647-0180|alejandro.interian@va.gov|4617
273072|NCT00356369|GlaxoSmithKline|GSK Response Center|866-435-7343||
296846|NCT01709422|Prince of Songkhla University|Dr. Nisa Netinatsunton|6674451965|nisasan@yahoo.com|9
273073|NCT00356408|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
273074|NCT00356434|Johns Hopkins Univ|Abimbola Aina|410-955-8496|aaina1@jhmi.edu|
273075|NCT00356525|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273076|NCT00356590|Amgen Inc.|Study Director|866-572-6436||
273077|NCT00356603|GlaxoSmithKline|GSK Response Center|866-435-7343||
281995|NCT00831753|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
281996|NCT00831766|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jeffrey Lancet|813-745-1387|jeffrey.lancet@moffitt.org|
281997|NCT00831779|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
281998|NCT00831792|UT MD Anderson Cancer Center|Corn,Paul,M.D. Ph.D. / Genitourinary Medical Oncology|713-792-7734|PCORN@MDANDERSON.ORG|
281999|NCT00831844|Children's Oncology Group|Results Reporting Coordinator|626-241-0064|Resultsreportingcoordinator@childrensoncologygroup.org|
296847|NCT01709474|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
282000|NCT00831987|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
282001|NCT00832000|University of Kansas Medical Center|Richard J. Barohn, MD|913-588-6095|rbarohn@kumc.edu|
282002|NCT00832078|Coloplast|Scientific Manager|+4549113557|dkkg@coloplast.com|
282003|NCT00832091|RegeneRx Biopharmaceuticals, Inc.|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|301-208-9191|nturjman@regenerx.com|108
273078|NCT00356759|McMaster University|Dr. Sam Schulman|19055270271|schulms@mcmaster.ca|44810
273079|NCT00356811|GlaxoSmithKline|GSK Response Center|866-435-7343||
273080|NCT00356863|The Gertner Institute for Epidemiology and Health Service Research|Rachel S Dankner, MD, MPH|972-3-5305390|RachelD@gertner.health.gov.il|
296848|NCT01709500|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
273081|NCT00356889|University of Wisconsin Cancer Center|William Schelman, M.D.||wrs@medicine.wisc.edu|
273082|NCT00356915|GlaxoSmithKline|GSK Response Center|866-435-7343||
273083|NCT00356993|Addictions Program|Dr. Peter Selby|416-535-8501|peter_selby@camh.net|77432
273084|NCT00357006|Monash Alfred Psychiatry Research Centre|Prof Jayashri Kulkarni|+61 390766924|j.kulkarni@alfred.org.au|66924
273085|NCT00357032|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
267643|NCT03225170|NHGRI|Dr. Lori Erby|301-443-2635|lori.erby@nih.gov|
308384|NCT02575807|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
273086|NCT00357097|GlaxoSmithKline|GSK Response Center|866-435-7343||
273087|NCT00357110|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
273088|NCT00357162|Washington University|Amanda Cashen, M.D.||acashen@im.wustl.edu|
308385|NCT02575833|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
273089|NCT00357214|Tufts University|Bess Dawson-Hughes|617 556 3066|bess.dawson-hughes@tufts.edu|6175100519
273090|NCT00357331|Weill Medical College|Assistant Professor of Medicine|212-746-1670|sinhana@med.cornell.edu|
273091|NCT00357370|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
273092|NCT00357396|Memorial Sloan Kettering Cancer Center|Dr. Susan Prockop|212-639-6715|prockops@mskcc.org|
267644|NCT03220854|Virginia Commonwealth University Massey Cancer Center|Alfredo I Urdaneta|(804) 828-0450|MasseyRadOnc@vcu.edu|
273093|NCT00357500|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
267645|NCT03219034|Texas A&M University College of Dentistry|Dr. Emet Schneiderman|2148288377|eschneiderman@tamu.edu|
273094|NCT00357552|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
273095|NCT00357656|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
273096|NCT00357734|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
273097|NCT00357760|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
273098|NCT00357877|Kaiser Permanente Data Coordinating Center|Dr. William Vollmer|503-335-6755|william.vollmer@kpchr.org|
273099|NCT00357903|Amgen Inc.|Study Director|866-572-6436||
273100|NCT00357955|Providence VA Medical Center|Wen-Chih Wu, MD; Principal Investigator|4012737100|wen-chih.wu@va.gov|6237
273101|NCT00357968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273102|NCT00357994|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
273103|NCT00358007|Thomas Jefferson University|Pramila Rani Anne, MD|215-955-6702|Pramila.Anne@jefferson.edu|
267646|NCT03181789|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
267647|NCT03168438|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
267648|NCT03110380|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
267649|NCT03109262|Stanford University|Andrei Iagaru, PROFESSOR OF RADIOLOGY (NUCLEAR MEDICINE)|1650-725=4711|aiagaru@stanford.edu|
267650|NCT03078478|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
267651|NCT03040661|Inova Heart and Vascular Institute|Vineet Kumar|(703) 289-9400|vineet.kumar@inova.org|
267652|NCT02993263|Cleveland Clinic|Daniel Sessler, MD|216-444-9400|sesslers@ccf.org|
267653|NCT02985684|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
267654|NCT02964897|Center for Healthcare Organization and Implementation Research, VA Bedford Healthcare System|Keith McInnes, Principal Investigator|617-504-1630|donald.mcinnes@va.gov|
267655|NCT02951052|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
267656|NCT02903914|Call Center|Incyte Corporation|1-855-463-3463|medinfo@incyte.com|
267657|NCT02879448|Abbott Medical|Jordan Anderson, Clinical Scientist|651 756 3360|ClinicalTrials.gov_SH_Inquiries@abbott.com|
267658|NCT02873195|Duke University Medical Center|Niharika Bansal Mettu, M.D.|919-681-2954|niharika.mettu@duke.edu|
267659|NCT02821000|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267660|NCT02785952|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
267661|NCT02758717|Lombardi Comprehensive Cancer Center|Bruce D. Cheson, M.D.|507-266-0800|bdc4@georgetown.edu|
267662|NCT02748616|NYU Langone Health|Norman Javitt, MD|212-263-6588|Norman.Javitt@nyulangone.org|
267663|NCT02719522|Medtronic Neurovascular|Claudia Campo|0039 0224137325|claudia.campo@medtronic.com|
267664|NCT02664181|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nathan Pennell|1-866-223-8100|TaussigResearch@ccf.org|
267665|NCT02633241|Boston Children's Hospital|Joseph P. Cravero|617-355-4292|Joseph.Cravero@childrens.harvard.edu|
267666|NCT02586025|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
267667|NCT02585232|Tuscaloosa VA Medical Center|Dr. Michelle Hilgeman|205-554-2000|Michelle.Hilgeman@va.gov|3278
267668|NCT02583269|Wake Forest University Health Sciences|Study Nurse|336-713-7748|saverill@wakehealth.edu|
267669|NCT02556606|Michael E. DeBakey VA Medical Center|Marijn Lijffijt, PhD|3618274395|marijn.lijffijt@bcm.edu|
267670|NCT02545283|www.roche.com/about_roche/roche_worldwide.htm|Reference Study ID Number: WO29519|888-662-6728 (U.S. Only)|global-roche-genentech-trials@gene.com|
273104|NCT00358150|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
273105|NCT00358215|Amgen Inc.|Study Director|866-572-6436||
273106|NCT00358332|University of Maryland School of Medicine|Christopher V. Plowe|410-706-3082|cplowe@medicine.umaryland.edu|
273107|NCT00358436|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
273108|NCT00358449|GlaxoSmithKline|GSK Response Center|866-435-7343||
273109|NCT00358462|University of Washington|Lisa E. Manhart, PhD - PI|206-744-3646|lmanhart@uw.edu|
273110|NCT00358501|Jazz Pharmaceuticals|Head of Clinical Development|650.496.3777||
273111|NCT00358579|Singapore General Hospital|A/Prof Marcus Ong Eng Hock|+6563213590|marcus.ong.e.h@sgh.com.sg|
273112|NCT00358644|Eisai Inc.|Eisai Call Center|888-422-4743||
273113|NCT00358657|Fred Hutchinson Cancer Research Center|Dr. Kanwaldeep Mallhi|206-667-2014|kmallhi@fredhutch.org|
273114|NCT00358670|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
273115|NCT00358735|Medical Compression Systems|Clifford W Colwell, M.D Scripps Clinic|972-4-6266630|Jbarak@mcsmed.com|412
273116|NCT00358826|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
273117|NCT00358917|Abbott|Medical Information Specialist|800-633-9110||
273118|NCT00358956|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
273119|NCT00359021|Tibotec|SENIOR DIRECTOR R&D|1 609 730-7548||
273120|NCT00359073|University of Wisconsin Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
273121|NCT00359203|Medtronic Italia SpA|Silvia Giuli|003932814224|silvia.giuli@medtronic.com|
273122|NCT00359281|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|msumeray@aegerion.com|
273123|NCT00359294|PharmaMar USA Inc|Responsible medical officer|1 212 201 6770|ccoronado@pharmamar.com|
273124|NCT00359424|University of Cincinnati Academic Health Center|Joseph P. Broderick|513-558-5429|broderjp@ucmail.uc.edu|
273125|NCT00359619|GlaxoSmithKline|GSK Response Center|866-435-7343||
273126|NCT00359632|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296849|NCT01709513|Regeneron Pharmaceuticals, Inc|Clinical Trial Administrator||clinicaltrials@regeneron.com|
296850|NCT01709578|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
273127|NCT00359736|Miami VAHS|Dr. Robert M Jackson, ACOS/R|305-575-3548|robert.jackson4@va.gov|
273128|NCT00359762|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
273129|NCT00359788|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
267671|NCT02524171|Center for Innovation to Implementation, VA Palo Alto|Daniel M. Blonigen, PhD|650-493-5000|daniel.blonigen@va.gov|27828
267672|NCT02489422|Wake Forest University Health Sciences|Study coordinator|336-716-9055|megreen@wakehealth.edu|
267673|NCT02487251|Michigan State University|Holly E. Brophy-Herb, PI|517-355-3397|hbrophy@msu.edu|
267674|NCT02476968|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
267675|NCT02367040|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
273130|NCT00359801|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
273131|NCT00359944|Sunovion|Medical Director, CNS|1-866-503-6351||
273132|NCT00359983|GlaxoSmithKline|GSK Response Center|866-435-7343||
273133|NCT00360009|University of Florida Department of Neurology|Michael Okun, M.D.|352-273-5550|okun@neurology.ufl.edu|
273134|NCT00360126|GlaxoSmithKline|GSK Response Center|866-435-7343||
273135|NCT00360230|GlaxoSmithKline|GSK Response Center|866-435-7343||
273136|NCT00360243|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
273137|NCT00360269|Medical University of South Carolina|Aimee McRae-Clark, Pharm.D., BCPP|843-792-5215|mcraeal@musc.edu|
273138|NCT00360282|University of Pittsburgh|Joseph M. Furman, MD, PhD|(412) 647-2115|furmanjm@upmc.edu|
273139|NCT00360308|Eisai Call Center|Eisai Inc.|888-422-4743||
273140|NCT00360334|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
273141|NCT00360360|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-MY-1-SCRI|asksarah@scresearch.net|
273142|NCT00360399|Emory University|Helen Mayberg|404-727-6740|hmayber@emory.edu|
273143|NCT00360412|Eisai Call Center|Eisai Inc.|888-422-4743||
273144|NCT00360490|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
273145|NCT00360529|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com|
273146|NCT00360555|Sprout Pharmaceuticals|Scientific Program Director|9198820850|clinicaltrials@sproutpharma.com|
273147|NCT00360568|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
273148|NCT00360672|UT MD Anderson Cancer Center|Gautam Borthakur, M.D./Associate Professor|713-563-1586|eharriso@mdanderson.org|
273149|NCT00360685|Moffitt Cancer Center|Janelle Perkins, PharmD|813-745-7226|Janelle.Perkins@moffit.org|
273150|NCT00360698|sanofi-aventis|Medical Affairs study director||publicregistryGMA@sanofi-aventis.com|
273151|NCT00360724|NY State Psychiatric Institute|David Hellerstein MD|6467748000|hellers@nyspi.columbia.edu|
273152|NCT00360828|H. Lee Moffitt Cancer Center and Research Institute|Edward Pan, M.D.|813-745-3871|edward.pan@moffitt.org|
273153|NCT00360971|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
273154|NCT00361140|Moffitt Cancer Center|Dr. Teresa Field|(813) 745-7202|Teresa.Field@moffitt.org|
273155|NCT00361218|Massachusetts General Hospital|John W. Denninger, MD, PhD|617-726-2985|jdenninger@partners.org|
273156|NCT00361231|Massachusetts General Hospital|Dr. Andrew X. Zhu|617-724-4000|azhu@mgh.harvard.edu|
273157|NCT00361257|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
273158|NCT00361270|Michael E DeBakey VAMC|Wright Williams, Ph.D., ABPP|713-794-7629|wright.williams@va.gov|
273159|NCT00361283|University of Florida|Reginald F. Frye, PhD, Associate Professor|3522735453|fryerf@ufl.edu|
273160|NCT00361296|Johns Hopkins University|Doug Smith, MD|4102872935|smithdo@jhmi.edu|
273161|NCT00361335|Centocor, Inc.|Senior Director Clinical Research|1-800-457-6399||
282004|NCT00832117|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
273162|NCT00361374|Massachusetts General Hospital|Dr David Mischoulon, Director of Research, Depression Clinical and Research Program|617-724-5198|dmischoulon@partners.org|
273163|NCT00361439|University of Chicago|Jayant Pinto, MD|773-702-6727|jpinto@surgery.bsd.uchicago.edu|
273164|NCT00361504|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
273165|NCT00361569|Duramed Research|Duramed Research Protocol Chair|215-293-7279|medicalaffairs@barrlabs.com|
273166|NCT00361595|Cleveland Clinic|Chad Deal|216-444-6575|dealc@ccf.org|
273167|NCT00361634|Amgen Inc.|Study Director|866-572-6436||
273168|NCT00361712|Rabin Medical Center|Dr Leonid Edilman|972-9376850|leidelman@clalit.org.il|
273169|NCT00361842|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
273170|NCT00361972|university of utah|kathryn peterson|8015817804|kathryn.peterson@hsc.utah.edu|
273171|NCT00362115|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
273172|NCT00362128|Albert Einstein College of Medicine|Judith Wylie-Rosett|718-430-3345|Judith.Wylie-Rosett@einstein.yu.edu|
273173|NCT00362180|Kastle Therapeutics, LLC|Christopher Bryant, Ph.D.|8152633913|cbryant@kastletx.com|
273174|NCT00362232|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
273175|NCT00362297|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
273176|NCT00362336|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
273177|NCT00362375|SisterLove, Inc.|Dazon Dixon-Diallo, Executive Director|404-505-7777|ddiallo@sisterlove.org|
282005|NCT00832130|TearScience, Inc. (formerly Kolis Scientific)|Christy Stevens, OD|919-459-4815|cstevens@tearscience.com|
282006|NCT00832260|Hospital Universitari i politecnic La Fe|Dr. José Olagüe|+34 961 24 40 00|jolague@terra.com|
282007|NCT00832338|Emory University|Jane Meisel, MD|404-778-1900|jane.l.meisel@emory.edu|
282008|NCT00832377|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282009|NCT00832390|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
282010|NCT00832416|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
267676|NCT02306122|Brown University|Joanne Michaud|401-863-9317|joanne_michaud@brown.edu|
282011|NCT00832585|Rush University Medical Center - Department of Dermatology|Dr. Michael D. Tharp|312-563-4001|derm@rush.edu|
282012|NCT00832637|University of New Mexico|Yehuda Patt, MD|5059250405|yzpatt@salud.unm.edu|
282013|NCT00832650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282014|NCT00832767|Covidien|Jessica Carlson|203-821-4734|jessica.carlson@covidien.com|
282015|NCT00832780|University of New Mexico Comprehensive Cancer Center|Ben Liem, MD|505-272-0086|BLiem@salud.unm.edu|
282016|NCT00832819|Eisai Co., Ltd.|Wataru Yusa|+81 3-3817-5252||5252
282017|NCT00832871|University of New Mexico Comprehensive Cancer Center|Dr. Fa-chyi Lee|505-925-0405|FLee@salud.unm.edu|
267677|NCT02304991|University of North Carolina School of Medicine|Edwin Kim, MD, MS|919-962-4960|edwinkim@email.unc.edu|
267678|NCT02223520|Johns Hopkins Medical Institutions|Aaron M. Milstone, M.D., M.H.S.|410-614-3917|amilsto1@jhmi.edu|
267679|NCT02178709|IndianaU|Dr. Amikar Sehdev|(317) 274-0339|asehdev@iupui.edu|
267680|NCT02147184|Baylor College of Medicine|Dr. Chadi Calarge|832-824-4764|chadi.calarge@bcm.edu|
267681|NCT02122198|University of Colorado Denver|Kerry Hildreth, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
267682|NCT02075840|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
267683|NCT02055053|Lahey Clinic|dmitry nepomnayshy MD|781 744 8576|dmitry.nepomnayshy@lahey.org|
267684|NCT02000219|OxThera|Chief Operating Officer|0046 86600223|elisabeth.lindner@oxthera.com|
267685|NCT01978938|La Jolla Pharmaceutical Company|Chief Development Officer|617-715-3600|ljpcregulatory@ljpc.com|
267686|NCT01854385|University of Washington|Dr. Jeanne Hoffman|(206) 221-6511|jeanneh@uw.edu|
267687|NCT01844856|La Jolla Pharmaceutical Company|Chief Development Officer|+1.617.715.3600|ljpcregulatory@ljpc.com|
267688|NCT01788306|University of Washington|Dr. Caleb Banta-Green|206-543-0937|calebbg@uw.edu|
267689|NCT01776723|H Lee Moffitt Cancer Center & Research Institute|Eric Padron, MD|813-745-3907|Eric.Padron@Moffitt.org|
267690|NCT01744041|Washington University - School of Medicine|Dr. Shannon Lenze|3143622752|slenze@wustl.edu|
267691|NCT01733147|Mayo Clinic|Dr. Prasad Iyer|507-293-7911|iyer.Prasad@mayo.edu|
267692|NCT01712789|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
267693|NCT01660451|Bayer|Therapeutic Area Head|+1-888-8422937|clinical-trials-contact@bayer.com|
267694|NCT01651403|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
267695|NCT01543633|Neuroscience Statistics Research Laboratory, Massachusetts General Hospital|Dr. Emery N. Brown|(617) 726-8786|enb@neurostat.mit.edu|
267696|NCT01542736|University of Colorado Denver|Jennifer Raybin, PhD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
267697|NCT01535807|Inova Heart and Vascular Institute|Lisa Fornaresio, PhD|703-776-7071|lisa.fornaresio@inova.org|
267698|NCT01147666|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
267699|NCT01065454|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
267700|NCT00982111|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
267701|NCT00193219|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
267702|NCT00116142|Dana Farber Cancer Institute|Anthony D'Amico|617.732.6310|ADAMICO@LROC.HARVARD.EDU|
267703|NCT00070018|SWOG Statistical Center|Study Statistician|206-667-4623||
267704|NCT04631796|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
267705|NCT04447287|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
292588|NCT01435759|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
273178|NCT00362414|University of California Irvine|Dr. Steven Cramer|(714) 456-6876|scramer@uci.edu|
273179|NCT00362440|BIDMC|Dr. Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
273180|NCT00362453|Tufts Medical Center|Chenchen Wang, MD, MSc, Associate Professor|617-636-3251|cwang2@tuftsmedicalcenter.org|
273181|NCT00362466|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
273182|NCT00362609|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
273183|NCT00362648|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
273184|NCT00362817|The Ohio State University Medical Center and James Cancer Hospital & Solove Research Inst.|Herbert Newton,|614-293-4448|newton.12@osu.edu|
273185|NCT00362882|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
273186|NCT00363051|Novartis Pharmaceuticals|Novartis Study Director|(862 778-8300||
273187|NCT00363077|GlaxoSmithKline|GSK Response Center|866-435-7343||
273188|NCT00363129|Mayo Clinic|Lisa Kottschade, RN, MSN, CNP|507-284-2511|kottschade.lisa@mayo.edu|
273189|NCT00363142|GlaxoSmithKline|GSK Response Center|866-435-7343||
273190|NCT00363168|Johns Hopkins University|Neil M. Bressler|410-955-8342|nbressler@jhmi.edu|
273191|NCT00363246|James A. Haley Veterans' Hospital|Andrea M. Spehar, DVM, MPH, JD|813-558-3947|Andrea.Spehar@va.gov|
273192|NCT00363298|Stanford University Medical Center, Department of Psychiatry|Lorrin M. Koran, M.D.|650 498-5035|lkoran@stanford.edu|
273193|NCT00363311|GlaxoSmithKline|GSK Response Center|866-435-7343||
273194|NCT00363415|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273195|NCT00363467|H. Lee Moffitt Cancer Center|Jeffrey Lancet MD|813-745-6841|Jeffrey.Lancet@moffitt.org|
273196|NCT00363480|GlaxoSmithKline|GSK Response Center|866-435-7343||
267706|NCT04203537|Concentric Analgesics|Nancy Wu|(415) 484-7921|nancy@concentricanalgesics.com|
267707|NCT04125745|University of California San Francisco|Marc Simon, MD, Director of Pulmonary Vascular Disease and Pulmonary Hypertension Comprehensive Care|415-476-1325|Marc.Simon@ucsf.edu|
273197|NCT00363545|GlaxoSmithKline|GSK Response Center|866-435-7343||
273198|NCT00363649|Johns Hopkins University|Doug Smith, MD|4102872935|smithdo@jhmi.edu|
273199|NCT00363675|Shrines Hospitals for Children - Boston|Mary Jo Baryza, Diredtor of Therapeutic Services|617-371-4749|mbaryza@shrinenet.org|
273200|NCT00363766|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273201|NCT00363779|National Cancer Institute (NCI), National Institutes of Health (NIH)|Thomas Waldmann, M.D.|301-496-6653|Thomas_Waldmann@nih.gov|
273202|NCT00363805|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
273203|NCT00363883|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
273204|NCT00363896|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
273205|NCT00364013|Amgen Inc.|Study Director|866-572-6436||
273206|NCT00364130|Children's Hospital of Philadelphia|Mary Leonard, MD, MSCE|215-590-0874|leonard@email.chop.edu|
273207|NCT00364156|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
273208|NCT00364182|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
267708|NCT04074928|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
273209|NCT00364286|The University of Texas MD Anderson Cancer Center|Susan O'Brien, MD/ Professor|713-792-7543|eharriso@mdanderson.org|
273210|NCT00364351|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
273211|NCT00364377|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
273212|NCT00364533|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-6780||
273213|NCT00364611|Sanofi-aventis|Trial Transparency Team||Contact-us@sanofi.com|
273214|NCT00364793|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
273215|NCT00364819|University of California Davis|Christopher L. Bowlus, MD|916-734-8986|clbowlus@ucdavis.edu|
273216|NCT00364832|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
273217|NCT00364845|Amgen Inc.|Study Director|866-572-6436||
273218|NCT00364858|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
273219|NCT00364923|Allos Therapeutics, Inc|Michael Saunders, M.D.|303-426-6262|msaunders@allos.com|
273220|NCT00364949|Northwestern University|Dr. Andrea Dunaif|312-503-2902|a-dunaif@northwestern.edu|
273221|NCT00365053|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
273222|NCT00365105|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
273223|NCT00365144|UCaliforniaSF|Andrew Ko, MD|415-353-9888|andrewko@medicine.ucsf.edu|
273224|NCT00365209|University of California, Irvine|Dr. Frank L. Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
273225|NCT00365261|University of California, San Diego|Joel Dimsdale, M.D., Principal Investigator|619 543-5592|jdimsdale@ucsd.edu|
273226|NCT00365274|The University of Texas (UT) MD Anderson Cancer Center|Michelle Fanale, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
273227|NCT00365300|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
273228|NCT00365352|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
273229|NCT00365365|Sanofi|Trial Transparency Team||Contact_Us@sanofi.com|
273230|NCT00365378|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
273231|NCT00365391|Wayne State University|Philip A. Philip, M.D., Ph.D., F.R.C.P.||philipp@karmanos.org|
273232|NCT00365417|NSABP Foundation, Inc.|Diana Gosik|412-339-5333|diana.gosik@nsabp.org|
273233|NCT00365456|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
273234|NCT00365508|University of Pennsylvania|Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
273235|NCT00365547|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
273236|NCT00365599|H. Lee Moffitt Cancer Center and Research Institute|Susan Minton, D.O.|813-745-3806|susan.minton@moffitt.org|
273237|NCT00365716|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
273238|NCT00365768|Columbia University Medical Center|Julia Glade-Bender, MD|212-305-3379|jg589@cumc.columbia.edu|
273239|NCT00365794|University of Southern California|Fred Sattler, MD|323-409-4635|fsattler@usc.edu|
273240|NCT00365846|Emory University|Stuart Knechtle, MD|404-727-8465|stuart.knechtle@emoryhealthcare.org|
273241|NCT00365859|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
267709|NCT04039503|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
273242|NCT00365872|H. Lee Moffitt Cancer Center and Research Institute|Scott J. Antonia, M.D., Ph.D.|813-745-3883|scott.antonia@moffitt.org|
273243|NCT00365976|Duke University|Jenny Bridgers, CRC|919-684-0752|jenny.bridgers@duke.edu|
273244|NCT00365989|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
273245|NCT00366028|Department of Veterans Affairs|Dr. Carol VanDeusen Lukas|857-364-5685|carol.vandeusenlukas@va.gov|
273246|NCT00366106|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
296851|NCT01709695|Icahn School of Medicine at Mount Sinai|Department of Psychiatry|212-241-6623||
273247|NCT00366249|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
273248|NCT00366275|Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia|Luca Arcaini MD|+390382501308|luca.arcaini@unipv.it|
273249|NCT00366301|Brigham and Women's Hospital|Aruna Pradhan|617-732-8777|apradhan@partners.org|
273250|NCT00366340|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273251|NCT00366444|Xanodyne Pharmaceuticals, Inc.|Steve Boesing|1-877-926-6396|clinical-trials@xanodyne.com|
273252|NCT00366457|Massachusetts General Hospital|Lawrence S. Blaszkowsky, MD|6172191230|LBLASZKOWSKY@mgh.harvard.edu|
273253|NCT00366535|Symptoms Biology Unit, DIR, NINR, NIH|Leorey Saligan, Chief|301-451-1685|saliganl@mail.nih.gov|
273254|NCT00366548|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
273255|NCT00366626|Medical University of South Carolina|Dr. Raymond F. Anton, Distinguished University Professor|843-792-1226|antonr@musc.edu|
308386|NCT02575911|Alcon, A Novartis Division|Global Brand Med Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
308387|NCT02575950|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
308388|NCT02576041|Allergology Unit, Azienda Ospedaliero-Universitaria Policlinico di Modena|Patrizia Pepe, MD|+39. 059 4225449||
267710|NCT03695172|Duke University Medical Center|Amanda Kumar, MD|919-681-4607|amanda.kumar@duke.edu|
267711|NCT03485287|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
308389|NCT02576054|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308390|NCT02576067|Icahn School of Medicine at Mount Sinai|Zahi Fayad, PhD|212-824-8471|zahi.fayad@mssm.edu|
267712|NCT03433040|University of South Florida|Wendy Duncan, QA/QI Research Compliance Manager|8139747454|wduncan3@usf.edu|
267713|NCT03394027|National Cancer Institute|Dr. Alexandra Zimmer|240-760-6132|alexandra.zimmer@nih.gov|
267714|NCT03357952|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
267715|NCT03287947|Atrium Health/Levine Cancer Institute, Department of Cancer Biostatistics|Danielle M Boselli|12017903385|Danielle.Boselli@AtriumHealth.org|
267716|NCT03237234|Shepherd Center|Dr. Edelle C. Field-Fote|404-603-4274|edee.field-fote@shepherd.org|
267717|NCT03170869|University of Colorado|Dr. Thor Johnson|720-848-1765|thor.johnson@ucdenver.edu|
267718|NCT03066622|Regions Hospital|Meghan O'Brien|651-254-5303|meghan.e.obrien@healthpartners.com|
267719|NCT03052920|Washington University in St. Luis|Jill B Firszt, PI|314-362-4760|FirsztJ@wustl.edu|
267720|NCT03029104|CXL Ophthalmics, LLC|Chief Clinical Development Officer|339-234-6020|info@cxlophthalmics.com|
267721|NCT03016312|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
267722|NCT02876172|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
267723|NCT02722434|Mayo Clinic|Charles L Loprinzi MD|507/284-2511|cloprinzi@mayo.edu|
267724|NCT02721979|University of Washington|Dr. Michael Schweizer|(206) 606-6252|schweize@uw.edu|
267725|NCT02604511|Dana-Farber Cancer Institute|Dr. Steven Treon|617-632-2681|steven_treon@dfci.harvard.edu|
267727|NCT02369536|IRCCS Neuromed|Dr. Chiara Cerletti, operative responsible of the trial and corresponding author of the data public|0865915246|chiara.cerletti@moli-sani.org|
267728|NCT02358681|Columbia University|Daniel Tsze MD MPH|212-317-0997|dst2141@cumc.columbia.edu|
267729|NCT02101788|NRG Oncology|Linda Gedeon for Austin Miller, PhD|716-845-1169|linda.gedeon@roswellpark.org|
267730|NCT01963728|Inova Health Care System|Anne Whitney Brown, MD Principal Investigator|703.776.3067|anne.brown@inova.org|
273256|NCT00366678|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
273257|NCT00366899|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
273258|NCT00367003|Emory University|Dr. Patricio Riva Posse||privapo@emory.edu|
273259|NCT00367016|University of California-Davis, Department of Dermatology|Fu-Tong Liu, M.D., Ph.D.|916-734-6556|fliu@ucdavis.edu|
273260|NCT00367055|GlaxoSmithKline|GSK Response Center|866-435-7343||
273261|NCT00367133|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrnet@jaeb.org|
273262|NCT00367237|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
273263|NCT00367341|Emory University School of Medicine|Helen Mayberg, MD|404-727-6740|hmayber@emory.edu|
273264|NCT00367380|Malaria Vaccine and Drug Development|Sócrates Herrera MD, principal investigator|(572) 5216232 - 5574929|sherrera@inmuno.org|
273265|NCT00367432|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
273266|NCT00367458|National Cancer Institute|Frank Maldarelli|301-435-8019|fmalli@mail.nih.gov|
273267|NCT00367484|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Bettina Stubinski/Senior Medical Director|+49 6151 72 5200|service@merckgroup.com|
273268|NCT00367601|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
273269|NCT00367640|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
273270|NCT00367679|GlaxoSmithKline|GSK Response Center|866-435-7343||
273271|NCT00367744|Case Western Reserve University|Dr. Grace McComsey|216 844 3607|mccomsey.grace@clevelandactu.org|
273272|NCT00367770|Actelion Pharmaceuticals Ltd.|Loïc Perchenet, Head of Global Post-Approval Studies|+41 61 565 64 57|loic.perchenet@actelion.com|
273273|NCT00367835|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
273274|NCT00367991|New York University School of Medicine|Stuart Katz, MD|212-263-3946|stuart.katz@nyumc.org|
273275|NCT00368069|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
273276|NCT00368108|Eisai Call Center|Eisai Inc.|888-422-4743||
273277|NCT00368251|UCB|UCB Cares|+1877 822||9493
282018|NCT00832975|Hospital Clínico Universitario Puerta de Hierro|Dr Ignacio Fernández Lozano|913445000|iflozano@secardiologia.es|
296852|NCT01709708|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
296853|NCT01709721|CTI Clinical Trial and Consulting Services|Heather Kapushoc, Sr. Biostatistician|571-315-2574|hkapushoc@ctifacts.com|
282019|NCT00833027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282020|NCT00833040|AcelRx Pharmaceuticals, Inc.|Dr. Pamela Palmer|650-216-3504|ppalmer@acelrx.com|
282021|NCT00833053|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
282022|NCT00833092|USDA Grand Forks Human Nutrition ResearchCenter|Forrest H Nielsen, PhD|701-790-8455|forrest.nielsen@ars.usda.gov|
282023|NCT00833105|Oregon Health & Science University|Dr. Paul Cordo|503 418 2520|cordop@ohsu.edu|
282024|NCT00833248|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
282025|NCT00833261|UT Southwestern Medical Center|Dr. Lucien Nedzi|214-645-7653|lucien.nedzi@utsouthwestern.edu|
282026|NCT00833365|University of Utah|Dr. Gary Chan|801-587-7508|gary.chan@hsc.utah.edu|
282027|NCT00833417|Genentech, Inc.|Medical Communications|800-821-8590||
282028|NCT00833443|UCLA|Keith Heinzerling MD|323-461-3106|kheinzerling@mednet.ucla.edu|
282029|NCT00833469|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
282030|NCT00833482|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
296854|NCT01709747|CTI Clinical Trial and Consulting Services|Heather Kapushoc, Sr. Biostatistician|571-315-2574|hkapushoc@ctifacts.com|
282031|NCT00833547|Massachusetts General Hospital|Dr. Dara Manoach|617-726-6148|dara@nmr.mgh.harvard.edu|
282032|NCT00833560|Jan-Cil Germany|Therapeutic Areas Director|+49 2137 955-492||
282033|NCT00833638|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282034|NCT00833690|The Parkinson Study Group|Michael A. Schwarzschild, MD, PhD|617-724-9611|mschwarzschild@partners.org|
282035|NCT00833703|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
282036|NCT00833755|Massachusetts General Hospital|Dr. Jianren Mao|6177246102|mghpainresearch@partners.org|
282037|NCT00833781|Mass General Hospital|Dr. Rajesh Gandhi|617-724-9690|rgandhi@partners.org|
282038|NCT00833794|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
267731|NCT01248247|UT MD Anderson Cancer Center|Dr. Marcelo Vailati Negrao, MD, Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 614-4938|mvnegrao@mdanderson.org|
282039|NCT00833833|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
282040|NCT00833898|University of Colorado Denver|Mark L. Laudenslager, PhD|303-724-9279|biel@ucdenver.edu|
282041|NCT00833911|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
282042|NCT00833924|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com|
282043|NCT00833976|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
267732|NCT01164228|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
282044|NCT00833989|GlaxoSmithKline|GSK Response Center|866-435-7343||
282045|NCT00834041|Novartis Pharmaceuticals|Study Director|862 778-8300||
282046|NCT00834080|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|Bernard.Silverman@alkermes.com|
267733|NCT01012167|Maryland Psychiatric Research Center|William Carpenter, Jr.|410-402-7101|wcarpent@mprc.umaryland.edu|
267734|NCT00924326|National Cancer Institute|Steven Rosenberg, M.D., Ph.D.|240-858.3080|sar@nih.gov|
267735|NCT00591318|New York State Psychiatric Institute|Brian Fallon|646-774-8052|brian.fallon@nyspi.columbia.edu|
267736|NCT00321100|Fox Chase Cancer Center|Dr. Steven Cohen|215-214-1676|steven.cohen@fccc.edu|
282047|NCT00834106|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282048|NCT00834171|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
282723|NCT00869999|Massachusetts General Hospital Cancer Center|Jeffrey Barnes, MD|617-724-4000|jabarnes@partners.org|
282724|NCT00870103|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
282725|NCT00870194|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
282726|NCT00870233|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi ME|212-639-5016|chid@mskcc.org|
282727|NCT00870363|University of California Davis Medical Center|David M Asmuth|(916) 734-8695|dasmuth@ucdavis.edu|
282728|NCT00870467|Abbott|Global Medical Services|800-633-9110||
282729|NCT00870545|Memphis VAMC|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
282730|NCT00870584|Novartis Pharmaceuticals|Study Director|862-778-8300||
282731|NCT00870727|Indiana University|Christopher J. McDougle, MD|781-860-1783|cmcdougle@partners.org|
273278|NCT00368277|Novaris Phamaceuticals|Study Director|862-778-8300||
296855|NCT01709786|University of Cincinnati|Betty Tsuei, MD|513-558-5661|Betty.Tsuei@uc.edu|
296856|NCT01709799|University of Florida|Dr. Dawn Bowers|(352) 392-3450|dawnbowers@phhp.ufl.edu|
273279|NCT00368290|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
273280|NCT00368316|PDMI, NICHD, NIH|Dr. Rachel Schneerson, Co-Director|301-469-0850|schneerr@mail.nih.gov|
273281|NCT00368355|Baylor College of Medicine|Dr. Robert A. Krance|832-824-4661|rakrance@txch.org|
273282|NCT00368459|Stanford University|Victor Henderson|650-723-5456|vhenderson@stanford.edu|
273283|NCT00368472|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
273284|NCT00368537|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
273285|NCT00368550|University of Pennsylvania|Henry R. Kranzler, M.D.|215-222-3200|kranzler_h@mail.trc.upenn.edu|137
273286|NCT00368641|Baxter Healthcare|Bruce Culleton, MD|800-422-9837|onebaxter@baxter.com|
273287|NCT00368745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
273288|NCT00368836|Carolinas Medical Center|Dr. Jeffrey Kline|704-355-3181|jkline@carolinas.org|
296857|NCT01709838|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
273289|NCT00368849|The University of Iowa|Leigh J. Beglinger, Ph.D.|319-335-8765|leigh-beglinger@uiowa.edu|
273290|NCT00368875|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
296858|NCT01709864|Novartis Pharmaceuticals|Study Director|862-778-8300||
273291|NCT00368927|National Jewish Health|James R. Jett, M.D.|303-270-2601|JettJ@NJHealth.org|
273292|NCT00368940|Weill Cornell Medicine|Dimitris N. Kiosses, Ph.D.|914-997-4381|dkiosses@med.cornell.edu|
273293|NCT00368966|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
273294|NCT00368979|GlaxoSmithKline|GSK Response center|866-435-7343||
273295|NCT00368992|SWOG|Lung Committee Statistician|206-667-4623||
273296|NCT00369122|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
273297|NCT00369161|Novartis Pharmaceuticals|Study Director|862-778-8300||
273298|NCT00369226|Dana-Farber Cancer Institute|John Koreth, MBBS, D.Phil|(617) 632-2949|jkoreth@partners.org|
273299|NCT00369278|Novartis Pharmaceuticals|Study Director|862-778-8300||
267737|NCT04534517|Johnson & Johnson Vision Care Inc.|Thomas Karkkainen, OD, MS, FAAO- Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
267738|NCT04494646|NYU Langone Health|Sripal Bangalore, MD, MHA|(212) 263 3540|Sripal.Bangalore@nyulangone.org|
267739|NCT04258020|OhioHealth|Dr. Kiran Devulapally|614-566-9143|kiran.devulapally@ohiohealth.com|
267740|NCT04234464|Avillion LLP|Chief Medical Officer|+44 (0)203 764 9530|avillion@avillionllp.com|
267741|NCT04126733|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
267742|NCT03860259|University of Pittsburgh Medical Center Department of Anesthesiology and Perioperative Medicine|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
267743|NCT03852316|University of California, San Diego|Sheldon Morris, MD, MPH|619-543-4761|shmorris@ucsd.edu|
267744|NCT03789318|Concentric Analgesics|Head of Clinical Operations|14154847921|nancy@concentricanalgesics.com|
267745|NCT03774875|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
267746|NCT03613662|Scilex Pharmaceuticals, Inc.|Associate Director Clinical Operations|6503866709|cambrose@scilexpharma.com|
267747|NCT03562156|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
267748|NCT03232736|University of Colorado Anschutz Medical Campus|William Cornwell|16142961686|william.cornwell@ucdenver.edu|
267749|NCT03208530|Brigham and Women's Hospital|Kei Ouchi, MD, MPH|(617) 732-5640|kei_ouchi@dfci.harvard.edu|
267750|NCT03158688|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
267751|NCT03103321|Mayo Clinic|Jon C. Tilburt, MD|5072661105|tilburt.jon@mayo.edu|
267752|NCT03079869|Kaiser Permanente|KPSC PRS Administrator|626-720-7463|RE-CTCAT@kp.org|
267753|NCT03033875|Emory University|Dr. Kenneth Hepburn|404-712-9286|khepbur@emory.edu|
267754|NCT02935595|The University of Texas Health Science Center at Houston|Sudhakar Selvaraj, MD, PhD, Assistant Professor|(713) 486-2500|Sudhakar.Selvaraj@uth.tmc.edu|
267755|NCT02887248|Sarah Cannon Development Innovations, LLC|Sarah Cannon|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
267756|NCT02849990|University of Washington|Dr. Michael Schweizer|2066066252|schweize@uw.edu|
267757|NCT02673151|Stanford University|Andrei Iagaru, Professor of Radiology (Nuclear Medicine)|(650) 725-4711|aiagaru@stanford.edu|
267758|NCT02523274|University of Florida|Dr. Stephen Anton|(352) 273-7514|santon@ufl.edu|
267759|NCT02467270|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
267760|NCT02452554|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
273300|NCT00369343|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
273301|NCT00369382|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273302|NCT00369486|Jaeb Center for Health Research, Diabetic Retinopathy Clinical Research Network|Adam R. Glassman, M.S., Director|(813) 975-8690|drcrnet@jaeb.org|
273303|NCT00369512|University of Alabama at Birmingham|Eben Rosenthal, MD Department of Surgery Department|(205) 934-9714|erosenthal@uabmc.edu|
273304|NCT00369564|Nemours Children's Clinic|Scott Bradfield, MD|904-697-3793|sbradfie@nemours.org|
273305|NCT00369577|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
273306|NCT00369590|Adult Brain Tumor Consortium|Stuart A Grossman, MD Director of ABTC|410-955-8837|grossman@jhmi.edu|
273307|NCT00369629|Northwestern University|Barbara Pro||barbara.pro@nm.org|
273308|NCT00369655|Mayo Clinic|Dr. Timothy Hobday|507-284-1159|hobday.timothy@mayo.edu|
296859|NCT01709903|Novartis Pharmaceuticals|Study Director|862-778-8300||
273309|NCT00369668|University of Florida, Motor Behavior Laboratory|James Cauraugh, Ph.D., PI|352-294-1623|jcaura@hhp.ufl.edu|
273310|NCT00369681|Johns Hopkins University|Dr. Yvette Kasamon|410-955-8839|ykasamon@jhmi.edu|
273311|NCT00369707|Northwestern University|Leo Gordon, MD|312-695-4520|l-gordon@northwestern.edu|
273312|NCT00369746|New York State Psychiatric Institute|Patrick J. McGrath, M.D.|646-774-8076|mcgrath@nyspi.columbia.edu|
273313|NCT00369785|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
273314|NCT00369824|GlaxoSmithKline|GSK Response Center|866-435-7343||
273315|NCT00369915|NIMH/NIH|Maura Furey, PhD|301-594-7773|mfurey@mail.nih.gov|
273316|NCT00369928|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
273317|NCT00369941|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
273318|NCT00369967|VCUHS|Nicole Karjane|804-828-8614|nkarjane@mcvh-vcu.edu|
273319|NCT00370032|GlaxoSmithKline|GSK Response Center|866-435-7343||
273320|NCT00370071|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
282732|NCT00870740|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
273321|NCT00370149|Riley Hospital for Children|Elaine G Cox, MD|317-944-7260|elmcox@iu.edu|
273322|NCT00370292|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273323|NCT00370331|GlaxoSmithKline|GSK Response Center|866-435-7343||
273324|NCT00370396|GlaxoSmithKline|GSK Response Center|866-435-7343||
273325|NCT00370552|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
273326|NCT00370682|Phramongkutklao Hospital, Bangkok, Thailand|Verrachai Watanaveeradej, MD|662-644-8971|veerachaiw@yahoo.com|
296860|NCT01709981|NYU Langone Health|Dr. Binita Shah|212-263-6631|Binita.Shah@nyulangone.org|
296861|NCT01710020|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308391|NCT02576145|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
267761|NCT02427568|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
267762|NCT02335424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267763|NCT02318277|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
267764|NCT02296801|NSABP Foundation Inc|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
267765|NCT02143063|UConn Health|Sheila Alessi, PhD|860-679-1849|salessi@uchc.edu|
267766|NCT02017964|Children's Oncology Group|Results Reporting Coordinator|626-446-0064|resultsreportingcoordinator@childrensoncologygroup.org|
267767|NCT01968785|Medstar Health Research Institute|Megan Rowland|2028772959|megan.e.rowland@medstar.net|
267768|NCT01956110|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
267769|NCT01648023|University of Louisville|Robert Martin, MD, PhD|502-629-3355|robert.martin@louisville.edu|
267770|NCT01335581|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
267771|NCT01209923|University of Southern California|Edward Schroeder|323-442-2498|eschroed@usc.edu|
267772|NCT01083433|Rainbow Babies and Children's Hospital|Sarah A. MacLeish, DO|216-844-3661|sarah.macleish2@uhhospitals.org|
267773|NCT00920387|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
308392|NCT02576249|Mayo Clinic|Dr. Jacob Sellon|507-255-1141|sellon.jacob@mayo.edu|
267774|NCT00787176|Northwerstern University|Paloma Toledo|312-472-3585|p-toledo@northwestern.edu|
267775|NCT00352534|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
267776|NCT00033293|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
273327|NCT00370838|Johns Hopkins University|Dr. Harvey Singer|410-955-7212|hsinger@jhmi.edu|
273328|NCT00370994|Pain Management Center of Paducah|Dr. Laxmaiah Manchikanti|270-554-8373|drlm@thepainmd.com|101
273329|NCT00371137|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Medical Monitor & Director of Clinical Development|650-496-3777||
273330|NCT00371150|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
273331|NCT00371176|Boston VA Healthcare System|Dr. Brett Litz|857 364 4131|brett.litz@va.gov|
273332|NCT00371254|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
273333|NCT00371267|San Francisco VA Medical Center|Timothy P. Carmody, Ph.D.|415-221-4810|Timothy.Carmody@va.gov|6344
273334|NCT00371293|UPenn|Julio Chirinos|2158235800|julio.chirinos@uphs.upenn.edu|
273335|NCT00371345|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
273336|NCT00371397|Ohio State University Institute for Behavioral Medicine Research|Janice Kiecolt-Glaser, PhD|614-292-0033|Kiecolt-Glaser.1@osu.edu|
273337|NCT00371436|VA RR&D, NCRAR|James A. Henry, Ph.D.|5032208262|james.henry@va.gov|57466
273338|NCT00371449|Mountain Home VA Medical Center|Sherri L. Smith|423.926.1171|sherri.smith@va.gov|7569
273339|NCT00371540|Indiana University School of Medicine|Kara Wools-Kaloustian|317-274-7936|kwools@iu.edu|
273340|NCT00371566|GlaxoSmithKline|GSK Response Center|866-435-7343||
273341|NCT00371631|Michael E. DeBakey Veterans Affairs|Dr. Barbara Trautner, MD, PhD|713-440-4438|barbara.trautner@va.gov|
273342|NCT00371644|VA North Texas Health Care System|Dr. Alina Suris|2148572312|alina.suris@va.gov|
273343|NCT00371683|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
273344|NCT00371761|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
273345|NCT00371787|Centre for Contact Lens Research|Dr. Craig Woods|1-519-888-4567|cawoods@uwaterloo.ca|36547
273346|NCT00371826|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
273347|NCT00371839|Portland VAMC|Dr. Marjorie R. Leek|(909)825-7084|Marjorie.Leek@va.gov|7293
273348|NCT00371865|VA San Diego Healthcare System|Dr. Julie Wetherell, PI|858-552-8585|Julie.Wetherell@va.gov|2752
282733|NCT00870870|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
267777|NCT04497415|New York State Psychiatric Institute|Yuval Y. Neria|646-774-8092|ny126@cumc.columbia.edu|
273349|NCT00372060|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
273350|NCT00372112|GlaxoSmithKline|GSK Response Center|866-435-7343||
273351|NCT00372190|Radboud University Medical Center|Dr. M.I.J.Withagen|+31 6 51262468|M.I.J.Withagen@umcutrecht.nl|
273352|NCT00372255|GlaxoSmithKline|GSK Response Center|866-435-7343||
273353|NCT00372385|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
273354|NCT00372411|Dept. of Veterans Affairs, Cooperative Studies Program, West Haven, CT|Peter Guarino, MPH, PhD, Director, WH-CSPCC|203-932-5711|peter.guarino@va.gov|3780
273355|NCT00372424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273356|NCT00372489|Affymax|VP, Clinical Development|650-812-8700|info@affymax.com|
273357|NCT00372528|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273358|NCT00372567|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273359|NCT00372593|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
273360|NCT00372619|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|ResultsReportingCoordinator@childrensoncologygroup.org|
273361|NCT00372697|Novartis Pharmaceuticals|Study Director|862 778-8300||
273362|NCT00372775|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273363|NCT00372905|Northwestern University|Jane Winter, MD|312 695 4033|Jwinter@nm.org|
273364|NCT00372957|GlaxoSmithKline|GSK Response Center|866-435-7343||
267782|NCT03725293|Beaumont Hospitals|Amit Bahl, MD|(248) 898-9111|ahmit.bahl@beaumont.edu|
273365|NCT00372970|Temple University|Frank Friedenberg|215-707-9900|frank.friedenberg@temple.edu|
273366|NCT00372996|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273367|NCT00373113|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
267783|NCT03702231|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Christopher Pleyer, M.D. Principal Investigator, NIH, NHLBI|510.709.6649|christopher.pleyer@nih.gov|
267784|NCT03690284|University of Texas Southwestern|Clinical Research Coordinator|3106127741|matthew.oh@utsouthwestern.edu|
267785|NCT03670277|Johnson & Johnson Vision Care|Xu Cheng, MD, PhD, FAAO - Sr. Principal Clinical Scientist|1-800-843-2020|xcheng6@its.jnj.com|
267786|NCT03600805|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
267787|NCT03556358|Tanvex|Study Director|19494838507|jennifer.lai@tanvex.com|
267788|NCT03290781|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
267789|NCT03263195|Department of Pediatrics Ribeirão Preto Medical School|Dr. Marisa Mussi-Pinhata|55-16-3602-2807|mmmpinha@fmrp.usp.br|
267790|NCT03228680|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
267791|NCT03196167|Yale University|Amit Bardia|2038436469|amit.bardia@yale.edu|
267792|NCT03170882|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
267793|NCT03077204|Ascension Texas Spine and Scoliosis|Devender Singh, Research Scientist|512 324 3580|dpsingh@ascension.org|15916
267794|NCT03064126|Boston Scientific|Philip Ghizoni|763-255-0036|Philip.Ghizoni@bsci.com|
267795|NCT03029611|UWashington (University of Washington)|Director of Clinical Operations|206-616-2305|childj@u.washington.edu|
267796|NCT02891798|VA Pittsburgh Health System, and University of Pittsburgh|Brian A. Williams, MD, MBA|412-360-1602|brian.williams6@va.gov|
308393|NCT02576509|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
267797|NCT02679781|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+97226776135|fuxavia@gmail.com|
267798|NCT02624869|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
267799|NCT02614690|Connecticut Children's Medical Center|Dr, Mark Lee|860-837-7421|Mlee01@connecticutchildrens.org|
267800|NCT02569242|Ono Pharmaceutical Co. Ltd|Medical Information Center|ー|clinical_trial@ono.co.jp|
267801|NCT02516969|UPMC Hillman Cancer Center|Barbara M. Stadterman, MPH, MSCR, CCRP|412-647-5554|stadtermanbm@upmc.edu|
267802|NCT02507960|University of Maryland Medical Center|Elizabeth Nichols|4103287586|enichols1@umm.edu|
267803|NCT02435433|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@Lilly.com|
267804|NCT02426125|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
267805|NCT02417142|UMass Medical School|Xiaoduo Fan, MD, MPH|(508) 856 -3881|xiaoduo.fan@umassmed.edu|
267806|NCT02368886|Mayo Clinic Arizona|Tanios Bekaii-Saab, M.D.|507/266-0800|Bekaii-Saab.Tanios@mayo.edu|
267807|NCT02354703|University of Maryland School of Medicine|Dr. David Gorelick|410-408-6806|dgorelick@som.umaryland.edu|
267808|NCT02312258|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
273368|NCT00373256|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273369|NCT00373269|Temple University|Dr. Nina T. Gentile|215-707-8402|ngentile@temple.edu|
273370|NCT00373295|New York State Psychiatric Institute|Dr. Margaret Haney|646-774-6129|reslabsurc@gmail.com|
273371|NCT00373334|Braintree Laboratories, Inc.|Clinical Operations Manager|781-843-2202|jmcgowan@braintreelabs.com|
273372|NCT00373360|United Therapeutics Corporation|Rex Mauthe; Senior Director, Regulatory Affairs|919-485-8350|rmauthe@unither.com|
273373|NCT00373386|Research Institute at Nationwide Children's hospital|Robert P. Hoffman MD|614-722-4425|robert.hoffman@nationwidechildrens.org|
273374|NCT00373399|New York State Psychiatric Institute|Margaret Haney|646-774-6153|mh235@cumc.columbia.edu|
273375|NCT00373425|Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Oncology||clinicaltrial.disclosure@us.astellas.com|
273376|NCT00373490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
273377|NCT00373529|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
282049|NCT00834210|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
282050|NCT00834236|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
282051|NCT00834288|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
282052|NCT00834366|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
282053|NCT00834483|Rush University Medical Center|Dr. Brett R. Levine|312-432-2466|brettlevine@gmail.com|
282054|NCT00834626|Kirloskar Hospital|Dr. Neeraj Gupta|+91-40-23296241|drugale@kirloskarhospital.com|
282055|NCT00834652|Washington University School of Medicine|Patrick J. Lustman, Ph.D.|3142861320|lustmanp@psychiatry.wustl.edu|
282056|NCT00834678|The Ohio State University Comprehensive Cancer Center|Rachel Layman, MD|614-366-8541|Rachel.Layman@osumc.edu|
282057|NCT00834808|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
282058|NCT00834834|NYSPI|Barbara Stanley, Ph.D.|6467747582|stanley@nyspi.columbia.edu|
282059|NCT00834886|University of Bergen|Dr. Bjørn Bjorvatn|55586130|bjorn.bjorvatn@igs.uib.no|
282060|NCT00834899|University of North Carolina at Chapel Hill|Kenneth I. Ataga, MD|919-966-0178|kataga@med.unc.edu|
282061|NCT00834912|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
282062|NCT00835003|Aarhus University Hospital, Dep. Obstetrics and Gynecology, Aarhus, Denmark|MD, PhD Julie Glavind|+4578450000|julie.glavind@dadlnet.dk|
282063|NCT00835068|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282064|NCT00835120|University Hospitals Case Medical Center|Carla Conroy|216-844-2871|carla.conroy@Uhhospitals.org|
296862|NCT01710033|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282065|NCT00835159|NYU Langone Medical Center|ALEXANDER ZASLAVSKY|212-263-5569|michael.haile@nyumc.org|
282066|NCT00835185|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282067|NCT00835198|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
296863|NCT01710046|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282068|NCT00835224|James J Peters VAMC|Dr. Jill M. Wecht|718 584-9000|jm.wecht@va.gov|3122
282069|NCT00835237|GlaxoSmithKline|GSK Response Center|866-435-7343||
282070|NCT00835341|Peking University School of Oncology|Department of Etiology|+8610-88196752|dengdajun@bjmu.edu.cn|
282071|NCT00835380|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282072|NCT00835510|Taro Pharmaceuticals|Medical Director|(914) 345-9001|medical.affairs@taro.com|6427
282073|NCT00835731|Planned Parenthood League of Massachusetts|Principal Investigator|6176161600||
282074|NCT00835770|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
282075|NCT00835861|Maternal-Fetal Medicine and Obstetrics at UT Southwestern|M. Ashley Hickman Zink|469-303-3591|m.ashley.hickman@gmail.com|
296864|NCT01710137|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@pennmedicine.upenn.edu|
267778|NCT04231396|BioSpeech|K. Lindaas, Principal Investigator|(503) 522-6276|kirstylindaas@biospeech.com|
267779|NCT04118348|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
267780|NCT03894540|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
267781|NCT03816202|Integra LifeSciences|Andrew Tummon, Director, Global Clinical Trials|609-936-5490|andrew.tummon@integralife.com|
267809|NCT01981551|National Cancer Institute|Dr. Geraldine H O'Sullivan Coyne|240-781-3371|osullivancoyngh@nci.nih.gov|
267810|NCT01772472|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
267811|NCT00740181|Brown Univeristy Oncology Research Group|James Butera|401-863-3000|Kayla_Rosati@brown.edu|
267812|NCT00468130|Rutgers University|Sherie Novotny, MD|7322354119|novotnsl@ubhc.rutgers.edu|
267813|NCT00384111|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
282076|NCT00835900|Roswell Park Cancer Institute|Dr. Martin Mahoney|7168452300|martin.mahoney@roswellpark.org|
282077|NCT00835926|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
282078|NCT00835978|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282079|NCT00836017|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
282080|NCT00836095|Penn State Milton S. Hershey Medical Center|Sonia Vaida MD, Professor of Anesthesiology|7175318433|svaida@hmc.psu.edu|
282081|NCT00836186|Johns Hopkins University|Jean Wright, MD PI|410-614-3950|jwrigh71@jhmi.edu|
282082|NCT00836277|University of Pittsburgh Cancer Institute|Weijing Sun, MD|412-864-7764|sunw@upmc.edu|
282083|NCT00836342|Clinical Unit for Research Trials in Skin, Massachusetts General Hospital|Kristen Corey|617-726-1302|kcorey1@partners.org|
282084|NCT00836407|The Sidney Kimmel Comprehensive Cancer Center at Johns|Dr. Dung Le||dle@jhmi.edu|
282085|NCT00836433|Durham VA GRECC|Dr. Cathleen Colon-Emeric|9192860411|cathleen.colonemeric@va.gov|6777
282086|NCT00836498|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
282087|NCT00836589|BIOTRONIK, INC|Kelly Mohr|800-547-0394|kelly.mohr@biotronik.com|
282088|NCT00836641|Goethe University Childrens Hospital|Prof Markus Rose|0049-696301|Markus.Rose@kgu.de|5754
282089|NCT00836693|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282090|NCT00836719|LSU Health Sciences Center-New Orleans|Jesus Lovera MD|5045686700|jlover@lsuhsc.edu|
282091|NCT00836745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282092|NCT00836758|University of Florida|Richard B. Berry, MD|352-262-1575|sleep_doc@msn.com|
282093|NCT00836810|University of Bristol|Professor John Kirwan|+44 117 342 2904|John.Kirwan@Bristol.ac.uk|
282094|NCT00836875|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308394|NCT02576535|NYU Langone Medical Center|Paul Huang|212-263-6414|Paul.Huang@nyumc.org|
273378|NCT00373685|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296865|NCT01710254|University of Utah, Dept. of Radiology Research|Edward DiBella, Ph.D.|801-585-5543|edward.dibella@hsc.utah.edu|
273379|NCT00373698|VA Medical Center, White River Junction, VT|Dr. Paula Schnurr and Dr. Mathew Friedman|802-296-5132|Paula.Schnurr@va.gov; Matthew.Friedman@va.gov|
273380|NCT00373880|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|646-774-6153|meg.haney@nyspi.columbia.edu|
273381|NCT00373958|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273382|NCT00374088|University of Michigan - Pediatric Cardiology|Ranjit Aiyagari, MD|734-647-8761|ranjita@umich.edu|
273383|NCT00374127|New York State Psychiatric Institute at Columbia University Medical Center|Dr. Meg Haney, Professor of Neurobiology|6467746153|meg.haney@nyspi.columbia.edu|
273384|NCT00374140|University of Pittsburgh|Ahmad Tarhini, MD, PhD|(412) 648-6578|tarhiniaa@upmc.edu|
273385|NCT00374231|University of Cincinnati|E. Steve Woodle, MD|(513) 558-6001|woodlees@uc.edu|
273386|NCT00374244|Yale University School of Medicine, Dept of Psychiatry|Handan Gunduz-Bruce MD|(203) 932-5711|handan.gunduz-bruce@yale.edu|4130
273387|NCT00374322|GlaxoSmithKline|GSK Response Center|866-435-7343||
267814|NCT04854642|Dompé farmaceutici SpA|Francesco Sergio, MD|+39 02 583831|clinops@pec.dompe.it|
273388|NCT00374335|Children's Mercy Hospitals and Clinics|Dr. Kimberly Horii|816-234-3924|kahorii@cmh.edu|
273389|NCT00374452|VA Palo Alto Health Care System|Mary K. Goldstein, MD|650-493-5000|mary.goldstein@va.gov|1,1,62105
273390|NCT00374556|Johns Hopkins University School of Medicine|Michael Smith, PhD, Associate Professor of Psychiatry, Director of Behavioral Medicine|410-550-7000|msmith62@jhmi.edu|
273391|NCT00374803|University of Cincinnati|Rita Alloway, PharmD|5135581568|rita.alloway@uc.edu|
273392|NCT00374842|GlaxoSmithKline|GSK Response Center|866-435-7343||
273393|NCT00374868|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
296866|NCT01710306|Department of Veteran's Affairs- Office of Research and Development|Anne G. Sadler, Ph.D., R.N.|319-338-0581|anne.sadler@va.gov|7992
273394|NCT00374907|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
273395|NCT00375167|Queens University|Dr. Terry Krupa|613-533-6236|terry.krupa@queensu.ca|
273396|NCT00375219|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
273397|NCT00375427|Novartis Pharmaceuticals|Study Director|862-778-8300||
273398|NCT00375492|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
267815|NCT04608344|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
267816|NCT04583592|Sagent Pharmaceuticals, Inc.|Cynthia Tinkoff, Pharm.D. Manager, Medical Affairs|847-908-6913|ctinkoff@sagentpharma.com|
267817|NCT04572399|Cedars-Sinai|Melissa Hampton|3104230617|Melissa.Hampton@cshs.org|
267818|NCT04388787|Virginia Commonwealth University|Olivier Rolin, MD, PhD|(804) 828-4230|olivier.rolin@vcuhealth.org|
267819|NCT04380090|Cleveland Clinic Lutheran Hospital|Kathleen Gonzalez|2162174226|gonzalk2@ccf.org|
267820|NCT04377620|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
267821|NCT04355169|Shionogi Inc.|Shionogi Clinical Trials Administrator Clinical Support Help Line|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
267822|NCT04338971|Neurolutions|Director of Clinical Affairs|831-316-5466|lsouders@neurolutions.com|
267823|NCT04310566|Johnson & Johnson Vision Care|Thomas Karkkainen - Sr.Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
267824|NCT04206020|Mitotech S.A.|Chief Operating Officer|+352621692785|info@mitotechpharma.com|
267825|NCT04097301|AGC Biologics|Anna Stornaiuolo|0221277440|astornaiuolo@agcbio.com|
267826|NCT04054375|Northwestern University School of Medicine|Dr. Senda Ajroud-Driss|(312) 944-0063|s-ajroud@northwestern.edu|
267827|NCT03953079|Graybug Vision|Executive Director, Biostatistics|650-459-4235|pdinh@graybug.vision|
296867|NCT01710332|Mid Atlantic Retina|Allen C. Ho, MD|215-459-0477|mformoso@midatlanticretina.com|
267828|NCT03922750|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
267829|NCT03910673|Duke Vaccine and Trials Unit|Emmanuel Walter, MD, MPH|919-620-5346|chip.walter@duke.edu|
267830|NCT03885999|The Chinese University of Hong Kong, Department of Surgery, Prince of Wales Hospital|Dr. Kaori Futaba|0085264630121|kfutaba@surgery.cuhk.edu.hk|
267831|NCT03882970|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
267832|NCT03879525|Wake Forest School of Medicine|Heidi Munger Clary, MD, MPH|336-716-7110|hmungerc@wakehealth.edu|
267833|NCT03867734|University of Washington|Lindley A. Barbee, MD, MPH|206-744-2595|lbarbee@uw.edu|
267834|NCT03787095|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
273399|NCT00375505|Novartis|Study Director|862-778-8300||
273400|NCT00375518|Memorial Sloan Kettering Cancer Center|Dr. David Amar|212-639-6798|amard@mskcc.org|
273401|NCT00375609|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
273402|NCT00375674|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1800718|ClinicalTrials.gov_Inquiries@pfizer.com|1021
273403|NCT00375713|UCB Pharma|UCB Clinical Trial Call Center|+ 1 877 822 9493||
273404|NCT00375752|Novartis Pharmaceuticals|Study Director|862-778-8300||
273405|NCT00375830|Stanford University|Andrei Iagaru, Professor of Radiology (Nuclear Medicine)|650-725-4711|aiagaru@stanford.edu|
296868|NCT01710345|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
273406|NCT00375934|Xanodyne Pharmaceuticals, Inc.|Steve Boesing|1-877-926-6396|clinical-trials@xanodyne.com|
273407|NCT00375973|University of Cincinnati College of Medicine|Lesley M. Arnold, M.D.|513-558-7700|lesley.arnold@uc.edu|
273408|NCT00375999|Gangnam Severance Hospital, Yonsei University College of Medicine|Dr. Jae Yong Cho|82-2-2019-4363|chojy@yuhs.ac|
273409|NCT00376168|Protalix Ltd.|Einat Almon|972-4-9889488|einata@protalix.com|137
273410|NCT00376220|Johns Hopkins University School of Medicine|Jennifer L. Payne M.D.|410-502-0050|jpayne5@jhmi.edu|
273411|NCT00376246|UCSD Medical Center|Ori Ben-Yehuda, MD|619-543-2814|obenyehuda@ucsd.edu|
273412|NCT00376259|Novartis Pharmaceuticals|Study Director|862-778-8300||
273413|NCT00376363|University of North Carolina|Donald Budenz|919-843-0297|donald_budenz@med.unc.edu|
273414|NCT00376506|James Madison University|Christy L. Ludlow, PhD|540-568-3876|ludlowcx@jmu.edu|
273415|NCT00376532|Thomas Jefferson University|David J. Whellan MD|215 955 2636|david.whellan@jefferson.edu|
273416|NCT00376558|nyspi|Diana Martinez|212-543-6628|dm437@columbia.edu|
273417|NCT00376597|The Ohio State University Comprehensive Cancer Center|Electra D. Paskett, PhD|614-293-3917|electra.paskett@osumc.edu|
296869|NCT01710358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273418|NCT00376675|Mayo Clinic|Dr. Amit Sood|507-284-1623|sood.amit@mayo.edu|
273419|NCT00376688|The University of Chicago Comprehensive Cancer Center|Dr. Gini F. Fleming|773-702-6712|gfleming@medicine.bsd.uchicago.edu|
273420|NCT00376805|Masonic Cancer Center, University of Minnesota|Sarah Cooley, MD|612-625-8474|cool0023@umn.edu|
273421|NCT00376935|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
273422|NCT00376948|Barbara Ann Karmanos Cancer Institute|Almhanna Khaldoun, M.D.|313-576-8746|almhanna@karmanos.org|
273423|NCT00376961|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
273424|NCT00377156|Mayo Clinic|Paul Brown, M.D.|507-538-0948|Brown.Paul@mayo.edu|
273425|NCT00377234|Hoffmann-LaRoche|Medical Communications|800-821-8590||
308395|NCT02576587|Cleveland Clinic|Dr. Reena Mehra|216-444-4946|mehrar@ccf.org|
273426|NCT00377260|Children's Hospital of Pittsburgh of UPMC|Efficacy of Antimicrobials in Young children with Acute Otitis Media|412-692-5249|Hoberman@chp.edu|
273427|NCT00377299|UT Southwestern Medical Center at Dallas|Dr. E. Sherwood Brown, M.D., Ph.D.|214-645-6950|sherwood.brown@utsouthwestern.edu|
273428|NCT00377312|University of Pittsburgh|Mara J Horwitz|412-692-2848|horwitz@pitt.edu|
273429|NCT00377364|UT Southwetern Medical Center at Dallas|E.Sherwood Brown, M.D., Ph.D.|214-645-6950|Sherwood.Brown@utsouthwestern.edu|
267835|NCT03781778|Fred Hutchinson Cancer Research Center|Marian L. Neuhouser, PhD|2066674797|mneuhous@fredhutch.org|
267836|NCT03770455|Tulane University School of Medicine|Jodi L. Layton, MD|504-988-6121|jlayton@tulane.edu|
267837|NCT03764735|Mitotech S.A.|Chief Operating Officer|+352621692785|info@mitotechpharma.com|
267838|NCT03730480|Ascensia Diabetes Care|Pragathi Shelat|1 (862) 229-6679|pragathi.shelat@ascensia.com|
267839|NCT03713073|The University of Texas Health Science Center at Houston|Chun-Teh Lee, DDS, DMSc, MS|713-486-4384|Chun-Teh.Lee@uth.tmc.edu|
267840|NCT03713034|Yale University|Tyra Pendergrass Boomer|(203) 737-6101|tyra.pendergrass@yale.edu|
267841|NCT03654404|Dana-Farber Cancer Institute|Hermioni L. Amonoo|617-732-6727|Hermioni_Amonoo@dfci.harvard.edu|
267842|NCT03567057|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
267843|NCT03548987|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
273430|NCT00377403|Washington University in St Louis|Jane Garbut,MD|314-454-8613|jgarbutt@dom.wustl.edu|
273431|NCT00377429|Fresenius Biotech|Anne Kuan|781 699 4618|anne.kuan@fresenius-biotech.com|
273432|NCT00377520|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
273433|NCT00377572|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
273434|NCT00377611|GlaxoSmithKline|GSK Response Center|866-435-7343||
273435|NCT00377637|Hoffman-LaRoche|Medical Communications|800-821-8590||
273436|NCT00377676|VeroScience|Richard Scranton|401 816-0525|richard_scranton@veroscience.com|
273437|NCT00377741|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
273438|NCT00377819|Amgen Inc.|Study Director|866-572-6436||
273439|NCT00377832|Weill Cornell Medical College|Daniel W. Skupski, MD|718-670-1495|dwskupsk@med.cornell.edu|
273440|NCT00377858|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273441|NCT00377962|Novartis Pharmaceuticals|Study Director|862 778-8300||
273442|NCT00378014|Novartis Pharmaceuticals|Study Director|862-778-8300||
273443|NCT00378079|Friends Research Institute|Dr. Timothy Kinlock|(410) 837-3977|tkinlock@friendsresearch.org|224
273444|NCT00378105|Dana-Farber Cancer Institute|Dr. Richardson|617-632-2104|Paul_Richardson@dfci.harvard.edu|
273445|NCT00378209|Dana-Farber Cancer Institute|Dr. Paul Richardson|617-632-2104|Paul_Richardson@dfci.harvard.edu|
273446|NCT00378326|Rockefeller University|Robert B. Darnell, MD, PhD|212-327-7474|darnelr@rockefeller.edu|
273447|NCT00378352|National Institute on Aging, NIH|Edward Lakatta, M.D.|410-558-8218|lakattae@grc.nia.nih.gov|
273448|NCT00378482|AstraZeneca Clinical Study Information Center|Global Clinical Lead|8772409479|information.center@astrazeneca.com|
273449|NCT00378508|Yale University|Kevan Herold, MD|203-785-6507|kevan.herold@yale.edu|
273450|NCT00378534|NIH NHLBI OCD DIR ORIC|Sara Hauffe, RN Protocol Liaison|301-827-2720|sara.hauffe@nih.gov|
273451|NCT00378560|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
273452|NCT00378573|sanofi-aventis|Medical Affairs study director||publicregistryUSMA@sanofi-aventis.com|
273453|NCT00378599|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
273454|NCT00378703|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
273455|NCT00378898|Vanderbilt University Medical Center|Dr. Michael Vaezi|615-322-3739|michael.vaezi@vanderbilt.edu|
273456|NCT00379080|Adult Brain Tumor Consortium|Stuart A Grossman, MD Director of ABTC|410-955-8837|grossman@jhmi.edu|
273457|NCT00379145|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
273458|NCT00379197|University of Minnesota, Dept. Medicine|Dr. Douglas Yee, MD|612-273-5700|yeexx006@umn.edu|
273459|NCT00379210|University of Pennsylvania|Amishi Jha|215-898-8011|apjha@psych.upenn.edu|
273460|NCT00379236|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
273461|NCT00379340|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
273462|NCT00379353|University of Texas M.D. Anderson Cancer Center|Dr. Eduardo Bruera, Professor|713-563-4157|ammarin@mdanderson.org|
273463|NCT00379574|Asan Medical Center, Ulsan University College of Medicine|Dr. Cheolwon Suh|+82-2-3010-3209|csuh@amc.seoul.kr|
273464|NCT00379587|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH|617-632-5946|corey_cutler@dfci.harvard.edu|
273465|NCT00379639|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
273466|NCT00379769|GlaxoSmithKline|GSK Response Center|866-435-7343||
273467|NCT00379795|Genentech|Genentech||ctg-post-d@gene.com|
267844|NCT03548064|University of Maryland|Wilbur H. Chen, MD, MS|410-706-1188|wchen@som.umaryland.edu|
273468|NCT00379808|University of Florida|Dr Julie Johnson, PI|352-273-6007|johnson@cop.ufl.edu|
273469|NCT00379821|Malaria Section, Center for Vaccine Development, University of Maryland School of Medicine|Christopher Plowe, MD, MPH|410-706-2491|cplowe@medicine.umaryland.edu|
273470|NCT00379834|West Virginia University|Dr. Tony Realini|3045986926|realinia@wvuhealthcare.com|
273471|NCT00379899|Amgen Inc.|Study Director|866-572-6436||
273472|NCT00379912|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
273473|NCT00380029|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
273474|NCT00380068|Gilead Sciences Inc|Martine Allard, PhD; Senior Clinical Research Scientist|650-524-3898|martine.allard@gilead.com|
273475|NCT00380081|Purdue Pharma LP|Clinical Leader|800-733-1333||
273476|NCT00380250|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
273477|NCT00380367|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282095|NCT00836888|Ono Pharmaceutical Co. Ltd|Ohyama Yukiya||y.ohyama@ono.co.jp|
267845|NCT03446456|University of Maryland School of Nursing|Rachel Massalee|4107068244|rmassalee@umaryland.edu|
267846|NCT03382834|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|3016283313|ACTGCT.Gov@s-3.com|
267847|NCT03371823|University of Delaware|Dr. Megan Wenner|302-831-7343|mwenner@udel.edu|
267848|NCT03366337|Reata Pharmaceuticals, Inc.|Kris Loerwald|+1 972-865-2219|MedicalAffairs-Team@reatapharma.com|
267849|NCT03353350|Hanmi Pharmaceutical Co., Ltd.|Sujin Jung|+82-2-410-0473|sujin.jung@hanmi.co.kr|
267850|NCT03350503|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
267851|NCT03326193|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
267852|NCT03287687|University of Iowa|Dr. Warren Bishop, Professor of Pediatrics|319 356 2977|warren-bishop@uiowa.edu|
267853|NCT03282565|University of Michigan|Dr. Riann Palmieri-Smith|734-615-3154|riannp@umich.edu|
267854|NCT03276936|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
267855|NCT03271021|Foamix Pharmaceuticals|Senior Director, Clinical Operations|9089630117|kendra.gulbronson@foamix.com|
267856|NCT03255083|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
267857|NCT03227471|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
267858|NCT03221842|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
267859|NCT03194321|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
267860|NCT03165721|National Cancer Institute|Dr. John Glod|240-760-6194|john.glod@nih.gov|
267861|NCT03085095|Myovant Sciences GmbH|Clinical Trials at Myovant|650-278-8743|ClinicalTrials@Myovant.com|
267862|NCT03048422|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
267863|NCT03032068|Cleveland Clinic|Jayson Zadzilka|216-445-8023|zadzilj@ccf.org|
267864|NCT02965729|Pennington Biomedical Research Center|Dr. Amanda Staiano|225-763-2729|amanda.staiano@pbrc.edu|
267865|NCT02908672|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
267866|NCT02864407|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
267867|NCT02835690|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
267868|NCT02828982|University of Michigan|Dr. Deanna Gates|(734) 647-2698|gatesd@umich.edu|
267869|NCT02823457|GV Sonny Montgomery VAMC|Mary Jane Burton|6013624471|mary.burton2@va.gov|
267870|NCT02815280|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
267871|NCT02815267|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
267872|NCT02802228|Cumberland Pharmaceuticals|Jerry Fox, DVM|615-255-0068|jfox@cumberlandpharma.com|
267873|NCT02719691|University of Colorado|Jennifer Diamond, MD|303-724-5499|jennifer.diamond@cuanschutz.edu|
282096|NCT00836927|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282097|NCT00836953|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
282098|NCT00837031|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
282099|NCT00837096|Acelity|VP, Global Clinical Affairs|210-255-5595|jane.hart@acelity.com|
282100|NCT00837148|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
282101|NCT00837161|Philips Healthcare|Sarah Baxter|425-487-7665|sarah.baxter@philips.com|
282102|NCT00837200|Milton S Hershey Medical Center|Joseph J Drabick, MD|717-531-5911|jdrabick@hmc.psu.edu|
267874|NCT02701283|Medtronic Structural Heart & Aortic Clinical Research & Medical Science|Kristin Smith, Clinical Research Manager|763-526-3095|kristin.m.smith@medtronic.com|
282103|NCT00837213|GlaxoSmithKline|GSK Response Center|866-435-7343||
282104|NCT00837252|National Eye Institute|Catherine M. Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
308396|NCT02576639|Novartis Pharmaceuticals|Study Director|862-778-8300||
296870|NCT01710501|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
273478|NCT00380393|GlaxoSmithKline|GSK Response Center|866-435-7343||
273479|NCT00380588|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273480|NCT00380692|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273481|NCT00380718|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
267875|NCT02674516|Nanyang Technological University|Dr. Olivia Choy|(65) 65921522|oliviachoy@ntu.edu.sg|
273482|NCT00380744|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273483|NCT00380861|DePuy Orthopaedics|Tammy O'Dell|574-372-7104|TOdell2@its.jnj.com|
273484|NCT00380874|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
273485|NCT00380978|Department of Anesthesiology; Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
273486|NCT00381004|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor, Leukemia||CR_Study_Registration@mdanderson.org|
273487|NCT00381043|University of North Carolina at Chapel Hill|Dr. J.C. Garbutt|919-966-4652|jc_garbutt@med.unc.edu|
273488|NCT00381095|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273489|NCT00381238|GlaxoSmithKline|GSK Response Center|866-435-7343||
273490|NCT00381303|Tibotec Therapeutics Clinical Affairs (TTCA), Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
267876|NCT02655016|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
267877|NCT02607046|Department of Veterans Affairs|Dr. Steven Prior|410-605-7000|steven.prior@va.gov|54129
267878|NCT02505425|The University of Alabama at Birmingham, School of Nursing|Marie A. Bakitas, DNSc, NP-C, FAAN|(205) 934-5277|mbakitas@uab.edu|
267879|NCT02487979|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
267880|NCT02463448|Beaumont Hospitals|Jennifer Giordano|248-551-3517|jennifer.geiordano@beaumont.org|
273491|NCT00381550|Sidney Kimmel Comprehensive Cancer Center|Michael McDevitt, MD PhD|410-955-9175|mmcdev1@jhmi.edu|
273492|NCT00381563|New England Baptist Hospital|Director of Clinical Trials|(617)754-6602|pmccree@caregroup.harvard.edu|
273493|NCT00381615|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
273494|NCT00381628|Riley Hospital for Children|Dr. James Chmiel|317-948-7180|jfchmiel@iu.edu|
273495|NCT00381641|University of Chicago|Dr. Tanguy Seiwert|(773) 702-2452|tseiwert@medicine.bsd.uchicago.edu|
273496|NCT00381680|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
273497|NCT00381693|Mayo Clinic|Dr. Ruben A. Mesa|507-284-3533|mesa.ruben@mayo.edu|4-3533
273498|NCT00381706|Dana Farber Cancer Institute|Peter Enzinger, M.D.||peter_enzinger@dfci.harvard.edu|
273499|NCT00381797|St. Jude Children's Research Hospital|Shengjie Wu|(901) 595-2859|shengjie.wu@stjude.org|
273500|NCT00381810|Genentech, Inc.|Medical Communications Specialist|800 821-8590|genentech@druginfo.com|
273501|NCT00381849|Mayo Clinic|Beverly Tietje, Study Coordinator|507-255-0401|tietje.beverly@mayo.edu|
273502|NCT00381862|OHSU Knight Cancer Institute|Joseph Bubalo, PharmD, BCPS, BCOP|503-494-1080|bubaloj@ohsu.edu|
273503|NCT00381888|Masonic Cancer Center, University of Minnesota|Levi S. Downs, Jr., M.D.|612-626-6628|downs008@umn.edu|
273504|NCT00381940|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
273505|NCT00381966|Johns Hopkins University|Daniel Song|401-502-5875|dsong2@jhmi.edu|
273506|NCT00382018|SWOG|Breast Committee Statistician|2066675712|jmiao@fredhutch.org|
273507|NCT00382031|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
273508|NCT00382070|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
273509|NCT00382109|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
273510|NCT00382148|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
273511|NCT00382174|RegeneRx Biopharmaceuticals, Inc.|Nabila Turjman, PhD, Executive Director, Regulatory Affairs|301-280-1992|nturjman@regenerx.com|108
273512|NCT00382265|George Washington University|Andrew Meltzer, MD, MS|202-741-2952|ameltzer@mfa.gwu.edu|
273513|NCT00382291|University of Florida|Dr. Regina Bussing|(352) 273-7550|rbussing@ufl.edu|
273514|NCT00382408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|info.era-clinical@teva.de|
273515|NCT00382590|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-745-3428|eharriso@mdanderson.org|
273516|NCT00382720|sanofi-aventis|International Clinical Development Clinical Study Director||contact-us@sanofi-aventis.com|
273517|NCT00382733|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
273518|NCT00382785|University of Delaware|Paula Klemm, PhD, RN, OCN|(302) 831-8501|klemmpa@udel.edu|
273519|NCT00382824|Lahey Hospital & Medical Center|Jordan Jara|7817442958|jordan.jara@lahey.org|2958
273520|NCT00382863|Paracor Medical, Inc.|Michael Kolber, General Manager, VP of Regulatory Affairs|408-734-6000|info@paracor.com|
273521|NCT00382928|Atlanta Research and Education Foundation|Dr. A. Maziar Zafari|404-321-6111|azafari@emory.edu|4019
273522|NCT00382967|GE Healthcare|Igor Grachev, MD|1-609-514-6857|igor.grachev@ge.com|
273523|NCT00382993|Glaxo Smith Kline|GSK Response Center|1-866-435-7343||
273524|NCT00383019|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273525|NCT00383071|SAIC/National Institute of Allergy and Infectious Diseases|John Beigel, M.D.|+1 301 451 9881|jbeigel@niaid.nih.gov|
273526|NCT00383084|Johns Hopkins University|Kevin Fontaine, PhD|443-449-4314|kfontai1@jhmi.edu|
273527|NCT00383110|Ralph H. Johnson VAMC|Leonard Egede, MD, MS|843-789-6670|leonard.egede@va.gov|
273528|NCT00383123|GlaxoSmithKline|GSK Response Center|866-435-7343||
273529|NCT00383149|Organization: Bristol-Myers Squibb|Name/Official Title: BMS Study Director||Clinical.Trials@bms.com|
273530|NCT00383162|GlaxoSmithKline|GSK Response Center|866-435-7343||
273531|NCT00383188|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273532|NCT00383266|Washington University School of Medicine|Maria Baggstrom, M.D.|314-362-5740|mbaggstr@dom.wustl.edu|
273533|NCT00383292|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273534|NCT00383331|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
273535|NCT00383448|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
273536|NCT00383500|Stanford University|Stanley G. Rockson|650-725-7571|rockson@stanford.edu|
273537|NCT00383565|MD Anderson Cancer Center|Dr. Luis E. Fayad / Associate Professor|713-792-2860|jmdennison@mdanderson.org|
296871|NCT01710514|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
267881|NCT02288897|Provectus Biopharmaceuticals, Inc.|Eric Wachter, Chief Technology Officer|865-769-4011|wachter@pvct.com|23
267882|NCT02276547|Neovasc|Lisa Read, Clinical Study Manager|8558025180|lread@neovasc.com|323
267883|NCT02263885|InSightec|Nadir Alikacem, PhD|214-630-2000|nadira@insightec.com|
273538|NCT00383643|Stanford University School of Medicine, Dept of Psychiatry|Dr. Jed Black|650 736 4559|jedblack@stanford.edu|
267885|NCT02213926|AstraZeneca Clinical -Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
273539|NCT00383747|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
267887|NCT02008396|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
267888|NCT01995175|GlaxoSmithKline|GSK Response Center|866-435-7343|lr24921@gsk.com|
267889|NCT01883804|Barbara Davis Center for Diabetes, University of Colorado School of Medicine|Dr. Aaron Michels|303-724-1923|aaron.michels@ucdenver.edu|
267890|NCT01804296|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
267891|NCT01804270|Mayo Clinic|Paul E. Croarkin, D.O., M.S.|507-293-2557|Croarkin.Paul@mayo.edu|
267892|NCT01781390|Mesoblast, Inc.|Kenneth Borow, MD (Lead, Global Cardiovascular Development)|(212) 880-2060|Ken.Borow@Mesoblast.com|7951
267893|NCT01566695|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
267894|NCT01412333|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
267895|NCT01338636|Brigham and Women's Hospital Heart and Vascular Center|Aaron B. Waxman|617-525-9733|abwaxman@partners.org|
267896|NCT01253161|Moffitt Cancer Center|Jonathan Strosberg, MD|813-745-6585|Jonathan.Strosberg@moffitt.org|
267897|NCT01247324|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
267898|NCT01208974|University of Miami|Cristiane Takita MD|305-243-4337|ctakita@med.miami.edu|
267899|NCT01063517|AstraZeneca|Anitra Fielding|+44 1625 517178|aztrial_results_posting@astrazeneca.com|
267900|NCT00938912|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
267901|NCT00925652|Dana-Farber Cancer Institute|Erica Mayer MD MPH|617-632-2335|emayer@partners.org|
267902|NCT00792948|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|(206) 667-4623||
267903|NCT00676715|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
267904|NCT00579826|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
267905|NCT00322218|Spectrum Pharmaceuticals,Inc.|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
267906|NCT00186888|St. Jude Children's Research Hospital|Ibrahim Qaddoumi MD|1-866-278-5833|info@stjude.org|
267907|NCT04579549|University of Wisconsin - Madison|Kristi Hall|608-890-0844|klhall1@wisc.edu|
267908|NCT04460690|University of Wisconsin - Madison|Kristi Hall|608-890-0844|klhall1@wisc.edu|
267915|NCT03597295|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
267916|NCT03086369|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
273540|NCT00383760|Princess Margaret Cancer Centre|Dr. Malcolm Moore|416-945-2263|malcolm.moore@uhn.ca|
273541|NCT00383786|Baylor College of Medicine|Sanjay Mathew, MD/PI|7137985439|sjmathew@bcm.edu|
273542|NCT00383942|Loyola University|Scott Graziano, M.D.|708-216-6288|sgrazia@lumc.edu|
273543|NCT00384033|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273544|NCT00384059|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273545|NCT00384085|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi-aventis.com|
273546|NCT00384176|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
273547|NCT00384189|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
273548|NCT00384241|Medical College of Georgia, Georgia Regents University|Haidong Zhu MD, PhD, Assistant Professor|706 721 5470|hzhu@gru.edu|
273549|NCT00384332|University of Alabama at Birmingham|Candace Cromer|2059753442|clreed@uab.edu|
273550|NCT00384397|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
273551|NCT00384449|Oregon Health & Science University|Dr. Christina J. Flaxel|(503) 418-3352|flaxelc@ohsu.edu|
273552|NCT00384670|Department of Pediatrics, Pharamongkutklao Hospital|Sriluck Simasathien ; Infectious Disease Consultant|66-2-644-8971||
273553|NCT00384748|University of Georgia|Neale Chumbler, PhD|706-369-5975|chumbler@uga.edu|
273554|NCT00384774|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
273555|NCT00384813|Emory University School of Medicine|Marianne Celano, PhD, ABPP|404-778-1536|mcelano@emory.edu|
273556|NCT00384839|Texas Oncology, P.A|Dr. Guru Sonpavde|(281) 332-7505|Guru.Sonpavde@USOncology.com|
273557|NCT00384865|Penn|Steven Kawut|215-573-0258|kawut@upenn.edu|
273558|NCT00384930|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
296872|NCT01710527|GlaxoSmithKline|GSK Response Center|866-435-7343||
273559|NCT00384956|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
273560|NCT00385008|GlaxoSmithKline|GSK Response Center|866-435-7343||
273561|NCT00385138|The Medicines Company|Meredith Todd|973.290.6088|meredith.todd@themedco.com|
273562|NCT00385203|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
273563|NCT00385216|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
273564|NCT00385255|GlaxoSmithKline|GSK Response Center|866-435-7343||
273565|NCT00385268|University of Pennsylvania|Dr. Helen Pettinati|215-222-3200|helenp@mail.med.upenn.edu|139
273566|NCT00385541|Columbia University|Dr. Pamela Flood|201-370-3933|pflood@stanford.edu|
273567|NCT00385580|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
273568|NCT00385593|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
273569|NCT00385671|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273570|NCT00385684|Tuscaloosa VA Medical Center|Andrea L. Snow|205-554-2000|lynn.snow@va.gov|2260
267909|NCT04374019|University of Kentucky|Susanne Arnold MD|8592579568|smarno0@uky.edu|
273571|NCT00385723|Institute for Behavioral Medicine Research, Ohio State University College of Medicine, OH, USA|Dr. Janice K. Kiecolt-Glaser|+1 614 293 3499|Janice.Kiecolt-Glaser@osumc.edu|
296873|NCT01710657|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
273572|NCT00385736|Abbott|Global Medical Services|800-633-9110||
273573|NCT00385762|Weill Cornell Medical College|Peter N Schlegel, MD|2127465491|pnschleg@med.cornell.edu|
273574|NCT00385788|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
273575|NCT00385801|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
273576|NCT00385827|Janssen Research & Development|Director||ClinicalTrialDisclosure@its.jnj.com|
273577|NCT00385840|GlaxoSmithKline|GSK Response Center|866-435-7343||
282734|NCT00870896|University of South Florida|Thomas Truncale|813 974 8952|ttruncal@health.usf.edu|
282735|NCT00871000|GlaxoSmithKline|GSK Response Center|866-435-7343||
282736|NCT00871117|GlaxoSmithKline|GSK Response Center|866-435-7343||
282737|NCT00871143|Institute of Psychiatry|Dr. David Veale|0203 228 3461|david.veale@kcl.ac.uk|
296874|NCT01710709|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
282738|NCT00871169|University of New Mexico Comprehensive Cancer Center|Fa-chyi Lee, MD|505-925-0405|flee@salud.unm.edu|
282739|NCT00871234|Indiana University School of Medicine|Samir K. Gupta, MD, MS|317-274-7926|sgupta1@iupui.edu|
282740|NCT00871260|The University of Chicago|Dr. Amit Patel|773-702-9461|apatel2@medicine.bsd.uchicago.edu|
282741|NCT00871286|Northwestern|Rakesh Chandra|312-695-8182|rchandra@nmff.org|
282742|NCT00871338|GlaxoSmithKline|GSK Response Center|866-435-7343||
282743|NCT00871377|UCLA School of Medicine|Christopher M. DeGiorgio, MD|310-206-3753|cmd@mednet.ucla.edu|
282744|NCT00871403|GlaxoSmithKline|GSK Response Center|866-435-7343||
282745|NCT00871429|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
282746|NCT00871494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282747|NCT00871572|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282748|NCT00871624|Tufts Medical Center|Russel Roberts, PharmD|617-636-4576|rroberts@tuftsmedicalcenter.org|
292589|NCT01435772|BioMarin Pharmaceutical Inc.|Debra Lounsbury, Principal Scientist, Clinical Sciences|415-506-6348|DLounsbury@bmrn.com|
292590|NCT01435798|Translational Pain Research, Brigham and Women's Hospital|Christine N. Sang, MD, MPH|617-525-7246|paintrials@partners.org|
296875|NCT01710787|Jean Brown Research|Adam D. Marberger, DDS|801-261-2000||
292591|NCT01435824|The Hospital for Sick Children|Dr. Shinya Ito|416-813-5776|shinya.ito@sickkids.ca|205776
292592|NCT01435928|Sunovion|Medical Director, CNS|1-866-503-6351||
292593|NCT01436006|Università di Palermo|Sergio Salerno|00390916552315|sergio.salerno@unipa.it|2315
292594|NCT01436045|HealthPartners Institute for Education and Research|Michael H Rosenbloom, MD|6512547900|michael.h.rosenbloom@healthpartners.com|
292595|NCT01436071|GlaxoSmithKline|GSK Response Center|866-435-7343||
292596|NCT01436110|GlaxoSmithKline|GSK Response Center|866-435-7343||
292597|NCT01436149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
292598|NCT01436162|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
292599|NCT01436175|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
296876|NCT01710800|Walter Reed National Military Medical Center|Dr. Fouad J. Moawad|(301) 400-1551|Fouad.Moawad@us.army.mil|
267910|NCT04357730|Denver Health Medical Center|Dr. Ernest Moore, Director of Surgical Research|3036021820|ernest.moore@dhha.org|
267911|NCT04311463|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
267912|NCT04175509|Aultman Hospital|Dr. Michaela Beynon|2488218826|michaelabeynon@gmail.com|
267913|NCT03930186|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
267914|NCT03740100|MD Anderson Cancer Center|Dr. Faye Johnson|7137922121|fmjohns@mdanderson.org|
267917|NCT03053362|Brain and Cognition Discovery Foundation|Dr. Roger McIntyre|(416) 943-6284|rogermcintyre28@gmail.com|
267918|NCT02849626|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
267919|NCT02810418|National Cancer Institute|Dr. Christine C. Alewine|240-760-6146|christine.alewine@nih.gov|
267920|NCT02779855|Moffitt Cancer Center|Hatem Soliman, MD|813-745-4985|hatem.soliman@moffitt.org|
267921|NCT02654132|Bristol Myers-Squibb|Ph 2 Trial of of Elotuzumab, Polalidomide, & Dexamethasone Versus Polalidomide and Dexamethasone|Please email|Clinical.Trials@bms.com|
267922|NCT02603432|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
267923|NCT02600923|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273578|NCT00385918|University of Maryland Rehabiitation and Orthopaedic Institute|Peter H. Gorman, MD Chief Division of Rehabilitation Medicine|410-448-6261|pgorman@umm.edu|
273579|NCT00385944|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273580|NCT00385996|Weill Cornell Medical College|Nasser Altorki, MD|212-746-5156|nkaltork@med.cornell.edu|
273581|NCT00386009|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273582|NCT00386022|Massachusetts General Hospital|Dr. Janet E. Hall|617-877-1112|hall.janet@mgh.harvard.edu|
273583|NCT00386100|GlaxoSmithKline|GSK Response Center|866-435-7343||
273584|NCT00386152|Centocor Ortho Biotech Services, LLC|Nephrology Therapeutic Area, Medical Lead|215-325-4176||
273585|NCT00386243|Center on Implementing Evidence Based Practice|Matthew J. Bair, MD MS|317-988-2058|mbair@iupui.edu|
273586|NCT00386256|VA Greater Los Angeles Healthcare System|Nancy Harada, PhD|310-268-3632|Nancy.Harada@va.gov|
273587|NCT00386308|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
273588|NCT00386334|Sepracor Inc.|Lunesta Medical Director|1-866-503-6351||
273589|NCT00386360|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
273590|NCT00386425|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273591|NCT00386477|Indiana University School of Medicine|David M. Haas, MD, MS|317-630-7837|dahaas@iupui.edu|
273592|NCT00386607|Novartis Pharmaceuticals|Study Director|862-778-8300||
273593|NCT00386776|Beth Israel Deaconess Medical Center|Dr. Warner V. slack|617 278 8155|wslack@bidmc.harvard.edu|
273594|NCT00386880|Doylestown Hospital|Abraham A. Ashkenazi, MD-Principal Investigator|215-625-2894|aashkenazi2001@yahoo.com|
273595|NCT00387010|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
273596|NCT00387023|UT MD Anderson Cancer Center|Bita Esmaeli, MD / Professor||CR_Study_Registration@mdanderson.org|
273597|NCT00387036|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
273598|NCT00387088|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
273599|NCT00387127|GlaxoSmithKline|GSK Response Center|866-435-7343||
273600|NCT00387153|Myriad Therapeutics, Inc.|Richard Wenstrup, MD, VP Chief Medical Officer|801-584-3009|rwenstru@myriad.com|
273601|NCT00387335|University of Chicago|Ezra Cohen|773-702-4137|ecohen@medicine.bsd.uchicago.edu|
273602|NCT00387348|Massachusetts General Hospital|William F Pirl, MD|617-724-9151|wpirl@partners.org|
273603|NCT00387426|UT MD Anderson Cancer Center|Srdan Verstovsek, MD / Associate Professor||eharriso@mdanderson.org|
273604|NCT00387465|SKCCC|John Wrangle, MD|843-792-7789|wrangle@musc.edu|
267924|NCT02597790|David Geffen School of Medicine at UCLA|Kara Chew, MD, MS|310-825-0796|kchew@mednet.ucla.edu|
267925|NCT02484664|Brigham and Women's Hospital|Dr. David Kwiatkowski|8573070781|dk@rics.bwh.harvard.edu|
273605|NCT00387621|Mayo Clinic|Dr Horng Chen|507-284-4343|chen.horng@mayo.edu|
273606|NCT00387647|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
273607|NCT00387660|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
273608|NCT00387712|Baltimore VAMC|Charlene Hafer-Macko|410-605-7000|charlene.hafer-macko@va.gov|5451
273609|NCT00387725|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273610|NCT00387751|University of Texas Health Science Center at San Antonio|Dr. John Sarantopoulos|210-450-1000|sarantopoulo@uthscsa.edu|
273611|NCT00387764|GlaxoSmithKline|GSK Response Center|866-435-7343||
273612|NCT00387790|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
273613|NCT00387829|Intergra LifeSciences|Director of Medical Affairs|609-275-0500|clinicalaffairs-neuro@integralife.com|
273614|NCT00387881|GlaxoSmithKline|GSK Response Center|866-435-7343||
273615|NCT00387894|University of California San Francisco|Michael Prados, MD|415-353-7500|PradosM@neurosurg.ucsf.edu|
273616|NCT00387959|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker|212-639-3468|barkerj@mskcc.org|
273617|NCT00388037|Cancer Centre of Southeastern Ontario at Kingston|Dr. James Biagi|(613) 544-2630|jim.biagi@krcc.on.ca|
273618|NCT00388154|University of Texas (UT) MD Anderson Cancer Center|Jubilee Brown, MD/Associate Professor, Gynecology Oncology & Reproductive Medicine|713-745-8837|CR_Study_Registration@mdanderson.org|
273619|NCT00388297|The George Washington University Biostatistics Center|Elizabeth Thom, Ph.D.|301-881-9260|e_thom@bsc.gwu.edu|
273620|NCT00388349|Stanford University|Dr. Sally Arai|650-723-0822|sarai1@stanford.edu|
273621|NCT00388362|Stanford University|Laura Johnston, MD|650-723-0822|janices1@stanford.edu|
273622|NCT00388414|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
273623|NCT00388453|Vanderbilt University|Michael Vaezi, MD, PhD|615.322.3739|michael.vaezi@vanderbilt.edu|
273624|NCT00388505|Novartis Pharmaceuticals|Study Director|862-778-8300||
273625|NCT00388583|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
273626|NCT00388674|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
273627|NCT00388726|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
273628|NCT00388804|UT MD Anderson Cancer|Andrew Lee, MD / Professor||lhamblin@mdanderson.org|
273629|NCT00388947|Whitinsville Medical Center|Dr Samuel Zylstra|508-243-6260|samuelzylstra@milreg.org|
273630|NCT00388973|AstraZeneca|Medical Science Director, Seroquel||AZTrial_Results_Posting@astrazeneca.com|
273631|NCT00389064|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
273632|NCT00389168|Karolinska Institutet, Stockholm, Sweden|Thomas Kahan, MD|+46 8 123 568 61|thomas.kahan@ds.se|
273633|NCT00389207|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
273634|NCT00389324|Grifols Therapeutics, Inc.|Henry Li, PhD|800-520-2807|henry.li@grifols.com|
273635|NCT00389441|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273636|NCT00389467|Georgetown University|Chelsea S. Kidwell, MD|202-687-7302|ck256@georgetown.edu|
273637|NCT00389493|New York State Psychiatric Institute|Dr. Helen Blair Simpson|646-774-7000|kimeldo@nyspi.columbia.edu|
273638|NCT00389519|King Pharmaceuticals, Inc.|Professional Information Services|1-800-776-3637||
273639|NCT00389532|Sanofi pasteur Inc|Medical Director||RegistryContactUS@sanofipasteur.com|
296877|NCT01710839|Retina Consultants of Houston|Charles C Wykoff, PhD, MD|713-524-3434|ccwmd@houstonretina.com|
273640|NCT00389597|LDR Spine|Noah Bartsch, VP, Clinical,Regulatory,Quality|512-344-3319|noah.bartsch@ldrspine.com|
273641|NCT00389805|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
273642|NCT00389818|AMC|Ronald Mitsuyasu, MD|310-557-1803|rmitsuya@mednet.ucla.edu|
273643|NCT00389831|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
273644|NCT00389857|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
273645|NCT00389974|Princess Margaret Hospital, Toronto, Canada|Dr. Helen Mackay|(416) 946-2253|helen.mackay@uhn.ca|
296878|NCT01710891|MinneapolisMRF|Brian Driver|6128739528|Brian.Driver@hcmed.org|
273646|NCT00390013|University of Iowa|Colleen Kennedy Stockdale, MD, MS|319-384-6849|colleen-stockdale@uiowa.edu|
273647|NCT00390182|University of Maryland Baltimore|Nancy Kennedy|410-328-2513|nkennedy@umm.edu|
273648|NCT00390221|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
267926|NCT02412735|Mesoblast, Inc.|Christopher James, VP Head of Clinical Operations|212-880-2060|Christopher.James@Mesoblast.com|7925
273649|NCT00390234|Princess Margaret Hospital|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
273650|NCT00390299|Mayo Clinic|Evanthia Galanis, M.D.|+1 (507) 266-0584|Galanis.Evanthia@mayo.edu|
296879|NCT01711177|Université de Montreal|Pierre Forcier|514-343-7468|pierre.forcier@umontreal.ca|
296880|NCT01711216|Abbott|Senior Global Medical Director|+49 160 749 0615|Claire.Pexman-Fieth@abbott.com|
273651|NCT00390325|The Ohio State University Comprehensive Cancer Center|Manisha Shah, MD|614-293-8629|Manisha.Shah@osumc.edu|
273652|NCT00390364|Sidney Kimmel Comprehensive Cancer Center at JHMI|Manuel Hidalgo, MD (no longer works at Hopkins)|410-502-5328|tbrown55@jhmi.edu|
273653|NCT00390416|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
273654|NCT00390429|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
273655|NCT00390455|Dana-Farber Cancer Institue|Harold Burstein, M.D.||hburstein@partners.org|
273656|NCT00390468|UT MD Anderson Cancer Center|Quality Assurance Specialist|713-792-2830|caperez@mdanderson.org|
273657|NCT00390546|University of British Columbia|Dr. Shubhayan Sanatani|604-875-2345|ssanatani@cw.bc.ca|7955
267927|NCT02371889|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-746-1943|kranzler@pennmedicine.upenn.edu|
267928|NCT02337829|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
267929|NCT02272803|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
267930|NCT02186834|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rachid Baz|813-745-8212|rachid.baz@moffitt.org|
267931|NCT02121158|VA Cooperative Studies Program Coordinating Center, West Haven, CT|Michael T. Wininger, Ph.D., Study Biostatistician|203-932-5711|michael.wininger@va.gov|3262
267932|NCT02100722|Stanford University|William Fearon, MD|650-725-2621|wfearon@stanford.edu|
267933|NCT02059265|NRG Oncology|Christopher Purdy on behalf of Austin Miller|(716)845-1300|purdyc@nrgoncology.org|2296
267934|NCT02046096|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
267935|NCT01945775|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
267936|NCT01781637|Boston Children's Hospital|Lynda Schneider|617-355-6180|lynda.schneider@childrens.harvard.edu|
267937|NCT01711541|Alliance for Clinical Trials in Oncology|Everett E. Vokes, M.D.|773-702-9306|evokes@medicine.bsd.uchicago.edu|
267938|NCT01670539|West Virginia University|Georgia L Narsavage|304-293-6729|gnarsavage@hsc.wvu.edu|
267939|NCT01371981|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
267940|NCT01196390|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
267941|NCT00980460|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
267942|NCT00407602|Second Sight Medical Products, Inc.|Jessy Dorn, PhD, Director of Clinical and Scientific Affiars|8188335089|jdorn@secondsight.com|
267943|NCT00345345|National Heart Lung and Blood Institute|Cordes, Stefan|+1 240 383 6460|stefan.cordes@nih.gov|
273658|NCT00390559|Virginia Commonwealth University|Thomas Eissenberg|804.827.4617|teissenb@vcu.edu|
273659|NCT00390572|VA HSRD|Christi S. Ulmer, PhD|9192860411|christi.ulmer@va.gov|4044
273660|NCT00390611|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
273661|NCT00390689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
273662|NCT00390780|Bioalliance Pharma|Dr Pierre Attali|+33 (0)1 45 58 76 00|pierre.attali@bioalliancepharma.com|
273663|NCT00390806|GlaxoSmithKline|GSK Response Center|866-435-7343||
273664|NCT00390858|Novartis Pharmaceuticals|Study Director|862-778-8300||
273665|NCT00390884|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
273666|NCT00390910|GlaxoSmithKline|GSK Response Center|866-435-7343||
273667|NCT00390949|Imperial College London|Professor Simon Gregson|+4402075943279|Sajgregson@aol.com|2075943279
273668|NCT00391027|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
273669|NCT00391053|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
273670|NCT00391079|GW Pharmaceuticals|Richard Potts Clinical Operations Director|+44 1223 266800|rp@gwpharm.com|
296881|NCT01711294|Boston Scientific Corporation|Lina Ginnetti, Clinical Endoscopy Director|508-683-4512|lina.ginnetti@bsci.com|
273671|NCT00391092|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
273672|NCT00391118|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
273673|NCT00391222|Janssen Cilag Spain|EMEA Medical Affairs Director|+34 91 7228043||
273674|NCT00391274|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273675|NCT00391365|Center For Limb Loss Prevention and Prosthetic Engineering, VA Puget Sound Health Care System|Alan Wesley, Program Manager|206 277 1079|alan.wesley@va.gov|
273676|NCT00391391|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
273677|NCT00391443|Actelion Pharmaceuticals Ltd|Isabelle Leconte,PhD -Data Science Group Leader, Director|+41 61 565 64 18|isabelle.leconte@actelion.com|
282105|NCT00837330|Southeast Retina Center, P.C.|Dr. Dennis M Marcus Principal Investigator|706-650-0061|dmarcus@southeastretina.com|
282106|NCT00837434|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
282107|NCT00837447|Ewha Womans University School of Medicine|Young-Hoo Kim, MD|822-26505900|younghookim@ewha.ac.kr|
282108|NCT00837473|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
282109|NCT00837486|Medtronic Neuromodulation|Eric Williamson, Clinical Evidence Specialist|763-526-7982|medtronicneurotrials@medtronic.com|
282110|NCT00837512|Emory University School of Medicine|Dr. Eric Felner|404-727-7651|efelner@emory.edu|
282111|NCT00837577|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282112|NCT00837590|Indiana University|Dr. Kieren Mather|317-278-2187|kmather@iupui.edu|
282113|NCT00837616|Nemours Children's Clinic|Dr. Nelly Mauras|(904) 697-3674|nmauras@nemours.org|
282114|NCT00837694|University at Buffalo|Jennifer L. Temple|716-829-5593|jltemple@buffalo.edu|
282115|NCT00837759|NIDDK, National Institutes of Health|Dr. Rana Malek|3015945288|malekr@mail.nih.gov|
282116|NCT00837811|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282117|NCT00837824|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
282118|NCT00837876|Vanderbilt-Ingram Cancer Center|Jordan Berlin, MD|615-343-4128|jordan.berlin@vanderbilt.edu|
267944|NCT05143541|Kantonsspital St. Gallen|Dr. André E. Dutly|071 494 9944|andre.dutly@kssg.ch|
282119|NCT00837902|Vanderbilt University Medical Center|Dr. C. Michael Stein|615-936-3420|mike.stein@vumc.org|
282120|NCT00837967|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
282121|NCT00838006|Central Arkansas Veterans Healthcare System|Jeff Pyne, MD|501-257-1083|jeffrey.pyne@va.gov|
282122|NCT00838097|Amgen Inc.|Study Director|866-572-6436||
296882|NCT01711359|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282123|NCT00838110|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
267945|NCT04685213|Baylor College of Medicine|Prof. Bijan Najafi|7137987536|bijan.najafi@bcm.edu|
267946|NCT04567186|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD, MS, FAAO, Sr. Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
267947|NCT04190693|Imcyse SA|Jean Van Rampelbergh|+3243251100|j.vanrampelbergh@imcyse.com|
267948|NCT04065074|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
267949|NCT03980730|vTv Therapeutics LLC|VP Clinical Operations|3368410300|jfreeman@vtvtherapeutics.com|
267950|NCT03793010|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
267951|NCT03644017|Merit Medical Systems, Inc.|Casey Holland, Senior Director Clinical Operations|+1 (617) 842-0251|casey.holland@merit.com|
267952|NCT03592186|Brown University School of Public Health|Sara Becker, Ph.D, Principal Investigator|4018636604|sara_becker@brown.edu|
267953|NCT03529942|Flexion Therapeutics, Inc.|David Golod, Vice President, Clinical Operations|(781) 305-7572|dgolod@flexiontherapeutics.com|
267954|NCT03373760|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
267955|NCT03349775|Beth Israel Deaconness Medical Center|Dr. Jennifer Ho|617-735-4102|jho@bidmc.harvard.edu|
267956|NCT03292471|VA Pittsburgh/California State University, East Bay|Dr. Michelle Gravier|510 885-3215|michelle.gravier@csueastbay.edu|
267957|NCT03256344|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
267958|NCT03207815|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
267959|NCT03077737|Northwestern University|Dr. Brian Hitsman, PhD|312-503-2074|b-hitsman@northwestern.edu|
267960|NCT03073733|jCyte, Inc.|Robert Beathard|9492430687|rob.beathard@jcyte.com|
267961|NCT02991937|NYU Langone Health|Jason Fisher, MD|212-263-7391|Jason.Fisher@nyulangone.org|
267962|NCT02968563|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
267963|NCT02915783|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
267964|NCT02913482|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
267965|NCT02787044|Brigham and Women's Hospital|Dr. Scott Solomon|857-307-1960|ssolomon@bwh.harvard.edu|
267966|NCT02698163|UCLA School of Dentistry|Dr. Eric Sung|(310) 206-6407|esung@dentistry.ucla.edu|
267967|NCT02586857|Acerta Pharma, LLC|Priti Patel, MD, Executive Director - Head of Clinical Development|1-888-292-9613|acertamc@dlss.com|
267968|NCT02586675|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hatem Soliman|813-745-4933|hatem.soliman@moffitt.org|
267969|NCT02367105|Michael E DeBakey VA Medical Center|Dennis T Villareal, MD|713-794-7156|dennis.villareal@va.gov|
267970|NCT02352948|AstraZeneca|Medical Science Director|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
267971|NCT02332590|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
282124|NCT00838162|Jan-Cil UK|VP Head of Discovery & Early Development|44 1494 553458|ksimmen1@its.jnj.com|
282125|NCT00838201|Amgen Inc.|Study Director|866-572-6436||
282126|NCT00838331|Emory University|John Roback, MD PhD|404-712-1774|jroback@emory.edu|
296883|NCT01711372|CogCubed|Dr Monika Roots, Chief Medical Officer|6173082009|monika@cogcubed.com|
273678|NCT00391469|University of Washington|Francis Kim, MD Associate Professor of Medicine|206-744-8712|fkim@u.washington.edu|
273679|NCT00391586|Dana Farber Cancer Institute|Dennie Jones, MD|617-632-6478|DennieV_Jones@DFCI.HARVARD.EDU|
273680|NCT00391599|Edith Wolfson Medical Center|Investigator|+972-35028329|lurie@wolfson.health.gov.il|
273681|NCT00391625|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
273682|NCT00391716|The Scripps Research Institute|Dr. Barbara J. Mason|858-784-7324|mason@scripps.edu|
273683|NCT00391768|Collaborative Antiviral Study Group|Penelope Jester|877-975-7280|PJester@peds.uab.edu|
273684|NCT00391807|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
273685|NCT00391846|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
273686|NCT00391872|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
273687|NCT00391898|Novartis Pharmaceuticals|Study Director|862 778-8300||
273688|NCT00391976|Novartis Pharmaceuticals|Study Director|862 778-8300||
296884|NCT01711424|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
273689|NCT00391989|GIMEMA|Dr. Paola Fazy; Dr. Marco Vignetti|+39 06.70390521|gimema@gimema.it|
273690|NCT00392015|United States Military Malaria Vaccine Program Naval Medical Research Center|Dr. Judith Epstein|301-252-9026|judith.epstein@med.navy.mil|
273691|NCT00392041|Princeton University|Lesley Allen, Ph.D.|609-924-9213|lesleyaallen@gmail.com|
273692|NCT00392054|Population Health Research Institute|Carlos A. Morillo, MD, FRCPC, FACC, FHRS, FESC, FHRS|905-527-4322|Carlos.Morillo@phri.ca|40311
273693|NCT00392171|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
273694|NCT00392197|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
273695|NCT00392210|University of Rochester|Michael K. Flynn, MD|585-273-3232||
273696|NCT00392223|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
273697|NCT00392236|Feinstein Institute for Medical Research|Delbert Robinson, M.D.|718 470-8195|drobinso@nshs.edu|
273698|NCT00392288|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
273699|NCT00392379|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
273700|NCT00392392|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
273701|NCT00392444|The Ottawa Hospital Cancer Centre|Dr. Scott Laurie|613-737-7700|slaurie@toh.on.ca|70175
273702|NCT00392496|Sunnybrook Health Sciences Centre|Dr. Rena Buckstein|416-480-5847|rena.buckstein@sunnybrook.ca|
273703|NCT00392665|Massachusetts General Hospital|Lori J. Wirth, MD|617-724-4000|LWIRTH@mgh.harvard.edu|
273704|NCT00392678|Joslin Diabetes Center|Allison B. Goldfine, MD co-investigator|617-309-2643|allison.goldfine@joslin.harvard.edu|
273705|NCT00392704|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
273706|NCT00392769|UT MD Anderson Cancer Center|Judith Wolff, MD / Professor||CR_Study_Registration@mdanderson.org|
273707|NCT00392782|Masonic Cancer Center, University of Minnesota|Daniel Weisdorf, M.D.|612-624-0123|weisd001@umn.edu|
273708|NCT00392808|Centro Superior de Investigacion en Salud Publica|Javier Diez-Domingo|+34961925937|diez_jav@gva.es|
296885|NCT01711619|Medtronic|Global Clinical Study Manager||medtronicneurotrials@medtronic.com|
273709|NCT00392821|Sarah Cannon Research Institute|John D Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
273710|NCT00392834|University of Arkansas for Medical Sciences|Jeannette Lee, Ph.D.|501-526-6712|jylee@uams.edu|
273711|NCT00392925|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
273712|NCT00392951|Children's Hospital of Philadelphia|David T. Teachey, MD|267-426-5802|teacheyd@email.chop.edu|
296886|NCT01711645|Vanderbilt Medical Center|Kathryn M. Edwards, MD|615-322-3078|Kathryn.edwards@vanderbilt.edu|
273713|NCT00392990|Northwestern University|Leo Gordon, MD||l-gordon@northwestern.edu|
273714|NCT00393029|National Cancer Institute (NCI), National Institutes of Health (NIH)|Steven Rosenberg, M.D., Ph.D.|301-496-4164|Steven.Rosenberg@nih.gov|
267972|NCT02256631|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
273715|NCT00393042|Dept. of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
273716|NCT00393068|Sarah Cannon Research Institute|Johanna C. Bendell, MD|615-329-7274|jbendell@tnonc.com|
273717|NCT00393094|National Cancer Institute, National Institutes of Health|Howard A. Fine, M.D.|301-402-6383|hfine@mail.nih.gov|
267973|NCT01972217|AstraZeneca|Medical Director|+13028851180|ClinicalTrialTransparency@astrazeneca.com|
273718|NCT00393367|The Children's Hospital of Philadelphia|Cynthia J. Mollen|215-590-4410|mollenc@email.chop.edu|
273719|NCT00393380|The EMMES Corporation|Adam Mendizabal, Statistician|301-251-1161|amendizabal@emmes.com|221
273720|NCT00393458|Novartis Pharmaceuticals|Study Director|862 778-8300||
273721|NCT00393484|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
273722|NCT00393510|Institute of Chinese Medicine, Chinese University of Hong Kong|Prof. Leung Ping Chung|(852)2252 8863|pingcleung@cuhk.edu.hk|
273723|NCT00393523|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
273724|NCT00393705|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273725|NCT00393718|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
273726|NCT00393796|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain, M.D.|1-800-865-1125|mahahuss@umich.edu|
273727|NCT00393848|UAMS|Arny Ferrando|501-526-5711|aferrando@uams.edu|
273728|NCT00393861|IndianaU|Lawrence H. Einhorn, M.D.|(317) 944-0920|leinhorn@iu.edu|
267974|NCT01816165|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicaresearchsupportcenter@ucdenver.edu|
267975|NCT01813929|University of Colorado Denver|Irene Schauer, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
273729|NCT00393874|University of Pittsburgh|Dr. Anne Germain|412-383-2150|GERMAX@upmc.edu|
273730|NCT00393887|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
273731|NCT00393913|NYU School o Medicine|Indu Ayappa, PhD|2125628437|indu.ayappa@nyumc.org|
273732|NCT00393939|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273733|NCT00393978|University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience|Melissa P. DelBello, MD|513-558-2989|Melissa.DelBello@uc.edu|
273734|NCT00394082|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
273735|NCT00394095|University of Cincinnati|Melissa DelBello, MD|513-558-4489|melissa.delbello@uc.edu|
273736|NCT00394212|Davol Inc., Subsidiary of C.R. Bard|Dawn Heimer, Clinical Research|401-825-8681|Dawn.Heimer@crbard.com|
273737|NCT00394251|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
273738|NCT00394277|Hoffmann-La Roche|Medical Communications|800-821-8590||
273739|NCT00394329|Penn State College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
273740|NCT00394433|Dana-Farber Cancer Institute|Peter C. Enzinger, MD|617-632-6855|Peter_Enzinger@dfci.harvard.edu|
273741|NCT00394472|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
273742|NCT00394524|Emory University|Guillermo Umpierrez, MD|404-778-1665|geumpie@emory.edu|
273743|NCT00394589|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
273744|NCT00394654|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
273745|NCT00394706|University of Washington|Siobhan Brown, PhD-Biostatistician|206-685-1302|spes@uw.edu|
273746|NCT00394771|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
273747|NCT00394836|GlaxoSmithKline|GSK Response Center|866-435-7343||
267976|NCT01502085|Hackensack Meridian Health|Joshua Zenreich|551-996-4248|joshua.zenreich@hmhn.org|
273748|NCT00394888|Medical College of Wisconsin|Dr. Beth Drolet|414-266-1569|bdrolet@mcw.edu|
273749|NCT00394901|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
273750|NCT00394914|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
273751|NCT00394953|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
273752|NCT00395018|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
267977|NCT01178814|Columbia University Irving Medical Center|Mark Heaney, MD|646-317-5199|mlh2192@cumc.columbia.edu|
273753|NCT00395044|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
273754|NCT00395057|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
273755|NCT00395083|VA Boston Healthcare System - MAVERIC|Dr. Sarah Leatherman|857-364-4220|sarah.leatherman@va.gov|
267978|NCT01125176|Weill Cornell Medical College|Richard Furman, MD|646-962-2064|rrfurman@med.cornell.edu|
267979|NCT00882050|University of Pennsylvania|Kim Lacy, RN BSN|215-893-7234|kim.lacy@uphs.upenn.edu|
267980|NCT00070564|SWOG Statistical Center|Breast Committee Statistician|206-667-4623|jmiao@fredhutch.org|
267981|NCT05167370|Cincinnati Children's Hospital Medical Center|Dr. Sonata Jodele|(513) 636-5917|Sonata.Jodele@cchmc.org|
267982|NCT04753710|Sintetica SA|Barbara Piccagli|0041 91 640 42 50|bpiccagli@sintetica.com|
267983|NCT04500821|Johnson & Johnson Surgical Vision|Luis Vargas, MD|714-247-8200|LVarga17@ITS.JNJ.com|
267984|NCT04425720|Montefiore Medical Center|Dr. Jonathan Leff|7189204316|jleff@montefiore.org|
267985|NCT04409509|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
267989|NCT04136548|University of Texas Southwestern Medical Center|Dr. Craig Crandall|2143454623|craigcrandall@texashealth.org|
267990|NCT04126057|SightGlass Vision, Inc.|Joe Rappon, OD, MS, FAAC|678-642-9117|joe@sightglassvision.com|
267991|NCT04087395|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
267992|NCT04072432|Renibus Therapeutics|Donald J Keyser, Chief Operating Officer|18178756991|jkeyser@renibus.com|
267993|NCT04069585|TEOXANE SA|Clinical Project Manager|+41(0) 22 344 96 36|clinical@teoxane.com|
267994|NCT03922321|Immunovant, Inc|Central Study Contact|1-800-797-0414|clinicaltrials@immunovant.com|
267995|NCT03911713|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
267996|NCT03879642|Nemours Children's Health-Jacksonville|Dr. Susana Patton|904-697-2000|susana.patton@nemours.org|
296887|NCT01711658|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
267997|NCT03852459|Aponia Labs|Kenneth Corroon|917-574-5335|kcorroon@aponialabs.com|
267998|NCT03740919|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
267999|NCT03700970|Vanderbilt university medical center|Dr. Galen Perdikis|+1 (615) 936-0198|galen.perdikis@vumc.org|
268000|NCT03652454|IzmirKCU|dr.dt.mücahid faik şahin|+902323254040|m.faiksahin@hotmail.com|
268001|NCT03647488|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
268002|NCT03614923|AnaptysBio, Inc.|Clinical Project Leader|858-362-6295|info@anaptysbio.com|
268003|NCT03517540|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
268004|NCT03502187|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
268005|NCT03447262|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
268006|NCT03432819|RAND Corporation|Laura Bogart, PhD|(310) 393-0411|lbogart@rand.org|7281
273756|NCT00395135|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
273757|NCT00395161|University of Utah|Jeri Burr, MS, RN-BC, CCRC|801-587-7753|jeri.burr@hsc.utah.edu|
273758|NCT00395226|Essentia Institute of Rural Health|Brian Johnson|218-786-8856|bjohnson3@eirh.org|
268007|NCT03365791|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
268008|NCT03323749|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
273759|NCT00395291|University of Virginia|W. Kline Bolton, MD|434-924-9692|wkb5s@Virginia.edu|
273760|NCT00395304|Penn State Hershey College of Medicine|Vernon M. Chinchilli|717-531-4262|vchinchi@psu.edu|
273761|NCT00395343|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
273762|NCT00395447|BIOTRONIK, Inc|Crystal Miller, Clinical Studies Engineer|503-451-8051|crystal.miller@biotronik.com|
273763|NCT00395460|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
273764|NCT00395486|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
273765|NCT00395512|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
273766|NCT00395538|Rho, Inc|Robert James|(919) 595-6468|robert_james@rhoworld.com|
296888|NCT01711736|GlaxoSmithKline|GSK Response Center|866-435-7343||
273767|NCT00395629|Novartis Pharmaceuticals|Study Director|862-778-8300||
273768|NCT00395642|BIOTRONIK, Inc.|Katerina de Metz (Director, Clinical Studies)|800-547-0394|katerina.demetz@biotronik.com|
273769|NCT00395694|GlaxoSmithKline|GSK Response Center|866-435-7343||
273770|NCT00395733|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
273771|NCT00395746|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
273772|NCT00395850|University of Arkansas for Medical Sciences|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
273773|NCT00395863|Bracco Diagnostics Inc.|Gianpaolo Pirovano, MD, Executive Director, Head Corporate Medical Development|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
273774|NCT00395876|Genentech, Inc.|Medical Communications|800-821-8590||
273775|NCT00395967|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
273776|NCT00395993|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
273777|NCT00396006|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
282127|NCT00838435|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
296889|NCT01711853|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
296890|NCT01711866|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
296891|NCT01711879|University of Colorado School of Medicine|Rachel Gerle|720-848-2020|rachel.gerle@ucdenver.edu|
308397|NCT02576652|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
267986|NCT04380519|R-Pharm|Sergey Grishin, Head of Scientific Affairs Department|0074959567937|sa.grishin@rpharm.ru|1506
267987|NCT04362813|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
267988|NCT04231409|Boston Scientific|Roshini Jain, Sr. Director Clinical Sciences|16619494350|roshini.jain@bsci.com|
268009|NCT03322566|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
268010|NCT03322540|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
268011|NCT03240601|Shepherd Center|Dr. Edelle Field-Fote|4046034274|edelle.field-fote@shepherd.org|
268012|NCT03189719|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268013|NCT03155997|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
282128|NCT00838513|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc||clinicaltrials@alxn.com|
282129|NCT00838526|Eisai Call Center|Eisai Inc.|888-422-4743||
282130|NCT00838539|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
282131|NCT00838565|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282132|NCT00838578|KYOWA KIRIN PHARMA|Project Leader|6099191100|clinical.info@kyowa-kirin-pharma.com|
282133|NCT00838682|The Catholic University of Korea, Uijeongbu St. Mary's Hospital|Hiun-Suk Chae|82-31-820-3019|chs@catholic.ac.kr|
282134|NCT00838695|VAnderbilt University Medical Center|Dr. C. Michael Stein|615-936-3420|mike.stein@vumc.org|
282135|NCT00838903|GlaxoSmithKline|GSK Response Center|866-435-7343||
282136|NCT00838916|GlaxoSmithKline|GSK Response Center|866-435-7343||
282137|NCT00838929|Thomas Jefferson University|Wenyin Shi, MD, PhD|215-955-4111|Wenyin.Shi.@jefferson.edu|
282138|NCT00839072|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
282139|NCT00839098|Human Engineering Reserach Laboratories|Clinical Coordinator|412-822-3700|annmarie.kelleher@va.gov|
282140|NCT00839241|Astra Tech AB|Head of Clinical Research Area Health Care|+46317761000||
282141|NCT00839254|GlaxoSmithKline|GSK Response Center|866-435-7343||
282142|NCT00839306|Eisai Inc.|Eisai Medical Services|888-422-4743||
282143|NCT00839319|University of Washington|Mara Roth, MD|206-221-0519|mylang@u.washington.edu|
282144|NCT00839332|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282145|NCT00839423|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
282146|NCT00839436|NIAID|Dr. Virginia Sheikh|3014357939|sheikhv@niaid.nih.gov|
282147|NCT00839527|GlaxoSmithKline|GSK Response Center|866-435-7343||
282148|NCT00839540|Michigan State University|Dr. Gary E.Stein, Pharm.D.|517-353-5126|steing@msu.edu|
282749|NCT00871689|Masonic Cancer Center, University of Minnesota|Michael Verneris, M.D.|612-626-2961|verneris@umn.edu|
282750|NCT00871715|University of Southern California|Carolee Winstein, Principal Investigator|3234422903|winstein@usc.edu|
308398|NCT02576678|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
282751|NCT00871728|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
282752|NCT00871741|GlaxoSmithKline|GSK Response Center|866-435-7343||
282753|NCT00871780|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
282754|NCT00871819|Boston Scientific|Nitzan Mekel-Bobrov, Ph.D.|(661) 949-4537|Nitzan.Mekel-Bobrov@bsci.com|
282755|NCT00871845|Allegheny Singer Research Institute|Hossam Kandil||Hossam.KANDIL@ahn.org|
296892|NCT01711918|University of Iowa|Dr. Ron Schey|3193849756|ron-schey@uiowa.edu|
273778|NCT00396019|AstraZeneca|Dr. Regina Jakacki||regina.jakacki@astrazeneca.com|
273779|NCT00396032|Genentech, Inc.|Medical Communications|800-821-8590||
273780|NCT00396084|Case Western Reserve University, Tuberculosis Research Unit|John L. Johnson, M.D.|(216) 368-1949|jlj@case.edu|
273781|NCT00396097|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273782|NCT00396136|Biotronik, Inc.|Clinical Studies|503-451-8050|katerina.demetz@biotronik.com|
273783|NCT00396162|University of Michigan|Jeffrey E. Terrell|734 936 7633|terrelj@umich.edu|
273784|NCT00396201|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
273785|NCT00396253|Genentech, Inc.|Medical Communications|800-821-8590||
273786|NCT00396266|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
273787|NCT00396279|Amgen Inc.|Study Director|866-572-6436||
273788|NCT00396292|Luitpold Pharmaceuticals, Inc.|Marc Tokars|610-650-4200|mtokars@lpicrd.com|
268014|NCT03104400|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
273789|NCT00396318|Genentech, Inc.|Medical Communications|800-821-8590||
273790|NCT00396331|Genzyme|Medical Monitor||medinfo@genzyme.com|
273791|NCT00396383|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
273792|NCT00396409|Novartis Pharmaceuticals|Study Director|862-778-8300||
273793|NCT00396565|Janssen Pharmaceutical K.K.|Director of Clinical R&D Dept. 3|81-3-4411-5652||10118
273794|NCT00396591|sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
273795|NCT00396630|GlaxoSmithKline|GSK Response Center|866-435-7343||
273796|NCT00396656|Novartis Pharmaceuticals|Study Director|862 778-8300||
273797|NCT00396812|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
273798|NCT00396877|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi-aventis.com|
273799|NCT00396981|University of California, UCSF Medical Center|S. Claiboren Johnston, MD, PhD|415-502-7487|Clay.Johnston@ucsfmedctr.org|
273800|NCT00397020|UCSD Medical Center|Dr. David Feifel|619-543-2485|dfeifel@ucsd.edu|
273801|NCT00397033|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
273802|NCT00397046|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
273803|NCT00397150|Centre for International Health, University of Bergen, Norway|Prof Thorkild Tylleskar|+47 55588562|Thorkild.Tylleskar@cih.uib.no|
273804|NCT00397189|Neurim Pharmaceuticals|VP clinical and regulatory affairs|+972-3-6499340|Talin@neurim.com|
273805|NCT00397215|GlaxoSmithKline|GSK Response Center|866-435-7343||
273806|NCT00397462|Binghamton University, SUNY|Professor Kenneth McLeod|(607)777-5779|kmcleod@binghamton.edu|
273807|NCT00397488|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
273808|NCT00397514|University of British Columbia|Dr. Shubhayan Sanatani|6048752345|ssanatani@cw.bc.ca|7955
273809|NCT00397540|Seoul National University Hospital Boramae Medical Center|Won Kim|82 2 870 2233|wonshiri@yahoo.com|
268015|NCT03104374|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
268016|NCT03072043|Moffitt Cancer Center|David Sallman, MD|813-745-6841|David.Sallman@moffitt.org|
268017|NCT02970981|NYU Langone Health - Perlmutter Cancer Center|Jeffrey S. Weber, MD, PhD|212 731 6262|Jeffrey.Weber@nyulangone.org|
268018|NCT02946853|University of Rochester|Dr. Jonathan Steinberg|9734364155|jsteinberg@summithealth.com|
268019|NCT02905032|Mayo Clinci|Peter A. Noseworthy, M.D.|507-255-2446|Noseworthy.Peter@mayo.edu|
268020|NCT02837029|Northwestern University, Feinberg School of Medicine|Aparna Kalyan, MBBS, FRACP|312 926 4291|Aparna.kalyan@northwestern.edu|
268021|NCT02740127|UT MD Anderson Cancer Center|Bobby Bellard, Assistant Professor, Anesthesiology & PeriOper Med|(713) 794-1461|bbellard@mdanderson.org|
268022|NCT02737553|Ege University|Ali Akdemir|+905056748904|md.aliakdemir@gmail.com|
268023|NCT02737475|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
268024|NCT02703714|University of California, San Francisco|Dr. R. Katie Kelley, MD|(415) 353-9888|katie.kelley@ucsf.edu|
268025|NCT02642965|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
268026|NCT02629159|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
268027|NCT02604433|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
268028|NCT02550652|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
268029|NCT02519738|University of Michigan|Ron Hirschl|734 764-6482|rhirschl@med.umich.edu|
268030|NCT02502071|University of Colorado School of Medicine|Dr. Petter Bjornstad, Assistant Professor|7207774659|petter.bjornstad@childrenscolorado.org|
268031|NCT02420821|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
268032|NCT02412670|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
268033|NCT02410343|Teva Branded Pharmaceutical Products|Director of Clinical Trials|215-591-3000|Public_CTD@tevapharm.com|
268034|NCT02343224|Emory University|Dolly Aguilera MD|404-785-3515|Dolly.Aguilera@choa.org|
268035|NCT02339740|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
268036|NCT02291445|Maastricht University (Medical Center)|Z. Weerts||z.weerts@maastrichtuniversity.nl|
268037|NCT02248688|Dayton Interventional Radiology-Research|Mubin Syed, MD|937-215-0878|mubinsyed@aol.com|
268038|NCT02125461|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
268039|NCT02045303|Texas Health Resources Presbyterian Hospital of Dallas|Lisley Viana, Physical Therapist|214-345-4334|lisleyviana@texashealth.org|
273810|NCT00397579|University of Texas Southwestern Medical Center at Dallas|Clinical Research Office|214-648-7097|studyfinder@utsouthwestern.edu|
273811|NCT00397631|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
273812|NCT00397813|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
273813|NCT00397839|Hoffmann-La Roche|Medical Communications|800-821-8590||
273814|NCT00397878|University of Texas MD Anderson Cancer Center|Cathy Eng, MD / Professor|713-792-2828|ceng@mdanderson.org|
273815|NCT00397891|Wyeth|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273816|NCT00397904|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
273817|NCT00397930|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
273818|NCT00397943|GlaxoSmithKline|GSK Response Center|866-435-7343||
273819|NCT00397982|University of Virginia|Craig Slingluff|434 924 1730|cls8h@virginia.edu|
273820|NCT00398047|Wake Forest University Health Sciences|Ralph D'Agostino Jr., Ph.D.|113-716-3483|rdagosti@wfubmc.edu|
273821|NCT00398073|Memorial Sloan Kettering Cancer Center|Jedd Wolchok, MD, Chief Attending|+1646-888-2315|wolchokj@MSKCC.ORG|
273822|NCT00398086|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
273823|NCT00398112|Mayo Clinic|Tait Shanafelt||shanafelt.tait@mayo.edu|
273824|NCT00398138|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak, Attending|+1212-639-5518|maslakp@mskcc.org|
273825|NCT00398216|Daiichi Sankyo, Inc.|William Maxwell, Assoc. Director|732-590-5000|wmaxwell@dsi.com|
273826|NCT00398320|Stanford University School of Medicine|Pamela L Kunz, MD|650-725-8738|pkunz@stanford.edu|
273827|NCT00398398|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
273828|NCT00398411|University of Cologne|Prof. Dr. Oliver A. Cornely|+49 221 478 88794|oliver.cornely@zks-koeln.de|
273829|NCT00398476|GlaxoSmithKline|GSK Response Center|866-435-7343||
273830|NCT00398567|Puma Biotechnology, Inc|Senior Director, Clinical Operations|+1 424 248 6500|clinicaltrials@pumabiotechnology.com|
273831|NCT00398632|Stanford University Medical Center, Department of Psychiatry|Lorrin Koran, M.D., Professor of Psychiatry, Emeritus|650 498 5035|lkoran@stanford.edu|
273832|NCT00398866|Hospital for Special Surgery|Dr. Lisa Mandl|2127742754|MandlL@hss.edu|
273833|NCT00398918|Boston University|Ofra Sarid-Segal, MD|617-414-1990|ofra.segal@bmc.org|
268040|NCT02025556|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
273834|NCT00398983|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD / Associate Professor|713-745-0394|eharrison@mdanderson.org|
273835|NCT00399035|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
273836|NCT00399308|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
273837|NCT00399360|Massachusetts General Hospital|Dr. Steven Grinspoon, Principal Investigator|617-726-3890|sgrinspoon@partners.org|
273838|NCT00399490|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268041|NCT01986933|Chugai Pharmaceutical|Clinical trials information||clinical-trials@chugai-pharm.co.jp|
273839|NCT00399516|Boston Scientific|Brad Hershey, MS|(661) 949-4828|Brad.Hershey@bsci.com|
273840|NCT00399529|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Leisha Emens|412-623-3239|emensla@upmc.edu|
273841|NCT00399542|Sucampo Pharmaceuticals, Inc.|Raymond Panas, PhD|301-961-3400|info@sucampo.com|
273842|NCT00399568|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
273843|NCT00399763|Denver Health|Christian Thurstone, M.D.|303-436-6006|christian.thurstone@dhha.org|
273844|NCT00399802|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
273845|NCT00399880|Vanderbilt University Medical Center|Kathryn Goggins, Research Coordinator|6159364819|Kathryn.m.goggins@vanderbilt.edu|
296893|NCT01711983|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
273846|NCT00399893|Duke University Medical Center|Michael Freemark, MD|919-684-5091|andrea.haqq@albertahealthservices.ca|
273847|NCT00400153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257 Option 4|clintriage.rdg@boehringer-ingelheim.com|
273848|NCT00400179|Taiho Pharma USA, Inc.|Fabio Benedetti, MD, Chief Medical Officer|609-750-5300|benedetti@taihopui.com|
273849|NCT00400205|Emory University Winship Cancer Institute|Nabil Saba, MD|1-888-946-7447|nfsaba@emory.edu|
273850|NCT00400400|Novartis Pharmaceuticals|Study Director|862-778-8300||
273851|NCT00400439|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
273852|NCT00400517|Cleveland Clinic|Dr. Jorge Garcia|2164447774|Garciaj4@ccf.org|
296894|NCT01712009|Amgen Inc.|Study Director|866-572-6436||
268042|NCT01986075|New York State Psychiatric Institute|Kenneth Carpenter, PhD|646-774-8181|kenneth.carpenter@nyspi.columbia.edu|
268043|NCT01841333|University of Colorado|Dr. Daniel Pollyea|720-848-8084|DANIEL.POLLYEA@cuanschutz.edu|
268044|NCT01835145|Alliance for Clinical Trials in Oncology|Jason J. Luke, M.D.||jluke@medicine.bsd.uchicago.edu|
268045|NCT01802788|Abbott|Angelic Roach, Clinical Program Director|+16517563379|angelic.roach@abbott.com|
268046|NCT01701674|H. Lee Moffitt Cancer Center and Research Institute|Dr. Amod Sarnaik|813-745-8581|amod.sarnaik@moffitt.org|
268047|NCT01597388|AstraZeneca|Julie Charlton|+ 01625-582828|ClinicalTrialTransparancy@astrazeneca.com|
268048|NCT01563107|Vanderbilt University Medical Center|Alfredo Gamboa MD|6158751003|alfredo.gamboa@vumc.org|
268049|NCT01320072|Montefiore Medical Center|Dr. Elina Jerschow, attending physician|9173625291|ejerscho@montefiore.org|
268050|NCT01194570|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
268051|NCT01146652|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
268052|NCT01116648|Dana-Farber Cancer Institute|Dr. Joyce Liu|617-632-5269|joyce_liu@dfci.harvard.edu|
268053|NCT01064648|SWOG Statistics & Data Management Center|SWOG statistician|2066674263|jmiao@fredhutch.org|
273853|NCT00400569|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
273854|NCT00400634|Ceregene, Inc.|Raymond T. Bartus, Executive Vice President and Cheif Scientific Officer|858-458-8823|rtbartus@ceregene.com|
296895|NCT01712061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273855|NCT00400686|Cleveland Clinic|Beth Faiman, MSN,CNP, AOCN|216-445-3738|faimanb@ccf.org|
273856|NCT00400712|Queen's University|Brenda Brouwer|613-533-6079|brouwerb@queensu.ca|
273857|NCT00400764|Hoffman-LaRoche|Medical Communications|800-821-8590||
273858|NCT00400803|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
273859|NCT00400829|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
273860|NCT00400881|Texas Tech University|Juan Figueroa-Casas|915 5456626|juan.figueroa@ttuhsc.edu|235
273861|NCT00400946|Dana-Farber Cancer Institute|Lewis B. Silverman, MD|617.632.6191|Lewis_Silverman@dfci.harvard.edu|
296896|NCT01712074|Pfizer|Pfizer|1-8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
273862|NCT00400985|Medtronic BRC, The Netherlands, Maastricht|Director CRDM|+31 43 3566||566
273863|NCT00401102|Iona College|Dr. Colleen Jacobsonn|646-207-3563|cjacobson@iona.edu|
273864|NCT00401193|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
273865|NCT00401245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273866|NCT00401258|McLean Hospital|Brian Brennan, M.D.|617-855-2911|bbrennan@partners.org|
273867|NCT00401375|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
273868|NCT00401401|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
273869|NCT00401414|Brigham and Women's Hospital|Mark A. Creager|617-732-5267|mcreager@partners.org|
273870|NCT00401518|Globus Medical|Director of Clinical Affairs|610-930-1800|jmyer@globusmedical.com|
273871|NCT00401531|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
273872|NCT00401544|Amgen Inc.|Study Director|866-572-6436||
273873|NCT00401622|LifeScan Scotland|Mike Grady|(44) 01463 721889|mgrady@its.jnj.com|
273874|NCT00401726|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
273875|NCT00401752|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
273876|NCT00401778|Emory University|Suresh S. Ramalingam, MD|404-778-5378|ssramal@emory.edu|
273877|NCT00401817|Weill Cornell Medicine|John Leonard, MD|646.962.2064|amr2017@med.cornell.edu|
282149|NCT00839800|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
282150|NCT00839852|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
282151|NCT00839917|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282152|NCT00839956|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
282153|NCT00839982|FCHRC|Elihu Estey, MD, Director of AML Program|206-288-7176|eestey@seattlecca.org|
282154|NCT00840034|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
268054|NCT01064479|UT MD Anderson Cancer Center|Dr. Xiuning Le, MD, Assistant Professor, Thoracic-Head & Neck Med Onc|(713) 792-6980|xle1@mdanderson.org|
296897|NCT01712178|AbbVie|Global Medical Services|800-633-9110||
268055|NCT01042522|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
268056|NCT00944528|Assistant Research Practice Manager|Jennifer Mewshaw, MS RN|(919) 668-5211|Jennifer.Mewshaw@duke.edu|
268057|NCT00941915|Assistant Research Practice Manager|Joan Cahill, BSN RN OCN CCRP|(919) 668-5211|joan.cahill@duke.edu|
268058|NCT00826462|University of Oslo|Professor Morten Lindbaek|+47-22850646|morten.lindbak@medisin.uio.no|
268059|NCT00710970|Baylor College of Medicine|Seth P. Lerner, M.D., F. A. C. S.|713-798-6841|slerner@bcm.edu|
268060|NCT00685919|Vanderbilt University Medical Center|Alfredo Gamboa, MD|615-875-1003|alfredo.gamboa@vumc.org|
282155|NCT00840060|Lamar University|Monica Harn|409-880-8174|monica.harn@lamar.edu|
282156|NCT00840086|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
282157|NCT00840294|University of Chicago|Scott Eggener|(773) 702-5195|seggener@surgery.bsd.uchicago.edu|
282158|NCT00840307|UT Southwestern Medical Center|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
282159|NCT00840450|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
282160|NCT00840463|UT Southwestern|Kelly Chin|214-645-1825|kelly.chin@utsouthwestern.edu|
282161|NCT00840658|University of California, San Diego|Steffanie Strathdee, PhD|(858) 822-1952|sstrathdee@ucsd.edu|
282162|NCT00840749|Accuray Inc|study admin|4087164608|ccheung@accuray.com|
282163|NCT00840970|Intersect ENT|Chris Lewis, VP Clinical Affairs|423-598-6681|clewis@intersectent.com|
282164|NCT00840996|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
282165|NCT00841087|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
282166|NCT00841100|University of Miami|Judy Schaechter|305-243-3993|JSchaech@med.miami.edu|
282167|NCT00841204|The University of Arizona|H-H. Sherry Chow, Ph.D.|520-626-3358|schow@azcc.arizona.edu|
282168|NCT00841269|University of Utah|Dr. Douglas Kondo|(801) 587-1549|doug.kondo@hsc.utah.edu|
282169|NCT00841321|Portland VA Medical Center Multiple Sclerosis Center of Excellence|Dennis Bourdette, MD|503-220-8262|dennis.bourdette@va.gov|54594
282170|NCT00841412|Tennessee Valley Healthcare System, GRECC and Vanderbilt University, School of Medicine, Division of Geriatrics, Center for Quality Aging|Sandra F. Simmons, PhD, Associate Professor of Medicine|615-343-6729|Sandra.Simmons@Vanderbilt.edu|
282171|NCT00841555|The Ohio State University Comprehensive Cancer Center|Mario Ammirati, MD|614-293-1970|Mario.Ammirati@osumc.edu|
282172|NCT00841568|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
282173|NCT00841672|Novartis Pharmaceuticals|Study Director|862-778-8300||
296898|NCT01712204|TWi Biotechnology, Inc.|Medical Director|+886-2-26573350|Carl.Brown@twipharma.com|368
296899|NCT01712230|University of Colorado Anschutz Medical Campus|Wendy Kohrt, PhD|303-724-1913|Wendy.Kohrt@CUAnschutz.edu|
282174|NCT00841763|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
273878|NCT00401830|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
273879|NCT00401843|Janssen R&D UK|Project Physician||ClinicalTrialDisclosure@its.jnj.com|
273880|NCT00401882|Beaumont|David Haines, MD|248-898-4198|david.haines@beaumont.edu|
273881|NCT00401960|Weill Medical College|K Rhee|6469626224|kyr9001@med.cornell.edu|
273882|NCT00401973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273883|NCT00401986|Boston Scientific Corp.|G Mark Grubb, RN, CCRA|(412) 716-0717|grubbm@bsci.com|
273884|NCT00402025|Amgen, Inc.|Study Director|866-572-6436||
273885|NCT00402051|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
273886|NCT00402103|Novartis Pharmaceuticals|Study Director|862-778-8300||
273887|NCT00402116|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273888|NCT00402168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
296900|NCT01712256|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
273889|NCT00402194|Indiana University|Dr. Kieren Mather|317-278-7826|kmather@iu.edu|
296901|NCT01712334|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
273890|NCT00402233|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
273891|NCT00402246|Medtronic, Inc|CONNECT Clinical Trial Specialist||medtronicCRMtrials@medtronic.com|
273892|NCT00402285|University of California, San Francisco|Peter Carroll, MD|415-353-7098|pcarroll@urology.ucsf.edu|
273893|NCT00402298|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
273894|NCT00402324|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
273895|NCT00402337|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
273896|NCT00402363|GlaxoSmithKline|GSK Response Center|866-435-7343||
273897|NCT00402597|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|VP FRANCHISE MED LDR|1 908 927 7767||
273898|NCT00402649|University of Maryland Center for Vaccine Development|Ina Stephens, MD|410-706-1123|istephen@medicine.umaryland.edu|
273899|NCT00402688|Ortho-McNeil Janssen Scientific Affairs, LLC|Therapeutic Area Lead, Anti-Infective Franchise|908-927-5220||
273900|NCT00402714|Yale University School of Medicine|Francine Foss MD|2037375312|francine.foss@yale.edu|
273901|NCT00402727|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
296902|NCT01712360|Merz North America, Inc.|Ashlee Duncan|984-222-6040|Ashlee.Duncan@merz.com|
273902|NCT00402740|Abbott Vascular|Ellen Travis, MS, NFP|408 845-1512|Ellen.Travis@av.abbott.com|
273903|NCT00402779|UT MD Anderson Cancer Center|Dr. John V. Heymach, PHD/Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
273904|NCT00402831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
273905|NCT00402896|The University of Texas (UT) MD Anderson Cancer Center|Carlos A. Jimenez, MD/Professor, Pulmonary Medicine||CR_Study_Registration@mdanderson.org|
273906|NCT00402987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
273907|NCT00403117|New York State Psychiatric Institute|Margaret Haney, PhD|646-774-6153|mh235@cumc.columbia.edu|
282175|NCT00841776|GlaxoSmithKline|GSK Response Center|866-435-7343||
268061|NCT00344487|University of Maryland Institute of Human Virology|Charles E. Davis, Jr. MD|410-706-1684|cdavis@ihv.umaryland.edu|
268062|NCT00281658|GlaxoSmithKline|GSK Response Center|866-435-7343||
268063|NCT04368910|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
268064|NCT04365985|William Beaumont Hospitals|Matthew Sims, MD|248 551-0027|matthew.sims@beaumont.org|
268065|NCT04034355|Egetis Therapeutics AB|Kristina Sjoblom Nygren|+46 732344698|kristina.sjoblom@egetis.com|
268066|NCT03781726|University of Pennsylvania|Peter Reese|215-573-8070|Peter.Reese@pennmedicine.upenn.edu|
268067|NCT03721276|Yale University|Dr. John Pachankis|6463444060|john.pachankis@yale.edu|
268068|NCT03700658|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
268069|NCT03637491|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268070|NCT03610334|Inflectis Bioscience|Dr Anne Visbecq (Chief Medical Officer)|0630632020|annevisbecq@inflectisbioscience.com|33
268071|NCT03584464|Medtronic, plc|Alissa Anderson, Clinical Study Manager|7075912434|alissa.anderson@medtronic.com|
268072|NCT03334539|Hanall Biopharma|Project Manager|82-222041763|parksm@hanall.co.kr|
296903|NCT01712399|MedImmune, LLC.|Marius Albulescu, MD|301-398-0000|clinicaltrialenquiries@medimmune.com|
268073|NCT03311854|Sobi AG|Veronica Asnaghi, MD|+41 61 201 13 20|veronica.asnaghi@sobi.com|
268074|NCT03269344|Henry Ford Cancer Institute|Dr. Andrew Cook|3135568400|acook11@hfhs.org|
268075|NCT03079284|Maine Medical Center|Dr. Alexa Craig|207-396-7337|craiga@mmc.org|
268076|NCT03076775|University of North Carolina at Chapel Hill|Ashley Battarbee, MD, MSCR|205-975-2361|anbattarbee@uabmc.edu|
268077|NCT02933944|Targovax|Chief Medical Officer|+ 47 21398810|contact@targovax.com|
268078|NCT02921997|Vanderbilt Vaccine Research Program|C. Buddy Creech, MD, MPH|615-343-0332|buddy.creech@vanderbilt.edu|
268079|NCT02833935|McGill University|Shane Sweet|514-398-4184|shane.sweet@mcgill.ca|09903
268080|NCT02660827|Medtronic Minimed|Vivian Chen, Statistician|8185763309|vivian.chen@medtronic.com|
268081|NCT02627963|AVEO Pharmaceuticals, Inc.|AVEO Clinical Trial Office|857-400-0101|Clinical@aveooncology.com|
268082|NCT02581930|University of North Carolina at Chapel Hill|Dr. Stergios Moschos|919-843-7713|stergios_moschos@med.unc.edu|
296904|NCT01712438|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
268083|NCT02496676|National Institute of Allergy and Infectious Diseases|Ravell Aumaitre, Juan|+1 301 761 6669|juan.ravell@nih.gov|
268084|NCT02425644|Actelion Pharmaceuticals Ltd (a Janssen Pharmaceutical Company of Johnson & Johnson)|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
296905|NCT01712516|Novartis Pharmaceuticals|Study Director|862-778-8300||
273908|NCT00403130|Stanford University Medical Center|George Albert Fisher, MD, PhD|650-725-9057|georgeaf@stanford.edu|
273909|NCT00403234|Purdue Pharma L.P.|Clinical Leader, Director of Clinical Research|800-733-1333||
273910|NCT00403260|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
273911|NCT00403273|minneapolis VAMC|jasvinder singh|205-504-9559||
273912|NCT00403390|Children's Hospital Boston|Jeremi Carswell, MD|617-355-7476|Jeremi.Carswell@childrens.harvard.edu|
268085|NCT02395614|Vanderbilt university medical center|Dr. Kent K. Higdon|615-936-0160|kent.hidgon@vumc.org|
273913|NCT00403403|Genentech, Inc.|Medical Communications|800-821-8590||
273914|NCT00403455|Department of Veterans Affairs|Dr. Zhewu Wang|(843) 789-7949|Zhewu.Wang@va.gov|
273915|NCT00403481|Daiichi Sankyo|John J. Raia, R.Ph, Pharm. D.|1-877-437-7763|druginfo@dsus.com|
273916|NCT00403494|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
296906|NCT01712685|National Cancer Institute|Dr. Adam Metwalli|301-435-6237|metwallia@mail.nih.gov|
273917|NCT00403546|Massachusetts General Hospital|Donald C. Goff, MD||Donald.Goff@nyumc.org|
273918|NCT00403585|GlaxoSmithKline|GSK Response Center|866-435-7343||
273919|NCT00403754|Novartis Pharmaceuticals|Study Director|862 778-8300||
273920|NCT00403767|Johnson & Johnson Pharmaceutical Research & Development L.L.C.|Head of Development, CV & UROL|1 908-927-7767||
273921|NCT00403845|Novartis Pharmaceuticals|Study Director|862 778-8300||
273922|NCT00404066|Stanford University Medical Center|George Albert Fisher, MD, PhD|650-725-9057|georgeaf@stanford.edu|
273923|NCT00404079|Oslo University Hospital Ullevaal|Project Manager: Philip Wilkens|004723016140|philip.wilkens@medisin.uio.no|
273924|NCT00404092|University of Cologne|Oliver A. Cornely|+49 221 478 6494|Oliver.Cornely@zks-koeln.de|
273925|NCT00404235|Mayo Clinic|Svetomir N. Markovic, MD, Ph.D|(507) 284-1370|markovic.svetomir@mayo.edu|
273926|NCT00404248|Adult Brain Tumor Consortium Central Office - Johns Hopkins|Director of Adult Brain Tumor Consortum|410-955-3657|jfisher@jhmi.edu|
273927|NCT00404352|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
273928|NCT00404495|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268086|NCT02340221|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
268087|NCT02270957|Oklahoma Medical Research Foundation|Joan T. Merrill, M.D.|405 822 2336|joan-merrill@omrf.org|
268088|NCT02134925|University of Pittsburgh|Robert E. Schoen, M.D., M.P.H|412-864-7078|rschoen@pitt.edu|
268089|NCT02054104|National Cancer Institute|Dr. David Schrump|240-858-7000|schrumpd@mail.nih.gov|
268090|NCT01899144|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
268091|NCT01793610|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
268092|NCT01757665|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
268093|NCT01482195|King Faisal Specialist Hospital and Research Center|Dr. Fowzan Al Kuraya|+966 11 442 7875|falkuraya@kfshrc.edu.sa|
268094|NCT01468831|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
268095|NCT01383109|Shin Poong Pharmaceutical Co., Ltd.|Jansik Shin|+82-2-2189-3468|jsshin@shinpoong.co.kr|
268096|NCT00822120|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
273929|NCT00404547|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
273930|NCT00404651|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
273931|NCT00404755|New York State Psychiatric Institute|Jonathan W. Stewart, M.D.|646-774-8000|jws6@columbia.edu|
273932|NCT00404768|GlaxoSmithKline|GSK Response Center|866-435-7343||
273933|NCT00404820|Novartis Pharmaceuticals|Study Director|862 778-8300||
273934|NCT00404924|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
273935|NCT00405067|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
273936|NCT00405275|VA Nebraska-Western Iowa Health Care System|James R. O'Dell, MD|402-559-7288|jrodell@unmc.edu|
273937|NCT00405288|The Hospital for Sick Children|Dr. Gideon Koren||gkoren@sickkids.ca|
273938|NCT00405353|UCLA|Dr. Rhonda Voskuhl|(310) 206-4636|rvoskuhl@mednet.ucla.edu|
273939|NCT00405392|GlaxoSmithKline|GSK Response Center|866-435-7343||
273940|NCT00405509|Allegheny General Hospital|Deborah Gentile, MD|412-359-6654|dgentile@wpahs.org|
273941|NCT00405522|The Hospital for Sick Children, Toronto, Ontario, Canada|Dr. Jason Hayes|416-813-7654|jason.hayes@sickkids.ca|208963
273942|NCT00405548|Mayo Clinic|Dr. Horng H. Chen|507-538-2354|chen.horng@mayo.edu|
273943|NCT00405587|Plexxikon Inc.|Dr. Henry Hsu|510-647-4000|hhsu@plexxikon.com|
273944|NCT00405639|Mayo Clinic|Dr. Horng H. Chen|507-538-2354|chen.horng@mayo.edu|
273945|NCT00405652|Novartis Pharmaceuticals|Study Director|862-778-8300||
273946|NCT00405704|UNC Chapel Hill|Dr. Myra Carpenter, Senior Investigator|919-962-3245|myra_carpenter@unc.edu|
273947|NCT00405756|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
273948|NCT00405821|NIAID|Steven Reynolds|256-772-220-087|sjreynolds@niaid.nih.gov|
273949|NCT00405912|Mayo Clinic|Dr. Amit Sood|507-266-1944|nicotineresearch@mayo.edu|
273950|NCT00405938|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
273951|NCT00406029|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
273952|NCT00406107|Palmetto Retina Center|John A. Wells, III, M.D.|803-931-0077|jackwells@palmettoretina.com|
273953|NCT00406133|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D., Director|813-975-8690|rbeck@jaeb.org|
273954|NCT00406276|Emory University|Dr.Suresh Ramalingam, MD|404-778-5378|ssramal@emory.edu|
273955|NCT00406315|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
273956|NCT00406354|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
273957|NCT00406367|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
273958|NCT00406393|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
273959|NCT00406419|F. Hoffmann-La Roche Ltd|Medical Communications|+41 616878333|global.trial_information@roche.com|
273960|NCT00406640|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
273961|NCT00406653|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
273962|NCT00406692|Boston University|Clifford Knapp, PhD|617-414-1990|cknapp@bu.edu|
273963|NCT00406718|UT_SanAntonio UTHSCSA|Dr. Dawn Velligan|210-567-5508|velligand@uthscsa.edu|
273964|NCT00406848|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
273965|NCT00407030|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
273966|NCT00407355|Wilmer Eye Institute|Peter Campocahiro|: 410-955-5106|pcampo@jhmi.edu|
273967|NCT00407381|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
273968|NCT00407420|University of Bristol|Julian Hamilton-Shield|00441173420183|j.p.h.shield@bristol.ac.uk|
273969|NCT00407485|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
273970|NCT00407511|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
273971|NCT00407537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
273972|NCT00407550|Mayo Clinic|Julian R. Molina, M.D., Ph.D.|507-284-8318|molina.julian@mayo.edu|
273973|NCT00407563|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
273974|NCT00407654|Princess Margaret Cancer Centre|Dr. Malcolm Moore|416-945-2263|malcolm.moore@uhn.ca|
273975|NCT00407745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
273976|NCT00407758|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
273977|NCT00407797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282176|NCT00841828|Department of Medical Oncology, Hospital Universitario Virgen de la Victoria|Dr. Emilio Alba||emilioalbac@gmail.com|
282177|NCT00841906|Sleep Center of Greater Pittsburgh|Sukhdev Grover MD|412-681-7771|Info@SleepCenterOfGreaterPittsburgh.com|
282178|NCT00841971|University of Pittsburgh|Dr Nina Singh|412 360-1688|nis5@pitt.edu|
282179|NCT00842023|Western University of Health Sciences|Dr. Sheryl L. Chow|9094695379|schow@westernu.edu|
296907|NCT01712711|Tehran University of Medical Sciences|Professor Raika Jamali|00982163120000|jamalira@tums.ac.ir|411
282180|NCT00842075|UColorado|Dr. H. Peter Chase|303-724-2323|peter.chase@ucdenver.edu|
282181|NCT00842153|GlaxoSmithKline|GSK Response Center|866-435-7343||
282182|NCT00842231|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
268097|NCT00603954|CHU de Liège|Dr. Frédéric Baron|003243667201|f.baron@ulg.ac.be|
268098|NCT05087524|University of Wisconsin - Madison|Dr. Ellen Wald|(608) 263-8558|erwald@pediatrics.wisc.edu|
268099|NCT04532294|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
268100|NCT04250077|We The Village|Jane Macky, CEO|9176844267|jane@wethevillage.co|
268101|NCT04068142|UAMS|Dr Michael Wilson|501-686-7000|MPWilson@uams.edu|
268104|NCT03702439|Imperial Prostate|David Eldred-Evans|020 7594 7773|d.eldred-evans@imperial.ac.uk|
268105|NCT03687190|Changhua Christian Hospital|Chung-Min Chiu|*886-982-506-067|shongdiah@gmail.com|
268106|NCT03583931|Denver Health and Hospital Authority|Dr Fredric Pieracci|303-602-1863|Fredric.Pieracci@dhha.org|
268107|NCT03441360|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
268108|NCT03412565|Janssen Research & Development, LLC|GLOBAL MEDICAL HEAD|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268109|NCT03296553|Instituto Nacional de Cancerología|Dr. Patricia Volkow|01 55 5628 0400|pvolkowf@gmail.com|12120
282183|NCT00842244|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282184|NCT00842257|Massachusetts General Hospital|Dr. David Patrick Ryan, Chief, Hem/Onc|617-974-4545|DPRYAN@mgh.harvard.edu|
268112|NCT03194646|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
268113|NCT03148795|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268114|NCT03143218|London School of Hygiene and Tropical Medicine|Professor Brian Greenwood|+442072994707|brian.greenwood@lshtm.ac.uk|
268115|NCT03052608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268116|NCT03038438|Medtronic|Steve Ratchford, Clinical Study Manager|847-710-5440|steve.m.ratchford@medtronic.com|
268117|NCT03000569|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
268118|NCT03000530|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
268119|NCT02978781|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
268120|NCT02964507|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
268121|NCT02964078|Moffitt Cancer Center|Jad Chahoud MD, MPH|813-745-6926|Jad.Chahoud@moffitt.org|
268122|NCT02942277|Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Patrick E. Duffy|301.761.5089|patrick.duffy@nih.gov|
268123|NCT02942017|Sage Therapeutics|Medical Monitor|617-299-8380|info@sagerx.com|
268124|NCT02942004|Sage Therapeutics|Medical Monitor|617-299-8380|info@sagerx.com|
268125|NCT02924064|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
268126|NCT02916706|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk|Please e-mail|cti-inq-ml@ml.mt-pharma.co.jp|
268127|NCT02890355|SWOG Statistical Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
282185|NCT00842296|Medtronic|Stephanie Brucato, Principal Clinical Research Specialist|508-261-8000|stephanie.m.brucato@medtronic.com|
273978|NCT00407888|Medical Oncology University of Washington|Hannah Linden MD FACP|206-288-6989|hmlinden@uw.edu|
296908|NCT01712776|Cleveland Clinic|Dr. Sharon E. Mace, Director of Research, ESI|(216) 445-4598|maces@ccf.org|
273979|NCT00407966|SKCCC|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
273980|NCT00408005|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
273981|NCT00408070|UCHC|Paige Dunion|860-679-6571|pdunion@uchc.edu|
296909|NCT01712984|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
273982|NCT00408200|University of Pennsylvania|Anthony Killian|215-615-5299|tony.killian@uphs.upenn.edu|
273983|NCT00408317|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
273984|NCT00408408|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
273985|NCT00408421|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
273986|NCT00408434|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
273987|NCT00408460|University of Washington|Renato G Martins, MD|206-288-2048|rgmart@uw.edu|
273988|NCT00408499|University of California, Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
273989|NCT00408564|Medical University of South Carolina|Kate Anderton, MPH, CCRP|843-792-2708|anderton@musc.edu|
273990|NCT00408590|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-2511|galanis.evanthia@mayo.edu|
273991|NCT00408603|Sunesis Pharmaceuticals, Inc.|Dr. Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com|
296910|NCT01713036|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
273992|NCT00408629|Abbott|Global Medical Services|800-633-9110||
273993|NCT00408681|Fred Hutchinson Cancer Research Center|Paul J. Martin, M.D.|206-667-4798|pmartin@fredhutch.org|
273994|NCT00408694|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
273995|NCT00408876|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
273996|NCT00408902|Case Comprehensive Cancer Center|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
273997|NCT00408928|Thomas Jefferson University|John Wagner, MD|215-955-8874|John.Wagner@jefferson.edu|
273998|NCT00408993|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
273999|NCT00409006|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274000|NCT00409175|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274001|NCT00409188|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
274002|NCT00409240|Providence VAMC|Wen-Chih Wu, MD|401-273-7100|wen-chih.wu@va.gov|6237
274003|NCT00409292|Dana-Farber Cancer Institute|Brian Wolpin, MD|617-632-3000|brian_wolpin@dfci.harvard.edu|
274004|NCT00409409|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
274005|NCT00409539|Sunovion|Medical Director, Urology|1-866-503-6351||
274006|NCT00409565|University of Pittsburgh Cancer Institute|Michael Gibson, MD|412-692-2600|gibsonmk@upmc.edu|
274007|NCT00409578|Novartis Pharmaceuticals|Study Director|862 778-8300||
268102|NCT03961009|Kedrion S.p.A|Dr. Mirella Calcinai, MD, Clinical Research Director|+393486559761|m.calcinai@kedrion.com|
268103|NCT03875495|Genenta Science|Chief Medical Officer|+39 02 2643 3982|info-trial@genenta.com|
268129|NCT02861014|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
268130|NCT02775435|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268131|NCT02767531|UT Southwestern Medical Center|Abhimanyu Garg, MD|2146482895|abhimanyu.garg@utsouthwestern.edu|
268132|NCT02726880|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
274008|NCT00409617|Abbott|Global Medical Services|800-633-9110||
274009|NCT00409682|Abbott|Global Medical Services|800-633-9110||
268135|NCT02642042|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
268136|NCT02614547|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
268137|NCT02601209|Memorial Sloan-Kettering Cancer Center|William D. Tap, MD|646-888-4156|tapw@mskcc.org|
268138|NCT02592551|Baylor College of Medicine|Bryan Burt, MD|713-798-6376|burt@bcm.edu|
268139|NCT02583048|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
268140|NCT02574481|Boston Scientific|Nicole Kilburn|970-294-4082|Nicole.Kilburn@bsci.com|
268141|NCT02546986|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
268142|NCT02539160|University of Florida College of Medicine Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3378|dominick.angiolillo@jax.ufl.edu|
268143|NCT02507973|The R Adams Cowley Shock Trauma Center|Dr Deborah Stein|410-328-3495|dstein@umm.edu|
268144|NCT02500797|Memorial Sloan-Kettering Cancer Center|Sandra P. D'Angelo, M.D.|646-888-4159|dangelos@mskcc.org|
274010|NCT00409708|Novartis Pharmaceuticals|Study Director|862 778-8300||
268146|NCT02477696|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
268147|NCT02477618|Sage Therapeutics|Helen Colquhoun, MD - Vice President, Medical Science|(617) 229-5234|Helen@sagerx.com|
274011|NCT00409747|NIH/NIMH/PDN Branch|Dr. Susan Swedo|301-496-5323|swedos@mail.nih.gov|
274012|NCT00409786|University of Pittsburgh|Kathleen McTigue|412-692-2940|mctiguekm@upmc.edu|
274013|NCT00409825|University of Pittsburgh|Steve N. Caritis, MD|412-641-4874|scaritis@mail.magee.edu|
274014|NCT00409838|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
274015|NCT00410046|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
274016|NCT00410059|UT MD Anderson Cancer Center|Vice President Clinical Research/Clinical Research Operations|713-792-7734|CR_Study_Registration@mdanderson.org|
274017|NCT00410072|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
274018|NCT00410124|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
296911|NCT01713283|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
274019|NCT00410150|Cincinnati Children's Hospital Medical Center|Dr. Derek Wheeler|513-636-4239|derek.wheeler@cchmc.org|
274020|NCT00410163|GlaxoSmithKline|GSK Response Center|866-435-7343||
274021|NCT00410189|University of Texas (UT) MD Anderson Cancer Center|Anne S. Tsao, MD / Associate Professor, Thoracic/Head & Neck Med Oncology|713-792-6363|CR_Study_Registration@mdanderson.org|
274022|NCT00410202|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
274023|NCT00410280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296912|NCT01713348|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
274024|NCT00410384|GlaxoSmithKline|GSK Response Center|866-435-7343||
274025|NCT00410410|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
274026|NCT00410423|Thomas Jefferson University|Joanne Filicko-O'Hara, MD|215-955-8874|Joanne.Filicko@jefferson.edu|
274027|NCT00410488|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||CR_Study_Registration@mdanderson.org|
274028|NCT00410514|Astellas Pharma Global Development, Inc. (APGD)|Associate Medical Director, Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
274029|NCT00410605|Univerisity of Wisconsin Carbone Cancer Center|Dr. Natalie Callander|608-265-8690|nsc@medicine.wisc.edu|
274030|NCT00410761|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
274031|NCT00410813|SWOG Statistical Center|SWOG Breast Committee Statistician|206-667-4623||
274032|NCT00410826|University of Washington|Renato G. Martins, MD, MPH|2062882048|rgmart@uw.edu|
274033|NCT00410891|Stanford|Professor|6504984791|cta@stanford.edu|
274034|NCT00410904|Barbara Ann Karmanos Cancer Institute|Shirish M. Gadgeel, M.D.|313-576-8753|gadgeels@karmanos.org|
274035|NCT00411086|UT MD Anderson Cancer Center|Clinical Research Operations Team, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
274036|NCT00411151|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|M. Kabisch|++49 (0)6131-179922|kabisch@izks-mainz.de|
274037|NCT00411216|Emory|Susan J Herdman, PT, PhD|4047120612|sherdma@emory.edu|
274038|NCT00411398|SUNY Upstate|Thomas Schwartz|3154643166|schwartt@upstate.edu|
274039|NCT00411411|Gentofte University Hospital|Dr. Kasper Aaboe|+4522170200|kasper@dadlnet.dk|
274040|NCT00411450|Amgen Inc.|Study Director|866-572-6436||
274041|NCT00411463|University of Pittsburgh|Holly Swartz, MD|412-246-5588|swartzha@upmc.edu|
274042|NCT00411554|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
282756|NCT00871858|Institut Bergonié, Medical Oncology department|Dr. Nathalie Quenel-Tueux|05.56.33.33.33|N.Quenel-Tueux@bordeaux.unicancer.fr|
282757|NCT00871871|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
282758|NCT00871923|UT MD Anderson Cancer Center|James Welsh,MD- Associate Professor, Radiation Oncology Department|(713) 563-2447|jwelsh@mdanderson.org|
282759|NCT00871975|LABORIE|Clinical Research Administrator|905 612 1170|acampbell@laborie.com|2274
296913|NCT01713400|H. Lee Moffitt Cancer Center and Research Institute|Dr. Joseph Pidala|813-745-2556|joseph.pidala@moffitt.org|
282760|NCT00872001|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
282761|NCT00872027|University of Minnesota|Craig Weinert MD|612-624-0999|weine006@umn.edu|
282762|NCT00872079|University of Louisville|Michael Brier|502-852-0246|mbrier@louisville.edu|
274043|NCT00411619|Cincinnati Children's Hospital Medical Center|Dr. David Franz|513-636-4222|david.franz@cchmc.org|
296914|NCT01713530|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
282763|NCT00872170|New England Research Institutes|Nancy Gee|617-972-3295|ngee@neriscience.com|
282764|NCT00872339|New England Research Institutes|Felicia Trachtenberg|6179723120|ftrachtenberg@neriscience.com|
282765|NCT00872521|Jan-Cil Australia|Regional Medical Affairs Director Asia Pacific|61 427564369||
282766|NCT00872534|PLx Pharma|Ronald Zimmerman, CEO & President|1-713-842-1249|ron.zimmerman@plxpharma.com|205
282767|NCT00872599|Vanderbilt University|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
282768|NCT00872729|Horizon Orphan LLC|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
282769|NCT00872833|New England Research Institutes, Inc.|Eric Gerstenberger|6179237747|egerstenberger@neriscience.com|
282770|NCT00872898|Forest Research Institute|Ephraim Katz, PhD / Associate Director|201-427-8000|Ephraim.Katz@frx.com|8169
282771|NCT00872989|SWOG Statisticial Center|Lung Committee Statistician|206-667-4623||
282772|NCT00873015|University of Virginia Medical Center|Dr. Edward Oldfield|(434) 982-0059|EHO4U@hscmail.mcc.virginia.edu|
282773|NCT00873041|Novartis Pharmaceuticals|Study Director|862-778-8300||
296915|NCT01713582|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282774|NCT00873093|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
282775|NCT00873119|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
282776|NCT00873327|Duke University Medical Center|Brian Smith, MD. MPH|919-668-8951|brian.smith@duke.edu|
282777|NCT00873457|Duke University Medical Center|Daphne Friedman, MD|919-684-9220|daphne.friedman@dm.duke.edu|
282778|NCT00873730|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
282779|NCT00873782|University of North Carolina at Chapel HIll|William J. Powers, MD|919 966 8178|powersw@neurology.unc.edu|
282780|NCT00873821|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282781|NCT00873860|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
282782|NCT00873873|National Jewish Health|Head, Pediatric Clinical Pharmacology|303-398-1193|szeflers@njhealth.org|
282783|NCT00873912|MedImmune, LLC|Elissa Malkin, DO|301-398-0000|malkine@medimmune.com|
296916|NCT01713608|Medicines for Malaria Venture|Dr Fiona Macintyre|+41 22 799 4078|macintyref@mmv.org|
274044|NCT00411632|UT MD Anderson Cancer Center|Dr. John V Heymach, PHD/ Chair, Thoracic-Head & Neck Med Onc|713-792-6363|jheymach@mdanderson.org|
274045|NCT00411645|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
274046|NCT00411671|University of Texas (UT) MD Anderson Cancer Center|George Blumenschein, MD / Professor, Thoracic/Head & Neck Med Oncology||CR_Study_Registration@mdanderson.org|
274047|NCT00411684|HRA Pharma|Paul Carter - Chief Scientific Officer|+33 1 40 33 11 30|p.carter@hra-pharma.com|
274048|NCT00411749|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274049|NCT00411762|Yale University|Howard Hochster||Howard.Hochster@yale.edu|
274050|NCT00411788|Yale University|Abu-Khalaf, Maysa|(203) 785-4095|maysa.abu-khalaf@yale.edu|
274051|NCT00412061|Novartis Pharmaceuticals|Study Director|862-778-8300||
274052|NCT00412074|Medical University of South Carolina|Carol Wagner|18437922112|wagnercl@musc.edu|
296917|NCT01713621|Medicines for Malaria Venture|Dr. Jörg J. Möhrle|+41 22 555 03 00|moehrlej@mmv.org|
274053|NCT00412087|Medical University of South Carolina|Dr. Carol Wagner|18437922112|wagnercl@musc.edu|
274054|NCT00412113|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
274055|NCT00412217|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
274056|NCT00412243|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
274057|NCT00412360|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
274058|NCT00412373|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136|jhulihan@its.jnj.com|
274059|NCT00412425|UT MD Anderson Cancer Center|Agop Bedikian, MD Professor||asreckew@mdanderson.org|
274060|NCT00412451|ThromboGenics NV|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
274061|NCT00412464|Children's Hospital Los Angeles|Guy Young|323-361-5507|gyoung@chla.usc.edu|
274062|NCT00412516|PATH|Anthony A Marfin, Director Japanese Encephalitis Vaccine Introduction and Sustainability Project|2062853500|aamarfin@path.org|
274063|NCT00412529|Novartis Pharmaceuticals|Study Director|862-778-8300||
274064|NCT00412542|UT MD Anderson Cancer Center|Vinay Puduvalli, MD / Associate Professor|713-745-5769|kuhunter@mdanderson.org|
274065|NCT00412607|Biosense Webster, Inc.|Karen Cropper, Manager, Clinical Operations|(800) 729-9010|Kcropper@its.jnj.com|8607
274066|NCT00412737|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
274067|NCT00412750|Novartis Pharmaceuticals|Study Director|862-778-8300||
274068|NCT00412841|NYULMC|Dr. H. Michael Belmont|212-598-6518|michael.belmont@nyumc.org|
274069|NCT00412854|GlaxoSmithKline|GSK Response Center|866-435-7343||
268148|NCT02424851|Oxford University Hospitals NHS Foundation Trust|Richard Brouwer|441865226950|richard.brouwer@ouh.nhs.uk|
274070|NCT00412867|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
274071|NCT00412893|Astellas Pharma Global Development, Inc.|Medical Head Immunology, Transplant and Infectious Disease Therapeutic Area||resultsdisclosure@astellas.com|
274072|NCT00412958|ThromboGenics|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
274073|NCT00412971|Fredriksberg hospital|Gregers G. Hermann|(+45) 38163536|gregershermann@hotmail.com|
268149|NCT02285504|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
274074|NCT00412984|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
308399|NCT02576899|VISN 1 MIRECC|Megan M. Kelly, Ph.D.|781-687-3317|Megan.Kelly1@va.gov|
274075|NCT00413010|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
274076|NCT00413036|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
274077|NCT00413049|Novartis Pharmaceuticals|Study Director|862 778-8300||
282186|NCT00842309|Massachusetts General Hospital|Dr. Hilary Weingarden|617-643-6206|hilary_weingarden@mgh.harvard.edu|
282187|NCT00842335|Jubilant Clinsys Inc.|Jane Fisher, Senior Manager, Regulatory Affairs|+1 (919) 518-8786|jfisher@clinsys.com|
282188|NCT00842348|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
308400|NCT02576938|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
282189|NCT00842361|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
282190|NCT00842530|Sanofi Pasteur|Medical Director||Contact-US@sanofi.com|
282191|NCT00842543|Nemours Children's Clinic|J. Atilio Canas MD|9046973600|jcanas@nemours.org|3674
282192|NCT00842608|Regenstrief Institute, Inc.|Dr. Malaz Boustani|(317) 274-9235|mboustan@iu.edu|
282193|NCT00842712|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
282194|NCT00842751|University of Washington, Dept. of Medicine|John Amory, MD|(206) 616-1727|jamory@u.washington.edu|
282195|NCT00842764|Department of Otolaryngology/UCI|Brian J Wong, MD, PhD|7144565753|bjwong@uci.edu|
282196|NCT00842829|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
282197|NCT00842946|Department of Veterans Affairs (formerly Drexel University)|Dr. Erica England|207-239-6323|elengland02@yahoo.com|
282198|NCT00842985|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
282199|NCT00843024|GlaxoSmithKline|GSK Response Center|866-435-7343||
282200|NCT00843115|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
282201|NCT00843167|Oregon Health & Science University|Dr. Jackilen Shannon|541-706-6861|shannoja@ohsu.edu|
308401|NCT02576951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
308402|NCT02576977|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268151|NCT02257528|NRG Oncology|Linda Gedeon for Wei Deng|716-845-1169|linda.gedeon@roswellpark.org|
268153|NCT02227394|Zambon S.p.A.|Luca Raiteri, MD|+39 02 6652461|luca.raiteri@zambongroup.com|
274078|NCT00413153|Massachusetts General Hospital|Steven K. Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
274079|NCT00413166|The University of Texas (UT) MD Anderson Cancer Center|Dr. Farhad Ravandi-Kashani, Professor, Leukemia|7137927734|fravandi@mdanderson.org|
274080|NCT00413192|Eisai Ltd. Mosquito Way, Hatfield, Hertfordshire, AL 10 9SN|Gitta Irmer Associate Director, Data Quality & Standards Global Regulatory Operations|+44 (0) 845 676 1618||
274081|NCT00413218|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
274082|NCT00413231|Medtronic Vascular, Inc.|PJ Belmont, Clinical Research Specialist|707-480-3025|PJ.Belmont@Medtronic.com|
274083|NCT00413244|Icahn School of Medicine at Mount Sinai|Dr. Mary Ann McLaughlin|(212) 241-3340|maryann.mclaughlin@mountsinai.org|
274084|NCT00413283|Amgen Inc.|Study Director|866-572-6436||
274085|NCT00413335|Yale University School of Medicine|Dr. Sonia Caprio, Principal Investigator|203-785-5692|Sonia.Caprio@yale.edu|
274086|NCT00413374|Brigham and Women's Hospital|Research Coordinator|617-732-6984|arao2@partners.org|
274087|NCT00413400|Massachusetts General Hospital|Steven K. Grinspoon|617-724-9109|sgrinspoon@partners.org|
274088|NCT00413413|Novartis Pharmaceuticals|Study Director|862 778-8300||
274089|NCT00413478|University of Texas (UT) MD Anderson Cancer Center|Zeev Estrov, MD/Professor, Leukemia|713-794-1675|CR_Study_Registration@mdanderson.org|
274090|NCT00413582|Children's Mercy Hospital|Shawn D. St. Peter, MD|816-983-6479|sspeter@cmh.edu|
274091|NCT00413634|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
274092|NCT00413660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274093|NCT00413777|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
274094|NCT00413894|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
274095|NCT00413920|Novartis Pharmaceuticals|Study Director|862-778-8300||
274096|NCT00413959|Oncology Specialists SC|Sigrun Hallmeyer, MD Director of Research|847-268-8200|shallmeyer@oncmed.net|
274097|NCT00414011|U.S. Army Warfighter Refractive Surgery Research Center|Principal Investigator|571-231-1600|rose.sia@us.army.mil|
274098|NCT00414050|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1 800 672 6372|ClinicalTrialsDisclosure@merck.com|
274099|NCT00414076|UT MD Anderson Cancer Center|Coleman,Robert,M.D. / Gyn Onc & Reproductive Medicine|7137923203|RColeman@mdanderson.org|
274100|NCT00414167|Yale University School of Medicine|Dr. Marney A. White|203-785-4349|marney.white@yale.edu|
274101|NCT00414206|CoMentis, Inc.|Carl Grove|650-869-7600|cgrove@comentis.com|
274102|NCT00414271|Johns Hopkins Singapore|Prof Alex Chang|+65 68802220|alexchang@imc.jhmi.edu|
274103|NCT00414310|The University of Texas (UT) MD Anderson Cancer Center|Hagop Kantarjian, MD/Chair, Leukemia Department|713-792-7026|hkantarjian@mdanderson.org|
274104|NCT00414388|Oncology Specialists, S.C.|Sigrun Hallmeyer, MD (Director of Research); Chadi Nabhan, MD (PI)|847-268-8200|shallmeyer@oncmed.net|
274105|NCT00414440|Novartis|Study Director|+1 (862) 778-8300||
268157|NCT02073968|Montefiore Medical Center / Albert Einstein College of Medicine|Dr. Nitin Ohri|718-920-7750|nohri@montefiore.org|
268158|NCT02003924|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268159|NCT01971970|Erasmus University Medical Centre - Sophia Childrens Hospital|Professor J.C. Escher|+31107036076|j.escher@erasmusmc.nl|
268160|NCT01969409|University of Alabama at Birmingham|Steven R. Duncan, MD|(205) 934-5017|duncsr19@uab.edu|
274106|NCT00414466|Medtronic Neuromodulation|Robert Spencer, Clinical Research Manager|(763) 514-0253|robert.j.spencer@medtronic.com|
268162|NCT01853748|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
268163|NCT01665144|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
274107|NCT00414518|University of Colorado Denver|Michelle A. Barron|303-724-4939|michelle.barron@ucdenver.edu|
268165|NCT01385176|Institut Lorrain du Coeur et des Vaisseaux, CHU de Nancy, France|Principal Investigator of the Study, Prof. Faiez Zannad|+33 3 83 15 73 22|f.zannad@chu-nancy.fr|
274108|NCT00414544|Cosmeta, A Gel-Del Technolgies Company|Dr. David B. Masters|651 209-0707|dmasters@gel-del.com|
274109|NCT00414596|NEMA Research, Inc|Jospeph V Pergolizzi, MD|239-597-3564|nemaresearch@aol.com|
274110|NCT00414609|Novartis Pharmaceuticals|Study Director|862-778-8300||
274111|NCT00414635|Community Research Initiative of New England (CRINE)|Calvin Cohen, MD|617 502 1700|ccohen@crine.org|
274112|NCT00414661|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274113|NCT00414700|TiGenix n.v.|Nel Van Lommel, MSc, Manager Clinical Operations Europe, TiGenix n.v.|+3216396060|nel.vanlommel@tigenix.com|
274114|NCT00414726|Massachusetts General Hospital|Aneesh B. Singhal, MD|617 726 8459|asinghal@partners.org|
274115|NCT00414765|Novartis Pharmaceuticals|Study Director|18627788300|Novartis.email@novartis.com|
274116|NCT00414817|Kaiser Permanente, Center for Health Research|Dr. William Vollmer, Senior Investigator|503-335-6755||
274117|NCT00414908|Abbott Products|Sven Voet - Global Communication|+41 61 487 08 56|sven.voet@abbott.com|
274118|NCT00414960|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
274119|NCT00414973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274120|NCT00415051|US Army Medical Research Institute of infectious Diseases (USAMRIID)|COL Phillip R. Pittman, MD, MPH|301-619-4994|phillip.pitman@amedd.army.mil|
274121|NCT00415168|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274122|NCT00415194|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274123|NCT00415363|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
274124|NCT00415493|ASTHMA Inc.|Principal Investigator|(510) 620-5714|dennis.shusterman@cdph.ca.gov|
274125|NCT00415506|Oregon Health & Science University|Dr. Eric B. Suhler|503-494-5023|suhlere@ohsu.edu|
274126|NCT00415519|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
274127|NCT00415532|Amgen Inc.|Study Director|866-572-6436||
274128|NCT00415597|King Pharmaceuticals Research and Development, Inc.|Vice President, Clinical Development|919-653-7001||
274129|NCT00415610|University of Minnesota|Adnan I Qureshi, MD|612-624-2431|qureshai@gmail.com|
274130|NCT00415636|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274131|NCT00415857|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/792-7305|eharrison@mdanderson.org|
274132|NCT00415870|UCSD|Project Coordinator|858-534-9329|ldillon@ucsd.edu|
274133|NCT00415909|University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor, Leukemia|713-794-5783|CR_Study_Registration@mdanderson.org|
274134|NCT00416078|VAGLAHS at West Los Angeles|Dr. Theodore Hahn|3102684108|thahn@ucla.edu|
274135|NCT00416182|Vermont Children's Hospital at Fletcher Allen Health Care|Dr. Thomas Lahiri, Principal Investigator|802-847-8600|thomas.lahiri@vtmednet.org|
274136|NCT00416195|Eisai Call Center|Eisai Inc.|888-422-4743||
296918|NCT01713660|AMO|Carrie Garufis|7145663728|carrie.garufis@amo.abbott.com|
274137|NCT00416312|Johns Hopkins University, School of Medicine|George Sgouros, Ph.D.|410 614 0116|gsgouros@jhmi.edu|
274138|NCT00416455|NRG Oncology Statistics and Data Management Center|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
274139|NCT00416494|Duke University Medical Center|Brant Hamel|919-68-1861|brant.hamel@duke.edu|
274140|NCT00416520|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
274141|NCT00416572|Carnegie Mellon University|Michael F. Scheier, PhD|412-268-3791|scheier@cmu.edu|
274142|NCT00416598|The Ohio State University|William Blum, M.D.||William.Blum@osumc.edu|
274143|NCT00416624|Mayo Clinic|Charles L. Loprinzi, M.D.|507-266-6247|loprinzi.charles@mayo.edu|
274144|NCT00416715|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
274145|NCT00416793|UT MD Anderson Cancer Center|Gauri Varadhachary, MD Associate Professor|713-792-2828|mjlim@mdanderson.org|
274146|NCT00416884|Center for Hematologic Malignancies|Center for Hematologic Malignancies|503-494-1551||
274147|NCT00416949|SKCCC|George Sgouros|4106140116|gsgouros@jhmi.edu|
274148|NCT00417027|Northwestern University Feinberg School of Medicine|Robert J. McCarthy, PharmD|312-926-9015|r-mccarthy@northwestern.edu|
274149|NCT00417079|sanofi-aventis|International Clinical Development Study Director||GV-Contact-us@sanofi-aventis.com|
274150|NCT00417170|Novartis Pharmaceuticals|Study Director|862-778-8300||
274151|NCT00417274|Clevland BioLabs|Michael Kurman, MD|716-849-6810|mkurman@cbiolabs.com|
274152|NCT00417417|NHLBI/NIH|Richard O. Cannon III, MD|301-496-9895|cannonr@nih.gov|
274153|NCT00417482|New York State Psychiatric Institute|Davangere P. Devanand, MD|212-543-5612|dpd3@columbia.edu|
274154|NCT00417612|Yale University School of Medicine|Dr. Thomas O. Carpenter|203-785-6526|thomas.carpenter@yale.edu|
268167|NCT01307787|UMCG|G.Breedland||g.breedland@cvr.umcg.nl|
296919|NCT01713686|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
268168|NCT01275677|NRG Oncology|Director, Department of Regulatory Affairs|412-339-5300|langerj@nrgoncology.org|
268169|NCT01250912|University of Maryland, Baltimore|Dr. Timm-Michael Dickfeld|410-328-7801|tdickfel@som.umaryland.edu|
268170|NCT01218555|Emory University|Taofeek K. Owonikoko, MD, PhD, MSCR|404-778-1900|towonik@emory.edu|
274155|NCT00417859|University Hospital of Lausanne|Prof Brigitte Jolles|0213149629|brigitte.jolles@chuv.ch|
268172|NCT01141712|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
268173|NCT01111305|NIAID/NIH|Dr. Amy Klion|301-435-8903|aklion@niaid.nih.gov|
268174|NCT00843882|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
268175|NCT00659646|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
268176|NCT00567580|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
268177|NCT00477412|UT MD Anderson Cancer Center|Michael Wang, Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
268178|NCT00369317|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordintator@childrensoncologygroup.org|
268179|NCT00261807|U. of Maryland Medical Systems, R Adams Cowley Shock Trauma Center|Dr. Manjari Joshi|410-328-3656|mjoshi@som.umaryland.edu|
268180|NCT04964193|Pharma Metric Labs, Indonesia|Pharma Metric Labs|+62 21 4265310|nabila.sutanto@pharmametriclabs.com|
268181|NCT04826731|Ankara Sanatoryum Training and Research Hospital|Dr. Kerem Ensarioğlu|905426142727|kerem.ensarioglu@gmail.com|
268182|NCT04620798|Indiana University Bloomington School of Public Health|Molly Rosenberg, MPH, PhD|(812) 856-2509|rosenmol@indiana.edu|
268183|NCT04507321|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
268184|NCT04256629|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
268185|NCT04174521|Vanderbilt University Medical Center|Bryan Shepherd|615-343-3496|bryan.shepherd@vumc.org|
268186|NCT04014075|Daiichi Sankyo|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
268187|NCT03554850|Stryker Neurovascular|Fei Qin|+8613524821775|fei.qin@stryker.com|
268188|NCT03284853|Aerie Pharmaceuticals Inc.|Michelle Senchyna, PhD. Vice President, Clinical Development & Medical Affairs.|+1 908 947 3551|msenchyna@aeriepharma.com|
268189|NCT03032250|Wake Forest Baptist Comprehensive Cancer Center|Principal Investigator|336-713-1432|cnightin@wakehealth.edu|
268190|NCT02942966|Philips Image Guided Therapy|Nicolas Aguirre|(612) 297-6655|nicolas.aguirre@philips.com|
268191|NCT02774889|University of Wisconsin-Madison|Associate Research Specialist|6082631105|wpalmer3@wisc.edu|
268192|NCT02721069|Neurelis, Inc.|Cyndi Guerra|9736156258|cguerra@neurelis.com|
268193|NCT02625090|Cares|UCB|001-844-599-2273|UCBCares@ucb.com|
268194|NCT02367456|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
274156|NCT00417885|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274157|NCT00417963|C.R. Bard Inc.|Director of Clinical Affairs|480-303-2644|john.reviere@crbard.com|2644
274158|NCT00417976|The Ohio State University|Tanios Bekaii-Saab|614-293-9863|Tanios.saab@osumc.edu|
296920|NCT01713868|Boston University|Michael Corwin, MD||mjcorwin@bu.edu|
274159|NCT00417989|Medtronic|Scott Lee, M.D.|8185764204|scott.w.lee@medtronic.com|
274160|NCT00418015|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|3129269015|r-mccarthy@northwestern.edu|
274161|NCT00418028|GEICAM (Grupo Español de Investigación en Cancer de Mama)|The Oncologist 2015;20:1-2 http://www.theoncologist.com/ Scientific Director and CEO|+34916592870|geicam@geicam.org|
274162|NCT00418093|Dana-Farber Cancer Institute|Neil Horowitz, MD|617-732-8843|nhorowitz@partners.org|
274163|NCT00418184|Enzymotec Ltd|Yael Richter Ph.D|+972 74 7177 177|Yaelr@enzymotec.com|144
274164|NCT00418262|University of Oklahoma Health Sciences Center|Mark Wolraich, M.D.|(405) 271-5700|mark-wolraich@ouhsc.edu|45123
274165|NCT00418314|St. Jude Medical|Sr. Director Clinical Studies|(408) 522-6410|tshipman@sjm.com|
274166|NCT00418379|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
274167|NCT00418457|Cleveland Clinic|Daniel Sessler, MD|216-444-4900|sessled@ccf.org|
274168|NCT00418522|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
274169|NCT00418561|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
274170|NCT00418574|Menarini Ricerche SpA|Clinical Research Director||abagovomab@menarini-ricerche.it|
274171|NCT00418665|Amgen Inc.|Study Director|866-572-6436||
274172|NCT00418691|UT MD Anderson Cancer Center|Jeffrey Wefel, PHD/ Associate Professor, Neuropsychology|713-563-0514|jwefel@mdanderson.org|
274173|NCT00418717|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
274174|NCT00418886|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
274175|NCT00418938|Amgen Inc.|Study Director|866-572-6436||
274176|NCT00418951|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
274177|NCT00418964|The Chinese University of Hong Kong|Pauline Lui|852 2632 3072|pauline@ort.cuhk.edu.hk|
282202|NCT00843180|UCSF|Dr. Wolf Mehling, MD|415-353 9506|mehlingw@ocim.ucsf.edu|
282203|NCT00843193|GlaxoSmithKline|GSK Response Center|866-435-7343||
282204|NCT00843284|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
282205|NCT00843349|University of Miami|Dr. Myles Wolf, Associate Professor of Medicine, Chief-Division of Nephrology and Hypertension|305-243-7745|mwolf@med.miami.edu|
282206|NCT00843466|Unilever|Jamie Regan|203-381-4448|Jamie.Regan@unilever.com|
282207|NCT00843479|Laboratory of Investigation on Metabolism and Diabetes - LIMED / State University of Campinas - Brazil|Dr. Bruno Geloneze|+55 19 35218589|bgeloneze@terra.com.br|
282208|NCT00843492|GlaxoSmithKline|GSK Response Center|866-435-7343||
282209|NCT00843518|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
296921|NCT01713933|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
282210|NCT00843531|University of California, San Francisco|Emily Bergsland, MD|(415) 514-6520|Emily.Bergsland@ucsf.edu|
268195|NCT02297438|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268196|NCT02297412|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-6026|cloprinzi@mayo.edu|
268197|NCT02292758|Dana-Farber Cancer Institute|Kimmie Ng, M.D., M.P.H.|(617) 632-4150|Kimmie_Ng@dfci.harvard.edu|
268198|NCT02288247|Astellas Pharma Europe Ltd. (APEL)|Clinical Trial Disclosure|+31 (0) 71 5455 050|astellas.resultsdisclosure@astellas.com|
268199|NCT02250326|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
268200|NCT01856270|University of Washington|Dr. Jeanne Hoffman|206-221-6511|jeanneh@uw.edu|
268201|NCT01503515|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
268202|NCT01491893|Istari Oncology|Garrett Nichols, MD|(919) 245.7662|gnichols@istarioncology.com|
268203|NCT00565851|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
268204|NCT00245960|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282211|NCT00843622|Fagerström Consulting AB|Dr Karl Fagerström||karl.fagerstrom@swipnet.se|
282212|NCT00843635|University of Miami|Donald T. Weed MD FACS|305-243-9095|dweed@miami.edu|
282213|NCT00843713|University of California, San Francisco|Priscilla Hsue, MD|415-206-8257|Priscilla.Hsue@ucsf.edu|
282214|NCT00843726|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
282215|NCT00843778|UCB|UCB Clinical Trial Call Center|+1 877 822||9493
296922|NCT01713946|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
296923|NCT01713998|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
282216|NCT00843843|Rush University Medical Center|Dr. Helen Burgess|3125634785|Helen_J_Burgess@rush.edu|
282217|NCT00843856|Imperial College NHS Trust|Dr Megan Griffith|02083835272|megan.griffith1@nhs.net|
282218|NCT00844051|Children's Hospital Los Angeles|Pia Pannaraj, MD, MPH|323-361-2509|ppannaraj@chla.usc.edu|
282219|NCT00844090|Omaha VA Medical Center|Cyrus Desouza MD|402-995-5506|cyrus.desouza@va.gov|
282220|NCT00844194|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282221|NCT00844298|Asan Medical Center, University of Ulsan College of Medicine|Dr. Dae-Young Kim|82230105930|dani@amc.seoul.kr|
282222|NCT00844376|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
282223|NCT00844415|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282224|NCT00844428|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alxn.com|
282225|NCT00844519|University of California San Francisco|Dr. Priscilla Hsue|415-206-8257|phsue@medsfgh.ucsf.edu|
296924|NCT01714024|UNC School of Dentistry|Steven Offenbacher, DDS, PhD, MMSc|919-537-3205|steven_offenbacher@unc.edu|
274178|NCT00418977|Icahn School of Medicine at Mount Sinai|Katharine Loeb, PhD|212-659-8724|katharine.loeb@mssm.edu|
274179|NCT00419003|Baylor College of Medicine|Dr. Sanjay Mathew|7137985439|sjmathew@bcm.edu|
274180|NCT00419094|UCB, Inc.|Study Director|+1 877 822 9493||
274181|NCT00419120|Tengion, Inc.|Sunita Sheth, MD - Chief Medical Officer|267-960-4805|sunita.sheth@tengion.com|
296925|NCT01714063|Department of Pediatrics UAMS/COM|Ariel Perlinkski MT||berlinskiariel@uams.edu|
274182|NCT00419159|Novartis Pharmaceuticals|Study Director|862-778-8300||
274183|NCT00419263|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|(919) 859-1302||
274184|NCT00419315|Philadelphia VA Medical Center|David Oslin|215 823 5894|dave.oslin@va.gov|
274185|NCT00419341|CSL Behring|Clinical Trial Disclosure Manager|Use email contact.|clinicaltrials@cslbehring.com|
274186|NCT00419380|University of Colorado School of Medicine - Department of Pediatric Otolaryngology|Kenny H. Chan, MD|7207774776|kenny.chan@childrenscolorado.org|
274187|NCT00419393|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
274188|NCT00419445|CoMentis (formerly Athenagen)|Carl Grove|650-869-7600|cgrove@comentis.com|
274189|NCT00419562|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
274190|NCT00419666|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
274191|NCT00419744|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
274192|NCT00419757|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
274193|NCT00419770|Los Angeles Biomedical Research Institute|Brad Spellberg|310-781-3680|bspellberg@labiomed.org|
274194|NCT00419926|Novartis Pharmaceuticals|Study Director|862-778-8300||
274195|NCT00419952|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
274196|NCT00420004|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274197|NCT00420017|Purdue University|James E Tisdale PharmD|317-613-2315|hwroblew@iupui.edu|306
274198|NCT00420056|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274199|NCT00420095|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
274200|NCT00420147|University of Delaware|Todd Royer|302-831-4351|royer@udel.edu|
274201|NCT00420199|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
274202|NCT00420212|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
274203|NCT00420238|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
274204|NCT00420290|Vanderbilt University|Adriana Hung, MD||adriana.hung@vanderbilt.edu|
274205|NCT00420303|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
296926|NCT01714232|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
268205|NCT04565353|Behavior Change for Good initiative|Dr. Joseph Kay|2157466609|jskay@wharton.upenn.edu|
268206|NCT04015336|National Cancer Institute|Dr. Scott Norberg, D.O.|301-275-9668|scott.norberg@nih.gov|
268207|NCT03972813|University of Michigan|Abram Wagner|7347632330|awag@umich.edu|
268208|NCT03920280|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
268209|NCT03913091|NYU Langone Health|Uchenna O. Umeh, MD|(212) 598-6085|Uchenna.Umeh@nyulangone.org|
268210|NCT03802565|Neurana Pharmaceuticals, Inc.|Randall Kaye, MD - Chief Medical Officer|858-732-0708|rkaye@neuranapharma.com|
268211|NCT03769194|Valneva Austria GmbH|Director Clinical Strategy|+43120620|office@valneva.com|0
268212|NCT03738332|University of Pennsylvania|Dr. Jie Deng|215-573-2393|jiedeng@nursing.upenn.edu|
268214|NCT03451786|Carl Zeiss|Michael Bonilla|+1 925-557-4100|michael.bonilla@zeiss.com|
268215|NCT03416179|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268216|NCT03353922|Neurana Pharmaceuticals|Judy Caron, Chief Operating Officer|(617) 640-5043|jcaron@neuranapharma.com|
268217|NCT03322384|University of California, Davis|Analyst|9167348053|nlogihara@ucdavis.edu|
268218|NCT03243071|NYU Langoen Health|Girardin Jean-Louis, PhD|646-501-3431|Girardin.Jean-Louis@nyulangone.org|
268219|NCT03173456|Department of Emergency Medicine Albert Einstein Coll of Med|Dr. Polly Bijur|914-661-4707|polly.bijur@einsteinmed.org|
268220|NCT03101566|University of Michigan Rogel Cancer Center|Vaibhav Sahai, MBBS, MS|734-936-4991|vsahai@med.umich.edu|
268221|NCT03020160|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
268222|NCT03003520|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
268223|NCT02862457|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268224|NCT02820753|Northwestern University|Stephanie Batio|312-503-4684|stephanie.batio@northwestern.edu|
268225|NCT02733042|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
268226|NCT02668874|University of Iowa College of Dentistry|Director of Clinical Research|319-467-1398|dentistry-research@uiowa.edu|
268227|NCT02609737|Memorial Sloan Kettering Cancer Center|Dr. Lisa Bodie, MD, PhD|212-639-6650|bodeil@mskcc.org|
268228|NCT02574286|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
268229|NCT02471144|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
274206|NCT00420316|GlaxoSmithKline|GSK Response Center|866-435-7343||
274207|NCT00420342|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
274208|NCT00420381|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
274209|NCT00420407|University of Texas Health Science Center at San Antonio|Stephen Cohn, M.D.|210-567-5724|mccarthyj@uthscsa.edu|
296927|NCT01714310|University of California, Los Angeles|James J. McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
274210|NCT00420420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274211|NCT00420459|Cincinnati Childrens Hospital|Craig Erickson|5136366265|craig.erickson@cchmc.org|
274212|NCT00420511|Leadership Sinai Centre for Diabetes, Mount Sinai Hospital|Dr. Ravi Retnakaran|416-586-4800|rretnakaran@mtsinai.on.ca|3941
274213|NCT00420628|Bausch & Lomb|Timothy Comstock OD|(585) 338-6631|tcomstock@bausch.com|
274214|NCT00420641|GlaxoSmithKline|GSK Response Center|866-435-7343||
274215|NCT00420745|GlaxoSmithKline|GSK Response Center|866-435-7343||
274216|NCT00420771|NYSPI|John J. Mariani, MD|212-543-5987|jm2330@columbia.edu|
274217|NCT00420784|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
274218|NCT00420849|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
274219|NCT00420927|Abbott|Global Medical Services|1-800-633-9110||
274220|NCT00420992|King Pharmaceuticals Research and Development, Inc.|Vice President, Clinical Development|919-653-7001||
274221|NCT00421148|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268230|NCT02440464|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
274222|NCT00421174|The EMMES Corporation|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|221
274223|NCT00421304|AstraZeneca Clinical study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
274224|NCT00421343|Hebrew SeiorLife|Sarah Berry|617-971-5355|sarahberry@hrca.harvard.edu|
274225|NCT00421408|Yale University|Dr. Karl Insogna|203-737-2871|Karl.insogna@yale.edu|
274226|NCT00421603|NYSPI|Daniel Brooks|212-740-3205|brooksd@nyspi.columbia.edu|
274227|NCT00421707|GlaxoSmithKline|GSK Response Center|866-435-7343||
308403|NCT02576990|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274228|NCT00421733|Abbott|Global Medical Services|800-633-9110||
274229|NCT00421889|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
274230|NCT00421928|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
274231|NCT00421993|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
274232|NCT00422032|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, MD / Professor|713-792-7026|eharriso@mdanderson.org|
274233|NCT00422058|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
268231|NCT02384421|Stanford University|Dr. Helen Bronte-Stewart, MD, MSE|650-723-6709|bronte-stewart-lab@stanford.edu|
268232|NCT02366728|Duke University|Mustafa Khasraw, M.D.|919-668-6688|mustafa.khasraw@duke.edu|
268233|NCT02236572|Yale Cancer Center|Lajos Pusztai, MD, DPhil|(203) 200-2328|lajos.pusztai@yale.edu|
268234|NCT02083354|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
268235|NCT01885078|Eli Lilly & Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
268236|NCT01775813|University of Colorado School of Medicine|Dr. Megan Kelsey|720-777-0991|megan.kelsey@childrenscolorado.org|
268237|NCT01694069|West Virginia Universtiy, WVCTSI|Clinical Trials Compliance Coordinator|304-293-0216|ctgovadmin@hsc.wvu.edu|
268238|NCT01446016|Houston Methodist|Dr. Jenny Chang|713-441-0681|jcchang@houstonmethodist.org|
268239|NCT01445327|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
268240|NCT01434602|National Cancer Institute|Dr. Mark R. Gilbert|240-760-6023|mark.gilbert@nih.gov|
268241|NCT01411332|University of Miami|Alan Pollack MD, PhD|305-243-4916|apollack@med.miami.edu|
268242|NCT01399918|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman|646-888-4740|Feldmand@MSKCC.ORG|
268243|NCT01377753|National Cancer Institute|Dr. Peter Pinto|240-760-6249|pintop@mail.nih.gov|
268244|NCT01147653|Duke University School of Medicine, Division of Pediatric Blood and Marrow Transplantation|Jesse Troy, PhD||cordbloodtherapyinfo@dm.duke.edu|
268245|NCT01078454|ECOG Statistical Office|Study Statistician|617-632-3012||
268246|NCT00687596|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
268247|NCT00458536|Beth Israel Deaconess Medical Center|David Avigan, MD|617-667-9920|davigan@bidmc.harvard.edu|
268248|NCT00112840|University of Miami - Sylvester Comprehensive Cancer Center|Jaime Merchan, M.D.||jmerchan2@med.miami.edu|
274234|NCT00422084|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
274235|NCT00422097|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
274236|NCT00422162|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274237|NCT00422201|HRA Pharma|Head of Clinical Research|0033140331130|s.durand@hra-pharma.com|
274238|NCT00422227|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
274239|NCT00422279|Nobel Biocare|Isabelle Arrighi, Head Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
274240|NCT00422292|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
274241|NCT00422383|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
274242|NCT00422422|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
274243|NCT00422448|Medical University of Graz - Austria|Prof. Dr. Iris Zalaudek|+436763328269|iris.zalaudek@gmail.com|
274244|NCT00422461|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274245|NCT00422513|Hoffman-LaRoche|Medical Communications|800-821-8590||
274246|NCT00422591|UT MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD|713-792-7734|CR_Study_Registration@mdanderson.org|
274247|NCT00422656|Dana-Farber Cancer Institute|Irene M. Ghobrial, MD|617-632-4198|irene_ghobrial@dfci.harvard.edu|
274248|NCT00422695|Rutgers School of Dental Medicine|Eli Eliav|973 972 7210|eliavel@sdm.rutgers.edu|
274249|NCT00422734|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
274250|NCT00422799|Dana-Farber Cancer Institute|Irene M. Ghobrial|(617) 632-4218|Irene_Ghobrial@DFCI.HARVARD.EDU|
274251|NCT00422812|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
274252|NCT00422903|GlaxoSmithKline|GSK Response Center|866-435-7343||
274253|NCT00423046|GlaxoSmithKline|GSK Response Center|866-435-7343||
274254|NCT00423085|Novartis Pharmaceuticals|Study Director|862-778-8300||
274255|NCT00423098|Novartis Pharmaceuticals|Study Director|862-778-8300||
274256|NCT00423137|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
274257|NCT00423150|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
274258|NCT00423189|Retina Consultants of Houston|David M. Brown|713-524-3434|dmbmd@houstonretina.com|
274259|NCT00423267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
274260|NCT00423293|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
274261|NCT00423319|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
282784|NCT00874029|Halt Medical, Inc|Laura Kemp, Sr. VP Clinical Affairs|408-375-1465|lkemp@haltmedical.com|
282785|NCT00874094|NY Eye & Ear Infirmary|Anthony P Sclafani, MD|212-979-4200|asclafani@nyee.edu|
296928|NCT01714323|Massachusetts General Hospital|Nancy Rigotti, MD|617-724-4709|nrigotti@partners.org|
282786|NCT00874120|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
282787|NCT00874237|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
296929|NCT01714336|Mayo Clinic|Dr. Mark Pagnano|507-284-2511|pagnano.mark@mayo.edu|
282788|NCT00874250|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
282789|NCT00874276|University of Florida|Dr. Peter Stacpoole/Principal Investigator|1-352-273-9023|pws@ufl.edu|
282790|NCT00874432|University of Wisconsin - Madison|Dr. Arjang Djamali|(608) 262-9306|axd@medicine.wisc.edu|
282791|NCT00874497|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
282792|NCT00874510|Center for Health Incentives and Behavioral Economics|Kevin Volpp, MD, PhD|215.573-0270|volpp70@exchange.upenn.edu|
282793|NCT00874549|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
282794|NCT00874614|Progenics Pharmaceuticals, Inc|Jessica D Jensen, MPH|646-975-2513|jjensen@progenics.com|
282795|NCT00874731|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282796|NCT00874770|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
282797|NCT00874822|University of Nebraska Medical Center|Jason Shiffermiller, MD, MPH|402-559-7299|jshiffermiller@unmc.edu|
282798|NCT00874848|Biothera|Jamie Lowe, Vice President, Clinical Development|651-256-4653|jlowe@biothera.com|
296930|NCT01714492|The University of Tennessee|Richard Komistek, Ph. D.|8659744159|rkomiste@utk.edu|
282799|NCT00874887|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
296931|NCT01714505|University of Virginia|Boris Kovatchev, PhD|434-924-5592|boris@virginia.edu|
296932|NCT01714544|Promius Pharma|Director Clinical Operations|609-282-1404|jfraser@drreddys.com|
296933|NCT01714609|Yale University|Dr. Garcia-Tsao|(203) 737-6063|guadalupe.garcia-tsao@yale.edu|
296934|NCT01714635|Abbott Medical Optics|Kendra Hileman, Ph.D., Director, Clinical Research & Development|714-247-8613|kendra.hileman@amo.abbott.com|
296935|NCT01714687|Acclarent, Inc|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
268249|NCT04957732|University of Florida Shands Emergency Department|Richard Petrik, MD, Clinical Assistant Professor|352-265-5911||
274262|NCT00423332|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
268251|NCT04207749|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
268252|NCT04167345|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
268253|NCT04042077|Menarini Ricerche S.p.A.|Corporate Director of Clinical Sciences|0555680|acapriati@menarini-ricerche.it|9990
268254|NCT04001803|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
268255|NCT03936699|Elira Therapeutics, Inc.|Stephanie Amlung, PhD, RN, Vice President, Clinical Affairs|513.236.6799|samlung@elira.com|
268256|NCT03925324|Medstar Health Research Institute|Megan Rowland|202-877-2959|megan.e.rowland@medstar.net|
268257|NCT03875092|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268258|NCT03814382|Massachusetts General Hospital|Jessica Gerber, DAc.|617-724-1992|jgerber2@mgh.harvard.edu|
268259|NCT03738397|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
268260|NCT03666624|University of Washington|Karen Fredriksen Goldsen|206-543-5722|fredrikk@uw.edu|
268261|NCT03649217|Moterum Technologies, Inc.|Brianne Darcy|(864) 659-3180|brie@moterumtechnologies.com|
268262|NCT03633461|Oyster Point Pharma, Inc.|Jeffery Nau|609-382-9035|jnau@oysterpointrx.com|
268263|NCT03576976|New York State Psychiatric Institute|Dr. Alice Medalia|646-774-8482|am2938@cumc.columbia.edu|
268264|NCT03569293|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
268265|NCT03564353|UT Dallas|Clinical Trial Manager|972-883-7277|Sarah.McLeod@utdallas.edu|
268266|NCT03541499|Vanderbilt Vaccine Research Program|Dr. C Buddy Creech|615-3430332|buddy.creech@vanderbilt.edu|
268267|NCT03473977|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|marc.rothenberg@cchmc.org|
268268|NCT03415022|New York State Psychiatric Institue|Dr. Franklin Schneier|646-774-8041|Franklin.Schneier@nyspi.columbia.edu|
268269|NCT03400943|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
268270|NCT03373110|Massachusetts General Hospital|Dr. Andrew Nierenberg|617-512-2641|anierenberg@mgh.harvard.edu|
268271|NCT03370133|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
268272|NCT03365102|Brown University|Richard Jones|401-444-1943|rich_jones@brown.edu|
268273|NCT03318003|University of Michigan|Louise O'Brien|734 647-9064|louiseo@med.umich.edu|
274263|NCT00423358|University of Wisconsin|Karen E Hansen, MD, MS|608-263-3457|keh@medicine.wisc.edu|
274264|NCT00423436|UT MD Anderson Cancer Center|Charles S Cleeland, PhD, Professor||asaleeba@mdanderson.org|
274265|NCT00423449|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274266|NCT00423592|Gilead Sciences, Inc.|Annemarie Vance|650-524-3829|Annemarie.Vance@gilead.com|
274267|NCT00423605|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Director Clinical Development & Medical Monitor|650-496-3777||
274268|NCT00423657|Cerexa, Inc.|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
274269|NCT00423670|Merck, Sharp and Dohme|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
274270|NCT00423683|North Shore LIJ Health System|Valerie Blake|516-562-0100|vblake@nshs.edu|
274271|NCT00423722|UT MD Anderson Cancer Center|Principal investigator: Eduardo Bruera, MD / Professor|713-563-4157|CR_Study_Registration@mdanderson.org|
268274|NCT03309072|University of Texas at Dallas|Dr. Sven Vanneste, Principal Investigator|972-883-7277|sven.vanneste@utdallas.edu|
274272|NCT00423735|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
274273|NCT00423800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
274274|NCT00423813|Jazz Pharmaceuticals, Inc.|Grace Wang, MD, Medical Monitor & Director of Clinical Development|650-496-3777||
274275|NCT00423852|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman, Assistant Attending|+1646-422-4491|Feldmand@mskcc.org|
274276|NCT00423878|Columbia University|Dr. Scott Stroup|212-543-5676|stroups@nyspi.columbia.edu|
274277|NCT00423891|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
282226|NCT00844532|Abbott Vascular|David R Rutledge|408-845-3820|david.rutledge@av.abbott.com|
282227|NCT00844545|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc||clinicaltrials@alxn.com|
282228|NCT00844558|University of Iowa|Neil Segal|3193560737|segal-research@uiowa.edu|
282229|NCT00844597|Sarepta Therapeutics|Edward M. Kaye, MD, Interim CEO, SVP & Chief Medical Officer|617-274-4003|EKaye@Sarepta.com|
282230|NCT00844649|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
296936|NCT01714726|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
282231|NCT00844714|University of California, San Francisco|Priscilla Hsue, MD|415-206-8257|phsue@medsfgh.ucsf.edu|
282232|NCT00844753|University of Pittsburgh|Ben Handen|412-235-5452|HandenBL@upmc.edu|
282233|NCT00844805|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
282234|NCT00844831|University of Louisville|John M. Wo, MD|502-852-6991|johnwogi@gmail.com|
296937|NCT01714804|SeaSpine|Vice President, Orthobiologics Research & Development|760.216.5138|frank.vizesi@seaspine.com|
282235|NCT00844844|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals Inc.||clinicaltrials@alxn.com|
282236|NCT00844857|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282237|NCT00844883|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
268275|NCT03216499|Adult Brain Tumor Consortium (ABTC)|Roy Strowd, MD|410-955-8837|jfisher@jhmi.edu|
282238|NCT00844896|Massachusetts General Hospital|Frederick J. Stoddard Jr., M.D.,|(617) 371-4762|fstoddard@partners.org|
282239|NCT00845000|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282240|NCT00845039|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
282241|NCT00845065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
282242|NCT00845130|Univeristy of Kansas Medical Center|In-Young Choi, Ph.D.|913-588-0174|ichoi@kumc.edu|
282243|NCT00845182|UTexas_SanAntonio|Devjit Tripathy|2105676691|tripathy@uthscsa.edu|
282244|NCT00845195|Alcon Research Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
282245|NCT00845429|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
282246|NCT00845481|LEO Pharma|Torsten Skov, Senior Medical Advisor|+45 20 73 62 94|torsten.skov@leo-pharma.com|
282247|NCT00845507|University of Cincinnati|Dr. DelBello|513-558-2989|Melissa.Delbello@uc.edu|
282248|NCT00845520|RxSight, Inc.|Maureen O'Connell Vice President, Regulator and Clinical Affairs|978-207-12415|moconnell@rxsight.com|
282800|NCT00875017|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
282801|NCT00875056|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282802|NCT00875212|Federal University of Paraiba|Fabio Correia Sampaio (research leader)|+55 83 3216 7795|fabios@ccs.ufpb.br|
282803|NCT00875277|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
282804|NCT00875329|Tampa VAMC|Rodney Vanderploeg, Ph.D|(813) 972-2000|Rodney.Vanderploeg@va.gov|6728
282805|NCT00875342|Weil Cornell Medical College|Program director|212 821 0783|jdifede@med.cornell.edu|
282806|NCT00875420|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
282807|NCT00875433|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282808|NCT00875485|GlaxoSmithKline|GSK Response Center|866-435-7343||
282809|NCT00875524|Sanofi Pasteur SA|Medical Director||Contact-US@sanofi.com|
282810|NCT00875550|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
282811|NCT00875563|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science & Biostatistics|765-463-7537|SSnyder@medinst.com|
282812|NCT00875589|Daroff-Dell'Osso Ocular Motility Laboratory|Jonathan Jacobs, PhD|216-791-3800|jxj24@case.edu|2947
296938|NCT01714921|Medtronic GmbH|ProSA clinical research contact|004921598149|rs.dusclinicalcooperation@medtronic.com|0
268276|NCT03138590|University of Texas at Dallas|Dr. Sven Vanneste, Principal Investigator|972-883-7277|sven.vanneste@utdallas.edu|
268277|NCT03132753|Chestnut Health's Lighthouse Institute; Chicago, Illinois|Dennis Watson|224-534-0114|dpwatson@chestnut.org|
268278|NCT03085680|University of Florida|Dr. Robert Mankowski|+1 (352) 294-5055|r.mankowski@ufl.edu|
268279|NCT03084471|AstraZeneca Clinical study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
274278|NCT00423917|Mayo Clinic|Winston Tan MD|507/284-1159|tan.winston@mayo.edu|
274279|NCT00423930|Memorial Sloan Kettering Cancer Center|David Pfister, MD|646-888-4232|pfisterd@mskcc.org|
274280|NCT00423943|University of California, Los Angeles|Michael Minzenberg|310-825-7642|MMinzenberg@mednet.ucla.edu|
274281|NCT00424021|Gilead Sciences, Inc.|Karen L Miller, PhD|650-524-3892|KarenL.Miller@gilead.com|
274282|NCT00424047|Celgene Corporation|Anne McClain, Senior Manager|1-866-260-1599|ClinicalTrialDisclosure@celgene.com|
274283|NCT00424177|GlaxoSmithKline|GSK Response Center|866-435-7343||
274284|NCT00424190|Cerexa|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
274285|NCT00424255|GlaxoSmithKline|GSK Response Center|866-435-7343||
274286|NCT00424268|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
274287|NCT00424294|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274288|NCT00424346|Novartis Pharmaceuticals|Study Director|862-778-8300||
274289|NCT00424372|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274290|NCT00424385|Oncology Specialists, SC|Sigrun Hallmeyer, MD Director of Research; Chadi Nabhan, MD FACP (PI)|847-268-8200|shallmeyer@oncmed.net|
274291|NCT00424398|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
274292|NCT00424463|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
274293|NCT00424476|GlaxoSmithKline|GSK Response Center|866-435-7343||
274294|NCT00424489|Northwestern University|Dr. Richard Burt|312-695-4960|rburt@northwestern.edu|
274295|NCT00424502|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
274296|NCT00424515|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
274297|NCT00424528|Sepracor Inc|Respiratory Medical Affairs Director|866-503-6351||
296939|NCT01714947|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
268280|NCT03067077|Stanford University School of Medcine|Edward E. Manche|6507255765|edward.manche@stanford.edu|
274298|NCT00424554|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
274299|NCT00424593|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274300|NCT00424619|McMaster University|Dr. Alexandra Papaioannou|905-521-2100|papaioannou@hhsc.ca|77715
274301|NCT00424632|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
274302|NCT00424749|Mayo Clinic|Dr. Fernando C. Fervenza||fervenza.fernando@mayo.edu|
274303|NCT00424762|University of Texas Southwestern Medical Center at Dallas|Dr. Darren K. McGuire|214 645 7520|darren.mcguire@utsouthwestern.edu|
274304|NCT00424775|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
274305|NCT00424827|Universiy of MA Medical School|Bilal Piperdi, MD|508-426-0442|UMMScommunications@umassmed.edu|
274306|NCT00424840|University of Massachusetts Medical School|Dr. William Walsh|508-334-5539|William.Walsh@umassmemorial.org|
274307|NCT00425061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274308|NCT00425113|National Institute of Allergy and Infectious Diseases|Ray Chen|301-443-5816|ray.chen@nih.gov|
296940|NCT01715064|University of Guelph-Humber|Dr. Daniel Santa Mina|416-798-1331|daniel.santamina@guelphhumber.ca|6065
274309|NCT00425269|University of Oslo|Victoria Telle Hjellset|0047 22 85 06 12|t.v.t.hjellset@medisin.uio.no|
274310|NCT00425308|Novartis Pharmaceuticals|Study Director|862-778-8300||
274311|NCT00425373|Novartis Pharmaceuticals|Study Director|862 778-8300||
274312|NCT00425386|OHSU Knight Cancer Institute|Dr. Christopher Ryan|5034946197|ryanc@ohsu.edu|
274313|NCT00425477|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|B. Douglas Smith|410-614-5068|smithdo@jhmi.edu|
274314|NCT00425503|Baylor College of Medicine|Dr. Teresa Hayes - Associate Professor|713-794-7368|thayes@bcm.edu|
268281|NCT03059446|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
274315|NCT00425555|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
274316|NCT00425607|Dana-Farber Cancer Institute|Dr. Mark Kieran|617-632-4907|mark_kieran@dfci.harvard.edu|
274317|NCT00425672|University of Washington|Principal Investigator||TrialTVG@medicine.washington.edu|
274318|NCT00425698|Saarland University Medical Centre|Prof. Dr. Danilo Fliser|(49) 6841|indfli@uks.eu|1623526
274319|NCT00425750|Vanderbilt-Ingram Cancer Center|Barbara Murphy, M.D.|615-343-4677||
274320|NCT00425802|Memorial Sloan Kettering Cancer Center|Hugo Castro-Malaspina, MD|212-639-8197|castro-h@mskcc.org|
274321|NCT00425854|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
274322|NCT00425945|Stanford University School of Medicine|Dr. Randall Stafford|650-724-2400|rstafford@stanford.edu|
274323|NCT00426127|University of Iowa|Daniel Berg, MD|319-353-7800|daniel-j-berg@uiowa.edu|
274324|NCT00426153|Mayo Clinic|Marie Hogan, MD, PhD, Assistant Prof of Medicine, College of Medicine|507-266-9364|hogan.marie@mayo.edu|
274325|NCT00426231|Johns Hopkins University|Dhananjay Vaidya|410-6142307|dvaidya1@jhmi.edu|
274326|NCT00426270|Octapharma USA|Michael Eppolito|201 604-1155|michael.eppolito@octapharma.com|
274327|NCT00426283|Cincinnati Children's Hospital Medical Center|Marc E Rothenberg|513-636-7177|rothenberg@cchmc.org|
274328|NCT00426361|GlaxoSmithKline|GSK Response Center|866-435-7343||
274329|NCT00426517|National Institute of Allergy and Infectious Diseases|Kang, Elizabeth|+1 301 402 7567|ekang@niaid.nih.gov|
274330|NCT00426556|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
274331|NCT00426660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274332|NCT00426751|GlaxoSmithKline|GSK Response Center|866-435-7343||
282249|NCT00845650|Emergent Product Development Gaithersburg, Inc.|Study Director||clinicalstudies@ebsi.com|
274333|NCT00426764|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
274334|NCT00426842|James J Peters VAMC|Dr. Jill M. Wecht|718-584-9000|jm.wecht@va.gov|3122
274335|NCT00426855|Kantonsspital Aarau|Dr. Peter Moosmann|+41 62 838 60 51|peter.moosmann@ksa.ch|
274336|NCT00427011|Eisai Call Center|Eisai Inc.|888-422-4743||
274337|NCT00427037|Emory University School of Medicine|Vin Tangpricha|404-727-7254|vin.tangpricha@emory.edu|
274338|NCT00427193|Duke University Medical Center|William E. Kraus, Director of Clinical Research, Duke Center for Living|919-681-6733|william.kraus@duke.edu|
274339|NCT00427297|University of Washington|Grace John-Stewart|206 5434278|gjohn@uw.edu|
274340|NCT00427336|UT MD Anderson Cancer Center|Paolo Anderlini, MD / Professor||mvpacheco@mdanderson.org|
274341|NCT00427349|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
274342|NCT00427557|MD Anderson Cancer Center|Dr. Partow Kebriaei|713-563-5174|celsaenz@mdanderson.org|
274343|NCT00427635|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
274344|NCT00427648|NorthShore Health|Frank F. Tu|8475702521|ftu@northshore.org|
274345|NCT00427661|University of Pittsburgh-Department of Pediatrics|Nancy Harter-Administrative Director of Research|412-692-7487|harterne@upmc.edu|
274346|NCT00427700|Hospital de Clínicas de Porto Alege|Dr. Ricardo Francalacci Savaris|51 33598405|rsavaris@hcpa.ufrgs.br|
274347|NCT00427765|UT MD Anderson Cancer Center|Partow Kebriaei, MD/Associate Professor||celsaenz@mdanderson.org|
274348|NCT00427778|Queen's University|Dr Marie-Andree Harvey|613-548-6115|harveym@queensu.ca|
274349|NCT00427791|UT MD Anderson Cancer Center|Dr. Partow Kebriaei, Associate Professor|713-792-2648|ytdinh@mdanderson.org|
274350|NCT00427804|Emory University|Vin Tangpricha, M.D., Ph.D.|404-727-7254|vin.tangpricha@emory.edu|
274351|NCT00427895|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296941|NCT01715129|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
274352|NCT00427908|GlaxoSmithKline|GSK Response Center|866-435-7343||
274353|NCT00427921|Abbott Laboratories|Medical Information Specialist|Phone: (800) 633-9110||
296942|NCT01715207|SamsungMC|Prof Duk-Kyung Kim|01099333413|dukkyung.kim@samsung.com|
274354|NCT00427934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
274355|NCT00427960|Astrazeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
274356|NCT00427973|Massachusetts General Hospital Cancer Center|Andrew X. Zhu, MD|617-643-3415|azhu@partners.org|
274357|NCT00427999|Novartis Pharmaceuticals|Study Director|862-778-8300||
274358|NCT00428077|University of Utah Huntsman Cancer Institute|Michael Deininger, MD, PhD|801-585-3229|michael.deininger@hci.utah.edu|
274359|NCT00428090|GlaxoSmithKline|GSK Response Center|866-435-7343||
274360|NCT00428116|University of Washington|Grace John-Stewart|206 543 4278|gjohn@uw.edu|
268282|NCT03035409|UT MD Anderson Cancer Center|Dr. Sriram Yennu, Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
268283|NCT03019575|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268284|NCT03011034|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268285|NCT02980666|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
268286|NCT02962102|Brigham and Women's Hospital|Dr. David Leaf|617-525-7612|deleaf@bwh.harvard.edu|
268287|NCT02921971|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
268288|NCT02853331|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268289|NCT02847637|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
268290|NCT02841644|Atrium Health|Vice Chair of Research|7043552000|Rachel.Seymour@atriumhealth.org|
268291|NCT02781584|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
268292|NCT02749045|University of Pittsburgh Medical Center|Prem Soman, MD, PhD|412 647 3435|somanp@upmc.edu|
268293|NCT02667587|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
268294|NCT02659605|The University of Texas Health Science Center at Houston|Dr. Pamela D. Berens|(713) 500-6471|Pamela.D.Berens@uth.tmc.edu|
268295|NCT02601014|University of Minnesota Division of Hematology, Oncology and Transplantation|Emmanuel Antonarakis, MD|612-301-2180|anton401@umn.edu|
268296|NCT02579096|Boston CSP Coordinating Center|Ryan E. Ferguson, ScD, MPH, Director|1-857-364-4201|Ryan.Ferguson@va.gov|
268297|NCT02545868|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
268298|NCT02538666|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
268299|NCT02527200|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
296943|NCT01715233|Baylor University Medical Center Dallas Texas|Ronan J. Kelly MD MBA|214-820-2828|Ronan.Kelly@bswhealth.org|
268300|NCT02511106|AstraZeneca AB|Global Clinical Leader|+447920183730|ClinicalTrialTransparency@astrazeneca.com|
268301|NCT02477358|UNMC|Dr. Elisabeth Easley|5305246020|eleasley@gmail.com|
268302|NCT02432209|Yale School of Public Health|Fangbai Sun|2037855185|fangbai.sun@yale.edu|
274361|NCT00428220|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274362|NCT00428246|Indiana University|Rajiv Agarwal|317-988-2241|ragarwal@iupui.edu|
274363|NCT00428298|Johns Hopkins UNiversity School of Medicine|Jennifer L. Payne MD|410-502-0050|jpayne5@jhmi.edu|
274364|NCT00428389|Novartis Pharmaceuticals|Study Director|862-778-8300||
274365|NCT00428441|University of Insubria|Dr. Walter Ageno|+39 0332 278831|agewal@yahoo.com|
274366|NCT00428584|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|fernando.dangond@emdserono.com|
274367|NCT00428597|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
274368|NCT00428610|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274369|NCT00428714|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
274370|NCT00428792|Novartis Pharmaceuticals|Study Director|862 778-8300||
274371|NCT00428844|Cubist Pharmaceuticals, Inc.|Ed Campanaro, VP Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
274372|NCT00428922|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy, MD|614-293-0066|Bhuvaneswari.Ramaswamy@osumc.edu|
274373|NCT00428948|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
274374|NCT00428974|Can-Fite BioPharma Ltd|Pnina Fishman, PhD|011972 3 924 1114|pnina@canfite.co.il|
274375|NCT00429104|University of Texas MD Anderson Cancer Center|Naoto Ueno, MD.PhD./Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
274376|NCT00429143|Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|neal.flomenberg@jefferson.edu|
274377|NCT00429169|Columbia University/NYSPI|Michael F. Grunebaum, MD|212-543-5842|mfg14@columbia.edu|
282250|NCT00845663|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
282251|NCT00845676|San Francisco General Hospital/UCSF|Brad Hare, MD|415-476-4082|chare@php.ucsf.edu|556
282252|NCT00845728|Novartis Pharmaceuticals|Study Director|862-778-8300||
296944|NCT01715298|Novartis Pharmaceuticals|Study Director|862-778-8300||
282253|NCT00845832|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
282254|NCT00845858|Evoke Pharma|Marilyn R. Carlson|858-345-1494|mcarlson@evokepharma.com|
268303|NCT02392637|UT MD Anderson Cancer Center|Dr. Milind Javle, Professor, GI Medical Oncology|(713) 792-5434|mjavle@mdanderson.org|
282255|NCT00845871|Novartis pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
296945|NCT01715415|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
282256|NCT00845897|Washington University School of Medicine|Mary Hastings PT, DPT, ATC|314 286 1433|hastingsmk@wustl.edu|
296946|NCT01715571|Johns Hopkins University School of Medicine|Arthur Burnett, MD|410-614-3986|aburnet1@jhmi.edu|
282813|NCT00875615|University of Miami Sylvester Comprehensive Cancer Center|Lynn Feun MD|305-243-4981|lfeun@med.miami.edu|
268304|NCT02253316|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8323|rvij@wustl.edu|
282814|NCT00875641|GlaxoSmithKline|GSK Response Center|866-435-7343||
268305|NCT02224573|Greenwich Biosciences|Medical Enquiries|1-833-424-6724|medinfo@greenwichbiosciences.com|
268306|NCT01991067|Medical University of Vienna, Department of Medicine I, Division of Infectious Diseases|Assoc. Prof. Dr. Christina Bahrs|+4314040044400|christina.a.forstner@meduniwien.ac.at|
268307|NCT01966471|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
268308|NCT01928732|Palo Alto CSPCC|Lisa Zehm|(650) 493-5000|Lisa.Zehm@va.gov|28805
268309|NCT01925573|University of Maryland Medical Center|Caitlin Eggleston|4103287586|caitlineggleston@umm.edu|
268310|NCT01774721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268311|NCT01747447|Brigham and Women's Hospital|Meryl S LeBoff, M.D.|1-800-388-3963|vitalstudy@partners.org|
268312|NCT01709331|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268313|NCT01689740|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
268314|NCT01659151|Moffitt Cancer Center|Amod Sarnaik, M.D.|813-745-8581|Amod.Sarnaik@moffitt.org|
268315|NCT01656434|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268316|NCT01518517|Erytech Pharma|Anne-Sophie Clermont|+33 4 78 78 15 70|anne-sophie.clermont@erytech.com|
268317|NCT01496118|Sarah Cannon Development Innovations, LLC|Dr. Jesus Berdeja|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
268318|NCT01350934|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268319|NCT01286207|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268320|NCT01263769|UT MD Anderson Cancer Center|Dr. Jose Karam, MD, Associate Professor, Urology|(713) 745-0374|jakaram@mdanderson.org|
268321|NCT01227187|George Washington University|Lakhmir Chawla|202-715-4752|lchawla@mfa.gwu.edu|
268322|NCT01222247|The George Washington University Biostatistics Center|Elizabeth Thom, Ph.D.|301-881-9260|e_thom@bsc.gwu.edu|
268323|NCT01211405|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
268324|NCT01146418|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268325|NCT01144416|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268326|NCT01140048|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268327|NCT01077817|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268328|NCT01065779|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268329|NCT00974571|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282815|NCT00875667|Celgene Corporationi|Anne McClain, Senior Manager, Clinical Trial Disclosure|8882601599|ClinicalTrialDisclosure@Celgene.com|
282816|NCT00875706|Department of Veterans Affairs|Dr. Carol VanDeusen Lukas|857-364-5685|carol.vandeusenlukas@va.gov|
282817|NCT00875797|UMCLjubljana|Lidija Kompan, principal Investigator|0038651301781|lidija.kompan@gmail.com|
282818|NCT00875810|MedtronicSpineECA|Cristina Faria|+41 21 802 70 00|cristina.faria@medtronic.com|
282819|NCT00875836|MUSC|Dr. Aimee McRae-Clark|843.792.5216|mcraeal@musc.edu|
282820|NCT00875979|Hoffmann-La Roche|Medical Communications|800 821-8590||
282821|NCT00876018|GlaxoSmithKline|GSK Response Center|866-435-7343||
274378|NCT00429182|University of Texas MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
274379|NCT00429273|University of California, Los Angeles|James T. McCracken, M.D.|310-825-0470|jmccracken@mednet.ucla.edu|
274380|NCT00429299|GlaxoSmithKline|GSK Response Center|866-435-7343||
274381|NCT00429364|New England Research Institutes, Inc.|Paul Stark, PhD|617-972-3362|pstark@neriscience.com|
274382|NCT00429403|UT MD Anderson Cancer Center|Naoto Ueno, MD / Professor||CR_Study_Registration@mdanderson.org|
274383|NCT00429416|Thomas Jefferson University|John Wagner, MD|215-955-8874|John.Wagner@jefferson.edu|
274384|NCT00429494|The University of Texas (UT) MD Anderson Cancer Center|Dr. Naoto T. Ueno, MD, PhD / Professor||CR_Study_Registration@mdanderson.org|
274385|NCT00429507|University of Texas (UT) MD Anderson Cancer Center|Nato Ueno, MD, PhD/Professor, Breast Medical Oncology||CR_Study_Registration@mdanderson.org|
274386|NCT00429572|UT MD Anderson Cancer Center|Naoto Ueno, MD, PhD/Professor|713-792-8754|CR_Study_Registration@mdanderson.org|
274387|NCT00429585|Boston Medical Center|Paul Tornetta, MD|617-414-6295|paul.tornetta@bmc.org|
274388|NCT00429663|Boston Medical Center|Paul Tornetta III, MD|617-414-6295|paul.tornetta@bmc.org|
274389|NCT00429702|SunCoast CCOP Research Base|SunCoast CCOP Research Base Lead Biostatistician|18009091242|ccop@epi.usf.edu|
274390|NCT00429793|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
274391|NCT00429949|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
274392|NCT00430183|Memorial Sloan-Kettering Cancer Center|James A. Eastham, MD|646-422-4390|easthamj@mskcc.org|
274393|NCT00430248|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Sciences|800-778-2860|clinicaltrialregistry@tpna.com|
274394|NCT00430300|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274395|NCT00430352|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
268330|NCT00972738|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
268331|NCT00968201|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
268332|NCT00968149|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
268333|NCT00963469|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268334|NCT00960141|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
268335|NCT00943683|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
268336|NCT00943397|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
268337|NCT00937937|SWOG Statistical Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
268338|NCT00911547|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268339|NCT00899379|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268340|NCT00898677|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268341|NCT00897949|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268342|NCT00897104|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268343|NCT00803790|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
268344|NCT00725491|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268345|NCT00703014|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268346|NCT00702845|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268347|NCT00702624|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268348|NCT00702546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268349|NCT00702520|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268350|NCT00702338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268351|NCT00702273|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268352|NCT00702234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268353|NCT00697255|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268354|NCT00696878|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274396|NCT00430482|Boston University Charles River Campus|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
274397|NCT00430495|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
274398|NCT00430521|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
274399|NCT00430573|BostonUCRC|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
274400|NCT00430625|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
274401|NCT00430638|Daiichi Sankyo|Global Clinical Leader|1-908-992-6400||
274402|NCT00430677|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
274403|NCT00430716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274404|NCT00430755|Robert-Bosch-Hospital|Prof. Dr. Mark Dominik Alscher|+4971181013496|dominik.alscher@rbk.de|
274405|NCT00430768|UMASS Medical School|Dr. Terry Flotte|(508) 856-2107|Terry.Flotte@umassmed.edu|
274406|NCT00430781|GlaxoSmithKline|GSK Response Center|866-435-7343||
274407|NCT00430937|Novartis Pharmaceuticals|Study Director|862-778-8300||
268355|NCT00696800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274408|NCT00430989|Bayside health|Professor Paul Myles|+61390762000|p.myles@alfred.org.au|3176
274409|NCT00431041|Astellas Pharma Global Development|Astellas Medical Monitor||ClinicalTrials@us.astellas.com|
274410|NCT00431067|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
274411|NCT00431132|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
274412|NCT00431184|McLean Hospital|Beth Murphy MD|617-855-2297|BMurphy5@partners.org|
274413|NCT00431444|Novartis Pharmaceuticals|Study Director|862-778-8300||
274414|NCT00431496|Amgen Inc.|Study Director|866-572-6436||
274415|NCT00431626|Northwestern U|Borko D. Jovanovic, MS, PhD|312 503 2008|borko@northwestern.edu|
274416|NCT00431834|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
274417|NCT00431847|Philadelphia Veterans Affairs Medical Center|Rollin M Gallagher, MD, MPH|(215) 823-5800|Rollin.Gallagher@va.gov|4907
296947|NCT01715805|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
296948|NCT01715831|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
308404|NCT02577003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Dvelopment|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268356|NCT00616967|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|443-287-6489|vstearn1@jhmi.edu|
268357|NCT00461032|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268358|NCT00442338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268359|NCT00353938|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
268360|NCT00335777|Jefferson Headache Center|Stephen D. Silberstein, MD|215-955-2243|stephen.silberstein@jefferson.edu|
268361|NCT00289874|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268362|NCT00250458|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
268363|NCT00245570|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268364|NCT00229970|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268365|NCT00092131|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
268366|NCT00092118|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
268367|NCT00090142|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268368|NCT00043108|Fox Chase Cancer Center|Dr. Mark Hallman|215-728-2581|Mark.Hallman@fccc.edu|
274418|NCT00431951|SIGA Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
308405|NCT02577016|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274419|NCT00431964|Seattle Children's Hospital|Nicole Hamblett|206-987-5725|tdncc@seattlechildrens.org|
274420|NCT00432042|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274421|NCT00432159|Depuy Synthes|Lynn Wilson|508-880-8109|lwilso45@its.jnj.com|
274422|NCT00432172|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
274423|NCT00432237|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
274424|NCT00432276|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
274425|NCT00432341|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
274426|NCT00432380|GlaxoSmithKline|GSK Response Center|866-435-7343||
274427|NCT00432458|Mayo Clinic|Dr. Thomas Witzig||witzig@mayo.edu|
274428|NCT00432562|Adventrx Pharmaceuticals|Chief Executive Officer|858-768-6325|culley@adventrx.com|
274429|NCT00432601|VA HSRD|Dr. Angela Fagerlin|801-587-1694|angie.fagerlin@hsc.utah.edu|
274430|NCT00432666|Merz Pharmaceuticals GmbH|Angelika Hanschmann|++49-69-1503|angelika.hanschmann@merz.de|538
274431|NCT00432679|GlaxoSmithKline|GSK Response Center|866-435-7343||
274432|NCT00432744|University of Florida|Dr. Peter W Stacpoole|352-273-9023|pws@ufl.edu|
274433|NCT00432809|Cleveland Clinic|Dr. Philip Schauer|216-444-4794|schauep@ccf.org|
274434|NCT00432835|University of Mississippi Medical Center|Thomas L. Abell, MD, Professor of Medicine|6019844540|tabell@umc.edu|
274435|NCT00432965|Acelity|Sr Director, Global Clinical Development|210-255-5595|jane.hart@kci1.com|
274436|NCT00432991|Weill Cornell Medicine, Department of Anesthesiology|Michele Steinkamp, Research Nurse Specialist|212-746-2953|mls9004@med.cornell.edu|
274437|NCT00433004|University of Pennsylvania|Arden McAllister|215-662-3532|arden.mcallister@uphs.upenn.edu|267
274438|NCT00433017|Novartis Pharmaceuticals|Study Director|862 778-8300||
274439|NCT00433147|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@Alexion.com|
274440|NCT00433160|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274441|NCT00433199|Abbott|Global Medical Services|800-633-91110||
274442|NCT00433290|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274443|NCT00433329|Actelion Pharmaceuticals, US, Inc.|Rajiv Patni/Medical Officer|(650) 624-6900||
274444|NCT00433381|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
274445|NCT00433446|SWOG Statistical Center|Study Statistician|206-667-4623||
274446|NCT00433537|ECOG Statistical Office|Study Statistician|617-632-3012||
274447|NCT00433550|Mayo Clinic|Robert R. McWilliams, M.D.||mcwilliams.robert@mayo.edu|
274448|NCT00433654|Medtronic, Inc|EnRhythm MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
274449|NCT00433745|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
274450|NCT00433771|Boston Scientific Corporation|Jeremy Bolt|508-683-4006|boltj@bsci.com|
274451|NCT00433836|Novartis Pharmaceuticals|Study Director|862-778-8300||
274452|NCT00433914|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
268369|NCT04771013|GIMUNICAH|Héctor M. Ramos-Zaldívar|+56934988958|hramos@unicah.edu|
274453|NCT00433966|Cardiovascular Research Foundation|Ori Ben-Yehuda, MD, Executive Director, Clinical Trials Center|646-434-4123|obenyehuda@crf.org|
274454|NCT00433992|Case Western Reserve University|Dr. Grace McComsey|216-844-2739|mccomsey.grace@clevelandactu.org|
274455|NCT00434018|VACO|Dr. Shirley Groer|202-553-9899|Shirley.Groer@va.gov|
274456|NCT00434057|Electro-Optical Sciences, Inc.|Joanna Adrian / Director, Clinical Operations and Medical Affairs|(914)591-3783|adrian@eosciences.com|732
274457|NCT00434109|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
274458|NCT00434122|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
274459|NCT00434148|Novartis Pharmaceuticals|Study Director|862-778-8300||
274460|NCT00434161|Swedish Orphan Biovitrum AB|Medical Director|+4686972000|clinical@sobi.com|
274461|NCT00434213|Noven Pharmaceuticals, Inc.|Amaury Sanchez, Sr. Manager, Regulatory Affairs||asanchez@noven.com|
268370|NCT04497987|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
268371|NCT04198584|University of North Carolina at Chapel Hill|Donna Evon, PhD|919-966-6732|donna_evon@med.unc.edu|
268372|NCT04013932|University of North Carolina at Chapel Hill|Joy Noel Baumgartner|919.923.8534|joy.baumgartner@unc.edu|
268373|NCT03840616|Mycovia Pharmaceuticals Inc|Clinical Trial Administration|919-467-8539|adminops@mycovia.com|
268374|NCT03623373|Washington University School of Medicine|Brad S. Kahl, M.D.|314-273-3591|bkahl@wustl.edu|
268375|NCT03581279|MDC Associates, Inc.|Manager, Regulatory and Clinical Affairs|9787055012|t2@mdcassoc.com|
268376|NCT03512210|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|301-628-3348|ACTGCT.gov@fstrf.org|
268377|NCT03506412|Mayo Clinic|Naveen L. Pereira, M.D.|507-284-8612|Pereira.Naveen@mayo.edu|
268378|NCT03493854|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
268379|NCT03420768|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
268380|NCT03417245|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
268381|NCT03395288|Washington University|Jerry Lowder, MD|314-362-0063|lowderj@wustl.edu|
268382|NCT03180307|On Target Laboratories|Tommy Lee, MSHS, Vice President, Clinical Operations|765-588-4547|Tlee@ontargetlabs.com|
268383|NCT03151083|VA Connecticut Healthcare System|Dr. Eric Hermes|203 932 5711|eric.hermes@va.gov|7422
268384|NCT02831673|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
268385|NCT02668822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268386|NCT02668783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268387|NCT02616146|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268388|NCT02538510|University of Washington|Cristina Rodriguez|2066066748|rodrigcr@uw.edu|
268389|NCT02524288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268390|NCT02489942|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0217|clintriage.rdg@boehringer-ingelheim.com|
268391|NCT02409342|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
268392|NCT02293655|Cincinnati Children's Hospital Medical Center|Tanya Froehlich, MD|5136361154|tanya.froehlich@cchmc.org|
268393|NCT02275546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268394|NCT02227238|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
268395|NCT02077166|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
268396|NCT01891344|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
268397|NCT01847274|TESARO|Chief Medical Officier|781-257-2536|officeofcmo@tesarobio.com|
268398|NCT01670656|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274462|NCT00434252|Genentech, Inc.|Medical Communications|800-821-8590||
274463|NCT00434278|Genentech, Inc.|Medical Communications|800-821-8590||
274464|NCT00434304|GlaxoSmithKline|GSK Response Center|866-435-7343||
274465|NCT00434330|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
274466|NCT00434356|Genentech, Inc.|Medical Communications Specialist|800-821-8590||
274467|NCT00434421|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
274468|NCT00434434|Genentech, Inc.|Medical Communications|800-821-8590||
274469|NCT00434512|GlaxoSmithKline|GSK Response Center|866-435-7343||
274470|NCT00434577|GlaxoSmithKline|GSK Response Center|866-435-7343||
274471|NCT00434642|Hoffman-LaRoche|Medical Communications|800-821-8590||
274472|NCT00434759|Central Institute of Mental Health, Mannheim, Germany|Prof. Martin Bohus|+49 621 1703 4002|martin.bohus@zi-mannheim.de|
274473|NCT00434876|Philadelphia VAMC|Subhajit Chakravorty|215-823-5800|Subhajit.Chakravorty@va.gov|3405
274474|NCT00434954|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
268399|NCT01501955|Zimmer Biomet|Paul Kwakman|20215414|paul.kwakman@zimmerbiomet.com|
268400|NCT01335399|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
274475|NCT00434967|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
274476|NCT00434993|Acute Respiratory Distress Syndrome (ARDS) Network|David Schoenfeld, ARDSNet CCC PI|617-726-6111|dschoenfeld@partners.org|
274477|NCT00435019|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
282822|NCT00876187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282823|NCT00876200|Hospices Civils de Lyon|Dr Behrouz KASSAI-KOUPAI|472116911|behrouz.kassai-koupai@chu-lyon.fr|+33
296949|NCT01715857|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
282824|NCT00876265|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com|
282825|NCT00876343|Otsuka Pharmaceutical Co., Ld.|Director of Clinical Research and Development|+81-3-6361-7366||
282826|NCT00876395|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
282827|NCT00876447|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
296950|NCT01715883|University of Pittsburgh|Matthew Morrell, MD|412-647-8477|morrellmr@upmc.edu|
282828|NCT00876460|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282829|NCT00876694|Novartis Pharmaceuticals|Study Director|862-778-8300||
268401|NCT01277211|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268402|NCT01267812|City of Hope|Dr. Matthew Mei|626-359-8111|mamei@coh.org|
268403|NCT01244828|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268404|NCT01207492|Dana-Farber Cancer Institute|Andrew Wagner, MD, PhD|617.632.5204|andrew_wagner@dfci.harvard.edu|
268405|NCT01181778|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268406|NCT01047540|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
268407|NCT01044056|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268408|NCT00944216|Wright State University School of Medicine, Dept of Dermatology|Amy Chen, MD|927-224-3345|amy.chen@wright.edu|
268409|NCT00886691|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
268410|NCT00778999|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268411|NCT00620464|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268412|NCT00620035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268413|NCT00210249|Institut Bergonié, Comprehensive Cancer Center, Bordeaux, FR|Pr Simone Mathoulin-Pélissier|+33 (0)5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
282830|NCT00876733|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282831|NCT00876915|University of Rochester|Charles Francis, MD|(585) 275-5823|charles_francis@urmc.rochester.edu|
282832|NCT00876928|Charles R. Drew University|Mayer B. Davidson, MD|323 357-3439|mayerdavidson@cdrewu.edu|
282833|NCT00876993|Johns Hopkins All Children's Hospital|Stacie Stapleton|727-767-4176|stacie.stapleton@jhmi.edu|
282834|NCT00877006|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
282835|NCT00877032|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282836|NCT00877058|Göteborg University|Professor Synneve Dahlin-Ivanoff (Research leader)|+46317865733|synneve.dahlin-ivanoff@gu.se|
282837|NCT00877370|University of Michigan|Bruce A. Mueller|(734) 615-4578|muellerb@umich.edu|
282838|NCT00877383|Novartis Pharmaceuticals|Study Director|862 778-8300||
282839|NCT00877448|BiondVax Pharmaceuticals Ltd.|Tamar Ben-Yedidia, PhD|972-8-9302529|benyedidia@BiondVax.com|
282840|NCT00877487|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
282841|NCT00877604|Fondazione Istituto Neurologico Carlo Besta|Alberto Albanese|+39 02 2392 4552|alberto.albanese@unicatt.it|
282842|NCT00877773|University of Texas (UT) MD Anderson Cancer Center|Daniel Karp, MD / Professor, Investigational Cancer Therapeutics||CR_Study_Registration@mdanderson.org|
282843|NCT00877799|Cara Therapeutics Inc.|Frédérique Menzaghi, PhD, Vice President Research & Development|203-567-1502|fmenzaghi@caratherapeutics.com|
282844|NCT00877877|GlaxoSmithKline|GSK Response Center|866-435-7343||
282845|NCT00877890|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
282846|NCT00877929|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282847|NCT00878072|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
282848|NCT00878189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292600|NCT01436201|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292601|NCT01436266|Boston Medical Center|Sarita Sonalkar, MD|617 414 7304|sarita.sonalka@bmc.org|
292602|NCT01436279|Boston Medical Center|Olivera Vragovic|617 414 7304|Olivera.Vragovic@bmc.org|
292603|NCT01436305|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
292604|NCT01436357|University of New Mexico and Johns Hopkins University|Kimberly Page, Ph.D., M.P.H. and Andrea Cox, M.D., Ph.D.|505-272-2520, 410-502-2715|pagek@salud.unm.edu, acox@jhmi.edu|
292605|NCT01436370|Department of Internal Medicine, University of Iowa|Jack Stapleton, MD|319-356-3168|jack-stapleton@uiowa.edu|
292606|NCT01436396|Sanofi Pasteur|Director||Contact-US@sanofi.com|
292607|NCT01436435|Boston Scientific|DeeAnn Tinjum, Clinical Trial Manager|763-494-1927|deeann.tinjum@bsci.com|
292608|NCT01436500|Cumberland Pharmaceuticals Inc|Jerry Fox, DVM|615-255-0068|jfox@cumberlandpharma.com|
292609|NCT01436526|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
292610|NCT01436643|Novartis Pharmaceuticals|Study Director|862-778-8300||
292611|NCT01436799|Gachon University Gil Medical Center|Dr.HJ Kwak|82-32-460-3400|hyun615@gilhospital.com|
292612|NCT01437098|Medtronic|Hiroko Ookubo|81367760811|hiroko.ookubo@medtronic.com|
292613|NCT01437124|Wirral NHS Trust|Hussain Kazi|0151 678 6111|hussainkazi@nhs.net|
274478|NCT00435045|GlaxoSmithKline|GSK Response Center|866-435-7343||
274479|NCT00435162|Novartis Pharmaceuticals|Study Director|862-778-8300||
308406|NCT02577029|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
268414|NCT03604549|Penn State Health Milton S. Hershey Medical Center|Richard S. Legro, M.D., Principal Investigator|717-531-6210|rsl1@psu.edu|
268415|NCT03513068|ResMed|Maureen Crocker, Sr. Manager Market Access|+65 9815 2195|maureen.crocker@resmed.com|
268416|NCT03502811|Abbott|Nadia Bouhdi|32-479-94-10-37|nadia.bouhdi@abbott.com|
268417|NCT03272711|Washington University School of Medicine|Dr. Eric Lenze|314-362-1671|lenzee@wustl.edu|
268418|NCT03221270|University of North Carolina at Chapel Hill|Rachel Force, PhD|984-974-6239|rachel_force@med.unc.edu|
268419|NCT03191903|Anika|Carol Pekar, VP Clinical Affairs|781-457-9218|cpekar@anikatherapeutics.com|
268420|NCT04425538|Neely Center for Clinical Research, Tufts Medical Center|Director of Clinical Trials|617-636-5000|ncccr@tuftsmedicalcenter.org|3264
268421|NCT04422990|Alcon Research, LLC|CDMA Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
268423|NCT04289051|Sunstar Americas, Inc.|Akane Takemura|18477944276|akane.takemura@us.sunstar.com|
268424|NCT04210180|Rose Research Center|Jed E. Rose, Ph.D.|9193282345|jed.rose@roseresearchcenter.com|
268425|NCT04097223|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
268426|NCT04095416|Henry Ford Hospital|Raef Ali Fadel|3139321347|rfadel2@hfhs.org|
268427|NCT03675308|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
268428|NCT03573817|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
268429|NCT03318861|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
268430|NCT03170349|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
268431|NCT03119064|Brown University Oncology Research Group|Heinrich Elinzano, MD|401-863-3000|BrUOG@BROWN.EDU|
268432|NCT03097328|Dana Farber Cancer Institute|Bradley McGregor, MD|617-632-6328|Bradley_McGregor@DFCI.harvard.edu|
268433|NCT03095456|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
268434|NCT03064113|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
268435|NCT02938013|Johns Hopkins University School of Medicine|Dr. Mark Sulkowski|443-997-1900|msulkowski@jhmi.edu|
268436|NCT02919683|Dana-Farber Cancer Institute|Jonathan Schoenfeld, M.D. M.P.H.|617-632-3591|jonathan_schoenfeld@dfci.harvard.edu|
268437|NCT02901548|Moffitt Cancer Center|Jingsong Zhang, MD, PhD|813-745-6926|Jingsong.Zhang@moffitt.org|
268438|NCT02790138|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
268439|NCT02642315|University of Missouri Columbia|Pradeep Sahota MD|573-882-6402|sahotap@missouri.edu|
268440|NCT02518139|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
268441|NCT02514239|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
268442|NCT02512510|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
268443|NCT02481830|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|1(800) 332-2056|Clinical.Trials@bms.com|
268444|NCT02459080|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
268445|NCT02245672|Mylan Pharma UK Ltd|Dik Ng, PhD|+44-7467-941703|dik.ng@mylan.co.uk|
268446|NCT02109172|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
268447|NCT02040792|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
268448|NCT01979003|University of Arkansas for Medical Sciences|Alexander Burnett|5016868274|aburnett@uams.edu|
268449|NCT01892722|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
268450|NCT01879228|University of Pennsylvannia|Paola Alvarado|215-746-2081|paola.alvarado@pennmedicine.upenn.edu|
268451|NCT01704404|Theravance Biopharma|Head of Clinical Development & Medical Affairs|1-855-633-8479|medinfo@theravance.com|
268452|NCT01307813|University Hospitals Cleveland Medical Center|Jeffrey Marks, MD - General Surgeon|216-983-4930|Jeffrey.Marks@uhhospitals.org|
268453|NCT00799396|University of Maryland School of Medicine|Alan R Shuldiner, MD|410-706-1623|ashuldin@medicine.umaryland.edu|
268454|NCT00308685|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|888-483-8279|USMedInfo@tevapharm.com|
268455|NCT00069238|National Cancer Institute|Dr. Wyndham WIlson|301-435-2415|wilsonw@mail.nih.gov|
268456|NCT00001322|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
268457|NCT03082898|Vanderbilt University|Dr. Michael Goldfarb|615 343 6924|michael.goldfarb@vanderbilt.edu|
268458|NCT03056443|West Virginia University|Robert Stansbury, MD|304-293-4661|rstansbury@hsc.wvu.edu|
268459|NCT04748783|University of North Carolina at Chapel Hill|Laura Jacox, DMD, PhD, MS|919-537-3424|ljacox@live.unc.edu|
268460|NCT04482647|UT MD Anderson Cancer Center|Santhosshi Narayanan, MD-Assistant Professor, Integrative Medicine Program|(346) 228-6676|snarayanan2@mdanderson.org|
268461|NCT04405570|Ridgeback Biotherapeutics|Dr. Wendy Painter|786-687-2495|EIDD2801@ridgebackbio.com|
268462|NCT04135937|Durham VA Health Care System|Angela Kirby|919-286-0411|angela.kirby@va.gov|175526
268463|NCT03989232|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
268464|NCT03926611|Novartis Pharmaceuticals|Study Director|(862) 778-8300|novartis.email@novartis.com|
268465|NCT03896295|Momenta Pharmaceuticals, Inc.|DIRECTOR CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268466|NCT03213457|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
268467|NCT02982720|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317.921.2050|jsmith@hoosiercancer.org|
268468|NCT02548754|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|4052714742|stavros-stavrakis@ouhsc.edu|
274480|NCT00435188|Durham VA Research and Development|Miriam C. Morey, Ph.D.|919-286-0411|miriam.morey@va.gov|6776
274481|NCT00435370|Baylor College of Medicine|Dr. Thomas R. Kosten|(713) 794-7032|kosten@bcm.edu|
274482|NCT00435409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274483|NCT00435461|GlaxoSmithKline|GSK Response Center|866-435-7343||
274484|NCT00435487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
274485|NCT00435539|ThromboGenics|Petra Kozma-Wiebe, MD|+32 16751310|petra.kozma@thrombogenics.com|
274486|NCT00435591|Astellas Pharma Global Development|Senior Medial Director, Medical Affairs||clinicaltrials@us.astellas.com|
274487|NCT00435812|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
274488|NCT00435825|Hoffman-LaRoche|Medical Communications|800-821-8590||
268469|NCT02425904|Dana-Farber Cancer Institute/Boston Children's Hospital|Barbara Degar, MD|617-632-5186|Barbara_Degar@dfci.harvard.edu|
268470|NCT02421939|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
268471|NCT02375672|Hoosier Cancer Research Network|Fauzia Sharmin|(317) 634-5842|fsharmin@hoosiercancer.org|75
268472|NCT02329327|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|+1.855.752.2356|clinicaltrials@alexion.com|
268473|NCT02153645|Osmotica Pharmaceuticals|George Wagner, VP of Regulatory Affairs|908-809-1357|gwagner@osmotica.ccom|
268474|NCT02153632|Osmotica Pharmaceuticals|George Wagner, VP of Regulatory Affairs|9088091357|gwagner@osmotica.ccom|
268475|NCT02063724|H. Lee Moffitt Cancer Center and Research Institute|Dr. Brian Czerniecki|813-745-7575|brian.czerniecki@moffitt.org|
268476|NCT01942135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268477|NCT01689909|Medical College of Georgia; Augusta University|William Vaughn McCall|706-721-6719|WMCCALL@augusta.edu|
268478|NCT01566149|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268479|NCT01481935|University of Maryland School of Medicine|Anthony D. Harris, MD MPH|410-706-0064|aharris@epi.umaryland.edu|
268480|NCT01386125|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268481|NCT01257568|Stryker Orthopaedics|Shaherah Yancy, Director, Clinical Operations|901-650-6601|shaherah.yancy@stryker.com|
268482|NCT01165424|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268483|NCT01135134|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268484|NCT00867165|Merck Sharp & Dohme.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268485|NCT00733005|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268486|NCT00732381|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
274489|NCT00435929|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
274490|NCT00435942|Bolton Medical, Inc.|Annie Weiller|954-838-9699|AWeiller@boltonmedical.com|
274491|NCT00435994|Indiana University|Robert Tepper, MD, Ph.D.|317-274-9647|rtepper@iu.edu|
274492|NCT00436007|GlaxoSmithKline|GSK Response Center|866-435-7343||
274493|NCT00436046|Baylor College of Medicine|Robert Couch, MD|713-798-4474|rcouch@bcm.tmc.edu|
274494|NCT00436163|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
274495|NCT00436215|National Cancer Institute|Dr. Christina Annunziata|301-402-7189|annunzic@mail.nih.gov|
274496|NCT00436280|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274497|NCT00436332|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fhcrc.org|
274498|NCT00436345|GlaxoSmithKline|GSK Response Center|866-435-7343||
274499|NCT00436436|National Cancer Institute|Dr. Mark Gilbert|301-402-6383|gilbertmr@mail.nih.gov|
274500|NCT00436475|Tufts Medical Center|Dr. Anastassios G. Pittas|617-636-5689|apittas@tuftsmedicalcenter.org|
274501|NCT00436501|UT MD Anderson Cancer Center, Office of Multicenter Clinical Research|Robert Coleman, MD / Professor||RColeman@mdanderson.org|
274502|NCT00436553|Novartis Pharmaceuticals|Study Director|862 778-8300||
274503|NCT00436566|Mayo Clinic|Dr. Edith A. Perez|507-266-0800|perez.edith@mayo.edu|
274504|NCT00436605|Yale University School of Medicine|Harriet Kluger|203-737-2572|Harriet.Kluger@yale.edu|
274505|NCT00436618|Mayo Clinic|Thomas E. Witzig M.D.|(507) 284-0527|witzig.thomas@mayo.edu|
274506|NCT00436644|Mayo Clinic|Dr. Paul Haluska|507-266-2123|haluska.paul@mayo.edu|
274507|NCT00436748|Amgen Inc.|Study Director|866-572-6436||
274508|NCT00436852|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
274509|NCT00436904|Mayo Clinic|Dr. Clive Zent|507-284-5362|zent.clive@mayo.edu|
274510|NCT00436917|Mayo Clinic Jacksonville|Stephanie L. Hines, M.D.|507-266-0800|hines.stephanie@mayo.edu|
274511|NCT00436956|National Cancer Institute|William L. Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
274512|NCT00436969|DePuy Mitek|Aileen Michael|508.828.3337|amichae2@its.jnj.com|
274513|NCT00436982|Stryker EU Operations B.V. Herikerbergweg 110 1101 CM Amsterdam The Netherlands|Eric Garling, PhD, Snr. Director Medical & Scientific Affairs Europe|+31 20 219 2660|Eric.Garling@stryker.com|
274514|NCT00437034|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
274515|NCT00437073|GlaxoSmithKline|GSK Response Center|866-435-7343||
274516|NCT00437125|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274517|NCT00437203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274518|NCT00437268|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274519|NCT00437281|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274520|NCT00437294|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274521|NCT00437489|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
274522|NCT00437645|Novartis Pharmaceuticals|Study Director|862 778-8300||
274523|NCT00437658|AbbVie|Global Medical Services|800-633-9110||
296951|NCT01715896|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
268487|NCT00654095|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268488|NCT00653523|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268489|NCT00599027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268490|NCT00552032|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268491|NCT00546052|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268492|NCT00442117|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclcosure@merck.com|
268493|NCT00424008|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268494|NCT00423176|Merck, Sharp & Dohme Corp.|Senior Vice Presdient, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268495|NCT00383240|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268496|NCT04471935|Flint Rehabilitation Devices|Ian Russell|3392232676|irussell@flintrehab.com|
268497|NCT04439344|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
268498|NCT04439279|ECOG-ACRIN Cancer Research Group|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
268502|NCT03912298|University of Pennsylvania|Peggy Compton|2158986679|pcompton@nursing.upenn.edu|
268503|NCT02498132|University of Kansas|Professor Carl Lejuez|240-535-0467|clejuez@ku.edu|
268504|NCT02450760|University of Pennsylvania|Michael Mullen|215-662-3339|Michael.Mullen@Pennmedicine.Upenn.edu|
268505|NCT03618056|Fred Hutchinson Cancer Research Center|Jessica Andriesen|206-667-5812|jandries@fredhutch.org|
268506|NCT03503617|Flint Rehabilitation Devices|Daniel Zondervan|9493137322|dzondervan@flintrehab.com|
296952|NCT01715948|Capital Health|Dr. Manohar Bance|902-473-5975|m.bance@dal.ca|
268507|NCT03298867|Horizon Pharma USA, Inc.|Suzy Hammel|866-479-6742|clinicaltrials@horizontherapeutics.com|
268508|NCT03227224|Janssen Research & Development, LLC|SENIOR DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268509|NCT03220581|UConn Health|Kristyn Zajac, PhD|860-679-8572|zajac@uchc.edu|
268510|NCT03099486|Fox Chase Cancer Center|Dr. Namrata Vijayvergia|215-214-4283|Namrata.Vijayvergia@fccc.edu|
268511|NCT02991482|European Thoracic Oncology Platform (ETOP)|Heidi Roschitzki|+41 31 511 94 00|Heidi.Roschitzki@etop-eu.org|
268512|NCT02768870|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
268513|NCT02648698|Department of Hysteroscopic Centre, Fuxing Hospital, the Eighth Clinical Medical College, Capital Medical University, Beijing, China|Dr. Dongmei Song|13651294056|echosdm@163.com|86
268514|NCT02432196|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structrual Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
268515|NCT02340676|Dana-Farber Cancer Institute|Dr. John Koreth, MBBS, DPhil|(617) 632-2949|John_Koreth@dfci.harvard.edu|
268516|NCT02000882|US Oncology Research|Taqi Mohammad|7138702175|taqi.mohammad@mckesson.com|
268517|NCT01654315|The Ohio State University|Dr. Stephen Page|614-292-5490|STEPHEN.PAGE@OSUMC.EDU|614
268518|NCT01642004|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
268519|NCT01366092|Dana-Farber Cancer Institute|John Koreth, MBBS, DPhil|617-632-2949|JKoreth@partners.org|
268520|NCT01326104|University of Florida|Kristine Wynne|352-273-9727|kristine.wynne@neurosurgery.ufl.edu|
268521|NCT01244815|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268522|NCT01142596|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268523|NCT01098110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268524|NCT01006265|Actelion Pharmaceuticals Ltd.|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268525|NCT00591227|Rush University Medical Center|David Baldwin MD|312-942-6163|david_baldwin@rush.edu|
268526|NCT00534976|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268527|NCT00337675|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
274524|NCT00437983|Sourazky Tel-Aviv Medical Center|Prof. A. Korczyn|972-3-6974229|amosk@tasmc.health.gov.il|
274525|NCT00438100|The University of Tokyo|Tempei Miyaji|+81-3-5800-9086|tmiyaji@m.u-tokyo.ac.jp|
274526|NCT00438191|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
274527|NCT00438204|Barbara Ann Karmanos Cancer Institute|Antionette J. Wozniak, M.D., F.A.C.P.|(313)576-8752|wozniakt@karmanos.org|
274528|NCT00438256|Massachusetts General Hospital|Theodore Hong, MD|617-724-1159|TSHONG1@mgh.harvard.edu|
274529|NCT00438360|Novartis Pharmaceuticals|Study Director|862-778-8300||
274530|NCT00438399|Galderma|Farzaneh SIDOU Clinical Project Manager|00 33 4 93 95 70 70|farzaneh.sidou@galderma.com|70 51
274531|NCT00438451|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|C. Ruckes|+49 (0) 6131 17|ruckes@izks-mainz.de|9919
274532|NCT00438464|University of Texas (UT) MD Anderson Cancer Center|Jeri Kim, MD / Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
274533|NCT00438490|Massachusetts General Hospital|Corrine Welt, MD|617-726-8437|cwelt@partners.org|
274534|NCT00438633|Massachusetts General Hospital|Dr. Neal Chen|6177264700|nchen1@partners.org|
274535|NCT00438659|Mayo Clinic|Robert C. Miller, M.D.||miller.robert@mayo.edu|
274536|NCT00438672|Massachusetts General Hospital|Dr. David Ring|617-724-3953|dring@partners.org|
274537|NCT00438750|Orthopaedic Hand and Upper Extremity Service, Massachusetts General Hospital|David Ring, MD, PhD|617-724-3953|dring@partners.org|
274538|NCT00438802|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
274539|NCT00438815|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
268499|NCT04439123|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
268500|NCT04439110|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
268501|NCT04180540|Emory University|Michael lloyd|404-712-4063|mlloyd@emory.edu|
268528|NCT00317772|UT MD Anderson Cancer Center|Diane C Bodurka,Chief Education & Training Ofc, Education & Training|(713) 745-3358|dcbodurka@mdanderson.org|
268529|NCT00291486|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
268530|NCT00284856|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268531|NCT00070707|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
274540|NCT00438854|Massachusetts General Hospital|Philip C. Amrein, M.D.|617-726-8748|pamrein@partners.org|
274541|NCT00438880|Mayo Clinic Cancer Center|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
274542|NCT00438932|University of Miami Miller School of Medicine|Tamara Isakova, MD, MMSc|305-243-4374|tisakova@med.miami.edu|
274543|NCT00438971|Rush University|Dr. Mark Pollack|312-942-5372|mark_pollack@rush.edu|
274544|NCT00439140|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
274545|NCT00439179|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
274546|NCT00439218|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
274547|NCT00439231|NHLBI/NIH|Georg Aue|301.451.7141|AueG@nhlbi.nih.gov|
274548|NCT00439244|Novartis Pharmaceuticals|Study Director|862-778-8300||
274549|NCT00439270|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
274550|NCT00439296|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
274551|NCT00439309|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
274552|NCT00439335|Baylor College of Medicine|Shital Patel, MD|713-798-3793|shitalp@bcm.tmc.edu|
274553|NCT00439374|Northwestern University Medical School|William Grobman, MD|312-472-4661|w-grobman@northwestern.edu|
274554|NCT00439413|National Institute on Drug Abuse|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
274555|NCT00439465|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|603-650-6432|Kenneth.R.Meehan@hitchcock.org|
274556|NCT00439517|Merck KGaA|Merck KGaA Communication Center|+49-6151-75-5200|service@merckgroup.com|
274557|NCT00439556|UT MD Anderson Cancer Center|Dr. Khouri,Issa,M.D. / Stem Cell Transplantation|713-792-8750|ikhouri@mdanderson.org|
274558|NCT00439608|BrUOG|Howard Safran, MD|401-863-3000|Hsafran@lifespan.org|
274559|NCT00439647|Novartis Pharmaceuticals|Novartis Study Director|862-778-8300||
274560|NCT00439673|GIMEMA|Alfonso Piciocchi|+39 06.70390521|a.piciocchi@gimema.it|
274561|NCT00439725|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
274562|NCT00439777|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
274563|NCT00439946|United Therapeutics|Remodulin Program Leader|(919) 485-8350|ClinicalRecordsManagement@unither.com|
274564|NCT00440011|Allergan, Inc.|Vice President Medical Affairs|(714)246-4500|clinicaltrials@allergan.com|
274565|NCT00440037|Kyowa Kirin Co., Ltd.|Research & Development Planning Department , Research & Development Division||clinical.info.jp@kyowakirin.com|
274566|NCT00440050|Oregon Health and Sciences University/Portland VA Medical Center, Portland, Oregon.|Joseph Quinn, MD|503-494-6976|quinnj@ohsu.edu|
274567|NCT00440115|Department of Preventive Medicine & Public Health|Edward F. Ellerbeck, MD, MPH, Chair|913-588-2829|eellerbe@kumc.edu|
274568|NCT00440180|University of Utah|Marie Gibson|801-213-2845|marie.gibson@hsc.utah.edu|
274569|NCT00440193|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
274570|NCT00440232|Jefferson Headache Center/Thomas Jefferson University|Stephen D. Silberstein, M.D.|215-955-2243|stephen.silberstein@jefferson.edu|
274571|NCT00440297|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274572|NCT00440310|Light Sciences Oncology, Inc.|Vice President of Regulatory Affairs and Clinical Operations|425-957-8986|lisak@lsoncology.com|
274573|NCT00440401|Medical Scientific Strategy|Medical Responsible|+45 4677 1111|clinicaltrials@nycomed.com|
274574|NCT00440466|J&J PRD|Peter Bowers|908-927-2116||
274575|NCT00440505|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
274576|NCT00440518|UCB Clinical Trial Call Center|Study Director|+1 877 822 9493||
274577|NCT00440557|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Sr Director of Clinical Research|908-927-2116||
282849|NCT00878215|Washington University School of Medicine|William C. Chapman, M.D.|314-362-7792|chapmanw@wustl.edu|
282850|NCT00878228|Hospital for Special Surgery|Dr. David Kim|212-606-1206|KimD@hss.edu|
282851|NCT00878436|NYU Langone Medical Center|Fraustina Hsu|646 754 712|fraustina.hsu@nyumc.org|
282852|NCT00878501|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
282853|NCT00878553|Somnus Therapeutics, Inc|Dr. Christine Blumhardt, Chief Regulatory Officer|617-710-0928|cblumhardt@somnusthera.com|
282854|NCT00878644|University of Utah|Marianne Gildea, BSN, MS; Director of THAPCA Trials|801-608-4907|marianne.gildea@hsc.utah.edu|
282855|NCT00878709|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
282856|NCT00878722|Topotarget A/S|PRS Admnistrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
282857|NCT00878800|Topotarget A/S|PRS Administrator Gunilla Emanuelson|+45 39 17 83 92|enquiries@topotarget.com|
282858|NCT00878826|Stanford University|Dr. Deirdre Lyell|650-736-1191|dlyell@stanford.edu|
282859|NCT00878878|GE Healthcare|Ruben Sheng, M.D.|1-609-514-6899|Rubin.Sheng@ge.com|
268532|NCT02358993|University of Pennsylvania|Dr Uduak Andy|215-662-7709|uduak.andy@pennmedicine.upenn.edu|
274578|NCT00440596|Kent State University|Joel Hughes|330-672-7721|jhughes1@kent.edu|
274579|NCT00440700|University of Minnesota|Dr. Linda Chlan|612-624-6658|chlan001@umn.edu|
268533|NCT03566199|University of California, San Francisco|Dr. Sabine Mueller, MD, PhD.|(415) 502-7301|Sabine.Mueller@ucsf.edu|
268534|NCT03414983|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trails@bms.com|
268535|NCT03275168|Johns Hopkins University|Dr Maria Trent|4109552910|mtrent2@jhu.edu|
268536|NCT04528641|Reithera|Medical Director|06 99775|roberto.camerini@reithera.com|352
268537|NCT04498832|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
268538|NCT04497883|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
268539|NCT04034238|National cancer Institute|Dr. Christine C. Alewine|240-760-6146|christine.alewine@nih.gov|
268540|NCT03984305|Global Kinetics Corporation|Director of Clinical Affairs|612.240.2437|karen.krygier@globalkineticscorp.com|
268541|NCT03982368|Dompé farmaceutici SpA|Maria De Pizzol, BSc|+39 02 583831|info@pec.dompe.it|
268542|NCT03952143|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
268543|NCT03924752|Georgia Institute of Technology|Dr. Aaron Young|404-385-5306|aaron.young@me.gatech.edu|
268544|NCT03829514|Medical University of South Carolina|Misti Leyva|endo office|leyva@musc.edu|
268545|NCT03691428|Yale|Dr. Joan Monin|203785-2895|joan.monin@yale.edu|
268546|NCT03685708|National Institutes of Health (NIH) / The National Heart, Lung, and Blood Institute (NHLBI)|Christopher Pleyer, M.D. Principal Investigator, NIH, NHLBI|510.709.6649|christopher.pleyer@nih.gov|
268547|NCT03669588|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
268548|NCT03531632|MacroGenics, Inc.|Stephen Eck, M.D., Chief Medical Officer|301 251-5172|ecks@macrogenics.com|
268549|NCT03488030|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
268550|NCT03474107|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
268551|NCT03412604|Massachusetts General Hospital|Emiliano Santarnecchi|617-667-0326|esantarnecchi@mgh.harvard.edu|
268552|NCT03206073|National Cancer Institute|Dr. Tim F. Greten|240-760-6114|tim.greten@nih.gov|
268553|NCT03195127|University of Maryland, Baltimore|Avelino C. Verceles, M.D., M.S.|4103288141|avercele@medicine.umaryland.edu|
268554|NCT03102034|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
268555|NCT03076164|Memorial Sloan Kettering Cancer Center|Dr. Helene Yu, MD|646-608-3912|YuH@mskcc.org|
268556|NCT02723864|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
268557|NCT02701556|Valeant Pharmaceuticals|Johnson Varughese|908 927-1162|johnson.varughese@bauschhealth.com|
268558|NCT02691013|University of California San Diego|Dr. Robert Owens|858-657-5258|rowens@ucsd.edu|
268559|NCT02597062|Canadian Cancer Trials Group|Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
268561|NCT02130882|National Institute of Allergy and Infectious Diseases, NIH|Dr. Amy Klion|301-435-8903|aklion@nih.gov|
274580|NCT00440726|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
274581|NCT00440830|Columbia University|Pamela Flood, MD|212-305-2008|pdf3@columbia.edu|
274582|NCT00440947|ViiV Healthcare|GSK Response Center|866-435-7343||
274583|NCT00440999|Medicines for Malaria Venture|Stephan Duparc, MD|+41 22 555 0300|duparcs@mmv.org|
274584|NCT00441012|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274585|NCT00441064|Novartis Pharmaceuticals|Study Director|862-778-8300||
274586|NCT00441090|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
274587|NCT00441103|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
274588|NCT00441116|GlaxoSmithKline|GSK Response Center|866-435-7343||
274589|NCT00441129|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
274590|NCT00441142|Dana-Farber Cancer Institute|Dr. Eudocia Quant Lee|617-632-2166|eqlee@partners.org|
274591|NCT00441168|Jan-Cilag Germany|EMEA Medical Affairs Director Oncology|+49 2137 955-492|rangermu@its.jnj.com|
274592|NCT00441259|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
274593|NCT00441285|Universidad Peruana Cayetano Heredia|Hector H. Garcia, MD, PhD|+511 3287360|hgarcia@jhsph.edu|
274594|NCT00441337|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
274595|NCT00441350|Menarini Group|Angela Capriati, MD PhD - Global Director Clinical Sciences|+39 055 5680|acapriati@menarini-ricerche.it|9990
282860|NCT00878995|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8707|melmoore@utmb.edu|
282861|NCT00879034|Dana-Farber Cancer Institute|Dr. Mark Kieran|617-632-4907|mark_kieran@dfci.harvard.edu|
282862|NCT00879060|Tufts Medical Center|Martin Maron, MD|(617) 636-8066|mmaron@tuftsmedicalcenter.org|
282863|NCT00879190|Stanford University, Department of Obstetrics & Gynecology|Anna Girsen, Manager of Maternal-Fetal Medicine Research Operations|(650) 725-0499|agirsen@stanford.edu|
282864|NCT00879229|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
282865|NCT00879255|Department of Veterans Affairs|Leslie A. Morland, Clinical Psychologist|(619) 497-8406|leslie.morland@va.gov|
282866|NCT00879333|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
282867|NCT00879359|Cleveland Clinic|Lynn Borzi|2164453158|borzil@ccf.org|
282868|NCT00879398|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282869|NCT00879411|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282870|NCT00879437|Baylor College of Medicine|Jack Su|8328224306|jmsu@txch.org|
274596|NCT00441363|VeroScience|Donna Cowan|401 816-0525|donna_cowan@veroscience.com|
268562|NCT01920932|St. Jude Children's Research Hospital|Monika Metzger, MD|(901) 595-4974|monika.metzger@stjude.org|
268563|NCT01850563|Dartmouth-Hitchcock Medical Center|Alan Hartford, MD, PhD, FACR, Professor of Medicine (RadOnc) Director, Radiation Oncology|603-650-6600|Alan.C.Hartford@Hitchcock.org|
268564|NCT01827111|UT MD Anderson Cancer Center|Adi Diab, MD-Associate Professor, Melanoma Medical Oncology|(713) 745-7336|adiab@mdanderson.org|
268565|NCT01729754|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268566|NCT01553149|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
268567|NCT01437111|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268568|NCT01386385|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|jmiao@fredhutch.org|
268569|NCT01057121|AIDS Malignancy Consortium|AMC Statistical Center|501-526-6712|jylee@uams.edu|
268570|NCT01004263|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268571|NCT01001234|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268572|NCT00924170|National Cancer Institute|Dr. Robert Kreitman|301-496-6947|Robert_Kreitman@nih.gov|
268573|NCT00894556|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268574|NCT00840177|SWOG Statistical Center|S0919 Statistician|2066674623|amoseley@fredhutch.org|
268575|NCT00820950|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
268576|NCT00806416|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
274597|NCT00441441|GlaxoSmithKline|GSK Response Center|866-435-7343||
274598|NCT00441467|Eleison Pharmaceuticals|VP Clinical Development|6097211227|matthew.parris@eleison-pharma.com|
274599|NCT00441480|The Institute for Lipid and Atherosclerosis Research and Internal Medicine C, Sheba Medical Center, Tel Hashomer|Prof. Dror Harats|972-3-5302940|dror@vbl.co.il|
274600|NCT00441545|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
274601|NCT00441558|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
274602|NCT00441584|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
274603|NCT00441701|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274604|NCT00441727|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
274605|NCT00441766|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
274606|NCT00441792|Advocate Christ Medical Center|Erik Kulstad, MD, MS|7086843889|kulstad@uic.edu|
274607|NCT00441883|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
274608|NCT00441974|GlaxoSmithKline|GSK Response Center|866-435-7343||
274609|NCT00442013|Johns Hopkins University|Janet Holbrook|443-287-3170|ala-acrc@jhsph.edu|
274610|NCT00442169|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
274611|NCT00442286|CVRx|Vice President of Clinical Research|763-416-2876|lgalle@cvrx.com|
274612|NCT00442364|BTG International Inc|David DI Wright MB BS|610-278-1660|david.wright@btgplc.com|
274613|NCT00442416|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
274614|NCT00442468|GlaxoSmithKline|GSK Response Center|866-435-7343||
274615|NCT00442507|Washington University School of Medicine|Daniel Morgensztern, M.D.|314-362-5740|dmorgens@dom.wustl.edu|
274616|NCT00442572|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
274617|NCT00442598|Eleison Pharmaceuticals|VP Clinical Development|6097211227|matthew.parris@eleison-pharma.com|
274618|NCT00442611|Stanford University|Dr. Lorinda Chung|(650)493-5000|shauwai@stanford.edu|6242
274619|NCT00442689|Northwestern University|Dr. Laura Torchen|312-227-6492|ltorchen@luriechildrens.org|
274620|NCT00442702|Hoffman-LaRoche|Medical Communications|800-821-8590||
274621|NCT00442767|Montefiore Medical Center|Dr. Rubina Heptulla|718-920-4664|rheptull@montefiore.org|
274622|NCT00442936|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274623|NCT00442962|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
274624|NCT00443053|GlaxoSmithKline|GSK Response Center|866-435-7343||
274625|NCT00443079|UCSDMED|Dr. Heather Patton|619-543-2470|hpatton@ucsd.edu|
274626|NCT00443118|FUNDASAMIN-Fundacion para la Salud Materno Infantil|Edgardo Szyld MD, MSc|5491144093095|eszyld@gmail.com|
274627|NCT00443209|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274628|NCT00443261|University of Kansas Cancer Center|Dr. Stephen Williamson|9139455059|swilliam@kumc.edu|
274629|NCT00443352|Thomas Jefferson University|William B Young, MD|215-955-2243|william.b.young@jefferson.edu|
274630|NCT00443430|University of Washington and Seattle Children's Hospital|Carol Wallace, MD Principal Investigator|206-987-2057|cwallace@u.washington.edu|
274631|NCT00443456|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
274632|NCT00443534|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274633|NCT00443547|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
274634|NCT00443560|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy, PharmD|312-926-9015|r-mccarthy@northwestern.edu|
274635|NCT00443599|Boston Children's Hospital|Dr. Michael Agus|617-355-5849|michael.agus@childrens.harvard.edu|
282871|NCT00879645|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
282872|NCT00879658|Novartis Pharmaceuticals|Study Director||Novartis.email@novartis.com|
274636|NCT00443651|Genentech, Inc.|Medical Communications|800-821-8590||
274637|NCT00443703|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
274638|NCT00443729|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274639|NCT00443755|Mayo Clinic|K. Sreekumaran Nair, MD, Ph.D.|507-255-3605|nair@mayo.edu|
274640|NCT00443781|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
274641|NCT00443820|Novartis Pharmaceuticals|Study Director|862-778-8300||
274642|NCT00443846|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274643|NCT00443872|University of Kansas Medical Center|Dr. Kelly Lyons|9135887159|klyons@kumc.edu|
274644|NCT00443898|Novartis Pharmaceuticals|Study Director|862-778-8300||
274645|NCT00444028|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
274646|NCT00444067|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
274647|NCT00444080|University of Virginia|Peter A. Netland, MD, PhD|434-982-1086|pan9c@virginia.edu|
274648|NCT00444106|Novartis Pharmaceuticals|Study Director|862-778-8300||
274649|NCT00444145|Vanderbilt University|Dr. Michael Vaezi|615-322-3739|tina.higginbotham@vanderbilt.edu|
274650|NCT00444275|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
274651|NCT00444457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274652|NCT00444535|Novartis Pharmaceuticals|Clinical Disclosure Office|8620778-8300||
274653|NCT00444587|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
274654|NCT00444600|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrnet@jaeb.org|
274655|NCT00444626|Genzyme|Genzyme Medical Information (MedInfo)||medinfo@genzyme.com|
274656|NCT00444678|NYU Langone Health|Deirdre Cohen, MD|212-731-5656|Deirdre.Cohen@nyulangone.org|
274657|NCT00444795|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
274658|NCT00444821|Medtronic|Kristel Wittebols|707-591-3275|kristel.wittebols@medtronic.com|
274659|NCT00444912|Genzyme|Medical Information||medinfo@genzyme.com|
274660|NCT00444925|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
274661|NCT00444951|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
274662|NCT00444964|Children's Mercy Hospital|Jaylene Weigel|816-701-1359|jweigel@cmh.edu|
274663|NCT00445003|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|aglassman@jaeb.org|
274664|NCT00445068|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
274665|NCT00445146|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@Gilead.com|
274666|NCT00445211|William Beaumont Hospital|Dr. Justin Trivax|(248)587-2300|Justin.Trivax@beaumont.edu|
274667|NCT00445224|University of Kentucky|Dr. Tim L. Uhl Principal Investigator|859-323-1100|tluhl2@uky.edu|80858
274668|NCT00445263|SAMU 93|Pr Frédéric Lapostolle|0033148964454|frederic.lapostolle@avc.aphp.fr|
274669|NCT00445302|Genzyme Corporation|Genzyme Medical Information|1-800-745-4447||
274670|NCT00445315|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274671|NCT00445328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
274672|NCT00445341|National Cancer Institute, National Institutes of Health|Kieron Dunleavy, M.D.|301-435-1007|DunleavK@mail.nih.gov|
274673|NCT00445432|Abbott|Global Medical Services|800-633-9110||
274674|NCT00445458|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
274675|NCT00445484|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Ivan Borrello|(410) 955-4967|iborrell@jhmi.edu|
274676|NCT00445549|National Cancer Institute, National Institutes of Health|Elise C. Kohn, M.D.|301-496-4916|kohne@mail.nih.gov|
274677|NCT00445588|Adult Brain Tumor Consortium|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
282873|NCT00879684|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282874|NCT00879697|University of São Paulo|Raphael Dias|55 81 9728 6878|raphaelritti@gmail.com|
282875|NCT00879710|Medical College of Wisconsin|Srividya Kidambi, MD, MS|414-955-4843|skidambi@mcw.edu|
282876|NCT00879775|Department of Family Medicine, Dongguk University Ilsan Hospital, Republic of Korea|Sang-Yeon Suh, M.D.,Ph.D|0082-031-961-7490|fmmodel@gmail.com|
282877|NCT00879814|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282878|NCT00879879|SunCoast CCOP Research Base|Dr. Jeffrey Krischer, Principal Investigator|813-396-9245|ccop@epi.usf.edu|
282879|NCT00879970|GlaxoSmithKline|GSK Response Center|866-435-7343||
282880|NCT00879996|SUNY Buffalo|Dr. Richard Blondell|716-898-4971|blondell@buffalo.edu|
296953|NCT01716013|OptMed|Associate Director of Quality Assurance|(908) 720-2372|nyajnik@optmed.com|
296954|NCT01716039|Alimentiv (Formerly Robarts Clinical Trails)|Dr.Jenny Jeyarajah (Sr. Biostatistician)||jenny.jeyarajah@alimentiv.com|
282881|NCT00880009|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282882|NCT00880022|vanderbilt university|sheila h ridner|615-322-0831|Sheila.Ridner@Vanderbilt.edu|
282883|NCT00880048|GlaxoSmithKline|GSK Response Center|866-435-7343||
282884|NCT00880087|University of Utah|Dr. Rich Holubkov, Professor of Pediatrics|807-587-3326|richard.holubkov@hsc.utah.edu|
282885|NCT00880100|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1- 800- 472- 263||
282886|NCT00880165|Philadelphia VA Medical Center|Samuel T. Kuna, MD|215-823-4400|Samuel.Kuna@va.gov|
282887|NCT00880191|Mayo Clinic|Debra L. Barton RN, PhD, AOCN|507/284-1623|barton.debra@mayo.edu|
274678|NCT00445601|SWOG Statistics and Data Management Center|Catherine Tangen, Genitourinary Committee Statistician|206-667-2933|ctangen@fredhutch.org|
274679|NCT00445679|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
274680|NCT00445692|Fred Hutch Cancer Research Center|Leona A. Holmberg, MD, PhD|206-667-6447|lholmber@fredhutch.org|
274681|NCT00445705|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
274682|NCT00445744|FHCRC|H. Joachim Deeg MD|206 667 4409|jdeeg@fhcrc.org|
274683|NCT00445770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274684|NCT00445848|Swog Statistical Center|Lung Committee Statistican|2066674623|jmoon@fredhutch.org|
274685|NCT00445887|NRG Oncology|Linda Gedeon for James Kauderer, MA|716-845-1169|lgedeon@gogstats.org|
274686|NCT00445939|Abbott|Global Medical Services|800-633-9110||
296955|NCT01716104|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Director of Clinical Research and Medical Information|+74952761571|PutilovskiyMA@materiamedica.ru|302
274687|NCT00445978|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
274688|NCT00446030|sanofi-aventis|Trial Transparency Team||Contact-us@sanofi-aventis.com|
274689|NCT00446095|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
274690|NCT00446134|Valeant Pharmaceuticals International, Inc.|Senior Director Clinical Development|908-927-1782|ralph.doyle@valeant.com|
274691|NCT00446147|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
274692|NCT00446199|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
274693|NCT00446251|University of Washington|Dr. Connie L. Davis|206-598-6079|cdavis@u.washington.edu|
274694|NCT00446264|University of Lille|Violeta Raverdy|00 33 3 20 62 34 30|vraverdi@univ-lille2.fr|
274695|NCT00446290|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
274696|NCT00446446|Amgen Inc.|Study Director|866-572-6436||
274697|NCT00446459|University of Washington|Dr. Connie L. Davis|206-598-7162|cdavis@u.washington.edu|
274698|NCT00446511|Novartis Pharmaceuticals|Study Director|862-778-8300||
274699|NCT00446550|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@amicusrx.com|
274700|NCT00446563|Novartis Pharmaceuticals|Study Director|862-778-8300||
274701|NCT00446641|Asan Medical Center, University of Ulsan College of Medicine|Professor Sun U. Kwon|82-2-3010-3960|sukwon@amc.seoul.kr|
274702|NCT00446654|Progen Pharmacauticals Ltd|Director of Clinical Trials|+61 7 32739133||
274703|NCT00446797|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
274704|NCT00446849|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
274705|NCT00446966|Carient Heart and Vascular|Dr Chirag Sandesara|7033358750|csandesara@carient.org|
274706|NCT00446992|University of Nevada School of Medicine|Dr. Brian Kirkpatrick|775-682-8459|bkirkpatrick@medicine.nevada.edu|
274707|NCT00447005|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274708|NCT00447057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274709|NCT00447083|Wake Forest University Health Sciences|Steve feldman, MD|336-716-3775|sfeldman@wakehealth.edu|
274710|NCT00447122|BrUOG|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
274711|NCT00447226|GlaxoSmithKline|GSK Response Center|866-435-7343||
308407|NCT02577042|Fundació Lluita contra la SIDA|Director of Clinical Trials|+34 93 497 84 14|enegredo@flsida.org|
308408|NCT02577107|Novartis Pharmaceuticals|Study Director|862-778-8300||
268577|NCT00729651|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268578|NCT00698815|Massachusetts General Hospital|Rebecca S. Heist, MD||rheist@partners.org|
268579|NCT00698022|Corcept_Therapeutics|Robert Roe, MD|650-688-8812|rroe@corcept.com|
268580|NCT00692913|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268581|NCT00617994|Incyte|Incyte Corporation Call Center (US)|1.855.463.3463|medinfo@incyte.com|
268582|NCT00617708|SWOG|Study Statistician|206-667-4623||
268583|NCT00516737|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268584|NCT00358527|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268585|NCT00326898|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
268586|NCT00156065|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268587|NCT00150176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268588|NCT00145509|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
308409|NCT02577146|Washington University School of Medicine|Alana Desai, M.D.|(314) 362-7581|desaia@wustl.edu|
268589|NCT00145496|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268590|NCT00145470|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268591|NCT00129402|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
268592|NCT00101439|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268593|NCT00096200|University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Steven Waggoner, MD|216-844-5011|steven.waggoner@uhhospitals.org|
274712|NCT00447265|DAIT/NIAID|Associate Director for Clinical Research|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
274713|NCT00447278|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274714|NCT00447330|Duke University Medical Center|Brant Hamel|919-668-1861|brant.hamel@duke.edu|
274715|NCT00447382|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
274716|NCT00447499|Ipsen|Bert Bakker, MD, PhD.|+1 650 238 1669|bert.bakker@ipsen.com|
274717|NCT00447590|Apollo Endosurgery|Laura Eaton, R.N., BSN, CCRN-R|949-468-9301|laura.eaton@apolloendo.com|
274718|NCT00447694|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
274719|NCT00447772|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
274720|NCT00447876|Ipsen|Medical Director||clinical.trials@ipsen.com|
274721|NCT00447902|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
274722|NCT00448019|The University of Texas (UT) MD Anderson Cancer Center|MD Anderson Cancer Center Leukemia Department|713-792-7734|CR_Study_Registration@mdanderson.org|
274723|NCT00448123|William Beaumont Hospital|Robert Swor, DO|248-89-81970|raswor@beaumont.edu|
274724|NCT00448136|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
274725|NCT00448175|Uroplasty, Inc|Clinical Study Manager|952-426-6153|megan.otoole@uroplasty.com|
274726|NCT00448201|UNC Lineberger Comprehensive Cancer Center|Dr. Thomas Shea|919-966-7746|tom_shea@med.unc.edu|
274727|NCT00448227|Novartis Pharmaceuticals|Study Director|862-778-8300||
274728|NCT00448279|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
274729|NCT00448344|VA Connecticut|Dr. Lori Bastian|860-667-6853|lori.bastian@va.gov|
296956|NCT01716117|Stryker Neurovascular|Scott Courts, Clinical Program Manager|5104132170|scott.courts@stryker.com|
296957|NCT01716156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274730|NCT00448357|UNC Lineberger Comprehensive Cancer Center|Dr. Thomas Shea|919-966-7746|tom_shea@med.unc.edu|
274731|NCT00448435|GlaxoSmithKline|GSK Response Center|866-435-7343||
274732|NCT00448448|University of Iowa Dept of Orthopaedics and Rehabilitation|Dr. Lori A. Dolan|319-356-1075|lori-dolan@uiowa.edu|
274733|NCT00448539|Eisai Inc.|Eisai Medical Information|1 8882472378|esi_medinfo@eisai.com|
274734|NCT00448591|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
274735|NCT00448630|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
274736|NCT00448669|National Institutes of Health|Dr. Michael Thigpen|1-240-669-2877|michael.thigpen@nih.gov|
274737|NCT00448708|Angiotech Pharmaceuticals|Dr. Trudy Estridge|604-221-7676|testridge@angio.com|
274738|NCT00448747|Aeterna Zentaris|Nicola Ammer|+496942602|nammer@aezsinc.com|3472
282888|NCT00880230|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
282889|NCT00880256|VA Puget Sound Health Care System|Dr. David Kearney|206-764-2285|david.kearney@va.gov|
282890|NCT00880269|Novartis Pharmaceuticals|Study Director|862-778-8300||
282891|NCT00880334|Dana-Farber Cancer Institute|Toni Choueiri, MD|617-632-5456|toni_choueiri@dfci.harvard/edu|
282892|NCT00880360|University of Texas Health Science Center at San Antonio|Dr. Tyler Curiel|210-450-1000|curielt@uthscsa.edu|
282893|NCT00880399|GlaxoSmithKline|GSK Response Center|866-435-7343||
282894|NCT00880425|Thomas Jefferson University|Jessica Ailani, MD/ Headache Fellow|631-807-8194|Jessica.Ailani@gmail.com|
282895|NCT00880464|Mass General Brigham|Beth Overmoyer|617 632 3800|Beth_Overmoyer@DFCI.HARVARD.EDU|
292614|NCT01437267|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
292615|NCT01437319|Johnson &Johnson Vision Care, Inc|Tawnya Wilson, OD Principal Research Optometrist|904-443-3500|TWilson@ITS.JNJ.com|1834
292616|NCT01437397|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
268594|NCT04498273|University of Pittsburgh|Dr. Frank Sciurba|412-648-6494|sciurbafc@upmc.edu|
292617|NCT01437423|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
296958|NCT01716169|Stanford School of Medicine|Dr. Alfred Lane|650 721 7166|atlane@stanford.edu|
292618|NCT01437449|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
292619|NCT01437488|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Jean Hoffman-Censits|215 955-8874|jean.hoffman-censits@jefferson.edu|
292620|NCT01437501|Johns Hopkins Bloomberg School of Public Health|Thomas W. Kensler, PhD|410-955-1292|tkensler@jhsph.edu|
296959|NCT01716195|University of California Davis|Dr. Megan Daly|916-734-5428|medaly@ucdavis.edu|
292621|NCT01437540|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
292622|NCT01437605|Moffitt Cancer Center|Dr. Nikhil Khushalani|813-745-3437|Nikhil.Khushalani@Moffitt.org|
292623|NCT01437852|Stratatech Corporation, a Mallinckrodt Company|Mary Lokuta|608-441-8358|mlokuta@stratatechcorp.com|
292624|NCT01437878|Actelion Pharmaceutical Ltd|Maziar Assadi Gehr|+41 61 565 5525|maziar.assadi-gehr@actelion.com|
292625|NCT01437943|Brigham and Women's Hospital|Anil Chandraker, MD|617-732-7412|achandraker@partners.org|
292626|NCT01437995|Johns Hopkins University|Alexis Rea|4432878496|area5@jhu.edu|
292627|NCT01438008|Children's Hospital of Eastern Ontario|Dr. Denise Harrison|6137377600|dharrison@cheo.on.ca|6045
292628|NCT01438060|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
292629|NCT01438151|Mount Sinai|Dr. Shradha Agarwal|212-659-9261|shradha.agarwal@mssm.edu|
292630|NCT01438177|Perlmutter Cancer Center|Amitabha Mazumder, MD|212-731-5757|amitabha.mazumder@nyumc.org|
292631|NCT01438229|St. Jude Medical|Steven Madej|651-756-2230|smadej@sjm.com|
292632|NCT01438294|Universidade Nove de Julho|Evelim Leal de Freitas Dantas Gomes, PhD PT|5511976333349|evelimfreitas@hotmail.com|
292633|NCT01438307|UAB|Francisco Robert, MD|205-934-5077|paco@uab.edu|
292634|NCT01438411|Retrophin, Inc.|Retrophin Medical Information|1-877-659|medinfo@retrophin.com|5518
292635|NCT01438424|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
292636|NCT01438476|UT MD Anderson Cancer Center|Dr. Jean-Nicolas Vauthey,MD/Professor, Surgical Oncology|713- 792-2022|jvauthey@mdanderson.org|
296960|NCT01716208|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
274739|NCT00448760|UM/Sylvester Comprehensive Cancer Center|Bach Ardalan MD, Professor|305-243-4909|bardalan@med.miami.edu|
274740|NCT00448812|Boston Scientific Corp.|G Mark Grubb, RN, CCRA|+1 (412) 716-0717|grubbm@bsci.com|
274741|NCT00448864|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
274742|NCT00448916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274743|NCT00449007|Perelman School of Medicine, University of Pennsylvania|Maria A. Oquendo, M.D., Ph.D.|215-662-2818|moquendo@pennmedicine.upenn.edu|
274744|NCT00449033|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
274745|NCT00449046|GlaxoSmithKline|GSK Response Center|866-435-7343||
274746|NCT00449072|sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
274747|NCT00449150|AEterna Zentaris|Daniel Croteau, Medical Manager|418-652-7669|DCroteau@aezsinc.com|272
274748|NCT00449163|UM/Sylvester Comprehensive Cancer Center|Bach Ardalan MD|305-243-4909|bardalan@med.miami.edu|
274749|NCT00449176|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
274750|NCT00449540|Neuralieve|Cynthia Merrell|408-245-6400|cmerrell@neuralieve.com|
274751|NCT00449644|Janssen Infectious Diseases - Diagnostics BVBA|Medical Leader|1 609 730-7768||
274752|NCT00449670|GlaxoSmithKline|GSK Response Center|866-435-7343||
274753|NCT00449696|Seikagaku Corporation|Clinical Development Dept.|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp|
274754|NCT00449748|The University of Texas M. D. Anderson Cancer Cent|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
274755|NCT00449761|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
274756|NCT00449787|Montefiore Medical Center|Benjamin Friedman|718-920-6626|bwfriedmanmd@gmail.com|
274757|NCT00449865|University of Rochester|Karl Kieburtz, Director of CTSI|585-275-0553|Karl.kieburtz@chet.rochester.edu|
274758|NCT00449930|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
274759|NCT00449956|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
274760|NCT00450073|Emory University|Vin Tangpricha|4047277254|vin.tangpricha@emory.edu|
274761|NCT00450112|Seikagaku Corporation|Clinical Development Dept.|81-3-5220-8950|hiroyuki.hosokawa@seikagaku.co.jp|
274762|NCT00450177|Weill Cornell Medical College|Philip S. Barie, MD|646-962-2580|pbarie@med.cornell.edu|
274763|NCT00450190|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
274764|NCT00450216|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
274765|NCT00450242|University of North Carolina, Dept. of Obstetrics and Gynecology|Denniz Zolnoun, MD, MPH|919-966-7764|denniz_zolnoun@med.unc.edu|
282896|NCT00880555|Department of Veterans Affairs|Dr. David Glenn Clark|843-792-7446|clarkda@musc.edu|
308410|NCT02577315|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282897|NCT00880568|Merck Sharp & Dohme|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308411|NCT02577445|Livanova|Clinical Project Manager|0032498644704|renske.dezwaef@livanova.com|
268595|NCT05224453|Prince Sattam bin Abdulaziz University|Dr. Gopal Nambi|0501878382|physio_gopal@rediffmail.com|
268596|NCT04823221|Boao Yiling Life Care Center|Dr. Ming Liu|139 1103 6970|liuming9876@yeah.net|+86
268597|NCT04723173|Sonova AG|Bernhard Buschle|+41 58 928 44 21|bernhard.buschle@sonova.com|
268598|NCT04537078|Elshatby University Maternity Hospital|Dr. Aly Hussein|002-0119448000|emam_aly@me.com|
268599|NCT04425252|Clear Creek Bio, Inc.|Vice President Clinical Operations|(617) 765-2252|clinical@clearcreekbio.com|
268600|NCT04368260|University of Virginia|Dr. Amy Mathers|434-924-9678|ajm5b@virginia.edu|
268601|NCT03940326|Mazandaran University of medical sciences|Nasim Tabrizi|+981133343015|nasimtabrizi@gmail.com|
268608|NCT03132467|UT MD Anderson Cancer Center|Dr. Jennifer Litton, MD- VP, Clinical Research, Clinical Research|(713) 792-2817|jlitton@mdanderson.org|
268609|NCT03096288|University of Florida College of Medicine - Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3378|dominick.angiolillo@jax.ufl.edu|
268610|NCT02919436|Maine Medical Center|Dr. Anand Rughani|207-885-0011|arughani@mmc.org|
268611|NCT02877134|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268612|NCT02446600|NRG Oncology|Linda Gedeon for Austin Miller, PhD.|716-845-1169|Linda.Gedeon@roswellpark.org|
268613|NCT02315703|Janssen Vaccines & Prevention B.V.|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268614|NCT02135484|UT MD Anderson Cancer Center|John C. Araujo, Associate Professor, Genitourinary Medical Oncology|(713) 792-2830|johna@mdanderson.org|
268615|NCT02091960|Astellas Global Development, Inc. (APGD)|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|5473
268616|NCT02028884|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
268617|NCT01983774|Columbia University|Emily DiMango, MD|212-305-0631|ead3@cumc.columbia.edu|
268618|NCT01974206|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
268619|NCT01970865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268620|NCT01896531|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
268621|NCT01856192|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
268622|NCT01622868|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
268623|NCT01592370|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
268624|NCT01015833|Memorial Sloan-Kettering Cancer Center|Ghassan Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
268625|NCT00980538|Janssen Research & Development, LLC|DIRECTOR CLINICAL LEADER EST PRODUCTS|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
282898|NCT00880581|Stanford University|Ronald Levy|6507256452|levy@stanford.edu|
292637|NCT01438489|MedImmune, LLC|Gabor Illei, MD, Senior Director|301-398-0000|illeig@Medimmune.com|
274766|NCT00450255|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
274767|NCT00450294|Department of Anesthesia|Dr. Amit Chopra|204-880-5370|amitchopra1@live.com|
274768|NCT00450372|UM/Sylvester Comprehensive Cancer Center|Lynn Feun MD|305-243-4909|lfeun@med.miami.edu|
274769|NCT00450385|University of Miami|Izidore Lossos MD|305-243-4785|ilossos@med.miami.edu|
274770|NCT00450411|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
274771|NCT00450424|Fox Chase Cancer Center|Kristen Sorice|215-214-1433|Kristen.Sorice@fccc.edu|
274772|NCT00450437|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
296961|NCT01716221|University of Colorado|Dr. Olga Klepitskaya|303-724-8984|olga.klepitskaya@ucdenver.edu|
296962|NCT01716234|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274773|NCT00450450|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
274774|NCT00450463|National Cancer Institute|Dr. Ravi Madan|301-480-7168|ravi_madan@nih.gov|
274775|NCT00450580|GlaxoSmithKline|GSK Response Center|866-435-7343||
274776|NCT00450619|National Cancer Institute, National Institutes of Health|Dr. James Gulley, M.D.|301-435-2956|gulleyj@mail.nih.gov|
274777|NCT00450658|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
274816|NCT00453193|The University of Texas M D Anderson Cancer Center|Farhad Ravandi-Kashani MD/Associate Professor|713-745-0394|eharriso@mdanderson.org|
274817|NCT00453206|Wake Forest University Health Sciences|David Hurd, MD|336-716-2843|dhurd@wakehealth.edu|
274818|NCT00453310|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
274819|NCT00453336|University of Miami Sylvester Comprehensive Cancer Center|Francisco Civantos MD|305-243-5276|fcivanto@med.miami.edu|
296963|NCT01716455|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
274820|NCT00453349|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
274821|NCT00453362|Hoffman-LaRoche|Medical Communications|800-821-8590||
274822|NCT00453388|Fred Hutchinson Cancer Research Center|Dr. Hans-Peter Kiem|206-667-4425|hkiem@fredhutch.org|
308412|NCT02577510|CF|Gaurav Gupta|6139451601|gaurav00gupta@gmail.com|
274823|NCT00453479|GlaxoSmithKline|GSK Response Center|866-435-7343||
274824|NCT00453895|University of Würzburg|Prof. Dr. Martin Fassnacht|+49-931-201-39201|fassnacht_m@medizin.uni-wuerzburg.de|
274825|NCT00453921|Dartmouth Hitchcock Medical Center|Dr. Laura Flashman|6036505824|Laura.A.Flashman@hitchcock.org|
274826|NCT00453973|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
274827|NCT00453986|GlaxoSmithKline|GSK Response Center|866-435-7343||
274828|NCT00453999|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
274829|NCT00454051|Novartis Pharmaceuticals|Study Director|862-778-8300||
274830|NCT00454116|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
274831|NCT00454142|National Cancer Centre Singapore|Dr. Wan Teck LIM|65-64368174|dmolwt@nccs.com.sg|
274832|NCT00454181|Amarillo Biosciences, Inc.|Martin J. Cummins|806-376-1741|mcummins@amarbio.com|14
274833|NCT00454194|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|507-284-9265|alex.adjei@roswellpark.org|
274834|NCT00454207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
268602|NCT03875313|Calithera Biosciences, Inc|Study Director|650-870-1000|clinicaltrials@calithera.com|
268603|NCT03694353|BioMarin Pharmaceutical Inc|Debra Lounsbury/Sr. Director, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
268604|NCT03692052|Agios Pharmaceuticals, Inc.|Medical Affairs|833-228-8474|medinfo@agios.com|
268605|NCT03583554|Baylor College of Medicine and Michael E. DeBakey VA Medical Center|Dr. Marijn Lijffijt, Assistant Professorq|713-798-5642|marijn.lijffijt@bcm.edu|
268606|NCT03538717|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268607|NCT03408873|Case Western Reserve University and University Hospitals Cleveland Medical Center|Joy Yala, MPH|216-368-0783|jxy790@case.edu|
268626|NCT00589420|Abramson Cancer Center|Ravi Amaravadi|2156622222|ravi.amaravadi@pennmedicine.upenn.edu|
268627|NCT00588770|ECOG-ACRIN Cancer Reserch Group Statistical Office|Study statistician|6176323012|eatrials@jimmy.harvard.edu|
268628|NCT00433511|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
268629|NCT00324805|ECOG-ACRIN Statistical Center|Study Statistician|617-632-3012||
274835|NCT00454246|Hoffman-LaRoche|Medical Communications|800-821-8590||
274836|NCT00454324|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
274837|NCT00454363|UT MD Anderson Cancer Center|Dr. James Yao, MD/Professor, GI Medical Oncology, Study Principal Investigator|713-792-2828|jyao@mdanderson.org|
274838|NCT00454532|Bionovo|Mary Tagliaferri, MD|5106012000|clinicaltrials@bionovo.com|
274839|NCT00454584|Centocor Research & Development, Inc.|Senior Director, Compound Development Team Leader|1 215-793-7612||
274840|NCT00454636|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
274841|NCT00454649|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274842|NCT00454779|Amgen Inc.|Study Director|866-572-6436||
274843|NCT00454805|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
274844|NCT00454818|Celladon Corporation|Jeffrey J. Rudy, Vice President|1 858-366-4288|jrudy@celladon.net|
274845|NCT00454857|Amgen Inc.|Study Director|866-572-6436||
274846|NCT00454909|GlaxoSmithKline|GSK Response Center|866-435-7343||
274847|NCT00454987|GlaxoSmithKline|GSK Response Center|866-435-7343||
274848|NCT00455013|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
274849|NCT00455195|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
274850|NCT00455312|Masonic Cancer Center, University of Minnesota|Dr. Jakub Tolar, MD||tolar003@umn.edu|
274778|NCT00450723|UM/Sylvester Comprehensive Cancer Center|Eli Avisar MD|305-243-4902|eavisar@med.miami.edu|
274779|NCT00450749|University of Texas MD Anderson Phase I/II Prevention Consortium|Powel H Brown, MD, PhD/Professor of Medicine and Cancer Prevention|713-792-2830|PHBrown@mdanderson.org|
274780|NCT00450801|University of Miami|Izidore Lossos MD|305-243-4785|ilossos@med.miami.edu|
274781|NCT00450814|Mayo Clinic|Angela Dispenzieri, M.D., Morie A. Gertz, M.D.|(507) 284-2511|Dispenzieri.Angela@mayo.edu, Gertz.Morie@mayo.edu|
274782|NCT00450866|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
274783|NCT00450983|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
274784|NCT00451035|Novartis pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
274785|NCT00451048|Princess Margaret Hospital|Dr. Karen Yee|416-946-4495|karen.yee2@uhn.on.ca|
274786|NCT00451178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
274787|NCT00451191|George Washington University Biostatistics Center|Kathryn Hirst, PhD, Research Professor, PI of coordinating center|301-881-9260|khirst@bsc.gwu.edu|8025
274788|NCT00451204|University of California Los Angeles|Dr. Rhonda Voskuhl|310-206-4636|rvoskuhl@mednet.ucla.edu|
274789|NCT00451217|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274790|NCT00451282|Children's Hospital of Philadelphia|Nancy Kassam-Adams|215-590-3118|nlkaphd@mail.med.upenn.edu|
274791|NCT00451321|GlaxoSmithKline|GSK Response Center|866-435-7343||
274792|NCT00451451|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
274793|NCT00451555|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
274794|NCT00451698|Medical College of Wisconsin|Dr. Steven Zangwill|414-266-2380|szangwill@chw.org|
274795|NCT00451906|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
274796|NCT00451958|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
274797|NCT00452114|University of Massachusetts Medical School|Stephen Krinzman, Principal Investigator|508-856-1975|stephen.krinzman@umassmed.edu|
274798|NCT00452335|Sucampo Pharma Americas, Inc.|VP, Clinical Development|301-961-3400|info@sucampo.com|
274799|NCT00452348|GlaxoSmithKline|GSK Response Center|866-435-7343||
274800|NCT00452374|The University of Texas M. D. Anderson Cancer Center|William Wierda, M.D./Associate Professor|713-745-0428|eharriso@mdanderson.org|
274801|NCT00452387|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
274802|NCT00452400|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
274803|NCT00452413|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
274804|NCT00452426|Ethicon Endo-Surgery|James Martin, PhD|513 337-7000||
274805|NCT00452439|University of Texas (UT) MD Anderson Cancer Center|Maria Cabanillas, Associate Professor, Endocrine Neoplasia and HD|(713) 563-0764|mcabani@mdanderson.org|
274806|NCT00452452|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
274807|NCT00452530|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
274808|NCT00452543|Massachusetts General Hospital|Dr. Janet Witte|617-726-5104|jwitte@partners.org|
274809|NCT00452673|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
274810|NCT00452699|GlaxoSmithKline|GSK Response Center|866-435-7343||
274811|NCT00452790|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274812|NCT00452868|Wake Forest Baptist Health|Dr. Janet Tooze|336-716-0286|jtooze@wakehealth.edu|
274813|NCT00453102|University of Miami|Izidore S. Lossos|305-243-4785|ilossos@med.miami.edu|
274814|NCT00453154|Duke University Medical Center|Dr. Neal Ready||ready001@mc.duke.edu|
274815|NCT00453180|Cincinnati Childrens Hospital|Craig Erickson|513-636-6258|craig.erickson@cchmc.org|
268630|NCT00310180|ECOG-ACRIN Cancer Research Group|ECOG-ACRIN statistician|617-632-3000|eatrials@jimmy.harvard.edu|
268631|NCT05043142|Yuria-Pharm|Tetiana Sprynsian|+380665134849|Tetiana.Sprynsian.pm@pharmaxi.com.ua|
268632|NCT04993339|University of Miami|Dr. Francesco Travascio|3052842371|f.travascio@miami.edu|
268633|NCT04992442|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
268634|NCT04929522|AinShams University|Director of Clinical Trials in Endodontics|+2022639083|endohashem@gmail.com|
268636|NCT04919161|Gaylord Hospital Inc.|Dr. Henry C. Hrdlicka, Research Coordinator|203-284-2864|hhrdlicka@gaylord.org|
268637|NCT04912700|Beaumont Hospitals|Ahmit Bahl, MD|(248) 898-9111|ahmit.bahl@beaumont.edu|
268639|NCT04904640|IRCCS Istituto Ortopedico Rizzoli|Francesco Castagnini, MD|+390516366418|francesco.castagnini@ior.it|
268641|NCT04891874|Shanghai Eastern Hepatobiliary Surgery Hospital|Dr. SHI Changying|+86-021-81887735|nona-peach@hotmail.com|
268642|NCT04883541|Üsküdar Üniversitesi|Assistant Professor Tuğba YILMAZ ESENCAN|+905057084946|tugba.yilmazesencan@uskudar.edu.tr|
268643|NCT04881968|The Dartmouth Institute|Dr. Amber Barnato|603-646-5237|amber.barnato@dartmouth.edu|
268644|NCT04486560|Johns Hopkins University|Dr. Lonny Yarmus|410-502-5224|lyarmus@jhmi.edu|
268645|NCT04357782|Central Virginia VA Health Care System|Dr. Brian Davis|804-675-5000|Brian.Davis5@va.gov|
268646|NCT04153435|Aarhus University|Lars W. Andersen|+4551781511|lwandersen@clin.au.dk|
268647|NCT04090658|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
268648|NCT03811028|Sobi|Global Communication|+4686972000|info@sobi.com|
268649|NCT03760068|Sr. Director Global Clinical Operations, General Medicine|Keri L. Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
268650|NCT03742986|NYU Langone Health - Perlmutter Cancer Center|Maryann Kwa, MD|(212) 731-6364|maryann.kwa@nyulangone.org|
268651|NCT03628781|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|15136368296|jeff.epstein@cchmc.org|
268652|NCT03560206|University of Kentucky|Misook Chung, PhD|(859) 323-8024|misook.chung@uky.edu|
274851|NCT00455429|Janssen Research and Development, 3210 Merryfield Row San Diego, CA 92121|William Barchuk, M.D.|858-784-3111||
274852|NCT00455455|CCLR|Dr Craig A Woods|519 888 4567|cawoods@uwaterloo.ca|36547
274853|NCT00455520|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Leader|609-730-4537||
274854|NCT00455533|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
274855|NCT00455650|Massachusetts General Hospital|A. Eden Evins, MD, MPH|617-643-4679|aeevins@mgh.harvard.edu|
268635|NCT04927858|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0217|clinicaltriage.rdg@boehringer-ingelheim.com|
274856|NCT00455663|UTHSCSA|Dawn I. Velligan|210-567-5508|velligand@uthscsa.edu|
274857|NCT00455689|Brigham & Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
274858|NCT00455702|Massachusetts General Hopsital|Donald C Goff|617-912-7899|goff@psych.mgh.harvard.edu|
274859|NCT00455741|Massachusetts General Hospital|Dr. Janet E. Hall|617-877-1112|hall.janet@mgh.harvard.edu|
274860|NCT00455858|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
274861|NCT00455923|GlaxoSmithKline|GSK Response Center|866-435-7343||
274862|NCT00455962|Massachusetts General Hospital|Janet E. Hall, MD|617-877-1112|jehall@partners.org|
274863|NCT00455975|Sarah Cannon Research Institute|John Hainsworth MD|1-877-691-7274|asksarah@scresearch.net|
274864|NCT00456014|Stony Brook University School of Medicine|Ramin V. Parsey, MD, PhD|631-444-3084|Ramin.Parsey@stonybrookmedicine.edu|
274865|NCT00456092|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
274866|NCT00456261|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
274867|NCT00456300|Montefiore Medical College|Rubina Heptulla|832824000|rubhep@gmail.com|
274868|NCT00456365|PKD Research Group, University of Colorado Anschutz Medical Campus|Melissa Cadnapaphornchai, MD|3037241690|pkd@ucdenver.edu|
274869|NCT00456495|The New York Eye Cancer Center|Clinic Coordinator|212-832-8170|kchin@eyecancer.com|
274870|NCT00456508|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
274871|NCT00456521|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|Medinfo@Orexigen.com|
274872|NCT00456547|Northwestern University Feinberg School of Medicine|Dr. Robert J McCarthy, Pharm D|312-926-9015|r-mccarthy@northwestern.edu|
274873|NCT00456599|University of Michigan|Mark Zalupski, MD|734-615-3969|zalupski@med.umich.edu|
274874|NCT00456625|GlaxoSmithKline|GSK Response Center|866-435-7343||
274875|NCT00456755|Department of Otorhinolaryngology, Head & Neck Surgery, West China Hospital, Sichuan University, China|Zhao Yu||yutzhao@gmail.com|
274876|NCT00456807|GlaxoSmithKline|GSK Response Center|866-435-7343||
274877|NCT00456846|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
282899|NCT00880607|Children's Hospital of Colorado, University of Colorado|Mindy Cohen, MD FAAP, Assistant Professor, Department of Anesthesiology||Mindy.cohen@childrenscolorado.org|
282900|NCT00880620|Impax Laboratories, LLC|Kaihong Jiang, Senior Director, Head of Biometrics|908-307-2234|kaihong.jiang@amneal.com|
282901|NCT00880685|University of Chicago|Dr. Jon Grant|773-834-1326|jongrant@uchicago.edu|
282902|NCT00880698|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
282903|NCT00880750|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
282904|NCT00880763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282905|NCT00880893|Sanofi Pasteur|Director||Contact-US@sanofi.com|
268638|NCT04912297|Finnish Institute for Health and Welfare|Dr. Merit Melin, Research manager||merit.melin@thl.fi|
268640|NCT04901897|Bausch & Lomb|Daniel Donatello|5853385306|Daniel.Donatello@bausch.com|
268653|NCT03443635|Tulane University Goldring Center for Culinary Medicine|Principal Investigator|3373290724|dominique.monlezun@gmail.com|
268654|NCT03340766|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
268655|NCT03277105|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268656|NCT03201965|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268657|NCT03043599|H Lee Moffitt Cancer Center & Research Institute|Bradford Perez, MD|813-745-8234|Bradford.Perez@moffitt.org|
268658|NCT02968381|University of Arizona|Judith Gordon|520-626-4970|judithg@email.arizona.edu|
268659|NCT02874742|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268660|NCT02720185|University of Wisconsin Carbone Cancer Center|Kari Wisinski|(608) 262-2876|kbwisinski@medicine.wisc.edu|
268661|NCT02706847|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
268662|NCT02701777|Hines VA|Reagan Morehouse|312-238-2993|rmorehouse@sralab.org|
268663|NCT02677896|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
268664|NCT02657434|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
268665|NCT02564900|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|1-908-992-6400|CTRinfo@dsi.com|
268666|NCT02561299|Cardiovascular Systems Inc.|Clinical Trials Manager|651.259.2500|clintrials_csi@csi360.com|
268667|NCT02548143|LFB USA|Kerry Biron, Director US Clinical Operations|508.370.5166|kerry.biron@lfb-usa.com|
268668|NCT02489318|Aragon Pharmaceuticals, Inc.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268669|NCT02448680|LFB USA, Inc.|Kerry Biron, Director US Clinical Operations|508-370-5166|kerry.biron@lfb-usa.com|
268670|NCT02393859|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
282906|NCT00880906|Vanderbilt University|Michael Vaezi, MD, PhD|615-322-3739|michael.vaezi@vanderbilt.edu|
282907|NCT00880919|University of Minnesota|Dr. S. Charles Schulz, MD|612-273-9820|scs@umn.edu|
282908|NCT00880997|Baylor College of Medicine|Thomas Kosten, MD|713-794-7032|kosten@bcm.edu|
282909|NCT00881335|Shanghai Tenth People's Hospital, Tongji University|Zhang Xiangyu|86-21-66307174|xiangyu62@126.com|
274878|NCT00456885|BIDMC|Jody Dushay|6177353343|jdushay@bidmc.harvard.edu|617
274879|NCT00457002|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
274880|NCT00457015|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
274881|NCT00457197|The University of Texas Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D., Professor|214-645-6950|sherwood.brown@utsouthwestern.edu|
274882|NCT00457249|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
274883|NCT00457301|Lung transplant program, University of Alberta Hospital|Maria Jose Santana|780-441-1661|msantana@ualberta.ca|
274884|NCT00457366|USC|Dr George Simpson|7604687106|gsimpson@usc.edu|
274885|NCT00457392|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274886|NCT00457418|Merck Sharp & Dohme Corp.|Senior Vice President,Global CLinical Development||ClinicalTrialsDisclosure@merck.com|
274887|NCT00457626|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
268671|NCT02352103|Vattikuti Urology Institute, Henry Ford Hospital|Deepansh Dalela, MD|3139162600|ddalela1@hfhs.org|
274888|NCT00457639|UT Southwestern Medical Center|Zahid Ahmad, M.D.|214-648-2377|zahid.ahmad@utsouthwestern.edu|
274889|NCT00457665|UTSouthwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
274890|NCT00457691|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274891|NCT00457730|MS Center at Evergreenhealth Care|Theodore R. Brown, MD Principle Investigator|425-899-5350|trbrown@evergreenhealth.com|
274892|NCT00457743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
274893|NCT00457795|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
274894|NCT00457821|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
274895|NCT00457977|University of Minnesota|Sarah Harnden|612-626-9011|sharnden@ccbr.umn.edu|
274896|NCT00458211|Bronx Psychiatric Center|Nigel Bark MD|718 862 5429|Nigel.Bark@omh.ny.gov|
274897|NCT00458237|Beth Israel Deaconess Medical Center|Gerburg Wulf|(617) 667-1910|gwulf@bidmc.harvard.edu|
274898|NCT00458302|Jan-Cilag Germany|EMEA Medical Affairs Director Virology|+49 7624 907580||
274899|NCT00458341|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
274900|NCT00458393|University of California, San Francisco|David Glidden|415-514-8009|david.glidden@ucsf.edu|
274901|NCT00458406|CTRC, Children's Hospital of Philadelphia|Paul R. Gallagher, MA|215-590-2739|gallagherp@email.chop.edu|
274902|NCT00458484|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Mitchell Machtay MD|216-844-2530|mitchell.machtay@uhhospitals.org|
296964|NCT01716468|VA Pittsburgh Healthcare System|Jocelyn Tan, MD|412-360-6178|Jocelyn.Tan@va.gov|
274903|NCT00458705|Memorial Sloan Kettering Cancer Center|Dr. Heather Landau|212-639-8808|landauh@mskcc.org|
268672|NCT02277444|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
274904|NCT00458783|Cleveland Clinic|Andra Duncan, MD|216-445-2372|duncana@ccf.org|
274905|NCT00458822|Memorial Sloan Kettering Cancer Center|Dr. Heather Landau|212-639-8808|LandauH@mskcc.org|
282910|NCT00881361|Mayo Clinic|Judy C. Boughey, MD|507-284-3629|boughey.judy@mayo.edu|
268673|NCT02273362|Mayo Clinic|Kenneth K. Tanabe, M.D.|507-284-2511|ktanabe@partners.org|
268674|NCT02257736|Aragon Pharmaceuticals, Inc.|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268675|NCT02252172|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268676|NCT02195479|Janssen Research and Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268677|NCT02178358|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
268678|NCT02136134|Janssen R&D US|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
268679|NCT02076009|Janssen R&D US|Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
268680|NCT02073279|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
268681|NCT02051933|CarolinasHS|Christine Churchill|704-355-6947|christine.churchill@carolinashealthcare.org|
268682|NCT01946204|Janssen Research & Development, LLC|Senior Medical Director, WC Clinical Oncology Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268683|NCT01615029|Janssen Research & Development, LLC|Senior Director, Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
268684|NCT01544127|Canandaigu VA Medical Center|Dr. Peter Britton|585-393-7926|peter.britton@va.gov|
268685|NCT01314118|Janssen Services, LLC|Strategic Lead Oncology Tas||ClinicalTrialDisclosure@its.jnj.com|
268686|NCT01171898|Aragon Pharmaceuticals, Inc.|Senior Medical Director, WC Clinical Oncology Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268687|NCT00806390|UMaryland|Stephen Gottlieb|410-328-8788|sgottlie@medicine.umaryland.edu|
268688|NCT00777036|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
268689|NCT00566618|UT MD Anderson Cancer Center|Debu Tripathy, Chair, Breast Medical Oncology|(713) 792-2817|dtripathy@mdanderson.org|
268690|NCT00442559|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268691|NCT00117338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
274906|NCT00458848|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
274907|NCT00458952|Progenics Pharmaceuticals, Inc.|Senior Director, Clinical Science Communications|914 784-1825|vdipippo@progenics.com|
274908|NCT00459043|DFCI|Robert Haddad|6176326725|robert_haddad@dfci.harvard.edu|
274909|NCT00459056|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
274910|NCT00459108|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
274911|NCT00459134|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
274912|NCT00459186|Dana-Farber Cancer Institute|Dr. Mary-Ellen Taplin|617-632-3237|Mary_Taplin@dfci.harvard.edu|
274913|NCT00459290|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
274914|NCT00459303|National Taiwan University Hospital|Fung-Rong Hu|+886223123456|fungronghu@ntuh.gov.tw|2131
274915|NCT00459316|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
274916|NCT00459342|The University of Texas (UT) MD Anderson Cancer Center|Faye Johnson, MD / Associate Professor|713-792-7734|fmjohns@mdanderson.org|
274917|NCT00459355|Bedford VA Medical Center|Dr. Kathy Horvath|781-687-2006|Kathy.Horvath@va.gov|
274918|NCT00459368|Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454||
274919|NCT00459381|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-8837|jfisher@jhmi.edu|
274920|NCT00459537|Novartis Pharmaceuticals|Study Director|862 778-8300||
274921|NCT00459667|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
274922|NCT00459706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274923|NCT00459732|Children's Hospital & Research Center, Oakland|Ellen Fung, PhD RD CCD|510-428-3885|efung@mail.cho.org|4939
274924|NCT00459810|Oregon Health & Science University Knight Cancer Institute|Study Coordinator|(503) 494-2897|eilersk@ohsu.edu|
274925|NCT00459862|Mayo Clinic|Julian Molina, M.D, Ph.D.||Molina.julian@mayo.edu|
274926|NCT00459875|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
274927|NCT00459953|Stanford University|Joel D Killen|(650) 723-5895|jkillen@stanford.edu|
274928|NCT00459979|CCCC|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
274929|NCT00460031|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@ccf.org|
296965|NCT01716520|GlaxoSmithKline|GSK Response Center|866-435-7343||
274930|NCT00460109|Mayo Clinic|Stephen M. Ansell, M.D., Ph.D.|507/284-4642|ansell.stephen@mayo.edu|
274931|NCT00460239|Johns Hopkins University School of Medicine|Eric C. Strain, M.D.|410-550-1191|ecsgss@aol.com|
274932|NCT00460265|Amgen Inc.|Study Director|866-572-6436||
274933|NCT00460408|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274934|NCT00460421|Swedish Orphan Biovitrum|Medical Program Director|+46 8 697 20 00|clinical@sobi.com|
274935|NCT00460434|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
274936|NCT00460525|Department of Epidemiology of Parasitic Diseases, University of Bamako|Mahamadou A. Thera, MD, MPH|223-222-8109|mthera@mrtcbko.org|
268692|NCT04871815|Emphycorp/Cellular Sciences, inc.|Dr. Alain Martin|9082371561|dr.martin@erols.com|
268693|NCT04851314|UC Irvine Health|Dr. Robert Ryan Field|7145065703|fieldr@uci.edu|
268694|NCT04845633|Damascus University|Dr. Line Droubi|00963966896989|droubiline@gmail.com|
268695|NCT04821245|Benaroya Research Institute|Joseph M. Neal, MD|206-223-6980|Joseph.Neal@virginiamason.org|
268696|NCT04814459|Oakland University|Dr. Sara Arena|2483648682|arena@oakland.edu|
268697|NCT04799782|JOHN D DINGELL VA MEDICAL CENTER|Dr. Abdulghani Sankari Principal Investigator|13135761000|abdulghani.sankari@va.gov|63105
268698|NCT04780919|Charles University, 2nd Faculty of Medicine|Jakub Katolicky|+420 739 081 676|jakub@katolicky.eu|
268700|NCT04773028|Kartal Kosuyolu Hihg Speciality Training and Research Hospital|Dr.Ahmet Zengin|+905365022173|dr.zenginahmet@gmail.com|
268701|NCT04755595|SUNY Downstate Health Sciences University|Jared Jagdeo MD, MS|(718) 270-1229|jared.jagdeo@downstate.edu|
268702|NCT04749745|Butler Hospital|Dr. Shiwen Yuan|2025783000|shiwen_yuan@brown.edu|
268704|NCT04737278|BDL Biochemistry, consultant for Mitosynergy|Dr Barbara Leinweber, PhD|(520)334-5444|barb@bdlbiochem.com|
268706|NCT04732819|Hebrew SeniorLife|Sarah Berry, MD|617-971-5355|sarahberry@hsl.harvard.edu|
268707|NCT04732338|Hackensack Meridian Health|Alphonsa Thomas, DO|7328364504|Alphonsa.Thomas@hmhn.org|
268708|NCT04728802|Applied Biology, Inc.|Dr. John McCoy|+1 (949)387-4526|johnm@appliedbiology.com|
268709|NCT04728594|Geisinger Clinic|Amir Goren, PhD|5702144395|agoren@geisinger.edu|
268710|NCT04725500|Philips|Chuck Cain|412-657-1814|chuck.cain@philips.com|
296966|NCT01716533|GlaxoSmithKline|GSK Response Center|866-435-7343||
268712|NCT04716426|ELJ Consultancy|Ernesto Cesar Pinto Leal Junior|+55 11 975222856|ceo@eljconsultancy.com|
268713|NCT04709068|Current Health|Clinical Research Lead|617-208-4239|study.team@currenthealth.com|
268714|NCT04704713|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager||mail@clinuvel.com|
268716|NCT04698993|Draegerwerk AG & Co. KGaA|Dr Rainer Polzius|+498824514429|rainer.polzius@draeger.com|
268718|NCT04693078|Shaare Zedek Medical Center|Dr. Dan Meir Livovsky|+34603833576|danlivo@yahoo.com|
268719|NCT04688346|University of Washington|Dr. Travis Nelson|206-290-2899|tmnelson@uw.edu|
268720|NCT04684992|Cairn Diagnostics|Chief Scientist and Compliance Officer|615-376-5464|cwilliams@cairndx.com|
268721|NCT04674644|Suleyman Demirel University|Dr Esra Oz|05326788040|esrakaraagac@sdu.edu.tr|
274937|NCT00460551|Genmab A/S|Eva Järlid Westerberg PhD|+45 7020 2728|E.Westerberg@genmab.com|
274938|NCT00460564|GlaxoSmithKline|GSK Response Center|866-435-7343||
274939|NCT00460577|Novartis Pharmaceuticals|Study Director|862-778-8300||
274940|NCT00460603|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274941|NCT00460655|GlaxoSmithKline|GSK Response Center|866-435-7343||
274942|NCT00460746|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488|rfalcon@its.jnj.com|
274943|NCT00460798|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
274944|NCT00460811|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
274945|NCT00460993|Atlanta VA Medical Center|Dr. Patricia C. Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
308413|NCT02577601|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|503-494-0757|mccrimmo@ohsu.edu|
296967|NCT01716559|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
274946|NCT00461045|Triphase Accelerator|Associate Director of Clinical and Regulatory Operations|858-295-4337|jennifer.ki@triphaseco.com|
274947|NCT00461097|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
296968|NCT01716585|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
274948|NCT00461123|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
274949|NCT00461175|Center for Epidemiology and Health Research, Germany|Dr. Klaas Heinemann|0049 (0) 30 945 101 20|k.heinemann@zeg-berlin.de|
296969|NCT01716663|Biosense Webster|Ellen Harris, Project Manager, Clinical Operations|909-839-7376|eharris8@its.jnj.com|
274950|NCT00461253|Center for Epidemiology and Health Research, Germany|Dr. Jürgen Dinger|0049 (0) 30 945 101 20|dinger@zeg-berlin.de|
274951|NCT00461292|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
274952|NCT00461305|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
296970|NCT01716715|NRG Oncology|Linda Gedeon on behalf of Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
274953|NCT00461331|Tulane University Health Sciences Center|Tina K. Thethi, MD, MPH|504-988-5044|tthethi@tulane.edu|
274954|NCT00461500|GlaxoSmithKline|GSK Response Center|866-435-7343||
274955|NCT00461513|Veterans Health Administration|Dr. Meg Plomondon|303-370-75770|Meg.Plomondon@va.gov|
274956|NCT00461552|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
274957|NCT00461591|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
274958|NCT00461630|Clinical Trial Service Unit, University of Oxford|Professor Jane Armitage|+44 (0)1865 743743|thrive@ctsu.ox.ac.uk|
274959|NCT00461708|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
274960|NCT00461734|Princess Alexandra Hospital|Dr. Gerald Kaye|07 3176 2111|gerald.kaye@health.qld.gov.au|
274961|NCT00461773|The Christ Hospital|Gina G. Chung, MD|(513) 564-7771|gina.chung@thechristhospital.com|
274962|NCT00461786|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
274963|NCT00461851|Yale University Yale Cancer Center|Dr Michael Hurwitz|2037371600|Hari.deshpande@yale.edu|
274964|NCT00461981|MedImmune, LLC|Christopher Ambrose, MD|301-398-0000|ambrosec@medimmune.com|
274965|NCT00462020|Children's Mercy Hospital|Shawn D. St. Peter, MD|816-983-6479|sspeter@cmh.edu|
274966|NCT00462072|University of Rochester|Rick Barrett|585-275-1647|rick_barrett@urmc.rochester.edu|
274967|NCT00462124|BioProtect|Galit Itzhaki|+972-9-7731929|galit@bioprotect.co.il|
274968|NCT00462228|Department of Physical Medicine and Rehabilitation, University of Missouri|Dr. S. Jon Rupright|573-882-3101|RuprightJ@health.missouri.edu|
274969|NCT00462280|University of California, Irvine|Dr. Kenneth G. Linden|714-456-3719|kglinden@uci.edu|
274970|NCT00462306|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
274971|NCT00462332|GIMEMA Foundation Data Center|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
274972|NCT00462345|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
274973|NCT00462384|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
274974|NCT00462423|Northern California Medical Center|Lynn E. Spitler, MD|415-435-9861|lynn@drspitler.com|
274975|NCT00462449|Department of Physical Medicine and Rehabilitation University of Pittsburgh|Dr. Michael C. Munin|412-648-6848|muninm@upmc.edu|
274976|NCT00462462|Orfagen|Clinical Project Manager|+33 5 34 50 64 62|info@orfagen.com|
274977|NCT00462488|Sesen Bio|Rachelle Dillon, Ph.D.|204-452-7126|rachelle.dillon@sesenbio.com|308
282911|NCT00881465|University of South Florida|Eric Storch, Ph.D.|7277678230|estorch@health.usf.edu|
282912|NCT00881504|Georgetown University Medical Center|Dr. John L Marshall|202-444-7064|marshalj@georgetown.edu|
282913|NCT00881530|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282914|NCT00881569|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
282915|NCT00881621|Georgetown University|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
282916|NCT00881647|University of California, San Francisco|Thomas C. Neylan, MD|415-750-6961|thomas.neylan@ucsf.edu|
282917|NCT00881712|University of Florida Proton Therapy Institute|Bradford Hoppe, M.D.|904-588-1800|bhoppe@floridaproton.org|
282918|NCT00881751|Medical University of South Carolina|Kate Anderton, MPH, CCRP|anderton@musc.edu|anderton@musc.edu|
282919|NCT00881868|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
282920|NCT00881894|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
282921|NCT00881959|Zimmer Dental|Hai Bo Wen|760 929 4312|haibo.wen@zimmer.com|
282922|NCT00882102|The University of Texas MD Anderson Cancer Center|Gautam Borthakur, MD/Associate Professor|713-563-1586|eharriso@mdanderson.org|
282923|NCT00882115|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
282924|NCT00882206|University of Minnesota, Pediatric Hematology Dept.|Dr. Michael Burke, MD|612.672.7422||
282925|NCT00882362|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
282926|NCT00882518|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
282927|NCT00882557|Cubist Pharmaceuticals, Inc.|Ed Campanaro/Vice President, Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
282928|NCT00882583|FDA|Shanthi Marur|2404026373|shanthi.marur@fda.hhs.gov|
282929|NCT00882661|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|
282930|NCT00882687|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
282931|NCT00882713|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
282932|NCT00882778|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
296971|NCT01716754|Novartis Pharmaceuticals|Study Director|862-778-8300||
296972|NCT01717001|University of Tennessee|Rebecca Robertson|865-974-2093|rrober28@utk.edu|
274978|NCT00462501|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
274979|NCT00462605|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|B. Douglas Smith|410-614-5068|smithdo@jhmi.edu|
274980|NCT00462644|Wake Forest University, Department of Surgery|Amy N. Hildreth, MD||ahildret@gmail.com|
274981|NCT00462670|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
274982|NCT00462709|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
268699|NCT04779606|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
274983|NCT00462722|University of Colorado Anschutz Medical Campus|Catherine Jankowski|303-724-7383|catherine.jankowski@ucdenver.edu|
274984|NCT00462735|Florida Radiation Oncology Group|Dr. Johnny Kao|813-661-6442|johnnykaomd@gmail.com|
274985|NCT00462761|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
274986|NCT00462826|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
274987|NCT00462839|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|(312)926-9015|r-mccarthy@northwestern.edu|
274988|NCT00462865|BrUOG|Bachir Sakr, MD|4018633000|kayla_rosati@brown.edu|
274989|NCT00462917|Brigham and Women's Hospital and Harvard Medical School|Robert C. Green, MD, MPH|617-264-5838|rcgreen@genetics.med.harvard.edu|
274990|NCT00462982|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
274991|NCT00463047|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
274992|NCT00463060|Good Samaritan Hospital Medical Center|Dr. Johnny Kao|(631) 376-4444|johhny.kao@chsli.org|
268703|NCT04748341|Lahore school of nursing, University of lahore, Pakistan|Ms. Mishal Liaqat (Principal Investigator)|+923441481666|mishee861@gmail.com|
274993|NCT00463151|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
274994|NCT00463229|McMaster University|Maureen Markle-Reid|905-525-9140|mreid@mcmaster.ca|22306
274995|NCT00463346|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|2039325711|elizabeth.ralevski@yale.edu|4282
274996|NCT00463385|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
268705|NCT04736069|Ufuk University|Nihan Cüzdan|5052706846|nihancuzdan@hotmail.com|
274997|NCT00463437|GlaxoSmithKline|GSK Response Center|866-435-7343||
274998|NCT00463476|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
274999|NCT00463567|Novartis Pharmaceuticals|Study Director|862-778-8300||
275000|NCT00463580|Emory University|Andrew H. Miller|404-727-8260|amill02@emory.edu|
275001|NCT00463606|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
275002|NCT00463684|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
275003|NCT00463788|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
275004|NCT00463801|Novartis Pharmaceuticals|Study Director|862-778-8300||
275005|NCT00463840|New York University Cancer Institute|Theresa Ryan, MD|212-731-5430|theresa.ryan@nyumc.org|
268711|NCT04724538|P. Hertsen Moscow Oncology Research Institute|Mariia Sedova, MD|+79253093463|mariya.sedova58@gmail.com|
275006|NCT00463866|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
268715|NCT04701814|Pharos university in Alexandria|P.T Moataz Abdelaal|1060081213|moataz.abd.student@pua.edu.eg|+20
268717|NCT04697888|Children's Mercy Hospital|Joel Lim, MD - Principal Investigator|(816)234-3000|jlim@cmh.edu|
268722|NCT04673214|MEXICAN SOCIAL SECURITY INSTITUTE|Dr. GILBERTO CRUZ ARTEAGA|55 87 44 22|gilberto.cruz@imss.gob.mx|15320
268723|NCT04668989|Coopervision|Jose A. Vega, O.D., MSc, FAAO|9256213761|jvega2@coopervision.com|
275007|NCT00464087|Medstar Health Research Institute|Ron Waksman, MD|202-877-2812|ron.waksman@medstar.net|
275008|NCT00464204|Fresenius Kabi Aktiengesellschaft|Professor Dr. Martin Westphal|+49 6172 686|martin.westphal@fresenius-kabi.com|7280
275009|NCT00464269|UCB|Clinical Trial Call Center|+1 877 822 9493||
275010|NCT00464308|Janssen-Cilag Pty Ltd|Executive Director, Medical & Scientific Affairs|+61 2 9815 3219|mhandel@its.jnj.com|
275011|NCT00464334|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275012|NCT00464438|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
275013|NCT00464464|Rutgers- Robert Wood Johnson Medical School|Dr. Roseanne Dobkin|732-235-4051|dobkinro@rutgers.edu|
275014|NCT00464490|University of California San Francisco|Julin F. Tang, MD, MS|415-206-5274|tangj@anesthesia.ucsf.edu|
275015|NCT00464542|University of Pittsburgh|Thomas Cherpes|412 692 5930|cherpestl@upmc.edu|
275016|NCT00464568|GlaxoSmithKline|GSK Response Center|866-435-7343||
275017|NCT00464620|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
275018|NCT00464646|NSABP Foundation, Inc.|Director, Department of Site and Study Management|1-800-270-3165|industrytrials@nsabp.org|
275019|NCT00464672|Novartis Vaccines and Diagnostics|Novartis Vaccines and Diagnostics||RegContactVacUS.nvdit@Novartis.com|
275020|NCT00464685|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
275021|NCT00464698|Massachusetts General Hospital|Darin D. Dougherty, MD|617-724-6300|ddougherty@partners.org|
275022|NCT00464711|Massachusetts General Hospital|Dr. Dan Iosifescu||diosifescu@partners.org|
275023|NCT00464737|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
275024|NCT00464815|GlaxoSmithKline|GSK Response Center|866-435-7343||
275025|NCT00464945|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
275026|NCT00465088|Abbott|Global Medical Services|800-633-9110||
275027|NCT00465101|American Medical Systems|Mara M. LaRock, Senior Manager, Clinical Franchise Lead|952-930-6000|mara.larock@bsci.com|
275028|NCT00465179|The University of Texas (UT) MD Anderson Cancer Center|Nizar M Tannir, MD, Professor, Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
282933|NCT00882908|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
282934|NCT00882921|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
275029|NCT00465270|Abbott|Dr. Laura O'Brien||laura.obrien@abbott.com|
275030|NCT00465361|Children's Mercy Hospitals and Clinics|Sarah S. Nyp|816-234-3000|ssnyp@cmh.edu|
275031|NCT00465530|University of Kansas Medical Center|Dr. Julie Wei|(913) 588-6664|jwei@kumc.edu|
275032|NCT00465569|Johns Hopkins University|Robert A. Wood, MD|410-955-5883|rwood@jhmi.edu|
275033|NCT00465595|Johns Hopkins University School of Medicine|Roland R. Griffiths, Ph.D., Principal Investigator|4105500034|rgriff@jhmi.edu|
275034|NCT00465647|Purdue Pharma L.P.|Executive Medical Director|800-733-1333||
275035|NCT00465738|Merz Pharmaceuticals GmbH|Claus Goebel, MD|+49-69-1503-6461|claus.goebel@merz.de|
275036|NCT00465816|GlaxoSmithKline|GSK Response Center|866-435-7343||
275037|NCT00465894|University of Alabama at Birmingham|Dr. Holly E. Richter|205-934-1704|hrichter@uabmc.edu|
275038|NCT00465972|Duke University School of Medicine|Andrew Krystal, MD, MS, Professor of Psychiatry and Behavioral Sciences|919-681-8742|andrew.krystal@duke.edu|
275039|NCT00465985|Novartis Pharmaceuticals|Study Director|862-778-8300||
268724|NCT04668352|Adicet Bio|Nick Harvey|857-315-5528|nharvey@adicetbio.com|
275040|NCT00465998|Stavanger University Hospital|Professor Torbjørn Moe Eggebø|+4792699433|tme@lyse.net|
275041|NCT00466167|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
275042|NCT00466193|Purdue Pharma LP|Clinical Leader|800-733-1333||
275043|NCT00466206|UCSF-Benioff Children's Hospital|Michael Harrison, MD|415 476-2538|pedsurg@ucsfmedctr.org|
275044|NCT00466310|DUMC|Rima Kaddurah-Douk, Associate Professor|919-684-2611|rima.kaddurah-daouk@duke.edu|
275045|NCT00466323|VA VISN 5 Mental Illness Research, Education and Clinical Center|Amy Drapalski, Ph.D.|410-637-1855|amy.drapalski@va.gov|
275046|NCT00466440|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
275047|NCT00466505|Vanderbilt-Ingram Cancer center|Jordan Berlin, MD|615-343-4128|jordan.berlin@vanderbilt.edu|
275048|NCT00466661|Medical University of South Carolina|Bryan K. Tolliver, M.D., Ph.D. (Principal Investigator)|(843) 792-4869|tollive@musc.edu|
275049|NCT00466687|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, M.D.||jeff.sosman@vanderbilt.edu|
275050|NCT00466726|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
275051|NCT00466752|University of Washington / Seattle Cancer Care Alliance|Evan Yu|206-288-1152|evanyu@u.washington.edu|
275052|NCT00466817|University of Alabama in Birmingham|David Kimberlin, MD|205-934-2424|dkimberlin@peds.uab.edu|
282935|NCT00882999|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
275053|NCT00466921|Northwestern University|Clinical Trials Office|312-695-1301||
275054|NCT00466947|GlaxoSmithKline|GSK Response Center|866-435-7343||
275055|NCT00466960|Seattle Cancer Care Alliance|Barbara Goff|206-543-3668|bgoff@u.washington.edu|
275056|NCT00467038|James J Peters VAMC|Marianne Goodman, MD|718-584-9000|marianne.goodman@va.gov|5188
275057|NCT00467051|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
275058|NCT00467077|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
275059|NCT00467259|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
275060|NCT00467272|University of Texas (UT) MD Anderson Cancer Center|Issam Raad, MD / Chair, Infectious Diseases|713-792-7943|iraad@mdanderson.org|
275061|NCT00467285|Samuel Stratton VAMC|Dr. Subhashini Yaturu|518-626-5642|Subhashini.Yaturu@va.gov|
275062|NCT00467298|VA Puget Sound Health Care System-Seattle|Cynthia M. Dougherty|206 764 2205|cynthia.dougherty@va.gov|
275063|NCT00467350|Children's Mercy Hospitals and Clinics|Melissa Miller MD|8162343000|mmiller@cmh.edu|
296973|NCT01717014|Covidien|Julie Doyle|781-839-1729|Julie.Doyle@Covidien.com|
275064|NCT00467363|NICHD|Dr Enrique Schisterman|(301) 435-6893|schistee@mail.nih.gov|
275065|NCT00467389|Substance Abuse Research Laboratory, Kansas City VA Medical Center|Kenneth Grasing|(816) 922-2756|kenneth.grasing@va.gov|
275066|NCT00467519|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
275067|NCT00467558|University of Minnesota|Jon E. Grant, MD|612-273-9736|grant045@umn.edu|
275068|NCT00467584|Mayo Clinic|Dr. Dean M. Wingerchuk|480-301-6328|wingerchuk.dean@mayo.edu|
275069|NCT00467597|Portland VA Health Care System (PORVAHCS)|Kathryn Chung, MD|503.220.8262|CHUNGKA@OHSU.EDU|51091
275070|NCT00467610|Rush university medical center|Jamile shammo|312-942-5157|jamile_shammo@rush.edu|
275071|NCT00467649|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
275072|NCT00467740|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
275073|NCT00467779|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
275074|NCT00467818|UMDNJ|Sherie Novotny MD|(732) 235-4119|novotnsl@rutgers.edu|
275075|NCT00467831|NHGRI/NIH|Dr. Thomas Markello|301-451-1305|markellot@mail.nih.gov|
275076|NCT00467844|GTx Inc.|Senior Director, Clinical Operations|901-523-9700|mdesordi@gtxinc.com|
275077|NCT00467857|Kimberly-Clark Health Care|Dr. Shu-Ping Yang|770-587-7267|Shu-Ping.Yang@kcc.com|
282936|NCT00883051|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
282937|NCT00883090|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
282938|NCT00883103|Baystate Medical Center|Oz Harmanli, MD|4137945608|oz.harmanli@baystatehealth.org|
282939|NCT00883116|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
282940|NCT00883129|David Geffen School of Medicine at UCLA|Donald P. Tashkin, M.D.|310-825-5316|dtashkin@mednet.ucla.edu|
282941|NCT00883168|Meda Pharmaceuticals, Inc.|David Ginsberg,D.O.|732 564-2364|david.ginsberg@meda.us|
282942|NCT00883181|Amgen Inc.|Study Director|866-572-6436||
282943|NCT00883233|Galderma|Jean-Charles Dhuin|+33492952921|jean-charles.dhuin@galderma.com|
282944|NCT00883246|Medtronic|Clinical Program Manager|763-398-7000|michael.p.swierzewski@medtronic.com|
282945|NCT00883337|sanofi|Trial Transparency Team||Contact-US@sanofi.com|
275078|NCT00467870|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
275079|NCT00467896|Actelion Pharmaceuticals, US, Inc.|Wade Benton, Pharm D / Director, Medical Affairs Veletri and Ventavis|(650) 624-6900|wade.benton@actelion.com|
275080|NCT00467961|NIH NHLBI|Minocher Battiwalla, MD|301-827-0939|minoo.battiwalla@mail.nih.gov|
275081|NCT00468052|UMDNJ|Anuradha Patel, MD|973 972-5254|patelan@umdnj.edu|
275082|NCT00468104|Midwest Pulmonary and critical care|George Thommi|402 206 7372|tommi4@cox.et|
275083|NCT00468143|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
275084|NCT00468169|University of Chicago|Everett E Vokes, MD|(773) 702-9306|evokes@medicine.bsd.uchicago.edu|
275085|NCT00468208|Vasculitis Clinical Research Consortium|Carol A Langford, MD MHS|216-445-6056|langfoc@ccf.org|
275086|NCT00468286|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
275087|NCT00468299|University of Rochester|Dr. Sarah Betstadt|585-276-5368|sarah_betstadt@urmc.rochester.edu|
275088|NCT00468481|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
296974|NCT01717040|Univeristy Hospitals Cleveland Medical Center|Carla Conroy, MPH|216-844-2871|carla.conroy@UHhospitals.org|
296975|NCT01717053|Duke University|Dr. Bridget Koontz|919-668-5213|bridget.koontz@duke.edu|
275089|NCT00468546|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
275090|NCT00468559|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
275091|NCT00468585|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-4558|trainat@mskcc.org|
275092|NCT00468650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
275093|NCT00468676|Dept Psychiatry, University of Washington Medical School|Dr Wayne Katon, Professor and Vice Chair|206-543-7177|wkaton@uw.edu|
275094|NCT00468728|Optimer Pharmaceuticals, Inc.|Chief Scientific Officer|1-855-343-4243|medinfo@optimerpharma.com|
275095|NCT00468819|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
275096|NCT00468845|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275097|NCT00468858|GSK|Faina Rose, PhD|610-664-8986|faina.v.rose@gsk.com|
275098|NCT00468910|Northwestern University|Dr. Seema Khan|312-503- 4236|skhan@nm.org|
275099|NCT00469014|University of Texas MD Anderson Cancer Center|Richard Champlin, MD / Professor, Chair, Stem Cell Transplantation|713-792-3618|CR_Study_Registration@mdanderson.org|
275100|NCT00469079|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
275101|NCT00469092|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
275102|NCT00469144|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
275103|NCT00469209|University of Texas M.D. Anderson Cancer Center|Muzaffar H. Qazilbash, MD/Professor, Stem Cell Transplantation|713-745-3458|mqazilba@mdanderson.org|
275104|NCT00469274|Vanderbilt University Medical Center|Dr. Thomas R. Talbot|615-322-2789|tom.talbot@vanderbilt.edu|
275105|NCT00469391|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
275106|NCT00469456|Forest Research Institute, a subsidiary of Forest Laboratories Inc.|Stephen Graham, PhD|201-427-8156|stephen.graham@frx.com|
308414|NCT02577640|Ohio State University|Casey McClurkin|614-293-6255|casey.mclurkin@osumc.edu|
275107|NCT00469508|UCLA Center for Behavioral and Addiction Medicine|Steven Shoptaw PhD|310 794 0619|sshoptaw@mednet.ucla.edu|225
268725|NCT04653766|Bioxodes|Scientific writer|+32 (0)71 239 602|stephanie.demoulin@bioxodes.com|
268726|NCT04646291|Mosie Baby (Consultant)|Karina Loyo, Ph.D., MBA, CCDM|512-563-1393|karina@drkarina.com|
268728|NCT04637997|University Hospital Erlangen, Vascular Surgery|Dr. med. Antje Mükke|+4991318532968|antje.muekke@uk-erlangen.de|
268729|NCT04634903|Stony Brook University|Dr. Jessica Schleider|917-439-1872|jessica.schleider@stonybrook.edu|
268733|NCT04628221|MCRA, LLC|Nicole Harris|202-552-5800|nharris@mcra.com|5823
268734|NCT04625426|Tan Tock Seng Hospital|George Glass, Nurse Researcher|+65 6903-5440|glass_george_frederick@ttsh.com.sg|
268735|NCT04617509|Gesynta Pharma AB|Charlotte Edenius|+46733864246|charlotte.edenius@gesynta.se|
268737|NCT04610489|Carilion Clinic|John Epling, MD, MSEd|540-581-0123|jwepling@carilionclinic.org|
268740|NCT04599959|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
268741|NCT04596085|Natural Supplements LLC|Dr. Mahir Abduldaim|+966557880299|maherdaim@yahoo.com|
268742|NCT04590027|University of Tuebingen, Department of Anaesthesiology and Intensive Care Medicine|Dr. Barbara Schlisio|+4970712985535|barbara.schlisio@med.uni-tuebingen.de|
268743|NCT04578457|Sonova AG|Juliane Raether|+41 58 928 01 01|juliane.raether@sonova.com|
268749|NCT04563767|HealthPartners Neurology|Michael Rosenbloom, MD|651-495-6363|michael.h.rosenbloom@healthpartners.com|
268750|NCT04560374|Marmara University Faculty of Health Sciences Department of Pediatric Nursing|Dr. Çağrı Çövener Özçelik|009-0216-777-57-00|ccovener@gmail.com|5773
268751|NCT04555525|Skin Sciences, PLLC|Senen Pena|502-451-9000|spdermresearch@yahoo.com|
268754|NCT04548622|Yale University Department of Psychiatry|Dr. Philip R. Corlett PhD|(203) 974-7866|philip.corlett@yale.edu|
268757|NCT04542694|A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation|Academician Dmitry Pushkar|+7495-609-67-00|dmitry.pushkar@gmail.com|
268758|NCT04542226|NPO Petrovax Pharm, LLC|Nikolay Dodonov, Head of medical department|Phone: +7(495) 730-75-45 ext.|DodonovNS@petrovax.ru|125
268761|NCT04534764|Johnson & Johnson Vision Care|Meredith Bishop, OD, MS, FAAO-Sr. Principal Research Optometrist|904-443-1783|mbishop4@its.jnj.com|
268762|NCT04534491|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
268763|NCT04534465|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
268770|NCT04615832|Fisher & Paykel Healthcare Ltd.|Bhavi Ogra|+64 9 574 0123|bhavi.ogra@fphcare.co.nz|7882
275108|NCT00469833|Cincinnati VAMC|David D'Alessio, MD, Section head, Endocrinology, Cincinnati VAMC|513-475-6478|david.d'alessio@va.gov|
296976|NCT01717209|Stanford University|Charles Hill|(650) 725-1930|chill1@stanford.edu|
275109|NCT00469859|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
275110|NCT00469898|Vanderbilt-Ingram Cancer Center|Leora Horn, M.D.|615-322-4967|leora.horn@vanderbilt.edu|
275111|NCT00469911|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-0183|groplerr@mir.wustl.edu|
275112|NCT00470054|Wake Forest University|Antonius Miller||aamiller@wfubmc.edu|
296977|NCT01717287|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275113|NCT00470093|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Carol Ann Huff|410-955-8842|huffca@jhmi.edu|
275114|NCT00470106|VA Greater Los Angeles|Michael F. Green, PhD|(310)2693376|michael.green6@va.gov|
275115|NCT00470158|AHRQ|Stephanie Chang|301 427-1490|stephanie.chang@ahrq.hhs.gov|
275116|NCT00470184|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
275117|NCT00470262|Denver VA Medical Center|Dr. Neda Rasouli|303-399-8020|neda.rasouli@ucdenver.edu|4314
275118|NCT00470275|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
275119|NCT00470301|Montefiore Medical Center|NYCC Coordinating Center|718-405-8404|jsparano@montefiore.org|
275120|NCT00470366|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman, MD|646-422-4491|feldmand@mskcc.org|
275121|NCT00470392|Louis Stokes VA Medical Center and University Hospitals Case Medical Center|Kevin D. Cooper MD|216 844 3111|kevin.cooper@uhhospitals.org|
275122|NCT00470418|James J Peters VA Medical Center|Dr. Hillel Grossman|718-584-9000|hillel.grossman2@va.gov|5752
275123|NCT00470470|Memorial Sloan-Kettering Cancer Center|Dr. Richard Carvajal|646-888-4161|carvajar@mskcc.org|
275124|NCT00470535|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
275125|NCT00470548|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
275126|NCT00470600|Cumberland Pharmaceuticals|Amy Rock, Ph.D.|615-255-0068|arock@cumberlandpharma.com|
275127|NCT00470626|Cook|Scott Snyder|765-463-7537|ssnyder@medinst.com|
296978|NCT01717313|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275128|NCT00470717|UHClevelandMC|Dr. Lydia Furman|216-844-8260|Lydia.Furman@uhhospitals.org|
275129|NCT00470834|GlaxoSmithKline|GSK Response Center|866-435-7343||
275130|NCT00470847|Dana-Farber Cancer Institute|Nancy Lin, MD|617-632-2335|nlin@partners.org|
275131|NCT00471068|Alcon Labs|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
275132|NCT00471081|GlaxoSmithKline|GSK Response Center|866-435-7343||
275133|NCT00471107|NIH/NINDS|Eric Wassermann|301-496-0151|wassermanne@ninds.nih.gov|
275134|NCT00471146|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275135|NCT00471237|GlaxoSmithKline|GSK Response Center|866-435-7343||
275136|NCT00471276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275137|NCT00471315|Medical University of South Carolina|Peter Cotton, MD|(843) 792-6999|CottonP@MUSC.edu|
275138|NCT00471328|Novartis Pharmaceuticals|Study Director|862-778-8300||
275139|NCT00471354|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
296979|NCT01717326|Merck Sharp & Dohme Corp.|Results Point of Contact* Name or Official Title Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268727|NCT04646109|Afyonkarahisar Health Sciences University|Prof. Dr. Nurullah Okumuş|+90 532 4372406|drnuri@hotmail.com|
268730|NCT04633642|Diabetic Foot Unit, Clínica Universitaria de Podología, Facultad de Enfermería, Fisioterapia y Podología, Universidad Complutense de Madrid, 28040 Madrid, Spain|Dr. Francisco Javier Álvaro Afonso|913-941-502|alvaro@ucm.es|+34
268731|NCT04633564|Mylan GmbH|Keri Vaughan, Senior Director|+215.280.2846|keri.vaughan@viatris.com|
268732|NCT04633174|Dartmouth-Hitchcock Medical Center|Dr. Nicholas Daniel, Staff Physician, Emergency Services|(603) 650-7254|Nicholas.Daniel@hitchcock.org|
268736|NCT04616430|Atossagenetics|Dr. Steven Quay|206.419.4873|steven.quay@atossainc.com|
268738|NCT04608500|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
268744|NCT04578496|CLINUVEL PHARMACEUTICALS LIMITED|Clinical Operations Manager||mail@clinuvel.com|
268752|NCT04553497|Ege University Faculty of Medicine, Physical Medicine and Rehabilitation|Dr. Emine Duran|+905372103145|docemineduran@gmail.com|
268755|NCT04547036|Dept. Ophthalmology at Paracelsus Medical University Salzburg|PD Dr. Markus Lenzhofer PhD FEBO|+43 57255|m.lenzhofer@salk.at|24201
268759|NCT04540627|mAbxience Research SL|Director of Clinical Trials|+34917711500|susana.millan@mabxience.com|
268760|NCT04540510|Nuvance Health (formerly Western Connecticut Health Network)|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
268764|NCT04533204|VA Ann Arbor Healthcare System; University of Michigan|Dr. Benjamin Hampstead|734-763-9259|bhampste@med.umich.edu|
268771|NCT04432272|Beaumont Hospitals|Matthew Sims, MD|248-551-0027|matthew.sims@beaumont.org|
268772|NCT04246541|University Hospitals Cleveland Medical Center|Dr. Michael Karns|216-844-7200|michael.karns@uhhospitals.org|
268773|NCT04093258|Johnson & Johnson Vision Care|Thomas R. Karkkainen, OD, MS, FAAO|1-800-843-2020|tkarkkai@its.jnj.com|
275140|NCT00471380|Alcon Research, LTD|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
275141|NCT00471445|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
275142|NCT00471497|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
275143|NCT00471536|Karmanos Cancer Institute at Wayne State University|Ulka Vaishampayan, M.D.||vaishamu@karmanos.org|
275144|NCT00471705|Universidad de Antioquia - Colombia|Iván Darío Vélez Bernal|574 + 219 6501 - 02|idvelez@pecet-colombia.org|
275145|NCT00471718|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-936-3048|jeff.sosman@vanderbilt.edu|
275146|NCT00471822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
296980|NCT01717391|The University of Iowa|John M. Buatti, MD|319-356-2699|john-buatti@uiowa.edu|
275147|NCT00471848|European Group for Blood and Marrow Transplantation|Prof. Judith Marsh|+31 (0)71 5265005|a.j.barrois@lumc.nl|
275148|NCT00471887|UCLA|Antoni Ribas, MD|310-206-3928|aribas@mednet.ucla.edu|
275149|NCT00472030|University of Iowa|Janet Fairley, M.D.|319-384-8560|janet-fairley@uiowa.edu|
275150|NCT00472056|UT MD Anderson Cancer Center|Chitra M. Hosing, MD / Associate Professor||mvpacheco@mdanderson.org|
275151|NCT00472199|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
275152|NCT00472290|Amgen Inc.|Study Director|866-572-6436||
275153|NCT00472303|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
275154|NCT00472420|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
275155|NCT00472446|Cantonal Hospital St. Gallen|Thomas Steffen, MD|0041 71 494 1111|thomas.steffen@kssg.ch|
275156|NCT00472576|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|Dr. Carlos Zarate|301-451-0861|zaratec@mail.nih.gov|
275157|NCT00472641|Stanford University School of Medicine|Dr. Po W. Wang|650-723-2483|wangp0@stanford.edu|
275158|NCT00472732|Children's Research Institute|Andrea Gropman, M.D.|202-476-2120|agropman@childrensnational.org|
282946|NCT00883389|University of Maryland, School of Medicine|Dr. Jeffrey C. Fink, Associate Professor, Nephrology|410-328-5720|jfink@medicine.umaryland.edu|
282947|NCT00883415|University of Maryland Baltimore|Jeffrey C. Fink MD, MS; Principal Investigator|410-328-4822|jfink@som.umaryland.edu|
308415|NCT02577718|MD Anderson Cancer Center|Dr. A M Chaftari|7137923491|achaftar@mdanderson.org|
282948|NCT00883493|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
292638|NCT01438541|Molnlycke Health Care AB|Tina Kjellén|+46317223098|tina.kjellen@molnlycke.com|
292639|NCT01438710|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
292640|NCT01438814|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
268739|NCT04607291|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
308416|NCT02577822|Northwestern University|David Manning, MD|312-695-6800|david.manning@nm.org|
292641|NCT01438840|Eisai Call Center|Eisai Inc.|888-422-4743||
292642|NCT01438957|Pfizer|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308417|NCT02577887|Abbott (previously St Jude Medical)|Grant Kim|818-493-3147|grant.kim@abbott.com|
292643|NCT01438996|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
292644|NCT01439009|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
292645|NCT01439035|Massachusetts General Hospital|Dr. Gary Tearney PI|617-724-2979|gtearney@partners.org|
308418|NCT02577900|Queen Elizabeth Hospital|Dr. Tsang Ka-Kit|+852-35062610|kktsang3@netvigator.com|
292646|NCT01439074|Changhai Hospital of Shanghai|Prof Xia, Zhaofan|+86 2181873471||
308419|NCT02577978|Northwestern Medicine|David W Manning|3124726023|David.Manning@nm.org|
292647|NCT01439087|Massachusetts General Hospital|Gary Tearney, MD, PhD|617-724-2979|GTEARNEY@PARTNERS.ORG|
292648|NCT01439126|Concordia Pharmaceuticals Inc.|John AR McCleery, CPA, CA, Managing Director and CFO|1-246-256-1861|jmccleery@concordiarx.com|
296981|NCT01717456|University of North Carolina at Chapel Hill|William E. Whitehead, PhD, Professor of Medicine|(919) 843-6961|William_Whitehead@med.unc.edu|
296982|NCT01717521|UWMC|Dr. Laurent Bollag|2063277328|bollag@uw.edu|
296983|NCT01717638|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
296984|NCT01717742|Hospital for Sick Children|Dr. Eyal cohen|416-813-7654|eyal.cohen@sickkids.ca|
296985|NCT01717768|TesoRx Pharma LLC|Michael Oefelein, MD, Chief Medical Officer|909-595-0500|karl@tesorx.com|104
296986|NCT01717859|UCLA|Veena K. Ranganath|310-825-4321|vranganath@mednet.ucla.edu|
296987|NCT01717872|Women and Children's Hospital of buffalo|Dr. Jerrold Lerman|716 878 7701|jerrold.lerman@gmail.com|
296988|NCT01717898|University of California, San Francisco|Charles Ryan, MD|877-827-3222|clinicaltrials@ucsf.edu|
296989|NCT01717976|Durham VA HSR&D|Susan N. Hastings|919-286-0411|susan.hastings@va.gov|4033
268745|NCT04577183|RedDress Medical|Clinical Trial Manager|1-800-674-9615|alon@reddress.co.il|
296990|NCT01717989|Amgen Inc.|Study Director|866-572-6436||
296991|NCT01718028|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D.|1-888-451-3937|alcon.medinfo@alcon.com|
296992|NCT01718353|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
296993|NCT01718483|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
296994|NCT01718509|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
296995|NCT01718522|Kinder- und Jugendkrankenhaus Auf der Bult|Prof. Dr. Thomas Danne|0511-8115-3331|danne@hka.de|
308420|NCT02577991|Northwestern University Department of Orthopaedic Surgery|Surabhi Bhatt|312-472-6024|surabhi.bhatt@nm.org|
268753|NCT04551677|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
268756|NCT04544566|Coloplast A/S|Head of Scientific Affairs|+45 4911 1111|clinicaltrialsgovSA@coloplast.com|
268765|NCT04532164|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
268766|NCT04531813|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
268767|NCT04531527|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
268768|NCT04531540|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
268774|NCT04011826|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAP.trial@fphcare.co.nz|7044
268775|NCT03993379|CytomX Therapeutics|Lawrence Lu|(650) 515-3185|clinicaltrials@cytomx.com|
268776|NCT03956615|Vrije Universiteit Brussel|Dr. Matthias D'Huyvetter|+3224776013|afspraak_nucleaire@uzbrussel.be|
268777|NCT03803059|Crown Laboratories, Inc|Thomas Hitchcock, PhD.|8883723982|THitchcock@crownlaboratories.com|
275159|NCT00472797|EMD Serono, INc.|Fernando Dangond, MD|781 681 2348|fernando.dangond@emdserono.com|
275160|NCT00472849|The University of Texas MD Anderson Cancer Center|William G. Wierda, MD, PhD, BS / Associate Professor|713-745-0428|eharriso@mdanderson.org|
275161|NCT00473083|BC Cancer Agency|Dr. Barbara Melosky, Principal Investigator|604-877-6000|BMelosky@bccancer.bc.ca|
275162|NCT00473265|Columbia University Medical Center|John P. Bilezikian MD|212-305-2663|jpb2@columbia.edu|
275163|NCT00473330|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
275164|NCT00473382|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
275165|NCT00473434|Jan-Cil Australia|Regional Medical Affairs Therapeutic Lead Immunol|61 2 88753219||
296996|NCT01718535|Mount Sinai Services Inc.|Azar Azad|416-856-8545|aazad@mtsinai.on.ca|
275166|NCT00473512|Janssen R & D|Senior Director, Clinical Research|(310) 943-8040||2917
275167|NCT00473564|University of Alabama at Birmingham|William Carroll, MD|205-934-9767|wcarroll@uabmc.edu|
275168|NCT00473590|Hoffman-LaRoche|Medical Communications|800-821-8590||
275169|NCT00473642|Retina Specialists of Michigan|Scott Westhouse, DO|616-954-2020|s.westhouse@gmail.com|
275170|NCT00473655|AstraZeneca|Gerard Lynch|09645895|aztrial_results_posting@astrazeneca.com|44 15
275171|NCT00473668|GlaxoSmithKline|GSK Response Center|866-435-7343||
275172|NCT00473694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275173|NCT00473746|Janssen R&D US|Sr. Director, Clinical Research|(310)914-2917||
275174|NCT00473824|ADMA Biologics, Inc.|Rebecca Avila|561-989-5853|reavila@admabio.com|
296997|NCT01718691|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1125||
268746|NCT04574999|Italfarmaco|Dr. Concepción Nieto|+34 91 657 23 23|cnieto@itfsp.com|
268769|NCT04530591|Hospital of the University of Pennsylvania|Jacob Brenner, Assistant Professor of Medicine|215-662-2222|Jacob.Brenner@pennmedicine.upenn.edu|
268778|NCT03723590|Medline Industries|Julie Miller|630-418-6891|jamiller@medline.com|
268779|NCT03720392|Massachusetts General Hospital|Zachariah DeFilipp, MD|617-643-3944|ZDEFILIPP@MGH.HARVARD.EDU|
268780|NCT03515226|University of Washington, Department of Psychiatry & Behavioral Sciences|Dr. Patricia Arean, Director, UW ALACRITY Center|206-221-8692|parean@uw.edu|
268781|NCT03430895|Memorial Sloan Kettering Cancer Center|Dr. Samuel Funt, MD|646-888-4770|funts@mskcc.org|
268782|NCT03402841|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
268783|NCT03388138|Johnson & Johnson Vision Care, Inc.|Brian Pall O.D, MS, FAAO|1-800-843-2020|bpall@its.jnj.com|
268784|NCT03321617|New York State Psychiatric Institute|Ragy Girgis, MD|646-774-5553|ragy.girgis@nyspi.columbia.edu|
268785|NCT03230838|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268786|NCT03183778|NYU Langone Health|David Goldfarb, MD|212-263-0744|David.Goldfarb@nyulangone.org|
268787|NCT03113955|Zhongda Hospital Southeast University|Dr. Gaojun Teng|13805171500|gjteng@vip.sina.com|+86
268788|NCT03029234|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
268789|NCT02995694|Alvogen Pine Brook|Meena Venugopal|973-532-7824|meena.venugopal@alvogen.com|
268790|NCT02937818|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
268791|NCT02926833|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
275175|NCT00473837|Medical Research Council Unit, The Gambia|Mrs Vivat Thomas-Njie|+220-4495442/6|vthomas@mrc.gm|2204
275176|NCT00473876|University of Dundee|Professor Chim C Lang|0044(0)1382 496375|c.c.lang@dundee.ac.uk|
275177|NCT00473889|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
282949|NCT00883558|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
282950|NCT00883675|Maestro|Michael Mann, MD|650-380-9579|michael.mann@ucsfmedctr.org|
282951|NCT00883688|The University of Texas (UT) MD Anderson Cancer Center|MD Anderson Multicenter coordinating for Collaborative Ependymoma Research Network Study (CERN)||CR_Study_Registration@mdanderson.org|
282952|NCT00883740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282953|NCT00883753|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
282954|NCT00883779|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
282955|NCT00884039|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
282956|NCT00884052|University od California San Diego|Sponsor and Principal Investigator|8588226700|rhaas@ucsd.edu|
282957|NCT00884065|Catalan Institut of Health - Servei de Rhb Sant Ildefons|Martín Eusebio Barra López||martinbarra@gmail.com|
282958|NCT00884117|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
282959|NCT00884221|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
282960|NCT00884273|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
282961|NCT00884286|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
282962|NCT00884312|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
282963|NCT00884325|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
282964|NCT00884377|Walter Reed Army Medical Center|Dr. Naomi Aronson, Principal Investigator|202-782-8691|naronson@usuhs.mil|
282965|NCT00884390|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
282966|NCT00884585|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
282967|NCT00884611|Stanford University|Dr. Bruce Buckingham, MD||buckingham@stanford.edu|
282968|NCT00884650|Children's Hospital Colorado|Dr. Frank Chang|720-777-6900|Chang.Frank@tchden.org|
282969|NCT00884741|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
282970|NCT00884754|London Health Sciences Centre|Philip Jones|519-685-8500|philip.jones@lhsc.on.ca|36306
308421|NCT02578186|Procter & Gamble|Andrew L. Carr, PhD|513-622-0928|carr.an@pg.com|
275178|NCT00474045|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
275179|NCT00474058|UCB|UCB Clinical Trial Call Center|+1877 822 9493||
275180|NCT00474123|Heart Institute (InCor) Hospital of the Faculty of Medicine, University of São Paulo (HCFMUSP)|Comparison of Antiplatelet and Anti-inflammatory Effects of High Dose Statin Monotherapy Versus Mode|55-11-30695058|eduardopesaro@hotmail.com|
275181|NCT00474175|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275182|NCT00474201|National Institutes of Health|Scott Penzak|301-496-2997|sp286u@nih.gov|
275183|NCT00474240|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
275184|NCT00474253|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275185|NCT00474266|GlaxoSmithKline|GSK Response Center|866-435-7343||
275186|NCT00474383|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024.|Senior Director|310-943-8040||2917
275187|NCT00474487|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
275188|NCT00474526|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
275189|NCT00474539|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
275190|NCT00474617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275191|NCT00474630|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
296998|NCT01719003|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
275192|NCT00474708|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
275193|NCT00474760|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275194|NCT00474786|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275195|NCT00474812|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Charles Nock MD|216-844-3862|charles.nock@uhhospitals.org|
275196|NCT00474851|Boston Children's Hospital|Dr. Amy D. DiVasta|617-355-3792|Amy.DiVasta@childrens.harvard.edu|
275197|NCT00474903|Mayo Clinic Rochester|Paul J. Limburg, M.D., M.P.H.||limburg.paul@mayo.edu|
275198|NCT00474929|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
275199|NCT00474955|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
296999|NCT01719172|Covidien|Julie Totten|781-839-1729|Julie.Totten@Covidien.com|
275200|NCT00474968|CytoCore, Inc.|Richard Domanik, Ph.D.|312-222-9550|rdomanik@cytocoreinc.com|
275201|NCT00474994|Memorial Sloan Kettering Cancer Center|Dr. Mary Keohan|646-888-4160|KeohanM@mskcc.org|
275202|NCT00475020|UT MD Anderson Cancer Center|Popat,Uday,M.D. / Stem Cell Transplantation|713-745-3055|UPOPAT@MDANDERSON.ORG|
275203|NCT00475033|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
275204|NCT00475085|University of Rochester|Dr. Charles Heckler|585 273-1141|checkler@urmc.rochester.edu|
275205|NCT00475150|University of Wisconsin Comprehensive Cancer Center|Mark B. Juckett, MD||mbj@medicine.wisc.edu|
275206|NCT00475176|National Institute of Diabetes and Digestive and Kidney Diseases, National In|Jay H. Hoofnagle, M.D.|301-496-1333|hoofnaglej@mail.nih.gov|
275207|NCT00475215|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275208|NCT00475228|University o Pittsburgh|Heather Hohmann, MD|412-641-1441|hhohmann@mail.magee.edu|
275209|NCT00475241|VA Ann Arbor Healthcare System|Dr. Sheila A.M. Rauch|734-845-3545|sherauch@med.umich.edu|
275210|NCT00475306|Montefiore Medical Center|Dr. BW Friedman|718-920-6626|befriedm@montefiore.org|
275211|NCT00475319|Dermatologicals & Ophthalmologicals, Otsuka Pharmaceutical Co., Ltd.|Eiji Murakami|+81-6-6231-6067||
275212|NCT00475423|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
275213|NCT00475501|Geriatric Research Education and Clinical Center|Stephen Borst, Ph.D|352-374-6114|stephen.borst@va.gov|5033
275214|NCT00475644|Eli Lilly and Company|Cheif Medical Officer|800-545-5979||
275215|NCT00475670|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
275216|NCT00475709|St Jude Medical|Kelly Erickson|16517566580|kaerickson@sjm.com|
268747|NCT04572997|Prof. Dr. Kristian Reich|Prof. Dr. Kristian Reich|+49 1722701941|kreich@jerucon.com|
268792|NCT02700698|University of Arkansas for Medical Sciences; Arkansas Children's Research Institute|Elisabet Borsheim, PhD|501-364-3053|EBorsheim@uams.edu|
268793|NCT02699086|BioLite, Inc.|Hsien-Ming Wu|+886-6579631|sonnywu@bioliteinc.com|
268794|NCT02698865|DePuy Synthes|FRANCHISE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
268795|NCT02660086|Massachusetts General Hospital|Dr. Anne Thorndike, Prinicipal Investigator|6177244608|athorndike@mgh.harvard.edu|
268796|NCT02653482|Saint Luke's Hospital of Kansas City|Program Manager, Cardiometabolic Research|8166957561|DEFINE-HF@saint-lukes.org|
268797|NCT02454933|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
268798|NCT02335749|Zeltiq Aesthetics|Kerrie Jiang, Director Clinical Affairs|925-621-7462|kerrie.jiang@allergan.com|
268799|NCT02282020|AstraZeneca AB|Global Clinical Leader|1-877-240-9479|ClinicalTrialTransparency@astrazeneca.com|
268800|NCT02129647|NYU Langone|Theodore Nicolaides|212-263-9959|Theodore.Nicolaides@nyualangone.org|
268801|NCT02071901|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Sudipto Mukherjee|1-866-223-8100|TaussigResearch@ccf.org|
268802|NCT01959139|SWOG Statistical Center|SWOG Statistician|2066674623|mduong@fredhutch.org|
268803|NCT01874353|AstraZeneca|Global Clinical Program Lead|1-877-240-9479|information.center@astrazeneca.com|
268804|NCT01597778|The Emmes Company|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|10221
268805|NCT01522976|SWOG Statistical Center|Leukemia Committee Statistician|206-667-6597|amoseley@fredhutch.org|
268806|NCT01286272|Alliance for Clinical Trials in Oncology|Kristie A. Blum, MD|614-293-8858|kristie.blum@osumc.edu|
275217|NCT00475722|University of Michigan|Dr. Zora Djuric|734-615-6210|zoralong@umich.edu|
275218|NCT00475735|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275219|NCT00475787|Canandaigua VA Medical Center|Paul Dougherty, DC|585-463-2673|paul.dougherty@va.gov|
275220|NCT00475852|Johnson & Johnson Pharmaceutical Research & Development, LLC|Vice President, Franchise Development|610-651-6628||
275221|NCT00475865|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
275222|NCT00475878|Butler Hospital|Dr. Michael Stein|401-455-6646|michael_stein@brown.edu|
275223|NCT00475904|EpiCept Corporation|Chief Medical Officer|914-606-3500|sallard@epicept.com|
275224|NCT00475982|VA Medical Center Greater Los Angeles Healthcare System|William Aronson, MD|3102683446|waronson@ucla.edu|
275225|NCT00476008|Charles E. Schmidt College of Medicine, Florida Atlantic University|Peter Holland, MD|561-297-0164|holland@fau.edu|
275226|NCT00476021|University of Pittsburgh|Principal Investigator|412-641-5496|chenba@upmc.edu|
275227|NCT00476047|Fred Hutchinson Cancer Research Ctr|Mazyar Shadman, MD|2066675467|mshadman@fredhutch.org|
275228|NCT00476086|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susanna_campos@dfci.harvard.edu|
275229|NCT00476151|EpiCept Corporation|Chief Medical Officer|914-606-3500|deverton@epicept.com|
275230|NCT00476229|UT MD Anderson Cancer Center|Chitra M. Hosing, MD/Associate Professor||gmccormi@mdanderson.org|
275231|NCT00476242|NYS Psychiatric Institute|Adam Bisaga|646-774-6155|amb107@columbia.edu|
275232|NCT00476476|Dana-Farber Cancer Institute|Neil Horowitz MD|617.732.8843|NHOROWITZ@mgh.harvard.edu|
275233|NCT00476593|Department of Ophthalmology, St. Olavs Hospital, Trondheim Norway|Dr Alexandra Wexler|99716763|a.wexler@online.no|0074
275234|NCT00476645|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
275235|NCT00476788|Greenville Hospital System|Elaine Moreland MD|8644545661|emoreland@ghs.org|
268748|NCT04570670|Banner Life Sciences LLC|Thomas Lategan, PhD|3368990959|thomas.lategan@bannerls.com|
275236|NCT00476957|Medtronic Bakken Research Center|Dr. Frank van Leeuwen, Director Clinical Research Coronary and Renal Denervation|+31 43 3566622|frank.van.leeuwen@medtronic.com|
275237|NCT00476996|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
275238|NCT00477087|Stanford University Medical Center|Sandy Srinivas, MD; Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
275239|NCT00477152|Baxter Halthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
275240|NCT00477165|Stanford University|Uri Ladabaum, MD, MS||ladabau@stanford.edu|
275241|NCT00477191|Department of Dermatology, Mass General Hospital|Alexa Boer Kimball, MD MPH|617-726-0149|akimball@partners.org|
275242|NCT00477204|University of Colorado Denver|David Maahs, MD, PhD|303-724-2323|david.maahs@ucdenver.edu|
275243|NCT00477269|Novartis Pharmaceuticals|Study Director|862-778-8300||
275244|NCT00477295|Eisai Call Center|Eisai Inc.|888-422-4743||
275245|NCT00477334|Novartis Pharmaceuticals|Study Director|862-778-8300||
275246|NCT00477386|IndianaU|Daniela Matai, MD|317-944-0920|dmatai@iupui.edu|
275247|NCT00477451|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
275248|NCT00477464|GlaxoSmithKline|GSK Response Center|866-435-7343||
275249|NCT00477490|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
275250|NCT00477594|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
275251|NCT00477607|VA RR&D National Center for Rehbilitative Auditory Research|Dawn Konrad-Martin|503-220-8262|dawn.martin@va.gov|52962
275252|NCT00477633|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
275253|NCT00477659|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
275254|NCT00477672|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
268807|NCT01145495|Weill Cornell Medical College|Peter Martin, M.D.||pem9019@med.cornell.edu|
268808|NCT01134601|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citind@mail.nih.gov|
268809|NCT01118026|Alliance for Clinical Trials in Oncology|Ann S. LaCasce, MD|617-632-5959|alacasce@partners.org|
268810|NCT00879086|Eisai Inc.|Eisai Medical Information|888-274-2378|esi_oncmedinfo@eisai.com|+1
268811|NCT00864227|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
268812|NCT00731731|Mayo Clinic|Evanthia Galanis, M.D.||galanis.evanthia@mayo.edu|
268813|NCT00685360|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
268814|NCT00299728|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
268815|NCT00159588|St. lavs Hospital|Professor Knut hagen|95401579|knut.hagen@stolav.no|
268816|NCT00095784|University of Chicago|Olatoyosi Odenike, MD|773-702-3354|todenike@medicine.bsd.uchicago.edu|
268817|NCT00070499|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
275255|NCT00477685|Grewal Eye Institute|S.P.S Grewal, MD|+91-172-5056969|drgrewal@gmail.com|
275256|NCT00477750|Mayo Clinic|Dr. Vivek Roy||roy.vivek@mayo.edu|
275257|NCT00477971|Mayo Clinic|Dr. Morie Gertz||gertz.morie@mayo.edu|
275258|NCT00478023|Grunenthal GmbH|Claudia Leinweber|49 241 569 2509|claudia.leinweber@grunenthal.com|
275259|NCT00478036|University of Colorado, Dept. of Ophthalmology|Malik Kahook, MD|720-848-2501|Malik.kahook@ucdenver.edu|
275260|NCT00478140|The University of Texas (UT) MD Anderson Cancer Center|Dr. Ahmed Kaseb / Associate Professor|713-792-2828|akaseb@mdanderson.org|
275261|NCT00478192|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
275262|NCT00478205|Eisai Call Center|Eisai Inc.|888-422-4743||
275263|NCT00478218|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
275264|NCT00478231|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275265|NCT00478244|Masonic Cancer Center, University of Minnesota|John E. Wagner, M.D.|612-626-2961|wagne002@umn.edu|
275266|NCT00478257|UCSD|Dr. Sonia Ancoli-Israel|858 642-7710|sancoliisrael@ucsd.edu|
297000|NCT01719224|Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital|Matthias Eikermann, MD, PhD|617-643-7735|meikermann@partners.org|
275267|NCT00478335|University of Colorado Denver|Melissa Cadnapaphornchai, MD|720776263|melissa.cadnapaphornchai@ucdenver.edu|
275268|NCT00478361|UT MD Anderson Cancer Center, Community Clinical Oncology Program Research Base|Nizar M Tannir, MDChair Ad Interim, Genitourinary Medical Oncology|713-563-7265|ntannir@mdanderson.org|
275269|NCT00478426|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2082|amit.oza@uhn.ca|
275270|NCT00478556|UAB Hospital Radiology|Lisa Nelson|205-934-4015|lnelson@uabmc.edu|
275271|NCT00478569|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
275272|NCT00478608|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
275273|NCT00478647|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
275274|NCT00478673|Boston Scientific Corporation|Jim Taufen, Regulatory Affairs Manager|763-255-0683|taufenj@bsci.com|
275275|NCT00478777|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
297001|NCT01719367|Florida Electrophysiology Associates|Matthew Kolek, MD|(561) 434-0353|info@heartrhythmexperts.com|
275276|NCT00478881|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
275277|NCT00478933|Medtronic BRC|Margriet Kruijshoop, Clinical Research Manager|+31623910708|margriet.kruijshoop@medtronic.com|
282971|NCT00884793|UCSF|Steven Yukl|415-221-4810|steven.yukl@ucsf.edu|3930
282972|NCT00884806|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
282973|NCT00884832|Mayo Clinic|Dr. Adil E. Bharucha|507-266-9156|bharucha.adil@mayo.edu|
282974|NCT00884897|Maryland Psychiatric Research Center|Deanna L. Kelly Pharm.D., BCPP|410-402-96860|dkelly@mprc.umaryland.edu|
282975|NCT00884910|Netherlands Cancer Institute|Prof Dr FJM Hilgers|+31 20 512 2550|f.hilgers@nki.nl|
282976|NCT00884949|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
282977|NCT00885079|Otsuka Pharmaceutical Co., Ltd.|Mr. Kyoji Imaoka|-81-6-6943-7722||
282978|NCT00885092|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
282979|NCT00885105|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
282980|NCT00885118|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
282981|NCT00885170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282982|NCT00885352|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
282983|NCT00885365|Chiesi Farmaceutici S.p.A.|Chiesi Clinical Trials||clinicaltrials_info@chiesi.com|
282984|NCT00885378|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
282985|NCT00885482|Catholic University of S. Heart|Andrea De Luca|+390630155366|deluca.andrea@fastwebnet.it|
282986|NCT00885534|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
282987|NCT00885638|Lund University|Professor Bo Ahrén|+46462220758|Bo.Ahren@med.lu.se|
282988|NCT00885677|Medtronic EMEA RCC|Valentina Amori|3425417863|valentina.amori@medtronic.com|
282989|NCT00885703|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
282990|NCT00885742|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
282991|NCT00885755|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
282992|NCT00885768|Kidney Reasearch Center, Tehran University of Medical Sciences|Mohammad Reza Khatami MD|00982161192659|khatami@hbi.ir|
268818|NCT04450823|Global Surgery Amsterdam|Dr Matthijs Botman|0031648073683|matthijsbotman@gmail.com|
268819|NCT04446247|Owlet Baby Care, Inc|Madison Kenley, Clinical Research Director|801-552-8383|mkenley@owletcare.com|
268820|NCT04347564|Augenheilkunde Lindenthal|Daniela Claessens|017229227962|daniela.claessens@gmx.de|
268822|NCT04274556|Demiroglu Bilim University|Nurten OZEN|+90 212 213 64 86|ozenurten@yahoo.com.tr|
268823|NCT04270292|Demiroglu Bilim University|Nurten OZEN|+90 (212) 275 75 82|ozenurten@yahoo.com.tr|
268824|NCT04182217|Université d'État d'Haïti|Axler JEAN PAUL, Author|+50943776900|jeanpaulaxler@hotmail.com|
268826|NCT04083404|Queen Margaret University|Dr Susan Prior|44 (0)131 474 0000|sprior@qmu.ac.uk|
268834|NCT03977818|Institut Bergonié|Pr Antoine Italiano|33 5 56 33 33 33|a.italiano@bordeaux.unicancer.fr|
268835|NCT03976531|Institut Bergonié|Pr S Mathoulin-Pélissier|33 5 56 33 33 33|s.mathoulin@bordeaux.unicancer.fr|
268836|NCT03964649|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268837|NCT03941015|Department of Anesthesiology, Beijing Anzhen Hospital, Capital Medical University|Dr. Jun Ma|13370103671|18710168703@163.com|
268838|NCT03889028|Clinical University Hospital of Valencia|David Navarro|+34961973500|david.navarro@uv.es|
268839|NCT03842683|Steno Diabetes Center North Denmark|Dr. Morten Hasselstrøm Jensen|+4522226964|mhj@hst.aau.dk|
268840|NCT03839511|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
268841|NCT03835546|Fundació Lluita contra la SIDA|Jose A. Muñoz-Moreno|+34 93 497 84 14|jmunoz@flsida.org|
268847|NCT03727373|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
268848|NCT05017493|Hiwa Hospital - KRG|Dr. Dara Omer|+9647701586707|mailto:danaomar1979@gmail.com|
268852|NCT04347941|National University of Ireland, Galway|Dr Bairbre McNicholas|+35391893063|bmcnicholas@nuigalway.ie|
268853|NCT04308694|Duke University|William John, Ph.D.|919-681-7291|william.john@duke.edu|
268854|NCT03999411|University of Miami|Dr. Taghrid Asfar|305-243-3826|tasfar@med.miami.edu|
268855|NCT03803605|University of North Carolina at Chapel Hill|Cynthia Gay, MD, MPH|919-966-2537|cynthia_gay@med.unc.edu|
282993|NCT00885846|Bastyr University|Guan-Cheng Sun, PhD|425-602-3389|gsun@bastyr.edu|
275278|NCT00479037|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
275279|NCT00479089|The University of Texas (UT) MD Anderson Cancer Center|Arlene Siefker-Radtke, MD/Associate Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
275280|NCT00479115|Cincinnati Children's Hospital Medical Center|Stella Davies, MBBS, PhD, MRCP|513-636-1371|Stella.Davies@cchmc.org|
275281|NCT00479154|NINDS/NIH|Fatta Nahab|301-496-9526|nahabf@ninds.nih.gov|
275282|NCT00479232|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275283|NCT00479336|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
268821|NCT04330157|University hospital Osijek|Nenad Neskovic|+385996787250|nneskov@gmail.com|
275284|NCT00479388|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
275285|NCT00479401|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
275286|NCT00479466|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275287|NCT00479557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275288|NCT00479674|Duke University Medical Center|Dr. Kimberly Blackwell|919-668-1748|black034@duke.edu|
275289|NCT00479687|Bioventus LLC|Regulatory and Clinical Affairs|18003964325|CT.gov@bioventusglobal.com|
275290|NCT00479765|BTG International Inc|Claire Daugherty|610-278-1660|claire.daugherty@btgplc.com|
275291|NCT00479856|GlaxoSmithKline|GSK Response Center|866-435-7343||
275292|NCT00479882|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297002|NCT01719380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268825|NCT04160988|Acer Healthcare Inc.|Regulator Manager|886-6-26963131|Johnny.Lu@acer.com|5789
275293|NCT00480025|GlaxoSmithKline|GSK Response Center|866-435-7343||
275294|NCT00480077|Medtronic Bakken Research Center|Director CRDM|31-43-3566813||
275295|NCT00480324|GlaxoSmithKline|GSK Response Center|866-435-7343||
275296|NCT00480441|Treatment Research Center|Dr. Marina Goldman, Principle Study Investigator|215 222 3200|marinag@mail.med.upenn.edu|104
275297|NCT00480493|University of Massachusetts, Worcester|Susan Sullivan-Bolyai|508-856-4185|susan.sullivan-bolyai@umassmed.edu|
275298|NCT00480532|University of Hawaii (UH)|Bliss Kaneshiro|808-203-6500|bkaneshiro@ucera.org|
275299|NCT00480636|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275300|NCT00480740|Children's National Medical Center|Dr. Julia Finkel|202-476-4867|jfinkel@childrensnational.org|
275301|NCT00480779|University of Pittsburgh|M. Kaye Kramer|4123831286|mkk3@pitt.edu|
275302|NCT00480857|University of Michigan Comprehensive Cancer Center|Dr. Daniel Hamstra|(734) 936-4300|dhamm@umich.edu|
275303|NCT00480987|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
308422|NCT02578199|YALE|Dr. Rachel Barnes|203-785-6395|rachel.barnes@yale.edu|
308423|NCT02578238|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
308424|NCT02578316|Eisai Inc.|Eisai Medical Services|888-||
268827|NCT04079114|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
268828|NCT04075279|Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health|Dr. Tyler Quinn|412-386-4450|yhh7@cdc.gov|
268829|NCT04066686|Imperial College Healthcare NHS Trust|Dr Annabelle Lee|02033121077|annabellelee@nhs.net|
268842|NCT03825393|Tokat State Hospital|Association of Ferritin Levels With Clinical Parameters in Patients With Fibromyalgia Syndrome|5308211797|doctorsevil@yahoo.com|
268849|NCT04870138|University of North Carolina at Chapel Hill|Marcia M. Hobbs, PhD|919-843-6893|mmhobbs@med.unc.edu|
268850|NCT04374149|Prisma Health|Dr. Julie Martin, Director of Cancer Research|(864) 455-3667|julie.martin@prismahealth.org|
268851|NCT04348500|Cedars Sinai Medical Center|Dr. Stanley C. Jordan, MD|310-423-2641|sjordan@cshs.org|
268856|NCT03799198|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
268857|NCT03770728|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
268858|NCT03760146|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268859|NCT03760081|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
268860|NCT03737110|Kiniksa Pharmaceuticals (UK), Ltd. c/o Kiniksa Pharmaceuticals Corp.|Clinical Operations Study Director|1-781-431-9100|studyinfo@kiniksa.com|
268861|NCT03713684|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
268862|NCT03644550|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|hassanr@mail.nih.gov|
268863|NCT03557970|Oregon Health and Science University|Elie Traer, MD PhD|5034943553|traere@ohsu.edu|
275304|NCT00481065|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
275305|NCT00481078|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
275306|NCT00481195|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
275307|NCT00481247|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
275308|NCT00481351|Universidade de São Paulo|Otavio Celeste Mangili, MD|+554499928818|otaviomangili@yahoo.com.br|
275309|NCT00481507|GEORGETOWN UNIVERSITY|Daniel Merenstein, MD|202-687-2745|djm23@georgetown.edu|
275310|NCT00481676|Novartis Pharmaceuticals|Study Director|862 778-8300||
275311|NCT00481767|GlaxoSmithKline|GSK Response Center|866-435-7343||
275312|NCT00481832|Stanford University School of Med|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
275313|NCT00481845|Stanford Cancer Institute, Stanford University|Mark Daniel Pegram; Susy Yuan-Huey Hung Professor|650-723-5801|mpegram@stanford.edu|
275314|NCT00481871|Allos Therapeutics, Inc.|Michael Saunders, MD|303-426-6262|msaunders@allos.com|
275315|NCT00481988|Division of Experimental Therapeutics, NY State Psychiatric Organization|Peter Bulow MD, Assistant Professor of Clinical Psychiatry|(212) 543 5664|pb2182@columbia.edu|
275316|NCT00482001|Sunnybrook Health Sciences Centre|Dr. Mark Rapoport|416-480-4085|Mark.Rapoport@sunnybrook.ca|
275317|NCT00482014|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
275318|NCT00482053|Stanford University Medical Center|Wen-Kai Weng, Assistant Professor of Medicine|650-723-7689|wkweng@stanford.edu|
275319|NCT00482170|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275320|NCT00482274|Oregon Health & Science University Knight Cancer Institute|Study Coordinator|503 494-2897|eilersk@ohsu.edu|
297003|NCT01719653|Gastroenterology Services, Ltd|David Gerard, MD|630 969 1167|davidpgerard@comcast.net|
275321|NCT00482391|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang|914-367-7181|dangc@mskcc.org|
275322|NCT00482547|C. R. Bard|Vanessa Dell Clinical Research Scientist|908-277-8094|vanessa.dell@crbard.com|
275323|NCT00482612|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
275324|NCT00482625|Weill Cornell College of Medicine|Dr. Steven Lipkin|212-774-7160|stl2012@med.cornell.edu|
275325|NCT00482677|Canadian Cancer Trials Group|Keyue Ding|613-5336430|kding@ctg.queensu.ca|
275326|NCT00482703|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
275327|NCT00482729|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
275328|NCT00482911|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-435-7507|sbpso@mail.nih.gov|
275329|NCT00483002|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275330|NCT00483041|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
275331|NCT00483184|Nobel Ilac San ve Tic. A.S.|Hasan Zeytin MD., Ph.D.|+90 216 6336012|hasan.zeytin@nobel.com.tr|6012
297004|NCT01719744|Princess Margaret Cancer Centre|Dr. ALBIRUNI RAZAK|416-586-4800|Albiruni.Razak@uhn.ca|5371
275332|NCT00483223|Massachusetts General Hospital|Steven Isakoff, MD, PhD|617-726-4920|SISAKOFF@mgh.harvard.edu|
275333|NCT00483262|Dana-Farber Cancer Institute|Irene Ghobrial, MD|617-632-4198|irene_ghobrial@dfci.harvard.edu|
275334|NCT00483327|Perlmutter Cancer Center at NYU Langone|Stephanie Blank, MD|212-731-5705|stephanie.blank@nyumc.org|
275335|NCT00483379|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
275336|NCT00483405|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
275337|NCT00483496|Orfagen|Clinical project manager|0033534506462|caroline.miklaszewski@orfagen.com|
275338|NCT00483509|Molmed S.p.A|Clinical Operations|003902212771|clinical.operations@molmed.com|
268830|NCT04058626|Imperial College London/ Imperial College Healthcare NHS Trust|Mr Pasha Normahani|020 3312 6666|p.normahani@imperial.ac.uk|switch
275339|NCT00483548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
297005|NCT01719757|Suyoun Yang|CR head|82-2-527-9219|suyoun.yang@mundipharma.co.kr|
275340|NCT00483561|University of Nebraska Medical Center|Ralph Hauke, MD|402-354-8124|rhauke@nebraskacancer.com|
275341|NCT00483574|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
275342|NCT00483652|Acorda Therapeutics, Inc.|Andrew Blight, Chief Scientific Officer|(914) 347-4300|ablight@acorda.com|102
268831|NCT04057235|Integrity Implants Inc|Lauren Kamer, Senior Director of Regulatory and Clinical Affairs|+1.561.529.3861|lkamer@integrityimplants.com|
268843|NCT03813719|Imperial College London|Dr Diana Marcus|07525133957|d.marcus16@imperial.ac.uk|
268844|NCT03798756|Keele University|Mrs Sarah Lawton|01782 734887|s.a.lawton@keele.ac.uk|
268864|NCT03369197|The Johns Hopkins University|Dr. Laeben Lester|410-955-7519|llester4@jhmi.edu|
268865|NCT03368196|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
268866|NCT03332095|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
268867|NCT03022461|Abbott|Poornima Sood|+17818528334|poornima.sood@abbott.com|
268868|NCT02979587|Medtronic|Kathleen Drewiske, Clinical Study Manager|651-788-1645|katie.a.drewiske@medtronic.com|
268869|NCT02964039|Ralph H. Johnson VAMC / MUSC|Jesse Dean|8437929566|deaje@musc.edu|
268870|NCT02930889|University of Minnesota|Jafar Golzarian, MD|612-626-5566|jafar@umn.edu|
268871|NCT02919618|Washington University|Dr. Phillip Cuculich|314-454-7698|pcuculic@wustl.edu|
268872|NCT02844946|Baylor College of Medicine|Dr. Lilian Dindo|713-440-4637|lilian.dindo@bcm.edu|
268873|NCT02675114|Edwards Lifesciences|Research Director|949-250-2500|THV_CT.gov@Edwards.com|
268874|NCT02564796|UC San Diego|Dr. David Werho|(858) 966-5855|dwerho@rchsd.org|
268875|NCT02562716|SWOG Statistics and Data Management Center|SWOG Statistician|2066674623|smcdonou@fredhutch.org|
268876|NCT02442349|AstraZeneca|Global Clinical Lead, Serban Ghiorghiu|+44 1625 512243||
268877|NCT02211131|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
268878|NCT02094261|AstraZeneca|Senior Medical Director, Tagrisso||ClinicalTrialTransparency@astrazeneca.com|
268879|NCT01803854|Department of Veterans Affiairs, Office of Research and Development|Dr. Christina D. Williams, Acting Director of Cooperative Studies Program Epidemiology Center Durham|919-286-0411|christina.williams4@va.gov|175464
268880|NCT01496976|Moffitt Cancer Center|Celeste M. Bello, MD|813-745-8623|Celeste.Bello@moffitt.org|
268881|NCT01472081|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
275343|NCT00483704|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275344|NCT00483717|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D|601-650-4200|dbregman@lpicrd.com|828
275345|NCT00483756|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275346|NCT00483938|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
275347|NCT00484094|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
275348|NCT00484159|Johns Hopkins|Steven P. Cohen|410-955-1822|scohen40@jhmi.edu|
275349|NCT00484185|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297006|NCT01719783|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
275350|NCT00484198|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
275351|NCT00484289|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
275352|NCT00484315|Boston Scientific|Andrey Nersesov, Clinical Project Manager|508-683-4988|andrey.nersesov@bsci.com|
275353|NCT00484354|Wake Forest School of Medicine|Michael Rocco, MD|3367164650|mrocco@wakehealth.edu|
275354|NCT00484393|Fraser Health|Brandi Newby|604-585-5666|brandi.newby@fraserhealth.ca|774374
275355|NCT00484679|University of Minnesota|Maria Hordinsky, MD|612-624-5721|hordi001@umn.edu|
275356|NCT00484874|Dana-Farber Cancer Institute|Heather Jacene, MD|617-632-3767|hjacene@partners.org|
275357|NCT00484939|Hoffmann-La Roche|Medical Communications|800 821-8590||
275358|NCT00485069|GlaxoSmithKline|GSK Response Center|866-435-7343||
275359|NCT00485134|US Army Medical Materiel Development Activity (USAMMDA)|Division of Regulated Activies and Compliance|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
275360|NCT00485173|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
275361|NCT00485264|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
275362|NCT00485303|Janssen Research & Development, 10990 Wilshire Blvd, Suite 1200, Los Angeles, California 90024|Senior Director, Clinical Research|(310) 943-8040||2917
282994|NCT00886015|JohnHopkins U|Sheila West|410-955-2606|shwest@jhmi.edu|
282995|NCT00886119|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
282996|NCT00886145|James J. Peters VA Medical Center|William A. Bauman|718-584-9000|william.bauman@va.gov|5428
282997|NCT00886236|Medical University of South Carolina|Larry Field|843-876-5744|field@musc.edu|
282998|NCT00886262|Medical University of South Carolina|Dr. Scott Reeves|843-792-5699|reevess@musc.edu|
297007|NCT01719861|Stanford University Medical Center|Joel Neal, MD, PhD; Assistant Professor of Medicine|650-725-3081|jwneal@stanford.edu|
282999|NCT00886288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283000|NCT00886340|Yale School of Nursing|Robin Whittemore, PhD|203-737-2351|robin.whittemore@yale.edu|
283001|NCT00886379|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|617-525-7929|jr33@partners.org|
268832|NCT04041037|Integra LifeSciences|Allison Matthews|443-766-3869|allison.matthews@integralife.com|
283002|NCT00886483|The Ohio State University|L. Eugene Arnold, M.D. M.Ed.|614-685-6708|L.Arnold@osumc.edu|
283003|NCT00886587|Johnson & Johnson Consumer Inc|Amisha Parikh-Das, PhD/Study Director|973 385-2863 USA EST|AParikh1@its.jnj.com|
283004|NCT00886613|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
283005|NCT00886626|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
283006|NCT00886639|Schön Klinik BGL|Dr. Klaus Kenn|0865293|iheinzelmann@schoen-kliniken.de|1540
268833|NCT04034043|IRCSS Istituto Ortopedico Rizzoli|Federico Giardina|+390516366418|federico.giardina@ior.it|
268845|NCT03790917|National Medical Research Center for Preventive Medicine|professor Sergey Yu. Martsevich|89161643690|sergeymartsevich@mail.ru|
268846|NCT03790306|Genesee Orthopedic & Hand Surgery Associates, P.C.|Andrew Wickline, MD|315-735-4496|awickline23@gmail.com|
268882|NCT01309672|University of Colorado, School of Medicine|Dr. Thomas W. Flaig, MD||Thomas.Flaig@ucdenver.edu|
268883|NCT01131169|Memorial Sloan Kettering Cancer Center|Sergio Giralt, MD|646-608-3731|GiraltS@mskcc.org|
268884|NCT00774345|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@BMS.com|
268885|NCT00457951|Chimerix|Zahra Masoud|763-300-0559|zmasoud@chimerix.com|
268886|NCT00345943|New York State Psychiatric Institute|Dr. Rachel Marsh|6467745774|rachel.marsh@nyspi.columbia.edu|
268887|NCT00258427|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-273-2800|macmi002@umn.edu|
268888|NCT03722810|BIHAM, University of Bern|Prof. Michael Harris|+44 1761 241366|michael.harris@biham.unibe.ch|
268889|NCT00000125|Washington University School of Medicine|Michael Kass MD|314-362-5713|kass@vision.wustl.edu|
268890|NCT00000134|Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
268891|NCT00000135|Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
268892|NCT00000136|The Johns Hopkins University|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
268893|NCT00000142|Johns Hopkins Bloomberg School of Public Health|Dr. Curtis Meinert|410-955-8175|cmeinert@jhsph.edu|
268894|NCT00000143|Johns Hopkins School of Public Health|Curtis Meinert, PhD|410-955-8198|cmeinert@jhsph.edu|
268895|NCT00000371|Freedom Clinic Trail, Massachusetts General Hospital|Dr. Donald Goff|617-921-7899|goff@psych.mgh.harvard.edu|
268896|NCT00000378|New York State Psychiatric Institute|Steven Roose MD|646-774-8661|spr2@columbia.edu|
268897|NCT00000392|NIMH|Benedetto Vitiello, MD - Supervisory Medical Officer|301-443-3357|bvitiell@mail.nih.gov|
268898|NCT00000479|Brigham and Women's Hospital|Julie E. Buring|617 732 4965|jburing@rics.bwh.harvard.edu|
268899|NCT00000575|Johns Hopkins Bloomberg School of Public Health, Dept of Epidemiology|Alice Sternberg|410-955-3752|asternbe@jhsph.edu|
268900|NCT00000620|Wake Forest School of Medicine|Tim Craven / Senior Biostatistician|336-716-6109|tcraven@wakehealth.edu|
268901|NCT00001151|NIH|Stephen J. Marx, M.D./National Institute of Diabetes and Digestive and Kidney Diseases|3014965051|marxs@mail.nih.gov|
268902|NCT00001213|National Institutes of Health|Rachel J. Bishop, MD, Principal Investigator, National Eye Institute|301-402-3771|bishopra@nei.nih.gov|
268903|NCT00001262|National Institute of Child Health and Human Development|Kaler, Stephen G|+1 301 451 6034|kalers@mail.nih.gov|
283007|NCT00886704|Ludwig Maximilians-University Munich|Clemens von Schacky, Head, Preventive Cardiology, University of Munich|+498951600|clemens.vonschacky@med.uni-muenchen.de|2165
283008|NCT00886743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283009|NCT00886769|Novartis Pharmaceuticals|Study Director|862-778-8300||
283010|NCT00886795|Johns Hopkins University|Clifton O. Bingham III, M.D.|410-550-0578|cbingha2@jhmi.edu|
283011|NCT00886821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283012|NCT00886834|University of Utah, Department of Obstetrics and Gynecology|Dr. David Turok|801-581-7647|david.turok@hsc.utah.edu|
283013|NCT00886899|BridgePoint Medical|VP, Clinical Affairs|763-225-8500|jschultz@bridgepointmedical.com|
283014|NCT00886938|Washington University|Dr. Jay F Piccirillo|(314) 362-8641|piccirilloj@ent.wustl.edu|
283015|NCT00887068|UT MD Anderson Cancer Center|Dr. Richard E. Champlin, MD/ Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
283016|NCT00887159|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
283017|NCT00887198|Janssen R&D US|SENIOR DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
283018|NCT00887224|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
283019|NCT00887289|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283020|NCT00887341|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
297008|NCT01719900|University of Calgary|Dr. Raylene Reimer|14032208218|reimer@ucalgary.ca|
283021|NCT00887354|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
283022|NCT00887432|Roswell Park Comprehensive Cancer Center|Kris Attwood|716-845-1300|Kris.Attwood@roswellpark.org|
283023|NCT00887458|Johns Hopkins University|Dr. Michael Carducci|410-614-3977|carducci@jhmi.edu|
283024|NCT00887471|SUNY Downsate Medical Center|Nira A Goldstein, MD|718-270-1638|ngoldstein@downstate.edu|
283025|NCT00887484|GlaxoSmithKline|GSK Response Center|888-435-7343||
283026|NCT00887510|University of Florida|Rhonda M Cooper-DeHoff|352 273-6184|dehoff@cop.ufl.edu|
283027|NCT00887549|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
283028|NCT00887562|Columbia University|Michio Hirano, MD|12123051048|mh29@cumc.columbia.edu|
283029|NCT00887575|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
283030|NCT00887588|Novartis Pharmaceuticals|Study Director|862-778-8300||
283031|NCT00887640|Duke University Medical Center|Dr. Andrew Armstrong|919-668-8108|andrew.armstrong@dm.duke.edu|
283032|NCT00887653|THE MIRIAM HOSPITAL|Aadia Rana|4017934680|arana@lifespan.org|
283033|NCT00887679|Duke University Medical Center|Dr. Ashwin A Patkar Associate Professor|919-668-3626|ashwin.patkar@duke.edu|
283034|NCT00887744|Medtronic Spinal & Biologics Europe and Central Asia|E. Wülfert, Medical Affairs & Clinical Operations Director||inca.studyregistration@medtronic.com|
283035|NCT00887783|Dept. Oncology, Odense University Hospital|Dr. Olfred Hansen, Professor, Ph.D.|+4524241588|olfred.hansen@rsyd.dk|
283036|NCT00887809|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
297009|NCT01720043|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
283037|NCT00887822|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
283038|NCT00887913|Syneron Medical Ltd|Hanit Brenner-Lavie|972-73-244-2200|hanitb@syneron.com|581
283039|NCT00887926|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297010|NCT01720069|Vectura Limited|Gary Burgess, MD|+44(0)1249 667700|clinical.enquiries@vectura.com|
283040|NCT00887965|Amgen Inc.|Study Director|866-572-6436||
283041|NCT00887978|United Therapeutics Corporation|Kevin Laliberte, PharmD|919-425-8350|klaliberte@unither.com|
283042|NCT00888134|Massachusetts General Hospital|Donald P. Lawrence|617-643-3614|dplawrence@mgh.harvard.edu|
283043|NCT00888173|NRG Oncology|Linda Gedeon For Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
283044|NCT00888238|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
283045|NCT00888329|Mayo Clinic|Javier Magrina MD|480-301-8000|magrina.javier@mayo.edu|
283046|NCT00888381|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
283047|NCT00888433|Baker IDI Heart and Diabetes Institute|Murray Esler, Principal Investigator||murray.esler@bakeridi.edu.au|
283048|NCT00888459|Mayo Clinic|Jon O. Ebbert|507-266-1944|ebbert.jon@mayo.edu|
292649|NCT01439165|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
292650|NCT01439204|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
292651|NCT01439282|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
292652|NCT01439360|GlaxoSmithKline|GSK Response Center|866-435-7343||
292653|NCT01439373|GlaxoSmithKline|GSK Response Center|866-435-7343||
292654|NCT01439555|UMass Medical School|Elizabeth DeGrush, DO|508-334-1000|elizabeth.degrush@umassmemorial.org|
292655|NCT01439568|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
292656|NCT01439581|Henry Ford Health System|Robert Behrendt|313-874-9537|Rbehren9@hfhs.org|
292657|NCT01439594|Massachusetts General Hospital|Dr. Gary Tearney, PI|617-724-2979|GTEARNEY@PARTNERS.ORG|
292658|NCT01439620|Massachusetts General Hospital|Gary Tearney, MD|Optical Frequency Domain Imagi|gtearney@partners.org|
292659|NCT01439633|Massachusetts General Hospital|Gary Tearney, PI|617-724-2979|gtearney@partners.org|
292660|NCT01439672|University of Virginia|Sue Brown, MD||sab2f@virginia.edu|
292661|NCT01439711|Duke University Medical Center|E. Shelley Hwang MD MPH|919-684-6849|shelley.hwang@duke.edu|
292662|NCT01439724|Instituto Nacional de Cancer|Dr. Heliton Spindola Antunes|55 21 32076597|hspindola@inca.gov.br|
292663|NCT01439815|Ora|Caitlin Pearson|978-685-8900|cpearson@oraclinical.com|
297011|NCT01720173|NRG Oncology|Angela Kuras on behalf of Wei Deng, PhD|716-845-5702|kurasa@nrgoncology.org|
283049|NCT00888511|Odense University Hospital|Olfred Hansen|+45 2424 1588|olfred.hansen@rsyd.dk|
283050|NCT00888615|NRG Oncology|Christopher Purdy on behalf of James Kauderer|(716)845-1300|purdyc@nrgoncology.org|2296
283051|NCT00888628|Massachusetts General Hospital|James F. Markmann, M.D. Ph.D - Chief, Division of Transplant Surgery|617-643-4087|kcrisalli@mgh.harvard.edu|
283052|NCT00888654|Barbara Ann Karmanos Cancer Institute|Elisabeth Heath, M.D.|313-576-8715|heathe@karmanos.org|
283053|NCT00888849|Ethicon Endo Surgery, Inc|Sheryl Helsinger/Clinical Affairs Director|513-337-3079|shelsing@its.jnj.com|
283054|NCT00888927|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
283055|NCT00888940|Cubist Pharmaceuticals, Inc.|Alistair Wheeler, MD MFPM, Senior Director Clinical Research|781-860-8660|awheeler@cubist.com|
283056|NCT00888979|UConn Health|Cheryl Oncken|860-679-3425|oncken@uchc.edu|
283057|NCT00889005|New York Langone Medical Center Department of Psychiatry|Arieh Y. Shalev, M.D.|6467544782|arieh.shalev@nyumc.org|
283058|NCT00889187|Brigham and Women's Hospital / Dana Farber Cancer Institute|Harvey Mamon, MD, PhD|617-732-8564|HMAMON@LROC.HARVARD.EDU|
283059|NCT00889200|Butler Hospital|Linda Carpenter, MD|401 455 6349|Linda_Carpenter_MD@Brown.edu|
283060|NCT00889226|CMC|Dr. Hoyoung Sohn|82-2-222-2222|abc@snu.ac.kr|3333
283061|NCT00889252|Vistakon|Brian Pall OD MS FAAO|904-443-1290||
297012|NCT01720225|The University of Texas MD Anderson Cancer Center|Elias Joseph MD./Professor|713-792-4764|ejabbour@mdanderson.org|
283062|NCT00889265|Zimmer Dental|Dr Hai Bo Wen, Director of Research|760-929-4312|haibo.wen@zimmer.com|
283063|NCT00889330|Johnson & Johnson Vision Care, Inc.|Arthur Shedden, MD|904-443-1557|ashedden@its.jnj.com|
283064|NCT00889512|University Reproductive Associates|Dr. Peter G. McGovern|201-288-6330|mcgovepg@uranj.com|
283065|NCT00889603|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283066|NCT00889681|Medtronic- AF Solutions|Dana Wigert- Sr. Clinical Research Specialist|763-526-2802|dana.wigert@medtronic.com|
283067|NCT00889707|Sophiris Bio Corp (formerly Protox Therapeutics)|Chief Medical Officer|858-255-4711|richard@sophiris.com|
283068|NCT00889720|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283069|NCT00889824|WashingtonU|Joel Goebel, MD|(314) 362-7344|goebelj@ent.wustl.edu|
283070|NCT00889863|Novartis Pharmaceuticals|Study Director|862-778-8300||
283071|NCT00889915|Duke Clinical Research Institute - Duke University School of Medicine|John S. March, MD, MPH|919-668-7818|john.march@duke.edu|
283072|NCT00889928|Ethicon Endo Surgery, Inc|Sheryl Helsinger|513-337-3079|SHelsing@its.jnj.com|
268904|NCT00001304|National Institute of Child Health and Human Development|WINER, Karen|+1 301 435 6877|winerk@mail.nih.gov|
268905|NCT00001305|National Institute of Child Health and Human Development|Marini, Joan|+1 301 594 3418|marinij@mail.nih.gov|
268906|NCT00001566|National Cancer Institute (NCI), National Institutes of Health (NIH)|Crystal Mackall, M.D.|301-402-5940|mackallc@mail.nih.gov|
268907|NCT00001575|National Cancer Institute|Thomas Waldmann M.D.|301-496-6653|waldmann@nih.hhs.gov|
268908|NCT00001586|National Cancer Institute, National Institutes of Health|Wyndham H. Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
268909|NCT00001596|National Human Genome Research Institute|Dr. William A. Gahl|301-402-2739|gahlw@mail.nih.gov|
268910|NCT00001656|National Institute of Mental Health|Judith L. Rapoport, M.D.|301-496-6080|rapoporj@mail.nih.gov|
268911|NCT00001703|National Cancer Institute, National Institutes of Health|Samir N. Khleif, M.D.|301-496-0901|khleifs@mail.nih.gov|
268912|NCT00001723|National Institute of Child Health and Human Development, NIH|Jack A. Yanovski, MD, PhD, Chief SGO, PDEGEN|301-496-4686|yanovskj@mail.nih.gov|
297013|NCT01720251|ANERGIS SA|Dr Gilles DELLA CORTE Clinical Development Director|+41 21 651 92 30|gilles.dellacorte@anergis.ch|
268913|NCT00001832|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
268914|NCT00001849|NIDDK, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
268915|NCT00001880|National Heart Lung and Blood Institute (NHLBI)|Richard Childs, M.D. Principal Investigator, NIH, NHLBI|301.451.7128|childsr@nhlbi.nih.gov|
268916|NCT00001941|National Cancer Institute, National Institues of Health|Thomas Waldmann, M.D.|301-496-6653|tawald@mail.nih.gov|
283073|NCT00890045|Houston Methodist Hospital|George M. Nassar M.D.|713-790-1963|georgemnassar@gmail.com|
283074|NCT00890084|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297014|NCT01720264|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
283075|NCT00890097|Alcon Research, Ltd.|Dana Sager, Clinical Manager Group Leader|1-888-451-3937|alcon.medinfo@alcon.com|
297015|NCT01720277|Brown University and Providence VA Medical Center|Dr. Stefan Gravenstein|401-863-3172|Stefan_gravenstein@brown.edu|
283076|NCT00890162|National Institute of Allergy and Infectious Diseases|Carter, Melody|+1 301 496 8772|mc396j@nih.gov|
283077|NCT00890201|Hospital de La Serena|Marcelo A. Beltran, M.D. - Department of Surgery - Hospital de La Sererna|56 51 485923|beltran_01@yahoo.com|
283078|NCT00890396|New England Research Institutes, Inc.|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
283079|NCT00890552|Stanford University School of Medicine|Brenda Hann, RN, MBA, CCRC|650-723-0966|bhann@stanford.edu|
283080|NCT00890617|Barbara Ann Karmanos Cancer Institute|Dr. Frank A. Baciewicz|(313) 993-0580|FBaciewi@dmc.org; baciewic@karmanos.org|
283081|NCT00890656|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
283082|NCT00890682|Pacira Pharmaceuticals, Inc|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
283083|NCT00890695|KEMRI/Wellcome Trust Research Programme|Dr James Berkley|+254 41 522535|jberkley@kilifi.kemri-wellcome.org|
283084|NCT00890721|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
283085|NCT00890825|AstraZeneca|Tracy Cunningham|1-877-400-4656|clinicaltrialtransparency@astrazeneca.com|
283086|NCT00890916|Louis Stokes Cleveland VAMC|Dr. Kevin Kilgore|216-9573657|klk4@case.edu|
283087|NCT00890929|Stanford University Medical Center|Bruno C Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
283088|NCT00890981|Amgen Inc.|Study Director|866-572-6436||
283089|NCT00891020|Hoffman-LaRoche|Medical Communications|800-821-8590||
283090|NCT00891046|Novartis Pharmaceuticals|Study Director|862--778--8300||
283091|NCT00891176|GlaxoSmithKline|GSK Response Center|866-435-7343||
283092|NCT00891202|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
283093|NCT00891228|NICHD|H. Trent MacKay, MD, MPH|301-435-6988|mackayt@mail.nih.gov|
283094|NCT00891293|GlaxoSmithKline|GSK Response Center|866-435-7343||
283095|NCT00891319|MetroHealth Medical Center|Dr. Jayme Knutson|2169573557|jsk12@case.edu|216
283096|NCT00891371|Ipsen|Medical Director, Gastroenterology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
283097|NCT00891436|Rush University Medical College|James N. Moy, M.D.|312-942-6176|jmoy@rush.edu|
297016|NCT01720316|McLean Hospital|Dr. Deborah L. Levy|617-855-2854|dlevy@mclean.harvard.edu|
283098|NCT00891462|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
283099|NCT00891527|Boston Childrens Hospital|Kathy Jenkins MD MPH|6173557275|kathy.jenkins@cardio.chboston.org|
283100|NCT00891618|University of Texas MD Anderson Cancer|Michael Wang, MD / Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
283101|NCT00891657|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
297017|NCT01720446|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
283102|NCT00891735|Genentech, Inc.|Medical Communications|800-821-8590||
283103|NCT00891774|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
283104|NCT00891813|Abbott|Global Medical Services|1-800-633-9110||
283105|NCT00891839|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
283106|NCT00891878|Mayo Clinic|Aminah Jatoi, M.D|(507) 284-5352|jatoi.aminah@mayo.edu|
283107|NCT00891930|Amgen Inc.|Study Director|866-572-6436||
283108|NCT00891982|GlaxoSmithKline|GSK Response Center|866-435-7343||
283109|NCT00891995|Jaeb Center for Health Research|Katrina Ruedy|8139758690|kruedy@jaeb.org|
283110|NCT00892008|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
283111|NCT00892047|University of Pittsburgh|Charles F. Reynolds III, MD|412-246-6414|reynoldscf@upmc.edu|
283112|NCT00892099|Massachusetts General Hospital|Dr. Ishir Bhan|617-726-3934|ibhan@mgh.harvard.edu|
283113|NCT00892151|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
283114|NCT00892177|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-7733|galanis.evanthia@mayo.edu|
283115|NCT00892281|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
283116|NCT00892437|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
283117|NCT00892606|University Louisville|Nancy Alsip|502-852-2905|nlalsi01@exchange.louisville.edu|
297018|NCT01720524|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
268917|NCT00001959|NIDDK, NIH|Jeffrey B Kopp, MD|3015943403|jbkopp@nih.gov|
283118|NCT00892697|University at Buffalo|Andrew Talal, MD|716-888-4737|ahtalal@buffalo.edu|
268918|NCT00001962|NIH National Heart, Lung and Blood Institute|Neal Young MD|301-496-5093|youngns@nhlbi.nih.gov|
268919|NCT00001984|NIDDK, NIH|Dr. Alan Kirk||allank@intra.niddk.nih.gov|
268920|NCT00002525|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
268921|NCT00002540|Early Detection Research Group, NCI, NIH|Paul F. Pinsky, Ph.D.|301-496-8544|pinskyp@mail.nih.gov|
268922|NCT00002558|Memorial Sloan Kettering Cancer Center|Dr. Robert Motzer|646-422-4312|motzerr@mskcc.org|
268923|NCT00002597|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
268924|NCT00002601|City of Hope|Paul Frankel, Ph.D.|(626)256-4673|pfrankel@och.org|65265
268925|NCT00002651|SWOG Statistical Center|Study Statistician|206-667-4623||
268926|NCT00002766|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak|212-639-5518|maslakp@mskcc.org|
268927|NCT00002842|City of Hope|Jeffrey Longmate, Ph.D.|626-256-4673|jlongmate@coh.org|
268928|NCT00002850|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
268929|NCT00002874|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
268930|NCT00002931|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
268931|NCT00003042|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
268932|NCT00003138|ECOG Statistical Office|Study Statistician|617-632-3012||
268933|NCT00003199|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
268934|NCT00003222|University of Virginia|Craig L. Slingluff, MD|434-924-1730|CLS8H@hscmail.mcc.virginia.edu|
268935|NCT00003224|University of Virginia|Craig Slingluff|434-924-1730|cls8h@virginia.edu|
268936|NCT00003270|Roswell Park Comprehensive Cancer Center|Dr. Theresa Hahn|716-845-5819|theresa.hahn@roswellpark.org|
275363|NCT00485433|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
275364|NCT00485472|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
275365|NCT00485485|UT MD Anderson Cancer Center|Anne Tsao, M.D. / Associate Professor|713-792-6363|mejprice@mdanderson.org|
275366|NCT00485589|F. Hoffmann-La Roche AG|Medical Communications|41 616878333|global.trial_information@roche.com|
275367|NCT00485693|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
275368|NCT00485732|GlaxoSmithKline|GSK Response Center|866-435-7343||
275369|NCT00485758|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
275370|NCT00485836|Genentech, Inc.|Medical Communications|800-821-8590||
283119|NCT00892710|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
297019|NCT01720602|University of Washington|Hannah Linden, MD|206-288-6989|hmlinden@u.washington.edu|
268937|NCT04617860|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
268938|NCT04617847|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
268939|NCT04426318|Center for Healthy Minds|Matthew Hirshberg|608-262-0035|hirshberg@wisc.edu|
268940|NCT04255381|Yale University|Dr. Stuart Weinzimer|203-785-5831|stuart.weinzimer@yale.edu|
268941|NCT04063657|University of California, Davis|Dr. Christopher Kreulen|(916) 734-6805|ckreulen@ucdavis.edu|
268942|NCT04042623|Aravive|Dr. Reshma Rangwala, Chief Medical Officer|936-355-1910|rrangwala@aravive.com|
268943|NCT03882047|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268944|NCT03879772|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268945|NCT03861559|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268946|NCT03855228|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268947|NCT03855189|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268948|NCT03847974|LIB Therapeutics|Evan A Stein MD PhD FACC|18596533141|estein@libtherapeutics.com|
268949|NCT03764631|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
268950|NCT03764072|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
268952|NCT03645408|Boston Medical Center/Boston University School of Medicine|Dr. Eric Devine|617-414-1990|eric.devine@bmc.org|
268953|NCT03578809|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
268954|NCT03571204|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|msneller@niaid.nih.gov|
268955|NCT03523091|William Beaumont Hospital|Jennifer Giordano|248-551-3517|jennifer.giordano@beaumont.org|
268956|NCT03503474|University of Leeds|Professor Mark Wilcox|+441133926818|mark.wilcox@nhs.net|
268957|NCT03476317|Children's Hospital of Philadelphia|Lindsey Albenberg, DO|267-426-0139|albenbergl@chop.edu|
268958|NCT03391960|3M|Helen Han|651-737-9234|mhan3@mmm.com|
268959|NCT03362190|IVERIC bio, Inc|Hersh Patel, OD / Zimura Medical Director|609-474-6755|clinicaltrials@ivericbio.com|
268960|NCT03338790|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
268961|NCT03252522|Oregon Health & Science University|Jeanette Johnstone, PhD|5034943700|jojeanet@ohsu.edu|
268962|NCT03235544|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
268963|NCT03225833|Wave Life Sciences|Medical Director|855-215-4687|clinicaltrials@wavelifesci.com|
268964|NCT03167242|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
268965|NCT03144674|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
275371|NCT00485953|University of Pittsburgh|Dr. Susan Greenspan|412-692-2476|greenspn@pitt.edu|
275372|NCT00486018|Genentech, Inc.|Medical Communications|800-821-8590||
275373|NCT00486031|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
275374|NCT00486044|University of Wisconsin School of Medicine and Public Health|Cynthia M. Carlsson, MD, MS|608-280-7000|cmc@medicine.wisc.edu|
275375|NCT00486226|Codman&Shurtleff|Arnaud Nicolas|+33 0 155 004 543|anicolas@its.jnj.com|
275376|NCT00486252|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
275377|NCT00486265|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
283120|NCT00892723|Capstone Therapeutics|Denise Lamon|800-937-5520|dlamon@capstonethx.com|5206
283121|NCT00892775|GlaxoSmithKline|GSK Response Center|866-435-7343||
283122|NCT00892957|BAXTER INNOVATIONS GmbH|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
283123|NCT00893074|Johns Hopkins University|Ryan Vandrey, PhD|410-550-4036|rvandrey@jhmi.edu|
283124|NCT00893113|Chesapeake Urology Research Associates|Ronald Tutrone, MD|443.471.5742|hthomas@cua.md|
283125|NCT00893152|VA HSR&D Center for Mental Healthcare & Outcomes Research|Ellen P. Fischer, PhD|501-257-1711|Ellen.Fischer@va.gov|
283126|NCT00893464|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
283127|NCT00893737|Clinvest|Rebecca Browning|(417) 841-3664|rbrowning@clinvest.com|
283128|NCT00893763|University of South Florida|Cindy L. Munro, APRN, PhD|813-974-7597|cmunro2@health.usf.edu|
283129|NCT00893971|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|605-305-2600|creisner@pearltherapeutics.com|
283130|NCT00893984|Minneapolis Heart Institute Foundation|Chief Medical Officer|612-863-3900|scott.sharkey@allina.com|
283131|NCT00893997|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
283132|NCT00894127|bioAffinity|Maria Zannes|505-400-9747|mz@bioaffinitytech.com|
283133|NCT00894166|Duke University Medical Center|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@duke.edu|
283134|NCT00894322|Clinical Trial Transparency|AstraZeneca||Clinical.Trial.Transparency@astrazeneca.com|
283135|NCT00894361|PI/study coordinator retired due to personal family health matters and study sponsor then withdrew funding. Study terminated and no data was collected or analyzed from any participant.|Terence J. Gioe, M.D.||tjgioe@gmail.com|
283136|NCT00894387|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
283137|NCT00894413|Johns Hopkins University School of Medicine|Zubair Khan, MD|410-955-3157|zkhan@jhmi.edu|
283138|NCT00894465|Washington University School of Medicine|Dr. Paul Austin|(314) 454-6034|austinp@wustl.edu|
283139|NCT00894504|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
283140|NCT00894517|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
268966|NCT03137537|Dana Farber Cancer Institute|Dr. Anju Nohria|6175257052|anohria@partners.org|
297020|NCT01720667|University of California San Diego, School of Medicine|Dr. Richard Haas|(858) 822-6700|rhaas@ucsd.edu|
297021|NCT01720797|University of Florida|Calogero Dolce, DDS, PhD|352-273-5700|cdolce@dental.ufl.edu|
268967|NCT03126019|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
268968|NCT03113383|Vanderbilt University Medical Center|Thomas C Naslund, MD|5-322-2343|thomas.naslund@vumc.org|
268969|NCT03057106|Canadian Cancer Trials Group|Dr. Keyue Ding|1-613-533-6430|kding@ctg.queensu.ca|77705
268970|NCT03028896|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|31
268971|NCT03008369|Mayo Clinic|Ashish Vitthalrao Chintakuntlawar, MBBS, Ph.D.|5072930504|Chintakuntlawar.Ashish@mayo.edu|
268972|NCT02978326|Sage Therapeutics|Medical Monitor|(617) 299-8380|info@sagerx.com|
268973|NCT02970929|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1 866-503-6351|clinicaltrialdisclosure@sunovion.com|
268974|NCT02963493|Oncopeptides|Global Clinical Project Lead|866-596-6626|info@oncopeptides.com|
268975|NCT02899078|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
268976|NCT02873975|Dana-Farber Cancer Institute|Geoffrey Shapiro M.D., PhDDana-Farber Cancer Institute|617-632-6594|Geoffrey_Shapiro@dfci.harvard.edu|
268977|NCT02797951|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
268978|NCT02753751|Yale University|Francis P. Wilson|2037376095|francis.p.wilson@yale.edu|
268979|NCT02748057|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268980|NCT02741271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268981|NCT02741245|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268982|NCT02717611|Acerta Pharma|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
275378|NCT00486278|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
275379|NCT00486291|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
275380|NCT00486330|Yale University AIDS Program|R. Douglas Bruce|2037374040|robert.bruce@yale.edu|
275381|NCT00486434|Nordic Bioscience A/S|Bente Juel Riis, Medical Director|+4522901317|bjr@nordicbioscience.com|
275382|NCT00486447|GE Healthcare|Angela N. Johnson, Senior Manager Clinical Affairs Operations|262-226-9495|angela.johnson@ge.com|
275383|NCT00486525|Ohio State University Comprehensive Cancer Center|Janice Kiecolt-Glaser, Principal Investigator|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu|
275384|NCT00486603|Adult Brain Tumor Consortium|Director of ABTC|410-955-3657|jfisher@jhmi.edu|
275385|NCT00486642|Bristish Columbia Cancer Agency|Dr. Kim N. Chi|604-877-6000|kchi@bccancer.bc.ca|2746
275386|NCT00486720|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
275387|NCT00486759|Hoffmann-La Roche|Medical Communications|800 821-8590||
275388|NCT00486811|Grünenthal GmbH|Claudia Leinweber|+49 241 569 2509|claudia.leinweber@grunenthal.com|
275389|NCT00486824|Stanford University|Dr. Deirdre Lyell|6507255720|dlyell@stanford.edu|
275390|NCT00486837|Grifols Therapeutics|Henry Li|1-800-520-2807|henry.li@grifols.com|
275391|NCT00486863|Warren Alpert Medical School of Brown University, Lifespan Center for International Health Research|Jennifer Friedman, M.D., Ph.D|(401) 444-7449|jennifer_friedman@brown.edu|
275392|NCT00486902|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
275393|NCT00486954|GlaxoSmithKline|GSK Response Center|866-435-7343||
275394|NCT00487084|Northwestern University|Cynthia A. Wong,M.D.|630-472-3555|c-wong2@northwestern.edu|
275395|NCT00487188|Hoffman-LaRoche|Medical Communications|800-821-8590||
275396|NCT00487240|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
275397|NCT00487279|St. Jude Medical CRMD|Heidi Hinrichs/Sr. Director, Clinical Operations|(818) 493-3297|hhinrichs@sjm.com|
275398|NCT00487396|Given Imaging|Director, Clinical Affairs|+972-4-9097777|Hila.Debby@givenimaging.com|
275399|NCT00487435|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
275400|NCT00487539|Janssen Research & Development|Senior Director|215-793-7540||
275401|NCT00487552|MED Institute, Inc.|Scott Snyder, Ph.D., Manager, Biostatistics and Data Management, Senior Statistician|765-463-7537|ssnyder@medinst.com|
275402|NCT00487565|DePuy Orthopaedics, Inc.|Tammy O'Dell|574-372-7104|TOdell2@its.jnj.com|
275403|NCT00487669|Dartmouth-Hitchcock Medical Center|James Rigas, MD|603-650-6344|james.r.rigas@hitchcock.org|
275404|NCT00487695|Johns Hopkins University School of Medicine Division of Gastroenterology and Hepatology|Dr. Marcia Canto.|410-614-5388|mcanto@jhmi.edu|
275405|NCT00487721|University of Colorado, Denver|Dr. Thomas Flaig|(720) 848 0655|Thomas.Flaig@ucdenver.edu|
275406|NCT00487747|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
275407|NCT00487825|Novartis Pharmaceuticals|Study Director|862-778-8300||
275408|NCT00487942|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
275409|NCT00488033|Intermountain Heart Institute|J.Brent Muhlestein|8015074702|jbrent.muhlestein@imail.org|
275410|NCT00488059|Hoffmann-La Roche|Medical Communications|800-821-8590||
275411|NCT00488293|Department of Veterans Affairs|John D. Whited, MD, MHS|919-286-6926|john.whited@va.gov|
275412|NCT00488319|Johnson & Johnson Research & Development, LLC|Director Clinical Research|1-609-730-6771||
275413|NCT00488345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275414|NCT00488475|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275415|NCT00488488|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275416|NCT00488514|GlaxoSmithKline|GSK Response Center|866-435-7343||
275417|NCT00488592|Hematology Branch, NHLBI|Minoo Battiwalla, MD|301 827 0939|battiwam@nhlbi.nih.gov|
283141|NCT00894543|University of Pennsylvania School of Medicine|Dr. Ellen W. Freeman|215-349-5521|freemane@mail.med.upenn.edu|
283142|NCT00894647|Graceway Pharmaceuticals|Vice President Medical Affairs|267-948-0400|Sharon.levy@gracewaypharma.com|
283143|NCT00894686|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283144|NCT00894699|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
283145|NCT00894738|Washington University School of Medicine|Dr. Ginger Nicol|(314) 362-2461|nicolg@psychiatry.wustl.edu|
283146|NCT00894803|University of Cincinnati|Dr Arthur Pancioli|513-558-8087|arthur.pancioli@uc.edu|
268983|NCT02688608|Stanford Medicine at Stanford University|Saad A Khan, MD|650-507-5624|Saad.A.Khan@stanford.edu|
283147|NCT00894933|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
283148|NCT00895011|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|medaffairs@vivus.com|
292664|NCT01439854|University of Texas Health San Antonio|Muhammad Abdul-Ghani|210-557-1157|abdulghani@uthscsa.edu|
292665|NCT01439867|Amgen Inc.|Study Director|866-572-6436||
292666|NCT01439880|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
292667|NCT01439945|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
292668|NCT01439971|Catalyst Biosciences|Chief Medical Officer|1-650-266-8671|hlevy@catbio.com|
292669|NCT01440049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292670|NCT01440101|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
292671|NCT01440283|St. Jude Children's Research Hospital|Chia-ho Hua, PhD|901-595-3610|chia-ho.hua@stjude.org|
292672|NCT01440322|Alcon Research, Ltd.|Sharon Holden Thomas, Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
292673|NCT01440374|Novartis Pharmaceuticals|Study Director|862-778-8300||
292674|NCT01440387|GlaxoSmithKline|GSK Response Center|866-435-7343||
292675|NCT01440543|Digestive Diseases Center, Vitkovice Hospital, Ostrava, Czech Republic|Premysl Falt MD|+420602689561|faltprem@centrum.cz|
297022|NCT01721044|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292676|NCT01440569|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
292677|NCT01440634|UT Southwestern Medical Center|Dr. Carlos H Timaran|2146450533|timaran1@msn.com|
292678|NCT01440647|Women & Infants Hospital of Rhode Island|Abbot R. Laptook, MD, Professor of Pediatrics The Warren Alpert Medical School of Brown University M|401-274-1122|ALaptook@WIHRI.org|7404
292679|NCT01440764|Beth Israel Deaconess Medical Center|Robert Banzett, PhD|(617)667-0572|rbanzett@bidmc.harvard.edu|
292680|NCT01440803|Columbia University|Elizabeth Shane, MD|212-305-7225|es54@cumc.columbia.edu|
292681|NCT01440816|OncoSec Medical Incorporated|Sharron E Gargosky, Chief Clinical Regulatory Officer|+1 858-255-4729|ClinicalTrialsInfo@OncoSec.com|
292682|NCT01440881|University of Florida|Dr. Thomas Beaver|352-273-5501|thomas.beaver@surgery.ufl.edu|
292683|NCT01440920|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
292684|NCT01440946|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
292685|NCT01440959|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
292686|NCT01440972|University of Iowa|Dr. Neil Segal|3193358204|segal-research@uiowa.edu|
292687|NCT01441037|National Heart Lung and Blood Institute|Young, Neal|+1 301 496 5093|youngns@mail.nih.gov|
297023|NCT01721057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297024|NCT01721070|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
268984|NCT02675231|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
268985|NCT02659514|Spectrum Pharmaceuticals, Inc, Research and Development Office 157 Technology Drive Irvine, CA 92618|Shanta Chawla|9497886700|shanta.chawla@sppirx.com|
268986|NCT02634268|VA Puget Sound Health Care System|Margaret Collins|206.764.2085|margaret.collins@va.gov|
268987|NCT02605967|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
268988|NCT02584634|Pfizer Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
268989|NCT02581137|University of Arizona|Dr. Sherry Chow|5206263358|schow@azcc.arizona.edu|
268990|NCT02562235|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
268991|NCT02553265|NYU Langone Health|Horacio C Kaufmann, MD|212-263-7225|Horacio.Kaufmann@nyulangone.org|
268992|NCT02550288|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268993|NCT02510040|Jaeb Center for Health Research|Raymond Kraker, PEDIG Coordinating Center Director|813-975-8690|rkraker@jaeb.org|
268994|NCT02499328|Astrazeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
268995|NCT02463981|UESTC|Prof. Keith Kendrick|+86028-61830811|k.kendrick.uestc@gmail.com|
268996|NCT02460224|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
268997|NCT02460159|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
268998|NCT02457910|Vanderbilt University Medical Center|Vandana Abramson, MD|(615)936-8422|vandana.abramson@vumc.org|
268999|NCT02407236|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
269000|NCT02320396|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275418|NCT00488618|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
275419|NCT00488631|Janssen Research & Development|Senior Director|215-793-7540||
275420|NCT00488644|UT MD Anderson Cancer Center|Victor Levin, MD, BS / Professor||kuhunter@mdanderson.org|
275421|NCT00488683|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
275422|NCT00488774|Janssen Research & Development|Senior Director|215-793-7540||
275423|NCT00488826|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
275424|NCT00488865|Rex Medical|James Bressler|610-940-0665|ebressler@rexmedical.com|
283149|NCT00895037|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283150|NCT00895154|Washington University|Dr. Allison King|314-454-4291|king_a@wustl.edu|
283151|NCT00895180|Sidney Kimmel Comprehensive Cancer Center|Dr. Jaishri Blakely|(410) 955-8893||
283152|NCT00895193|University of Kansas Medical Center|Julie-Ann Dutton, MS, RD|(913) 588-4064|jdutton@kumc.edu|
283153|NCT00895232|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|844
297025|NCT01721096|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
283154|NCT00895245|University of Washington|Dr. Keith Eaton|206-288-2048|kdeaton@uw.edu|
283155|NCT00895310|University of California Davis|Analyst|9167340294|pkaujla@ucdavis.edu|
283156|NCT00895414|Masonic Cancer Center, University of Minnesota|Dr. Anne Blaes|612-626-8138|blaes004@umn.edu|
283157|NCT00895453|Vienna Medical School|Armin Witt MD|+43140400|armin.witt@meduniwien.ac.at|2821
297026|NCT01721109|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
269001|NCT02282345|UT MD Anderson Cancer Center|Dr. Jennifer Litton,VP, Clinical Research, VP Clinical Research|(713) 792-2817|jlitton@mdanderson.org|
269002|NCT02230410|Mayo Clinic|Dr. Kenneth K. Wang|507-293-7911|wang.kenneth@mayo.edu|
269003|NCT02053246|University of Florida|Dr. Julio Duarte|352-273-8132|juliod@cop.ufl.edu|
269004|NCT02043678|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
269005|NCT02005471|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
269006|NCT01984346|AtriCure|Medical Director of Clinical Education|513-560-5974|SGaynor@atricure.com|
269007|NCT01980940|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269008|NCT01958593|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
269009|NCT01923298|The University of Arizona Cancer Center|Dr. Pavani Chalasani|520-626-0191|pchalasani@uacc.arizona.edu|
269010|NCT01918033|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269011|NCT01916980|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269012|NCT01916967|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269013|NCT01910402|GlaxoSmithKline|GSK Response Center|866-435-7343||
269014|NCT01893320|The University of Texas MD Anderson Cancer Center|Naval Daver MD, Associate Professor|713-794-4392|NDaver@mdanderson.org|
269015|NCT01870401|Becton Dickinson|Lisa Erickson|763-463-2897|Lisa.Erickson@bd.com|
269016|NCT01867606|Mayo Clinic|Aminah Jatoi, M.D.|(507) 284-4918|jatoi.aminah@mayo.edu|
269017|NCT01857063|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269018|NCT01854268|University of Florida|Alexandra E. Brandimore, M.A. CCC/SLP|352-273-3711|aessman@ufl.edu|
275425|NCT00488982|University of California, San Francisco|Dr. Rahul Aggarwal|(415) 353-9278|Rahul.Aggarwal@ucsf.edu|
275426|NCT00489086|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
275427|NCT00489216|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
275428|NCT00489255|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
275429|NCT00489268|Mayo Clinic, Arizona|David E. Fleischer, M.D.|(480) 301-4461|fleischer.david@mayo.edu|
275430|NCT00489281|Johns Hopkins University|F Javier Bolanos Meade, MD|4106146398|fbolano2@jhmi.edu|
275431|NCT00489359|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
275432|NCT00489411|University of Michigan School of Nursing|Ellen Lavoie Smith, PhD, APRN, AOCN, FAAN|734-936-1267|Ellenls@med.umich.edu|
275433|NCT00489424|Novartis Pharmaceuticals|Study Director|862-778-8300||
275434|NCT00489476|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
275435|NCT00489489|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
275436|NCT00489541|Boston Scientific|Andrey Nersesov, Clinical Project Manager|508-683-4988|andrey.nersesov@bsci.com|
275437|NCT00489554|GlaxoSmithKline|GSK Response Center|866-435-7343||
275438|NCT00489736|sanofi-aventis|International Clinical Development, Clinical Study Director||GV-Contact-us@sanofi-aventis.com|
275439|NCT00489827|Dept Cardiothoracic Surgery, Linköping University Hospital, SE58185 Linköping, Sweden|Rolf Svedjeholm|+46101034825|rolf.svedjeholm@regionostergotland.se|
275440|NCT00489853|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
275441|NCT00489866|Durham VAMC|Christine E. Marx, MD|9192860411|marx0001@mc.duke.edu|7426
275442|NCT00489918|Zosano Pharma Inc.|Don Kellerman, VP of Clinical Development and Medical Affairs|(510) 745-4004|dkellerman@zosanopharma.com|
275443|NCT00489970|GlaxoSmithKline|GSK Response Center|866-435-7343||
275444|NCT00490009|Stanford University Medical Center|Susan J Knox, MD, Associate Professor of Radiation Oncology|650-725-2720|sknox@stanford.edu|
275445|NCT00490022|University of Washington|Dr. Stephanie Page, PhD, MD|206.616.0483|page@u.washington.edu|
275446|NCT00490035|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
275447|NCT00490061|Stanford University|Quynh Le|650-498-5032|qle@stanford.edu|6506370734
275448|NCT00490100|National Institute of Allergy and Infectious Diseases|De Ravin, SukSee|+1 301 496 6772|sderavin@mail.nih.gov|
275449|NCT00490139|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
275450|NCT00490256|Emory University|Paul Kirshbom, MD|404-785-6330|pkirshb@emory.edu|
275451|NCT00490269|Uniformed Services University for the Health Sciences|Dr. Lou Cantelina|301-295-3240|louis.cantelina@usuhs.edu|
275452|NCT00490282|The University of Texas (UT) MD Anderson Cancer Center|Adam Garden, MD/Radiation Oncology Department|(713) 563-2300|agarden@mdanderson.org|
283158|NCT00895531|University Louisville|Nancy Alsip|502-852-2905|nlalsi01@exchange.louisville.edu|
269019|NCT01852812|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269020|NCT01844986|AstraZeneca|Elizabeth Lowe|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
269021|NCT01828021|MacroGenics, Inc.|Chief Medical Officer|301-251-5172|info@macrogenics.com|
269022|NCT01709318|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269023|NCT01698918|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
269024|NCT01673620|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269025|NCT01660243|Toray Industries, Inc|Clinical Trials Information Desk||clinical-trials.toray.mb@mail.toray|
269026|NCT01617187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269027|NCT01611883|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269028|NCT01572675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269029|NCT01554163|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269030|NCT01502371|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269031|NCT01490190|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269032|NCT01471340|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269033|NCT01462370|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269034|NCT01436253|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269035|NCT01414192|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269036|NCT01390415|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269037|NCT01381679|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269038|NCT01370603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269039|NCT01370590|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269040|NCT01368185|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269041|NCT01349907|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269042|NCT01345786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269043|NCT01306929|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
275453|NCT00490451|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
275454|NCT00490477|University of Turin, Italy|V. M. Ranieri, MD|00390116334001|marco.ranieri@unito.it|
275455|NCT00490490|Stanford University Medical Center|Susan J. Knox, MD, Associate Professor of Radiation Oncology|(650) 725-2720|sknox@stanford.edu|
275456|NCT00490529|Stanford University|Ronald Levy|650-725-6452|levy@stanford.edu|
275457|NCT00490542|Tufts Medical Center|S. Nassir Ghaemi, MD, MPH|617-636-5735|nghaemi@tuftsmedicalcenter.org|
275458|NCT00490555|University of Washington|Dr. Stephanie Page|2066160483|page@u.washington.edu|
275459|NCT00490568|GlaxoSmithKline|GSK Response Center|866-435-7343||
275460|NCT00490646|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
275461|NCT00490698|The University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD / Professor||CR_Study_Registration@mdanderson.org|
275462|NCT00490724|Clinical Science Initiative Dept. Janssen Pharmaceutical K.K./ Tokyo Japan|Manager|+81.3.4411.5653||
275463|NCT00490802|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
275464|NCT00490815|Alimera Sciences, Inc|Kathleen Billman, Senior Director of Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
275465|NCT00490841|Abbott Vascular|Ellen Travis|408-845-1512|Ellen.Travis@av.abbott.com|
275466|NCT00490919|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
275467|NCT00490945|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marelene.dressman@vandapharma.com|
275468|NCT00490971|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clinical Leader|609-730-2436||
275469|NCT00491075|U.T. MD Anderson Cancer Center|Quality Assurance Specialist|713-792-2830|guclinicaltrials@mdanderson.org|
275470|NCT00491179|National Taiwan University Hospital|Chen-Hua Liu|886223123456|jacque_liu@mail2000.com.tw|63572
275471|NCT00491244|National Taiwan University Hospital|Dr. Chen-Hua Liu|+886-2-23123456|jacque_liu@mail2000.com.tw|63572
275472|NCT00491322|Massachusetts General Hospital|Dr. Sherri-Ann M. Burnett-Bowie|6177245594|sburnett-bowie@mgh.harvard.edu|
275473|NCT00491374|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
275474|NCT00491491|Chaim Sheba Medical Center|Dr Avichai Shimoni|972 3 530 5303|ashimoni@sheba.health.gov.il|
275475|NCT00491530|Abbott|Medical Information Specialist|800-633-9110||
275476|NCT00491556|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
275477|NCT00491608|ZymoGenetics, a Bristol-Myers Squibb company|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
283159|NCT00895583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283160|NCT00895622|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
283161|NCT00895661|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
283162|NCT00895752|Cincinnati Childrens Hospital|Craig Erickson MD|5136366265|craig.erickson@cchmc.org|
283163|NCT00895817|Walter Reed Army Medical Center|Dr. Fouad J Moawad|(301) 295-4600|fouad.moawad@us.army.mil|
283164|NCT00895830|Acacia Pharma Ltd|Dr Gabriel Fox||gabrielfox@acaciapharma.com|
283165|NCT00895843|University of Manchester|Mr Sin L Yong|01612756806|sin.l.yong@manchester.ac.uk|
283166|NCT00895895|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283167|NCT00895921|Veterans Medical Research Foundation|Jonathan M. Meyer, MD|858-964-0777|jmmeyer@ucsd.edu|
283168|NCT00895934|Fred Hutchinson Cancer Research Center|Roland B. Walter, MD, PhD|206-667-3599|rwalter@fhcrc.org|
269044|NCT01294696|Merck Sharp & Dohme Corp|Vice President, Late Stage Group Development Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269045|NCT01277822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269046|NCT01261247|Mayo Clinic Cancer Center|Patrick Johnston, MD, PhD|507-284-2511|johnston.patrick@mayo.edu|
269047|NCT01244763|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
269048|NCT01208207|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269049|NCT01208181|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269050|NCT01206517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269051|NCT01190267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269052|NCT01190254|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269053|NCT01154036|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269054|NCT01101464|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
269055|NCT01098071|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269056|NCT01077830|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269057|NCT01070966|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269058|NCT01070953|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269059|NCT01030341|Johns Hopkins Data Coordinating Center|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
269060|NCT00979901|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
269061|NCT00977574|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
269062|NCT00963599|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
269063|NCT00954915|MacroGenics, Inc.|Teplizumab Program Manager||info@macrogenics.com|
269064|NCT00953680|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
269065|NCT00945035|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269066|NCT00943852|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
269067|NCT00927953|MacroGenics, Inc.|Medical Officer||info@macrogenics.com|
269068|NCT00909389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269070|NCT00820027|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269071|NCT00788710|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
275478|NCT00491751|Boston University School of Medicine|Naomi M. Hamburg, MD|617-638-7462|nhamburg@bu.edu|
275479|NCT00491764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275480|NCT00491829|Sprout Pharmaceuticals|Scientific Program Director|9198820850|clinicaltrials@sproutpharma.com|
275481|NCT00491894|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
275482|NCT00492024|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
275483|NCT00492063|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
275484|NCT00492089|The University of Texas MD Anderson Cancer Center|Monica Loghin, MD / Assistant Professor|K Hunter, RN 713-745-5769|CR_Study_Registration@mdanderson.org|
275485|NCT00492115|UCSD|Dr. Sonia Ancoli-Israel|858 822 7710|sancoliisrael@ucsd.edu|
275486|NCT00492206|University of Pittsburgh Cancer Institute|Ahmad Tarhini, MD|412-648-6507|tarhiniaa@upmc.edu|
275487|NCT00492232|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
275488|NCT00492284|QLT Inc.|Medical Information Department|1-800-663-5486|medaff@qltinc.com|
275489|NCT00492297|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
275490|NCT00492336|Maryland Psychiatric Research Center|Dr. Robert Buchanan, M.D.|410-402-7876|rbuchanan@som.umaryland.edu|
275491|NCT00492401|The Ohio State University Comprehensive Cancer Center|William Blum, MD|614-293-9273|William.Blum@osumc.edu|
275492|NCT00492531|Professor of Medicine: Chief, Pulmonary, Allergy and Critical Care Medicine: Director, Hemostasis and Vascular Biology Research Institute; University of Pittsburgh School of Medicine|Mark Gladwin|412-692-2117|gladwinmt@upmc.edu|
275493|NCT00492544|GlaxoSmithKline|GSK Response Center|866-435-7343||
275494|NCT00492557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275495|NCT00492583|Georgetown University|Daniel J Merenstein, MD|202-687-2745|djm23@georgetown.edu|
283169|NCT00895947|Amarillo Biosciences, Inc.|Martin J. Cummins|806-376-1741|mcummins@amarbio.com|14
283170|NCT00896012|University at Buffalo|Oleh G. Pankewycz, MD||opankewycz@kaleidahealth.org|
283171|NCT00896038|National Institute on Alcohol Abuse and Alcoholism|Melanie Schwandt|3014516960|melanies@mail.nih.gov|
283172|NCT00896051|Tibotec|Senior Director|+32 (0) 14 641 265||
283173|NCT00896064|GlaxoSmithKline|GSK Response Center|866-435-7343||
283174|NCT00896168|Xian-Janssen Pharmaceutical Ltd|Director of Medical Affairs|(8610) 5821 8359||
283175|NCT00896181|Stanford University|Dr. A. Dimitrios Colevas, Professor of Medicine (Oncology)|650-724-9707|colevas@stanford.edu|
283176|NCT00896233|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
297027|NCT01721161|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
269072|NCT00785291|UCSF Comprehensive Cancer Center|Hope Rugo, M.D.||hrugo@medicine.ucsf.edu|
269073|NCT00783224|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269074|NCT00780403|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269075|NCT00779116|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269076|NCT00778700|Incyte Organization|Study Director|1-855-463-3463|medinfo@incyte.com|
297028|NCT01721200|Yale University|Liana Fraenkel, MD, MPH, Department of Medicine||liana.fraenkel@yale.edu|
269077|NCT00764478|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269078|NCT00761527|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269079|NCT00757627|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
269080|NCT00756938|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269081|NCT00746590|BTG International Ltd.|Claire Daugherty|+1 801 556 8882|claire.daugherty@btgplc.com|
269082|NCT00730132|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269083|NCT00728416|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269084|NCT00724477|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269085|NCT00723736|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269086|NCT00705081|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269087|NCT00704769|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269088|NCT00704535|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
275496|NCT00492622|University Louisville|Nancy Alsip|502-852-2905|nancy.alsip@louisville.edu|
275497|NCT00492648|GlaxoSmithKline|GSK Response Center|866-435-7343||
275498|NCT00492726|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
275499|NCT00492752|BAYER|Therapeutic Area Head|<not disclosed>|clinical-trials-contact@bayerhealthcare.com|
275500|NCT00492856|SWOG Statistical Center|SWOG Leukemia Committee Statistician|206-667-4408||
275501|NCT00492921|JHU SKCCC|Dr. Javier Bolanos Meade|410-614-6398|Fbolano2@jhmi.edu|
275502|NCT00492973|Lexington Clinic|Cale Jacobs, PhD|859-258-8238|cjaco@lexclin.com|
275503|NCT00493012|Heart and Diabetes Center North Rhine-Westfalia|Dr. Armin Zittermann|+49 5731 97|azittermann@hdz-nrw.de|1912
275504|NCT00493038|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
275505|NCT00493064|PaloAltoMF|Renee Kaneshiro, study coordinator|650-853-4744|kaneshr@pamf.org|
275506|NCT00493181|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
275507|NCT00493220|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
275508|NCT00493246|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
275509|NCT00493285|MedImmune, LLC|Elissa Malkin, DO, MPH|301-398-0000|malkine@medimmune.com|
275510|NCT00493311|Mallinckrodt Pharmaceuticals|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com|
275511|NCT00493454|The University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
275512|NCT00493467|University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD/Associate Professor, Lymphoma/Myeloma|713-563-1509|fsamaniego@mdanderson.org|
275513|NCT00493636|ACORN Research, LLC|Study Chair|901-435-5570|lschwartzberg@acornresearch.net|
275514|NCT00493649|US Oncology Research, McKesson Specialty Health|Dr. Stephen E Jones|832-381-7580|steve.jones@usoncology.com|
275515|NCT00493779|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
275516|NCT00493805|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
275517|NCT00493974|University of Minnesota|Sarah Lindberg|612-626-9011|slindberg@umn.edu|
275518|NCT00494013|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
275519|NCT00494026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
275520|NCT00494091|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275521|NCT00494143|VA Puget Sound Health Care System|Dr. Joseph Czerniecki|206 277 5188|joseph.czerniecki@va.gov|
275522|NCT00494221|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
275523|NCT00494234|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com|
275524|NCT00494299|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
275525|NCT00494442|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
275526|NCT00494481|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
283177|NCT00896298|UT Southwestern Medical Center|Dr. Abhimanyu Garg|214-648-2895|abhimanyu.garg@utsouthwestern.edu|
283178|NCT00896337|Boston Scientific|Angela Schutt|763-494-2166|schutta@bsci.com|
297029|NCT01721226|George Washington University|Dr. Irene Kuo|202-994-0367|ikuo@gwu.edu|
269089|NCT00694369|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
269090|NCT00671528|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269091|NCT00667823|Actelion Pharmaceuticals Ltd|Senior Clinical Leader PH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
269092|NCT00652327|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269093|NCT00604500|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsresultsdisclosure@merck.com|
269094|NCT00602641|ECOG Statistical Office|Study Statistician|617-632-3012||
269095|NCT00568178|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269096|NCT00549848|St. Jude Children's Research Hospital|Sima Jeha, MD|(901) 595-3901|sima.jeha@stjude.org|
269097|NCT00545844|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
269098|NCT00511433|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269099|NCT00511355|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269100|NCT00511342|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269101|NCT00511199|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269102|NCT00491504|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269103|NCT00468312|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269104|NCT00453063|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269105|NCT00447603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269106|NCT00442351|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269107|NCT00423488|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269108|NCT00413972|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269109|NCT00413062|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269110|NCT00391170|National Heart Lung and Blood Institute|Clara, Joseph|+1 301 402 2399|joseph.clara@nih.gov|
269111|NCT00359138|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269112|NCT00350701|University at Buffalo|Dr. Paresh Dandona|7165351850|dandona@buffalo.edu|
269113|NCT00319449|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269114|NCT00305344|University of Florida|Dr Michael Haller|352.273.9264|hallemj@peds.ufl.edu|
269115|NCT00289887|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275527|NCT00494494|University of North Carolina at Chapel Hill|Kennth L. Cohen, MD|919 843-0292|klc@med.unc.edu|
275528|NCT00494507|University of Rochester|Robert Griggs, MD|585-275-3707|robert_griggs@urmc.rochester.edu|
275529|NCT00494585|The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
275530|NCT00494676|Schepens Eye Research Institute|Alex Bowers|617-912-2512|alex_bowers@meei.harvard.edu|
275531|NCT00494780|GlaxoSmithKline|GSK Response Center|866-435-7343||
275532|NCT00494806|MD Anderson Cancer Center|Robert L. Massey, PhD, RN|713-792-3704|rlmassey@mdanderson.org|
275533|NCT00494871|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
275534|NCT00494975|Dermatology|Ko Mei-Ju|886-223123456|kmjmay@gmail.com|2141
275535|NCT00495040|UT MD Anderson Cancer Center|Chang,Joe Y.,M.D. / Radiation Oncology|713-563-2337|jychang@mdanderson.org|
275536|NCT00495079|Talon Therapeutics|Chief Medical Officer|650-588-6404|info@talontx.com|
275537|NCT00495157|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
275538|NCT00495170|UT MD Anderson Cancer Center|Dr. Joe Chang / Professor, Radiation Oncology Department|713-563-2337|jychang@mdanderson.org|
275539|NCT00495391|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
275540|NCT00495469|GlaxoSmithKline|GSK Response Center|866-435-7343||
275541|NCT00495495|Indiana University School of Dentistry|Domenick T. Zero, DDS MS Principal Investigator|317-274-8822|dzero@iupui.edu|
275542|NCT00495521|Jacobus Pharmaceutical Company, Inc.|Dr. Kathy Aleš, Medical Director|609-921-7448|kathy.ales@jacobus-pharmaceutical.com|238
275543|NCT00495586|CAMFIC|Carl Llor|+34 3011777|carles.llor@urv.cat|
275544|NCT00495612|Genentech, Inc.|Medical Communications|800 821-8590||
275545|NCT00495625|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
275546|NCT00495677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275547|NCT00495755|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH, FRCP(C)|617-632-5946|cscutler@partners.org|
275548|NCT00495794|VA Center for Clinical Management Research; University of Michigan|Dr. Michele Heisler|734-845-3504|mheisler@umich.edu|
275549|NCT00495820|Central Arkansas Veterans Healthcare System|Prasad Padala, MD, MS, Associate Director for Clinical Programs, GRECC|5012572537|prasad.padala@va.gov|
275550|NCT00496015|GlaxoSmithKline|GSK Response Center|866-435-7343||
275551|NCT00496054|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
275552|NCT00496080|Ethicon|Piet Hinoul MD|908-218-2585|phinoul@its.jnj.com|
275553|NCT00496197|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275554|NCT00496262|CSL Behring|Program Director, Clinical R&D|Use email contact.|clinicaltrials@cslbehring.com|
283179|NCT00896363|GlaxoSmithKline|GSK Response Center|866-435-7343||
283180|NCT00896389|University of Maryland, Baltimore|Dr. Yen Pei Christy Chang|410-706-6737|cchang@som.umaryland.edu|
283181|NCT00896441|Stanford University|Mike Greicius|650-723-8331|greicius@stanford.edu|
283182|NCT00896454|Amgen Inc.|Study Director|866-572-6436||
297030|NCT01721317|GlaxoSmithKline|GSK Response Center|866-435-7343||
283183|NCT00896480|GlaxoSmithKline|GSK Response Center|866-435-7343||
283184|NCT00896532|Amgen Inc.|Study Director|866-572-6436||
283185|NCT00896649|Boston Medical Center|Gustavo Mercier, House Radiologist|617-638-6610|gustavo.mercier@bmc.org|
283186|NCT00896779|Stanford University|Steven Sanislo, MD|650-723-6995|ssanislo@stanford.edu|
283187|NCT00897390|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
269116|NCT00281320|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269117|NCT00276016|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269118|NCT00265343|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269119|NCT00264147|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269120|NCT00202878|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269121|NCT00174265|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269122|NCT00159783|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269123|NCT00114101|Roswell Park Cancer Institute|Philip McCarthy, MD||philip.mccarthy@roswellpark.org|
269124|NCT00092677|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269125|NCT00090259|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
269126|NCT00003298|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
269127|NCT00003377|Gynecologic Oncology Group Statistical & Data Center|Melissa Leventhal|(716)845-5702|mleventhal@gogstats.org|
269128|NCT00003389|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
269129|NCT00003404|Dartmouth Hitchcock Medical Center|Richard J. Barth Jr., MD|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
269130|NCT00003453|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269131|NCT00003456|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269132|NCT00003457|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269133|NCT00003459|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269134|NCT00003460|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269135|NCT00003468|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269136|NCT00003469|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269137|NCT00003470|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269138|NCT00003471|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
297031|NCT01721330|Massachusetts General Hospital|Leah Feinberg|617-726-4651|lkfeinberg@mgh.harvard.edu|
269139|NCT00003472|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269140|NCT00003473|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269141|NCT00003474|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
275555|NCT00496340|H. Lee Moffitt Cancer Center and Research Institute|Marcie Riches, MD|813-745-6284|marcie.riches@moffitt.org|
275556|NCT00496366|Rutgers Cancer Institute of New Jersey|Deborah Toppmeyer, MD|732-235-6789|toopmede@cinj.rutgers.edu|
275557|NCT00496379|Dana-Farber Cancer Institute|Dr. Nancy Lin|617-632-2335|nlin@partners.org|
275558|NCT00496470|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
275559|NCT00496483|Veloxis A/S|Christina Sylvest, Sr VP, Global Clinical Development and Operations|+45 20553877|csy@veloxis.com|
275560|NCT00496587|The University of Texas MD Anderson Cancer Center|Dr. Nazir Tannir/|713-792-7734|CR_Study_Registration@mdanderson.org|
275561|NCT00496626|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275562|NCT00496769|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
275563|NCT00496808|UT MD Anderson Cancer Center|Raphael E Pollock,PHD/Professor Emeritus, Surgical Oncology|(713) 792-6928|CR_Study_Registration@mdanderson.org|
275564|NCT00496860|Altor Bioscience|Hing C. Wong, Chief Clinical Officer|9544438600|hingwong@altorbioscience.com|
275565|NCT00496873|University of Texas (UT) MD Anderson Cancer Center|Felipe Samaniego, MD/Associate Professor, Lymphoma/Myeloma||CR_Study_Registration@mdanderson.org|
275566|NCT00496964|Virginia Commonwealth University|Dr. Sheryl Finucane|804-628-3639|sfinucan@vcu.edu|
275567|NCT00497055|San Francisco Department of Public Health|Phillip O. Coffin, Director of Substance Use Research|415-437-6282|phillip.coffin@sfdph.org|
275568|NCT00497081|San Francisco Department of Public Health|Glenn-Milo Santos, MPH|415.437.6231|glenn-milo.santos@sfdph.org|
275569|NCT00497146|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
275570|NCT00497198|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
275571|NCT00497289|B.Braun Melsungen AG|Study manager|+49 5661 71|studies@bbraun.com|0
275572|NCT00497770|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
283188|NCT00897676|The Children's Hospital of Philadelphia|Diva DeLeon, MD|267-426-5529|deleon@email.chop.edu|
297032|NCT01721369|Hospital Vall hebron|Dr. Angel Moya||amoyamitjans@gmail.com|
283189|NCT00897715|VA Tennessee Valley Healthcare System.|Adriana Hung|615-873-7480|adriana.hung@va.gov|
283190|NCT00897897|Philips Healthcare|Director, Clinical and Regulatory Affairs|425-487-7665|sarah.baxter@philips.com|
283191|NCT00898222|Brigham and Women's Hospital|Dr. Shamsah Kazani|617-732-8201|skazani@partners.org|
283192|NCT00898443|UAB|Marsha Wakefield, M.D.|205-934-4696|mwakefield@uab.edu|
283193|NCT00898560|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
283194|NCT00898807|Johns Hopkins|Anne Casper|410-955-8183|ashankl1@jhu.edu|
283195|NCT00898937|Georgetown University Medical Center - Lombardi Comprehensive Cancer Center|Claudine Isaacs|202-444-3677|isaacsc@georgetown.edu|
283196|NCT00899353|Marshall University Joan C. Edwards School of Medicine|Dr. W. Elaine Hardman|304-696-3721|hardmanw@marshall.edu|
283197|NCT00899392|Children's Hospital of Philadelphia/OHSU/Doernbecher Children's Hospital|Joel A Friedlander|503-494-1078|friedlan@ohsu.edu|
283198|NCT00899431|The University of Texas MD Anderson Cancer Center|Dr. Issa F. Khouri, MD/Professor, Stem Cell Transplantation|713- 745-0049|ikhouri@mdanderson.org|
283199|NCT00899470|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
283200|NCT00899548|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Antonio C. Wolff, M.D.|410-614-4192|awolff@jhmi.edu|
283201|NCT00899574|NYU Cancer Institute|Sylvia Adams, MD|212-263-6485|sylvia.adams@nyumc.org|
283202|NCT00899600|Dartmouth-Hitchcock Medical Center|Dr. Randy Loftus|6036504642|randy.w.loftus@hitchcock.org|
283203|NCT00899678|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
283204|NCT00899717|University of Santiago de Compostela|Urbano Santana Penín|0034647344093|urbano.santana@usc.es|
283205|NCT00899847|Stanford University School of Med|Wen-Kai Weng, MD; Associate Professor of Medicine|650-723-7689|wkweng@stanford.edu|
283206|NCT00900029|Smith & Nephew, Inc.|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
283207|NCT00900146|Novartis Pharmaceuticals|Study Director|862-778-8300||
283208|NCT00900159|Brigham and Women's Hospital; Harvard Medical School|Dr. Orfeu M. Buxton|617-507-9177|Orfeu_Buxton@HMS.Harvard.edu|
283209|NCT00900237|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
283210|NCT00900562|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
283211|NCT00900601|Oslo University Hospital|Thomas Kibsgård|99030831|kibsgard@gmail.com|+47
283212|NCT00900627|Astrazeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
283213|NCT00900666|Mary Free Bed Rehabilitation Hospital|Krisanne B. Chapin, PhD|616-493-9831|krisanne.chapin@maryfreebed.com|
297033|NCT01721408|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283214|NCT00900731|Novartis Pharmaceuticals|Study Director|862 778-8300||
283215|NCT00900757|Duke University Medical Center|Mary Lou Affronti|919-684-6239|mary.affronti@dm.duke.edu|
283216|NCT00900796|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283217|NCT00900822|Institut Straumann AG|Clinial Trial Manager|+41 61 965 11 11|info@straumann.com|
283218|NCT00901017|Institut Straumann AG|Marc Quirynen, Professor|+4161965|michael.hotze@straumann.com|1235
283219|NCT00901186|Novartis Pharmaceuticals|Study Director|1-862-778-8300||
283220|NCT00901199|Children's Hospital & Research Center at Oakland|Ashutosh Lal, MD|510-428-3172|ashutosh.lal@ucsf.edu|
283221|NCT00901225|Duke University Medical Center|Mitchell E Horwitz, MD, Principal Investigator|919-668-1045|mitchell.horwitz@duke.edu|
283222|NCT00901316|Texas Children's Hospital|Sheldon L. Kaplan, MD|832-824-4330|skaplan@bcm.edu|
283223|NCT00901342|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
283224|NCT00901394|University of Chicago|Principal Investigator|7737022544||
283225|NCT00901459|Duke Center for Nicotine and Smoking Cessation Research|Jed E. Rose, Ph.D.|919-668-5055|jed.rose@mc.duke.edu|
283226|NCT00901485|Royal Brompton Hospital|Miss Julia Kelly|+44 2073528121|j.kelly@rbht.nhs.uk|4183
283227|NCT00901576|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
283228|NCT00901628|Joint Reconstruction Center, Seoul National University Bundang Hospital|Tae Kyun Kim|82-31-787-7196|osktk@snubh.org|
283229|NCT00901901|BAYER|Therapeutic Area Head|(+)1-888-84-22937|clinical-trials-contact@bayer.com|
283230|NCT00901927|The University of Texas (UT) MD Anderson Cancer Center|Nathan Fowler/Clinical Professor, Lymphoma-Myeloma|(832) 671-3018|nfowler@mdanderson.org|
283231|NCT00902018|Weill Cornell Medical College|Dr James Bussel|22-746-3474|jbussel@med.cornell.edu|
283232|NCT00902161|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
283233|NCT00902174|Novartis Pharmaceuticals|Study Director|862-778-8300||
283234|NCT00902226|H. Lundbeck A/S|Study Director|email contact via|LundbeckClinicalTrials@lundbeck.com|Lundbeck
269142|NCT00003475|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
283235|NCT00902265|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
283236|NCT00902278|University of Massachusetts Medical School|Mary Co|5088562927|mary.co@umassmed.edu|
283237|NCT00902304|Novartis Pharmaceuticals|Study Director|862-778-8300||
283238|NCT00902330|Virginia Commonwealth University|Debra Lyon, RN, PhD, FNP|804-828-7743|delyon@vcu.edu|
283239|NCT00902486|Incyte Corporation|Study Director|855 463-3463||
283240|NCT00902538|Daiichi Sankyo Europe GmbH|Bettina Ammentorp|0049 89 7808 0|bettina.ammentorp@daiichi-sankyo.eu|585
283241|NCT00902564|H. Lundbeck A/S|Study Director|Email contact via|LundbeckClinicalTrials@lundbeck.com|Lundbeck
283242|NCT00902577|ACRIN|Donna Harfeil, Director of Protocol Management|215-717-2765|dhartfeil@acr.org|
283243|NCT00902746|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
283244|NCT00902850|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|585-338-6399|Robert.Steffen@bausch.com|
283245|NCT00903032|VA ECHCS|P. Michael Ho|720-857-5115|Michael.Ho@va.gov|
283246|NCT00903162|Dana-Farber Cancer Institute|Ann Partridge, MD, MPH|617.632.3800|ann_partridge@dfci.harvard.edu|
283247|NCT00903175|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
283248|NCT00903201|GlaxoSmithKline|GSK Response Center|866-435-7343||
292688|NCT01441063|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
292689|NCT01441076|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Grayson, Peter|+1 301 827 9187|peter.grayson@nih.gov|
292690|NCT01441102|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
292691|NCT01441180|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
292692|NCT01441245|Department of Internal Medicine, University of Siena, Le Scotte hospital, Siena, Italy|Alberto Palazzuoli MD, Cardiology Unit|+39577585363|palazzuoli2@unisi.it|
292693|NCT01441401|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269143|NCT00003476|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
292694|NCT01441414|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292695|NCT01441440|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inuiries@pfizer.com|
292696|NCT01441466|Princess Amlia Children's Clinic, Isala|Jolita Bekhof|+31384245050|j.bekhof@isala.nl|
292697|NCT01441492|Baylor College of Medicine|Amy McElhany, Clinical Research Manager|7137981016|pancreas@bcm.edu|
292698|NCT01441570|Brigham and Women's Hospital|Dr. Steven Gabardi|617-732-7658|sgabardi@partners.org|
292699|NCT01441596|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
292700|NCT01441635|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
292701|NCT01441765|Beth Israel Deaconess Medical Center|Dr. David Avigan, Principal Investigator|617-667-9920|davigan@bidmc.harvard.edu|
292702|NCT01441843|Erasmus University Medical Centre|Dr. M. Klimek|+31107033713|m.klimek@erasmusmc.nl|
297034|NCT01721447|University of Utah Division of Cardiovascular Medicine|Dr. Brent Wilson|801-585-2341|brent.wilson@hsc.utah.edu|
292703|NCT01441882|Oregon Health & Science University|Stephen Spurgeon|503-494-4606|spurgeos@ohsu.edu|
292704|NCT01441960|Mass General Hospital|Ala Nozari|978-318-3933|anozari@partners.org|
292705|NCT01441973|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
292706|NCT01442038|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
292707|NCT01442064|Genentech|Genentech||ctg-post-d@gene.com|
297035|NCT01721460|University od Wisconsin - Madison|Dr. Aeyal Raz|608-263-8100|raz@wisc.edu|
297036|NCT01721473|VA San Diego Healthcare System|Arthur Brody|8585528585|arthur.brody@va.gov|
292708|NCT01442103|Molnlycke Health Care|Joan wilson|+1 706-650-1012|joan.wilson@molnlycke.com|
292709|NCT01442129|Mount Sinai|Deborah D. Ascheim, MD, Associate Professor, Clinical Director of Research, InCHOIR|212-659-9567|deborah.ascheim@mountsinai.org|
297037|NCT01721486|Beaumont Hsopital|Kaveh Aslani, MD|248-898-1907|kaveh.aslani@beaumont.org|
292710|NCT01442155|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
292711|NCT01442181|UF Healthcare|Dr. Thomas Beaver|352-273-5503|thomas.beaver@surgery.ufl.edu|
292712|NCT01442376|Helsinn Healthcare SA|Spinelli Tulla|+4191985 21 21|tulla.spinelli@helsinn.com|
292713|NCT01442493|Friends Research Institute|Robert Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
292714|NCT01442675|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
269144|NCT00003477|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269145|NCT00003483|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269146|NCT00003487|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269147|NCT00003492|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269148|NCT00003498|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269149|NCT00003499|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269150|NCT00003508|Burzynski Research Institute, Inc|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269151|NCT00003509|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269152|NCT00003511|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269153|NCT00003526|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269154|NCT00003531|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269155|NCT00003535|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269156|NCT00003537|Burzynski Research Institute, Inc.|S. R. Burzynski, MD, PhD|713-335-5664|srb@burzynskiclinic.com|
269157|NCT00003590|SWOG Statistical Center|Study Statistician|(206)667-4623||
269158|NCT00003631|Memorial Sloan Kettering Cancer Center|Dr. Joachim Yahalom|1212-639-5999|yahalomj@mskcc.org|
269159|NCT00003641|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
269160|NCT00003644|NRG Oncology|Linda Gedeon, Christopher Purdy on behalf of Mark Brady, PhD|(716) 845-1169|lgedeon@gogstats.org|
275573|NCT00497796|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
275574|NCT00497874|Pro-Change Behavior Systems, Inc.|Deborah A. Levesque, Ph.D.|(401) 360-2975|dlevesque@prochange.com|
275575|NCT00498173|Lurie Center for Autism, Massachusetts General Hospital|Christopher John McDougle, M.D.|7818601721|cmcdougle@mgh.harvard.edu|
275576|NCT00498186|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
275577|NCT00498355|University of California San Francisco|Dr. Nisha Acharya|415-476-8131|nisha.acharya@ucsf.edu|
292715|NCT01442688|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
283249|NCT00903331|Actelion Pharmaceuticals Ltd|Parisa Danaietash||parisa.danaietash@actelion.com|
283250|NCT00903344|University of Kansas Medical Center|Dr. Leigh Eck|913-588-6022|leck2@kumc.edu|
283251|NCT00903357|Department of Pediatrics, Soonchunhyang University Hospital|Bok Yang Pyun, M.D.|+82-2-709-9339|bypyun@hanmail.net|
283252|NCT00903370|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
269161|NCT00003645|UT MD Anderson Cancer Center|Dr. Curtis A. Pettaway, M.D.- Professor, Urology|713-792-7734|cpettawa@mdanderson.org|
283253|NCT00903383|Lexicon Pharmaceuticals, Inc.|Joel Freiman, MD, MPH|281-863-3070||
283254|NCT00903409|GlaxoSmithKline|GSK Response Center|866-435-7343||
283255|NCT00903448|The Procter & Gamble Company|John Mcrorie, PhD, FACG, AGAF|513-622-1423|mcrorie.jw@pg.com|
297038|NCT01721564|Royal Prince Alfred Hospital, Sydney, Australia|Prof David Celermajer|+61 2 9515 6519|david.celermajer@email.cs.nsw.gov.au|
283256|NCT00903617|GlaxoSmithKline|GSK Response Center|866-435-7343||
283257|NCT00903630|University of Minnesota, Dept. of OBGYN|Dr. Levi Downs, Jr|612-626-3111|downs008@umn.edu|
283258|NCT00903682|Janssen-Cilag EMEA|EMEA Medical Affairs Director Virology|+31 6 542 454 37||
283259|NCT00903695|UOklahoma Health Sciences Center|Marilee Monnot, PhD|405-456-5773|marilee-monnot@ouhsc.edu|5773
283260|NCT00903760|The University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Professor, Leukemia|713-745-3428|ggarciam@mdanderson.org|
283261|NCT00903786|Eisai Inc.|Eisai Medical Services Inc.|1-888-422-4743|esi_medinfo@eisai.com|
283262|NCT00903877|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
283263|NCT00903929|University of Rochester|Jane L. Liesveld|585-275-5823|jane_liesveld@urmc.rochester.edu|
283264|NCT00903968|Dana-Farber Cancer Institute|Irene M. Ghobrial, MD|617-632-4198|Irene_Ghobrial@dfci.harvard.edu|
283265|NCT00904007|Veterans Affairs Boston Healthcare System|Dr. B. Price Kerfoot|7742869230|price.kerfoot@gmail.com|
283266|NCT00904033|University of Rochester|Luke J Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
283267|NCT00904150|Centre for Neuroscience and Trauma, Queen Mary, University of London|Professor Anne MacGregor|+44 7774 868628|e.macgregor@qmul.ac.uk|
283268|NCT00904215|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283269|NCT00904345|University of Michigan Rogel Cancer Center|Shruti Jolly, M.D.|734-936-4302|shrutij@med.umich.edu|
283270|NCT00904371|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297039|NCT01721603|University of California, San Francisco|Alain Algazi, MD|(415) 353-7552|Alain.Algazi@ucsf.edu|
283271|NCT00904488|UNC Eshelman School of Pharmacy|Dr. Jo Ellen Rodgers|(919) 962-2249|jerodgers@unc.edu|
283272|NCT00904618|Centre Hospitalier Universitaire de Sherbrooke|Louis-Olivier Gagnon|1-819-437-4965|louis.olivier.gagnon@gmail.com|
297040|NCT01721681|Bio Products Laboratory Ltd|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
283273|NCT00904670|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283274|NCT00904722|The University of Texas (UT) MD Anderson Cancer Center|Sattva S. Neelapu, MD/Associate Professor, Lymphoma/Myeloma||CR_Study_Registration@mdanderson.org|
283275|NCT00904748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283276|NCT00904813|Karolinska Institutet|Anna Martling|+46851770000|anna.martling@ki.se|
283277|NCT00904826|Mayo Clinic|Dr. Sean J. Pittock|507-284-4741|pittock.sean@mayo.edu|
283278|NCT00904839|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283279|NCT00904917|Children's Hospital of Philadelphia|Rhonda C. Boyd, Ph.D.|215-590-3945|boydr@email.chop.edu|
283280|NCT00904969|American Medical System|Laura Olson, Clinical Project Manager|952-930-6000|laura.olson2@bsci.com|
283281|NCT00904982|University of Pennsylvania Perelman School of Medicine|Stephen E. Kimmel, MD, MSCE/Director, Clinical Epidemiology|(215) 898-1740|stevek@mail.med.upenn.edu|
283282|NCT00904995|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
283283|NCT00905021|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
283284|NCT00905034|University of Texas (UT) MD Anderson Cancer Center|Gautam Borthakur, MD/Associate Professor, Leukemia|713-563-1586|CR_Study_Registration@mdanderson.org|
283285|NCT00905060|University of California, Davis|Dr. Orin Bloch, MD||obloch@ucdavis.edu|
283286|NCT00905125|Medicine and Molecular Virology & Microbiology, Baylor College of Medicine|Shital M. Patel, M.D.|713-798-3793|shitalp@bcm.edu|
283287|NCT00905151|Tufts Medical Center|Associate Professor|617-636-2569|linker@tuftsmedicalcenter.org|
283288|NCT00905255|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
283289|NCT00905268|The National Hospital, University College London|Prof. Nicholas William Wood|020 7837 3611|n.wood@ucl.ac.uk|
283290|NCT00905307|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800-562-3924||
283291|NCT00905359|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
283292|NCT00905424|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
283293|NCT00905437|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283294|NCT00905450|Bausch Health|Study Director||susan.harris@bauschhealth.com|
283295|NCT00905489|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283296|NCT00905515|East Carolina University|Director of Clinical Trials|252-744-0671|bryantw@ecu.edu|
283297|NCT00905554|Valduce Hospital - Como - Italy|Vittorio Terruzzi, MD|+39031324009|vterruzzi@valduce.it|
283298|NCT00905580|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|Dr. So Yeon Kim|82-2-2227-3642|kimsy326@hanmail.net|
283299|NCT00905632|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283300|NCT00905827|Department of Veteran Affairs|Kathryn Magruder|843-789-7280|Kathryn.Magruder@va.gov|
283301|NCT00905840|Johannes-Gutenberg-University Mainz|Prof. Dr. Dr Bilal Al-Nawas, Principal Investigator|0049 6131 17|al-nawas@mkg.klinik.uni-mainz.de|3083
283302|NCT00906074|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283303|NCT00906087|University of Michigan|Sayoko E. Moroi|734-763-3732|smoroi@med.umich.edu|
283304|NCT00906165|UCL Eastman Dental lnstitute University College London|Professor N Donos|+4420 3456 1075|n.donos@eastman.ucl.ac.uk|
283305|NCT00906178|Center for Innovative Public Health Reserch|Dr. Michele Ybarra|877-302-6858|michele@innovativepublichealth.org|1-801#
283306|NCT00906204|Wright State University Boonshoft School of Medicine, Dayton, Ohio, USA|Dr. R. Brian Stevens, MD, PhD, FACS|937-545-4817|rbstevens1@icloud.com|
283307|NCT00906243|University of Florida|Dr. Johannes Vieweg|352 273-6815|j.vieweg@urology.ufl.edu|
283308|NCT00906282|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
283309|NCT00906347|University of Texas Southwestern Medical Center|Dr. April Bleich|214-648-2316|april.bleich@gmail.com|
283310|NCT00906373|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
283311|NCT00906399|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
283312|NCT00906425|Institut Straumann|Michael Hotze, PhD|+4161965|michael.hotze@straumann.com|1235
283313|NCT00906503|Barbara Ann Karmanos Cancer Institute|Barbara Ann Karmanos Cancer Institute|313-576-9370|davisv@karmanos.org|
283314|NCT00906698|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297041|NCT01721746|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
283315|NCT00906776|Rotschild hospital|Prof Philippe Bouchard|+33614656947|phbouch@noos.fr|
283316|NCT00906789|Georgetown University Medical Center|Matthew T. Freedman|4105429680|MTFreedman@verizon.net|
283317|NCT00906945|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
283318|NCT00906958|ResMed Ltd|Alison Wimms|+44 7901332675|alison.wimms@resmed.com|
283319|NCT00906971|Universidade Federal de Pernambuco|Carlos André Gomes Silva|+55 83 9913-4949|carlosandrejpa@hotmail.com|
283320|NCT00907088|The Hospital for Sick Children|Dr. Patricia Parkin|416-813-7654|patricia.parkin@sickkids.ca|301544
297042|NCT01721772|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
283321|NCT00907101|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
283322|NCT00907153|Penn State Hershey Medical Center|Dr. Nazia Raja-Khan|717-531-8395|nrajakhan@psu.edu|
283323|NCT00907257|Valeant Pharmaceuticals International, Inc|David Lineberry|949-973-1153|David.Lineberry@valeant.com|
283324|NCT00907296|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
283325|NCT00907335|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
283326|NCT00907374|Charles R. Drew University|Mayer B. Davidson, MD|323 357-3439|mayerdavidson@cdrewu.edu|
283327|NCT00907426|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
283328|NCT00907478|Amgen Inc.|Study Director|866-572-6436||
283329|NCT00907517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269162|NCT00003659|Memorial-Sloan Kettering Cancer Center|Dr. David Scheinberg|646-888-2190|scheinbd@mskcc.org|
269163|NCT00003702|NRG Oncology|Angela M. Kuras on behalf of Virginia Filiaci|7168455702|kurasa@nrgoncology.org|
269164|NCT00003782|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
269165|NCT00003816|Roswell Park Comprehensive Cancer Center|Theresa Hahn, PhD|716-845-5819|theresa.hahn@roswellpark.org|
269166|NCT00003820|Stanford University|Ranjana Advani, MD, Professor of Lymphoma|650-725-6456|radvani@stanford.edu|
269167|NCT00003830|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
269168|NCT00003869|Mayo Clinic|Dr. Edith A. Perez||perez.edith@mayo.edu|
269169|NCT00003875|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
269170|NCT00003895|Providence Cancer Center, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center|Walter J. Urba, MD, PhD; Physician Director of Research|503-215-5696|Walter.Urba@providence.org|
269171|NCT00003896|SWOG Statistical Center|Gynecologic Committee Statistician|206-667-4623||
269172|NCT00003901|Memorial Sloan Kettering Cancer Center|Valerie Rusch, MD|212-639-5873|ruschv@mskcc.org|
269173|NCT00003907|ECOG Statistical Office|Study Statistician|617-632-3012||
269174|NCT00003910|ECOG Statistical Office|Study Statistician|617-632-3012||
269175|NCT00004031|SWOG Statistics and Data Management Center|Study Statistician|2066674623||
269176|NCT00004054|NRG Oncology|Wendy Seiferheld||wseiferheld@nrgoncology.org|
269177|NCT00004088|City of Hope|Brenda Williams, Senior Director, Clinical Trials Office|626-218-2702|bwilliams@coh.org|
275578|NCT00498368|Mayo Clinic|Dr. Fernando Fervenza|507-255-3712|Fervenza.Fernando@mayo.edu|
275579|NCT00498433|Novartis Pharmaceuticals|Study Director|862-778-8300||
275580|NCT00498485|Rutgers|Dr Benjamin Natelson|973-2236370|bnatelson@chpnet.org|
275581|NCT00498550|Dartmouth Medical School|Christopher OKeefe|603-271-5287|chris.okeefe@hitchcock.org|
275582|NCT00498602|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275583|NCT00498615|Johns Hopkins University|Gwen Leatherman, R.N.|410-550-8582|gleathe@jhmi.edu|
275584|NCT00498628|NIAAA|Dr. Raye Litten|301-443-0636||
292716|NCT01442714|Stanford University|Dr. Bruno Medeiros|650-723-5007|brunom@stanford.edu|
275585|NCT00498706|Northwestern University|Dr. David C. Mohr|312-503-1403|d-mohr@northwestern.edu|
275586|NCT00498797|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
275587|NCT00498927|Memorial Sloan Kettering Cancer Center|Dr. Antonio Omuro|212 639 7523|omuroa@mskcc.org|
283330|NCT00907621|Department of General practice, University of Oslo|Dr. Holgeir Skjeie|+4722850550|Holgeir.Skjeie@medisin.uio.no|
283331|NCT00907738|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
283332|NCT00907777|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
283333|NCT00907803|SIGA Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
283334|NCT00907881|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
283335|NCT00908011|St. Paul's Hospital/University of B.C.|Dr. Greg Bondy|604-806-8192|gbondy@providencehealth.bc.ca|
283336|NCT00908037|GlaxoSmithKline|GSK Response Center|866-435-7343||
283337|NCT00908076|Baylor College of Medicine|Christine Hunter|713-798-6556|chunter@bcm.edu|
283338|NCT00908115|GlaxoSmithKline|GSK Response Center|866-435-7343||
297043|NCT01721837|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297044|NCT01721876|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283339|NCT00908141|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Robert Dreicer MD|216-445-4623|dreicer@ccf.org|
297045|NCT01721954|Sirtex Medical|Janet Bell, M.B.A.|+ 888-474-7839|jbell@sirtex.com|710
283340|NCT00908232|Janssen-Cilag Germany|EMEA Medical Affairs Director Oncology|+49 2137 955-492||
283341|NCT00908310|GE Healthcare|Debra Mansfield|609-514-6329|debra.mansfield@ge.com|
283342|NCT00908349|Supernus Pharmaceuticals, Inc|Janet K. Johnson, PhD|301-838-2623|jjohnson@supernus.com|
283343|NCT00908375|Northwestern University|K Malik|3129262280|kmalikmd@yahoo.com|
283344|NCT00908388|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
283345|NCT00908466|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
283346|NCT00908544|MUC Research GmbH|Dr. phil. Eva Wolf|+49 (0)89-558703-0|Eva.Wolf@MUCResearch.de|
283347|NCT00908583|University of Cincinnati|E. Steve Woodle|513-558-6001|woodlees@ucmail.uc.edu|
297046|NCT01721967|Duke University Health System|Andrew Wang, MD|919-681-6197|a.wang@duke.edu|
283348|NCT00908596|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
308425|NCT02578680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292717|NCT01442779|Texas Tech University Health Sciences Center|Lorenz Lutherer, MD, PhD|806-743-2532|Lorenz.Lutherer@ttuhsc.edu|
292718|NCT01442844|Massachusetts General Hospital|Dr. Alexandra Kimball|617-726-5066|harvardskinstudies@partners.org|
292719|NCT01443026|University of Illinois at Chicago|Dr. Peter Gann|312-355-3723|pgann@uic.edu|
292720|NCT01443078|Memorial Sloan Kettering Cancer Center|Chaft, Jamie, MD|646-888-4545|ChaftJ@mskcc.org|
297047|NCT01722045|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator||clinicaltrials@regeneron.com|
297048|NCT01722071|University of Michigan|Tiffany Love, PhD|734-219-3674|tiflove@umich.edu|
308426|NCT02578706|Icahn School of Medicine at Mount Sinai|Dr. Meagan O'Brien||Meagan.O'Brien@mssm.edu|
308427|NCT02578732|Brown University Oncology Research Group|Howard Safran, MD|401-863-300|BrUOG@BROWN.EDU|
308428|NCT02578745|Washington University|Methodius Tuuli|6785582874|methodiustuuli@yahoo.com|
308429|NCT02578862|Ochsner Medical Center|Edward D McCoul, MD, MPH|504-842-4080|edward.mccoul@ochsner.org|
308430|NCT02578901|University of Washington|Dr. Susanne May|206-685-1302|sjmay@uw.edu|
308431|NCT02578940|Blue Earth Diagnostics, Ltd.|Peter Gardiner MB ChB, MRCP, FFPM|1-781-552-3403|P.Gardiner@blueearthDx.com|
269178|NCT00004092|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626) 256-4673|pfrankel@coh.org|65265
269179|NCT00004124|SWOG Statistics and Data Management Center|Catherine Tangen, Genitourinary Committee Statistician|(206) 667-4623|ctangen@fredhutch.org|
269180|NCT00004143|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|Mitchell.Horwitz@duke.edu|
269181|NCT00004146|Adult Brain Tumor Consortium|Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
269182|NCT00004228|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
269183|NCT00004259|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
269184|NCT00004412|Boston University School of Medicine|Douglas V. Faller, Ph.D., M.D., Susan P. Perrine, M.D.|(617) 638-5639|sperrine@bu.edu|
269185|NCT00004418|Kennedy Krieger Institute|Gerald Raymond|443-923-2750|raymond@kennedykrieger.org|
269186|NCT00004445|Louis Stokes Cleveland VAMC|Lisa Lombardo, MPT|216-791-3800|lisa.lombardo2@va.gov|4909
269187|NCT00004500|Discovery Laboratories, Inc.|Dr. Robert Segal|215-488-9300|rsegal@discoverylabs.com|
269188|NCT00004547|National Cancer Institute, National Institutes of Health|Marybeth S. Hughes, M.D.|301-594-9341|hughesm@mail.nih.gov|
269189|NCT00004562|New York University School of Medicine|Judith S. Hochman, M.D.|212-263-6927|judith.hochman@nyumc.org|
269190|NCT00004563|University of Texas Health Science Center at Houston|Maureen Mayes, MD|+1 (713) 500-6900|Maureen.D.Mayes@uth.tmc.edu|
269191|NCT00004635|National Cancer Institute, National Institutes of Health|William L. Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
269192|NCT00004732|Mayo Clinic|Thomas G. Brott, MD - Principal Investigator|904-953-0556|Brott.thomas@mayo.edu|
269193|NCT00004859|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
269194|NCT00004888|Eastern Cooperative Oncology Group Statistical Office|Study Statistician|617-632-3012||
269195|NCT00004978|Division of Biostatistics, University of Minnesota|James Neaton, PhD|612-626-9040|jim@ccbr.umn.edu|
269196|NCT00004980|Yale University School of Medicine|Ralph Hoffman|203-688-9734|ralph.hoffman@yale.edu|
269197|NCT00005044|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
292721|NCT01443130|University of Maryland School of Medicine|Miriam K. Laufer, MD, MPH|410-706-5333|mlaufer@medicine.umaryland.edu|
308432|NCT02578992|Tri-Service General Hospital|Dr. Wei-Hung Chan|+886-2-87927128|whcken@gmail.com|
292722|NCT01443364|UCB|UCB Clinical Trial Call Center|+1877 822||9493
269198|NCT00005047|University of Southern California|Dr. Susan Groshen|323-865-0375|Susan.Groshen@med.usc.edu|
283349|NCT00908791|Norris Cotton Cancer Center|Burton Eisenberg, MD, Deputy Director, Norris Cotton Cancer Center|603-653-3613|Burton.L.Eisenberg@Dartmouth.edu|
283350|NCT00908830|University of Michigan Health System|Linda Stuckey, Pharm.D|734-936-8129|lindastu@med.umich.edu|
283351|NCT00908882|Eastern Colorado Health Care System|Catherine Battaglia PhD RN|720-857-5099|catherine.battaglia@va.gov|
283352|NCT00908895|Département d'orthopédie, CHA-Pavillon Enfant-Jésus Québec|Dr Stéphane Pelet, MD, PhD|418-649-0252|stephane.pelet.ortho@gmail.com|3165
283353|NCT00908908|Eisai Call Center|Eisai Inc.|888-422-4743||
283354|NCT00908947|BD/Bard|Talar Saber, Senior Project Manager, Clinical Affairs|1.480.379.2839|Talar.Saber@crbard.com|
269199|NCT00005669|National Institute of Child Health and Human Development, NIH|Jack A. Yanovski, MD, PhD, Chief, Unit on Growth and Obesity|301-496-0858|yanovskj@mail.nih.gov|
283355|NCT00908960|Beth Israel Deaconess Medical Center|Jeffrey Zwicker, MD|617-667-9299|jzwicker@bidmc.harvard.edu|
283356|NCT00909038|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283357|NCT00909064|UC Davis|Gavin Pereira|916-534-0919|gcpereira@ucdavis.edu|
283358|NCT00909090|University of Georgia|Dr. Billy Hammond, Principal Investigator|(706) 54204812|bhammond@uga.edu|
283359|NCT00909155|University of Wisconsin|Dr. Michael Peterson|608 265 8130|mpeterson2@wisc.edu|
283360|NCT00909181|Antares Pharma|Kaushik Dave|609 359 3020|kdave@antarespharma.com|
283361|NCT00909220|Northwestern University|Jackie Gollan, Ph.D. Associate Professor of Psychiatry and Behavioral Sciences|312-695-6121|j-gollan@northwestern.edu|
283362|NCT00909324|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
283363|NCT00909363|Weill Cornell Medicine|Dr james B Bussel|917-291-5091|jbussel@med.cornell.edu|
297049|NCT01722097|Herlev Hospital, University of Copenhagen, Department of Anaesthesiology|Dr. Matias Vested Madsen|+45 38683868|matias.vested.madsen@regionh.dk|
283364|NCT00909428|Loyola University Chicago|Mary P FitzGerald|708-216-2170|mfitzg8@lumc.edu|
283365|NCT00909480|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
283366|NCT00909532|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
283367|NCT00909545|Feinberg School of Medicine, Northwestern University|Tanya Simuni, MD|312-503-2970|TSimuni@nmff.org|
283368|NCT00909727|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
283369|NCT00909779|Sunovion|Respiratory Medical Director|1-866-503-6351||
283370|NCT00909792|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
283371|NCT00909844|Ipsen Pharma|Medical Director, Endocrinology||clinical.trials@ipsen.com|
283372|NCT00909857|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
283373|NCT00909870|Shire Regenerative Medicine|Mollie Carter, MD, Medical Director|(858) 754-5678|mcarter@shire.com|
297050|NCT01722162|Washington University School of Medicine|Manik A. Amin, M.D.|314-362-9115|manikamin@wustl.edu|
283374|NCT00910000|Dana-Farber Cancer Institute|Ursula Matulonis, MD|617-632-2334|umatulonis@partners.org|
283375|NCT00910039|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
297051|NCT01722266|University at Buffalo|Nitesh D Kuhadiya,MD,MPH ;Co-Investigator;Assistant Professor of Medicine, Section of Endocrinology|716-626-7998|niteshku@buffalo.edu|
283376|NCT00910091|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
269200|NCT00005803|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
283377|NCT00910208|Albert Einstein College of Medicine|Polly Bijur, PhD|718-430-4217|polly.bijur@einstein.yu.edu|
283378|NCT00910247|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
283379|NCT00910273|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283380|NCT00910299|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297052|NCT01722292|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
297053|NCT01722318|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
283381|NCT00910429|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
283382|NCT00910481|King's College London|Professor Divaka Perera|02071887188|divaka.perera@kcl.ac.uk|
283383|NCT00910520|Allergan, Inc|Therapeutic Area Head,|714-246-4500 ext:|clinicaltrials@allergan.com|
283384|NCT00910624|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
283385|NCT00910663|TEVA Pharmaceuticals USA|Associate DIrector, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
283386|NCT00910689|Ohio University|Kenneth Holroyd|(740) 593-1085|holroyd@ohio.edu|
283387|NCT00910715|UMC Ljubljana, Department of Infectious Diseases|Dr.Dasa Stupica|+386 1 522 2110|cerar.dasa@gmail.com|
283388|NCT00910728|AstraZeneca|Dr Gregory Curt, MD|+1 301 398 0109|Gregory.Curt@astrazeneca.com|
283389|NCT00910845|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
283390|NCT00910858|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
283391|NCT00910871|Janssen Infectious Diseases - Diagnostics BVBA|Medical Leader|1 609 730-7768||
283392|NCT00910910|Celgene Corporation|Anne McClain, Senior Manager of Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
283393|NCT00910962|GlaxoSmithKline|GSK Response Center|866-435-7343||
283394|NCT00910988|Washington University|Julie Schweiger/Michael Yingling|3143623153/5735791412|schweigj@psychiatry.wustl.edu/yinglinm@psychiatry.wustl.edu|
283395|NCT00911144|GlaxoSmithKline|GSK Response Center|866-435-7343||
283396|NCT00911157|GlaxoSmithKline|GSK Response Center|866-435-7343||
283397|NCT00911170|Amgen Inc.|Study Director|866-572-6436||
283398|NCT00911300|GlaxoSmithKline|GSK Response Center|866-435-7343||
283399|NCT00911326|Navidea Biopharmaceuticals|Dr. Frederick O. Cope, Chief Scientific Officer|614-793-7500|fcope@navidea.com|140
297054|NCT01722331|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297055|NCT01722435|Centre for Interdisciplinary Addiction research of Hamburg University ZIS|Prof. Dr. Jens reimer|+4940741057900|reimer@uke.de|
269201|NCT00005879|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
269202|NCT00005901|National Institute of Child Health and Human Development|Joan Marini|+1 301 594 3418|marinij@cc1.nichd.nih.gov|
269203|NCT00005906|TMB/NHLBI|Joel Moss|301-496-1597|mossj@nhlbi.nih.gov|
269204|NCT00005908|National Cancer Institute, National Institutes of Health|JoAnne Zujewski, M.D.|301-435-9207|zujewskij@mail.nih.gov|
269205|NCT00005937|NIH National Heart, Lung and Blood Institute|Neal S. Young MD|301-402-1806|youngns@nhlbi.nih.gov|
269206|NCT00005947|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com|
269207|NCT00005957|Juravinski Cancer Centre at Hamilton Health Sciences|Dr. Timothy J. Whelan|1(905) 387-9495|twhelan@HHSC.CA|
269208|NCT00006011|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
269209|NCT00006046|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
269210|NCT00006099|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
269211|NCT00006101|University of California, Irvine|Dr. Thomas Ahlering|(714) 456-6068|tahlerin@uci.edu|
269212|NCT00006110|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
269213|NCT00006151|University of Pennsylvania|Peter Gariti||gar1iti@mail.med.upenn.edu|
269214|NCT00006156|National Institute of Child Health and Human Development|Nelson, Lawrence Merle|+1 301 402 6608|nelsonl@mail.nih.gov|
269215|NCT00006164|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|James E. Everhart, MD, MPH, Project Officer|301-594-8878|EverhartJ@extra.niddk.nih.gov|
269216|NCT00006170|University of Pittsburgh|Dr. Michele Levine|412-647-0703|levinem@upmc.edu|
269217|NCT00006178|National Institutes of Health|Dr. Allan D. Kirk||allank@intra.niddk.nih.gov|
269218|NCT00006184|National Cancer Institute, National Institutes of Health|Dr, Claude Sportes, M.D.|301-435-5280|csportes@mail.nih.gov|
269219|NCT00006227|NRG Oncology|Christopher Purdy on behalf of Mark Brady PhD|(716)845-1300|purdyc@nrgoncology.org|2296
269220|NCT00006237|SWOG statistical office|SWOG Melanoma Statistician|206-667-4408||
269221|NCT00006244|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
275588|NCT00498940|Columbia University Medical Center|Santos Cabreriza/ Associate Scientist|212-305-9515|sc45@cumc.columbia.edu|
275589|NCT00499031|NRG Oncology Statisics and Data Management Center, Buffalo Office|Melissa Leventhal|716-845-4030|mleventhal@gmail.com|
275590|NCT00499083|University of Nebraska Medical Center|Elizabeth Reed, MD|402-559-5166|ereed@unmc.edu|
275591|NCT00499096|Department of Veterans Affairs|Dr. Amy M. Kilbourne, PhD, MPH|734-845-3502|Amy.Kilbourne@va.gov|
275592|NCT00499109|H. Lee Moffitt Cancer Center and Research Institute|Charles C. Williams, M.D., Study Chair|813-745-7282|charles.williams@moffitt.org|
275593|NCT00499122|UM/Sylvester Comprehensive Cancer Center|Alberto Montero MD|305-243-3771|amontero2@med.miami.edu|
275594|NCT00499174|Canadian Cancer Trials Group|Keyue Ding, Biostatistician|613-533-6430|kding@ctg.queensu.ca|
275595|NCT00499252|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
275596|NCT00499343|U.T. M.D. Anderson Cancer Center|Chitra M. Hosing, MD / Associate Professor|713-792-8750||
275597|NCT00499369|SWOG|Study Statistician|206-667-4623||
275598|NCT00499408|Comprehensive Cancer Center of Wake Forest University|K.C. Balaji, MD|336-716-5690|kbalaji@wakehealth.edu|
275599|NCT00499447|Comprehensive Cancer Center of Wake Forest University|Dr. James Urbanic|336-713-3600|jurbanic@wakehealth.edu|
275600|NCT00499460|Clinical Research Division, Fred Hutchinson Cancer Research Center|Danny D. Shen, Member (Retired)|206-685-2920|ds@uw.edu|
275601|NCT00499473|The Ohio State University Comprehensive Cancer Center|Robert Cavaliere, MD|614-293-4968|Robert.Cavaliere@osumc.edu|
275602|NCT00499486|The Sidney Kimmel Comprehensive Cancer Centre at Johns Hopkins|Dr. Hidalgo||mhidalgo@cnio.es|
275603|NCT00499603|The University of Texas MD Anderson Cancer Center|Clinical Research Operations, Office of VP Clinical Research|713-792-7734|CR_Study_Registration@mdanderson.org|
275604|NCT00499616|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
275605|NCT00499655|City of Hope|Karen L. Reckamp, M.D.|(626) 256-4673|kreckamp@coh.org|
275606|NCT00499681|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD, Principal Investigator|615-936-2033|ingrid.mayer@vanderbilt.edu|
275607|NCT00499694|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
275608|NCT00499746|Johns Hopkins University School of Medicine|Eric C. Strain, M.D.|410-550-1191|ecsgss@aol.com|
275609|NCT00499863|Noven Pharmaceuticals, Inc.|Amaury Sanchez, Sr. Manager, Regulatory Affairs||asanchez@noven.com|
275610|NCT00499889|UT MD Anderson Cancer Center|Richard E. Champlin, MD/Professor|713-792-8848|pmcadams@mdanderson.org|
275611|NCT00499915|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
275612|NCT00500071|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
275613|NCT00500110|MD Anderson Cancer Center|Quality Assurance Specialist|713-563-1602|caperez@mdanderson.org|
275614|NCT00500149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
275615|NCT00500240|UT MD Anderson Cancer Center|Khanh D Vu, MD/ Associated Professor|713-745-4516|eharriso@mdanderson.org|
275616|NCT00500266|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275617|NCT00500292|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
275618|NCT00500318|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
283400|NCT00911495|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
283401|NCT00911508|Mayo Clinic|Dr. Douglas L. Packer|507-255-6263|CABANA@mayo.edu|
283402|NCT00911534|Eisai Call Center|Eisai Inc.|888-422-4743||
283403|NCT00911586|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
283404|NCT00911612|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
297056|NCT01722487|Pharmacyclics LLC|Dr. Lori Styles, Medical Monitor|+1 (408) 215-3770|lstyles@pcyc.com|
283405|NCT00911625|Rush University Medical Center|David Baldwin, MD|312-942-2813|david_baldwin@rush.edu|
283406|NCT00911742|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
283407|NCT00911768|Kyung Hee East-West Neo Medical Center|Jae-Woo Park, KMD, PhD|+082-02-440-6219|pjw2907@khu.ac.kr|
283408|NCT00911807|EBEWE Pharma|Dr. Philipp Novak|01143-7665-8123|philipp.novak@ebewe.com|733
283409|NCT00911820|Dana-Farber Cancer Insitute|Peter Enzinger, MD|617-632-6855|Peter_Enzinger@dfci.harvard.edu|
283410|NCT00911859|Janssen R&D BE|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
269222|NCT00006289|National Institute of Nursing Research|Dr. Leorey Saligan (Principal Investigator, former PI: Dr. Raymond Dioone)|301-451-1685|saliganl@mail.nih.gov|
283411|NCT00911898|South Texas Accelerated Research Therapeutics|Dr. Muralibhar Beeram|210-593-5921|murali.beeram@stoh.com|
283412|NCT00911937|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283413|NCT00911989|Ethicon-Endo Surgery|Director of Clinical Operations|1.513.337.3079|SHelsing@its.jnj.com|
283414|NCT00912002|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
283415|NCT00912015|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
283416|NCT00912028|University of Campinas, Brazil|Carlos E Leite Arieta MD, PhD||ra-visus-clnclstds@its.jnj.com|
283417|NCT00912093|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
283418|NCT00912197|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
283419|NCT00912288|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283420|NCT00912301|Mayo Clinic|Michael L. Camilleri, MD|507-266-2306|camilleri.michael@mayo.edu|
283421|NCT00912340|Emory University|Elisavet Paplomata, Principal Investigator|404-778-1900|elisavet.paplomata@emory.edu|
283422|NCT00912405|Intersect ENT|James Stambaugh|650-641-2103|jstambaugh@intersectent.com|
283423|NCT00912509|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
283424|NCT00912743|Astra Zeneca LLP|Angela Sawyer, Clinical Delivery Director|+44 1625 512397|angele.sawyer@astrazeneca.com|
283425|NCT00912782|Emory University|Monnie Wasse MD/MPH / Associate Professor of Medicine|404-727-1598|hwasse@emory.edu|
283426|NCT00912795|Center for Innovative Public Health Research|Dr. Michele Ybarra|877-302-6858|michele@innovativepublichealth.org|1 - 801#
283427|NCT00912808|Oregon Health & Science University|Kathryn Chung, MD|503 220 8262|chungka@ohsu.edu|51091
283428|NCT00912873|University California San Diego|Brian Ilfeld, MD, MS|(858) 822-0776|bilfeld@health.ucsd.edu|
283429|NCT00912912|The University of Texas (UT) MD Anderson Cancer Center|Lance Pagliaro, MD/Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
269223|NCT00006305|University of Pittsburgh|Dr. Maria Brooks|4126241618|brooks@edc.pitt.edu|
283430|NCT00912925|Genzyme Corporation|Genzyme Medical Information||medinfo@genzyme.com|
283431|NCT00912964|Astellas Pharma Global Development, Europe|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
283432|NCT00912990|Rady Children's Hospital San Diego|Dr. Sandeep Khanna|858-966-5863||
269224|NCT00006389|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
269225|NCT00006392|SWOG Statistical Center|Study Statistician|2066674623||
269226|NCT00006400|New England Research Institutes, Inc|Julie Miller|617-972-3197|JMiller@healthcore.com|
269227|NCT00006409|University of North Carolina - Chapel Hill|June Stevens|919-966-7218|june_stevens@unc.edu|
269228|NCT00006411|JCHR|Roy W. Beck, MD, PhD|813-975-8690|cds@jaeb.org|
269229|NCT00006489|University of Pennsylvania|Dr. Edna Foa|215-746-3327|foa@mail.med.upenn.edu|
269230|NCT00006604|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
269231|NCT00006721|SWOG Statistical Center|Study Statistician|206-667-4623||
269232|NCT00006903|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
269233|NCT00007020|Retrophin, Inc.|Retrophin Medical Information|+1 8776595|medinfo@retrophin.com|518
269234|NCT00007345|National Cancer Institute|Dr. Kieron Dunleavy|301-435-1007|DunleavK@mail.nih.gov|
269235|NCT00007475|National Institute of Diabetes & Digestive & Kidney Diseases|Jeffrey B. Kopp, MD|+1 (301) 594-3403|jbkopp@nih.gov|
269236|NCT00007644|Minneapolis VA Medical Center|Timothy Wilt, MD|612-467-2158|timothy.wilt@va.gov|
269237|NCT00008138|SWOG Statistical Center|GYN Committee Statistician|206-667-4623||
269238|NCT00008385|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
269239|NCT00009737|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
269240|NCT00009945|NSABP Foundation, Inc.|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
269241|NCT00010257|ECOG Statistical Office|Study Statistician|617-632-3012||
269242|NCT00010374|Synapse Biomedical, Inc.|Anthony Ignagni|440-774-2488|aignagni@synapsebiomedical.com|110
269243|NCT00010439|Medical University of South Carolina|Deborah A Bowlby, M.D., Assistant Professor, Pediatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
269244|NCT00010803|University of Virginia|Steven T. DeKosky MD|434-924-5118|SD3ZC@hscmail.mcc.virginia.edu|
269245|NCT00011986|Gynecologic Oncology Group Statistical and Data Center|Linda Gedeon, BS, CCRP|716-845-1169|lgedeon@gogstats.org|
283433|NCT00913003|Northwestern University|Paul Fitzgerald|312-695- 1064|p-fitzgerald2@northwestern.edu|
283434|NCT00913068|Capital District Health Authority|Dr. Ricardo A. Rendon|9024736604|rrendon@dal.ca|
283435|NCT00913081|University of Pennsylvania|Richard L. Dunbar, MD, PI|609 413-1067|richard.dunbar@uphs.upenn.edu|
283436|NCT00913133|Canyon Pharmaceuticals|Director of Clinical Trials|888-434-7003|info@canyonpharma.com|
283437|NCT00913263|Dept. of Surgery, Tampere University Hospital, Tampere, Finland|Teuvo Tammela, Professor|+358-3-31164621|teuvo.tammela@uta.fi|
283438|NCT00913380|Seoul National University Bundang Hospital|Kyoung Ho Lee|82-31-787-7607|kholeemail@gmail.com|
283439|NCT00913458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283440|NCT00913510|Wellspect HealthCare|Dikran Shamoun|+46313764000||
283441|NCT00913523|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Senior Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
283442|NCT00913627|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283443|NCT00913744|ThromboGenics NV|Dr. Petra Kozma-Wiebe|+32 16 751 310|Petra.kozma@thrombogenics.com|
283444|NCT00913770|Yale University|Gail D'Onofrio, MD, MS|203-785-4404|gail.donofrio@yale.edu|
283445|NCT00913835|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
283446|NCT00913913|Dartmouth-Hitchcock Medical Center|Dr. Marc Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
269246|NCT00012012|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
283447|NCT00913978|Northwestern University|Meltem Yilmaz, MD|312-695-0061|m-yilmaz@northwestern.edu|
283448|NCT00914069|Bard Access Systems, Inc.|Gina Gilbert|407-489-0835|Gina.Gilbert@crbard.com|
269247|NCT00012298|Mayo Clinic|Thomas E. Witzig, M.D.||witzig.thomas@mayo.edu|
292723|NCT01443403|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
292724|NCT01443442|SCCO at MBKU|Jerry R. Paugh, OD, PhD|714-449-7487|jpaugh@ketchum.edu|
292725|NCT01443494|Intensive Care Unit, Zhongda Hospital, Southeast University|Jingyuan Xu|86-025-83262550|xujingyuanmail@163.com|
269248|NCT00013611|University of Minnesota|Gary Collins, M.S.|612-626-9006|gary-c@ccbr.umn.edu|
292726|NCT01443546|Weill Cornell Medical College|Ina Cholst, MD|646-962-3025|icholst@med.cornell.edu|
292727|NCT01443845|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
292728|NCT01443858|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
292729|NCT01444027|University of Washington, School of Nursing|Dr. George Demiris|206-221-3866|gdemiris@uw.edu|
292730|NCT01444287|Vistakon|Noel Brennan|1 904 4433494|nbrenna2@its.jnj.com|
292731|NCT01444300|Oregon Health & Science University|Dr. Michelle Cameron|503-218-1971|cameromi@ohsu.edu|
292732|NCT01444378|Abbott Vascular|Robert McGreevy|408-845-3932|Robert.mcgreevy@abbott.com|
292733|NCT01444391|Acclarent|Director Clinical|650-687-5888|lenglan1@its.jnj.com|
292734|NCT01444417|Amgen Inc.|Study Director|866-572-6436||
292735|NCT01444430|AstraZeneca Research and Development|Carin Jorup, Global Clinical Lead (GCL) SYMBICORT|+46 31 7761000|Carin.Jorup@astrazeneca.com|
292736|NCT01444456|Amgen Inc.|Study Director|866-572-6436||
269249|NCT00014222|Canadian Cancer Trials Group|Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
292737|NCT01444651|Massachusetts General Hospital|Dr. Jennifer Ho|617-726-6411|jho1@partners.org|
292738|NCT01444716|The University of Texas MD Anderson Cancer Center|Allessandra Ferrajoli, MD./Professor|713-792-2063|aferrajo@mdanderson.org|
292739|NCT01444742|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor|713-745-3428|CR_Study_Registration@mdanderson.org|
292740|NCT01444781|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
292741|NCT01444898|Children's Hospital Los Angeles|Dr. Mitchell Geffner|323-361-7032|mgeffner@chla.usc.edu|
292742|NCT01444911|University of Wisconsin Carbone Cancer Center|Dr. David Kushner|608-263-1210|dmkushner@facstaff.wisc.edu|
292743|NCT01444924|University of Wisconsin Hospitals and Clinics|Dr. David Kushner|608-263-0796|dmkushner@facstaff.wisc.edu|
292744|NCT01445028|MidAtlantic Retina|Richard Kaiser, MD|215-928-3092|research@midatlanticretina.com|
292745|NCT01445080|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
292746|NCT01445171|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
269250|NCT00014495|Memorial Sloan Kettering Cancer Center|Dr. Martin Tallman|212-639-3842|tallmanm@mskcc.org|
269251|NCT00014911|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
269252|NCT00015457|National Institutes of Health|Barbara I Karp, MD|301-496-0150|karpb@ninds.nih.gov|
269253|NCT00015847|OHSU Knight Cancer Institute|Dr. Brian Druker|(503) 494 5596|drukerb@ohsu.edu|
269254|NCT00016354|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Antonio Wolff|410-614-4192|awolff@jhmi.edu|
269255|NCT00016718|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
269256|NCT00016913|Department of Medicine, Memorial Sloan-Kettering Cancer Center|Wm. Kevin Kelly, DO||kellyw@mskcc.org|
269257|NCT00017563|OHSU Knight Cancer Institute|Tomasz Beer, M.D.|503-494-1080|beert@ohsu.edu|
269258|NCT00018031|NIAID/NIH|Dr. Shyam Kottilil|301-435-036|skottilil@niaid.nih.gov|
269259|NCT00019604|National Cancer Institute, National Institutes of Health|Caryn Steakley|301-435-3685|steaklec@mail.nih.gov|
269260|NCT00019682|Indiana University Health|Dr Douglas Schwartzentruber|317-948-6873|dschwart@iuhealth.org|
269261|NCT00021229|Pediatric Brain Tumor Consortium|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|901-595-4986|james.boyett@stjude.org|
269262|NCT00021255|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
269263|NCT00021541|National Institutes of Health, National Cancer Institute|Brigitte Widemann, M.D.|301-496-7387|widemanb@mail.nih.gov|
269264|NCT00022490|OHSU Knight Cancer Institute|Dr. Brian Druker|(503) 494 5596|drukerb@ohsu.edu|
292747|NCT01445301|GlaxoSmithKline|GSK Response Center|866-435-7343||
297057|NCT01722552|Boston University School of Public Health|Dr Lora Sabin|617-414-1272|lsabin@bu.edu|617
269265|NCT00022516|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
269266|NCT00022633|Cleveland Clinic|Dr. Derek Raghavan|216-445-6888|raghavd@cc.ccf.org|
269267|NCT00022659|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
269268|NCT00022672|Hoffman-LaRoche|Medical Communications|800-821-8590||
269269|NCT00022698|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
269270|NCT00022763|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
269271|NCT00023309|National Institute of Diabetes and Digestive and Kidney Diseases, NIH|Marc G. Ghany, M.D|3014961721|marcg@mail.nih.gov|
269272|NCT00023322|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Theo Heller, M.D.|(301) 402-7147|Theoh@mail.nih.gov|
269273|NCT00023452|CDC|Dr Elsa Villarino|404-639-5340|mev1@cdc.gov|
269274|NCT00023595|Duke University Health System|Dr. Eric Velazquez|919-668-8700|velaz002@mc.duke.edu|
269275|NCT00023673|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
269276|NCT00023712|Gynecologic Oncology Group(GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
269277|NCT00023764|Memorial Sloan-Kettering Cancer Center|Dr. John Gerecitano|212-639-3748|gerecitj@mskcc.org|
275619|NCT00500331|GlaxoSmithKline|GSK Response Center|866-435-7343||
275620|NCT00500357|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
275621|NCT00500370|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
275622|NCT00500448|University of Michigan|Riann Palmieri-Smith|7346153154|riannp@umich.edu|
275623|NCT00500539|Novartis Pharmaceuticals|Study Director|862-778-8300||
275624|NCT00500578|UT MD Anderson Cancer Center|Roy F Chemaly, MD/MPH, MBA /Associate Professor|713-745-1116|rfchemaly@mdanderson.org|
275625|NCT00500656|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
275626|NCT00500682|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
275627|NCT00500760|Amgen Inc.|Study Director|866-572-6436||
275628|NCT00500903|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
275629|NCT00501007|Rutgers, The State University of New Jersey|Marc L. Steinberg, Ph.D.|732-235-4341|marc.steinberg@rutgers.edu|
275630|NCT00501046|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
275631|NCT00501059|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
275632|NCT00501085|Apollo Endosurgery, Inc.|Laura Eaton, R.N., BSN, CCRN-R|949-468-9301|laura.eaton@apolloendo.com|
275633|NCT00501293|Shire Pharmaceutical|Timothy Whitaker, MD||twhitaker@shire.com|
275634|NCT00501540|University of Wisconsin Carbone Cancer Center|Dr. Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
275635|NCT00501592|Intercept Pharmaceuticals, Inc.|Cathi Sciacca, Sr. Director, Clinical Operations|858-652-6800|csciacca@interceptpharma.com|
275636|NCT00501631|Alkermes, Inc.|Bernard L. Silverman, MD|1-781-609-6000|bernard.silverman@alkermes.com|
275637|NCT00501644|UT MD Anderson Cancer Center|Michael E. Garcia, RN, BSN||mgarcia@mdanderson.org|
275638|NCT00501852|Novartis Pharmaceuticals|Study Director|862-778-8300||
275639|NCT00501891|The Preston Robert Tisch Brain Tumor Center at Duke|Annick Desjardins, MD|919-684-6173|annick.desjardins@duke.edu|
275640|NCT00501943|UCSF|Dr Emmanuelle Waubant, MD|415- 514 2468|Emmanuelle.Waubant@ucsf.edu|
275641|NCT00501969|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
275642|NCT00501995|Johns Hopkins University|Gwen Leatherman,R.N.,M.S.|410-550-8582|gleathe@jhmi.edu|
275643|NCT00502203|UT MD Anderson Cancer Center|Lois M. Ramondetta, MD / Professor||CR_Study_Registration@mdanderson.org|
275644|NCT00502216|Yale University School of Medicine|Benjamin Toll, Ph.D.|203-974-5767|benjamin.toll@yale.edu|
275645|NCT00502242|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275646|NCT00502307|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
275647|NCT00502320|Lehigh Valley Hospital|Edward R. Norris, MD|610-402-5766|Edward.Norris@lvh.com|
275648|NCT00502593|GlaxoSmithKline|GSK Response Center|866-435-7343||
275649|NCT00502671|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
275650|NCT00502697|Vanderbilt University|Melanie Lutenbacher, PhD, MSN, FAAN|615-343-3314|melanie.lutenbacher@vanderbilt.edu|
275651|NCT00502775|GlaxoSmithKline|GSK Response Center|866-435-7343||
275652|NCT00502801|Janssen Scientific Affairs, LLC|Vice President, Data Generation|908 927-2943||
275653|NCT00502840|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
275654|NCT00502853|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
275655|NCT00502905|UT MD Anderson Cancer Center|Gabriela Rondon, MD / Assistant Professor|713 745-2294|celsaenz@mdanderson.org|
275656|NCT00502944|Massachusetts General Hospital|Rochelle P. Walensky, MD, MPH|(617) 724-8445|rwalensky@partners.org|
275657|NCT00502996|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
275658|NCT00503113|Hoffman-LaRoche|Medical Communications|800-821-8590||
275659|NCT00503139|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275660|NCT00503308|UCSF, San Francisco General Hospital|Deborah Cohan, MD|415 206 3658|cohand@obgyn.ucsf.edu|
275661|NCT00503399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
275662|NCT00503425|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
275663|NCT00503685|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
275664|NCT00503698|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
283449|NCT00914186|Taisho Pharmaceutical R&D Inc.|Fred Henry MS, MPH,|973-898-6200|F-Henry@taihso-rd.com|
269278|NCT00024102|University of North Carolina|Hyman Muss, MD||hyman.muss@gmail.com|
297058|NCT01722604|Bausch & Lomb|Daniel Donatello|(585) 338-5306|Daniel.Donatello@bausch.com|
283450|NCT00914316|William Beaumont Hospital|Barbara Higgins, RN|248 551-1535|Barbara.Higgins@beaumont.org|
283451|NCT00914459|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283452|NCT00914485|Southeast Louisiana Veterans Health Care System|P. Adam Kelly, PhD, MBA|504-988-6630|peter.kelly@va.gov|
283453|NCT00914589|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
297059|NCT01722643|Dartmouth-Hitchcock|Dr. Catherine Stanger|603-646-7023|catherine.stanger@dartmouth.edu|
283454|NCT00914628|AGC Biologics S.p.A|Anna Stornaiuolo|00390221277440|astornaiuolo@agcbio.com|
283455|NCT00914732|Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|sharon.frey@health.slu.edu|
283456|NCT00914810|Minneapolis VA Health Care System|Ken Kunisaki, M.D.|612-467-4400|kunis001@umn.edu|
283457|NCT00914849|Washington University School of Medicine|John DiPersio, M.D., Ph.D.|314-454-8304|jdipersi@dom.wustl.edu|
283458|NCT00914862|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
283459|NCT00914927|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
283460|NCT00914940|Fred Hutchinson Cancer Research Center|Marie Bleakley, MD|206-667-6572|mbleakle@fredhutch.org|
283461|NCT00914966|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
283462|NCT00915005|UT MD Anderson Cancer Center|Dr. Zhongxing Liao, MD/Professor, Radiation Oncology Department|(713) 563-2300|zliao@mdanderson.org|
283463|NCT00915018|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
283464|NCT00915031|University of California, Irvine|Linda Huynh|7144567354|lindamh@uci.edu|
283465|NCT00915148|Stavanger UH|Torbjørn Moe Eggebø, phd|004792699433|tme@lyse.net|
283466|NCT00915278|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283467|NCT00915343|Shire|Study Physician|1866-842-5335|clinicaltransparency@shire.com|
283468|NCT00915356|AstraZeneca|Gerard Lynch||clinicalTrialTransparency@astrazeneca.com|
283469|NCT00915473|Mayo Clinic|Dr. David Dodick|480-301-5797|dodick.david@mayo.edu|
283470|NCT00915499|ResMed|June Mendoza|1-800-424-0737|june.mendoza@resmed.com|
283471|NCT00915525|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
283472|NCT00915538|Western Sky Medical Research|Lyndon Mansfield MD|915-544-2557|immunman@westernskymed.com|
283473|NCT00915551|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
283474|NCT00915590|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@meei.harvard.edu|
283475|NCT00915603|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
283476|NCT00915655|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Medical Leader|+1 609 730-7548||
283477|NCT00915759|Warfighter Refractive Eye Surgery Program and Research Center at FT Belvoir|Principal Investigator|571-231-1600|rose.sia@us.army.mil|
283478|NCT00915772|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283479|NCT00915798|UC Irvine|Dr. Jean Gehricke|949-267-0404|jgehrick@uci.edu|
297060|NCT01722669|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617-667-9299|jzwicker@bidmc.harvard.edu|
297061|NCT01722734|Harvard School of Public Health|Dr Günther Fink|6174327389|gfink@hsph.harvard.edu|
297062|NCT01722877|Midwest Cardiovascular Research Foundation|Dr Nicolas W Shammas|5633200263|shammas@mchsi.com|
269279|NCT00024167|University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD/Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
269280|NCT00024258|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner|212-639-6793|kushnerb@mskcc.org|
269281|NCT00025155|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
269282|NCT00025233|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
269283|NCT00025259|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
269284|NCT00025506|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
269285|NCT00025662|NHLBI|A. John Barrett|301-402-4170|barrettjj@mail.nih.gov|
269286|NCT00025883|National Institute of DIabetes and Digestive and Kidney Dseases, National Institutes of Health|Dr. Phillip Gorden|301-402-7340|phillipg@mail.nih.gov|
269287|NCT00026208|Stanford Univeristy Medical Center|Jessica C Lam, BS|650-723-0437|jclam11@stanford.edu|
269288|NCT00026221|The Ohio State University Comprehensive Cancer Center|William E. Carson III, MD|614-293-6306|William.Carson@osumc.edu|
269289|NCT00026312|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
269290|NCT00026494|Memorial Sloan Kettering Cancer Center|Dr. Lisa Deangelis|212-639-7997|deangell@mskcc.org|
269291|NCT00026793|National Cancer Institute|Dr. Robert Yarchoan|240-760-6075|robert.yarchoan@nih.gov|
269292|NCT00027027|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
269293|NCT00027378|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
269294|NCT00027560|Memorial Sloan-Kettering Cancer Center|Dr. Hugo Castro-Malaspina|212-639-8197|castro-h@mskcc.org|
269295|NCT00027846|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
275665|NCT00503750|Emory University|Dr. Ruth O'Regan|404-778-8808|roregan@emory.edu|
275666|NCT00503776|Vanderbilt-Ingram Cancer Center|Barbara Murphy, MD|615-343-9444|barbara.murphy@vanderbilt.edu|
283480|NCT00915876|University of Michigan|Amy Pai|7346470005|amypai@med.umich.edu|
283481|NCT00915902|Nemours Alfred I. duPont Hospital for Children|Dr. Samuel Gidding|302-651-6607|sgidding@nemours.org|
283482|NCT00915928|Odense University Hospital, Odense, Denmark|Frantz Rom Poulsen, Professor, consultant|0045 65413600|frantz.r.poulsen@rsyd.dk|
283483|NCT00915954|Cedars-Sinai Medical Center|Dr. Odelia Cooper|310-423-2830|coopero@cshs.org|
283484|NCT00915967|Oregon Health & Science University|Director of Clinical Trials|503-494-4314|nsgclinicalresearch@ohsu.edu|
283485|NCT00916006|LEO Pharma|Dr. Torsten Skov|+4520736294|tosdk@leo-pharma.com|
283486|NCT00916032|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
269296|NCT00028002|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
283487|NCT00916058|Weill Cornell Medical College|Tsiporah Shore|646-962-7950|tbs2001@med.cornell.edu|
283488|NCT00916136|Vanderbilt|William Obremskey MD MPH|615-936-0112|william.obremskey@vanderbilt.edu|
283489|NCT00916149|VA New York Harbor Healthcare System, NYU|Beth Leeman-Markowski, MD|212-686-7500|beth.leeman-markowski@nyumc.org|
283490|NCT00916279|Lutonix Inc. a subsidiary of C.R. Bard|Chris Barry|763-445-2352|LutonixResearch@crbard.com|
283491|NCT00916305|London School of Hygiene & Tropical Medicine|Clare Gilbert|+44 207 958 8332|clare.gilbert@lshtm.ac.uk|
283492|NCT00916344|BIOTRONIK SE & Co.KG|Dr. Evelyn Diessel|+49 (0) 30 68905|evelyn.diessel@biotronik.com|1231
283493|NCT00916357|Halozyme|Vice President, Endocrinology Clinical Development|858-794-8889||
297063|NCT01722994|University of Mississippi Medical Center|Dr. Robert Brodell|601-815-8000|rbrodell@umc.edu|
283494|NCT00916370|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
283495|NCT00916383|Teikoku Pharma USA, Inc.|Director of Clinical Trials|(408) 501-1821||
283496|NCT00916539|Massachusetts General Hospital|Taylor Pong, Research Coordinator|617-726-1569|tpong1@partners.org|
283497|NCT00916578|UT MD Anderson Cancer Center|Woodward,Wendy,M.D., PH.D.|713-792-7734|CR_Study_Registration@mdanderson.org|
283498|NCT00916617|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283499|NCT00916643|B. Braun Medical, Inc.|Kevin Minnich|610 596 2358|kevin.minnich@bbraun.com|
283500|NCT00916721|Massachusetts General Hospital|A. Eden Evins, MD, MPH, Director Center for Addiction Medicine|617-643-4679|a_eden_evins@hms.harvard.edu|
283501|NCT00916929|St Jude Medical|Tamara Shipman|408 522-6410|tshipman@sjm.com|
283502|NCT00917124|University Hospital Center Zagreb|Zeljko Colak|00385915624189|zcolak2000@yahoo.com|
283503|NCT00917150|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
283504|NCT00917267|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
283505|NCT00917384|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
283506|NCT00917462|Memorial Sloan Kettering Cancer Center|Dr. David Ilson, MD, PhD|646-888-4183|ilsond@mskcc.org|
283507|NCT00917501|University of Cincinnati|Dr. Robert McNamara|513-558-5601|robert.mcnamara@uc.edu|
308433|NCT02579057|Johns Hopkins Hospital|Stuart Russell MD|4109555708|srusse14@jhmi.edu|
283508|NCT00917553|University of Michigan|Dr. Thomas W. Gardner|734 232-8404|tomwgard@med.umich.edu|
283509|NCT00917579|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
283510|NCT00917644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
283511|NCT00917735|University of Minnesota|Dr. Mindy Kurzer|612-624-9789|mkurzer@umn.edu|
283512|NCT00917852|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
283513|NCT00917865|Emory University|David Schuster, MD|404-712-4859|dschust@emory.edu|
283514|NCT00918125|Duke University Medical Center|Dr. Kevin Thomas|919-668-7857|kevin.thomas@dm.duke.edu|
269297|NCT00028093|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Combination of Pegylated Interferon and Ribavirin as Therapy for Patients With Chronic Hepatitis C W|3014961333|hoofnaglej@extra.niddk.nih.gov|
269298|NCT00028262|National Institute of Child Health and Human Development|Dr. Anil Mukherjee|+1 301 496 7213|mukherja@exchange.nih.gov|
269299|NCT00028769|SWOG Statistical Center|Study Statistician|206-667-4623||
269300|NCT00029107|NIAID/NIH|Michael C Sneller, MD|301-496-0491|msneller@niaid.nih.gov|
269301|NCT00029146|University of North Carolina at Chapel HIll|William J. Powers, MD||powersw@neurology.unc.edu|
269302|NCT00029172|Roudebush VAMC Center of Excellence|Dr. Linda Williams|317-988-3337|linda.williams6@va.gov|
269303|NCT00029536|Beth Israel Deaconess Medical Center|Dr. Andrew G. Herzog|781-431-0277|aherzog@bidmc.harvard.edu|
269304|NCT00030147|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
269305|NCT00030264|Children's Hospital of Philadelphia|Ratnakar Patti|267-426-5503||
269306|NCT00030823|Memorial Sloan Kettering Cancer Center|Dr. Teresa Gilewski|646-888-4557|gilewskt@mskcc.org|
269307|NCT00030901|SWOG Statistical Center|Study Statistician|206-667-4623||
269308|NCT00030992|National Cancer Institute, National Institutes of Health|Tito Fojo, M.D.|301-496-2631|FojoT@mail.nih.gov|
269309|NCT00031447|Collaborative Antiviral Study Group|Penelope M Jester|205-934-2424|pjester@peds.uab.edu|
269310|NCT00031460|Collaborative Antiviral Study Group|Penelope M. Jester|(205) 934-2424|pjester@peds.uab.edu|
269311|NCT00031486|University of Alabama at Birmingham|Penny Jester|(877) 975-7280|pjester@peds.uab.edu|
269312|NCT00031551|NINR/NIH|Suzanne Wingate|301-827-0982|suzanne.wingate@nih.gov|
269313|NCT00031590|Childrens Hospital of Philadelphia|Peter Phillips|215-590-1000|phillipsp@email.chop.edu|
269314|NCT00031694|Montefiore Medical Center-New York cancer Consortium|Joseph Sparano|718-405-8404|jsparano@montefiore.org|
269315|NCT00032487|Hines CSPCC|Project Manager|708-202-5785|tamara.paine@va.gov|
269316|NCT00032591|Palo Alto CSPCC|Bob Edson|(650) 493-5000|Bob.Edson@va.gov|22250
269317|NCT00032630|VA Medical Center, Denver, Colorado|Frederick Grover, MD|303-393-2863|Frederick.Grover@ucdenver.edu|
297064|NCT01723072|Novartis Pharmaceuticals|Study Director|1-888-669-6682||
283515|NCT00918138|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
283516|NCT00918203|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
283517|NCT00918229|BioProtect|Shaul Shohat|+972545423774|Shaul@bioprotect.com|
283518|NCT00918255|Abbott|Global Medical Services|800-633-9110||
283519|NCT00918281|GE Healthcare|Matthew Miller|011-44-1494-543981|matthew.miller@ge.com|
283520|NCT00918333|Mayo Clinic Cancer Center|Shaji Kumar, MD|507-284-2511|Kumar.shaji@mayo.edu|
283521|NCT00918346|Santen Oy|Auli Ropo|+358405012416|auli.ropo@santen.fi|
283522|NCT00918385|Duke University|Dr. Daniel George|(919) 668 4615|daniel.george@duke.edu|
283523|NCT00918567|SUNY Buffalo|James Waxmonsky M.D.|305 348 3258|jwaxmons@fiu.edu|
283524|NCT00918580|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283525|NCT00918671|NTNU|Professor Knut Hagen|+4772575080|knut.hagen@ntnu.no|
283526|NCT00918684|Weill Cornell Medical College|Dr. George Alexopoulos, M.D.|914-997-5767|galexopoulos@med.cornell.edu|
283527|NCT00918723|Fred Hutchinson Cancer Research Center|Dr. Mazyar Shadman|2066675467|mshadman@fredhutch.org|206
283528|NCT00918736|Veterans General Hospital, Kaohsiung, Taiwan|Shu-Fen Sun|886-73422121|sfsun.tw@yahoo.com.tw|4210
283529|NCT00918749|Warner Chilcott|Grexan Wulff, Manager, Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
283530|NCT00918866|Lantheus Medical Imaging|Dana Washburn, M.D.|978-671-8686|dana.washburn@lantheus.com|
283531|NCT00918879|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
297065|NCT01723163|Durham Veterans Affairs Medical Center|Dr. Patrick Calhoun|919-286-0411|patrick.calhoun2@va.gov|7970
283532|NCT00918931|Organization: The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
283533|NCT00918957|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
297066|NCT01723228|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
297067|NCT01723254|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
283534|NCT00919035|Oncolgy Specialists, SC|Sigrun Hallmeyer, MD|847-268-8200|shallmeyer@oncmed.net|
283535|NCT00919061|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa|646-888-4184|abou-alg@mskcc.org|
283536|NCT00919100|MMJ Labs|Dr. Amy Baxter|877-805-2899|abaxter@mmjlabs.com|106
283537|NCT00919113|Watson Laboratories, Inc.|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|801 588-6641|gary.hoel@watson.com|
283538|NCT00919126|University Hospital Schleswig-Holstein|Prof. Dr. Med Berthold BEIN|+49(0)431-5973 739|bein@anasthesie.uni-kiel.de|
283539|NCT00919191|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
283540|NCT00919503|Fred Hutchinson Cancer Research Center|Dr. Lauri Burroughs|206-667-2396|lburroug@fredhutch.org|
283541|NCT00919633|Medtronic, Inc.|Study Trial Manager|763-505-4594|sarah.mische@medtronic.com|
283542|NCT00919711|Amgen Inc.|Study Director|866-572-6436||
283543|NCT00919724|Indiana University School of Medicine|Samir K. Gupta, MD, MS|317-274-7926|sgupta1@iu.edu|
269318|NCT00033371|University of Texas (UT) MD Anderson Cancer Center|Patrick Lynch, MD/Professor, Gastroenterology/Hepatology|713-794-5073|plynch@mdanderson.org|
283544|NCT00919763|Galderma|Michael Graeber, MD, Head of Global Clinical Project Management and US Development|609-860-8201|michael.graeber@galderma.com|
269319|NCT00033514|Medical University of South Carolina|Carolyn Britten|843-792-4271|britten@musc.edu|
269320|NCT00033540|Southwest Oncology Group (SWOG) Statistical Center|Study Statistician|206-667-4623||
269321|NCT00033631|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
269322|NCT00033657|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
269323|NCT00033917|Yale University School of Medicine|Dr. Laura Ment|203-785-5708|laura.ment@yale.edu|
269324|NCT00035555|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
269325|NCT00035815|Mayo Clinic|Eric J. Sorenson, MD|507 538-1037|sorenson.eric@mayo.edu|
269326|NCT00035932|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
269327|NCT00036270|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269328|NCT00036569|National Cancer Institute|Kathy Warren, M.D.|301-435-4683|warrenk@mail.nih.gov|
269329|NCT00036738|Fred Hutchinson Cancer Research Center|Dr. George Georges|206-667-6886|ggeorges@fredhutch.org|
269330|NCT00037830|Thomas Jefferson University|Dr. Jay Schneider|215-503-0370|jay.schneider@jefferson.edu|
269331|NCT00038103|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
269332|NCT00038467|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269333|NCT00038610|The University of Texas (UT) MD Anderson Cancer Center|Naval Daver, MD/Leukemia||CR_Study_Registration@mdanderson.org|
269334|NCT00038649|University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia Department|713-794-5783|CR_Study_Registration@mdanderson.org|
269335|NCT00038857|MDAnderson Cancer Center|Dr. Richard E. Champlin|713-792-8750|celsaenz@mdanderson.org|
269336|NCT00038948|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
269337|NCT00039130|Duke University Medical Center|David Rizzieri, M.D.||rizzi003@dm.duke.edu|
269338|NCT00039195|Memorial Slaon Kettering|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
269339|NCT00039377|Roswell Park Cancer Institute|Meir Wetzler, M.D.||meir.wetzler@roswellpark.org|
269340|NCT00039741|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
269341|NCT00039871|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269342|NCT00040365|National Cancer Institute (NCI), National Institutes of Health (NIH)|Kevin A. Camphausen|301-496-5457|camphauk@mail.nih.gov|
283545|NCT00919802|UAB|Timothy Ness|205-975-9643|tness@uabmc.edu|
283546|NCT00919854|Janssen R&D US|Senior Director R&D|1 609 730-7548||
283547|NCT00919867|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
297068|NCT01723384|San Francisco Department of Public Healt|Dr. Glenn-Milo Santos|415-437-6231|glenn-milo.santos@ucsf.edu|
297069|NCT01723397|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
297070|NCT01723514|Amgen Inc.|Study Director|866-572-6436||
283548|NCT00919932|University of Pittsburgh|Dr Han Liang|412-624-4141|liangh2@upmc.edu|
292748|NCT01445535|National Cancer Institute|Dr. Wyndham Wilson|240-760-6092|wyndham_wilson@nih.gov|
297071|NCT01723696|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
297072|NCT01723722|Eastern Maine Medical Center|Dr Mark S Brown|207-973-8670|mbrown@emh.org|
297073|NCT01723826|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
297074|NCT01723904|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
297075|NCT01724021|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
297076|NCT01724060|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
297077|NCT01724177|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
297078|NCT01724216|Spectrum Health|Mark Charles DeLano, M.D., Principal Investigator|616-363-7339|delanom@msu.edu|
297079|NCT01724359|Jan-Cil Mexico|GERENTE MEDICO REGIONAL|52 55 5237 3410||
297080|NCT01724489|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|kkmiller@mgh.harvard.edu|
297081|NCT01724528|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Clinical Research Director|+39 055 5680|acapriati@menarini-ricerche.it|9933
297082|NCT01725126|GlaxoSmithKline|GSK Response Center|866-435-7343||
297083|NCT01725217|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
297084|NCT01725282|Astellas Pharma Inc.|Vice President, Clinical Development Administration||clinicaltrials@us.astellas.com|
297085|NCT01725308|Astellas Pharma Inc.|Head of Clinical Development Administration||Astellas.resultsdisclosure@astellas.com|
297086|NCT01725386|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
297087|NCT01725451|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297088|NCT01725529|Janssen R&D US|ASSOCIATE DIRECTOR, MEDICAL DEPARTMENT||ClinicalTrialDisclosure@its.jnj.com|
297089|NCT01725750|Icahn School of Medicine at Mount Sinai|Jacob Greisman|212-241-4886|Jacob.greisman@mountsinai.org|
297090|NCT01725815|Emory University|Dr. Benjamin Druss|404-712-9602|bdruss@emory.edu|
297091|NCT01725984|Ludwig Maximilian Universität|Dr. Ricarda Bauer|+49 89 7095|Ricarda.Bauer@med.uni-muenchen.de|
269343|NCT00040443|RespireRx Pharmaceuticals|Richard Purcell|732-492-1797|rpurcell@respirerx.com|
297092|NCT01726023|AstraZeneca|David Wilson, Statistical Team Leader - Infection|+44 1625 517830|David.Wilson2@astrazeneca.com|
297093|NCT01726036|TriHealth|Rachel G. Sinkey MD - PI|513-862-6918|pam_plummer@trihealth.com|
297094|NCT01726049|University Hospital Groningen, NL|E.S. Hoendermis, MD, PHD|0031503616161|e.s.hoendermis@umcg.nl|
297095|NCT01726270|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297096|NCT01726335|Janssen-Cilag Ltd.|Medical Group Manager|+55 11 30302738||
297097|NCT01726504|Guang An Men Hosptial of China Academy of Chinese Medical Sciences|Liu Zhishun|86 13651016313|liuzhishun@hotmail.com|
297098|NCT01726517|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
297099|NCT01726621|Medtronic MiniMed, Inc|Clinical Research Manager|8185765171|julie.sekella@medtronic.com|
297100|NCT01726673|Feinstein Institute for Medical Research at Northwell Health|Johanna Chang, Senior Research Coordinator|(516) 562-3646|jchang14@northwell.edu|
275667|NCT00503867|Sirtex Medical|Medical Director|011 61 2 9964 8470|dcade@sirtex.com|
297101|NCT01726738|University of North Carolina Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
297102|NCT01726803|University of Utah|Julie Fritz|801-581-6861|julie.fritz@hsc.utah.edu|
297103|NCT01727024|Novartis Pharmaceuticals|Study Director|862-778-8300||
269344|NCT00040664|GlaxoSmithKline|GSK Response Center|866-435-7343||
297104|NCT01727089|City of Hope|Jeff Longmate, Ph.D.|626-218-2478|jlongmate@coh.org|
297105|NCT01727141|Novartis Pharmaceuticals|Study Director|862-778-8300||
297106|NCT01727154|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
269345|NCT00040742|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
269346|NCT00040846|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
269347|NCT00040937|SWOG|Robert Z. Orlowski, MD,PhD|(713) 792-2860|rorlowsk@mdanderson.org|
269348|NCT00041067|SWOG|Study statistician|206-667-4623||
269349|NCT00041080|Gynecologic Oncology Group (GOG) Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
269350|NCT00041119|Dana-Farber Cancer Institute|Lawrence N. Shulman, M.D.|(617)-632-2277|Lawrence_Shulman@dfci.harvard.edu|
269351|NCT00041132|SWOG Statistical Center|Study Statistician|206-667-4623||
269352|NCT00041392|Duke University|Dr. Mark F. Newman|919-681-6646|newma005@mc.duke.edu|
269353|NCT00041470|University of Washington|Julie Gralow, MD|206-288-2053|pink@u.washington.edu|
269354|NCT00041717|Acorda Therapeutics, Inc.|Andrew Blight, Ph.D. Chief Scientific Officer|914-347-4300|ablight@acorda.com|5102
269355|NCT00041756|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
269356|NCT00041938|Columbia University|Dr. J.L.P. (Seamus) Thompson|212-342-1252|jlt12@columbia.edu|
297107|NCT01727180|Far Eastern Memorial Hospital|Hon-Yen Wu, MD, PHD|+886-2-8966-7000|honyenwu@gmail.com|1164
297108|NCT01727258|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
297109|NCT01727297|Medtronic, Inc.|Medtronic Cardiac Rhythm and Heart Failure clinical trial manager|763-505-6000|medtronicCRMtrials@medtronic.com|
269357|NCT00042224|Northshore LIJ Health System|Georgios Petrides, M.D.|718-470-8569|GPetride@NSHS.EDU|
297110|NCT01727336|Acceleron Pharma|Sr. Vice President, Regulatory Affairs|617-649-9200|jdesiderio@acceleronpharma.com|
297111|NCT01727414|Cincinnati Children's Hospital|Tanya Froehlich|5136361154|tanya.froehlich@cchmc.org|
297112|NCT01727505|University of Miami School of Medicine, Dept. of Pediatrics - Div. of Neonatology|Nelson Claure, MSc, PhD, Director Neonatal Pulmonary Research Lab|305 585 6408|nclaure@miami.edu|
297113|NCT01727700|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
269358|NCT00042432|Amgen Inc.|Study Director|866-572-6436||
269359|NCT00042666|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
269360|NCT00042939|ECOG Statistical Office|Study Statistician|617-632-3012||
269361|NCT00042991|Operations and Biostatistics Center for Pediatric Brain Tumor Consortium (PBTC)|Mehmet Kocak|9015952947|mehmet.kocak@stjude.org|
269362|NCT00043186|Amgen Inc.|Study Director|866-572-6436||
269363|NCT00043550|Adelphi University, The Derner Institute of Advanced Psychological Studies|Jacques P.Barber, PhD, Dean and Professor|516.877.4807|jbarber@adelphi.edu|
269364|NCT00043979|National Cancer Institute, National Institutes of Health|Dr. Terry Fry|301-402-0215|fryt@mail.nih.gov|
269365|NCT00044005|Sunovion|Josephine Cucchiaro, PhD|201-592-2050|josepine.cucchiaro@sunovion.com|
269366|NCT00044044|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
269367|NCT00044083|Office of the Clinical Director-NIMH-NIH-HHS|Jose A. Apud|3015946561|apudj@mail.nih.gov|
269368|NCT00044213|Mount Sinai Medical Center|Gervasio A. Lamas, M.D.|305-674-2162|Gervasio.Lamas@msmc.com|
269369|NCT00044512|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
269370|NCT00044655|NYSPI|Nancy H. Covell, Ph.D.|6469450227|covelln@nyspi.columbia.edu|
269371|NCT00045032|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
269372|NCT00045110|Adult Brain Tumor Consortium|Lauren E Abrey, MD|410-955-8837|jfisher@jhmi.edu|
269373|NCT00045162|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
269374|NCT00045305|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
269375|NCT00045435|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|206-667-4961|bsandmai@fhcrc.org|
269376|NCT00045487|University of Texas Health Science Center San Antonio|Alain Mita, MD|210-450-5094|goodwine@uthscsa.edu|
269377|NCT00045630|SWOG Statistical Center|Study Statistician|206-667-4623||
275668|NCT00503906|UM/Sylvester Comprehensive Cancer CEnter|Stefan Gluck MD|305-243-4909|sgluck@med.miami.edu|
275669|NCT00503984|University of Miami|Rakesh Singal MD|305-243-9544|rsingal@med.miami.edu|
275670|NCT00503997|Vanderbilt-Ingram Cancer Center|Jill Gilbert, M.D.|615-343-4677|jill.gilbert@vanderbilt.edu|
275671|NCT00504023|Memorial Sloan Kettering Cancer Center|Dr. Dennis Chi, MD|212-639-5016|chid@mskcc.org|
275672|NCT00504075|Bio Products Laboratory Limited|Tim Aldwinckle, MD|+44 2089572565|Tim.Aldwinckle@bpl.co.uk|
275673|NCT00504153|The University of Chicago|Dr. Hedy Kindler|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
275674|NCT00504166|University of California San Francisco|Dr. Thomas M. Link|415-353-2450|Thomas.Link@ucsf.edu|
275675|NCT00504231|University of Washington|Ru-Chien Chi B.S., M.D., M.S.|206 768-5217|rchi@u.washington.edu|
275676|NCT00504257|H. Lee Moffitt Cancer Center and Research Institute|Robert Wenham, Principal Investigator|813-745-8478|robert.wenham@moffitt.org|
275677|NCT00504309|Penn State University|Ann Skulas-Ray|814-863-0856|aus164@psu.edu|
283549|NCT00920023|Massachusetts General Hospital|Ralph Weissleder|6177268226|RWEISSLEDER@MGH.HARVARD.EDU|
283550|NCT00920075|Medical University of South Carolina|Deborah A Bowlby, Asst.Professor, Pediatric Endocrinology|843-792-6807|bowlbyd@musc.edu|
283551|NCT00920140|GlaxoSmithKline|GSK Response Center|866-435-7343||
283552|NCT00920218|GlaxoSmithKline|GSK Response Center|866-435-7343||
283553|NCT00920231|Baltimore VA MC|Dr Cha-Min Tang|410 706-2347|ctang@som.umaryland.edu|
283554|NCT00920374|GlaxoSmithKline|GSK Response Center|866-435-7343||
283555|NCT00920426|ViiV Healthcare|GSK Response Center|866-435-7343||
283556|NCT00920439|GlaxoSmithKline|GSK Response Center|866-435-7343||
283557|NCT00920556|GlaxoSmithKline|GSK Response Center|866-435-7343||
283558|NCT00920621|Brigham and Women's Hospital|Scott T. Weiss, MD, MS|617-525-2278|scott.weiss@channing.harvard.edu|
283559|NCT00920647|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
283560|NCT00920686|NeurAxon, Inc|Thomas Lategan, PhD|417 673 6697|tlategan@neuraxon.com|
283561|NCT00920699|Johns Hopkins University|Christopher A. Ross M.D. Ph.D.|410-614-0011|caross@jhmi.edu|
283562|NCT00920790|Kyowa Hakko Kirin|Project Management Department, Development Division||clinical.info@kyowa-kirin.co.jp|
283563|NCT00920816|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283564|NCT00920829|Medical University of South Carolina|Dr. Raymond Anton|843-792-1226|antonr@musc.edu|
283565|NCT00920855|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
283566|NCT00920907|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
283567|NCT00921024|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
283568|NCT00921115|University of Kansas Cancer Center|Qamar Khan, MD|(913) 588-6029|QKHAN@kumc.edu|
283569|NCT00921310|Washington University School of Medicine|Maria Baggstrom, M.D.|314-362-5737|mbaggstr@dom.wustl.edu|
283570|NCT00921518|Wilkes University|Judith Kristeller|570-408-4272|judith.kristeller@wilkes.edu|
283571|NCT00921557|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
283572|NCT00921687|Louis Stokes Cleveland VA Medical Center|Paul Drawz, MD, MHS, MS|6126255423|draw0003@umn.edu|
283573|NCT00921843|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
283574|NCT00921895|Rapid Pathogen Screening, Inc.|Robert Sambusky, MD|941-556-1853|sambursky@rpsdetectors.com|
269378|NCT00045708|Johns Hopkins - Adult Brain Tumor Consortium (ABTC)|Director Adult Brain Tumor Consortium|410-955-8837|jfisher@jhmi.edu|
297114|NCT01727713|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
283575|NCT00921934|Department for Complementary and Alternative Medicine|Dr. med. Martin Schencking|+0049-2602-684-614||
283576|NCT00921947|VaxInnate|Dr. David N.Taylor|609-860-2260|david.taylor@vaxinnate.com|
283577|NCT00922116|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
283578|NCT00922194|Sircar Diabetes Clinic|Dr. Amulya R Sircar|+ 91 (522) 2324747|arsircar@yahoo.com|
283579|NCT00922207|HoffmannLa Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
283580|NCT00922233|FHI360|Dr. Vera Halpern|9195447040|vhalpern@fhi360.org|
283581|NCT00922272|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
283582|NCT00922428|Pascoe pharmazeutische Präparate GmbH|Anja Braschoss|0049 641 7960100|KlinischeForschung@pascoe.de|
283583|NCT00922441|Boryung Pharmaceutical|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
283584|NCT00922480|Boryung Pharmaceuticals|Manager of Clinical Research|+82-2-708-8069|rainbowleo@boryung.co.kr|
283585|NCT00922623|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4000|clinicaltrials@merzaesthetics.com|
283586|NCT00922636|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
283587|NCT00922701|University G. D'Annunzio|Mario Bonomini, M.D.|+39 0871 540120|m.bonomini@nephro.unich.it|
283588|NCT00922766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283589|NCT00922779|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
283590|NCT00922883|NHLBI|Cynthia E Dunbar|301-496-5093|dunbarc@nhlbi.nih.gov|
283591|NCT00922935|Straumann|Kristina Espemar Holst, Senior Clinical Trial Manager|+41 61 965 11 11|info@straumann.com|
283592|NCT00922974|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
283593|NCT00922987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283594|NCT00923078|VA Connecticut Healthcare System|Dr Jason K. Johannesen|2039325711|jason.johannesen@va.gov|2224
283595|NCT00923091|Daiichi Sankyo Europe, GmbH|Bettina Ammentorp|00498978080|bettina.ammentorp@daiichi-sankyo.eu|
283596|NCT00923117|National Cancer Institute, National Institutes of Health|Dr. Teri Kreisl|301-402-3423|kreislt@mail.nih.gov|
283597|NCT00923130|National Cancer Institute|Dr. Ravi Madan|301-496-3493|madanr@mail.nih.gov|
283598|NCT00923156|Novartis Pharmaceuticals|Study Director|862-778-8300||
283599|NCT00923195|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
283600|NCT00923260|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran|Dr. Miguel F Herrera|(+52) 55 54870208|miguelfherrera@gmail.com|
283601|NCT00923273|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
283602|NCT00923351|National Cancer Institute, National Institutes of Health|Dr. John Glod|301-451-0391|john.glod@nih.gov|
283603|NCT00923364|National Cancer Institute|Dr. Dennis Hickstein|301-594-1718|hicksted@mail.nih.gov|
283604|NCT00923481|National Cancer Institute, National Institutes of Health|Dr. Shivaani Kummar|301-435-5402|kummars@mail.nih.gov|
297115|NCT01727726|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
269379|NCT00045734|Adult Brain Tumor Consortium (ABTC)|Patrick Wen, MD|410-955-8837|jfisher@jhmi.edu|
269380|NCT00045942|Novartis|Study Director|862-778-8300||
269381|NCT00046228|Centocor Inc.|Executive Director Clinical Research|1-800-972-9063|EBarnath@ITS.JNJ.COM|6171
269382|NCT00046475|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
269383|NCT00046566|Tulane University|Jiang He, MD, PhD, Chair of Epidemiology|5049885165|jhe@tulane.edu|504
269384|NCT00046839|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
269385|NCT00046891|Mayo Clinic|Debra L. Barton, R.N., Ph.D.|507-266-6247|barton.debra@mayo.edu|
269386|NCT00046930|ECOG Statistical Office|Study Statistician|617-632-3012||
269387|NCT00047008|NRG Oncology|Wendy Seiferheld||SeiferheldW@nrgoncology.org|
269388|NCT00047060|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
269389|NCT00047320|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
269390|NCT00047385|Early Detection Research Group, NCI, NIH|Christine D. Berg, M.D.|301-496-8544|bergc@mail.nih.gov|
269391|NCT00047463|Vanderbilt University|Beth Malow/Principal Investigator|615-322-0283|beth.malow@vanderbilt.edu|
269392|NCT00047619|University of Calgary|Dr. Chester Ho|(403) 944 4620|chester.ho@albertahealthservices.ca|
269393|NCT00047697|University of Pittsburgh|Benjamin L. Handen, PhD|412-235-5445|handenbl@upmc.edu|
275678|NCT00504348|Tokyo Medical and Dental University|Kazuki Takada, M.D.|81-3-3813-6111|takada.rheu@tmd.ac.jp|
275679|NCT00504426|Headwuarters of New Product Evaluation and Development, Otsuka Pharmaceutical Co., Ltd.|IMAOKA, Kyoji, Operatin Officer, Gemeral Manager|+81-3-6361-7366||
275680|NCT00504504|University of Texas (UT) MD Anderson Cancer|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
275681|NCT00504556|Daiichi Sankyo Inc.|William Maxwell, Assoc. Director|732-590-5000|wmaxwell@dsi.com|
275682|NCT00504582|UT MD Anderson Cancer Center|Dr. Paul F Mansfield, Professor, Surgical Oncology|(713) 794-5499|pmansfie@mdanderson.org|
275683|NCT00504595|Novartis Pharmaceuticals|Study Director|862-778-8300||
275684|NCT00504660|UT MD Anderson Cancer Center|Charles A. Conrad, MD / Professor|713-745-1896|skang@mdanderson.org|
275685|NCT00504725|Duke University Medical Center|Andrew Shaw MD|9192866938|andrew.shaw@duke.edu|
275686|NCT00504751|Weill Cornell Medicine|Richard Furman, MD|646.962.2064|amr2017@med.cornell.edu|
275687|NCT00504777|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
275688|NCT00504829|Life Cycle Pharma|H. Eugene Griffin, MS, DVM|646-200-8505|ggr@lcpharma.com|
283605|NCT00923559|Dept of Women's and Children's Health, Karolinska Institutet|Björn Salomonsson|+46851777206|bjorn.salomonsson@ki.se|
283606|NCT00923598|University of California San Diego|Dr. Brian Ilfeld, Professor of Anesthesiology, In Residence|(858) 444-5949|bilfeld@ucsd.edu|
283607|NCT00923845|National Cancer Institute|Dr. Daniel Fowler|301-435-8641|fowlerda@mail.nih.gov|
283608|NCT00923910|National Cancer Institute|Dr. Terry Fry|301-402-0215|fryt@mail.nih.gov|
283609|NCT00923936|National Cancer Institute|Dr. Robert Yarchoan|301-496-0328|yarchoanr@pop.nci.nih.gov|
283610|NCT00923949|National Cancer Institute|Giuseppe Giaccone M.D.|301-496-4916|giacconeg@mail.nih.gov|
283611|NCT00923975|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
283612|NCT00924001|National Cancer Institute, National Institutes of Health|Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
283613|NCT00924040|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitman@mail.nih.gov|
283614|NCT00924053|Theracos, Inc|Yuan-Di Halvorsen|617 726-4236|yhalvorsen@ccib.mgh.harvard.edu|
283615|NCT00924066|National Cancer Institute|Antonio Fojo, M.D.|301-496-2631|fojot@mail.nih.gov|
283616|NCT00924118|Johns Hopkins Hospital|Steven P. Schulman, MD|4109557378|sschulma@jhmi.edu|410
297116|NCT01727765|University of Portsmouth|Dr Mitch Lomax|02392845297|mitch.lomax@port.ac.uk|
283617|NCT00924209|National Cancer Institute, National Institutes of Health|Caryn Steakley, Deputy Clinical Director|240-858-3749|steaklec@nih.gov|
283618|NCT00924287|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
283619|NCT00924313|National Cancer Institute, National Institutes of Health|Dr. Peter L. Choyke|301-402-8409|pchoyke@mail.nih.gov|
283620|NCT00924352|Vector Oncology (formerly Accelerated Community Oncology Research Network, Inc.)|Vice President of Scientific Affairs|901-435-5570|mwalker@vectoroncology.com|
283621|NCT00924404|University of Iowa|Lakshmi Durairaj|319-353-7968|lakshmi-durairaj@uiowa.edu|
283622|NCT00924443|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
283623|NCT00924469|Janssen Research & Development, LLC 10990 Wilshire Blvd, Suite 1200 Los Angeles, CA 90024|Senior Director, Clinical Research|(310) 914-2917||
283624|NCT00924482|University of California San Francisco|Arthur Wallace, M.D., Ph.D.|415-750-2069|wallacea@anesthesia.ucsf.edu|3732
283625|NCT00924508|UCSF|John Koo, MD|415-476-6281|john.koo@ucsfmedctr.org|
283626|NCT00924560|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
283627|NCT00924612|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
283628|NCT00924638|Medtronic, Inc.|Medtronic CRDM clinical trial manager|763-505-6000|medtronicCRMtrials@medtronic.com|
283629|NCT00924651|University of Rochester Medical Center|Karen M. Mustian, PhD, MPH, Associate Professor|585-273-1796|Karen_Mustian@urmc.rochester.edu|
283630|NCT00924664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283631|NCT00924703|BioMarin Pharmaceutical Inc.|Debra Lounsbury/Sr Principle Scientist, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
283632|NCT00924729|Johns Hopkins University|Walter J. Stark, M.D./Professor of Ophthalmology|410-955-5490|wstark@jhmi.edu|
283633|NCT00924781|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
283634|NCT00924820|The University of Texas (UT) MD Anderson Cancer Center|John F de Groot, Professor, Neuro-Oncology|(713) 745-3072|jdegroot@mdanderson.org|
283635|NCT00924885|Vitrolife|Director of clinical investigations|0046708228063|thardarson@vitrolife.com|
283636|NCT00924898|The University of North Carolina|Dr. Cynthia Gay|919-843-2726|cynthia_gay@med.unc.edu|
283637|NCT00924950|UCSF|Tina Bhutani|4154763396|tinabhutanimd@gmail.com|
283638|NCT00925002|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283639|NCT00925015|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
283640|NCT00925054|BioMarin Pharmaceutical Inc.|Medical Director|415-475-5854|ari.gershman@bmrn.com|
283641|NCT00925119|University of Maryland|Dr. Amber Beitelshees|410-706-0118|abeitels@medicine.umaryland.edu|
283642|NCT00925132|University of Iowa|Mohammed Milhem|319-356-2324||
283643|NCT00925288|Johns Hopkins University|Dr. Brandon Brown|949-266-4401|bbrown@jhsph.edu|
308434|NCT02579135|North Carolina State University|Dr. Laura Widman|919-513-2546|lmwidman@ncsu.edu|
269394|NCT00047879|National Cancer Institute, National Institutes of Health|Howard A. Fine, M.D.|301-402-6383|hfine@mail.nih.gov|
269395|NCT00048035|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
269396|NCT00048048|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
269397|NCT00048061|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
269398|NCT00048074|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
269399|NCT00048165|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
269400|NCT00048347|NIAID|Peter Mannon, MD|205-934-4726|pmannon@uab.edu|
269401|NCT00048542|Abbott|Global Medical Services|800-633-9110||
269402|NCT00048568|Bristol Myers-Squibb|BMS Study Director||clinical.trials@bms.com|
269403|NCT00048581|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
269404|NCT00048724|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269405|NCT00048737|UT MD Anderson Cancer Center|Issa Khouri, MD / Professor||rvalverde@mdanderson.org|
269406|NCT00048815|Cedars Sinai Medical Center|Mark Hyman Rapaport, M.D.|310-423-2600|mark.rapaport@cshs.org|
269407|NCT00048893|National Cancer Institute (NCI), National Institutes of Health (NIH)|Claude Sportes, M.D.|301-435-5280|csportes@mail.nih.gov|
269408|NCT00048932|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
269409|NCT00048997|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||seiferheldw@nrgoncology.org|
269410|NCT00049036|AIDS Malignancy Consortium|Jeannette Lee|501-526-6712|jylee@uams.edu|
297117|NCT01727791|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283644|NCT00925301|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
283645|NCT00925353|St. Luke's Mountain States Tumor and Medical Research Institute|Colleen K. Lambertz, MBA, MSN, FNP|208 463 6018|lambertc@slhs.org|
283646|NCT00925522|St. Jude Medical|Nancy Ouch, Project Manager|949.769.5041|nouch@sjm.com|
283647|NCT00925587|Amgen Inc.|Study Director|866-572-6436||
283648|NCT00925600|Amgen Inc.|Study Director|866-572-6436||
292749|NCT01445548|National Eye Institute|Wai T. Wong, MD, PhD|301-496-7566|wongw@nei.nih.gov|
297118|NCT01727895|Radboud UMC|Drs. Jenneke Leentjens|0031-243668420|Jenneke.Leentjens@radboudumc.nl|
292750|NCT01445613|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
292751|NCT01445626|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
292752|NCT01445652|Alcon Research, Ltd.|Jami Kern, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
292753|NCT01445678|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
292754|NCT01445730|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-4717 1990|marja-riitta.taskinen@helsinki.fi|
292755|NCT01445769|Incyte Corporation|Study Director|855 463-3463||
292756|NCT01445821|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
292757|NCT01445847|King Saud University Medical City - College of Medicine|Dr. Khalid Al-Faleh, Chairman, Institutional Review Board|966556031222|kfaleh@ksu.edu.sa|
292758|NCT01445873|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292759|NCT01445886|Department of Traditional Chinese Medicine, Chang Gung Memorial Hospital at Keelung, Taiwan|Yin-Ku Lin|886-2-2431-3131|lin1266@adm.cgmh.org.tw|2127
292760|NCT01445951|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
297119|NCT01728077|Cares|UCB|+1844599||2273
297120|NCT01728116|GI Dynamics, Inc|Brian Callahan|781.357.3302|bcallahan@gidynamics.com|
269411|NCT00049127|Mayo Clinic|Kurt A. Jaeckle, M.D.|5072841370|jaecle.kurt@mayo.edu|
269412|NCT00049257|Translational Oncology Research International|Dr. Fairooz Kabbinavar, Chief Medical Officer|310 824 1934|FKabbina@mednet.ucla.edu|
269413|NCT00049322|University of California Los Angeles|Carolyn Britten, M.D.|310 829 4971|cbritten@mednet.ucla.edu|
269414|NCT00049504|Fred Hutchinson Cancer Research Center|Rachel Salit|206-667-1317|rsalit@fredhutch.gov|
269415|NCT00049517|ECOG Statistical Office|Statistician|617-632-3012||
269416|NCT00049530|ECOG Statistical Office|Study Statistician|617-632-3012||
269417|NCT00049543|NCIC Clinical Trials Group|Dr. Keyue Ding|1-613-533-6000|king@ctg.queensu.ca|77705
269418|NCT00049673|Canadian Cancer Trials Group|Director of Clinical Trials|613-533-6340|jdancey@ctg.queensu.ca|
269419|NCT00049842|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269420|NCT00050011|Novartis Pharmaceuticals|Study Director|862-778-8300||
269421|NCT00050089|VAMC Bronx|Dr. Sheldon Brown|(718) 584-9000|sheldon.brown@va.gov|6666
269422|NCT00050167|UT MD Anderson Cancer Center|Aman Buzdar, M.D./Professor||agmadrig@mail.mdanderson.org|
269423|NCT00050622|Florida International University|William E. Pelham, Jr.|305-348-3002|wpelham@fiu.edu|
269424|NCT00050778|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
269425|NCT00050960|Eisai Call Center|Eisai, Inc.|888-422-4743||
269426|NCT00050986|University of Texas, M. D. Anderson Cancer Center|W.K. Yung,MD/Clinical Professor, Neuro-Oncology|(713) 794-1285|wyung@mdanderson.org|
269427|NCT00051025|Eisai Call Center|Eisai Inc|888-422-4743||
269428|NCT00051168|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
275689|NCT00504881|UCB Clinical Trial Call Center|UCB (Study Director)|+1 877 822 9493||
275690|NCT00504894|Weill Cornell Medicine|Kane Pryor|(212) 746-2953|kap9009@med.cornell.edu|
275691|NCT00505076|Semel Institute at UCLA|Stephen R. Marder|310-268-3647|marder@ucla.edu|
275692|NCT00505284|Eisai Call Center|Eisai Inc.|888-422-4743||
275693|NCT00505362|Stanford University|Anna Girsen, Manager of Research Operations|6507250499|agirsen@stanford.edu|
275694|NCT00505375|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
275695|NCT00505414|Grünenthal GmbH|Director of Clinical Trials|+49 (0)241 569 3223|Clinical-Trials@grunenthal.com|
275696|NCT00505518|Massachusetts General Hospital|Albert Yeung|617-724-5138|ayeung@partners.org|
275697|NCT00505622|Eisai Call Center|Eisai Inc.|888-422-4743||
275698|NCT00505635|UT MD Anderson Cancer Center|Nicholas E. Papadopoulos, MD / Professor|713-792-2921|CR_Study_Registration@mdanderson.org|
275699|NCT00505661|UT MD Anderson Cancer Center|John Kavanagh, MD / Professor|713-792-2933||
275700|NCT00505687|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
275701|NCT00505752|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
275702|NCT00505765|Semel Institute at UCLA|Stephen R. Marder|310-268-3647|marder@ucla.edu|
275703|NCT00505778|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
275704|NCT00505895|University of Texas MD Anderson Cancer Center|Muzaffar Qazilbash, MD / Professor, Stem Cell Transplantation|713-745-4371|CR_Study_Registration@mdanderson.org|
275705|NCT00505921|UT MD Anderson Cancer Center|Issa F. Khouri, MD / Associate Professor|713-792-8848|pmcadams@mdanderson.org|
275706|NCT00505934|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
275707|NCT00506025|University of California Irvine Medical Center|Deborah A. Wing, MD|714-456-5967|dwing@uci.edu|
275708|NCT00506077|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275709|NCT00506129|University of Texas (UT) MD Anderson Cancer Center|Chitra M. Hosing, Professor, Stem Cell Transplantation|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
275710|NCT00506142|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@appirx.com|
297121|NCT01728194|Well Cornell Medicine|Faith M. Gunning, PhD, Vice Chair for Research, Dept of Psychiatry|212-746-5832|fgd2002@med.cornell.edu|
283649|NCT00925704|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
283650|NCT00925756|UCSD|Sheldon Morris|6195438080|shmorris@ucsd.edu|
283651|NCT00925769|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
283652|NCT00925782|University of Kansas Medical Center|Omar Aljitawi, M.D., Assistant Professor of Medicine|913-588-6029|oaljitawi@kumc.edu|
283653|NCT00925899|Bispebjerg Hospital|Lise Pedersen|004535312305|lise.pedersen.01@regionh.dk|
283654|NCT00925938|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
283655|NCT00925990|Conatus Pharmaceuticals Inc.|Vice President, Clinical Development|858-457-7227|mhuyghe@conatuspharma.com|
297122|NCT01728246|Janssen Pharmaceutica|Medical Affairs Manager|+632-8247901||
283656|NCT00926003|Michigan State University|Dr. Michael J. Boivin|5174324204|Michael.Boivin@hc.msu.edu|
283657|NCT00926029|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
297123|NCT01728324|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283658|NCT00926185|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
308435|NCT02579343|Counseling and Psychological Services|Adam McCabe|239-590-7950|amccabe@fgcu.edu|
283659|NCT00926211|Restoration Robotics|Miguel Canales, M.D.|650-965-3612|miguel@restorationrobotics.com|206
283660|NCT00926237|University of Arkansas for Medical Sciences|Dr Mark Mennemeier|205 410 2413|msmennemeier@uams.edu|
283661|NCT00926263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308436|NCT02579382|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
283662|NCT00926289|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283663|NCT00926328|Colgate Palmolive|William De Vizio, DMD|732-878-7901|William_Devizio@colpal.com|
283664|NCT00926367|GlaxoSmithKline|GSK Response Center|866-435-7343||
308437|NCT02579421|University of Minnesota|Dr. Sharon Allen|612-624-0446|allen001@umn.edu|
308438|NCT02579603|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283665|NCT00926380|Massachusetts General Hospital|Natalie David||ndavid2@mgh.harvard.edu|
308439|NCT02579616|Eisai Co.,Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
283666|NCT00926393|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
283667|NCT00926497|Children's Hospital of Lucerne|Martin Stocker, MD|0041412051288|martin.stocker@ksl.ch|
283668|NCT00926536|Stanford University|Dr Nishita Kothary|6504986020|kothary@stanford.edu|
283669|NCT00926588|VA HSRD|Dr. Kurt Kroenke|317-988-3476|kkroenke@regenstrief.org|
283670|NCT00926783|Biosense Webster EMEA|Ellen Harris, Sr. Clinical Research Associate, Clinical Operations|(800) 729-9010|eharris@its.jnj.com|
283671|NCT00926796|University of Arkansas for Medical Sciences|Shelly Lensing|501-686-8203|sylensing@uams.edu|
283672|NCT00926848|UNebraska|Bernice Yates, Principal Investigator|402-861-1713|bcyates@unmc.edu|
283673|NCT00926887|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
283674|NCT00926952|Innovaderm Research Inc.|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
283675|NCT00927069|Innovaderm Research, Inc.|Annie Levesque|514 521 4285|alevesque@innovaderm.ca|222
283676|NCT00927082|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
283677|NCT00927095|University of North Carolina at Chapel Hill|Dr. Susan Girdler|919-966-2179|susan_girdler@med.unc.edu|
283678|NCT00927160|Icahn School of Medicine at Mount Sinai|Dr. William Hung|718-584-9000|william.hung@mssm.edu|
283679|NCT00927186|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
283680|NCT00927251|Medtronic, Bakken Research Center|Model 4296 Left Ventricular (LV) Lead Study Sr. CRS|+31-43-3566602|margriet.kruijshoop@medtronic.com|
283681|NCT00927264|Johns Hopkins University|Cynthia Rand, Ph.D.|410-550-0487|crand@jhmi.edu|
283682|NCT00927355|Emory|Dr. George Beck|404-686-1000|gbeck@emory.edu|
283683|NCT00927368|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
283684|NCT00927394|Novartis Pharmaceuticals|Study Directors|862-778-8300||
283685|NCT00927472|Taro Pharmaceuticals U.S.A.,|Director, Clinical Research|914-345-9001|Natalie.Yantovskiy@Taro.com|
283686|NCT00927485|University of Puerto Rico Medical Sciences Campus|Dr. Marcia Cruz-Correa|787-758-2525|marcia.cruz1@upr.edu|1722
283687|NCT00927563|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
275711|NCT00506155|University of Texas (UT) MD Anderson Cancer Center|Arlene Siefker-Radtke, MD/Associate Professor, Genitourinary Medical Oncology||CR_Study_Registration@mdanderson.org|
275712|NCT00506285|Psychiatry Research Clinic|Barrie K. Marchant|801 585-6663|barriemarchant@aol.com|
275713|NCT00506350|GlaxoSmithKline|GSK Response Center|866-435-7343||
275714|NCT00506389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275715|NCT00506415|Novartis|Study Director|862 778 8300||
275716|NCT00506441|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
275717|NCT00506454|Sepsicure L.L.C.|Vice President|212-606-4352|bianuale@metromediacompany.com|
275718|NCT00506493|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
275719|NCT00506519|LEO Pharma A/S|Disclosure|+45 44 94 58 88|disclosure@leo-pharma.com|
275720|NCT00506597|The University of Texas (UT) MD Anderson Cancer Center|Robert J. Wells, MD / Professor||CR_Study_Registration@mdanderson.org|
275721|NCT00506662|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
275722|NCT00506675|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-975-8690|pedig@jaeb.org|
275723|NCT00506714|Arthritis Foundation|Meika A. Fang, MD|310-478-3711|meika.fang@va.gov|84503
283688|NCT00927576|VANCHCS|Dr. David L. Woods|925-372-2571|dlwoods@ucdavis.edu|
283689|NCT00927589|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
283690|NCT00927758|Sandoz|Study Director|609-627-8889|yaping.zhu@sandoz.com|
283691|NCT00927784|Mount Sinai School of Medicine|Deborah Ascheim, MD, Principal Investigator, Data Coordinating Center|212-659-9567|deborah.ascheim@mssm.edu|
283692|NCT00927810|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
283693|NCT00927823|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283694|NCT00927849|Mansoura university hospital|ayman elnakeeb|0020106752021|elnakeebayman@yahoo.com|
283695|NCT00927862|Intermountain Healthcare|Dr. Jeffrey L. Anderson, Director of CV Research and Professor of Medicine|801-507-4704|jeffrey.anderson@imail.org|
283696|NCT00927888|Stanford University|David Drover, MD|6507250364|ddrover@stanford.edu|
283697|NCT00927901|Novartis Pharmaceuticals|Study Director|862 778-8300||
283698|NCT00927927|Novo Nordisk A/S|Public Access to Clinical Trials||RA-RNDUS-ClinTriDisc@ITS.JNJ.com|
283699|NCT00927940|Medtronic Japan Co.,Ltd|Hiroko Okubo|+81-3-6430-7017|rs.medtroniccardiovascularclinicaltrials@medtronic.com|
283700|NCT00927992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283701|NCT00928018|Dana Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|parmand@partners.org|
283702|NCT00928057|BD Medical, Medical Affairs|Kenneth Kassler-Taub, MD|201 847 6729|kenneth_kassler-taub@bd.com|
269429|NCT00051311|National Cancer Institute|Dr. Ronald Gress|240-760-6167|Ronald_Gress@nih.gov|
283703|NCT00928070|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283704|NCT00928083|Medicines for Malaria Venture|Dr. Joerg Moehrle|+41 22 555 0330|moehrlej@mmv.org|
283705|NCT00928135|University of Iowa|Lakshmi Durairaj|3193537968|lakshmi-durairaj@uiowa.edu|
283706|NCT00928174|The Queen's Medical Center|Sandi Kwee, Principal Investigator|808-691-5466|skwee@queens.org|
283707|NCT00928187|UMI 233 IRD Montpellier|Dr Laura Ciaffi|00237 694926786|lauraciaffi2002@yahoo.fr|
283708|NCT00928200|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
283709|NCT00928252|The Queen's Medical Center|Sandi Kwee, MD, PhD|8086915466|skwee@queens.org|
283710|NCT00928304|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
283711|NCT00928395|Uroplasty, Inc|Clinical Study Manager|952-426-6153|megan.otoole@uroplasty.com|
283712|NCT00928408|Amgen Inc.|Study Director|866-572-6436||
283713|NCT00928421|BTG International Inc|David Wright MB FRCS|610-943-3513|david.wright@btgplc.com|
283714|NCT00928434|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
283715|NCT00928486|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@celgene.com|
283716|NCT00928512|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
283717|NCT00928564|UC Irvine|Dr. Felicia Lane|17144566155|kbacca@uci.edu|
283718|NCT00928642|Madigan Army Medical Center|COL David E. McCune, MD, MC|253-968-1155|david.e.mccune.mil@mail.mil|
283719|NCT00928668|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283720|NCT00928694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
283721|NCT00928707|Italfarmaco SpA|Carlo Bianchini, MD|+39 02 6443 2540|c.bianchini@italfarmaco.com|
269430|NCT00051363|Stanford University|Deborah A. Nichols|208-908-7364|dnichols@cableone.net|
269431|NCT00051558|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
269432|NCT00051636|Novartis|Study Director|862-778-8300||
269433|NCT00052078|Johns Hopkins University|John Walkup|212-746-1891|jtw9001@med.cornell.edu|
269434|NCT00052429|Memorial Sloan Kettering Cancer Center|Dr. Suzanne Wolden|212-639-5148|woldens@mskcc.org|
269435|NCT00052442|Memorial Sloan-Kettering Cancer Center|Owen A. O'Connor, MD, PhD|212-639-8889|oo2130@columbia.edu|
269436|NCT00052715|North American Brain Tumor Consortium|Michael Prados, MD|410-955-8837|jfisher@jhmi.edu|
269437|NCT00052910|Yale Cancer Center|Charles S. Fuchs, MD, MPH|(203) 785-4095|charles.fuchs@yale.edu|
269438|NCT00052962|National Cancer Institute, National Institutes of Health|Marybeth Hughes, M.D.|301-594-9341|hughesm@mail.nih.gov|
269439|NCT00053014|SWOG statistical office|SWOG leukemia statistician|206-667-4408||
269440|NCT00053352|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
269441|NCT00053365|Gynecologic Oncology Group|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
269442|NCT00053417|Acorda Therapeutics|Andrew Blight, PhD|914-347-4300|ablight@acorda.com|102
269443|NCT00053482|Emergent BioSolutions|Eddie Darton, Medical Director|240-631-3688|dartone@ebsi.com|
269444|NCT00053495|Emergent BioSolutions|Eddie Darton, Medical Director|240-631-3688|dartone@ebsi.com|
269445|NCT00053677|University of Chicago|Dr. Jon E. Grant|773-834-1325|jongrant@uchicago.edu|
269446|NCT00053703|UNC Chapel Hill|Linmarie Sikich, MD|919-972-9744|lsikich@med.unc.edu|
269447|NCT00053846|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
269448|NCT00053898|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
269449|NCT00053989|Roswell Park Comprehensive Cancer Center|Theresa Hahn, PhD|716084505819|theresa.hahn@roswellpark.org|
269450|NCT00054028|The Ohio State University Comprehensive Cancer Center|Maryam Lustberg, MD|614-293-0066|Maryam.Lustberg@osumc.edu|
269451|NCT00054132|Memorial Sloan Kettering Cancer Center|Dr. Maura Dickler|646-888-4560|dicklerm@mskcc.org|
269452|NCT00054275|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Paula Silverman, MD|216-844-3951|paula.silverman@uhhospitals.org|
297124|NCT01728337|CBED|Dr Doris Hexsel|30262633|cbed@cbed.com.br|
283722|NCT00928720|University of Virginia School of Nursing|Ann Gill Taylor, Professor Nursing|434-924-0113|agt@virginia.edu|
283723|NCT00928746|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283724|NCT00928772|VAMC|Grigory Chernyak, MD|405-326-1885|grigory.chernyak@va.gov|
283725|NCT00928889|Novartis Pharmaceuticals|Study Director|862 778-8300||
283726|NCT00928954|Case Western Reserve University|R. John Leigh, M.D.|216-844-3190|rjl4@case.edu|
308440|NCT02579629|Emory University|Katherine Egan|404-727-8463|kfegan@emory.edu|
283727|NCT00929071|Susan H. Weinkle, MD|Susan H. Weinkle, MD|941-794-5432|sweinkle@aol.com|
283728|NCT00929110|Novartis Pharmaceuticals|Study Director|862 778-8300||
269453|NCT00054327|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Kenneth Cooke MD|216-844-3345|kenneth.cooke@uhhospitals.org|
283729|NCT00929162|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
283730|NCT00929201|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
283731|NCT00929240|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
283732|NCT00929305|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
283733|NCT00929331|GlaxoSmithKline|GSK Response Center|866-435-7343||
283734|NCT00929344|The Scripps Research Institute|Barbara J. Mason, Ph.D.|858-784-7328|mason@scripps.edu|
283735|NCT00929357|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283736|NCT00929383|Stryker Neurovascular|David Hess, Manager Clinical Affairs|1-510-413-2642|david.hess@stryker.com|
283737|NCT00929500|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
283738|NCT00929526|GlaxoSmithKline|GSK Response Center|866-435-7343||
269454|NCT00054353|Fred Hutch|Marco Mielcarek, MD||mmielcar@fredhutch.org|
283739|NCT00929578|Tufts Medical Center|Alice Gottlieb, MD PhD|617-636-7462|agottlieb@tuftsmedicalcenter.org|
283740|NCT00929643|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283741|NCT00929656|Malcom Randall VAMC|Dr. Dorian Rose, Research Health Scientist|352-376-1611|Dorian.Rose@va.gov|5238
283742|NCT00929669|University of Pennsylvania|Peter J. Snyder, MD|215-898-0208|pjs@mail.med.upenn.edu|
283743|NCT00929695|Fred Hutchinson Cancer Research Center|Marco Mielcarek|206-667-2827|mmielcar@fhcrc.org|
283744|NCT00929708|AstraZeneca|Carin Jorup, MSD||clinicaltrialtransparency@astrazeneca.com|
283745|NCT00929734|University of Oslo|Professor Torbjørn Omland|+47 40107050|torbjorn.omland@medisin.uio.no|
283746|NCT00929773|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
283747|NCT00929838|Medical College of Wisconsin|Jennifer Campbell|414-955-8829|jacampbell@mcw.edu|
283748|NCT00929864|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
292761|NCT01446003|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292762|NCT01446042|Trimel Pharmaceuticals Corp.|Natalia Tkachenko, MD Director Clinical Affairs|9054641755|ntkachenko@trimelpharmaceuticals.com|
269455|NCT00054639|UT MD Anderson Cancer Center|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
269456|NCT00054665|National Cancer Institute, National Institues of Health|Wyndham Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
269457|NCT00054691|University of Texas (UT) MD Anderson Cancer Center|Bonnie Glisson, MD / Professor, Thoracic/Head & Neck Med Oncology|713-792-6363|CR_Study_Registration@mdanderson.org|
269458|NCT00054704|NIMH, DIRP, Experimental Therapeutics and Pathophysiology Branch|Dr. Carlos Zarate|3014510861|zaratec@mail.nih.gov|
269459|NCT00054717|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
269460|NCT00054756|NIDDK|Dr Joanna Klubo-Gwiezdzinska|301-496-1211|joanna.klubo-gwiezdzinska@nih.gov|
269461|NCT00054847|Southern Arizona VA Health Care System|Steven Goldman, MD|(520) 792-1450|Steven.Goldman@va.gov|4624
269462|NCT00055237|National Cancer Institute, National Institutes of Health|Robert Yarchoan, M.D.|301-496-0328|Robert.Yarchoan@nih.gov|
269463|NCT00055471|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
269464|NCT00055497|Abbott|Global Medical Services|800-633-9110||
269465|NCT00055601|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
269466|NCT00055692|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
269467|NCT00056160|Celgene Corporation|Robert Knight, M.D.|908-673-9749|rknight@celgene.com|
269468|NCT00056316|University of Missouri-St. Louis|Ann M. Steffen, PhD, Associate Professor|314-516-5382|ann_steffen@umsl.edu|
269469|NCT00056407|GlaxoSmithKline|GSK Response Center|866-435-7343||
269470|NCT00056472|Weill Cornell Medical College|Barnett S. Meyers, MD|914-997-5721|bmeyers@med.cornell.edu|
275724|NCT00506753|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-5562|lynda_stein@uri.edu|
275725|NCT00506779|University of Texas (UT) MD Anderson Cancer Center|David Gershenson, MD|713-745-2565|DGershen@mdanderson.org|
275726|NCT00506831|Stanford University|Lorinda Chung|650-493-5000|shauwei@stanford.edu|62042
275727|NCT00506857|UT MD Anderson Cancer Center|Richard E. Champlin/Professor||ytdinh@mdanderson.org|
275728|NCT00506883|AR Scientific, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
275729|NCT00506922|UT MD Anderson Cancer Center|Marcos de Lima, MD / Professor|713-745-3219|bmcmullin@mdanderson.org|
275730|NCT00506948|University of Texas (UT) MD Anderson Cancer Center|Amin Alousi, MD /Professor, Stem Cell Transplantation|713-745-8613|aalousi@mdanderson.org|
292763|NCT01446159|MedImmune, LLC|Shahram Rahimian|+1-800-236-9933|information.center@astrazeneca.com|
292764|NCT01446237|GlaxoSmithKline|GSK Response Center|866-435-7343||
292765|NCT01446289|Novartis vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
292766|NCT01446419|Relievant Medsystems, Inc.|V.P. of Clinical & Regulatory Affairs|650-261-2259|lhook@relievant.com|
283749|NCT00929981|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283750|NCT00929994|Toronto Rehab|Dr.|4169781739|dina.brooks@utoronto.ca|
283751|NCT00930046|Boston Children's Hospital|Dr. Navil Sethna|781-216-1650|navil.sethna@childrens.harvard.edu|
283752|NCT00930059|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283753|NCT00930176|Bio Products Laboratory|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
283754|NCT00930293|University of Pittsburgh|Jill M. Cyranowski, PhD|412-246-5588|cyranowskijm@upmc.edu|
283755|NCT00930553|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
283756|NCT00930644|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
283757|NCT00930761|Instituto de Puericultura e Pediatria Martagão Gesteira - UFRJ|Dr. Arnaldo Prata Barbosa|+55 21 25904891|arnaldoprata@globo.com|
283758|NCT00930774|National Center for Rehabilitative Auditory Research, Portland VA Medical Center|Dr. Gabrielle H Saunders|503-220-8262|gabrielle.saunders@va.gov|56210
283759|NCT00930813|Lutonix Inc. a subsidiary of C.R. Bard|Chris Barry|763-445-2352|LutonixResearch@crbard.com|
297125|NCT01728376|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297126|NCT01728454|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
297127|NCT01728584|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297128|NCT01728623|Eisai Inc.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
297129|NCT01728636|Northwestern University|Luanne Carabini MD|312-695-0061|l-carabini@northwestern.edu|
297130|NCT01728779|Johns Hopkins University|Dana Kaplin|410-614-3950|dkaplin1@jhmi.edu|
308441|NCT02579759|Pharnext|Susanne Dorn|+33 (0)1 41 09 22 30|contact@pharnext.com|
308442|NCT02579772|Queen's University|Dr. J. Alberto Neder|613-548-2255|nederalb@gmail.com|
308443|NCT02579811|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Moshe Ornstein|1-866-223-8100|TaussigResearch@ccf.org|
308444|NCT02579863|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308445|NCT02579876|The Children's Hospital of Philadelphia|Jonathan Spergel|215 590 1000|spergel@email.chop.edu|
308446|NCT02579915|McLean Hospital|Courtney Beard|16178553557|CBEARD@MCLEAN.HARVARD.EDU|
308447|NCT02579928|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
308448|NCT02580058|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269471|NCT00056498|Maryland Psychiatric Research Center|Robert W. Buchanan, MD|410-402-7876|rwbuchanan@mprc.umaryland.edu|
275731|NCT00507026|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269472|NCT00056550|GTC Biotherapeutics|Denise Tilton, RN, MHA, Director Clinical Development|508-370-5257|denise.tilton@gtc-bio.com|
269473|NCT00056563|Center for Management of Complex Chronic Care|Frances M. Weaver, Ph.D, Study Investigator|(708) 202-2414|Frances.Weaver@va.gov|
269474|NCT00056862|National Institute of Diabetes and Digestive and Kidney Diseases|Jay H. Hoofnagle, M.D.|3014961333|hoofnaglej@extra.niddk.nih.gov|
269475|NCT00057330|GlaxoSmithKline|GSK Response Center|866-435-7343||
269476|NCT00057551|Weill Cornell Medical College|James H. Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
269477|NCT00057577|Vanderbilt University|Dr. Steven D. Hollon|615-322-3369|steven.d.hollon@vanderbilt.edu|
275732|NCT00507130|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
275733|NCT00507208|University of Alabama at Birmingham|William Carroll, MD|205-934-9713|wcarroll@uabmc.edu|
275734|NCT00507416|Millennium Pharmaceuticals Inc|Medical Director|1-800-778-2860|clinicaltrialregistry@tpna.com|
275735|NCT00507429|OXiGENE, Inc.|Peter Langecker, MD, PhD|650 635 7008|plangecker@oxigene.com|
275736|NCT00507442|Millennium Pharmaceuticals, Inc|Dixie-Lee Esseltine, MD|(617) 679-7000||
275737|NCT00507455|Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
283760|NCT00930930|Vanderbilt-Ingram Cancer Center|Dr. Ingrid Mayer|615-936-2033|ingrid.mayer@vanderbilt.edu|
283761|NCT00930969|Medtronic Cardiac Rhythm Disease Management|ST Detect Study Team|1-800-328-2518|medtronicCRMtrials@medtronic.com|
283762|NCT00930982|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
283763|NCT00931164|University of Utah|Dr. Kathryn Swoboda|801-585-9717|taran@genetics.utah.edu|
283764|NCT00931242|Tufts Medical Center|Alice B Gottlieb, MD, PhD|617 636 4802|agottlieb@tuftsmedicalcenter.org|
283765|NCT00931255|UMaryland|Abdolreza Haririan, MD|410-328-5720|ahariria@medicine.umaryland.edu|
283766|NCT00931268|Q-Med AB|Head of Clinical Development|+46 (0)18 4749000|reception.SEUPP@galderma.com|
283767|NCT00931307|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
297131|NCT01728792|Takeda|Takeda Study Registration Call Center, Central Contact|+1-877-825-3327|medicalinformation@tpna.com|
283768|NCT00931359|Miramar Labs|Kathy O'Shaughnessy, PhD|408-940-8700|kathyo@miramarlabs.com|
283769|NCT00931385|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283770|NCT00931411|Innovaderm Research|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
269478|NCT00057681|Washington University in St. Louis|Barbara Geller, M.D.|314-747-3657|gellerb@wustl.edu|
283771|NCT00931463|The Kirby Institute|Prof Sean Emery|+61293850900|semery@kirby.unsw.edu.au|
283772|NCT00931489|University of California Davis, Department of Ophthalmology & Vision Science|Lawrence S. Morse, MD, PhD|916 734 6074|lsmorse@ucdavis.edu|
283773|NCT00931515|Pioneer Surgical Technology|Director of Regulatory and Clinical Affairs|906-225-5602|emilydowns@pioneersurgical.com|
283774|NCT00931528|NRG Onoclogy|Wendy Seiferheld||seiferheldw@nrg.oncology.org|
283775|NCT00931632|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
283776|NCT00931710|Novartis Pharmaceuticals|Study Director|862-778-8300||
283777|NCT00931723|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
283778|NCT00931762|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
283779|NCT00931801|Community Research Initiative of New England|Calvin J. Cohen MD, MSc, Director of Research|617-502-1700|ccohen@crine.org|
283780|NCT00931879|Eastern Virginia Medical School|Dr. Henri Parson|(757)446-7976|parsonhk@evms.edu|
283781|NCT00931892|Beth Israel Deaconess Medical Center|Dr. Ciaran Kelly|617-667-1272|ckelly2@bidmc.harvard.edu|
283782|NCT00931918|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
283783|NCT00931944|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
297132|NCT01728805|Kyowa Kirin Inc|Fiona Herr, Associate Director, Medical Communications|1 (908) 234-1096|medinfo-US@kyowakirin.com|
297133|NCT01728844|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
297134|NCT01729026|South Texas Veterans Health Care System; University of Texas Health Science Center at San Antonio|Dr. Stephen Stern|210-887-3754|stephen.stern@va.gov; sterns@uthscsa.edu|
297135|NCT01729039|James H Quillen VAMC|Dr. Courtney Hall|423-926-1171|courtney.hall@va.gov|7518
308449|NCT02580188|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|
308450|NCT02580201|FIDEC Corporation|Ricardo Rüttimann|+17863546335|rruttimann@fidec-online.org|
308451|NCT02580240|Subei People's Hospital|QQLv|18051063899|bonhomie2014@163.com|
308452|NCT02580318|St. Luke's University Health Network|Holly Stankewicz, D.O.|610-360-2725|holly.stankewicz@gmail.com|
308453|NCT02580357|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
308454|NCT02580591|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308455|NCT02580799|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
308456|NCT02580877|Benaroya Research Institute|Carla Greenbaum, MD|1-800-425-8631|cjgreen@benaroyaresearch.org|
269479|NCT00057746|NRG Onoclogy|Wendy Seiferheld||seiferheldw@nrg.oncology.org|
269480|NCT00057785|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
269481|NCT00057811|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
269482|NCT00057837|ECOG Statistical Office|Study Statistician|617-632-3012||
269483|NCT00057863|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
269484|NCT00057876|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
269485|NCT00057941|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
269486|NCT00057954|ECOG Statistical Office|Study Statistician|617-632-3012||
269487|NCT00058019|University of Chicago Medical Center|Dr. Sonali M. Smith|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
269488|NCT00058058|American College of Radiology Imaging Network|Senior Director of Protocol Management||Donna Hartfeil <dhartfeil@acr.org>|
269489|NCT00058123|North American Brain Tumor Consortium|Susan Chang, MD|410-955-8837|jfisher@jhmi.edu|
269490|NCT00058214|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
269491|NCT00058240|The Ohio State University Comprehensive Cancer Center|John Byrd, MD|614-293-3196|John.Byrd@osumc.edu|
269492|NCT00058370|Memorial Sloan Kettering Cancer Center|Dr. Ira Dunkel, MD|212-639-2153|dunkeli@mskcc.org|
269493|NCT00058422|Memorial Sloan Kettering Cancer Center|Paul A. Hamlin, M.D.|646-608-1667|hamlinp@mskcc.org|
269494|NCT00058539|Hoffmann-LaRoche|Medical Communications|: 800-821-8590|genentech@druginfo.com|
269495|NCT00058552|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
269496|NCT00058825|Baylor College of Medicine|George Carrum, MD||GCarrum@houstonmethodist.org|
269497|NCT00059202|Mayo Clinic|Dr. Keith Lindor|507-284-2511||
269498|NCT00059215|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
269499|NCT00059228|National Institute of Mental Health|Schmidt, Peter|+1 301 496 6120|peterschmidt@mail.nih.gov|
269500|NCT00059332|UCLA, David Geffen School of Medicine|Dr. Jeffrey Saver|310-794-6379|jsaver@mednet.ucla.edu|
283784|NCT00931996|Ullinois|Dr. Jeffrey Bishop|312-413-3495|jbishop@uic.edu|
283785|NCT00932022|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
283786|NCT00932035|City of Hope|Carolyn Behrendt, Ph.D.|(626)359-8111|Cbehrendt@coh.org|61148
283787|NCT00932113|Tufts Medical Center|Nicole Dumont|617 636 7462|ndonovan1@tuftsmedicalcenter.org|
283788|NCT00932126|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297136|NCT01729156|Department of Nuclear Medicine & PET Centre, Aarhus University Hospital|Lars C. Gormsen, Consultant|004578456260|lars.christian.gormsen@clin.au.dk|
283789|NCT00932165|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
283790|NCT00932282|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
283791|NCT00932321|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
283792|NCT00932360|University of Iowa|Dana Dailey|319-335-7149|dana-dailey@uiowa.edu|
283793|NCT00932373|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
297137|NCT01729208|CooperVision Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
283794|NCT00932399|Seattle Epidemiologic Research and Information Center|Alyson Littman|206-277-4182|alyson.littman@va.gov|
297138|NCT01729247|Aerocrine, Inc.|Nancy Herje, BSN, RN, MBA|919-449-8873|Nancy.Herje@aerocrine.com|
297139|NCT01729338|Duke University Medical Center|Gwynn Long|919-668-0838|gwynn.long@duke.edu|
297140|NCT01729494|University of Cincinnati|Rita R. Alloway, Pharm.D., Director of Clinical Trials|513-558-1568|rita.alloway@uc.edu|
283795|NCT00932425|University of California San Francisco|Wade Smith, MD, PhD|415-353-8897|smithw@neurology.ucsf.edu|
283796|NCT00932438|University of Louisville|Robert Martin, Md, PhD|602-629-3355|robert.martin@louisville.edu|
283797|NCT00932451|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283798|NCT00932477|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
283799|NCT00932620|University of Ioannina|Prof Moses Elisaf|+302651007509|egepi@cc.uoi.gr|
283800|NCT00932646|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283801|NCT00932659|Duke University|Patrick Pun, MD, MHS|919-660-6865|patrick.pun@duke.edu|
283802|NCT00932698|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
283803|NCT00932828|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
283804|NCT00932893|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283805|NCT00933166|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
283806|NCT00933244|University of Wisconsin - School of Medicine & Public Health|Dr. Karen E Hansen|608-265-8162|keh@medicine.wisc.edu|
283807|NCT00933270|Abbott Vascular|Margo Zaugg|408-845-0576|margo.zaugg@av.abbott.com|
269501|NCT00059475|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-6375|nciirbadmin@mail.nih.gov|
269502|NCT00059787|Montefiore Medical Center - New York Cancer Consortium|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
269503|NCT00059839|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
269504|NCT00060008|Children's Hospital of Philadelphia|Dr. Michael Fisher|215 590 2800|fisherm@email.chop.edu|
269505|NCT00060333|Mayo Clinic|Barbara A. Pockaj, MD|507/284-3559|pockaj.barbara@mayo.edu|
269506|NCT00060346|ECOG Statistical Office|Study Statistician|617-632-3012||
269507|NCT00060424|Fred Hutch|David G Maloney, MD PhD||dmaloney@fredhutch.org|
269508|NCT00060528|National Cancer Instititute (NCI), National Institutes of Health (NIH)|James L. Gulley, M.D.|301-435-2956|gulleyj@mail.nih.gov|
269509|NCT00060606|George Washington University Biostatistics Center|Dr. Elizabeth A Thom|301-881-9260|e_thom@bsc.gwu.edu|8035
269510|NCT00060840|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
269511|NCT00060944|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
269512|NCT00061048|National Cancer Institute, National Institutes of Health|Thomas A. Waldmann, M.D.|301-496-6653|Thomas.Waldmann2@nih.gov|
269513|NCT00061373|NIH/NINDS and University of Texas Southwestern, Clinical Research Institute of Austin|Steven Warach, MD, PhD; Principal Investigator|512-324-8383|swarach@seton.org|
269514|NCT00061633|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
269515|NCT00061893|Children's Oncology Group|Results Reporting Coordinator||resultsreportingcoordinator@childrensoncologygroup.org|
269516|NCT00061932|Montefiore Medical Center|Rutvi Patel|718-379-6861|rupatel@montefiore.org|
269517|NCT00061945|University of Chicago Medical Center|Wendy Stock, M.D.||wstock@medicin.bsd.uchicago.edu|
269518|NCT00062010|ECOG Statistical Office|Study Statistician|617-632-3012||
269519|NCT00062166|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
269520|NCT00062374|Memorial Sloan-Kettering Cancer Center|Dr. David P. Kelsen|646-888-4179|kelsend@mskcc.org|
269521|NCT00062439|SWOG Statistical Center|Lung Committee Statistician|206-667-4623||
269522|NCT00062647|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
269523|NCT00062738|UMDNJ - RWJMS|Matthew Menza, MD|732-235-4440|menza@umdnj.edu|
269524|NCT00062764|National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health|Jay H. Hoofnagle, MD|3014961333|hoofnaglej@extra.niddk.nih.gov|
269525|NCT00062868|Baylor College of Medicine|Dr. Helen E. Heslop|832-824-4662|hheslop@bcm.edu|
269526|NCT00063154|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
269527|NCT00063232|National Institute of Diabetes and Digestive and Kidney Diseases|Jay Hoofnagle, M.D.|3014961333|hoofnaglej@extra.niddk.nih.gov|
269528|NCT00063258|University of Texas M.D. Anderson Cancer Center|Mellanie Price, B.S.|713-792-4392|mejprice@mdanderson.org|
283808|NCT00933335|GlaxoSmithKline|GSK Response Center|866-435-7343||
269529|NCT00063362|University Hospitals Case Medical Center|Dr. Keming Gao|216-844-2865|keming.gao@UHhospitals.org|
283809|NCT00933491|University of Michigan|Tae-Ju Oh|734-647-3320|taejuoh@umich.edu|
283810|NCT00933543|Photocure|Project director Per Fuglerud|+47 22 06 16 54|pf@photocure.no|
269530|NCT00063570|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
283811|NCT00933608|NYU School of Medicine|Lidia Glodzik|212.263.5698|Lidia.Glodzik@nyumc.org|
283812|NCT00933686|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
283813|NCT00933933|Abbott Diagnostic Division|Barbara Kaesdorf, Associate Director Clinical Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
269531|NCT00063622|Virginia Commonwealth University|Arun J. Sanyal||asanyal@mcvh-vcu.edu|
283814|NCT00934024|MUSC|Dr. Karen Hartwell|843-792-8174|hartwelk@musc.edu|
283815|NCT00934050|Transition Therapeutics Ireland Limited and Transition Therapeutics USA Inc.|Susan Abushakra, MD, Chief Medical Officer|+1 650 425 6370|susan.abushakra@tthi.us|
283816|NCT00934089|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283817|NCT00934102|University of Waterloo|Craig Woods, PhD, FAAO / Research Manager|1-519-888-4742|cclr2@uwaterloo.ca|
283818|NCT00934128|The University of Texas (UT) MD Anderson Cancer Center|David Hui, MD, MSc, FRCPC||HMoreno@mdanderson.org|
283819|NCT00934141|University of Wisconsin - Madison|Dr. David H Gustafson|608-890-1436|dhgustaf@wisc.edu|
283820|NCT00934362|University of North Carolina at Chapel Hill|Dr. Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
283821|NCT00934375|Eisai Inc.|Anita Murthy, Study Director|201-692-1100||
283822|NCT00934440|University of Kansas Cancer Center|Dr. Peter Van Velduizen|(913) 945-5059|SWILLIAM@kumc.edu|
283823|NCT00934544|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
283824|NCT00934596|Cardiothoracic Surgery, Skåne University Hospital Lund|Dr. Bansi Koul MD, PhD, Principal Investigator|+46 46 171649|bansi.koul@skane.se|
283825|NCT00934622|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
283826|NCT00934635|Janssen Cilag|Medical Development Manager; Medical and Scientific Affairs|0049-2137-955-1240||
283827|NCT00934648|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
283828|NCT00934661|Anesthesiology|Dr. Pamela Nagle Assistant Professor|336-716-7180||
283829|NCT00934843|Medical University of South Carolina|Dr. Eric Graham|843-792-8704|grahamem@musc.edu|
283830|NCT00934856|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
283831|NCT00934934|CERU Queens University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
283832|NCT00934947|UNC Department of Anesthesiology|Samuel McLean|919-966-7315|smclean@aims.unc.edu|
283833|NCT00935012|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283834|NCT00935064|University of Delaware/Christiana Care Health System|Dr. Raelene E. Maser|302-831-8400|rmaser@udel.edu|
283835|NCT00935220|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283836|NCT00935259|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297141|NCT01729559|Scripps Mercy Hospital|Steven R. Shackford, MD|619-299-2600|shackford.steven@scrippshealth.org|
297142|NCT01729598|University of Kentucky|Dr. Gregory A. Jicha|859-323-5550|gregory.jicha@uky.edu|
269532|NCT00063635|Columbia University Medical Center|Joel E. Lavine, MD, PhD||jl3553@columbia.edu|
269533|NCT00063882|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
269534|NCT00063934|UTMDACC|Francisco Esteva, MD, PHD / Professor|713-792-2817|Francisco.Esteva@nyumc.org|
269535|NCT00063986|ECOG Statistical Office|Study Statistician|617-632-3012||
269536|NCT00063999|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD.|716-545-8321|lgedeon@gogstats.org|
269537|NCT00064025|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@norgoncology.org|
269538|NCT00064038|SWOG|Robert Z. Orlowski, MD, PhD|(713) 792-2860|rorlowsk@mdanderson.org|
269539|NCT00064077|NRG Oncology|Angela Kuras on behalf of Michael Sill and Helen Huang|716-845-5702|kurasa@nrgoncology.org|
269540|NCT00064259|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-405-8404|jsparano@montefiore.org|
269541|NCT00064298|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
269542|NCT00064337|SWOG Statistical Center|Study Statistician|206-667-4623||
269543|NCT00064350|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
269544|NCT00064662|New England Research Institutes|Anne M. Stoddard, ScD|617-972-3331|astoddard@neriscience.com|
269545|NCT00064701|Astellas Pharma Global Development, Inc.|Vice President, Therapeutic Area Head, Transplantation||ClinicalTrials.Disclosure@us.astellas.com|
269546|NCT00064753|University of North Carolina at Chapel Hill|Dr. Myra Carpenter|9199429408|myra_carpenter@unc.edu|
269547|NCT00064792|NICHD, NIH|Dr. Forbes Porter, Clinical Director, NICHD|301-435-4432|fdporter@mail.nih.gov|
269548|NCT00064844|Yale University School of Medicine|Ned Cooney, PhD|860-594-6339|ned.cooney@yale.edu|
269549|NCT00064987|Massachusetts General Hospital|Dr. William Crowley|617-724-2470|wcrowley@partners.org|
269550|NCT00065065|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
275738|NCT00507507|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
275739|NCT00507546|VAPAHCS|Dr. Jamie Zeitzer|6504935000|jzeitzer@stanford.edu|62410
275740|NCT00507559|Medtronic Endovascular|Kristin Schwartz|(763) 514-4000|kristin.schwartz@medtronic.com|
275741|NCT00507689|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
275742|NCT00507728|UT MD Anderson Cancer Center|Paul M Cinciripini, MD, Chair, Behavioral Science|(713) 745-1868|pcinciri@mdanderson.org|
275743|NCT00507767|MD Anderson Cancer Center|Dr. Vassiliki Papadimitrakopoulou, Professor|713-792-6363|vpapadim@mdanderson.org|
283837|NCT00935272|Medicis Global Services|Heather M Corey|480-291-5981|hcorey@medicis.com|
283838|NCT00935311|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
283839|NCT00935428|OHSU|Dr. John Mayberry|503-494-5300|mayberrj@ohsu.edu|
283840|NCT00935493|Yale University|Christopher van Dyck|203-764-8100|christopher.vandyck@yale.edu|
283841|NCT00935532|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
283842|NCT00935584|VA san Diego Healthcare System|Dr. Zia Agha|8586421295|zia.agha@va.gov|
283843|NCT00935701|Kennedy Krieger Institute|Lana Warren|4439239312|WarrenL@kennedykrieger.org|
283844|NCT00935766|Denver Health Medical Center|Carlin Long, MD|303-602-3899|carlin.long@dhha.org|
283845|NCT00935792|Mayo Clinic|Timothy Call, M.D.|5076682050|Call.Timothy@mayo.edu|
283846|NCT00935818|Mayo Clinic|Dr. Jon Ebbert|507-284-4736|ebbert.jon@mayo.edu|
283847|NCT00935857|Northwestern University|Rajesh N. Keswani|312-695-5620|raj-keswani@northwestern.edu|
283848|NCT00935883|University of Miami Miller School of Medicine|Philip J Rosenfeld|305-326-6148|prosenfeld@med.miami.edu|
292767|NCT01446666|Asan Medical Center, University of Ulsan College of Medicine|Professor Young-Suk Lim|+82-02-3010-5933|limys@amc.seoul.kr|
292768|NCT01446705|Center for Health Information and Communication, Roudebush VA Medical Center|Dr. David A. Haggstrom|317-988-2067|dahaggst@iu.edu|
292769|NCT01446809|University of Washington|Dr Darin Davidson|206-543-3690|djdavi@uw.edu|
292770|NCT01446874|Washington University School of Medicine|Varun Puri, M.D.|314-362-4191|varunpuri@wustl.edu|
297143|NCT01729728|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
292771|NCT01446913|Yale University School of medicine|Henry Klar Yaggi, MD (PI)|203-785-4163|henry.yaggi@yale.edu|
308457|NCT02581111|Washington University in St. Louis School of Medicine|Dr. Rajat Dhar|3143622999|dharr@neuro.wustl.edu|
292772|NCT01446965|University of California, San Francisco|Jeffrey Olgin, MD|415-476-1000|jeffrey.olgin@ucsf.edu|
292773|NCT01447017|Centre for Clinical Studies in Malmö|Dr. Pekka Koskinen|+46 (0)40 97 12 60|pekka@clsm.se|
292774|NCT01447121|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3062|carmine.greene@ascensia.com|
292775|NCT01447225|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
308458|NCT02581163|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
292776|NCT01447407|NovaDigm Therapeutics, Inc.|John P. Hennessey, Jr.|12676405189|john_hennessey@novadigm.net|
292777|NCT01447420|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
292778|NCT01447433|Changhai Hospital|Prof. Donglian Cai|86 21 81873168|nutrition1226@126.com|
292779|NCT01447446|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
292780|NCT01447511|University of Minnesota|Dr. Richard Brundage|612-624-3115|brund001@umn.edu|
292781|NCT01447576|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
292782|NCT01447706|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
292783|NCT01447719|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
292784|NCT01447849|TexasTech|Dr. Jerzy Sarosiek, Director, Mol. Medicine Research|915-215-5255|jerzy.sarosiek@ttuhsc.edu|
292785|NCT01447888|Allina Health|John Mrachek, MD|612-871-7639|John.Mrachek@allina.com|
292786|NCT01447914|University of Texas (UT) MD Anderson Cancer Center|Robert Orlowski, MD, PhD / Professor, Department of Lymphoma/Myeloma|713-792-2860|ROrlowski@mdanderson.org|
292787|NCT01447927|University Hospitals of Cleveland, Case Medical Center|Dr. Amitabh Chak|216-844-5385|Amitabh.chak@case.edu|
269551|NCT00065156|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
269552|NCT00065182|GlaxoSmithKline|GSK Response Center|866-435-7343||
269553|NCT00065260|NIH NHLBI|Dr. Bhavisha Patel|301.402.3477|bhavisha.patel@nih.gov|
269554|NCT00065429|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
269555|NCT00065442|Dendreon Corporation|Kathleen Picha|206-274-6762|kpicha@dendreon.com|
269556|NCT00065468|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269557|NCT00065507|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
269558|NCT00065611|NIDDK, NIH|Jeffrey B Kopp, MD|3015943403|jbkopp@nih.gov|
269559|NCT00065806|Duke University Medical Center|Laura Schanberg, MD|919-684-6575|laura.schanberg@duke.edu|
269560|NCT00066066|The Forsyth Institute|Ricardo P Teles, DDS, DMSc|617 892-8556|rteles@forsyth.org|
269561|NCT00066170|Jazz Pharmaceuticals, Inc|Grace Wang, MD Director of Clinical Development & Medical Monitor|650-496-3777||
269562|NCT00066222|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
269563|NCT00066365|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
269564|NCT00066469|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
269565|NCT00066573|NCIC Clinical Trials Group|Dr. Wendy Parulekar|1-613-533-6430|wparulekar@ctg.queensu.ca|
269566|NCT00066677|Fox Chase Cancer Center|Steven J. Cohen|215-728-2450|s_cohen@fccc.edu|
269567|NCT00066690|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
269568|NCT00066703|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
269569|NCT00066729|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
269570|NCT00066742|SWOG Statistical Center|Lung Committee Statistician|206-652-2267||
269571|NCT00066781|Mayo Clinic|Matthew Goetz, M.D.|(507) 284-2511|goetz.matthew@mayo.edu|
297144|NCT01729819|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
269572|NCT00066937|Johns Hopkins University|Jennifer Haythornthwaite|410-550-7985|jhaytho1@jhmi.edu|
269573|NCT00066963|Professor, S/D- PREV/REST|Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
283849|NCT00936065|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283850|NCT00936117|University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia Department|713-745-2723|CR_Study_Registration@mdanderson.org|
283851|NCT00936208|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
283852|NCT00936221|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
283853|NCT00936299|University of Colorado Denver|Paula Riggs, MD|303.724.2235|paula.riggs@ucdenver.edu|
283854|NCT00936351|Roudebush VA Medical Center|Louanne W. Davis PsyD|317-988-4523|louanne.davis@va.gov|
283855|NCT00936377|University of Colorado|Robert MacLaren|303 724-2622|rob.maclaren@ucdenver.edu|
283856|NCT00936455|University of California San Diego|Dr Brett Meyer|619-543-7760|bcmeyer@ucsd.edu|
283857|NCT00936481|Vanderbilt Universit|Kanika Bagai, MD, Assistant Professor|6153220283|kanika.bagai@vanderbilt.edu|
283858|NCT00936611|Dana-Farber Cancer Institute|Irene Ghobrial|6176324101|irene_ghobrial@dfci.harvard.edu|
283859|NCT00936663|University of Nebraska Medical Center|Vijay Shivaswamy|402-559-6208|vshivaswamy@unmc.edu|
283860|NCT00936702|Mayo Clinic|Matthew P. Goetz, M.D.|507 284-2511|goetz.matthew@mayo.edu|
283861|NCT00936715|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
269574|NCT00067002|UT MD Anderson Cancer Center|Simrit Parmar, MD/Associate Professor, Stem Cell Transplantation|713-792-7734|SParmar@mdanderson.org|
283862|NCT00936741|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
283863|NCT00936858|Dana-Farber Cancer Institute|Dr. Glenn Hanna|6176323090|glenn_hanna@dfci.harvard.edu|
283864|NCT00936884|Salix Pharmaceuticals|David Sorscher|919-862-1827|david.sorscher@salix.com|
283865|NCT00936897|Amgen Inc.|Study Director|866-572-6436||
283866|NCT00936910|Children's Hospital of Pittburgh|Dr. William McGhee, Clinical Pharmacy Specialist, Transplant|412-692-5733|william.mcghee@chp.edu|
283867|NCT00936975|ECOG-ACRIN Cancer Research Group|Results Reporting Statistician|401-863-9188|bherman@stat.brown.edu|
283868|NCT00937040|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
283869|NCT00937105|University Hospitals Eye Institute|Loretta Szczotka-Flynn OD, PhD|216-844-3609|loretta.szczotka@uhhospitals.org|
283870|NCT00937118|Oregon Health & Science University|John Mayberry, MD|503-494-5300|mayberrj@ohsu.edu|
283871|NCT00937157|Buffalo Neuroimaging Analysis Center|Robert Zivadinov, MD, PhD|716-859-7040|rzivadinov@bnac.net|
283872|NCT00937235|University of Pennsylvania|Dr. Edna Foa|2157463327|foa@mail.med.upenn.edu|
283873|NCT00937326|GlaxoSmithKline|GSK Response Center|866-435-7343||
283874|NCT00937378|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
283875|NCT00937391|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
283876|NCT00937404|GlaxoSmithKline|GSK Response Center|866-435-7343||
283877|NCT00937495|University of Wisconsin|Steven Attia, D.O.||sa2@medicine.wisc.edu|
283878|NCT00937521|Novartis Vaccines|Novartis Vaccines||RegistryContactVaccinesUS@novartis.com|
283879|NCT00937547|Instituto de Oncología Dr. Luis Razetti, Caracas Venezuela|Dr. Jorge Sánchez-Lander Corresponding Author|582129870165|animamotrix@live.com|
283880|NCT00937560|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
269575|NCT00067028|The University of Texas M. D. Anderson Cancer Center|Hagop M Kantarjian,MD/Chair, Leukemia|(713) 792-7026|hkantarjian@mdanderson.org|
269576|NCT00067236|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
269577|NCT00067470|BioMarin Pharmaceutical Inc.|Medical Information Services|800-983-4587|medinfo@bmrn.com|
275744|NCT00507819|The Children's Hospital of Philadelphia|David J. Goldberg, MD|267-426-8143|goldbergda@email.chop.edu|
275745|NCT00508001|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
275746|NCT00508027|Children's Hospital & Research Center Oakland|Dr. Carolyn Hoppe, Principal Investigator|(510)428-3193|choppe@mail.cho.org|
275747|NCT00508105|Ottawa Hospital Research Institute|Peter Lapner|613-737-8899|plapner@toh.ca|74700
275748|NCT00508118|Duke University Medical Center|Andrew Shaw MD|919 286 6938|andrew.shaw@duke.edu|
275749|NCT00508144|The University of Texas (UT) MD Anderson Cancer Center|Ralph Zinner, MD/Thoracic & Head and Neck Medicine|713-792-7734|CR_Study_Registration@mdanderson.org|
297145|NCT01729845|Fred Hutch Cancer Research Center|Dr. Anna Halpern|2066676233|halpern2@uw.edu|206
275750|NCT00508157|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
275751|NCT00508183|Ottawa Hospital Research Institute|Dr. Peter Lapner|613-737-8899|plapner@toh.ca|74700
275752|NCT00508196|University of Dundee|DR Anna Maria Choy|01382 383482|a.choy@dundee.ac.uk|
275753|NCT00508261|GlaxoSmithKline|GSK Response Center|866-435-7343||
275754|NCT00508274|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
275755|NCT00508300|lausanne university hospital|martin hübner|+41795561506|martin.hubner@chuv.ch|
275756|NCT00508391|BIOTRONIK, Inc.|Clay Cohorn|503-387-2614|clay.cohorn@biotronik.com|
275757|NCT00508404|Amgen Inc.|Study Director|866-572-6436||
275758|NCT00508469|Alcon France|Severine Durier, PharmD|+33 1 47 10 48 43||
275759|NCT00508482|Guang'anmen Hospital Affiliated to China Academy of Chinese Medical Sciences|Dr. Zhishun Liu|0086-010-88001124|liuzhishun@aliyun.com|
275760|NCT00508521|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center|(352) 376-1611|janis.daly@neurology.ufl.edu|6603
275761|NCT00508651|MedImmune, LLC|Judith Falloon, MD|301 398 0000|falloonj@medimmune.com|
275762|NCT00508716|Griffin Hospital|Dr. Dorothea Wild|203 7327327|dwild@griffinhealth.org|
275763|NCT00508742|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275764|NCT00508755|Malcom Randall VA Medical Center, Gainesville Florida|Janis Daly, Ph.D., M.S.; Director, Brain Rehabilitation Research Center of Excellence|(352) 376-1611|janis.daly@neurology.ufl.edu|5223
275765|NCT00508820|Amgen Inc.|Study Director|866-572-6436||
283881|NCT00937768|Mayo Clinic|Dr. R. Jeffrey Karnes|507 284-4430|Karnes.R@mayo.edu|
283882|NCT00937794|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
283883|NCT00937833|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@CookBiotech.com|
283884|NCT00937859|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
308459|NCT02581189|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
283885|NCT00937950|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
283886|NCT00938015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283887|NCT00938041|GlaxoSmithKline|GSK Response Center|866-435-7343||
283888|NCT00938314|Stem Cell Therapeutics Corp.|Chief Scientific Officer|403.245.5495|adavidoff@stemcellthera.com|226
283889|NCT00938327|GlaxoSmithKline|GSK Response Center|866-435-7343||
283890|NCT00938340|Penn State University|Penny Kris-Etherton||pmk3@psu.edu|
283891|NCT00938366|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
283892|NCT00938392|GlaxoSmithKline|GSK Response Center|866-435-7343||
283893|NCT00938431|UCB|Study Director|+1877 822 9493||
283894|NCT00938457|Mayo Clinic|Dr. Robert C. Miller|507-284-2669|miller.robert@mayo.edu|
283895|NCT00938470|Mayo Clinic|Steven R Alberts MD MPH|507-284-4918|alberts.steven@mayo.edu|
283896|NCT00938548|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Department of surgery, Yonsei University College of Medicine|Dr. So Yeon Kim|82-2-2227-3642|kimsy326@hanmail.net|
283897|NCT00938639|Seqirus|Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
283898|NCT00938704|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
283899|NCT00938717|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
283900|NCT00938782|Stanford University|Dr. David R Drover|650-725-0364|ddrover@stanford.edu|
283901|NCT00938860|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
283902|NCT00938886|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
283903|NCT00938964|Duke University Health System|Joseph Mathew, M.D|919-681-6646|joseph.mathew@duke.edu|
283904|NCT00939003|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
283905|NCT00939029|Mayo Clinic|Dr. Jon Ebbert|507-284-4736|ebbert.jon@mayo.edu|
283906|NCT00939055|EndoGastric Solutions|Senior Director Clinical Affairs|650-823-9093|gsahyun@endogastricsolutions.com|
283907|NCT00939094|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
283908|NCT00939107|Back and Rehabilitation Center Copenhagen|Tom Petersen|+45 35304974|tom.petersen@suf.kk.dk|
283909|NCT00939120|Research institute at Deaconess Clinic|Dr. Paul Siami|812-426-9548|paul.siami@deaconess.com|
283910|NCT00939159|UT MD Anderson Cancer Center|Guillermo Garcia-Manero, MD / Associate Professor|713-792-7305|eharriso@mdanderson.org|
283911|NCT00939185|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
283912|NCT00939198|George Washington University|Dr. David Diemert|2029942909|ddiemert@gwu.edu|
283913|NCT00939211|AstraZeneca|Gerard Lynch|+441509645895|clinicaltrialtransparency@astrazeneca.com|
283914|NCT00939341|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|28062
283915|NCT00939367|Accutest Research Laboratories Pvt. Ltd.|Kedar Joshi|+91 22 27780718||
283916|NCT00939393|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
283917|NCT00939471|Acclarent, Inc.|Laura England, Manager-Clinical|650-687-4466|lenglan1@its.jnj.com|
283918|NCT00939484|St. Jude Children's Research Hospital|Tong Lin (Biostatistician)|9015952048|Tong.Lin@stjude.org|
283919|NCT00939510|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Robert Dreicer|216-445-4623|dreicer@ccf.org|
283920|NCT00939523|Cedars-Sinai Medical Center|Odelia Cooper|310-423-4774|coopero@cshs.org|
283921|NCT00939536|Accutest Research Laboratories Pvt. Ltd.|Kedar Joshi|+91 22 27780718||
283922|NCT00939562|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
283923|NCT00939627|Vanderbilt Ingram Cancer Center|Jill Gilbert, M.D.|615-343-4677|jill.gilbert@vanderbilt.edu|
283924|NCT00939640|University of Michigan|Dr. Scott Hummel|734-998-7991|scothumm@med.umich.edu|
283925|NCT00939653|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
283926|NCT00939692|Gateway Medical Research, Inc.|Walter A Parham|(314) 663-4550||
283927|NCT00939705|Gateway Medical Research, Inc.|Walter A Parham|(314) 663-4550||
283928|NCT00939731|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283929|NCT00939770|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
283930|NCT00939783|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283931|NCT00939796|Acclarent|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
283932|NCT00939809|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@nrgoncology.org|
283933|NCT00939822|University of Wisconsin School of Medicine and Public Health|Dr. Cynthia M. Carlsson|608-256-1901|cmc@medicine.wisc.edu|11691
283934|NCT00939874|St Vincents Hospital|Professor Andrew Carr|+61 2 8382 3359|andrew.carr@svha.org.au|
283935|NCT00939900|SeoulNUBH|Professor|82317877194|khkoo@snu.ac.kr|
283936|NCT00939952|Albany College of Pharmacy and Health Sciences|Katie Cardone|518-694-7875|katie.cardone@acphs.edu|
283937|NCT00939991|Duke University Medical Center|Katherine Peters, MD, PhD|919-684-3914|katherine.peters@dm.duke.edu|
283938|NCT00940017|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
283939|NCT00940108|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
283940|NCT00940290|ITESM|Carlos A. Cuello-García|+52 (81)88882154|carlos.cuello@gmail.com, carlos.cuello@itesm.mx|
283941|NCT00940316|Northwestern University|Dr. Al Benson|(312) 695-0184|albenson@nm.org|
283942|NCT00940342|The University of Texas MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
283943|NCT00940446|OrthoIndy|Dr David A Fisher|(317) 802-2000|dafisher@orthoindy.com|
283944|NCT00940485|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
283945|NCT00940537|Washington University School of Medicine|Gary Skolnick|314-362-5292|gskolnic@wustl.edu|
283946|NCT00940576|University of Jena, Institute of Nutrition, Department of Nutritional Physiology Jena, Thuringia, Germany|Gerhard Jahreis, Prof. Dr.|+(49)3641/949610|gerhard.jahreis@uni-jena.de|
308460|NCT02581202|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
283947|NCT00940589|Neurim Pharmaceuticals (1991) LTD|Amnon Katz|972-3-768-4906|amnonk@neurim.com|
283948|NCT00940602|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
269578|NCT00067808|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, MD / Professor|713-792-7026||
292788|NCT01448044|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
292789|NCT01448057|Novartis consumer Health a GSK Consumer Healtcare company|Director Clinical research Respiratory|(1) 5512065988|anna.x.grinienko@gsk.com|
292790|NCT01448213|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
269579|NCT00067990|University_of_Minnesota|Hassan N. Ibrahim, MD|(612) 624-9444|ibrah007@umn.edu|
292791|NCT01448356|Singapore Eye Research Institute|Dr Andrea Petznick|+65 6322|andrea.petznick@seri.com.sg|4512
269580|NCT00068107|Baylor Research Institute|Dr. Raphael Schiffmann|214-820-4533|raphael.schiffmann@baylorhealth.edu|
292792|NCT01448421|keystoneheart|Karen Jaffe, VP RA./QA/CA|97246158005|karen.jaffe@keystoneheart.com|8005
292793|NCT01448447|Mercy|Dr. Robert Frazier|314-251-6844|Robert.Frazier@mercy.net|
292794|NCT01448486|St. Vincent's Hospital, Sydney|Prof. Bruce Brew|61 2 8382 1111|b.brew@unsw.edu.au|4100
269581|NCT00068237|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
269582|NCT00068250|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
269583|NCT00068341|Jonsson Comprehensive Cancer Center|Helena Chang, M.D., Ph.D., Revlon/UCLA Breast Center|310-794-5640|hchang@mednet.ucla.edu|
269584|NCT00068367|SWOG Statistical Center|Study Statistician|206-667-4623|sarcoma@crab.org|
269585|NCT00068380|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
269586|NCT00068393|ECOG Statistical Office|Study Statistician|617-632-3012||
269587|NCT00068406|NRG Oncology|Linda Gedeon for Wei Deng, PhD.|716-845-1169|lgedeon@gogstats.org|
269588|NCT00068419|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
269589|NCT00068445|Mayo Clinic|Charles L. Loprinzi, M.D.|507-284-3731|cloprinzi@mayo.edu|
269590|NCT00068575|UT MD Anderson Cancer Center|Peter Pisters, MD / Professor||asanmigu@mdanderson.org|
269591|NCT00068588|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
269592|NCT00068601|SWOG Statistics and Data Management Center|Cancer Survivorship Committee Statistician|206-667-4623||
269593|NCT00068692|ECOG-ACRIN statistical office|Statistician||eatrials@jimmy.harvard.edu|
269594|NCT00068718|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
269595|NCT00068770|Johns Hopkins University|Dr. Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
269596|NCT00068822|Mayo Clinic|David F. Kallmes, M.D.|507-266-3350|kallmes.david@mayo.edu|
269597|NCT00069095|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
269598|NCT00069108|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
269599|NCT00069121|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
269600|NCT00069160|National Cancer Institute, National Institutes of Health|Susan E. Bates, M.D.|301-402-1357|BatesS@mail.nih.gov|
269601|NCT00069264|Eisai Inc.|Dr. Peter Tarassoff|888-422--4743||
269602|NCT00069277|Eisai Inc|Eisai Call Center|888-422-4743||
275766|NCT00508924|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
275767|NCT00509002|The University of Texas (UT) MD Anderson Cancer Center|George R Blumenschein Jr, MD, Professor, Thoracic/Head & Neck Med. Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
275768|NCT00509028|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
275769|NCT00509041|University of Minnesota Masonic Cancer Center|Arkadiusz Dudek, MD, PhD||dudek002@umn.edu|
275770|NCT00509067|Department of Psychiatry Georgetown University Medical School|Dr. Stephen I. Deutsch|757.446.5888|DeutscSI@EVMS.EDU|
275771|NCT00509093|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Anjali Advani|+1 216-445-9354|advania@ccf.org|
275772|NCT00509106|Cerexa, Inc.|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
275773|NCT00509145|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
292795|NCT01448525|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
275774|NCT00509171|London Health Sciences Centre|Emil H. Schemitsch, MD, FRCS|5196633349|emil.schemistch@lhsc.on.ca|
275775|NCT00509197|Hôpital du Sacré-Coeur de Montréal|Dr Catherine Lemiere|514 338 2796|catherine.lemiere@umontreal.ca|
275776|NCT00509223|Baker IDI Heart and Diabetes Institute|Jonathan Shaw, MD, FRACP, FRCP|+61 (0) 3 8532 1821|jonathan.shaw@bakeridi.edu.au|
275777|NCT00509236|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292796|NCT01448616|University of Washington|Rachel Bender Ignacio, MD MPH|2065204340|rbi13@uw.edu|
292797|NCT01448707|Janssen Research & Development, LLC|EMEA Medical Affairs Program Lead||ClinicalTrialDisclosure@its.jnj.com|
292798|NCT01448824|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292799|NCT01448850|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
297146|NCT01729871|Janssen Scientific Affairs, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
297147|NCT01729923|University of Washington|Dr. Stacey Cohen, Principal Investigator|206-606-6658|shiovitz@uw.edu|
308461|NCT02581345|Momenta|Jim Jin|+16173954905|jjin@momentapharma.com|
308462|NCT02581384|Dana-Farber Cancer Institute|Karen Marcus MD|16177328783|karen_marcus@dfci.harvard.edu|
308463|NCT02581410|GlaxoSmithKline|GSK Response Center|866-435-7343||
269603|NCT00069329|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Goldbach-Mansky, Raphaela|+1 301 435 6243|goldbacr@mail.nih.gov|
269604|NCT00069576|GWU Biostatistics Center|Rebecca Clifton, Ph.D.|(301) 881-9260|rclifton@bsc.gwu.edu|
269605|NCT00069641|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
269606|NCT00069784|sanofi|Trial Transparency Team||Contact_US@sanofi.com|
269607|NCT00069823|Johns Hopkins University|Ellen Brown|443-287-3170|ala-acrc@jhsph.edu|
269608|NCT00069953|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
269609|NCT00070070|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
269610|NCT00070109|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
269611|NCT00070135|The Ohio State University|Steven Devine, MD||steven.devine@osumc.edu|
269612|NCT00070291|ECOG Statistical Office|Study Statistician|617-632-3012||
269613|NCT00070317|NRG Oncology|Linda Gedeon for Wei Deng, PhD.|716-845-1169|lgedeon@gogstats.org|
269614|NCT00070941|NYU Parkinson and Movement Disorders Center|Dr. Alessandro Di Rocco|212-263-4838|Alessandro.Dirocco@nyumc.org|
269615|NCT00071006|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269616|NCT00071032|Rutgers Robert Wood Johnsom Medical School|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@rutgers.edu|
269617|NCT00071058|National Cancer Institute, National Institutes of Health|Antonio Fojo, M.D.|301-496-2631|FojoT@mail.nih.gov|
269618|NCT00071110|University of Pittsburgh|Benoit H. Mulsant, MD|(416) 535-8501|benoit_mulsant@camh.net|3655
269619|NCT00071396|The University of Texas M. D. Anderson Cancer Center|Alessandra Ferrajoli, MD, BS / Assistant Professor|713-745-4613|eharriso@mdanderson.org|
269620|NCT00071487|GlaxoSmithKline|GSK Response Center|866-435-7343||
269621|NCT00071513|Univeristy of Washington|Elizabeth McCauley, PHD, Principal Investigator|206-987-2579|eliz@uw.edu|
269622|NCT00071721|Alzheimer's Disease Cooperative Study|Paul Aisen|858-622-2028|paisen@ucsd.edu|
269623|NCT00071760|ViiV Healthcare|GSK Response Center|866-435-7343||
269624|NCT00071799|Celgene Corporation|CL Beach||CLBeach@celgene.com|
269625|NCT00071812|GlaxoSmithKline|GSK Response Center|866-435-7343||
269626|NCT00071890|INSERM U897 Bordeaux FRANCE|Pr G. Chene|557571392|genevieve.chene@isped.u-bordeaux2.fr|+33
269627|NCT00071981|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
269628|NCT00072176|Princess Margaret Hospital, Toronto, Canada|Dr. Amit M. Oza|416 946 4501|amit.oza@uhn.ca|2818
269629|NCT00072189|California Cancer Consortium|DCC Project Administrator|: 626-256-4673|CCCP@coh.org|60094
269630|NCT00072280|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
269631|NCT00072293|IBCSG|Rudolf Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
275778|NCT00509249|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
275779|NCT00509262|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275780|NCT00509288|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
275781|NCT00509366|Duke University|Neal Ready, MD, PhD|919-681-6932|neal.ready@duke.edu|
275782|NCT00509392|VNUS Medical Technologies / Covidien (sponsor)|Eppie Chang, MS; Director Clinical Research|408-360-7200|eppie.chang@covidien.com|
275783|NCT00509496|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
275784|NCT00509587|Princess Margaret Cancer Centre|Dr. Natasha Leighl|416-946-2399|natasha.leighl@uhn.ca|
275785|NCT00509665|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
275786|NCT00509769|Genentech, Inc.|Medical Communications|800 821-8590||
275787|NCT00509795|Regeneron Pharmaceuticals|Clinical Trials Administrator||clinicaltrials@regeneron.com|
275788|NCT00509821|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
275789|NCT00509873|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
275790|NCT00509899|Incyte Corporation|Study Director|1-855-463-3463||
275791|NCT00509925|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
275792|NCT00510068|Novartis Pharmaceuticals|Study Director|862-778-8300||
275793|NCT00510146|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
275794|NCT00510198|Medtronic CRDM Clinical Research and Reimbursement|Clinical Trial leader|7635262788|ming.duanmu@medtronic.com|
275795|NCT00510224|UCSF|Charles J. Ryan, MD|415-353-9279|ryanc@medicine.ucsf.edu|
275796|NCT00510276|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
275797|NCT00510289|Duke University Medical Center|David Rizzieri, MD|919-668-1014|David.Rizzieri@duke.edu|
275798|NCT00510458|Stryker Orthopaedics|Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
275799|NCT00510484|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32 (0)2 509 69 77|sven.voet@solvay.com|
275800|NCT00510497|University of Pittsburgh|Sharon A. Riddler, MD, MPH|412-383-1675|riddler@pitt.edu|
275801|NCT00510510|Novartis Pharmaceuticals|Study Director|862-778-8300||
275802|NCT00510653|The University of Texas (UT) MD Anderson Cancer Center|David Gershenson, MD / Professor||CR_Study_Registration@mdanderson.org|
275803|NCT00510692|S.L.A. Pharma (UK) Ltd|Dr Chris Jordan|+44 (0)1923 681001|cjordan@slapharma.com|
308464|NCT02581475|Shandong University Qilu Hospital|Dr. Yanqing Li|+86-531-82169236|liyanqing@sdu.edu.cn|
283949|NCT00940771|Bill Holt Clinic, Phoenix Children's Hospital|Janice Piatt, MD, Medical Director|602-933-0955|jpiatt@phoenixchildrens.com|
283950|NCT00940823|Prism Eye Institute|Dr. Iqbal Ike K. Ahmed|905-456-3937|ike.ahmed@utoronto.ca|
283951|NCT00940875|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
283952|NCT00940888|Saint Jude Medical|Grant Kim, Director Clinical Studies|818-493-3147|gkim@sjm.com|
283953|NCT00940901|Johns Hopkins University, School of Medicine|Dr. Arthur L. Burnett, Director of Sexual Medicine Fellowship Program|410-614-3986|aburnett@jhmi.edu|
283954|NCT00940927|Nemours Children's Clinic|Kathryn Blake, Pharm.D.|904 858 3806|kblake@nemours.org|
283955|NCT00940992|Solgel|Ofra Levy-Hacham, Ph.D, VP of Quality Assurance|972-8-9313433|ofra.levy-hacham@sol-gel.com|3802
283956|NCT00941005|University of Wisconsin - Madison|Jeffrey Larson, MD|(608) 417-6175|larsonjef@surgery.wisc.edu|
283957|NCT00941031|Novartis Pharmaceuticals|Study Director|862-778-8300||
283958|NCT00941070|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Charles Kunos|330-375-4485|kunosc@summahealth.org|
283959|NCT00941304|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
297148|NCT01730040|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
283960|NCT00941330|Emory University|Jane Meisel, MD|404-778-1900|jane.l.meisel@emory.edu|
283961|NCT00941603|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
283962|NCT00941655|National Cancer Institute, National Institutes of Health|Dr. Udo Rudloff|301-496-3098|Udo.Rudloff@nih.gov|
283963|NCT00941668|Colgate Palmolive|Willliam DeVizio-DMD|732-878-7901|William_DeVizio@colpal.com|
283964|NCT00941681|Cytokinetics, Inc.|Project Manager|650-624-2918||
283965|NCT00941720|CCCC|Dr. Ronald Sobecks|216-444-6833|sobeckr@ccf.org|
283966|NCT00941733|Medtronic - CardioVascular|Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
269632|NCT00072384|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
269633|NCT00072449|Johns Hopkins University|Dr. Stuart A Grossman|410-955-3657|jfisher@jhmi.edu|
269634|NCT00072475|University of Minnesota|Pankaj Gupta, M.D.||gupta013@umn.edu|
269635|NCT00072514|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
269636|NCT00072566|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
269637|NCT00072761|Vanderbilt University School of Medicine|Michael R. DeBaun, MD, MPH|615-875-3040|m.debaun@vanderbilt.edu|5-3040
269638|NCT00073008|GlaxoSmithKline|GSK Response Center|866-435-7343||
269639|NCT00073021|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
269640|NCT00073073|Georgetown University|Dr. Claudine Isaacs|(202)444-3677|isaacsc@georgetown.edu|
269641|NCT00073307|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
269642|NCT00073333|University of Central Florida|Deborah C. Beidel, Ph.D.|407-823-3254|deborah.beidel@ucf.edu|
269643|NCT00073528|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
269644|NCT00073749|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269645|NCT00073918|Fred Hutchinson Cancer Research Center|Ajay K. Gopal, MD|206-288-2037|agopal@u.washington.edu|
269646|NCT00073957|Beth Israel Deaconess Medical Center|Robin Joyce, MD|617-667-9920|rjoyce@bidmc.harvard.edu|
269647|NCT00073983|SARC|SARC Chief Operating Officer|734-930-7600|sarc@sarctrials.org|
269648|NCT00074035|The Ohio State University Medical Center|Sherif S. Farag, M.D., Ph.D.||farag-1@medctr.osu.edu|
269649|NCT00074152|International Breast Cancer Study Goup|Barbara Ruepp|+4131 3899222|barbara.ruepp@ibcsg.org|
269650|NCT00074165|OHSU Knight Cancer Institute|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
269651|NCT00074269|UCSD|Dr. Edward Ball, Director BMT Program|858-822-6600|tball@ucsd.edu|
269652|NCT00074282|ECOG-ACRIN Statistical Office|Study Statistician|617 632 3012|eatrials@jimmy.harvard.edu|
269653|NCT00074308|Abramson Cancer Center of the University of Pennsylvania|Jane Daly|215-662-2812|jane@mail.med.upenn.edu|
269654|NCT00074412|Statistical Center for HIV/AIDS Research and Prevention|Statistical Research Associate|2066677524|cherron@fhcrc.org|
269655|NCT00074490|National Cancer Institute|Dr. Steven Pavletic|301-402-4899|steven_pavletic@nih.gov|
269656|NCT00074581|Fred Hutchinson Cancer Research Center|Dr. Deborah Donnell|2066675661|deborah@scharp.org|
269657|NCT00074711|Creighton University|Robert P Heaney, MD|402 280 4029|rpheaney@creighton.edu|
269658|NCT00074802|Temple University|Richard G. Heimberg, Ph.D.|215.204.7489|heimberg@temple.edu|
269659|NCT00074815|Duke University School of Medicine|Jeffrey Sapyta, PhD|919-668-0069|jeffrey.sapyta@duke.edu|
269660|NCT00074958|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
269661|NCT00074984|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
269662|NCT00075023|NINR/NIH|Suzanne Wingate|301-827-0982|suzanne.wingate@nih.gov|
269663|NCT00075088|University of California, San Francisco|Barbara J Drew, PhD|415-476-4302|barbara.drew@nursing.ucsf.edu|
269664|NCT00075218|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
269665|NCT00075270|GlaxoSmithKline|GSK Response Center|866-435-7343||
275804|NCT00510718|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275805|NCT00510744|University of Pittsburgh|Stephen O'Keefe|412 648 7217|sjokeefe@pitt.edu|
275806|NCT00510783|Emory|Brittney Copeland|404-616-0301|bcopel3@emory.edu|
275807|NCT00510809|University of Kansas Medical Center|James Backes, PharmD|(913) 588-5324|JBACKES@kumc.edu|
275808|NCT00510835|UPittsburgh|Derek C. Angus, MD, MPH, FRCP|(412) 647-6965|angusdc@ccm.upmc.edu|
275809|NCT00510874|GlaxoSmithKline|GSK Response Center|866-435-7343||
275810|NCT00510887|Duke University Medical Center|Dr. David Rizzieri|919-668-1000|rizzi003@mc.duke.edu|
275811|NCT00510952|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
283967|NCT00941798|Novartis Pharmaceuticals|Study Director|862-778-8300||
283968|NCT00941863|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
297149|NCT01730053|Regeneron Pharmaceuticals|Clinical Trial Management||clinicaltrials@regeneron.com|
283969|NCT00941889|Washington University|Steven Hunt, MD|314-454-7177|hunts@wudosis.wustl.edu|
283970|NCT00941993|Acclarent|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
283971|NCT00942084|Duke Clinical Research Institute|P. Brian Smith, MD MPH MHS|919-668-8951|brian.smith@duke.edu|
283972|NCT00942149|Duke University Medical Center|Brian Smith|9196688951|brian.smith@duke.edu|
283973|NCT00942162|GlaxoSmithKline|GSK Response Center|866-435-7343||
283974|NCT00942175|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
283975|NCT00942188|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
283976|NCT00942266|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
283977|NCT00942305|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
283978|NCT00942357|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD. and Helen Huang, MS.|716-845-1169|lgedeon@gogstats.org|
297150|NCT01730339|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269666|NCT00075335|NHLBI NIH|Dr. Richard Childs|301-594-8008|childsr@nhlbi.nih.gov|
269667|NCT00075400|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
297151|NCT01730378|GlaxoSmithKline|GSK Response Center|866-435-7343||
269668|NCT00075478|Fred Hutchinson Cancer Research Center/|Dr. Brenda Sandmaier|206-667-4961|bsandmai@fhcrc.org|
269669|NCT00075504|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
269670|NCT00075582|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
269671|NCT00075725|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
269672|NCT00075764|SWOG|Breast Committee Statistician|206-667-4623||
269673|NCT00075803|NHLBI|Nancy DiFronzo, PhD|301-435-0065|difronozon@nhlbi.nih.gov|
269674|NCT00075816|The EMMES Corporation|Adam Mendizabal|301-251-1161|amedizabal@EMMES.com|
269675|NCT00075829|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
269676|NCT00075881|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
269677|NCT00075946|ECOG Statistical Office|Study Statistician|617-632-3012||
275812|NCT00511004|NIAID|Thomas B. Nutman|301-496-5398|tnutman@niaid.nih.gov|
275813|NCT00511095|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
275814|NCT00511108|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
275815|NCT00511134|Yale University|Andrea H. Weinberger, Ph.D.|203-974-7598|andrea.weinberger@yale.edu|
275816|NCT00511147|Grifols Therapeutics Inc|Henry Li, PhD|1 + 919 316 6042|henry.li@grifols.com|
275817|NCT00511173|Creighton University|Christopher Destache|402-280-4744|destache@creighton.edu|
275818|NCT00511238|Onyx Pharmaceuticals|Onyx Medical Information|1-877-ONYX-121|medinfo@onyx.com|
275819|NCT00511472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275820|NCT00511667|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275821|NCT00511706|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
275822|NCT00511797|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
275823|NCT00511810|University of Cincinnati|Robert McNamara, PhD|513-558-5601|robert.mcnamara@uc.edu|
275824|NCT00511836|Alkermes, Inc.|Bernard L. Silverman|781-609-6000|bernard.silverman@alkermes.com|
275825|NCT00511862|BTG International Canada Inc.|Director of Clinical Operations|613-801-1880|TheraSphereClinical@btgplc.com|
275826|NCT00511875|University of Michigan|Dr. Thomas W. Gardner|734 232-8404|tomwgard@med.umich.edu|
275827|NCT00511901|University of Medicine and Dentistry of New Jersey|Jeffrey L Carson, MD|732-235-7122|carson@umdnj.edu|
275828|NCT00511914|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
275829|NCT00511992|University of Oklahoma|Ingrid Block, CTO Director|405 271-8001|ingrid-block@ouhsc.edu|
275830|NCT00512096|UT MD Anderson Cancer Center|Cherie A. Perez||caperez@mdanderson.org|
275831|NCT00512135|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
275832|NCT00512148|Tengion declared bankruptcy in 2014|Tengion declared bankruptcy and there is no results contact|There is no Tengion phone||
275833|NCT00512252|Washington University School of Medicine|Geoffrey L. Uy, M.D.|314-454-8304|guy@dom.wustl.edu|
275834|NCT00512278|Cleveland Clinic|Nizar Zein|216-444-6126|zeinn@ccf.org|
275835|NCT00512707|Brigham and Women's Hospital|Dr. Shalender Bhasin|617-525-9150|sbhasin@partners.org|
297152|NCT01730534|AstraZeneca|Global Study Leader|+49 4103 708 3792|Sandra.ranft@astrazeneca.com|
275836|NCT00512798|Vanderbilt-Ingram Cancer Center|Jeffrey Sosman, M.D.||jeff.sosman@vanderbilt.edu|
275837|NCT00512876|U.S. Army Warfighter Refractive Surgery Research Center|Principal Investigator|571-231-1600|rose.sia@us.army.mil|
275838|NCT00512902|University of California at Los Angeles|Dr. Daniel Furst, Carl M Pearson Professor of Rheumatology|310-794-9504|defurst@mednet.ucla.edu|
275839|NCT00513019|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
275840|NCT00513071|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
275841|NCT00513240|Baylor College of Medicine|Dr. Dean B. Andropoulos|832-826-5831|dra@bcm.edu|
275842|NCT00513292|University of Texas MD Anderson Cancer Center, Houston, TX, USA|Aman U. Buzdar, MD|713-792-2817|abuzdar@mdanderson.org|
283979|NCT00942422|Barbara Ann Karmanos Cancer Institute|Jeffrey Zonder, M.D.|313-576-8732|zonderj@karmanos.org|
283980|NCT00942448|IBSA Institut Biochimique|Barbara Gugliotta|+41 58 360 1000|barbara.gugliotta@ibsa.ch|
269678|NCT00076011|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269679|NCT00076024|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269680|NCT00076050|University of Miami|Silvina Levis MD|305-575-3388|slevis@med.miami.edu|
269681|NCT00076102|National Cancer Institute (NCI), National Institutes of Health (NIH)|Brigitte C. Widemann, M.D.|301-496-7387|widemanb@mail.nih.gov|
269682|NCT00076219|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|Paul M. Palevsky MD|410-360-3932|paul.palevsky@va.gov|
269683|NCT00076245|Department of Psychology, University of Vermont|Kelly J. Rohan, Ph.D.|802-656-0798|kelly.rohan@uvm.edu|
269684|NCT00076258|UT Southwestern Medical Center|Madhukar H Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
269685|NCT00076336|Novartis Pharmaceuticals|Study Director|862-778-8300||
269686|NCT00076570|NIDDK, National Institutes of Health|Dr. Monique Cho|3014355058|moniquec@intra.niddk.nih.gov|
269687|NCT00076622|University of Pennsylvania|Joel Streim||Joel.Streim@uphs.upenn.edu|
269688|NCT00076687|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
269689|NCT00076752|National Cancer Institute, National Institutes of Health|Dr. Steven Pavletic|301-402-4899|pavletis@mail.nih.gov|
269690|NCT00076804|Johns Hopkins University Center for TB Research|Richard E. Chaisson|4109551755|rchaiss@jhmi.edu|
269691|NCT00076999|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
269692|NCT00077064|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
269693|NCT00077207|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|Resultsreportingcoordinator@childrensoncologygroup.org|
269694|NCT00077376|ECOG Statistical Office|Study Statistician|617-632-3012||
269695|NCT00077610|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
269696|NCT00077623|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
269697|NCT00077636|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
269698|NCT00077649|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
269699|NCT00077675|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
269700|NCT00077766|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
269701|NCT00077857|Hoffman-LaRoche|Medical Communications|800-821-8590||
269702|NCT00077922|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitmar@mail.nih.gov|
269703|NCT00077974|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
269704|NCT00078286|Duke University|Dr. Ranga Krishnan|919-668-3647|krish001@mc.duke.edu|
269705|NCT00078312|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
275843|NCT00513305|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
275844|NCT00513344|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, Principal Investigator|+41217858054|maurice.beaumont@rdls.nestle.com|
275845|NCT00513357|University of Texas MD Anderson Cancer Center|Dr. Egidio Del Fabbro|713-563-4157|ammarin@mdanderson.org|
275846|NCT00513370|Abbott|Medical Information Specialist|1-800-633-9110||
275847|NCT00513409|GlaxoSmithKline|GSK Response Center|866-435-7343||
275848|NCT00513435|Memorial Sloan-Kettering Cancer Center|Matthew Fury, MD|646-888-4233|furym@mskcc.org|
275849|NCT00513461|University of California, Irvine|Dr. Timothy R. Morgan|562-826-5756|timothy.morgan@va.gov|
275850|NCT00513474|Massachusetts General Hospital|Bimalangshu R. Dey, MD, PhD||bdey@mgh.harvard.edu|
275851|NCT00513500|Boston University|Kojo Yeboah-Antwi|617-414-1275|kyantwi@bu.edu|
275852|NCT00513526|AMC|Group Statistician|501-526-6712|jylee@uams.edu|
275853|NCT00513604|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
275854|NCT00513682|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
275855|NCT00513695|Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium|Jennifer Specht, MD|(206) 288-6889|jspecht@uw.edu|
275856|NCT00513708|SUNY Buffalo|Schieder, Jeffrey|716-645-2977|jss10@buffalo.edu|
275857|NCT00513747|The Arthur James Comprehensive Cancer Center|John Byrd, MD|614-293-9869|john.byrd@osumc.edu|
275858|NCT00513799|Washington University|Stephanie Fritz|314-454-6050|fritz_s@kids.wustl.edu|
275859|NCT00514020|Vanderbilt-Ingram Cancer Center|Laura Goff, MD|615-936-0059|laura.goff@vanderbilt.edu|
275860|NCT00514046|National Cancer Institute|Dr. Brigitte Widemann|240-760-6203|widemanb@nih.gov|
275861|NCT00514137|Mayo Clinic Cancer Center|Shaji Kumar, M.D.||kumar.shaji@mayo.edu|
275862|NCT00514215|Barbara Ann Karmanos Cancer Institute|Peter Littrup, M.D.|313-576-8758|littrupp@karmanos.org|
275863|NCT00514449|Western Psychiatric Institute and Clinic|Dr. Konasale Prasad|412-586-9014|prasadkm@upmc.edu|
275864|NCT00514501|Progenics Pharmaceuticals, Inc.|Senior Director of Clinical Communications|914 784-1825|vdipippo@progenics.com|
275865|NCT00514514|Novartis|Study Director|862-778-8300||
275866|NCT00514540|University of Texas MD Anderson Cancer Center|Lisa Pruitt, Quality Assurance Specialist|713-792-0411|LPruitt@mdanderson.org|
275867|NCT00514592|Umeå University|Dr Elias Johansson|+46907850000|elias.johansson@neuro.umu.se|
275868|NCT00514683|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
275869|NCT00514709|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
275870|NCT00514735|Medtronic|Linda Nelson, Director of Clinical Research|763-526-2891|linda.k.nelson@medtronic.com|
275871|NCT00514852|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
297153|NCT01730586|The University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Overman, Associate Professor, GI Medical Oncology|713-792-7734|MOverman@mdanderson.org|
283981|NCT00942578|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
283982|NCT00942604|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
283983|NCT00942708|UT Southwestern|Kelly Chin|214-645-5989|kelly.chin@utsouthwestern.edu|
269706|NCT00078325|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
269707|NCT00078338|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
269708|NCT00078377|Cephalon, Inc.|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
269709|NCT00078403|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
269710|NCT00078559|University of Wisconsin - Department of Medicine, Madison, Wisconsin|Arjang Djamali, MD, MS, FASN|608-262-7330|axd@medicine.wisc.edu|
269711|NCT00078715|Experimental Therapeutics and Pathophysiology Branch, DIRP, NIMH|Dr. Carlos A. Zarate, Jr.|301-451-0861|zaratec@mail.nih.gov|
269712|NCT00078728|The Johns Hopkins University School of Medicine|Golda Ginsburg, PhD,Professor|410-955-1544|gginnsbu@jhmi.edu|
269713|NCT00078754|The University of Chicago|Dr. Emil F. Coccaro, MD|773-834-4083|ecoccaro@yoda.bsd.uchicago.edu|
269714|NCT00078767|Allegheny Singer Research Institute|Judith Cohen, MD||judith.cohen@ahn.org|
269715|NCT00078819|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
269716|NCT00078897|University of Arizona|Dr. Elizabeth Jacobs|(520) 626-0341|jacobse@email.arizona.edu|
269717|NCT00078949|NCIC|Seninor Biostatistician for LY12|613-533-6000|bechen@ctg.queensu.ca|77703
269718|NCT00079001|Massachusetts General Hospital|Matthew Smith, MD, PhD||smith.matthew@mgh.harvard.edu|
269719|NCT00079040|ECOG Statistical Office|Study Statistician|617-632-3012||
269720|NCT00079183|Fred Hutchinson Cancer Research Center|Dr. Paul A. Carpenter|(206) 667-5191|pcarpent@fredhutch.org|
269721|NCT00079274|North Central Cancer Treatment Group|Dr. Steven Alberts|507-284-8432|alberts.steven@mayo.edu|
269722|NCT00079326|Dana-Farber Cancer Institute|Craig Bunnell|617-632-3800|cbunnell@partners.org|
269723|NCT00079339|Pediatric Brain Tumor Consortium|Pediatric Brain Tumor Consortium (James M. Boyett, Ph.D)|901-595-4986|james.boyett@stjude.org|
269724|NCT00079391|NIH National Heart, Lung and Blood Institute|Minocher Battiwalla|301-402-4170|battiwalla@nhlbi.nih.gov|
269725|NCT00079417|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
269726|NCT00079677|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
269727|NCT00079781|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
269728|NCT00079937|Novartis Pharmaceuticals|Study Director|862-778-8300||
269729|NCT00080119|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
269730|NCT00080223|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
269731|NCT00080288|Cephalon|Sponsor's Medical Director, Clinical Research|1-877-237-4879||
269732|NCT00080301|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
269733|NCT00080470|Boston Scientific|Director of Clinical Operations|866-360-4747|Valerie.Lucero-Cimmarust@bsci.com|
269734|NCT00080483|University of Pennsylvania|Peter J. Snyder M.D.|215-898-0208|pjs@mail.med.upenn.edu|
275872|NCT00514904|GlaxoSmithKline|GSK Response Center|866-435-7343||
297154|NCT01730729|Northwestern University|Cesar Santa-Maria, MD|312-695-6180|cancertrials@northwestern.edu|
275873|NCT00514917|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
275874|NCT00514943|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
275875|NCT00515008|tufts medical center|chenchen wang|617-636-3251|cwang2@tuftsmedicalcenter.org|
275876|NCT00515021|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
275877|NCT00515034|Johnson and Johnson Pharmaceutical Research and Development L.L.C.|Senior Director of Clinical Development|510 248-2310||
283984|NCT00942734|University of Texas (UT) MD Anderson Cancer Center|Vali Papadimitrakopoulou, MD||CR_Study_Registration@mdanderson.org|
283985|NCT00942786|Department of Anesthesiology and Intensive Care Medicine, Medical University of Graz, Austria|Elisabeth Mahla, MD|++43316385|elisabeth.mahla@medunigraz.at|13027
283986|NCT00942825|CanBas Co., Ltd.|Takumi Kawabe, MD, PhD|81559543666|takumi@canbas.co.jp|
283987|NCT00942851|Office of the Clinical Director, NINDS, NIH|Codrin Lungu, MD|301-496-5295|lunguci@ninds.nih.gov|
283988|NCT00942877|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@nih.gov|
283989|NCT00942890|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
297155|NCT01730846|Yale School of Medicine|Sherry McKee, PhD|203-737-3529|sherry.mckee@yale.edu|
283990|NCT00942903|The Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5122550|f.hilgers@nki.nl|
283991|NCT00942968|Pfizer, Inc.|Pfizer ClinicalTrials.gov|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
283992|NCT00942994|Novartis Pharmaceuticals|Study Director|862-778-8300||
283993|NCT00943072|Regeneron Pharmaceuticals|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
283994|NCT00943098|IBSA Institut Biochimique|Barbara Gugliotta, Clincial Research Manager|+41 58 360 10 00|barbara.gugliotta@ibsa.ch|
283995|NCT00943111|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
283996|NCT00943124|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
283997|NCT00943150|Medtronic Surgical Technologies|Robert Swain, PhD|(+1-603) 294-5428|robert.e.swain@medtronic.com|
283998|NCT00943202|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|freyse@slu.edu|
283999|NCT00943306|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
284000|NCT00943319|UChicago|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
297156|NCT01730872|Ora|Keith Lane|9786858900|klane@oraclinical.com|
269735|NCT00080535|National Cancer Institute, National Institutes of Health|Robert J. Kreitman, M.D.|301-496-6947|kreitmar@mail.nih.gov|
269736|NCT00080899|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|: 60094
269737|NCT00080912|NCIC Clinical Trials Group|Dr. Bingshu Chen|613-533-6000|bechen@ctg.queensu.ca|77703
269738|NCT00080938|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
269739|NCT00081159|University of Texas (UT) MD Anderson Cancer Center|Shi-Ming Tu, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
269740|NCT00081263|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
269741|NCT00081289|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
269742|NCT00081328|TODAY Coordinating Center at George Washington University Biostatistics Center|Dr. Kathryn Hirst, Coordinating Center PI|301-881-9260|khirst@bsc.gwu.edu|8025
269743|NCT00081458|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
269744|NCT00081497|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
269745|NCT00081653|Hoffmann-La Roche|Clinical Trials Study Director|+1 973 235 5000||
269746|NCT00081731|University of Toledo|Christopher Cooper, MD|419-383-6297|christopher.cooper@utoledo.edu|
269747|NCT00081770|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269748|NCT00081861|U.T. M.D. Anderson Cancer Center|Barbara Pro, MD / Associate Professor||CR_Study_Registration@mdanderson.org|
269749|NCT00081939|The Myeloma Institute, University of Arkansas for Medical Sciences|Director of Clinical Trials and Regulatory Affairs|501-526-6990|npetty@uams.edu|
269750|NCT00082017|National Cancer Institute, National Institues of Health|Wyndham Wilson, M.D.|301-435-2415|wilsonw@mail.nih.gov|
269751|NCT00082173|Johns Hopkins University|Dr. Richard Chaisson|410-955-1755|rchaiss@jhmi.edu|
269752|NCT00082329|NHLBI NIH|Dr. Richard Childs|301-594-8008|childsr@nhlbi.nih.gov|
269753|NCT00082342|NINDS, NIH|Mark Hallett, MD, Chief|301-496-9526|hallettm@ninds.nih.gov|
269754|NCT00082355|NIHCC|Dr Richard Chang|301-402-0256|rchang@cc.nih.gov|
269755|NCT00082368|National Cancer Institute|Dr. Peter Choyke|301-402-8409|peter_choyke@nih.gov|
269756|NCT00082381|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
269757|NCT00082407|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
269758|NCT00082433|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
269759|NCT00082628|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
269760|NCT00082641|University of Nebraska|Principal Investigator|402-559-5166|ereed@unmc.edu|
269761|NCT00082758|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
269762|NCT00082810|Montefiore Medical Center - New York|NYCC Regulatory Coordinator|718-379-6862|sforde@montefiore.org|
269763|NCT00082888|Mayo Clinic|Thomas E. Witzig, M.D.|507-266-2040|witzig@mayo.edu|
269764|NCT00083122|Mayo Clinic Cancer Center|Keith C. Bible, M.D, Ph.D.||Bible.Keith@mayo.edu|
269765|NCT00083174|Canadian Cancer Trials Group|Senior Biostatistician|613-533-6430|dtu@ctg.queensu.ca|
275878|NCT00515073|University of Texas MD Anderson Cancer Center|Anuja Jhingran, MD / Professor, Radiation Oncology Department|713-563-6900|CR_Study_Registration@mdanderson.org|
275879|NCT00515086|Novartis Pharmaceuticals|Study Director|862-778-8300||
275880|NCT00515099|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
275881|NCT00515177|University of Minnesota|Cynthia Gross PhD|612-624-8676|gross002@umn.edu|
275882|NCT00515203|Amgen Inc.|Study Director|866-572-6436||
275883|NCT00515216|Washington University School of Medicine|A. Craig Lockhart, M.D.|314-362-5740|alockhar@dom.wustl.edu|
275884|NCT00515294|Boston University|Jonathan Howland, Professor|617 638 5158|jhowl@bu.edu|
275885|NCT00515411|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
275886|NCT00515437|Solstice Neurosciences, Inc|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
275887|NCT00515463|Amgen Inc.|Study Director|866-572-6436||
275888|NCT00515502|GlaxoSmithKline|GSK Response Center|866-435-7343||
275889|NCT00515528|Department of Medicine|Thomas F. Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
275890|NCT00515541|Invitrox, Inc|Dr. Don A. Gabriel|(919) 485-4600|dgabriel@invitrox.com|
275891|NCT00515619|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
275892|NCT00515697|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
275893|NCT00515723|Washington University School of Medicine and Florida Atlantic University|John Newcomer, M.D.|561-297-0252|jnewcomer@fau.edu|
275894|NCT00515827|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
275895|NCT00515879|Boston University|Dr. Stefan G. Hofmann, Ph.D., Professor of Psychology|617 353 9233|shofmann@bu.edu|
275896|NCT00516048|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
275897|NCT00516074|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
275898|NCT00516139|GlaxoSmithKline|GSK Response Center|866-435-7343||
275899|NCT00516165|Massachusetts General Hospital|Dr.Andrew X. Zhu|617-724-4000|azhu@mgh.harvard.edu|
275900|NCT00516217|University of Chicago|Sonali Smith, M.D.||smsmith@medicine.bsd.uchicago.edu|
275901|NCT00516269|UT MD Anderson Cancer Center|Carmen Escalante, MD / Professor||RABaker@mdanderson.org|
275902|NCT00516295|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
275903|NCT00516321|GlaxoSmithKline|GSK Response Center|866-435-7343||
275904|NCT00516386|Massachusetts General Hospital|Madhu Misra, MD|617-724-5602|mmisra@partners.org|
297157|NCT01730950|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
297158|NCT01731002|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
297159|NCT01731041|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD-Associate Professor of Medicine Director, Cardiovascular Research|+1-904-244-3005|dominick.angiolillo@jax.ufl.edu|
269766|NCT00083226|ECOG Statistical Office|Study Statistician|617-632-3012||
269767|NCT00083382|UAMS Myeloma Institute|Bart Barlogie|526-6990|barlogiebart@uams.edu|2420
269768|NCT00083551|UAMS Myeloma Institute|Bart Barlogie|501-526-6990|barlogiebart@uams.edu|2420
269769|NCT00083616|Amgen Inc.|Study Director|866-572-6436||
269770|NCT00083720|ImClone, LLC|Chief Medical Officer||ClinicalTrials@imclone.com|
269771|NCT00083889|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
269772|NCT00084084|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
269773|NCT00084136|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
269774|NCT00084149|University of California, San Diego|Dr. Florin Vaida|619 543-8045|fvaida@ucsd.edu|
269775|NCT00084266|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269776|NCT00084318|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
269777|NCT00084383|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
275905|NCT00516503|Mayo Clinic|Debra Barton, R.N., Ph.D.||Barton.debra@mayo.edu|
275906|NCT00516893|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
275907|NCT00516906|3M|J M Heilman|651-733-9897|jmheilman@mmm.com|
275908|NCT00516919|Yale University School of Medicine|Dr. Carlos Grilo|203-785-2792|carlos.grilo@yale.edu|
275909|NCT00517010|University of California Davis|Susanna Park MD PhD|916-734-6074|sscpark@ucdavis.edu|
275910|NCT00517296|Vanderbilt University Medical Center|David A. Schwartz, MD|615-322-4643|david.a.schwartz@vanderbilt.edu|
275911|NCT00517413|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
275912|NCT00517530|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
275913|NCT00517556|The Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
275914|NCT00517595|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
275915|NCT00517634|GlaxoSmithKline|GSK Response Center|866-435-7343||
275916|NCT00517751|Medtronic Spinal and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
275917|NCT00517829|Texas Oncology, Tyler Cancer Center|Dr. Donald Richards|903-579-9800|donald.richards@usoncology.com|
275918|NCT00517881|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
275919|NCT00517933|Duke Clinical Research Institute|Kevin J Anstrom, PhD|919-668-8902|kevin.anstrom@duke.edu|
275920|NCT00518011|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
275921|NCT00518089|Allergan, Inc.|Therapeutic Area Head|(714) 246-4500|clinicaltrials@allergan.com|
275922|NCT00518115|GlaxoSmithKline|GSK Response Center|866-435-7343||
275923|NCT00518154|Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán|Dr. Carlos Aguilar Salinas, Director of Ethics in Human Research Committee|5554870900|carlos.aguilars@incmnsz.mx|4524
275924|NCT00518180|Novartis Vaccine and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
275925|NCT00518206|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org|
275926|NCT00518284|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
275927|NCT00518323|Johnson & Johnson Pharmaceutical Research & Development|Compound Development Team Leader (CDTL)|609-730-4530||
275928|NCT00518336|GlaxoSmithKline|GSK Response Center|866-435-7343||
275929|NCT00518349|NorwegianDohsa|Dr. Geir Hoff|+4791866762|hofg@online.no|
275930|NCT00518531|Amgen Inc.|Study Director|866-572-6436||
275931|NCT00518622|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
275932|NCT00518687|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
275933|NCT00518713|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
275934|NCT00518882|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
275935|NCT00518973|UCSD Eating Disorders Treatment and Research Center|Walter H. Kaye|858-534-3951|wkaye@ucsd.edu|
275936|NCT00518986|Cephalon, Inc.|Medical monitor|1-800-896-5855||
275937|NCT00519077|The University of Chicago|Tanguy Lim-Seiwert|773-702-2452|seiwert@uchicago.edu|
275938|NCT00519194|St. Jude Medical|Sue Walgren, Manager Sr., Clinical Project|6517563210|swalgren@sjm.com|
275939|NCT00519285|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
275940|NCT00519376|GlaxoSmithKline|GSK Response Center|866-435-7343||
275941|NCT00519428|NYSPInstitute|Jonathan W. Stewart, M.D.|212-543-5745|jws6@columbia.edu|
275942|NCT00519532|UCB|UCB Clinical Trial Call Center|+18778229493||
275943|NCT00519584|Cleveland Clinic|K. C. Cummings III, MD|216-444-1016|cummink2@ccf.org|
275944|NCT00519623|Altea Therapeutics|Pei-Ling Roerig, Sr. Manager Clinical Research, Altea Therapeutics|404-835-6415|proerig@alteatherapeutics.com|
275945|NCT00519636|GlaxoSmithKline|GSK Response Center|866-435-7343||
275946|NCT00519649|GlaxoSmithKline|GSK Response Center|866-435-7343||
275947|NCT00519779|The Ohio State University|Dr. Janice Kiecolt-Glaser|614-293-3499|Janice.Kiecolt-Glaser@osumc.edu|
275948|NCT00519818|Diurnal Ltd|Richard JM Ross|0044 114 2712386|r.j.ross@sheffield.ac.uk|
275949|NCT00519831|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
275950|NCT00519896|University of Washington|Renato G Martins|206-288-2048|rgmart@uw.edu|
275951|NCT00520013|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susana_campos@dfci.harvard.edu|
284001|NCT00943384|DePuy Synthes Clinical Affairs|Allyson Morris, PhD, CCRP, Staff Clinical Research Scientist|610-719-5298|morris.allyson@synthes.com|
284002|NCT00943436|Healthy Eating and Activity Laboratory- University of Tenneessee|Emily Jokisch|865-974-0754|ejokisch@utk.edu|
284003|NCT00943488|Carver College of Medicine, University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
284004|NCT00943579|Children's Health Council|Glen R. Elliott, Ph.D., MD|650.688.3649|gelliott@chconline.org|
284005|NCT00943592|University of Chicago|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
284006|NCT00943631|Center for Vaccine Development, University of Maryland|Karen Kotloff, MD|401-706-5328|kkotloff@medicine.umaryland.edu|
284007|NCT00943670|Hoffman-LaRoche|Medical Communications|800-821-8590||
284008|NCT00943722|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284009|NCT00943735|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284010|NCT00943761|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284011|NCT00943787|University of Virginia|Mary Oliveri|434-982-0602|mc7m@virginia.edu|
284012|NCT00943800|University of Chicago|Hongtao Liu|773-834-8980|hliu2@medicine.bsd.uchicago.edu|
284013|NCT00943826|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
284014|NCT00943878|Division of Infectious Diseases and Immunology, Saint Louis University Medical School|Sharon E. Frey, M.D.|314-977-5500|freyse@slu.edu|
284015|NCT00943904|University of California, Riverside|Dr. Karen Noblett|(951) 827-7581|karen.noblett@ucr.edu|
284016|NCT00943917|Intarcia Therapeutics, Inc|Michelle Baron MD|510-782-7800|clinicaltrials@intarcia.com|
297160|NCT01731119|UNC-Chapel Hill|Dr. Linmarie Sikich||linmarie_sikich@med.unc.edu|
284017|NCT00944021|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212 227 7540|Dan.Everitt@tballiance.org|
284018|NCT00944034|Novartis Vaccines|Posting Director|+39 0577 245863|anh.phung@novartis.com|
284019|NCT00944047|University of Kansas Cancer Center|Dr. Qamar Khan|(913) 588-6029|ctnursenav@kumc.edu|
284020|NCT00944073|Center for Vaccine Development, University of Maryland|Karen Kotloff, MD|401-706-5328|kkotloff@medicine.umaryland.edu|
284021|NCT00944125|Aurora Health Care|Imran K. Niazi, MD|414-645-6070|imran.niazi@aurora.org|
284022|NCT00944450|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284023|NCT00944554|Johns Hopkins University|Maxine Stitzer, PhD|410-550-0042|mstitze1@jhmi.edu|
284024|NCT00944645|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284025|NCT00944658|Imperial College London|Peter Taylor|+44 (0) 2075941872|jrco@imperial.ac.uk|
284026|NCT00944671|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
284027|NCT00944697|Mundipharma Research GmbH|Director of Medical Operations|44 01223424900|info@contact-clinical-trials.com|
284028|NCT00944710|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
284029|NCT00944749|National Heart Lung and Blood Institute|Dr Danielle Townsley|301-402-3477|townsleydm@nhlbi.nih.gov|
284030|NCT00945009|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
284031|NCT00945061|University Hospitals Cleveland Medical Center , Case Comprehensive Cancer Center|Dr. Janice A. Lyons, MD|+1 216-844-2536|Janice.Lyons@uhhospitals.org|
284032|NCT00945100|Jaeb Center for Health Research|Ray Kraker, M.S.P.H., Director of PEDIG Coordinating Center|(813) 975-8690|rkraker@jaeb.org|
284033|NCT00945139|University of Vermont CC|Dr. Claire Verschraegen|802-656-5487|claire.verschraegen@vtmednet.org|
284034|NCT00945191|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
284035|NCT00945243|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
284036|NCT00945256|University of Texas Medical Branch|Dr Melinda Sheffield-Moore, Professor of Medicine|409-772-8707|melmoore@utmb.edu|
284037|NCT00945282|ViiV Healthcare|GSK Response Center|866-435-7343||
284038|NCT00945295|New Mexico VA Healthcare System|JoAnn Harnar, Research Nurse|505-256-5701|Joann.Harnar@va.gov|
284039|NCT00945321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284040|NCT00945334|Cedars-Sinai Medical Center|Mark Pimentel|3104233792|chuak@cshs.org|
284041|NCT00945477|Illinois CancerCare, P.C.|James Knost, M.D.|309-243-3000|jknost@illinoiscancercare.com|
284042|NCT00945555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284043|NCT00945594|University of Oklahoma Health Sciences Center|Lieschen Quiroz, MD|405-271-8787|lieschen-quiroz@ouhsc.edu|
284044|NCT00945659|Nemours Foundation: Dept. of Biomedical Research|Tim Wysocki, PhD|904-697-3483|twysocki@nemours.org|
284045|NCT00945750|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284046|NCT00945815|SWOG Statistical Center|SWOG Leukemia Statistician|206-667-4408||
284047|NCT00945854|Federico II University|Riccardi Gabriele|+390817462117|riccardi@unina.it|
284048|NCT00945893|MedImmune, LLC|Raburn Mallory, MD Senior Director Clinical Development|301-398-0000|malloryr@medimmune.com|
292800|NCT01449006|St Vincent's Hospital, Sydney, Australia|Prof. Bruce Brew|61 2 8382 1111|bruce.brew@svha.org.au|4100
292801|NCT01449240|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
292802|NCT01449266|Guerbet|Dr. Pierre Desché, MD - VP Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
292803|NCT01449279|Stanford Cancer Institute|Dr. Susan J Knox|650-725-2720|sknox@stanford.edu|
292804|NCT01449305|isRed Pharma & Biotech Research Corporation|Mirror Hsieh|886-8-7628188|mingrong@bioisred.com|
292805|NCT01449370|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
292806|NCT01449461|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
284049|NCT00945906|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
284050|NCT00945945|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284051|NCT00945958|SPARC|Dr Shravanti Bhowmik||shravanti.bhowmik@sparcmail.com|
308465|NCT02581488|Smith and Nephew|SR. Clinical Study Manager, US Global Clinical Operations|+1 817-302-3959|Darrell.Lange@smith-nephew.com|
284052|NCT00946023|Johns Hopkins University|Rich Ambinder, MD|4109558839|rambind1@jhmi.edu|
284053|NCT00946088|Stanford University School of Medicine|Deirdre Lyell, MD|(650) 384-5107|deirdre.lyell@stanford.edu|
284054|NCT00946101|MedImmune, LLC an affiliate of AstraZeneca AB|Elissa Malkin, D.O.|301-398-0000|malkine@medimmune.com|
284055|NCT00946114|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284056|NCT00946153|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
284057|NCT00946192|Massachusetts General Hospital and Harvard Medical School|Madhu Misra, MD; Chief, Pediatric Endocrine|6177245602|mmisra@mgh.harvard.edu|
284058|NCT00946270|The University of Texas MD Anderson Cancer Center|Dr. Srdan Verstovsek, MD./Professor|713-745-3429|sverstov@mdanderson.org|
284059|NCT00946296|UMass Medical School|Dr. Giles Whalen|508-334-5202|Giles.Whalen@umassmemorial.org|
284060|NCT00946309|Fred Hutchinson Cancer Research Center|Dr. Daniel Lin|206-221-0797|dwlin@uw.edu|
284061|NCT00946322|Trauma Recovery Center, Cincinnati VA Medical Center|Jeremiah A. Schumm, PhD, Associate Director|859-572-6717|Jeremiah.Schumm@va.gov|
284062|NCT00946348|Geisel School of Medicine at Dartmouth|Alan I. Green, M.D.|603-650-7549|alan.i.green@dartmouth.edu|
284063|NCT00946478|UCSD Dermatology|Dr. Tissa Hata|858-657-8390|ucsddermstudies@gmail.com|
284064|NCT00946530|Stanford University|Jerome A. Yesavage, MD|650-493-5000|yesavage@stanford.edu|x64330
284065|NCT00946647|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
284066|NCT00946712|SWOG Statistics & Data Management Center|Lung Committee Statistican|2066675712|jmiao@fredhutch.org|
284067|NCT00946881|STEBA Biotech|Bertrand Gaillac International Project Leader|+ 33 974197905|b.gaillac@stebabiotech.com|
284068|NCT00946920|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
284069|NCT00946998|University of Texas Southwestern Medical Center|Susan Hedayati, MD, Professor of Medicine|214-645-6106|susan.hedayati@utsouthwestern.edu|
284070|NCT00947115|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
284071|NCT00947154|Stanford Medical Center, Department of Psychiatry|Matthew White, M.D., clinical assistant professor|650 725-5598|mpwhite@stanford.edu|
284072|NCT00947167|Stanford University School of Medicine|Pamela L. Kunz, MD, Leader GI Oncology Research Group|650-725-8738|pkunz@stanford.edu|
284073|NCT00947193|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
284074|NCT00947219|Lexington International, LLC|David Michaels|561-417-0200|dm@hairmax.com|
284075|NCT00947271|The Miriam Hospital|Dr. Michael Carey|401-793-8218|michael_carey@brown.edu|
284076|NCT00947297|Hyperion Therapeutics|Craig James|650-745 7840|craig.james@hyperiontx.com|
284077|NCT00947310|University of Rochester, Heart Research Follow-up Program|Dr. Arthur J. Moss|585-275-5391|arthur.moss@heart.rochester.edu|
284078|NCT00947349|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
284079|NCT00947427|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
284080|NCT00947505|Lexington International, LLC|David Michaels|561-417-0200|dm@hairmax.com|
284081|NCT00947531|EVERNeuro Pharma|Head of R&D|+43 7665 20555|stefan.winter@everpharma.com|0
284082|NCT00947544|Hyperion Therapeutics|Craig James-Associate Director, Clinical Operations|650-745-7840|craig.james@hyperiontx.com|
284083|NCT00947661|Sun Pharma Advanced Research Company|Dr Shravanti Bhowmik||shravanti.bhowmik@sparcmail.com|
284084|NCT00947752|Teva Neuroscience, Inc.|Thomas Smith, MD, VP, Medical Affairs|816-508-5000|tom.smith@tevapharm.com|
284085|NCT00947765|Dr. Chetan Muralidhara Rao Dojode. Resident in Orthopaedics and Traumatology.|Dr. Chetan Muralidhara Rao Dojode, MBBS,MS(Ortho)|91 9844592532|docchetanmd@yahoo.co.in|
284086|NCT00947856|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
284087|NCT00947882|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
284088|NCT00948025|AxoGen, Inc|Vice President, Clinical and Translational Sciences|3864626829|edevinney@axogeninc.com|
284089|NCT00948064|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia Department|713-745-3428|CR_Study_Registration@mdanderson.org|
284090|NCT00948090|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
269778|NCT00084409|University of Colorado Denver|Robert Keith, M.D.|303-399-8020|robert.keith@ucdenver.edu|3182
269779|NCT00084487|Case Comprehensive Cancer Center|Afshin Dowlati MD|216-844-1228|afshin.dowlati@uhhospitals.org|
269780|NCT00084552|Fox Chase Cancer Center|Eric Horwitz|215-728-2995|Eric.Horwitz@fccc.edu|
269781|NCT00084617|National Cancer Institute|Joanna Brell MD|240-276-7050|brelljm@mail.nih.gov|
269782|NCT00084682|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
269783|NCT00084747|UCLA|Dr. Gary Schiller|310-206-5755|gschiller@mednet.ucla.edu|
269784|NCT00084838|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
269785|NCT00084864|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
269786|NCT00084929|ACRIN|Donna Harfeil, Director of Protocol Management|215-717-2765|dhartfeil@acr.org|
269787|NCT00085098|Children's Oncology Group|Results Coordinator|(626) 447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
269788|NCT00085254|Adult Brain Tumor Consortium (ABTC)|Louis Burt Nabors, MD|205-934-1432|bnabors@uab.edu|
269789|NCT00085293|University of Texas MD Anderson Cancer Center|Steven I. Sherman, MD / Professor|713-792-2841|sisherma@mdanderson.org|
269790|NCT00085410|Fox Chase Cancer Center|Assistant Professor, Medical Oncology|215-214-1676|crystal.denlinger@fccc.edu|
284091|NCT00948155|University of Pennsylvania|Andrew A. Strasser, Ph.D., Associate Professor|215 746 5788|strasse3@mail.med.upenn.edu|
284092|NCT00948246|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
284093|NCT00948298|Charles Drew University of Medicine and Science|Dr. David Martins|323-568-3353|davidmartins@cdrewu.edu|
284094|NCT00948389|Bristol-Myers Squibb|BMS Study Director||clinical.trials@bms.com|
284095|NCT00948428|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
284096|NCT00948441|University of Pittsburgh|Judith M. Martin, MD|412-692-7028|judy.martin@chp.edu|
284097|NCT00948506|University of Pennsylvania|Joy Wan|2157466364|joy.wan@uphs.upenn.edu|
284098|NCT00948610|UCLA|Michael R. Irwin|3108258281|mirwin1@ucla.edu|
284099|NCT00948675|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
297161|NCT01731171|Sheppard Pratt Health System|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
284100|NCT00948688|Massachusetts General Hospital|Lawrence S. Blaszkowsky, M.D.|617-219-1230|lblaszkowsky@mgh.harvard.edu|
284101|NCT00948766|Novartis Pharmaceuticals|Study Director|862 778-8300||
284102|NCT00948792|University of Oklahoma Health Sciences Center|Doug Dannaway|4052715215|douglas-dannaway@ouhsc.edu|42048
284103|NCT00948818|Forest Research Institute|Paul F.C. Eng Ph.D Director, Clinical Development|201-427-8071|Paul.Eng@frx.com|
284104|NCT00948857|Center for Human Reproduction|Dr. Norbert Gleicher|212-994-4400|ngleicher@thechr.com|
284105|NCT00948896|University of California, San Francisco|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
284106|NCT00948922|H. Lee Moffitt Cancer Center and Research Institute|Dr. Melissa Alsina|813-745-7202|melissa.alsina@moffitt.org|
269791|NCT00085423|Dartmouth-Hitchcock|Dr. Marc Ernstoff|603 650 5534|marc.s.ernstoff@hitchcock.org|
284107|NCT00948935|Abramson Cancer Center|Bruce Giantonio|(215) 615-5858|bruce.giantonio@uphs.upenn.edu|
284108|NCT00948974|Drexel University|Evan Forman|215.553.7113|evan.forman@drexel.edu|
284109|NCT00949078|Johns Hopkins University School of Medicine|Professor Robert Wood, M.D.|rwood@jhmi.edu|rwood@jhmi.edu|
284110|NCT00949117|SunCoast CCOP Research Base|Cristina Burroughs, Clinical Research Coordinator|(813) 396-9237|Cristina.Burroughs@epi.usf.edu|
284111|NCT00949234|UCLA CARE Center|Dr. Raphael Landovitz|310-557-1891|rlandovitz@mednet.ucla.edu|
284112|NCT00949325|Johns Hopkins University|David M. Loeb, M.D., Ph.D.|410-502-7247|loebda@jhmi.edu|
284113|NCT00949533|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
284114|NCT00949650|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
284115|NCT00949702|Hoffmann-La Roche|Medical Communications|800-821-8590||
284116|NCT00949715|Medtronic CRDM|Rachael Rose|763-526-2332|rachael.k.rose@medtronic.com|
284117|NCT00949884|Daiichi Sankyo, Inc.|Robert Dubiel, PharmD|973-944-2963|bdubiel@dsi.com|
284118|NCT00949910|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
284119|NCT00949975|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
284120|NCT00950170|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284121|NCT00950235|Kaiser Permanente Center for Health Research|Victor J. Stevens, PhD Principle Investigator|503 335 6751|victor.j.stevens@kpchr.org|
284122|NCT00950248|National Institute of Allergy and Infectious Diseases, National Institutes of Health|Dr. Bibiana Bielekova|(240) 669-2724|bibi.bielekova@nih.gov|
284123|NCT00950300|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
284124|NCT00950352|The Brain Institute of the University of Utah|Perry Renshaw, MD, PhD, MBA|801-587-1216|perry.renshaw@hsc.utah.edu|
284125|NCT00950365|Montefiore Medical Center|Roman Perez-Soler, MD|(718) 405-8505|RPEREZSO@montefiore.org|
284126|NCT00950599|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
284127|NCT00950612|GlaxoSmithKline|GSK Response Center|866-435-7343||
284128|NCT00950651|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
269792|NCT00085436|Dartmouth-Hitchcock Medical Center|Dr. Marc S. Ernstoff|603-650-5534|marc.s.ernstoff@hitchcock.org|
269793|NCT00085540|Adult Brain Tumor Consortium (ABTC)|Howard Fine, MD|410-955-8837|jfisher@jhmi.edu|
269794|NCT00085566|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher|646-422-4323|scherh@mskcc.org|
269795|NCT00085644|Abbott|Global Medical Services|800-633-9110||
269796|NCT00085709|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
269797|NCT00085735|Childrens's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
269798|NCT00085839|Astellas Pharma Global Development|Medical Monitor||clinicaltrials@us.astellas.com|
269799|NCT00085917|RCHSPB|John Tierney|301-451-5136|john.tierney@nih.gov|
269800|NCT00086047|Cincinnati Children's Hospital Medical Center|Susmita Kashikar-Zuck, PhD|513 636 6337|Susmita.Kashikar-Zuck@cchmc.org|
269801|NCT00086138|JHU|Paul Rosenberg|410-550-9883|prosenb9@jhmi.edu|
269802|NCT00086190|University of Rochester Medical Center|Irene H. Richard, MD|585-341-7500|irene_richard@urmc.rochester.edu|
269803|NCT00086281|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director Clinical Development & Medical Monitor|650-496-3777||
269804|NCT00086307|NIMH|Dr. Carlos A. Zarate|301-451-0861|zaratec@mail.nih.gov|
269805|NCT00086346|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
269806|NCT00086385|University of California, San Francisco|Sharon M. Hall, PhD|415-476-7574|sharon.hall@ucsf.edu|
269807|NCT00086411|University of Pennsylvania|Peter Gariti, Ph.D.|215-222-3200|gar1iti@mail.med.upenn.edu|0
269808|NCT00086450|Icahn School of Medicine at Mount Sinai|Dr. Valentin Fuster, M.D., Ph.D.|212-860-1056|valentin.fuster@mssm.edu|
269809|NCT00086502|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
284129|NCT00950664|Seoul National University Hospital|BS Jeon|+82220722876|brain@snu.ac.kr|
284130|NCT00950729|Centre hospitalier universitaire de Sherbrooke (CHUS)|François Cabana|1-819-346-1110|francois.cabana@usherbrooke.ca|14233
284131|NCT00950742|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
284132|NCT00950755|GlaxoSmithKline|GSK Response Center|866-435-7343||
284133|NCT00950807|GlaxoSmithKline|GSK Response Center|866-435-7343||
284134|NCT00950833|GlaxoSmithKline|GSK Response Center|866-435-7343||
284135|NCT00950859|ViiV Healthcare|GSK Response Center|866-435-7343||
284136|NCT00950872|Covidien|Noreen Fahey, Director, Clinical Program Management|203-821-4716|noreen.fahey@covidien.com|
284137|NCT00950911|Amgen Inc.|Study Director|866-572-6436||
284138|NCT00950950|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
284139|NCT00950963|Denver Health|Raymond Estaico, MD|303-860-9900|Ray.Estacio@cpcmed.org|
284140|NCT00951015|ViiV Healthcare|GSK Response Center|866-435-7343||
284141|NCT00951041|GlaxoSmithKline|GSK Response Center|866-435-7343||
284142|NCT00951080|KCI|VP, Global Clinical Development|12102555595|jkhart@mmm.com|
284143|NCT00951093|Clinica Gastrobese|Carlos AS Madalosso, Director of Department of Metabolic and Bariatric Surgery|+55(54)3045-4070|madalosso@gastrobese.com.br|
284144|NCT00951171|WIHRI|Andrew S Blazar, MD Principal Investigator|401-274-1122|ablazar@WIHRI.org|8461
284145|NCT00951275|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
284146|NCT00951379|University of Texas (UT) MD Anderson Cancer Center|University of Texas MD Anderson Phase I/II Prevention Consortium||CR_Study_Registration@mdanderson.org|
284147|NCT00951483|Loyola University Chicago|Angelos Halaris, MD, PhD|708-216-3275|ahalaris@lumc.edu|
284148|NCT00951496|NRG Oncology|Linda Gedeon for Mark Brady, PhD|716-845-1169|lgedeon@gogstats.org|
292807|NCT01449513|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
292808|NCT01449526|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|585-338-6399|robert.steffen@bausch.com|
292809|NCT01449539|University of Arkansas for Medical Science-MIRT|Sarah Waheed, MD|501-686-8230|mirt@uams.edu|
292810|NCT01449630|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292811|NCT01449682|Retina Macula Institute|Ron P. Gallemore, M.D., Ph. D.|310) 944-9393|rongallemoremd@gmail.com|
292812|NCT01449708|Coastal Anesthesiology|Patrick Ziemann-Gimmel, MD|904-819-4478|pziemann@yahoo.com|
292813|NCT01449721|Christiana Care Health System|Ryan Arnold, MD, Director of Research, Emergency Medicine|302-733-5108|ryarnold@christianacare.org|
292814|NCT01449734|CSCC Germany, Jena University Hospital|Christiane Hartog, MD|+49 3641 9323171|christiane.hartog@med.uni-jena.de|
292815|NCT01449747|The Catholic University of Korea|Dr. Ji Hyun Kim|82-2-961-4534|kjhyun@catholic.ac.kr|
292816|NCT01449812|GlaxoSmithKline|GSK Response Center|866-435-7343||
292817|NCT01449864|University of Pennsylvania|John Plastaras, MD, PhD|267-972-3539|plastaras@uphs.upenn.edu|
292818|NCT01449929|GlaxoSmithKline|GSK Response Center|866-435-7343||
292819|NCT01449955|UT Southwestern/VA North Texas|Dr. Alina Suris|214-857-0334|alina.suris@va.gov|
292820|NCT01450007|Mayo Clinic|Dr. David M. Rosenfeld|480-301-7586|Rosenfeld.David@mayo.edu|
292821|NCT01450098|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292822|NCT01450137|Department of Rheumatology, Immunology and Allergology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland|Prof Peter M Villiger||peter.villiger@insel.ch|
292823|NCT01450189|University of North Carolina at Chapel Hill|William C Miller|9199669407|bill_miller@unc.edu|
292824|NCT01450306|Hartford Hospital|Dr David Tolin|860-545-7685|david.tolin@hhchealth.org|
292825|NCT01450319|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
292826|NCT01450397|Hospital for Special Surgery|Scott W. Wolfe|212-606-1529|WolfeS@hss.edu|
292827|NCT01450540|Philips|Senior Data Scientist|+14125423651||
292828|NCT01450631|KCI USA, Inc.|Jill Twardowski, Director of Clinical Operations|210-515-4166|jill.twardowski@kci1.com|
292829|NCT01450683|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
292830|NCT01450696|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
292831|NCT01450761|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
292832|NCT01450787|Coa Research Foundation|Kenneth A Beckman, MD|614-506-4720|kenbeckman22@aol.com|
269810|NCT00086515|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269811|NCT00086580|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
269812|NCT00086619|Massachusetts General Hospital|Robert Neer, MD|617-726-6723|rneer@partners.org|
269813|NCT00086684|Janssen R&D US|SENIOR DIRECTOR CLINICAL LEADER|1 609 730-4529||
269814|NCT00086957|City of Hope|Paul Frankel, Ph.D.|626-359-8111|pfrankel@coh.org|65265
269815|NCT00086996|SWOG Statistical Center|Study Statistician|206-667-4623||
269816|NCT00087022|Heidelberg Pharma AG (previously Wilex AG)|Head of R&D||info@hdpharma.com|
269817|NCT00087126|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
269818|NCT00087139|ECOG Statistical Office|Study Statistician|617-632-3012||
269819|NCT00087152|SWOG|Lead Statistician - Breast Cancer Committee|(206) 839-1761|williamb@crab.org|
269820|NCT00087438|Radition Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@gmail.com|
269821|NCT00087490|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269822|NCT00087516|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
269823|NCT00087529|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
269824|NCT00087555|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director of Clinical Development & Medical Monitor|650-496-3777||
269825|NCT00087568|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
292833|NCT01450800|Duke University Medical Center|Dr. Alexis Dieter|919-401-1006|alexis.dieter@duke.edu|
292834|NCT01450813|Fletcher Allen Health Care at The University of Vermont|Donald Mathews, M.D.|(802) 847-2415|Donald.Mathews@vtmednet.org|
284149|NCT00951509|Human Engineering Research Labs|Rory Cooper, PhD|412-822-3700|rcooper@pitt.edu|
284150|NCT00951561|Another Way Products|Charles Tepper|917-538-6894|charles_tepper@yahoo.com|
284151|NCT00951665|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
284152|NCT00951808|New England Research Institutes|Hae-Young Kim|617-972-3251|hkim@nerisicence.com|
284153|NCT00951821|Brown University|Anthony Spirito|401-444-1929|anthony_spirito@brown.edu|
284154|NCT00951899|Mayo Clinic|Dr. Adrian Vella|507-284-3289|vella.adrian@mayo.edu|
284155|NCT00951912|the First Affiliated Hospital of Sun Yat-sen University|Dr. Yan-bin Ye|8620-87755766|yanbinye72@163.com|8179
269826|NCT00087594|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
284156|NCT00952068|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
308466|NCT02581839|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Paula Silverman|1-800-641-2422|CTUreferral@UHhospitals.org|
284157|NCT00952081|UMDNJ|Alex Bekker, MD, PhD|973-972-5007|bekkeray@umdnj.edu|
284158|NCT00952120|University of Chicago|Lawrence Gottlieb|(773) 702-6302|lgottlie@surgery.bsd.uchicago.edu|
284159|NCT00952133|NYU Langone Medical Center|Jeanna Blitz, MD|212-263|jeanna.viola@nyumc.org|0667
284160|NCT00952211|UCSD|Dr. Joel Dimsdale||jdimsdale@ucsd.edu|
284161|NCT00952276|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
284162|NCT00952289|Incyte Corporation|Study Director|855 463-3463||
308467|NCT02581865|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
284163|NCT00952315|IU Health Physicians Urology|James Lingeman, MD|317-962-3700||
284164|NCT00952341|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284165|NCT00952367|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284166|NCT00952380|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284167|NCT00952393|University of Colorado|Dr. Robert Freedman|3037244940|Robert.Freedman@ucdenver.edu|
284168|NCT00952419|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
284169|NCT00952484|Alexion Pharma GmbH|Alexion Pharma GmbH|(617) 494-1393|ClinicalTrials@alxn.com|
284170|NCT00952523|Valeant Pharmaceuticals International Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
284171|NCT00952588|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
308468|NCT02581891|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
308469|NCT02581995|Bayer AG|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
284172|NCT00952614|Duke University Medical Center|Glenn J. Jaffe, MD|919-684-4458|jaffe001@mc.duke.edu|
284173|NCT00952653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284174|NCT00952705|MedImmune, LLC|JA Sliman, MD, MPH, Director, Clinical Development|301-398-0000|SlimanJ@medimmune.com|
284175|NCT00952718|ChangGungMH|Dr. Liaw MY|+8867317123|myliaw1@yahoo.com.tw|8199
284176|NCT00952731|Northwestern University|Dr. Seema Khan|312-503-4236|s-khan2@northwestern.edu|
284177|NCT00952822|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
284178|NCT00952848|Virginia Commonwealth University|Thomas J. Smith, MD, FACP|410-955-2091|tsmit136@jhmi.edu|
284179|NCT00953017|Fort Belvoir Community Hospital|Dr. Michael Hjelkrem|531-231-2015|mhjelkrem@yahoo.com|
284180|NCT00953043|Mayo Clinic|Dr. Michael Camilleri, Professor of Medicine and Physiology, Gastroenterology|507-266-2305|camilleri.michael@mayo.edu|
269827|NCT00087607|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
284181|NCT00953056|Merck Sharp and Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
284182|NCT00953121|Preston Robert Tisch Brain Tumor Center at Duke University Medical Center|Dr. Annick Desjardins|919-684-1691|annick.desjardins@duke.edu|
269828|NCT00087633|Hoffmann-La Roche|Medical Communications|800-821-8590||
284183|NCT00953147|Sunovion|Respiratory Medical Director|1-866-503-6351||
269829|NCT00087646|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
269830|NCT00087672|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes, M.D./ Professor|713-794-5783|eharriso@mdanderson.org|
269831|NCT00087685|The University of Texas (UT) MD Anderson Cancer Center|Karen H. Lu, MD, Chair, Gynecologic Oncology & Reproductive Medicine|713-745-8902|CR_Study_Registration@mdanderson.org|
269832|NCT00087698|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
269833|NCT00088153|Massachusetts General Hospital|Anne Klibanski|617-726-3870|aklibanski@partners.org|
269834|NCT00088166|Celtic Pharma Development Services America Inc|Patrick O'Connor, MD, Managing Director Clinical Development|212-616-4050|patrick.oconnor@dev.celticpharma.com|
269835|NCT00088205|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
269836|NCT00088218|The University of Texas M. D. Anderson Cancer Center|Stefan Fader, M.D./Associate Professor|713/745-4613|eharriso@mdanderson.org|
269837|NCT00088374|National Cancer Institute, National Institutes of Health|William M. Linehan, M.D.|301-496-6353|linehanm@mail.nih.gov|
269838|NCT00088413|National Cancer Institute|Dr. James Gulley|301-480-8870|james_gulley@nih.gov|
269839|NCT00088452|Cincinnati Children's Hospital Medical Center|Tracy Glauser, MD|513-636-8854|tracy.glauser@cchmc.org|
269840|NCT00088465|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
269841|NCT00088530|CTIBioPharma Corp.|Simran Bedi Singh|(206) 272-4000|ssingh@ctibiopharma.com|
269842|NCT00088595|Novartis Pharmaceuticals|Study Director|862-778-8300||
269843|NCT00088621|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
284184|NCT00953160|Cutera Inc.|Ayse Turley, Clinical Development Researcher|415-657-5665|aturley@cutera.com|
284185|NCT00953173|Apollo Endosurgery Inc|Director of Clinical Affairs|512-279-5157|jose.naveira@apolloendo.com|
284186|NCT00953199|Penn State Hershey Medical center|Abraham Mathew MD|717 531 3834|amathew@hmc.psu.edu|
284187|NCT00953212|Maine Medical Center|Dr. Robert Kramer|207-662-2923|KRAMER@mmc.org|
284188|NCT00953225|Ralph H. Johnson VA Medical Center|Sebastiano Gattoni-Celli, M.D.|843-876-5103|gatttonis@musc.edu|
284189|NCT00953290|Cutera Inc.|Ayse Turley, Clinical Development Researcher|415-657-5665|aturley@cutera.com|
284190|NCT00953407|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
284191|NCT00953524|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
284192|NCT00953576|Beth Israel Deaconess Medical Center|Glenn Bubley, MD||gbubley@bidmc.harvard.edu|
284193|NCT00953654|The University of Georgia|Matthew P. Herring, PhD|706-542-4381|mph8@uga.edu|
284194|NCT00953667|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
284195|NCT00953706|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
284196|NCT00953719|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|shimden@its.jnj.com|
284197|NCT00953745|Washington University School of Medicine|Dr. Charles R. Conway, MD|314-362-7566|conwayc@psychiatry.wustl.edu|
284198|NCT00953849|Ralph H. Johnson VA Medical Center, Charleston, SC|M. Rita I. Young, Ph.D.|843-792-9953|rita.young@va.gov|
284199|NCT00953862|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
284200|NCT00953927|Aeras|Bernard Landry|301-547-2919|blandry@aeras.org|
284201|NCT00954109|Harry S Truman Memorial VA Hospital and University of Missouri|John Thyfault, Associate Professor|573-814-6000|thyfaultj@health.missouri.edu|53742
284202|NCT00954122|AstraZeneca|Gerard Lynch|4415 09645895|clinicaltrialtransparency@astrazeneca.com|
284203|NCT00954174|NRG Oncology|Linda Gedeon on behalf of Virginia Filiaci, PhD.|716-845-1169|Linda.Gedeon@roswellpark.org|
284204|NCT00954356|Xenon Pharmaceuticals Inc.|Vice President Clinical|6044843300|pgoldberg@xenon-pharma.com|
284205|NCT00954421|University of Florida|Dr. Kelly Foote|352-273-5550|foote@neurosurgery.ufl.edu|
284206|NCT00954447|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
284207|NCT00954512|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284208|NCT00954538|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284209|NCT00954681|NYSPI/Columbia University|John J. Mariani|6467746140|john.mariani@nyspi.columbia.edu|646
284210|NCT00954707|Cordis Corporation, a Johnson & Johnson company|Amy Orlick, Associate Director|908-541-4347|aorlick@its.jnj.com|
284211|NCT00954733|Northwestern University|Gildaasio De Oliveira, M.D.|312-472-3573|gjr@northwestern.edu|
284212|NCT00954824|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
297162|NCT01731470|Beaumont Hospital, Royal Oak|Kenneth Peters MD|248-551-0387|Kenneth.Peters@Beaumont.edu|
284213|NCT00954941|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-794-5783|eharriso@mdanderson.org|
284214|NCT00954993|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284215|NCT00955032|Center for Neurological Restoration Cleveland Clinic|Dr. Hubert Fernandez|(216) 445-1108|fernandez@neurology.ufl.edu|
284216|NCT00955110|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
284217|NCT00955201|Edward Hines Jr. VA Hospital|Evan Stubbs|708-202-3507|evan.stubbs@va.gov|
284218|NCT00955253|Imperial College London|Dr Paresh Malhotra|0208 846 1234|p.malhotra@imperial.ac.uk|
284219|NCT00955266|Brigham & Women's Hospital|Michael Nurok|617-899-5961|mnurok@gmail.com|
284220|NCT00955279|Johnson & Johnson Pharmaceutical Research & Development|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
284221|NCT00955305|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
284222|NCT00955357|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
284223|NCT00955409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284224|NCT00955474|Massachusetts General Hospital|John D. Matthews, MD|6177249144|jdmatthews@partners.org|
284225|NCT00955487|University of Colorado School of Medicine/Children's Hospital Colorado|Dr. John Kinsella|(303) 724-2853|john.kinsella@ucdenver.edu|
284226|NCT00955513|Novartis Consumer Health|Clinical Project Leader Pain category|+41223635528||
284227|NCT00955617|Guerbet|Emilie Huchet|+33 1 45 91 50 00|emilie.huchet@guerbet-group.com|7688
284228|NCT00955682|GlaxoSmithKline|GSK Response Center|866-435-7343||
284229|NCT00955708|Boston Scientific|Director of Clinical Trial Management - cRM franchise|1-800-227-3422|elaine.larson@bsci.com|
284230|NCT00955721|University of Miami|Peter J. Hosein MD|3052433462|phosein@miami.edu|
284231|NCT00955747|University of Kentucky|Robert Lodder|859-955-0845|lodder@uky.edu|
284232|NCT00955825|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
284233|NCT00955877|Washington University in St. Louis School of Medicine|Diego Morales|3144544688|d.morales@wustl.edu|
284234|NCT00955903|Wake Forest School of Medicine|Jamy Ard, MD|3367169837|jard@wakehealth.edu|
269844|NCT00088634|Sunovion|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
269845|NCT00088699|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
269846|NCT00088881|ECOG Statistical Office|Study Statistician|617-632-3012||
269847|NCT00088907|ECOG Statistical Office|Study Statistician|617-632-3012||
269848|NCT00088985|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@UNC.med.edu|
269849|NCT00089011|Fred Hutch|David G Maloney, MD PhD|(206) 667-5616|dmaloney@fredhutch.org|
284235|NCT00955916|H. Lee Moffitt Cancer Center and Research Institute|Rami Komrokji, M.D.|813-745-4291|rami.komrokji@moffitt.org|
284236|NCT00955955|Massachusetts General Hospital- Depression Clinical and Research Program|Dr. George Papakostas- Director of Treatment Resistant Depression Studies|617-726-6697|gpapakostas@partners.org|
269850|NCT00089024|University of Nebraska Medical Center|Jean L. Grem, MD|402-552-3233|jgrem@unmc.edu|
284237|NCT00955968|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
284238|NCT00956020|NYEEI Department of Otolaryngology|Anthony Sclafani, MD|212-979-4200|asclafani@nyee.edu|
284239|NCT00956085|Stanford University|Carolyn Rodriguez, MD, PhD, Assistant Professor|6507236158|cr2163@stanford.edu|
284240|NCT00956254|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602 910-2617|ldillaha@insysrx.com|
297163|NCT01731600|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
284241|NCT00956293|Novartis Pharmaceuticals|Study Director|+1 (862) 778-1873||
284242|NCT00956540|Hospital Virgen de la Salud|Dr. Gonzalo Hernández|0034629625428|ghernandezm@telefonica.net|
284243|NCT00956592|Oregon Health & Science University|Michael Aziz|503-494-5581|azizm@ohsu.edu|
284244|NCT00956631|Vertos Medical|VP of Clinical, Regulatory and Quality|9493490008|cmyers@vertosmed.com|216
284245|NCT00956657|NHS Greater Glasgow & Clyde|Gavin H. Taylor, Clinical Psychologist|0141 211 2134|gavin.taylor@ggc.scot.nhs.uk|
297164|NCT01731678|University of Calgary|Frank MacMaster, PI of the project|403-955-2784|fmacmast@ucalgary.ca|
297165|NCT01731691|Institute for Human Genetics and Biochemistry|Dr. Cynthia L. Bristow|631-444-6238|cynthia.bristow@stonybrook.edu|
284246|NCT00956709|CHU de Nantes|Dr Pham Dang|33 2 53 48 24 15|charles.phamdang@chu-nantes.fr|
284247|NCT00956761|Novartis Vaccines and Diagnostics S.r.l|Posting Director||RegistryContactVaccinesUS@novartis.com|
284248|NCT00956813|Mayo Clinic|Debra L. Barton, RN, PhD, AOCN||barton.debra@mayo.edu|
292835|NCT01450826|Duke University Medical Center|Mary Lou Affronti, DNP, RN, MHSc, ANP|9196845301|mary.affronti@duke.edu|
292836|NCT01450943|VA Northern California Health Care System|Sara Dahle, D.P.M., M.P.H.|916-843-7151|Sara.dahle@va.gov|
297166|NCT01731886|Columbia University|Suzanne Lentzsch, MD, PhD, Professor of Medicine|646-317-4840|sl3440@cumc.columbia.edu|
292837|NCT01451164|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
292838|NCT01451203|Astellas Pharma Inc|Vice President, Japan/Asia Clinical Development||Astellas.resultsdisclosure@astellas.com|
292839|NCT01451372|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
292840|NCT01451385|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
292841|NCT01451398|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
292842|NCT01451411|Cumberland Pharmaceuticals Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
292843|NCT01451424|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
292844|NCT01451437|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292845|NCT01451463|The Ohio State University|Sandra K Kostyk, MD, PhD|6142934969|sandra.kostyk@osumc.edu|
292846|NCT01451541|Sunovion|Respiratory Medical Director|1-866-503-6351||
269851|NCT00089076|Mayo Clinic|Dr. Stephen Ansell|507-284-0923|ansell.stephen@mayo.edu|
292847|NCT01451554|Mayo Clinic|Jon O. Ebbert, MD|507-255-3965|ebbert.jon@mayo.edu|
292848|NCT01451606|University of Maryland, Baltimore|Dr. Joel Greenspan|4107067090|jgreenspan@umaryland.edu|
297167|NCT01731912|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
297168|NCT01731938|Grifols Therapeutics, Inc.|Henry Li, PhD, RAC|1-919-316-6042|Henry.Li@Grifols.com|
297169|NCT01731951|Geron Corp.|Study Director|650-473-7700|myf2001-info@geron.com|
297170|NCT01731990|Novartis Pharmaceuticals|Study Director|862-778-8300||
297171|NCT01732107|Hoosier Cancer Research Network|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
297172|NCT01732263|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
297173|NCT01732406|Massachusetts General Hospital|Dr. Karen Miller|617-726-3870|kkmiller@partners.org|
297174|NCT01732419|Maxima Medical Center|Dr. J. Kraal|+31612520944|j.kraal@mmc.nl|
297175|NCT01732445|Mayo Clinic|Ruben A. Mesa, M.D.|480/301-8335|mesa.ruben@mayo.edu|
297176|NCT01732458|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297177|NCT01732471|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
297178|NCT01732484|Medical University of Vienna|Prof. Dr. R. Menapace|+43 699 19660272|rupert.menapace@meduniwien.ac.at|
297179|NCT01732510|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297180|NCT01732536|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
297181|NCT01732549|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
297182|NCT01732588|MMV|Dr Fiona Macintyre|+41 22 799 4060|macintyref@mmv.org|4078
297183|NCT01732627|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
297184|NCT01732640|Johns Hopkins University|Hao Wang|410-614-3426|hwang76@jhmi.edu|
297185|NCT01732692|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
297186|NCT01732718|University of North Carolina at Chapel Hill|Kenneth Ataga, MD|901-448-2813|kataga@uthsc.edu|
297187|NCT01732757|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
297188|NCT01732770|Amgen Inc.|Study Director|866-572-6436||
297189|NCT01732783|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
297190|NCT01732796|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297191|NCT01732809|Brazilian Center for Studies in Dermatology|Scientific Coordinator|+55 51 30262633|cientifico@cbed.org.br|
297192|NCT01732822|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00|kontakt@astrazeneca.com|
297193|NCT01732835|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
297194|NCT01732874|Nationwide Childrens Hospital|Dr. Christina J. Valentine MD,MS,RD|(614) 722-2000|Christina.Valentine@nationwidechildrens.org|
297195|NCT01733056|Emory University|Dr. Robert Swerlick|404-727-3669|rswerli@emory.edu|
284249|NCT00956839|Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow|Professor Eesh Bhatia|00915222494382|ebhatia@sgpgi.ac.in|
284250|NCT00956930|Northwestern University|Riad Salem MD|312-695-6371|rsalem1@nm.org|
284251|NCT00956943|University of Pennsylvania|Robert A. Schnoll, Ph.D.|215-746-7143|schnoll@mail.med.upenn.edu|
284252|NCT00957008|University of South Carolina|Project director|8037773881|msui@mailbox.sc.edu|
284253|NCT00957021|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@Stryker.com|
284254|NCT00957047|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
284255|NCT00957229|Children's Hospital of Oakland Research Institute, Oakland|Ervin H Epstein Jr., MD|510-450-5688|eepstein@chori.org|
284256|NCT00957242|University of Chicago Hospital|Imre Noth, MD, Associate Professor of Medicine|773-834-1832|inoth@medicine.bsd.uchicago.edu|
284257|NCT00957268|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
284258|NCT00957333|WanFangH|Ruei-Ming Chen|02-27361661|rmchen@tmu.edu.tw|3222
284259|NCT00957359|NYU Langone Health|Stephen Ross, MD|212-263-7264|Stephen.Ross@nyulangone.org|
284260|NCT00957372|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
284261|NCT00957424|Roswell Park Cancer Institute|Richard O'Connor|716-845-4517|richard.oconnor@roswellpark.org|
284262|NCT00957528|The University of Texas Medical Branch at Galveston|Randall Urban, M.D., Professor of Medicine|409- 772-1176|rurban@utmb.edu|
284263|NCT00957580|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
284264|NCT00957593|Lehigh Valley Health Netword|Joanne N. Quinones MD MSCE|6104021221|joanne_n.quinones@lvhn.org|
284265|NCT00957658|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
284266|NCT00957671|University of Texas Medical Branch|Randall Urban, MD|409-772-1176|rurban@utmb.edu|
284267|NCT00957684|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
284268|NCT00957723|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@Stryker.com|
284269|NCT00957801|University of Texas Medical Branch|Randall J Urban, Professor and Chair, Internal Medicine|409-772-1176|rurban@utmb.edu|
284270|NCT00957853|UT MD Anderson Cancer Center|Dr. Maura Gillison, PHD/Professor, Thoracic-Head & Neck Med Onc|713-792-6363|mgillison@mdanderson.org|
284271|NCT00957905|Memorial Sloan Kettering Cancer Center|Dr. Darren Feldman|646-422-4491|feldmand@mskcc.org|
284272|NCT00957931|University of California, San Francisco|Dr. Sandhya Kharbanda, MD||Sandhya.Kharbanda@ucsf.edu|
284273|NCT00957944|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
284274|NCT00957996|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
284275|NCT00958009|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|Fernando.dangond@emdserono.com|
284276|NCT00958035|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
284277|NCT00958074|University of Washington|Dr. Andrei Shustov|206-288-6744|ashustov@uw.edu|
284278|NCT00958126|Seqirus|Clinical Trials Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
284279|NCT00958165|CardioFocus, Inc|Burke T. Barrett|508 658-7200|bbarrett@cardiofocus.com|
284280|NCT00958191|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
284281|NCT00958217|VA San Diego Healthcare System/UCSD|Susan R. Tate, Ph.D., Clinical Psychologist|619-426-9402|srtate@ucsd.edu|
284282|NCT00958243|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
284283|NCT00958256|University of Texas (UT) MD Anderson Cancer Center|Jorge Romaguera, MD/Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
284284|NCT00958282|University of Minnesota|Dr. Marc Mooney|6129916875|moon0078@umn.edu|
284285|NCT00958308|Bio-K+ International. Inc.|Dr. Serge Carrière|450-978-2465|scarriere@biokplus.com|
284286|NCT00958334|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
284287|NCT00958360|Hines VA Blind Center|Joan Stelmack, O.D., M.P.H.|708-202-2124|joan.stelmack@va.gov|
284288|NCT00958412|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
284289|NCT00958438|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
284290|NCT00958477|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
284291|NCT00958568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284292|NCT00958581|NYU hospital for Joint Diseases|Dr. Thomas Errico (Chief of Spine), Dr. Kushagra Verma (Co-investigator)|212-598-6076|thomas.errico@nyumc.org; vermak01@gmail.com|
297196|NCT01733069|Gen-Probe Incorporated|Jennifer Reid, Director of Clinical Affairs|858-731-5985|jennifer.reid@hologic.com|
284293|NCT00958711|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
284294|NCT00958724|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
284295|NCT00958776|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
284296|NCT00958789|Stryker Orthopaedics|Ellen Axelson, Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
284297|NCT00958828|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
284298|NCT00958841|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
284299|NCT00958880|Southern Methodist University|Jasper Smits, Ph.D.|214-768-4310|jsmits@smu.edu|
297197|NCT01733121|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
284300|NCT00958919|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
284301|NCT00959049|Seqirus|Clinical Program Director||Seqirus.ClinicalTrials@Seqirus.com|
284302|NCT00959166|Imperial College London|Prof Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
284303|NCT00959192|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308470|NCT02582151|Lawson Health Research|Blayne Welk|5196466000|lawson@lawsonresearch.ca|
284304|NCT00959374|Covidien|Amy Pollack M.D. Vice President Medical Affairs, STI|203-821-4719|amy.pollack@covidien.com|
284305|NCT00959647|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
284306|NCT00959660|Wake Forest School of Medicine|Dalane W. Kitzman, M.D.|336-716-3274|dkitzman@wakehealth.edu|
284307|NCT00959699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
284308|NCT00959751|NeurAxon, Inc.|Thomas Lategan, PhD|417-673-6697|tlategan@neuraxon.com|
284309|NCT00959764|Tarsa Theapeutics, Inc.|Dr. David Krause, Chief Medical Officer|1-267-273-7940|dkrause@tarsatherapeutics.com|
284310|NCT00959842|Professor|Dr. Greg Shearer|814-867-3040|gcs13@psu.edu|
284311|NCT00959894|UNC School of Medicine|Michelle Floris-Moore, M.D., M.S.|919-966-2537|mfloris@med.unc.edu|
284312|NCT00959907|CBED|Débora Zechmeister do Prado|55 51 30262633|cbed@cbed.org.br|
284313|NCT00959920|Loyola University Medical Center|Dr. Sarita Massey|708-354-9250|smassey@lumc.edu|
308471|NCT02582216|Hôpital Erasme|Dominique Mouraux|+32/2.555.38.48|dmouraux@ulb.ac.be|
284314|NCT00959946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308472|NCT02582242|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
284315|NCT00959985|Massachusetts General Hospital|Dr. Alphonse G Taghian, MD PhD|617-726-6050|ataghian@partners.org|24369
284316|NCT00960011|The University of Hong Kong|Dr. Joe Fan King Man|852-22553111|drfanj@gmail.com|
284317|NCT00960063|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284318|NCT00960076|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
284319|NCT00960115|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
284320|NCT00960193|Mutual Pharmaceutical Company, Inc.|Medical Drector|215-697-1743|clinicaltrials@urlmutual.com|
284321|NCT00960206|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
284322|NCT00960323|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
284323|NCT00960375|V Maryland Healthcare System|Dr. Melanie Bennett, Research Health Scientist|410-637-1859|Melanie.Bennett@va.gov|
284324|NCT00960440|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284325|NCT00960505|University of Illinois Chicago|Krista Varady, PhD, Associate Professor|3129967897|varady@uic.edu|
284326|NCT00960531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284327|NCT00960570|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
284328|NCT00960622|St Luke's Roosevelt Hospital New York|Dr. Donald Phillip Kotler|212 523 3670|dkotler@chpnet.org|
284329|NCT00960661|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
284330|NCT00960687|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
284331|NCT00960778|Medical University of South Carolina|Dr. Karen Hartwell|843-792-8174|hartwelk@musc.edu|
284332|NCT00960804|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284333|NCT00960843|Ethicon Endo-Surgery Inc.|Michael Schwiers Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
284334|NCT00960856|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clincialtrials@urlmutual.com|
284335|NCT00960869|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
284336|NCT00960934|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
284337|NCT00960986|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284338|NCT00960999|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
269852|NCT00089102|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
284339|NCT00961051|Abbott Medical Optics|Eugenia Thomas, O.D.|714-247-8723|eugenia.thomas@amo.abbott.com|
284340|NCT00961064|National Heart Lung and Blood Institute|Young, Neal|+1 301 496 5093|youngns@mail.nih.gov|
284341|NCT00961116|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
284342|NCT00961181|University Medical Center, Freiburg i.Br., Germany|Prof. Dr. Christoph Hehrlein|+49 761 270|christoph.hehrlein@uniklinik-freiburg.de|6095
269853|NCT00089284|Northwestern University|Clinical Research Office Administrator|312-695-1301|cancertrials@northwestern.edu|
269854|NCT00089297|ECOG Statistical Office|Study Statistician|617-632-3012||
269855|NCT00089479|Hoffman-LaRoche|Medical Communications|800-821-8590||
269856|NCT00089505|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
269857|NCT00089544|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
269858|NCT00089583|ViiV Healthcare|GSK Response Center|866-435-7343||
269859|NCT00089609|National Cancer Institute, National Institutes of Health|Ravi Madan, M.D.|301-480-7168|rm480i@nih.gov|
269860|NCT00089635|Amgen Inc.|Study Director|866-572-6436||
269861|NCT00089648|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
269862|NCT00089661|Amgen Inc.|Study Director|866-572-6436||
269863|NCT00089674|Amgen Inc.|Study Director|866-572-6436||
269864|NCT00089752|University of Pennsylvania School of Nursing|Terri E. Weaver, PhD, RN, FAAN|215-898-2992|tew@nursing.upenn.edu|
284343|NCT00961220|Case Comprehensive Cancer Center|Dr. Kevin Cooper|216-844-3111|kevin.cooper@uhhospitals.org|
284344|NCT00961233|University of North Carolina School of Medicine|Evan S. Dellon, MD MPH|919-966-2511|edellon@med.unc.edu|
269865|NCT00089778|National Cancer Institute (NCI), National Institutes of Health (NIH)|James Yang, M.D.|301-496-1574|jamesyang@mail.nih.gov|
284345|NCT00961259|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
284346|NCT00961298|Allegheny General Hospital|Alicia Kaplan MD|412-330-4069|akaplan@wpahs.org|
284347|NCT00961311|Medtronic Cardiovascular|K. Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
284348|NCT00961350|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
292849|NCT01451632|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
292850|NCT01451645|Regeneron|Clinical Trials Administrator|914 847 5385|clinicaltrials@regeneron.com|
292851|NCT01451749|Dongzhimen Hospital,Beijing University of Chinese Medicine|Dr.Jinzhou Tian|86-10-84013380|jztian@hotmail.com|
292852|NCT01451762|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
292853|NCT01451775|boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
292854|NCT01451814|Brown University School of Public Health|Dr. Christopher Kahler|401 863-6651|Christopher_Kahler@brown.edu|
292855|NCT01451827|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
292856|NCT01451931|University of California, San Francisco|Dr. Rebecca Smith-Bindman|415-353-4946|rebecca.smith-bindman@ucsf.edu|
292857|NCT01451983|Cleveland Clinic Center for Autism|Thomas W. Frazier, PhD|216-448-6440|fraziet2@ccf.org|
292858|NCT01451996|University of Chicago|Anup Malani, J.D., Ph.D|773-702-9602|amalani@uchicago.edu|
292859|NCT01452126|UNM Department of Anesthesiology|Dr Tim Petersen|5052722610|timpetersen@salud.unm.edu|505
292860|NCT01452152|University of Maryland School of Medicine|Dr. Alan R. Shuldiner|410-706-1623|ashuldin@medicine.umaryland.edu|
292861|NCT01452191|University of Nottingham|Professor Denise Kendrick||denise.kendrick@nottingham.ac.uk|
292862|NCT01452269|University of Rochester|Dr. Steven Barnett|585-275-7347|steven_barnett@urmc.rochester.edu|
292863|NCT01452347|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
292864|NCT01452412|Albert Einstein College of Medicine|Michal Melamed, MD|718-430-2496|michal.melamed@einstein.yu.edu|
292865|NCT01452425|UCLouvain|Pr Patrice Forget|3227641821|forgetpatrice@yahoo.fr|
292866|NCT01452529|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
292867|NCT01452789|Thomas Jefferson University|Walter Kraft|215 955 9077|walter.kraft@jefferson.edu|
292868|NCT01452919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292869|NCT01453023|GlaxoSmithKline|GSK Response Center|866-435-7343||
292870|NCT01453036|The Catholic University of Korea|Dr. Jin Il Kim|+82-2-3779-2382|jikim@catholic.ac.kr|
292871|NCT01453049|GlaxoSmithKline|GSK Response Center|866-435-7343||
292872|NCT01453075|VA ORD|Mary Jane Burton|6013624471|mary.burton2@va.gov|1251
292873|NCT01453153|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
292874|NCT01453166|Instituto de Ensino e Pesquisa do Hospital do Coração|Dr. Otavio Berwanger|+ 55 11 30536677|oberwanger@hcor.com.br|8201
292875|NCT01453205|MedImmune, LLC|Mohammed Dar|301-398-4095|information.center@astrazeneca.com|
292876|NCT01453296|GlaxoSmithKline|GSK Response Center|866-435-7343||
292877|NCT01453348|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
292878|NCT01453361|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
292879|NCT01453374|Alkermes|Bernard L. Silverman, MD|781-609-6000|Bernard.Silverman@alkermes.com|
292880|NCT01453387|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
292881|NCT01453413|Taking Control of Your Diabetes|Dr. Steven Edelman, MD|858-755-5683|svedelman@vapop.ucsd.edu|
292882|NCT01453439|Massachusetts General Hospital|Dr. Sabine Wilhelm, Ph.D.|+1(617)724-6146|swilhelm@mgh.harvard.edu|
269866|NCT00089791|Amgen Inc.|Study Director|866-572-6436||
269867|NCT00089843|Massachusetts General Hospital|Anne Klibanski, M.D.|617-726-3870|aklibanski@partners.org|
269868|NCT00089973|GlaxoSmithKline|GSK Response Center|866-435-7343||
269869|NCT00089986|GlaxoSmithKline|GSK Response Center|866-435-7343||
269870|NCT00089999|GlaxoSmithKline|GSK Response Center|866-435-7343||
269871|NCT00090051|Hoffmann-La Roche|Medical Communications||global.clinical_trial_registry@roche.com|
269872|NCT00090064|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corp.|Julie B. Wang, MPH, PhD/ Senior Clinical Data Scientist|(831) 429-6362|juliewang@mapsbcorp.com|
269873|NCT00090103|GlaxoSmithKline|GSK Response Center|866-435-7343||
269874|NCT00090220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269875|NCT00090233|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
269876|NCT00090285|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269877|NCT00090363|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
275952|NCT00520039|West Virginia School of Osteopathic Medicine|Dr. Karen Steele|(304)667-4255|ksteele@osteo.wvsom.edu|
275953|NCT00520130|National Cancer Institute|Dr. Steven Z. Pavletic|301- 402-4899|sp326h@nih.gov|
275954|NCT00520234|Mycoses Study Group|Luis Ostrosky-Zeichner, MD|(713) 500-6733|Luis.Ostrosky-Zeichner@uth.tmc.edu|
275955|NCT00520286|National Institutes of Health|Liza Zeinert|301-443-1138|liza.zeinert@nih.gov|
275956|NCT00520299|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org|
275957|NCT00520351|Centre for Contact Lens Research|Craig A Woods, Research Manager|519-888-4567|cawoods@sciborg.uwaterloo.ca|36547
275958|NCT00520403|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
275959|NCT00520468|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
275960|NCT00520481|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292883|NCT01453569|Shanghai Greenvalley Pharmaceutical Co., Ltd.|Dr. Xianliang Xin|86 21-50504988|xinxianliang@hotmail.com|1370
275961|NCT00520494|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
284349|NCT00961402|University of Minnesota|Beth Lewis|612-625-0756|blewis@umn.edu|
297198|NCT01733186|MEDIPOST Co., Ltd.|Director of Product Development Department|+82-2-3465-6740|meehyunj@medi-post.co.kr|
284350|NCT00961415|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
284351|NCT00961441|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
284352|NCT00961532|Northwestern Medicine|Andrew M Naidech|312-503-3335|a-naidech@northwestern.edu|
284353|NCT00961571|Georgetown University, Department of Medicine and Oncology|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
284354|NCT00961636|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269878|NCT00090402|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
284355|NCT00961649|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
284356|NCT00961662|University of Kentucky|Robert Lodder|859-955-0845|lodder@uky.edu|
284357|NCT00961896|Novartis|Study Director|862-778-8300||
284358|NCT00961961|UPenn|Dr. Robert J. DeRubeis|215-573-5804|derubeis@psych.upenn.edu|
284359|NCT00962000|University of Louisville Kidney Disease Program|Richard A. Ward, Ph.D.|502-852-5757|richard.ward@louisville.edu|
284360|NCT00962013|Stryker Orthopaedics|Director of Clinical Research|201-831-5401|Ellen.Axelson@stryker.com|
284361|NCT00962039|The Ohio State University|John V. Campo|614-581-5984|john.campo@hsc.wvu.edu|
284362|NCT00962065|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH|281-863-3000||
284363|NCT00962078|Schoen Klinik Berchtesgadener Land, Schoenau am Koenigssee, Germany|Dr. Rainer Gloeckl|+49 8652 931630|rgloeckl@schoen-klinik.de|
284364|NCT00962091|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
297199|NCT01733212|New York Methodist Hospital|Sandip Darji|718/780-3779|darji_sandip2005@yahoo.com|
284365|NCT00962104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284366|NCT00962208|The Hong Kong Polytechnic University|Prof Pauline Cho|(852) 2766-6100|sopaulin@polyu.edu.hk|
284367|NCT00962247|SUNY Buffalo|Leonard H. Epstein|716-829-3400|lhenet@buffalo.edu|
284368|NCT00962390|Ausio Pharmaceuticals, LLC|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|513-731-0222|rick@ausiopharma.com|
284369|NCT00962585|Ausio Pharmaceuticals, LLC|Rick Schwen, PhD, DABT, RAC / Vice President of Regulatory Affairs|513-731-0222|rick@ausiopharma.com|
284370|NCT00962598|Icahn School of Medicine at Mount Sinai|Dr. Vilma Gabbay|212-659-1661|vilma.gabbay@mssm.edu|
284371|NCT00962650|Ethicon Endo-Surgery, Inc.|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
284372|NCT00962741|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284373|NCT00962754|Princess Amalia Children's Clinic, Isala Klinieken|Dr. J. Bekhof|0031-38-4245050|j.bekhof@isala.nl|
284374|NCT00962780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284375|NCT00962871|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
284376|NCT00962949|Vanderbilt University Medical Center|Hossam Mustafa||adcresearch@vanderbilt.edu|
284377|NCT00963105|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
284378|NCT00963157|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216||
284379|NCT00963235|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284380|NCT00963430|Group Health Research Institute|Lisa Jackson, MD, MPH|206-442-5216||
297200|NCT01733238|Sierra Oncology, Inc.|Barbara Klencke, MD|650-273-5762|bklencke@sierraoncology.com|
284381|NCT00963482|Divsion Substance Use Disorder, Psychiatric Hospital of the Univeristy of Basel|M. Sc. S. Müller (Site-investigator) Prof. G. A. Wiesbeck (PI)|+41 61 325 53 33|sandra.mueller@upkbs.ch|
284382|NCT00963508|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914 -345-9001|natalie.yantovskiy@taro.com|
284383|NCT00963547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284384|NCT00963560|Alcon Research, Ltd.|Director of Alcon Clinical|888-451-3937; 817-568-6725|medinfo@alconlabs.com|
284385|NCT00963638|William Beaumont Hospitals|Catherine Coleman, RN, BSN|248-655-5865|cjcoleman@beaumont.edu|
269879|NCT00090493|University of Arkansas for Medical Sciences - MIRT|Frits van Rhee, MD, PhD|(501) 686-8230|vanrheefrits@uams.edu|
269880|NCT00090519|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
269881|NCT00090545|National Cancer Institute, National Institues of Health|William Dahut, M.D.|301-435-8183|dahutw@mail.nih.gov|
269882|NCT00090584|New England Research Institutes|Anne Stoddard, ScD|617-972-3331|astoddard@neriscience.com|
269883|NCT00090610|Duke University Medical Center|Angeles Alvarez Secord, Director of Gynecologic Oncology Clinical Trials|919-684-3765|secor002@mc.duke.edu|
269884|NCT00090753|Hoffmann-La Roche|Medical Communications|800-821-8590||
269885|NCT00090766|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
269886|NCT00090779|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
269887|NCT00090844|Division of Hematology & Oncology, University of California, San Francisco|Pamela Munster, MD|415-476-1000|Pmunster@medicine.ucsf.edu|
297201|NCT01733277|ArthroLab Inc.|Dr Jean-Pierre Pelletier|15148908000|dr@jppelletier.ca|26666
269888|NCT00090857|Dana-Farber Cancer Institute|Judy E. Garber, MD, MPH|617.632.2282|Judy_Garber@dfci.harvard.edu|
269889|NCT00090987|AMC|Jeannette Y. Lee, Director of Statistical Center|(501) 526-6712|jylee@uams.edu|
269890|NCT00091026|University of Chicago|Hedy Kindler, MD|(773) 702-0360|hkindler@medicine.bsd.uchicago.edu|
269891|NCT00091169|ECOG-ACRIN Statistical Office|Study statistician|617-632-3012||
269892|NCT00091260|Boston Medical Center|Vaishali Sanchorawala|6176386521|vaishali.sanchorawala@bmc.org|
269893|NCT00091273|University of Virginia|Craig L. Slingluff, MD|434-924-1730|cls8h@virginia.edu|
284386|NCT00963677|The Second Xiangya Hospital of Central South University|Ru-Ping Dai, B.Sc(Med), PhD, Associate Professor|86-731-85295970|Ruping_dai@yahoo.com.cn|
284387|NCT00963807|Washington University in St. Louis|John P Crandall|(314) 747 - 5561|jcrandall@wustl.edu|
284388|NCT00963820|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
284389|NCT00963859|The University of Texas (UT) MD Anderson Cancer Center|John W. Davis, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
284390|NCT00963872|University of Minnesota|Dr. Claudio Brunstein|612-625-3918|bruns072@umn.edu|
284391|NCT00963911|Institut Bergonié|Pr Pierre Soubeyran|33(0)556333333|p.soubeyran@bordeaux.unicancer.fr|
284392|NCT00963924|Nathan Klein Institute for Psychiatric Research|Dr. Donald C Goff|646-754-4843|donald.goff@nyumc.org|
284393|NCT00963937|GlaxoSmithKline|GSK Response Center|866-435-7343||
284394|NCT00963989|Penumbra, Inc.|Director of Clinical Affairs|+1 510 995 2183|blawson@penumbrainc.com|
284395|NCT00964028|GlaxoSmithKline|GSK Response Center|866-435-7343||
284396|NCT00964119|University of Wisconsin - Madison|Dermatology Clinical Trials Administrator|608-287-2640|dbock@dermatology.wisc.edu|
284397|NCT00964158|GlaxoSmithKline|GSK Response Center|866-435-7343||
284398|NCT00964223|GlaxoSmithKline|GSK Response Center|866-435-7343||
284399|NCT00964353|University of Chicago|Dr David Meltzer|773-702-0836|dmeltzer@medicine.bsd.uchicago.edu|
284400|NCT00964366|GlaxoSmithKline|GSK Response Center|888-435-7343||
284401|NCT00964392|Biosense Webster, Inc.|Robert Stagg, Clinical Franchise|(800) 729-9010|RStagg@its.jnj.com|
284402|NCT00964431|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
269894|NCT00091390|NRG Oncology|Wendy Seiferheld||seiferheldw@nrgoncology.org|
284403|NCT00964444|Pinnacle Health|David B. Peisner MD|717-231-8472|dpeisner@pinnaclehealth.org|
284404|NCT00964496|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|Zhizheng Ge, MD. Ph.D. Director of the Clinical Trials|86-21-68383015|zhizhengge@yahoo.com.cn|
284405|NCT00964548|UMASS Medical School|Susanne Muehlschlegel, MD, MPH, Principal Investigator|508-856-4667|susanne.muehlschlegel@umassmemorial.org|
284406|NCT00964678|Virginia Commonwealth University Health System|Dan Grinnan, MD|804-828-9000|daniel.grinnan@vcuhealth.org|
284407|NCT00964743|H. Lee Moffitt Cancer Center and Research Institute|Edward Pan, M.D.|813-745-3871|edward.pan@moffitt.org|
284408|NCT00964782|Milton S. Hershey Medical Center|Compliance Specialist|7175310003|clinicaltrials.gov@pennstatehealth.psu.edu|287544
284409|NCT00964795|Regeneron|Clinical Trials Administrator|9148475385|clinicaltrials@regeneron.com|
284410|NCT00964860|Procter and Gamble|Holly Eynon|513-622-2920|eynon.ha@pg.com|
284411|NCT00964886|VA San Diego Healthcare System|Joseph H. Atkinson MD|858 552 8585|joseph.atkinson@va.gov|2568
284412|NCT00965081|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
269895|NCT00091442|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Director Medical Leader|908 218 7361||
284413|NCT00965094|Novartis Pharmaceuticals|Study Director|862-778-8300||
297202|NCT01733316|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
284414|NCT00965185|Massachusetts General Hospital|Dr. Steven K Grinspoon|617-724-9109|sgrinspoon@mgh.harvard.edu|
297203|NCT01733329|Hospital Universitario José Eleuterio González, Universidad Autónoma de Nuevo León|Dr. Flavio Hernández Castro|8112776459|flaviohernandezc@yahoo.com|
297204|NCT01733368|Hospital Clinico Universitario Virgen de la Victoria|Dr. Javier Alzueta Rodríguez|951 03 20 00|jalzueta@telefonica.net|
297205|NCT01733407|Massachusetts General Hospital|Dr. Florian Eichler|617-643-3799|Feichler@partners.org|
297206|NCT01733472|Region Skane|Andreas Harsten|46708870567|andreas.harsten@skane.se|
297207|NCT01733628|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
297208|NCT01733680|SUNy Upstate Medical University|Gail P DePalma|3154643260|depalmag@upstate.edu|
297209|NCT01733732|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
297210|NCT01733745|Alcon Research, Ltd.|Abayomi Ogundele, Pharm.D, Global Brand Medical Affairs Lead|1-888-451-3937|alcon.medinfo@alcon.com|
297211|NCT01733758|GlaxoSmithKline|GSK Response Center|866-435-7343||
269896|NCT00091507|Tufts Medical Center|Co-Principal Investigator|617-636-8788|jbeshansky@tuftsmedicalcenter.org|
269897|NCT00091572|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269898|NCT00091793|Amgen Inc.|Study Director|866-572-6436||
269899|NCT00091819|Theravance, Inc.|Steven Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
269900|NCT00091832|Amgen Inc.|Study Director|866-572-6436||
269901|NCT00091949|Yale School of Medicine|Walter N. Kernan|203-764-7000|walter.kernan@yale.edu|
269902|NCT00091962|University of Pittsburgh School of Medicine|Dr. Bruce L Rollman, Principal Investigator|(412) 692-2659|rollmanbl@upmc.edu|
269903|NCT00092417|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
269904|NCT00092443|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269905|NCT00092456|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269906|NCT00092495|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269907|NCT00092521|Merck Sharp & Dohme Corp.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269908|NCT00092534|Merck Sharp & Dohme Corp.|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269909|NCT00092547|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269910|NCT00093015|Amgen Inc.|Study Director|866-572-6436||
269911|NCT00093041|Genmab A/S|VP Clinical Operations Eva Järlid Westerberg|+45 7020 2728|E.Westerberg@genmab.com|
297212|NCT01733953|University of Minnesota|Cameron Naughton|612-625-3623|naug0009@umn.edu|
284415|NCT00965237|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
284416|NCT00965250|National Cancer Institute, National Institutes of Health|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
284417|NCT00965263|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|6467746153|meg.haney@nyspi.columbia.edu|
284418|NCT00965341|The University of Texas (UT) MD Anderson Cancer Center|Rony Dev, DO / Assistant Professor|713-745-4192|HMoreno@mdanderson.org|
284419|NCT00965419|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284420|NCT00965458|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
284421|NCT00965484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284422|NCT00965497|University of South Carolina School of Medicine|Meera Narasimhan, MD|803-434-1100|shardeman@uscmed.sc.edu|
284423|NCT00965523|Eisai|Tatsuo Watanabe, Study Director|+81-3-3817-5252||
284424|NCT00965562|Donaghue Medical Research Foundation|Dr. Kimberly Yonkers|1-203-764-6621|Kimberly.Yonkers@yale.edu|
284425|NCT00965575|Cincinnti Childrens|Sejal Jain|513-636-4222|sejal.jain@cchmc.org|
284426|NCT00965718|Yonsei university|Moonjae Chung, MD|82-2-2228-2274|MJCHUNG@yuhs.ac|
284427|NCT00965731|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284428|NCT00965848|Medical Affairs, Janssen-Cilag Ltd.,Thailand|Medical Affairs Director|662-792-7200||
284429|NCT00966186|Seoul National University Bundang Hospital|Jung-Won Hwang|82-31-787-7499|jungwon@snubh.org|
284430|NCT00966238|VaxInnate|Dr. David N. Taylor|609-860-2260|david.taylor@vaxinnate.com|
284431|NCT00966264|Helsinki University|Ritva Hurskainen|+23845872267|ritva.hurskainen@hus.fi|
284432|NCT00966277|University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor, Sarcoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
269912|NCT00093145|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
284433|NCT00966355|Korea University College of Medicine|Prof. Soon Ho Um|+82-2-920-5019|umsh@korea.ac.kr|
284434|NCT00966433|Wake Forest University Health Sciences|Dr. Thomas Templeton, MD|336-716-4285|ttemplet@wakehealth.edu|
284435|NCT00966446|Perelman School of Medicine, University of Pennsylvania|Ebbing Lautenbach, MD, MPH, MSCE|215-898-6977|ebbing@mail.med.upenn.edu|
284436|NCT00966550|Illinois Institute of Technology|Dr. Britt Burton-Freeman|312-567-5307|bburton@iit.edu|
284437|NCT00966641|PLx Pharma|Ronald Zimmerman|1-713-842-1249|ron.zimmerman@plxpharma.com|205
284438|NCT00966693|UT MD Anderson Cancer Center|Weber,Donna M.,M.D. / Lymphoma/Myeloma|713-792-2860|dmweber@mdanderson.org|
284439|NCT00966719|Children's Hospital of Eastern Ontario|Dr Catherine Pound|613-737-7600|cpound@cheo.on.ca|
284440|NCT00966823|Rhode Island Hospital|Francois I. Luks, MD, PhD|401-228-0556|Francois_Luks@brown.edu|
284441|NCT00966849|Imperial College London|Professor Simon Gregson|+4402075943279|Sajgregson@aol.com|2075943279
284442|NCT00966875|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284443|NCT00966940|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
284444|NCT00967005|Yale University|Dr. Marc N. Potenza, M.D., Ph.D.|203-737-3553|marc.potenza@yale.edu|
284445|NCT00967018|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
284446|NCT00967044|University of Texas MD Anderson Cancer Center|Yasuhiro Oki, MD / Assistant Professor, Lymphoma/Myeloma|713-792-2860|CR_Study_Registration@mdanderson.org|
284447|NCT00967226|Childrens Research Institute|Nancy M. Bauman MD, Principle Investigator|2024764270|nbauman@cnmc.org|
284448|NCT00967330|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
292884|NCT01453595|Memorial Sloan Kettering Cancer Center|Dr. Martin Voss|646-422-4631|vossm@mskcc.org|
292885|NCT01453725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292886|NCT01453855|Alcon Research, Ltd.|Theresa A Landry, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
292887|NCT01453894|Northwestern University Feinberg School of Medicine|David W. Baker, MD, MPH|312-503-6400|dbaker1@nmff.org|
292888|NCT01453998|GlaxoSmithKline|GSK Response Center|866-435-7343||
292889|NCT01454063|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
292890|NCT01454076|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
292891|NCT01454102|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
292892|NCT01454258|University Hospital Frankfurt|Prof Dr Dr Kai Zacharowski, FRCA|004969630186668|kai.zacharowski@kgu.de|
292893|NCT01454284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292894|NCT01454362|Queen Mary University of London|Dr Hayden McRobbie|0207 882 7260|researchamendments@bartsandthelondon.nhs.uk|
292895|NCT01454401|Reapplix Blokken 45 3460 Birkerød Denmark|MD, PhD Senior Consultant Magnus Löndahl||magnus.londahl@med.lu.se|
292896|NCT01454414|University of North Carolina at Chapel Hill|Dr. Meagan Vaughn|9196986208|meagan.vaughn@unc.edu|
292897|NCT01454505|Alcon Research, Ltd.|Terri Pasquine, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
292898|NCT01454531|ALK-ABELLÓ|ALICIA MARIN|+34 913276127|amaes@alk.net|
269913|NCT00093379|The University of Texas (UT) MD Anderson Cancer Center|Cathy Eng, MD/ Professor||CR_Study_Registration@mdanderson.org|
269914|NCT00093470|ECOG-ACRIN Statistical Office|Study statistician|617-632-6012||
269915|NCT00093496|Mayo Clinic Cancer Center|Charles Erlichman, M.D.||erlichman.charles@mayo.edu|
269916|NCT00093756|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D.|507/284- 9265|alex.adjei@roswellpark.org|
269917|NCT00093782|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
292899|NCT01454570|James J Peters VA Medical Center|Dr. Ann Spungen - PI|718-584-9000|ann.spungen@va.gov|5420
292900|NCT01454583|Foundation Stiftung Institut fuer Herzinfarktforschung Ludwigshafen, Germany|Professor Dr. Uwe Zeymer|+49 621 503 2813|Uwe.Zeymer@t-online.de|
284449|NCT00967343|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@Kiadis.com|
284450|NCT00967369|UT MD Anderson Cancer Center|Dr. Michelle A Fanale / Associate Professor, Lymphoma/Myeloma|713-792-2860|MFANALE@MDANDERSON.ORG|
284451|NCT00967473|Alcon Research, Ltd.|Director of Alcon Clinical|888-451-3937; 817-568-6725|medinfo@alconlabs.com|
284452|NCT00967486|Vascular center of excellence (CAMC medical staff-with admitting privileges)|Ali Fawazi AbuRahma MD|304-388-9973||
284453|NCT00967499|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
269918|NCT00093795|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|regulatory@nsabp.org|
284454|NCT00967551|Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Bahia, Brasil|Hugo Costa-Ribeiro||hugocrj@ufba.br|
284455|NCT00967616|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
284456|NCT00967668|VA Center for Clinical Management Research|Laura Damschroder|734-845-3603|laura.damschroder@va.gov|
297213|NCT01734161|Weill Cornell Medicine|Klaus Kjaer, MD|(212) 746-2953|klk9001@med.cornell.edu|
284457|NCT00967694|University of Utah Department of Anesthesiology|Dr. Eric Fox|775-340-0219|ericbfox@yahoo.com|
297214|NCT01734239|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284458|NCT00967798|Emory University|Arlene Stecenko, MD|404-712-2657|astecen@emory.edu|
284459|NCT00967941|CAMC Health System|Patrick Stone, MD|304-388-8250|pstone0627@yahoo.com|9901
284460|NCT00967993|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-379|medicalinfo@keryx.com|
284461|NCT00968019|Johnson and Johnson Medical Iberia|Mayda Lopez-Belmonte, PhD|+34 91 7228481|tlopezbe@its.jnj.com|
284462|NCT00968032|pfm medical ag|Christof Schmeer|+49 6873 9011|christof.schmeer@pfmmedical.com|41
284463|NCT00968071|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur M.D./Associate Proffesor|713-563-1586|eharriso@mdanderson.org|
284464|NCT00968227|Washington University|Michael Diringer PI|314-362-2999|diringerm@wustl.edu|
284465|NCT00968253|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PHD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
297215|NCT01734317|Mölnlycke Health Care|Joan Wilson|+1 706-650-1012|joan.wilson@molnlycke.com|
284466|NCT00968344|University of Texas Medical Branch|Douglas Paddon-Jones, Professor|409-772-3073|djpaddon@utmb.edu|
284467|NCT00968526|GlaxoSmithKline|GSK Response Center|866-435-7343||
284468|NCT00968539|GlaxoSmithKline|GSK Response Center|866-435-7343||
284469|NCT00968617|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
284470|NCT00968669|MedImmune|Joe Parker, MD|301-398-0000|parkerJ@medimmune.com|
284471|NCT00968708|Takeda|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
297216|NCT01734382|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
284472|NCT00968799|Cantonal Hospital St.Gallen|Sascha Müller, MD|+41 71 494 1317|ulrich.beutner@kssg.ch|
284473|NCT00968812|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
284474|NCT00968838|The University of Texas M D Anderson Cancer Center|Dr. Emil J. Freireich MD/Professor|713-792-2660|eharriso@mdanderson.org|
284475|NCT00968864|PRA Health Sciences|Dr. Andrew Gilman|704-615-2744|gilmanandy@prahs.com|
284476|NCT00968890|GlaxoSmithKline|GSK Response Center|866-435-7343||
284477|NCT00968968|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
284478|NCT00968981|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
284479|NCT00969124|Avantis Medical Systems , Inc.|Jack Higgins, MD - Chief Medical Officer|4086367226|jhiggins@avantismedical.com|
284480|NCT00969150|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
284481|NCT00969228|GlaxoSmithKline|GSK Response Center|866-435-7343||
284482|NCT00969280|Korea Institute of Oriental Medicine|Tae-Hun Kim, Researcher|82-10-6532-5524|rockandmineral@gmail.com|
308473|NCT02582255|FIDEC|Ricardo Rüttimann|+13058540075|rruttimann@fidec-online.org|
284483|NCT00969332|UCLA|Dr. Kara L. Calkins|310-825-9330|KCalkins@mednet.ucla.edu|
284484|NCT00969436|GlaxoSmithKline|GSK Response Center|866-435-7343||
308474|NCT02582515|Johns Hopkins University School of Medicine|Assistant Professor|443-287-5143|jfmcguire@jhmi.edu|
269919|NCT00093808|Mayo Clinic|Winston Tan, MD|904-953-7290|Tan.Winston@mayo.edu|
269920|NCT00093847|Massachusetts General Hospital|Dr George Papakostas, M.D.|6177266697|gpapakstas@partners.org|
269921|NCT00093964|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
269922|NCT00094055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269923|NCT00094094|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269924|NCT00094107|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269925|NCT00094172|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
269926|NCT00094211|Stanford University|Dr. Abby C. King|650-725-5394|king@stanford.edu|
269927|NCT00094302|New England Research Institutes|Brian Harty|617-972-3224|bharty@neriscience.com|
269928|NCT00094328|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
269929|NCT00094445|University of Texas (UT) MD Anderson Cancer Center|Vivek Subbiah, MD / Assistant Professor, Investigational Cancer Therapeutics|713-563-0393|CR_Study_Registration@mdanderson.org|
269930|NCT00094458|Centocor Ortho Biotech Services, L.L.C.|Study Director|215 325-7405||
269931|NCT00094497|University Hospital of Wuerzburg, Germany|Martin Fassnacht|+49-931-201-39021|fassnacht_m@ukw.de|
269932|NCT00094536|Cooper Surgical|Chief Medical Officer|203-601-5200|Robert.Auerbach@coopersurgical.com|
284485|NCT00969501|Georgia Institute for Clinical Research, LLC|Arnold Weil, MD|770-421-2030|research@lowbackpain.com|
284486|NCT00969540|Hologenix, LLC|Seth Casden|310-600-3673|seth.casden@celiant.com|
284487|NCT00969553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
284488|NCT00969618|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297217|NCT01734395|Jan-Cil Korea|Clinical Research Director|82 2 2094||4518
297218|NCT01734434|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
284489|NCT00969709|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
284490|NCT00969761|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
284491|NCT00969878|Baylor|Thomas Kosten|7137947032|kosten@bcm.edu|
284492|NCT00970073|Cleveland Clinic|Bijan Eghtesad|2164029954|eghtesb@ccf.org|
284493|NCT00970203|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
284494|NCT00970216|Chang Gung Memorial Hospital|Chau-Ting Yeh|88633281200|chautingy@gmail.com|8121
284495|NCT00970268|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
284496|NCT00970281|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284497|NCT00970294|University of Kansas Medical Center|Patricia Kluding PT PhD|913-588-6918|pkluding@kumc.edu|
284498|NCT00970307|GlaxoSmithKline|GSK Response Center|866-435-7343||
284499|NCT00970320|Ostfold Hospital Trust|Dr Hege Hølmo Johannessen|+4799721345|hege.holmo.johannessen@so-hf.no|
284500|NCT00970359|Memorial Sloan Kettering Cancer Center|Dr. Alan Ho|646-888-4235|hoa@mskcc.org|
284501|NCT00970489|Harvard School of Public Health|Namasha Schelling|617-432-1734|nschelling@hsph.harvard.edu|
284502|NCT00970502|Florida Radiation Oncology Group|Dr. Johnny Kao|813-661-6442|johnnykaomd@gmail.com|
284503|NCT00970593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284504|NCT00970632|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284505|NCT00970684|Case Comprehensive Cancer Center|Nathan Pennell MD|216-445-9285|penneln@ccf.org|
269933|NCT00094575|VAMC Minneapolis, MN|Dr. Frank A. Lederle|612-725-2158|Frank.Lederle@va.gov|
284506|NCT00970814|NIAAA|Megan Ryan - Clinical Trials Project Manager|301-443-4225|mryan1@mail.nih.gov|
284507|NCT00970853|Children's Hospital of Philadelphia|Dr. Jerilynn Radcliffe|215-590-7446|radcliffe@email.chop.edu|
284508|NCT00970944|Spaulding Rehabilitation Hospital|Joseph T Giacino, PhD|617-573-2757|jgiacino@partners.org|
284509|NCT00971048|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
284510|NCT00971178|Department of Anaesthesiology, the University of Hong Kong|Clinical Assistant Professor|852-22553303|cheucw@hku.hk|
269934|NCT00094653|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
284511|NCT00971204|CardioFocus, Inc.|Burke Barrett, VP Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
284512|NCT00971243|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
284513|NCT00971282|Galderma|Florence Paliargues|0033 4 92 95 29 57|Florence.Paliargues@Galderma.com|
284514|NCT00971295|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
284515|NCT00971321|GlaxoSmithKline|GSK Response Center|866-435-7343||
297219|NCT01734512|University of California, San Francisco|Dr. Sabine Mueller, MD, PhD|(415) 502-7301|sabine.mueller@ucsf.edu|
297220|NCT01734525|Federal University of Rio de Janeiro|Marcio Nucci|5521-39382463|mnucci@hucff.ufrj.br|
297221|NCT01734551|University of Kentucky|Dr. Henrietta S. Bada, Professor and Vice Chair, Academic Affairs|859-323-1019|hbada2@uky.edu|
297222|NCT01734655|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
297223|NCT01734746|MaastrichtUMC|R.F.P.M. Kruitwagen|+31433874767|r.kruitwagen@mumc.nl|
297224|NCT01734772|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297225|NCT01734785|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297226|NCT01734811|Inmunotek|Medical Director|916 510 010|mcasanovas@inmunotek.com|
297227|NCT01734850|CSL Behring|Trial Registration Coordinator|484-878-4000|clinicaltrials@cslbehring.com|
297228|NCT01734889|Swedish Orphan Biovitrum|Medical Director|+46 8 697 20 00|erik.brouwer@sobi.com|
297229|NCT01734902|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297230|NCT01734993|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
297231|NCT01735175|Sandoz|Strategic Planning, Biopharmaceutical Clinical Development|+49 (0) 8024 476 - 0|biopharma.clinicaltrials@sandoz.com|
269935|NCT00094757|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
269936|NCT00094770|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
269937|NCT00094809|Amgen Inc.|Study Director|866-572-6436||
269938|NCT00094835|Amgen Inc.|Study Director|866-572-6436||
269939|NCT00094861|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
269940|NCT00094887|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
269941|NCT00094900|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Raphaela Goldbach-Mansky, MD|13014356243|goldbacr@mail.nih.gov|
269942|NCT00095056|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
297232|NCT01735201|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
297233|NCT01735214|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
297234|NCT01735279|Department of Psychobiology, Universidade Federal de São Paulo (UNIFESP), Rua Napoleão de Barros, São Paulo , Brazil|Md PhD José Carlos F. Galduróz|+55 11 2149 0000|galduroz@unifesp.br|
269943|NCT00095121|Gilead Sciences|John Flaherty, PharmD, Director, Clinical Research|650-522-5592|John.Flaherty@gilead.com|
284516|NCT00971425|GlaxoSmithKline|GSK Response Center|866-435-7343||
284517|NCT00971620|National Cancer Institute|Dr. Edward Cowen|301-496-4299|cowene@mail.nih.gov|
284518|NCT00971633|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
284519|NCT00971737|Johns Hopkins University|Leisha Emens, MD, PhD||emensle@jhmi.edu|
284520|NCT00971750|Gundersen Lutheran Health System|Dr. Shanu Kothari|608-775-2331|snkothar@gundluth.org|
284521|NCT00971789|National Cancer Institute, National Institutes of Health|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
284522|NCT00971841|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
284523|NCT00971932|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
308475|NCT02582632|AbbVie|Global Medical Services|800-633-9110||
284524|NCT00971945|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
284525|NCT00971997|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284526|NCT00972088|bikur holim hospital|samuel n adler md, director of clinical trial|972 2 6464206|nasnadler@gmail.com|
284527|NCT00972153|Nimbic Systems|Sean Self|281-565-5715|self@nimbicsystems.com|
284528|NCT00972205|National Cancer Institute (NCI), National Institutes of Health (NIH)|Susan S. Bates, M.D.|301-402-0984|Batess@mail.nih.gov|
284529|NCT00972244|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
284530|NCT00972283|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
284531|NCT00972322|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284532|NCT00972335|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
284533|NCT00972374|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
284534|NCT00972439|USC/Norris Comprehensive Cancer Center|Celeste Pearce, Ph.D.|323 865 0437|cpearce@usc.edu|
284535|NCT00972478|SWOG|Study Statistician|206-667-4623||
284536|NCT00972504|GlaxoSmithKline|GSK Response Center|866-435-7343||
284537|NCT00972517|GlaxoSmithKline|GSK Response Center|866-435-7343||
284538|NCT00972530|Department of Research and Development County Council of Gavleborg/Uppsala University|Dr Tomas Weitoft|+46 26 154388|tomas.weitoft@lg.se|
284539|NCT00972543|Merck Serono S.A., a division of Merck KGaA|Medical Responsible|+49-6151-75-5200|service@merckgroup.com|
284540|NCT00972595|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284541|NCT00972621|Abbott Medical Optics, Inc.|Kendra Hileman, Ph.D., Head, Clinical Research & Development|714-247-8613|kendra.hileman@abbott.com|
284542|NCT00972725|GlaxoSmithKline|GSK Response Center|866-435-7343||
284543|NCT00972777|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
284544|NCT00972816|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
284545|NCT00972959|"Department of Clinical Therapeutics, University of Athens School of Medicine, Alexandra General Hospital of Athens,"|Prof. M. A. Dimopoulos|0030 210 3381511|mdimop@med.uoa.gr|
284546|NCT00973102|University of Washington|Scott Emerson, PhD|206-616-6678|semerson@uw.edu|
284547|NCT00973349|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
284548|NCT00973362|Hologic, Inc.|Vice President Clinical Affairs|858-410-8000|rainer.ziermann@hologic.com|
292901|NCT01454596|National Cancer Institute|Dr. Steven A. Rosenberg|240-858-3080|sar@nci.nih.gov|
292902|NCT01454726|Xuan Wu Hospital of Capital Medical University|Dr. Jianping JIA|0086-10-83198899|jiajp@vip.sina.com|8650
292903|NCT01454739|Bioverativ Therapeutics Inc.|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
269944|NCT00095147|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
269945|NCT00095173|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
269946|NCT00095199|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
269947|NCT00095212|Massachusetts General Hospital|Steven Grinspoon, MD|617 724 9109|sgrinspoon@partners.org|
269948|NCT00095238|Britol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
269949|NCT00095303|University of Miami Miller School of Medicine|Viviana E. Horigian, MD|305-243-4305|vhorigian@med.miami.edu|
269950|NCT00095498|Amgen Inc.|Study Director|866-572-6436||
269951|NCT00095563|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
269952|NCT00095576|Merck, Sharp & Dohme|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269953|NCT00095628|London Regional Cancer Centre|Dr. Eric Winquist|519-685-8600|eric.winquist@lhsc.on.ca|53243
269954|NCT00095836|Massachusetts General Hospital|John Clark, MD|617-724-4000|jrclark@partners.org|
269955|NCT00095875|Dana Farber Cancer Institute|Robert I Haddad, MD|617-632-3090|rihaddad@partners.org|
269956|NCT00095940|Pediatric Brain Tumor Consortium|Assistant Director Operations and Biostatistics Center|901-595-2617|dana.wallace@stjude.org|
269957|NCT00095979|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
269958|NCT00096018|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
269959|NCT00096031|SWOG Statistical Center|Study Statistician|206-667-4623||
269960|NCT00096044|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
269961|NCT00096109|Barbara Ann Karmanos Cancer Institute|Elaina Gartner, M.D.|(425) 527-4398|egartner@seagen.com|
269962|NCT00096122|UT MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
269963|NCT00096135|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
292904|NCT01454778|Sanford Health|Dr. Patrick Kelly|605-312-7300|Patrick.Kelly@SanfordHealth.org|
292905|NCT01454791|MS Center at Evergreenhealth Care|Theodore R, Brown, MD Principle Investigator|425-899-5350|trbrown@evergreenhealth.com|
292906|NCT01454830|The Pennsylvania State University|Amy M. Sawyer, PhD|814-863-1020|ams24@psu.edu|
284549|NCT00973479|Centocor, Inc.|Director Clinical Research|1-800-457-6399||
284550|NCT00973622|University of Arkansas for Medical Sciences|Christine Sheffer, PhD|212 650 6860|csheffer@med.cuny.edu|
284551|NCT00973674|University of Washington|Scott Emerson, PhD|206-616-6678|semerson@uw.edu|
284552|NCT00973700|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
284553|NCT00973739|New York University Langone Medical Center|Matthias Karajannis, MD|212-263-8400|matthias.karajannis@nyumc.org|
297235|NCT01735396|Tisch Cancer Center, Icahn School of Medicine at Mount Sinai|Dr. Matthew David Galsky|212-689-5412|matthew.galsky@mssm.edu|
284554|NCT00973752|Massachusetts General Hospital|Dr. Amir Fathi|617-724-1124|afathi@partners.org|
297236|NCT01735617|Diurnal Ltd.|CEO|+44 (0) 871 716 8848|info@diurnal.co.uk|
284555|NCT00973765|Washington Hospital Center|Gillian Schmitz, MD|919-724-9185|gillianmd@gmail.com|
284556|NCT00973921|Columbia University Medical Center|Giora Weisz MD|212-305 7060|gw2128@mail.cumc.columbia.edu|
284557|NCT00973973|AbbVie|Global Medical Services|800-633-9110||
284558|NCT00974051|UColorado|Dr. H Peter Chase|303-724-2323|peter.chase@ucdenver.edu|
284559|NCT00974090|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
284560|NCT00974142|University of Pittsburgh Medical Center|Michael Donahoe MD|412-648-9636|donahoem@upmc.edu|
284561|NCT00974220|Queen's University, Kingston, ON, Canada|Dr. Denis O'Donnell|1-613-548-2339|odonnell@queensu.ca|
284562|NCT00974233|University of Wisconsin|Julie E. Chang, MD|608-262-3970|jc2@medicine.wisc.edu|
284563|NCT00974246|Valley Medical Research|Meenakshi Patel, MD|937-208-8298|mpatelmd@ymail.com|
284564|NCT00974259|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732|Ramon.Diaz-Arrastia@uphs.upenn.edu|
284565|NCT00974311|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284566|NCT00974350|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
284567|NCT00974363|GlaxoSmithKline|GSK Response Center|866-435-7343||
284568|NCT00974376|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
284569|NCT00974480|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
284570|NCT00974493|Oxford University Hospitals NHS Trust|Matthew Scarborough|07872436461|matthew.scarborough@ouh.nhs.uk|
284571|NCT00974675|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
284572|NCT00974818|Memorial Slaon Kettering Cancer Center|Dr. Guido Dalbagni|646-422-4394|Dalbagng@mskcc.org|
284573|NCT00974974|Impax Laboratories, Inc.|Michelle Landolfi, Director, Regulatory Affairs|510-240-6402|mlandolfi@impaxlabs.com|
284574|NCT00975000|Amgen Inc.|Study Director|866-572-6436||
284575|NCT00975130|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
284576|NCT00975143|Cipher Pharmaceuticals Inc.|Julia Chan, RAC|905-602-5840|jchan@cipherpharma.com|326
284577|NCT00975156|Mischer Neuroscience Institute, Memorial Hermann-TMC|Elizabeth Noser||elizabeth.noser@memorialhermann.org|
284578|NCT00975195|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
284579|NCT00975221|Amgen Inc.|Study Director|866-572-6436||
284580|NCT00975286|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
284581|NCT00975416|National Institute on Drug Abuse|Mary R. Lee, M.D.|301-825-0545|leemary@mail.nih.gov|
284582|NCT00975481|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284583|NCT00975507|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284584|NCT00975585|Vistakon|Sheila Hickson-Curran, MCOptom/ Director, Medical Affairs|904-443-1754||
284585|NCT00975637|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
284586|NCT00975650|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Vice President, Scientific Affairs|1-416-679-0776|nbryson@aceruspharma.com|
284587|NCT00975676|International Breast Cancer Study Group (IBCSG)|Head Trial Activities and Deputy Director Dr. Heidi Roschitzki-Voser Organization|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
284588|NCT00975689|National Institute of Child Health and Human Development; NIH|Dr. Forbes D Porter, Senior Investigator|(301) 435-4432|fdporter@mail.nih.gov|
269964|NCT00096161|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
284589|NCT00975715|Novartis|Study Director|41 61 324 1111||
284590|NCT00975780|Yale University School of Medicine|Vincent James Quagliarello MD, Professor of Medicine (Infectious Diseases); Clinical Chief, Infectio|(203) 785-7571|vincent.quagliarello@yale.edu|
284591|NCT00975806|Celgene Corporation|Anne McClain,Senior Manager|1-888-260-1599|clinicaltrialsdisclosure@celgene.com|
284592|NCT00975884|GlaxoSmithKline|GSK Response Center|866-435-7343||
284593|NCT00975923|Vanderbilt University School of Medicine|Dr. Theodore Speroff|615-636-9476|ted.speroff@vanderbilt.edu|
284594|NCT00975975|IndianaU|Dr. Robert Nelson|317-944-0920|ronelson@iu.edu|
284595|NCT00976027|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
284596|NCT00976183|Gynecologic Oncology Associates|John P. Micha, M.D.|949-642-5165|Research@gynoncology.com|
284597|NCT00976209|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
269965|NCT00096174|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
269966|NCT00096226|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.org|
269967|NCT00096265|Radiation Therapy Oncology Group|Wendy Seiferheld||wseiferheld@acr.org|
269968|NCT00096278|NSABP Foundation, Inc.|Director, Division of Regulatory Affairs|412-330-4600||
269969|NCT00096356|Wake Forest University Comprehensive Cancer Center|Dr. Glenn Lesser|(336) 713-5440|glesser@wakehealth.edu|
269970|NCT00096382|National Cancer Institute, National Institutes of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
284598|NCT00976248|Dana-Farber Cancer Institute|Steven P. Treon, MD, PhD|617-632-2681|steven_treon@dfci.harvard.edu|
284599|NCT00976274|Department of Family Medicine, Yonsei University College of Medicine|Dr. Jae-Yong Shim|(+82) 2-2019-3480|hope@yuhs.ac|
284600|NCT00976352|University of Florida|Dr. Barry Byrne, Professor and Associate Chair|352-273-6563|bbyrne@ufl.edu|
284601|NCT00976391|GlaxoSmithKline|GSK Response Center|866-435-7343||
269971|NCT00096447|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
284602|NCT00976404|Northwestern University|Baiba Berzins, MPH|312-695-5012|baiba@northwestern.edu|
269972|NCT00096460|The EMMES Corporation|Adam Mendizabal, PhD|(301) 251-1161|amendizabal@emmes.com|221
284603|NCT00976456|Krankenhaus Martha-Maria Halle-Doelau gGmbH|Prof. Dr. Wolfgang Schuette|+49 345 5591440|wolfgang.schuette@martha-maria.de|
284604|NCT00976482|ospedale S Orsola- Malpighi, Bologna, Italy|dr Mauro Biffi|+393337661449|mauro.biffi@aosp.bo.it|
284605|NCT00976495|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
284606|NCT00976508|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284607|NCT00976521|Atrium Medical Corporation|Leah Hollins, Director of Clinical Affairs|603-880-1433|lhollins@atriummed.com|5365
284608|NCT00976560|GlaxoSmithKline|GSK Response Center|866-435-7343||
284609|NCT00976573|Mayo Clinic|Robert R. McWilliams, MD|507/284-8432|mcwilliams.robert@mayo.edu|
284610|NCT00976599|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284611|NCT00976664|National University of Health Sciences|Dr. Jerrilyn Cambron|630-889-6536|jcambron@nuhs.edu|
284612|NCT00976677|ECOG Statistical Office|Study Statistician|617-632-3012||
284613|NCT00976703|Metrohealth Medical Center|Kelly S Gibson, MD|216-778-5498|kgibson@metrohealth.org|
284614|NCT00976716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284615|NCT00976820|GlaxoSmithKline|GSK Response Center|866-435-7343||
275962|NCT00520533|Ludwig Institute for Cancer Research|Mary Macri, Senior Director, Clinical Trials Management|12124501546|mmacri@lcr.org|
284616|NCT00976898|Massachusetts General Hospital|Theodore Sunki Hong, MD|617-724-1159|tshong1@mgh.harvard.edu|
269973|NCT00096486|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
269974|NCT00096538|Memorial Sloan Kettering Cancer Center|Dr. Ariela Noy|212-639-7423|noya@mskcc.org|
284617|NCT00976911|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
284618|NCT00976937|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
284619|NCT00976950|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
284620|NCT00976989|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
284621|NCT00977080|Abbott|Global Medical Services|800-633-9110||
284622|NCT00977106|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
284623|NCT00977171|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
284624|NCT00977184|Department of Neurology, Centre Hospitalier Universitaire Vaudois|David H. Benninger, MD||David.Benninger@chuv.ch|
284625|NCT00977197|Mayo Clinic|Yuri A. Saito Loftus, M.D.|507-284-2687|saito.yuri@mayo.edu|
297237|NCT01735630|Transition Therapeutics Ireland Limited|Aleksandra Pastrak, MD, PhD, Vice President Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
284626|NCT00977314|Sonitus Medical, Inc.|Clinical Trials Manager|8668162076|lily@sonitusmedical.com|
284627|NCT00977379|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
284628|NCT00977431|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
284629|NCT00977470|Mass General Hospital Cancer Center|Maria Kempner|508-533-4132|mkempner@partners.org|
284630|NCT00977548|H. Lee Moffitt Cancer Center and Research Institute|Rami Komrokji, Principal Investigator|813-745-4692|rami.komrokji@moffitt.org|
284631|NCT00977561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284632|NCT00977613|Beth Israel Cancer Center|Victoria Rosenwald|212 844-8285|vrosenwa@chpnet.org|
284633|NCT00977665|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
284634|NCT00977691|National Heart Lung and Blood Institute|Fitzhugh, Courtney|+1 301 402 6496|courtney.fitzhugh@nih.gov|
284635|NCT00977704|Medicis R&D Clinical Research Department|Head of Clinical Trials||ClinicalTrialsQuery@Medicis.com|
284636|NCT00977769|Oslo University Hospital|Professor Leiv Arne Rosseland|+4723070000|lrossela@ous-hf.no|
284637|NCT00977808|University of Virginia|Boris Kovatchev, Ph.D./Principal Investigator|434-982-6479|pcm9b@virginia.edu|
284638|NCT00977938|Harvard Clinical Research Institute|Priscilla Driscoll Shempp, Sr. Director Trial Design, Development and Strategy|617.307.5200|pdriscoll@hcri.harvard.edu|
275963|NCT00520546|German Federal Armed Forces Hospital, Ulm|Major Medical Corps Dr. Markus Hartenbach|0049 731 1710 1851|markushartenbach@bundeswehr.org|
308476|NCT02582658|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
269975|NCT00096681|Desmond Tutu HIV Centre|Prof LG Bekker|+2721 633 6599|Linda-Gail.Bekker@hiv-research.org.za|21
308477|NCT02582671|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
269976|NCT00096785|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
269977|NCT00096941|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
275964|NCT00520572|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
275965|NCT00520676|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
275966|NCT00520741|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
275967|NCT00520767|Barbara Ann Karmanos Cancer Institute|Jeffrey Zonder, M.D.|313-576-8732|zonderj@karmanos.org|
275968|NCT00520845|Vanderbilt-Ingram Cancer Center|Dr. Leora Horn|615-322-4967|leora.horn@vanderbilt.edu|
275969|NCT00520884|University of Pennsylvania, Department of Medicine, Division of Endocrinology, Diabetes and Metabolism|Anne Cappola, M.D., Sc.M.|215-573-5359|ACappola@mail.med.upen.edu|
297238|NCT01735877|Christian Medical College & Hospital|Dr Jeyaraj D Pandian|09915784750|jeyarajpandian@hotmail.com|
297239|NCT01735916|Medtronic|MIRACLE EF Study Manager|(763) 514-4000|medtroniccrmtrials@medtronic.com|
297240|NCT01735981|The Ohio State University|Anne Kloos|614-688-5942|kloos.4@osu.edu|
297241|NCT01735994|Pennington Biomedical Research Center|Dr. Tiffany Stewart, Director, Behavior Technology Laboratory|2257632554|tiffany.stewart@pbrc.edu|
297242|NCT01736085|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
269978|NCT00096954|Hoffman-LaRoche|Medical Communications|800-821-8590||
269979|NCT00096993|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
269980|NCT00097253|The Ohio State University, Department of Psychiatry|Janice K. Kiecolt-Glaser, PhD|614-292-0033|Kiecolt-Glaser.1@osu.edu|
269981|NCT00097370|GlaxoSmithKline|GSK Response Center|866-435-7343||
269982|NCT00097448|Massachusetts Eye and Ear Infirmary|Dr. Steven Rauch|617-573-1166|steven_rauch@meei.harvard.edu|
269983|NCT00097500|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
269984|NCT00097539|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
269985|NCT00097591|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
269986|NCT00097669|VITATOPS|Clinical Trial Coordinator|+61892247004|julia.o'dea@health.wa.gov.au|
269987|NCT00097695|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
269988|NCT00097708|Jazz Pharmaceuticals, Inc.|Grace Wang, MD Director Clinical Development & Medical Monitor|650 - 496 - 3777||
269989|NCT00097721|Eisai Inc|Eisai Call Center|888-422-4743||
269990|NCT00097773|Seattle Childrens Hospital|Bonnie Ramsey, MD|206-987-5725|bonnie.ramsey@seattlechildrens.org|
269991|NCT00097786|Novartis Pharmaceuticals|Study Director|862 778-8300||
269992|NCT00097981|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Medical Director|1 215 325-5329||
275970|NCT00520910|University of Miami|Dr. Robert Kirsner|305-243-4472|RKirsner@med.miami.edu|
275971|NCT00520936|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
275972|NCT00520975|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
275973|NCT00521001|Mayo Clinic|Svetomir Markovic, MD, PhD|507/284-1370|markovic.svetomir@mayo.edu|
275974|NCT00521014|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
275975|NCT00521053|Provectus Biopharmaceuticals, Inc.|Eric Wachter, Chief Technology Officer|1-865-769-4011|wachter@pvct.com|23
275976|NCT00521079|EnteroMedics Inc|Senior Vice President of Clinical|651-634-3209|ktweden@enteromedics.com|
275977|NCT00521144|Memorial Sloan-Kettering Cancer Center|Dr. Lee Krug|646 888 4201|krugl@mskcc.org|
284639|NCT00978029|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
284640|NCT00978042|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
284641|NCT00978068|University of California, San Francisco|Tamara Clark|415-206-8790|tamara.clark@ucsf.edu|
284642|NCT00978120|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
284643|NCT00978250|National Cancer Institute|Dr. James Doroshow|240-781-3320|jim_doroshow@nih.gov|
284644|NCT00978341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
284645|NCT00978380|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
284646|NCT00978432|Duke University Medical Center|Anne Beaven, MD|919-684-8964|anne.beaven@duke.edu|
284647|NCT00978445|Cleveland Clinic Foundation|Dr. Heather Gornik|216-445-3689|gornikh@ccf.org|
284648|NCT00978562|OHSU KCI|Edward Neuwelt, MD|503-494-5626|huddlesa@ohsu.edu|
292907|NCT01454934|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
292908|NCT01454947|University of Southern California|Jason N. Doctor|213.821.8142|jdoctor@usc.edu|
292909|NCT01455012|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
292910|NCT01455064|Abbott Diabetes Care|Shridhara A. Karinka, Ph.D., Director of Clinical Affairs|510-749-6393|SHRIDHARA.ALVA@ABBOTT.COM|
292911|NCT01455181|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
292912|NCT01455194|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
292913|NCT01455220|University of South Florida|Dr.Tuan Vu/ Dr. Derrick Robertson|813-974-6378|droberts@health.usf.edu|
292914|NCT01455415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292915|NCT01455428|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292916|NCT01455519|Rehabilitation Institute of Chicago|Center for Pain Studies|312.238.5654|centerforpainstudies@ric.org|
292917|NCT01455545|SESCAM - HOSPITAL UNIVERSITARIO DE GUADALAJARA|Dr. Carlos Almonacid|+34 655 53 44 75|caralmsan@gmail.com|
292918|NCT01456000|CardioFocus, Inc.|Burke Barrett, VP Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
292919|NCT01456039|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
292920|NCT01456052|Lexicon Pharmaceuticals, Inc.|Manager of Regulatory Affairs|281-863-3260|plogan@lexpharma.com|
292921|NCT01456130|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
292922|NCT01456143|Mt Sinai|Brett Miles||Brett.Miles@mountsinai.org|
292923|NCT01456169|Takeda GlobalResearch and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
292924|NCT01456195|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
292925|NCT01456221|Coordinacion de Investigacion en Salud, Mexico|Dr. Mardia Guadalupe Lopez Alarcon||marsau2@prodigy.net.mx|
292926|NCT01456299|Ajou University|Dr.Kim|82-32-460-3400|kjyeop@ajou.ac.kr|
292927|NCT01456494|University of Chicago|Mary Akel|773-834-4489|makel@medicine.bsd.uchicago.edu|
284649|NCT00978627|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
284650|NCT00978731|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
284651|NCT00978757|Francisco C. Bonofiglio|MD|541149590200|francisco.bonofiglio@hospitalitaliano.org.ar|4949
284652|NCT00979017|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|Katherine B. Peters, MD, PhD|(919) 684-6173|katherine.peters@duke.edu|
284653|NCT00979069|Atlanta VAMC|Dr. Joe Nocera|404 321 6111|joe.nocera2@va.gov|6354
284654|NCT00979121|ARDS Network|David A. Schoenfeld, PhD ARDSNet CCC PI|617-726-6111|dschoenfeld@mgh.harvard.edu|
284655|NCT00979134|AstraZeneca|Donal Landers|+44 1625 231890|Donal.Landers@astrazeneca.com|
284656|NCT00979199|CNR Institute of Clinical Physiology, Pisa, Italy and Fondazione Toscana G. Monasterio, Pisa, Italy|Dr. Danilo Neglia|+390503152019|dneglia@ifc.cnr.it|2019
284657|NCT00979212|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
284658|NCT00979303|Children's Hospital Boston|Christina Miyake|832-826-5650|cymiyake@bcm.edu|
284659|NCT00979407|GlaxoSmithKline|GSK Response Center|866-435-7343||
284660|NCT00979420|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
284661|NCT00979459|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284662|NCT00979576|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
284663|NCT00979602|GlaxoSmithKline|GSK Response Center|866-435-7343||
284664|NCT00979615|Alcon Research, Ltd.|Maria J. Tort, PhD|(817) 302-5968|Maria.Tort@alconlabs.com|
284665|NCT00979628|EUSOM|Guillermo Umpierrez|4047781665|geumpie@emory.edu|
284666|NCT00979654|MedImmune, LLC|Jerry Green|1-888-483-7729|rtpsafety@ppdi.com|
284667|NCT00979732|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
284668|NCT00979745|CLINUVEL PHARMACEUTICALS LTD|Clinical Operations Manager||mail@clinuvel.com|
284669|NCT00979875|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
284670|NCT00979940|Indiana University School of Medicine|Dr. Rolf Kreutz|3179620500|rkreutz@iu.edu|
284671|NCT00979953|Cubist Pharmaceuticals|VP of Clinical Research|(781) 860-8660||
284672|NCT00979992|NRG Oncology Statistics and Data Management Center - Buffalo Office|Angela M. Kuras, Associate Director of Administration and Operations|716-845-5702|kurasa@nrgoncology.org|
284673|NCT00980005|GlaxoSmithKline|GSK Response Center|866-435-7343||
284674|NCT00980018|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
284675|NCT00980044|University of Kentucky College of Medicine|Michelle Lofwall, MD, Associate Professor|8593239321|michelle.lofwall@uky.edu|
284676|NCT00980057|Medtronic, Inc|Adaptive CRT Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|
284677|NCT00980148|University of Arkansas for Medical Sciences|Shelly Lensing, Statistician|501-686-8203|sylensing@uams.edu|
284678|NCT00980174|Amgen Inc.|Study Director|866-572-6436||
284679|NCT00980200|GlaxoSmithKline|GSK Response Center|866-435-7343||
284680|NCT00980278|University of Michigan School of Dentistry|Dr. William Giannobile, Chair Department of Periodontics and Oral Medicine|734-763-2105|wgiannob@umich.edu|
284681|NCT00980330|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
284682|NCT00980343|Adult Brain Tumor Consortium (ABTC)|Charles J Nock, MD|410-955-8837|jfisher@jhmi.edu|
284683|NCT00980395|University of Arizona|Amy Selegue, NCTN Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
284684|NCT00980590|Cleveland Clinic|Dr. Daniel Sessler|216-445-6500|sessled@ccf.org|
284685|NCT00980642|Cleveland Clinic|Dr. Andrea Kurz|216 445-9924|KURZA@ccf.org|
269993|NCT00098020|National Institutes of Diabetes, Digestive, and Kidney Disorders|Dr. Jeffery Kopp|301-594-3403|koppj@mail.nih.gov|
284686|NCT00980655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284687|NCT00980681|Guerbet|Pierre Desche, MD, Head of Clinical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
269994|NCT00098059|Novartis Pharmaceuticals|Study Director|862-778-8300||
269995|NCT00098254|National Cancer Institute|Giuseppe Giaccone, M.D., PH.D.|301-496-4916|giacconeg@mail.nih.gov|
269996|NCT00098293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269997|NCT00098306|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
269998|NCT00098345|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
269999|NCT00098371|The Ohio State University Comprehensive Cancer Center|John Byrd, MD|614-293-9869|John.Byrd@osumc.edu|
270000|NCT00098475|ECOG Statistical Office|Study Statistician|617-632-3012||
270001|NCT00098670|The Ohio State University|Dr. Thomas Lin||thomas.lin@osumc.edu|
270002|NCT00098722|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270003|NCT00098748|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270004|NCT00098774|University of California, San Francisco|James Rubenstein, MD, PhD||jamesr@medicine.ucsf.edu|
270005|NCT00098787|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
270006|NCT00098813|Memorial Sloan-Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
270007|NCT00098839|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
270008|NCT00098865|DFCI|Mark W. Kieran, MD, PhD|617-632-4907|mark_kieran@dfci.harvard.edu|
270009|NCT00098956|The Ottawa Hospital|Dr. Glenwood Goss|613-737-7700|ggoss@ottawahospital.on.ca|56708
270010|NCT00099021|Masonic Cancer Center, University of Minnesota|Frank G. Ondrey, M.D.|612-625-3200|ondre002@umn.edu|
270011|NCT00099047|Cleveland Clinic|Matt Kalaycio, MD|216-444-3705|kalaycm@ccf.org|
270012|NCT00099268|Novartis Pharmaceuticals|Study Director|862 778-8300||
297243|NCT01736124|James J. Peters Veterans Affairs Medical Center|Dr. Jeremy Silverman|718-584-9000|jeremy.silverman@va.gov; jeremy.silverman@mssm.edu|1700
284688|NCT00980746|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
284689|NCT00980785|University of Wisconsin School of Medicine and Public Health|Cynthia M. Carlsson, MD, MS|608-256-1901|cmc@medicine.wisc.edu|11691
284690|NCT00980798|Janssen-Cilag Ireland|EMEA Medical Affairs Director Analgesia|0035 878 339174||
284691|NCT00980980|University of California, Irvine|Dr. Susan Huang|949-824-5073|sshuang@uci.edu|
284692|NCT00981019|Max Planck Institute for Human Development, Harding Center for Risk Literacy|Dr. Odette Wegwarth|+49-30-82406|wegwarth@mpib-berlin.mpg.de|695
284693|NCT00981045|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
284694|NCT00981084|University of Missouri - Kansas City|Dr. Jared Bruce|401-499-4043|brucejm@umkc.edu|
284695|NCT00981149|ECU SODM|Sharon Gordon, DDS|2527377125|gordons@ecu.edu|
284696|NCT00981175|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
284697|NCT00981214|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
284698|NCT00981227|Bial-Portela & Cª, S.A.|Head of Clinical Research Section|+351 22 986 6100|clinical.trials@bial.com|
284699|NCT00981253|Duke Health|Dr. James A. Blumenthal|919-684-3828|james.blumenthal@duke.edu|
284700|NCT00981292|Northumbria university|Emma Wightman|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk|
284701|NCT00981305|SeoulNUH|Myung Jae Jeon|82-2-2072-1916|jeonmj@snu.ac.kr|
284702|NCT00981409|GlaxoSmithKline|GSK Response Center|866-435-7343||
284703|NCT00981435|Stanford University|Clinical Research Coordinator|6507236995|mnunez1@stanford.edu|
284704|NCT00981461|Lexington International, LLC|David Michaels|5614170200|dm@hairmax.com|
297244|NCT01736176|AbbVie|Global Medical Services|800-633-9110||
297245|NCT01736189|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
270013|NCT00099359|Westat|Margaret Camarca, Project Director|301-517-4128|margaretcamarca@westat.com|
284705|NCT00981474|Northwestern University|Paul C. Fitzgerald RN, BSN, MS|312-695-1064|p-fitzgerald2@northwestern.edu|
284706|NCT00981526|UMass Medical School|Dr. Xiaoduo Fan|508-856-3881|xiaoduo.fan@umassmed.edu|
284707|NCT00981578|InSightec|Nadir Alikacem|214.360.2000|nadira@insightec.com|
270014|NCT00099372|RTI International|Dr. Marie Gantz|919-597-5110|mgantz@rti.org|
284708|NCT00981630|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
308478|NCT02582684|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
284709|NCT00981669|Instituto Butantan|Alexander Roberto Precioso|+5511-2627-9372|alexrp@butantan.gov.br|9372
308479|NCT02582814|AstraZeneca|A clinical pharmacology and long-term safety study|+819039706431|Yu.Shimizuishi@astrazeneca.com|4669
284710|NCT00981682|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
284711|NCT00981747|University of Iowa|Dr. Alicia Gerke|319-356-1616|alicia-gerke@uiowa.edu|
284712|NCT00981799|Therapeutic Advancements of Childhood Leukemia and Lymphoma|Clinical Research Coordinator, Consortia|323-361-5312|rleong@chla.usc.edu|
284713|NCT00981812|University of Cincinnati Medical Center|Mary Mahoney, MD|513-584-4396|mary.mahoney@uchealth.com|
284714|NCT00981825|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
308480|NCT02582840|AstraZeneca K.K.|Yu Shimizuishi|81 6 7711 4669|Yu.Shimizuishi@astrazeneca.com|
284715|NCT00982007|Luitpold Pharmaceuticals, Inc.|Mark A. Falone|610-650-4200|mfalone@luitpold.com|
284716|NCT00982020|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
308481|NCT02582866|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
284717|NCT00982033|Wake Forest School of Medicine|Dalane W. Kitzman, M.D.|336-716-3274|dkitzman@wakehealth.edu|
284718|NCT00982072|Imperial College NHS Trust|Dr Megan Griffith|02033137309|m.e.griffith@imperial.ac.uk|
270015|NCT00099632|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
270016|NCT00099983|VA Connecticut HCS|John Krystal, MD|203-937-4790|john.krystal@yale.edu|
270017|NCT00100048|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270018|NCT00100165|University of Colorado, Denver|Dr. Robert Freedman|303 724-4940|robert.freedman@ucdenver.edu|
270019|NCT00100178|Barbara Davis Center for Childhood Diabetes, Health Sciences Center, University of Colorado|Peter Gottleib, MD|303-724-6714|Peter.Gottleib@uchsc.edu|
270020|NCT00100230|Retina Foundation of the Southwest|Dennis Hoffman, Ph.D., Sr. Research Scientist|214-363-3911|dhoffman@retinafoundation.org|125
270021|NCT00100659|Johns Hopkins University School of Medicine|Kathleen B. Schwarz, M.D.|410-955-8769|kschwarz@jhmi.edu|
270022|NCT00100698|Massachusetts General Hospital|Janet Lo|617-724-9109|jlo@partners.org|
270023|NCT00100789|SWOG Statistical Center|Study Statistician|206-667-4623||
270024|NCT00100802|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
270025|NCT00100815|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
270026|NCT00100841|Montefiore Medical Center|Lisa Escobar-Peralta|718-379-6866|lescobar@montefiore.org|
270027|NCT00100932|Eisai|Dr. Peter Tarassoff|888-422-4743||
270028|NCT00101010|UT MD Anderson Cancer Center, Community Clinical Oncology Program Research Base|Alma Rodriguez, MD, Lymphoma||CR_Study_Registration@mdanderson.org|
270029|NCT00101036|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
270030|NCT00101101|H. Lee Moffitt Cancer Center and Research Institute|Sophie Dessureault, M.D., Ph.D.|813-745-1965|sophie.dessureault@moffitt.org|
284719|NCT00982137|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
284720|NCT00982189|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
284721|NCT00982228|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
284722|NCT00982280|Grünenthal GmbH|Dr. Ilona Steigerwald|+49 241 569 0|Clinical-Trials@grunenthal.com|
284723|NCT00982319|Sidney Kimmel Comprehensive Cancer Center|Dr. Kala Visvanathan|410-614-1112|kvisvan1@jhu.edu|
284724|NCT00982345|Indiana University|Dr. Amit Anand|317-274-7422|aanand@iupui.edu|
297246|NCT01736215|Janssen Cilag Thailand|Medical Affairs Director|+6627927232||
284725|NCT00982397|Medtronic, plc|CRHF Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com|
284726|NCT00982410|Ann Arbor Veteran Affairs|Dr. Mark Ilgen|(734) 845-3646|Mark.Ilgen@va.gov|
284727|NCT00982423|Mayo Clinic|Dr. Horng Chen|507-538-2354|chen.horng@mayo.edu|
284728|NCT00982488|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
297247|NCT01736241|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284729|NCT00982553|Imperial College|Dr Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
284730|NCT00982592|Perlmutter Cancer Center at NYU Langone|Deirdre Cohen, MD|212-731-5656|deirdre.cohen@nyumc.org|
284731|NCT00982644|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
284732|NCT00982657|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284733|NCT00982735|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
284734|NCT00982865|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
284735|NCT00982878|Imperial College London|Professor Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
284736|NCT00982930|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
284737|NCT00983073|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
284738|NCT00983216|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
284739|NCT00983242|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlpharma.com|
284740|NCT00983281|University of Miami|Kenneth Proctor, PhD|305-243-4694|kproctor@med.miami.edu|
284741|NCT00983294|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
284742|NCT00983307|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Maria Werner-Wasik|215 955-6702|maria.werner-wasik@jefferson.edu|
284743|NCT00983346|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
284744|NCT00983359|The Ohio State University Comprehensive Cancer Center|Mario Ammirati, MD|614-293-1970|Mario.Ammirati@osumc.edu|
297248|NCT01736254|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284745|NCT00983372|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
284746|NCT00983385|Grünenthal GmbH|Director of Clinical Trials|+49 241 569|Clinical-Trials@grunenthal.com|3223
284747|NCT00983476|VA Greater Los Angeles Healthcare System, Los Angeles, CA|Dr. Alexander S. Young|310-794-7219|alexander.young@va.gov|
284748|NCT00983489|Deen Dayal Upadhaya Hospital, New Delhi|Dr Kanchan Sharma|919417938224|psaiims@yahoo.co.in|
292928|NCT01456780|Massachusetts Eye and Ear|Dr. Reza Dana|617-573-4431|Reza_Dana@meei.harvard.edu|4431
308482|NCT02582970|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
292929|NCT01456897|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials||CL_OPCJ_RDA_Team@otsuka.jp|
292930|NCT01456936|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292931|NCT01456949|Medtronic|Kirsten Rasmussen|763-526-2833|kirsten.l.rasmussen@medtronic.com|
292932|NCT01456962|University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences|Peter Anderson, Pharm D|303-724-6128|peter.anderson@ucdenver.edu|
292933|NCT01457014|Sleep and Alertness Research Inc.|Sharon A. Chung|416-603-5275|sachung@uhnres.utoronto.ca|
292934|NCT01457118|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
308483|NCT02582983|Hoffmann-La Roche|Medical Communications|800-821-8590||
308484|NCT02583230|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
292935|NCT01457196|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
292936|NCT01457339|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
292937|NCT01457352|Sun Pharma Advanced Research Company Limited|SPARC|912266455645|Clinical.Trials@Sparcmail.com|
292938|NCT01457417|Healthcare Pharmaceuticals, Inc|Cynthia Sirard, MD|617-714-0357|CSirard@hcven.com|
292939|NCT01457430|MGH Allergy Associates|Dr. Aleena Banerji|617-726-3850|abanerji@mgh.harvard.edu|
292940|NCT01457521|Gynuity Health Projects|Elizabeth Raymond|2124481230|eraymond@gynuity.org|
292941|NCT01457573|Houston Methodist Hosptial System|Timothy Boone, MD, PhD, Principal Investigator|713-441-6455|tboone3@houstonmethodist.org|
292942|NCT01457703|University of Colorado Denver|Clinical Research Regulatory Manager|303-724-6501|Chanel.mansfield@ucdenver.edu|
292943|NCT01457846|Astrazeneca|Donal Landers|+44 1625 231890|Donal.Landers@astrazeneca.com|
308485|NCT02583256|Seqirus|Seqirus Clinical Trial Disclosure Manager|Phone: 1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
292944|NCT01457885|University of Michigan Comprehensive Cancer Center|Dr. John Magenau, M.D.|734-936-8785|johnmage@umich.edu|
292945|NCT01457924|GlaxoSmithKline|GSK Response Center|866-435-7343||
292946|NCT01457950|GlaxoSmithKline|GSK Response Center|866-435-7343||
292947|NCT01458106|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
292948|NCT01458119|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
308486|NCT02583360|The Research Institute at Nationwide Children's Hospital|Sudarshan Jadcherla MD|614-355-6433|sudarshan.jadcherla@nationwidechildrens.org|
308487|NCT02583399|Cumberland Pharmaceuticals Inc.|Sr. Manager, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|
308488|NCT02583425|Dr. Reddy's|Director, Clinical Development|609-375-9900||
308489|NCT02583477|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
308490|NCT02583711|Imperial College London|Ms Aliza Abeles|07834987667|aliza.abeles@gmail.com|
284749|NCT00983515|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clincialtrials@urlmutual.com|
284750|NCT00983528|UC San Diego|MCC Clinical Trials Office|(858) 534-5417|tkipps@ucsd.edu|
284751|NCT00983541|Huntsman Cancer Institute|Christopher Anker, MD|801-213-4241|candace.larson@hci.utah.edu|
297249|NCT01736267|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736391|Daniel_Lee@meei.harvard.edu|
284752|NCT00983580|Mayo Clinic|Frank A. Sinicrope, M.D.||sinicrope.frank@mayo.edu|
284753|NCT00983619|MedImmune, LLC|Shahram Rahimian|800-236-9933|information.center@astrazeneca.com|
284754|NCT00983749|Department of Emergency Medicine, University of California San Diego Health System|Kama Guluma, M.D.|619-543-6463|kguluma@ucsd.edu|
284755|NCT00983801|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
284756|NCT00983827|University of Utah|Dr. Steven Edgley|801-581-4695|carma.hyde@hsc.utah.edu|
284757|NCT00983853|Vertex Pharmaceuticals Incorporated|Medical Monitor|1-617-444-6777|medicalinfo@vrtx.com|
284758|NCT00983892|Ann Arbor Veterans Administration|Maria J. Silveira MD MA MPH|734-763-4550|mariajs@med.umich.edu|
284759|NCT00983905|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
284760|NCT00983918|Baylor College of Medicine|Jaime Ortiz, MD|713-873-2860|jaimeo@bcm.edu|
284761|NCT00983931|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
284762|NCT00983957|Bristol-Myers Squibb International Corporation|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
284763|NCT00983983|Massachusetts General Hospital|Dr. Anne-Marie Wills|855-644-6387|awills@partners.org|
284764|NCT00984009|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
284765|NCT00984022|Maricopa Integrated Health System|David Drachman|602-344-5161|david.drachman@mihs.org|
297250|NCT01736358|Montefiore Medical Center|Dr.David Hoenig||dhoenig@montefiore.org|
284766|NCT00984061|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
284767|NCT00984126|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
284768|NCT00984139|GlaxoSmithKline|GSK Response Center|866-435-7343||
284769|NCT00984165|National Cancer Institute|Dr. Ronald E. Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
284770|NCT00984204|St. Jude Medical|Nabil Kanaan|949-769-5000|nkanaan@sjm.com|
284771|NCT00984256|US Army Medical Materiel Development Activity (USAMMDA)|Michelle Mathers|301-619-8061|Michelle.mathers@us.army.mil|
270031|NCT00101166|H. Lee Moffitt Cancer Center and Research Institute|Dr. Sophie Dessureault|813-745-1965|sophie.dessureault@moffitt.org|
284772|NCT00984282|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
284773|NCT00984295|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270032|NCT00101192|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-341-3408|mleventhal@gogstats.org|
284774|NCT00984308|Department of Veterans Affairs|Dawn M. Bravata, MD|317-988-2676|dawn.bravata2@va.gov|
284775|NCT00984334|S.L.A. Pharma UK Ltd|Dr C Jordan, Head of Clinical Operations|44 01923 681001|cjordan@slapharma.com|
284776|NCT00984542|Vanderbilt-Ingram Cancer Center|Leora Horn, MD|615-936-2033|leora.horn@vanderbilt.edu|
297251|NCT01736397|Keryx Biopharmaceuticals|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
284777|NCT00984568|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
284778|NCT00984594|RTI Biologics|Director, Clinical Projects|386-418-8888|rwaite@rtix.com|4172
284779|NCT00984620|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308491|NCT02584140|UCSD Medical Center, Antiviral Research Center|Jill Blumenthal, MD|(619) 471-3913|jblumenthal@health.ucsd.edu|
284780|NCT00984659|GlaxoSmithKline|GSK Response Center|866-435-7343||
284781|NCT00984698|University of Arizona|Dr. Patricia Haynes, Assistant Professor|5206261855|thaynes@email.arizona.edu|
284782|NCT00984815|Horizon Pharma|Amy Y. Grahn, MS|224-383-3012|agrahn@horizonpharma.com|
284783|NCT00984867|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
284784|NCT00985010|Materno-Perinatal Hospital of the State of Mexico|Hugo Mendieta Zerón|+52-722-2176605|mezh_74@yahoo.com|
284785|NCT00985088|GlaxoSmithKline|GSK Response Center|866-435-7343||
284786|NCT00985114|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3263|kwoessner@gidynamics.com|
308492|NCT02584257|Lupin Research Inc|Dr. Mark Lepore|(443) 740-9323|marklepore@lupin.com|
270033|NCT00101283|ECOG Statistical Office|Study Statistician|617-632-3012||
270034|NCT00101361|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|
270035|NCT00101400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
270036|NCT00101413|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
270037|NCT00101452|Massachusetts General Hospital|Maurizio Fava|617-724-2513|mfava@partners.org|
270038|NCT00101582|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
270039|NCT00101647|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
270040|NCT00101660|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
270041|NCT00101686|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270042|NCT00101816|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
270043|NCT00101868|University of Illinois|James F. Graumlich, MD, Professor of Medicine|309-655-7734|jfg@uic.edu|
270044|NCT00101907|Amgen Inc.|Study Director|866-572-6436||
284787|NCT00985140|Stanford University Cancer Center|Richard T. Hoppe, MD Henry S. Kaplan Harry Lebeson Professor of Cancer Biology|(650) 723-5510|hoppe@stanford.edu|
297252|NCT01736475|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
270045|NCT00101933|Medtronic Neuromodulation|Jim Vollhaber, Clinical Study Manager|763-526-8093|medtronicneurotrials@medtronic.com|
270046|NCT00102063|Otsuka Pharmaceutical Development & Commercialization, Inc.|Margaretta Nyilas|609-452-5673|Margaretta.nyilas@otsuka-us.com|
284788|NCT00985153|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
284789|NCT00985166|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284790|NCT00985192|UCLA GI Oncology Program, David Geffen School of Medicine at UCLA|Dr. Zev Wainberg|310 794-6500|zwainberg@mednet.ucla.edu|
284791|NCT00985231|Bausch & Lomb Incorporated|William Reindel, OD, MS|(585) 338-8129|william.t.reindel@bausch.com|
284792|NCT00985257|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
284793|NCT00985426|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-665-0414|rjanssen@dynavax.com|
284794|NCT00985439|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
284795|NCT00985465|GlaxoSmithKline|GSK Response Center|866-435-7343||
284796|NCT00985491|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3261|pkeating@gidynamics.com|
284797|NCT00985504|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284798|NCT00985517|Sangamo Therapeutics|Medical Monitor|510-970-6000|clinicaltrials@sangamo.com|
284799|NCT00985543|St Stephens Centre, Chelsea and Westminster Hospital|Dr Marta Boffito|+44 2088 466 507|marta.boffito@chelwest.nhs.uk|
284800|NCT00985621|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284801|NCT00985673|GlaxoSmithKline|GSK Response Center|866-435-7343||
297253|NCT01736527|Bausch & Lomb Incorporated|Raphaële Siou-Mermet, MD, MS|+33160871491|raphaele.siou-mermet@bausch.com|
284802|NCT00985686|Canadian Institute of Natural and Integrative Medicine|Dr. John Toews|4032200022|j.toews@cinim.org|111
297254|NCT01736540|Novartis|Study Director|862-778-8300||
284803|NCT00985712|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284804|NCT00985725|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
284805|NCT00985751|GlaxoSmithKline|GSK Response Center|866-435-7343||
284806|NCT00985790|GlaxoSmithKline|GSK Response Center|866-435-7343||
284807|NCT00985829|skin research center|Zohreh Tehranchi-nia, assist. prof|+989121029415|zohreh_tehranchi@yahoo.com|
284808|NCT00985907|University of California, San Francisco|Dr. Thomas Martin, MD|(415) 353-9365|Tom.Martin@ucsf.edu|
284809|NCT00985946|University of Wisconsin Carbone Cancer Center|Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
284810|NCT00985959|Janssen Pharm KK Japan|Director|+81-3-4411-5801||
284811|NCT00985985|GlaxoSmithKline|GSK Response Center|866-435-7343||
284812|NCT00986102|Jan-Cil Singapore|VP MEDICAL AFFAIRS ASIA PACIFIC|+65 6827 6753||
284813|NCT00986154|Daiichi Sankyo, Inc.|Lee Schwocho, Sr. Director|732-590-5000|lschwocho@dsi.com|
284814|NCT00986180|Janssen Pharmaceuticals|Vice President, Medical Affairs, Internal Medicine|1 908 218-7250||
284815|NCT00986232|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284816|NCT00986245|Seoul National University Hospital|BS Jeon|82-2-2072-2876|brain@snu.ac.kr|
284817|NCT00986258|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|clinical-trials@grunenthal.com|
297255|NCT01736553|The Ohio State Unviersity Wexner Medical Center|Dr. Stephen Kolb|614-366-9050|stephen.kolb@osumc.edu|
284818|NCT00986349|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
284819|NCT00986362|ThromboGenics NV|Dr. Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
284820|NCT00986401|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
284821|NCT00986427|Columbia University Dept of Dermatology|Julian Mackay-Wiggan, MD|212-305-6953|jc299@columbia.edu|
284822|NCT00986440|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
284823|NCT00986453|Medtronic Surgical Technologies|Robert Swain, PhD|+1 (603) 294-5428|robert.e.swain@medtronic.com|
284824|NCT00986479|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com|
297256|NCT01736566|Brigham and Women's Hospital|Carrie Blout, Genetic Counselor Project Manager|617-264-5837|carrie.blout@gmail.com|
275978|NCT00521339|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
270047|NCT00102440|Takeda Global Research & Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
270048|NCT00102518|Otsuka Pharmaceutical Development & Commercialization, Inc.|Margaretta Nyilas|609-452-5673|Margaretta.nyilas@otsuka-us.com|
270049|NCT00102531|Insmed|Margaret Galluzzi|(908) 977-9900|Margaret.Galluzzi@Insmed.com|
270050|NCT00102596|NINDS/NIH|Mark Hallett, M.D.|301-496-9526|hallettm@ninds.nih.gov|
270051|NCT00102687|Celgene Corporation|CL Beach||CLBeach@celgene.com|
270052|NCT00102804|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
270053|NCT00102960|Perinatal HIV Research Unit, Johannesburg and Children's Infectious Diseases Clinical Research Unit, Cape Town all in South Africa|Dr Avy Violari and Prof Mark Cotton|27 11 989 9702/27 21 938 4219|violari@mweb.co.za|9702/4219
270054|NCT00103012|National Institutes of Health, Clinical Center, Department of Pharmacy|Scott Penzak|301-496-2997|spenzak@cc.nih.gov|
270055|NCT00103116|UKentucky|Edward Hirschowitz|8596081981|eahirs2@uky.edu|
270056|NCT00103142|Duke University Medical Center|Dr. Michael Morse|919-684-5705|michael.morse@dm.duke.edu|
270057|NCT00103194|"ECOG Statistical Office"|"Study Statistician"|617-632-3012||
270058|NCT00103207|ECOG Statistical Office|Study Statistician|617-632-3012||
270059|NCT00103259|Eastern Cooperative Oncology Group (ECOG) Statistical Office|ECOG Statistician|617-632-3012||
270060|NCT00103285|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
270061|NCT00103311|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
270062|NCT00103376|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
297257|NCT01736579|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
284825|NCT00986544|"Department of Surgery, Hospital P. Colombo, Via Orti Ginnetti 7, 00049 Velletri (Rome), Italy"|Marcello Picchio|+39696102228|marcellopicchio@libero.it|
284826|NCT00986570|Biolab Sanus Farmacêutica Ltda.|Priscilla Padilha, MD|55(11)35736335|ppadilha@biolabfarma.com.br|
284827|NCT00986583|Cleveland Clinic|Alparslan Turan, M.D.|216-444-4000|turana@ccf.org|9857
284828|NCT00986674|ECOG Statistical Office|Study Statistician|617-632-3012||
284829|NCT00986830|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
284830|NCT00986856|LEO Pharma|Anders Rhod Larsen, Scientific advisor|+45 72262990|anders.larsen@leo-pharma.com|
284831|NCT00986921|Boston University Department of Obstetrics and Gynecology|Director of Clinical Research|617-414-5175|rstudy@bmc.org|
284832|NCT00986973|The Children's Hospital of Philadelphia|Dr. Can Ficicioglu|2155905876|ficicioglu@email.chop.edu|
284833|NCT00986986|University of Hawaii at Manoa|Dominic Chow|(808)737-2751|dominicc@hawaii.edu|
284834|NCT00987337|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284835|NCT00987389|McMaster University, Hamilton, Ontario|Dr. Michael Walsh|905-522-1155|lastwalsh1975@gmail.com|34055
284836|NCT00987402|University Hospital, Geneva|Stephan Harbarth MD|+41-22-372.3357|stephan.harbarth@hcuge.ch|
284837|NCT00987415|Duke University|Kevin Anstrom|919-668-8902|kevin.anstrom@dm.duke.edu|
284838|NCT00987467|Johns Hopkins University, Wilmer Eye Institute|Esen Akpek, MD, Associate Professor of Ophthalmology, Wilmer Eye Institute|410-955-5214|esakpek@jhmi.edu|
284839|NCT00987480|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-2429|bouladf@mskcc.org|
284840|NCT00987558|Bial - Portela & Cª, S.A.|Head of Clinical Research||jose.rocha@bial.com|
284841|NCT00987623|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
284842|NCT00987727|Allergan, Inc|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
284843|NCT00987831|Oklahoma Medical Research Foundation|Joan T Merrill, M.D|405-271-7805|JTMmail@aol.com|
284844|NCT00987935|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
284845|NCT00987948|Hawaii Center for AIDS, University of Hawaii|Dr. Cecilia M Shikuma|8086921328|shikuma@hawaii.edu|
284846|NCT00988000|Imperial College|Professor Martyn Partridge|+44 (0)20 7594 7959|m.partridge@imperial.ac.uk|
284847|NCT00988013|University of Illinois at Chicago|Dr. Damiano Rondelli|312-996-6179|drond@uic.edu|
284848|NCT00988065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
297258|NCT01736657|Terumo BCT, Inc.|Ray Goodrich, Phd, VP Scientifc and Clinical Affairs|303-205-2680||
297259|NCT01736683|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
297260|NCT01736696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297261|NCT01736852|Cook Research Incorporated|Alan Saunders,MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
297262|NCT01736865|Tufts Medical Center|Dr. Anastassios Pittas|617-636-5694|apittas@tuftsmedicalcenter.org|
297263|NCT01736917|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
297264|NCT01736930|Jaeb Center for Health Resesarch|Roy W. Beck, MD, PhD|813-975-8690|jdrfapp2@jaeb.org|
297265|NCT01736943|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
270063|NCT00103402|University of Pennsylvania|J. Richard Landis, PhD|215-573-4922|hultman@upenn.edu|
270064|NCT00103506|Janssen R&D UK|Project Physician||ClinicalTrialDisclosure@its.jnj.com|
270065|NCT00103610|Genzyme Corporation|Genzyme MedInfo||medinfo@genzyme.com|
270066|NCT00103662|Genzyme Corporation|Genzyme Medical Information|800-745-4447||
270067|NCT00103740|Novartis Pharmaceuticals|Study Director|862-778-8300||
270068|NCT00103844|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
270069|NCT00103857|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
270070|NCT00104052|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
270071|NCT00104104|Novatis Pharmaceuticals|Study Director|862-778-8300||
270072|NCT00104234|BioMarin Pharmaceutical Inc.|Medical Information Services|8009834587|medinfo@bmrn.com|
270073|NCT00104247|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
270074|NCT00104299|DAIT/NIAID|Associate Director, Clinical Research Program|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
270075|NCT00104416|GlaxoSmithKline|GSK Response Center|866-435-7343||
270076|NCT00104520|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
270077|NCT00104572|NIA|Josephine M. Egan,MD, clinical director NIA|410-558-8414|eganj@grc.nia.nih.gov|
275979|NCT00521352|Columbia University Department of Psychiatry, City University of New York|Dr. Antonio Mantovani|212-650-5417|AMantovani@med.cuny.edu|
275980|NCT00521365|AstraZeneca|Gerard Lynch|09645895|ClinicalTrialTransparency@astrazeneca.com|4415
275981|NCT00521404|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
275982|NCT00521456|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
275983|NCT00521586|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
275984|NCT00521976|Stavanger University Hospital|Dennis W.T. Nilsen MD PhD FESC FAHA|+4705151|nide@sus.no|9455
275985|NCT00521989|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
275986|NCT00522041|Allergan plc|Susan Fox, PhD|201-427-8225|susan.fox@allergan.com|
275987|NCT00522171|Ethicon Endo-Surgery|Sheryl Helsinger|513-337-3079|SHelsing@its.jnj.com|
275988|NCT00522275|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
275989|NCT00522379|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
275990|NCT00522392|ECOG Statistical Office|Study Statistician|617-632-3012||
275991|NCT00522418|Cyberonics, Inc|Mark Bunker, Senior Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
297266|NCT01737021|Imperial College London|Professor Elena Garralda|+44 (0)20 3312 6085|e.garralda@imperial.ac.uk|
284849|NCT00988091|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
284850|NCT00988117|UCaliforniaSF|Dr. Bruce Miller|415-476-5569|bmiller@memory.ucsf.edu; kpossin@memory.ucsf.edu|
284851|NCT00988143|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
284852|NCT00988156|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
270078|NCT00104637|Columbia University|David J. Lederer, MD|212-305-7771|dl427@columbia.edu|
284853|NCT00988169|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
297267|NCT01737268|Astellas Pharma Inc.|Vice-President, Japan-Asia Clinical Development Administration|+81-3-3244-0512|Astellas.resultsdisclosure@astellas.com|
284854|NCT00988208|Celgene Corporation|Senior Manager , Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
284855|NCT00988221|Hoffman-La Roche|Medical Communications|800 821-8590||
284856|NCT00988325|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
284857|NCT00988351|Malcom Randall VA|Dr. Richard B. Berry|3522621575|Richard.Berry@medicine.ufl.edu|
284858|NCT00988429|Bial - portela & Cª, S.A.|Head of Clinical Research|+351 22 986 6100|clinical.trials@bial.com|
284859|NCT00988442|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 6283313|ACTGCT.Gov@s-3.com|
284860|NCT00988533|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
284861|NCT00988559|Johns Hopkins University|Cornelia L. Trimble, MD|410-502-0512|ctrimbl@jhmi.edu|
284862|NCT00988598|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284863|NCT00988637|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Dierctor|817-961-5358|ron.gottschalk@galderma.com|
284864|NCT00988832|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
284865|NCT00988858|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284866|NCT00988884|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284867|NCT00989014|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
284868|NCT00989092|Amgen Inc.|Study Director|866-572-6436||
284869|NCT00989157|NRIFargo|Dr. James Roerig|701 365 4919|jroerig@nrifargo.com|
284870|NCT00989196|Octapharma AG|Dr. Sigurd Knaub|+41 554512141|sigurd.knaub@octapharma.com|
284871|NCT00989235|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
284872|NCT00989261|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
284873|NCT00989287|GlaxoSmithKline|GSK Response Center|866-435-7343||
284874|NCT00989573|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
284875|NCT00989586|The Ohio State University Comprehensive Cancer Center|Beth Christian|614-293-8858|beth.christian@osumc.edu|
284876|NCT00989612|GlaxoSmithKline|GSK Response Center|866-435-7343||
284877|NCT00989664|GlaxoSmithKline|GSK Response Center|866-435-7343||
284878|NCT00989768|Brazilian Center for Studies in Dermatology|Juliana de Souza|+55 51 3026 2633|pesquisa@cebd.org.br|
284879|NCT00989781|UCSD|R. Jeffrey Chang, M.D.|858-534-8930|rjchang@ucsd.edu|
284880|NCT00989833|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
284881|NCT00989911|Ahamanson/UCLA ACHDC|Dr. Jamil Aboulhosn|3108255950|jaboulhosn@mednet.ucla.edu|
284882|NCT00989950|CoxHealth|Arie Ashkenasi, MD|011 972 50 3007477|ashkenasi1@gmail.com|
270079|NCT00104650|Amgen Inc.|Study Director|866-572-6436||
270080|NCT00104676|Unicancer|Deputy Director R&D|(+33)1 44 23 04 19|b-juzyna@unicancer.fr|
270081|NCT00104858|Fred Hutchinson Cancer Research Center|Dr. Mohamed Sorror|206-667-6298|msorror@fredhutch.org|
270082|NCT00104871|UT MD Anderson Cancer Center|Steven Sherman, MD / Professor|713-792-2841|sisherma@mdanderson.org|
270083|NCT00104884|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
270084|NCT00105001|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
270085|NCT00105027|The EMMES Corporation|Paul C. VanVeldhuisen, Ph.D.|301-251-1161|score@emmes.com|
270086|NCT00105066|National Institute On Aging|Dr. James Strait|4105588084|straitj@mail.nih.gov|
270087|NCT00105079|Hoffman-LaRoche|Medical Communications|800-821-8590||
270088|NCT00105157|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
270089|NCT00105183|Fresenius Biotech|Regulatory Affairs|781 699 4618|anne.kuan@fresenius-biotech.com|
270090|NCT00105196|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
270091|NCT00105235|DAIT/NIAID|Associate Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
270092|NCT00105443|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
270093|NCT00105469|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270094|NCT00105482|Yale School of Medicine, Department of Psychiatry|Stephanie Samples O'Malley PhD, Director, Division of Substance Abuse Research|(203) 974-7590|stephanie.omalley@yale.edu|
270095|NCT00105508|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|496151725200|service@merckgroup.com|
270096|NCT00105521|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
270097|NCT00105534|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270098|NCT00105586|Washington University in St. Louis|Eric Lenze|314-362-1671|lenzee@wustl.edu|
284883|NCT00989963|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director||info@lungbiotechnology.com|
284884|NCT00989989|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
284885|NCT00990093|Coloplast|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
284886|NCT00990106|VA Puget Sound Health Care System|Murray Raskind, MD|206-277-3797|Murray.Raskind@va.gov|
284887|NCT00990184|SIBCR|Steven E. Kahn|206-277-5515|skahn@u.washington.edu|
284888|NCT00990236|Oregon Health & Science University|Samantha Underwood, Research Manager|503-494-8481|traumare@ohsu.edu|
284889|NCT00990249|The University of Texas (UT) MD Anderson Cancer Center|Partow Kebriaei, MD/Professor, Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
284890|NCT00990288|Hospital for Special Surgery|Mark P. Figgie MD|212-606-1932|figgiem@hss.edu|
284891|NCT00990314|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
284892|NCT00990340|Teva Neuroscience|Thomas Smith, MD, VP, Medical Affairs|816-508-5000|tom.smith@tevapharm.com|
284893|NCT00990509|University of Arizona|Chelsea Kidwell, MD|(520) 626-7159|ckidwell@neurology.arizona.edu|
284894|NCT00990561|UCSF|John Koo, Principle Investigator|415-476-4701|john.koo@ucsfmedctr.org|
284895|NCT00990652|Northwestern University|Jeffrey Raizer, MD|312-503-4724|jraizer@nmff.org|
284896|NCT00990665|St. Jude Medical|Clay Cohorn: Director, Clinical Study Management|972 309 8087|ccohorn@sjm.com|
284897|NCT00990704|Abbott|Global Medical Services|800-633-9110||
297268|NCT01737281|VA NY Harbor Healthcare System|Dr. Scott Sherman|212-686-7500|scott.sherman@va.gov|7386
284898|NCT00990769|Duke University Medical Center|Dr. Heather Frederick|919-812-6204|heather.frederick@duke.edu|
284899|NCT00990782|Cleveland Clinic|Dr. John Vargo|(216) 445-5012|vargoj@ccf.org|
284900|NCT00990821|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
284901|NCT00990938|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
284902|NCT00990964|Medtronic, Inc.|Attain Success Clinical Trial Leader|800-328-2518|medtronicCRMtrials@medtronic.com|62864
284903|NCT00991029|Medical University of South Carolina|Dr. Jordan Elm|843-876-1605|elmj@musc.edu|
284904|NCT00991081|Stanford University|Sean P. David, MD, SM, DPhil|650-498-4687|spdavid@stanford.edu|
284905|NCT00991185|duke|brian smith|919668951|brian.smith@duke.edu|
284906|NCT00991276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284907|NCT00991289|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
284908|NCT00991302|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
284909|NCT00991341|New England Research Institutes|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
284910|NCT00991406|Cleveland VAMC|Elizabeth Hardin|216-791-3800|Elizabeth.HardinvandenBogert@va.gov|4698
297269|NCT01737398|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
270099|NCT00105989|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
284911|NCT00991458|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
270100|NCT00106002|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
284912|NCT00991510|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
284913|NCT00991809|Johns Hopkins University, School of Medicine|Dr. D. Andrew Tompkins|410-550-5953|dtompki1@jhmi.edu|
284914|NCT00991887|Carolinas Medical Center|Rachel Seymour, PhD|704-355-6969|Rachel.Seymour@carolinashealthcare.org|
284915|NCT00991939|New England Research Institutes, Inc.|Susan F. Assmann, PhD|617-923-7747|sassmann@neriscience.com|548
284916|NCT00991952|Memorial Sloan-Kettering Cancer Center|Dr. Yelena Janjigian|646-888-4186|janjigiy@mskcc.org|
284917|NCT00992017|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|919-405-1429|mallen@fhi360.org|
284918|NCT00992056|University of Miami|Richard A Preston MD MSPH MBA|305 243 5930|rpreston@med.miami.edu|
284919|NCT00992108|UCLA Neurology|Marisa Chang, MD|310-794-1870|marisachang@mednet.ucla.edu|
284920|NCT00992186|Centocor Research & Development, Inc., PA, USA|Senior Director, Early Clinical Development Global Leader|+1-908-927-3159||
297270|NCT01737593|UCLA|Dr. Wendy Ren|310.267.8678|wren@mednet.ucla.edu|
270101|NCT00106028|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
270102|NCT00106080|Department of Veterans Affairs, Health Services Research and Development|David H. Au, MD, MS|206-764-2430|david.au@va.gov|
270103|NCT00106106|NIH/National Institute on Alcohol Abuse and Alcoholism|Markus A. Heilig, M.D., Ph.D.|301-435-9386|mheilig@mail.nih.gov|
270104|NCT00106119|National Institute of Diabetes and Digestive and Kidney Diseases|Dr. Kong Chen|3014511636|chenkong@niddk.nih.gov|
270105|NCT00106184|University of Pittsburgh|Chester V. Oddis, MD|412-383-8861|cvo5@pitt.edu|
270106|NCT00106249|CUNY|Dr. Antonio Mantovani|212-650-5417|amantovani@med.cuny.edu|
270107|NCT00106353|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270108|NCT00106392|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
270109|NCT00106431|Celgene Corporation|Elizabeth Faust, PhD, Vice President, Clinical Research Services|617/583-1300|EFaust@Celgene.com|
270110|NCT00106535|Hoffmann-La Roche|Medical Communications|800-821-8590||
270111|NCT00106639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270112|NCT00106704|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270113|NCT00106938|Abbott Vascular|Jennifer M Jones-McMeans, PhD (Associate Director Clinical Research)|408-845-1459|jennifer.jones@av.abbott.com|
308493|NCT02584452|Vanderbilt University Medical Center|Christopher Sobey, MD|615-322-4311|christopher.m.sobey@vumc.org|
284921|NCT00992225|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284922|NCT00992264|Group Health Research Institute|Jennifer McClure|206-287-2737|mcclure.j@ghc.org|
284923|NCT00992394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284924|NCT00992407|R&D Clinical Research, Seoul KOREA|Clinical Research Director|+82 2 2094 -4518||
284925|NCT00992433|Baylor College of Medicine|Hana El Sahly, MD|713-798-2058|hanae@bcm.edu|
284926|NCT00992446|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
284927|NCT00992459|Hyperion Therapeutics|Bruce Scharschmidt, MD, SVP, Chief MedicaL & Development Officer|650-745-7851|bruce.scharschmidt@hyperiontx.com|
284928|NCT00992511|GlaxoSmithKline|GSK Response Center|866-435-7343||
284929|NCT00992589|Janssen R&D US|PORTFOLIO/CDT LEADER|1 609 730-2548||
284930|NCT00992602|University of Washington|Maciej M. Mrugala, MD, PhD, MPH|206-543-4069|mmrugala@uw.edu|
284931|NCT00992719|Department of Obstetrics & Gynecology, Division of Maternal-Fetal Medicine, Duke University School of Medicine|Geeta K. Swamy, M.D.|919-681-5220|geeta.swamy@duke.edu|
284932|NCT00992784|GlaxoSmithKline|GSK Response Center|866-435-7343||
284933|NCT00992836|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|919-405-1429|mallen@fhi360.org|
284934|NCT00992927|Seoul National University Hospital|Sun Gun Chung/Professer|+82-2-2072-3954|suncg@snu.ac.kr|
284935|NCT00992992|GlaxoSmithKline|GSK Response Center|866-435-7343||
284936|NCT00993031|University of California, San Francisco|Diane V Havlir, MD|01-415-476-4082|dhavlir@php.ucsf.edu|400
284937|NCT00993044|Children's Hospital Los Angeles|Rajkumar Venkatramani|3233615504|rvenkatramani@chla.usc.edu|
284938|NCT00993148|Northwestern University|Dr. Babafemi Taiwo|312-695-5085|b-taiwo@northwestern.edu|
284939|NCT00993187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372||
284940|NCT00993200|University of Utah|Robert Pendleton|801 581 7818|robert.pendleton@hsc.utah.edu|
284941|NCT00993226|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
284942|NCT00993265|Yale University, Child Study Center|Dr. Michael Bloch, MD, MS|203-737-4809|michael.bloch@yale.edu|
284943|NCT00993291|Vanderbilt University|Fenna Phibbs M.D.|615-936-2025|fenna.phibbs@vanderbilt.edu|
284944|NCT00993317|Korea Otsuka Pharmaceutical|Eun Young Cho, Clinical Trial Manager|+82-2-3287-9233|hyerim@otsuka.co.kr|
284945|NCT00993421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
284946|NCT00993447|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
284947|NCT00993473|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
284948|NCT00993499|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297271|NCT01737684|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297272|NCT01737697|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
297273|NCT01737710|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
270114|NCT00106964|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
270115|NCT00107042|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
297274|NCT01737762|Smith and Nephew|Dr Innes Cargill|817-302-3913|innes.cargill@smith-nephew.com|
270116|NCT00107120|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Daniel Ventura, PhD|201-427-8252|daniel.ventura@frx.com|
270117|NCT00107172|Boston Medical Center|Hiran C. Fernando, MD|617-638-5600|hiran.fernando@bmc.org|
270118|NCT00107198|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
270119|NCT00107276|SWOG|Study statistician|206-667-4623||
270120|NCT00107380|SWOG Statistical Center|Study Statistician|206-667-4623||
270121|NCT00107536|The Ohio State University Comprehensive Cancer Center|Tanio Bekaii-Saab, MD|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
270122|NCT00107575|Brown University|Christopher Kahler|(401) 863-6651|Christopher_Kahler@brown.edu|
270123|NCT00107653|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
270124|NCT00107744|Tulane University|Jiang He, MD, PhD, Chair of Epidemiology|504-988-5165|jhe@tulane.edu|
270125|NCT00107783|NHGRI|William Gahl, MD/Clinical Director|301-402-2739|gahlw@mail.nih.gov|
270126|NCT00107900|Daiichi Sankyo, Inc.|Victor Fernandez|732-590-5000|vfernandez@dsi.com|
270127|NCT00107952|Theravance Biopharma Antibiotics, Inc.|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
270128|NCT00107978|Theravance, Inc|Steve Barriere, Pharm.D., Vice President, Clinical and Medical Affairs|650-808-6132|sbarriere@theravance.com|
270129|NCT00107991|UPenn|Jennifer Goldfarb|215-662-2540|jennifer.goldfarb@uphs.upenn.edu|
270130|NCT00108069|National Cancer Institute|Kathy Warren, M.D.|301-435-4683|warrenk@box-w.nih.gov|
270131|NCT00108082|GlaxoSmithKline|GSK Response Center|866-435-7343||
270132|NCT00108160|VA Ann Arbor Healthcare System|Suzanne F. Bradley, M.D.|734-845-5820|sbradley@umich.edu|55826
270133|NCT00108277|VA Palo Alto Health Care System / Stanford University School of Medicine|Walton T. Roth, M.D.|650-493-5000|wtroth@stanford.edu|65243
270134|NCT00108303|VA|Dr. Robert Freedman|3037244940|Robert.Freedman@ucdenver.edu|
270135|NCT00108355|VA-CT Healthcare System|Guadalupe Garcia-Tsao|203-932-5711|guadalupe.garcia-tsao@yale.edu|2210
270136|NCT00108485|Diabetes Research Institute|Dr. Ronald Goldberg|305-243-6574|RGoldber@med.miami.edu|
270137|NCT00108524|Durham VAMC|William S Yancy, Jr. MD, MHSc|919-286-0411|william.yancy2@va.gov|7770
270138|NCT00108550|VA San Diego Healthcare System|J. H. Atkinson MD|858-642-3775|joseph.atkinson@va.gov|
270139|NCT00108628|Philadelphia VA Medical Center|Dr. Richard Ross|(215) 823-4046|Richard.Ross2@va.gov|
270140|NCT00108732|ECOG Statistical Office|Study Statistician|617-632-3012||
297275|NCT01737840|Akdeniz University|Cenker Eken|00905321593948|cenkereken@akdeniz.edu.tr|
297276|NCT01737879|Amgen Inc.|Study Director|866-572-6436||
284949|NCT00993616|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
284950|NCT00993655|Canadian Cancer Trials Group|Senior Biostatistician|6135336430||
284951|NCT00993668|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
284952|NCT00993798|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
284953|NCT00993824|International Diabetes Center|Roger Mazze PhD|952-993-3796|rmazze@aol.com|
284954|NCT00993915|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284955|NCT00993928|Mayo Clinic|Charles Lawrence Loprinzi, M.D.||cloprinzi@mayo.edu|
284956|NCT00993954|University of Alberta|Dr Andrew Dixon|780-492-3553|andrew.dixon@albertahealthservices.ca|
284957|NCT00993967|Santhera Pharmaceuticals|Thomas Meier, PhD|+41 61 906 89 50|thomas.meier@santhera.com <Thomas.Meier@santhera.com>|
284958|NCT00994110|Memorial Sloan Kettering Cancer Center|Dr. Peter Allen|212-639-5132|allenp@mskcc.org|
284959|NCT00994123|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
284960|NCT00994175|National Heart Lung and Blood Institute|Levine, Stewart|+1 301 402 1448|levines@nhlbi.nih.gov|
284961|NCT00994214|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
284962|NCT00994240|University of Wisconsin-Madison|Clinical Research Administrator|608-287-2640|dbock@dermatology.wisc.edu|
284963|NCT00994279|Wake Forest NCI NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
284964|NCT00994318|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
284965|NCT00994422|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
297277|NCT01737931|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
284966|NCT00994448|UCLA|Keith Heinzerling MD|310-794-0619|KHeinzerling@mednet.ucla.edu|
284967|NCT00994461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284968|NCT00994604|Johns Hokpins Medical Institutions|Dr. Robert Brown|410-614-5451|rbrown2@jhmi.edu|
284969|NCT00994643|Thomas Jefferson University|Dr. Matthew Carabasi|215-955-8874|matthew.carabasi@jefferson.edu|
284970|NCT00994682|University of Florida|Dr. Kenneth Cusi|352-273-8662|kcusi@ufl.edu|
284971|NCT00994760|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666|clinicaltrials@nycomed.com|0
284972|NCT00994890|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
284973|NCT00994929|The University of Pittsburgh|Margaret V. Ragni, MD, MPH|412-209-7288|ragni@pitt.edu|
284974|NCT00995007|National Cancer Institute|Dr. Katherine E. Warren|301-435-4683|warrenk@box-w.nih.gov|
284975|NCT00995020|Affiliation: Oswaldo Cruz Foundation|Investigator: MJCamargo [Camargo Maria José] Official Title: PHD|00552199777009|mariaj.camargo@hotmail.com|
284976|NCT00995072|ECIR|Benjamin Epstein, PharmD|904-854-1354|benjamin.epstein@eastcoastresearch.net|
284977|NCT00995085|Alcobra Inc|Jonathan Rubin, MD, MBA|610-504-7814|jrubin@alcobra-pharma.com|
284978|NCT00995215|MetroHealth Medical Center|Dr. Anthony Dimarco|216-778-3906|adimarco@metrohealth.org|
284979|NCT00995345|ActivX Biosciences|Dr. Diane Plotkin, Sr. Director Clinical Development|858-558-5558|dianep@activx.com|
284980|NCT00995371|Coastal Orthopedics & Sports Medicine|Lois A. Davis|941-782-1353|ldavis@coastalorthopedics.com|
284981|NCT00995410|POZEN|John Fort, MD / Chief Medical Officer|919-913-1030|jfort@pozen.com|
284982|NCT00995436|ChestyerfieldNDRH|Jonathan Sandler|01246512106|JonSandler57@gmail.com|
284983|NCT00995449|KaloBios Pharmaceuticals, Inc.|Nestor A. Molfino, MD., MSc|650-243-3103|nmolfino@kalobios.com|
297278|NCT01737944|Antares Pharma|Jonathan Jaffe, MD; Vice President Clinical Development|1-609-359-3020|jjaffe@antarespharma.com|324
297279|NCT01737996|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297280|NCT01738191|Medical University of South Carolina|Dr. Vanessa Hinson|843-792-9115|hinsonvk@musc.edu|
297281|NCT01738321|Nationwide Children's Hospital|Senthil Krishna, MD|614-722-4200|Senthil.Krishna@nationwidechildrens.org|
297282|NCT01738438|Dana-Farber Cancer Institute|Sara Tolaney, MD|617.632.2335|Sara_Tolaney@DFCI.HARVARD.EDU|
270141|NCT00108745|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
270142|NCT00108862|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
270143|NCT00108953|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
270144|NCT00109005|National Cancer Institute, National Institutes of Health|Caryn Steakley|301-435-3685|steaklec@mail.nih.gov|
270145|NCT00109031|Swedish Orphan Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
270146|NCT00109343|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
270147|NCT00109473|Cincinnati Children's Hospital Medical Center|Lee A. Denson|513-636-7575|lee.denson@cchmc.org|
270148|NCT00109577|University of Calgary|Dr. Bonnie Kaplan|403-955-7363|kaplan@ucalgary.ca|
297283|NCT01738477|GlaxoSmithKline|GSK Response Center|866-435-7343||
270149|NCT00109590|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
270150|NCT00109707|NovartisPharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
270151|NCT00109733|EMD Serono|Sanja Dragnic/Medical Responsible|+7816814017|sanja.dragnic@emdserono.com|
270152|NCT00109772|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
270153|NCT00109837|SWOG Statistical Office|SWOG Leukemia Statistician|206-667-4408||
270154|NCT00109850|SWOG Statistical Center|Study Statistician|206-667-4623||
297284|NCT01738503|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
297285|NCT01738581|University of Minnesota|Dr. Teresa Kimberley|612-626-4096|tjk@umn.edu|
297286|NCT01738594|Northwestern University|Barbara Pro, MD|312-695-6832|barbara.pro@nm.org|
308494|NCT02584504|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
284984|NCT00995475|University of Dundee|Professor Brian J Lipworth|+44 1382 383188|b.j.lipworth@dundee.ac.uk|
297287|NCT01738646|Duke Univeristy Medical Center|Katherine Peters|919 684-3914|katherine.peters.@dm.duke.edu|
284985|NCT00995488|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain|734-647-8903|mahahuss@umich.edu|
270155|NCT00109876|Rhode Island Hospital/Alpert Medical School|Damian E. Dupuy, MD|401 - 444 - 5184|ddupuy@lifespan.org|
270156|NCT00109928|SWOG Statistical Center|Study Statistician|206-667-4623||
270157|NCT00109967|Mayo Clinic|Stephen M. Ansell, M.D., Ph.D.||ansell.stephen@mayo.edu|
270158|NCT00110019|ECOG Statistical Office|Study Statistician|617-632-3012||
270159|NCT00110084|Mayo Clinic|Dr. Vivek Roy|507-284-1159|roy.vivek@mayo.edu|
270160|NCT00110136|Wake Forest CCOP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
270161|NCT00110149|BIDMC|Robin Joyce, MD|617-667-9920|rjoyce@bidmc.harvard.edu|
270162|NCT00110214|Thomas Jefferson University|William Kevin Kelly, DO||wm.kevin.kelly@jefferson.edu|
270163|NCT00110266|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
270164|NCT00110305|Janssen-Virco BE|Director|32 14 641418||
270165|NCT00110357|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
270166|NCT00110396|Merck Serono SA|Bettina Stubinski/Medical Responsible|+41224143396||
270167|NCT00110461|Otsuka Pharmaceutical Development & Commercialization, Inc.|Andy Forbes||andy.forbes@otsuka-us.com|
270168|NCT00110513|GTC Biotherapeutics|Denise Tilton, RN, MHA, Director Clinical Affairs|508-370-5257|denise.tilton@gtc-bio.com|
270169|NCT00110617|Novartis Pharmaceuticals|Study Director|862-778-8300||
270170|NCT00110812|University of Minnesota|Deborah Wentworth|612-726-9005|wentw001@umn.edu|
270171|NCT00110890|Amgen Inc.|Study Director|866-572-6436||
270172|NCT00110994|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
270173|NCT00111007|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
270174|NCT00111228|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
270175|NCT00111241|Monash University|Prof Susan Davis|+61399030827|susan.davis@monash.edu|
275992|NCT00522431|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
275993|NCT00522548|University of Pennsylvania|Roy Bloom, MD|215-662-4643|roy.bloom@uphs.upenn.edu|
275994|NCT00522626|Johns Hopkins University School of Medicine|Dr. Lauren Jansson|410-550-5438|ljansson@jhmi.edu|
275995|NCT00522795|BrUOG|Kayla Rosati|401-863-3000|Kayla_Rosati@brown.edu|
275996|NCT00522873|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
275997|NCT00522925|Ligand Pharmaceuticals, Inc.|Ram Kapil, PhD/ Sr. Director, Clinical Pharmacology|858-550-7603|rkapil@ligand.com|
275998|NCT00522951|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
275999|NCT00523237|Stanford University|Philip Grant, MD|650-723-2804|pmgrant@stanford.edu|
276000|NCT00523302|Medical University of South Carolina|Edward B. Short|8437923295|shortb@musc.edu|
276001|NCT00523341|Amgen Inc.|Study Director|866-572-6436||
276002|NCT00523367|University of Florida|Juan Munoz, MD|904-633-0089|juan.munoz@jax.ufl.edu|
276003|NCT00523419|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276004|NCT00523549|Novartis Pharmaceuticals|Study Director|862-778-8300||
276005|NCT00523614|Berlin Center for Epidemiology and Health Research, Germany|Juergen Dinger, MD, PhD, Principal Investigator|+49 30 94510145|dinger@zeg-berlin.de|
276006|NCT00523640|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
276007|NCT00523705|University of Pennsylvania|Ellen Freeman, Principal Investigator|215 662-3329|freemane@mail.med.upenn.edu|
276008|NCT00523718|Yale University|Christopher Pittenger|(203) 974-7675|christopher.pittenger@yale.edu|
276009|NCT00523744|Novartis Pharmaceuticals|Study Director|862-778-8300||
276010|NCT00523848|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
276011|NCT00523978|Medtronic AF Solutions|Linda Nelson, RN, BSN, MBA - AF Solutions Clinical Operations Director|(763)526-2891|linda.k.nelson@medtronic.com|
276012|NCT00523991|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276013|NCT00524017|SKCCC|Dr. Zubair Khan|4109553157|zkhan@jhmi.edu|
276014|NCT00524030|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276015|NCT00524043|Johnson & Johnson Pharmaceutical Research & Development|Clinical Team Leader, Paliperidone|609 730-2436||
276016|NCT00524121|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
276017|NCT00524173|NIDDK|Marc Ghany, MD|301-402-5115|marcg@intra.niddk.nih.gov|
276018|NCT00524225|University of Pittsburgh|Dr. Margaret Ragni, Professor of Medicine|412-209-7288|ragni@dom.pitt.edu|
276019|NCT00524264|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
276020|NCT00524303|GlaxoSmithKline|GSK Response Center|866-435-7343||
276021|NCT00524316|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
276022|NCT00524342|University of Pittsburgh|Dr. Margaret Ragni|412-209-7288|ragni@dom.pitt.edu|
276023|NCT00524368|Tibotec Pharmaceuticals, Ireland|Medical Leader|+32 015 461 497||
276024|NCT00524420|University of Washington|David H. Avery, MD, Professor|206-744-4527|averydh@u.washington.edu|
276025|NCT00524472|Cleveland Clinic|Andra Duncan, MD|216 445-2372|DUNCANA@ccf.org|
276026|NCT00524537|AbbVie|Global Medical Information|800-633-9110||
276027|NCT00524576|GlaxoSmithKline|GSK Response Center|866-435-7343||
276028|NCT00524589|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
276029|NCT00524680|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
276030|NCT00524745|PATH|Kathleen Neuzil, Principal Investigator|206-285-3500|kneuzil@path.org|4864
284986|NCT00995501|Cleveland clinic|Daniel Sessler, MD|216-445-4900|sesseld@ccf.org|
284987|NCT00995553|Minneapolis VA Health Care System|Dr. Tasha Nienow|612-467-1004|Tasha.Nienow@va.gov|
284988|NCT00995566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270176|NCT00111475|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
270177|NCT00111657|Duke University Medical Center|John S. Sundy, MD, PhD|919-684-2347|john.sundy@duke.edu|
276031|NCT00524771|Center for Epidemiology and Health Research, Germany|Dr. Juergen Dinger|0049 (0)30 945 101 20|dinger@zeg-berlin.de|
276032|NCT00524940|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
276033|NCT00525031|UT MD Anderson Cancer Center|Wen-Jen Hwu, MD/Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
276034|NCT00525044|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276035|NCT00525057|UT MD Anderson Cancer Center|Patrick Lin, MD/Professor, Orthopaedic Oncology|(713) 745-0088|plin@mdanderson.org|
276036|NCT00525135|University of California San Francisco|UCSF PRS Administrator|415-502-3212|Elaine.Cooperstein@ucsf.edu|
276037|NCT00525148|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276038|NCT00525161|University of Kentucky|Dr. Suleiman Massarweh|8593238043|massarweh@uky.edu|
276039|NCT00525174|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
276040|NCT00525265|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
276041|NCT00525421|University of California San Francisco|Nita Chainani-Wu|415-476-2045|nita.wu@ucsf.edu|
276042|NCT00525499|AndroScience Corp|Charles CY Shih, PhD|(858) 638-7230|cyshih@androscience.com|
276043|NCT00525512|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276044|NCT00525525|University of California San Francisco|Michael D. Prados, MD, FACP|415-353-2383|pradosm@neurosurg.ucsf.edu|
276045|NCT00525590|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
276046|NCT00525603|The University of MD Anderson Cancer Center|William G. Wierda, MD/Associate Professor|713-745-0428|eharriso@mdanderson.org|
276047|NCT00525629|Beth Israel Deaconess Medical Center|Christos Mantzoros|617-667-8630|cmantzor@bidmc.harvard.edu|
276048|NCT00525733|Aaron Diamond AIDS Research Center|Martin Markowitz MD|212-448-5020|mmarkowitz@adarc.org|
276049|NCT00525785|The University of Texas (UT) MD Anderson Cancer Center|Dr. Jaffer Ajani, MD / Professor, GI Medical Oncology|713-792-2828|jajani@mdanderson.org|
276050|NCT00525798|Nordic Bioscience|Dr. Bente Juul Riis|+45 22901317|bjr@nordicbioscience.com|
276051|NCT00525824|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
276052|NCT00525837|Butler Hospital|Noah S. Philip MD|401-455-6258|noah_philip@brown.edu|
276053|NCT00525876|UT MD Anderson Cancer Center|Issa F. Khouri, MD/ Professor||celsaenz@mdanderson.org|
276054|NCT00525902|Oregon Health & Science University|Eric B. Suhler|503-494-5023|suhlere@ohsu.edu|
276055|NCT00525915|University of Texas (UT) MD Anderson Cancer Center|Jaffer Ajani, MD / Professor, GI Medical Oncology|713-792-2828|CR_Study_Registration@mdanderson.org|
276056|NCT00526058|B. Braun Medical Inc.|Kevin Minnich, Manager Clinical Affairs/Safety Officer|610-596-2358|kevin.minnich@bbraun.com|
276057|NCT00526071|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
276058|NCT00526097|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276059|NCT00526110|The University of Texas (UT) MD Anderson Cancer Center|Jaffer Ajani, MD/Professor, GI Medical Oncology|1-877-632-6789|CR_Study_Registration@mdanderson.org|
276060|NCT00526123|Tufts Medical Center|Dr. Klemens B. Meyer|617-636-9421|kmeyer@tuftsmedicalcenter.org|
276061|NCT00526162|Medtronic CRDM|CRDM Core Clinical Organization|800-328-2518|jamie.l.reynolds@medtronic.com|
276062|NCT00526188|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
276063|NCT00526292|Memorial Sloan Kettering Cancer Center|Dr. Katherine Hsu|646-888-2667|hsuk@mskcc.org|
276064|NCT00526474|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276065|NCT00526591|Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@case.edu|
276066|NCT00526630|University of Cincinnati|Alberto Espay, MD|513-403-4600|alberto.espay@uc.edu|
276067|NCT00526656|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Jorge Garcia, MD|216-444-7774|garciaj4@ccf.org|
276068|NCT00526669|GlaxoSmithKline|GSK Response Center|866-435-7343||
276069|NCT00526799|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
276070|NCT00526890|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
276071|NCT00526994|CDC|Joanne Klevens|770-488-1386|dzk8@cdc.gov|
276072|NCT00527072|Janssen Biotech, Inc.|Sr. Director, Clinical Research - Medical Affairs|215-325-5711||
276073|NCT00527098|University of Miami|Kenneth Proctor, PhD|305-243-4694|kproctor@med.miami.edu|
276074|NCT00527111|US Oncology Network, McKesson Specialty Health|Dr. David McCollum|214-370-1080|david.mccollum@usoncology.com|
276075|NCT00527124|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath|313-576-8715|heathe@karmanos.org|
276076|NCT00527319|Oxford Pharmaceutical Resources, Inc.|Dr. Richard Guarino|973-256-0600|Guarino@oxfordpharm.com|
276077|NCT00527332|Deptartment of Obstetrics and Gynecology, University Hospital, Linköping, Sweden|Dr Preben Kjolhede|+46101030000|Preben.Kjolhede@lio.se|3187
284989|NCT00995670|Zablocki VA Medical Center|Thomas J. Ebert, MD, PhD|414-384-2000|thomas.ebert@va.gov|42429
284990|NCT00995709|Novartis Pharmaceuticals|Study Director|862-778-8300||
284991|NCT00995722|University Of Miami|Dr. Benatar|305-243-6480|MBenatar@med.miami.edu|
284992|NCT00995761|Gyeongsang National University Hospital|Gyeong-Won Lee M.D.Ph.D.|82-55-750-8066|brightree@lycos.co.kr|
284993|NCT00995774|Washington DC Veterans Affairs Medical Center|Peter Lum, PhD|202-319-5181|lum@cua.edu|
308495|NCT02584608|Indiana Univerity School of Medicine|Micheal Econs|317-274-1339|mecons@iu.edu|
270178|NCT00111761|Amgen Inc.|Study Director|866-572-6436||
270179|NCT00111800|GlaxoSmithKline|GSK Response Center|866-435-7343||
270180|NCT00111813|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270181|NCT00111839|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|496151725200|service@merckgroup.com|
270182|NCT00111917|National Jewish Health|Lisa Maier, MD|303-398-1983|maierl@njhealth.org|
270183|NCT00112047|Gilead Sciences|Dara Wambach MA, Associate Director, Regulatory Affairs|650-522-5163|dara.wambach@gilead.com|
270184|NCT00112112|MedImmune, LLC|Raburn Mallory|301-398-0000|malloryr@medimmune.com|
270185|NCT00112125|Impulse Dynamics (USA) Inc|Angela Stagg, Sr. Director, Clinical and Data Operations|8453592389|angelas@impulse-dynamics.com|
270186|NCT00112151|Univeristy of Colorado at Denver|Dr. Robert S. Schwartz, Head, Division of Geriatric Medicine|303-724-1919|robert.schwartz@ucdenver.edu|
270187|NCT00112242|Department of Oncology, Division of Medical Oncology University Hospital Lausanne|Prof Olivier Michielin|+41 21 314 01 85|Olivier.Michielin@chuv.ch|
270188|NCT00112294|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
270189|NCT00112359|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
270190|NCT00112385|Brigham and Women's Hospital|A Pilot Study of Etanercept in Dermatomyositis|617-732-8046|aamato@partners.org|
270191|NCT00112437|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270192|NCT00112463|Wake Forest School of Medicine|Dr. Doug Case|336-716-1048|dcase@wakehealth.edu|
270193|NCT00112489|NRG Oncology - Buffalo Office|Melissa Leventhal|716-341-3408|mleventhal@gogstats.org|
270194|NCT00112502|The University of Texas (UT) MD Anderson Cancer Center|John F de Groot, Chair Ad Interim, Neuro-Oncology|713-745-3072|jdegroot@mdanderson.org|
270195|NCT00112580|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
270196|NCT00112593|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
270197|NCT00112671|Princess Margaret Phase II Consortium|Dr. Srikala Sridhar|416-946-4501|srikala.sridhar@uhn.ca|2662
270198|NCT00112723|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-293-3507|Jeffrey.Jones@osumc.edu|
270199|NCT00112736|Adult Brain Tumor Consortium (ABTC)|Dr. Patrick Y Wen||pwen@partners.org|
270200|NCT00112827|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
270201|NCT00112866|Adult Brain Tumor Consortium (ABTC)|Mark Gilbert, MD|410-955-8837|jfisher@jhmi.edu|
270202|NCT00112905|ECOG Statistical Office|Study Statistician|617-632-3012||
270203|NCT00112918|Hoffman-LaRoche|Medical Communications|800-821-8590||
270204|NCT00112957|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org|
270205|NCT00113022|Experimental Therapeutics and Pathophysiology Branch, NIMH|Dr. Carlos Zarate|301-451-0861|zaratec@mail.nih.gov|
270206|NCT00113087|New England Research Institute|Lynn Sleeper|617-972-3235|lsleeper@neriscience.com|
276078|NCT00527397|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
276079|NCT00527423|Regeneron Pharmaceuticals|Clinical Trials Administrator||clinicaltrials@regeneron.com|
276080|NCT00527475|Texas Retina Associates|David Callanan, MD|817-261-9625|dcallanan@texasretina.com|
276081|NCT00527488|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
276082|NCT00527514|Daiichi Sankyo|John Raia|(973) 630-2683|jraia@dsus.com|
276083|NCT00527566|National Jewish Health|Michael Wechsler|617-285-4987|wechslerm@NJHealth.org|
276084|NCT00527592|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
276085|NCT00527605|GlaxoSmithKline|GSK Response Center|866-435-7343||
276086|NCT00527618|University of Washington, Virology Research Clinic|Tara Perti, MD|(206) 520-4340|tarap@u.washington.edu|
276087|NCT00527644|University of Missouri Health Care|Bruce Ramshaw, M.D.|5738841925|kadysj@health.missouri.edu|
276088|NCT00527722|UT MD Anderson Cancer Center|Sanjay Gupta, MD|713-563-7341|srao@mdanderson.org|
276089|NCT00527735|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
276090|NCT00527787|POZEN Inc|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
276091|NCT00527826|GlaxoSmithKline|GSK Response Center|866-435-7343||
276092|NCT00527878|NIAID, NIH|Alexandra Freeman MD, Staff Clinician, Lead Associate Investigator for Protocol|301-594-9045|freemaal@mail.nih.gov|
276093|NCT00527904|POZEN|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
276094|NCT00527943|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276095|NCT00528021|BTG International|Thomas Logan Ph.D.|610-943-3518|thomas.logan@btgplc.com|
276096|NCT00528112|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
276097|NCT00528190|Ottawa Hospital Research Institute|Shawn Aaron|613-737-8259|saaron@ohri.ca|
276098|NCT00528268|University of Utah|Dr. Kathryn Swoboda|801-585-9717|swoboda@genetics.utah.edu|
276099|NCT00528372|AstraZeneca Pharmaceuticals|Boaz Hirshberg||ClinicalTrialTransparency@astrazeneca.com|
276100|NCT00528398|City of Hope National Medical Center|Anthony Stein, M.D.|626-256-4673|AStein@coh.org|82405
276101|NCT00528411|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
276102|NCT00528424|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
276103|NCT00528450|Memorial Sloan Kettering Cancer Center|Dr. Peter Maslak|212-639-5518|maslakp@mskcc.org|
276104|NCT00528528|Janssen Research & Development, LLC Titusville, NJ|Clinical Leader|609-730-3174||
276105|NCT00528541|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
276106|NCT00528567|Hoffman-LaRoche|Medical Communications|800-821-8590||
276107|NCT00528580|University of Chicago|Millie Maleckar|773-702-1472|mmalecka@bsd.uchicago.edu|
284994|NCT00995865|GE Healthcare- Life Sciences|Amanda Culliton|1-508-683-2232|Amanda.Culliton@ge.com|
284995|NCT00995904|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
284996|NCT00995930|Novartis Pharmaceuticals|Study Director|862-778-8300||
276108|NCT00528606|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
284997|NCT00996034|Yale University|Irina Esterlis, Ph.D.|203-932-5711|irina.esterlis@yale.edu|3109
284998|NCT00996125|GlaxoSmithKline|GSK Response Center|866-435-7343||
284999|NCT00996164|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
285000|NCT00996203|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
285001|NCT00996216|GlaxoSmithKline|GSK Response Center|866-435-7343||
285002|NCT00996281|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
285003|NCT00996307|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
285004|NCT00996346|University of New Mexico Cancer Center|Monte Shaheen, MD / Study Principal Investigator|505-925-0404|MoShaheen@salud.unm.edu|
285005|NCT00996372|Sprout Pharmaceuticals|VP, Clinical Development|9198820850|clinicaltrials@sproutpharma.com|
285006|NCT00996437|Diabetic Retinopathy Clinical Research Network|Adam R. Glassman|813-975-8761|drcrstat4@jaeb.org|
285007|NCT00996476|Janssen Pharmaceutical K.K., Japan|DIrector|81 3 44115639||
276109|NCT00528645|Mayo Clinic|Julian R. Molina, M.D., Ph.D.|507-284-8318|molina.julian@mayo.edu|
276110|NCT00528788|Duke University Medical Center|Jula Inrig, MD|919-660-6882|Jula.Inrig@duke.edu|
276111|NCT00528801|Children's Hospital of Oakland and Research Institute|Elliott Vichinsky, MD|510-428-3651|evichinsky@mail.cho.org|
276112|NCT00528840|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
276113|NCT00528866|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
276114|NCT00528879|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
276115|NCT00528931|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
276116|NCT00528957|Gilead Sciences|Clinical Trial Disclosures & Transparency||GileadClinicalTrials@gilead.com|
276117|NCT00528970|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
276118|NCT00528996|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276119|NCT00529035|Dana-Farber Cancer Institute|John Koreth, MBBS, D.Phil|(617) 632-2949|jkoreth@partners.org|
276120|NCT00529087|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
276121|NCT00529100|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276122|NCT00529126|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
276123|NCT00529191|Children's Hospital of Philadelphia|Steven Willi, MD|215-590-3174|willi@chop.email.edu|
276124|NCT00529204|University of California Davis Medical Center|Christopher L. Bowlus, MD|916-734-8986|chris.bowlus@ucdmc.ucdavis.edu|
276125|NCT00529217|Columbia University Department of Psychiatry, City University of New York|Dr. Antonio Mantovani|212-650-5417|AMantovani@med.cuny.edu|
276126|NCT00529243|Kaiser Permanente|William Towner, MD|323-783-7855|William.J.Towner@KP.org|
276127|NCT00529308|Yale University|Dr. Angeli Landeros-Weisenberger||angeli.landeros-weisenberger@yale.edu|
276128|NCT00529373|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development,|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276129|NCT00529386|Dept of Urology, Queen's University|J C Nickel|613 548 2497|jcn@queensu.ca|
276130|NCT00529399|Benaroya Research Institute|Carla Greenbaum||cjgreen@benaroyaresearch.org|
276131|NCT00529451|Novartis Pharmaceuticals|Study Director|862-778-8300||
276132|NCT00529516|GlaxoSmithKline|GSK Response Center|866-435-7343||
276133|NCT00529529|Novartis Pharmaceuticals|Study Director|862 778-8300||
276134|NCT00529542|Milton S. Hershey Medical Center|Richard S. Legro|717-531-8478|rsl1@psu.edu|
276135|NCT00529555|Sunstar Americas, Inc|Marie Wilson, Clinical Program Manager|773-481-3327|marie.wilson@us.sunstar.com|
276136|NCT00529568|GlaxoSmithKline|GSK Response Center|866-435-7343||
276137|NCT00529633|University of California, Davis|George Kaysen MD PhD, Principal Investigator|916-734-3774|gakaysen@ucdavis.edu|
276138|NCT00529659|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
276139|NCT00529789|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276140|NCT00529802|The University of Chicago|Walter Stadler, MD|(773) 702-4150|wstadler@medicine.bsd.uchicago.edu|
276141|NCT00529958|University of Calgary Sport Medicine Centre|ACL RCT Research Coordinator|403-220-8944|aclstudy@ucalgary.ca|
276142|NCT00530023|Director, Program Management, Clinical Research|Harold Torunsky|8185765445|harold.torunsky@medtronic.com|
276143|NCT00530075|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
276144|NCT00530088|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
276145|NCT00530218|City of Hope National Medical Center|Ricardo Spielberger, MD|626-359-8111|RSpielberger@coh.org|65298
276146|NCT00530257|The Children's Hospital of Philadelphia|Dr. Nathan Blum|215-590-6336|blum@email.chop.edu|
276147|NCT00530270|Rho Federal Systems Division|Karen Kesler, PhD|919-408-8000|karen_kesler@rhoworld.com|244
276148|NCT00530335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276149|NCT00530348|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
276150|NCT00530439|Odense University Hospital|Dr. Christina Vinter|+45 21782118|c.vinter@dadlnet.dk|
276151|NCT00530504|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
276152|NCT00530621|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276153|NCT00530634|City of Hope|Jeff Longmate, Ph.D.|626-256-4673|jlongmat@coh.org|62478
285008|NCT00996489|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
285009|NCT00996580|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
285010|NCT00996593|GlaxoSmithKline|GSK Response Center|866-435-7343||
285011|NCT00996606|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
285012|NCT00996632|University of Trieste|Prof. Nicolò de Manzini|+390403994152|nicolo.demanzini@aots.sanita.fvg.it|
285013|NCT00996658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285014|NCT00996736|F.I. Proctor Foundation, University of Califonia, San Francisco|Dr. Thomas Lietman|415-502-2662|tom.lietman@ucsf.edu|
285015|NCT00996775|Center for Mental Healthcare and Outcomes Research, Central Arkansas Veterans Healthcare System|Michael A. Cucciare, Ph.D.|501-257-1068|michael.cucciare@va.gov|
285016|NCT00996801|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clincaltrialsdisclosure@merck.com|
285017|NCT00996840|GlaxoSmithKline|GSK Response Center|866-435-7343||
285018|NCT00996892|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
285019|NCT00996918|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285020|NCT00996931|Sutter Institute for Medical Research|Carol Parise, PhD|916-733-4413|PariseC@sutterhealth.org|
285021|NCT00996944|GlaxoSmithKline|GSK Response Center|866-435-7343||
285022|NCT00996996|GlaxoSmithKline|GSK Response Center|866-435-7343||
285023|NCT00997035|University of California, San Francisco|Kathryn Ray|415-514-3227|kathryn.ray@ucsf.edu|
285024|NCT00997113|Minneapolis Medical Reseach Foundation|James Miner|6128738791|miner015@umn.edu|
285025|NCT00997126|MinneapolisMRF|James Miner|6128732493|miner015@umn.edu|
276154|NCT00530712|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
276155|NCT00530764|GW Pharma Ltd.|Matthew Hersch, Senior Clinical Project Manager|+44 1353 616600|mhersch@gwpham.com|
276156|NCT00530777|University of Washington|Dr. Carey Farquhar|206-543-4278|cfarq@uw.edu|
276157|NCT00530790|GlaxoSmithKline|GSK Response Center|866-435-7343||
276158|NCT00530803|Montefiore Medical Center|Associate Professor, Dept of Pediatrics|718-741-2460|cskae@montefiore.org|
276159|NCT00530816|Onyx Pharmaceuticals, Inc.|Onyx Medical Information|1-877-ONYX-121|medinfo@onyx.com|
276160|NCT00530842|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276161|NCT00530855|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
276162|NCT00530894|Edwards Lifesciences|Tenley Koepnick|949-250-6504|tenley_koepnick@edwards.com|
276163|NCT00530920|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276164|NCT00530946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
276165|NCT00531011|Abbott Vascular, Italy|Maria Jose' M. Lopera|+39-02-516251|mariajose.lopera@av.abbott.com|
276166|NCT00531050|Novartis Pharmaceuticals|Study Director|862-778-8300||
276167|NCT00531206|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276168|NCT00531232|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
276169|NCT00531284|Amgen, Inc.|Study Director|866-572-6436||
276170|NCT00531427|Purdue Pharma|Clinical Leader, Executive Medical Director|800-733-1333||
276171|NCT00531453|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
276172|NCT00531479|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276173|NCT00531518|Maine Medical Center Research Institute|William R McFarlane, M.D.|207-662-4348|mcfarw@mmc.org|
276174|NCT00531661|CardioMEMS, Inc.|Jordan Bauman|4043458235|jbauman@cardiomems.com|
276175|NCT00531752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276176|NCT00531817|Hoffmann-La Roche|Medical Communications|800-821-8590||
276177|NCT00531843|UCSF/SF General Hospital|M. Margaret Knudson, MD|415.205.4623|pknudson@sfghsurg.ucsf.edu|
285026|NCT00997139|Northwestern University Department of Dermatology|Clinical Trials Unit Coordinator|312-695-6829|mandybrowning2015@u.northwestern.edu|
285027|NCT00997204|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
285028|NCT00997243|Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center|Alison Walker, MD|614-293-3196|Alison.Walker@osumc.edu|
285029|NCT00997321|MinneapolisMRF|James Miner|612-873-3000|miner015@umn.edu|
285030|NCT00997334|Dana-Farber Cancer Institute|David M. Jackman, MD|617.632.3468|David_Jackman@dfci.harvard.edu|
285031|NCT00997373|UC Davis|Lloyd H. Smith MD, PhD|916-734-6945|lhsmith@ucdavis.edu|
285032|NCT00997425|James A. Haley VA Hospital, Tampa, FL|Dorothy H. Moore, PhD|813 558-3931|Dorothy.Moore4@va.gov|
285033|NCT00997438|VA Portland Health Care System|Dr. Sonemany Salinthone|5032208262|salintho@ohsu.edu|54394
285034|NCT00997503|Boston Scientific Corporation|Peter Maurer, Director of Clinical Trials|1-508-683-6678|Peter.Maurer@bsci.com|
285035|NCT00997516|University of California, San Francisco|Jonathan T. Carter, MD, FACS|415-476-0974|jonathan.carter@ucsfmedctr.org|
285036|NCT00997555|Hurley Medical Center|John Alfred Carr, MD|810-262-4993|heartandbones@yahoo.com|
285037|NCT00997594|Mie University|Dr. Koichiro Yamakado|+81-59-231-5029|yama@clin.medic.mie-u.ac.jp|5630
285038|NCT00997620|Westernsky|Lyndon E Mansfield, MD|915-544-2557|immunman@westernskymed.com|
285039|NCT00997672|University Federico II, Naples, Italy|Dr. Francesco Saccà|3470734774|francesco.sacca@unina.it|+39
285040|NCT00997893|University of Illinois at Chicago|Dr. Pauline Maki|312 996-6941|pmaki1@uic.edu|
285041|NCT00997932|University of North Carolina School of Medicine|Dr. G Stuart|919-962-4880|gstuart@med.unc.edu|
285042|NCT00997984|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
285043|NCT00998010|University of California at Los Angeles|Mark Glover|(310) 794-8742|mglover@mednet.ucla.edu|
285044|NCT00998023|University of Florida|J Mocco, M.D.|352-273-9000|jmocco@neurosurgery.ufl.edu|
285045|NCT00998049|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
285046|NCT00998205|University of Missouri-Columbia|Anand Chockalingam|573-882-2296|chockalingama@missouri.edu|
297288|NCT01738672|University of Pittsburgh|Ya'aqov Abrams, MD||abramsym@upmc.edu|
285047|NCT00998296|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285048|NCT00998309|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276178|NCT00531882|University Hospitals Case Medical Center|Michael W Konstan, MD|2168445267|michael.konstan@uhhospitals.org|
276179|NCT00531934|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
276180|NCT00531947|Mylan Specialty L.P.|Kim Portland, Ph.D.|908.542.2636|kimberly.portland@mylan.com|
276181|NCT00531960|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
276182|NCT00532129|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
276183|NCT00532155|Sanofi-aventis|Trial Transparency Team||Contact-Us@sanofi.com|
276184|NCT00532259|CureTech Ltd.|Director Clinical Resaerch|+972-8-9324000|talh@curetechbio.com|
276185|NCT00532298|GlaxoSmithKline|GSK Response Center|866-435-7343||
276186|NCT00532441|Hoosier Cancer Research Network, Inc.|Dr. EG Chiorean, MS|317-921-2050|jsmith@hoosiercancer.org|
276187|NCT00532480|Indiana University|Dr. Amit Anand|317-944-7422|aanand@iupui.edu|
276188|NCT00532493|VA Puget Sound Health Care System|Dr. Murray Rasknd|(206) 764-2702|Murray.Raskind@va.gov|
276189|NCT00532779|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
276190|NCT00532844|BioMarin Pharmaceutical Inc.|Joshua Lilienstein/Medical Director, Global Medical Affairs|651.523.0310|MEDINFO@bmrn.com|
276191|NCT00532883|NHLBI|Harvey Luksenburg|301-435-0050|luksenburgh@mail.nih.gov|
276192|NCT00532935|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276193|NCT00532948|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
276194|NCT00533117|NYSPI|Barbara Stanley|6467747582|bhs2@columbia.edu|
276195|NCT00533273|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
276196|NCT00533429|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276197|NCT00533442|University of Miami|Dr. George W. Burke, III|305-355-5111|gburke@med.miami.edu|
276198|NCT00533507|GlaxoSmithKline|GSK Response Center|866-435-7343||
276199|NCT00533546|University of Rochester|Curtis Benesch, M.D., M.P.H.|585 275-2530|curtis_benesch@urmc.rochester.edu|
276200|NCT00533702|Eli Lilly and company|Chief Medical Officer|800-545-5979||
276201|NCT00533845|Maimonides Medical center|Danny A Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
276202|NCT00533897|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
276203|NCT00533910|Hunter Holmes McGuire VAMC|Jasmohan Bajaj|804 675 5802|jasmohan@gmail.com|
276204|NCT00533949|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
276205|NCT00534001|Roswell Park Cancer Institute|Martin Mahoney|716-845-2300|martin.mahoney@roswellpark.org|
276206|NCT00534092|Medtronic Spine and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
276207|NCT00534105|Baystate Medical Center|Glenn Markenson MD|413-794-8073|glenn.markenson@bhs.org|
276208|NCT00534118|Roswell Park Cancer Institute|Theresa Hahn|716-845-2300|theresa.hahn@roswellpark.org|
276209|NCT00534209|UM/Sylvester Comprehensive Cancer Center|Luis Raez MD|305-243-4909|lraez@med.miami.edu|
276210|NCT00534235|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
276211|NCT00534248|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
276212|NCT00534313|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
276213|NCT00534352|Tibotec Therapeutics Clinical Affairs, Division of Centocor Ortho Biotech Services, LLC|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
276214|NCT00534365|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
276215|NCT00534404|University of Michigan|Larry An, MD|734-763-6099|lcan@med.umich.edu|
276216|NCT00534417|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
276217|NCT00534495|Children's Hospital at Montefiore|Dr.Norman T.Ilowite|718-696-2602|NILOWITE@montefiore.org|
276218|NCT00534599|AstraZeneca|Gerard Lynch||AZtrial_results_posting@astrazeneca.com|
276219|NCT00534638|GlaxoSmithKline|GSK Response Center|866-435-7343||
276220|NCT00534703|Imperial College London|Dr Alexander Lyon|+442075943409|a.lyon@imperial.ac.uk|
276221|NCT00534794|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||clinicaltrialsdisclosure@merck.com|
276222|NCT00534833|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
276223|NCT00534937|Allegheny General Hospital|Dr. Satish Muluk|(412) 359-3714|muluk@usa.net|
276224|NCT00535002|Medical University of South Carolina|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
276225|NCT00535132|Ortho McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
276226|NCT00535145|Ortho-McNeil Janssen Scientific Affairs, LLC|Vice President, Medical Affairs, CNS|609-730-2136||
276227|NCT00535223|Atlanta VA Medical Center|David J. Ready,Ph.D.|(404) 321-6111|David.Ready@va.gov|7082
276228|NCT00535236|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276229|NCT00535288|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276230|NCT00535301|SCPMG/Kaiser Permanente|John N. Nguyen, MD|562-657-2642|john.n.nguyen@kp.org|
276231|NCT00535392|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
276232|NCT00535496|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
285049|NCT00998335|University of Florida|Dr. Kenneth Cusi|352-273-7236|KCusi@ufl.edu|
276233|NCT00535587|Oregon Health & Science University|Kim Dupree Jones|503 494 3837|joneskim@ohsu.edu|
285050|NCT00998374|Lenox Hill Hospital|Dr. Mitchell Roslin|212-434-3285|MRoslin@NSHS.edu|
285051|NCT00998400|University of Bologna|Professor Chiara Rafanelli|0039 051 2091847|chiara.rafanelli@unibo.it|
285052|NCT00998426|Johns Hopkins Medicine|Kirti Shetty, MD|202 660 5555|kshetty1@jhmi.edu|
285053|NCT00998517|Washington University in St. Louis|Indi Trehan|5039284634|itrehan@wustl.edu|
285054|NCT00998582|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
285055|NCT00998660|Medtronic, Inc.|Todd Weaver, PhD|763-526-8130|todd.weaver@medtronic.com|
276234|NCT00535613|University of Wisconsin|Cari Meyer|(608) 265-5980|cmeyer@wisc.edu|
285056|NCT00998764|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285057|NCT00998790|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
285058|NCT00998868|Seoul National University Hospital|Tai Ryoon Han, MD, PhD./Professor|+82-2-2072-3218|tairyoon@snu.ac.kr|
285059|NCT00998881|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
285060|NCT00998946|Spectrum Pharmaceuticals, Inc|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
285061|NCT00998985|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285062|NCT00999037|University of California at Los Angeles|Katherine Wesseling-Perry|310-206-6987|kwesseling@mednet.ucla.edu|
285063|NCT00999102|NY Presbyterian Hospital - Weill Cornell Medical Center|Dr. Samuel Mann, PI|212-746-2200|sjmann@med.cornell.edu|
285064|NCT00999141|Baxter Innovations, GmbH|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
297289|NCT01738737|University of Sao Paulo|Sarah Rubia Ferreira de Meneses|+55(11)470898-71|sarah.meneses@usp.br|
285065|NCT00999167|Horizon Therapeutics, Inc.|Julia Egofske|224-383-3078|jegofske@horizonpharma.com|
285066|NCT00999466|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
297290|NCT01738750|University of Utah|Dr. Eric Scaife|801-662-2950|eric.scaife@imail2.org|
285067|NCT00999518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285068|NCT00999544|University of Kentucky|Dr. Sharon Walsh|859-257-6485|sharon.walsh@uky.edu|
285069|NCT00999596|Philips Healthcare|Sarah Baxter or Linda Jalbert|425-487-7665 / 978-659-7434|sarah.baxter@philips.com, linda.jalbert@philips.com|
285070|NCT00999661|Ethicon Endo-Surgery, Inc.|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
285071|NCT00999687|Chang Gung Memorial Hospital|Lin Yin-Ku MD.Ph.D.|886-2-24313131|lin1266@adm.cgmh.org.tw|2127
285072|NCT00999713|Penn State College of Medicine|Neal J. Thomas, M.D.|717-531-5337|nthomas@psu.edu|
285073|NCT00999804|Baylor College of Medicine|Dr. Mothaffar Rimawi|7137981311|rimawi@bcm.edu|
285074|NCT00999830|HOPITAL DE PURPAN Service Hematologie|Dr Michel ATTAL|+33 (0)5.61.77.77.84|attal.m@chu-toulouse.fr|
285075|NCT00999908|Novartis Pharmaceuticals|Study Director|862 778-8300||
285076|NCT00999921|Medical College and Hospital Kolkata|Md Tanveer Adil|0091-9830154566|tanveer.cmc@gmail.com|
285077|NCT01000025|NCIC Clinical Trails Group|Dr. Keyue Ding|1-613-533-6000|kding@ctg.queensu.ca|77705
285078|NCT01000051|MD Anderson Cancer Center|Dr. Popat, Uday / Professor, Stem Cell Transplantation|713-745-3055|upopat@mdanderson.org|
285079|NCT01000064|Vanderbilt University Medical Center|Dr. Michael G. Tramontana|615-327-7144|Michael.Tramontana@Vanderbilt.Edu|
297291|NCT01738919|Aarhus University Hospital|Janni Kjaergaard Thillemann|+45 28137303|teamjanni@gmail.com|
297292|NCT01738971|University of Edinburgh|Dr Lucy Michie|0131 5361542|michieluc@yahoo.co.uk|
285080|NCT01000155|Brigham&Women's Hospital|Maureen Okam, MD, MPH|617-732-5048|mokam@partners.org|
285081|NCT01000285|Washington University School of Medicine|Lee Ratner, M.D., Ph.D.|314-362-8836|lratner@dom.wustl.edu|
285082|NCT01000311|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
276235|NCT00535626|Stryker Orthopedics|Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
297293|NCT01738984|University of Hawaii, School of Nursing and Dental Hygiene|Cheryl Albright|8089569716|cherylal@hawaii.edu|
285083|NCT01000324|GlaxoSmithKline|GSK Response Center|866-435-7343||
285084|NCT01000337|Aretaieio Hospital, University of Athens|Argyro Fassoulaki|+30210 7286334|fassoula@aretaieio.uoa.gr|
285085|NCT01000376|Eisai|Dr. Peter Tarassoff|888-422-4743||
285086|NCT01000480|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285087|NCT01000493|GlaxoSmithKline|GSK Response Center|866-435-7343||
285088|NCT01000506|GlaxoSmithKline|GSK Response Center|866-435-7343||
285089|NCT01000610|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
285090|NCT01000636|Galderma|Farzaneh SIDOU Clinical Project Manager|00 33 4 93 95 70 70|farzaneh.sidou@galderma.com|
285091|NCT01000649|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
285092|NCT01000662|NYU Langone Medical Center|Dr. Silvia Formenti, Chairman, Department of Radiation Oncology|(212) 731-5039|silvia.formenti@nyumc.org|
297294|NCT01739231|PATH|Richard Walker|202-822-0033|rwalker@path.org|
297295|NCT01739309|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276236|NCT00535652|University of Ulm|Prof. Dr. Henne-Bruns, PI|++4973150053500|doris.henne-bruns@uniklinik-ulm.de|
276237|NCT00535730|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276238|NCT00535743|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276239|NCT00535769|MGH Curtis|Dr. Alexa B. Kimball|617-726-5066|harvardskinstudies@partners.org|
285093|NCT01000727|GlaxoSmithKline|GSK Response Center|866-435-7343||
285094|NCT01000805|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285095|NCT01000818|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285096|NCT01000961|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
308496|NCT02584660|Janssen Scientific Affairs, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
285097|NCT01000974|GlaxoSmithKline|GSK Response Center|866-435-7343||
285098|NCT01000987|Yale University|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
285099|NCT01001052|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
285100|NCT01001078|Maisonneuve-Rosemont Hospital|Nikola Joly, M.D.|+1 514 252 3426|nikola.joly@umontreal.ca|
285101|NCT01001104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285102|NCT01001169|GlaxoSmithKline|GSK Response Center|866-435-7343||
285103|NCT01001195|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
285104|NCT01001208|Amgen Inc.|Study Director|866-572-6436||
285105|NCT01001221|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
285106|NCT01001299|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
285107|NCT01001325|Mount Sinai Hospital|Dr. Brenda Coleman|416-586-4800|bcoleman@mtsinai.on.ca|4161
285108|NCT01001377|Amgen Inc.|Study Director|866-572-6436||
285109|NCT01001403|Seoul National University Hospital|CW Jung|82-2-2072-2467|spss@snuh.org|9
285110|NCT01001429|Rutgers New Jersey Medical School|Anuradha Patel, MD|973 972-1886|patelan@njms.rutgers.edu|
285111|NCT01001442|Biotest AG|Iris Bobenhausen|+49 6103 801|iris.bobenhausen@biotest.com|4832
285112|NCT01001494|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
285113|NCT01001520|University of Pennsylvania|Caryn Lerman, PhD|215-746-7141|clerman@mail.med.upenn.edu|
285114|NCT01001546|Durham VA Medical Center - HSRD|Dr. Patrick S. Calhoun|919-286-0411|patrick.calhoun2@va.gov|7970
285115|NCT01001559|Red Oak Psychiatry Associates|Dr. Lawrence Ginsberg|281-893-4111|larrydg@earthlink.net|151
308497|NCT02584673|The Cooper Health System|Irwin Gratz|856-968-8527|gratz-irwin@cooperhealth.edu|
285116|NCT01001572|Novartis Pharmaceuticals|Study Director|862 778-8300||
285117|NCT01001598|Boston Children's Hospital|Colin A. Sieff|617 919-4241|colin.sieff@childrens.harvard.edu|
285118|NCT01001702|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affair|800 562-3974||
285119|NCT01001767|University Hospitals Case Medical Center|Grace McComsey, MC|216-844-3607|mccomsey.grace@clevelandactu.org|
276240|NCT00535782|Hoffman-LaRoche|Medical Communications|800-821-8590||
285120|NCT01001806|Bucci Laser Vision|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
285121|NCT01001832|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
285122|NCT01001910|Montefiore Medical Center|Clinical Supervisor|718-405-8395|bkhaksari@montefiore.org|
285123|NCT01001975|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
285124|NCT01001988|Sanofi Pasteur|Medical Director|800-633-1610|RegistryContactUS@sanofi.com|
285125|NCT01002105|Shaar Menashe Mental Health Center|Prof. Alexander Grinshpoon|+972-4-6278719|alexander.grinshpoon@sm.health.gov.il|
285126|NCT01002118|University of Iowa|Jennifer Robinson|319-384-1563|jennifer-g-robinson@uiowa.edu|
285127|NCT01002287|Integra LifeSciences|Stefani Battaglia|44 7880 732691|stefani.battaglia@integralife.com|
285128|NCT01002339|Hospital Universitario de Canarias. Universidad de La Laguna. Spain|Dr. Armando Torres Ramírez|+34630989515|atorres@ull.es|
285129|NCT01002456|Dept. of Veterans Affairs|Dr. Madeline McCarren|708 786 7987|madeline.mccarren@va.gov|
285130|NCT01002482|CH Chartres|Dr. Pierre Kalfon|003323730303073|pkalfon@ch-chartres.fr|
285131|NCT01002547|Malcom Randall VA Medical Center|Dr. Kenneth Cusi|352-273-8662|Kenneth.Cusi@va.gov; Kenneth.Cusi@medicine.ufl.edu|
285132|NCT01002573|Cumberland Pharmaceuticals Inc.|Senior Manager, Clinical Operations|615-255-0068|bkaelin@cumberlandpharma.com|
285133|NCT01002742|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
285134|NCT01002755|The University of Texas M D Anderson Cancer Center|Ferrajoli,Alessandra M.D.|713-792-2063|aferrajo@mdanderson.org|
285135|NCT01002989|Hypertension Center, Third University Department of Medicine, Sotiria Hospital|George S. Stergiou, MD, FRCP, Associate Professor of Medicine|+30 2107763117|gstergi@med.uoa.gr|
285136|NCT01003067|Hirslanden Bern|Prof. Christoph A. Maurer|+41 31 335 33 33|christoph.maurer@hin.ch|
285137|NCT01003080|Montefiore Medical Center|Dr. Sun Jin Kim|718-920-2060|sukim@montefiore.org|
285138|NCT01003106|Wilmer Eye Institute, Johns Hopkins University School of Medicine|Peter A. Campochiaro, MD|(410) 955-5106|pcampo@jhmi.edu|
285139|NCT01003184|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
285140|NCT01003210|University of Washington|Dr. James Taylor|206-6165-1206|uncjat@uw.edu|
285141|NCT01003249|Wake Forest University Health Sciences|Dr. Gopal Badlani|3367165928|gbadlani@wakehealth.edu|
285142|NCT01003275|University of Washington|Ian H. de Boer, MD, MS, Associate Professor of Medicine|2066165403|deboer@u.washington.edu|
285143|NCT01003288|University of Bergen|Professor Rebecca Cox|+4755974668|rebecca.cox@uib.no|
285144|NCT01003301|Johns Hopkins University|Sarbjit S. Saini|410-550-2129|ssaini@jhmi.edu|
285145|NCT01003418|GlaxoSmithKline|GSK Response Center|866-435-7343||
285146|NCT01003639|University of Iowa Hospitals and Clinics|Dr. Michael Wall|319-353-3942|michael-wall@uiowa.edu|
276241|NCT00535821|Loma Linda University|H. Bryant Nguyen|909-558-4000|hbnguyen@llu.edu|44023
276242|NCT00535847|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
276243|NCT00535873|The University of Texas M D Anderson Cancer Center|Alessandra Ferrajoli, MD/Associate Professor|713-792-2063|eharriso@mdanderson.org|
276244|NCT00535925|University of Campania|Prof. Ferdinando Carlo Sasso. MD, PhD|+39-081-5665010|ferdinandocarlo.sasso@unicampania.it|
276245|NCT00535938|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
285147|NCT01003769|Mayo Clinic|Asher Alban Chanan-Khan, M.D.|(716) 845-3221|chanan-khan.asher@mayo.edu|
285148|NCT01003886|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297296|NCT01739335|Bronx VA Medical Center|Dr. Julia Golier; Chief of Psychiatry|718-584-9000|julia.golier@va.gov|6587
297297|NCT01739348|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297298|NCT01739361|LSU Health Sciences Center New Orleans|Dr. David R Janz, MD, MSc, Assistant Professor of Medicine|504-568-3167|djanz@lsuhsc.edu|
297299|NCT01739400|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
297300|NCT01739595|Repros Therapeutics Inc|Jennifer Wike|2817193402|jwike@reprosrx.com|
297301|NCT01739699|Northshore University Healthsystem, Evanston Hospital|Dr. Steven Greenberg|8475702760|sbgreenb@gmail.com|
297302|NCT01739764|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
297303|NCT01739790|Minneapolis VA Healthcare System|Dennis E. Niewoehner, MD|612-467-4412|niewo001@umn.edu|
297304|NCT01739803|University of Tennessee College of Pharmacy|Marie Chisholm-Burns|901-448-7141|mchisho3@uthsc.edu|
297305|NCT01739933|Vanderbilt University Medical Center|Dr. Pratik Pandharipande, Vice Chair Faculty Affairs, PI|6153436268|pratik.pandharipande@vumc.org|
297306|NCT01740089|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
297307|NCT01740128|James J. Peters VAMC|Noam Y. Harel, MD, PhD|718-584-9000|noam.harel@va.gov|1742
297308|NCT01740206|Nationwide Children's Hospital|Richard Cartabuke, MD|614-722-4200|Richard.Cartabuke@nationwidechildrens.org|
297309|NCT01740258|Duke University|Annick Desjardins, MD, FRCPC|919-681-1691|annick.desjardins@duke.edu|
297310|NCT01740297|Amgen Inc.|Study Director|866-572-6436||
297311|NCT01740323|Emory University|Andrew Miller, MD|404-727-8260|amill02@emory.edu|
297312|NCT01740362|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297313|NCT01740388|Valeant Pharmaceuticals|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
297314|NCT01740401|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
297315|NCT01740414|New York State Psychiatric Institute|Dr. Sandra Comer|646-774-6146|comersd@nyspi.columbia.edu|
297316|NCT01740427|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297317|NCT01740440|BioMedical Research Ltd|Gary Rainsford|0035391774361|grainsford@bmr.ie|
297318|NCT01740713|Consorzio per Valutazioni Biologiche e Farmacologiche|Clinical Research Coordinator|0039 0382 25075|mariagraziafelisi@cvbf.net|
297319|NCT01740726|Emory University School of Medicine|Research Coordinator|404-727-4799|sean.carey@emory.edu|
297320|NCT01740791|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
297321|NCT01740817|University of Texas Health Science Center at San Antonio|Dr. Nicolas Musi|200-562-6152|musi@uthscsa.edu|
297322|NCT01741012|Wayne State University School of Medicine|Dr. J. Patricia Dhar, MD, Principal Investigator|313-577-6011|pdhar@med.wayne.edu|
297323|NCT01741259|OB Anesthesia Associates|Christy Morgan, MD|314-469-6800|christylmorganmd@gmail.com|
297324|NCT01741272|Alberta Health Services|Dr. Robert Balyk|7804395858|rbalyk6@aol.com|
297325|NCT01741350|University of Connecticut|Dr. Michael M. Copenhaver, Ph.D.|860 208-3632|michael.copenhaver@uconn.edu|
297326|NCT01741454|University of Wisconsin School of Medicine & Public Health|Shuang Li (Linda)|608.263.8336|lis@urology.wisc.edu|
297327|NCT01741480|WashingtonU|Dr. Marin Kollef|314-454-8764|mkollef@dom.wustl.edu|
297328|NCT01741532|ApoPharma Inc.|Caroline Fradette|416-401-7543|cfradett@apopharma.com|
297329|NCT01741545|Bristol Myers Squibb|Bristol Myers Squibb Study Director|Please email|clinical.trials@bms.com|
297330|NCT01741688|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
297331|NCT01741701|University of Kansas Medical Center|Dr. Rajesh Pahwa|913-588-6782|rpahwa@kumc.edu|
297332|NCT01741792|Amgen, Inc.|Study Director|866-572-6436||
297333|NCT01742065|Kaiser Permanente Center for Health Research|Gloria D. Coronado|503 335 2427|Gloria.D.Coronado@kpchr.org|
297334|NCT01742078|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297335|NCT01742091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297336|NCT01742117|Mayo Clinic|Dr. Naveen L. Pereira|507-284-4441|Pereira.Naveen@mayo.edu|
276246|NCT00536107|AstraZeneca|Sharon Chang||aztrial_results_posting@astrazeneca.com|
276247|NCT00536120|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
276248|NCT00536172|University of Nebraska|William Burke MD|4025526005|wjburke@Unmc.edu|
276249|NCT00536198|Yale University School of Medicine|Kimberly A. Yonkers, M.D.|203-764-5914|Kimberly.Yonkers@yale.edu|
276250|NCT00536263|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
276251|NCT00536341|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
276252|NCT00536471|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276253|NCT00536484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
276254|NCT00536510|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276255|NCT00536575|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
276256|NCT00536601|Roswell Park Cancer Institute|Theresa Hahn, PhD|716-845-5819|theresa.hahn@roswellpark.org|
276257|NCT00536731|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
276258|NCT00536744|SANUWAVE, Inc.|Dr. Daniel Jorgensen, MD|678-578-0116|daniel.jorgensen@sanuwave.com|
276259|NCT00536809|GlaxoSmithKline|GSK Response Center|866-435-7343||
276260|NCT00536874|Memorial Sloan-Kettering Cancer Center|Dr. Eileen O'Reilly|646-888-4182|oreillye@mskcc.org|
297337|NCT01742208|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
276261|NCT00536913|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
297338|NCT01742286|Study Director|Study Director|862-778-8300|novartis.email@novartis.com|
297339|NCT01742364|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
297340|NCT01742832|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
276262|NCT00536939|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
276263|NCT00536991|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
276264|NCT00537017|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276265|NCT00537030|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
276266|NCT00537056|David Geffen School of Medicine at UCLA|Andrew Quon, M.D. Professor Division of Nuclear Medicine|310-983-1419|aquon@mednet.ucla.edu|
276267|NCT00537082|Novartis Pharmaceuticals|Study Director|862-778-8300||
276268|NCT00537095|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
276269|NCT00537238|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276270|NCT00537277|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
276271|NCT00537290|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
276272|NCT00537303|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
276273|NCT00537316|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
276274|NCT00537329|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
276275|NCT00537381|Janssen Research & Development, L.L.C.|Senior Director|908-927-2116||
276276|NCT00537394|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301)628-3313|ACTGCT.Gov@s-3.com|
276277|NCT00537407|Debiopharm International S.A.|Jean-Maurice Dumont, Vice President Medical Affairs|4121 321 01 11|jean-maurice.dumont@debiopharm.com|
285149|NCT01003899|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285150|NCT01003938|NYU Cancer Institute|Franco Muggia, MD|212-263-6485|franco.muggia@nyumc.org|
285151|NCT01003990|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
285152|NCT01004003|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285153|NCT01004029|AMAG Pharmaceuticals|Medical Information|1-877-411-2510|amag@druginfo.com|
285154|NCT01004042|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|cientifico@cbed.org.br|
285155|NCT01004107|Merz North America|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
285156|NCT01004146|University of Texas at Houston Medical School / Dept. of Anesthesiology|Dr. Davide Cattano|713-500-6235|davide.cattano@uth.tmc.edu|
285157|NCT01004159|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
285158|NCT01004172|Dana-Farber Cancer Institure|Nancy Lin, MD|617.632.2335|nlin@partners.org|
285159|NCT01004185|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
285160|NCT01004250|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285161|NCT01004354|University of Massachusetts Medical School|Benjamin U Nwosu, MD|5083347872|benjamin.nwosu@umassmemorial.org|
285162|NCT01004393|Seirei Hamamatsu General Hospital|Masanori Mori, MD|81-53-474-2222|Masanori.Mori@sis.seirei.or.jp|
285163|NCT01004406|VA North Texas Health Care System, Dallas, TX and University of Texas Southwestern Medical Center|Dr. Subhash Banerjee|214-857-1608|Subhash.Banerjee@va.gov, Subhash.Banerjee@UTSouthwestern.edu|
285164|NCT01004432|Janssen Scientific Affairs, LLC|Study Director|215-325-4209|rdehorat@its.jnj.com|
285165|NCT01004614|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285166|NCT01004705|Ferrer Internacional S.A.|Natalia Oudovenko|+34 93 509 32 82|noudovenko-research@ferrergrupo.com|
285167|NCT01004718|University of Pennsylvania|Ellen Napier, CRNP|215.279.1972|ellen.napier@pennmedicine.upenn.edu|
285168|NCT01004744|Columbia University|Dr. Katherine Crew|212-305-1732|kd59@cumc.columbia.edu|
285169|NCT01004770|GE Healthcare|Rubin Sheng, MD|1-609-514-6899|rubin.sheng@ge.com|
285170|NCT01004822|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285171|NCT01004848|Icahn School of Medicine at Mount Sinai|Carol R. Horowitz, MD, MPH|212-659-9567|carol.horowitz@mountsinai.org|
285172|NCT01004874|Duke University Medical Center|Dr. Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
285173|NCT01004939|GlaxoSmithKline|GSK Response Center|866-435-7343||
285174|NCT01004991|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
285175|NCT01005251|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
285176|NCT01005290|Ferrer Internacional S.A.|Natalia Oudovenko|+34 93 509 32 82|noudovenko-research@ferrergrupo.com|
285177|NCT01005316|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
285178|NCT01005329|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@gmail.com|
285179|NCT01005355|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285180|NCT01005407|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
285181|NCT01005459|Wake Forest School of Medicine-Anesthesiology|Peter H. Pan MD, MSEE|336-718-8278|ppan@wakehealth.edu|
285182|NCT01005576|Washington University School of Medicine|Dr. Shalini Shenoy|314-454-6018|shalinishenoy@wustl.edu|
285183|NCT01005602|University of Illinois at Chicago|Dr. Robert J. DiDomenico|(312) 413-4654|rdidom1@uic.edu|
285184|NCT01005680|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297341|NCT01742897|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-739-7200||5888
285185|NCT01005706|Medical University of South Carolina|Charles F. Bratton, MD|843-792-4003|brattocf@musc.edu|
285186|NCT01005719|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
285187|NCT01005732|University of Washington|Loren Engrav|206-744-3209|engrav@u.washington.edu|
285188|NCT01005745|H. Lee Moffitt Cancer Center and Research Institute|Amod Sarnaik, M.D.|813-745-8581|amod.sarnaik@moffitt.org|
285189|NCT01005810|Medical University of South Carolina|Dr. Kevin M. Gray, Associate Professor|843-792-6330|graykm@musc.edu|
285190|NCT01005875|University of Alabama at Birmingham|Dr. Kimberly Keene|2-5-934-5670|kkeene@uab.edu|
285191|NCT01005888|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
285192|NCT01005901|Novartis Pharmaceuticals|Study Director|862-778-8300||
285193|NCT01005966|GlaxoSmithKline|GSK Response Center|866-435-7343||
285194|NCT01006122|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285195|NCT01006135|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285196|NCT01006252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285197|NCT01006291|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
285198|NCT01006356|Medical department / Korea|Medical Director|+82-2-2094-4518||
285199|NCT01006369|Rutgers Cancer Institute of New Jersey|Elizabeth Poplin MD|732-235-7620|poplinea@cinj.rutgers.edu|
276278|NCT00537485|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6131-7366||
285200|NCT01006538|King's College Hospital, London|Mr Tim Jackson|+44 2032999000|t.jackson1@nhs.net|1297
285201|NCT01006590|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
285202|NCT01006603|AstraZeneca|Boaz Hirshberg , MSD||ClinicalTrialTransparency@astrazeneca.com|
285203|NCT01006616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285204|NCT01006629|Abbott|Global Medical Services|800-633-9110||
285205|NCT01006655|Rambam medical Center|Prof Lea Bentur|xx 972 4 854 3263|l_bentur@rambam.health.gov.il|0502062400
285206|NCT01006707|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
285207|NCT01006889|University of Florida|Dr. Kenneth Cusi|352-273-8661|kcusi@ufl.edu|
285208|NCT01006967|Geisel School of Medicine at Dartmouth|Jon D. Lurie, MD, MS|603 653-3575|jon.d.lurie@dartmouth.edu|
285209|NCT01006980|Hoffman-LaRoche|Medical Communications|800-821-8590||
285210|NCT01007032|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285211|NCT01007071|Stanford University|Dr. Laurence Katznelson|650-736-9551|katznels@stanford.edu|
285212|NCT01007110|University of Kansas Medical Center|Kathleen Gustafson, Ph.D.|(913) 588-0065|kgustafson@kumc.edu|
285213|NCT01007123|Albireo|Dr Mats Ekelund|+46 31 741 14 80|info@albireopharma.com|
285214|NCT01007136|University of Texas Southwestern|Timea Hodics, M.D.||Timea.Hodics@UTSouthwestern.edu|
285215|NCT01007149|Novartis Pharmaceuticals|Study Director|862-778-8300||
285216|NCT01007253|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
285217|NCT01007396|Samsung Medical Center|Won-Jung Koh|82-2-3410-3429|wjkoh@skku.edu|
276279|NCT00537511|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
276280|NCT00537576|University of California, San Francisco|Anke Hemmerling, Project Director|415-597-4963|ahemmerling@globalhealth.ucsf.edu|
276281|NCT00537680|Santhera Pharmaceuticals|Dr Thomas Meier|+41619068964|thomas.meier@santhera.com|
276282|NCT00537745|PIRE|Patricia Hokanson|505-765-2325|info@bhrcs.org|
276283|NCT00537771|AstraZeneca|James J. Armbrust|+44 1625 518062|ClinicalTrialTransparency@astrazeneca.com|
276284|NCT00537810|Yale University School of Medicine|Dr. Carlos Grilo|2037852792|carlos.grilo@yale.edu|
276285|NCT00537823|Washington University School of Medicine|David Linehan, M.D.||David_Linehan@URMC.Rochester.edu|
276286|NCT00537940|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276287|NCT00537979|Abbott|Global Medical Services|800-633-9110||
276288|NCT00538213|GlaxoSmithKline|GSK Response Center|866-435-7343||
276289|NCT00538291|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
276290|NCT00538304|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
276291|NCT00538434|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000||
276292|NCT00538473|GlaxoSmithKline|GSK Response Center|866-435-7343||
276293|NCT00538512|University of Michigan School of Public Health|Arnold S. Monto, MD|734-764-5453|asmonto@umich.edu|
276294|NCT00538590|Hospital of Universität Köln|Thomas Dietlein, Ph. D., MD|+49 221 4785862|thomas.dietlein@uk-koeln.de|4300
276295|NCT00538616|Duke University|Dr. Carmelo Graffagnino|919/681-3751|Carmelo.Graffagnino@duke.edu|
276296|NCT00538629|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
276297|NCT00538642|University of Texas Health Science Center at San Antonio|Dr. Alexander Miller|210-567-5508|millera@uthscsa.edu|
276298|NCT00538681|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
276299|NCT00538733|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
276300|NCT00538759|Minneapolis Heart Institute Foundation|Lisa Tindell, Director of Clinical Operations|6128633816|Lisa.Tindell@allina.com|
276301|NCT00538785|MedImmune, LLC|Pamela Griffin, Senior Director, Clinical Development|301 398 0000|griffinp@medimmune.com|
276302|NCT00538824|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
285218|NCT01007435|Hoffmann-La Roche|Medical Communications|800 821-8590||
285219|NCT01007448|Bausch Health Americas, Inc.|Director of Clinical Operations||aloncaric@bauschhealth.com|
285220|NCT01007526|Samsung Medical Center|Won Seog Kim|82234106548|wskimsmc@skku.edu|
285221|NCT01007552|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|groman@appliedstats.com|847
285222|NCT01007591|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
285223|NCT01007643|University of Manitoba|Dr Erika Persson|780-492-4752|epersson@ualberta.ca|
285224|NCT01007656|PingTung Christian Hospital Ruiguang Branch|Dr. Choo-Aun Neoh|886-8-736-8686|neohca@gmail.com|5310
285225|NCT01007812|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
285226|NCT01007838|UWalesBangor|Danielle Kirkman|00 44 1248 388254|pepa03@bangor.ac.uk|
285227|NCT01007916|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
285228|NCT01007942|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
285229|NCT01007994|Northwell|Christine Sethna|7184703423|csethna@northwell.edu|
285230|NCT01008059|Washington University|Evan D. Kharasch, MD PhD|314-362-8796|kharasch@wustl.edu|
285231|NCT01008150|NSABP Foundation, Inc|Director, Department of Regulatory Affairs|412-339-5300|judy.langer@nsabp.org|
285232|NCT01008280|VISN 22 Network Office|Peter Hauser, MD, VISN 22 Mental Health Services Lead|562 826 8000|peter.hauser2@va.gov|2629
285233|NCT01008319|University of Oklahoma|LaTasha Craig, MD|405-271-8787|latasha-craig@ouhsc.edu|
285234|NCT01008410|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
285235|NCT01008423|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
285236|NCT01008449|UAB|Principal Investigator|205-934-3411|dana_figueroa_marzilli@hotmail.com|
297342|NCT01742936|Nationwide Children's Hospital|Vidya Raman, MD|614-722-4200|Vidya.Raman@nationwidechildrens.org|
285237|NCT01008462|Fred Hutchinson Cancer Research Center|Dr. Mohamed L. Sorror|(206) 667-6298|msorror@fredhutch.org|
285238|NCT01008475|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
285239|NCT01008553|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
285240|NCT01008605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285241|NCT01008618|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
285242|NCT01008696|Medical Affairs, Seoul, Korea|Clinical Research Associate|82-2-2094-4835||
285243|NCT01008722|University of California, San Diego|Dr. Sanjiv Narayan (Professor of Medicine, Principal Investigator)|(650) 498-8161|sanjiv1@stanford.edu|
285244|NCT01008748|UT MD Anderson Cancer Center - Clinical Research Operations|Dr. Sharon Giordano, MD/Chair, Health Svcs Research-Clinical|713-563-0020|sgiordan@mdanderson.org|
285245|NCT01008904|Virginia Commonwealth University|Thomas J. Smith, MD|410-955-2091|tsmit136@jhmi.edu|
285246|NCT01008943|Cook Medical|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
285247|NCT01008969|University of California, San Francisco|Youngho Seo, PhD|415-353-9464|youngho.seo@ucsf.edu|
285248|NCT01008995|Janssen R&D US|Director, Clinical Research|1 215-793-7646||
297343|NCT01742949|Hopital Bichat-Claude Bernard|Dr Marie-Pia D'Ortho|+33140258080|marie-pia.dortho@bch.aphp.fr|
297344|NCT01743001|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk||clinical-trials-disclosure@actelion.com|
297345|NCT01743027|Alcon Research, Ltd.|James Wheeler, Unit Head, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
297346|NCT01743040|UCLA Biomed|Joseph Thomas, MD|310-222-2544|jthomas@labiomed.org|
297347|NCT01743092|Centre for Addiction and Mental Health|Nigel Turner, Ph.D.|416-535-8501|nigel.turner@camh.ca|36063
297348|NCT01743131|Boston Children's Hospital|Dr. Leslie Kean|404-376-0187|leslie.kean@childrens.harvard.edu|
308498|NCT02584686|Department of Andrlolgy, Sexology & STDs, Cairo University|Prof. Dr. Hussein Ghanem, Chairman of Andrology Department|00201001176111|hmhghanem@gmail.com|
308499|NCT02584725|Columbia University Irving Medical Center|Robert Maniker, MD|212-305-9876|rm3046@cumc.columbia.edu|
308500|NCT02584790|Pamela Youde Nethersole Eastern Hospital|Dr Wong Kai Chuen|(852) 64600771|wkc568@ha.org.hk|
308501|NCT02584855|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
308502|NCT02584868|Centre Hospitalier Universitaire Brugmann|Philippe Van der Linden, MD, PhD|+32 2 477 23 30|philippe.vanderlinden@chu-brugmann.be|
308503|NCT02584959|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
308504|NCT02584998|CMC VAMC|Emily Carter Paulson, MD MSCA|215-823-5880|emily.paulson@va.gov|
308505|NCT02585245|ThedaCare|Lori Hartz MS, RDN Manager of Nutrition and Diabetes Education|920 831-5077|lori.hartz@thedacare.org|
308506|NCT02585700|Clinical Center of Serbia-Clinic for Infectious and Tropical Diseases|Dr. Goran Stevanovic|+381 64 1703059|goran_ste@yahoo.com|
308507|NCT02585713|Mayo Clinic|Robert D. McBane, M.D.|507/284-4565|Mcbane.robert@mayo.edu|
308508|NCT02585778|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
308509|NCT02585830|University of Colorado Anschutz Medical Campus|Stacey L. Simon|720-777-5681|stacey.simon@childrenscolorado.org|
308510|NCT02585843|Columbia University|A. Reshad Garan|(917) 374-3346|arg2024@cumc.columbia.edu|
308511|NCT02585895|Amgen Inc.|Study Director|866-572-6436||
308512|NCT02585934|Axovant Sciences, Inc.|Ilise Lombardo, MD|646-822-8626|ilise.lombardo@axovant.com|
308513|NCT02585960|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
308514|NCT02585999|Boston Medical Center|Dr. Antonella Lavelanet|6174143745|Katharine.White@bmc.org|
308515|NCT02586012|University of Pittsburgh|Craig Seaman, MD|412-209-7308|seamanc@upmc.edu|
308516|NCT02586064|Providence VA Medical Center|Dr. Tracie Shea|401-273-7100|MaryTracie.Shea@va.gov|6248
308517|NCT02586077|OrthoCarolina Research Institute|Susan Odum|7049457710|susan.odum@orthocarolina.com|
308518|NCT02586155|Resverlogix Corp.|Sr. Director of Clinical Operations|403.254.9252|clinicaltrials@resverlogix.com|
308519|NCT02586207|Sanford Health|Steven F. Powell, MD|605-328-8000|Steven.Powell@sanfordhealth.org|
308520|NCT02586233|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
297349|NCT01743469|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
297350|NCT01743521|Kirby Institute|A/Prof Gail Matthews|+61 (0)2 9385 0900|gmatthews@kirby.unsw.edu.au|
276303|NCT00538850|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602 910-2617|ldillaha@insysrx.com|
276304|NCT00538863|Insys Therapeutics, Inc.|Larry Dillaha, M.D., Chief Medical Officer|602-910-2617|ldillaha@insysrx.com|
276305|NCT00538902|Abbott|Global Medical Services|800-633-9110||
276306|NCT00538915|DallasAllergyImmunology|Richard L. Wasserman, M.D., Ph.D.|(972) 566-7788|drrichwasserman@gmail.com|
276307|NCT00539006|GlaxoSmithKline|GSK Response Center|866-435-7343||
276308|NCT00539032|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
276309|NCT00539110|Shriners Hospitals for Children|Michele Gottschlich PhD|513-872-6298|mgottschlich@shrinenet.org|
276310|NCT00539188|Yale University School of Medicine|Christopher Pittenger, MD Ph.D|203-974-7675|christopher.pittenger@yale.edu|
276311|NCT00539240|Southern Arizona VA Health Care System|Christopher Wendel, MS|520 792 1450|christopher.wendel@va.gov|1824
276312|NCT00539253|Johns Hopkins Hospital|Ihab R. Kamel, M.D. PhD|410-955-4567|ikamel@jhmi.edu|
276313|NCT00539279|VA San Diego Healthcare System|Steven R. Thorp, Ph.D., ABPP|(858) 552-8585|Steven.Thorp@va.gov|2468
276314|NCT00539305|University of Washington|Monique Cherrier PhD.|206-277-3594|cherrier@u.washington.edu|
276315|NCT00539500|University of Texas MD Anderson Cancer Center|Laura L. Worth, MD / Professor, Pediatrics|713-792-6620|CR_Study_Registration@mdanderson.org|
276316|NCT00539513|Yale University School of Medicine|Christopher Pittenger, MD Ph.D|203-974-7675|christopher.pittenger@yale.edu|
276317|NCT00539526|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
276318|NCT00539539|Resusciatation Outcomes Consortium, University of Washington|Susanne May, Ph.D.|206-685-1302|sjmay@uw.edu|
276319|NCT00539591|St. Jude Children's Research Hospital|Alberto Pappo, MD|901-595-2322|info@stjude.org|
276320|NCT00539656|Johns Hopkins University School of Medicine|Allen Chen, MD,PhD,MHS|410-614-4434|chenal@jhmi.edu|
276321|NCT00539695|Texas Children's Hospital|Dr. Rayne Rouce|832-824-4716|rouce@bcm.edu|
276322|NCT00539734|Prince of Songkla University|Patama Bhurayanontachai|66-74-451380|tpatama@hotmail.com|
276323|NCT00539864|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
276324|NCT00539942|University of Alabama at Birmingham|Warner K. Huh, MD|205-996-4662|warner.huh@ccc.uab.edu|
276325|NCT00539981|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
276326|NCT00539994|GlaxoSmithKline|GSK Response Center|866-435-7343||
276327|NCT00540007|Washington University School of Medicine|Todd Fehniger, M.D., Ph.D.|314-747-1385|tfehnige@wustl.edu|
276328|NCT00540046|Basic Health International|Miriam Cremer MD MPH|(646) 593-8694|miriam.cremer@gmail.com|
276329|NCT00540124|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276330|NCT00540228|GlaxoSmithKline|GSK Response Center|866-435-7343||
276331|NCT00540293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
276332|NCT00540423|GlaxoSmithKline|GSK Response Center|866-435-7343||
276333|NCT00540436|GlaxoSmithKline|GSK Response Center|866-435-7343||
276334|NCT00540449|Janssen Infectious Diseases BVBA|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
276335|NCT00540514|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
276336|NCT00540579|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
276337|NCT00540592|GlaxoSmithKline|GSK Response Center|866-435-7343||
276338|NCT00540644|IndianaU|Dr. Attaya Suvannasankha|317-944-0920|asuvanna@iu.edu|
276339|NCT00540722|Adult Brain Tumor Consortium (ABTC)|John Fiveash, MD|410-955-8837|jfisher@jhmi.edu|
276340|NCT00540982|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
276341|NCT00540995|City of Hope Medical Center|Dr. Anthony Stein|626-359-8111||
276342|NCT00541034|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens|1212-639-7053|brentjer@mskcc.org|
276343|NCT00541099|Barbara Ann Karmanos Cancer Institute|Shirish Gadgeel, M.D.|(313) 576-8753|sgadgeel@med.umich.edu|
276344|NCT00541190|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
276345|NCT00541229|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
276346|NCT00541242|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
276347|NCT00541307|W. L. Gore & Associates, Inc.|Chad Badorek|928/437-8181|cbadorek@wlgore.com|
276348|NCT00541346|University of Oklahoma Health Sciences Center|Thomas M. Lock, M.D.|405-271-5700|Thomas-Lock@ouhsc.edu|45167
276349|NCT00541385|Medicines for Malaria Venture (MMV)|Stephan Duparc, MD, Chief Medical Officer|+41 22 555 0300|duparcs@mmv.org|351
276350|NCT00541450|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||clinicaltrialsdisclosure@spcorp.com|
276351|NCT00541593|Baystate Medical Center|Dr. John R. Romanelli|(413) 794-3175|john.romanelli@bhs.org|
276352|NCT00541658|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
276353|NCT00541671|Christiana Care Health System|Deb Marco|302-733-4130|DMarco@christianacare.org|
276354|NCT00541775|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276355|NCT00541866|Sunesis Pharmaceuticals, Inc.|Mike Johnston, Senior Director Regulatory Affairs|(650) 266-3727|mjohnston@sunesis.com|
276356|NCT00541931|Stanford University|Dr. Anne Chang, MD|(650)721-7151|alschang@stanford.edu|
276357|NCT00541970|GlaxoSmithKline|GSK Response Center|866-435-7343||
276358|NCT00542178|Wake Forest University School of Medicine|Dr. Walter Ambrosius, PhD|336-716-6281|wambrosi@wakehealth.edu|
276359|NCT00542191|Leo W. Jenkins Cancer Center|Dr. Paul Walker|252-744-1015|walkerp@ecu.edu|
297351|NCT01743560|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
297352|NCT01743677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297353|NCT01743729|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
297354|NCT01743859|University of Colorado|Dr. Daniel Pollyea||daniel.pollyea@ucdenver.edu|
297355|NCT01743963|Eastern Colorado Health Care System, VA|Liron Caplan, Primary Investigator|7208575103|liron.caplan@ucdenver.edu|
297356|NCT01743976|Wake Forest School of Medicine|James C. Eisenach|336-716-4182|jimeisenach@gmail.com|
297357|NCT01743989|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
276360|NCT00542269|Novartis Pharmaceuticals|Study Director|862 778-8300||
276361|NCT00542308|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
276362|NCT00542321|University of Texas Health Science Center at Houston|Sandra K. Hanneman, PhD, RN, FAAN|713-500-2030|Sandra.K.Hanneman@uth.tmc.edu|
276363|NCT00542386|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
276364|NCT00542425|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
276365|NCT00542490|University of Oklahoma|Lisa Landrum, MD|405 271-8001|lisa-landrum@ouhsc.edu|
276366|NCT00542620|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
276367|NCT00542750|Medical University of South Carolina|Kevin M. Gray, M.D.|8437920135|graykm@musc.edu|
276368|NCT00542789|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
276369|NCT00542815|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
276370|NCT00542828|Genzyme Corporation|Genzyme MedInfo|800-745-4447|medinfo@genzyme.com|
276371|NCT00542880|AstraZeneca|Gerard Lynch||AZTrial_Results_Posting@astrazeneca.com|
276372|NCT00542919|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
276373|NCT00542971|The University of MD Anderson Cancer Center|Farhad Ravandi-Kashani, M.D./Associate Professor|713-745-0394|fravandi@mdanderson.org|
276374|NCT00542997|CSL Behring|Program Director, Clinical R&D|Use email contact|clinicaltrials@cslbehring.com|
276375|NCT00543062|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
276376|NCT00543101|Community Research Initiative of New England (CRINE)|Clavin Cohen MD|617 502 1700|ccohen@crine.org|
276377|NCT00543127|Department of Medical Oncology, Hospital Universitario Gregorio Marañón|Dr. Miguel Martin||miguel.martin@salud.madrid.org|
285249|NCT01009034|Maple Leaf Research|Tony Antoniou|4164657936|tantoniou@smh.toronto.on.ca|
285250|NCT01009047|Janssen Research & Development, LLC|Senior Director, Clinical Leader|+1-609-730-2436||
285251|NCT01009060|GlaxoSmithKline|GSK Response Center|866-435-7343||
285252|NCT01009086|Janssen Research & Development, LLC|Director, Clinical Research|1-800-526-7736||
285253|NCT01009099|Edward Hines Jr., VA Hospital|Eileen Collins|708-202-3525|eileen.collins@va.gov|
285254|NCT01009138|Research Institute of the Diabetes Academy Mergentheim|Dr. Bernhard Kulzer|+49 7931|kulzer@diabetes-zentrum.de|594151
285255|NCT01009203|University of Pittsburgh Medical Center|Julie E. Bauman, MD|4126486507|baumanje@upmc.edu|
285256|NCT01009281|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
285257|NCT01009333|Medtronic Neuromodulation|Maureen McGuire, Sr. Program Manager|763-526-8425|maureen.mcguire@medtronic.com|
285258|NCT01009346|Johns Hopkins|Ranee Mehra, MD||rmehra1@jhmi.edu|
285259|NCT01009463|GlaxoSmithKline|GSK Response Center|866-435-7343||
285260|NCT01009515|University of New Mexico|Montaser Shaheen, MD, PhD|505-925-0404|MoShaheen@salud.unm.edu|
285261|NCT01009554|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
285262|NCT01009580|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
285263|NCT01009619|Katholieke Universiteit Leuven and University Hospital Leuven|Prof. Dr. GM Verleden|+32 16 34 68 08|geert.verleden@uzleuven.be|
285264|NCT01009645|Northwestern University|Kenzie Cameron, PhD, MPH|312-503-3910|kcameron@northwestern.edu|
285265|NCT01009762|Statens Serum Institut|Professor Anders Fomsgaard|+45-32683460|afo@ssi.dk|
285266|NCT01009814|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
285267|NCT01009840|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
285268|NCT01009918|University of South Florida|Maya Guglin, MD, PhD|813-259-0600|mguglin@health.usf.edu|
285269|NCT01009983|Wake Forest University Health Sciences|Dr. Susan Melin|336-716-2839|smelin@wakehealth.edu|
285270|NCT01010009|Northumbria university|Emma Wightman|+44 (0) 191 2437253|emma.l.wightman@unn.ac.uk|
285271|NCT01010061|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
285272|NCT01010126|Mayo Clinic|Henry Pitot, M.D.|(507) 284-2511|pitot.henry@mayo.edu|
285273|NCT01010204|Western Psychiatric Institute and Clinic, University of Pittsburgh Medical Center|K.N. Roy Chengappa, Md|412-246-5006|chengappakn@upmc.edu|
285274|NCT01010217|UT MD Anderson Cancer Center|Dr. Stefan O Ciurea, Associate Profeddor of Stem Cell Transplantation|713-745-0146|sciurea@mdanderson.org|
285275|NCT01010230|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|866-278-5833|kiri.ness@stjude.org|
285276|NCT01010282|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
285277|NCT01010399|Franco Felizarta, MD|Franco Felizarta, MD|661-324-3128|felizarta@pol.net|
285278|NCT01010477|Rutgers-Robert Wood Johnson Medical School|Jill Williams, MD, Principal Investigator|7322354341|Jill.williams@rutgers.edu|
285279|NCT01010503|Hoffmann- LaRoche.|Medical Communications|800-821-8590|genentech@druginfo.com|
285280|NCT01010555|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
285281|NCT01010568|Georgetown University Hospital|Bruce D. Cheson|202-444-1212|bdc4@georgetown.edu|
285282|NCT01010633|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
285283|NCT01010750|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
297358|NCT01744093|Weill Cornell Medicine|Grace W. Mammen, BA, CCRP|646-962-2672|gwm2004@med.cornell.edu|
285284|NCT01010763|Zimmer Biomet G.K.|Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
285285|NCT01010776|Jan-Cil Brazil|Medical Group Manager|55 11 3030-2770||
285286|NCT01010854|University of California, San Francisco|Pamela Munster, MD|877-827-3222|clinicaltrials@ucsf.edu|
285287|NCT01010867|Columbia University Medical Center|Monica Bhatia, MD|2123055808|mb2476@cumc.columbia.edu|
285288|NCT01010906|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285289|NCT01010932|Guerbet|Dr Pierre Desché, MD - VP Head of Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
285290|NCT01010971|Sunovion|Respiratory Medical Director|1-866-503-6351||
285291|NCT01010984|University of Louisville|Robert Martin, MD, PhD|502-629-3355|robert.martin@louisville.edu|
285292|NCT01011049|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
285293|NCT01011075|University of Pittsburgh Cancer Institute|Julie E. Bauman, MD|412-648-6507|baumanje@upmc.edu|
285294|NCT01011153|MELA Sciences, Inc.|Joanna Adrian, Director of Clinical Operatons and Medical Affairs|914-591-3783|adrian@melasciences.com|732
285295|NCT01011179|The Hospital for Sick Children|Dr. Jennifer Stinson|416-813-7654|jennifer.stinson@sickkids.ca|304514
285296|NCT01011218|Stanford University Medical Center|Oxana RG Palesh, MD, PhD; Assistant Professor of Psychiatry and Behavioral Sciences|650-725-7011|oxana.palesh@stanford.edu|
285297|NCT01011283|Eisai Inc.|Erhan Berrack, M.D.|888-422-4743||
285298|NCT01011309|IDRI|Jill Ashman, MSc, Associate Director of Clinical Operations|206-858-6041|jill.ashman@idri.org|
285299|NCT01011335|Uniformed Services University of the Health Sciences|David Tribble, MD, DrPH|301-816-8404|dtribble@idcrp.org|
276378|NCT00543140|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
276379|NCT00543296|Duke University Medical Center|Glenn J. Jaffe, MD|919-684-4458|jaffe001@mc.duke.edu|
276380|NCT00543309|Ann & Robert H. Lurie Children's Hospital of Chicago|John M. Costello, M.D., M.P.H.|312 227 1551|jmcostello@luriechildrens.org|
276381|NCT00543387|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276382|NCT00543400|Momenta Pharmaceuticals|Jim Roach, MD Chief Medical Officer|617-491-9700|jroach@momentpharma.com|
276383|NCT00543439|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276384|NCT00543543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276385|NCT00543569|Astellas Pharma Global Development, Inc. (APGD)|Global Head Global Medical Sciences--Transplant and Immunology/Inflammation||Astellas.resultsdisclosure@astellas.com|
276386|NCT00543725|Janssen Infectious Diseases BVBA|Medical Leader|32 14 641418||
276387|NCT00543764|BIDMC|Bernard Lee|617-632-7835|blee3@bidmc.harvard.edu|
276388|NCT00543777|UT MD Anderson Cancer Center|Haesun Choi, MD/Professor, Abdominal Imaging Department|(713) 745-4693|hchoi@mdanderson.org|
276389|NCT00543803|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276390|NCT00543855|Eisai Co., Ltd.|Masaki Nakagawa, Study Director|+81-3-3817-5245||
276391|NCT00543985|University of Missouri|Kevin C. Dellsperger, MD, PhD, Professor, Internal Medicine|573-884-2013|dellspergerk@health.missouri.edu|
276392|NCT00544076|City of Hope|Laura Crocitto, M.D.|626-218-3708|lcrocitto@coh.org|
276393|NCT00544167|Sarah Cannon Research Institute|John Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
276394|NCT00544440|Clinical Research, Janssen R&D, 10990 Wilshire Blvd, Suite 1200, Los Angeles, CA 90024|Senior Director|310-943-8040||2917
276395|NCT00544544|McLean Hospital|Brian P. Brennan, M.D.|617-855-2911|bbrennan@partners.org|
276396|NCT00544557|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276397|NCT00544648|Vanderbilt-Ingram Cancer Center|Vicki Keedy, MD|615-936-3524|vicki.keedy@vanderbilt.edu|
276398|NCT00544674|Proacta, Inc.|Director of Clinical Development|858-642-0386|clinicalops@proacta.com|
276399|NCT00544713|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
276400|NCT00544778|City of Hope National Medical Center|Paul Frankel, Ph. D.|(626)359-8111|pfrankel@coh.org|65265
276401|NCT00544817|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
276402|NCT00544869|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7314||
276403|NCT00544882|Teva Branded Pharmaceutical Products R&D|Director of Clinical Research|610-786-7047|clinicaltrialsdisclosure@tevapharm.com|
276404|NCT00544908|City of Hope|Paul Frankel, Ph.D.|626-256-4673|pfrankel@coh.org|65265
276405|NCT00545025|GlaxoSmithKline|GSK Response Center|866-435-7343||
276406|NCT00545051|Hoffmannb-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
276407|NCT00545064|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
276408|NCT00545077|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
276409|NCT00545103|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
276410|NCT00545155|University of Rochester|Manish N. Shah|585-463-2920|manish.shah@rochester.edu|
276411|NCT00545168|ParaPRO LLC|Director, Quality and Regulatory|317-810-6205|kerrym@parapro.com|
276412|NCT00545181|Indiana University School of Medicine|David Haas, MD MS|3176307837|dahaas@iupui.edu|
276413|NCT00545233|Hoffman-LaRoche|Medical Communications|800-821-8590||
276414|NCT00545272|Novartis Pharmaceuticals|Study Director|862-778-8300||
285300|NCT01011387|Mölnlycke Health Care AB|Jenny Thorell|0046 31 7223000|jenny.thorell@molnlycke.com|
285301|NCT01011413|University of New South Wales|Sean Emery|02 9385 0900|semery@kirby.unsw.edu.au|
285302|NCT01011439|CLIOSS S.r.l.|Dr. Cristina Davite|+39 0031 58|regulatory@clioss.com|1482
285303|NCT01011465|Harvard School of Public Health|Dr. Laura Kubzansky|617-432-3589|lkubzans@hsph.harvard.edu|
285304|NCT01011556|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285305|NCT01011673|Montefiore Medical Center, Albert Einstein College of Medicine|Benjamin Friedman, MD|718-920-6626|BEFRIEDM@montefiore.org|
285306|NCT01011738|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
285307|NCT01011816|formerly Spinal Restoration, Inc|Jeff Doerzbacher||jdoerzbacher@renascentmed.com|
285308|NCT01011829|University of California, Los Angeles|Steve Shoptaw PhD|310 794 0619|sshoptaw@mednet.ucla.edu|225
285309|NCT01011868|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285310|NCT01011894|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens|212-639-7053|brentjer@mskcc.org|
308521|NCT02586415|Stanford University/School of Medicine|Dr. Gregory Albers|650-723-4448|albers@stanford.edu|
285311|NCT01011907|UCSF: EGCRC|Jennifer Mitchell, Clinical Project Director|510-985-3100|jmitchell@gallo.ucsf.edu|
285312|NCT01011933|Gynecologic Oncology Group Statistical and Data Center|Melissa Leventhal|716-845-4030|mleventhal@gogstats.org|
285313|NCT01011946|University of Chicago|Dr. Daniel Appelbaum|(773) 834-2012|dappelbaum@radiology.bsd.uchicago.edu|
285314|NCT01012037|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285315|NCT01012089|University of Oklahoma College of Pharmacy|Teresa Lewis Pharm D|405-271-2859|Teresa-Lewis@ouhsc.edu|
285316|NCT01012219|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285317|NCT01012245|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
285318|NCT01012258|Merck Serono (Beijing) Pharmaceutical R&D Co., Ltd.|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
285319|NCT01012297|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Administration and Operations|(716) 845-5702|kurasa@nrgoncology.org|
285320|NCT01012323|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
285321|NCT01012336|Samsung Medical Center|Pf Duk-Soo Bae|82-2-3410-3519|huna0@naver.com|
285322|NCT01012362|Masonic Cancer Center, University of Minnesota|Dr. Arkadiusz Dudek|651-254-3321|Arkadiusz.Z.Dudek@HealthPartners.com|
285323|NCT01012388|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com|
285324|NCT01012440|University of Chicago|Dr. Kirti Kulkarni|(773) 702-2781|kkulkarni@radiology.bsd.uchicago.edu|
285325|NCT01012492|Emory University School of Medicine|Leslie S Kean|404-376-0187|Leslie.kean@emory.edu|
285326|NCT01012609|Memorial Sloan Kettering Cancer Center|Dr. Ira Dunkel, MD|212-639-2153|dunkeli@mskcc.org|
285327|NCT01012622|Janssen Korea MAF, Korea|Clinical Research Associate|82-2-2094-4837||
285328|NCT01012661|Merz Aesthetics, Inc.|Merz Aesthetics, Inc.|650-286-4041|clinicaltrials@merzaesthetics.com|
285329|NCT01012674|Guerbet|Dr Pierre Desché, MD - VP Head of Development, Medical and Regulatory Affairs|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
285330|NCT01012713|University of California San Francisco|Dr. John Koo|4154764701|john.koo@ucsfmedctr.org|
285331|NCT01012739|Novartis Pharmaceuticals|Study Director|862 778-8300||
285332|NCT01012765|Novartis Pharmaceuticals|Study Director|862-778-8300||
285333|NCT01012921|Institut Straumann AG|Julia Dorn|0041619651111|julia.dorn@straumann.com|
285334|NCT01012947|Ajou University|Dr. Kang Soo Lee|821087812077|kpsimon@hanmail.net, antiaging@ajou.ac.kr|
285335|NCT01012973|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
285336|NCT01012999|University of Utah|Robert Stephen, MD|801-587-7653|rlstephen@comcast.net|
285337|NCT01013194|ISMETT-UPMC|Dr Giada Pietrosi|+390912192111|gpietrosi@ismett.edu|
276415|NCT00545298|Nitric BioTherapeutics Inc|Frank J. McCaney, CEO Sponsor|215-788-6200|fmccaney@nbtherapeutics.com|
276416|NCT00545363|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
276417|NCT00545402|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
276418|NCT00545441|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
276419|NCT00545532|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
276420|NCT00545571|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
276421|NCT00545584|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276422|NCT00545623|Boston University|Bei-Hung Chang|508-856-8959|bhchang@bu.edu|
276423|NCT00545662|Columbia University|Dr. William Friedewald|212-305-3017|wtf1@columbia.edu|
276424|NCT00545688|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
276425|NCT00545714|Hoffmann-La Roche|Medical Communications|800--821--8590|global-roche-genentech-trials@gene.com|
276426|NCT00545740|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
276427|NCT00545753|ParaPRO LLC|Director of Quality and Regulatory|317-810-6205|kerrym@parapro.com|
276428|NCT00545779|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
276429|NCT00545792|Dana-Farber Cancer Institute|Akila N. Viswanathan, MD, MPH|617-732-6331|aviswanathan@lroc.harvard.edu|
276430|NCT00545818|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
276431|NCT00545948|Duke University Medical Center|Neal Ready, PhD, MD|919-681-6932|neal.ready@duke.edu|
276432|NCT00545974|UCSF Memory and Aging Center|Dr. Adam L. Boxer|4154760668|aboxer@memory.ucsf.edu|
276433|NCT00546000|Fougera Pharmaceuticals Inc.|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
297359|NCT01744197|Evergreen Hematology and Oncology|Melanie Matson, RN, BSN|5094642873|mmatson@evergreen4cure.com|
297360|NCT01744340|BrUOG-Brown University Oncology Research Group|Howard Safran, MD|4018633000|kristen_mitchell@brown.edu|
297361|NCT01744353|Brown Oncology Research Group|Helena Lau|4018633000|helena_lau@brown.edu|
297362|NCT01744392|Health Services Research & Development, Durham VAMC|Hayden B. Bosworth, PhD|919-286-0411|hayden.bosworth@va.gov|7107
297363|NCT01744483|Oregon Health Science & Science University|Dr Miriam Treggiari|(503) 494-8311|treggiar@ohsu.edu|
297364|NCT01744496|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
297365|NCT01744574|University of Minnesota|Dr. Sharon Allen|612-624-0446|allen001@umn.edu|
297366|NCT01744665|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
276434|NCT00546078|GlaxoSmithKline|GSK Response Center|866-435-7343||
276435|NCT00546104|Duke University Health System|Kimberly Blackwell, MD|919-668-1478|kimberly.blackwell@duke.edu|
276436|NCT00546117|Washington University|Judith Lieu, MD|314-454-6162|lieuj@wustl.edu|
276437|NCT00546156|Dana-Farber Cancer Institute|Dr Ian Krop|617-632-2335|ian.krop@dfci.harvard.edu|
276438|NCT00546260|Portola Pharmaceuticals Inc.|Kevin Romanko, Senior Director Clinical Operations|650-246-7305|kromanko@portola.com|
276439|NCT00546351|UCB Clinical Trial Call Center|UCB (Study Director)|1-887-822-9493||
276440|NCT00546364|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
276441|NCT00546377|Memorial Sloan Kettering Cancer Center|Dr. Renier Brentjens, Associate Attending|+1212-639-7053|brentjer@mskcc.org|
276442|NCT00546390|University of Alb erta|Dr B Finegan|7809701302|bfinegan@ualberta.ca|780
276443|NCT00546429|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|SHimden@its.jnj.com|
276444|NCT00546481|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
276445|NCT00546572|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276446|NCT00546637|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
276447|NCT00546715|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
276448|NCT00546728|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
276449|NCT00546819|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
276450|NCT00546871|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
276451|NCT00546884|University of Minnesota|John Song MD MPH MAT|612-624-8936|songx006@umn.edu|
276452|NCT00546897|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
276453|NCT00546910|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276454|NCT00547105|UT Southwestern Medical Center|Director of Clinical Trial||ClinicalTrials@utsouthwestern.edu|
276455|NCT00547118|Maryland Psychiatric Research Center|Dr. Robert W. Buchanan|410-402-7876|rwbuchanan@mprc.umaryland.edu|
276456|NCT00547157|Amgen Inc.|Study Director|866-572-6436||
276457|NCT00547248|GlaxoSmithKline|GSK Response Center|866-435-7343||
276458|NCT00547365|University of Tennessee Graduate School of Medicine|Alan Solomon, MD|865-305-9167|asolomon@utmck.edu|
276459|NCT00547378|Pelvic Health & Gastric Therapies|Shenita Bolstrom|763-526-8254|shenita.bolstrom@medtronic.com|
276460|NCT00547521|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
276461|NCT00547534|University of Rochester Medical Center|Dr. Jonathan Friedberg|585-275-4911|Jonathan_Friedberg@urmc.rochester.edu|
276462|NCT00547586|Bausch Health|Study Director||susan.harris@bauschhealth.com|
276463|NCT00547638|Ethicon, Inc.|John Lombard, Clinical Research Manager|908 218 2877|jlombar8@its.jnj.com|
276464|NCT00547703|Cleveland Clinic Florida|Fernando Castro|954-659-5646|castrof@ccf.org|
276465|NCT00547729|Abbott|Clay Cohorn - Director, Clinical Research|469-929-7116|clay.cohorn@abbott.com|
276466|NCT00547898|Valeant Pharmaceuticals|Johnson Varughese|9089271162|christine.hnatko@valeant.com|
276467|NCT00547911|National Institutes of Health|Dr. David Goldstein|301-496-1115|goldsteind@ninds.nih.gov|
276468|NCT00548041|Temple University Hospital|Dr. Ellen Tedaldi|215-707-2000|ellen.tedaldi@tuhs.temple.edu|
276469|NCT00548132|Washington University School of Medicine|Bernard C. Camins, MD|3144548351|bcamins@dom.wustl.edu|
276470|NCT00548145|Osaka University Hospital|Hiroaki Kazui,Ph.D.|81-6-6879-3051|kazui@psy.med.osaka-u.ac.jp|
276471|NCT00548171|GlaxoSmithKline|GSK Response Center|866-435-7343||
276472|NCT00548184|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
276473|NCT00548197|Iran university of medical Sciences|Mehdi Modarres|009888602217|mmodarres51@yahoo.com|
276474|NCT00548249|Rockwell Medical|Richard C. Yocum, MD|858-229-8585|ryocum@rockwellmed.com|
276475|NCT00548262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276476|NCT00548340|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
276477|NCT00548405|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
285338|NCT01013207|ResMed Ltd|Alison Wimms|+61 8884 2583|alison.wimms@resmed.com.au|
285339|NCT01013285|UCLA Neuro-Oncology Program|Albert Lai|310-825-5321|albertlai@mednet.ucla.edu|
285340|NCT01013350|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
285341|NCT01013597|University of Wisconsin Carbone Cancer Center|Abigail Mapes, Thoracic Oncology Research Program Manager|608-262-8158|acmapes@medicine.wisc.edu|
285342|NCT01013740|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
285343|NCT01013753|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285344|NCT01013792|HCA Retreat Hospital, Institute of Plastic and Reconstructive Surgery|Joseph V. Boykin, Jr., MD|804-353-8100|joseph.boykin@HCAhealthcare.com|
285345|NCT01013844|Northwestern University Department of Dermatology|June Robinson, MD|312-695-6624|june-robinson@northwestern.edu|
285346|NCT01013870|Baylor College of Medicine|Claudia Robertson, MD|713-873-2792|claudiar@bcm.edu|
285347|NCT01013883|Darlington Memorial Hospital|Dr Rajender singh|01325380100|drrsdogra@yahoo.com|3444
285348|NCT01013961|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
297367|NCT01744691|Pharmacyclics, Inc.|Dr. Alvina Chu|855-427-8846|medinfo@pcyc.com|
297368|NCT01744704|Dompé s.p.a.|Flavio Mantelli, MD, PhD|+39 0862 3381|info@dompe.it|
297369|NCT01744730|Duke Clinical Research Institute, Duke University School of Medicine|Kevin Watt, MD|919-668-8556|kevin.watt@dm.duke.edu|
297370|NCT01744782|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224-383-3000|clinicaltrials@horizonpharma.com|
297371|NCT01744821|Northwestern University|Assistant Professor|312-472-4684|dcarson@nm.org|
297372|NCT01744860|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
297373|NCT01744977|Durham Veterans Affairs Medical Center|Hayden Bosworth, PhD|919-286-6936|hayden.bosworth@va.gov|
297374|NCT01745055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297375|NCT01745094|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512 Ext:|motoko.ida@astellas.com|
297376|NCT01745120|bluebird bio, Inc.|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
297377|NCT01745133|DermResearch PLLC|leon kircik|5023965310|wedoderm@yahoo.com|
297378|NCT01745146|Moss Rehabilitation Research Institute|Dr. Tessa Hart, PhD|215-663-6153|thart@einstein.edu|
297379|NCT01745211|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
297380|NCT01745367|Aveo Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
297381|NCT01745380|University of Pennsylvania School of Dental Medicine|Elliott V. Hersh, Principal Investigator|215-898-9686|evhersh@pobox.upenn.edu|
276478|NCT00548418|Washington University School of Medicine|David G. Mutch, M.D.|314-362-2181|mutchd@wudosis.wustl.edu|
297382|NCT01745393|Temple University|Bradley Collins|215-204-2849|collinsb@temple.edu|
297383|NCT01745627|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
297384|NCT01745822|French National Research Institute for Sustainable Development (IRD)|Gonzague Jourdain|+66818830065|gonzague.jourdain@ird.fr|
297385|NCT01745848|University of Pittsburgh|Dr. Jessica Bon Field|412-648-6494|bonjm@upmc.edu|
297386|NCT01745952|UZ Leuven|Prof W Van Paesschen & Dr L Seynaeve|+3216349062|laura.seynaeve@uzleuven.be|
297387|NCT01746017|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297388|NCT01746043|UT MD Anderson Cancer Center|Lin,Steven H,M.D. Ph.D. / Radiation Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
297389|NCT01746095|Savara Inc.|Head of Clinical Development|+45 7930 1414|info@savarapharma.com|
297390|NCT01746108|GlaxoSmithKline|GSK Response Center|866-435-7343||
297391|NCT01746173|Dana-Farber Cancer Institute|Philippe Armand MD, PhD|617.632.2305|Philippe_Armand@dfci.harvard.edu|
297392|NCT01746225|International Breast Cancer Study Group (IBCSG)|Heidi Roschitzki-Voser|+41 31 511 94 18|heidi.roschitzki@ibcsg.org|
297393|NCT01746264|Mayo Clinic|Dr. Seema Kumar|507-538-2724|Kumar.Seema@mayo.edu|
297394|NCT01746368|Tuscaloosa VA Medical Center (Retired)|Ann Mahaney-Price, DNP|205-409-8301|amparnp@yahoo.com|
297395|NCT01746420|Wright Medical|Justin Moss|615-236-4984|justin.moss@wright.com|
308522|NCT02586493|GlaxoSmithKline|GSK Response Center|866-435-7343||
297396|NCT01746511|University of Rochester|Carl D'Angio|585-273-4911|carol_dangio@urmc.rochester.edu|
297397|NCT01746732|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297398|NCT01746745|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297399|NCT01746784|N30 Pharmaceuticals|Dr. Steven Shoemaker|720-945-7700|steven.shoemaker@n30pharma.com|
276479|NCT00548431|Rigshospitalet, Juliane Marie Centret|Thomas Frandsen|+45 35458364|thomas.leth.frandsen@rh.regionh.dk|
297400|NCT01746862|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
308523|NCT02586506|GlaxoSmithKline|GSK Response Center|866-435-7343||
297401|NCT01746901|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297402|NCT01746940|STATKING Clinical Services|Lori Christman, PhD|513-858-2989|lori@statkingclinical.com|317
297403|NCT01746979|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
297404|NCT01747330|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
297405|NCT01747343|University of Kansas|Brian D. Greer, Ph.D.|386-852-7171|brian.greer@unmc.edu|
297406|NCT01747486|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
276480|NCT00548470|Nathan Kline Institute for psychaitric Research|Robert C Smith MD|845-398-6531|rsmith@nki.rfmh.org|
276481|NCT00548548|Hoffman-LaRoche|Medical Communications|800-821-8590||
276482|NCT00548652|VANebraska|Cyrus Desouza|4023468800|cyrus.desouza@va.gov|5506
276483|NCT00548691|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
276484|NCT00548717|Dana Farber Cancer Institute|Dr. Corey Cutler|617-632-3470|Corey_Cutler@dfci.harvard.edu|
276485|NCT00548808|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276486|NCT00548847|Emory University|Martha Arellano, MD|404-778-1900|marella@emory.edu|
276487|NCT00548860|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
276488|NCT00549042|Covidien|Alfredo Bozzini, MD|314-654-2000|Alfredo.Bozzini@covidien.com|
276489|NCT00549055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276490|NCT00549172|University of Helsinki|Dr. Teppo Järvinen, Head of study chair||teppo.jarvinen@helsinki.fi|
276491|NCT00549198|GlaxoSmithKline|GSK Response Center|866-435-7343||
276492|NCT00549302|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276493|NCT00549393|Johns Hopkins University|Dr. Aaron Milstone|4106143917|amilsto1@jhmi.edu|
276494|NCT00549445|University of Alabama at Birmingham|J. Edwin Blalock, PhD|205-934-6439|blalock@uab.edu|
285349|NCT01014013|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
285350|NCT01014091|GlaxoSmithKline|GSK Response Center|866-435-7343||
285351|NCT01014143|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
285352|NCT01014169|Boston University School of Medicine/Boston Medical Center|Dr Caroline Kistin|617-414-3642|caroline.kistin@bmc.org|
285353|NCT01014208|GlaxoSmithKline|GSK Response Center|866-435-7343||
285354|NCT01014351|SCRI Development Innovations LLC|John D. Hainsworth, M.D.|615-329-7274|asksarah@scresearch.net|
285355|NCT01014390|Hôpital Erasme|Jacques Devière, MD, PhD|(32) 0-2-555-4697.|Jacques.Deviere@erasme.ulb.ac.be|
276495|NCT00549549|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285356|NCT01014403|UT Southwestern Medical Center|Dr. Herb Phelan|214-648-6841|herb.phelan@utsouthwestern.edu|
285357|NCT01014442|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
285358|NCT01014455|Mayo Clinic|David O. Warner MD|5072846277|warner.david@mayo.edu|
285359|NCT01014533|University of Michigan|Kirk Brower||kbrower@med.umich.edu|
285360|NCT01014585|Forest Research Institute, Inc., a subsidiary of Forest Laboratories, Inc.|Joel Trugman, MD|201-427-8681|joel.trugman@frx.com|
285361|NCT01014624|Daiichi Sankyo, Inc.|Brian Baker|973-944-2712|bbaker@dsi.com|
285362|NCT01014689|Galderma|Florence Paliargues / CPM|+33492952957|florence.paliargues@galderma.com|
285363|NCT01014728|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
285364|NCT01014741|Icahn School of Medicine at Mount Sinai|Dr. Vivek Reddy|212-241-7114|vivek.reddy@mountsinai.org|
285365|NCT01014871|Galderma|Florence Paliargues / CPM|+33492952957|florence.paliargues@galderma.com|
285366|NCT01014910|Children's Mercy Hospital Kansas City|Dr. Russell McCulloh|816-234-3061|rmcculloh@cmh.edu|
276496|NCT00549562|Indiana University School of Medicine|David D. Dunn MD|317-944-8164|ddunn@iupui.edu|
285367|NCT01014936|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
285368|NCT01014975|Grifols Therapeutics, Inc.|Henry Li, PhD|800-520-2807|henry.li@grifols.com|
285369|NCT01014988|GlaxoSmithKline|GSK Response Center|866-435-7343||
285370|NCT01015118|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285371|NCT01015131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285372|NCT01015170|Centre for Addiction and Mental Health|Dr. Peter Selby; Dr. Laurie Zawertailo Principal Investigator|416-535-8501|laurie.zawertailo@camh.ca|77422
285373|NCT01015287|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285374|NCT01015326|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
285375|NCT01015443|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
285376|NCT01015534|Instituto Nacional de Cancerologia de Mexico|Carlos Gamboa Vignolle/ Radiation Oncologist|0155556280400|cswgamboa@yahoo.com|441
285377|NCT01015560|SWOG Statistical Center|Study Statistician|206-667-4623||
285378|NCT01015586|Medical University of South Carolina|Bryan K. Tolliver, MD PhD|843-792-4869|tollive@musc.edu|
285379|NCT01015612|Medtronic|Dr Deama Amr (PhD)|+61 2 9857 9157|deama.amr@medtronic.com|
285380|NCT01015638|GlaxoSmithKline|GSK Response Center|88-435-7343||
285381|NCT01015677|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285382|NCT01015703|BTG International Inc.|SVP Clinical Development|610-278-1660|angela.ogden@btgplc.com|
285383|NCT01015768|Southern California College of Optometry|Jerry R. Paugh, OD, PhD|714-449-7487|jpaugh@scco.edu|
285384|NCT01015781|VA RR&D, NCRAR|James A. Henry, Ph.D., Principal Investigator|5032208262|james.henry@va.gov|57466
285385|NCT01015807|Univerisity of Washington|Dr. Laurent Bollag|+12063277328|bollag@uw.edu|
285386|NCT01015820|Mayo Clinic|Dr. Michael B. Wallace|904-953-6970|wallace.michael@mayo.edu|
285387|NCT01015976|University of North Dakota - Neuropsychiatric Research Institute|James L. Roerig PharmD, BCPP|701 365 4919|jroerig@nrifargo.com|
285388|NCT01016015|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
285389|NCT01016067|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
285390|NCT01016106|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
285391|NCT01016132|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
285392|NCT01016262|Forest Laboratories|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
285393|NCT01016353|KCI|Senior Director, Global Clinical Development|(210) 255-5595|jane.hart@kci1.com|
285394|NCT01016483|Merck Serono, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+496151725200|service@merckgroup.com|
285395|NCT01016600|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
285396|NCT01016652|Johnson & Johnson Vision Care|Thomas R. Karkkainen OD, MS, FAAO Senior Principal Research Optometrist|(904)443-3402|TKarkkai@its.jnj.com|
285397|NCT01016678|Premiere Research Institute|Paul Winner, DO|561-845-0500|pwinner777@aol.com|102
285398|NCT01016691|Vistakon|Brian Schwam MD|1-904-443-1482|bschwam@its.jnj.com|
285399|NCT01016769|Memorial Sloan Kettering Cancer Center|Dr. David Pfister, MD|646-888-4237|pfisterd@mskcc.org|
276497|NCT00549601|Novartis Pharmaceuticals|Study Director|862-778-8300||
276498|NCT00549640|Mayo Clinic|Dr. Richard D. Hurt|507-266-1944|nicotineresearch@mayo.edu|
276499|NCT00549718|Sunovion Pharmaceuticals Inc.|Josephine Cucchiaro|201-592-2050|josephine.cucchiaro@sunovion.com|
276500|NCT00549757|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
285400|NCT01016834|Zogenix|Judith Myers, Senior Director Clinical Operations|510-550-8300|jmyers@zogenix.com|
276501|NCT00549770|Novartis Pharmaceuticals|Study Director|862-778-8300||
276502|NCT00549783|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
276503|NCT00549822|Massachusetts General Hospital|Dr. Paul Goss|617-724-3118|pgoss@mgh.harvard.edu|
285401|NCT01016873|Oraya Therapeutics Inc.|Denis O'Shaugnessy, Ph.D.|917-417-3974|doshaughnessy@orayainc.com|
285402|NCT01016912|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
285403|NCT01016938|Universtity of Maryland School of Medicine|Warren D'Souza, PhD, MBA|410-328-7159|wdsouza@umm.edu|
285404|NCT01016964|Lexington International, LLC|David Michaels|5614170200|las@hairmax.com|
285405|NCT01016977|GlaxoSmithKline|GSK Response Center|866-435-7343||
285406|NCT01017003|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
285407|NCT01017029|Pharmaceuticals|Novartis|+1(862)778-8300||
276504|NCT00549900|GlaxoSmithKline|GSK Response Center|866-435-7343||
285408|NCT01017042|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
285409|NCT01017120|GlaxoSmithKline|GSK Response Center|866-435-7343||
285410|NCT01017146|GlaxoSmithKline|GSK Response Center|866-435-7343||
285411|NCT01017237|University of North Carolina School of Dentistry|Jay Anderson, DDS, MD|919-966-1126|janderson@aims.unc.edu|
285412|NCT01017250|Duke University Radiation Oncology|John Kirkpatrick, MD, PhD|919 668-7342|robert.clough@dm.duke.edu|
276505|NCT00549939|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
297407|NCT01747499|Washington University School of Medicine|Mark A. Schroeder, M.D.|314-454-8304|markschroeder@wustl.edu|
297408|NCT01747551|Dana-Farber Cancer Institute|Peter Enzinger|617-632-3029||
308524|NCT02586727|Murray Ocular Oncology & Retina|Dr. Timothy Murray|3054877470|tmurray@murraymd.com|
276506|NCT00550043|Incyte Corporation|Study Director|1-855-463-3463||
276507|NCT00550147|Indiana University School of Medicine|David W. Dunn, MD|317-944-8162|ddunn@iupui.edu|
276508|NCT00550173|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276509|NCT00550238|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
276510|NCT00550277|Sarah Cannon Research Institute|John D. Hainsworth, MD|615-329-7274|jhainsworth@tnonc.com|
276511|NCT00550290|Aultman Health Foundation|Jane Sewell|330-363-6793|Jane.Sewell@aultman.com|
276512|NCT00550368|Stanford University|Dr. Julie Parsonnet|(650) 725-4561|parsonnt@stanford.edu|
276513|NCT00550394|University of Cincinnati|Melissa DelBello, MD, MS|513-558-2989|delbelmp@uc.edu|
276514|NCT00550407|GlaxoSmithKline|GSK Response Center|866-435-7343||
276515|NCT00550420|GlaxoSmithKline|GSK Response Center|866-435-7343||
276516|NCT00550446|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276517|NCT00550459|Otsuka Pharmaceutical Development & Commercialization, Inc.|Frank Czerwiec, MD, PhD; Sr. Director, Global Clinical Development|(240) 683-3523|frank.czerwiec@otsuka.com|
276518|NCT00550537|Vanderbilt-Ingram Cancer Center|Dr. Leora Horn, Principal Investigator||leora.horn@vanderbilt.edu|
276519|NCT00550550|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
276520|NCT00550589|Statistical Center of AIDS Malignancy Consortium|Jeannette Lee|(501) 526-6712|jylee@uams.edu|
276521|NCT00550615|University of Nebraska|Julie M Vose, MD|402-559-348|jmvose@unmc.edu|
276522|NCT00550654|National Cancer Institute, National Institutes of Health|Deborah Citrin, M.D.|301-496-5457|citrind@mail.nih.gov|
276523|NCT00550680|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
276524|NCT00550732|Merck Sharp & Dohme Corp.|Senior Vice President, Globalo Clinical Development||ClinicalTrialsDisclosure@merck.com|
276525|NCT00550745|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276526|NCT00550771|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
276527|NCT00550836|Mayo Clinic|Steven R. Alberts, M.D.||alberts.steven@mayo.edu|
276528|NCT00550862|Intercept Pharmaceuticals|Dr. David Shapiro|858-652-6800|dshapiro@interceptpharma.com|
276529|NCT00550953|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276530|NCT00551031|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
276531|NCT00551070|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
276532|NCT00551135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276533|NCT00551161|North Shore-LIJ Health System|Marc L. Gordon,MD|516-562-3492|MLGordon@nshs.edu|
276534|NCT00551174|Hoffmann-La Roche|Medical Communications|800-821-8590||
276535|NCT00551200|Hyperion Therapeutics|Sr. Vice President and Chief Medical Officer, Bruce F. Scharschmidt|(650) 745-7851|bruce.scharschmidt@hyperiontx.com|
276536|NCT00551213|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276537|NCT00551291|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
276538|NCT00551369|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
276539|NCT00551421|Dana-Farber Cancer Institute|Dr. Kimmie Ng|617-632-4150|kimmie_ng@dfci.harvard.edu|
276540|NCT00551460|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|2066674623|amoseley@fredhutch.org|
276541|NCT00551525|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
276542|NCT00551642|Mallinckrodt|Medical Information Call Center|800-556-3314|medinfo@mnk.com|
276543|NCT00551707|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
276544|NCT00551746|Intermountain Healthcare|Benjamin D Horne, PhD, MPH|801-507-4708|Benjamin.Horne@imail.org|
285413|NCT01017497|Duke University Medical Center|John Kirkpatrick MD|919 6687342|john.kirkpatrick@dm.duke.edu|
308525|NCT02586805|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
285414|NCT01017536|Aeras|Bernard Landry|301-547-2900|blandry@aeras.org|
276545|NCT00551759|ECOG Statistical Office|Study Statistician|617-632-3012||
285415|NCT01017549|iCAD, Inc. Xoft, Inc|Michael A. Patz MBA, RAC, Senior Director Clinical Affairs|603-882-5200|mpatz@icadmed.com|7308
285416|NCT01017575|Bristol-Myers Squibb International Corporation|BristolMyers Squibb Study Director||clinical.trials@bms.com|
285417|NCT01017601|Mayo Clinic|Julian Molina, M.D, Ph.D.|507-284-1328|Molina.julian@mayo.edu|
285418|NCT01017653|Preston Robert Tisch Brain Tumor Center|Annick Desjardins||annick.desjardins@dm.duke.edu|
285419|NCT01017731|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285420|NCT01017874|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285421|NCT01017952|GlaxoSmithKline|GSK Response Center|866-435-7343||
285422|NCT01018030|GlaxoSmithKline|GSK Response Center|866-435-7343||
285423|NCT01018056|Johns Hopkins University|Dr. Harvey S. Singer|410-955-7212|hsinger@jhmi.edu|
285424|NCT01018095|Tulane University|Patricia Kissinger, PhD|5049887320|kissing@tulane.edu|
285425|NCT01018134|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
276546|NCT00552058|UCB|Study Director|+1 877 822 9493||
285426|NCT01018186|GlaxoSmithKline|GSK Response Center|866-435-7343||
285427|NCT01018264|University of South Florida|Theresa Zesiewicz, MD, Professor of Neurology|813-974-5909|tzesiewi@health.usf.edu|
285428|NCT01018394|Mayo Clinic|Dr. Jon Ebbert|507-266-1944|nicotineresearch@mayo.edu|
285429|NCT01018420|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
285430|NCT01018511|Astellas Pharma Europe B.V.|Medical Director, Global Medical Science||Astellas.resultsdisclosure@astellas.com|
285431|NCT01018680|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276547|NCT00552071|Cedars-Sinai Medical Center|Vivian Hwe|4224-315-4489|hwev@cshs.org|
285432|NCT01018732|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
285433|NCT01018862|Meda Pharmaceuticals Inc|Sr.Director Medical Scientific Affairs|732 564 2200|David.ginsberg@meda.us|
285434|NCT01018953|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
285435|NCT01018979|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
285436|NCT01018992|Emory University|Dr. Boadie Dunlop|404-727-8474|bdunlop@emory.edu|
285437|NCT01019135|University Health Network & York University|Dr. Sherry L Grace|416.736.2100|sgrace@yorku.ca|22364
285438|NCT01019252|Massachusetts General Hospital|Susan Sprich, Ph.D.|617-726-5991|ssprich@mgh.harvard.edu|
285439|NCT01019317|University of Texas (UT) MD Anderson Cancer Center|Elias Joseph Jabbour MD/Assistant Professor|713-792-4764|eharriso@mdanderson.org|
285440|NCT01019369|Baylor College of Medicine|Anitra Beasley, MD, MPH|832-826-7318|anitra.beasley@bcm.edu|
285441|NCT01019486|University of Colorado, Denver|Robert A. Quaife M.D.|720-848-6562|robert.quaife@ucdenver.edu|
285442|NCT01019694|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285443|NCT01019707|University of California Los Angeles|Edythe D London|310 825 0606|elondon@mednet.ucla.edu|
285444|NCT01019928|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
285445|NCT01020006|Pharmacyclics|Dr. Laurence Elias|855-427-8846|pharmacyclics@medcomsol.com|
285446|NCT01020019|New York State Psychiatric Institute|Daniel Brooks|646-774-6171|brooksd@nyspi.columbia.edu|
297409|NCT01747629|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
276548|NCT00552084|Vanderbilt University Medical Center|Dr. C Michael Stein|615-936-3420|mike.stein@vanderbilt.edu|
276549|NCT00552110|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
276550|NCT00552175|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276551|NCT00552188|Tallikut Pharmaceuticals, Inc.|Brian Cunningham, MD|312-505-0420|brian@baycitycapital.com|
276552|NCT00552240|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276553|NCT00552279|GlaxoSmithKline|GSK Response Center|866-435-7343||
276554|NCT00552305|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
276555|NCT00552344|UCB Cares|UCB (Study Director)|+1 887 822 9493||
276556|NCT00552396|Innate Pharma|Dr Renaud Buffet Senior Director, Clinical Development and Translational Research|+33430303032|renaud.buffet@innate-pharma.fr|
276557|NCT00552409|University of Washington|Dr. Ian de Boer|206-616-5403|deboer@u.washington.edu|
276558|NCT00552422|Columbia University|David Lederer|212-342-4167|tjb2134@cumc.columbia.edu|
276559|NCT00552448|TexasTech|Dr. Adaobi Kanu|806 743 7336|adaobi.kanu@ttuhsc.edu|
276560|NCT00552513|Population Health Research Institute|TIMACS Project Office|19055244322|timacs@phri.ca|
276561|NCT00552578|SUNY Buffalo|R Blondell|716-898-4971|blondell@buffalo.edu|
276562|NCT00552617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276563|NCT00552669|Centro de Estudios en Cardiologia Intervencionista|Alfredo Rodriguez, MD, PHD|541149648721|rodrigueza@sanatorio-otamendi.com.ar|
276564|NCT00552695|Stony Brook U|Adam Singer|631-444-7857|adam.singer@stonybrook.edu|
276565|NCT00552760|Lehigh Valley Hospital|Edward R. Norris, MD|(610) 402-5766|Edward.Norris@lvh.com|
276566|NCT00552786|National Taiwan University|Dr. Yue-Liang Guo|+886-2-33228216|leonguo@ntu.edu.tw|
276567|NCT00552812|Johns Hopkins School of Medicine|Dr. Richard E. Ringel|410-614-6745|rringel@jhmi.edu|
276568|NCT00552929|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276569|NCT00553059|University of Texas (UT) MD Anderson Cancer Center|Michael J. Fisch, MD/Department of General Oncology|713-563-9905|mfisch@mdanderson.org|
285447|NCT01020123|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
297410|NCT01747655|AbbVie|Global Medical Information|1-800-633-9110||
285448|NCT01020305|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
297411|NCT01747772|Division of Abdominal Imaging and Interventional Radiology, Massachusetts General Hospital|Anthony E. Samir MD||asamir@partners.org|
297412|NCT01747811|University of Arizona|William Killgore|520-621-0605|killgore@psychiatry.arizona.edu|
297413|NCT01747837|Icahn School of Medicine at Mount Sinai|Sam Commack|212-824-8931|sam.cammack@mountsinai.org|
297414|NCT01747850|CAMH|Dr. Jose Trigo|416.535.8501|jose.trigo@camh.ca|30021
297415|NCT01747876|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
297416|NCT01747915|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297417|NCT01747928|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297418|NCT01748045|Tufts Medical Center|Dr. Christiane Dammann|617-636-8738|cdammann@tuftsmedicalcenter.org|
297419|NCT01748071|Huazhong University of Science&Technology|Xianwei Zhang|027 83662853|ourpain@163.com|
297420|NCT01748227|Richard L. Roudebush VAMC HSR&D|Dr. Marianne Matthias|317-988-4514|marianne.matthias@va.gov|
297421|NCT01748240|academic group|Groupe Francophone des Myelodysplasies|+ 33 (0)1 71 20 70 59|fatiha.chermat@aphp.fr|
297422|NCT01748292|Retina Consultants of Houston|Charles C. Wykoff, MD, PhD|713-524-3434|ccwmd@houstonretina.com|
297423|NCT01748552|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297424|NCT01748643|Ziekenhuis Oost-Limburg|Dr. Pascal Vanelderen|+3289325298|pascal.vanelderen@gmail.com|
297425|NCT01748695|Brigham and Women's Hospital|Dr. Christine N. Sang, Director of Translational Pain Research|617-525-7246|csang@partners.org|
297426|NCT01748760|Brown University|Shirley Yen, Ph.D.|401-444-1915|Shirley_Yen_PhD@Brown.edu|
297427|NCT01748799|Centre for Addiction and Mental Health (CAMH)|Bernard Le Foll|416.535.8501|bernard.lefoll@camh.ca|34772
297428|NCT01748825|National Cancer Institute|Dr. Naoko Takebe|240-781-3320|takeben@nih.gov|
297429|NCT01748916|University of Hohenheim|Dr. Ralf Schweiggert|0049-711-459-22995|ralf.schweiggert@uni-hohenheim.de|
297430|NCT01748942|Oregon Health and Science University|Daniel Clayburgh, MD PhD|503-494-8510|clayburg@ohsu.edu|
297431|NCT01748955|New York State Psychiatric Institute|Michael F. Grunebaum, MD|6467747573|mgruneb@nyspi.columbia.edu|646
297432|NCT01748994|Pennington Biomedical Research Center|Dr. Eric Ravussin|225-763-3186|eric.ravussin@pbrc.edu|
297433|NCT01749033|Northwerstern University|Ling Hu M.D.|312-695-3428|l-hu2@northwestern.edu|
297434|NCT01749215|University of California, San Francisco/San Francisco VA Healthcare System|Dr. Steven L. Batki|415-221-4810|steven.batki@ucsf.edu|23671
297435|NCT01749293|University of Illinois|Dr. Pritesh Patel|312-996-5762|prpatel8@uic.edu|
297436|NCT01749410|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
297437|NCT01749501|William Beaumont Hospital|Dr. Martin Espinosa|248-898-0633|Martin.espinosa@beaumont.edu|
297438|NCT01749605|University of Iowa|Brett Faine, PI|319-310-8067|brett-faine@uiowa.edu|
297439|NCT01749631|AbbVie|Global Medical Information|800-633-9110||
308526|NCT02586896|NYU School of Medicine|Michael Bogenschutz|646-501-4026|michael.bogenschutz@nyulangone.org|
297440|NCT01749735|Spaulding Rehabilitation Hospital|Dr. Paolo Bonato|617-952-6319|pbonato@partners.org|
297441|NCT01749800|Spaulding Rehabilitation Hospital|Paolo Bonato|+1-617-952-6319|pbonato@partners.org|
297442|NCT01749904|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
297443|NCT01749930|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
297444|NCT01749956|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
297445|NCT01749982|Columbia University|Megan N Hall|212-305-3161|mh2825@columbia.edu|
297446|NCT01749995|General Hospital Groeninge, Kortrijk, Belgium|Dr. Philip Debruyne|+32 056 63 39 00|philip.debruyne@azgroeninge.be|
297447|NCT01750086|Massachusetts General Hospital|Dr. Joy Tsai|617-726-6723|jntsai@mgh.harvard.edu|
297448|NCT01750190|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|060study@fibrogen.com|
308527|NCT02586909|Axovant Gene Therapies|Yi Mo, PhD|1-929-227-3828|yi.mo@axovant.com|
308528|NCT02586974|Città della Salute e della Scienza di Torino - Ospedale Molinette|Dr. Marco Oderda|+393479383465|marco.oderda@libero.it|
308529|NCT02587065|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
308530|NCT02587117|B.P. Koirala Institute of Health Sciences|Dr. Ramayan Prasad Kushwaha|977-9842207716|visitramayan007@yahoo.com|
308531|NCT02587143|Servicio de Urgencias, Hospital de Basurto, Bilbao, España|Dr. Ballesteros-Peña|(+34)946012804|sendoa.ballesteros@ehu.eus|
308532|NCT02587221|Seqirus|Seqirus Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
308533|NCT02587234|University of Kentucky|Lumy Sawaki, MD, PhD||lumy.sawaki@uky.edu|
308534|NCT02587351|University of Minnesota|John Connett|612-626-9010|john-c@umn.edu|
308535|NCT02587520|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
308536|NCT02587819|Biosceptre UK|Dr Shaun McNulty|01223496092|shaun.mcnulty@biosceptre.com|
308537|NCT02587962|Medivir AB|Chief Medical Officer|+46854683100|info@medivir.com|
308538|NCT02588092|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
285449|NCT01020435|Palmer College of Chiropractic|Christine M Goertz, DC, PhD (Study Principal Investigator)|563-884-5150|christine.goertz@palmer.edu|
285450|NCT01020448|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
285451|NCT01020474|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285452|NCT01020487|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
285453|NCT01020526|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285454|NCT01020591|CDHA|Wendy Jardine|902 429 6218|wendymjardine@gmail.com|
285455|NCT01020747|Massachusetts General Hospital|Monica Tettamanti|617-643-5696|mtettamanti@ccib.mgh.harvard.edu|
285456|NCT01020773|Beijing Shijitan Hospital|Department of Respiratory Medicine|86-010-63926385|mayingmin@hotmail.com|
285457|NCT01020786|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285458|NCT01020799|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
285459|NCT01020812|Stanford University|Daniel T Chang|650-723-6171|dtchang@stanford.edu|
285460|NCT01020838|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
285461|NCT01020877|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
285462|NCT01020981|VHA HSR&D|Marcia Valenstein, MD|7349453649|marcia.valenstein@va.gov|
285463|NCT01021007|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
285464|NCT01021020|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
276570|NCT00553098|Fred Hutch Cancer Research|Dr. Lauri Burroughs|206-667-2396|lburroug@fredhutch.org|
285465|NCT01021111|Stanford University|Professor Thomas P. Andriacchi|6507238024|tandriac@stanford.edu|
285466|NCT01021137|James H. Quillen VA Medical Center|Director of Vestibular Laboratory|423-926-1171|faith.akin@va.gov|7376
285467|NCT01021215|University of Texas (UT) MD Anderson Cancer|Dr. Powel H. Brown, MD Anderson Phase I/II Prevention Consortium|(713) 745-3672|CR_Study_Registration@mdanderson.org|
285468|NCT01021293|GlaxoSmithKline|GSK Response Center|866-435-7343||
285469|NCT01021306|Palmer Center for Chiropractic Research, Palmer College of Chiropractic|Dr. James DeVocht|563.884.5150|james.devocht@palmer.edu|
285470|NCT01021332|Astellas Pharma Europe B.V.|Medical Director, Global Medical Science||astellas.resultsdisclosure@astellas.com|
285471|NCT01021423|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
285472|NCT01021553|GlaxoSmithKline|GSK Response Center|866-435-7343||
285473|NCT01021618|Hartford Hospital|Gary V Heller, MD, PhD|860-545-5527|aahlber@harthosp.org|
285474|NCT01021683|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
285475|NCT01021748|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285476|NCT01021761|Bucci Laser Vision|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
285477|NCT01021813|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285478|NCT01021852|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297449|NCT01750229|Medtronic Neuromodulation|Neuro Clinical Trials||medtronicneurotrials@medtronic.com|
285479|NCT01021878|Pontifícia Universidade Católica do Paraná|Dr. Roberto Pecoits-Filho and Dr. Thyago P. Moraes|554132713150|r.pecoits@pucpr.br|
285480|NCT01021956|STEBA Biotech|Bertrand Gaillac International Project Leader|+33 9 74 19 79 05|b.gaillac@stebabiotech.com|
285481|NCT01022073|San Francisco VA Medical Center|William J. Marks, Jr., M.D.|415-750-2100|William.Marks@va.gov|
285482|NCT01022112|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
285483|NCT01022190|Radboud University Nijmegen Medical Centre|Study director|+31 24 36 13918||
285484|NCT01022203|Southeast Louisiana Veterans Health Care System (SLVHCS)|Frederic Sautter, Ph.D.|504-988-3026|Fsautter@tulane.edu|
285485|NCT01022242|Uppsala University Hospital|Monica Wiig||monica.wiig@akademiska.se|
285486|NCT01022307|VANCHCS|David L. Woods, Chief Clinical Neurophysiology|925-372-2571|David.Woods@va.gob|
285487|NCT01022359|Imperial College London|Neill Duncan|+44 (0 )207 594 7243|n.duncan@imperial.ac.uk|
297450|NCT01750242|Medtronic Neuromodulation|Stephanie Salisbury|763-526-8096|stephanie.salisbury@medtronic.com|
276571|NCT00553150|Mayo Clinic|Jann N. Sarkaria, M.D.|507/284-3559|sarkaria.jann@mayo.edu|
276572|NCT00553163|Barts Health NHS Trust|Prof D S Rampton|+442035943300|d.rampton@qmul.ac.uk|
276573|NCT00553202|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
276574|NCT00553254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276575|NCT00553267|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276576|NCT00553280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276577|NCT00553319|Columbia University|Frances R. Levin, M.D.|646-774-6137|frl2@columbia.edu|
285488|NCT01022424|Otsuka Pharmaceutical Co.,Ltd.|Director of Clinical Trials|+81-3-6361-7366||
285489|NCT01022502|Chang Gung Memorial Hospital|Yin-Ku Lin, MD. PhD.|886-2-24313131|lin1266@adm.cgmh.org.tw|2127
285490|NCT01022567|Turku University Hospital|Paulina Salminen|+358 2 313 0542|paulina.salminen@tyks.fi|
285491|NCT01022580|University of California, San Francisco|Roberta A Ballard, MD|415-476-4193|roberta.ballard@ucsf.edu|
285492|NCT01022762|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
285493|NCT01022853|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285494|NCT01022996|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
285495|NCT01023022|Institute of Cardiology|Prof. Hanna Szwed|48 22 343 46 00|hszwed@ikard.pl|
285496|NCT01023035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285497|NCT01023061|University of Washington|Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
285498|NCT01023074|Portland VA Medical Center|Robert Folmer, Ph.D.|503-220-8262|Robert.Folmer@va.gov|51868
285499|NCT01023178|Stanford University|Sejal Shah MD|6507235791|sshah2@stanford.edu|
285500|NCT01023217|Asan Medical Center|Professor Young-Suk Lim|+82-2-3010-5933|limys@amc.seoul.kr|
297451|NCT01750255|Universidad de Antioquia|Pedro Amariles Muñoz|57 4 2195456|pedro.amariles@udea.edu.co|
285501|NCT01023256|MorphoSys|Roman Korolkiewicz|+498989927|Roman.Korolkiewicz@morphosys.com|208
285502|NCT01023269|Medtronic International Trading Sarl|Alexandra Delacour, Clinical Research Manager|0041218027622|alexandra.delacour@medtronic.com|
285503|NCT01023308|Novartis Pharmaceuticals|Study Director|862-778-8300||
285504|NCT01023477|Inova Health Care|Kirsten Edmiston, MD|703-850-9555|Kirsten.edmiston@inova.org|
285505|NCT01023516|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
285506|NCT01023568|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
285507|NCT01023581|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
285508|NCT01023659|Centre for Addiction and Mental Heatlh|Dr. Peter Selby|416-535-8501|peter.selby@camh.ca|74946
285509|NCT01023672|Mayo Clinic|Dr. Bradley F. Boeve|507-266-4106|bboeve@mayo.edu|
285510|NCT01023711|University of Rochester|John Treanor, M.D.|585-275-5871|john_treanor@urmc.rochester.edu|
285511|NCT01023724|Bucci Laser Visiosn|Frank A. Bucci, Jr., MD|570-825-5949|Buccivision@aol.com|
285512|NCT01023776|University of Rochester|John Treanor< M.D.|585-275-5871|john_treanor@urmc.rochester.edu|
285513|NCT01023789|Abbott Vascular International BVBA|Susan Veldhof|+31653428610|susan.veldhof@av.abbott.com|
297452|NCT01750268|San Francisco VA Health Care System/University of California, San Francisco|Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
297453|NCT01750294|Indiana University & Richard L Roudebush VA Medical Center|Rajiv Agarwal, MD, FAHA, FASN, FASH|317-988-2241|ragarwal@iu.edu|
285514|NCT01023815|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
285515|NCT01023841|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
285516|NCT01023958|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285517|NCT01024010|Mayo Clinic|Tait D. Shanafelt, M.D.||shanafelt.tait@mayo.edu|
285518|NCT01024036|Janssen R&D US|DIRECTOR CLINICAL RESEARCH||ClinicalTrialDisclosure@its.jnj.com|
285519|NCT01024231|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
285520|NCT01024244|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285521|NCT01024296|Stanford University|Bilal M Shafi, MD|(215) 738-0400|bmshafi@stanford.edu|
285522|NCT01024309|OrthoCarolina Research Institute|Dr. Susan Odum|704.323.2265|Susan.Odum@OrthoCarolina.com|
285523|NCT01024335|NYS Psychiatric Institute|Adam Bisaga|646-774-6155|amb107@columbia.edu|
276578|NCT00553332|The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute|Tanios Bekaii-Saab, MD|614-293-9863|Tanios.Bekaii-Saab@osumc.edu|
285524|NCT01024387|Dana-Farber Cancer Institute|Matthew H. Kulke, MD|617.632.5136|Matthew_Kulke@dfci.harvard.edu|
285525|NCT01024465|ReShape Medical|Director of Clinical Operations|949-429-6680|lfong@reshapemedical.com|
285526|NCT01024569|University of Illinois at Chicago|Judith A Cook|312-355-3921|jcook@uic.edu|
285527|NCT01024686|U.S. Military Malaria Vaccine Program (USMMVP)|Dr. Michele Spring|301-319-9307||
285528|NCT01024738|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
285529|NCT01024751|Bausch & Lomb Incorporated|William Reindel, OD, MS|(585) 338-8129|william.reindel@bausch.com|
297454|NCT01750346|National Institutes of Health|Dr. Codrin Lungu|301-402-0976|lunguci@ninds.nih.gov|
285530|NCT01024855|Abbott Medical Optics, Inc.|Nick Tarantino, Head, Clinical Research and Development|714-247-8613|nicholas.tarantino@amo.abbott.com|
285531|NCT01024920|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285532|NCT01024946|Memorial Sloan Kettering Cancer Center|Dr. Lee Krug|646-888-4201|krugl@mskcc.org|
276579|NCT00553358|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@Novartis.com|
276580|NCT00553410|International Breast Cancer Study Group (IBCSG)|Meredith M. Regan|+1 617 632 3012|mregan@jimmy.harvard.edu|
276581|NCT00553436|Ethicon Endo-Surgery, Inc|Amy Mahanes, Clinical Research Associate II|513-337-8366|amahanes@its.jnj.com|
276582|NCT00553462|Yale Cancer Center|Rogerio Lilenbaum, M.D.||Rogerio.lilenbaum@yale.edu|
276583|NCT00553475|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
276584|NCT00553501|University of Vermont, Vermont Cancer Center|Barbara Grant, MD||barbara.grant@vtmednet.org|
276585|NCT00553514|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
276586|NCT00553540|Cleveland Clinic Florida|Dr. David Westerdahl|954-659-5422|westerd@ccf.org|5422
276587|NCT00553605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276588|NCT00553631|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
276589|NCT00553644|Veterans Affairs Medical Center/University of Minnesota|Vicki Morrison, M.D.||morri002@umn.edu|
276590|NCT00553696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276591|NCT00553735|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@MEEI.Harvard.edu|
276592|NCT00553787|Vivus, Inc|Wesley W Day PhD|650-934-5200|day@vivus.com|
285533|NCT01024959|Gen-Probe, Incorporated|Jennifer Reid, Director of Clinical Affairs|858-731-5985|jennifer.reid@hologic.com|
285534|NCT01024972|University of Massachusetts Medical School|Dr. Susanne Muehlschlegel|508-421-5500|susanne.muehlschlegel@umassmemorial.org|
297455|NCT01750398|SKCCC at Johns Hopkins|Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
285535|NCT01025037|Tornier, Inc.|Manager of Clinical Operations|952-426-7674|serickson@tornier.com|
285536|NCT01025076|Royal Alexandra Hospital/CAMIS|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
285537|NCT01025154|The University of Texas MD Anderson Cancer Center|Stefan Faderl, MD / Associate Professor|713-745-4613|eharriso@mdanderson.org|
285538|NCT01025193|Hospital of the University of Pennsylvania|Jennifer Trofe-Clark|215-614-4274|jennifer.trofe-clark@uphs.upenn.edu|
285539|NCT01025232|Retinal Consultants of Houston|David M. Brown, MD Director of Clinical Research|713-394-7534|dmbmd@houstonretina.com|
285540|NCT01025284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285541|NCT01025336|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285542|NCT01025427|University of California, San Francisco|Hiroyu Hatano|415-476-4082|hhatano@php.ucsf.edu|122
285543|NCT01025453|Memorial Sloan Kettering Cancer Center|Dr. Eric Sherman, MD|646-888-4234|shermane@mskcc.org|
285544|NCT01025635|Bayer HealthCare Pharmaceuticals, Inc. (formerly Intendis GmbH)|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
285545|NCT01025752|VA Connecticut Healthcare System|Dr. Alicia Heapy|203-932-5711|alicia.heapy@va.gov|2299
285546|NCT01025791|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285547|NCT01025817|Novartis|Study Director|+1 (862) 778-8300||
285548|NCT01025830|University of California Berkeley|Jayne Byakika Tusiime|1 510 219 7567|tusiimej@berkeley.edu|
297456|NCT01750502|Department of Cardiology, the Second Affiliated Hospital, Wenzhou Medical University, Zhejiang province, Wenzhou,China|Dr. JiFei Tang|15968766021|jiftang@126.com|
297457|NCT01750684|Acorda Therapeutics, Inc.|Chief Scientific Officer|914-347-4300|acorda@acorda.com|
297458|NCT01750697|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
297459|NCT01750840|Biomet|Manager of Research|973-299-9300|hallie.murray@zimmerbiomet.com|3415
297460|NCT01750879|Massachusetts General Hospital|Dr. Wayne Shreffler|617-726-6147|WSHREFFLER@mgh.harvard.edu|
297461|NCT01750918|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
297462|NCT01750931|GlaxoSmithKline|GSK Response Center|866-435-7343||
297463|NCT01751022|Medtronic|Shelby Li|+17635262704|shelby.li@medtronic.com|
297464|NCT01751061|Duke University|Dr. Christopher Cox|9196817232|Christopher.cox@duke.edu|
297465|NCT01751087|Planned Parenthood League of Massachusetts, Inc.|Principal Investigator|617.616.1600||
297466|NCT01751113|GlaxoSmithKline|GSK Response Center|866-435-7343||
297467|NCT01751139|GlaxoSmithKline|GSK Response Center|435-7343|GSKClinicalSupportHD@gsk.com|866
297468|NCT01751165|GlaxoSmithKline|GSK Response Center|866-435-7343||
297469|NCT01751178|GlaxoSmithKline|GSK Response Center|866-435-7343||
297470|NCT01751230|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|leanne.redman@pbrc.edu|
297471|NCT01751308|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
297472|NCT01751386|National Institute on Alcohol Abuse and Alcoholism|Lorenzo Leggio|+1 301 435 9398|lorenzo.leggio@mail.nih.gov|
297473|NCT01751399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297474|NCT01751412|Massachusetts General Hospital|Thomas F. DeLaney, MD|617-726-6876|TDELANEY@mgh.harvard.edu|
297475|NCT01751451|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher, MD|646-888-4878|scherh@MSKCC.ORG|
297476|NCT01751568|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 544-7040|mallen@fhi360.org|11246
297477|NCT01751646|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
297478|NCT01751724|University of Miami|Eduardo Bancalari M.D., Director Division of Neonatology|3055856408|ebancalari@miami.edu|
297479|NCT01751802|Psyadon Pharmaceuticals|President/CEO|301-919-2020|info@psyadonrx.com|
297480|NCT01751867|Janssen R&D US|SR DIR COMPD DEV TM LDR|1 908 704-5197||
297481|NCT01751906|Abbott Vascular|Dana Haudek / Project Manager|928-925-4054|dana.haudek@abbott.com|
297482|NCT01751971|Brigham and Women's Hospital|Scott Sands, PhD|6172780911|sasands@bwh.harvard.edu|
297483|NCT01752036|SKCCC|Terrence Caldwell|443-287-1889|caldwte@jhmi.edu|
308539|NCT04960228|Lady Davis Institute for Medical Research|Ben Haward, Research Assistant|514-340-8222|ben.haward@ladydavis.ca|23978
308540|NCT03922477|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
276593|NCT00553839|Stanford University|Chandra Ramamoorthy, MBBS, FRCA|650-723-5728|chandrar@stanford.edu|
276594|NCT00553969|University of Minnesota Medical School|Jay N. Cohn, M.D.|612.625.5646|cohnx001@umn.edu|
276595|NCT00554099|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
276596|NCT00554216|Vivus, Inc.|Wesley W. Day PhD|650-934-5200|day@vivus.com|
276597|NCT00554229|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
276598|NCT00554372|SillaJen Biotherapeutics, Inc.|Manager, IP, Contracts, Translational Research|415 281 8886|tchiaverotti@sillajen.com|
276599|NCT00554463|NRG Onocology|Wendy Seiferheld||wseiferheld@nrgonology.org|
276600|NCT00554515|Beth Israel Deaconess Medical Center|David F. McDermott, MD||dmcdermo@bidmc.harvard.edu|
276601|NCT00554619|GlaxoSmithKline|GSK Response Center|866-435-7343||
276602|NCT00554671|Providence VA Medical Center|Wen-Chih Wu, MD|4012737100|wen-chih.wu@va.gov|6237
276603|NCT00554749|Centre for Child and Adolescent Mental Health, Eastern and Southern Norway|Dr. Hanne Kristensen|+4722586000|hanne.kristensen@r-bup.no|
276604|NCT00554788|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
276605|NCT00554801|Portland VA Medical Center|Marjorie R. Leek|503-220-8262|Marjorie.Leek@va.gov|54525
276606|NCT00554840|Maryland Psychiatric Research Center|Elaine Weiner, M.D.|410-402-7694|eweiner@mprc.umaryland.edu|
276607|NCT00554853|UMichigan|PPAR-gamma agonist, rheumatoid arthritis and cardiovascular disease|734-936-7905|makaplan@umich.edu|
308541|NCT03688074|AstraZeneca|Globall Clinical Head|+1 877-240-9479|information.center@astrazeneca.com|
297484|NCT01752400|Massachusetts General Hospital|Alice Shaw, MD, PhD|617-724-4000|ashaw1@mgh.harvard.edu|
285549|NCT01025843|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285550|NCT01026012|University of Maryland Cardiology|Dr. Scott Jerome|410-876-0086|sjerome@medicine.umaryland.edu|
285551|NCT01026038|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285552|NCT01026103|Covidien|Noreen Fahey|203-821-4716|noreen.fahey@covidien.com|
285553|NCT01026142|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
285554|NCT01026181|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
285555|NCT01026194|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
285556|NCT01026324|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617-632-5053|stephen_hodi@dfci.harvard.edu|
285557|NCT01026389|Guerbet|Post M. A. Clinical Unit Manager|+33 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
285558|NCT01026402|AstraZeneca|Bryony Harrop|01625 582828|ClinicalTrialTransparency@astrazeneca.com|
285559|NCT01026454|University of Washington|Connie Celum, MD, MPH|206-520-3800|ccelum@uw.edu|
285560|NCT01026493|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
285561|NCT01026623|Memorial Sloan Kettering Cancer Center|Dana Rathkopf|646-422-4379|rathkopd@mskcc.org|
285562|NCT01026792|BC Cancer Agency, Vancouver Clinic, Vancouver, BC, Canada|Dr. Anna Tinker|604 877 6217|atinker@bccancer.bc.ca|
285563|NCT01026805|Interlace Medical, Inc.|John Vozella, V.P. Clinical & Regulatory Affairs|508-875-1343|john@interlacemedical.com|112
285564|NCT01026818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285565|NCT01026831|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285566|NCT01026844|Massachusetts General Hospital|Lecia Sequist, MD|617-724-4000|lvsequist@partners.org|
285567|NCT01026909|Seattle Children's Hospital|Dr Klane White|206-987-5678|klane.white@seattlechildrens.org|
285568|NCT01026948|University of Liverpool|Professor Zarko Alfirevic|00 44(1)51 702|zarko@liverpool.ac.uk|4100
285569|NCT01026974|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
285570|NCT01027000|Dana Farber Cancer Institute|Edwin P. Alyea, MD||edwin_alyea@dfci.harvard.edu|
285571|NCT01027195|The Cleveland Clinic|Wael K Barsoum, MD|216-444-7515|barsouw@ccf.org|
285572|NCT01027273|Icahn School of Medicine at Mount Sinai|Carol R Horowitz, MD, MPH|212-659-9567|carol.horowitz@mountsinai.org|
285573|NCT01027286|The Cleveland Clinic|Wael K Barsoum, MD|216-444-7515|barsouw@ccf.org|
285574|NCT01027351|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
285575|NCT01027364|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
285576|NCT01027416|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
285577|NCT01027468|Medical University of Vienna|Assoc.Prof.PD.Dr.Stefan Sacu|+43404001|stefan.sacu@meduniwien.ac.at|7937
285578|NCT01027559|University of Pennsylvania|Dr. Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
285579|NCT01027598|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
285580|NCT01027650|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
285581|NCT01027702|PRA Health Sciences|Dr. Andrew Gilman|704-615-2744|gilmanandy@prahs.com|
285582|NCT01027754|Albert Einstein College of Medicine/Montefiore Medical Center|Dr. Shadi Nahvi|718 920 5379|SNAHVI@montefiore.org|
285583|NCT01027780|University of Rochester|Dr. Jan Moynihan|585-275-4648|jan_moynihan@urmc.rochester.edu|
276608|NCT00554970|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
276609|NCT00554996|Barbara Trautner, MD, PhD|Barbara Trautner, MD, PhD|713-440-4438|barbara.trautner@va.gov|
276610|NCT00555048|Fred Hutchinson Cancer Research Center|Ann Woolfrey, MD|206-667-4453|awoolfre@fredhutch.org|
276611|NCT00555061|GlaxoSmithKline|GSK Response Center|866-435-7343||
276612|NCT00555152|University of Texas (UT) MD Anderson Cancer Center|Powel H. Brown, MD/Chair, Clinical Cancer Prevention||CR_Study_Registration@mdanderson.org|
276613|NCT00555217|VA Pittsburgh Healthcare System and University of Pittsburgh School of Medicine, Pittsburgh, PA|Linda Fried, MD, MPH|412-360-3930|Linda.Fried@va.gov|
276614|NCT00555321|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
276615|NCT00555360|Ann Arbor VA Healthcare System|Dr. John Piette, PhD|734-845-3626|jpiette@umich.edu|
276616|NCT00555425|Yale University|Dr. David Fiellin|203-688-2471|david.fiellin@yale.edu|
276617|NCT00555438|CHU SAINT-ETIENNE|Pr patrick MISMETTI|33(1)477127788|patrick.mismetti@chu-st-etienne.fr|
276618|NCT00555464|Medical College of Wisconsin|Beth Drolet, MD|414-955-2817|sjoachim@mcw.edu|
276619|NCT00555477|University of Michigan Comprehensive Cancer Center|Dr. Norah Lynn Henry|734-936-4991|norahh@umich.edu|
276620|NCT00555568|CHOIR (Center for Healthcare Organization & Implementation Research|Susan V. Eisen|781-687-2858|susan.eisen@va.gov|
276621|NCT00555581|Hospital for Special Surgery|Robert F. Spiera|212-774-2048|spierar@hss.edu|
276622|NCT00555620|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276623|NCT00555672|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276624|NCT00555750|Brigham and Women's Hospital|Dr. John Winkelman, MD, PhD|617-278-0061|jwwinkelman@partners.org|
276625|NCT00555880|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
285584|NCT01027793|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|cientifico@cbed.org.br|
285585|NCT01027806|School of Medicine, University of Missouri Health|Leila Kheirandish-Gozal, M.D., M.Sc.|(573) 884-3229|gozall@health.missouri.edu|
285586|NCT01027819|Seoul National University Hospital|Dr. Dongwook Kim|821067395311|daljookim@gmail.com|
285587|NCT01027845|GlaxoSmithKline|GSK Response Center|866-435-7343||
285588|NCT01027871|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285589|NCT01027884|University Hospital Leuven-Children Hospital|Dr Gunnar Buyse|+32 016343845|gunnar.buyse@uzleuven.be|
285590|NCT01027897|Grady Health System|Prasad Abraham|404-616-3246|pabraham@gmh.edu|
285591|NCT01027910|Massachusetts General Hospital|Dr. Edwin Choy|617-724-4000|echoy@mgh.harvard.edu|
285592|NCT01027949|United Therapeutics|Louis Holdstock, PhD|919-425-8866|lholdstock@unither.com|
285593|NCT01028014|University of Alabama at Birmingham|Dr. William Jerod Greer|205-934-7874|wjgreer@uab.edu|
285594|NCT01028027|Bausch & Lomb Incorporated|Tuyen Ong, MD|(973) 360-6389|tuyen.ong@bausch.com|
285595|NCT01028053|GE Healthcare|Paul Sherwin M.D.|16095146820|Paul.Sherwin@ge.com|
285596|NCT01028131|Wayne State University|Steven J. Ondersma|313-577-6680|s.ondersma@wayne.edu|
297485|NCT01752413|Memorial Blood Centers|Jed B Gorlin MD, MBA|651-332-7284|Jed.Gorlin@innovativeblood.org|
297486|NCT01752426|The University of Texas MD Anderson Cancer Center|Jan Burger MD./Professor|713-563-1487|jaburger@mdanderson.org|
297487|NCT01752634|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
297488|NCT01752712|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu|
297489|NCT01752842|Washington University School of Medicine|Jean E. Schaffer, MD|314-362-8717|jschaff@wustl.edu|
297490|NCT01752855|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
297491|NCT01752907|Amgen Inc.|Study Director|866-572-6436||
297492|NCT01752920|Basilea Pharmaceutica International Ltd.|Study Director|+41615671546|marc.engelhardt@basilea.com|
297493|NCT01752933|Astex Pharmaceuticals, Inc.|Dr. Harold Keer, Senior Vice President Clinical Development|925-719-0741|Harold.Keer@astx.com|
297494|NCT01752985|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
297495|NCT01753076|GlaxoSmithKline|GSK Response Center|866-435-7343||
297496|NCT01753115|Emergent BioSolutions|Robert Hopkins, MD, MPH & TM, FACP, FIDSA, Medical Monitor|301-944-0136|HopkinsR@ebsi.com|
297497|NCT01753193|MedImmune, LLC|Raj Tummala|+1 301-398-0548|information.center@astrazeneca.com|
297498|NCT01753297|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
297499|NCT01753310|Ipsen Biopharmaceuticals, Inc.|Medical Director||clinical.trials@ipsen.com|
297500|NCT01753323|Novartis Pharmaceuticals|Study Director|862-778-8300||
297501|NCT01753336|Ipsen Biopharmaceuticals, Inc.|Medical Director||clinical.trials@ipsen.com|
297502|NCT01753362|University at Buffalo|Dr. Paresh Dandona|716-535-1850|dandona@buffalo.edu|
297503|NCT01753401|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
297504|NCT01753518|Mayo Clinic|Dr. Margaret Dow|507-266-8008|dow.margaret@mayo.edu|
297505|NCT01753557|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
297506|NCT01753570|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
297507|NCT01753713|Case Comprehensive Cancer Center|Manmeet Ahluwalia, MD|216-844-5060|ahluwam@ccf.org|
297508|NCT01753739|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
297509|NCT01753830|Q-Med AB|Clinical Project Manager|+46 18 4749000|reception.seupp@galderma.com|
297510|NCT01753856|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297511|NCT01753999|Rutgers Robert Wood Johnson Medical School|Dr. Jag Sunderram|732-235-7038|sunderja@rwjms.rutgers.edu|
297512|NCT01754129|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
297513|NCT01754194|Medtronic MITG|Maria Young - Clinical Research Manager|+353 (0)1 4381611|maria.young@medtronic.com|
297514|NCT01754207|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
297515|NCT01754259|Brigham and Women's Hospital|Dr. Marcelo Di Carli|617-732-6291|mdicarli@partners.org|
297516|NCT01754350|JohannWGUH|Johannes Rieger|+4969630187711|j.rieger@uni-tuebingen.de|
297517|NCT01754376|MGH Cancer Center|Ryan Sullivan|617-724-4000|rsullivan7@mgh.harvard.edu|
297518|NCT01754389|Dana Farber Cancer Institute|Dr. John Koreth|617-632-2949|John_Koreth@dfci.harvard.edu|
297519|NCT01754402|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|cristina.gasparetto@duke.edu|
297520|NCT01754467|Northwestern University|Christine Pellegrini, PhD|312-503-1395|c-pellegrini@northwestern.edu|
297521|NCT01754480|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
297522|NCT01754493|New York State Psychiatric Institute|Roberto Lewis-Fernandez|646-774-8102|rlewis@nyspi.columbia.edu|
276626|NCT00555893|Marshfield Clinic Research Foundation|Edward Belongia, MD|715-389-3783|belongia.edward@mcrf.mfldclin.edu|
276627|NCT00555906|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276628|NCT00555971|Cleveland Clinic|David M. Lang|216-444-6933|langd@ccf.org|
276629|NCT00555997|Massachusetts General Hospital|Dr. George Papakostas|617-726-6697|gpapakostas@partners.org|
276630|NCT00556049|MGH Cancer Center|Dr. M. Dror Michaelson|617-726-1594|dmichaelson1@partners.org|
276631|NCT00556140|Massachusetts General Hospital|Dr. John Matthews|617-724-0847|jmatthews@partners.org|
276632|NCT00556322|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
276633|NCT00556374|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
276634|NCT00556426|C.R. Bard|John Reviere, Director of Clinical Affairs|480-303-2644|john.reviere@crbard.com|
276635|NCT00556439|Cleveland Clinic|Carol A Langford, MD MHS|216-445-6056|langfoc@ccf.org|
276636|NCT00556452|University of Michigan Cancer Center|Dr. John Magenau|734/936-8785|johnmage@umich.edu|
276637|NCT00556478|Plethora Solutions|Chief Scientific Officer|+44 (0) 20 3077 5400|mail@plethorasolutions.co.uk|
276638|NCT00556491|St Louis University|Tarek El-Achkar|317 278 6822|telachka@iu.edu|
276639|NCT00556504|TCM Biotech International|Dr. Ya-Chun Wang, EVP/CSO|886-2-26581677|yachunwang@tcmbio.com|733
276640|NCT00556543|Oregon Health & Science University|John Mayberry, MD|503-494-5300|mayberrj@ohsu.edu|
276641|NCT00556673|Novartis Pharmaceuticals|Study Director|862-778-8300||
285597|NCT01028222|Study Director|Novartis|862-778-8300||
285598|NCT01028352|University of Michigan Comprehensive Cancer Center|Dr. Norah L. Henry|734-936-4991|norahh@umich.edu|
285599|NCT01028378|Clinical Research Consultants, Inc.|Barbara S. Fant, Pharm.D.|513-961-8200|bsfant@crc-regulatory.com|
285600|NCT01028391|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372||
285601|NCT01028560|Jacobi Medical Center / Albert Einstein College of Medicine|Gabriele de Vos, M.D.|7184152809|gabriele.de-vos@einstein.yu.edu|
285602|NCT01028651|United Therapeutics Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com|
285603|NCT01028677|UNC_ChapelHill|Dr. Cort Pedersen|919 966-4447|cort_pedersen@med.unc.edu|
285604|NCT01028820|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
285605|NCT01028911|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285606|NCT01028937|NTK Enterprises, Inc.|Nancy Lockerman|831-869-1384|nlockerman@opti-k.com|
285607|NCT01029054|University of Michigan Hospital|Dr. Mark Kaminski, M.D.|734-936-5310|mkaminsk@umich.edu|
285608|NCT01029262|Celgene Corporation|Anne McClain, Senior Study Manager|888-260-1588|clinicaltrialdisclosure@celgene.com|
285609|NCT01029340|BAYER|Therapeutic Area Head||clinical-trial-contact@bayerhealthcare.com|
285610|NCT01029353|Vanderbilt University Medical Center|Martin L Blakely, MD|615-936-7211|martin.blakely@vumc.org|
285611|NCT01029366|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
285612|NCT01029392|William Beaumont Hospital|Dr. Peter Gerrits|248-551-0487|peter.gerrits@beaumont.org|
297523|NCT01754519|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
285613|NCT01029405|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285614|NCT01029535|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
285615|NCT01029587|Johns Hopkins University|Benjamin Philosophe|443-287-7178|bphilosophe@jhmi.edu|
285616|NCT01029652|Novartis Pharmaceuticals|Study Director|862 778-8300||
285617|NCT01029691|University of Michigan|Louise O'Brien|734 647-9064|louiseo@med.umich.edu|
285618|NCT01029704|Theracos, Inc.|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
285619|NCT01029730|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
285620|NCT01029782|Interior Health|Dawn Dalen|250-862-4449|dawn.dalen@interiorhealth.ca|
285621|NCT01029795|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285622|NCT01029886|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
285623|NCT01029912|MetroHealth Medical Center|Dr. Jayme Knutson|2167787342|jsk12@case.edu|216
285624|NCT01029925|University of California Los Angeles Jonsson Comprehensive Cancer Center|Edward Garon, MD|310 586 2098|egaron@mednet.ucla.edu|
285625|NCT01030133|Medical University of South Carolina|Dr. Jeffery J Borckardt|843.792.3127|borckardt@musc.edu|
285626|NCT01030289|Medical University of South Carolina|Jeffrey Borckardt, Ph.D|843-792-3295|borckard@musc.edu|
285627|NCT01030406|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
308542|NCT03342001|University of Maryland School of Medicine|Dr. Kashif Munir|443-682-6873|kmunir@som.umaryland.edu|
285628|NCT01030458|University of Leuven|Prof. Dr. Jan A Staessen|+32 16 34 7104|jan.staessen@med.kuleuven.be|
285629|NCT01030523|Dentsply Sirona Implants|Manager of Global Clinical Research|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
285630|NCT01030536|MedImmune LLC, Milstein Building, Granta Park, Cambridge, CB21 6GH, United Kingdom|Edward Bradley, MD|+44 (0)1223 895997||
285631|NCT01030575|RTI International|Dr. Abhik Das|301-770-8214|adas@rti.org|
285632|NCT01030653|University of Michigan|Manjuanth Pai|7346470006|amitpai@med.umich.edu|
285633|NCT01030666|JWGUniversity|Prof. Dr. Peter Eickholz|+496963015642|eickholz@med.uni-frankfurt.de|
285634|NCT01030718|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
285635|NCT01030783|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|617-588-1960|Clinical@aveooncology.com|
285636|NCT01030822|GlaxoSmithKline|GSK Response Center|866-435-7343||
285637|NCT01030861|Benaroya Research Institute|Carla Greenbaum, MD|206-342-6933|cjgreen@benaroyaresearch.org|
285638|NCT01030874|VAORD|Mark Helfand, MD|5032203406|mark.helfand@va.gov|
285639|NCT01030952|Novartis Pharmaceuticals|Study Director|+1-800-244-7668||
285640|NCT01030965|GlaxoSmithKline|GSK Response Center|866-435-7343||
285641|NCT01031004|Vistakon|John Buch/Principal Research Optometrist|904-443-1707||
285642|NCT01031043|Georgia Regents University|Gregory N. Postma MD|706-721-6100|gpostmat@gru.edu|
285643|NCT01031069|GlaxoSmithKline|GSK Response Center|866-435-7343||
285644|NCT01031095|Bursa Postgraduate Hospital|Dr.Hasan ARI|00902243605050|hasanari03@yahoo.com|1739
285645|NCT01031134|Weill Cornell Medical College|Patrick Raue, Ph.D.|206-543-3807|praue@uw.edu|
285646|NCT01031381|UPMC Cancer Centers|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
285647|NCT01031420|Fox Chase Cancer Center|Elizabeth Plimack|215-728-3889|Elizabeth.Plimack@fccc.edu|
285648|NCT01031446|Vanderbilt-Ingram Cancer Center|Ingrid A. Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
297524|NCT01754623|Florida Hospital Orlando (Formerly at Moffitt Cancer Center)|Ravi Shridhar, M.D., Ph.D.|407-303-5857|ravi.shridhar.md@flhosp.org|
297525|NCT01754688|Minnesota Medical Research Foundation and University of Minnesota|Tina M. Slusher, MD|612-624-4586|tslusher@umn.edu|
297526|NCT01754714|Abbott|Associate Director Clinical Services|+31 29-44-79-196|taco.baardman@abbott.com|
297527|NCT01754727|AbbVie|Global Medical Information|800-633-9110||
285649|NCT01031498|UT MD Anderson Cancer Center|Jorge Cortes, MD / Professor|713-745-5783|eharrison@mdanderson.org|
285650|NCT01031537|Division of Occupational Health and Safety, NIH|Dr. James M. Schmitt|301-496-4411|james_schmitt@nih.gov|
285651|NCT01031680|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
285652|NCT01031706|University of North Carolina at Chapel Hill|Dr. Scott H. Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
285653|NCT01031810|New York State Psychiatric Institute|Dr. Patrick J. McGrath|(646) 774-8076|mcgrath@nyspi.columbia.edu|
285654|NCT01031836|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
285655|NCT01031914|Philips|Dr. David P. White|724 387 4554|Dr.DavidWhite@philips.com|
285656|NCT01031953|Oregon Health & Science University|Dr. Joseph Bubalo|503-494-8007|bubaloj@ohsu.edu|
285657|NCT01031979|Ralph H. Johnson VAMC|Dr. Peter Tuerk|(843) 789-6188|peter.tuerk@va.gov|
285658|NCT01032018|Columbia University Medical Center|Karina W Davidson, PhD|212-342-4493|kd2124@cumc.columbia.edu|
285659|NCT01032044|Mayo Clinic, Jacksonville, Florida, USA|Dr Michael B. Wallace|904 953-7630|wallace.michael@mayo.edu|
285660|NCT01032070|Astellas Pharma Global Development, Inc|Senior Medical Director, Medical Oncology||ClinicalTrials.Disclosure@us.astellas.com|
285661|NCT01032135|University of Pennsylvania|James McKay, PhD|215-746-7704|jimrache@mail.med.upenn.edu|
285662|NCT01032174|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285663|NCT01032200|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
285664|NCT01032239|Medtronic Clinical Neuromodulation|Alessandra Calabrese, PhD||alessandra.calabrese@medtronic.com|
285665|NCT01032265|Umeå University, Umeå, Sweden|Dr. Eva Samuelsson|+46706966440|eva.samuelsson@jll.se|
285666|NCT01032291|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
285667|NCT01032330|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
285668|NCT01032382|US Army Medical Materiel Development Activity (USAMMDA)|Director, Division of Regulated Activites and Compliance|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
285669|NCT01032538|Martina Hansens Hospital|Tor Kjetil Nerhus|+47 93409934|kjnerhus@gmail.com|
285671|NCT01032629|Janssen- Cilag International NV|Senior Director Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
285672|NCT01032694|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285673|NCT01032733|University of Florida|Stephen Anton|352-273-7514|santon@ufl.edu|
285674|NCT01032759|Duke University Medical Center|Dr. Ashraf Habib|9196686266|habib001@dm.duke.edu|
285675|NCT01032837|Hoffman-LaRoche|Medical Communications|800-821-8590||
285676|NCT01032850|University of New Mexico Cancer Center|Dr. Yehuda Patt, MD|505-925-0405|yzpatt@salud.unm.edu|
285677|NCT01032889|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
285678|NCT01032915|Novartis|Study Director|862-778-8300||
285679|NCT01032928|Ralph H Johnson VA Medical Center|Dr. Bonnie Martin Harris|843-792-0879|Bonnie.Martin-Harris@va.gov|
285680|NCT01032954|Brazilian Center for Studies in Dermatology|Dr Doris Hexsel|555130262633|cientifico@cbed.org.br|
285681|NCT01032993|BIDMC|Catherine Buettner, MD MPH, Assistant Professor of Medicine|617-754-9600|cbuettne@bidmc.harvard.edu|
297528|NCT01754753|The University of Sheffield|Daniel Hind - Assistant Director Sheffield Clinical Trials Research Unit|441142220707|d.hind@sheffield.ac.uk|
285682|NCT01033019|Novartis|Study Director|862-778-8300||
285683|NCT01033032|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
285684|NCT01033071|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
285685|NCT01033136|Michael E. DeBakey VA Medical Center|Dr. Ellen Teng|(713) 578-5513|Ellen.Teng@va.gov|
285686|NCT01033227|Children's Hospital Los Angeles|Dr. Thomas Coates|323 361 3841|TCoates@chla.usc.edu|
285687|NCT01033240|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
285688|NCT01033383|Yale University|Dr. Manisha Juthani-Mehta|(203)785-7571|manisha.juthani@yale.edu|
285689|NCT01033422|Can-Fite BioPharma Ltd|Zivit Harpaz|972-3-9241114|zivit@canfite.co.il|
285690|NCT01033448|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
297529|NCT01754766|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
285691|NCT01033487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285692|NCT01033565|University of Nebraska|Howard Needelman MD|4025594097|hneedelm@unmc.edu|
297530|NCT01754909|Baltimore VAMC|Dr Eric Cohen|410 605 7000|eric.cohen@va.gov|5/7182
285693|NCT01033643|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297531|NCT01754922|VA NJ Health Care System|Dr. Michael Falvo|973-676-1000|Michael.Falvo@va.gov|2423
285694|NCT01033734|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
285695|NCT01033747|Novartis Pharmaceuticals|Study Director|862 778-8300||
276642|NCT00556712|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
276643|NCT00556842|The Centre for Evidence-Based Orthopaedics|Paula McKay|905-521-2100|mckayp@mcmaster.ca|44131
276644|NCT00556894|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
276645|NCT00556933|Wright State University, Dayton, Ohio|R. Brian Stevens, MD, PhD|937-545-4817|rbstevens1@icloud.com|
276646|NCT00556946|University of California, Irvine|Kristen M. Kelly, M.D.|949-824-7103|kmkelly@uci.edu|
276647|NCT00556972|Coloplast A/S|Thais Benjamin N. Christensen, Senior Clinical Project Manager|+4549112668|dkthc@coloplast.com|
276648|NCT00556998|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285696|NCT01033773|MedStar Health Research Institute|Dr Michelle Magee|2028772383|michelle.f.magee@medstar.net|
285697|NCT01033825|Sunovion|Respiratory Medical Director|1-866-503-6351||
285698|NCT01033851|Massachusetts General Hospital|Dr. Elizabeth Hoge|6177240859|ehoge@partners.org|
285699|NCT01033864|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
276649|NCT00557076|Edward Hines, Jr VA Hospital|Dr. Theresa Pape|708-202-4953|Theresa.Pape@va.gov|
285700|NCT01033942|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
285701|NCT01034111|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285702|NCT01034137|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
285703|NCT01034163|Novartis|Study Director|862-778-8300||
285704|NCT01034176|Brigham and Women's Hospital|Dr. Anil Chandraker|617-525-8203|achandraker@partners.org|
285705|NCT01034306|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
285706|NCT01034358|Mayo Clinic|Jeanne Tung, MD|507-266-0114|tung.jeanne@mayo.edu|
285707|NCT01034397|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
285708|NCT01034462|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
285709|NCT01034527|Mayo Clinic|Dr. Timothy Hewett|513-636-5971|hewett.timothy@mayo.edu|
285710|NCT01034540|Biofortis Clinical Research (formerly Provident)|Dr. Kevin Maki, Chief Science Officer|630-516-3800|kevin.maki@mxns.com|
285711|NCT01034553|Mayo Clinic|Alexander Keith Stewart, M.B.CH.B|(480)301-4411|stewart.keith@mayo.edu|
276650|NCT00557193|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
285712|NCT01034579|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
285713|NCT01034592|Stanford University Medical Center|Jason R Gotlib, MD, Professor of Medicine (Hematology)|650-867-2823|jason.gotlib@stanford.edu|
285714|NCT01034631|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
285715|NCT01034657|Novartis|Study Director|862-778-8300||
285716|NCT01034709|QIAGEN|Kevin Modarress, PhD Senior Manager Regulatory Affairs Operations NA, Regulatory Affairs|301-944-7103|kevin.modarress@qiagen.com|
285717|NCT01035047|Wake Forest Baptist Medical Center|Erin Harper|336-716-2059|erharper@wakehealth.edu|
276651|NCT00557245|University of Washington|Dr. Connie Celum|206-520-3824|ccelum@uw.edu|
285718|NCT01035060|University of Florida|Dr. Thomas Buford|352-273-5918|tbuford@ufl.edu|
285719|NCT01035099|Weill Cornell Medicine|Rodriq Stubbs|646-962-3276|res2011@med.cornell.edu|
285720|NCT01035138|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276652|NCT00557284|IMMUNOe International Research Centers|Dr. Isaac Melamed, principle investigator|303-773-9000|melamedi@immunoe.com|
285721|NCT01035151|University of South Caroina|Jeannette Andrews|803 777 3862|j.andrews@sc.edu|
285722|NCT01035229|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
285723|NCT01035255|Novartis Pharmaceuticals|Study Director|862-778-8300||
285724|NCT01035333|Albany College of Pharmacy and Health Sciences|Dr Margaret Malone|518 694 7275|margaret.malone@acphs.edu|
276653|NCT00557310|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285725|NCT01035346|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276654|NCT00557323|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
285726|NCT01035463|University of Nebraska Medical Center|Julie M. Vose, MD|402-559-3848|jmvose@unmc.edu|
285727|NCT01035606|VA Northern California|Anthony Chen, MD|925-372-2000|anthony.chen@ucsf.edu|
285728|NCT01035658|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
285729|NCT01035749|GlaxoSmithKline|GSK Response Center|866-435-7343||
285730|NCT01035788|Department of Veterans Affairs|Dr. Louanne Davis|317-988-4523|louanne.davis@va.gov|
285731|NCT01035905|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
285732|NCT01036009|Benioff Children's Hospital at UCSF|Biljana Horn|415 476 2188|hornb@peds.ucsf.edu|
285733|NCT01036022|GlaxoSmithKline|GSK Response Center|866-435-7343||
285734|NCT01036165|EMD Serono, Inc.|Fernando Dangond, MD|781-681-2348|Fernando.dangond@emdserono.com|
285735|NCT01036321|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D.|813-745-6885|nagi.kumar@moffitt.org|
285736|NCT01036438|Molnlycke Health Care AB|Ann Larkö|+46 722 3338|ann.larko@molnlycke.com|
285737|NCT01036490|Hines VA Hospiral|David J. Leehey, M.D.|(708)2022589|david.leehey@va.gov|
285738|NCT01036529|Boston Scientific|Valerie Lucero-Cimmarusti|661-949-4745|Valerie.Lucero-Cimmarusti@bsci.com|
285739|NCT01036594|University of California, San Francisco|Dr. Terence Friedlander, MD|(415) 514-6380|Terence.Friedlander@ucsf.edu|
285740|NCT01036724|CTI Clinical Trials and Consulting|Dr. Tina Hunter, Consulting Statistician to Biosense Webster|513-619-5541|tinah@s2stats.com|
285741|NCT01036763|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285742|NCT01036802|University of North Carolina, Chapel Hill|Kenneth I. Ataga, MD|919-843-7708|kataga@med.unc.edu|
285743|NCT01037088|UCaliforniaDavis|Dr. Barth Wilsey, MD|916-843-9082|blwilsey@ucdavis.edu|
285744|NCT01037114|GlaxoSmithKline|GSK Response Center|866-435-7343||
285745|NCT01037127|GlaxoSmithKline|GSK Response Center|866-435-7343||
285746|NCT01037192|Fraser Health Authority|Anna Yuen, BSc. Pharm|604-520-4005|anna.yuen@fraserhealth.ca|
285747|NCT01037218|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
285748|NCT01037244|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
297532|NCT01755026|west virginia university|michael stitely|304-293-5631|mstitely@hsc.wvu.edu|
297533|NCT01755091|University of Illinois at Chicago|David W. Carley, PhD|312-996-3827|dwcarley@uic.edu|
285749|NCT01037309|Prosensa|Fiona Lawrence|+31(0)713322100|f.lawrence@prosensa.nl|
297534|NCT01755143|Medtronic Cardiac Rhythm and Heart Failure|5076MRI Clinical Team|1-800-328-2518|MedtronicCRMtrials@medtronic.com|
297535|NCT01755156|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285750|NCT01037413|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285751|NCT01037452|Novartis|Head New Therapeutic Opportunities|973-503-8000||
285752|NCT01037790|University of Pennsylvania|Jennifer Louie, Program Manager|267-414-6179|Jennifer.Louie2@pennmedicine.upenn.edu|
285753|NCT01037881|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
297536|NCT01755169|MUSC|Dr. Amy-Lee Bredlau|843-876-0444|bredlau@musc.edu|
285754|NCT01037985|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285755|NCT01038128|McLean Hospital|Study Coordinator|617-855-2984|eryan@mclean.harvard.edu|
285756|NCT01038297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285757|NCT01038323|Wake Forest|dennis ang|336-716-4209|dang@wakehealth.edu|
285758|NCT01038336|VA RR&D National Center for Rehabilitative Auditory Research, Portland VA Medical Center|Gabrielle Saunders Ph.D.|503-220-2862|gabrielle.saunders@va.gov|56210
285759|NCT01038427|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
285760|NCT01038557|Oregon Health & Science University|Dr. Martin A. Schreiber|503-494-8324|schreibm@ohsu.edu|
285761|NCT01038609|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
285762|NCT01038635|The University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
285763|NCT01038687|Mayo Clinic|Michael Camilleri, MD|507-266-2305|camilleri.michael@mayo.edu|
285764|NCT01038713|Dartmouth-Hitchcock Medical Center|Timothy Gardner|603-650-6472|timothy.b.gardner@hitchcock.org|
285765|NCT01038778|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|7168451300|adrienne.groman@roswellpark.org|
285766|NCT01038856|University of Oklahoma|Research Regulatory Specialist III|405-271-8777|sharon-ross@ouhsc.edu|48394
285767|NCT01038869|DermResearch, PLLC|Leon Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
285768|NCT01038921|Emory University|Dr. Abinav Goyal|404-727-8758|agoyal4@emory.edu|
285769|NCT01039207|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
285770|NCT01039376|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
285771|NCT01039428|KDL|Study Director|818058844243|toiawase@advance-cro.co.jp|
285772|NCT01039467|Fuwai Hospital|Dr. Shu Zhang|861088398833|zsfuwai@vip.163.com|
285773|NCT01039519|Synta Pharmaceuticals|VP Clinical Research|781-541-7156|aoneill@syntapharma.com|
308543|NCT03227029|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
285774|NCT01039584|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
285775|NCT01039675|GlaxoSmithKline|GSK Response Center|866-435-7343||
285776|NCT01039688|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285777|NCT01039792|UCSF|Dr. Robert Hendren|415-502-3500|STAR@ucsf.edu|
285778|NCT01040052|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
285779|NCT01040130|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285780|NCT01040169|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
285781|NCT01040208|Sprout Pharmaceuticals|Krista Barbour|9198820850|kbarbour@sproutpharma.com|
285782|NCT01040260|University of California, San Francisco|Dr. Timothy Carmody|(415) 221-4810|Timothy.Carmody@ucsf.edu|26344
276655|NCT00557349|University of Missouri|Archana Ramaswamy, MD|573-884-4003|ramaswamya@health.missouri.edu|
276656|NCT00557362|University of California San Francisco Proctor Foundation|Tom M/ Lietman|4155022662|tom.lietman@ucsf.edu|
276657|NCT00557440|Novartis Pharmaceuticals|Study Director|862-778-8300||
276658|NCT00557466|Novartis Pharmaceuticals|Study Director|862-778-8300||
276659|NCT00557492|UPMC CancerCenter|Herbert Zeh, MD|4126922852|zehxhx@upmc.edu|
276660|NCT00557505|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276661|NCT00557622|GlaxoSmithKline|GSK Response Center|866-435-7343||
276662|NCT00557830|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
276663|NCT00557856|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276664|NCT00557882|MedStar Washington Hospital Center|Andrew Sokol, MD|2028776526|andrew.i.sokol@medstar.net|
276665|NCT00557947|Ethicon Inc|John Lombard|908-218-2877|Jlombar8@its.jnj.com|
276666|NCT00558012|University of Pittsburgh|Dr. Susan Greenspan|412-692-2477|greenspn@pitt.edu|
276667|NCT00558025|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276668|NCT00558064|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285783|NCT01040351|Cairo university|Usama M.Fouda, M.D, PhD|+20123595106|umfrfouda@yahoo.com|
285784|NCT01040403|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285785|NCT01040689|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285786|NCT01040728|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285787|NCT01040780|Cancer Hospital, Chinese Academy of Medical Sciences|Yan Sun, M.D.|0086-010-87788519|zhangheping@csco.org.cn|
276669|NCT00558103|GlaxoSmithKline|GSK Response Center|866-435-7343||
276670|NCT00558246|Ethicon|Phyllis Britnell|1 908 218-3060|pbritnel@its.jnj.com|
285788|NCT01040793|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285789|NCT01040819|Baylor College of Medicine|Dr. Yochai Birnbaum|713-798-0273|ybirnbau@bcm.edu|
285790|NCT01040832|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
285791|NCT01040845|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
285792|NCT01040858|Portland VA Healthcare System|Dr. Daniel Storzbach|503-220-8262|Daniel.Storzbach@va.gov|56497
285793|NCT01040871|Johnson & Johnson Pharmaceutical Research & Development|Dr. Helgi van de Velde||HVDVELDE@ITS.JNJ.COM|
285794|NCT01041209|Hospital General de Niños Pedro de Elizalde|Dr. Fernando Torres|+54 11 43070140|slaip@intramed.net|
285795|NCT01041248|Childrens Hospital of Eastern Ontario|Dr Johannes Roth|6137377600|jroth@cheo.on.ca|1015
285796|NCT01041274|NYU Langone Medical Center|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
285797|NCT01041287|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
285798|NCT01041404|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
285799|NCT01041417|Emory University School of Medicine|Dr. Arshed Quyyumi|4047273655|aquyyum@emory.edu|
285800|NCT01041495|SUNY Upstate MEdical Univ|thomas schwartz|3154643166|schwartt@upstate.edu|
276671|NCT00558259|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285801|NCT01041521|Tufts University|Christine Wanke, Principal Investigator||christine.wanke@tufts.edu|
285802|NCT01041573|Valneva Austria GmbH|Senior Manager Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
285803|NCT01041638|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
285804|NCT01041781|Fox Chase Cancer Center|Martin J. Edelman, M.D.|(215) 728-4790|martin.edelman@fccc.edu|
285805|NCT01041859|Janssen Research&Development|Director, Clinical Leader|609-730-6777||
285806|NCT01041976|Edith Nourse Rogers Memorial VA|Lisa Mueller|781-687-3192|Lisa.Mueller@va.gov|
285807|NCT01042093|Towson Orthopaedic Associates|David F. Dalury, MD|410-337-7900|ddalury@gmail.com|1221
285808|NCT01042145|Washington University School of Medicine|Dr. Jane Garbutt|314-454-8613|jgarbutt@dom.wustl.edu|
285809|NCT01042158|Johns Hopkins University|Paul Hassoun, MD|410-614-5158|phassoun@jhmi.edu|
285810|NCT01042236|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285811|NCT01042288|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
276672|NCT00558272|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
285812|NCT01042366|University of Pittsburgh|John Kirkwood, MD|(412) 623-7707|KirkwoodJM@upmc.edu|
285813|NCT01042392|Novartis Pharmaceuticals|Study Director|862-778-8300||
285814|NCT01042496|Mayo Clinic|Dr. Mark A. Frye|507-284-6213|MFrye@mayo.edu|
285815|NCT01042509|Hospital Universitario|Dr. David Gomez-Almaguer|5281-83488510|hematohu@yahoo.com|
285816|NCT01042535|H. Lee Moffitt Cancer Center and Research Institute|Hatem Soliman, M.D.|813-745-4933|hatem.soliman@moffitt.org|
285817|NCT01042600|Albany Medical Center|Joaquim Pinheiro, MD, MPH|518-262-5421|pinheij@mail.amc.edu|
285818|NCT01042613|St. Jude Children's Research Hospital|Luis Trujillo Huaccho, MD|1-866-278-5833|info@stjude.org|
285819|NCT01042678|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
285820|NCT01042795|University of Michigan|Cheryl T. Lee|614-685-6666|cheryl.lee@osumc.edu|
285821|NCT01042938|University of Rochester Medical Center|Julie L Ryan, PhD, MPH (PI)|585-276-3862|julie_ryan@urmc.rochester.edu|
285822|NCT01042977|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
285823|NCT01043094|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
285824|NCT01043133|USUHS|Ronald W. Gimbel|301-295-3077|rgimbel@usuhs.mil|
285825|NCT01043146|Corimmun, GmbH|Gary Peters, MD, Managing Director|001-215 628-5257|gpeters7@its.jnj.com|
276673|NCT00558285|Novartis Pharmaceuticals|Study Director|862-778-8300||
276674|NCT00558363|GlaxoSmithKline|GSK Response Center|866-435-7343||
276675|NCT00558428|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276676|NCT00558467|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276677|NCT00558519|University of Chicago|Wendy Stock, MD|773-834-8982|wstock@medicine.bsd.uchicago.edu|
285826|NCT01043185|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
285827|NCT01043393|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
285828|NCT01043432|Rocky Mountain MIRECC|Lisa A. Brenner|303-399-8020|lisa.brenner@va.gov|2571
285829|NCT01043523|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
285830|NCT01043562|Vanderbilt University (current institution)|Dr. Andrew E. Radbill|615-322-7447|andrew.radbill@vanderbilt.edu|
285831|NCT01043640|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
285832|NCT01043653|VISN 5 MIRECC|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
285833|NCT01043705|Medtronic plc|Lynn Landborg, Clinical Research Manager|763 526 2877|lynn.landborg@medtronic.com|
285834|NCT01043874|Novartis Pharmaceuticals|Study Director|862-778-8300||
285835|NCT01043926|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285836|NCT01043939|Masonic Cancer Center, University of Minnesota|Cindy K. Blair, MPH|612-624-9668|blair016@umn.edu|
285837|NCT01044030|Boston Children's Hospital|Louis Vernacchio, MD, MSc|617-919-4283|louis.vernacchio@childrens.harvard.edu|
285838|NCT01044212|University of Rochester|Gunhilde Buchsbaum, Division Director Urogynecology|585-273-3233|gunhilde_buchsbaum@urmc.rochester.edu|
285839|NCT01044264|Perrigo Company|Manager|718-960-0119|jonathan.schwartz@perrigo.com|
285840|NCT01044290|HSRD, Durham VAMC|Karen Steinhauser, PhD|919 668-2148|karen.steinhauser@duke.edu|
285841|NCT01044303|East Carolina University|Dr. Paul Bolin|252-744-3773|bolinp@ecu.edu|
285842|NCT01044433|Abramson Cancer Center|Dr. Corey Langer|215-615-5121|Corey.Langer@uphs.upenn.edu|
285843|NCT01044459|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
285844|NCT01044498|Hoffmann-La Roche|Medical Communications|800 821-8590||
276678|NCT00558571|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285845|NCT01044537|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285846|NCT01044576|Imperial College London|Professor Paolo Muraro|02075946670|p.muraro@imperial.ac.uk|
285847|NCT01044589|Cleveland Clinic|Dr. Massarat Zutshi|(216) 444-3540|zutshim@ccf.org|
285848|NCT01044693|Vanderbilt University|Italo Biaggioni MD|615-936-3420|italo.biaggioni@vanderbilt.edu|
297537|NCT01755195|National Cancer Institute|Dr. Alice Chen|240-781-3274|chenali@mail.nih.gov|
297538|NCT01755234|Northwestern University|Gildasio De Oliveira|312-695-4858|g-jr@northwestern.edu|
297539|NCT01755416|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
297540|NCT01755455|Dartmouth-Hitchcock Medical Center|Alex H. Gifford, M.D.|603-650-5533|alex.h.gifford@hitchcock.org|
297541|NCT01755546|BIODELIVERY|Vice President, Operations|919-582-0294|twarneke@bdsi.com|
297542|NCT01755598|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
297543|NCT01755637|GlaxoSmithKline|GSK Response Center|866-435-7343||
297544|NCT01755702|GlaxoSmithKline|GSK Response Center|866-435-7343||
297545|NCT01755767|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
297546|NCT01755858|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
297547|NCT01755949|Mayo Clinic|Joseph L. Blackshear, Principal Investigator|904-953-7279|blackshear.joseph@mayo.edu|
276679|NCT00558636|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
297548|NCT01756053|Center for Interdisciplinary Research on Nicotine Addiction|Benjamin Albelda (Project Manager)|2157467173|albeldab@mail.med.upenn.edu|
308544|NCT03091192|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
308545|NCT02871934|VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA|Dr. Jason Vassy|857-364-2561|jvassy@partners.org|
308546|NCT02859558|ACTG Network Coordinating Center, Social and Scientific Systems, a DLH Holdings Company|ACTG Clinicaltrials.gov Coordinator|(301) 628-3348|ACTGCT.gov@fstrf.org|
308547|NCT02818920|Duke University|Neal Ready, MD, PhD|919-681-6932|neal.ready@duke.edu|
308548|NCT02481310|Northwestern University|Barbara Pro, MD|312-695-6832|barbara.pro@northwestern.edu|
308549|NCT02343952|Hoosier Cancer Research Network|Annesha Majumdar|3179212050|amajumdar@hoosiercancer.org|
308550|NCT02326155|Celltrion Inc|JiWoong Lim|82-32-850-5702|jiwoong.lim@celltrion.com|
308551|NCT02304367|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
276680|NCT00558701|USAISR|Leopoldo C. Cancio, COL, MC|210-916-3301|leopoldo.c.cancio.mil@mail.mil|
276681|NCT00558753|Rush University Medical Center|Asokumar Buvanendran, M.D.|(312) 942-3685|asokumar@aol.com|
276682|NCT00558792|Bracco Diagnostics Inc|Usha Halemane, Executive Director of Medical Biometrics and Medical Writing|609-514-2578|usha.halemane@diag.bracco.com|
276683|NCT00558831|Northwestern University|Amy Paller, MD|312-695-6829|apaller@nmff.org|
276684|NCT00558844|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
276685|NCT00558896|Mayo Clinic|Dr. Martha Lacy||lacy.martha@mayo.edu|
276686|NCT00559013|Synovis|Lesa Hobright-Turner, Director of Clinical Affairs|651-796-7506|lesa.hobrightturner@synovissurgical.com|
276687|NCT00559104|City of Hope National Medical Center|Dr. Auayporn Nademanee|626-256-4673|anademanee@coh.org|62691
276688|NCT00559273|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
276689|NCT00559364|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
276690|NCT00559377|UWMC Dept of Radiology|Joseph G Rajendran|206-221-4421|rajan@u.washington.edu|
276691|NCT00559468|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285849|NCT01044706|Kremers Urban Development Company|Bang Qian Xu, Ph.D., Director of Biopharmaceutics|812-523-5453|Bang.xu@ucb.com|
285850|NCT01044732|Avantis Medical Systems|Jack Higgins, MD - Chief Medical Officer|6508239216|jhiggins@avantismedical.com|
285851|NCT01044745|University of Nebraska Medical Center|R. Gregory Bociek, MD|402-559-5388|rgbociek@unmc.edu|
285852|NCT01044758|Johns Hopkins University School of Medicine|Gregory Krauss, M.D.|(410) 955-2822|gkrauss@jhmi.edu|
285853|NCT01044771|Metropolis Medical|Dr. Fritz Bredeek|415 292 5477|fritz@doctor.com|
276692|NCT00559507|Memorial Sloan-Kettering Cancer Center|Clifford Hudis, MD|646-888-4551|hudisc@mskcc.org|
285854|NCT01044862|Yale University|Heping Zhang, PhD|203-785-5185|heping.zhang@yale.edu|
285855|NCT01044966|Medical University of South Carolina|Dr. Bruce Frankel|8437922052|frankel@musc.edu|
285856|NCT01045031|Health and Prevention Center, Sanatorium Hera, Vienna, Austria|Dr. Robert Winker|0043(1)-31350|robert.winker@hera.co.at|45666
285857|NCT01045057|Atos Medical AB|Director of Clinical Affairs|+1 352 870 0872|Corina.van.As@atosmedical.com|
285858|NCT01045096|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
285859|NCT01045122|University of Rochester Medical Center|Dr. Suzanne Karan|585-275-5161|Suzanne_Karan@urmc.rochester.edu|
285860|NCT01045135|Akershus University Hospital|Dr.Jette Stær-Jensen, Dr. Franziska Siafarikas|+47-6796000|jett@ahus.no|
297549|NCT01756079|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285861|NCT01045161|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
285862|NCT01045174|University Hospitals Cleveland Medical Center|Dr. Jerri Rose|216-844-7147|jerri.rose@uhhospitals.org|
285863|NCT01045187|Xoft, Inc.|Kelly W Elliott RN, MS|408-419-2428|Kelliott@xoftinc.com|
285864|NCT01045265|Maple Leaf Research|Tony Antoniou|4164657936|tantoniou@smh.toronto.on.ca|
285865|NCT01045421|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
285866|NCT01045447|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
285867|NCT01045460|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
297550|NCT01756157|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
285868|NCT01045499|Columbia University|Jeffrey Zitsman, MD|212-305-8862|jlz2@cumc.columbia.edu|
285869|NCT01045551|Columbia University Medical Center|Julian Mackay-Wiggan, MD, MS|212-305-6953|jc299@cumc.columbia.edu|
285870|NCT01045707|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
285871|NCT01045798|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285872|NCT01045967|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
285873|NCT01045993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
285874|NCT01046084|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
285875|NCT01046110|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
285876|NCT01046136|Reckitt Benckiser|Kim Clark|855.966.5483|ClinicalRequests@rb.com|
285877|NCT01046253|TEVA Pharmaceuticals, USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
285878|NCT01046396|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
285879|NCT01046565|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
285880|NCT01046643|The University of Michigan|Dr. Yolanda Smith|(734) 936-7401|ysmith@med.umich.edu|
285881|NCT01046669|Spectral Diagnostics Inc.|Debra Foster, VP Clinical Development|4166263233|dfoster@spectraldx.com|2001
285882|NCT01046682|UHospitalsCleveland|Grace McComsey, MC|216-844-3607|mccomsey.grace@clevelandactu.org|
308552|NCT01810705|Erytech Pharma|Anne-Sophie Clermont|+33 4 78 78 15 70|anne-sophie.clermont@erytech.com|
285883|NCT01046695|Mayo Clinic|Deborah J. Engen, OT, CMT|507-255-5504|engen.deborah@mayo.edu|
285884|NCT01046877|Acclarent|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
276693|NCT00559585|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
276694|NCT00559637|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
276695|NCT00559754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
276696|NCT00559845|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
276697|NCT00559936|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-3313|cornea_research@meei.harvard.edu|
276698|NCT00559949|UNC Lineberger Comprehensive Cancer Center|Dr. David Neil Hayes|919-966-3786|hayes@med.unc.edu|
276699|NCT00559962|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867||
276700|NCT00559988|Biotronik, Inc|Crystal Miller|503-451-8051|crystal.miller@biotronik.com|
276701|NCT00560066|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
276702|NCT00560105|VA WNY Health Care System|Dr. S. Sethy|716-862-7875|ssethi@buffalo.edu|
276703|NCT00560235|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276704|NCT00560313|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
276705|NCT00560352|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
276706|NCT00560391|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
276707|NCT00560404|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
276708|NCT00560417|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276709|NCT00560508|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276710|NCT00560560|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285885|NCT01046903|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285886|NCT01047007|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285887|NCT01047189|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wfubmc.edu|
285888|NCT01047241|Copenhagen University Hospital, Rigshospitalet|Sponsor's contact person Bettina Nygaard Nielsen|+45 35459546|bettina.nygaard.nielsen@regionh.dk|
285889|NCT01047293|Huntsman Cancer Institute|Sunil Sharma|801-587-5559|sunil.sharma@hci.utah.edu|
297551|NCT01756209|Pugliese Hospital of Catanzaro|Dr Francesco Peltrone, Responsible of clinical trial|+.39 0961 7123222|gallelli@unicz.it|
297552|NCT01756235|AbbVie|Global Medical Information|800-633-9110||
285890|NCT01047306|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
285891|NCT01047332|Brigham and Women's Hospital|Dr. David L. Carr-Locke, MD, FRCP||dcarrlocke@chpnet.org|
276711|NCT00560573|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285892|NCT01047345|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285893|NCT01047358|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285894|NCT01047436|Xidea Solutions Limited|Dr D Bendel||daryl@xideasolutions.com|
285895|NCT01047475|Microbio / Sophie Chang|Director of Clinical Trials|886-2-2570-5596|sophie_chang@fountainmab.com|556
285896|NCT01047527|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
285897|NCT01047553|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
285898|NCT01047709|University of Michigan|Devin Brown, MD|7349369075|devinb@umich.edu|
285899|NCT01047839|Valneva Austria GmbH|Senior Scientist Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
285900|NCT01048099|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
285901|NCT01048242|University of Pennsylvania|Nalaka Gooneratne|215 349 5938|ngoonera@mail.med.upenn.edu|
285902|NCT01048333|Astra Zeneca|Gerard Lynch|+44 1509 645895|ClinicalTrialTransparency@astrazeneca.com|
285903|NCT01048424|University of California, San Francisco|Alison Huang, MD|415-353-9751|ahuang@medicine.ucsf.edu|
285904|NCT01048502|UPenn|Muredach Reilly|215-573-1214|muredach@mail.med.upenn.edu|
285905|NCT01048541|Coloplast|Kristine Gjødsbøl, PhD|+4549113557|dkkg@coloplast.com|
285906|NCT01048593|Eyepoint Pharmaceuticals, Inc.|Regulatory Affairs Specialist|6179726318|dbauer@eyepointpharma.com|
297553|NCT01756274|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
285907|NCT01048606|Université de Sherbrooke|Pr Isabelle Dionne, Ph.D., vice-dean to research and graduate studies|1-819-821-8000|isabelle.dionne@usherbrooke.ca|63327
285908|NCT01048658|Oregon Health & Science University|Dr. Rosenne Botha|503-494-3666|whru@ohsu.edu|
285909|NCT01048671|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285910|NCT01048697|Texas Tech UHSC|Ronald Hall|214-654-9404|ronald.hall@ttuhsc.edu|
285911|NCT01048788|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
285912|NCT01048866|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
285913|NCT01048879|University of Michigan|Bruce A. Mueller|7346154578|muellerb@umich.edu|
285914|NCT01048905|Emory University School of Medicine|Claudia R. Morris MD, FAAP|404-727-5500|claudia.r.morris@emory.edu|
285915|NCT01048944|Southern Illinois University Carbondale|David G. Gilbert, Ph.D.|618-45303558|dgilbert@siu.edu|
285916|NCT01049009|Emory University School of Medicine|Dr. Arshed A. Quyyumi|404-727-3655|aquyyum@emory.edu|
285917|NCT01049217|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285918|NCT01049243|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-1877|sfeldman@wfubmc.edu|
285919|NCT01049308|VA Loma Linda Healthcare System|Dr Helme Silvet|9095836097|helme.silvet@va.gov|
285920|NCT01049334|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
285921|NCT01049360|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
276712|NCT00560612|Durham VA Medical Center|Christine Marx, MD|919 286-0411|marx0001@mc.duke.edu|7426
276713|NCT00560703|Organization: Galderma R&D, Inc|Michael Graeber|609-409-7701|clinicaltrials@galderma.com|
276714|NCT00560755|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276715|NCT00560794|Amgen Inc.|Study Director|866-572-6436||
276716|NCT00560833|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276717|NCT00560859|University of Pennsylvania|Dr. Susan S. Ellenberg|215-573-3904|sellenbe@upenn.edu|
276718|NCT00560885|AtriCure, Inc.|Jim Lucky|1-513-755-4101|jlucky@atricure.com|
276719|NCT00560937|Durham Veterans Affairs Medical Center|Christine E. Marx, MD, MA|919 286-0411|marx0001@mc.duke.edu|7426
276720|NCT00560950|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
276721|NCT00561002|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
276722|NCT00561015|Janssen Research & Development, LLC|Clinical Leader|609-730-3174||
276723|NCT00561080|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
285922|NCT01049373|PASCOE pharmazeutische Präparate GmbH|Dr. Gabriele Weiss|0049/641/7960-0|klinischeforschung@pascoe.de|
285923|NCT01049412|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285924|NCT01049503|Bauru Dental School/University of São Paulo|Dr. Marília Buzalaf|+55 14 32358346|mbuzalaf@fob.usp.br|
285925|NCT01049581|ChangGungMH|Dr Chia- Ling Chen|886-3-3281200|clingchen@gmail.com|3846
285926|NCT01049776|Illinois CancerCare, P.C.|Sachdev Thomas, M.D.|309-243-3000|sthomas@illinoiscancercare.com|
285927|NCT01049802|The Rehabilitation Institute of Chicago|Richard L. Harvey, MD|312-238-1000|rharvey@ric.org|
285928|NCT01049919|Zimmer Biomet|Hillary Overholser|574-373-2042|hillary.overholser@zimmerbiomet.com|
285929|NCT01049945|Mayo Clinic|Shaji K. Kumar, M.D.||kumar.shaji@mayo.edu|
285930|NCT01049984|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
276724|NCT00561145|Wageningen University|Dr Lisette de Groot|+31-317482220|lisette.degroot@wur.nl|
285931|NCT01050062|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
285932|NCT01050153|Denver Health Medical Center|Ernest E. Moore|303.602.1820|Ernest.Moore@dhha.org|
285933|NCT01050205|University of Pittsburgh|Dr. Andrea Kriska|412-383-1286|aky@pitt.edu|
285934|NCT01050231|University of California Irvine|Dr David Reinkensmeyer|(949) 824-5218|dreinken@uci.edu|
285935|NCT01050257|Hoffman-LaRoche|Medical Communications|800-821-8590||
285936|NCT01050530|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
285937|NCT01050543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
285938|NCT01050569|University of Minnesota|Dorothy Hatsukami|612 626-2121|hatsu001@umn.edu|
285939|NCT01050582|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Clinical Leader|609-730-6581||
285940|NCT01050634|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285941|NCT01050647|Stanford University|Dr. Anna Girsen|6507255720|agirsen@stanford.edu|
285942|NCT01050660|Yale University|Dr. Orly Levit|203-688-2320|orly.levit@yale.edu|
285943|NCT01050673|Northwestern Medical Faculty Foundation|Dr Robert D Galiano, Assistant Professor of Surgery|312-695-6022|rgaliano@nmh.org|
285944|NCT01050764|Stanford University Medical Center|Everett H Meyer, MD, PhD; Assistant Professor of Medicine|650-725-5816|evmeyer@stanford.edu|
285945|NCT01050790|Virginia Commonwealth University/Massey Cancer Center|Amir A. Toor, MD, Associate Professor of Medicine|804-828-4360|atoor@mcvh-vcu.edu|
285946|NCT01050816|Eulji General Hospital|Lee Gyeong Tae|+82-11-214-3323|lkt2408@hanmail.net|
285947|NCT01050907|Fast-Track Drugs and Biologics, LLC|Jonathan D. Berman|301-922-2097|jberman@fasttrackresearch.com|
285948|NCT01050946|Medical College of Wisconsin|Jeanne Palmer,MD|414-805-6800|jpalmer@mcw.edu|
297554|NCT01756300|Biosense Webster, EMEA|Liesbeth Vanderlinden, Manager Clinical Research|+32(0)2 7463527|lvanderl@its.JNJ.com|
297555|NCT01756352|Brigham and Women's Hospital|Marcelo DiCarli, MD|(617) 732-6290|mdicarli@bwh.harvard.edu|
297556|NCT01756391|Boston Children's Hospital|Wanda Phipatanakul|617-355-6117|wanda.phipatanakul@childrens.harvard.edu|
297557|NCT01756456|Dompè|Flavio Mantelli, MD, PhD|+3902583831|info@dompe.com|
297558|NCT01756833|University of Maryland School of Medicine|Michael L. Terrin, MDCM, MPH, Contact Principal Investigator|410-706-6139|mterrin@som.umaryland.edu|
297559|NCT01756846|University Medical Center Utrectht|Dr. Judith Poldervaart|008875 55105|j.poldervaart@umcutrecht.nl|
297560|NCT01756885|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@pennmedicine.upenn.edu|
297561|NCT01756898|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
297562|NCT01756976|Haemonetics|Clinical Project Manager|781-356-9595|michael.dioguardi@haemonetics.com|
297563|NCT01757067|University of Maryland Medical Center|Dr. Timm-Michael Dickfeld|410-328-7801|Tdickfel@som.umaryland.edu|
297564|NCT01757171|Weill Cornell Medical College|Navjot Kaur, GI Program Manager|646-962-9350|nak2028@med.cornell.edu|
297565|NCT01757184|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
297566|NCT01757197|Weill Cornell Medicine|Usama Gergis, MD|(212) 746-2119|usg2001@med.cornell.edu|
297567|NCT01757275|AstraZeneca|Huifang Chen|+86 21 60301335|ariel.chen@astrazeneca.com|
297568|NCT01757288|UT Southwestern Medical Center|Dr. Yuanyuan Zhang|214-648-6764|Yuanyuan.Zhang@UTSouthwestern.edu|
297569|NCT01757301|Richard L. Roudebush VA Medical Center|Erica Evans|317-988-3476|erica.evans2@va.gov|
297570|NCT01757392|Nielsen Biosciences, Inc|David Burney|858-571-2726|david@nielsenbio.com|
276725|NCT00561340|University of Nebraska Medical Center|Christopher Kratochvil|4025526005|ckratoch@unmc.edu|
276726|NCT00561353|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
276727|NCT00561392|Novartis Pharmaceuticals|Study Director|862 778-8300||
276728|NCT00561418|The Ohio State University Comprehensive Cancer Center|Craig Hofmeister, MD|614-293-9869|craig.hofmeister@osumc.edu|
276729|NCT00561431|University of Alabama at Birmingham|Ashita Tolwani, M.D.|2059752021|atolwani@uab.edu|
276730|NCT00561457|Bard Peripheral Vascular|Director of Clinical Affairs|480-303-2644|John.Reviere@crbard.com|
276731|NCT00561470|sanofi-aventis|International Clinical Development Study Director||contact-us@sanofi.com|
276732|NCT00561574|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276733|NCT00561600|DePuy Orthopaedics|Dave Whalen Clinical Portfolio Leader|574-372-7028|dwhalen@its.jnj.com|
276734|NCT00561652|Minneapolis VA Medical Center|Dr. Howard Fink|612-467-3304|howard.fink@va.gov|
297571|NCT01757405|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
297572|NCT01757561|FirstSunYetSen|Juan-ying Guo|8602087755766(8273)|gjunying@aliyun.com|
297573|NCT01757678|HeartFlow|VP Clinical, Quality & Regulatory Affairs|650-241-1221|clinicalresearch@heartflow.com|
297574|NCT01757691|Novartis|Study Director|862-778-8300||
297575|NCT01757704|Lunds University|Dr. Bansi Koul|+4646171649|bansi.koul@skane.se|
297576|NCT01757717|Memorial Sloan Kettering Cancer Center|Josh Yamada, MD|212-639-2950|yamadaj@mskcc.org|
297577|NCT01757821|University of Minnesota|James Carey|612-626-2746|carey007@umn.edu|
297578|NCT01757847|VA San Diego Healthcare System|Niloofar Afari, PhD|858-642-3387|niloofar.afari@va.gov|
276735|NCT00561678|Icahn School of Medicine at Mount Sinai|Dr. Stacie Deiner|212-241-7749|stacie.deiner@mountsinai.org|
297579|NCT01757964|University of Washington|David Suskind MD Professor of Pediatrics|206-987-2521|Jani.Klien@seattlechildrens.org|
297580|NCT01758289|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
297581|NCT01758432|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
285949|NCT01050998|MedImmune, LLC|Marius Albulescu, Associate Medical Director|301-398-0000|albulescum@medimmune.com|
285950|NCT01051063|GlaxoSmithKline|GSK Response Center|866-435-7343||
285951|NCT01051310|Medtronic|M. Hollander|+31620534428|maarten.hollander@medtronic.com|
285952|NCT01051323|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
285953|NCT01051349|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
285954|NCT01051440|Steward St. Elizabeth's Medical Center|Tara Lauriat|617-789-2404|tara.lauriat@steward.org|
297582|NCT01758523|University of Connecticut School of Medicine|Dr. Jonathan Covault|860-679-7560|jocovault@uchc.edu|
285955|NCT01051466|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285956|NCT01051518|Medtronic|M. Hollander|+31620534428|maarten.hollander@medtronic.com|
285957|NCT01051557|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley|212-639-5122|kaleyt@mskcc.org|
285958|NCT01051570|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath M.D.|313-576-8717|vaishamu@karmanos.org|
285959|NCT01051596|Georgetown University|Michael Pishvaian, MD, PhD|202-444-2223|pishvaim@georgetown.edu|
285960|NCT01051661|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
285961|NCT01051739|Iowa City Veterans Administration Medical Center|Michael Wall, M.D.|319-3380581|michael-wall@uiowa.edu|
285962|NCT01051778|Cairo university|Usama .M .Fouda|+20123595106|umfrfouda@yahoo.com|
285963|NCT01051791|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
285964|NCT01051817|Novartis Pharmaceuticals|Study Director|862-778-8300||
285965|NCT01051856|Mayo Clinic|Florencia G. Que, MD|507-284-6178|que.florencia@mayo.edu|
276736|NCT00561730|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
276737|NCT00561821|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276738|NCT00561834|Rocky Mountain Lions Eye Institute, Dept. of Ophthalmology|Dr. Naresh Mandava, M.D.|720-848-2500|Naresh.mandava@ucdenver.edu|
276739|NCT00561925|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276740|NCT00561951|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
276741|NCT00561977|UMass Medical School|Barbara Olendzki, RD MPH LDN|508-856-5195|barbara.olendzki@umassmed.edu|
276742|NCT00562094|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
276743|NCT00562120|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276744|NCT00562159|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
276745|NCT00562302|Angiotech|Thomas Doyle|352.338.0440|tdoyle@angio.com|
276746|NCT00562315|Emory University|David M. Schuster, MD|404-712-4859|dschust@emory.edu|
276747|NCT00562328|Mayo Clinic|Timothy G. Call, M.D.|507-266-4671|Call.Timothy@mayo.edu|
276748|NCT00562354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276749|NCT00562484|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
285966|NCT01051960|University of California, Los Angeles|Rajan Saggar, MD|(310) 794-9718|rsaggar@mednet.ucla.edu|
285967|NCT01051986|Seoul National University Hospital|Ki-Bong Kim|+82-2-2072-3482|kimkb@snu.ac.kr|
285968|NCT01052012|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
285969|NCT01052038|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
285970|NCT01052077|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
285971|NCT01052103|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
285972|NCT01052116|ALA - ACRC|Robert A. Wise|(410) 550-0545|rwise@jhmi.edu|
285973|NCT01052207|CHOA/Emory|Dr. Kiran Hebbar|404-785-6135|khebbar@emory.edu|
285974|NCT01052272|University of Alabama at Birmingham|Louis . J. Dell'Italia, M.D|205-934-3969|Dell'Italia@PHYSIOLOGY.UAB.EDU|
285975|NCT01052428|University of Alabama at Birmingham|Louis J. Dell'Italia, M.D.|205-934-0850|loudell@uab.edu|
285976|NCT01052480|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
285977|NCT01052493|Imperial College London|Dr Tricia Tan|020 83838038|t.tan@imperial.ac.uk|
285978|NCT01052545|Michael E. DeBakey VA Medical Center|Barbara Trautner, MD, PhD|713-440-4438|barbar.trautner@va.gov|
285979|NCT01052662|University of Massachusetts Medical School|Gerardo Gonzalez, MD|508 856 6480|gerardo.gonzalez@umassmed.edu|
285980|NCT01052701|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410) 614-8762|ejfuchs@jhmi.edu|
285981|NCT01052714|Psychiatry Department at VA Greater Los Angeles Healthcare System|Dr. Donna Ames, Principal Investigator|310-478-3037|donna.ames@va.gov|
285982|NCT01052779|AMAG Pharmaceuticals, Inc.|Medical Information|1-877-411-2510|amag@druginfo.com|
285983|NCT01052831|University of Pennsylvania|Dr. Daniel Weintraub|12153498389|Daniel.Weintraub@uphs.upenn.edu|
285984|NCT01052844|Faculdade de Medicina do ABC|Felipe Melo Cruz|+55+11+27595914|felipemcruz@yahoo.com.br|
285985|NCT01052948|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285986|NCT01053000|Roger H. Stewart MD PA|Barry Galitzer MD|954-491-0510|barry@galitzer.com|
285987|NCT01053013|The Rogosin Institute|Betty-Jane Sloan, Clinical Research Manager|646-317-0701|bjsloan@nyp.org|
285988|NCT01053078|University of Minnesota|Elizabeth Seaquist|612 624 9176|seaqu001@umn.edu|
285989|NCT01053156|MIND Institute, University of California Davis Medical Center|Randi J. Hagerman MD, Medical Director of the MIND Institute|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu|
285990|NCT01053247|Fougera Pharmaceuticals Inc|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
285991|NCT01053312|GE Healthcare|Paul Sherwin, MD|1-609-514-6820|paulsherwin@ge.com|
297583|NCT01758588|Weill Cornell Medicine|Assistant Director of Leukemia and BMT Clinical Trials|646-962-9305|ell2028@med.cornell.edu|
285992|NCT01053429|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
285993|NCT01053507|Clinvest/A Division of Banyan Group, Inc.|Dr. Roger K. Cady|417-841-3673|jtarrasch@clinvest.com|
285994|NCT01053663|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
285995|NCT01053741|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410)614-8762|ejfuchs@jhmi.edu|
285996|NCT01053819|University of Alabama at Birmingham|Boni Elewski, MD|205-502-9960|beelewski@gmail.com|
285997|NCT01053897|Garnet BioTherapeutics, Inc.|Gerri Henwood, CEO|484-395-2440|ghenwood@garnetbio.com|
285998|NCT01053962|Synergy Pharmaceuticals Inc|Dr. Laura Barrow/Senior Vice President Clinical Development|212-297-0020|lbarrow@synergypharma.com|
285999|NCT01053988|GlaxoSmithKline|GSK Response Center|866-435-7343||
286000|NCT01054079|Comprehensive Cancer Center of Wake Forest University|Dr. K.C. Balaji|336-618-2272|kbalaji@wakehealth.edu|
286001|NCT01054144|Moffitt Cancer Center|Rachid Baz, MD|813-745-3163|Rachid.Baz@moffitt.org|
286002|NCT01054170|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
286003|NCT01054183|Akron Children's Hospital|Michael T. Bigham, MD|330-543-8639|MBigham@chmca.org|
286004|NCT01054209|Brighton and Sussex University Hospitals Trust|Dr Mark Harper|01273696955|mark.harper@bsuh.nhs.uk|4307
286005|NCT01054222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286006|NCT01054300|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286007|NCT01054339|Applied Genetic Technologies Corp.|Ellery D. Mangas|386-462-7106|emangas@agtc.com|
286008|NCT01054404|Northwestern University|Dr. John F. Bebawy, Assistant Professor of Anesthesiology & Neurological Surgery|312-695-0061|j-bebawy@northwestern.edu|
276750|NCT00562588|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276751|NCT00562627|Baerum Hospital|Ulrich Johannes Spreng|004798499184|ulispreng@hotmail.com|
276752|NCT00562718|UT Southwestern Medical Center|ann spangler|(214) 648-3111|ResearchRegistry@utsouthwestern.edu|
276753|NCT00562861|Tufts Medical Center|Nassir Ghaemi|6176365735|nghaemi@tuftsmedicalcenter.org|
276754|NCT00562965|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276755|NCT00562978|City of Hope National Medical Center|Dr. Auayporn Nademanee|626-256-4673|ANademanee@coh.org|82405
276756|NCT00563186|University of Calgary|Dr. John Conly|403-944-8090|John.Conly@albertahealthservices.ca|
276757|NCT00563290|The Ohio State University Comprehensive Cancer Center|Thomas Olencki, DO|614-293-2886|Thomas.Olencki@osumc.edu|
276758|NCT00563316|Amgen Inc.|Study Director|866-572-6436||
276759|NCT00563368|Vivus, Inc.|Wesley W. Day PhD|650-934-5200|day@vivus.com|
276760|NCT00563381|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
276761|NCT00563706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276762|NCT00563784|UT MD Anderson Cancer Center|Dr. Steven H. Lin/Radiation Oncology|713-563-8490|shlin@mdanderson.org|
286009|NCT01054443|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
286010|NCT01054456|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
286011|NCT01054560|Covidien|Director of Clinical Affairs|9498373700||
286012|NCT01054573|Janssen Research & Development, LLC|Medical Leader|1 609 730-3174||
286013|NCT01054586|GlaxoSmithKline|GSK Response Center|866-435-7343||
286014|NCT01054599|VA New York Harbor Healthcare System, NYU|Beth Leeman-Markowski, MD|212-686-7500|beth.leeman-markowski@nyumc.org|
286015|NCT01054625|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
286016|NCT01054703|Acclarent|Laura England, Manager-Clinical Research|650-687-4466|lenglan1@its.jnj.com|
286017|NCT01054729|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
286018|NCT01054742|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
286019|NCT01054768|Children's Hospital & Research Center at Oakland|Ashutosh Lal, MD|5104283172|ashutosh.lal@ucsf.edu|
286020|NCT01054820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286021|NCT01054846|Parkview Health|Thein Zhu|260-266-1279|thein.zhu@parkview.com|
286022|NCT01054885|GlaxoSmithKline|GSK Response Center|866-435-7343||
286023|NCT01054911|University of Alabama in Birmingham, Comprehensive Cancer Center|Dr. James Posey, MD|205-934-0916|jposey@uabmc.edu|
286024|NCT01054976|Jan-Cil Korea|Business Unit Director|82 2 2094-4537||
286025|NCT01055028|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
286026|NCT01055067|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
286027|NCT01055132|Johnson & Johnson Vision Care|Ross Franklin|1-904-443-1379|RFrankl1@its.jnj.com|
286028|NCT01055171|Medical University of South Carolina|Dr. Michael Saladin|843-792-5306|saladinm@musc.edu|
286029|NCT01055184|University of Rochester|Dr. John J. Treanor|585-275-5871|john_treanor@urmc.rochester.edu|
286030|NCT01055197|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
286031|NCT01055223|GlaxoSmithKline|GSK Response Center|866-435-7343||
286032|NCT01055262|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
286033|NCT01055314|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
286034|NCT01055457|Johson & Johnson Vision Care Inc.|Kristy Canavan, O.D.- PRINCIPAL RESEARCH OPTOMETRIST, Clin Ops|904-443-3500|KCANAVA2@its.jnj.com|
286035|NCT01055496|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276763|NCT00563797|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|203-932-5711|elizabeth.ralevski@yale.edu|4282
286036|NCT01055613|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D.- Research Principle Optometrist|904-443-1290|BPALL@its.jnj.com|
286037|NCT01055639|VA San Diego Healthcare System|Dr. Julie Wetherell|858-552-8585|jwetherell@ucsd.edu|2752
297584|NCT01758731|University of Colorado, Denver|Dr. David Raben|303-724-3027|david.raben@ucdenver.edu|
286038|NCT01055704|Mayo Clinic|Dr Michael Camilleri|5072662305|camilleri.michael@mayo.edu|
286039|NCT01055769|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286040|NCT01055782|Specialist Doctors Rolighedsvej|Lene Hendel MD|+4545819090|lene@hendel.dk|
286041|NCT01055834|Eisai Co., Ltd.|Kenya Nakai, Study Director|+81-3-3817-3865|k3-nakai@hhc.eisai.co.jp|
286042|NCT01055886|VA Medical Center|Angela Kirby|919-286-0411|angela.kirby@va.gov|5526
286043|NCT01056016|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|5136368296|jeff.epstein@cchmc.org|
286044|NCT01056107|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
286045|NCT01056198|Healthpoint Biotherapeutics|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
286046|NCT01056263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286047|NCT01056276|Sarah Cannon Development Innovations|Charles Davis, RAC||charles.davis2@scri-innovations.com|
286048|NCT01056289|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297585|NCT01758900|Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine|Zhizheng Ge, MD. Ph.D. Director of the Clinical Trials|86-21-68383015|zhizhengge@yahoo.com.cn|
276764|NCT00564018|UT Southwestern Medical Center|Soumya Adhikari, MD|214 456 5959|soumya.adhikari@utsouthwestern.edu|
276765|NCT00564070|Behavioral Medicine Service, Massachusetts General Hospital|Dr. Steven Safren|(305) 284-2818|ssafren@miami.edu|
276766|NCT00564265|Hospital de La Serena|Dr. Marcelo A. Beltran|56 - 51 - 485923|beltran_01@yahoo.com|
276767|NCT00564278|Columbia Univ Med Center and New York State Psychiatric Institute|Roberto Lewis-Fernandez, MD, Professor of Psychiatry CUMC - NYSPI|646-774-8102|rlewis@nyspi.columbia.edu|
276768|NCT00564395|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
276769|NCT00564447|Inspire Pharmaceuticals, Inc.|Director of Clinical Research|010-941-9777|kkuhn@inspirepharm.com|
276770|NCT00564486|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
276771|NCT00564629|Mallinckrodt Pharmaceuticals|Lawrence Hill|(908) 238-6370|lawrence.hill@mallinckrodt.com|
276772|NCT00564681|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
276773|NCT00564733|University of Washington|Keith D. Eaton, MD, PhD|2062886249|kdeaton@uw.edu|
276774|NCT00564850|Ipsen|Medical Director, Endocrinology||clinical.trials@ipsen.com|
276775|NCT00564889|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
276776|NCT00564902|James A. Lovell Federal Health Care Center|Dr. Stuart P. Richer|224-610-5440|Stuart.Richer1@va.gov|
276777|NCT00564954|Novartis Pharmaceuticals|Study Director|862-778-8300||
297586|NCT01759160|First Affiliated Hospital of Sun Yat-sen University|Dr. Xia Feng|008613688877856|fengxiar@yahoo.cn|
297587|NCT01759251|Abbott|Associate Director Clinical Services||taco.baardman@abbott.com|
297588|NCT01759264|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
297589|NCT01759277|University of California San Diego|Brian Ilfeld|858-822-2171|bilfeld@ucsd.edu|
297590|NCT01759290|Abbott Vascular|Kunal Sampat|408-845-0746|kunal.sampat@av.abbott.com|
297591|NCT01759368|VTT Technical Research Centre of Finland|Anna-Leena Orsama|+358408485966|anna-leena.orsama@vtt.fi|
297592|NCT01759381|Duke|Carlos A. Bagley|919-943-1564|carlos.bagley@gmail.com|
297593|NCT01759407|Nationwide Children's Hospital|Nicole Elsey, MD|614-722-4200|Nicole.Elsey@nationwidechildrens.org|
297594|NCT01759420|Carl R Darnall Army Medical Center|Peter Moffett MD|254-288-8302|peter.m.moffett.mil@mail.mil|
297595|NCT01759446|Acura Pharma|Dr. Al Brzeczko|847-705-7709|abrzeczko@acurapharm.com|
297596|NCT01759511|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
297597|NCT01759602|Johns Hopkins University|Michael Levy, MD, PhD|443-287-4412|mlevy@jhmi.edu|
297598|NCT01759862|Stanford University|Paul Grimm|6507237903||
297599|NCT01760187|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|8572425142|alison.long@aegerion.com|
297600|NCT01760239|HealthPartners Institute|Elyse Kharbanda, MD MPH|952-967-5038|Elyse.O.Kharbanda@healthpartners.com|
297601|NCT01760291|Boston Scientific|Director of Clinical Trials|18002273422|peter.maurer@bsci.com|
297602|NCT01760304|Brigham and Women's Hospital|Dr. Miguel Divo|8573070311|mdivo@bwh.harvard.edu|
297603|NCT01760447|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297604|NCT01760473|New York State Psychiatric Institute|Dr. Sandra Comer|646 774-6146|sdc10@columbia.edu|
297605|NCT01760733|Telemark Hospital Trust|MD, PhD Kristian Heldal|+4790018417|hkri@ous-hf.no|
297606|NCT01760785|Denver Research Institute|Dr. Thomas Beresford|303-399-8020|thomas.beresford@ucdenver.edu|3732
297607|NCT01760876|Queen Mary Hospital,University of Hong kong|Prof. Stephen Wai-luen LEE|(852) 22555409 or 28181314|prof.stephenlee@gmail.com ; kongsl@hku.hk|
297608|NCT01760954|AbbVie|Global Medical Services|800-633-9110||
297609|NCT01761019|Department of Dermatology, University of Pittsburgh School of Medicine|Laura K. Ferris, MD, PhD|412-647-2013|ferrlk@upmc.edu|
297610|NCT01761084|University of Waterloo|Dr. Lora Giangregorio|5198884567|lmgiangr@uwaterloo.ca|36357
297611|NCT01761162|Biotronik, Inc.|Clinical Studies Engineer|503-927-7230|justin.michalski@biotronik.com|
297612|NCT01761175|CHU de Québec, Département d'Anesthésie-Réanimation de l'Hôpital de l'Enfant-Jésus|Dre Marie-Josée Nadeau|418 649-5807|marie-josee.nadeau@fmed.ulaval.ca|
297613|NCT01761266|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
297614|NCT01761279|Portsmouth Hospitals NHS Trust|Dr Pete Basford, Endoscopy Research Fellow|+447890990445|petebasford@hotmail.com|
297615|NCT01761292|Italfarmaco SpA|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
286049|NCT01056302|Department of Veterans Affairs|Dr. Rebeka Silva|415-221-4810|rebeka.silva@va.gov|22784
286050|NCT01056328|St. Jude Medical|Nicole Glowacki, Clinical Project Manager|651-756-3432|NGlowacki@sjm.com|
286051|NCT01056341|Pierre Fabre Dermatologie|Dr. Jean-Jacques VOISARD - General Manager -|+33 5 63 58 88 00|jean.jacques.voisard@pierre-fabre.com|
276778|NCT00565045|MetroHealth Medical Center|Dr. Jayme Knutson|216-778-8364|jsk12@case.edu|
286052|NCT01056380|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
286053|NCT01056484|University of Wisconsin Madison|Aleksandra Zgierska, MD PhD|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu|
286054|NCT01056510|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
286055|NCT01056523|Jewish General Hospital|Dr. Assouline|514-340-8222|sarit.assouline@mcgill.ca|8434
286056|NCT01056536|Travel Clinic, Department of Ambulatory Care and Community Medicine, University Hospital of Lausanne|Dr Serge de Vallière|+41 79 556 43 12|serge.de-valliere@unisante.ch|
276779|NCT00565058|Aptose Biosciences Inc.|Peter Murray, Director Clinical Development|647-479-9812|pmurray@aptose.com|
276780|NCT00565084|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
276781|NCT00565110|USC Suzanne Dworak-Peck School of Social Work|Kathleen Ell, DSW, Principle Investigator|760-399-0263|ell@usc.edu|
276782|NCT00565136|Boston Urogynecology Associates|Peter Rosenblatt, MD; Director of Urogynecology|(617) 354-5452|prosenbl@mah.harvard.edu|
276783|NCT00565266|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
276784|NCT00565370|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
276785|NCT00565409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276786|NCT00565448|sanofi|Trial Transparency Team||Contact-us@sanofi.com|
276787|NCT00565604|Lake Washington Vascular Surgery|Daniel Pepper, MD|(425) 453-1772||
276788|NCT00565617|Medical University of South Carolina|Gregory Sahlem|843-792-5716|sahlem@musc.edu|
276789|NCT00565643|Lehigh Valley Health Network|Daniel Kiefer|484-664-7521|daniel_g.kiefer@lvhn.org|
276790|NCT00565669|Carolina Eye|Helga Sandoval||hps@cepmd.com|
276791|NCT00565721|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|paul.gordon@ge.com|
276792|NCT00565747|Origio A/S|Chief Scientific Officer|+45 46790200|sbendz@origio.com|
276793|NCT00565773|Duke University|Allan D. Kirk, MD, PhD|919-681-1400|allan.kirk@duke.edu|
276794|NCT00565812|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276795|NCT00565864|Oregon Health & Science University|Dr. Mary Samuels|5034945242|samuelsm@ohsu.edu|
276796|NCT00565916|Washington University School of Medicine|Dr. Robert Gropler MD|314-747-3878|groplerr@mir.wustl.edu|
276797|NCT00566020|GlaxoSmithKline|GSK Response Center|866-435-7343||
276798|NCT00566098|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
276799|NCT00566111|Yale University Department of Psychiatry|Dr. Gerard Sanacora|(203) 974-7535|gerard.sanacora@yale.edu|
276800|NCT00566150|Yale University|Dr. Zubin Bhagwagar|203-974-7560|zubin.bhagwagar@yale.edu|
276801|NCT00566228|Mayo Clinic|Luis F. Porrata, M.D.|507/284-2511|Porrata.Luis@mayo.edu|
276802|NCT00566254|Eisai Call Center|Eisai Inc.|888-422-4743||
276803|NCT00566501|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
276804|NCT00566527|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276805|NCT00566540|The Ohio State University Comprehensive Cancer Center|Enzer Ozer, MD|614-293-8074|enver.ozer@osumc.edu|
276806|NCT00566579|Department of OBGYN, Faculty of Medicine, Khon Kaen University, 40002, THAILAND|Bandit Chumworathayi|66818733327|bunchu@kku.ac.th|
276807|NCT00566631|Janssen-Cilag Germany|EMEA Therapeutic Area Leader CNS|+492137955153||
276808|NCT00566696|St. Jude Children's Research Hospital|Brandon Triplett, MD|866-278-5833|referralinfo@stjude.org|
276809|NCT00566709|"University Hospital Virgen del Rocío"|Santiago R Leal-Noval, MD, PhD|0034954012528|srlealnoval@gmail.com|
276810|NCT00566722|Abbott|Global Medical Services|800-633-9110||
286057|NCT01056601|Masonic Cancer Center, University of Minnesota|Arkaduisz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
286058|NCT01056640|Mayo Clinic|Dr. Paul Takahashi|507-284-2511|takahashi.paul@mayo.edu|
286059|NCT01056653|University of Calgary, Faculty of Nursing|Dr. Karen Benzies|403-220-2294|benzies@ucalgary.ca|
286060|NCT01056718|Mercy Hospital East Communities|Denise Janosik, MD|314-251-3920|Denise.Janosik@mercy.net|
286061|NCT01056822|Pharmaceuticals|Novartis|+1 (862) 778-8300||
286062|NCT01056913|St John of God Hospital Vienna|Bernhard Dauser (MD)|+43121121|bernhard.dauser@gmail.com|5098
286063|NCT01057017|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
286064|NCT01057225|Mayo Clinic|Joseph Riad Mikhael, M.D.||Mikhael.Joseph@mayo.edu|
286065|NCT01057251|Forest Research Institute|Manfred Stapff, MD, PhD|201-427-8000|manfred.stapff@frx.com|8686
286066|NCT01057277|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
286067|NCT01057381|Baylor College of Medicine|Olutoyin A. Olutoye, M.D., M.Sc.|(832) 824-5800|oao@bcm.edu|
286068|NCT01057394|CardioFocus, Inc.|Burke Barrett, VP, Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
286069|NCT01057433|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
286070|NCT01057589|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286071|NCT01057693|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286072|NCT01057810|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
286073|NCT01057862|Yale University|Dr. Marc N Potenza|2037373553|marc.potenza@yale.edu|
276811|NCT00566735|Massachusetts General Hospital|Dr. John Matthews|617-724-0847|jmatthews@partners.org|
276812|NCT00566813|University of Illinois at Chicago|Jose Oberholzer, MD|312-996-6771|jober@uic.edu|
276813|NCT00566852|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
286074|NCT01057888|University of Rochester, Deparentment of Pediatrics|Dr. Peter Szilagyi|585 275-5798|peter_szilagyi@urmc.rochester.edu|
286075|NCT01057901|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
286076|NCT01058005|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
286077|NCT01058070|Torax Medical, Inc.|VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
286078|NCT01058096|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
286079|NCT01058239|Massachusetts General Hospital|Jeremy Abramson, M.D|617-724-4000|JABRAMSON@mgh.harvard.edu|
286080|NCT01058265|Mayo Clinic in Arizona|Larry Bergstrom, MD|480-301-7108|bergstrom.larry@mayo.edu|
308553|NCT02588261|Astellas Pharma Global Development, Inc.|Senior Medical Director|1800 888-7704|astellas.resultsdisclosure@astellas.com|
286081|NCT01058304|Health Services Research & Development, Durham VAMC|Kelli D. Allen|919-286-0411|kelli.allen@va.gov|7090
276814|NCT00566930|UQTR|Martin Descarreaux|819 376-5011|martin.descarreaux@uqtr.ca|3077
286082|NCT01058356|Pharmbio Korea Co., Ltd.|Korea Association for the Study of Intestinal Disease (KASID)|82-2-587-2551|pharmbio@hotmail.com|
276815|NCT00566943|Synovis Surgical Innovations|Lesa Hobright-Turner, Director Clinical Affairs|651-796-7506|lesa.hobrightturner@synovissurgical.com|
286083|NCT01058395|Wayne State University|Dr. Jay Meythaler|(313) 375-7226|jmeythal@med.wayne.edu|
276816|NCT00566969|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehmet.sofuoglu@yale.edu|4809
276817|NCT00566982|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
276818|NCT00567008|UPenn|Jennifer Plebani|2152223200|jplebani@mail.med.upenn.edu|152
276819|NCT00567112|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276820|NCT00567164|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
276821|NCT00567190|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
276822|NCT00567229|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun|212-639-3228|hassounh@mskcc.org|
276823|NCT00567242|University of Florida|Bruce Crosson, PhD / Professor|352-273-6617|nossorc1@phhp.ufl.edu|
276824|NCT00567255|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
276825|NCT00567268|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276826|NCT00567307|Wake Forest School of Medicine, Winston Salem, NC|Dr. Elsayed Z Soliman, Director of the Epidemiological Cardiology Research Center|336-716-8632|esoliman@wakehealth.edu|
276827|NCT00567320|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
276828|NCT00567359|Massachusetts General Hospital|Lecia Van Dam Sequist, M.D.|617-724-4000|LVSEQUIST@PARTNERS.ORG|
276829|NCT00567398|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
276830|NCT00567476|Novartis Pharmaceuticals|Study Director|862 778-8300||
276831|NCT00567489|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
276832|NCT00567502|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
276833|NCT00567541|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
276834|NCT00567593|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
276835|NCT00567840|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
276836|NCT00567879|Novartis|Study Director|862-778-8300||
286084|NCT01058421|University of Colorado|Dr. Marc Moss|303-724-6079|marc.moss@ucdenver.edu|
286085|NCT01058655|Dana-Farber Cancer Institute|Brian M. Wolpin|617.632.6942||
286086|NCT01058668|Allergan, Inc.|Therapeutic Area Head|714-246-4500||
286087|NCT01058707|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
286088|NCT01058863|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
286089|NCT01058941|Oregon Health & Science University|Dr. Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
286090|NCT01058993|University of Washington|David D. Dale, MD|206-543-7215|dcdale@u.washington.edu|
286091|NCT01059071|NMTRC|Giselle Sholler, MD|6162670335|giselle.sholler@helendevoschildrens.org|
286092|NCT01059175|Medtronic|Latifa Foudali|+33 631992144|latifa.foudali@medtronic.com|
286093|NCT01059305|The University of Texas (UT) MD Anderson Cancer Center|Bonnie Glisson, MD/Professor, Thoracic/Head & Neck Med Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
286094|NCT01059318|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
286095|NCT01059344|The Role of Centralized Reading of Endoscopy in a Randomized Controlled Trial of Mesalamine for Ulcertive Colitis|Brian G. Feagan et al|Gastroenterology 2013; 145:||149-157
286096|NCT01059357|Wake Forest University Health Sciences|Dr. Joshua Waltonen|3367169068|jwaltone@wakehealth.edu|
286097|NCT01059435|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
286098|NCT01059526|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
286099|NCT01059539|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
286100|NCT01059565|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
286101|NCT01059617|GlaxoSmithKline|GSK Response Center|866-435-7343||
286102|NCT01059630|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
286103|NCT01059643|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286104|NCT01059682|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
286105|NCT01059760|Intermountain Heart Institute|Benjamin D. Horne|8015074708|benjamin.horne@imail.org|
286106|NCT01059773|Janssen-Cilag France|EMEA THERAPEUTIC AREA LEADER|+33 6 15167408||
286107|NCT01059799|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
286108|NCT01059812|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
286109|NCT01059825|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286110|NCT01059851|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286111|NCT01059864|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286112|NCT01059877|QuietMind Foundation|Marvin Berman, PhD|610.940.0488|marvinberman@quietmindfdn.org|
286113|NCT01059903|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
286114|NCT01059929|University of Chicago|John Kress|773-702-6790|jkress@medicine.bsd.uchicago.edu|
286115|NCT01059994|University of Texas Medical Branch|Melinda Sheffield-Moore|4097728126|melmoore@utmb.edu|
297616|NCT01761565|AcelRx Pharmaceuticals, Inc.|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
286116|NCT01060007|Washington University School of Medicine|Parag Parikh, M.D.|314-362-9703|pparikh@radonc.wustl.edu|
286117|NCT01060020|Washington University School of Medicine|Brian R. Lindman, MD, Assistant Professor of Medicine|314-747-3617|brlindman@wustl.edu|
286118|NCT01060059|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
286119|NCT01060072|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
286120|NCT01060098|Imperial College London|Sonya Abraham|+44 (0)20 3313 4114|s.abraham@imperial.ac.uk|
286121|NCT01060111|Medical Affairs / Janssen-Cil Korea|Clinical Research Associate|82-2-2094-4837||
286122|NCT01060124|Medical affairs, Janssen Korea, Ltd.|CRA|82220944835||
286123|NCT01060150|Medical Affairs / Janssen-Cil Korea|Clinical Research Director|82-2-2094-4518||
286124|NCT01060345|University of Chicago|Nora Jaskowiak, MD|773-702-2048|njaskowi@surgery.bsd.uchicago.edu|
286125|NCT01060384|University of Nebraska Medical Center|Julie M. Vose, M.D.|402-559-3848|jmvose@unmc.edu|
286126|NCT01060540|Durham VA Medical Center|Corrine Voils, PhD|919-286-0411|corrine.voils@va.gov|5196
297617|NCT01761643|UC San Diego|Mike Duszynski|6195438080|mduszynski@health.ucsd.edu|
286127|NCT01060553|Veteran Affairs New Jersey Health Care System|Thomas W. Findley, MD, PhD|973-676-1000|thomas.findley@va.gov|2713
286128|NCT01060592|Crospon|John O'Dea PhD|+353-91-519880|jodea@crospon.com|
286129|NCT01060670|Integra LifeSciences, Inc.|Katie Bush, PhD- Manager, Global Medical Affairs- Tissue Technology|617-268-1616|katie.bush@integralife.com|267
286130|NCT01061008|UWalesBangor|Dr. Jamie Macdonald|+441248383272|j.h.macdonald@bangor.ac.uk|
297618|NCT01761747|Dana-Farber Cancer Institute|Dr. Peter Hammerman|617-632-6335|phammerman@partners.org|
286131|NCT01061034|Assaf Harofeh medical center|Dr. Keren Doenyas-Barak|972-57-7346651|kerendoenyas@gmail.com|
286132|NCT01061177|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
286133|NCT01061333|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286134|NCT01061359|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286135|NCT01061385|ReShape Medical|Director of Clinical Operations|949-429-6680|lfong@reshapemedical.com|
286136|NCT01061476|Johns Hopkins University|Dr. Susheel Patil|410-550-0574|spatil@jhmi.edu|
286137|NCT01061528|University of Texas at Austin|Dr. Richard A. Brown|512-471-8584|brown2@utexas.edu|
286138|NCT01061567|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
286139|NCT01061606|Montefiore Medical Center|Lisa Escobar-Peralta, Program Manager|718-379-6866|lescobar@montefiore.org|
286140|NCT01061671|University of Minnesota|Sarah Lindberg|612-626-9011|sharnden@ccbr.umn.edu|
286141|NCT01061710|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286142|NCT01061723|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
286143|NCT01061736|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
286144|NCT01061775|Children's Hospitals and Clinics of Minnesota|Dr. Jennifer Abuzzahab|651-220-6867|jennifer.abuzzahab@childrensmn.org|
286145|NCT01061866|National Institute of Neurology and Neurosurgery of Mexico|Julio Sotelo|5255-5652-8285|jsotelo@unam.mx|
286146|NCT01062009|UCSF Benioff Childrens Hospital Oakland|Natalie Cvijanovich, MD|510-428-3784|NCvijanovich@mail.cho.org|
286147|NCT01062061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286148|NCT01062074|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297619|NCT01762059|Massachusetts General Hospital|Dr. Steven J. Russell|617-726-1848|sjrussell@mgh.harvard.edu|
297620|NCT01762345|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
297621|NCT01762501|Sogo Rinsho Medefi Co., Ltd|Naoyuki Takano|+81-3-6901-6079|takano.naoyuki@sogo-medefi.jp|
297622|NCT01762631|Pennington Biomedical Research Center|Leanne Redman, PhD|2257630947|leanne.redman@pbrc.edu|
297623|NCT01762722|Duke University Medical Center|Dr David MacLeod|919-812-3201|david.macleod@duke.edu|
297624|NCT01762800|GlaxoSmithKline|GSK Response Center|866-435-7343||
297625|NCT01762904|Universidad de Guanajuato|Alejandro E. Macías|+52 477 7 14 58 59|aaeemmhh@yahoo.com|4644
297626|NCT01762943|University of North Carolina at Chapel Hill|Dr. Crystal Schiller|9199664810|crystal_schiller@med.unc.edu|
297627|NCT01762982|GlaxoSmithKline|GSK Response Center|866-435-7343||
297628|NCT01763047|Johnson & Johnson Vision Care Inc.|Thomas R. Karkkainen, OD., M.S., F.A.A.O- Senior Principal Research Optometrist|904-443-3500|TKarkkai@its.jnj.com|3402
297629|NCT01763164|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297630|NCT01763203|Icahn School of Medicine at Mount Sinai|Dr. Barbara Vickrey; Chair of Neurology|2122415698|barbara.vickrey@mssm.edu|
297631|NCT01763333|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297632|NCT01763346|University or Southern California|Dr. Thomas Buchanan|3234794319|buchanan@usc.edu|
297633|NCT01763567|Medtronic, Inc.|Julie Sekella|818-576-5000|Julie.Sekella@medtronic.com|
286149|NCT01062113|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
286150|NCT01062126|Abbott (Previously St Jude Medical)|Grant Kim|818-493-3147|grant.kim1@abbott.com|
286151|NCT01062165|Texas Tech UHSC|Ronald Hall|214-654-9404|ronald.hall@ttuhsc.edu|
286152|NCT01062230|Huntsman Cancer Institute at the University of Utah Medical Center|Maurizio Zangari, MD Principal Investigator|801-585-3229||
286153|NCT01062256|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
286154|NCT01062269|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|Harold E. Bays, MD|502-515-5672|HBaysMD@aol.com|
286155|NCT01062308|Christian Medical College and Hospital, Ludhiana, Punjab, India|Jeyaraj D Pandian|09915784750|jeyarajpandian@hotmail.com|
286156|NCT01062399|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
286157|NCT01062555|University of Minenesota|Arthur Matas|612-625-5151|matas001@umn.edu|
286158|NCT01062568|UCSD|Dr. R. Jeffery Chang|858-534-8930|rjchang@ucsd.edu|
286159|NCT01062763|Dept. of Endocrinology, Odense University Hospital|Dr. Ib A. Jacobsen|+45 27203135|ib.abildgaard@rsyd.dk|
286160|NCT01062841|University of Michigan|Lona Mody, MD, MSc|734-764-8942|lonamody@umich.edu|
286161|NCT01062893|Wake Forest University School of Medicine|Peter H. Pan, MD|336-718-8278|ppan@wakehealth.edu|
297634|NCT01763606|Memorial Sloan Kettering Cancer Center|Dr. Lisa DeAngelis, MD|212-639-8000|deangell@mskcc.org|
286162|NCT01062971|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
286163|NCT01063036|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
286164|NCT01063049|Gastroenterology Services|Dr. David Gerard|630 969 1167|davidpgerard@comcast.net|
286165|NCT01063062|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
286166|NCT01063075|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286167|NCT01063153|Massachusetts General Hospital|Chief, Clinical and Research Programs in Pediatric Psychopharmacology and Adult ADHD|(617)-724-0006|jbiederman@partners.org|
297635|NCT01763645|BIOCAD|Biryulin Andrey|+7812380 49 33|biryulin@biocad.ru|925
286168|NCT01063283|Inova|Michael Maitland, MD, PhD|571-472-4724|Michael.Maitland@inova.org|
286169|NCT01063348|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
286170|NCT01063595|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
286171|NCT01063712|"Cardiology Medical Center Kardiozentrum"|Alexandra Heath MD Ph.D|005912 2785037|draheath@gmail.com|
286172|NCT01063764|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
286173|NCT01063829|AiCuris Anti-infective Cures GmbH|Chief Medical Officer|004920231763|info@aicuris.com|0
286174|NCT01063855|Janssen Research & Development, LLC|CDTL, Cardiovascular and Metabolism|1 908 704-4648||
286175|NCT01063868|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
286176|NCT01063881|Janssen Research & Development, LLC|Sr. Director CDTL, RA CVM Urology|1 908 704-4648||
286177|NCT01063907|Kyowa Hakko Kirin Pharma, Inc.|Senior VP Drug Development|609-919-1100|clinical.info@kyowa-kirin-pharma.com|
286178|NCT01063972|University of Kansas Medical Center|Sharon Fitzgerald, MPH|913-588-3488|sfitzgerald@kumc.edu|
286179|NCT01064076|Cameron Health, Inc. a subsidiary of Boston Scientific|Michael Husby, Clinical Studies Manager|312-402-1877|michael.husby@bsci.com|
286180|NCT01064167|Cardiovascular Institute & Fuwai Hospital|Guyan Wang|86-10-88398377|guyanwang2006@163.com|
286181|NCT01064284|"Centro Emofilia e Trombosi Angelo Bianchi Bonomi, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico di Milano"|Prof. Flora Peyvandi|0039 0255035414|flora.peyvandi@unimi.it|
297636|NCT01763684|Zimmer Biomet|Linda Meijer, Clinical Operations Manager|+31786292935|linda.meijer@zimmerbiomet.com|
286182|NCT01064297|GlaxoSmithKline|GSK Response Center|866-435-7343||
286183|NCT01064310|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
286184|NCT01064323|Johns Hopkins University School of Medicine|Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology|410-550-5717|hsilber@jhmi.edu|
286185|NCT01064362|GlaxoSmithKline|GSK Response Center|866-435-7343||
286186|NCT01064401|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
286187|NCT01064414|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
286188|NCT01064531|Smith & Nephew, Inc|Tracey Brengola, MS|978-749-1491|Tracey.brengola@smith-nephew.com|
286189|NCT01064622|University of Chicago|Hedy Kindler, MD|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
286190|NCT01064687|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297637|NCT01763827|Amgen Inc.|Study Director|866-572-6436||
297638|NCT01763866|Amgen Inc.|Study Director|866-572-6436||
276837|NCT00567892|Washington University|Dr. Jay F. Piccirillo|314.362.8641|piccirilloj@ent.wustl.edu|
297639|NCT01763905|Amgen Inc.|Study Director|866-572-6436||
276838|NCT00567996|Novartis Pharmaceuticals|Study Director|862-778-8300||
276839|NCT00568022|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
276840|NCT00568061|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
276841|NCT00568087|Minneapolis VA Health Care System|Gihyun Yoon, MD|612-467-3996|Gihyun.Yoon@va.gov|
276842|NCT00568126|Depression Clinical and Research Program, Massachusetts General Hospital|Dr. David Mischoulon, Director|617-724-5198|dmischoulon@partners.org|
276843|NCT00568321|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276844|NCT00568334|GlaxoSmithKline|GSK Response Center|866-435-7343||
276845|NCT00568386|Alcon Research|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
276846|NCT00568399|Washington University School of Medicine|James Delmez, MD|314 362 7207|jdelmez@dom.wustl.edu|
297640|NCT01763918|Amgen Inc.|Study Director|866-572-6436||
297641|NCT01763931|SKCCC at Johns Hopkins|Vered Stearns, MD|410-614-1361|HopkinsBreastTrials@jhmi.edu|
286191|NCT01064713|University of Texas (UT) MD Anderson Cancer Center|Agop Y. Bedikian, MD/Professor||CR_Study_Registration@mdanderson.org|
286192|NCT01064739|Vanderbilt University|Dr. Emily Garland|615 936 1748|emily.garland@vanderbilt.edu|
286193|NCT01064817|Promedior, Inc.|Elizabeth G. Trehu, MD|781-538-4203|btrehu@promedior.com|
286194|NCT01064830|University of North carolina-Chapel Hill|Aida Lugo-Somolinos MD|919-843-9447|alugosom@med.unc.edu|
286195|NCT01064856|AbbVie|Global Medical Services|800-633-9110||
286196|NCT01064882|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
286197|NCT01064947|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
286198|NCT01065350|Mayo Clinic|Nathan J. Smischney, MD|507-255-6032|smischney.nathan@mayo.edu|
286199|NCT01065428|Department of Critical Care Medicine, Nanjing Zhong-Da Hospital, Southeast University School of Medicine, China|Dr. Haibo Qiu; Dr. Christer Sinderby|008613951965301|haiboq2000@yahoo.com.cn|
276847|NCT00568451|Mayo Clinic Cancer Center|Svetomir N. Markovic M.D., Ph.D.|507-284-2511|markovic.svetomir@mayo.edu|4-2511
286200|NCT01065480|New York State Psychiatric Institute|Edward V. Nunes, MD|646-774-6122|nunesed@nyspi.columbia.edu|
286201|NCT01065506|The University of Texas at Austin|Jasper Smits|512-475-8095|smits@utexas.edu|
286202|NCT01065558|Psyadon Pharmaceuticals|Dr. Richard Chipkin|301-919-2020|rchipkin@psyadonrx.com|
286203|NCT01065571|University of Illinois at Chicago|Joanne Tobacman, MD|312-569-7826|jkt@uic.edu|
286204|NCT01065597|Department of Psychiatry, University of Maryland School of Medicine|William T. Regenold, MDCM|410-328-6511|wregenol@psych.umaryland.edu|
286205|NCT01065714|DermResearch, PLLC|Leon Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
286206|NCT01065766|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-888-577-8839|ClinicalTrialsDisclosure@merck.com|
286207|NCT01065844|The University of Iowa|John M. Buatti, M.D., Chair, Department of Radiation Oncology|319-356-2699|john-buatti@uiowa.edu|
286208|NCT01066000|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
286209|NCT01066026|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|55 51 30262633|cientifico@cbed.org.br|
286210|NCT01066039|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
286211|NCT01066052|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
286212|NCT01066104|MGH|Dr. Ellen Dutta|6177248256|edutta@mgh.harvard.edu|
286213|NCT01066143|McLean|Igor Elman, PI|(800) 333-0338|ielman@partners.org|
286214|NCT01066156|Cambridge Health Alliance|Igor Elman|(617) 665-1000|ielman@challiance.org|
286215|NCT01066364|UCSD|Rohit Loomba, MD|858-246-2201|roloomba@ucsd.edu|
286216|NCT01066520|Biologische Heilmittel Heel GmbH|Dr. Istvan Zatik|+4972215013192|istvan.zatik@heel.com|
286217|NCT01066546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286218|NCT01066585|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
286219|NCT01066624|South Texas Veterans Health Care System|Juan J Toro|210-617-5300|juan.toro2@va.gov|16777
286220|NCT01066780|Advanced Bionics, LLC|Kenneth Ripley, Director of Clinical Research|1.661.362.1400|clinical.research@advancedbionics.com|
286221|NCT01066793|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
286222|NCT01066819|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
286223|NCT01066871|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
286224|NCT01066897|Stanford University|Dr. Jennifer Keller|650-724-0070|jkeller@stanford.edu|
286225|NCT01066923|University of Pittsburgh|Clifton Callaway|412-647-3078|callawaycw@upmc.edu|
286226|NCT01066936|Smith & Nephew|Tracey Brengola|978-319-2702|tracey.brengola@smith-nephew.com|
286227|NCT01067105|Sunovion|Respiratory Medical Director|1-866-503-6351||
286228|NCT01067144|Stanford University|Dr. Ian Carroll|(650) 723-6411|ic38@stanford.edu|
286229|NCT01067326|Mayo Clinic|Dr. Amir Lerman|507-255-4152|lerman.amir@mayo.edu|
286230|NCT01067339|Mayo Clinic|Amir Lerman, MD|507-284-6429|lerman.amir@mayo.edu|
286231|NCT01067352|Merck Serono S.p.A., Italy, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
286232|NCT01067456|MGH|Dr. Udo Hoffmann|617-726-1255|uhoffmann@partners.org|
297642|NCT01763970|SKCCC at Johns Hopkins|Matthew Ladra,MD|(202) 537-4788|mladra@jhmi.edu|
286233|NCT01067469|UT MD Anderson Cancer Center|Dr. John F de Groot/Chair Ad Interim, Neuro-Oncology|713- 745-3072|jdegroot@mdanderson.org|
286234|NCT01067508|UCLA Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
286235|NCT01067716|Abbott Medical Optics|Amelia Saliba|408-273-4158|amelia.saliba@amo.abbott.com|
276848|NCT00568555|Stanford University School of Medicine|Jarred Younger, PhD|650-724-2795|jyounger@stanford.edu|
276849|NCT00568633|Stanford University|Robert Lowsky, Professor of Medicine (Blood and Marrow Transplantation)|650-725-8950|rlowsky@stanford.edu|
276850|NCT00568685|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
276851|NCT00568776|Transition Therapeutics Ireland Limited|Aleksandra pastrak, MD, PhD, Vice President, Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
276852|NCT00568854|Los Angeles County Department of Public Health|Dr. Alicia Chang|213-745-0846|alchang@ph.lacounty.gov|
276853|NCT00568958|Yale University School of Medicine|Dr. Stephanie S. O'Malley|203-974-7590|stephanie.omalley@yale.edu|
276854|NCT00569010|The University of MD Anderson Cancer Center|Jean-Pierre Issa, M.D./Professor|713-745-2260|eharriso@mdanderson.org|
276855|NCT00569127|SWOG|SWOG Statistician|206-667-4408||
276856|NCT00569166|Mayo Clinic|Dr. Amit Sood|507-538-7623|sood.amit@mayo.edu|8-7623
276857|NCT00569192|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
286236|NCT01067768|Hospital Pablo Tobón Uribe|Dr. María Victoria Restrepo|57-4-4459315|mrestrepo@hptu.org.co|
286237|NCT01067781|Valneva Austria GmbH|Head Clinical Developement|0043120620|info@valneva.com|0
276858|NCT00569231|University of Arkansas for Medical Sciences|Mayumi Nakagawa, MD, PhD|(501) 686-8635|mnakagawa@uams.edu|
286238|NCT01067846|Brain Imaging Research Center|Clint Kilts, PhD|526-8163|CDKilts@uams.edu|
286239|NCT01067976|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
286240|NCT01068158|Sanofi Topaz|Medical Director||RegistryContactUs@sanofipasteur.com|
297643|NCT01763996|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
286241|NCT01068262|Merck Sharp and Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286242|NCT01068418|Brigham and Women's Hospital, Harvard Medical School|Jonathan S. Williams|6177325666|jwilliams5@partners.org|
286243|NCT01068509|PrimaBioMed, Ltd.|Marc Voigt|49 173 6771602|marc.voigt@primabiomed.com.au|
286244|NCT01068548|VANTHCS|Eric Mortensen, MD|214-857-1588|ericm.mortensen@va.gov|
286245|NCT01068600|Novartis Pharmaceuticals|Study Director|862-778-8300||
297644|NCT01764022|BIOCAD|Dr. Mariia Shustova|+7812380 49 33|shustova@biocad.ru|651
286246|NCT01068626|University of Gothenburg|Kristjan Karason|+46 31 342 7554|kristjan.karason@gu.se|
286247|NCT01068652|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
286248|NCT01068665|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
297645|NCT01764256|PATH|Jorge Flores|2028220033|jeflores@path.org|
297646|NCT01764386|Orexigen Therapeutics, Inc.|Executive Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
297647|NCT01764464|University of Rochester|John Markman|585-276-3616|john_markman@urmc.rochester.edu|
297648|NCT01764607|University of Florida|Priya K Gopalan|352-273-8699|gopalpk@ufl.edu|
308554|NCT02588339|Moffitt Cancer Center|Lia E. Perez, MD|813-745-3665|Lia.Perez@moffitt.org|
276859|NCT00569270|Arthur F Gelb MD|Arthur F Gelb MD Principal Investigator|562-633-2204|afgelb@msn.com|
276860|NCT00569309|The Ohio State University Comprehensive Cancer Center|Craig Hofmeister, MD|614-293-9869|Craig.Hofmeister@osumc.edu|
276861|NCT00569374|University of Arkansas for Medical Sciences Center for Addiction Research|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
276862|NCT00569530|University of California, San Francisco|Roberta R. Keller, MD|415-514-3192|roberta.keller@ucsf.edu|
276863|NCT00569582|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
276864|NCT00569660|The University of Texas M. D. Anderson Cancer Center|Srdan Verstovsek M.D./Associate Professor|713-792-7305|eharriso@mdanderson.org|
276865|NCT00569673|NRG Oncology, Statistics and Data Management Center, Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
276866|NCT00569777|Vistakon|Brian Pall OD MS FAAO|904-443-1290||
276867|NCT00569803|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
276868|NCT00569855|University of Arkansas, Arkansas Children's Hospital, Dept. of Pediatrics|Research Program Manager, Cardiovascular Surgery, Dept. of Pediatrics|501-364-1100|althagekarena@uams.edu|5859
276869|NCT00569946|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276870|NCT00570037|Duke University Medical Center|Emmanuel Walter MD, Principal Investigator|919-620-5374|walte002@mc.duke.edu|
286249|NCT01068678|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
286250|NCT01068717|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
286251|NCT01068730|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
286252|NCT01068743|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
286253|NCT01068769|Dana-Farber Cancer Institute|Dr. Suzanne George|617-632-5204|sgeorge2@partners.org|
286254|NCT01068821|Mayo Clinic, Florida|Dr. Mary Ellen Wechter|904 412 7351|wechter.mary@mayo.edu|
286255|NCT01068860|Novartis Pharmaceuticals|Dr. Tom Thuren/Global Brand Medical Director|862-778-1828|tom.thuren@novartis.com|
286256|NCT01068873|Lewis Katz School of Medicine at Temple University|Lisa Landsberg|12157077303|lisa.landsberg@temple.edu|
286257|NCT01068912|MediVector, Inc., managing member MDVI, LLC|Dr. Carol Epstein, Chief Medical Officer|617-439-4500|cepstein@medivector.com|
286258|NCT01068964|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
286259|NCT01069003|Medtronic|Sidney Cohen, Sr. Clinical Medical Advisor|707-591-7277|sidney.a.cohen@medtonic.com|
286260|NCT01069172|AMO Development, LLC|Luis Atiles, Manager, Clinical Research|214 537-6784|luis.atiles@amo.abbott.com|
286261|NCT01069185|Pablo Tobon Uribe Hospital|Dr.Jorge Donado Research Unit Chief|+574459753|jdonado@hptu.org.co|
286262|NCT01069289|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
286263|NCT01069315|McMaster University|Paula McKay, Manager|9055274322|mckayp@mcmaster.ca|44131
286264|NCT01069341|The University of Medicine and Dentistry of New Jersey|Dr. Neelakshi Bhagat|973-972-2032|bhagatne@umdnj.edu|
286265|NCT01069354|Merz North America, Inc.|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
286266|NCT01069419|UCB Clinical Trial Call Center|UCB (Study Director)|+1887 822 9493||
286267|NCT01069484|Norwegian School of Sport Sciences, Department of Sports Medicine, Oslo, Norway|Dr. Gunvor Hilde|+47 41366045|gunvor.hilde@gmail.com|
286268|NCT01069510|Oregon Health and Science Univ.|Dr. Craig Broberg|503-494-7400|brobergc@ohsu.edu|
286269|NCT01069523|University of Texas Health Science Center at San Antonio|Steven R.Pliszka MD|210-567-5475|pliszka@uthscsa.edu|
286270|NCT01069562|Post Graduate Institute of Medical Education and Research|Puri GD|91-9914209509|gdpuri007@hotmail.com|
297649|NCT01764633|Amgen Inc.|Study Director|866-572-6436||
286271|NCT01069627|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
286272|NCT01069705|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
286273|NCT01069900|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
286274|NCT01069939|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
286275|NCT01070043|Novartis Pharmaceuticals|Study Director|862 - 778- 8300||
286276|NCT01070095|St. Michael's Hospital|Dr. Samir Gupta|(416) 864-6060|guptas@smh.ca|2252
286277|NCT01070173|Tripler Army Medical Center|Dr. Jordan Pinsker|808-433-6338|jordan.pinsker@us.army.mil|
286278|NCT01070303|Abbott|Global Medical Services|800-633-9110||
286279|NCT01070316|Cincinnati Children's Hospital Medical Center|Elizabeth Hoskins|(513) 803-7263|elizabeth.hoskins@cchmc.org|
286280|NCT01070329|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286281|NCT01070381|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
286282|NCT01070394|NYU School of Medicine|Dr. Lenard Adler|(212) 263-3580|lenard.adler@nyumc.org|
286283|NCT01070550|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
286284|NCT01070693|Helsinki University Central Hospital|Dr. Georgios Pierides|+358 9 4711|georgios.pierides@hus.fi|
286285|NCT01070771|University Hospital Southampton NHS Foundation Trust|Professor Nick Curzen|+44 023 80777222|nick.curzen@uhs.nhs.uk|
286286|NCT01070784|AstraZeneca|Goran Eckerwall, MSD||ClinicalTrialTransparency@astrazeneca.com|
286287|NCT01070810|BIDMC|Michael W Donnino|617-754-2295|mdonnino@bidmc.harvard.edu|
286288|NCT01070888|Boston Children's Hospital|Wanda Phipatanakul|857-218-5336|wanda.phipatanakul@childrens.harvard.edu|
286289|NCT01070979|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
286290|NCT01071044|Rochester Center for Behavioral Medicine|Joel L. Young, MD|248-608-8800|jyoung@rcbm.net|261
286291|NCT01071070|Abbott|Global Medical Services|800-633-9110||
286292|NCT01071083|Biogen Idec Inc|Biogen Idec Medical Director|1-617-679-2000|neurologyclinicaltrials@biogenidec.com|
286293|NCT01071096|Clinvest|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
286294|NCT01071200|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
286295|NCT01071252|Novartis Pharmaceuticals|Study Director|862-778-8300||
286296|NCT01071278|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286297|NCT01071317|Montefiore Health|Benjamin W. Friedman, MD|718-920-6626|befriedm@montefiore.org|
286298|NCT01071356|Public Health Institute: Alcohol Research Group|Dr. Douglas Polcin|510-597-3440|dpolcin@arg.org|277
297650|NCT01764659|UMMC MSGCC|Howard Zhang, PhD|(410)706-6510|hzhang@umm.edu|
297651|NCT01764685|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@mail.med.upenn.edu|
276871|NCT00570063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276872|NCT00570089|Cedars-Sinai Medical Center|C. Noel Bairey Merz, MD|310-423-9680|merz@cshs.org|
276873|NCT00570128|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
276874|NCT00570141|Healthpoint, Ltd.|Herbert B. Slade, M.D., FAAAI|917-900-4000|bert.slade@healthpoint.com|
276875|NCT00570232|University of Alabama at Birmingham|Eben Rosenthal,MD|2059349713|erosenthal@uabmc.edu|
276876|NCT00570310|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286299|NCT01071395|Rush University of Medical Center|Dr. Christopher G. Goetz|312-942-8016|cgoetz@rush.edu|
297652|NCT01764841|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
286300|NCT01071512|University of Chicago|Dr. Adil Javed|773.834.0558|ajaved@neurology.bsd.uchicago.edu|
286301|NCT01071538|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
286302|NCT01071798|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
286303|NCT01071915|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
286304|NCT01071954|Amgen (EUROPE) GmbH|IHQ Medical Info-Clinical Trials||MedInfoInternational@amgen.com|
286305|NCT01072006|VANCHCS|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
286306|NCT01072032|Baltimore Veterans Affairs|Dr. Ron Goodman|410-605-7000|ronald.goodman@va.gov|
286307|NCT01072136|University of Arkansas for Medical Sciences|Shelly Lensing|501-686-8203|sylensing@uams.edu|
286308|NCT01072149|GlaxoSmithKline|GSK Response Center|866-435-7343||
286309|NCT01072188|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
286310|NCT01072201|Colgate Palmolive Co|William De Vizio, DMD|732-878-7901|William_Devizio@colpal.com|
286311|NCT01072331|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
286312|NCT01072344|Memorial Sloan Kettering Cancer Center|Dr. Jun Mao|646-888-0866|maoj@mskcc.org|
286313|NCT01072357|Massachusetts Eye and Ear|Dr. Reza Dana|617-573-4431|Reza_Dana@meei.harvard.edu|4431
286314|NCT01072396|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
286315|NCT01072409|University of Michigan|Teresa Zwolan, Ph.D.|(313) 618-9669|zwolan@umich.edu|
286316|NCT01072448|Novartis Pharmaceuticals|Study Director|862 778-8300||
276877|NCT00570323|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
286317|NCT01072500|Wake Forest School of Medicine|Michael Miller|336-716-6837|mmiller@wakehealth.edu|
286318|NCT01072539|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286319|NCT01072617|BIDMC|Alvaro Pascual-Leone|617-667-0203|apleone@bidmc.harvard.edu|
286320|NCT01072630|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
286321|NCT01072643|The Children's Hospital of Philadelphia|Dr. Aruna T. Nathan|215-590-1858|aruna.nathan@gmail.com|
286322|NCT01072656|Cleveland Clinic|Dr Andre Machado|216-444-4270|machada@ccf.org|
286323|NCT01072669|Cleveland Clinic|Dr. Soumya Chatterjee|216-444-9945|chattes@ccf.org|
286324|NCT01072773|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
286325|NCT01072877|BTG International Inc|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
286326|NCT01072929|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
286327|NCT01073020|Joslin Diabetes Center|Mary Elizabeth Patti MD|617 309 1966|mary.elizabeth.patti@joslin.harvard.edu|
286328|NCT01073163|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
286329|NCT01073267|University of Texas (UT) MD Anderson Cancer Center|Bouthaina Dabaja, MD/Associate Professor, Radiation Oncology Department||CR_Study_Registration@mdanderson.org|
286330|NCT01073293|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286331|NCT01073449|Dept. of Arrhythmology - Cliniche Humanitas Gavazzeni|Dr. Giosue Mascioli|+39 035 4204159|giosuemascioli@mac.com|
286332|NCT01073462|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
286333|NCT01073566|Calibra Medical|Vice President Clinical Affairs|650-298-4750|ddreon@calibra.com|
286334|NCT01073605|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286335|NCT01073618|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286336|NCT01073631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286337|NCT01073657|Veterans Health Adminstration|Marsha Langer Ellison, Ph.D.|781 687 3401|Marsha.Ellison@va.gov|
286338|NCT01073865|AstraZeneca|Global Clinical Lead|+44 1509 645895|clinicaltrialtransparency@astrazeneca.com|
286339|NCT01073930|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
286340|NCT01073943|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
286341|NCT01074008|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
286342|NCT01074034|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
286343|NCT01074047|Celgene|Anne McClain, Senior Manager Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
286344|NCT01074099|Harvest Technologies|Director of Clinical Operations|508-732-7530|CLI2011communication@harvesttech.com|
286345|NCT01074125|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
286346|NCT01074164|Northwestern University Department of Dermatology|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
286347|NCT01074177|Massachusetts General Hospital|Lecia Van Damn Sequist|617-724-4000|lvsequist@partners.org|
286348|NCT01074216|Memorial Sloan Kettering Cancer Center|Dr. Barrie Cassileth|646-888-0801|Cassileth@mskcc.org|
297653|NCT01764854|Ardelyx, Inc.|Chief Development Officer|617 513-4929|drosenbaum@ardelyx.com|
297654|NCT01764919|Biomed valley discoveries|Dr. Michelle Zhang, Executive Director|7815339412|mzhang@biomed-valley.com|
297655|NCT01764945|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297656|NCT01765153|University of Alberta|Dr. Jaynie Yang|780-492-2894|jaynie.yang@ualberta.ca|
297657|NCT01765179|Clarus Therapeutics|Sr. VP Clinical and Medical Affairs|847-562-4300|tdanoff@clarustherapeutics.com|
297658|NCT01765192|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
297659|NCT01765270|Duke Clinical Research Institute|L. Kristin Newby, MD, MHS|919-668-8805|kristin.newby@duke.edu|
297660|NCT01765426|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
297661|NCT01765465|DongGuk University Ilsan Hospital|Dr. In Woong Han||cardioman76@gmail.com|
286349|NCT01074229|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
297662|NCT01765530|Massachusetts General Hospital|Robert M Kacmarek PhD, RRT|617-724-4490|rkacmarek@partners.org|
297663|NCT01765543|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
297664|NCT01765569|Organization: Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
297665|NCT01765582|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
297666|NCT01765647|University of Alberta|Dory Sample|780-248-5599|dory.sample@ahs.ca|
297667|NCT01765673|James Madison University|Christy Ludlow|540-937-3007|ludlowcx@jmu.edu|
297668|NCT01765712|Nicholas Institute of Sports Medicine and Athletic Trauma|Malachy McHugh Director of Research|2124342714|mchugh@nismat.org|
297669|NCT01765751|Palmer College of Chiropractic|Maruti R. Gudavalli, PhD|563-884-5260|gudavalli_r@palmer.edu|
297670|NCT01765764|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
297671|NCT01765803|University of New Mexico|Stuart Winter, MD|505-272-4461|SWinter@salud.unm.edu|
297672|NCT01765920|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
297673|NCT01765972|Johnson & Johnson Vision Care Inc.|Katherine Osborn Lorenz, OD, MS|614 459-9477|KOSBORN@its.jnj.com|
297674|NCT01766024|BIOCAD|Director of Clinical Trials|7 (812) 380 49 33|biryulin@biocad.ru|925
297675|NCT01766037|Aspire Bariatrics, Inc.|VP Regulatory & Quality|484-200-1031|monica.ferrante@aspirebariatrics.com|
297676|NCT01766050|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
297677|NCT01766076|Makarere University|Damalie Nakanjako|41407000|dnakanjako@gmail.com|249
297678|NCT01766102|Massachusetts General Hospital|Michelle Specht, MD|617-726-0340|MSPECHT@mgh.harvard.edu|
297679|NCT01766206|GlaxoSmithKline|GSK Response Center|866-435-7343|sss42438@gsk.com|
297680|NCT01766219|Wake Forest University Health Sciences|Caio Max Rocha Lima|336-703-4246|crochali@wakehealth.edu|
297681|NCT01766310|Queen Sirikit National Institute of Child Health|Dr. Orawan Iamopas|66-2-354-8415|orawaneamopas@yahoo.com|3327
297682|NCT01766336|Transition Therapeutics Ireland Limited|Aleksandar Pastrak, MD, PhD, Vice President Clinical Development|+1 416 263 1227|apastrak@transitiontherapeutics.com|
297683|NCT01766401|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
297684|NCT01766440|Galderma|Michael Graeber|(817)961-5000|michael.graeber@galderma.com|
297685|NCT01766466|The Medicines Company|Jayne Prats, PhD - VP, Global Knowledge Management|888.779.MDCO|jayne.prats@themedco.com|1510
297686|NCT01766713|UCSD|Rohit Loomba|858-534-2624|roloomba@ucsd.edu|
297687|NCT01766778|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
297688|NCT01766817|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
297689|NCT01766921|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
297690|NCT01766986|University Hospital Hamburg-Eppendorf|Dr. Matthias Reeh|+49015222816521|m.reeh@uke.de|
297691|NCT01767064|USCalifornia|Jason Doctor|213.821.8142|jdoctor@usc.edu|
297692|NCT01767103|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
276878|NCT00570349|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
297693|NCT01767116|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
297694|NCT01767142|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
297695|NCT01767155|Aeterna Zentaris|Dr. Nicola Ammer|+496942602|nammer@aezsinc.com|3472
276879|NCT00570362|St.Mary's Hospital, College of Medicine, The Catholic University of Korea|Jung-Il Moon|82-2-3779-2114|jimoon@catholic.ac.kr|1243
308555|NCT02588573|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
308556|NCT02588586|The Rockefeller University|Dr. Marina Caskey, Professor of Clinical Investigation|2123277396|mcaskey@rockefeller.edu|
308557|NCT02588599|Arizona Institute of Footcare Physicians|Kerry Zang DPM|480-834-8804|kerryzang@aol.com|
276880|NCT00570401|Memorial Sloan Kettering Cancer Center|Dr. Gregory Riely|646-888-4199|rielyg@mskcc.org|
308558|NCT02588612|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
308559|NCT02588664|Wake Forest University Health Sciences|Dr. Pamela W. Duncan|(336) 716-5068|pduncan@wakehealth.edu|
308560|NCT02588833|Apellis Pharmaceuticals, Inc|Apellis Clinical Trial Information Line|1-833-284-6361|clinicaltrials@apellis.com|
308561|NCT02588872|Rush University Medical Center|Mukesh Ahuja|312-432-2380|cole.research@rushortho.com|
308562|NCT02588976|Triemli City Hospital|Director Clinical Trial|+41 44 416 25 52|christoph.hofer@triemli.stzh.ch|
308563|NCT02589067|The Lundquist Institute at Harbor-UCLA|Dr. Loren G. Miller|310-222-3775|lmiller@lundquist.org|
308564|NCT02589171|The University of Texas Health Science Center at Houston|Associate Professor|(713) 500-7277|Shinil.K.Shah@uth.tmc.edu|
308565|NCT02589405|Galderma R&D|Stephanie Leclerc|492386706|stephanie.leclerc@galderma.com|+33
308566|NCT02589626|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308567|NCT02589639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308568|NCT02589665|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
308569|NCT02589808|Imperial College|Petros Nihoyannopoulos|020 3311 3311|p.nihoyannopoulos@imperial.ac.uk|
308570|NCT02589847|Rebiotix, Inc.|Clinical Development|651-705-8778|US8-StudyInfo@ferring.com|
276881|NCT00570492|GlaxoSmithKline|GSK Response Center|866-435-7343||
276882|NCT00570505|Apollo Endosurgery|Laura Eaton|949-468-9301|laura.eaton@apolloendo.com|
276883|NCT00570661|Italfarmaco SpA|Maurizio Caserini, MD|+39 0264431|m.caserini@italfarmaco.com|
297696|NCT01767194|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
308571|NCT02589977|Vanderbilt University Medical Center|Marvin Kronenberg, MD|615-322-2318|marvin.w.kronenberg@vumc.org|
286350|NCT01074242|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286351|NCT01074255|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286352|NCT01074268|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
286353|NCT01074307|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
286354|NCT01074450|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
286355|NCT01074463|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
297697|NCT01767285|Duke University|Dr. Beverly Gray|919-684-8111|beverly.gray@dm.duke.edu|
286356|NCT01074554|Vanderbilt University School of Medicine|Dr. Wonder Drake|615-322-2035|wonder.drake@vanderbilt.edu|
286357|NCT01074658|Medronic Bakken Research Center|Hanne Gonnissen|+3143356|hanne.gonnissen@medtronic.com|6734
286358|NCT01074931|Abbott|Global Medical Services|1-800-633-9110||
286359|NCT01074944|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
286360|NCT01075048|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
286361|NCT01075074|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
286362|NCT01075087|Northwestern University|Gildasio De Oliveira MD,MS|312-472-3573|g-jr@northwestern.edu|
286363|NCT01075100|US Oncology Research, McKesson Specialty Health|Dr. Cynthia Osborne|214-370-1057|Cynthia.Osborne@usoncology.com|
286364|NCT01075152|University of Minnesota|Dr. David R Boulware|6126249996|coat.trial@gmail.com|
286365|NCT01075178|Abbott|Global Medical Services|800-633-9110||
286366|NCT01075191|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
286367|NCT01075204|Abbott|Esther Oppermann, Clinical Trial Manager|49 511 6750 3954|esther.oppermann@abbott.com|
286368|NCT01075217|Bracco Diagnostics Inc|Usha Halemane|609.514.2578|Usha.Halemane@diag.bracco.com|
286369|NCT01075243|GlaxoSmithKline|GSK Response Center|866-435-7343||
286370|NCT01075256|GlaxoSmithKline|GSK Response Center|866-435-7343||
286371|NCT01075282|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286372|NCT01075321|Mayo Clinic|Craig B. Reeder MD|480.301.8000|Reeder.Craig@mayo.edu|
286373|NCT01075347|Natinal Taiwan University Hospital|We-Li Chen , MD|886-2-2356|chenweili@ntu.edu.tw|5206
286374|NCT01075399|Certus International, Inc.|Edward M. Aten, MD, President|603.627.1212|eaten@certusintl.com|
286375|NCT01075412|The University of Iowa|Sarah McGuire, PhD|214-645-7613|Sarah.McGuire@utsouthwestern.edu|
286376|NCT01075516|Department of Cardiology, San Filippo Neri Hospital - Rome|Dr. Renato P. Ricci||renatopietroricci@tin.it|
286377|NCT01075646|Department of Anesthesia, Reanimation Bellvitge University Hospital|Noelia Fustran|932607323|nfustran@bellvitgehospital.cat|
297698|NCT01767376|GlaxoSmithKline|GSK Response Center|866-435-7343||
286378|NCT01075685|Inpes|Juliette Guillemont|+331 49 33 22 55|juliette.guillemont@inpes.sante.fr|
276884|NCT00570674|Dana-Farber Cancer Institute|Roy B. Tishler, MD|617.632.5734|RTISHLER@LROC.HARVARD.EDU|
286379|NCT01075763|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
286380|NCT01075815|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
286381|NCT01075958|Northumbria University|Dr Philippa Jackson|+44 191 204 8818|philippa.jackson@northumbria.ac.uk|
286382|NCT01075971|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
286383|NCT01075984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Cllinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286384|NCT01076010|AVEO Pharmaceuticals, Inc.|Cheif Medical officer|857-400-0101|Clinical@aveooncology.com|
286385|NCT01076036|Corindus, Inc|Michail M. Pankratov, MD, PhD, Vice President of Clinical & Regulatory Affairs|508-653-3335|Michail.Pankratov@Corindus.com|206
286386|NCT01076049|Irrimax Corporation|Chevy Brown, Clinical Trials Manager|770-807-3355|chevy.brown@irrisept.com|15
286387|NCT01076075|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286388|NCT01076088|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286389|NCT01076153|Abbott|Global Medical Services|1-800-633-9110||
286390|NCT01076166|Abbott|Global Medical Services|1-800-633-9110||
286391|NCT01076179|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
286392|NCT01076192|AbbVie|Global Medical Information|800-633-9110||
286393|NCT01076205|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
286394|NCT01076231|University of Pennsylvania|Dr. Jacob Shabason|215-662-3998|susan.mazzoni@uphs.upenn.edu|
286395|NCT01076244|Center for Pain Relief|Timothy Deer|(304) 347-6144|Diana.tolentino@stfh.net|
286396|NCT01076270|Fred Hutchinson Cancer Research Center|Dr. William Bensinger|206-667-4730|wbensing@fredhutch.org|
286397|NCT01076283|Brown University|Lorenzo Leggio, MD|401-863-1000|lorenzoleggio@gmail.com|
286398|NCT01076296|GE Healthcare|Anita Johnson|262-548-2825|Anita.Johnson@ge.com|
276885|NCT00570687|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
276886|NCT00570700|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
276887|NCT00570713|Morphotek, Inc.|Susan Weil, MD|610-423-6182|sweil@morphotek.com|
276888|NCT00570739|Daiichi Sankyo, Inc.|John Raia, Senior Director Professional Affairs|(973) 944-2683|jraia@dsi.com|
276889|NCT00570765|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
286399|NCT01076335|The University of Texas (UT) MD Anderson Cancer Center|Lance Pagliaro, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
286400|NCT01076348|Medtronic, Inc.|Stefanie Lorinser, Sr. Clinical Research Specialist|763-526-2742|stefanie.lorinser@medtronic.com|
297699|NCT01767415|Weill Cornell Medicine|Anita Ou|646-962-8188|ano2014@med.cornell.edu|
286401|NCT01076361|Medtronic|4968 Clinical Trial Leader||medtroniccrmtrials@medtronic.com|
286402|NCT01076400|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286403|NCT01076452|Hines Veterans Affairs Hospital Center for Management of Complex Chronic Care|Frances M. Weaver, Ph.D|708-202-8387|frances.weaver@va.gov|25866
286404|NCT01076504|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
286405|NCT01076543|University of Chicago|Dr. Sonali Smith, Professor of Medicine|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
286406|NCT01076647|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
286407|NCT01076686|Pacira Pharmaceuticals|Executive Medical Director|203-837-6500|erolo@pacira.com|
286408|NCT01076959|Abbott|Global Medical Services|800-633-9110||
286409|NCT01076972|Abbott|Global Medical Services|800-633-9110||
286410|NCT01076985|Abbott|Global Medical Services|800-633-9110||
286411|NCT01077024|University of Cincinnati Addiction Sciences Division|Dr. Theresa Winhusen|513-585-8227|winhust@ucmail.uc.edu|
286412|NCT01077050|SciBase|Director of Clinical Operations|+46841062001|per.svedenhag@scibase.se|
286413|NCT01077063|Sidney Kimmel Comprehensive Cancer Center at JHMI|Daniel Laheru, MD|410-955-8974|laherda@jhmi.edu|
286414|NCT01077076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
286415|NCT01077128|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
286416|NCT01077154|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
286417|NCT01077193|Ethicon-Endo Surgery, Inc.|Michael L. Schwiers|513-337-1172|mschwier@its.jnj.com|
286418|NCT01077258|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
286419|NCT01077271|Abbott|Global Medical Services|1-800-633-9110||
286420|NCT01077284|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
286421|NCT01077310|Yale School of Medicine|Principle Investigator|203-737-2883|sandra.springer@yale.edu|
286422|NCT01077323|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
286423|NCT01077362|Janssen Research & Development, LLC|Senior Director, Clinical Research|1-800-526-7736||
286424|NCT01077375|Forest Research Institute|Allan Spera, Director, Clinical Development|(201) 427-8399|Allan.Spera@frx.com|
297700|NCT01767467|GlaxoSmithKline|GSK Response Center|866-435-7343||
286425|NCT01077401|University of Nebraska|Quan Dong Nguyen, MD, MSc|4025591855|quan.nguyen@unmc.edu|
286426|NCT01077518|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
286427|NCT01077544|Novartis Pharmaceuticals|Study Director|82-778-8300|trialandresults.registries@novartis.com|
286428|NCT01077596|GlaxoSmithKline|GSK Response Center|866-435-7343||
286429|NCT01077622|GlaxoSmithKline|GSK Response Center|866-435-7343||
286430|NCT01077713|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
286431|NCT01077739|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
286432|NCT01077804|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
286433|NCT01077856|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286434|NCT01077921|Duke University Medical Center|Laura De Castro, MD, MHSc|(412) 623-7026|laura.decastro@dm.duke.edu|
286435|NCT01077960|EMD Serono|EMD Serono Medical Information|1-888-ASK-SERO (275-7376)||
286436|NCT01077973|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286437|NCT01078090|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
286438|NCT01078116|Abbott|Global Medical Services|1-800-633-9110||
286439|NCT01078155|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
286440|NCT01078168|Clinic of Psychiatry and Psychotherapy, University Medical Center JGU Mainz|Prof. Dr. Andreas Fellgiebel|+49-6131-17-7363|Andreas.Fellgiebel@unimedizin-mainz.de|
286441|NCT01078207|Covidien|Fran Haury, RRT Research Coordinator, Clinical Affairs|303 305-2314|fran.haury@covidien.com|
286442|NCT01078220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286443|NCT01078233|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286444|NCT01078246|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286445|NCT01078298|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297701|NCT01767493|Invicro|Stephanie Pizarro|203-990-1613|spizarro@invicro.com|
297702|NCT01767506|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
276890|NCT00570778|Novartis Pharmaceuticals|Study Director|862-778-8300||
297703|NCT01767519|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
297704|NCT01767597|Service des maladies infectieuses et tropicales - Hôpital Saint-Antoine|Dr. Julie Bottero|+33 1 49 28 04 24|julie.bottero@aphp.fr|
297705|NCT01767636|Mayo Clinic|Brian Costello MD|507/284-2511|Costello.Brian@mayo.edu|
297706|NCT01767688|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297707|NCT01767701|Queen Mary University of London|Professor Gavin Giovannoni||g.giovannoni@qmul.ac.uk|
276891|NCT00570908|Baylor Coolege of Medicine|Dr. Mothaffar Rimawi|7137981811|rimawi@bcm.edu|
276892|NCT00570921|University of Kentucky|Dr. Mara D. Chambers|866-340-4488|mdcham2@email.uky.edu|
276893|NCT00570960|University of Virginia|Patrick G. Northup, M.D.|434-924-0000|northup@virginia.edu|
276894|NCT00571038|Clement J. Zablocki VA Medical Center|Jeff Whittle, MD, MPH|414-384-2000|jeffrey.whittle@va.gov|46444
276895|NCT00571064|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
276896|NCT00571103|University of Iowa Carver College of Medicine|Dr. Donald W Black|319-3534431|donald-black@uiowa.edu|
286446|NCT01078363|Stanford University|William F. Fearon, M.D.|650 725-2621|wfearon@stanford.edu|
286447|NCT01078376|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
286448|NCT01078389|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
297708|NCT01767792|The University of Alabama at Birmingham|Bruce Korf, MD, PhD|205.934.4010|bkorf@uabmc.edu|
297709|NCT01767857|Janssen Research & Development, LLC|Product Development Portfolio Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
297710|NCT01767909|Wake Forest School of Medicine|Suzanne Craft, PhD, Project Director for Clinical Trial|(336) 713-8830|suzcraft@wakehealth.edu|
297711|NCT01767935|Wake Forest University Health Sciences|Dr. David Childs|336-716-2471|dchilds@wakehealth.edu|
297712|NCT01767987|Kettering Health Network|Suzanne Coleman, PhD|937-395-8390|suzanne.coleman@khnetwork.org|
297713|NCT01768000|Centre for Addiction and Mental Health|Sean Kidd|416-535-8501|sean.kidd@camh.ca|36295
297714|NCT01768013|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
297715|NCT01768117|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297716|NCT01768286|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
297717|NCT01768325|Indiana University School of Medicine|John DeWitt, MD|317-944-1113|jodewitt@iu.edu|
297718|NCT01768520|Hanlim Pharm|Clinical Trial Unit|82234896297|yrsong@hanlim.com|2234896297
297719|NCT01768559|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
297720|NCT01768572|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
297721|NCT01768637|University of Arkansas for Medical Sciences|Nishank Jain, MD|5016865295|njain2@uams.edu|
297722|NCT01768676|Vivus|Wesley D Day, PhD|650-934-5200||
297723|NCT01768832|Washington University in St. Louis|Dr. Gammon M. Earhart|314-286-1407|earhartg@wustl.edu|
297724|NCT01768845|West Virginia Universtiy|Michael Craig, MD|304-293-4980|craigm@wvumedicine.org|
297725|NCT01768858|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
297726|NCT01769105|Department of ophthalmology, University of Duesseldorf|Dr. David Finis|+49 211 8117320|David.Finis@med.uni-duesseldorf.de|
297727|NCT01769170|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
297728|NCT01769196|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
297729|NCT01769209|Stanford University Medical Center|Michaela Liedtke, MD|650-498-6000|mliedtke@stanford.edu|
297730|NCT01769222|Stanford University Medical Center|George Albert Fisher, MD|650-725-9057|georgeaf@stanford.edu|
297731|NCT01769248|Northwestern University|Srinadh Komanduri|312-695-0484|koman1973@gmail.com|
297732|NCT01769274|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297733|NCT01769326|University of California Irvine|Steven Cramer, M.D.|(949) 824-8748|scramer@uci.edu|
297734|NCT01769339|Janssen Philippines|Medical Affairs Manager|+6328248935||
297735|NCT01769352|Johns Hopkins University School of Medicine|Dr. Peter A. Campochiaro|410-955-5106|pcampo@jhmi.edu|
297736|NCT01769365|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@isca.vghks.gov.tw|8233
297737|NCT01769378|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297738|NCT01769391|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297739|NCT01769404|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
297740|NCT01769456|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
297741|NCT01769469|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
297742|NCT01769508|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
276897|NCT00571259|Satellite Healthcare, Inc.|Veronica Legg, MS: Director of Research Business|360-607-6892|leggv@satellitehealth.com|
297743|NCT01769573|UW Madison|Gina Crisafi|608-262-5240|gmc@medicine.wisc.edu|
297744|NCT01769586|VA Connecticut Healthcare System|Dr. Loren Laine|203-932-5711|loren.laine@yale.edu|
297745|NCT01769612|Institut Pasteur of Tunis|Afif Gen Salah, MD, PhD|011-216-71-792-429|noemailavailable@no.com|
297746|NCT01770145|US WorldMeds|Regulatory Associate, Clinical Operations|5028158130|rgerlach@usworldmeds.com|
297747|NCT01770314|Inflexxion|Emil Chiauzzi|617-614-0429|echiauzzi@inflexxion.com|
297748|NCT01770353|Ipsen Bioscience, Inc|Medical Director|See email|clinical.trials@ipsen.com|
308572|NCT02590003|Yale University|Rogerio C. Lilenbaum, MD, Professor of Medicine (Medical Oncology); Chief Medical Officer of Smilow|(203) 200-5864|rogerio.lilenbaum@yale.edu|
276898|NCT00571324|Children's Hospital of Philadelphia|Diva De Leon, MD|267-426-5529|DELEON@email.chop.edu|
276899|NCT00571428|Sunovion|Brovana Medical Director|1-866-503-6351||
276900|NCT00571493|University of Nebraska Medical Center|Julie M. Vose, M.D.|402-559-3848|jmvose@unmc.edu|
276901|NCT00571519|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
276902|NCT00571649|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
276903|NCT00571662|University of Nebraska Medical Center Division of Oncology/Hematology|R. Gregory Bociek, MD|402-559-5388|rgbociek@unmc.edu|
276904|NCT00571688|University of Alabama at Birmingham|Tracy Manley|205-975-3442|tlmanley@uabmc.edu|
276905|NCT00571701|Northwell Health (previously known as NorthShore-LIJ Health System)|Dr. Bettie Steinberg|516-562-1159|bsteinbe@northwell.edu|
276906|NCT00571948|Research Institute of Child Nutrition|Dortmund Intervention Trial for Optimization of Infant Nutrition|0049 231 7922100|kersting@fke-do.de|
276907|NCT00571961|Yale University AIDS Program|R. Douglas Bruce, MD, MA, MSc|(203) 737-6133|robert.bruce@yale.edu|
276908|NCT00571974|Roswell Park Cancer Institute|Gal Shafirstein, D.Sc.|716-845-4025|Gal.Shafirstein@RoswellPark.org|
276909|NCT00571987|UAMS|Dr. Suzanne Klimberg|501-686-6504|klimbergsuzanne@uams.edu|
276910|NCT00572039|Thomas Jefferson University|Barry W. Rovner, MD|2155031254|Barry.Rovner@jefferson.edu|
276911|NCT00572117|Stanford University School of Medicine|Michael J. Ostacher, MD, MPH, MMSc|650-493-5000|ostacher@stanford.edu|
286449|NCT01078402|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
286450|NCT01078441|ECOG Statistical Office|Study Statistician|617-632-3012||
286451|NCT01078545|Abbott|Global Medical Services|1-800-633-9110||
286452|NCT01078558|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
286453|NCT01078571|Abbott|Global Medical Services|1-800-633-9110||
286454|NCT01078584|Abbott|Global Medical Services|800-633-9110||
286455|NCT01078623|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
286456|NCT01078662|AstraZeneca|Anitra Fielding|+44 1625 517178|aztrial_results_posting@astrazeneca.com|
286457|NCT01078675|AstraZeneca, R&D, B&I|Niklas Berglind, GPS|+46317766310|niklas.berglind@astrazeneca.com|
286458|NCT01078753|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
286459|NCT01078805|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286460|NCT01078909|The Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
286461|NCT01078922|Oncology Specialists, SC|Research Manager|847-410-0658|ktolzien@oncmed.net|
286462|NCT01078974|Dana-Farber Cancer Institute|Steven P. Treon|617-632-2681|steven_treon@dfci.harvard.edu|
286463|NCT01079130|Novartis Pharmaceuticals|Study Director|862-778-8300||
286464|NCT01079143|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
286465|NCT01079182|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
286466|NCT01079195|Abbott|Global Medical Services|1-800-633-9110||
286467|NCT01079234|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
286468|NCT01079299|Center for Curative and Palliative Wound Care Calvary Hospital|Oscar M. Alvarez / Principal Investigator|718-518-2577|oalvarez@calvaryhospital.org|
286469|NCT01079390|Mass General Hospital|Jian Kong|617-726-7893|kongj@nmr.mgh.harvard.edu|
286470|NCT01079663|Dexcel Pharma|Clinical Trial Department Manager|972-4-6364000|sigalit.melcer@dexcel.com|467
286471|NCT01079741|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
286472|NCT01079806|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
286473|NCT01079832|Case Comprehensive Cancer Center|Dr. Charles Kunos|330-375-4485|kunosc@summahealth.org|
286474|NCT01079936|University of Texas (UT) MD Anderson Cancer Center|Muzaffar H. Qazilbash, Professor, Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
286475|NCT01079949|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
286476|NCT01079962|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
286477|NCT01079988|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
286478|NCT01080118|Northwestern University Feinberg School of Medicine|Dr. Gildasio DeOliveira|312-472-3573|g-jr@northwestern.edu|
286479|NCT01080131|Novartis Pharmaceuticals|Study Director|862 778-8300||
286480|NCT01080196|University of Utah|Dr Paul LaStayo|8019719298|paul.lastayo@health.utah.edu|
286481|NCT01080209|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
286482|NCT01080248|Washington University School of Medicine|Joel Picus, M.D.|314-362-5740|jpicus@dom.wustl.edu|
297749|NCT01770366|Baystate Medical Center|Sofija Zagarins|413-794-2876|sofija.zagarins@baystatehealth.org|
286483|NCT01080261|Boston Scientific Corporation|Ruth Starzyk, Ph.D.|508-683-6577|ruth.starzyk@bsci.com|
286484|NCT01080300|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
286485|NCT01080326|Mayo Clinic|Juliane Bingener-Casey, M.D.|507-538-9007|BingenerCasey.Juliane@mayo.edu|
286486|NCT01080391|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
286487|NCT01080625|SNUH|Chul-Woo Jung/ Assistant professor|82-2-2072-0640|spss@snuh.org|
286488|NCT01080677|Stanford University School of Medicine|Professor of Neurology|650-723-5184|chos@stanford.edu|
286489|NCT01080716|Vaccine Trial Treatment Center, Mahidol University|Punnee Pitisutithum, MBBS, DTM&H, FRCPT|66-2-643-5599|tmppt@mahidol.ac.th|
286490|NCT01080794|Beth Israel Deaconess Medical Center|Dr. Alvaro Pascual-Leone|(617) 667-0203|apleone@bidmc.harvard.edu|
308573|NCT02590354|Institute of Tropical Medicine Antwerp|Dr. Eric Florence|+32 3 247 66 42|eflorence@itg.be|
276912|NCT00572156|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
276913|NCT00572195|NeuroPace, Inc.|Dr. Martha Morrell, Chief Medical Officer|650-237-2776|mmorrell@neuropace.com|
276914|NCT00572234|University of Nebraska Medical Center|Dr. Kathleen Grant, M.D.|(402) 995-4347|kathleen.grant2@va.gov|
276915|NCT00572455|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276916|NCT00572468|Portland VA Health Care System|Wesley Stoller|503-220-8262|wesley.stoller@va.gov|54931
276917|NCT00572533|University of Louisville|Adam E Gaweda|502-852-0766|adam.gaweda@louisville.edu|
276918|NCT00572572|Hoosier Cancer Research Network|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
276919|NCT00572624|Washington University School of Medicine|Dr. Linda Peterson, M.D.|314-362-4577|lpeterso@dom.wustl.edu|
276920|NCT00572728|ACRIN|Ben Herman|401.863.9188|bherman@stat.brown.edu|
276921|NCT00572832|University of Pittsburgh|Richard Zimmerman|412-383-2354|zimmer@pitt.edu|
276922|NCT00572897|Univeristy of Illinois Hospital & Health Sciences System|Dr. Damiano Rondelli|312-996-6179|drond@uic.edu|
276923|NCT00572910|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276924|NCT00572936|UNMC|Carol Toris, PhD|402-559-1852|ctoris@unmc.edu|
276925|NCT00573066|Children's Hospital of Philadelphia|Athena Zuppa|267-426-7359|zuppa@email.chop.edu|
276926|NCT00573131|BTG International|Senior Manager Biostatistics|801-556-8882|claire.daugherty@btgplc.com|
276927|NCT00573144|Mayo Clinic|Dr. Horng H. Chen|507-284-1644|chen.horng@mayo.edu|
276928|NCT00573170|GlaxoSmithKline|GSK Response Center|866-435-7343||
286491|NCT01080807|Cephalon, Inc.|Vice President, Medical Affairs|610-727-6353||
286492|NCT01080976|BIDMC|Charles Safran|617-278-8170|csafran@bidmc.harvard.edu|
286493|NCT01081041|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286494|NCT01081132|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
286495|NCT01081145|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
286496|NCT01081249|University of California, San Diego Medical Center, Department of Psychiatry|Dr. Kai MacDonald|619-203-7393||
286497|NCT01081301|University of Alberta|Dr. Wendy Duggleby|780-492-8660|wendy.duggleby@ualberta.ca|
286498|NCT01081626|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
297750|NCT01770379|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
286499|NCT01081665|Abbott|Global Medical Services|1-800-633-9110||
286500|NCT01081678|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
286501|NCT01081769|Janssen-Cilag Germany|EMEA Medical Affairs Director Psychiatry||ClinicalTrialDisclosure@its.jnj.com|
286502|NCT01081795|Janssen Pharmaceutical KK Japan|Group Manager|+81-3-4411-5072||
286503|NCT01081834|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
286504|NCT01081873|Abbott|Global Medical Services|800-633-9110||
286505|NCT01081912|Zogenix|Kevin Romanko|(510) 550-8323|kromanko@zogenix.com|
286506|NCT01081951|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
286507|NCT01082081|GlaxoSmithKline|GSK Response Center|866-435-7343||
297751|NCT01770392|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297752|NCT01770431|Huazhong University of Science and Technology, Tongji Hospital Affiliated to Tongji Medical College, Huazhong Wuhan, Hubei, China|Xiaoping Chen, Professor|+86 27 83663400|chenxp@medmail.com.cn|
297753|NCT01770483|SIMS|Prof. Faisal Masud|00923004260213|faisalmasud@hotmail.com|
297754|NCT01770509|The Department of Dermatology, Sheba Medical Center|Dr. Shoshana Greenberger|972-3-5302443|shoshana.greenberger@sheba.health.gov.il|
297755|NCT01770652|ApoPharma Inc.|Fernando Tricta, MD|Phone: 416-401-7332|ftricta@apopharma.com|
297756|NCT01770691|ConTIPI LTD.|Dr. Elan Ziv|972-4-627-6066|eziv@contipi.com|
297757|NCT01770743|Emergent BioSolutions|Dr. Gurdyal Kalsi|301-216-9927|kalsig@ebsi.com|
297758|NCT01770860|Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.|Associate Director, Clinical Research|973-385-7984||
297759|NCT01770912|University of Florida|Charles G. Widmer, Associate Professor|352-273-5696|widmer@dental.ufl.edu|
297760|NCT01771055|University of Louisville|Dr. Jason Smith|502-852-5675|josmit19@louisville.edu|
297761|NCT01771172|Medtronic, Inc.|Medtronic CRDM Clinical Trial Manager|763-505-6000|medtronicCRMtrials@medtronic.com|
297762|NCT01771250|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297763|NCT01771627|MUSC|Dr. Ben Toll|843-792-9162|toll@musc.edu|
297764|NCT01771666|Stanford University|Dr. Irene Wapnir|650-724-1953|Wapnir@stanford.edu|
297765|NCT01771731|University of California San Francisco|Donald I. Abrams, MD|415-476-4082|Donald.Abrams@ucsf.edu|444
297766|NCT01771809|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
297767|NCT01771913|Faculdade de Medicina - Universidade de Sao Paulo|Dr. Luiz Alexandre Lorico Tissiani|55-11-981798707|latissiani@gmail.com|
297768|NCT01771952|University of Virginia, Kinesiology|Joe Hart|4349246187|jmh3zf@virginia.edu|
297769|NCT01771965|MUSC|Tracy Stecker, PhD|843.792.7287|stecker@musc.edu|
297770|NCT01771991|Sanford Health|Dr Chad Spanos MD|605-328-8200||
297771|NCT01772134|GlaxoSmithKline|GSK Response Center|866-435-7343||
297772|NCT01772147|GlaxoSmithKline|GSK Response Center|866-435-7343||
297773|NCT01772160|GlaxoSmithKline|GSK Response Center|866-435-7343||
276929|NCT00573183|Univerity of Washington Alcohol & Drug Abuse Institute|Dr. Dennis Donovan|206-543-0937|ddonovan@u.washington.edu|
297774|NCT01772316|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
297775|NCT01772368|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000||
297776|NCT01772537|The Johns Hopkins University|Dr. Charles Brown|410-955-0994|cbrown@jhmi.edu|
297777|NCT01772550|Becton, Dickinson and Company|Randall Jones, MD|801 565-2843|randall_jones@bd.com|
297778|NCT01772576|Boston Scientific|Ursula Appl|003224167213|ursula.appl@bsci.com|
297779|NCT01772654|Mayo Clinic|Cheolsu Shin, M.D.|507-284-4961|shin@mayo.edu|
297780|NCT01772693|Insightec|Nadir Alikacem, Ph.D., VP Clinical Research|214-630-2000|nadira@insightec.com|
297781|NCT01772758|Augusta University|Ryan Harris, Ph.D.|706-721-5998|ryharris@augusta.edu|
297782|NCT01772823|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
297783|NCT01773070|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
297784|NCT01773109|University of Pennsylvania (Abramson Cancer Center)|Dr. Charu Aggarwal|2156624000|charu.aggarwal@pennmedicine.upenn.edu|
276930|NCT00573248|University of California, Irvine|Jean Gehricke, Ph.D.|949-824-1834|jgehrick@uci.edu|
276931|NCT00573261|Duke University Medical Center|Dr. Wei Jiang|919-668-0762|weijiang@duke.edu|
276932|NCT00573287|Geisel School of Medicine at Dartmouth|Alan I. Green, M.D.|6036507549|alan.i.green@dartmouth.edu|
276933|NCT00573313|University of California Davis|Dr. Charles H. Halsted|530-752-4054|chhalsted@ucdavis.edu|
276934|NCT00573430|AstraZeneca|Gerard Lynch|+44 7780 956181|aztrial_results_posting@astrazeneca.com|5895
276935|NCT00573443|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
276936|NCT00573469|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
297785|NCT01773122|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
286508|NCT01082159|Vertos Medical|VP Clinical Research|949-349-0008|cmyers@vertosmed.com|216
286509|NCT01082211|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
297786|NCT01773135|Ain Shams University Maternity Hospital|Mohamed Saied Eldein El-Safty, Lecturer of Obstetrics and Gynecology Faculty of Medicine - Ain Shams|01003922211|dr.mai_elshahm@yahoo.com|002
286510|NCT01082328|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
286511|NCT01082367|Novartis|Study Director|862-778-8300||
286512|NCT01082380|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286513|NCT01082575|Covidien|Fran Haury Clinical Program Manager II|303 305-2314|fran.haury@covidien.com|
286514|NCT01082588|Massachusetts General Hospital|Dr. David Henderson|617-912-7800|dchenderson@partners.org|
286515|NCT01082614|Loma Linda University|Tonya Hamilton|909-558-9408|thamilton@llu.edu|
286516|NCT01082640|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
286517|NCT01082874|Population Health Research Institute|P.J. Devereaux, MD, PhD, FRCPC|905-527-4322|philipj@mcmaster.ca|40654
286518|NCT01082939|The University of Texas MD Anderson Cancer Center|William G. Wierda, MD, PhD, BS / Associate Professor|713-745-0428|eharriso@mdanderson.org|
286519|NCT01082952|King Saud University|Dr. Rabih Halwani|00966551307134|rhalwani@ksu.edu.sa|
286520|NCT01082965|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286521|NCT01083121|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
286522|NCT01083160|Abbott|Global Medical Services|1-800-633-9110||
286523|NCT01083173|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
286524|NCT01083186|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
286525|NCT01083199|American Medical Systems|Laura Olson, Clinical Project Manager|952-930-6428|laura.olson2@bsci.com|
276937|NCT00573508|Astellas Pharma Global Development|Astellas Medical Monitor||clinicaltrials@us.astellas.com|
286526|NCT01083316|Boston Medical Center|Vaishali Sanchorawala|6176386521|vaishali.sanchorawala@bmc.org|
286527|NCT01083368|Case Comprehensive Cancer Center|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
286528|NCT01083485|Mundipharma Research|Maggie Wilson|+ 4401223 424444||2303
286529|NCT01083576|US Army Medical Materiel Development Activity (USAMMDA)|Director, Division of Regulated Activites and Compliance|301-619-0197|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
286530|NCT01083602|Novartis Pharmaceuticals|Study Director|862-778-8300||
286531|NCT01083628|University of California, Berkeley|Dr. Adrian Aguilera|510-642-8564|aguila@berkeley.edu|
286532|NCT01083641|University of Wisconsin Carbone Cancer Center|Dr. Kari Wisinski|608-262-2876|kbwisinski@medicine.wisc.edu|
286533|NCT01083654|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
286534|NCT01083667|HSS/WCMC|Dale Lange|6467978917|langed@hss.edu|
286535|NCT01083680|AbbVie|Global Medical Information|800-633-9110||
286536|NCT01083693|Abbott|Global Medical Services|1-800-633-9110||
286537|NCT01083706|Fred Hutchinson Cancer Research Center|Bart Scott|206-667-1990|bscott@fredhutch.org|
286538|NCT01083732|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
286539|NCT01083758|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
286540|NCT01083771|Brown University Oncology Research Group (BrUOG)|Anthony Mega, MD|4018633000|kayla_rosati@brown.edu|
286541|NCT01083810|Abbott|Global Medical Services|1-800-633-9110||
297787|NCT01773187|CTI BioPharma Corp.|Beth Ziemba|206-272-4347|bziemba@ctibiopharma.com|
286542|NCT01083849|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
286543|NCT01083901|University of Colorado Denver|Catherine M. Jankowski|303-724-7383|catherine.jankowski@ucdenver.edu|
286544|NCT01083979|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
286545|NCT01084005|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
286546|NCT01084083|ECOG-ACRIN Statistical Office|ECOG-ACRIN statistician|617-632-3012||
286547|NCT01084135|Duke University Medical Center|Jane Ann Baker,MS, CGC|919-668-4576|janeann.mckillop@duke.edu|
286548|NCT01084148|Orfagen|Clinical Project Manager|0033 5 34 50 64 62|caroline.miklaszewski@orfagen.com|
297788|NCT01773226|Zimmer Biomet|Linda Korthout, Scientific Affairs Specialist|+31.610.072.853|Linda.Korthout.external@zimmerbiomet.com|
297789|NCT01773291|Kaohsiung Chang Gung Memorial Hospital|Wen-Long Hu, Deputy Director, Department of Chinese Medicine|+886-7-7317123|oolonghu@gmail.com|2334
297790|NCT01773421|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
276938|NCT00573534|Columbia University/New York State Psychiatric Instittue|Stephen J. Donovan MD|646 774 8078|sd45@columbia.edu|
297791|NCT01773473|Eli Lilly and Company|Medical Officer|800-545-5979||
297792|NCT01773889|The Cancer and Therapy Center at The University of Texas Health Science Center San Antonio|Tyler Curiel, MD|210-562-5287|CURIELT@UTHSCSA.EDU|
297793|NCT01773954|Mid Atlantic Retina|Michele Formoso|215-928-3092|research@midatlanticretina.com|
297794|NCT01773967|Cincinnati Children's Hospital Medical Center|Dr. David Schnadower|5138035526|david.schnadower@cchmc.org|
297795|NCT01773993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276939|NCT00573755|Mayo Clinic|Dr. Vivek Roy|507-284-1159|roy.vivek@mayo.edu|
276940|NCT00573768|Novartis Consumer Health|Sandy Hamelsky|+19735037258|sandy.hamelsky@novartis.com|
276941|NCT00573794|AbbVie|Global Medical Services|800-633-9110||
276942|NCT00573833|Memorial Sloan Kettering Cancer Center|Dr. Josh Yoshiya Yamada, Assistant Attending|+1212-639-2950|yamadaj@mskcc.org|
276943|NCT00573859|University of California, Irvine|Jean Gehricke, Ph.D.|949-824-1834|jgehrick@uci.edu|
276944|NCT00573872|University of Alabama at Birmingham|John Fiveash, MD|205-975-0224|jfiveash@uabmc.edu|
276945|NCT00573989|Wake Forest University Health Sciences|Dr. Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
297796|NCT01774045|Taipei Veterans General Hospital|Dr. Cheng-Ta Li|886-2-2871-2121|on5083@msn.com|7027
297797|NCT01774084|Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset, Stockholm, Sweden;|Thomas Nyström MD, PhD|+4686163211|thomas.nystrom@ki.se|
286549|NCT01084174|Johns Hopkins University|Robert A. Wood, MD|410-955-5883|rwood@jhmi.edu|
286550|NCT01084239|Massachusetts Genderal Hospital Biostatistics Center|Pearl Zakroysky|617 724 0309|pzakroysky@partners.org|
286551|NCT01084252|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
286552|NCT01084265|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
286553|NCT01084278|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
286554|NCT01084499|Asan Medical Center|Principal Investigator||mdlhs@amc.seoul.kr|
286555|NCT01084538|Abbott|Global Medical Services|1-800-633-9110||
286556|NCT01084551|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
286557|NCT01084603|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
286558|NCT01084655|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
286559|NCT01084668|Abbott|Global Medical Services|800-633-9110||
286560|NCT01084694|Northside Hospital|Dr. Dawn Speckhart, PhD|404-255-1930|dawn.speckhart@northside.com|
286561|NCT01084707|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
286562|NCT01084759|SKCCC at Johns Hopkins|Dr. Samuel Denmeade|410-955-8875|denmesa@jhmi.edu|
286563|NCT01084772|Smith & Nephew, Inc.|Stuart Pratt|+1 (901) 497-0365|stuart.pratt@smith-nephew.com|
286564|NCT01085006|Tehran University of Medical Sciences|Dr. Laleh Eslamian|+982184902415|leslamian@tums.ac.ir|
286565|NCT01085045|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
286566|NCT01085136|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
286567|NCT01085201|BloodCenter of Wisconsin|Dr. Joshua J. Field|414-937-3848|joshua.field@bcw.edu|
286568|NCT01085214|Massey Cancer Center, Virginia Commonwealth University|Steven Grant, M.D.|804-828-5211|stgrant@vcu.edu|
286569|NCT01085318|EMD Serono, Inc.|Fernando Dangond, MD FAAN|781-681-2348|fernando.dangond@emdserono.com|
286570|NCT01085331|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
276946|NCT00574067|Friends Research Institute|Dr. Michael Gordon|410-837-3977|mgordon@friendsresearch.org|251
286571|NCT01085344|The Hospital for Sick Children|Dr. Brian Feldman|416-813-5828|brian.feldman@sickkids.ca|
286572|NCT01085357|Transcend Medical, Inc.|Vice President of Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
286573|NCT01085500|Mayo Clinic|Benjamin Zendejas, MD|507-538-5413|zendejas.benjamin@mayo.edu|
286574|NCT01085513|Given Imaging|director of clinical affairs|+972-4-9097774|Hila.debby@givenimaging.com|
286575|NCT01085539|Covidien|Fran Haury, RRT Research Coordinator|303 305-2314|fran.haury@covidien.com|
286576|NCT01085591|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
286577|NCT01085630|HealthPartners Cancer Care Center|Arkadiusz Z. Dudek M.D., Ph.D.|651 254-3321|Arkadiusz.Z.Dudek@HealthPartners.Com|
286578|NCT01085682|The Catholic University of Korea|Kun-Ho Yoon, professor|82-2-2258-8281|yoonk@catholic.ac.kr|
286579|NCT01085734|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
286580|NCT01085760|Mayo Clinic|Dr. Jayant A. Talwalkar|507-538--4877|talwalkar.jayant@mayo.edu|
286581|NCT01085786|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|886-7-3462121|pihsu@isca.vghks.gov.tw|8233
286582|NCT01085812|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
286583|NCT01085825|Planned Parenthood of NYC|Research Director|212-274-7255|cti@ppnyc.org|
286584|NCT01085903|University of Arkansas for Medical Sciences|Mark Mennemeier, PhD|501 526 7773|msmennemeier@uams.edu|
276947|NCT00574119|Vanderbilt University School of Medicine|Marvin W. Kronenberg,M.D.|615 936-7437|marvin.w.kronenberg@vumc.org|
286585|NCT01085968|VA Overton Brooks|Elizabeth Disbrow|318-6757184|edisbr@lsuhsc.edu|
286586|NCT01086033|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
286587|NCT01086150|Albany Medical College|Charles E. Argoff, MD|518 262-0034|argoffc@mail.amc.edu|
286588|NCT01086215|Boston Scientific Corporation|DeeAnn Tinjum|763-450-8707|deeann.tinjum@bsci.com|
286589|NCT01086228|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
276948|NCT00574145|Vanderbilt-Ingram Cancer Center|Nancy Wells, DNSc., R.N|615-322-6184|nancy.wells@vanderbilt.edu|
286590|NCT01086358|Cleveland Clinic Foundation|Jennifer Kriegler, MD|216-444-8265|krieglj@ccf.org|
286591|NCT01086384|GlaxoSmithKline|GSK Response Center|866-435-7343||
286592|NCT01086410|GlaxoSmithKline|GSK Response Center|866-435-7343||
286593|NCT01086423|GlaxoSmithKline|GSK Response Center|866-435-7343||
286594|NCT01086475|Christian Sarkine Autism Treatment Center|Dr. Minshawi|317-944-8162|nminshaw@iupui.edu|
286595|NCT01086540|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
286596|NCT01086605|Mayo Clinic|Alvaro Moreno-Asptia, M.D.|507/284-1159|morenoaspitia.alvaro@mayo.edu|
286597|NCT01086761|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
276949|NCT00574171|UW Carbone Cancer Center|Dr. William Schelman|608-265-4347|wrs@medicine.wisc.edu|
276950|NCT00574197|Cedars-Sinai Medical Center|Ernst Schwarz, MD, PhD|(310) 840-7089|Ernst.Schwarz@cshs.org|
276951|NCT00574236|University of Wisconsin Carbone Cancer Center|Dr. Anne Traynor|608-262-5092|amt@medicine.wisc.edu|
276952|NCT00574249|Abbott|Medical Information Specialist|1-800-633-9110||
276953|NCT00574275|Sanofi|International Clinical Development Study Director||Contact-Us@sanofi.com|
286598|NCT01086852|Bio Products Laboratory|Miranda Norton|020 8 957 2661|miranda.norton@bpl.co.uk|
297798|NCT01774097|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|lemmoye@msn.com|
297799|NCT01774110|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
286599|NCT01086969|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
276954|NCT00574288|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
286600|NCT01087489|Miami Veterans Affairs Medical Center|Dr. Ninel Gregori, MD|305-575-7000|ngregori@med.miami.edu|3081
286601|NCT01087502|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
286602|NCT01087528|Givenimaging|Hilla Debby/Director of clinical affairs|972490977740|hila.debby@givenimaging.com|77740
286603|NCT01087541|Jordi Gol i Gurina Foundation|Cecilia Borau|34 934824617|cborau@idiapjgol.org|
286604|NCT01087723|The Medicines Company|Global Health Science Center|800-388-1183||
286605|NCT01087736|University of California, San Francisco|David L. Pennington, PhD (Research Psychologist II)|415-221-4810|david.pennington2@va.gov|4504
286606|NCT01087762|Cares|UCB|+1887822||9493
286607|NCT01087775|San Francisco VA Medical Center|Dr. Karen Seal|4152214810|Karen.Seal@va.gov|24852
286608|NCT01087788|Cares|UCB|+1877 822||9493
286609|NCT01087801|ChiRhoClin, Inc.|Edward Purich, Ph.D.|301-476-8388|mdoerr@chirhoclin.com|
286610|NCT01087814|University of Minnesota|Ann Seguin|612-625-7472|segu0017@umn.edu|
286611|NCT01087905|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.medicine.wisc.edu|
286612|NCT01087918|UZurich|Hubertus van Hedel, PhD|+41 44 762 52 91|hubertus.vanhedel@kispi.uzh.ch|
286613|NCT01087931|Vanderbilt University|Kevin O'Neill|615-936-5677||
286614|NCT01087944|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
286615|NCT01087957|Innovative Neurotronics|Helen Rogers PT, PhD|512-721-1922|hrogers@ininc.us|
286616|NCT01087970|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
276955|NCT00574340|University of Maryland, Baltimore|Dr. Stephen N. Davis|410-328-2488|sdavis@medicine.umaryland.edu|
286617|NCT01087996|The EMMES Corporation|Adam Mendizabal|301 251 1161|amendizabal@emmes.com|221
286618|NCT01088048|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
276956|NCT00574405|Arkansas Children's Hospital Research Institute|Kathryn Thrailkill, MD|501-364-1430|thrailkillkathrynm@uams.edu|
286619|NCT01088243|National Jewish Health|Dr. Lisa A. Maier|303-398-1983|MaierL@NJHealth.org|
286620|NCT01088295|University of California, Los Angeles|Jordan E. Lake, M.D., M.Sc.|(310)557-1891|jlake@mednet.ucla.edu|
286621|NCT01088399|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286622|NCT01088412|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
286623|NCT01088438|University of Illinois at Chicago|Dr. Alan Schwartz|312-996-2070|alansz@uic.edu|
286624|NCT01088464|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286625|NCT01088503|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286626|NCT01088529|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
286627|NCT01088646|Givenimaging|Hilla Debby/Director of clinical affairs|97249097774|hila.debby@givenimaging.com|7774
286628|NCT01088672|Stryker NV|Amelia Saliba, AIS Clinical Program Manager|510-413-2500|aisstudies@stryker.com|
286629|NCT01088711|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286630|NCT01088984|Teva Pharmaceuticals USA|Manager|1-866-384-5525|clinicaltrialqueries@tevausa.com|
286631|NCT01088997|Children's Hospital of Philadelphia|Haresh Kirpalani, MD, MSc|215-590-2455|kirpalanih@email.chop.edu|
286632|NCT01089023|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
286633|NCT01089062|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
286634|NCT01089127|Novartis Pharmaceuticals|Study Director|862 778-8300||
297800|NCT01774149|Norwegian Center for Integrated Care and Telemedicine|Dr. Stein Olav Skrøvseth|+4795805841|stein.olav.skrovseth@telemed.no|
286635|NCT01089231|Leibniz Universität Hannover|M. Sc. Simone Schmidt|+49 (511) 762 5931|Schmidt@nutrition.uni-hannover.de|
286636|NCT01089361|Beth Israel Deaconess Medical Center|Dr. Daniel Talmor|617-754-2675|dtalmor@bidmc.harvard.edu|
286637|NCT01089413|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
286638|NCT01089504|University of Rochester|Ronnie Guillet|585-275-6209|ronnie_guillet@urmc.rochester.edu|
286639|NCT01089517|Ophthotech|Jeffrey Nau|646-573-7045|jeff.nau@ophthotech.com|
286640|NCT01089543|Eisai Inc.|Yoshiumi Okubo, Study Director|+81-3-3817-3908|y4-okubo@hhc.eisai.co.jp|
286641|NCT01089556|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286642|NCT01089569|International Diabetes Center|Dr. Richard M. Bergenstal|952-993-1913|richard.bergenstal@parknicollet.com|
286643|NCT01089582|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276957|NCT00574548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286644|NCT01089595|Fox Chase Cancer Center|Margaret von Mehren, Principal Investigator|215-728-4300|margaret.vonmehren@fccc.edu|
286645|NCT01089608|Laboratoires Thea|Dr Pascale POULIQUEN|0473981436|p.pouliquen@laboratoires-thea.fr|
297801|NCT01774253|NMTRC|Giselle Sholler, MD|6162670335|genevieve.bergendahl@helendevoschildrens.org|
276958|NCT00574587|Montefiore Medical Center|Markenya Mirander|718-862-8840|MMIRANDE@montefiore.org|
276959|NCT00574704|Cytos Biotechnology AG|Head of Clinical Develpment|+41 44 733 4|info@cytos.com|7 47
276960|NCT00574795|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
276961|NCT00574834|University of Maryland Baltimore|Stephen N. Davis, MBBS- Principal Investigator|410-328-2488|sdavis@medicine.umaryland.edu|
276962|NCT00574847|Duke University Medical Center|Wei Jiang, MD|919-668-0762|jiang001@mc.duke.edu|
286646|NCT01089647|University of Cincinnati|Dr. Ann Romaker|513-475-7500|romakean@ucmail.uc.edu|
286647|NCT01089725|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286648|NCT01089751|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
297802|NCT01774305|Yonsei Univ. Health System, Gangnam Severance Hospital|Dr. Jeongsoo Lee|+82-2-2019-6092|ration99@yuhs.ac|
297803|NCT01774344|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
297804|NCT01774591|University of Chicago|George L. Bakris, MD|773-702-7936|bbrisky@medicine.bsd.uchicago.edu|
297805|NCT01774604|Penn State Hershey Medical Center/Dartmouth-Hitchcock Medical Center|John M. Levenick|603-667-1332|jlevenick@hmc.psu.edu|
297806|NCT01774760|Turku University Hospital, Turku, Finland|Prof. Heikki Minn|+35823130000|heikki.minn@tyks.fi|30149
297807|NCT01774786|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
297808|NCT01774799|Hebrew SeniorLife|Dr. Susan Mitchell|617-971-5326|smitchell@hsl.harvard.edu|
297809|NCT01774851|Merrimack Pharmaceuticals|MM-111 Medical Director|617-441-1000||
297810|NCT01774903|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||
297811|NCT01774929|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||5888
297812|NCT01774968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297813|NCT01774981|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297814|NCT01775124|Novartis|Study Director|862-778-8300||
297815|NCT01775137|Novartis Pharmaceuticals|Study Director|862-778-8300||
297816|NCT01775189|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297817|NCT01775371|Albert Einstein College of Medicine|Dr. Polly Bijur|718-430-4217|polly.bijur@einsteinmed.edu|
297818|NCT01775410|Avinger, Inc.|Director of Clinical Trials|650 241 7030|tlawson@avinger.com|
297819|NCT01775501|Massachusetts General Hospital|Dr. Lipika Goyal|617-724-4000|LGOYAL@PARTNERS.ORG|
297820|NCT01775553|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|212-241-7873|ajai.chari@mountsinai.org|
297821|NCT01775670|Massachusetts General Hospital|Taylor Pong||tpong1@partners.org|
297822|NCT01775722|University of California, Irvine. Beckamn Laser Institute|J Stuart Nelson|9498247997|jsnelson@uci.edu|
297823|NCT01775735|Boston Scientific|Director, Clinical Sciences and Scientific Communication||Roshini.Jain@bsci.com|
297824|NCT01775774|University of California San Francisco|Michael A. Matthay, MD|415-353-1206|michael.matthay@ucsf.edu|
297825|NCT01775787|UConn Health|Dr. Cheryl Oncken|860-679-3425|oncken@uchc.edu|
297826|NCT01775800|The Rogosin Institute|Dr. Nathaniel Berman|212-746-9766|nab2009@nyp.org|
297827|NCT01775852|Baylor College of Medicine|Lilian Dindo, PhD|713-791-1414|lilian.dindo@bcm.edu|10296
297828|NCT01775865|University of Iowa|Gary Pierce|319-335-9487|gary-pierce@uiowa.edu|
297829|NCT01775904|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297830|NCT01775930|UT MD Anderson Cancer Center|Dr. Eric Jonasch, MD / Professor, Genitourinary Medical Oncology|713- 563-7232|ejonasch@mdanderson.org|
297831|NCT01775995|University of Wisconsin Madison|Aleksandra Zgierska, MD PhD|(608) 263-7882|aleksandra.zgierska@fammed.wisc.edu|
297832|NCT01776008|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.||cma@dom.wustl.edu|
297833|NCT01776268|Vanderbilt University Medical Center|James Wynn MD||james.wynn@peds.ufl.edu|
297834|NCT01776307|Sumitomo Dainippon Pharma Oncology|Tegan Nguyen|617-674-8745|tnguyen@bostonbiomedical.com|
297835|NCT01776424|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
297836|NCT01776541|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
297837|NCT01776554|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
297838|NCT01776632|San Diego State University|Elva Arredondo|(619) 594-3481|earredon@sdsu.edu|
297839|NCT01776645|Stanford University|Dr. Sean Mackey|650-724-2795|smackey@pain.stanford.edu|
297840|NCT01777126|Pharmacy Department, University Hospitals Leuven & Department of Pharmaceutical and Pharmacological Sciences, KULeuven, Belgium|Peter Declercq|003216342340|peter.declercq@uzleuven.be|
297841|NCT01777139|GlaxoSmithKline|GSK Response Center|866-435-7343||
297842|NCT01777152|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
297843|NCT01777191|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297844|NCT01777217|Century Cancer Centers|Dr. Sanjay Mehta|713-631-8181||
297845|NCT01777269|GlaxoSmithKline|GSK Response Center|866-435-7343||
297846|NCT01777282|GlaxoSmithKline|GSK Response Center|866-435-7343||
297847|NCT01777308|GlaxoSmithKline|GSK Response Center|866-435-7343||
297848|NCT01777321|GlaxoSmithKline|GSK Response Center|866-435-7343||
308574|NCT02590406|Institut universitaire Cardiologie et Pneumologie de Québec|Dr Jean S Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|2944
276963|NCT00574873|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276964|NCT00574912|University of Maryland, Baltimore|Dr. Stephen N. Davis|4103282488|sdavis@medicine.umaryland.edu|
276965|NCT00574951|NRG Oncology|Angela Kuras on behalf of Mike Sill, PhD|716-845-5702|kurasa@nrgoncology.org|
276966|NCT00574990|Salt Lake City VA HSRD IDEAS 2.0 Center of Innovation|Dr. Charlene Weir|801-582-1565|charlene.weir@utah.edu|5114
276967|NCT00575016|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
276968|NCT00575029|University of Arkansas|Dr. Donald Bodenner|501-526-5710|bodennerdonald@uams.edu|
276969|NCT00575042|University of Miami|Dr. Cynthia Levy|305-243-2330|clevy@med.miami.edu|
276970|NCT00575094|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
276971|NCT00575146|Dr. Senckenberg Institute of Neurooncology|Dr. Johannes Rieger|+49 69 6301|johannes.rieger@med.uni-frankfurt.de|87711
308575|NCT02590432|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
308576|NCT02590562|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
308577|NCT02590588|Boston Medical Center|Mark Sloan MD|617-638-2367|mark.sloan@bmc.org|
308578|NCT02590939|CEFALY Technology|Clinical Trials Department director|+32 4 367 67 22|info@cefaly.com|
308579|NCT02591056|Regulatory Insight, Inc.|Elvira Cawthon, Clinical Consultant|615-712-9743|elvira@reginsight.com|
286649|NCT01090011|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
286650|NCT01090050|Clinvest/A Division of Banyan Group Inc.|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
286651|NCT01090063|Tufts Medical Center|Dr. Alice Gottlieb|617-636-7462|Agottlieb@tuftsmedicalcenter.org|
286652|NCT01090076|Changi General Hospital|Mr Alvin Wong|68504627|alvin_wong@cgh.com.sg|
286653|NCT01090102|University of California, San Francisco|Dr. Ma Somsouk|415-206-6480|somsoukma@medsfgh.ucsf.edu|
297849|NCT01777334|GlaxoSmithKline|GSK Response Center|866-435-7343||
286654|NCT01090180|Veterans Affairs North Texas Health Care System|Alina Suris|817-715-0625|alina.suris@va.gov|
297850|NCT01777412|Johns Hopkins University|Michael Levy|443-287-4412|mlevy@jhmi.edu|
297851|NCT01777425|UZ Leuven|Prof. Dr. P. Hellings|+3216332340|peter.hellings@uzleuven.be|
297852|NCT01777438|UZ Leuven|Dr Hellings|+32 16 332338|peter.hellings@uzleuven.be|
297853|NCT01777490|HSR&D/COIN, Durham VAHCS|Courtney Van Houtven|(919)286-6936|Courtney.VanHoutven@va.gov|
297854|NCT01777542|Boston Children's Hospital|Dr. Mustafa Sahin, Director of Translational Neuroscience Center|617-919-6258|ResearchTNC@childrens.harvard.edu|
297855|NCT01777568|Cleveland Clinic|Kurz, M.D., Andrea|(216) 445-9924|KURZA@ccf.org|
297856|NCT01777581|Duke University Medical Center|David Marks, MD|919 668-2859|d.marks@duke.edu|
297857|NCT01777620|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
297858|NCT01777763|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
297859|NCT01777776|Array BioPharma, Inc.|Study Director|303-381-6604|info@arraybiopharma.com|
297860|NCT01777932|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
297861|NCT01777945|Hoffmann-La Roche|Medical Communications|1-800-821-8590||
297862|NCT01777997|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
276972|NCT00575159|GlaxoSmithKline|GSK Response Center|866-435-7343||
297863|NCT01778010|New York State Psychiatric Institute at Columbia University Medical Center|Margaret Haney, Ph.D.|646-774-6153|meg.haney@nyspi.columbia.edu|
297864|NCT01778023|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
297865|NCT01778049|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297866|NCT01778062|Novartis Pharmaceuticals|Study Director|862-778-8300||
297867|NCT01778127|St. Jude Children's Research Hospital|Kirsten K. Ness, PT, PhD|901-595-5157|kiri.ness@stjude.org|
297868|NCT01778179|Brazilian Center for Studies in Dermatology|Dr. Doris Hexsel|+55 51 30262633|doris@hexsel.com.br|
297869|NCT01778296|The Second Hospital of Tangshan|Dr. Chao Chen|86-13700350471|ts_chenchao@163.com|
297870|NCT01778426|Medtronic|Neuromodulation, Clinical Study Management||medtronicneurotrials@medtronic.com|
297871|NCT01778465|Western University|Clinical Trials Program Coordinator|+15196466100|taciano.rocha@sjhc.london.on.ca|61125
297872|NCT01778530|National Cancer Institute|Dr. Joohee Sul|301-402-6298|Joohee_Sul@nih.gov|
297873|NCT01778556|NIDDK|Dr. Rebecca Brown|301-594-0609|brownrebecca@mail.nih.gov|
297874|NCT01778634|University of Maryland|Rose Marie Viscardi, M.D.|410-706-1913|rviscard@som.umaryland.edu|
297875|NCT01778751|Durham Veterans Affairs Medical Center|Dr Matthew J Crowley|919-286-6936|matthew.crowley@va.gov|
297876|NCT01778855|UCLA|David S Liebeskind, MD|310-794-6379|dliebeskind@mednet.ucla.edu|
297877|NCT01778985|University of Texas Southwestern Medical Center|David D. Rahn, M.D.|214-648-6430|david.rahn@utsouthwestern.edu|
297878|NCT01779024|National Institute on Alcohol Abuse and Alcoholism|Leggio, Lorenzo|+1 301 435 9398|lorenzo.leggio@nih.gov|
297879|NCT01779141|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
297880|NCT01779167|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
297881|NCT01779219|Wroclaw University Hospital, Department of Neurosurgery|Dr. Marcin Czyz|+48 734-34-00|mt.czyz@gmail.com|
297882|NCT01779375|George Washington University Biostatistics Center|Sharon Edelstein|3018819260|sharone@bsc.gwu.edu|
297883|NCT01779440|Dartmouth-Hitchcock|Mary F. Brunette, MD|603-229-5419|Mary.F.Brunette@hitchcock.org|
297884|NCT01779648|SMG-SNU Boramae Medical Center|Principal Investigator|+82-10-9988-2691|turejsreal@hanmail.net|
297885|NCT01779700|Indiana University|Dr. Alan Breier|317-880-8495|abreier@iupui.edu|
297886|NCT01779856|Medtronic, plc|RCS Sr. Director of Medical Affairs|763-505-4566|amy.denise.roettger@medtronic.com|
297887|NCT01779869|Washington University School of Medicine|Pamela K. Woodard, M.D.|314-362-7130|woodardp@wustl.edu|
297888|NCT01780324|Seattle Children's Hospital|Neil Uspal, MD|206-987-2599|neil.uspal@seattlechildrens.org|
308580|NCT02591238|Peking Union Medical College Hospital.|Prof. Changwei Liu. Director of vascular surgery.|+86 1069152509|aresbill@outlook.com|
308581|NCT02591290|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
276973|NCT00575185|University of Minnesota|Hank Balfour MD|(612) 626-5670|balfo001@umn.edu|
276974|NCT00575328|Depression Clinical and Research Program, Massachusetts General Hospital|Dr. David Mischoulon, Director|617-724-5198|dmischoulon@partners.org|
276975|NCT00575367|Inspire Pharmaceuticals, Inc.|Karen Kuhn/ Director|919 941-9777|kkuhn@inspirepharm.com|
276976|NCT00575380|Inspire|Mike Schiewe|919-941-9777|mschiewe@inspirepharm.com|
276977|NCT00575510|Mayo Clinic|Dr. Carmen Radecki Breitkopf|507-266-0969|radeckibreitkopf.carmen@mayo.edu|
286655|NCT01090310|Novartis|Study Director|862-778-8300||
286656|NCT01090323|Novartis Pharmaceuticals|Study Director|862-778-8300||
308582|NCT02591511|Taipei medical university|Dr. Chia-Yun Lin|+886919986391|windoct@hotmail.com|
308583|NCT02591537|Northwestern University|Dr. Robert Galiano, Associate Professor of Surgery|312.695.3908||
308584|NCT02592018|UCSF Department of Dermatology|Dr. Wilson Liao|415-476-4701|wilson.liao@ucsf.edu|
297889|NCT01780337|Columbia University|William Whang|212-305-8620|ww42@cumc.columbia.edu|
286657|NCT01090414|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
286658|NCT01090427|Janssen Research & Development, LLC|VICE PRESIDENT IMMUNOLOGY||ClinicalTrialDisclosure@its.jnj.com|
286659|NCT01090453|GlaxoSmithKline|GSK Response Center|866-435-7343||
286660|NCT01090479|Northwestern University|Michael Murray, MD|312-926-4444|m.murray8278@gmail.com|
286661|NCT01090492|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286662|NCT01090739|University of Michigan, Professor of Obstetrics and Gynecology|Dee Fenner, MD, Study Coordinating Investigator|734-647-5866|deef@med.umich.edu|
286663|NCT01090752|University Hospital Geneva and Lausanne, Switzerland|Zanchi Anne, MD|0041213140775|azanchidel@hotmail.com|
297890|NCT01780350|University of Texas Health Science Center San Antonio|David Wampler, PhD|210.567.7598|wamplerd@uthscsa.edu|
286664|NCT01090765|National Cancer Institute|Dr. William Dahut|301-496-4251|dahutw@mail.nih.gov|
286665|NCT01090921|BVARI|Nikhil C. Munshi, M.D.|857-203-6172|nikhil_munshi@dfci.harvard.edu|
286666|NCT01090973|H. Lee Moffitt Cancer Center and Research Institute|Celeste Bello, M.D.|813-745-8623|celeste.bello@moffitt.org|
286667|NCT01091103|Medivation, Inc.|Mohammad Hirmand, MD, VP, Clinical Development|415-829-4126|mohammad.hirmand@medivation.com|
286668|NCT01091116|Menarini-Ricerche|Clinical Research Director|+39-055-56809990||
286669|NCT01091155|novoGI|Eran Choman, VP Clinical Affairs & Statistics|+972 9 8603000|eran.choman@novogi.com|
286670|NCT01091168|INSTITUT DE RECHERCHE PIERRE FABRE|Dr Karim Keddad|+33 5 34 50 61 69|karim.keddad@pierre-fabre.com|
286671|NCT01091246|MedImmune, LLC|Judy Falloon, MD/ Sr Director Clinical Development|301-398-0000|falloonj@medimmune.com|
286672|NCT01091259|Perlmutter Cancer Center at NYU Lagone|Franco Muggia, MD|212-263-6485|Franco.Muggia@nyumc.org|
286673|NCT01091363|University of Massachusetts Medical School|Dr. Sun S Kim|201-388-2656|sun.kim@umb.edu|
286674|NCT01091428|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
286675|NCT01091454|Mayo Clinic|Alvaro Moreno-Aspitia MD|507-284-1159|morenoaspitia.alvaro@mayo.edu|
286676|NCT01091519|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286677|NCT01091662|Sunovion Phamaceuticals Inc.|Eslicarbazepine acetate Medical Director|866-503-7813|clinicaltrialsdisclosure@sunovion.com|
297891|NCT01780389|Duke University Medical Center|David Marks, MD|619 668-2859|d.marks@duke.edu|
286678|NCT01091675|Unidad de Reumatología, Hospital Parc Tauli de Sabadell. Institut Universitari UAB|Dr. Jordi Gratacós Masmitjá|937.23.10.10|jgratacosmas@gmail.com|
286679|NCT01091948|Cleveland Clinic Foundation|Dr. Basem Abdelmalak|216-444-3746|abdelmb@ccf.org|
286680|NCT01091974|University of Rochester Medical Center|Joseph A. Roscoe Ph.D.|(585) 275-9962|Joseph_Roscoe@URMC.Rochester.edu|
286681|NCT01092182|National Cancer Institute|Dr. Mark J. Roschewski|240-760-6183|roschewskimj@nih.gov|
286682|NCT01092195|National Institutes of Health|Pamela Stratton MD|301-435-4068|strattop@mail.nih.gov|
286683|NCT01092338|Children's Hospital of Philadephia|Virginia Stallings|215-590-1664|stallingsv@email.chop.edu|
286684|NCT01092364|Duke University Medical Center|Dr. Laura P. Svetkey|919-660-6626|laura.svetkey@dm.duke.edu|
286685|NCT01092416|Cardiovascular Systems, Inc.|Clinical Project Manager|6512591600|clinicaltrials_csi@csi360.com|
286686|NCT01092442|CryoLife, Inc.|Scott B. Capps, MS|800-438-8285|clinicaltrialregistration@cryolife.com|
286687|NCT01092507|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
297892|NCT01780454|Massachusetts General Hospital|Dr. David Sachs|617-726-4065|David.Sachs@tbrc.mgh.harvard.edu|
286688|NCT01092546|GE Healthcare|Paul Sherwin, M.D.|609-514-6820|Paul.Sherwin@ge.com|
286689|NCT01092559|GeNO, LLC|Director of Clinical Development|321-785-2613|matthew.rush@genollc.com|
286690|NCT01092637|National Perinatal Epidemiology Unit, University of Oxford|Clinical Trials Unit|+44 1865 289700|ctu@npeu.ox.ac.uk|
286691|NCT01092663|KineMed, Inc.|Carine Beysen, PhD|510-655-6525|cbeysen@kinemed.com|123
286692|NCT01092676|LHSC Lawson HRI|Rodrick Lim|5198525496|rod.lim@lhsc.on.ca|
286693|NCT01092702|Mayo Clinic|J Taylor Hays. MD|507-266-1944|nicotineresearch@mayo.edu|
286694|NCT01092728|The University of Texas (UT) MD Anderson Cancer Center|Kevin Kim, MD/Melanoma Medical Oncology|1-877-MDA-6789|CR_Study_Registration@mdanderson.org|
286695|NCT01092767|Medtronic, Inc., Aortic and Peripheral Vascular|Laura Regan, MPH - Study Lead|707-591-2743|laura.e.regan@medtronic.com|
286696|NCT01092780|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286697|NCT01092832|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286698|NCT01092910|Envoy Medical Corp.|Elizabeth Anderson, PhD|651-361-8080|landerson@envoymedical.com|
276978|NCT00575588|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
286699|NCT01092923|Austin Health|Dr Phil Peyton|9496 5000|phil.peyton@austinhealth.org.au|5704
286700|NCT01093014|University of Iowa / Iowa City VA Medical Center|Richard K. Shields PhD, PT|319-335-9791|richard-shields@uiowa.edu|
286701|NCT01093027|Mayo Clinic|Virgilio Evidente MD|480-301-8000|evidente.virgilio@mayo.edu|
276979|NCT00575666|UMass Medical School|Xiaoduo Fan, MD, MPH, MS|508-856-3881|Xiaoduo.Fan@umassmed.edu|
276980|NCT00575887|Marmara University|Ufuk Abacioglu|902123853100|ufuk@abacioglu.com|
276981|NCT00575965|Dana Farber Cancer Institute|Steven P. Treon MD, PhD|617 632 5880|steven_treon@dfci.harvard.edu|
276982|NCT00576056|University of Pittsburgh Medical Center|Dr. David Geller|412-692-2001|gellerda@upmc.edu|
276983|NCT00576147|Baylor College of Medicine|Claudia Robertson|(713) 798-8932|claudiar@bcm.edu|
276984|NCT00576199|Hoffmann-La Roche|Medical Communications|800 821-8590||
276985|NCT00576251|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
276986|NCT00576303|F. Hoffmann-La Roche AG|Name/Official Title:Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
276987|NCT00576316|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
286702|NCT01093183|University of Nebraska Medical Center|James Schwarz, MD|402-559-5166|jkschwarz@unmc.edu|
286703|NCT01093222|SWOG|Study Statistician|206-667-4623||
286704|NCT01093417|University Hospitals Case Medical Center|Grace McComsey, MD|2168443607|gam9@case.edu|
286705|NCT01093469|Wake Forest|Dr Alan Fleischer|336-716-3775|adclark@wakehalth.edu|
286706|NCT01093482|VENTILA group|Andres Esteban|34916834982|aesteban@ucigetafe.com|
286707|NCT01093521|University of Washington|A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients|206-543-3166|goss@u.washington.edu|
286708|NCT01093534|Astellas Pharma Europe Ltd.|Director Medical Affairs - Urology||clinicaltrials@us.astellas.com|
286709|NCT01093573|Case Comprehensive Cancer Center|Brenda Cooper MD|(216) 844-3213|Brenda.cooper@uhhospitals.org|
286710|NCT01093586|Case Comprehensive Cancer Center|Brenda Cooper MD|216-844-3213|brenda.cooper@uhhospitals.org|
286711|NCT01093599|University of Wisconsin|James M. Davis MD, Assistant Professor, Duke University|608-217-9405|jjamesdavis@hotmail.com|
286712|NCT01093625|Vistakon|Katherine E. Osborn||clinicalstudies@its.jnj.com|
286713|NCT01093651|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
286714|NCT01093690|Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University|Suthinee Ithimakin, MD|6624197000|aesi105@yahoo.co.th|4489
286715|NCT01093755|Mayo Clinic|Prasad Iyer, MD|507-284-0970|Iyer.Prasad@mayo.edu|
286716|NCT01093794|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
297893|NCT01780506|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
286717|NCT01093885|University of Pennsylvania Health System|Dr. Chris Derk|215-662-2792|chris.derk@uphs.upenn.edu|
286718|NCT01093976|University of Minnesota|Jon E. Grant|612-273-9800|grant045@umn.edu|
286719|NCT01094106|Kuopio University Hospital|Matti Reinikainen|+358447176681|matti.reinikainen@kuh.fi|
286720|NCT01094119|Cleveland Clinc|Daniel Sessler|216-444-4900|DS@OR.org|
286721|NCT01094171|GlaxoSmithKline|GSK Response Center|866-435-7343||
286722|NCT01094184|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
286723|NCT01094288|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
286724|NCT01094301|SPRTherapeutics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
286725|NCT01094522|Stanford University School of Medicine|Dr. Gregory Hammer|6507367359|ham@stanford.edu|
286726|NCT01094548|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
286727|NCT01094574|Stanford School of Medicine|Martin Angst, MD, Professor, Dept. of Anesthesia, Stanford SOM|650-498-5109|ang@stanford.edu|
286728|NCT01094704|UNC-Chapel Hill|Scott Donaldson|919-966-9198|scott_donaldson@med.unc.edu|
286729|NCT01094717|University of Utah, Derpartment of Dermatology|Kristina Callis-Duffin|8015816465|Kristina.Duffin@hsc.utah.edu|
286730|NCT01094730|Johnson & Johnson Vision Care|John R. Buch, O.D., M.S., F.A.A.O., Principal Research Optometrist|1-904-443-1707|jbuch@its.jnj.com|
286731|NCT01094743|Johnson & Johnson Vision Care|Huan Sheng, MD, PhD|1-904-443-3440|HSheng2@its.jnj.com|
286732|NCT01094782|Massachusetts General Hospital|Dr. Lucy Chen|6177246102|mghpainresearch@partners.org|
297894|NCT01780545|Hoosier Cancer Research Network|Clinical Data Manager|3176345842|hcrndm@hoosiercancer.org|41
286733|NCT01094808|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
286734|NCT01094886|Janssen Scientific Affairs, LLC|VP Medical Affairs, Internal Medicine|1 908 218-7250||
286735|NCT01095003|Institut de Recherche Pierre Fabre|Karim Keddad|+33.5.34.50.61.69|Karim.keddad@pierre-fabre.com|
286736|NCT01095094|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|David Peereboom, MD|216-445-6068|peerebd@ccf.org|
286737|NCT01095497|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
297895|NCT01780584|Pediatric Cardiac ICU National Cardiovascular Center Harapan Kita|Dr Eva M Marwali, Principal Investigator|+62215684085|evamarwali@yahoo.com|2807
286738|NCT01095510|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
286739|NCT01095653|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
286740|NCT01095666|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
286741|NCT01095757|Winship Cancer Institute Emory University|Dr. Edmund Waller|404-727-4995|ewaller@emory.edu|
286742|NCT01095796|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
286743|NCT01095835|Hoffmann-La Roche|Medical Communications|800-821-8590||
286744|NCT01095887|Mayo Clinic|Dr. Mark D. Stegall|507-266-2812|stegall.mark@mayo.edu|
286745|NCT01095978|Abbott|Global Medical Services|1-800-633-9110||
286746|NCT01096017|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
286747|NCT01096056|GlaxoSmithKline|GSK Response Center|866-435-7343||
276988|NCT00576381|The Children's Hospital of Philadelphia|Dr Athena Zuppa|267-426-5753|zuppa@email.chop.edu|
286748|NCT01096160|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
276989|NCT00576407|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
276990|NCT00576420|BAXTER INNOVATIONS GmbH|Edith Hantak, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
276991|NCT00576472|St. Jude Children's Research Hospital|Heather Conklin PhD|1-866-278-5833|info@stjude.org|
276992|NCT00576576|Emory|Dr. Habib Samady|4047781237|hsamady@emory.edu|
276993|NCT00576628|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
276994|NCT00576680|Dana-Farber Cancer Institute|Dr. Jennifer Chan|617-632-6315|jang@partners.org|
297896|NCT01780662|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
297897|NCT01780831|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
297898|NCT01780870|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
286749|NCT01096186|Impax Laboratories, Inc.|Daven Mody, PharmD, MBA, Director, Regulatory Affairs|510-240-6073|dmody@impaxlabs.com|
286750|NCT01096290|University of South Alabama|Jack DiPalma, MD|251-660-5555|jdipalma@health.southalabama.edu|
297899|NCT01780922|Washington State Unviversity|Boon P. Chew|5093351427|boonchew@wsu.edu|
297900|NCT01780935|Novartis Pharmaceuticals|Study Director|862-778-8300||
297901|NCT01780974|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
297902|NCT01780987|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
297903|NCT01781078|Boston Scientific|Kelly Aspinwall|651-582-4560|Kelly.Aspinwall@bsci.com|
297904|NCT01781169|Shenzhen Center for Chronic Disease Control|Dr. Ji-Chang Zhou|86-755-25503842|jichangzhou@gmail.com|
297905|NCT01781208|Cincinnati Children's Hospital Medical Center, Department of Radiology|Jonathan Dillman, MD|513 803-7114|jonathan.dillman@cchmc.org|
297906|NCT01781234|University of Illinois College of Pharmacy|Dr. Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
297907|NCT01781286|University of Missouri|Dr. Heather Leidy|(573) 882-4288|leidyh@health.missouri.edu|
297908|NCT01781299|University of Pittsburgh Plastic Surgery|Kenneth Shestak|412-641-1487|shestakkc@upmc.edu|
297909|NCT01781403|Asan Medical Center|Dr. Tae Won Kim|+82-2-3010-3910|twkimmd@amc.seoul.kr|
297910|NCT01781429|BioMed Valley Discoveries|Brent Kreider, PhD|816-960-4644|bkreider@biomed-valley.com|
297911|NCT01781468|Mayo Clinic Arizona|Alyx B. Porter Umphrey, M.D.|480-301-4062|Porter.alyx@mayo.edu|
297912|NCT01781481|Children's HOspital of Eastern Ontario|Dr. Janice Cohen|613-737-7600|cohen@cheo.on.ca|2497
297913|NCT01781572|Pfizer|Study Director|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276995|NCT00576693|Medical University of South Carolina|Marc I. Chimowitz, MBChB|843-792-3020|mchimow@musc.edu|
297914|NCT01781611|Oklahoma Medical Research Foundation|Joan T. Merrill, M.D.|405-822-2336|joan-merrill@omrf.org|
297915|NCT01781806|UCLA CARE Center|Dr. Raphael J. Landovitz|(310) 825-6689|rlandovitz@mednet.ucla.edu|
297916|NCT01781832|Cincinnati Children's Hospital Medical Center|Ethan Smith, MD|513 636-4200|Ethan.Smith@cchmc.org|
297917|NCT01781962|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
297918|NCT01781975|University of South Florida|Melissa Parker|8133969378|MELISSA.PARKER@EPI.USF.EDU|
297919|NCT01782131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
297920|NCT01782209|University of Alabama at Birmingham|Richard J. Whitley, MD|205.638.2530|rwhitley@peds.uab.edu|
297921|NCT01782222|UCB|UCB Cares|+1 877 822 9493||
297922|NCT01782313|Northwestern University|Mark Agulnik, MD|312 695 6182|magulnik@nm.org|
297923|NCT01782326|Novartis Pharmaceuticals|Study Director|862-778-8300||
297924|NCT01782378|VA Boston Healthcare System, Jamaica Plain Campus, Boston, MA|Margaret Naeser, PhD|857-364-4030|Margaret.Naeser@va.gov; mnaeser@bu.edu|
297925|NCT01782469|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
297926|NCT01782482|Alcon Research, Ltd.|Sharon Thomas, O.D., Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
297927|NCT01782495|AbbVie|Global Medical Services|800-633-9110||
297928|NCT01782664|GlaxoSmithKline|GSK Response Center|866-435-7343||
297929|NCT01782690|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
297930|NCT01782742|Cleveland Clinic Lou Ruvo Center for Brain Health|Jeffrey Cummings, MD, ScD|702.483.6029|cumminj@ccf.org|
297931|NCT01782833|KoreaOtsukaPharma|Jeong, Hyo-Won||jhw0159@otsuka.co.kr|
297932|NCT01782859|Hospital for Special Surgery|Kethy Jules-Elysee, MD|2126061206|juleselyseek@hss.edu|
297933|NCT01782872|Hospital for Special Surgery|Dr. Jacques YaDeau|212774224|yadeauj@hss.edu|
297934|NCT01782885|Universidad Autónoma de Nuevo León|M Sc Mario Simental-Mendía|+52 (81) 8329 4174|mario.simental@gmail.com|
297935|NCT01782898|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
297936|NCT01782963|Massachusetts General Hospital|Noopur Raje, MD|617-724-4000|NRAJE@mgh.harvard.edu|
297937|NCT01783054|Medical University of South Carolina|Eric Kimchi, MD|842-792-4271|kimchi@musc.edu|
297938|NCT01783080|NY State Psychiatric Institute|David J Hellerstein MD, Professor of Clinical Psychiatry, Columbia|646-774-8000|hellers@nypsi.columbia.edu|
297939|NCT01783236|Weill Cornell Medicine|Hugh Hemmings, MD, PhD|212-746-2953|hchemmi@med.cornell.edu|
297940|NCT01783418|Ste-Justine's Hospital|Catherine Malboeuf-Hurtubise, Post-doctoral fellow|514-343-6111|catherine.malboeuf-hurtubise@umontreal.ca|4594
297941|NCT01783444|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
297942|NCT01783470|NIDDK / NIH|Aaron M. Cypess, MD, PhD, MMSc|301-435-9267|aaron.cypess@nih.gov|
297943|NCT01783483|Zimmer Biomet|Brian M Hatcher, PhD|904-741-4400|brian.hatcher@zimmerbiomet.com|
297944|NCT01783496|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
297945|NCT01783522|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Beth Faiman|216-444-3705|faimanb@ccf.org|
297946|NCT01783548|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
297947|NCT01783561|Neonatal Research Institute, Sharp Mary Birch Hospital for Women and Newborns|Anup Katheria, M.D.|858-939-4170|anup.katheria@sharp.com|
308585|NCT02592421|University of Texas Health San Antonio|Ralph DeFronzo|210-567-6691|defronzo@uthscsa.edu|
308586|NCT02592434|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
276996|NCT00576732|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Clinical Leader|609 730 2317||
276997|NCT00576758|Hoffman-LaRoche|Medical Communications|800-821-8590||
276998|NCT00576823|Sanofi|Trial Transparency Team||Contact-Us@sanofi.com|
276999|NCT00576836|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
277000|NCT00576901|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
286751|NCT01096316|Dept Psychiatry & Behavioral Sciences University of Washington|Jurgen Unutzer MD MPH MA, Professor and Chair|206-543-3752|unutzer@uw.edu|
286752|NCT01096342|Mayo Clinic Cancer Center|Shaji Kumar, M.D.||kumar.shaji@mayo.edu|
286753|NCT01096446|OSF Saint Francis Medical Center|Dr. Kamlesh Macwan|309-624-0611|kamlesh.s.macwan@osfhealthcare.org|
286754|NCT01096550|Friends Research Institute|Dr. Shannon Gwin Mitchell|410-837-3977|smitchell@friendsresearch.org|238
286755|NCT01096589|Centre for Reasearch and Implementation of Clinical Practice (CRICP)|Prof. Christine Moffatt, Principal Investigator|+44 20 73 51 14 11|christine.moffatt@cricp.org.uk|
286756|NCT01096667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286757|NCT01096680|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
286758|NCT01096771|Indiana University School of Medicine|Dr. William Carlos|3178807819|wcarlos@iu.edu|
286759|NCT01096784|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
286760|NCT01096810|Mount Sinai|Dr. Sundar Jagannath|2122417873|sundar.jagannath@mountsinai.org|
286761|NCT01096823|Pediatric Pain and Palliative Care Program; University of California, Los Angeles|Dr. Lonnie K. Zeltzer, MD|(310) 825-0731|LZeltzer@mednet.ucla.edu|
286762|NCT01096849|Achaogen, Inc.|Clinical Trials Posting Group||clinical-trials@achaogen.com|
286763|NCT01096875|Ankara University Medical Faculty, Department of Cardiovascular Surgery|Prof. A. Ruchan Akar MD., FRCS(CTh).|+90 533 646 06 84|akarruchan@gmail.com|
286764|NCT01096992|The University of Texas MD Anderson Cancer Center|William Wierda, MD./Professor|713-745-0428|CR_Study_Registration@mdanderson.org|
286765|NCT01097005|Mylan EPD Japan|Takao Miki, Medical Affairs||takao.miki@mylan.com|
286766|NCT01097044|Clinuvel Pharmaceuticals Limited|Dr. Dennis Wright, Acting Chief Scientific Officer|646 527 7310|Dennis.Wright@clinuvel.com|
286767|NCT01097057|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
286768|NCT01097304|University of Arizona|Dr. Sherry Chow|520-626-3358|schow@azcc.arizona.edu|
286769|NCT01097330|Population Health Research Institute|Dr. Carlos Morillo|905-527-4322|Carlos.Morillo@phri.ca|40311
286770|NCT01097343|St. Vincent Medical Group|Dr. Joseph S. Rossi|765 482 0656|jrossi@thecaregroup.com|
286771|NCT01097395|University of Colorado|Jennifer Kiser|3037246131|jennifer.kiser@cuanschutz.edu|
286772|NCT01097421|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
286773|NCT01097460|Merrimack Pharmaceuticals|Dr. Victor Moyo|1-617-441-1094|vmoyo@merrimackpharma.com|
286774|NCT01097577|US Air Force|Julie Meek, Clinical Pharmacist|210-808-2200|julie.m.meek.mil@mail.mil|
286775|NCT01097616|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286776|NCT01097629|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286777|NCT01097642|The Methodist Hospital Research Institute|Dr. Jenny Chang|713 441-0680|jcchang@houstonmethodist.org|
286778|NCT01097655|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
286779|NCT01097668|Apitope Technology (Bristol) Ltd|Chief Executive Officer|+44(0)117 3707720|keith.martin@apitope.com|
297948|NCT01783574|Massachusetts General Hospital|Dr. Karen K. Miller|617-726-3870|KKMILLER@MGH.HARVARD.EDU|
308587|NCT02592447|H Lee Moffitt Cancer Center and Research Institute|Heather Jim, PhD|813-745-6369|Heather.Jim@moffitt.org|
286780|NCT01097694|Brigham and Women's Hopsital|Elliot Israel, MD|617-732-8110|eisrael@partners.org|
286781|NCT01097707|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286782|NCT01097785|University of Missouri|Paul Fadel|1-573-884-5220|fadelp@health.missouri.edu|
286783|NCT01097863|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
286784|NCT01097915|University of Cagliari|Iole Tomassini Barbarossa, Associate Professor|+390706754144|tomassin@unica.it|
286785|NCT01098006|GlaxoSmithKline|GSK Response Center|866-435-7343||
286786|NCT01098032|Clinica Mediterranea|Dr. Carlo Briguori, Principal Investigator|+390817259|carlobriguori@clinicamediterranea.it|764
286787|NCT01098097|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
286788|NCT01098162|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
286789|NCT01098240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286790|NCT01098253|University of Pennsylvania, Perelman School of Medicine|Dr. Hillary R Bogner|215-746-4181|hillary.bogner@uphs.upenn.edu|
286791|NCT01098266|Molmed S.p.A|Clinical Operations|003902212771|clinical.operations@molmed.com|
286792|NCT01098305|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
286793|NCT01098318|University of Pennsylvania|Dr. Jun Mao, Associate Professor|215-746-2481|jun.mao@uphs.upenn.edu|
286794|NCT01098422|UC San Diego|Dr. Tony Reid|8583531942|treid@ucsd.edu|
286795|NCT01098461|GlaxoSmithKline|GSK Response Center|866-435-7343||
286796|NCT01098474|GlaxoSmithKline|GSK Response Center|866-435-7343||
286797|NCT01098487|GlaxoSmithKline|GSK Response Center|866-435-7343||
277001|NCT00576927|Emory University Division of General Medicine and Geriatrics|Dr. Patricia Griffiths|404-321-6111|pcgriff@emory.edu|7138
286798|NCT01098500|GlaxoSmithKline|GSK Response Center|866-435-7343||
277002|NCT00577005|University of Massachusetts Medical School|Gerardo Gonzalez, MD|508 856 6480|gerardo.gonzalez@umassmed.edu|
277003|NCT00577031|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
277004|NCT00577083|Indiana University|Douglas K Rex, MD|317-948-8741|drex@iu.edu|
277005|NCT00577096|University of Arkansas for Medical Sciences|Elizabeth Ann Coleman|501-661-7902|colemanelizabetha@uams.edu|
277006|NCT00577122|IndianaU|Kathy Miller, MD||kathmill@iupui.edu|
286799|NCT01098539|GlaxoSmithKline|GSK Response Center|866-435-7343||
286800|NCT01098578|Ottawa Hospital Research Institute|Dr. Shaun Kilty|613-798-5555|skilty@ottawahospital.on.ca|18514
286801|NCT01098747|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286802|NCT01098812|Abbott Medical Optics|Kristen Featherstone|714-247-8621|kristen.featherstone@amo.abbott.com|
286803|NCT01098851|Covidien|Fran Haury|303 305-2314|fran.haury@covidien.com|
286804|NCT01099111|KFMC|Dr. Ahmed Al Omair|+96612889999|aalomair@kfmc.med.sa|8771
286805|NCT01099202|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
286806|NCT01099215|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
286807|NCT01099267|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
286808|NCT01099358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286809|NCT01099397|University of Florida|Mariellen Moore|352-273-6381|marielm@ufl.edu|
286810|NCT01099449|Mayo Clinic|Charles Loprinzi, M.D.|(507) 284-3731|cloprinzi@mayo.edu|
286811|NCT01099475|Maastricht University Medical Centre|Dr. MAJ van den Broek, MD|31 43 3884502|m.vandenbroek@maastrichtuniversity.nl|
286812|NCT01099579|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
286813|NCT01099618|Emory University SOM|Dawn Smiley|4047781665|dsmiley@emory.edu|
286814|NCT01099631|Masonic Cancer Center, University of Minnesota|Daniel Saltzman|612 626 4214|saltz002@umn.edu|
286815|NCT01099709|Purdue Pharma LP|Stephen C. Harris, MD|203-588-7592|Stephen.Harris@pharma.com|
286816|NCT01099761|Acceleron Pharma|Dr. Kenneth Attie|617-649-9200|kattie@xlrn.com|350
286817|NCT01099774|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
286818|NCT01099917|Memorial Sloan Kettering Cancer Center|Dr. Barrie Cassileth|646-888-0801|Cassileth@mskcc.org|
286819|NCT01099969|The University of Texas Health Science Center at Houston|Dr. Davide Cattano|713.500.6235|davide.cattano@uth.tmc.edu|
286820|NCT01100034|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277007|NCT00577135|Duke University|Jeff Sharp|919.668.7086|jeff.sharp@dm.duke.edu|
286821|NCT01100073|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
286822|NCT01100086|Purdue Pharma L.P.|Stephen Harris, M.D.|203-588-7592|Stephen.Harris@Pharma.com|
286823|NCT01100112|Santarus, Inc.|Michael Huang, MD, Senior Medical Director, Clinical Research|8583145700|contact@santarus.com|
286824|NCT01100242|University of New Mexico|Richard Lauer, MD|5052725837|rlauer@salud.unm.edu|
286825|NCT01100255|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|6507236158|carolynrodriguez@stanford.edu|
286826|NCT01100268|Columbia University Department of Psychiatry|Dr. Carolyn Rodriguez|(646) 774-8061|cr2163@columbia.edu|
286827|NCT01100307|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286828|NCT01100320|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
286829|NCT01100437|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286830|NCT01100502|Seagen Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
286831|NCT01100528|Cleveland Clinic, Case Comprehensive Cancer Center|Yogen Saunthararajah, MD|866-223-8100|CancerCenterResearch@ccf.org|
286832|NCT01100567|Boston Children's Hospital|Dr. Amy DiVasta, PI|6173553792|amy.divasta@childrens.harvard.edu|
286833|NCT01100606|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
286834|NCT01100723|University of Colorado|Dr. David M. Spiegel|303-724-7797|david.spiegel@ucdenver.edu|
286835|NCT01100762|University of Maryland, Baltimore|Gad Alon, PhD, PT|410-706-7733|galon@som.umaryland.edu|
286836|NCT01100853|University of Pennsylvania|Dr. Helen Pettinati|215-222-3200|helenp@mail.med.upenn.edu|139
286837|NCT01100931|National Cancer Institute, National Institutes of Health|Dr. Giuseppe Giaccone|301-496-4916|giacconeg@mail.nih.gov|
286838|NCT01100944|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
286839|NCT01101022|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
286840|NCT01101035|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
286841|NCT01101061|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
286842|NCT01101100|Valeant Pharmaceuticals International|Lindsey Mathew|908|lindsey.mathew@valeant.com|
277008|NCT00577382|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
277009|NCT00577408|New York State Psychiatric Institute|Edward V. Nunes, MD|646-774-6122|edward.nunes@nyspi.columbia.edu|
277010|NCT00577460|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277011|NCT00577473|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
277012|NCT00577512|University of Arkansas for Medical Sciences, Myeloma Institute|Nathan M. Petty|501-526-6990|pettynathanm@uams.edu|2461
277013|NCT00577590|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
277014|NCT00577629|Duke University Medical Center|Anne Beaven, MD|919-684-8964|anne.beaven@duke.edu|
277015|NCT00577642|Massachusetts General Hospital|Dr Noopur Raje|6177260711|nraje@partners.org|
277016|NCT00577655|Teval Global Respiratory Research LLC|Teva Study Physician|215-293-6482||
277017|NCT00577707|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
277018|NCT00577720|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
277019|NCT00577824|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
277020|NCT00577863|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286843|NCT01101165|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
286844|NCT01101178|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
286845|NCT01101191|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
286846|NCT01101308|Purdue Pharma L.P.|Stephen Harris, MD|203-588-7592|Stephen.Harris@Pharma.com|
286847|NCT01101321|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
286848|NCT01101334|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
297949|NCT01783639|Gardia Medical|Dr. Vardit Segal|+972-4-6277166|Vardit@Gardiamedical.com|106
297950|NCT01783678|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
297951|NCT01783730|AbbVie|Global Medical Services|800-633-9110||
297952|NCT01783743|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
297953|NCT01783821|Mayo Clinic|Dr. Emir Festic|904-953-9758|Festic.Emir@mayo.edu|
297954|NCT01783847|Iran university of Medical Sciences|Mohsen Bahmani Kashkouli|00989121777003|mkashkouli2@gmail.com|
297955|NCT01783860|Rasoule-Akram Hospital|Dr. Mohsen Bahmani-Kashkouli|00982166558811|bahmanik@eyeplasticsurgeries.com|
297956|NCT01783886|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
297957|NCT01783912|Center for Tobacco Research and Intervention|Bruce Christiansen|608-262-4087|bc1@ctri.wisc.edu|
297958|NCT01783938|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
297959|NCT01783990|New England Research Institutes, Inc|Julie Miller|617-972-3197|JMiller@healthcore.com|
297960|NCT01784029|Children's Hospital at Montefiore|Hina Talib|718-920-6781|htalib@montefiore.org|
297961|NCT01784055|NeoChord, Inc.|Lori E Adels, PhD|1-952-698-7804|ladels@neochord.com|
297962|NCT01784068|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
297963|NCT01784211|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297964|NCT01784419|University of California, San Francisco|Dennis W. Nielson, MD, PhD||Dennis.Nielson@ucsf.edu|
297965|NCT01784523|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
297966|NCT01784588|Boston Scientific|Teresa Takle-Flach|952-930-6000|Teresa.Takle-Flach@bsci.com|
297967|NCT01784614|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
297968|NCT01784666|Massachusetts General Hospital, Center for Quantitative Health|Dr. Roy Perlis|617-643-6310|rperlis@partners.org|
297969|NCT01784770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
297970|NCT01784796|Edward Hines VA Hospital|Karen Saban, PhD|708-202-5264|Karen.Saban@va.gov|
297971|NCT01784848|HCor|Dr Carlos Schiavon|1130536611|schiavon.ca@gmail.com|8201
297972|NCT01784861|Washington University School of Medicine|Benjamin Tan, M.D.|314-362-5740|btan@wustl.edu|
297973|NCT01784926|Oslo University Hospital|Dr. Olav Kristianslund|+4723015168|olav.kristianslund@medisin.uio.no|
297974|NCT01784965|Stanford Universtiy|Gerald Reaven, Professor Emeritus|650-724-3416|greaven@stanford.edu|
297975|NCT01785069|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
297976|NCT01785095|IBSA Institut Biochimique SA|IBSA Clinical Research Manager|+41583601000|rd@ibsa.com|
297977|NCT01785134|Karolinska Institutet|Dr Erik Näslund|+46812355017|Erik.Naslund@ki.se|
297978|NCT01785160|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
297979|NCT01785186|Tropical Institute of the Ludwig-Maximilians University in Munich, Germany|Dr. Norbert Heinrich|0049 89 2180 17605|heinrich@lrz.uni-muenchen.de|
297980|NCT01785459|Carolinas Medical Center|Dr. Sean Fox|704-355-3181|Sean.Fox@atriumhealth.org|
297981|NCT01785472|Novartis|Study Director|862-778-8300||
297982|NCT01785524|Victoria University|Jason D. Allen, PhD|61 3 9919 4264|jason.allen@vu.edu.au|
297983|NCT01785602|Novartis|Study Director|862-778-8300||
297984|NCT01785615|University of Florida College of Medicine Jacksonville|Dr. Gladys Velarde|(904)244-2060|Gladys.Velarde@jax.ufl.edu|
297985|NCT01785628|China Medical University Hospital|The chief, Department of Neurology|8864-22052121|d8079@mail.cmuh.org.tw|5035
297986|NCT01785680|Washington University School of Medicine in St. Louis|Mark Manary|3144542178|manary@kids.wustl.edu|
297987|NCT01785810|Abramson Cancer Center|Michael Gardo|215-615-2232|michael.gardo@uphs.upenn.edu|
297988|NCT01785849|Amgen Inc.|Study Director|866-572-6436||
297989|NCT01785875|Amgen Inc.|Study Director|866-572-6436||
297990|NCT01786109|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
297991|NCT01786148|Emory University|Marcia McDonnell Holstad|404-727-1307|nurmmcd@emory.edu|
297992|NCT01786161|Massachusetts General Hospital|Hsin Lin|6177241314|hlin13@mgh.harvard.edu|
297993|NCT01786174|Massachusetts General Hospital|James D. Berry, MD, MPH|617-726-5097|jdberry@mgh.harvard.edu|
308588|NCT02592486|Department of Pulmonary Medicine, Kameda Medical Center|Kei Nakashima, Associate Chief|81-4-7092-2211|kei.7.nakashima@gmail.com|8614
277021|NCT00577889|Mayo Clinic Cancer Center|Robert McWilliams, M.D.||McWilliams.robert@mayo.edu|
277022|NCT00577993|UT MD Anderson Cancer Center|Nathan Fowler,MD, Clinical Professor, Lymphoma-Myeloma|(832) 671-3018|nfowler@mdanderson.org|
277023|NCT00578071|Duke University Medical Center Radiation Oncology|Dr Brian Czito|668-7336|brian.czito@duke.edu|
277024|NCT00578136|The Children's Hospital of Philadelphia|Harshad Gurnaney, MBBS, MPH|267-426-5850|gurnaney@email.chop.edu|
277025|NCT00578175|GlaxoSmithKline|GSK Response Center|866-435-7343||
277026|NCT00578214|Mayo Clinic|Dr. Clark C. Otley|507-284-3579|otley.clark@mayo.edu|
277027|NCT00578227|GlaxoSmithKline|GSK Response Center|866-435-7343||
277028|NCT00578279|Indiana University Medical Center|Julia K. LeBlanc, MD|(317) 948-8125|juleblan@iupui.edu|
277029|NCT00578292|Baylor College of Medicine/Texas Children's Hospital|Dr. Tami D. John|832-824-4723|tdjohn@texaschildrens.org|
277030|NCT00578305|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
277031|NCT00578318|Georgetown University Medical Center|Alfiee M. Breland-Noblem Ph.D., MHSc|2026872392|ab2892@georgetown.edu|
308589|NCT02592629|Penn State Hershey Medical Center|Robert Gallo, M.D.|7175310003|rgallo@pennstatehershey.psu.edu|289222
297994|NCT01786187|Michigan State University|Amy Hoffman, RN, PhD|517 355 8348|amy.hoffman@ht.msu.edu|
297995|NCT01786239|Northwell Health|Delbert Robinson MD|7184708195|drobinso@northwell.edu|
297996|NCT01786252|Michigan State University|Dr. Asgerally Fazleabas|(517) 884-6031|asgi@hc.msu.edu|
286849|NCT01101477|Chang Gung Memorial Hospital|Dr. Ting-Yu Lin|886 3 3281200|yuebaoyuebao@yahoo.com.tw|5108
286850|NCT01101542|GlaxoSmithKline|GSK Response Center|866-435-7343||
286851|NCT01101750|MedStar Health Research Institute|Veronica Gomez-Lobo, MD|202-877-4099|veronica.gomez-lobo@medstar.net|
286852|NCT01101841|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
286853|NCT01101867|The Ohio State University|Dr. Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
286854|NCT01101880|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
286855|NCT01101958|ThoraxKlinik, University of Heidelberg|Prof. Dr. F.J.F. Herth|650-216-0176|Felix.Herth@thoraxklinik-heidelberg.de|
286856|NCT01101971|Queen's University|Dr. Robert Reid|6135332898|reidr@queensu.ca|32898
286857|NCT01101997|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
297997|NCT01786330|University of Kansas School of Medicine - Wichita|Zachary Kuhlmann, DO|316-685-7234|zkuhlmann@kumc.edu|
286858|NCT01102218|Fresenius Medical Care North America|Christina Kahn, Senior Manager of Clinical Trials|615-345-5542|christina.meng@fmc-na.com|
286859|NCT01102231|IFCT|Communications Officer|+33156811045|contact@ifct.fr|
286860|NCT01102257|Mount Sinai School of Medicine|Dr. Penny Asbell|(212) 241-7977|penny.asbell@mssm.edu|
286861|NCT01102270|Brigham and Women's Hospital|Atul Malhotra|6177326488|amalhotra1@partners.org|
286862|NCT01102374|University of Colorado School of Medicine|Adit Ginde, MD, MPH, Professor of Emergency Medicine|720-848-6777|adit.ginde@ucdenver.edu|
286863|NCT01102413|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
286864|NCT01102426|Pharma Mar, S.A.|Pharma Mar, S.A.|0034918466000|clinicaltrials@pharmamar.com|
277032|NCT00578331|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
286865|NCT01102491|Joint Reconstruction Center, Seoul National University Bundang Hospital|TK Kim|82-31-787-7196|osktk@snubh.org|
286866|NCT01102738|Imperial College London|Dr. Kathleen Sim|(+44) (0)20 7594 3695|k.sim@imperial.ac.uk|
286867|NCT01102764|Medical University of South Carolina|Ron Acierno, PhD|843-792-2949|acierno@musc.edu|
286868|NCT01102777|VA Ann Arbor Center for Clinical Management Research|Fatima Makki|+1 (734) 845-3623|Fatima.Makki@va.gov|
286869|NCT01102803|Southern Methodist University|Dr. Jasper Smits|214-768-4125|jsmits@smu.edu|
286870|NCT01102894|University of Minnesota|Dr. Joanne Slavin|612-624-7234|jslavin@umn.edu|
286871|NCT01102972|ViiV Healthcare|GSK Response Center|866-435-7343||
286872|NCT01103063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286873|NCT01103141|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Affairs|765-463-7537|Scott.Snyder@CookMedical.com|
286874|NCT01103232|Vakif Gureba Training and Research Hospital|ILHAN KARACAN|+ 90 212 4531700|ilhankaracan@hotmail.com|
286875|NCT01103245|Vanderbilt University Medical Center|James M. Luther|(615) 936-3420|james.luther@vanderbilt.edu|
286876|NCT01103271|Massachusetts General Hospital|Dr. Maurizio Fava|617-724-0838|mfava@partners.org|
286877|NCT01103284|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
286878|NCT01103323|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
286879|NCT01103362|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
286880|NCT01103414|Mstabolic Solutions Company. LLC|Dr. Jerry Colca, President & CSO|269.343.6732|jcolca@msdrx.com|
286881|NCT01103440|Icahn School of Medicine at Mount Sinai|Dr. Annapoorna S Kini|(212) 241-4181|Annapoorna.Kini@mountsinai.org|
277033|NCT00578344|Baylor College of Medicine/Texas Children's Hospital|Dr. Tami D. John|832-824-4723|tdjohn@texaschildrens.org|
277034|NCT00578383|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
277035|NCT00578448|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
277036|NCT00578461|Baylor College of Medicine|Robert Krance, MD|832-824-4661|rakrance@txch.org|
277037|NCT00578539|Baylor College of Medicine|Robert Krance, MD|832-824-4661|rakrance@txch.org|
277038|NCT00578552|Mayo Clinic|Amit Sood|507-266-1944|nicotineresearch@mayo.edu|
277039|NCT00578565|Mayo Clinic|Eric. L. Matteson, M.D.|507-284-8450||
297998|NCT01786343|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani MD/Professor|713-745-0394|fravandi@mdanderson.org|
277040|NCT00578617|Mayo Clinic|Kristi Monahan|507-255-6676|CABANA@mayo.edu|
277041|NCT00578643|Baylor College of Medicine|Robert Krance, MD|(832) 824-4661|rakrance@txch.org|
277042|NCT00578669|UT Austin School of Nursing|Dr. Richard A. Brown|512-471-8584|brown2@utmail.utexas.edu|
277043|NCT00578734|Penn State Children's Hospital|Dr. Neal J. Thomas|717-531-5337|nthomas@hmc.psu.edu|
286882|NCT01103466|Coloplast A/S|Dr. Lis Hentze Poulsen|4549111111|dklhp@coloplast.com|
286883|NCT01103479|Northwestern University|Kenzie A. Cameron|312-503-3910|k-cameron@northwestern.edu|
286884|NCT01103492|University Hospitals Case Medical Center|Jeffrey Marks, MD|216-983-4930|Jeffrey.Marks@uhhospitals.org|
286885|NCT01103505|Notal Vision|Grace Chang, MD, PhD|571-719-6416|Grace.Chang@NotalVision.com|
286886|NCT01103713|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286887|NCT01103778|Rogosin Institute|Dr. Choli Hartono|212-746-1578|chh2001@nyp.org|
286888|NCT01103934|University of Chicago|Robert M Naclerio, MD|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
286889|NCT01103960|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
286890|NCT01103973|Boston IVF|Alice D. Domar, PhD|781-434-6500|domar@domarcenter.com|
286891|NCT01104025|Cincinnati Children's Hospital Medical Center|Michael Jordan, MD|513-803-9063|Michael.Jordan@cchmc.org|
286892|NCT01104090|The University of Texas Health Science Center at Houston|Davide Cattano, MD, PhD|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
286893|NCT01104103|The University of Texas Health Science Center at Houston|Dr. Richard Bradley|713-500-7878|Richard.N.Bradley@uth.tmc.edu|
286894|NCT01104155|Eisai Inc.|Eisai Medical Information|1-888-422-4743|esi_oncmedinfo@eisai.com|
286895|NCT01104207|VA Portland Medical Center|Robert L. Folmer, Ph.D.|503-220-8262|Robert.Folmer@va.gov|51868
286896|NCT01104246|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
286897|NCT01104285|Maimonides Medical Center|Yizhak Kupfer MD|718-283-8380|ykupfer@maimonidesmed.org|
286898|NCT01104311|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
286899|NCT01104376|Indiana University|Zeruesenay Desta, PhD|317-630-8860|zdesta@iupui.edu|
286900|NCT01104402|Johns Hopkins University & University of Washington|Dr. Noah Lechtzin & Dr. Christopher Goss|410-502-7044|nlechtz@jhmi.edu|
286901|NCT01104415|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
286902|NCT01104493|MedImmune, LLC|Dr. Robert Gasser|301-398-0000|gasserr@medimmune.com|
286903|NCT01104545|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286904|NCT01104558|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
286905|NCT01104584|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
286906|NCT01104636|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286907|NCT01104662|Cubist Pharmaceuticals, Inc.|Vice President, Clinical Research|1.781.860.8660||
286908|NCT01104701|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTrasparency@astrazeneca.com|
286909|NCT01104766|Allergan|Medical Director|877-277-8566|IR-CTRegistration@Allergan.com|
286910|NCT01104779|Allergan|Medical Director|877-277-8566|IR-CTRegistration@Allergan.com|
286911|NCT01104792|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com,|
286912|NCT01104870|United Therapeutics, Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com|
286913|NCT01105065|Massachusetts Eye and Ear Infirmary|Louis R. Pasquale, MD|617-573-4270|Louis_Pasquale@meei.harvard.edu|
286914|NCT01105091|Actelion Pharmaceuticals, US|Wade Benton, PharmD, Director of Medical Affairs|650-808-6562|wade.benton@actelion.com|
286915|NCT01105117|Actelion Pharmaceuticals, US|Wade Benton, PharmD, Director of Medical Affairs|650-808-6562|wade.benton@actelion.com|
286916|NCT01105130|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
286917|NCT01105247|Pharmacyclics|Danelle James|855-427-8846|medinfo@pcyc.com|
286918|NCT01105312|Mayo Clinic|Winston Tan MD|507-284-1159|tan.winston@mayo.edu|
286919|NCT01105377|Johns Hopkins Oncology Center|Nilofer S. Azad, M.D.||nazad2@jhmi.edu|
286920|NCT01105533|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286921|NCT01105650|Masonic Cancer Center, University of Minnesota|Dr. Melissa Geller|612-626-3111|gelle005@umn.edu|
286922|NCT01105702|Perlmutter Cancer Center at NYU Langone|Michael Gruber, MD|212-731-5577|michael.gruber@nyumc.org|
286923|NCT01105754|University of Rochester|Dr. Jill Halterman|585-275-5798|jill_halterman@urmc.rochester.edu|
286924|NCT01105767|USUHS|LTC Michael Ellis|301-295-2254|Michael.Ellis@usuhs.edu|
286925|NCT01105936|GlaxoSmithKline|GSK Response Center|866-435-7343||
286926|NCT01105975|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286927|NCT01106014|Actelion Pharmaceuticals Ltd|Clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
286928|NCT01106027|Mayo Clinic|Dr. Mark Stegall|507-284-6275|Stegall.Mark@mayo.edu|
286929|NCT01106040|Navidea Biopharmaceuticals|Dr. Frederick Cope|614-793-7500|fcope@navidea.com|140
286930|NCT01106092|GlaxoSmithKline|GSK Response Center|866-435-7343||
286931|NCT01106157|University of Florida|Michael J Haller|3522739264|hallemj@peds.ufl.edu|
286932|NCT01106248|Eisai|Dr. Peter Tarassoff|888-422-4743||
286933|NCT01106287|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
286934|NCT01106326|University of Rochester|Maria Fagnano|5852758220|maria_fagnano@urmc.rochester.edu|
277044|NCT00578786|Gilead Sciences, Inc.|Hunter Gillies, MD, DSEM|650-522-1214|hunter.gillies@gilead.com|
277045|NCT00578812|NuVasive, Inc|Julie Pairamore, Sr. Manager, Clinical Affairs|858-320-5258|jpairamore@nuvasive.com|
277046|NCT00578864|BAYLOR|Peter Zage, MD|832-824-4615|pezage@txch.org|
277047|NCT00578877|CONRAD|Jill Schwartz, M.D.|703-276-3913|jschwartz@conrad.org|
277048|NCT00578903|Baylor College of Medicine|Kathryn Leung|832-824-4269|kleung@bcm.edu|
277049|NCT00578929|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
277050|NCT00578942|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
277051|NCT00578968|Mayo Clinic|Bruce D. Johnson, PhD|507-284-4441|johnson.bruce@mayo.edu|
277052|NCT00579059|Biomet, LLC|Megan Lawson, Clinical Research Specialist|1-800-348-9500|megan.lawson@biomet.com|1183
277053|NCT00579098|Mayo Clinic|Paul A. Friedman, MD|507-255-2398|friedman.paul@mayo.edu|
277054|NCT00579111|Baylor|Rammurti Kamble, MD|713-394-6252|rtkamble@tmhs.org|
297999|NCT01786512|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
277055|NCT00579137|Baylor|Robert Krance, MD|832-824-4661|rkrance@bcm.edu|
277056|NCT00579280|University of South Florida College of Medicine|David V. Sheehan, MD, MBA|813-974-4544|dsheehan@health.usf.edu|
277057|NCT00579345|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
277058|NCT00579436|University of Kentucky|Phillip Kern|859 323 4933|pake2222@uky.edu|
277059|NCT00579501|PharmaMar SA, Av de los Reyes 1 Mine Industrial Estate, 28770 Colmenar Viejo, Madrid, Spain|Medical Specialist, Clinical Oncology|+34 91 646-6087||
277060|NCT00579527|Duke University Medical Center|M. Louise Markert, MD, PhD Professor of Pediatrics and Immunology|919-684-6263|marke001@mc.duke.edu|
277061|NCT00579553|University of Oklahoma Health Science Center|Andrew Elimian, MD|19146465194|aelimian@aol.com|
286935|NCT01106352|Bayer|Therapeutic Area Head||Clinical-Trial-Disclosure@bayer.com|
286936|NCT01106391|Cordis Corp.|Amy Berman, Associate Director Clinical Research|908-541-4347|AOrlick@its.jnj.com|
286937|NCT01106404|Neuromodulation Emerging Therapy Clinical Research, Medtronic, Inc|Mark Sun, Senior Clinical Research Manager|763-526-8098|mark.sun@medtronic.com|
286938|NCT01106430|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
286939|NCT01106456|The University of Kansas Medical Center|Dr. Won S. Choi|(913) 588-4742|wchoi@kumc.edu|
286940|NCT01106586|Gilead Sciences, Inc|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
286941|NCT01106625|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
286942|NCT01106651|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise||ClinicalTrialDisclosure@its.jnj.com|
286943|NCT01106677|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
286944|NCT01106690|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
298000|NCT01786551|Brigham and Women's Hospital|Gail K Adler|617-732-5661|gadler@partners.org|
298001|NCT01786564|Northwestern University|Kristen Knutson|312-503-1526|kristen.knutson@northwestern.edu|
298002|NCT01786603|University of Kansas Medical Center|Dr. Richard Barohn|913-945-9944|rbarohn@kumc.edu|
298003|NCT01786629|Braintree Laboratories, Inc.|John McGowan, Director Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
298004|NCT01786668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298005|NCT01786707|University of Miami School of Medicine|Dr. Rodolfo Alejandro|3052435324|ralejand@med.miami.edu|
298006|NCT01786876|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
298007|NCT01786902|Asan Medical Center|Dr. Hanwook Yoo|82-2-3010-3374|hwyoo@amc.seoul.kr|
298008|NCT01786954|Duke Eye Center|Dr Paul Hahn|919-684-5631|paul.s.hahn@duke.edu|
298009|NCT01786967|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH|919-966-0014|jennifer_wu@med.unc.edu|
298010|NCT01786993|St. Jude Medical|Director of Clinical Studies|972-309-8000|ccohorn@sjm.com|8087
298011|NCT01787006|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
298012|NCT01787032|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298013|NCT01787097|Imperial College|Dr Omar S Usmani|+44 (0)20 7351 8051|o.usmani@imperial.ac.uk|
298014|NCT01787175|University of Utah Health Care System|Dr. Jonathan Nebeker|801-582-1565|Jonathan.Nebeker@hsc.utah.edu|2458
298015|NCT01787188|Iroko Pharmaceuticals, LLC|Daniel Solorio, Executive Director of Clinical Operations|267-546-3150|dsolorio@iroko.com|
298016|NCT01787240|MGH|Dr. Cristina Cusin|617 726 6421|ccusin@partners.org|
298017|NCT01787279|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
298018|NCT01787292|Health Science Specialist|Dr. Keith McGregor|4043216111|keith.mcgregor2@va.gov|126792
298019|NCT01787331|University of California, San Francisco|Rahul Aggarwal, MD|877-827-3222|cancertrials@ucsf.edu|
298020|NCT01787383|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leopharma.com|
298021|NCT01787461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298022|NCT01787591|The Ohio State University|Richard S. Bruno, PhD, RD|614-292-1698|bruno.27@osu.edu|
298023|NCT01787604|MeshalkinRI|Dmitry|+79069090505|dmhvan@mail.ru|
298024|NCT01787760|Vistakon, USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
298025|NCT01787799|Boston Scientific|Peter Maurer, MPH; Director of Clinical Trials|508-683-6678|peter.maurer@bsci.com|
298026|NCT01787825|CapsoVision, Inc.|Director of Clinical Affairs|408-624-1488|andra.thomas@capsovision.com|117
298027|NCT01787838|Carilion Clinic|Rebecca Culver Clark|540-588-8184|rcclark@carilionclinic.org|
298028|NCT01787916|CHU de Quebec|Weisnagel|4185254444|john.weisnagel@crchul.ulaval.ca|47035
298029|NCT01788046|Amgen Inc.|Study Director|866-572-6436||
298030|NCT01788150|Svelte Medical|Betsy Lowry|19082642181|blowry@sveltemedical.com|
298031|NCT01788163|AstraZeneca|Haiyi Jiang/Asia Medical Director|+86 21 60302408|Haiyi.Jiang@astrazeneca.com|
298032|NCT01788215|University of Rochester|Kathleen Hoeger MD MPH|585-275-7891|kathleen_hoeger@urmc.rochester.edu|
298033|NCT01788228|GlaxoSmithKline|GSK Response Center|866-435-7343||
298034|NCT01788358|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
298035|NCT01788423|Indiana University, Department of Speech and Hearing Sci|Larry E. Humes|812-855-3507|humes@indiana.edu|
298036|NCT01788566|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298037|NCT01788631|Dana-Farber Cancer Institute|Dr. David G. Nathan|61746322155|David_Nathan@dfci.harvard.edu|
298038|NCT01788943|University of Pennsylvania|Jacob Dubroff,M.D., Ph.D., Assistant Professor of Radiology|215-662-3041|jacob.dubroff@uphs.upenn.edu|
298039|NCT01789047|Rush University Medical Center|Director of Clinical Research|312 942 8002|Teresa_Chmura@rush.edu|
298040|NCT01789138|Department of Public Health, University of Tartu, ESTONIA|Prof. Anneli Uusküla|+372 7374195|anneli.uuskula@ut.ee|
277062|NCT00579670|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277063|NCT00579813|University of Arkansas for Medical Sciences|Robert E. McGehee Jr., Ph.D.|501-603-1998|rem@uams.edu|
277064|NCT00579878|University of Nebraska Medical Center|Dr. James O'Dell|402 559-7288|jrodell@unmc.edu|
277065|NCT00579982|GlaxoSmithKline|GSK Response Center|866-435-7343||
277066|NCT00580034|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
277067|NCT00580047|UNebraska|Dr. Lynn Mack, Associate Professor|4025596208|lmack@unmc.edu|
298041|NCT01789203|Methodist Hospital|Samir Patel|267-808-0577|spatel2@houstonmethodist.org|
308590|NCT02592655|Marcus Migura|Marcus Migura|(619) 436-7323|mwmigura@gmail.com|
277068|NCT00580073|University of Wisconsin-Madison|CRA|608-265-4347|smccarthy@medicine.wisc.edu|
277069|NCT00580138|University of Arkansas for Medical Sciences Medical Center|Gary McCullough|501-852-7886|mcculloughgaryh@uams.edu|
286945|NCT01106833|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
286946|NCT01106846|Northwestern University|Shireen Ahmad, M.D.|321-472-3585|sah704@northwestern.edu|
286947|NCT01106859|Purdue Pharma LP|Clinical Leader|800-733-1333||
286948|NCT01106898|University of Nebraska Medical Center|Elizabeth Reed, MD|402-559-5166|ereed@unmc.edu|
298042|NCT01789255|University of Michigan Comprehensive Cancer Center|Pavan Reddy, M.D.|734-647-5954|reddypr@umich.edu|
298043|NCT01789281|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
298044|NCT01789320|Clearside Biomedical, Inc.|Thomas Ciulla, MD|(678) 392-2318|thomas.ciulla@clearsidebio.com|
298045|NCT01789476|Cara Therapeutics, Inc.|Frédérique Menzaghi, PhD, Vice President Research & Development|(203) 567-1502|fmenzaghi@caratherapeutics.com|
298046|NCT01789567|Medtronic Bakken Research Center|Kitty Schapira|+31433566802|kitty.schapira@medtronic.com|
298047|NCT01789606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298048|NCT01789775|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
308591|NCT02592798|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
308592|NCT02592876|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
308593|NCT02593006|Hackensack University Medical Center|Yukiko Kimura MD|551-996-5306|yukiko.kimura@hackensackmeridian.org|
308594|NCT02593032|University of Pennsylvania|Dr. Nalaka Gooneratne|215 573 2048|ngoonera@pennmedicine.upenn.edu|
308595|NCT02593097|Mayo Clinic|Amaal J. Starling, M.D.|480-301-6574|Starling.Amaal@mayo.edu|
308596|NCT02593149|Pursuit Vascular, Inc.|Laurie Lynch, PhD|6124249006|llynch@pursuitvascular.com|
308597|NCT02593305|University of Iowa|Dr. Darren P. Casey|3193841009|darren-casey@uiowa.edu|
308598|NCT02593318|University of Kansas Medical Center|Russell H. Swerdlow, MD|9135885000|rswerdlow@kumc.edu|
308599|NCT02593396|UNIVERSITY MALAYA|Dr. Anne Yee|+60379492068|annyee17@um.edu.my|
308600|NCT02593539|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
308601|NCT02593630|University of New England|Peter S. Millard, MD, Phd|2072992131|pmillard@mac.com|207
308602|NCT02593773|Horizon Pharma Ireland, Ltd, Dublin Ireland|Julie Ball, Executive Director, Clinical Development & Operations|(224) 383-3000|clinicaltrials@horizonpharma.com|
308603|NCT02593825|Duquesne University|Regina Harbourne, Primary Investigator|4026570538|harbourner@duq.edu|
308604|NCT02593864|Stanford University|Constance Chu, MD|650-723-5643|chucr@stanford.edu|
308605|NCT02593903|Medical College of Wisconsin|Clinical Research Coordinator|414-337-3441|ebedjeti@mcw.edu|
308606|NCT02594098|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
308607|NCT02594111|VA NY Harbor Healthcare System|Dr. Binita Shah|212-686-7500|binita.shah@va.gov|
308608|NCT02594163|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
308609|NCT02594644|UC Davis Department of Dermatology|Tatyana Petukhova MD||tpetukhova@ucdavis.edu|
308610|NCT02594826|Fox Chase Cancer Center|Dr. Carolyn Fang|1-888-369-2427|carolyn.fang@fccc.edu|
308611|NCT02595008|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
308612|NCT02595073|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
277070|NCT00580151|University of Texas-Galveston|Walter Meyer, M.D.|409-770-6718|wmeyer@utmb.edu|
308613|NCT02595398|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
308614|NCT02595437|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
308615|NCT02595450|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
308616|NCT02595502|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S., F.A.A.O - Senrior Principal Research Optometrist|904-443-1290|BPALL@its.jnj.com|
308617|NCT02595528|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
308618|NCT02595567|Washington University School of Medicine|Alexander Chen, Director of Interventional Pulmonology|314-454-8764|achen@dom.wustl.edu|
308619|NCT02595684|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
308620|NCT02595723|UT Southwestern Medical Center|E. Sherwood Brown, M.D., Ph.D.|214-645-6950|sherwood.brown@utsouthwestern.edu|
308621|NCT02595749|USC Dept. of Preventive Medicine|Matthew Kirkpatrick|3234428221|mgkirkpa@usc.edu|
277071|NCT00580229|University of South Florida|John D. Carter, M.D.|813-974-2681|jocarter@health.usf.edu|
308622|NCT02595970|Novartis Pharmaceuticals|Study Director|+1(862)778-8300|Novartis.email@novartis.com|
308623|NCT02595983|Alnylam Pharmaceuticals Inc|Chief Medical Office|866.330.0326|Clinicaltrials@alnylam.com|
308624|NCT02596009|Novartis Pharmaceuticals|Study Director|862-778-8300||
308625|NCT02596022|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
308626|NCT02596035|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
308627|NCT02596230|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308628|NCT02596321|Abbott|Therapeutic Area Clinical Director|+31294477008|dmitri.kazei@abbott.com|
308629|NCT02596451|Glenmark Pharmaceuticals Ltd|Cathy Tyrrell|91 2267720000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
277072|NCT00580294|Icahn School of Medicine at Mount Sinai|Marco Pappagallo, MD|212-241-7749|dionne.bobb@mountsinai.org|
277073|NCT00580333|Massachusetts General Hospital|Dr. Steven Isakoff|617 726 6500|sisakoff@partners.org|
277074|NCT00580372|University of Arkansas for Medical Science|Dr. Bart Barlogie|501-526-2873||
277075|NCT00580398|Massachusetts General Hospital|Elyse Park, Ph.D., MPH|617-724-6836|epark@partners.org|
277076|NCT00580502|NYULMC|Heekoung Youn|2122632174|younh01@nyumc.org|
277077|NCT00580606|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsgov@niaid.nih.gov|
286949|NCT01106911|University of Pittsburgh|Dr. Jules H. Sumkin|412-641-1976|jsumkin@upmc.edu|
286950|NCT01106950|Masonic Cancer Center, University of Minnesota|Jeffrey S. Miller, M.D.|612-625-7409|mille011@umn.edu|
286951|NCT01106976|VAAAHS|Nicolaas Bohnen|7349988400|Nicolaas.Bohnen@va.gov|
286952|NCT01107015|Univeristy of Maryland Baltimore|Charlene C. Quinn|4107062406|cquinn@som.umaryland.edu|
286953|NCT01107197|"Department of Clinical Nutrition and Dietetics, Azienda Ospedaliera Maggiore della Carità"|Dr. Federico D'Andrea|+39 0321.373.3275|dietologia@maggioreosp.novara.it|
298049|NCT01789814|Tufts Medical Center|Carey Kimmelstiel, MD Director of the Adult Cardiac Catheterization Laboratory|617-636-4504|Ckimmelstiel@tuftsmedicalcenter.org|
286954|NCT01107353|Roxane Laboratories, Inc.|Anton (Tony) Amann, PhD., Executive Director, DRAMA|614-272-4785|tony.amann@boehringer-ingelheim.com|
286955|NCT01107379|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
286956|NCT01107392|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
286957|NCT01107405|Bausch & Lomb Incorporated|Tuyen Ong, MD MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
298050|NCT01789840|Merit Medical|Casey Holland|1 (617) 842-0251|casey.holland@merit.com|
298051|NCT01789905|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286958|NCT01107418|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
286959|NCT01107444|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
286960|NCT01107457|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286961|NCT01107535|Abbott|Global Medical Services|1-800-633-9110||
308630|NCT02596620|Chang Gung Memorial Hospital, Taiwan|Dr. Wei-Chen Tai|886-975056026|luketai1019@gmail.com|
286962|NCT01107626|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
286963|NCT01107665|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
286964|NCT01107730|Attikon Hospital|Ioannis K. Toumpoulis|00306977243942|toumpoul@otenet.gr|
286965|NCT01107743|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
286966|NCT01107834|Washington University|William T. Cade|314-286-1432|tcade@wustl.edu|
286967|NCT01107886|AstraZeneca LP|Boaz Hirshberg MD, MBA|1 302 885 4997|ClinicalTrialTransparency@astrazeneca.com|
286968|NCT01107899|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286969|NCT01107912|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286970|NCT01107925|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
286971|NCT01107964|Milton S. Hershey Medical Center|Dr. David Liang|717-497-9469|dliang12@yahoo.com|
286972|NCT01108003|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
286973|NCT01108068|University of Maryland School of Medicine|Elizabeth Streeten, MD|410-328-3335|estreete@som.umaryland.edu|
286974|NCT01108081|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
286975|NCT01108094|Stanford University Medical Center|Jean Tang MD PhD, Associate Professor of Dermatology|650-723-6316|tangy@stanford.edu|
286976|NCT01108185|Abbott|Global Medical Services|1-800-633-9110||
286977|NCT01108237|DePuy Orthopaedics, Inc.|Sam Himden|574-372-7231|SHimden@its.jnj.com|
286978|NCT01108263|Georgetown University|Dr. John Steinberg, Principal Investigator|202-444-0793|zr40@georgetown.edu|
286979|NCT01108341|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
286980|NCT01108406|Sonitus Medical, Inc.|Lily Woodby, AuD|8668162076|lily@sonitusmedical.com|
286981|NCT01108445|Duke University Medical Center|Dr. Andrew J Armstrong|919-668-4615|andrew.armstrong@duke.edu|
286982|NCT01108458|Stanford University Medical Center|George Albert Fisher, MD|650-725-9057|georgeaf@stanford.edu|
286983|NCT01108510|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
286984|NCT01108718|Beth Israel Medical Center|Diana Vu|212-844-6747|dvu@bethisraelny.org|
286985|NCT01108731|Beth_IsraelMC|Dr Benjamin Natelson|212-844-6747|bnatelson@chpnet.org|
286986|NCT01108757|Cleveland Clinic|Lynn Borzi|2164453158|borzil@ccf.org|
286987|NCT01108796|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
286988|NCT01108809|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
286989|NCT01108835|The Chinese University of Hong Kong|Fanny Ko|85226323133|fannyko@cuhk.edu.hk|
286990|NCT01109056|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
277078|NCT00580645|Yale School of Medicine|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
286991|NCT01109069|Pharmacyclics|James Dean|669-224-1880|jdean@pcyc.com|
286992|NCT01109108|Boston Medical Center|Stephen I Pelton|617-414-5591|spelton@bu.edu|
286993|NCT01109147|Hopital Sainte Marguerite - APHM - Service du Pr. Azorin|Dr. Eric Fakra||eric.fakra@ap-hm.fr|
286994|NCT01109173|Alcon Research|Dana Sager, Clinical Manager Group Leader|1-817-551-8603|dana.sager@alconlabs.com|
277079|NCT00580671|Geisel School of Medicine at Dartmouth|Alan J. Budney, PhD|855-290-2822|alan.j.budney@dartmouth.edu|
286995|NCT01109316|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
277080|NCT00580723|University of California, Irvine|Brian Swasdibutra, Clinical Research Coordinator|9498247103|bswasdib@uci.edu|
277081|NCT00580788|University of Pittsburgh|Mara J Horwitz, MD|4126922848|horwitz@pitt.edu|
277082|NCT00580801|Janssen Research & Development, LLC, Titusville, NJ|Clinical Leader|609-730-3174||
277083|NCT00580840|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
277084|NCT00580853|Yale University|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
286996|NCT01109381|Synergy Pharmaceuticals Pte Ltd|Medical Director|+64 9 522 4278|damian@pethica.net|
298052|NCT01789970|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
286997|NCT01109524|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
277085|NCT00580866|Vanderbilt|William Obremskey|6159363630|william.obremskey@Vanderbilt.Edu|
286998|NCT01109576|VHAPORHCS|Mitchel Turbin, PhD|503-220-8262|Bonnie.Becker@va.gov|
286999|NCT01109602|Colorado State University, Department of Occupational Therapy|Arlene Schmid, PhD, OTR|970-491-7562|arlene.schmid@colostate.edu|
287000|NCT01109849|Penn State College of Medicine|James Waxmonsky MD|7175318646|jwaxmonsky@pennstatehealth.psu.edu|
287001|NCT01109940|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
287002|NCT01109979|Brigham and Women's Hospital|Ellen Seely, MD|617-732-5012|eseely@partners.org|
287003|NCT01109992|Brigham and Women's Hospital|Sharmila Dorbala|617-732-6215|sdorbala@partners.org|
287004|NCT01110005|Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-6210|rsl1@psu.edu|
287005|NCT01110135|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
287006|NCT01110187|University of Alabama at Birmingham|Jerzy P. Szaflarski, MD|205-934-3866|szaflaj@uab.edu|
287007|NCT01110200|GlaxoSmithKline|GSK Response Center|866-435-7343||
287008|NCT01110239|University Miami|Sebastian Koch|305 243-6733|skoch@med.miami.edu|
287009|NCT01110252|Labcel|João Tadeu Ribeiro Paes|55 18 3302 5800|labcel.tronco@gmail.com|5856
287010|NCT01110330|Jan-Cil Switzerland|Director Infectious Diseases|41 41 7673477||
287011|NCT01110382|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
287012|NCT01110395|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
287013|NCT01110408|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
287014|NCT01110421|Janssen R&D US|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
287015|NCT01110434|Brown University|Dr. Robert Miranda|401.863.6658|Robert_Miranda_Jr@brown.edu|
277086|NCT00580957|Vanderbilt University|Italo Biaggioni, M.D. Professor of Medicine|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
287016|NCT01110499|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
287017|NCT01110681|Q-Med AB|Head of Medical Affairs|+ 46 (0)18 4749000|reception.SEUPP@galderma.com|
287018|NCT01110707|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
287019|NCT01110876|University of Texas (UT) MD Anderson Cancer Center|John de Groot, MD/Associate Professor, NEURO-ONCOLOGY|(713) 745-3072|jdegroot@mdanderson.org|
287020|NCT01110915|Medtronic, Inc|Advisa MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
287021|NCT01110967|Medtronic Spinal & Biologics|Cristina Faria|+41 (0)21 802 70 00|cristina.faria@medtronic.com|
287022|NCT01111058|University of Chicago|Everett Vokes, MD|(773) 702-9306|evokes@medicine.bsd.uchicago.edu|
287024|NCT01111123|Mount Siani School of Medicine Department of Dermatology|Jason Emer, MD|2122413288|jason.emer@mssm.edu|43288
287025|NCT01111149|University of Minnesota|Dr. S. Hossein Fatemi|612-626-3633|fatem002@umn.edu|
287026|NCT01111162|University of Pennsylvania|Pablo Tebas|2153498092|pablo.tebas@uphs.upenn.edu|
287027|NCT01111240|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
287028|NCT01111292|Northwestern University|Dr. Seema Khan|(312) 503-4236|SKhan@nm.org|
287029|NCT01111318|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287030|NCT01111331|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287031|NCT01111370|Dexcom, Inc|Andy Balo/Sr. VP|8582000203|abalo@dexcom.com|
287032|NCT01111461|Eisai, Inc.|Eisai Medical Services|18884224743|esi_medinfo@eisai.com|
287033|NCT01111474|Federal University of São Paulo|Dr. Olga Dumont Flecha - PHD student|38 35326082|olgaflecha@gmail.com|
287034|NCT01111526|H. Lee Moffitt Cancer Center and Research Institute|Dr. Lia Perez|813-745-3665|lia.perez@moffitt.org|
287035|NCT01111539|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
287036|NCT01111552|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
287037|NCT01111604|Eli Lilly and Compnay|Chief Medical Officer|800-545-5979||
287038|NCT01111825|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
287039|NCT01111838|Memorial Sloan Kettering Cancer Center|Dr. Andrea Cercek|646-888-4189|CercekA@mskcc.org|
287040|NCT01111851|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
277087|NCT00580970|Virginia Commonwealth University/Massey Cancer Center|Mitchell S. Anscher, M.D. Professor and chairman|804-828-7238|mitchell.anscher@vcuhealth.org|
277088|NCT00580983|University of Michigan Comprehensive Cancer Center|Dr. Avraham Eisbruch, M.D.|734-936-4302|eisbruch@umich.edu|
277089|NCT00581048|Vanderbilt University Medical Center|Ryszard Dworski|615-322-3412|ryszard.dworski@Vanderbilt.Edu|
287041|NCT01112059|UAB|Amit Gaggar, MD|934-5400|agaggar@uab.edu|
277090|NCT00581061|University of California, Irvine|Doug Skarecky|714-456-6744|dwskarec@uci.edu|
277091|NCT00581100|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
277092|NCT00581230|UT Medical School at Houston|Carin A. Hagberg|713-500-6222|carin.a.hagberg@uth.tmc.edu|
277093|NCT00581256|University of Michigan Cancer Center|Dr. Lori Pierce, M.D.|734-764-9922|ljpierce@umich.edu|
277094|NCT00581308|W. L. Gore & Associates|Jay Donosky|(800) 437-8181|jdonosky@wlgore.com|
287042|NCT01112228|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
287043|NCT01112241|Azienda Ospedaliera Universitaria San Martino, Genova, Italy|Dr. Giovanni Barisione, MD|+39 010 5553367|giovanni.barisione@hsanmartino.it|
287044|NCT01112267|Janssen Korea/ Seoul|Therapeutic area Scientist|+82-2-2094-4802||
287045|NCT01112293|AbramsonCC|James Robinson|215-662-8758|jamesrobinson2@pennmedicine.upenn.edu|
287046|NCT01112358|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center,|496151725200|service@merckgroup.com|
287047|NCT01112514|Massachusetts General Hospital|Andrew T. Chan|617 726 3212|achan@partners.org|
287048|NCT01112579|Medtronic Cardiac Rhythm and Heart Failure|DEFEAT-HF Clinical Team|1-800-328-2518|MedtronicCRMtrials@medtronic.com|
298053|NCT01790048|Washington University School of Medicine in St. Louis|Dr. Mark Manary|314 454 2178|manarymj@wustl.edu|
298054|NCT01790113|Arthrex|Clinical Affairs Manager|2392161894|melissa.hirschberg@arthrex.com|
298055|NCT01790126|Janssen Research & Development, LLC|EXECUTIVE MEDICAL DIRECTOR|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
298056|NCT01790178|Duke University|Lisa Hobson-Webb|919-668-2277|lisa.hobsonwebb@dm.duke.edu|
298057|NCT01790243|Becton Dickinson|Anna Lovas|7634452382|anna.lovas@bd.com|
298058|NCT01790295|Icahn School of Medicine at Mount Sinai|Dr. John Mascarenhas|212-241-3417|john.mascarenhas@mssm.edu|
298059|NCT01790438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298060|NCT01790490|NYSPI|Elias Dakwar, MD|(646) 774-8728|dakware@nyspi.columbia.edu|
298061|NCT01790503|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
298062|NCT01790516|Inova Health Care System|Dr John Deeken, PI|703 776 8161|john.deeken@inova.org|
298063|NCT01790568|University of Michigan Comprehensive Cancer Center|Dr. Pavan Reddy, M.D.|734-936-8785|reddypr@umich.edu|
298064|NCT01790581|UNC Charlotte|Erik Wikstrom|704-778-5784|ewikstrom@uncc.edu|
298065|NCT01790594|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
298066|NCT01790633|Service des maladies infectieuses et tropicales - Hôpital Saint-Antoine|Dr. Julie Bottero|+33 1 49 28 04 24|julie.bottero@aphp.fr|
298067|NCT01790659|Instituto Conmemorativo Gorgas de Estudios de la Salud|Nestor Sosa, MD, FACP|507-527-4950|drnsosa@gmail.com|
298068|NCT01790685|Johns Hopkins|Dr. Peter A. Campochiaro|410-955-5106|pcampo@jhmi.edu|
298069|NCT01790750|University of Florida|Curt DeGroff|(352) 273-7831|degroffc@peds.ufl.edu|
298070|NCT01790828|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298071|NCT01790932|Dana-Farber Cancer Institute|Nancy Lin, MD|617.632.2335|nlin@partners.org|
298072|NCT01790984|University of Surrey|Professor Bruce A.Griffin|+44 0483 689724|b.griffin@surrey.ac.uk|
298073|NCT01791127|BIOTRONIK, Inc.|Clinical Studies Engineer Manager|1-800-547-0394|crystal.miller@biotronik.com|
298074|NCT01791153|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
298075|NCT01791205|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
298076|NCT01791244|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
298077|NCT01791413|Mahidol University|Dr. Weena Krutsawad|66812070264|vna_fe2@hotmail.com|
298078|NCT01791465|Vanderbilt University Medical Center|John Koethe MD|615-343-0533|john.r.koethe@vanderbilt.edu|
298079|NCT01791491|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
298080|NCT01791517|Johnson & Johnson Vision Care, Inc.|Chantal Coles-Brennan, PRINCIPAL RESEARCH OPTOMETRIST, Global Med Affairs|904-443-3500|CColesb@ITS.JNJ.com|3449
298081|NCT01791725|Transition Therapeutics Ireland Limited|Aleksandra Pastrak,MD, PhD, VP of Clinical Development and Medical Officer|+1 416 263 1227|apastrak@transitiontherapeutics.com|
298082|NCT01791803|North Shore Medical Center|Dr. Faysal M. Hasan|978-741-1200|fhasan@partners.org|4901
298083|NCT01791894|Stanford University School of Medicine, Department of Dermatology|Jean Y Tang MD PhD|650-721-7149|baileyhi@stanford.edu|
298084|NCT01791972|Director, Clinical Research|Teva Branded Pharmaceutical Products, R&D Inc.|1-215-591-3000|ustevatrials@tevapharm.com|
298085|NCT01792024|University of Chicago|Dr. Aytekin Oto|773-834-7424|aoto@radiology.bsd.uchicago.edu|
298086|NCT01792115|NIDDK|Dr. Yaron Rotman|301-451-6553|rotmanyaron@mail.nih.gov|
298087|NCT01792284|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298088|NCT01792518|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298089|NCT01792635|Pfizer, Inc.|Pfizer ClnicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298090|NCT01792817|electroCore, LLC|Clinical Affairs|+1 973-355-6683|clinical@electrocorellc.com|
298091|NCT01792830|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
298092|NCT01792986|Intermountain Heart Institute|Benjamin D. Horne|8015074708|benjamin.horne@imail.org|
298093|NCT01793051|UT MD Anderson Cancer Center|Dr. Robert Orlowski, Professor, Lymphoma-Myeloma|(713) 794-3234|rorlowski@mdanderson.org|
277095|NCT00581347|University of Rochester Medical Center|Peter Szilagyi|585-275-5798|peter_szilagyi@urmc.rochester.edu|
298094|NCT01793142|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298095|NCT01793285|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298096|NCT01793688|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298097|NCT01793792|MicroVention, Inc|Anne Hurley|714-247-8000|anne.hurley@microvention.com|
298098|NCT01793883|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
308631|NCT02596711|UT MD Anderson Cancer Center|Dr. Marcel A. de Dios / Health Disparities Research|713-792-7734|CR_Study_Registration@mdanderson.org|
277096|NCT00581360|Clinical Research Services, UPCI|Rita Johnson, Associate Director of Clinical Research Services|412-647-8571|johnsonr1@upmc.edu|
277097|NCT00581386|UTHSC- Houston Medical School|Dr. Carin A. Hagberg|713.500.6222|maddukuri.vineela@uth.tmc.edu|
277098|NCT00581399|University of California, Irvine Medical Center|Dr. Jeffrey C. Milliken|714-456-3634|jcmillik@uci.edu|
277099|NCT00581529|University of Michigan Comprehensive Cancer Center|Dr. Lori Pierce, M.D.|734-764-9922|ljpierce@umich.edu|
277100|NCT00581542|University of Rochester, Strong Mem orial Hospital|Franci Gigilotti|585 275-0588|francis_gigilotti@urmc.rochester.edu|
287049|NCT01112670|University of Colorado|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
287050|NCT01112683|University of Colorado School of Medicine|Dr. Alberto Costa|303-724-6007|Alberto.Costa@ucdenver.edu|
287051|NCT01112696|Medtronic|Scott Lee M.D.|818-576-4204|scott.w.lee@medtronic.com|
287052|NCT01112735|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|734-646-8214|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
287053|NCT01112865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287054|NCT01112917|BRIGHT Research Partners|Andrea Fenton Abbs - Study Director|612-298-7460|andrea@brightresearchpartners.com|
287055|NCT01112982|University of South Florida|John Carter, M.D|813-974-2473|mpatelli@health.usf.edu|
287056|NCT01113008|H Virgen de la Victoria|Dr Manuel Jiménez Navarro|951 032 354|jimeneznavarro@secardiologia.es|0034
287057|NCT01113385|Children's National|Asha Moudgil MD, Professor of Pediatrics|202-476-5058|amoudgil@childrensnational.org|
287058|NCT01113398|Duke University Medical Center|Katherine B. Peters, MD, PhD|919-684-6173|katy.peters@duke.edu|
287059|NCT01113463|University of Texas MD Anderson Cancer Center|Charles A. Conrad, MD / Professor, Neuro Oncology|713-792-2883|CR_Study_Registration@mdanderson.org|
287060|NCT01113502|Abramson Cancer Center of the University of Pennsylvania|Dr. Noelle Frey||noelle.frey@pennmedicine.upenn.edu|
287061|NCT01113541|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287062|NCT01113580|Seqirus|Clinical Study Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
287063|NCT01113632|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
287064|NCT01113710|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
277101|NCT00581555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277102|NCT00581581|University of Rochester|Ronnie Guillet, MD, PhD|585-275-6209|ronnie_guille@urmc.rochester.edu|
277103|NCT00581776|University of Wisconsin- Madison|Brad S Kahl|608-263-1836|bsk@medicine.wisc.edu|
277104|NCT00581828|University of Wisconsin|Dr Karen Hansen|608-263-3457|keh@medicine.wisc.edu|
277105|NCT00581854|University of Wisconsin|Brad S Kahl, MD|608-263-1836|bsk@medicine.wisc.edu|
277106|NCT00581867|University of Kansas Medical Center|Dr. Jeffrey Burns|(913) 588-0555|jburns2@kumc.edu|
277107|NCT00581893|University of Iowa|Erik St. Louis|507-266-7456|StLouis.Erik@mayo.edu|
277108|NCT00581919|University of Wisconsin Hospital and Clinics|Dr. Natalie Callander|608-265-8690|nsc@medicine.wisc.edu|
277109|NCT00581945|Study Director|Novartis Pharmaceuticals|862-778-8300||
287065|NCT01113723|Department of Anesthesiology, Cedars-Sinai Medical Center|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
287066|NCT01113749|University of North Carolina Chapel Hill|Laura C. Hanson, MD, MPH|9199665945|lhanson@med.unc.edu|
287067|NCT01113801|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287068|NCT01113879|The Ohio State University|Stacy Harnish|614-688-1471|harnish.18@osu.edu|
287069|NCT01113892|Getinge Group|Elizabeth Bulger|603 880 1433|Elizabeth.Bulger@getinge.com|5368
287070|NCT01113931|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
287071|NCT01113983|Edwards Lifesciences|Shin Sakai, PhD||shin_sakai@edwards.com|
287072|NCT01114139|AMAG Pharmaceuticals, Inc.|Medical Information|+1-877-411-2510|amag@druginfo.com|
287073|NCT01114204|AMAG Pharmaceuticals, Inc.|Medical Information|1-877-411-2510|amag@druginfo.com|
287074|NCT01114217|AMAG Pharmaceuticals, Inc.|Medical Information|1-877-411-2510|amag@druginfo.com|
287075|NCT01114334|Denver Health and University of Colorado Denver|Dr. Robert D. Keeley|303-602-8270|robert.keeley@dhha.org|
287076|NCT01114360|Emory University|Frederic Rahbari-Oskoui, Associate Professor of Medicine|404-727-2590|frahbar@emory.edu|
308632|NCT02596750|UC Davis Department of Dermatology|Raja Sivamani MD|916-703-5145|dermstudies@ucdavis.edu|
287077|NCT01114373|Emory University|Frederic Rahbari-Oskoui, Associate Professor of Medicine|404-727-3425|frahbar@emory.edu|
287078|NCT01114438|GI Dynamics|Clinical Affairs Manager|781.357.3263|kwoessner@gidynamics.com|
287079|NCT01114503|GlaxoSmithKline|GSK Response Center|866-435-7343||
287080|NCT01114516|Northwestern University Feinberg School of Medicine|Dr. Emily Miller|3124724685|emily-miller-1@northwestern.edu|
287081|NCT01114529|Novartis Pharmaceuticals|Study Director|+1(862)778-8300|trialandresults.registries@novartis.com|
287082|NCT01114555|Memorial Sloan Kettering Cancer Center|Dr. Shakeel Modak, MD|212-639-7623|modaks@mskcc.org|
287083|NCT01114581|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
287084|NCT01114620|GlaxoSmithKline|GSK Response Center|866-435-7343||
287085|NCT01114646|Hartford Hostpial|Arben Ademi, CCRP|860-972-3561|arben.ademi@hhcealth.org|
287086|NCT01114672|Winthrop University Hospital|Mary Schanler, Principal Investigator|5156639028|mschanler@winthrop.org|
287087|NCT01114724|Medtronic Inc., Aortic and Peripheral Vascular|Celeste Claudy - Study Lead|763-514-0130|celeste.m.claudy@medtronic.com|
287088|NCT01114737|BioMarin Pharmaceutical Inc.|Medical Information Services|1-800-983-4587|medinfo@bmrn.com|
287089|NCT01114828|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
287090|NCT01114880|Abbott|Global Medical Services|1-800-633-9110||
287091|NCT01114893|Alcon Research, Lt.d|Alcon Clinical|888.451.3937|medinfo@alconlabs.com|817.568.67
287092|NCT01114945|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
287093|NCT01114971|Cedars Sinai Medical Center|Proffesor Paul F. White|2147703775|paul.white@cshs.org|
287094|NCT01114997|Cedars Sinai Medical Center|Dr. Roya Yumul|310-423-1682|Roya.Yumul@cshs.org|
287095|NCT01115101|University of Rostock|Dr. Max Dieterich|+493814401|max.dieterich@uni-rostock.de|4500
287096|NCT01115166|Department of Anaestesilogy and Intensive Care|Joachim Zdolsek|+46101030000|joachim.zdolsek@lio.se|
277110|NCT00581971|UAB Hospital|Dr. Sharon Spencer Professor of Radiation Oncology|205-934-2762|sspencer@uabmc.edu|
287097|NCT01115231|Ralph H. Johnson VA Medical Center, Division of Research, Charleston, SC, USA|Baerbel Rohrer, PhD; VA Research Scientist|843-792-5086|rohrer@musc.edu|
287098|NCT01115309|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
287099|NCT01115452|GlaxoSmithKline|GSK Response Center|866-435-7343||
287100|NCT01115491|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
287101|NCT01115517|Robert Cizik Eye Clinic|Dr. Nan Wang|713-559-5200|nwang@cizikeye.org|
287102|NCT01115556|Vitreous Retina Macula Consultants of New York|K. Bailey Freund, MD (or Galyna Ganieva, Research Manager)|212-861-9797|gganieva@vrmny.com|6929
287103|NCT01115569|Zogenix|Kevin Romanko|(510) 550-8323|kromanko@zogenix.com|
287104|NCT01115582|Retrophin, Inc.|Retrophin Medical Information|1-877-659|medinfo@retrophin.com|5518
287105|NCT01115660|Wake Forest School of Medicine|Dr. Cheryl Bushnell|(336) 716-2357|cbushnel@wakehealth.edu|
287106|NCT01115673|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
287107|NCT01115738|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287108|NCT01115803|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287109|NCT01115855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287110|NCT01115933|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
287111|NCT01115998|University of Oklahoma Health Sciences Cetner|Director of Sponsored Programs|405-271--2090|mary-cotter@ouhsc.edu|
287112|NCT01116024|Medtronic, Inc.|Ryan Palmer, Principal Clinical Research Specialist|763-514-9732|ryan.j.palmer@medtronic.com|49732
287113|NCT01116037|Medtronic|Ryan Palmer|+17635149732|ryan.j.palmer@medtronic.com|
287114|NCT01116102|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
287115|NCT01116401|Brigham & Women's Hospital|Hadine Joffe|617-732-4906|hjoffe@partners.org|
287116|NCT01116427|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
287117|NCT01116440|Mereo BioPharma Group Plc.|William Moore|+44333023300|WM@mereobiopharma.com|
287118|NCT01116466|Otto Bock Healthcare Products GmbH|Medical Affairs Manager|004315233786733|Milana.Mileusnic@ottobock.com|
287119|NCT01116544|Oregon Health & Science University|Dr. Paul Cordo|503 418 2520|cordop@ohsu.edu|
287120|NCT01116661|University of California San Francisco|Mitch Berger, MD; Director of Neurosurgery|415-353-7500|Mtich.Berger@ucsf.edu|
287121|NCT01116687|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
277111|NCT00582010|University of Alabama at Birmingham|Rakesh Patel|205-934-3411|rakeshp@uab.edu|
277112|NCT00582075|University of Alabama at Birmingham|John Fiveash, MD|205-975-0224|jfiveash@uabmc.edu|
277113|NCT00582114|Professor of Medicine|Dr. Rajiv Agarwal|317-988-2241|ragarwal@iu.edu|
277114|NCT00582166|University of Wisconsin Carbone Cancer Center|Lymphoma/Myeloma Disease Oriented Team|608-265-3794|barnstable@wisc.edu|
277115|NCT00582205|University of Oklahoma|Dr. Joan Walker|405-271-8707|joan-walker@ouhsc.edu|
277116|NCT00582309|UNM|Gary Iwamoto|505-272-4751|giwamoto@salud.unm.edu|
277117|NCT00582361|UAB|Research Nurse Coordinator|205-996-6781|Talyor.vlack@ortho.uab.edu|
277118|NCT00582400|University of Texas Medical Branch at Galveston|Dr. Avi B. Markowitz|4097721164|abmarkow@utmb.edu|
277119|NCT00582426|Novartis|Study Director|1-800-778-8300||
277120|NCT00582491|Yale University School of Medicine|Peter Morgan, MD, PhD|203-974-7515|Peter.Morgan@yale.edu|
277121|NCT00582517|University of Alabama at Birmingham|Taylor Vlack, RN|205-996-6781|tmwebb@uabmc.edu|
277122|NCT00582556|University of Wisconsin Carbone Cancer Center|Dr. Douglas McNeel|608-263-4198|dm3@medicine.wisc.edu|
277123|NCT00582608|Memorial Sloan Kettering Cancer Center|Dr. Shakeel Modak|212-639-7623|modaks@mskcc.org|
277124|NCT00582660|University of Alabama at Birmingham|Martin J. Heslin M.D.|205-975-0450|marty.heslin@ccc.uab.edu|
277125|NCT00582738|Pharmaceuticals|Novartis|41613241111||
277126|NCT00582790|University of Wisconsin Carbone Cancer Center|Study coordinator|(608) 263-7107|uwcccgu@medicine.wisc.edu|
287122|NCT01116739|University of Colorado Denver|Patricia A. Braun|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
287123|NCT01116882|Harvard Clinical Research Institute|Priscilla Driscoll-Shemp|617-307-5200|priscilla.driscoll-shempp@hcri.harvard.edu|
287124|NCT01116895|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
287125|NCT01116921|Unviersity of Minnesota|Kari D. Roberts, MD|612-625--9577|rober694@umn.edu|
287126|NCT01116934|JWGUniversity|Prof. Dr. Peter Eickholz|+49-69-6301|eickholz@med.uni-frankfurt.de|5642
287127|NCT01116986|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
287128|NCT01117012|Vertex|Medical Monitor|617-444-6777|medicalinfo@vrtx.com|
287129|NCT01117051|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
287130|NCT01117090|Medtronic Restorative Therapies Group - Targeted Drug Delivery|Restorative Therapies Group Clinical Trials||medtronicneurotrials@medtronic.com|
287131|NCT01117181|Johns Hopkins|Anne Casper, MA|410-955-8183|ashankli@jhsph.edu|
287132|NCT01117311|Mayo Clinic|Dr. Adrian Vella|507-284-3289|vella.adrian@mayo.edu|
287133|NCT01117337|Moulana Hospital|Mohamed Ismail, Chief Consultant, Moulana Hospital, Perianthalmanna|0091-9447128511|drgargpankaj@yahoo.com, mdismail13@gmail.com|
287134|NCT01117350|sanofi|Trial Transparency Team||Contact-us@sanofi.com|
287135|NCT01117428|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
287136|NCT01117454|Vanderbilt University Medical Center|Dr. Prince J. Kannankeril, MD, MSCI|615 322-7447|prince.kannankeril@vanderbilt.edu|
287137|NCT01117480|AbbVie|Global Medical Information|800-633-9110||
287138|NCT01117623|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
287139|NCT01117727|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
277127|NCT00582816|University of Wisconsin Carbone Cancer Center|Dr. Ken DeSantes|608-263-8563|kbdesantes@pediatrics.wisc.edu|
287140|NCT01117766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287141|NCT01117792|Boston Scientific|Tom Stoltz, Clinical Trial Manager|1-800-227-3422|thomas.stoltz@bsci.com|
287142|NCT01117857|Massachusetts General Hospital|Dr. Marlene Freeman, MD|617-643-6403|mfreeman@partners.org|
287143|NCT01117870|McMaster University/ St. Joseph's Healthcare Hamilton|Dr. Harsha Shanthanna|905-522-1155|harshamd@gmail.com|
298099|NCT01793909|University of Colorado|Dr. Judy Regensteiner|303-724-2247|judy.regensteiner@ucdenver.edu|
298100|NCT01793935|University of Pittsburgh|Dr. K.N. Roy Chengappa - PI|412-246-5006|chengappakn@upmc.edu|
298101|NCT01794000|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298102|NCT01794039|Mayo Clinic|Shaji K. Kumar, M.D.|(507) 284-2017|kumar.shaji@mayo.edu|
298103|NCT01794117|National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)|Dr. Edward W. Cowen|301-827-2328|cowene@mail.nih.gov|
298104|NCT01794299|Kiadis Pharma Netherlands B.V.|Andrew Sandler, MD / Chief Medical Officer|+1 206 779 9213|a.sandler@kiadis.com|
298105|NCT01794312|Laboratoires Théa|Clinical Development Director|+33(0)473981414|Corentin.LECAMUS@theapharma.com|
298106|NCT01794455|Vanderbilt University|Dr. Warren Taylor|615-936-3555|warren.d.taylor@vanderbilt.edu|
298107|NCT01794689|Johns Hopkins University|Dr. Michael T. Smith, PhD|410-550-7000|msmith62@jhmi.edu|
298108|NCT01794702|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD./Associate Professor|713-745-6080|njain@mdanderson.org|
298109|NCT01794741|Meda Pharmaceuticals|Dr Nancy Ruiz, MD|732 564 2390|nancy.ruiz@meda.us|
298110|NCT01794780|Novartis Pharmaceutical|Study Director|862-778-8300||
298111|NCT01794806|University of Iowa|Gustavo Avila-Ortiz|3193357241|gustavo-avila@uiowa.edu|
277128|NCT00582894|University of Oklahoma Health Sciences Center|George Selby, MD|405/271-4022|george-selby@ouhsc.edu|
277129|NCT00582907|Shaare Zedek Medical Center/Cleveland Clinic|Philip Hashkes, MD, MSc|972-2-6555307|hashkesp@szmc.org.il|
277130|NCT00582933|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-2429|bouladf@mskcc.org|
277131|NCT00582946|EarLens Corporation|Sunil Puria|650-366-9000|spuria@earlenscorp.com|
277132|NCT00582972|University of Wisconsin|Dr. Karen Hansen|608-263-3457|keh@medicine.wisc.edu|
277133|NCT00582998|University of Alabama at Birmingham|Asya Love, RN|205-996-6781|asyalove@uab.edu|
277134|NCT00583011|University of Oklahoma Health Science Center|Andrew Elimian, MD|9142317323|aelimian@aol.com|
277135|NCT00583050|Massachusetts General Hospital|Matthew Eagleton, M. D.|617-726-8279|MEAGLETON@mgh.harvard.edu|
277136|NCT00583102|University of Iowa|Raymond Hohl, MD|319-356-8110|rhohl@pennstatehealth.psu.edu|
277137|NCT00583219|Mayo Clinic|Dr. Steven P. Petrou|904-953-7330|petrou.steven@mayo.edu|
277138|NCT00583362|GlaxoSmithKline|GSK Response Center|866-435-7343||
277139|NCT00583375|Wright Medical|Stephen Roach|615-656-7466|Stephen.Roach@wright.com|
277140|NCT00583414|Massachusetts General Hospital|Matthew Eagleton, MD|617-726-8279|meagleton@mgh.harvard.edu|
298112|NCT01794845|University of Miami|Matthew C. Abramowitz MD|305-243-4319|MAbramowitz@med.miami.edu|
277141|NCT00583453|University of Iowa|Douglas Van Daele|319-353-8162|douglas-van-daele@uiowa.edu|
277142|NCT00583492|Henry Ford Health System|Benjamin Movsas|313-516-2319|bmovsas1@hfhs.org|
277143|NCT00583557|GlaxoSmithKline|GSK Response Center|866-435-7343||
298113|NCT01794923|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298114|NCT01794949|Emory University|Henry Liberman, MD|404-686-2503|hliberm@emory.edu|
298115|NCT01795079|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|fregni.felipe@mhg.harvard.edu|
298116|NCT01795105|KoreaOtsukaPharma|Jeong, Hyo-Won||jhw0159@otsuka.co.kr|
298117|NCT01795495|Nationwide Children's Hospital|David Martin, MD|6147224200|David.Martin@nationwidechildrens.org|
298118|NCT01795534|Bangor University|Dr Jamie Macdonald|+441248383272|j.h.macdonald@bangor.ac.uk|
298119|NCT01795547|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
298120|NCT01795638|University of Cincinnati Medical Center|Barbara Isemann|513-584-5060|barbara.isemann@uchealth.com|
298121|NCT01795716|Shanghai Jiaotong University School of Medicine Ruijin Hospital|Dr. Zhou Li|13816510379|lizhou999_999@yahoo.com|
298122|NCT01795833|Imperial College London|Nick Oliver|02033111093|nick.oliver@imperial.ac.uk|
298123|NCT01795859|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
298124|NCT01795898|Janssen Philippines|Medical Affairs Manager|+632-8247901||
298125|NCT01795937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298126|NCT01796236|Ear Nose Throat, University Medical Center Utrecht, Utrecht|Professor Robert Stokroos|0031 8875 56644|R.J.Stokroos@umcutrecht.nl|
298127|NCT01796301|Amgen Inc.|Study Director|866-572-6436||
298128|NCT01796392|Pulmonx Corporation|Narinder Shargill|650-216-0108|nshargill@pulmonx.com|
298129|NCT01796470|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
298130|NCT01796548|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||5888
298131|NCT01796665|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
298132|NCT01796860|University of Texas Southwestern Medical Center|Karen J McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
298133|NCT01796912|Imperiwal College London|Dudley Pennell|+44 (0)20 3811 6871|d.pennell@imperial.ac.uk|
298134|NCT01796964|Alcon Research, Ltd.|Clinical Project Group Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
298135|NCT01796977|Halyard Health, Inc.|Director of Clinical Affairs|470-448-5352|david.curd@hyh.com|
298136|NCT01797029|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
277144|NCT00583596|St. Jude Medical Formally AGA Medical Corporation|Jeffrey Mifek|6517565586|jmifek@sjm.com|
287144|NCT01117948|JSW-Lifesciences|Director of Clinical Trials|0043316 258111|office@jsw-lifesciences.com|310
287145|NCT01117987|Novartis Pharmaceuticals|Study Director|862-778-8300|Trialandresults.registries@novartis.com|
287146|NCT01118052|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
287147|NCT01118091|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
287148|NCT01118117|Terumo Medical Corporation|Adam Thompson, Clinical Program Manager|201-398-3283|adam.thompson@terumomedical.com|
298137|NCT01797081|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
298138|NCT01797094|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
298139|NCT01797120|PrECOG, LLC|Carolyn Andrews|267-207-4070|candrews@precogllc.org|
298140|NCT01797159|The SKCCC at Johns Hopkins|The SKCCC at Johns Hopkins|4109556980|kjansen3@jhmi.edu|
298141|NCT01797185|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
298142|NCT01797263|VA Center for Health Information and Communication|Dr. Matthew J. Bair|317-988-2058|mbair@iupui.edu; matthew.bair@va.gov|
277145|NCT00583622|The University of Texas MD Anderson Cancer|Yago Nieto, MD, PhD / Professor||celsaenz@mdanderson.org|
298143|NCT01797302|University of Pittsburgh School of Medicine|Kumaravel Rajakumar|412-692-5822|kumaravel.rajakumar@chp.edu|
298144|NCT01797328|UHLinkopeing|Fredrik H Nystrom|+46101037749|fredrik.h.nystrom@liu.se|
298145|NCT01797432|University of Minnesota|Maria Hordinsky, MD|612-625-6118|hordi001@umn.edu|
277146|NCT00583661|Berlin Heart Inc.|Robert Kroslowitz, CEO|1-281-863-9700|kroslowitz@berlinheart.com|
298146|NCT01797445|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
298147|NCT01797458|Preventive and Paediatric Dentistry Department of Greifswald University, Germany|Prof. Dr. Christian Splieth|+ 49 3834 867101|splieth@uni-greifswald.de|
298148|NCT01797471|University of Miami|Jean L. Wright MD|305-243-5965|jwright3@med.miami.edu|
308633|NCT02596854|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
308634|NCT02596867|TTUHSC-EP|Zeina Nahleh|9152155195|zeina.nahleh@ttuhsc.edu|
308635|NCT02596893|Celgene Corporation|Anne Mcclain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
277147|NCT00583700|West Virginia University|Geraldine Jacobson, MD, MBA, MPH, FACR|(304) 293-7227|GMJACOBSON@hsc.wvu.edu|
277148|NCT00583713|Braintree Laboratories, Inc.|Russell Pelham, PhD|781-843-2202|rpelham@braintreelabs.com|
277149|NCT00583791|Abbott|Maren Wagner|6517565585|maren.wagner@abbott.com|
277150|NCT00583804|MetroHealth Medical Center|Principal Investigator|2169573683|ue.fes.clinicaltrials@gmail.com|
277151|NCT00583908|Vistakon|Kurt Moody, OD FAAO|904-443-3088|kmoody1@its.jnj.com|
277152|NCT00583947|Sepracor Inc|Respiratory Medical Director|866-503-6351||
277153|NCT00584077|University of Texas-Galveston|Alexander Duarte, MD|409-772-2436|aduarte@utmb.edu|
277154|NCT00584194|USAMRIID Medical Division|Janice Rusnak, MD|301-619-4156|janice.rusnak@amedd.army.mil|
277155|NCT00584220|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|kmoody1@its.jnj.com|
308636|NCT02596906|Center for BrainHealth, The university of Texas at Dallas|Dr. Namrata Das|9728833266|Namrata.Das@utdallas.edu|
277156|NCT00584285|University of Iowa|Dr. Christine W. Sindt|319-356-2916|christine-sindt@uiowa.edu|
277157|NCT00584402|University of Califonia, Davis|John McGahan, M.D.|(916)734-0519|john.mcgahan@ucdmc.ucdavis.edu|
277158|NCT00584415|University of Oklahoma Health Sciences Center|Sunny Po, MD., Study Principal Investigator|405-271-9696|sunny-po@ouhsc.edu|
308637|NCT02596945|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
308638|NCT02596958|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
308639|NCT02596971|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
308640|NCT02597049|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
308641|NCT02597101|Allegheny Health Network|Dr. Nick Giannoukakis|412-359-6394|nick.giannoukakis@ahn.org|
308642|NCT02597127|The Medicine's Company|Global Health Science Center|1-888-997-6326|Medical.Information@themedco.com|
308643|NCT02597452|Penn Medicine|Dr. Ari D Brooks|215-829-8461|ari.brooks@pennmedicine.upenn.edu|
308644|NCT02597478|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|(713) 792-6258|dhui@mdanderson.org|
308645|NCT02597543|UCSD|Paul Kim, MD|3104907217|pjk017@ucsd.edu|
308646|NCT02597582|Taichung Veterans General Hospital|Shih-An Liu|+886-4-23592525|saliu@vghtc.gov.tw|5409
308647|NCT02597673|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
308648|NCT02597712|Trio Medicines Ltd|Dr Malcolm Boyce|+44 20 8961 4130|mboyce@triomedicines.com|
308649|NCT02597855|Yeungnam University College of Medicine|Dr. Min Sagong|82-53-620-4191|msagong@ynu.ac.kr|
308650|NCT02597907|Kyungpook National University|Dr Younghoon Jeon|82534205871|jeon68@gmail.com|
308651|NCT02597920|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308652|NCT02597933|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308653|NCT02597946|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308654|NCT02598076|Yale Comprehensive Epilepsy Center, Department of Neurology, Yale Univseristy School of Medicine|Benjamin Tolchin, MD, MS|347-721-8491|benjamin.tolchin@yale.edu|
277159|NCT00584454|UAMRIID Division of Medicine|LTC Robert Rivard, MD|301-619-8244|robert.g.rivard.mil@mail.mil|
277160|NCT00584480|UCSF|Robert L. Hendren, D.O.|415-476-7198|Robert.Hendren@ucsf.edu|
277161|NCT00584558|University of Oklahoma Health Sciences Center|Karen Beckman, MD|405-271-9696|karen-beckman@ouhsc.edu|37536
287149|NCT01118143|University of Tromsø|Professor Jan Bergdahl|+4777649122|jan.bergdahl@uit.no|
287150|NCT01118221|MVAHS|Robert M Jackson, MD|305-575-3548|robert.jackson4@va.gov|
287151|NCT01118273|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
287152|NCT01118299|Abbott|Sripad Bellary|408845814|sripad.bellary@abbott.com|
287153|NCT01118312|Johns Hopkins University|Razan Yasin|443-287-5796|ryasin1@jhu.edu|
287154|NCT01118325|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
287155|NCT01118338|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
287156|NCT01118351|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Jorge Garcia|216-444-7774|garciaj4@case.edu|
287157|NCT01118377|Hoffmann-La Roche|Medical Communications|800 821-8590||
287158|NCT01118455|Cyberonics, Inc.|Mark Bunker, PharmD, Sr. Director, Global Medical Affairs|281-228-7223|Mark.Bunker@cyberonics.com|
287159|NCT01118520|Imperial College London|Professor Neil Poulter|+44(0) 20 7594 3446|n.poulter@imperial.ac.uk|
287160|NCT01118624|Spectrum Pharmaceuticals|Pankaj Sharma, MD|949-743-9264|pankaj.sharma@sppirx.com|
287161|NCT01118663|Cumberland Pharmaceuticals Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
287162|NCT01118715|Athens Orthopedic Clinic|Dr. Michael Shuler|706-549-1663|mshuler@athensorthopedicclinic.com|
287163|NCT01118728|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
287164|NCT01118741|Johns Hopkins University|Michael Carducci, MD|410-614-3977|carducci@jhmi.edu|
287165|NCT01118780|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298149|NCT01797484|University Heart Centre Hamburg Eppendorf|Dr. Tjark F. Schwemer|+49 40 7410|t.schwemer@uke.de|56800
277162|NCT00584701|UCSF|Robert Hendren, DO|415-476-7198|robert.hendren@ucsf.edu|
277163|NCT00584727|Vistakon|Kurt Moody, OD, FAAO|904-443-3088||
277164|NCT00584740|Novartis|Study Director|862-778-8300||
277165|NCT00584805|USAMRIID Medical Division|Anthony Cardile, D.O.|301-619-8833|anthony.cardile.mil@mail.mil|
277166|NCT00584831|Vistakon|Kurt Moody, OD, FAAO|904-443-3088|kmoody1@its.jnj.com|
277167|NCT00584844|USAMRIID|Mark Goldberg, MD|301-619-4562|mark.goldberg@amedd.mil|
277168|NCT00584857|UAB|J. Michael Straughn, MD|205-934-4986|Michael.straughn@ccc.uab.edu|
277169|NCT00584870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277170|NCT00584909|UAB|J. MIchael Straughn, MD|205-934-4986|Michael.Straughn@ccc.uab.edu|
277171|NCT00584922|University of Oklahoma Health Science Center|Sunny Po, MD, PhD|405-271-9696|Sunny-Po@ouhsc.edu|
277172|NCT00584948|University of California, Davis Medical Center|Randi J Hagerman, MD|916-703-0247|randi.hagerman@ucdmc.ucdavis.edu|
277173|NCT00584987|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
277174|NCT00585013|Baylor College of Medicine|Paul Checchia MD|832-826-5011|checchia@bcm.edu|
277175|NCT00585039|Phoenix Children's Hospital|Dr Blake Bulloch|602-546-1950|bbulloch@phoenixchildrens.com|
277176|NCT00585052|University of Iowa|Raymond Hohl, MD|319-335-6564|rhohl@pennstatehealth.psu.edu|
277177|NCT00585078|Beth Israel Deaconess Medical Center Beth Israel Deaconess|Rebecca Miksad MD MPH|617.667.2100|rmiksad@bidmc.harvard.edu|
287166|NCT01118845|Symbio Pharmaceuticals|Toshihiko Nagase|81-3-5472-1127|tnagase.331@symbiopharma.com|
287167|NCT01118949|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
287168|NCT01118962|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
287169|NCT01118975|University of Maryland|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
287170|NCT01118988|Pediatric Pain and Palliative Care Program; University of California, Los Angeles|Dr. Lonnie K. Zeltzer, MD|310-825-0731|LZeltzer@mednet.ucla.edu|
287171|NCT01119001|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
287172|NCT01119040|University Hospitals Case Medical Center|Jeffrey Marks, MD/Principal Investigator|216-983-4930|jeffrey.marks@UHhospitals.org|
287173|NCT01119105|Nabriva Therapeutics|Jennifer Schranz, M.D., Chief Medical Officer|610-981-2842|jennifer.schranz@nabriva.com|
287174|NCT01119118|University of Wisconsin Carbone Cancer Center|Dr. Glenn Liu|608-265-8689|gxl@medicine.wisc.edu|
287175|NCT01119131|VA Portland Health Care System|Amie Hiller, MD|503.721.1091|peterami@ohsu.edu|
287176|NCT01119222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287177|NCT01119248|Rutgers/New Jersey Medical School|Anuradha Patel, MD Director of Pediatric Anesthesiology|973 972-1886|patelan@njms.rutgers.edu|
287178|NCT01119287|Alcon Research|Head, Alcon Clinical|1-888-451-3937||
287179|NCT01119443|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287180|NCT01119456|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
287181|NCT01119508|UT MD Anderson Cancer Center|Dr. Sapna P. Patel, Assistant Professor, Melanoma Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
287182|NCT01119625|GlaxoSmithKline|GSK Response Center|866-435-7343||
287183|NCT01119703|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
287184|NCT01119716|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
287185|NCT01119755|Hypertension Center, Third Department of Medicine, University of Athens, Greece|George S Stergiou, Associate Professor of Internal Medicine and Hypertension|+302107763117|gstergi@med.uoa.gr|
287186|NCT01119768|AstraZeneca|Gerard Lynch||az_trials_posting@astrazeneca.com|
287187|NCT01119794|Brown University Oncology Research Group (BrUOG)|Eric Winer, MD|4018633000|kayla_rosati@brown.edu|
287188|NCT01119846|GlaxoSmithKline|GSK Response Center|866-435-7343||
287189|NCT01119859|Hoffmann-La Roche|Medical Communications|800 821-8590||
287190|NCT01119898|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
287191|NCT01119937|Novartis Pharmaceuticals|Study Director|862-778-8300||
287192|NCT01119950|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
287193|NCT01119963|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
287194|NCT01120028|University of Oxford|Prof Peter Friend|01865223872|ccc@ctsu.ox.ac.uk|
287195|NCT01120067|VA Boston Healthcare System|John Otis|857-364-5740|john.otis@va.gov|
298150|NCT01797536|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
287196|NCT01120093|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
287197|NCT01120184|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
287198|NCT01120197|Faculty of Health Sciences, Oslo University College, Oslo, Norway|Professor, Ph. D, Researcher. Astrid Bergland.|+4722452507|astrid.bergland@hf.hio.no|
287199|NCT01120210|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director Translational Medicine|858.320.3408|wradzisz@its.jnj.com|
287200|NCT01120223|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
287201|NCT01120236|Department of Medicine, Division of Oncology, University of Washington|Evan Y. Yu, MD||evenyu@u.washington.edu|
287202|NCT01120275|SWOG Statistical Center|Melanoma Committee Statistician|2066674623|jmoon@fredhutch.org|
298151|NCT01797562|Allerderm(dba) SmartPractice|Kathryn Shannon|602 225 0595|kshannon@smarthealth.com|
287203|NCT01120379|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
287204|NCT01120405|Population Health Research Institute - Mc Master University, Hamilton CANADA|Yannick LE MANACH, MD, PhD|0012892606840|Yannick.Lemanach@phri.ca|
287205|NCT01120600|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
287206|NCT01120626|Stanford University|Allan Reiss, MD|650-498-4538|reiss@stanford.edu|
287207|NCT01120639|Stanford University|Dr. Scott Soltys (Associate Professor of Radiation Oncology)|650-724-1569|sgsoltys@stanford.edu|
287208|NCT01120691|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
287209|NCT01120704|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
287210|NCT01120717|Novartis Pharmaceuticals|Study Director|862 778-8300||
287211|NCT01120756|VA Northern California|Anthony Chen, MD|925-372-2000|anthony.chen@va.gov|
287212|NCT01120782|Johnson & Johnson Vision Care|Ross Franklin, OD|1-904-443-1379|RFrankl1@its.jnj.com|
287213|NCT01120808|Stanford Department of Emergency Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
287214|NCT01120834|Weill Cornell Medicine|Peter Martin, MD|646.962.2064|amr2017@med.cornell.edu|
287215|NCT01120899|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
287216|NCT01120990|Hypertension Center, Third University Department of Medicine, University of Athens|George S Stergiou, MD|+30 210 7763117|gstergi@med.uoa.gr|
287217|NCT01121146|AORI|C. Anderson Engh, Jr., MD|703-619-4411|research@aori.org|
287218|NCT01121172|4th Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki|Assimina Galli-Tsinopoulou, As.Professor of Pediatric Endocrinology|00302310991537|agalli@auth.gr|
287219|NCT01121185|MassBiologics|Director Clinical Affairs|617-474-3000|MBLclinicaldirector@umassmed.edu|
287220|NCT01121211|Massachusetts General Hospital|Dr. Anne Klibanski|6177263870|aklibanski@partners.org|
287221|NCT01121224|VA North Texas Health Care System|Dr. Subhash Banerjee|(214) 857-1608|Subhash.Banerjee@va.gov|
287222|NCT01121250|Memphis VA Medical Center|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
287223|NCT01121263|Icahn School of Medicine at Mount Sinai|Deborah Ascheim, MD|212-659-9567|deborah.ascheim@mssm.edu|
287224|NCT01121393|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287225|NCT01121406|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287226|NCT01121484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298152|NCT01797575|The University of Texas Health Science Center at Houston|Jair C Soares, MD|713-486-2627|jair.c.soares@uth.tmc.edu|
298153|NCT01797705|DeVilbiss Healthcare|Jim Froehlich|814-443-7692|Jim.Froehlich@devilbisshc.com|
298154|NCT01797731|Hospital for Special Surgery|David Mayman|2127742024|maymand@hss.edu|
298155|NCT01797783|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-888-451-3937|alcon.medinfo@alcon.com|
298156|NCT01797822|Baylor College of Medicine|Stephen Pflugfelder|713-798-6100|stevenp@bcm.edu|
298157|NCT01797835|RAND|Dr. Elizabeth D'Amico|3103930411|damico@rand.org|6487
308655|NCT02598089|IVAC|Dr. Le Van Be||ivaclevanbe@gmail.com|
308656|NCT02598128|Alcresta Therapeutics, Inc.|Russell G. Clayton, D.O., Chief Medical Officer|215.813.5100|rclayton@alcresta.com|
308657|NCT02598193|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
308658|NCT02598297|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
308659|NCT02598583|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
308660|NCT02598934|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
308661|NCT02599129|Icahn School of Medicine at Mount Sinai|Dr. Mark Lebwohl|2122413288|giselle.singer@mssm.edu|
308662|NCT02599194|Stanford University|Andrei H. Iagaru|(650) 725-4711|aiagaru@stanford.edu|
308663|NCT02599402|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
308664|NCT02599441|University at Buffalo|Research coordinator|7162043209|mk67@buffalo.edu|
308665|NCT02599649|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor|713-745-3428|ggarciam@mdanderson.org|
308666|NCT02599688|Peregrine Ophthalmic Pte Ltd|Chief Operating Officer|65 97914382|jchua@peregrineop.com|
308667|NCT02599766|Swiss TPH|Dr. Karin Hediger|0041795197885|karin.hediger@unibas.ch|
308668|NCT02599961|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
287227|NCT01121536|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
287228|NCT01121549|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287229|NCT01121562|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287230|NCT01121575|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287231|NCT01121666|Five Office Ltd|Dr. Melanie Ruf|+41 44 9324132|clin@five.ch|
287232|NCT01121757|Duke University Health Center|Anne Beaven, MD, Associate Professor|9196848964|anne.beaven@duke.edu|
287233|NCT01121900|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
287234|NCT01121913|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
287235|NCT01121926|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
287236|NCT01121939|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
287237|NCT01121991|EMD Serono Canada Inc., an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+1-888-737-6668|david.sciberras@emdserono.com|5248
287238|NCT01122030|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
287239|NCT01122108|Louisville Metabolic and Atherosclerosis Research Center (L-MARC)|Harold E. Bays, MD|502-515-5672|kschmitz@lmarc.com|
287240|NCT01122160|USDA|Beverly Clevidence|301-504-8367|beverly.clevidence@ars.usda.gov|
277178|NCT00585104|University of Utah Health Sciences Center|Andrew D. Michaels, MD|(801) 585-5971|Andrew.Michaels@hsc.utah.edu|
287241|NCT01122173|Auris Health, Inc.|Emir Deljkich/Sr. Director, Clinical Affairs|650-397-2677|emir.deljkich@aurisrobotics.com|
287242|NCT01122238|UWisconsin|Stevens Smith|608-262-7563|sss@ctri.medicine.wisc.edu|
287243|NCT01122264|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287244|NCT01122316|University of California Los Angeles|Tamara Horwich, MD, MS|310-825-8816|thorwich@mednet.ucla.edu|
287245|NCT01122394|VA New York Harbor Healthcare System|Jennifer Friedberg, Ph.D.|212-951-3314|jennifer.friedberg@va.gov|
287246|NCT01122446|LundU|Helena Elding Larsson, PI|+4640337676|helena.elding_larsson@med.lu.se|
287247|NCT01122576|Bausch & Lomb Incorporated|Quintus Ngumah, OD, PhD|(973) 360-6450|Quintus.Ngumah@bausch.com|
287248|NCT01122680|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298158|NCT01797965|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
298159|NCT01798004|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
298160|NCT01798056|GlaxoSmithKline|GSK Response Center|866-435-7343||
298161|NCT01798134|Boston Scientific Corporation|Senior Clinical Program Manager|763-494-2172|hansenj2@bsci.com|
308669|NCT02600325|Erasmus MC|Dr. B. J. A. Rijnders|0|b.rijnders@erasmusmc.nl|
298162|NCT01798186|Johns Hopkins University|Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
298163|NCT01798225|Medical University of South Carolina|Renata Leite|843-792-3908|leiter@musc.edu|
298164|NCT01798264|Intarcia|Michelle Braon|510-782-7800||
298165|NCT01798316|Northwell|Director of Clinical Research, Department of Anesthesiology|718-470-7630|odowling@northwell.edu|
298166|NCT01798394|University of Minnesota|Nicole Tosun|612-624-5439|tosun004@umn.edu|
298167|NCT01798485|Synta Pharmaceuticals|President, Chief Executive Officer|781-541-7261||
298168|NCT01798550|Emory University|Christine Kempton MD, MSc|404-778-1900|ckempto@emory.edu|
298169|NCT01798589|Dermatology Specialists|Joseph Fowler, MD|502-583-7546|fowlerjoe@msn.com|
298170|NCT01798641|Johns Hopkins University|Dr. Daniele Rigamonti, MD FACS|410-955-2259|hydrocephalus@jhmi.edu|
298171|NCT01798706|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
298172|NCT01798849|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
298173|NCT01798927|UT Southwestern Medical Center|Karen McCain, PT, DPT, NCS|214-648-1559|karen.mccain@utsouthwestern.edu|
298174|NCT01798966|Hamilton Glaucoma center|Anjali Parekh|+1858 822-1553|anjalism@gmail.com|
298175|NCT01798992|University of Colorado, Denver|Dr. Michael Bristow, MD PhD|303-724-5453|Michael.Bristow@ucdenver.edu|
298176|NCT01799135|Dana Farber Cancer Institute|Raymond H. Mak|617.632.3591|RMAK@PARTNERS.ORG|
298177|NCT01799213|Veterans Health Administration, West Haven, CT|Lisa G. Suter, MD|2039325711|lisa.suter@va.gov; lisa.suter@yale.edu|
298178|NCT01799226|UMichigan|Janet Kinney|734-615-5452|kinneyj@umich.edu|
298179|NCT01799239|Coloplast A/S|Camilla Felsvang Vibjerg, Senior Clinical manager|+45 4911 1990|dkcfv@coloplast.com|
298180|NCT01799278|Weill Cornell Medical College|Dr. Himisha Beltran|(646) 962-2072|GUONC@med.cornell.edu|
298181|NCT01799590|Janssen Pharmaceutical KK Japan|Group Manager|+81-3-4411-5072||
298182|NCT01799720|Universidad Miguel Hernández|Dr. Elena García García|965222025|egarcia@umh.es|2025
298183|NCT01799889|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
298184|NCT01799941|Avanir Pharmaceuticals|Nadine Knowles; Executive Director, Research & Development Operations|1-949-268-8972|nknowles@avanir.com|
277179|NCT00585169|Yale Unviersity|Marc N. Potenza, M.D., Ph.D.|203-737-3553|marc.potenza@yale.edu|
277180|NCT00585182|University of Utah|Dr Robert Pendleton|801 581 7818|robert.pendleton@hsc.utah.edu|
277182|NCT00585247|University of Ccalifornia, Irvine. Beckman Laser Institute|Dr. Kristen Kelly|949.824.7997|kmkelly@uci.edu|
277183|NCT00585286|University of California, Irvine|Christopher Zachary, FRCP, MBBS/Prinicipal Investigator|(949) 824-7103|czachary@uci.edu|
298185|NCT01799993|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
298186|NCT01800058|Hospital Universitario de La Princesa|Almudena Zapatero, MD PhD|+34 91 520 23 15|almudena.zapatero@salud.madrid.org|
287249|NCT01122849|GlaxoSmithKline|GSK Response Center|866-435-7343||
287250|NCT01122862|GlaxoSmithKline|GSK Response Center|866-435-7343||
287251|NCT01122901|Adult Brain Tumor Consortium|David Peereboom, MD|410-955-8837|jfisher@jhmi.edu|
287252|NCT01122927|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
287253|NCT01123070|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|1-888-483-8270|USMedInfo@tevapharm.com|
287254|NCT01123083|GlaxoSmithKline|GSK Response Center|866-435-7343||
287255|NCT01123148|University of Michigan|Jane Huggins, PhD|734-936-7177|janeh@umich.edu|
287256|NCT01123161|Cedars-Sinai Medical Center|Dr. Patrick Lyden|310-423-5166|lydenp@cshs.org|
287257|NCT01123200|University of Michigan|Jane Huggins|734-936-7177|janeh@umich.edu|
287258|NCT01123356|Medical University of South Carolina|Clinical Trials Network Manager|843-792-1753|adraleta@musc.edu|
287259|NCT01123382|MetroHealth Medical Center|Richard WIlson, MD|216-957-3559|rwilson@metrohealth.org|
287260|NCT01123395|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
298187|NCT01800201|University of Pennsylvania|Noora Marcus|215-746-4429|noora.marcus@uphs.upenn.edu|
287261|NCT01123512|Benvenue Medical, Inc.|Barbara S. Lindsay, Vice President Clinical & Regulatory Affairs|408-454-9300|blindsay@benvenuemedical.com|
287262|NCT01123642|VISN 17 Center of Excellence for Research on Returning War Veterans|Sandra B. Morissette, Ph.D.|254-297-5170|sandra.morissette@va.gov|
287263|NCT01123655|Memphis VAMC|Arnold E. Postlethwaite,MD Principal Investigator|901 448 5774|apostlet@uthsc.edu|
287264|NCT01123889|Loma Linda University Orthopaedic Surgery|Liz Clarke|909-558-5592|eaclarke@llu.edu|
287265|NCT01123928|Zhongshan Ophthalmic Center|Dr. Nathan Congdon|13925056342|ncongdon1@gmail.com|
287266|NCT01123941|Novartis Vaccines Institute for Global Health|Dr. Audino Podda, MD|+39 0577 243496|audino.podda@novartis.com|
287267|NCT01123980|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
287268|NCT01124006|DePuy Synthes Spine|Mark Lotito|508-880-8045|Mlotito@its.jnj.com|
287269|NCT01124045|Alcon Research, Ltd.|Pam Kaur, PhD|1-888-451-3937|alcon.medinfo@alcon.com|
287270|NCT01124097|BIAL - Portela & Cª S.A.|Director R&D|+351-229866100|clinical.trials@bial.com|
287271|NCT01124149|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
287272|NCT01124162|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
287273|NCT01124175|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
287274|NCT01124188|UPMC Late Life Depression|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
287275|NCT01124292|Georgia Institute of Technology|Dr. Maysam Ghovanloo|404-385-7048|mgh@gatech.edu|
287276|NCT01124305|AORI|Knee Project Director|7036194423|nparks@aori.org|
287277|NCT01124370|Respicardia|Linda Nelson, VP Clinical Affairs|952-540-4479|lnelson@respicardia.com|
287278|NCT01124422|GlaxoSmithKline|GSK Response Center|866-435-7343||
287279|NCT01124448|Complutense University Madrid|Dr. Juan M Rodríguez|34 91 3943837|jmrodrig@vet.ucm.es|
287280|NCT01124604|Neuroscience Department, Clinical Science Department, R&D in Janssen Japan Chiyodaku, Tokyo 101-0065 Japan|Manager|+81-3-4411-5509||
287281|NCT01124617|Neuroscience department, clinical science department, R&D in Janssen Japan, Chiyodaku, Tokyo 101-0065 Japan|Manager|+81-3-4411-5509||
287282|NCT01124643|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
287283|NCT01124734|Penn State Cancer Institute|Joseph Drabick, MD|717 531 5059|jdrabick@pennstatehealth.psu.edu|
277184|NCT00585312|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277185|NCT00585325|University of Wisconsin-Madison|Cindy Schmitz, RN, MS, NP|608-262-2664|CSchmitz@uwhealth.org|
277186|NCT00585351|University of Iowa|Enrique Leira, MD, MS|319-356-8755|enrique-leira@uiowa.edu|
277187|NCT00585377|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
277188|NCT00585468|University of Utah|Fuad Shihab, MD|801-585-3823|fuad.shihab@hsc.utah.edu|
277189|NCT00585494|University of Wisconsin Madison|Ann Marie Sheehy, M.D., M.S.|608-335-6734|asr@medicine.wisc.edu|
277190|NCT00585533|Huntsman Cancer Institute/University of Utah|Wallace Akerley, MD|801-585-5986|wallace.akerley@hci.utah.edu|
277191|NCT00585546|University of Michigan|Francis Pagani|734 647-2894|fpagani@med.umich.edu|
277192|NCT00585637|Dana-Farber Cancer Institute|Kimmie Ng, MD, MPH|617-632-4150|Kimmie_Ng@dfci.harvard.edu|
277193|NCT00585650|Wake Forest Baptist Health, Department of Dermatology|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wakehealth.edu|
277194|NCT00585689|University of Michigan Comprehensive Cancer Center|Dr. David Smith, M.D.|734-936-6884|dcsmith@umich.edu|
277195|NCT00585715|University of California, Irvine|Kristen M. Kelly, M.D.|949-824-7103|kmkelly@uci.edu|
277196|NCT00585780|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Rajita Sinha|2038592840|rajita.sinha@yale.edu|
277197|NCT00585910|Massachusetts General Hospital|Kerry Brodziak|617-503-1043|kbrodziak@partners.org|
277198|NCT00585923|Biomet|Jacquelyn Hughes|973-299-9300|jacquelyn.hughes@biomet.com|3075
277199|NCT00585975|ISTA Pharmaceuticals, Inc.|Tim McNamara, PharmD|949-788-6000|tmcnamara@istavision.com|
277200|NCT00586001|Boston University Charles River Campus|Todd Farchione|(617) 353-9610|tfarchio@bu.edu|
277201|NCT00586066|Massachusetts General Hospital|Andrew Nierenberg, Principal Investigator|6177240837|anierenberg@partners.org|
277202|NCT00586105|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
277203|NCT00586157|Massachusetts General Hospital|Timothy Wilens, MD|617-726-1731|twilens@partners.org|
277204|NCT00586170|Biomet|Manager of Research|973-299-9300|hallie.murray@zimmerbiomet.com|3415
277205|NCT00586196|BIDMC|Edward R Marcantonio|617-754-1405|emarcant@bidmc.harvard.edu|
287284|NCT01124786|Clovis Oncology, Inc.|VP Clinical Development|415-409-5440|clinicaltrialinfo@clovisoncology.com|
287285|NCT01124838|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
287286|NCT01124864|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
287287|NCT01124916|Loyola University|Elizabeth Mueller, M.D.|708-216-2180|emuelle@lumc.edu|
287288|NCT01124955|Federal University of São Paulo|Tatiana Molinas Hasegawa|55 115576 4239|tatianamolinas@hotmail.com|
287289|NCT01125046|Northwestern University|Priya Kumthekar, MD||Priya.Kumthekar@nm.org|
287290|NCT01125098|Department of Oncology Haematology and Respiratory Diseases|Leonardo Fabbri|+39 059422|leonardo.fabbri@unimore.it|4227
287291|NCT01125163|UTexas_Houston|Dr. Kathleen A. Kennedy|713-500-6708|Kathleen.A.Kennedy@uth.tmc.edu|
287292|NCT01125189|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
287293|NCT01125202|New York University School of Medicine|Mary Ann Sevick, ScD|6465012621|mary.sevick@nyumc.org|646
287294|NCT01125293|Dana-Farber Cancer Institute|Irene Ghobrial|617-632-4101|irene_ghobrial@dfci.harvard.edu|
287295|NCT01125358|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287296|NCT01125514|Novartis Pharmaceuticals|Study Director|862-778-8300||
287297|NCT01125566|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287298|NCT01125605|Pascoe pharmazeutische Praeparate GmbH|Director of Clinical Trials|0049 641 7960100|klinische.forschung@pascoe.de|
298188|NCT01800318|University of Arkansas for Medical Sciences|Richard W. Hall, professor of pediatrics, co-director of neonatal intensive care unit|501-680-7894|HallRichardw@uams.edu|
298189|NCT01800786|Brigham and Women's Hospital|Ina Djonlagic|617 667 5129|idjonlag@bidmc.harvard.edu|
298190|NCT01800838|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Elma Baron|216-368-4971|elma.baron@uhhospitals.org|
277206|NCT00586261|Mayo Clinic|Dr. Patricia Best|507-284-4441|best.patricia@mayo.edu|
298191|NCT01800877|Centre de Recherche du CHUS|Marie-Hélène Masse|819-346-1110|marie-helene.masse3@usherbrooke.ca|14173
298192|NCT01800890|Coloplast A/S|Marian Sinvani|+45 4911 2356|dkmards@coloplast.com|
298193|NCT01800903|Coloplast A/S|Trine Møller Senior Clinical Manager|+45 4911 2174|dktrm@coloplast.com|
298194|NCT01800916|Coloplast A/S|Marian Sinvani|+45 49112356|dkmards@coloplast.com|
298195|NCT01800968|Duke Clinical Research Institute|Adrian Hernandez, MD|919-668-7515|adrian.hernandez@duke.edu|
298196|NCT01801007|MicroVention, Inc., A TERUMO Group Company|Senior Manager, Clinical Quality Compliance and Clinical Operations|714-247-8000|jennifer.jelf@microvention.com|
298197|NCT01801111|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
298198|NCT01801124|Maimonides Medical Center|Mark Kronefeld, MD|(718) 283-8816||
298199|NCT01801241|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
298200|NCT01801280|Charité University Hospital - Department of Nephrology|Olesja Rissling|+49 30 450 514 153|olesja.rissling@charite.de|
298201|NCT01801358|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
298202|NCT01801436|Janssen Pharmaceutical Taiwan|Medical Affairs Director|+886-2-23762155||
298203|NCT01801449|National Inst of Arthritis and Musculoskeletal and Skin Diseases|Montealegre, Gina|+1 301 761 7747|montealegrega@mail.nih.gov|
298204|NCT01801475|Stanford University|Dr. David R Drover|6507250364|ddrover@stanford.edu|
298205|NCT01801735|Iroko Pharmaceuticals, LLC|Alexis Gomez, Director of Clinical Operations|267-546-1426|agomez@iroko.com|
298206|NCT01801865|Cincinnati Children's Hospital Medical Center|Dr. Beth Kline-Fath|(513) 636-1856|beth.kline-fath@cchmc.org|
298207|NCT01801917|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
298208|NCT01801930|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
298209|NCT01801982|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298210|NCT01802073|Stanford University|Dr. Kenneth Cox|(650) 723-5070|KCox@stanfordchildrens.org|
298211|NCT01802151|Department of Food Science and Human Nutrition, University of Florida|Dr. Wendy Dahl|352-392-1991|wdahl@ufl.edu|224
298212|NCT01802216|University of California, San Francisco|Dr. Vanessa Grubbs|415-206-5649|Vanessa.Grubbs@ucsf.edu|
277207|NCT00586313|Indiana University Hospital|John DeWitt, MD|317-944-1113|jodewitt@iu.edu|
277208|NCT00586326|Hologic, Inc.|Nancy Chenette, Director, Clinical Affairs|508-263-8770|nancy.chenette@hologic.com|
277209|NCT00586339|GlaxoSmithKline|GSK Response Center|866-435-7343||
277210|NCT00586469|GlaxoSmithKline|GSK Response Center|866-435-7343||
277211|NCT00586482|Mayo Clinic|David O. Warner, MD|507-255-4288|warner.david@mayo.edu|
277212|NCT00586495|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
277213|NCT00586508|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
277214|NCT00586521|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
277215|NCT00586573|Massachusetts General Hospital|Craig Surman, MD|617-503-1424|csurman@partners.org|
277216|NCT00586612|GlaxoSmithKline|GSK Response Center|866-435-7343||
277217|NCT00586625|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
277218|NCT00586664|ISTA Pharmaceuticals, Inc.|Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
277219|NCT00586690|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
277220|NCT00586703|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
277221|NCT00586729|Maricopa Integrated Health System|Karen Richey, RN|602-344-5125|karen.richey@mihs.org|
277222|NCT00586820|Mayo Clinic|Dr. Amir Lerman|507-255-6670|lerman.amir@mayo.edu|
277223|NCT00586846|Memorial Sloan Kettering Cancer Center|Dr. Paul Meyers|212-639-5952|meyersp@mskcc.org|
277224|NCT00586898|Memorial Sloan Kettering Cancer Center|Dr. Howard Scher|646-422-4323|Scherh@mskcc.org|
277225|NCT00587041|Mayo Clinic|Use of Symbiotics to Reduce Urinary Oxalate Excretion|507-266-7960|lieske.john@mayo.edu|
277226|NCT00587054|Memorial Sloan-Kettering Cancer Center|Dr. Ann Jakubowski|212-639-5013|jakubowa@mskcc.org|
298213|NCT01802281|RTI International|Marie Gantz|919-541-5110|mgantz@rti.org|
287299|NCT01125722|Ethicon Endo-Surgery|Michael Schwiers, Principal Biostatistician|513-337-1172|mschwier@its.jnj.com|
287300|NCT01125748|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
287301|NCT01125774|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
287302|NCT01125800|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
287303|NCT01125813|Octapharma AG|Dr Sigurd Knaub|41 55 451 21 41|sigurd.knaub@octapharma.ch|
287304|NCT01125917|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
287305|NCT01125930|University of Michigan|Dr. Lisa Maier|734-936-4192|maierl@med.umich.edu|
287306|NCT01126060|Samsung medical center|Dr. Man Ki Chung|82-2-3410-1845|manki.chung@samsung.com|
287307|NCT01126099|VA Puget Sound|Lucy Wang|206-277-5089|wanglucy@u.washington.edu|
287308|NCT01126268|The University of Texas Health Science Center at Houston|Dr. Adelaide A Hebert|(713) 500-8339|Adelaide.A.Hebert@uth.tmc.edu|
277227|NCT00587067|Memorial Sloan Kettering Cancer Center|Dr. William Jarnagin, MD|212-639-3624|jarnagiw@mskcc.org|
287309|NCT01126359|Department of Orthopaedics|Dr. Erik Kubiak|801-587-5404|Erik.Kubiak@hsc.utah.edu|
287310|NCT01126424|Astellas Pharma Europe Ltd.|Associate Medical Director Urology||clinicaltrials@us.astellas.com|
287311|NCT01126437|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287312|NCT01126541|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
308670|NCT02600351|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
287313|NCT01126580|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287314|NCT01126593|Orlando Orthopaedic Center|Dr. Randy Schwartzberg|(407) 254-2500|orlandosportsdoc@yahoo.com|
287315|NCT01126619|Abbott|Global Medical Services|800-633-9110||
287316|NCT01126671|Boston Children's Hospital|Dr. Sarah Pitts|617-355-3732|sarah.pitts@childrens.harvard.edu|
287317|NCT01126723|Institute for Aging Research, Hebrew SeniorLife|Dr. Lewis Lipsitz|617-971-5318|lipsitz@hsl.harvard.edu|
287318|NCT01127061|University of Michigan School of Medicine|Dr. Sara Saberi, MD, MS|734-764-4500|saberis@med.umich.edu|
287319|NCT01127087|Mayo Clinic|Dr. John C. Lieske|507-266-7960|lieske.john@mayo.edu|
287320|NCT01127139|Abbott|Global Medical Services|1-800-633-9110||
287321|NCT01127165|Eisai Korea Inc.|Jihee Mun, Pharmacist, Medical Department manager|+82-2-3451-5531|jihee_mun@eisaikorea.com|
287322|NCT01127321|MedImmune, LLC.|David Close, Director, Clinical Development|301-398-0000|closeda@medimmune.com|
287323|NCT01127373|Memorial Sloan Kettering Cancer Center|Dr. Simon Powell, MD|212-639-3639|powells@mskcc.org|
277228|NCT00587132|Mayo Clinic|Dr. Naoki Takahashi|507-284-7249|takahashi.naoki@mayo.edu|
287324|NCT01127438|Eisai Call Center|Eisai Inc.|888-422-4743||
287325|NCT01127581|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
287326|NCT01127607|Florida International University|Dr. James Waxmonsky|717 531 8646|jwaxmons@fiu.edu|
287327|NCT01127633|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287328|NCT01127646|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
277229|NCT00587158|Mayo Clinic|Hatem Amer, MD, FASN; Assistant Professor of Medicine; Division of Nephrology and Hypertension|507-256-1963|amer.hatem@mayo.edu|
277230|NCT00587171|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H.|813-975-8690|pedig@jaeb.org|
277231|NCT00587288|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
277232|NCT00587431|Memorial Sloan-Kettering Cancer Center|Dr. Dana Rathkopf|646-422-4379|rathkopd@mskcc.org|
277233|NCT00587457|MedImmune, LLC.|Mark C Lanasa|301-398-0000|clinicaltrialenquiries@medimmune.com|
277234|NCT00587483|Mayo Clinic|Dr. William Mauermann|507-255-4240|mauermann.william@mayo.edu|
277235|NCT00587587|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinical@organo.com|
277236|NCT00587639|Mayo Clinic|Dr. Christopher Wall|5072843352|wall.chris@mayo.edu|
277237|NCT00587678|University of Virginia|Dr Christopher Kramer|434-243-0736||
277238|NCT00587769|Mayo Clinic|Jon O. Ebbert|507-284-2511|ebbert.jon@mayo.edu|
277239|NCT00587834|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinical@organo.com|
277240|NCT00587847|North Shore-Long Island Jewish Health System|Kanti Rai, MD|(718) 470-4050|krai@nshs.edu|
287329|NCT01127659|University of Buffalo|Paresh Dandona|716) 961-9900|pdandona@kaleidahealth.org|
287330|NCT01127737|Northwestern University|June Robinson, MD|312-695-6624|june-robinson@northwestern.edu|
287331|NCT01127763|Mt Sinai School of Medicine|Amy Tiersten, MD|212-249-3300|amy.tiersten@mssm.edu|
287332|NCT01127893|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287333|NCT01128049|University of Rochester Medical Center, Flaum Eye Institute|James Aquavella, MD|585-275-8944|James_Aquavella@URMC.Rochester.Edu|
287334|NCT01128153|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
287335|NCT01128179|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
287336|NCT01128192|Veterans Medical Research Foundation|Principal Investigator|858-552-8585|rrhenry@ucsd.edu|
287337|NCT01128244|University of Florida|Dr. Jesse F. Gregory|(352) 392-1991|jfgy@ufl.edu|225
287338|NCT01128270|University of Florida|Peter W. Stacpoole,MD|(352) 273-9023|pws@ufl.edu|
287339|NCT01128296|UPMC CancerCenter|Herbert Zeh, MD|412-692-2852|zehxhx@upmc.edu|
287340|NCT01128361|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|jburns2@kumc.edu|
287341|NCT01128387|University of Wisconsin Carbone Cancer Center|Dr. Mark Ritter|608-263-8500|ritter@humonc.wisc.edu|
287342|NCT01128400|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu|
287343|NCT01128413|Washington University School of Medicine|Dr. Chris Holthaus|314-747-5994|holthauscv@wustl.edu|
287344|NCT01128426|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287345|NCT01128543|GlaxoSmithKline|GSK Response Center|866-435-7343||
287346|NCT01128569|GlaxoSmithKline|GSK Response Center|866-435-7343||
287347|NCT01128595|GlaxoSmithKline|GSK Response Center|866-435-7343||
287348|NCT01128621|GlaxoSmithKline|GSK Response Center|866-435-7343||
298214|NCT01802320|The University of Texas MD Anderson Cancer Center, Clinical Research Operations|Dr. Scott Kopetz/Associate Professor, GI Medical Oncology|713-792-2828|SKopetz@mdanderson.org|
298215|NCT01802333|SWOG Statistics and Data Management Center|Leukemia Committee Statistician|206-667-4623|amoseley@fredhutch.org|
298216|NCT01802385|University of Minnesota|Joshua Rhein|612-624-1966|joshua.rhein@gmail.com|
298217|NCT01802411|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|Pacira Pharmaceuticals, Inc.|MedInfo@pacira.com|
298218|NCT01802437|University of Minnesota|Meredith Gunlicks-Stoessel|612-273-9844|mgunlick@umn.edu|
298219|NCT01802515|Yale University|Dr. Mehmet Sofuoglu, Principal Investigator|203 937-4809|mehmet.sofuoglu@yale.edu|
298220|NCT01802554|University of California San Diego|Brent T Mausbach, PhD|858-822-7529|BMausbach@ucsd.edu|
298221|NCT01802580|Wake Forest University Health Sciences|Dr. Steve Feldman, Professor of Dermatology, Public Health Scienes, and Pathology|336-716-7740|sfeldman@wakehealth.edu|
298222|NCT01802710|Hospital Galdakao-Usansolo|Dra Miren Orive|0034 944007105|miren.orivecalzada@osakidetza.net|
298223|NCT01802775|Daiichi Sankyo Development Inc.|Clinical Trial Information|+44 1753482800|info@dsd-eu.com|
298224|NCT01802879|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
298225|NCT01803074|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
298226|NCT01803204|USP|Cristina Sousa|+5511996017972|crissousa@usp.br|
298227|NCT01803269|University of Chicago|Theodore Karrison, PhD|773-702-9326|tkarrison@health.bsd.uchicago.edu|
298228|NCT01803282|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
298229|NCT01803464|University of Delaware|Dr. Christopher Modlesky|302-831-4185|modlesky@udel.edu|
277241|NCT04545008|Prisma Health|Dr. Julie Martin - Director, Cancer Research|864-455-3667|julie.martin@prismahealth.org|
298230|NCT01803607|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
298231|NCT01803646|Auris Medical Inc.|Thomas Meyer, CEO|+1 312 396 4150|hear@aurismedical.com|
298232|NCT01803737|University of Arizona|David O. Garcia, PhD|520-626-4641|davidogarcia@email.arizona.edu|
298233|NCT01803880|Smith & Nephew, Inc|Stephan Mangin, Director, Global Clinical Strategy|M +1 (512) 913-8192|stephan.mangin@smith-nephew.com|
298234|NCT01804036|University of Utah|Yoshio Nakamura, PhD|801-585-7690|yn5@utah.edu|
298235|NCT01804049|VAORD - Portland VA Health Care System|Dr Robert Klein|503-220-8268|kleinro@ohsu.edu|57496
298236|NCT01804062|Medtronic|Michael Luna-Victoria|303 305 2463|michael.luna-victoria@medtronic.com|
298237|NCT01804075|Eastern Maine Medical Center|Dr. Mark Brown|207-973-9503|mbrown@emh.org|
298238|NCT01804101|Fred Hutchinson Cancer Center|Dr. Roland B. Walter|206-667-3599|rwalter@fredhutch.org|
298239|NCT01804114|NSUHS|Michael Ujiki, MD|8475701700|rpulido@northshore.org|
298240|NCT01804140|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
298241|NCT01804257|Zucker Hillside Hospital, Glen Oaks, NY|John M. Kane MD|(718) 470-8141|psychiatry@nshs.edu|
298242|NCT01804465|University of California, San Francisco|Dr. Lawrence Fong, MD|(415) 514-3160|Lawrence.Fong@ucsf.edu|
298243|NCT01804582|University of Maryland, Baltimore|Gloria M. Reeves, M.D.|410-328-3522|greeves@psych.umaryland.edu|
298244|NCT01804673|Clinic for Anaesthesiology, Intensive Care Unit and Pain Therapy at the Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Str. 33, 48149 Munster.|Head|+49 251 / 83 - 4 72 52||
298245|NCT01804842|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
298246|NCT01804881|North York Family Health Team|Principal Investigator|4164943003|dsouthgate@nyfht.com|130
298247|NCT01804946|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761575|PutilovskiyMA@materiamedica.ru|302
298248|NCT01805024|Santhera Pharmaceuticals|Roxana Drake|+41 61 906 89 29|roxana.drake@santhera.com|
277246|NCT04033991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308671|NCT02600403|Wills Eye Hospital|Michael Waisbourd|2159283000|MWaisbourd@willseye.org|
277247|NCT03930849|Department of Veterans Affairs|Carolyn Turvey, Ph.D.|319 338 0581|Carolyn.Turvey@va.gov|637714
277248|NCT03793439|Oregon Health & Science University|Dr. Marcia Friedman|5034948637|friedmam@ohsu.edu|
277249|NCT03711266|Michigan Medicine|Rebecca Sripada|734-222-7432|rekaufma@med.umich.edu|
277250|NCT03655691|Eirion Therapeutics|Chief Executive Officer|(781) 935-1216|info@eirionthera.com|
277251|NCT03630393|OhioHealth|Dr. Ryan Hedgepeth|614-788-2870|ryan.hedgepeth@ohiohealth.com|
277252|NCT03531788|University of Pittsburgh|Roxanna M. Bendixen, Principal Investigator|4123836603|bendixen@pitt.edu|
277253|NCT03402230|University of Arizona|Sherry Chow, PhD|5206263358|schow@azcc.arizona.edu|
277254|NCT03359811|UT MD Anderson Cancer Center|Dr. Juan Cata, MD, Associate Professor, Anesthesiology & PeriOper Med|(713) 792-7452|jcata@mdanderson.org|
308672|NCT02600559|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
277255|NCT03249714|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
277256|NCT03241589|VHA|Sara Peracca|415-750-2091|sara.peracca@va.gov|
277257|NCT03096834|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
277258|NCT02959775|Shanxi Medical University|Suping Wang, PhD|#86-351-4135103|spwang88@163.com|
277259|NCT02954406|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
277260|NCT02927145|University of Oxford|Dr Angela Minassian|0044 01865611425|angela.minassian@ndm.ox.ac.uk|
277261|NCT02910583|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
277262|NCT02699060|IMSechenovMMA|MD, PhD Ivashkin Vladimir Trofimovich|+79252667987|motility_2013@mail.ru|
287349|NCT01128738|GlaxoSmithKline|GSK Response Center|866-435-7343||
287350|NCT01128829|Washington University School of Medicine|M. Yanina Pepino|3143628113|ypepino@dom.wustl.edu|
287351|NCT01128842|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
287352|NCT01128894|GlaxoSmithKline|GSK Response Center|866-435-7343||
287353|NCT01128946|GlaxoSmithKline|GSK Response Center|866-435-7343||
287354|NCT01128959|Lundbeck LCC|Lundbeck LLC|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
287355|NCT01128972|GlaxoSmithKline|GSK Response Center|866-435-7343||
287356|NCT01129011|POZEN|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
287357|NCT01129024|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
287358|NCT01129102|Nobelpharma|Department director of clinical development department 1|+81-5651-1177|murakami@nobelpharma.co.jp|
287359|NCT01129115|University of Kansas Medical Center|Dr. Jeffrey Burns|913-588-0555|kuamp@kumc.edu|
287360|NCT01129128|University of Washington|James A Taylor, MD|206-616-1206|uncjat@uw.edu|
287361|NCT01129141|NCRAR, VA RR&D|James A. Henry, Ph.D.|503.220.8262|james.henry@va.gov|57466
298249|NCT01805037|Northwestern University, Feinberg School of Medicine|Barbara Pro, MD|312-695-6180|barbara.pro@northwestern.edu|
298250|NCT01805089|DFCI|Dr. Wendy Chen|617-632-3800|wychen@partners.org|
298251|NCT01805154|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
298252|NCT01805180|Terumo BCT|Raymond P. Goodrich, PhD / VP, Scientific and Clinical Affairs; Chief Science Officer-BBT|303.205.2680|Ray.Goodrich@terumobct.com|
298253|NCT01805297|Dean McGee Eye Institute|Robert E. Leonard, II, MD|405-271-6060|sonny-icks@dmei.org|
298254|NCT01805323|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
298255|NCT01805440|Department of Psychiatry|Douglas Kondo, MD|801-583-2500|doug.kondo@hsc.utah.edu|
298256|NCT01805687|Cornerstone Therapeutics, Inc.|W. James Alexander, MD, MPH|919-678-6925|jim.alexander@chiesi.com|
298257|NCT01805791|Hutchison MediPharma Ltd|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
298258|NCT01805882|National Institute of Allergy and Infectious Diseases|Shyam Kottilil MD|+1 410 706 4872|Skottilil@ihv.umaryland.edu|
298259|NCT01805895|Augusta University|Dr Jeffrey Switzer|7067211691|jswitzer@augusta.edu|
298260|NCT01806064|TRACON Pharmaceuticals Inc.|Charles Theuer|(858) 550-0780|ctheuer@traconpharma.com|233
298261|NCT01806168|Vancouver Coastal Health / Vancouver General Hospital|Kawai Leong, MD, MSc, FRCPC|604-875-8289|kawai.leong@vch.ca|
298262|NCT01806259|UoA|Prof Patrice Forget|497 12 28 36|forgetpatrice@yahoo.fr|
298263|NCT01806298|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
298264|NCT01806389|Johns Hopkins University School of Medicine|Dr. Lauren Jansson|410-550-5438|ljansson@jhmi.edu|
298265|NCT01806506|Department of General, Transplant and Liver Surgery, Medical University of Warsaw|Piotr Kalinowski|0048 22 599 2546|kalip@o2.pl|
298266|NCT01806545|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
298267|NCT01806571|Mayo Clinic|Aref Al-Kali, M.D.|(507) 538-0591|alkali.aref@mayo.edu|
298268|NCT01806584|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
298269|NCT01806597|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
298270|NCT01806623|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298271|NCT01806662|Rockefeller University|James Krueger|2123278333|gilleap@mail.rockefeller.edu|
298272|NCT01806675|Stanford University|Sanjiv Sam Gambhir, Professor for Clinical Investigation in Cancer Research and Professor|650-725-6175|sgambhir@stanford.edu|
298273|NCT01806688|Agriculture and Agri-Food Canada|Dr. Heather Blewett|204 237-2954|hblewett@sbrc.ca|
298274|NCT01806714|University of Rochester|Dr. Cynthia Rand|585 275-9316|cynthia_rand@urmc.rochester.edu|
298275|NCT01806740|Guerbet|Corinne Dubourdieu, Head of Clinical Projects|+33145915000|corinne.dubourdieu@guerbet.com|
298276|NCT01806779|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
298277|NCT01806857|Center for Neurological Study|Richard Smith, MD|858-455-5463|cnsonline@ymail.com|
298278|NCT01806896|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298279|NCT01807000|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
298280|NCT01807026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298281|NCT01807065|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
298282|NCT01807091|University of Washington|Elihu Estey, MD|206-606-6744|eestey@seattlecca.org|
298283|NCT01807104|VOA Research Foundation|Dr. William P. Barrett, MD|425-656-5060|wpbarrett@comcast.net|3063
298284|NCT01807156|Emory University|Bassel El-Rayes, MD|404-778-1900|bassel.el-rayes@emoryhealthcare.org|
298285|NCT01807221|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
298286|NCT01807234|Johns Hopkins University School of Medicine|Dr. B. Lee Peterlin|410-550-9550|hnitchi1@jhmi.edu|
298287|NCT01807299|Universidade Federal de São Paulo|PhD José Carlos F. Galduróz||galduroz@unifesp.br|
298288|NCT01807455|Q-Med AB|Chief Medical Officer|+ 46 (0) 18 474 90 00|Reception.SEUPP@galderma.com|
298289|NCT01807520|Novartis Pharmaceuticals|Study Director|862-778-8300||
298290|NCT01807585|Medtronic Endovascular|Melissa Hasenbank, Clinical Research Director|707-525-0111|melissa.hasenbank@medtronic.com|
298291|NCT01807598|Stanford University|Jason R. Gotlib|650-736-1253|jason.gotlib@stanford.edu|
298292|NCT01807624|Jean Brown Research Center|Dr. Derek Muse|(801) 261-2000|participate@jeanbrownresearch.com|
298293|NCT01807637|University of Arkansas for Medical Sciences|Mark Mennemeier, PhD|15015267773|msmennemeier@uams.edu|
287362|NCT01129206|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii Saab, MD|614-293-6529|Tanio.Saab@osumc.edu|
287363|NCT01129245|Oregon Health and Science University|Alison Edelman|503-494-5949|edelmana@ohsu.edu|
287364|NCT01129284|Columbia University Medical Center|Dr. Andrew S. Bomback, MD, MPH|212-305-0320|asb68@columbia.edu|
287365|NCT01129336|Novartis Pharmaceuticals|Study Director|862-778-8300||
287366|NCT01129440|University of California, San Francisco|Dr. Stuart Gansky|415-502-8094|stuart.gansky@ucsf.edu|
298294|NCT01807650|Amryt Pharma|Head of Clinical Development|+353 1 518 0200|medinfo@amrytpharma.com|
287367|NCT01129531|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
287368|NCT01129557|Columbia University Medical Center, Division of Nephrology|Andrew Bomback, MD|212-305-5020|asb68@columbia.edu|
287369|NCT01129583|Columbia University Medical Center|TTC research fellow|212-305-3912|ttc@gmail.com|
287370|NCT01129609|Medtronic|Rianna Rapson|763-526-2170|rianna.k.rapson@medtronic.com|
287371|NCT01129622|Mount Sinai Hospital|Robert F Casper|416-972-0777|casper@lunenfeld.ca|
287372|NCT01129765|Advanced Pediatrics|Mary Margaret Thorne|703-938-5555|mthorne@pop.powweb.com|
287373|NCT01129778|Stanford University|W. Ray Kim, MD, Chief of Gastroenterology and Hepatology|650-725-6511|wrkim@stanford.edu|
287374|NCT01129804|UConn Health|Mark D. Litt, PhD; Principal Investigator|860-679-4680|litt@uchc.edu|
287375|NCT01129882|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
287376|NCT01129921|Napa Pain Institute|Eric Grigsby, MD|707-252-9660|egrig@aol.com|
287377|NCT01129960|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
287378|NCT01130051|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
287379|NCT01130103|Research Foundation for Mental Hygiene|Franklin Schneier MD|212-543-5368|frs1@columbia.edu|
287380|NCT01130168|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
287381|NCT01130272|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
287382|NCT01130337|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
298295|NCT01807871|University of Vermont|Dr. John Hughes|802-656-1640|John.Hughes@med.uvm.edu|
287383|NCT01130493|Impax Laboratories, LLC|Kaihong Jiang, Senior Director, Head of Biometrics|(908) 307-2234|Kaihong.Jiang@amneal.com|
287384|NCT01130532|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287385|NCT01130597|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
287386|NCT01130740|Center for Health Services Reserach in Primary Care, Durham VAMC|Kelli D. Allen, PhD|919-286-0411|kelli.allen@va.gov|7090
287387|NCT01130831|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
287388|NCT01130844|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
287389|NCT01130883|Abbott|Global Medical Services|1-800-633-9110||
287390|NCT01130896|Johns Hopkins University|Henry Halperin, MD|410-955-2412|nsaju1@jhmi.edu|
287391|NCT01130974|Bausch & Lomb Inc.|Robert Steffen|(585) 338-6399|robert.steffens@bausch.com|
287392|NCT01131052|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
287393|NCT01131065|Instituto Grifols, S.A.|Michael Woodward, BSc, M.Sc|+34 935712200|michael.woodward@grifols.com|
277242|NCT04496414|Integra LifeSciences (Shanghai) Co., Ltd.|Dr. Hua Tang|0086 21 63179772|hua.tang@integralife.com|
277243|NCT04411680|Partner Therapeutics, Inc.|Medical Information|1-888-479-5385|PartnerTx@medcomminc.com|
277244|NCT04364984|Medical Practice Prof D.Ivanov|Prof Dmytro Ivanov|0504448788|drivanovdd@gmail.com|+38
277245|NCT04363437|Maimonides Medical Center|Dr. Felix Yang|7182836000|fyang@maimonidesmed.org|
277263|NCT02598388|Janssen Vaccines & Prevention B.V.|MEDICAL LEADER|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
277264|NCT02493751|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277265|NCT02285166|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
277266|NCT02278120|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
287394|NCT01131078|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
287395|NCT01131104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287396|NCT01131130|Bausch + Lomb|Dr. Robert Steffen|585-338-6399|robert.steffen@bausch.com|
287397|NCT01131182|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
287398|NCT01131260|The George Washington University Biostatistics Center|Rebecca Clifton, Ph.D.|301-881-9260|rclifton@bsc.gwu.edu|
287399|NCT01131299|NIH NHLBI|Dr. Marcelo Amar|301-402-0521|mamar@mail.nih.gov|
287400|NCT01131312|National Cancer Institute|Dr. Mark Schiffman|240-276-7259|schiffmm@nih.gov|
287401|NCT01131325|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
287402|NCT01131351|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
287403|NCT01131494|University Federal of Bahia|Natalie Argolo Ponte|55 31 3274 5579|natyargolo@hotmail.com|
287404|NCT01131507|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
287405|NCT01131520|Friends Research Institute|Robert Schwartz|410-837-3977|rschwartz@friendsresearch.org|
287406|NCT01131585|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
287407|NCT01131676|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
287408|NCT01132118|Brigham and Women's Hospital|Dr. Daniel H. Solomon|617-525-8127|dsolomon@partners.org|
287409|NCT01132144|University of Sao Paulo|Dr. Wellington P Martins|55162231|wpmartins@gmail.com|
287410|NCT01132313|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287411|NCT01132326|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
287412|NCT01132378|Heekin Institute for Orthopaedic Research|R. David Heekin MD, FACS|904-634-0640|drheekin@heekinortho.com|
298296|NCT01807923|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
298297|NCT01807949|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
287413|NCT01132482|National Jewish Health|Jennifer Taylor-Cousar, Principal Investigator|3032702764|Taylor-CousarJ@NJHealth.org|
287414|NCT01132495|St. Jude Medical|Sr. Director, Global Clinical Affairs|651-756-5586|jmifek@sjm.com|
287415|NCT01132508|Synthes GmbH|Clinical Research Scientist|+41619656592|clinicalaffairs.emea@synthes.com|
287416|NCT01132547|SunCoast CCOP Research Base at the University of South Florida|Angelina Fink, Research Base Administrator|813-396-9245|angelina.fink@epi.usf.edu|
287417|NCT01132612|Novartis Pharmaceuticals|Study Director|862-778-8300||
287418|NCT01132651|Northwestern University|Mandy Browning|312-695-6829|mandybrowning2015@u.northwestern.edu|
298298|NCT01808066|CogCubed|Chief Medical Officer|612-250-9737|monika@cogcubed.com|
287419|NCT01132664|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
287420|NCT01132690|Protalix Biotherapeutics|Senior VP Development|+972-4-902-8100|einat@protalix.com|
298299|NCT01808092|AstraZeneca|David Wilson, Statistical Team Leader - Infection|+44 1625 517830|David.wilson2@astrazeneca.com|
298300|NCT01808118|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
298301|NCT01808144|Ardea Biosciences, Inc.|Nihar Bhakta, MD|1-858-652-6671|nbhakta@ardeabio.com|
298302|NCT01808196|Cincinnati Children's Hospital Medical Center|Pablo Abonia, MD|513-636-|pablo.abonia@cchmc.org|
298303|NCT01808209|Opthalmic Research Group, Aston University, Birmingham, UK|Jonathan Walker||JWalker@coopervision.co.uk|
298304|NCT01808222|Emory University|David Schuster MD|404-712-4859|dschust@emory.edu|
298305|NCT01808248|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
298306|NCT01808313|GlaxoSmithKline|GSK Response Center|866-435-7343||
298307|NCT01808326|GlaxoSmithKline|GSK Response Center|866-435-7343||
298308|NCT01808339|GlaxoSmithKline|GSK Response Center|866-435-7343||
298309|NCT01808508|Children's Hospital of Philadelphia|Carole L. Marcus, MBBCh|267-426-5842|marcus@email.chop.edu|
298310|NCT01808534|IndianaU|Dr. Lawrence H. Einhorn|(317)274-3515|leinhorn@iu.edu|
298311|NCT01808547|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
298312|NCT01808560|TearScience, Inc.|Manager of Clinical and Medical Affairs|919-459-4842|LJi4@its.jnj.com|
298313|NCT01808573|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|424-248-6500|clinicaltrials@pumabiotechnology.com|
298314|NCT01808612|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298315|NCT01808651|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298316|NCT01808690|University of Colorado Denver/Children's Hospital Colorado|Dr. Kristen J Nadeau|720-777-2855|Kristen.Nadeau@childrenscolorado.org|
298317|NCT01808755|Divisione Urologia IRCCS Policlinico San Matteo Pavia, Italy|D. Porru|39-0382-503868/503872|danieleporru@tin.it|
308673|NCT02600611|Motif BioSciences|David Huang|936-577-5770|david.huang@motifbio.com|
308674|NCT02600637|VA Northern California|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
308675|NCT02600715|University of Kansas School of Medicine-Wichita|Jennifer Duong, MPH, Research Associate|316-962-3126|jduong@kumc.edu|
308676|NCT02600767|CDC|Alexandre Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
308677|NCT02600819|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
308678|NCT02600845|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
308679|NCT02600871|University of Texas Health San Antonio|Dr. Adriana Segura Olson|2152649796|adriana.s.olson@gmail.com|
277267|NCT02075593|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
277268|NCT01856140|Seoul National University College of Medicine|Dr. Sang Yoon Lee|028702673|rehabilee@gmail.com|
277269|NCT00587860|Mayo Clinic|Yuri A. Saito Loftus, M.D., M.P.H.|507-284-5010|saito.yuri@mayo.edu|
277270|NCT00587964|Memorial Sloan Kettering Cancer Center|Dr. Kathryn Beal|212-639-5159|bealk@mskcc.org|
277271|NCT00587990|EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@emmes.com|221
277272|NCT00588094|Memorial Sloan Kettering Cancer Center|Dr. Craig Moskowitz|212-639-7992|moskowic@mskcc.org|
277273|NCT00588159|Mayo Clinic|Dr. Michelle A. O. Kinney|507-266-9877|kinney.michelle@mayo.edu|
277274|NCT00588237|Memorial Sloan Kettering Cancer Center|Dr. Jason Konner|646-888-4219|konnerj@mskcc.org|
277275|NCT00588341|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|(646) 888-4162|chapmanp@mskcc.org|
277276|NCT00588354|Mayo Clinic|Dr. Marc A. Huntoon|(507) 284-2511|huntoon.marc@mayo.edu|
277277|NCT00588380|Mayo Clinic|Adrian Vella|507-284-3754|vella.adrian@mayo.edu|
277278|NCT00588406|North Shore Long Island Jewish Health System|Dr. Robert Silverman|718-470-7501|rsilverman@nshs.edu|
308680|NCT02601001|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
308681|NCT02601027|Stanford University|Gordon Kwanlyp Lee, Professor of Surgery (Plastic and Reconstructive Surgery)|650-723-5824|glee@stanford.edu|
308682|NCT02601105|UC Davis Department of Dermatology|Raja Sivamani MD|916-703-5145|dermstudies@ucdavis.edu|
308683|NCT02601170|Tri-service general hospital|Dr. Tsung-Ying Li|886-2-87927166|doc31141@gmail.com|
308684|NCT02601300|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
308685|NCT02601313|Kite, A Gilead Company|Medical Information|844-454-5483(1-844-454-KITE)|medinfo@kitepharma.com|
308686|NCT02601469|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
308687|NCT02601560|MedImmune, LLC|Richard George, MD, Director, Clinical Development|+1-301-398-5681|information.center@astrazeneca.com|
308688|NCT02601573|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
277279|NCT00588445|Memorial Sloan Kettering Cancer Center|Dr. Charles Rudin|646-888-4527|rudinc@mskcc.org|
277280|NCT00588536|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett|212-639-8267|trippet1@mskcc.org|
298318|NCT01808963|UC Davis Medical Center|Dr. Neal Fleming|916-734-5394|nwfleming@ucdavis.edu|
298319|NCT01809054|Sinai Center for Thrombosis Research|Kevin Bliden|4106014795|kbliden@lifebridgehealth.org|
287421|NCT01132755|Memorial Sloan Kettering Cancer Center|Dr. Peter Kingham MD|212-639-5260|kinghamt@mskcc.org|
287422|NCT01132807|Alliance for Clinical Trials in Oncology|David J. Straus, MD|212-639-8365|strausd@mskcc.org|
287423|NCT01132820|NRG Oncology /GOG|Linda Gedeon for Michael Sill, PhD|716 845-1169|lgedeon@gogstats.org|
287424|NCT01132846|Duke University|Kevin Anstrom|919-668-8902|kevin.anstrom@dm.duke.edu|
287425|NCT01133067|Dept. of Radiation Oncology, Tata Memorial Hospital|Dr. J.P. Agarwal|+91 22 24177000|agarwaljp@tmc.gov.in|7164
287426|NCT01133158|GELTAMO|Francisco Javier Peñalver|91 621 98 24|fjpenalver@fhalcorcon.es|
287427|NCT01133171|Department of Veterans Affairs|Dawn M. Bravata, MD|317-988-2676|dawn.bravata2@va.gov|
287428|NCT01133275|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rami Komrokji|813-745-4692|rami.komrokji@moffitt.org|
287429|NCT01133379|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
287430|NCT01133392|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287431|NCT01133405|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
287432|NCT01133418|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|5136368296|jeff.epstein@cchmc.org|
287433|NCT01133522|Amgen Inc.|Study Director|866-572-6436||
287434|NCT01133626|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
287435|NCT01133665|The University of Chicago|Dr. Everett Vokes|773-702-9306|evokes@medicine.bsd.uchicago.edu|
287436|NCT01133678|University of Chicago|Everett Vokes, MD|(773) 702-6227|evokes@medicine.bsd.uchicago.edu|
287437|NCT01133704|Dendreon Corporation|Kathleen Picha|206-265-4545|kpicha@dendreon.com|
287438|NCT01133756|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
287439|NCT01133821|University of Pittsburgh School of Medicine|Holly A. Swartz M.D.|412-246-5588|swartzha@upmc.edu|
287440|NCT01133847|University of Texas Health Science Center Houston|Dr. Carolyn Denton|713-500-3891|carolyn.a.denton@uth.tmc.edu|
287441|NCT01133860|IRCCS Policlinico San Matteo Foundation|Prof. Carlo Balduini|0039.0382.502580|c.balduini@smatteo.pv.it|
287442|NCT01133977|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
287443|NCT01134016|Golden Biotechnology Corp.|Dr. Howard Cheng, Director of clinical trials|886-2808-6006|howard@goldenbiotech.com.tw|
287444|NCT01134042|GlaxoSmithKline|GSK Response Center|866-435-7343||
287445|NCT01134055|GlaxoSmithKline|GSK Response Center|866-435-7343||
287446|NCT01134081|University of Michigan|Dr. William Giannobile|734 763 2105|wgiannob@umich.edu|
287447|NCT01134107|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287448|NCT01134198|new york state psychiatric institute|wilfrid raby, md|212-923-3031|wilfrid.raby@nyspi.columbia.edu|
298320|NCT01809106|Mario Negri Institution|Dr. Oscar Corli|+390239014564|oscar.corli@marionegri.it|
298321|NCT01809132|UTexas Southwestern Medical Center|Dr. Mack C. Mitchell|2146485036|mack.mitchell@utsouthwestern.edu|
298322|NCT01809197|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
298323|NCT01809210|AstraZeneca|Dr Gabriella Mariani , MD|+44 (0)207 6048000|ClinicalTrialTransparency@astrazeneca.com|
298324|NCT01809262|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298325|NCT01809314|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
298326|NCT01809327|Janssen Research & Development, LLC|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
298327|NCT01809639|Spartanburg Regional Healthcare System|John Lucas|423-309-5646|jlucas@srhs.com|
298328|NCT01809834|School of Optometry, University of Waterloo|Lyndon Jones, PhD, FCO|519-888-4742|ljones@uwaterloo.ca|
298329|NCT01809938|GuysThomasNHSTrust / Rockingham General Hospital|Dr. Sam Hillyard|+61424055820|sghillyard@yahoo.co.uk|
298330|NCT01810016|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org|
277281|NCT00588640|Memorial Sloan Kettering Cancer Center|Dr. Natalia Moryl|646-888-2681|moryln@mskcc.org|
277282|NCT00588666|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
277283|NCT00588692|Mayo Clinic|Dr. Barry A. Borlaug|507-284-4442|borlaug.barry@mayo.edu|
277284|NCT00588731|Yale University|Mohini Ranganathan, M.D.|203-932-5711|mohini.ranganathan@yale.edu|2546
277285|NCT00588809|The University of Chicago Medicine|Olatoyosi Odenike, MD|(773) 702-6149|todenike@medicine.bsd.uchicago.edu|
277286|NCT00588822|Mayo Clinic|Dr. Benn E. Smith|480-301-6711|bsmith@mayo.edu|
277287|NCT00588848|MetroHealth Medical Center|Dr. Dennis Auckley|216-778-7212|dauckley@metrohealth.org|
277288|NCT00588900|UNC Lineberger Comprehensive Cancer Center|Bert O'Neil, M.D.||bert_oneil@med.unc.edu|
277289|NCT00588952|Yale University|Ismene Petrakis|203-932-5711|Ismene.petrakis@yale.edu|2244
277290|NCT00588965|MetroHealth Medical Center|Dr. Elizabeth Kaufman|216-778-2349|ekaufman@metrohealth.org|
277291|NCT00589056|University of Pennsylvania|Ramesh Rengan, M.D., Ph.D.|(215) 662-2428|Rengan@xrt.upenn.edu|
277292|NCT00589108|Mayo Clinic|Dr. Robert T. Trousdale|507-284-3663|trousdale.robert@mayo.edu|
277293|NCT00589121|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
277294|NCT00589277|Yale University School of Medicine|Benjamin Toll, Ph.D. Associate Professor of Psychiatry|(203) 974 5767|benjamin.toll@yale.edu|
277295|NCT00589290|National Institutes of Health (NIH), National Cancer Institute (NCI)|Arun Rajan, M.D.|301-594-5322|rajana@mail.nih.gov|
277296|NCT00589303|Mayo Clinic|Dr. Win K. Shen|480-342-0348|wshen@mayo.edu|
298331|NCT01810042|Pusan National University Hospital|Ji Eun Lee|+82-51-240-7957|jlee@pusan.ac.kr|
298332|NCT01810263|Seoul National University Bundang Hospital|Nam-Jong Paik|82-031-787-7731|njpaik@snu.ac.kr|
298333|NCT01810289|University of California at San Francisco|Dr. Elvin Geng|415-476-4082|elvin.geng@ucsf.edu|409
298334|NCT01810380|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
298335|NCT01810432|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298336|NCT01810666|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
298337|NCT01810692|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287449|NCT01134263|Sanofi Pasteur|Trial Transparency Team||Contact-US@sanofi.com|
287450|NCT01134276|Seoul National University College of Medicine|Sun-Whe Kim|+82-2-2072-2315|sunkim@plaza.snu.ac.kr|
287451|NCT01134315|AbbVie|Global Medical Services|800-633-9110||
287452|NCT01134328|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
287453|NCT01134393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287454|NCT01134510|Cedars-Sinai Medical Center|Stanely Jordan, MD|310-428-8186|stan.jordan@cshs.org|
287455|NCT01134549|Amgen, Inc|Study Director|866-572-6436||
287456|NCT01134562|Amgen, Inc|Study Director|866-572-6436||
298338|NCT01810783|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@Lundbeck.com|
298339|NCT01810939|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
298340|NCT01810952|Baylor College of Medicine|Professor of Medicine|713-660-9902|glennc@bcm.edu|
298341|NCT01810991|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
298342|NCT01811004|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
298343|NCT01811030|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
298344|NCT01811147|Cleveland Clinic Foundation|Dr. Amit Anand|216-636-2840|ananda@ccf.org|
298345|NCT01811186|Asan Medical Center|Hoseong Lee|82-2-3010-3521|hosng@amc.seoul.kr|
298346|NCT01811212|The Ohio State University Compreshive Cancer Center|Manisha Shah, MD|614-366-6994|manisha.shah@osumc.edu|
298347|NCT01811225|University of Minnesota|Dr. Sharon Allen|612-624-2446|allen001@umn.edu|
298348|NCT01811238|Samsung Medical Center|Dr.Sungsoo Chung|82-3410-1226|ssc0385@skku.edu|
308689|NCT02601625|AstraZeneca AB|Anifrolumab Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
308690|NCT02601820|University of North Carolina at Chapel Hill|Donna Evon, PhD|919-260-4062|donna_evon@med.unc.edu|
308691|NCT02601833|University of Michigan School of Dentistry|Emily Yanca Project and Data Manager|734-763-3988|emthorpe@umich.edu|
308692|NCT02601976|Getz Pharma|Mr. Jaffer Bin Baqar|111111511|jaffer.baqar@getzpharma.com|2710
308693|NCT02602080|Hospital for Special Surgery|George Birch|212-774-7377|birchg@hss.edu|
308694|NCT02602223|Oregon Health & Sciences University|Dr. Sivaraman Prakasam|503-346-4711|prakasam@ohsu.edu|
308695|NCT02602496|University of Nebraska Lincoln|Dr. Devin Rose|402-472-2802|drose3@unl.edu|
308696|NCT02603107|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
308697|NCT02603120|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
308698|NCT02603172|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
308699|NCT02603211|Temple University|Chang-hee Won|2152046158|cwon@temple.edu|
277297|NCT00589329|MetroHealth Medical CEnter|Larraine Presley|216-778-8927|lpresley@metrohealth.org|
277298|NCT00589472|Memorial Sloan Kettering Cancer Center|Dr. Susan Slovin|646-422-4470|slovins@mskcc.org|
277299|NCT00589563|City of Hope Medical Center|Dr. Ryotaro Nakamura|626-256-4673|rnakamura@coh.org|65285
277300|NCT00589602|Cleveland Clinic|Jarek Maciejewski, MD|216-445-5962|maciejj@ccf.org|
277301|NCT00589628|Duke Health Systems|Dr. C. Egla Rabinovich|919-668-0238|egla.rabinovich@duke.edu|
277302|NCT00589667|Memorial Sloan-Kettering Cancer Center|David Pfister, MD|646-888-4232|pfisterd@mskcc.org|
277303|NCT00589693|Janssen R&D US|Sr Director Clinical Development|1 510 248-2310||
277304|NCT00589784|Memorial Sloan Kettering Cancer Center|Dr. Thomas Kaley|212-639-5122|KaleyT@mskcc.org|
277305|NCT00589797|Aesculap Inc.|Associate Director of Medical and Scientific Affairs|800-258-1946|mikhail.chkolnik@aesculap.com|5173
277306|NCT00589836|Cleveland Clinic|Zoran Popovic MD|216 444-9242|popoviz@ccf.org|
277307|NCT00589849|Creighton University|Dr. Aryan Mooss|402-280-4566|aryanmooss@creighton.edu|
277308|NCT00589888|Emory Univ SOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
277309|NCT00589914|Johnson & Johnson Pharmaceutical Research & Development LLC|Clinical Leader Psychiatry|1 609 730-2324||
277310|NCT00589979|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator|Use e-mail contact|clinicalsite.inquiries@endo.com|
277311|NCT00590005|Emory University Department of Pediatrics|Dr. Anne Fitzpatrick, Director, Emory Asthma Clinical Research Program|404-727-9112|anne.fitzpatrick@emory.edu|
277312|NCT00590018|Baylor College of Medicine|Dr. Heather Dickerson|832-826-5637|had@bcm.edu|
277313|NCT00590031|Memorial Sloan Kettering Cancer Center|Dr. David Ilson, Attending|+1646-888-4183|ilsond@mskcc.org|
308700|NCT02603393|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
308701|NCT02603419|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308702|NCT02603666|Karolinska University Hospital, Huddinge, 141 86 Stockholm|Ferenc Karpati M.D., Ph.D., Senior Consultant|+46858580000|ferenc.karpati@karolinska.se|81656
308703|NCT02603809|Idorsia Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 58 844 19 77|clinical-trials-disclosure@idorsia.com|
308704|NCT02603887|UT MD Anderson Cancer Center|Dr. Elisabet Manasanch/ Assistant Professor, Lymphoma-Myeloma|713-745-8092|eemanasanch@mdanderson.org|
308705|NCT02603926|UC Davis MIND Institute|Dr. Randi Hagerman|916-703-0247|rjhagerman@ucdavis.edu|
308706|NCT02603952|MedImmune, LLC|Raburn Mallory|301-398-4095|information.center@astrazeneca.com|
308707|NCT02604017|AbbVie|Global Medical Services|800-633-9110||
308708|NCT02604160|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
308709|NCT02604173|Stanford University|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
308710|NCT02604199|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
308711|NCT02604212|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
287457|NCT01134575|The University of Texas MD Anderson Cancer Center|Hagop M. Kantarnian, MD/Chair|713-792-7026|hkantarjian@mdanderson.org|
287458|NCT01134614|ECOG Statistical Office|Study Statistician|617-632-3012||
287459|NCT01134627|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
287460|NCT01134705|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
287461|NCT01134731|UAB|Dr. Richard Shelton|205-934-2484|rshelton@uab.edu|
298349|NCT01811303|RSSL|Rungano Munyuki (Clinical Project Manager)|0118 9184034||
287462|NCT01134783|University of North Carolina, Chapel Hill|Dr. Leslie A. Lytle|919-843-8171|llytle@email.unc.edu|
287463|NCT01134887|Veterans Administration Health Services Research and Development|Richard M. Frankel Ph.D.|317-988-4000|Richard.Frankel@VA.Gov|
287464|NCT01134900|The University of Texas Health Science Center at Houston (UTHealth)|Allison B. McCoy, PhD|713-500-6931|allison.b.mccoy@uth.tmc.edu|
287465|NCT01134939|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287466|NCT01134952|LondonHSC|Dr Vivian McAlister|5196632920|vmcalist@uwo.ca|
287467|NCT01135017|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
287468|NCT01135069|Spear Pharma|K.L. Spear M.D.|239-433-3442|spear@spearpharma.com|
287469|NCT01135095|Department of Medicine, Cardiology Division, Columbia University Medical Center and New York Presbyterian Hospital, New York|Dr. Andrew J. Einstein|+1 212 305-4275|Andrew.einstein@columbia.edu|
287470|NCT01135186|Stanford University|Dr. Linda Anh B. Nguyen|650-736-5555|nguyenlb@stanford.edu|
287471|NCT01135329|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Yvette Kasamon|410-955-8839|ykasamo1@jhmi.edu|
287472|NCT01135368|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
287473|NCT01135381|University of California San Francisco (UCSF); University of Alabama at Birmingham (UAB)|Dr. Christine Ritchie|415-514-0605|christine.ritchie@ucsf.edu; critchie@uab.edu|
287474|NCT01135394|University of Maryland School of Medicine|Soren Snitker, MD, PhD|4107061511|ssnitker@som.umaryland.edu|
287475|NCT01135420|Department of Veterans Afairs|Christine Timko|650-493-5000|Christine.Timko@va.gov|
287476|NCT01135498|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
287477|NCT01135511|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287478|NCT01135524|Purdue Pharma L.P.|Clinical Leader, Medical Director|800-733-1333||
287479|NCT01135537|Sickkids|Dr Tal Schechter-Finkelstein|4168136906|tal.schechter-finkelstein@sickkids.ca|
287480|NCT01135914|Novartis Pharmaceuticals|Study Director|862-778-8300||
308712|NCT02604264|Fresenius Medical Care North America|Jeffrey L. Hymes, MD|615-567-4821|Jeffrey.HymesMD@fmc-na.com|
287481|NCT01135992|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
287482|NCT01136174|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287483|NCT01136226|Chesapeake Urology Research Associates|Heather Thomas, Administrator|443.471.5742|hthomas@cua.md|
287484|NCT01136291|Department of Obstetrics and Gynecology - University of Campinas|Fernanda Garanhani de Castro Surita|+551935219304|surita@unicamp.br|
287485|NCT01136356|Johns Hopkins University, School of Medicine|Eric C. Strain, MD|410-550-1191|estrain1@jhmi.edu|
287486|NCT01136382|AstraZeneca|Geoff Gilmartin||ClinicalTrialTransparency@astrazeneca.com|
287487|NCT01136408|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287488|NCT01136486|North Shore LIJ|Dr. Rosemarie Basile|718 226-6501|rbasile1@siuh.edu|
287489|NCT01136655|AstraZeneca|Göran Eckerwall, MSD||ClinicalTrialTransparency@astrazeneca.com|
287490|NCT01136733|Eisai Medical Inc.|Eisai Medical Services|1-888-422-4743||
287491|NCT01136746|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287492|NCT01136772|Columbia University|T. Scott Stroup|646-774-8435|stroups@nyspi.columbia.edu|
287493|NCT01136785|The University of Chicago|Dr. Eve Van Cauter/Dr. Babak Mokhlesi|773-702-0169 or 773-702-2181|evcauter@medicine.bsd.uchicago.edu; bmokhles@medicine.bsd.uchicago.edu|
287494|NCT01136798|The University of Chicago|Eve Van Cauter, PhD|773-834-4001|evcauter@bsd.uchicago.edu|
287495|NCT01136876|Bracco Diagnostics Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
287496|NCT01136915|Bracco Diagnostics, Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
287497|NCT01136954|Eisai Call Center|Eisai Inc.|888-422-4743||
287498|NCT01137006|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287499|NCT01137032|Fougera Pharmaceuticals Inc.|Angela C. Kaplan, Associate Director Clinical Development|631-659-2256|angela.kaplan@sandoz.com|
277314|NCT00590044|Emory University SOM|Guillermo Umpierrez|4047781663|geumpie@emory.edu|
287500|NCT01137071|Recepta Biopharma|Director of Clinical Trials|55 11 3709-2140|recepta@receptabio.com.br|
287501|NCT01137110|Washington University|Dr Theresa Human|314-747-8799|theresa.human@bjc.org|
287502|NCT01137292|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287503|NCT01137370|Department of Medicine and Lung Institute, Seoul National University College of Medicine|Jae-Joon Yim|+82-2-2072-2059|yimjj@snu.ac.kr|
287504|NCT01137396|Yale University|Peter Morgan|203-974-7560|peter.morgan@yale.edu|
287505|NCT01137435|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
277315|NCT00590161|Cleveland Clinic Lerner College of Medicine of Case Western Reserve University|Claudia O. Zein, MD, MSc|216-444-0421|zeinc@ccf.org|
277316|NCT00590226|EUSOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
277317|NCT00590317|Emory University|Dr. Daniel Wu|(404) 251-8875|dtwu@emory.edu|
277318|NCT00590369|Cleveland Clinic|Nancy M. Albert PhD, RN|216-444-7028|albertn@ccf.org|
277319|NCT00590395|Cedars Sinai Medical Center|Alan Waxman, M.D.|310-423-8000|Alan.Waxman@cshs.org|
277320|NCT00590460|BAYLOR|Malcolm Brenner, MD|832-824-4663|mbrenner@bcm.edu|
287506|NCT01137474|Clinical Trial Transparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
287507|NCT01137539|Michigan Institute of Women's Health|Salil Khandwala/Medical Director|313-982-0200||
287508|NCT01137578|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
287509|NCT01137604|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
298350|NCT01811316|Sunstar Americas, Inc.|Akane Takemura|+1-847-794-4276|akane.takemura@us.sunstar.com|
287510|NCT01137682|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
287511|NCT01137786|Bracco Diagnostics Inc.|Maria Luigia Storto, M.D.|609-514-2262|MariaLuigia.Storto@diag.bracco.com|
287512|NCT01137812|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
287513|NCT01137890|Johns Hopkins University|Dr. Annie Umbricht|410-550-1917|annieumbricht@jhu.edu|
287514|NCT01138007|GlaxoSmithKline|GSK Response Center|866-435-7343||
287515|NCT01138046|GlaxoSmithKline|GSK Response Center|866-435-7343||
287516|NCT01138098|GlaxoSmithKline|GSK Response Center|866-435-7343||
287517|NCT01138111|Piramal Imaging|Juergen Hirschfeld, Senior Director Regulatory Affairs|+49 30 461 1246 15|juergen.hirschfeld@piramal.com|
287518|NCT01138124|GlaxoSmithKline|GSK Response Center|866-435-7343||
287519|NCT01138150|The Johns Hopkins University School of Medicine|Dr. Lee Peterlin|410-550-5452|lpeterlin@jhmi.edu|
277321|NCT00590564|Memorial Sloan Kettering Cancer Center|Dr. Gary Deng|646-888-0841|dengg@mskcc.org|
287520|NCT01138475|William Beaumont Hospital|Kerstyn Zalesin|248-655-5900|Kerstyn.zalesin@beaumont.edu|
287521|NCT01138501|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
287522|NCT01138514|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
287523|NCT01138657|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
287524|NCT01138735|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
287525|NCT01138826|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287526|NCT01138917|AVITA Medical|Director of Clinical Research|661-367-9170|clinicaltrial@avitamedical.com|
287527|NCT01138969|KaohsiungVGH|Dr. Ping-I Hsu|886-7-3462121|pihsu@isca.vghks.gov.tw|8233
287528|NCT01138995|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
287529|NCT01139008|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
287530|NCT01139021|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
287531|NCT01139047|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
287532|NCT01139164|Medical University of South Carolina|Dr. Robert K Stuart|843-792-4271|stuartrk@musc.edu|
287533|NCT01139190|PLx Pharma LLC|Ronald Zimmerman, CEO & President|713-842-1249|ron.zimmerman@plxpharma.com|205
287534|NCT01139411|Weight Control and Diabetes Research Center|Dr. Elissa Jelalian|(401) 793-9716|elissa_jelalian@brown.edu|
287535|NCT01139450|Fougera Pharmaceuticals Inc.|Angela C. Kaplan|631-659-2256|angela.kaplan@sandoz.com|
287536|NCT01139515|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287537|NCT01139580|GlaxoSmithKline|GSK Response Center|866-435-7343||
287538|NCT01139658|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287539|NCT01139762|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
277322|NCT00590577|Johnson & Johnson Pharmaceutical Research & Development|Compound Development Team Leader, Paliperidone|609-730-4530||
277323|NCT00590590|KV Pharmaceutical|Jim Joffrion, Sr. Director, Clinical Affairs|314-645-6600|jjoffrion@kvph.com|
277324|NCT00590681|University of Chicago|Amanda Spratt|773-834-4031|aspratt@bsd.uchicago.edu|
298351|NCT01811355|Mayo Clinic, Jacksonville|Dr. Bjorn Oskarsson|9049536896|oskarsson.bjorn@mayo.edu|
277325|NCT00590707|Johns Hopkins|frederick Sieber|410-550-0942|fsieber1@jhmi.edu|
277326|NCT00590720|MedImmune|Joseph Parker, MD|301-398-0000|parkerj@medimmune.com|
277327|NCT00590759|W. L. Gore and Associates, Inc.|Robert Makowsky|6232345784|rmakowsk@wlgore.com|
277328|NCT00590772|Penn State University|Timothy Craig|717-531-6525|tcraig@psu.edu|
277329|NCT00590824|University of Madison Carbone Cancer Center|Paul Sondel, MD, PhD|(608) 263-9069|pmsondel@humonc.wisc.edu|
277330|NCT00590863|Univeristy of Texas Southwestern Medical Center, Dallas|Madhukar H. Trivedi, M.D.|214-648-0188|Madhukar.Trivedi@UTSouthwestern.edu|
277331|NCT00590889|St.Jude Medical|Heidi Hinrichs, VP of Clinical Study Management, St. Jude Medical||hhinrichs@sjm.com|
277332|NCT00590902|Memorial Sloan Kettering Cancer Center|Dr. Mark Kris|646-888-4205|krism@mskcc.org|
277333|NCT00590954|Memorial Sloan Kettering Cancer Center|Thomas Kaley, MD|212-639-5122|kaleyt@mskcc.org|
277334|NCT00590967|Washington University School of Medicine|Perry Grigsby, M.D.|314-362-8502|grigsby@radonc.wustl.edu|
287540|NCT01139775|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287541|NCT01139801|Aultman Health Foundation|Jane Sewell|330-363-6793|Jane.Sewell@aultman.com|
287542|NCT01139814|Catheter Robotics, Inc.|Vice President, Clinical and Regulatory Affairs|973-426-0300|research@catheterrobotics.com|
287543|NCT01139879|Wolcott and Associates|Randy Wolcott|806-793-8869|lisa@randallwolcott.com|
287544|NCT01140061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
287545|NCT01140191|Walter Reed National Military Medical Center (WRNMMC)|COL Glenn W. Wortman|301-295-6400|glenn.wortmann@amedd.army.mil|
287546|NCT01140295|The Children's Hospital of Philadelphia|Petar Mamula|215-590-9146|mamula@email.chop.edu|
287547|NCT01140347|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287548|NCT01140360|Indiana University|Dr. Kent Robertson|317-944-4969|krobert@iu.edu|
298352|NCT01811472|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
308713|NCT02604342|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
287549|NCT01140477|Bausch & Lomb, a division of Valeant Corporation|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
287550|NCT01140503|Stanford University Department of Dermatology|David Fiorentino|650-721-7160|fiorentino@stanford.edu|
287551|NCT01140568|UCSD - Moores Cancer Center|Lara Rose|858-822-6575|ljrose@ucsd.edu|
287552|NCT01140646|Mayo Clinic|Dr. Amit Sood|507-284-1623|sood.amit@mayo.edu|
298353|NCT01811485|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
298354|NCT01811563|Duke University Medical Center|Samuel Wellman, MD|919-681-4055|samuel.wellman@duke.edu|
298355|NCT01811654|NYU Langone Health|Dennis Cardone, DO|212-460-0176|ariel.aponte@nyumc.org|
298356|NCT01811680|Tan Tock Seng Hospital|Dr Karen Chua|65 68894580|karen_chua@ttsh.com.sg|
298357|NCT01811693|Keck School of Medicine of USC|Nerses Sanossian, MD|323-442-7793|nsanossi@usc.edu|
298358|NCT01811706|University of Florida|Dr. Guangbin Xia, Assistant Professor|352-273-5550|guangbin.xia@neurology.ufl.edu|
298359|NCT01811732|Melinta Therapeutics, Inc.|Sue Cammarata (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
298360|NCT01811875|Bio Products Laboratory Ltd|European Medical Affairs Lead|+44 20 8957 2200|medinfo@bpl.co.uk|
298361|NCT01811940|NYSPI|Frances R. Levin, M.D.|646-774-6137|Frances.levin@nyspi.columbia.edu|
298362|NCT01811953|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298363|NCT01812005|The Ohio State University James Comprehensive Cancer Center|Kristie Blum, MD|614-293-7807|Kristie.Blum@osumc.edu|
298364|NCT01812044|Duke University Medical Center|Laura Enyedi, M.D.|919-684-2038|laura.enyedi@dm.duke.edu|
298365|NCT01812057|Duke University Medical Center|Dr Terrence K Allen|9196682024|terrence.allen@duke.edu|
298366|NCT01812109|University of Texas Southwestern Medical Center|Dr. Linda Baker|214/456-2480|Linda.baker@childrens.com|
298367|NCT01812473|Universitaire Ziekenhuizen Leuven|Kim Vanstraelen, PharmD|0032 16 342339|kim_vanstraelen@hotmail.com|
298368|NCT01812655|Arkansas Children's Hospital|Debra Jeffs, PhD, RN, Principal Investigator|501-364-3239|jeffsda@archildrens.org|
298369|NCT01812668|Barbara Ann Karmanos Cancer Institute|Dr. Elisabeth Heath|313-576-8734|heathe@karmanos.org|
298370|NCT01812681|Dr. Sami Ulus Children's Hospital|Dr. Serdar Beken|00903123056449|serbeken@gmail.com|
298371|NCT01812707|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
298372|NCT01812759|UT MD Anderson Cancer Center|Kumar Alagappan,Chair, Emergency Medicine|(713) 745-9911|kalagappan@mdanderson.org|
298373|NCT01812837|UC Davis|Dr. Raja Sivamani|9167035145|rksivamani@ucdavis.edu|
298374|NCT01813019|Novartis Pharmaceuticals|Study Director|862-778-8300||
298375|NCT01813058|Boston Children's Hospital|susan Goobie, MD, FRCPC|6173667737|susan.goobie@childrens.harvard.edu|
298376|NCT01813071|PATH|Jennifer O'Reilly|202-540-4510|joreilly@path.org|
298377|NCT01813110|Pennsylvania State University|Dr. Penny Kris-Etherton|814-863-2923|pmk3@psu.edu|
298378|NCT01813149|Cleveland Clinic Foundation|Michael Stanton Hicks, MD|216-445-3497|stantom@ccf.org|
298379|NCT01813214|Lombardi Comprehensive Cancer Center|Dr Michael Atkins|202-687-2795|mba41@georgetown.edu|
298380|NCT01813357|Monash University and Alfred Health|Dr Janine Trevillyan|03 90762000|janine.trevillyan@monash.edu|
298381|NCT01813422|Amgen Inc.|Study Director|866-572-6436||
298382|NCT01813435|Jessa Ziekenhuis, Hasselt, Belgium|Dr. Pascal Vranckx|+32 11 30 9589|pascal.vranckx@jessazh.be|
298383|NCT01813474|AstraZeneca|Medical Director||ClinicalTrialTransparency@astrazeneca.com|
298384|NCT01813721|Amgen Inc.|Study Director|866-572-6436||
298385|NCT01813734|Massachusetts General Hospital|Dr. Alice Shaw|617-724-4000|ASHAW1@mgh.harvard.edu|
298386|NCT01813890|Janssen Research & Development, L.L.C.|Mila Etropolski, Clinical Leader|609-730-4537|MEtropol@its.jnj.com|
298387|NCT01814007|Zeltiq Aesthetics|Kerrie Jiang, Executive Director Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
277335|NCT00590980|University of Illinois at Chicago|Sepideh Amin-Hanjani, MD|312-996-4842|hanjani@uic.edu|
277336|NCT00591006|The University of Texas Southwestern Medical Center|E. Sherwood Brown|214 645 6950|sherwood.brown@utsouthwestern.edu|
277337|NCT00591019|University of Arkansas for Medical Sciences (UAMS)|Dr John Dornhoffer|501 686-5140|dornhofferjohnl@uams.edu|
277338|NCT00591123|UCLA GI Oncology Program, David Geffen School of Medicine at UCLA|Zev Wainberg, MD|310-829-5471|zwainberg@mednet.ucla.edu|
277339|NCT00591149|University of Kansas Medical Center|Chao Huang, MD|913-588-6029|chuang2@kumc.edu|
277340|NCT00591214|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
277341|NCT00591240|VA Palo Alto Health Care System|Dr. Joseph Liao|650-493-5000|joseph.liao@va.gov|65581
277342|NCT00591253|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
277343|NCT00591266|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
277344|NCT00591305|Boston Medical Center|Zhi Wang, MD|617-414-1590|zwang@bu.edu|
277345|NCT00591344|Northwestern University|Daniel Corcos, PhD|708-214-5454|daniel.corcos@northwestern.edu|
277346|NCT00591370|Memorial Sloan-Kettering Cancer Center|Dr. Paul Chapman|212-639-7357|chapmanp@mskcc.org|
277347|NCT00591409|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
277348|NCT00591565|SUNY Upstate|Thomas Schwartz|3154643166|schwartt@upstate.edu|
277349|NCT00591578|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
277350|NCT00591591|ISS, Inc., Champaign Illinois|Antonios Michalos|217-359-8681|antonios.michalos@iss.com|
277351|NCT00591630|University of Texas MD Anderson Cancer Center|Issa F. Khouri, MD / Stem Cell Transplantation|713-792-8750|ikhouri@mdanderson.org|
277352|NCT00591721|University of Illinois at Chicago|Marcia Finlayson, PhD|312-996-4603|marciaf@uic.edu|
287553|NCT01140815|AORI|Knee Research Director|7036194423|nancylparks@gmail.com|
287554|NCT01140880|Friends Research Institute, Inc.|Dr. Cathy J. Reback|323-463-1601|reback@friendsresearch.org|
287555|NCT01140906|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
287556|NCT01141049|NYSPI|john mariani md|646-774-6140|john.mariani@nyspi.columbia.edu|
287557|NCT01141075|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
287558|NCT01141205|Statens Serum Institut|Dr Anders Fomsgaard|+45-32683460|afo@ssi.dk|
287559|NCT01141283|Purdue Pharma LP|Clinical Leader, Medical Director|800-733-1333||
287560|NCT01141374|University of São Paulo|Leonice Fumiko Sato Kurebayashi|55-11-91126023|fumie_ibez@yahoo.com.br|
287561|NCT01141478|Loma Linda University Medical Center|Diane Scavone, research coordinator|909 558-3636|dscavone@llu.edu|33670
287562|NCT01141491|MabVax Therapeutics, Inc.|Dave Hansen|858.259.9405|dhansen@mabvax.com|301
287563|NCT01141569|BC Cancer Agency Vancouver Cancer Centre|Dr. Christian Kollmannsberger|604-877-6000|ckollmannsberger@bccancer.bc.ca|
287564|NCT01141595|Arkansas Children's Hospital Reseach Insitute|Richard Frye|501-364-5465|REFrye@uams.edu|
287565|NCT01141608|UT Southwestern Medical Center|Dr. Madhukar H Trivedi|214-648-0188|madhukar.trivedi@utsouthwestern.edu|
287566|NCT01141647|James A. Haley Veterans' Hospital|Lisa Ottomanelli, PhD|813-558-3917|lisa.ottomanelli-slone@va.gov|
287567|NCT01141660|Eastern Virginia Medical School|Cristina Baldassari|7576689853|baldassc@yahoo.com|
287568|NCT01141725|FHCRC/UWMC|Elihu Estey, MD, Director of AML Program|206-288-7176|eestey@uw.edu|
287569|NCT01141907|Johns Hopkins University|Dr. Cheryl Dennison|443-287-4174|cdennis4@jhu.edu|
287570|NCT01142089|Cosmo Technologies Ltd.|Richard Jones|+35318170370|RJones@cosmopharma.com|
287571|NCT01142115|Clinical Regulatory Development, Global R&D|Trine Møller Kruse|+4549112174|dktrm@coloplast.com|
287572|NCT01142193|Upsher-Smith Laboratories, Inc.|Bob Anders, Sr. Director of Clinical Operations|763-315-2000|Bob.Anders@upsher-smith.com|
287573|NCT01142232|IndianaU|Dr. Attaya Suvannasankha|(317) 278-9306|asuvanna@iu.edu|
287574|NCT01142297|University of Texas Health Science Center at San Antonio|Thomas W. Oates|210-567-3590|oates@uthscsa.edu|
287575|NCT01142310|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
287576|NCT01142323|University of Miami|Dr. Cynthia Levy|305-243-2147|clevy@med.miami.edu|
287577|NCT01142336|University of Washington|Ge Li, MD, PhD|(206) 764-2485|gli@uw.edu|
277353|NCT00591734|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
287578|NCT01142388|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
287579|NCT01142466|Merck Serono GmbH, Germany, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49 6151 72 5200|service@merckgroup.com|
287580|NCT01142661|Eisai Inc.|Prash Gopalakrishna|888-422-4743||
287581|NCT01142726|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
287582|NCT01142791|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
287583|NCT01142908|Veterans Administration HSRD, Durham COIN|Hayden B. Bosworth, PhD, Assoc Dir, Durham HSR&D COIN|919-286-0411|hayden.bosworth@va.gov|6936
287584|NCT01142947|Center for Individualized and Genomic Medicine Research, Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454|kwillia5@hfhs.org|
287585|NCT01143038|Amgen Inc.|Study Director|866-572-6436||
287586|NCT01143051|Amphastar Pharmaceuticals, Inc.|Stephen A. Campbell, Esq.|(909) 980-9484|stephenc@amphastar.com|2016
287587|NCT01143077|Sunovion Pharmaceuticals|Medical Director, CNS|1-866-503-6351||
287588|NCT01143090|Sunovion Pharmaceuticals Inc|Medical Director, CNS|1-866-503-6351||
287589|NCT01143142|University of Colorado|Amanda Dempsey|303-724-6679|amanda.dempsey@ucdenver.edu|
287590|NCT01143181|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
287591|NCT01143207|FHI 360|Vera Halpern, MD|919-54-7040|vhalpern@fhi360.org|11390
287592|NCT01143259|Intermountain Healthcare|Matthew Peters RN MS|801-442-3703|matthew.peters@imail.org|
277354|NCT00591760|Federico II University|Prof. Antonio Cittadini|0039(0)817464375|antonio.cittadini@unina.it|
277355|NCT00591773|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
277356|NCT00591786|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
277357|NCT00591825|Laureate Institute for Brain Research (LIBR)|Robin Aupperle, PhD|(913) 588-9078|raupperle@laureateinstitute.org|
277358|NCT00591838|Washington University School of Medicine|Clifford Robinson, M.D.|314-362-4633|clifford.robinson@wustl.edu|
277359|NCT00591851|Memorial Sloan-Kettering Cancer Center|Dr. Chau Dang|914-367-7181|dangc@mskcc.org|
277360|NCT00591864|Mayo Clinic|Amy Lynn Conners MD|(507) 284-2511|MBI@mayo.edu|
277361|NCT00591942|University of Iowa|Dr. Clark Stanford|319-335-7381|Clark-Stanford@uiowa.edu|
277362|NCT00592072|Yale School of Medicine|Dr Robert Sherwin|203-785-6222|robert.sherwin@yale.edu|
277363|NCT00592124|Johns Hopkins University|Craig W. Hendrix, MD|1 410 955-9707|chendrix@jhmi.edu|
277364|NCT00592176|University of Alabama at Birmingham|Dr. Tyler Hall, M.D.|205-325-8310|tandrewhall@yahoo.com|
277365|NCT00592319|Trustee of Boston Univ. Medical Campus|Dr. Zhi Wang|617-414-1590|zwang@bu.edu|
277366|NCT00592358|Massachusetts General Hospital|Janet Wozniak, MD|(617)503-1038|jwozniak@partners.org|
287593|NCT01143272|Johns Hopkins Bloomberg School of Public Health|Stephan Ehrhardt|410-502-3872|sehrhard@jhsph.edu|
287594|NCT01143324|MedtronicSpineECA|Christel Van Dam|+31433566523|christel.van.dam@medtronic.com|
287595|NCT01143337|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
287596|NCT01143389|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
287597|NCT01143402|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646 888 4162|chapmanp@mskcc.org|
277367|NCT00592384|University of Washington|Dr. Jesse R. Fann|206 6854280|fann@uw.edu|
287598|NCT01143610|School of Dentistry at Bauru - USP|Adriana Campos Passanezi Sant'Ana|00 55 14 3235-8278|acpsantana@usp.br|
287599|NCT01143636|Spaulding Rehabilitation Hospital, Boston, MA.|Dr. Felipe Fregni, Director of the Laboratory of Neuromodulation|617.952.6153|info@neuromodulationlab.org|
287600|NCT01143649|Laboratory of Neuromodulation and Center of Clinical Research Training. Spaulding Rehabilitation Hospital.|Dr. Felipe Fregni|617.952.6153|info@neuromodulationlab.org|
287601|NCT01143688|National Jewish Health|Michael E. Wechsler M.D.|617-285-4987|wechslerm@NJHealth.org|
287602|NCT01143701|Cincinnati Children's Hospital Medical Center|Jeff Epstein, Ph.D.|5136368296|jeff.epstein@cchmc.org|
287603|NCT01143714|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
287604|NCT01143727|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
287605|NCT01143766|Indiana University|Gregory A. Cote|317-944-2740|gcote@iupui.edu|
287606|NCT01143792|The Ohio State University|Natasha Slesnick|614 247-8469|slesnick.5@osu.edu|
287607|NCT01143818|Abbott|Global Medical Services|800-633-9110||
287608|NCT01143870|University of Pennsylvania|Anjali Gopalan|575-640-3893|agopalan@upenn.edu|
287609|NCT01143883|University of South Florida|Jorge E. Marcet, M.D.|813-844-4545|jmateka@health.usf.edu|
287610|NCT01143896|Michael E. DeBakey VA Medical Center|Fasiha Kanwal, MD, MSHS|(713) 440-4495|Fasiha.Kanwal@va.gov|
287611|NCT01144026|Thymon LLC|Dr. Gideon Goldstein|(973) 467-9558|gidgold@gmail.com|
287612|NCT01144052|Ospedale Civico|Claudio Globbi, Dr. med.|+41 91 811 6921|claudio.gobbi@eoc.ch|
287613|NCT01144143|University of Kansas Medical Center|Dr. Herbert Lindsley|(913) 588-3402|HLINDSLE@kumc.edu|
287614|NCT01144182|VA New York Harbor Healthcare System|Sundar Natarajan, MD, M.Sc.|212-951-3395|sundar.natarajan@va.gov|
277368|NCT00592475|Astellas Pharma Global Development|Senior Medical Director, Medical Affairs||clinicaltrials@us.astellas.com|
287615|NCT01144286|Privatni gynekologicka ambulance|Vladimir Dvorak|+420 542 221 661|ssgcr@ti.cz|
287616|NCT01144299|GlaxoSmithKline|GSK Response Center|866-435-7343||
287617|NCT01144338|Astrazaneca Inc.|Peter Ohman|1(301)398-0120|Peter.Ohman@astrazeneca.com|
287618|NCT01144364|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
287619|NCT01144377|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287620|NCT01144403|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
287621|NCT01144442|Masonic Cancer Center|Peter Argenta, MD|612-626-3111|argenta@umn.edu|
287622|NCT01144455|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
287623|NCT01144494|UNMC|Dr Carol Toris|402-559-1852|ctoris@unmc.edu|
287624|NCT01144598|Abbott|Global Medical Services|1-800-633-9110||
287625|NCT01144624|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
287626|NCT01144637|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
287627|NCT01144663|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
287628|NCT01144715|Kinetic Muscles|James Koeneman, PhD|602-677-5256|jimkoeneman509@gmail.com|
287629|NCT01144949|Watson Laboratories, Inc.|Gary Hoel, RPh PhD, VP Global Brands Clinical Research|801 588-6641|gary.hoel@watson.com|
287630|NCT01145001|Yale University|Dana Cavallo, Assistant Professor|2039747607|dana.cavallo@yale.edu|
298388|NCT01814046|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|steven-rosenberg@nih.gov|
277369|NCT00592488|Vanderbilt University|Todd Rice, MD|615 322-3412|todd.rice@vanderbilt.edu|
277370|NCT00592501|Massachusetts General Hospital|Annie W. Chan, MD|617-726-5184|AWCHAN@PARTNERS.ORG|
277371|NCT00592553|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
277372|NCT00592631|Indiana University|Robert Tepper, MD, Ph.D.|317-274-9647|rtepper@iu.edu|
277373|NCT00592683|Massachusetts General Hospital|Janet Wozniak, MD|617-503-1038|jwozniak@partners.org|
277374|NCT00592761|UAMS Medical Center|Gary McCullough|501-852-7886|mcculloughgaryh@uams.edu|
277375|NCT00592774|Eisai Call Center|Eisai Inc.|888-422-4743||
277376|NCT00592839|Duramed Research|Duramed Research Protocol Chair|215-293-7279|medicalaffairs@barrlabs.com|
277377|NCT00592852|Massachusetts General Hospital|Gagan Joshi, MD|617-503-1084|joshi.gagan@mgh.harvard.edu|
277378|NCT00592904|Eisai Call Center|Eisai Inc.|888-422-4743||
277379|NCT00592943|Massachusetts General Hospital; Harvard Medical School|Thomas J. Spencer, MD|(617) 726-1731|tspencer@partners.org|
277380|NCT00593112|Massachusetts General Hospital|Paul Hammerness, M.D.|617-503-1040|phammerness@partners.org|
277381|NCT00593333|Department of Surgery/Division of Orthopaedics|Taylor Vlack, Research Nurse Coordinator|205-996-6781|tmwebb@uabmc.edu|
277382|NCT00593346|Washington University School of Medicine|Imran Zoberi, M.D.|314-362-8525|izoberi@radonc.wustl.edu|
277383|NCT00593372|UAMS Medical Center|Gary McCullough|501-852-7886|garyhmccullough@uams.edu|
287631|NCT01145053|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287632|NCT01145066|Wake Forest University Health Sciences|Dr. Michael Seeds|3367169811|mseeds@wakehealth.edu|
287633|NCT01145183|Baylor College of Medicine|Thomas Kosten, MD|713 798 8628|kosten@bcm.edu|
287634|NCT01145209|National Heart Lung and Blood Institute|Ahn, Inhye|+1 301 827 1203|inhye.ahn@nih.gov|
287635|NCT01145222|PAION UK Ltd|Trial Information||reg_paion@paion.com|
287636|NCT01145352|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287637|NCT01145391|University of Colorado Denver School of Medicine|Amy Huebschmann|303-724-2268|amy.huebschmann@ucdenver.edu|
287638|NCT01145417|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287639|NCT01145482|The University of Texas at Austin|Dr. Andreana Haley|512-232-0863|haley@psy.utexas.edu|
287640|NCT01145508|ECOG Statistical Office|Study Statistician|617-632-3012||
287641|NCT01145547|Legacy Health System|W. Kenneth Ward|503-413-5171|kenward503@msn.com|
287642|NCT01145560|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
298389|NCT01814072|Northwestern University Feinberg School of Medicine|Bonnie Spring, PhD, ABPP|312-908-2293|bspring@northwestern.edu|
287643|NCT01145625|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|Study Director|(973) 385-3203||
287644|NCT01145638|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
287645|NCT01145755|AstraZeneca|Gerard Lynch|645895|aztrial_results_posting@astrazeneca.com|+44 1509
287646|NCT01145833|University of CA, San Diego Center for Healthy Eating and Activity Research|Kerri Boutelle, Principal Investigator|858-534-8037|kboutelle@ucsd.edu|
298390|NCT01814137|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
287647|NCT01145885|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287648|NCT01145898|Indiana University|Alon Harris|317-278-00177|alharris@indiana.edu|
298391|NCT01814241|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
298392|NCT01814332|San Francisco VA Medical Center|Jennifer Hlavin|415-221-4810|jennifer.hlavin@va.gov|26624
298393|NCT01814371|Washington University School of Medicine|Stephanie Fritz, MD, MSCI|3144544115|fritz.s@wustl.edu|
298394|NCT01814397|University of Michigan Comprehensive Cancer Center|Dr. Norah Lynn Henry|734-936-4991|norahh@med.umich.edu|
298395|NCT01814553|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298396|NCT01814670|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
298397|NCT01814696|Partners Healthcare Connected Health Innovation|Kamal Jethwani, MD, MPH|617-724-3410|kjethwani@partners.org|
298398|NCT01814748|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
298399|NCT01814761|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
298400|NCT01814774|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
298401|NCT01814787|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
298402|NCT01814800|ADMA Biologics|Jimmy Mond, M.D., Ph.D|201-478-5552|jmond@admabio.com|
298403|NCT01814813|Mayo Clinic|Ian Parney, MD, PhD|507-284-8167|Parney.Ian@mayo.edu|
298404|NCT01814878|Janssen Korea/25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702, Korea|Clinical Research Director|82-2-2094-4518||
298405|NCT01815008|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
298406|NCT01815099|Hartford Hospital|Gretchen Diefenbach|860-545-7685|gretchen.diefenbach@hhchealth.org|
298407|NCT01815138|UConn Helth|Lawrence Engmann|8605258283|lengmann@uchc.edu|
298408|NCT01815229|Washington University School of Medicine|Dr. Carlos Puyo|314-747-1709|cpuyo@wustl.edu|
298409|NCT01815333|UT MD Anderson Cancer Center|Haesun Choi, MD/ Professor, Abdominal Imaging Department|713-745-4693|hchoi@mdanderson.org|
298410|NCT01815424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298411|NCT01815502|MUSC|Dr. Andrew M Atz|843-876-1698|atzam@musc.edu|
298412|NCT01815515|Johns Hopkins University|Steven Rowe, M.D, Ph.D|4105021520|srowe8@jhmi.edu|
298413|NCT01815645|Federal University of Sao Paulo|Andre Q. C. Miguel|005511 965884111|aqcmiguel@gmail.com|
298414|NCT01815671|Specialists in Gastroenterology, LLC|Leonard Weinstock, MD|314-997-0554|lw@gidoctor.net|102
298415|NCT01815736|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
298416|NCT01815840|Hoffmann-La Roche|Medical Communications|800 821-8590||
298417|NCT01815918|Hospital for Special Surgery|Kethy Jules-Elysee, MD|212-606-1206|JulesElyseeK@HSS.EDU|
298418|NCT01816048|University of Wisconsin Carbone Cancer Center|Dr. Justine Bruce|608-262-4961|jybruce@medicine.wisc.edu|
298419|NCT01816061|DCVAMC|Dr.Joel Scholten|2027458000|joel.scholten@va.gov|55099
298420|NCT01816074|Dept of Psychiatry, University of Washington|Dr. Mark Stein|206-987-1161|mstein42@uw.edu|
298421|NCT01816230|Gamida Cell|Kelly Myers|026595631|kelly@gamida-cell.com|
298422|NCT01816243|Medical Affairs, Janssen-Cilag (Thailand)|Medical Affairs Director|662-792-7200||
298423|NCT01816295|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298424|NCT01816451|University of Trás-os-Montes and Alto Douro|Ph.D. Laura Castro de Garay|+55 21 22275084|laura@virtualsoftware.com.br|
298425|NCT01816477|Mayo Clinic|Dr. Dawn E. Jaroszewski|480-301-7865|Jaroszewski.Dawn@mayo.edu|
308714|NCT02604407|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
277384|NCT00593385|Getinge|Elizabeth Bulger, Director of Clinical Affairs|1-603-864-5368|elizabeth.bulger@getinge.com|
277385|NCT00593450|CATT Research Group|Dr. Maureen Maguire|215-615-1501|maguirem@mail.med.upenn.edu|
277386|NCT00593489|Lawson Research Institute|Dr. Stewart Harris|519 858-5028|sharris1@uwo.ca|
277387|NCT00593554|IndianaU|Dr. Sherif Farag|317-278-0460|ssfarag@iu.edu|
277388|NCT00593606|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
277389|NCT00593645|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
277390|NCT00593684|Baylor Health Care System|Furgan Moin, MD|214-820-7604|Furgan.Moin@baylorhealth.edu|
277391|NCT00593736|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
277392|NCT00593814|W.L. Gore and Associates|Tab Bonny|928 864 4275|tbonny@wlgore.com|
277393|NCT00593827|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
277394|NCT00593840|Washington University School of Medicine|Wade Thorstad, M.D.|314-362-8516|thorstad@radonc.wustl.edu|
277395|NCT00593866|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski|734-615-3969|zalupski@umich.edu|
277396|NCT00593918|University of Wisconsin-Madison|Theresa Guilbert, MD|608-263-9608|tguilbert@wisc.edu|
298426|NCT01816594|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
308715|NCT02604550|Emory University|John Xerogeanes, MD|404-778-7202|jxeroge@emory.edu|
308716|NCT02604589|William Beaumont Hospital|Rose Callahan|248 551-5147|rose.callahan@beaumont.org|
308717|NCT02604810|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
308718|NCT02605122|Cempra Pharmeuticals, a wholly owned subsidary of Melinta Therapeutics, Inc.|Melissa Allaband|9199140822|mallaband@melinta.com|
287649|NCT01146054|Stanford University Comprehensive Cancer Center|Albert C. Koong, M.D., Ph.D., Sue and Bob McCollum Professor, Associate Chair of Radiation Onocology|650-498-7703|akoong@stanford.edu|
287650|NCT01146275|Q-Med AB|Head of Medical Affairs|+46 (0) 18 4749000|reception.SEUPP@galderma.com|
287651|NCT01146288|Rabin Medical Center|Dr Boris Zingerman||borisz@clalit.org.il|
287652|NCT01146379|Washington University School of Medicine|Dr. Catherine Lang|314-286-1945|langc@wustl.edu|
287653|NCT01146457|BIDMC|Philip Hess|617-667-3353|phess@bidmc.harvard.edu|
287654|NCT01146496|University of Edinburgh|Michael Eddleston|01312426776|m.eddleston@ed.ac.uk|
298427|NCT01816685|Duke University|Andrew Krystal|(919) 668-1212|andrew.krystal@dm.duke.edu|
298428|NCT01816711|Aarhus University Hospital|Mette Abildgaard Pedersen|31411180|meabpe@rm.dk|
298429|NCT01816763|VA Palo Alto|Karl Lorenz MD MSHS, Principal Investigator|6504935000|kalorenz@stanford.edu|
298430|NCT01816776|Respicardia, Inc.|Linda Nelson, VP Clinical Affairs|952-540-4479|lnelson@respicardia.com|
298431|NCT01816893|Brigham and Women's Hospital|Dr. Gail Kurr Adler|(617) 732-8742|gadler@bwh.harvard.edu|
298432|NCT01816906|Staffordshire University|Professor Nachiappan Chockalingam|+44 1782 295853|n.chockalingam@staffs.ac.uk|
298433|NCT01816945|Yale University|Megan Smith Associate Professor|203 764 8655|megan.smith@yale.edu|
308719|NCT02605174|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
308720|NCT02605187|Stanford University School of Medicine|Dr. Brendan Carvalho|650-861-8607|bcarvalho@stanford.edu|
308721|NCT02605304|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
308722|NCT02605395|GlaxoSmithKline|GSK Response Center|866-435-7343||
308723|NCT02605447|Boston Scientific Corp.|Peter Maurer, Director Clinical Trials|+1 (508) 683|Peter.Maurer@bsci.com|6678
308724|NCT02605642|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
308725|NCT02605837|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
277397|NCT00593957|Kennedy Krieger Institute|Dr Sakkubai Naidu Professor of Neurology and Pediatrics|443-923-2778|naidu@kennedykrieger.org|
308726|NCT02605863|University of Rochester|Edward Messing, ND|585-275-0998|edward_messing@urmc.rochester.edu|
308727|NCT02605876|University of North Carolina at Chapel Hill|Troy Blackburn|9198432021|troyb@email.unc.edu|
308728|NCT02605928|Department of Medicine, Division of Rheumatology, Helsinki University Central Hospital and University of Helsinki, Finland|PhD MD Ritva Peltomaa||ritva.peltomaa@hus.fi|
308729|NCT02605954|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
308730|NCT02605993|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
308731|NCT02606253|Lipscomb University College of Pharmacy|Dr. Zachary Cox, Associate Professor|6159667163|zac.cox@lipscomb.edu|
308732|NCT02606500|University medical centre Ljubljana|Professor Eda Vrtacnik Bokal|+38615226060|eda.bokal@guest.arnes.si|
308733|NCT02606604|Stony Brook University|Lori Hochman|631-444-1193|lori.hochman@stonybrook.edu|
308734|NCT02606643|Saint Louis University|Gary Furhman|314-977-2090|jathompson@slu.edu|
308735|NCT02606708|New York University School of Medicine|Carmen Perez, MD|212 731 5003|carmen.perez@nyumc.org|
308736|NCT02606734|Osprey Medical|Michele Shepard|952-955-5236|mshepard@ospreymed.com|
308737|NCT02606838|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
308738|NCT02606877|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308739|NCT02606903|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308740|NCT02607124|Cincinnati Childrens Hosptial Medical Center|Renee Doughman|513-636-1699|renee.doughman@cchmc.org|
277398|NCT00594009|University of Texas Medical Branch|Victor Cardenas, MD|(409) 772-2436|vcardena@utmb.edu|
277399|NCT00594022|R.P. Chiacchierini & Associates|R.P. Chiacchierini & Associates|(240) 683-3738|rpc@rpcaconsulting.com|
277400|NCT00594035|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
277401|NCT00594061|University of Iowa|Bruce Gantz|319-353-8776|bruce-gantz@uiowa.edu|
277402|NCT00594100|W. L. Gore & Associates|Andrew Garcia|(800) 437-8181|AGarcia@WLGore.com|
277403|NCT00594165|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
277404|NCT00594178|Dept of PM&R; University of Arkansas for Medical Sciences|Thomas S. Kiser|501-221-1311|kiserthomass@uams.edu|
277405|NCT00594204|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
277406|NCT00594230|Sarah Cannon Research Institute|John Hainsworth, MD|1-877-691-7274|ASKSARAH@scresearch.net|
277407|NCT00594256|Nathan Kline Institute|Joshua Kantrowitz MD|845-398-5503|jkantrowitz@nki.rfmh.org|
277408|NCT00594308|Indiana University School of Medicine|Robert Nelson, MD|317-278-6871|ronelson@iupui.edu|
277409|NCT00594386|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
277410|NCT00594399|Durham VA Medical Center (GRECC/HSRD)|Miriam C. Morey, Ph.D.|919-286-0411|miriam.morey@va.gov|6776
277411|NCT00594425|Virginia Clinical Research, Inc|David Pariser MD|757-625-0151|dpariser@pariserderm.com|
277412|NCT00594464|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
277413|NCT00594516|Johnson & Johnson Pharmaceutical Research & Development|Mila Etropolski, MD Clinical Leader|609-730-4537|metropol@its.jnj.com|
277414|NCT00594568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
277415|NCT00594646|Fenway Health|Dr. Kenneth Mayer|617-927-6400|kmayer@fenwayhealth.org|
277416|NCT00594659|Geisel School of Medicine at Dartmouth College|Alan J. Budney, PhD Principal Investigator|855-290-2822|Alan.J.Budney@dartmouth.edu|
277417|NCT00594685|New England Research Institutes|Susan Assmann|617-923-7747|sassmann@neriscience.com|548
277418|NCT00594815|Memorial Sloan Kettering Cancer Center|Dr. Antonio Omuro|212-639-7523|omuroa@mskcc.org|
277419|NCT00594854|Pozen Inc.|Senior Vice President, Clinical Research|919-913-1030|eorlemans@pozen.com|
277420|NCT00594880|the Wistar Institute|Luis Montaner|215 898 3934|montaner@mail.wistar.org|
287655|NCT01146561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287656|NCT01146600|Emory University School of Medicine|Lynn Marie Trotti, MD, MSc|404-728-4752|lbecke2@emory.edu|
287657|NCT01146613|NIAAA|Megan Ryan, M.B.A.|301-443-4225|mryan1@mail.nih.gov|
287658|NCT01146665|University of Alberta|Dr. Amanda Newton|780-248-5581|an6@ualberta.ca|
287659|NCT01146704|Department of Veterans Affairs, VAGLAHS|Dr. Joseph Pisegna|3104783711|Joseph.Pisegna@va.gov|41664
287660|NCT01146782|ApniCure, Inc.|Andrea Brown, Director, Clinical Affairs|650-361-9000|abrown@apnicure.com|122
287661|NCT01146795|Columbia University|Jason Wright, MD|212-305-3410|jw2459@cumc.columbia.edu|
287662|NCT01146808|Columbia University Medical Center|Robert S. Brown Jr., MD, MPH|(212) 305-3839|tt2103@columbia.edu|
287663|NCT01146834|Weill Cornell Medicine|Ruben Niesvizky, MD|646-962-9376|run9001@med.cornell.edu|
287664|NCT01146860|ENT practice|Dr. Rainer Jund, Specialist in Otorhinolaryngology|+49 89 804880|RainerJund@gmx.de|
287665|NCT01146873|Columbia University|Louise Kuhn, PhD|212-305-2398|lk24@cumc.columbia.edu|
298434|NCT01816984|University of Chicago Medicine and Biological Sciences|Dr Everett Vokes, MD|855-702-8222|evokes@medicine.bsd.uchicago.edu|
287666|NCT01146912|Columbia University|Melissa Stockwell, MD MPH|212-342-5372|mss2112@columbia.edu|
287667|NCT01146951|Eisai Call Center|Eisai Inc.|888-422-4743||
287668|NCT01147055|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287669|NCT01147068|Protein Sciences Corporation|Dr. Ruvim Izikson, M.D.|203-599-6064|rizikson@proteinsciences.com|163
287670|NCT01147107|University of Hawaii at Manoa John A Burns School of Medicine|Dr. Cecilia Shikuma|8086921328|shikuma@hawaii.edu|
287671|NCT01147172|Anika Therapeutics|Adrian Orr, Director Clinical Affairs|781.457.9000|aorr@anikatherapeutics.com|
277421|NCT00594906|University of Rochester|Dr. J. Edward Puzas|(585) 275-3664|edward_puzas@urmc.rochester.edu|
287672|NCT01147250|Sanofi|Trail Transparency Team||Contact-US@sanofi.com|
287673|NCT01147302|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
287674|NCT01147341|michael schiff|Michael schiff|303 773 8429|michael.schiff@me.com|
287675|NCT01147380|University of Miami|Dr. Seigo Nishida|305-355-5760|snishida@med.miami.edu|
287676|NCT01147406|N30 Pharmaceuticals Inc.|Janice M Troha|720-945-7714|janice.troha@n30pharma.com|
277422|NCT00594932|Oklahoma Medical Research Foundation|Joan T Merrill M.D.|405 271 7805|joan-merrill@omrf.org|
287677|NCT01147458|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287678|NCT01147471|Virginia Commonwealth University|Ajai K Malhotra, MD|804-827-2409|akmalhot@mcvh-vcu.edu|
287679|NCT01147497|Emory University|Eva Lathrop, MD, MPH|404-778-1379|elathro@emory.edu|
287680|NCT01147601|Oregon Health & Science University|Dr. Alfons Krol|503-494-9993|krola@ohsu.edu|
287681|NCT01147627|The Third Affiliated Hospital of Sun Yat-sen University|Dr. Jianping Weng|86-20-85253162|wjianp@mail.sysu.edu.cn|
287682|NCT01147640|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
287683|NCT01147744|GlaxoSmithKline|GSK Response Center|866-435-7343||
287684|NCT01147809|GlaxoSmithKline|GSK Response Center|866-435-7343||
287685|NCT01147848|GlaxoSmithKline|GSK Response Center|866-435-7343||
287686|NCT01147874|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287687|NCT01147900|GlaxoSmithKline|GSK Response Center|866-435-7343||
287688|NCT01147926|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
287689|NCT01148017|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
277423|NCT00594945|Jazz Pharmaceuticals, Inc.|Executive Director, Clinical Development|650 496 3777||
277424|NCT00594958|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|0
277425|NCT00594997|Brigham and Women's Hospital|Nancy Shadick|617-732-5266|nshadick@partners.org|
277426|NCT00595075|Sentara Neurology Specialists|Daniel Cohen|757-388-6323|dacohen@sentara.com|
277427|NCT00595088|Bnai Zion Medical Center|Dr. Sarel Halachmi|+97248359542|sarel.halachmi@b-zion.org.il|
277428|NCT00595101|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
277429|NCT00595114|Brigham and Women's Hospital|Dr. Bruce D. Levy|617-525-5407|blevy@partners.org|
277430|NCT00595127|Memorial Sloan Kettering Cancer Center|Farid Boulad, MD, Attending|+1212-639-2429|bouladf@mskcc.org|
277431|NCT00595153|University of California, San Francisco|John V. Fahy, MD, MSc|4154769940|john.fahy@ucsf.edu|
287690|NCT01148225|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
277432|NCT00595231|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|9143265775|ckenney@acorda.com|
277433|NCT00595270|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar.kastner@intercell.com|0
277434|NCT00595309|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
277435|NCT00595335|Mayo Clinic|Dr. Rebecca S. Bahn|507-284-2462|bahn.rebecca@mayo.edu|
277436|NCT00595361|Brigham and Women's Hopsital|Elliot Israel, MD|617-732-8110|eisrael@partners.org|
277437|NCT00595413|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
287691|NCT01148420|Harbor - UCLA Medical Center|Anita Nelson|310-222-3871|anitanelsonwhc@earthlink.net|
277438|NCT00595465|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
287692|NCT01148459|GlaxoSmithKline|GSK Response Center|866-435-7343||
287693|NCT01148511|Novartis Pharmaceuticals|Study Director|862 778-8300||
287694|NCT01148524|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
287695|NCT01148537|Purdue Pharma L.P.|Executive Medical Director|800-733-1333||
287696|NCT01148563|Louisiana State Univeristy Health Care Services Division|Dr. Ron Horswell|225-763-2983|rhorsw@lsuhsc.edu|
287697|NCT01148693|Tehran medical university of science|Dr. Rasoul sotoudehmanesh|(+98 21) 82414000|r.sotudemanesh@gmail.com|82415000
287698|NCT01148745|Dialysis Clinic, Inc.|Dr. Toros Kapoian, M.D., F.A.C.P.|732-940-8368|Toros.Kapoian@dciinc.org|
287699|NCT01148771|Center for Anti-Infective Research and Development, Hartford Hospital|Joseph L. Kuti, Pharm.D. / Associate Director, Clinical and Economic Studies|860-545-3612|jkuti@harthosp.org|
287700|NCT01148810|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
287701|NCT01148836|Cleveland Clinic|Jacqueline Sharp, CNP|216-636-0000|pylej@ccf.org|
287702|NCT01148862|Medtronic|Thomas P Troub|818-576-3142|thomas.troub@medtronic.com|
287703|NCT01148940|Albert Einstein College of Medicine|Dr. Henny Billett|718-430-2186|hbillett@montefiore.org|
287704|NCT01148979|McLean Hospital|J. Alexander Bodkin, MD|617-855-3186|abodkin@mclean.harvard.edu|
287705|NCT01149057|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
287706|NCT01149096|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
298435|NCT01817075|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
298436|NCT01817374|UAB Radiology Research|Marianne Vetrano|205-934-4080|mvetrano@uabmc.edu|
298437|NCT01817491|Cleveland Clinic|Michael Macknin, MD|216 444-5512|macknim@ccf.org|
298438|NCT01817530|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
298439|NCT01817582|Bausch & Lomb Incorporated|Director of Clinical Operations||Jon.Williams@bauschhealth.com|
298440|NCT01817712|VA Cooperative Studies Program|Tassos C. Kyriakides, Ph.D, Biostatistician|203-932-5711|tassos.kyriakides@va.gov|3771
298441|NCT01817725|Chang Gung Memorial Hospital, Linkou Branch|Dr. Ming-Wei Lai|886-3-3281200|a22141@adm.cgmh.org.tw|8969
308741|NCT02607228|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
308742|NCT02607254|Johns Hopkins University|Dr. Mohammad Khoshnoodi|410-955-5406|mkhoshn1@jhmi.edu|
308743|NCT02607280|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
308744|NCT02607306|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
308745|NCT02607618|Motif BioSciences|Stephanie Noviello|908-432-7802|stephanie.noviello@motifbio.com|
308746|NCT02607735|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
308747|NCT02607800|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
308748|NCT02607865|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
308749|NCT02607930|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
308750|NCT02607956|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
308751|NCT02608099|Baim Institute for Clinical Research|Director of Trial Design and Development|617-307-5200|TrialDesignandDevelopmentStaff@baiminstitute.org|
308752|NCT02608177|Kidney Research Institute, University of Washington|Dr. Ian de Boer, Associate Director|2067444029|IDeBoer@Nephrology.washington.edu|
308753|NCT02608229|Washington University School of Medicine|Kian-Huat Lim, M.D., Ph.D.|314-362-6157|kian-huat.lim@wustl.edu|
308754|NCT02608450|Cassiopea SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
277439|NCT00595478|Dartmouth College|Catherine Stanger, Ph.D.|603-646-7023|catherine.stanger@dartmouth.edu|
277440|NCT00595504|Massachusetts General Hospital|David C. Henderson, M.D.|617-912-7800|dchenderson@partners.org|
277441|NCT00595517|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
277442|NCT00595530|Connecticut Children's Medical Center|Dr. William T. Zempsky|860-837-5207|wzempsk@ConnecticutChildrens.org|
277443|NCT00595556|UCHC|Albert J. Arias, M.D.|8606794423|alarias@uchc.edu|4423
277444|NCT00595621|Texas Tech|Irene Sarosiek, MD, AGAF, FACG, CCRP|915.215.5254|Irene.sarosiek@ttuhsc.edu|
277445|NCT00595764|Yale University|Dr. David Fiellin|203-737-3347|david.fiellin@yale.edu|
277446|NCT00595790|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|0
277447|NCT00595868|University of Vermont|John R. Hughes, MD|802-656-3195|john.hughes@uvm.edu|
277448|NCT00595881|Children's Hospital of Pittsburgh|Jennifer Marin|412-692-7692|jennifer.marin@chp.edu|
277449|NCT00595946|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
277450|NCT00595959|Spectranetics Inc|Thomas M. Rasmussen V.P. Clinical Affairs|719-447-2471|thomas.rasmussen@spnc.com|
277451|NCT00596011|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D.|813-745-6885|nagi.kumar@moffitt.org|
277452|NCT00596102|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43 1 20620|info@valneva.com|0
277453|NCT00596167|Indiana University School of Medicine|Brian Decker MD, PharmD|317-278-2868|bsdecker@iupui.edu|
277454|NCT00596271|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43 1 206 20|info@valneva.com|0
277455|NCT00596362|Memorial Sloan Kettering Cancer Center|Dr. David Abramson|212-639-7232|abramsod@mskcc.org|
277456|NCT00596427|Kinemed, Inc|Carine Beysen, PhD|5106556525|cbeysen@kinemed.com|123
277457|NCT00596440|University of Pennsylvania|Dr. Robert Schnoll|215-746-7143|schnoll@mail.med.upenn.edu|
277458|NCT00596453|Johns Hopkins Medical Institutions|Misop Han, M.D.|410-502-7454|mhan1@jhmi.edu|
277459|NCT00596466|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277460|NCT00596622|Indiana University School of Medicine|Amit Anand|3172747422|aanand@iupui.edu|
277461|NCT00596635|Yale University School of Medicine|Manisha Juthani-Mehta, MD|(203)785-4140|manisha.juthanimehta@yale.edu|
277462|NCT00596687|Emory Univ SOM|Guillermo Umpierrez|4047781665|geumpie@emory.edu|
277463|NCT00596752|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
287707|NCT01149148|UmichiganHS|Dr. Wei C. Lau|734 9369479|weiclau@med.umich.edu|
287708|NCT01149343|GlaxoSmithKline|GSK Response Center|866-435-7343||
287709|NCT01149369|Johns Hopkins Data Coordinating Center|Katherine Yates|443-287-0082|kyates1@jhu.edu|
298442|NCT01817751|Virginia Commonwealth University Massey Cancer Center|Massey Cancer Center CTO Operations Managers|877-4627739|ctoclinops@vcu.edu|
287710|NCT01149421|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287711|NCT01149434|Huntsman Cancer Institute Unversity of Utah|Sunil Sharma, MD|801-585-0255|sunil.sharma@hci.utah.edu|
287712|NCT01149460|Teva Pharmaceuticals USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
287713|NCT01149473|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
287714|NCT01149486|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
298443|NCT01817764|GlaxoSmithKline|GSK Response Center|866-435-7343||
287715|NCT01149512|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
287716|NCT01149538|University of Minnesota|Jeffrey R. Wozniak, Ph.D.|612-273-9741|jwozniak@umn.edu|
298444|NCT01817777|GlaxoSmithKline|GSK Response Center|866-435-7343||
287717|NCT01149616|Beth Israel Deaconess Medical Center|Dr Lauren Fisher|6176671853|lauren_fisher@dmgaz.org|
287718|NCT01149655|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
287719|NCT01149681|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
287720|NCT01149733|Teva Pharmaceuticals USA|Associate Director, Biopharmaceutics|866-384-5525|clinicaltrialqueries@tevausa.com|
298445|NCT01817790|GlaxoSmithKline|GSK Response Center|866-435-7343||
287721|NCT01149759|Rockefeller University|Emma Guttman Yassky, MD|212-327-8333|skhattri@rockefeller.edu|
287722|NCT01149772|Michael E. DeBakey VA Medical Center|Dr. Jeffrey Cully|713-794-8526|Jeffrey.Cully@va.gov|
287723|NCT01149785|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287724|NCT01149863|Emory University|Dr. Harvey|404-778-4381|rdharve@emory.edu|
298446|NCT01817855|AstraZeneca|Naimish Patel|+1 781 839 4061|Naimish.Patel@astrazeneca.com|
287725|NCT01149876|MGH|Dr. Molly Wanner|617-726-2914|harvardskinstudies@partners.org|
298447|NCT01817907|Brigham and women's Hospital|D. Andrew Wellman|617-732-8483|awellman@rics.bwh.harvard.edu|
287726|NCT01150045|Alliance for Clinical Trials in Oncology|Jeffrey A. Meyerhardt, MD, MPH|617-632-6855|jmeyerhardt@partners.org|
298448|NCT01817959|Dompé farmaceutici|Andrea Vergani, MD|+39 02 583831|info@dompe.it|
287727|NCT01150097|Novartis Pharmaceuticals|Study Director|862-778-8300||
287728|NCT01150123|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
308755|NCT02608463|University of Arkansas for Medical Sciences|Dr. Shona Ray-Griffith|501-526-8428|slray@uams.edu|
308756|NCT02608476|Cassiopea, SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
287729|NCT01150357|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
287730|NCT01150461|Massachusetts General Hospital|Michael A. Fifer, MD|617 726-1832|mfifer@partners.org|
308757|NCT02608489|Soonchunhyang University Hospital|Dr. JinKwon Chung|82-2-709-9354|schcornea@schmc.ac.kr|
287731|NCT01150474|Mayo Clinic|Dr. Kristina A. Butler|480-301-5934|butler.kristina@mayo.edu|
287732|NCT01150500|Study Manager|Hiroko Ookubo|+81-3-6430-7017|hiroko.ookubo@medtronic.com|
287733|NCT01150760|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
287734|NCT01150838|University of Virginia|George Politis MD|434-924-2283|GDP8A@hscmail.mcc.virginia.edu|
287735|NCT01150903|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287736|NCT01150981|University of Massachusetts Medical School|Samir Malkani, MD|5088563800|samir.malkani@umassmemorial.org|
308758|NCT02608684|Cedars-Sinai Medical Center|Christine Walsh, MD|310-423-5456|Christine.Walsh@cshs.org|
308759|NCT02608879|NYU Langone Medical Center|Patricia Corby, Principal Investigator|646-501-2615|patricia.corby@nyumc.org|
308760|NCT02608892|Children's Hospital of Eastern Ontario|Dr Denise Harrison|613-737-7600|dharrison@cheo.on.ca|4140
308761|NCT02609100|Washington University School of Medicine in St. Louis|Dr. Vladimir M. Kushnir|314-362-3685|vkushnir@wustl.edu|
308762|NCT02609113|Wake Forest Baptist Health|Vanessa Baute, MD|336-716-8140|vbaute@wakehealth.edu|
277464|NCT00596817|H. Lundbeck A/S|H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
277465|NCT00596830|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277466|NCT00596934|University of Michigan|Dr. Elif A. Oral|734-615-7271|eliforal@med.umich.edu|
277467|NCT00596960|VAMC|Eric Dieperink, MD|612-467-3964|eric.dieperink@va.gov|
277468|NCT00597012|The Brigham and Women's Hospital|Jeffrey N. Katz, MD, MSc|617-732-5338|jnkatz@bwh.harvard.edu|
277469|NCT00597038|UCSF Helen Diller Family Comprehensive Cancer Center|Adil Daud, Director, Melanoma Clinical Research|415-353-7392|adaud@medicine.ucsf.edu|
277470|NCT00597116|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
277471|NCT00597207|ZOLL Medical Corporation|Sr. Director of Clinical Research|978-421-9655|uherken@zoll.com|
277472|NCT00597246|Memorial Sloan Kettering Cancer Center|Ronald Blasberg, MD|646-888-2211|blasberr@mskcc.org|
277473|NCT00597272|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman|646-888-4162|chapmanp@mskcc.org|
277474|NCT00597376|Rush University Medical Center|Raj C. Shah, MD|312-563-2902|Raj_C_Shah@rush.edu|
277475|NCT00597402|Duke University Medical Center|Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
277476|NCT00597428|Sucampo Pharma Americas, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com|
277477|NCT00597493|Duke University Health System|David Reardon, MD|617-632-2166|David_Reardon@DFCI.harvard.edu|
277478|NCT00597506|Duke University Medical Center|Herbert Hurwitz, MD|919-668-1861|herbert.hurwitz@duke.edu|
287737|NCT01151020|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
287738|NCT01151046|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
298449|NCT01818063|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Edith Mitchell|215-955-8874|edith.mitchell@jefferson.edu|
298450|NCT01818141|Hartford Hospital|Dr. David P. Nicolau, PharmD, FCCP, FIDSA|860-972-3941|david.nicolau@hhchealth.org|
287739|NCT01151085|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298451|NCT01818245|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287740|NCT01151098|Purdue Pharma L.P.|Clinical Leader, Executive Medical Director|800-733-1333 OR 800-745-7445||
298452|NCT01818258|Organization: Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
298453|NCT01818284|UT MD Anderson Cancer Center|Chitra Hosing, MD/Professor, Stem Cell Transplantation|713-792-7734|cmhosing@mdanderson.org|
287741|NCT01151137|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi.com|
298454|NCT01818297|Medtronic Neuromodulation|Neuro Clinical Trials||medtronicneurotrials@medtronic.com|
287742|NCT01151189|Aeras|Product Director; Bernard Landry|301-547-2919|blandry@aeras.org|
298455|NCT01818336|AllerQuest|Dr. Franklin Adkinson Jr., MD-Vice President, Chief Medical Officer|410-550-2051|fadkinson@allerquest.com|
287743|NCT01151215|Astrazeneca|Dr Serban Ghiorghiu||ClinicalTrialTransparency@astrazeneca.com|
287744|NCT01151280|Boston Scientific Corporation|Alexis James, Clinical Project Manager|508-683-4074|jamesa@bsci.com|
298456|NCT01818414|University of Minnesota|Christy Boraas, MD, MPH|612-273-7111|bora0021@umn.edu|
287745|NCT01151345|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287746|NCT01151371|Vistakon|Kathy Lorenz-Osborn, OD|+1 904 443-1032|kosborn@its.jnj.com|
287747|NCT01151410|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
287748|NCT01151423|Ablynx|Medical Monitor|+32 (9) 262 00 00|clinicaltrials@ablynx.com|
298457|NCT01818427|University of Pittsburgh|Dr. Jason Sperry|412 6922850|sperryjl@upmc.edu|
298458|NCT01818492|Sobi AB|Carl Johan Treutiger|46 76 00 11 815|CarlJohan.Treutiger@sobi.com|
298459|NCT01818518|Mednax. Inc|Kimberly Maurel|714-593-9171|kimberly_maurel@mednax.com|
308763|NCT02609178|Stomatological Hospital of FMMU|Pingting Lin, PhD|+86 15249049902|biu79@hotmail.com|
308764|NCT02609204|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
308765|NCT02609308|Universidad Autónoma de Nuevo León|Carlos Acosta-Olivo, PhD|+52 81 8347-3056|dr.carlosacosta@gmail.com|
308766|NCT02609399|Johns Hopkins University|Dr. Richard Rothman|410-735-6428|rrothma1@jhmi.edu|
308767|NCT02609607|University of Pittsburgh Medical Center|Dr. David Levinthal|14123030525|levinthald@upmc.edu|
308768|NCT02609633|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
308769|NCT02609659|AbbVie|Global Medical Services|800-633-9110||
308770|NCT02609672|McMaster University/University of Waterloo|Dr. Monica Maly|519-888-4567|mrmaly@uwaterloo.ca|37916
308771|NCT02609841|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
308772|NCT02609984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308773|NCT02610140|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
308774|NCT02610192|Zimmer Biomet|Mr. Cahit Akbas|+31622981737|Cahit.Akbas@zimmerbiomet.com|
308775|NCT02610231|Kyowa Kirin|Development Devision - Project Management Department|609-919-1100|kkd.clintrial.82@kyowakirin.com|
308776|NCT02610634|Newcastle University|Professor Lynn Rochester|0191 208 1291|lynn.rochester@ncl.ac.uk|
308777|NCT02610725|Massachusetts General Hospital|Louisa G. Sylvia, Ph.D.|617-643-4804|lsylvia2@mgh.harvard.edu|
308778|NCT02610777|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
308779|NCT02610816|Cincinnati Childrens Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|Marc.Rothenberg@cchmc.org|
308780|NCT02610842|Unicamp - University of Campinas|Dr. Eduardo de Paiva Magalhaes|+55 (19) 35217113|dreduardomagalhaes@gmail.com|
277479|NCT00597519|Memorial Sloan Kettering Cancer Center|Dr. Juliet Barker|212-639-3468|barkerj@mskcc.org|
277480|NCT00597545|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
277481|NCT00597558|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director|919-843-9087|edwinkim@email.unc.edu|
277482|NCT00597584|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
277483|NCT00597675|University of North Carolina at Chapel Hill|Dr. Edwin Kim, Director of the UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
277484|NCT00597701|Essentia Health|Charles E Gessert, MD, MPH|218-786-8176|cgessert@eirh.org|
277485|NCT00597714|Duke University Medical Center|David Rizzieri, MD|919-668-1040|david.rizzieri@duke.edu|
277486|NCT00597727|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
298460|NCT01818531|Wake Forest University Health Sciences|Dr. Daryl Henshaw|3367166344|dhenshaw@wakehealth.edu|
298461|NCT01818596|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
298462|NCT01818700|Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University school of medicine, Seoul Korea|Dr. Whan Eoh|82-2-3410-3491|w.eoh@samsung.com|
298463|NCT01818726|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
298464|NCT01818739|The Ohio State University Comprehensive Cancer Center|Floor Backes, MD|614-730-6968|Floor.Backes@osumc.edu|
298465|NCT01818752|Amgen Inc.|Study Director|866-572-6436||
298466|NCT01818765|Oxford university hospitals NHS Foundation Trust|Dr James Gamble|+441865221012|drjgamble1@jhpg.net|
298467|NCT01818804|Aalborg University hospital|Salome Kristensen, MD. PhD|+45 97664015|sakr@rn.dk|
298468|NCT01819129|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
298469|NCT01819194|Vistakon|Daria Wicks|904-443-1391|RA-VISUS-ClnclStds@its.jnj.com|
308781|NCT02610868|Solstice Neurosciences|Regulatory Affairs Specialist|502-815-8148|regulatoryaffairs@usworldmeds.com|
287749|NCT01151436|Galderma|Ma May|+33 4 92 38 67 33|may.ma@galderma.com|
287750|NCT01151449|Princess Margaret Cancer Centre|Dr. Srikala Sridhar|416-946-2662|srikala.sridhar@uhn.ca|
287751|NCT01151540|Eisai Co., Ltd.|Customer Joy Department. EJ|8133817-3700|_ML_CLNCL@hhc.eisai.co.jp|
287752|NCT01151579|Genesys Regional Medical Center|Dr. Fahim Khorfan|810-606-7722|kbarber@genesys.org|
287753|NCT01151618|Philips Respironics|Bob Romano, Biomedical Engineer|724-387-7781|bob.romano@philips.com|
287754|NCT01151761|Stanford University Cancer Center|Dr. Daniel Chang|650-724-3547|dtchang@stanford.edu|
287755|NCT01151813|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@upenn.edu|152
287756|NCT01151852|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
287757|NCT01152021|Department of Anesthesia, Perioperative and Pain Medicine|Rachel Dabek|857-218-5413|rachel.dabek@childrens.harvard.edu|
287758|NCT01152112|Hologic, Inc.|Christina Mastandrea / Clinical Research manager|5082638772|christina.mastandrea@hologic.com|
287759|NCT01152190|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287760|NCT01152294|Massachusetts General Hospital|Karen Sepucha, Ph.D.|617-724-3350|ksepucha@partners.org|
287761|NCT01152307|Massachusetts General Hospital|Dr. Karen Sepucha|617-724-3350|ksepucha@partners.org|
287762|NCT01152359|VA Medical Center|William S. Yancy, Jr.|919-286-0411|william.yancy2@va.gov|7770
287763|NCT01152385|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
287764|NCT01152437|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298470|NCT01819233|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Nicole Simone|215-955-6702|nicole.simone@jefferson.edu|
287765|NCT01152450|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287766|NCT01152515|Department of Anaesthesiology and Pain Medicine and Anaesthesia and Pain Research Institute, Yonsei University College of Medicine|Dr. Shin Ok Koh|82-2-2228-2420|sokoh@yuhs.ac|
298471|NCT01819272|Elcelyx Therapeutics, Inc|Senior Director, Development|858-876-1814|info@elcelyx.com|
287767|NCT01152554|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
287768|NCT01152580|Duquesne University|Dr. Paula Witt-Enderby, Professor of Pharmacology and Toxicology|412-396-4346|wittp@duq.edu|
287769|NCT01152697|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|2168442808|martha.sajatovic@uhhospitals.org|
287770|NCT01152788|NCIC Clinical Trials Group|Dr. Janet Dancey|1-613-533-6430|jdancey@ctg.queensu.ca|
287771|NCT01152814|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
287772|NCT01152996|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
287773|NCT01153009|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
298472|NCT01819311|Florida International University|Jeremy W. Pettit (PI)|305-348-1671|jpettit@fiu.edu|
287774|NCT01153269|Abbott|Global Medical Services|1-800-633-9110||
287775|NCT01153321|AstraZeneca|Anna Malmgren||ClinicalTrialTransparency@astrazeneca.com|
298473|NCT01819415|Maisonneuve-Rosemont Hospital|Dr. Flavio Rezende|514-867-2990|frezendef@hotmail.com|
287776|NCT01153347|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
287777|NCT01153425|University of Pennsylvania, Perelman School of Medicine|Felix W. Wehrli, Ph.D.|215-662-7951|wehrli@mail.med.upenn.edu|
277487|NCT00597753|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
277488|NCT00597766|MetroHealth Medical Center|Dr. Richard Wilson|216-957-3529|rwilson@metrohealth.org|
277489|NCT00597818|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
277490|NCT00597896|Mount Sinai School of Medicine|Katherine E. Burdick, PhD||katherine.burdick@mssm.edu|
277491|NCT00597935|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
277492|NCT00598078|Jazz Pharmaceuticals|Grace Wang, MD Director Clinical Development and Medical Monitor|650-496-3777||
277493|NCT00598273|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
277494|NCT00598442|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
277495|NCT00598481|Orchard Therapeutics (Netherlands) BV|Medical Information||medinfo@orchard-tx.com|
277496|NCT00598507|H. Lee Moffitt Cancer Center and Research Institute|Ronald DeConti, M.D., Principal Investigator|813-745-8466|ronald.deconti@moffitt.org|
287778|NCT01153503|University of Texas Southwestern Medical Center|Irina Gasanova, MD, PhD|214-590-0064|Irina.Gasanova@UTSouthwestern.edu|
287779|NCT01153516|University of Texas Southwestern at Dallas|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
287780|NCT01153581|Yale School of Medicine|Nina Stachenfeld|203-562-9901|nina.stachenfeld@yale.edu|219
287781|NCT01153620|B. Braun Medical, Centre of Excellence|Medical Affairs Manager|+41 58 258 55 47||
287782|NCT01153633|B. Braun Medical AG|Medical Scientific Affairs Manager|+41 58 258 55 47||
287783|NCT01153672|University of Washington|Hannah M. Linden, MD|206-288-6989|hmlinden@u.washington.edu|
287784|NCT01153685|GlaxoSmithKline|GSK Response Center|866-435-7343||
287785|NCT01153698|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287786|NCT01153711|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287787|NCT01153724|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287788|NCT01153763|GlaxoSmithKline|GSK Response Center|866-435-7343||
287789|NCT01153815|GlaxoSmithKline|GSK Response Center|866-435-7343||
287790|NCT01153841|GlaxoSmithKline|GSK Response Center|866-435-7343||
287791|NCT01153893|GlaxoSmithKline|GSK Response Center|866-435-7343||
287792|NCT01153958|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
298474|NCT01819506|Ralph H Johnson VAMC|Michelle Woodbury|843-792-1671|Woodbuml@musc.edu|
287793|NCT01153971|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
287794|NCT01153984|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
277497|NCT00598559|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
287795|NCT01154010|Massachusetts Eye and Ear Infirmary|Director of the Ocular Immunology and Uveitis Service|617-573-5549|George_Papaliodis@meei.harvard.edu|
287796|NCT01154088|GlaxoSmithKline|GSK Response Center|866-435-7343||
287797|NCT01154101|GlaxoSmithKline|GSK Response Center|866-435-7343||
287798|NCT01154127|Novartis Pharmaceuticals|Study Director|862-778-8300||
287799|NCT01154140|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287800|NCT01154153|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
287801|NCT01154166|GlaxoSmithKline|GSK Response Center|866-435-7343||
287802|NCT01154192|UC San Diego School of Medicine|Dr. R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
287803|NCT01154218|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287804|NCT01154231|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287805|NCT01154283|UMichigan|Kirsten Gruis|7346041172|klgruis@gmail.com|
287806|NCT01154296|Department of Sociomedical Sciences/Mailman School of Public Health/Columbia University|Lisa Metsch, PhD, Stephen Smith Professor and Chair of Sociomedical Sciences|212-305-3577|lm2892@columbia.edu|
287807|NCT01154322|ResMed|June Mendoza|1-800-424-0737|june.mendoza@resmed.com|
287808|NCT01154335|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
287809|NCT01154452|Memorial Sloan Kettering Cancer Center|Dr. Mrinal Gounder|646-888-4167|gounderm@mskcc.org|
287810|NCT01154634|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
287811|NCT01154673|University of Toronto|Mario Ostrowski, Principal Investigator, Professor of Medicine|416-946-5805|mario.ostrowski@gmail.com|
298475|NCT01819597|Cedars-Sinai Medical Center|Nestor Gonzalez, MD. Professor of Neurosurgery|310 423 0783|nestor.gonzalez@cshs.org|
287812|NCT01154699|University of California San Diego|Robert L. Owens|8586575258|rowens@ucsd.edu|
287813|NCT01154751|Abbott Vascular|Margo Zaugg|408-845-0576|margo.zaugg@av.abbott.com|
287814|NCT01154816|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
287815|NCT01154985|Mochida Pharmaceutical Company Ltd.|Hironori Sato, Director|+81-3-3225-6331|hnsato@mochida.co.jp|
287816|NCT01155011|UCSD|Jacqueline Kerr|858-534-9305|jkerr@ucsd.edu|
287817|NCT01155024|The Ohio Willow Wood Company|Applied Research Engineer|740-869-3377|mariag@owwco.com|
287818|NCT01155050|PenningtonBRC|Ronald Horswell|225-763-2931|Ronald.Horswell@pbrc.edu|
298476|NCT01819727|BioMarin Pharmaceutical Inc.|Principal Scientist I, Clinical Sciences|415-506-6348|dlounsbury@bmrn.com|
298477|NCT01819844|Massachusetts General Hospital|Steven J. Russell|617-726-8722|sjrussell@partners.org|
298478|NCT01819883|Massachusetts General Hospital|Karen Miller|617-726-3870|KKMiller@MGH.Harvard.edu|
298479|NCT01819922|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298480|NCT01819935|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308782|NCT02610972|Gynuity Health Projects|Hillary Bracken|2124481230|hbracken@gynuity.org|
308783|NCT02611154|Sports Medicine Research & Testing Laboratory|Dr. Geoffry Miller|801-994-9519|gmiller@smrtl.org|
308784|NCT02611362|Rhode Island Hospital|Dr. Larry K. Brown|(401) 793-8808|lkbrown@lifespan.org|
277498|NCT00598585|Charles R. Drew University|Theodore C. Friedman MD PhD|3106685197|theodorefriedman@cdrewu.edu|
308785|NCT02611479|Surgical Outcomes Research Center - SORCE|Dr. Amy Cizik - Research Assistant Professor, Ph.D., M.P.H.,|206-744-4631|amorgan2@uw.edu|
308786|NCT02611752|Braeburn|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
308787|NCT02611765|Baylor College of Medicine|Jose Serpa-Alvarez|713 798-7910|jaserpaa@bcm.edu|
277499|NCT00598650|Eisai Co., Ltd.|Masaki Nakagawa|+81-3-3817-5245||5245
277500|NCT00598663|University Children's Hospital Vrazov trg 1 SI-1525 Ljubljana, Slovenia|Tadej Battelino|+386 1 522 50 50|tadej.battelino@mf.uni-lj.si|
277501|NCT00598689|Georgia Regents University|David D. Bogorad, MD, FACS|706-721-1160|dbogorad@gru.edu|
308788|NCT02611778|bioeq GmbH|Head of Clinical Development|+498024463330|columbus@bioeq.com|
277502|NCT00598702|Mallinckrodt Pharmaceuticals|Lawrence Hill, VP Clinical Development|908-238-6370|lawrence.hill@mallinckrodt.com|
277503|NCT00598806|Spectrum Pharmaceuticals|Gajanan Bhat, PhD|949-743-9219|Gajanan.Bhat@sppirx.com|
277504|NCT00598819|University of California, Irvine Medical Center|Dr. Jeffrey C. Milliken|714-456-3634|jcmillik@uci.edu|
277505|NCT00598832|Galderma|Michael Graeber MD/ Head of Global Clinical Project Management|609-860-8201|michael.graeber@galderma.com|
277506|NCT00598871|ReGenTree, LLC|Won S. Yang, President & CEO|609-734-4328|wonsyang@regentreellc.com|
277507|NCT00598975|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
277508|NCT00599014|Emory University|Dr. Javed Butler|404-778-5136|jbutle4@emory.edu|
277509|NCT00599053|University of Alabama at Birmingham|Dr. David Randolph|205-934-4680|drandolph@peds.uab.edu|
277510|NCT00599196|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
277511|NCT00599248|TissueGene, Inc|R. Ogden Copeland|(301) 921-6000|ocopeland@tissuegene.com|122
277512|NCT00599313|Texas Oncology Cancer Center|Dr. Guru Sonpavde|2813327505|Guru.Sonpavde@USOncology.com|
277513|NCT00599326|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
277514|NCT00599339|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
308789|NCT02611817|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
277515|NCT00599521|Galderma|Michael Graeber MD/ Head of Global Clinical Project Management|609-860-8201|michael.graeber@galderma.com|
287819|NCT01155063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277516|NCT00599638|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298481|NCT01820260|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
298482|NCT01820364|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
298483|NCT01820416|Dept. of Communication Sciences & Disorders, University of Iowa|Shawn S Goodman|319-335-8700|shawn-goodman@uiowa.edu|
287820|NCT01155141|Stanford University|Dr. Richard Lafayette|650-498-6063|czar@stanford.edu|
287821|NCT01155154|SUNY Downstate Medical Center|Shahriar Zehtabchi|718-245-2973|shahriar.zehtabchi@downstate.edu|
287822|NCT01155167|UCSF|Andrew Boyle MD|4153533817|aboyle@medicne.ucsf.edu|
287823|NCT01155180|Beth Israel Deaconess Medical Center|Dr. Christos Manztoros|617-667-8630|cmantzor@bidmc.harvard.edu|
287824|NCT01155193|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
287825|NCT01155219|Laboratoires Thea|Dr Pascale Pouliquen|0473981436|p.pouliquen@laboratoires-thea.fr|
287826|NCT01155284|Sanford Research|Kurt J. Griffin, PhD, MD, Director of Clinical Trials|6053126000|kurt.griffin@sanfordhealth.org|
287827|NCT01155323|Johnson and Johnson K.K.|Wakana Katabami|81-34411-8040|wkatabam@its.jnj.com|22025
287828|NCT01155336|University of Rochester|Dr. Robert Block|585 275-3356|robert_block@urmc.rochester.edu|
298484|NCT01820559|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
287829|NCT01155466|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
287830|NCT01155479|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
287831|NCT01155531|Theracos, Inc|Monica Tettamanti, MSc|617-643-5696|mtettamanti@ccib.mgh.harvard.edu|
287832|NCT01155570|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
287833|NCT01155583|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Jason Valent|+1 216-445-7238|VALENTJ3@ccf.org|
287834|NCT01155661|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287835|NCT01155726|Alcon Research|Director of Clinical Trials|1-800-241-7629||
298485|NCT01820572|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
298486|NCT01820585|Bial - Portela & Cª, S.A.|Head of Clinical Research Section|+ 351 22 986 61 00|clinical.trials@bial.com|
287836|NCT01155778|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
287837|NCT01155830|University of Utah|Dr. Christian Yost|801/581-7052|christian.yost@hmbg.utah.edu|
287838|NCT01155869|Providence VA Medical Center|Peter Friedmann|401-273-7100|peter.friedmann@va.gov|6240
287839|NCT01155999|Laboratoires Thea|Pascale Pouliquen (Medical director)|0473963614|p.pouliquen@laboratoires-thea.fr|
298487|NCT01820637|Boston Scientific|Lieve Cornelis, Clinical Trial Manager|+ 32 476-840-183|Lieve.Cornelis@bsci.com|
308790|NCT02611830|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
287840|NCT01156012|Laboratoires Théa|Dr Pascale Pouliquen - Medical Director|33 473 981 436|p.pouliquen@laboratoires-thea.fr|
287841|NCT01156051|Children's Specialized Hospital|Thomas A Rugino MD|732-797-3826|trugino@childrens-specialized.org|
287842|NCT01156116|University of Chicago|Esra Tasali|773-702-1497|etasali@medicine.bsd.uchicago.edu|
287843|NCT01156142|Mayo Clinic|Robert C. Miller, M.D.|507/266-6247|Miller.Robert@mayo.edu|
287844|NCT01156311|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
287845|NCT01156363|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
287846|NCT01156376|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
287847|NCT01156480|NorthShore University HealthSystem|Dr. Brandy Frost|847-570-2033|bfrost@northshore.org|
308791|NCT02611882|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|2264
308792|NCT02612064|GlaxoSmithKline|GSK Response Center|866-435-7343||
287848|NCT01156532|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
298488|NCT01820754|Duke University Medical Center|Neal Ready, MD|919 681-6932|neal.ready@duke.edu|
308793|NCT02612077|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
298489|NCT01821105|The Ohio State University|Edward Martin, MD|614-293-8843|Edward.Martin@osumc.edu|
298490|NCT01821118|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
308794|NCT02612155|Duke University|Dr. Kim Fisher, Ph.D., FNP-BC|919-681-4913|kimberley.fisher@duke.edu|
298491|NCT01821300|The Children's Hopsital of Philadelphia|Dr. Andrea Kelly|215590-3174|kellya@email.chop.edu|
298492|NCT01821326|Shanghai Jiaotong University|Dr.Zhizheng GE|86-68383015|tanwei_1987@163.com|
308795|NCT02612194|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
308796|NCT02612428|Vital Therapies, Inc.|Robert Ashley, Chief Technical Officer|001 858-673-6840|rashley@vitaltherapies.com|
308797|NCT02612610|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308798|NCT02612623|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308799|NCT02612688|Brown University|Jessica A. Ogarek, Senior Biostatistician|401-863-9356|jessica_ogarek@brown.edu|
308800|NCT02612727|Minnesota Medical Research Foundation (now Hennepin Healthcare) and University of Minnesota|Tina M. Slusher|612-624-4586|tslusher@umn.edu|
308801|NCT02612779|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
308802|NCT02612857|Idera|Senior Development Operations Director|877-888-6550|clinicaltrials@iderapharma.com|2
308803|NCT02612909|IVAC|Le Van Be|(+84 90) 3501529|ivaclevabe@dng.vnn.vn|
308804|NCT02613117|Procter and Gamble|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
308805|NCT02613169|University of Washington|Dr. Sylvia M. LaCourse|206-616-5978|sylvial2@uw.edu|
308806|NCT02613182|Prothena|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
308807|NCT02613208|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
287849|NCT01156571|The Medicines Company|Meredith Todd - Sr. Director Program Management|+1.973.290.6088|meredith.todd@themedco.com|
277517|NCT00599755|Merck Sharp and Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
287850|NCT01156597|University of Miami Miller School of Medicine|Armando J. Mendez, Ph.D.|305-243-5342|a.mendez@miami.edu|
277518|NCT00599872|Greer Laboratories|Bob Esch, VP Research & Development|828.759.7845|esch@greerlabs.com|
287851|NCT01156675|Globus Medical|Director, Clinical Affairs|610-930-1800|jmyer@globusmedical.com|1669
287852|NCT01156701|GlaxoSmithKline|GSK Response Center|866-435-7343||
287853|NCT01156714|VAORD|Fred Ivey|410-605-7000|Frederick.Ivey@va.gov|6582
287854|NCT01156792|GlaxoSmithKline|GSK Response Center|866-435-7343||
287855|NCT01156805|Hospital General de Granollers|Dr. Esteve Llargues|938425000|ellargues@fhag.es|2675
298493|NCT01821352|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
287856|NCT01156844|Novartis Pharmaceuticals|Study Director|862-778-8300||
298494|NCT01821378|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
287857|NCT01156987|University of MN|Curt Corum|(612) 625-5000|corum003@umn.edu|
298495|NCT01821391|Galderma R&D SNC|CTA Coordinator|+33 493 95 70 85|cta.coordinator@galderma.com|
298496|NCT01821417|University of Alabama at Birmingham|Nicolaas C. Geurs, DDS MS|2059344506|ngeurs@uab.edu|
298497|NCT01821534|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
298498|NCT01821560|University of Pennsylvania|Dr. Teresa R. Franklin|215-746-1883|teresafr@pennmedicine.upenn.edu|
298499|NCT01821625|UT Southwestern Medical Center at Dallas|William M Lee, MD|214 645 6111|william.lee@utsouthwestern.edu|
298500|NCT01821729|Massachusetts General Hospital|Dr. Theodore Hong|617-726-6050|TSHONG1@mgh.harvard.edu|
298501|NCT01821807|Adiyaman University Research Hospital, Department of Anesthesiology and Reanimation|Dr. Ruslan Abdullayev|+905063010833|ruslan_jnr@hotmail.com|
298502|NCT01821937|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308808|NCT02613221|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
308809|NCT02613338|University of Tennessee|Adrija Sharma, Principal Investigator|8659747684|adrija.sharma@utk.edu|
308810|NCT02613364|University of Rochester Medical Center|Dr. Karen Mustian, Study PI|585-275-0557|karen_mustian@urmc.rochester.edu|
277519|NCT00599924|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
308811|NCT02613403|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308812|NCT02613481|Yardley Dermatology Associates, PC|Director of Clinical Trials|2155796155|rfried@yardleyderm.com|
308813|NCT02613507|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
308814|NCT02613572|Scheie Eye Institute; Perelman School of Medicine; University of Pennsylvania|Benjamin J. Kim, MD|215-662-8675|benjamin.kim@uphs.upenn.edu|
308815|NCT02613871|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
277520|NCT00600015|Sarah Cannon Research Institute|John D. Hainsworth, MD|877-691-7274|ASKSARAH@scresearch.net|
277521|NCT00600028|Johns Hopkins University School of Medicine|Maureen R. Horton|410-955-4176|mhorton2@jhmi.edu|
277522|NCT00600067|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
308816|NCT02613884|Kate Farms|Vanessa Millovich|3522634409|vannanole@gmail.com|
277523|NCT00600080|Johnson & Johnson Vision Care|Kurt Moody, OD|+1 904 443-3088|kmoody1@its.jnj.com|
277524|NCT00600106|Cedars-Sinai Medical Center|C. Noel Bairey Merz|310-423-9680|Noel.BaireyMerz@cshs.org|
277525|NCT00600119|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
277526|NCT00600171|GlaxoSmithKline|GSK Response Center|866-435-7343||
277527|NCT00600340|CECOG|MD. Christiane Thallinger|+43 1 409 77 25|office@cecog.at|
277528|NCT00600353|University of Kansas Medical Center|Dr. Omar Aljitawi|913-588-6029|oaljitawi@kumc.edu|
308817|NCT02613897|University of Texas Health San Antonio|Yuejuan Qin|210-617-5300|qiny@uthscsa.edu|
277529|NCT00600613|Memorial Sloan Kettering Cancer Center|Dr. Yoshiya Yamada|212-639-2950|yamadaj@mskcc.org|
308818|NCT02613910|GlaxoSmithKline|GSK Response Center|866-435-7343||
277530|NCT00600704|Larissa University Hospital Dept. of Anesthesiology|Dr Athina Kleitsaki|00306948481865|theoath1@gmail.com|
277531|NCT00600743|St. Luke's/Roosevelt Hospital|Harry R. Kissileff|212-523-4200|hrk2@columbia.edu|
277532|NCT00600756|AstraZeneca|Gerard Lynch||clinicaltrialtransparency@astrazeneca.com|
277533|NCT00600821|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277534|NCT00600886|Novartis Pharmaceuticals|Study Director|862-778-8300||
277535|NCT00600925|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
277536|NCT00600938|Novartis Pharnaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
277537|NCT00601107|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
277538|NCT00601146|DFCI|Andrea Ng|617-732-6310|ang@lroc.harvard.edu|
277539|NCT00601172|GlaxoSmithKline|GSK Response Center|866-435-7343||
277540|NCT00601250|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277541|NCT00601354|Stanford University|Dr. Debra L Safer|650-723-7928|dlsafer@stanford.edu|
277542|NCT00601367|Sprout Pharmaceuticals|Krista Barbour, Ph.D.|9198820850|kbarbour@sproutpharma.com|
277543|NCT00601419|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277544|NCT00601458|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
277545|NCT00601484|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287858|NCT01157065|Alcon Research, Ltd.|Mehdi Hosseini, Clinical Trial Manager|1-888-451-3937|alcon.medinfo@alcon.com|
287859|NCT01157078|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
287860|NCT01157117|Ichan School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
287861|NCT01157169|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
298503|NCT01822119|The HEARing CRC & Hearworks, Audiology Hearing and Speech Science, Melbourne, Australia|Professor Robert Cowan|+61 3 9035 5346|r.cowan@unimelb.edu.au|
298504|NCT01822132|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
298505|NCT01822197|Nationwide Childrens Hospital|Dr Ben Kopp|6147224766|benjamin.kopp@nationwidechildrens.org|
287862|NCT01157182|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
298506|NCT01822223|University of Alabama at Birmingham|Michael S. Reddy, DMD, DMSc|2059344720|mreddy@uab.edu|
298507|NCT01822301|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
287863|NCT01157234|University of Florida|Alfonso H. Santos Jr, M,D,|352-273-6374|Alfonso.santos@medicine.ufl.edu|
287864|NCT01157351|Janssen Research & Development|Director, Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
287865|NCT01157364|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
277546|NCT00601523|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287866|NCT01157377|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
287867|NCT01157416|Tulane University School of Medicine|Dr. Michael Scheeringa|5046692322|mscheer@tulane.edu|
287868|NCT01157429|Tulane University|Dr. Michael Scheeringa|5049882167|mscheer@tulane.edu|
287869|NCT01157676|University of Miami|Dipen Parekh, MD|305 243 6591|parekhd@miami.med.edu|
298508|NCT01822353|Helsinki University Hospital, Helsinki, Finland|Paula Kauppi, Chief Specialist|+358504286802|paula.kauppi@hus.fi|
277547|NCT00601627|Alliance for Clinical Trials in Oncology|George P. Kim, M.D.|507-284-4918||
277548|NCT00601640|University of Arizona/Arizona Cancer Center|Joanne Jeter, MD|520.626.9295|jjeter@azcc.arizona.edu|
277549|NCT00601705|Cleveland Clinic|Dr. David Adelstein|216 444-9310|ADELSTD@ccf.org|
277550|NCT00601718|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
277551|NCT00601731|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
277552|NCT00601796|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-2158|alberto.chiappori@moffitt.org|
277553|NCT00601835|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
287870|NCT01157845|Virginia Commonwealth University|R. Todd Stravitz|804-828-8514|rstravit@vcu.edu|
277554|NCT00601926|The Ohio State University Comprehensive Cancer Center|Paul Monk, MD|614-293-2886|Paul.Monk@osumc.edu|
277555|NCT00601952|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|6192293740|namir@mail.sdsu.edu|
277556|NCT00601965|Veterans Medical Research Foundation|Dr. Julie Wetherell|858-552-8585|jwetherell@ucsd.edu|2752
277557|NCT00602043|University of Pennsylvania|Dr. David Mankoff|(2015) 615-3687|david.mankoff@uphs.upenn.edu|
277558|NCT00602225|University of Washington|Pamela Becker, MD, PhD|206-288-7273|pbecker@uw.edu|
277559|NCT00602290|University of California, Los Angeles|Dr. Helen Lavretsky|310-794-4619|hlavretsky@mednet.ucla.edu|
277560|NCT00602355|Women and Infants Hospital|Caron Zlotnick|401-455-6529|czlotnick@butler.org|
277561|NCT00602420|University of Rochester Medical Center|Charles E. Heckler, PhD, MS. Research Assistant Professor|585-273-1141|checkler@urmc.rochester.edu|
277562|NCT00602446|Masonic Cancer Center, University of Minnesota|Linda J. Burns, MD|612-624-8144|burns019@umn.edu|
277563|NCT00602459|Ohio State University|John Byrd, M.D.||john.byrd@osumc.edu|
277564|NCT00602472|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277565|NCT00602537|University of Pennsylvania|Dr. Jay Amsterdam|(215) 662-3462|jamsterd@mail.med.upenn.edu|
277566|NCT00602771|SKCCC|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
277567|NCT00602797|University of Nebraska Medical Center|Associate Director of Clinical Research|402-559-5622|aganti@unmc.edu|
277568|NCT00602836|Mayo Clinic|Dr. Tait Shanafelt||shanafelt.tait@mayo.edu|
277569|NCT00602927|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
277570|NCT00602953|UT Southwestern Medical Center, Dallas, TX|Dr. ILDIKO LINGVAY|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
277571|NCT00602979|Weill Cornell Medicine|Michele Steinkamp|212-746-2953|mls9004@med.cornell.edu|
277572|NCT00603018|UCSD|Walter Kaye, MD/Director, Eating Disorders Program Professor, UCSD Department of Psychiatry|858- 534-8019|wkaye@ucsd.edu|
277573|NCT00603044|The University of Chicago Medicine|Fuad Baroody, MD|(773) 702-4790|fbaroody@surgery.bsd.uchicago.edu|
277574|NCT00603187|University of Washington|Dr. John K. Amory|206.616.1727|jamory@u.washington.edu|
277575|NCT00603239|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
277576|NCT00603265|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
277577|NCT00603278|GlaxoSmithKline|GSK Response Center|866-435-7343||
277578|NCT00603291|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
277579|NCT00603304|University of Alabama at Birmingham|Dr. Alan Cantor|(205) 934-6887|acantor@uab.edu|
277580|NCT00603382|GlaxoSmithKline|GSK Response Center|866-435-7343||
277581|NCT00603408|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wudosis.wustl.edu|
277582|NCT00603447|Amgen, Inc.|Study Director|866-572-6436||
277583|NCT00603473|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277584|NCT00603512|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277585|NCT00603525|GlaxoSmithKline|GSK Response Center|866-435-7343||
277586|NCT00603538|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298509|NCT01822366|University of Washington|Dr. Shannon Dorsey|(206) 543-4527|dorsey2@uw.edu|
298510|NCT01822457|Imperial Vascular Unit|Mr Pasha Normahani|+44 (0) 20 759 48904|pnormahani@gmail.com|
287871|NCT01157897|WRAIR|Donna Tosh|301-319-9332|donna.m.tosh.ctr@mail.mil|
287872|NCT01158118|Washington University School of Medicine|Mark Schroeder, M.D.|314-454-8304|markschroeder@wustl.edu|
287873|NCT01158157|Cangene Corporation|Christine Hall, Ph.D. Director Clinical|204-275-4248|chall@ebsi.com|
287874|NCT01158222|Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
287875|NCT01158261|Ethicon, Inc|Director of Clinical Development|908-218-2492|jbatill2@its.jnj.com|
287876|NCT01158378|HyperBranch Medical Technology, Inc|Michael Carnahan, PhD|919-433-3329|michaelc@hyperbranch.com|
277587|NCT00603564|IRCCS Fondazione Po.Ma.Re, Milan, Italy|Roberto Cosentini, MD|00390255033602|roberto.cosentini@policlinico.mi.it|
277588|NCT00603590|Tehran University of Medical Sciences|Mansoor Rastegarpanah|+989121255960|rastegar@sina.tums.ac.ir|
277589|NCT00603642|Amgen Inc.|Study Director|866-572-6436||
277590|NCT00603720|Washington University School of Medicine|Robert Gropler, MD, Chief of Cardiovascular Imaging Laboratory|314-747-3877|groplerr@mir.wustl.edu|
277591|NCT00603733|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
277592|NCT00603746|GlaxoSmithKline|GSK Response Center|866-435-7343||
277593|NCT00603798|Graceway Pharmaceuticals|Sharon F Levy, MD|267-948-0400|sharon.levy@gracewaypharma.com|
277594|NCT00603837|University of Oklahoma Health Sciences Center|Doug Dannaway, MD|405-271-5215|douglas-dannaway@ouhsc.edu|42048
277595|NCT00603889|Albert B. Sabin Vaccine Institute|Dr. David Diemert, Director of Clinical Trials|202-842-5025|david.diemert@sabin.org|
277596|NCT00603902|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
287877|NCT01158404|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
287878|NCT01158521|Cleveland Clinic|Dr. Brian Rini|(216) 444-9567|rinib2@ccf.org|
287879|NCT01158534|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. Brian Rini|216-444-9567|rinib2@ccf.org|
287880|NCT01158573|University of Michigan|Michael Coffey M.D.|734-936-6267|coffeym@umich.edu|
287881|NCT01158651|UAB|Karen Cole-Plourde|205-934-5140|kplourde@uab.edu|
287882|NCT01158703|BROOKE ARMY MEDICAL CENTER|AHMAD M. SLIM, MD, LTC, MC|210-916-4717|AHMAD.SLIM@US.ARMY.MIL|
287883|NCT01158716|Cardiovasular RS|Theodoros Zografos|+306956161001|theodoroszografos@gmail.com|
287884|NCT01158820|Department of Anesthesiology & Critical Care|Jeff E Mandel MD MS|2156150553|mandelj@uphs.upenn.edu|
287885|NCT01158885|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
287886|NCT01158924|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
287887|NCT01158950|University of California, San Francisco|Dr. Jennifer Mitchell|510-985-3522|jennifer.mitchell@ucsf.edu|
287888|NCT01158976|University of Chicago|Kathry Keenan|773-702-4449|kekeenan@uchicago.edu|
287889|NCT01159015|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
287890|NCT01159054|Brigham and Women's Hospital|Kambiz Zandi-Nejad|617-732-6660|kzandinejad@partners.org|34769 page
287891|NCT01159067|City of Hope National Medical Center|Dr. Vinod Pullarkat|626-256-4673|vpullarkat@coh.org|82405
287892|NCT01159171|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
287893|NCT01159262|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
287894|NCT01159431|UCLA|Dr. Christopher DeGiorgio|310-206-3753|cmd@mednet.ucla.edu|
287895|NCT01159535|University of Washington|Dr. Sarah Bowen|(206) 543-3452|swbowen@uw.edu|
287896|NCT01159574|Weill Cornell Medical College|Jennifer Hess|6469629440|jmh2004@med.cornell.edu|
287897|NCT01159600|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287898|NCT01159665|ThromboGenics|Dr. Petra Kozma-Wiebe|+32 16751310|Petra.kozma@thrombogenics.com|
287899|NCT01159691|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
287900|NCT01159743|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
287901|NCT01159769|Alcon Research, Ltd.|Director of Medical Affairs|800-862-5266|medinfo@alconlabs.com|
287902|NCT01159912|GlaxoSmithKline|GSK Response Center|866-435-7343||
287903|NCT01159938|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287904|NCT01160198|GlaxoSmithKline|GSK Response Center|866-435-7343||
287905|NCT01160211|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
287906|NCT01160237|GlaxoSmithKline|GSK Response Center|866-435-7343||
287907|NCT01160289|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287908|NCT01160354|The University of Texas (UT) MD Anderson Cancer Center|Dr. Jan Burger, Associate Professor, Leukemia|7137927734|CR_Study_Registration@mdanderson.org|
287909|NCT01160380|Oncotherapeutics|Director of Clinical Operations|310-623-1200|lthulin@oncotherapeutics.com|
287910|NCT01160445|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
287911|NCT01160458|National Cancer Institute, National Institutes of Health|Dr. Raffit Hassan, M.D.|301-451-8742|hassanr@mail.nih.gov|
287912|NCT01160484|Oncotherapeutics|Director, Clinical Operations|323-623-1200|lthulin@oncotherapeutics.com|
287913|NCT01160614|Purdue Pharma L.P.|Medical Services|888-726-7535, option 1||
287914|NCT01160640|University of Pittsburgh|Dr. Harold Wiesenfeld|412-641-1403|wieshc@mail.magee.edu|
298511|NCT01822496|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
298512|NCT01822535|James J. Peters VA Medical Center|Dr. John P. Handrakis|718-584-9000|john.handrakis@va.gov|5439
298513|NCT01822548|Azienda ospedaliero-universitaria di Parma|Prof.ssa Ivana Zavaroni|+390521033306|ivana.zavaroni@unipr.it|
298514|NCT01822561|Tufts Medical Center|Andre Witkin|6176367950|awitkin@tuftsmedicalcenter.org|
298515|NCT01822574|Mayo Clinic|Robert T. Trousdale, M.D.|507-284-6586|trousdale.robert@mayo.edu|
287915|NCT01160744|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
287916|NCT01160770|Lundbeck LLC|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
287917|NCT01160822|Novartis Pharmaceuticals|Study Director|862-778-8300||
287918|NCT01160848|Photocure ASA|Project Director|+47 22062210|pf@photocure.no|
287919|NCT01161043|Medtronic Diabetes|Suiying Huang|8185763319|suiying.huang@medtronic.com|
287920|NCT01161121|St. Louis University|Dr. Michael Lim|314-268-7992|limmj@slu.edu|
298516|NCT01822587|MUSC|Michael Saladin|843-792-5306|saladinm@musc.edu|
298517|NCT01822665|GlaxoSmithKline|GSK Response Center|866-435-7343||
298518|NCT01822678|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
298519|NCT01822691|H. Lee Moffitt Cancer Center and Research Institute|Dr. Rami Komrokji|813-745-4692|rami.komrokji@moffitt.org|
298520|NCT01822756|Incyte Corporation|Study Director|1-855-463-3463||
298521|NCT01822821|Cleveland Clinic|Nicole Zimmerman|216-636-9449|zimmern2@ccf.org|
298522|NCT01822886|"Policlinico S.Orsola-Malpighi - Institute of Hematology L. e A. Seràgnoli, University of Bologna, Via Massarenti, 9-40138 Bologna, Italy"|Zinzani Pier Luigi/Argnani Lisa|+39 0516364042|pierluigi.zinzani@unibo.it/lisa.argnani@unibo.it|
298523|NCT01822899|GlaxoSmithKline|GSK Response Center|866-435-7343||
298524|NCT01822925|NeuroBo Pharmaceuticals, Inc.|Vice President Clinical Operations|617-313-7331|nikki.shannon@neurobopharma.com|
308819|NCT02614079|University of Toledo Medical Center|Joseph Atallah, MD|419-383-6699|joseph.atallah@utoledo.edu|
308820|NCT02614131|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
308821|NCT02614183|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
308822|NCT02614196|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
308823|NCT02614222|The Cooper Health System|Dr. Ronak Desai|856-342-2000|desai-ronak@cooperhealth.edu|
308824|NCT02614261|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
308825|NCT02614274|University of Missouri|James L. Cook, Director of Research|573-884-4689|cookjl@health.missouri.edu|
308826|NCT02614287|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
308827|NCT02614469|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-764-9611|michaels@helix.mgh.harvard.edu|
308828|NCT02614560|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
308829|NCT02614703|Dostor's Hospital at Renaissance|Dr Ingrid M Chacon|(956) 362-3636|I.chacon@dhr-rgv.com|
308830|NCT02614729|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
308831|NCT02614794|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
277597|NCT00603915|Univerisity Health Network|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.on.ca|
277598|NCT00603941|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
277599|NCT00603980|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
277600|NCT00603993|Abbott|Global Medical Services|1-800-633-9110||
277601|NCT00604019|RUSH University Medical Center|Gourang Patel, PharmD|312-942-4258|gourang_p_patel@rush.edu|
277602|NCT00604045|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|6192293740|namir@mail.sdsu.edu|
277603|NCT00604162|Given Imaging|Hila Debby|+972 4 9097774|Hila.Debby@givenimaging.com|
277604|NCT00604175|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301)-628-3313|ACTGCT.Gov@s-3.com|
308832|NCT02614924|UHCW NHS Trust|Dr Ratidzo Danha|02476 964000|Ratidzo.Danha@uhcw.nhs.uk|25871
277605|NCT00604188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
277606|NCT00604214|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
277607|NCT00604279|Xian-Janssen Pharmaceutical Ltd|Local Trial Manager|86-10-5821 8213||
277608|NCT00604383|Chromaderm|info@chroma-derm.com||info@chroma-derm.com|
277609|NCT00604461|H. Lee Moffitt Cancer Center and Research Institute|Tawee Tanvetyanon, M.D.|813-745-3050|tawee.tanvetyanon@moffitt.org|
277610|NCT00604552|Medtronic Vascular|Angela Parsons|707-591-2293|angela.r.parsons@medtronic.com|
277611|NCT00604565|Rockwell Medical|Ajay Gupta, MD|248-960-9009|rd@rockwellmed.com|
277612|NCT00604669|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
277613|NCT00604695|Brigham & Women's Hospital|C. Michael Gibson, MS, MD|617-632-7753|mgibson@perfuse.org|
277614|NCT00604708|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
277615|NCT00604721|UNC Lineberger Comprehensive Cancer Center|Bert. H. O'Neil, Associate Professor, Clinical Research|919-966-4431|bert_oneil@med.unc.edu|
277616|NCT00604786|Johns Hopkins University|Sarbjit S. Saini|410-550-2129|ssaini@jhmi.edu|
277617|NCT00604825|GlaxoSmithKline|GSK Response Center|866-435-7343||
277618|NCT00604890|Berg LLC|Nathaniel DiTommaso|617-588-1002|nate.ditommaso@berghealth.com|
277619|NCT00604968|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
277620|NCT00605033|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
277621|NCT00605072|University of Southern California|Dr. Ihab Hajjar|323-226-6720|ihajjar@usc.edu|
277622|NCT00605085|Intercell AG|Senior Manager Clinical Research|+43 1 206 20|kdubischar-kastner@intercell.com|1175
277623|NCT00605150|Carolinas Healthcare System|David Iannitti, MD|704-446-4838|jessica.drummond@carolinashealthcare.org|
277624|NCT00605176|Graceway Pharmaceuticals LLC|Sharon F. Levy, MD|267-948-0400|sharon.levy@gracewaypharma.com|
277625|NCT00605189|KCI, an Acelity Company|Senior Director, Global Clinical Development|210-255-5595|jane.hart@kci1.com|
277626|NCT00605202|Oulu University Hospital, Department of Internal Medicine|Janne Hukkanen|+358-8-315 6212|janne.hukkanen@oulu.fi|
287921|NCT01161160|GlaxoSmithKline|GSK Response Center|866-435-7343||
287922|NCT01161173|Hoffman-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
287923|NCT01161225|University of Rochester Medical Center|Hyekyun Rhee|5852763775|hyekyun_rhee@urmc.rochester.edu|
287924|NCT01161329|UppsalaU|Karin Hellström|+46184714762|karin.hellstrom@neuro.uu.se|
298525|NCT01823107|DSM Biomedical|Forde Hansell|484-713-2152|forde.hansell@dsm.com|
287925|NCT01161407|Purdue University|Kathleen M. Hill Gallant|765-494-0101|hillgallant@purdue.edu|
287926|NCT01161420|Inspire Medical Systems|Quan Ni|763-205-7968|quanni@inspiresleep.com|
287927|NCT01161446|University of Washington|Dr. David Katz|206-744-5877|dkatz7@u.washington.edu|
298526|NCT01823146|University of Florida|Dr. Natalie Ebner|203 691 0371|natalie.ebner@ufl.edu|
287928|NCT01161472|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287929|NCT01161498|Amgen, Inc.|Study Director|866-572-6436||
287930|NCT01161524|Eisai Inc.|Eisai Call Center|888-422-4743||
287931|NCT01161537|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
298527|NCT01823224|Womack Army Medical Center|Anthony R Plunkett, MD|910-907-6000|anthonyrplunkett@gmail.com|
287932|NCT01161563|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
287933|NCT01161628|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD (Principal Investigator)|404-255-1930|ssolomon@bmtga.com|
298528|NCT01823289|Department of Respiratory Medicine, SHANGHAI First People's Hospital Affiliated to SHANGHAI JiaoTong University|Director of Respiratory Department|86-21-63071428|xzhou53@163.com|
277627|NCT00605267|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
277628|NCT00605280|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277629|NCT00605293|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
277630|NCT00605306|Novartis Pharmaceuticals|Study Director|862-778-8300||
277631|NCT00605319|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
277632|NCT00605345|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
277633|NCT00605358|Weill Cornell Medicine|Dr. Jo Anne Sirey|9149974333|jsirey@med.cornell.edu|
277634|NCT00605384|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
277635|NCT00605423|Johns Hopkins University|Peter Campochiaro, M.D.||pcampo@jhmi.edu|
277636|NCT00605475|Novartis Pharmaceuticals|Study Director|862 778 8300||
277637|NCT00605540|HC/FMB-Unesp|Renata Ferrari|55 14 38116213|renataferrarifisio@gmail.com|
277638|NCT00605566|Princess Margaret Cancer Centre|Dr. Lillian Siu||lillian.siu@uhn.ca|
277639|NCT00605644|Bausch Health|Study Director||susan.harris@bauschhealth.com|
277640|NCT00605657|NIAID|V. Koneti Rao, MD|301-496-6502|korao@niaid.nih.gov|
277641|NCT00605696|Albert Einstein College of Medicine of Yeshiva University|Michelle Ng Gong, MD, MS|718 920 5464|mgong@montefiore.org|
277642|NCT00605722|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
277643|NCT00605813|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277644|NCT00605826|Bausch Health|Study Director||susan.harris@bauschhealth.com|
277645|NCT00605839|Indiana University School of Medicine|Aaron E. Carroll|3172780552|aaecarro@iupui.edu|
277646|NCT00605865|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277647|NCT00605904|NIAAA, NIH|Markus Heilig|301.435.9386|mheilig@mail.nih.gov|
277648|NCT00605917|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277649|NCT00606008|H. Lee Moffitt Cancer Center and Research Institute|Dr. Edward Pan|813-745-3871|edward.pan@moffitt.org|
277650|NCT00606021|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
277651|NCT00606034|Mountain Diabetes and Endocrine Center|Dr. Wendy Lane, Director of Clinical Research|828-258-2404|mountaindiabetes@msn.com|314
277652|NCT00606047|The Ottawa Hospital Research Institute|Dr Paul Beaule|613-737-8920|pbeaule@toh.ca|
277653|NCT00606086|GlobeImmune, Inc.|Clinical Operations Manager|3036252700|Alicia.Mattson@globeimmune.com|
277654|NCT00606138|Rush University Medical Center|Mathew MacCumber, MD, PhD|312-563-4032|denise_voskuil-marre@rush.edu|
277655|NCT00606177|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
277656|NCT00606229|Otsuka Pharmaceutical CO., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
277657|NCT00606281|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
277658|NCT00606294|Memorial Sloan Kettering Cancer Center|Dr. Nancy Lee, MD|212-639-3341|leen2@mskcc.org|
277659|NCT00606307|Italfarmaco S.p.A.|Tiziano Oldoni, MD|+39 02 6443|t.oldoni@italfarmaco.com|2540
277660|NCT00606320|Otsuka Pharmaceutical Co, Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
277661|NCT00606489|Cumberland Pharmaceuticals|Amy Rock, Doctor of Philosophy (Ph.D.)|6152550068|arock@cumberlandpharma.com|
277662|NCT00606502|Allos Therapeutics, Inc|Medical Monitor|303-426-6262|gweems@allos.com|
277663|NCT00606554|Boston University School of Medicine|Allan Walkey, MD, MSc|617-638-4860|alwalkey@bu.edu|
277664|NCT00606580|US Army Medical Materiel Development Activity (USAMMDA)|Division of Regulated Activies and Compliance|301-619-0317|usarmy.detrick.medcom-usammda.mbx.usamrmc-regulatory-affairs@mail.mil|
277665|NCT00606593|Actelion Pharmaceuticals Ltd|Pascal Charef/Clinical Trial Leader|+41 61 565 65 65||
277666|NCT00606632|Heidelberg Pharma AG (former Wilex AG)|Head of R&D||info@hdpharma.com|
277667|NCT00606684|GlaxoSmithKline|GSK Response Center|866-435-7343||
277668|NCT00606801|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
277669|NCT00606892|Yale University|Mehmet Sofuoglu, M.D., Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
277670|NCT00606905|University of Chicago|Mary D. Stephenson, M.D. MSc|773 834-1167|mstephen@babies.bsd.uchicago.edu|
277671|NCT00606931|Naviscan Inc|Judith E Kalinyak, MD, PhD, Medical Director|858-587-3641|jkalinyak@naviscan.com|108
287934|NCT01161771|Allergan, Inc.|Vice President, Global Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
298529|NCT01823328|Hennepin Healthcare|Audrey Hendrickson|612-873-9528|Audrey.Hendrickson@hcmed.org|
287935|NCT01161862|Department of Biomedical Engineering, Boston University, Boston, Massachusetts.|Edward R. Damiano|(617) 353-9493|edamiano@bu.edu|
287936|NCT01162005|Seoul National University Children's Hospital|Hee Gyung Kang|+82-2-2072-0658|pedneph@snuh.org|
287937|NCT01162096|Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|neal.flomenberg@jefferson.edu|
277672|NCT00606944|Seoul National University Bundang Hospital|Sung-Bum Kang|+82-31-787-7093|kangsb@snubh.org|
298530|NCT01823341|Jaeb Center for Health Research|Judy Sibayan, MPH, CCRP|813-975-8690|jsibayan@jaeb.org|
287938|NCT01162122|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
287939|NCT01162135|Thomas Jefferson University|Jianqing Lin, MD|215-955-8874|Jianqing.Lin@jefferson.edu|
287940|NCT01162239|University of California, San Francisco|Dr. Gary Humfleet, PhD|(415) 476-7674|Gary.Humfleet@ucsf.edu|
287941|NCT01162317|Atlanta VAMC|Wei Huang (PI)|404-321-6111|wei.huang@va.gov|6517
298531|NCT01823497|Medical College of Wisconsin|Keri R. Hainsworth|414-266-6306|khainswo@mcw.edu|
298532|NCT01823510|Icahn School of Medicine at Mount Sinai|Dr. Juan Badimon|212-241-8484|juan.badimon@mssm.edu|
298533|NCT01823536|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
298534|NCT01823614|Central Research Institute for Epidemiology|Dmitry Kireev|+74959749646|dmitry.kireev@pcr.ru|2227
308833|NCT02615145|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
308834|NCT02615158|University of Maryland School of Medicine|Dr. Maureen Black|410-706-2136|mblack@som.umaryland.edu|
308835|NCT02615171|University of Connecticut|Dr. Sherry Pagoto|8604868979|Sherry.Pagoto@uconn.edu|
308836|NCT02615249|Allerderm (dba) SmartPractice|Kathryn Shannon|6022250595|kshannon@smartpractice.com|7208
308837|NCT02615470|Auburn University|Salisa Westrick|3348448314|westrsc@auburn.edu|
277673|NCT00607022|University of Iowa|Clark Stanford|319-335-7381|CStanford@uiowa.edu|
277674|NCT00607048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277675|NCT00607087|sanofi-aventis|Medical Affairs Study Director||publicregistryGMA@sanofi-aventis.com|
277676|NCT00607113|UT MD Anderson Cancer Center|Dr. James Yao|713-792-2828|mjlim@mdanderson.org|
277677|NCT00607126|DAvdi Geffen School of Medicine at UCLA|Barbara Giesser,MD|310-825-7313|bgiesser@mednet.ucla.edu|
277678|NCT00607243|Seoul National University Hospital|Myoung-don Oh, M.D.|+82-2-2072-2945|mdohmd@snu.ac.kr|
277679|NCT00607269|Friends Research Institute, Inc.|Jesse B. Fletcher, Ph.D., Statistician|323-463-1601|jfletcher@friendsresearch.org|
277680|NCT00607321|Medtronic Cardiovascular|K Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
277681|NCT00607373|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
277682|NCT00607386|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
277683|NCT00607594|Cross Cancer Institute|Dr. Heather-Jane Au|780-432-8500|heathera@cancerboard.ab.ca|
277684|NCT00607620|University of Washington|Douglas Zatzick, MD|206-744-6701|dzatzick@uw.edu|206
277685|NCT00607672|Vanderbilt University School of Medicine|Dr. Mias Pretorius|16153430665|mias.pretorius@vanderbilt.edu|
277686|NCT00607724|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
277687|NCT00607789|Lindner Center of HOPE|Susan McElroy, MD|513-536-0718|susan.mcelroy@lindnercenter.org|
277688|NCT00607815|Cincinnati VA Medical Center|Dr. Kathleen M. Chard|859-572-6741|Kathleen.Chard@va.gov|
277689|NCT00607867|Minneapolis VA Health Care System, Metabolic Research Labortory|Mary C. Gannon, Ph.D.|6124672895|ganno004@umn.edu|
277690|NCT00607880|Mayo Clinic|Albert G. Hakaim, M.D.||Hakaim.Albert@mayo.edu|
277691|NCT00607893|Case Western Reserve University|Reena Mehra|216-445-1698|mehrar@ccf.org|
277692|NCT00607919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
277693|NCT00607997|Sunesis Pharmaceuticals, Inc.|Linda Neuman, Vice President, Clinical Development|(650) 266-3760|lneuman@sunesis.com|
287942|NCT01162343|Vanderbilt University Medical Center|Dr. Jin Han, MD|615-936-0253|jin.h.han@vanderbilt.edu|
287943|NCT01162421|AbbVie|Global Medical Information|800-633-9110||
287944|NCT01162473|The Children's Hospital of Philadelphia|Rushani W. Saltzman MD|215-590-2549|allergyandimmunology@email.chop.edu|
287945|NCT01162486|Johns Hopkins University School of Medicine|Dr. Kelly E. Dooley|410-955-3100|kdooley1@jhmi.edu|
287946|NCT01162499|Children's Hospital of Philadelphia|Diva De Leon, MD|267-426-5529|DELEON@email.chop.edu|
287947|NCT01162551|CHOP|Susan Rheingold, MD|215-590-2801|cancertrials@email.chop.edu|
287948|NCT01162733|Christiana Care Health System|Deb Marco|302 733-4130|dmarco@christianacare.org|
298535|NCT01823653|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
298536|NCT01823679|Stanford University Medical Center|Alexander Dimitrios Colevas, MD|650-724-9707|colevas@stanford.edu|
298537|NCT01823835|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
298538|NCT01823861|London School of Hygiene and Tropical Medicine|Dr. Chris Smith|07974562199|christopher.smith@lshtm.ac.uk|
298539|NCT01823991|H. Lee Moffitt Cancer Center and Research Institute|Dr. Nagi Kumar|813-745-6885|nagi.kumar@moffitt.org|
298540|NCT01824082|University of California San Diego|Brian M. Ilfeld|858-822-0776|bilfled@health.ucsd.edu|
298541|NCT01824160|Johns Hopkins University|RICHARD RINGEL|410-714-6745|rringel@jhmi.edu|
298542|NCT01824290|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
298543|NCT01824303|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
298544|NCT01824342|Amgen Inc.|Study Director|866-572-6436||
298545|NCT01824355|Ascensia Healthcare|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
298546|NCT01824394|Biosense Webster, Inc.|Megan Holden|(949) 923-4700|mholden8@its.jnj.com|
298547|NCT01824446|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
277694|NCT00608023|Theratechnologies|Jean-Claude Mamputu, PhD, Senior Medical Advisor|514-336-7800|jmamputu@theratech.com|
298548|NCT01824472|University of Pennsylvania|Dr. Nalaka Gooneratne|215 573 2048|ngoonera@upenn.edu|
287949|NCT01162863|University of Michigan|Dr. Richard J Saad|734-936-4780|rsaad@umich.edu|
287950|NCT01163032|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
287951|NCT01163097|Swedish Orphan Biovitrum|Medical Program Director|+46 8 697 20 00|clinical@sobi.com|
287952|NCT01163149|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
287953|NCT01163162|Indiana University|Dr. Rajiv Agarwal|317 988 2241|ragarwal@iu.edu|
287954|NCT01163214|Mayo Clinic|Mark J. Spangehl, M.D.|480-342-2377|spangehl.mark@mayo.edu|
287955|NCT01163253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287956|NCT01163266|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
287957|NCT01163279|Baycrest Health Sciences|Dr. Deirdre Dawson|416-785-2500|ddawson@research.baycrest.org|2136
287958|NCT01163292|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
287959|NCT01163318|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
287960|NCT01163461|VAMC Puget Sound|Dr. Diane Kendall (PI)|206-762-1010|diane.kendall@va.gov|
287961|NCT01163474|Houston VA HSR&D|Donna Smith/Project Coordinator|(713)440-4423|Donna.Smithd19d7@va.gov|
277695|NCT00608062|University of Colorado Anschutz Medical Campus|Dr. Kerrie Moreau. PI|303-724-1914|kerrie.moreau@cuanschutz.edu|
277696|NCT00608140|Duke University|Mary Ann Sellers|919-668-8544|maryann.sellers@duke.edu|
287962|NCT01163604|jinling hospital|xinfeng Liu|025-84801861|xfliu2@vip.163.com|
287963|NCT01163617|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
287964|NCT01163643|Bausch Health|Study Director||susan.harris@bauschhealth.com|
287965|NCT01163656|The Children's Hospital of Philadelphia|John Fiadjoe, MD|215-590-3916|fiadjoej@email.chop.edu|
287966|NCT01163721|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
287967|NCT01163747|Hoffman-LaRoche|Medical Communications|800-821-8590||
287968|NCT01163760|Vistakon|Kurt Moody OD, FAAO|904-443-3088||
287969|NCT01163786|Northwestern University|Clinical Trials at Northwestern University|312-695-6180|cancertrials@northwestern.edu|
287970|NCT01163851|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287971|NCT01163916|Abbott|Global Medical Services|800-633-9110||
287972|NCT01163955|Glinn and Giordano Physical Therapy|W. Brian Monroe, Doctor of Physical Therapy|661-832-9737|tandbmonroe@hotmail.com|
287973|NCT01164007|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
308838|NCT02615509|Philips AB|Daniel Stenströmer|+46 708 303 767|daniel.stenstromer@philips.com|
287974|NCT01164098|University of Miami|George W. Burke, M.D.|3053555315|gburke@med.miami.edu|
287975|NCT01164137|Westview Physician Collaborative|Allan Bailey, M.D.; Study Principal Investigator|(780)-975-1131|baileymd@telusplanet.net|
287976|NCT01164475|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
287977|NCT01164501|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
287978|NCT01164579|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
287979|NCT01164644|University of Wisconsin School of Medicine and Public Health|Dr. Scott R. Chaiet|(608) 263-1092|scottchaiet@yahoo.com|
287980|NCT01164722|AIDS Malignancy Consortium|Group Statistician|1-501-526-6712|jylee@uams.edu|
287981|NCT01164865|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
287982|NCT01164891|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
308839|NCT02615535|Spaulding Rehabilitation Hospital|Dr. Ginger Polich|617 952 5000|ginger.polich@mgh.harvard.edu|
287983|NCT01164956|Dana-Farber Cancer Institute|Christina K. Ullrich, MD, MPH|617.632.4997|Christina_Ullrich@dfci.harvard.edu|
287984|NCT01165021|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
287985|NCT01165047|Aurora Health Care|Katernie Slotke|414-649-2615|katherine.Slotke@aurora.org|
287986|NCT01165112|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
287987|NCT01165138|GlaxoSmithKline|GSK Response Center|866-435-7343||
287988|NCT01165177|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
287989|NCT01165203|GlaxoSmithKline|GSK Response Center|866-435-7343||
287990|NCT01165216|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
287991|NCT01165229|GlaxoSmithKline|GSK Response Center|866-435-7343||
287992|NCT01165242|GlaxoSmithKline|GSK Response Center|866-435-7343||
287993|NCT01165281|Janssen Pharm KK Japan|Medical Director|＋81-3-5509||
287994|NCT01165307|Mayo Clinic|Dr. Abimbola O. Famuyide|507-284-7035|Famuyide.Abimbola@mayo.edu|
287995|NCT01165320|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308840|NCT02615717|University of Nebraska, Lincoln|Christina Hein, M.A.|7036184722|chein9@gmail.com|
308841|NCT02615743|Children's Hospital of Philadelphia|Dr. Chen Kenyon, Faculty PolicyLab and Assistant Professor University of Pennsylvania|267-426-6339|kenyonc@email.chop.edu|
308842|NCT02616029|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
308843|NCT02616250|GALDERMA|Fabien AUDIBERT, Sr CPM|+33 (0) 4 9238 3034|fabien.audibert@galderma.com|
308844|NCT02616380|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
308845|NCT02616393|Kadmon Corporation|Miranda Ross|724-778-6170|Miranda.Ross@kadmon.com|
287996|NCT01165541|Geisel School of Medicine At Dartmouth|Mary Brunette, MD|603-271-7642|mary.brunette@dartmouth.edu|
287997|NCT01165554|GE Healthcare|Dr. Paul Sherwin|1-609-514-6820|paulsherwin@ge.com|
287998|NCT01165684|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
298549|NCT01824498|USDA, GFHNRC|Susan Raatz, PhD, RD|701-795-8294|susan.raatz@ars.usda.gov|
287999|NCT01165775|Stanford School of Medicine|Yasser El-Sayed, MD|(650) 723-3198|Yasser.el-sayed@stanford.edu|
288000|NCT01165840|Texas Tech University HSC|Ronald Hall|214-358-9009|ronald.hall@ttuhsc.edu|
288001|NCT01165983|Beth Israel Deaconess Medical Center|Aristidis Veves, Research Director|617-632-7075|aveves@bidmc.harvard.edu|
288002|NCT01165996|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Yogen Saunthararajah, MD|216-444-8170|saunthy@ccf.org|
288003|NCT01166126|H. Lee Moffitt Cancer Center and Research Institute|Ragini Kudchadkar, M.D.|813-745-8581|ragini.kudchadkar@moffitt.org|
288004|NCT01166139|Hospital For Special Surgery|Annel Fernandez|212 774 2123|fernandeza@hss.edu|
288005|NCT01166230|The University of Texas|H. Barton Grossman, MD|713-563-7456|hbgrossman@mdanderson.org|
288006|NCT01166282|AbbVie|Global Medical Information|800-633-9110||
288007|NCT01166347|Medtronic|Thomas Vassiliades|+15085321942|thomas.a.vassiliades@medtronic.com|
298550|NCT01824576|Advanced Circulatory|Sr. Clinical Research Associate|651.403.5606|nburkhart@zoll.com|
298551|NCT01824589|Advanced Circulatory|Sr. Clinical Research Associate|651.403.5600|nburkhart@advancedcirculatory.com|
298552|NCT01824602|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
298553|NCT01824693|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
298554|NCT01824823|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
298555|NCT01824901|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012||
308846|NCT02616523|University Clinical Center Ljubljana|dr. Lea Andjelković|0038615223810|lea.andjelkovic@gmail.com|
308847|NCT02616601|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
308848|NCT02616614|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
308849|NCT02616783|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
308850|NCT02616900|eSight Corporation|Rob Hilkes|613 276-4145|rhilkes@eSightcorp.com|
277697|NCT00608205|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Dr. David Adelstein|216-444-9310|adelstd@ccf.org|
288008|NCT01166373|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
308851|NCT02617589|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
277698|NCT00608244|Veloxis Pharmaceuticals A/S|Christina Sylvest|+45 20553877|csy@veloxis.com|
277699|NCT00608322|Cooper University Hospital|Stephen Trzeciak, MD, MPH|856-342-3342|trzeciak-stephen@cooperhealth.edu|
277700|NCT00608426|Center for Chronic Disease Outcomes Research|Steven Fu, Director|612-467-1979|steven.fu@va.gov|
277701|NCT00608491|Duke University|Jenny Ibarra|9192363291|jenny.ibarra@duke.edu|
277702|NCT00608517|Vanderbilt-Ingram Cancer Center|Brian Engelhardt, M.D.|615-936-1803||
277703|NCT00608530|VA San Diego Healthcare System|Joseph H. Atkinson MD, Principal Investigator|858 642 3775|joseph.atkinson@va.gov|
277704|NCT00608543|UT Southwestern Medical Center|Dr.Prabha Sunderajan|214-648-0156|prabha.sunderajan@utsouthwestern.edu|
277705|NCT00608569|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
277706|NCT00608582|VA Boston Healthcare System and Boston University School of Medicine|Margaret Naeser, PhD|857-364-4030|mnaeser@bu.edu|
277707|NCT00608634|Arizona Cancer Center|Steven P. Stratton, PhD|520-626-9295|sstratton@azcc.arizona.edu|
277708|NCT00608829|W.L. Gore and Associates|Abe Letter|928 864 3113|aletter@wlgore.com|
277709|NCT00608842|Kythera Biopharmaceuticals, Inc.|Clinical Trial Disclosure||clinical_trials@kythera.com|
277710|NCT00608868|Medical, Astrazeneca Korea|Hui Jung Sin||huijung.sin@astrazeneca.com|
277711|NCT00608881|Massachusetts General Hospital|Dr. Merit Cudkowicz|617-726-0813|mcudkowicz@partners.org|
277712|NCT00608894|Veloxis Pharmaceuticals, Inc.|Director, Regulatory Affairs|919-591-3090|bbu@veloxis.com|
277713|NCT00608907|Johnson & Johnson Pharmaceutical Research & Development|Helgi van de Velde, MD, PhD||HVDVELDE@ITS.JNJ.COM|
277714|NCT00608959|Cadence Pharmaceuticals, Inc|Catherine J Hardalo, MD Vice President, Anti-Infectives Clinical Development|858 4361439|chardalo@cadencepharm.com|
277715|NCT00608985|Actelion Pharmaceuticals Ltd|Ouali Berkani/Clinical Trial Leader|+41 61 565 5342||
277716|NCT00609128|University of Wisconsin-Madison|Jim Stahl, PhD|608-263-6177|jlstahl@wisc.edu|
288009|NCT01166386|Carolinas Healthcare System, Carolinas Medical Center|Dr. Janet Niemeier|704 355 2046|janet.niemeier@carolinashealthcare.org|
288010|NCT01166438|RTI International|Dr. Marie Gantz|919-597-5110|mgantz@rti.org|
288011|NCT01166568|Refocus Group, Inc.|Director of Regulatory & Quality|214-368-0200|lstewart@refocus-group.com|431
288012|NCT01166646|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
288013|NCT01166659|Transcend Medical, Inc.|Vice President of Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
288014|NCT01166750|University of Kansas Medical Center|Michael A. Rapoff, PhD., Principal Investigator|913-588-6323|mrapoff@kumc.edu|
288015|NCT01166763|University of Kansas Medical Center|Bruce F. Kimler, Ph.D.|913-588-4523|bkimler@kumc.edu|
288016|NCT01166945|University of Wisconsin School of Medicine and Public Health|Ellen Wald, MD|608-263-8558|erwald@pediatrics.wisc.edu|
288017|NCT01166958|University of Wisconsin Osteoporosis Clinical Research Program|Neil Binkley, MD|608-265-6410|uwosteoporosis@gmail.com|
288018|NCT01166971|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
288019|NCT01166984|AtoxBio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1 919-219-6377|wayned@atoxbio.com|
288020|NCT01166997|EKOS Corporation|Lynn Allen|4254153100|Lynn.Allen@ekoscorp.com|
288021|NCT01167023|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288022|NCT01167140|Myoscience|Francis Rogers Palmer III, MD|650-474-2600|thenry@myoscience.com|
288023|NCT01167153|Novartis Pharmaceuticals|Study Director|862-778-8300||
288024|NCT01167179|Radboud University Nijmegen Medical Center|Jacqueline de Leeuw MSc|+31243614925|j.deleeuw@kno.umcn.nl|
288025|NCT01167192|Washington University School of Medicine|Rebecca Aft, M.D., Ph.D.|314-747-0063|aftr@wustl.edu|
288026|NCT01167257|Department of Urology, Buddhist Tzu Chi General Hospital and Tzu Chi University|Dr. Hann-Chorng Kuo|886-3-8561825|hck@tzuchi.com.tw|2113
288027|NCT01167426|Teva Pharmaceuticals Medical Affairs|Thomas Smith, MD|816-508-5128|tom.smith@tevapharm.com|
288028|NCT01167452|Texas Tech University Health Sciences Center|Ronald Hall, PharmD, MSCS|214-358-9009|ronald.hall@ttuhsc.edu|
298556|NCT01824979|Fisher and Paykel Healthcare|Clinical Research Scientist|+ 64 09 574 0100|CPAPtrial@fphcare.co.nz|
288029|NCT01167504|Institute of Food Research|Professor Peter Wilde|+441603255258|peter.wilde@ifr.ac.uk|
277717|NCT00609167|Mayo Clinic|Dr. A. Keith Stewart||stewart.keith@mayo.edu|
277718|NCT00609245|Vanderbilt University Medical Center|Bassel Abou-Khalil, MD|615-936-0060|bassel.abou-khalil@vanderbilt.edu|
277719|NCT00609271|Tulane University|Dr. Lydia Bazzano|5049887323|lbazzano@tulane.edu|
277720|NCT00609336|University of Washington|Andrew Coveler, MD|206-288-7509|acoveler@uw.edu|
277721|NCT00609362|University of Aarhus|Torben Harsløf, MD|+4589497681|torbhars@rm.dk|
277722|NCT00609466|Grunenthal|René Allard|49 241 569 3223|Clinical-Trials@grunenthal.com|
277723|NCT00609492|GlaxoSmithKline|GSK Response Center|866-435-7343||
298557|NCT01825057|Yale School of Medicine|Steve Martino|203-932-5711|steve.martino@yale.edu|7418
277724|NCT00609518|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
277725|NCT00609609|The University of Texas (UT) MD Anderson Cancer Center|Dr. Amin Majid Alousi, Associate Professor, Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
277726|NCT00609622|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277727|NCT00609674|GlaxoSmithKline|GSK Response Center|866-435-7343||
277728|NCT00609739|Masonic Cancer Center, University of Minnesota|Margaret MacMillan, M.D.|612-626-2778|macmi002@umn.edu|
277729|NCT00609804|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
277730|NCT00609869|H. Lee Moffitt Cancer Center and Research Institute|Javier Pinilla-Ibarz|813-745-1387|javier.pinilla@moffitt.org|
277731|NCT00609947|Medtronic CardioVascular|Lynda Chaplin - Study Manager|(707) 543-5459|lynda.chaplin@medtronic.com|
277732|NCT00609973|University of North Carolina|Hans Herfarth|9199666806|hherf@med.unc.edu|
277733|NCT00609986|Medical University of South Carolina|Dr. Kathie Hermayer|843-792-2529|hermayer@musc.edu|
277734|NCT00610116|Department of Cardiology and Rhythmology, Augusta Hospital, Duesseldorf, Germany.|Joachim Winter, MD|+49 (0) 2118|joachim.winter@uniklinik-duesseldorf.de|1173
298558|NCT01825122|Invion, Inc.|Mitchell Glass, M.D., EVP of R&D|+61 7 3295 0500|mitchell.glass@inviongroup.com|
277735|NCT00610129|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy|646-888-4185|ReidyD@mskcc.org|
277736|NCT00610155|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277737|NCT00610168|GlaxoSmithKline|GSK Response Center|866-435-7343||
288030|NCT01167569|Rutgers RWJMS|Alan Spotnitz, MD|732-235-9806|spotnitz@rwjms.rutgers.edu|
288031|NCT01167582|Rutgers University|Jeffrey Carson|732-235-7122|jeffrey.carson@rutgers.edu|
288032|NCT01167595|CERU Queen's University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
288033|NCT01167608|Rutgers-Robert Wood Johnson Medical School|Dr. Roseanne Dobkin, Associate Professor of Psychiatry|732-235-4051|dobkinro@rutgers.edu|
298559|NCT01825200|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
288034|NCT01167634|University of Pennsylvania School of Medicine|Laurie Norton|2155738799|lanorton@mail.med.upenn.edu|215
298560|NCT01825408|UNC Department of Otolaryngology|Dr. Adam Zanation||adam_zanation@med.unc.edu|
288035|NCT01167712|NRG Oncology|Linda Gedeon for Mark Brady, PhD.|716-845-1169|lgedeon@gogstats.org|
288036|NCT01167829|University of Washington, Dept. of Medicine|John Amory, MD|(206) 616-1727|jamory@u.washington.edu|
288037|NCT01167881|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288038|NCT01167907|Wake Forest School of Medicine|Robert S. Weller, MD|336-716-7150|rweller@wakehealth.edu|
288039|NCT01168024|Osprey Medical|VP Of Clinial Affairs|952-955-8230|mshepard@ospreymed.com|
288040|NCT01168232|NRG Oncology Statistics and Data Management Center - Buffalo Office|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
288041|NCT01168349|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
288042|NCT01168401|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
288043|NCT01168427|Medtronic - CRDM|RIO Clinical Research Specialist.|1-800-328-2518|MedtronicCRMtrials@medtronic.com|63277
288044|NCT01168596|University of Florida Center for Movement Disorders and Neurorestoration|Irene A. Malaty, MD|352-273-5550|Irene.Malaty@neurology.ufl.edu|
298561|NCT01825512|Consorzio per Valutazioni Biologiche e Farmacologiche|Donato Bonifazi|+393936698076|ceo@cvbf.net|
288045|NCT01168674|Tufts Medical Center|Dr. Nassir Ghaemi|6176365735|nghaemi@tuftsmedicalcenter.org|
288046|NCT01168687|Ernest Gallo Clinic and Research Center, UCSF|Jennifer Mitchell, Clinical Project Director|510-985-3100|jmitchell@gallo.ucsf.edu|
288047|NCT01168726|University of Missouri|Dr. Matthew P. Martens, Professor; Division Executive Director|573-882-3382|martensmp@missouri.edu|
288048|NCT01168856|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
298562|NCT01825577|Saint Louis University|Dr. Ahsan Khan|314-977-4826|khanay@slu.edu|
298563|NCT01825655|Virginia Commonwealth University|Santhosh Kumar, MD|804-628-1605|santhosh.kumar@vcuhealth.org|
298564|NCT01825785|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
298565|NCT01825798|Holland Bloorview Kids Rehabilition Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
277738|NCT00610207|Cook Biotech, Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@CookBiotech.com|
298566|NCT01825837|BIAL - Portela & Ca, SA|Head of Clinical Research Section|351 22 986 6100|clinical.trials@bial.com|
298567|NCT01825876|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
277739|NCT00610311|National Cancer Institute, National Institues of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
277740|NCT00610363|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management||clinicaltrials@regeneron.com|
277741|NCT00610428|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
277742|NCT00610441|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
277743|NCT00610480|UT Southwestern Medical Center|Peter Chen|214-648-3837|peter.chen@utsouthwestern.edu|
277744|NCT00610649|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
277745|NCT00610675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
277746|NCT00610688|Cincinnati Children's Hospital Medical Center|Dr. Adekunle Dawodu|513-636-1966|Adekunle.Dawodu@cchmc.org|
277747|NCT00610701|University of Missouri|Brett D. Crist, MD|5738826562|cristb@health.missouri.edu|
277748|NCT00610714|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
277749|NCT00610727|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
277750|NCT00610740|Masonic Cancer Center, University of Minnesota|Levi Downs, Jr., M.D.|612-626-6628|downs008@umn.edu|
277751|NCT00610857|University of Pittsburgh Cancer Institute|Ahmad Tarhini, MD|4126486507|tarhiniaa@upmc.edu|
277752|NCT00610883|Memorial Sloan Kettering Cancer Center|Dr. Tanya Trippett|212-639-8267|trippet1@mskcc.org|
298568|NCT01825889|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
277753|NCT00610935|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
277754|NCT00610987|University of Missouri, Department of Orthopaedics|Dr. Brett Crist|573-882-6562|cristb@health.missouri.edu|
277755|NCT00611026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277756|NCT00611130|Catalyst Pharmaceutical Partners, Inc.|M Douglas Winship|305-529-2522|dwinship@catalystpharma.com|12
277757|NCT00611247|Stanford University Medical Center|Bruno C Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
277758|NCT00611325|Duke University Medical Center|Dr. Katherine B. Peters|(919) 684-6173|katherine.peters@duke.edu|
277759|NCT00611351|University of Nebraska Medical Center|Lori Maness-Harris, MD|402-559-3848|lmaness@unmc.edu|
288049|NCT01168908|Kennedy Krieger Institute|Kathryn Wagner, MD, PhD|443-923-9525|wagnerk@kennedykrieger.org|
288050|NCT01168934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288051|NCT01168973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288052|NCT01168986|University of Florida|Joel Bialosky, PT, PhD|352-273-8636|jbialosky@phhp.ufl.edu|
288053|NCT01168999|University of Florida|Dr. Joel Bialosky|352-273-8636|bialosky@phhp.ufl.edu|
288054|NCT01169038|Vanderbilt University|Wonder Drake|615-322-2035|wonder.drake@vanderbilt.edu|
288055|NCT01169064|Vanderbilt University Medical Ctr., Dept OB/GYN|Dr. Kelly Bennett; Director of Maternal Fetal Medicine|6153436275|kelly.a.bennett@vanderbilt.edu|
288056|NCT01169103|Massachusetts General Hospital|Madhusmita Misra|617-724-5602|mmisra@partners.org|
288057|NCT01169259|Brigham and Women's Hospital; 900 Commonwealth Ave, 3rd fl.; Boston, MA 02215|VITAL Study Director|1-800-388-3963|vitalstudy@partners.org|
288058|NCT01169311|Covidien|Tam LaFleur|203-821-4744|tam.lafleur@covidien.com|
288059|NCT01169337|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
288060|NCT01169350|University of Washington|Dr. Janet F. Eary|206-598-6244|jeary@uw.edu|
288061|NCT01169467|Duke University Medical Center|Dr. Keith Dombrowski|(919)|keith.dombrowski@dm.duke.edu|
288062|NCT01169493|Duke University Medical Center|Brett D. Atwater, MD|9196848111|brett.atwater@duke.edu|
288063|NCT01169519|Duke University Medical Center|Dr. Kevin Hill|919-668-8305|kevin.hill@duke.edu|
288064|NCT01169532|Fox Chase Cancer Center|Elizabeth Plimack|215-728-3889|Elizabeth.Plimack@fccc.edu|
288065|NCT01169558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
288066|NCT01169636|UT MD Anderson Cancer Center|Dr. Christopher Flowers, MD/ Chair, Chair, Lymphoma-Myeloma|713-745-6095|crflowers@mdanderson.org|
288067|NCT01169649|Memorial Sloan Kettering Cancer Center|Dr. Diane Reidy-Lagunes|646-888-4185|reidyd@mskcc.org|
288068|NCT01169675|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288069|NCT01169701|Novartis Pharmaceuticals|Study Director|862-778-8300||
288070|NCT01169779|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
288071|NCT01169844|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
288072|NCT01169987|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
288073|NCT01170039|Emory University|Jennifer Christie|404-778-4594|jchris6@emory.edu|
288074|NCT01170065|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288075|NCT01170091|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288076|NCT01170117|Columbia Center for Eating Disorders|Dr. Evelyn Attia|646-774-8085|ea12@cumc.columbia.edu|
288077|NCT01170208|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
288078|NCT01170221|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|Philippe.Prokocimer@cubist.com|241
288079|NCT01170247|University of Iowa|Brett Faine|319-310-8067|brett-faine@uiowa.edu|
288080|NCT01170273|Miami VA Medical Center|Silvina Levis MD|305-575-3388|silvina.levis-dusseau@va.gov|
298569|NCT01825941|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|718-920-6266|befriedm@montefiore.org|
288081|NCT01170364|NYPInstitute|Dr. Laurel Mayer|646-774-8067|lsm16@columbia.edu|
288082|NCT01170390|Oregon Health & Science University|Dr. Alison Edelman|503.418.2585|edelmana@ohsu.edu|
288083|NCT01170533|University of Florida-Jacksonville|Dominick J. Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
308852|NCT02617628|University of Pennsylvania Office of Research Services|W. Stuart Watson|215-573-6707|wswatson@upenn.edu|
277760|NCT00611403|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
277761|NCT00611442|Carl R Darnall Army Medical Center|Dr. Joel Stengel|2545531804|joel.stengel@us.army.mil|
277762|NCT00611455|GlaxoSmithKline|GSK Response Center|866-435-7343||
277763|NCT00611468|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs||mwalker@acorncro.com|
277764|NCT00611533|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
277765|NCT00611559|GlaxoSmithKline|GSK Response Center|866-435-7343||
277766|NCT00611624|Yale Comprehensive Cancer Center|Kira F. Pavlik, CCRP Clinical Research Coordinator Therapeutic Radiology|(203) 737-2587|kira.pavlik@yale.edu|
277767|NCT00611715|Vanderbilt-Ingram Cancer Center|Ingrid Mayer, MD|615-936-2033|ingrid.mayer@vanderbilt.edu|
277768|NCT00611767|Yale University School of Medicine|Dr. Ismene L. Petrakis, Professor of Psychiatry|203-932-5711|Ismene.petrakis@yale.edu|2244
277769|NCT00611806|Massachusetts General Hospital|Joshua L. Roffman, MD|617-724-1920|jroffman@partners.org|
277770|NCT00611858|Dana-Farber Cancer Institute|Jeffrey Meyerhardt, MD, MPH|617-632-6855|Jeffrey_Meyerhardt@dfci.harvard.edu|
277771|NCT00611884|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
277772|NCT00611897|Yale School of Medicine, Department of Psychiatry|Handan Gunduz-Bruce, MD|(203) 785-2117|handan.gunduz-bruce@yale.edu|
277773|NCT00611923|Weill Cornell Medical College and Yale School of Medicine|Margaret Altemus|646-209-6277|maltemus@med.cornell.edu|
277774|NCT00611975|Yale School of Medicine|Margaret Altemus|646-209-6277|margaret.altemus@yale.edu|
277775|NCT00612040|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
277776|NCT00612066|University of California, Los Angeles|Anthony Heaney, M.D. Ph.D|310 267 4980|aheaney@mednet.ucla.edu|
277777|NCT00612105|Valeant Pharmaceuticals International, Inc.|Associate Director Clinical Operations|919-294-3080|david.lineberry@valeant.com|
308853|NCT02617667|Novaliq GmbH|Dr Sonja Krösser, VP Preclinical and Clinical Development|+49 6221 50259-0||
277778|NCT00612222|National Cancer Institute (NCI), National Institutes of Health (NIH)|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
277779|NCT00612235|Beth Israel Deaconess Medical Center|Andrew G. Herzog M.D., M.Sc.|781-431-0277|aherzog@bidmc.harvard.edu|
277780|NCT00612313|UT Southwestern Medical Center|Dr. Graham Emslie and Dr. Betsy Kennard|214-456-5900|beth.kennard@utsouthwestern.edu|
288084|NCT01170546|Department of Physical Medicine and Rehabilitation, Chang Gung Memorial Hospital|Shih-Wei Chou, MD, PhD|88633281200|h0711@ms13.hinet.net|3846
288085|NCT01170598|University Health Network|Sara O'Neill|416-597-3422|o'neill.sara@torontorehab.on.ca|7860
288086|NCT01170663|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288087|NCT01170715|Rockefeller University|James G. Krueger MD, PhD|212-327-7730|kruegej@rockefeller.edu|
288088|NCT01170754|Temple University|Frank Friedenberg, MD|215-707-9900|frank.friedenberg@temple.edu|
298570|NCT01826201|Moleculin, LLC|Chief Medical Officer|713-953-7676|Carena@moleculin.com|232
298571|NCT01826214|Novartis Pharmaceuticals|Study Director|82-778-8300|trialandresults.registries@novartis.com|
298572|NCT01826227|Memorial Sloan Kettering Cancer Center|Dennis Chi, MD|212-639-5016|chid@mskcc.org|
298573|NCT01826370|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298574|NCT01826422|IMSS|Dr. Maricela Rodriguez-Cruz|5256276900|maricela.rodriguez.cruz@gmail.com|. 22483
298575|NCT01826448|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
298576|NCT01826487|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
298577|NCT01826513|University of Western Australia|Prof. David Hillman & Prof. Peter Eastwood|+61 8 9346 1706|peter.eastwood@health.wa.gov.au|
298578|NCT01826604|Saint Louis University|Dr. Katherine M. Scolari Childress|314-977-2090|scolarik@slu.edu|
298579|NCT01826812|The Wilmer Eye Institute, Johns Hopkins|Dr. Esen K. Akpek|410-955-5214|esakpek@jhmi.edu|
298580|NCT01826825|Brigham and Women's Hospital|Deborah J. Culley, M.D., Principal Investigator|6177327330|dculley@bwh.harvard.edu|
298581|NCT01826851|URochester|Peter A. Knight, MD|(585) 275-6340|Peter_Knight@URMC.Rochester.edu|
298582|NCT01826981|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
298583|NCT01827046|Johns Hopkins University Division of Brain Injury Outcomes|Dr. Daniel F. Hanley|4106146996|dhanley@jhmi.edu|
298584|NCT01827163|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang, MD|914-367-7181|dangc@mskcc.org|
298585|NCT01827254|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298586|NCT01827267|Puma Biotechnology|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
298587|NCT01827306|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|7179915595|jslaski@ssrehab.com|
298588|NCT01827319|CryoLife, Inc.|Scott Capps|800-438-8285|brown.carolyn@cryolife.com|
298589|NCT01827332|MUSC|Aimee McRae-Clark|843-792-5216|mcraeal@musc.edu|
298590|NCT01827358|University of Maryland Medical Center|Karen Kotloff, MD|410-706-5328|kkotloff@medicine.umaryland.edu|
298591|NCT01827371|Group Health Research Institute|Lisa Jackson, M.D., M.P.H.|206-442-5216|Jackson.L@ghc.org|
298592|NCT01827462|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
298593|NCT01827475|Emergency Medicine, Stony Brook U|Dr. Adam Singer|631 444 7856|adam.singer@stonybrook.edu|
298594|NCT01827592|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
298595|NCT01827670|GlaxoSmithKline|GSK Response Center|866-435-7343||
298596|NCT01827787|Dana-Farber Cancer Institute|Dr. Erica Mayer|617-632-2335|Erica_Mayer@dfci.harvard.edu|
288089|NCT01170884|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
277781|NCT00612339|Duke University Medical Center|Katherine Peters, MD, PhD|9196846173|katherine.peters@duke.edu|
277782|NCT00612352|Yale University|Ismene Petrakis||ismene.petrakis@yale.edu|
277783|NCT00612430|Duke University Medical Center|David Reardon, MD|919-668-2329|David_Reardon@DFCI.harvard.edu|
277784|NCT00612456|GlaxoSmithKline|GSK Response Center|866-435-7343||
277785|NCT00612508|Women's Health Research Unit|Oregon Health & Science University|503-494-3666|whru@ohsu.edu|
277786|NCT00612534|AcelRx|Pamela Palmer, MD PhD|650-216-3500|ppalmer@acelrx.com|
298597|NCT01827839|GlaxoSmithKline|GSK Response Center|866-435-7343||
277787|NCT00612560|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
277788|NCT00612573|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
277789|NCT00612586|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
277790|NCT00612690|University of Illinois at Chicago|Marc S. Atkins, Ph.D.|312-413-1048|atkins@uic.edu|
277791|NCT00612716|Masonic Cancer Center, University of Minnesota|Dr. Daniel J.Weisdorf, M.D|612 624-3101|weisd001@umn.edu|
277792|NCT00612768|SmartPractice|Kathy Shannon|602-225-0595|kshannon@smarthealth.com|7208
277793|NCT00612807|Duke University Medical Center|Jill Compton, Ph.D.|919-416-2089|compton@duke.edu|
277794|NCT00612924|Terumo|Amanda Isula, Clinical Research Coordinator|800-262-3304|amanda.isula@terumomedical.com|5549
277795|NCT00613015|MUSC|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
277796|NCT00613028|Preston Robert Tisch Brain Tumor Center at Duke|David A. Reardon, MD|919-668-1409|reard003@mc.duke.edu|
288090|NCT01170949|University Charité Berlin|Markus Magerl|+4930450618304|markus.magerl@charite.de|
288091|NCT01170962|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
288092|NCT01171118|University of Rochester|Dr. Suzanne Karan|585-275-5161|suzanne_karan@urmc.rochester.edu|
288093|NCT01171183|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
288094|NCT01171521|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
288095|NCT01171612|Corporacion Sanitaria y Universitaria Parc Tauli|Anna Rodriguez-Pont|0034937231010|anna.r.pont@gmail.com|21283
288096|NCT01171625|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
288097|NCT01171677|NYUMED|John Rotrosen|212 951 3294|john.rotrosen@nyumc.org|
288098|NCT01171690|Mayo Clinic|Marius Stan, MD|507-284-2463|stan.marius@mayo.edu|
288099|NCT01171794|Stanford University School of Medicine|Grant S Lipman ( PI)|4152909286|lipmangrant@gmail.com|
288100|NCT01171820|Abbott Vascular|Robert Smith Jr, Ph.D., Sr Clinical Research Scientist|408-845-8265|robert.smithjr@av.abbott.com|
298598|NCT01827930|Institut Bergonié|Pr Simone Mathoulin-Pelissier|05 56 33 33 33|S.Mathoulin@bordeaux.unicancer.fr|
298599|NCT01827943|Institut Bergonie|Dr Nadine Houede, oncologist|05.56.33.33.33|nadine.HOUEDE@chu-nimes.fr|
298600|NCT01828034|Memorial Sloan Kettering Cancer Center|Dr. Ghassan Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
298601|NCT01828073|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
298602|NCT01828112|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
298603|NCT01828164|SmileSonica Inc.|John Simon, Regulatory Affairs Manager|780-975-0095|john@johnsimon.ca|
298604|NCT01828216|Chinese University of Hong Kong|David SC Hui|852 2632 2211|dschui@cuhk.edu.hk|
298605|NCT01828255|The New York Eye and Ear Infirmary|Dr Gustavo De Moraes|+1 212 477 7540|demoraesmd@gmail.com|
298606|NCT01828281|Chinese University of Hong Kong|Prof David SC Hui|2632 3134|dschui@cuhk.edu.hk|
298607|NCT01828476|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|732-235-5773|steinmn@cinj.rutgers.edu|
298608|NCT01828515|UT Southwestern Medical Center|Dr. E. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
298609|NCT01828554|University of Madison Carbone Cancer Center|Kari B. Wisinski|(608) 262-2876|kbwisinski@medicine.wisc.edu|
298610|NCT01828567|Durham VA Center of Innovation in Primary Care|Eugene Z Oddone, MD, MPSc|919-286-0411|eugene.oddone@va.gov|
298611|NCT01828593|Entera Health|Senior Director, Clinical Research|515-963-7565|audrey.shaw@enterahealth.com|
298612|NCT01828983|Memphis VA Medical Center|Dr. Linda Nichols|901 523-8990|linda.nichols@va.gov|5082
298613|NCT01829048|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298614|NCT01829113|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
298615|NCT01829165|Stanford University|Amit Etkin, MD, PhD|(650) 725-5736|aetkin@stanford.edu|
298616|NCT01829191|Vistakon, USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
298617|NCT01829217|Dana-Farber Cancer Institute|Principal Investigator: Geoffrey Oxnard, MD|617-632-6049|geoffrey_oxnard@dfci.harvard.edu|
298618|NCT01829230|Vistakon USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
298619|NCT01829243|Duke University Medical Center|Ashwin A. Patkar, MD|919-668-3626|ashwin.patkar@duke.edu|
298620|NCT01829295|F.I. Proctor Foundation, UCSF|Dr. Nisha Acharya|4154768131|Nisha.Acharya@ucsf.edu|
298621|NCT01829347|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
298622|NCT01829360|University of Kansas|Holly Storkel|7858640099|hstorkel@ku.edu|
298623|NCT01829399|Anesthesiology Department, University of NC at Chapel Hill|Randall F. Coombs, M.D.|919-966-5136|rcoombs@aims.unc.edu|
298624|NCT01829425|University of New Mexico|Dr. Yuko Komesu|5052490726|ykomesu@salud.unm.edu|
298625|NCT01829464|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
288101|NCT01171924|Curis, Inc.|Associate Director of Regulatory Affairs|(617) 503-6548|lsaunders@curis.com|
288102|NCT01171963|GlaxoSmithKline|GSK Response Center|866-435-7343||
288103|NCT01171976|Novartis Pharmaceuticals|Study Director|862-778-8300||
277797|NCT00613080|Radiation Therapy Oncology Group (RTOG)|Wendy Seiferheld||wseiferheld@acr.com|
277798|NCT00613106|Horizon Pharma, Inc.|Amy Grahn, MS Senior Vice President, Clinical Development and Operations|224-383-3012|agrahn@horizonpharma.com|
277799|NCT00613171|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
277800|NCT00613301|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277801|NCT00613314|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277802|NCT00613327|Medical Affairs, Janssen Korea|Clinical Research Associate|+82-2-2094-4935||
277803|NCT00613366|Oregon Health & Science University|Dr. Alison Edelman|503.494.5949|edelmana@ohsu.edu|
277804|NCT00613379|Cytodyn, Inc.|Dr. Nader Pourhassan|360-980-8524|npourhassan@cytodyn.com|
277805|NCT00613405|Medical University of South Carolina|Aimee McRae-Clark, PharmD|843-792-5126|mcraeal@musc.edu|
277806|NCT00613509|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
277807|NCT00613574|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277808|NCT00613626|Hoosier Cancer Research Network|Georgia Gould|317-921-2050|ggould@hoosiercancer.org|
277809|NCT00613821|Oregon Health & Science University|Dr. Alison Edelman|503-494-3666|whru@ohsu.edu|
277810|NCT00613834|The Ohio State University|Dr. Michelle Isley|614-293-4203|Michelle.Isley@osumc.edu|
277811|NCT00613925|Oregon health & Science University|Alison Edelman, Associate Professor|503-418-2585|edelmana@ohsu.edu|
277812|NCT00613938|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Leader|609-730-4537||
277813|NCT00613951|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
277814|NCT00614055|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
277815|NCT00614120|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
277816|NCT00614198|Center for Autisme|Lennart Pedersen|44982355|lpe@centerforautisme.dk|
277817|NCT00614315|Bard Peripheral Vascular, Inc.|John Reviere, Director, Clinical Affairs|480-303-2644|John.Reviere@crbard.com|
277818|NCT00614380|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277819|NCT00614393|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
277820|NCT00614406|Oregon Health and Sciences University|Allison Edelman, MD, MPH|503-494-5949|edelmana@ohsu.edu|
288104|NCT01171989|GlaxoSmithKline|GSK Response Center|866-435-7343||
288105|NCT01172067|CRT, Global Clinical Affairs, Cardiac Arrhythmias and Heart Failure, Abbott Medical Devices|Clay Cohorn, Program Director|+1 972 309 8087|clay.cohorn@abbott.com|
288106|NCT01172145|Brown University|Laura L. Frakey|401-729-3163|lfrakey@gmail.com|
288107|NCT01172184|Kaohsiung veterans general hospital|Dr. Shih-Hung Hsiao|886-7-3422121|irb@vghks.gov.tw|1518
288108|NCT01172197|NHS Tayside|Dr G McLeod|+44 1382 7974440848|g.a.mcleod@dundee.ac.uk|
288109|NCT01172275|Yale University|Dr. Michael H. Bloch|203-737-4809|michael.bloch@yale.edu|
288110|NCT01172288|Yale University- School of Medicine|Associate Professor|(203)737-4809|michael.bloch@yale.edu|
288111|NCT01172353|Hospital Sao Lucas|Vitor Osório Gomes, MD, PhD|55 51 33203494|pesquisa@cardiarte.com.br|
288112|NCT01172418|University of Miami|George W. Burke, M.D.|305-355-5315|gburke@med.miami.edu|
288113|NCT01172522|ConnecticutSC|Edward M. Lane|2033720009|EMLMD@msn.com|
288114|NCT01172535|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
288115|NCT01172600|Cleveland Clinic|Alparslan Turan, MD|216-445-9857|turana@ccf.org|
288116|NCT01172639|University Hospitals Leuven|Prof. Dr. Patrick Verschueren|+32 16 34 25 41|patrick.verschueren@uzleuven.be|
288117|NCT01172808|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288118|NCT01172821|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288119|NCT01172847|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
288120|NCT01172873|New York State Psychiatric Institute/Columbia University|Moira A. Rynn, M.D.|646-774-5805|RynnM@nyspi.columbia.edu|
288121|NCT01172938|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|clinicaltrialdisclosure@celgene.com|
288122|NCT01173016|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
288123|NCT01173029|Universidade Gama Filho|Paulo Robeto Benchimol Barbosa|+55-21-95320182|ecgar@yahoo.com|
288124|NCT01173055|University of Michigan|Daniel Clauw, MD|734-998-6901|dclauw@med.umich.edu|
288125|NCT01173120|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
288126|NCT01173159|Cincinnati Children's Hospital Medical Center|Crystal Slaughter, BA, CCRC|513-636-0137|crystal.slaughter@cchmc.org|
288127|NCT01173211|Baylor College of Medicine|Shital M. Patel, M.D.|713-798-3793|shitalp@bcm.edu|
288128|NCT01173471|AstraZeneca|Stuart McIntosh||ClinicalTrialTransparency@astrazeneca.com|
288129|NCT01173523|Dana-Farber Cancer Institute|David M. Jackman, MD|617.632.3468||
288130|NCT01173601|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288131|NCT01173653|Vanderbilt University Emergency Medicine Department|Benjamin Heavrin, MD|615-936-0253-|benjamin.heavrin@vanderbilt.edu|
288132|NCT01173679|Massachusetts General Hospital|Philip C. Amrein, M.D.|6177243456|pamrein@partners.org|
288133|NCT01173692|UT MD Anderson Cancer Center|Brandon Gunn, MD/ Associate Professor, Radiation Oncology Department|(713) 563-2562|gbgunn@mdanderson.org|
288134|NCT01173718|W. L. Gore & Associates|Debby Pfile, Clinical Research Associate|623-234-5226|dpfile@wlgore.com|
288135|NCT01173848|Cleveland Clinic|Dr. James Simon|216-445-4891|simonj2@ccf.org|
288136|NCT01173874|New York State Psychiatric Institute|Dr. Joshua Kantrowitz|646-774-8436|mcarlson@nyspi.columbia.edu|
288137|NCT01174004|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
277821|NCT00614432|University of Hawaii|Investigator|808-203-6500|whrc@hawaii.edu|
277822|NCT00614445|Duchesnay, Inc.|Michael Gallo|450-433-7734|mgallo@duchesnay.com|
277823|NCT00614458|UNC Chapel Hill|Professor of Medicine, Director Translational Research IGHID|919 966 6388|dmargo@med.unc.edu|
277824|NCT00614484|Professor of Radiation Medicine, Loma Linda University Medical Center|David Bush MD|909-558-4280|dbush@llu.edu|
277825|NCT00614523|Amgen Inc.|Study Director|866-572-6436||
277826|NCT00614575|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277827|NCT00614614|GlaxoSmithKline|GSK Response Center|866-435-7343||
277828|NCT00614744|Brown University, Women & Infants Hospital of Rhode Island|Abbot Laptook|401-274-1122|alaptook@wihri.org|47421
277829|NCT00614822|Christiana Care Health System|Dr. Michael Guarino|302 366 1200|mguarino@cbg.org|
277830|NCT00614874|Creighton University School of Medicine|Dr. Tammy Wichman|402-449-4486|wichman@creighton.edu|
277831|NCT00614913|Radiation Medicine - Loma Linda University Medical Center|David Bush MD|909-558-4280|dbush@dominion.llumc.edu|
277832|NCT00614926|Columbia University|Judith Rabkin, PhD|212 543 5762|jgr1@columbia.edu|
277833|NCT00614939|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
277834|NCT00614991|Garden State Infectious Disease Associates|David Condoluci|856-566-3190|dcondoluci@gsida.org|
277835|NCT00615017|AstraZeneca|Justin Lindemann||ClinicalTrialTransparency@astrazeneca.com|
277836|NCT00615030|Novartis Pharmaceuticals|Study Director|862-778-8300||
277837|NCT00615056|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277838|NCT00615069|W.L. Gore and Associates|Jennifer Gorman|928 864 3381|jgorman@wlgore.com|
277839|NCT00615108|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277840|NCT00615199|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277841|NCT00615264|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
277842|NCT00615290|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277843|NCT00615420|BC Cancer|Dr. Philippa Hawley|(604) 877-6000|phawley@bccancer.bc.ca|67-2752
277844|NCT00615433|Sunovion Pharmacetuicals Inc.|Josephine Cucchiaro, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
277845|NCT00615459|Novartis Pharmaceuticals|Study Director|862-778-8300||
277846|NCT00615472|Columbia University|Eric J Heyer|212-305-9072|ejh3@cumc.columbia.edu|
277847|NCT00615550|Columbia Laboratories|George W Creasy MD|973-486-8797|Gcreasy@columbialabs.com|
277848|NCT00615589|University of Michigan Comprehensive Cancer Center|Dr. Attaphol Pawarode, M.D.|734-936-8785|pawarode@umich.edu|
277849|NCT00615719|VCU|John D. Grizzard|804-828-8569|jdgrizzard@vcu.edu|
277850|NCT00615784|abramsoncc, University of Pennsylvania|Harjeet Sembhi, research program director|215-220-9688|harjeet.sembhi@pennmedicine.upenn.edu|
277851|NCT00615836|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
277852|NCT00615901|Memorial Sloan Kettering Cancer Center|Dr. Pamela Drullinksy|516-256-3955|drullinp@mskcc.org|
288138|NCT01174030|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
288139|NCT01174043|IndianaU|Dr. Hamid Sayar|(317)278-6871|ssayar@iu.edu|
288140|NCT01174082|UT MD Anderson Cancer Center|Qazilbash,Muzaffar,M.D. / Stem Cell Transplantation|713-792-7734|CR_Study_Registration@mdanderson.org|
288141|NCT01174160|Cardiome Pharma|Jonathan Mather, Director, Head of Regulatory Affairs|+44 (0)7581148916|jmather@cardiome.com|
288142|NCT01174173|Northwestern University|Sanjiv J. Shah, MD|3129262926|sanjiv.shah@northwestern.edu|
298626|NCT01829503|University of Pittsburgh Cancer Institute|Dr. Annie P. Im|412-623-2393|imap@upmc.edu|
288143|NCT01174186|Silkeborg Regional Hospital|René Oestgaard|0045 78 41 50 00|ostgard@immunology.au.dk|
288144|NCT01174238|University of California, San Francisco|Adil Daud, MD|415-353-7392|adaud@medicine.ucsf.edu|
288145|NCT01174264|University of Chicago|Theodore Karrison|773-702-9326|tkarrison@health.bsd.uchicago.edu|
288146|NCT01174342|Meir Medical Center|Amit Meshi|+972523580222|amitmeshi@gmail.com|
288147|NCT01174446|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
288148|NCT01174459|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298627|NCT01829516|University of California, San Francisco|Jennifer Mitchell, PhD|510-985-3921|jennifer.mitchell@ucsf.edu|
298628|NCT01829919|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
298629|NCT01829997|RTI Surgical|Kristina Shine|386-418-8888|kshine@rtix.com|4404
298630|NCT01830127|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298631|NCT01830140|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
298632|NCT01830205|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
298633|NCT01830543|Janssen Scientific Affairs, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
298634|NCT01830595|Minneapolis Medical Research Foundation|Jason Baker|612-873-2705|baker@umn.edu|
298635|NCT01830621|The Ottawa Hospital Regional Cancer Centre|Dr. Derek Jonker|613-737-7700|djonker@ottawahospital.on.ca|70170
298636|NCT01830699|Keesler Medical Center|Matthew B. Carroll, MD|228-376-3629|matthew.carroll.1@us.af.mil|
298637|NCT01830816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
298638|NCT01830842|University of Arkansas for Medical Sciences|Merideth Addicott|501-526-8436|MAddicott@uams.edu|501
277853|NCT00615914|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277854|NCT00615927|Duke University Medical Center|Annick Desjardins, MD, FRCPC|919-668-|annick.desjardins@dm.duke.edu|
277855|NCT00615992|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277856|NCT00616018|Denver Health|Jody Green|303-389-1246|jody.green@rmpdc.org|
277857|NCT00616109|University of Michigan|Gregory Kalemkerian, M.D.|(734) 936-4991|kalemker@umich.edu|
277858|NCT00616122|University of California, San Francisco|Hope S. Rugo|877-827-3222|clinicaltrials@ucsf.edu|
277859|NCT00616200|UNC Center for Functional GI & Motility Disorders|Stephan R. Weinland, Ph.D.|9198437828|stephan_weinland@med.unc.edu|
277860|NCT00616239|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
277861|NCT00616421|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@Novartis.com|
277862|NCT00616434|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
277863|NCT00616629|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
277864|NCT00616655|Sunovion|Eszopiclone Medical Director|866-503-7813|clinicaltrialdisclosure@sunovion.com|
277865|NCT00616772|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
277866|NCT00616902|Abbott|Global Medical Services|800-633-9110||
277867|NCT00616928|GlaxoSmithKline|GSK Response Center|866-435-7343||
277868|NCT00616941|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org|
277869|NCT00617058|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
277870|NCT00617084|Medtronic Bakken Research Center B.V.|Miraida Weldam|+ 31 43 356|miraida.weldam@medtronic.com|6652
277871|NCT00617097|University of California, Davis|Dr. Catherine Cansino|9167346930|Catherine.Cansino@ucdmc.ucdavis.edu|
277872|NCT00617123|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
277873|NCT00617175|MEDTRONIC Clinical Research Institute|Laura Manotta|+39022413.1|laura.manotta@medtronic.com|
277874|NCT00617188|Masonic Cancer Center, University of Minnesota|Peter Argenta, M.D.|612-626-6037|argenta@umn.edu|
277875|NCT00617201|University of Kentucky|Dr. Sharon Walsh|859-257-2684|sharon.walsh@uky.edu|
277876|NCT00617240|The University of North Carolina at Chapel Hill|Linmarie Sikich, MD|(919) 972-7500|lsikich@med.unc.edu|
277877|NCT00617279|W. L. Gore & Associates, Inc.|Chad Badorek, Clinical Study Manager|928.864.3486|cbadorek@wlgore.com|
277878|NCT00617305|Gilead Sciences|Ellen Shen, PhD, Senior Manager, Regulatory Affairs|+1 (650) 522-5278|Ellen.Shen@gilead.com|
277879|NCT00617344|Sanofi Pasteur Inc.|Medical Director||Contact-US@sanofi.com|
277880|NCT00617357|LifeCell|Dr Michael Franz|908 947 1100|mfranz@lifecell.com|
277881|NCT00617396|UNC Chapel Hill|Dr. Douglas Drossman|919-966-0141|douglas_drossman@med.unc.edu|
277882|NCT00617409|H. Lee Moffitt Cancer Center and Research Institute|Dr. Scott Antonia|813-745-3883|scott.antonia@moffitt.org|
277883|NCT00617461|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
277884|NCT00617539|University of California San Francisco|Michelle Melisko, MD|415-353-7070|Michelle.Melisko@ucsf.edu|
277885|NCT00617591|H. Lee Moffitt Cancer Center and Research Institute|Rachid Baz, M.D.|813-745-8212|rachid.baz@moffitt.org|
277886|NCT00617604|Astellas Pharma Europe B.V|Senior Director Medical Science||Astellas.resultsdisclosure@astellas.com|
277887|NCT00617669|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
277888|NCT00617734|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
277889|NCT00617773|Recepta Biopharma|Dr. Oren Smaletz, M.D., Medical Director|55 11 3709-2140|oren.smaletz@receptabiopharma.com.br|
277890|NCT00617851|Novartis Vaccines and Diagnostics|Posting Director||RegContactVacUS.nvdit@Novartis.com|
277891|NCT00617890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
277892|NCT00617903|Bayer|Therapeutic Area Head||clinical-trials-contact@bayer.com|
277893|NCT00617929|Masonic Cancer Center, University of Minnesota|Jakub Tolar, MD|612-624-7180|tolar003@umn.edu|
277894|NCT00617942|Brown University Oncology Research Group (BrUOG)|William Sikov, MD|4018633000|BrUOG@brown.edu|
277895|NCT00617981|Celsion Corporation|Nicholas Borys, M.D. Senior Vice President and Chief Medical Officer|609-896-9100|nborys@celsion.com|
277896|NCT00618072|New York Medical College|Harriette R. Mogul MD MPH|914-594-2278|Harriette_Mogul@NYMC.edu|
288149|NCT01174550|Duke University Medical Center|Dr. Pamela Douglas|919-668-8700|pamela.douglas@duke.edu|
288150|NCT01174576|Harokopio University|Dr. Mary Yannakoulia|00302109549175|myianna@hua.gr|
288151|NCT01174784|Avinger Inc.|Thomas Lawson, PhD|650.241.7900|tlawson@avinger.com|
288152|NCT01174823|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
288153|NCT01175005|Phoenixchildrens|Amanda Kasem|6025461910|akasem@phoenixchildrens.com|
288154|NCT01175018|Virginia Commonwealth University|Antonio Abbate|804-828-0513|aabbate@mcvh-vcu.edu|
288155|NCT01175031|Shanghai Jiao Tong University School of Medicine|Quing Yun Li, MD, PhD|86-21-64314162|liqingyun68@hotmail.com|
288156|NCT01175083|GlaxoSmithKline|GSK Response Center|866-435-7343||
288157|NCT01175135|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288158|NCT01175148|Mary Babb Randolph Cancer Center|Pam Bunner, Clinical Research Specialist|304-598-4511|bunnerp@wvuhealthcare.com|
288159|NCT01175213|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
288160|NCT01175226|Aviragen Therapeutics, Inc.|Anna Novotney-Barry|678-221-3356|abarry@aviragentherapeutics.com|
288161|NCT01175317|Maastricht University Medical Center|Kostan Reisinger|0031433881494|k.reisinger@maastrichtuniversity.nl|
288162|NCT01175343|Princess Margaret Cancer Centre|Dr. Amit M. Oza|416-946-2818|amit.oza@uhn.ca|
288163|NCT01175356|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
288164|NCT01175369|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
288165|NCT01175382|University of Alabama at Birmingham|Dr. Kathryn Burgio|205-558-7064|kburgio@uabmc.edu|
288166|NCT01175395|University of Illinois at Chicago|Jennifer I Lim MD|312-413-0704|jennylim@uic.edu|
288167|NCT01175434|University of Rochester|Dr. Jill Halterman|5852755798|jill_halterman@urmc.rochester.edu|
277897|NCT00618332|University of Chicago|Dr. Robert Naclerio|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
277898|NCT00618371|University of Pittsburgh|Deborah McMahon|412-383-1675|mcmahond@pitt.edu|
277899|NCT00618410|The University of Chicago|Dr. Robert M. Naclerio, MD|(773) 702-1865|rnacleri@surgery.bsd.uchicago.edu|
277900|NCT00618436|University of Pittsburgh|Dr. Lori Shutter|1-412-647-8410|shutterla@upmc.edu|
277901|NCT00618449|University of California, San Francisco|Julius Schachter, PhD / Emeritus Professor of Laboratory Medicine|+1 (415) 824-5115|Julius.Schachter@ucsf.edu|
277902|NCT00618514|Image Guided Surgery Associates|Robert Worthington-Kirsch|(610) 327-7236|kirsch@igsapc.com|
277903|NCT00618540|University of Minnesota, Pediatric BMT|Dr. Angela Smith, MD|612-626-2778|smith719@umn.edu|
277904|NCT00618618|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
277905|NCT00618722|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
277906|NCT00618748|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
277907|NCT00618774|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277908|NCT00618787|Tyco Healthcare Group|Tonya Eggleston, RN, MPH, Study Director|(508) 261-8420|Tonya.Eggleston@Covidien.com|
277909|NCT00618813|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
277910|NCT00618826|University of Cincinnati|Alison Kastl|513-584-0436|kastla@ucmail.uc.edu|
277911|NCT00618839|Stratatech Corporation|Mary Lokuta|608-441-8358|mlokuta@stratatechcorp.com|
277912|NCT00618917|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
277913|NCT00618956|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|201-427-8218|robert.palmer@frx.com|
277914|NCT00618982|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
277915|NCT00618995|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
277916|NCT00619060|University of Arizona|Steve Stratton,PhD Chairman of Scientific Review Comittee|(520) 626-9295|SStratton@uacc.arizona.edu|
277917|NCT00619073|Children's Hospital Boston|Alan D. Michelson, M.D.|617-919-2116|alan.michelson@childrens.harvard.edu|
277918|NCT00619099|Eisai Inc.|Erhan Berrack, M.D.|888-422-4743||
277919|NCT00619112|UCSF|Nicholas Butowski|4153532966|Butowski@neurosurg.ucsf.edu|
277920|NCT00619177|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277921|NCT00619190|UNC Chapel Hill|Linmarie Sikich, MD|919-972-7499|lsikich@med.unc.edu|
277922|NCT00619229|UCB|UCB Clinical Trial Call Center|+ 1 877 822 9493 (UCB)||
277923|NCT00619255|University of Washington|Doug Zatzick, MD|(206) 744-6701|dzatzick@uw.edu|
277924|NCT00619307|Merck Serono, a division of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
277925|NCT00619359|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
277926|NCT00619385|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
277927|NCT00619476|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
277928|NCT00619489|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
277929|NCT00619502|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
277930|NCT00619619|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277931|NCT00619645|University of California Davis|Data Manager|916-734-8381|nmahaffey@ucdavis.edu|
277932|NCT00619684|Fred Hutchinson Cancer Research Ctr|Dr. William Bensinger|2066674730|wbensing@fredhutch.org|
277933|NCT00619723|Psychoneuroendocrine Research Group|Dr. Sherwood Brown|214-645-6950|sherwood.brown@utsouthwestern.edu|
277934|NCT00619762|LifeCell|Director of Clinical Operations|908.809.7856|djacobs@lifecell.com|
277935|NCT00619801|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
277936|NCT00619827|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
277937|NCT00619866|AbbVie|Global Medical Services|800-633-9110||
277938|NCT00619892|UCSF Fresno|Andrew Goddard, M.D.|559-499-6580|agoddard@fresno.ucsf.edu|
277939|NCT00619918|Children's Hospital Los Angeles|Susan Wu|323-361-6177|suwu@chla.usc.edu|
277940|NCT00619957|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
277941|NCT00619970|CHLA|Brynie Slome Collins MD|323 361 2181|bcollins@chla.usc.edu|
277942|NCT00619983|Wake Forest School of Medicine|Dr. James Eisenach|336-716-4182|jimeisenach@gmail.com|
277943|NCT00620022|Novartis Pharmaceuticals|Study Director|862 778-8300||
277944|NCT00620061|Sucampo Pharma Americas, LLC|VP, Clinical Development|301-961-3400|info@sucampo.com|
277945|NCT00620074|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
277946|NCT00620113|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
277947|NCT00620126|University of Maryland. Baltimore|PI|410-706-3387|rcross@medicine.umaryland.edu|
277948|NCT00620191|Columbia University Medical Center|Jose Luchsinger|212-3054730|jal94@cumc.columbia.edu|
277949|NCT00620282|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
277950|NCT00620321|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
288168|NCT01175473|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
288169|NCT01175590|Bausch & Lomb Inc.|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
288170|NCT01175668|Baystate Medical Center|Rachana Singh, MD|413-794-2400|rachana.singhmd@bhs.org|
277951|NCT00620373|Mayo Clinic|Dr. Deborah J. Rhodes|507-538-1703|rhodes.deborah@mayo.edu|
277952|NCT00620425|Zogenix, Inc|Edward Smith III, PhD, VP Regulatory Affairs & Product Quality/Safety|510 550 8325|esmith@zogenix.com|
277953|NCT00620503|Repros Therapeutics Inc, an Allergan Affiliate|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
288171|NCT01175707|Cubist Pharmaceuticals|Vice President, Clinical Research|781-860-8318||
277954|NCT00620542|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
277955|NCT00620555|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
277956|NCT00620659|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
277957|NCT00620698|Beth Israel Deaconess Medical Center|Seward Rutkove|617-667-8130|srutkove@bidmc.harvard.edu|
277958|NCT00620711|Vanderbilt university|William F Walsh|615-322-0545|bill.walsh@vanderbilt.edu|
277959|NCT00620750|New York University School of Medicine|Marc Gourevitch, MD, MPH|212-263-8553|marc.gourevitch@nyumc.org|
277960|NCT00620763|United States Department of Agriculture Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
277961|NCT00620776|University of Pennsylvania|Dr. Paul Crits-Christoph|(215) 662-7993|crits@mail.med.upenn.edu|
277962|NCT00620815|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
277963|NCT00620828|Duke UMC|Michael Bolognesi, MD|919-668-4732|bolog002@mc.duke.edu|2
277964|NCT00620854|Tarsa Therapeutics, Inc.|Thomas Wicks, Ph.D., Vice-President Global RA/QA|267 273 7946|twicks@tarsatherapeutics.com|
277965|NCT00620945|Cleveland Clinic|Muhammad A. Mumtaz, MD|216 444 9125|mumtazm@ccf.org|
277966|NCT00621023|Duke University Medical Center|Dr. Carlos de Castro|919-684-8964|decas003@mc.duke.edu|
277967|NCT00621049|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
277968|NCT00621140|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277969|NCT00621153|AstraZeneca|Gerard Lynch|+44 1509 64589|aztrial_results_posting@astrazeneca.com|4589
277970|NCT00621179|Colorado Center for Reproductive Medicine|Eric Surrey|303-788-8300|esurrey@colocrm.com|
277971|NCT00621192|Eunice Kennedy Shriver National Institute of Child Health and Human Development|David Siegel, MD|301-595-8670|siegelda@mail.nih.gov|
277972|NCT00621244|Novartis Pharmaceuticals|Study Director|862-778-8300||
277973|NCT00621257|children's Hospital Boston|Helen Pappa, MD, MPH, Principal Investigator|617-355-6058|helen.pappa@childrens.harvard.edu|
277974|NCT00621296|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
277975|NCT00621309|University of Washington|Dr. David L. Eaton|206-543-7468|deaton@uw.edu|
277976|NCT00621322|GlaxoSmithKline|GSK Response Center|866-435-7343||
277977|NCT00621348|AIIMS|Rakesh Lodha|91 11 26593621|rakesh_lodha@hotmail.com|
277978|NCT00621504|Cerexa, Inc|Vice President, Clinical Sciences|(510) 285-9200|clinicaltrials@cerexa.com|
277979|NCT00621517|East Tennessee State University|Max Bayard MD|802-524-8805|mmbayard3@gmail.com|
277980|NCT00621530|Wake Forest School of Medicine|Dr. James C. Eisenach|336-716-4498|jimeisenach@gmail.com|
277981|NCT00621543|University of Rochester|Sarah Betstadt, MD, MPH|585-276-5368|sarah_betstadt@urmc.rochester.edu|
277982|NCT00621582|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277983|NCT00621621|Medtronic- AF Solutions|Adam Cline, MD, MSc.- Sr. Clinical Research Specialist|763-526-9601|adam.cline@medtronic.com|
277984|NCT00621686|Mayo Clinic|Evanthia Galanis, M.D.|507/284-3559|Galanis.evanthia@mayo.edu|
277985|NCT00621751|Atrium Health; Currently at Indiana University School of Medicine|Flora Hammond, MD|317-292-6781|flora.hammond@rhin.com|
277986|NCT00621764|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
277987|NCT00621777|Massachusetts General Hospital|A. Eden Evins, MD, MPH|6176434679|a_eden_evins@hms.harvard.edu|
277988|NCT00621842|Case Western Reserve University|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
277989|NCT00621855|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277990|NCT00621933|Allergan, Inc|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
277991|NCT00621946|The University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|Sherwood.Brown@UTSouthwestern.edu|
277992|NCT00621959|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
277993|NCT00621985|Children's Hospital Boston|Joseph Majzoub|617-355-7476|joseph.majzoub@childrens.harvard.edu|
277994|NCT00622180|UT Southwestern Medical Center at Dallas|Amit Pandya, M.D.|214-645-8300|amit.pandya@utsouthwestern.edu|
277995|NCT00622284|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
277996|NCT00622336|Celgene Corporation|Senior Manager, Clinical Trial Disclosure|1-888-260-1599|ClinicalTrialDisclosure@celgene.com|
288172|NCT01175798|Icahn School of Medicine at Mount Sinai|Anita Mehrotra MD|2122415153|anita.mehrotra@mssm.edu|
288173|NCT01175811|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288174|NCT01175824|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288175|NCT01175850|Medtronic - CardioVascular|Clinical Research Director|+31433566580|kristel.wittebols@medtronic.com|
288176|NCT01175902|Seoul St. Mary's Hospital|Chan Kee Park|82222586208|ckpark@catholic.ac.kr|
288177|NCT01175980|Barbara Ann Karmanos Cancer Institute|Dr. Ulka N. Vaishampayan|313-576-8718|vaishamu@karmanos.org|
288178|NCT01176032|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
288179|NCT01176058|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288180|NCT01176240|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
288181|NCT01176266|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
288182|NCT01176292|Anderson Orthopaedic Research Institute|Dr. William Hamilton|703-619-4411|research@aori.org|
288183|NCT01176435|University of Minnesota|C. Gail Summers, MD|612-625-6469|summe001@umn.edu|
288184|NCT01176448|University of Virginia Dept of Otolaryngology Head and Neck Surgery|J. Jared Christophel MD|434-243-9391|jjchristop@gmail.com|
288185|NCT01176565|University of Minnesota|Adnan I. Qureshi, MD|612-624-2431|qureshai@gmail.com|
288186|NCT01176591|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@upenn.edu|152
277997|NCT00622388|GlaxoSmithKline|GSK Response Center|866-435-7343||
277998|NCT00622401|Beth Israel Deaconess Medical Center|David Avigan, MD|617-667-9920|davigan@bidmc.harvard.edu|
277999|NCT00622427|University of Alabama at Birmingham|Rachel Fargason|205-934-5151|mfargason@uab.edu|
278000|NCT00622440|University of California, San Francisco|Naomi Jay, PhD|415-353-7443|Naomi.Jay@ucsf.edu|
278001|NCT00622466|The University of Texas Southwestern Medical Center|Dr. Barbara Haley|214-648-4180|barbara.haley@utsouthwestern.edu|
278002|NCT00622505|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
278003|NCT00622518|University of Washington|James A. Taylor, MD|206-616-1206|uncjat@u.washington.edu|
278004|NCT00622544|University of MN|Clifford E. Kashtan|646 692 9309|cassi044@umn.edu|
278005|NCT00622635|Novartis Pharmaceuticals|Study Director|862 778-8300||
278006|NCT00622700|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
278007|NCT00622713|Novartis Pharmaceuticals|Study Director|862-778-8300||
278008|NCT00622726|University of Texas Health Science Center-Houston|Helen Mintz-Hittner, M.D.|713-559-5277|Helen.A.Mintz-Hittner@uth.tmc.edu|
278009|NCT00622739|Baylor College of Medicine|Kirti Saxena|832-822-4065|kxsaxen1@texaschildrens.org|
278010|NCT00622869|Novartis Pharmaceuticals|Study Director|862 778-8300||
278011|NCT00622895|Fred Hutchinson Cancer Research Center|George E. Georges MD|206-667-6886|ggeorges@fredhutch.org|
278012|NCT00622908|Bausch & Lomb Incorporated|Timothy Comstock|(585) 338-6631|timothy.comstock@bausch.com|
278013|NCT00623012|Yale University|Dr. Stuart Seropian|203-737-2477|Stuart.Seropian@yale.edu|
278014|NCT00623103|Novartis Pharmaceuticals|Study Director|862-778-8300||
278015|NCT00623181|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
278016|NCT00623194|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
278017|NCT00623233|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298639|NCT01830855|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278018|NCT00623363|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
278019|NCT00623428|Hoffman-LaRoche|Medical Communications|800-821-8590||
278020|NCT00623441|Medtronic Bakken Research Center|Sofia Pateraki, MSc - Sr. Clinical Research Specialist|+31 43 3566785|sofia.pateraki@medtronic.com|
278021|NCT00623467|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
278022|NCT00623480|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
278023|NCT00623506|Durham VA Medical Center|Christine E. Marx, MD|919 286-0411|marx0001@mc.duke.edu|7426
278024|NCT00623545|University of Wisconsin-Madison|Dale A Schoeller|608-262-1082|dschoell@nutrisci.wisc.edu|
278025|NCT00623597|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
278026|NCT00623623|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
278027|NCT00623636|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
278028|NCT00623714|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
278029|NCT00623727|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
278030|NCT00623766|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
278031|NCT00623779|AstraZeneca|Gerard Lynch|+44 1509 645895|aztrial_results_posting@astrazeneca.com|
278032|NCT00623805|Hoffmann-La Roche|Medical Communications|800 821-8590||
278033|NCT00623831|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org|
278034|NCT00623935|University of Michigan Comprehensive Cancer Center|Dr. Gregory Yanik, M.D.|734-936-8785|gyanik@umich.edu|
278035|NCT00624013|Charles Drew University of Medicine and Science|Diana Echeverry, MD, Principal Investigator|3235634800||
278036|NCT00624052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
278037|NCT00624065|GlaxoSmithKline|GSK Response Center|866-435-7343||
278038|NCT00624195|UCSD|Dr. Ron Ellis|619-543-5079|roellis@ucsd.edu|
278039|NCT00624221|Cornea Research Foundation of America|Marianne O. Price, PhD|317-814-2990|mprice@cornea.org|
278040|NCT00624234|Vanderbilt University|Dr. Laurie Cutting|615-875-1054|Laurie.Cutting@Vanderbilt.Edu|
278041|NCT00624286|Novartis Pharmaceuticals|Study Director|862 778-8300||
278042|NCT00624338|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
278043|NCT00624377|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
278044|NCT00624416|Pennington Biomedical Research Center|Leanne Redman|225-763-0947|Leanne.Redman@pbrc.edu|
278045|NCT00624442|Cytokinetics, Inc.|Medical Director|(650) 624-3011||
278046|NCT00624468|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
278047|NCT00624520|Department of Veterans Affairs|Dr Douglas C Russell|608-256-1901|Dcrussel@facstaff.wisc.edu|
278048|NCT00624559|University of Delaware|Dr. William Farquhar|302-831-6178|wbf@udel.edu|
278049|NCT00624585|H. Lee Moffitt Cancer Center and Research Institute|Alan F. List, Executive Vice President & President, Moffitt Medical Group|813-745-6086|alan.list@moffitt.org|
278050|NCT00624780|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278051|NCT00624806|Center of Innovation for Complex Chronic Health Care|Marylou Guihan, PhD|708-202-2414|marylou.guihan@va.gov|
278052|NCT00624819|GlaxoSmithKline|GSK Response Center|866-435-7343||
288187|NCT01176617|Hospital of the University of Pennsylvania|Dr. Sanjay Dixit|215-615-4337|sanjay.dixit@uphs.upenn.edu|
288188|NCT01176773|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
298640|NCT01830881|Oregon Health and Science University|Lisa Bayer, MD|503-494-3666|whru@gmail.com|
278053|NCT00624832|Novartis Pharmaceuticals|Study Director|862-778-8300||
278054|NCT00624910|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
278055|NCT00624923|Joslin Diabetes Center|Dr. Allison Goldfine|617-309-2400|allison.goldfine@joslin.harvard.edu|
278056|NCT00625131|VA Medical Center, Durham, NC|Angela Kirby, MS; Regulatory Coordinator|9192860411|angela.kirby@va.gov|5526
278057|NCT00625183|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
278058|NCT00625365|Lantheus Medical Imaging|Dana Washburn, M.D.|978-671-8686|dana.washburn@lantheus.com|
278059|NCT00625391|Texas Tech University Health Sciences Center|Dr. Chwan-Li Shen|(806) 743-2815|Leslie.Shen@ttuhsc.edu|
278060|NCT00625404|FHI 360|Jennifer Deese, Principal Investigator|919-544-7040|jdeese@fhi360.org|11292
278061|NCT00625443|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
278062|NCT00625729|Masonic Cancer Center, University of Minnesota|Veronika Bachanova, M.D.|612-625-5469|bach0173@umn.edu|
278063|NCT00625807|Massachusetts General Hospital|Sara Lazar|617-724-2256|slazar@mgh.harvard.edu|
278064|NCT00625820|University of Michigan|Rajiv Saran, MD|734-763-6611|rsaran@umich.edu|
278065|NCT00625846|Mayo Clinic|Keith C. Bible, M.D., Ph.D.|507-284-2511|bible.keith@mayo.edu|
278066|NCT00625872|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278067|NCT00625989|McMaster University|Dr. Gail Gauvreau|905-525-9140|gauvreau@mcmaster.ca|22791
298641|NCT01830920|Thrasos Therapeutics, Inc.|Jerome Rossert, MD, PhD, Chief Scientific Officer||Jerome.Rossert@thrasos.com|
278068|NCT00626028|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
278069|NCT00626093|St. Jude Medical|Ashish Oza|818-493-3648|aoza@sjm.com|
278070|NCT00626197|F. Hoffmann-La Roche Ltd/Genentech Inc.|Medical Communications|1-800-821-8590|genentech@druginfo.com|
278071|NCT00626210|VAPAHCS|Dr. Jamie Zeitzer|6504935000|jzeitzer@stanford.edu|62410
278072|NCT00626275|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
278073|NCT00626327|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
278074|NCT00626340|University of Pennsylvania|Dr. Cynthia Neill Epperson|215-573-8871|cepp@mail.med.upenn.edu|
278075|NCT00626366|University of Nebraska Medical Center|Erin K. O'Brien MD|402-559-6463|IRBORA@unmc.edu|
278076|NCT00626392|Abbott|Medical Information Specialist|800-633-9110||
278077|NCT00626405|Mayo Clinic|Svetomir Markovic, M.D., Ph.D.|5072840527|markovic.svetomir@mayo.edu|
278078|NCT00626431|Abbott|Global Medical Services|800-633-9110||
278079|NCT00626522|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
278080|NCT00626548|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
298642|NCT01830933|University of California, San Francisco|Celia P. Kaplan, Professor|415-502-5601|celia.kaplan@ucsf.edu|
278081|NCT00626574|University of South Florida|Enrico M Camporesi MD|813-844-7170|ecampore@health.usf.edu|
278082|NCT00626626|Penn State Hershey Medical Center|Dr David Claxton|717-531-8401|dclaxton@hmc.psu.edu|
278083|NCT00626639|Biovitrum|Hans Olivecrona, MD PhD|+46 8 697 20 00|hans.olivecrona@sobi.com|
278084|NCT00626743|INJE University Pusan Paik Hospital|Jae Gook Shin, MD,PhD|+82-51-890-8954|phshinjg@paik.ac.kr|
278085|NCT00626782|Wills Eye Hospital|Prinicipal Investigator|484-434-2700|mpro2020@yahoo.com|
278086|NCT00626795|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
278087|NCT00626808|MedImmune, LLC|Chris Ambrose|301-398-0000|ambrosec@medimmune.com|
278088|NCT00626821|Coloplast|Helle Aaes Senior Scientific Manager|+45 49112949|dkheaa@coloplast.com|
278089|NCT00626886|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
278090|NCT00626912|Centre de Recherches du Centre Hospitalier de l'Université de Montréal|Ruby Klink, coordinator|(514) 890 8000|ruby.klink@crchum.qc.ca|25245
278091|NCT00626925|University of Pennsylvania Perelman School of Medicine|Henry R. Kranzler, M.D.|215-386-6662|kranzler@mail.med.upenn.edu|
278092|NCT00627016|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
278093|NCT00627042|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
278094|NCT00627094|Coloplast|Scientific Manager|+4549113557|dkkg@coloplast.com|
278095|NCT00627367|Department of Emergency Medicine, Albert Einstein College of Medicine|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
278096|NCT00627393|New England Research Institutes, Inc.|Susan Assmann, PhD|617-972-3048|sassmann@neriscience.com|
288189|NCT01176877|Northwestern University, Feinberg School of Medicine, Department of Dermatology|Dr. Steven Nwe, Clinical Research Fellow|312-695-4625|steven.nwe@northwestern.edu|
288190|NCT01176916|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288191|NCT01176955|Wake Forest Baptist Medical Center|Brad Yentzer|336-716-4735|byentzer@wakehealth.edu|
288192|NCT01176968|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288193|NCT01176981|Hospital for Sick Children|Dr. Abha Gupta|14168137744|abha.gupta@sickkids.ca|
288194|NCT01177007|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
288195|NCT01177059|Janssen-Cilag Pty Ltd, Australia|Executive Director Medical & Scientific|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
288196|NCT01177098|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
288197|NCT01177137|Center for Clinical Trials and Evidence Synthesis, Johns Hopkins Bloomberg School of Public Health|Roberta W. Scherer, Director Data Coordinating Center|410 502 4636|rschere1@jhu.edu|
288198|NCT01177189|Salt Lake City VAMC|Van Reese|801 582 1565|van.reese@hsc.utah.edu|
288199|NCT01177228|Millennium Pharmaceuticals Inc|Medical Director|1-800-778-2860|clinicaltrialregistry@tpna.com|
288200|NCT01177293|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298643|NCT01830972|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
278097|NCT00627406|Fertility Clinic Regional Hospital Skive|Dr. Peter Humaidan|+45 78 44 57 60|peter.humaidan@viborg.rm.dk|
278098|NCT00627445|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
278099|NCT00627458|GlaxoSmithKline|GSK Response Center|866-435-7343||
278100|NCT00627497|Medtrionic spinal and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
278101|NCT00627523|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278102|NCT00627679|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|(650) 386-3100|dkellerman@mappharma.com|
278103|NCT00627705|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
278104|NCT00627861|The Rogosin Institute|Warren Bobb, N.P.|212-746-9114|wab9006@nyp.org|
278105|NCT00627926|Vertex Pharmaceuticals Incorporated|Jeff Chodakewitz, M.D.|617-341-6777|Jeff_Chodakewitz@vrtx.com|
278106|NCT00627978|Weill Cornell Medicine|Linda Vahdat, MD|646-962-9888|ltv2001@med.cornell.edu|
278107|NCT00628030|Virginia Commonwealth University|Suzanne E Mazzeo, Professor of Psychology|804-827-9211|semazzeo@vcu.edu|
278108|NCT00628108|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
278109|NCT00628134|University of Pittsburgh|Tim Corcoran, Ph.D.|412-624-8918|corcorante@upmc.edu|
278110|NCT00628147|SF VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|24103
278111|NCT00628212|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
278112|NCT00628251|AstraZeneca|Paula del Rosario|+44 7884 735492|ClinicalTrialTransparency@astrazeneca.com|
278113|NCT00628355|Ribeirao Preto Medical School - University of Sao Paulo|Omero Benedicto Poli Neto|551636023183|polineto@fmrp.usp.br|
278114|NCT00628394|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
278115|NCT00628407|Children's Hospital of Philadelphia|Vinay Nadkarni, MD|215-590-7430|nadkarni@email.chop.edu|
278116|NCT00628446|Carolinas Healthcare System|Dr. Jesse Lieberman|704-355-0649|Jesse.Lieberman@Carolinashealthcare.org|
278117|NCT00628498|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|(215) 832-3750||
278118|NCT00628589|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
278119|NCT00628628|The University of Texas (UT) MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||CR_Study_Registration@mdanderson.org|
278120|NCT00628758|AstraZeneca|Gerard Lynch|+44 1509 645895|aztrial_results_posting@astrazeneca.com|
278121|NCT00628862|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278122|NCT00628901|Boston Scientific|Ana Becker / Sr. Clinical Program Manager|651-581-4605|Ana.Becker@bsci.com|
278123|NCT00628927|University of Cincinnati|Dr. Theresa Winhusen|513-487-7800|winhusen@carc.uc.edu|
278124|NCT00629018|UMC Ljubljana|Prof. Dr. Bojan Vrtovec|+3861 522 2844|bvrtovec@stanford.edu|
298644|NCT01831076|University of Colorado|Anthony Elias|720-848-0347|anthony.elias@ucdenver.edu|
278125|NCT00629083|Contura International A/S|Ieva Ankorina-Stark, Ph D, Chief Scientific Officer|011 45 8110 0900|ieva.ankorina-stark@contura.com|
278126|NCT00629122|Weill Cornell Medical College|Meredith J. Aull, Pharm.D.|(212) 746-8720|mea9008@med.cornell.edu|
278127|NCT00629239|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278128|NCT00629265|Boston Medical Center|Dr. Susan Langmore, PhD, Director of Speech Language Pathology|617-414-1753|langmore@bu.edu|
278129|NCT00629499|Sarah Cannon Research Institute|Director, Breast Cancer Research|615-329-7274|asksarah@scresearch.net|
278130|NCT00629525|Duke University|Dr. Daniel George|919-668-4615|daniel.george@duke.edu|
278131|NCT00629707|University of California, Davis|Dr. Nicole Glaser|916-734-7098|nsglaser@ucdavis.edu|
278132|NCT00629772|Innovaderm Research|Annie Levesque|514 521 4285|alevesque@innovaderm.ca|222
278133|NCT00630032|Unicancer|Deputy Director R&D|(+33)1 44 23 04 19|b-juzyna@unicancer.fr|
278134|NCT00630058|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
278135|NCT00630253|Masonic Cancer Center, University of Minnesota|Margaret L. MacMillan, M.D.|612-273-2800|macmi002@umn.edu|
298645|NCT01831089|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology Business Unit.|+34 91 846 60 00|clinicaltrials@pharmamar.com|
278136|NCT00630305|Johnson & Johnson Vision Care, Inc.|Kurt Moody, OD|1-904-443-3088|kmoody1@its.jnj.com|
288201|NCT01177384|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
288202|NCT01177410|Salix Pharmaceuticals, Inc.|Vice President of Clinical Operations|919-862-1000|enoch.bortey@salix.com|
288203|NCT01177553|University of South Florida|Research Coordinator|813-259-8680|obgynclinicalresearch@health.usf.edu|
288204|NCT01177670|Hologic, Inc.|Edward Evantash, MD|508-263-8475|edward.evantash@hologic.com|
288205|NCT01177709|Nathan Kline insistute for Psychiatric Research|Robert C smith MD|845-298-6531|rsmith@nki.rfmh.org|
288206|NCT01177722|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
288207|NCT01177735|University of Arkansas for Medical Sciences|Saad Usmani, MD|501-526-6876||
288208|NCT01177787|Gachon University of Medicine and Science|Dr. Kyu Rae LeeMD.PhD.|8232-770-1215|baria07@daum.net|
288209|NCT01177800|Beijing, China R&D|Senior Therapeutic Area Physician|+86 010 58218358||
288210|NCT01177813|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288211|NCT01177943|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
288212|NCT01177956|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
288213|NCT01177969|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
288214|NCT01178073|GlaxoSmithKline|GSK Response Center|866-435-7343||
288215|NCT01178086|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
288216|NCT01178099|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
278137|NCT00630331|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
278138|NCT00630344|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-8313|mary_taplin@dfci.harvard.edu|
278139|NCT00630396|Georgia Health Sciences University|David Hess, MD|706-721-1691|dhess@georgiahealth.edu|
278140|NCT00630409|University of Pittsburgh|Leonard Appleman, MD, PhD|412-648-6538|applemanlj@upmc.edu|
278141|NCT00630539|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
298646|NCT01831154|James A Haley Veterans Hosptial|Dr. Sierra Gower|(813) 972-2000|sierra.gower@va.gov|5946
278142|NCT00630734|University of Colorado Denver|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
278143|NCT00630747|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
298647|NCT01831219|Think Surgical|Senior Manager of Clinical Applications|510-249-2339|nnetravali@thinksurgical.com|
308854|NCT02617784|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
278144|NCT00630786|Amgen Inc.|Study Director|866-572-6436||
278145|NCT00630812|Pharmaxis|Brett Charlton|02 94547210|Brett.Charlton@pharmaxis.com.au|
278146|NCT00630825|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
278147|NCT00630838|University of Michigan|Daniel Teitelabum|734-936-8464|dttlbm@umich.edu|
278148|NCT00630864|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278149|NCT00630877|Abbott|Medical Information Specialist|800-633-9110||
278150|NCT00630916|Sorin Group USA|Director of Clinical and Medical Affairs|512-435-3602|barbara.mathews@sorin.com|
278151|NCT00630955|Yale University|Dr. Suchitra Krishnan-Sarin, Associate Professor of Psychiatry|203-974-7595|suchitra.krishnan-sarin@yale.edu|
278152|NCT00630994|Mayo Clinic|Dr. Ruben A. Mesa|507-284-2511|mesa.ruben@mayo.edu|
278153|NCT00631007|InteKrin Therapeutics|Chief Executive Officer|650-941-5501|Info@intekrin.com|
278154|NCT00631020|UCLA Center for Health Promotion and Disease Prevention|Dr. Steven Shoptaw|310-794-0619|sshoptaw@mednet.ucla.edu|225
278155|NCT00631163|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
278156|NCT00631189|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278157|NCT00631319|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
278158|NCT00631358|Alcon Labs|Alcon Clinical|1-888-451-3937; 1-817-568-6725|medinfo@alconlabs.com|
288217|NCT01178125|Teva Pharmaceuticals USA|Manager, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
278159|NCT00631371|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278160|NCT00631410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278161|NCT00631449|University of California, San Francisco|Steven Deeks, MD|415-476-4082|Steven.Deeks@ucsf.edu|404
278162|NCT00631475|Actelion Pharmaceuticals Ltd|Isabelle Leconte, PhD/Data Science Group Leader, Director|+ 41 61 565 64 18|isabelle.leconte@actelion.com|
278163|NCT00631488|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278164|NCT00631540|Cook Incorporated|Scott Snyder, PhD|765-463-7537|ssnyder@medinst.com|
278165|NCT00631566|Infectious Disease Clinical Research Program, USUHS and HJF|Dr. Brian Agan, Deputy Science Director|301-816-8446|bagan@idcrp.org|
278166|NCT00631657|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
288218|NCT01178138|University of Arkansas for Medical Sciences|W. Brooks Gentry, MD|501 686 6119|gentrywilliamb@uams.edu|
288219|NCT01178216|Cedars-Sinai Medical Center|Noriko Ammerman, PharmD|3102488186|noriko.ammerman@cshs.org|
288220|NCT01178268|Abbott Vascular|Dana Haudek|928-925-4054|dana.haudek@av.abbott.com|
288221|NCT01178281|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
288222|NCT01178294|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
288223|NCT01178333|New England Research Institutes|Dr. Susan Assmann, Principal Research Scientist|617-972-3048|sassmann@neriscience.com|
288224|NCT01178385|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
288225|NCT01178411|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
288226|NCT01178528|IRCCS San Raffaele|G Rosano|0652252309|giuseppe.rosano@sanraffaele.it|
288227|NCT01178671|Research Foundation for Mental Hygiene|Franklin Schneier MD|6467748041|fschneier@nyspi.columbia.edu|
288228|NCT01178762|National Taiwan University Hospital|Yan-Ming Chen / Yu-Chih Hou|886-2-2312-3456|louice1070@gmail.com|62131
288229|NCT01178827|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
288230|NCT01178853|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
288231|NCT01178944|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
288232|NCT01179048|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
288233|NCT01179113|Cedars Sinai Medical Center|Dr. Roya Yumu', Anesthesiology Program Director|310-423-1682|Roya.Yumul@cshs.org|
288234|NCT01179191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288235|NCT01179217|Emmaus Medical, Inc|Yutaka Niihara, MD, MPH|310-214-0065|yniihara@emmausmedical.com|
288236|NCT01179334|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
288237|NCT01179347|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288238|NCT01179477|Abbott|Clay Cohorn, Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
288239|NCT01179490|Symbio Pharmaceuticals|Toshihiko Nagase|81-3-5472-1127|tnagase.331@symbiopharma.com|
288240|NCT01179516|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
288241|NCT01179568|Columbia School of Social Work|M. Katherine Shear, MD|212-851-2176|ks2394@columbia.edu|
278167|NCT00631670|University of Florida, Dept. of Radiation Oncology|Bridget Fitzgerald, Clinical trials coordinator|352-265-0680|fitzgb@shands.ufl.edu|87829
278168|NCT00631696|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278169|NCT00631748|VA Puget Sound Health Care System|Andre Tapp, MD|253-589-4176|andre.tapp@va.gov|
278170|NCT00631852|Southern Illinois University School of Medicine|Director of Oncology Clinical Trials|217-545-8000|krobinson@siumed.edu|
278171|NCT00631917|Novartis Pharmaceuticals|Study Director|862-778-8300||
278172|NCT00631969|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
278173|NCT00632021|Vanderbilt University Medical Center|Research Coordinator|6159364819|Kathryn.m.goggins@vanderbilt.edu|
278174|NCT00632099|New York State Psychiatric Institute|Dr. Suzette Evans|646-774-6136|se18@columbia.edu|
278175|NCT00632125|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
278176|NCT00632203|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
278177|NCT00632229|University of South Florida|Dr. Eric Storch|727-767-8230|estorch@health.usf.edu|
278178|NCT00632281|University of Florida|Bridget Fitzgerald, Clinical Research Coordinator|352-265-0680|fitzgb@shands.ufl.edu|87829
278179|NCT00632359|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
278180|NCT00632411|University of Tennessee Health Science Center|Dr. Robert Klesges|901-448-3174|lcolvin1@uthsc.edu|
278181|NCT00632424|Organization: Bristol-Myers Squibb|Name/Official Title: BMS Study Director||Clinical.Trials@bms.com|
278182|NCT00632463|ADMA Biologics|Chief Medical Officer|201-478-5552|agrossman@admabio.com|
278183|NCT00632489|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
278184|NCT00632502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278185|NCT00632541|Hoosier Cancer Research Network|Jeff Smith|317-634-5842|jsmith@hoosiercancer.org|41
278186|NCT00632619|Florida International University|James G Waxmonsky|305 348 3258|jwaxmons@fiu.edu|
278187|NCT00632632|Weill Cornell Medical College|JoAn Difede, PhD|212 746 3079|jdifede@med.cornell.edu|
278188|NCT00632736|GlaxoSmithKline|GSK Response Center|866-435-7343||
278189|NCT00632749|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
278190|NCT00632814|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
278191|NCT00632827|University of California, San Francisco|Lawrence Kaplan, MD|(415) 353-2661|LKaplan@ucsf.edu|
288242|NCT01179672|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
278192|NCT00632931|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
278193|NCT00632970|Medical Faculty Associates|Gary Simon|202 741-2234|Gsimon@mfa.gwu.edu|
298648|NCT01831232|Fred Hutchinson Cancer Research Ctr|Dr, Mazyar Shadman|206-667-5467|mshadman@fredhutch.org|
278194|NCT00633009|Nielsen BioSciences, Inc.|Stewart Nielsen|858.571.2726|stewart@nielsenbio.com|
278195|NCT00633022|GlaxoSmithKline|GSK Response Center|866-435-7343||
278196|NCT00633074|GlaxoSmithKline|GSK Response Center|866-435-7343||
288243|NCT01179919|University of Michigan|Manjunath Pai|7346473466|amitpai@med.umich.edu|
288244|NCT01179984|Bard Peripheral Vascular|Associate Director of Clinical Affairs|480-379-2838|josh.smale@crbard.com|
288245|NCT01180036|Mayo Clinic|Dr. Fernando Fervenza|507-266-1045|fervenza.fernando@mayo.edu|
288246|NCT01180049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288247|NCT01180127|Columbia University Medical Center, Division of Behavioral Medicine in Psychiatry|Richard Sloan|646-774-8940|rps7@cumc.columbia.edu|
288248|NCT01180244|Department of Mechanical Engineering, Kettering University|Dr. Jeffrey B. Hargrove||jhargrov@kettering.edu|
308855|NCT02617888|Ft. Belvoir Community Hospital|Michael K. Cheezum, MD|571-231-2159|Michael.k.cheezum.mil@mail.mil|
308856|NCT02617901|Sheffield Children's NHS Foundation Trust|Dr Amaka C Offiah|0114 271 7557|a.offiah@sheffield.ac.uk|
308857|NCT02618031|Cleveland Clinic Akron General|John Elias|330-344-6176|eliasj@ccf.org|
308858|NCT02618187|Seres Therapeutics|Dr. Michele Trucksis, Chief Medical Officer|617-945-9626|mtrucksis@serestherapeutics.com|
308859|NCT02618343|UT Health San Antonio|David Wampler, PhD, LP|210-414-9548|wamplerd@uthscsa.edu|
308860|NCT02618382|Dignity Health Research Institute|Lisa Arnold, Clinical Research Operations Manager|602-406-9593|lisa.arnold@arrowneuro.org|
308861|NCT02618512|Alexion|Alexion Medical Monitor|617-613-1071|Bert.Yao@alexion.com|
308862|NCT02618616|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
308863|NCT02618642|Rzeszow University|Jolanta Zwolińska PhD|48 505095199|jolantazwolinska@op.pl|
308864|NCT02618759|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
308865|NCT02618772|MUHC|Dr. Jennifer Turnbull|514-412-4400|jennifer.turnbull@mcgill.ca|23039
308866|NCT02618915|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|Medinfo@ultragenyx.com|
308867|NCT02618928|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
308868|NCT02618967|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
308869|NCT02619175|Loewenstein Rehabilitation Hospital|Mrs. Shirley Handelzalts|972-9-7709010|peregshir@gmail.com|
308870|NCT02619396|John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust|Dr Milena Leo|0186522055|milena.leo@ouh.nhs.uk|
308871|NCT02619409|Medical University of South Carolina|Dr. Eric Bolin|8437922322|bolin@musc.edu|
308872|NCT02619591|UMASS Memorial Department of Emergency Medicine|Executive Vice Chairman|508-421-1400|Romolo.Gaspari@umassmemorial.org|
308873|NCT02619617|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
308874|NCT02619799|Rangaraya medical college|Dr.Paleti Sophia|9948599758 ,08842343023|dr.sophia29@gmail.com|
278197|NCT00633126|Cerexa, Inc.|David Friedland, MD|510-285-9200|clinicaltrials@cerexa.com|
298649|NCT01831258|SleepMed of South Carolina|Dr Richard Bogan|8777537633|rbogan@sleepmedinc.com|
298650|NCT01831427|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
278198|NCT00633139|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
278199|NCT00633152|Cerexa, Inc.|Vice President, Clinical Sciences|510-285-9200|clinicaltrials@cerexa.com|
278200|NCT00633217|GlaxoSmithKline|GSK Response Center|866-435-7343||
278201|NCT00633243|Yale University|R. Douglas Bruce|(203) 737-6133|robert.bruce@yale.edu|
278202|NCT00633256|Yale University|James Poling, Ph.D.|203-937-4830|james.poling@yale.edu|
278203|NCT00633360|Brigham & Women's Hospital|Dr Hadine Joffe|617-732-4906|hjoffe@partners.org|
278204|NCT00633399|Massachusetts General Hospital CNTI|George I Papakostas, M.D. - Scientific Director|6177266697|gpapakostas@partners.org|
278205|NCT00633464|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
278206|NCT00633477|Takeda|Takeda Study Registration Call Center|800-778-2860|medicalinformation@tpna.com|
278207|NCT00633594|Sarah Cannon Research Institute|Ian Flinn, MD|1-877-691-7274|asksarah@scresearch.net|
278208|NCT00633750|Vanderbilt-Ingram Cancer Center|Carlos Arteaga, M.D.|(615) 936-1919||
278209|NCT00633867|NHS Grampian|W Brampton||william.brampton@nhs.net|
278210|NCT00633880|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
278211|NCT00633893|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
278212|NCT00633919|ALK-Abelló S.A.|Santiago Martín - Trial Manager|+34 913276127|santiago.martin@alk-abello.com|
278213|NCT00633932|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278214|NCT00633945|University of Pennsylvania|Dr. Victoria Werth|215-898-0168|werth@mail.med.upenn.edu|
278215|NCT00633984|Boston University|Dr. Stefan G. Hofmann|617 353 9233|shofmann@bu.edu|
278216|NCT00634036|University of Pittsburgh|Dr. Fernando Holguin|412-692-2817|holguinf@upmc.edu|
278217|NCT00634049|Astellas Pharma Global Development, Inc.|Vice President, Medical Head ID/IM/TX|(224) 205-8800|Astellas.resultsdisclosure@astellas.com|
278218|NCT00634088|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
278219|NCT00634101|Johnson & Johnson Vision|DIR CLINICAL NEW PRODUCT DEVELOPMENT|1-800-843-2020|KMoody1@its.jnj.com|
278220|NCT00634114|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278221|NCT00634166|Mylan Pharmaceuticals Inc.|Eric Davis, M.D.|304.554.6503|eric.davis@mylan.com|
278222|NCT00634179|Emory University|Christopher R. Flowers, MD, MS|404-778-3935|crflowe@emory.edu|
278223|NCT00634244|ECOG Statistical Office|Study Statistician|617-632-3012||
278224|NCT00634270|The Univ of Alabama at Birmingham|Bruce Korf, MD, PhD|205.934.5140|kcole@uab.edu|
278225|NCT00634283|Laboratory of Brain, Behavior, and Pharmacology at UCLA|Director of the Laboratory of Brain|310-825-0207|info@brain.ucla.edu|
278226|NCT00634504|BTG International Inc.|SVP, Clinical Development|610-278-1660|angela.ogden@btgplc.com|
278227|NCT00634543|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|Clinical Research Director|82-2-2094-4518||
278228|NCT00634569|Grifols|Paul J. Pinciaro, PhD|410-814-7617|paul.pinciaro@grifols.com|
278229|NCT00634621|GE Healthcare|Emilio Moreno Carretero, M.D.|011-34-9166-30970|Emilio.Morenocarretero@ge.com|
278230|NCT00634647|National Cancer Institute, National Institutes of Health|Dr. William Dahut|301-435-8183|dahutw@mail.nih.gov|
298651|NCT01831466|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278231|NCT00634751|University of Wisconsin Carbone Cancer Center|Dr. Noelle LoConte|608-265-5883|ns3@medicine.wisc.edu|
278232|NCT00634803|Yale University|Richard S. Schottenfeld, M.D.|203-974-7349|richard.schottenfeld@yale.edu|
278233|NCT00634842|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
278234|NCT00634907|University of Utah|Dr. Gwen McMillin/Principal Investigator|801-583-2787|gwen.mcmillin@aruplab.com|2671
298652|NCT01831544|Medtronic|Methee Schreuder|+31611597388|methee.schreuder@medtronic.com|
278235|NCT00634920|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
278236|NCT00634933|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278237|NCT00635024|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
278238|NCT00635050|UAB|John Carpenter, M.D.|205-910-8886 or 205-934-2084|jtc4321@bellsouth.net|
278239|NCT00635089|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
278240|NCT00635102|Yale University School of Medicine|Dr John Krystal|203-785-6396|john.krystal@yale.edu|
278241|NCT00635128|GlaxoSmithKline|GSK Response Center|866-435-7343||
278242|NCT00635154|Mayo Clinic|Dr. John Lust||lust.john@mayo.edu|
278243|NCT00635219|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
278244|NCT00635232|Ligand Pharmaceuticals|Director of Project Management|858-550-7892|hzientek@ligand.com|
278245|NCT00635349|Janssen Korea / 25F, LS Yongsan Tower, 191 Hankangro 2-Ga, Yongsan-Gu, Seoul 140-702 Korea|Clinical Research Director|82-2-2094-4518||
278246|NCT00635362|University of Chicago|Amy Whitaker, MD|773-834-4129|awhitaker@babies.bsd.uchicago.edu|
278247|NCT00635427|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
278248|NCT00635453|Universidade Federal de Ciências da Saúde de Porto Alegre|Dr. Marcia Vitolo|+555133038798|marciavitolo@hotmail.com|
278249|NCT00635479|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
278250|NCT00635492|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
278251|NCT00635570|Department of Obstetrics and Gynecology, The University of Chicago|Melissa Gilliam|773-834-0840|mgilliam@babies.bsd.uchicago.edu|
278252|NCT00635609|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
298653|NCT01831726|Novartis Pharmaceuticals|Study Director|862-778-8300||
278253|NCT00635648|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278254|NCT00635661|New York University,. Rusk Institute|Dr. Irene Ward|212-263-6073|Irene.ward@nyumc.org|
278255|NCT00635700|Yale University|Scott W. Woods, M.D.|203-974-7038|scott.woods@yale.edu|
278256|NCT00635739|Tufts University|Dr. Roger Fielding|6175563083|Roger.Fielding@tufts.edu|
278257|NCT00635778|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278258|NCT00635804|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278259|NCT00635817|Abbott|Global Medical Services|800-633-9110||
278260|NCT00635830|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278261|NCT00635999|Penn State University|Michelle G. Newman|814-863-1148|mgn1@psu.edu|
278262|NCT00636077|Kidney Disease Program, University of Louisville|Richard A Ward, Ph.D.|502-852-5757|richard.ward@louisville.edu|
278263|NCT00636155|Duke University Medical Center|Mark Lanasa, MD, PhD|919-286-6897|mark.lanasa@duke.edu|
278264|NCT00636168|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
278265|NCT00636181|Stanford Sleep Medicine Center|Clete A. Kushida, MD, PhD|(650) 721-7560|clete@stanford.edu|
278266|NCT00636194|Bausch & Lomb|Robert Steffen OD|(585) 338-6399|robert.steffen@bausch.com|
278267|NCT00636207|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278268|NCT00636220|Chembio Diagnostic Systems, Inc.|Javan Esfandiari|(631) 924-1135|jesfandiari@chembio.com|112
278269|NCT00636363|Bausch & Lomb|Robert Steffen|(585) 338-6399|robert.steffen@bausch.com|
278270|NCT00636389|Gambro Renal Products|Jeff Shideman, Ph.D.|952-835-4018|Jeff.Shideman@us.gambro.com|
278271|NCT00636441|Duke University Medical Center|P. Kelly Marcom, M.D.|919-684-3877|marco001@mc.duke.edu|
278272|NCT00636506|American Medical Systems|Men's Health Clinical Affairs|952-930-6328|Karen.Seybold@ammd.com|
278273|NCT00636610|Genentech, Inc.|Medical Communications|800-821-8590||
278274|NCT00636636|Depomed|Head of R&D|650-462-5900|msweeney@depomed.com|108
278275|NCT00636649|Duke University Medical Center|Kishore Gadde|919-668-0208|kishore.gadde@duke.edu|
278276|NCT00636675|University of North Carolina Chapel HIll|Ruth A. Anderson|919-966-8785|rutha@email.unc.edu|
278277|NCT00636701|Atlanta VA Medical Center|Dr. Andrew Butler|404-413-1415|andrewbutler@gsu.edu|
278278|NCT00636792|Millennium Pharmaceutical Inc|Carol Satler|(617) 551-3729||
278279|NCT00636805|Duke University Medical Center|Mary Lou Affronti|919-6846239|mary.affronti@dm.duke.edu|
278280|NCT00636818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
278281|NCT00636961|Novartis Pharmaceuticals|Study Director|862-778-8300||
278282|NCT00636987|St Jude Medical|Sr. Clinical Manager|6517566803|jjohnson101@sjm.com|
278283|NCT00637000|Reckitt Benckiser Pharmaceuticals, Inc.|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|804-379-1090|ed.johnson@reckittbenckiser.com|7089
278284|NCT00637156|Medtronic Spine and biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
278285|NCT00637195|GlaxoSmithKline|GSK Response Center|866-435-7343||
278286|NCT00637247|AmpliMed Corporation|Robert Dorr|520-626-7892|bdorr@azcc.arizona.edu|
278287|NCT00637273|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
278288|NCT00637299|Fondazione Salvatore Maugeri|Ercole Zanotti|39 385 247|ercole.zanotti@fsm.it|324
278289|NCT00637377|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
278290|NCT00637494|Corcept Therapeutics|Thaddeus S. Block, MD|(650) 688-8816|tblock@corcept.com|
278291|NCT00637572|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
278292|NCT00637780|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
278293|NCT00637923|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
278294|NCT00638014|Duke University|Elliott Bennett-Guerrero|9196819660|benne011@mc.duke.edu|
278295|NCT00638027|University of Rochester|Cynthia Irish, RN, MSCN|585-275-6120|cindy_irish@urmc.rochester.edu|
278296|NCT00638157|Cubist Pharmaceuticals|Ed Campanaro / Vice President, Clinical Operations|781-860-8318|ed.campanaro@cubist.com|
288249|NCT01180296|Fetal Medicine Foundation?USA|David McKenna|937-208-4005|dsmckenna@mvh.org|
288250|NCT01180400|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
288251|NCT01180478|CROES|J. de la Rosette, chairman CROES|+31 20 5666030|info@croesoffice.org|
288252|NCT01180647|NYU School of Medicine|Joshua D. Lee|212-263-4242|joshua.lee@nyumc.org|
288253|NCT01180660|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
288254|NCT01180777|Johnson & Johnson Vision Care|Michael S. Mayers, O.D., FAAO|1-904-443-3252|MMayers@its.jnj.com|
288255|NCT01180790|Achillion Pharmaceuticals, Inc.|Kevin Kucharski, VP Clinical Operations|203-624-7000|Kkucharski@achillion.com|
288256|NCT01180894|Denver Health Hospital|Dr. Fredric Pieracci|303-436-4029|fredric.pieracci@dhha.org|
288257|NCT01180985|Johnson & Johnson Vision Care|John Buch, OD, MS, FAAO|1 904 443-1707|jbuch@its.jnj.com|
288258|NCT01180998|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|KOsborn@its.jnj.com|
288259|NCT01181011|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|800-542-6257|clintriage.rdg@boehringer-ingelheim.com|Option 4
288260|NCT01181050|Novo Nordisk A/S|Public Access to Clinical Trials||RA-RNDUS-ClinTriDisc@ITS.JNJ.com|
288261|NCT01181076|Oslo University Hospital|Kristin Skaarud|4723070000|kskaarud@ous-hf.no|
288262|NCT01181102|Daiichi Sankyo.,LTD|Kei Ibusuki, Associate Director|81-90-2732-9505|ibusuki.kei.tx@daiichisankyo.co.jp|
298654|NCT01831765|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
288263|NCT01181128|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
288264|NCT01181141|Daiichi Sankyo.,LTD|Kenichi Sakakura, Manager|81-90-1885-0271|sakakura.kenichi.ef@daiichisankyo.co.jp|
278297|NCT00638183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
278298|NCT00638235|Eastern Virginia Medical School|Dr. James C Lukban, Professor & Director Division of urogynecology|7574467900|lukbanjc@evms.edu|
278299|NCT00638274|Wake Forest University School of Medicine|Peter H. Pan, MD|336-718-82748|ppan@wakehealth.edu|
278300|NCT00638365|KaloBios Pharmaceuticals, Inc.|Nestor A. Molfino, MD., MSc|650-243-3103|nmolfino@kalobios.com|
278301|NCT00638378|Incyte Corporation|Study Director|1-855-463-3463||
278302|NCT00638404|Wake Forest School of Medicine-Anesthesiology|Peter H. Pan MD, MSEE|336-718-8278|ppan@wakehealth.edu|
278303|NCT00638443|University of Rochester|John Markman, MD|585-340-8926|maria_frazer@urmc.rochester.edu|
278304|NCT00638456|Univeristy of California, San Diego|Dr. Ranjan Dohil|(858) 966-4003|rdohil@ucsd.edu|
278305|NCT00638508|Maimonides Medical Center|Kalpana Tyagaraj, M.D.|718-283-9162|Kalpana_tyagaraj@msn.com|
278306|NCT00638651|University of Miami|Dr. Keyvan Nouri|305-243-3380|knouri@med.miami.edu|
278307|NCT00638690|Johnson & Johnson Pharmaceutical Research & Development|Senior Director, Clinical Research|310-914-2915||
278308|NCT00638716|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
278309|NCT00638820|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
278310|NCT00638846|Vistakon|Kurt Moody OD|904-443-3088||
278311|NCT00638885|Atlanta VAMC|J Douglas Bremner MD|404-712-9569|jdbremn@emory.edu|
278312|NCT00638924|Unicamp|Juliana Gomes Zabatiero||juzabatiero@yahoo.com.br|
278313|NCT00638937|The Ottawa Hospital Cancer Centre|Dr. Scott Laurie|613-737-7700|slaurie@ottawahospital.on.ca|70175
278314|NCT00638963|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
278315|NCT00638989|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
278316|NCT00639002|Incyte Corporation|Study Director|855 463-3463||
278317|NCT00639093|GRAP, Clinique de Psychologie au Travail|Benoît Girard|418-542-2030|g.r.a.p@videotron.ca|
278318|NCT00639158|Abbott|Global Medical Services|800-633-9110||
278319|NCT00639223|U. of Pennsylvania Health System|Steven Halbert MD, MSCE|215 510 2221|shalbert@mail.med.upenn.edu|
278320|NCT00639379|Vistakon|Kurt Moody, OD|904-443-3088||
278321|NCT00639418|MedImmune LLC|Chris Ambrose|301-398-0000|ambrosec@medimmune.com|
278322|NCT00639457|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
278323|NCT00639509|Memorial Sloan-Kettering Cancer Center|Ghassan K. Abou-Alfa, MD|646-888-4184|abou-alg@mskcc.org|
278324|NCT00639678|GlaxoSmithKline|GSK Response Center|866-435-7343||
278325|NCT00639717|University of Michigan Comprehensive Cancer Center|Dr. Gregory Yanik|734-764-3243|jelevine@umich.edu|
278326|NCT00639769|Vanderbilt-Ingram Cancer Center|Barbara Murphy, M.D.||barbara.murphy@vanderbilt.edu|
278327|NCT00639860|University of Michigan School of Dentistry|Dr. William Giannobile, Chair Department of Periodontics and Oral Medicine|734-763-2105|wgiannob@umich.edu|
278328|NCT00640016|MedImmune, LLC|Meena Jain, MB BChir/Associate Medical Director|301-398-0000|jainm@medimmune.com|
278329|NCT00640042|King Pharmaceuticals, Inc.|Professional Information Services|1-800-776-3637||
278330|NCT00640133|Butler Hospital|Dr. Benjamin Greenberg|(401) 455-6602|be3ngreenb@gmail.com|26602
278331|NCT00640146|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
278332|NCT00640224|Children's Hospital of Pittsburgh of UPMC|Dr. Silva Arslanian|412-692-6935||
278333|NCT00640250|Institute of Clinical Research, Department of Dermoto Venerology and Allergy Center|Evy Paulsen, MD|+45 65 41 27 08||
278334|NCT00640289|Children's Hospital of Orange County|Clinical Trial Coordinator||KBirschbach@choc.org|
278335|NCT00640315|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
278336|NCT00640328|GlaxoSmithKline|GSK Response Center|866-435-7343||
278337|NCT00640341|Bausch & Lomb Incorporated|Gerard Cairns|(585) 338-5170|gerard.cairns@bausch.com|
278338|NCT00640393|Innovaderm Research Inc|Annie Levesque|514-521-4285|alevesque@innovaderm.ca|222
278339|NCT00640510|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298655|NCT01831791|GlaxoSmithKline|GSK Response Center|866-435-7343||
278340|NCT00640562|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
278341|NCT00640601|AstraZeneca|Gerard Lynch|441625 518062|aztrial_results_posting@astrazeneca.com|
278342|NCT00640614|Allerderm|Kim Sullivan|602-225-0595||
278343|NCT00640653|University of Pennsylvania|Dr. John B. Jemmott III|215-573-9366|jjemmott@asc.upenn.edu|
278344|NCT00640822|LeoPharma|Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
278345|NCT00640835|Reckitt Benckiser Pharmaceuticals, Inc.|Rolley E. Johnson, PharmD, Vice President, Clinical, Scientific and Regulatory Affairs|804-379-1090|ed.johnson@reckittbenckiser.com|7089
278346|NCT00640926|Melinta Therapeutics, Inc.|Sue Cammarata, MD|(203) 624-5606|scammarata@melinta.com|
278347|NCT00640978|UT MD Anderson Cancer Center|Milind Javle, MD/Associate Professor|713-792-2828|mjlim@mdanderson.org|
278348|NCT00641043|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
278349|NCT00641056|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
278350|NCT00641147|Johns Hopkins University|Study Coordinator|410-955-3817|lhylind1@jhmi.edu|
278351|NCT00641563|University Hospital Bern, Switzerland|Dr. M. Hänggi|0316323029|matthias.haenggi@insel.ch|
278352|NCT00641641|University of New South Wales|Sean Emery|9385 0900|semery@kirby.unsw.edu.au|
278353|NCT00641667|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
278354|NCT00641706|Mayo Clinic|Evanthia Galanis, M.D.|(507) 284-3902|Galanis.evanthia@mayo.edu|
278355|NCT00641719|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
278356|NCT00641745|Sunovion|Josephine Cucchiaro, PhD; Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
278357|NCT00641797|Lehigh Valley Health Network|Regina Sacco, DPT, BA, BHSC|610-969-0300|Regina_R.Sacco@lvhn.org|
278358|NCT00641862|Harvard T.H. Chan School of Public Health|Dr. Christopher Duggan|617-355-7612|christopher.duggan@childrens.harvard.edu|
278359|NCT00642018|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
278360|NCT00642174|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288265|NCT01181167|Daiichi Sankyo Co., Ltd.|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
278361|NCT00642278|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
278362|NCT00642304|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
278363|NCT00642356|Novartis Pharmaceuticals|Study Director|862 778-8300||
278364|NCT00642369|Guang Dong Provinical Mental Health Institute|Zhang Bin|86-20-81888553|zhang73bin@hotmail.com|
278365|NCT00642460|Hoffman-LaRoche|Medical Communications|800-821-8590||
278366|NCT00642473|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
278367|NCT00642616|Sanofi|Trial Transparency Team||ContactUS@sanofi.com|
278368|NCT00642642|Biologics Consulting Group|Dr/ Joseph Fratantoni|(301) 340-8432|jfratantoni@bcg-usa.com|
278369|NCT00642668|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
278370|NCT00642694|UT Southwestern Medical Center|Dr.Prabha Sunderajan- Assistant Professor|214-645-6964|psunderajan@utsouthwestern.edu|
278371|NCT00642707|CytoDyn, Inc.|Kush Dhody|301-956-2536|kushd@amarexcro.com|
278372|NCT00642746|OHSU Knight Cancer Institute|Charles Lopez, MD|503-494-8534|lopezc@ohsu.edu|
278373|NCT00642759|Massachusetts General Hospital|Dr. Rebecca Heist|6177244000|rheist@partners.org|
278374|NCT00642772|Center for Health Services Research in Primary Care, Durham VA Medical Center|Dr. Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
278375|NCT00642811|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278376|NCT00642850|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
278377|NCT00642902|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
298656|NCT01831804|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
278378|NCT00642941|F. Hoffmann-La Roche AG|Study Director|+41 616878333|global.trial_information@roche.com|
278379|NCT00642954|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278380|NCT00642993|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278381|NCT00643006|Gothenburg University|Dr. K Mannerkorpi|046-31-24220|kaisa.mannerkorpi@rheuma.gu.se|
278382|NCT00643097|Duke University Medical Center|Dr. John H. Sampson|919-684-9041|john.sampson@duke.edu|
278383|NCT00643123|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
278384|NCT00643162|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
278385|NCT00643201|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
278386|NCT00643279|Medtronic|Dana Wigert|763-526-2802|dana.wigert@medtronic.com|
278387|NCT00643448|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278388|NCT00643487|Upstate Medical University|Thomas V. Smallman|315-464-8618|smallmat@me.com|
278389|NCT00643565|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
278390|NCT00643578|University of Florida Asthma Research Lab|Dr. Leslie Hendeles|352-273-6027|hendeles@cop.ufl.edu|
278391|NCT00643604|United Therapeutics Corporation|Remodulin Program Leader|919-485-8350|clinicalrecordsmanagement@unither.com|
278392|NCT00643682|Boston Medical Center|Brian Jacobson, MD, Principal Investigator|6176386563|brian.jacobson@bmc.org|
278393|NCT00643760|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
278394|NCT00643851|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
278395|NCT00643864|CarolinasHS|Dr. Mark Hirsch, Senior Scientist|704 355 7673|mark.hirsch@carolinashealthcare.org|
278396|NCT00643916|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
288266|NCT01181258|Masonic Cancer Center, University of Minnesota|Dr. Veronika Bachanova|612-625-5469|bach0173@umn.edu|
288267|NCT01181271|Mass General Hospital|Yi-Bin Chen, MD|617-726-5765|ychen6@partners.org|
288268|NCT01181323|Cincinnati Children's Hospital Medical Center|Mark Steinhoff, MD|513-636-2791|Mark.steinhoff@cchmc.org|
288269|NCT01181349|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
288270|NCT01181479|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
288271|NCT01181492|Huazhong University of Science&Technology|Zhang Xianwei|027 83662853|ourpain@163.com|
288272|NCT01181531|Amgen Inc.|Study Director|866-572-6436||
298657|NCT01831817|GlaxoSmithKline|GSK Response Center|866-435-7343||
288273|NCT01181596|University of California - San Diego|Jae Kim, MD|619-543-3759|neojae@ucsd.edu|
288274|NCT01181609|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
288275|NCT01181674|McMaster University|Dr. Natalia McInnes (nee Yakubovich)|905-521-2100|natalia.mcinnes@mcmaster.ca|
288276|NCT01181726|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
288277|NCT01181804|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
288278|NCT01181895|GlaxoSmithKline|GSK Response Center|866-435-7343||
288279|NCT01181947|St. Antonius Ziekenhuis|Dr. Robin Heijmen|0031306092047|r.heijmen@antoniusziekenhuis.nl|
288280|NCT01181986|Phoenix VA Health Care System|Dr. Juraj Koska|602-277-5551|juraj.koska@va.gov|7685
288281|NCT01182103|Kaohsiung Chang Gung Memorial Hospital|Tiao-Lai Huang|886-7-7317123|a540520@adm.cgmh.org.tw|8753
288282|NCT01182181|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
278397|NCT00644059|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
278398|NCT00644189|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
278399|NCT00644228|SWOG Statistical Center|Study Statistician|206-667-4623||
278400|NCT00644280|University of California San Francisco|Shan C. Lin, MD|415-353-2608|lins@vision.ucsf.edu|
278401|NCT00644332|Gilead Sciences|Emmanuelle Bellemin, Senior Manager, Regulatory Affairs||emmanuelle.bellemin@gilead.com|
278402|NCT00644358|Allergan, Inc.|Therapeutic Area Head|1-877-277-8566|IR-CTRegistration@allergan.com|
278403|NCT00644423|Durham VA Medical Center|Christine Marx, MD MA|919-286-0411|marx0001@mc.duke.edu|3626
278404|NCT00644592|University of Florida|Reginald F. Frye, PhD, Associate Professor|3522735453|fryerf@ufl.edu|
278405|NCT00644657|University of Oklahoma Health Sciences Center|Eliot Schechter, MD|405-456-5378|eliot-schechter@ouhsc.edu|
278406|NCT00644787|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
278407|NCT00644878|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
278408|NCT00644917|Smith & Nephew Biotherapeutics|Jaime E Dickerson, Jr, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
278409|NCT00644969|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278410|NCT00644995|Group Health Cooperative|Jennifer McClure, PhD|206-287-2737|mcclure.j@ghc.org|
278411|NCT00645047|University of California San Diego|Zia Agha|858-552-8585|zagha@ucsd.edu|
278412|NCT00645099|Janssen-Cilag Germany|EMEA Therapeutic Area Leader CNS|+492137955153||
278413|NCT00645164|DFB Pharmaceuticals|Herbert B. Slade MD, FAAAAI|817.302.3919|bert.slade@dfbpharmaceuticals.com|
278414|NCT00645333|University of Michigan|Anne F. Schott, MD|1-800-865-1125|canceranswerline@umich.edu|
278415|NCT00645411|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
278416|NCT00645450|Manchester VA Medical Center|Dr. Scott P. Orr|603-624-4366|scott.orr@va.gov|6565
278417|NCT00645528|Hunter Holmes McGuire VA Medical Center|Sonja K Fredrickson, MD|804-675-5151|sonja.fredrickson@va.gov|
278418|NCT00645593|University of Michigan Comprehensive Cancer Center|Dr. Maha Hussain, M.D.|(734) 647-8903|mahahuss@umich.edu|
278419|NCT00645671|Bausch & Lomb|Dr. Tuyen Ong|(973) 360-6389|Tuyen.Ong@bausch.com|
278420|NCT00645710|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
278421|NCT00645762|Entellus Medical|Entellus Medical|763-463-1599||
278422|NCT00645788|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
278423|NCT00645827|Emory University|G. Randy Smith Jr.|404.686.6730|grsmith@emory.edu|
278424|NCT00645840|UT Southwestern Medical Center|Perrin White|214 648 6875|perrin.white@utsouthwestern.edu|
278425|NCT00645853|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278426|NCT00645944|Yale University|Cenk Tek, M.D.|203-974-7484|cenk.tek@yale.edu|
278427|NCT00645970|James A. Haley Veterans' Hospital|Kristin Phillips|813-972-2000|kristin.phillips3@va.gov|6721
278428|NCT00646048|Boston Scientific|Colleen Holthe, Clinical Project Manager|651-581-4632|Colleen.Holthe@bsci.com|
278429|NCT00646113|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
278430|NCT00646399|Biosynexus|Irwin Scher, MD|301-330-5800|irwinscher@biosynexus.com|
278431|NCT00646451|Baylor College of Medicine|Dr. Joseph Jankovic|713-798-6556|josephj@bcm.edu|
278432|NCT00646581|UMass Medical School|Matthew Goodnow|508-856-2494|matthew.goodnow@umassmed.edu|
278433|NCT00646646|University of Alabama at Birmingham|Dr. Michael Froelich|205-934-4711|froelich@uab.edu|
278434|NCT00646763|Emory University Winship Cancer Institute|Edmund Waller, MD, PhD|1-888-946-7447|ewaller@emory.edu|
298658|NCT01831856|Institut de Recherche Pierre Fabre|Karim KEDDAD, MD, PhD Head of Medical Unit|+33 5 34 50 61 69|Karim.keddad@pierre-fabre.com|
278435|NCT00646776|Bristol-Myers Squibb|BMS Study Director||ClinicalTrials@bms.com|
278436|NCT00646906|University of Pennsylvania|Tilo Grosser, MD|215-573-7600|tilo@pennmedicine.upenn.edu|
278437|NCT00646958|Melinta Therapeutics|Eugene Sun, M.D.|203.624.5606|esun@melinta.com|
278438|NCT00647270|Abbott|Global Medical Services|800-633-9110||
278439|NCT00647296|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
278440|NCT00647348|University of London|Professor Jeremy Chataway, Chief Investigator|07974752295|j.chataway@ucl.ac.uk|
278441|NCT00647400|Abbott|Global Medical Services|800-633-9110||
278442|NCT00647556|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
278443|NCT00647699|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
278444|NCT00647998|Hospital of the University of Pennsylvania|Steven Messe, MD|2156623363|messe@mail.med.upenn.edu|
278445|NCT00648037|Memorial Sloan Kettering Cancer Center|Papadopoulos, Esperanza, MD (Attending)|+1212-639-8276|papadope@mskcc.org|
298659|NCT01831921|Wake Forest School of Medicine|Mara Z. Vitolins, DrPH, MPH, RDN|(336) 716-2886|mvitolin@wakehealth.edu|
278446|NCT00648115|VA North Texas Health Care System|James LePage|210-857-0240|james.lepage@va.gov|
278447|NCT00648167|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
278448|NCT00648375|Yale School of Medicine|Margaret Altemus|646-209-6277|margaret.altemus@yale.edu|
278449|NCT00648648|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278450|NCT00648739|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
278451|NCT00648908|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
278452|NCT00649220|Merz Pharmaceuticals GmbH|Manager Public Disclosure|+49 69 1503 865|matthias.zerm@merz.de|
298660|NCT01831934|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
278453|NCT00649389|Daiichi Sankyo|Howard Kessler|732-590-5032|hmkessler@dsi.com|
278454|NCT00649428|CBR International Corp.|Kevin Hennegan|720-746-1190|khennegan@cbrintl.com|
278455|NCT00649792|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
278456|NCT00649961|Imperial College London|Dr Nazakat Merchant|00447825881907|nazakat.merchant@kcl.ac.uk|
278457|NCT00650078|Horizon Pharma|Senior Vice President, Clinical Development & Operations|224-383-3012|agrahn@horizonpharma.com|
278458|NCT00650091|Duke Clinical Research Institute|Kevin J Anstrom|919-668-8902|kevin.anstrom@duke.edu|
278459|NCT00650104|GlaxoSmithKline|GSK Response Center|866-435-7343||
278460|NCT00650260|University of South Florida Dept of Surgery/Anesthesiology|Enrico Camporesi MD|813-844-7170|ecampore@health.usf.edu|
278461|NCT00650546|Department of Gastroenterology, San Antonio Uniformed Services Health Consortium|Patrick R Kenney, DO||pat.kenney@us.army.mil|
278462|NCT00650585|PIRE|Heddy Clark|919-265-2643|hclark@pire.org|
278463|NCT00650767|Array BioPharma, Inc.|Study Director|303-381-6604|clinicaltrials@arraybiopharma.com|
278464|NCT00650806|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 800 526 7736||
278465|NCT00650845|Guerbet|Pierre Desché, MD - VP Development, Medical and Regulatory Affairs.|+33 1 45 91 50 00|pierre.desche@guerbet-group.com|
278466|NCT00650858|Johns Hopkins University|Daniel F. Hanley, MD|410-614-6996|dhanley@jhmi.edu|
278467|NCT00650936|Abbott|Maren Wagner, Clinical Program Director|7517565585|maren.wagner@abbott.com|
278468|NCT00651040|Rheumatology Institute Prague|Rheumatology Institute Prague|+420234075111|vencovsky@revma.cz|
278469|NCT00651118|Meda Pharmaceutical|David Ginsberg,..|732 564 2364|david.ginsberg@meda.us|
278470|NCT00651157|Mayo Clinic Cancer Center|Evanthia Galanis, M.D.||galanis.evanthia@mayo.edu|
278471|NCT00651183|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Pharmaceuticals|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
278472|NCT00651261|Dana Farber Cancer Institute|Richard Stone, MD||rstone@partners.org|
278473|NCT00651313|Columbia Laboratories, Inc.|George W. Creasy, MD Vice President, Clinical Research|973-486-8797|gcreasy@columbialabs.com|
278474|NCT00651482|Stanford University Medical Center|Associate Professor of Medicine (Oncology)|650-725-2078|sandysri@stanford.edu|
278475|NCT00651573|Cleveland Clinic Foundation|Daniel Sessler, MD|216-4444900|ds@or.org|
298661|NCT01831960|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
278476|NCT00651625|University of New Mexico|Wilmer L. Sibbitt, MD, Principal Investigator|505 272-4761|wsibbitt@salud.unm.edu|
278477|NCT00651664|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
278478|NCT00651755|University of Texas MD Anderson Cancer Center|Saroj Vadhan-Raj, MD / Professor||xzhou@mdanderson.org|
278479|NCT00651794|University of Texas HSC-Houston|Dr. Eric Thomas|713-500-7958|Eric.Thomas@uth.tmc.edu|
278480|NCT00651820|Healthpoint, Ltd.|Herbert B. Slade, M.D., FAAAI|817-900-4000|bert.slade@healthpoint.com|
278481|NCT00651924|VA Connecticut Healthcare System|Robert Kerns, Ph.D.|203-932-5711|robert.kerns@va.gov|3841
278482|NCT00651937|The University of Texas (UT) MD Anderson Cancer Center|Dr. Richard E Champlin,MD/Chair, Stem Cell Transplantation|713- 203-8632|rchampli@mdanderson.org|
278483|NCT00652028|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
278484|NCT00652080|Berg LLC|Nathaniel DiTommaso|617-588-1002|nate.ditommaso@berghealth.com|
278485|NCT00652093|Translational Pain Research, University of Rochester Medical Center|Dr. John D. Markman, MD|585-276-3616|john_markman@urmc.rochester.edu|
278486|NCT00652145|University of Pennsylvania|James D. Lewis, MD, MSCE|215-573-5137|lewisjd@mail.med.upenn.edu|
278487|NCT00652314|Vascular Solutions, Inc.|Lisa Gallatin, RAC|763-656-4399|lgallatin@vasc.com|
298662|NCT01832038|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
278488|NCT00652340|Tragara Pharmaceuticals|Tracy Parrott|858-350-6919|tparrott@tragarapharma.com|
278489|NCT00652366|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
278490|NCT00652626|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
278491|NCT00652743|GlaxoSmithKline|GSK Response Center|866-435-7343||
278492|NCT00652834|UCLA Kidney Transplant Research Program|Dr. Bunnapradist|310-794-8516|bunnapradist@mednet.ucla.edu|
278493|NCT00652899|University of Minnesota, Dept. Ob/Gyn|Melissa Geller, M.D.|612-626-3111|gelle005@umn.edu|
278494|NCT00652938|GlaxoSmithKline|GSK Response Center|866-435-7343||
278495|NCT00652951|GlaxoSmithKline|GSK Response Center|866-435-7343||
278496|NCT00653068|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
288283|NCT01182194|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
288284|NCT01182207|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
288285|NCT01182285|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
288286|NCT01182298|NIAID|Shyam Kottilil||Skottilil@niaid.nih.gov|
288287|NCT01182337|DePuy Synthes Spine|Mark Lotito|508-880-8045|Mlotito@its.jnj.com|
288288|NCT01182350|Dana-Farber Cancer Institute|Karen Wright|617.632.6740|KarenD_Wright@dfci.harvard.edu|
288289|NCT01182376|University of Utah|Clinical Research Manager|8015873889|christina.pacchia@hsc.utah.edu|
288290|NCT01182415|Massachusetts General Hospital|Dr. Yi-Bin Chen|617-726-0187|YCHEN6@PARTNERS.ORG|
288291|NCT01182428|Abbott Vascular|Ellen Travis, Clinical Science|408-845-3000|Ellen.Travis@av.abbott.com|
288292|NCT01182441|Boston Scientific|WATCHMAN Trial Manager|1-800-227-3422||
288293|NCT01182480|Denver Health and Hospital Authority|Andrew W. Steele, MD, MPH, MSc|303-602-9773|andy.steele@dhha.org|
288294|NCT01182493|CHU Caen|Prof. Yves Reznik|+33231064585|reznik-y@chu-caen.fr|
288295|NCT01182675|UCSF|Christopher C. Dvorak, MD|415-476-2188|dvorakc@peds.ucsf.edu|
288296|NCT01182727|Maryland Psychiatric Research Center|Dr. Robert Buchanan, M.D.|410-402-7876|rwbuchanan@mprc.umaryland.edu|
288297|NCT01182805|University of Michigan|Theodore J. Kolias, MD|(734) 615-4907|tkolias@umich.edu|
298663|NCT01832090|Merz North America, Inc.|Ashlee Duncan|984-222-6040|ashlee.duncan@merz.com|
278497|NCT00653133|I-Flow Corporation|Alan Dine Director of Clinical Research|513-253-8033|alan.dine@kcc.com|
278498|NCT00653159|The University of Chicago Department of Health Studies, Biostatistics Laboratory|Dr. Sydeaka Watson, PhD|773-834-2378|swatson@health.bsd.uchicago.edu|
278499|NCT00653224|UCB Pharma|UCB Clinical Trial Call Center|+1 877 822 9493||
278500|NCT00653263|UArkansas|Michael J Mancino|501-526-8442|mjmancino@uams.edu|
278501|NCT00653328|Vanderbilt-Ingram Cancer Center|Marta Crispens, M.D.|800-811-8480|marta.crispens@vanderbilt.edu|
298664|NCT01832155|University of Minnesota|Corjena Cheung, Assistant Professor|612-624-5198|corjena@umn.edu|
278502|NCT00653432|Anika Therapeutics, Inc.|Adrian Orr, Director Clinical Affairs|781.457.9000|aorr@anikatherapeutics.com|
278503|NCT00653861|Allergan Medical|Therapeutic Area Head|(805) 961-5500|devicetrials@allergan.com|
278504|NCT00653939|OXiGENE, Inc.|Chief Executive Officer|650-635-7000|info@oxigene.com|
278505|NCT00653991|Annenberg School for Communication and Journalism, University of Southern California|Professor Lynn Carol Miller|310-874-3402|lmiller@usc.edu|
278506|NCT00654004|Oregon Health & Science Univeristy|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
278507|NCT00654030|University of Kentucky|Dr. Edward Hirschowitz|859-323-5045|eahirs2@uky.edu|
278508|NCT00654069|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
278509|NCT00654147|University of Miami School of Medicine|Director AIDS Clinical Research Unit|305-243-3838|mfischl@med.miami.edu|
278510|NCT00654186|Oncology Specialists, SC|Sigrun Hallmeyer, MD|847-268-8200|shallmeyer@oncmed.net|
278511|NCT00654238|Abramson Cancer Center at the University of Pennsylvania|Dr. Marcia Brose|215-746-6344|brosem@mail.med.upenn.edu|
278512|NCT00654329|Children's National Medical Center|Julia C. Finkel, MD|202-476-4867|jfinkel@cnmc.org|4867
278513|NCT00654355|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3885|sfeldman@wfubmc.edu|
278514|NCT00654368|Amgen Inc.|Study Director|866-572-6436||
278515|NCT00654381|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
278516|NCT00654420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278517|NCT00654498|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
278518|NCT00654511|Children's National Medical Center|Julia Finkel, MD|202-476-4867|jfinkel@cnmc.org|4867
278519|NCT00654615|Wake Forest University Health Sciences|Zhongyu Li, MD, PhD, Professor - Department of Orthopaedic Surgery|336-716-9520|zli@wakehealth.edu|
278520|NCT00654641|West Viginia University|Michael L. Stitely, MD|304-293-1566|mstitely@hsc.wvu.edu|
278521|NCT00654654|CBR International Corp.|Kevin Hennegan|(720)746-1190|khennegan@cbrintl.com|
278522|NCT00654732|UT MD Anderson Cancer Center|Dr. Hun Ju Lee, Associate Professor, Lymphoma/Myeloma|713 794-1829|hunlee@mdanderson.org|
278523|NCT00654745|Daiichi Sankyo|James McCarthy|732-590-3430|jmccarthy@dsi.com|
278524|NCT00654784|Santhera|Thomas Meier|+4161 906 8964|thomas.meier@santhera.com|
278525|NCT00654836|Loyola University|Shelly S. Lo, M.D.|708-327-3154|shlo@lumc.edu|
278526|NCT00654875|Novartis Pharmaceuticals|Study Director|862-778-8300||
278527|NCT00654901|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
278528|NCT00654927|Acorda Therapeutics, Inc.|Andrew Blight, PhD Chief Scientific Officer|914-347-4300|ablight@acorda.com|4102
278529|NCT00654940|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
278530|NCT00654953|UAMS|Alison Oliveto, Ph.D.|501-526-8441|olivetoalison@uams.edu|
278531|NCT00655083|Menarini Group- Clinical Research|Angela Capriati, Clinical research Director|+ 39-055 56809990|acapriati@menarini-ricerche.it|
278532|NCT00655356|CBR International Corp.|Kevin Hennegan|720-746-1190|khennegan@cbrintl.com|
278533|NCT00655473|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
278534|NCT00655486|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
278535|NCT00655499|GERCOR|Regulatory affairs|00331 40 29 85 00|Regulatory.Affairs@gercor.com.fr|
278536|NCT00655538|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
298665|NCT01832259|Huntsman Cancer Institute / University of Utah|Josiah Lyn Hawks|801-585-0601|Josiah.Hawks@hci.utah.edu|
278537|NCT00655551|UCB, Inc|UCB Clinical Trial Call Center|+1 877 822 9493||
278538|NCT00655564|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wakehealth.edu|
288298|NCT01182844|Medical University of Graz|Dr. Norbert Tripolt|+43 316 385|norbert.tripolt@medunigraz.at|78038
288299|NCT01183013|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288300|NCT01183065|Memorial Sloan Kettering Cancer Center|Ho, Alan, MD, PhD (Assistant Attending)|+1646-888-4235|HoA@mskcc.org|
288301|NCT01183104|Japan Association for Diabetes Education and Care|Prof. Yasuo Terauchi|+81-3-3514-1721|terauchi-tky@umin.ac.jp|
288302|NCT01183143|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
288303|NCT01183169|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
298666|NCT01832402|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
288304|NCT01183234|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
288305|NCT01183260|Cleveland Clinic|Alison Klika, Research Program Manager|216-444-4954|klikaa@ccf.org|
288306|NCT01183312|Emory University School of Medicine|Dr. Lynn Marie Trotti|404-728-4752|lbecke2@emory.edu|
288307|NCT01183390|TEVA Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
298667|NCT01832480|Tulane University School of Public Health and Tropical Medicine|Patricia Kissinger, Ph.D.|504-988-7320|kissing@tulane.edu|
278539|NCT00655629|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
278540|NCT00655642|Vanderbilt University|Dr. Tyler Barrett|6159360253|tyler.barrett@vanderbilt.edu|
278541|NCT00655668|Celgene|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
278542|NCT00655707|ImperialC|Professor Nagy Habib|+442033138574|nagy.habib@imperial.ac.uk|
278543|NCT00655733|Hutchison MediPharma|Hua Mu,Senior Vice President of Clinical Research and Development|861 3564487805|huam@hmplglobal.com|
278544|NCT00655746|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
278545|NCT00655811|University of Miami|Gil Yosipovitch, MD, Professor|305-243-5121|gyosipovitch@med.miami.edu|
278546|NCT00655850|University of Alabama at Birmingham|Francisco Robert, MD|205-934-5077|pacorobertuab@cs.com|
278547|NCT00655863|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
278548|NCT00655876|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
278549|NCT00655889|Biologics Consulting Group|Dr. Joseph Fratantoni|(301) 340-8432|jfratantoni@bcg-usa.com|
278550|NCT00655928|Imperial College LOndon|Mark J Griffiths|+44 (0) 2073518523|m.griffiths@imperial.ac.uk|
278551|NCT00655980|University of Chicago Medicine|Principal Investigator|7737022544||
278552|NCT00656019|StanfordU|Dr. Melinda Telli|650-724-9533|steinhau@stanford.edu|
278553|NCT00656058|National Cancer Institute|Dr. Ronald E. Gress|301-496-1791|gressr@dc10a.nci.nih.gov|
278554|NCT00656084|New York Oncology Hematology|Dr. Lawrence E. Garbo|(518) 489-0044|Lawrence.Garbo@usoncology.com|
278555|NCT00656136|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308875|NCT02620020|Regeneron Pharmaceuticals|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
278556|NCT00656175|UCLA CARE Center|Dr. Jordan Lake|310-557-9679|jlake@mednet.ucla.edu|
278557|NCT00656201|Brigham and Women's Hospital|Elena Yanushpolsky, MD|617-732-4648|lgreenberg@partners.org|
278558|NCT00656292|Mayo Clinic|Michael J. Brown, M.D.|507-284-6317|Brown.Michael3@mayo.edu|
308876|NCT02620384|Aultman Hospital|Director of Research Programs|330-363-7274|mary.amos@aultman.com|
278559|NCT00656305|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
278560|NCT00656370|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
278561|NCT00656448|The University of Texas M. D. Anderson Cancer Center|Jorge Cortes M.D./Professor|713/794-5783|eharriso@mdanderson.org|
278562|NCT00656474|Glycotex|Dr. Reinhard Koenig, CEO|301-670-2825|Reinhard.Koenig@glycotexinc.com|
308877|NCT02620683|University of North Carolina Chapel Hill|Dr Raymond P. White Jr|919-537-3944|ray_white@unc.edu|
278563|NCT00656487|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
278564|NCT00656513|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
308878|NCT02620774|Center for Anti-infective Research and Development|David Nicolau|860-972-3941|david.nicolau@hhchealth.org|
278565|NCT00656617|University of Texas (UT) MD Anderson Cancer Center|Guillermo Garcia-Manero, MD/Professor, Leukemia Department|713-745-3428|CR_Study_Registration@mdanderson.org|
278566|NCT00656630|The Scripps Research Institute|Barbara J. Mason, Ph.D.-Principal Investigator|858784-7328|mason@scripps.edu|
278567|NCT00656656|University of Lübeck|Prof. Dr. Detlef Zillikens|+49-451-500-41500|detlef.zillikens@uksh.de|
278568|NCT00656669|IndianaU|Dr. Kathy Miller|317-944-0920||
278569|NCT00656799|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
278570|NCT00656851|Washington Univ Med Sch|Kevin Yarasheski, PhD|3143628173|key@wustl.edu|
278571|NCT00656968|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|886-7-3422121|pihsu@isca.vghks.gov.tw|8233
278572|NCT00657020|GlaxoSmithKline|GSK Response Center|866-435-7343||
278573|NCT00657046|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
278574|NCT00657150|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
278575|NCT00657267|Dana-Farber Cancer Institute / Brigham & Women's Hospital|Patrick Y. Wen, MD|617-632-2166|pwen@partners.org|
278576|NCT00657280|Stanford Hospital and clinics|Dr. Michael Fowler Director of the Heart Failure|650-721-5540|mfowler@stanford.edu|
278577|NCT00657358|UAB|Dr. Michael Froelich|205-975-0145|froelich@uab.edu|
278578|NCT00657371|UT MD Anderson Cancer Center|Robert S. Bresalier, MD / Professor||CR_Study_Registration@mdanderson.org|
278579|NCT00657540|Rocky Mountain Poison and Drug Center|Victoria Anderson - Research Projects Manager|303-389-1236|victoria.anderson@rmpdc.org|
278580|NCT00657605|University of Miami|Richard Bookman|305-243-0494|y.p.davis@med.miami.edu|
278581|NCT00657618|WRAIR|Roseanne A. Resnner, MD|301-295-6400|rose.resnner@us.armyh.mil|
278582|NCT00657657|GlaxoSmithKline|GSK Response Center|866-435-7343||
278583|NCT00657709|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
278584|NCT00657917|Uniformed Services University of the Heralth Sciences|COL Naomi Aronson MC|301-295-3621|naronson@usuhs.mil|
278585|NCT00658021|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
278586|NCT00658112|Wake Forest University Health Sciences|Steve Feldman MD|336-716-3775|sfeldman@wakehealth.edu|
278587|NCT00658138|University of Bologna, Italy|Professor Giovanni Dondi dall'Orologio|+39 051-2088132|gdondi@alma.unibo.it|
278588|NCT00658320|Novartis Pharmaceuticals|Study Director|862-778-8300||
278589|NCT00658333|Novartis Pharmaceuticals|Study Director|862-778-8300||
278590|NCT00658359|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278591|NCT00658385|Memorial Sloan Kettering Cancer Center|Dr. Farid Boulad|212-639-6684|bouladf@mskcc.org|
288308|NCT01183481|Sunnybrook Health Sciences Centre|Dr. Edward Chow|416-480-4998|edward.chow@sunnybrook.ca|
288309|NCT01183533|University of Texas Health Science Center at Houston|Sean I. Savitz, MD|713-500-7083|sean.i.savitz@uth.tmc.edu|
288310|NCT01183546|Human Engineering Research Laboratories|Dr. Alicia Koontz|412-822-3700|alicia.koontz@va.gov|
278592|NCT00658411|Dana-Farber Cancer Institute|Philippe Armand, MD, PhD|617-632-2305|parmand@partners.org|
278593|NCT00658515|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
278594|NCT00658528|Eisai Call Center|Eisai Inc.|888-422-4743||
278595|NCT00658541|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
278596|NCT00658567|ACADIA Pharmaceuticals Inc.|Roger Mills, MD|858-202-7563|rmills@acadia-pharm.com|
288311|NCT01183559|Igor Astsaturov, MD, PhD, Assistant Professor, Medical Oncology|Igor Astsaturov, MD, PhD, Assistant Professor, Medical Oncology|215 728-3135|Igor.Astsaturov@fccc.edu|
288312|NCT01183650|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288313|NCT01183689|Wake Forest University School of Medicine|Mark Espeland|336-716-2826|mespelan@wakehealth.edu|
288314|NCT01183728|Instituto de Biología y Genética Molecular (IBGM)|Dr. Javier García-Sancho|+34 98 318 48 27|jgsancho@ibgm.uva.es|
288315|NCT01183780|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298668|NCT01832493|Medtronic CRHF|Medtronic SOCR Clinical Trial Leader|1-800-328-2518|medtronicCRMtrials@medtronic.com|
298669|NCT01832506|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
298670|NCT01832532|Cincinnati Children's Hospital Medical Center|Raouf Amin, MD|(513) 636-7945|Raouf.Amin@cchmc.org|
298671|NCT01832610|Medtronic|Thomas Vassiliades, MD - VP MCS Clinical/Medical Affairs|+15085321956|thomas.a.vassiliades@medtronic.com|
298672|NCT01832727|Amgen, Inc|Study Director|866-572-6436|medinfo@amgen.com|
298673|NCT01832753|The Children's Hospital of Philadelphia|Andrea Kelly, MD MSCE|215-590-3174|kellya@email.chop.edu|43174
298674|NCT01832766|University of Colorado Denver|Lynn Johnson, Pharm.D.|303 724 6221|lynn.johnson@ucdenver.edu|
298675|NCT01832818|RTI Surgical|Robin Waite|386-418-8888|rwaite@rtix.com|
298676|NCT01832961|Imperial College|Ada Clarice Gastaldi|55 020 7351 8051|ada@fmrp.usp.br|
298677|NCT01833026|University of Illinois at Chicago|Min Joo|3129968039||
298678|NCT01833065|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
298679|NCT01833078|University of Pennsylvania|Dr. Anne Cappola, PI|215-573-5359|acappola@mail.med.upenn.edu|
298680|NCT01833117|Alcon Research, Ltd.|Michela Montecchi-Palmer, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
298681|NCT01833130|Allergan, Inc|Medical Director,||clinicaltrials@allergan.com|
298682|NCT01833143|Memorial Sloan Kettering Cancer Center|Gregory Riely, MD, PhD|646-608-3913|rielyg@mskcc.org|
298683|NCT01833169|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
298684|NCT01833247|Stanford University Department of Neurology|Robert S. Fisher, MD, PhD|650-7215289|robert.fisher@stanford.edu|
298685|NCT01833403|University of Minnesota|Lisa Chow MD|612-625-8934|chow0007@umn.edu|
298686|NCT01833455|University of Wisconsin|Stephen Wasmund, PhD|801-587-3740|stephen.wasmund@carma.utah.edu|
298687|NCT01833481|University of Tennessee|Dr. Richard D. Komistek|8659742093|rkomiste@utk.edu|
298688|NCT01833494|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
298689|NCT01833520|UT MD Anderson Cancer Center|Vivek Subbiah,Associate Professor, Invest. Cancer Therapeutics|(713) 563-0393|vsubbiah@mdanderson.org|
298690|NCT01833533|AbbVie|Global Medical Information|800-633-9110||
298691|NCT01833546|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
298692|NCT01833741|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
298693|NCT01833754|Amgen Inc.|Study Director|866-572-6436||
298694|NCT01833832|National Cancer Institute|Dr. Jeremy Davis|240-760-6229|jeremy.davis@nih.gov|
298695|NCT01833845|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|104
298696|NCT01833897|New York State Psychiatric Institute|Joshua Kantrowitz|646-774-6738|jkantrowitz@nki.rfmh.org|
298697|NCT01833936|Orthopedic Foot and Ankle Center|Dr. Christopher Hyer|6148958747|ofacresearch@orthofootankle.com|
298698|NCT01833988|Massachusetts General Hospital Diabetes Research Center|Dr. Steven J. Russell|617.726.1848|sjrussell@partners.org|
298699|NCT01834027|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
298700|NCT01834222|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298701|NCT01834261|Stony Brook University|Lilianne Mujica Parodi, PhD / Study Principal Investigator|631-632-1008|lilianne.strey@stonybrook.edu|
298702|NCT01834274|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
298703|NCT01834326|University of Michigan|Stephen E. Feinberg|734 763 5963|sefein@med.umich.edu|
298704|NCT01834404|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
298705|NCT01834586|EvergreenHealth Multiple Sclerosis Center|Theodore Brown|425-8995350|trbrown@evergreenhealth.com|
298706|NCT01834651|Cedars-Sinai Medical Center|Dr. Edwin Posadas|310-423-7600|Edwin.Posadas@cshs.org|
298707|NCT01834716|Mayo Clinic|Neill Graff-Radford|9049537103|graffradford.neill@mayo.edu|
298708|NCT01834729|Mayo Clinic|Dr. Adil E. Bharucha|507-284-2687|bharucha.adil@mayo.edu|
298709|NCT01835015|Alcon Research, Ltd.|Director, Translational Medicine Expert, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
298710|NCT01835132|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
298711|NCT01835158|Harvard|Toni K. Choueiri, MD|(617) 632-5456|toni_choueiri@dfci.harvard.edu|
298712|NCT01835223|Roswell Park Cancer Institute|Katy Wang, Statistician, M.A.|716-845-1300|katy.wang@roswellpark.org|6269
298713|NCT01835262|Maimonides Medical Center|Antonios Likourezos|718-283-6896|alikourezos@maimonidesmed.org|
298714|NCT01835379|Smith & Nephew, Inc.|Vice President, Medical & Clinical Affairs|817-302-3914|jaime.dickerson@smith-nephew.com|
298715|NCT01835431|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
298716|NCT01835470|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
298717|NCT01835496|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
298718|NCT01835548|Neos Tx|Carolyn Sikes, PhD|972-408-1300|csikes@neostx.com|1255
278597|NCT00658606|Astellas Pharma Canada, Inc.|Director, Scientific Affairs||ClinicalTrials@us.astellas.com|
298719|NCT01835587|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
278598|NCT00658619|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
278599|NCT00658632|Eisai Inc.|Eisai Medical Services|888-422-4743||
278600|NCT00658658|Amgen Inc.|Study Director|866-572-6436||
278601|NCT00658684|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278602|NCT00658697|DFCI|Rana R. McKay, MD|6176323237|rana_yehia@dfci.harvard.edu|
278603|NCT00658723|ETHICON, Inc.|Jonathan Batiller, Director Clinical Development|908-218-2819|JBatill2@its.jnj.com|
278604|NCT00658736|Cleveland Clinic|Dr. Tyler Stevens|216 445-1996|stevent@ccf.org|
278605|NCT00658775|Eisai Call Center|Eisai Inc.|888-422-4743||
278606|NCT00658788|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
278607|NCT00658814|SWOG|Study Statistician|206-667-4623||
278608|NCT00658879|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278609|NCT00658996|Bausch & Lomb Incorporated|Gerard Cairns, PhD, MCOptom|(585) 338-5170|gerard.cairns@bausch.com|
278610|NCT00659165|Univ NM|Mark Burge|505-272-4658|mburge@salud.unm.edu|
278611|NCT00659230|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|lori.davis@va.gov|3819
278612|NCT00659269|University of New Mexico|Zoneddy Dayao, MD|5059250404|zdayao@salud.unm.edu|
278613|NCT00659295|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
278614|NCT00659334|OHSU Knight Cancer Institute|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
278615|NCT00659360|Cross Cancer Institute|Dr. Margaret Von Mehren|215-214-1663|margaret.vonmehren@fccc.edu|
278616|NCT00659373|IBCSG|Rudolph Maibach, Executive Officer for International Trial Activities|+41 31 389 91 96|rudolf.maibach@ibcsg.org|
278617|NCT00659425|MedImmune, LLC|Mark Lanasa, MD Associate Director, Clinical Development, Oncology|301-398-0000|information.center@AstraZeneca.com|
278618|NCT00659438|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
278619|NCT00659490|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278620|NCT00659529|National Jewish Health|Jennifer L. Taylor-Cousar, MD|(303) 270-2764|Taylor-CousarJ@NJHealth.org|
278621|NCT00659581|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288316|NCT01183858|Hoffmann-La Roche|Medical Communications|800-821-8590|genetech@druginfo.com|
278622|NCT00659607|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
278623|NCT00659633|University of Alabama at Birmigham|Dr. Michael Froelich|205-975-3328|mfroelich@uabmc.edu|
278624|NCT00659724|Gambro Renal Products, Inc.|Jeffrey R. Shideman PhD|952-835-4018|Jeff.Shideman@us.gambro.com|
278625|NCT00659737|Drexel university|Michael Green|215-762-1524|micheal.green@drexelmed.edu|
278626|NCT00659789|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
278627|NCT00659802|Hutchison Medipharma|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
278628|NCT00659815|Bausch & Lomb Incorporated|Gerard Cairns|(585) 338-5170|gerard.cairns@bausch.com|
278629|NCT00659828|University of Miami|Richard Bookman|305-243-0494|y.p.davis@med.miami.edu|
278630|NCT00659880|RTI Surgical|Robin Waite, RN|386-418-8888|rwaite@rtix.com|
278631|NCT00659945|University of Pittsburgh|Manuel C. Vallejo, MD|412-641-4260|vallejomc@anes.upmc.edu|
278632|NCT00659984|NANT Consortium|NANT Operations Center|323-361-5687|nantops@chla.usc.edu|
278633|NCT00660010|Abbott Laboratories|Global Medical Services|800-633-9110||
278634|NCT00660023|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
278635|NCT00660049|Stanford University|Anne Chang, MD|(650) 721 7151|alschang@stanford.edu|
278636|NCT00660075|Laval University|Patrick Couture|418-654-2106|patrick.couture@crchul.ulaval.ca|
288317|NCT01183923|Johns Hopkins University School of Medicine|Elizabeth Matsui, MD MHS|410-502-3858|ematsui@jhmi.edu|
288318|NCT01183975|Ethicon, Inc.|Birgit Temiz|+49 (0) 40 5297 3144|btemiz@its.jnj.com|
288319|NCT01184014|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
288320|NCT01184053|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
288321|NCT01184079|University of Pittsburgh Department of Family Medicine|Chyongchiou Jeng Lin, PhD|412/383-2360|cjlin@pitt.edu|
288322|NCT01184118|UW Madison|Mihaela Teodorescu, MD|608-256-1901|mt3@medicine.wisc.edu|
288323|NCT01184326|Dana-Farber Cancer Institute|Dr. Mark Pomerantz|617-632-4524|mark_pomerantz@dfci.harvard.edu|
288324|NCT01184417|Alameda County Medical Center|Jonathan Rosenson MD|510-407-6743|jonrosenson@yahoo.com|
288325|NCT01184508|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288326|NCT01184755|Rutgers - Robert Wood Johnson Medical School|Lynn Clemow, PhD|732-235-6972|lynn.clemow@rutgers.edu|
288327|NCT01184846|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
288328|NCT01184859|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
288329|NCT01184872|Novartis Pharmaceutical|Study Director|862 778 8300||
288330|NCT01184885|Thomas Jefferson University|Margaret Kasner, MD|215-955-8874|Margaret.Kasner@jefferson.edu|
288331|NCT01184898|Thomas Jefferson University|Margaret Kasner, MD|215-955-8874|Margaret.Kasner@jefferson.edu|
288332|NCT01184989|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288333|NCT01185028|NIAID/NIH|Dr. Shyam Kottilil|301-435-0936|skottilil@niaid.nih.gov|
288334|NCT01185080|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278637|NCT00660179|Actelion Pharmaceuticals Ltd|Parisa Danaietash||parisa.danaietash@actelion.com|
278638|NCT00660192|Yale School of Medicine|Baman,Jabbari M.D. Porfessor of Neurology|203-737-2464|bahman.jabbari@yale.edu|
278639|NCT00660309|Novartis Pharmaceuticals|Study Director|862-778-8300||
278640|NCT00660387|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
278641|NCT00660400|H. Lee Moffitt Cancer Center and Research Institute|Teresa Field, M.D., Ph.D.|813-745-7202|teresa.field@moffitt.org|
278642|NCT00660504|Cancer Hospital of Chinese Academy of Medical Sciences|Dr.Sunyan|86-10-87788519|suny@csco.org.cn|
278643|NCT00660517|Meda Pharmaceuticals|David Ginsberg, D.O.|7325642364|david.ginsberg@meda.us|
278644|NCT00660530|University of Illinois College of Pharmacy|Dr. Alan Lau|(312) 996-0894|alanlau@uic.edu|
278645|NCT00660543|Oregon Health and Science University|Dr. Edward Neuwelt|503-494-5626|neuwelte@ohsu.edu|
278646|NCT00660660|AstraZeneca|Clinical Trial Transparency||ClinicalTrialTransparency@astrazeneca.com|
278647|NCT00660699|Washington University School of Medicine|Benjamin Tan, M.D.|314-362-5740|btan@dom.wustl.edu|
278648|NCT00660790|Medical University of Graz|Dr. Norbert Tripolt|+43 316 385|norbert.tripolt@medunigraz.at|78038
278649|NCT00660816|CCCC|Dr. Afshin Dowlati|216-844-1228|afshin.dowlati@uhhospitals.org|
278650|NCT00660829|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
278651|NCT00660907|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
278652|NCT00660985|Galderma|Michael Graeber, MD, Head of Global Clinical Project Management and US Development|609-860-8201|michael.graeber@galderma.com|
278653|NCT00661037|Ospedali del Tigullio, Lavagna, Italy|Dr Michele Brignole|0185 329567329|aritmo@asl4.liguria.it|0039
278654|NCT00661089|The Rehabilitation Institute of Chicago|Dr. Christina Marciniak|312-238-1000|cmarciniak@ric.org|
278655|NCT00661141|Horizon Pharma USA, Inc.|Beth Robinson, Executive Director||clinicaltrials@horizonpharma.com|
278656|NCT00661193|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
278657|NCT00661258|Boston University Center for Global Health and Development|Dr. Lora Sabin|617-414-1272|lsabin@bu.edu|
298720|NCT01835626|University of California, San Francisco|Dr. Sue Yom|(415) 353-9893|Sue.Yom@ucsf.edu|
278658|NCT00661271|Johns Hopkins School of Medicine|Erica Sibinga|410-550-4134|esibinga@jhmi.edu|
278659|NCT00661362|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278660|NCT00661388|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
278661|NCT00661427|Memorial Sloan Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
278662|NCT00661453|University of Utah|Dr. Kathryn Swoboda|801-585-9717|swoboda@genetics.utah.edu|
278663|NCT00661479|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
278664|NCT00661492|US Oncology|Dr. Mark T. Fleming|757-827-9400|Mark.Fleming@USONCOLOGY.COM|
278665|NCT00661505|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
278666|NCT00661531|Georgetown University|Dr. Claudine Isaacs|2024443677|isaacsc@georgetown.edu|
278667|NCT00661544|U.T. M.D. Anderson Cancer Center|Muzaffar H. Qazilbash, MD / Associate Professor|713-745-3458||
278668|NCT00661557|GlaxoSmithKline|GSK Response Center|866-435-7343||
278669|NCT00661570|Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5122550|f.hilgers@nki.nl|
278670|NCT00661583|University of Colorado Denver|Dr.Malik Kahook|720-848-2020|malik.kahook@ucdenver.edu|
288335|NCT01185171|University of Chicago Medicine and Biological Sciences|Dr Everett Vokes, MD|855-702-8222|evokes@medicine.bsd.uchicago.edu|
288336|NCT01185249|Central DuPage Hospital|Dr. Alice Siehoff, Nurse Scientist|1-630-858-0260|asiehoffrn@msn.com|
288337|NCT01185288|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
288338|NCT01185301|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
288339|NCT01185340|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288340|NCT01185353|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288341|NCT01185366|UT MD Anderson Cancer Center|Amado Zurita-Saavedra,Associate Professor, Genitourinary Medical Oncology|(713) 563-6966|azurita@mdanderson.org|
288342|NCT01185509|Dana-Farber Cancer Institute|Ian Krop, MD, PhD|617.632.6973|Ian_Krop@dfci.harvard.edu|
288343|NCT01185522|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
288344|NCT01185548|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288345|NCT01185561|Loyola University|Sue Penckofer, Ph.D.|708-216-9303|spencko@luc.edu|
288346|NCT01185600|University of Miami|Wenche Jy, PhD, Research Associate Professor, Principal Investigator|305-243-6617|wjy@med.miami.edu|
288347|NCT01185639|Wake Forest University Health Sciences|Dr. William Blackstock|336-713-6501|ablackst@wakehealth.edu|
288348|NCT01185704|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
298721|NCT01835743|Coughlin Foot and Ankle Clinic|Michael Coughlin, MD|208-367-3330|thefootmd@gmail.com|
298722|NCT01835756|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
298723|NCT01835899|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298724|NCT01835912|BrockU|Panagiota Klentrou|19056885550|nklentrou@brocku.ca|4538
298725|NCT01836029|VentiRx|Kristi Manjarrez|206 689 2256|kmanjarrez@ventirx.com|
298726|NCT01836042|Glaukos|Jeff Wells, PharmD, MBA, RAC|949-367-9600|jwells@glaukos.com|227
298727|NCT01836133|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
298728|NCT01836185|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298729|NCT01836198|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
298730|NCT01836276|University of Kansas Medical Center|Dr. Nicole Nollen|913-588-3784|nnollen@kumc.edu|
298731|NCT01836445|Northwestern University|Dr. Brian Mustanski|312-503-5421|brian@northwestern.edu|
298732|NCT01836458|Novartis Pharmaceuticals|Study Director|862-778-8300||
298733|NCT01836471|Novaratis Pharmaceuticals|Study Director|862-778-8300||
278671|NCT00661609|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
298734|NCT01836523|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
278672|NCT00661622|Thomas Jefferson University|Takami Sato, MD|215-955-8874|Takami.Sato@jefferson.edu|
278673|NCT00661661|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278674|NCT00661674|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
278675|NCT00661687|Bausch & Lomb Incorporated|Gerard Cairns|(585)338 - 5170|gerard.cairns@bausch.com|
278676|NCT00661713|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
278677|NCT00661726|NERI|Nancy Gee, TCRN Network Manager|617-972-3295|ngee@neriscience.com|
278678|NCT00661778|Hoffmann-La Roche|Medical Communications|800 821-8590||
278679|NCT00661830|Interdisciplinary Center for Clinical Trials (IZKS Mainz)|A. Kaiser|++49(0)6131-179921|kaiser@izks-mainz.de|
278680|NCT00661895|Creighton Cardiac Center|Tammy Burns, PharmD, Research Manager|402-280-4292|TammyBurns@creighton.edu|
278681|NCT00661960|UCaliforniaDavis|David Asmuth/Principal Investigator|9167348695|david.asmuth@ucdmc.ucdavis.edu|
278682|NCT00661999|Mayo Clinic Rochester|Dr. Charles L. Loprinzi|507-284-8666|cloprinzi@mayo.edu|
278683|NCT00662012|Uniformed Services University of Health Sciences (USUHS)|Naomi Aronson, MD|(301) 295-3621|naomi.e.aronson.civ@mail.mil|
278684|NCT00662025|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278685|NCT00662038|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
278686|NCT00662129|Mayo Clinic|Donald W. Northfelt, MD, FACP|507/284-1159|northfelt.donald@mayo.edu|
278687|NCT00662155|University of Pennsylvania|Michael Perlis|(215) 746-3577|mperlis@upenn.edu|
278688|NCT00662207|Hines VA Hospital, Research Service|James S. Walter, Ph.D.|708-202-5805|James.Walter@va.gov|
278689|NCT00662259|University of California San Diego|Gregory G. Brown|858-246-0607|gbrown@ucsd.edu|
278690|NCT00662298|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
298735|NCT01836549|University of Tennessee Health Science Center|Dr. Mehmet Kocak|9014482937|mkocak1@uthsc.edu|901
278691|NCT00662311|Departments of Radiation Oncology and Global Health University of Washington Medical Center|Shilpen Patel|206-598-4100|shilpenp@uw.edu|
298736|NCT01837069|NYU Langone Health|Jeffrey Berger|212 263 4004|Jeffrey.Berger@nyulangone.org|
298737|NCT01837524|Kaiser Center for Clinical and Outcomes Research|Kristina Lewis|404-364-7150|khlewis@wakehealth.edu|
278692|NCT00662363|Rehabilitation Institute of Chicago|Christina Marciniak|312-238-1000|cmarciniak@ric.org|
278693|NCT00662532|OraPharma|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|215-420-4064|bpatel@orapharma.com|
278694|NCT00662545|UCSF SFGH|Anne Luetkemeyer|415 476 4082|aluetkemeyer@php.ucsf.edu|130
278695|NCT00662558|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
278696|NCT00662649|Novartis Pharmaceuticals|Study Director|862 778-8300||
288349|NCT01185782|Merck Serono Co., Ltd., Japan, an affiliate of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
288350|NCT01185821|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
288351|NCT01185834|Alcon Research, Ltd.|Sameena Haque-Khan, PhD, BSc(Hons)Optom, MCOptom, FAAO|1-800-241-7629||
288352|NCT01185964|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288353|NCT01186250|Stanford University|Kiran K. Khush, MD|650-721-3241|kiran@stanford.edu|
288354|NCT01186328|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
288355|NCT01186406|Duke University Medical Center|Annick Desjardins, MD, FRCPC|9196846173|annick.desjardins@duke.edu|
298738|NCT01837537|Medtronic|Michael Luna-Victoria|303 305 2463|michael.luna-victoria@medtronic.com|
288356|NCT01186419|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
288357|NCT01186458|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
288358|NCT01186562|University of Minnesota|Melena D. Bellin|612-624-5409|bell0130@umn.edu|
288359|NCT01186692|Medtronic|Susan Patterson|763.526.1544|susan.patterson@medtronic.com|
288360|NCT01186705|Memorial Sloan Kettering Cancer Center|Dr. Leonard Saltz|646-888-4286|saltzl@mskcc.org|
288361|NCT01186744|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288362|NCT01186770|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
288363|NCT01186796|Mayo Clinic|Johannes. D. Veldhuis, M.D.|507-255-0902|Veldhuis.Johannes@mayo.edu|
288364|NCT01186809|Asst Papa Giovanni XXIII|Prof Alessandro Rambaldi|+390352673681|arambaldi@asst-pg23.it|
288365|NCT01186939|Celgene Corporation|CL Beach||CLBeach@celgene.com|
288366|NCT01186978|Duke University Health System|Assistant Research Practice Manager (ARPM) for Clinical Trials|919-668-5211|Jennifer.Mewshaw@duke.edu|
288367|NCT01187004|UTurin|Dr Daniela Pasero|00390116335511|daniela.pasero@unito.it|
288368|NCT01187017|NIHNHLBI|Bhavisha Patel, MD|301.402.3477|bhavisha.patel@nih.gov|
288369|NCT01187043|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
288370|NCT01187095|Aarhus University|Yoon Frederiksen|+4587565871|yoonf@psy.au.dk|
288371|NCT01187329|Cleveland Clinic|Andra E. Duncan, M.D|216-445-2372|DUNCANA@ccf.org|
298739|NCT01837550|Sodra Alvsborg, Hearing Organisation|Milijana Malmberg, PhD student|0046 703 80 36 63|milijana.lundberg.malmberg@vgregion.se|
288372|NCT01187355|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
288373|NCT01187381|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
288374|NCT01187407|Eli Lilly and Company|Chief Medical Officer|800-545-597||
288375|NCT01187433|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
288376|NCT01187446|Stanford University Medical Center|Youn H Kim, MD|650-521-3545|younkim@stanford.edu|
288377|NCT01187498|Birmingham VA Medical Center|Kathryn L. Burgio, PhD|205-558-7064|kburgio@uabmc.edu|
288378|NCT01187511|National Institute on Alcohol Abuse and Alcoholism|Leggio, Lorenzo|+1 301 435 9398|lorenzo.leggio@nih.gov|
278697|NCT00662675|Johnson & Johnson Pharmaceutical Research & Development, LLC|Director, Clinical Team Leader|609-730-3158||
278698|NCT00662818|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278699|NCT00662831|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278700|NCT00662857|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
278701|NCT00662909|Astellas Pharma Global Development, Inc.|Medical Director, Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
278702|NCT00663026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278703|NCT00663039|MPRC|Elliot Hong|410-402-6828|ehong@mprc.umaryland.edu|
278704|NCT00663117|Pennsylvania State University, College of Medicine Hershey, PA 17033|Jill P Smith, MD Professor of Medicine, Gastroenterology Division|717-531-3694|jsmith2@psu.edu|
278705|NCT00663169|Novartis Pharmaceuticals|Study Director|862-778-8300||
278706|NCT00663208|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
278707|NCT00663234|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
278708|NCT00663260|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
278709|NCT00663403|University of Michigan College of Pharmacy|Bruce A. Mueller|7347636629|muellerb@umich.edu|
278710|NCT00663702|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
278711|NCT00663793|University of Washington|John K Amory, MD, MPH|206-616-1727|jamory@u.washington.edu|
298740|NCT01837654|Assaf Harofhe MC|Dr. Kobi Stav|972-8-9779409|stavkobi@yahoo.com.au|
278712|NCT00663819|CMU College of Medicine|Dr. Anthony Senagore|989-790-1001|anthony.senagore@cmich.edu|
278713|NCT00663858|Aeterna Zentaris|Herbert Sindermann|+49 69 42602 3429|HSindermann@aezsinc.com|
278714|NCT00663871|University of Pittsburgh, Heart and Vascular Institute|Matthew F. Muldoon, MD, MPH|412-624-8798|mfm10@pitt.edu|
278715|NCT00663923|Tabriz University of Medical Sciences|Mohammad R sedghipour,MD|+98 411 3306619|sedghipm@yahoo.com|
278716|NCT00663962|Queen's University|Pregabalin and Post-thoracotomy pain|(613) 548-7827|zamoraj@kgh.kari.net|
278717|NCT00664105|Vanderbilt-Ingram Cancer Center|Vicki Keedy, M.D.|(615) 322-4967||
278718|NCT00664209|UCaliforniaLA|Jeff Bronstein MD, PhD|310 206-9799|jbronste@mednet.ucla.edu|
278719|NCT00664326|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
278720|NCT00664430|Abbott|Global Medical Services|800-633-9110||
278721|NCT00664521|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
278722|NCT00664534|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
278723|NCT00664560|POZEN Inc|Sr VP Clinical Research|919-913-1030|eorlemans@pozen.com|
278724|NCT00664742|Novartis Pharmaceuticals|Study Director|862-778-8300||
278725|NCT00664755|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
278726|NCT00664859|Veloxis Pharmaceuticals, Inc.|Director, Regulatory Affairs|919-591-3090|bbu@veloxis.com|
278727|NCT00665002|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey E. Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
278728|NCT00665132|Bioness|Keith McBride, CTO|661-362-4866|Keith.McBride@bioness.com|
278729|NCT00665353|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
278730|NCT00665366|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
278731|NCT00665392|GERCOR|Regulatory Affairs|+33 (0)1 40 29 85 00|regulatory.affairs@gercor.com.fr|
278732|NCT00665431|Pozen|Sr VP Clinical Research|919 913 1030|eorlemans@pozen.com|
278733|NCT00665457|University of Nebraska Medical Center|Elizabeth Reed, M.D.|402-559-5388|ereed@unmc.edu|
278734|NCT00665470|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
278735|NCT00665561|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278736|NCT00665626|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
278737|NCT00665652|Dartmouth Hitchcock Medical Center|Elijah Stommel|603-650-5104|elijah.w.stommel@hitchcock.org|
278738|NCT00665704|VA Center for Clinical Management Research Health Services Research & Development, VA Ann Arbor Healthcare System, Ann Arbor, MI.|Sonia A. Duffy, Ph.D., R.N., FAAN|734.395.0613|Sonia.Duffy@va.gov|
308879|NCT02620787|Center for Anti Infective Research and Development|Dr. David P. Nicolau|(860) 972-3941|david.nicolau@hhchealth.org|
278739|NCT00665847|Tibotec Pharmaceuticals, Ireland|Senior Director|32 14 641 265|gdsmedt1@its.jnj.com|
278740|NCT00665925|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
278741|NCT00666029|University Hospital Southampton|Professor Christopher Byrne|+44 238120 5006|cdtb@soton.ac.uk|
278742|NCT00666198|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278743|NCT00666211|Vanderbilt-Ingram Cancer Center|Nancy Wells, Director of Nursing Research Patient Care Svcs|615-322-6184|nancy.wells@vanderbilt.edu|
278744|NCT00666224|Teva Pharmaceutical Industries, Ltd.|Yossi Gilgun, PhD, Global Clinical Leader|972-9-863-1491|yossi.gilgun@teva.co.il|
278745|NCT00666263|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
288379|NCT01187550|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
288380|NCT01187771|University of Pittsburgh|Sanjay Patel|412-692-2035|patelsr2@upmc.edu|
288381|NCT01187901|University of Utah|N. Jewel Samadder|801-213-4211|jewel.samadder@hsc.utah.edu|
288382|NCT01187914|Arrhythmia Research Center, University of Utah|Dr. Kavitha Damal, Clinical research Manager|8012133775|kavitha.damal@carma.utah.edu|
288383|NCT01187953|Veloxis Pharmaceuticals|Christina Sylvest|+4520553877|csy@veloxis.com|
288384|NCT01188109|Emory University|Shishir K. Maithel, MD|404-778-1900|smaithe@emory.edu|
288385|NCT01188226|UCLA|Neal Garrett, MD||ngarrett@ucla.edu|
288386|NCT01188343|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
278746|NCT00666276|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278747|NCT00666328|The Medicines Company|Jason Campagna. MD, PhD|973-290-6199|jason.campagna@themedco.com|
278748|NCT00666406|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
278749|NCT00666458|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
298741|NCT01837680|Roosevelt Hospital, Mount Sinai Health System|Dr. Kimberly M. Herrera||kimmerher@gmail.com|
278750|NCT00666536|Novartis Pharmaceuticals|Study Director|862-778-8300||
278751|NCT00666562|University of Wisconsin|Howard H. Bailey|608-263-8624|hhbailey@wisc.edu|
278752|NCT00666588|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
278753|NCT00666666|Rutgers Cancer Institute of New Jersey|Robert DiPaola, MD|732-235-8675|zelinsta@cinj.rutgers.edu, dipaolrs@cinj.rutgers.edu, rizzoji@cinj.rutgers.edu|
278754|NCT00666679|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278755|NCT00666705|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
278756|NCT00666718|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
278757|NCT00666757|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
278758|NCT00666835|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
278759|NCT00666848|Vanderbilt University School of Medicine|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
278760|NCT00666926|Verastem, Inc.|Mitchell Keegan|617-252-9300|mkeegan@verastem.com|
278761|NCT00666965|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
278762|NCT00666978|University of Kansas Medical Center|Lisa Sanderson Cox|913-588-2643|lcox@kumc.edu|
278763|NCT00667004|Bausch Health|Study Director||susan.harris@bauschhealth.com|
278764|NCT00667095|Mayo Clinic|Dr. Steven P. Petrou|904-953-7330|peterou.steven@mayo.edu|
278765|NCT00667186|University of Cincinnati College of Medicine|Michael S. Lyons|513-558-0890|lyonsme@ucmail.uc.edu|
278766|NCT00667225|University of North Carolina, Chapel Hill|Dean Morrell|919-843-5539|morrell@med.unc.edu|
278767|NCT00667251|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
298742|NCT01837719|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
278768|NCT00667277|Icahn School of Medicine at Mount Sinai|Dr. Ronald Hoffman|(212) 241-2297|ronald.hoffman@mssm.edu|
278769|NCT00667342|St. Jude Children's Research Hospital|Michael Bishop, MD|866-278-5833|referralinfo@stjude.org|
298743|NCT01837797|Study Director|Email contact via H. Lundbeck A/S||LundbeckClinicalTrials@lundbeck.com|
278770|NCT00667355|Abbott|Global Medical Services|1-800-633-9110||
278771|NCT00667368|University of Alabama at Birmingham|Dr. Jane Schwebke|205-975-5665|schwebke@uab.edu|
278772|NCT00667381|University of California, Irvine|Arnold Seto|714-456-6699|aseto@uci.edu|
278773|NCT00667394|National Cancer Institute, National Institutes of Health|Dr. Katherine Warren|301-435-4683|warrenk@box-w.nih.gov|
278774|NCT00667420|MassGH|David P. Ryan|617-724-0245|dpryan@partners.org|
278775|NCT00667446|AbbVie, (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
278776|NCT00667459|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
278777|NCT00667511|NxStage Medical, Inc.|Kristen Sheppard|978-687-4700||
278778|NCT00667563|AMC|Jeannette Y. Lee|5015266712|jylee@uams.edu|
278779|NCT00667576|Abbott Japan Co., Ltd.|Global Medical Services|800-633-9110||
278780|NCT00667589|Northwestern University|Hae Bae|312-695-6829|j-bae@northwestern.edu|
278781|NCT00667602|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
278782|NCT00667615|Memorial Sloan Kettering Cancer Center|David Straus MD|212-639-8365|strausd@mskcc.org|
278783|NCT00667693|Cleveland Clinic Foundation|Daniel I Sessler, MD|216-445-8396|sesslerd@ccf.org|
278784|NCT00667719|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
278785|NCT00667732|Oregon Health and Science University|Dr. Matthew Riddle|503-494-0557|riddlem@ohsu.edu|
278786|NCT00667745|Bipolar Clinic and Research Program at|Dr. Andrew Nierenberg, Director of the Bipolar Trials Network|617-724-0837|ANIERENBERG@PARTNERS.ORG|
278787|NCT00667810|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278788|NCT00667849|Bioventus LLC|Peter Heeckt, MD (CMO)|1-800-396-4325|peter.heeckt@bioventusglobal.com|
278789|NCT00667862|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
278790|NCT00667875|Medical University of South Carolina|Raymond F. Anton, MD|843-792-1226|antonr@musc.edu|
278791|NCT00667888|UT MD Anderson Cancer Center|Karen Huffman, MD/ Associate Professor, Radiation Oncology Department|(713) 563-2339|khoffman1@mdanderson.org|
278792|NCT00667992|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
298744|NCT01837823|Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai|Dr. Annapoorna Kini|212-241-4181|annapoorna.kini@mountsinai.org|
278793|NCT00668148|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
278794|NCT00668200|Novartis Pharmaceuticals|Study Director|8627788300||
278795|NCT00668317|Hull and East Yorkshire Hospitals Trust|Clinical trials Manager|01482 624067|c.e.wright@hull.ac.uk|
278796|NCT00668382|UMass Medical Scool|Dr. Sheila Noone|508 856 5015|Sheil.Noone@umasmed.edu|
288387|NCT01188369|Aarhus University Hospital|Dr. Peter Juhl-Olsen|+4578451199|peter.juhl-olsen@ki.au.dk|
288388|NCT01188421|Johns Hopkins University, School of Medicine|Eric C. Strain, MD|410-550-1191|estrain1@jhmi.edu|
288389|NCT01188447|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
288390|NCT01188460|OHRI|Dr. Keith Wilson||kewilson@toh.ca|
288391|NCT01188499|TetraLogic Pharmaceuticals|Vice President, Clinical Research|610-889-9900|Jeffrey.Skolnik@tetralogicpharma.com|141
288392|NCT01188538|Galderma|Farzaneh SIDOU|00 33 4 93 95 70 51|farzaneh.sidou@galderma.com|
278797|NCT00668395|Indiana University School of Medicine|Zeruesenay Desta, PhD|317-274-2823|zdesta@iu.edu|
278798|NCT00668434|Kaiser Permanente, Northern California|Dr. Andrew Avins|510-891-3557|andy.l.avins@kp.org|
278799|NCT00668525|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Carl Gommoll, MS|201-427-8000|carl.gommoll@frx.com|
278800|NCT00668564|Masonic Cancer Center, University of Minnesota|Paul Orchard, M.D.|612-626-2313|orcha001@umn.edu|
278801|NCT00668707|The Centre for Health Innovation|Mark Legacy, Clinical Trial Coordinator|613-792-1222|mlegacy@thechi.ca|1
278802|NCT00668733|Graceway Pharmaceuticals|Sharon F. Levy, MD / Sr. VP, Clinical Product Development|267-948-0400|sharon.levy@gracewaypharma.com|
278803|NCT00668746|OraPharma|Ms. Bindu Patel, Senior Scientist, Regulatory Affairs and Quality Assurance|215-420-4064|bpatel@orapharma.com|
278804|NCT00668811|MedStar Washington Hospital Center|Dr Kenneth D. Burman|202-877-8109|kenneth.d.burman@medstar.net|
278805|NCT00668863|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278806|NCT00668902|Indiana University School of Medicine|Zeruesenay Desta|+1 (317) 274-2823|zdesta@iu.edu|
278807|NCT00669019|University of Chicago|Dr. Thomas F. Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
278808|NCT00669032|Tedec-Meiji Farma, S.A.|R&D Director|918870980|m.gimeno@tedecmeiji.com|
278809|NCT00669071|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
278810|NCT00669110|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278811|NCT00669162|University of Kansas Cancer Center|Xinglei Shen, MD|913-588-3600|ctnursenav@kumc.edu|
278812|NCT00669214|Genentech, Inc.|Medical Communications|800-821-8590||
278813|NCT00669240|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278814|NCT00669279|University of Florida|Dr. Benjamin J Epstein|3523590945|epstein@cop.ufl.edu|
278815|NCT00669318|Mayo Clinic Cancer Center|Timothy G. Call MD||call.timothy@mayo.edu|
278816|NCT00669331|Pharmaxis Ltd|Dr Brett Charlton, Medical Director|+61 2 94547210|brett.charlton@pharmaxis.com.au|
278817|NCT00669383|OHSU|Cindy McEvoy, MD|503-494-0223|mcevoyc@ohsu.edu|
278818|NCT00669396|University of Utah|David Turok, MD|801-581-7647|david.turok@hsc.utah.edu|
278819|NCT00669409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278820|NCT00669539|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
278821|NCT00669552|Columbia University|Jose' Dizon, MD|212-305-8559|jmd11@columbia.edu|
278822|NCT00669578|Mayo Clinic|Ayalew Tefferi, M.D.||tefferi.ayalew@mayo.edu|
278823|NCT00669617|Novartis Pharmaceuticals|Study Director|862-778-8300||
278824|NCT00669669|Fred Hutch Cancer Research Center|Hans-Peter Kiem, M.D., Ph.D.|206.667.4425|hkiem@fredhutch.org|
278825|NCT00669682|Columbia University|Jose' Dizon, MD|212-305-8559|jmd11@columbia.edu|
278826|NCT00669864|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
278827|NCT00669877|The University of Texas (UT) MD Anderson Cancer Center|Naval Daver, Assistant Professor, Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
278828|NCT00669903|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278829|NCT00669916|Novartis|Study Director|862-778-8300||
278830|NCT00669942|Novartis|Study Director|862-778-8300||
278831|NCT00669955|Axcan Pharma Inc.|Monique Giguere, PhD, Programs Director,|1-800-565-3255||2078
278832|NCT00670007|CSL Behring|Clinical Trial Disclosure Manager|Use Email contact|clinicaltrials@cslbehring.com|
278833|NCT00670046|UTHSCSA|Ron Rodriguez, MD, PhD|2105675643|rodriguezr32@uthscsa.edu|
278834|NCT00670111|Boston Scientific|Elke Sommerijns|+32 479 76 71 56|elke.sommerijns@bsci.com|
278835|NCT00670202|Brigham and Women's Hospital|Anju Nohria|617-525-7052|anohria@partners.org|617
278836|NCT00670228|sanofi-aventis|Trial Transparency Team||GV-contact-us@sanofi-aventis.com|
278837|NCT00670241|LEO Pharma|Anders Rhod Larsen, Scientific Advisor|+4572262990|anders.larsen@leo-pharma.com|
278838|NCT00670267|Baylor College of Medicine|N.A. Hanania, M.D.||hanania@bcm.edu|
278839|NCT00670306|AEterna Zentaris|Daniel Croteau, Medical Manager|418-652-7669|DCroteau@aezsinc.com|272
278840|NCT00670449|Novartis Pharmaceuticals|Study Director|862 778-8300||
278841|NCT00670462|University of Minnesota|Robert W. Jeffery PhD|612-626-8580|jeffe001@umn.edu|
278842|NCT00670488|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278843|NCT00670540|University Hospital Grenoble|Jean-Luc Bosson|33 4 76 76 50 40|jean-luc.bosson@imag.fr|
278844|NCT00670709|UCLA|Jennifer Villalobos|310-825-3351|info@brain.ucla.edu|
278845|NCT00670748|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|sar@mail.nih.gov|
278846|NCT00670774|Mayo Clinic|Dr. Mark D. Stegall|507-284-6275|Stegall.Mark@mayo.edu|
278847|NCT00670800|University of Michigan|Yolanda Smith|(734) 936-7401|ysmith@umich.edu|
278848|NCT00670930|Novartis Pharmaceuticals|Study Director|862-778-8300||
288393|NCT01188551|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
288394|NCT01188564|Pharming Technologies|Anurag Relan, Vice President Clinical Research and Medical Affairs||a.relan@pharming.com|
288395|NCT01188577|Amphastar Pharmaceuticals, Inc.|Stephen A. Campbell, Esq.|(909) 980-9484|stephenc@amphastar.com|2016
288396|NCT01188603|Sprout Pharmaceuticals|Sprout Pharmaceuticals|1-919-882-0850|clinicaltrials@sproutpharma.com|
278849|NCT00670956|University of California San Francisco|Hanmin Lee, MD|415-476-4086|hanmin.lee@ucsf.edu|
278850|NCT00670982|Dana-Farber Cancer Institute|Harold J. Burstein, MD|617-632-2335|hal_burstein@dfci.harvard.edu|
278851|NCT00671034|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
278852|NCT00671060|Gynuity Health Projects|Hillary Bracken|2124481230|hbracken@gynuity.org|
278853|NCT00671177|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|24103
278854|NCT00671437|Washington University School of Medicine|Dr. Douglas R. Adkins|314-362-5654|dadkins@dom.wustl.edu|
278855|NCT00671502|Meda Pharma US|David Ginsberg, MD Sr Medical Director|732 564 2364|david.ginsberg@meda.us|
308880|NCT02620878|Università di Padova-Italy|Dr. Daniela Bruttomesso|00390498212183|daniela.bruttomesso@unipd.it|
278856|NCT00671515|University Hospitals Cleveland Medical Center|Dr. Joseph Calabrese|216-844-2865|Joseph.Calabrese@UHhospitals.org|
278857|NCT00671554|Greenville Hospital System|Joe Stephenson, MD|864-455-3600|joe.stephenson@usoncology.com|
278858|NCT00671658|The University of Texas (UT) MD Anderson Cancer Center|Hagop Kantarjian, MD./ Chair|713-792-7026|eharriso@mdanderson.org|
278859|NCT00671671|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278860|NCT00671723|University of Oklahoma Health Sciences Center|Dr. Houssein Youness|405-271-6173|houssein-youness@ouhsc.edu|
278861|NCT00671749|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
278862|NCT00671788|Gynecologic Oncology Group Statistical and Data Center|Jessalyn Reboy|716-845-7738|reboyj@nrgoncology.org|
278863|NCT00671853|University Hospitals Cleveland Medical Center|Dr. Kemp Gao|216-844-2865|keming.gao@UHhopsitals.org|
278864|NCT00671879|Meda Pharma US|David Ginsberg, DO Sr Dir Medical Scientific Affairs|732 564 2347|david.ginsberg@meda.us|
278865|NCT00671918|Navidea Biopharmaceuticals|Dr. Frederick Cope|614-793-7500|fcope@navidea.com|140
278866|NCT00671931|Cincinnati Children's Hospital|Mohamed Mahmoud, MD Principal Investigator|513 636-7426|mohamed.mahmoud@cchmc.org|
278867|NCT00671970|Dana Farber Cancer Institute|Dr. David Reardon|(617) 632-2166|David_Reardon@DFCI.HARVARD.EDU|
278868|NCT00672100|William Beaumont Hospital|Craig T. Hartrick, MD|248-964-3440|chartrick@beaumont.edu|
278869|NCT00672139|Salix Pharmaceuticals|David Sorscher|919-862-1827|david.sorscher@salix.com|
278870|NCT00672204|University of Minnesota|Bernhard J. Hering, M.D.|612-626-5735|bhering@umn.edu|
278871|NCT00672243|The Preston Robert Tisch Brain Tumor Center at Duke|David A. Reardon, MD|(919) 668-1409|reard003@mc.duke.edu|
278872|NCT00672256|Duke University Medical Center|Joseph McClernon|919-668-3987|mccle011@mc.duke.edu|
278873|NCT00672438|Stanford University|Dr. Martin Angst, Professor of Anesthesia|650-498-5109|ang@stanford.edu|
278874|NCT00672451|Wake Forest University Health Sciences|Dr. John Burkart|33671662958|jburkart@wakehealth.edu|
278875|NCT00672477|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
308881|NCT02620904|Montefiore Einstein|Jessica Maria Atrio|7184058260|jatrio@montefiore.org|
278876|NCT00672490|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278877|NCT00672555|Department of surgery, Cantonal hospital of St. Gallen|Lukas Marti; principal investigator|0041794120153|lukas.marti@kssg.ch|
278878|NCT00672594|Duke University|Dr. Daniel George|919-668-4615|daniel.george@duke.edu|
278879|NCT00672620|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
278880|NCT00672633|Boston Children's Hospital|Dr. Stavroula Osganian, Principal Investigator|8572184728|stavroula.osganian@childrens.harvard.edu|
278881|NCT00672646|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278882|NCT00672737|Stanford University|Anthony Doufas, MD, PhD|(650) 498-7699|agdoufas@stanford.edu|
278883|NCT00672841|University of Utah|Kimberly E. Hanson, MD, MHS|801.585.2867|kim.hanson@hsc.utah.edu|
278884|NCT00672854|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
278885|NCT00672932|UCSF|Richard W. Price, M.D.|415-206-4487|rwprice@sfgh.ucsf.edu|
278886|NCT00672958|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
278887|NCT00672984|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
278888|NCT00673049|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278889|NCT00673075|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
278890|NCT00673114|Duke University Medical Center|Dr. Joanne Kurtzberg|919-668-1100|kurtz001@mc.duke.edu|
278891|NCT00673127|Beth Israel Deaconess|Steven Balk|617-735-2065|sbalk@bidmc.harvard.edu|
278892|NCT00673153|Fred Hutch Cancer Research Center|Roland B. Walter, MD, PhD, MS|(206) 667-3599||
278893|NCT00673231|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
278894|NCT00673244|Department of Anesthesiology and Critical Care Medicine, George Washington University|Lakhmir S. Chawla|202-994-7903|minkchawla@gmail.com|
278895|NCT00673257|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
278896|NCT00673387|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
288397|NCT01188655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288398|NCT01188668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288399|NCT01188681|Emergent BioSolutions|Scott C. Stromatt|206-859-6675|sstromatt@ebsi.com|
288400|NCT01188694|University of Washington|Lori Zoellner|206 685-3617|zoellner@u.washington.edu|
288401|NCT01188772|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
288402|NCT01188811|Oregon Health & Science University|Rebecca Spain, MD, MSPH|503-494-5759|spainr@ohsu.edu|
288403|NCT01188876|Massachusetts General Hospital|Marcela del Carmen, MD, MPH|617-724-4800|MDELCARMEN@mgh.harvard.edu|
288404|NCT01188928|Leo Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
288405|NCT01188967|Massachusetts General Hospital|Maurizio Fava M.D.|617-724-2513|mfava@partners.org|
288406|NCT01189032|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
288407|NCT01189110|VAMC St. Louis MO|Deborah Fritz FNP PhD|314-652-4100|deborah.fritz@va.gov|53692
288408|NCT01189123|Vanderbilt University Medical Center|Dr. Keipp Talbot|6153222035|keipp.talbot@vanderbilt.edu|
308882|NCT02620917|University of Padova|Daniela Bruttomesso|0039 049/8212183|daniela.bruttomesso@unipd.it|
278897|NCT00673400|Cantonal Hospital St. Gallen, Department of Surgery|Ulrich Beutner PhD|+41 71 494 1111|ulrich.beutner@kssg.ch|
278898|NCT00673439|James Graham Brown Cancer Center|Goetz H Kloecker, MD, MSPH|502/562-4358|ghkloe01@exchange.edu|
278899|NCT00673452|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
278900|NCT00673465|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
278901|NCT00673660|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278902|NCT00673673|Yale University|Dr. Jill Lacy|203-737-1600|jill.lacy@yale.edu|
298745|NCT01837901|Okuvision GmbH|Dr. R. Schippert|+49 7121 15935|ruth.schippert@okuvision.de|50
298746|NCT01837966|NYU School of Medicine|Associate Professor ; Res Program Dir/Medical Dir Day Surgery; Vice Chair for Education|212.263.5072|michael.wajda@nyumc.org|
278903|NCT00673712|Halyard Health|Sr. Director Clinical Research|5132538033|alan.dine@hyh.com|
278904|NCT00673738|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-3050|alberto.chiappori@moffitt.org|
278905|NCT00673764|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
278906|NCT00673790|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
278907|NCT00673816|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
278908|NCT00673855|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
278909|NCT00673881|Radiant Research|Michael H. Davidson, MD FACC|312-494-2220|michaeldavidson@radiantresearch.com|2220
278910|NCT00673894|Garvan Institute of Medical Research|Dr. Dorit Samocha-Bonet|+61292958309|d.samochabonet@garvan.org.au|
278911|NCT00673920|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
278912|NCT00673933|Dermatology Institute|Dr Ashish Bhatia|630-942-5040|acbhatia@gmail.com|
278913|NCT00673959|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
278914|NCT00674115|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
278915|NCT00674128|Mayo Clinic|Gregory Altemose MD|480-301-8000|altemose.gregory@mayo.edu|
278916|NCT00674154|Aarhus University Hospital|Lars Rolighed|004520677876|larsrolighed@gmail.com|
278917|NCT00674206|Emory University|Dr. Amelia Zelnak|404-778-1900|amelia.zelnak@emoryhealthcare.org|
278918|NCT00674219|UCLA Department of Psychiatry|Alexander Bystritsky MD PhD|(310) 206-5133|abystritsky@mednet.ucla.edu|
278919|NCT00674297|Hospital for Special Surgery|Doruk Erkan, MD|212 774-2291|erkand@hss.edu|
278920|NCT00674323|Novartis Pharmaceuticals|Study Director|862-778-8300||
278921|NCT00674362|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
278922|NCT00674466|ConjuChem Biotechnologies Inc.|Associate Director of Regulatory Affairs|310-405-7549|Aleece.Nolasco@nantbio.com|
278923|NCT00674479|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani, MD/Professor|713-745-0394|fravandi@mdanderson.org|
278924|NCT00674492|Center for Healthcare Organization and Implementation Research|Jack A. Clark, PhD|781.687.2937|Jack.Clark@va.gov|
278925|NCT00674570|San Francisco VA Health Care System|Sabra Inslicht, Ph.D.|415-221-4810|sabra.inslicht@ucsf.edu|23341
278926|NCT00674583|GlaxoSmithKline|GSK Response Center|866-435-7343||
278927|NCT00674609|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
278928|NCT00674622|University of Pittsburgh School of Medicine Department of Psychiatry|Ronald Glick, MD|412-623-3023|glickrm@upmc.edu|
278929|NCT00674661|Avedro, Inc.|Vineeta Belanger, VP of Clinical Affairs|781-768-3459|vbelanger@avedro.com|
278930|NCT00674700|Stallergenes|Michel Roux, Medical Director|+33 1 55 59 2970|mroux@stallergenes.com|
278931|NCT00674739|Graceway Pharmaceuticals|Robert Babilon, Vice President, Product Development|267-948-0400|robert.babilon@gracewaypharma.com|20428
278932|NCT00674765|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
278933|NCT00674817|GlaxoSmithKline|GSK Response Center|866-435-7343||
278934|NCT00674973|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
278935|NCT00674986|Hoffman-LaRoche|Medical Communications|800-821-8590||
278936|NCT00675025|Eisai Inc|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
298747|NCT01838044|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278937|NCT00675103|Savient Pharmaceuticals, Inc.|Chief Medical Officer|732-418-9300||
278938|NCT00675259|The Ohio State University|Ewa Mrozek, MD|614-293-0066|Ewa.mrozek@osumc.edu|
278939|NCT00675415|Cleveland Clinic|Dr. John Vargo|(216) 445-5012|vargoj@ccf.org|
278940|NCT00675428|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
278941|NCT00675441|UT MD Anderson Cancer Center|Amin Alousi, MD / Assisstant Professor||CR_Study_Registration@mdanderson.org|
278942|NCT00675506|Massachusetts General Hospital|Steven K. Grinspoon MD|617-726-3890|sgrinspoon@partners.org|
278943|NCT00675558|Columbia University Medical Center|Paul D. Berk, MD|2120-305-4491|pb2158@columbia.edu|
278944|NCT00675584|Penn State Hershey College of Medicine|Vernon M. Chinchilli, PhD|717-531-4262|vchinchi@psu.edu|
278945|NCT00675597|Memorial Sloan Kettering Cancer Center|Dr. Mark G. Kris|646-888-4205|Krism@mskcc.org|
278946|NCT00675766|West Los Angeles Veterans Association|Dr. Charles Hinkin|310-478-3711|chinkin@ucla.edu|44214
278947|NCT00675792|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
278948|NCT00675909|Seattle Children's Hospital|Eileen Klein, MD, MPH|206-987-2599|eileen.klein@seattlechildrens.org|
278949|NCT00675922|University of Texas Medical Branch|David Herndon, MD|409-770-6731|dherndon@utmb.edu|
278950|NCT00675948|GW Pharma LTD.|Mr Richard Potts, Clinical Operations Director|00 44 1223 266 800|rp@gwpharm.com|
278951|NCT00675987|Brigham and Women's Hospital|Mark A. Creager, MD|617-732-5267|mcreager@partners.org|
278952|NCT00676013|University of Texas Medical Branch|David Herndon, MD|409-770-6731|dherndon@utmb.edu|
278953|NCT00676052|GlaxoSmithKline|GSK Response Center|866-435-7343||
278954|NCT00676065|Center for Epidemiology and Health Research Germany|Juergen Dinger, MD, PhD|+49 30 945 101 20|dinger@zeg-berlin.de|
278955|NCT00676091|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278956|NCT00676130|Brigham and Women's Hospital|Daniel J. Pallin, MD, MPH|617-525-6614|dpallin@partners.org|
278957|NCT00676143|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278958|NCT00676182|James A. Haley Veterans' Hospital|Dr. Kris Siddharthan|813-558-3950|Krishnaswami.Siddharthan@va.gov|
278959|NCT00676195|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
278960|NCT00676208|Louis Stokes VA Medical Center|Michelle Davidson|(216) 791-2300|michelle.davidson@va.gov|2338
278961|NCT00676338|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
278962|NCT00676364|Lehigh Valley Health Network|Jenny Boucher|610-402-8844|jenny.boucher@LVH.com|
278963|NCT00676403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
278964|NCT00676520|Abbott Vascular|Ellen Travis|408-845-3000|Ellen.Travis@av.abbott.com|
278965|NCT00676572|Imperial College London|Professor Kian Fan Chung|00442075947954|f.chung@imperial.ac.uk|
278966|NCT00676585|Beth Israel Deaconess Medical Center|Dr. Michael Donnino||mdonnino@bidmc.harvard.edu|
278967|NCT00676650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278968|NCT00676663|Syndax Pharmaceuticals, Inc.|Michael Meyers, MD, PhD, Chief Medical Officer|+1-646-690-7620|mmeyers@syndax.com|
278969|NCT00676676|Massachusetts General Hospita|Dr. Karen K. Miller|617-726-3870|kkmiller@partners.org|
278970|NCT00676689|Edwards Lifesciences|Sharanjeet Dhanjal|949-250-2083|sharanjeet_dhanjal@edwards.com|
278971|NCT00676780|LSUShreveport|Dr. Jerry W. McLarty, Ph.D.|(318)813-1446|jmclar@lsuhsc.edu|
278972|NCT00676793|LSU Health, Shreveport|Dr. Jerry w. McLarty, Ph.D.|(318)813-1446|jmclar@lsuhsc.edu|
278973|NCT00676806|Tufts Medical Center|Andreas Klein, MD|617-636-8884|aklein2@tuftsmedicalcenter.org|
278974|NCT00676897|Beth Israel Deaconess Medical Center|Dr. Michael W. Donnino|6177542341|mdonnino@bidmc.harvard.edu|
278975|NCT00677014|Boston Scientific|Greg Voss, Clinical Director|651-581-3068|gregory.voss@bsci.com|
278976|NCT00677040|Essentia Health|Ken Dornfeld|218 786-1311|kenneth.dornfeld@essentiahealth.org|
278977|NCT00677092|University of Massachusetts Medical School|Jonathan Kay, MD|508-793-6936|jonathan.kay@umassmemorial.org|
278978|NCT00677235|Bard Peripheral Vascular|John Van Vleet|1-800-321-4254|John.VanVleet@CRBard.com|
278979|NCT00677352|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278980|NCT00677365|Horizon Pharma USA, Inc.|Jeffery Nieves, PharmD, Senior Director||clinicaltrials@horizonpharma.com|
298748|NCT01838200|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org|
278981|NCT00677534|University of Kansas Medical Center|Dr. Jason Stubbs|913-588-3867|jstubbs@kumc.edu|
278982|NCT00677690|Fondazione Salvatore Maugeri, IRCCS, Pavia, Italy|Ercole Zanotti|39 385 247|ercole.zanotti@fsm.it|324
278983|NCT00677807|Novartis Pharmaceuticals|Study Director|862-778-8300||
278984|NCT00677820|MedImmune LLC, an affiliate of AstraZeneca|Raburn Mallory, MD/ Sr Dir Clinical Development|301-398-0000|malloryr@medimmune.com|
278985|NCT00677833|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278986|NCT00677898|VA VISN 5 Mental Illness Research, Education and Clinical Center|Julie Kreyenbuhl, Pharm.D., Ph.D.|410-637-1864|Julie.Kreyenbuhl@va.gov|
278987|NCT00677924|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
278988|NCT00678015|University of California, San Francisco|Dr. Terence Friedlander|415-353-7171|terence.friedlander@ucsf.edu|
278989|NCT00678080|UT Health|Dr. Jerrie Refuerzo, M.D.|713-500-6416|jerrie.s.refuerzo@uth.tmc.edu|
278990|NCT00678210|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278991|NCT00678249|Bard Peripheral Vascular, Inc.|John Reviere, Director, Clinical Affairs|480-303-2644|john.reviere@crbard.com|
278992|NCT00678301|GlaxoSmithKline|GSK Response Center|866-435-7343||
278993|NCT00678379|Charlotte Eye Ear Nose and Throat|Jonathan Moss MD|704-295-3000|jmoss@ceenta.com|
278994|NCT00678392|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
278995|NCT00678418|Alkermes, Inc.|Bernard L. Silverman, MD|1-781-609-6000|bernard.silverman@alkermes.com|
278996|NCT00678444|UPittsburgh|Dr. Jerry Lowder|314-747-1402|lowderj@wudosis.wustl.edu|
288409|NCT01189136|Women & Infants Hospital of Rhode Island|Charles R. Rardin, MD|401 453-7560|crardin@wihri.org|
308883|NCT02621034|Zahedan university of medical sciences|Seyed Roholla Havaei|+989215257093|marty_zl@yahoo.com|
288410|NCT01189201|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288411|NCT01189240|Adult Brain Tumor Consortium (ABTC)|Dr. Edward Pan||Edward.Pan@UTSouthwestern.edu|
288412|NCT01189266|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
288413|NCT01189279|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
288414|NCT01189292|Department of General, Abdominal and Transplant Surgery, University of Heidelberg|Dr. Ignazio Tarantino||ignazio.tarantino@med.uni-heidelberg.de|
288415|NCT01189370|University of Kansas Cancer Center|Dr. Peter Van Velduizen|913-945-5059|SWILLIAM@kumc.edu|
288416|NCT01189409|BC Cancer|Dr. Philippa Hawley|607-877-6000|PHawley@bccancer.bc.ca|67-2707
288417|NCT01189461|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288418|NCT01189487|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288419|NCT01189500|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288420|NCT01189604|Astrazeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
278997|NCT00678470|University of California at San Francisco|John Koo MD|4154764701|john.koo@ucsfmedctr.org|
278998|NCT00678496|University of Sheffield|Daniel Hind, Assistant Director, Sheffield CTRU|+441142220707|d.hind@sheffield.ac.uk|
278999|NCT00678535|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
279000|NCT00678561|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279001|NCT00678587|GlaxoSmithKline|GSK Response Center|866-435-7343||
298749|NCT01838213|Vestre Viken Hospital Trust|Arne Søraas, PhD|+4790652904|arne@meg.no|
279002|NCT00678639|Wake Forest University Baptist Medical Center|Chadwick Miller, MD|336-716-1740|cmiller@wfubmc.edu|
279003|NCT00678652|Clinical Trials Center, WRAIR|Paul B. Keiser, M.D.||noinformation@available.com|
279004|NCT00678691|SUNY Upstate Medical University|Thomas Schwartz|3154643166|schwartt@upstate.edu|
279005|NCT00678795|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
279006|NCT00678834|The Ohio State University Wexner Medical Center|Dr. Chandan K. Sen, PhD. Professor and Associate Dean|614-247-7658|chandan.sen@osumc.edu|
298750|NCT01838226|Durham VAHCS HSR&D|Dr. David Edelman|919-286-6936|david.edelman@va.gov|
279007|NCT00678886|GlaxoSmithKline|GSK Response Center|866-435-7343||
279008|NCT00678899|Cochlear Americas|Ginger Grant/Clinical Project Manager|410-375-0883|ggrant@cochlear.com|
279009|NCT00679029|University of Nebraska|Dr. Elizabeth Reed, Professor of Internal Medicine - Oncology/Hematology|402-559-5388|ereed@unmc.edu|
279010|NCT00679042|CellTrans Inc.|Jennifer Cook|312-413-7727|jenny@celltransinc.com|
279011|NCT00679055|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279012|NCT00679081|Organogenesis Inc.|Director of Clinical Operations|781-575-0775|clinicaltrials@organo.com|
279013|NCT00679172|Emergent Product Development Gaithersburg|Dr. Tim Babinchak|(240) 631-3585||
279014|NCT00679211|Genentech, Inc.|Medical Communications|800-821-8590||
279015|NCT00679263|Medicinova Inc|Kazuko Matsuda, MD, Vice President Clinical Development|858-373-1500|matsuda@medicinova.com|132
279016|NCT00679289|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org|
279017|NCT00679302|Southern Illinois University, School of Medicine|Dr. Myto Duong, Pediatric Emergency Medicine Director|217-545-7409|myto_duong@yahoo.com|
279018|NCT00679341|Genentech, Inc.|Medical Communications|800 821-8590||
279019|NCT00679354|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
279020|NCT00679367|Boston Medical Center|Vaishali Sanchorawala|617-638-8265|vaishali.sanchorawala@bmc.org|
279021|NCT00679380|Santarus, Inc.|Michael Huang, M.D., Senior Medical Director|858-314-5700|contact@santarus.com|
279022|NCT00679432|Santarus, Inc.|Michael Huang, MD, Senior Medical Director, Clinical Research|8583145700|mhuang@santarus.com|
279023|NCT00679549|The Ohio State Unveristy|Rami Khayat|6142477717|rami.khayat@osumc.edu|
279024|NCT00679627|Johnson & Johnson Pharmaceutical Research & Development|Director, Clinical Research|1 609-730-7674||
279025|NCT00679783|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
279026|NCT00679913|Seoul National University Hospital|Sun-Whe Kim, M.D., Ph.D., FACS|82-2-2072-2310|sunkim@plaza.snu.ac.kr|
279027|NCT00679939|GlaxoSmithKline|GSK Response Center|866-435-7343||
279028|NCT00679952|Seoul National University College of Medicine|Clinical instructor|82-2-2072-2817|meejookang@gmail.com|
279029|NCT00680017|AstraZeneca|Gerard Lynch|+44 1509 645 895|aztrial_results_posting@astrazeneca.com|
279030|NCT00680043|Affymax|Vice President, Clinical Development|650-812-8700|info@affymax.com|
279031|NCT00680056|UNIFESP|Danilo Berton|55-11-55718384|dcberton@gmail.com|
279032|NCT00680121|University of Kansas Medical Center|Ann Manzardo, PhD|(913) 588-6473|amanzardo@kumc.edu|
279033|NCT00680186|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298751|NCT01838304|University of Pennsylvania|Vice-Chair of Research|(215) 662-3766|roderic.eckenhoff@uphs.upenn.edu|
279034|NCT00680225|New England Retina Associates|Dr. Peter Liggett|203-288-2020|neretina@msn.com|
288421|NCT01189617|Johnson & Johsnon Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist|9285-277-0715|jhauze@its.jnj.com|
288422|NCT01189747|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
288423|NCT01189760|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
298752|NCT01838317|University of Texas Southwestern Medical Center|Dr. Muhammad Shaalan Beg|214-648-4180|muhammad.beg@utsouthwestern.edu|
288424|NCT01189812|Columbia Northwest Pharmaceuticals|Director of Clinical Operations|425.453.0404|jhobus@nwcrc.net|
288425|NCT01189890|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
288426|NCT01190007|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288427|NCT01190020|University of Iowa|Robert Summers, MD|319-356-2130|robert-summers@uiowa.edu|
288428|NCT01190085|Brown University|Dr. Lorenzo Leggio|401-863-1000|Lorenzo_Leggio@Brown.edu|
288429|NCT01190098|Cleveland Clinic|Nancy Foldvary-Schaefer, DO, MS|216-445-2990|foldvan@ccf.org|
288430|NCT01190124|Hospital de Santa Maria - Centro Hospitalar Lisboa Norte|Doroana, Maria Manuela, M.D.|351 217938043|manuela.doroana@hsm.min-saude.pt|
288431|NCT01190150|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
288432|NCT01190176|GlaxoSmithKline|GSK Response Center|866-435-7343|pr266560@gsk.com|
279035|NCT00680368|Loma Linda VA Healthcare System|T. Michael Kashner, PhD, PI|909 825-7084|michael.kashner@va.gov|2853
279036|NCT00680407|Meda Pharmaceuticals, Inc.|Associate Director, Clinical Research and Operations||michael.purzycki@meda.us|
279037|NCT00680459|Baystate Medical Center|Dr. Christine McKiernan|413-794-5370|Christine.McKiernan@bhs.org|
279038|NCT00680524|VA Puget Sound Health Care System|Bradford Felker, MD|(206)277-1191|Bradford.Felker@VA.GOV|
279039|NCT00680628|Indiana University School of Medicine|Jeffrey Kline|3172873004|jefkline@iupui.edu|
279040|NCT00680706|Baystate Medical Center|Howard Smithline|413-794-3433|howard.smithline@baystatehealth.org|
298753|NCT01838447|Children's Hospital of Eastern Ontario|Katie O'Hearn, PICU Research Coordinator|613-737-7600|kohearn@cheo.on.ca|4006
279041|NCT00680745|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
279042|NCT00680771|University of rochester|Wilfred Pigeon|(585) 275-3374|Wilfred_pigeon@urmc.rochester.edu|
279043|NCT00680797|VA Greater Los Angeles|Dr. Cathy Lee|310-478-3711|cathy.lee2@va.gov|42627
279044|NCT00680823|Children's Hospital of Pittsburgh|Dr. Robert Hickey|412 692 7692|robert.hickey@chp.edu|
279045|NCT00680836|George E. Wahlen V.A. Medical Center, Salt Lake City, UT|Ashok Tuteja, M.D.|801-582-1565|ashok.tuteja@va.gov|4019
279046|NCT00680862|VHA|Henry Anaya|310-478-3711|henry.anaya@va.gov|48488
298754|NCT01838499|AstraZeneca|Humphrey Gardner MD FCAP|+1 781 839 4523|Humphrey.Gardner@astrazeneca.com|
298755|NCT01838551|Strongbridge Biopharma|Chief Medical Officer|14845890392|f.cohen@strongbridgebio.com|
279047|NCT00680901|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
279048|NCT00680914|GlaxoSmithKline|GSK Response Center|866-435-7343||
298756|NCT01838590|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
279049|NCT00680953|Daiichi Sankyo Co., Ltd.|H. Takami|+81 3 5740 3445|takami.hideo.hs@daiichisankyo.co.jp|
279050|NCT00680992|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
279051|NCT00681031|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279052|NCT00681083|Fisher & Paykel Healthcare|Hansinie Laing|+64 9 574 0123|CPAP.TRIAL@fphcare.co.nz|8601
288433|NCT01190189|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
288434|NCT01190215|GlaxoSmithKline|GSK Response Center|866-435-7343||
288435|NCT01190228|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
288436|NCT01190410|Cares|UCB|+1844599|UCBCares@ucb.com|2273
288437|NCT01190436|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
288438|NCT01190449|Weill Cornell Medicine Cornell University|Cara Rosenbaum, MD|(646) 962-6500|car9156@med.cornell.edu|
298757|NCT01838616|Grünenthal GmbH|Study Director|+49 241 569|Clinical-Trials@grunenthal.com|3223
288439|NCT01190475|Mereo BioPharma|Jacqueline Parkin|+44 333 0237300|enquiries@mereobiopharma.com|
288440|NCT01190514|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
288441|NCT01190527|University of Michigan Comprehensive Cancer Center|Dr. Shruti Jolly, M.D.|734-936-4300|shrutij@umich.edu|
288442|NCT01190566|Seoul National University Hospital|Woo Kyung Moon|82-2-2072-2584|moonwk@snu.ac.kr|
288443|NCT01190813|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
298758|NCT01838642|National Cancer Institute|Dr. James Gulley|301-496-4916|gulleyj@mail.nih.gov|
288444|NCT01190839|Janssen Pharmaceuticals|Strategic Lead Gastroenterology||ClinicalTrialDisclosure@its.jnj.com|
288445|NCT01190865|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
298759|NCT01838655|National Institutes of Health|Brian Brooks, MD, PhD, Principal Investigator, NEI|301-451-2238|brian.brooks@nih.gov|
298760|NCT01838681|H. Lundbeck A/S|Email contact via||LundbeckClinicalTrials@lundbeck.com|
298761|NCT01838694|Invion, Inc.|Mitchell Glass, M.D., EVP of R&D|+61 7 3295 0500|mitchell.glass@inviongroup.com|
298762|NCT01838785|Chang Gung Memorial Hospital|Dr. kun-Ju Lin|033281200|lin4857@adm.cgmh.org.tw|2632
298763|NCT01838863|Denver Health Medical Center|Dr. Ernest E. Moore|303.602.1820|Ernest.Moore@dhha.org|
308884|NCT02621047|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
308885|NCT02621060|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
308886|NCT02621073|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
308887|NCT02621463|University of Utah|Dr. Kai Kuck, PhD|8012051010|kai.kuck@hsc.utah.edu|
308888|NCT02621606|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308889|NCT02621619|Albany Medical Center|Dr. Andrew Chang|518-262-0042|changa1@amc.edu|
308890|NCT02621892|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
308891|NCT02621931|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
308892|NCT02621983|Atlanta VA Medical Center|Dr. Erica Duncan|404-321-6111|erica.duncan@va.gov|207532
308893|NCT02622074|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308894|NCT02622113|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
308895|NCT02622178|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
308896|NCT02622191|Wills Eye Hospital, Glaucoma Research Center|Dr. L. Jay Katz|215-928-3123|ljkatz@willseye.org|
308897|NCT02622321|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
308898|NCT02622568|University of Texas Southwestern|Dr. Nnenna Agim|2144561631|Nnenna.Agim@childrens.com|
298764|NCT01838876|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
279053|NCT00681109|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|(617) 573-4331|Reza_Dana@meei.harvard.edu|
279054|NCT00681187|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
279055|NCT00681265|Eyeon Therapeutics, Inc.|David M. Kleinman||dave@eyeontherapeutics.com|
279056|NCT00681291|LifeCell|Donna Jacobs|908-809-7856|djacobs@lifecell.com|
279057|NCT00681473|Massachusetts General Hospital|Helen A. Shih, MD|617-724-9627|HSHIH@Partners.org|
279058|NCT00681538|GW Pharma Ltd|Richard Potts, Clinical Operations Director|+44 1353 616600|rp@gwpham.com|
279059|NCT00681564|Universidad del Valle|Jorge Hernán Ramírez and Adolfo Contreras (adolfo@yahoo.com).|5723753778|jorge.h.ramirez00@gmail.com|
279060|NCT00681590|University of Miami|Dr. Silvina Levis|305-575-3388|slevis@miami.edu|
279061|NCT00681668|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
279062|NCT00681811|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
279063|NCT00681824|Baxter Healthcare Corporation|Guenter Zuelow, Associate Medical Director||guenter_zuelow@baxter.com|
279064|NCT00681863|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
279065|NCT00681889|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-3313|Cornea_Research@meei.harvard.edu|
279066|NCT00682357|University of Kansas Medical Center|Dr. Herbert Lindsley|(913) 588-3402|HLINDSLE@kumc.edu|
279067|NCT00682435|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
279068|NCT00682448|Rush University Medical Center|Stephanie Cavanaugh, MD||Stephanie_Cavanaugh@rush.edu|
279069|NCT00682461|GlaxoSmithKline|GSK Response Center|866-435-7343||
279070|NCT00682539|Department of Ophthalmology, Medical University Vienna|Dr. Katharina Kriechbaum|00431 40400 79480|katharina.kriechbaum@meduniwien.ac.at|
279071|NCT00682565|Cytokinetics, Inc.|Medical Director|650-624-3053||
279072|NCT00682617|Oregon Health & Science University|Dr. Nels Carlson|(503) 494-6420|carlsonn@ohsu.edu|
279073|NCT00682643|GlaxoSmithKline|GSK Response Center|866-435-7343||
279074|NCT00682734|Montefiore Medical Center|Benjamin Friedman|718 920 6626|befriedm@montefiore.org|
279075|NCT00682786|Washington University School of Medicine|Benjamin R. Tan, M.D.|314-362-3560|btan@dom.wustl.edu|
298765|NCT01838941|McGill University Health Centre|Dr. Nancy Braverman, Associate Professor, Human Genetics and Pediatrics|(514) 934-1934|nancy.braverman@mcgill.ca|23404
279076|NCT00682838|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
279077|NCT00682851|Magee-Womens Research Institute|Lorna Rabe|412-641-6042|lrabe@mwri.magee.edu|
298766|NCT01838980|Motus GI Medical Technologies Ltd.|Medical Consultant|+972-4-6214446|rose@motusgi.com|104
279078|NCT00682890|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
279079|NCT00682929|UC Davis Health|Janelle Butters, NP|916-734-6276|jbutters@ucdavis.edu|
279080|NCT00683020|University of California, San Francisco|Dean Schillinger, MD/Study Principal Investigator|415-206-8940|dschillinger@medsfgh.ucsf.edu|
279081|NCT00683046|University of Chicago Medicine|Dr. Andrew Artz|773-834-8980|aartz@medicine.bsd.uchicago.edu|
298767|NCT01839058|Western University|Keith McIntosh|519-646-6100|keith.mcintosh@sjhc.london.on.ca|61312
279082|NCT00683085|Research Hospital, The Institute of Medical Science, The University of Tokyo|Hitomi Nagayama, M.D., Ph.D. / Project Lecturer|+81-3-3443-8111|zephyrus@ims.u-tokyo.ac.jp|
279083|NCT00683163|UNIVERSITY OF CALIFORNIA, SAN FRANCISCO|Dr. Dennis Black|415-514-8159|dblack@psg.ucsf.edu|
279084|NCT00683293|Kantonsspital Aarau|Dimtri SARLOS|00418384141|la.kots@ksa.ch|
279085|NCT00683332|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279086|NCT00683384|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279087|NCT00683410|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279088|NCT00683449|MediciNova, Inc.|Kazuko Matsuda, MD PhD MPH, Vice President, Clinical Development|858-373-1500|matsuda@medicinova.com|132
279089|NCT00683475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
279090|NCT00683592|PGxHealth, LLC|Director of Medical Affairs|203-786-3400||
279091|NCT00683618|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
298768|NCT01839110|University of Pennsylvania|Dr. Yuchi Han|215-662-2855|yuchi.han@uphs.upenn.edu|
279092|NCT00683644|University of Iowa|richard tyler|319 356 2471|rich-tyler@uiowa.edu|
279093|NCT00683657|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
279094|NCT00683696|Biotronik, Inc.|Kelly Mohr|800-547-0394|kelly.mohr@biotronik.com|
279095|NCT00683774|Virginia Commonwealth University|Dr. John Nestler|804-828-3389|jnestler@mcvh-vcu.edu|
279096|NCT00683800|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288446|NCT01190878|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
288447|NCT01190891|Madigan Army Medical Center|Troy Patience, Research Operations Service|(253) 968-1160|usarmy.jblm.medcom-mamc.mbx.dci@mail.mil|
288448|NCT01190930|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
298769|NCT01839188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
298770|NCT01839279|Acorda Therapeutics, Inc.|Executive Medical Director|914-437-4300|paupperle@acorda.com|5263
298771|NCT01839318|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
298772|NCT01839487|Halozyme Therapeutics|VP, Clinical Development|858-794-8889|medinfo@halozyme.com|
298773|NCT01839604|AstraZeneca Pharmaceuticals LP|Martin Scott, MD/PhD|Martin.Scott@astrazeneca.com|Martin.Scott@astrazeneca.com|
298774|NCT01839656|Biogen|US Biogen Clinical Trial Center|866-633-4636|clinicaltrials@biogen.com|
298775|NCT01839695|Medtronic Vascular|Taryn Dellaripa, Senior Clinical Research Specialist|541-301-3181|taryn.dellaripa@medtronic.com|
298776|NCT01839708|Ohio State University|Mei-Wei Chang|(614) 292-4041|chang.1572@osu.edu|
279097|NCT00683826|Columbia University Medical Center|Henry N. Ginsberg MD, Gissette Reyes Soffer MD|2123059298|gr2104@columbia.edu|
279098|NCT00683852|Massachusetts General Hospital, CTNI|Martina Flynn, Director, Clinical Trial Operations|617-643-6028|mflynn2@partners.org|
279099|NCT00683878|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
279100|NCT00683904|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
279101|NCT00683930|Hoffmann-La Roche|Medical Communications|800-821-8590||
279102|NCT00684021|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
279103|NCT00684047|Grifols Biologicals Inc.|Paul Pinciaro|443-375-8825|Paul.Pinciaro@grifols.com|
279104|NCT00684060|UT-Houston School of Public Health|Lemuel Moye, MD, PhD|713-500-9518|Lemmoye@msn.com|
279105|NCT00684073|Schering-Plough|Head, Clinical Trials Registry and Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
298777|NCT01839799|University of Pennsylvania|Jennifer Louie, Program Manager|215-220-9668|Jennifer.Louie2@pennmedicine.upenn.edu|
279106|NCT00684138|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
279107|NCT00684177|GlaxoSmithKline|GSK Response Center|866-435-7343||
279108|NCT00684203|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279109|NCT00684242|UT MD Anderson Cancer Center|Sriram Yennurajalingam, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
279110|NCT00684307|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
279111|NCT00684320|San Diego State University/University of California Joint Doctoral Program in Clinical Psychology|Dr. Nader Amir|(619) 229-3740|namir@mail.sdsu.edu|
279112|NCT00684411|Dana-Farber Cancer Institute|Eric Jacobsen, MD|617.632.6633|EDJACOBSEN@PARTNERS.ORG|
279113|NCT00684424|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
279114|NCT00684515|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279115|NCT00684541|SDSU|Professor Nader Amir|6192293744|namir@mail.sdsu.edu|
279116|NCT00684554|New York State Psychiatric Institute|Dr. Frances Levin|646-774-6137|frl2@columbia.edu|
298778|NCT01839916|University of Chicago|Dr. Hongtao Liu|773-834-1736|hliu2@medicine.bsd.uchicago.edu|
279117|NCT00684567|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279118|NCT00684593|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
288449|NCT01191008|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288450|NCT01191086|Upsher-Smith Laboratories, Inc.|Bob Anders, Sr. Director of Clinical Operations|763-315-2000|bob.anders@upsher-smith.com|
288451|NCT01191190|University of California, San Diego|Januario E Castro, MD|(858) 822-6600|jecastro@ucsd.edu|
288452|NCT01191242|Intermountain Heart Institute|John Carlquist, PhD|8014081028|john.carlquist@imail.org|74707
288453|NCT01191255|Keryx Biopharmaceuticals Inc|Medical Information|1-844-44-KERYX (1-844-445-3799|medicalinfo@keryx.com|
288454|NCT01191268|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288455|NCT01191320|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
288456|NCT01191333|Director, VISN21 MIRECC, Department of Veterans Affairs|Jerome Yesavage, MD|650-852-3287|Jerome.Yesavage@va.gov|
298779|NCT01840072|Tulane University|Dr. Jiang He|5049885165|jhe@tulane.edu|
288457|NCT01191398|University of Texas Southwestern Dallas Medical Center|Craig J. Huang, MD|214-456-6371|craig.huang@utsouthwestern.edu|
288458|NCT01191411|University of Texas Southwestern Medical Center|Keith E. Argenbright, MD|817-288-9898|keith.argenbright@utsouthwestern.edu|
288459|NCT01191476|Abbott|Global Medical Services|800-633-9110||
298780|NCT01840163|University of Michigan|Dr. Sarah Hawley|734-936-8816|sarahawl@med.umich.edu|
288460|NCT01191541|Department of pediatrics, Institute of Hematology and Blood Diseases Hospital.|xiaofan Zhu|+86 22 23909001|xfzhu@ihcams.ac.cn|
288461|NCT01191723|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
288462|NCT01191736|Maricopa Integrated Health System|David Drachman|602-344-5161|david.drachman@mihs.org|
288463|NCT01191749|University of Texas (UT) MD Anderson Cancer Center|Tapan Kadia, MD|1-877-632-6789|CR_Study_Registration@mdanderson.org|
288464|NCT01191762|Kenneth R. Phelps, M.D.|Kenneth R. Phelps, M.D.|518-626-5641|kenneth.phelps@va.gov|
288465|NCT01191788|RAND Corporation|Katherine Watkins|(310) 393-0411|kwatkins@rand.org|6509
288466|NCT01191801|Sunesis Pharmaceuticals, Inc|Judy Fox, Chief Scientific Officer|(650) 266-3736|jfox@sunesis.com|
288467|NCT01191827|Denver VA Medical Center|Research Biologist|303-724-6232|jason.tregellas@va.gov|
308899|NCT02622724|Faron Pharmaceuticals|Chief Medical Officer|+3584005529411|medical@faron.com|
308900|NCT02623218|AOMA Graduate School of Integrative Medicine|Dr. John Finnell|512-492-3057|jfinnell@aoma.edu|
288468|NCT01191840|Duke University Health System|Vance Fowler|919-668-8044|fowle003@mc.duke.edu|
288469|NCT01191944|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288470|NCT01192022|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
288471|NCT01192100|Purdue University|Dr. Heather Leidy|765-496-0184|hleidy@purdue.edu|
288472|NCT01192126|Bausch & Lomb Incorporated|Dr. Robert Steffen OD|585-338-6399|robert.steffen@bausch.com|
288473|NCT01192139|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
288474|NCT01192152|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
288475|NCT01192178|GlaxoSmithKline|GSK Response Center|866-435-7343||
288476|NCT01192191|GlaxoSmithKline|GSK Response Center|866-435-7343||
298781|NCT01840228|Ohio State University|Dr. Heather Frey|614-688-6798|Heather.Frey@osumc.edu|
298782|NCT01840319|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279119|NCT00684645|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279120|NCT00684671|GlaxoSmithKline|GSK Response Center|866-435-7343||
279121|NCT00684723|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
279122|NCT00684749|University of Minnesota|Umar Choudry/Bruce Cunningham|6126250697|choud008@umn.edu|
279123|NCT00684762|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
279124|NCT00684775|"Johns Hopkins School of Medicine: Department of Psychiatry"|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
279125|NCT00684788|Hopkins School of Medicine: Department of Psychiatry|Dr. Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
279126|NCT00684814|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
279127|NCT00684983|Mayo Clinic|Paul Haluska Jr MD PhD|507-284-1159|haluska.paul@mayo.edu|
279128|NCT00684996|SWOG Statistical Center|Study Statistician|206-667-4623||
298783|NCT01840345|Virginia Commonwealth University|Dr. Dace Svikis|(804) 827-1184|dssvikis@vcu.edu|
279129|NCT00685035|University of Minnesota School of Medicine|Dr. Robert Kempainen|612-873-6413|kempa001@umn.edu|
279130|NCT00685139|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
279131|NCT00685165|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
279132|NCT00685178|Johns Hopkins University|Dr. Annie Umbricht|410-550-1917|annieumbricht@jhu.edu|
279133|NCT00685295|Harvard/MGH|Stephen Thomas|6177267622|sthomasmd@gmail.com|
279134|NCT00685334|New York State Psychiatric Institute|Evelyn Attia, MD|212-253-5923|ea12@columbia.edu|
279135|NCT00685373|Novartis Pharmaceuticals|Study Director|862-778-8300||
279136|NCT00685399|Novartis Pharmaceuticals|Study Director|862-778-8300||
279137|NCT00685477|Temple University|Alan Maurer, MD|215-707-8269|amaurer@temple.edu|
298784|NCT01840410|Novartis|Study Director|862-778-8300||
279138|NCT00685516|UCLA|Susanne Henning, Ph.D., Principal Investigator|310-825-9345|shenning@mednet.ucla.edu|
279139|NCT00685659|University of Pennsylvania|James R. McKay, Ph.D.|215-746-7704|jimrache@mail.med.upenn.edu|
279140|NCT00685685|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
279141|NCT00685698|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
279142|NCT00685750|GlaxoSmithKline|GSK Response Center|866-435-7343||
279143|NCT00685763|University of Florida Proton Therapy Institute|Charles Nichols, M.D.|904-588-1800|rnichols@floridaproton.org|
279144|NCT00685802|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
279145|NCT00685932|University of Iowa Hospitals and Clinics|Abbey Hardy-Fairbank, MD|319-356-2291|abbey-hardy-fairbanks@uiowa.edu|
279146|NCT00685945|Vanderbilt University|Dr. Mias Pretorius|615-343-0665|mias.pretorius@vanderbilt.edu|
279147|NCT00686075|MedImmune, LLC.|Filip Dubovsky, Vice President, Clinical Development|301-398-0000|dubovskyf@medimmune.com|
279148|NCT00686127|University of California, San Francisco|Dr. Christine Miaskowski, PI|415-476-9407|chris.miaskowski@nursing.ucsf.edu|
279149|NCT00686166|SWOG Statistical Center|SWOG Statistician|206-667-4408||
279150|NCT00686205|Abbott Diagnostics Division|Peggy Moreno|847-937-2044|Peggy.Moreno@abbott.com|
288477|NCT01192204|The Ohio State University|Susan R, Mallery DDS, PhD|614 292-5892|mallery.1@osu.edu|
288478|NCT01192282|Groote Schurr Hospital / University of Cape Town|Dr Shahila Tayib|0060195773376|syarq@yahoo.com|
288479|NCT01192295|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
288480|NCT01192347|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
288481|NCT01192399|Alexion Pharmaceuticals, Inc|Alexion Pharmaceuticals, Inc||clinicaltrials@alexion.com|
288482|NCT01192412|St. George's, University of London|Dr. Laura A. Magee|+442086729944|LMagee@sgul.ac.uk|52621
288483|NCT01192516|Veterans Affairs--Ann Arbor Health Care System|Research Health Science Specialist|734-936-2123|sumurphy@umich.edu|
288484|NCT01192542|Johnson and Johnson Vision Care|Brian Pall, O.D., M.S. F.A.A.O. Principal Research Optometrist|1 904 443-1290|bpall@its.jnj.com|
288485|NCT01192698|Carolinas Medical Center|Dr. Mark W. Russo|704-355-6649|mark.russo@carolinashealthcare.org|
288486|NCT01192776|Wayne State University|Seetha Shankaran|(313) 745-1436|sshankar@med.wayne.edu|
288487|NCT01192815|Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Panayiotis Savvides, MD|216-844-5946|Panayiotis.Savvides@uhhospitals.org|
288488|NCT01192828|University of Colorado Denver|Dr. Johan Van Hove, Primary Investigator|303-724-2338|johan.vanhove@childrenscolorado.org|
288489|NCT01193010|Massachusetts General Hospital|Rachel Gottlieb, Clinical Research Coordinator|617.724.4985|rgottlieb3@mgh.harvard.edu|
288490|NCT01193049|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
288491|NCT01193101|Novartis Pharmaceuticals|Study Director|+1 (862) 778-1873||
288492|NCT01193114|The Ohio State University|Dr. Natasha Slesnick|614 247-8469|slesnick.5@osu.edu|
288493|NCT01193127|Omeros Corporation|Chief Medical Officer|(206) 676-5000|swhitaker@omeros.com|
288494|NCT01193153|Janssen Scientific Affairs, LLC, Titusville, NJ|Director of Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
288495|NCT01193218|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288496|NCT01193244|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
288497|NCT01193257|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
288498|NCT01193283|NIH NHLBI|Dr. Danielle Townsley|301-402-3477|townsleydm@nhlbi.nih.gov|
298785|NCT01840579|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279151|NCT00686231|UCSF|Andrew Boyle|415-514-0827|aboyle@medicine.ucsf.edu|
279152|NCT00686257|Tufts Medical Center|Nicholas Hill MD|617-636-4288|nhill@tuftsmedicalcenter.org|
279153|NCT00686335|Horizon Pharma|Senior Vice President, Clinical Development & Operations|224-383-3012|agrahn@horizonpharma.com|
279154|NCT00686517|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279155|NCT00686543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279156|NCT00686582|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
279157|NCT00686595|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279158|NCT00686634|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
279159|NCT00686647|AngioScore|Gary Gershony, MD/ Chief Medical Officer|510-933-7900|gary@angioscore.com|
279160|NCT00686686|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279161|NCT00686699|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279162|NCT00686712|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
279163|NCT00686725|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279164|NCT00686777|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279165|NCT00686790|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
279166|NCT00686803|Palatin Technologies, Inc.|Robert Jordan, Executive Director of Clinical Operations|609.495.2200|rjordan@palatin.com|
279167|NCT00686829|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279168|NCT00686842|AMC|Susan Krown, MD, Protocol Chair|301-251-1161|amcpm@emmes.com|
279169|NCT00686855|Dana-Farber Cancer Institute|Nathaniel S. Treister, DMD, DMSc|617-632-2806|ntreister@partners.org|
279170|NCT00686881|Merck Sharp & Dohme Corp..|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279171|NCT00686894|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279172|NCT00686920|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
279173|NCT00686959|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
279174|NCT00686998|Astrazeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
279175|NCT00687076|Baylor College of Medicine|Gerd Brunner, PhD|713-790-5800|gbrunner@bcm.edu|
279176|NCT00687102|Wake Forest University Health Sciences|Sally A. Shumaker, PhD|336-71696934|sshumake@wakehealth.edu|
279177|NCT00687167|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
279178|NCT00687193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279179|NCT00687219|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279180|NCT00687271|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279181|NCT00687297|PrECOG|Study Statistician|617-632-3633|jmanola@jimmy.harvard.edu|
279182|NCT00687323|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279183|NCT00687362|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279184|NCT00687401|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279185|NCT00687440|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279186|NCT00687453|Charles R. Drew University of Medicine and Science|Stanley H. Hsia, MD|323-357-3633|stanleyhsia@cdrewu.edu|
279187|NCT00687544|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279188|NCT00687609|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
279189|NCT00687674|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
279190|NCT00687713|National Institute on Drug Abuse|Ann Anderson, MD|301-827-5916|aanderso@nida.nih.gov|
279191|NCT00687739|University of Colorado Anschutz Medical Campus|Wendy M Kohrt, PhD|3037241913|wendy.kohrt@ucdenver.edu|
279192|NCT00687804|Novartis Pharmaceuticals|Study Director|862 778-8300||
279193|NCT00687830|Cleveland Clinic Florida|Dr. Shibu Varughese and Dr. Anand Kumar|305-310-1238|akuma003@fiu.edu|
279194|NCT00687856|University of Pittsburgh|John Gorcsan MD|4126476570|gorcsanj@upmc.edu|
279195|NCT00687908|Galderma|Clinical Project Manager|+33 492 95 29 21|jean-charles.dhuin@galderma.com|
279196|NCT00687973|Novartis Pharmaceuticals|Study Director|862 778-8300||
288499|NCT01193335|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288500|NCT01193348|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|clinicaltrials@alxn.com|clinicaltrials@alxn.com|
288501|NCT01193517|UT MD Anderson Cancer Center|Dr. Michael J Overman/ Professor, GI Medical Oncology|713-792-2828|moverman@mdanderson.org|
288502|NCT01193582|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288503|NCT01193608|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288504|NCT01193660|CHA Bundang Medical Center, CHA University|Minyoung Kim, MD, PhD|82-31-780-1872|kmin@cha.ac.kr|
288505|NCT01193686|VA Puget Sound Health Care System|Rhonda Williams, Ph.D.|206-277-6290|Rhonda.Williams1@va.gov|
288506|NCT01193868|The University of Texas MD Anderson Cancer Center|George Blumenschein, MD / Professor|713-792-2734|CR_Study_Registration@mdanderson.org|
298786|NCT01840605|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
298787|NCT01840722|University of Kentucky|Michele Staton, Associate Professor|859-257-2483|mstaton@uky.edu|
298788|NCT01840943|Xian Janssen Pharmaceutical LTD|Senior Director Clin Development||ClinicalTrialDisclosure@its.jnj.com|
298789|NCT01841021|H. Lee Moffitt Cancer Center and Research Institute|Dr. Lubomir Sokol|813-745-8212|lubomir.sokol@moffitt.org|
298790|NCT01841047|Institut Bergonié|Pr Guy KANTOR||G.Kantor@bordeaux.unicancer.fr|
279197|NCT00688064|Galderma|Jean-Charles Dhuin, Clinical Project Manager|+33 4 92 95 29 21|jean-charles.dhuin@galderma.com|
279198|NCT00688103|School of Medicine, Toho University|Dr. Hideto Kameda|+81-3-3468-1251|hideto.kameda@med.toho-u.ac.jp|2326
279199|NCT00688155|Wake Forest School of Medicine|Mark Espeland, PhD|336-761-2826|mespelan@wakehealth.edu|336
279200|NCT00688181|Boston Scientific Corporation|Director, Clinical Operations|(952) 930-6300|Teresa.Takle-Flach@bsci.com|
279201|NCT00688259|VA Greater Los Angeles Healthcare System at West Los Angeles|Shirley M. Glynn, Ph.D.|3102683939|shirley.glynn@va.gov|
279202|NCT00688324|Maryland Psychiatric Research Center|Robert W. Buchanan, M.D.|410-402-7876|rwbuchanan@som.umaryland.edu|
279203|NCT00688467|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279204|NCT00688519|GlaxoSmithKline|GSK Response Center|866-435-7343||
279205|NCT00688545|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279206|NCT00688597|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|clinicaltrials@amicusrx.com|
279207|NCT00688623|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
298791|NCT01841060|Institut Bergonie|Pr Simone Mathoulin-Pélissier|33556333333|s.mathoulin@bordeaux.unicancer.fr|
279208|NCT00688636|Univerisity of Pittsburgh|Research Coordinator|412-648-9173|goldbyreffnerka@upmc.edu|
279209|NCT00688662|Medical University of South Carolina|Dr Peter Cotton|8438767217|cottonp@musc.edu|
279210|NCT00688688|Astellas Pharma Global Development, Inc.|Medical Director, Global Medical Sciences||ClinicalTrials.Disclosure@us.astellas.com|
279211|NCT00688701|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
279212|NCT00688740|sanofi-aventis|International Clinical Development Study Director||Contact-us@sanofi-aventis.com|
279213|NCT00688753|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
279214|NCT00688844|Emory University|Rani H. Singh|404-448-8519|rsingh@emory.edu|
279215|NCT00688870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279216|NCT00688909|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
279217|NCT00689026|Georgia Regent University|Dr. Sherman M. Chamberlain, Professor of Medicine|706-721-2238|schamberlain@gru.edu|
279218|NCT00689078|ORA|Paul Gomes|9786858900|pgomes@oraclinical.com|
279219|NCT00689091|University of Michigan|Dr. George A Mashour|734-936-4280|gmashour@med.umich.edu|
279220|NCT00689104|Astellas Pharma Europe B.V.|Director Medical Science||ClinicalTrials.Disclosure@us.astellas.com|
279221|NCT00689117|GlaxoSmithKline|GSK Response Center|866-435-7343||
279222|NCT00689221|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
279223|NCT00689260|EMD Serono, Inc.|Sanja Dragnic, MD|781-681-2337|sanja.dragnic@emdserono.com|
279224|NCT00689273|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279225|NCT00689299|Greer Laboratories, Inc. for Antigen Laboratories, Inc.|Mark Hites|828-759-7548|mhites@greerlabs.com|
279226|NCT00689338|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279227|NCT00689351|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
279228|NCT00689390|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279229|NCT00689481|GlaxoSmithKline|GSK Response Center|866-435-7343||
279230|NCT00689572|University of Virginia|Nassima Ait-Daoud Tiouririne, M.D.|(434)243-0570|nat7b@virginia.edu|
279231|NCT00689611|Divisions of Cardiology and Clinical Epidemiology, Jewish General Hospital/McGill University|Dr. Mark J. Eisenberg|514.340.8222|mark.eisenberg@mcgill.ca|3564
279232|NCT00689728|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
279233|NCT00689793|Departement of ambulatory care and community medicine, University of Lausanne, Switzerland|Dr Bernard Favrat MD|+41795566183314|Bernard.favrat@chuv.ch|
279234|NCT00689819|Wayne State University|Phillip Levy, MD|3139938558|plevy@med.wayne.edu|
279235|NCT00689871|Allergan Medical|Medical Monitor|(805) 961-5000|devicetrials@allergan.com|
279236|NCT00689936|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
279237|NCT00690040|Hemek Medical center|Dr. Raed Salim|97246494031|salim_ra@clalit.org.il|
279238|NCT00690235|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
279239|NCT00690274|University of Texas Southwestern Medical Center|Carol A. Tamminga, MD|214-645-2789|carol.tamminga@utsouthwestern.edu|
279240|NCT00690339|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
279241|NCT00690378|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
279242|NCT00690430|Novartis Pharmaceuticals|Study Director|862-778-8300||
279243|NCT00690443|Aegerion Pharmaceuticals|Chief Medical Officer|617-500-7867||
279244|NCT00690482|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
279245|NCT00690495|B.Braun Melsungen AG|Study manager|+49 5661 71|studies@bbraun.com|0
279246|NCT00690573|Abbott|Global Medical Services|800-633-9110||
279247|NCT00690612|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
279248|NCT00690755|James A. Haley VA Research Department|Robert Farese, MD|813-972-2000|Robert.Farese@va.gov|
279249|NCT00690794|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
279250|NCT00690820|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32(0)2 509 69 77|sven.voet@solvay.com|
308901|NCT02623322|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
279251|NCT00690833|Wake Forest University Health Sciences|Dr Steve feldman|336-716-3775|sfeldman@wakehealth.edu|
279252|NCT00690898|Ipsen|Medical Director, Endocrinology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
279253|NCT00690924|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
279254|NCT00691002|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
279255|NCT00691015|Barbara Ann Karmanos Institute|Zaid Al-Kadhimi, M. D.|(404) 778-1900|zalkadh@emory.edu|
279256|NCT00691028|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
279257|NCT00691054|University of Miami Sylvester Comprehensive Cancer Center|Caio Max Rocha Lima MD|305-243-7770|crocha@med.miami.edu|
279258|NCT00691093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
279259|NCT00691132|University of Minnesota|Dr. Dorothy Hatsukami|612-626-2121|hatsu001@umn.edu|
279260|NCT00691197|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
279261|NCT00691210|Columbia University Medical Center|Owen A. O'Connor, MD, Ph.D.|212-326-5720|oo2130@cumc.columbia.edu|
279262|NCT00691301|Gynecologic Oncology Group|Linda Gedeon for Mark Brady, PhD|716-845-1169|lgedeon@gogstats.org|
279263|NCT00691327|Allergan, Inc.|Medical Monitor|714-246-4500|clinicaltrials@allergan.com|
279264|NCT00691483|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279265|NCT00691600|Baylor College of Medicine|Andrea T. Cruz, MD, MPH|832-824-5582|acruz@bcm.edu|
279266|NCT00691665|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
279267|NCT00691704|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|cristina.gasparetto@duke.edu|
279268|NCT00691808|Lexicon Pharmaceuticals, Inc.|Joel P. Freiman, MD, MPH - Medical Director, Drug safety|281-863-3000||
279269|NCT00691938|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
279270|NCT00692185|New York State Psychiatric Institute|Evelyn Attia, MD|212-543-5923|ea12@columbia.edu|
279271|NCT00692198|Johns Hopkins Bloomberg School of Public Health|James Tonascia, PhD|410-955-8175|jtonasc1@jhu.edu|
279272|NCT00692211|New Mexico VA Health Care System|Richard Hoffman, MD|505-265-1711|richard.hoffman2@va.gov|5318
279273|NCT00692237|Sapienza University of Rome|Dr Andrea Isidori|+39 0649970540|andrea.isidori@uniroma1.it|
279274|NCT00692276|Vertiflex|Steve Reitzler|442-325-5934|sreitzler@vertiflex.com|
279275|NCT00692341|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|Pfizer, Inc.|ClinicalTrials.gov_Inquiries@pfizer.com|
279276|NCT00692406|DukeUMC|Dr. F. Joseph McClernon|919-668-3987|mccle011@mc.duke.edu|
279277|NCT00692419|VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion|Steven D. Weisbord MD|412-360-3911|steven.weisbord@va.gov|
279278|NCT00692692|Vanderbilt University Medical Center|Jason Wendel, MD|615-936-0160|jason.wendel@vanderbilt.edu|
279279|NCT00692770|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
279280|NCT00692978|Imperial College London|Dr Omar Usmani|02073158051|o.usmani@imperial.ac.uk|
279281|NCT00693160|Wake Forest School of Medicine|James C. Eisenach, M.D.|336-716-4498|jimeisenach@gmail.com|
279282|NCT00693225|Mayo Clinic|Dr. Yvonne Romero|507-266-9156|romero.yvonne@mayo.edu|
279283|NCT00693303|Shenandoah University|Deborah Marr ScD, OTR/L|540-678-4312|dmarr@su.edu|
279284|NCT00693420|Allergan, Inc.|Therapeutic Area Head|(714)246-4500|clinicaltrials@allergan.com|
279285|NCT00693472|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279286|NCT00693485|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
288507|NCT01193907|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
279287|NCT00693498|University of Rochester|Jill M. Cholette MD, Principle Investigator|585-275-8138|Jill_Cholette@urmc.rochester.edu|
279288|NCT00693654|Wake Forest University Health Sciences|Alan Fleischer, Jr., MD|336-716-7753|afleisch@wfubmc.edu|
279289|NCT00693693|Wake Forest University Health Sciences|Steven Feldman, MD, PhD|336-716-3775|sfeldman@wfubmc.edu|
279290|NCT00693706|GlaxoSmithKline|GSK Response Center|866-435-7343||
279291|NCT00693719|University of Arizona Cancer Center|Dr. Robert Livingston|520/626-4175|rlivingston@azcc.arizona.edu|
279292|NCT00693784|Spinal Restoration, Inc.|Jeff F. Doerzbacher|512 225-0405|jeffdoerzbacher@spinalrestoration.com|
279293|NCT00693992|University of Pittsburgh|Mark A. Socinski, M.D.||socinskima@upmc.edu|
279294|NCT00694018|VA Ann Arbor Center for Clinical Management Research|Sarah L. Krein, PhD, RN|734-845-3621|sarah.krein@va.gov|
279295|NCT00694070|Ascensia Diabetes Care|Clinical Research Scientist|574-257-3063||
279296|NCT00694096|Huntsman Cancer Institute|Mark Wade, Ph.D. - Compliance Officer|801-213-5746|mark.wade@hci.utah.edu|
288508|NCT01193920|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
288509|NCT01194089|Mayo Clinic|Dr. Toby N. Weingarten|507-255-1612|weingarten.toby@mayo.edu|
288510|NCT01194154|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
288511|NCT01194219|Celgene Corporation|Anne McClain|1-888-260-1599|ClinicalTrialDisclosure@Celgene.com|
288512|NCT01194245|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|858-794-8889||
288513|NCT01194258|Halozyme Therapeutics|Vice President, Endocrinology Clinical Development|858-794-8889||
288514|NCT01194271|The University of Texas (UT) MD Anderson Cancer Center|Padmanee Sharma, Professor, Genitourinary Medical Oncology|713-792-2830|CR_Study_Registration@mdanderson.org|
288515|NCT01194297|University of Rochester|Dr. Carl D'Angio|585-275-2972|carl_dangio@urmc.rochester.edu|
288516|NCT01194414|Hoffman-LaRoche|Medical Communications|800-821-8590||
288517|NCT01194440|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Vered Stearns|443-287-6489|HopkinsBreastTrials@jhmi.edu|
288518|NCT01194453|Sun Yat-sen University Cancer Center|Dr. Li Zhang|87342288|zhangli6@mail.sysu.edu.cn|
288519|NCT01194466|Mount Mercy University/The University of Iowa|Dr. Jen Lee|3193231623|jlee@mtmercy.edu|
288520|NCT01194479|Department of Internal Medicine and Endocrinology, Yale University School of Medicine, New Haven, CT|Robert Sherwin, MD|(203) 785-3482|robert.sherwin@yale.edu|
288521|NCT01194531|Natera (formerly Gene Security Network)|Nina Wemmer, MS,CGC, Study Coordinator|650-249-9090|nwemmer@natera.com|
279297|NCT00694109|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
279298|NCT00694122|Massachusetts General Hospital|David M. Nathan, MD|617-726-1848|dnathan@partners.org|
279299|NCT00694161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279300|NCT00694304|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
279301|NCT00694356|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279302|NCT00694473|Massachusetts General Hospital|Steven J Russell, M.D. PhD|617-726-8722|sjrussell@mgh.harvard.edu|
279303|NCT00694551|H. Lee Moffitt Cancer Center and Research Institute|Mayer Fishman, M.D., Ph.D.|813-745-4398|mayer.fishman@moffitt.org|
279304|NCT00694564|UC San Diego|Dr. Jeannie Huang|858-576-1700|jshuang@ucsd.edu|7322
279305|NCT00694603|Massachusetts General Hospital|Dr. Lecia Sequist|617-724-4000|lvsequist@partners.org|
279306|NCT00694707|Allergan|Willie R. Earley, MD Associate Vice President Clinical Development-CNS|714-246-4500|IR-CTRegistration@allergan.com|
279307|NCT00695019|Amarillo Biosciences, Inc.|Martin J. Cummins, Director of Clinical & Regulatory Affairs|806-376-1741|mcummins@amarbio.com|14
279308|NCT00695097|University of California, San Francisco|Flavio Vincenti|415-353-1322|flavio.vincenti@ucsfmedctr.org|
298792|NCT01841073|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
279309|NCT00695110|Clarus Therapeutics, Inc.|Robert E. Dudley, PhD, CEO and President|847-562-4300|rdudley@clarustherapeutics.com|
279310|NCT00695136|Pediatrics & Developmental Neuroscience Branch, NIMH|Susan E. Swedo, MD|301-496-5323|swedos@mail.nih.gov|
279311|NCT00695188|Department of Clinical Pharmacology, Medical University of Vienna|Eva-Luise Hobl|+43 1 40400 2981|eva-luise.hobl@meduniwien.ac.at|
279312|NCT00695253|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center|Rodney A. White, M. D.|310 963-5230|rawhite@ucla.edu|
279313|NCT00695292|Sarah Cannon Research Institute|Dr. David Spigel|615-329-7274|askSARAH@scresearch.net|
279314|NCT00695318|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
279315|NCT00695396|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Head of Hematology and Nephrology||pbowers@its.jnj.com|
279316|NCT00695409|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|82405
279317|NCT00695435|Alcon Research, LTD|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
279318|NCT00695500|National Institute on Alcohol Abuse and Alcoholism|Ramchandani, Vijay|+1 301 402 8527|vijayr@mail.nih.gov|
279319|NCT00695565|Arcion Therapeutics, Inc.|Dr. James Campbell|(410) 522-8701|jcampbell@arciontherapeutics.com|
279320|NCT00695578|Wake Forest University Health Sciences|Steve Feldman MD|336-716-3775|sfeldman@wakehealth.edu|
279321|NCT00695669|GlaxoSmithKline|GSK Response Center|866-435-7343||
279322|NCT00695786|UT MD Anderson Cancer Center|Felipe Samaniego,MD/Professor, Lymphoma-Myeloma|(713) 745-6824|fsamaniego@mdanderson.org|
279323|NCT00695864|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@pain.stanford.edu|
279324|NCT00695903|Cubist Pharmaceuticals|Medical Director||ellie.hershberger@cubist.com|
279325|NCT00695955|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
279326|NCT00696020|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
279327|NCT00696072|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
279328|NCT00696137|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
279329|NCT00696241|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
279330|NCT00696293|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
279331|NCT00696384|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
279332|NCT00696410|University of Michigan|Jennifer Cowger, MD, Assistant Professor|734 936-5265|jennmatt@med.umich.edu|
279333|NCT00696423|GlaxoSmithKline|GSK Response Center|866-435-7343||
279334|NCT00696436|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
279335|NCT00696449|Wake Forest University Health Sciences|Steven Feldman|3367167740|sfeldman@wakehealth.edu|
279336|NCT00696488|Wake Forest University Health Sciences|Steve Feldman, MD|336-716-3775|sfeldman@wakehealth.edu|
279337|NCT00696618|Johns Hopkins School of Medicine|Associate Director, Drug Development Unit|(410)641-8762|ejfuchs@jhmi.edu|
279338|NCT00696657|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
279339|NCT00696696|NYU Cancer Institute|Deirdre Cohen, MD|212-731-5656|deirdre.cohen@nyumc.org|
279340|NCT00696709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279341|NCT00696761|the Department of Urology, Asan Medical Center, University of Ulsan College|Kanghyon Song, Myung-Soo Choo, Kyu-Sung Lee, Ji-Yeon Han, Young-Suk Lee,|82-2-3010-3735|mschoo@amc.seoul.kr|
279342|NCT00696774|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
279343|NCT00696787|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
279344|NCT00697073|Santhera|Dr Thomas Meier|+41 61 906 8964|thomas.meier@santhera.com|
279345|NCT00697112|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279346|NCT00697190|Vistakon|John Buch OD|904-443-1707||
279347|NCT00697203|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
279348|NCT00697346|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
279349|NCT00697463|Columbia University|Elizabeth Shane, MD|212-305-7225|es54@cumc.columbia.edu|
279350|NCT00697515|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
279351|NCT00697541|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
279352|NCT00697593|Merck Serono S.A., a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
279353|NCT00697619|Sun Yat-sen University Cancer Centre|Dr. Li Zhang|86-20-87343458(O)|zhangli6@mail.sysu.edu.cn|
279354|NCT00697697|MAP Pharmaceuticals, Inc. a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
279355|NCT00697788|Mass General Hospital for Children|Erik Shank, MD|6177242250|eshank@partners.org|
279356|NCT00697801|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
279357|NCT00697827|Synthes|Ann Marie Simon|610-719-5418|simon.annmarie@synthes.com|
279358|NCT00698035|University of California, San Francisco|Michelle Melisko, MD|415-353-7070|mmelisko@medicine.ucsf.edu|
279359|NCT00698139|Columbia University|Dr. Paolo C. Colombo|212-305-2638|pcc2001@columbia.edu|
279360|NCT00698204|University of Connecticut Health Center|Dr. Rajesh V. Lalla|860-679-8007|lalla@uchc.edu|
279361|NCT00698451|Janssen Services, LLC|Senior Director|1 215 325-5329|tmcgowan@its.jnj.com|
279362|NCT00698516|GlaxoSmithKline|GSK Response Center|866-435-7343||
279363|NCT00698581|UCB|UCB Cares|+1 877 822 9493||
279364|NCT00698646|Novartis Pharmaceuticals|Study Director|862-778-8300||
279365|NCT00698685|University of Arizona, Arizona Cancer Center|Andrew M. Yeager, MD|520-626-0662|ayeager@azcc.arizona.edu|
279366|NCT00698841|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
279367|NCT00698867|Zimmer Biomet|Kelly Francher, Clinical Affairs Manager|574-371-9783|kelly.francher@zimmerbiomet.com|
279368|NCT00698932|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
279369|NCT00698997|University California Davis|Dr. Sally Rogers|916-703-0264|sjrogers@ucdavis.edu|
279370|NCT00699010|Acura Pharma|Dr. Ron Spivey|847-705-7709|rspivey@acurapharm.com|
298793|NCT01841216|Sport & Spine Rehab Clinical Research Foundation|Jena Etnoyer, Clinical Research Coordinator|240-766-0300|jetnoyer@ssrehab.com|838
279371|NCT00699140|Instituto Grifols, S.A|Marta Carretero, PhD, Clinical Project Leader|+ 34 93 571 22 00|marta.carretero@grifols.com|
279372|NCT00699153|Bausch & Lomb, Inc.|Laura Trusso, MS.|(585) 338-5561|laura.trusso@bausch.com|
279373|NCT00699192|Novartis Pharmaceuticals|Study Director|862 778-8300||
279374|NCT00699218|UC Davis|Guohua Xia|916-734-3574|gxia@ucdavis.edu|
279375|NCT00699283|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
279376|NCT00699335|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
279377|NCT00699348|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
279378|NCT00699374|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298794|NCT01841281|UC Davis|Dr. Nicholas Kenyon|916-734-3564|njkenyon@ucdavis.edu|
279379|NCT00699400|EMD Serono, Inc.|Mary C. Mahony, PhD, HCLD (AAB)|781.681.2438|mary.mahony@emdserono.com|
279380|NCT00699491|Washington University School of Medicine|Cynthia Ma, M.D., Ph.D.||cma@im.wustl.edu|
279381|NCT00699556|Yale University|Sherry McKee|(203) 737-3529|sherry.mckee@yale.edu|
279382|NCT00699582|Eisai Call Center|Eisai Inc.|888-422-4743||
279383|NCT00699608|GlaxoSmithKline|GSK Response Center|866-435-7343||
279384|NCT00699660|Veterans Affairs at TVHS|Theodore Speroff PhD|615-636-9476|ted.speroff@va.gov|
279385|NCT00699699|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
279386|NCT00699751|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
279387|NCT00699803|Bausch Health|Study Director||susan.harris@bauschhealth.com|
279388|NCT00699816|Seoul National University College of Medicine|Jung-Hwan Yoon, MD, PhD|+82-2-2072-2228|yoonjh@snu.ac.kr|
279389|NCT00699907|University of Arizona|Dr. Setsuko K. Chambers|520-626-0950|schamber@uacc.arizona.edu|
279390|NCT00699972|Eisai Call Center|Eisai Inc.|888-422-4743||
279391|NCT00699998|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
279392|NCT00700011|Texas Oncology - Amarillo|Dr. Seah Lim|806-358-8654|seah.lim@usoncology.com|
298795|NCT01841554|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
279393|NCT00700063|Leo Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|ctr.disclosure@leo-pharma.com|
279394|NCT00700102|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
279395|NCT00700115|Emory University School of Medicine|Dr. Igho Ofotokun|404-616-0659|iofotok@emory.edu|
279396|NCT00700141|Nycomed Deutschland GmbH|Medical Responsible|+49 7531 3666 0|clinicaltrials@nycomed.com|
288522|NCT01194674|National Institutes of Health|H. Nida Sen, Principal Investigator, National Eye Institute|301-402-3254|senh@nei.nih.gov|
288523|NCT01194804|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
288524|NCT01194830|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288525|NCT01194869|Emory University|Elisavet Paplomata, MD|404-778-1900|elisavet.paplomata@emory.edu|
288526|NCT01194973|Alexion Pharmaceuticals Inc|Alexion Pharmaceuticals Inc||clinicaltrials@alexion.com|
288527|NCT01194999|Barrie Urology Associates - The Male/Female Health and Research Centre|Joseph A Zadra, MD CM FRCSC|705-727-0551|joezadra@rogers.com|
288528|NCT01195025|University Hospital Linköping|Dr. Joachim Zdolsek|+46101030000|joachim.zdolsek@lio.se|
288529|NCT01195090|Department of Internal Medicine, Mackay Memorial Hospital|Dr. Sung-Chen Liu|886-2-2543-3535|pine3.tw@yahoo.com.tw|2174
288530|NCT01195103|Mayo Clinic|John B Leslie MD|480-301-8000|leslie.john@mayo.edu|
298796|NCT01841567|Klinik und Poliklinik für Orthopädie und Unfallchirurgie der Uniklinik Köln|Dr Kourosh Zarghooni|+49 2247887294|kourosh.zarghooni@uk-koeln.de|
288531|NCT01195116|University of Rochester|Dr. Suzanne Karan|5852751384|suzanne_karan@urmc.rochester.edu|
288532|NCT01195272|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
288533|NCT01195363|UTHSCSA|Charles L Bowden, MD|210-567-5393|BowdenC@uthscsa.edu|
288534|NCT01195415|University of Michigan Comprehensive Cancer Center|Dr. Mark Zalupski, M.D.|734-615-3969|zalupski@umich.edu|
279397|NCT00700180|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
279398|NCT00700271|Novartis Pharmaceuticals|Study Director|862-778-8300||
279399|NCT00700310|Eisai Call Center|Eisai Inc.|888-422-4743||
279400|NCT00700336|CanBas Co., Ltd.|Takumi Kawabe, MD, PhD|81559543666|takumi@canbas.co.jp|
279401|NCT00700375|Osaka General Medical Center|Prevention on Conrast-Induced Nephropathy With Bolus Injection of Sodium Bicarbonate|81-6-6692-1201|u_hiromichi@yahoo.co.jp|
279402|NCT00700401|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
279403|NCT00700427|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
279404|NCT00700440|Cancer Center, Sun Yat-sen University|Dr. Lu Tai-xiang|86-20-87343372|lutx@mail.sysu.edu.cn|
279405|NCT00700570|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
279406|NCT00700622|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
279407|NCT00700635|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
279408|NCT00700713|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
279409|NCT00700739|DePuy Synthes Spine|Mark Lotito|(508) 880-8045|Mlotito@its.jnj.com|
279410|NCT00700752|Vistakon|Kurt Moody OD|904-443-3088||
279411|NCT00700804|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Reserch Center|Janet Hunt, PhD|701-795-8353|janetrhunt@gmail.com|
279412|NCT00700817|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
279413|NCT00700882|ECOG-ACRIN Statistical Office|Study Statistician|6176323012|eatrials@jimmy.harvard.edu|
279414|NCT00700973|VA Palo Alto Health Care System|Christine Timko|650-617-2746|Christine.Timko@va.gov|
279415|NCT00700999|Jesse Brown VA Medical Center|Dr. K Luan Phan|312-569-7161|Kinh.Phan@va.gov|
279416|NCT00701038|The Ohio State Universtiy|Rami Khayat|614-247-7707|rami.khayat@osumc.edu|
279417|NCT00701051|Baltimore VA Medical Center|Steven J. Prior, PhD|410-605-7000|steven.prior@va.gov|4129
279418|NCT00701064|VA|Shawn Youngstedt|803-767-3208|shawn.youngstedt@asu.edu|
279419|NCT00701090|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279420|NCT00701103|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279421|NCT00701129|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
279422|NCT00701311|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
279423|NCT00701363|Ipsen|Medical Director, Clinical Endocrinology and Metabolism|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
279424|NCT00701376|Cleveland Clinic|Brian Parker, MD|216-444-9950|parkerb1@ccf.org|
279425|NCT00701389|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279426|NCT00701415|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
279427|NCT00701441|Ohio State University|Rami Khayat|614-247-7707|rami.khayat@osumc.edu|
279428|NCT00701558|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
279429|NCT00701636|LA BioMed at Harbor-UCLA Medical Center|Loren Miller MD|310-222-3813|Lgmiller@ucla.edu|
279430|NCT00701662|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
279431|NCT00701675|Ralp H. Johnson VA Medical Center|Olga Brawman-Mintzer, MD|8437242302|mintzero@musc.edu|2834
279432|NCT00701701|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
279433|NCT00701714|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
279434|NCT00701727|Radiant Research|Michael H Davidson, MD FACC|312-494-2220|michaeldavidson@radiantresearch.com|
279435|NCT00701779|Deaconess Clinic, Inc.|Paul F. Siami, MD CPI|812-426-9576|research.paul.siami@deaconess.com|
279436|NCT00701805|Abbott|Global Medical Services|800-633-9110||
279437|NCT00701896|Ohio State University|Dr. Philip Diaz|6142934925|diaz.3@osu.edu|
279438|NCT00701935|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
279439|NCT00702052|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
279440|NCT00702143|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
279441|NCT00702208|CUNY School of Public Health, Hunter College|Heidi Jones|212-396-7750|hjon@hunter.cuny.edu|
279442|NCT00702221|BTG International Inc.|SVP, Clinical Development|610-278-1660|thomas.king@btgplc.com|
279443|NCT00702299|University of Arizona|Dr. Setsuko Chambers|520/626.0950|schambers@azcc.arizona.edu|
279444|NCT00702325|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
279445|NCT00702364|Craig Hospital|Cynthia Harrison-Felix, PhD|303-789-8565|charrison-felix@craighospital.org|
279446|NCT00702377|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
279447|NCT00702403|Fred Hutchinson Cancer Research Center|Dr. Paul A. Carpenter|(206) 667-5191|pcarpent@fredhutch.org|
279448|NCT00702468|GW Pharma Ltd|Richard Potts Clinical Operations Director|+44 1353 616600|rp@gwpharm.com|
279449|NCT00702507|GlaxoSmithKline|GSK Response Center|866-435-7343||
279450|NCT00702650|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
279451|NCT00702689|National Institute of Arthritis and Musculoskeletal and Skin Diseases|Edward Cowen, M.D.|301-827-2328|cowene@mail.nih.gov|
279452|NCT00702715|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279453|NCT00702754|Solstice Neurosciences, Inc|Regulatory Affairs Specialist||regulatoryaffairs@usworldmeds.com|
279454|NCT00702780|Seoul National University Hospital|Young Min Choe|82-2-2072-1730|howlow44@daum.net|
279455|NCT00702884|The Ohio State University Comprehensive Cancer Center|Tanios Bekaii-Saab|614-293-6529|Tanios.Bekaii-Saab@osumc.edu|
279456|NCT00702923|University of Wisconsin Carbone Cancer Center|Douglas McNeel, M.D., Ph.D.|(608) 263-4198|dm3@medicine.wisc.edu|
279457|NCT00702949|Mayo Clinic|Charles Loprinzi, M.D.|507/284-1623|cloprinzi@mayo.edu|
279458|NCT00703053|Saint Louis University|Robert Belshe, MD|314-977-9030|belsherb@slu.edu|
279459|NCT00703118|Tibotec|Medical Leader|1 609 730-3174||
279460|NCT00703157|Medtronic Bakken Research Center, Coronary and Structural Heart Disease Management|Ber Kleijnen|+31 (0) 43 356 6566|ber.kleijnen@medtronic.com|
279461|NCT00703261|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279462|NCT00703391|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
279463|NCT00703508|Virginia Commonwealth University|Dr. Kai Cheang|(804) 828-2257|kicheang@vcu.edu|
279464|NCT00703664|Massey Cancer Center, Virginia Commonwealth University|Dr. Beata Holkova|804-628-2581|bholkova@mcvh-vcu.edu|
279465|NCT00703677|Westat|René Gonin, PhD (Math. Stats.)|301-251-1500|renegonin@westat.com|
279466|NCT00703729|CU Sports Medicine|Dr. Eric McCarty|303-441-2118|cyndi.long@ucdenver.edu|
279467|NCT00703781|ISTA Pharmaceuticals, Inc.|Tim McNamara, PharmD|949-788-6000|tmcnamara@istavision.com|
279468|NCT00703820|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
279469|NCT00703846|GlaxoSmithKline|GSK Response Center|866-435-7343||
279470|NCT00703911|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
279471|NCT00703924|Institute Pasteur Tunisia|Afif Ben Salah, MD, PhD|216-71-792-429|afif.bensalah@pasteur.rns.tn|
279472|NCT00703937|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
279473|NCT00703963|Mayo Clinic|Dr. Hartzell V. Schaff|507-255-7068|schaff@mayo.edu|
279474|NCT00703976|University of Pittsburgh|Julie Bauman, MD|412-623-7833|baumanje@upmc.edu|
298797|NCT01841593|SSAT Research, Chelsea & Westminster Hospital|Dr. Marta Boffito|+442033155601|marta.boffito@chelwest.nhs.uk|
279475|NCT00704028|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
279476|NCT00704132|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279477|NCT00704171|Covidien|Jennifer L. Doyle, Global Director of Clinical Affairs|781-839-1770|jennifer.doyle@covidien.com|
279478|NCT00704184|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279479|NCT00704262|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
279480|NCT00704340|Integra LifeSciences|Director, Medical Affairs|609-275-0500||
279481|NCT00704353|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|610-650-4200|mfalone@luitpold.com|
279482|NCT00704379|Baylor College of Medicine|Dr. Ricardo Jorge|713-794-7010|Ricardo.Jorge@bcm.edu|
279483|NCT00704405|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279484|NCT00704418|ISTA Pharmaceuticals, Inc.|Tim McNamara, Vice President, Clinical Research & Medical Affairs|949-788-6000|tmcnamara@istavision.com|
279485|NCT00704522|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279486|NCT00704717|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279487|NCT00704730|Exelixis, Inc|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
279488|NCT00704808|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279489|NCT00704847|Nordic Bioscience A/S|Bente Juel Riis, Medical Director|+45 22901317|bjr@nordicbioscience.com|
279490|NCT00704912|Penn State College of Medicine, Penn State Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-8478|rsl1@psu.edu|
279491|NCT00704938|National Cancer Institute, National Institues of Health|Steven A. Rosenberg, M.D.|301-496-4164|sar@mail.nih.gov|
279492|NCT00704964|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279493|NCT00705003|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@partners.org|
279494|NCT00705016|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
279495|NCT00705107|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279496|NCT00705133|UC Los Angeles|Rajan Saggar|310-206-6766|rsaggar@mednet.ucla.edu|
288535|NCT01195467|St Stephen's AIDS Trust|Dr Mark Nelson|02033|mark.nelson@chelwest.nhs.uk|155610
288536|NCT01195545|University of Washington|Brant Oelschlager, MD|206-543-3518|brant@uw.edu|
288537|NCT01195584|General Hospital Amstetten|Wolfgang Senker, MD|+43 7472 6040|wolfgang.senker@aon.at|6611
288538|NCT01195597|University of Catania|Prof Riccardo Polosa|0957436413|polosa@unict.it, p.caponnetto@unict.it|0039
288539|NCT01195623|Uppsala UH|Lena Blomgren MD PhD|+46851774173|lena.blomgren@karolinska.se|
288540|NCT01195636|Xenon Pharmaceuticals Inc.|Dr. Paul Goldberg, VP Clinical Development|604-484-3300|pgoldberg@xenon-pharma.com|
288541|NCT01195662|ClinicalTrialTransparency|AstraZeneca||ClinicalTrialTransparency@astrazeneca.com|
288542|NCT01195675|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288543|NCT01195701|TriHealth Hatton Research Institute|Academic Clinical Research Supervisor|513-862-2330|Angie_Fellner@trihealth.com|
288544|NCT01195779|GlaxoSmithKline|GSK Response Center|866-435-7343||
288545|NCT01195831|Leo Pharma|Malin Jaernkrants|+4544945888|malin.jaernkrants@leo-pharma.com|
288546|NCT01195844|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
288547|NCT01195883|Cleveland Clinic|Daniel I. Sessler, MD|216-444-4900|DS@OR.org|
288548|NCT01195922|University of California San Diego|D. J. Silvio Gutkind|(858) 534 5980|sgutkind@ucsd.edu|
298798|NCT01841606|UBC Department of Anesthesia - BC Women's Hospital|Mr. James Taylor|604-875-2424|james.taylor1@phsa.ca|6076
298799|NCT01841619|UC Irvine Dermatology Research Center|Sergei A. Grando|949 824 7103|sgrando@uci.edu|
298800|NCT01841632|University Hospital Regensburg|Prof. Dr. Marc-H. Dahlke, Ph. D.|+49941944|marc.dahlke@ukr.de|6809
298801|NCT01841697|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279497|NCT00705146|VIHA|Helia Sillem MScOT|2507557611|helia.sillem@viha.ca|
279498|NCT00705159|Bausch & Lomb Incorporated|Tuyen Ong, MD, MRCOphth|(973) 360-6389|tuyen.ong@bausch.com|
279499|NCT00705224|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279500|NCT00705250|Memorial Sloan Kettering Cancer Center|Craig Moskowitz, MD|(212) 639-7992|moskowic@mskcc.org|
279501|NCT00705263|Schering-Plough|Head, Clinical Trials Registry & Results Disclosure Group||ClinicalTrialsDisclosure@spcorp.com|
279502|NCT00705289|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279503|NCT00705341|Johns Hopkins University|Anne Capser|410-955-8183|ashankli@jhsph.edu|
279504|NCT00705367|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
279505|NCT00705406|BioCryst Pharmaceuticals, Inc.|William P. Sheridan, MBBS|919-859-1302||
308902|NCT02623335|University of Wisconsin, Madison|Gretchen Lee Schwarze, MD, MPP, FACS|(608) 265-2358|schwarze@surgery.wisc.edu|
279506|NCT00705432|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279507|NCT00705484|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279508|NCT00705523|UPenn|Dr. Jennifer Plebani|215-222-3200|jplebani@mail.med.upenn.edu|152
279509|NCT00705536|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
279510|NCT00705575|Novartis Pharmaceuticals|Study Director|862 778-8300||
279511|NCT00705614|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279512|NCT00705653|Progen Industries|Michael Fitzgerald|919-803-9988|michaelf@progen-pharma.com|
279513|NCT00705666|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279514|NCT00705679|University of Washington|Jeanne Marrazzo, MD, MPH, FACP, FIDSA|206-744-3679|jmm2@uw.edu|
279515|NCT00705718|Medtronic|Karla Betz, Principal Clinical Research Specialist|763-526-2737|karla.h.betz@medtronic.com|
279516|NCT00705757|Summa Health System ( at the time of the trial)|Deepak P. Edward, MD|330-780-0399|deepak.edward@gmail.com|
279517|NCT00705783|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
279518|NCT00705874|Progen Pharmaceuticals Pty Ltd|Director of Clinical Trials|+61 7 32739133|darrynb@progen-pharma.com|
279519|NCT00705939|Protalix Ltd.|Vice President Product Development|+(972) 4-9889488|einata@protalix.com|137
279520|NCT00706004|University of Arkansas for Medical Sciences|Catherine O'Brien|501-364-1828|obriencatherinee@uams.edu|
279521|NCT00706030|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
279522|NCT00706095|Eisai Call Center|Eisai Inc.|888-422-4743||
279523|NCT00706121|SWOG Statistical Center|SELECT/S0000D Statistician|206-667-4623||
279524|NCT00706134|Novartis Pharmaceuticals|Study Director|862-778-8300||
279525|NCT00706238|GlaxoSmithKline|GSK Response Center|866-435-7343||
279526|NCT00706264|Hospital Vall d'Hebron|Maria M Goya|934893085|maria.goya@vhir.org|4652
279527|NCT00706342|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
279528|NCT00706355|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279529|NCT00706381|NIDDK|Kong Chen, Ph.D.|301-451-1636|chenkong@niddk.nih.gov|
279530|NCT00706394|Endologix|Sharone Trifskin|949-599-8860|strifskin@endologix.com|
288549|NCT01195948|National Institutes of Health|Robert Nussenblatt, MD, MPH|301-496-3123|robert.nussenblatt@nih.gov|
288550|NCT01196026|GlaxoSmithKline|GSK Response Center|866-435-7343||
288551|NCT01196052|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
288552|NCT01196078|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
288553|NCT01196091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288554|NCT01196104|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
288555|NCT01196117|Medical College of Wisconsin|B. Tucker Woodson|414-805-7667|bwoodson@mcw.edu|
288556|NCT01196377|Vanderbilt University School of Medicine|Dr. Donald H Arnold|6155790516|don.arnold@vanderbilt.edu|
288557|NCT01196416|Memorial Sloan Kettering Cancer Center|Dr. Mark Dickson|646-888-4164|DicksonM@mskcc.org|
288558|NCT01196429|NRG Oncology Statistics and Data Management Center - Buffalo|Linda Gedeon for William Brady PhD|716-845-5702|lgedeon@nrgoncology.org|
288559|NCT01196442|Virginia Commonwealth University|Dr. Craig W. Swainey|804-828-9723|cswainey@mcvh-vcu.edu|
288560|NCT01196533|Morristowm Memorial Hospital|Dr. Frank Smart|973-214-2601|frank.smart@atlantichealth.org|
288561|NCT01196741|University of Glasgow|Prof Iain McNeish, Professor of Gynaecological Oncology|+44 (0)141 330 3968|iain.mcneish@glasgow.ac.uk|
288562|NCT01196793|Imperial College London NHS Trust|Dr Hermione Lyall|02033126965|hermione.lyall@nhs.net|
288563|NCT01196819|Shanghai Microport Medical (Group) Co.,Ltd.|Kefei Li|+86-21-38954600×6700|kfli@microport.com|
288564|NCT01196871|Medical Affairs|Amicus Therapeutics|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
288565|NCT01196923|CardioFocus, Inc.|Burke Barrett, VP, Regulatory & Clinical Affairs|508 658-7200|bbarrett@cardiofocus.com|
288566|NCT01196936|University of Alabama at Birmingham|Dr. Smita Bhatia|(205) 638-2120|sbhatia@peds.uab.edu|
288567|NCT01196975|GlaxoSmithKline|GSK Response Center|866-435-7343||
288568|NCT01196988|GlaxoSmithKline|GSK Response Center|866-435-7343||
288569|NCT01197300|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
288570|NCT01197326|Philips Healthcare|Duane A Young-Kershaw RN, BSN, Clinical Researcher|508-817-7001|duane.young-kershaw@philips.com|
288571|NCT01197378|Horizon Pharma USA, Inc.|Evelyn Olson|224-383-3000|clinicaltrials@horizonpharma.com|
288572|NCT01197417|Medical College of Wisconsin|David Brousseau MD, MS|414-266-2625|dbrousse@mcw.edu|
288573|NCT01197456|UC San Diego|Irene Su, MD MSCE|858-822-5986|hisu@ucsd.edu|
279531|NCT00706407|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
279532|NCT00706433|Dusa Pharmaceuticals, Inc.|Anna Houlihan||houlihana@dusapharma.com|
279533|NCT00706446|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
279534|NCT00706485|Massachusetts General Hospital|Thomas F. DeLaney, M.D.|617-726-6876|tdelaney@mgh.harvard.edu|
279535|NCT00706511|University of Chicago|Eve Van Cauter, PhD|773-702-0169|evcauter@bsd.uchicago.edu|
279536|NCT00706550|Michael E. DeBakey Veterans Affairs Medical Center|Dr. Maria C. Rodriguez-Barradas|713-794-7384|Maria.Rodriguez-Barradas2@va.gov|
279537|NCT00706563|GlaxoSmithKline|GSK Response Center|866-435-7343||
279538|NCT00706589|Kiho Moon|Medical Director|+82-2-3287-9009|khmoon@otsuka.co.kr|
279539|NCT00706628|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
279540|NCT00706641|Hoosier Cancer Research Network, Inc.|Noah Hahn, MD|317-921-2050|jsmith@hoosiercancer.org|
279541|NCT00706654|Otsuka Pharmaceutical Development and Commercialization|Global Medical Affairs|800 562-3974||
279542|NCT00706706|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279543|NCT00706719|Repros Therapeutics, Inc|Ronald Wiehle, PhD|281.719.3406|rwiehle@reprosrx.com|
279544|NCT00706784|MGH|Alexandra B. Kimball, MD|617-726-5066|akimball@partners.org|
279545|NCT00706810|Huntsman Cancer Institute|Dr. Randy Jensen|801-581-6908|randy.jensen@hci.utah.edu|
279546|NCT00706823|University of Texas Medical School at Houston|Carin A. Hagberg, MD|713-500-6222|carin.a.hagberg@uth.tmc.edu|
279547|NCT00706836|University of California San Diego|Murray B. Stein MD, MPH|858-534-6400|mstein@ucsd.edu|
279548|NCT00706849|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
279549|NCT00706901|Charleston VAMC|Elizabeth Santa Ana, Ph.D.|(843) 789-7168|elizabeth.santaana2@va.gov|
279550|NCT00706914|AstraZeneca|Esther Garcia||ClinicalTrialTransparency@astrazeneca.com|
279551|NCT00706966|University of California San Francisco|Mack Roach, MD|415-353-9855|tdiep@radonc.ucsf.edu|
279552|NCT00706979|Medical University of South Carolina'|Matthew J. Carpenter|843-792-3974|carpente@musc.edu|
279553|NCT00706992|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
279554|NCT00707031|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
279555|NCT00707057|SCOLR Pharma Inc|Stephen Turner, VP and Chief Technical Officer|425-368-1050|sturner@scolr.com|1001
279556|NCT00707174|University of Utah|Glen Bowen, MD|801-581-0255|glen.bown@hci.utah.edu|
279557|NCT00707239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298802|NCT01841762|Actelion Pharmaceuticals US, Inc.|Scott Tsurutani / Associate Director, Clinical Operations|6508086586|scott.tsurutani@actelion.com|
279558|NCT00707343|Huntsman Cancer Institute|Mark Wade, Ph.D. - Compliance Officer|801-213-5746|mark.wade@hci.utah.edu|
279559|NCT00707447|FIDAM|Norbert Hermanns|0049 7931 594|hermanns@diabetes-zentrum.de|553
279560|NCT00707486|HemCon Medical Technologies|Staci McAdams|(503)245-0459|staci@hemcon.com|103
279561|NCT00707577|Massachusetts General Hospital|Dr. Anne Thorndike|617-724-4608|athorndike@mgh.harvard.edu|
279562|NCT00707655|Genmab A/S|Eva Järlid Westerberg, VP Clinical Operations|+45 7020 2728|E.Westerberg@genmab.com|
298803|NCT01841970|Medtronic Surgical Innovations|Study Director, Clinical Research|508-452-4028||
279563|NCT00707746|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
279564|NCT00707759|FONDECYT|Maria Angela Delucchi|56-2-25755972|madelucchi@gmail.com|
279565|NCT00707863|Indiana Uiniveristy|Amit Anand MD|3172747422|aanand@iupui.edu|
279566|NCT00707915|Minami-hanno Hospital|Director of clinical trials|81.42.972.7111|haloperidol1mg@hotmail.com|
279567|NCT00707954|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
279568|NCT00707967|GlaxoSmithKline|GSK Response Center|866-435-7343||
279569|NCT00707980|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
279570|NCT00707993|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
279571|NCT00708019|University of California, San Francisco|Christine Miaskowski|415-476-9407|chris.miaskowski@nursing.ucsf.edu|
279572|NCT00708032|Johnson & Johnson Vision Care, Inc.|Kathy Osborn, OD|+1 904 443-1032|clinicalstudies@its.jnj.com|
279573|NCT00708071|Baxter Innovations, GmbH|Edith Hantak, DVM, Dir, Global Therapeutic Area, BioSurgery||edith_hantak@baxter.com|
279574|NCT00708097|GlaxoSmithKline|GSK Response Center|866-435-7343||
279575|NCT00708110|ViiV Healthcare|GSK Response Center|866-435-7343||
279576|NCT00708123|GlaxoSmithKline|GSK Response Center|866-435-7343||
279577|NCT00708162|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
279578|NCT00708175|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
279579|NCT00708201|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
279580|NCT00708214|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
279581|NCT00708227|Nemours Children's Specialty Care|Kathryn Blake|9046973806|kathryn.blake@nemours.org|
279582|NCT00708305|GlaxoSmithKline|GSK Response Center|866-435-7343||
279583|NCT00708422|Alcon Research, Ltd.|Director of Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
279584|NCT00708435|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
279585|NCT00708461|University of Minnesota|Jennifer A. Linde, Ph.D.|612-624-0065|linde074@umn.edu|
279586|NCT00708500|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279587|NCT00708526|University of Utah|Dwayne Westenskow, PhD|801-581-2478|Dwayne.Westenskow@hsc.utah.edu|
279588|NCT00708552|GlaxoSmithKline|GSK Response Center|866-435-7343||
279589|NCT00708643|Vistakon|Kurt Moody, O.D. FAOO|904-443-3088||
279590|NCT00708682|Pfizer, Inc.|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@Pfizer.com|
279591|NCT00708708|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279592|NCT00708721|Huntsman Cancer Institute|Dr. Paul Shami|801-585-0100|paul.shami@hci.utah.edu|
279593|NCT00708851|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel, MD|609-443-4501|dreamacres1@aol.com|
279594|NCT00708877|University of Utah|Dr. Jason Schwarz|8015852708|jason.schwartz@hsc.utah.edu|
279595|NCT00708942|Photocure|Bjørn Klem, Project Director|+47 22 06 22 10|bk@photocure.no|
279596|NCT00709059|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
288574|NCT01197495|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
288575|NCT01197508|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
288576|NCT01197521|AstraZeneca|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
288577|NCT01197534|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
288578|NCT01197547|Boston Scientific|Meaghan Wilk|5086834113|wilkm@bsci.com|
288579|NCT01197560|Celgene|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
288580|NCT01197573|Cleveland Clinic|Bijan Eghtesad, MD|216 444-9898|eghtesb@ccf.org|
288581|NCT01197612|University of Michigan|Garrett Griffin, MD||ggriffin@mw-fp.com|
288582|NCT01197755|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
288583|NCT01197794|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
288584|NCT01197833|BTG International Inc|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
288585|NCT01197898|Healthpoint, Ltd.|Jaime E. Dickerson, PhD; Sr. Director Clinical Affairs|817-302-3914|jaime.dickerson@healthpoint.com|
288586|NCT01197911|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
288587|NCT01198002|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288588|NCT01198028|MD Anderson Cancer Center|Dr. Bonnie Glisson, MD,Professor, Thoracic-Head & Neck Med Onc|(713) 792-6363|bglisson@mdanderson.org|
288589|NCT01198132|Merck KGaA|Title: Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
288590|NCT01198145|Mayo Clinic|Robert C. Miller, M.D., M.S.||miller.robert@mayo.edu|
288591|NCT01198158|Georgetown University Hospital|George Philips MBBS, MD, MPH, FACP|202-444-2198|George.K.Philips@gunet.georgetown.edu|
288592|NCT01198275|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|Dr. Savina Nodari|00390303996|nodari@med.unibs.it|587
288593|NCT01198327|Wilmer Eye Institute|Peter Campocahiro|410-955-5106|pcampo@jhmi.edu|
288594|NCT01198366|Aeras|Product Director|301-547-2919|blandry@aeras.org|
288595|NCT01198470|Globus Medical|Jacqueline Myer|610-930-1800|jmyer@globusmedical.com|1669
288596|NCT01198509|New York University School of Medicine|Steven B. Abramson, MD|212-263-8003|StevenB.Abramson@nyumc.org|
288597|NCT01198574|South East Asia Ministers of Education Organization, Regional Center for Food and Nutrition|Dr. Min Kyaw Htet, Township Health Officer, Ministry of Health, Myanmar|+62-857-27262672|kyawhtet@gmail.com|
288598|NCT01198587|Boston Children's Hospital|Michelle Niescierenko MD MPH|617-919-4121|michelle.niescierenko@childrens.harvard.edu|
288599|NCT01198600|Alcon Research|R. Alan Landers, O.D., M.S., F.A.A.O.|1-800-241-7629||
288600|NCT01198691|TriHealth|Donna Lambers, MD|513-862-2828|donna_lambers@trihealth.com|
288601|NCT01198756|GlaxoSmithKline|GSK Response Center|866-435-7343||
288602|NCT01198769|GlaxoSmithKline|GSK Response Center|866-435-7343||
288603|NCT01198795|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|58124
288604|NCT01198873|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
288605|NCT01198977|Rehabilitation Care Services; MS Center of Excellence (MSCOE), VA Puget Sound Health Care System|Aaron Turner, PhD, Director, Rehabilitation Psychology; Asst Director Research, MSCOE|206-277-6134|Aaron.Turner@med.va.gov|
288606|NCT01199016|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288607|NCT01199042|Bethesda North Hospital|Dr. Shahrokh Javaheri|513-793-7378|shahrokhjavaheri@icloud.com|
288608|NCT01199055|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
288609|NCT01199068|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
288610|NCT01199146|University of California, San Francisco|Charles Ryan, MD|415-353-9279|charles.ryan@ucsf.edu|
288611|NCT01199198|University of Texas (UT) MD Anderson Cancer Center|Carmen Escalante,MD/Chair, General Internal Med|(713) 745-4516|cescalan@mdanderson.org|
288612|NCT01199237|University of California, San Francisco|Rachel Eshima McKay|415-502-1715|eshimar@anesthesia.ucsf.edu|
288613|NCT01199263|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|linda.gedeon@roswellpark.org|
288614|NCT01199289|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
288615|NCT01199380|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
288616|NCT01199471|Abbott|Global Medical Services|800-633-9110||
288617|NCT01199575|University of California, San Diego|Thomas Kipps, MD PhD|858-534-5400|tkipps@ucsd.edu|
288618|NCT01199601|Columbia University|Dr. Catherine Todd|212-305-4805|cst2121@columbia.edu|
288619|NCT01199705|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
288620|NCT01199731|ViiV Healthcare|GSK Response Center|866-435-7343||
288621|NCT01199744|GlaxoSmithKline|GSK Response Center|866-435-7343||
288622|NCT01199822|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288623|NCT01199848|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
288624|NCT01199861|Novartis Pharmaceuticals|Study Director|862-778-8300||
288625|NCT01199926|Purdue University|Dr. Dorothy Teegarden|765-494-8791|teegarden@purdue.edu|
288626|NCT01199939|Janssen Pharmaceuticals|SENIOR MEDICAL DIRECTOR|1 609 730-2931||
288627|NCT01199952|University of California, San Francisco|Director for Research Operations|415-206-2476|abby.sokoloff@ucsf.edu|
279597|NCT00709098|Actelion Pharmaceuticals Ltd|Laila Rouault, MD/International Clinical Leader|+ 41 61 565 8128||
298804|NCT01842061|The University Of British Columbia|Associate Professor MC Ashe|604-675-2574|maureen.ashe@ubc.ca|
279598|NCT00709111|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
279599|NCT00709124|Johns Hopkins University School of Medicine|Dr Dale Needham|(410) 955-3467|dale.needham@jhmi.edu|
279600|NCT00709202|Nathan Kline Institute for Psychiatric Research|Dr. Robert C Principal Investigator. Smith,|845-398-6531|robert.smith@nki.rfmh.org|
279601|NCT00709228|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279602|NCT00709306|Fox Chase Cancer Center|Carolyn Heckman, PhD|215-214-3962|carolyn.heckman@fccc.edu|
279603|NCT00709319|Jaeb Center for Health Research|Adam R. Glassman, Director DRCR.net Coordinating Center|813-975-8690|drcrstat3@jaeb.org|
279604|NCT00709592|Virginia Commonwealth University|Amir A Toor, MD|804-828-4360|atoor@mcvh-vcu.edu|
279605|NCT00709618|GlaxoSmithKline|GSK Response Center|866-435-7343||
279606|NCT00709696|University of Minnesota|Dr. Marc Mooney|612-991-6875|moon0078@umn.edu|
279607|NCT00709722|Nippon Kayaku Co., Ltd.|Pharmaceuticals Group|+81-3-6731-5200||
279608|NCT00709735|Massachusetts General Hospital|Roger K. Pitman, M.D.|617-726-5333|roger_pitman@hms.harvard.edu|
279609|NCT00709761|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
279610|NCT00709826|Tragara Pharmaceuticals|Tracy Parrott|760-208-6919|tparrott@tragarapharma.com|
288628|NCT01199965|MAP Pharmaceuticals Inc., a wholly owned subsidiary of Allergan|VP, Scientific Affairs|650-386-3100|dkellerman@mappharma.com|
288629|NCT01200030|The Hong Kong Polytechnic University|Dr. Shamay Ng|(852) 2766-4889|Shamay.Ng@polyu.edu.hk|
288630|NCT01200069|Rutgers/New Jersey Medical School|Vasanti Tilak, MD|974 972-5254|tilakva@njms.rutgers.edu|
288631|NCT01200160|Abbott Laboratories de México|Carlos A Gonzalez MD, PhD|(5255) 5809-|carlos.gonzalez@abbott.com|7576
288632|NCT01200238|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
288633|NCT01200290|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288634|NCT01200329|UT MD Anderson Cancer Center|Yago Nieto/Stem Cell Transplantation and Cellular Therapy|713-792-8750|ynieto@mdanderson.org|
288635|NCT01200342|UT MD Anderson Cancer Center|Sapna P. Patel, MD / Assistant Professor||CR_Study_Registration@mdanderson.org|
288636|NCT01200355|Memorial Sloan Kettering Cancer Center|Dr. Genovefa Papanicolaou MD|212-639-8361|papanicg@mskcc.org|
288637|NCT01200368|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288638|NCT01200394|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288639|NCT01200407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288640|NCT01200433|Clevland Clinic Foundation|Ehab Farag, MD|216-444-9950|farage@ccf.org|
288641|NCT01200485|UT MD Anderson Cancer Center|Saroj Vadhan, MD/Professor, Cytokine & Supportive Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
288642|NCT01200498|The University of Texas MD Anderson Cancer Center|Alfonso Quintas-Cardama, MD/Assistant Professor|713-745-4009|eharriso@mdanderson.org|
288643|NCT01200511|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
288644|NCT01200524|AstraZeneca|Heather Bryson||clinicaltrialtransparency@astrazeneca.com|
288645|NCT01200589|Novartis Pharmaceuticals|Study Director|862-778-8300||
288646|NCT01200758|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
288647|NCT01200797|Vanderbilt-Ingram Cancer Center|Marta A. Crispens, M.D.|615-322-8072|marta.crispens@Vanderbilt.Edu|
298805|NCT01842308|Mayo Clinic|Suzanne R. Hayman, M.D|(855) 776-0015|hayman.suzanne@mayo.edu|
288648|NCT01200810|Rutgers Cancer Institute of New Jersey|Mark Stein, MD|(732) 235-8675|steinmn@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu|
298806|NCT01842334|Beth Israel Deaconess Medical Center|Dr. Kevin P Hill, Director of the Division of Addiction Psychiatry|617-667-1504|khill1@bidmc.harvard.edu|
298807|NCT01842438|Australian Catholic University|Prof Liz Forbat, PI|+61 475978476|elizabeth.forbat@acu.edu.au|
298808|NCT01842464|Western Galilee MC|Menahem Neuman|+972546444033|mneuman@netvision.net.il|
298809|NCT01842581|Bausch Health Americas, Inc.|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
298810|NCT01842594|Shin Kong Wu Ho-Su Memorial Hospital|Kwan-Hwa Chi|+886-28332211|M006565@ms.skh.org.tw|2612
298811|NCT01842607|GlaxoSmithKline|GSK Response Center|866-435-7343||
298812|NCT01842620|GlaxoSmithKline|GSK Response Center|866-435-7343||
298813|NCT01842633|GlaxoSmithKline|GSK Response Center|866-435-7343||
298814|NCT01842646|H. Lee Moffitt Cancer Center and Research Institute|Dr. Jeffrey Lancet|813-745-1387|jeffrey.lancet@moffitt.org|
298815|NCT01842789|Acessa Health, Inc.|Laura Kemp, Clinical Affairs Consultant|4083751465|lkemp@acessahealth.com|
298816|NCT01842815|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
298817|NCT01842841|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
298818|NCT01842906|Stanford Department of Emergency Medicine|Dr. Grant Lipman|415-290-9286|gslipman@stanford.edu|
298819|NCT01842958|Straumann USA, LLC|Kelly Jork|978-747-2533|kelly.jork@straumann.com|
298820|NCT01843023|Friends Research Institute|Dr. Shannon Gwin Mitchell|410-837-3977|smitchell@friendsresearch.org|238
298821|NCT01843062|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
298822|NCT01843192|Ethicon, part of Johnson & Johnson|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
298823|NCT01843205|University of Kentucky|Craig R. Rush, Ph.D.|(859) 257-5388|crush2@email.uky.edu|
298824|NCT01843348|Novartis Pharmaceuticals|Study Director|862-779-8300||
298825|NCT01843374|AstraZeneca|Paul Stockman, MD, PhD|+44 162-523-1815|Paul.Stockman@astrazeneca.com|
298826|NCT01843465|Clinique Pasteur, Toulouse, France|Dr Serge Boveda|(33) 5 62 21 16 45|sboveda@clinique-pasteur.com|8819
279611|NCT00709852|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
279612|NCT00709878|Northwestern University|Mario Lacouture, MD|212-610-0079|LacoutuM@mskcc.org|
279613|NCT00709891|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
279614|NCT00709956|Actelion|Laila Rouault, M.D.|+ 41 61 565 8128|laila.rouault@actelion.com|
279615|NCT00709995|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
279616|NCT00710021|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
279617|NCT00710034|University of Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
279618|NCT00710203|UC Davis, Department of Dermatology|Daniel Eisen, M.D.|916-734-6479|dbeisen@ucdavis.edu|
279619|NCT00710385|Substance Abuse|Sandra D. Comer|646-774-6146|sdc10@columbia.edu|
279620|NCT00710424|GW Pharm Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
279621|NCT00710554|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
279622|NCT00710593|Westat|Dr. Bob Harris|301-251-1500|bobharris@westat.com|
279623|NCT00710606|Columbia University|Carolyn Westhoff|212-305-4805|clw3@columbia.edu|
279624|NCT00710684|GlaxoSmithKline|GSK Response Center|866-435-7343||
279625|NCT00710749|Astra Tech AB|Head of Clinical Research Area Health Care|+46317763000||
279626|NCT00710762|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
279627|NCT00710814|Columbia University|Judith Korner, M.D., PhD|2123053725|jk181@cumc.columbia.edu|
279628|NCT00710840|University of Colorado Denver, Anschutz Medical Center|Dr. Jennifer Stevens-Lapsley|303-724-9170|Jennifer.Stevens-Lapsley@ucdenver.edu|
279629|NCT00710866|British Columbia Centre for Disease Control|Danuta M Skowronski, MD|604-660-6067|danuta.skowronski@bccdc.ca|
279630|NCT00710879|Bausch & Lomb Incorporated|Joseph Barr, OD, MS|(585) 338-6439|joseph.t.barr@bausch.com|
279631|NCT00710905|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
279632|NCT00710931|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
279633|NCT00710944|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
279634|NCT00710996|Alcon Research, Ltd.|Rick Potvin|817-551-4815|Rick.Potvin@alconlabs.com|
279635|NCT00711009|Abbott|Global Medical Services|800-633-9110||
279636|NCT00711022|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
279637|NCT00711100|University_of_Minnesota|Dorothy Hatsukami, Ph.D.|612-626-2121|hatsu001@umn.edu|
279638|NCT00711113|DENTSPLY Implants|Manager Global Clinical Operations|+46313763500||
279639|NCT00711191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279640|NCT00711243|Northwestern University|Mary Mulcahy (MD)|312.695.6182|Mary.Mulcahy@nm.org|
279641|NCT00711269|Clinical Research, Drug Development Division|Regional Function Head of CNS Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
279642|NCT00711347|Alcon Research, Ltd.|Erin Rogut|813-426-4036|Erin.Rogut@alconlabs.com|
279643|NCT00711412|Northwestern University|Dr. Mary Mulcahy|312 695 6182|Mary.Mulcahy@nm.org|
279644|NCT00711425|DENTSPLY Implants|Manager Global Clinical Operations|+46313763500||
279645|NCT00711464|University of California, Los Angeles|Michael Minzenberg, MD|(310) 825-7642|MMinzenberg@mednet.ucla.edu|
279646|NCT00711477|Orexigen Therapeutics, Inc.|Senior Vice President, Head of Global Development|(858) 875-8600|MedInfo@Orexigen.com|
279647|NCT00711490|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyelec@nei.nih.gov|
279648|NCT00711516|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
279649|NCT00711529|Stanford Hospital|Shannon MacLaughlan, MD|650-724-0456|smaclaug@stanford.edu|
279650|NCT00711594|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
279651|NCT00711646|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
279652|NCT00711711|HECVSanté|Pr. Claude Pichonnaz|++41213168126|claude.pichonnaz@hesav.ch|
279653|NCT00711802|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
279654|NCT00711828|Mayo Clinic|Craig B. Reeder, M.D.||Reeder.Craig@mayo.edu|
279655|NCT00711867|Mayo Clinic|Terrence L Trentman MD|480-301-8000|trentman.terrence@mayo.edu|
279656|NCT00711880|GW Pharma Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
279657|NCT00711958|Sandoz|Biopharmaceutical Clinical Development, Strategic Planning|0049 80244760|biopharma.clinicaltrials@sandoz.com|
279658|NCT00711971|University of Michigan|Ellen Mozurkewich, Adjunct Assistant Professor|(734) 546-2772|emozurkewich@salud.unm.edu|
279659|NCT00711997|BioCancell Ltd.|Monique Ben-Am, M.Sc.|+972-2-5486533|monique.ben-am@biocancell.com|
279660|NCT00712010|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont|+41217858054|maurice.beaumont@rdls.nestle.com|
279661|NCT00712075|VA San Diego Healthcare System, San Diego|Eric Granholm, PhD|858-552-8585|egranholm@ucsd.edu|7768
279662|NCT00712166|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
279663|NCT00712179|Ralph H Johnson VA Medical Center|Dr. Steven A Kautz|843-792-3867|kautz@musc.edu|
279664|NCT00712244|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
279665|NCT00712270|Kettering Health Network|Manager, Research Operations and Regulatory Compliance|937-395-8367|innovationcenter@ketteringhealth.org|
279666|NCT00712296|Icahn School of Medicine at Mount Sinai|Xiu-Min Li, MD|212-241-1755|Xiu-min.li@mssm.edu|
279667|NCT00712335|Inje University|Dr. Chang-Keun Kim|82-2-950-8832|kimck@paik.ac.kr|
279668|NCT00712348|Protalix Ltd.|VP Medical Affairs|+972-4-9028100|raul@protalix.com|
279669|NCT00712530|Szent Laszlo Hospital, Budapest, Hungary|Dr. Denes Banhegyi|+3614558152|immunol@mail.datanet.hu|
279670|NCT00712543|Cumberland Pharmaceuticals Inc.|Bryan Voss, Ph.D.|615-255-0068|bvoss@cumberlandpharma.com|
279671|NCT00712673|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
279672|NCT00712712|Institute Bergonie|Dr. Jean Palussière|05 56 33 37 50|j.palussiere@bordeaux.unicancer.fr|
279673|NCT00712725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279674|NCT00712920|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
279675|NCT00712959|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
279676|NCT00712985|Milton S. Hershey Medical Center|Allan Lipton, MD|717-531-5960|alipton@hmc.psu.edu|
279677|NCT00713206|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
279678|NCT00713219|Memorial Sloan Kettering Cancer Center|Dr. Matthew Fury|646-888-4233|furym@mskcc.org|
279679|NCT00713284|California Pacific Medical Center|Dr. V. Ram Peddi|415-600-1000|peddir@sutterhealth.org|
279680|NCT00713310|Warner Chilcott|Grexan Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
279681|NCT00713323|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
279682|NCT00713349|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
279683|NCT00713427|Boston Scientific Corporation|Joyce Peetermans, PhD - Vice President, Global Clinical Programs|508-683-4211|Joyce.Peetermans@bsci.com|
279684|NCT00713479|University of California, Los Angeles|Dr Edythe London|(310) 825-0606|elondon@mednet.ucla.edu|
279685|NCT00713544|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
279686|NCT00713583|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|(713) 486-2867|Joy.M.Schmitz@uth.tmc.edu|
279687|NCT00713609|GlaxoSmithKline|GSK Response Center|866-435-7343||
279688|NCT00713648|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
279689|NCT00713661|Nycomed|Clinical Trial Operations|+45 4677 1111|clinicaltrials@nycomed.com|
279690|NCT00713700|Abbott|Ashish Oza|1-818-493-3648|aoza@sjm.com|
279691|NCT00713817|GW Pharma Ltd|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
279692|NCT00713830|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
279693|NCT00714051|Edward Hines Jr., VA Hospital|Eileen Collins PhD, RN|708-202-3525|eileen.collins@va.gov|
279694|NCT00714168|University of Pittsburgh|John M. Jakicic, PhD|412-383-4001|jjakicic@pitt.edu|
279695|NCT00714233|University of Rochester|Kathleen M Hoeger MD MPH|5852757891|Kathy_hoeger@urmc.rochester.edu|
279696|NCT00714259|UAB|William Vaughan, MD|20-934-0066|liwilliams@uabmc.edu|
288649|NCT01200875|Stanford University|Jason Dragoo, Associate Professor|(650) 721-3430|jdragoo@stanford.edu|
288650|NCT01200992|Prometic Biosciences Inc.|Aline Hagerimana, MD, Senior Director Clinical Affairs|(514) 781-0115|a.hagerimana@prometic.com|
288651|NCT01201057|Starpharma|Dr Jeremy Paull||jeremy.paull@starpharma.com|
288652|NCT01201265|Hoffmann-La Roche|Medical Communications|800-821-8590||
288653|NCT01201317|AstraZeneca|Heather Bryson||clinicaltrialtransparency@astrazeneca.com|
288654|NCT01201343|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
288655|NCT01201356|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
288656|NCT01201486|StavangerUH|Torbjørn Moe Eggebø, phd|004792699433|tme@lyse.net|
288657|NCT01201629|OKC VA Medical Center|Dr. Meheroz H. Rabadi|405-456-5298|meheroz.rabadi@va.gov|
288658|NCT01201759|UNIVERSITY OF MIAMI- The Miami Project to Cure Paralysis|Dr. Mark S. Nash|(305) 243-3628|MNash@med.miami.edu|
288659|NCT01201772|University of Florida|Dominick Angiolillo|904-244-3933|dominick.angiolillo@jax.ufl.edu|
288660|NCT01201785|University of Florida-Jacksonville|Dominick J. Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
288661|NCT01201798|Alcon Research, Ltd.|Head, Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
288662|NCT01201811|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
288663|NCT01201850|Children's Hospital Colorado|Margaret Macy, MD|720-777-5877|margaret.macy@childrenscolorado.org|
288664|NCT01201863|Craig Hospital|Don Gerber, PsyD|303-789-8478|dgerber@craighospital.org|
288665|NCT01201915|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
288666|NCT01201967|Massachusetts General Hospital|Jeff C. Huffman, MD|6177242910|jhuffman@partners.org|
288667|NCT01202071|Eisai Co., Ltd.|Masaharu Yokoyama, Director|+81-3-3817-3908|m-yokoyama@hhc.eisai.co.jp|
288668|NCT01202162|Northwestern University|Gildasio De Oliveira, M.D.|312-926-8371|g-jr@northwestern.edu|
288669|NCT01202175|Univeristy of California, San Diego|Joachim H. Ix, MD, MAS|858-552-7528|joeix@ucsd.edu|
288670|NCT01202188|Novartis Pharmaceuticals|Study Director|862-778-8300||
288671|NCT01202227|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288672|NCT01202253|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288673|NCT01202279|Reckitt Benckiser|Kim Clark|855.966.5483|ClinicalRequests@rb.com|
288674|NCT01202409|UT MD Anderson Cancer Center|Dr. Michael J Overman/ Professor, GI Medical Oncology|713-745-4317|moverman@mdanderson.org|
288675|NCT01202565|AbbVie|Global Medical Services|800-633-9110||
288676|NCT01202578|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
288677|NCT01202591|Astrazeneca|Richard Mather|+44 1763 263593|ClinicalTrialTransparency@astrazeneca.com|
308903|NCT02623348|University of California, San Francisco|Anoop Sheshadri|415-221-4810|anoop.sheshadri@ucsf.edu|22576
288678|NCT01202643|Center for Human Reproduction|Dr. David Barad|212 994-4400|dbarad@theCHR.com|
288679|NCT01202656|Center for Human Reproduction|Dr. David Barad|212 994-4400|dbarad@theCHR.com|
288680|NCT01202721|Population Health Research Institute|Dr. Tara McCready, Program Director||tara.mccready@phri.ca|
288681|NCT01202747|TearScience, Inc. (formerly Kolis Scientific)|Christy Stevens, OD|919-459-4815|cstevens@tearscience.com|
288682|NCT01202760|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288683|NCT01202773|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
308904|NCT02623361|UCSF|Matthias Behrends, PI|415 476 3761|matthias.behrends@ucsf.edu|
279697|NCT00714272|eXcorLab GmbH|Dr. Horst-Dieter Lemke|+49-6022-812648|horstdieter.lemke@excorlab.de|
279698|NCT00714285|GlaxoSmithKline|GSK Response Center|866-435-7343||
298827|NCT01843621|Dept of Pediatrics, Pharmongkutklao Hospital, Bankok, Thailand|Sriluck Simasathien, MD|66-2-644-8971|ssriluck@yahoo.com|
279699|NCT00714311|Medical University of Vienna|Stephan Doering|+43140400|stephan.doering@meduniwien.ac.at|25190
279700|NCT00714389|University of Rochester|Gunhilde Buchsbaum, MD|585-273-3232|gunhilde_buchsbaum@urmc.rochester.edu|
279701|NCT00714415|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279702|NCT00714493|Centocor Ortho Biotech, Inc.|Sr. Director, Clinical Research - Medical Affairs|215-325-6811|Ddeckto2@its.jnj.com|
279703|NCT00714571|VA Ann Arbor Healthcare System|Dr. Benjamin M. Hampstead|734-763-9259|Benjamin.Hampstead@va.gov|
279704|NCT00714688|Janssen-Cilag Germany|EMEA Medical Affairs Director|+49 2137 955258||
279705|NCT00714714|Valeant Pharmaceuticals International, Inc|David Lineberry, Associate Director Clinical Operations|949-973-1153|David.Linberry@valeant.com|
279706|NCT00714753|Mayo Clinic|Thomas M. Pisansky, M.D.||Pisansky.Thomas@mayo.edu|
279707|NCT00714792|University of Rochester|Michael K. Flynn, MD|585-273-3232|michael_flynn@urmc.rochester.edu|
279708|NCT00714870|St. Elizabeth's Medical Center|Dr. Shirley Gonzalez|617-926-0114|shirleyg2008@gmail.com|
279709|NCT00715026|Zimmer|Director, Clinical Affairs|574-371-8019|erin.osborn@zimmer.com|
279710|NCT00715078|Dendreon|Shabnam Vaziri|206-455-2323|Svaziri@Dendreon.com|
279711|NCT00715104|Dendreon Corporation|Lynn Ngo|206-274-6763|lngo@dendreon.com|
308905|NCT02623725|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|ext 1#
279712|NCT00715117|Pennsylvania State University|Jill P Smith, MD Professor Emeritus of medicine|717-531-3694|jsmith2@psu.edu|
279713|NCT00715208|Millennium Pharmaceuticals|Carol Ann Satler, MD, PhD|617- 551-3729|carol.satler@mpi.com|
279714|NCT00715299|VAHSRD and Medical University of South Carolina|Steve Kautz, PhD, Principal Investigator|843-792-3867|kautz@musc.edu|
279715|NCT00715390|The Children's Hospital of Philadelphia|Ronald Litman, DO|215-590-5091|litmanr@email.chop.edu|
279716|NCT00715403|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
279717|NCT00715429|University of Wisconsin School of Pharmacy|Dr. Mary Elliott|608-695-7501|meelliott@pharmacy.wisc.edu|
279718|NCT00715520|Emory University|Dr. Cathrin Buetefisch|4047121894|cathrin.buetefisch@emory.edu|
279719|NCT00715559|Mount Sinai School of Medicine|Dr. James Murrough|212-241-7574|james.murrough@mssm.edu|
279720|NCT00715624|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
279721|NCT00715650|Yale University|Dr. Marc Rosen|203-932-5711|marc.rosen@yale.edu|2575
279722|NCT00715676|Deltanoid Pharmaceuticals|Hector F. DeLuca, President and Chief Executive Officer|608-238-7710|info@deltanoid.com|
279723|NCT00715728|Vienna General Hospital/University of Vienna|Olga Plattner, Medical Doctor|43-1-40-400-4103|olga.plattner@meduniwien.ac.at|
279724|NCT00715741|University of Utah|Harriet Hopf, MD|801-205-1013|Harriet.Hopf@hsc.utah.edu|
279725|NCT00715754|University of Utah|Laurie Moyer-Mileur|801/587-7488|Laurie.Moyer-Mileur@hsc.utah.edu|
279726|NCT00715793|University of Pittsburgh|Hussein Tawbi, MD, PhD|713-792-6111|HTawbi@mdanderson.org|
279727|NCT00715884|Cordis|Amy Orlick, Associate Director Clinical Research|908-541-4347|AOrlick@its.jnj.com|
279728|NCT00715910|GlaxoSmithKline|GSK Response Center|866-435-7343||
279729|NCT00715949|The Children's Hospital of Philadelphia|Michael L. Nance|215-590-5932|nance@email.chop.edu|
279730|NCT00715962|Birmingham VAMC|Cynthia J. Brown, MD, MSPH|205-933-8101|cynthia.brownd44b2@va.gov|7300
279731|NCT00716079|The George Institute for Global Health|Professor Craig Anderson|+612 9993 4521|canderson@georgeinstitute.org.au|
279732|NCT00716092|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
279733|NCT00716144|GlaxoSmithKline|GSK Response Center|866-435-7343||
279734|NCT00716274|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
279735|NCT00716417|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
279736|NCT00716443|Galderma Laboratories, L.P.|Ron W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
279737|NCT00716456|Memorial Sloan Kettering Cancer Center|Dr. Gregory J. Riely|646-888-4199|rielyg@mskcc.org|
279738|NCT00716482|SuperSonic Imagine|Research Coordinator|+33 442 99 24 24|sharon.bruce@supersonicimagine.fr|
279739|NCT00716586|University of Illinois at Chicago|Emeritus Professor of Ophthalmology|312 997-3646|gerafish@uic.edu|
279740|NCT00716625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279741|NCT00716742|Allergan, Inc.|Vice President, Global Health Outcomes Strategy and Research|714-246-4500|clinicaltrials@allergan.com|
279742|NCT00716820|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279743|NCT00716859|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279744|NCT00716963|McMaster University|Dr. Gail Gauvreau|905-525-9140|gauvreau@mcmaster.ca|22791
279745|NCT00716976|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
279746|NCT00717041|University of Rochester|Manish N. Shah, MD MPH|585-275-1198|manish.shah@rochester.edu|
279747|NCT00717054|Drexel University College of Medicine|Michael Green, DO|215-762-7798|michael.green@drexelmed.edu|
279748|NCT00717067|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
279749|NCT00717093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298828|NCT01843660|Janssen China, Beijing|Therapeutic Area Physician|+86-10-58218709||
298829|NCT01843673|Virginia Commonwealth University|Joshua Evans, Ph.D.|804-628-0661|jevans2@mcvh-vcu.edu|
298830|NCT01843751|University of Wisconsin|Randall Brown|608-263-6558|rtbrown@wisc.edu|
279750|NCT00717197|University of Florida|Erin M. Dunbar, MD|(352) 273-9000|edunbar@neurosurgery.ufl.edu|
279751|NCT00717236|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
279752|NCT00717249|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S. Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|1290
279753|NCT00717288|The Ohio State University|Kathleen Dungan, MD|614-292-3800|kathleen.dungan@osumc.edu|
279754|NCT00717314|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
279755|NCT00717366|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
279756|NCT00717405|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
279757|NCT00717418|Allergan, Inc.|Vice President, GHOSR|714-246-4500|clinicaltrials@allergan.com|
279758|NCT00717522|Celgene Corporation|Associate Director, Clinical Trial Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
279759|NCT00717574|Department of Anesthesia. OUHSC|Dr. Mehmet Ozcan, MD|405-271-4351|mehmet-ozcan@ouhsc.edu|
279760|NCT00717626|The Hospital for Sick Children|Dr. Brian Feldman|416-813-5828|brian.feldman@sickkids.ca|
279761|NCT00717756|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
279762|NCT00717769|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
279763|NCT00717860|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279764|NCT00717873|Barnes Jewish Hospital|Darnetta Clinkscale|(314) 362-1276|MDB3455@bjc.org|
279765|NCT00717886|Memorial Sloan Kettering Cancer Center|Dr. Leslie Montgomery|(212) 639-5386|Montgoml@mskcc.org|
279766|NCT00717912|Biofortis|Doctor|0240205799|info@mxns.com|
298831|NCT01843777|National Center for Rehabilitative Auditory Research|M. Samantha Lewis, PhD|503-220-8262|Michele.Lewis3@va.gov|51996
279767|NCT00717977|Jaeb Center for Health Research|Roy W. Beck, M.D., Ph.D.|813-975-8690|rbeck@jaeb.org|
279768|NCT00718042|Abbott Laboratories|Associate Director Clincal Affairs|847-937-8702|barbara.kaesdorf@abbott.com|
279769|NCT00718081|AcelRx|Dr. Pamela Palmer|650-216-3500|ppalmer@acelrx.com|
279770|NCT00718094|University Louisville|Gerald Dryden, MD|502-852-0156|gwdryd01@louisville.edu|
279771|NCT00718120|GlaxoSmithKline|GSK Response Center|866-435-7343||
279772|NCT00718159|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
279773|NCT00718237|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279774|NCT00718302|Boston Medical Center|Paul Tornetta, III, MD|617-414-6295|tornetta@bu.edu|
279775|NCT00718315|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
279776|NCT00718328|Johns Hopkins University SOM (former employer during the study)|Neeraj Naval|9042026290|neerajnaval@gmail.com|
279777|NCT00718419|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
279778|NCT00718510|Department of Psychiatry, University of Alberta|Dr. Serdar Dursun|(780) 492-7319|dursun@ualberta.ca|
279779|NCT00718523|Translational Research In Oncology (formerly CIRG)|Matthieu Rupin|+331 58 10 08 89|matthieu.rupin@trioncology.org|
279780|NCT00718549|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
279781|NCT00718666|GlaxoSmithKline|GSK Response Center|866-435-7343||
279782|NCT00718718|Janssen Research & Development, LLC|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
279783|NCT00718770|University of Colorado School of Medicine|Joshua Klopper, MD|303-724-3921|joshua.klopper@ucdenver.edu|
279784|NCT00718809|IndianaU|Dr. Patrick Loehrer|317-944-0920|ploehrer@iu.edu|
279785|NCT00718861|Novartis Pharmaceuticals|Study Director|8627788300||
279786|NCT00718887|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
279787|NCT00719043|GlaxoSmithKline|GSK Response Center|866-435-7343||
279788|NCT00719134|Beth Israel Deacxoness Medical Center|Rami Burstein|617 735 2832|rburstei@bidmc.harvard.edu|
288684|NCT01202877|The University of Texas (UT) MD Anderson Cancer Center|Jorge Cortes, MD/Professor, Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
288685|NCT01202903|Novartis Pharmaceuticals|Study Director|862-778-8300||
288686|NCT01202955|University of Pennsylvania|Dr. Caryn Lerman|215-746-7141|clerman@mail.med.upenn.edu|
288687|NCT01202994|University of Utah|Dr. Kevin Duff|8015859983|kevin.duff@hsc.utah.edu|801
288688|NCT01203046|Dr. Silvia M. Pinango L|Dr. Silvia M. Pinango L.|+584169267988|pinangosilvia@yahoo.com|
288689|NCT01203072|Daiichi Sankyo.,LTD|Kei Ibusuki, Associate Director|81-90-2732-9505|ibusuki.kei.tx@daiichisankyo.co.jp|
288690|NCT01203098|Daiichi Sankyo.,LTD|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
288691|NCT01203189|Saint Louis Univ Hospital|Aibing Mary Guo, M.D., Assistant Professor|3142563430|aguo@slu.edu|
288692|NCT01203319|Jiangsu Provincial Center for Disease Control and Prevention|Fengcai Zhu|#86-25-83759418|jszfc@vip.sina.com|
288693|NCT01203644|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
288694|NCT01203774|University of Colorado Denver|Director, Clinical Research Administration|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
288695|NCT01203787|UNIVERSITY OF FLORIDA|Roniel Cabrera, MD|352-273-9468|RONIEL.CABRERA@MEDICINE.UFL.EDU|
288696|NCT01203826|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
288697|NCT01203852|University of Florida|Dr. Julie A. Johnson|(352) 273-6309|johnson@cop.ufl.edu|
288698|NCT01203878|Tennessee Clinical Research Center|Medical Director|615-383-2400|jbiron@tnclinicalresearch.com|
288699|NCT01203917|AstraZeneca|Haiyi Jiang|+86 21 60302408|aztrial_results_posting@astrazeneca.com|
288700|NCT01203930|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
279789|NCT00719160|Yale University|Karl L. Insogna, M.D.|203-737-2871|Karl.insogna@yale.edu|
279790|NCT00719186|Yale University|Heping Zhang|203-785-5185|rmn-dcc@panlists.yale.edu|
279791|NCT00719212|Translational Research In Oncology (formerly CIRG)|Matthieu Rupin|+33 (1) 58 10 08 89|matthieu.rupin@trioncology.org|
279792|NCT00719264|Novartis Pharmaceuticals|Study Director|862-778-8300||
279793|NCT00719329|Johns Hopkins Bloomberg School of Public Health|Dr. Luke Mullany|410-502-2626|lmullany@jhsph.edu|
279794|NCT00719355|University of Illinois at Chicago|Eileen G. Collins PhD, RN|312-413-5621|ecollins@uic.edu|
279795|NCT00719472|Genentech, Inc.|Medical Communications|800-821-8590||
279796|NCT00719537|William Beaumont Hospital|John Uckele|2485510610|john.uckele@beaumont.edu|
298832|NCT01843803|Department of Veterans Affairs|Frances M Weaver|708-202-5866|frances.weaver@va.gov|
288701|NCT01203956|Sleep Medicine Associates of Texas|Leon Rosenthal, MD|214-750-7776|LRosenthal@sleepmed.com|
288702|NCT01204203|University of Alabama at Birmingham|Francisco Robert, MD|205-934-5077|pacorobertuab@cs.com|
288703|NCT01204255|Virginia Commonwealth University|Thomas J. Smith, MD|804-828-9723|tsmith5@mcvh-vcu.edu|
288704|NCT01204294|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298833|NCT01843842|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761575|PutilovskiyMA@materiamedica.ru|302
288705|NCT01204398|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288706|NCT01204658|GlaxoSmithKline|GSK Response Center|866-435-7343||
288707|NCT01204671|GlaxoSmithKline|GSK Response Center|866-435-7343||
288708|NCT01204697|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
288709|NCT01204710|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288710|NCT01204736|Rehabilitation Institute of Chicago|Dr. Wendy Murray|3122386965|w-murray@northwestern.edu|
288711|NCT01204775|AstraZeneca AB, S-151 85 Södertälje, Sweden|Eva Johnsson, Clinical Science Lead, GLOBAL_MEDICINES_DEV|+46 31 7762484|Eva.Johnsson@astrazeneca.com|762 484
288712|NCT01204853|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288713|NCT01204905|University of Maryland, Baltimore, IHV|Gregory Brogden|410-706-1660|gbrogden@ihv.umaryland.edu|
288714|NCT01204918|Yale University|Gerard Sanacora, PhD, MD: Professor of Psychiatry; Director, Yale Depression Research Program|(203) 974-7535|gerard.sanacora@yale.edu|
288715|NCT01205035|Eye Center of Northern Colorado, PC|Dr. Arthur Korotkin, MD|970-221-2222|retina@eyecenternoco.com|
288716|NCT01205126|Janssen Research & Development, LLC|Director, Established Products|+1 609 730 3387;||
288717|NCT01205152|Alexion Pharmaceuticals, Inc.|Director of Clinical Trials|475-230-2596|ClinicalTrials@alexion.com|
288718|NCT01205165|GlaxoSmithKline|GSK Response Center|866-435-7343||
288719|NCT01205230|GlaxoSmithKline|GSK Response Center|866-435-7343||
288720|NCT01205269|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
288721|NCT01205399|C. R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
288722|NCT01205438|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288723|NCT01205451|GlaxoSmithKline|GSK Response Center|866-435-7343||
288724|NCT01205503|Markey Cancer Center Biostatistics Shared Resource Facility|Emily Dressler, PhD|859 323-3076|emilydressler@uky.edu|
288725|NCT01205529|Vanderbilt University Medical Center|Dan Roden|6153220067|dan.roden@Vanderbilt.Edu|
288726|NCT01205568|Boston Childrens Hospital|Kathy Jenkins MD MPH|6173557275|kathy.jenkins@childrens.harvard.edu|
288727|NCT01205581|St. Jude Children's Research Hospital|Jon McCullers, MD|866-278-5833|info@stjude.org|
288728|NCT01205646|Barbara Ann Karmanos Cancer Institute|Ulka Vaishampayan, M.D.|(313) 576-8718|vaishamu@karmanos.org|
288729|NCT01205685|Vanderbilt-Ingram Cancer Center|Dr. Ingrid Mayer|615-936-2033|ingrid.mayer@vanderbilt.edu|
288730|NCT01205776|Abbott Vascular|Rhonda Hensley, Clinical Project Manager|+1 828-559-0080|rhonda.hensley@abbott.com|
288731|NCT01205828|Georgetown University Medical Center|Dr. Aiwu Ruth He|202-444-8642|arh29@georgetown.edu|
288732|NCT01206062|Wake Forest University Health Sciences|David Reboussin|336-716-6844|drebouss@wakehealth.edu|
288733|NCT01206140|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
288734|NCT01206166|CERU Queen's University|Dr.Daren Heyland|403-915-5573|dkh2@queensu.ca|
288735|NCT01206322|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
288736|NCT01206387|Taro Pharmaceuticals U.S.A., Inc|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
288737|NCT01206452|University of Kansas Medical Center|Donita Atkins, RN, CCRC|(913) 588-9714|datkins2@kumc.edu|
288738|NCT01206465|University of Nebraska Medical Center|Jean L. Grem,MD|402-559-5166|jgrem@unmc.edu|
288739|NCT01206478|University of Kansas Medical Center|Ann M Davis, PI|913-588-6300|adavis6@kumc.edu|
288740|NCT01206582|Mayo Clinic|Dr. Adil E. Bharucha|507-284-6439|bharucha.adil@mayo.edu|
288741|NCT01206595|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
288742|NCT01206608|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
288743|NCT01206660|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914-345-9001|natalie.yantovskiy@taro.com|
288744|NCT01206738|University of Aberdeen|Prof Shaun Treweek||streweek@mac.com|
288745|NCT01206764|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
288746|NCT01206777|The Ohio State University Comprehensive Cancer Center|Jeffrey Jones, MD|614-688-7942|Jeffrey.Jones@osumc.edu|
288747|NCT01206816|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288748|NCT01207219|The Department of Psychiatry,HKU|Dr.Lin Jingxia|+85222553064|jingxia.lin@gmail.com|
298834|NCT01843920|Mid Atlantic Retina|Jason Hsu, MD|215-928-3092|research@midatlanticretina.com|
308906|NCT02623803|Mayo Clinic|Dr. Elird Bojaxhi|904-956-3327|bojaxhi.elrid@mayo.edu|
298835|NCT01843933|Yale University|Melissa Langhan|2037377413|melissa.langhan@yale.edu|
298836|NCT01843972|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298837|NCT01844076|Fox Chase Cancer Center|Crystal Denlinger MD, FACP|215-214-1676|Crystal.Denlinger@fccc.edu|
279797|NCT00719563|University of Michigan School of Nursing|Debra L. Barton, RN, PhD, AOCN, FAAN|734-763-3868|debbartn@umich.edu|
279798|NCT00719576|Vericel Corporation|Ann Remmers, Senior Director, Clinical Science|734-428-4526|aremmers@vcel.com|
279799|NCT00719615|University of Nebraska Medical Center|Whitney S Goldner, MD|402-559-6205|wgoldner@unmc.edu|
279800|NCT00719680|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
298838|NCT01844115|Forest Research Institute, Inc|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
279801|NCT00719706|McLean Hospital|Dr. Brian Brennan|617-855-2911|bbrennan@partners.org|
279802|NCT00719732|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
279803|NCT00719810|Melinta Therapeutics|Eugene Sun, M.D.|203.624.5606|esun@melinta.com|
279804|NCT00719849|Fred Hutchinson Cancer Research Center|Dr. Colleen Delaney|2066671385|cdelaney@fredhutch.org|
279805|NCT00719862|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2351|WWheeler@medapharma.us|
279806|NCT00719901|Mayo Clinic|A. Keith Stewart|480-301-4411|stewart.keith@mayo.edu|
279807|NCT00719953|Sourazky Tel-Aviv Medical Center|Professor N. Vaisman|972-3-6974807|vaisman@tasmc.health.gov.il|
279808|NCT00720057|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
279809|NCT00720096|H. Lee Moffitt Cancer Center and Research Institute|Robert Wenham, M.D., via Moffitt Cancer Center|813-745-4933|robert.wenham@moffitt.org|
279810|NCT00720109|Children's Oncology Group|Results Reporting Coordinator|626-241-1546|resultsreportingcoordinator@childrensoncologygroup.org|
279811|NCT00720122|Massachusetts General Hospital|Madhusmita Misra, M.D., Associate Professor in Pediatrics, Assistant Pediatrician|617-724-5602|mmisra@partners.org|
279812|NCT00720213|Sleepcare Diagnostics|Shahrokh Javaheri, MD|513-459-7750|javaheri@snorenomore.com|
288749|NCT01207388|Amgen Inc.|Study Director|866-572-6436||
288750|NCT01207401|University of California, San Diego|Dr. Sheila Krishnan Mody|(619)543-6777|smody@ucsd.edu|
288751|NCT01207414|Novartis Pharmaceuticals|Study Director|862-778-8300||
288752|NCT01207427|Cubist Pharmaceuticals|Vice President Clinical Research|(781) 860-8660||
288753|NCT01207440|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
288754|NCT01207453|Brigham and Women's Hospital|Yvonne C Lee, MD, MMSc|617-732-8736|ylee9@partners.org|
288755|NCT01207466|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|joseph.rappon@cibavision.com|
288756|NCT01207570|The Hong Kong Polytechnic University|Dr. Marco Pang|85227667156|Marco.Pang@inet.polyu.edu.hk|
288757|NCT01207583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288758|NCT01207596|International Clinical Research Institute|Srinivas Nalamachu|913-317-5300|nalamachu@yahoo.com|
288759|NCT01207648|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
288760|NCT01207687|Johns Hopkins Comprehensive Neurofibromatosis Center|Dr. Jaishri Blakeley|410-614-3853|jblakel3@jhmi.edu|
288761|NCT01207752|Southern California College of Optometry at MBKU|Jerry Paugh, OD, PhD|714-449-7487|jpaugh@ketchum.edu|
298839|NCT01844193|OrthoIndy|Dr. Frank Kolisek|3178845160|fkolisek@orthoindy.com|
288762|NCT01207765|Tufts Medical Center|Andreas Klein, MD|617-636-8884|aklein2@tuftsmedicalcenter.org|
288763|NCT01207908|Cincinnati Children's Hospital Medical Center|Dr. Meilan Rutter|513-636-4744|meilan.rutter@cchmc.org|
288764|NCT01207934|Washington University School of Medicine|Samuel Klein, MD|3143628708|sklein@wustl.edu|
288765|NCT01208038|Chelsea and Westminster NHS Trust|Dr Kate Maclaran|020 3315 3000|kate.maclaran@nhs.net|
288766|NCT01208051|University of Chicago|Chih-Yi Liao, MD|(773) 702-6241|andyliao@medicine.bsd.uchicago.edu|
288767|NCT01208103|UT MD Anderson Cancer Center|Dr. Michael Overman/Gastrointestinal Medical Oncology|713-745-4317|MOverman@mdanderson.org|
288768|NCT01208220|LSUShreveport|Dr. Stanley McCallon|318-813-2996|smccal@lsushc.edu|
288769|NCT01208233|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288770|NCT01208324|University of Pennsylvania|C. Neill Epperson, M.D|215-573-8871|cepp@mail.med.upenn.edu|
288771|NCT01208337|University of Pittsburgh|Dr. Rakesh Sindhi|412-692-6110|rakesh.sindhi@chp.edu|
288772|NCT01208402|Duke University Medical Center - Department of Anesthesiology|William White / Statistician|919-684-4081|white013@mc.duke.edu|
288773|NCT01208415|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Affairs|765-463-7537|Scott.Snyder@CookMedical.com|
288774|NCT01208870|SUNY Buffalo|Leonard H. Epstein, Ph.D.|716-829-3400|lhenet@buffalo.edu|
288775|NCT01208922|Dr. Falk Pharma GmbH|Department of Clinical Research|0049 7611514|zentrale@drfalkpharma.de|0
288776|NCT01208961|AstraZeneca Pharmaceuticals|Torbjörn Lundström, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
288777|NCT01209078|GlaxoSmithKline|GSK Response Center|866-435-7343||
288778|NCT01209143|Genentech, Inc.|Medical Communications|800 821-8590|genentech@druginfo.com|
288779|NCT01209195|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
288780|NCT01209234|University of California, Irvine|Susan Huang, Principal Investigator & Medical Director of Epidemiology and Infection Prevention|949-824-5073|sshuang@uci.edu|
288781|NCT01209260|University of California San Diego|Jonathan Hsu, MD, MAS|415-476-5706|jonathan.hsu@ucsd.edu|
288782|NCT01209286|Amgen Inc.|Study Director|866-572-6436||
288783|NCT01209325|University of California, San Francisco|Dr. Joel M. Palefsky|415-476-1574|jpalefsky@medicine.ucsf.edu|
288784|NCT01209442|University of Colorado|Douglas Ney, M.D.|303-724-2184|Douglas.Ney@ucdenver.edu|
288785|NCT01209598|Memorial Sloan Kettering Cancer Center|Mark Dickson, MD|646-888-4164|dicksonm@mskcc.org|
288786|NCT01209624|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288787|NCT01209689|Hoffmann-La Roche|Medical Communications|800 821-8590||
288788|NCT01209702|Hoffman-LaRoche|Medical Communications|800-821-8590||
288789|NCT01209780|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
279813|NCT00720226|Johns Hopkins University School of Medicine|Robert A. Wise|410 550 0545|rwise@jhmi.edu|
279814|NCT00720278|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
279815|NCT00720330|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
279816|NCT00720356|Northwestern University|Jeffery Raizer, MD|312-503-4724|Jeffrey.Raizer@nm.org|
279817|NCT00720369|McLean Hospital|Cara McCabe, BA|617-855-2410|cfmccabe@partners.org|
279818|NCT00720382|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2393|WWheeler@medapharma.us|
279819|NCT00720434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279820|NCT00720473|McLean Hospital|Dr. Brent Forester|(617) 855-3622|bforester@partners.org|
279821|NCT00720499|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
279822|NCT00720629|H. Lee Moffitt Cancer Center and Research Institute|Lia Perez, M.D.|813-745-7202|lia.perez@moffitt.org|
279823|NCT00720759|VAHSRD|Stephen E. Nadeau|352-374-6082|stephen.nadeau@va.gov|
279824|NCT00720798|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
279825|NCT00720876|City of Hope|Paul Frankel, Ph.D.|626-812-5265|pfrankel@coh.org|
279826|NCT00720941|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
279827|NCT00721110|Cleveland Clinic|Daniel Sessler, MD|216-444-4200|sesslerd@ccf.org|
279828|NCT00721123|Hoffmann-La Roche|Medical Communications|800 821-8590||
279829|NCT00721136|Johns Hopkins Medical Institutions|Charles Henrikson, MD|503 494 7400|chenriks@jhmi.edu|
279830|NCT00721149|Biosense Webster, Inc.|Diana Bordley, Director, Regulatory Affairs|800-729-9010|dbordley@its.jnj.com|8604
279831|NCT00721162|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
279832|NCT00721175|Khon Kaen University|Assist. Prof. Apichat Sangchan|66850004651|apichaz@yahoo.com|
279833|NCT00721188|Luitpold Pharmaceuticals, Inc.|Mark A. Falone, MD|610-650-4200|mfalone@luitpold.com|
279834|NCT00721214|Massey Cancer Center|John M. McCarty, MD|804-828-4360|jmccarty@vcu.edu|
279835|NCT00721227|Ethicon Endo Surgery, Inc.|Amy Mahanes, Senior Clinical Research Associate|513-337-8366|amahanes@its.jnj.com|
279836|NCT00721253|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
279837|NCT00721279|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
279838|NCT00721357|Ralph H Johnson VAMC|Chris Gregory|(843)792-1078|Christopher.Gregory@va.gov|
279839|NCT00721396|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
279840|NCT00721409|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279841|NCT00721500|Vistakon|Kurt Moody OD FAOO / Director|904-443-3088||
279842|NCT00721513|Wake Forest University Health Sciences|Dr. Mercedes Porosnicu|336-716-8664|mporosni@wakehealth.edu|
279843|NCT00721539|Stanford|Edward Damrose, MD, associate professor|650-725-6500|edamrose@stanford.edu|
279844|NCT00721578|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279845|NCT00721617|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
279846|NCT00721630|Memorial Sloan Kettering Cancer Center|Dr. Tiffany Traina|646-888-5209|trainat@mskcc.org|
279847|NCT00721734|Amgen, Inc.|Study Director|866-572-6436||
279848|NCT00721799|The University of Iowa Department of Radiology|Yusuf Menda, MD|319-356-3214|yusuf-menda@uiowa.edu|
279849|NCT00721955|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|:jcassella@alexza.com|
279850|NCT00721968|Glaukos|Jeff Wells. Sr VP, Clinical, Regulatory, and Quality Affairs|949-367-9600|jwells@glaukos.com|227
279851|NCT00722007|Corin USA Limited|Lucinda Gerber|(772) 321 2478|lucinda.gerber@coringroup.com|
279852|NCT00722020|Winthrop University|Jon Roberts, MD|516-663-4600|jroberts@winthrop.org|
279853|NCT00722072|OHSU Knight Cancer Institute|Dr. Stephen Chui|503-494-8534|chuis@ohsu.edu|
279854|NCT00722111|VAHSRD|Dr. JoAnne Robbins|608-256-1901|bert.landreth@va.gov|11697
279855|NCT00722124|Mayo Clinic|Amit Sood, MD|507-266-1944|nicotineresearch@mayo.edu|
279856|NCT00722137|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
279857|NCT00722371|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279858|NCT00722423|VA San Diego Healthcare System|Dr. Samuel B. Ho|8586423280|Samuel.Ho2@va.gov|
279859|NCT00722436|The Childrens Hospital of Pittsburgh of UPMC|Franklyn Cladis|412-692-5260|cladfp@upmc.edu|
279860|NCT00722553|Allos Therapeutics, Inc.|Medical Monitor|303-426-6262|gweems@allos.com|
279861|NCT00722566|Johnson & Johnson Pharmaceutical Research & Development|Helgi Van de Velde, M.D., Ph.D.||HVDVELDE@ITS.JNJ.COM|
279862|NCT00722722|Mayo Clinic|Mark Stegall, MD|507-266-2812|Stegall.Mark@mayo.edu|
279863|NCT00722761|MGH Curtis|Alexa B. Kimball|617-726-5066|harvardskinstudies@partners.org|
279864|NCT00722800|MGH|Alexandra B. Kimball, MD|617-726-5066|harvardskinstudies@partners.org|
279865|NCT00722865|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
279866|NCT00723008|U.S. Army Institute of Surgical Research|LTC. Elizabeth Mann-Salinas, PhD, RN,CCRN,CCNS|210-916-3527|Elizabeth.Mann@us.army.mil|
279867|NCT00723021|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279868|NCT00723073|Brigham and Women's Hospital|David Kubiak, Principle Investigator|617-525-8417|dwkubiak@partners.org|
279869|NCT00723099|Fred Hutchinson Cancer Research Center|Rachel Salit|206-667-1317|rsalit@fredhutch.org|
279870|NCT00723125|BrUOG|William Sikov, MD|4018633000|Roxanne_Wood@brown.edu|
279871|NCT00723177|NYSPI/Columbia University|Sandra Comer PhD|646 774-6146|SDC10@columbia.edu|
279872|NCT00723190|Shionogi USA|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
279873|NCT00723203|City of Hope National Medical Center|Paul Frankel, Ph.D.|(626)359-8111|pfrankel@coh.org|65265
279874|NCT00723229|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
279875|NCT00723255|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
298840|NCT01844284|Abbott Vascular|Hajime Kusano|408-845-1626|hajime.kusano@av.abbott.com|+1
279876|NCT00723294|Weill Cornell Medicine|Rache M. Simmons, MD|(212) 821-0870|rms2002@med.cornell.edu|
279877|NCT00723398|Milton S. Hershey Medical Center|Dr. Andrea Manni|717-531-8395|amanni@pennstatehealth.psu.edu|
279878|NCT00723450|GlaxoSmithKline|GSK Response Center|866-435-7343||
279879|NCT00723489|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
279880|NCT00723528|Janssen Research & Development, LLC|Senior Director, Clinical Development|793-7633||215
279881|NCT00723554|Actelion Pharmaceuticals, US, Inc.|Wade Benton, PharmD/ Director, Medical Affairs Veletri and Ventavis|(650) 624-6900|wade.benton@actelion.com|
279882|NCT00723580|Child Psychopharmacology Institute|Bill J. Duke, Ph.D.|701-241-9281|bduke@ChildPsychopharmacologyInstitute.org|2
279883|NCT00723606|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279884|NCT00723632|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279885|NCT00723645|Merck Sharp & Dohme Corp|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279886|NCT00723697|Merck Sharp & Dohme Corp|Vice President of Late Stage Development||ClinicalTrialsDisclosure@merck.com|
279887|NCT00723710|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279888|NCT00723749|RB Pharmaceuticals|Global Medical Director|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com|
279889|NCT00723788|Children's National Health System|Pranav Vyas, MD|2024760186|PVyas@childrensnational.org|
279890|NCT00723801|Brigham and Women's Hospital|Mark Creager|617-732-5267|mcreager@partners.org|
279891|NCT00723827|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279892|NCT00723840|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279893|NCT00723892|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800--672-6372|ClinicalTrialsDisclosure@merck.com|
279894|NCT00723931|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279895|NCT00723944|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
279896|NCT00723957|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
288790|NCT01209832|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288791|NCT01209949|Galderma Laboratories, L.P.|Norman Preston|817-961-5360|Norman.Preston@galderma.com|
288792|NCT01210001|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288793|NCT01210079|School of Nursing, University of California, Los Angeles|Margaret (Peggy) Compton, RN PhD|(310) 206-2825|pcompton@sonnet.ucla.edu|
288794|NCT01210118|Hellenic Anticancer Society|Professor Panagiotis Behrakis|00302106470056|pbehraki@hsph.harvard.edu|
288795|NCT01210144|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
288796|NCT01210170|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
288797|NCT01210222|NRG Oncology|Linda Gedeon for Michael Sill, PhD.|716-845-1169|lgedeon@gogstats.org|
288798|NCT01210352|Endo Pharmaceuticals|Saji Vijayan|(800) 462-3636|ClinicalTrials@Endo.com|
288799|NCT01210443|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288800|NCT01210495|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288801|NCT01210560|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
288802|NCT01210651|UCSF|Sudha Prathikanti, MD|415-516-3867|sudha.prathikanti@gmail.com|
288803|NCT01210664|University of California San Francisco Diabetes Center|Jeffrey Bluestone, PhD|415-502-5677|jeff.bluestone@ucsf.edu|
288804|NCT01210690|UCB|UCB Cares|+1 877 822 9493||
288805|NCT01210716|Fenwal, Inc|Sr. Mgr. Clinical Affairs|847-550-5620|carrie.pineda@fenwalinc.com|
288806|NCT01210807|University Eye Clinic, Tubingen, Germany|PD Dr. med. Peter Szurman|49-7071-29-84915|peter.szurman@med.uni-tuebingen.de|
288807|NCT01210820|AMO Development, LLC|Carrie Garufis|714-566-3728|carrie.garufis@amo.abbott.com|
288808|NCT01211106|Cpl Micheal J Crescenz VA Medical Center|David Oslin, MD|215-823-5894|dave.oslin@va.gov|
288809|NCT01211145|AstraZeneca|Jamie Mullen, Medical Science Director|781-472-5032|jamie.mullen@astrazeneca.com|
288810|NCT01211184|Södertälje Hospital|Robert Hahn|+46855024670|robert.hahn@sodertaljesjukhus.se|4670
288811|NCT01211197|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288812|NCT01211262|Immunocore, LLC|Chris Holland, Executive Director Head of Biostatistics|1-267-589-9204|chris.holland2@immunocore.com|
288813|NCT01211288|University of Alabama at Birmingham|Dr. Toni Tien Neumeier|205-934-5459|neumeier@uab.edu|
288814|NCT01211340|University of Missouri|Debra Parker Oliver|573-884-5301|oliverdr@missouri.health.edu|
288815|NCT01211483|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
288816|NCT01211522|Vanderbilt University Medical Center|E Wesley Ely|‭(615) 936-3395‬|wes.ely@vumc.org|
288817|NCT01211535|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
298841|NCT01844375|Faculty of Medicine siriraj Hospital|Dr.Mingkwan Wongyingsinn|6624197995|mingkwan.won@mahidol.ac.th|
298842|NCT01844388|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
288818|NCT01211600|Geisinger|Dr. A. Dhanya Mackeen|570-714-1099|admackeen@geisinger.edu|
288819|NCT01211613|University of Pittsburgh, Department of Physical Therapy'|Michael J Schneider, DC, PhD|412-383-6640|mjs5@pitt.edu|
288820|NCT01211665|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
298843|NCT01844479|University of Michigan|James Wrobel, DPM, MS|734-647-4940|jswrobel@med.umich.edu|
279897|NCT00724009|The University of Chicago|Wendy Stock, MD|773-834-8982|wstock@medicine.bsd.uchicago.edu|
279898|NCT00724061|Northwestern University|Dr. Timothy Kuzel|312-695-6180|cancertrials@northwestern.edu|
279899|NCT00724126|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
279900|NCT00724152|VA Connecticut Healthcare System|Dr. Caroline Schmidt, Co-investigator|203-932-5711|Caroline.Schmidt@va.gov|3391
279901|NCT00724243|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279902|NCT00724308|VA NY Harbor Healthcare System|Dr. Scott Sherman|212-686-7500|scott.sherman@va.gov|7386
279903|NCT00724347|VANCHCS|David L. Woods, Ph.D.|925-372-2571|David.Woods@va.gov|
279904|NCT00724373|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279905|NCT00724451|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279906|NCT00724464|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@Merck.com|
279907|NCT00724503|Sirtex Medical|Janet Bell, M.B.A.|+ 888-474-7839|jbell@sirtex.com|710
279908|NCT00724568|University of Michigan Comprehensive Cancer Center|Dr. Moshe Talpaz|734-764-8195|mtalpaz@umich.edu|
279909|NCT00724594|Medical University of South Carolina|Dr. Dorothea Jenkins|843-792-4341|jenkd@musc.edu|
279910|NCT00724711|Gilead Sciences|Dara Wambach, MA, Associate Director, Regulatory Affairs|650 522 5163|Dara.Wambach@gilead.com|
279911|NCT00724750|University of Chicago|Lawrence Gottlieb|(773) 702-6302|lgottlie@surgery.bsd.uchicago.edu|
279912|NCT00724815|NuPathe Inc.|Mark Pierce, MD, PhD|484-567-0130|mpierce@nupathe.com|
279913|NCT00724854|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279914|NCT00724867|GlaxoSmithKline|GSK Response Center|866-435-7343||
279915|NCT00724893|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279916|NCT00724932|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279917|NCT00724945|Vistakon|Thomas Karkkainen OD|904-443-3402|tkarkkai@its.jnj.com|
279918|NCT00724958|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialDisclosure@merck.com|
279919|NCT00724971|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279920|NCT00724984|Pharmacyclics|Dr. Thorsten Graef|855-427-8846|pharmacyclics@medcomsol.com|
279921|NCT00725010|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279922|NCT00725049|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
279923|NCT00725075|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279924|NCT00725101|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
279925|NCT00725153|Alcon Research, Ltd.|Jessie Lemp, MS|817-615-2739|Jessie.Lemp@alconlabs.com|
279926|NCT00725205|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279927|NCT00725270|Stanford University|Alan Schatzberg|650-723-8331|afschatz@stanford.edu|
279928|NCT00725283|GlaxoSmithKline|GSK Response Center|866-435-7343||
279929|NCT00725296|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279930|NCT00725322|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
279931|NCT00725361|StanfordU|Lorinda Chung|650-736-0727|shauwei@stanford.edu|
279932|NCT00725452|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279933|NCT00725504|Stanford University|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@pain.stanford.edu|
279934|NCT00725530|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
279935|NCT00725543|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279936|NCT00725608|RB Pharmaceuticals|Global Medical Director|+1 (804) 379 1090|Tim.Baxter@reckittbenckiser.com|
279937|NCT00725621|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279938|NCT00725712|GlaxoSmithKline|GSK Response Center|866-435-7343||
279939|NCT00725725|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Develpment|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279940|NCT00725751|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279941|NCT00725764|GlaxoSmithKline|GSK Response Center|866-435-7343||
279942|NCT00725842|Merck Sharp & Dohme|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279943|NCT00725920|Federal University of Sao Paulo|Marcelo F Mello|55 11 50822860|mf-mello@uol.com.br|
279944|NCT00725959|Colorado School of Public Health|Dr. Sheana Bull|303-724-1238||
279945|NCT00726063|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
279946|NCT00726232|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
279947|NCT00726323|GlaxoSmithKline|GSK Response Center|866-435-7343||
279948|NCT00726375|University of Michigan Comprehensive Cancer Center|Dr. Sung Choi|734-615-5707|sungchoi@umich.edu|
279949|NCT00726388|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279950|NCT00726414|Mutual Phrmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
279951|NCT00726453|Medtronic Vascular|K. Bogdanovich||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
279952|NCT00726557|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279953|NCT00726609|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279954|NCT00726622|Mayo Clinic|Tonia M. Young-Fadok, M.D.||youngfadok.tonia@mayo.edu|
279955|NCT00726661|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
279956|NCT00726713|Pamlab Inc.|Page Young, Clinical Project Manager|985-867-5788|pyoung@pamlab.com|
279957|NCT00726739|Masonic Cancer Center, University of Minnesota|Arkadiusz Dudek, M.D.|612-624-0123|dudek002@umn.edu|
279958|NCT00726752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279959|NCT00726882|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
279960|NCT00726895|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
279961|NCT00726986|Case Comprehensive Cancer Center|Afshin Dowlati MD|216-844-1228|afshin.dowlati@uhhospitals.org|
279962|NCT00726999|Medical College of Wisconsin|Lynn Rusy, MD|414-266-2555|lrusy@chw.org|
279963|NCT00727025|Dartmouth-Hitchcock|Dr. Carolyn Kerrigan|603 650-5148|carolyn.l.kerrigan@hitchcock.org|
279964|NCT00727064|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
279965|NCT00727090|Northwestern University|Andrew M Naidech|312-503-3592|a-naidech@northwestern.edu|
279966|NCT00727194|Alexion Pharmaceuticals|Alexion Pharmaceuticals|855-752-2356|clinicaltrials@alexion.com|
279967|NCT00727220|IndianaU|Linda A DiMeglio|317-944-3889|dimeglio@iu.edu|
279968|NCT00727246|University of Pittsburgh|Patricia M Arenth PhD|412-648-6666|arenpm@upmc.edu|
279969|NCT00727259|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
279970|NCT00727272|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
279971|NCT00727298|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@Merck.com|
279972|NCT00727311|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclsoure@merck.com|
279973|NCT00727337|Department of Veterans Affairs|Rachel McArdle|727-398-6661|Rachel.mcardle@va.gov|17479
279974|NCT00727402|Case Western Reserve University Dept Ophthalmology & Visual Sciences|Loretta Szczotka-Flynn OD, PhD|216-844-3609|loretta.szczotka@uhhospitals.org|
279975|NCT00727415|GIMEMA|Alfonso Piciocchi|+39 06 70390513|a.piciocchi@gimema.it|
279976|NCT00727441|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Daniel Laheru|410-955-8974|laherda@jhmi.edu|
279977|NCT00727506|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
279978|NCT00727532|Northwestern University|Results Entry Administrator|312-695-1301|croqualityassurance@northwestern.edu|
279979|NCT00727558|Vistakon|Kurt Moody OD, FAAO/ Director|904-443-3088|kmoody1@its.jnj.com|
279980|NCT00727571|Amgen Inc.|Study Director|866-572-6436||
279981|NCT00727597|Georegtown University|Dr. Princy Kumar|2024440086|kumarp@georgetown.edu|
279982|NCT00727636|Children's Hospital Boston|Dr. Athos Bousvaros|617-355-2962|athos.bousvaros@childrens.harvard.edu|
298844|NCT01844531|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
279983|NCT00727649|Birmingham VA Medical Center|Dr. Alayne Markland, PI of this clinical trial|205-933-8101|alayne.markland@va.gov|6365
279984|NCT00727714|Telemark Hospital|Dr. Anne Kristin M. Fell, MD, PhD|+4735003106|annfel@sthf.no|
279985|NCT00727740|Yale University School of Medicine|Priya Jamidar, MD|203-785-6228|priya.jamidar@yale.edu|
279986|NCT00727844|Tuberculosis Research Section, LCID, NIAID, NIH|Dr. Clifton Barry|301-451-9554|cbarry@niaid.nih.gov|
279987|NCT00727857|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
279988|NCT00727909|VA TVHS|Gene W. Bratt, Ph.D.|615-873-6068|gene.bratt@va.gov|
279989|NCT00727961|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279990|NCT00728130|Simmons Cancer Institute at Southern Illinois University School of Medicine|Director of Clinical Trials|217-545-1946|krobinson@siumed.edu|
279991|NCT00728182|NoNO Inc.|Roberta Anderson, Vice President of Clinical Development|613 833-1020|randerson@nonoinc.ca|
279992|NCT00728260|Sanofi Pasteur Inc|Medical Drector||RegistryContactus@sanofipasteur.com|
279993|NCT00728468|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
279994|NCT00728481|Mayo Clinic|Dr. Amy Foxx-Orenstein, D.O., Associate Prof. of Medicine, College of Medicine|480-301-8806|foxx-orenstein.amy@mayo.edu|
279995|NCT00728494|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
279996|NCT00728507|Johns Hopkins University|Susan Dorman|410-955-1755|dsusan1@jhmi.edu|
288821|NCT01211730|Northwestern University Feinberg School of Medicine|Mark E. Molitch, M.D.|312 503-4130|molitch@northwestern.edu|
288822|NCT01211769|UNIFESP|José Carlos Fernandes Galduróz|55 11 21490168|galduroz@psicobio.epm.br|
288823|NCT01211873|Guerbet|Jing Hao, MD|+33145915000|jing.hao@guerbet.com|
288824|NCT01212094|NINDS, NIH|Dr. Bibiana Bielekova, Prinicipal Investigator|301-402-4488|bibiana.bielekova@nih.gov|
288825|NCT01212107|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
288826|NCT01212159|Temple University School of Medicine|Alfred A. Bove|215-707-9259|alfred.bove@tuhs.temple.edu|
288827|NCT01212172|UC Irvine Dermatology Research Center|Christopher B. Zachary|949 824 7103|czachary@uci.edu|
288828|NCT01212185|UNC_ChapelHill|Dr. Cort Pedersen|919-966-4447|cort_pedersen@med.unc.edu|
288829|NCT01212302|Cardiology Dep, Ruhr-University Bochum|Dr Horst Neubauer|+49-234-509-2326|Horst.Neubauer@rub.de|
288830|NCT01212445|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
288831|NCT01212471|Bausch Health|Study Director||susan.harris@bauschhealth.com|
288832|NCT01212484|NYU Medical Center|Horacio Kaufmann, MD; director of Dysautonomia Center|212 263 7225|horacio.kaufmann@nyumc.org|
288833|NCT01212588|IndianaU|Dr. Alan Breier|317-880-8495|abreier@iupui.edu|
288834|NCT01212627|Brown University Oncology Research Group (BrUOG)|Angela Taber, MD|4018633000|kayla_rosati@brown.edu|
288835|NCT01212744|BioMarin Pharmaceutical Inc.|Medical Director|415-475-5854|ari.gershman@bmrn.com|
298845|NCT01844583|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
279997|NCT00728689|Siga Technologies, Inc.|Annie Frimm, Vice President, Regulatory Affairs|951-303-8797|afrimm@siga.com|
279998|NCT00728728|VHA Durham|Christine E. Marx, MD|9192860411|christine.marx@va.gov|3626
279999|NCT00728754|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
280000|NCT00728819|Penn Medicine|Associate Professor of Radiology|2156627892|ITKINMAX@GMAIL.COM|
280001|NCT00728884|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
280002|NCT00728910|University of Pennsylvania|Richard Dunbar MD|215-662-9024|richard.dunbar@uphs.upenn.edu|
280003|NCT00728923|New York State Psychiatric Institute|Dr. Carolyn Rodriguez|212-543-5637|cr2163@columbia.edu|
280004|NCT00728936|Idera Pharmaceuticals, Inc|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
280005|NCT00728949|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
280006|NCT00728962|Biomet 3i LLC|Clinical Research Manager|5617766722|cristina.matthews@biomet.com|
280007|NCT00728988|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280008|NCT00729053|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
280009|NCT00729157|Memorial Sloan Kettering Cancer Center|Dr. David Pfister|646-888-4237|pfisterd@mskcc.org|
280010|NCT00729183|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280011|NCT00729248|Northwestern University|Lorenzo Gallon, MD - Study Principal Investigator|312-695-4457|l-gallon@northwestern.edu|
280012|NCT00729326|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
280013|NCT00729378|University of Arizona|Dr. Scott Going, Ph.D.|520-626-3432|going@u.arizona.edu|
280014|NCT00729430|Brigham and Women's Hospital|Dr. Raymond Y. Kwong, Director of Cardiac Magnetic Resonance Imaging|857-307-1960|rykwong@partners.org|
280015|NCT00729469|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrialsadmin@shionogi.com|1454
280016|NCT00729482|Asan Medical Center|Dr. Yoon-Koo Kang|+82-2-3010-3210|ykkang@amc.seoul.kr|
280017|NCT00729521|Medical College of Wisconsin|Peter Layde, MD, MSc|414-955-8113|playde@mcw.edu|
280018|NCT00729586|NRG Oncology|Angela Kuras on behalf of Virginia Filiaci|716-845-5702|kurasa@nrgoncology.org|
280019|NCT00729612|The Ohio State University|Gregory Otterson, MD|614-293-2887|Greg.Otterson@osumc.edu|
280020|NCT00729677|Beth Israel Cancer Center|Victoria Rosenwald, RN MPH|212 844-8285|vrosenwa@chpnet.org|
280021|NCT00729690|Rush University|Asokumar Buvanendran|(312) 942-3685|asokumar@aol.com|
280022|NCT00729781|Medtronic Xomed, Inc.|David Hodge, Project Manager|(+1-904) 281-2774|david.l.hodge@medtronic.com|
280023|NCT00729807|University of Maryland Greenebaum Cancer Center|Edward A. Sausville, M.D., Ph.D.|410-328-7394|esausville@umm.edu|
288836|NCT01212757|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
288837|NCT01212770|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
288838|NCT01212874|Loma Linda University Anesthesiology|Patricia Moore|1-909-558-4475|pamoore@llu.edu|
298846|NCT01844687|Columbia University Medical Center|Margaret Haney, PhD., Professor|(646) 774-6153|mh235@columbia.edu|
288839|NCT01212900|National Heart Lung and Blood Institute|Mehta, Nehal|+1 301 827 0483|mehtann@mail.nih.gov|
288840|NCT01212952|Mayo Clinic|Martha Q. Lacy, M.D.|(507) 284-8430|lacy.martha@mayo.edu|
288841|NCT01212991|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
288842|NCT01213043|Grifols Therapeutics Inc.|Benjamin King, PhD||ben.king@grifols.com|
288843|NCT01213082|University of California Davis|Susanna Park, MD|9167346074|sscpark@ucdavis.edu|
288844|NCT01213173|AstraZeneca|Gerard Lynch|+44 1625 518062|aztrial_results_posting@astrazeneca.com|
288845|NCT01213199|GALDERMA|Fabien AUDIBERT, CPM|+ 33 4 92 95 29 21|fabien.audibert@galderma.com|
288846|NCT01213251|Medtronic plc|PRomPT Clinical Team|+1 800-328-2518|MedtronicCRMtrials@medtronic.com|
288847|NCT01213264|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
288848|NCT01213316|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
298847|NCT01844700|Zucker Hillside Hospital, Division of Psychiatry Research|Anil Malhotra, MD|718-470-8281|amalhotra@nshs.edu|
298848|NCT01844765|NovartisPharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
308907|NCT02623829|Icahn School of Medicine at Mount Sinai|Dr. Daniel Bernstein|212-731-3311|daniel.bernstein@mountsinai.org|
308908|NCT02623855|UCSF Benioff Children's Hospital Oaland|Dr. Nooshin Razani, Principal Investigator|415-428-3129|nrazani@mail.cho.org|
308909|NCT02624050|Milton S. Hershey Medical Center|Dr. Anthony Bonavia|717-531-6140|abonavia@pennstatehealth.psu.edu|
308910|NCT02624180|Johns Hopkins Hospital|Robert G. Weiss, MD|410-955-1703|rweiss@jhmi.edu|
308911|NCT02624284|University of Pennsylvania|Mary Falcone, Ph.D.|215-746-3782|mfalc@pennmedicine.upenn.edu|
308912|NCT02624375|University of Washington|Dr. Christine Johnston, Associate Professor|206 520 4340|cjohnsto@uw.edu|
308913|NCT02624492|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308914|NCT02624687|University of Pittsburgh|Bethany Barone Gibbs|4123834002|bbarone@pitt.edu|412
308915|NCT02624700|Virginia Commonwealth University Massey Cancer Center|Andrew Poklepovic, MD|(804) 828-0450|AskMassey@vcu.edu|
308916|NCT02624713|Tel-Hai College|Prof. Moria Golan|972547240330|moria.golan@mail.huji.ac.il|
308917|NCT02624791|UVa Center for Behavioral Medicine Research|Project Coordinator|434-924-8656|tab2v@hscmail.mcc.virginia.edu|
308918|NCT02624843|South Florida Family Health & Research|Elisabeth Rivera|3053870051|elisabeth@sffhrc.com|
308919|NCT02624986|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
280024|NCT00729833|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280025|NCT00729846|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
280026|NCT00729859|University of Washington|Stephanie T. Page, MD, PhD|206-616-0483|page@u.washington.edu|
280027|NCT00729924|Vanderbilt University|David W. Haas, MD|615-936-8594|david.w.haas@vanderbilt.edu|
280028|NCT00729937|Olive View-UCLA Medical Center|David A. Talan, MD|818-364-3107|dtalan@ucla.edu|
280029|NCT00730015|Ironwood Pharmaceuticals|Doug Levine, MD|617.374.3906|dlevine@ironwoodpharma.com|
280030|NCT00730028|San Francisco General Hospital, UCSF|Henry F. Chambers, MD|(415) 206 - 5437|hchambers@medsfgh.ucsf.edu|
280031|NCT00730041|Medtronic Xomed, Inc.|David Hodge|904-281-2774|david.l.hodge@medtronic.com|
280032|NCT00730158|UPMC Hillman Cancer Center|Edward Chu, MD|(412) 648-6589|chue2@upmc.edu|
280033|NCT00730171|Ironwood Pharmaceuticals, Inc.|Michael Hall, MD|(617) 621-7722||
280034|NCT00730236|Aegerion Pharmaceuticals|Mark Sumeray, MD, Chief Medical Officer|617-500-7867|msumeray@aegerion.com|
280035|NCT00730275|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280036|NCT00730327|Apollo Endosurgery|Laura Eaton, Study Director, RN, BSN, CCRN-R,|949-468-9301|laura.eaton@apolloendo.com|
280037|NCT00730353|Hoosier Oncology Group|Nasser Hanna, M.D.|317-274-3515|nhanna@iupui.edu|
280038|NCT00730405|GlaxoSmithKline|GSK Response Center|866-435-7343||
280039|NCT00730483|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
280040|NCT00730522|Catalyst Pharmaceuticals|Chief Scientific Officer|305-420-3200|gingenito@catalystpharma.com|
280041|NCT00730691|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
280042|NCT00730730|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
280043|NCT00730756|GlaxoSmithKline|GSK Response Center|866-435-7343||
288849|NCT01213472|GlaxoSmithKline|GSK Clinical Trials|877-379-3718|GSKClinicalSupportHD@gsk.com|
298849|NCT01844778|Novartis|Study Director|862-778-8300||
288850|NCT01213524|Brown University|Jennifer Tidey, Ph.D.|401-863-6418|Jennifer_Tidey@brown.edu|
288851|NCT01213576|University of Liverpool|Professor Neil French|+441517959630|french@liv.ac.uk|
288852|NCT01213589|Medtronic|Richard Jonkers, PhD|800-217-1617|richard.jonkers@medtronic.com|3727
288853|NCT01213706|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
298850|NCT01844817|Sarah Cannon Development Innovations|Charles Davis, RAC||Charles.Davis2@scri-innovations.com|
288854|NCT01213823|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288855|NCT01213836|Astra Zeneca|Gerard Lynch||ClinicalTrailTransparency@astrazeneca.com|
288856|NCT01213940|University of South Alabama, Department of Surgery|William O. Richards, MD|251-471-7993|brichards@health.southalabama.edu|
288857|NCT01213966|Faculty of Tropical Medicine|Professor Sasithon Pukrittayakamee|(662) 354-9400-19|yon@tropmedres.ac|1435
288858|NCT01214044|Oregon Health & Science University and VA Portland Health Care System|Jonathan Emens, M.D.|503-220-8262|emensj@ohsu.edu|58490
288859|NCT01214057|The University of Texas Health Science Center at Houston|Davide Cattano, MD|(713) 500-6200|Davide.Cattano@uth.tmc.edu|
288860|NCT01214083|VA Connecticut Healthcare System|Gihyun Yoon, MD|203-932-5711|gihyun.yoon@va.gov|7421
288861|NCT01214109|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288862|NCT01214161|Columbia University|Anne Davis, MD|212-305-4951|ard4@cumc.columbia.edu|
288863|NCT01214174|Icon Bioscience, Inc.|Wendy Murahashi, MD|650-369-4049|wendymurahashi@iconbioscience.com|
288864|NCT01214187|Brigham and Women's Hospital|Ivan Rosas, MD|617-278-0434|irosas@rics.bwh.harvard.edu|
298851|NCT01844830|Loma Linda University|Yiming Li, DDS|909-558-4600|kkellingsworth@llu.edu|
288865|NCT01214200|Temple University School of Medicine|Mark Weir, MBChB|215-707-5864|mark.weir@tuhs.temple.edu|
288866|NCT01214239|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288867|NCT01214252|Covidien|Annie Choi|781-839-1756|annie.choi@covidien.com|
298852|NCT01844895|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
288868|NCT01214317|Isfahan University of medical sciences|Director of clinical trial|+983136202020|etemadifar.m@gmail.com|
298853|NCT01845025|Novartis Pharmaceuticals|Study Director|862-778-8300||
288869|NCT01214330|Mike O'Callaghan Federal Medical Center|Jill Clark, Clinical Research Manager|702-653-3298|jill.clark.3.ctr@us.af.mil|
308920|NCT02625181|Vanderbilt University Medical Center|Jonathan Wanderer|615-536-5194|jon.wanderer@vanderbilt.edu|
288870|NCT01214356|MUSC|Vanessa Diaz, MD MSCR|8438762923|diazva@musc.edu|
288871|NCT01214395|PathWest Laboratory Medicine WA|Dr Kerry Carson Trial Manager|+61 8 93464092|kerry.carson@uwa.edu.au|
288872|NCT01214421|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
308921|NCT02625207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288873|NCT01214434|Promius Pharma, LLC|Medical Information Center|888 966-8766|product-complaints@promiuspharma.com|
288874|NCT01214603|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288875|NCT01214616|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
280044|NCT00730847|GlaxoSmithKline|GSK Response Center|866-435-7343||
288876|NCT01214629|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288877|NCT01214642|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288878|NCT01214655|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
280045|NCT00730912|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
298854|NCT01845077|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
280046|NCT00730925|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
280047|NCT00730964|GE Healthcare|Rubin Sheng, MD|1-609-514-6899|Rubin.Sheng@ge.com|
280048|NCT00731042|3M Company|Chou Eyberg|651-737-0934|cieyberg1@mmm.com|
280049|NCT00731055|New York State Psychiatric Institute|Dr. Adam Bisaga|646-774-6155|amb107@columbia.edu|
280050|NCT00731094|VA Pittsburgh Healthcare System|Kelly Hyman Burkitt, PhD|412-360-2202|Kelly.Burkitt@va.gov|
280051|NCT00731120|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
280052|NCT00731133|UAMS|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
280053|NCT00731198|Changhai Hospital, Second Military Medical University, Shanghai, China|Zhaoshen Li M.D.|86-21-81873271|zhaoshenlismmu@gmail.com|
280054|NCT00731211|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
280055|NCT00731341|Galil Medical|Joy Benson, CRA|651-287-5112|joy.benson@galilmedical.com|
280056|NCT00731484|TearLab, Inc.|Dr. Benjamin Sullivan|855-832-7522|bdsulliv@TearLab.com|
280057|NCT00731549|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
280058|NCT00731588|University of Iowa|John A. Widness, M.D.|319-356-8102|john-widness@uiowa.edu|
280059|NCT00731614|San Francisco VA Medical Center|John R. McQuaid, Ph.D.|415-221-4810|john.mcquaid@va.gov|4106
280060|NCT00731640|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280061|NCT00731653|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@partners.org|
280062|NCT00731666|Coloplast Corp|Clinical Trials Manager|612-302-4990|usdibe@coloplast.com|
280063|NCT00731679|Salix|David Sorscher|919-862-1827|david.sorscher@salix.com|
280064|NCT00731692|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
280065|NCT00731783|Washington University|Stephanie A. Fritz, M.D., M.S.C.I.|314-454-6050|fritz_s@kids.wustl.edu|
298855|NCT01845103|CryoLife, Inc.|Scott Capps, MS/ Vice President, Clinical Research|800-438-8285|clinicaltrialregistration@cryolife.com|
280066|NCT00731822|GlaxoSmithKline|GSK Response Center|866-435-7343||
280067|NCT00731874|Weill Cornell Medical College/Division of Transplant Surgery|Dr. Meredith J Aull|(212) 746-0727|mea9008@med.cornell.edu|
280068|NCT00731939|Coloplast Corp|Clinical Trial Manager|612-302-4990|usdibe@coloplast.com|
280069|NCT00732030|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280070|NCT00732069|Vanderbilt University|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
280071|NCT00732160|Vanderbilt University Medical Center|James M. Luther|(615) 936-3420|James.Luther@Vanderbilt.edu|
280072|NCT00732199|John D. Dingell VA Medical Center|Susmita Chowdhuri|313 576 1000|susmita.chowdhuri@va.gov|3685
280073|NCT00732212|CURE Digestive Diseases Research Center|Dennis M. Jensen, M.D.|310-268-3569|djensen@mednet.ucla.edu|
280074|NCT00732225|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280075|NCT00732238|Michael E DeBakey VA Medical Center-Baylor College of Medicine|Rabih Darouiche|713-841-3882|rdarouiche@aol.com|
280076|NCT00732251|Cedars Sinai Medical Center|Felicia Mayes|310-423-0825|mayesf@cshs.org|
280077|NCT00732303|Hoosier Cancer Research Network, Inc.|Clinical Data Coordinator|317-921-2050|jsmith@hoosiercancer.org|
280078|NCT00732472|GlaxoSmithKline|GSK Response Center|866-435-7343||
298856|NCT01845155|Deutsches Zentrum für Musiktherapieforschung (Viktor Dulger Institut) DZM e.V. - German Center for Music Therapy Research|Dr. Heike Argstatter|+49-6221-7963960|heike.argstatter@dzm-heidelberg.de|
298857|NCT01845220|Johns Hopkins University|Jed W. Fahey, Sc.D.|4106142607|jfahey@jhmi.edu|
280079|NCT00732498|University of Arizona|NCTN Program Coordinator|520-626-0301|aselegue@email.arizona.edu|
280080|NCT00732615|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
280081|NCT00732641|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280082|NCT00732654|Johns Hopkins University|Corinne Keet|4109555883|pediatricallergy@jhmi.edu|
280083|NCT00732758|Children's Hospital of Pittsburgh|Kumaravel Rajakumar|412-692-5822|rajakumark@upmc.edu|
280084|NCT00732875|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280085|NCT00732901|Virginia Commonwealth University|F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
280086|NCT00732940|GlaxoSmithKline|GSK Response Center|866-435-7343||
280087|NCT00732992|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280088|NCT00733096|Johns Hopkins School of Medicine|Steven P. Cohen|410-955-1822|scohen40@jhmi.edu|
280089|NCT00733135|Covidien|Director of Medical Communications|763-591-3047|jean.ahlstrom@covidien.com|
280090|NCT00733226|Kecioren Education and Training Hospital|Cem Hasan RAZİ|090 312 3659000|cemrazi2@gmail.com|1139
280091|NCT00733278|LA BioMed|Dr. Anita Nelson||anitanelsonwhc@earthlink.net|
280092|NCT00733291|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280093|NCT00733304|GlaxoSmithKline|GSK Response Center|866-435-7343||
280094|NCT00733330|DePuy International|Kimberly Dwyer||kdwyer2@its.jnj.com|
280095|NCT00733343|Department of Cardiology, Imperial College London, Dovehouse St., London SW3 6LY, United Kingdom|Martin R. Cowie, MD|+44 (0)20 7589 0|m.cowie@imperial.ac.uk|5111
280096|NCT00733356|University of California Irvine Child Development Center|Kinberley Lakes|949-824-3009|klakes@uci.edu|
288879|NCT01214668|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288880|NCT01214720|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
288881|NCT01214759|The University of Texas Health Science Center at Houston|Dr. Karen Vigil|(713) 500-6703|Karen.J.Vigil@uth.tmc.edu|
288882|NCT01214811|Molnlycke Health Care|Viktoria Ahlenius Körner|0046 31 7223000|viktoria.ahleniuskorner@molnlycke.com|
288883|NCT01214824|Abbott Diabetes Care|Director Global Clinical and EMEA Regulatory Affairs|01993863164|joe.bugler@abbott.com|
288884|NCT01214837|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
280097|NCT00733369|DePuy Ortho Joint US|Kimberly Dwyer, PhD, CCRA||kdwyer2@its.jnj.com|
280098|NCT00733408|University of Washington|Jennifer Specht, MD, Associate Professor|(206) 606-1000|jspecht@uw.edu|
280099|NCT00733421|Foot & Ankle Surgical Centre|Jan Jakobsson PI, MD, PhD, Professor|46702500960|jan.jakobsson@ki.se|
280100|NCT00733499|DePuy Ortho Joint US|Tamiko Magee-Rodgers, PhD||TMageeRo@its.jnj.com|
280101|NCT00733512|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280102|NCT00733746|Alliance for Clinical Trials in Oncology|Peter Pisters, MD||ppisters@mdanderson.org|
280103|NCT00733824|Washington University School of Medicine|Amanda F. Cashen, M.D.|314-454-8304|acashen@wustl.edu|
280104|NCT00733902|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280105|NCT00733954|Galderma Laboratories, L.P.|Ronald W. Gottschalk, MD / Medical Director|817-961-5358|ron.gottschalk@galderma.com|
280106|NCT00733980|GlaxoSmithKline|GSK Response Center|866-435-7343||
280107|NCT00733993|Virginia Commonwealth University|F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
280108|NCT00734032|GlaxoSmithKline|GSK Response Center|866-435-7343||
280109|NCT00734071|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
280110|NCT00734097|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
280111|NCT00734149|Duke University Medical Center|Cristina Gasparetto, MD|919-668-1017|gaspa001@mc.duke.edu|
280112|NCT00734162|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
280113|NCT00734214|McMaster University|Dr. Karen Choong|905-5212100|choongk@mcmaster.ca|75617
280114|NCT00734305|Merrimack Pharmaceuticals, Inc.|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
280115|NCT00734344|University of Alabama at Bimingham|Principal Investigator|996-2371|heaths@uab.edu|
280116|NCT00734409|Duke University Health System|DaiWai M Olson, PhD RN|(919) 668-3751|Olson006@mc.duke.edu|
280117|NCT00734474|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
280118|NCT00734500|Duke University|Michael Cohen-Wolkowiez|9196688812|michael.cohenwolkowiez@duke.edu|
280119|NCT00734539|Duke Univiersity Medical Center|Daniel K. Benjamin Jr|919-668-7081|danny.benjamin@dm.duke.edu|
280120|NCT00734578|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
280121|NCT00734591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280122|NCT00734604|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
280123|NCT00734617|Duke Center for Nicotine & Smoking Cessation Research|Jed E. Rose, Ph.D.|919 668-5093|rose0003@mc.duke.edu|
280124|NCT00734630|Forest Laboratories, Inc.|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|2014278000|noah.rosenberg@frx.com|2133
280125|NCT00734656|University of Connecticut Health Center|Jonathan Covault|860-679-7560|jocovault@uchc.edu|
280126|NCT00734734|Novartis Vaccines and Diagnostics S.r.l|Posting Director||RegistryContactVaccinesUS@novartis.com|
280127|NCT00734747|Medigus Ltd|Aviel Roy-Shapira, MD|+972 8646 6880|avrish@gmail.com|
280128|NCT00734799|Durham VAMC|Christi S. Ulmer, PhD|9192860411|christi.ulmer@va.gov|4044
280129|NCT00734851|DukeUMC|Andrew J. Armstrong, MD ScM FACP|(919) 668-8797|andrew.armstrong@duke.edu|
280130|NCT00734903|VA BOSTON|Lisa Najavits, PhD|617-299-1620|lisa.najavits@va.gov; najavits@bu.edu|
280131|NCT00734929|Duke University Medical Center|Dr. Ashraf Habib|9196686265|habib001@mc.duke.edu|
280132|NCT00734968|University of Missouri|Daniel Jackson MD|573 499 6041|jacksondl@health.missouri.edu|
280133|NCT00734994|Duke University, Division of Urology|Brant A. Inman, MD, MS|919 684-1322|brant.inman@duke.edu|
280134|NCT00735007|Merck Serono International, S.A., an affiliate of Merck KGaA, Darmstadt, Germany|Elisabetta Verdun di Cantogno|+41 22 414 4887|elisabetta.verdun@merckserono.net|
280135|NCT00735072|University of California, San Francisco|Peter W. Hunt, MD|(415) 476-4082|phunt@php.ucsf.edu|345
280136|NCT00735306|Duke University|Dr. Brian Czito|919-668-7336|brian.czito@duke.edu|
280137|NCT00735371|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
288885|NCT01214850|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
288886|NCT01214915|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
288887|NCT01214980|University South Florida|Dr. Lisa Gould|(410) 736-4646|lgould44@hotmail.com|
288888|NCT01215032|Mass General Hospital Cancer Center|Maria Kempner|508.533.4132|mkempner@partners.org|
288889|NCT01215097|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288890|NCT01215110|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|212-227-7540|Dan.Everitt@tballiance.org|
288891|NCT01215123|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
288892|NCT01215175|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
288893|NCT01215188|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
288894|NCT01215227|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
288895|NCT01215240|University of Alberta|Dr. Lindsay Ryerson|780 407 3396|ryerson@ualberta.ca|780
288896|NCT01215253|University of Rochester|Wojciech Zareba|585-275-5391|wojciech.zareba@heart.rochester.edu|
288897|NCT01215279|AstraZeneca|Anna Malmgren||ClinicalTrialTransparency@astrazeneca.com|
280138|NCT00735397|Eisai Inc.|Eisai Call Center|888-422-4743||
280139|NCT00735436|Duke University Medical Center|Annick Desjardins, MD, FRCPC||annick.desjardins@dm.duke.edu|
280140|NCT00735449|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
280141|NCT00735462|Graceway Pharmaceuticals|Robert Babilon, Vice President, Product Development|267-948-0400|robert.babilon@gracewaypharma.com|20428
280142|NCT00735475|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
280143|NCT00735618|UT MD Anderson Cancer Center|Ying Guo, MD, MS/Associate Professor||jaallo@mdanderson.org|
280144|NCT00735644|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
298858|NCT01845636|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
280145|NCT00735670|University of Michigan Spinal Cord Injury System|Dr. Denise G Tate|734 763-0971|dgtate@umich.edu|
280146|NCT00735696|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
280147|NCT00735709|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
280148|NCT00735787|Abbott Laboratories|Global Medical Services|1-800-633-9110||
280149|NCT00735826|Dartmouth-Hitchcock Medical Center|Konstnatin Dragnev, MD Professor of Medicine|603-650-6344|Konstantin.H.Dragnev@Hitchcock.org|
280150|NCT00735839|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280151|NCT00735878|Dartmouth-Hitchcock Medical Center (DHMC)|Konstantin H. Dragnev, MD|(603) 650-6344|konstantin.h.dragnev@hitchcock.org|
298859|NCT01845792|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
280152|NCT00735904|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280153|NCT00735917|University of Colorado Cancer Center|Wells A. Messersmith, M.D.||wells.messersmith@ucdenver.edu|
280154|NCT00735943|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280155|NCT00735969|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|High Dose Ribavirin in Combination With Peginterferon for Patients With Chronic Hepatitis C Genotype|(301) 402-5115|mg228m@nih.gov|
280156|NCT00736034|Sourazky Tel-Aviv Medical Center|Dr. V. Vakhapova|972-3-6973698|vedanicek@gmail.com|
280157|NCT00736073|DUMC|Dr. Martin Poleski|9196841817|martin.poleski@dm.duke.edu|
280158|NCT00736099|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
280159|NCT00736125|Duke University Medical Center|Dr. Terri Monk|919-286-6938|terri.monk@duke.edu|
280160|NCT00736190|Gilead Sciences, Inc.|Eduardo Bruno Martins, MD, DPhil, Sr. Director, Medical Affairs - Hepatitis|650-522-5792|eduardo.martins@gilead.com|
280161|NCT00736229|Saint Luke's Health System|Steven P. Marso, MD|816-932-5773|smarso@saint-lukes.org|
280162|NCT00736242|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280163|NCT00736255|DukeUMC|Scott Kollins, PhD|9196810014|kolli001@mc.duke.edu|
280164|NCT00736333|Merck Sharp & Dohme Corp.|Senior Vice President, Global Cllinical Development||ClinicalTrialsDisclosure@merck.com|
280165|NCT00736450|University of Nebraska Medical Center|Julie Vose, MD|402-559-3848|jmvose@unmc.edu|
280166|NCT00736476|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
280167|NCT00736489|AstraZeneca|Carin Jorup, MSD||ClinicalTrialTransparency@astrazeneca.com|
280168|NCT00736502|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
280169|NCT00736580|West Virginia University|Michael Stitely, MD|304-293-1566|mstitely@hsc.wvu.edu|
280170|NCT00736632|Washington University in St. Louis|Dr. Carlos Bernal-Mizrachi|314-362-0947|cbernal@wustl.edu|
280171|NCT00736645|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
280172|NCT00736723|University|Prof. Dr. Manfred Weiss|#49 731 500 60226|manfred.weiss@uni-ulm.de|
280173|NCT00736840|Exalenz Bioscience|Clinical Trial Manager|972-8-9737500|avrahamh@exalenz.com|513
280174|NCT00736853|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K.|Medical Director|+81-3-4411-5509||
280175|NCT00736879|Clinical Trial Transparency|AstraZeneca||Clinical.Trial.Transparency@astrazeneca.com|
280176|NCT00736944|Washington University School of Medicine|Dr. Douglas R. Adkins|314-362-5654|dadkins@dom.wustl.edu|
298860|NCT01845818|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
280177|NCT00736957|Neuroscience Department, Clinical Science Division, R&D, JANSSEN PHARMACEUTICAL. K.K. 5-2, Nishi-kanda 3-chome, Cyiyoda-ku, Tokyo 101-0065 JAPAN|Medical Director|+81-3-4411-5509||
280178|NCT00736996|University of Colorado|Robert S. Schwartz, M.D.|303-724-1919|robert.schwartz@ucdenver.edu|
280179|NCT00737048|JANSSEN PHARMACEUTICAL. K.K. , Neuroscience Department, Clinical Science Division|Medical Director|+81-3-4411-5509||
288898|NCT01215292|University of Washington|Mara Roth, MD|206-221-0519|mylang@uw.edu|
288899|NCT01215318|University Hospital of Zurich|Irene A Burger|+41 44 255 11 11|irene.burger@usz.ch|
288900|NCT01215344|Vanderbilt-Ingram Cancer Center|Madan Jagasa, M.D.|(6150 936-8422|madan.jagasia@vanderbilt.edu|
288901|NCT01215357|Psyadon Pharmaceuticals|Dr. Richard Chipkin|301-919-2020|rchipkin@psyadonrx.com|
288902|NCT01215422|UNIVERSITY OF ALBERTA|DR. JOAN ROBINSON|780-248-5540|jr3@ualberta.ca|
288903|NCT01215435|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
288904|NCT01215513|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
288905|NCT01215643|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
288906|NCT01215695|University Louisville|Rainer Lenhardt, MD|502-228-7517|rainer.lenhardt@louisville.edu|
288907|NCT01215721|UC Irvine|Thomas Ahlering, MD|714-456-6068|tahlerin@uci.edu|
288908|NCT01215734|Vanderbilt University|Natasha Halasa, Associate Professor of Pediatrics|615-322-3346|natasha.halasa@vanderbilt.edu|
288909|NCT01215786|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
298861|NCT01845831|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
288910|NCT01215851|Global Alliance for TB Drug Development|Daniel E. Everitt, MD, Vice President and Senior Medical Officer|(212) 227-7540|dan.everitt@tballiance.org|
288911|NCT01215916|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288912|NCT01215929|UAMS|Michael J Mancino MD|501-526-8440|mjmancino@uams.edu|
288913|NCT01215942|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
280180|NCT00737061|Hologic, Inc.|Edward Evantash, MD, Medical Director, Vice President Medical Affairs|508-263-8475|edward.evantash@hologic.com|
280181|NCT00737100|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
280182|NCT00737178|Columbia University|Anne Davis, MD|2123054951|ard4@columbia.edu|
280183|NCT00737204|New York State Psychiatric Institute|Judith G. Rabkin, Ph.D., M.P.H.|(646) 774-8075|jgr1@columbia.edu|
280184|NCT00737243|Sarah Cannon Research Institute|John D. Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
280185|NCT00737360|The University of Texas M.D, Anderson Cancer Center|Dr. Anne Tsao, Principal Investigator|713-792-6363||
280186|NCT00737438|Memorial Sloan Kettering Cancer Center|Dr. David Ilson|646-888-4183|ilsond@mskcc.org|
280187|NCT00737464|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
280188|NCT00737477|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
280189|NCT00737529|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialsdisclosure@celgene.com|
298862|NCT01845974|Advocate Medical Group Cardiology|Scott M. Miller MD|847-698-5500|scott.miller@advocatehealth.com|
280190|NCT00737568|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
298863|NCT01846039|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
280191|NCT00737633|Vivus, Inc|Wesley W Day, PhD|650-934-5200|day@vivus.com|
280192|NCT00737672|W.L. Gore and Associates, Inc.|Clinical Project Manager|928-864-3771|cavery@wlgore.com|
280193|NCT00737698|Imperial College London|Dr Samantha Amanda Sathyapala|+442073518029|s.sathyapala@imperial.ac.uk|
280194|NCT00737711|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
280195|NCT00737737|National Institutes of Health Clinical Center|Andrew Mannes, M.D.|301-594-3427|Andrew.Mannes@nih.gov|
280196|NCT00737893|Johns Hopkins Brady Urological Institute|Dr. Hiten Patel|410-502-7710|hiten.patel@lumc.edu|
288914|NCT01215955|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288915|NCT01215968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288916|NCT01215981|Masonic Cancer Center, University of Minnesota|Michael Verneris, M.D.|612-626-2961|verneris@umn.edu|
288917|NCT01216072|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
288918|NCT01216163|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288919|NCT01216176|University of Miami|Joyce Slingerland MD PhD FCRP(C)|305-243-7265|jslingerland@med.miami.edu|
288920|NCT01216189|Karolinska Institutet|Professor Anna Martling|+46851770000|anna.martling@ki.se|
288921|NCT01216202|Karolinska Institutet|Anna Martling|+46851770000|anna.martling@ki.se|
288922|NCT01216241|University of Rochester|Dr. Robert F. Betts|585-275-5871|robert_betts@urmc.rochester.edu|
288923|NCT01216319|Cook Biotech Incorporated|Jason Hodde, Clinical Affairs Manager|765-497-3355|jhodde@cookbiotech.com|
288924|NCT01216332|Vanderbilt|Dr. Natasha Halasa|6153223346|natasha.halasa@vanderbilt.edu|
288925|NCT01216397|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
288926|NCT01216410|Duke University Medical Center|Ashraf Habib|919 668 6266|habib001@dm.duke.edu|
288927|NCT01216683|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
288928|NCT01216735|University of Miami|Adam Wanner, MD|(305) 243-2568|awanner@med.miami.edu|
288929|NCT01216748|University of Miami|Matthias Salathe, MD|(305)243-2568|msalathe@med.miami.edu|
288930|NCT01216761|University of Michigan Health System|Laraine Washer, MD|734-936-5205|laraine@med.umich.edu|
288931|NCT01216943|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
288932|NCT01217073|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
288933|NCT01217112|GW Research Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223266800|rp@gwpharm.com|
288934|NCT01217190|Par Pharmaceutical|Medical Affairs|1-800-828-9393|DrugInfo@strativapharma.com|
288935|NCT01217229|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
288936|NCT01217307|University Medical Center Groningen|Dr. I.C.C. van der Horst||i.c.c.van.der.horst@umcg.nl|
288937|NCT01217385|American College of Radiology|Donna Hartfeil, Director Protocol Management|215-717-2765|dhartfeil@acr.org|
288938|NCT01217411|University of Texas (UT) MD Anderson Cancer Center|Morris D. Groves, MD / Professor|713-792-2573|mgroves@mdanderson.org|
288939|NCT01217437|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
288940|NCT01217463|Olympus France S.A.S|Mr. Akira Kondo, Manager, Clinical R&D|+33-1-4560-6849|akira.kondo@olympus.fr|
288941|NCT01217476|Olympus France S.A.S|Mr. Akira Kondo, Manager, Clinical R&D|+33-1-4560-6849|akira.kondo@olympus.fr|
288942|NCT01217515|S.L.A. Pharma UK Ltd|Dr C Jordan, Head of Clinical Operations|44 01923 681001|cjordan@slapharma.com|
288943|NCT01217606|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
288944|NCT01217749|Pharmacyclics, Inc.|Dr. Jutta K. Neuenburg|877-877-3536|medinfo@pcyc.com|
288945|NCT01217801|Par Pharmaceutical|Medical Affairs|800-828-9393|DrugInfo@strativapharma.com|
288946|NCT01217814|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
288947|NCT01217827|VA Palo Alto HCS|Paul Heidenreich|650-849-1205|paul.heidenreich@va.gov|
288948|NCT01217840|Stanford University|Sejal Shah MD|6507211811|sshah2@stanford.edu|
298864|NCT01846104|Department of Clinical Research Division of Medicine USAMRIID|Matthew Chambers, MD|301-619-6731|matthew.s.chambers@mail.mil|
298865|NCT01846208|Icahn School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
298866|NCT01846221|Columbia University|Allison Lee, MD - Assistant Professor of Anesthesiology|212-342-2028|al3196@cumc.columbia.edu|
298867|NCT01846299|Novartis|Study Director|862-778-8300||
298868|NCT01846416|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
280197|NCT00738023|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
280198|NCT00738049|University of Texas Medical School at Houston|K. Lance Gould, MD|713-500-6611|K.Lance.Gould@uth.tmc.edu|
280199|NCT00738062|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
280200|NCT00738101|Baylor College of Medicine|Dr. Muralidhar H Premkumar|8328267980|premkuma@bcm.edu|
280201|NCT00738283|Baylor College of Medicine|Steven A. Abrams, MD|713-798-7164|sabrams@bcm.edu|
280202|NCT00738361|Ohio State University Comprehensive Cancer Center|Thomas Olencki, D.O.|614-293-2886|Thomas.Olencki@osumc.edu|
280203|NCT00738374|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
280204|NCT00738400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
280205|NCT00738426|Cosmetic Surgery|Dr. Robert F. Jackson|765-662-8303|rjlipodr@comteck.com|
280206|NCT00738530|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
280207|NCT00738543|University of Guanajuato|Alejandro Macias|52 477 7145859|aaeemmhh@yahoo.com|400
280208|NCT00738673|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
280209|NCT00738699|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
280210|NCT00738881|Roswell Park Cancer Institute|Alex A. Adjei, M.D., Ph.D|507/538-1760|alex.adjei@roswellpark.org|
280211|NCT00738894|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
280212|NCT00739102|Cordis Corporation, a Johnson & Johnson company|Patricia Schleckser, Director Medical Affairs|908-541-4564|pschleck@its.jnj.com|
280213|NCT00739297|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280214|NCT00739310|Maimonides, Department of Pulmonary Medicine|Kathryn Fitzgerald, NP|718-283-7339|kfitzgerald@maimonidesmed.org|
280215|NCT00739336|SUNY Upstate Medical University|Clinical Trials Officer|315-464-5476|Rudesj@upstate.edu|
280216|NCT00739583|Johns Hopkins University|Simon C Mears|410-550-0101|smears1@jhmi.edu|
280217|NCT00739596|Novartis Pharmaceuticals|Study Director|862-778-8300||
280218|NCT00739648|Horizon Pharma USA, Inc.|Jeffery Nieves, PharmD, Senior Director||clinicaltrials@horizonpharma.com|
280219|NCT00739661|Genentech, Inc|Medical Communications|800-821-8590||
280220|NCT00739752|Indiana University|Dr. Gregory Zimet|317-274-8812|gzimet@iu.edu|
280221|NCT00739765|New York State Psychiatric Institute|John C. Markowitz, M.D.|646 774-8098|jcm42@cumc.columbia.edu|
280222|NCT00739908|CeNeRx BioPharma Inc.|Mahnaz Asgharnejad, Pharm.D.; Daniel Burch, M.D.|(919) 655 1435; (919) 674 6041|masgharnejad@cenerx.com; danburch@cenerx.com|
280223|NCT00739934|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280224|NCT00739960|UIC|Nadera J Sweiss, MD|312-996-5723|nsweiss@uic.edu|
280225|NCT00739973|Novartis Pharmaceuticals|Study Director|862 778-8300||
280226|NCT00739999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
280227|NCT00740051|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
280228|NCT00740129|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
280229|NCT00740207|Bracco Diagnostics Inc.|Usha Halemane|609-514-2578|usha.halemane@diag.bracco.com|
280230|NCT00740220|Wake Forest University|Arjun Chatterjee, MD, MS, FCCP|336.716.4649|achatter@wfubmc.edu|
280231|NCT00740376|Corin|Global Regulatory Affairs and Clinical Director|+44 (0)1285 659866||
280232|NCT00740584|Starpharma Pty Ltd|Clinical Development Manger|+61 3 9532 2700|clare.price@starpharma.com|
280233|NCT00740636|Memorial Sloan Kettering Cancer Center|Dr. Maria C. Pietanza|646-888-4203|PietanzM@mskcc.org|
280234|NCT00740714|Weill Medical College of Cornell University|M. Flint Beal, MD|212-746-6575|fbeal@med.cornell.edu|
280235|NCT00740779|Watson Pharmaceuticals|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
280236|NCT00740792|Meda Pharmaceuticals|David Ginsberg,D.O.|7325642364|david.ginsberg@meda.us|
280237|NCT00740831|PregLem SA|Dr Elke Bestel|+41 22 884 03 40|medical@preglem.com|
280238|NCT00740857|Wyeth|U. S. Contact Center||clintrialresults@wyeth.com|
280239|NCT00740870|Medtronic|Karla Mezera|612-306-4325|karla.p.mezera@medtronic.com|
280240|NCT00741013|Washington University School of Medicine|Delphine L. Chen|314-362-7029|chend@mir.wustl.edu|
280241|NCT00741026|American Medical Association|Vance L. Albaugh, Principle Investigator|(800) 243-1455|vance.l.albaugh@vanderbilt.edu|
280242|NCT00741039|Memorial Sloan Kettering Cancer Center|Dr. Susan Seo|212-639-3151|seos@mskcc.org|
280243|NCT00741091|Boston Scientific Corporation|Todd Kornmann, Specialist, Prin Reg Affairs|763-494-1348|Todd.Kornmann@bsci.com|
280244|NCT00741104|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280245|NCT00741156|The Hospital for Sick Children|Dr. Kyong-Jin Lee|416-813-7326|kyong-jin.lee@sickkids.ca|
280246|NCT00741260|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
280247|NCT00741273|Repros Therapeutics|Jennifer Wike|2817193402|jwike@reprosrx.com|
280248|NCT00741286|Department of Neurology, Sanggye Paik Hospital, Inje University College of Medicine|Sang Won Han|82-2-950-8864|swhan@paik.ac.kr|
280249|NCT00741338|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
280250|NCT00741390|Becton Dickinson|Kenneth Kassler-Taub, VP Medical Affairs|201-847-7009|kenneth_kassler_taub@bd.com|
280251|NCT00741455|Dartmouth-Hitchcock Medical Center|Darcie Findley|603-650-4595|darcie.l.findley@hitchcock.org|
280252|NCT00741468|Repros Therapeutics Inc.|Jennifer Wike|281-719-3402|jwike@reprosrx.com|
280253|NCT00741598|Mood and Anxiety Disorders Program, Icahn School of Medicine at Mount Sinai|Dr. Dan V. Iosifescu|212-241-4480|dan.iosifescu@mssm.edu|
280254|NCT00741611|CR Bard|Anne Marie Harcarik|908-277-8051|annemarie.harcarik@crbard.com|
280255|NCT00741819|United Therpaeutics Corporation|Inhaled Treprostinil Program Head|919-485-8350|clinicalrecordsmanagment@unither.com|
280256|NCT00741858|university of illinois at chicago|k.v. slavin|312-996-4842|kslavin@uic.edu|
280257|NCT00741936|Hong Kong Baptist University|Prof. Zhao-xiang Bian|(852) 3411 2905|bzxiang@hkbu.edu.hk|
280258|NCT00742001|Terumo BCT|Marty Huntington / Sr Mgr Global Clinical Affairs|+1 (303) 231-4849|Marty.Huntington@terumobct.com|
280259|NCT00742027|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
280260|NCT00742053|C.R. Bard|Christopher DiMatteo/Clinical Scineces Manager|801-522-5487|chris.dimatteo@crbard.com|
280261|NCT00742079|Massachusetts General Hospital|Jennifer Gottlieb, PhD|617-912-7800|jgottlieb2@partners.org|
280262|NCT00742170|McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
280263|NCT00742183|Mölnlycke Health Care|Viktoria Ahlenius Körner|+46-31-722 32 46|viktoria.ahleniuskorner@molnlycke.com|
280264|NCT00742209|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
280265|NCT00742235|Massachusetts General Hospital|Principal Investigator|617-726-3934|ibhan@partners.org|
280266|NCT00742274|W.L. Gore and Associates|Jennifer Gorman|928-864-3381|jgorman@wlgore.com|
280267|NCT00742313|Duke University Medical Center|Terry Ainsworth, Director, Clinical Research Operations, Education & Training|919-681-7084|terry.ainsworth@duke.edu|
280268|NCT00742326|NIAID|Colleen Hadigan MD MPH|301-594-5754|hadiganc@niaid.nih.gov|
280269|NCT00742391|LEO Pharma|Dr. Torsten Skov|+4520736294|torsten.skov@leo-pharma.com|
280270|NCT00742417|Instituto Grifols S.A.|Mireia Torres|+34935710500|mireia.torres@grifols.com|12273
280271|NCT00742469|Valeant Pharmaceuticals|Valeant Pharmaceuticals|(866) 246-8245||
280272|NCT00742508|GlaxoSmithKline|GSK Response Center|866-435-7343||
280273|NCT00742560|AbbVie|Global Medical Services|800-633-9110||
280274|NCT00742573|New York State Psychiatric Institute|Mark Olfson, MD, MPH|646-774-6413|mark.olfson@nyspi.columbia.edu|
280275|NCT00742625|Massachusetts General Hospital Cancer Center|Eyal Attar, MD|617-724-1124|eattar@partners.org|
280276|NCT00742781|Pennsylvania State University|Dr. Margherita Cantorna|814-863-2819|mxc69@psu.edu|
280277|NCT00742859|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
280278|NCT00742872|American University of Beirut Medical Center|Dr. Ala Sharara|+961-3-350000|as08@aub.edu.lb|
280279|NCT00742885|GlaxoSmithKline|GSK Response Center|866-435-7343||
280280|NCT00742924|Children's Oncology Group|Results Reporting Coordinator|352-273-0558|resultsreportingcoordinator@childrensoncologygroup.org|
280281|NCT00742963|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
280282|NCT00743093|Denver Heatlh Rocky Mountain Poison and Drug Center|Jody Green, PhD|303-389-1246|jody.green@rmpdc.org|
280283|NCT00743106|Cleveland Clinic Foundation|Jerome O'Hara, MD|216-444-8278|oharaj@ccf.org|
280284|NCT00743119|New York State Psychiatric Institute|Dr. Ziva Cooper|646-774-6129|zc2160@cumc.columbia.edu|
280285|NCT00743145|New York State Psychiatric Institute|Margaret Haney, PhD|646-774-6153|mh235@cumc.columbia.edu|
280286|NCT00743249|Alcon Research, Ltd.|Theresa A. Landry, Ph.D.|1-888-451-3937|alcon.medinfo@alcon.com|
280287|NCT00743262|Netherlands Cancer Institute|Prof. Dr. F.J.M. Hilgers|+31-20-5252550|f.hilgers@nki.nl|
280288|NCT00743275|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
298869|NCT01846442|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
298870|NCT01846455|RECKITT BENCKISER PHARMACEUTICALS, INC.|Reckitt Benckiser Pharmaceuticals, Inc.|804-379-1090||
280289|NCT00743288|Oncotherapeutics|Director, Clinical Operations|323-623-1200|lthulin@oncotherapeutics.com|
280290|NCT00743340|Gilead Sciences|Clinical Trial Disclosures & Data Transparency|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
298871|NCT01846494|Duke Clinical Research Institute|Allison DeLong|919-668-6855|allison.delong@duke.edu|
280291|NCT00743366|New York State Psychiatric Institute|Dr. Ziva Cooper|646-774-6129|reslabsurc@gmail.com|
280292|NCT00743431|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280293|NCT00743444|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
280294|NCT00743483|Swedish Orphan Biovitrum|Maria Öhman, TA Clinical Head Neonatology|+46 70 694 81 61|maria.ohman@sobi.com|
280295|NCT00743509|University of Michigan|Scott Schuetze|734-647-8925|scotschu@umich.edu|
280296|NCT00743574|Yale University|Dr. Lubna Pal|203-737-5619|lubna.pal@yale.edu|
288949|NCT01217892|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
288950|NCT01217944|Novartis Pharmaceuticals|Study Director|862-778-8300||
288951|NCT01217957|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
298872|NCT01846507|Nationwide Children's Hospital|Sarah O'Brien, MD|614-722-3070|sarah.obrien@nationwidechildrens.org|
288952|NCT01218009|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
288953|NCT01218048|University of Pittsburgh Cancer Institute|Robert Ferris, MD, PhD|412-623-3205|ferrrl@upmc.edu|
288954|NCT01218087|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
288955|NCT01218100|Forest Research Institute|Manfred Stapff, MD, PhD|201-427-8000|Manfred.stapff@frx.com|
288956|NCT01218113|GlaxoSmithKline|GSK Response Center|866-435-7343||
288957|NCT01218126|GlaxoSmithKline|GSK Response Center|866-435-7343||
288958|NCT01218204|GlaxoSmithKline|GSK Response Center|866-435-7343||
288959|NCT01218243|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|Zhishun Liu, Director of the study|8610-010-88001124|liuzhishun@yahoo.com.cn|
288960|NCT01218308|GlaxoSmithKline|GSK Response Center|866-435-7343||
288961|NCT01218399|Astra Zeneca|Elena Pizzi|+1 302 885 2677|Elena.Pizzi@astrazeneca.com|
298873|NCT01846611|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
288962|NCT01218438|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
288963|NCT01218477|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
288964|NCT01218516|Morphotek (subsidiary of Eisai)|Morphotek (subsidiary of Eisai)|1-888-422-4743|esi_medinfo@eisai.com|
288965|NCT01218542|Emory University|Dr. Hui-Kuo Shu|404-778-2161|hgshu@emory.edu|
280297|NCT00743652|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280298|NCT00743717|Los Alamitos Orthopaedic Group|Dr. Perry Secor|805-384-2748|vsarin@kinamed.com|
280299|NCT00743730|Medical College of Wisconsin|Keri R. Hainsworth, PhD, Research Director|414-266-6306|khainswo@mcw.edu|
280300|NCT00744042|Alexion Pharma GmbH|Alexion Pharma GmbH||ClinicalTrials@alxn.com|
280301|NCT00744055|Yale University School Of Medicine Department of Psychiatry|Elizabeth Ralevski|2039325711|elizabeth.ralevski@yale.edu|4282
280302|NCT00744211|University of South Carolina SOM|Francis G. Spinale|803-777-3964|cvctrc@uscmed.sc.edu|
280303|NCT00744237|Forest Laboratories, Inc|Noah Rosenberg , MD, Exec. Dir, Clin Dev, Cardiovascular and Metabolism|2014278000|noah.rosenberg@frx.com|2133
280304|NCT00744263|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298874|NCT01846624|Stanford University Medical Center|David Joseph Iberri, MD; Clinical Assistant Professor (Hematology)|650-498-6000|diberri@stanford.edu|
280305|NCT00744328|Northwestern University|Research Study Coordinator|312-695-8441|emily.pinheiro@northwestern.edu|
280306|NCT00744380|University of Colorado|Robert MacLaren|303 724-2622|rob.maclaren@ucdenver.edu|
280307|NCT00744471|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280308|NCT00744497|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
288966|NCT01218594|Sun Yat-Sen University Cancer Center|Ming Chen|86-20-87343640|chenming@sysucc.org.cn|
288967|NCT01218646|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
288968|NCT01218659|Amicus Therapeutics|Medical Affairs|+1-877-426-4287 (877-4-AMICUS)|MedInfoUSA@amicusrx.com|
288969|NCT01218672|Boston Scientific Corporation|Teresa Takle-Flach, Director, Clinical Operations|(952)930-6000|teresa.takle-flach@bsci.com|
288970|NCT01218802|Case Western Reserve University|Grace McComsey, MD|2168442739|gam9@case.edu|
288971|NCT01218867|National Cancer Institute|Dr. Steven Rosenberg|301- 496-4164|sar@mail.nih.gov|
298875|NCT01846702|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
288972|NCT01218958|Alkermes, Inc.|Bernard L. Silverman, VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
288973|NCT01218971|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|bernard.silverman@alkermes.com|
288974|NCT01218984|Alkermes, Inc.|Bernard L. Silverman, VP, Clinical Development|781-609-6000|bernard.silverman@alkermes.com|
288975|NCT01218997|Alkermes, Inc.|Bernard L. Silverman|781-609-6000|bernard.silverman@alkermes.com|
288976|NCT01219738|University of Miami|Eliana Mendes|(305) 243-2568|e.mendes@miami.edu|
288977|NCT01219777|The Ohio State University Comprehensive Cancer Center|Ritu Salani, MD, MBA|614-293-3873|Ritu.Salani@osumc.edu|
288978|NCT01219855|OPKO Health, Inc.|Douglass Laidlaw, PhD, Vice President, Medical Affairs|305-575-4172|dlaidlaw@opko.com|
288979|NCT01219881|The Ohio State University|Dr. Joseph Werner|614-293-8487|Joseph.Werner@osumc.edu|
288980|NCT01219933|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
288981|NCT01219959|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
288982|NCT01219985|Centre Hospital-Universitaire d'Amiens|Pr. Marc-Etienne Meyer|+33 3 22 45 59 64|meyer.marc-etienne@chu-amiens.fr|
288983|NCT01220024|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
288984|NCT01220128|GlaxoSmithKline|GSK Response Center|866-435-7343||
288985|NCT01220167|Par Pharmaceutical|Medical Affairs|800-828-9393|DrugInfo@strativapharma.com|
288986|NCT01220180|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
288987|NCT01220297|Stanford Univesity|Laura Johnston, MD|650-723-0822|laura.johnston@stanford.edu|
288988|NCT01220401|University of Tulsa|Dr. Noelle Balliett|918-631-3976|noelle-balliett@utulsa.edu|
288989|NCT01220414|University of Wisconsin-Madison|Kelli F. Koltyn|608 262-4234|kelli.koltyn@wisc.edu|
288990|NCT01220466|Abbott Medical Optics|Amelia Saliba, Sr. Manager, Clinical Research|408-273-4158|amelia.saliba@amo.abbott.com|
288991|NCT01220557|Forschungsinstitut der Diabetes Akademie Mergentheim|Norbert Hermanns, PhD|+49 7931 594|hermanns@diabetes-zentrum.de|553
288992|NCT01220609|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
288993|NCT01220687|OUHSC College of Medicine, Pediatrics, Neonatal-Perinatal Medicine|Krishnamurhty Sekar, MD, Professor of Pediatrics|405-271-5215|kris-sekar@ouhsc.edu|
288994|NCT01220726|Weill Cornell Medical College|Dr. Alexis Te|646-962-4811|aet2005@med.cornell.edu|
288995|NCT01220739|University of California, San Diego|Dr. Thomas Hemmen|858-657-7190|themmen@ucsd.edu|
288996|NCT01220856|Dompé SpA|Luisa Daffonchio, PhD|+39 583831|daffonchio@dompe.it|
288997|NCT01220869|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
288998|NCT01220973|Rutgers Cancer Institute of New Jersey|Susan Goodin PharmD, FCCP, BCOP|732-235-6783|goodin@cinj.rutgers.edu|
288999|NCT01220999|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@lcr.org|
289000|NCT01221090|Scott & White Hospital|Dr. Samuel N. Forjuoh|(254) 771-7695|SFORJUOH@sw.org|
289001|NCT01221181|Columbia University Medical Center|Andrew Bomback, MD, MPH|212-305-0320|asb68@cumc.columbia.edu|
289002|NCT01221194|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
289003|NCT01221207|UT Southwestern Medical Center at Dallas|Lawrence Lavery, DPM, MPH|214-645-0544|Larry.Lavery@UTSouthwestern.edu|
289004|NCT01221233|University of Delaware, Department of Physical Therapy|Dr. Jaclyn Megan Sions, PhD, DPT, PT|302-831-7231|megsions@udel.edu|
289005|NCT01221272|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
289006|NCT01221285|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
289007|NCT01221298|AbbVie|Global Medical Services|800-633-9110||
280309|NCT00744523|Medtronic Aortic and Peripheral Vascular|Arslan Malik, Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
280310|NCT00744627|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
280311|NCT00744653|Copenhagen University Hospital Herlev|MD Louise Wichmann Matthiessen|+ 45 38 68 98 58|louise.wichmann.matthiessen@gmail.com|
280312|NCT00744692|Duke University Medical Center|Dr. Suhag Parikh|919-668-1100|suhag.parikh@dm.duke.edu|
280313|NCT00744757|Medical Affairs, Janssen Taiwan|Medical Director|+886-2-23761255||
280314|NCT00744796|University of Texas Southwestern Medical Center|Dr. Vinod Mootha|214-648-3837|peter.chen@utsouthwestern.edu|
280315|NCT00744848|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
280316|NCT00744861|Bioventus LLC|Manager Clinical Affairs|1-800-396-4325||
280317|NCT00744874|Medtronic AF Solutions|Linda Nelson, RN, BSN, MBA- AF Solutions Clinical Operations Director|(763)526-2891|linda.k.nelson@medtronic.com|
280318|NCT00744939|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
280319|NCT00744965|UT Southwestern Medical Center|Kenneth J. Leveno, MD|214-648-2316|kenneth.leveno@utsouthwestern.edu|
280320|NCT00744978|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280321|NCT00744991|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
280322|NCT00745095|JJPVAMC National Center of Excellence for the Medical Consequeunces of Spinal Cord Injury|Dr. Mark A. Korsten, Chief of Gastroenterology|718-584-9000|mark.korsten@va.gov|6753
280323|NCT00745121|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
280324|NCT00745251|Vivus, Inc|Wesley W. Day, PhD|650-934-5200|day@vivus.com|
280325|NCT00745290|Pacira Pharmaceuticals Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
280326|NCT00745368|University of Rochester|Robert DiCenzo|518 694 7228|rob.dicenzo@acphs.edu|
280327|NCT00745420|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
280328|NCT00745498|Seoul National University Bundang Hospital Department of Ophthalmology|Dr. Se Joon Woo|+82-31-787-7377|sejoon1@hanmail.net|
280329|NCT00745615|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
280330|NCT00745823|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1- 800-672-6372|ClinicalTrialsDisclosure@merck.com|
280331|NCT00745849|University of Texas Southwestern|Ganesh Shanmugam, MD|9797036112|ganesh01@yahoo.com|
280332|NCT00745875|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
280333|NCT00745901|North America Pharmaceutical (Ortho-McNeil Janssen Scientific Affairs, LLC)|Chief Scientific Officer|1-888-526-5060||2915
280334|NCT00745940|Lakehead University|Dr. Michel Bédard|807-343-8630|mbedard@lakeheadu.ca|
280335|NCT00746096|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
280336|NCT00746122|Imperial College London|Professor Janet Powell|44-2033117312|j.powell@imperial.ac.uk|
280337|NCT00746187|DENTSPLY Implants|Senior Manager Global Clinical Research|+46313763500|clinicalresearchmolndal@dentsply.com|
280338|NCT00746252|University of Marylland, Baltimore|Gloria M. Reeves, M.D.|410-706-3522|greeves@psych.umaryland.edu|
280339|NCT00746330|Novartis Pharmaceuticals|Study Director|862-778-8300||
280340|NCT00746356|St. Jude Medical|Ashish Oza, Clinical Studies Director|818 362 6822|aoza@sjm.com|3648
280341|NCT00746395|University of South Alabama|Jack A. DiPalma, M.D.|251-660-5555|jdipalma@usouthal.edu|
280342|NCT00746421|Emory University|Jeffrey Rakofsky, MD|404-712-5083|jrakofs@emory.edu|
280343|NCT00746512|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280344|NCT00746551|Mahidol University, Department of Obstetrics and Gynaecology, Division of Maternal Fetal Medicine, Faculty of Medicine, Siriraj Hospital|Pharuhas Chanprapaph|+66819920053|pharuhasc@gmail.com|
280345|NCT00746564|St. Jude Medical|Director, Clinical Studies|1-800-733-3455|tshipman@sjm.com|
280346|NCT00746668|Jesse Brown VAMC|Dr. Janet P. Szlyk, PhD|312-997-3644|Janet.Szlyk@va.gov|
280347|NCT00746694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280348|NCT00746733|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
280349|NCT00746785|The Mind Reseach Network|Kent Hutchison, Ph.D.|505-272-5028|khutchison@mrn.org|
280350|NCT00746798|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
280351|NCT00746863|UNC Hospitals|Gena Dunivan, MD|919-966-4717|gdunivan@med.unc.edu|
280352|NCT00746889|UCSD|Jeannie Chao|858-657-7040|j5chao@ucsd.edu|
280353|NCT00746941|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
280354|NCT00746954|Louis Stokes DVA Medical Center|Kingman P. Strohl MD|216-7913800|kingman.strohl@va.gov|
280355|NCT00747006|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
280356|NCT00747149|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
280357|NCT00747214|Zalicus|Margaret Lee, PhD|617-301-7142|mlee@zalicus.com|
280358|NCT00747227|Abbott medical Optics, Inc.|Nicholas Taranatino, O.D., Head, Global Clinical Research & Devlopment|866-427-8477|nicholas.tarantino@amo.abbott.com|8613
280359|NCT00747344|Janssen Research & Development, LLC|Director, Clinical Research|215-793-7646||
280360|NCT00747435|MED-EL Corporation|Sr. Clinical Research Associate||clinicaltrials@medelus.com|
289008|NCT01221311|Medical University of South Carolin|Gregory Cote|843-876-4261|cotea@musc.edu|
289009|NCT01221350|Centro Universitario de Ciencias de la Salud, Mexico|Fernando R Siller Lopez, Ph.D.|523310585200|fsiller@cucs.udg.mx|33723
289010|NCT01221363|Research Centre for Prevention and Health|Mette Aadahl|+45 38663359|mette.aadahl@regionh.dk|
289011|NCT01221441|TissueGene, Inc|R. Ogden Copeland|(301) 921-6000|ocopeland@tissuegene.com|122
289012|NCT01221597|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
289013|NCT01221623|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
280361|NCT00747474|Taiwan Liposome Company, Ltd.|Shu Chi Hsu|650-872-8816|shuchi@tlcbio.com|102
280362|NCT00747552|University of Utah|Donald Null M.D.|801.588-3865|donald.null@imail.org|
280363|NCT00747565|Abbott Medical Optics, Inc.|Nicholas Tarantino, O.D., Head, Global Clinical Research & Development|866-427-8477|nicholas.tarantino@amo.abbott.com|8613
280364|NCT00747617|UCSD School of Medicine|R. Jeffrey Chang, M.D.|858-534-8930|rjchang@ucsd.edu|
280365|NCT00747643|H. Lee Moffitt Cancer Center and Research Institute|Thomas H. Brandon, Ph.D.|813-745-1750|thomas.brandon@moffitt.org|
280366|NCT00747747|Galsor s.r.l.|Dr. Sandro Soriano/Director of Clinical Trials|0039 0827 601723|sandro.soriano@galsor.it|
280367|NCT00747812|Boston Scientific|Lyn Pimentel, Clinical Project Manager|(661) 949-4174|Lyn.Pimentel@bsci.com|
298876|NCT01846728|University of Colorado Anschutz Medical Campus|Edward Melanson, PhD|303-724-0935|ed.melanson@cuanschutz.edu|
280368|NCT00748033|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
280369|NCT00748072|University of Bari|Dr. Carlo Manno|390805478878|c.manno@nephro.uniba.it|
280370|NCT00748098|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
280371|NCT00748189|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
280372|NCT00748215|University of Texas (UT) MD Anderson Cancer Center|Bryan Kee, MD/Assistant Professor, GI Medical Oncology|713-792-2828|bkkee@mdanderson.org|
280373|NCT00748241|Astra Tech AB|Head of Clinical Research Area Dental|+46317763000||
280374|NCT00748410|GlaxoSmithKline|GSK Response Center|866-435-7343||
280375|NCT00748540|MED-EL Corporation|Allison Racey, AuD|888-633-3524|allison.racey@medel.com|
280376|NCT00748553|Huntsman Cancer Institute|Kimberlee Taylor|8012135673|Kimberlee.Taylor@hci.utah.edu|
280377|NCT00748566|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280378|NCT00748657|NRG Oncology Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
298877|NCT01846741|Cyberonics, Inc.|Bita Najimipour, Clinical Study Manager|(281) 228-7370|bita.najimipour@cyberonics.com|
280379|NCT00748709|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
280380|NCT00748826|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280381|NCT00748865|Alcon Research Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280382|NCT00748956|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-659-9145|adriana.feder@mssm.edu|
308922|NCT02625220|Johnson & Johnson Vision Care Inc.|Benjamin Straker, BAppSc(Optom)(HonS) Principal Research Optometrist|904-443-3500|Bstraker@ITS.JNJ.com|1380
280383|NCT00748969|LA Biomed at Harbor-UCLA Medical Center|Dr. Lynda Polgreen|310-222-1972|lpolgreen@labiomed.org|
280384|NCT00748982|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
308923|NCT02625233|Johson & Johnson Vision Care Inc.|Kristy Canavan, O.D., FAAO Principal Research Optometrist|904 443-1474|KCANAVA2@its.jnj.com|
280385|NCT00749073|Vertos Medical|VP Clinical, Regulatory, Quality|9493490008|cmyers@vertosmed.com|216
280386|NCT00749125|University of Pennsylvania|Yvette Sheline|215-573-0082|sheline@pennmedicine.upenn.edu|
280387|NCT00749190|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
280388|NCT00749203|Icahn School of Medicine at Mount Sinai|Dr. Adriana Feder|212-241-1563|adriana.feder@mssm.edu|
280389|NCT00749268|Covidien|Jessica Carlson, Clinical Project Manager|(203) 821-4734|jessica.carlson@covidien.com|
280390|NCT00749398|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280391|NCT00749411|GlaxoSmithKline|GSK Response Center|866-435-7343||
280392|NCT00749463|J&J Consumer and Personal Products Worldwide|Joyce Hauze, Sr Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
280393|NCT00749515|St. Jude Children's Research Hospital|Ellis Neufeld, MD, PhD|901-595-7509|ellis.neufeld@stjude.org|
280394|NCT00749580|USF Health|Charurut Somboonwit, MD|813 3078067|csomboon@health.usf.edu|
280395|NCT00749606|SUNY Upstate Medical University|Ruth S. Weinstock MD PhD|315-464-5740|weinstor@upstate.edu|
280396|NCT00749671|Baystate|James R. Cook MD|413-794-4492|james.cook@bhs.org|
289014|NCT01221727|Amgen Inc.|Study Director|866-572-6436||
289015|NCT01221753|Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA02215|Robert Haddad, MD|617-632-3090|robert_haddad@dfci.harvard.edu|
289016|NCT01221857|Gamida Cell|Kelly Myers|+972-2-659-5631|clinicaltrials@gamida-cell.com|
289017|NCT01221948|Bostons Scientific Neuromodulation|Nic Van Dyck, Director International Clinical Operations|+31 43 3568328|vandyckn@bsci.com|
289018|NCT01222078|GlaxoSmithKline|GSK Response Center|866-435-7343||
289019|NCT01222091|Stanford University School of Medicine|Dr. Larry Chu|(650) 723-6632|lchu@stanford.edu|
289020|NCT01222104|St Jude Medical|Andrew Campbell|651-756-5538|acampbell2@sjm.com|
289021|NCT01222117|Grifols Therapeutics|Kimberly Steinmann, MD|919-308-5444|kimberly.steinmann@grifols.com|
289022|NCT01222195|The University of Texas M. D. Anderson Cancer Center|Gautam Borthakur, MBBS / Assistant Professor|713-792-7305|eharriso@mdanderson.org|
289023|NCT01222234|University of Kansas Medical Center|Dr. Jason Stubbs|913-588-9252|jstubbs@kumc.edu|
289024|NCT01222260|Columbia University Medical Center|Suzanne Lentzsch, M.D., PhD.|212-304-5485|sl3440@cumc.columbia.edu|
289025|NCT01222273|Children's Hospital of Pittsburgh of UPMC|Joseph M. Pilewski, MD|(412) 692-2164|pilewskijm@upmc.edu|
289026|NCT01222286|Innate Pharma|Dr Renaud Buffet|33 4 30 30 30 32|renaud.buffet@innate-pharma.fr|
289027|NCT01222299|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
289028|NCT01222390|Northwestern University|John Y.S. Kim, MD|312-695-0208|jokim@nmh.org|
298878|NCT01846871|Massachusetts General Hospital|Dr. Elizabeth Gerstner|617-724-8770|EGERSTNER@mgh.harvard.edu|
298879|NCT01846988|Cincinnati Children's Hospital Medical Center|Dr. Neepa Gurbani, Assistant Professor|(513) 736-1814|Neepa.Gurbani@cchmc.org|
298880|NCT01847001|Columbia University Medical Center|Dr. Kevin Kalinsky|212-305-1925|cancerclinicaltrials@cumc.columbia.edu|
280397|NCT00749684|Merck Sharp and Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
280398|NCT00749749|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|Innocoll|484-406-5211|ctucker@innocoll.com|
280399|NCT00749775|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298881|NCT01847014|Actelion Pharmaceuticals US, Inc.|Scott Tsurutani|6508086586|scott.tsurutani@actelion.com|
280400|NCT00749879|Repros Therapeutics Inc, an Allergan Affiliate|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
280401|NCT00749892|UT MD Anderson Cancer Center|Dr. Arlene O. Siefker-Radtke,Professor, Genitourinary Medical Oncology|(713) 792-2830|asiefker@mdanderson.org|
280402|NCT00749931|Dune Medical Devices|Clinical Research Manager|+97246178000|shiri@dunemedical.com|
280403|NCT00749944|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280404|NCT00749957|Applied Genetic Technologies Corporation|Chief Medical Officer|386-462-2204|jchulay@agtc.com|7205
280405|NCT00749996|Medtronic Spinal & Biologics|Irène Ayer, Clinical research specialist|+41 21 803 84 27|irene.ayer@medtronic.com|
280406|NCT00750061|China Spinal Cord Injury Network|Dr. Wendy Cheng|+852 28660829|wendycheng@chinasci.net|
280407|NCT00750139|Merz Pharmaceuticals, LLC|Associate Medical Director- Dermatology|800-334-0514||
280408|NCT00750152|Merz Pharmaceuticals, LLC|Merz Pharmaceuticals, LLC|800-334-0514||
280409|NCT00750165|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 9 574 0123|cpaptrial@fphcare.co.nz|7044
280410|NCT00750191|The Center for Clinical Research|Dr. Leonard Kapural|1-336-765-6181|LKapural@ccrpain.com|
280411|NCT00750269|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
280412|NCT00750282|Piramal Imaging|Dr. Juergen Hirschfeld|49 30 461 1246 15|juergen.hirschfeld@piramal.com|
280413|NCT00750308|Vanderbilt University|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
280414|NCT00750360|GlaxoSmithKline|GSK Response Center|866-435-7343||
280415|NCT00750373|Asan Medical Center|Dr. Duk-Hyun Kang|82-2-3010-3149|dhkang@amc.seoul.kr|
280416|NCT00750438|Imperial College London|Prof Gary Frost|+44 (0)20 7594 0959|g.frost@imperial.ac.uk|
280417|NCT00750737|University of Texas (UT) MD Anderson Cancer Center|Issam Raad, MD / Chair, Infectious Diseases|713-792-7943|CR_Study_Registration@mdanderson.org|
280418|NCT00750815|H. Lee Moffitt Cancer Center and Research Institute|Melissa Alsina, M.D.|813-745-6886|melissa.alsina@moffitt.org|
280419|NCT00750867|University of Massachusetts Medical School|Dr.Peter Novak|508-334-4973|novakp@ummhc.org|
280420|NCT00750880|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
280421|NCT00750893|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
298882|NCT01847027|University of North Texas Health Science Center|Meharvan Singh, PhD|8177355429|meharvan.singh@unthsc.edu|
280422|NCT00750919|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280423|NCT00751023|Medical University of South Carolina|Bryan K. Tolliver, MD PhD|843-792-4869|tollive@musc.edu|
280424|NCT00751036|Novartis Pharmaceuticals|Study Director|862-778-8300||
289029|NCT01222403|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
298883|NCT01847092|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
298884|NCT01847131|Faculty of Medicine Siriraj Hospital, Mahidol University|Torpong Thongngarm, M.D.|66-2-419-8263|torpong.tho@mahidol.ac.th|
298885|NCT01847196|BiO2 Medical|Margaret Tumas, VP of Clinical Affairs|720-635-3232|mtumas@bio2medical.com|
298886|NCT01847209|Brigham and Women's Hospital|Dr. Raphael Bueno|617-732-8148|rbueno@partners.org|
298887|NCT01847313|University College Dublin|Prof Carel le Roux|+353 1 716 6831|carel.leroux@ucd.ie|
298888|NCT01847430|GlaxoSmithKline|GSK Response Center|866-435-7343||
298889|NCT01847443|GlaxoSmithKline|GSK Response Center|866-435-7343||
298890|NCT01847469|Yale University School of Medicine, VA Connecticut Healthcare System|Dr. Ismene Petrakis|(203) 932-5711|ismene.petrakis@yale.edu|
298891|NCT01847547|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298892|NCT01847560|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298893|NCT01847638|Toyos Clinic|Melissa Toyos|6153274015|mtoyos@toyosclinic.com|
298894|NCT01847755|Jupiter Medical Center|Dr. Barry Miskin|561-263-5791|clinicaltrials@jupitermed.com|
298895|NCT01847885|SPR Therapeutics|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
298896|NCT01848041|RVL Pharmaceuticals|Sr. Director, Clinical Development|908-809-1423|mvelasco@osmotica.com|
298897|NCT01848054|PRA International|Lynn R. Webster, MD|801-892-5140|LRWebsterMD@gmail.com|
298898|NCT01848067|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Jianqing Lin|(215) 955-8874|jianqing.lin@jefferson.edu|
298899|NCT01848145|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|Charles.Davis2@scri-innovations.com|
298900|NCT01848158|Seattle Children's Hospital|Jane Di Gennaro, MD MS|206-987-6988|jane.digennaro@seattlechildrens.org|
308924|NCT02625259|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
298901|NCT01848184|Medtronic|Michelle DiSalvo|774 284 6089|michelle.v.disalvo@medtronic.com|
298902|NCT01848210|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
280425|NCT00751101|University of California, San Francisco|Dr. Hope Rugo, MD|(415) 353-7618|Hope.Rugo@ucsf.edu|
289030|NCT01222416|Vanderbilt-Ingram Cancer Center|A Bapsi Chakravarthy, MD Program Director, Radiation Oncology|615-322-2555|babsi.chak@vanderbilt.edu|
289031|NCT01222494|Washington University|Dr. Ginger Nicol|314-362-2461|nicolg@wustl.edu|
289032|NCT01222507|Washington University|Dr. Jay Piccirillo|314-362-7508|piccirilloj@ent.wustl.edu|
289033|NCT01222520|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
280426|NCT00751114|sanofi-aventis|Trial Transparency Team||Contact-US@sanofi.com|
280427|NCT00751140|H. Lee Moffitt Cancer Center and Research Institute|Philippe E. Spiess, M.D.|813-745-8343|philippe.spies@moffitt.org|
280428|NCT00751179|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280429|NCT00751296|University Health Network - Princess Margaret Cancer Centre|Dr. Christine Chen|416-946-2827|Christine.Chen@uhn.ca|
280430|NCT00751348|GlaxoSmithKline|GSK Response Center|866-435-7343||
280431|NCT00751400|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
280432|NCT00751530|Community Research Initiative|Project Manager|617 502 1700|pmacht@crine.org|
280433|NCT00751621|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
280434|NCT00751634|Northwestern University|Dr. Andrew Naidech|312-503-3335|a-naidech@northwestern.edu|
280435|NCT00751777|Valneva Austria GmbH|Head Clinical Development|0043120620|info@valneva.com|0
280436|NCT00751790|Debiopharm S.A.|Eija Lundström|+41 21 3210111|elundstrom@debiopharm.com|
280437|NCT00751881|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
280438|NCT00751972|HeartWare Inc|Director Clinical Project Management|508 739-0867|sbell@heartwareinc.com|
280439|NCT00751998|Boston Scientific Corporation|Joyce Peetermans, PhD, Director Endoscopy Clinical|508-683-4211|peetermj@bsci.com|
280440|NCT00752089|GlaxoSmithKline|GSK Response Center|866-435-7343||
280441|NCT00752102|Joslin Diabetes Center|Dr. Sylvia Rosas|617-309-2477|sylvia.rosas@joslin.harvard.edu|
280442|NCT00752128|Medtronic Bakken Research Center B.V.|Marianne Wanten|+3143356|marianne.wanten@medtronic.com|6815
280443|NCT00752206|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
280444|NCT00752219|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298903|NCT01848288|Alcon Research, Ltd.|Doug Fanney, Director, Global Medical Affairs, Cataract Instrumentation|1-888-451-3937|alcon.medinfo@alcon.com|
280445|NCT00752232|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280446|NCT00752557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280447|NCT00752609|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
280448|NCT00752622|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280449|NCT00752726|GlaxoSmithKline|GSK Response Center|866-435-7343||
280450|NCT00752791|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
280451|NCT00752856|UCSD|Sheldon Morris|8583364088|shmorris@ucsd.edu|
280452|NCT00752895|Wake Forest NCORP Research Base|Dr. Doug Case|(336) 716-1048|dcase@wakehealth.edu|
280453|NCT00752908|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
280454|NCT00752973|Taro Pharmaceuticals U.S.A., Inc.|Director, Clinical Research|914 345 9001|natalie.yantovskiy@taro.com|
280455|NCT00753012|Massachusetts General Hospital|Dr. Paul Hammerness|(503)617-1040|phammerness@partners.org|
280456|NCT00753142|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
280457|NCT00753220|Prostate Institute of America|Dr. Duke K. Bahn|888-234-0004|DKBahn@CMHhospital.org|
280458|NCT00753272|GlaxoSmithKline|GSK Response Center|866-435-7343||
298904|NCT01848353|University of Oklahoma Health Sciences Center|Kevin Short, PhD, Associate Professor|(405) 271-8001|kevin-short@ouhsc.edu|43094
280459|NCT00753298|Astra Tech AB|Head of Therapeutic Area Health Care|+46317763000||
280460|NCT00753337|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
298905|NCT01848366|William Beaumont Hospital|Dr. Kenneth Peters|248-551-0387|Kenneth.Peters@Beaumont.org|
280461|NCT00753363|Baltimore VAMC|Dr. Alice Ryan|410-605-7851|aryan@grecc.umaryland.edu|
280462|NCT00753415|Merck Sharpe & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280463|NCT00753454|UCB Clinical Trial Call Center|UCB (Study Director)|1-887-822-9493||
280464|NCT00753506|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
280465|NCT00753519|Department of Neurology, Centre Hospitalier Universitaire Vaudois|David H. Benninger, MD||David.Benninger@chuv.ch|
280466|NCT00753545|AstraZeneca|Elizabeth Lowe||ClinicalTrialTransparency@astrazeneca.com|
280467|NCT00753623|MGH Center for Translational Pain Research|Dr. Jianren Mao|617-724-6102|mghpainresearch@partners.org|
280468|NCT00753636|Northwestern University|Dr. Tanya Simuni, MD|312-503-2970|tsimuni@nmff.org|
280469|NCT00753649|GlaxoSmithKline|GSK Response Center|866-435-7343||
280470|NCT00753675|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
280471|NCT00753688|GlaxoSmithKline|GSK Response Center|866-435-7343||
280472|NCT00753714|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
280473|NCT00753766|VA Boston Healthcare System|Paul R. Conlin, M.D.|8572035111|paul.conlin@va.gov|
280474|NCT00753896|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
280475|NCT00753922|Ethicon Endo-Surgery|Michael L. Schwiers|513-337-1172|mschwier@its.jnj.com|
280476|NCT00753935|Vanderbilt_University MC|John A. Oates, MD|615 4343 4847|john.oates@vanderbilt.edu|
280477|NCT00753948|James J. Peters VAMC|Joshua Hobson|(718) 584-9000|joshua.hobson@va.gov|3129
280478|NCT00754065|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
280479|NCT00754130|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280480|NCT00754156|University of Kentucky Medical Center|Phillip Chang, M.D. PI or Anna Rockich, Pharm.D. GSRP Director|859-323-6346|arockich@uky.edu|247
280481|NCT00754208|University of Nebrasa Medical Center|Joan Daughton, MD|4025526006|jdaughton@childrensomaha.org|
280482|NCT00754234|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
280483|NCT00754247|University of Miami|Dr. Robert Kirsner|305-243-4472|RKirsner@med.miami.edu|
280484|NCT00754325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
298906|NCT01848457|The Children's Hospital of Philadelphia|Frank Balis, MD|2674265414|balisf@email.chop.edu|
280485|NCT00754338|Centre for Contact Lens Research|Craig A Woods, Research Manager|1 519 888 4567|cawoods@sciborg.uwaterloo.ca|36547
280486|NCT00754377|Louis Stokes VA Medical Center|Dr. David Aron|(216) 791-2300|david.aron@va.gov|5836
280487|NCT00754390|United States Department of Agriculture (USDA) Grand Forks Human Nutrition Research Center|Brenda Ling|701-795-8300|brenda.ling@ars.usda.gov|
280488|NCT00754442|University of Maryland School of Medicine|Elizabeth A Streeten, MD|410-328-6219|estreete@medicine.umaryland.edu|
298907|NCT01848483|Emory University|Marcia McDonnell Holstad|404-727-1307|nurmmcd@emory.edu|
280489|NCT00754468|University of Miami|Dr. Alfonso Ribeiro|305-243-4000|Aribeiro@med.miami.edu|
280490|NCT00754494|University of California, Irvine|Dr. Timothy R. Morgan|562-826-5756|timothy.morgan@va.gov|
280491|NCT00754546|Dartmouth-Hitchcock Medical Center|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
280492|NCT00754559|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
280493|NCT00754572|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
280494|NCT00754624|MannKind Corporation|Chief Medical Officer|201-983-5000|aboss@mannkindcorp.com|
280495|NCT00754650|Hoffmann-La Roche|Medical Communications|800 821-8590||
298908|NCT01848756|Esanex Inc|Eric Orlemans, Chief Scientific Officer|919-338-2019|eorlemans@esanexpharma.com|
280496|NCT00754741|Henry Ford Health System|L. Keoki Williams, MD, MPH|313-874-5454|chphsr@hfhs.org|
289034|NCT01222533|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289035|NCT01222572|Dana-Farber Cancer Institute/Brigham and Women's Hospital|Raymond Mak, MD|6177328651|rmak@partners.org|
289036|NCT01222585|Duke Clinical Research Institute|Michael Cohen-Wolkowiez, MD|919668-8812|michael.cohenwolkowiez@dm.duke.edu|
289037|NCT01222689|university of california san francisco|Dr. Andrew Ko, MD|415-353-7286|Andrew.Ko@ucsf.edu|
289038|NCT01222715|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
289039|NCT01222767|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
289040|NCT01222832|SEMC|Peter catalano|617-789-5004|peter.catalano@steward.org|
289041|NCT01222884|Pharmacosmos A/S|Vice President Research & Development Department|+45 59485959|llt@pharmacosmos.com|
289042|NCT01223027|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registry@novartis.com|
298909|NCT01848821|Massachusetts General Hospital|Dr. Daniel Dante Yeh, Assistant Professor of Surgery|617-724-8604|dyeh2@partners.org|
289043|NCT01223183|University of Pittsburgh|Tim Corcoran|412-624-8918|corcorante@upmc.edu|
289044|NCT01223196|UT Health Science Center San Antonio|Franco Folli, MD PhD/Professor|210-567-4826|FOLLI@uthscsa.edu|
289045|NCT01223235|Memorial Sloan Kettering Cancer Center|Dr. Paul Sabbatini, MD|212-639-4016|sabbatip@mskcc.org|
289046|NCT01223352|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk||clinical-trials-disclosure@actelion.com|
298910|NCT01848834|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289047|NCT01223365|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
289048|NCT01223378|Bausch & Lomb|H DeCory, PhD|585-338-8161|heleen.decory@bausch.com|
298911|NCT01848847|namik kemal university|cem celik|905324205365|cemcel@yahoo.com|
298912|NCT01848899|NYU Langone Medical Center|Binita Shah|212-263-4235|binita.shah@nyumc.org|
298913|NCT01848938|Umeå University, Umeå, Sweden|Dr. Eva Samuelsson|+46706966440|eva.samuelsson@umu.se|
298914|NCT01848977|Seoul National University Hospital|Jin-Tae Kim|82-10-6260-8490|jintae73@gmail.com|
298915|NCT01848990|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
298916|NCT01849055|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
308925|NCT02625298|Faculty of Dentistry, University of Belgrade|Dr. Dejan Markovic, professor at Clinic for Pediatric and Preventive Dentistry|+381600203041|dejan.markovic@stomf.bg.ac.rs|
298917|NCT01849068|Laval University|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
298918|NCT01849172|Guang'an Men Hospital, China Academy of Chinese Medical Sciences|Dr.Zhishun Liu|+86 01088002331|liuzhishun@aliyun.com|
298919|NCT01849276|Northwestern University|Dr. Jessica Altman|312-503-1761|J-altman@northwestern.edu|
298920|NCT01849289|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
298921|NCT01849419|University of Chicago|Dr. Harriet de Wit|(773) 702-3560|hdew@uchicago.edu|
298922|NCT01849458|Tornier Inc.|Marcela Bravo|9526837481|marcela.bravo@tornier.com|
298923|NCT01849497|Amgen Inc.|Study Director|866-572-6436||
298924|NCT01849562|Achillion Pharmaceuticals|Kevin Kucharski, VP of Clinical Operations|203-624-7000|Kkucharski@achillion.com|
298925|NCT01849575|Umea University, Sweden|Dr Margareta Norberg|+46907865544|margareta.norberg@umu.se|
298926|NCT01849588|Massachusetts General Hospital|Dr. Andrew Zhu|617-724-4000|azhu@partners.org|
298927|NCT01849692|Alcon Research, Ltd.|Clinical Project Group Leader, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
298928|NCT01849770|University of Washington|Michael D. Weiss, MD|206-598-7688|mdweiss@uw.edu|
298929|NCT01849822|California Institute of Technology|Dr. Richard Andersen|16263958336|andersen@vis.caltech.edu|
298930|NCT01849848|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1127||
308926|NCT02625324|Medtronic|Katrin Dias - Clinical Study Manager|707-525-0111|katrin.a.dias@medtronic.com|
298931|NCT01849874|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298932|NCT01850030|Abbott|Erik van Leeuwen MSc, PMP|+31294479241|erik.vanleeuwen@abbott.com|
280497|NCT00754832|Oregon Health & Science University|Dr. Michelle Cameron|503-418-1971|cameromi@ohsu.edu|
280498|NCT00754845|Canadian Cancer Trials Group|Senior Biostatistician|6135336430|dtu@ctg.queensu.ca|
280499|NCT00754923|OSU|Miguel Villalona|614-366-5068|miguel.villalona@osumc.edu|
280500|NCT00754936|Weill Cornell Medicine|George S Alexopoulos|914-997-5767|gsalexop@med.cornell.edu|
280501|NCT00755040|Vanderbilt Ingram Cancer Center|Madan Jagasia, M.D.|(615) 936-8422|madan.jagasia@vanderbilt.edu|
280502|NCT00755079|VAHSRD|Joshua Hobson, MS|(718) 584-9000|joshua.hobson@va.gov|3129
280503|NCT00755105|USDA Grand Forks Human Nutrition Research Center|Janet Hunt, PhD|701-795-8353|janetrhunt@gmail.com|
280504|NCT00755131|University of Naples Federico II|Prof. Carlo Vigorito, Director Cardiac Rehabilitation Unit, Federico II University|+39081746|vigorito@unina.it|2639
280505|NCT00755183|Andover Eye|Dr. Mark Abelson|9784750705||
298933|NCT01850394|Faculty of Medicine, Ramathibodi Hospital, Mahidol University|Dr. Paphon Sa-ngasoongsong|66-2-2011589|chan3s@hotmail.com|
280506|NCT00755196|Pfizer,Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280507|NCT00755222|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
280508|NCT00755235|Group Health Research Institute|Gregory Simon, Principal Investigator|206-287-2979|simon.g@ghc.org|
280509|NCT00755274|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
280510|NCT00755326|University of Maryland Center for Integrative Medicine|Brian M. Berman|410706-6181|bberman@som.umaryland.edu|
280511|NCT00755417|Depomed|Head of Research & Development|650-462-5900|msweeney@depomed.com|108
280512|NCT00755716|UConn Health|Dr. Cheryl Oncken|860-679-3425|oncken@uchc.edu|
280513|NCT00755755|PregLem S.A.|Dr Elke Bestel|+41 22 884 03 40|medical@preglem.com|
280514|NCT00755807|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
280515|NCT00755846|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
280516|NCT00755911|University of Michigan|Darnell Kaigler|734-998-1468|dkaigler@umich.edu|
289049|NCT01223404|University of Maryland School of Medicine|Dr. Britta Hahn|4104026112|bhahn@mprc.umaryland.edu|
289050|NCT01223469|St. Jude Medical/Endosense|Hendrik Lambert PhD, VP of Clinical and Regulatory Affairs||Hendrik.Lambert@endosense.com|
289051|NCT01223703|Department of Experimental and Applied Medicine-Section of Cardiovascular Diseases|Dr Savina Nodari|00390303996|nodari@med.unibs.it|587
289052|NCT01223937|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
289053|NCT01223963|Q-Med AB|Chief Medical Officer|+46 18 4749000|reception.seupp@galderma.com|
289054|NCT01224015|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
289055|NCT01224145|Innocoll|Charlene A. Tucker, MS Executive Director, Medical Writing and Document Management|484-406-5211|ctucker@innocoll.com|
289056|NCT01224158|Johnson & Johnson Consumer and Personal Products Worldwide|Director Oral Health, Medical Affair & Clinical Research|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
289057|NCT01224171|Millennium Pharmaceuticals Inc.|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
289058|NCT01224210|Tufts Medical Center|Ioana Preston MD|617-636-7609|ipreston@tuftsmedicalcenter.org|
289059|NCT01224236|University of Texas Health Science Center - Houston|Kathleen Kennedy|+1 (713) 500-5651|Kathleen.A.Kennedy@uth.tmc.edu|
289060|NCT01224431|Phoenix Children's Hospital|Angelique Ferayorni|602-546-1910|aferayorni@phoenixchildrens.com|
289061|NCT01224444|White River Junction VA|Heiko Pohl|802-295-9363|heiko.pohl@dartmouth.edu|5595
289062|NCT01224626|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289063|NCT01224639|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
298934|NCT01850446|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
289064|NCT01224678|University of Vermont|Marie E. Wood, M.D|802-656-5452|marie.wood@uvm.edu|
289065|NCT01224782|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
289066|NCT01224821|GlaxoSmithKline|GSK Response Center|866-435-7343||
289067|NCT01224925|UiT The Arctic University of Norway (Tromsø university)|Associate professor Rita Kundzina|+4777649118|rita.kundzina@uit.no|
289068|NCT01225029|Icahn School of Medicine at Mount Sinai|Dr. Annemarie Stroustrup|212-241-6186|annemarie.stroustrup@mssm.edu|
289069|NCT01225055|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
289070|NCT01225068|Northwestern University Feinberg School of Medicine|Thomas J Schnitzer|3125032315|tjs@northwestern.edu|
289071|NCT01225146|Retina Consultants of Houston|David M. Brown, MD|713-524-3434|dmbmd@houstonretina.com|
289072|NCT01225159|Department of Anesthesiology, Faculty of Medicine, Prince of Songkla University, Hat Yai, Songkhla 90110, Thailand|Dr.Panthila Rujirojindakul, Staff|+66 74 45 1651|rpanthi@medicine.psu.ac.th|
289073|NCT01225172|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
289074|NCT01225211|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
289075|NCT01225250|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
289076|NCT01225263|BIDMC|Catherine Buettner, MD MPH|617-754-9600|cbuettne@bidmc.harvard.edu|
289077|NCT01225289|Tehran University of Medical Sciences|The Study of the Effects of Vitamin A Supplementation on Immune System and Th1/Th2 Balance in Patien|+98 912 2182815|sjafarirad@gmail.com|
289078|NCT01225354|DeNova Research|Jack Arkins, Data Manager|312-335-2070|jack@drdayan.com|
289079|NCT01225549|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
289080|NCT01225562|AstraZeneca AB|Anders Himmelmann, MD PhD|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
289081|NCT01225731|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289082|NCT01225822|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
280517|NCT00755937|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280518|NCT00756002|Takeda Global Research & Development Center, Inc.|Sr VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
280519|NCT00756093|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280520|NCT00756106|Massachusetts General Hospital|Dr. Elizabeth Gerstner||EGERSTNER@mgh.harvard.edu|
280521|NCT00756236|Department of Anesthesia. OUHSC|Dr. Mehmet Ozcan, MD|405-271-4351|mehmet-ozcan@ouhsc.edu|
280522|NCT00756275|Brown University|Damaris Rohsenow, PhD|401-863-6665|Damaris_Rohsenow@brown.edu|
280523|NCT00756314|IMIP - Instituto Materno Infantil Prof. Fernando Figueira|Ana Laura Carneiro Gomes Ferreira - MD|+558121224779|analaura@imip.org.br|
280524|NCT00756444|Amgen Inc.|Study Director|866-572-6436||
280525|NCT00756457|Ithaca College|Jeff Houck, PhD|585-340-9619|jhouck@ithaca.edu|
280526|NCT00756470|University of Texas (UT) MD Anderson Cancer Center|Ricardo Alvarez, MD/Breast Medical Oncology|713-792-2817|CR_Study_Registration@mdanderson.org|
280527|NCT00756496|Siemens Medical Solutions USA, Inc.|Milind Dhamankar|+1 (610) 448-6467|milind.dhamankar@siemens-healthineers.com|
280528|NCT00756548|Braintree Laboratories, Inc.|John McGowan, Director, Clinical Research|781-843-2202|jmcgowan@braintreelabs.com|
280529|NCT00756561|University of Washington, Dept. of Medicine|Mara Roth, MD|(206) 221-0519|mylang@u.washington.edu|
280530|NCT00756600|Boston Children's Hospital Anesthesia Foundation|Dr Mary Ellen McCann|6173557737|mary.mccann@childrens.harvard.edu|
280531|NCT00756613|VA|Tamara Paine|7082028387|tamara.paine@va.gov|25785
280532|NCT00756652|Mentor Worldwide, LLC|Sponsor|949-453-6408|mgpas@its.jnj.com|
280533|NCT00756678|Allergan, Inc|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
280534|NCT00756717|Loyola University Medical Center|Dr. Kathy Albain|708-327-3102|KALBAIN@lumc.edu|
280535|NCT00756730|Community Research initiavte|Dr. Daniel Skiest|413 794 5376|Daniel.Skiest@baystatehealth.org|
280536|NCT00756886|Surgery - Cardiovascular/Thoracic|Ayesha S. Bryant, MD|(205) 996-7561|abryant@uab.edu|
280537|NCT00756964|University of Florida|A. Ahsan Ejaz, M.D.|3522735328|ejazaa@medicine.ufl.edu|
280538|NCT00756977|Braintree Laboratories|John McGowan|781-843-2202|jmcgowan@braintreelabs.com|
280539|NCT00757003|Stanford University|Dr. Daniel Sze, Principal Investigator|650-723-0728|dansze@stanford.edu|
280540|NCT00757172|Washington University School of Medicine|Dr. A. Craig Lockhart|314-454-8306|alockhar@dom.wustl.edu|
280541|NCT00757237|Gilead Sciences, Inc.|Mark Bresnik, MD, Director, Clinical Research|(650) 522-5934|mark.bresnik@gilead.com|
280542|NCT00757484|University of Rochester Medical Center|Dr. Erin Duecy|585-275-4004|erin_duecy@urmc.rochester.edu|
280543|NCT00757588|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
280544|NCT00757601|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280545|NCT00757666|Boston Scientific|Director of Clinical Affairs|651-582-2277|cshd@bsci.com|
280546|NCT00757705|Janssen Research & Development|Medical Director|886 2 23762155||
280547|NCT00757783|Johnson & Johnson Pharmaceutical Research & Development|Vice President, Tibotec Therapeutics Clinical Affairs|877-732-2488||
280548|NCT00757822|Central Arkansas Veterans Healthcare System|Dr. Muhammad Jaffar|501-688-9310|Muhammad.Jaffar@va.gov|
280549|NCT00757848|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
298935|NCT01850485|Medical Center Leeuwarden|Matty Koopmans, MSc|0031582866738|matty.koopmans@znb.nl|
280550|NCT00758043|Vertex Pharmaceuticals Incorporated|Robert Kauffman, MD, PhD|617-444-6158|Robert_Kauffman@vrtx.com|
280551|NCT00758069|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
280552|NCT00758160|Janssen Pharmaceutical, Taiwan|Medical Affairs Director|+886-2-23762155||
280553|NCT00758264|GlaxoSmithKline|GSK Response Center|866-435-7343||
298936|NCT01850524|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
280554|NCT00758342|Alcon Research, Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280555|NCT00758394|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
280556|NCT00758420|BTG International Inc.|David Wright MBBS|610-943-3538|david.wright@btgplc.com|
280557|NCT00758459|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
280558|NCT00758485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
298937|NCT01850550|Penn State Hershey Medical Center|Jennifer Kraschnewski|717-531-8161|jkraschnewski@hmc.psu.edu|
280559|NCT00758498|Cephalon, Inc.|Medical Monitor|1-800-896-5855||
298938|NCT01850589|Staten Island University Hospital|Dr. Jonathan Deitch, PI, Director of Vascular Surgery|718-226-9000|jonathan_deitch@siuh.edu|1278
280560|NCT00758524|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
280561|NCT00758550|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280562|NCT00758576|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280563|NCT00758589|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
280564|NCT00758602|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
280565|NCT00758667|Vanderbilt University|R. Bruce Shack, MD|615-936-0160|bruce.shack@vanderbilt.edu|
280566|NCT00758680|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280567|NCT00758706|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
280568|NCT00758745|Alcon Research, Ltd.|Director of Clinical Research|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280569|NCT00758758|Zimmer, Inc|Laura Herdrich, Sr. CRA|952-830-6224|laura.herdrich@zimmer.com|
280570|NCT00758771|UCSF|John V. Fahy, MD, MSc|4154769940|john.fahy@ucsf.edu|
280571|NCT00758784|Bausch Health|Study Director||susan.harris@bauschhealth.com|
280572|NCT00758836|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280573|NCT00758862|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
280574|NCT00759031|Colgate Palmolive|William DeVizio - DMD|732-878-7901|william_devizio@colpal.com|
298939|NCT01850602|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
280575|NCT00759096|Alcon Research, Ltd.|Benny Li, PhD|+86 21 6375 8762|Benny.Li@Alconlabs.com|
280576|NCT00759109|Merck Sharp and Dohme Corp.|Senior Vice President,Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280577|NCT00759148|Alcon Research, Ltd.|Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
280578|NCT00759161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280579|NCT00759174|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280580|NCT00759187|Colgate Palmolive|William DeVizio- DMD|732-878-7901|William_Devizio@colpal.com|
280581|NCT00759330|Teikoku Pharma USA, Inc.|Director of Clinical Trials|408-501-1821||
280582|NCT00759356|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
280583|NCT00759395|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
280584|NCT00759408|Brigham and Women's Hospital|Anju Nohria, MD|617-525-6852|ANOHRIA@PARTNERS.ORG|
280585|NCT00759473|MUSC|Dr. McRae-Clark|843-792-5216|mcraeal@musc.edu|
280586|NCT00759525|Brigham and Women's Hospital|Mark A. Creager, MD|617-732-5267|mcreager@partners.org|
280587|NCT00759564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280588|NCT00759603|The University of Texas (UT) MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor, Leukemia||CR_Study_Registration@mdanderson.org|
280589|NCT00759642|University of Kansas Cancer Center|Priyanka Sharma, MD|913-945-5059|PSHARMA2@kumc.edu|
280590|NCT00759655|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280591|NCT00759668|Alcon Italia SpA|Marcello Fornoni|39.02.81.303.226|marcello.fornoni@alconlabs.com|
280592|NCT00759681|Greenville Memorial Hospital|David Cull, MD|864-455-9825||
280593|NCT00759707|Brigham and Women's Hospital|Dr. Joshua Beckman|6175257053|jbeckman@partners.org|
280594|NCT00759759|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
298940|NCT01850615|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
280595|NCT00759772|Massachusetts General Hospital|Pouneh K. Fazeli, MD|617-726-3870|pkfazeli@partners.org|
280596|NCT00759785|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289083|NCT01225835|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
289084|NCT01225887|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
289085|NCT01225926|Alcon Research, Ltd.|Manoj Venkiteshwar, Brand Lead, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
289086|NCT01225952|Bausch & Lomb Incorporated|Omid Khodai, OD,RAC|(949) 521-7894|omid.khodai@bausch.com|
289087|NCT01225991|University of California, Los Angeles|Dr. Helen Lavretsky,|310-794-4619|hlavretsky@mednet.ucla.edu|
289088|NCT01226043|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
289089|NCT01226095|Abbott|Global Medical Services|800-633-9110||
289090|NCT01226121|Indiana Hand to Shoulder Center|F. Thomas D. Kaplan|3178759105|tdk@hand.md|
289091|NCT01226420|Dana-Farber Cancer Institute|Corey S. Cutler, MD, MPH, FRCP(C)|617-632-5946|cscutler@partners.org|
289092|NCT01226459|Johnson & Johnson Healthcare Products Division of MCNEIL-PPC, Inc.|Study Director|(973) 385-3203||
289093|NCT01226472|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
289094|NCT01226485|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
289095|NCT01226511|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289096|NCT01226706|Gynecology, Regina Qu'Appelle Health Region|Dr. Corrine Jabs|(306) 586-3120|corrinejabs@hotmail.com|
289097|NCT01226719|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
289098|NCT01226732|Sarah Cannon Research Institute|John D Hainsworth, MD|1-877-691-7274|asksarah@scresearch.net|
289099|NCT01226745|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
289100|NCT01226914|Medical University of South Carolina - Department of Otolaryngology - Head and Neck Surgery|Shaun A. Nguyen, MD, FAPCR|8437921356|nguyensh@musc.edu|
289101|NCT01226979|SKCCC at Johns Hopkinis|Amol Narang, MD|(410) 955-7390|anarang2@jhmi.edu|
289102|NCT01227005|University of Texas Health Science Center-Houston|Bryan A. Cotton, MD, MPH|713-500-7354|bryan.a.cotton@uth.tmc.edu|
289103|NCT01227018|Vanderbilt-Ingram Cancer Center|Dr. Dana Cardin|615-936-8580|dana.cardin@vanderbilt.edu|
289104|NCT01227044|Yale School of Medicine|Dr. Lynn Fiellin|203-737-3347|lynn.fiellin@yale.edu|
298941|NCT01850641|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
289105|NCT01227057|VASDHS|Catherine Ayers|8585528585|catherine.ayers1@va.gov|2976
289106|NCT01227252|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289107|NCT01227265|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289108|NCT01227278|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
289109|NCT01227382|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
289110|NCT01227395|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289111|NCT01227421|Romark Laboratories, L.C.|Marc Ayers|813-282-8544|Marc.Ayers@romark.com|
289112|NCT01227434|University of California San Francisco|Michael Prados, MD|4154767217|pradosm@neurosurg.ucsf.edu|
298942|NCT01850745|Liver Section. Hospital del Mar|Professor Ricard Sola|0034932483200|35783@parcdesalutmar.cat|
298943|NCT01850823|Teva Pharmaceuticals Inc., USA|Director, PD/CE Studies|1-888-483-8279|usmedinfo@tevapharm.com|
280597|NCT00759798|The University of Texas MD Anderson Cancer Center|William Wierda MD/Professor|713-745-0428|wwierda@mdanderson.org|
280598|NCT00759811|Instituto de Cardiologia do Rio Grande do Sul|Daniel Medeiros Moreira, MD. MSc.|55 (51) 3219-2802|danielmedeirosmoreira@gmail.com|
280599|NCT00759863|Photozig, Inc.|Bruno Kajiyama|650-694-7496|lifezig@photozig.com|3
280600|NCT00759876|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
298944|NCT01851330|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
280601|NCT00759902|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
280602|NCT00759915|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
280603|NCT00759941|Alcon Research, Ltd.|Head, Global Medical Affairs|800-862-5266|medinfo@alconlabs.com|
280604|NCT00759954|Actavis Inc.|Meena Venugopal, Director, Clinical R&D|908-659-2885|MVenugopal@actavis.com|
280605|NCT00759967|Ottawa Hospital Research Institute|Dr. Deborah Zimmerman|613-738-8400|dzimmerman@ohri.ca|82534
280606|NCT00760006|Chilsren's Hospital of Pittsburgh of UPMC|Dr. Joseph E. Losee|412-692-6203|joseph.losee@chp.edu|
280607|NCT00760019|Brigham and Women's Hospital|Dr. Joshua Beckman|617-732-6186|jbeckman@partners.org|
280608|NCT00760084|Eisai Inc.|Yufang Lu, MD, PhD|888-422-4743||
280609|NCT00760214|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
280610|NCT00760266|Novartis Pharmaceuticals|Study Director|862-778-8300||
280611|NCT00760383|Human Physiology, University of Oregon|Hans C. Dreyer, PT, PhD|541-346-5775|hcdreyer@uoregon.edu|
280612|NCT00760435|University of California, San Diego|Dr. Adriana H. Tremoulet|858-246-0012|atremoulet@ucsd.edu|
280613|NCT00760474|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
280614|NCT00760487|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280615|NCT00760513|University Hospital Southampton|Professor CD Byrne|02381205006|c.d.byrne@soton.ac.uk|
280616|NCT00760526|Jaeb Center for Health Research|Katrina Ruedy|813-975-8690|direcnet@jaeb.org|
280617|NCT00760552|Iowa City VA Health Care System|Dr. Gary Rosenthal|319-338-0581|gary-rosenthal@uiowa.edu|
280618|NCT00760578|Metabolic Solutions Development Company|Jerry Colca, PhD|269-343-6732|jcolca@msdrx.com|
280619|NCT00760617|GlaxoSmithKline|GSK Response Center|866-435-7343||
280620|NCT00760669|Clinical Research Team, Medical Affairs, Medical Dept. Janssen Korea|Clinical Research Associate|+82-2-2094-4879||
280621|NCT00760747|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
280622|NCT00760838|Ghent University Hospital|dr. Brusselle Guy|003293322604|guy.brusselle@uzgent.be|
280623|NCT00760877|Novartis|Study Director|862-778-8300||
280624|NCT00760929|F. Hoffmann-La Roche AG|Study Director|+41 616878333|global.trial_information@roche.com|
280625|NCT00760994|VA Puget Sound Health Care System|Tracy Simpson, Ph.D.|206-277-3337|tracy.simpson@va.gov|
280626|NCT00761007|Menarini Group- Clinical Research|Angela Capriati MD PhD, Clinical Research Director|+39 055 5680|acapriati@menarini-ricerche.it|9933
280627|NCT00761085|Washington University|Evan Kharasch MD PhD|3143628796|kharasch@wustl.edu|
280628|NCT00761137|NeuroHealing Pharmaceuticals|Daniel Katzman|617-965-0872|info@neurohealing.com|
280629|NCT00761150|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
280630|NCT00761189|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2094-4804||
280631|NCT00761202|Allergan, Inc.|Vice President Medical Affairs - Europe|(714)246-4500|clinicaltrials@allergan.com|
280632|NCT00761215|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|philippe.prokocimer@cubist.com|241
280633|NCT00761267|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280634|NCT00761280|Isarna Therapeutics GmbH, formerly Antisense Pharma GmbH|Medical Officer|+49-89-890831|info@isarna-therapeutics.com|0
280635|NCT00761306|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
280636|NCT00761319|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
280637|NCT00761345|Fox Chase Cancer Center|Dr. Steven J. Cohen|215-728-4300|steven.cohen@fccc.edu|
280638|NCT00761462|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
280639|NCT00761514|Abbott|Medical Information Specialist|1-800-633-9110||
280640|NCT00761579|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2094-4804||
280641|NCT00761592|Allergan, Inc.|Vice President Medical Affairs|(714)246-4500|clinicaltrials@allergan.com|
280642|NCT00761605|Clinical Research Team, Medical Affairs Korea|Senior Clinical Research Associate|82-2-2094-4804||
280643|NCT00761631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280644|NCT00761657|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
280645|NCT00761735|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280646|NCT00761748|Coloplast A/S|Director of Medical Outcome||dkbir@coloplast.com|
280647|NCT00761761|Univeristy Of Pittsburgh Medical Center|K.N. Roy Chengappa, MD|412-246-5006|chengappakn@upmc.edu|
280648|NCT00761774|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
280649|NCT00761813|University of Minnesota|Principal Investigator|612.273.8000|swion001@umn.edu|
280650|NCT00761865|University of Rochester|Benedict DiGiovanni|5852731611|benedict_digiovanni@urmc.rochester.edu|
280651|NCT00761891|Department of Pharmacology, School of Medicine, Vanderbilt University|Olivier Boutaud, PhD|615-343-7398|olivier.boutaud@vanderbilt.edu|
280652|NCT00761930|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
298945|NCT01851590|Department of Cardiac Surgery, Heart and Lung Centre, Helsinki University Hospital, Finland|Janne Jokinen, MD, PhD, Consultant Cardiothoracic Surgeon|50 554 8103|janne.jokinen@helsinki.fi|+358
280653|NCT00761956|Zimmer, Inc|Kacy Arnold, Associate Director, Clinical Affairs|574-371-8336|kacy.arnold@zimmer.com|
280654|NCT00761969|Department of Vascular Diseases, University of Ljubljana Med Ctr|Ales Blinc, MD, DSc|+386 1 522 80 32|ales.blinc@kclj.si|
280655|NCT00762021|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280656|NCT00762034|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
280657|NCT00762073|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
280658|NCT00762086|A. Stein Regulatory Affairs Consulting|Shmulik Adler|972-9-767-0002|shmulik@asteinrac.com|
280659|NCT00762164|Bronx VA Medical Center|Dr. Lawrence Baruch|718-584-9000|lawrence.baruch@va.gov|6776
280660|NCT00762177|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
280661|NCT00762216|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280662|NCT00762229|Bronx VA Medical Center|Dr. Lawrence Baruch|718-584-9000|lawrence.baruch@va.gov|6776
280663|NCT00762268|McLean Hospital|Beth Murphy MD|617-855-2297|BMurphy5@partners.org|
280664|NCT00762307|Zeltiq Aesthetics|Kerrie Jiang, Director of Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
280665|NCT00762320|Phoenix Children's Hospital|Laura Clarke-Steffen, PhD, RN|602-933-0234|lclarke@choenixchildrens.com|
280666|NCT00762359|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
280667|NCT00762372|Baxter Healthcare|Baxter Clinical Trial Disclosures Call Center|(224)948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
280668|NCT00762385|Vistakon|Kurt Moody, OD FAAO|904-443-3088||
298946|NCT01851655|University of Florida|Dr. Terese Chmielewski|352-273-6104|tchm@ufl.edu|
280669|NCT00762411|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
280670|NCT00762424|WellSpan Health|Barbara Stahlman MS, Clinical Research Associate|717-851-2450|bstahlman@wellspan.org|
280671|NCT00762450|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
280672|NCT00762463|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280673|NCT00762476|University of Virginia|Dr. Ronald Turner|(434) 243-9864|RBT2N@hscmail.mcc.virginia.edu|
280674|NCT00762502|Johnson & Johnson Vision Care, Inc.|John Buch, OD|1-904-443-1707|RA-Visus-ClnclStds@its.jnj.com|
280675|NCT00762515|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
280676|NCT00762528|Colgate Palmolive Company|William DeVizio, DMD|732-878-7901|william_Devizio@colpal.com|
280677|NCT00762606|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280678|NCT00762619|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
280679|NCT00762645|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280680|NCT00762710|VA Puget Sound|Dr. Tracy Simpson|(206) 277-3337|Tracy.Simpson@va.gov|
280681|NCT00762762|Colgate Palmolive Co.|William DeVizio, DMD|732-878-7901|william_devizio@colpal.com|
280682|NCT00762788|Vistakon|Kathy Osborn, OD, MS, FAAO, FBCLA Senior Principal Research Optometrist|1 904 443-1032|kosborn@its.jnj.com|
280683|NCT00762853|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
280684|NCT00762892|UT Health Science Center Houston|Tanvir Bell, MD|713-500-6759|Tanvir.K.Bell@uth.tmc.edu|
280685|NCT00762931|electroCore LLC|Clinical Affairs electroCore LLC|+1 973 355 6683|clinical@electrocorellc.com|
280686|NCT00762970|Vistakon USA|XU CHENG, PRINCIPAL CLINICAL SCIENTIST|1 904 443-1245|xcheng6@its.jnj.com|
280687|NCT00762996|Vistakon|Kurt Moody, OD, FAAO|904-443-3088||
298947|NCT01851720|Johns Hopkins School of Medicine|Alex Coon|410-955-2438|acoon2@jhmi.edu|
280688|NCT00763035|Wake Forest University Health Sciences|Gregory Hundley|+1 (336) 716-0607|ghundley@wakehealth.edu|336
280689|NCT00763048|Colgate Palmolive Co.|William Devizio|732-878-7901|William_Devizio@colpal.com|
280690|NCT00763061|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280691|NCT00763139|Vanderbilt|Dr. Charles Michael Stein|615-936-3420|mike.stein@vanderbilt.edu|
280692|NCT00763243|Indiana University School of Medicine|William Kronenberger, Ph.D.|317-944-8162|wkronenb@iupui.edu|
280693|NCT00763256|Colgate Palmolive Co.|William DeVizio, DMD|732-878-7901|william_devizio@colpal.com|
298948|NCT01851772|Xoft, Inc.|Crystal Leonard, CCRP|9375038588|cleonard@icadmed.com|
308927|NCT02625402|Massachusetts General Hospital|Karen Sepucha|6177243350|ksepucha@partners.org|
280694|NCT00763269|Colgate Palmolive Co.|William De Vizio|732-878-7901|William_Devizio@colpal.com|
280695|NCT00763282|Center of Innovation for Complex Chronic Health Care|Marylou Guihan, PhD|708-202-2414|marylou.guihan@va.gov|
280696|NCT00763321|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
289113|NCT01227512|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
289114|NCT01227551|Viralytics|Mark Grose|1 647 821 7673|Mark.Grose@Viralytics.com|
289115|NCT01227564|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289116|NCT01227577|Novartis|Study Director|862-778-8300||
289117|NCT01227616|AMAG Pharmaceuticals|Medical Information|1-877-411-2510|amag@druginfo.com|
308928|NCT02625428|Mayo Clinic|J. Scott Kriegshauser|480-342-5664|skriegshauser@mayo.edu|
289118|NCT01227629|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289119|NCT01227655|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
289120|NCT01227668|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
289121|NCT01227681|Buddhist Tzu Chi General Hospital Hualien|Dr. Chen Shin-Yuan|+886-3-8561825|william.sychen@msa.hinet.net|2151
289122|NCT01227707|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
308929|NCT02625545|NeoTract/Teleflex|Emily Hergenreter, Sr. Director of Clinical Affairs|650-793-5570|Emily.Hergenreter@Teleflex.com|
289123|NCT01227785|Guidant, a Boston Scientific Company|Paji Vitoff, Senior Clinical Manager|651-582-5415|paji.vitoff@bsci.com|
289124|NCT01227824|GlaxoSmithKline|GSK Response Center|866-435-7343||
280697|NCT00763360|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
298949|NCT01851863|Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, Shanghai, China|Sheng-Liang Chen, MD|86-21-58752345|slchenmd@hotmail.com|
308930|NCT02625571|Penn State College of Medicine|Dr. Brian Allen|717-531-4100|ballen1@pennstatehealth.psu.edu|323492
280698|NCT00763386|Zimmer|Kacy Arnold, Associate Director, Clinical Affairs|574-371-8336|kacy.arnold@zimmer.com|
280699|NCT00763412|Washington University in St Louis|Ana Maria Arbelaez|314-286-1138|arbelaez_a@kids.wustl.edu|
280700|NCT00763451|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
280701|NCT00763490|University of Michigan Comprehensive Cancer Center|Dr. Daniel Couriel, M.D.|734-936-8785|dcouriel@umich.edu|
280702|NCT00763698|St. Jude Medical|Director, Clinical Affairs|(408) 522-6410|tshipman@sjm.com|
280703|NCT00763750|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
280704|NCT00763815|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
280705|NCT00763867|Duke University|Jenny Ibarra|919.236.3291|jenny.ibarra@duke.edu|
280706|NCT00763919|University Hospitals Case Medical Center|Christopher Bialko|216-286-4362|Christopher.Bialko@UHhospitals.org|
280707|NCT00763958|University of Alabama at Birmingham|Dr. Karen Cropsey|205-917-3786|kcropsey@uab.edu|205
280708|NCT00763971|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
280709|NCT00764309|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
280710|NCT00764322|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
280711|NCT00764361|Nanotherapeutics, Inc.|John Abernethy, MD - Medical Director|386-462-9663|jabernethy@nanotherapeutics.com|326
280712|NCT00764465|GSIDA|David Condoluci|856-566-3190|dcondoluci@gsida.org|
280713|NCT00764491|Spineology|Rose Griffith, Sr. Director, Clinical Affairs|651-256-8503|Rgriffith@spineology.com|
280714|NCT00764504|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|6323
280715|NCT00764517|Knight Cancer Institute, Oregon Health & Science University|Dr. Stephen E. Spurgeon MD|503-494-4606|spurgeos@ohsu.edu|
280716|NCT00764660|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280717|NCT00764673|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|6323
280718|NCT00764738|Retina Macula Institute|Dr. Ron Gallemore||rongallemoremd@gmail.com|
280719|NCT00764751|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
280720|NCT00764790|GlaxoSmithKline|GSK Response Center|866-435-7343||
280721|NCT00764868|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
280722|NCT00764881|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
280723|NCT00764946|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280724|NCT00765037|DJO Surgical|Jane M. Jacob - Manager of Clinical Affairs|512-834-6323|jane.jacob@djosurgical.com|
280725|NCT00765063|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280726|NCT00765076|GlaxoSmithKline|GSK Response Center|866-435-7343||
280727|NCT00765102|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
280728|NCT00765128|Mayo Clinic|Mitchell R. Humphreys MD|480-301-8000|humphreys.mitchell@mayo.edu|
280729|NCT00765193|Department of Dermatology, Medical University of Graz-Austria|Iris Zalaudek, MD|+436763328269|iris.zalaudek@medunigraz.at|
280730|NCT00765206|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280731|NCT00765232|Mayo Clinic|Mitchell R. Humphreys MD|480-301-8000|humphreys.mitchell@mayo.edu|
280732|NCT00765245|Vanderbilt-Ingram Cancer Center|Dr. Nishitha Reddy|800-811-8480|nishitha.reddy@vanderbilt.edu|
280733|NCT00765336|Medicis Global Services Corporation|Director of Clinical Trials||ClinicalTrials@Medicis.com|
280734|NCT00765362|DJO Surgical|Manager of Clinical Affairs|512-832-9500|jane.jacob@djosurgical.com|1323
280735|NCT00765375|DeNova Research|Jack Arkins, Data Manager|312-335-2070|jack@drdayan.com|
280736|NCT00765388|Coloplast A/S|Seema Suchdev Wrisberg|+4549113519|dkssw@coloplast.com|
280737|NCT00765570|Summa Health System|Tracy Mondello, MS|330-375-6131|mondellot@summahealth.org|
280738|NCT00765648|Cleveland Clinic|Frank Peacock MD|(216) 445-4557|peacocw@ccf.org|
280739|NCT00765661|Veloxis|Christina Sylvest, Sr VP Global Clinical Development & Operations|45 20553877|csy@veloxis.com|
280740|NCT00765674|Novartis Pharmaceuticals|Study Director|862 778-8300||
280741|NCT00765726|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280742|NCT00765817|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
280743|NCT00765843|Rosalind Franklin University of Medicine and Science|Ryan Crews|847-578-8437|ryan.crews@rosalindfranklin.edu|
280744|NCT00765856|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
280745|NCT00765882|Forest Research Institute|Paul F.C. Eng, PhD. Director, Clinical Development|201-427-8071|Paul.Eng@frx.com|
280746|NCT00765895|Johns Hopkins Data Coordinating Centers|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
280747|NCT00765947|Novartis Pharmaceuticals|Study Director|862-778-8300||
280748|NCT00765999|Allergan, Inc.|Vice President, Clinical Development, Gastrointestinal|1-862-261-7000|IR-CTRegistration@allergan.com|
280749|NCT00766038|University of Pennsylvania|Ramon Diaz-Arrastia|215-662-9732|Ramon.Diaz-Arrastia@uphs.upenn.edu|
280750|NCT00766051|University of Utah at the time of the study|Lynne La Corte, PhD, OTR/L, OTD|970 4330981|lflacorte@independence.net|
280751|NCT00766090|GlaxoSmithKline|GSK Response Center|866-435-7343||
280752|NCT00766116|University of California, San Diego|Edward D. Ball, MD|858-822-6600|tball@ucsd.edu|
280753|NCT00766142|Institut Bergonié|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
280754|NCT00766363|EnVivo Pharmaceuticals, Inc.|Maria Gawryl, Ph.D., Vice President, Regulatory Affairs & Drug Development|617-225-4264|mgawryl@envivopharma.com|
280755|NCT00766376|Palomar Medical Technologies, Inc.|Director of Regulatory Affairs|781-993-2414|stimberlake@palomarmedical.com|
280756|NCT00766415|AstraZeneca|Alison Holt||ClinicalTrialTransparency@astrazeneca.com|
280757|NCT00766467|Dana-Farber Cancer Insitute|Eudocia Quant Lee, MD|617-632-2166|eqlee@partners.org|
280758|NCT00766493|W. L. Gore & Associates|Bryan Randall|(800) 437-8181|BRandall@WLGore.com|
280759|NCT00766506|Janssen-Cilag Ltd. 50-100 Holmers Farm Way, High Wycombe , BUCKS, UK, HP12 4EG|Study Responsible Physician|+44 (0) 1494 567 444||
280760|NCT00766532|University of Wisconsin|Dr. Karen Hansen|608-263-0517|keh@medicine.wisc.edu|
280761|NCT00766597|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
280762|NCT00766649|National Eye Institute|Wai T. Wong|(301) 905-7301|wongw@nei.nih.gov|
280763|NCT00766675|Janssen Pharmaceutics Taiwan|Medical Affairs Director|+886-2-23762155||
280764|NCT00766727|Neodyne|VP, R&D/OPS|5104564128|jzepeda@neodynebio.com|128
280765|NCT00766753|University of Pittsburgh Cancer Institute|Frank Lieberman|(412) 648-6507|liebermanf@upmc.edu|
280766|NCT00766831|Medical Affairs|Clinical Research Associate|82-2-2094-4835||
280767|NCT00767000|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280768|NCT00767039|Boston Medical Center|Alan Fujii MD (PI)|617-4414-3735|Alan.Fujii@bmc.org|
280769|NCT00767104|Wake Forest University Health Sciences|Alan Fleischer, Jr. MD|336-716-3775|Afleisch@wfubmc.edu|
298950|NCT01851876|Karadeniz Technical University, School of Medicine, Dept Obs and Gyn.|Dr. Suleyman Guven, Director of clinical trial|+904623775869|drsuleymanguven@yahoo.com|
280770|NCT00767325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
280771|NCT00767338|University of Michigan|Gregory Christman, MD|734-764-8142|growthh@umich.edu|
280772|NCT00767364|Wayne State University School of Medicine, Children's Hospital of Michigan|Eric McGrath, MD|313-745-5863|emcgrath@med.wayne.edu|
280773|NCT00767455|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
298951|NCT01852019|The Medicines Company|Jayne Prats, PhD - VP, Global Knowledge Management|888-779-MDCO|jayne.prats@themedco.com|1510
280774|NCT00767507|The Medicines Company|Meredith Todd - Sr. Director Program Management|+1.973.290.6088|meredith.todd@themedco.com|
280775|NCT00767520|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
280776|NCT00767572|UCSF|Dr. Doreen DeFaria Yeh|617-643-7024|ddefariayeh@partners.org|
280777|NCT00767624|STANFORD UNIVERSITY|Rachel Manber, PhD|6504981266|rmanber@stanford.edu|
280778|NCT00767676|Smith & Nephew Biotherapeutics|Jaime Dickerson, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
280779|NCT00767767|Weill Cornell Medicine|Kane Pryor|(212) 746-2969|kap9009@med.cornell.edu|
280780|NCT00767806|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
298952|NCT01852032|UC Davis|John Brock Staff Research Associate|916-734-3101|jmbrock@ucdavis.edu|
280781|NCT00767819|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
280782|NCT00768053|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280783|NCT00768066|The EMMES Corporation|Adam Mendizabal, Biostatistician|301-251-1161|amendizabal@emmes.com|221
280784|NCT00768079|MedImmune, LLC|Joseph M. Parker, Director, Clinical Development|+1 301-398-4095|information.center@astrazeneca.com|
280785|NCT00768118|Barbara Ann Karmanos Cancer Institute|Fazlul Sarkar, Ph.D.|(313) 576-8327|sarkarf@karmanos.org|
280786|NCT00768144|Dana-Farber Cancer Institute|Susana M. Campos, MD, MPH|617-632-5269|susana_campos@dfci.harvard.edu|
280787|NCT00768222|J&J Medical, China Ltd.|Xiaowei SUN, MD PhD|86 10 5952 3103|xsun5@its.jnj.com|
280788|NCT00768261|Washington University|John G. Csernansky, MD|(312) 926-2323|jgc@northwestern.edu|
280789|NCT00768287|Medexus Pharma, Inc.|Clinical Trial Manager|1-312-548-3125|julissa.leon@medexus.com|
280790|NCT00768300|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
280791|NCT00768430|Baylor College of Medicine|Dr. Sanjay Mathew|7137911414|sjmathew@bcm.edu|5439
280792|NCT00768469|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
280793|NCT00768521|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
280794|NCT00768560|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
280795|NCT00768599|AmDerma Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amderma.com|
280796|NCT00768651|Faculty of Medicine and Dentistry, University of Alberta|Peter Senior, MD, PhD - Professor of Medicine, Medical Director-Clinical Islet Transplant Program,|780-407-1480|peters@islet.ca|
298953|NCT01852045|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
289125|NCT01227889|GlaxoSmithKline|GSK Response Center|866-435-7343||
289126|NCT01227902|GlaxoSmithKline|GSK Response Center|866-435-7343||
289127|NCT01227928|GlaxoSmithKline|GSK Response Center|866-435-7343||
289128|NCT01227954|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
289129|NCT01227967|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D.|301-451-9881|jbeigel@niaid.nih.gov|
289130|NCT01227980|National Institute on Alcohol Abuse and Alcoholism|Melanie Schwandt|301-451-6960|melanies@mail.nih.gov|
289131|NCT01227993|National Eye Institute|Catherine Meyerle, MD|301-435-7821|meyerlec@nei.nih.gov|
289132|NCT01228019|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289133|NCT01228071|Endo Pharmaceutical, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
298954|NCT01852058|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
298955|NCT01852071|Orchard Therapeutics (Europe) Ltd|Orchard Medical Information|+44 (0) 203 808 8286|medinfo@orchard-tx.com|
280797|NCT00768664|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280798|NCT00768716|Washington State University|Dr Michael H. Court|5093350817|michael.court@wsu.edu|
280799|NCT00768755|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
298956|NCT01852084|Bausch Health|Study Director||susan.harris@bauschhealth.com|
280800|NCT00768898|Alcon Research, Ltd.|Alison Ramsey, O.D., Manager|817-551-6986|Alison.ramsey@alconlabs.com|
280801|NCT00768989|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
280802|NCT00769015|Thomas Jefferson University|Robin Casten|215-503-1250|Robin.Casten@jefferson.edu|
280803|NCT00769067|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280804|NCT00769119|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
280805|NCT00769132|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280806|NCT00769184|NeoStrata Co., Inc.|Barbara Green, RPH, MS|(609) 520-0715|bgreen@neostrata.com|
280807|NCT00769314|BioAlliance Pharma|Dr Pierre ATTALI|+33145587600|pierre.attali@bioalliancepharma.com|
298957|NCT01852110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280808|NCT00769392|Lahey Clinic|Gregory Blaha, MD|781-744-2580|christine.gould@lahey.org|
280809|NCT00769483|UT MD Anderson Cancer Center|Milind Javle, MD/Professor, GI Medical Oncology|713-792-2828|mjavle@mdanderson.org|
280810|NCT00769561|Department of Clinical Psychology and Psychotherapy, Philipps University of Marburg, Germany|Dr. Meike Shedden Mora|+49-6421-282|m.shedden@staff.uni-marburg.de|3657
280811|NCT00769600|MSKCCC|Charles Rudin, MD|646-888-4336|rudinc@mskcc.edu|
280812|NCT00769704|Amgen, Inc.|Study Director|866-572-6436||
280813|NCT00769808|Bausch & Lomb Incorporated|Study Director|9083009926|susan.harris@bauschhealth.com|
280814|NCT00769860|University of Kansas Medical Center|Dr. Richard Barohn|(913) 588-6094|RBAROHN@kumc.edu|
289134|NCT01228084|Oregon Health & Science University, Knight Cancer Institute|Joshi Alumkal, MD|503-494-1091||
289135|NCT01228149|Dept. of Ophthalmology, University Medical Center Mainz|Dr. Dr. Katrin Lorenz|00496131174069|lorenz@augen.klinik.uni-mainz.de|
289136|NCT01228175|University of Colorado Boulder|Dr. Kent Hutchison|303-492-8163|kent.hutchison@colorado.edu|
289137|NCT01228318|Emory University|Igho Ofotokun, MD, MSc|404-616-0659|iofotok@emory.edu|
289138|NCT01228435|Massachusetts General Hospital|Lecia Sequist|617-726-7812|lvsequist@partners.org|
289139|NCT01228591|Johnson & Johnson Vision Care|Brian Pall, O.D., M.S., F.A.A.O. Principal Research Optometrist|1 904 443-1290|bpall@its.jnj.com|
289140|NCT01228734|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
289141|NCT01228747|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
289142|NCT01228903|University of Colorado|Diana Jalal|3037244867|diana.jalal@ucdenver.edu|
289143|NCT01228929|University of Rochester|Dr. James V. Aquavella|585-275-8944|james_aquavella@urmc.rochester.edu|
289144|NCT01228968|Washington University School of Medicine|Gary Skolnick|3143625292|gskolnic@wustl.edu|
289145|NCT01229111|Case Comprehensive Cancer Center|Dr. Smitha Krishnamurthi|216-844-5234|smitha.krishnamurhti@uhhospitals.org|
289146|NCT01229150|National Cancer Institute|Dr. Arun Rajan|301-594-5322|rajana@mail.nih.gov|
289147|NCT01229176|Novartis Vaccines Institute for Global Health|Dr. Audino Podda|+39 0577 243496|audino.podda@novartis.com|
289148|NCT01229228|Iroko Pharmaceuticals, LLC|Steven Jensen|267-546-3003|sjensen@iroko.com|
298958|NCT01852162|University of Florida|Dominick Angiolillo, MD, PhD|904-244-3933|dominick.angiolillo@jax.ufl.edu|
298959|NCT01852175|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD-Associate Professor of Medicine Director, Cardiovascular Research|+1-904-244-3005|dominick.angiolillo@jax.ufl.edu|
298960|NCT01852201|Medical University of SC|Jonathan Lena, MD|843-792-9226|lena@musc.edu|
298961|NCT01852214|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
298962|NCT01852292|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
298963|NCT01852344|University of Michigan|Dr. Chandra Sripada, MD PhD||csripada@umich.edu|
298964|NCT01852383|New York State Psychiatric Institute|Dr. D.P. Devanand|(646) 774-8658|dpd3@columbia.edu|
298965|NCT01852513|The University of Chicago|Dr. Jayant Pinto, PI|773-702-6727|jpinto@surgery.bsd.uchicago.edu|
298966|NCT01852591|H. Lee Moffitt Cancer Center and Research Institute|Frederick Locke, M.D.|813-745-3509|frederick.locke@moffitt.org|
298967|NCT01852669|Monash University|Dr Shaun Lee|55145890|shaun.lee@monash.edu|
298968|NCT01852799|Shanghai Changzheng Hospital|Jian Hou, PhD|86021-63610109-73221|houjian@medmail.com.cn|
298969|NCT01852825|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
298970|NCT01852942|University of Minnesota|Timothy Schacker, MD|612-626-6577|olso7966@umn.edu|
298971|NCT01852955|Northwestern University|Gildasio De Oliveira, M.D.|312-695-4858|gjr@northwestern.edu|
298972|NCT01853046|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
298973|NCT01853072|Alcon Research, Ltd.|Therapeutic Unit Head, Cornea and Inflammation|1-888-451-3937|alcon.medinfo@alcon.com|
298974|NCT01853085|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
298975|NCT01853137|Osama AlAli|Dr.|00963992262582|osama-alali@hotmail.com|
298976|NCT01853215|Vidacare Corporation|Larry J. Miller, MD|210-375-8500|larry.miller@vidacare.com|
298977|NCT01853228|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
298978|NCT01853254|Hoffmann-La Roche|Medical Communications|800 821-8590||
298979|NCT01853280|Massachusetts General Hospital|Dr. Craig Surman|617-726-8422|csurman@partners.org|
308931|NCT02625610|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
308932|NCT02625623|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
280815|NCT00769886|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
280816|NCT00770029|Merz Pharmaceuticals GmbH|Dr. Matthias Zerm|0049-69-1503|matthias.zerm@merz.de|865
280817|NCT00770120|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
280818|NCT00770133|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
280819|NCT00770146|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
280820|NCT00770211|Merz Pharmaceuticals GmbH|Dr. Matthias Zerm|0049-69-1503|matthias.zerm@merz.de|865
280821|NCT00770224|SWOG Statistics and Data Management Center|Lymphoma Committee Statistician|206-667-4623|lymph@crab.org|
298980|NCT01853332|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678630|cmantzor@bidmc.harvard.edu|
280822|NCT00770289|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280823|NCT00770315|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280824|NCT00770328|Vanderbilt University Medical Center|James Muldowney|615-936-1720|james.muldowney@vanderbilt.edu|
280825|NCT00770341|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@Merck.com|
280826|NCT00770367|Medical University of South Carolina|Dana King MD|843-792-8112|kingde@musc.edu|
298981|NCT01853371|Ministry of Health|Dr. Nouran Aleyeidi|00966504304577|dr.nouran@live.com|
280827|NCT00770432|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
280828|NCT00770484|Vanderbilt University|Italo Biaggioni, MD., Professor of Medicine and Pharmacology|(615) 936-3420|italo.biaggioni@vanderbilt.edu|
280829|NCT00770510|Eisai Co., Ltd.|Atsushi Kamijo, Study Director|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp|
289149|NCT01229254|Portola Pharmaceuticals, Inc.|Head of Clinical Development|650-246-7000||
298982|NCT01853384|Smith & Nephew, Inc|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
298983|NCT01853397|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
298984|NCT01853462|Aristotle University of Thessaloniki|Lazaros Lazarou||lazarosphysiotherapist@gmail.com|
289150|NCT01229267|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289151|NCT01229371|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
289152|NCT01229397|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
289153|NCT01229410|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
289154|NCT01229423|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
289155|NCT01229436|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289156|NCT01229449|Reckitt Benckiser Healthcare International|Clinical Research Director, Clinical Research||clinicalrequests@rb.com|
289157|NCT01229462|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
289158|NCT01229527|Department of Anesthesia and Intensive Care|Dr. Massimo Agostoni|+39.02.2643.2656|agostoni.massimo@hsr.it|
289159|NCT01229722|Dimagi Inc.|Dr. Vikram Kumar|6176492214|information@dimagi.com|
289160|NCT01229735|UCB Pharma|UCB Clinical Trial Call Center|+1877 822||9493
289161|NCT01229891|National nutrition and food technology institute|T Neyestani|0982122376471|neytr@yahoo.com|
289162|NCT01229943|Dana-Farber Cancer Institute|Matthew Kulke, MD, MMSc||matthew_kulke@dfci.harvard.edu|
289163|NCT01230021|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
289164|NCT01230060|Bausch & Lomb Incorporated|Jon Hayashida|(949) 521-7876|jon.hayashida@bausch.com|
289165|NCT01230125|Bausch Health|Study Director||susan.harris@bauschhealth.com|
289166|NCT01230177|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289167|NCT01230424|Tufts Medical Center|Dr. Timothy McAlindon|6176365610|tmcalindon@tuftsmedicalcenter.org|
289168|NCT01230502|University of Wisconsin|Professor William Burlingham, PhD|(608) 263-0119|BURLINGHAM@SURGERY.WISC.EDU|
289169|NCT01230554|Bausch Health Americas, Inc|Robert Steffen||Robert.Steffen@bausch.com|
289170|NCT01230593|Icahn School of Medicine at Mount Sinai|Albert Wu MD PhD|2125184524|albert.wu@mssm.edu|
289171|NCT01230710|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
298985|NCT01853475|Medicines for Malaria Ventire (MMV)|Dr Thomas Rueckle|+41 22 799 4567|ruecklet@mmv.org|
289172|NCT01230749|Janssen R&D US|Director, Translational Medicine|1 908 927-7881||
289173|NCT01230801|BioMarin Pharmaceutical Inc.|Manager, Clinical Operations|415-455-7448|Slava.Titov@bmrn.com|
289174|NCT01230814|University of Arkansas for Medical Sciences|Shelly Lensing, MS|501-686-8203|sylensing@uams.edu|
289175|NCT01230827|Johnson & Johnson Pharmaceutical Research & Development|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
289176|NCT01230892|Emory University|Dr. Habib Samady|404-778-5299|hsamady@emory.edu|
298986|NCT01853553|University of Colorado|Dr. Michel Chonchol|303-724-7796|Michel.Chonchol@ucdenver.edu|
298987|NCT01853605|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
298988|NCT01853618|National Cancer Institute|Dr. Tim F. Greten|(301) 451-4723|tim.greten@nih.gov|
298989|NCT01853644|Northwestern University|Daniela Matei|312.472.4684|daniela.matei@northwestern.edu|
298990|NCT01853696|Cornea Research Foundation of America|Marianne Price, PhD|317-814-2990|mprice@cornea.org|
298991|NCT01853774|Arizona State University|Professor, College of Nursing and Health Innovation|6024960740|linda.larkey@asu.edu|
298992|NCT01853839|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
298993|NCT01853878|GlaxoSmithKline|GSK Response Center|866-435-7343||
298994|NCT01853930|Jesse Brown VA Medical Center|Dr. Janet P. Szlyk, PhD|312-997-3644|janet.szlyk@va.gov|
280830|NCT00770562|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
289177|NCT01230931|The University of Texas Health Science Center at Houston|Catherine G. Ambrose, PhD||Catherine.G.Ambrose@uth.tmc.edu|
298995|NCT01854034|Massachusetts General Hospital|Lecia Van Dam Sequist, M.D.|617-724-4000|lvsequist@partners.org|
280831|NCT00770588|AstraZeneca|Gerard Lynch|52564555|aztrial_results_posting@astrazeneca.com|86 21
280832|NCT00770601|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|Novartis.email@novartis.com|
280833|NCT00770653|Takeda Pharma GmbH, Aachen (Germany)|Medical Director|+49 800 8253325|clinicaltrialregistry@tpna.com|
308933|NCT02625844|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
280834|NCT00770679|Johns Hopkins University School of Medicine|Harry Silber, M.D., Ph.D. Assistant Professor of Medicine, Division of Cardiology|4105505717|hsilber@jhmi.edu|
280835|NCT00770692|Eisai Co., Ltd.|Atsushi Kamijo, Study Director|+81-3-3817-5245|a-kamijo@hhc.eisai.co.jp|
280836|NCT00770757|Washington University School of Medicine|John F. DiPersio, M.D., Ph.D.|314-454-8603|jdipersi@dom.wustl.edu|
308934|NCT02625909|The Kirby Institute|Pip Marks, Clinical Trials Manager|+61 2 9385 0886|pmarks@kirby.unsw.edu.au|
280837|NCT00770770|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
280838|NCT00770809|University of North Carolina - Lineberger Comprehensive Cancer Center|Lisa Carey, M.D.||lisa_carey@med.unc.edu|
280839|NCT00770861|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
280840|NCT00770874|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
280841|NCT00770913|Eisai Co.,Ltd. Eisai Product Creation Systems|Tomoki Kubota, Study Director|+81-3-3817-3908|t2-kubota@hhc.eisai.co.jp|
280842|NCT00770991|Cleveland Clinic|Dr. Carol Burke|216 444-6864|burkec1@ccf.org|
280843|NCT00771030|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
280844|NCT00771056|Northwell Health (formerly North Shore LIJ Health System)|Kanti R Rai, MD|(718)470-4050|krai@nshs.edu|
280845|NCT00771173|Loyola University Chicago|Dr. Linda Brubaker|708-216-3960|lbrubaker@lumc.edu|
280846|NCT00771238|Nebraska Medical Center|Joyce Black, PhD, RN|402-559-6573|JBlack@unmc.edu|
280847|NCT00771264|Uroplasty, Inc.|Susan Holman, Cheif Operating Officer|952-426-6143|susan.holman@uroplasty.com|
280848|NCT00771277|VA Medical Center Memphis|Dr. Linda O. Nichols|901 523-8990|linda.nichols@va.gov|5082
280849|NCT00771407|LifeCell Corporation|Chief Medical Officer|908-947-1104|mfranz@lifecell.com|
280850|NCT00771472|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280851|NCT00771537|Indiana University|Gregory D Zimet|317-274-8812|gzimet@iupui.edu|
280852|NCT00771615|GlaxoSmithKline|GSK Response Center|866-435-7343||
280853|NCT00771667|Janssen Research and Development, US|Director, Clinical Research|610-651-6554||
280854|NCT00771745|University of Cincinnati|Dr. Rita Alloway|513-558-1568|Rita.Alloway@uc.edu|
280855|NCT00771758|Ortho-McNeil Janssen Scientific Affair, LLC.|Senior Director of Clinical Development, Pain|(908)927-5465||
280856|NCT00771810|Tarix Pharmaceuticals|Elizabeth Wagner|6178760223|elizabeth.wagner@tarixpharma.com|
280857|NCT00771849|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
280858|NCT00771875|University of Cincinnati|E. Steve Woodle, MD|513-558-6001|woodlees@ucmail.uc.edu|
280859|NCT00771901|Washington University School of Medicine in Saint Louis, Missouri|Samuel Klein, M.D.|314-362-8708|sklein@wustl.edu|
280860|NCT00771914|University of Rochester Division of Epidemiology, Department of Community and Preventive Medicine|Robert Block, MD, MPH, FACP|585-275-3356|robert_block@urmc.rochester.edu|
280861|NCT00771927|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
280862|NCT00771953|University of Maryland Baltimore Greenebaum Cancer Center|Michelle Medeiros|410-328-1160|mmedeiros@umm.edu|
280863|NCT00772005|Cephalon, Inc.|Vice President, Clinical Research, CNS/Pain|1-800-896-5855||
280864|NCT00772031|The EMMES Corporation|Anne S Lindblad, PhD|301 251 1161|alindblad@emmes.com|105
280865|NCT00772070|Sanofi Pasteur Inc|Medical Director||RegistryContactUs@sanofipasteur.com|
280866|NCT00772109|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
280867|NCT00772148|Veloxis Pharmaceuticals|Christina Sylvest|+45 20553877|csy@veloxis.com|
280868|NCT00772304|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
280869|NCT00772330|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
280870|NCT00772369|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
280871|NCT00772382|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
280872|NCT00772447|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
280873|NCT00772538|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
280874|NCT00772577|Novartis Pharmaceuticals|Study Director|862-778-8300||
280875|NCT00772590|Kirby Institute, University of New South Wales|Sean Emery|+612 938509900|semery@kirby.unsw.edu.au|
280876|NCT00772603|Supernus Pharmaceuticals, Inc|Stefan Schwabe, M.D., Ph.D., Chief Medical Officer|301-838-2500|sschwabe@supernus.com|2527
280877|NCT00772629|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
280878|NCT00772668|UM/Sylvester Comprehensive Cancer|Denise Pereira MD|305-243-9127|dpereira2@med.miami.edu|
280879|NCT00772707|Alcon Global Medical Affairs|Jami Kern, Ph.D.|1-888-451-3937||
280880|NCT00772772|The Rockefeller University|Dr. Mansih Ponda|212-327-7631|mponda@rockefeller.edu|
280881|NCT00772889|GlaxoSmithKline|GSK Response Center|866-435-7343||
280882|NCT00772915|Mayo Clinic|Dr. Shaji Kumar||kumar.shaji@mayo.edu|
298996|NCT01854047|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
298997|NCT01854138|ProMedica|Karl J. Beer, MD|419-578-4260|karl.beer@promedica.org|
298998|NCT01854177|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
298999|NCT01854242|University of Florida|David A. Weinstein, MD, MMSc|3522650855|weinsda@peds.ufl.edu|
299000|NCT01854281|University Hospital Motol|Jakub Honek, MD|+42022443|jakub.honek@gmail.com|4901
280883|NCT00772928|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
280884|NCT00772941|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280885|NCT00772954|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
280886|NCT00772967|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280887|NCT00773097|University Pittsburgh|Robert E. Schoen ME|412-648-9115|rschoen@pitt.edu|
280888|NCT00773136|University of Miami|Dr. Sara Wester|305-326-6132|swester2@med.miami.edu|
280889|NCT00773175|Halozyme Therapeutics|Dimitrios Chondros, M.D., Chief Medical Officer|858-794-8889|dchondros@halozyme.com|
299001|NCT01854359|National Institutes of Allergy and Infectious Diseases|Dr. Peter Kosa (Staff Scientist)|(301) 731-6444|peter.kosa@nih.gov|
280890|NCT00773253|University of California San Francisco|Graham A. Glass, MD|415-353-2311|Graham.Glass@ucsf.edu|
280891|NCT00773279|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
280892|NCT00773292|Imperial College London|Graham P Taylor|0207 594 3910|g.p.taylor@imperial.ac.uk|
280893|NCT00773370|VA Medical Center, Baltimore Maryland|Mary Stuart, ScD, VA Research Investigator|410-455-2084|stuart@umbc.edu|
280894|NCT00773383|Hoffman-LaRoche|Medical Communications|800-821-8590||
280895|NCT00773422|Yale School of Medicine|Sherry McKee, PhD|2037373529|sherry.mckee@yale.edu|
280896|NCT00773461|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
289178|NCT01231230|University of Miami|Adam Wanner, MD|(305)243-2568|awanner@med.miami.edu|
289179|NCT01231321|Abbott|Global Medical Services|800-633-9110||
289180|NCT01231334|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
299002|NCT01854528|AbbVie|Global Medical Information|800-633-9110||
289181|NCT01231373|BTG International Inc.|David Wright MBBS|610-278-1660|david.wright@btgplc.com|
289182|NCT01231399|City of Hope|Paul Frankel, Ph.D.|(626) 218-5265|pfrankel@coh.org|
289183|NCT01231412|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
289184|NCT01231464|GlaxoSmithKline|GSK Response Center|866-435-7343||
289185|NCT01231503|GlaxoSmithKline|GSK Response Center|866-435-7343||
289186|NCT01231516|GlaxoSmithKline|GSK Response Center|866-435-7343||
289187|NCT01231555|ViiV Healthcare|GSK Response Center|866-435-7343||
299003|NCT01854593|Department of Ophthalmology, Surugadai Hospital of Nihon University|Dr. Ayumu Manabe|+81-3-3293-1711|ayumu.m76@gmail.com|429
289188|NCT01231581|GlaxoSmithKline|GSK Response Center|866-435-7343||
289189|NCT01231607|GlaxoSmithKline|GSK Response Center|866-435-7343||
289190|NCT01231620|GlaxoSmithKline|GSK Response Center|866-435-7343||
289191|NCT01231633|Long Island Vitreoretinal Consultants|Vincent A. Deramo, MD|5164660390|vaderamo@gmail.com|222
289192|NCT01231646|North Shore-LIJ Health System|Connie Lau, MS, CCRC|516-325-7022|clau@nshs.edu|
289193|NCT01231659|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
289194|NCT01231841|Cleveland Clinic Foundation|Jaroslaw Maciejewski, MD PhD, Principal Investigator|216-445-5962|maciejj@ccf.org|
289195|NCT01231906|Children's Oncology Group|Results Reporting Coordinator|6264470064|resultsreportingcoordinator@childrensoncologygroup.org|
289196|NCT01231984|Becton Dickinson|Laurence Hirsch, MD|201-847-6513|Laurence_Hirsch@bd.com|
289197|NCT01232127|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
289198|NCT01232205|Dept Obstetrics Gynecology Indonesia University|Yuditiya Purwosunu|+44 753 870 6897|yudi@med.showa-u.ac.jp|
289199|NCT01232283|Celgene Corporation|Anne McClain|888-260-1599|ClinicalTrialDisclosure@celgene.com|
289200|NCT01232296|Novartis Pharmaceuticals|Study Director|862-778-8300||
289201|NCT01232452|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289202|NCT01232465|North Shore|Dennis Marchesi|516-562-1761|dmarches@nshs.edu|
289203|NCT01232491|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
289204|NCT01232504|Department of Hematology, Shanghai Jiao Tong University Affiliated First People's Hospital, China|Chun Wang||wangchun2@medmail.com.cn|
289205|NCT01232556|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289206|NCT01232569|Hoffmann-La Roche|Medical Communications|800 821-8590||
289207|NCT01232738|UKansasMCRI|Yunxia Wang|913-588-6970|ywang@kumc.edu|
289208|NCT01232790|Yale University School of Medicine, Department of Psychiatry|Cenk Tek MD, Associate Professor of Psychiatry; Director, Psychosis Program, CMHC|(203) 974-7484|cenk.tek@yale.edu|
289209|NCT01232829|University of Colorado Cancer Center|Dr. Wells Messersmith|303-724-3808|wells.messersmith@ucdenver.edu|
289210|NCT01232868|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
289211|NCT01232894|Novartis|Study Director|41 61 324 1111||
289212|NCT01232920|Proctor Foundation, University of California San Francisco|Nisha Acharya|415-476-8131|nisha.acharya@ucsf.edu|
289213|NCT01232946|Indiana University|Kieren J. Mather MD|317-278-7826|kmather@iu.edu|
289214|NCT01233050|Penn Medicine|Dr. Najjia Mahmoud, MD, Cheif of Colorectal Surgery|(215) 662-2078|najjia.mahmoud@uphs.upenn.edu|
289215|NCT01233076|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|Joseph.Rappon@cibavision.com|
289216|NCT01233232|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
299004|NCT01854632|PATH|Senior Clinical Research Scientist|206-285-3500|klewis@path.org|
299005|NCT01854645|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
289217|NCT01233258|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
289218|NCT01233284|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289219|NCT01233518|Heartflow, Inc.|Whitney Huey|650.257.6697|whuey@heartflow.com|
289220|NCT01233609|Foundation Fighting Blindness Clinical Research Institute|Chief Drug Development Officer|410 423 0581|pzilliox@blindness.org|
299006|NCT01854658|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
280897|NCT00773474|Hoosier Cancer Research Network, Inc.|Principal Investigator|317-921-2050|jsmith@hoosiercancer.org|
280898|NCT00773513|Hoffmann-La Roche|Medical Communications|(+41) 616878333|global.trial_information@roche.com|
299007|NCT01854697|AbbVie|Global Medical Information|800-633-9110||
280899|NCT00773604|University of California, San Francisco|Jill Ostrem|415-353-7885|Jill.Ostrem@ucsf.edu|
280900|NCT00773734|Celgene Corporation|Anne McClain|888-243-1360|clinicaltrialdisclosure@celgene.com|
280901|NCT00773747|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280902|NCT00773786|Saint Francis Hospital and Medical Center|Richard ZuWallack, MD||rzuwalla@stfranciscare.org|
280903|NCT00773838|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280904|NCT00773955|Washington University|Maria Q. Baggstrom, M.D.||Mbaggstr@im.wustl.edu|
280905|NCT00773968|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
280906|NCT00774046|University of Chicago|Dr. Lucy A. Godley|773-702-4140|lgodley@medicine.bsd.uchicago.edu|
280907|NCT00774163|Tulane University School of Public Health and Tropical Medicine|Dr. Richard Oberhelman|504-988-2511|oberhel@tulane.edu|
280908|NCT00774202|Weill Cornell Medical College|James B. Bussel, M.D. Professor of Pediatrics|212-746-3474|jbussel@med.cornell.edu|
280909|NCT00774267|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280910|NCT00774397|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
280911|NCT00774566|Stardtisches Klinikum Karlsruhe, Medizinische Klinik IV|Dr. Armin Luik|0049-721974|armin.luik@klinikum-karlsruhe.de|2901
280912|NCT00774579|Imperial College Healthcare London|Prof. Desmond Johnston|020 3312 1253|desmond.johnston@imperial.ac.uk|
280913|NCT00774748|UNC Chapel Hill School of Medicine Dept. Hematology|Clinical Research Coordinator|919-966-2359|catherine_soriano@med.unc.edu|
299008|NCT01854710|Alexza Pharmaceuticals, Inc|Chief Scientific Officer|650.944.7777|jcassella@alexza.com|
280914|NCT00774787|Rigel Dermatology|Darrell Rigel|212-684-5964|dsrigel@prodigy.net|
280915|NCT00774800|Halozyme Therapeutics, Inc.|Vice President, Endocrinology Clinical Development|(858) 794-8889||
280916|NCT00774852|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
280917|NCT00774930|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
280918|NCT00774995|GlaxoSmithKline|GSK Response Center|866-435-7343||
280919|NCT00775021|Vistakon|Kurt Moody, Director Design R&D|904-443-3088||
308935|NCT02625922|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
280920|NCT00775138|Insmed|Dr. Kevin Mange, Sr. Vice President, Clinical Development|908-947-2651|Kevin.Mange@Insmed.com|
280921|NCT00775203|Labopharm Inc.|Director of Regulatory Affairs|1 450 686 1017||
280922|NCT00775229|University of Chicago|Dr. Jon Grant|773-834-1325|jongrant@uchicago.edu|
280923|NCT00775268|National Cancer Institute|Dr. Esther Mena|240-760-6111|esther.menagonzalez@nih.gov|
280924|NCT00775346|Covidien|Manager, Clinical Affairs|303 305 2591|Norma.Prince@Covidien.com|
280925|NCT00775411|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
280926|NCT00775437|AbbVie|Global Medical Information|800-633-9110||
280927|NCT00775450|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
280928|NCT00775463|United Therapeutics Corporation|Oral Treprostinil Program Head|919-485-8350|klaliberte@unither.com|
280929|NCT00775528|Solvay Pharmaceuticals|Sven Voet - Global Communication|+32 (0)2 509 69 77|sven.voet@solvay.com|
280930|NCT00775593|GIMEMA|Edoardo La Sala|+39 06 70390524|e.lasala@gimema.it|
280931|NCT00775606|Rush University Medical Center|Allan R. Tenorio|312-942-3665|allan_s_tenorio@rush.edu|
280932|NCT00775645|SWOG Statistical Center|Study Statistician|206-667-4623||
280933|NCT00775658|Vanderbilt Medical Center|John Fahrenholz, M.D.|615-936-2727|john.m.fahrenholz@vanderbilt.edu|
280934|NCT00775671|Vanderbilt University|Nancy J Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
280935|NCT00775684|University of Pennsylvania|Associate Professor of Medicine. Director, Translational Research Center|215 746-0025|rickels@mail.med.upenn.edu|
280936|NCT00775931|Masonic Cancer Center, University of Minnesota|Dr. Paul Orchard|612-626-2313|orcha001@umn.edu|
280937|NCT00775944|University of Nottingham|Graeme Docherty|01158321380|graeme.docherty@nottingham.ac.uk|
280938|NCT00775983|UCSF|Abby Sokoloff|4155140440|sokoloffa@obgyn.ucsf.edu|
280939|NCT00776009|Novartis Pharmaceuticals|Study Director|862 778-8300||
280940|NCT00776230|Valneva Austria GmbH|Katrin Dubischar-Kastner|+43120620|info@valneva.com|0
280941|NCT00776295|H. Lee Moffitt Cancer Center|Mohamed Kharfan Dabaja, MD|961-1350000|MK143@aub.edu.lb|5350
280942|NCT00776594|Dana Farber Cancer Institute|Mary-Ellen Taplin, MD|617-632-6328|Mary_taplin@dfci.harvard.edu|
280943|NCT00776659|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280944|NCT00776789|AIIMS|Dr Anu Thukral|01126594605|dranuthukral@yahoo.com|
280945|NCT00776919|GlaxoSmithKline|GSK Response Center|866-435-7343||
280946|NCT00776984|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
280947|NCT00776997|Torax Medical|Amy Derosier, VP of Clinical Affairs|651-361-8900|aderosier@toraxmedical.com|
280948|NCT00777023|Depomed|Head of R&D|650-462-5900|msweeney@depomed.com|108
289221|NCT01233687|University of Pittsburgh|Ahmad Tarhini, MD|(412) 648-6578|tarhiniaa@upmc.edu|
289222|NCT01233726|Intensive Care Unit, Hospital Clínico Universitario|Alfonso Mesejo|961 97 35 00|mesejo_alf@gva.es|
289223|NCT01233817|Department of Physical Medicine and Rehabilitation, School of Medicine, University of Utah|Aga Lewelt MD, Principal Investigator|801-518-4572|aga@genetics.utah.edu|
289224|NCT01233869|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
280949|NCT00777049|Translational Research in Oncology (TRIO)|Valérie Bee-Muntenau, Director of Project Management|+33 1 58 10 09 09|Valerie.Bee@trioncology.org|
280950|NCT00777062|University of Pennsylvania|Dr. Kyle Kampman|215-222-3200|kampman@mail.med.upenn.edu|109
280951|NCT00777088|Medtronic|Darren LaCour|949-680-1274|darren.j.lacour@medtronic.com|
280952|NCT00777101|Puma Biotechnology, Inc.|Senior Director, Clinical Operations|+1 (424) 248-6500|clinicaltrials@pumabiotechnology.com|
280953|NCT00777153|AstraZeneca|Gerard Lynch||ClinicalTrialTransparency@astrazeneca.com|
280954|NCT00777179|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
280955|NCT00777205|Veterans Affairs Healthcare System|Marcia Valenstein, MD|734-845-3649|marcia.valenstein@va.gov|
280956|NCT00777257|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
280957|NCT00777296|Insmed Incorporated|Dr. Kevin Mange, Sr. Vice President, Clinical Development|908-947-2651|Kevin.Mange@Insmed.com|
299009|NCT01854775|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
280958|NCT00777335|University of California Los Angeles (UCLA) / Cancer International Research Group (CIRG) (Translational Research in Oncology TRIO) Inc.|Dr. Richard Finn|+ 1 310 586 2091|RFinn@mednet.ucla.edu|
280959|NCT00777491|NRG Oncology|Wendy Seiferheld, M.S.|215-574-3208|seiferheldw@nrgoncology.org|
280960|NCT00777556|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
280961|NCT00777608|Merck Sharp and Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280962|NCT00777634|McLean Hospital|Study Coordinator|617-855-2984|eryan@mclean.harvard.edu|
280963|NCT00777764|Genentech, Inc.|Medical Communications|800-821-8590||
280964|NCT00777790|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
280965|NCT00777803|Merz Pharmaceuticals GmbH|Matthias Zerm|+49 69 1503|matthias.zerm@merz.de|865
280966|NCT00777829|UCSD|Dr. Sara C. Mednick|8586423192|mednicks@uci.edu|
280967|NCT00777855|UCSF|Leslie Benet|(415) 476-3853|leslie.benet@ucsf.edu|
280968|NCT00777920|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
280969|NCT00777946|Novartis Pharmaceuticals|Study Director|862-778-8300||
280970|NCT00778102|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
280971|NCT00778167|University of Colorado Denver|Dr. David R. Camidge|720-848-0449|ross.camidge@ucdenver.edu|
280972|NCT00778258|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
280973|NCT00778310|University of Texas Health Science Center at San Antonio|Steven R. Pliszka MD|210-567-5475|pliszka@uthscsa.edu|
280974|NCT00778336|Boston Scientific Corporation|DeeAnn Tinjum|763-450-8707|deeann.tinjum@bsci.com|
280975|NCT00778375|University of Texas (UT) MD Anderson Cancer Center|Farhad Ravandi-Kashani, Professor, Leukemia Department||CR_Study_Registration@mdanderson.org|
280976|NCT00778622|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
280977|NCT00778648|Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie , Charité - Universitätsmedizin Berlin, Germany|Dr. Stephanie Roll|+49 30 450 529023|stephanie.roll@charite.de|
280978|NCT00778817|The University of Chicago|Walter M. Stadler, MD|(773) 702-6149|wstadler@medicine.bsd.uchicago.edu|
280979|NCT00778830|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
280980|NCT00778869|Merck, Sharp & Dohme Corp|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280981|NCT00778895|GlaxoSmithKline|GSK Response Center|866-435-7343||
280982|NCT00778921|Novartis Pharmaceuticals|Study Director|862-778-8300||
280983|NCT00779025|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
280984|NCT00779103|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
308936|NCT02625974|BAYER|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
280985|NCT00779142|Wake Forest Baptist Health Eye Center|Dr. Shree Kurup|336-716-4091|skurup@wakehealth.edu|
280986|NCT00779155|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303-795-3222|abraswell@pico-tesla.com|
280987|NCT00779246|Christiana Care Health System|Marci Drees, MD, MS|302-733-5602|mdrees@christianacare.org|
280988|NCT00779259|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
280989|NCT00779285|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
280990|NCT00779311|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
280991|NCT00779324|Indiana University School of Medicine|Flora Hammond, MD|3173292106|flora.hammond@rhin.com|
280992|NCT00779402|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
280993|NCT00779467|Wake Forest School of Medicine|Peter H. Pan, MD, MSEE|336-718-8278|ppan@wakehealth.edu|
280994|NCT00779506|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
280995|NCT00779558|Stanford University|Alan Schroeder|408 885-5260|alan.schroeder@hhs.sccgov.org|
280996|NCT00779584|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289225|NCT01233921|Fred Hutchinson Cancer Research Cetner|Dr. Paul J. Martin|206-667-4798|pmartin@fhcrc.org|
289226|NCT01233999|Emory University|Dr. Suephy Chen|404-778-3084|schen2@emory.edu|
289227|NCT01234207|UCaliforniaBerkeley|Andrew D. Graham|510-643-9252|agraham@berkeley.edu|
289228|NCT01234337|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
289229|NCT01234350|Ferring Pharmaceuticals|Clinical Development Support|-/-|DK0-Disclosure@ferring.com|
289230|NCT01234402|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
299010|NCT01854827|University of Michigan|DCC PI|734-936-3585|mageej@med.umich.edu|
299011|NCT01854879|Cochlear Americas|Lori O'Neill Director of Research|(303) 790-9010|loneill@cochlear.com|
280997|NCT00779675|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
280998|NCT00779701|Temple University Hospital|Dr. Nina Gentile|215-707-2000|ngentile@temple.edu|8402
280999|NCT00779766|GlaxoSmithKline|GSK Response Center|866-435-7343||
281000|NCT00779779|GlaxoSmithKline|GSK Response Center|866-435-7343||
281001|NCT00779857|AtriCure, Inc.|Jim Lucky|1-513-755-4101|jlucky@atricure.com|
281002|NCT00779870|Imperial College London|Prof Fan Chung|00442075947954|f.chung@imperial.ac.uk|
281003|NCT00779909|Boston University School of Dental Medicine|Raul I Garcia, DMD|617-638-6385|rig@bu.edu|
281004|NCT00780026|University of Michigan|Subramanian Sathishkumar||ssatish@med.umich.edu|
281005|NCT00780143|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
281006|NCT00780208|Medical University of South Carolina|Aimee McRae-Clark, Professor|843-792-5216|mcraeal@musc.edu|
281007|NCT00780234|Rocky Mountain Regional VA Medical Center|Robert L. Keith, MD|720-857-5120|robert.keith@ucdenver.edu|
281008|NCT00780273|University if Rochester Medical Center|Dr. George Romanos|585-276-4149|GeorgiosRomanos@urmc.rochester.edu|
281009|NCT00780338|RAND|Matthew Chinman|412 683-2300|chinman@rand.org|4287
281010|NCT00780416|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
281011|NCT00780442|Medical University of South Carolina|Dr. Kimber L. Price|843-792-4847|pricekl@musc.edu|
281012|NCT00780494|Stanford University|Pamela Kunz|650-725-8738|pkunz@stanford.edu|
281013|NCT00780559|University of Maryland School of Medicine|Clinical Research Coordinator|(410) 328-6583|inmed@som.umaryland.edu|
281014|NCT00780572|VA SLC HCS|Director HSR&D|801-582-1565|IDEAS@va.gov|
281015|NCT00780676|University of Texas (UT) MD Anderson Cancer Center|Stacy Moulder, MD/Associate Professor, Breast Medical Oncology|713-792-2360|CR_Study_Registration@mdanderson.org|
281016|NCT00780715|University of Dundee|Professor Ewan Pearson|+44 (0) 1382 383387|e.z.pearson@dundee.ac.uk|
281017|NCT00780741|Jaeb Center for Health Research|Ray Kraker, Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
281018|NCT00780910|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
281019|NCT00780962|Beth Israel Deaconess Medical Center|Nathan I. Shapiro, MD, MPH|617-754-2323|nshapiro@bidmc.harvard.edu|
281020|NCT00780975|Pharma Mar, S.A.|Clinical Development Department of PharmaMar´s Oncology,Business Unit.,|+34 918466000|clinicaltrials@pharmamar.com|
281021|NCT00781079|Pittsburgh VA|Matthew Chinman|412 360-2438|matthew.chinman@va.gov|
281022|NCT00781274|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
281023|NCT00781326|University of Pittsburgh|Ellen Whyte, MD|412 246 5066|whyteem@upmc.edu|
281024|NCT00781365|HealthPartners Institute for Education and Research|Dr. Karen Margolis, MD MPH|952-967-7301|karen.l.margolis@healthpartners.com|
281025|NCT00781391|Daiichi Sankyo, Inc.|James Hanyok, Sr. Director|732-590-5000|jhanyok@dsi.com|
281026|NCT00781456|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
281027|NCT00781508|MetroHealth Medical Center|Robert C. Bahler, MD|216 778-2431|rbahler@metrohealth.org|
281028|NCT00781599|University of Kansas Medical Center|Dr. Nikki Nollen|(913) 588-3784|NNOLLEN@kumc.edu|
281029|NCT00781768|Loyola University Medical Center|Patrick Stiff, M.D.|708-327-3148|pstiff@lumc.edu|
281030|NCT00781859|ThromboGenics|Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
281031|NCT00781885|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
281032|NCT00781898|University Of Pennsylvania|Charle P. O'Brien|215-222-3200|obrien@mail.med.upenn.edu|
281033|NCT00781911|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281034|NCT00781937|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
281035|NCT00781950|St. Boniface Hospital Research Centre|Dr. Grant Pierce|(204) 235-3414|GPierce@sbrc.ca|
281036|NCT00781963|VA Greater Los Angeles Healthcare System|Dr. Cathy Alessi|818 895-9311|Cathy.Alessi@va.gov|
281037|NCT00782067|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
281038|NCT00782171|Institut Straumann AG - Clinical Research|Institut Straumann AG|+41 61 965 11 11|research@straumann.com|
281039|NCT00782210|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281040|NCT00782275|Beth Israel Deaconess Medical Center|David F. McDermott MD PhD|617-632-9262|dmcdermo@bidmc.harvard.edu|
281041|NCT00782288|Johns Hopkins University|Pamela L. Zeitlin, M.D., Ph.D., Professor and Director of SOM Pediatric Pulmonary|443-287-8981|pzeitlin@jhmi.edu|
281042|NCT00782340|Chelsea Therapeutics Inc.|Chief Scientific Officer|704-973-4202|hewitt@chelsearx.com|
281043|NCT00782379|Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
281044|NCT00782418|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281045|NCT00782496|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
281046|NCT00782509|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281047|NCT00782626|Dana-Farber Cancer Institute|Mark Kieran|(617) 632-4907|mark_kieran@dfci.harvard.edu|
281048|NCT00782639|Bracco Diagnostics, Inc|Usha Halemane|609-514-2578|usha.halemane@diag.bracco.com|
289231|NCT01234467|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
289232|NCT01234480|Becton Dickinson|Karen Yanson|410-316-4793|karen_a_yanson@bd.com|
289233|NCT01234649|Woman's Hospital|Dr Karen Elkind-Hirsch|225 231-5275|karen.elkind-hirsch@womans.org|2
289234|NCT01234675|Cleveland Sleep Research Center|Mansoor Ahmed, MD|4402438044|sleepresearchcenter@yahoo.com|
289235|NCT01234714|University of Zurich|Dr Dimitri Aristotle Raptis, Principal Investigator|+41442553300|dimitri.raptis@usz.ch|
289236|NCT01234766|Dartmouth-Hitchcock Medical Center|Frederick Lansigan, MD|603-650-4628|Frederick.Lansigan@hitchcock.org|
281049|NCT00782717|Alcon Research, Ltd.|Director of Alcon Clinical|888.451.3937 and 817.568.6725|medinfo@alconlabs.com|
281050|NCT00782756|Memorial Sloan Kettering Cancer Center|Dr. Philip Gutin|212-639-8556|gutinp@mskcc.org|
299012|NCT01854905|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
281051|NCT00782795|University of Michigan|Matthew DiMagno||mdimagno@umich.edu|
281052|NCT00782821|University of Cincinnati|E. Steve Woodle, MD|513-558-6001|woodlees@ucmail.uc.edu|
281053|NCT00782834|Fox Chase Cancer Center|Margaret von Mehren, M.D., Director of Sarcoma Oncology|215-728-2814|margaret.vonMehren@fccc.edu|
281054|NCT00783094|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299013|NCT01854918|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
281055|NCT00783198|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
281056|NCT00783289|MedImmune, LLC.|Rene van der Merwe, MBChB/Senior Director, Clinical Development|301-398-0000|vandermerwer@medimmune.com|
281057|NCT00783302|GE Healthcare|Paul Gordon, PhD|011-47-2318-5822|paul.gordon@ge.com|
281058|NCT00783367|University of Pennsylvania, Clinical Research Unit, Lymphoma Group|Ellen Napier, CRNP|215.279.1972|Ellen.Napier@pennmedicine.upenn.edu|
281059|NCT00783432|Meda Pharmaceuticals|William Wheeler, PhD|732-564-2351|wwheeler@medapharma.us|
281060|NCT00783614|Minneapolis Medical Foundation|Dr. Jason Baker|612-873-2705|baker459@umn.edu|
281061|NCT00783692|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
281062|NCT00783705|Mayo Clinic Rochester|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
299014|NCT01854944|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
281063|NCT00783718|Millennium Pharmaceuticals Inc|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
281064|NCT00783796|Abbott Vascular|David R Rutledge|(408) 845-3820|david.rutledge@av.abbott.com|
281065|NCT00783835|Janssen-Cilag Farmaceutica Ltda|Medical Manager|+55 11 30302738||
281066|NCT00783952|Massachusetts General Hospital|Robert M Kacmarek PhD, RRT|617-314-2222|rkacmarek@partners.org|
281067|NCT00783965|ChildrensHRCOakland|Raj Prasad|510-450-7602|rprasad@chori.org|7602
281068|NCT00784030|New York University School of Medicine|Dr. Irina Barash|212.263.5851|irina.barash@nyumc.org|
281069|NCT00784095|VA Health Services Research and Development|Dr. Karen Steinhauser|9196682148|karen.steinhauser@va.gov|
281070|NCT00784134|Johns Hopkins University Division of Brain Injury Outcomes|Dr. Daniel F. Hanley|4106146996|dhanley@jhmi.edu|
281071|NCT00784147|TaiMed Biologics, Inc.|Stanley T. Lewis, Jr., MD|949-769-6543|stlewis@taimedbiologics.com|108
281072|NCT00784225|SWOG Statistical Center|SELECT/S0000B Statistician|2066674623|adarke@fredhutch.org|
281073|NCT00784238|Clinical Research Team, Medical Affairs Korea|Senior Clinical research Associate|82-2-2094-4804||
281074|NCT00784277|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Senior Director, Clinical Leader|609-730-4537||
299015|NCT01855048|Organization:Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
281075|NCT00784303|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
281076|NCT00784368|Global Medical Organization; Janssen R&D|Director, Established Products|(609) 730-7674||
281077|NCT00784459|Washington University|Dr Jonathan Green|314-747-3591|jgreen@wustl.edu|
281078|NCT00784524|Masonic Cancer Center, University of Minnesota|Dr. Douglas Yee|612-626-8487|yeexx006@umn.edu|
281079|NCT00784550|GlaxoSmithKline|GSK Response Center|866-435-7343||
281080|NCT00784563|Veterans Affairs Medical Center of Iowa City|Ergun Y. Uc, MD|319-356-8753|ergun-uc@uiowa.edu|
281081|NCT00784641|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
281082|NCT00784654|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
281083|NCT00784693|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281084|NCT00784719|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281085|NCT00784758|University of California, Los Angeles|Dr. Eric Kleerup|310-794-6593|ekleerup@mednet.ucla.edu|
299016|NCT01855074|Janssen. Pharmaceutical Companies of Johnson and Johnson|Medical Manager Neurosciences|+507-3989740|dmuschet@its.jnj.com|
281086|NCT00784784|Mount Sinai Hospital|Dr. Brenda Coleman|416-586-4800|bcoleman@mtsinai.on.ca|4161
281087|NCT00784810|Napp Pharmaceuticals Ltd|Director of Medical Affairs|01223 424444||
281088|NCT00784836|Biogen Idec Inc.|Biogen Idec Medical Director||clinicaltrials@biogenidec.com|
281089|NCT00784849|LSU Dept of Surgery|Dr. Eugene Woltering|504 464-8500|ewolte@lsuhsc.edu|
281090|NCT00784875|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281091|NCT00784927|Mayo Clinic Arizona|Craig B. Reeder, MD||Reeder.Craig@mayo.edu|
281092|NCT00784979|Tampa General Hospital|Dr. John Leone|813-844-5666|jpleone@tgh.org|
281093|NCT00785044|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
281094|NCT00785213|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
281095|NCT00785486|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
281096|NCT00785512|Forest Laboratories|John Whalen, MD Executive Director of Clinical Development - Cardiovascular and Metabolism|1-201-427-8259|John.Whalen@frx.com|
289237|NCT01234831|Massachusetts General Hospital|Dr. Erica S. Shenoy|617-726-2036|eshenoy@partners.org|
289238|NCT01234870|Northwestern University|Dr. James Carr|(312)695-4218|jcarr@northwestern.edu|
289239|NCT01234883|Baxter Healthcare|Drew Jones, M.D.|224-270-2659|Drew_Jones@baxter.com|
289240|NCT01234922|Wake Forest Baptist Health|William J. Petty, MD|336-716-3313|wpetty@wakehealth.edu|
289241|NCT01235195|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289242|NCT01235234|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
289243|NCT01235338|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
281097|NCT00785538|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281098|NCT00785577|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281099|NCT00785629|Denver Nephrologists, P.C.|Geoffrey A. Block, MD|303-364-4775|gablock@denverneph.net|
281100|NCT00785707|MED-EL Corporation|Sr. Clinical Research Associate||clinicaltrials@medelus.com|
281101|NCT00785772|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281102|NCT00785785|Novartis Pharmaceuticals|Study Director|862-778-8300||
281103|NCT00785798|Yale University School of Medicine|Francine Foss, MD||Francine.Foss@yale.edu|
281104|NCT00785928|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281105|NCT00785980|Mutual Pharmaceutical Company, Inc.|Medical Director|215-697-1743|clinicaltrials@urlmutual.com|
281106|NCT00786019|University of Colorado|Judith Regensteiner, PhD|303-724-2247|judy.regensteiner@ucdenver.edu|
281107|NCT00786032|Hines Coordinating Center|Project Manager|708-202-5785|tamara.paine@va.gov|
281108|NCT00786188|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
281109|NCT00786409|University of Chicago|Linda Wagner-Weinter, MD|773-702-2245|lww@uchicago.edu|
281110|NCT00786422|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
281111|NCT00786474|Duke University Medical Center|Thomas Ortel, MD, PhD, Principal Investigator|919-684-5350|thomas.ortel@duke.edu|3
281112|NCT00786487|University of Minnesota|Dr. Lisa Chow|612-625-8934|chow0007@umn.edu|
281113|NCT00786565|Bausch & Lomb|Jon Hayashida|(585) 338-6370|jon.hayashida@bausch.com|
281114|NCT00786643|Accelerated Community Oncology Research Network, Inc.|Vice President of Scientific Affairs|901-435-5570|mwalker@acorncro.com|
281115|NCT00786799|University of California, San Francisco|Robert L. Hendren, D.O.|415-476-7198|robert.hendren@ucsf.edu|
281116|NCT00786825|University of Minnesota|Elizabeth Seaquist, MD|612-624-9176|seaqu001@umn.edu|
281117|NCT00786838|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Senior Medical Director|1 908 704-5779||
281118|NCT00786864|University of the Witwatersrand|Gina L Fanucchi|+27 11 616 4400|gfanucs@mweb.co.za|
281119|NCT00786916|Akron Children's Hospital|Michael D. Reed, Pharm.D.|330-543-3193|MReed@chmca.org|
281120|NCT00786994|Center for Dermatooncology, Department of Dermatology, University Hospital Tübingen, Tübingen, Germany|Dr Annette Pflugfelder||annette.pflugfelder@med.uni-tuebingen.de|
281121|NCT00787020|Duke University Medical Center|DaiWai M Olson|9196683751|Olson006@mc.duke.edu|
281122|NCT00787137|PanGenetics UK Limited|John Powell|+441763257869|info@pangenetics.com|
281123|NCT00787150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281124|NCT00787189|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
281125|NCT00787202|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281126|NCT00787241|Northwestern University Feinberg School of Medicine|Dr. Robert J. McCarthy|312-926-9015|r-mccarthy@northwestern.edu|
281127|NCT00787254|Takeda Global Research and Development Center, Inc.|Sr. VP Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
281128|NCT00787267|Duke University Medical Center|Michael Kelley , MD|919-286-0411|kelleym@duke.edu|7326
281129|NCT00787319|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281130|NCT00787332|Canyon Pharmaceuticals|Director of Clinical Trials|888-434-7003|info@canyonpharma.com|
281131|NCT00787527|University of Texas MD Anderson Cancer Center|Yasuhiro Oki, MD/ Associate Professor|713-792-2860|yoki@mdanderson.org|
281132|NCT00787566|Aviana Consulting, LLC|Vanaja V. Ragavan, M.D.|610-795-7403|vvragavan@comcast.net|
281133|NCT00787605|Novartis Pharmaceuticals|Study Director|862-778-8300||
281134|NCT00787644|University of Vermont|Dr. Anne Dixon|802 656 3525|anne.dixon@uvm.edu|
281135|NCT00787722|Northwestern University|Kathleen Quigley|312-695-8192|k-quigley@northwestern.edu|
281136|NCT00787761|Blood and Marrow Transplant Group of Georgia|Asad Bashey, MD, PhD, Principal Investigator|404-255-1930|abashey@bmtga.com|
281137|NCT00787787|Cancer Consortium|Medical Director, Clinical Research Support|206-667-5767|lmendels@fredhutch.org|
281138|NCT00787800|Mayo Clinic|Paul A. Friedman, MD, Professor of Medicine|507-284-7661|friedman.paul@mayo.edu|
281139|NCT00787839|Atlanta VA Medical Center|Lawrence S Phillips, MD|404-728-7608|lawrence.phillips@va.gov|
281140|NCT00787852|BrUOG|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
281141|NCT00787891|Janssen R&D US|PORTFOLIO/CDT LEADER|1 609 730-2548||
281142|NCT00787904|Emory University|Vin Tangpricha|404-727-7254|vin.tangpricha@emory.edu|
281143|NCT00787930|Duke University Medical Center|John Beyer, MD|919-668-0209|john.beyer@dm.duke.edu|
281144|NCT00787943|Northwestern University|Amy Paller, MD|312-695-3721|apaller@northwestern.edu|
281145|NCT00788008|Duke University Medical Center|Deborah Attix, PhD|919-668-2846|deborah.koltai@dm.duke.edu|
281146|NCT00788073|Seaside Therapeutics|Dr. Paul Wang, Vice President of Clinical and Medical Affairs|617-374-9009|pwang@seasidetherapeutics.com|1015
281147|NCT00788151|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
281148|NCT00788255|Stanford University School of Medicine|Dr. Alexander Butwick|(650) 736-8513|ajbut@stanford.edu|
281149|NCT00788372|Janssen Research & Development, L.L.C. USA|Director, Clinical Research|1 609 730-3387||
281150|NCT00788593|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
281151|NCT00788697|Bracco Diagnostics Inc.|Maria Luigia Storto, MD Executive Director X-Ray and Ultrasound Medical Affairs|(609) 514-2200|MariaLuigia.Storto@diag.bracco.com|
281152|NCT00788775|Dana-Farber Cancer Institute|F. Stephen Hodi, MD|617.632.5053|Stephen_Hodi@dfci.harvard.edu|
281153|NCT00788827|Imperial College London|Professor Charles Pusey|+44 3313 2308|c.pusey@imperial.ac.uk|
281154|NCT00788892|Jazz Pharmaceuticals|Associate Director, Clinical Trial Disclosure & Transparency|215-832-3750||
281155|NCT00788957|Amgen Inc.|Study Director|866-572-6436||
281156|NCT00789035|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281157|NCT00789074|Queen Mary University of London|Professor Peter Hajek|+44 207 882 8231|p.hajek@qmul.ac.uk|
281158|NCT00789113|University of Minnesota College of Pharmacy|Dr. Rory P. Remmel|6126240472|remme001@umn.edu|
281159|NCT00789191|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
281160|NCT00789256|Dartmouth-Hitchcock Medical Center|Marc Gautier, MD - Principal Investigator|603-650-5529|marc.gautier@hitchcock.org|
281161|NCT00789321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|clinicaltrialsdisclosure@merck.com|
281162|NCT00789360|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7071|ClinicalTrialsInfo@alexza.com|
281163|NCT00789373|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281164|NCT00789438|Institut für Anästhesiologie und Operative Intensivmedizin, Universitätsklinukum Schleswig-Holstein, Campus Kiel|Christoph Ilies M.D.|+49-431-597|christoph.ilies@anaesthesie.uni-kiel.de|2991
281165|NCT00789477|Regeneron|Clinical Trial Management|9148475385|clinicaltrials@regeneron.com|
281166|NCT00789529|Manhattan Vision Associates / Institute for Vision Research|Dr. George Zikos|2126884277|gzikos@mvaivr.com|
281167|NCT00789555|Alcon Research|Terri Pasquine, Sr. Clinical Lead|817-551-4760|terri.pasquine@alconlabs.com|
281168|NCT00789581|Sarah Cannon Development Innovations|Charles H. Davis, RAC|615 524-4341|charles.davis2@scri-innovations.com|
281169|NCT00789672|Jaeb Center for Health Research|Raymond Kraker, MSPH|813-875-8690|pedig@jaeb.org|
281170|NCT00789685|Faron Pharmaceuticals Limited|Dr Ilse Piippo, MD|+358 2469 5151|ilse.piippo@faronpharmaceuticals.com|
281171|NCT00789698|Sunovion Pharmaceuticals|Medical Director, CNS|1-866-503-6351||
281172|NCT00789724|VCU Pauley Heart Center|Antonio Abbate, MD, PhD|8048280513|aabbate@mcvh-vcu.edu|
281173|NCT00789737|Daiichi Sankyo Pharma Development|Director Metabolic Clinical Development|732-590-5000||
281174|NCT00789750|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400||
281175|NCT00789776|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
281176|NCT00789802|Washington University|Dr. Tessa Madden|3147471331|maddent@wustl.edu|
281177|NCT00789815|Chung Gung Memorial Hospital|Ting-Yu Lin|886 3 3281200|yuebaoyuebao@yahoo.com.tw|5108
281178|NCT00789828|Novartis Pharmaceuticals|Study Director|862-778-8300||
281179|NCT00789854|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
281180|NCT00789867|Imperial College|Samia Soussi|0207 594 7980|s.soussi@imperial.ac.uk|
281181|NCT00789880|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
281182|NCT00789958|SWOG|SWOG Statistician|206-667-4408||
281183|NCT00789997|The Ottawa Hospital Research Institute|Dr Shawn Aaron||saaron@ohri.ca|
281184|NCT00790023|Sunovion|Respiratory Medical Director|1-866-503-6351||
281185|NCT00790036|Novartis Pharmaceuticals|Study Director|862-778-8300||
281186|NCT00790062|University of Alabama at Birmingham|Alan T. N. Tita, MD|(205) 934-9616|atit@uab.edu|
281187|NCT00790088|Medtronic Int. Trading SaRL|Dr Odile Carrette|+41218038119|odile.osullivan@medtronic.com|
281188|NCT00790192|Sunovion|Josephine Cucchiaro, PhD, Executive Director|201-592-2050|josephine.cucchiaro@sunovion.com|
299017|NCT01855126|Rensselaer Polytechnic Institute|Mariana Figueiro|(518)687-7142|figuem@rpi.edu|
281189|NCT00790205|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281190|NCT00790218|Can-Fite BioPharma|Sari Fishman, Director of Clincal Trials|972528998666|sari@canfite.co.il|
281191|NCT00790270|Stony Brook U|Adam Singer|631 444 7856|adam.singer@stonybrook.edu|
281192|NCT00790296|University of Connecticut Health Center|Andrew Winokur MD PhD|860-679-6775|awinokur@uchc.edu|
281193|NCT00790335|Washington University in St. Louis|Dr. Suresh Vedantham, Principal Investigator|3143622900|vedanthams@mir.wustl.edu|314
281194|NCT00790400|Novartis Pharmaceuticals|Novartis Pharmaceuticals|862-778-8300||
281195|NCT00790556|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281196|NCT00790569|Butler Hospital|Dr. Michael Stein|401-455-6646|michael_stein@brown.ed|
289244|NCT01235351|TIMI Study Group|Jessica L. Mega, MD, MPH|6172780145|jmega@partners.org|
289245|NCT01235377|Veterans Health Administration Pharmacy Benefits Management|Madeline McCarren, PhD|7087867987|madeline.mccarren@va.gov|
289246|NCT01235403|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
289247|NCT01235442|Amgen Inc.|Study Director|866-572-6436||
289248|NCT01235507|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
299018|NCT01855243|Cairo University|Eman Said Sayed|01001186079|gaviota_3011@hotmail.com|002
299019|NCT01855360|Brigham and WQomen's Hospital|Rodney H Falk|6175257053|rfalk@bwh.harvard.edu|
299020|NCT01855399|VA HSRD: CCMR Ann Arbor and University of Michigan Medical School|Dr. Michele Heisler|(734) 845-3614|mheisler@umich.edu|
299021|NCT01855412|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
299022|NCT01855425|Carestream Health, Inc.|Susan Pate, RN, MS, RAC|585-627-6557|susan.pate@carestream.com|
299023|NCT01855750|Janssen Research & Development, LLC|Medical Officer|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
299024|NCT01855789|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
299025|NCT01855828|Yale University|Lajos Pusztai, MD, DPhil|203-737-6858|lajos.pusztai@yale.edu|
299026|NCT01855919|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299027|NCT01855945|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
299028|NCT01855958|Hospital de Clínicas de Porto Alegre|Wolnei Caumo, MD,PhD.|+555133598430|caumo@cpovo.net|
299029|NCT01855997|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
299030|NCT01856114|UT MD Anderson Cancer Center|Dr. David Hui, MD, Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
281197|NCT00790582|Forbes Norris MDA/ALS Center|Giovanna Kushner|415-600-3983|kushneg@cpmcri.org|
281198|NCT00790647|Boston Medical Center|Vaishali Sanchorawala|617-638-8265|vaishali.sanchorawala@bmc.org|
281199|NCT00790673|Can-Fite Biopharma|Pnina Fishman, PhD|011972 39241114|pnina@canfite.co.il|
281200|NCT00790699|Texas Diabetes & Endocrinology|Thomas Blevins,MD|5812.334.3505|blevins@texasdiabetes.com|
281201|NCT00790738|The Zucker Hillside Hospital|Raphael J. Braga, MD|718-4708060|rbraga@nshs.edu|
281202|NCT00790751|Vivus, Inc|Wesley W Day PhD|650-934-5200||
281203|NCT00790790|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281204|NCT00790803|Wake Forest Baptist Health Eye Center|Dr. Shree Kurup|336-716-4091|skurup@wakehealth.edu|
281205|NCT00790842|PrECOG|PrECOG Statistician|978-835-3516|jbmanola@gmail.com|
281206|NCT00790855|The University of MD Anderson Cancer Center|Hagop M. Kantarjian, M.D.|713-792-7026|eharriso@mdanderson.org|
281207|NCT00790868|BostonUCRC|Michael W. Otto, Ph.D.|(617)353-9610|mwotto@bu.edu|
281208|NCT00790907|GlaxoSmithKline|GSK Response Center|866-435-7343||
281209|NCT00790933|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
281210|NCT00791037|University of Washington|Dr. Mary L. Disis|206-543-8557|ndisis@u.washington.edu|
281211|NCT00791089|University of Michigan|Hakan Oral|734 936-6868|oralh@med.umich.edu|
281212|NCT00791102|University of Chicago|Robert Naclerio, MD|773-702-0080|rnacleri@surgery.bsd.uchicago.edu|
281213|NCT00791128|GI Dynamics, Inc.|Project Manager, Clinical and Regulatory|781.357.3263|kwoessner@gidynamics.com|
281214|NCT00791219|Mayne Pharma|Stuart Mudge, VP Scientific Affairs|+613 8614 7704|stuart.mudge@maynepharma.com|
281215|NCT00791258|Daiichi Sankyo, Inc|John Raia|(973) 944-2683|jraia@dsi.com|
281216|NCT00791323|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
281217|NCT00791388|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
281218|NCT00791479|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281219|NCT00791492|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281220|NCT00791518|GlaxoSmithKline|GSK Response Center|866-435-7343||
281221|NCT00791557|University Hospitals of Cleveland|Dr. Amanda Suggs, MD|216-844-7546|Amanda.suggs@uhhospitals.org|
281222|NCT00791648|Vanderbilt University|Frederic Billings|615-343-6268|frederic.t.billings@vanderbilt.edu|
281223|NCT00791661|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281224|NCT00791700|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281225|NCT00791765|Amgen Inc.|Study Director|866-572-6436||
281226|NCT00791778|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
281227|NCT00791817|Procter & Gamble|Peter Thomas|513.622.4838|thomas.pr@pg.com|
281228|NCT00791908|Northwestern University|Murad Alam, MD|312-695-6785|m-alam@northwestern.edu|
281229|NCT00791921|Professor, Department of Allergy and Rheumatology, Division of Internal Medicine, Graduate School of Medicine, University of Tokyo|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp|
281230|NCT00791934|Acclarent, Inc.|Clinical Director|650-687-5888|lenglan1@its.jnj.com|
281231|NCT00791973|University of Chicago|Dr. Robert Naclerio|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
289249|NCT01235546|University of Alabama at Birmingham, Maternal & Fetal Medicine|Alan Tita, MD|205-934-9616|atita@uab.edu|
289250|NCT01235598|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
289251|NCT01235689|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
289252|NCT01235715|Hospital for Special Surgery|Dr. Mark P. Figgie|212-606-1932|figgiem@hss.edu|
289253|NCT01235728|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289254|NCT01235741|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
289255|NCT01235793|Cedars-Sinai Medical Center|Yuliya Linhares, MD|310-423-4646|Yuliya.Linhares@cshs.org|
289256|NCT01235897|University of California, San Francisco|Jo Chien, MD|415-885-7577|crss@ucsf.edu|
289257|NCT01235910|University of Colorado|Christina Aquilante, Pharm.D.|303-724-6126|christina.aquilante@ucdenver.edu|
289258|NCT01235923|University of New Mexico|Robin Ohls|505-272-6410|rohls@salud.unm.edu|
289259|NCT01235949|GlaxoSmithKline|GSK Response Center|866-435-7343||
289260|NCT01235975|GlaxoSmithKline|GSK Response Center|866-435-7343||
289261|NCT01236001|UCB Clinical Trial Call Center|UCB (Study Director)|+1 887 822 9493||
289262|NCT01236053|GlaxoSmithKline|GSK Response Center|866-435-7343||
289263|NCT01236105|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289264|NCT01236118|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289265|NCT01236170|VA Pittsburgh Healthcare System|Dr. Larissa Myaskovsky|4123602241|Larissa.Myaskovsky@va.gov|
289266|NCT01236196|San Francisco VA Medical Center|Dr. Timothy Carmody|415-221-4810|Timothy.Carmody@va.gov|6344
289267|NCT01236300|University of Chicago Medical Center|Dr. Vani J.A. Konda|773-702-1460|vkonda@medicine.bsd.uchicago.edu|
289268|NCT01236326|Weill Cornell Medical College|Meredith J. Aull, Pharm.D.|(212) 746-0727|mea9008@med.cornell.edu|
289269|NCT01236339|W.L. Gore and Associates, Inc.|Arthur Scott / Clinical Study Manager|623.234.5263|artscott@wlgore.com|
289270|NCT01236352|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
281232|NCT00791999|Medical Advisor of the Clinical Trial|Dr. Kazuhiko Yamamoto, Medical Advisor of the Clinical Trial|+81 3 5800 8825|yamamoto-tky@umin.ac.jp|
281233|NCT00792077|UT MD Anderson Cancer Center|Sriram Yennu, MD- Professor, Palliative Care Med|(713) 792-3938|syennu@mdanderson.org|
281234|NCT00792103|NuPathe Inc.|Mark Pierce, MD PhD|484-567-0130|mpierce@nupathe.com|
289271|NCT01236365|Nemours Children's Clinic|Nelly Mauras, MD|904-697-3674|nmauras@nemours.org|
289272|NCT01236378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281235|NCT00792142|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
281236|NCT00792298|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281237|NCT00792428|Beth Israel Deaconess Medical Center|Gottfried Schlaug, MD, PhD|617-632-8917|gschlaug@bidmc.harvard.edu|
281238|NCT00792467|Italfarmaco SpA|Maurizio Caserini, MD|+39 0264431|m.caserini@italfarmaco.com|
281239|NCT00792571|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292||
281240|NCT00792610|National Taiwan University Hospital|Jan, Chyi-Feng|886-2-23562147|jcf036@ntu.edu.tw|
281241|NCT00792623|GlaxoSmithKline|GSK Response Center|866-435-7343||
281242|NCT00792636|GlaxoSmithKline|GSK Response Center|866-435-7343||
281243|NCT00792688|Glycotex, Inc.|Dr. Reinhard Koenig, CEO|301-670-2825|Reinhard.Koenig@glycotexinc.com|
281244|NCT00792701|SWOG Statistical Center|Lung Committee Statistician|206-667-6197|jmoon@fredhutch.org|
281245|NCT00792805|Novartis Pharmaceuticals|Study Director|862 778-8300||
281246|NCT00792909|GlaxoSmithKline|GSK Response Center|866-435-7343||
281247|NCT00792922|Johns Hopkins University|Sheila K West|410 955 2606|shwest@jhmi.edu|
281248|NCT00792935|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281249|NCT00793104|RI Biologics|Robin Waite , Clinical Projects Director|386-418-8888|rwaite@rtix.com|
281250|NCT00793182|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical Writing|33 (0) 1 45 91 50 00|corinne.dubourdieu@guerbet-group.com|
281251|NCT00793325|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281252|NCT00793403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281253|NCT00793455|Northwestern University|Kenzie A. Cameron, PhD, MPH|312-503-3910|k-cameron@northwestern.edu|
281254|NCT00793546|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281255|NCT00793572|Fred Hutchinson Cancer Research Center|Dr. Marco Mielcarek|(206) 667-2827|mmielcar@fhcrc.org|
281256|NCT00793585|1st Affiliated Hospital, Sun Yat-Sen University|Xueqing Yu , M.D. & Ph.D.|8620-87766335|yuxq@mail.sysu.edu.cn|
281257|NCT00793598|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
281258|NCT00793611|University of New Mexico Health Sciences Center and CTSC|Yuko Komesu MD|505-925-4395|ykomesu@salud.unm.edu|
281259|NCT00793624|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281260|NCT00793650|Emory University|Dr. Sagar Lonial|404-727-5572|sloni01@emory.edu|
281261|NCT00793780|Yale University|Erin Sullivan|+1 (203) 974-7317|erin.reutenauer@yale.edu|
281262|NCT00793793|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281263|NCT00793819|Watson Pharmaceuticals|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
281264|NCT00793871|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281265|NCT00793910|Carl R. Darnall Army Medical Center|Matthew Kuhnle, DO|216-965-3518|matthew.kuhnle@us.army.mil|
281266|NCT00794040|Mood, Brain and Development Unit, Emotion and Development Branch, National Institute of Mental Health, National Institutes of Health|Dr Argyris Stringaris|(301) 443-8019|argyris.stringaris@nih.gov|
281267|NCT00794118|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281268|NCT00794144|Alcon Research Ltd|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
281269|NCT00794157|Novartis Pharmaceuticals|Study Director|862 778-8300||
281270|NCT00794170|University of Pennsylvania|Karen Glanz|215-898-0613|kglanz@upenn.edu|
281271|NCT00794196|Parc Sanitari Sant Joan de Déu|Dr. Antoni Serrano Blanco|+34936406350|aserrano@pssjd.org|12215
281272|NCT00794313|Oregon Health & Science Universtiy|Kathyrn Chung MD|503 721 - 1091|chungka@ohsu.edu|
281273|NCT00794339|ACR|Donna Hartfeil|215-717-2765|dhartfeil@acr.org|
281274|NCT00794365|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281275|NCT00794417|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
281276|NCT00794469|Hadassah Medical Organization|Gal Dubnov-Raz|+972+54-4570250|gal-d@bezeqint.net|
281277|NCT00794508|University of California Los Angeles|Dr. Donald B. Kohn|310-794-1964|dkohn1@mednet.ucla.edu|
281278|NCT00794547|University of Michigan Comprehensive Cancer Center|Dr. Nithya Ramnath|734-647-1417|nithyar@umich.edu|
281279|NCT00794560|Pharmaceutical Care Research Group, University of Basle, Switzerland|Dr. Seraina Mengiardi|061 267 15 29|seraina.mengiardi@unibas.ch|0041
281280|NCT00794573|Jewish General Hospital / McGill University|Mark Eisenberg, MD MPH|5143408222|mark.eisenberg@ladydavis.ca|
281281|NCT00794664|Genzyme Corporation|Genzyme Medical Information|617-252-7832||
281282|NCT00794820|University of Texas (UT) MD Anderson Cancer Center|Susan O'Brien, MD/ Leukemia|1-877-632-6789|CR_Study_Registration@mdanderson.org|
281283|NCT00794950|University of Michigan|Alon Z. Weizer, MD, MS|734-615-6662|aweizer@umich.edu|
281284|NCT00794963|North Shore Long Island Jewish Health System, Zucker Hillside Hospita, Glen Oaks, NY|Peter Manu, MD|718 470-8290 pmanu@nshs.edu||
281285|NCT00795002|The Sidney Kimmel Comprehensive Cancer Center|Judith Karp, MD|410-502-7726|jkarp2@jhmi.edu|
281286|NCT00795132|University of Utah|Dr. Michael Pulsipher|801-588-2680|michael.pulsipher@hsc.utah.edu|
281287|NCT00795145|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
281288|NCT00795184|Mauna Kea Technologies|Christophe Bailleul|+ 33 1 70 08 09 74|christopheb@maunakeatech.com|
281289|NCT00795210|Massachusetts General Hospital|Steven Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
281290|NCT00795275|University of Colorado Anschutz Medical Campus|Leigh Perreault, MD|303-249-7732|leigh.perreault@ucdenver.edu|
281291|NCT00795288|Washington University|Michael Diringer|314-362-2999|diringerm@wustl.edu|
299031|NCT01856218|Ultragenyx Pharmaceutical Inc|Kim Mooney, Associate Director, Patient Advocacy Medical Services|408-981-3526|kmooney@ultragenyx.com|
281292|NCT00795340|Division of Medical Oncology, the Ottawa Hospital, Ottawa, Ontario, Canada|Dr. Scott Laurie|1-613-737-7700|slaurie@toh.on.ca|
281293|NCT00795366|University of Miami|Kenneth Proctor, PhD, Professor of Surgery|305-585-1178|kproctor@med.miami.edu|
281294|NCT00795509|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299032|NCT01856257|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
281295|NCT00795535|University of Miami|Kenneth Proctor, PhD, Professor of Surgery|305-355-4960|kproctor@med.miami.edu|
281296|NCT00795600|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
289273|NCT01236391|Pharmacyclics, Inc.|Dr. Darrin Beaupre|855-427-8846|medinfo@pcyc.com|
289274|NCT01236521|VA Center for Health Information and Communication|Dr. Matthew J. Bair|317-988-2058|mbair@iupui.edu; Matthew.Bair@va.gov|
289275|NCT01236534|University of Rochester|Andrew Goodman, MD|585-275-7854|andrew_goodman@urmc.rochester.edu|
299033|NCT01856309|Johnson & Johnson Pharmaceutical Research & Development, L.L.C.|Associate Director, Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
289276|NCT01236547|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
289277|NCT01236560|Children's Oncology Group|Results Reporting Coordinator|626-446-0064|resultsreportingcoordinator@childrensoncologygroup.org|
289278|NCT01236573|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
289279|NCT01236742|The Hong Kong Polytechnic University|Prof Pauline Cho|+852 2766 6100|pauline.cho@polyu.edu.hk|
299034|NCT01856491|Boston Scientific|Anneleen Viville|0032479983495|anneleen.viville@bsci.com|
289280|NCT01236755|The Hong Kong Polytechnic University|Prof Pauline Cho|+852 2766-6100|pauline.cho@polyu.edu.hk|
289281|NCT01236768|Agile Therapeutics|Lisa Flood, Associate Director of Clinical Operations|609-683-1880|lflood@agiletherapeutics.com|
289282|NCT01237041|NICHD, National Institutes of Health|Dr. Jack Yanovski|13014960858|yanovskj@mail.nih.gov|
289283|NCT01237054|National Cancer Institute|Dr. Peter Choyke|301-402-8409|pchoyke@mail.cc.nih.gov|
289284|NCT01237080|Department of Anaesthesiology, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark|Mogens Ydemann|+4531155995|clinicaltrials@ydemann.dk|
289285|NCT01237197|University of Minnesota|Aaron S. Kelly, Ph.D.|612-626-3492|kelly105@umn.edu|
289286|NCT01237223|Novartis Pharmaceuticals|Study Director|862-778-8300||
289287|NCT01237301|International Diabetes Center|Dr. Richard Bergenstal|952-993-3796|richard.bergenstal@parknicollet.com|
289288|NCT01237327|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289289|NCT01237340|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
289290|NCT01237353|University of California San Francisco|Dr. Leslie Benet|415-476-3853|leslie.benet@ucsf.edu|
289291|NCT01237587|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
289292|NCT01237678|ImmunoGen Inc.|Dr. Richard Bates, Sr. Manager, Publications|781 895 0196|Richard.Bates@immunogen.com|
289293|NCT01237821|Penn State Hershey Medical Center|Diane Thiboutot|717-531-1513|dthiboutot@pennstatehealth.psu.edu|
289294|NCT01237899|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289295|NCT01237951|UT MD Anderson Cancer Center|Dr. Nieto, Yago, M.D./Stem Cell Transplantation|713-792-2466|ynieto@mdanderson.org|
289296|NCT01238120|University of Rochester Medical Center|Michelle C. Janelsins, PhD, MPH|(585) 276-4656|Michelle_Janelsins@urmc.rochester.edu|
289297|NCT01238172|Moores Cancer Center|J. Kellogg Parsons, M.D., MHS|858-822-7874|jkparsons@ucsd.edu|
289298|NCT01238341|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
289299|NCT01238471|Rambam Medical Center|Professor Imad Makhoul|972-4-8542219|makhoul@rambam.health.gov.il|
289300|NCT01238536|University of Washington|Janna Friedly M.D.|206-744-3664|friedlyj@uw.edu|
289301|NCT01238549|VAORD|Dr. Ann Spungen|718-584-9000|ann.spungen@va.gov|5814
289302|NCT01238575|Emory University|Lawrence Scahill, MSN, PhD||lawrence.scahill@emory.edu|
289303|NCT01238588|Brigham and Women's Hospital|Kambiz Zandi-Nejad|617-732-5500|kzandinejad@partners.org|34769
289304|NCT01238640|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhaue@its.jnj.com|
289305|NCT01238822|Cincinnati Children's Hospital Medical Center|Jeff Epstein||jeff.epstein@cchmc.org|
289306|NCT01238835|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
289307|NCT01238848|Hospital General de Niños Pedro de Elizalde|Maria I. Espelt, MD|541146136968|cespelt@fibertel.com.ar|
289308|NCT01238861|MedImmune, LLC|Rene van der Merwe, MBChB, MFPM, Medical Officer|301-398-0000|vandermerwer@medimmune.com|
289309|NCT01238900|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
289310|NCT01238991|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289311|NCT01239043|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
289312|NCT01239056|University of Florida|Dr. Peter V. Draganov|(352) 273-9472|Peter.Draganov@medicine.ufl.edu|
289313|NCT01239121|James J. Peters VA Medical Center|Kenneth Boockvar|718-584-9000|kenneth.boockvar@va.gov|3807
289314|NCT01239160|Tactile Medical|Director of Clinical Research|612-540-5267|astone@tactilemedical.com|
289315|NCT01239212|Cincinnati Children's Hospital Medical Center|Dr. Stephanie Merhar|513-636-4200|stephanie.merhar@cchmc.org|
289316|NCT01239316|St. Jude Children's Research Hospital|Tong Lin (Biostatistician)|9015952048|Tong.Lin@stjude.org|
289317|NCT01239342|The University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-7734|EJonasch@mdanderson.org|
289318|NCT01239355|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
299035|NCT01856530|Boston University|Dr. Stefan G. Hofmann|617-353-9233|shofmann@bu.edu|
281297|NCT00795639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281298|NCT00795704|University of Mississippi Medical Center|Daniel Riche|601-984-2640|driche@umc.edu|
281299|NCT00795717|Tufts University School of Medicine|Christine A. Wanke, MD|617-636-3811|christine.wanke@tufts.edu|
281300|NCT00795769|Fred Hutchinson Cancer Research Center|Dr. Leona A. Holmberg|206-667-6447|lholmber@fredhutch.org|
281301|NCT00795821|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281302|NCT00795886|Primary Children's Medical Center|Michael Pulsipher, MD|801-662-4732|Michael.Pulsipher@hsc.utah.edu|
281303|NCT00795951|Rady Children's Hospital, San Diego, CA|SE Jacob, MD and L Eichenfield, MD|858-576-1700|leichenfield@rchsd.org|4825
281304|NCT00796003|Janssen Pharm KK Japan|Director|+81-3-4411-5801||
281305|NCT00796120|PharmaMar SA Av de los Reyes 1, Poligono Industrial La Mina 28770 Colmenar Viejo, Madrid, Spain|Medical Specialist, Clinical Oncology|+34 91 646-6087||
281306|NCT00796224|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
281307|NCT00796302|Ohio State University|Michael Aman|614-688-4196|Aman.1@osu.edu|
281308|NCT00796315|Procter & Gamble|Guhan Balan|513.622.2657|balan.g@pg.com|
281309|NCT00796328|IWK Health Centre|Dr. Ron George|470-6627|rbgeorge@dal.ca|
281310|NCT00796367|Vivus, Inc|Wesley W Day, PhD|650.934.5200|day@vivus.com|
281311|NCT00796419|Emory University|Greg Martin, MD, MSc|404-616-0148|greg.martin@emory.edu|
281312|NCT00796445|GlaxoSmithKline|GSK Response Center|866-435-7343||
281313|NCT00796549|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281314|NCT00796562|Johns Hopkins University|Heather Symons, MD|4105029961|hsymons2@jhmi.edu|
281315|NCT00796614|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281316|NCT00796627|Johns Hopkins University|Dr. John Harmon|410-550-0405|jharmon@jhmi.edu|
281317|NCT00796653|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281318|NCT00796666|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281319|NCT00796705|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
281320|NCT00796718|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
281321|NCT00796744|US Biotest|Dr. Shelagh Verco|805-595-1300|shelagh.verco@usbiotest.com|
281322|NCT00796757|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
281323|NCT00796822|Indiana University School of Medicine|Dr. Samir K. Gupta|317-274-7926|sgupta1@iu.edu|
281324|NCT00796926|Singapore National Eye Center|Dr Louis Tong|65 62277255|Louis.tong.h.t@snec.com.sg|
281325|NCT00796978|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Cynthia Owusu|+1 216-844-7670|cynthia.owusu@uhhospitals.org|
281326|NCT00796991|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
281327|NCT00797108|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281328|NCT00797212|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
281329|NCT00797225|AbbVie|Global Medical Services|800-633-9110||
281330|NCT00797277|National Taiwan University Hospital|Dr. Tzung-Jeng Hwang|+886-2-23123456|tjhwang@ntu.edu.tw|66792
281331|NCT00797316|Novartis Pharmaceuticals|Study Director|862-778-8300||
281332|NCT00797459|Medicis|Ron Staugaard|480-291-5652|rstaugaard@medicis.com|
281333|NCT00797511|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
281334|NCT00797563|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
281335|NCT00797667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281336|NCT00797732|Dana-Farber Cancer Institute|Weidong Lu, PhD, MB, Lic.Ac.|617.632.4350|weidong_lu@dfci.harvard.edu|
281337|NCT00797797|Forest Research Institute, a subsidiary of Forest Laboratories, Inc.|Robert Palmer, MD|1-201-427-8218|robert.palmer@frx.com|
281338|NCT00797823|Legacy Health System|W Kenneth Ward MD|503-413-5171|wardk@ohsu.edu|
281339|NCT00797862|Novartis Pharmaceuticals|Study Director|862- 778- 8300||
281340|NCT00797966|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
281341|NCT00798018|Department of Anesthesiology, West China Second Hospital|Han Huang|80-028-8550-3753|huanghan1981@hotmail.com|
281342|NCT00798096|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
281343|NCT00798135|IndianaU|Kathy Miller, MD||kathmill@iupui.edu|
281344|NCT00798161|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281345|NCT00798174|Washington University in St. Louis|Dr. Timothy W. Smith|314-286-1501|tsmith@wustl.edu|
281346|NCT00798304|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281347|NCT00798317|ThromboGenics|Petra Kozma-Wiebe|+32 16751310|petra.kozma@thrombogenics.com|
281348|NCT00798369|Novartis Pharmaceuticals|Study Director|862-778-8300||
281349|NCT00798434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281350|NCT00798486|Ascensia Diabetes Care|Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
281351|NCT00798577|Alcon Labs|Alcon Clinical|1.888.451.3937; 817.568.6725|medinfo@alconlabs.com|
281352|NCT00798603|Roswell Park Cancer Institute|Grace K. Dy, M.D.|507-284-9265|grace.dy@roswellpark.org|
281353|NCT00798655|University of Pittsburgh|Robert Ferris, MD|412-647-4654|ferrrl@UPMC.EDU|
281354|NCT00798694|Wills Eye Hospital|Principal Investigator|215-928-3197|ljaykatz@gmail.com|
281355|NCT00798707|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
308937|NCT02626000|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
281356|NCT00798720|University of Wisconsin|Abigail Mapes, Thoracic Oncology Research Program Manager|(608) 262-8158|acmapes@medicine.wisc.edu|
281357|NCT00798759|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
281358|NCT00798889|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281359|NCT00798967|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
281360|NCT00799227|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
281361|NCT00799383|Baylor College of Medicine|Chadi Calarge, MD|832-824-4764|chadi.calarge@bcm.edu|
281362|NCT00799409|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
281363|NCT00799422|Alcon Research, Ltd.|Head, Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
281364|NCT00799435|Baylor|David Aguilar, MD|713-798-0280|daguilar@bcm.edu|
281365|NCT00799474|The University of North Carolina at Chapel Hill, Gillings School of Global Public Health|Dr. Noel Brewer, PhD|919-966-3282|ntb1@unc.edu|
281366|NCT00799487|Ortho-McNeil Janssen Scientific Affairs, LLC|VP Medical Affairs, CNS|609-730-2136||
281367|NCT00799578|Columbia University|Dr. Joel Lavine|212 304 5533|jl3553@columbia.edu|
299036|NCT01856543|Memorial Sloan Kettering Cancer Center|Dr. Daphna Gelblum|914-367-7273|gelblumd@mskcc.org|
281368|NCT00799591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281369|NCT00799604|The Medicines Company|Jason Campagna. MD, PhD|973-290-6199|jason.campagna@themedco.com|
281370|NCT00799617|University of Pennsylvania, Perelman School of Medicine|Peter J. Snyder, MD|215-898-0208|pjsnyder@upenn.edu|
281371|NCT00799643|Joslin Diabetes Center|Allison B.Goldfine|617-309-2400|allison.goldfine@joslin.harvard.edu|
281372|NCT00799708|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372||
281373|NCT00799812|BD|Erin Zook|847-362-9047|erin.zook@bd.com|
281374|NCT00799825|GlaxoSmithKline|GSK Response Center|866-435-7343||
281375|NCT00799903|GlaxoSmithKline|GSK Response Center|866-435-7343||
281376|NCT00799981|Wellspect Health Care|Head of Medical Affairs|+46313763000|mace@wellspect.com|
281377|NCT00800176|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
281378|NCT00800202|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
281379|NCT00800254|University of Colorado Denver|Jennifer Stevens-Lapsley, PhD|303-724-9170|jennifer.stevens-lapsley@ucdenver.edu|
281380|NCT00800345|Vector Oncology|Vice President of Scientific Affairs|901.435.5570|mwalker@vectoroncology.com|1759
281381|NCT00800384|Population Health Research Institute, McMaster University|Dr. Jeff Healey|001 905 330 6760|jeff.healey@phri.ca|
281382|NCT00800436|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
281383|NCT00800540|Alcon Research, Ltd.|Director, Global Medical Affairs|1-888-451-3937||
281384|NCT00800683|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281385|NCT00800735|Hoffmann-La Roche|Medical Communications|800 821-8590||
281386|NCT00800839|The University of Texas (UT) MD Anderson Cancer Center|Amin M. Alousi, MD/Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
281387|NCT00800865|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281388|NCT00800982|University of California San Francisco|Dr Ethan Levin|4154764019|levine@derm.ucsf.edu|
281389|NCT00801099|Swiss Tropical Institute|Franziska Saxer, MD||franziskabrenneke@yahoo.com|
281390|NCT00801138|Cleveland Clinic Foundation|Daniel I Sessler, MD|2164458396|sesslerd@ccf.org|
281391|NCT00801229|Massachusetts General Hospital|Joseph Biderman, MD|617-726-1746||
281392|NCT00801242|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
281393|NCT00801398|Endo Pharmaceuticals|Saji Vijayan|(800) 462-3636|ClinicalTrials@Endo.com|
281394|NCT00801632|DAIT/NIAID|Director, Clinical Research Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
281395|NCT00801684|Alkermes, Inc.|Bernard L. Silverman, MD|781-609-6000|bernard.silverman@alkermes.com|
281396|NCT00801723|Bausch Health|Study Director||susan.harris@bauschhealth.com|
289319|NCT01239381|Massachusetts General Hospital|Theodore S Hong, MD, physician radiation oncology|617-726-6050|TSHONG1@mgh.harvard.edu|
289320|NCT01239394|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
289321|NCT01239472|Hospital e Maternidade Marieta Konder Bornhausen|Dr Andre Barreto Pereira|+55 47 984482826|andrebarper@yahoo.com.br|
289322|NCT01239511|Sinphar Pharmaceutical Co., Ltd.|Melanie Huang|886-2-27603688|wthuang@sinphar.com.tw|2190
289323|NCT01239732|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
289324|NCT01239745|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289325|NCT01239797|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
289326|NCT01239992|University Munich|Klaus G. Parhofer|+49-89-7095-3010|klaus.parhofer@med.uni-muenchen.de|
289327|NCT01240122|Abbott Medical Optics|Senior Manager, Clinical Research|714.247.8723|eugenia.kao@amo.abbott.com|
289328|NCT01240135|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
289329|NCT01240200|Emory University School of Medicine|Christopher Newton, MD|404-355-4393|cnewton@atlantadiabetes.com|
289330|NCT01240330|Venous Health Systems, Inc.|Director of Quality Assurance & Operations|(650)646-3327|rlaguna@venoushealth.com|104
289331|NCT01240356|The University of Texas Health Science Center at Houston|James C. Grotta, MD|+1 (713) 500-7088|james.c.grotta@uth.tmc.edu|
289332|NCT01240382|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
289333|NCT01240551|National Cancer Institute|Dr. Karen Kurdziel|301-443-0622|kurdziek@mail.nih.gov|
289334|NCT01240590|National Cancer Institute|Dr. James Gulley|301-480-7164|gulleyj@mail.nih.gov|
289335|NCT01240746|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
281397|NCT00801801|UAB|Dr. Francisco Robert|205-934-5077|pacorobertuab@cs.com|
281398|NCT00801827|Vanderbilt_University|Julia Dunn, MD|615-343-8389|julia.dunn@va.gov|
281399|NCT00801892|University of Pittsburgh|E. Chasens, PhD|412-624-9380|chasense@pitt.edu|
281400|NCT00801983|University of Pittsburgh|Dr. Nancy Baker|412 383-6607|nab36@pitt.edu|
281401|NCT00802074|Garden State Infectious Disease Associates|David Condoluci|856-566-3190|dcondoluci@gsida.org|
281402|NCT00802100|Columbia University|Scott Stroup|(212) 543-5676|stroups@nyspi.columbia.edu|
281403|NCT00802113|Columbia University|Prakash Satwani, MD|(212) 305-0223|ps2087@cumc.columbia.edu|
281404|NCT00802178|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
299037|NCT01856569|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281405|NCT00802204|Vanderbilt University|Julia Dunn, MD|615-343-8389|julia.dunn@va.gov|
281406|NCT00802360|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
281407|NCT00802412|VA San Diego|Neal Doran, PhD|8585528585|neal.doran@va.gov|2421
281408|NCT00802438|UW Madison|Gina Crisafi, BS|608-265-4554|gmc@medicine.wisc.edu|
281409|NCT00802464|GlaxoSmithKline|GSK Response Center|866-435-7343||
281410|NCT00802503|Geneva University Hospitals, Division of Intensive Care,Rue Gabrielle Perret Gentil 4, CH-1211 Geneva 14/Switzerland|Dr CP Heidegger|+41223827440|claudia-paula.heidegger@hcuge.ch|
281411|NCT00802529|Imperial College London|Professor Adolfo Bronstein (Clinical professor and Head of neuro-otology group)|(0)20 3313 5525|a.bronstein@imperial.ac.uk|+44
281412|NCT00802633|Vanderbilt University|Sam Chang|615-322-2101|sam.chang@Vanderbilt.Edu|
281413|NCT00802672|Perrigo Company|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
281414|NCT00802685|University of Miami|Ilene R. S. Sosenko, M.D.|305-585-6408|isosenko@miami.edu|
281415|NCT00802737|GlaxoSmithKline|GSK Response Center|866-435-7343||
281416|NCT00802841|Novartis|Study Director|862-778-1873||
281417|NCT00802854|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281418|NCT00802867|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
281419|NCT00802880|Washington University School of Medicine|Brian Van Tine, M.D., Ph.D.|314-362-5817|bvantine@dom.wustl.edu|
308938|NCT02626026|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
281420|NCT00802919|Nathan Kline Institute for Psychiatric Research|Robert C. Smith MD|845-398-6531|rsmith@nki.rfmh.org|
281421|NCT00802945|Nektar|Alison Hannah, MD||AHannah@nektar.com|
281422|NCT00802997|Baylis Medical|Meghal Khakhar, Director of Regulatory and Scientific Affairs|9056024875|mkhakhar@baylismedical.com|
281423|NCT00803010|H. Lee Moffitt Cancer Center|Dr. Joseph Pidala|813-745-4673|Joseph.Pidala@moffitt.org|2556
281424|NCT00803023|Jazz Pharmaceuticals|Director of Clinical Development|650-496-3777||
281425|NCT00803049|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
281426|NCT00803062|NRG Oncology Statistics and Data Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
281427|NCT00803101|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
281428|NCT00803205|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
281429|NCT00803244|Stallergenes|Laurence Paolozzi, Medical Director|+33 (0) 1 55 59 26 33|lpaolozzi@stallergenes.com|
281430|NCT00803270|New England Resesarch Institutes|Anne M. Stoddard|617-972-3331|astoddard@neriscience.com|
281431|NCT00803361|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281432|NCT00803400|Psychiatry Academic Unit at J.A.Fernandez Hospital, University of Buenos Aires Medicine School Department of Mental Health|Dr. Marcelo Rudelir|54 11 48254740|mrudelir@hotmail.com|
281433|NCT00803452|University of Louisville|Professor Douglas Borchman|502 852 7435|borchman@louisville.edu|
281434|NCT00803543|University of Alabama at Birmingham|Nicholas Van Wagoner|205-934-2840|nvw@uab.edu|
281435|NCT00803569|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org|
281436|NCT00803595|Daiichi Sankyo Pharma Development|Howard Kessler|732-590-5032|hmkessler@dsi.com|
281437|NCT00803634|The Medicines Company|Jason Campagna|973-290-6199|jason.campagna@themedco.com|
281438|NCT00803647|NSABP Foundation|Diana Gosik, Director Department of Site and Study Management|412-339-5333|diana.gosik@nsabp.org|
281439|NCT00803686|Tarsa Therapeutics, Inc|Nicholas LaBella, Jr. Vice-President Global RA/QA|267-273-7944|nlabella@tarsatherapeutics.com|
281440|NCT00803712|Amgen Inc.|Study Director|866-572-6436||
281441|NCT00803738|Perrigo Pharmaceuticals|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
308939|NCT02626156|Medical University of South Carolina|Teresa J. Kelechi|843-792-4602|kelechtj@musc.edu|
281442|NCT00803751|UT Medical School, Houston|Maria Matuszczak|713-498-2768|maria.matuszczak@uth.tmc.edu|
281443|NCT00803777|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
281444|NCT00803959|New England Research Institutes|Heather Litman, PhD|617 972 3297|hlitman@neriscience.com|
281445|NCT00804141|Bausch Health Americas, Inc|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
281446|NCT00804193|Perrigo|Jonathan Schwartz|718-960-0119|jonathan.schwartz@perrigo.com|
281447|NCT00804570|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281448|NCT00804596|Ascensia Diabetes Care|Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
281449|NCT00804609|Stanford University|Brendan Carvalho|650-861-8607|bcarvalho@stanford.edu|
281450|NCT00804648|Vistakon|Arthur Shedden MD|904-443-1557||
281451|NCT00804687|Janssen Research and Development|Senior Medical Director|858-784-3111||
281452|NCT00804843|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281453|NCT00804908|AbbVie|Global Medical Information|800-633-9110||
281454|NCT00804973|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281455|NCT00804986|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281456|NCT00804999|University of Iowa|Dr. Christine W. Sindt|319-356-2916|christine-sindt@uiowa.edu|
299038|NCT01856582|Cincinnati Children's Hospital Medical Center|Rebecca Marsh, MD/Associate Professor of Pediatrics|513-803-9063|Rebecca.Marsh@cchmc.org|
281457|NCT00805025|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
281458|NCT00805038|Case Western Reserve University|Ash Sehgal|216-778-7728|axs81@cwru.edu|
281459|NCT00805142|Janssen R&D, 1125 Trenton-Harbourton Road, Titusville, PA 18902, USA|Senior Director, Clinical Leader|609-730-6777||
281460|NCT00805194|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281461|NCT00805207|Washington University in St Louis|Gordon Smith, PhD|314-362-4375|gsmith@wustl.edu|
281462|NCT00805285|University of Maryland, Baltimore|Raymond Cross, MD, MS|410-706-3387|rcross@medicine.umaryland.edu|
281463|NCT00805389|GlaxoSmithKline|GSK Response Center|866-435-7343||
281464|NCT00805441|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
281465|NCT00805467|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
281466|NCT00805480|Novartis Pharmaceuticals|Study Director|862-778-8300||
281467|NCT00805493|Emotion and Development Branch, NIMH-IRP|Kenneth Towbin, M.D., Chief Clinical Child and Adolescent Psychiatry|301-402-4403|Kenneth.Towbin@nih.gov|
281468|NCT00805532|VA Portland Health Care System|Amy W. Wagner, Ph.D.|(503) 220-8262|amy.wagner@va.gov|33365
281469|NCT00805545|University of Florida|Patrick Duff, M.D.|352 273 7673|duffp@ufl.edu|
281470|NCT00805675|Novartis Pharmaceuticals|Study Director|862-778-8300||
281471|NCT00805740|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281472|NCT00805766|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
281473|NCT00805792|Mayo Clinic|James F. Meschia, MD|904-953-2903|meschia.james@mayo.edu|
281474|NCT00805870|Western Michigan University|Dr. Christopher C. Cheatham|269-387-2542|chris.cheatham@wmich.edu|
281475|NCT00805935|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
281476|NCT00805948|Medtronic, Inc|Michael McGuffey, Clinical Research Director|707-591-7126|michael.mcguffey@medtronic.com|
281477|NCT00806026|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281478|NCT00806078|Mutual Pharmaceutical Company, Inc.|Medical Affairs Director|215-697-1743|clinicaltrials@urlmutual.com|
281479|NCT00806156|Nektar Therapeutics|Study Director||medicalaffairs@nektar.com|
281480|NCT00806195|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
281481|NCT00806221|Oregon Health & Science University|Eric Simpson, MD, MCR|503-494-2121|simpsone@ohsu.edu|
281482|NCT00806234|Johns Hopkins University|Dr. Mark Riddle|410-302-6120|mriddle1@jhmi.edu|
281483|NCT00806260|Vivus, Inc.|Wesley W Day, PhD|650-934-5200|day@vivus.com|
281484|NCT00806286|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
281485|NCT00806351|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281486|NCT00806442|Brigham and Women's Hospital|Elliot Israel, MD|617-732-2801|eisrael@partners.org|
281487|NCT00806494|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281488|NCT00806546|NuPathe Inc.|Mark Pierce, MD, PhD|484-567-0130|mpierce@nupathe.com|
281489|NCT00806585|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDevelopment@merck.com|
281490|NCT00806598|The University of Texas MD Anderson Cancer Center|Tapan Kadia, MD/Assistant Professor|713-563-3534|eharriso@mdanderson.org|
281491|NCT00806624|Daiichi Sankyo.,LTD|Atsushi Nonogaki, Manager|81-80-3029-7553|nonogaki.atsushi.zz@daiichisankyo.co.jp|
281492|NCT00806676|Johns Hopkins University School of Medicine|Dr. Jeffrey Fadrowski|410-955-2467|jfadrow1@jhmi.edu|
281493|NCT00806819|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281494|NCT00806988|Icahn School of Medicine at Mount Sinai|Alan Moskowitz, MD|212-659-9568|alan.moskowitz@mountsinai.org|
281495|NCT00807001|Idenix Pharmaceuticals, Inc.|John Z. Sullivan-Bolyai, MD, MPH|877-433-6491||
281496|NCT00807014|GlaxoSmithKline|GSK Response Center|866-435-7343||
289336|NCT01240785|Department of Obstetrics and Gynecology, Turku University Central Hospital|Dr Kristiina Tertti|+358 2 3130000|kristiina.tertti@tyks.fi|
289337|NCT01240811|University of Pittsburgh|Sharon Achilles, MD, PhD|412-641-1403|achisx@upmc.edu|
289338|NCT01240863|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
289339|NCT01240902|Medtronic, Inc.|Hatice Bilgic Lim||rs.medtroniccardiovascularclinicaltrials@medtronic.com|
289340|NCT01240915|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289341|NCT01241240|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
289342|NCT01241292|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
289343|NCT01241318|"Ariadne Labs|BWH & HSPH"|Katherine Semrau (Epidemiologist, co-PI)|6177805311|ksemrau@ariadnelabs.org|
289344|NCT01241344|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
289345|NCT01241435|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289346|NCT01241448|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289347|NCT01241461|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
289348|NCT01241513|USARIEM|Charles S Fulco, PI|508 233-4893|charles.fulco@us.army.mil|
299039|NCT01856595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299040|NCT01856673|CISALVA, Universidad del Valle|Maria Isabel Gutierrez|+57-2-5577206|maria.gutierrez@correounivalle.edu.co|103
299041|NCT01856686|Spanish Foundation for Neurometrics Development|Dr. Moises Aguilar|+34 634 54 87 20|moises.aguilar@gmail.com|
281497|NCT00807040|Icahn School of Medicine at Mount Sinai|Alan Moskowitz, MD|212-659-9568|alan.moskowitz@mountsinai.org|
281498|NCT00807092|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
299042|NCT01856712|University of Wisconsin|Randall Brown|6082636558|rtbrown@wisc.edu|
281499|NCT00807144|Imperial College Healthcare NHS Trust|Adam McLean|+44 020 8383 5164|adammclean@nhs.net|
281500|NCT00807209|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
281501|NCT00807235|Discovery Laboratories, Inc.|Robert Segal, MD|215-488-9300|rsegal@discoverylabs.com|
281502|NCT00807248|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
281503|NCT00807456|DENTSPLY Implants|Manager Global Clinical Affairs|+46313763500|ClinicalResearchMolndal@dentsplysirona.com|
281504|NCT00807495|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
281505|NCT00807560|Icahn School of Medicine at Mount Sinai|Katharine Loeb, PhD|212-659-8724|Katharine.Loeb@mssm.edu|
281506|NCT00807573|Memorial Sloan Kettering Cancer Center|Dr. Maria Pietanza, Assistant Attending|+1646-888-4203|PietanzM@mskcc.org|
281507|NCT00807586|Minneapolis Heart Institute Foundation|Dr. Daniel Melby|612-863-3900|daniel.melby@allina.com|
281508|NCT00807599|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun, MD|212-639-3228|hassounh@mskcc.org|
281509|NCT00807664|Coloplast|Dr Birte Petersen Jacobsen|004549110000|DKBIR@coloplast.com|1395
281510|NCT00807742|Brown University|Damaris Rohsenow, Ph.D.|401-863-6648|damaris_rohsenow@brown.edu|
281511|NCT00807768|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|lgedeon@gogstats.org|
281512|NCT00807846|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281513|NCT00807885|Baxter Healthcare Corporation|George Harb, MD, MPH||george_harb@baxter.com|
281514|NCT00807937|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
281515|NCT00807989|Yonsei University Severance Hospital|Dr. Yoon||BILEE@yuhs.ac|
281516|NCT00808015|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281517|NCT00808028|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281518|NCT00808067|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281519|NCT00808132|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281520|NCT00808210|F. Hoffmann-La Roche Ltd|Medical Communications|+41 616878333|global.trial_information@roche.com|
281521|NCT00808236|BeneChill, Inc.|Becky Inderbitzen, Vice President of Clincial Affairs|858-695-8118|binderbitzen@benechill.com|
281522|NCT00808249|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
281523|NCT00808340|Vistakon|Tom Karkkainen, OD|904-443-3402||
281524|NCT00808405|University of Washington|Connie Celum, MD, MPH|206-520-3824|ccelum@uw.edu|
281525|NCT00808444|GlaxoSmithKline|GSK Response Center|866-435-7343||
281526|NCT00808470|University of Texas at Dallas|Dr. Colleen Le Prell|214-905-3018|colleen.leprell@utdallas.edu|
281527|NCT00808483|University of Oslo|Professor Anne Marit Mengshoel|004790036933|a.m.mengshoel@medisin.uio.no|
281528|NCT00808509|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
281529|NCT00808639|Dana-Farber Cancer Institute|Toni Choueiri, MD|617-632-5456|toni_choueiri@dfci.harvard.edu|
281530|NCT00808665|Vanderbilt University Medical Center|James Blair DO|615-343-6082|james.l.blair@vanderbilt.edu|
281531|NCT00808808|MedImmune, LLC|Seth Toback, MD|301-398-0000|tobacks@medimmune.com|
281532|NCT00808834|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
281533|NCT00809055|Brigham and Women's Hospital|Dr. Terrie Inder|617-525-6650|tinder@partners.org|
281534|NCT00809094|Stanford University|Dr. Carol Conrad|650-723-8325|cconrad@stanford.edu|
281535|NCT00809133|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281536|NCT00809146|University of Michigan|Robert Silbergleit MD, Principal Investigator|734-232-2142|robie@umich.edu|
281537|NCT00809159|Novartis|Study Director|862-778-8300||
281538|NCT00809185|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|Anjali Advani|216-445-9354|advania@ccf.org|
281539|NCT00809276|SKCCC|Leo Luznik, MD|410-502-7732|lluznik2@jhmi.edu|
281540|NCT00809328|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281541|NCT00809354|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281542|NCT00809445|Columbia University, Mailman School of Public Health|Dr. Lisa Metsch|212-305-3577|lm2892@columbia.edu|
281543|NCT00809471|Vivus, Inc|Wesley W Day PhD|650-934-5200||
281544|NCT00809523|Yale University|Paul Desan, MD, PhD|203 785 2618|paul.desan@yale.edu|
281545|NCT00809614|Novartis|Study Director|862-778-8300||
281546|NCT00809757|Sunovion|Respiratory Medical Director|1-866-503-6351||
281547|NCT00809783|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281548|NCT00809809|Integrative Medicine Institute|David Riley, MD|505 690-0688|dsriley@integrativemed.org|
281549|NCT00809835|Yale University School of Medicine|Kathleen M. Carroll, Ph.D., Albert E Kent Professor of Psychiatry|203.937.3486|kathleen.carroll@yale.edu|7403
281550|NCT00809848|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
281551|NCT00809926|Novartis Pharmaceuticals|Study Director|862-778-8300||
281552|NCT00809965|Johnson & Johnson Pharmaceutical Research and Development, L.L.C.|Development Head Cardiovascular/Urology|1 215 628-5257||
281553|NCT00810043|Medtronic|John Tillman|408-548-6518|tillmj1@mspexcng.medtronic.com|
281554|NCT00810069|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281555|NCT00810082|Dartmouth College|Dr. Jon D. Lurie, MD, MS|603-653-3575|Jonathan D. Lurie <Jonathan.D.Lurie@hitchcock.org>|
281556|NCT00810095|MindFrame, Inc .|Dr. Thomas J. McCarthy|949-204-0806|tmccarthy@mindframeinc.com|
281557|NCT00810108|University of California San Diego|Dr. Brookie M. Best, Associate Professor|858-822-5550|brookie@ucsd.edu|
299043|NCT01856764|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
281558|NCT00810199|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
281559|NCT00810264|BIOTRONIK|Clinical Studies Engineer Group Manager|800-547-0394|celestial@biotronik.com|
281560|NCT00810277|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
281561|NCT00810303|Department of Clinical Pharmacology|Danilo Wegner|+4903834865640|dwegner@uni-greifswald.de|
281562|NCT00810342|University of Hawaii, School of Nursing|Cheryl Albright|8089569716|cherylal@hawaii.edu|
281563|NCT00810355|Richard L. Roudebush VA Medical Center|Dr. Paul Lysaker|317-988-2546|paul.lysaker@va.gov|
281564|NCT00810368|Georgetown University Medical Center|Dr. James N Baraniuk|202-687-8231|baraniuklab@gmail.com|
281565|NCT00810394|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
281566|NCT00810407|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281567|NCT00810459|Philips|Jeff Jasko|412-542-3651|Jeff.Jasko@philips.com|
281568|NCT00810498|Philips|Jeff Jasko|412-542-3651|jeff.jasko@philips.com|
281569|NCT00810511|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
281570|NCT00810576|UT MD Anderson Cancer Center|Barbara Pro, MD|713-792-2933||
281571|NCT00810602|University of Michigan Comprehensive Cancer Center|Dr. Sung Choi|734-764-8630|sungchoi@med.umich.edu|
281572|NCT00810615|San Antonio Military Medical Center, Wilford Hall Ambulatory Surgical Center|Dr. George Wolf, Associate Investigator|210-292-3483|earl.wolf.ctr@us.af.mil|
281573|NCT00810641|KONOS|Treatment of apogeotropic HC BPPV|82 10 5538 6565|ohsun@jbnu.ac.kr|
281574|NCT00810693|Bayer|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
281575|NCT00810719|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
281576|NCT00810771|VA Ann Arbor Healthcare System, Center for Clinical Management Research|Sarah Hawley, Ph.D.|734-936-8816|sarahawl@umich.edu|
281577|NCT00810797|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
281578|NCT00810810|Bloodworks Northwest (formerly Puget Sound Blood Center)|Karen Nelson, PhD., Vice President Laboratories|206-689-6549|knelson@bloodworksnw.org|
281579|NCT00810888|Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Center|Dr Jane Khoury, Professor of Pediatrics|513-636-2690|jane.khoury@cchmc.org|
281580|NCT00810901|University of Hawaii, School of Nursing|Cheryl Albright|8089569716|cherylal@hawaii.edu|
281581|NCT00811018|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281582|NCT00811057|University of Mississippi Medical Center|Dr. Rick Martin|601-815-7035|rmartin@umc.edu|
281583|NCT00811070|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281584|NCT00811135|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
281585|NCT00811174|Octapharma|Michael Eppolito|201-604-1155|michael.eppolito@octapharma.com|
281586|NCT00811187|Montefiore Medical Center|Research Program Administrator|718-405-8526|fheitor@montefiore.org|
281587|NCT00811252|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
281588|NCT00811317|Massachusetts General Hospital|Steven Russell|6177261848|sjrussell@mgh.harvard.edu|
281589|NCT00811382|BIOTRONIK|Mathias Freudigmann|+49(0)30 68905 - 1248|mathias.freudigmann@biotronik.com|
281590|NCT00811395|sanofi-aventis|Trial Transparency Team||Contact_US@sanofi-aventis.com|
281591|NCT00811434|Riley Hospital|Girish Subbarao|317-944-3774|gsrao@iupui.edu|
281592|NCT00811473|AstraZeneca|Gerard Lynch||aztrail_results_posting@astrazeneca.com|
281593|NCT00811564|Allergan, Inc.|Vice President Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
281594|NCT00811577|Capstone Therapeutics Corp.|Denise Lamon|602-286-5206|dlamon@capstonethx.com|
281595|NCT00811642|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
281596|NCT00811655|Duke University Medical Center|Denise Lally-Goss, NP|919-684-3862|denise.lallygoss@dm.duke.edu|
289349|NCT01241539|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289350|NCT01241552|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289351|NCT01241565|Covidien|Noreen Fahey|203-821-4716|noreen.fahey@covidien.com|
289352|NCT01241591|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289353|NCT01241604|Philips Respironics|Jeremy Powers|412-542-3669|jeremy.powers@philips.com|
289354|NCT01241760|Janssen Infectious Diseases BVBA|Compound Development Team Leader|32 14 64 13 70||
289355|NCT01241903|University of Kentucky|Dr. Susan S. Smyth|(859) 323-2274|ssmyt2@uky.edu|
289356|NCT01241916|Massachusetts General Hospital|Dr. David Ring|617-724-3953|dring@partners.org|
289357|NCT01242085|VA Palo Alto HCS|Steven T Woolson, MD|650-493-5000|steven.woolson@va.gov|66101
289358|NCT01242111|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|800-983-4587|medinfo@bmrn.com|
289359|NCT01242176|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289360|NCT01242241|Baylor College of Medicine|Dr. Olutoyin A. Olutoye|832-824-5800|oao@bcm.edu|
289361|NCT01242371|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
289362|NCT01242514|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
289363|NCT01242527|AstraZeneca Pharmaceuticals|Torbjörn Lundström, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
289364|NCT01242644|University of South Alabama|Office of Research Compliance|251-460-7573|swhite@southalabama.edu|
289365|NCT01242748|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
289366|NCT01242813|Novartis Pharmaceuticals|Study Director|862-778-8300||
281597|NCT00811720|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
281598|NCT00811733|GlaxoSmithKline|GSK Response Center|866-435-7343||
281599|NCT00811798|GlaxoSmithKline|GSK Response Center|866-435-7343||
281600|NCT00811850|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
281601|NCT00811928|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
281602|NCT00811941|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
281603|NCT00811954|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
281604|NCT00812097|Mentor|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
281605|NCT00812110|Akron Children's Hospital|P. Cooper White, M.D.|330-543-8530|CWhite@chmca.org|
281606|NCT00812253|The Ohio State University|Kathleen Dungan|6146853333|kathleen.dungan@osumc.edu|
281607|NCT00812331|Janssen Research & Development United States|Global Clinical DVLP Manager||ClinicalTrialDisclosure@its.jnj.com|
289367|NCT01243112|Scott & White Healthcare|James Collins, MD|254-724-7508|jbcollins@swmail.sw.org|0612
289368|NCT01243151|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289369|NCT01243177|UCB Cares|UCB (Study Director)|+1 887 822 9493||
289370|NCT01243242|Alcobra|Dr Yaron Daniely CEO|972-072-2204662|yaron@alcobra-pharma.com|
289371|NCT01243268|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289372|NCT01243294|Coloplast A/S|Pia Nordmand, Clinical Trial Manager|+4549113250|dkpialn@coloplast.com|
289373|NCT01243320|University of Utah|Mark A. Munger, Pharm.D.|8015816165|mmunger@hsc.utah.edu|
289374|NCT01243333|Huntsman Cancer Institute Research Compliance Officer|Josiah Hawks|8015850601|Josiah.Hawks@hci.utah.edu|
289375|NCT01243411|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
289376|NCT01243424|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289377|NCT01243450|Cu-Tech, LLC|William J. Cunningham, MD|(973) 331-1620|wcunningham@cu-tech.com|
289378|NCT01243567|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
289379|NCT01243580|Agile Therapeutics|Lisa Flood|609-683-1880|lflood@agiletherapeutics.com|
289380|NCT01243593|Sick Kids Hospital|Dr. Jason Hayes|416-813-7445|jason.hayes@sickkids.ca|
289381|NCT01243619|Brigham and Women's Hospital / Dana Farber Cancer Institute|Harvey Mamon MD, PhD|617-732-8564|hmamon@lroc.harvard.edu|
299044|NCT01856790|Yale University School of Medicine|Dr. Jennifer Sherr|203-785-5831|jennifer.sherr@yale.edu|
289382|NCT01243671|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
289383|NCT01243762|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289384|NCT01243775|Chonnam National University Hwasun Hospital|Dr. Young-Chul Kim|82-61-379-7614|kyc0923@jnu.ac.kr|
289385|NCT01243944|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
289386|NCT01243957|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289387|NCT01244035|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289388|NCT01244061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289389|NCT01244126|Baylor College of Medicine, Department of Anesthesiology|Dr. Helena Karlberg Hippard|832-824-5800|hxkarlbe@texaschildrens.org; karlberg@bcm.edu|
289390|NCT01244191|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
299045|NCT01856907|Woman's Hospital|Dr Karen Elkind-Hirsch|225-231-5278|karen.elkind-hirsch@womans.org|
289391|NCT01244243|University of California, Irvine|Steve Cramer|7144566876|scramer@uci.edu|
299046|NCT01856933|Brown University Oncology Research Group (BrUOG)|Heinrich Elinzano, MD|4018633000|kayla_rosati@brown.edu|
289392|NCT01244412|University of Rochester|David Kleinman, MD||david_kleinman@urmc.rochester.edu|
289393|NCT01244425|BAXTER INNOVATIONS GmbH|Ildiko Szabo, MD, MBA Medical Director, Biosurgery||ildiko_szabo@baxter.com|
289394|NCT01244451|GIMEMA|Alfonso Piciocchi|+39 06 70390528|a.piciocchi@gimema.it|
289395|NCT01244477|Michael E DeBakey VAMC|Wright Williams, PhD, ABPP|713-794-7629|wright.williams@va.gov|
289396|NCT01244490|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
289397|NCT01244503|Virginia Commonwealth University|Arun J Sanyal|804 828 6314|asanyal@mcvh-vcu.edu|
289398|NCT01244516|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|KOsborn@its.jnj.com|
289399|NCT01244529|Johnson & Johnson Vision Care|Kathy Osborn, OD|1-904-443-1032|kosborn@its.jnj.com|
289400|NCT01244633|Psyadon Pharmaceuticals|Dr. Richard Chipkin|3019192020|rchipkin@psyadonrx.com|
289401|NCT01244711|Weill Cornell Medical College|james kocsis|212-746-5913|jhk2002@med.cornell.edu|
289402|NCT01244724|Weill Cornell Medical College|James H. Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
289403|NCT01244893|Johnson & Johnson Vision Care|Brian Pall, O.D., M.S., F.A.A.O. Senior Research Optometrist|(904) 443-1290|BPALL@its.jnj.com|
289404|NCT01244906|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
289405|NCT01244984|GlaxoSmithKline|GSK Response Center|866-435-7343||
289406|NCT01245049|GlaxoSmithKline|GSK Response Center|866-435-7343||
289407|NCT01245062|GlaxoSmithKline|GSK Response Center|866-435-7343||
289408|NCT01245101|University of Miami|Rafael E. Campo|305-689-7030|rcampo@med.miami.edu|
289409|NCT01245140|GlaxoSmithKline|GSK Response Center|866-435-7343||
289410|NCT01245270|University of Aberdeen Rowett Institute of Nutrition and Health|Dr Nigel Hoggard|[+44] (0) 1224 438700|N.Hoggard@abdn.ac.uk|
281608|NCT00812461|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
289411|NCT01245283|UF&Shands Orthopaedics and Sports Medicine Institute|Kevin R. Vincent, M.D. Ph.D.|352-273-7458|vincekr@ortho.ufl.edu|
281609|NCT00812487|Ohio State University|Kathleen Dungan, MD, MPH|614-685-3333|kathleen.dungan@osumc.edu|
281610|NCT00812565|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201-604-1155|michael.eppolito@octapharma.com|
281611|NCT00812604|University of Hong Kong|Dr. Ricky Wing Kit Wong, Associate professor in orthodontics|852-2859 0554|fyoung@hkucc.hku.hk|
281612|NCT00812812|GlaxoSmithKline|GSK Response Center|866-435-7343||
281613|NCT00812838|Baylor College of Medicine|Mohit Khera, MD|713-798-6593|mkhera@bcm.edu|
281614|NCT00812877|Oregon Health & Science University|Dr. Thomas J. Hilton|503.494.8672|hiltont@ohsu.edu|
281615|NCT00812916|Biosense Webster, EMEA|Nathalie Macours|+32 2 7463076|MNathalie@its.jnj.com|
281616|NCT00812929|GlaxoSmithKline|GSK Response Center|866-435-7343||
281617|NCT00812955|AstraZeneca|Gerard Lynch|+44 1509 645 895|aztrial_results_posting@astrazeneca.com|
281618|NCT00812968|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
281619|NCT00812981|GlaxoSmithKline|GSK Response Center|866-435-7343||
281620|NCT00813098|Lexicon Pharmaceuticals, Inc.|Clinical Project Manager|281-863-3000||
281621|NCT00813111|Pacira Pharmaceuticals, Inc.|Executive Medical Director|203-837-6500|ErolOnel@pacira.com|
281622|NCT00813124|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation|713-792-3618|rchampli@mdanderson.org|
281623|NCT00813150|Jan-Cil Germany|Therapeutic Areas Director||ClinicalTrialDisclosure@its.jnj.com|
281624|NCT00813176|University of Iowa|Dr Javier H Campos|3193567208|javier-campos@uiowa.edu|
281625|NCT00813293|Beth Israel Deasoness Medical Center|Andrea Bullock MD, MPH||abullock@bidmc.harvard.edu|
281626|NCT00813319|Emory University Rollins School of Public Health|Dr. Ralph DiClemente, Principal Investigator|404-727-0237|rdiclem@emory.edu|
281627|NCT00813358|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
281628|NCT00813488|Cephalon, Inc.|Sponsor's Medical Expert, Clinical Research|1-800-896-5855||
281629|NCT00813592|Huntsman Cancer institute|Randy Jensen, MD, PhD|801-585-0255|randy.jensen@hci.utah.edu|
281630|NCT00813709|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
281631|NCT00813748|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
281632|NCT00813761|Vistakon|Kristy Canavan, OD|1-904-443-1474|kcanava2@its.jnj.com|
281633|NCT00813800|Mayo Clinic|Mark Frye, MD|507-255-9391|mfrye@mayo.edu|
281634|NCT00813813|DePuy Synthes Spine|Mark Lotito|508-880-8045|mlotito@its.jnj.com|
281635|NCT00813865|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|Clinicaltrials@amicusrx.com|
281636|NCT00813904|ZymoGenetics, a Bristol-Myers Squibb company|John Pribble, Vice President, Medical Affairs; Scot Maxon, Scientific Information|(206) 428-2756; (206) 434-3365|John.Pribble@bms.com; Scot.Maxon@bms.com|
281637|NCT00813917|Mayo Clinic|Jon O. Ebbert, MD|507-266-1944|nicotineresearch@mayo.edu|
281638|NCT00813943|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
281639|NCT00813982|CIBA VISION|Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs|1-800-241-7629|priya.janakiraman@cibavision.com|
281640|NCT00813995|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
281641|NCT00814138|University of Kansas Medical Center|Richard J. Barohn, MD/ Chairman of Neurology|913-588-6094|rbarohn@kumc.edu|
281642|NCT00814164|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
281643|NCT00814177|McMaster University|Sam Schulman, MD|1-905-5270271|schulms@mcmaster.ca|44479
281644|NCT00814255|NYUmed|Howard Trachtman|646-501-2663|howard.trachtman@nyumc.org|
281645|NCT00814307|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281646|NCT00814320|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
281647|NCT00814346|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
281648|NCT00814463|Duke University Medical Center|Denise Lally-Goss, NP|919-684-3862|denise.lallygoss@dm.duke.edu|
281649|NCT00814489|GlaxoSmithKline|GSK Response Center|866-435-7343||
281650|NCT00814502|Massachusetts General Hospital|Kaloyan Tanev, M.D.|617-726-7511|ktanev@partners.org|
281651|NCT00814580|Ortho-McNeil Janssen Scientific Affair, LLC|Senior Director of Clinical Development, Pain|(908)927-5469|GVorsang@its.jnj.com|
281652|NCT00814632|William Beaumont Hospital|Kenneth M. Peters, MD|248-551-0387|kmpeters@beaumont.edu|
281653|NCT00814658|Jan-Cil Brazil|Medical Group Manager|55 11 3030-2770||
299047|NCT01857102|Johnson and Johnson Vision Care Inc.|Kathrine E. Osborn, OD, MS, FAAO- DIRECTOR GLOBAL STRATEGIC CLAIMS|904-443-1032|KOSBORN@its.jnj.com|
281654|NCT00814671|Johns Hopkins University|Susan Dorman|410-955-1755|dsusan1@jhmi.edu|
281655|NCT00814697|The NY Memory and Healthy Aging Services|Dr. Gayatri Devi|212-517-6881|gd@nymemory.org|
281656|NCT00814710|GlaxoSmithKline|GSK Response Center|866-435-7343||
281657|NCT00814775|Cleveland Clinic|Roberta Johnson|216-444-9950|johnsor13@ccf.org|
281658|NCT00814788|University of California Davis|Analyst|916 734 0294|pkaujla@ucdavis.edu|
281659|NCT00814801|Janssen Pharm KK Japan|Director|81-3-4411-5717||
281660|NCT00814879|Yale University School of Medicine: Internal Medicine: Infectious Diseases: AIDS Care Program / Viral Hepatitis Program|Dr. Michael J. Kozal|(203)737-4040|michael.kozal@yale.edu|
281661|NCT00814970|Medtronic Aortic and Peripheral Vascular|Arslan Malik - Senior Clinical Research Manager|(707) 541-3256|arslan.malik@medtronic.com|
281662|NCT00815035|University of North Carolina at Chapel Hill|Edwin Kim, Director UNC Food Allergy Initiative|919-843-9087|edwinkim@email.unc.edu|
281663|NCT00815087|Wang tyng|Dr.Wang TG|+886-2-23123456|patty.jt@gmail.com|67587
281664|NCT00815191|Cleveland Clinic Foundation|Daniel Sessler|216-444-4900|DS@OR.org|
281665|NCT00815295|Duke University Medical Center|Neal Ready, MD|919-668-6688|neal.ready@duke.edu|
281666|NCT00815308|Shandong Cancer Hospital and Institute|Jinming Yu|86-531-87984729|jn7984729@public.jn.sd.cn|
281667|NCT00815347|University of Connecticut Health Center|MArk Metersky, MD|860-679-3582|metersky@nso.uchc.edu|
281668|NCT00815360|Retina Associates of Florida, P.A.|Dr. Ivan J. Suner|813-875-6373|ivansuner@gmail.com|
281669|NCT00815490|Duke University Medical Center|Dr David MacLeod|919-812-3201|david.macleod@duke.edu|
281670|NCT00815516|Astellas Pharma Global Development, Inc. (APGD)|Senior Medical Director, Global Medical Science||Astellas.resultsdisclosure@astellas.com|
281671|NCT00815659|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
281672|NCT00815685|H. Lee Moffitt Cancer Center and Research Institute|Nagi Kumar, Ph.D., via Moffitt Cancer Center|813-745-6885|nagi.kumar@moffitt.org|
281673|NCT00815698|Herlev Hospital, dept. of Surgery|Jacob Rosenberg|+45 26237323|jacob.rosenberg@regionh.dk|
281674|NCT00815776|Ascentia Health, Inc.|Lawrence G. Clayton, M.A., Study Director|(815) 484-9258|LGClayton@aol.com|
281675|NCT00815919|Dana-Farber Cancer Institute|John Koreth, MBBS, DPhil|617-632-2949|John_Koreth@dfci.harvard.edu|
281676|NCT00815997|NPO International TRI Network|Sigeru Saito, MD, Principal Investigator|+81-467-461717|saito@shonankamakura.or.jp|10490
281677|NCT00816023|Cubist Pharmaceuticals, Inc.|Alistair Wheeler, MD, MFPM, Senior Director Clinical Research|781-860-8660|awheeler@cubist.com|
281678|NCT00816036|Department of Veterans Affairs|David Katz, MD, MSc|319-338-0581|david-katz@uiowa.edu|7598
281679|NCT00816062|Medtronic|Rianna Rapson|7635262170|rianna.k.rapson@medtronic.com|
281680|NCT00816101|Sheftel Associates Dermatology, LLC|Scott Sheftel, MD|520-293-5757|ssheftel@sheftelderm.com|7106
281681|NCT00816166|Codman Neuro|Jonathan Megerian, MD PhD|508-880-8274|jmegeri1@its.jnj.com|
281682|NCT00816348|NSLIJ Health System|Cindy Haller MD|516-472-3650|challer@lij.edu|
281683|NCT00816361|MedImmune LLC|Susan Perez MD, MSc|+1 301-398-2827|information.center@astrazeneca.com|
281684|NCT00816400|MedImmune|A Dose-escalation Study to Evaluate the Safety, Tolerability, and Antitumor Activity of MEDI-575|1-877-240-9479|information.center@astrazeneca.com|
281685|NCT00816556|Mayo Clinic|Maire Brid MacBride MB BCh|507-538-2271|MacBride.Maire@mayo.edu|
281686|NCT00816595|Mayo Clinic|Tait Shanafelt, M.D.||shanafelt.tait@mayo.edu|
281687|NCT00816751|UC San Diego Health|Jessica M. Kingston, MD|858-249-1204|jkingston@ucsd.edu|
281688|NCT00816829|Solvay Pharmaceuticals|Sven Voet, Global Communication|+32 (0) 2 509 69 77|sven.voet@solvay.com|
281689|NCT00816907|Columbia University|Dr. Scott Stroup|212-543-5676|stroups@nyspi.columbia.edu|
281690|NCT00817063|GlaxoSmithKline|GSK Response Center|866-435-7343||
281691|NCT00817089|UPENN|David Oslin|215 823 5894|oslin@upenn.edu|
281692|NCT00817206|Veloxis Pharmaceuticals A/S|Christina Sylvest|+45 20553877|csy@veloxis.com|
281693|NCT00817219|LEO Pharma A/S|Malin Järnkrants|+45 7226 2990|malin.jaernkrants@leo-pharma.com|
281694|NCT00817336|Nathan Kline Institute|Joshua Kantrowitz|646-774-6738|jk3380@cumc.columbia.edu|
281695|NCT00817414|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
281696|NCT00817479|The University of Chicago, Department of Medicine|Dr. Gini Fleming, MD|(773) 702-6149|gfleming@medicine.bsd.uchicago.edu|
289412|NCT01245374|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
289413|NCT01245387|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289414|NCT01245413|Lægehuset, Skodsborg Strandvej 125A, 2942 Skodsborg, Denmark|Dr. Claus Hyldahl|4545801331|hyldahl@info.dk|
289415|NCT01245439|Hoffmannb-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
289416|NCT01245595|Stanford University Medical Center|Dr. David M. Axelrod|650-723-7913|daxelrod@stanford.edu|
289417|NCT01245647|University of Florida|Dr. Bob Cook|352-273-5869|cookrl@ufl.edu|
289418|NCT01245673|University of Pennsylvania|Liz Veloso|215|eveloso@pennmedicine.upenn.edu|
289419|NCT01245699|Maricopa Integrated Health System|Bentley J Bobrow, MD|602-364-0580|bentley.bobrow@azdhs.gov|
289420|NCT01245738|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289421|NCT01245751|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289422|NCT01245764|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289423|NCT01245972|ucsdmed|S. Brian Jiang|8586571663|s2jiang@ucsd.edu|
289424|NCT01246050|VA Medical Center Nashville|Henry Ooi|615-8736373|henry.ooi@va.gov|
289425|NCT01246063|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@wustl.edu|
289426|NCT01246076|Washington University School of Medicine|Ravi Vij, M.D.|314-454-8304|rvij@dom.wustl.edu|
289427|NCT01246206|Barbara Ann Karmanos Cancer Institute|Dr. Zaid Al-Kadhimi|800-527-6266|zalkadh@emory.edu|
289428|NCT01246258|Imperial Health|Joanne Rimmer|0061402931120|rimmer.joanne@gmail.com|
289429|NCT01246349|The Hospital for Sick Children|Beverly Walpole|416. 813 7654|bwalpole@uoguelph.ca|328363
289430|NCT01246401|Yale University|Dr. Sandra Springer||sandra.springer@yale.edu|
289431|NCT01246466|AtriCure|Vice President, Clinical Affairs and Biometrics|1-513-644-8192|nndikintum@atricure.com|
289432|NCT01246479|Valneva Austria GmbH|Senior Scientist Clinical Research|+43120620|info@valneva.com|0
289433|NCT01246583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289434|NCT01246713|BIDMC|Michael Ganetsky, MD|6177542323|mganetsk@bidmc.harvard.edu|
289435|NCT01246791|Nobelpharma|Department director of clinical development department 1|+81-3-5651-1177|murakami@nobelpharma.co.jp|
289436|NCT01246895|Piramal Healthcare (Canada) Limited - Bio-Orthopaedics Division|David Castelo, Clinical Research Manager|450-686-2437|david.castelo@piramal.com|313
289437|NCT01246960|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289438|NCT01246973|University of Rochester|Julie Ryan|585-276-3862|julie_ryan@urmc.rochester.edu|
289439|NCT01246986|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
289440|NCT01246999|University of Rochester|John Treanor MD, Professor of Medicine|585-275-5871|John_Treanor@urmc.rochester.edu|
281697|NCT00817531|Baylor College of Medicine|Dr. Mothaffar Rimawi|713-798-1311|rimawi@bcm.edu|
281698|NCT00817596|Medasys, Inc.|Clinical Trials Manager|973-426-9229|jarrambide@medasyspumps.com|
281699|NCT00817635|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
281700|NCT00817778|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
281701|NCT00817804|Respironics California|Adam Seiver|760-703-6993|adam.seiver@philips.com|
281702|NCT00817843|UMC Utrecht|Professor F.L.J. Visseren, MD PhD|0031-88-7555555|f.l.j.visseren@umcutrecht.nl|
281703|NCT00817999|Creighton University|Tammy Burns, PharmD|402-280-4292|TammyBurns@creighton.edu|
281704|NCT00818116|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
281705|NCT00818168|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
281706|NCT00818207|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
281707|NCT00818246|RoseLab Skin Optics Laboratory|Dr Daniel Barolet|(514) 343-4444|daniel.barolet@mcgill.ca|
299048|NCT01857206|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
281708|NCT00818259|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289441|NCT01247064|Cincinnati Children's Hospital Medical Center|Todd Florin|513-636-7966|todd.florin@cchmc.org|
289442|NCT01247090|Columbia University Medical Center|Anjali Ganda, MD|617-835-3789|ag355@columbia.edu|
289443|NCT01247220|Retina Associates of Florida|Ivan J. Suner, MD|813-875-6373|ivansuner@gmail.com|
289444|NCT01247272|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
289445|NCT01247285|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
289446|NCT01247298|University of Alabama at Birmingham (UAB)|Rojymon Jacob, MD|205-975-9704|rjacob@uabmc.edu|
308940|NCT02626182|National Jewish Health|Jennifer Taylor-Cousar, MD, MSCS, ATSF|3032702764|Taylor-CousarJ@NJHealth.org|
308941|NCT02626611|Stanford|Dr. Kari Nadeau|650-867-4592|knadeau@stanford.edu|
289447|NCT01247350|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289448|NCT01247363|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
308942|NCT02626780|The GID Group|Director of Clinical Affairs|3039524901|GIDAA-01@thegidgroup.com|
308943|NCT02626819|Manhattan Campus of the VA NY Harbor Healthcare System|Melanie Jay, MD MS|212-686-7500|melanie.jay@va.gov|5097
308944|NCT02626910|University of Pennsylvania|Dr. Hillary R. Bogner|215-746-4181|Hillary.Bogner@uphs.upenn.edu|
308945|NCT02627001|San Antonio Military Medical Center|Dr. Michael D. April|(210) 916-0808|Michael.D.April@post.harvard.edu|
308946|NCT02627118|UConn Health|Andre Kaplan, MD||kaplan@uchc.edu|
308947|NCT02627144|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
308948|NCT02627495|Spaulding Rehabilitation Hospital|Prof. Felipe Fregni|+1 (617) 935-2743|Fregni.Felipe@mgh.harvard.edu|
308949|NCT02627677|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
308950|NCT02627794|Cedars-Sinai Medical Center|Dr. Martin L. Hopp|310-657-7704|marty@towerent.com|
308951|NCT02627924|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
308952|NCT02628028|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
308953|NCT02628093|Weill Cornell Medicine|Koianka Trencheva|646-9622342|kivanova@med.cornell.edu|
308954|NCT02628106|West China Hospital of Sichuan University|Mr.Zhi-cheng Li|+86 13795581617|wangcaizi2@163.com|
289449|NCT01247428|Micell Technologies|Dennis Donohoe, MD, Chief Medical Advisor|919-313-2102|ddonohoeconsult@gmail.com|
289450|NCT01247571|NRG Oncology|Linda Gedeon for William Brady, PhD.|716-845-1169|lgedeon@gogstats.org|
289451|NCT01247675|Ascendis Pharma A/S|Michael Beckert, MD|(+49) 172-155-2596|mb@ascendispharma.com|
299049|NCT01857232|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-875149|GabrielFox@acaciapharma.com|149
299050|NCT01857258|The Ohio State University|Richard Bruno, PhD, RD|6142925522|bruno.27@osu.edu|
299051|NCT01857297|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
299052|NCT01857310|NICHD|Dr. Enrique Schisterman|3014356893|schistee@mail.nih.gov|
299053|NCT01857323|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
299054|NCT01857362|Swedish Orphan Biovitrum|Dr Erik Brouwer, Medical Director|+4686972000|erik.brouwer@sobi.com|
299055|NCT01857531|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
299056|NCT01857583|Daiichi Sankyo.,LTD|Masayuki Fukuzawa, Associate Director|81-90-5584-2197|fukuzawa.masayuki.gn@daiichisankyo.co.jp|
299057|NCT01857622|Daiichi Sankyo.,LTD|Kenichi Sakakura, Manager|81-90-1885-0271|sakakura.kenichi.ef@daiichisankyo.co.jp|
299058|NCT01857713|Somna Therapeutics, L.L.C.|James Miller|262-345-5553|jmiller@somnatherapeutics.com|102
299059|NCT01857869|GlaxoSmithKline|GSK Response Center|866-435-7343||
299060|NCT01857882|University Health Network|Dr. Toni Zhong|416-340-3858|toni.zhong@uhn.ca|
299061|NCT01857973|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
299062|NCT01857986|Hospitech Respiration|Clinical Trials Manager|+972-3-9191648|adir@hospitech.co.il|5
299063|NCT01858194|Icahn School of Medicine at Mo|Betsy Ellsworth, Research Program Director|212 824 8902|betsy.ellsworth@mountsinai.org|
299064|NCT01858363|Spectranetics|Nicolas Aguirre|+1-312-297-6655|nicolas.aguirre@philips.com|
299065|NCT01858376|The Ohio State University|Chandan K. Sen|6142477786|chandan.sen@osumc.edu|
299066|NCT01858389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
299067|NCT01858428|Spectranetics|Julie Wolfram Smith|763-955-1072|julie.wolframsmith@spnc.com|
299068|NCT01858532|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
299069|NCT01858545|Integra LifeSciences|Manager, Clinical Research|443-766-3869|allison.matthews@integralife.com|
299070|NCT01858558|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Philip Imus, MD|410-955-8873|pimus1@jhmi.edu|
299071|NCT01858636|St. Jude Medical|Andrew Campbell|+1.651.756.5538|acampbell2@sjm.com|
299072|NCT01858701|Alcon Research, Ltd.|Jessie Lemp, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
299073|NCT01858753|Castle Creek Biosciences|Head, Research and Development|13128471291|medinfo@castlecreekbio.com|
299074|NCT01858766|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
299075|NCT01859013|University of Minnesota|Claudia Fox|612-626-6616|lusc0001@umn.edu|
299076|NCT01859078|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299077|NCT01859143|MedImmune, LLC|Raburn Mallory, MD/Senior Director, Clinical Development|301-398-0000|malloryr@medimmune.com|
299078|NCT01859195|The Miriam Hospital|Principal Investigator|401-793-4775 or 401-793-8180|scu-uvin@lifespan.org; kate.guthrie@lifespan.org|
308955|NCT02628223|Temple University Hospital|Dr. Jeffrey Henderer|267-418-9126|Jeffrey.Henderer@tuhs.temple.edu|
308956|NCT02628236|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|8452681943|Anna.Houlihan@sunpharma.com|
308957|NCT02628418|Fondazione Salvatore Maugeri|Dr. Palmira Bernocchi|00390308253|palmira.bernocchi@fsm.it|260
308958|NCT02628444|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
308959|NCT02628600|Insmed Inc|Kevin Mange (Senior Vice President, Clinical Development & Medical Affairs, ALIS)|908-947-2651|kevin.mange@insmed.com|
308960|NCT02628743|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
308961|NCT02628769|Imperial College London|Louise Donnelly|+44 02075947895|l.donnelly@imperial.ac.uk|
308962|NCT02628873|Wright State University|Steven Lindheim|858-740-1083|doclalalindheim@gmail.com|
308963|NCT02628938|Riyadh Colleges of Dentistry and Pharmacy|Dr. Mohammad Rayyan|00966508821318|mohammadrayyan1979@gmail.com|
308964|NCT02628964|NYU Langone Health|Donna Shelley, MD MPH|917-494-4210|donna.shelley@nyulangone.org|
308965|NCT02629094|National Institute of Allergy and Infectious Diseases|Hadigan, Colleen|+1 301 594 5754|hadiganc@mail.nih.gov|
308966|NCT02629133|Womene and Infants Hospital|Caron Zlotnick|401-474-3332|czlotnick@butler.org|
308967|NCT02629354|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308968|NCT02629822|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308969|NCT02629861|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@Tevapharm.com|
308970|NCT02629965|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308971|NCT02629991|Albert Einstein College of Medicine|Bonnie Taylor|7188397530|botaylor@montefiore.org|
308972|NCT02630017|University of Arkansas for Medical Sciences|Merideth Addicott|501-526-8436|maddicott@uams.edu|
308973|NCT02630030|Emory University|Dr. Jeffrey Olson|404-778-5770|jolson@emory.edu|
308974|NCT02630186|Clovis Oncology, Inc.|Elizabeth Bradley|1-415-409-5495|ebradley@clovisoncology.com|
308975|NCT02630251|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
308976|NCT02630316|United Therapeutics|United Therapeutics Global Medical Information|919-485-8350|clinicaltrials@unither.com|
308977|NCT02630459|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
289452|NCT01247922|Astellas Pharma Global Development, Inc.|Sr. Medical Director||Astellas.resultsdisclosure@astellas.com|
289453|NCT01247974|CorMatrix Cardiovascular|Director of Clinical Trials|6785662628|agreen@cormatrix.com|
289454|NCT01248013|Mind-Body Digestive Center|Charles D. Gerson, M.D.|212 496 6161|cgerson@yahoo.com|
289455|NCT01248065|Penn State University Dept. of Public Health Sciences|Tonya S. King, PhD|717-531-7178|tking@psu.edu|
289456|NCT01248104|Loma Linda University Medical Center|Dr. Jason Gatling|909-558-4475|jgatling@llu.edu|44475
289457|NCT01248221|Mayo Clinic|Dr. Adil E. Bharucha|507-284-2687|bharucha.adil@mayo.edu|
289458|NCT01248364|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289459|NCT01248416|Nemours Children's Clinic|Dr. Nelly Mauras|904-697-3674|nmauras@nemours.org|
289460|NCT01248455|National Cancer Institute|Dr. Dickran Kazandijian|301-480-0532|kazandjiandg@mail.nih.gov|
289461|NCT01248468|Novartis Consumer Health|Clinical Project Leader|973-503-8000||
289462|NCT01248585|Canadian Cancer Trials Group|Keyue Ding, Biostatistician|613-533-6430|kding@ctg.queensu.ca|
299079|NCT01859247|The University of New Mexico Health Sciences Center|Dr. Sarah Pirio Richardson, MD|505-272-3342|spiriorichardson@salud.unm.edu|
289463|NCT01248715|University Louisville|Dr. Paula Peyrani|502-852-3905|paula.peyrani@louisville.edu|
289464|NCT01248728|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-425-6220|eanagnostou@hollandbloorview.ca|6005
299080|NCT01859312|National Institute of Child Health and Human Development (NICHD)|Deborah P. Merke, MD, MS|301-496-0718|DMerke@cc.nih.gov|
289465|NCT01248741|British Columbia Cancer Agency|Dr Juanita Crook|2507123958|jcrook@bccancer.bc.ca|
289466|NCT01248780|Janssen Research & Development|Associate Director, Clinical Research|610-500-3369||
289467|NCT01248793|Janssen Research & Development|Associate Director, Clinical Research|610-500-3369||
289468|NCT01248884|GlaxoSmithKline|GSK Response Center|866-435-7343||
299081|NCT01859325|National Institute of Allergy and Infectious Diseases|Sneller, Michael|+1 301 496 0491|MSNELLER@niaid.nih.gov|
299082|NCT01859390|University of Colorado School of Medicine|Dr. Scott Sagel, Professor of Pediatrics|720-777-2522|scott.sagel@ucdenver.edu|
299083|NCT01859403|VA San Diego Health Sciences|Amir Zarrinpar, MD, PhD, Assistant Professor of Gastroenterology|858-246-1665|azarrinpar@health.ucsd.edu|
299084|NCT01859494|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
299085|NCT01859507|Cairo University. Department of Obstetrics and Gynecology|Abdelmaguid Ramzy|+201008606060|amramzy@gmail.com|
299086|NCT01859598|The George Institute for Global Health at Peking University Health Science Center|Pro. Linong Ji|82800577|jiln@bjmu.edu.cn|
308978|NCT02630563|Roche Trial Information Hotline|F. Hoffmann-La Roche AG|+41 61 6878333|global.trial_information@roche.com|
308979|NCT02630693|Canadian Cancer Trials Group|Dr. Wendy Parulekar|613-533-6430|wparulekar@ctg.queenus.ca|
308980|NCT02630706|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
308981|NCT02630719|Truman Medical Center|Sean Gratton MD|816-404-5275|sean.gratton@tmemed.org|
308982|NCT02630953|Brown University|Dr. Bess Marcus, Principle Investigator|401-863-6950|bess_marcus@brown.edu|
308983|NCT02630966|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
308984|NCT02630992|University of Pittsburgh|Nader Shaikh|412-692-8111|nader.shaikh@chp.edu|
308985|NCT02631057|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
308986|NCT02631525|Universidade federal de Minas Gerais|Dr Renato Gomez|553134099760|renatogomez2000@yahoo.com.br|
308987|NCT02631538|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
308988|NCT02631551|Glenmark Pharmaceuticals Ltd.|Study Director|(201) 684-8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
308989|NCT02631577|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
308990|NCT02631590|Moffitt Cancer Center|Richard Kim, MD, Principal Investigator|813-745-1277|Richard.Kim@moffitt.org|
308991|NCT02631746|Duke University - Duke Cancer Institute LAO|Christy Arrowood|919-613-6130|christy.arrowood@duke.edu|
289469|NCT01248936|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
289470|NCT01248949|MedImmune, LLC|Mohammed Dar, MD|301-398-0000|information.center@astrazeneca.com|
289471|NCT01248962|Memorial Sloan Kettering Cancer Center|Dr. Roisin O'Cearbhaill, MD|646-888-4227|ocearbhr@mskcc.org|
289472|NCT01249027|Abbott Vascular|Leong Roy|8133 7475|roy.leong@abbott.com|+65
289473|NCT01249092|Cleveland Clinic|Claudia O. Zein, MD|216-444-0421|zeinc@ccf.org|
289474|NCT01249118|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
289475|NCT01249131|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
289476|NCT01249261|Warner Chilcott|Grexan J. Wulff, Manager Regulatory Affairs|973-442-3376|gwulff@wcrx.com|
289477|NCT01249274|Yale University|Kimberly A. Yonkers, M.D.|203-764-6621|kimberly.yonkers@yale.edu|
289478|NCT01249365|GlaxoSmithKline|GSK Response Center|866-435-7343||
289479|NCT01249404|Ipsen|Medical Director, Neurology||clinical.trials@ipsen.com|
289480|NCT01249417|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
289481|NCT01249625|University of Texas Southwestern|Dr. Trish Perl|214-648-9022|Trish.Perl@UTSouthwestern.edu|
289482|NCT01249651|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
299087|NCT01859611|ELECTRONIC ENGINEERING EL.EN. SPA|ALESSANDRO BIZZARRI STUDY DIRECTOR|+390558826807|A.BIZZARRI@ELEN.IT|
289483|NCT01249664|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
289484|NCT01249833|Trial Management Group Inc.|Joanne Morris, Clinical Research Quality Manager|4169297717|joanne@tmginvestigators.com|
299088|NCT01859637|Sandoz Biopharmaceutical, Hexal AG|Roumen Nakov|+49 8024 4764704|roumen.nakov@sandoz.com|
299089|NCT01859702|Alcon Research, Ltd.|Abayomi Ogundele, Global Medical Affairs Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
289485|NCT01249872|University Hospital Of Patras, Greece|Dr Anastasia Zotou|0026130603341|anzotou@hotmail.com|
289486|NCT01250002|Northwestern University|Gildasio De Oliveira, MD|312-926-8373|g-jr@northwestern.edu|
289487|NCT01250054|CIBA VISION|Joe Rappon, OD, MS, FAAO / Head, Clinical Trial Management|1-678-415-3343|Joseph.Rappon@cibavision.com|
289488|NCT01250119|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
289489|NCT01250145|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299090|NCT01859715|University of Colorado|Andrew A Monte, MD||andrew.monte@ucdenver.edu|
289490|NCT01250171|Novartis Pharmaceuticals|Study Director|862 778-8300||
289491|NCT01250184|university of Antioquia, Research Group Rehabilitation in Health|Dr. Luz Helena Lugo, Head of Research Group Rehabilitation in Health|+57 4 2196475|luzh.lugo@gmail.com|
289492|NCT01250210|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
289493|NCT01250379|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
289494|NCT01250418|Northwestern University|Gildasio De Oliveira MD|312-472-3573|g-jr@northwestern.edu|
289495|NCT01250509|University of California, San Francisco|Jennifer Daubenmier, PhD|415-514-8601|jennifer.daubenmier@ucsf.edu|
289496|NCT01250717|BIDMC|Glenn Bubley MD, Director of GU ONC|617-735-2062|gbubley@bidmc.harvard.edu|
289497|NCT01250730|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289498|NCT01250756|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289499|NCT01250769|Philips Healthcare, Office of Medical and Health Affairs|Director of Clinical Operations|425 908-1208|wendy.jenkins@philips.com|
299091|NCT01859741|OncoMed Pharmaceuticals, Inc.|Manager, Regulatory Affairs|6509958322|imran.chaudhry@oncomed.com|
289500|NCT01250834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289501|NCT01250873|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289502|NCT01250899|University of California, Los Angeles|Dr Jordan Lake|310-557-2273|jlake@mednet.ucla.edu|
289503|NCT01250925|Massachusetts Eye and Ear Infirmary|Dr. Pedram Hamrah|617-573-3313|cornea_research@meei.harvard.edu|
289504|NCT01250977|Center for Interdisciplinary Research on Nicotine Addiction|Benjamin Albelda (Project Manager)|215-746-7173|albeldab@pennmedicine.upenn.edu|
289505|NCT01250990|University of Pennsylvania|Richard L Dunbar|215-662-9024|richard.dunbar@uphs.upenn.edu|
289506|NCT01251042|Wellspect HealthCare|Emma Tällberg, Clinical Research Manager|+46313764000||
289507|NCT01251146|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
299092|NCT01859793|Medical College of Wisconsin|Michael E. Widlansky|414-955-6806|mwidlans@mcw.edu|
289508|NCT01251276|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289509|NCT01251315|Charles R Drew University of Medicine and Science|Dr .Naureen Tareen|323-568-3359|aaant@aol.com|
289510|NCT01251354|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
289511|NCT01251367|Ipsen|Medical Director, Neurology,||clinical.trials@ipsen.com|
289512|NCT01251380|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
289513|NCT01251393|Universidade Federal de São Paulo|PhD José Carlos F. Galduróz||galduroz@unifesp.br|
289514|NCT01251536|UZ Leuven|Prof Dr Eric Van Cutsem|003216344218|eric.vancutsem@uzleuven.be|
299093|NCT01859923|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
289515|NCT01251575|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
289516|NCT01251588|Vericel Corporation|Ann Remmers, Senior Director, Clinical Science|734-428-4526|aremmers@vcel.com|
289517|NCT01251614|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
308992|NCT02631772|Medical University of South Carolina|Dr. Derek Dubay|843-792-3368|dubay@musc.edu|
289518|NCT01251653|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289519|NCT01251744|GlaxoSmithKline|GSK Response Center|866-435-7343||
289520|NCT01251757|Kaiser Permanente Center for Health Research|William M Vollmer, PhD|503-335-2400|william.vollmer@kpchr.org|
289521|NCT01251770|Hospital General de Niños Pedro de Elizalde|Dr Facundo Jorro Barón|00541143632100|jorrobox@yahoo.com.ar|2035
289522|NCT01251861|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
289523|NCT01251887|NIAAA/NIA|Ramsden, Christopher|+1 410 558 8369|ramsdence@mail.nih.gov|
289524|NCT01251965|The University of Texas (UT) MD Anderson Cancer Center|Srdan Verstovsek, Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
289525|NCT01251978|New England Retina Associates|Leslie Hurst- study coordinator|203-288-2020|lhurst@retinamd.com|
289526|NCT01252095|Progen Pharmaceuticals Ltd|Director of Clinical Development|+61 7 32739133||
289527|NCT01252134|Alcon Research, Ltd.|Director of Medical Affairs|888.451.3937|medinfo@alconlabs.com|
299094|NCT01859949|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289528|NCT01252147|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
289529|NCT01252186|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
289530|NCT01252238|Brigham and Women's Hospital|Dr. Jonathan Williams|617-278-0882|jwilliams5@partners.org|
289531|NCT01252251|Memorial Sloan Kettering Cancer Center|Dr. Michael Postow, MD|646-888-4589|PostowM@mskcc.org|
308993|NCT02631850|University of Massachusetts Lowell|Lynne Gauthier|9789345383|lynne_gauthier@uml.edu|
308994|NCT02631876|ImmunoGen, Inc|CMO, ImmunoGen|781-895-0600|clinicaltrials@immunogen.com|
308995|NCT02631954|INHA UNIVERSITY HOSPITAL|Sang-Heon Cho, Ph.D.|82-32-890-1122|shcho123@inha.ac.kr|
308996|NCT02632110|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|anna.houlihan@sunpharma.com|
308997|NCT02632526|AstraZeneca AB|A study to assess the safety, tolerability, pharmacokinetics & dynamics of AZD5718 in healthy male||ClinicalTrialTransparency@astrazeneca.com|
308998|NCT02632552|U.S. Department of Veterans Affairs, Center for Healthcare Organization and Implementation Research (CHOIR)|Timothy P. Hogan, PhD,|508-244-2303|Timothy.Hogan@VA.gov|
308999|NCT02632747|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309000|NCT02632786|Prothena|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
309001|NCT02632812|Galeno Desenvolvimento de Pesquisas Ltda.|Gilberto De Nucci, PhD, principal investigator|55.19.32516928|denucci@gilbertodenucci.com|
309002|NCT02632838|School of Nursing, Rutgers, the State University of New Jersey|Dr. Peijia Zha|7327637412|peijiaz@sn.rutgers.edu|
309003|NCT02633020|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
309004|NCT02633046|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
309005|NCT02633215|University of Kentucky|Dr. Lumy Sawaki||lsawa2@uky.edu|
309006|NCT02633306|University of Minenesota|Stephen Haines, MD|612 624-6666|shaines@umn.edu|
309007|NCT02633358|China Medical University Hospital, Taichung, Taiwan|Dr. Da-Long Chen, director of cardiac intensive care unit|0952122027|my686chen@gmail.com|
309008|NCT02633371|University of Colorado|Dr. Anna Bruckner|720-777-0955|anna.bruckner@ucdenver.edu|
309009|NCT02633488|University of Virginia|Eugene J. Barrett MD PhD|434-924-1263|ejb8x@virginia.edu|
309010|NCT02633501|Guerbet|Jing Hao, MD, Global Head of Medical Affairs & Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
309011|NCT02633527|Supernus|Joseph Hull, PhD, Director Clinical Research|240-403-5324|jhull@supernus.com|
309012|NCT02633735|HealthPartners Institute|Elyse Kharbanda|952-967-5038|elyse.o.kharbanda@healthpartners.com|
309013|NCT02633787|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
309014|NCT02633800|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400|CTRinfo@DSI.com|
309015|NCT02633956|Intercept Pharmaceuticals, Inc|Medical Information|844-782-4278|medinfo@interceptpharma.com|
309016|NCT02634073|GlaxoSmithKline|GSK Response Center|866-435-7343||
309017|NCT02634151|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
309018|NCT02634177|Genomind|Chief Medical Officer|267-989-3461|dkrause@genomind.com|
309019|NCT02634320|Alkermes, Inc.|ARISTADA Medical Information|866-204-7823|usmedinfo@alkermes.com|
309020|NCT02634333|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|mhuggins@jaeb.org|
309021|NCT02634346|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
309022|NCT02634580|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
309023|NCT02634684|UC San Diego|Neal Swerdlow, M.D., Ph.D.|619-543-6270|nswerdlow@health.ucsd.edu|
299095|NCT01859988|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
299096|NCT01860079|AcibademU|Prof.Dr.Şevket Görgülü|+902623174444|sevket5@yahoo.com|4123
299097|NCT01860170|Spectrum Health|A. Samer A;-Homsi|616-486-5933|a.samer.al-homsi@spectrumhealth.org|
299098|NCT01860287|University of Chicago|Dr. Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
299099|NCT01860521|IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy|Dr. Umberto Leone Roberti Maggiore|00393289461340|ulrm@libero.it|
299100|NCT01860534|University of Texas medical Branch, Galveston|Dr. Cara Geary|409-772-2815|cageary@utmb.edu|
299101|NCT01860573|Women & Infants Hospital|Dr. Joseph Bliss|4012741100|jbliss@wihri.org|
299102|NCT01860586|Mid-Atlantic Retina|Dr. Jason Hsu, Principal Investigator|215-928-3092|jshu@midatlanticretina.com|
289532|NCT01252277|University of Kansas Medical Center|Carol J. Fabian, M.D.|913-588-7791|cfabian@kumc.edu|
289533|NCT01252290|University of Kansas Medical Center|Carol J. Fabian, MD; Professor|913-588-7791|cfabian@kumc.edu|
289534|NCT01252355|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
289535|NCT01252563|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289536|NCT01252667|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fredhutch.org|
289537|NCT01252732|Melinta Therapeutics, Inc.|Karen Fusaro|6098270956|kfusaro@melinta.com|
289538|NCT01252745|Acerus Pharmaceuticals Corporation|Vice President|(416) 679-0776|nbryson@aceruspharma.com|
289539|NCT01252810|GE Healthcare|Ruben Sheng, M.D.|609-514-6899|Rubin.Sheng@ge.com|
289540|NCT01252940|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
289541|NCT01252953|Nuffield Department of Population Health, University of Oxford|Prof Martin Landray|+44 (0)1865 743743|martin.landray@ndph.ox.ac.uk|
289542|NCT01252966|University of Pennsylvania (Perelman School of Medicine)|Benjamin Albelda (Project Manager)|2157467173|albeldab@mail.med.upenn.edu|
289543|NCT01253018|VA Maryland Health Care System|Dr. Christopher T. Bever, Jr. MD, MBA|(410) 605-7000|christopher.bever@va.gov|7130
289544|NCT01253044|VA San Diego Healthcare System and UCSD|Dr. Ariel Lang|858-246-0631|ajlang@ucsd.edu|
289545|NCT01253070|Washington University School of Medicine|Geoffrey Uy, MD||guy@dom.wustl.edu|
289546|NCT01253135|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
299103|NCT01860651|Hvidovre University Hospital|Dr. Katrine Carlsen|26180513|katrinec@gmail.com|0045
289547|NCT01253148|H. Lee Moffitt Cancer Center and Research Institute|Sarah Hoffe, M.D.|813-745-3814|sarah.hoffe@moffitt.org|
289548|NCT01253174|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
299104|NCT01860677|McLean Imaging Center, McLean Hospital|Scott E. Lukas, Ph.D.|617-855-2767|slukas@mclean.harvard.edu|
299105|NCT01860703|ApoPharma Inc.|Fernando Tricta, MD|416-401-7332|ftricta@apopharma.com|
299106|NCT01860807|UCLA|Keith Heinzerling MD|310-319-4700|kheinzerling@mednet.ucla.edu|
299107|NCT01860846|AbbVie|Global Medical Services|800-633-9110||
299108|NCT01860950|Medical University of South Carolina|Dr. Jeffrey J. Borckardt|8437923295|borckard@musc.edu|
299109|NCT01860976|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
299110|NCT01860989|Novartis Pharmaceuticals|Study Director|862-778-8300||
299111|NCT01861002|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Roy Leong, BA, CCRP|323-361-5132|rleong@chla.usc.edu|
299112|NCT01861028|Conformis|Director of Clinical and Technical Research|781-345-9103|sumesh.zingde@conformis.com|
299113|NCT01861054|Dompé Farmaceutici|Pier Adelchi Ruffini, MD|+39 (0)2 583831|info@dompe.it|
299114|NCT01861301|University of Chicago|Hedy Kindler, MD|773-702-0360|hkindler@medicine.bsd.uchicago.edu|
299115|NCT01861457|Medical University of South Carolina|Shaun A. Nguyen, MD, Associate Professor- Director of Clinical Research|8437921356|nguyensh@musc.edu|
299116|NCT01861522|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
299117|NCT01861574|Medical University of South Carolina|JEFFREY J BORCKARDT|(843)792-3295|borckard@musc.edu|
299118|NCT01861587|Medical University of South Carolina|Jeffrey Borckardt, Ph.D|843-792-3295|borckard@musc.edu|
299119|NCT01861665|Ronald O. Perelman and Claudia Cohen Center for Reproductive Medicine.|Dr. Glenn Schattman, Associate Professor|646-962-3836|glschatt@med.cornell.edu|
299120|NCT01861704|InSound Medical, Newark, California|Tanya Arbogast, Study Principal Investigator|510-792-4000|Srikant.Mantha@phonak.com|
299121|NCT01861756|Aristotle University Thessaloniki|Dr. Apostolos Tsapas||atsapas@auth.gr|
299122|NCT01861925|Haag Streit AG|Dr. Lucio Robledo, Clinical Trials Biometry|+41 31 978 01 11|lucio.robledo@haag-streit.com|209
299123|NCT01862029|National Institute of Health, NHLBI, Laboratory of Obesity and Aging Research|Jay H. Chung, Ph.D, MD|301-496-3075|chungj@nhlbi.nih.gov|
299124|NCT01862133|Regenstrief Institute|William M. Tierney, MD|(317) 274-9094|wtierney@regenstrief.org|
299125|NCT01862159|Region Örebro län, Sweden AND Örebro University, Sweden|Dr Erik Stenberg|+46196021000|erik.stenberg@regionorebrolan.se|
299126|NCT01862250|University of Toronto|Estelle B. Gauda|416-813-4908|estelle.gauda@sickkids.ca|
299127|NCT01862328|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
299128|NCT01862419|Yale University School of Medicine|Francis Perry Wilson, MD MSCE|2037371704|francis.p.wilson@yale.edu|
299129|NCT01862484|The University of Texas Health Science Center at San Antonio|Steven R. Pliszka MD|210-567-0136|pliszka@uthscsa.edu|
299130|NCT01862536|VA Boston Healthcare System|Dr. Ronald Goldstein|857-203-6578|Ronald.Goldstein@va.gov|
299131|NCT01862614|The Ohio State University College of Dentistry|Dr. John Nusstein, Professor|614-292-3596|nusstein.1@osu.edu|
299132|NCT01862640|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|DT-inquiry@otsuka.jp|
299133|NCT01862796|National Institute of Diabetes Digestive and Kidney Diseases/NIH|Dr. Marci E. Gluck|602-200-5317|gmarci@mail.nih.gov|
299134|NCT01862874|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
299135|NCT01862991|Stanford University|Dr. Kate Shaw|6507211562|familyplanningresearch@stanford.edu|
299136|NCT01863017|University of Kansas Medical Center|Merlin G Butler|9135881800|mbutler4@kumc.edu|
299137|NCT01863030|University of Kentucky Medical Center|Scott Roth M.D.|859-323-6346|sroth@uky.edu|240
299138|NCT01863134|First Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland|Miroslaw Wilczynski|+48 32 20 24 025|miroslaw.wilczynski@cardiosurg.pl|
299139|NCT01863186|US WorldMeds|Medical Affairs|1-888-900-8796|medinfo@usworldmeds.com|
299140|NCT01863368|Alcon Research, Ltd.|Global Brand Med Affairs Lead, Pharma, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
299141|NCT01863433|Seqirus|Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
299142|NCT01863498|Children's Mercy Kansas City|Dr. Shawn St. Peter|816-234-3575|sspeter@cmh.edu|
299143|NCT01863563|Children's Hospital of the Kings Daughters|Craig Derkay, MD|757.668. 9327|Craig.Derkay@chkd.org|
289549|NCT01253187|Bayer HealthCare AG|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
289550|NCT01253200|Boston Scientific|Timothy Meyer; Director of Clinical Trials|651 581 3425|Timothy.meyer@bsci.com|
299144|NCT01863667|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289551|NCT01253226|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289552|NCT01253265|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289553|NCT01253291|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
289554|NCT01253304|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299145|NCT01863680|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
289555|NCT01253317|Boston Children's Hospital|Walter E. Kaufmann, MD|617-355-5230|rettresearch@childrens.harvard.edu|
289556|NCT01253343|Cincinnati Children's Hospital Medical Center|Dr. Drew Barzman|513-636-4788|drew.barzman@cchmc.org|
299146|NCT01863732|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
299147|NCT01863758|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
289557|NCT01253369|Dana-Farber Cancer Institute|David Jackman, MD|617-632-6049|DJACKMAN@PARTNERS.ORG|
299148|NCT01863771|Janssen Pharmaceutical K.K.|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
289558|NCT01253408|Mayo Clinic|Dr. Michael Camilleri|507-266-2306|camilleri.michael@mayo.edu|
309024|NCT02634788|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
289559|NCT01253421|McLean Hospital|Diego Pizzagalli, Ph.D.|617-855-4230|dap@mclean.harvard.edu|
289560|NCT01253447|The University of Texas (UT) MD Anderson Cancer Center|Marina Konopleva, MD, PHD / Professor||CR_Study_Registration@mdanderson.org|
289561|NCT01253460|The University of Texas MD Anderson Cancer Center|William G Wierda, MD/Professor|713-745-0428|wwierda@mdanderson.org|
289562|NCT01253525|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
309025|NCT02634801|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
309026|NCT02634814|University of North Carolina at Chapel Hill|Brian Pietrosimone, PhD|919-962-3617|brian@unc.edu|
309027|NCT02634983|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
309028|NCT02635035|NYU Langone Health|Terry Leon|1 646 754 4841|Terry.Leon@nyulangone.org|
309029|NCT02635204|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
309030|NCT02635347|Rutgers-NJ Medical School|Baburao Koneru, MD, MPH|973-972-9599|koneruba@njms.rutgers.edu|
309031|NCT02635386|Woman's Hospital|Dr Karen Elkind-Hirsch|2252315278|karen.elkind-hirsch@womans.org|
309032|NCT02635425|Ain Shams university|Dr. Ahmad Hussieny Salama|00201223114626|ahmdhsf@hotmail.com|
309033|NCT02635542|University of Chicago|Rebecca M Gerlach, MD|773-702-6700|rgerlach@dacc.uchicago.edu|
309034|NCT02635646|University of Guanajuato|Dr. Rodolfo Guardado-Mendoza||guardamen@gmail.com|
309035|NCT02635724|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
309036|NCT02635737|UHSM|Mr James Harvey|01612914436|james.harvey@uhsm.nhs.uk|
309037|NCT02635828|The Ohio State Universtiy Wexner Medical Center|Director of Neuroanesthesia|6142933559|sergio.bergese@osumc.edu|
309038|NCT02635880|Cutera|Ginger Pocock|4156575702|gpocock@cutera.com|
309039|NCT02635984|AU Medical Center / University of Georgia College of Pharmacy|Dr. Amber Clemmons, Clinical Pharmacist - BMT/Hematology & Clinical Associate Professor|706-721-6493|aclemmons@augusta.edu|
309040|NCT02636049|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
309041|NCT02636361|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
309042|NCT02636595|AbbVie|Global Medical Services|800-633-9110||
309043|NCT02636608|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309044|NCT02636699|DBV Technologies|Chief Medical Officer|33-1-55-42-78-78|clinicaltrials@dbv-technologies.com|
309045|NCT02636712|Zhongshan Hospital|Dr Yangang Su|+86 13788905096|suyangang111@163.com|
309046|NCT02636725|University of Miami|Jonathan Trent MD|305-243-2581|JTrent@med.miami.edu|
309047|NCT02636868|Windtree Therapeutics, Inc.|Executive Director of Biostatistics & Data Management|215-488-9477|psimmons@windtreetx.com|
309048|NCT02636907|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309049|NCT02637037|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
309050|NCT02637063|Oregon Center for Applied Science|Amelia J Birney (PI), Director of Research|541-342-7227|abirney@orcasinc.com|541
309051|NCT02637076|CAMH|Dr. Stephen Kish|416-535-8501|stephen.kish@utoronto.ca|36256
309052|NCT02637141|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
309053|NCT02637232|Galderma|Stéphanie Leclerc|+33492386706|stephanie.leclerc@galderma.com|
309054|NCT02637323|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
289563|NCT01253564|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
289564|NCT01253577|Intersect ENT|James Stambaugh, Vice President Clinical Affairs|650-641-2103|jstambaugh@intersectent.com|
289565|NCT01253642|OHSU Knight Cancer Institute|Kristi Eilers|503-494-2897|eilersk@ohsu.edu|
299149|NCT01863849|Fluart Innovative Vaccines Ltd|Zsolt Németh|+3620|info@fluart.hu|4197020
289566|NCT01253811|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
289567|NCT01253824|Nobelpharama|Department director of clinical development department 1|+81-23-5651-1177|murakami@nobelpharma.co.jp|
289568|NCT01253902|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
289569|NCT01253980|Poisons Information Centre, Red Cross War Memorial Children's Hospital and University of Cape Town|Dr Kate Balme|+27 21 658 5308|kate.balme@uct.ac.za|
289570|NCT01254019|GlaxoSmithKline|GSK Response Center|866-435-7343||
289571|NCT01254045|Stanford University School of Medicine|Scott S. Hall, PhD|650-498-4799|hallss@stanford.edu|
299150|NCT01863953|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
299151|NCT01864005|Astrazeneca|Judith Hsia|1-301-398-0102|judithhsia@astrazeneca.com|
289572|NCT01254188|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
289573|NCT01254214|University of Minnesota|Cynthia Gross PhD|612-624-8676|gross002@umn.edu|
289574|NCT01254227|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
289575|NCT01254292|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
289576|NCT01254305|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
289577|NCT01254318|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289578|NCT01254331|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
289579|NCT01254344|Merck Sharp & Dohme (China) Ltd.|Naimi Missoum|+8621 2211 8546|naimi_missoum@merck.com|
289580|NCT01254396|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299152|NCT01864148|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
289581|NCT01254409|Promedior, Inc.|Dr. Bernt van den Blink|781-538-4203|bvandenblink@promedior.com|
289582|NCT01254422|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
289583|NCT01254552|Guerbet|Corinne Dubourdieu, Head of Clinical Projects and Medical Writing|+33(0)1 45 91 50 00|corinne.dubourdieu@guerbet.com|
289584|NCT01254565|Amgen, Inc|Study Director|866-572-6436||
289585|NCT01254604|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289586|NCT01254630|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289587|NCT01254643|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289588|NCT01254656|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289589|NCT01254669|Boston Medical Center|Dr. Natalie Joseph|1-617-414-5202|napierre@bu.edu|
289590|NCT01254721|SM&M Korea|Hui Jung Sin / Clinical Project Leader|82-2-2188-2165|ClinicalTrialTransparency@astrazeneca.com|
289591|NCT01254747|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
289592|NCT01254760|Alcon Research, Ltd.|Director of Alcon Clinical|1-800-241-7629||
289593|NCT01254851|Loyola University Medical Center|Linda Brubaker|708-216-4033|lbrubaker@lumc.edu|
299153|NCT01864174|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
299154|NCT01864200|BTG|Shirley Steiner, Director of Clinical Operations|610 943 3631|shirley.steiner@btgplc.com|
299155|NCT01864291|Massachusetts Eye & Ear Infirmary|Dr. Daniel Lee|6175736391|Daniel_Lee@meei.harvard.edu|
299156|NCT01864434|University of Tennessee|Adrija Sharma, Ph. D.|8659742093|asharma1@utk.edu|
299157|NCT01864525|Syracuse University|Dr. Soren Lowell|315-443-9648|slowell@syr.edu|
289594|NCT01254877|JohnHopkinsU|Mary E McCaul|410-955-9526|mmccaul1@jhmi.edu|
289595|NCT01254890|University of Texas (UT) MD Anderson Cancer Center|Farhad Ravandi-Kashani, Professor, Leukemia Department||CR_Study_Registration@mdanderson.org|
299158|NCT01864538|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilso2112@gmail.com|
289596|NCT01255137|National Cancer Institute, National Institutes of Health|Dr. Tito Fojo|301-496-2631|FojoT@mail.nih.gov|
289597|NCT01255163|National Institute on Aging (NIA/NIH)|Dimitrios Kapogiannis, Clinical Investigator|410-350-3953|kapogiannisd@mail.nih.gov|
289598|NCT01255306|"University Hospital Sestre milosrdnice"|Mia Zoric Geber, MD|+385 1 3787 354|mia.zoric-geber@zg.t-com.hr|
309055|NCT02637427|Rutgers, The State University of New Jersey|Jeffrey L Carson, MD|732-235-7122|Jeffrey.Carson@Rutgers.edu|
289599|NCT01255423|Novartis Consumer Health|Clinical Project Leader|0041223635528||
289600|NCT01255436|University of the Philippines Manila|Dr. Lia M. Palileo|6325679740|liapalileo@gmail.com|
289601|NCT01255449|IRCCS Azienda Ospedaliera Universitaria San Martino IST - Genova, Italy|Dr. Giovanni Barisione|+39010555|giovanni.barisione@hsanmartino.it|3367
289602|NCT01255592|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
289603|NCT01255631|CUMC Plastic Surgery|Christine Rohde|212-342-3707|chr2111@cumc.columbia.edu|
289604|NCT01255670|Helsinki University Central Hospital|Dr. Karin Blomgren|+358504271579|karin.blomgren@hus.fi|
289605|NCT01255722|Section Head Interventional and Cardiac Radiology - Kantonsspital Lucerne, Spitalstrasse, 6006 Lucerne, Switzerland|Prof. Dr. med. Martin HOFFMANN|+41 41 205 4660|martin.hoffmann@luks.ch|
289606|NCT01255761|UCB Clinical Trial Call Center|(UCB) Study Director|+1 887 822 9493||
289607|NCT01255787|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
289608|NCT01255865|3M|Terri White|651-733-0228|twhite3@mmm.com|
309056|NCT02637557|Ironwood Pharmaceuticals, Inc.|IW-3718-202 Study Chair|1 (617) 621-7722|Info@ironwoodpharma.com|
309057|NCT02637804|CooperVision Inc.|Director, Professional Service|+81 3 5449 6619|Taku.Muraoka@jp.coopervision.com|
309058|NCT02637856|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
289609|NCT01255904|Baylor College of Medicine|Jason Reynolds|(210) 704-2680|jmreynol@bcm.edu|
289610|NCT01256008|Wenzhou Medical University|Director of Clinical Trials|+86 0577 55579363|hjc@wmu.edu.cn|
289611|NCT01256034|Chiba University Graduate School of Medicine|Dr. Katsunori Furukawa|+81-43-226-2269|k-furukawa@umin.ac.jp|
289612|NCT01256060|Holland Bloorview Kids Rehabilitation Hospital|Dr. Evdokia Anagnostou|416-753-6005|eanagnostou@hollandbloorview.ca|
299159|NCT01864564|University of Texas at Austin|Lorie M. Harper, MD, MSCI|512-324-7036|lorie.harper@austin.utexas.edu|
289613|NCT01256164|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
289614|NCT01256177|AstraZeneca|Dhaval Desai (MSD, Seroquel)|+13028857643|aztrial_results_posting@astrazeneca.com|
289615|NCT01256190|Mallinckrodt|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
289616|NCT01256294|Novartis Pharmaceuticals|Study Director|862-778-8300||
289617|NCT01256385|University of Chicago|Dr. Tanguy Seiwert|(773) 702-2452|tseiwert@medicine.bsd.uchicago.edu|
289618|NCT01256398|University of California San Diego Moores Cancer Center|Matthew Wieduwilt, MD, PhD|858-822-6848|mwieduwilt@ucsd.edu|
289619|NCT01256411|Novartis Pharmaceuticals|Study Director|862-778-8300||
289620|NCT01256424|Photocure|Vice President Research and Development|+47 22062210|ifh@photocure.no|
289621|NCT01256450|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
289622|NCT01256476|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@KowaUS.com|
289623|NCT01256502|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
299160|NCT01865084|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289624|NCT01256567|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
309059|NCT02637895|University of Miami Miller School of Medicine|Dr. Philip Harvey|305 243 4094|pharvey@med.miami.edu|
289625|NCT01256593|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289626|NCT01256658|Novartis|Study Director|41 61 324 1111||
289627|NCT01256671|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
289628|NCT01256684|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
289629|NCT01256788|Steadman Hawkins Clinic of the Carolinas/Greenville Health System|Dr. Douglas Wyland|864-454-7422|dwyland@ghs.org|
289630|NCT01256840|UCLA Department of Psychology|Dr. A. Janet Tomiyama|3102066875|tomiyama@psych.ucla.edu|
309060|NCT02637999|MYR GmbH|Dr. med. Alexander Alexandrov|+491777168259|alexandrov@myr-pharma.com|
289631|NCT01256879|U of Maryland|James Polli, Professor|410-706-8292|jpolli@rx.umaryland.edu|
289632|NCT01256918|Dr. Ram Manohar Lohia Hospital|Dr. Praveen Kumar Malik|00919810405681|praveenk002@yahoo.com|
289633|NCT01256944|Taipei Medical University - WanFang Hospital|Dr. Ming-I Hsu|886-2-2930-7930|hsumigni@yahoo.com.tw|2508
289634|NCT01256983|University Hospital Zürich|Mrs. Hanna Burkahlter|0041 76 371 12 35|hanna.burkhalter@usz.ch|
289635|NCT01257087|Imperial College|Carel le Roux|07970719453|c.leroux@imperial.ac.uk|
289636|NCT01257204|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
289637|NCT01257217|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
289638|NCT01257230|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289639|NCT01257347|Columbia University Medical Center|Ian Kronish, MD, MPH|2123421335|ik2293@columbia.edu|
289640|NCT01257425|Ipsen|Director, Uro-oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
289641|NCT01257438|Bard Peripheral Vascular|Josh Smale, Associate Director Clinical Affairs|(480) 603-8140|Josh.Smale@crbard.com|
289642|NCT01257503|University of Washington|James A Taylor|206-616-1206|uncjat@uw.edu|
289643|NCT01257542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289644|NCT01257581|Massachusetts General Hospital|Nazem Atassi, MD|617-643-1807|natassi@partners.org|
289645|NCT01257698|Mid Atlantic Retina|Jason Hsu MD|215-928-3092|jhsu@midatlanticretina.com|
309061|NCT02638012|St. Michael's Hospital|Dr. John Lee|416-864-5306|John.Lee@unityhealth.to|
309062|NCT02638051|Clifford Hospital|Prof. Clifford LK Pang, President of Clifford Hospital|(8620) 34710038|cpang@cliffordgroup.com|
309063|NCT02638103|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
309064|NCT02638168|Penn State Health Milton S Hershey Medical Center|Raman Baweja, MD, MS|7175318134|rbaweja@pennstatehealth.psu.edu|
309065|NCT02638207|CRMG|Mikaela Raymond|866-337-1868|ctgov@clinicalresearchmgt.com|
309066|NCT02638259|Sandoz|Sandoz Biopharma Clinical Development - Strategic Planning|0049(0)80244760|biopharma.clinicaltrials@sandoz.com|
309067|NCT02638337|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
309068|NCT02638493|University of North Carolina at Chapel Hill|Julie B. Dumond, PharmD, MS, BCPS, AAHIVP|919-966-5017|jdumond@unc.edu|
309069|NCT02638597|University of Texas Southwestern Medical Center|Principal Investigator|2146480188|madhukar.trivedi@UTSouthwestern.edu|
309070|NCT02638623|West Virginia University Department of Orthopaedics|Matthew J. Dietz, MD|304-285-7445|mdietz@hsc.wvu.edu|
309071|NCT02638948|Bristol-Myers Squibb Study Director|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
309072|NCT02638974|University of Manchester|Dr Kerry Gutridge, Trial Manager|0161-306-7931|kerry.gutridge@manchester.ac.uk|
309073|NCT02639052|Lewis Katz School of Medicine at Temple University|Susan G. Fisher, M.S., Ph.D., Associate Dean and Director, Temple Clinical Research Institute|215-707-3577|susan.fisher@tuhs.temple.edu|
309074|NCT02639182|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
309075|NCT02639247|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
309076|NCT02639286|NIDDK|Dr. Rebecca Brown|301-594-0609|rebecca.brown@nih.gov|
289646|NCT01257737|Horizon Therapeutics, LLC|Colleen Canavan, Director|1-224-383-3000|clinicaltrials@horizonpharma.com|
289647|NCT01257750|Massachusetts Eye and Ear Infirmary|Reza Dana, MD, MPH, MSc|617-573-3313|Cornea_Research@meei.harvard.edu|
289648|NCT01257802|University of Michigan|W Joseph McCune MD Professor of Rheuntic Diseases University of Michigan|734 936 5560|jmccune@med.umich.edu|
299161|NCT01865448|Unidad de Apoyo a la Investigacion. Hospital Rio Hortega|Dr. Daniel de Luis|983420400|dadluis@yahoo.es|83523
299162|NCT01865487|Aeras|Dr. Dereck Tait|27214424991|dtait@aeras.org|
299163|NCT01865552|Samsung Bioepis|Director of Clinical Development|+82 31 8061 4534|sbregistry@samsung.com|
299164|NCT01865708|Children's Healthcare of Atlanta|Dr. Jana Stockwell|404-785-1868|jana.stockwell@choa.org|
299165|NCT01865747|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
299166|NCT01865812|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
299167|NCT01866098|Connecticut Mental Health Center|Associate Professor of Psychiatry; Director, Psychosis Program, CMHC|(203) 974-7500|cenk.tek@yale.edu|
299168|NCT01866150|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
299169|NCT01866163|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
299170|NCT01866293|Memorial Sloan Kettering Cancer Center|Sergio Giralt, MD|212-639-6009|GiraltS@mskcc.org|
299171|NCT01866306|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
299172|NCT01866319|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
299173|NCT01866410|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
299174|NCT01866423|USC Norris Comprehensive Cancer Center|Victoria Soto, Project Specialist|323-865-0454|Victoria.Soto@med.usc.edu|
299175|NCT01866592|University of Pennsylvania|Suzette Baez VanderBeek, MPH|2156623514|suzette.baezvanderbeek@uphs.upenn.edu|
299176|NCT01866826|NCI|Frank Maldarelli, MD|301-846-5611|fmalli@mail.nih.gov|
299177|NCT01866839|National Heart Lung and Blood Institute|Aue, Georg|+1 301 451 7141|aueg@nhlbi.nih.gov|
299178|NCT01866917|Montefiore Medical Center|Ja Hyun Shin|718-920-5157|JASHIN@montefiore.org|
299179|NCT01866943|Hospital for Special Surgery|Research Fellow|917-843-6655|berlinerz@hss.edu|
299180|NCT01867008|Cochlear Americas|Clinical Project Manager|303-264-2340|knix@cochlear.com|
299181|NCT01867021|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
299182|NCT01867047|Duke University Medical Center|Michael Bolognesi, MD||michael.bolognesi@duke.edu|
299183|NCT01867086|Gradalis, Inc.|Director of Clinical Trials|2144428124|info@gradalisinc.com|
299184|NCT01867164|Global Clinical Operations Mexico|Clinical Research Director|+52 55 5484 3184||
299185|NCT01867216|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299186|NCT01867294|Mayo Clinic|Aminah Jatoi, M.D.|507.284.1623|jatoi.aminah@mayo.edu|
299187|NCT01867307|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
299188|NCT01867424|National Cancer Institute|Dr. Ismail Baris Turkbey|301-443-2315|turkbey@nih.gov|
299189|NCT01867515|VA Portland HCS, RR&D National Center for Auditory Rehabilitative Research|Michelle R. Molis, PhD|503-220-8262|michelle.molis@va.gov|55574
299190|NCT01867580|KCI, an Acelity Company|Anthony Tate, RN, BSN|210-515-4060|anthony.tate@kci1.com|
299191|NCT01867632|MUHC|Dr. Mirko Gilardino|514.934.1934|Mirko.Gilardino@muhc.mcgill.ca|
299192|NCT01867658|C.R. Bard Inc.|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
299193|NCT01867671|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
299194|NCT01867710|Janssen Pharmaceutica N.V|Medical Affairs Director||ClinicalTrialDisclosure@its.jnj.com|
299195|NCT01868009|GlaxoSmithKline|GSK Response Center|866-435-7343||
299196|NCT01868022|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
299197|NCT01868035|GlaxoSmithKline|GSK Response Center|866-435-7343||
299198|NCT01868074|University of Iowa|Neil Segal, M.D., M.S.|3193560737|segal-research@uiowa.edu|
299199|NCT01868165|Imperial College London|Dr Ruth Peters|07950289662|r.peters@imperial.ac.uk|
299200|NCT01868243|Hospital Ana Nery|Andre Rodrigues Duraes|+557191888399|andreduraes@gmail.com|
299201|NCT01868334|University of Pittsburgh|Richard K. Zimmerman, MD, MPH, MA|412-383-2354|zimmer@pitt.edu|
299202|NCT01868425|University of Wisconsin - Madison|John Shepler|608-263-8100|jashepler@wisc.edu|
299203|NCT01868477|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
299204|NCT01868503|Stanford University|Dr. Kathleen Horst|6507360921|kateh@stanford.edu|
299205|NCT01868542|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
299206|NCT01868594|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
299207|NCT01868633|University of Iowa|Dr. Unyime Ituk|3193562633|unyime-ituk@uiowa.edu|
299208|NCT01868646|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical Research and Medical Information Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
299209|NCT01868776|The Ohio State University|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
299210|NCT01868789|Orthopedic Foot and Ankle Center|Dr. Gregory Berlet|6148958747|ofacresearch@orthofootankle.com|
299211|NCT01868893|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
299212|NCT01868997|Horizon Pharma USA, Inc.|Julie Ball, Executive Director||clinicaltrials@horizonpharma.com|
299213|NCT01869075|Sunnybrook HSC|Artemis Diamantouros|416-480-6100|artemis.diamantouros@sunnybrook.ca|3654
299214|NCT01869192|University of Colorado|Anthony Elias, MD|17208480347|anthony.elias@ucdenver.edu|
299215|NCT01869348|The University of Texas Medical Branch|Eloisa Martinez|4092669643|esmartin@utmb.edu|
299216|NCT01869374|New York State Psychiatric Institute|Stefan Rowny, MD|(646) 774-5417|stefan.rowny@nyspi.columbia.edu|
299217|NCT01869439|WoundVision LLC|Dr. James G. Spahn, M.D.|(317) 775-6080|brett@woundvision.com|
309077|NCT02639338|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
289649|NCT01257880|Swedish Medical Center|Jill T. Jesurum, Ph.D.|206-683-1505|jill.jesurum@swedish.org|
289650|NCT01258049|Xidea Solutions Limited|Dr Daryl Bendel||daryl@xideasolutions.com|
309078|NCT02639351|GlaxoSmithKline|GSK Response Center|866-435-7343|kt144805@gsk.com|
309079|NCT02639429|The University of Texas Health Science Center at Houston|Mesk Alrais, MD|(713) 566-5735|Mesk.A.Alrais@uth.tmc.edu|
309080|NCT02639494|Mayo Clinic|Dr. Rajiv Gulati|507-538-6325|Gulati.Rajiv@mayo.edu|
309081|NCT02639559|Washington University School of Medicine|Geoffrey Uy, M.D.|314-454-8304|guy@wustl.edu|
309082|NCT02639637|Vanderbilt University Medical Center|Nancy J. Brown, M.D., Principal Investigator|6153644022|nancy.j.brown@vanderbilt.edu|
309083|NCT02639884|Masimo Corporation|Vikram Ramakanth|9492977416|vramakanth@masimo.com|
309084|NCT02640053|Mayo Clinic|Charles L. Loprinzi, M.D.|507/284-6026|cloprinzi@mayo.edu|
309085|NCT02640157|AbbVie|Global Medical Services|800-633-9110||
309086|NCT02640235|Baxter Healthcare Corporation|Clinical Trials Disclosure Group|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
309087|NCT02640404|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
309088|NCT02640482|AbbVie|Global Medical Services|800-633-9110||
309089|NCT02640547|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309090|NCT02640612|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
270207|NCT00113217|University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD / Associate Professor|713-563-7232|ejonasch@mdanderson.org|
270208|NCT00113230|UT MD Anderson Cancer Center|Christopher H. Crane, MD / Associate Professor|713-792-2933||
270209|NCT00113269|Astellas Pharma Global Development|Senior Medical Director||clinicaltrials@us.astellas.com|
270210|NCT00113295|Massachusetts General Hospital|Naomi M. Simon, M.D., M.Sc.|(617) 726-7913|nsimon@partners.org|
270211|NCT00113321|The University of Texas M. D. Anderson Cancer Center|Hagop Kantarjian, M.D., Professor|713/792-7026|eharriso@mdanderson.org|
270212|NCT00113334|University of Texas (UT) MD Anderson Cancer Center|Edward Kim, MD, BS / Assistant Professor|713-792-6363|CR_Study_Registration@mdanderson.org|
270213|NCT00113360|UT M. D. Anderson Cancer Center|James Yao, M.D./Associate Professor|713-792-2828|CR_Study_Registration@mdanderson.org|
270214|NCT00113373|NRG Statistics and Data Management Center - Buffalo|Angela M. Kuras, Associate Director of Data Management|716-845-7733|kurasa@nrgoncology.org|
270215|NCT00113425|University of Michigan Dept of Dermatology|Dr. Jeffrey Orringer|734-936-4075|jorringe@umich.edu|
270216|NCT00113490|MedImmune|M. Pamela Griffin, MD/ Clinical Development|301-398-0000|clinicaltrialenquiries@medimmune.com|
270217|NCT00113516|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270218|NCT00113529|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.govCallCenter@pfizer.com|
270219|NCT00113555|Uromedica|Timothy Plouffe|763-999-7048|tplouffe@uromedica-inc.com|
270220|NCT00113568|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
270221|NCT00113607|Janssen R&D US|Director Clinical Research Medical Leader|908 704 5779||
270222|NCT00113763|Amgen Inc.|Study Director|866-572-6436||
270223|NCT00113841|UT MD Anderson Cancer Center|Saroj Vadhan-Raj, MD/Professor|713-792-9660|xzhou@mdanderson.org|
270224|NCT00113880|MedImmune, LLC|Chris Ambrose, MD, Sr Director, Medical Affairs|301-398-0000|ambrosec@medimmune.com|
270225|NCT00114114|Massachusetts General Hospital|Dr. Ben Leder|617-726-6723|bzleder@partners.org|
270226|NCT00114127|Massachusetts General Hospital|Dr. Naomi Simon|617-726-7913|nsimon@partners.org|
289651|NCT01258075|Daiichi Sankyo|Contact of Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
289652|NCT01258101|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
309091|NCT02640716|Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, China|Dr. Yi Tang|+86 10 83199456|tangyi@xwhosp.org|
289653|NCT01258153|Menarini Ricerche|Dr. Angela Capriati|+39 05556809990|acapriati@menarini-ricerche.it|
299218|NCT01869634|University of California, Davis Health, Department of Internal Medicine|Dr. David Asmuth, Professor of Medicine|916-734-8695|dasmuth@UCDAVIS.EDU|
289654|NCT01258348|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289655|NCT01258374|Hospital Clinic|Dr. Josep Mallolas Masferrer|00 44 93 227 54 00|mallolas@clinic.cat|3312
289656|NCT01258387|Acorda Therapeutics, Inc.|Anthony Caggiano, MD, PhD|914-347-4300|tcaggiano@acorda.com|5150
299219|NCT01869647|Yale Emergency Medicine|Dr. Chris L. Moore|(203)737-3313|chris.moore@yale.edu|
289657|NCT01258504|University of Heidelberg|Prof. Dr. med. Gerd Mikus|4962215639197|gerd.mikus@med.uni-heidelberg.de|
289658|NCT01258582|Massachusetts General Hospital|Rochelle P. Walensky, MD, MPH|(617) 724-8445|rwalensky@partners.org|
289659|NCT01258595|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
289660|NCT01258608|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
289661|NCT01258660|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
289662|NCT01258738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289663|NCT01258790|Cincinnati Children's Hospital Medical Center|Steve Wu, MD|513-636-4222|steve.wu@cchmc.org|
289664|NCT01258855|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
289665|NCT01258985|Tufts Medical Center|chenchen wang|617-636-3251|cwang2@tuftsmedicalcenter.org|
289666|NCT01258998|The University of Texas (UT) MD Anderson Cancer Center|Christopher R Flowers,Chair, Lymphoma-Myeloma|713- 745-6095|crflowers@mdanderson.org|
309092|NCT02640755|AstraZeneca|Medical Science Director||clinicaltrialtransparency@astrazeneca.com|
309093|NCT02640807|Revimmune|Dr Michel Morre, DVM, Chief Scientific Officer|+33(0)603357060|m.morre@revimmune.com|
289667|NCT01259011|Emory University|Dr. Mi-Kyung Song|404-727-3134|mi-kyung.song@emory.edu|
309094|NCT02641067|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289668|NCT01259063|Memorial Sloan Kettering Cancer Center|Dr. Guido Dalbagni|646-422-4394|dalbagng@mskcc.org|
289669|NCT01259089|Northwestern University|Clinical Trials Office|312-695-1301||
289670|NCT01259102|Purdue Pharma L.P.|Executive Medical Director, Clinical Pharmacology|800-733-1333||
289671|NCT01259115|Purdue Pharma L.P.|Executive Medical Director, Clinical Pharmacology|800-733-1333||
289672|NCT01259128|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
289673|NCT01259245|Kwong Wah Hospital|Dr Lorna Ng|(852) 23322311|ngl@ha.org.hk|
289674|NCT01259297|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
289675|NCT01259375|Huntsman Cancer Institute|Dr. Sunil Sharma|801-587-5559|sunil.sharma@hci.utah.edu|
289676|NCT01259388|Birmingham VA Medical Center|Dr. John Rinker|205-934-2402|John.Rinker@va.gov|
289677|NCT01259401|VA Greater Los Angeles Healthcare System|Dr. Jennifer Martin|818 891-7711|Jennifer.Martin@va.gov|9173
289678|NCT01259427|VISN 5 MIRECC|Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
289679|NCT01259440|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
289680|NCT01259466|Yale University School of Medicine|Dr. Marney A. White|203-785-4349|marney.white@yale.edu|
289681|NCT01259492|Novartis Pharmaceuticals|Study Director|8627788300||
289682|NCT01259596|Wake Forest School of Medicine|Gretchen A. Brenes, Ph.D.|336-716-4551|gbrenes@wakehealth.edu|
289683|NCT01259713|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
289684|NCT01259726|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
289685|NCT01259856|Icahn School of Medicine at Mount Sinai|Dr. Ronald Hoffman|212-241-2296|ronald.hoffman@mssm.edu|
289686|NCT01259869|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
289687|NCT01260142|Eisai Call Center|Eisai Inc.|888-422-4743||
289688|NCT01260181|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
309095|NCT02641080|West Virginia University Department of Orthopaedics|Matthew J. Dietz, MD|304-285-7445|mdietz@hsc.wvu.edu|
289689|NCT01260194|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
289690|NCT01260272|L-MARC Research center|Kathy Schmitz, Site Manager|502 214 3990|kschmitz@lmarc.com|
289691|NCT01260311|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289692|NCT01260324|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309096|NCT02641249|University of California|Dr. Kalpashri Kesavan|3108256304|KKesavan@mednet.ucla.edu|
309097|NCT02641353|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
309098|NCT02641379|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
309099|NCT02641392|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|amcclain@celgene.com|
309100|NCT02641522|Benaroya Research Institute|Sarah Robinson/ Administrative Assistant|(206) 342-6931|diabetes@benaroyaresearch.org|
309101|NCT02641561|Cooper University Hospital|Shaffer R. S. Mok, M.D., M.B.S.|6099804564|mok.shaffer@gmail.com|
309102|NCT02641587|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|christelle.haziza@pmi.com|
309103|NCT02641691|Washington University School of Medicine|Hyun Kim, M.D.|314-362-8502|kim.hyun@wustl.edu|
309104|NCT02641730|Janssen Pharmaceutical K.K.|Senior Director, Immunology General|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
309105|NCT02641834|Department of Experimental and Clinical Medicine, University of Florence, Italy|Prof. Francesco Sofi|+390557949429|francescosofi@gmail.com|
309106|NCT02641912|GlaxoSmithKline|GSK Response Center|866-435-7343||
309107|NCT02642159|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
309108|NCT02642237|Radboud university medical centre|Matthijs Kox|+31243653881|matthijs.kox@radboudumc.nl|
289693|NCT01260350|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
289694|NCT01260454|University of Rochester|R. James White, MD, PhD|585-486-0869|jim_white@urmc.rochester.edu|
289695|NCT01260467|University of Rochester Medical Center|Jennifer Serventi Research Associate|585-276-3971|jennifer_serventi@urmc.rochester.edu|
289696|NCT01260493|Vårdalinstitute, University of Gothenburg|Professor Synneve Dahlin-Ivanoff ( Research leader)|+46 31 7865733|synneve.dahlin-ivanoff@gu.se|
289697|NCT01260584|Daiichi Sankyo|Brian Baker|973-944-2712|bbaker@dsi.com|
299220|NCT01869686|Amgen Inc.|Study Director|866-572-6436||
289698|NCT01260649|MGH|Dr. Cristina Cusin|617 726 64221|ccusin@mgh.harvard.edu|
289699|NCT01260662|MinneapolisMRF|James Miner|612-873-3000|miner015@umn.edu|
289700|NCT01260688|Princess Margaret Cancer Centre|Dr. Lillian Siu|416-946-2911|lillian.siu@uhn.ca|
289701|NCT01260701|SWOG Statistical Center|Study Statistician|206-667-4623||
299221|NCT01869699|University of California, San Francisco|Dr. Hildy Schell-Chaple|415-353-1039|hildegarde.schell-chaple@ucsf.edu|
289702|NCT01260883|Seattle Children's Hospital|Anne Lynn MD|206 987-2518|anne.lynn@seattlechildrens.org|
289703|NCT01260896|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
289704|NCT01260922|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
289705|NCT01260948|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
289706|NCT01261000|Cedars-Sinai Medical Center|Vivian Hwe|424-315-4489|hwev@cshs.org|
289707|NCT01261052|Legacy Health System|Dr. W Kenneth Ward|503-413-5171|kenward503@msn.com|
309109|NCT02642393|Massachusetts General Hospital|Dr. Michael Schwarzschild|617-724-9611|michaels@helix.mgh.harvard.edu|
309110|NCT02642432|AbbVie|Global Medical Services|800-633-9110||
289708|NCT01261325|UCB Clinical Trial Call Center|Study Director|+1 887 822 9493||
289709|NCT01261338|University of Cincinnati|Ronald J. Jandacek, PhD, Principal Investigator|513-558-5492|ronald.jandacek@uc.edu|
309111|NCT02642536|VA|Dr. Gina Evans|713-440-4459|gina.evans@va.gov|
289710|NCT01261390|Brigham and Women's Hospital|Dr. Susan Redline|617-732-5859|sredline1@rics.bwh.harvard.edu|
309112|NCT02642575|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
289711|NCT01261507|Georgetown University Medical Center|Matthew T. Freedman, MD|4105429680|freedmmt@georgetown.edu|
289712|NCT01261559|University of Washington|Dr. Claire Sandstrom|206-744-3561|cks13@uw.edu|
289713|NCT01261611|Ipsen Innovation|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
289714|NCT01261624|Italfarmaco S.p.A.|Clinical R&D Director|026443|p.bettica@italfarmaco.com|2584
309113|NCT02642614|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289715|NCT01261780|University of Wisconsin Carbone Cancer Center|Toby Campbell|608-263-3962|tcc@medicine.wisc.edu|
289716|NCT01261793|Care|UCB|+1844599|UCBCares@ucb.com|2273
289717|NCT01261819|Florida Hospital|Katherine Kratz, M.D.||katiegoodrich@gmail.com|
309114|NCT02642627|Suneva Medical|Director of Clinical Affairs|858-324-6268|alehman@sunevamedical.com|
289718|NCT01261975|Bausch & Lomb|Omid Khodai|(949) 521-7894|Omid.Khodai@bausch.com|
289719|NCT01262027|The University of Texas (UT) MD Anderson Cancer Center|Vicente Valero, MD/Professor, Breast Medical Oncology|713-792-7734|vvalero@mdanderson.org|
289720|NCT01262092|University of Arkansas for Medical Sciences|Dr. Alison Oliveto|501-526-8441|olivetoalison@uams.edu|
289721|NCT01262105|Nimbic Systems|Sean Self|281-565-5700|self@nimbicsystems.com|
289722|NCT01262118|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289723|NCT01262131|Pico-Tesla Magnetic Therapies, LLC|Allen S. Braswell CEO|303 795-3222|abraswell@pico-tesla.com|
309115|NCT02642653|University of California Davis|Dr. Randi Hagerman|9167030247|rjhagerman@ucdavis.edu|
309116|NCT02642679|Brigham and Women's Hospital|Indranil Sinha, MD|617-732-5282|isinha@bwh.harvard.edu|
289724|NCT01262287|University of Connecticut School of Medicine|Dr. Jonathan Covault|860-679-7560|jocovault@uchc.edu|
289725|NCT01262352|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
289726|NCT01262365|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
289727|NCT01262456|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
289728|NCT01262547|Massachusetts General Hospital|Dr. Alexandra Kimball|617-726-5066|harvardskinstudies@partners.org|
289729|NCT01262560|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
289730|NCT01262573|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
289731|NCT01262599|Columbia University Medical Center|Dr. Christine Rohde|(212) 342-3707|chr2111@columbia.edu|
289732|NCT01262638|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
289733|NCT01262651|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
289734|NCT01262677|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289735|NCT01262755|Temple University|Frank Friedenberg, MD|215-707-9900|frank.friedenberg@temple.edu|
289736|NCT01262820|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
289737|NCT01262846|University of Pennsylvania|Pablo Tebas|215-6626932|pablo.tebas@uphs.upenn.edu|
289738|NCT01262872|GlaxoSmithKline|GSK Response Center|866-435-7343||
289739|NCT01262898|GlaxoSmithKline|GSK Response Center|866-435-7343||
289740|NCT01262976|GlaxoSmithKline|GSK Response Center|866-435-7343||
289741|NCT01262989|GlaxoSmithKline|GSK Response Center|866-435-7343||
289742|NCT01263015|GlaxoSmithKline|GSK Response Center|866-435-7343||
299222|NCT01869725|University of Iowa|M. Sue O'Dorisio, MD, PhD|319-335-7234|sue-odorisio@uiowa.edu|
289743|NCT01263054|Halyard Health, Inc.|Mark Lavigne|508-837-1427|mark.lavigne@hyh.com|
289744|NCT01263093|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299223|NCT01869764|Wake Forest University Health Sciences|Edward Levine, MD|336-716-5440|elevine@wakehealth.edu|
289745|NCT01263106|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289746|NCT01263119|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289747|NCT01263132|Merck S.A. de C.V., Mexico, an affiliate of Merck KGaA, Darmstadt, Germany|Medical Responsible|+49-6151-72-5200|service@merckgroup.com|
299224|NCT01869777|Wake Forest University Health Sciences|Principal investigator|336-716-5440|tpardee@wakehealth.edu|
299225|NCT01869959|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299226|NCT01870076|Shriners Hosptials for Children|Laura Fowler/Clinical Research Coordinator|513-872-6000|lfowler@shrinenet.org|6249
299227|NCT01870297|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979||
299228|NCT01870388|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299229|NCT01870583|Stony Brook Medicine|Dr David Garry|631-444-7650|david.garry@stonybrookmedicine.edu|
299230|NCT01870596|Sidney Kimmel Comprehensive Cancer Center|B. Douglas Smith|(410) 287-2935|bdsmith@JHMI.edu|
309117|NCT02642835|Medway NHS Foundation Trust|Professor Jonaathan Duckett -Consultant Urogynaecologist|01634|jraduckett@hotmail.com|835154
309118|NCT02642952|Ramón y Cajal University Hospital|Dr. Andrés Reyes Valdivia|0034 629586239|cauzaza@hotmail.com|
309119|NCT02642991|CooperVision, Inc.|Paul Chamberlain|925 730-6754|PChamberlain@coopervision.com|
309120|NCT02643004|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
309121|NCT02643082|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|650-305-2600|creisner@pearltherapeutics.com|
309122|NCT02643095|The Ohio State University College of Optometry|Jennifer Fogt|614-292-2020|Fogt.78@osu.edu|
309123|NCT02643199|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
309124|NCT02643225|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
309125|NCT02643251|BDSI|Tim Warneke|919-582-0294|twarneke@bdsi.com|
309126|NCT02643355|Hennepin Healthcare|Dr. Marc Martel|612-873-7448|Edresearch@hcmed.org|
309127|NCT02643394|UT Southwestern Medical Center|David McDonagh, MD|214-648-8083|david.mcdonagh@utsouthwestern.edu|
309128|NCT02643459|Herlev Hospital, Department of Cardiology|Dr. Martin Schultz|004538683868|martin.schultz@regionh.dk|
309129|NCT02643472|Children's National Health System|Dr. Karen Fratantoni|202-476-4793|kfratant@childrensnational.org|
309130|NCT02643615|The Ohio State University Wexner Medical Center|Dr. Sergio Bergese|6142933559|sergio.bergese@osumc.edu|
309131|NCT02643628|Suneva Medical|Director of Clinical Affairs|858-324-6268|alehman@sunevamedical.com|
309132|NCT02643693|Philip Morris Products S.A.|Christelle Haziza, PhD|+41 (58) 242 11 11|ClinicalTrials.PMI@pmi.com|
309133|NCT02643849|SRS Medical|Director of Clinical Trials|800-345-5642|info@srsmedical.com|
309134|NCT02643862|Stanford|Dr. Kari Nadeau|650-867-4592|knadeau@stanford.edu|
309135|NCT02643875|The Hong Kong Polytechnic University|Prof Pauline Cho|(852) 2766-6100|sopaulin@polyu.edu.hk|
309136|NCT02643979|Icahn School of Medicine at Mount Sinai|Dr. Daniel Katz|212-241-7475|daniel.katz@mountsinai.org|
309137|NCT02644096|University of Copenhagen|Chief researcher Britta Hørdam|+ 45 22214383|britta@hordam.dk|
309138|NCT02644109|Nutrition and Food Technology Institute, University of Chile|Dr. Sandra Hirsch|+56229781495|shirsch@inta.uchile.cl|
309139|NCT02644122|University of California, San Diego|Ezra Cohen, MD|(858)822-5800|ecohen@ucsd.edu|
309140|NCT02644278|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
309141|NCT02644343|Cochlear|Cochlear Clinical Studies|(303) 790-9010|clinicalstudies@cochlear.com|
309142|NCT02644356|Collinge and Associates, Inc.|William Collinge, PhD, MPH|541-632-3502|william@collinge.org|
309143|NCT02644668|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
309144|NCT02645019|Nationwide Children's Hospital|Mineto Kamada|6147224200|mineto.kamata@gmail.com|
309145|NCT02645123|University of Ioannina School of Medicine|Dr. Georgios Krekoukias|00306934609400|gkrekos@gmail.com|
309146|NCT02645253|AstraZeneca AB|AZD7594 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
309147|NCT02645409|Indiana University|Courtney Dhondt, Clinical Research Nurse|317-274-1791|cgerler@iu.edu|
289748|NCT01263197|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299231|NCT01870726|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
299232|NCT01870739|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
289749|NCT01263223|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299233|NCT01870778|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
289750|NCT01263301|Mennonite Christian Hospital|Ling-Chih Wu MD|88638241234|lingchihwu@yahoo.com|1810
289751|NCT01263314|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289752|NCT01263444|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
289753|NCT01263470|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
289754|NCT01263483|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
299234|NCT01870843|Xian-Janssen Pharmaceutical Ltd|Associate TA Manager||ClinicalTrialDisclosure@its.jnj.com|
289755|NCT01263496|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
299235|NCT01870856|Alcon Research, Ltd.|Anne Brobst, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
289756|NCT01263509|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
289757|NCT01263561|Department of Ophthalmology and Vision Sciences, University of Toronto|Dr Yvonne Buys|416-603-5682|y.buys@utoronto.ca|
299236|NCT01870869|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
289758|NCT01263639|Vanderbilt Medical Center|Dr. Brent J. Morris Orthopaedic Resident|615-835-0699|brent.j.morris@vanderbilt.edu|
289759|NCT01263665|W.L. Gore & Associates|Keli Sapp|9288643964|kesapp@wlgore.com|
289760|NCT01263691|Emergent BioSolutions|Dr. Robert Hopkins|(301) 944-0136|hopkinsr@ebsi.com|
289761|NCT01263704|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
299237|NCT01870921|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
289762|NCT01263717|Massachusetts General Hospital|Steven K. Grinspoon, MD|617-724-9109|sgrinspoon@partners.org|
299238|NCT01870973|The Ohio State University|Dr. Melissa Drum|6142923596|drum.13@osu.edu|
299239|NCT01870999|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Medical Affairs|800-562-3974||
299240|NCT01871077|Laboratorios Sophia|PhD. Ricardo Llamas|+52 (33) 3001 4200|drricardollamas@gmail.com|1259
289763|NCT01263782|UT MD Anderson Cancer Center|Dr. George Simon, Thoracic/Head & Neck Med Onc|713-794-4740|GSIMON@MDANDERSON.ORG|
289764|NCT01263873|University Hospitals of Cleveland|Brian Radesic|3309725175|radesic@uakron.edu|
289765|NCT01263925|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
289766|NCT01263938|University of Pennsylvania School of Medicine|Dr. Ronald Collman|215-898-0193|collmanr@pennmedicine.upenn.edu|
289767|NCT01264016|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
289768|NCT01264081|National Cancer Institute|Dr. Udo Rudloff'|301-496-3098|rudloff@nih.gov|
289769|NCT01264380|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
299241|NCT01871090|St Jude Medical, Inc.|Todd Stirman, Clinical Manager|(972) 526-9625|Tstirman@sjm.com|
289770|NCT01264419|Silk Road Medical, Inc.|Richard Ruedy, Exec VP Clinical Affairs|408-828-7281|ric@silkroadmed.com|
289771|NCT01264601|University of Michigan|Matthew Greenhawt, MD, MBA|734/936-5634|mgreenha@umich.edu|
289772|NCT01264614|UNION COLLEGE|Cay Anderson-Hanley, PhD|518-388-6355|andersoc@union.edu|
299242|NCT01871142|Colorado State University|Christopher Bell, Ph.D.|(970) 491-7522|christopher.bell@colostate.edu|
289773|NCT01264705|UT Southwestern Medical Center|Adam Yopp, MD|214-648-5870|adam.yopp@utsouthwestern.edu|
289774|NCT01264718|Medica Research Institute|Dr. Glenn Flores, Distinguished Chair of Health Policy Research|952-992-3367|Glenn.Flores@medica.com|
289775|NCT01264770|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
289776|NCT01264887|Grünenthal GmbH|Director Clinical Trials|+49 241 569|clinical-trials@grunenthal.com|3223
289777|NCT01264939|Genentech, Inc.|Medical Communications|800 821-8590||
289778|NCT01264952|Institute of Oncology Ljubljana|Gregor Sersa, PhD|+386 1 5879 434|gsersa@onko-i.si|
309148|NCT02645617|Advantage Silver Dental Arrest, LLC|Peter Milgrom|2062516831|drmilgrom@silverarrest.com|
289779|NCT01265056|The University of Iowa|Jennifer Lassner|319-335-2123|jennifer-lassner@uiowa.edu|
289780|NCT01265394|GE Healthcare|Dr. Paul Sherwin|1-609-514-6820|paulsherwin@ge.com|
289781|NCT01265420|Indiana Hand to Shoulder Center|F. Thomas D. Kaplan|317-875-9105|tdk@hand.md|
309149|NCT02645760|Khonkaen University|Rungthip Chalermsan|+66 835603675|chalermsanrungthip@gmail.com|
289782|NCT01265446|Novartis Consumer Health, Nyon, Switzerland|Clinical Project Leader|+41223633279|Rowland.Furcha@novartis.com|
289783|NCT01265459|Q-Med AB|Head of Medical Affairs|+46 (0) 18 4749000|reception.SEUPP@galderma.com|
289784|NCT01265498|Johns Hopkins Data Coordinating Centers|Mark Van Natta|410-614-1362|mvannat1@jhu.edu|
289785|NCT01265511|Scynexis|Katyna Borroto-Esoda|9192374431|katyna.borroto-esoda@scynexis.com|
289786|NCT01265524|Sorbent Therapeutics|Howard Dittrich, MD FACC|858-405-1429|hdittrich@sorbent.com|
289787|NCT01265537|St. Paul's Hospital|Dr. Jagbir Gill|6046822344|JAGill@providencehealth.bc.ca|64706
289788|NCT01265550|Dallas VA Medical Center|Stuart Spechler||sjspechler@aol.com|
289789|NCT01265563|VA- STVHCS|Dr. Shweta Bansal|2105674700|bansals3@uthscsa.edu|
289790|NCT01265615|Ural Institute of Cardiology, Ural State Medical Academy|Dr. Alexander Kharlamov|+79638547663|drskharlamov@gmail.com|
289791|NCT01265667|Can-Fite BioPharma Ltd|Zivit Harpaz|972-3-9241114|zivit@canfite.co.il|
309150|NCT02646124|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
289792|NCT01265719|Pfizer, Inc|Pfizer Clinical Trials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299243|NCT01871285|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
299244|NCT01871402|Therapeutics, Inc.|Clinical Research, Therapeutics, Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
299245|NCT01871441|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Neal Flomenberg|215 955-0182|dolores.gross@jefferson.edu|
289793|NCT01265797|University of Toledo|Gretchen Tietjen, MD|419-383-3544|gretchen.tietjen@utoledo.edu|
289794|NCT01265823|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
289795|NCT01265875|Dartmouth-Hitchcock Medical Center|Timothy Gardner, MD|603-650-6472|timothy.b.gardner@hitchcock.org|
289796|NCT01265953|Oregon Health & Science University|Dr.Jackilen Shannon|503-418-9860|shannoja@ohsu.edu|
289797|NCT01265966|Tripler Army Medical Center|Dr. Jordan Pinsker|808-433-6338|jordan.pinsker@us.army.mil|
289798|NCT01265992|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
289799|NCT01266018|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org|
289800|NCT01266070|The University of Texas (UT) MD Anderson Cancer Center|Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
289801|NCT01266122|Behavioral Medicine Service, Massachusetts General Hospital|Dr. Steven Safren|617-724-0817|ssafren@partners.org|
289802|NCT01266148|Novartis Pharmaceuticals|Study director|862-778-8300||
289803|NCT01266161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289804|NCT01266265|United Therapeutics Corporation|Nicole Leedom|919-425-5870|nleedom@unither.com|
299246|NCT01871506|Elyse Park|Associate Professor|617-724-6836|epark@mgh.harvard.edu|
289805|NCT01266291|University of Pennsylvania|John Pollard, MD|215-873-5909|john.pollard@uphs.upenn.edu|
289806|NCT01266317|University of Pittsburgh|Dr. Michael Donahoe|412-383-2049|donahoem@upmc.edu|
289807|NCT01266447|NRG Oncology|Linda Gedeon, Clinical Data Coordinator|716-845-1169|lgedeon@gogstats.org|
289808|NCT01266460|NRG Oncology|Christopher Purdy on behalf of Austin Miller PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
289809|NCT01266590|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299247|NCT01871519|Medtronic Spinal|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
289810|NCT01266603|U T MD Anderson Cancer Center|Dr. Michael A Davies, BA,MD,PHD/Melanoma Medical Oncology|713-792-3454|MDavies@mdanderson.org|
289811|NCT01266642|UT MD Anderson Cancer Center|Dr. Benjamin Smith, Professor, Radiation Oncology Department|(713) 563-2380|bsmith3@mdanderson.org|
289812|NCT01266850|Vanderbilt University Medical Center|Kathryn M. Edwards, MD|615-322-3078|kathryn.edwards@vanderbilt.edu|
289813|NCT01266876|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
299248|NCT01871532|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
289814|NCT01266902|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
289815|NCT01266967|GlaxoSmithKline|GSK Response Center|866-435-7343||
289816|NCT01266993|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
289817|NCT01267019|VA Greater Los Angeles, VISN 22 MIRECC|Michael F. Green, PhD|(310) 268-3376|mgreen@ucla.edu|
289818|NCT01267045|VA Puget Sound Health Care System|David J. Kearney, MD|206-277-1445|David.Kearney@VA.gov|
289819|NCT01267136|Children's Hospitals and Clinics of Minnesota|Andrea Postier/Clinical Research Program Manager|612-813-6409|andrea.postier@childrensmn.org|
289820|NCT01267175|Medtronic Diabetes|Harold Torunsky|(818) 576 5445|harold.torunsky@medtronic.com|
309151|NCT02646332|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|williamhsup@yahoo.com.tw|78233
289821|NCT01267201|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289822|NCT01267227|University of Mississippi|Dr. Daniel Riche|601-984-2640|driche@umc.edu|
289823|NCT01267240|Princess Margaret Cancer Centre|Dr.Eric Chen, Principal Investigator|416-946-4501|eric.chen@uhn.ca|2263
289824|NCT01267253|NRG Oncology|Linda Gedeon for Wei Deng,PhD|716-845-1169|lgedeon@gogstats.org|
289825|NCT01267266|University of Chicago|Walter M. Stadler|773-702-4150|wstadler@medicine.bsd.uchicago.edu|
309152|NCT02646371|LimmaTech Biologics AG|Director of Clinical Trials|+41 44 733 8585|info@lmtbio.com|
309153|NCT02646423|University of California, San Francisco|Miriam Kupperman, PhD, MPH|415-502-4089|miriam.kupperman@ucsf.edu|
309154|NCT02646449|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
289826|NCT01267279|Spokane Joint Replacement Center|Principal Investigator|509-466-6393|dfscott@mac.com|
289827|NCT01267292|The University of Texas Health Science Center at Houston|Scott Lane, PhD|713-486-2535|Scott.D.Lane@uth.tmc.edu|
289828|NCT01267422|Department of Ophthalmology, Tongji Hospital Tongji Medical College, Huazhong University of Science and Technology|Bin Li|+86-13638673626|libin-12@163.com|
289829|NCT01267656|Bausch Health|Study Director||susan.harris@bauschhealth.com|
289830|NCT01267864|Albert Einstein College of Medicine, Montefiore Medical Center|Benjamin Friedman, MD|718-920-6626|befriedm@montefiore.org|
299249|NCT01871545|Icahn School of Medicine at Mount Sinai|Dr. Bachir Taouli|212-824-8475|bachir.taouli@mountsinai.org|
289831|NCT01267929|Postgraduate Studied Program, faculty of medicine, Thammasat University|Miss Namfon Mahasup|+66 867733596|namfon_pt@yahoo.com|
289832|NCT01267955|Institut Bergonie|Pr Italiano Antoine, Department of Medical Oncology|0524071947|a.italiano@bordeaux.unicancer.fr|
289833|NCT01267994|North Shore-LIJ Health System|Andrea Vambutas, MD, FACS|718-470-7748|vambutas@nshs.edu|
289834|NCT01268046|Massachusetts General Hospital|Janet Hall, MD|617-877-1112|janet.hall@nih.gov|
289835|NCT01268059|MedImmune, LLC|Mohammed Dar, MD, Vice President & Head, Clinical Development, Oncology|+1 301-398-0000|information.center@astrazeneca.com|
289836|NCT01268098|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
289837|NCT01268111|Mayo Clinic|A J Vinaya Simha|5072664321|simha.aj@mayo.edu|
289838|NCT01268150|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
289839|NCT01268189|USAISR|Leopoldo C. Cancio, COL, MC|210-916-3301|leopoldo.c.cancio.mil@mail.mil|
289840|NCT01268267|Ascensia Diabetes Care|Carmine Greene|574-257-3040|carmine.greene@ascensia.com|
289841|NCT01268293|Eisai Co., Ltd.|Tatsuya Sasaki|81-3-3817-5252||5252
289842|NCT01268306|Arthur B. Epstein, OD|Dr. Arthur Epstein|424-226-2020|artepstein@yahoo.com|
289843|NCT01268488|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|914-333-6280|carmine.greene@ascensia.com|
289844|NCT01268501|Alcon Research, Ltd.|Director of Alcon Clinical|1-800-241-7629||
289845|NCT01268514|Medtronic|Andrea DiScipio, Clinical Research Associate|781-491-5350|andrea.l.discipio@medtronic.com|
289846|NCT01268527|Eisai Medical Research Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
289847|NCT01268553|Los Angeles Biomedical research INst at Harbor-UCLA|Dr. Ronald Oudiz|310-222-3560|roudiz@labiomed.org|310
289848|NCT01268566|MedImmune, LLC, an affiliate of AstraZeneca|A Phase 2 Study of MEDI-575 in Adult Subjects with Recurrent Glioblastoma Multiforme|1-877-240-9479|information.center@astrazeneca.com|
299250|NCT01871558|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
299251|NCT01871805|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
299252|NCT01871870|Legacy Health System|Dr. Ken Ward|971-570-2632|kenward503@msn.com|
299253|NCT01872078|AstraZeneca Pharmaceuticals LP|Martin L. Scott, MD/PhD|781-472-5130|martin.scott@astrazeneca.com|
299254|NCT01872325|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
299255|NCT01872338|VA New Jersey Healthcare System|Alejandro Interian, PHD|908-647-0180|alejandro.interian@va.gov|4617
299256|NCT01872611|Alcon Research, Ltd.|Therapeutic Unit Head, Cornea and Inflammation|1-888-451-3937|alcon.medinfo@alcon.com|
299257|NCT01872689|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
299258|NCT01872715|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5000|elizabeth.nieman@galderma.com|
299259|NCT01872819|University of Washington|Dr. Pamela Becker|206-288-7273|pbecker@u.washington.edu|
299260|NCT01872910|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
299261|NCT01873287|Children's Hospital of Eastern Ontario|Dr. Roger Zemek|613-737-7600|rzemek@cheo.on.ca|
299262|NCT01873417|Biogen Idec|Biogen Idec Study Medical Director||clinicaltrials@biogenidec.com|
299263|NCT01873495|Emory University|Martha Arellano, MD|404-778-1900|marella@emory.edu|
299264|NCT01873586|SeaSpine|Director Clinical Affairs||tish.mikoczi@seaspine.com|
299265|NCT01873729|Pediatric Psychopharmacology at Massachusetts General Hospital|Dr. Thomas Spencer|6177243883|tspencer@partners.org|
299266|NCT01873742|Modum Bad Research Institute|Dr. Terje Tilden|+4732749869|tilden@modum-bad.no|
299267|NCT01873846|Bausch Health Americas, Inc|Robert Steffen||Robert.Steffen@bausch.com|
299268|NCT01873859|Cardiovascular research center, Shahid Beheshti University of Medical Sciences|Dr. Saeed Alipour Parsa, director of clinical trial|+9821 2208 3106|s_alipour@sbmu.ac.ir|
299269|NCT01873950|U.S. Food and Drug Administration|David G Strauss, MD, PhD|301-796-6323|david.strauss@fda.hhs.gov|
299270|NCT01873989|Yale University|Dr. Declan Barry|203-285-2708|declan.barry@yale.edu|
299271|NCT01874054|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
299272|NCT01874119|Saint Louis University|Dr. John Richart|314-577-8854|richartj@slu.edu|
299273|NCT01874132|University of Trás-os-Montes e Alto Douro|Professor Nelson Sousa|259350756|nelsons@utad.pt|+351
299274|NCT01874145|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
299275|NCT01874262|AstraZeneca|Susanna Jerström|+46 8 553 260 00||
299276|NCT01874275|Independent Principal Investigator|Charlotte Stelly-Seitz, MD|713-523-3463|drstellyseitzmd@gmail.com|
299277|NCT01874288|Alopexx Oncology, LLC|Chief Medical Officer||daniel.vlock@alopexx.com|
299278|NCT01874340|Novartis|Study Director|862-778-8300||
299279|NCT01874392|Sansum Diabetes Research Institute|Director of Research and Innovation|8056827640|dkerr@sansum.org|
299280|NCT01874431|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
299281|NCT01874535|Kaohsiung Chang Gung Memorial Hospital, Taiwan|Dr. Seng-Kee Chuah and Dr. Wei-Chen Tai|886-975056007|chuahsk@seed.net.tw|
299282|NCT01874665|Ariad Pharmaceuticals|Medical Director|+1-844-662-8532|globaloncologymedinfo@takeda.com|
289849|NCT01268644|UT Southwestern Medical Center|Dr. Abhimanyu Garg|2146482895|abhimanyu.garg@utsouthwestern.edu|
289850|NCT01268683|Biogen|Medical Director|866-633-4636|clinicaltrials@biogen.com|
289851|NCT01268891|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
289852|NCT01268943|Chinese Academic Medical Sciences|Dr. Jing Jin|010-87788503|tangyu.pumc@gmail.com|
289853|NCT01269047|Children's Hospital at Montefiore|Dr. Rubina Heptulla|718-920-7004|rheptull@montefiore.org|
289854|NCT01269125|Dept. of Ob/Gyn, Patra University School of Medicine, Greece|Apostolos Kaponis, M.D.|+30-2610999569|kaponisapostolos@hotmail.com|
289855|NCT01269346|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
289856|NCT01269372|Givenimaging|Hilla Debby/ Director of Clinical Affairs|97299077740|hila.debby@medtronic.com|77740
289857|NCT01269385|Mayo Clinic|Stephen M. Ansell MD||Ansell.Stephen@mayo.edu|
289858|NCT01269710|The University of North Carolina at Chapel Hill|Linmarie Sikich, M.D.|(919) 972-7499|lsikich@med.unc.edu|
289859|NCT01269736|Yale University|Professor Marjorie Funk, PhD, RN|(203) 737-2346|marjorie.funk@yale.edu|
289860|NCT01269801|AboutSkin|Joel L. Cohen, MD|303-756-7546|research@aboutskinderm.com|
299283|NCT01874756|Indiana University|Dr. Alan Breier|3178808495|abreier@iupui.edu|
299284|NCT01874951|Depression Clinical and Research Program, Massachusetts General Hospital|David Mischoulon, MD, PhD, Director of Research|617-724-5198|dmischoulon@partners.org|
299285|NCT01875159|Uniformed Services University|Carl E. Hunt, M.D.|240-694-2676|carl.hunt@usuhs.edu|
299286|NCT01875237|UT MD Anderson Cancer Center|Champlin,Richard,M.D. / Stem Cell Transplantation|713-792-8750|rchampli@mdanderson.org|
299287|NCT01875250|National Cancer Institute|Dr. Ravi A. Madan|301-480-7168|m480i@nih.gov|
299288|NCT01875367|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
299289|NCT01875445|University of Chicago|Dr. Jon Grant|773-834-3778|jongrant@uchicago.edu|
299290|NCT01875471|Johnson & Johnson Vision Care|Daria Wicks|1 904 443-1391|RA-VISUS-ClnclStds@its.jnj.com|
299291|NCT01875510|Dr. Sami Ulus Children's Hospital|Dr. Serdar Beken|00903123056449|serbeken@gmail.com|
299292|NCT01875731|Hospital General de Niños Pedro de Elizalde|Dr. Fernando Torres|+54 11 43632100|torresfernandoadrian@gmail.com|1014
299293|NCT01875783|Joslin Diabetes Center|Dr. Jennifer Sun|617-209-2554|jennifer.sun@joslin.harvard.edu|
299294|NCT01875848|VACT West Haven HealthCare System|William, Becker M.D|203-932-5711|william.becker4@va.gov|2247
299295|NCT01875861|Central Arkansas Veterans Healthcare System|Dr. Richard Owen|(501) 257-1710|Richard.Owen2@va.gov|
299296|NCT01875874|Vital Therapies, Inc.|Robert Ashley|858-673-6840|rashley@vitaltherapies.com|
299297|NCT01875978|China Medical University Hospital|Dr. Dalong Chen|+886-227919696|my686chen@gmail.com|1205
299298|NCT01875991|Amgen Inc.|Study Director|866-572-6436||
299299|NCT01876043|Institut Bergonié|Dr Antoine ITALIANO|+33556333333|a.italiano@bordeaux.unicancer.fr|
299300|NCT01876082|Department of Medical Oncology, Institut bergonié|Pr Antoine Italiano, coordinating investigator|05.47.30.60.88|a.italiano@bordeaux.unicancer.fr|
299301|NCT01876212|UPMC Hillman Cancer Center|Barbara Stadterman, MPH MCCR|412-647-5554|stadtermanbm@upmc.edu|
299302|NCT01876251|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
299303|NCT01876329|Keesler Medical Center|Matthew B. Carroll, MD|228-376-3629|matthew.carroll.1@us.af.mil|
299304|NCT01876368|Novartis Pharmaceuticals|Study Director|862-778-8300||
299305|NCT01876381|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
299306|NCT01876420|Medtronic|Terry Noel|763-526-0309||
299307|NCT01876446|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
299308|NCT01876485|Department of Veterans Affairs|Dr. LeChauncy Woodard|(713) 440-4441|woodard.lechauncy@va.gov|
299309|NCT01876511|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dung Le, MD|443-287-0002|dle@jhmi.edu|
299310|NCT01876706|NeoTract|Monica Ransom Director of Clinical Operations|4159648770|Monica.Ransom@Teleflex.com|
299311|NCT01876732|Staten Island University Hospital|Suzanne El-Sayegh|718-226-6158|uviola@siuh.edu|
309155|NCT02646566|Acacia Pharma|Dr Gabriel Fox|01223875919764|GabrielFox@acaciapharma.com|
299312|NCT01876784|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
299313|NCT01876810|Centre for Addiction and Mental Health|Bernard LeFoll|416-535-8501|bernard.lefoll@camh.ca|34772
299314|NCT01876823|Columbia Psychiatry|Dr. Gregory Pelton, MD|(646) 774-8669|ghp4@columbia.edu|
299315|NCT01876901|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
299316|NCT01876953|City of Hope Medical Center|Ahmed Aribi|626-359-8111|aaribi@coh.org|
299317|NCT01876979|OMFS & HD|Department Chair|302-320-6458|dmeara@christianacare.org|
299318|NCT01876992|Johns Hopkins University|Sally Radovick|7322359524|sradovick@jhmi.edu|7733073353
299319|NCT01877083|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
299320|NCT01877148|Universidade Federal de Pernambuco|Kátia Monte-Silva|+ 55 (81) 2126-7579|monte.silvakk@gmail.com|
299321|NCT01877161|Seoul National University Bundang Hospital|Nam-Jong Paik|031-787-7731|njpaik@snu.ac.kr|7731
299322|NCT01877187|Yale University|Todd Schlachter, MD|(203) 785-5885|todd.schlachter@yale.edu|
299323|NCT01877239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299324|NCT01877265|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299325|NCT01877278|University of Messina|Gianfilippo Bagnato|00390902212502|gianbagnato@gmail.com|
299326|NCT01877408|University of New England|Dr. Peter Millard|2078663503|pmillard@mac.com|
299327|NCT01877421|Oral Health Research Institute, Indiana University School of Dentistry|Domenick T. Zero, DDS, MS|240-457-0668|dzero@iu.edu|
299328|NCT01877538|Department of Nuclear Medicine & PET Center, Aarhus University Hospital|Dr. Per Borghammer|+0045 23818581|perborgh@rm.dk|
299329|NCT01877551|Washington University School of Medicine|Dr. Dominic Reeds|3143628430|dreeds@wustl.edu|
299330|NCT01877642|Alexza Pharmaceuticals, Inc|Executive VP, Research & Development, Regulatory & Quality|650.944.7777|ClinicalTrialsInfo@alexza.com|
289861|NCT01269918|Cleveland Clinic|Daniel Sessler, MD|216-445-6500|sesslerd@ccf.org|
299331|NCT01877668|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
299332|NCT01877720|Seoul National University College of Medicine|Dr. Han-Suk Kim|82-2-2072-1696|kimhans@snu.ac.kr|
289862|NCT01270126|Otto-von-Guericke University of Magdeburg, Medical Faculty, Institute of Medical Psychology, Magdeburg, Germany|Prof. Bernhard A. Sabel|0049 3916721800|bernhard.sabel@med.ovgu.de|
289863|NCT01270139|Ural Institute of Cardiology|Dr. Alexander Kharlamov|0031627849118|drskharlamov@gmail.com|
299333|NCT01877915|Janssen Research & Development, LLC|SENIOR DIRECTOR, CLINICAL LEADER CV|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
289864|NCT01270256|University of Chicago|Dr. Robert M Naclerio|773-702-0080|rnackeri@surgery.bsd.uchicago.edu|
289865|NCT01270321|Emory University|Dr. Taofeek Owonikoko|404-778-5575|TOWONIK@emory.edu|
289866|NCT01270464|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
299334|NCT01877941|University of California San Francisco|Arthur Wallace, M.D., Ph.D.|415-750-2069|art.wallace@va.gov|3732
289867|NCT01270503|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
289868|NCT01270516|University of Kentucky|Emily Bradford, Clinical Trial Compliance Administrator|859) 323-2973|emily.bradford@uky.edu|
289869|NCT01270529|University of California, San Francisco|Dr. Kirsten Johansen|415-221-4810|kirsten.johansen@ucsf.edu|23598
289870|NCT01270542|Doheny Eye Institute/USC/University of Iowa|Dr. Elliott Sohn|319-356-3185|elliott-sohn@uiowa.edu|
289871|NCT01270555|Massachusetts General Hospital|Timothy Wilens, MD|617-503-1053|twilens@partners.org|
289872|NCT01270620|Stanford University School of Medicine|Dr. Pedro Tanaka|6507244066|ptanaka@stanford.edu|
299335|NCT01878006|National Institute on Alcohol Abuse and Alcoholism|Ramchandani, Vijay|+1 301 402 8527|vijayr@mail.nih.gov|
289873|NCT01270659|University of Oklahoma Health Sciences Center Tulsa|Dr. Nasir Mushtaw|918/660-3680|Nasir-Mushtaq@ouhsc.edu|
289874|NCT01270711|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299336|NCT01878084|Alexandria University|Prof. Mona K. Marei|002-03-4858353|mona.marei@gmail.com|
289875|NCT01270802|Indiana University School of Medicine|Dr. Samir K. Gupta, Principal Investigator|317-274-7926|sgupta1@iu.edu|
289876|NCT01270828|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299337|NCT01878097|University of Kentucky|Dr. Ann Coker|859-323-6758|ann.coker@uky.edu|
299338|NCT01878149|Baxano Surgical®|Sr. Director of Clinical Affairs|919.899.9760|teresa.schroeder@baxsurg.com|
289877|NCT01270841|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
289878|NCT01270867|Concentric Medical / Stryker Neurovascular Inc|Paula Schmidt, Clinical Project Manager|510-413-2271|paula.schmidt@stryker.com|
289879|NCT01270880|Barbara Ann Karmanos Cancer Institute|Elisabeth I. Heath, M.D.|313-576-8715|heathe@karmanos.org|
289880|NCT01270958|GlaxoSmithKline|GSK Response Center|866-435-7343||
289881|NCT01270971|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com|
289882|NCT01271010|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
289883|NCT01271036|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist|928-277-0715|jhauze@its.jnj.com|
289884|NCT01271244|VA NEBRASKA WESTERN IOWA VA HEALTHCARE|SRIRAM RAMASWAMY MD|4029954712|SRIRAM.RAMASWAMY@VA.GOV|
289885|NCT01271413|Johns Hopkins University School of Medicine|Dr. Miriam Mintzer|410 550-0529|mmintzer@jhmi.edu|
299339|NCT01878175|Durham VA Medical Center|Kelli Allen|919-286-0411|kelli.allen@va.gov|7090
289886|NCT01271452|Allergan, Inc.|Vice President, Medical Affairs|714-246-4500|clinicaltrials@allergan.com|
270227|NCT00114140|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
289887|NCT01271504|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
289888|NCT01271543|Penn State Milton S. Hershey Medical Center|Sonia Vaida|7175318433|svaida@hmc.psu.edu|
289889|NCT01271686|University of California, San Diego|Dr. John Liu|858 534-7056|joliu@ucsd.edu|
289890|NCT01271712|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
309156|NCT02646618|University of Connecticut|Dr. Sherry Pagoto|8604868979|Sherry.Pagoto@uconn.edu|
309157|NCT02646761|University of Pittsburgh|Dr. James J. Irrgang|(412) 383-9865|jirrgang@pitt.edu|
309158|NCT02646826|Wellesley Pharmaceuticals, LLC|David Dill|2154930168|ddill@wellesleypharma.com|
309159|NCT02646891|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
309160|NCT02646917|Crown Laboratories, Inc.|Thomas Hitchcock, PhD|8883723982|THitchcock@crownlaboratories.com|
309161|NCT02647203|University of Talca|Dr. Rodrigo Giacaman|+56712201546|giacaman@utalca.cl|2654
309162|NCT02647281|GlaxoSmithKline|GSK Response Center|866-435-7343||
309163|NCT02647320|Daiichi Sankyo|Daiichi Sankyo Contact for Clinical Trial Information|+81-3-6225-1111(M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
309164|NCT02647346|Podimetrics Inc|Brian Petersen|860-558-9204|brian@podimetrics.com|
309165|NCT02647645|Nova Southeastern University|Raymond L Ownby, MD, PhD|9542621481|ro71@nova.edu|
309166|NCT02647658|University of Pittsburgh|Dr. Charity Patterson|412-383-4812|cgp22@pitt.edu|4123834812
309167|NCT02647788|University of Pennsylvania|Dr. Benjamin Gray|215-294-9650|Benjamin.Gray@uphs.upenn.edu|
309168|NCT02647866|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
309169|NCT02647905|Senseonics|Vice President, Clinical Sciences|3015157260|katherine.tweden@senseonics.com|
309170|NCT02647944|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
309171|NCT02648022|Va San Diego Healthcare System|Dr. Samuel B. Ho|858-552-8585|Samuel.Ho2@va.gov|3280
309172|NCT02648178|The Koop Institute at Dartmouth, Geisel School of Medicine|Dr James Sargent|603-653-9025|James.D.Sargent@dartmouth.edu|
289891|NCT01271725|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289892|NCT01271803|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
289893|NCT01271855|Northwestern University|Kimberly Kenton MD, MS|312-472-3874|kkenton@nm.org|
289894|NCT01271868|Aptevo Therapeutics|Dr. David Schaaf|206-859-6655|schaafd@apvo.com|
289895|NCT01271907|National Cancer Institute, National Institutes of Health|James Yang, M.D.|301-496-1574|jamesyang@mail.nih.gov|
289896|NCT01271933|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289897|NCT01271946|Arstasis|Debra Cogan, Director of Quality, Regulatory and Clinical|650-261-8073|dcogan@arstasis.com|
289898|NCT01272011|Malcom Randall VAMC|Dr. Nicole Tester|352-376-1611|ntester@phhp.ufl.edu|7507
289899|NCT01272076|TLC Eyecare and Laser Centers|Carmelina Gordon, MD|(517) 7821213|shellie.fuentes@tlcmi.com|
289900|NCT01272180|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
299340|NCT01878214|Washington University School of Medicine in St. Louis|Jaime Strickland, MA|314-454-7337|jstrickl@dom.wustl.edu|
289901|NCT01272193|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
299341|NCT01878253|Zimmer Biomet Inc|Clinical Operation Director|574-371-9823|Bill.Bourdeau@zimmerbiomet.com|
289902|NCT01272219|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
289903|NCT01272232|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
289904|NCT01272245|UT MD Anderson Cancer Center|Kantarjian,Hagop M|713-792-7026|CR_Study_Registration@mdanderson.org|
289905|NCT01272284|Coloplast Corp|Clinical Trials Manager|612-302-4990|usdibe@coloplast.com|
289906|NCT01272388|Washington University School of Medicine|Brian R. Lindman, MD|314-747-3617|brlindman@wustl.edu|
289907|NCT01272583|Academic Medical Center|Dr. Josefine E. Schopman|+31 20 5669111|j.e.schopman@amc.uva.nl|
289908|NCT01272635|Penn State University|David Mauger|717-531-7178|dtm5@psu.edu|
289909|NCT01272661|UHospitalsCleveland; Rainbow Babies and CHildren's Hospital|Lydia Furman MD, PI|216-844-8260|Lydia.Furman@uhhospitals.org|
289910|NCT01272804|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289911|NCT01272830|Clinic Orthopaedic Center|Thomas Bear, MD|330-375-3906|kovacikm@summahealth.org|
289912|NCT01272869|Coloplast A/S|Director Medical Affairs|4549111111|dkbir@coloplast.com|
289913|NCT01272882|ChristianaCHS|Gerard Fulda|302-733-4260|gfulda@christianacare.org|
289914|NCT01272908|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
289915|NCT01272921|Northwestern University|Mark Kendall, M.D.|312-695-2528|m-kendall@northwestern.edu|
289916|NCT01272934|Novartis Consumer Health|Clinical Project Leader|0041223635228||
289917|NCT01272947|Novartis Consumer Health S.A.|Clinical Project Leader|+41 22 3635528||
289918|NCT01272960|University of Alabama School of Medicine|Dr. Lorie Harper|205-975-0515|lmharper@uabmc.edu|
289919|NCT01272999|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289920|NCT01273038|Coloplast A/S|Director of Medical Affairs|4549111111|dkbir@coloplast.com|
289921|NCT01273155|National Cancer Institute|Naoko Takebe, M.D., Ph.D.|240-781-3398|Takeben@mail.nih.gov|
289922|NCT01273181|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
289923|NCT01273207|National Heart Lung and Blood Institute|Dr Richard Childs|+301-451-7128|childsr@nhlbi.nih.gov|
289924|NCT01273519|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
289925|NCT01273597|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
289926|NCT01273623|Boston Scientific|Susanna Kennedy|763.494.2601|susanna.kennedy@bsci.com|
289927|NCT01273766|Comprehensive Cancer Center of Wake Forest University|Dr. Mary Ann Knovich|336-716-7973|mknovich@wakehealth.edu|
289928|NCT01273805|Dana-Farber Cancer Institute|Brian M. Wolpin|617.632.6942|Brian_Wolpin@dfci.harvard.edu|
289929|NCT01273818|S.B.Ankara Diskapi Yildirim Beyazit Education and Teaching Hospital|Dr.Gaye Seker|+905323360618|gayeebru@superonline.com|
289930|NCT01273857|Okayama University Hospital|Prof. Hidemasa Oh|+81-086-235-6506|hidemasa@md.okayama-u.ac.jp|
309173|NCT02648204|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
309174|NCT02648217|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
309175|NCT02648230|Columbia University|Ajay Kirtane, MD, SM|212-305-7060|akirtane@columbia.edu|
289931|NCT01273883|Mayo Clinic|Dr. Michael J. Cevette|480-301-7020|mcevette@mayo.edu|
289932|NCT01273896|Memorial Sloan Kettering Cancer Center|Modi, Shanu/Medicine (Assistant Attending)|+1646-888-4564|modis@mskcc.org|
289933|NCT01274182|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
289934|NCT01274338|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
289935|NCT01274351|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
289936|NCT01274520|Columbia University College of Physicians and Surgeons - Center for Liver Disease and Transplantation|James V. Guarrera, MD, FACS|(212)305.3839|jjg46@cumc.columbia.edu|
289937|NCT01274585|Massachusetts General Hospital|Does Percutaneous Tibial Nerve Stimulation (PTNS) Improve Outcomes in Patients|617-643-0541|lsavitt@partners.org|
289938|NCT01274637|Ottawa Hospital Research Institute|Dr. Marc Rodger|6137388899|mrodger@ohri.ca|
289939|NCT01274715|Michael DeBakey VAMC|Aanand Naik, MD|713-794-8541|anaik@bcm.edu|
289940|NCT01274897|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
289941|NCT01275053|Beth Israel Deaconess Medical Center|Dr. Christos Mantzoros|6176678633|cmantzor@bidmc.harvard.edu|
299342|NCT01878292|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
289942|NCT01275066|BioMarin Pharmaceutical Inc.|BioMarin Medical Information Services|(800) 983-4587|medinfo@bmrn.com|
289943|NCT01275092|Columbia University Medical Center, New York, NY, 10032|Giora Weisz, MD; Director of Clinical Resarch Center for Interven tional Vascular Therapy|212-305-7060|gweisz@crf.org|
289944|NCT01275131|Halozyme Therapeutics, Inc|Vice President, Endocrinology Clinical Development|(858)794-8889||
289945|NCT01275144|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
289946|NCT01275170|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289947|NCT01275196|Novartis Pharmaceuticals|Study Director|862-778-8300||
289948|NCT01275222|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
299343|NCT01878383|University of Alabama at Birmingham|David Kimberlin, MD|205.638.2530|DKimberlin@peds.uab.edu|
299344|NCT01878526|Khon Kaen University|Dr.Chingching Foocharoen|6643363746|fching@kku.ac.th|
299345|NCT01878604|Central South University|Shuiping Zhao|86-731-85295806|zhaosp@medmail.com.cn|
299346|NCT01878656|Chung-Ang University Hospital|Dr. Chong Wha Baek|82-2-6299-2579|nbjhwa@naver.com|
299347|NCT01878799|National Institute of Allergy and Infectious Diseases|Dr. Shyam Kottilil|+1 301 435 0936|skottilil@niaid.nih.gov|
299348|NCT01878812|GlaxoSmithKline|GSK Response Center|866-435-7343||
309176|NCT02648438|AstraZeneca AB|Global Clinical Leader|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
309177|NCT02648646|University of North Carolina|Yvonne Golightly PT, PhD, Assistant Professor of Epidemiology|919-966-0566|golight@email.unc.edu|
309178|NCT02648880|University of Colorado|Ryan Marker|3037240819|ryan.marker@cuanschutz.edu|
309179|NCT02648919|University of Hawaii Cancer Center|Stacy Mercado, IIT/ Education Manager|8084404561|smercado@cc.hawaii.edu|
309180|NCT02648932|University of Chicago|Hongtao Liu|773-834-0589|hliu2@medicine.bsd.uchicago.edu|
309181|NCT02648971|Wake Forest University|Dr. John Hubbard|336-998-1297|jhubbard@wakehealth.edu|
309182|NCT02649192|St. Jude Children's Research Hospital|Nehali Patel, MD|866-278-5833|info@stjude.org|
309183|NCT02649218|Novartis Pharmaceuticals|Study Lead|+1 (862) 778-8300|novartis.email@novartis.com|
309184|NCT02649231|University of Exeter|Professor Celia Morgan|01392 724649|Celia.Morgan@exeter.ac.uk|
309185|NCT02649322|Orlando Health|Daryl C. Osbahr, MD|321.843.4800|Daryl.Osbahr@orlandohealth.com|
309186|NCT02649439|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
309187|NCT02649556|Philip Morris Products S.A.|Christelle Haziza|+41 58 242 11 11|christelle.haziza@pmi.com|
309188|NCT02649608|H. Lundbeck A/S|Email contact via H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
309189|NCT02649634|University of Calgary|Dr. Kristin von Ranson|403.220.7085|kvonrans@ucalgary.ca|
309190|NCT02649842|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman, OD, FAAO|1+ 714-247-8429|djanaki1@its.jnj.com|
309191|NCT02649894|Becton Dickinson|Dawn Heimer|2018476800|dawn.heimer@bd.com|
309192|NCT02650128|Shockwave Medical, Inc.|Beaux Alexander, Vice President Clinical Affairs|510-279-4262|balexander@shockwavemedical.com|145
309193|NCT02650193|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309194|NCT02650219|St Joseph Hospital Marseille|Dr Christine Serratrice|0041798731474|cserratrice@hotmail.fr|
309195|NCT02650284|Stryker|Alissa Connelly|+61294671000|alissa.connelly@stryker.com|1075
309196|NCT02650440|Coordination of Improvement of Higher Level Personnel - CAPES|Thais A. Rodrigues, MS, PT.|55 (61) 2022-6002|faleconosco@capes.gov.br|
309197|NCT02650466|Alfred E. Mann Insitute at the University of Southern California|Cesar E. Blanco,PhD; Sr Director R&D|2138211619|cblanco@usc.edu|2138211619
309198|NCT02650856|Universidad Autonoma de Nuevo Leon|FELIX VILCHEZ CAVAZOS|8183476698|vilchez.doctor@gmail.com|
309199|NCT02650895|OncoImmune, Inc.|Dr. Pan Zheng|2027516823|pzheng@oncoimmune.com|
309200|NCT02650921|Galderma Research & Development, LLC|Assoc Director of Clinical Operations|817-961-5000|courtney.maguire@galderma.com|
309201|NCT02650999|University of Pennsylvania, Clinical Research Unit|Ellen Napier, Nurse Pracitioner|215.279.1972|ellen.napier@pennmedicine.upenn.edu|
309202|NCT02651103|Nationwide Children's Hospital|Clinical Research Coordinator|6147222997|heather.dellinger@nationwidechildrens.org|
309203|NCT02651116|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309204|NCT02651155|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
309205|NCT02651194|AbbVie|Global Medical Services|800-633-9110||
309206|NCT02651220|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
309207|NCT02651259|Family Health International (FHI 360|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
309208|NCT02651272|Bosotn Medical Center|Elizabeth Klings, MD|617-638-7480|elizabeth.klings@bmc.org|
309209|NCT02651337|Alcyone LifeSciences|Director of Clinical Operations|9787091946|jmcguire@alcyonels.com|
309210|NCT02651415|BC Cancer|Dr. Barbara Melosky|604-877-6000|bmelosky@bccancer.bc.ca|
309211|NCT02651428|CorMedix Inc.|Head of Clinical Operations|908-517-9500|lmasson@cormedix.com|
309212|NCT02651467|GlaxoSmithKline|GSK Response Center|866-435-7343||
309213|NCT02651545|UBMD Neurology|Michael Jaworski|716-323-0550|mgjawors@buffalo.edu|
309214|NCT02651584|Braeburn Pharmaceuticals|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
309215|NCT02651688|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
309216|NCT02651922|PASCOE Pharmazeutische Präparate GmbH|Dr. Inga Trompetter and Jennifer Lebert|0049-(0)641-7960-955|Jennifer.lebert@pascoe.de|
309217|NCT02651987|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
309218|NCT02652156|Midwestern Regional Medical Center|Director of Clinical Trials|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
309219|NCT02652208|Massachusetts General Hospital|Dr. Karen Sepucha|617-724-3350|ksepucha@partners.org|
309220|NCT02652221|Cincinnati Children's Hospital Medical Center|Andrew T. Trout, MD|513-803-3004|andrew.trout@cchmc.org|
289949|NCT01275300|Upenn|Wenliang Song, MD|215-662-4652.|wenliangsong@gmail.com|
289950|NCT01275313|University of Pittsburgh|David Brienza, Professor|412-624-6383|DBRIENZA@pitt.edu|
289951|NCT01275339|Washington University School of Medicine|Brian R. Lindman, MD|615-936-5949|brlindman@wustl.edu|
289952|NCT01275365|Brigham and Women's Hospital|Shalendar Bhasin, MD|617-525-9040|Sbhasin@partners.org|
289953|NCT01275430|Bard Access Systems, Inc.|Sharon Molotsky|856-266-1327|sharon.molotsky@crbard.com|
289954|NCT01275586|Indiana University|Dr. Melissa Markel|317-944-4969|memarkel@iu.edu|
289955|NCT01275625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299349|NCT01878825|GlaxoSmithKline|GSK Response Center|866-435-7343||
289956|NCT01275664|NRG Oncology|Linda Gedeon for Helen Huang, MS|716-845-1169|lgedeon@gogstats.org|
289957|NCT01275755|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
289958|NCT01275833|Boston Scientific|Elke Sommerijns|+32479767156|elke.sommerijns@bsci.com|
289959|NCT01276041|Memorial Sloan Kettering Cancer Center|Dr. Chau Dang, MD|914-367-7181|dangc@mskcc.org|
289960|NCT01276106|TWi Biotechnology, Inc.|Medical Director|+886-2-26573350|Carl.Brown@twipharma.com|368
289961|NCT01276171|University of Iowa Hospitals and Clinics|Dr. Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|48517
289962|NCT01276184|University of Maryland School of Medicine|Dr. J. Kathleen Tracy, PhD|410-706-1205|ktracy@som.umaryland.edu|
289963|NCT01276197|CHOIR|Dr. Thomas K. Houston|781-687-2884|thomas.houston2@va.gov|
289964|NCT01276223|Alcon Research|Director of Alcon Clinical|1-888-451-3937||
299350|NCT01878890|Institut Bergonié|Dr Guilhem Roubaud|33 5 56 33 33 33|g.roubaud@bordeaux.unicancer.fr|
289965|NCT01276236|University of California, San Francisco|Dr. Toby Maurer, MD|(628) 206-8680|Toby.Maurer@ucsf.edu|
289966|NCT01276288|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
299351|NCT01879059|University of Kansas Medical Center|John P. Thyfault, PhD|913-588-1790|jthyfault@kumc.edu|
299352|NCT01879072|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
289967|NCT01276301|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289968|NCT01276314|Chang Gung Memorial Hospital, Linko|Drug Hypersensitivity Clinical and Research Center, Laboratory of Dr. Wen-Hung Chung,|886-3-328-1200|kiruamairo@gmail.com|8494
289969|NCT01276327|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289970|NCT01276353|Clinical Development. JAC PCU. Eisai Co., Ltd.|Naoki Kubota|+81-3-3817-5245||
289971|NCT01276379|GEMCAD|Joan Maurel Santasusana|+ 34 93 434 44 12|JMAUREL@clinic.cat|
289972|NCT01276457|Novartis Pharmaceuticals|Study director|862 778-8300||
289973|NCT01276509|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
299353|NCT01879176|Medical University of Vienna|Dr. Martin H. Bernardi|004314040041090|martin.bernardi@meduniwien.ac.at|
289974|NCT01276535|Westlake Dermatology|Gregory A. Nikolaidis, MD|512-328-3376|karen@westlakedermatology.com|
289975|NCT01276639|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
289976|NCT01276652|University of Iowa|Brian Gehlbach, MD|319-356-3603|brian-gehlbach@uiowa.edu|
289977|NCT01276756|Cairo University|Dr. Hany Shehab|00201111111071|h.shehab@drshehab.com|
289978|NCT01276821|Department of Child Health, Tribhuvan University Teaching Hospital, Institute of Medicine.|Dr. Aayush Khanal|977-1-4421532|aayush_khanal@yahoo.com|
299354|NCT01879319|Amgen Inc.|Study Director|866-572-6436||
289979|NCT01276847|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
289980|NCT01276860|Arkansas Children's Hospital|Clinical Research Coordinator|501-364-2018|boswelljl@archildrens.org|
289981|NCT01277042|GlaxoSmithKline|GSK Response Center|866-435-7343||
289982|NCT01277081|GlaxoSmithKline|GSK Response Center|866-435-7343||
289983|NCT01277159|HSS|Dr. Yadeau|212.606.1206|YadeauJ@hss.edu|
289984|NCT01277302|Genentech, Inc.|Medical Communications|800 821-8590||
289985|NCT01277341|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
289986|NCT01277354|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
289987|NCT01277510|Amgen Inc.|Study Director|866-572-6436||
289988|NCT01277523|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
299355|NCT01879332|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
299356|NCT01879345|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
299357|NCT01879371|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
289989|NCT01277549|Terumo BCT|Jerome R Bill, M.D.|303-231-4729|jerry.bill@terumobct.com|
299358|NCT01879410|GlaxoSmithKline|GSK Response Center|866-435-7343||
289990|NCT01277601|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
289991|NCT01277666|GlaxoSmithKline|GSK Response Center|866-435-7343||
289992|NCT01277718|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
289993|NCT01277744|UT MD Anderson Cancer Center|Andrea Hayes-Jordan M.D. / Surgical Oncology|713-794-4616|AHJORDAN@MDANDERSON.ORG|
289994|NCT01277757|University of Texas (UT) MD Anderson Cancer Center|Funda Meric-Bernstam, MD/Chair, Investigational Cancer Therapeutics|713-563-4347|fmeric@mdanderson.org|
289995|NCT01277783|Medtronic Bakken Research Center B.V.|Mireille van Ginneken, Principal Clinical Research Specialist|+31433566801|mireille.vanginneken@medronic.com|
289996|NCT01277861|University of Texas Southwestern Medical Center at Dallas|Girish P. Joshi, MD|214-590-7259|girish.joshi@utsouthwestern.edu|
289997|NCT01277887|Yale University School of Medicine|Lisa Fucito, PhD|203 974-5759|lisa.fucito@yale.edu|
289998|NCT01278030|St. Jude Medical|John Gill|818-493-2609|jgill@sjm.com|
289999|NCT01278160|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
290000|NCT01278173|Lundbeck|H||LundbeckClinicalTrials@Lundbeck.com|
290001|NCT01278303|Johns Hopkins Hospital|Dr. Richard E. Ringel|410-614-6745|rringel@jhmi.edu|
290002|NCT01278342|Novartis Pharmaceuticals|Study Director|862-778-8300||
290003|NCT01278394|Anacor Pharmaceuticals, Inc.|Sheryl Baldwin, RN/Associate Director|650-223-8597|clinicaltrials@anacor.com|
290004|NCT01278407|Eisai Co., Ltd.|Masaki Nakagawa|+81-3-3817-5245||5245
290005|NCT01278485|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290006|NCT01278615|University of Chicago|Dr. Sonali M. Smith|773-834-2895|smsmith@medicine.bsd.uchicago.edu|
290007|NCT01278745|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
290008|NCT01278797|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290009|NCT01278862|3M HCBG Clinical Operations|Rolf Halvorson|651-733-3384|rhhalvorson@mmm.com|
290010|NCT01278927|The EMMES Corporation|Adam Mendizabal|301-251-1161|amendizabal@EMMES.com|
290011|NCT01278953|Abbott|Lori Rusch, Ph.D.|651-756-2668|lori.rusch@abbott.com|
290012|NCT01279044|San Francisco Department of Public Health|Dr. Phillip Coffin, Director of Substance Abuse Research Unit|(415) 437 6282|phillip.coffin@sfdph.org|
290013|NCT01279057|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
290014|NCT01279070|Parc Sanitari Sant Joan de Déu|Dr. Aida Farreny|+34 936406350|afarreny@pssjd.org|2373
290015|NCT01279109|Wake Forest School of Medicine|Dr. Sabina B. Gesell|336-713-8738|sgesell@wakehealth.edu|
290016|NCT01279187|University of Michigan|Jill Bashutski||jillbashutski@gmail.com|
290017|NCT01279200|University of Michigan|Senait Fisseha, MD, JD|734-763-4323|sfisseha@med.umich.edu|
290018|NCT01279265|University of Texas Health Science Center at Houston|Dr. J. Marc Rhoads, Director, Pediatric Gastroenterology|713-500-7642|j.marc.rhoads@uth.tmc.edu|
290019|NCT01279317|Maastricht University Medical Centre|Drs. Jan-Willem van Dijk|+31(0)433881394|janwillem.vandijk@maastrichtuniversity.nl|
290020|NCT01279343|Washington University School of Medicine|Jeanine Carbone MD|314-362-8523|jfcarbone@hotmail.com|
299359|NCT01879540|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
290021|NCT01279447|Northwestern|Lawrence Hsu, MD|312 9262000|larryphsu@gmail.com|
290022|NCT01279486|SPD Swiss Precision Diagnostics GmbH/SPD Development Company Ltd|Dr Sarah Johnson, Head of Clinical and Regulatory Affairs|01234835486|sarah.johnson@spdspark.com|
290023|NCT01279564|Rambam Health Care Campus|Dr. Michal Barak|972 4 8542487|m_barak@rambam.health.gov.il|
290024|NCT01279681|Mayo Clinic|Joleen M. Hubbard, M.D.|507 284-3121|hubbard.joleen@mayo.edu|
290025|NCT01279850|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290026|NCT01279954|Oregon Health & Science University|Eric Suler, MD|503-494-5023|suhlere@ohsu.edu|
299360|NCT01879553|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
290027|NCT01280058|The Ohio State University Comprehensive Cancer Center|Anne Noonan, MD|614-685-6912|Anne.Noonan@osumc.edu|
290028|NCT01280110|Departamento de Oftalmologia - Universidade Estadual de Campinas - Campinas - Brazil|Vital Paulino Costa|55-19-35217396|vp.costa@uol.com.br|
290029|NCT01280123|Northwestern University|Tanya Simuni, MD||TSimuni@nm.org|
290030|NCT01280201|Group for Neuroendocrine Tumors (GETNE)|Dr. Enrique Grande (Hospital Universitario Ramón y Cajal)|931780742|getne@getne.org|201
290031|NCT01280266|Seoul National University|Dr. Eun Bong Lee|+82 2 2072-3944|leb7616@snu.ac.kr|
299361|NCT01879579|New York University School of Medicine|Dr. Natalie Levy|2122638924|Natalie.Levy@nyumc.org|
290032|NCT01280357|Monica Healthcare Ltd|Ian How|+44 (0)115912|ianhow@monicahealthcare.com|4540
299362|NCT01879618|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290033|NCT01280409|University of Texas Health Science Center at Houston|Dr Jerrie Refuerzo|713.500.7780|Jerrie.S.Refuerzo@uth.tmc.edu|
299363|NCT01879683|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
299364|NCT01879722|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
299365|NCT01879735|Dept. of Nuclear Medicine & PET-center, Dept. of Hepatology and Gastroenterolgy. Aarhus University Hospital|Susanne Keiding M.D., Associate professor, D.Sc.|+45 7846 3031|susanne@pet.auh.dk|
299366|NCT01879800|Baylor College of Medicine|Dr. Lilian Dindo|713-791-1414|lilian.dindo@bcm.edu|10296
299367|NCT01879826|University of California San Francisco|Cynthia Kim|(415)353-1328|cynthia.kim@ucsf.edu|
299368|NCT01879852|University of Florida|Dr. Terese Chmielewski|(352)273-6104|tchm@ufl.edu|
309221|NCT02652260|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
309222|NCT02652390|Hässleholm Hospital, Hässleholm, Sweden|Dr. Isam Atroshi|+46443091260|Isam.Atroshi@skane.se|
309223|NCT02652416|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309224|NCT02652442|James H Quillen VAMC|Research Health Science Specialist|(423) 926-1171|courtney.hall@va.gov|7518
309225|NCT02652481|Boston Scientific|Clinical Trial Manager|+32479983495|anneleen.viville@bsci.com|
309226|NCT02652624|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
309227|NCT02652767|GenSight Biologics|Regulatory Affairs|176217220|ipengue@gensight-biologics.com|0033
309228|NCT02652780|GenSight Biologics|Regulatory Affairs|176217220|ipengue@gensight-biologics.com|0033
309229|NCT02653144|Montefiore Medical Center|Dr. Amaresh Vydyanathan|7189204316|avydyana@montefiore.org|
309230|NCT02653170|Michigan State University|Dr. Mathew Reeves|517-353-8623|reevesm@msu.edu|
309231|NCT02653183|Universitair Ziekenhuis Gent|Prof. Dr. Hilde Beele|+32 9 332 21 11|Hilde.Beele@uzgent.be|
299369|NCT01880047|Weill Cornell Medicine|Sujit Sheth|2126463400|shethsu@med.cornell.edu|
290034|NCT01280552|ImmunoCellular Therapeutics Ltd.|Anthony Gringeri, Ph.D. Senior Vice President Strategic Resources|818 264 2300|anthony.gringeri@imuc.com|
290035|NCT01280591|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
290036|NCT01280604|Mercer University/ Kaiser Permanente|Kendra Manigault, PharmD, BCPS, BCACP, CDE|678-547-6216|manigault_kr@mercer.edu|
290037|NCT01280617|Lahey Hospital & Medical Ctr|Mary Ann Simpson, Ph.D|781-744-2500|Mary.a.Simpson@Lahey.org|
290038|NCT01280656|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
290039|NCT01280695|Metabolic Solutions Development Company|Jerry Colca, PhD|269.343.6732|jcolca@msdrx.com|
290040|NCT01280721|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366||
290041|NCT01280812|UC San Francisco|Yoshimi Fukuoka, PhD, RN, FAAN|415-476-8419|yoshimi.fukuoka@ucsf.edu|
290042|NCT01280903|University of Pittsburgh|Elizabeth A. Schlenk|412-624-4103|els100@pitt.edu|
290043|NCT01280942|Washington Univ Sch of Medicine|Thomas C. Bailey, MD|314-454-8293|tbailey@dom.wustl.edu|
290044|NCT01280955|Duke University Medical Center|Mitchell Horwitz, MD|919-668-1045|mitchel.horwitz@duke.edu|
290045|NCT01280968|Duke University Medical Center|Alexey G Mukhin, M.D., Ph.D.|Telephone: 919-668-5055|amukhin@duke.edu|
290046|NCT01280981|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
299370|NCT01880073|Center for Reproductive Medicine|Dr. Steven Spandorfer|646-962-3638|sdspando@med.cornell.edu|
299371|NCT01880086|Weill Cornell Medical College|Dr. Peter N. Schlegel|2127465491|pnschleg@med.cornell.edu|
299372|NCT01880099|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-937-4809|mehmet.sofuoglu@yale.edu|
299373|NCT01880320|Galderma R&D|Galderma CPM|00 33 4 93 95 70 70|clinicaltrials@galderma.com|
299374|NCT01880424|AstraZeneca|Peter Zeng|+86 21 6030 1867|peter.zeng@astrazeneca.com|
299375|NCT01880437|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
299376|NCT01880515|Instituto Nacional de Cancerología|Oscar Arrieta|+52 55 56 28 04 00|ogar@servidor.unam.mx|832
299377|NCT01880528|Mayo Clinic|Terence T Sio, MD, MS|480/301-7050|Sio.Terence@mayo.edu|
299378|NCT01880554|Institut Bergonie|Derek Dinart||d.dinart@bordeaux.unicancer.fr|
299379|NCT01880593|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-241-7574|james.murrough@mssm.edu|
299380|NCT01880697|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
299381|NCT01880723|University of Arizona|Courtney Wheatley|507-266-2696|wheatley.courtney@mayo.edu|
299382|NCT01880736|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
299383|NCT01880840|Meda Pharmaceutical|Dr.Nancy Ruiz Chief Medical Officer|732 564 2200|nancy.ruiz@meda.us|2390
299384|NCT01881009|Stanford University|Bruce Buckingham, M.D.|408-356-0911|buckingham@stanford.edu|
299385|NCT01881087|Fundación Valle del Lili|Dr. Fredy Ariza, MD., MSc., PhD(a).|+57 3319090|fredyariza@hotmail.com|4122
299386|NCT01881113|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
299387|NCT01881126|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
299388|NCT01881230|Celgene|Anne McClain, Senior Manager Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
299389|NCT01881373|University of Hawaii|Rachel Novotny|808-956-3848|novotny@hawaii.edu|
299390|NCT01881412|Rhode Island Hospital and Brown University|Dr. Aris Garro|401-480-8682|arisgarro1@gmail.com|
299391|NCT01881620|Institut Bergonié, Medical Imaging Department|Dr. Anne-Laure Cazeaux, Nuclear physician|05.56.33.78.60|A.cazeaux@bordeaux.unicancer.fr|
299392|NCT01881737|Stanford University School of Medicine|Antonio Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
299393|NCT01881750|Stanford University School of Medicine|Antonio Hardan, MD|650-736-1235|hardanay@stanford.edu|
299394|NCT01881776|StLukeNY|Dr.Admir Hadzic|212-665-1400|admir@nysora.com|
299395|NCT01881789|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
299396|NCT01881828|Jaeb Center for Health Research|Kellee Miller|15310 Amberly Drive|t1dstats@jaeb.org|
299397|NCT01881867|Cancer Immunotherapy Trials Network|CITN Director|206-667-4141|mcheever@fredhutch.org|
299398|NCT01882062|Inserm U1127|Dr Fanny MOCHEL|+33 (0)1 5727 46 78|fanny.mochel@upmc.fr|
299399|NCT01882088|Federal research Center of Nutrition and Biotechnology|Dr Sergey Morozov, Senior Reseracher, Dpt Gastroenterology and Hepatology|+74996131091|morosoffsv@mail.ru|
299400|NCT01882257|University of Michigan Health System|Robert G. Sitrin, M.D.|(734) 936-5201|rsitrin@umich.edu|
299401|NCT01882413|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
299402|NCT01882439|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
299403|NCT01882465|Johnson & Johnson Vision Care Inc.|Charis Lau, PharmD, OD, FAAO- Principal Research Optometrist|904-433-3500|charislau@gmail.com|
299404|NCT01882543|Department of Urology, Queens University, Ontario|J. Curtis Nickel|613-548-2497|jcn@queensu.ca|
299405|NCT01882647|Therapeutics, Inc.|Clinical Research, Therapeutics Inc.|585-571-1800|clinicalreseach@therapeuticsinc.com|
299406|NCT01882725|Arizona Institute of Footcare Physicians|Kerry Zang, DPM|480-834-8804|kerryzang@aol.com|
299407|NCT01882764|Hutchison MediPharma Ltd|Dr. Rongjun Liu|+86 21 2067 3203|rongjunl@hmplglobal.com|
299408|NCT01882803|Verastem Oncology|Gloria Patrick|781-469-1594|gpatrick@verastem.com|
299409|NCT01882829|Icahn School of Medicine at Mount Sinai|Dr. James W Murrough|212-241-7574|james.murrough@mssm.edu|
299410|NCT01882868|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
299411|NCT01882907|Pusan National University Hospital|In Joo Kim|+82-51-240-7224|injkim@pusan.ac.kr|
299412|NCT01882985|University of California, Irvine|Dr. John P. Fruehauf|714-456-5153|jfruehau@uci.edu|
299413|NCT01883141|Medtronic, plc|CRHF Clinical Research|800-328-2518|medtroniccrmtrials@medtronic.com|
299414|NCT01883362|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
299415|NCT01883427|Umeå University|MD, PhD Krister Tano|0046705569043|krister.tano@umu.se|
299416|NCT01883440|Umeå University|MD, PhD Krister Tano|0046705569043|krister.tano@umu.se|
290047|NCT01281007|EMS|Manager of Clinical Trials|+5501938874176|pesquisa.clinica@ems.com.br|
290048|NCT01281137|International Breast Cancer Study Group (IBCSG)|Head Trial Activities and Deputy Director: Dr. Heidi Roschitzki-Voser|+41 31 511 94 00|heidi.roschitzki@ibcsg.org|
299417|NCT01883453|Umeå University|Dr Krister Tano|0046705569043|krister.tano@umu.se|
299418|NCT01883492|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
299419|NCT01883635|University of Rochester|Dr. Charles Kamen|585-275-9958|charles_kamen@urmc.rochester.edu|
299420|NCT01883856|University of Virginia|Peter A. Netland, MD, PhD|4349821086|pan9c@virginia.edu|
299421|NCT01883895|UW Madison|Nalini Sehgal|608-263-8639|sehgal@rehab.wisc.edu|
299422|NCT01883986|VA Puget Sound Health Care System|Lynn F. Reinke, PhD, ARNP|206-277-4186|lynn.reinke1@va.gov|
299423|NCT01883999|W.L. Gore & Associates|Abe Letter|928-864-3113|aletter@wlgore.com|
299424|NCT01884025|Central Arkansas Veterans Healthcare System|Dr. Kristen Viverito|501-257-1699|KRISTEN.VIVERITO@VA.GOV|
299425|NCT01884064|University of Minnesota|Dr. Teresa Jacobson Kimberley|612-626-4096|tjk@umn.edu|
299426|NCT01884311|Bio Products Laboratory Ltd|European Medical Affairs Lead|+44 (0)20 8957 2200|medinfo@bpl.co.uk|
299427|NCT01884337|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
299428|NCT01884350|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
299429|NCT01884519|GlaxoSmithKline|GSK Response Center|866-435-7343||
299430|NCT01884545|NYU Rory Meyers College of Nursing|Allison A. Vorderstrasse, DNSc, APRN, FAAN|212-998-5786|allisonvorderstrasse@nyu.edu|
299431|NCT01884571|Emory University|Jonathan Glass, MD|404-727-3507|jglas03@emory.edu|
299432|NCT01884597|Retina Consultants of Hawaii, Inc.|Gregg Kokame, MD|(808) 487-8928|retinahi@aol.com|
299433|NCT01884675|GlaxoSmithKline|GSK Response Center|866-435-7343||
299434|NCT01884688|University of Arkansas for Medical Sciences|Frits van Rhee|501-526-6990|vanrheefrits@uams.edu|
299435|NCT01884844|Department of Psychiatry, Universtity of Massachusetts|Director of the Bipolar Disorders Specialty Clinic|508-334-5052|wendy.marsh@umassmemorial.org|
299436|NCT01885000|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
299437|NCT01885104|Merck Sharpe & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
299438|NCT01885117|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
299439|NCT01885182|Mundipharma (China) Pharmaceutical Co. LTD|Clinical study manager|0086-10-65636800|Wei.Zhu@mundipharma.com.cn|6900
299440|NCT01885195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299441|NCT01885208|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
299442|NCT01885559|Mayo Clinic|Dr. Vicente Torres||torres.vicente@mayo.edu|
299443|NCT01885871|Cutera, Inc|Clinical Research Department|1-888-428-8372|gweiss@cutera.com|
299444|NCT01885897|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-626-4024|mille011@umn.edu|
299445|NCT01885910|DermResearch, PLLC|Dr. Leon Kircik|502-451-9000|wedoderm@yahoo.com|
299446|NCT01885936|Duke University|Dwight Koeberl, M.D., Ph.D.|919-681-9919|dwight.koeberl@duke.edu|
299447|NCT01886105|Johns Hopkins University|Dr. Brian H. Ladle|443-287-3534|bladle@jhmi.edu|
299448|NCT01886235|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
309232|NCT02653300|Oramed Pharmaceuticals|Miriam Kidron, Ph.D.|+972-2-566-0100|miriam@oramed.com|
309233|NCT02653326|Universidad de Valparaiso|Carla Taramasco|2508306|carla.taramasco@uv.cl|+56 32
309234|NCT02653391|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
309235|NCT02653417|Radius Pharmaceuticals, Inc.|Clinical Operations|617-551-4000|clinopsinfo@radiuspharm.com|
309236|NCT02653456|Ra Medical Systems, Inc.|Vice President of Regulatory Affairs and Quality Assurance|877-635-1800|vchester@ramed.com|207
309237|NCT02653560|UT Southwestern Medical Center|Dr Wanpen Vongpatanasin|2146489078|wanpen.vongpatanasin@utsouthwestern.edu|
309238|NCT02653625|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
309239|NCT02653664|University of Washington|Dr. Mark Jensen|206-543-3185|mjensen@uw.edu|
309240|NCT02653768|Center to Accelerate Discovery and Practice Transformation, Durham VA|Kelli Allen, Associate Director|919-286-0411|kelli.allen@va.gov|177090
309241|NCT02653872|AstraZeneca AB|AZD7986 Global Clinical Leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
309242|NCT02654002|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
309243|NCT02654054|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309244|NCT02654145|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
309245|NCT02654314|Yale Center for Analytical Sciences|Jesse S Reynolds|(203) 785-5445|jesse.reynolds@yale.edu|
309246|NCT02654483|Stanford University|Irene Bailey, CRC|650-721-7149|baileyhi@stanford.edu|
309247|NCT02654652|Universidade Federal de Minas Gerais|Dr. Maria Isabel Correia|+55 31 34098033|isabel_correia@uol.com.br|
309248|NCT02654691|Aarhus University|Nanna Finnerup|0045 78463382|finnerup@clin.au.dk|
309249|NCT02654717|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|6093759900|srinivassidgiddi@drreddys.com|
309250|NCT02654769|Teva Pharmaceuticals Inc., USA|Senior Director, Clinical R&D|1-888-483-8279|USMedinfo@tevapharm.com|
309251|NCT02654808|Columbia University|Dr. Timothy Ryntz|212-305-4973|ter2111@cumc.columbia.edu|
309252|NCT02654860|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
309253|NCT02654977|University of Michigan|Dr. Elif Oral|734-615-7271|eliforal@umich.edu|
309254|NCT02655224|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
290049|NCT01281189|Knopp Biosciences|Head of Regulatory|4124881776|greg@knoppbio.com|
290050|NCT01281202|National Institute on Drug Abuse|David McCann, Ph.D.|301-443-2999|dmccann@nida.nih.gov|
290051|NCT01281306|Novartis|Study Director|862-778-8300||
290052|NCT01281475|Boston Children's Hospital|Wen-Hann Tan|617-355 6394|wen-hann.tan@childrens.harvard.edu|
290053|NCT01281501|Department of Medicine, Faculty of Medicine, Chulalongkorn University and King Chulalongkorn Memorial Hospital.|Khrongwong Musikatavorn, MD|+662-256-4000|kmusikatavorn@yahoo.com|4553-5
290054|NCT01281839|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
290055|NCT01281865|Memorial Sloan-Kettering Cancer Center|Dr. Mary Keohan|646-888-4160|keohanm@mskcc.org|
290056|NCT01281917|University of Wisconsin Carbone Cancer Center|Lymphoma Disease Oriented Team|608-265-5542|neils@wisc.edu|
290057|NCT01281956|National Institutes of Health|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
290058|NCT01281969|NIMH|Dr. David I. Driver|301.496.1683|david.driver@nih.gov|
290059|NCT01282086|Abbott (Ukraine)|Global Medical Services|1-800-633-9110||
290060|NCT01282138|Alcon Research|Head, Global Medical Affairs|1-800-862-5266|medinfo@alconlabs.com|
290061|NCT01282164|Cleveland Clinic|Dr. Amir H. Hamrahian|216-445-8555|hamraha@ccf.org|
290062|NCT01282203|AbbVie (prior sponsor Abbott)|Global Medical Services|1-800-633-9110||
290063|NCT01282229|Millenium Dental Technologies, Inc|Dr. David Harris|510-502-3345|dharris@LANAP.com|
299449|NCT01886287|H. Lee Moffitt Cancer Center and Research Institute|Jonathan Strosberg, M.D.|813-745-7257|jonathan.strosberg@moffitt.org|
290064|NCT01282242|Massachusetts General Hospital|Lee H. Schwamm, MD|617-724-1597|lschwamm@mgh.harvard.edu|
290065|NCT01282294|Synthes GmbH|Clinical Research Scientist|0041 32 720 44 65|clinicalaffairs.emea@synthes.com|
290066|NCT01282372|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
290067|NCT01282424|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
299450|NCT01886300|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
299451|NCT01886313|Winston Pharmaceuticals|Dr. Scott B. Phillips|8473628200|scott@winstonlabs.com|
309255|NCT02655237|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
309256|NCT02655354|University of Washington School of Medicine|Douglas Zatzick|206-744-6701|dzatzick@uw.edu|
309257|NCT02655419|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309258|NCT02655510|Mayo Clinic|Vijay Shah, M.D.|507-284-3917|Shah.Vijay@mayo.edu|
309259|NCT02655653|Montefiore Medical Centr|Dr. Jonathan Leff|7189205409|jleff@montefiore.org|
309260|NCT02655666|Medtronic Minimed|Willam Lv|86-21-20325454|william.lv@medtronic.com|
309261|NCT02655679|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
309262|NCT02655887|Becton Dickinson (BPV)|Megan Hill|480-350-6468|Megan.Hill@bd.com|
309263|NCT02656069|Xeris Pharamaceuticals, Inc.|Martin J. Cummins, VP, Clinical Development|806-282-2120|mcummins@xerispharma.com|
309264|NCT02656160|Brigham and women's Hospital|Andrew Wellman, MD, PhD||awellman@rics.bwh.harvard.edu|
309265|NCT02656173|Astellas Pharma Inc.|Medical Director|+81-3-3244-0512|astellas.resultsdisclosure@astellas.com|
309266|NCT02656290|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
309267|NCT02656329|GE Healthcare|Francois Tranquart, M.D., Ph.D.|0-44-1494-543037|francois.tranquart@ge.com|
309268|NCT02656420|JHSPH|Dr. Thomas W. Kensler|410-955-1292|tkensle1@jhu.edu|
309269|NCT02656485|AOBIOME|Masha Gaber|617-475-1605|mgaber@aobiome.com|
309270|NCT02656680|University of Connecticut|Dr. Sherry Pagoto|8604868979|sherry.pagoto@uconn.edu|
309271|NCT02656693|Brigham and Women's Hospital|Heather J. Baer, ScD|617-525-7503|hbaer@bwh.harvard.edu|
309272|NCT02656745|Click Therapeutics|Director of Scientific Affairs|646-844-2158|brian@clicktherapeutics.com|
309273|NCT02656836|Queen's University Belfast|Augusto Azuara-Blanco|2890976350|a.azuara-blanco@qub.ac.uk|
309274|NCT02656875|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
309275|NCT02657031|University Medical Center Emergency Department|Dr. Tony Zitek|7022247124|zitek10@gmail.com|
309276|NCT02657226|The University of Pittsburgh|Dr. John Kellum|4123834202|kas287@pitt.edu|
309277|NCT02657252|UPECLIN|Dr. Matheus Bertanha|+551438116305|matheus.fameca@ig.com.br|
309278|NCT02657369|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
309279|NCT02657408|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309280|NCT02657538|Department of Preventive, Restorative and Pediatric Dentistry, University of Bern|PD Dr. Klaus Neuhaus|+41 (0)31 632 49 74|klaus.neuhaus@zmk.unibe.ch|
309281|NCT02657564|Evergreen General Hospital|Dr. Chiliang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|1510
309282|NCT02657629|HackensackUMC|Nicole Spillane MD|917-446-6656|nspillane@hackensackumc.org|
309283|NCT02657889|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
309284|NCT02657915|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
309285|NCT02657928|Mayo Clinic|Gerardo Colon-Otero, MD|904/953-2000|gcolonotero@mayo.edu|
309286|NCT02658019|University of Miami|Lynn G. Feun, MD|305-243-6606|lfeun@med.miami.edu|
309287|NCT02658084|University of Miami|Dr. Reshma Mahtani|954-698-3639|rmahtani@miami.edu|
290068|NCT01282463|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
290069|NCT01282476|Massachusetts General Hospital Cancer Center|Jeremy Abramson, MD|617-724-4000|jabramson@mgh.harvard.edu|
309288|NCT02658149|Beaumont Health|Dr. James Verner|1(248)551-9722|jverner1@aol.com|
309289|NCT02658175|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
290070|NCT01282710|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
290071|NCT01282723|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
290072|NCT01282801|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
290073|NCT01282814|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
290074|NCT01282866|Laser & Skin Surgery Medical Group Inc.|Suzanne Kilmer, MD|916-456-0400|Study@skinlasers.com|
290075|NCT01283009|Memphis VA Medical Center|Dr. Gianfranco U. Meduri|(901) 577-7520|Gianfranco.Meduri@va.gov|
290076|NCT01283022|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
299452|NCT01886378|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
290077|NCT01283035|DFCI|Joyce Liu, MD, MPH|617-632-5269|joyce_liu@dfci.harvard.edu|
290078|NCT01283139|MedImmune, LLC|Gabor Illei, MD, Senior Director, Clinical Development|301-398-0000|IlleiG@Medimmune.com|
290079|NCT01283152|Baylor University Medical Center|Robert S. Rahimi, M.D., M.S.C.R. Assistant Professor, Department of Medicine|214-820-8500|Robert.Rahimi@Baylorhealth.edu|
290080|NCT01283282|Emory University|Dr. Arshed Quyyumi|404-727-3655|aquyyum@emory.edu|
290081|NCT01283321|University of Maryland|Dr. Kenichi Tanaka|412-328-0205|ktanaka@anes.umm.edu|
290082|NCT01283334|Emory University|Nabil F. Saba, MD|404-778-1900|nfsaba@emory.edu|
290083|NCT01283386|Hoffmann-LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
290084|NCT01283464|Johns Hopkins Dermatology|Dr. Anna L. Chien|4105027546|ctrep@jhmi.edu|
290085|NCT01283516|Novartis Pharmaceuticals|Study Director|862-778-8300||
290086|NCT01283542|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
290087|NCT01283555|PATH|Jessica Cohen|206-285-3500|jcohen@path.org|
290088|NCT01283581|Melinta Therapeutics|Dr. Sue Cammarata|312-724-9401|scammarata@melinta.com|
290089|NCT01283971|Hoffman-LaRoche|Medical Communications|800-821-8590||
290090|NCT01284062|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299453|NCT01886690|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
290091|NCT01284114|Division of Nephrology, Department of Internal Medicine, Jichi Medical University|Dr. Yoshiyuki Morishita|81-285-58-7346|ymori@jichi.ac.jp|
290092|NCT01284127|Johns Hopkins University|Michael Levy|443-287-4612|mlevy@jhmi.edu|
290093|NCT01284140|University of Iowa|Brian K. Gehlbach, MD|319-356-3603|brian-gehlbach@uiowa.edu|
290094|NCT01284244|Mount Sinai Hospital|Dr. Danny Lovatsis|416-586-4566|danny.lovatsis@sinaihealthsystem.ca|
299454|NCT01886716|Miami University|Dr. Elise Clerkin|513-529-2483|clerkiem@miamioh.edu|
299455|NCT01886781|University of Stellenbosch, South Africa|Cheryl Stevenson|0827514411|cheryl@retaildc.co.za|
299456|NCT01886807|UTSouthwestern Medical Center|Dr. Jeffrey Steiner, PI|214-456-0606|jeffrey.steiner@utsouthwestern.edu|
299457|NCT01886833|CIDRZ|Dr. Roma Chilengi|+2609173724935|Roma.Chilengi@cidrz.org|
299458|NCT01886937|New York State Psychiatric Institute|Dr. Laurel Mayer|646-774-8067|lsm16@cumc.columbia.edu|646
299459|NCT01886963|Carolinas HealthCare System|Dr. Todd Heniford|7043551813|todd.heniford@carolinashealthcare.org|
299460|NCT01887132|National Institute of Mental Health (NIMH)|Ashura W Buckley|(301) 496-5190|shu.buckley@nih.gov|
299461|NCT01887171|Republican scientific and practical center for organ and tissue transplantation|Aliaksej Shcherba|+375293330689|aleina@tut.by|
299462|NCT01887210|Rhode Island Hospital|Dr. Larry Brown|401-793-8808|lkbrown@lifespan.org|
299463|NCT01887327|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|ClinicalTrials@mnk.com|5
299464|NCT01887353|Intermountain Healthcare|T. Jared Bunch|8015074701|jared.bunch@imail.org|
299465|NCT01887418|Antares Pharma Inc.|Jonathan Jaffe, MD; Vice President Clinical Development|609-329-3020|jjaffe@antarespharma.com|324
299466|NCT01887470|Cumberland Pharmaceuticals, Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
299467|NCT01887587|Medical College of Wisconsin|Ehab Atallah, MD|414-805-8900|eatallah@mcw.edu|
299468|NCT01887600|Astellas Pharma Europe B.V. (APEB)|Clinical Trial Disclosure|31 (0) 715455050|astellas.resultsdisclosure@astellas.com|
299469|NCT01887678|Biologische Heilmittel Heel GmbH|Christine Frank, PhD, Global Clinical Project Manager|+49 7221 501 3188|christine.frank@heel.com|
299470|NCT01887717|BTG International Inc.|Manager of Clinical Development|613-801-1844|TheraSphereClinical@btgplc.com|
299471|NCT01887912|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
299472|NCT01887990|University of Cincinnati|Cheryl McCullumsmith|513-5588022|cheryl.mccullumsmith@uc.edu|
299473|NCT01888003|University of Alabama at Birmingham Department of Anesthesiology and Perioperative Medicine|Dr. Thomas Vetter|205.934.6501|tvetter@uab.edu|
299474|NCT01888367|Promius Pharma, LLC, Dr. Reddy's Laboratories|VP, Drug Development|609-375-9855|kallenby@drreddys.com|
299475|NCT01888432|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
299476|NCT01888484|Clinical Research Management Group|Mikaela Raymond|866-337-1868|ctgov@cllinicalresearchmgt.com|
299477|NCT01888497|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299478|NCT01888640|University of Iowa|Dr. Kathleen A. Sluka|319-335-9791|kathleen-sluka@uiowa.edu|
299479|NCT01888874|Galapagos N.V.|Clinical Trial Information Desk|+32 (0)15 342 900|rd@glpg.com|
299480|NCT01888900|National Institute of Diabetes and Digestive and Kidney Diseases|Dr. Marc Ghany|301-402-5515|marcg@mail.nih.gov|
299481|NCT01888952|CTRC@UTHSCSA|Anand Karnad, MD|210-450-1000|karnad@uthscsa.edu|
299482|NCT01888965|Georgetown Lombardi Comprehensive Cancer Center|John L Marshall|202 444 7064|marshalj@georgetown.edu|
299483|NCT01889069|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
299484|NCT01889238|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
290095|NCT01284296|University of California, San Francisco|Ronald D. Miller|415 476-9034|millerr@anesthesia.ucsf.edu|
290096|NCT01284335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
290097|NCT01284361|Hollister Incorporated|Malford Cullum PhD/Sr Clin Res Scientist|847-918-3975|malford.cullum@hollister.com|
290098|NCT01284426|Division of Allergy and Immunology, Department of Pediatrics, Siriraj Hospital, Mahidol University|Professor Orathai Jirapongsananuruk, Director of Clinical Trials|024197000|siojr@mahidol.ac.th|
299485|NCT01889251|Alcon Japan, Ltd.|Group Manager, Clinical Development|+81368995277||
290099|NCT01284517|Sunovion|Medical Director, CNS|1-866-503-6351||
290100|NCT01284621|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290101|NCT01284634|GW Research Ltd|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
290102|NCT01284959|Chonbuk National University Hospital|Prof. Youngchul Chung|+82-63-250-2185|chungyc@chonbuk.ac.kr|
290103|NCT01285024|Cleveland Clinic|President and CEO Cleveland Clinic Florida|216-444-7515|barsouw@ccf.org|
290104|NCT01285050|Johns Hopkins University|David Thomas|410-502-6043|dthomas@jhmi.edu|
290105|NCT01285076|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290106|NCT01285310|Celgene Corporation|Anne McClain|888-260-1599|clinicaltrialdisclosure@celgene.com|
290107|NCT01285323|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
290108|NCT01285349|Social Intervention Group|Dr. Nabila El-Bassel|212-851-2391|ne5@columbia.edu|
290109|NCT01285401|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
290110|NCT01285427|Life Technologies|Deanna Vella, Staff Regulatory Engineer|760-918-3000|deanna.vella@lifetech.com|
290111|NCT01285492|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
299486|NCT01889355|AgaMatrix, Inc|Senior Clinical Research Technician|603-328-6035|krocha@agamatrix.com|
299487|NCT01889563|Federal university of Sao Carlos|Audrey Borghi e Silva|+55 163351-8952|audrey@ufscar.br|
299488|NCT01889602|University of Minnesota|Dr. Susan Marino|612-624-2964|marin007@umn.edu|
299489|NCT01889667|Oramed|Chief Scientific Officer|+972-2-566-0001|aviva@oramed.com|
299490|NCT01889797|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3627|jmanola@jimmy.harvard.edu|
309290|NCT02658240|UT Southwestern Medical Center|Irina Gasanova|4694191997|Irina.Gasanova@UTSouthwestern.edu|
309291|NCT02658448|Oncternal|Mary Breitmeyer|858-434-1113|MBreitmeyer@oncternal.com|
309292|NCT02658461|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
309293|NCT02658487|Vanderbilt University Medical Center|Stephen Strickland, MD|(615) 936-8422|stephen.strickland@vumc.org|
309294|NCT02658630|VA Pittsburgh Healthcare System|George F. Wittenberg|412-648-4178|GeoWitt@Pitt.edu|
309295|NCT02658734|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
309296|NCT02658851|Apyx Medical|Kari Larson|8012440058|kari.larson@apyxmedical.com|
309297|NCT02658994|Human Development Research Foundation|Siham Sikander|+923330590373|sihamsikander@gmail.com|
309298|NCT02659020|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
309299|NCT02659059|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
309300|NCT02659098|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
309301|NCT02659150|Massachusetts General Hospital|Ahmed Tawakol, MD|617-724-3699|atawakol@mgh.harvard.edu|
309302|NCT02659501|Loma Linda University, Department of Plastic Surgery|Saba Motakef, Resident Physican|714-925-8932|smotakef@llu.edu|
309303|NCT02659540|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@lcr.org|
309304|NCT02659631|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309305|NCT02659709|Wills Eye Hospital, Glaucoma Service|Dr. Jonathan S. Myers|215-928-3197|jmyers@willseye.org|
309306|NCT02659787|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
309307|NCT02659943|National Cancer Institute|Dr. James N. Kochenderfer|240-760-6062|kochendj@nih.gov|
309308|NCT02660112|Mayo Clinic|Ralitza H. Gavrilova, M.D.|507-293-1283|Gavrilova.Ralitza@mayo.edu|
309309|NCT02660138|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
309310|NCT02660229|Mundipharma Korea Ltd.|Mrs Suyoun Yang/CR head|82-2-527-9219|suyoun.yang@mundipharma.co.kr|
309311|NCT02660242|Jaeb Center for Health Research|Stephanie DuBose|813.975.8690|sdubose@jaeb.org|
309312|NCT02660359|Ipsen|Medical Director|See email|clinical.trials@ipsen.com|
309313|NCT02660489|Imperial College London|Professor Sebastian Johnston|+44 (0)20 7594 3764|s.johnston@imperial.ac.uk|
309314|NCT02660580|Fresenius Kabi SwissBioSim GmbH|Eugenia Kunina, senior clinical development manager|+41791093376|clinical.development@fresenius-kabi.com|
309315|NCT02660788|BC Cancer|Dr. Alan Nichol|604-877-6046|anichol@bccancer.bc.ca|
309316|NCT02660801|UQTR|Pr Martin Descarreaux|819-376-5011|martin.descarreaux@uqtr.ca|3791
309317|NCT02660853|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
309318|NCT02660918|Christiana Care Health System|Dr. Matthew Hoffman Chair Department of OB/GYN|302 733 3350|mhoffman@christianacare.org|
309319|NCT02660944|Resolve Therapeutics LLC|James Posada|(208)7277010|jp@resolvebio.com|
309320|NCT02660983|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
309321|NCT02661061|Trinity College Dublin|Dr Martha Finnegan|0863638264|mfinneg@tcd.ie|
299491|NCT01889862|BioMarin Pharmaceutical Inc|Debra Lounsbury/Sr Principle Scientist, Clinical Sciences|415-506-6348|Dlounsbury@bmrn.com|
309322|NCT02661126|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290112|NCT01285518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290113|NCT01285609|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
299492|NCT01890031|University of Rochester|Robert Block, MD, MPH; Clinical Trial Director|585-275-3356|robert_block@urmc.rochester.edu|
290114|NCT01285635|University of Michigan Cancer Center|Dr. Francis Worden, M.D.|734-936-0453|fworden@umich.edu|
290115|NCT01285713|New York University, Langone Medical Center|Dr. Kari Posner|212-263-7300|kariposner@gmail.com|
290116|NCT01285791|Hadassah Medical Organization|Dr Ido Mizrahi|+972-2-5844550|idomiz17@gmail.com|
290117|NCT01285843|Medacta International|Ing. Elisa Bonacina, Clinical Data Manager|+41 91 696 60 60|bonacina@medacta.ch|
290118|NCT01285908|National Institute of Neurological Disorders & Stroke|Dr. David S. Goldstein||david.goldstein1@nih.gov|
290119|NCT01285960|InSightec|Nadir Alikacem|214-630-2000|nadira@insightec.com|
290120|NCT01286012|Rockwell Medical|Raymond Pratt, MD CMO|248 960 9009|rd@rockwellmed.com|
290121|NCT01286077|Janssen-Cilag Greece|EMEA Medical Affairs Director|+30 210 8090738||
290122|NCT01286129|IUCPQ|Louis-Philippe Boulet, principal investigator|418-656-4747|lpboulet@med.ulaval.ca|
290123|NCT01286168|Mayo Clinic|Dr. Amy C. Degnim|507-284-6357|Degnim.Amy@mayo.edu|
290124|NCT01286259|University of California, San Francisco|Steven G. Deeks|(415) 476-4082|Steven.Deeks@ucsf.edu|
290125|NCT01286311|Northwestern University|Stephen D. Persell, MD MPH|312-503-6464|spersell@nmff.org|
290126|NCT01286324|University of Michigan|Suzanna M Zick|734-998-9553|szick@umich.edu|
290127|NCT01286402|University of Texas Health Science Center at Houston|Angela Stotts, PhD, PI|713-500-7590|Angela.L.Stotts@uth.tmc.edu|
290128|NCT01286441|Santalis Pharmaceuticals|Dr. Paul Castella Ph.D.|210-399-2316|paulc@santalispharma.com|101
290129|NCT01286454|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290130|NCT01286480|University of Alberta|Dr. Andrew Mackie|780-407-8361|andrew.mackie@ualberta.ca|
290131|NCT01286493|Queen Saovabha Memorial Institute|Dr.Suda Sibunruang|+66 2 2520161|sudapunrin@gmail.com|125
290132|NCT01286558|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290133|NCT01286740|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
290134|NCT01286753|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
299493|NCT01890109|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
290135|NCT01286779|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
290136|NCT01286805|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
290137|NCT01286818|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299494|NCT01890122|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
290138|NCT01286870|Mentor Worldwide, LLC|Laura Vellucci|(805) 879-6000|lvelucci@its.jnj.com|
290139|NCT01286987|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290140|NCT01287013|National Institutes of Health|Bradford Wood, MD|(301) 496-7739|bwood@nih.gov|
290141|NCT01287039|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
290142|NCT01287065|GlaxoSmithKline|GSK Response Center|866-435-7343||
290143|NCT01287078|National Heart Lung and Blood Institute|Dr Richard Childs|301-451-7128|childsr@nhlbi.nih.gov|
290144|NCT01287104|National Cancer Institute|Dr. Nirali N. Shah|301-451-0390|shahnn@nih.gov|
290145|NCT01287117|Genentech, Inc.|Medical Communications|800 821-8590||
290146|NCT01287195|Brigham and Women's Hospital|Scott B. Snapper, M.D., Ph.D.|617-919-4973|ssnapper@partners.org|
290147|NCT01287208|Massachusetts General Hospital|Anne Thorndike, MD, MPH|617-724-4608|athorndike@partners.org|
290148|NCT01287221|Mayo Clinic|Dr. Phillip A. Low|507-284-3375|low@mayo.edu|
299495|NCT01890148|AstraZeneca|Larsson, Bengt|+46 (0) 317064277|ClinicalTrialTransparency@astrazeneca.com|
299496|NCT01890226|Emory University|Dr. Benjamin Druss|404-712-9602|bdruss@emory.edu|
299497|NCT01890265|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441|067study@fibrogen.com|
299498|NCT01890343|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
299499|NCT01890421|Bayer|Therapeutic Area Head|+1 888-8422937|clinical-trials-contact@bayer.com|
299500|NCT01890434|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
299501|NCT01890473|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
299502|NCT01890512|Guidant Europe SA/NV A Boston Scientific Company|Giovanni Raciti|+39 02 26983213|giovanni.raciti@bsci.com|
299503|NCT01890642|Medical College of Wisconsin|Maren Lunoe|414-266-2625|mlunoe@mcw.edu|
299504|NCT01890707|Northwestern University|Shireen Ahmad MD|312-472-3585|sahmad@northwestern.edu|
299505|NCT01890746|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
299506|NCT01890759|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
299507|NCT01890785|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
299508|NCT01890915|James J. Peters VA Medical Center|Dr. John P. Handrakis|718-584-9000|john.handrakis@va.gov|5439
299509|NCT01890954|University of Virginia|Daniel Chernavvsky|434-243-1395|drc2v@virginia.edu|
299510|NCT01890967|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299511|NCT01891305|Viamet Pharmaceuticals Inc|Neil Moore||nmoore@viamet.com|
299512|NCT01891331|Viamet Pharmaceuticals Inc|Neil Moore||nmoore@viamet.com|
299513|NCT01891357|on behalf of Westdeutsche Studiengruppe GmbH|Anja Braschoss, Consultant Clinical Research and Medical Writing|0049-176-82119153|anja.braschoss@wsg-online.com|
299514|NCT01891669|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
299515|NCT01891721|VA Greater Los Angeles Healthcare System|Dr. Carol Jahchan|310-478-3711|carol.jahchan@va.gov|42953
299516|NCT01891734|Department of Veterans Affairs San Diego|Kathleen Grubbs|808-383-9757|kathleen.grubbs@va.gov|
290149|NCT01287364|Sunovion|Respiratory Medical Director|1-866-503-6351||
290150|NCT01287377|UCSD|Dr. Shu-Hong Zhu|8583001056|szhu@ucsd.edu|
290151|NCT01287403|Clinical Development Unit / Metabolic Unit|Dr Maurice Beaumont, MD, PhD|+41217858054|maurice.beaumont@rdls.nestle.com|
290152|NCT01287416|University of Manitoba|Shay-Lee Bolton|204-787-5082|sbolton@hsc.mb.ca|
290153|NCT01287520|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
290154|NCT01287611|DrLutfi|Dr. Cem Turan|00905323513423|cemturan@gmail.com|
290155|NCT01287754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
290156|NCT01287832|St. John Hospital and Medical Center|Leonard Johnson MD|3133438823|leonard.johnson@stjohn.org|
290157|NCT01287897|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290158|NCT01288027|Sanofi|Trial Transparency Team||Contact-us@sanofi.com|
290159|NCT01288053|Northwestern University|Dr Richard Burt|312-695-4960|rburt@northwestern.edu|
290160|NCT01288079|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
290161|NCT01288209|Janssen Pharmaceutical K.K., Japan|Manager|81 3 44115639||
290162|NCT01288287|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
290163|NCT01288430|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
290164|NCT01288443|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
290165|NCT01288469|Sanofi|Trial Transparency Team||Contact --US@sanofi.com|
290166|NCT01288521|University of Iowa|Sony Tuteja, Pharmd|215-573-7834|sony.tuteja@gmail.com|
290167|NCT01288534|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, M.D.|734-936-9630|sprattda@med.umich.edu|
290168|NCT01288612|Mayo Clinic|Prasad G. Iyer|507-284-6469|iyer.prasad@mayo.edu|
290169|NCT01288729|Stanford Childrens Health|Bruce Buckingham|650725-6549|buckingham@stanford.edu|
290170|NCT01288781|UWalesBangor|Mr Justin Stevan Lawley|00441248382810|pepa16@bangor.ac.uk|
290171|NCT01288807|UCSD|Tobias Moeller-Bertram (PI)|7603211315|moellerbertram@yahoo.com|
290172|NCT01288833|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|94121
290173|NCT01288859|University of Naples|Prof. Vincenzo Fogliano|+39 0812539356|fogliano@unina.it|
290174|NCT01288911|Astellas Pharma Global Development, Inc. (APGD)|Executive Medical Director||Astellas.resultsdisclosure@astellas.com|
299517|NCT01891864|Sandoz|Dr Guido Wuerth - Global Program Medical Director|+4980244762925|guido.wuerth@sandoz.com|
299518|NCT01891890|Emory University|David Loring, PhD|404-778-5943|dloring@emory.edu|
299519|NCT01891968|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero, MD|713-745-3428|CR_Study_Registration@mdanderson.org|
299520|NCT01891994|National Heart Lung and Blood Institute|Dunbar, Cynthia|+1 301 827 1164|dunbarc@nhlbi.nih.gov|
299521|NCT01892007|NIHR Nottingham Biomedical Research Centre, University of Nottingham|Dr Helen Henshaw|+44 (0)115 8232606|helen.henshaw@nottingham.ac.uk|
299522|NCT01892020|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
299523|NCT01892163|Moorfields Eye Hospital NHS Foundation Trust|Professor Sobha Sivaprasad|02072533411|sobha.sivaprasad@moorfields.nhs.uk|
299524|NCT01892189|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
299525|NCT01892267|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
299526|NCT01892293|Adaptimmune|Clinical Trials Management||clinicaltrials@adaptimmune.com|
299527|NCT01892306|Massachusetts General Hospital|Kristen Ellard, PhD|617-726-6422|kellard@partners.org|
299528|NCT01892345|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
299529|NCT01892436|Novartis Pharmaceuticals|Clinical Disclosure Office|+1 (862) 778-8300|novartis.email@novartis.com|
299530|NCT01892501|Institute Bergonie|Dr. Dominique Bechade, Coordinating Investigator|0556337805|d.bechade@bordeaux.unicancer.fr|
299531|NCT01892540|University Hospitals|Philipp Frank Graner|+1 216-844-8275|philipp.graner@uhhospitals.org|
299532|NCT01892657|Galderma Laboratories, L.P.|Elizabeth M. Nieman, Medical Information Specialist|817-961-5130|elizabeth.nieman@galderma.com|
299533|NCT01892709|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7476|achang@montefiore.org|
299534|NCT01892865|Michael E. DeBakey VAMC|Panos Kougias MD MSc|713.794.7700|panagiotis.kougias@va.gov|
299535|NCT01893203|Helsinki university hospital|Noora Neittaanmäki-Perttu|+358407190362|noora.neittaanmaki@fimnet.fi|
299536|NCT01893281|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299537|NCT01893346|AstraZeneca Pharmaceuticals|Paul Newell, MBBS MRCP MFPM|+44 1625 515727|paul.newell@astrazeneca.com|
299538|NCT01893372|The Universtiy of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
299539|NCT01893411|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
299540|NCT01893567|Galderma Laboratories, L.P.|Senior Clinical Project Manager|817-961-5000|jay.mashburn@galderma.com|
299541|NCT01893632|NYSPI|john mariani, md|646-774-6140|john.mariani@nyspi.columbia.edu|
299542|NCT01893801|Cancer Research and Biostatistics|Adam Rosenthal|(206) 839-1797|adamr@crab.org|
299543|NCT01893827|NYU Langone Health|Mia Malone|646-501-3577|mia.malone@nyulangone.org|
299544|NCT01893879|Stanford University|Leslie Roche, RN|650-723-1396|lesroche@stanford.edu|
299545|NCT01893905|Complejo Hospitalario de La Coruña (CHUAC)|Dr Francisco Blanco, study coordinator|981 17 80 00|fblagar@sergas.es|
299546|NCT01893983|San Francisco VA Healthcare System|Dr. Karen Seal|415-2214810|karen.seal@va.gov|24852
299547|NCT01894022|GlaxoSmithKline|GSK Response Center|866-435-7343||
299548|NCT01894087|University of Michigan|Amy Bohnert|734-845-3638|amybohne@med.umich.edu|
309323|NCT02661178|Drugs for Neglected Diseases initiative|Sophie Delhomme|+41229069230|sdelhomme@dndi.org|
290175|NCT01288937|Columbia University|Thomas H. Brannagan, MD|(212) 305-0405|tb2325@cumc.columbia.edu|
290176|NCT01288976|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
290177|NCT01288989|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
290178|NCT01289015|Merz Pharmaceuticals, LLC|Stefan Plaum, MD Associate Medical Director|800-334-0514|clinicaltrials@merzusa.com|
290179|NCT01289028|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
290180|NCT01289041|Novartis Pharmaceuticals|Study Director|862-778-8300||
290181|NCT01289067|Icahn School of Medicine at Mount Sinai|Dr. Bobby Liaw|(212) 604-6010|bobby.liaw@mountsinai.org|
290182|NCT01289080|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
290183|NCT01289119|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
290184|NCT01289210|VentiRx Pharmaceuticals Inc.|Kristi Manjarrez, Vice President, Clinical Affairs|206-689-2259|kmanjarrez@ventirx.com|
299549|NCT01894100|University of North Carolina at Chapel Hill|Yvonne M. Golightly, PT, PhD|919-966-0566|golight@email.unc.edu|
290185|NCT01289275|UC San Diego, California Smokers' Helpline|Sharon Cummins, Ph.D.|8583001046|scummins@ucsd.edu|
299550|NCT01894152|Abbott Vascular|Roy Leong|+65 (6277) 3202|roy.leong@abbott.com|
290186|NCT01289353|NYU Langone Health - PCC CTO|Carmen Perez, MD, PhD|212-731-5003|carmen.perez@nyulangone.org|
290187|NCT01289392|Associação Fundo de Incentivo à Pesquisa|Dr Teresa Cristina Barros Schutz|55-21-99868033|schutzferraz@gmail.com|
290188|NCT01289418|Laval University|Gaston De Serres|418-666-7000|gaston.deserres@ssss.gouv.qc.ca|274
290189|NCT01289431|Bausch Health|Study Director||susan.harris@bauschhealth.com|
290190|NCT01289457|The University of Texas M D Anderson Cancer Center|Jabbour,Elias Joseph, M.D./Associate Professor|713-792-4764|CR_Study_Registration@mdanderson.org|
290191|NCT01289522|Centre Antoine Lacassagne|Pr. Joël GUIGAY|+33492031000|joel.guigay@nice.unicancer.fr|
290192|NCT01289548|Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology|Hua zheng|00862783663173|huaz1980@hotmail.com|
290193|NCT01289574|AndroScience Corp|Charles CY Shih, PhD|(858) 638-7230|cyshih@androscience.com|
290194|NCT01289639|VA Puget Sound Health Care System|Kristina Utzschneider|206-277-3568|kutzschn@u.washington.edu|6-3568
290195|NCT01289665|AdventHealth|Dr. Ashley Hill|407-303-1444|Ashley.Hill.MD@adventhealth.com|
290196|NCT01289678|Brody School of Medicine|Paul R. Walker, MD|2527441888|walkerp@ecu.edu|2527441888
290197|NCT01289782|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
290198|NCT01289821|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
290199|NCT01289847|Bio Products Laboratory|Head of Medical Affairs|+44 20 8957 2200|medinfo@bpl.co.uk|
299551|NCT01894178|Baylor College of Medicine|Dr. Lee Chang|713-873-4321|lcchang@bcm.edu|
309324|NCT02661217|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
309325|NCT02661256|NYU-Winthrop Hospital|Nazeeh Hanna, MD|6314211424|nazeehhanna@gmail.com|
309326|NCT02661490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
309327|NCT02661594|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-919764|GabrielFox@acaciapharma.com|
309328|NCT02661737|LG Chem|Study Leader|82-2-6987-4148|sodam@lgchem.com|
309329|NCT02661815|Dana-Farber Cancer Insitute|Dr. Joyce Liu|617-632-5269|joyce_liu@dfci.harvard.edu|
309330|NCT02661828|Emory University|Boadie Dunlop, MD|404-727-8474|vcruz@emory.edu|
309331|NCT02662023|University of California, San Diego|Brian M. Ilfeld, MD, MS||bilfeld@ucsd.edu|
309332|NCT02662036|Washington University School of Medicine|Terence Myckatyn, M.D.|314-996-8800|myckatyn@wustl.edu|
309333|NCT02662244|UCSD|Dr. Arisa Ortiz|858-657-1697|dermstudies@ucsd.edu|
309334|NCT02662387|Loma Linda University Children's Hospital|Dr. Janeth Ejike|9095584000|jejike@llu.edu|44250
309335|NCT02662556|AcelRx Pharmaceuticals, Inc.|Pamela P. Palmer, MD, PhD, Chief Medical Officer|650-216-3504|ppalmer@acelrx.com|
309336|NCT02662569|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
309337|NCT02662582|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
309338|NCT02662608|The University of Texas (UT) MD Anderson Cancer Center|Dr. Renata Ferrarotto, Asst Professor/Thoracic/Head & Neck Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
309339|NCT02662764|AcelRx Pharmaceuticals, Inc|Pamela Palmer, MD, PhD|650-216-3504|ppalmer@acelrx.com|
309340|NCT02663128|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
309341|NCT02663232|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
309342|NCT02663453|Thammasat University|Dr.Wilaiporn Techasatid|66890339442|wilaiporn66@gmail.com|
309343|NCT02663674|Duke Clinical Vaccine Unit|Emmanuel Walter, M.D., M.P.H.|919-620-5346|walte002@mc.duke.edu|
309344|NCT02663687|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
309345|NCT02663817|University of Miami|Dr. Ivaylo Mihaylov|305-243-8223|i.mihaylov@med.miami.edu|
309346|NCT02663882|Yeshiva University|Dr. Andrea Weinberger|(646) 592-4474|andrea.weinberger@yu.edu|
309347|NCT02663895|Stanford University|Dr. Lorinda Chung|(650) 723-6961|shauwei@stanford.edu|
309348|NCT02664220|McGovern Medical School, University of Texas Health Sciences Center at Houston|Dr. Kuojen Tsao|713-500-7300|Kuojen.Tsao@uth.tmc.edu|
309349|NCT02664272|Smith & Nephew, Inc.|Vice President of Medical Affairs|+41 41 7662222|luca.orlandini@smith-nephew.com|
290200|NCT01289912|Boston Children's Hospital|Dr. Mustafa Sahin|617-355-8994|Mustafa.Sahin@childrens.harvard.edu|
290201|NCT01289990|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdf@boehringer-ingelheim.com|
290202|NCT01290029|Amgen Inc.|Study Director|866-572-6436||
299552|NCT01894230|Duke University|Dr. Deepak Voora|919-668-1755|Deepak.vorra@duke.edu|
299553|NCT01894243|AstraZeneca|Anitra Fielding - Senior Research Physician||ClinicalTrialTransparency@astrazeneca.com|
299554|NCT01894256|AstraZeneca|Dr Anitra Fielding|+44 1625 582828|anitra.fielding@astrazeneca.com|
299555|NCT01894477|Fred Hutchinson Cancer Research Center|Eileen J Sickle|206-271-7066|esickle@fredhutch.org|
309350|NCT02664311|Beth Israel Deaconess Medical Center|Eleanor Greene|617-667-1836|ergreene@bidmc.harvard.edu|
290203|NCT01290068|Alcon Research, Ltd.|Brand Lead, Surgical, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
290204|NCT01290094|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
290205|NCT01290224|Mayo Clinic|Dr. Charles L. Loprinzi|507-284-2511|cloprinzi@mayo.edu|
290206|NCT01290237|Boston Children's Hospital|Dr. Alicia Demirjian||alicia.demirjian@post.harvard.edu|
290207|NCT01290263|Dana-Farber Cancer Institute|David A. Reardon, MD|617-632-2166|dreardon3@partners.org|
290208|NCT01290315|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@luitpold.com|811
290209|NCT01290341|Merz Pharmaceuticals, LLC|Stefan Plaum, MD Associate Medical Director|800-334-0514|clinicaltrials@merzusa.com|
290210|NCT01290445|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290211|NCT01290484|Stanford University|Dr. Alfred Lane|650-721-7170|alfred.lane@stanford.edu|
290212|NCT01290523|University of California San Francisco Department of Radiology|Dr Nicholas Fidelman|(415) 353-1300|Nicholas.Fidelman@ucsf.edu|
290213|NCT01290536|University of California San Francisco|Nicholas Fidelman, MD|1-415-353-1300|Nicholas.Fidelman@ucsf.edu|
290214|NCT01290601|WRAIR|Shirley Lee-Lecher|301-251-5000|usarmy.detrick.medcom-wrair.mbx.ocid@mail.mil|
290215|NCT01290614|University of Minnesota|Paul Drawz, MD|6126255423|draw0003@umn.edu|
290216|NCT01290627|The University of Tennessee|Richard Komistek, Ph. D.|86598744159|rkomiste@utk.edu|
299556|NCT01894503|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
290217|NCT01290640|The University of Tennessee|Dr. Richard Komistek, Professor|865-974-4159|rkomiste@utk.edu|
290218|NCT01290666|University of California, Irvine|Michael J Stamos, MD|888-532-4123||
290219|NCT01290679|Jan-Cil France|Global Clinical Development Manager||ClinicalTrialDisclosure@its.jnj.com|
290220|NCT01290731|Janssen Pharmaceutical K.K., Japan|Manager|81 3 44115639||
290221|NCT01290757|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290222|NCT01290796|Bard Medical Division|Jaime Ritter, MPH, CCRP, CIC|770-784-6437|jaime.ritter@crbard.com|
290223|NCT01290874|Brigham and Women's Hospital|Dr. Elliot Israel|6177328201|eisrael@partners.org|
290224|NCT01290887|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
290225|NCT01290913|Boston Children's Hospital|Clinical Coordinator|6173556127|sara.little@childrens.harvard.edu|
290226|NCT01290952|Azienda Ospedaliera Luigi Sacco|Dr. Massimo Lemma|0039 0239042876|lemma.massimo@hsacco.it|
290227|NCT01290978|cyberDERM Clinical Studies|Dr. Gary Grove|610-325-0112||
290228|NCT01291017|University of Florida|Priya K Gopalan, MD|352-273-8699|gopalpk@ufl.edu|
290229|NCT01291056|University of Utah Department of Obstetrics & Gynecology|Dr. Jessica Pittman|801-339-4103|jessica.pittman@hsc.utah.edu|
290230|NCT01291108|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
290231|NCT01291160|Ogenix|S.Sarangapani|7817026732|ssarangapani@ogenix.com|
299557|NCT01894516|Galapagos N.V.|Clinical Trial Information Desk|+32 (0)15 342 900|rd@glpg.com|
290232|NCT01291173|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
290233|NCT01291225|Center for Injury Research and Policy|Dr. Gary Smith|614-355-5850|Gary.Smith@Nationwidechildrens.org|
290234|NCT01291264|University of California, San Francisco|Dr. Julius Schachter, Professor of Laboratory Medicine|415 824 5115|julius.schachter@ucsf.edu|
290235|NCT01291277|Yale School of Medicine|Dr. Loren Laine|203-937-3462|loren.laine@yale.edu|
290236|NCT01291498|Oxford University Hospitals NHS Trust|Mr Radu Mihai||radu.mihai@ouh.nhs.uk|
290237|NCT01291784|Icahn School of Medicine at Mount Sinai|Dr. John O. Mascarenhas|212-241-6756|john.mascarenhas@mssm.edu|
290238|NCT01291836|Alere San Diego|William Arnold|858-505-2000|william.arnold@alere.com|
290239|NCT01292005|Mayo Clinic|Dr. Santhi Swaroop Vege|507-284-2175|vege.santhi@mayo.edu|
290240|NCT01292057|Medical University of South Carolina|Joseph Schacht, Ph.D.|(843) 792-7497|schacht@musc.edu|
290241|NCT01292135|Pharmacyclics|Thorsten Graef, MD|855.427.8846|medinfo@pcyc.com|
290242|NCT01292187|Tarsa Therapeutics, Inc.|Dr. David Krause, Chief Medical Officer|1-267-273-7940|dkrause@tarsatherapeutics.com|
290243|NCT01292226|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
290244|NCT01292239|Janssen Pharmaceutical K.K., Japan|Director|81 3 44115639||
290245|NCT01292252|University of California, San Francisco|Shane Burch, MD|415-353-4487|Shane.Burch@ucsf.edu|
290246|NCT01292304|University of Florida|Giuseppe (Joseph) Morelli, MD|352-273-9508|giuseppe.morelli@medicine.ufl.edu|
290247|NCT01292447|Women and Infants Hospital|Rebecca Allen|4012741122|rhallen@wihri.org|
290248|NCT01292473|Genentech, Inc|Medical Communications|800 821-8590||
299558|NCT01894555|Johns Hopkins School of Medicine|Rehan Qayyum|410-955-7781|rqayyum@jhmi.edu|
299559|NCT01894568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299560|NCT01894581|University of Colorado Denver|Dr. Alex Polotsky|303-724-2001|alex.polotsky@ucdenver.edu|
299561|NCT01894607|University of Texas (UT) MD Anderson Cancer Center|Ott Le, MD/Associate Professor, Diagnostic Radiation Body Imaging||CR_Study_Registration@mdanderson.org|
299562|NCT01894620|University of Manitoba|Dr Zahra Moussavi|204 474-7023|Zahra.Moussavi@umanitoba.ca|
299563|NCT01894672|Memorial Sloan Kettering Cancer Center|Dr. Paul Chapman MD|646-888-4162|chapmanp@MSKCC.ORG|
299564|NCT01894776|Ottawa Hospital Research Institute|Dr. Bill Cameron|613-737-8899|bcameron@toh.ca|78923
299565|NCT01894841|Providence VAMC|Jennifer Primack|401 273-7100|jennifer.primack@va.gov|6295
299566|NCT01894906|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
299567|NCT01894919|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
299568|NCT01894984|XIAN-JANSSEN PHARMACEUTICAL|Medical affairs director|86-10-58218307||
299569|NCT01895036|NYSPI|Linda Sherman|6467747158|lsherma@nyspi.columbia.edu|
299570|NCT01895062|5i Sciences|Dr. Richard Rose|858-759-2205|rrose@5isciences.com|
290249|NCT01292486|Terumo BCT|Jerome R Bill, M.D.|303-231-4729|jerry.bill@terumobct.com|
290250|NCT01292538|Regulatory Insight, Inc.|Elvira Walls|615-712-9743|elvira@reginsight.com|
290251|NCT01292603|Hoffmann- LaRoche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
290252|NCT01292629|Hoya Surgical Optics, Inc.|Kees den Besten, Vice President Global Quality, Regulatory Affairs, and Clinical Research|+65 6681 0025|kees.denbesten@HOYA.com|
290253|NCT01292642|McLean Hospital|Kevin P Hill, MD, MHS|617-855-4501|khill@mclean.harvard.edu|
290254|NCT01292746|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
290255|NCT01292798|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
290256|NCT01292837|UCB|UCB Clinical Trial Call Center|++1 877 822 9493||
290257|NCT01292876|University of Pittsburgh|Maria Alexander, Office Manager|412-624-5308|alexanderm3@upmc.edu|
290258|NCT01292928|Boston Scientific Corporation|Philip Ghizoni, Clinical Trial Manager|763-255-0036|Philip.Ghizoni@bsci.com|
290259|NCT01293006|Merck Sharp & Dohme Corp|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290260|NCT01293032|Virginia Commonwealth University/Massey Cancer Center|Harry D Bear, MD, PhD|804-828-9325|harry.bear@vcuhealth.org|
290261|NCT01293084|Johns Hopkins Univeristy|Beth Laube Professor|410-502-5791|blaube@jhmi.edu|
290262|NCT01293240|Alcon Research|Peter Bergenske|1-800-241-7629||
290263|NCT01293396|Medical University of Graz|Dr. Norbert Tripolt|0316385|norbert.tripolt@medunigraz.at|78038
290264|NCT01293539|Johns Hopkins|Monica Pearl, M.D.|410-955-8525|msmit135@jhmi.edu|
299571|NCT01895088|AcuFocus, Inc.|Eugenia Thomas, Director Clinical Trials|9495859511|nthomas@acufocus.com|
299572|NCT01895101|Amphia Hospital|Dr. Thierry V Scohy|0031765955570|tscohy@amphia.nl|
299573|NCT01895127|Brigham and Women's Hospital|Anil Chandraker|617-732-7412|achandraker@bwh.harvard.edu|
299574|NCT01895270|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
299575|NCT01895309|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
299576|NCT01895322|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
299577|NCT01895335|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
299578|NCT01895361|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
299579|NCT01895452|Alkermes, Inc.|ARISTADA Medical Information|866-204-7823|usmedinfo@alkermes.com|
299580|NCT01895543|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
299581|NCT01895608|James H Quillen VAMC|Dr. Courtney Hall|423-926-1171|courtney.hall@va.gov|7518
299582|NCT01895634|Johnson & Johnson K.K. Medical Company|Depertment Chief, Clinical Operation|+81-3-4411-6789|yikeda5@its.jnj.com|
299583|NCT01895647|Mackay Memorial Hospital|Dr. Kuang-Hua Cheng|886-975837711|jeff01@mmh.org.tw|
309351|NCT02664363|Duke University Medical Center|Principal Investigator|9196845301|dukebrain1@duke.edu|
309352|NCT02664415|MHRP|Biostatistician|3015003715|spinyakorns@hivresearch.org|
309353|NCT02664532|Tata Main Hospital|Dr.Deb Sanjay Nag|+91-7763807101|debsanjay@gmail.com|
309354|NCT02664610|University of Michigan|Lesli Skolarus|734-936-9075|lerusche@umich.edu|
290265|NCT01293682|University of Rochester|Luke J Peppone, PhD, MPH|585-275-7827|Luke_Peppone@urmc.rochester.edu|
290266|NCT01293695|Baylor University|Dr. Gary Elkins, Director of the Mind-Body Medicine Research Laboratory|254-296-0643|gary_elkins@baylor.edu|
290267|NCT01293825|University Hospitals of Cleveland|Martha Sajatovic, Professor of Psychiatry|(216) 844-2808|martha.sajatovic@uhhospitals.org|
299584|NCT01895777|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|8002430127|clintriage.rdg@boehringer-ingelheim.com|
299585|NCT01895855|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
299586|NCT01895946|AstraZeneca UK Limited|Dr Justin P. O. Lindemann, MBChB MBA, Medical Science Director, AZD5363|(0)7920 250301|Justin.Lindemann@astrazeneca.com|+44
299587|NCT01895972|Bausch + Lomb, a division of Valeant Pharmaceuticals|H. DeCory, Director Medical Affairs|585 732-3284|heleen_H_decory@bausch.com|
299588|NCT01896050|University of Michigan Comprehensive Cancer Center|Norah Lynn Henry, MD|734-936-4991|norahh@med.umich.edu|
309355|NCT02664909|UConn Health|Vincent Williams, M.D.|(860) 679-8384|vwilliams@uchc.edu|
309356|NCT02664922|University of California, Los Angeles|Jennifer Scovotti|310.206.4484|jscovotti@mednet.ucla.edu|
309357|NCT02664961|TRACON Pharmaceuticals|Medical Monitor|8585500780|ctheuer@traconpharma.com|
309358|NCT02664987|Mundipharma Pte Ltd|Valerie Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
309359|NCT02665052|Baltimore VA Medical Center VA Maryland Health Care System|Dr. Susan S. Conroy|(410) 637-3213|susan.conroy@va.gov|
309360|NCT02665260|Montefiore Medical center|Dr. Steven Cohen|718-920-8470|dermpharmeinstein@gmail.com|
309361|NCT02665273|Montefiore|Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
309362|NCT02665286|Montefiore Medical Center|Benjamin W. Friedman, MD, MS|(718)920-6266|befriedm@montefiore.org|
309363|NCT02665364|Neovacs|Head of Regulatory Affairs|+33153109300|info@neovacs.com|
309364|NCT02665455|Abbott Diabetes Care|Jolyon Bugler, Snr Director Clinical Development & Regulatory Affairs|+44 1993 863094|joe.bugler@abbott.com|
309365|NCT02665468|VA-CHOIR|Dr. Timothy P. Hogan|781-687-3181|timothy.hogan@va.gov|
309366|NCT02665689|Charité University, Berlin|Prof. Dr. Antonia Joussen|+49 30 84452331|antonia.joussen@charite.de|
309367|NCT02665728|Braintree Laboratories, Inc.|Vice President, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
309368|NCT02665741|University of California, Davis|Dr. Sooraj Tejaswi|916-734-7215|stejaswi@ucdavis.edu|
309369|NCT02665975|Anglia Ruskin Univeristy|Eldre Beukes|01223698847|eldre.beukes@anglia.ac.uk|2847
309370|NCT02666222|Envoy Medical Corp.|Elizabeth Anderson, PhD|651-361-8080|landerson@envoymedical.com|
309371|NCT02666352|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
309372|NCT02666430|Director Global Clinical Operations, General Medicine|Keri L Vaughan|+1 267.980.5015|keri.vaughan@mylan.com|
309373|NCT02666508|UIC College of Dentistry|Kimberly Fasula RDH, MS, MPH|(312) 996-5513|kfasul1@uic.edu|
309374|NCT02666560|University College London|Joanne Lindop|07909116145|joanne.lindop.12@ucl.ac.uk|
309375|NCT02666664|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
309376|NCT02666742|Kansas City Heart Rhythm Institute|Donita Atkins|913-253-3064|Donita.Atkins@hcahealthcare.com|
270228|NCT00114166|NRG Oncology, Statistics and Data Management Center - Buffalo Office|Jessalyn Reboy|716-845-7738|ReboyJ@nrgoncology.org|
270229|NCT00114218|NRG Oncology|Linda Gedeon for Austin Miller, PhD.|716-845-1169|lgedeon@gogstats.org|
270230|NCT00114231|Memorial Sloan Kettering Cancer Center|Julio Garcia-Aguilar, MD|212-639-5506|garciaaj@mskcc.org|
270231|NCT00114244|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
270232|NCT00114504|Kurume University|Hisashi Kai|+81-942-31-7562|naikai@med.kurume-u.ac.jp|
270233|NCT00114517|University of Southern California|Howard N. Hodis, M.D., Director, Atherosclerosis Research Unit|323 442 1478|athero@usc.edu|
290268|NCT01293968|Qazvin University of Medical Sciences|Dr.Katayun Borhanmojabi|09127841440|ka.mojabi@yahoo.com|
290269|NCT01294098|Washington University School of Medicine|Lauren Westlund|314-454-5345|davislauren@wustl.edu|
290270|NCT01294150|NeoTract|Emily Hergenreter Director of Clinical Affairs|650-739-5570|ehergenreter@neotract.com|
290271|NCT01294163|Radboudumc, Department of Anaesthesiology|Dr. Jan HOFLAND|+31243611111|Jan.Hofland@radboudumc.nl|3658
290272|NCT01294228|Alere San Diego|Director of Clinical Affairs|1-858-805-4808|william.arnold@alere.com|
290273|NCT01294241|Amryt Pharma|Head of Clinical Development|+353 1 669 4606|medinfo@amrytpharma.com|
290274|NCT01294267|Icahn School of Medicine at Mount Sinai, Helmsley Electrophysiology Center|Vivek Y. Reddy, MD|212-241-7114|vivek.reddy@mountsinai.org|
290275|NCT01294306|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
290276|NCT01294319|Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)|Dr. Lynnette Nieman|301-496-4000|niemanl@mail.nih.gov|
290277|NCT01294358|National Cancer Institute|Dr. Udo Rudloff|301-496-3098|udo_rudloff@nih.gov|
290278|NCT01294371|Abbvie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
290279|NCT01294384|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
290280|NCT01294397|Amgen Inc.|Study Director|866-572-6436||
290281|NCT01294423|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
290282|NCT01294436|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
290283|NCT01294449|University of Rochester Heart Research Follow-up Program|Dr. Arthur Moss|585-275-5291|Arthur.Moss@heart.rochester.edu|
290284|NCT01294462|AstraZeneca|Judith Hsia||ClinicalTrialTransparency@astrazeneca.com|
290285|NCT01294514|Covidien|Ulf Borg, Director of Clinical Affairs|303 305 2400|ulf.borg@covidien.com|
290286|NCT01294553|GlaxoSmithKline|GSK Response Center|866-435-7343||
290287|NCT01294579|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
290288|NCT01294592|GlaxoSmithKline|GSK Response Center|866-435-7343||
290289|NCT01294644|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
290290|NCT01294683|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290291|NCT01294709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290292|NCT01294748|Micell Technologies|Jeffrey Mifek, VP Clinical Affairs|919-313-2102|jmifek@micell.com|
290293|NCT01294787|Novartis Pharmaceuticals|Study Director|41 61 324 1111||
290294|NCT01294800|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290295|NCT01294917|Centre for Contact Lens Research|Clinical Scientist|519-888-4567|marc.schulze@uwaterloo.ca|36590
290296|NCT01295034|Icahn School of Medicine at Mount Sinai|Andrea D. Branch PhD|212 659 8371|andrea.branch@mssm.edu|
290297|NCT01295112|The Emmes Corporation|Traci Clemons|1-301-251-1161|tclemons@emmes.com|10212
290298|NCT01295216|Institute of Nutrition of Central America and Panama|Manuel Ramirez-Zea|+502 24719913|mramirez@incap.int|
290299|NCT01295281|Wellspect HealthCare|Dikran Shamoun|+46313764275|dikran.shamoun@wellspect.com|
290300|NCT01295320|GlaxoSmithKline|GSK Response Center|866-435-7343||
290301|NCT01295515|National Cancer Institute|Dr. Frank Maldarelli|301- 846-5611|frank_maldarelli@nih.gov|
290302|NCT01295580|Bioventus, LLC|Director, Regulatory and Clinical Affairs|1-800-396-4325||
290303|NCT01295671|Boston Children's Hospital|Dr. David Ludwig|617-355-4878|david.ludwig@childrens.harvard.edu|
290304|NCT01295710|Neovii|Anne Kuan|781 966 3832|anne.kuan@neovii.com|
290305|NCT01295814|IC Study, LLC|Philip C. Bosch, MD|760-743-3135|pboschmd@gmail.com|
290306|NCT01295827|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290307|NCT01295840|Hospital Universitario Virgen de la Victoria|Dr Javier Alzueta|+34 952 64 15 50|jalzueta@telefonica.net|
290308|NCT01295879|Brigham and Women's Hospital|David E. Leaf, M.D., Renal Fellow|617-732-5951|DELEAF@partners.org|
290309|NCT01295905|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
299589|NCT01896115|Boston Scientific|Stephen Carcieri, PhD|661-949-4756|Stephen.Carcieri@bsci.com|
290310|NCT01296035|Women & Infants Hospital|Director of Clinical Trials|401-274-1122|jmari@wihri.org|
290311|NCT01296152|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
290312|NCT01296191|Bucci Laser Vision|Frank A. Bucci Jr., MD|570-825-5949|buccivision@aol.com|
290313|NCT01296347|ImperialNHSTrust|Dr Gillian Chumbley|+44 203 311 1000|gillian.chumbley@imperial.nhs.uk|Bleep 5865
290314|NCT01296360|Valneva Austria GmbH|Senior Manager Clinical Research|+43 1 206 20|katrin.dubischar-kastner@valneva.com|1175
290315|NCT01296412|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290316|NCT01296542|Bucci Laser Vision|Frank A. Bucci Jr., MD|570-825-5949|buccivision@aol.com|
290317|NCT01296568|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
290318|NCT01296646|University of North Carolina at Chapel Hill|James C. Garbutt, M.D., Professor of Psychiatry|919-966-4652|jc_garbutt@med.unc.edu|
290319|NCT01296672|UT Health|Jonathan Gelfond|210 567-0836|gelfondjal@uthscsa.edu|
290320|NCT01296698|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, RPS Sr. Specialist, Clinical Research Operations|928-277-0715|jhauze@its.jnj.com|
290321|NCT01296763|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Thomas Brown|410-502-5328|tbrown55@jhmi.edu|
290322|NCT01296815|Centro de Investigación en. Enfermedades Infecciosas|Gustavo Reyes-Teran|52 55 56667985|gustavo.reyesteran@gmail.com|
290323|NCT01296841|VA Palo Alto|Roy Soetikno|650-493-5000|soetikno@earthlink.net|64800
290324|NCT01296932|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290325|NCT01297062|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
290326|NCT01297244|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
290327|NCT01297257|Clinical Research Director|Frank van Leeuwen, M.D.|+31433566622|frank.van.leeuwen@medtronic.com|
290328|NCT01297270|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290329|NCT01297283|Medtronic|Latifa Foudali|+33 631992144|latifa.foudali@medtronic.com|
290330|NCT01297309|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
299590|NCT01896128|Burke Rehabilitation Hospital|Pasquale Fonzetti MD|(914) 597-2502|pfonzett@burke.org|
299591|NCT01896193|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
299592|NCT01896206|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|Joseph.Tobias@nationwidechildrens.org|
299593|NCT01896232|Amgen Inc.|Study Director|866-572-6436||
299594|NCT01896271|UT Southwestern Medical Center|Dr. Raquibul Hannan|214-645-8525|Raquibul.Hannan@UTSouthwestern.edu|
299595|NCT01896297|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309377|NCT02666846|Futura Medical Developments Limited|Director of Clinical Development|01483685683|tim.holland@futuramedical.com|
309378|NCT02666950|Mayo Clinic|Lisa Sproat, M.D.|480/301-8000|Sproat.Lisa@mayo.edu|
309379|NCT02667236|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
309380|NCT02667275|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
309381|NCT02667288|Aclaris Therapeutics|Judy Schnyder, Sr. Director Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
309382|NCT02667301|StratejikYG|Murat Haluk Ozkul|0905327777842|kbbhaluk@gmail.com|
309383|NCT02667392|VAORD|Dr. Dorian Rose|352-376-1611|dorian.rose@va.gov; dkrose@phhp.ufl.edu|105238
309384|NCT02667457|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
309385|NCT02667626|University of California, San Diego|Irene Su, MD MSCE|8588225986|hisu@ucsd.edu|
309386|NCT02667704|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309387|NCT02667821|Canadian Memorial Chiropractic College|Dr. Nicholas Moser|416-482-2340|nmoser@cmcc.ca|319
309388|NCT02667912|Tomsk National Research Medical Center of the Russian Academy of Sciences|Dr. Stanislav Pekarskiy|+73822558122|pekarski@cardio-tomsk.ru|
309389|NCT02667951|School of Nursing, College of Medicine, Chang Gung University, Taoyuan, Taiwan|Dr. Yea-Ing L. Shyu|+886-3-211 8800|yeaing@mail.cgu.edu.tw|5275
309390|NCT02668003|University of Aberdeen|Professor Gary Macfarlane|01224 437 143|g.j.macfarlane@abdn.ac.uk|
309391|NCT02668185|Imperial College London|Professor Wajit Dhillo|+44 (0)20 7594 2489|w.dhillo@imperial.ac.uk|
309392|NCT02668198|Mayo Clinic|Dr. Michael B. Wallace|904-953-2221|wallace.michael@mayo.edu|
309393|NCT02668302|Collin County ENT|Keith E Matheny, MD (Principal Investigator)|(972) 596-4005|kmatheny618@gmail.com|
309394|NCT02668393|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309395|NCT02668432|University of Texas Health San Antonio|Bethany Kalich, PharmD|210-883-1177|kalich@uiwtx.edu|
309396|NCT02668640|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309397|NCT02668692|LEO Pharma A/S|Clinical Trial Disclosure Manager||disclosure@leo-pharma.com|
309398|NCT02668952|Dept of Anesthesiology, University of New Mexico|Neal Gerstein, MD|5052722610|ngerstein@salud.unm.edu|
309399|NCT02669017|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
309400|NCT02669043|Massachusetts General Hospital|Dr.Cristina Cusin|617-726-6421|ccusin@partners.org|
309401|NCT02669082|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
309402|NCT02669095|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D., FAAO Principal Research Optometrist|904 443-1474|KCANAVA2@its.jnj.com|
309403|NCT02669121|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
290331|NCT01297322|Daniel & Daniel Consulting, LLC|Michael A. Daniel, Consulting VP Regulatory Affairs|7753922970|madaniel@clinregconsult.com|
290332|NCT01297335|The Center for Clinical Research|Medical Director|3367656181|rrauck@ccrpain.com|
290333|NCT01297348|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquires@pfizer.com|
290334|NCT01297465|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
290335|NCT01297491|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
290336|NCT01297504|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
290337|NCT01297517|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
290338|NCT01297595|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290339|NCT01297920|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
290340|NCT01297959|Excited States/Exoxemis, Inc|Jackson T Stephens, Jr|(402) 884-2316|sstephens@exoxemis.com|
290341|NCT01297985|Center on Mental Health Services Research and Policy, University of Illinois at Chicago, Department of Psychiatry|Dr. Judith A. Cook, Director|312-355-3921|jcook@uic.edu|
290342|NCT01298063|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290343|NCT01298128|Mount Sinai Hospital|Dr. Kimberly Liu|416-586-5367|kliu@mtsinai.on.ca|
290344|NCT01298141|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
299596|NCT01896544|Massachusetts General hospital|Tiffany M.N. Otero|4074950753|totero@partners.org|
290345|NCT01298167|Yale University|David Leffell, MD|203 785 7999|david.leffell@yale.edu|
290346|NCT01298193|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
290347|NCT01298219|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
299597|NCT01896557|Heart Institute of University of Sao Paulo Medical School|Remo Holanda de Mendonca Furtado|+5511 26615058|remo_holanda@hotmail.com|
290348|NCT01298323|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
299598|NCT01896687|Virginia Commonwealth University|Dr. Angela Starkweather|8048283986|astarkweathe@vcu.edu|
299599|NCT01896700|Portland VA Health Care System|Andrea Hildebrand|503-220-8262|hildeand@ohsu.edu|52016
299600|NCT01896726|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299601|NCT01896856|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Nilofer Azad|410-614-9169|nazad2@jhmi.edu|
299602|NCT01896869|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Dung Le|443-287-0002|dle2@jhmi.edu|
299603|NCT01896895|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
299604|NCT01896921|University of Maryland|Gregg Brogden|4107061660|gbrogden@ihv.umaryland.edu|
299605|NCT01896934|Vanderbilt University Medical Center|Dr. Warren D Taylor|615-936-3555|warren.d.taylor@vanderbilt.edu|
299606|NCT01896986|MCRI|Dr. Nigel Crawford|9345 4772|nigel.crawford@rch.org.au|
299607|NCT01897025|National University Hospital|Dr Effie Chew|65-67726198|effie_chew@nuhs.edu.sg|
299608|NCT01897077|Johns Hopkins School of Medicine|Corinne Keet|410-955-5883|ckeet1@jhmi.edu|
299609|NCT01897233|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
299610|NCT01897285|Arrowe Park Hospital|Mrs Gwenneth Lawrence|0151 678 5111|gwen.lawrence@nhs.net|8362
299611|NCT01897402|JN-International Medical Corporation|Regulatory Affairs Director|4028843477|dr_orten@jn-vaccines.org|
299612|NCT01897493|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299613|NCT01897532|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
299614|NCT01897714|Oncopeptides AB|Eva Nordström|+4686152040|trials@oncopeptides.com|
299615|NCT01897727|University of Alabama at Birmingham|Dr. Eric Judd|205 934-9281|ejudd@uab.edu|
299616|NCT01897766|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299617|NCT01897792|UAB Department of Anesthesiology|Jean-Francois Pittet, MD|205-996-4755|jpittet@uabmc.edu|
299618|NCT01897896|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
299619|NCT01898013|Durham VA Medical Center|Jennifer C. Naylor, PhD|9192860411|jennifer.naylor2@va.gov|
299620|NCT01898078|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
299621|NCT01898091|Medical University of South Carolina|Susan G. Reed, DDS, MPH, DrPH|843 792-1577|reedsg@musc.edu|
299622|NCT01898130|Northwestern University|Priya Kumthekar, MD|312-503-1818|p-kumthekar@northwestern.edu|
299623|NCT01898195|Department of Population Health, New York University School of Medicine|Donna Shelley, MD, MPH/ Vice Chair for Research; Associate Professor of Population Health and Medici|646-501-2526|Donna.Shelley@nyumc.org|
299624|NCT01898208|Mayo Clinic|Ritu Banerjee, M.D., Ph.D.|507-284-6904|banerjee.ritu@mayo.edu|
299625|NCT01898286|CBR International|Dr. Jeanne Novak|7207461190|jnovak@cbrintl.com|
299626|NCT01898299|New York State Psychiatric Institute|Joshua Kantrowitz|6467746738|jk3380@cumc.columbia.edu|
299627|NCT01898403|Stanford University Medical Center|Dana T Lin, MD; Clinical Assistant Professor|650-498-6000|danalin@stanford.edu|
299628|NCT01898429|Dartmouth Hitchcock Medical Center|Paul E. Holtzheimer, MD|603-650-4914|Paul.E.Holtzheimer@hitchcock.org|
299629|NCT01898442|University of Florida - Jacksonville|Dominick J. Angiolillo, MD, PhD|9042443933|dominick.angiolillo@jax.ufl.edu|
299630|NCT01898598|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
299631|NCT01898611|University of Pennsylvania|Anne Cappola, MD|215-573-5359|acappola@mail.med.upenn.edu|
299632|NCT01898689|UC San Diego|Dr. Brian Ilfeld|(858) 444-5949|bilfeld@ucsd.edu|
299633|NCT01898754|University of Washington|Professor Lisa Frenkel|+1 206 987-5140|lfrenkel@uw.edu|
299634|NCT01898806|Columbia University|Grace Ulerio|212-305-6953|gu2102@cumc.columbia.edu|
299635|NCT01898884|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
299636|NCT01898923|Oneness Biotech Co., Ltd.|Henry Chang, Associate Director of Clinical Research|+886 2 2703 1098|henry.chang@onenessbio.com.tw|366
299637|NCT01899053|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
299638|NCT01899300|Asian Institute of Gastroenterology|Rajesh Gupta, MD|+91 4023378888|drrajeshgupta98@gmail.com|
299639|NCT01899677|Zeynep Kamil Maternity and Children's Education Training Hospital|Ozge Serce (Investigator, MD)|+905323270375|ozge_serce@hotmail.com|
290349|NCT01298362|Hellenic Society of Breast Surgeons|Christos J Markopoulos, MD, MPhil Professor of Surgery-Athens University Medical School|+30 210 6862527|cmarkop@hol.gr|
290350|NCT01298492|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
290351|NCT01298518|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290352|NCT01298531|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290353|NCT01298544|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290354|NCT01298570|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
290355|NCT01298596|University of Washington|Dr. Michael H. Chung|‭(206) 302-8361‬|mhchung@uw.edu|
290356|NCT01298648|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
290357|NCT01298661|Universidade Federal de São Carlos|Juliano Ferreira Arcuri|+55 (16) 33518343|julianoarcuri@gmail.com|
290358|NCT01298700|Allergan, Inc|Michael Robinson, MD|714-246-4500|clinicaltrials@allergan.com|
290359|NCT01298752|Bausch Health|Study Director||susan.harris@bauschhealth.com|
290360|NCT01298765|BIODELIVERY|Vice President, Operations|919-582-0294|twarneke@bdsi.com|
290361|NCT01298778|Wake Forest School of Medicine|Dr. Jessica Booth|336-718-8278|jbooth@wakehealth.edu|
299640|NCT01899729|Idera Pharmaceuticals, Inc.|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
290362|NCT01298999|Columbia University Medical Center|Julian A Abrams, MD|2123059541|ja660@cumc.columbia.edu|
290363|NCT01299025|Region Örebro County|Dr Anette Forsberg|+46-19-6025788|anette.forsberg@regionorebrolan.se|
290364|NCT01299038|Beth Israel Deaconess Medical Center|Jeffrey Zwicker, MD|617-667-9299|jzwicker@bidmc.harvard.edu|
290365|NCT01299077|Eisai China Inc.|Haibo Song|0086-21-24192864|songhaibo@eisai.com.cn|
290366|NCT01299090|Moy, Fincher, Chipps Medical Group|Lisa Chipps, MD|(310) 274-5372|lchipps@ucla.com|
290367|NCT01299103|Chicago Center for Facial Plastic Surgery|Dr. Steven Dayan|(312) 335-2070|sdayan@drdayan.com|
290368|NCT01299116|FHI 360|Dr. David Hubacher|919 544 7040|dhubacher@fhi360.org|11223
290369|NCT01299272|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
290370|NCT01299285|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299641|NCT01899742|GlaxoSmithKline|GSK Response Center|866-435-7343||
299642|NCT01899768|GlaxoSmithKline|GSK Response Center|866-435-7343||
299643|NCT01899911|University of California, San Francisco (UCSF)|Philip E. Bickler, MD, PhD, Professor of Anesthesia|415-476-1411|Philip.Bickler@UCSF.edu|
299644|NCT01900054|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
299645|NCT01900067|Mölnlycke Health Care AB, Surgical Division|Jenny Höglind|0046 31 722 30 00|Jenny.Hoglind@molnlycke.com|
299646|NCT01900249|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
309404|NCT02669264|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
309405|NCT02669329|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
309406|NCT02669407|Duke University|Marat Fudim, M.D.|919-684-8111|marat.fudim@duke.edu|
309407|NCT02669433|Axovant Sciences, Inc.|Ilise Lombardo, MD|646-822-8626|ilise.lombardo@axovant.com|
309408|NCT02669615|Medical College of Wisconsin|Parameswaran Hari|4148054600|phari@mcw.edu|
309409|NCT02669667|MedImmune|Rene van der Merwe|+44 (0)1223 898263|information.center@astrazeneca.com|
309410|NCT02669758|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
309411|NCT02669784|Milton S. Hershey Medical Center|Rekha Cherian, M.D.|717-531-6735|rcherian@pennstatehealth.psu.edu|
309412|NCT02669849|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
309413|NCT02669862|Aclaris Therapeutics, Inc.|Judy Schnyder, Senior Director of Clinical Operations|484-329-2144|jschnyder@aclaristx.com|
309414|NCT02669914|Washington University School of Medicine|Ramaswamy Govindan, M.D.|314-362-5737|rgovindan@wustl.edu|
309415|NCT02669940|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309416|NCT02670083|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
309417|NCT02670122|Ramon y Cajal University Hospital. Vascular and Interventional Radiology Service|Jose Urbano Garcia, MD, PhD, EBIR, FCIRSE|+ 34 606 31 84 30|jurbano34@gmail.com ; jurbano@salud.madrid.org|
309418|NCT02670330|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
309419|NCT02670343|Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center|Christina Wang, MDAssociate Director UCLA Clinical and Translational Science Institute|1-310-222-1888|wang@labiomed.org|
309420|NCT02670382|Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University|Dr. Stefania Lamon-Fava, Scientist I|617-556-3105|stefania.lamon-fava@tufts.edu|
309421|NCT02670473|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
309422|NCT02670538|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
309423|NCT02670551|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
309424|NCT02670629|"Servicio de Ortopedia y Traumatología . Hospital Universitario José Eleuterio González"|Dr. Adriana Hernández|8112901288|adrianahl@gmail.com|
309425|NCT02670811|Centro de Investigación en Alimentación y Desarrollo, A.C.|Dr. Belinda Vallejo Galland|526622892400|vallejo@ciad.mx|365
309426|NCT02670915|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
309427|NCT02670928|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
309428|NCT02671032|Cochlear|Bernadette Pickering|+61296115909|bpickering@cochlear.com|
309429|NCT02671266|Massachusetts General Hospital/Harvard Medical School|Dr. Angela Fang|617-643-7717|afang@mgh.harvard.edu|
290371|NCT01299376|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290372|NCT01299389|Janssen Pharmaceutical K.K|Medical director|+81-3-4411-5509||
290373|NCT01299454|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800-562-3974||
281709|NCT00818272|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
290374|NCT01299480|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290375|NCT01299571|GlaxoSmithKline|GSK Response Center|866-435-7343||
290376|NCT01299584|GlaxoSmithKline|GSK Response Center|866-435-7343||
290377|NCT01299610|GlaxoSmithKline|GSK Response Center|866-435-7343||
290378|NCT01299727|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
290379|NCT01299766|Thomas Jefferson University|Robin Casten|215-503-1250|robin.casten@jefferson.edu|
290380|NCT01299805|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
290381|NCT01299896|Vanderbilt University|Dr. Hilary A. Tindle|615-875-9726|hilary.tindle@vanderbilt.edu|
290382|NCT01299909|University of Wisconsin|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
290383|NCT01299961|UCLA|Veena K. Ranganath, MD, MS Assistant Clinical Professor|310-825-3061|vranganath@mednet.ucla.edu|
290384|NCT01300052|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290385|NCT01300065|Bausch Health|Study Director|908-300-9920|susan.harris@bauschhealth.com|
290386|NCT01300234|GlaxoSmithKline|GSK Response Center|866-435-7343||
290387|NCT01300247|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
290388|NCT01300260|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
290389|NCT01300286|Duke University Medical Center|Dr. Ian Welsby|919-668-2699|ian.welsby@duke.edu|
290390|NCT01300338|Mayo Clinic|Dr. Frederick North|507-284-5164|North.Frederick@mayo.edu|
290391|NCT01300351|AstraZeneca China|Guofei Dai|+86 21 60301242|guofei.dai@astrazeneca.com|
290392|NCT01300455|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290393|NCT01300546|Clinvest/A Division of Banyan Group Inc.|Jeanne Tarrasch|417-841-3673|jtarrasch@clinvest.com|
290394|NCT01300559|Duke University Medical Center|Steven E. Hill, M.D.|681-6614|hill0012@mc.duke.edu|
290395|NCT01300572|Fred Hutchinson Cancer Research Center|Brenda Sandmaier, MD|(206) 667-4961|bsandmai@fredhtuch.org|
290396|NCT01300624|Brain Rehabilitation Research Center, Malcom Randall VA, Gainesville, FL|Lisa Edmonds, PhD|352.262.4465|lisa.annamarie.edmonds@gmail.com|
290397|NCT01300650|Virginia Commonwealth University|Benjamin Van Tassell|8049820997|bvantassell@vcu.edu|
290398|NCT01300728|Sutter Neurology Medical Group|Shawn Kile, MD|(916) 454-6850|KileS@sutterhealth.org|
290399|NCT01300741|Alcon Research|Director of Clinical Trials|1-800-241-7629||
290400|NCT01300767|Alcon Research|Director of Clinical Trials|1-800-241-7629||
290401|NCT01300819|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
290402|NCT01300923|Cincinnati Childrens Hospital|Craig Erickson|5136366265|craig.erickson@cchmc.org|
290403|NCT01300949|Wills Eye Hospital|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
290404|NCT01301001|University of Tennessee Health Science Center|Dr. Candace Brown|9014124341|CSBROWN@TENNESSEE.EDU|
290405|NCT01301027|University of Utah|Srinivansan Beddhu, M.D.|801-585-3810|srinivansan.beddhu@hsc.utah.edu|
290406|NCT01301066|Kowa Research Institute, Inc.|Roger Morgan, MD, FACS|919-433-1600|RMorgan@kowaus.com|
290407|NCT01301079|Federal University of Sao Paulo|Plínio da Cunha Leal|55-98-8852-2021|pliniocunhaleal@hotmail.com|
290408|NCT01301092|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
290409|NCT01301183|Massachusetts General Hospital|Madhu Misra|6177265790|mmisra@mgh.harvard.edu|
290410|NCT01301274|Intensive Care Unit - Hospital Pedro de Elizalde|Dr Facundo Jorro Barón|00541143632100|jorrobox@yahoo.com.ar|2035
290411|NCT01301391|CLIOSS S.r.l.|Dr. Davite Cristina|+39 0031 58|regulatory@clioss.com|1482
290412|NCT01301456|Pfizer, Inc.|Pfizer ClinicalTrials.gov|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290413|NCT01301508|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290414|NCT01301625|Abbott Vascular|Jeffrey T. Ellis|(408) 845-8184|jeffrey.ellis@av.abbott.com|
290415|NCT01301729|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
290416|NCT01301742|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290417|NCT01301833|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
290418|NCT01301950|DePuy Synthes|Sam Himden, Clinical Portfolio Leader|574-372-7231|shimden@its.jnj.com|
290419|NCT01302041|Astellas Pharma Global Devlopment, Inc.|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
290420|NCT01302054|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290421|NCT01302067|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290422|NCT01302080|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290423|NCT01302119|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@Pfizer.com|
290424|NCT01302366|Perlmutter Cancer Center at NYU Langone|Amitabha Mazumder, MD|212-731-5757|amitabha.mazumder@nyumc.org|
290425|NCT01302379|University of San Diego, California|Ruth Patterson|8585349235|repatterson@ucsd.edu|
290426|NCT01302392|Amgen, Inc.|Study Director|866-572-6436||
290427|NCT01302418|QIAGEN|Tony Lam|301-944-7090|tony.lam@qiagen.com|
281710|NCT00818324|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Research and Development|+81-3-6361-7366||
281711|NCT00818337|Creighton University|Kathleen Packard, PharmD|402-280-2668|kpackard@creighton.edu|
281712|NCT00818363|Durect Corporation|Deborah Scott|408-777-1417|deborah.scott@durect.com|
281713|NCT00818389|Massachusetts General Hospital|Elizabeth Simpson|617-726-3430|esimpson1@partners.org|
281714|NCT00818441|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290428|NCT01302483|Department of Periodontics & Endodontics, School of Dental Medicine, University of Buffalo, SUNY|Dr. Sebastian Ciancio|(716) 829-3848|ciancio@buffalo.edu|
290429|NCT01302548|University of Florida|Richard F Petrik, MD|352-265-5911|rpetrik@ufl.edu|
290430|NCT01302691|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290431|NCT01302743|Mike O'Callaghan Federal Medical Center|Jill M. Clark, MBA/HCM|702-653-3298|jill.clark.3.ctr@us.af.mil|
290432|NCT01302808|UT Southwestern Medical Center|David Gerber, MD|2146484180|david.gerber@utsouthwestern.edu|
290433|NCT01302834|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
290434|NCT01302860|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
290435|NCT01302899|Novartis Pharmaceuticals|Study Director|862-778-8300||
290436|NCT01302938|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290437|NCT01302964|Massachusetts General Hospital|Christopher J. McDougle, MD|781-860-1783|cmcdougle@mgh.harvard.edu|
290438|NCT01303068|University of New Mexico|Hengameh Raissy|5052725484|hraissy@salud.unm.edu|
290439|NCT01303159|Weill Cornell Medical College|Michel Kahaleh|646-962-4797|mik9071@med.cornell.edu|
299647|NCT01900314|University of Michigan|Stephan Taylor|734-936-4955|sftaylor@umich.edu|
290440|NCT01303172|Immodulon Therapeutics Ltd|Chief Medical Officer|+44 (0) 20 3137 6346|info@immodulon.com|
290441|NCT01303224|Menarini Ricerche S.p.A.|Angela Capriati MD PhD, Corporate Director of Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9933
290442|NCT01303380|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
290443|NCT01303406|National Hospital for Neurology and Neurosurgery|Dr Paola Giunti|020 3448 3141|violet.le-fevre@uclh.nhs.uk|
290444|NCT01303419|GE Healthcare|Jean-Paul Antonini|+33 130709703|Jean-Paul.antonini@ge.com|
290445|NCT01303445|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
299648|NCT01900392|UPENN|Catherine Reale|2157464009|catherine.reale@uphs.upenn.edu|
309430|NCT02671422|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309431|NCT02671500|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
309432|NCT02671760|Sequential Medicine Ltd|Head of Product Development|617-818-2735|tadahl@outlook.com|
309433|NCT02672111|Braeburn|Sonnie Kim|1 610 467 8717|sonnie@braeburnrx.com|
309434|NCT02672176|University of California, Davis|Heather M. Young, Principal Investigator|916-734-4745|hmyoung@ucdavis.edu|
309435|NCT02672423|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
309436|NCT02672514|Herzzentrum Coswig|Dr. Jessica Vogler|+491749740710|j_vo@web.de|
309437|NCT02672553|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, HVT|949-250-2500|mary_edwards@edwards.com|1536
309438|NCT02672852|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309439|NCT02673138|Yale Pediatric Diabetes|Neha S. Patel, DO|203-764-6747|neha.patel@yale.edu|
309440|NCT02673203|Yale University School of Medicine|Renata Belfort De Aguiar, MD, PhD; Assistant Professor of Medicine (Endocrinology)|(877) 925-3637|renata.aguiar@yale.edu|
309441|NCT02673333|Memorial Sloan Kettering Cancer Center|Diane Reidy-Lagunes, MD|646-888-4185|reidyd@mskcc.org|
309442|NCT02673372|Maimonides Medical Center|Sergey Motov, Director of Research|718-283-8693|smotov@maimonidesmed.org|
309443|NCT02673489|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
309444|NCT02673515|Medical University of Graz|Assoc.-Prof.Dr. Harald Sourij|+43 316 385|norbert.tripolt@medunigraz.at|78038
309445|NCT02673541|Dartmouth-Hitchcock Medical Center|Dr Jeffrey Adler|603-650-5261|Jeffrey.m.adler@hitchcock.org|
309446|NCT02673619|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
309447|NCT02673918|University of British Columbia|Bolette Rafn|604-827-1914|bolette.rafn@ubc.ca|
309448|NCT02673944|Laborie|Clinical Researcher|905-612-1170|sbitzos@laborie.com|1755
309449|NCT02674061|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
309450|NCT02674334|West Virginia University Department of Orthopaedics|Dr. George K Bal|304-293-1310|gbal@hsc.wvu.edu|
309451|NCT02674386|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309452|NCT02674399|Nature Cell co., ltd|Project Manager|02-545-4137|tin50@stemcellbio.com|
309453|NCT02674412|Cleveland Clinic|Scott Gabbard, MD|216 444-6523|gabbars@ccf.org|
309454|NCT02674477|Johns Hopkins University|Dr. Alexis Hammond|410-550-0045|ahammon9@jhmi.edu|
290446|NCT01303510|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
290447|NCT01303627|Ministry of Health Diskapi Yildirim Beyazit Training and Research Hospital 1. Anesthesiology|Derya Özkan MD|0903125962553|derya_z@yahoo.com|
290448|NCT01303744|Cerespir|Richard Margolin|(646) 202-2562|rmargolin@cerespir.com|
299649|NCT01900431|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
299650|NCT01900444|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
299651|NCT01900561|Department of Veterans Affairs|Dr. Sarah Hawley|734-936-8816|sarahawl@umich.edu|
299652|NCT01900652|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299653|NCT01900665|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299654|NCT01900704|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
299655|NCT01900899|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299656|NCT01901055|University of Pittsburgh|Eileen R. Chasens, PhD, Professor of Nursing|412-624-9380|chasense@pitt.edu|
299657|NCT01901146|Amgen Inc.|Study Director|866-572-6436||
299658|NCT01901185|Amgen Inc.|Study Director|866-572-6436||
299659|NCT01901211|Holland Bloorview Kids Rehabilitation Hospital|Darcy Fehlings, MD, MSc, FRCP(C)|416-425-6220|dfehlings@hollandbloorview.ca|3586
299660|NCT01901250|Case Western Reserve University|Dr. Suchitra Nelson|216-368-3469|sxn15@case.edu|
299661|NCT01901289|Cook Research Incorporated|Manager, Biostatistics|7654637537|Alan.Saunders@CookMedical.com|321204
299662|NCT01901302|Cubist Pharamceuticals|Vice President Clinical Research|1.781.860.8660||
299663|NCT01901328|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
299664|NCT01901341|Cubist Pharmaceuticals|Vice President, Clinical Research|(781) 860-8660||
299665|NCT01901393|Cumberland Pharmaceutical Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
299666|NCT01901419|Department of Anesthesiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan|Dr. Tso-Chou Lin|+886-2-87927128|tclin@mail.ndmctsgh.edu.tw|
299667|NCT01901575|NYU Langone Medical Center|Avrimin M. Kogan, MD|(212) 263-5072|Avrimin.Kogan@nyumc.org|
299668|NCT01901588|NYU School of Medicine|Assistant Professor, Department of Anesthesiology, Perioperative Care, and Pain Medicine|212.263.5072|wanda.chin@nyumc.org|
299669|NCT01901614|Oregon Health & Science University|David Huang, MD, PhD|503-494-3000|huangd@ohsu.edu|
299670|NCT01901653|AbbVie Stemcentrx|Senior Director, Clinical Operations|(650) 827-4879|isobel.lakatos@abbvie.com|
299671|NCT01901809|Johns Hopkins University School of Medicine|Kavita Sharma, MD|410-955-7670|ksharma8@jhmi.edu|
299672|NCT01901848|Durham Veterans Health Care System|Eric Dedert, Ph.D.|919-384-8582|eric.dedert@va.gov|4055
299673|NCT01901874|W. L. Gore & Associates|Bryan Randall|928-864-4832|BRandall@WLGore.com|
299674|NCT01902004|UCLA Semel Institute for Neuroscience and Human Behavior|Dr. Helen Lavretsky|(310)794-4619|hlavretsky@mednet.ucla.edu|
299675|NCT01902134|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Director of Clinical Research|+3905556809933|ACapriati@menarini-ricerche.it|
299676|NCT01902173|SWOG|Melanoma Statistician|2066674623|jmoon@fredhutch.org|
299677|NCT01902303|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
299678|NCT01902459|Ethicon, Inc|Richard Kocharian, MD, PhD|+1 908-218-2013|rkochar1@its.jnj.com|
299679|NCT01902628|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
299680|NCT01902758|University of Montana|Director of the Montana Center for Work Physiology and Exercise Metabolism|406-243-2117|brent.ruby@mso.umt.edu|
299681|NCT01902901|Kaiser Permanente Center for Health Research|Katrina Goddard|503-335-6353|katrina.ab.goddard@kpchr.org|
299682|NCT01902953|Maimonides|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
299683|NCT01903005|TRY Research|Kent Hoffman, DO|(407) 691-3960|Suboxdoc1@yahoo.com|
299684|NCT01903031|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
299685|NCT01903148|Hospital de Bellvitge|Dr. Alberto Martínez Castelao|610 459 262|albertomcastelao@gmail.com|
299686|NCT01903187|St. Jude Medical, Inc.|Steven Madej|651-756-2230|smadej@sjm.com|
299687|NCT01903252|Tillotts Pharma AG|Dr. Robert Hofmann, MD PhD|+4161 935 27 14|robert.hofmann@tillotts.com|
299688|NCT01903265|Tonix Pharmaceuticals|Gregory M. Sullivan, MD, Chief Medical Officer|212 980 9155|Gregory.Sullivan@TonixPharma.com|117
299689|NCT01903356|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
299690|NCT01903434|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299691|NCT01903460|Mirum|Study Physician|+1 650-667-4085|medinfo@mirumpharma.com|
299692|NCT01903525|Scottish Rite for Children|Dr. Shane Miller|469-515-7222|shane.miller@tsrh.org|
299693|NCT01903564|University of Wisconsin-Madison|Ronald Wakai, Ph.D.|6082654988|rtwakai@wisc.edu|
299694|NCT01903720|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
299695|NCT01903733|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299696|NCT01903798|SCIRE|Executive Director, Southern California Institute for Research and Education|562-826-8000|Sabry.Eassa@va.gov|5747
299697|NCT01903811|SWOG Statistical Center|S1304 Statistician|2066674623|rachaels@crab.org|
299698|NCT01903837|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
299699|NCT01903863|Duke University Hospital|Dr. Caroline Ozment|919-681-2554||
299700|NCT01903876|Georgia State University|Dr. Laura Salazar|404-413-1396|lsalazar1@gsu.edu|
299701|NCT01903993|Hoffmann-La Roche|Medical Communications|800 821|genentech@druginfo.com|8590
299702|NCT01904019|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
299703|NCT01904058|Mirum|Study Physician|1-650-667-4085|medinfo@mirumpharma.com|
299704|NCT01904071|Maimonides Medical Center|Dr. Eitan Dickman, Director of EM Ultrasound|718-283-6057|edickman@maimonidesmed.org|
299705|NCT01904149|Menarini Ricerche S.p.A.|Dr. Angela Capriati, Corporate Director of Clinical Research|+3905556809933|ACapriati@menarini-ricerche.it|
290449|NCT01303835|Duke University Medical Center, The Preston Robert Tisch Brain Tumor Center|Katherine B. Peters, MD, PhD|(919) 684-6173|katherine.peters@duke.edu|
290450|NCT01303861|Duke University Medical Center - Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@dm.duke.edu|
290451|NCT01303939|Wills Eye Hospital, Glaucoma Research Center|George L. Spaeth, MD|215-928-3123|gspaeth@willseye.org|
290452|NCT01303965|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
290453|NCT01304082|Massachusetts General Hospital|Brian Wainger|617-726-8810|bwainger@partners.org|
290454|NCT01304147|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-7574|james.murrough@mssm.edu|
299706|NCT01904383|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290455|NCT01304238|GlaxoSmithKline|GSK Response Cente|866-435-7343||
290456|NCT01304277|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
290457|NCT01304329|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290458|NCT01304407|Baylor College of Medicine|Dr. Steven Abrams|512-495-4700|sabrams@bcm.edu|
290459|NCT01304498|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290460|NCT01304589|University of Tennessee Health Science Center|Dr. Candace Brown|901-412-4341|csbrown@uthsc.edu|
290461|NCT01304641|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290462|NCT01304693|Alcon Research, Ltd.|Georges Weissgerber, Executive Director, Novartis Pharma AG|1-888-451-3937|alcon.medinfo@alcon.com|
290463|NCT01304706|Alimera Sciences, Inc.|Kathleen Billman, Senior Director, Scientific Affairs|678-527-1302|kathleen.billman@alimerasciences.com|
290464|NCT01304940|VA ORD|Suzanne Pineles|857-364-5906|suzanne.pineles@va.gov|
290465|NCT01304966|Queen Sirikit Nation Institute of Thailand|Dr.Pavinee Intakorn|06623548333|pintakorn@yahoo.com|2301
290466|NCT01305044|Huntsman Cancer Institute|Anita Kinney, PhD, RN|801-585-1151|anita.kinney@hci.utah.edu|
290467|NCT01305200|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreporingcoordinator@childrensoncologygroup.org|
290468|NCT01305213|NRG Oncology|Linda Gedeon for Michael Sill, PhD|716-845-1169|lgedeon@gogstats.org|
290469|NCT01305239|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290470|NCT01305252|Stanford University School of Medicine|Roham Zamanian, MD, FCCP|650- 725-5495|zamanian@stanford.edu|
290471|NCT01305265|Dept. of Anesthesia & Perioperative Care, UCSF San Francisco|Kolodzie, Kerstin M.D, PhD, Principal Investigator|4158853647|kolodziek@anesthesia.ucsf.edu|
290472|NCT01305356|Wright Medical|Justin Moss|615-236-4984|Justin.Moss@wright.com|
290473|NCT01305408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
290474|NCT01305473|C.R. Bard: Davol, Inc.|Dawn Heimer/Director, Clinical Affairs|401-825-8681|dawn.heimer@crbard.com|
290475|NCT01305564|Bard Peripheral Vascular|Ryan Melloy|480-350-6074|ryan.melloy@crbard.com|
290476|NCT01305577|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
290477|NCT01305655|NOPHO|Dr Jesper Heldrup|+46705172389|jesper.heldrup@skane.se|
290478|NCT01305772|Duke University Medical Center|Neal Ready,MD|919-681-6932|neal.ready@dm.duke.edu|
290479|NCT01305811|New England School of Acupuncture|Lisa Conboy|6175581788|lconboy@nesa.edu|145
290480|NCT01305941|UNC Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
290481|NCT01306032|National Cancer Institute|Dr. Alice Chen|301-435-0517|chenali@mail.nih.gov|
290482|NCT01306058|Principal Investigator|Dr. Tim Greten|301-451-4723|tim.greten@nih.hhs.gov|
290483|NCT01306162|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290484|NCT01306175|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290485|NCT01306201|Covidien|Ulf Borg, Director of Clinical Affairs|303-305-2400|ulf.borg@covidien.com|
290486|NCT01306214|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290487|NCT01306253|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
290488|NCT01306292|Bracco Diagnostics Inc.|Dr. Maria Luigia Storto|609-514-2262|marialuigia.storto@diag.bracco.com|
290489|NCT01306305|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
290490|NCT01306331|Evofem|Chief Medical Officer|858-550-1900|kculwell@evofem.com|
290491|NCT01306617|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
290492|NCT01306643|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
290493|NCT01306656|Columbia University|Shonni Silverberg, MD|212-305-6291|sjs7@cumc.columbia.edu|
290494|NCT01306877|Covidien|Tam LaFleur, Clinical Project Manager|203-821-4744|tam.lafleur@covidien.com|
290495|NCT01306890|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@Dendreon.com|
290496|NCT01306942|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
290497|NCT01306968|Uniformed Services University of Health Sciences|Dr. R. Scott Miller, M.D.|301-816-8424|robert.s.miller@us.army.mil|
290498|NCT01307007|Luitpold Pharmaceuticals, Inc.|Sumita Chowdhury, MD, MPH, FACC, MBA|610-650-4200|SChowdhury@lpicrd.com|
290499|NCT01307020|Menarini Ricerche S.p.A.|Dr Angela Capriati, Corporate Clinical Research Director|+39 055 5680 9933|acapriati@menarini-ricerche.it|
290500|NCT01307098|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
290501|NCT01307111|University of New Mexico|Eve Espey, MD, MPH, Principle Investigator|505-272-6372|eespey@salud.unm.edu|
290502|NCT01307267|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290503|NCT01307319|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
290504|NCT01307397|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
290505|NCT01307423|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
290506|NCT01307449|Emory University|Rouphael, Nadine|404-712-1435|nroupha@emory.edu|
290507|NCT01307462|FHCRC|Guang-Shing Cheng MD|206-667-7074|gcheng2@fhcrc.org|
290508|NCT01307501|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
290509|NCT01307579|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
290510|NCT01307618|University of Chicago Comprehensive Cancer Center|Tomas Gajewski|773-702-4601|tgajewsk@medicine.bsd.uchicago.edu|
290511|NCT01307748|Oregon Health & Science University|Irina Chamine|503.577.6211|fonareva@ohsu.edu|
290512|NCT01307891|University of Alabama at Birmingham|Andres Forero, M.D.|205-934-7167|aforero@uab.edu|
299707|NCT01904448|University of North Carolina at Chapel Hill|Craig A. Buchman, MD, FACS|314-362-7395|buchmanc@wustl.edu|
290513|NCT01307930|TTUHSC|Ronald Hall|2143589009|ronald.hall@ttuhsc.edu|
290514|NCT01307956|University of Nebraska Medical Center|Jean L. Grem, MD|402-559-5166|jgrem@unmc.edu|
290515|NCT01308008|VA GRECC|Neil Alexander MD|734-845-3048|nalexand@umich.edu|
290516|NCT01308060|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
290517|NCT01308294|Department of Oncology, Division of Medical Oncology University Hospital Lausanne|Prof. Olivier Michielin, MD PhD|+41 21 314 01 85|Olivier.Michielin@chuv.ch|
290518|NCT01308424|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
290519|NCT01308450|BioBDx|Calvin R. Sumner, MD, CMO, Sr. VP for Clinical Development|978-431-5103|calvin_sumner@biobdx.com|
290520|NCT01308463|Zimmer Biomet|Kelly Francher|574-371-9783|kelly.francher@zimmerbiomet.com|
290521|NCT01308476|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290522|NCT01308567|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
290523|NCT01308580|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
290524|NCT01308619|Galderma Laboratories|Dr. Warren Winkelman|817-961-5494|warren.winkelman@galderma.com|
290525|NCT01308736|Rutgers Robert Wood Johnson Medical School|Dr. Marc Steinberg|7322354341|marc.steinberg@rutgers.edu|
290526|NCT01308749|Duke University Center for Autism and Brain Development|Linmarie Sikich, MD|9196810026|linmarie.sikich@duke.edu|
290527|NCT01308762|Immodulon Therapeutics, The London Clinic Cancer Centre, London W1G 6JA,|Clinical Trials Co-ordinator|+44 (0)203 219 3568/3572|Ilda@immodulon.com|
290528|NCT01308788|Indiana University|Alon Harris|3170278-0177|alharris@indiana.edu|
290529|NCT01308814|University of North Carolina at Chapel Hill|Susan S. Girdler, Ph.D.|919-966-2179|susan_girdler@med.unc.edu|
290530|NCT01308840|University of Rochester|Aram F Hezel|585-275-5823|aram_hezel@urmc.rochester.edu|
290531|NCT01308853|Akademikliniken, Stockholm, Sweden|Dr. Per Hedén|+46 8 614 54 00|per.heden@ak.se|
290532|NCT01308918|Institut universitaire de cardiologie et de pneumologie de Quebec|Nathalie Gagne|418 656-8711|nathalie.gagne@criucpq.ulaval.ca|2645
290533|NCT01309100|Bausch & Lomb|Dr. Robert Steffen|585 338 6399|robert.steffen@bausch.com|
290534|NCT01309165|Sunnybrook Research Institute|Dr. Sara McEwen|4162266780|sara.mcewen@sunnybrook.ca|7957
290535|NCT01309204|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
290536|NCT01309243|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
290537|NCT01309269|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
290538|NCT01309282|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
290539|NCT01309308|Baskent University|Ayse Parlakgumus|00903224586868|ayseparlakgumus@yahoo.de|2102
290540|NCT01309360|Helios-Kliniken Schwerin|Dr.med.Ronald Seidel|0049 (0)385 520-4251|ronald.seidel@helios-kliniken.de|
290541|NCT01309386|Neuroscience department, Clinical science department, R&D in Janssen, Chiyodaku, Tokyo 101-0065, Japan|Manager|+81-3-4411-5509||
290542|NCT01309451|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
290543|NCT01309646|GlaxoSmithKline|GSK Response Center|866-435-7343||
290544|NCT01309659|Duke University Medical Center|Harvey J Cohen, MD|919-660-7502|harvey.cohen@dm.duke.edu|
290545|NCT01309737|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290546|NCT01309802|Southern Illinois University School of Medicine|Research Administrator|217-545-2531|surgeryresearch@siumed.edu|
290547|NCT01309828|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
290548|NCT01309841|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
299708|NCT01904526|Yale School of Medicine|Sherry McKee, PhD|2037373529|sherry.mckee@yale.edu|
299709|NCT01904604|DAIT/NIAID|Director, Clinical Research Program|(301) 594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
299710|NCT01904721|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
299711|NCT01904760|Department of Anesthesiology, Peking University School and Hospital of Stomatology, Beijing, China|Xudong Yang|8610-82195287|kqyangxudong@163.com|
299712|NCT01904773|AstraZeneca Pharmaceuticals LP, Neuroscience Innovative Medicines Unit|Joel Posener, MD - Head, Early Clinical Development||ClinicalTrialTransparency@astrazeneca.net|
299713|NCT01904864|Baylor College of Medicine|Jacquelyn M. Powers, MD||jacquelyn.powers@bcm.edu|
299714|NCT01904903|MedStar|Allison Moses|301-256-2728|Allison.E.Moses@medstar.net|
299715|NCT01905241|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
299716|NCT01905254|Universitiy Clinic Hamburg eppendorf|PD Dr. Ulrike Denzer|040741055380|u.denzer@uke.de|
299717|NCT01905267|University of Illinois at Chicago|Rachel Jacobs|3124139178|rjacobs@psych.uic.edu|312
299718|NCT01905423|Washington University in St Louis Medical School|Peter Fischer|+1 (314) 747-5198|pufischer@wustl.edu|
299719|NCT01905540|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
299720|NCT01905553|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
299721|NCT01905592|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
290549|NCT01309867|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
290550|NCT01309880|Bausch & Lomb|Dr. Robert Steffen|585 338 6399|robert.steffen@bausch.com|
290551|NCT01309893|Bausch & Lomb|Dr. Robert Steffen|585 338-6399|robert.steffen@bausch.com|
290552|NCT01309906|Bausch Health|Study Director||robert.steffen@bausch.com|
290553|NCT01309919|Baystate Medical Center|Dr. Katharine White|413-794-5256|katharine.white@bhs.org|
290554|NCT01309997|FHCRC|Stephanie J. Lee MD MPH|206-667-6190|sjlee@fhcrc.org|
290555|NCT01310036|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
290556|NCT01310075|UT MD Anderson Cancer Center|Dr. Mark W Clemens, Associate Professor, Plastic Surgery|713-794-1247|mwclemens@mdanderson.org|
290557|NCT01310127|Discover Vision Centers|Melissa Toyos, MD|816-478-1230|mtoyos@discovervision.com|
290558|NCT01310179|University of Alabama at Birmingham|Eben Rosenthal, MD|205-934-9713|erosenthal@uabmc.edu|
299722|NCT01905657|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290559|NCT01310231|Mount Sinai Hospital|Pamela Goodwin/PI|416 586-8211|Pamela.goodwin@sinaihealth.ca|
290560|NCT01310400|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
290561|NCT01310413|GlaxoSmithKline|GSK Response Center|866-435-7343||
290562|NCT01310582|Clinical Research Group|Kirtanaa Voralu, Associate Director Research Management|215-255-7878|kirtanaa.voralu@drexelmed.edu|7878
290563|NCT01310699|San Francisco VA Medical Center|Dr. Tonya Kaltenbach|415-221-4810|tonya.kaltenbach@va.gov|94121
290564|NCT01310777|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
290565|NCT01310855|UCL and CTC Cancer Trials Centre|Mark Phillips|0207 679 9139|ctc.doric@ucl.ac.uk|
290566|NCT01310868|University College London|GALA-5 Trial Coorinator|0207 679 9898|ctc.sponsor@ucl.ac.uk|
290567|NCT01311024|head of Clinical Research Unit, National Institute for Health and Welfare|Arto Palmu, MD, PhD Research manager,|+358295247910|arto.palmu@thl.fi|
290568|NCT01311102|Harbor-UCLA Medical Center|Dr. Anita Nelson|310-222-3871|anitanelsonwhc@earthlink.net|
290569|NCT01311362|University of Heidelberg|Prof. Dr. med. Gerd Mikus|4966215639197|gerd.mikus@med.uni-heidelberg.de|
299723|NCT01905683|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
299724|NCT01905943|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
299725|NCT01905956|InQpharm Europe Ltd|Pee-Win Chong|+603 6201 9690|pwchong@inqpharm.com|358
299726|NCT01906008|UT MD Anderson Cancer Center|Dr. James Yao, MD, Director of GI Medical Oncology|(713) 792-2828|jyao@mdanderson.org|
299727|NCT01906346|University of Kentucky|Joshua A. Lile, Ph.D.|859-420-0503|jalile2@uky.edu|
299728|NCT01906372|University of Pittsburgh, Division of Rheumatology|Rohit Aggarwal, MD|412-647-2840|aggarwalr@upmc.edu|
309455|NCT02674568|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309456|NCT02674633|Akili Interactive Labs|Kathryn Jenkins|8572543399|kjenkins@akiliinteractive.com|
309457|NCT02674659|Harapan Kita National Cardiovascular Center|Bambang Dwiputra, MD, FIHA|0215684093|bambangdwiputra@gmail.com|
309458|NCT02674685|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309459|NCT02674854|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
281715|NCT00818454|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309460|NCT02675075|James A. Haley VA Hospital|Dr. Sam Phillips|813 558 3995|samuel.phillips@va.gov|
309461|NCT02675426|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309462|NCT02675517|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309463|NCT02675543|University of Brescia|Francesco Semeraro|+30 030 3995308|francesco.semeraro@unibs.it|
309464|NCT02675634|Scientific and Regulatory affairs|Sara Gosk|+45 49113568|dksargo@coloplast.com|
309465|NCT02675764|Medical University of South Carolina|Dr. Na Jin Seo|8437920084|seon@musc.edu|
309466|NCT02675907|Recro Pharma, Inc.|Randall Mack|484-395-2470|rmack@recropharma.com|2406
309467|NCT02675998|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
309468|NCT02676375|Department of Psychiatry, University of California San Diego|Dr. Arthur Brody|8585528585|abrody@ucsd.edu|3775
309469|NCT02676466|University of Florida|ENRGISE Coordinating Center Project Manager|352-294-5800|ENGISEACC@aging.ufl.edu|
309470|NCT02676778|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
309471|NCT02676843|Columbia University|William Kreisl, MD|212-342-2380|wck2107@cumc.columbia.edu|
309472|NCT02676882|Massachusetts General Hospital Center for Women's Mental Health|Dr. Marlene Freeman|617-643-6403|mfreeman@partners.org|
309473|NCT02676895|GlaxoSmithKline|GSK Response Center|866-435-7343|antonella.s.scire@gsk.com|
309474|NCT02677116|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
309475|NCT02677220|Cochlear|Director of Clinical Research|3032647180|loneill@cochlear.com|
309476|NCT02677324|DFCI|Jorge J. Castillo|617-632-2681|jorgej_Castillo@dfci.harvard.edu|
309477|NCT02677428|VA Connecticut Healthcare System|Marc Rosen|203-932-5711|marc.rosen@va.go|2112
309478|NCT02677493|IL-YANG PHARM.|Clinical Research Manager|+82-70-7165-7316|hlpark@ilyang.co.kr|7316
309479|NCT02677623|Columbia University|Nisha Philip, Clinical Research Manager|212-305-4973|np2173@cumc.columbia.edu|
309480|NCT02677701|Seattle Children's Hospital|Arthur Baines|2068841431|arthur.baines@seattlechildrens.org|
281716|NCT00818519|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
281717|NCT00818623|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
281718|NCT00818649|Masonic Cancer Center, University of Minnesota|Erica Warlick, M.D.|612-625-5467|ewarlick@umn.edu|
281719|NCT00818662|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
281720|NCT00818753|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
299729|NCT01906476|Northwestern University|Mary Kwasny|312-503-2294|m-kwasny@northwestern.edu|
290570|NCT01311505|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290571|NCT01311557|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
290572|NCT01311648|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
290573|NCT01311661|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290574|NCT01311674|Emergent Biosolutions|Christine Hall, Sr. Director Clinical Research||chall@ebsi.com|
290575|NCT01311687|Celgene Corporation|Associate Director, Clinical Trials Disclosure|1-888-260-1599||
290576|NCT01311895|Montefiore Medical Center|Dr. Andrew Chang|718-920-6626|achang3@yahoo.com|
290577|NCT01312038|Middle Ear Physiology Laboratory|Ellen Mandel, MD|412-692-6214|mandele@pitt.edu|
290578|NCT01312129|The Mind Research Network|Kent Hutchison, Ph.D.|720-663-0745|khutchison@mrn.org|
290579|NCT01312181|ResearchFMH|Dr. Efrat Aharonovich|646-774-7954|efrat.aharonovich@nyspi.columbia.edu|
290580|NCT01312233|Spine Institute for Quality|Christine M Goertz, DC, PhD (Study Principal Investigator)|301-335-0071|cgoertz@spineiq.org|
290581|NCT01312272|VISN 22 Mental Illness Research, Education, and Clinical Center|Dr. Michael C. Davis|3104783711|mcdavis@mednet.ucla.edu|49234
290582|NCT01312389|University of Pennsylvania|Director of Clinical Trial Operations|215-662-3324|tracey.thomas@pennmedicine.upenn.edu|
290583|NCT01312467|University of California, Irvine|Dr. Frank L. Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
290584|NCT01312519|Vidacare Corporation|Senior Director of Science and Clinical|210-375-8500|thomas.philbeck@vidacare.com|
290585|NCT01312675|B. Braun Medical Inc.|Dr. Diana Velencia, Associate Director of Clinical Affairs|610-596-2875|diana.valencia@bbraunusa.com|
299730|NCT01906515|Cairo University School Of Medicine|Dr Wael N Awada|00201006481958|waoool@hotmail.com|
299731|NCT01906658|Mallinckrodt Pharmaceuticals|Lawrence Hill|908-238-6370|lawrence.hill@mallinckrodt.com|
299732|NCT01906866|Neurim Pharmaceuticals|Dr. Tali Nir|972-7684902|talin@neurim.com|
299733|NCT01907087|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|PSlasor@bmrn.com|
299734|NCT01907100|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
299735|NCT01907113|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
299736|NCT01907217|St Patrick's University Hospital|Prof Declan McLoughlin|+353 1 2493343|d.mcloughlin@tcd.ie|
299737|NCT01907269|University of Alabama at Birmingham|Dr. Elizabeth J. Rahn|2059966552|rahneli@uab.edu|
299738|NCT01907321|University of Florida|Dr. Karen Hegland, PI|352 294-8366|kwheeler@ufl.edu|
309481|NCT02677714|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
309482|NCT02677740|University of Minnesota|Silvia Mangia, Associate Professor|6126254920|mangia@umn.edu|
309483|NCT02677753|University of Louisville|Dr. Sean Francis|5025617260|sean.francis@louisville.edu|
309484|NCT02677766|University of Modena and Reggio Emilia|Stefania Costi|+390522522441|stefania.costi@unimore.it|
309485|NCT02677779|AOU Careggi|Dr. Matteo Monami, Director Diabetic Foot Unit|00390557946563|matteo.monami@unifi.it|
309486|NCT02677844|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
309487|NCT02678000|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
309488|NCT02678039|Dartmouth-Hitchcock|Mark P. Yeager, MD|603-650-5922|mark.p.yeager@hitchcock.org|
309489|NCT02678247|Northwestern University|Dr. Stefania Fatone, Principle Investigator|3125035717|s-fatone@northwestern.edu|
309490|NCT02678286|Recro Pharma|Randall Mack|484-35-2470|rmack@recropharma.com|2406
309491|NCT02678390|Research Centre on Aging|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
309492|NCT02678416|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
309493|NCT02678442|Mayo Clinic|Dr. Michael B. Wallace|904-953-2222|wallace.michael@mayo.edu|
309494|NCT02678676|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
309495|NCT02678923|The Medicines Company|Global Health Science Center|1-888-977-6326|medical.information@themedco.com|
309496|NCT02679079|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
309497|NCT02679222|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
309498|NCT02679235|University of Sherbrooke|Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
309499|NCT02679274|University of Texas Medical Branch|Dr. Edgar L. Dillon|409 772 8701|eldillon@utmb.edu|
309500|NCT02679287|University of Virginia|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
309501|NCT02679469|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
309502|NCT02679573|Melinta Therapeutics, Inc.|Sue Cammarata|312-724-9401|scammarata@melinta.com|
309503|NCT02679690|University of Pittsburgh|Sheryl Ondrejko, DNP||sherylannmarieo@gmail.com|
270234|NCT00114530|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
309504|NCT02679729|AstraZeneca AB|Global Clinical Leader|+46 766 346712|ClinicalTrialTransparency@astrazeneca.com|
290586|NCT01312766|IBSA Institut Biochimique SA|Dr. Barbara Cometti, Senior Clinical Research Manager, IBSA|+41 58 360 10 00|barbara.cometti@ibsa.ch|
290587|NCT01312779|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
290588|NCT01312805|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
290589|NCT01312818|University of Minnesota, Pediatric Hematology Dept.|Dr. Michael Burke, MD|612-672-7422||
290590|NCT01312844|Massachusetts General Hospital|Dr. John Matthews|617-643-9095|jmatthews@partners.org|
290591|NCT01312909|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290592|NCT01312948|ResMed Ltd|Alison Wimms|+6188842583|alison.wimms@resmed.com.au|
290593|NCT01312961|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
290594|NCT01313039|University of Miami Sylvester Comprehensive Cancer Center|Judith Hurley MD|305-243-6462|JHurley@med.miami.edu|
290595|NCT01313078|National Cancer Institute, National Institutes of Health|Elise Kohn, M.D.|301-496-9336|kohne@mail.nih.gov|
299739|NCT01907334|University of Florida|Leslie Hendeles, PharmD|352-273-6027|hendeles@cop.ufl.edu|
299740|NCT01907490|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
299741|NCT01907516|John A Burns School of Medicine / University of Hawaii Dept of Obstetrics and Gynecology|Marguerite Lisa Bartholomew MD|808-983-6761|mbarthol@hawaii.edu|
299742|NCT01907607|Institut Bergonié|Pr Antoine Italiano|33 5 56 33 33 33|a.italiano@bordeaux.unicancer.fr|
299743|NCT01907737|HCFMUSP/FFM|Adriana Conforto|551126617955|adriana.conforto@gmail.com|
299744|NCT01907815|The University of Texas MD Anderson Cancer Center|Nitin Jain, MD, Assistant Professor, Leukemia|713-792-7734|CR_Study_Registration@mdanderson.org|
299745|NCT01907828|Abbott|Rebecca Maslow, MA, Clinical Project Manager|+1 651-756-5564|rebecca.maslow@abbott.com|
299746|NCT01907854|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
309505|NCT02679755|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309506|NCT02679807|University of Virginia|Ronald Turner|434-981-9141|rbt2n@virginia.edu|
309507|NCT02679911|Galderma|Farzaneh SIDOU Clinical Project Manager|0493957051|farzaneh.sidou@galderma.com|33
309508|NCT02679976|Johnson & Johnson Vision Care Inc.|Tom Karkkainen SR. PRINCIPAL RESEARCH OPTOMETRIST|904-443-3500|TKarkkai@its.jnj.com|3402
309509|NCT02680002|BARDA|Silvija Tresnjak-Smith|202-557-1993|Silvija.Tresnjak-Smith@hhs.gov|
309510|NCT02680041|Blue Earth Diagnostics, Ltd.|Peter Gardiner MB ChB, MRCP, FFPM|1-781-552-3403|P.Gardiner@blueearthDx.com|
309511|NCT02680054|Oxford University Hospitals NHS Trust|Dr Rachel Besser|01865 741741|rachel.besser@ouh.nhs.uk|
309512|NCT02680145|Mayo Clinic|Dr. John A. Occhino|(507) 538-5883|Occhino.John@mayo.edu|
309513|NCT02680158|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
309514|NCT02680301|Seton Family of Hospitals/Ascension|Katherine Sebastian|801-598-2484|krsebastian@ascension.org|
309515|NCT02680314|Montefiore Medical Center|Peter Bernstein, MD|718-904-2767|pbernste@montefiore.org|
309516|NCT02680457|Instituto de Terapéutica Experimental y Clínica, Universidad de Guadalajara|Dr. Manuel González Ortiz|+52 3310585200|uiec@prodigy.net.mx|34212
309517|NCT02680639|Philips|Senior Clinical Development Scientist|(724) 733-5835|chuck.cain@philips.com|
309518|NCT02680665|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309519|NCT02680756|Shield Therapeutics|Jackie Mitchell MA DPhil|0044 752 565 6885|jmitchell@shieldtx.com|
309520|NCT02680834|TactileMedical|Clinical Research Director|612-540-5267|astone@tactilemedical.com|
309521|NCT02680847|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309522|NCT02681094|AstraZeneca|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
309523|NCT02681172|Piramal Imaging|Dr. Juergen Hirschfeld, Head of GRA & PV|+49 30461124615|Juergen.Hirschfeld@piramal.com|
290596|NCT01313117|Northwestern University|Jeffrey Allen M.D.|312-695-8636|jallen1@nmff.org|
290597|NCT01313182|New York University School of Medicine|Dr. Michael Phillips|212 263 4316|michael.phillips@nyumc.org|
290598|NCT01313208|Amgen Inc.|Study Director|866-572-6436||
290599|NCT01313221|Amgen Inc.|Study Director|866-572-6436||
290600|NCT01313286|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299747|NCT01907906|Terumo BCT Biotechnologies, LLC|Ray Goodrich, PhD|(303) 231-4832||
290601|NCT01313299|Ipsen|Medical Director, Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
290602|NCT01313312|Ipsen Innovation|Medical Director, Neurology.||clinical.trials@ipsen.com|
299748|NCT01908062|Oregon Health & Science University|Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
290603|NCT01313494|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
290604|NCT01313507|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
309524|NCT02681458|Islamic Azad University of Mashhad|Dr. Hassan Yazdanfar|00985136631004|hasanyazdanfar@yahoo.com|
290605|NCT01313520|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader||ClinicalTrialsDisclosure@merck.com|
290606|NCT01313559|Thomas Jefferson University|Jianqing Lin, MD|215-955-8874|Jianqing.Lin@jefferson.edu|
309525|NCT02681510|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
309526|NCT02681523|Imperial College London|Laura Kenny|+44 (0)20 7594 2806|l.kenny@imperial.ac.uk|
309527|NCT02681614|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Bryan Traughber|+1 216-884-2516|bryan.traughber@uhhospitals.org|
309528|NCT02681757|Children's Hospital Colorado|Choi Young Mee MD|7207770859|youngmeeyoungmee@gmail.com|
309529|NCT02681809|ThromboGenics|Global Clinical Development|+3216751310|info@oxurion.com|
309530|NCT02682030|Cedars Sinai Medical Center - 8700|Dr. Ashraf Elsayegh|3105560335|ashraf.elsayegh@cshs.org|
309531|NCT02682056|Emory University|Eric Felner MD|404-727-7651|efelner@emory.edu|
309532|NCT02682069|MolecuLight Inc.|Liis Teene|416.542.5530|lteene@moleculight.com|
309533|NCT02682264|Cassiopea, SPA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
309534|NCT02682381|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
309535|NCT02682420|BD Peripheral Intervention|Courtney Rothwell, Clinical Project Manager|602-830-5544|courtney.rothwell@bd.com|
309536|NCT02682498|UC Irvine Health|Joseph Rinehart|714-456-5059|jrinehar@uci.edu|
309537|NCT02682563|AmsterdamUMC|Erik van Bommel|+31 20 444 2264|e.vanbommel@amsterdamumc.nl|
309538|NCT02682602|University of Tennessee|Richard Komistek, Principal Investigator|8659742093|rkomiste@utk.edu|
309539|NCT02682784|Medical University of South Carolina|Lisa Nunn|843-792-0476|jenkinli@musc.edu|
309540|NCT02682823|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
309541|NCT02683083|Camel-IDS|Tony Lahoutte|0032 24799360|tony.lahoutte@camel-ids.com|
309542|NCT02683109|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309543|NCT02683161|Johns Hopkins University|Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
309544|NCT02683174|NHS Lothian|Dr Matt Reed|+44 131 242 1448|Matthew.Reed@nhslothian.scot.nhs.uk|
309545|NCT02683187|Duke University Medical Center|Dr. David D'Alessio|919-684-5778|david.d'alessio@duke.edu|
309546|NCT02683421|Navidea Biopharmaceuticals|Bonnie C. Abbruzzese, MS, RD|614-822-2327|babbruzzese@navidea.com|
309547|NCT02683525|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
309548|NCT02683577|Ipsen Pharma|Medical Director||clinical.trials@ipsen.com|
309549|NCT02683668|Imperial College London|Dr Omar Usmani|02073158051|o.usmani@imperial.ac.uk|
309550|NCT02683707|JohnsHopkinsU|Dr J William McEvoy|4109555000|jmcevoy1@jhmi.edu|
309551|NCT02683746|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
309552|NCT02683772|ResMed|Maureen Crocker, Manager Medical Affairs|8588366653|maureen.crocker@resmed.com|
309553|NCT02683785|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
309554|NCT02683876|MEBO Research|Maria De la Torre|7862286880|maria.delatorre@meboresearch.org|
290607|NCT01313624|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
290608|NCT01313637|GlaxoSmithKline|GSK Response Center|866-435-7343||
290609|NCT01313650|GlaxoSmithKline|GSK Response Center|866-435-7343||
290610|NCT01313663|GlaxoSmithKline|GSK Response Center|866-435-7343||
290611|NCT01313676|GlaxoSmithKline|GSK Response Center|866-435-7343||
290612|NCT01313728|Valeant Pharmaceuticals International Inc|David Lineberry, Associate Director, Clinical Operations|949-973-1153|David.Lineberry@valeant.com|
290613|NCT01313767|Clinical Development Team of Medytox Inc.|Medytox Inc.|82-70-8666-6911|hgpark@medytox.com|
290614|NCT01313780|Seoul Asan Hospital|Taewon Kim|82-2-3010-3910|twkimmd@amc.seoul.kr|
290615|NCT01313858|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290616|NCT01313884|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
290617|NCT01313897|University of Arkansas for Medical Sciences|Frits van Rhee|501-526-6990|vanrheefrits@uams.edu|
299749|NCT01908101|Seattle Cancer Care Alliance|Stefanie Parker|206-889-0917|parkers@seattlecca.org|
299750|NCT01908127|Tehran University of Medical Sciences|Dr. Mehrsa Paryab|00989121091675|drmparyab@yahoo.com|
299751|NCT01908140|AstraZeneca|Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
299752|NCT01908205|Holland Bloorview Kids Rehabilitation Hospital|Lisa Genore|416-425-6220|lgenore@hollandbloorview.ca|6443
299753|NCT01908426|Exelixis, Inc.|Exelixis Medical Information|855-292-3935|druginfo@exelixis.com|
299754|NCT01908530|Imperial College London|Prof Nick Oliver|07957163617|nick.oliver@imperial.ac.uk|
299755|NCT01908582|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299756|NCT01908634|Illinois Institute of Techology|Britt Burton-Freeman|708-341-0178|bburton@iit.edu|
299757|NCT01908699|Lung Biotechnology PBC|Lung Biotechnology PBC Study Director|301-608-9292|info@lungbiotechnology.com|
299758|NCT01908751|McMaster University|Dr. Mohit Bhandari|9055274322|bhandam@mcmaster.ca|
309555|NCT02683928|Ichnos Sciences SA|Study Director|2013314000|clinicaltrialsdisclosuredesk@ichnossciences.com|
309556|NCT02683941|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
309557|NCT02683954|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
309558|NCT02684097|Icahn School of Medicine at Mount Sinai|Dr. Emma Guttman|212-241-9728|emma.guttman@mountsinai.org|
309559|NCT02684136|HenryFordHS|Timothy Roehrs PhD Study Investigator|313-916-5177|troehrs1@hfhs.org|
309560|NCT02684188|University of Montana|Tom Seekins, Ph.D.|2432654|TOm.Seekins@UMontana.edu|406
309561|NCT02684279|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
309562|NCT02684344|University of Rochester|Edward Messing|585 - 275 - 0998|edward_messing@urmc.rochester.edu|
309563|NCT02684357|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309564|NCT02684370|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309565|NCT02684396|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
309566|NCT02684435|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
309567|NCT02684591|UCSD|Rohit Loomba, MD, MHSc|858-246-2201|roloomba@ucsd.edu|
309568|NCT02684604|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
309569|NCT02684617|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
309570|NCT02684630|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
309571|NCT02684851|CarolinasHS|Rachel Seymour, PhD|704-355-6969|Rachel.Seymour@carolinashealthcare.org|
309572|NCT02684942|Chulabhorn hospital|Saengrawee Thanthong|+662-576-6021|saengrawee81@gmail.com|
309573|NCT02684981|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309574|NCT02685007|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
309575|NCT02685033|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
309576|NCT02685072|Yale School of Public Health|Kimberly Yonkers, MD|(203) 764-6621|kimberly.yonkers@yale.edu|
309577|NCT02685267|PCCTC|Jake Vinson|646-422-4383|vinsonj@mskcc.org|
309578|NCT02685293|Pearl Therapeutics Inc.|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
309579|NCT02685436|Manicure university children hospital|Dr.Ahmed Zaki|0201008335567|drahmedmd17@yahoo.com|
309580|NCT02685488|University of Arizona|Dr. John J.B. Allen|(520) 621-7448|john.jb.allen@arizona.edu|
309581|NCT02685566|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
309582|NCT02685826|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
309583|NCT02685956|Global BioClinical|Jennifer Maas|206-240-8632|jen.maas@globalbioclinical.com|
309584|NCT02685995|University of Pennsylvania|Gregory Nadolski, MD|(215) 662-7892|gregory.nadolski@pennmedicine.upenn.edu|
309585|NCT02686034|electroCore INC|Clinical Affairs|+1 973 355 6683|clinical@electrocore.com|
309586|NCT02686138|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
309587|NCT02686164|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
309588|NCT02686437|Sport and Spine Rehab Clinical Research Foundation|Jena Etnoyer-Slaski|301-251-2777|jslaski@ssrehab.com|838
309589|NCT02687035|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
309590|NCT02687126|Shahid Gangalal National Heart Centre|Santosh Sharma Parajuli|+9779806532132|santoshparajuli77@hotmail.com|
290618|NCT01313910|UCaliforniaDavis|David Asmuth, MD|9167348695|david.asmuth@ucdmc.ucdavis.edu|
290619|NCT01313936|UCSF Dept of Pediatrics|Steven DuBois, MD|415-476-3831|duboiss@peds.ucsf.ed|
290620|NCT01314001|University of Pennsylvania|Paul M. Sanborn, M.S.|215-746-7150|sanborn@mail.med.upenn.edu|
290621|NCT01314014|James P. Wilmot Cancer Center, University of Rochester|Paul M. Barr, MD|585-273-3258|Paul_Barr@urmc.rochester.edu|
290622|NCT01314105|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290623|NCT01314261|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
299759|NCT01908803|Alcon Research, Ltd.|Sr Clinical Project Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
299760|NCT01908816|Novartis Pharmaceuticals|Study Director|862-778-8300||
299761|NCT01908829|Astellas Pharma Europe Ltd|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
299762|NCT01908842|University of Virginia|Dr. Erik Gunderson, MD, FASAM|(434) 202-8612|EWG2N@hscmail.mcc.virginia.edu|
299763|NCT01908907|Sanford Health|Lora Black, Senior Director of Clinical Research|605-328-1368|lora.black@sanfordhealth.org|
299764|NCT01908972|Seoul National University College of Medicine|Prof. Tae Hyun Choi|82-10-5595-5829|psthchoi@snu.ac.kr|
299765|NCT01909011|Mount Sinai Beth Israel|Igor Galynker MD PhD|212-420-4535|igalynke@chpnet.org|
299766|NCT01909141|Cairo University|Dr. Ghada Abdel Fattah|00201006513305|ghadaabdelfatah2007@yahoo.com|
309591|NCT02687139|Johns Hopkins University|Mohamad Allaf, MD|410-502-7710|mallaf@jhmi.edu|
309592|NCT02687191|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309593|NCT02687217|Lady Hardinge Medical College and associated Hospitals|Dr. Swati Sattavan|9891777424|swatisattavan@gmail.com|91
309594|NCT02687412|SichuanCHRI|Dr Cui Ling|+8618181422637|cuiling1985@qq.com|
309595|NCT02687451|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|clinicaltrials@endo.com|
309596|NCT02687529|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
309597|NCT02687542|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309598|NCT02687711|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
309599|NCT02687815|University of Pittsburgh|Dr. Juan Celedón|(412) 692-8429|juan.celedon@chp.edu|
309600|NCT02687919|University of Iowa|Amanda Irish||amanda.k.irish@gmail.com|
309601|NCT02688153|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, HVT|949-250-2500|mary_edwards@edwards.com|1536
309602|NCT02688192|Rutgers Cancer Inst. of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
309603|NCT02688218|Oregon Health and Science University|Joseph El Youssef|503-418-5128|elyoussj@ohsu.edu|
309604|NCT02688387|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
309605|NCT02688556|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|clinical.trials@sparcmail.com|
309606|NCT02688621|University of Vermont|Doris Ogden|802-656-1960|doris.ogden@uvm.edu|
309607|NCT02688764|Vifor Fresenius Medical Care Renal Pharma France|Milica Enoiu / Clinical Research Manager|+41588518264|milica.enoiu@viforpharma.com|
309608|NCT02688829|Microport Medical, Shanghai, China|Dr Zhang Haotian|8621-38954600|zhanght@microport.com|8552
309609|NCT02688842|Shanghai Microport Medical (Company) Co.,Ltd.|Haotian Zhang|+86-21-38954600|zhanght@microport.com|8552
309610|NCT02688868|Shanghai Microport Medicine|HT Zhang|+862138954600|zhanght@microport.com|8552
309611|NCT02688933|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
309612|NCT02689063|AFT Pharmaceuticals|Jennifer Zhang -Project Manager|+ 64 9 488 0232|jenniferz@aftpharm.com|710
309613|NCT02689076|James J. Peters VA Medical Center|Kimberly M. Judon|718-584-9000|Kimberly.Judon@va.gov|1174
309614|NCT02689154|Children's Hospital of Los Angeles|Dr. Alaina Vidmar|323-361-3385|avidmar@chla.usc.edu|
270235|NCT00114634|NICHD, NIH|Forbes D Porter|301-435-4432|fdporter@mail.nih.gov|
270236|NCT00114738|National Cancer Institute|Dr. Wyndham Wilson|301-435-2415|wyndham_wilson@nih.gov|
270237|NCT00114777|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
270238|NCT00114959|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
270239|NCT00114972|Boston Scientific|Nic Van Dyck / Senior Program Manager|+ 31 43 356 8328|vandyckn@bsci.com|
270240|NCT00115037|UPENN|David Oslin, MD|215-823-5894|oslin@upenn.edu|
270241|NCT00115063|PenningtonBRC|Tiffany Prather, RN, CDE|225-763-2979|tiffany.prather@pbrc.edu|
270242|NCT00115076|Rockefeller University|James G. Krueger MD, PhD|212-327-7730|kruegej@rockefeller.edu|
270243|NCT00115297|UMass|Craig M. Lilly, MD|508-868-5106|craig.lilly@umassmed.edu|
270244|NCT00115336|Cincinnati Children's Hospital Medical Center|Dr. Charles Quinn|5138033086|charles.quinn@cchmc.org|
270245|NCT00115349|UCL Cancer Institute|John Porter, MD, Principal Investigator|+011 (44) 207 679 6224|j.porter@ucl.ac.uk|
270246|NCT00115739|University of Michigan Comprehensive Cancer Center|Frances Worden, M.D.|(734) 615-6633|fworden@umich.edu|
270247|NCT00115765|Amgen Inc.|Study Director|866-572-6436||
270248|NCT00115778|Columbia University Medical Cetner|Selim Arcasoy, MD|212-305-7771|sa2059@columbia.edu|
270249|NCT00115804|University of Cincinnati|Dr. Lesley Arnold|513-475-8110|lesley.arnold@uc.edu|
281721|NCT00818766|Brigham & Women's Hospital|David Oxman, MD|215-503-1198|doxman2001@yahoo.com|
281722|NCT00818779|Texas Tech University Health Sciences Center School of Medicine|Gary Meyerrose|806-743-3150|gary.meyerrose@ttuhsc.edu|
281723|NCT00818805|Alcon Labs|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
281724|NCT00818883|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
281725|NCT00818961|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
281726|NCT00819013|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
290624|NCT01314313|Edwards Lifesciences|Tenley Koepnick||Tenley_Koepnick@edwards.com|
290625|NCT01314417|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
290626|NCT01314443|Ohio State University|Richard Bruno, PhD, RD|614-292-5522|bruno.27@osu.edu|
290627|NCT01314703|CareFusion|Jennifer Raeder-Devens|847-454-4939|jennifer.raeder-devens@carefusion.com|
290628|NCT01314716|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
290629|NCT01314742|Vanderbilt University Sch of Medicine|Dr. Beatrice Stefanescu|6159365933|beatrice.stefanescu@Vanderbilt.edu|
290630|NCT01314872|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
299767|NCT01909154|Hospital Universitario Puerta de Hierro Majadahonda, Madrid|Dr. Vaquero Crespo|91 191 7760|jesus.vaquero@salud.madrid.org|
290631|NCT01314911|Leidos Biomedical Research, Inc. is support to the National Institute of Allergy and Infectious Diseases (NIAID)|John Beigel, M.D|301-451-9881|jbeigel@niaid.nih.gov|
290632|NCT01314963|Stanford Univeristy Medical Center|Craig Levin, PhD; Professor of Radiology (Molecular Imaging Program at Stanford/Nuclear Medicine)|650-736-0449|cslevin@stanford.edu|
299768|NCT01909180|GE Healthcare|RIchard Petrisko|262-548-4637|richard.petrisko@ge.com|
299769|NCT01909336|HIMFG|Claudia Montserrat Flores Robles|(52) 5566756686|montseflores@hotmail.com|
299770|NCT01909453|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299771|NCT01909466|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
299772|NCT01909674|Weill Cornell Medical College|Dr. Matthew Ebben|6469629318|mae2001@med.cornell.edu|
299773|NCT01909713|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
299774|NCT01909778|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
299775|NCT01909791|Jaeb Center for Health Research|Adam Glassman|8139758690|drcrnet@jaeb.org|
299776|NCT01909804|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
299777|NCT01909973|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
309615|NCT02689206|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
309616|NCT02689219|IndianaU|Dr. Nabil Adra|(317) 944-5349|nadra@iu.edu|
309617|NCT02689492|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309618|NCT02689804|Columbia University|Carolyn L. Westhoff, MD|212-305-4805|clw3@columbia.edu|
309619|NCT02689973|SWPS University of Social Sciences and Humanities|Dr Aleksandra Luszczynska, Principal Investigator|+4877507260|aluszczynska@swps.edu.pl|
309620|NCT02690168|Pennington Biomedical Research Center|Dr. David McDougal|2257630278|DAVID.MCDOUGAL@PBRC.EDU|
309621|NCT02690181|GlaxoSmithKline|GSK Response Center|866-435-7343||
309622|NCT02690194|Boston Children's Hospital|Greggory Kobelski|7812161093|Greggory.Kobelski@childrens.harvard.edu|
309623|NCT02690207|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
309624|NCT02690558|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
309625|NCT02690649|Parkview Health|Julie Hughbanks|260-266-1444|julie.hughbanks@parkview.com|
309626|NCT02690701|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|Novartis.email@novartis.com|
309627|NCT02690714|Prometic Biotherapeutics Inc.|Senior Director, Clinical Development|301-549-9761|clinical@prometic.com|
309628|NCT02690727|Algorithme Pharma Inc.|Dr. Eric Sicard|(514) 858-6077|esicard@algopharm.com|
309629|NCT02690935|ECSOR|Dr. Stephane Heijmans|3267444093|Jacques.Bruhwyler@ecsor.com|
309630|NCT02690948|Stanford University|Anne Lynn S. Chang, Associate Professor of Dermatology|650-721-7151|alschang@stanford.edu|
309631|NCT02690974|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
309632|NCT02691143|Sport and Spine Rehab Clinical Research Foundation|Jena Slaski|240-766-0300|jslaski@ssrehab.com|838
309633|NCT02691247|Caladrius Biosciences|William Sietsema|9495352391|bsietsema@caladrius.com|
309634|NCT02691260|University of Wisconsin-Madison|Corrine Voils|608-262-9636|voils@surgery.wisc.edu|
309635|NCT02691416|The Third Central Clinical College of Tianjin Medical University, Tianjin the Third Central Hospital|Dr.Haiyun Wang|13752211206|why819@126.com|
309636|NCT02691455|The University of Texas Health Science Center at Houston|Robert M. Feldman, MD|(713) 559-5239|Robert.M.Feldman@uth.tmc.edu|
309637|NCT02691468|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
309638|NCT02691494|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309639|NCT02691507|Johnson & Johnson Consumer, Inc|Amisha Parikh-Das, PhD/Study Director|973-255-8701 USA EST|AParikh1@its.jnj.com|
309640|NCT02691572|Department of Anesthesia and Surgical Intensive Care, Mansoura University Hospitals, Mansoura, Egypt.|Dr. Mohamed Mohamed Tawfik|1001183400|m2tawfik@mans.edu.eg|0020
309641|NCT02691702|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309642|NCT02691741|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
309643|NCT02691936|Cleveland Clinic Foundation|Dr. Marie Fidela Paraiso|216-444-3428|PARAISM@ccf.org|
309644|NCT02691962|Becton Dickinson and Company|Dawn Heimer|+1-401-825-8681|Dawn.Heimer@bd.com|
309645|NCT02692040|Imperial College London|Dr Tricia Tan|020 838 38038|t.tan@imperial.ac.uk|
290633|NCT01315002|University Hospital Bonn, Department of Psychiatry and Psychotherapy|Prof. Dr. Michael Wagner|004922828716377|michael.wagner@uni-bonn.de|
290634|NCT01315028|University of Glasgow|Professor Andrew Gumley|0044 141 211 3927|andrew.gumley@glasgow.ac.uk|
290635|NCT01315132|Sidney Kimmel Cancer Center at Thomas Jefferson University|Neal Flomenberg, MD|215-955-4367|Neal.Flomenberg@jefferson.edu|
290636|NCT01315145|Vertos Medical|VP of Clinical Affairs|9493490008|kdavis@vertosmed.com|
290637|NCT01315158|Washington University School of Medicine|Faris Murad, M.D.||fmurad@northshore.org|
290638|NCT01315236|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development)|908-947-2651|kevin.mange@insmed.com|
290639|NCT01315249|Novartis|Study Director|41 61 324 1111||
290640|NCT01315574|Massachusetts Eye and Ear Infirmary|Dr. Pedram Hamrah|617-573-6060|ophthalmologyclinicalresearch@meei.harvard.edu|
290641|NCT01315665|Riley Hospital for Children|James Chmiel|317-948-7180|jfchmiel@iu.edu|
290642|NCT01315678|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development and Medical Affairs)|908-947-2651|kevin.mange@insmed.com|
299778|NCT01910064|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
299779|NCT01910116|Seoul National University Hospital|Prof. Eun Bong Lee|822-2072-3944|leb7616@snu.ac.kr|
299780|NCT01910129|electroCore Inc.|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
299781|NCT01910181|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
299782|NCT01910298|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
299783|NCT01910311|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299784|NCT01910519|Emory University|Nadine Rouphael MD|404-712-1435|nroupha@emory.edu|
299785|NCT01910636|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
299786|NCT01910688|Columbia University Medical Center|Dr. Julian Abrams|(212) 235-1496|ja660@cumc.columbia.edu|
299787|NCT01910792|Vitamin D, Skin, and Bone Research Laboratory|Dr. Michael F Holick|6176384546|mfholick@bu.edu|
309646|NCT02692209|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
309647|NCT02692235|AWFiS|Robert Olek|+48 58 5547392|robol@awf.gda.pl|
309648|NCT02692391|Ohio State University|Georgios Papachristou, MD PhD|6142836255|georgios.papachristou@osumc.edu|
309649|NCT02692417|University of Michigan|Dr. Tim Bruns|(734) 647-8727|bruns@umich.edu|
309650|NCT02692482|Istituto Ortopedico Rizzoli|Cristiana Forni|0516366694|cristiana.forni@ior.it|0039
309651|NCT02692495|MEBO Research|Irene Gabashvili, Scientific Director|(408) 341-9355|irene.gabashvili@meboresearch.org|
309652|NCT02692560|Kaiser Permanente Washington Health Research Institute|Dori Rosenberg, PhD, MPH|206-287-2532|rosenberg.d@ghc.org|
309653|NCT02692586|Inari Medical|Ashleigh Willson|877-923-4747|ashleigh.willson@inarimedical.com|
309654|NCT02692703|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
290643|NCT01315847|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290644|NCT01316042|Milton S. Hershey Medical Center|Richard S. Legro, M.D.|717-531-8478|rlegro@hmc.psu.edu|
299788|NCT01910831|Center for Clinical and Cosmetic Research|Andrew Frisina, Clinical Research Coordinator|305 933 6716|A.Frisina@admcorp.com|
290645|NCT01316055|Vice President - Clinical Development & Medical Affairs (CDMA)|Herbert Henney, PharmD|(914) 347-4300|hhenney@acorda.com|5138
290646|NCT01316211|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
290647|NCT01316224|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
290648|NCT01316263|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299789|NCT01911065|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
299790|NCT01911169|Medical University of South Carolina|Dr. James Oates|843-789-6797|oatesjc@musc.edu|
299791|NCT01911221|Novartis Vaccines and Diagnostics|Posting Director||RegistryCpontactVaccinesUS@novartis.com|
299792|NCT01911260|Federal University of Sao Paulo|Ana Paula Poblacion|+55 11 55391783|anapoblacion@yahoo.com.br|
299793|NCT01911273|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299794|NCT01911351|NYCHHC Jacobi Medical Center|Dr. Sandra Cunningham|718 918 5250|sandra.cunningham@nbhn.net|
299795|NCT01911390|Department of Environmental and Radiological Health Sciences|Dr Elizabeth Ryan|970-491-1536|E.P.Ryan@colostate.du|
299796|NCT01911403|Hospital de Sao Joao, E.P.E.|Dr. Paulo Morgado|+351 22 551 2100|vilaresmorgado@iol.pt|
299797|NCT01911429|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
299798|NCT01911442|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
299799|NCT01911546|Former: Cedars-Sinai Medical Center, Comprehensive Transplant Center|Dr. Joseph Kahwaji, MD, MPH|310-423-2641|joseph.m.kahwaji@kp.org|
309655|NCT02692716|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
309656|NCT02692755|Georgetown University|Nicole Swanson|2026879194|ns1209@georgetown.edu|
309657|NCT02692859|jiangsuPCDCP|Kai Chu|18915999781|chukai19812007@163.com|
309658|NCT02693106|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
309659|NCT02693119|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-(617) 600-6888|jim.carr@stealthbt.com|
309660|NCT02693132|University of Colorado Denver|Seth Creasy|720-848-6477|seth.creasy@ucdenver.edu|
309661|NCT02693262|University of California, San Diego|Jonathan Hsu, MD, MAS|858-246-2972|jonathan.hsu@ucsd.edu|
309662|NCT02693418|Evofem Biosciences|Kelly Culwell, MD, MPH, FACOG|858-550-1900|kculwell@evofem.com|225
309663|NCT02693691|Abbott|Dr. Marie-Elena Brett|7815283613|marieelena.brett@abbott.com|
309664|NCT02693704|EPFL|Gilles Courtois|0041216932631|gilles.courtois@epfl.ch|
309665|NCT02693834|Baylor Institute for Rehabilitation|Priya Karakkattil, PT PhD|469-888-5172|Pjke7991@gmail.com|
309666|NCT02694029|UT Southwestern Medical Center|Asal Rahimi, MD|214/645-8556|Asal.Rahimi@UTSouthwestern.edu|
309667|NCT02694185|Rocky Mountain Regional VA Medical Center|Elizabeth Cheng|720-857-5101|elizabeth.cheng@va.gov|
309668|NCT02694198|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
309669|NCT02694315|Ain Shams Maternity hospital|amr ahmed mahmoud riad|01005347179|amr.riad@med.asu.edu.eg|+2
309670|NCT02694328|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
309671|NCT02694445|Department of Neurology, Xuan Wu Hospital,Beijing,China|Jianping Jia|010-63150669|jiajp@vip.126.com|
309672|NCT02694523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309673|NCT02694536|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
309674|NCT02694549|CaveoMed GmbH|Albertus M. Scheule, MD, PhD, MBA|+49(0)7071-53982-10|albertus.scheule@caveomed.com|
309675|NCT02694562|Boston Scientific|Angela Schutt|763-494-2166|angela.schutt@bsci.com|
309676|NCT02694601|Université de Sherbrooke|Pr. Stephen Cunnane|819-780-2220|stephen.cunnane@usherbrooke.ca|45670
309677|NCT02694718|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
309678|NCT02694744|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
309679|NCT02694835|Alcon, A Novartis Division|Clinical Project Lead, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
309680|NCT02694978|AMAG Pharmaceuticals, Inc.|Medical Information|1-877-411-2510|amag@druginfo.com|
309681|NCT02695290|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309682|NCT02695329|Zimmer Biomet G.K.|Clinical Affairs Senior Manager|+81-6402-6777|takahito.nakai@zimmerbiomet.com|
309683|NCT02695420|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
309684|NCT02695446|BioPharmX, Inc.|AnnaMarie Daniels|310-701-2080|amdaniels@biopharmx.com|
299800|NCT01911689|Sichuan Key Laboratory of Medical Imaging, Department of Radiology, Affiliated Hospital of North Sichuan Medical College|Dr.XiaoMing Zhang|+86 817 2262218|cjr.zhxm@vip.163.com|
290649|NCT01316276|Insmed Incorporated|Kevin Mange (Senior VP, Clinical Development)|908-947-2651|kevin.mange@insmed.com|
290650|NCT01316302|The Medical Research Network, LLC|Michael R. Liebowitz, M.D.|(212) 595-5012|MLiebowitz@MedicalResearchNetwork.com|
290651|NCT01316315|N30 Pharmaceuticals Inc.|Janice M. Troha|720-945-7714|janice.troha@n30pharma.com|
290652|NCT01316341|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage@boehringer-ingelheim.com|
290653|NCT01316380|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290654|NCT01316419|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290655|NCT01316510|UC Davis|Mark Underwood|916-734-8672|munderwood@ucdavis.edu|
290656|NCT01316575|University of Saskatchewan|Dr. William McKay|306-655-1202|william.mckay@saskatoonhealthregion.ca|
290657|NCT01316614|Washington University School of Medicine|Daniel K. Mullady, M.D.|314-362-8546|dmullady@dom.wustl.edu|
290658|NCT01316692|Vanderbilt-Ingram Cancer Center|Jeff Sosman, MD|615-875-8359|jeff.sosman@vanderbilt.edu|
299801|NCT01911780|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
299802|NCT01911819|Loma Linda University|Prof. Joseph Kan|(909) 558-4980|jkan@llu.edu|
299803|NCT01911845|AbbVie|Global Medical Information|800-633-9110||
299804|NCT01911910|Queen Mary University London/ Barts Health NHS Trsut|Dr Mohammed Khanji|020 7363 8079|m.khanji@qmul.ac.uk|
299805|NCT01912222|Takeda|Medical Director|+1-866-835-2233|GlobalOncologyMedinfo@takeda.com|
299806|NCT01912274|Helsinn HealthcareSA|Edwin de Wit - Head of Clinical development|+ 41 919852121|info-HHC@helsinn.com|
299807|NCT01912287|NYU Langone Health|Naomi Simon|646-754-4507|Naomi.Simon@nyulangone.org|
299808|NCT01912339|Boston Scientific Corporation|Kevin Hagelin, Clinical Program Manager|(800) 328-3881|kevin.hagelin@bsci.com|
299809|NCT01912352|Seoul National University|Dr. Jae-Won Kim|822-2072-3648|adore412@paran.com|
309685|NCT02695524|University of São Paulo|Anamaria Siriani de Oliveira|+551633154415|siriani@fmrp.usp.br|
309686|NCT02695537|University of Alabama at Birmingham|Dr. Martina Bebin, MD|205-934-3866|ebebin@uab.edu|
309687|NCT02695628|Stanford University|Rajesh Shah|650-723-0728|rajshah@stanford.edu|
309688|NCT02695719|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
309689|NCT02696031|Novartis Pharma AG|Study Director|1-888-669-6682|novartis.email@novartis.com|
309690|NCT02696070|Regenesis Biomedical|Heather Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
309691|NCT02696083|Regenesis Biomedical|Clinical Operations Manager|602-428-7041|heather.vanderploeg@regenesisbio.com|
309692|NCT02696200|Cincinnati Childrens Hospital|Kim Foss|513-636-5971|kim.foss@cchmc.org|
309693|NCT02696291|Emergent Product Development Gaithersburg, Inc.|Tim Babinchak, MD|(240) 631-3585|tbabinchak@ebsi.com|
309694|NCT02696317|Alcon, A Novartis Division|Sr. Brand Lead, Global Medical Affairs, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
309695|NCT02696434|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
309696|NCT02696759|University of Arkansas for Medical Sciences|Beth Scanlan|6868274|bscanlan@uams.edu|
309697|NCT02696785|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
309698|NCT02696798|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
309699|NCT02696850|WashingtonU|Dr. Jay F. Piccirillo, Principal Investigator|(314) 362-8641|piccirij@wustl.edu|
309700|NCT02696902|MedImmune, LLC|Mark Esser|+1 301 3986849|information.center@astrazeneca.com|
309701|NCT02696967|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
309702|NCT02697071|Lewis Gale Medical Center|Corey Heitz, MD|5406322364|coreyheitzmd@gmail.com|
309703|NCT02697188|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|212
309704|NCT02697214|The Cleveland Clinic|Marc Gillinov, MD|216 445-8841|GILLINOM@ccf.org|
309705|NCT02697240|Children's National Medical Center|Suvankar Majumdar|2024763800|smajumdar@childrensnational.org|
309706|NCT02697292|Mayo Clinic|Sean J. Pittock, M.D.|507-2084-4741|Pittock.Sean@mayo.edu|
309707|NCT02697435|VAPHS|Debra Kaye Weiner, M.D.|412-360-2920|Debra.Weiner@va.gov|
309708|NCT02697591|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
309709|NCT02697617|Indiana University School of Medicine|Dr. Sharon Moe|317 278 2868|smoe@iu.edu|
309710|NCT02697734|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
309711|NCT02697773|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309712|NCT02697890|TuftsUSDM|Y. Natalie Jeong|6176366531|natalie.jeong@tufts.edu|
309713|NCT02697916|Duke University; Duke Clinical Research Institute|W. Schuyler Jones, MD|919-668-8917|schuyler.jones@duke.edu|
309714|NCT02698033|Massachusetts General Hospital|Wayne Shreffler|6177266147|wshreffler@mgh.harvard.edu|
309715|NCT02698176|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
309716|NCT02698189|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
309717|NCT02698215|University of California Los Angeles|Lara Ray, PhD|310-794-5383|lararay@psych.ucla.edu|
309718|NCT02698241|Medtronic CRHF Clinical Research|Joe Hobbs Clinical Research Specialist|800-633-8766|joe.hobbs@medtronic.com|
309719|NCT02698371|University Fernando Pessoa|Prof. Patricia Manarte-Monteiro; Associate Professor|+351 225 071 300|patmon@ufp.edu.pt|
309720|NCT02698410|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
309721|NCT02698423|Geneva University Hospitals|Dr Manuela Viviano|07955 32 272|manuela.viviano@hcuge.ch|
299810|NCT01912456|CSL Behring GmbH|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
309722|NCT02698436|JNJWorldwide|Lisa Fitzgerald|+1 908-904-6235|lfitzge6@its.jnj.com|
299811|NCT01912495|Erasmus MC|B.J.A.Rijnders|0031107034529|b.rijnders@erasmusmc.nl|
290659|NCT01316770|NIDCR/NIH|Ilias Alevizos|3014966207|alevizosi@mail.nih.gov|
290660|NCT01316887|GlaxoSmithKline|GSK Response Center|866-435-7343||
290661|NCT01316900|GlaxoSmithKline|GSK Response Center|866-435-7343||
290662|NCT01316913|GlaxoSmithKline|GSK Response Center|866-435-7343||
290663|NCT01316926|GlaxoSmithKline|GSK Response Center|866-435-7343||
290664|NCT01316939|GlaxoSmithKline|GSK Response Center|866-435-7343||
290665|NCT01317004|Novartis Pharmaceuticals|Study Director|862-778-8300||
290666|NCT01317030|Bausch & Lomb Incorporated|Robert Steffen, O.D., M.S.|585-338-6399|Robert.Steffen@bausch.com|
290667|NCT01317095|Thomas Jefferson University|Hitoshi Hirose, Professor of Surgery|2159556925|Hitoshi.Hirose@jefferson.edu|
290668|NCT01317160|Karolinska university Hospital|Dr. Paul W. Ackermann|+46851770000|paul.ackermann@karolinska.se|
299812|NCT01912599|University of North Carolina|Jean-Claude Mwanza, MD, MPH, PhD|919-843-4917|jean-claude_mwanza@med.unc.edu|
299813|NCT01912612|University of Michigan Rogel Cancer Center|Lynn Henry, MD, PhD|734-936-9868|norahh@med.umich.edu|
299814|NCT01912716|Indiana University|Dr. Evan Fogel|317-944-2816|efogel@iu.edu|
299815|NCT01912729|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
299816|NCT01912768|Alcon Research, Ltd.|Clinical Project Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
299817|NCT01912781|Alcon Research, Ltd.|Clinical Project Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
299818|NCT01912807|University of Saskatchewan|Andrea Vasquez Camargo|306 7660444|a.vasquez@usask.ca|
309723|NCT02698475|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
309724|NCT02698566|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
309725|NCT02698735|University of Southern California Department of Dermatology|Dr. David Woodley|(323)442-0084|dwoodley@med.usc.edu|
309726|NCT02698787|Cochlear|Naomi Croghan|+13032642131|ncroghan@cochlear.com|
309727|NCT02698800|Columbia University Medical Center|Dr. Ari Shechter, Principal Investigator|212-342-4487|as4874@cumc.columbia.edu|
309728|NCT02699099|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
309729|NCT02699125|University of California San Diego|Michael G. Ziegler, M.D.|619 543 2885|mziegler@ucsd.edu|
309730|NCT02699450|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
309731|NCT02699463|ResMed Ltd|Dr Alison Wimms|+61 8884 1123|alison.wimms@resmed.com|
309732|NCT02699593|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO -Sr. Principal Research Optometrist|904 443-1290|BPALL@its.jnj.com|
309733|NCT02699632|Pennington Biomedical Research Center|Leanne Redman, Principal Investigator|2257630947|Leanne.Redman@pbrc.edu|
309734|NCT02699684|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
309735|NCT02699749|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
309736|NCT02699866|Institut Straumann AG|Dr. Michael McCaskey, Team Leader Clinical Research|+41619651741|michael.mccaskey@straumann.com|
309737|NCT02699892|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
309738|NCT02699970|Philips Digital Pathology Solutions|Mischa Nelis, Clinical Study Director||dpsclinicaltrials@philips.com|
309739|NCT02699983|Rutgers Robert Wood Johnson Medical School|Jeanne Ferrante|848-932-5252|jeanne.ferrante@rutgers.edu|
309740|NCT02699996|Rutgers Cancer Inst. of NJ|Dr. Katie Devine|7322357549|katie.devine@rutgers.edu|
309741|NCT02700165|Zeltiq Aesthetics|Kerrie Jiang, Exective Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
309742|NCT02700334|INSTITUTO DE TERAPUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
309743|NCT02700412|University of Alabama at Birmingham|Dr. Jerzy Szaflarski, MD, PhD|205-934-3866|jszaflarski@uabmc.edu|
309744|NCT02700425|The University of Chicago|Dr. Gaurav A. Upadhyay, MD|773-702-5988|gupadhyay@medicine.bsd.uchicago.edu|
309745|NCT02700815|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309746|NCT02700919|Mereo BioPharma Group|Ian Hodgson, Head of Clinical Operations|+44 3330237300|enquiries@mereobiopharma.com|
309747|NCT02700945|Medtronic|Carola Alfaro Vives|763-526-1539|carola.alfaro.vives@medtronic.com|
309748|NCT02700984|Alcon Research|Sr Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
309749|NCT02700997|TriHealth Inc.|Rachel Pauls MD|513-463-4300|Rachel_Pauls@trihealth.com|
309750|NCT02701049|Brigham and Women's Hospital|Dr. Adil H. Haider|617-525-9280|ahhaider@bwh.harvard.edu|
309751|NCT02701062|AtriCure|Nfii Ndikintum, VP Clinical Affairs and Biometrics|(513) 644-8192|nndikintum@atricure.com|
309752|NCT02701101|Bruin Biometrics|Vignesh Iyer|3102689494|viyer@bruinbiometrics.com|
309753|NCT02701192|Carolinas Healthcare System|Rachel Seymour, PhD|704-355-2000|Rachel.Seymour@carolinas.org|
309754|NCT02701257|MGH Diabetes Research Center|Courtney Balliro|617-726-1242|cballiro@partners.org|
290669|NCT01317199|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Dr. Channing Paller|410-955-8239|cpaller1@jhmi.edu|
290670|NCT01317277|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
290671|NCT01317472|Indiana University|Terese Stevens, Dept administrator|317-278-3187|tstevens@iupui.edu|
290672|NCT01317550|MD Anderson Cancer Center|Dr. Zhongxing Liao, MD/Professor, Radiation Oncology Department|713-563-2300|zliao@mdanderson.org|
299819|NCT01912872|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
290673|NCT01317615|Novartis|Study Director|862-778-8300||
290674|NCT01317641|Orion Pharma, Development, R&D|Head of Oncology|+358 10 4261|mika.mustonen@orionpharma.com|
290675|NCT01317667|US Army Medical Research Institute of Infectious Diseases (USAMRIID)|Denise P Clizbe, RN, CCRC|301.619.6869|denise.p.clizbe.civ@mail.mil|
290676|NCT01317797|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
290677|NCT01317901|Aptevo Therapeutics|Scott C. Stromatt|206-859-6675|sstromatt@apvo.com|
290678|NCT01317940|Children's Hospital Los Angeles|Dr. Etan Orgel|3233612672|eorgel@chla.usc.edu|
290679|NCT01318018|Dept. of Anesthesiology and Intensive Care Medicine|Prof. Dr.Martin Soehle|++49-228-287-|martin.soehle@ukb.uni-bonn.de|11378
299820|NCT01912963|Dana-Farber Cancer Institute|Rachel Freeman MD|617.632.3000|Rachel_Freedman@dfci.harvard.edu|
299821|NCT01913041|Peking Union Medical College Hospital, Anesthesia Department|Dr. Jie Yi|+86 10 69152025|neyil@pumch.cn|
299822|NCT01913314|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299823|NCT01913340|University of California San Francisco|Yvonne Wu, MD MPH||wuy@ucsf.edu|
299824|NCT01913353|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
299825|NCT01913405|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
299826|NCT01913470|Emory University|Miriam Vos, MD, MSPH|404-727-9930|mvos@emory.edu|
299827|NCT01913483|Miami Cardiac & Vascular Institute, Baptist Health South Florida|Chief Medical Executive|800-273-2700|MCVI@BaptistHealth.net|
299828|NCT01913535|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|mfava@mgh.harvard.edu|
299829|NCT01913600|Medtronic, Coronary & Structural Heart Clinical|Lisa Bousquette, Clinical Research Director|707-591-2967|rs.medtroniccardiovascularclinicaltrials@medtronic.com|
299830|NCT01913639|Memorial Sloan Kettering Cancer Center|Dr. Yelena Janjigian, MD|646-888-4186|janjigiy@mskcc.org|
299831|NCT01913795|Boston Children's Hospital|Dr. Wanda Phipatanakul|617-355-6117|Wanda.Phipatanakul@childrens.harvard.edu|
299832|NCT01914003|QOL Medical, LLC|Heather Smith, Director of One Patient Services|919-832-4949|hsmith@onepatientservices.com|
299833|NCT01914159|Dept of Ophthalmology, University of Bonn, Bonn, Germany|Tim U. Krohne, MD, FEBO|+49 228 287|krohne@uni-bonn.de|15505
299834|NCT01914393|Sunovion Pharmaceuticals Inc.|CNS Medical Director|866-503-6351|ClinicalTrialDisclosure@sunovion.com|
299835|NCT01914510|University Health Network - Princess Margaret Cancer Centre|Dr. Amit Oza|416-946-2818|amit.oza@uhn.ca|
299836|NCT01914666|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299837|NCT01914679|University of Michigan|Daniel Clauw, MD|734-998-6901|dclauw@med.umich.edu|
299838|NCT01914757|AstraZeneca|Mitchell Goldman, Medical Science Director|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
299839|NCT01914926|Maimonides Medical Center|Christian Fromm, MD; Director of Research|718-283-6391|cfromm@maimonidesmed.org|
299840|NCT01915095|Hines VA|Audrey Wilson|3122383637|awilson03@sralab.org|
299841|NCT01915108|assistant professor|Dr. Sangjin Park|82-53-620-3366|apsj0718@naver.com|
299842|NCT01915173|Massachusetts General Hospital|Michelle L. Dossett, MD, PhD, MPH|617-643-6034|mdossett@mgh.harvard.edu|
299843|NCT01915303|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
299844|NCT01915563|Althaia Xarxa Assistencial Universitaria de Manresa|Dr Rafael Fernandez|34.8732550|rfernandezf@althaia.cat|3730
299845|NCT01915732|GlaxoSmithKline|GSK Response Center|866-435-7343||
299846|NCT01915771|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-500-5142|alison.long@aegerion.com|
299847|NCT01915823|Meda Pharmaceuticals|Dr.Nancy Ruiz,MD|7325642390|nancy.ruiz@meda.us|
299848|NCT01915849|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
309755|NCT02701270|Danisco Sweeteners Oy|Kirsti Tiihonen|+358 10 431 050|kirsti.tiihonen@dupont.com|
309756|NCT02701296|ST. FRANCIS HOSPITAL AND MEDICAL CENTER|Sanjay Sinha, MD||sanjaysinha@comcast.net|
309757|NCT02701361|Duke University Health System|Christopher Cox|9196817232|christopher.cox@duke.edu|
309758|NCT02701387|UCLA School of Dentistry|Perry R. Klokkevold, DDS, MS, FACD|310-825-1927|pklokkevold@dentistry.ucla.edu|
309759|NCT02701400|Emory University|Dr. Taofeek Owonikoko|404-778-5575|TOWONIK@emory.edu|
309760|NCT02701413|Northwestern University|Dr. Christina Lewicky-Gaupp|312-472-3874|christina.lewickygaupp@nm.org|
309761|NCT02701582|NYU School of Medicine|Marc Bloom, MD, PHD|305 689-2388|mbloom@miami.edu|
309762|NCT02701634|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
309763|NCT02701647|The Hong Kong Polytechnic University|Chloe Chung|2766|chloe.lh.chung@connect.polyu.hk|7092
309764|NCT02701764|University of Miami|Dr. Anat Galor|305-450-6050|agalor@med.miami.edu|
309765|NCT02701868|Pennington Biomedical Research Center|Abby Altazan|2257632801|Abby.Altazan@pbrc.edu|
309766|NCT02701985|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
309767|NCT02702011|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309768|NCT02702193|University of Miami|Victoria Mitrani|305 284-9139|vmitrani@miami.edu|
309769|NCT02702388|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
309770|NCT02702401|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
309771|NCT02702518|University of Illinois Chicago|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
309772|NCT02702609|Sunstar Americas, Inc.|Akane Takemura|8477944276|akane.takemura@us.sunstar.com|
309773|NCT02702921|Ethicon Endo Surgery|Jason Waggoner, PhD|+1 513.337.8310|jwaggon1@its.jnj.com|
309774|NCT02702999|The University of Texas Health Science Center at Houston|Olaide Azizat Ashimi Balogun, MD|(713) 500-6412|Olaide.A.Ashimi@uth.tmc.edu|
290680|NCT01318070|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
290681|NCT01318083|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
290682|NCT01318109|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
290683|NCT01318122|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
290684|NCT01318135|Japan Development Center, Pharmaceutical Development Division|General Manager|+81-6-6204-5257|clinicaltrialregistry@tpna.com|
290685|NCT01318278|Baylor College of Medicine|Dr. Danielle R. Rios|832-826-1380|drrios@texaschildrens.org|
290686|NCT01318356|Radboud university medical center|S.P. Keijmel, MD PhD|0031243611111|stephan.keijmel@radboudumc.nl|
290687|NCT01318382|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
299849|NCT01915914|GlaxoSmithKline|GSK Response Center|866-435-7343||
299850|NCT01915940|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
299851|NCT01916109|Memorial Sloan Kettering Cancer Center|Dr. Dean Bajorin|646-422-4333|bajorind@mskcc.org|
299852|NCT01916226|GlaxoSmithKline|GSK Response Center|866-435-7343||
299853|NCT01916304|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
299854|NCT01916629|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
299855|NCT01916655|VA San Diego Healthcare System|Carl J. Stepnowsky, PhD|858-642-1240|Carl.Stepnowsky@va.gov|
299856|NCT01916681|University of Pennsylvania|Dr. Lisa Levine|2156626913|lisa.levine@uphs.upenn.edu|
299857|NCT01916824|Emory University|Boadie Dunlop, MD|404-727-8969|bdunlop@emory.edu|
299858|NCT01916928|Medstar Washington Hospital Center|Cecily A. Clark-Ganheart|202-877-3067|ganheartmd@gmail.com|
299859|NCT01916941|University of New Mexico|Dr. Claire Wilcox|505-272-2333|cewilcox@salud.unm.edu|
299860|NCT01917006|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
299861|NCT01917084|New England Research Institutes|Felicia Trachtenberg|617-972-3120|FTrachtenberg@neriscience.com|
299862|NCT01917136|University of Pennsylvania|Dr. Yuchi Han|215-662-2855|yuchi.han@uphs.upenn.edu|
299863|NCT01917188|Intermountain Heart Institute|Patti Spencer|8015074700|patti.spencer@imail.org|
299864|NCT01917214|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299865|NCT01917344|Boston Children's Hospital|Susan Waisbren, P.h.D|617-355-7346|susan.waisbren@childrens.harvard.edu|
299866|NCT01917513|Helios Dr. Horst Schmidt Kliniken, Wiesbaden, Germany|Prof. Ralf Kiesslich||ralf.kiesslich@hsk-wiesbaden.de|
299867|NCT01917526|Mahidol University|Department of Anesthesiology, Siriraj Hospital|66-2-41979889|manee95@hotmail.com|501
299868|NCT01917656|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
299869|NCT01917682|Corindus, Inc.|John Van Vleet, VP of Clinical and Regulatory Affairs|(260)615-8892|john.van_vleet@siemens-healthineers.com|
299870|NCT01917747|UK Dept. of Otolaryngology Head and Neck Surgery|Dr. Matthew L. Bush|859-218-2168|matthew.bush@uky.edu|
299871|NCT01917773|Riley Hospital for Children, Indiana University|Joseph Croffie|317-944-3774|jcroffie@iupui.edu|
299872|NCT01917812|Johns Hopkins University School of Medicine|Dr. Seth S Martin|410-955-7376|smart100@jhmi.edu|
299873|NCT01917968|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
299874|NCT01918072|VA Greater Los Angeles Healthcare System, West Los Angeles, CA|Donna L. Washington, MD, MPH|310-478-3711|donna.washington@va.gov|49479
299875|NCT01918085|Coloplast|Henrik Sigaard Knoth|+ 45 4911 3469|dkhsk@coloplast.com|
299876|NCT01918189|VA Boston Healthcare System|Diana M. Higgins, PhD|857-364-2221|diana.higgins2@va.gov|
299877|NCT01918306|Vanderbilt-Ingram Cancer Center|Dr. Vandana Abramson|800-811-8480|vandana.abramson@vanderbilt.edu|
299878|NCT01918332|Yonsei University Healthcare System Severance Hospital|Prof. YangSoo Jang|82-2-6924-3109|yejung@lgls.com|
299879|NCT01918371|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
299880|NCT01918761|Cecog|MD Christiane Thallinger|+43 1 409 77 25|office@cecog.at|
299881|NCT01918774|Richard L. Roudebush VA Medical Center|Marina Kukla|317-988-3330|marina.kukla2@va.gov|
299882|NCT01918800|Portland VA Medical Center|Cinda Hugos|503-220-8262|hugosc@ohsu.edu|52338
299883|NCT01919112|Beth Israel Deaconess Medical Center|Sandeep Kumar, MD|617-632-8917|skumar@bidmc.harvard.edu|
299884|NCT01919164|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
299885|NCT01919190|Pacira Pharmaceuticals, Inc.|Paci|1-855-793-9727|MedInfo@pacira.com|
299886|NCT01919216|New York State Psychiatric Institute|Bret Rutherford|6467748660|brr8@cumc.columbia.edu|
299887|NCT01919229|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
299888|NCT01919307|Denver Health and Hospital Authority|Edward Maa|303-602-5099|Edward.Maa@dhha.org|
299889|NCT01919398|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
299890|NCT01919411|Massachusetts Eye & Ear Infirmary|Dr. Eric Holbrook|617-573-3209|Eric_Holbrook@meei.harvard.edu|
299891|NCT01919450|Cardiovascular Imaging Technologies, LLC|Timothy M. Bateman, MD|816-531-2842|tbateman@cvit.com|
299892|NCT01919489|Emory University|Dr. Francisco Pasquel|404-778-1695|fpasque@emory.edu|
299893|NCT01919606|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
299894|NCT01919697|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
299895|NCT01919723|University of Alabama at Birmingham|Mehak Goel ,PhD|205-975-4021|mehakgoel@uabmc.edu|
299896|NCT01919801|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
299897|NCT01919814|Pennington Biomedical Research Center|Frank Greenway, MD|2257632578|frank.greenway@pbrc.edu|
309775|NCT02703259|Christiana Care Health Systems|Dr. Terri Huynh|302-623-4410|terri.huynh@christianacare.org|
299898|NCT01919970|Baylor College of Medicine|Dr. Eric Storch|727-767-8230|eric.storch@bcm.edu|
290688|NCT01318408|Drexel University College of Medicine|Carol Lippa, MD|215-762-7090|clippa@drexelmed.edu|
290689|NCT01318499|Alcon Research|Dana Sager, Clinical Manager Group Leader|1-817-551-8603|dana.sager@alconlabs.com|
290690|NCT01318512|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
290691|NCT01318538|McLean Hospital|Shelly F. Greenfield, MD, MPH|617-855-2241|sgreenfield@mclean.harvard.edu|
290692|NCT01318577|Bausch Health|Study Director|585-338-6399|robert.steffen@bausch.com|
299899|NCT01919996|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290693|NCT01318694|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
290694|NCT01318733|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
290695|NCT01318811|Vanderbilt_Univeristy MC|Dr. Thomas Golper|615-322-5914|thomas.golper@vumc.org|
299900|NCT01920061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299901|NCT01920152|University of Colorado, Denver|Omer Mei-Dan, MD|3033159900|omer.meidan@cuanschutz.edu|
299902|NCT01920178|Cambridge Health Alliance|Paul M. Heffernan, D.P.M.|617-665-2556|pheffernan@challiance.org|
299903|NCT01920282|Virginia Tech|Dr. Kevin Davy|(540) 231-3487|kdavy@vt.edu|
309776|NCT02703311|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
309777|NCT02703324|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
309778|NCT02703337|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
309779|NCT02703350|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
309780|NCT02703454|Abbott|Clinical Program Director|6517566717|kristin.ruffner@abbott.com|
309781|NCT02703467|Imperial College London|Professor Fan Chung|00442075947954|f.chung@imperial.ac.uk|
309782|NCT02703532|Emory University|Sarah Blanton, PT, DPT, NCS, FNAP|404-712-2222|sblanto@emory.edu|
309783|NCT02703636|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
309784|NCT02703779|University of Kansas Cancer Center|Dr. Sid Ganguly|913-588-6030|sganguly@kumc.edu|
309785|NCT02703909|University of Missouri - Columbia|Terri G. Monk, MD, Principal Investigator|(573)-882-2568|monkt@health.missouri.edu|
309786|NCT02703948|Galderma R&D, LLC|US A&C Clinical Operations|8179615111|courtney.maguire@galderma.com|
309787|NCT02703987|Danone Nutricia Research|Danone Nutricia Research||register.clinicalresearchnutricia@danone.com|
309788|NCT02704091|Ipsen Pharma SAS|Medical Director|see email|clinical.trials@ipsen.com|
309789|NCT02704104|Arch Therapeutics, Inc|Medical/Scientific Affairs|617 431-2313|jprats@archtherapeutics.com|
309790|NCT02704143|Changhai Hospital affiliated to Navy Medical University|Dr. Huojun Zhang|86-021-31162207|chyyzhj@163.com|
309791|NCT02704156|Changhai Hospital affiliated to Naval Medical University|Huojun Zhang|86-021-31162207|chyyzhj@163.com|
309792|NCT02704689|Stryker|Jennifer Warnke|(201) 749-8000|jennifer.warnke@stryker.com|
309793|NCT02704702|Celerion|Dr.Laura Sterling|1-402-476-2811|laura.sterling@celerion.com|
309794|NCT02705105|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
309795|NCT02705352|Massachusetts Eye and Ear|Shyana Harper|6173915982|Shyana_harper@meei.harvard.edu|
309796|NCT02705365|Massachusetts General Hospital|Sanja Percac-Lima, MD, PhD|617-643-6980|spercaclima@partners.org|
309797|NCT02705586|VA Portland Health Care System|Dr. Amie Hiller|503 721 1091|peterami@ohsu.edu|
309798|NCT02705625|Medivir|Linda Basse, Cheif Medical Officer|+46 8 546 831 00|linda.basse@medivir.com|
309799|NCT02705716|GlaxoSmithKline|GSK Response Center|866-435-7343||
309800|NCT02705807|GlaxoSmithKline|GSK Response Center|866-435-7343||
309801|NCT02706041|The University of Texas Health Science Center at Houston|John A. Harvin, MD, FACS, Associate Professor|(713) 500-7244|John.Harvin@uth.tmc.edu|
309802|NCT02706249|Beth Israel Deaconess Medical Center, Harvard Medical School|Jeffrey Zwicker, Division of Thrombosis and Haemostasis, Division of Hematology and Oncology|617.667.9299|jzwicker@bidmc.harvard.edu|
290696|NCT01318876|Laval University|Gaston De Serres|418-666-7000|gaston.deserres@ssss.gouv.qc.ca|274
299904|NCT01920477|Novartis Pharmaceuticals|Study Director|1-888-669-6682|Novartis.email@novartis.com|
290697|NCT01318902|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
290698|NCT01318915|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
290699|NCT01318967|Wake Forest School of Medicine|Michael Rocco, MD|336-716-4650|mrocco@wfubmc.edu|
290700|NCT01319045|UCLA|Jamil Aboulhosn|310-825-5950|jaboulhosn@mednet.ucla.edu|
290701|NCT01319110|Beth Israel Deaconess Medical Center|Dr. Michael Cocchi||mcocchi@bidmc.harvard.edu|
290702|NCT01319318|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
290703|NCT01319383|UNC Chapel Hill School of Medicine|Dr. David Margolis|919-966-6388|dmargo@med.unc.edu|
290704|NCT01319396|ResMed|Paul Phillips|+353 1 716 3755|paul.phillips@resmed.com|
290705|NCT01319422|Yale University|Madhav Dhodapkar, M.D.|203-785-4144|madhav.dhodapkar@yale.edu|
290706|NCT01319500|Center for Epidemiology and Health Research Berlin|Dr Juergen Dinger|+49 (0)30 945 10145|dinger@zeg-berlin.de|
299905|NCT01920555|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|MFAVA@mgh.harvard.edu|
299906|NCT01920568|GlaxoSmithKline|GSK Response Center|866-435-7343||
299907|NCT01920594|GlaxoSmithKline|GSK Response Center|866-435-7343||
299908|NCT01920711|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
299909|NCT01920802|New York State Psychiatric Institute|Jeffrey A. Lieberman, MD|646-774-8436|jlieberman@columbia.edu|
299910|NCT01920854|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
299911|NCT01920893|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
299912|NCT01920958|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
299913|NCT01921101|University of Illinois at Chicago|Dr. Carol Braunschweig, Professor|3129962575|braunsch@uic.edu|
299914|NCT01921166|AtriumHealth|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|brad.hurst@atriumhealth.org|
299915|NCT01921179|San Francisco VA HCS|Dr Tatjana Novakovic-Agopian|415-753-3888|tatjana.novakovic-agopian@va.gov|
299916|NCT01921205|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
299917|NCT01921257|Circassia Ltd|VP Clinical Operations|+44 1864 405560||
299918|NCT01921270|Emory University|Dr. Stewart Factor|404-728-4952|sfactor@emory.edu|
299919|NCT01921296|University of Michigan Hospital|Dr. Norah Lynn Henry, Associate Professor of Internal Medicine|734-936-4991|norahh@umich.edu|
299920|NCT01921322|Medtronic Diabetes|John Shin, PhD|818-576-4019|john.shin@medtronic.com|
299921|NCT01921348|University of MS Medical Center|Gailen D. Marshall, Jr., MD, PhD, Director, Division of Clinical Immunology and Allergy|6018155527|gmarshall@umc.edu|
299922|NCT01921387|Seattle Cancer Care Alliance|Ajay Kumar Gopal, MD, Director of Clinical Research|(206) 606-2037|agopal@uw.edu.org|
299923|NCT01921452|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|49-6151-72-5200|service@merckgroup.com|
299924|NCT01921517|University of Pennsylvania Perelman School of Medicine|Felix W. Wehrli, Principal Investigator|215-662-7951|felix.wehrli@pennmedicine.upenn.edu|
299925|NCT01921634|The Pennsylvania State University, Hershey Medical Center|Andrea Benton, MD|717-531-5394|abenton@pennstatehealth.psu.edu|
299926|NCT01921751|NRG Oncology|Wendy Seiferheld, M.S.||seiferheldw@nrgoncology.org|
299927|NCT01921829|University of Pittsburgh|Dr. Kelly Liang|507-269-7812|liangk@upmc.edu|
299928|NCT01921894|University of Pittsburgh|Dr. Juan C. Celedon, Niels K. Jerne Professor of Pediatrics|412-692-8429|juan.celedon@chp.edu|
299929|NCT01922011|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
299930|NCT01922024|Curetis USA, Inc.|Clinical Operations|800-659-1221|neil.mucci@curetis.com|
299931|NCT01922037|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
299932|NCT01922050|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
299933|NCT01922089|Novartis Pharmaceuticals|Study Director|862-778-8300||
299934|NCT01922102|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
299935|NCT01922115|UNC Chapel Hill|Dr. Elizabeth Geller|919-966-4717|elizabeth_geller@med.unc.edu|
299936|NCT01922219|NYSPI|Jeffrey Miller, M.D.|646-774-7613|jm2233@cumc.columbia.edu|
299937|NCT01922258|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
299938|NCT01922271|Novartis Pharmaceuticals|Study Director|862-778-8300||
299939|NCT01922336|Samsung Bioepis Co., Ltd.|Director of Clinical Trials|+82 31 8061 4534|sbregistry@samsung.com|
299940|NCT01922349|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
299941|NCT01922739|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
299942|NCT01922934|Denver Health|Dr. Daniel H. Bessesen|303-602-5021|daniel.bessesen@ucdenver.edu|
299943|NCT01922986|University of Minnesota|James R. Carey|612-626-2746|carey007@umn.edu|
299944|NCT01923129|Cedars Sinai Medical Center|Dr. Phillip Fleshner|(310) 289-9224|Phillip.Fleshner@cshs.org|
299945|NCT01923181|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
299946|NCT01923285|Abbott|Robyn Capobianco|512-286-4274|robyn.capobianco@abbott.com|
299947|NCT01923311|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
299948|NCT01923363|Loma Linda University Medical Center|Dr. Steven Forland|909-558-4000|sforland@llu.edu|43980
309803|NCT02706327|Eastern Mediterranean University|Yasin YURT|+905338724271|fzt.yasinyurt@gmail.com|
309804|NCT02706483|Bausch Health|Matt Markovich|908-541-1341|Matthew.Markovich@bauschhealth.com|
290707|NCT01319539|Columbia University Medical Center|Kevin Kalinsky, MD|212-305-1945|kk2693@cumc.columbia.edu|
290708|NCT01319552|Columbia University|Dr. Steven Spitalnik|2123425648|eldad.hod@gmail.com|
309805|NCT02706717|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
309806|NCT02706834|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
290709|NCT01319617|UCSD|Felipe Medeiros|858 82245-92|fmedeiros@glaucoma.ucsd.edu|
290710|NCT01319721|State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University|Dr. Shiyou Zhou|+86-020-87331540|zhoushiy@mail.sysu.edu.cn|
290711|NCT01319773|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
290712|NCT01319799|Sahlgrenska University Hospital,Cardiothoracic Anesthesia, 41345 Gothenburg ,SWEDEN|Dr Bjorn Reinsfelt|0046702954263|bjorn.reinsfelt@gu.se|
290713|NCT01319812|BIOTRONIK|Amy Culley, Director of Vascular Intervention|503-451-8034|amy.culley@biotronik.com|
290714|NCT01319851|Emory University|Dr. John Horan|404-785-1272|jthoran@emory.edu|
290715|NCT01319877|Hoffmann-La Roche|Medical Communications|800-821-8590||
290716|NCT01319929|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
290717|NCT01319994|Queen Mary University of London|Prof M Korbonits|+442078826197|m.korbonits@qmul.ac.uk|
290718|NCT01320033|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
299949|NCT01923389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
299950|NCT01923428|Ardelyx|Chief Development Officer|510 745 1752|drosenbaum@ardelyx.com|
299951|NCT01923467|University of Michigan|Larry An, MD|734-763-6099|lcan@med.umich.edu|
299952|NCT01923740|Abbott Vascular|Siok Hwee Tan|+1 408-845-3581|siokhwee.tan@abbott.com|
299953|NCT01923805|Cleveland Clinic|Alison Klika; Research Program Manager, Adult Reconstruction|216-444-4954|klikaa@ccf.org|
299954|NCT01923896|Emory University|William G. Sharp Ph.D.|404-419-5162|wgsharp@emory.edu|
299955|NCT01923961|eXcorLab GmbH|'Dr. Horst-Dieter Lemke|+49-6022-812647|horstdieter.lemke@excorlab.de|
299956|NCT01924169|The University of Texas MD Anderson Cancer Center|Alessandra Ferrajoli, MD/Professor|713-792-7734|CR_Study_Registration@mdanderson.org|
299957|NCT01924182|Medtronic Neuromodulation|Mary Markert Sr Prin Clinical Research Specialist|763-526-8162|mary.a.markert@medtronic.com|
299958|NCT01924299|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299959|NCT01924364|University of Pittsburgh Plastic Surgery|Danielle Minteer|412-383-4804|minteerdm@upmc.edu|
299960|NCT01924390|UTHSCSA Periodontics|Brian L. Mealey|210-567-3589|mealey@uthscsa.edu|
299961|NCT01924429|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Newcorn|212-659-8775|Jeffrey.newcorn@mssm.edu|
299962|NCT01924442|VA Medical Center, Denver, Colorado|Frederick Grover, MD|303-724-2798|Frederic.Grover@ucdenver.edu|
299963|NCT01924533|AstraZeneca|Gershon Locker Global Clinical Lead (GCL)||gershon.locker@astrazeneca.com|
299964|NCT01924559|Lehigh Valley Hospital|Marna Rayl Greenberg, DO, MPH|484-884-7514|Marna.Greenberg@lvh.com|
299965|NCT01924689|BioMed Valley Discoveries, Inc.|Brent Kreider|816-960-4644|bkreider@biomed-valley.com|
299966|NCT01924754|University of California, San Francisco|Dr. Joel Palefsky, MD|(415) 476-8885|Joel.Palefsy@ucsf.edu|
299967|NCT01924767|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
299968|NCT01924806|Smith & Nephew|Henry Jaimes|01923-477-164|henry.jaimes@smith-nephew.com|
299969|NCT01924845|BioMarin Pharmaceuticals|Debra Lounsbury, Principal Scientist, Clinical Sciences|415-506-6348|DLounsbury@bmrn.com|
299970|NCT01924871|Chung-Ang University Hospital|Dr. Chong Wha Baek|82-2-6299-2579|nbjhwa@naver.com|
299971|NCT01924949|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
299972|NCT01924975|University of Iowa Hopspital & Clinics|Satoshi Hanada/Clinical Assistant Professor|3193561219|satoshi-hanada@uiowa.edu|
299973|NCT01924988|Georgetown University Medical Center|James B. Spies MD MPH|202-444-3450|spiesj@gunet.georgetown.edu|
299974|NCT01925014|The LOCAT Group|Kyoung Ho Lee|82317877607|kholeemail@gmail.com|
299975|NCT01925144|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299976|NCT01925170|Mayo Clinic|Dr. Deborah Rhodes|507-284-7971|rhodes.deborah@mayo.edu|
299977|NCT01925183|Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna|Markus Peck-Radosavljevic (Principal Investigator)|+43 1 40400|markus.peck@meduniwien.ac.at|47440
299978|NCT01925209|Novartis Pharmaceuticals|Study Director|862-778-8300||
309807|NCT02706873|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309808|NCT02706886|Alnylam Pharmaceuticals Inc|Chief Medical Officer|866-330-0326|Clinicaltrials@alnylam.com|
309809|NCT02706899|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
309810|NCT02706925|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309811|NCT02706938|Universidad Nacional de Colombia|Dr. Ivan Mauricio Villamil Morales|+573178755369|imvillamilm@unal.edu.co|
309812|NCT02706951|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309813|NCT02707146|Division of Research, Kaiser Permanente Northern California|Dr. Richard Grant|510-891-5993|Richard.W.Grant@kp.org|
309814|NCT02707172|Kaohsiung Medical University|Dr. Ming-Tsang Wu|+886-7-3121101|e_encourage@yahoo.com|2315
309815|NCT02707432|University of North Carolina at Chapel Hill|Stephanie Hoover, PhD|919-966-1649|stephanie_hoover@med.unc.edu|
309816|NCT02707523|UAB|Dr. Michele Kong, PI|205-6389387|mkong@peds.uab.edu|
309817|NCT02707601|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
309818|NCT02707640|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
309819|NCT02707757|Imperial Healthcare NHS Trust|Dr Damien Ashby||d.ashby@imperial.ac.uk|
309820|NCT02707770|Imperial college healthcare NHS trust|vijay padmanaban|02033122349|vijay.padmanaban@nhs.net|
309821|NCT02707861|TaiMed Biologics USA Corp.|Manager - Clinical Operations|713-478-2927|bbell@taimedbio.com|
309822|NCT02707952|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309823|NCT02707965|University of Maryland, School of Pharmacy|Dr. James Polli|410-706-8292|jpolli@rx.umaryland.edu|
290719|NCT01320085|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290720|NCT01320137|GlaxoSmithKline|GSK Response Center|866-435-7343||
290721|NCT01320150|Rush University Medical Center|Dr. Robert McCarthy|(312) 563-0448|Robert_J_McCarthy@rush.edu|
290722|NCT01320202|Rockwell Medical|Senior Director, Clinical Research & Operations|248-960-9009|rd@rockwellmed.com|
290723|NCT01320293|University of North Carolina|Aida Lugo-Somolinos MD|919-843-9447|alugosom@med.unc.edu|
299979|NCT01925274|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290724|NCT01320553|SPARC|Shravanti Bhowmik, MD||shravanti.bhowmik@sparcmail.com|
290725|NCT01320722|Brigham and Women's Hospital|John P Forman, MD||jforman@partners.org|
290726|NCT01320735|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
290727|NCT01320826|University of Alberta|Dr. Michael Kolber|(780) 616-8411|mkolber@ualberta.ca|
290728|NCT01320943|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
290729|NCT01321073|The University of Alabama at Birmingham|Robert Bourge, M.D., Professor of Medicine, Radiology, and Surgery|(205)934-7400|bbourge@uab.edu|
290730|NCT01321151|UT Southwestern Medical Center|Megan Marks, Ph.D.|214-648-0882|megan.marks@utsouthwestern.edu|
299980|NCT01925339|University of Michigan|Dr. Hom-Lay Wang|734-763-3383|homlay@umich.edu|
299981|NCT01925404|RAND|Deborah Cohen|310 3930411|dcohen@rand.org|
299982|NCT01925417|Rebiotix|Sarah Mische PhD, Associate Director of Clinical Research|6512122839|smische@rebiotix.com|
299983|NCT01925469|University of Pennsylvania|Dr. Emelia Bachman|443-955-9195|emeliacleo@gmail.com|
299984|NCT01925612|Seattle Genetics, Inc.|Chief Medical Officer|(855)473-2436|medinfo@seagen.com|
299985|NCT01925677|University of Maryland, Baltimore|Dr. Rolf Barth|4103286020|rnbarth@som.umaryland.edu|4103286020
299986|NCT01925703|University of Maryland School of Pharmacy, Department of Pharmacy Practice and Science|Dr. Brent N. Reed||breed@rx.umaryland.edu|
299987|NCT01925768|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
299988|NCT01925781|Creighton University|Director of Clinical Trials|402-280-4961|sandrabyers@creighton.edu|
299989|NCT01925950|Soligenix, Inc.|Dr. Richard Straube|609-538-8200||
299990|NCT01925989|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
299991|NCT01926015|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
299992|NCT01926028|NovaDigm Therapeutics, Inc.|Chief Scientific Officer|2676405189|john_hennessey@novadigm.net|
299993|NCT01926119|Stanford University|Kevin Johnson, PhD RN|(650) 721-1988|johnsk@stanford.edu|
299994|NCT01926444|PCC INC.|Patrick Colin|514-586 9297|PCOLIN@VIDEOTRON.CA|
299995|NCT01926496|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
299996|NCT01926509|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
299997|NCT01926626|Duke Center for Smoking Cessation|Dr. Jed E. Rose|919-668-5055|jed.rose@duke.edu|
299998|NCT01926782|Regeneron Pharmaceuticals, Inc|Clinical Trial Management||clinicaltrials@regeneron.com|
299999|NCT01926886|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
309824|NCT02707991|Johns Hopkins University|Laura Starbird|9787587909|Lstarbi1@jhu.edu|
309825|NCT02708095|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
309826|NCT02708121|Department of Health Education and Behavior, College of Health and Human Performance, University of Florida|Dr. Megan McVay|(352)294-7029|megan.mcvay@ufl.edu|
309827|NCT02708186|Axovant Sciences GMBH|Senior Director of Clinical Research|1-833-296-8268|clinicaltrials@axovant.com|
309828|NCT02708212|Evergreen General Hospital|Dr. Chiliang Cheng|+886-3-4631230|chiliang.cheng@gmail.com|
309829|NCT02708238|"Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II"|Annamaria Staiano|00390817462679|staiano@unina.it|
309830|NCT02708277|The First Affiliated Hospital of Sun Yat-sen University|Yuqing Chen|+86 020-87755766-8341|fangchenyq@163.com|
309831|NCT02708290|ImagiRation LLC|Dr. Andrey Vyshedskiy, Founder|6174338577|vysha@bu.edu|
309832|NCT02708355|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309833|NCT02708433|University of North Carolina at Chapel Hill|Raymond P. White, Jr. DDS, PhD|919-537-3944|ray_white@unc.edu|
309834|NCT02708485|USherbrooke|Stephen Cunnane|1-819-780-2220|Stephen.Cunnane@USherbrooke.ca|45670
309835|NCT02708498|Department of Health Sciences, Lund University|Professor Gerd Ahlström|+46702747767|gerd.ahlstrom@med.lu.se|
309836|NCT02708524|Johnson & Johnson Vision Care Inc.|Kristy Canavan, O.D. PRINCIPAL RESEARCH OPTOMETRIST|904-443-1474|KCANAVA2@its.jnj.com|
309837|NCT02708641|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
309838|NCT02708745|Seattle Children's Hospital|Dr. Doug Opel|206-987-2000|douglas.opel@seattlechildrens.org|
309839|NCT02708862|HHRI|Audrey Hendrickson|6128737448|audrey.hendrickson@hcmed.org|
309840|NCT02708966|Institute of Experimental and Clinical Therapeutics|Dra. Esperanza Martínez Abundis|+52-33-10-58-52-00|esperanzamartnezabundi@yahoo.com|34211
309841|NCT02709005|University of Iowa Hospitals and Clinics|Patricia Winokur, MD|319-384-4590|patricia-winokur@uiowa.edu|
309842|NCT02709018|University of California San Diego|Murray B. Stein MD, MPH|858-534-6451|mstein@health.ucsd.edu|
309843|NCT02709096|BioPharmX, Inc.|AnnaMarie Daniels|310-701-2080|amdaniels@biopharmx.com|
309844|NCT02709109|Parion Sciences|Alison Church|919-313-1183|achurch@parion.com|
309845|NCT02709330|Duke University|Richard Bedlack, MD, PhD|919-668-2839|richard.bedlack@duke.edu|
309846|NCT02709369|Wake Forest School of Medicine|Dr. Charles H. Tegeler|+1 (336) 716-7651|ctegeler@wakehealth.edu|
309847|NCT02709486|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
309848|NCT02709538|Glenmark Pharmaceuticals Ltd.|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
290731|NCT01321177|Northwell Health|Patricia Marcy|347-439-8035|pmarcy@northwell.edu|
290732|NCT01321437|UC Irvine Health / Chao Family Comprehensive Cancer Center|UC Irvine Health / Chao Family Comprehensive Cancer Center|1-877-UC-STUDY|ucstudy@uci.edu|
290733|NCT01321541|Institut de Recherches Internationales Servier|Anton Egorov, Associate Project Director Clinical Development|+33 1 55 72 31 94|anton.egorov@servier.com|
290734|NCT01321554|Eisai, Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
290735|NCT01321606|William S. Middleton Memorial Veterans Affairs Medical Center|Dr. Nasia Sardar|608-256-1901|nasia.safdar@va.gov|17800
290736|NCT01321710|University of California, San Francisco|Kathryn Lee, RN, PhD|415-476-4442|kathryn.lee@nursing.ucsf.edu|
290737|NCT01321723|Unigene Laboratories, Inc.|Nozer Mehta, PhD. Chief Scientific Officer|(973) 265-1100|nmehta@unigene.com|
290738|NCT01321749|XuanWu Hospital, Capital Medical University|Xunming Ji, M.D.,Ph.D.|8683198127|jixm70@hotmail.com , Jixm@ccmu.edu.cn|
290739|NCT01321879|UT MD Anderson Cancer Center|Dr. Issam I. Raad/ Chair, Infectious Diseases|713- 792-7943|iraad@mdanderson.org|
290740|NCT01322009|University of Pittsburgh|Robert Clark|412-692-7260|clarkrs@ccm.upmc.edu|
290741|NCT01322022|Children's Hospital of Pittsburgh/University of Pittsburgh|Dr. Cynthia Johnson|412-692-8404|cynthia.rheney.johnson@gmail.com|
300000|NCT01926977|Sierra Eye Associates|Arshad Khanani M.D., Vitreo-Retinal Diseases and Surgery|775-329-0286|arshad.khanani@gmail.com|
300001|NCT01927055|H. Lundbeck A/S|Study director||LundbeckClinicalTrials@Lundbeck.com|
300002|NCT01927120|H. Lee Moffitt Cancer Center and Research Institute|Dr. Brian Betts|813-745-5410|brian.betts@moffitt.org|
300003|NCT01927341|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300004|NCT01927367|QEII Health Sciences Centre, Halifax, Nova Scotia|Dr. Jafna L Cox|(902) 473-7811|jafna.cox@dal.ca|
300005|NCT01927497|Academic medical center|prof. dr. P.J. Tanis|0031205669111|g.d.musters@amc.nl|
300006|NCT01927562|Fractyl|Sarah Hackett|617-596-9522|shackett@fractyl.com|
300007|NCT01927575|Fujifilm Medical Systems, U.S.A., Inc.|Robert Uzenoff|(203) 602-3664|ruzenoff@fujifilm.com|
300008|NCT01927627|Case Comprehensive Cancer Cent|Jorge Garcia MD|216-444-7774|garciaj4@ccf.org|
300009|NCT01927718|UT MD Anderson Cancer Center|Qaiser Bashir, MD/Associate Professor, Stem Cell Transplantation|713-792-7734|QBashir@mdanderson.org|
300010|NCT01927757|Amgen Inc.|Study Director|866-572-6436||
300011|NCT01927861|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
300012|NCT01927887|Massachusetts General Hospital|Mukesh Harisinghani|6176432009|mharisinghani@partners.org|
300013|NCT01928030|Stanford University|Dr. Mark Pegram, Susy Yuan-Huey Hung Professor|650-723-5801|mpegram@stanford.edu|
300014|NCT01928186|University of Washington / Seattle Cancer Care Alliance|Dr. Hannah Linden|206-288-6989|hmlinden@uw.edu|
300015|NCT01928199|Washington University in St. Louis|Rowena Delos Santos|314-362-8351|delossantos@wustl.edu|
300016|NCT01928225|University of Colorado|Cynthia Frinhaber|720-848-0000|cynthia.firnhaber@cuanschutz.edu|
300017|NCT01928290|Washington University School of Medicine|Haeseong Park, M.D.|314-747-6268|haeseongpark@wustl.edu|
300018|NCT01928329|C.N.H. Long Professor of Immunobiology and of Medicine (Endocrinology)|Kevan Herold, MD|(203) 785-6507|kevan.herold@yale.edu|
300019|NCT01928381|AstraZeneca Pharmaceuticals LP, Neuroscience Innovative Medicine Unit|Joel Posener, MD - Head Early Clinical Development||CinicalTrialTransparency@astrazeneca.net|
300020|NCT01928394|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
300021|NCT01928433|Universityhospital Gießen and Marburg, Germany|Prof. Dr. med. Florian Wagenlehner|+49-641-98544516|Florian.Wagenlehner@chiru.med.uni-giessen.de|
300022|NCT01928446|Boston CSP Coordinating Center|Ryan E. Ferguson, ScD, MPH, Director|1-857-364-4201|Ryan.Ferguson@va.gov|
300023|NCT01928472|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
300024|NCT01928485|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Lee Ponsky|+1 216-844-4831|lee.ponsky@uhhospitals.org|
300025|NCT01928524|Odense University Hospital|Per Pfeiffer|+45-26283844|per.pfeiffer@rsyd.dk|
300026|NCT01928680|Chinese Academy of Medical Science|Dr. Qiao Li|86-18500027849|liqiaopumc@qq.com|
300027|NCT01928693|Cornea Consultants of Nashville|Ira Shivitz MD|615-320-7200|jhatley@corneaconsultants.net|
309849|NCT02709577|GI Dynamics, Inc.|Manager of Clinical Affairs|781.357.3263|kwoessner@gidynamics.com|
309850|NCT02709694|Hospital for Special Surgery|Dr. Lisa Mandl|(212) 774-2960|mandll@hss.edu|
309851|NCT02709746|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
309852|NCT02709785|Saint Louis University|D. Douglas Miley|314-977-8381|ddouglas.miley@health.slu.edu|
309853|NCT02709889|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309854|NCT02710045|University of Tasmania|Katie Flanagan|+61 3 6777 4081|katie.flanagan@ths.tas.gov.au|
290742|NCT01322048|Vanderbilt University Medical Center|Mayur B. Patel|6153225000|mayur.b.patel@vanderbilt.edu|
290743|NCT01322347|Rockwell Medical|Senior Director, Clinical Research & Development|248-960-9009|rd@rockwellmed.com|
290744|NCT01322360|Roxane Laboratories, Inc|Anton (Tony) Amann, PhD, Executive Director, Drug Regulatory and Medical Affairs|614-272-4785|Tony.Amann@boehringer-ingelheim.com|
290745|NCT01322386|Stanford University|Kenneth L Cox, MD / Principal Investigator|650-723-5070|KCox@stanfordchildrens.org|
290746|NCT01322490|Bavarian Nordic A/S|Program Lead, Clinical Operations|+ 45 3326|info@bavarian-nordic.com|8383
290747|NCT01322594|MedImmune, Limited|Ed Piper|+44 (0) 1223 471 471|pipered@medimmune.com|
290748|NCT01322607|Baltimore VA Medical Center (VAHMCS)|Research Specilist|410-605-7156|alyssa.stookey@va.gov|
300028|NCT01928719|Penn State College of Medicine|Nicolle Krebs|717-531-5673|nkrebs@pennstatehealth.psu.edu|
300029|NCT01928758|Penn State College of Medicine|Jonathan Foulds|717-531-3504|jfoulds@psu.edu|
300030|NCT01928771|AstraZeneca|Mitchell Goldman , Medical Science Director|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
300031|NCT01928797|Brigham and Women's Hospital|Dr. Bhavani Kodali|617-732-8220|BKODALI@BWH.HARVARD.EDU|
300032|NCT01928849|Duke University Department of Anesthesiology|Thomas Buchheit, MD Division Chief, Pain Medicine|9196811924|Thomas.Buchheit@duke.edu|
300033|NCT01928862|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
300034|NCT01928927|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
300035|NCT01928940|GlaxoSmithKline|GSK Response Center|866-435-7343||
300036|NCT01929018|University of Colorado Denver, Anschutz Medical Campus|Dr. Cory Christiansen|303.724.9101|cory.christiansen@ucdenver.edu|
300037|NCT01929031|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300038|NCT01929044|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300039|NCT01929057|UCSD Dermatology Clinical Trials|Dermatology Clinical Trial Manage|(858)657-8390|dermstudies@ucsd.edu|
300040|NCT01929083|Indiana University|Dr. James E Tisdale|317-880-5418|jtisdale@purdue.edu|
300041|NCT01929109|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
300042|NCT01929135|Universidad de los Andes|Dra. Catherine Andrade|056-972862308|catherine.perio@gmail.com|
300043|NCT01929226|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
300044|NCT01929291|GlaxoSmithKline|GSK Response Center|866-435-7343||
300045|NCT01929317|GlaxoSmithKline|GSK Response Center|866-435-7343||
300046|NCT01929343|UT Southwestern Medical Center|Josh Becker|2146485277|joshua.becker@utsouthwestern.edu|
300047|NCT01929395|Dartmouth Hitchcock Medical Center|Dr Richard J. Barth Jr.|(603) 650-9479|Richard.J.Barth.Jr@hitchcock.org|
300048|NCT01929408|Fred Hutchinson Cancer Research Center|Mohamed Sorror, MD, MSc|(206) 667-6298|msorror@fredhutch.org|
309855|NCT02710071|University of California San Diego|Michael G. Ziegler, M.D.|619 543 2885|mziegler@ucsd.edu|
309856|NCT02710136|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
309857|NCT02710214|University of California, San Francisco|Dr. Riley Bove|415-595-2795|riley.bove@ucsf.edu|
309858|NCT02710240|University of Pennsylvania|Marie Kerr, Project Manager|215-829-6720|marie.kerr@pennmedicine.upenn.edu|
309859|NCT02710292|Alcon Japan Ltd.|Clinical Manager|1-888-451-3937|alcon.medinfo@alcon.com|
309860|NCT02710422|University of Miami|Sanoj Punnen MD, MAS|305-243-6596|s.punnen@med.miami.edu|
309861|NCT02710526|Braeburn Inc|Sonnie Kim|6104678718|sonnie@braeburnrx.com|
309862|NCT02710591|EspeRare Fondation|Florence Porte-Thomé|22 794 4004|porte.florence@esperare.org|+41
309863|NCT02710630|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309864|NCT02710669|Vanderbilt University Medical Center|Benjamin Shoemaker, MD|615-322-2318|moore.b.shoemaker@vumc.org|
309865|NCT02710890|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
309866|NCT02710981|OB-GYN department, Assiut University, Egypt|Essam R. Othman|+201006607801|essamrash@yahoo.com|
309867|NCT02711306|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
309868|NCT02711345|Novartis Pharma AG|Study Director|862 778-8300|Novartis.email@novartis.com|
309869|NCT02711553|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
309870|NCT02711800|Duke University|Nancy Zucker|9196680075|zucke001@mc.duke.edu|
309871|NCT02711839|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
309872|NCT02711956|Zenith Epigenetics Ltd|Zenith Study Team|(415) 470-5600|ZEN003694-002@zenithepigenetics.com|
309873|NCT02711995|Weill Cornell Medicine|Katerina Andreadis|646-962-9883|kaa2055@med.cornell.edu|
309874|NCT02712008|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
309875|NCT02712047|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
309876|NCT02712099|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
309877|NCT02712320|Foresee Pharmaceuticals Co., Ltd.|Dr. John Mao|+886 2-2655-2658|john.mao@foreseepharma.com|
309878|NCT02712333|Fudan University|Dr. Haidong Kan|86-21-54237908|kanh@fudan.edu.cn|
309879|NCT02712359|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
309880|NCT02712398|Becton Dickinson|Dawn Heimer / Sr. Director Medical Affairs|401-479-1253|dawn.heimer@bd.com|
309881|NCT02712424|Geisel School of Medicine|Dr C Fordham von Reyn|6036505000|fvr@dartmouth.edu|
309882|NCT02712554|Charleston Laboratories, Inc.|Chief Commercial Officer|561-748-2007|cliregulatory@charlestonlabs.com|
309883|NCT02712788|Indiana University|Heather Cero, RN - research cooordinator|317-396-1398|hcero@iupui.edu|
309884|NCT02712983|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
309885|NCT02712996|Vanderbilt University Medical Center|Michael Tramontana,PhD|615-327-7144|michael.tramontana@vumc.org|
290749|NCT01322633|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290750|NCT01322815|Ruesch Center at Georgetown Lombardi|John L Marshall|202.444.7064|marshalj@georgetown.edu|
290751|NCT01322841|Indiana University School of Medicine|Aaron Carroll|3172789616|aaecarro@iu.edu|
300049|NCT01929460|Kaiser Permanente, Los Angeles Medical Center|Karl Kwok, MD|800-954-8000|regional-research-committee@kp.org|
300050|NCT01929473|IROM CS Co., Ltd.|Tsutomu Takeda|+81-92-738-0500|tsutomu-takeda@irom-cs.co.jp|
300051|NCT01929642|Boling Center for Developmental Disabilities|Dr. Tanjala Gipson|901-448-6512|sbarden@uthsc.edu|
300052|NCT01929681|McLean Hospital|Dr. Michael Rohan|617-855-3127|mrohan@mclean.harvard.edu|
300053|NCT01929707|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
300054|NCT01929759|Boston Medical Center, Boston University School of Medicine|Dr. Nina Lin|617-414-5242|nina.lin@bmc.org|
300055|NCT01929863|GlaxoSmithKline|GSK Response Center|866-435-7343||
300056|NCT01929876|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
300057|NCT01929889|Northwestern University|Dr. John Csernansky|312-503-9096|jcsernan@nmff.org|
300058|NCT01929980|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-9063|Pooja.Khandelwal@cchmc.org|
300059|NCT01929993|Fundação Oswaldo Cruz|Dr Fábio Russomano|55 21 25541815|fabiorussomano@gmail.com|
300060|NCT01930045|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300061|NCT01930058|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300062|NCT01930162|Novartis Pharmaceuticals|Study Director|862-778-8300||
300063|NCT01930175|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
300064|NCT01930188|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
300065|NCT01930214|Cardiovascular Systems Inc.|Clinical Project Manager|6512591600|clinicaltrials_csi@csi360.com|
300066|NCT01930435|UCSF|Dr. Sue Yom|415-353-7175|yoms@radonc.ucsf.edu|
300067|NCT01930487|Ocular Vascular Research Center, Indiana University School of Medicine|Brent Siesky, PhD, Assistant Director|317-278-0177|bsiesky@indiana.edu|
300068|NCT01930643|Mackay Memorial Hospital|Dr. Kuang-Hua Cheng|+886-975837711|jeff01@mmh.org.tw|
300069|NCT01930747|az sint jan brugge|jan mulier|0032486729203|jan.mulier@azsintjan.be|
300070|NCT01930799|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
300071|NCT01930890|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
300072|NCT01931059|Northwell Health|Dr. Miklos Argyelan|718-470-8175|margyela@northwell.edu|
300073|NCT01931150|Memorial Sloan Kettering Cancer Center|Dr. Mario Lacouture|646-888-6014|LacoutuM@mskcc.org|
300074|NCT01931163|The Methodist Hospital Research Institute|Dr. Jenny Chang|713 441-0680|jcchang@houstonmethodist.org|
300075|NCT01931202|New York State Psychiatric Institute|Bret R. Rutherford|6467748660|bret.rutherford@nyspi.columbia.edu|
300076|NCT01931397|Oregon Health & Science University|Dr. Amira Al-Uzri , Professor of Pediatrics|503-494-6956|aluzria@ohsu.edu|
300077|NCT01931462|University of Wisconsin|Director of Clinical Research, Department of Surgery|608-262-0540|clinicalresearch@surgery.wisc.edu|
300078|NCT01931475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
300079|NCT01931527|Washington University School of Medicine|Elisa Fabbrini, MD, PhD|314-362-8156|efabbrini@dom.wustl.edu|
300080|NCT01931566|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
300081|NCT01931670|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
300082|NCT01931709|University of Washington|Jennifer Specht, MD|206-288-6889|jspecht@uw.edu|
300083|NCT01931735|VA Palo Alto Research|Jessica Asay|650-493-5000|asay@stanford.edu|65971
309886|NCT02713178|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
309887|NCT02713204|Regeneron Pharmaceuticals|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
309888|NCT02713230|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-397-2467|MedInfo@pacira.com|
309889|NCT02713243|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
309890|NCT02713256|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
309891|NCT02713425|Mayo Clinic|Stephen P. Whiteside, PhD, LP|507-284-2933|Whiteside.Stephen@mayo.edu|
309892|NCT02713490|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
309893|NCT02713529|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
309894|NCT02713542|Arthrex|Clinical Affairs Manager|2395984302|INC_ClinicalResearch@arthrex.com|
309895|NCT02713594|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|6082627563|sss@ctri.wisc.edu|
309896|NCT02713659|The Children's Hospital of Philadelphia|Dr. James Guevara|215-590-1130|guevara@email.chop.edu|
309897|NCT02713698|Centro Hospitalar do Porto|Ana Maria Araujo|22 2077549|amfariaaraujo@gmail.com|1280
309898|NCT02713711|UC de Maule|Professor Gabriel Nasri Marzuca Nassr|56 71 203463|gmarzuca@gmail.com|
309899|NCT02713789|Urovant Sciences GmbH|JP Nicandro, PharmD|833-219-5557|clinicaltrials@urovant.com|
309900|NCT02713828|ECOG Stats Center|Dr Zhuoxin Sun|617-632-3012|zhuoxin@jimmy.harvard.edu|
309901|NCT02713867|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
309902|NCT02714062|VIVUS|Sr. Director, Clinical Research|650-934-5200||
309903|NCT02714153|Yale School of Medicine|Jude Clancy, MD Associate Professor Term; Director, Lead Management Program|(203) 785-4126|jude.clancy@yale.edu|
309904|NCT02714283|Oregon Health & Science University|Emily Henkle, PhD, MPH|503-494-6226|henkle@ohsu.edu|
290752|NCT01322945|Barrow Neurological Institute|Andrew S. Little, MD|602-406-3181|heidi.jahnke@dignityhealth.org|
290753|NCT01323010|University of Sao Paulo|Dr Fabio Pereira Muchão|+5511 983835563|fabiomuchao@gmail.com|
290754|NCT01323140|Watson Laboratories, Inc.|Gary Hoel, RPh, PhD, Vice President, Global Brand Clinical Research|801-588-6641|gary.hoel@watson.com|
290755|NCT01323153|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
290756|NCT01323192|Janssen Pharm KK Japan|Medical Director|+81-3-4411-5509||
300084|NCT01931839|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
290757|NCT01323270|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290758|NCT01323387|Synthes Spine|Clinical Research Associate|610-719-5942|knappk@synthes.com|
290759|NCT01323478|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
290760|NCT01323517|Memorial Sloan Kettering Cancer Center|Dr. Charlotte Ariyan, MD|212-639-6280|ariyanc@mskcc.org|
290761|NCT01323530|Eisai Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
290762|NCT01323582|University of Florida|Baharak Moshiree MD|305-243-2515|bmoshiree@med.miami.edu|
290763|NCT01323595|Weill Cornell Medical College|Chairman, Department of Urology|212 746-5491|pnschleg@med.cornell.edu|
300085|NCT01931865|Yale University School of Medicine|Bahman Jabbari M.D.|203-737-2464|bahman.jabbari@yale.edu|
290764|NCT01323621|GlaxoSmithKline|GSK Response Center|866-435-7343||
300086|NCT01931878|Yale University School of Medicine|Bahman Jabbari M.D.|203-737-2464|bahman.jabbari@yale.edu|
309905|NCT02714400|UCSD|Dillon Gilbertson|8582452155|dcgilbertson@health.ucsd.edu|62155
309906|NCT02714426|University of Florida|Michael Marsiske, Ph.D.|352.273.5097|marsiske@phhp.ufl.edu|
290765|NCT01323634|GlaxoSmithKline|GSK Response Center|866-435-7343||
290766|NCT01323647|GlaxoSmithKline|GSK Response Center|866-435-7343||
300087|NCT01931956|Abbott Vascular|Jeffrey T Ellis||jeffrey.ellis@av.abbott.com|
300088|NCT01931995|Massachusetts General Hospital|Dr. Mark Eldaief|6177261728|MELDAIEF@PARTNERS.ORG|
300089|NCT01932060|Stanford University School of Medicine|Dr. Alexander Butwick|(650) 736-8513|ajbut@stanford.edu|
290767|NCT01323660|GlaxoSmithKline|GSK Response Center|866-435-7343||
290768|NCT01323673|GlaxoSmithKline|GSK Response Center|866-435-7343||
290769|NCT01323777|Alcon Japan, Ltd.|Group Manager, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
290770|NCT01323790|AstraZeneca|Mark Sostek||ClinicalTrialTransparency@astrazeneca.com|
290771|NCT01323855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
290772|NCT01323920|Dana Farber Cancer Institute|Dr. John Koreth|617-632-2949|John_Koreth@dfci.harvard.edu|
290773|NCT01323946|GlaxoSmithKline|GSK Response Center|866-435-7343||
290774|NCT01323959|GlaxoSmithKline|GSK Response Center|866-435-7343||
290775|NCT01323972|GlaxoSmithKline|GSK Response Center|866-435-7343||
290776|NCT01323998|GlaxoSmithKline|GSK Response Center|866-435-7343||
300090|NCT01932112|Seoul St Mary's hospital|Y. Oh, director of clinical trial|82-2-2258-1141|oys@catholic.ac.kr|
300091|NCT01932164|Hospital Sirio Libanes|Dra Daniela Franco Bueno|+5511997900159|dbuenousp@gmail.com|
300092|NCT01932242|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
300093|NCT01932294|University of Alabama at Birmingham|RongBing Xie|205-975-3624|rongbingxie@uabmc.edu|
300094|NCT01932437|Elusys Therapeutics, Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
300095|NCT01932606|Mayo Clinic|Dr. Barry A. Borlaug|507-284-6704|Borlaug.Barry@mayo.edu|
300096|NCT01932697|Mayo Clinic|Daniel J. Ma, M.D.|507/284-3261|Ma.Daniel@mayo.edu|
300097|NCT01932762|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300098|NCT01932788|Professor of Pediatrics|Carol,Wagner, MD|843-792-8829|wagnercl@musc.edu|
300099|NCT01932970|Amgen Inc.|Study Director|866-572-6436||
300100|NCT01932996|University of Minnesota|Rebekah Pratt|612-625-1196|rjpratt@umn.edu|
300101|NCT01933048|Uniformed Services University of the Health Sciences|Eugene V. Millar, PhD|301-816-8451|emillar@idcrp.org|
300102|NCT01933113|Allegheny Health Network|Donald Whiting, MD|412-359-6200|donald.whiting@ahn.org|
300103|NCT01933217|Children's Hospital Medical Center, Cincinnati|Brad Kurowski, MD, MS|513-803-3655|brad.kurowski@cchmc.org|
300104|NCT01933230|Cleveland Clinic|Dr. Jose Javier Provencio, Faculty, Neuroinflammation Research Center|216-445-242|provenj@ccf.org|
300105|NCT01933243|Nationwide Children's Hospital|Andrea Bonny|614-722-2458|andrea.bonny@nationwidechildrens.org|
300106|NCT01933334|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
300107|NCT01933399|MUSC|David Morrisette, PhD|843-792-2940|morrisdc@musc.edu|
300108|NCT01933425|Herlev Hospital, University of Copenhagen, Department of Anesthesiology|Dr. Matias Vested Madsen|+4538689058|matias.vested.madsen@regionh.dk|
300109|NCT01933464|UCSD Dermatology Clincal Trials|Dermatology Clinical Trial Manager|(858)657-8390|dermstudies@ucsd.edu|
300110|NCT01933594|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
300111|NCT01933672|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300112|NCT01933776|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
300113|NCT01933789|University of Washington|Dr. J. Randall Curtis|206-744-3356|jrc@uw.edu|
300114|NCT01933880|Xi'an Janssen Pharmaceutical Ltd.|Director - CNS & Pain, CDMA, China R&D and SA|+86 10 5821-8307||
300115|NCT01933919|AbbVie|Global Medical Services|800-633-9110||
300116|NCT01933984|Division of Critical Care Medicine, Department of Medicine, Changhua Christian Hospital|Dr. Shin-Hwar Wu|886-4-7238595|126366@cch.org.tw|3971
300117|NCT01934010|Auris Medical Inc.|Thomas Meyer, CEO|+1 312 396 4150|hear@aurismedical.com|
300118|NCT01934140|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300119|NCT01934192|GlaxoSmithKline|GSK Response Center|866-435-7343||
309907|NCT02714504|Univ Fed Rio de Janeiro|Dr Marcio Nucci|552139382463|mnucci@hucff.ufrj.br|
309908|NCT02714569|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
309909|NCT02714595|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
309910|NCT02714868|Department of Occupational Therapy, Boston University|Dr. Jessica Kramer, Assistant Professor, PI|617-353-2702|kramerj@bu.edu|
309911|NCT02715076|Department of outcomes research Cleveland Ohio|Dr. Daniel I. Sessler||ds@or.org|
309912|NCT02715258|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
309913|NCT02715700|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
309914|NCT02715726|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
309915|NCT02715804|Halozyme Therapeutics|VP, Medical, Regulatory and Drug Safety|858-794-8889|medinfo@halozyme.com|
309916|NCT02716194|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
309917|NCT02716298|CooperVision|Senior Manager Global Medical Scientific Affairs|925-621-3761|javega@coopervision.com|
309918|NCT02716324|The Children's Hospital of Philadelphia|James Guevara, MD MPH|2155901130|guevara@email.chop.edu|
309919|NCT02716506|Kanta-Häme Central Hospital|Dr Nina Mattsson|+358407338307|nina.mattsson@fimnet.fi|
309920|NCT02716584|VA Greater Los Angeles Healthcare System|Dr. Robert Kern|310-478-3711|Robert.Kern2@va.gov|49229
309921|NCT02716714|Korea University Ansan Hospital|Ilhwan Kim|+82314125986|kumcihk@korea.ac.kr|
290777|NCT01324024|University of Pennsylvania|Cynthia Neill Epperson, M.D.|215-573-8871|cepp@mail.med.upenn.edu|
290778|NCT01324102|VA Boston Healthcare System|Jennifer Moye|774-826-3721|jennifer.moye@va.gov|
290779|NCT01324128|Vifor Pharma|Medical Information|41 58 851 8222|medinfo@viforpharma.com|
290780|NCT01324141|National Cancer Institute|Dr. Deborah E. Citrin|301-496-5457|citrind@mail.nih.gov|
290781|NCT01324232|Avanir Pharmaceuticals|Avanir Medical Information|855-572-2722|medinfo@avanir.com|
290782|NCT01324271|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
290783|NCT01324310|Celgene Corporation|Senior Manager|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
290784|NCT01324323|Celgene Corporation|Senior Manager, Clinical Trials Disclosure|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
290785|NCT01324349|Covidien|Vice President, Medical Affairs|203-500-4256|amy.pollack@covidien.com|
290786|NCT01324388|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
290787|NCT01324401|Harvard Medical School / Massachusetts General Hospital|Wayne Shreffler|617-726-6147|wshreffler@mgh.harvard.edu|
290788|NCT01324440|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300120|NCT01934218|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8948|yuko.shibata@seikagaku.co.jp|
300121|NCT01934231|GlaxoSmithKline|GSK Response Center|866-435-7343||
300122|NCT01934335|Holden Comprehensive Cancer Center|Ronald Weigel, MD, PhD|319-353-7474|ronald-weigel@uiowa.edu|
300123|NCT01934517|U of Montreal|Vincent Peloquin|514-343-6056|vincent-claude.peloquin@umontreal.ca|
300124|NCT01934556|Palmetto Retina Center, LLC|John F. Payne, MD|(803) 931-0077|jpayne@palmettoretina.com|
300125|NCT01934582|United Therapeutics Corp.|Kevin Laliberte, PharmD|919-425-8176|KLaliberte@unither.com|
300126|NCT01934790|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
300127|NCT01934894|SCRI Development Innovations|Charles Davis, RAC|615-524-4341|Charles.Davis2@scri-innovations.com|
300128|NCT01934972|The Ohio State University|Nicholas Breitborde, PhD|614-685-6052|nicholas.breitborde@osumc.edu|
300129|NCT01935180|VA Medical Center|Dr. Heiko Pohl|8022959362|heiko.pohl@dartmouth.edu|5595
300130|NCT01935622|Virginia Commonwealth University|Antonio Abbate|8048280513|aabbate@vcu.edu|
300131|NCT01935700|Kaohsiung Medical University Hospital|Dr. Zu-Yau Lin|88677317123|linzuyau@yahoo.com.tw|
300132|NCT01935791|Imperial College London|Dr Chioma Izzi-Engbeaya|02075942454|c.izzi@imperial.ac.uk|
300133|NCT01935934|University Health Network - Princess Margaret Cancer Centre|Dr. Neesha Dhani|416-946-4501|neesha.dhani@uhn.ca|2361
300134|NCT01936181|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
300135|NCT01936259|Zimmer Biomet, Inc.|Director of Clinical Operations|800-613-6131|clinicaldirector@zimmerbiomet.com|
300136|NCT01936324|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
300137|NCT01936363|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
300138|NCT01936389|NYGRI|Jessica Jasien, MEn|2124777540|jjasien.ganyresearch@gmail.com|371
300139|NCT01936467|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
300140|NCT01936519|Penn State Milton S Hershey Medical Center|Dr Zakiyah Kadry|717 531 5921|zkadry@pennstatehealth.psu.edu|
300141|NCT01936623|Friends Research Institute|Robert Schwartz, M.D.|410-837-3977|rschwartz@friendsresearch.org|276
300142|NCT01936649|GE Healthcare|Dr. Jose Zubeldia|011-44-1494-543137|jose.zubeldia@ge.com|
300143|NCT01936662|IndianaU|Nicole Horn, MD|3179449981|ndhorn@hotmail.com|
300144|NCT01936844|Virginia Commonwealth University|Benjamin Van Tassell, PharmD|8048284583|bvantassell@vcu.edu|
300145|NCT01936857|Oregon Health & Science University|Dr. Todd Korthuis|503-494-8044|korthuis@ohsu.edu|
300146|NCT01936870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300147|NCT01936896|Virginia Commonwealth University|Antonio Abbate|8048280513|antonio.abbate@vcuhealth.org|
300148|NCT01936909|Virginia Commonwealth University|Benjamin Van Tassell|8048284583|bvantassell@vcu.edu|
309922|NCT02716727|University of North Carolina at Chapel Hill|Sumitha Ahmed, DDS|919-537-3946|sumitha_ahmed@unc.edu|
309923|NCT02716779|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
309924|NCT02716805|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@lcr.org|
309925|NCT02716818|Diurnal Limited|Information Line|+44 (0) 2920 682069|info@diurnal.co.uk|
309926|NCT02716896|University of Texas Health San Antonio|Dharam Kaushik|210-567-5676|kaushik@uthscsa.edu|
309927|NCT02716987|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
309928|NCT02717195|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
309929|NCT02717273|University of Virginia|Robert Sawyer|4349821632|rws2k@virginia.edu|
309930|NCT02717494|Westat|Lauren Laimon, Senior Study Director|240-453-2987|LaurenLaimon@westat.com|
309931|NCT02717546|Zimmer Biomet|Ryan Boylan, Clinical Affairs Manager|574.527.7934|ryan.boylan@zimmerbiomet.com|
309932|NCT02717754|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
309933|NCT02718040|Galderma Laboratories|Jay Mashburn||jay.mashburn@galderma.com|
309934|NCT02718118|Galderma Laboratories|Jay Mashburn||jay.mashburn@galderma.com|
309935|NCT02718131|University of Alabama at Birmingham|Karen Cole-Plourde|205-934-5140|kplourde@uab.edu|
309936|NCT02718157|GenePOC|Dr Keith Chiasson, PhD|418-650-3535|keith.chiasson@genepoc.ca|322
309937|NCT02718248|Ottawa Hospital Research Institute|Sarah MacLean|6137378899|samaclean@ohri.ca|73011
309938|NCT02718326|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
309939|NCT02718417|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|8007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
309940|NCT02718625|Smith & Nephew, Inc.|Natasha Schappell, Clinical Study Manager|817-302-3949|Natasha.Schappell@smith-nephew.com|
309941|NCT02718898|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
290789|NCT01324453|Minneapolis Heart Institute Foundation|Jane Fox|6128636289|jane.fox@allina.com|
290790|NCT01324518|Orion Global Clinical Operations|Clinical Study Director||jutta.hanninen@orionpharma.com|
290791|NCT01324570|Purdue Pharma L.P.|Clinical Leader|800-733-1333|stacy.baldridge@pharma.com|
290792|NCT01324622|DePuy Synthes|Allyson Morris|610-719-5298|amorris5@its.jnj.com|
290793|NCT01324687|University of Rochester|Manish N. Shah|585-276-6565|manish_shah@urmc.rochester.edu|
290794|NCT01324700|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD, Professor of Psychiatry|214-645-6950|sherwood.brown@utsouthwestern.edu|
290795|NCT01324830|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290796|NCT01324882|UConn Health Center|Joseph Anderson|8022959362|joseph.anderson@dartmouth.edu|6003
290797|NCT01324947|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
300149|NCT01936948|White River Junction VA Medical Center|Heiko Pohl|802-295-9363|heiko.pohl@va.gov|5591
300150|NCT01937026|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
300151|NCT01937117|Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Roisin Connolly|(410) 614-9217|rconnol2@jhmi.edu|
300152|NCT01937130|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
300153|NCT01937195|Evangelical Community Hospital|Norman R. Anderson|570-222-2000|nanderson@evanhospital.com|
300154|NCT01937260|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
300155|NCT01937299|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
300156|NCT01937312|Alcon Research, Ltd.|Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
300157|NCT01937351|Avinger|Thomas Lawson|650.241.7030|tlawson@avinger.com|
300158|NCT01937364|Essentia Health|Jeffrey E. Lyon, M.D.|218-786-2802|jeffrey.lyon@essentiahealth.org|
300159|NCT01937390|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300160|NCT01937520|Rutgers, The State University of New Jersey|Dennis Grech, MD|973 972-5007|grechde@njms.rutgers.edu|
300161|NCT01937559|Hawkins Foundation|Kyle Adams, Research Coordinator|864-454-7458|kyle.adams@hawkinsfoundation.com|
300162|NCT01937598|Div. Diabetology, Med. Dep. I, St. Josef-Hospital (Ruhr-Univeristy Bochum), change of address 01.01.20015|Prof. Dr. M. A. Nauck, Principle Investigator|+49-234-509|michael.nauck@rub.de|6332
300163|NCT01937624|Steadman Hawkins Clinic of the Carolinas/Greenville Health System|Dr. Kyle Cassas|864-454-7422|kcassas@ghs.org|
300164|NCT01937715|Pfizer Inc.|Pfizer ClincialTrials.gov Call Center|+18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
300165|NCT01937871|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
300166|NCT01937884|University of Arizona|Dr. Katri Typpo|5206265485|ktyppo@email.arizona.edu|
300167|NCT01937975|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300168|NCT01938001|Celgene Corporationi|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
300169|NCT01938040|Rutgers/State University of New Jersey (NJMS)|Alex Bekker, MD, PhD|973 972-5007|bekkeray@njms.rutgers.edu|
300170|NCT01938066|The Ohio State University|Gayle Gordillo|6142938566|gayle.gordillo@osumc.edu|
300171|NCT01938079|Columbia University|Amy L. Dzierba, Pharm.D., BCPS, BCCCP, FCCM|212-305-5852|ald9012@nyp.org|
300172|NCT01938170|UNC Chapel HIll|Ravi Jhaveri MD|919-962-5136|ravi.jhaveri@unc.edu|
300173|NCT01938378|Octapharma|Michael Eppolito|201-604-1155|michael.eppolito@octapharma.com|
300174|NCT01938391|NYU Langone Medical Center|Anvar Babaev, MD, PHD, FACC, FSCAI|212-263-5656|anvar.babaev@nyumc.org|
300175|NCT01938430|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
300176|NCT01938573|University of Washington|Dr. Bruce Montgomery|206-598-0860|rbmontgo@uw.edu|
300177|NCT01938625|Janssen Research & Development|Medical Leader||ClinicalTrialDisclosure@its.jnj.com|
300178|NCT01938664|Baylor College of Medicine|Thomas Kosten, MD|713-794-7032|kosten@bcm.edu|
300179|NCT01938846|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300180|NCT01938989|Alcon Research, Ltd.|Melvin Sarayba, Franchise Head Cataract, GMA|1-888-451-3937|alcon.medinfo@alcon.com|
300181|NCT01939002|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
300182|NCT01939028|University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center|Dr. Chad Michener|216-444-6601|michenc@ccf.org|
300183|NCT01939145|MGUH Center for Wound Healing and Hyperbaric Medicine|Paul J. Kim, DPM, Director of Research|202-444-3059|Paul.J.Kim@gunet.georgetown.edu|
300184|NCT01939158|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300185|NCT01939197|AbbVie|Global Medical Services|800-633-9110||
300186|NCT01939275|City of Hope|Paul Frankel, Ph.D.|626-812-5265|pfrankel@coh.org|
300187|NCT01939288|Imperial College London|Miss Katherine Williams|020 3311 7335|k.williams@imperial.ac.uk|
300188|NCT01939301|Indiana University|Jeffrey A. Kline, MD|317-880-3900|jefkline@iu.edu|
309942|NCT02718963|Seoul National University Bundang Hospital, Seoul National University College of Medicine|Ju Seok Ryu|82-31-787-7739|jseok337@snu.ac.kr|
309943|NCT02719028|Golden Biotechnology Corp|Howard Cheng|+886-2-28086006|howard@goldenbiotech.com|
309944|NCT02719158|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
309945|NCT02719171|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309946|NCT02719353|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
309947|NCT02719366|CooperVision, Inc.|Myhanh Nguyen|925-730-6716|mnguyen@coopervision.com|
309948|NCT02719535|The Hong Kong Polytechnic University|Dr. Andrew Lam|85227666109|andrew.kc.lam@polyu.edu.hk|
309949|NCT02719639|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309950|NCT02719743|GlaxoSmithKline|GSK Response Center|866-435-7343|ct427449@gsk.com|
309951|NCT02719938|University of North Carolina at Chapel Hill|Laura C. Hanson, MD, MPH|919-843-4096|lhanson@med.unc.edu|
290798|NCT01324999|University of North Carolina at Chapel Hill|H. James Ford, MD|(919) 966-2531|hjford@med.unc.edu|
290799|NCT01325181|Seoul National University Hospital|Jang Won Heo|82220720836|hjw68@snu.ac.kr|
290800|NCT01325207|Northwestern University|Jeffrey Raizer, MD||Jeffrey.Raizer@nm.org|
290801|NCT01325311|University of Wisconsin|Howard H. Bailey|608-263-8624|hhbailey@wisc.edu|
290802|NCT01325337|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
290803|NCT01325350|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
290804|NCT01325428|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290805|NCT01325493|Children's National Health System|Julia Finkel|2024764867|JFINKEL@childrensnational.org|
290806|NCT01325532|Massachusetts General Hospital, Dept of Psychiatry|Dr David Mischoulon|617-724-5198|dmischoulon@partners.org|
290807|NCT01325584|Midwestern Regional Medical Center|Director of Clinical Trials|847-731-1648|Bruce.Steinert@CTCA-Hope.com|
300189|NCT01939314|Indiana University School of Medicine|Jason Schaffer, MD|317-962-8026|jtschaff@iupui.edu|
300190|NCT01939353|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
300191|NCT01939366|Grünenthal GmbH|Study Director|+49 241 569 3223|Clinical-Trials@grunenthal.com|
300192|NCT01939405|MGH|Dr. Nicolas Oreskovic|6177260593|noreskovic@mgh.harvard.edu|
300193|NCT01939496|Janssen Scientific Affairs, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
300194|NCT01939548|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300195|NCT01939899|Millennium Pharmaceuticals, Inc.|Medical Director|+1-844-662-8532|globaloncologymedinfo@takeda.com|
300196|NCT01939938|Weill Cornell Medical College|Dr. Matthew Ebben|6469629318|mae2001@med.cornell.edu|
300197|NCT01939977|Hospital Universitari de Bellvitge|Dr. Josep M. Cruzado|0034932607602|jmcruzado@bellvitgehospital.cat|
300198|NCT01940120|Abbott Vascular Structural Heart (formerly Evalve, Inc.)|Chithra Sangli|650-430-1329|chithra.sangli@av.abbott.com|
300199|NCT01940146|SPARC|Shravanti Bhowmik, MD||shravanti.bhowmik@sparcmail.com|
300200|NCT01940276|Duke University|Daniel George, MD|919-668-4615|daniel.george@duke.edu|
300201|NCT01940354|Hospital of the University of Pennsylvania|Scott Trerotola, MD|215-662-6983|scott.trerotola@uphs.upenn.edu|
300202|NCT01940471|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
300203|NCT01940484|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
300204|NCT01940497|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
300205|NCT01940510|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
300206|NCT01940523|Hospital for Special Surgery|David Mayman MD|212.774.2024|maymand@hss.edu|
300207|NCT01940705|VA RR&D National Center for Rehabilitative Auditory Research|Gabrielle Saunders, PhD|503-220-8262|Gabrielle.Saunders@va.gov|56210
300208|NCT01940887|Ophthotech Corp.|Keith Westby|212-845-8200|Keith.Westby@ophthotech.com|
300209|NCT01940900|Ophthotech Corp.|Denise Teuber||denise.teuber@ophthotech.com|
300210|NCT01940939|Dr.LIU|ShanghaiMHC|862134773775|erliu110@126.com|
300211|NCT01941030|Cardiovascular Systems, Inc.|Clinical Trials Manager|651.259.2500|clinicaltrials_csi@csi360.com|
300212|NCT01941095|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
290808|NCT01325623|Cyberonics Europe BVBA|Wim Van Grunderbeek, Clinical Operations Manager Cyberonics Europe|+32 2 720 95 93|wim.vangrunderbeek@cyberonics.com|312
300213|NCT01941186|Child Health Institute of New Jersey|Manuel Jimenez, MD, MS|732-235-6230|jimenema@rwjms.rutgers.edu|
300214|NCT01941472|Peking Union Medical College Hospital|Bin Du|8610-69155036|dubin98@gmail.com|
300215|NCT01941485|Alcon Research, Ltd.|Global Brand Med Affairs Lead, Refractive, VGR|1-888-451-3937|alcon.medinfo@alcon.com|
300216|NCT01941498|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
300217|NCT01941537|Rockefeller University|James Krueger|2123277730|kruegej@rockefeller.edu|
300218|NCT01941628|Dept. of Anaesthesiology and Intensive Medicine, General University Hospital in Prague|Assoc. Prof. Jan Blaha, MD, PhD|+420 224962243|jan.blaha@lf1.cuni.cz|
300219|NCT01941745|"Tufts Medical Center | Division of Newborn Medicine"|Jonathan M. Davis, MD|(617) 636-5322|jdavis@tuftsmedicalcenter.org|
300220|NCT01941927|University of California, San Francisco|Adil Daud, MD|(415) 353-7392|Adil.Daud@ucsf.edu|
300221|NCT01941940|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
300222|NCT01942148|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Trials|+81-3-6361-7366||
300223|NCT01942161|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Trials|+81-3-6361-7366||
300224|NCT01942486|University of Utah|Bradley Katz|8015871079|bradley.katz@hsc.utah.edu|
300225|NCT01942590|Duke University Health System|Dwight Koeberl, M.D., Ph.D.|919-684-2036|dwight.koeberl@duke.edu|
300226|NCT01942668|TherapeuticsMD|Sebastian Mirkin, MD, Chief Medical Officer|561-961-1900|smirkin@therapeuticsmd.com|1952
300227|NCT01942694|Division of Endocrinology, Diabetes, and Metabolism, Tufts Medical Center|Dr. Anastassios Pittas|617-636-3232|apittas@tuftsmedicalcenter.org|
300228|NCT01942707|Universidade Federal de São Paulo|Dr. Heraldo Carlos Borges Inforzato|55-13-997112644|heraldo@litoral.com.br|
300229|NCT01942720|Medtronic|Clinical Trials Manager|+972-4-9097952|michal.kedar-datel@medtronic.com|
300230|NCT01942733|Email contact via H. Ludbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
300231|NCT01942785|Email contact via H. Lundbeck A/S|Study director||LundbeckClinicalTrials@lundbeck.com|
300232|NCT01942993|Icahn School of Medicine at Mount Sinai|Dr. Philip A Friedlander|212-824-8584|philip.friedlander@mssm.edu|
300233|NCT01943110|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
300234|NCT01943227|UC Davis Medical Center|Neal Fleming, MD, PhD|916-734-5046|nwfleming@ucdavis.edu|
300235|NCT01943292|Verastem|Lou Vaickus, MD, FACP/Chief Medical Officer|781-292-4200|lvaickus@verastem.com|
300236|NCT01943344|Vivasure Medical|Dr Chris Martin|+353 9 395 440|chris.martin@vsuremed.com|
290809|NCT01325701|Pharmacyclics, Inc.|Dr. Darrin Beaupre|855-427-8846|medinfo@pcyc.com|
290810|NCT01325714|Houston Center for Innovations in Quality, Effectiveness, and Safety|Mark Kunik, MD, MPH|713-794-8639|kunik.marke@va.gov|
290811|NCT01325792|W. L. Gore & Associates, Inc., Sponsor|Lori Norton, PhD|800-437-8181|lnorton@wlgore.com|
290812|NCT01325870|Advanced Circulatory|Clinical Research Associate|651-403-5606|nburkhart@advancedcirculatory.com|
290813|NCT01326026|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
290814|NCT01326481|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
290815|NCT01326533|University of Pittsburgh|Frederico Toledo|412-692-2848|.toledofs@upmc.edu|
290816|NCT01326546|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
290817|NCT01326702|Memorial Sloan Kettering Cancer Center|Dr. John Gerecitano|212-639-3748|gerecitj@mskcc.org|
300237|NCT01943435|University of Pittsburgh|Michael Schneider, PhD, DC - Associate Professor and Principal Investigator|412-383-6640|mjs5@pitt.edu|
300238|NCT01943461|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
300239|NCT01943474|C. R. Bard|Gina Gilbert|407-489-0835|gina.gilbert@crbard.com|
300240|NCT01943539|Akili Interactive Labs|SVP of Medical Devices|617-456-0984|skellogg@akiliinteractive.com|
300241|NCT01943552|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300242|NCT01943565|Brigham and Women's Hospital|Dirk J Varelmann, MD|617-732-8280|dvarelmann@partners.org|
300243|NCT01943591|Centre hospitalier de l'Université de Montréal Research Centre|Dr. Jean Raymond|514-890-8000|jraymond.nri@gmail.com|27235
300244|NCT01943799|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
300245|NCT01943825|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
300246|NCT01943851|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
300247|NCT01943864|GlaxoSmithKline|GSK Response Center|866-435-7343||
300248|NCT01943916|Seno Medical Instruments, Inc|Shaan Schaeffer, VP Clinical Operations|2106156501|sschaeffer@senomedical.com|
309952|NCT02720042|Becton, Dickinson and Company|Sandra van Guldener|+31 6 46900840|sandra.vanguldener@bd.com|
309953|NCT02720081|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
309954|NCT02720107|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
290818|NCT01326728|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@mail.nih.gov|
290819|NCT01326780|Valeant|Johnson Varughese|908 927-1162|johnson.varughese@bauschhealth.com|
290820|NCT01326910|Johnson & Johnson Consumer and Personal Products Worldwide|Joyce Hauze, Sr. Specialist Clinical Quality Systems and Process|928-277-0715|jhauze@its.jnj.com|
290821|NCT01326962|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 616878333|global.trial_information@roche.com|
290822|NCT01327053|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
290823|NCT01327157|Master-Pos graduação em Otorrinolaringologia|Dra Rosana de Queiroz Costa|55___11___98579-8799|rosanaqueiroz@msn.com|
290824|NCT01327274|UCSF Benioff Children's Hospital|Jill Imamura-Ching, RN|415-476-3446|Jill.Imamura-Ching@ucsf.edu|
290825|NCT01327300|University of Florida|Dr. Baharak Moshiree|(352)273-8393|bmoshiree@med.miami.edu|
300249|NCT01944046|Duke University|Linmarie Sikich, M.D.|919-681-0026|linmarie.sikich@duke.edu|
300250|NCT01944098|TeamHealth Anesthesia|Enrico Camporesi MD|813-844-7170|ecampore@health.usf.edu|
300251|NCT01944293|Columbia University Medical Center - NY State Psychiatric Institute|Michael Grunebaum, MD|646-774-7573|michael.grunebaum@nyspi.columbia.edu|
300252|NCT01944319|Peking University Third Hospital|Dr. Qingtao ZHOU|86-10-82265562|zhouqingtaobysy@sina.com|
309955|NCT02720198|Duke University Medical Center|Dr. Narei Hong|984-215-8493|narei.hong@duke.edu|
309956|NCT02720224|Estetra SPRL|Marie Mawet||mmawet@mithra.com|
309957|NCT02720484|Northwestern University|Devalingam Mahalingam|312.472.0564|mahalingam@northwestern.edu;|
309958|NCT02720523|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309959|NCT02720536|Novartis Pharmaceuticals|Study Director|888-778-8300|Novartis.email@novartis.com|
309960|NCT02720627|Cassiopea, SpA|Cassiopea R&D|+39 02 868 911 24|r&d@cassiopea.com|
309961|NCT02720757|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309962|NCT02720952|Diurnal Limited|Dr John Porter||info@diurnal.co.uk|
309963|NCT02721017|University of California San Francisco Department of Surgery|Dr. Benjamin Padilla|415-476-3642|Benjamin.Padilla@ucsf.edu|
309964|NCT02721147|Fox Chase Cancer Center|Dr. Jennifer Reese, Assistant Professor|215-214-3223|Jennifer.Reese@fccc.edu|
309965|NCT02721251|VA|David Thompson|602-496-0242|david.thompson4@va.gov|
309966|NCT02721355|Immunology Research Institute in Gifu|Dr. Van Sa Nguyen|+819068053288|nguyen@ew-nutrition.co.jp|
309967|NCT02721641|Hoffmann-La Roche|Medical Communications|800-821-8590|global-roche-genentech-trials@gene.com|
309968|NCT02721875|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
309969|NCT02721966|Novartis Pharma AG|Study Director|1-888-669-6682|novartis.email@novartis.com|
309970|NCT02722044|Momenta|Jim Jin|+16173954905|jjin@momentapharma.com|
309971|NCT02722148|University of North Carolina at Chapel Hill|Dr. Evan S. Dellon|(919) 966-2513|evan_dellon@med.unc.edu|
309972|NCT02722239|Biocard Research LLC|Nadiya Rizvanova|+74993088278|n.rizvanova@biocard.com|
309973|NCT02722278|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
309974|NCT02722304|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
309975|NCT02722330|ENT Department, Royal Hallamshire Hospital, Sheffield|Professor Jaydip Ray|+44 (0)114 271 1900|jaydip.Ray@sth.nhs.uk|
309976|NCT02722408|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
309977|NCT02722499|Medical College of Wisconsin|Jennifer A. Campbell|414-955-8829|jacampbell@mcw.edu|
309978|NCT02722564|St. Luke's University Health Network|Holly Stankewicz, D.O.|484-526-4000|holly.stankewicz@gmail.com|
309979|NCT02722577|State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China|Guodong Niu|+86(10)88398866|guodongniu@fuwai.com|
309980|NCT02722837|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
309981|NCT02722863|Korea Otsuka Pharmaceutical Co.,Ltd.|Huiyeong,Shim/Associate CTM for LPS & ISS|02-3287-9220|hyshim@otsuka.co.kr|
309982|NCT02722928|The Ohio State University Wexner Medical Center|Juan Fiorda-Diaz Postdoctoral Researcher|6142933559|juan.fiorda@osumc.edu|
309983|NCT02722967|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development||DT-inquiry@otsuka.jp|
309984|NCT02723006|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
309985|NCT02723084|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
309986|NCT02723175|Medical University of South Carolina|Jeffrey Borckardt|843-792-3295|borckard@musc.edu|
309987|NCT02723188|Tel Aviv University|Yair Bar-Haim|97236406393|yair1@post.tau.ac.il|
309988|NCT02723201|Medical Director|Takeda|+1-877-825-3327|trialdisclosures@takeda.com|
300253|NCT01944345|Wenzel Spine, Inc.|Director, Quality & Regulatory Affairs|5123148271|bnowatzke@wenzelspine.com|
300254|NCT01944371|University of California, San Francisco|Steven G. Deeks|4156064082|Steven.Deeks@ucsf.edu|404
290826|NCT01327313|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
300255|NCT01944423|Univeristy of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
290827|NCT01327339|GlaxoSmithKline|GSK Response Center|866-435-7343||
290828|NCT01327482|Massachusetts General Hospital|Dr. Caroline Mitchell|617-724-2182|caroline.mitchell@mgh.harvard.edu|
290829|NCT01327495|University of Washington|Stephanie Page, MD, PhD|206-616-0483|page@uw.edu|
290830|NCT01327508|Smith & Nephew, Inc.|Cathy Newbill|800-821-5700|cathy.newbill@smith-nephew.com|
290831|NCT01327547|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290832|NCT01327573|Yale University|Dr. Sanjay Kulkarni|203-785-6501|sanjay.kulkarni@yale.edu|
290833|NCT01327599|Alcon Research, Ltd.|Doug Hubatsch, Therapeutic Unit Head, Global Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
290834|NCT01327612|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
300256|NCT01944462|Thomas Jefferson University|Laura T. Pizzi, PharmD, MPH; Principal Investigator|215-955-1159|laura.pizzi@rutgers.edu|
300257|NCT01944631|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300258|NCT01944644|Weill Cornell Medical College|Marc Dubin, M.D.|(212) 746-5817|mrd9035@med.cornell.edu|
300259|NCT01944670|Skeletal Dynamics, LLC|Ana Escagedo|305-596-7585|AEscagedo@SkeletalDynamics.com|
300260|NCT01944722|Becton, Dickinson and Company|Clinical Study Manager|410-316-4000|BDClinicalTrials@bd.com|
300261|NCT01944774|TaiGen Biotechnology Co., Ltd.|Chen-En Tsai, M.D., Ph.D.|+886-2-8177-7072|cetsai@taigenbiotech.com|1211
300262|NCT01944839|Ophthotech|Denise Teuber||denise.teuber@ophthotech.com|
300263|NCT01944878|Hallym University College of Medicine, Chuncheon Sacred Heart Hospital|Dr. Chang Seok Bang|+82-33-240-5000|cloudslove@naver.com|
300264|NCT01944930|Lahey Hospital and Medical Center|Thomas Schnelldorfer|781-744-5100|thomas.schnelldorfer@lahey.org|
300265|NCT01944969|H. Lundbeck A/S|H. Lundbeck A/S|+45 36301311|LundbeckClinicalTrials@lundbeck.com|
300266|NCT01945034|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300267|NCT01945086|Janssen Research & Development, LLC.|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
300268|NCT01945112|Stanford Department of Emergency Medicine|Grant Lipman|415-290-9286|gslipman@stanford.edu|
300269|NCT01945138|University of Minnesota|Dr. Melena Bellin|612-624-5409|bell0130@umn.edu|
300270|NCT01945216|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
300271|NCT01945242|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
300272|NCT01945281|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300273|NCT01945294|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300274|NCT01945489|Allergan, Inc|Vice President Medical Affairs|1-877-277-8566|IR-CTRegistration@allergan.com|
300275|NCT01945580|Boston Scientific|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
300276|NCT01945593|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
300277|NCT01945710|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
300278|NCT01945866|Jaeb Center for Health Research|Adam Glassman|8139758690|drcrnet@jaeb.org|
300279|NCT01945944|Rainbow Babies and Children's Hospital|Steven Shein, MD|216-844-3310|drstevenshein@gmail.com|
300280|NCT01945970|Unilever R&D Research Vlaardingen|Dr Theo Mulder|+31 10 460 8315|theo.mulder@gmail.com|
300281|NCT01945996|University of Southern California|Elizabeth Burner|3232266667|eburner@usc.edu|
300282|NCT01946126|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
300283|NCT01946152|UT MD Anderson Cancer Center|Michael Wang,MD/ Professor, Lymphoma-Myeloma|(713) 792-2860|miwang@mdanderson.org|
300284|NCT01946165|UT MD Anderson Cancer Center|Christopher J. Logothetis M.D. / Genitourinary Medical Oncology|713-792-2830|clogothe@mdanderson.org|
300285|NCT01946178|Mirabilis Medica, Inc.|Director of Clinical Affairs|425-486-8230|patrick@mirabilismedica.com|
300286|NCT01946191|University of Utah|Dr. Molly Conroy|801-581-8310|Molly.Conroy@hsc.utah.edu|
300287|NCT01946243|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
300288|NCT01946282|University of Texas Southwestern Medical Center, Moncrief Cancer Institute|Dr. Keith Argenbright, Director, Moncrief Cancer Institute|817-288-0070|keith.argenbright@utsouthwestern.edu|
300289|NCT01946412|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
300290|NCT01946425|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
300291|NCT01946438|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
300292|NCT01946529|St. Jude Children's Research Hospital|Sara Federico, MD|901-595-2220|sara.federico@stjude.org|
300293|NCT01946802|Seoul National University Hospital|Pf. Gil Joon Suh|82-2-2072-2196|suhgil@snu.ac.kr|
300294|NCT01946880|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
300295|NCT01947127|Faculty of Medicine, Chulalongkorn University|Khrongwong Musikatavorn, M.D.|+6622564553|kmusikatavorn@yahoo.com|
300296|NCT01947153|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300297|NCT01947283|Disparities Research Unit, Department of Medicine, Massachusetts General Hospital|Margarita Alegria|617-724-4987|malegria@mgh.harvard.edu|
300298|NCT01947335|Heart Institute (Incor)|Dr. Pedro A. Lemos|+55 11 2661 5000|pedro.lemos@incor.usp.br|
300299|NCT01947491|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
300300|NCT01947517|Queen's University|Dr. Stephanie Baxter|613 544 3310|baxters@baxtereyemd.com|
300301|NCT01947582|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS, Principal Investigator|214-648-1559|karen.mccain@utsouthwestern.edu|
300302|NCT01947647|Ralph H. Johnson VAMC|Daniel Gros, PHD|843-789-7311|daniel.gros@va.gov|
290835|NCT01327651|Fred Hutchinson Cancer Research Center|Maoji Li (Statistical Research Associate)|2066676035|mli2@fredhutch.org|
290836|NCT01327677|Johns Hopkins University School of Medicine|Athir Morad, M.D.|4109552611|morada@jhmi.edu|
290837|NCT01327703|Aptalis Pharma US, Inc.|Robert Winkler, MD, VP, Clinical Development and Operations|1-800-472-2634||
290838|NCT01327846|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
290839|NCT01327885|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
290840|NCT01327963|EndoGastric Solutions|Adrian Lobontiu, Chief Medical Officer|1 650-474-9259|alobontiu@endogastricsolutions.com|
290841|NCT01327976|EnteroMedics|Director of Clinical Research|651-634-3209|mbroich@enteromedics.com|
290842|NCT01327989|Medtronic|Manish Gupta, Sr. Director of Medical Affairs|949-837-3700|manish.gupta@medtronic.com|
290843|NCT01328002|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
290844|NCT01328041|ViiV Healthcare|GSK Response Center|866-435-7343||
300303|NCT01947816|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
300304|NCT01947855|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300305|NCT01947894|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300306|NCT01947907|Ascendis Pharma A/S|VP Clinical Development|+49 172 155 2596|mb@ascendispharma.com|
300307|NCT01947946|AZ-PPD|Steven Fox|441480716682|steven.fox@ppdi.com|
300308|NCT01948050|Beth Israel Medical Center|Helena Knotkova, PhD|212-844-8541|hknotkov@chpnet.org|
300309|NCT01948063|BIDMC|Michael W Donnino|617-754-2341|mdonnino@bidmc.harvard.edu|
300310|NCT01948076|Brigham and Women's Hospital|Maria Yialamas|617-732-5500|myialamas@partners.org|
300311|NCT01948141|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
300312|NCT01948193|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
300313|NCT01948258|SPD Swiss Precision Diagnostics GmbH/SPD Development Company Ltd|Dr Sarah Johnson, Head of Clinical and Regulatory Affairs|01234835486|sarah.johnson@spdspark.com|
300314|NCT01948310|Duke Medical Center|Leslie Willis|9196606782|leslie.willis@duke.edu|
300315|NCT01948375|Guang'an Men Hospotal Affiliated to China Academy of Chinese Medical Sciences|Zhishun Liu, Director of the study|8610-010-88001124|liuzhishun@aliyun.com.cn|
300316|NCT01948388|Arthritis & Rheumatic Disease Specialties|Joanne Sagliani|3059324162|drnbg@rheum-care.com|
300317|NCT01948427|Horizon Therapeutics, LLC|Horizon Therapeutics, LLC|866-479-6742|clinicaltrials@horizontherapeutics.com|
300318|NCT01948518|Cleveland Clinic|Umur Hatipoğlu, MD|216-636-5344|HATIPOU@ccf.org|
300319|NCT01948739|Rice University|Marcia K. O'Malley, PhD|(713) 348-3545|omalley@rice.edu|
300320|NCT01948791|Novartis Pharmaceuticals|Study Director|862-778-8300||
300321|NCT01948830|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
300322|NCT01948908|Columbia University College of Physicians and Surgeons|Daniel S. Tsze|212-305-9825|dst2141@columbia.edu|
300323|NCT01948947|VA San Diego Healthcare System|Valerie Metzger Smith, Study Coordinator|858-750-0274|valerie.metzgersmith@va.gov|
300324|NCT01948986|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300325|NCT01949051|GlaxoSmithKline|GSK Response Center|866-435-7343||
300326|NCT01949090|GlaxoSmithKline|GSK Response Center|866-435-7343||
300327|NCT01949116|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
300328|NCT01949142|Otonomy, Inc|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
300329|NCT01949155|Otonomy, Inc.|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
300330|NCT01949337|Memorial Sloan-Kettering Cancer Center|Michael J. Morris, MD|646-422-4469|morrism@mskcc.org|
300331|NCT01949389|VA Connecticut Healthcare system|Eric Hermes|203 932 5711|eric.hermes@va.gov|7422
300332|NCT01949480|University of Pittsburgh|Dr. Anna Uskova, Principal Investigator|412) 623-2167|UskoAA@anes.upmc.edu|
300333|NCT01949532|Amgen, Inc.|Study Director|866-572-6436||
300334|NCT01949545|Amgen, Inc.|Study Director|866-572-6436||
300335|NCT01949662|UT MD Anderson Cancer Center|David Hui, MD/ Associate Professor, Palliative Care Medicine|713-792-6258|dhui@mdanderson.org|
300336|NCT01949779|Stryker Neurovascular|Cheryl Fontana, Sr. Manager, Clinical Services|510-413-2948|cheryl.fontana1@stryker.com|
300337|NCT01949844|Cedars-Sinai Medical Center|Dr. Behzad Sharif, Assistant Professor|310-423-7758||
309989|NCT02723344|Eastern Colorado Health Care System, Rocky Mountain MIRECC|Dr. Lisa A Brenner|720-723-6488|lisa.brenner@va.gov|
309990|NCT02723591|Astellas Pharma Global Development, Inc. (APGD)|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
309991|NCT02723630|Eisai Inc.|Eisai Medical Services|1-888-247-2378|esi-medinfo@eisai.com|
309992|NCT02723786|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
309993|NCT02723916|The Ohio State University, College of Nursing|Dr. Susie Breitenstein|6146884614|breitenstein.5@osu.edu|
309994|NCT02723929|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526158|Fregni.felipe@mgh.harvard.edu|
309995|NCT02724020|Takeda|Medical Director|+1-877-825-3327|TrialDisclosures@takeda.com|
290845|NCT01328054|GlaxoSmithKline|GSK Response Center|866-435-7343||
290846|NCT01328080|Johns Hopkins Dermatology|Ginette Okoye, MD, Director of Ethnic Skin Program|410-502-7546|ctrep@jhmi.edu|
290847|NCT01328158|AbbVie (prior sponsor, Abbott)|AbbVie Japan PMOS Desk|+81-3-4577-1125|abvj-pmos@abbvie.com|
290848|NCT01328184|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300338|NCT01949870|AstraZeneca|Dr Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
300339|NCT01950013|Indiana University, Dept of Speech & Hearing Sci|Larry Humes|812-855-3507|humes@indiana.edu|
300340|NCT01950039|Joslin Diabetes Center|Mary Elizabeth Patti MD|617 309 2635|mary.elizabeth.patti@joslin.harvard.edu|
300341|NCT01950078|Huazhong University of Science and Technology|Dr. Xianwei Zhang|027 83663173|znpin@sina.cn|
300342|NCT01950169|Department of Geriatric Medicine, Karolinska University Hospital, Stockholm, Sweden|Dr. Lena Flodin|Mobile: 0701910300|lena.flodin@sll.se|
300343|NCT01950260|Mayo Clinic|Dr. Marius N. Stan|507-284-2463|stan.marius@mayo.edu|
300344|NCT01950273|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300345|NCT01950299|Virginia Commonwealth University|Antonio Abbate, MD, PhD|804-828-0513|antonio.abbate@vcuhealth.org|
300346|NCT01950364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
300347|NCT01950663|Dean McGee Eye Institute / University of Oklahoma Health Sciences Center|Dr. Stephen R. Fransen|405-271-1092|stephen-fransen@dmei.org|
300348|NCT01950741|Pusan National University Hospital|Ji Eun Lee, Assoicated professor|+82-51-240-7957|jlee@pusan.ac.kr|
309996|NCT02724033|Department of Otolaryngology, Indiana University School of Medicine|Dr. Charles Yates, Primary Investigator|317-278-1286|cwyates@iupui.edu|
309997|NCT02724111|Korea University Guro Hospital|Dr Byung Gun Lim|82-2-2626-1437|bglim9205@korea.ac.kr|
309998|NCT02724423|Neurelis, Inc.|Sunita Misra, M.D. Medical Director|(832) 257-1975|smisra@neurelis.com|
309999|NCT02724449|North Shore University Hospital|Mary Brennan, Assist Director WOCN|516-562-8252|mbrennan@northwell.edu|
310000|NCT02724462|Fred Hutchinson Cancer Research Center|Dr. Jonathan Bricker|206-667-5077|jbricker@fredhutch.org|
310001|NCT02724592|University of Greifswald|Dr. Mohammad Alkilzy|0049-17623399340|alkilzym@uni-greifswald.de|
310002|NCT02724644|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquires@endo.com|
310003|NCT02724787|James A. Haley Veterans' Hospital|Dr. Shannon Miles|813-972-2000|shannon.miles@va.gov|6728
310004|NCT02724800|VA Pittsburgh Healthcare System|Adam Bramoweth, PhD|412-360-2806|Adam.Bramoweth@va.gov|
310005|NCT02724839|Cincinnati Children's Hospital Medical Center|Dr.Kristen Copeland|5136361687|kristen.copeland@cchmc.org|
310006|NCT02724878|Dana-Farber Cancer Institute|Toni Choueiri|617-632-5456|toni_choueiri@dfci.harvard.edu|
310007|NCT02724956|UT MD Anderson Cancer Center|Carin Hagberg, MD/Chief Academic Officer, CAO Office|713-792-5888|chagberg@mdanderson.org|
310008|NCT02725008|New York Presbyterian - Brooklyn Methodist Hospital|Christopher P Kelly|718.780.5040|chk9064@nyp.org|
310009|NCT02725268|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
310010|NCT02725411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
310011|NCT02725476|Xencor, Inc.|Vice President, Biometrics|858-480-3414|bburington@xencor.com|114
310012|NCT02725515|Xencor, Inc.|Vice President, Biometrics|858-480-3414|bburington@xencor.com|
310013|NCT02725645|Universidade Fernando Pessoa|Sandra Beatriz Pereira Rodrigues||sandrar@ufp.edu.pt|
310014|NCT02725710|Duke University|Jeremy M. Weber|919-681-4561|jeremy.m.weber@duke.edu|
310015|NCT02725788|3M|Laura Rutledge|651-733-5394|lfrutledge1@mmm.com|
310016|NCT02725801|University of Kentucky Division of Plastic Surgery|Lesley Wong|859-323-7505|lesley.wong@uky.edu|
310017|NCT02725866|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
310018|NCT02726022|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
310019|NCT02726074|Eisai Inc.|Eisai Korea Inc. Medical department|+82-2-3451-5539|h3-park@eisaikorea.com|
310020|NCT02726113|Medical University of South Carolina|Sebastiano Gattoni-Celli, M.D.; Professor of Radiation Oncology|843-876-5103|gattonis@musc.edu|
310021|NCT02726178|Sainte Justine university hospital center|Dr. Anne Monique Nuyt|514 3454931|anne-monique.nuyt@recherche-ste-justine.qc.ca|3971
310022|NCT02726451|DeNova Research|Steven Dayan, MD|3123352070|sdayan@drdayan.com|
310023|NCT02726542|Massachusetts General Hospital|Takara Stanley, MD|617-726-5312|tstanley@mgh.harvard.edu|
310024|NCT02726620|Vanderbilt University Medical Center|Jonathan Wanderer|615-536-5194|jon.wanderer@vanderbilt.edu|
310025|NCT02726789|Replicor Inc.|Chief Scientific Officer|514 733 1998|availlant@replicor.com|
310026|NCT02726945|The GID Group|Director of Clinical Affairs|7204124233|vgood@thegidgroup.com|
310027|NCT02726971|Department of Hysteroscopic Center, Fuxing Hospital, Capital Medical University, Beijing, China|Dr. YH Liu|8618301474064|emmagj@126.com|
310028|NCT02727192|Oslo University Hospital|Professor Lars Gullestad|+4797644772|lars.gullestad@medisin.uio.no|
310029|NCT02727322|University of Pittsburgh|Halina Zyczynski|421-641-1440|hzyczynski@upmc.edu|
310030|NCT02727660|Pearl Therapeutics, a Member of the AstraZeneca Group|Paul M. Dorinsky, MD|650-305-2600|paul.dorinsky1@astrazeneca.com|
310031|NCT02727699|Actinogen Medical Limited|Director of Drug Development & Strategy|+61289647401|info@actinogen.com.au|
310032|NCT02727751|Ardelyx|Chief Development Officer|5107451752|drosenbaum@ardelyx.com|
270250|NCT00115869|Fred Hutchinson Cancer Research Center|Arthur V. Peterson, Jr. PhD|206-667-5131|avpeters@fhcrc.org|
270251|NCT00115934|New England Research Institutes|Lynn Sleeper, ScD|617-972-3235|lsleeper@neriscience.com|
270252|NCT00116168|MedImmune|Don Raible, MD|301-398-0000|raibleD@medimmune.com|
290849|NCT01328249|Eisai Inc.|Eisai Medical Information|1-888-422-4743|esi_oncmedinfo@eisai.com|
290850|NCT01328366|AbbVie (prior sponsor, Abbott)|Global Medical Information|800-633-9110||
300349|NCT01950780|Columbia University Dept of Dermatology|Director of Clinical Research Dermatology|2123056953|jc299@cumc.columbia.edu|
300350|NCT01950819|Novartis Pharma|Study Director|8627788300|Novartis.email@novartis.com|
300351|NCT01951066|Wilmer Eye Institute, Johns Hopkins University School of Medicine|[Peter A. Campochiaro|(410) 955-5106|pcampo@jhmi.edu|
300352|NCT01951092|Alpert Medical School of Brown University/The Miriam Hospital|Aadia Rana, MD|401-793-4680|arana@lifespan.org|
300353|NCT01951105|Northwestern University|Apkar Vania Apkarian|312-503-0404|a-apkarian@northwestern.edu|
300354|NCT01951118|New York State Psychiatric Institute|Dr. Davangere Devanand|646-774-8658|dpd3@cumc.columbia.edu|
300355|NCT01951157|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
300356|NCT01951170|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
300357|NCT01951261|Hospital Puerta de Hierro|Dra Patricia Mínguez Clemente|911916859|drapat3@gmail.com|
300358|NCT01951326|RedHill Biopharma|Reza Fathi, Senior VP Research and Development|972-(0)3-541-3131|reza@redhillbio.com|
300359|NCT01951339|University of Colorado|Dr. Judy Regensteiner|303-724-2247|judy.regensteiner@ucdenver.edu|
300360|NCT01951352|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
300361|NCT01951391|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
300362|NCT01951417|Galderma Labratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
300363|NCT01951573|Alcon Research, Ltd.|Mary Fahmy, Head, Clinical Development, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
300364|NCT01951586|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
300365|NCT01951625|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
300366|NCT01951638|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
300367|NCT01951651|Baylor|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
300368|NCT01951703|Clinical Compliance Manager|Jurandir Araujo|904 443-1379|jaraujo7@jnj.com|
300369|NCT01951768|Geneva University Hospitals, Balgrist University Hospital|Dr. med. Ilker Uçkay|+41 44 386 11 11|ilker.uckay@balgrist.ch|
300370|NCT01951820|University of Michigan School of Dentistry|Dr. Carlos Gonzalez|734-763-3391|carlosgc@umich.edu|
300371|NCT01951950|Northwestern University|John F. Bebawy, MD, Principal Investigator|312-695-0061|j-bebawy@northwestern.edu|
310033|NCT02727777|UT MD Anderson Cancer Center|Dr. Jason R. Westin/Lymphoma/Myeloma|713-792-3750|jwestin@mdanderson.org|
310034|NCT02727816|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
310035|NCT02727842|Cochlear Americas|Kimberly Nix, Clinical Project Manager|303-264-2340|knix@cochlear.com|
310036|NCT02727894|Institution for Clinical and Experimental Medicine|Jan Král|+420605273008|jan.kral@centrum.cz|
310037|NCT02728089|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
310038|NCT02728102|The Emmes Company|Adam Mendizabal, PhD|301-284-1798|amendizabal@emmes.com|
310039|NCT02728206|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
310040|NCT02728830|Duke Cancer Center|Dr. Angeles Alvarez Secord|919-684-3765|secor002@mc.duke.edu|
310041|NCT02728895|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
310042|NCT02729025|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
310043|NCT02729038|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310044|NCT02729051|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310045|NCT02729194|University of Michigan Rogel Cancer Center|Dr. Ajjai Alva, M.D.|734-936-0091|ajjai@umich.edu|
310046|NCT02729545|Beijing Hospital of Integrated Traditional Chinese and Western Medicine|Dr. Yu Cao|086|howgreenbreeze@126.com|88223667
310047|NCT02729740|Penumbra, Inc.|Director of Clinical Affairs|+1 510 995 2183|blawson@penumbrainc.com|
310048|NCT02729753|C2 Therapeutics|Marcia Wachna, Director of Clinical Research||marcia@c2therapeutics.com|
310049|NCT02729831|Massachusetts General Hospital|Dr. Karen R. Sepucha|617-724-3350|KSEPUCHA@mgh.harvard.edu|
310050|NCT02729896|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
310051|NCT02729909|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
310052|NCT02730130|Memorial Sloan Kettering Cancer Center|Christopher Barker, MD|212-639-8168|barkerc@mskcc.org|
310053|NCT02730169|Mereo BioPharma Group|Jackie Parkin|+44 (0) 333 023 7300|enquiries@mereobiopharma.com|
310054|NCT02730195|Emory University|William Blum, MD|404-778-1900|william.g.blum@emory.edu|
290851|NCT01328379|Acorda Therapeutics|Vice President - Clinical Development & Medical Affairs|(914) 347- 4300|hhenney@acorda.com|5138
290852|NCT01328405|University of Wisconsin School of Medicine and Public Health|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
290853|NCT01328431|Yale University|Steven L. Bernstein, MD|203-737-3574|steven.bernstein@yale.edu|
290854|NCT01328444|GlaxoSmithKline|GSK Response Center|866-435-7343||
290855|NCT01328496|St. Jude Children's Research Hospital|Amr Qudeimat, MD|901-595-8342|amr.qudeimat@stjude.org|
290856|NCT01328535|Mayo Clinic|Roxana S. Dronca, M.D.|507/284-2511|Dronca.Roxana@mayo.edu|
290857|NCT01328548|McMaster University|Dr. Mark Loeb|905 515 9140|loebm@mcmaster.ca|26679
290858|NCT01328574|National Cancer Institute|Dr. Andrea Apolo|301-451-1984|apoloab@mail.nih.gov|
290859|NCT01328717|Ascensia Diabetes Care|Dr. Daniel Brown|574-256-7754|daniel.brown@ascensia.com|
290860|NCT01328743|Brown University|Christopher Kahler|4018636651|christopher_kahler@brown.edu|
290861|NCT01328756|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
290862|NCT01328769|University of Utah|Paul Hopkins|801-585-8139|paul.hopkins@utah.edu|
290863|NCT01328782|Children's Hospital Colorado|Gaia Georgopoulos, MD|720-777-2588|Gaia.Georgopoulos@childrenscolorado.org|
290864|NCT01328873|Northside Hospital|H. Kent Holland, MD|404-255-1930|kholland@bmtga.com|
300372|NCT01951963|Health Partners|Dr. Aaron Burnett|651-254-5304|Aaron.M.Burnett@HealthPartners.Com|
300373|NCT01952015|Novartis Pharmaceuticals|Study Director|862-778-8300||
300374|NCT01952041|University of Washington School of Medicine|Dror Ben-Zeev, PhD|(206) 685-9655|dbenzeev@uw.edu|
300375|NCT01952054|UT MD Anderson Cancer Center|Ueno,Naoto,M.D., PH.D. / Breast Medical Oncology|713-792-2817|nueno@mdanderson.org|
300376|NCT01952080|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
300377|NCT01952145|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
300378|NCT01952301|Perio Health Professionals, PLLC|Dr. Michael K. McGuire|713-783-5442|mkmperio@swbell.net|
300379|NCT01952366|Sykehuset Innlandet|Dr. Tom Borza|+47 91834607|tom.borza@sykehuset-innlandet.no|
300380|NCT01952418|Massachusetts General Hospital|Norman Nishioka, MD|6177264422|NNISHIOKA@PARTNERS.ORG|
300381|NCT01952444|Elusys Therapeutics Inc.|Senior Director of Regulatory|973-808-0222|cdillon@elusys.com|
300382|NCT01952470|Alfred Health|Benjamin James Tarrant|+61404455658|b.tarrant@alfred.org.au|
300383|NCT01952574|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
300384|NCT01952600|Arbor Research Collaborative for Health|Dr. Francesca Tentori|7346654108|francesca.tentori@arborresearch.org|
300385|NCT01952665|CooperVision|Donald Siegel, OD Principal Investigator|(949) 597-4700|dsiegel@coopervision.com|
300386|NCT01952678|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-543137|jose.zubeldia@ge.com|
300387|NCT01952691|Hacettepe University|Gul Oznur Karabicak|+90 505 3569409|guloznur@gmail.com|
300388|NCT01952834|Medical College of Wisconsin|Dr. Michael Widlansky|414-955-6755|mwidlans@mcw.edu|
300389|NCT01953003|Institut de Recherche Pierre Fabre, Toulouse France|Karim Keddad, Head of Medical Unit|+33.5.34.50.61.69|Karim.keddad@pierre-fabre.com|
300390|NCT01953081|Theravance Biopharma US, Inc.|Dr. Brett Haumann, SVP, Clinical Development|650-808-6000|BHaumann@theravance.com|
310055|NCT02730208|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
310056|NCT02730234|Midwest Cardiovascular Research Foundation|Nicolas W Shammas|5633242828|shammasg@mcrfmd.com|102
310057|NCT02730247|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR; CRS Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
310058|NCT02730260|Washington University School of Medicine|Dr. Walton Sumner|314-454-8164|wsumner@dom.wustl.edu|
310059|NCT02730351|GlaxoSmithKline|GSK Response Center|866-435-7343|sarah.l.west@gsk.com|
310060|NCT02730377|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
310061|NCT02730403|NYU Grossman School of Medicine|John Rotrosen|646-754-4763|john.rotrosen@nyulangone.org|
310062|NCT02730455|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
310063|NCT02730598|University of Kansas Medical Center|Neil Segal|(913) 945-8985|segal-research@kumc.edu|
310064|NCT02730663|Taewoong Medical Co., Ltd.|JiYoung Ahn/Assistant manager|+82-70-4649-1624|sarahahn@stent.net|628
310065|NCT02730728|University of Pennsylvania|Dr Nabil Elkassabany|2156628000|nabil.elkassabany@uphs.upenn.edu|
310066|NCT02730819|Mayo Clinic|Dr. Jason Sluzevich|904-953-9453|Sluzevich.Jason@mayo.edu|
310067|NCT02730871|Alcon, A Novartis Division|WW Brand Medical Director Ophtha, GMA Ophthalmics|1-888-451-3937|alcon.medinfo@alcon.com|
310068|NCT02730884|The University of Texas MD Anderson Cancer Center|Jorge Cortes, MD/Professor|713-794-5783|jcortes@mdanderson.org|
310069|NCT02730962|University of Minnesota|Dr. Alexander Khoruts|612-624-2101|khoru001@umn.edu|
310070|NCT02730988|Wake Forest University|Kristen Beavers|3367585855|beaverkm@wfu.edu|
310071|NCT02731131|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
310072|NCT02731157|Duke University|Ian Welsby, M.D.|919-681-6752|ian.welsby@duke.edu|
310073|NCT02731300|Department of Physiology; Faculty of Medicine, Khon Kaen University, Khon Kaen 40002, Thailand.|Paradee Auvichayapat|66896222624|aparad@kku.ac.th|
310074|NCT02731313|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
310075|NCT02731469|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
310076|NCT02731638|University of California, San Francisco|Dr. Jennifer Rose-Nussbaumer|+1 415 502 2666|jennifer.rose-nussbaumer@ucsf.edu|
310077|NCT02731690|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
310078|NCT02731729|Parker Institute for Cancer Immunotherapy|Jennifer Ayran|628-899-7623|jayran@parkerici.org|
310079|NCT02731742|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
310080|NCT02731755|University of Reading|Prof Jeremy Spencer|+44(0) 1183788724|j.p.e.spencer@reading.ac.uk|
310081|NCT02731820|Istituto Ortopedico Rizzoli|Director of Clinical Trials|+39 051.6366392|ctc@ior.it|
310082|NCT02731833|GlaxoSmithKline|GSK Response Center|866-435-7343||
310083|NCT02732015|UT MD Anderson Cancer Center|Saroj Vadhan,MD-Clinical Professor, Cytokine & Supportive Oncology|713-792-7966|svadhanr@mdanderson.org|
300391|NCT01953211|University Reproductive Associates|Michael Cho|(201) 288-6330|michaelcho@nyc.com|
290865|NCT01328951|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
290866|NCT01328964|GlaxoSmithKline|GSK Response Center|866-435-7343||
290867|NCT01329029|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
290868|NCT01329185|University of Minnesota|Dr. Priya Verghese, Director of Pediatric Kidney Transplantation|6126262922|pverghes@umn.edu|0
290869|NCT01329198|University of Florida Center for Movement Disorders & Neurorestoration|Assistant Director of Clinical Trials|352-294-5000|stacy.merritt@neurology.ufl.edu|
290870|NCT01329263|University of Pennsylvania|Dr. Andrew Strasser|2157465788|strasse3@mail.med.upenn.edu|
290871|NCT01329328|University of Verona|Prof. Carlo Zancanaro|+390458027155|carlo.zancanaro@univr.it|
290872|NCT01329380|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
290873|NCT01329419|GlaxoSmithKline|GSK Response Center|866-435-7343||
290874|NCT01329562|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cady|417-890-7888|jtarrasch@clinvest.com|
300392|NCT01953224|The University of Texas Medical Branch|Eloisa Martinez|4092669643|esmartin@utmb.edu|
300393|NCT01953237|University of Maryland, Baltimore|Julie Kreyenbuhl|410-637-1864|jkreyenb@som.umaryland.edu|
300394|NCT01953328|Amgen Inc.|Study Director|866-572-6436||
300395|NCT01953354|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
300396|NCT01953432|Michael E. DeBakey VA Medical Center|Daryl Shorter, MD|713-798-4870|shorter@bcm.edu|
300397|NCT01953575|Mayo Clinic|David A. Katzka|507-284-4824|Katzka.David@mayo.edu|
300398|NCT01953601|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300399|NCT01953692|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300400|NCT01953783|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
300401|NCT01953874|ResMed|Adam Benjafield|(858)836-6782|adam.benjafield@resmed.com|
300402|NCT01953913|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300403|NCT01954017|Leadiant Biosciences, Inc.|Scott Rodgers, MS, CCRA, ACRP-PM / Sr Director of Clinical Operations|301-670-1565|scott.rodgers@leadiant.com|
300404|NCT01954056|University of New Mexico|Dr. Kristi Watterberg|505-272-8609|KWatterberg@salud.unm.edu|
300405|NCT01954082|University of Rochester|Dale Phelps|(585) 275-2972|dale_phelps@urmc.rochester.edu|
300406|NCT01954121|UCB Cares|UCB (Study Director)|+1 887 822 9493||
300407|NCT01954251|GlaxoSmithKline|GSK Response Center|866-435-7343||
300408|NCT01954264|GlaxoSmithKline|GSK Response Center|866-435-7343||
300409|NCT01954342|Pennington Biomedical Research Center|Dr. Leanne Redman|2257630947|Leanne.Redman@pbrc.edu|
300410|NCT01954394|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
310084|NCT02732119|Novartis Pharmaceuticals|Study Director|+1 862 778 8300|Novartis.email@Novartis.com|
310085|NCT02732145|Ginekološka poliklinika Dr. Vesna Harni|Dr. Vesna Harni|0038512923648|vesnaharni@gmail.com|
310086|NCT02732210|Amgen Inc.|Study Director|866-572-6436||
310087|NCT02732366|University of Pittsburgh, Department of Physical Therapy|Christine M. McDonough, Assistant Professor of Physical Therapy|4123834603|cmm295@pitt.edu|
310088|NCT02732561|Wake Forest Health Sciences|James Kimball, MD|1 (336) 716-9702|jkimball@wakehealth.edu|
310089|NCT02732587|Yale University Dept of Psychiatry|Dr Suchitra Krishnan-Sarin|203-974-7595|suchitra.krishnan-sarin@yale.edu|
310090|NCT02732600|VISN 5 Mental Illness Research, Education, and Clinical Center|Richard Goldberg|410-637-1851|Richard.Goldberg@va.gov|
310091|NCT02732639|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
310092|NCT02732847|Memorial University|Reza Tabrizchi|706-864-3381|rtabrizc@mun.ca|
310093|NCT02732899|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
310094|NCT02732912|Oxford Brookes University|Dr Derick Wade|+447818452133|derick.wade@ntlworld.com|
310095|NCT02732938|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
310096|NCT02732951|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310097|NCT02733367|Diurnal|Information Line|+44 (0) 2920 682069|info@diurnal.co.uk|
300411|NCT01954628|Aquinox Pharmaceuticals (Canada) Inc.|Clinical|+1 (604) 629-9223|clinical@aqxpharma.com|
300412|NCT01954745|Massachusetts General Hospital Cancer Center|Dr. Lipika Goyal|617-724-4000|Lgoyal@partners.org|
290875|NCT01329679|DavidGrant|Sachin Shah|707-423-3277|sshah@pacific.edu|
290876|NCT01329848|Western University of Health Sciences|Dr. Chris Chase|909 706-3882|cchase@westernu.edu|
290877|NCT01329900|UT MD Anderson Cancer Center|Issa F Khouri, M.D. / Stem Cell Transplantation|713-745-0049|ikhouri@mdanderson.org|
290878|NCT01329939|North Shore - Long Island Jewish Health System; Hofstra North Shore-LIJ School of Medicine|Dr. Sherry Farzan, Attending Physician, Assistant Professor of Medicine and Pediatrics|5166225070|sfarzan@nshs.edu|
290879|NCT01329978|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
290880|NCT01330017|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
290881|NCT01330030|Stanford University|Dr Joel D Killen|650-723-5895|jkillen@stanford.edu|
290882|NCT01330043|Stanford University|Dr. Sean P. David|401-265-2275|spdavid@stanford.edu|
290883|NCT01330108|University of Alabama at Birmingham|Robert C Bourge|205-934-3624|bbourge@uab.edu|
290884|NCT01330134|University of Chicago|John P. Kress, MD|773-702-1000|jkress@medicine.bsd.uchicago.edu|
300413|NCT01954771|Beijing Anzhen Hospital|Dr.Yingsheng Zhou|0086-010-64456185|zys626@aliyun.com|
300414|NCT01954927|St. Jude Children's Research Hospital|Doralina Anghelescu, MD|(901) 595-4034|doralina.anghelescu@stjude.org|
300415|NCT01955005|Iowa City VA Health Care System|Carolyn L Turvey|319 338 0581|Carolyn.Turvey@VA.Gov|7714
300416|NCT01955044|NorthShore University HealthSystem|Brandy L Frost|847-570-2033|bfrost@northshore.org|
300417|NCT01955083|Chang Gung Memorial Hospital|Dr. Hsueh-Yu Li|886-3-3281200|hyli38@adm.cgmh.org.tw|3967
300418|NCT01955122|UMC Utrecht|Prof. Peter Siersema|+31 88 7559338|P.D.Siersema@umcutrecht.nl|
300419|NCT01955161|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
300420|NCT01955369|Klinikum der Stadt Ludwigshafen|Dr. Joachim Wolf|0049-621|joachim.wolf@diakonissen.de|4200
300421|NCT01955382|NIAID/NIH|Dr. Rick M. Fairhurst, Principal Investigator|301-761-5077|rfairhurst@niaid.nih.gov|
300422|NCT01955434|Mayo Clinic|P. Leif Bergsagel, MD|480/301-8335|Bergsagel.leif@mayo.edu|
300423|NCT01955473|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
300424|NCT01955564|Newron Pharmaceuticals S.p.A.|Dr. Ravi Anand|+39 026103461|ravi@anand.ch|
300425|NCT01955629|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
300426|NCT01955707|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
300427|NCT01955720|Boehringer Ingelheim pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300428|NCT01955733|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300429|NCT01955837|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.||toiawase@taiho.co.jp|
300430|NCT01955954|Palo Alto Health Sciences, Inc|Debra Reisenthel|9255948404|debra@pahealthsciences.com|
300431|NCT01956032|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
310098|NCT02733588|Joslin Diabetes Center|Mary-Elizabeth Patti, MD|617-309-2665|mary.elizabeth.patti@joslin.harvard.edu|
310099|NCT02733627|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310100|NCT02733653|Boston Scientific Japan K.K.|Yoko Takizawa/Clinical Project Manager|+81-3-6853-7500|Yoko.Takizawa@bsci.com|
310101|NCT02733757|Universidade federal de Minas Gerais|Dr Renato Gomez|553134099760|renatogomez2000@yahoo.com.br|
310102|NCT02733991|Medtronic Diabetes EMEA|Ohad Cohen M.D., Medical Affairs Director|+972 54 321 1108|ohad.cohen@medtronic.com|
310103|NCT02734056|Brigham|Bhavani Kodali|6175258449|kodali@zeus.bwh.harvard.edu|
310104|NCT02734147|Christiana Care Health Services|Jamie Rosini, Pharm D|302-733-6364|jrosini@christianacare.org|
310105|NCT02734212|VISN 5 MIRECC|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
310106|NCT02734238|Pennington Biomedical Research Center|Jennifer C. Rood|225-763-2524|jennifer.rood@pbrc.edu|
310107|NCT02734355|Research Institute for Complex Problems of Cardiovascular Diseases, Russia|Dr. Sergey Mamchur|+73842643308|reception@kemcardio.ru|
310108|NCT02734433|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
310109|NCT02734498|Wake Forest School of Medicine|James Kimball, MD|336-716-9702|jkimball@wakehealth.edu|
310110|NCT02734576|North Shore University Hospital Northwell Health|Dr. Athos Patsalides|516-562-2244|apatsalides@northwell.edu|
310111|NCT02734667|Stanford University|Dr. Korey Hood|6504976899|kkhood@stanford.edu|
310112|NCT02734693|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
310113|NCT02734810|Anthera Pharmaceuticals|Monica Gangal|510-856-5600|info@anthera.com|
310114|NCT02734849|Allakos, Inc.|Henrik Rasmussen, MD, PhD, Chief Medical Officer|1 6505975002|hrasmussen@allakos.com|
310115|NCT02734862|Cidara Therapeutics, Inc.|Taylor Sandison, M.D., MPH|858-888-7868|clinicaltrialinfo@cidara.com|
310116|NCT02734953|Allegheny Health Network|Dr Raymond Benza|412-359-3131|raymond.benza@ahn.org|
310117|NCT02734979|Stanford University|Dr. Stanley G Rockson, Allan and Tina Neill Professor of Lymphatic Research and Medicine|650-725-7571|rockson@stanford.edu|
310118|NCT02735044|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
310119|NCT02735096|Innervo Technology|Dr. Hui Tang|5732896776|htang@innervotech.com|
290885|NCT01330290|UCB|UCB Clinical Trials Call Center|+1 877 822 9493||
290886|NCT01330303|GlaxoSmithKline|GSK Response Center|866-435-7343||
300432|NCT01956071|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
310120|NCT02735174|Cincinnati Children's Hospital Medical Center|Theresa Guilbert, MD, MS|(513) 636-6771|Theresa.Guilbert@cchmc.org|
290887|NCT01330316|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290888|NCT01330355|Valeant Pharmaceuticals|Johnson Varughese|908-541-2179|Johnson.Varughese@valeant.com|
290889|NCT01330381|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
290890|NCT01330394|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 7775-7337|emnpalacios@gmail.com|
290891|NCT01330420|Massachusetts General Hospital|Kathleen Miller, RN|781-485-6176|kmiller16@partners.org|
290892|NCT01330433|Loma Linda University, Dept of Cardiovascular and Thoracic Surgery|Research Coordinator|909-558-4355|vayermiller@llu.edu|
290893|NCT01330459|Oregon Health and Science University|Alison Edelman, MD, Assistant Professor|(503) 494-3666|edelmana@ohsu.edu|
290894|NCT01330628|Spectranetics|Amanda Johnson, VP of Regulatory & Medical Affairs|(719) 447-2000|amanda.johnson@spnc.com|
290895|NCT01330914|San Francisco Veterans Affairs Medical Center|Dr. Anne Schafer|(415) 221-4810|anne.schafer@va.gov|24895
290896|NCT01330953|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
300433|NCT01956097|Ewha Brain Institute, Ewha W. University|Soonhyun Ban, RN, MS|+82-2-3277-6550|soonhyun.s.ban@gmail.com|6554
300434|NCT01956123|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
300435|NCT01956240|Methodist University of Piracicaba|Ms Dayana Patricia Rosa|+55 16 3306-6696|dad_rosa@hotmail.com|
300436|NCT01956279|Durham VA Medical Center|Christine Marx, MD MA|919-286-0411|marx0001@mc.duke.edu|3626
300437|NCT01956435|University of Texas at Austin Medical School and Seton Family of Hospitals|Ammar Ahmed, MD|512-504-0855|amahmed@seton.org|
300438|NCT01956773|Duke University Medical Center|Dr. Lori A. Orlando, Director Program in Precision Medicine|919-660-6606|orlan002@duke.edu|
300439|NCT01957085|Lewis Katz School of Medicine|Robert L. Bettiker, MD/MGA, Principle Investigator|215.707.1982|robert.bettiker@temple.edu|
300440|NCT01957111|University of Pennsylvania|Philip Gehrman|215-746-3578|gehrman@exchange.upenn.edu|
300441|NCT01957137|Pelvic Health and Gastric Therapies|Rachael McNamara / Clinical Research Specialist|763.526.8107|rachael.m.mcnamara@medtronic.com|
300442|NCT01957150|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
300443|NCT01957163|GlaxoSmithKline|GSK Response Center|866-435-7343||
300444|NCT01957202|GlaxoSmithKline|GSK Response Center|866-435-7343||
300445|NCT01957215|GlaxoSmithKline|GSK Response Center|866-435-7343||
300446|NCT01957384|Coloplast A/S|Marian Dyreborg Sinvani, Clinical Manager|+45 4911 2356|dkmards@coloplast.com|
300447|NCT01957397|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1395|dkbir@coloplast.com|
300448|NCT01957410|Janssen Research & Development, LLC|Director||ClinicalTrialDisclosure@its.jnj.com|
310121|NCT02735187|Philips Light & Health|Dr. Joerg Liebmann|+ 49-(0)1733715907|joerg.liebmann@philips.com|
310122|NCT02735200|Dammam University|Dr Dalal Bubshait|+966505848281|dbubshait@ud.edu.sa|
310123|NCT02735382|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health|Mark Zehner, MS|6082627568|mark.zehner@ctri.wisc.edu|
310124|NCT02735421|Galderma|Gaëlle CHARIER Clinical Project Manager|+33493957068|gaelle.charier@galderma.com|
310125|NCT02735551|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
310126|NCT02735577|New York State Psychiatric Institute|Nasir Naqvi, MD|6467748181|nasir.naqvi@nyspi.columbia.edu|
310127|NCT02735642|Yale University School of Nursing|Ann Kurth||ann.kurth@yale.edu|
310128|NCT02735915|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310129|NCT02735980|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
310130|NCT02736175|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
310131|NCT02736188|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
310132|NCT02736409|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
310133|NCT02736474|Shanghai Mental Health Center|Chief Physician Dr Du. Jiang Du|86-21-64387250|dujiangdou@163.com|
310134|NCT02736578|Stanford University|Eben Rosenthal|650-723-2967|elr@stanford.edu|
310135|NCT02736721|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
310136|NCT02736825|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
310137|NCT02736890|Icahn School of Medicine at Mount Sinai|Dr. Thomas Bryce|212-241-6321|thomas.bryce@mountsinai.org|
310138|NCT02736955|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
310139|NCT02737072|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
310140|NCT02737163|Johns Hopkins All Children's Hospital|Gerald Tuite, MD|7277678181|gtuite1@jhmi.edu|
310141|NCT02737332|SPARC|Head, Clinical Development|912266455645|clinical.trials@sparcmail.com|
310142|NCT02737358|Medical University of South Carolina|Erin A. McClure, Ph.D.|843-792-7192|mccluree@musc.edu|
310143|NCT02737397|Clinilabs, Inc|Magdy Shenouda, MD|201-417-7765|Jackie@sen-jam.com|
310144|NCT02737501|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
310145|NCT02737592|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
310146|NCT02737618|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
310147|NCT02737631|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annahita.ghassemi@churchdwight.com|
310148|NCT02737722|Lakewood Amedex|Chief Medical Officer|941 928 7774|poconnor@lakewoodamedex.com|
310149|NCT02737826|Medical University of South Carolina|Dr. Kelly Barth|843-792-0686|stephen@musc.edu|
310150|NCT02737852|Church & Dwight Co., Inc|Annahita Ghassemi|6098061200|annhita.ghassemi@churchdwight.com|
310151|NCT02737891|Saniona A/S|Kim Krogsgaard|20148384|kim.krogsgaard@saniona.com|0045
310152|NCT02737917|Lincoln Medical Center|Dr. Nicholas Caputo|718-579-6010|ncaputo.md@gmail.com|
290897|NCT01330966|George Clinical|Lindsey Munn|901-350-8801|lmunn@georgeclinical.com|
310153|NCT02737930|University of Rochester|Bogachan Sahin|(585) 275-2530|bogachan_sahin@urmc.rochester.edu|
290898|NCT01331005|Jaeb Center for Health Research|Adam Glassman|813-975-8690|drcrnet@jaeb.org|
290899|NCT01331083|Canadian Cancer Trials Group|Lesley Seymour|6135336430|lseymour@ctg.queensu.ca|
290900|NCT01331109|Forest Research Institute|Robert Palmer, MD|1-201-427-8200|robert.palmer@frx.com|8218
290901|NCT01331161|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
290902|NCT01331213|Mayo Clinic|Dr. Michael Camilleri|507-266-2305|camilleri.michael@mayo.edu|
290903|NCT01331239|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
290904|NCT01331291|Massachusetts General Hospital|Tracy T. Batchelor, MD|617-643-1938|tbatchelor@mgh.harvard.edu|
290905|NCT01331304|Massachusetts General Hospital|Dr. Andrew Nierenberg|617-724-0837|anierenberg@mgh.harvard.edu|
290906|NCT01331408|Galderma Uppsala|Head of Medical Affairs|+46 (0)18 474 9000|receptionen.SEUPP@galderma.com|
290907|NCT01331681|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
300449|NCT01957462|Coloplast|Daniel Carter|+45 49222523|dkdac@coloplast.com|
300450|NCT01957475|Coloplast|Daniel Carter|+45 49112523|dkdac@coloplast.com|
300451|NCT01957488|Coloplast|Medical Director|+45 4911 1395|dkbir@coloplast.com|
300452|NCT01957553|Coloplast|Dr. Birte P.Jakobsen|+45 4911 1395|dkbir@coloplast.com|
300453|NCT01957579|MedImmune, LLC|Medical Director||ClinicalTrialTransparency@astrazeneca.com|
300454|NCT01957644|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300455|NCT01957657|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300456|NCT01957709|Fred Hutchinson Cancer Research Center|Seth Pollack, MD|206-667-6629|spollack@fredhutch.org|
300457|NCT01957761|Ann & Robert H. Lurie Children's Hospital of Chicago|Larry Kociolek, MD, MSCI|312-227-4080|lkociolek@luriechildrens.org|
300458|NCT01957787|Galil Medical, a wholly owned indirect subsidiary of Boston Scientific|Sr. Clinical Trial Specialist|651-287-5000|GalilClinical@bsci.com|
300459|NCT01957865|Massachusetts General Hospital|Jessica Haberer|617 724 0351|jhaberer@partners.org|
300460|NCT01957930|Karolinska Institutet Södersjukhuset|Thomas Nyström|+46704325214|thomas.nystrom@sodersjukhuset.se|
300461|NCT01958008|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
300462|NCT01958060|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300463|NCT01958073|Kaiser Permanente San Diego|Dr. Kimberly Ferrante|6199801439|klf0409@gmail.com|
300464|NCT01958112|Dana-Farber Cancer Institute|Dr. Ursula Matulonis|617-632-2334|ursula_matulonis@dfci.harvard.edu|
300465|NCT01958125|electroCore Inc.|Director Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
300466|NCT01958164|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310154|NCT02738008|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
290908|NCT01331694|GlaxoSmithKline|GSK Response Center|866-435-7343||
290909|NCT01331824|Icahn School of Medicine at Mount Sinai|Dr. Matthew D. Galsky|212-241-6756|matthew.galsky@mssm.edu|
290910|NCT01331837|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
290911|NCT01332019|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
290912|NCT01332071|GlaxoSmithKline|GSK Response Center|866-435-7343||
290913|NCT01332123|university of pittsburgh|Goeran Fiedler|4126246475|gfiedler@pitt.edu|
290914|NCT01332149|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290915|NCT01332188|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
290916|NCT01332227|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
290917|NCT01332253|Senior Manager, Clinical Operations|Byron Kaelin|615-255-0068|bkaelin@cumberlandpharma.com|250
290918|NCT01332292|GlaxoSmithKline|GSK Response Center|866-435-7343||
290919|NCT01332305|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
300467|NCT01958281|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
300468|NCT01958294|Silk Road Medical, Inc.|Ric Ruedy, Exec VP, Clinical Affairs|408-585-2112|ric@silkroadmed.com|
300469|NCT01958320|University of California San Francisco|Ronald Clyman, MD PI|415-443-9305|clymanr@peds.ucsf.edu|
300470|NCT01958346|Teamhealth Anesthesia|Devanand Mangar MD|813-844-4434|devanandmangar@teamhealth.com|
300471|NCT01958437|VA Ann Arbor Healthcare System; University of Michigan|Dr. Benjamin Hampstead|7347639259|bhampste@med.umich.edu|
300472|NCT01958476|Tufts Medical Center Floating Hospital for Children|Jonathan M. Davis, MD|(617) 636-5322|jdavis@tuftsmedicalcenter.org|
300473|NCT01958489|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
300474|NCT01958606|University of Cincinnati|Pierce Boyne|513-558-7499|Pierce.Boyne@uc.edu|
300475|NCT01958619|Medicines for Malaria Venture (MMV)|Dr Thomas Rueckle PhD|+41 22 799 4567|ruecklet@mmv.org|
300476|NCT01958645|AstraZeneca|Anders Berggren, MD, PhD||clinicaltrialtransparency@astrazeneca.com|
300477|NCT01958671|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300478|NCT01958788|Concordia University|Elizabeth Hebert|1-514-848-2424|el_heber@live.concordia.ca|2199
300479|NCT01958827|AbbVie|Global Medical Information|800-633-9110||
300480|NCT01958918|Novartis Pharma AG|Study Director|+41613241111|Novartis.email@novartis.com|
300481|NCT01959035|H. Lundbeck A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
300482|NCT01959048|Hadassah-Hebrew University|Jacob Strahilevitz|972508946353|jstrahilevitz@hadassah.org.il|
300483|NCT01959113|University of California, San Diego|Director of Clinical Trials Unit|858-657-8390|dermstudies@ucsd.edu|
290920|NCT01332318|XenoPort, Inc.|XenoPort Call Center|877-936-6778||
300484|NCT01959165|Biometrics|Nii Masahiro|+81 6 7711 4571|Masahiro.Nii@astrazeneca.com|4571
310155|NCT02738086|University of Colorado Denver|Cory L. Christiansen|303-724-9101|cory.christiansen@cuanschutz.edu|
310156|NCT02738138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
310157|NCT02738151|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
310158|NCT02738203|Stanford University, Department of OB/GYN|Research Manager|6507211562|familyplanningresearch@stanford.edu|
310159|NCT02738255|Brigham and Women's Hospital|Andrew Wellman|6174078483|awellman@rics.bwh.harvard.edu|
310160|NCT02738333|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
310161|NCT02738450|AC Immune|Olivier Sol|+41 21 345 91 21|clinicaltrials@acimmune.com|
310162|NCT02738580|IVIValencia|DR. ERNESTO BOSCH|+34 963050900|Ernesto.Bosch@ivirma.com|
310163|NCT02738775|TG Therapeutics|TG Therapeutics Clinical Support Team|1-877-575-8489|clinicalsupport@tgtxinc.com|
310164|NCT02738801|Galapagos NV|Evelyn Fox|003215342900|evelyn.fox@glpg.com|3215342900
310165|NCT02738840|Abbott|Robyn A Capobianco|+1 512 934 3941|robyn.capobianco@abbott.com|
310166|NCT02738853|Medtronic|Sara Saul, PhD|763-526-1965|sara.m.saul@medtronic.com|
310167|NCT02738879|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
310168|NCT02739100|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
310169|NCT02739269|The University of Hong Kong|Dr. Raymond Li|+852 22554517|raymondli@hku.hk|
310170|NCT02739321|The Cleveland Clinic|Dr. Thomas Frazier||fraziet2@ccf.org|
310171|NCT02739360|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
310172|NCT02739594|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
310173|NCT02739698|University Hospital Reina Sofia, Cordoba, Spain|Angela Casado-Adam, MD|0034957010439|angeti@hotmail.com|
310174|NCT02739789|Stony Brook University|Dr. David Hsu, Assistant Professor of Psychiatry|(631) 638-1522|david.hsu@stonybrookmedicine.edu|
310175|NCT02739828|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
310176|NCT02739984|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
310177|NCT02739997|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
310178|NCT02740049|Imperial College London|Dr Coen Wiegman|+44(0)2075947846|c.wiegman@imperial.ac.uk|
310179|NCT02740114|UT MD Anderson Cancer Center|Pedro Ramirez, MD /Professor, Gyn Onc & Reproductive Med|713-745-5498|peramire@mdanderson.org|
310180|NCT02740153|Children's National Medical Center|Dr. Nicholas Ah Mew|202-476-5863|nahmew@childrensnational.org|
310181|NCT02740413|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
310182|NCT02740478|ResMed|Paul Phillips|+44 7789633508|paul.phillips@resmed.com|
290921|NCT01332331|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
290922|NCT01332357|GlaxoSmithKline|GSK Response Center|866-435-7343||
290923|NCT01332435|GlaxoSmithKline|GSK Response Center|866-435-7343||
290924|NCT01332461|GlaxoSmithKline|GSK Response Center|866-435-7343||
290925|NCT01332487|GlaxoSmithKline|GSK Response Center|866-435-7343||
290926|NCT01332500|GlaxoSmithKline|GSK Response Center|866-435-7343||
290927|NCT01332578|GlaxoSmithKline|GSK Response Center|866-435-7343||
290928|NCT01332630|UT MD Anderson Cancer Center|Ibrahim,Nuhad K.,M.D. / Breast Medical Oncology|713-792-7734|CR_Study_Registration@mdanderson.org|
290929|NCT01332721|TRACON Pharmaceuticals|Dr Charles Theuer|8585500780|ctheuer@traconpharma.com|233
290930|NCT01332851|Family and Child Nursing, University of Washington|Dr. Monica Oxford|206-685-6107|mloxford@uw.edu|
290931|NCT01332981|Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
290932|NCT01332994|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
300485|NCT01959178|Bausch Health|Study Director||robert.steffen@bausch.com|
300486|NCT01959230|Bausch & Lomb Incorporated|Director, Medical Affairs||Heleen.DeCory@bausch.com|
300487|NCT01959243|Bausch & Lomb Incorporated|Director, Medical Affairs||Heleen.DeCory@bausch.com|
300488|NCT01959334|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
300489|NCT01959347|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
300490|NCT01959412|Novartis Pharmaceuticals|Study Director|862-778-8300||
300491|NCT01959425|Biosense Webster Inc.|Stephanie Lyke|(949) 285-7966|SLyke@its.jnj.com|
300492|NCT01959464|Carolinas Healthcare System|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|bhurst@carolinas.org|
300493|NCT01959490|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Paula Silverman|1-800-641-2422|CTUreferral@UHhospitals.org|
300494|NCT01959503|C.R. Bard|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
300495|NCT01959516|Novartis Pharmaceuticals|Study Director|862-778-8300||
300496|NCT01959529|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
300497|NCT01959542|Brigham and Women's Hospital/Dana-farber Cancer Institute|Dr. Fiona Fennessy|617 632 4891|ffennessy@bwh.harvard.edu|
300498|NCT01959581|University of Delaware|Michele A. Lobo|302-831-8526|malobo@udel.edu|
290933|NCT01333033|Alliance for Clinical Trials in Oncology|Karyn Goodman, M.D.|(212) 639-3983|goodmank@mskcc.org|
300499|NCT01959607|Philip Morris Products S.A.|Christelle HAZIZA|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
300500|NCT01959672|University of Nebraska Medical Center|Dr. Chi Lin|402-552-3844|clin@unmc.edu|
300501|NCT01959685|Repros Therapeutics Inc.|Jennifer Wike|2817193402|jwike@reprosrx.com|
300502|NCT01959698|Roswell Park Comprehensive Cancer Center|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
310183|NCT02740504|ResMed|Paul Phillips|+447789633508|paul.phillips@resmed.com|
310184|NCT02740517|ResMed|Paul Phillips|+44 7789633508|paul.phillips@resmed.com|
310185|NCT02740543|NYU Langone Health - Bellevue Hospital|Angeliki Kazeros, MD|212-263-6479|Angeliki.Kazeros@nyulangone.org|
310186|NCT02740582|University of California, San Franciso|Jennifer Mitchell, PhD|510-985-3522|jennifer.mitchell@ucsf.edu|
310187|NCT02740660|Pennington Biomedical Research Center|Dr. Daniel Hsia|225-763-3000|clinicaltrials@pbrc.edu|
310188|NCT02740920|Canadian Cancer Trials Group|Janet Dancey|613-533-2430|jdancey@ctg.queensu.ca|
310189|NCT02741076|Janssen Pharmaceuticals, Inc.|John Han, Associate Director, Statistics|484-354-3547|jhan9@its.jnj.com|
310190|NCT02741284|Washington University in St Louis|Dr Nandini Raghuraman|314 362 7300|nraghuraman@wustl.edu|
310191|NCT02741297|Boston Scientific|Roshini Jain, Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
310192|NCT02741310|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
310193|NCT02741518|Brigham and Women's Hospital|Dr. Jessica Allegretti|617-732-5500|jallegretti@bwh.harvard.edu|
310194|NCT02741596|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
310195|NCT02741635|Fisher & Paykel Healthcare Ltd.|Christine Lambert|+64 9 574 0123|christine.lambert@fphcare.co.nz|7172
310196|NCT02741687|Emory University|Maya Fayfman, MD|404-778-1664|maya.fayfman@emory.edu|
310197|NCT02741713|Wake Forest Baptist Health|Dr.Jon Wells Reynolds|336-715-9695|jreynold@wakehealth.edu|
310198|NCT02742077|Corindus, Inc.|Clinical Research Manager|(757) 910-4818|tina.ridgeway@corindus.com|
310199|NCT02742103|CSL Behring|Trial Registration Coordinator|6108784000|clinicaltrials@cslbehring.com|
310200|NCT02742129|Duke Clinical Research Institute|Adrian Hernandez|919-668-7515|Adrian.Hernandez@duke.edu|
310201|NCT02742441|Therapeutics, Inc.|Clinical Research, Therapeutics, Inc.|858-571-1800|clinicalresearch@therapeuticsinc.com|
310202|NCT02742519|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
310203|NCT02742532|University of California, San Francisco|Jennifer Mitchell, PhD|510-985-3921|jennifer.mitchell@ucsf.edu|
310204|NCT02742649|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
290934|NCT01333059|Cook Children's Medical Center|Javier Gelvez, MD||Javier.Gelvez@cookchildrens.org|
290935|NCT01333072|MUSouthCarolina|C. Lindsay DeVane, Pharm.D.|8432701818|devaneL@musc.edu|
310205|NCT02742766|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
300503|NCT01959841|Maruho Co.,Ltd. Kyoto R&D Center|linical Development Dept.|+81-75-325-3255|ctinfo@mii.maruho.co.jp|
290936|NCT01333098|Washington University School of Medicine|Eric Lenze, MD|314-362-5154|lenzee@wustl.edu|
290937|NCT01333111|Novo Nordisk A/S|Global Clinical Regstry (GCR, 1452)||clinicaltrials@novonordisk.com|
290938|NCT01333189|University of Colorado, Denver|Cory L Christiansen, PT, PhD|303-724-9101|cory.christiansen@ucdenver.edu|
290939|NCT01333397|Ipsen|Medical Director|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
290940|NCT01333475|National Cancer Institute|Dr. Shivaani Kummar|301-435-0517|kummars@mail.nih.gov|
290941|NCT01333488|Memorial Healthcare System|Dr Greg Zorman|954 265 1840|csareli@mhs.net|
290942|NCT01333501|Novartis Pharmaceuticals|Study Director|862-778-8300||
290943|NCT01333527|Research Associate|Anelise Silveira|780-492-2398|anelise.silveira@ahs.ca|
290944|NCT01333592|Kissei Pharmaceutical Co., Ltd|Clinical Development Division||rinsyousiken@pharm.kissei.co.jp|
290945|NCT01333722|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
300504|NCT01959880|Mentor|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
300505|NCT01959919|Pfizer Clinical Trial.gov Call Center|Pfizer, Inc.|1-800-718-1021|ClinicalTrails.gov_Inquiries@Pfizer.com|
300506|NCT01959932|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
300507|NCT01959945|Protein Sciences Corporation|Lisa M. Dunkle, M.D., Chief Medical Officer|203-599-6064|ldunkle@proteinsciences.com|153
300508|NCT01960075|Medical University of South Carolina|Jordan Elm, PhD Biostatistician|843-876-1605|elmj@musc.edu|
300509|NCT01960114|McNeil Consumer Healthcare|Rajesh Mishra, MD, PhD/Vice President, Medical/Clinical Affairs, Global OTC|215-273-8569 USA EST|rmishr16@its.jnj.com|
300510|NCT01960140|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
300511|NCT01960257|University of California, San Diego|Dr. Sara H. Browne|619 543 8080|shbrowne@health.ucsd.edu|
300512|NCT01960296|Icahn School of Medicine at Mount Sinai|Dr. Celia M. Divino|212-241-5499|celia.divino@mountsinai.org|
300513|NCT01960348|Alnylam Pharmaceuticals, Inc.|Chief Medical Officer|866.330.0326|medinfo@alnylam.com|
300514|NCT01960387|University of Pittsburgh Cancer Institute|Michael Boyiadzis, MD|412-623-0040|boyiadzism@upmc.edu|
300515|NCT01960400|Université de Sherbrooke|Dr Yannick Tousignant-Laflamme|819-821-8000|Yannick.Tousignant-Laflamme@USherbrooke.ca|72912
300516|NCT01960413|Vanderbilt University Medical Center|Michael DeBaun, MD MPH|(615) 875-3040|m.debaun@vumc.org|
300517|NCT01960465|Jesse Brown VAMC|Dr. Bharati Prasad|312-569-6343|bharati.prasad@va.gov|
300518|NCT01960530|Diurnal Limited|Dr John Porter|02920 682069|info@diurnal.com|
300519|NCT01960725|Duke University School of Medicine|Dr. Dennis Clements|919-684-7790|dennis.clements@duke.edu|
300520|NCT01960790|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
300521|NCT01960816|Aerin Medical, Inc.|Scott Wolf, M.D., President and Chief Medical Officer|650-434-3247|scott@aerinmedical.com|
300522|NCT01960842|AbbVie|Global Medical Information|1-800-633-9110||
300523|NCT01960855|AbbVie|Global Medical Services|800-633-9110||
310206|NCT02742818|Hospital Israelita Albert Einstein|Dr. Nelson Wolosker|+55 11 2151-5423|nwolosker@yahoo.com.br|
310207|NCT02742987|Campus Bio-Medico University|Dr. Fabio Mangiacapra|003906225411612|f.mangiacapra@unicampus.it|
310208|NCT02743078|RTOG Foundation|Wendy Seiferheld|215-574-3208|wseiferheld@acr.org|
310209|NCT02743117|MedImmune, LLC|Raburn Mallory, MD|301-398-000|information.center@astrazeneca.com|
310210|NCT02743221|Institut de Recherches Internationales Servier (I.R.I.S.)|Dr Patrick Therasse|+33 1 55 72 43 47|patrick.therasse@servier.com|
310211|NCT02743312|San Francisco State University|Dr. Diane Allen|4153386837|ddallen@sfsu.edu|
310212|NCT02743377|National Institute of Mental Health|Dr Robert Innis|+1 301 693 2979|innisr@mail.nih.gov|
310213|NCT02743442|Fondation Ophtalmologique A. de Rothschild|Dr Amélie Yavchitz (deputy head of the clinical research unit)|+33148036454|ayavchitz@for.paris|
310214|NCT02743494|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
310215|NCT02743520|University of Miami, Miller School of Medicine|Alberto Ramos, MD, MSPH, FAASM|305-243-8393|a.ramos1@med.miami.edu|
310216|NCT02743702|University of Seville|Dr. Jose J. Jimenez-Rejano|+34667309369|jjjimenez@us.es|
310217|NCT02743780|Alcon, A Novartis Division|Translational Medicine Expert II, TM-Ophthalmic|1-888-451-3937|alcon.medinfo@alcon.com|
310218|NCT02743793|DAIT/NIAID|Director, Clinical Research Operations Program|13015947669|DAITClinicalTrialsGov@niaid.nih.gov|
310219|NCT02743936|Brooke Army Medical Center|Dr. Michael D. April|210-916-0808|Michael.D.April@post.harvard.edu|
310220|NCT02743949|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
310221|NCT02743962|University of Bradford|Hilary Pape|01274 236228|hpape@bradford.ac.uk|
310222|NCT02744066|Magee Womens, UPMC Hamot Hospital|Dr. Michael J. Balsan|814-877-3190|balsanmj@upmc.edu|
310223|NCT02744391|New York State Psychiatric Institute|Dr. Bret R. Rutherford|646-774-8660|brr8@cumc.columbia.edu|
310224|NCT02744534|Emory University|Baowei Fei, PhD|972-883-7239|bfei@utdallas.edu|
310225|NCT02744755|Hexal AG/Sandoz Inc.|Sandoz Biopharma Clinical Development - Strategic Planning|0049(0)80244760|biopharma.clinicaltrials@sandoz.com|
310226|NCT02744846|Harvard Pilgrim Health Care Institute|Dr. Jason Block|6178674841|jblock1@partners.org|
310227|NCT02744898|NYU Langone Health|Franco Muggia, MD|212 263 2172|Franco.Muggia@nyulangone.org|
310228|NCT02745080|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
310229|NCT02745119|Hoffmann-La Roche|Medical Communications|616878333|global.trial_information@roche.com|+41
310230|NCT02745145|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
310231|NCT02745353|UCSD|Eric Roeland, MD|(858) 534-7079|eroeland@ucsd.edu|
290946|NCT01333813|GlaxoSmithKline|GSK Response Center|866-435-7343||
290947|NCT01333865|Massachusetts General Hospital|Gagan Joshi, MD|617-724-2344|joshi.gagan@mgh.harvard.edu|
290948|NCT01333943|Hospital for Special Surgery|David H. Kim, MD|(212) 606-1206|KimD@HSS.EDU|
310232|NCT02745392|Zosano Pharma Corporation|Dr. Donald Kellerman|(510) 745-4004|dkellerman@zosanopharma.com|
290949|NCT01333956|Hospital for Special Surgery|Dr. Jacques YaDeau|212-606-1206|yadeauj@hss.edu|
290950|NCT01334086|Princess Margaret Cancer Centre|Dr. Karen Yee, Hematology and Medical Oncology Site Group Lead|416-946-4501|Karen.Yee@uhn.ca|4495
290951|NCT01334125|University of Massachusetts Medical School|Benjamin U. Nwosu, MD|5083347872|Benjamin.Nwosu@umassmemorial.org|
290952|NCT01334216|Indiana University School of Medicine|Stephen M. Downs, MD, MS|3172780552|stmdowns@iu.edu|317
290953|NCT01334229|Laval University|Dr. Patrick Couture MD, PhD, FRCP|418-654-2106|patrick.couture@crchul.ulaval.ca|
290954|NCT01334515|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
290955|NCT01334554|Vanderbilt University Medical Center|Cyndya A. Shibao|6159364584|cyndya.shibao@vanderbilt.edu|
290956|NCT01334710|Emory University|Dr. Bassel El-Rayes|404-778-1900|belraye@emory.edu|
290957|NCT01334723|GlaxoSmithKline|GSK Response Center|866-435-7343||
290958|NCT01334827|The Miriam Hospital|Dr Kate Guthrie, Co-Investigator, Project MIST Lead Investigator|401-793-8180|kate.guthrie@lifespan.org|
300524|NCT01960907|RESTECH srl|Dr. Pasquale Pio Pompilio, R&D manager|+39 02 3659 3690|p.pompilio@restech.it|
300525|NCT01960998|Birmingham VA Medcial Center|Kathryn L. Burgio, PhD|205-999-9537|kburgio@uabmc.edu|
300526|NCT01961089|Ziemer Ophthalmic Systems AG|Dr. Gregor Schmid|+41323327154|gregor.schmid@ziemergroup.com|
300527|NCT01961115|Fred Hutchinson Cancer Research Center|Dr. Martin A. Cheever|206-667-4141|mcheever@fredhutch.org|
300528|NCT01961167|W. L. Gore & Associates|Melissa Zambeck|928-856-4900|mzambeck@wlgore.com|
300529|NCT01961271|Mundipharma Pte Ltd|Valerie Anne Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
300530|NCT01961297|Icahn School of Medicine at Mount Sinai|Dr. Kristina Simonyan|212-241-0656|kristina.simonyan@mssm.edu|
300531|NCT01961323|Icahn School of Medicine at Mount Sinai|Dr. Partho Sengupta|212-659-8847|partho.sengupta@mountsinai.org|
300532|NCT01961349|CO RI&A TA, R&D|Hideo Negi|+81 6 4803 3533|H.Negi@astrazeneca.com|4716
300533|NCT01961362|National Jewish Health|Dr. Jeffrey J. Swigris|303-398-1621|swigrisj@njhealth.org|
300534|NCT01961531|BrUOG- Brown University Oncology Research Group|Jaroslaw Hepel, MD|401-863-3000|BrUOG@brown.edu|
300535|NCT01961544|Eisai Inc.|Eisai Medical Services|1-888-422-4743||
300536|NCT01961609|Novartis Pharmaceuticals|Study Director|862-778-1873||
300537|NCT01961687|Becton Dickinson|Dawn Heimer / Sr. Director Medical Affairs|401-479-1253|dawn.heimer@bd.com|
300538|NCT01961882|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
300539|NCT01961921|Alnylam Pharmaceuticals Inc|Chief Medical Officer|1-877-256-9526|Clinicaltrials@alnylam.com|
300540|NCT01962025|Ottawa HRI|Dr. Deborah Zimmerman|613-722-7000|dzimmerman@toh.ca|
300541|NCT01962103|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
300542|NCT01962207|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300543|NCT01962298|Antwerp University Hospital|Dr Tom Schepens|003238213265|tom.schepens@uza.be|
310233|NCT02745535|Institute of Human Virology, University of Maryland|Dr. Eleanor Wilson|1(410)706-1710|eleanor.wilson@ihv.umaryland.edu|
310234|NCT02745626|University of Connecticut Health|Dr. Madhur Upadhyay, Director Orthodontic Clinic, Assistant Professor|860-679-3729|maupadhyay@uchc.edu|
310235|NCT02746107|Carol Davila University of Medicine and Pharmacy Bucharest|Professor Cristian Baicus|+40788302355|cbaicus@gmail.com|
310236|NCT02746406|Laborie|Clinical Researcher|9056121170|sbitzos@laborie.com|1755
310237|NCT02746575|Washington University|Principal Investigator|7737022544||
310238|NCT02746627|Vanderbilt University Medical Center|Sarah Jaser, PhD|615-343-6775|sarah.jaser@vanderbilt.edu|
310239|NCT02746679|The First Affiliated Hospital of Sun Yat-sen University|Yuqing Chen|+86 020-87755766-8341|fangchenyq@163.com|
310240|NCT02746705|NYU Langone Health|Leigh Charvet|929 455 5125|leigh.charvet@nyulangone.org|
310241|NCT02746809|Medtronic|Sara Saul|763-526-1965|sara.m.saul@medtronic.com|
310242|NCT02746874|Northwestern University|David Walega, MD|312-695-0061|d-walega@northwestern.edu|
310243|NCT02746991|EyePoint Pharmaceutical|Flavio Leonin Jr., MD|617-972-6024|fleonin@eyepointpharma.com|
310244|NCT02747004|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
310245|NCT02747043|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
310246|NCT02747108|VA Center for Clinical Management Research|Jeffrey Kullgren, MD, MS, MPH - Principal Investigator|(734) 845-3502|jkullgre@med.umich.edu|
310247|NCT02747186|University of North Carolina at Chapel Hill|Raymond P. White Jr., DDS, PhD|919-537-3944|ray_white@unc.edu|
310248|NCT02747238|Icahn School of Medicine at Mount Sinai|Dr. Barbara Orlando|917-496-7490|barbara.orlando@mountsinai.org|
310249|NCT02747420|NYU Langone Health|Dr. Benjamin Brucker|+1 646 825 6300|Benjamin.Brucker@nyulangone.org|
310250|NCT02747433|MGH Institute of Health Professions|Susan Fasoli, ScD OTR/L, Associate Professor|617-643-4777|sfasoli@mghihp.edu|
310251|NCT02747615|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
310252|NCT02747628|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
310253|NCT02747875|Children's National Hospital|Dr. Andrew Waberski, Assistant Professor|2024762025|awabersk@childrensnational.org|
310254|NCT02747927|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
290959|NCT01334866|Medtronic, Inc.|Kristin Lawman|763-514-9809|kristin.j.lawman@medtronic.com|
290960|NCT01334918|Astellas Scientific and Medical Affairs, Inc. / Astellas Pharma Global Development, Inc.|Senior Medical Director, Medical Affairs||ClinicalTrials.Disclosure@us.astellas.com|
290961|NCT01334944|Cumberland Pharmaceutical Inc.|Dr. Amy Rock|615-255-0068|arock@cumberlandpharma.com|
290962|NCT01334957|Cumberland Pharmaceuticals Inc.|Dr. Amy Rock|615-255-0068|arock@cumberlandpharma.com|
290963|NCT01335009|Eisai Inc.|Eisai Medical Information|18882742378|esi_medinfo@eisai.com|
290964|NCT01335061|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290965|NCT01335191|Thymon LLC|Dr. Gideon Goldstein|(973) 467-9558|gidgold@gmail.com|
290966|NCT01335204|Medical University of South Carolina|Kate Anderton|843-792-2708|anderton@musc.edu|
290967|NCT01335230|University of Cincinnati, Associate Prof., PI.|Mohamed Tarek M. shata|(513) 558-6110|mohamed.shata@uc.edu|
290968|NCT01335308|University of Michigan|Ken Resnicow|734 647 0212|kresnic@umich.edu|
300544|NCT01962428|General Hospital of Chinese People's Armed Police Forces|huiliang Liu|+8601057976707|lhl518@vip.sina.com|
300545|NCT01962441|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
300546|NCT01962493|GlaxoSmithKline|GSK Response Center|866-435-7343||
310255|NCT02748070|Stanford University|Michael Chang|(650) 725-6500|michael.t.chang@stanford.edu|
310256|NCT02748096|University of Oxford|Professor Anrew Price|+44 1865 223421|andrew.price@ndorms.ox.ac.uk|
310257|NCT02748213|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
310258|NCT02748317|MedStar Health Research Institute|Inger Ljungberg|202-877-1694|inger.h.ljungberg@medstar.net|
310259|NCT02748356|MedStar Health Research Institute|Inger Ljungberg|202-877-1694|inger.h.ljungberg@medstar.net|
310260|NCT02748512|Axiom|Kelley Collins-Winters, RTR, BS, MBA|469-667-6655|kelleyc@axiom.cc|
310261|NCT02748525|The University of Texas Health Science Center at Houston|Isis Gayed, MD|713-704-1787|isis.w.gayed@uth.tmc.edu|
310262|NCT02748694|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
310263|NCT02748785|Seoul National University Hospital|Eun Bong Lee|+82-2-2072-4399|leb7616@snu.ac.kr|
310264|NCT02748863|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
310265|NCT02748889|Georgetown University Medical Center - Lombardi Comprehensive Cancer Center|Dr Giuseppe Giaccone|202-687-7072|gg496@georgetown.edu|
310266|NCT02748928|Syneron Medical|Director of Clinical Affairs|+972-73-2442347|shlomitm@syneron-candela.com|
310267|NCT02749201|maimonides medical center|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
310268|NCT02749370|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
310269|NCT02749721|Rush University Medical Center|Dr. John Zajecka|312-942-5592|John_Zajecka@rush.edu|
310270|NCT02749799|Dr. Reddys Laboratories Inc|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
310271|NCT02749903|Memorial Sloan Kettering Cancer Center|Alan Ho, MD, PhD|646-888-4235|hoa@mskcc.org|
310272|NCT02750267|Center for Diabetes Technology|Dr. Daniel R. Chernavvsky|4342431395|drc2v@virginia.edu|
310273|NCT02750306|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
310274|NCT02750332|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
310275|NCT02750345|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
310276|NCT02750410|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
310277|NCT02750501|Alcresta Therapeutics, Inc.|"Madhumalli (Molly) Sarkar, MD, PhD, Head of Clinical Development"|617 431 8866|msarkar@alcresta.com|
310278|NCT02750514|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
310279|NCT02750592|Novartis Pharmaceuticals|Study Director|1-888-669-6682|novartis.email@novartis.com|
310280|NCT02750618|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
310281|NCT02750709|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
310282|NCT02750761|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300547|NCT01962558|MicroTransponder|VP Clinical Affairs|512-371-4160|studies@microtransponder.com|
300548|NCT01962688|Icahn School of Mediine at Mount Sinai|Dr. Jagat Narula|212-241-4122|jagat.narula@mountsinai.org|
290969|NCT01335464|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290970|NCT01335477|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
290971|NCT01335542|Hospital for Special Surgery|Dr. Jacques YaDeau|2127742224|yadeauj@hss.edu|
290972|NCT01335620|Imperial College London|Alan Winston|+442033121603|a.winston@imperial.ac.uk|21603
290973|NCT01335698|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
290974|NCT01335724|Novartis Consumer Health|Clinical project Leader|+41223635528||
290975|NCT01335750|Erdy/Searcy Group|Dr. Gary Andrasko, MS|(614) 459-3363|gandrask@columbus.rr.com|
290976|NCT01335789|Medical University of South Carolina|Aimee McRae-Clark, Pharm.D., BCPP|843-792-5216|mcraeal@musc.edu|
290977|NCT01335867|University of Pennsylvania Treatment Research Center|Kyle M. Kampman, M.D.|215 746 2764|kampman@pennmedicine.upenn.edu|
300549|NCT01962714|VA Puget Sound Health Care System|David Kearney, MD|206-277-1445|david.kearney@va.gov|
300550|NCT01962870|Stanford University|Antonio Hardan, MD|(650) 736-1235|hardanay@stanford.edu|
300551|NCT01962896|University of Texas Southwestern Medical Center|Theodore Laetsch, MD|214-648-5475|ted.laetsch@utsouthwestern.edu|
300552|NCT01962922|Veloxis Pharmaceutical|Leslie Callahan|732-321-3221|lca@veloxis.com|
300553|NCT01962961|Indiana University School of Medicine|Samir K. Gupta|317-274-7926|sgupta1@iu.edu|
300554|NCT01962987|Teva Pharmaceuticals USA, Inc.|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
300555|NCT01963078|MUSC|Dr. Megan Moran-Santa Maria|843-817-6233|moranm@musc.edu|
300556|NCT01963091|MUSC|Dr. Moran-Santa Maria|843-792-8187|moranm@musc.edu|
300557|NCT01963117|Samsung Medical Center|Professor|82-2-3410-2612|hee.ro.park@gmail.com|
300558|NCT01963143|Bio Products Laboratory|Head of Medical Information|+44 (0)20 8957 2200|medinfo@bpl.co.uk|
300559|NCT01963169|University of Maryland, Baltimore|Eun-Shim Nahm|410-706-4913|enahm@son.umaryland.edu|
300560|NCT01963234|University of Wisconsin - Madison|Andrew Quanbeck|6082627385|arquanbe@wisc.edu|
300561|NCT01963260|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300562|NCT01963403|UC Davis|Dr. Mitchell Creinin|916-734-6670|mdcreinin@ucdavis.edu|
300563|NCT01963481|NYU Langone Health|Sylvia Adams|212 731 5795|Sylvia.Adams@nyulangone.org|
300564|NCT01963611|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
300565|NCT01963676|UNC Chapel Hill|Dr. Flavio Frohlich|(919) 966-4584|flavio_frohlich@med.unc.edu|
300566|NCT01963767|University of South Florida|Dr. Brent Small|813-974-9746|bsmall@usf.edu|
300567|NCT01963793|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
300568|NCT01963845|University of California, San Diego|Rohit Loomba, MD professor of Medicine|858-543-2230|roloomba@ucsd.edu|
300569|NCT01963923|Complejo Hospitalario Universitario A Coruña|Esther Gimenez Moolhuyzen|679336288|raquel.sebio@udc.es|
310283|NCT02750800|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
310284|NCT02750813|Alcon, A Novartis Division|Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
310285|NCT02750930|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310286|NCT02750943|GlaxoSmithKline|GSK Response Center|866-435-7343||
310287|NCT02751320|GlaxoSmithKline|GSK Response Center|866-435-7343||
310288|NCT02751359|University of California Los Angeles|Dr. Ziva Cooper, Principal Investigator|310-206-9942|zcooper@mednet.ucla.edu|
310289|NCT02751385|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310290|NCT02751424|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310291|NCT02751450|GlaxoSmithKline|GSK Response Center|866-435-7343||
310292|NCT02751580|Sidney Kimmel Cancer Center at Thomas Jefferson University|Nicole Simone, MD|215-955-6702|nicole.simone@jefferson.edu|
310293|NCT02751827|Institut Bergonié|Pr Simone Mathoulin-Pelissier|0556333333|S.Mathoulin@bordeaux.unicancer.fr|
310294|NCT02751879|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310295|NCT02751931|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
310296|NCT02751983|Rocky Mountain Mental Illness Research, Education, and Clinical Center|Sean Barnes|720-723-6560|Sean.Barnes2@va.gov|
310297|NCT02752048|Clinical Trial Registration Contact|Taiho Pharmaceutical Co., Ltd.|+81-3-3294-4527|toiawase@taiho.co.jp|
310298|NCT02752074|Incyte Corporation|Study Director|855-463-3463|medinfo@incyte.com|
310299|NCT02752087|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
310300|NCT02752256|University of Iowa Hospitals and Clinics|Brett Faine|319-384-6800|brett-faine@uiowa.edu|
310301|NCT02752490|The University of Texas Health Science Center at Houston|Nana-Ama E Ankumah, MD|713-500-6421|Nana.Ama.E.Ankumah@uth.tmc.edu|
310302|NCT02752633|Landspitali - The National University Hospital of Iceland|Vidar Orn Edvardsson|+3545431000|vidare@landspitali.is|3452
310303|NCT02752776|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
310304|NCT02752802|Osprey Medical, Inc|Michele Shepard, Vice President of Clinical Affairs|952-955-8236|mshepard@ospreymed.com|
310305|NCT02752880|Chang Gung Memorial Hospital|Dr. YH Huang|+886975360240|igighuang@gmail.com|
310306|NCT02752906|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
310307|NCT02752958|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310308|NCT02753075|GlaxoSmithKline|GSK Response Center|866-435-7343||
310309|NCT02753400|Kubota Vision Inc.|Clinical Trials Helpdesk|2068058310|clinicaltrials@kubotavision.com|
310310|NCT02753413|GlaxoSmithKline|GSK Response Center|866-435-7343||
310311|NCT02753595|Eisai, Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
310312|NCT02753699|Debiopharm International, S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
290978|NCT01335932|FHCRC|Dr.Michael Boeckh|206 667-6706|mboeckh@fredhutch.org|
290979|NCT01335971|Johns Hopkins University School of Medicine|Alexis Rea|(443) 287-8496|area5@jhu.edu|
290980|NCT01336023|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
290981|NCT01336140|Rush University Medical center|Rami Doukky|312-942-4655|rami_doukky@rush.edu|
290982|NCT01336205|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
290983|NCT01336296|UCincinnati|Research Associate Professor|5135852145|adele.rike@uc.edu|
290984|NCT01336413|VHA Durham|Christine E. Marx, MD MA|9192860411|christine.marx@va.gov|3626
290985|NCT01336569|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Medical Affairs Leader, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
290986|NCT01336608|GlaxoSmithKline|GSK Response Center|866-435-7343||
300570|NCT01964092|University of Oslo|Silje Endresen Reme|22845236|s.e.reme@psykologi.uio.no|+47
300571|NCT01964105|WASHINGTON UNIVERSITY SCHOOL OF MEDICINE, SAINT LOUIS|TERENCE MICHAEL MYCKATYN, PI, PROFESSOR, PLASTIC SURGERY|314-362-4263|myckatyn@wustl.edu|
300572|NCT01964222|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
300573|NCT01964300|Pediatric Brain Tumor Consortium|Catherine Billups|901-595-3709|catherine.billups@stjude.org|
300574|NCT01964326|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300575|NCT01964352|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300576|NCT01964378|Grünenthal GmbH|Study Director|+49 241 569 3223|Clinical-Trials@grunenthal.com|
300577|NCT01964430|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
300578|NCT01964521|The Norfolk & Norwich University Hospitals NHS Foundation Trust|Dr Ketan Dhatariya|+44 1603 286286|ketan.dhatariya@nnuh.nhs.uk|
300579|NCT01964547|GW Pharma Ltd.|Mr Richard Potts, Clinical Operations Director|0044 1223 266800|rp@gwpharm.com|
300580|NCT01964716|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300581|NCT01964755|University of Miami|Juan C. Ramos MD|305-243-1326|jramos2@med.miami.edu|
300582|NCT01964898|The Miriam Hospital|Andrew Busch PhD|4017938189|andrew_busch@brown.edu|
300583|NCT01964924|The Ohio State University Comprehensive Cancer Center|Bhuvaneswari Ramaswamy|614-293-8858|Bhuvaneswari.Ramaswamy@osumc.edu|
300584|NCT01964950|Takeda Pharmaceutical Company Limited|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
300585|NCT01964963|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
300586|NCT01964976|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
300587|NCT01965002|Stanford Univeristy Medical Center|Pejman Ghanouni, MD, PhD|650-498-4485|ghanouni@stanford.edu|
310313|NCT02753816|Spectrum Health|Dr. Betsy Steensma|(616) 391-5701|elizabeth.steensma@spectrumhealth.org|
310314|NCT02753842|Emory University|Aaron Siegler|404-712-9733|asiegle@emory.edu|
310315|NCT02753881|Yale University|Todd Schlachter, MD|(203) 785-5885|todd.schlachter@yale.edu|
310316|NCT02753920|Northwell Health|Marjorie Pilkinton|5166225114|mlpilk@gmail.com|
310317|NCT02753946|Nabriva Therapeutics plc|Chief Medical Officer|(610) 816-6640|officeUS@nabriva.com|
310318|NCT02754310|iLumens|Dr David Drummond|+0033144494848|david.drummond@ilumens.org|6
310319|NCT02754427|University of British Columbia|Dr. Kristin Campbell|604-827-4704|kristin.campbell@ubc.ca|
310320|NCT02754440|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
310321|NCT02754492|Terumo BCT, Inc.|Heather Pidcoke, MD, PhD|(303) 231-4805|Heather.Pidcoke@terumobct.com|
310322|NCT02754518|University of Chicago|Sara Kalantari, MD|773-834-6853|skalantari@medicine.bsd.uchicago.edu|
310323|NCT02754570|University of Colorado|Rachel Gerle|720-848-5096|rachel.gerle@ucdenver.edu|
310324|NCT02754661|Medtronic GIH (Given Imaging LTD)|Liron Bar Yaakov, Senior Manager Clinical Affairs|972-526060466|liron.baryaakov@medtronic.com|
310325|NCT02754674|Samsung Medical Center|Wang, JoonHo|82-2-3410-3507|mdwang88@gmail.com|
310326|NCT02755090|University of New Mexico|Sharla Biefeld Research Coordinator|505-272-9703|hsc-familyplanningresearch@salud.unm.edu|
310327|NCT02755116|Icahn School of Medicine at Mount Sinai|Dr. Jaime B. Hyman|212-241-7473|Jaime.hyman@mountsinai.org|
310328|NCT02755129|Medtronic|Ilaria Marcotullio|+39 06 32814218|ilaria.marcotullio@medtronic.com|
310329|NCT02755285|Fujifilm Medical Systems USA, Inc.|Randy Vader|(360) 356-6821|randy.vader@fujifilm.com|
310330|NCT02755649|Regeneron Pharmaceuticals, Inc.|Clinical Trial Administrator|844-734-6643|clinicaltrials@regeneron.com|
310331|NCT02755805|University of Pittsburgh|Elizabeth R. Skidmore, PhD, OTR/L, FAOTA|(412) 383-6617|skidmore@pitt.edu|
310332|NCT02755818|University of California, Davis|George Kaysen MD - Principal Investigator|916-734-3774|gakaysen@ucdavis.edu|
290987|NCT01336634|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|Novartis.email@novartis.com|
290988|NCT01336647|Hatchtech Pty Ltd|Clinical Manager|+61 3 9092 0490|tahveninen@hatchtech.com.au|
310333|NCT02755831|Naval Medical Center San Diego|CAPTAIN Dennis Spence, NC, USN, PhD, CRNA|6199161680|dennis.l.spence.mil@mail.mil|
310334|NCT02755935|Cochlear Americas|Ginger Grant, AuD|410-375-0883|ggrant@cochlear.com|
290989|NCT01336712|Blood and Marrow Transplant Group of Georgia|Scott R. Solomon, MD (Principal Investigator)|404-255-1930|ssolomon@bmtga.com|
290990|NCT01336738|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290991|NCT01336764|National Center for PTSD|Steven H. Woodward, PhD|650-493-5000|steve.woodward@va.gov|22111
290992|NCT01336803|Stanford University|Heike Daldrup-Link|650-723-8996|heiked@stanford.edu|
290993|NCT01336894|Boston Medical Center|Hiran C. Fernando, MD|617-638-5600|hiran.fernando@bmc.org|
290994|NCT01336933|University of Nebraska Medical Center|Julie M. Vose, M.D.|402-559-3848|jmvose@unmc.edu|
290995|NCT01336959|Mereo BioPharma|Dr. Ian Hodgson|+44 333 0237300|enquiries@mereobiopharma.com|
290996|NCT01336972|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
290997|NCT01337050|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
290998|NCT01337076|Mayo Clinic, Rochester|Dr. Colin Driscoll|507 266 1965|driscoll.colin@mayo.edu|
300588|NCT01965067|Department of Anesthesiology and Pain Medicine, Hanyang University Hospital|Kyo Sang Kim, MD, PhD|+82-2-2290-8680|kimks@hanyang.ac.kr|
300589|NCT01965158|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
300590|NCT01965262|Coopervision|Paul Chamberlain, BSc Honors, Sr. Manager Clinical Research|(925) 730-6754|pchamberlain@coopervision.com|
300591|NCT01965288|CooperVision|Jose A. Vega Sr. Mgr. Global Medical Scientific Affairs|(925) 621-3761|jvega2@coopervision.com|
300592|NCT01965327|Children's Hospital of Philadelphia|David Lynch, MD, PhD|215-590-1719|lynch@email.chop.edu|
300593|NCT01965366|Emory University|Dr. Barbara Rothbaum|404-712-8866|brothba@emory.edu|
300594|NCT01965431|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300595|NCT01965535|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
300596|NCT01965561|USAISR|John Kragh, MD|210.539.2210|john.f.kragh.civ@mail.mil|
300597|NCT01965600|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
300598|NCT01965652|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
300599|NCT01965665|Duke University Medical Center|Michael Kerzner, DMP|919-613-4449|michael.kerzner@duke.edu|
300600|NCT01965756|Massachusetts General Hospital|Dr. Steven E. Arnold MD|617-643-5607|SEARNOLD@mgh.harvard.edu|
300601|NCT01965834|University of Miami|Denise Pereira MD|305-243-4909|dpereira2@med.miami.edu|
300602|NCT01965860|Ghent University|Prof. Dr. Isabelle Van Herzeele|93325108|isabelle.vanherzeele@ugent.be|+32
300603|NCT01965899|Medtronic, plc|CRHF Clinical Research|800-328-2518|MedtronicCRMtrials@medtronic.com|
300604|NCT01965938|Vanderbilt University School of Medicine|Dr. Bret Alvis, MD|615-343-6268|bret.d.alvis@vanderbilt.edu|
300605|NCT01966003|Amgen Inc.|Study Director|866-572-6436||
300606|NCT01966042|Federal University of Sao Paulo (UNIFESP)|Dr. Nelson Americo Hossne Junior|+55 11 5571-2719|nelson.hossne@gmail.com|
310335|NCT02756013|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Peter Rose|+1 216-444-6601|ROSEP@ccf.org|
310336|NCT02756078|Johnson & Johnson Vision Care, Inc.|Chantal Coles-Brennan - PRINCIPAL RESEARCH OPTOMETRIST|1-904-443-3449|CColesb@its.jnj.com|
310337|NCT02756182|Laborie|Clinical Research Manager|9056121170|sgallone@laborie.com|1755
310338|NCT02756338|BIOTRONIK, Inc.|Crystal Miller|800-547-0394|crystal.miller@biotronik.com|
310339|NCT02756351|CytaCoat AB|Dr Jacob Odeberg|+46 (0) 70 2087571|jacob.odeberg@scilifelab.se|
310340|NCT02756364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
310341|NCT02756572|University of Washington/Seattle Cancer Care Alliance|Mary-Elizabeth Percival, MD, MS|206-606-1320|mperciva@seattlecca.org|
310342|NCT02756611|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
310343|NCT02756624|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
310344|NCT02756637|Abramson Cancer Center of the University of Pennsylvania|John Christodouleus|215-662-2428|John.Christodouleas@uphs.upenn.edu|
310345|NCT02756650|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
310346|NCT02756689|UAB|Lorie Harper, MD|205-934-5611|lmharper@uabmc.edu|
310347|NCT02756819|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
290999|NCT01337089|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
310348|NCT02756832|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
310349|NCT02756910|Peking Union Medical College Hospital|Lijian Pei|＋86 10 69152020|hazelbeijing@vip.163.com|
310350|NCT02756949|World Bank|Ms Marelize Gorgens|0012024730547|mgorgens@worldbank.org|
310351|NCT02757092|Chang Gung Memorial Hospital|Respiratory therapist Nai-Ying Kuo|+886077317123|ellen0605@gmail.com|2648
310352|NCT02757105|RedHill Biopharma Ltd.|Dr. Terry F. Plasse|972-(0)3-541-3131|terry@redhillbio.com|
310353|NCT02757326|Duke University Medical Center, Department of Medicine, Division of Hematologic Malignancies and Cellular Therapy|Yubin Kang, M.D., Principal Investigator|(919) 668-2331|yubin.kang@duke.edu|
310354|NCT02757352|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
291000|NCT01337115|Centro Hospitalar do Porto|Dr Raul Carvalho|+351226176114|raul@meo.pt|
291001|NCT01337167|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291002|NCT01337297|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 7775-7337|emnpalacios@gmail.com|
291003|NCT01337336|GlaxoSmithKline|GSK Response Center|866-435-7343||
291004|NCT01337596|Eli Lilly Company|Chief Medical Officer|1-800-545-5979||
291005|NCT01337635|Medical College of Wisconsin|Yvonne Chiu, MD|414-955-2818|ychiu@mcw.edu|
300607|NCT01966068|Children's Hospital of Philadelphia|Alexander Fiks, MD, MSCE|267-426-2304|fiks@email.chop.edu|
300608|NCT01966107|Study Information Center|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
300609|NCT01966120|Biofrontera Bioscience GmbH|Clinical Trial Department,|+49 2148763226|ameluz@biofrontera.com|
300610|NCT01966159|Shenyang Northern Hospital (The General Hospital of Shenyang Military Region)|Dr. Hanyaling|024-28897310|hanyl@medmail.com.cn|
300611|NCT01966354|Complejo Hospitalario de Navarra|Dr. Mikel Batllori|0034 848422174|mikel.batllori.gaston@cfnavarra.es|
300612|NCT01966380|Sahlgrenska university hospital|Prof. Jan Faergemann|031-3421000|jan.faergemann@derm.gu.se|
300613|NCT01966419|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
300614|NCT01966432|Duke University, Dept. of Psychiatry and Behavioral Sciences|Dr. Li-Tzy Wu, Professor in Psychiatry|(919) 889-9369|litzy.wu@duke.edu|
300615|NCT01966445|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
300616|NCT01966458|Medtronic|Thomas Vassiliades|+15085321942|thomas.a.vassiliades@medtronic.com|
300617|NCT01966718|Arthritis Treatment Center|Dr. Nathan Wei|301-694-5800|nwei@arthritistreatmentcenter.com|
300618|NCT01966770|Clinical Research Center-UC berkely|Meng C. Lin O.D., PhD, FAAO|510-643-9252|mlin@berkeley.edu|
300619|NCT01966796|Far Eastern Memorial hospital|Dr. Ping-huai Wang|886-2-89667000|pinghuaiwang@gmail.com|2816
300620|NCT01966809|Medical College of Wisconsin|Dr. Harry T. Whelan|414-266-7516|hwhelan@mcw.edu|
300621|NCT01966900|Imperial College London|Dr Tom Cole|+44(0)2033136198|t.cole@imperial.ac.uk|
300622|NCT01966926|University of Minnesota|Dr. Jennifer Linde|612-624-0065|linde074@umn.edu|
300623|NCT01966978|UT Southwestern Medical Center|Dr. Ildiko Lingvay|214-648-2779|ildiko.lingvay@utsouthwestern.edu|
300624|NCT01967069|Promius Pharma|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
300625|NCT01967121|Michigan State University|Tracey Covassin|517-353-2010|covassin@msu.edu|
300626|NCT01967134|IAVI|Dr. Dereck Tait|27214424991|dtait@iavi.org|
300627|NCT01967147|Alcon Research, Ltd.|Global Brand Med Affairs Lead, GCRA, GMA Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
300628|NCT01967173|Penn State University|David Mauger|717-531-7178|dmauger@psu.edu|
300629|NCT01967225|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
310355|NCT02757430|Abbott|Clinical Research Scientist|6517562885|amber.miller@abbott.com|
310356|NCT02757625|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
310357|NCT02757768|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
310358|NCT02757950|GlaxoSmithKline|GSK Clinical Trials|877-379-3718|GSKClinicalSupportHD@gsk.com|
310359|NCT02757963|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310360|NCT02758119|iLumens|David Drummond|0033144494848|david.drummond@ilumens.org|6
310361|NCT02758171|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310362|NCT02758210|Emory University|Mikhael El Chami, MD|404-686-2504|melcham@emory.edu|
310363|NCT02758301|Medtronic, PLC|Lindsay Werder, Senior Clinical Research Specialist|6123003066|lindsay.k.werder@medtronic.com|
310364|NCT02758613|Eli Lilly and Company|Chief Medical Officer|800-545-5079||
310365|NCT02758899|Washington University|Wilson Z. Ray|314-747-6145|rayz@wustl.edu|
310366|NCT02759016|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310367|NCT02759055|HealthPartners Institute|Patrick J O'Connor|952-967-5034|Patrick.J.OConnor@HealthPartners.Com|
310368|NCT02759120|Weill Cornell Medicine|Elizabeth Peters|646-962-2742|elp2018@med.cornell.edu|
310369|NCT02759146|Michigan State University|Dr. Gwen Wyatt|517-353-6672|gwyatt@msu.edu|
310370|NCT02759185|Multidisciplinary Association for Psychedelic Studies (MAPS) Public Benefit Corporation|Julie B. Wang, MPH, PhD (Senior Clinical Data Scientist)|(831) 429-6362|juliewang@mapsbcorp.com|
310371|NCT02759315|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
310372|NCT02759354|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
310373|NCT02759471|CooperVision|Senior Manager Global Medical Scientific Affairs|1-925-621-3761|javega@coopervision.com|
310374|NCT02759562|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
310375|NCT02759575|University of Cincinnati|Vinita Takiar, MD, PhD, Associate Professor|(513)584-8956|Vinita.Takiar@UCHealth.com|
291006|NCT01337674|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291007|NCT01337687|Montefiore Medical Center, Albert Einstein College of Medicine|Casara Jean Ferretti|3472499694|cferrett@montefiore.org|
291008|NCT01337700|Montefiore Medical Center, Albert Eins|Eric Hollander, MD|7189204287|eholland@montefiore.org|
291009|NCT01337739|Northwestern University|Paul Fitzgerald|312-472-3539|p-fitzgerald2@northwestern.edu|
291010|NCT01337960|VA Maryland Health Care System|Larry Forrester, PhD|410-637-3241|Larry.Forrester@va.gov|
291011|NCT01337973|VA Ann Arbor|Stephen Chermack, Ph.D.|734 845-5046|chermack@umich.edu|
291012|NCT01337986|Washington Univerisity St. Louis|Robert Naismith, MD|314-747-5576|naismithr@wustl.edu|
291013|NCT01338012|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
291014|NCT01338025|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
291015|NCT01338298|Maryland Psychiatric Research Center|AnnMarie Kearns, MS|4104066854|akearns@som.umaryland.edu|
300630|NCT01967277|Capillus LLC|Patricia Schnoor|7868881874|pschnoor@capillus.com|
300631|NCT01967342|University of Alabama|Beverly E. Thorn, Ph.D.|(205) 348-8024|bthorn@ua.edu|
300632|NCT01967433|University of Oklahoma Health Sciences Center and VAMC, Oklahoma City|Salman Nusrat|4052715428|salman-nusrat@ouhsc.edu|
300633|NCT01967537|Principal Investigator|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
300634|NCT01967550|Novartis Consumer Health|Clinical Project Leader pain category|+41223633111||
300635|NCT01967576|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
300636|NCT01967628|University of Iowa|Dr. Alicia Gerke|319-356-1869|alicia-gerke@uiowa.edu|
300637|NCT01967641|New York State Psychiatric Institute|Dr. Maria A. Sullivan, M.D., Ph.D|646-774-6152|mas23@columbia.edu|
300638|NCT01967706|Philip Morris Products S.A.|Christelle HAZIZA|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
300639|NCT01967719|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
300640|NCT01967732|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
300641|NCT01967784|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
300642|NCT01967836|Ascension Wisconsin|Dr Maureen Greene|414-447-2716|maureen.greene@ascension.org|
300643|NCT01967862|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
300644|NCT01967888|Dompé|Mauro P. Ferrari, Pharm D|+3902583831|info@dompe.com|
300645|NCT01967940|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
300646|NCT01968031|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
300647|NCT01968057|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
300648|NCT01968070|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
310376|NCT02759692|Johnson & Johnson Vision Care Inc.|Brian Pall, OD, MS, FAAO|904 443-1290|BPALL@its.jnj.com|
270253|NCT00116207|University of Michigan|Eva L. Feldman, Professor of Internal Medicine|7347637274|efeldman@med.umich.edu|
270254|NCT00116272|Amgen Inc.|Study Director|866-572-6436||
270255|NCT00116337|MetroHealth Medical Center|Dr. Anthony Dimarco|216-778-3906|adimarco@metrohealth.org|
270256|NCT00116428|Biosense Webster|Melissa Schultz, Project Manager, Regulatory Affairs|800-729-9010|mschult1@its.jnj.com|8787
270257|NCT00116558|University of Kentucky|Edward J. Kasarskis, M.D., Ph.D.|859-218-5061|ejkas@uky.edu|
270258|NCT00116584|ULouisville|Dr. In Kim|502-629-7212|in.kim@louisville.edu|
270259|NCT00116649|Graceway Pharmaceuticals LLC|Sharon Levy, MD VP Product Development|267-948-0500|sharon.levy@gracewaypharma.com|
270260|NCT00116688|Amgen Inc.|Study Director|866-572-6436||
310377|NCT02759939|Dartmouth College|Rachel Thompson|6036530860|rachel.thompson@dartmouth.edu|
310378|NCT02760056|OHSU|Anna Orban|503-494-3549|orban@ohsu.edu|
291016|NCT01338415|Actelion Pharmaceuticals Ltd|Principal Clinical Scientist||ClinicalTrialDisclosure@its.jnj.com|
291017|NCT01338493|Medtronic Spinal & Biologics|Cristina Faria|+41 (0)21 802 70 00|cristina.faria@medtronic.com|
291018|NCT01338506|Medical University of South Carolina|Dr. Sudie Back|843-792-9383|backs@musc.edu|
300649|NCT01968135|University of Colorado Denver|Chanel Mansfield|303-724-6501|chanel.mansfield@ucdenver.edu|
291019|NCT01338610|Alcon Research, Ltd.|Christian Leisner|1-888-451-3937|alcon.medinfo@alcon.com|
291020|NCT01338649|Northwestern University|Aleksandar Videnovic|3126234033|aleksvidenovic@gmail.com|
291021|NCT01338792|USC Norris Comprehensive Cancer Center|Jacek Pinski, MD|323-865-3900|pinski_j@ccnt.usc.edu|
291022|NCT01338818|Novartis Pharmaceuticals|Study Director|8627788300||
300650|NCT01968213|Clovis Oncology|Clovis Oncology Clinical Trial Navigation Service|1-855-262-3040|clovistrials@emergingmed.com|
291023|NCT01338857|New York University Langone Medical Center|Matthias A. Karajannis, MD|212-263-9630|matthias.karajannis@nyumc.org|
291024|NCT01338870|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291025|NCT01338987|National Cancer Institute|Dr. Christopher Kanakry|240-760-6171|christopher.kanakry@nih.gov|
300651|NCT01968317|Obstetrics and Gynecology Hospital of Fudan University|Xiaojun Chen|33189900|xiaojunchen2013@sina.com|
300652|NCT01968356|3M Health Care|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
300653|NCT01968382|Virginia Commonwealth University|Stephanie Taylor MSN, RN|804-828-9311|stephanie.taylor@vcuhealth.org|
300654|NCT01968421|Peking Union Medical College Hospital|Dr. Jinming Gao, Director of Clinical Trials|8610691550549|gjinming@yahoo.com|
300655|NCT01968434|Clalit HS|Prof. Herman Avner Cohen|00972 3-939-8203|hermanc@clalit.org.il|
300656|NCT01968447|LUMC|Albert Dahan|+31 71 52 62301|a.dahan@lumc.nl|
300657|NCT01968551|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
300658|NCT01968694|Brigham & Women's Hospital|Dr. Antje M Barreveld|617-243-6298|abarreveld@partners.org|
300659|NCT01968707|3M|Joan Paulson|651-736-6583|jepaulson@mmm.com|
300660|NCT01968811|Sahlgrenska university Hospital|Dr Marcus Langenskiöld|+46 709 433160|marcus.langenskiold@vgregion.se|
300661|NCT01968954|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300662|NCT01968967|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300663|NCT01968980|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300664|NCT01969058|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
300665|NCT01969084|Beth Israel deaconess Medical Center|Aristidis Veves|617 632 7075||
300666|NCT01969162|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
310379|NCT02760069|Brooke Army Medical Center|Dr. Michael D. April|210-916-0808|Michael.D.April.mil@mail.mil|
310380|NCT02760264|ReveraGen Biopharma Inc.|Dr. Eric P. Hoffman|240-672-0295|ericphoffman@gmail.com|
310381|NCT02760277|ReveraGen Biopharma Inc.|Dr. Eric P. Hoffman|240-672-0295|ericphoffman@gmail.com|
310382|NCT02760368|R-Pharm|Elena Korneva, Senior Scientific Advisor|0074959567937|korneva@rpharm.ru|3819
310383|NCT02760407|R-Pharm|Elena Korneva, Senior Scientific Advisor|0074959567937|korneva@rpharm.ru|3819
310384|NCT02760433|R-Pharm|Elena Korneva, Senior Scientific Advisor|0074959567937|korneva@rpharm.ru|3819
310385|NCT02760654|University of Michigan School of Nursing|Robert Knoerl, Doctoral Student|734-536-9369|rjknoerl@umich.edu|
310386|NCT02760810|Johnson & Johnson Vision Care Inc.|Andrea Le, OD, MBA - Manager, Global Medical Affairs|904 4431866|ale3@ITS.JNJ.com|
310387|NCT02760862|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
310388|NCT02760927|Hollister Incorporated|Stacy Haddad, Director Global Clinical Affairs|+1.847.680.2837|stacy.haddad@hollister.com|
310389|NCT02761252|Menarini International Operations Luxembourg SA|Medical Director|+352 2649761|aconte@menarini.lu|
310390|NCT02761330|Washington Universtiy School of Medicine|Alyssa Labonte|314-273-7338|alabonte@wustl.edu|
310391|NCT02761629|Hoffman-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
310392|NCT02761642|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
310393|NCT02761733|Felton Institute & Palo Alto University|Joyce Chu (Principal Investigator)|650-814-8376|jchu@paloaltou.edu|
310394|NCT02761915|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
310395|NCT02761967|University of Granada|Dr. Rodríguez-Blanque|+34644322567|rarobla@gmail.com|
310396|NCT02761980|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
310397|NCT02761993|Noveome Biotherapeutics, Inc|David Steed, MD|4124029913|dsteed@noveome.com|
310398|NCT02762071|Johns Hopkins University|Uma Srikumaran|443-546-1550|us@jhmi.edu|
310399|NCT02762084|PellePharm, Inc.|Chief Medical Officer|(510) 502-6144|Info@Pellepharm.com|
310400|NCT02762331|Virginia Commonwealth University|Donald Brophy, PharmD|(804) 827-1455|dbrophy@vcu.edu|
310401|NCT02762370|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
310402|NCT02762500|Lycera Corp.|H. Jeffrey Wilkins, MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
310403|NCT02762513|University of Michigan Rogel Cancer Center|Paul Swiecicki, M.D.|734-647-1017|pswiecic@med.umich.edu|
310404|NCT02762565|University of Pennsylvnia|Robyn Broach|215-662-7300|robyn.broach@uphs.upenn.edu|
310405|NCT02762578|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
310406|NCT02762799|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
291026|NCT01339000|National Cancer Institute|Dr. Ronald Gress|301-496-1791|gressr@mail.nih.gov|
291027|NCT01339013|Region Skane, Lund University Hospital, Lund, Sweden|Dr Louise Walther Sturesson|+46 46 171953|louise.waltersturesson@skane.se|
291028|NCT01339052|Dana-Farber Cancer Institute|Patrick Y. Wen, MD, Director, DFCI Center for Neuro-Oncology|617-632-2166|pwen@partners.org|
291029|NCT01339091|Durata Therapeutics|Michael Zelasky|203-871-4616|mzelasky@duratatherapeutics.com|
291030|NCT01339247|GlaxoSmithKline|GSK Response Center|866-435-7343||
291031|NCT01339260|Helsinn Healthcare SA|Head of Clinical Development|+41 91 9852121|marco.palmas@helsinn.com|
291032|NCT01339273|Oxford University Hospitals NHS Trust|Dr Nicholas Crabtree|01865 221590|nicholas.crabtree@ouh.nhs.uk|
300667|NCT01969201|IBSA Insitut Biochimique|Project Leader|+41 58 360 10 00|rd@ibsa.ch|
300668|NCT01969214|Analyze & Realize|Felix Alt|+49 30 4000 8194|FAlt@a-r.com|
300669|NCT01969240|Mayo Clinic|Dr. Erik Hess|507-284-7221|hess.erik@mayo.edu|
300670|NCT01969435|Washington University School of Medicine|Amanda F. Cashen, M.D.|314-454-8304|acashen@wustl.edu|
300671|NCT01969448|Washington University School of Medicine|Marissa J. Tenebaum, M.D.|314-996-8800|tenenbaumm@wustl.edu|
300672|NCT01969500|University of Washington|Dror Ben-Zeev|(206) 685-9655|dbenzeev@uw.edu|
300673|NCT01969539|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300674|NCT01969708|The Emmes Corporation|Principal Investigator of the SCORE2 Data Coordinating Center|301-251-1161|score2@emmes.com|
300675|NCT01969721|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300676|NCT01969747|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300677|NCT01969799|Cardeas Pharma|Bruce Montgomery, MD|2069713756|bruce.montgomery@cardeaspharma.com|
300678|NCT01969812|Atrium Health|Bradley Hurst, M.D.|704-355-3153|brad.hurst@atriumhealth.org|
300679|NCT01969851|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
300680|NCT01969916|University of Chicago|Victor Mor-Avi|773-702-7780|vmoravi@bsd.uchicago.edu|
300681|NCT01970007|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|Alan.Saunders@CookMedical.com|321204
300682|NCT01970176|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
300683|NCT01970241|HCMC|Lisa Fish MD|612-873-2705|lisa.fish@hcmed.org|
310407|NCT02762877|Genomic Health, Inc.|Director of Clinical Trials|1.650.569.2042|kgran@genomichealth.com|
310408|NCT02762994|BIOCAD|Nikiforova Aleksandra|+7(812) 380 49 33|nikiforovaan@biocad.ru|6254
310409|NCT02763046|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
310410|NCT02763124|Gainesville Eye Associates|Clayton Blehm, MD|7705324444|claytonblehm@gmail.com|
310411|NCT02763189|Wake Forest School of Medicine|Dr. Michael A. Olympio|3369182132|molympio@wakehealth.edu|
310412|NCT02763215|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
310413|NCT02763254|Cell Medica|Dr. Kurt Gunter (Chief Medical Officer)|832-581-4480|Kurt.Gunter@cellmedica.com|
310414|NCT02763566|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
310415|NCT02763579|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
310416|NCT02763644|Novartis Pharmaceuticals|Study Director|8627788300|novartis.email@novartis.com|
310417|NCT02763826|Medical University or SC|Scott Hutchison, Manager of COBRE Research Operations|843-792-2712|hutchis@musc.edu|
310418|NCT02763865|Medical University of South Carolina|Gonzalo REvuelta|843-792-7262|revuelta@musc.edu|
310419|NCT02764151|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
310420|NCT02764164|Cincinnati Childrens Hospital Medical Center|Dr. Ernest Pedapati|5137361901|ernest.pedapati@cchmc.org|
310421|NCT02764190|Seattle Children's Research Institute|Cari McCarty|206-884-8243|Carolyn.McCarty@seattlechildrens.org|
310422|NCT02764229|Lycera Corp.|H. Jeffrey Wilkins MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
310423|NCT02764320|Mayo Clinic|Dr. Todd J. Schwedt|480-301-9443|Schwedt.Todd@mayo.edu|
310424|NCT02764333|Memorial Sloan Kettering Cancer Center|Dr. Jason Konner, MD|848-225-6530|konnerj@MSKCC.ORG|
310425|NCT02764385|Oregon Health & Science University|Sue Flocke|5034946697|flocke@ohsu.edu|
310426|NCT02764697|Tampa Bay Uveitis Center, LLC|Dr. Grace Levy Clarke|855 798 8393|grace@tampabayuveitis.com|
310427|NCT02764762|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
310428|NCT02764775|Fort Worth Independent School district|Dr. Julie Brown|214-725-8232|jbrown18@twu.edu|
310429|NCT02764970|Medical University of Graz|Assoc. Prof. Dr. Dirk von Lewinski|31638580684|dirk.von-lewinski@medunigraz.at|316
310430|NCT02765035|Otto Bock Healthcare GmbH|Director of Clinical Research and Services Vienna|+4315233786733|Milana.Mileusnic@Ottobock.com|
310431|NCT02765100|Weill Cornell Medicine|James H Kocsis, M.D.|212-746-5913|jhk2002@med.cornell.edu|
310432|NCT02765165|Proximagen, LLC|Chief Medical Officer|952-658-7440|tcmeng@proximagen.com|
310433|NCT02765256|University of Pennsylvania|Lindsey Albenberg, DO|267-426-0139|albenbergl@email.chop.edu|
310434|NCT02765269|Xinhua Translational Institute for Cancer Pain, Shanghai|Gang Ding|021-69691540||
310435|NCT02765490|Janssen Research & Development, LLC|Trial Physician, Medical Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
310436|NCT02766023|University of California San Francisco|Craig Cohen, MD, MPH|(415) 476-5874|Craig.Cohen@ucsf.edu|
310437|NCT02766088|GlaxoSmithKline|GSK Response Center|866-435-7343|gskclinicalhd@gsk.com|
291033|NCT01339299|Fertility Clinic Regional Hospital Skive|Prof, M.D. Peter Humaidan|+45 78445760|peter.humaidan@viborg.rm.dk|
300684|NCT01970371|Achaogen, Inc.|Clinical Trials Registration Group||clinical-trials@achaogen.com|
300685|NCT01970397|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
300686|NCT01970475|Amgen Inc.|Study Director|866-572-6436||
291034|NCT01339390|Clement J. Zablocki VA Medical Center|Dr. Jeff Whittle|(414) 384-2000|jeffrey.whittle@va.gov|46444
291035|NCT01339403|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291036|NCT01339416|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291037|NCT01339429|Brigham and Women's Hospital|Dr. Gita Mody|617-921-8221|gmody@partners.org|
291038|NCT01339559|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
291039|NCT01339832|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
291040|NCT01339858|Indiana University Psychotic Disorders Program|Alan Breier|317-880-8495|abreier@iupui.edu|
291041|NCT01339897|N30 Pharmaceuticals Inc.|Janice M Troha|720-945-7714|janice.troha@n30pharma.com|
291042|NCT01339910|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
300687|NCT01970488|Amgen Inc.|Study Director|866-572-6436||
300688|NCT01970527|University of Washington Medical Center|Dr. Ramesh Rengan|206-598-4100|rengan@uw.edu|
300689|NCT01970540|Pharma Mar S.A.|Pharma Mar S.A.|0034918466000|clinicaltrials@pharmamar.com|
300690|NCT01970592|Medical University of South Carolina|Chris Gregory|8437921078|gregoryc@musc.edu|
300691|NCT01970787|Laser Surgery Care|Stephen E Goldstone|212-242-6500|segmd@prodigy.net|
300692|NCT01970878|Pearl Therapeutics Inc.|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
300693|NCT01970943|Massachusetts General Hospital|Dr David Borsook, study PI|6172817135|david.borsook@childrens.harvard.edu|
300694|NCT01970982|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
300695|NCT01970995|Philip Morris Products S.A.|Christelle HAZIZA, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
300696|NCT01971086|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300697|NCT01971203|Icahn School of Medicine at Mount Sinai|Cindy J. Aaronson, MSW, PhD|212-241-3169|cindy.aaronson@mssm.edu|
300698|NCT01971255|National Institute of Allergy and Infectious Diseases|Matthew James Memoli|+1 301 443 5971|memolim@niaid.nih.gov|
300699|NCT01971346|University of Michigan|Heather Chubb|734-936-6394|hdchubb@med.umich.edu|
300700|NCT01971385|Massachusetts General Hospital|Dr. Maria Alora-Palli|6177265066|mpalli@mgh.harvard.edu|
300701|NCT01971463|University of Pennsylvania|Michael Mullen|215-662-3339|mmullen@pennmedicine.upenn.edu|
300702|NCT01971476|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300703|NCT01971554|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300704|NCT01971567|Wake Forest School of Medicine|Dr. Charles H. Tegeler|+1 (336) 716-7651|ctegeler@wakehealth.edu|
300705|NCT01971580|UT Southwestern|Ari Cedars|3149224788|acedars97@gmail.com|
310438|NCT02766244|Texas Tech University Health Sciences Center|Dr. Sharmila Dissanaike|8067435609|sharmila.dissanaike@ttuhsc.edu|
310439|NCT02766283|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
310440|NCT02766374|Rutgers - Robert Wood Johnson Medical School|Paul M. Lehrer, PhD|(732) 235-4413|lehrer@rutgers.edu|
310441|NCT02766400|University of Pittsburgh|Elizabeth R. Skidmore, PhD, OTR/L, FAOTA|(412) 383-6617|skidmore@pitt.edu|
310442|NCT02766517|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
310443|NCT02766608|Pearl Therapeutics, a Member of the AstraZeneca Group|Paul M. Dorinsky, MD|650-305-2600|paul.dorinsky1@astrazeneca.com|
310444|NCT02766673|Children's Hospital of Philadelphia|Natalie Napolitano, MPH, RRT-NPS, FAARC|215-590-1708|napolitanon@email.chop.edu|
310445|NCT02766777|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
310446|NCT02766907|TissueTech|VP Medical Affairs|8882968858|hsheha@tissuetechinc.com|
310447|NCT02767011|Charleston Area Medical Center Research Institute|Mike Broce|304-388-9923|mike.broce@camc.org|
310448|NCT02767128|Rockwell Medical, Inc|Clinical Project Manager|248-960-9009|sgrimberg@rockwellmed.com|
310449|NCT02767271|Bausch Health Americas, Inc|Director of Clinical Operations||aloncaric@bauschhealth.com|
310450|NCT02767323|Duke University|Dr. Lysianne Beynel|9193386273|lysianne.beynel@gmail.com|
310451|NCT02767388|University of Nebraska Medical Center|Dr. David Anderson|402-559-6870|david.anderson@unmc.edu|
310452|NCT02767427|Columbia University|Dr. Kiehyun Daniel Riew, Professor of Orthopedic Surgery|212-932-4410|kr2637@cumc.columbia.edu|
310453|NCT02767492|Hawkins Foundation|Kyle Adams|864 454-7458|kyle.adams@hawkinsfoundation.com|
310454|NCT02767609|Loma Linda University medical Center|Brenda Bartnik Olson|909-558-4000|bbartnik@llu.edu|85216
291043|NCT01339923|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
291044|NCT01339936|Optometric Technology Group|Dr Michel Guillon|+44 2072224224|mguillon@otg.co.uk|
291045|NCT01340014|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
291046|NCT01340027|Astellas Pharma Europe, B.V.|Medical Director||Astellas.resultsdisclosure@astellas.com|
291047|NCT01340053|Ardelyx|Chief Development Officer|510 745 1752|drosenbaum@ardelyx.com|
291048|NCT01340066|Beech Tree Labs, Inc.|Dr. John McMichael|518-872-1144||
300706|NCT01971593|UT Southwestern|Ari Cedars|3149224788|acedars97@gmail.com|
300707|NCT01971645|Nationwide Children's Hospital|Giorgio Veneziano, MD|6147224200|Giorgio.Veneziano@nationwidechildrens.org|
300708|NCT01971723|Florida State University|Dr. Michael J. Ormsbee|(850) 644-4793|mormsbee@fsu.edu|
300709|NCT01972061|University of Pittsburgh|Dr. Christopher Chermansky|412-6418385|chermanskycj2@upmc.edu|
300710|NCT01972074|Massachusetts General Hospital|Gagan Joshi, MD|(617) 724-1541|joshi.gagan@mgh.harvard.edu|
300711|NCT01972152|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP, Drug Development|512-498-2675|mcummins@xerispharma.com|
300712|NCT01972204|Mirai Iryo Research Center|Tomoko Machida (Director)|81-3-3263-4801|machida@mirai-iryo.com|
300713|NCT01972282|St. Antonius Ziekenhuis, Nieuwegein, Netherlands|Dr. Lucas V.A. Boersma||l.boersma@antoniusziekenhuis.nl|
300714|NCT01972308|University of Pennsylvania|Andrea J Apter, MD|215 349-5120|andrea.apter@uphs.upenn.edu|
300715|NCT01972438|National Institutes of Health|Manuel B. Datiles, III, MD, Principal Investigator, NEI|301-594-7052|DatilesM@nei.nih.gov|
300716|NCT01972464|Yale School of Medicine|Ariadna Forray|2037648620|ariadna.forray@yale.edu|
300717|NCT01972516|Dana-Farber Cancer Institute|Susana Campos, MD|617-632-5269|susana_campos@dfci.harvard.edu|
300718|NCT01972529|Eisai Inc|Eisai Medical Services|1-888-274-2378|esi_medinfo@eisai.com|
300719|NCT01972568|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
300720|NCT01972659|Kocaeli University Medical Faculty|Assistant Professor Dr Z Ipek ARSLAN AYDIN|00905325011339|zehraipek48@gmail.com|
300721|NCT01972724|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
300722|NCT01972776|Novartis|Study Director|862-778-8300||
300723|NCT01972789|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
300724|NCT01972841|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 71 5455 050|astellas.resultsdisclosure@astellas.com|
300725|NCT01973036|Geisinger|Dr. A. Dhanya Mackeen|570-714-1099|admackeen@geisinger.edu|
300726|NCT01973205|Novartis|Clinical Project Leader|9735038000||
300727|NCT01973218|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
300728|NCT01973231|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
310455|NCT02767765|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
310456|NCT02767843|California Center for Sleep Disorders|Jerrold Kram, MD|510.263.3300|info@californiasleepcenters.com|
310457|NCT02767869|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
310458|NCT02767934|University of Washington|Dr. Ryan Cassaday|206-606-1202|cassaday@seattlecca.org|
310459|NCT02767947|Bausch Health Americas, Inc|Director of Clinical Operations||aloncaric@bauschhealth.com|
310460|NCT02768103|VA Palo Alto Health Care System|Dr Johanson|408-250-1982|lisa.johanson29@gmail.com|
310461|NCT02768129|Butler Hospital|Benjamin Greenberg|(401) 455-6200|bgreenberg@butler.org|
310462|NCT02768194|GlaxoSmithKline|GSK Response Center|866-435-7343||
291049|NCT01340144|Colorado Joint Replacement|Raymond Kim, MD|720-524-1367|raymondkim@ccentura.org|
291050|NCT01340196|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291051|NCT01340209|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291052|NCT01340300|Dana-Farber Cancer Institute|Meyerhardt, Jeffrey,M.D.,M.P.H.|617-632-6855|Jeffrey_Meyerhardt@dfci.harvard.edu|
291053|NCT01340482|Kyowa Kirin Pharmaceutical Development|Kyowa Kirin Pharmaceutical Development|609-919-1100|kkd.clintrial.82@kyowakirin.com|
300729|NCT01973283|New York State Psychiatric Institute|Patrick J Brown|646-774-8666|patrick.brown@nyspi.columbia.edu|
300730|NCT01973335|Ziekenhuis Oost-Limburg|Dr. Frederik Verbrugge, researcher|0473924199|frederik.verbrugge@zol.be|+32
300731|NCT01973348|Indiana University|Dr. Daniel Neely, PI|3172741214|deneely@iupui.edu|
300732|NCT01973387|Janssen Research & Development, LLC|Vice President (VP)||ClinicalTrialDisclosure@its.jnj.com|
300733|NCT01973413|Univeristy of VIrginia|Marc Breton, PhD|434-982-6484|mb6nt@virginia.edu|
300734|NCT01973439|MRC Clinical Trials Unit at UCL|Trial manager|02076704825|silvia.forcat@ucl.ac.uk|
300735|NCT01973491|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
300736|NCT01973569|Contact for Clinical Trial Information|Daiichi Sanyko|+81 362251111 (M-F 9-5 JST)|dsclinicaltrial@daiichisankyo.co.jp|
300737|NCT01973595|University of Florida|Dr. Bobbi Langkamp- Henken|352-392-1991|henken@ufl.edu|205
300738|NCT01973608|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
300739|NCT01973777|University of British Columbia|Dr Ellen Wiebe|6047095611|ellenwiebe@gmail.com|
300740|NCT01973972|Duke University|William S. Yancy, Jr.|919-681-2863|yancy006@mc.duke.edu|
300741|NCT01973998|Lewis Katz School of Medicine Temple University|Michael R. Jacobs - Director of Research Development|2157072242|michael.jacobs@tuhs.temple.edu|
300742|NCT01974050|Columbia University|Melissa S. Stockwell|212-342-5732|mss2112@cumc.columbia.edu|
300743|NCT01974089|Centre for Clinical Research, North Denmark Regional Hospital, Hjoerring, Denmark|Dorte Melgaard|+4526281086|dmk@rn.dk|
300744|NCT01974102|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Rajita Sinha|2038592840|rajita.sinha@yale.edu|
300745|NCT01974141|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
300746|NCT01974245|Federal University of São Paulo|Dr. Lilian Cuppari|+551159048499|lcuppari@uol.com.br|
300747|NCT01974323|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
300748|NCT01974687|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
310463|NCT02768298|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@@novartis.com|
310464|NCT02768558|RTOG Foundation|Wendy Seiferheld|215-574-3208|wseiferheld@acr.org|
310465|NCT02768753|General Hospital of Jinan Military Area|Dr.Qing Qing He，Dr.Gao Feng Ni|15653853675|m15653853675@163.com|
310466|NCT02768792|University of North Carolina Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
310467|NCT02769065|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
310468|NCT02769247|Walter Reed National Military Medical Center|Dr. Shana Miles|318 456 6389|shana.m.miles2.mil@mail.mil|
310469|NCT02769312|Providence VA Medical Center, Center for Neurorestoration and Neurotechnology|Dr. Noah S. Philip|401-273-7100|noah.philip@va.gov|6235
310470|NCT02769351|Fresenius Medical Care Deutschland GmbH|Dr. Jennifer Braun|+49617260893488|jennifer.braun@fmc-ag.com|
310471|NCT02769442|University of Maryland School of Medicine, Department of Emergency Medicine|Siamak Moayedi Md|4103288025|smoayedi@em.umaryland.edu|
310472|NCT02769481|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
310473|NCT02769624|Cincinnati Children's Hospital Medical Center|Katy Fischesser|513-803-5191|katy.fischesser@cchmc.org|
310474|NCT02769702|Washington University School of Medicine|Richard Brasington MD|314-454-7255|rbrasing@wustl.edu|
310475|NCT02769858|University of Michigan|Dr. Leslie Swanson|734-239-2248|LMSwan@med.umich.edu|
310476|NCT02770014|Dana-Farber Cancer Institute|Geoffrey Oxnard, MD|617-632-6049|geoffrey_oxnard@dfci.harvard.edu|
310477|NCT02770170|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310478|NCT02770248|Alcon, A Novartis Division|Field Medical, Ophthalmology|1-888-451-3937|alcon.medinfo@alcon.com|
310479|NCT02770287|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
310480|NCT02770365|Perrigo|Associate Director|718-960-9900|jonathan.schwartz@perrigo.com|
310481|NCT02770521|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
310482|NCT02770547|Purdue University|Bruno Roseguini, Assistant Professor|(765) 496-2612|brosegui@purdue.edu|
310483|NCT02770612|Brigham and Women's Hospital|Brian T Bateman|617-278-0930|bbateman@partners.org|
310484|NCT02770625|ISU ABXIS Co., Ltd.|Taekseung Kim|+82.31.696.4715|kimts@isu.co.kr|
310485|NCT02770820|FHCRC|Dr. Aude Chapuis|2066674369|achapuis@fredhutch.org|
310486|NCT02770846|Folktandvården Skåne AB|Björn Gjelvold|+46709467870|bjorn.gjelvold@gmail.com|
310487|NCT02771093|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
310488|NCT02771145|Alcon, A Novartis Division|Sr. Clinical Project Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
310489|NCT02771210|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
310490|NCT02771275|Edwards Lifesciences, LLC|Andrey Nersesov, Sr. Director of Clinical Affairs, Surgical Structural Heart|949-250-2500|Andrey_Nersesov@edwards.com|0225
310491|NCT02771340|Iconic Therapeutics|Gabriela Burian, M.D.|6504371000|gburian@iconictherapeutics.com|
310492|NCT02771366|University of Florida|Adam Woods, Ph.D.|352-294-5842|ajwoods@phhp.ufl.edu|
310493|NCT02771522|Calcivis Ltd|Director of Clinical Research|+44 131 658 5152|mwillins@calcivis.com|
310494|NCT02771574|Stanford University School of Medicine|Cindy Lamendola|650-723-3141|clamendola@stanford.edu|
291054|NCT01340495|Massachusetts General Hospital|Shannon MacDonald, MD|617-643-7250|SMACDONALD@mgh.harvard.edu|
291055|NCT01340586|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
291056|NCT01340625|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
291057|NCT01340651|Incyte Corporation|Study Director|855 463-3463||
291058|NCT01340664|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1 908 927-5775||
291059|NCT01340768|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291060|NCT01340794|Mayo Clinic Cancer Center|Keith Bible, M.D., Ph.D.||bible.keith@mayo.edu|
291061|NCT01340872|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
291062|NCT01340898|GlaxoSmithKline|GSK Response Center|866-435-7343||
291063|NCT01340937|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300749|NCT01974700|Indiana University|Dr. Aaron Cohen-Gadol|317-396-1300|ACohen@goodmancampbell.com|
300750|NCT01974752|AstraZeneca|Karin Bowen|+001 301 398 3254|karin.bowen@astrazeneca.com|
300751|NCT01974817|Michigan State University|Dr Subhashis Mitra|517-353-3128|mitrasub@msu.edu|
300752|NCT01974895|GlaxoSmithKline|GSK Response Center|866-435-7343||
310495|NCT02771990|Providence Veterans Affairs Medical Center|Benjamin Greenberg|4012737100|benjamin.greenberg@va.gov|
310496|NCT02772302|Massachusetts General Hospital|Brian Edlow|6177246352|bedlow@mgh.harvard.edu|
310497|NCT02772432|Mass General Hospital|Elyse Park|6177246836|epark@mgh.harvard.edu|
310498|NCT02772666|Mashhad University of Medical Sciences|Dr. Amirhossein Vejdani|+9151105411|amirhosein_vejdani@yahoo.com|
310499|NCT02772757|Mountain Home VA Medical Center|Sherri L. Smith, Au.D., Ph.D.|423.926.1171|sherri.smith@va.gov|7569
310500|NCT02772783|Boston Children's Hospital|Belinda Lennerz|617 355 7476|belinda.lennerz@childrens.harvard.edu|
310501|NCT02772809|University of Pennsylvania|Michelle J Johnson|215 893-2665|johnmic@pennmedicine.upenn.edu|
310502|NCT02772978|University of California at San Francisco|Andrew Kayser, MD PhD|415-502-7332|Andrew.Kayser@ucsf.edu|
310503|NCT02773368|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
310504|NCT02773446|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
310505|NCT02773537|Medical University of South Carolina|Dr. Eric Bolin|843-792-2322|bolin@musc.edu|
310506|NCT02773758|GlaxoSmithKline|GSK Response Center|866-435-7343||
310507|NCT02773836|European Network for Smoking and Tobacco Prevention|Dr Constantine Vardavas|+306937281680|vardavas@tobcontrol.eu|
310508|NCT02774213|Tools4Patient|Stephanie Alvarez|+32 71 14|stephanie.alvarez@tools4patient.com|02 00
310509|NCT02774226|Augusta University|Dr. Ryan Harris|706-721-5483|ryharris@augusta.edu|
310510|NCT02774278|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
310511|NCT02774343|The University of Texas Health Science Center at Houston|Joy M. Schmitz, PhD|713-486-2867|Joy.M.Schmitz@uth.tmc.edu|
310512|NCT02774616|Biotronik SE & Co.KG|Director Clinical Project Management|+49 30 68905|mathias.freudigmann@biotronik.com|0
310513|NCT02774681|Northwestern University|Massimo Cristofanilli, MD|312-503-5488|Massimo.cristofanilli@nm.org|
310514|NCT02774798|University Hospital of South Manchester|Nick Heywood|+447739002473|nheywood@doctors.org.uk|
310515|NCT02774850|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
310516|NCT02774941|Children's Health - Children's Medical Center, Dallas|Clinical Research Coordinator - Respiratory Care Dept|214-456-1367|gerald.moody@childrens.com|
310517|NCT02775240|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
310518|NCT02775344|Queen Mary Hospital|Dr Manwa Lui|22554647|ellenlui@hku.hk|
310519|NCT02775617|London School of Hygiene and Tropical Medicine|Dr Michael Marks|02079272566|michael.marks@lshtm.ac.uk|
310520|NCT02775864|Columbia University|Dr. Scott Stroup|646-774-8435|Scott.Stroup@nyspi.columbia.edu|
310521|NCT02775903|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
310522|NCT02775916|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
310523|NCT02776033|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310524|NCT02776553|University of Arkansas for Medical Sciences|Arny A. Ferrando, Ph.D.|501-526-5711|aferrando@uams.edu|
310525|NCT02776644|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
310526|NCT02776670|Alcon, A Novartis Division|Head, CDMA Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
310527|NCT02776683|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310528|NCT02776774|Surgical Outcomes Research Center - SORCE|Dr. Amy Cizik - Research Assistant Professor, Ph.D., M.P.H.,|206-744-4631|amorgan2@uw.edu|
310529|NCT02776904|University of Arkansas for Medical Sciences|Dr. Charlotte Yates|501-450-5542|cyates@uca.edu|
310530|NCT02777021|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
310531|NCT02777086|Texas Christian University|Wayne E.K. Lehman, Ph.D.|18172577226|w.lehman@tcu.edu|
310532|NCT02777125|University of Tennessee Health Sciences College of Medicine/Le Bonheur Children's Hospital|Mark Snider DO, Principal Investigator|9012875986|marksnider02@hotmail.com|
310533|NCT02777242|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
310534|NCT02777268|Simbec Research Limited|Dr Girish Sharma|+44 1443 690977||
310535|NCT02777333|University of Oxford|Mr P Garfjeld Roberts|01865 227374|patrick.garfjeldroberts@ndorms.ox.ac.uk|
300753|NCT01975090|Novate Medical|Gordon Crowley|+353 91 750 030|gordon.crowley@novate.ie|
300754|NCT01975220|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300755|NCT01975246|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291064|NCT01340976|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291065|NCT01341067|Rocky Mountain Diabetes and Osteoporosis Center|Mark Sulik, PharmD CCRP|208-528-9642|mark@idahomed.com|
291066|NCT01341301|Thomas Jefferson University|Dr. Neal Flomenberg|215-955-8874|neal.flomenberg@jefferson.edu|
291067|NCT01341444|Medstar Georgetown University Hospital|Dr. Matthew Cooper|202-444-0753|Matthew.Cooper@gunet.georgetown.edu|
291068|NCT01341457|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
291069|NCT01341470|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291070|NCT01341639|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291071|NCT01341652|University of Wisconsin Carbone Cancer Center|Douglas McNeel|608-263-4198|dm3@medicine.wisc.edu|
300756|NCT01975285|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Roya Yumul, M.D., Ph.D.|310-423-5841|(Roya.Yumul@cshs.org)|
291072|NCT01341730|The Catholic University of Korea|Dr. Eun Ho Choo|82-10-8500-4569|cmcchu@catholic.ac.kr|
300757|NCT01975376|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300758|NCT01975389|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300759|NCT01975428|Scripps Translational Science Institute|Eric J. Topol, M.D.|858-554-5708|etopol@scripps.edu|
300760|NCT01975519|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
300761|NCT01975675|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
300762|NCT01975701|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novatis.com|
300763|NCT01975831|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@lcr.org|
300764|NCT01975909|Beth Israel Deaconess Medical Center|Brad Manor, Ph.D.|617-971-5332|bmanor@bidmc.harvard.edu|
300765|NCT01975922|Vanderbilt University|Ann Kaiser|615-322-8163|ann.kaiser@vanderbilt.edu|
300766|NCT01975935|University of Michigan|Dr. Elif Oral|7346157271|eliforal@med.umich.edu|
300767|NCT01975948|Dalhousie University, Department of Psychiatry|Dr. Bianca Lauria-Horner|902-473-5633|bianca.horner@dal.ca|
300768|NCT01975974|University of Iowa Hospitals and Clinics|Dr. Kenichi Ueda|319-356-2633|kenichi-ueda@uiowa.edu|
300769|NCT01976104|Eisai Call Center|Eisai Inc.|888-422-4743|esi_medinfo@eisai.com|
300770|NCT01976299|Osprey Medical, Inc|Michele Shepard, Vice President of Clinical Affairs|9529558236|mshepard@ospreymed.com|
300771|NCT01976312|Novartis|Study Director|862-778-8300||
300772|NCT01976338|Novartis|Study Director|862-778-8300||
300773|NCT01976364|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300774|NCT01976390|Division of Transplant Surgery OSUMC|Director of Research Operations|614-293-8021|brenda.cuson@osumc.edu|
300775|NCT01976416|Indiana University|Dr Chandy John|317-274-8940|chjohn@iu.edu|
310536|NCT02777554|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
310537|NCT02777749|Columbia University Medical Center|Dr. Matthew Grosso|2123058193|mgrosso13@gmail.com|
310538|NCT02777827|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
310539|NCT02777918|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
310540|NCT02777931|Aevi Genomic Medicine|Garry A Neil, MD|610-254-4208|garry.neil@aevigenomics.com|
310541|NCT02777944|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
310542|NCT02777970|Menarini Ricerche|Dr. Angela Capriati (Clinical Sciences Director)|+39 055 5680|acapriati@menarini-ricerche.it|9933
310543|NCT02778074|Linkoping University|Dr Peter Johansson|0460700896548|peter.b.johansson@liu.se|
310544|NCT02778100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
310545|NCT02778113|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
310546|NCT02778152|The Research Institute at Nationwide Children's Hospital|Dr. Peter Minneci|614-722-3066|peter.minneci@nationwidechildrens.org|
310547|NCT02778555|Stanford University|Dr. Beth Darnall, Clinical Associate Professor, Division of Pain Medicine|(650) 721-2104|bdarnall@stanford.edu|
310548|NCT02778867|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513-636-7177|marc.rothenberg@cchmc.org|
310549|NCT02778880|Cincinnati Children's Hospital Medical Center|Theresa Frey, MD|513-636-7966|theresa.frey@cchmc.org|
310550|NCT02778932|University Hospital Schleswig-Holstein, Campus Kiel|Priv.-Doz. Dr. med. Axel Fudickar|0049500|axel.fudickar@uksh.de|20801
310551|NCT02779075|Mayo Clinic|Adrian Vella|507-202-8490|vella.adrian@mayo.edu|
310552|NCT02779166|Northwestern Univeristy Department of Orthopaedic Surgery|Dr. Michael Terry|312-926-4444||
310553|NCT02779491|Bournemouth University|Prof. Katherine Appleton|+441202965985|k.appleton@bournemouth.ac.uk|
310554|NCT02779543|Weill Cornell Medical College|Dr. Ana Krieger|6469629316|ack2003@med.cornell.edu|
291073|NCT01341782|Abbvie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
291074|NCT01341912|Octapharma|VP of Clinical Research and Development|+41 554512141|sigurd.knaub@octapharma.com|
291075|NCT01341977|Alcon Research, Ltd.|Alcon Clinical|888.451.3937; 817.568.6725|medinfo@alconlabs.com|
291076|NCT01341990|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
291077|NCT01342029|Cedars-Sinai Medical Center|C.Noel Bairey Merz, MD|310-423-9680|merz@cshs.org|
291078|NCT01342081|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
291079|NCT01342094|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
291080|NCT01342107|Alcon Research, Ltd.|Director of Alcon Clinical|1-888-451-3937|medinfo@alconlabs.com|
291081|NCT01342172|Icahn School of Medicine at Mount Sinai|Dr. Matthew Galsky|212-241-8816|matthew.galsky@mssme.edu|
300776|NCT01976442|University of Rochester Medical Center|Neil Blumberg MD|(585) 275-3189|neil_blumberg@urmc.rochester.edu|
300777|NCT01976507|Vanderbilt University Medical Center|Christopher Ellis||christopher.ellis@Vanderbilt.Edu|
300778|NCT01976572|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
300779|NCT01976624|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
300780|NCT01976650|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
300781|NCT01976663|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
300782|NCT01976728|Ferring Pharmaceuticals|Clinical Development Support|+1 833-548-1402|DK0-Disclosure@ferring.com|
300783|NCT01976741|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
300784|NCT01976806|Beth Israel Deaconess Medical Center|Dr. Kenneth Mukamal|617-754-1401|kmukamal@bidmc.harvard.edu|
300785|NCT01976819|University Medical Center Groningen and University of Groningen|Prof. Dr. Bernard F.A.M. van der Laan, PhD, MD|0031 (50) 361 27 00|b.f.a.m.van.der.laan@umcg.nl|
300786|NCT01976845|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Dr. Ronald H Wender|3104231682|ronald.wender@cshs.org|
300787|NCT01976871|Massachusetts General Hospital|Dr. John W. Winkelman|617-643-9101|jwwinkelman@partners.org|
300788|NCT01976975|McLean Hospital|David Crowley|6178554432|djcrowley@mclean.harvard.edu|
300789|NCT01976988|Cedars Sinai Medical Center|Phillip Fleshner MD|310-289-9224|pfleshner@aol.com|
300790|NCT01977040|Mednax. Inc|Kimberly Maurel|714593-9171|kimberly_maurel@mednax.com|
300791|NCT01977092|Public Health Institute|Elizabeth Mahoney|(818)310-2684|lmahoney@bhrsca.org|
300792|NCT01977222|Boston Children's Hospital|Dr. Fred Wu|6173556508|fred.wu@cardio.chboston.org|
300793|NCT01977352|Icahn School of Medicine at Mount Sinai|Dr. Ali Shariat||alishariatmd@gmail.com|
310555|NCT02780115|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
310556|NCT02780167|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
310557|NCT02780349|Gardia Medical|Vardit Segal Ph.D|972-4-6277166|vardit@gardiamedical.com|
310558|NCT02780388|Viela Bio|Viela Bio Clinical Operations|+1 240-558-0038|ClinicalTrials@VielaBio.com|
310559|NCT02780622|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
310560|NCT02780661|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310561|NCT02780687|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310562|NCT02780700|Boehringer Ingelheim|Boehringer IIngelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310563|NCT02780713|AstraZeneca AB|AZD9496 Global clinical leader|+46317761000|ClinicalTrialTransparency@astrazeneca.com|
310564|NCT02780765|Tata Memorial Hospital, Mumbai|Dr Vijaya Patil|+91-2224177000|vijayappatil@yahoo.com|7048
310565|NCT02780856|Calcivis Ltd|Director of Clinical Research|+ 44 131 658 5152|mwillins@calcivis.com|
310566|NCT02780869|Biom'up|Rachel Hoffman, Vice President Clinical Operations North America|404-702-9253|r.hoffman@biomup.com|
310567|NCT02781051|UT Southwestern Medical Center|Chad Rethorst, Associate Professor|2146480153|chad.rethorst@utsouthwestern.edu|
310568|NCT02781311|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
310569|NCT02781324|Children's Hospital Colorado|Eun Kim, Spine Research Assistant|720-777-8026|eun.kim@childrenscolorado.org|
310570|NCT02781454|University of Washington|Dr. Michael D. Weiss|206-598-7688|mdweiss@uw.edu|
310571|NCT02781480|MeiraGTx|Chief Medical Officer|+1 973 609-2156|robert.zeldin@meiragtx.com|
310572|NCT02781558|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
310573|NCT02781571|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
310574|NCT02781610|Seattle Children's|Michelle Skalland (Biostatistician)|206-884-7519|michelle.skalland@seattlechildrens.org|
310575|NCT02781649|Johns Hopkins University|Christine Durand, MD|410-955-5684|cdurand2@jhmi.edu|
310576|NCT02781818|UNC Dermatology|Dr. Christopher Sayed|984-974-3900|christopher_sayed@email.unc.edu|
310577|NCT02781844|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
310578|NCT02782065|Boston Children's Hospital|Leah Abecassis|6173552299|leah.abecassis@childrens.harvard.edu|
310579|NCT02782169|University of Hawaii|Family Planning Department|808-983-6000|hawaiimedab@gmail.com|
310580|NCT02782325|University of North Carolina at Chapel Hill|Hans Herfarth, MD|919-966-6806|hherf@med.unc.edu|
310581|NCT02782364|University Hospital of South Manchester|Karen Telford|01612916654|karen.telford@uhsm.nhs.uk|
310582|NCT02782377|University Hospital of South Manchester|Nick Heywood|+447739002473|nheywood@doctors.org.uk|
310583|NCT02782676|Abbott Medical Optics, Inc.|Kendra Hileman, Ph.D., Head of Clinical Sciences|714-247-8613|kendra.hileman@abbott.com|
310584|NCT02782741|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
310585|NCT02782780|San Francisco VA Health Care System|Dr. Linda Chao|415-221-4810|linda.chao@va.gov|24386
291082|NCT01342211|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291083|NCT01342341|Ernest Gallo Clinic and Research Center|Dr. Jennifer Mitchell, Clinical Project Director|510-985-3921|jmitchell@gallo.ucsf.edu|
291084|NCT01342367|The University of Chicago|Dr. Stanley Liauw|7737026870|sliauw@radonc.uchicago.edu|
291085|NCT01342445|University of Rhode Island|Dr. Lisa Weyandt|(401)874-2087|lisaweyandt@uri.edu|
291086|NCT01342458|University of Sao Paulo|Dr. Francis Trombini-Souza|55 11 3091 8426|trombinisouza@usp.br|
291087|NCT01342471|National Cancer Institute|Jeremy Steeves Ph.D.|(865)-308-3506|jeremy.steeves@nih.gov|
291088|NCT01342484|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291089|NCT01342510|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|Kristopher Schroeder, MD|608-263-8100|kmschro1@wisc.edu|
291090|NCT01342523|University of Wisconsin|Stevens Smith, PhD|608-262-7563|sss@ctri.wisc.edu|
300794|NCT01977456|University of Cincinnati|Dr. Opeolu Adeoye|513-558-3117|opeolu.adeoye@uc.edu|
300795|NCT01977482|GlaxoSmithKline|GSK Response Center|866-435-7343||
300796|NCT01977547|Washington University School of Medicine|Dr. Philip C. Spinella|3142860858|pspinella@wustl.edu|
300797|NCT01977573|GlaxoSmithKline|GSK Response Center|866-435-7343||
300798|NCT01977599|UCL|Dr Robert Kerrison, Senior Research Fellow|02076798268|Robert.kerrison.13@ucl.ac.uk|
300799|NCT01977612|Washington University School of Medicine|Lindsay Kuroki, M.D.|314-362-2368|kurokil@wustl.edu|
300800|NCT01977625|University of Pennsylvania|C. Neill Epperson, M.D|215-573-8871|cepp@mail.med.upenn.edu|
300801|NCT01977651|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
300802|NCT01977677|Stanford University School of Medicine|Lawrence Recht, MD, Professor of Neurology|650-725-8630|lrecht@stanford.edu|
300803|NCT01977690|Johann Wolfgang Goethe University|Stephan Duetzmann|001491781470479|stephan.duetzmann@gmail.com|
300804|NCT01977781|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana, MD, MPH|617-573-4331|reza_dana@meei.harvard.edu|
300805|NCT01977794|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
300806|NCT01977820|BioMarin Pharmaceutical Inc.|Medical Information Services|+1-800-983-4587|medinfo@bmrn.com|
300807|NCT01977846|Foundation Fighting Blindness|Chief Scientific Officer|410-423-0600|info@FightBlindness.org|
300808|NCT01977898|Northwestern University|Feyce Peralta, MD|312-472-3585|f-peralta@northwestern.edu|
300809|NCT01977937|OHSU|Dr Elizabeth Pedigo|5039705211|pedigo@ohsu.edu|
300810|NCT01978093|GlaxoSmithKline|GSK Response Center|866-435-7343||
300811|NCT01978119|GlaxoSmithKline|GSK Response Center|866-435-7343||
300812|NCT01978145|GlaxoSmithKline|GSK Response Center|866-435-7343||
310586|NCT02782923|NYU Langone Madison Avenue Orthopaedics|Yong H. Kim, MD|212-427-3986|Yong.Kim@nyulangone.org|
310587|NCT02783027|University of Pittsburgh|Dr. Daniel Patterson|412-864-3830|pdp3@pitt.edu|
310588|NCT02783066|Baylor College of Medicine|Prof.Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
310589|NCT02783170|Duke University|Dr. Geeta Swamy|919-681-5220|geeta.swamy@duke.edu|
310590|NCT02783443|University Hospital Hradec Kralove|Dr. David Astapenko|+420608177374|astapenko.d@seznam.cz|
310591|NCT02783469|University of Dundee|Professor Blair H. Smith|01382383795|b.h.smith@dundee.ac.uk|
310592|NCT02783573|AstraZeneca|AstraZeneca Information Center|1-877-240-9479|information.center@astrazeneca.com|
310593|NCT02783599|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
310594|NCT02783729|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
310595|NCT02783768|CUIMC|Elizabeth C. Oelsner, MD, MPH|212-305-9056|eco7@cumc.columbia.edu|
310596|NCT02783820|Medicines for Malaria Venture|Dr Cristina Donini|+41 22 555 0312|doninic@mmv.org|
310597|NCT02783898|NHS Lothian|Dr Matt Reed|+44 131 242 1448|Matthew.Reed@nhslothian.scot.nhs.uk|
310598|NCT02783911|LomaLindaU|Dr. Jung-Wei Chen, Program director|9095584690|jwchen@llu.edu|85909
310599|NCT02783950|University of Michigan|Todd Morgan, MD|734-647-8902|tomorgan@med.umich.edu|
310600|NCT02784106|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
310601|NCT02784275|NovMetaPharma Co., Ltd|Peter Lee|+82 (0)2 538 1893|Peter@NovMeta.com|
310602|NCT02784431|Cerus Endovascular|Lori E Adels, Ph.D.|510-651-4000|lori.adels@cerusendo.com|109
310603|NCT02784444|Cirius Therapeutics Inc.|Jules Lee|8583336274|jlee@ciriustx.com|514
310604|NCT02784548|VA San Diego Healthcare System|Dr. Thomas Rutledge|8585528585|thomas.rutledge@va.gov|7273
310605|NCT02784587|Maine Medical Center|Research coordinator|2076622862|richaj3@mmc.org|
310606|NCT02784613|San Diego Sexual Medicine|Irwin Goldstein|619-265-8865|dr.irwingoldstein@gmail.com|
310607|NCT02784834|UC San Diego|Dr. Michael Choi|(858) 534-1765|mychoi@ucsd.edu|
310608|NCT02784925|WanFangH|Ming-Shun Wu|88629307930|mswu@tmu.edu.tw|7923
310609|NCT02785159|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
310610|NCT02785172|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
310611|NCT02785185|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
310612|NCT02785354|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310613|NCT02785406|The University of Texas Health Science Center at Houston|Scott Lane|713-486-2535|Scott.D.Lane@uth.tmc.edu|
310614|NCT02785432|UT Southwestern|Jason Zafereo|146481002|jason.zafereo@utsouthwestern.edu|146481002
310615|NCT02785458|Northwestern University|Dr. Michael S. Wolf, PhD MPH|312-503-5592|mswolf@northwestern.edu|
300813|NCT01978184|UPMC Hillman Cancer Center|Barbara Stadterman|412-647-5554|stadtermanbm@upmc.edu|
310616|NCT02785588|GE Healthcare|Yvonne Celestial|+33 130709133|MarieYvonne.CELESTIAL@ge.com|
310617|NCT02785770|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
310618|NCT02785900|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
291091|NCT01342549|Michael E. DeBakey VAMC|Dr. Ricardo Jorge|713-794-7010|ricardo.jorge@va.gov|
291092|NCT01342640|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
291093|NCT01342666|Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran (INCMNSZ)|Favorable effect of tomato consumption on HDL-c serum levels|525555133891|shiverqks@hotmail.com|
291094|NCT01342757|Emory University School of Medicine|Jeffrey J. Olson, MD|404-778-3091|jolson@emory.edu|
291095|NCT01342770|Mayo Clinic|Dennis Wigle, M.D., Ph.D.|507-284-2511|wigle.dennis@mayo.edu|
291096|NCT01342796|Novartis Vaccines and Diagnostics|Posting Director||Novartis.email@novartis.com|
291097|NCT01342887|Fred Hutch Cancer Research Center|Roland B. Walter, MD, PhD, MS||rwalter@fredhutch.org|
291098|NCT01342913|GlaxoSmithKline|GSK Response Center|866-435-7343||
291099|NCT01342926|GlaxoSmithKline|GSK Response Center|866-435-7343||
291100|NCT01342965|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
300814|NCT01978236|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
300815|NCT01978262|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
300816|NCT01978314|University of Alabama, Birmingham|Dana Victor Rizk, M.D.||drizk@uab.edu|
300817|NCT01978509|Mayo Clinic|Dr. Francisco Ramirez|(480) 301-6990|Ramirez.Francisco@mayo.edu|
300818|NCT01978600|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
300819|NCT01978743|Boston University School of Medicine|Dr. Nina Lin|617-414-5242|nina.lin@bmc.org|
300820|NCT01978912|Teijin America, Inc.|President|+1-212-308-8744|clinical-trials-safety@teijinpo.com|
300821|NCT01979016|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
300822|NCT01979029|First Hospital of Jilin University|Jian Suo|0431-88785605|suojian42@hotmail.com|
300823|NCT01979133|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146466948|sherwood.brown@utsouthwestern.edu|
300824|NCT01979159|VA Salt Lake City Health Care System|Dr. Julie Wambaugh|801-582-1565|julie.wambaugh@va.gov|1363
300825|NCT01979185|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
300826|NCT01979276|Weill Cornell Medical College|Jennifer Hess|646-962-9440|jmh2004@med.cornell.edu|
300827|NCT01979445|The Medicines Company|Global Health Science Center, The Medicines Company|1-888-977-6326|medical.information@themedco.com|
300828|NCT01979523|Memorial Sloan Kettering Cancer Center|Dr. Alexander Shoushtari|646-888-4161|shoushta@mskcc.org|
300829|NCT01979614|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300|novartis.email@novartis.com|
300830|NCT01979835|principal investigator|Ellen Wiebe|6047095611|ellenwiebe@gmail.com|
300831|NCT01979952|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300832|NCT01980056|Weill Cornell Medicine|Clinical Trials Administrator|212-746-0284|ray2013@med.cornell.edu|
300833|NCT01980095|RedHill Biopharma|Dr. Ira Kalfus|1-917-817-7517|ira@redhillbio.com|
310619|NCT02785913|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
310620|NCT02785939|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
310621|NCT02786004|GE Healthcare|Beth Heckel|262-312-7269|beth.heckel@med.ge.com|
310622|NCT02786134|Brigham and Women's Hospital|Dr. Marcelo Di Carli|617-732-6290|mdicarli@bwh.harvard.edu|
310623|NCT02786355|UBC Department of Anesthesia - BC Women's Hospital|James Taylor|604-875-2424|james.taylor1@phsa.ca|6076
310624|NCT02786498|University of Maryland Baltimore, School of Medicine, Department of Orthopaedics|Dr Gerard Slobogean|410-28-6280|gslobogean@som.umaryland.edu|
310625|NCT02786719|Baylor College of Medicine|Sarah Whittle, MD MS|8328241471|whittle@bcm.edu|
310626|NCT02786771|Partners Connected Health Innovation|Odeta Dyrmishi - Acting Project Manager|6177243605|odyrmishi@partners.org|
310627|NCT02786810|University of Tennessee Health Science Center|Dr. David Hains|9012874876|dhains@uthsc.edu|
310628|NCT02786836|UT Southwestern Medical Center at Dallas|William M. Lee, MD|(214) 645-6110|William.Lee@UTSouthwestern.edu|
310629|NCT02786901|Bausch Health|Study Manager|(908) 242-8287|sandra.narain@bauschhealth.com|
310630|NCT02786927|GlaxoSmithKline|GSK Response Center|866-435-7343||
310631|NCT02786953|Vanderbilt University Medical Center|Sarah S Jaser|6153436775|sarah.jaser@vumc.org|
310632|NCT02787057|Peking University First Hospital|Dr. Jie Dong|+86 010 66551708|jie.dong@bjmu.edu.cn|
310633|NCT02787083|Philadelphia Urosurgical Associates, PC|Kristene E Whitmore MD|215-704-1457|bladder1@aol.com|
310634|NCT02787291|Abbott CAHF CRM|Dr. Adam Cline- Clinical Scientist|818-493-2025|adam.cline@abbott.com|
310635|NCT02787304|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
310636|NCT02787551|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
310637|NCT02787564|University of Hohenheim|Prof. Dr. Nanette Ströbele-Benschop|+49711 459 24260|N.Stroebele@uni-hohenheim.de|24260
310638|NCT02787655|Atl VA|Joe Nocera|404 321 6111|joe.nocera2@va.gov|206354
310639|NCT02787681|Loma Linda University|H. Bryant Nguyen, MD|909-558-4000|hbnguyen@llu.edu|
310640|NCT02787694|University of Alabama at Birmingham|David A. Brown, PT, PhD|205-975-2788|dbrownpt@uab.edu|
310641|NCT02787863|Samara State Medical University, Institute of Sera and Vaccines RAS|Professor Andrei Dmitrievich Protasov, Professor Mikhail Petrovich Kostinov|+79277444126|crosss82@mail.ru|
310642|NCT02788019|UT Southwestern Medical Center|Anthony Machi, MD, Assistant Professor|214-648-6400|Anthony.Machi@UTSouthwestern.edu|
310643|NCT02788097|Antalya IVF|Kevin Coetzee|090 242 345 4700|kevincoetzee61@yahoo.co.nz|
310644|NCT02788175|NIAID|Dr. Michael C. Sneller|301-496-0491|MSNELLER@niaid.nih.gov|
310645|NCT02788188|National Institute of Allergy and Infectious Diseases|Davey, Richard|+1 301 496 8029|rdavey@niaid.nih.gov|
310646|NCT02788201|National Cancer Institute|Dr. Andrea Apolo|301-480-0536|apoloab@nih.gov|
291101|NCT01343004|Radius Health, Inc.|Program Director|(617) 551-4700|info@radiuspharm.com|
310647|NCT02788279|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
291102|NCT01343043|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
300834|NCT01980485|Penn State University|Jonathan Foulds|717-531-3504|jfoulds@psu.edu|
291103|NCT01343056|University of Pittsburgh|Linda Siminerio, PhD|412-864-0158|simineriol@upmc.edu|
291104|NCT01343082|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
291105|NCT01343095|Wake Forest Baptist Health|Matthew C. Miles|336-716-7765|mmiles@wakehealth.edu|
291106|NCT01343160|W.L. Gore & Associates|Rizwan Afzal|623-234-5408|rafzal@wlgore.com|
291107|NCT01343251|St John Hospital and Medical Center|Dr. Robert Provenzano|313-886-8787|Rprovenzano@scsp.net|
291108|NCT01343277|Janssen Research & Development, LLC|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
291109|NCT01343368|Masonic Cancer Center, University of Minnesota|Dr. Angela Smith|612-626-8094|smith719@umn.edu|
291110|NCT01343407|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300835|NCT01980524|Medical University of Vienna|Dr. Peter Wolf|004314040043110|peter.wolf@meduniwien.ac.at|
300836|NCT01980589|Amgen, Inc.|Study Director|866-572-6436||
300837|NCT01980628|Pharmacyclics, LLC|Isaiah Dimery, MD, Senior Medical Director|408-215-3579|idimery@pcyc.com|
300838|NCT01980654|Pharmacyclics|Dr. Jutta Neuenburg|408-215-3735|jneuenburg@pcyc.com|
300839|NCT01980706|University of North Carolina at Chapel Hill|James C Garbutt, MD|984-974-2201|jc_garbutt@med.unc.edu|
300840|NCT01980771|State University of New York, Downstate Medical Center|Tracey Wilson, Principal Investigator|718 270 2105|Tracey.Wilson@downstate.edu|
300841|NCT01980888|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
300842|NCT01980914|Gerontology Research Unit|Boris Feldman|6048755115|boris.feldman@vch.ca|
300843|NCT01980992|Icahn School of Medicine at Mount Sinai|Dr. Hugh A. Sampson|212-659-9426|hugh.sampson@mssm.edu|
300844|NCT01981057|Medical University of Vienna|Nadja Haiden M.D.|+4314040032320|nadja.haiden@meduniwien.ac.at|
300845|NCT01981109|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
300846|NCT01981122|Dendreon|Shabnam Vaziri|206.455.2323|svaziri@Dendreon.com|
300847|NCT01981187|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300848|NCT01981356|Center for Innovation to Implementation, VA Palo Alto HCS|Matthew Boden, Ph.d.|650-493-5000|Matthew.Boden@va.gov|27529
310648|NCT02788357|University of Kentucky|Dr. Lumy Sawaki||lsawa2@uky.edu|
310649|NCT02788474|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310650|NCT02788513|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310651|NCT02788656|Brigham and Women's Hospital|Akshay Desai|617-732-7046|adesai@bwh.harvard.edu|
310652|NCT02788747|Stealth BioTherapeutics Inc.|Jim Carr PharmD Chief Clinical Development Officer|617-600-6888|jim.carr@stealthbt.com|
310653|NCT02788903|Penn State College of Medicine|Jennifer Kraschnewski|717-531-8161|jkraschnewski@pennstatehealth.psu.edu|
310654|NCT02789033|Universidad de Guadalajara|PhD. Leonel García Benavides|+52 (33) 20 00 23 00|drleonelgb@hotmail.com|64096
291111|NCT01343485|Planned Parenthood Federation of America|Zoe Unger, Research Program Coordinator|212-261-4702|zoe.unger@ppfa.org|
291112|NCT01343667|W. L. Gore & Associates|Bryan Randall, Clinical Biostatistician|928-864-4832|BRandall@WLGore.com|
291113|NCT01343693|Zimmer Biomet Spine|Zimmer Biomet Spine Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
291114|NCT01343823|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
291115|NCT01343888|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291116|NCT01343901|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
291117|NCT01344057|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
291118|NCT01344161|Tehran University of Medical Sciences|Dr.Farzad Shidfar|09123082922|f-shidfar@tums.ac.ir|
291119|NCT01344226|Discover Vision Centers|Melissa Morrison Toyos|8164781230|mtoyos@discovervision.com|
291120|NCT01344356|Mercy Research|Mercy Research Manager - Regulatory Operations|314-251-8827|michelle.bryant@mercy.net|
300849|NCT01981473|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300850|NCT01981564|Johns Hopkins University School of Medicine, Department of Pediatrics|Dr. Arlene Butz|410-614-5963|abutz@jhmi.edu|
300851|NCT01981590|Medtronic Bakken Research Center|Lilian Kornet, Prin.Scientist|+31433566710|lilian.kornet@medtronic.com|
300852|NCT01981616|Millennium Pharmaceuticals Inc.|Medical Director|800-778-2860|clinicaltrialregistry@tpna.com|
300853|NCT01981759|NYU Langone Health|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
300854|NCT01981772|The Ohio State University College of Dentistry|Sara Fowler|6142923596|fowler.276@osu.edu|
300855|NCT01981863|Stanford University Medical Center|Peter van der Starre|6507236412|pieterva@stanford.edu|
300856|NCT01981954|Astellas Pharma Europe B.V.|Medical Director|+31 (0) 715455050|astellas.resultsdisclosure@astellas.com|
300857|NCT01981967|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
300858|NCT01982123|University of Washington Medical Center|Dr. Jing Zeng|2065984110|jzeng13@uw.edu|
300859|NCT01982240|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
300860|NCT01982292|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
300861|NCT01982331|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
300862|NCT01982435|Cleveland Clinic Foundation|Dr. Justis Ehlers|216-636-0183|Ehlersj@ccf.org|
300863|NCT01982448|Dana-Farber Cancer Institute|Clinical Trials Office|617-632-5313|ctopm@dfci.harvard.edu|
300864|NCT01982539|Depomed|Clinical Operations||clinicaltrials@depomed.com|
300865|NCT01982643|UCLA Integrated Substance Abuse Programs|Walter Ling, MD|310-267-5888|lwalter@ucla.edu|
300866|NCT01982682|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Dolores Grosso|215-955-0182|dolores.grosso@jefferson.edu|
300867|NCT01982695|Nationwide Children's Hopsital|Dr. Jerry R. Mendell|(614) 722-5615|Jerry.Mendell@NationwideChildrens.org|
310655|NCT02789111|University of Virginia Department of Aneshtesiology|Bhiken Naik MD|434-924-2283|BIN4N@hscmail.mcc.virginia.edu|
310656|NCT02789137|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
310657|NCT02789176|University of Michigan|Stephanie Rau|734-232-8474|shatchew@med.umich.edu|
310658|NCT02789410|Mayo Clinic|Dr. Hans P. Sviggum|507-284-9697|sviggum.hans@mayo.edu|
310659|NCT02790073|Sanifit|Rekha Garg MD MS|18582815978|rekha.garg@sanifit.com|
310660|NCT02790281|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
310661|NCT02790437|Hansa Biopharma AB|Elisabeth Sonesson, Director Clinical Operations|+46 (0)708 54 86 46|elisabeth.sonesson@hansabiopharma.com|
310662|NCT02790463|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
310663|NCT02790606|C.R. Bard|Talar Saber, Clinical Project Manager|480-379-2839|talar.saber@crbard.com|
310664|NCT02790736|NY State Psychiatric Institute|Franklin Schneier MD|6467748041|fschneier@nyspi.columbia.edu|
310665|NCT02790788|National and Kapodistrian University of Athens|Associate Professor in Intensive Care Medicine|00302132043307|sdmentzelopoulos@yahoo.com|
310666|NCT02791191|Eli Lilly and Company|Chief Medical Officer|800-545-5079|Clinicaltrials.gov@lilly.com|
310667|NCT02791269|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
310668|NCT02791308|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
310669|NCT02791399|VA Portland Health Care System|Benjamin Morasco, PhD|5032208262|benjamin.morasco@va.gov|
310670|NCT02791438|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
310671|NCT02791490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
310672|NCT02791516|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
310673|NCT02791659|Gastroenterology endoscopy center|Phonthep Angsuwatcharakon, MD|6622564265|borndeb@yahoo.com|
310674|NCT02791763|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|7343
310675|NCT02791893|Mount Sinai Beth Israel, New York, NY|Dr. Benjamin Natelson|212-844-6768|Benjamin.Natelson@mountsinai.org|
310676|NCT02791906|University of Pennsylvania|Associate Professor|2152007779|julio.chirinos@uphs.upenn.edu|
310677|NCT02791945|University of California, San Francisco/San Francisco VA Healthcare System|Dr. Steven L. Batki, MD|415-221-4810|steven.batki@ucsf.edu|23671
310678|NCT02792049|Brooke Army Medical Center|Dr. Michael D. April|(210) 916 - 0808|Michael.D.April@post.harvard.edu|
310679|NCT02792062|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
310680|NCT02792192|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
310681|NCT02792218|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
310682|NCT02792231|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
310683|NCT02792504|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300868|NCT01982773|National Center for Telehealth and Technology|Nigel E. Bush, PhD|253-968-4153|nigel.e.bush.civ@mail.mil|
291121|NCT01344369|Teva Pharmaceuticals, USA|Associate Director, Biopharmaceutics|1-866-384-5525|clinicaltrialqueries@tevausa.com|
291122|NCT01344447|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
300869|NCT01982786|Canadian cancer trials group|Dr. Keyue Ding|1-613-533-6000|kding@ctg.queensu.ca|77705
291123|NCT01344460|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
291124|NCT01344538|University of Michigan|Suzanna M Zick|734-998-9553|szick@umich.edu|
291125|NCT01344616|PHCC LP|James G. Christian|7195468633|jim@phcclp.com|
291126|NCT01344629|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291127|NCT01344759|Cincinnati Children's Hosptial Medical Center|Dr. Mohamed Mahmoud|513-636-4408|Mohamed.Mahmoud@cchmc.org|
291128|NCT01344824|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
291129|NCT01344876|Otsuka Pharmaceutical Co., Ltd|"Leader of Department of Small Global Clinical Development"|+81-3-6361-7366||
291130|NCT01345019|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
300870|NCT01982812|University of Rochester|Gretchen L. Birbeck|585-273-4265|gretchen_birbeck@urmc.rochester.edu|
300871|NCT01982942|Medicinova Inc|Director, Medical Writing|8582468680|makhay@medicinova.com|
300872|NCT01982955|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
300873|NCT01982968|University of California, San Francisco|Harold Collard, MD|415 4761000|Harold.Collard@ucsf.edu|
300874|NCT01983020|Beth Israel Medical Center|Ronald Kaplan, MD||rkaplan@chpnet.org|
300875|NCT01983111|Mundipharma Korea Ltd.|PhD. Miyoung Song||miyoung.song@mundipharma.co.kr|
300876|NCT01983228|Minneapolis Veterans Affairs Health Care System|Dr. Diana Burgess, Principal Investigator|612-467-1591|diana.burgess@va.gov|
300877|NCT01983254|Duke University|Christopher Cox, PI|9196817232|christopher.cox@duke.edu|
300878|NCT01983293|Abbott|Clay Cohorn|1 972 309 8087|clay.cohorn@abbott.com|
300879|NCT01983553|Sanofi Pasteur SA|Director||Contact-US@sanofi.com|
300880|NCT01983566|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
300881|NCT01983683|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
300882|NCT01983787|Aarhus University Hospital, Department of infectious diseases|Kristina Öbrink-Hansen|+4578452845|krisoebr@rm.dk|
300883|NCT01983826|University of Iowa|Dr. Darren P. Casey||darren-casey@uiowa.edu|
300884|NCT01983839|Aarhus University Hospital, Department of infectious diseases|Dr Kristina Öbrink-Hansen|+4578452845|krisoebr@rm.dk|
300885|NCT01983878|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
300886|NCT01983930|UCLA|Helen Lavretsky, M.D.|310-794-4619|hlavretsky@mednet.ucla.edu|
300887|NCT01983969|UT MD Anderson Cancer Center|Nieto, Yago / Stem Cell Transplantation and Cellular Therapy|713-792-8750|ynieto@mdanderson.org|
310684|NCT02792517|Amgen Inc.|Study Director|866-572-6436||
310685|NCT02792699|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
310686|NCT02792777|Thomas Jefferson|Kristin L Rising, MD MS|215-503-5507|kristin.rising@jefferson.edu|
310687|NCT02792829|Eisai Inc.|Eisai Medical Research Inc.|1-888-422-4743|esi_medinfo@eisai.com|
310688|NCT02792959|Institute Bergonie|Dr. Anne Laure Cazeau, Coordinating Investigator|0556337860|A.Cazeau@bordeaux.unicancer.fr|
310689|NCT02793128|UroGen Pharma Ltd.|Madlen Malinowski|6467689533|madlen.malinowski@urogen.com|
310690|NCT02793154|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310691|NCT02793232|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
310692|NCT02793622|University of California, San Francisco|Grant Dorsey, MD|628-206-4680|grant.dorsey@ucsf.edu|
310693|NCT02793674|Presbyterian Hospital|Thomas Weiler, MD|505-724-7044|tweiler@gmail.com|
310694|NCT02793817|Kala Pharmaceuticals, Inc.|Head, Clinical Operations|781-996-5252|Results005@kalarx.com|
310695|NCT02793856|West China Hospital, Sichuan University|You Lu|+862885423571|283494287@qq.com|
310696|NCT02793947|University of Iowa Hospitals and Clinics|Dr. Michael Willey|319-384-8452|michael-willey@uiowa.edu|
310697|NCT02794103|Université de Montréal|Dr. Sylvie Le May, Professor & Researcher|514 345-4931|sylvie.lemay@umontreal.ca|4938
310698|NCT02794207|Children's Hospital of Philadelphia|Dr. Richard Aplenc|267-426-7252|aplenc@email.chop.edu|
310699|NCT02794246|Univ. of Pennsylvania|Emerging Med|855-216-0098|penncancertrials@emergingmed.com|
310700|NCT02794441|Children's Hospital of Eastern Ontario Research Institute|Dr. Roger Zemek|6137377600|rzemek@cheo.on.ca|3931
310701|NCT02794480|GlaxoSmithKline|GSK Response Center|866-435-7343||
310702|NCT02794597|Denver Health & Hospital Authority|Deborah Rinehart|303-602-2743|deborah.rinehart@dhha.org|
300888|NCT01984164|Emory University|Dr. Hajjar|404-712-2036|ihabhajjar@emory.edu|
310703|NCT02794727|Mayo Clinic|Sanjeev Nanda, MD|507-284-2511|nanda.sanjeev@mayo.edu|
310704|NCT02794766|Universidade de Passo Fundo|Prof. Fernando Fornari|+555433168395|fernandofornari@gmail.com|
291131|NCT01345058|Brigham and Women's Hospital|Jong Woo Lee, MD, PhD||JLEE38@BWH.HARVARD.EDU|
291132|NCT01345123|Health Dialog|David R Veroff, MPP, SVP Analytic Development|617-406-5219|dveroff@healthdialog.com|
291133|NCT01345162|IRCCS Policlinico S Matteo|Dr Massimo Allegri|00390382502627|massimo.allegri@unipv.it|
291134|NCT01345188|Midwest Cardiovascular Research Foundation|Dr Nicolas W Shammas|5633242828|shammas@mchsi.com|
291135|NCT01345253|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
291136|NCT01345292|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
291137|NCT01345318|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291138|NCT01345513|Ontario Institute for Cancer Research|Janet E. Dancey|1-613-533-6430|janet.dancey@oicr.on.ca|
291139|NCT01345591|University of Pittsburgh|J. Peter Rubin|412-624-9703|rubipj@upmc.edu|
291140|NCT01345630|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
300889|NCT01984229|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
300890|NCT01984242|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
300891|NCT01984294|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
300892|NCT01984398|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
300893|NCT01984424|Amgen Inc.|Study Director|866-572-6436||
300894|NCT01984515|Center for Integrated Healthcare|Dr. Kyle Possemato|315-425-4400|kyle.possemato@va.gov|53551
300895|NCT01984684|Melinta Therapeutics, Inc.|Sue Cammarata (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
300896|NCT01984697|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300897|NCT01984892|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
300898|NCT01985126|Janssen Research & Development, LLC|Senior Director Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
300899|NCT01985321|Benu BioPharma, Inc.|Dr. Eric M. Morrel|5082085634|emorrel@benubio.com|
300900|NCT01985334|Novartis Pharmaceuticals|Study Director|862-778-8300||
300901|NCT01985360|NYU Langone Health|Sripal Bangalore|(212) 263 3540|Sripal.Bangalore@nyulangone.org|
300902|NCT01985425|Population Health Research Institute|Dr. Philip Devereaux|905-527-4322|philipj@mcmaster.ca|40654
300903|NCT01985542|Helsinki University Hospital|Dr. Sanna Salmi|+358505431421|sanna.salmi@helsinki.fi|
300904|NCT01985581|Center for Pediatric Excellence|Dr. Judy van Stralen|613-726-7355|judyvanstralen@bellnet.ca|
300905|NCT01985685|Beth Israel Deaconess Medical Center|Dr. Katherine Berg|617-667-5864||
300906|NCT01985763|Icahn School of Medicine at Mount Sinai|Dr. Sofya Pintova|212-824-8461|Sofya.Pintova@mountsinai.org|
300907|NCT01985932|University of Pennsylvania|Curtiland Deville, MD|215-662-2428|deville@uphs.upenn.edu|
300908|NCT01985958|University of Pennsylvania|Edgar Ben-Josef, M.D.|215-662-3932|Edgar.Ben-Josef@uphs.upenn.edu|
300909|NCT01985971|University of Pennsylvania|Lilie Lin, MD|215-662-7267|lin@xrt.upenn.edu|
300910|NCT01986010|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300911|NCT01986062|Arbor Pharmaceuticals|Dr. Steve Caras|(470) 235-2327|scaras@arborpharma.com|
300912|NCT01986101|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
300913|NCT01986114|Sumitomo Dainippon Pharmaceutical|Clinical Research|+81-3-5159-2519|cc@ds-pharma.co.jp|
300914|NCT01986140|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
300915|NCT01986231|Legacy Health System|Kenneth Ward|971-570-2632|kenward503@msn.com|
300916|NCT01986348|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
300917|NCT01986361|Reckitt Benckiser Inc.|Gail Solomon, Director, Clinical Development|973-404-2752|gail.solomon@rb.com|
300918|NCT01986647|University of Pittsburgh|Jennifer S. Brach, PhD, PT|412-383-6533|jbrach@pitt.edu|
300919|NCT01986686|Stony Brook Medicine|Roberto Bergamaschi, MD, PhD|631-638-2215|roberto.bergamaschi@stonybrookmedicine.edu|
300920|NCT01986790|Washington University's School of Medicine|Mary C. Politi, PhD|314-747-1968|politim@wudosis.wustl.edu|
300921|NCT01986829|Washington University School of Medicine|Brian Van Tine, M.D.|314-362-5817|bvantine@wustl.edu|
300922|NCT01986855|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300923|NCT01986881|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
300924|NCT01986907|Novartis Pharmaceuticals|Study Director|+41613241111|trialandresults.registries@novartis.com|
300925|NCT01986920|Aclaris Therapeutics|Christopher Powala, Chief Operating Officer|484-324-7933|cpowala@aclaristx.com|
300926|NCT01986946|Duke University Hospital|Dr. Erin Manning|919-681-3551|erin.manning@duke.edu|
300927|NCT01986985|GE Healthcare|Terri Hanlon, Clinical Affairs Project Manager|609-578-0173|terri.hanlon@GE.com|
300928|NCT01987089|Crescenz VA Medical Center|Subhajit Chakravorty|(215)-823-5800|Subhajit.Chakravorty@va.gov|
300929|NCT01987102|Isofol Medical AB|Chief Medical Officer|+46 (0)702433750|karin.ganlov@isofolmedical.com|
300930|NCT01987219|NYU School of Medicine|Dr. Horacio Kaufmann|212 263 7225|horacio.kaufmann@nyumc.org|
300931|NCT01987232|Amgen Inc.|Study Director|866-572-6436||
300932|NCT01987349|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
300933|NCT01987401|Department of Veterans Affairs, Office of Research and Development|Dr. Nicholas L. Smith, Director of Seattle Cooperative Studies Program|2067642773|nicholas.smith@va.gov|
300934|NCT01987414|University of Minnesota|Chih-Huang Yu|6126262443|yuxxx648@umn.edu|
300935|NCT01987427|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
300936|NCT01987453|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
291141|NCT01345669|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291142|NCT01345682|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291143|NCT01345721|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
291144|NCT01345929|Cubist Pharmaceuticals, Inc.|Dr. Obi Umeh, Vice President Global Medical Sciences|781-860-8415|obiamiwe.umeh@cubist.com|
291145|NCT01346059|Beaumont Health|Rose Callahan|248 551-5147|rose.callahan@beaumont.org|
291146|NCT01346072|University of North Carolina Chapel Hill|Kirkwood F. Adams, Jr., MD|919-966-2877|kfa@med.unc.edu|
291147|NCT01346085|Ospedale San Raffaele|Dr Lorenzo Piemonti|+390226432706|piemonti.lorenzo@hsr.it|
291148|NCT01346176|University of Pennsylvania School of Medicine|Scott D. Halpern|215.573.9461|elcooney@exchange.upenn.edu|
300937|NCT01987479|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
300938|NCT01987505|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
300939|NCT01987557|WilfridLU|Matthew Lasswell|9056992087|lass3260@mylaurier.ca|
300940|NCT01987583|Ministry of Health|Dr. Nouran Aleyeidi|00966504304577|dr.nouran@live.com|
300941|NCT01987596|Barbara Ann Karmanos Cancer Institute|Dr. Maxim Yankelevich|313-745-5515|myankele@med.wayne.edu|
300942|NCT01987609|UCSD Medicine|Director of Clinical Trials Unit|858-657-8322|dermstudies@Ucsd.edu|
300943|NCT01987752|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
300944|NCT01987765|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
300945|NCT01987817|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
300946|NCT01987830|Massachusetts General Hospital|Dr. Elizabeth Gerstner|(617) 726-2000|EGERSTNER@mgh.harvard.edu|
300947|NCT01987895|Actelion Pharmaceuticals Ltd|Clinical Trial disclosure Desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
300948|NCT01987908|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
310705|NCT02794844|Nemours Children's Hospital|James P. Franciosi, MD|407-567-3832|jfrancio@nemours.org|
310706|NCT02794870|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
310707|NCT02794974|HELIOS Medical Center Schwerin, Germany|Ronald Seidel|+49 385 5204251|ronald.seidel@helios-kliniken.de|
310708|NCT02795117|Perrigo|Jonathan Schwartz|718-960-9900|jonathan.schwartz@perrigo.com|
310709|NCT02795767|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
310710|NCT02795780|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
310711|NCT02795819|Virginia Commonwealth University Massey Cancer Center|Andrew Poklepovic, MD|877-462-7739|AskMassey@vcu.edu|
310712|NCT02795832|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
310713|NCT02796092|GITMI (University of Zaragoza)|Prof. Alicia Laborda|0034 976 76 15 49|alaborda@unizar.es|
310714|NCT02796144|University of North Carolina at Chapel Hill|Lars Fredrik Jarskog, MD|919-843-7683|lars_jarskog@med.unc.edu|
310715|NCT02796274|Santhera Pharmaceuticals|Vanessa Dos Reis Ferreira|+41 61 906 89 50|office@santhera.com|
310716|NCT02796300|UCLA Medical Center|Principal Investigator|310-267-8771|EdwardLee@mednet.ucla.edu|
310717|NCT02796352|University of Pittsburgh Cancer Institute|Barbara Stadterman, Regulatory Supervisor|(412) 647-5554|stadtermanbm@upmc.edu|
310718|NCT02796560|University of Sherbrooke|Dr Marjorie Carbonneau|819-346-1110|Marjorie.Carbonneau@USherbrooke.ca|22180
310719|NCT02796625|University of Maryland Baltimore|Dr. David Seminowicz|14107063476|dseminowicz@umaryland.edu|
310720|NCT02796651|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
310721|NCT02796664|Asan Medical Center|Dr. Dae Chul Suh|+82-2-3010-4366|dcsuh@amc.seoul.kr|
310722|NCT02796677|AstraZeneca AB|Global Clinical Leader|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
310723|NCT02796755|Emory University|Andrew H Miller, MD|404-727-8260|amill02@emory.edu|
310724|NCT02796924|University of Manitoba|Dr. Mandana Modirrousta|2042372303|mmodirrousta@sbgh.mb.ca|
310725|NCT02796963|UNC Project-China|Dr. Weiming Tang|+86-21-83755824|weimingtangscience@gmail.com|
310726|NCT02797054|University of Colorado|Julie A Maertens|303-724-7319|julie.maertens@ucdenver.edu|
310727|NCT02797080|Horizon Pharma Ireland, Ltd, Dublin, Ireland|Julie Ball, MS, Executive Director, Clinical Development & Operations|(224) 383-3000|clinicaltrials@horizonpharma.com|
310728|NCT02797132|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
310729|NCT02797171|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
310730|NCT02797522|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
310731|NCT02797613|Memorial University|Peter Daley|7097250240|pkd336@mun.ca|
310732|NCT02797678|Philips Respironics|Senior Data Manager|7243877949|Jeff.Jasko@philips.com|
310733|NCT02797808|University of Minnesota|Dr. Gail Bernstein|612-625-1632|berns001@umn.edu|
310734|NCT02797821|Alexion Pharmaceuticals|Alexion Pharmaceuticals|475-230-2596|ClinicalTrials@Alexion.com|
310735|NCT02798211|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
310736|NCT02798289|Allergan, Inc.|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
310737|NCT02798315|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
310738|NCT02798354|Children's Hospital at Montefiore and Albert Einstein College of Medicine|Dr. Michael Rinke|718-741-2597|mrinke@montefiore.org|
310739|NCT02798380|Hallux, Inc.|Thomas M Tremblay, RN BSN, Vice President of Clinical Affairs|(415) 305-3491|ttremblay@halluxinc.com|
310740|NCT02798627|University of Pennsylvania Perelman School of Medicine|Kyle Kampman, MD|2157462764|kampman@pennemdicine.upenn.edu|
310741|NCT02798835|Department of Anesthesia and Perioperative Care, Vancouver General Hospital, Vancouver, BC, Canada.|Dr. Steven Lee|6048754111|steven.lee2@vch.ca|61534
310742|NCT02798861|University of Pittsburgh|Andres Duarte-Rojo|412-647-7922|duarterojoa@pitt.edu|
310743|NCT02798952|GlaxoSmithKline|GSK Response Center|866-435-7343|eg763112@gsk.com|
291149|NCT01346189|University of Pennsylvania and Department of Veteran Affairs|Dr. Kevin G. Volpp||volpp70@wharton.upenn.edu|
291150|NCT01346267|Wake Forest University School of Medicine|Thomas W. McLean, MD|336-716-4085|tmclean@wfubmc.edu|
300949|NCT01987960|A/S|H. Lundbeck||LundbeckClinicalTrials@Lundbeck.com|
300950|NCT01987986|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquires@endo.com|
300951|NCT01988012|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
300952|NCT01988090|Baylor College of Medicine|Tao Wang|7137985388|taow@bcm.edu|
300953|NCT01988103|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
300954|NCT01988129|Brigham and Women's Hospital|Steven W. Lockley PhD|16177324977|slockley@hms.harvard.edu|
300955|NCT01988246|Cole Eye Institute - Cleveland Clinic|Rishi Singh, MD|216-445-9497|singhr@ccf.org|
300956|NCT01988376|Far Eastern Memorial Hospital|Hsiao, Sheng-Mou|(02)89667000|smhsiao2@gmail.com|1424
300957|NCT01988402|San Antonio Military Medical Center|Jay B Higgs,|2109160797|jay.b.higgs.civ@mail.mil|
300958|NCT01988415|Abbott Medical Optics|Janice Tarrant|408-273-4163|janice.tarrant@abbott.com|
300959|NCT01988493|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
300960|NCT01988662|Novartis Pharmaceuticals|Study Director|862-778-8300||
300961|NCT01988779|UR Medicine Otolaryngology|Research Program Manager|5852751186|paul_allen@urmc.rochester.edu|
300962|NCT01988857|GlaxoSmithKline|GSK Response Center|866-435-7343||
300963|NCT01988922|Washington University in St. Louis School of Medicine|Dr. Lesley K Rao|3143690683|raol@wustl.edu|
300964|NCT01989130|University of California-Davis|Larissa May, MD|916-736-5010|lsmay@ucdavis.edu|
300965|NCT01989156|Philip Morris Products S.A.|Christelle Haziza, PhD|+41 (58) 242 2625|Christelle.Haziza@pmi.com|
300966|NCT01989169|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
300967|NCT01989195|Stanford University|Phillip C. Yang, MD|650-498-8008|phillip@stanford.edu|
300968|NCT01989208|Sulfagenix|President and CEO|1-318-349-3851|tgiordano@sulfagenix.com|
300969|NCT01989221|TempleU|Dr. Henry Parkman|2157072498|henry.parkman@temple.edu|
300970|NCT01989455|ApoPharma Inc.|Caroline Fradette, PhD|416-401-7543|cfradett@apopharma.com|
300971|NCT01989468|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
300972|NCT01989546|National Cancer Institute|Dr. Alice P. Chen|240-781-3274|chenali@mail.nih.gov|
300973|NCT01989572|ECOG Statistical Office|Study Statistician|617-632-3012||
300974|NCT01989689|Emory University|Arshed Ali Quyyumi MD/FACC|404-727-3655|aquyyum@emory.edu|
300975|NCT01989754|Janssen Research & Development, LLC|Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
300976|NCT01989793|Johns Hopkins University|Dr. Jeremy D. Walston, M.D. , Raymond and Anna Lublin Professor of Geriatric Medicine|410-550-1003|jwalston@jhmi.edu|
300977|NCT01989910|Taipei Veterans General Hospital|Dr. WEN-WEI KU|+886228751997|stephaneku@gmail.com|
300978|NCT01989975|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
300979|NCT01990261|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
300980|NCT01990300|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
300981|NCT01990313|Stanford University|Chioma Anidi|6507236709|chioma.anidi@stanford.edu|
300982|NCT01990339|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
300983|NCT01990495|VA Palo Alto Health Care System|Dr. Jonathan Myers|6504503440|Drj993@aol.com|
300984|NCT01990534|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
300985|NCT01990560|Ichan School of Medicine at Mount Sinai|Dr. Alice C. Levine|212-241-1500|alice.levine@mountsinai.org|
300986|NCT01990573|Washington University School of Medicine|Dr. Anshuman Sharma|314-457-3147|sharma.a@wustl.edu|
300987|NCT01990612|Northwestern University|Dr. William Grobman|312-472-4661|w-grobman@northwestern.edu|
300988|NCT01990664|Johnson & Johnson Vision Care, Inc.|Jurandir Araujo, Clinical Compliance Manager|9044431379|jaraujo7@its.jnj.com|
300989|NCT01990677|Wills Eye|Mitchell Fineman,MD|215-928-3092|research@midatlanticretina.com|
300990|NCT01990703|University of Utah, Department of OBGYN|Dr. David Turok|801-581-6170|david.turok@hsc.utah.edu|
300991|NCT01990742|University of Rochester|Dr. Helena Temkin-Greener|585-275-8713|Helena_Temkin-Greener@urmc.rochester.edu|
300992|NCT01990768|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
300993|NCT01990794|Cardno|Dr. David Galbraith|415-618-3211|david.galbraith@cardno.com|
300994|NCT01990820|NorthShore University HealthSystem|Dr. Mark Gerber|847-504-3300|mgerber@northshore.org|
300995|NCT01990859|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
300996|NCT01990898|Cleveland Clinic|Dr. Daniel Shoskes||dshoskes@gmail.com|
300997|NCT01990950|Cook Research Incorporated|Alan Saunders, MS, RAC; Manager, Biostatistics|765-463-7537|alan.saunders@cookmedical.com|321204
300998|NCT01991197|Clinical Research Centre, St Vincent's University Hospital, Dublin, Ireland|Dr Maeve Lynch||maeve.lynch2@hse.ie|
300999|NCT01991314|Barts Health NHS Trust|Prof David Rampton|+442035943500|d.rampton@qmul.ac.uk|7885
301000|NCT01991470|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
301001|NCT01991483|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
301002|NCT01991522|St. Michael's|Dr. Samir C. Grover|416-864-5628|samir.grover@utoronto.ca|
301003|NCT01991548|Medtronic Diabetes|Clinical Research Manager|818-576-5000||
301004|NCT01991743|Northwestern University|Dr. Robert J McCarthy|312-695-4976|r-mccarthy@northwestern.edu|
291151|NCT01346293|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
291152|NCT01346371|Minnesota Eye Consultants, P.A.|Ahmad Fahmy, OD|612-813-3665|amfahmy@mneye.com|
291153|NCT01346397|Boris Petrovsky research cener od surgery|Dr Michael Kaabak|+74992481344|kaabak@hotmail.com|
291154|NCT01346410|Mercy|Dr Kathy Baglan|3144345886|kathy.baglan@mercy.net|
291155|NCT01346475|University of Washington|Dr. Christine Johnston|206-520-4340|cjohnsto@u.washington.edu|
291156|NCT01346488|AbbVie|Global Medical Information|800-633-9110||
291157|NCT01346501|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
291158|NCT01346514|VA Puget Sound|Carol Malte|206.277.3780|carol.malte@va.gov|
291159|NCT01346540|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291160|NCT01346592|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
291161|NCT01346683|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
291162|NCT01346696|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
291163|NCT01346774|University of Michigan|Betsy Foxman, Hunein F. and Hilda Maassab Professor of Epidemiology|734-764-5487|bfoxman@umich.edu|
291164|NCT01346839|Michael E. DeBakey VA Medical Center and Baylor College of Medicine|Dr. Hardeep Singh|713-794-8515|hardeeps@bcm.edu|
301005|NCT01991795|Study Information Center|Global Clinical Lead|+1-877-240-9479|information.center@astrazeneca.com|
301006|NCT01991808|University of Pennsylvania|Lilie Lin, MD|215-622-6515|lin@uphs.upenn.edu|
301007|NCT01991821|Acacia Pharma|Dr Gabriel Fox|01223875130|GabrielFox@acaciapharma.com|149
301008|NCT01991860|Acacia Pharma Ltd|Dr Gabriel Fox|44-(0)1223-919764|Gabrielfox@acaciapharma.com|
301009|NCT01991977|Mayo Clinic|Nadia N. Laack, MD|507/284-2511|Laack.Nadia@mayo.edu|
301010|NCT01991990|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301011|NCT01992016|University of Colorado Cancer Center|Elaine Lam, MD|7208480273|elaine.lam@ucdenver.edu|
301012|NCT01992094|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
301013|NCT01992107|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
301014|NCT01992159|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
301015|NCT01992172|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
301016|NCT01992185|Physicians Institute|Sharon Keene, MD|(520) 290-5555|monican@appliedbiology.com|
301017|NCT01992354|GE Healthcare|John Strohmeyer|+1 609 865 7423|john.strohmeyer@ge.com|
301018|NCT01992380|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
301019|NCT01992523|Careggi Hospital|Guido Parodi|00390557947732|parodiguido@gmail.com|
301020|NCT01992536|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
301021|NCT01992549|Octapharma|Sylvia Werner|415 260-9577|sylvia.werner@octapharma.com|
301022|NCT01992757|University of Pennsylvania Hospital|Rupa Chowdary|215-615-4105|rupa.chowdary@uphs.upenn.edu|
301023|NCT01992874|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
301024|NCT01993017|Center for Behavioral Cardiovascular Health|Ian Kronish, MD, MPH, Principal Investigator|212-342-1335|ik2293@columbia.edu|
301025|NCT01993030|The Second Xiangya Hospital of Central South University|Dr. Li Qian|+86-13958104032|649418291@qq.com|
301026|NCT01993108|University of Michigan|Chandra Sripada|734 232 0281|sripada@umich.edu|
301027|NCT01993186|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8657|medinfo@ultragenyx.com|
301028|NCT01993238|Solta Medical|Director of Clinical Programs|510-259-5284|aloncaric@solta.com|
301029|NCT01993329|Merck, Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301030|NCT01993615|Madigan Army Medical Center|Daniel Rhon|253-968-0780|daniel.i.rhon.ctr@mail.mil|
301031|NCT01993667|University of Utah|Dr. Scott McIntosh, MD, MPH|801-581-2730|Scott.McIntosh@hsc.utah.edu|
301032|NCT01993823|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+39933946470|ejimenezv@salvatbiotech.com|
301033|NCT01993836|Duke University|Miles Berger, MD, PhD|919-684-8679|miles.berger@duke.edu|
301034|NCT01993849|Medical University of South Carolina|Kevin M. Gray, M.D.|843-792-6330|graykm@musc.edu|
301035|NCT01993875|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
301036|NCT01993888|Ethicon, Inc.|Senior Director of Ethicon Clinical R&D|908-218-2492|jbatill2@its.jnj.com|
301037|NCT01993927|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
301038|NCT01993940|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|1454
301039|NCT01994109|Solstice Neurosciences|Regulatory Affairs Associate||regulatoryaffairs@usworldmeds.com|
301040|NCT01994226|Keele University|Sponsor|01782|research.governance@keele.ac.uk|734882
301041|NCT01994291|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
301042|NCT01994395|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
301043|NCT01994486|UNIVERSITY OF FLORIDA|Giuseppe (Joseph) Morelli, MD|352-273-9467|GIUSEPPE.MORELLI@MEDICINE.UFL.EDU|
301044|NCT01994538|Minneapolis VA Health Care System|Dimitri Drekonja, MD, MS|612 467 4183|dimitri.drekonja@va.gov|
301045|NCT01994590|UT MD Anderson Cancer Center|Corn,Paul,M.D. Ph.D. / Genitourinary Medical Oncology|713-792-2830|PCorn@mdanderson.org|
301046|NCT01994629|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
310744|NCT02798978|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310745|NCT02799069|Biofrontera Bioscience GmbH|Dr. Beate Schmitz|+49 214 876 32|b.schmitz@biofrontera.com|41
310746|NCT02799082|Biofrontera Bioscience GmbH|Dr. Beate Schmitz|+49 214 876 32|b.schmitz@biofrontera.com|41
310747|NCT02799290|Tampere University Hospital|Ilkka Kaartinen|505687096|ilkka.kaartinen@pshp.fi|
310748|NCT02799381|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
310749|NCT02799472|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310750|NCT02799667|Tufts Medical Center|Ashley T. Peterson, MD, Study Coordinator|617-636-5000|apeterson@tuftsmedicalcenter.org|2382
291165|NCT01346852|GlaxoSmithKline|GSK Response Center|866-435-7343||
291166|NCT01346969|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291167|NCT01347008|Federal University of Sao Paulo|Fernando Villela Andrigueti, MD|+55 11 55764239|fernando.andrigueti@usp.br|
291168|NCT01347034|H. Lee Moffitt Cancer Center and Research Institute|Alberto Chiappori, M.D.|813-745-3050|alberto.chiappori@moffitt.org|
291169|NCT01347060|GlaxoSmithKline|GSK Response Center|866-435-7343||
291170|NCT01347073|Hyperion Therapeutics, Inc.|Craig James R.N. Associate Dir. UCD Clinical Operations|(650) 745- 7480|craig.james@hyperiontx.com|
291171|NCT01347086|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291172|NCT01347112|Mayo Clinic|Dr. Richard Hurt|507-284-7313|rhurt@mayo.edu|
291173|NCT01347255|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
291174|NCT01347307|Mercy Research|Lead Regulatory Coordinator - Investigator Initiated Trials|314-251-8827|michelle.mcfarland@mercy.net|
291175|NCT01347333|Mercy Research|Michelle McFarland, MPH, CHRC|314-251-8827|michelle.mcfarland@mercy.net|
301047|NCT01994720|AstraZeneca R&D|Brilinta Global Clinical Lead|+46 31 776 10 00||
301048|NCT01994746|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
310751|NCT02799745|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
310752|NCT02799784|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310753|NCT02800148|Perrigo|Associate Director|718-960-9900|jonathan.schwartz@perrigo.com|
310754|NCT02800213|San Antonio Uniformed Services Health Education Consortium|Dr. Michael D. April|2109160808|Michael.D.April@post.harvard.edu|210
291176|NCT01347541|University of Washington School of Medicine|Dr, Douglas Zatzick|206-744-6701|dzatzick@uw.edu|
291177|NCT01347554|Yonsei University Wonju College of Medicine|Dr. Seung-Hwan Lee|+82-33-741-0920|carshlee@yonsei.ac.kr|
291178|NCT01347580|AstraZeneca|Dr Tomas Andersson MD|00 46 31 77 61966|tomas.lg.andersson@astrazeneca.com|
291179|NCT01347710|Lantheus Medical Imaging|CMO|978-671-8544|c.orlandi@lantheus.com|
291180|NCT01347762|Beth Israel Deaconess Medical Center|Kevin P. Hill, M.D., M.H.S., Principal Investigator|617 667 1597|khill1@bidmc.harvard.edu|
291181|NCT01347788|Massachusetts General Hospital|Matthew R Smith, MDPhD|617-763-3748|smith.matthew@mgh.harvard.edu|
291182|NCT01347866|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291183|NCT01347879|Virginia Clinical Research, Inc.|Dr David Pariser|757-625-0151|dpariser@pariserderm.com|
301049|NCT01994785|Cleveland Clinic|John Vargo|216 445-5012|vargoj@ccf.org|
291184|NCT01347931|Clinical Reseach Consulting|Richard J. Morishige, MS, RRT|510-606-0375|rjmorishige@gmail.com|
291185|NCT01348087|Novartis Pharmaceuticals|Study Director|862-778-8300||
301050|NCT01994837|AbbVie|Global Medical Services|800-633-9110||
301051|NCT01994850|University of Pennsylvania Abramson Cancer Center|Jakub Svoboda, MD|855-216-0098|PennCancerTrials@emergingmed.com|
301052|NCT01994863|Coloplast A/S|Director Clinical Affairs||dkdac@coloplast.com|
301053|NCT01994876|Coloplast A/S|Director of Clinical Affairs|+45 4911 25 23|dkdac@coloplast.com|
301054|NCT01994889|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
301055|NCT01994902|Coloplast A/S|Medical Director|+45 49111395|dkbir@coloplast.com|
301056|NCT01994954|University of Massachusetts Medical School|Dr. Lawrence Rhein|508-334-6206|Lawrence.Rhein@umassmemorial.org|
301057|NCT01994993|Duke University Medical Center|Michael Cohen-Wolkowiez, M.D|9196688812|michael.cohenwolkowiez@duke.edu|
301058|NCT01995045|Emory University|Dr. Timothy Olsen|404-778-4996|tolsen@emory.edu|
301059|NCT01995071|AbbVie|Global Medical Services|800-633-9110||
301060|NCT01995123|Center for Tobacco Research and Intervention, University of Wisconsin School of Medicine and Public Health; William S Middleton Memorial Veterans Hospital|Jessica Cook, PhD|608-265-9775|jwcook@ctri.wisc.edu|
301061|NCT01995136|Alcon Japan, Ltd.|Senior Manager, Phase IV|1-888-451-3937|alcon.medinfo@alcon.com|
301062|NCT01995201|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
301063|NCT01995266|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|clinical.trials@bms.com|
301064|NCT01995357|Coloplast A/S|MD, Medical Director|+45 4911 1395|dkbir@coloplast.com|
301065|NCT01995461|Marshfield Clinic Research Foundation|Dr. Rachel Stankowski|715-389-3442|stankowski.rachel@mcrf.mfldclin.edu|
301066|NCT01995487|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
301067|NCT01995513|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
301068|NCT01995526|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
301069|NCT01995539|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
301070|NCT01995552|India Medtronic Pvt. Ltd.|Vinay Rajan Ph.D|+91 22.3307.4700|vinay.rajan@medtronic.com|
301071|NCT01995825|U of Maryland|James Polli|410-706-8292|jpolli@rx.umaryland.edu|
301072|NCT01995838|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
301073|NCT01996033|Abbott|Steven Madej|651-756-2230|steven.madej@abbott.com|
301074|NCT01996241|London School of Hygiene and Tropical Medicine|Dr Tara Beattie|0044 (0)2079272613|tara.beattie@lshtm.ac.uk|
301075|NCT01996254|SPR Therapeutics, Inc.|Clinical Affairs|216-378-9108|support@SPRTherapeutics.com|
301076|NCT01996319|Novartis Pharmaceuticals|Study Director|862-778-8300||
301077|NCT01996332|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301078|NCT01996592|Wake Forest School of Medicine|Jessica L. Booth, MD|336-718-8278|jbooth@wakehealth.edu|
301079|NCT01996644|Washington University|Cheri Levinson|5023456483|cherialevinson@wustl.edu|
301080|NCT01996657|Wuhan Asia Heart Hospital|Dr.Litao Zhang|+862765796888|zhengleetau@qq.com|8204
301081|NCT01996709|Alcon Research, Ltd.|Jessie Lemp, DrPH, GMA Brand Lead|1-888-451-3937|alcon.medinfo@alcon.com|
301082|NCT01996748|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
301083|NCT01996813|Loyola University Medical Center|Douglas Evans, M.D.|708-216-2523|devans@lumc.edu|
301084|NCT01996826|Mass. Eye and Ear|Reza Dana, M.D., M. Sc, MPH|6175734331|Reza_Dana@meei.harvard.edu|
301085|NCT01996839|Bausch Health|Study Director||susan.harris@bauschhealth.com|
301086|NCT01996904|CM Chungmu Hospital|Sang-Hoon Lhee|+82(2)2068/4525|cmirb@naver.com|
301087|NCT01996917|Columbia University|Christine Rohde, MD|212-342-3707|chr2111@cumc.columbia.edu|
301088|NCT01996943|University of California, San Francisco|Dr. Gregory Marcus|(415) 353-2554|Greg.Marcus@ucsf.edu|
310755|NCT02800356|San Raffaele Hospital|Prof. Giuseppe Querques|00390226434004|querques.giuseppe@hsr.it|
310756|NCT02800642|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
310757|NCT02800928|Yale School of Medicine|Sherry McKee PhD|203-737-3529|sherry.mckee@yale.edu|
310758|NCT02801006|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|javega@coopervision.com|
310759|NCT02801370|Otonomy|Medical Information Call Center|1-800-826-6411|medinfo@otonomy.com|
310760|NCT02801396|Johnson & Johnson Vision|Meredith Bishop, OD, MS, FAAO|904-443-1396|MBishop4@its.jnj.com|
310761|NCT02801578|The University of Texas MD Anderson Cancer Center|Prithviraj Bose, MD./Associate Professor|713-792-7747|PBose@mdanderson.org|
310762|NCT02801617|Laboratorios Sophia|Dr. Oscar Olvera|(33) 3001 4200|oscar.olvera@sophia.com.mx|1074
310763|NCT02801669|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
301089|NCT01997125|The Ohio State University|Marcia Bockbrader MD PhD|6142937604|bockbrader.13@osu.edu|
310764|NCT02801877|Northwestern University|Mary Kwasny|312-503-2294|m-kwasny@northwestern.edu|
310765|NCT02801942|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
291186|NCT01348100|Novartis Pharmaceuticals|Study Director|862 778-8300||
291187|NCT01348139|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
291188|NCT01348165|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291189|NCT01348347|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291190|NCT01348425|Cook|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|ssnyder@medinst.com|
291191|NCT01348490|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
291192|NCT01348542|Penn State University College of Medicine|Alexandros Vgontzas|717 531-7278|vgontzas@pennstatehealth.psu.edu|
291193|NCT01348607|SunCoast CCOP Research Base|Cristina Burroughs, Clinical Research Administrator|(813) 396-9237|Cristina.Burroughs@epi.usf.edu|
301090|NCT01997216|Alcon Research, Ltd.|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
301091|NCT01997229|Alexion Pharmaceuticals, Inc.|Jing-Jing Wang, MD|+1 (475) 230-2596|JingJing.Wang@alexion.com|
301092|NCT01997281|Seoul National University College of Medicine|Youn Min Cho, M.D, PhD|+82-2-2072-1965|ymchomd@snu.ac.kr|
301093|NCT01997333|Celldex Therapeutics|Head of Regulatory Affairs|844-723-9363|info@celldex.com|
301094|NCT01997398|Barrow Neurlogical Institute / St. Joseph's Hosptial & Medical Center|Francisco A. Ponce, MD|602-406-3242||
301095|NCT01997411|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
301096|NCT01997437|Kuban State Medical University|Dr. Paolo Macchiarini|+7(928)-268-80-00|pmacchiarini@ksma.ru|
301097|NCT01997515|Rhode Island Hospital|Director of Research|401-444-4933|mark.kendall@lifesapn.org|
301098|NCT01997723|UIllinois|Bharati Prasad|3129968433|bpradsad@uic.edu|
301099|NCT01997892|Amgen Inc.|Study Director|866-572-6436||
301100|NCT01997905|Methodist Hospital Houston|Basel Ramlawi, MD|713-441-5200|basel.ramlawi@gmail.com|
301101|NCT01998243|Hospital severo ochoa|Dr Luis Ramon Rabago Torre|34914818000|lrabagot@gmail.com|8326
301102|NCT01998269|University of North Carolina at Chapel Hill|Dr. Stacy Bailey|919-843-9834|scbailey@unc.edu|
301103|NCT01998360|University of New England|Peter S. Millard, MD, PhD|2078663503|pmillard@mac.com|
301104|NCT01998399|Vanderbilt University|Gordon Bernard, Professor of Medicine, Associate Vice Chancellor for Research|615-343-0077|gordon.bernard@Vanderbilt.Edu|
310766|NCT02802111|Children's Hospital Los Angeles|Dr. Patrick Ross|323-361-7864|pross@chla.usc.edu|
310767|NCT02802241|BIDMC|Anthony Lembo|6176672138|alembo@bidmc.harvard.edu|
310768|NCT02802319|UT Health Science Center at San Antonio|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
310769|NCT02802345|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310770|NCT02802449|Charles Drew University of Medicine and Science|Dr. David Martins|323-568-3353|davidmartins@cdrewu.edu|
310771|NCT02802501|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310772|NCT02802514|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310773|NCT02802735|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
310774|NCT02802865|University of Iowa|Dr. Rachel Mejia|319-356-3143|rachel-mejia@uiowa.edu|
310775|NCT02802878|University of Kansas Medical Center|Dr. Neil Segal|913-945-8985|segal-research@kumc.edu|
310776|NCT02803138|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
310777|NCT02803164|Mayo Clinic|Dr. Mathew Thomas|904-953-2000|thomas.mathew@mayo.edu|
310778|NCT02803229|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frl2@cumc.columbia.edu|
310779|NCT02803580|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310780|NCT02803749|University of Rochester|Dr. Ruth Schneider|584-341-7500|ruth_schneider@urmc.rochester.edu|
310781|NCT02804178|Millendo Therapeutics|Clinical Trial Information|+1 734-845-9000|millendo@millendo.com|
310782|NCT02804399|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|001800781021|ClinicalTrials.gov_Inquiries@pfizer.com|
310783|NCT02804594|University of California San Francisco|Emmanuelle Waubant, MD|415 514 2468|Emmanuelle.Waubant@ucsf.edu|
310784|NCT02804750|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
310785|NCT02804763|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
310786|NCT02805179|University of Michigan|Michelle Kim, MD|734-936-4300|michekim@med.umich.edu|
310787|NCT02805309|Hebrew SeniorLife Marcus Institute for Aging Research|Dr. Dae Hyun Kim, Associate Scientist|617-632-5362|daehyunkim@hsl.harvard.edu|
310788|NCT02805647|Department of Pediatric Orthopedics and Traumatology Medical University of Bialystok|MichałKarpiński|692224714|gufkarp@gmail.com|+48
310789|NCT02805660|Mirati Therapeutics|Tavette Neskorik, Senior Director, Clinical Science|858-332-3552|neskorikt@mirati.com|
310790|NCT02805790|Stealth BioTherapeutics Inc.|Rekha Sathyanarayana, Executive Director, Clinical Operations|617-762-2579|Rekha.Sathyanarayana@stealthbt.com|
310791|NCT02805907|MurciaSalud|Dr. Rubén Andújar-Espinosa|0034669500052|rubemed@hotmail.com|
310792|NCT02805972|University of California San Francisco|Ashley Mason, PhD|415 514 6820|ashley.mason@ucsf.edu|
310793|NCT02806024|University of Washington|Mallory Kremer|206.616.5258|mkremer@uw.edu|
310794|NCT02806232|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
291194|NCT01348698|National Cancer Institute|Dr. Naris Nilubol|301-451-2355|niluboln@nih.gov|
291195|NCT01348763|Imperial College London|Alan Winston|+442033121603|a.winston@imperial.ac.uk|21603
291196|NCT01348776|Syneron Beauty|Doran Rozen, Director of Clinical Affairs|+972-54-7800260|Doran.Rozen@syneron.com|
291197|NCT01348789|Northwestern Memorial Hospital|Dr. Jerome M. Garden|312-280-0891|j-garden@northwestern.edu|
291198|NCT01348828|Endologix|Sripad Bellary, Director Clinical Affairs|9257011628|sbellary@endologix.com|
291199|NCT01348854|Abbott Medical Optics|Carrie Garufis|714-247-8200|carrie.garufis@amo.abbott.com|
291200|NCT01349036|Daiichi Sankyo Inc.|Study Director|908-992-6400|CTRinfo@dsi.com|
291201|NCT01349049|Daiichi Sankyo Inc.|Medical Director|908-992-6400|CTRinfo@dsi.com|
291202|NCT01349114|University of Alabama at Birmingham|David A. Calhoun, MD|205-934-4633|dcalhoun@uab.edu|
291203|NCT01349140|University California San Diego|Brian Ilfeld, MD, MS|1-858-444-5949|bilfeld@ucsd.edu|
301105|NCT01998438|Fuwai Hospital|Dr. Hongwen Ji|+86 13701229553|jihongwen@hotmail.com|
301106|NCT01998477|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
301107|NCT01998581|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
301108|NCT01998633|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
301109|NCT01998737|Bone Index Finland Ltd.|CTO|+358 45 896 2650|janne.karjalainen@boneindex.fi|
301110|NCT01998880|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301111|NCT01998893|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301112|NCT01998906|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301113|NCT01998919|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301114|NCT01998958|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
301115|NCT01998984|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 4494 5888|disclosure@leo-pharma.com|
301116|NCT01999114|Purdue Pharma L.P.|Clinical Leader|800-733-1333|stephen.harris@pharma.com|
301117|NCT01999192|Biotest AG|Xuefei Zhou Manager Strategy & Development|+496103801|xuefei_zhou@biotest.de|1229
301118|NCT01999218|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301119|NCT01999231|Shanghai Public Health Clinical Center|Shuihua Lu|(+86)18930811818|tubercle@gmail.com|
301120|NCT01999322|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
301121|NCT01999335|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
301122|NCT01999348|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
301123|NCT01999400|University of Michigan|Dr. Duxin Sun|734-763-9783|pharmacy.research@umich.edu|
310795|NCT02806414|UCSD Dermatology|Director of Clinical Trials Unit|8586571697|dermstudies@ucsd.edu|
310796|NCT02806505|Hoffmann-La Roche|Medical Communications|800-821-8590|global.trial_information@roche.com|
310797|NCT02806544|Vanderbilt University|Laila Agrawal|615-322-4967|laila.saied@vanderbilt.edu|
310798|NCT02806713|University of Massachusetts UMass Memorial|Michael K Flynn|(508) 856-5152|michael.flynn@umassmemorial.org|
310799|NCT02806726|Johnson & Johnson Surgical Vision, Inc.|Priya Janakiraman|1 714 2478628|djanaki1@its.jnj.com|
310800|NCT02806869|University of Michigan|Dr. Duxin Sun|734-615-8740|duxins@med.umich.edu|
310801|NCT02806895|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
310802|NCT02806908|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
310803|NCT02806947|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
310804|NCT02806973|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
310805|NCT02806986|Grifols Therapeutics LLC|Rhonda Griffin|919-316-6693|rhonda.griffin@grifols.com|
310806|NCT02807259|Karnataka Health Promotion Trust|Prakash Javalkar|+91 80 4040 0200|prakashj@khpt.org|
310807|NCT02807376|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
310808|NCT02807402|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
310809|NCT02807623|Defense Health Agency Immunization Healthcare Division South Atlantic Region Vaccine Safety hub|Laurie Housel|910-432-4015|laurie.a.housel.civ@mail.mil|
310810|NCT02807844|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
310811|NCT02807857|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
310812|NCT02807948|Abbott|Adam M.Cline, MD, MSc.- Principal Scientist|818-493-2025|adam.cline@abbott.com|
310813|NCT02808052|Melinta Therapeutics|Global Health Science Center|1-844-633-6568|medinfo@melinta.com|
310814|NCT02808130|Ondokuz Mayıs University Dentalfaculty Periodontology Dep.|Assoc Prof Muge Lutfioglu|+905063073738|mugelutfioglu@hotmail.com|
310815|NCT02808312|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
310816|NCT02808338|Philips|Clinical Operations Manager|14125423669|jeremy.powers@philips.com|
310817|NCT02808429|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
310818|NCT02808819|AstraZeneca|AstraZeneca Information Center|+1 8002369933|information.center@astrazeneca.com|
310819|NCT02808975|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
310820|NCT02809053|Archigen Biotech Ltd|Medical Director|+44 (0)20 3749 5000|info@archigenbio.com|
310821|NCT02809183|Tricida, Inc.|Medical Information|415-429-7800|medinfo@tricida.com|
310822|NCT02809430|University of Washington|Dr. Sandeep Khot|206-744-3251|skhot@uw.edu|
310823|NCT02809833|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
291204|NCT01349192|University of North Carolina, Chapel Hill|Marianne S. Muhlebach, PI|(1) 919 966 1055|Marianne_Muhlebach@med.unc.edu|
301124|NCT01999465|University of Michigan|Dr. Lynda Yang|7349365017|bpclinic@umich.edu|
301125|NCT01999517|Mount Sinai Medical Center|Gervasio Lamas, MD|305-674-2162|gervasiolamas@gmail.com|
291205|NCT01349231|Yale University, Connecticut Mental Health Center|Dr. Michael Bloch, MD, MS|203-737-4809|michael.bloch@yale.edu|
291206|NCT01349465|Janssen Research & Development, LLC|Study Responsible Scientist||ClinicalTrialDisclosure@its.jnj.com|
291207|NCT01349491|University of Oklahoma Health Sciences Center|Stavros Stavrakis|405-271-9696|stavros-stavrakis@ouhsc.edu|37539
291208|NCT01349569|Johns Hopkins University|Ivan Borrello, MD|4109554967|iborrell@jhmi.edu|
291209|NCT01349660|Sarah Cannon Development Innovations|Charles Davis, RAC||Charles.Davis2@scri-innovations.com|
291210|NCT01349673|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
291211|NCT01349790|Octapharma USA|Michael Eppolito, Director, Clinical Operations Immunology and ICU Medicine|201 604-1155|michael.eppolito@octapharma.com|
291212|NCT01349803|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|973-975-0320|creisner@pearltherapeutics.com|
291213|NCT01349816|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
301126|NCT01999530|Centre for Addiction and Mental Health|Bernard Le Foll|416-535-8501|bernard.lefoll@camh.ca|34772
301127|NCT01999569|Carolinas Healthcare System|Bradley Hurst, M.D., Director of Assisted Reproduction|704-355-3149|bhurst@carolinas.org|
301128|NCT01999777|Proximagen, LLC|David Sequeira,|952-658-7437|dsequeira@proximagen.com|
301129|NCT01999868|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
301130|NCT01999894|Forest Research Institute|Ephraim Katz, PhD / Associate Director|201-427-8000|Ephraim.Katz@frx.com|8169
301131|NCT01999920|NYSPI|Franklin Schneier, MD|6464774-8041|fschneier@nyspi.columbia.edu|
301132|NCT01999946|NYU Langone Health|Joshua Lee, MD MS|646-501-3552|joshua.lee@nyulangone.org|
301133|NCT01999972|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
301134|NCT01999985|H. Lee Moffitt Cancer Center and Research Institute|Thoracic CRO, attn: Dr. Ben Creelan|813-745-3050|ben.creelan@moffitt.org; thoraciccro@moffitt.org|
301135|NCT02000115|Abbott Structural Heart|Alicia Kimber, PhD|224-229-7758|alicia.kimber@abbott.com|
301136|NCT02000154|SymBio Pharmaceuticals|Katsuhisa Goto|+81-3-5472-1127||
301137|NCT02000180|St. Michael's|Dr. Samir C. Grover|4168645628|samir.grover@utoronto.ca|
301138|NCT02000440|GlaxoSmithKline|GSK Response Center|866-435-7343||
301139|NCT02000531|HoffmannLa Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
301140|NCT02000583|University of Kansas Medical Center|Jeffrey M. Burns MD|913-588-0555|jburns2@kumc.edu|
301141|NCT02000622|AstraZeneca|Medical Science Director|1-877-240-9479|clinicaltrialtransparency@astrazeneca.com|
301142|NCT02000752|Fundación Investigación Biomédica Príncipe de Asturas|Beatriz López Garrido (Midwife)|+34 678210013|bealopega@gmail.com|
301143|NCT02000817|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
301144|NCT02000908|University of Minnesota|Peter Argenta MD|612-626-3111|argenta@umn.edu|
301145|NCT02000921|University of Minnesota|Dorothy Hatsukami|612 626-2121|hatsu001@umn.edu|
301146|NCT02000973|First Hospital of China Medical University|Jun Wang|8602483283100|wjun2000@hotmail.com|
301147|NCT02001051|National Cancer Institute|Dr. Dhaval Patel|301-827-4989|pateldt@nih.gov|
301148|NCT02001064|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
310824|NCT02809846|Scripps TSRI|Lase Ajayi|785.218.1643|tajayi@scripps.edu|
310825|NCT02809859|Fisher & Paykel Healthcare|Clinical Research Scientist|+64 9 574 0123|CPAP.TRIAL@fphcare.co.nz|7044
310826|NCT02809911|Regenesis Biomedical|Heather Vander Ploeg|602-4287041|Heather.VanderPloeg@regenesisbio.com|
310827|NCT02809976|Tufts Medical Center|David Romarin, MD Prinicpal Investigator|617 636 7462|drosmarin@tuftsmedicalcenter.org|
310828|NCT02810327|Medical University of South Carolina|Kimberly Brown Foil|843-792-6474|foilk@musc.edu|
310829|NCT02810340|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
310830|NCT02810392|Wake Forest School of Medicine|Cheryl Bushnell, MD|336-713-2983|cbushnel@wakehealth.edu|
310831|NCT02810457|Centus Biotherapeutics Limited|Clinical Trial Information|+353 1 609 7100|Clinical-Trial@centusbio.com|
310832|NCT02810509|Ilsan Paik Hospital Inje University|Keun-Sik Hong, MD, PhD, Prof|82-31-910-7680|nrhks@paik.ac.kr|
310833|NCT02810873|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Mathew Thakur|215-503-7874|mathew.thakur@jefferson.edu|
310834|NCT02810951|Castle Creek Biosciences|Chief Medical Officer|(484) 713-6000|medinfo@castlecreekbio.com|
310835|NCT02810964|Sheppard Pratt|Dr. Faith Dickerson|410-938-4359|fdickerson@sheppardpratt.org|
310836|NCT02811159|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
310837|NCT02811302|Medtronic - MITG, RGI|Melanie Crystal, Sr. Clinical Program Manager|720-435-5737|melanie.crystal@medtronic.com|
310838|NCT02811419|University of California San Francisco|Trilokesh Kidambi|909-973-0629|tkgastromd@gmail.com|
310839|NCT02811445|Tufts University HNRCA|Michael Lustgarten|617-556-3399|Michael.Lustgarten@tufts.edu|
310840|NCT02811640|Ottawa Hospital Research Institute|Dr. Deborah Zimmerman|613-738-8400|dzimmerman@toh.ca|81620
310841|NCT02811861|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_oncmedinfo@eisai.com|
310842|NCT02811913|VA Northeast Ohio Healthcare System|Dr. Svetlana Pundik|(216)791-3800|svetlana.pundik@va.gov|
310843|NCT02811965|Lincoln Memorial University|Jennifer Savage, DNP, APN, FNP-BC||jennifer.savage@lmunet.edu|
310844|NCT02812160|Spatz FGIA Inc.|Jeffrey Brooks MD|1-516-303-0613|jeff@spatzmedical.net|
310845|NCT02812186|Stony Brook University|Dr. Ruchir Gupta|917-443-1263|gupta2005@yahoo.com|
310846|NCT02812238|NHLBI|Dr. Michael N. Sack|301-402-9259|sackm@nih.gov|
310847|NCT02812342|Yale Dermatology - Middlebury|Brett King, MD, PhD, BA, Associate Professor of Dermatology|(203) 737-4825|brett.king@yale.edu|
310848|NCT02812771|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
310849|NCT02813070|GE Healthcare|Paul Sherwin, M.D., PhD|+1-774-843-3888|PaulSherwin@ge.com|
310850|NCT02813265|Kala Pharmaceuticals, Inc|VP, Clinical Development|(781) 996-5252|Results006@kalarx.com|
291214|NCT01349829|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
291215|NCT01349920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291216|NCT01349933|Mayo Clinic|Brigette Buig-Yue Ma, MBBS, FRACP||brigette@clo.cuhk.edu.hk|
291217|NCT01349972|University of North Carolina, Lineberger Comprehensive Cancer Center|Joshua Zeidner|(919) 962-5164|Joshua_Zeidner@med.unc.edu|
291218|NCT01350102|Penn State Milton S. Hershey Medical Center|Nell Blake, DPM|(717) 531-5638|nblake@pennstatehealth.psu.edu|
291219|NCT01350115|Novartis Pharmaceuticals|Study Director|862-778-8300||
291220|NCT01350128|Pearl Therapeutics, Inc|Colin Reisner, MD, FCCP, FAAAAI|650-305-2600|creisner@pearltherapeutics.com|
291221|NCT01350141|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
301149|NCT02001181|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
301150|NCT02001194|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh Patel||mpatel@upenn.edu|
301151|NCT02001558|University of Alabama at Birmingham|Yuying Chen, MD, PhD|205-934-3329|yuyingchen@uabmc.edu|
301152|NCT02001688|Kamada Ltd|Head of Clinical Operations|+972-72-2219172|sharonc@kamada.com|
301153|NCT02001714|Beaumont Health|Ananias C. Diokno, MD||ananias.diokno@beaumont.edu|
301154|NCT02001987|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
301155|NCT02002091|Algiers' university -1- Benyoucef Benkhedda, Faculty of Medicine Meherzi, Algiers.|Dr Wafia- Nadia Nibouche-Hattab|+213771810932|wani16000@yahoo.fr|
301156|NCT02002182|Baylor College of Medicine|Dr. Andrew Sikora|7137983909|Andrew.Sikora@bcm.edu|
301157|NCT02002208|Atopix Therapeutics Limited|Chief Medical Officer|+44 1235 841 522|atopix@atopixtherapeutics.co.uk|
301158|NCT02002221|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
301159|NCT02002494|Toronto Western Hospital/UHN|Emad Al Azazi|416-603-8500|emad.alazazi@uhnresearch.ca|6237
301160|NCT02002533|University of Rochester|Gary Morrow|585-275-9961|gary_morrow@urmc.rochester.edu|
301161|NCT02002650|Xijing hospital of digestive diseases|Hui Luo|862984771536|fmmulh@163.com|
301162|NCT02002689|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
301163|NCT02002702|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
301164|NCT02002767|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
301165|NCT02002832|Sumitomo Pharma (Suzhou) Co., Ltd.|Chief Medical Officer|+86-10-57322070|luo@dsmpharm.com.cn|
301166|NCT02002871|Philips GmbH Innovative Technologies Aachen|Prof. Dr. Matthias Born|+491735321764|matthias.born@philips.com|
301167|NCT02002884|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
301168|NCT02002936|SymBio Pharmaceuticals|Katsuhisa Goto|+81-3-5472-1127||
301169|NCT02002975|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
301170|NCT02003014|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
301171|NCT02003053|University of Kentucky|Dr. Peter Morris|8593235045|peter.morris@uky.edu|
301172|NCT02003183|UCLA Semel Institute for Neuroscience and Human Behavior|Dr. Gary Small|3108250291|gsmall@mednet.ucla.edu|
301173|NCT02003352|Brain Synergy Institute|Frederick R Carrick|321-868-6464|drfrcarrick@post.harvard.edu|
301174|NCT02003365|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
301175|NCT02003391|Alcon Research, Ltd.|Global Brand Leader, Medical Affairs, Glaucoma|1-888-451-3937|alcon.medinfo@alcon.com|
301176|NCT02003404|Loyola University of Chicago|Dr James Swan, MD|708-485-1271|jswan@lumc.edu|
301177|NCT02003508|Melbourne Sexual Health Centre|A/Prof Marcus Chen|+613 93416260|mchen@mshc.org.au|
301178|NCT02003534|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
301179|NCT02003573|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301180|NCT02003625|Massachusetts General Hospital|Bimalangshu Dey, MD, PhD|617-724-1124|BDEY@mgh.harvard.edu|
301181|NCT02003638|University of Pennsylvania|Dr. Emil deGoma|2156156521|emil.degoma@uphs.upenn.edu|
301182|NCT02003898|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
310851|NCT02813421|Children's Hospital Los Angeles|Dr. Jessica Ferris|323-361-4606|jeferris@chla.usc.edu|
310852|NCT02813473|ECRI|Ron van Amsterdam|+31102062802|RvAmsterdam@cardialysis.nl|
310853|NCT02813551|The University of Texas Health Science Center at Houston|Oscar Andres Viteri Molina, MD|(713) 500-6412|Oscar.A.ViteriMolina@uth.tmc.edu|
310854|NCT02813577|Becton Dickinson|Anna Lovas|763-445-2385|anna.lovas@bd.com|
291222|NCT01350245|Thomas Jefferson University|Dolores Grosso, CRNP, DNP|215-955-8874|Dolores.Grosso@jefferson.edu|
291223|NCT01350271|University of Kelaniya|Dr Balachandran Kumarendran|0094112961140|drbkumaran@gmail.com|
291224|NCT01350336|Boston Scientific Corp.|G Mark Grubb|(412) 716-0717|grubbm@bsci.com|
291225|NCT01350388|University of Utah|Srinivasan Beddhu, M.D.|801-585-3810|srinivansan.beddhu@hsc.utah.edu|
291226|NCT01350401|Adaptimmune|Clinical Trials Management||clinicaltrials@adaptimmune.com|
291227|NCT01350414|Boston Scientific|Narinder Shargill|408-635-3907|Narinder.Shargill@bsci.com|
291228|NCT01350453|University of Southampton|Jane Burridge|+44(0)2380 598 885|jhb1@soton.ac.uk|
291229|NCT01350479|VA Maryland Healthcare System|Mary-Claire Roghmann|410-706-0062|mroghman@epi.umaryland.edu|
291230|NCT01350492|William S. Middleton Memorial Veterans Hospital|Aaron J. Stegner, Ph.D.|608-262-1290|aaron.stegner@va.gov|
301183|NCT02003911|Mount Sinai Kravis Children's Hospital|Dr. Lindsey Douglas|2122416500|lindsey.douglas@mssm.edu|
301184|NCT02003963|Pennington Biomedical Research Center|Dr. Amanda Staiano|2257632729|amanda.staiano@pbrc.edu|
301185|NCT02004093|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301186|NCT02004132|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
301187|NCT02004158|Massachusetts General Hospital|Jeff Huffman|617-724-2910|jhuffman@partners.org|
301188|NCT02004236|BrainMech Foundation|Moises Aguilar president of Brainmech Foundation|+447940810382|bigdata4brain@gmail.com|
301189|NCT02004262|Aduro Biotech, Inc.|Corporate Communications|510-848-4400||
301190|NCT02004288|Sestre milosrdnice University Hospital Center Vinogradska 29, Zagreb, Croatia|Orjena Žaja, MD MSc PhD primarius Ass Prof Pediatrics, Pediatric gastroenterologist|P:+38513787342 M:+3859937872|Orjena Žaja <orjenazf@yahoo.com>|
301191|NCT02004353|Cochlear|Jasmin Kaur|+41612058238|jakaur@cochlear.com|
301192|NCT02004366|Emory University|Priyathama Vellanki|404-778-1665|priyathama.vellanki@emory.edu|
301193|NCT02004613|Cleveland Clinic Foundation|Dr. Alparslan Turan|216-445-9857|turana@ccf.org|
301194|NCT02004847|Philips GmbH Innovative Technologies Aachen|Prof. Dr. Matthias Born|+491735321764|matthias.born@philips.com|
301195|NCT02004873|Medtronic Cardiac Rhythm and Heart Failure|Micra Clinical Team|800-328-2518|MedtronicCRMtrials@medtronic.com|
301196|NCT02004886|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301197|NCT02004977|University of Minnesota|Dr. Susie Nanney|612-626-6794|msnanney@umn.edu|
301198|NCT02004990|University of Minnesota|Robert S. Jones DDS PhD|612-626-2900|rsjones@umn.edu|
301199|NCT02005016|VA Pittsburgh Healthcare System|Dr. Michael Dickey|412-360-6467|michael.dickey@va.gov|
301200|NCT02005029|Virginia Commonwealth University|Dr. Leslie Cloud|804-662-5304|leslie.cloud@vcuhealth.org|
301201|NCT02005211|AstraZeneca|Vice President, Neuroscience iMed||ClinicalTrialTransparency@astrazeneca.com|
301202|NCT02005250|Odense Universitetshospital, afd.M|Prof. Steen Bonnema|+4527339180|steen.bonnema@rsyd.dk|
301203|NCT02005276|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh Patel||mpatel@upenn.edu|
301204|NCT02005354|Plymouth Hospitals NHS Trust|Dr David Tucker|01752 432595|david.tucker1@nhs.net|
301205|NCT02005393|FujiFilm Medical Systems USA|Robert Uzenoff: Executive Director of Clinical Science|(203) 602-3664|ruzenoff@fujifilm.com|
301206|NCT02005484|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301207|NCT02005510|University of Washington|Dr. Rachel Winer|2066165081|rlw@uw.edu|
301208|NCT02005536|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
301209|NCT02005549|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301210|NCT02005562|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301211|NCT02005601|Hospital for Special Surgery|Dr. Jacques Yadeau|212-606-1206|yadeauj@hss.edu|
301212|NCT02005627|Imperial College London|Stephen R Durham|+44207-351-8024|s.durham@imperial.ac.uk|
301213|NCT02005666|Cadila Healthcare Limited|Mr Anuj K Saini|02717623666|Anuj.Saini@zyduscadila.com|314
301214|NCT02005692|Leaf Healthcare, Inc.|Barrett Larson, MD, Chief Medical Officer|650-701-3652|barrett.larson@leafhealthcare.com|
301215|NCT02005887|International Breast Cancer Study Group|Meredith M. Regan|+1 617-632-3012|mregan@jimmy.harvard.edu|
301216|NCT02006056|Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto|Dr. Edward Chow|416-480-4974|edward.chow@sunnybrook.ca|
301217|NCT02006108|Stanford University, Department of Radiology|Dr. Heike E. Daldrup-Link|650-497-8601|emisquez@stanford.edu|
301218|NCT02006121|Britannia Pharmaceuticals|Medical Director|+44 1189209500|reception@britannia-pharm.com|
301219|NCT02006160|UBMD Neurology|Dr. Ralph Benedict|7163230556|benedict@buffalo.edu|
301220|NCT02006264|Albert Einstein College of Medicine|Marla Keller, MD, Principal Investigator|718-430-3240|marla.keller@einstein.yu.edu|
301221|NCT02006342|The University of Texas Health Science Center at Houston|Dr. Pratik B. Doshi|713-608-6537|Pratik.B.Doshi@uth.tmc.edu|
301222|NCT02006420|University of Michigan|Dinesh Khanna|734-763-7182|khannad@umich.edu|
310855|NCT02813681|University of Texas Medical Branch|Denise Wilkes|409-772-1221|dwilkes@utmb.edu|
310856|NCT02813694|Nabriva Therapeutics US, Inc|Jennifer Schranz, M.D., Chief Medical Officer|610 981 2842|jennifer.schranz@nabriva.com|
310857|NCT02814175|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
310858|NCT02814227|University of Michigan|J. Todd Arnedt, PhD|734-615-8666|tarnedt@med.umich.edu|
310859|NCT02814279|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
310860|NCT02814448|Cleveland Clinic|Dr. Miriam Cremer|216-312-0618|cremerm@ccf.org|
310861|NCT02814565|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
310862|NCT02814643|AstraZeneca|Mitchell Goldman MD, PhD|+1 610 457 5585|Mitchell.Goldman@astrazeneca.com|
310863|NCT02814656|AstraZeneca|Ioannis Psallidas||ClinicalTrialTransparency@astrazeneca.com|
291231|NCT01350505|VA Palo Alto Health Care System|Dr. Jamie Zeitzer|650-493-5000|jamie.zeitzer@va.gov|62410
291232|NCT01350544|RAND Corporation|Laura M. Bogart, PhD|(310) 393-0411|lbogart@rand.org|7281
291233|NCT01350804|Novartis|Study Director|862-778-8300||
291234|NCT01350947|Huntsman Cancer Institute|Mark Wade|801-213-5746|mark.wade@hci.utah.edu|
291235|NCT01350973|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
291236|NCT01350999|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
291237|NCT01351025|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|301-628-3313|ACTGCT.Gov@s-3.com|
291238|NCT01351064|IUSM|Aaron Carroll|3172789696|aaecarro@iu.edu|
291239|NCT01351077|Indiana University School of Medicine|Aaron E. Carroll, MD, MS|3172789616|aaecarro@iu.edu|
291240|NCT01351090|Luitpold Pharmaceuticals, Inc.|David Bregamn, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
301223|NCT02006472|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
301224|NCT02006576|UNMC|Amy Nelson|402-559-5536|amyjnelson@unmc.edu|
301225|NCT02006628|GW Research Ltd|Medical Enquires|+44 01223 238170; 18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
301226|NCT02006641|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
301227|NCT02006654|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
301228|NCT02006667|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301229|NCT02006693|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
301230|NCT02006706|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301231|NCT02006719|Endo Pharmaceuticals Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
301232|NCT02006732|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301233|NCT02006758|Abbott|Rebecca Maslow, MA, Clinical Project Manager|+1 651-756-5564|rebecca.maslow@abbott.com|
301234|NCT02006836|Huazhong University of Science and Technology|Dr.Yu|862783662883|xfyu188@163.com|
301235|NCT02006888|IconBioscience|Howard Franklin|2153961332|hfranklin@iconbioscience.com|215
301236|NCT02006979|University of Alberta|Dr. Amy Kirkham, Postdoctoral Research Fellow|7804926874|amy.kirkham@ualberta.ca|
301237|NCT02007070|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301238|NCT02007096|Division of General Surgery, Department of Surgery, The Mount Sinai Medical Center|Dr. Celia M Divino|212-241-5499|Celia.Divino@mountsinai.org|
301239|NCT02007109|Baylor College of Medicine|Dr. Mary Felberg|832-824-5800|mafelber@texaschildrens.org|
301240|NCT02007200|University of Michigan Comprehensive Cancer Center|Gregory T. Wolf, M.D.|800-865-1125|gregwolf@umich.edu|
301241|NCT02007252|Novartis Pharmaceuticals|Study Director|862-778-8300||
301242|NCT02007278|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
301243|NCT02007291|Federal University of Minas Gerais|Luís Felipe José Ravic de Miranda|55-31-3225-2337|ravicmiranda@gmail.com|
301244|NCT02007369|School of Public Health, The University of Hong Kong|Dr. Cheung, Yee Tak Derek|+852 39176652|derekcheung@hku.hk|
301245|NCT02007434|Kythera|Clinical Trial Disclosure||clinical_trials@kythera.com|
301246|NCT02007512|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
301247|NCT02007577|Stanford Universtiy|Dr. Gerald Reaven|650-724-3416|greaven@stanford.edu|
301248|NCT02007720|Novartis Pharma AG|Study Director|+41613241111|novartis.email@novartis.com|
310864|NCT02814838|Dompé Farmaceutici SpA|Pier Adelchi Ruffini, MD|+39 02583831|pieradelchi.ruffini@dompe.com|
310865|NCT02814890|Huashan Hospital, Fudan University, Shanghai|Dr. Jun Zhang|0086-021-52887694|snapzhang@aliyun.com|
310866|NCT02815293|Allergan, Inc.|Therapeutic Area Head|877-277-8566|clinicaltrials@allergan.com|
310867|NCT02815644|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310868|NCT02815670|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310869|NCT02815709|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
310870|NCT02815735|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
310871|NCT02815982|University of South Florida|Dr. Marilyn Stern|8139740966|mstern1@usf.edu|
310872|NCT02816138|Vanderbilt University Medical Center|Warren D. Taylor, MD|6153221073|warren.d.taylor@vanderbilt.edu|
310873|NCT02816346|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
310874|NCT02816398|Avenu Medical - Sponsor|Gene Reu|949 276 2483|greu@avenumedical.com|102
310875|NCT02816710|Department of Ophthalmology, Ruijin Hospital Affiliated Shanghai Jiaotong University School of Medicine, 197 Ruijin Er Road, 200025, Shanghai, China.|Dr. Xi Shen|021-64370025|carl_shen2005@126.com|
310876|NCT02816723|VA Northern California Health Care System|Juliana Baldo|925-372-4649|Juliana.Baldo@VA.gov|
310877|NCT02817087|Houston Methodist Neurological Institute|David Chiu, M.D.|713-441-5801|dmccane@houstonmethodist.org|
310878|NCT02817516|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
310879|NCT02817555|Eastern Health|Andrea Woodland|7097778146|andrea.woodland@easternhealth.ca|
310880|NCT02817594|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
310881|NCT02817763|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@ict.unesp.br|
310882|NCT02817776|Biosense Webster Inc|Kendra McInnis|+1 949 322-8010|kmcinnis@its.jnj.com|
310883|NCT02817828|Estetra SPRL|Mithra Pharmaceuticals SA Pharma Department|+3243492822|clinical.trials@mithra.com|
291241|NCT01351337|Huashan Hospital|Dr Jinsong Wu|862152888771|wjsongc@126.com|
291242|NCT01351350|Takeda|Medical Director, Clinical Science|+1-866-835-2233|trialdisclosures@takeda.com|
291243|NCT01351376|Rehabilitation Medicine, New York University School of Medicine|Tara Denham, MD|212 263 8240|Tara.Denham@nyumc.org|
291244|NCT01351415|Hoffmann-La Roche|Medical Communications|888-6821-8590|genentech@druginfo.com|
291245|NCT01351480|AARDS Research, Inc.|Norman B Gaylis, MD|305-652-6676|drnbg@rheum-care.com|
291246|NCT01351506|Chiang Mai University|Dr.Kaweesak Chittawatanarat|+66815951259|kchittaw@gmail.com|
291247|NCT01351623|Memorial Sloan Kettering|Nikoletta Lendvai, MD|(212) 639-3368|lendvain@mskcc.org|
291248|NCT01351740|British Columbia Centre for Excellence in HIV/AIDS|Dr Marianne Harris|1-604-806-8771|mharris@cfenet.ubc.ca|
301249|NCT02007863|University of Miami|Martin Andreansky MD|305-243-0850|mandreansky@med.miami.edu|
301250|NCT02007954|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
301251|NCT02008149|Department of Veterans Affairs|Dr. Gary S. Beaupre|(650) 493-5000|Gary.Beaupre@va.gov|64272
301252|NCT02008227|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
301253|NCT02008318|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
301254|NCT02008526|Friends Research Institute|Dr. Cathy Reback|3234631601|reback@friendsresearch.org|
301255|NCT02008565|RTI International|Marie Gantz|919-597-5110|mgantz@rti.org|
301256|NCT02008617|Northwestern University, Feinberg School of Medicine|Rohit Rahangdale, M.D.|312-695-4814|rrahangd@nmff.org|
301257|NCT02008682|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
301258|NCT02008773|Indiana University Psychotic Disorders Program|Alan Breier, MD|317-880-8495|abreier@iupui.edu|
301259|NCT02008877|SARC|SARC|(734) 930-7600|sarc@sarctrials.org|
301260|NCT02008890|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
301261|NCT02008916|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
301262|NCT02008942|PLx Pharma|Ronald Zimmerman, President & CEO|713-842-1249|ron.zimmerman@plxpharma.com|205
301263|NCT02009046|PHI|Norman A. Constantine, Ph.D.|925-284-8118|nconstantine@berkeley.edu|
301264|NCT02009163|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
301265|NCT02009332|Aadi Bioscience|Berta Grigorian|818-416-8378|bgrigorian@aadibio.com|
301266|NCT02009397|University of Louisville, James Graham Brown Cancer Center|Dr. Jason Chesney|502-562-3429|jason.chesney@louisville.edu|
301267|NCT02009501|Mount Sinai St. Luke's|Dr. John C. Lantis II||JLantis@chpnet.org|
301268|NCT02009696|Biotronik, Inc.|Clinical Studies Engineer|503-927-7230|justin.michalski@biotronik.com|
301269|NCT02009722|Mayo Clinic|Dr. Hans Sviggum|507-581-6083|sviggum.hans@mayo.edu|
310884|NCT02817841|Estetra SPRL|Mithra Pharmaceuticals SA Pharma Department|+3243492822|clinical.trials@mithra.com|
310885|NCT02817906|Intra-Cellular Therapies, Inc.|ITI Clinical Trials|646-440-9333|ITCIClinicalTrials@itci-inc.com|
310886|NCT02818036|University of Pittsburgh|Dr. Tristen Inagaki|412-624-4211|inagaki@pitt.edu|
310887|NCT02818114|Minneapolis VA Health Care System|J. Irene Harris|612-467-1654|jeanette.harris2@va.gov|
310888|NCT02818244|Cleveland Clinic|Marc Gillinov MD|216 445-8841|GILLINOM@ccf.org|
310889|NCT02818569|Massachusetts General Hospital|Dr. Oluwaseun Johnson-Akeju|617-724-7200|ojohnsonakeju@partners.org|
310890|NCT02818777|University of Colorado|Dr. Maureen Anne Leehey|303-724-2194|maureen.leehey@ucdenver.edu|
310891|NCT02818998|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
310892|NCT02819011|Baylor College of Medicine|Prof.Bijan Najafi|17137987536|bijan.najafi@bcm.edu|
310893|NCT02819284|Kala Pharmaceuticals, Inc.|VP Clinical Development|(781) 996-5252|Results007@kalarx.com|
310894|NCT02819297|Braintree Laboratories, Inc.|VP, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
310895|NCT02819310|Braintree Laboratories, Inc.|VP, Clinical Affairs|781-843-2202|john.mcgowan@sebelapharma.com|
310896|NCT02819323|Braintree Laboratories, Inc.|Head of R&D, Gastroenterology|781-843-2202|studydirector@sebelapharma.com|
310897|NCT02819479|Norton Neuroscience Institute|Shervin R. Dashti, MD, PhD, Principal Investigator|502-394-6390|shervin.dashti@nortonhealthcare.org|
310898|NCT02819557|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
310899|NCT02819726|Archigen Biotech Ltd|Medical Director|+44(0)20 3749 5000|info@archigenbio.com|
310900|NCT02819973|Duke Clinical Research Institute|Kevin Thomas, MD|919-668-8700|kevin.thomas@duke.edu|
310901|NCT02820038|University of North Carolina at Chapel Hill|Susan J. Blalock, PhD|919-962-0080|s_blalock@unc.edu|
310902|NCT02820181|The First Hospital of Shanxi Medical University|Dr.Jun Tian|+8618612270351|zguotian@126.com|
310903|NCT02820298|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
310904|NCT02820324|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
310905|NCT02820597|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
310906|NCT02820844|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310907|NCT02820870|VA Center for Clinical Management Research|Jeremy Sussman, MD, MS - Principal Investigator|(734) 845-5200|jeremysu@med.umich.edu|
310908|NCT02821104|Nationwide Children's Hospi|Robert Hoffman|614-722-4425|robert.hoffman@nationwidechildrens.org|
310909|NCT02821338|US Food and Drug Administration|Office of Generic Drugs, Center for Drug Evaluation and Research|240-402-7920|genericdrugs@fda.hhs.gov|
310910|NCT02821403|The Hong Kong Polytechnic University|Dr. Tsz Wing Leung|27664268|jeffrey.TW.leung@polyu.edu.hk|
310911|NCT02821416|AstraZeneca|Maria Jison|001-202-577-6213|Maria.Jison@astrazeneca.com|
310912|NCT02821455|University of Edinburgh|E Alexandra Page|7938645122|s1305565@sms.ed.ac.uk|
310913|NCT02821715|Theranexus|Chief medical officer|+33680026779|werner.rein@theranexus.fr|
301270|NCT02009865|AstraZeneca AB|Hong Yang, Study Statistician|+46-(0)317762397|hong.yang1@astrazeneca.com|
301271|NCT02009878|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
310914|NCT02821819|Instituto Bernabeu|Dr. Juan Carlos Castillo|+34650562634|jcastillo@institutobernabeu.com|
291249|NCT01351753|University of Iowa|Gary Pierce, PhD|13193359487|gary-pierce@uiowa.edu|
301272|NCT02009930|David Grant Medical Center, Travis Air Force Base|Dr. Elijah Burton|707-423-7950|elijah.j.burton2.mil@mail.mil|
301273|NCT02010021|Dartmouth-Hitchcock Medical Center and Norris Cotton Cancer Center|Gary N. Schwartz, MD|(603) 653-6181|gary.n.schwartz@hitchcock.org|
301274|NCT02010151|Seoul National University Hospital|Dr. Sun Young Lee|+82-10-9269-2376|sy2376@gmail.com|
301275|NCT02010203|Clinical Development|Lori McDermott|9197948950|lmcdermott@heatbio.com|9197948950
301276|NCT02010216|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301277|NCT02010255|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
301278|NCT02010359|Children's Hospital of Philadelphia|Dr. Rachana Shah|215-590-3390|shahr@email.chop.edu|
301279|NCT02010567|UNC Lineberger|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
301280|NCT02010632|Khon Kaen University|Miss Nontaya Nakkam|66862642540|nonna_na@hotmail.com|
301281|NCT02010645|The University of Texas MD Anderson Cancer Center|Courtney DiNardo, MD/Associate Professor|713-794-1141|CDiNardo@mdanderson.org|
301282|NCT02010684|University of California Los Angeles|Dr. Jeanne Miranda|310-794-3710|mirandaj@ucla.edu|
301283|NCT02010697|UCSD|Principal Investigator|8583001056|szhu@ucsd.edu|
301284|NCT02010775|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
301285|NCT02010996|changhai hospital|Bi-Hongda|86-13918233009|bihongda0411@yahoo.com.cn|
301286|NCT02011113|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
301287|NCT02011386|Rigshospitalet, Denmark|Professor Mikkel Østergaard, MD, PhD, DMSc|+45 38633014|mo@dadlnet.dk|
301288|NCT02011464|Maimonides Medical Center|Dr. Piyush M Gupta|7182837189|pgupta@maimonidesmed.org|
301289|NCT02011490|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301290|NCT02011516|University of Pennsylvania|Teresa R. Franklin, Ph.D., Research Associate Professor of Neuroscience in Psychiatry|215-222-3200|teresafr@mail.med.upenn.edu|119
301291|NCT02011893|St. Jude Medical|Roni Diaz, Director Clinical Studies|972-309-8601|RDiaz@sjm.com|
301292|NCT02011945|Bristol-Myers squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@BMS.com|
301293|NCT02012192|Medical University of Innsbruck|Prof. Dr. Nicole Concin|+43 512 504|nicole.concin@i-med.ac.at|81433
310915|NCT02821910|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310916|NCT02821962|University of Ottawa Heart Institute|Dr. Robert Reid|613-696-7393|breid@ottawaheart.ca|
310917|NCT02822222|RMJ Holdings LLC d/b/a RMJH Rx|Russell Jaffe, M.D., Chief Executive Officer|(703) 840-4440|rjaffe@rmjholdings.com|
310918|NCT02822235|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
310919|NCT02822287|GlaxoSmithKline|GSK Response Center|866-435-7343||
310920|NCT02822599|Nicklaus Children's Hospital|Jenny Esteves|786-624-2854|jenny.esteves@nicklaushealth.org|
310921|NCT02822612|Moorfields Eye Hospital NHS Foundation Trust|Pearse Keane|02072533411|pearse.keane@moorfields.nhs.uk|
310922|NCT02822794|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
310923|NCT02822885|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
310924|NCT02822950|Michigan State University|Gary Stein|517-353-5126|steing@msu.edu|
310925|NCT02823080|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
310926|NCT02823431|Duke Biomedical Engineering|Warren Grill PhD|(919) 660-5276|warren.grill@duke.edu|
310927|NCT02823470|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
270261|NCT00116753|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
291250|NCT01351766|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
291251|NCT01351805|Brigham and Women's Hospital/ Harvard Medical School|Karen Costenbader|16177326088|kcostenbader@bwh.harvard.edu|
291252|NCT01352117|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
291253|NCT01352182|Cincinnati Children's Hospital Medical Center|Jennifer Kaplan|513-636-4259|jennifer.kaplan@cchmc.org|
291254|NCT01352221|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
291255|NCT01352286|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
291256|NCT01352442|AcuFocus, Inc.|Eugenia Thomas, OD|949-585-9511|ethomas@acufocus.com|
291257|NCT01352468|Cincinnati Children's Hospital Medical Center|Dr. Jeff Epstein|5136368296|jeff.epstein@cchmc.org|
291258|NCT01352507|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291259|NCT01352546|Plastic Surgery Professional Association|Peter T. Pacik, MD, FACS|603 387 7735|ptpacik@verizon.net|
301294|NCT02012218|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
291260|NCT01352585|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
291261|NCT01352598|Mercy|Jaymeson Stroud, MD|314-251-6844|Jaymeson.Stroud@mercy.net|
291262|NCT01352637|Weill Cornell Medical College|Dr. JoAnn Difede|212 746 3079|jdifede@med.cornell.edu|
291263|NCT01352715|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
301295|NCT02012283|Center for Human Nutrition, Department of Medicine, UCLA David Geffen School of Medicine|Zhaoping Li, Professor|310-206-1987|zli@mednet.ucla.edu|
301296|NCT02012348|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(585)-657-8390|dermstudies@ucsd.edu|
301297|NCT02012452|VA Boston healthcare system|Sandra Japuntich|6082398018|sjjapuntich@gmail.com|
301298|NCT02012491|University of Pennsylvania|Dr. Courtney Schreiber|215-615-5234|Courtney.Schreiber@uphs.upenn.edu|
301299|NCT02012582|vasopharm GmbH|Dr. Reinhard Schinzel|+49 931 359099|schinzel@vasopharm.de|115
301300|NCT02012621|University of Colorado-AMC|Dr. Jose Castillo-Mancilla|303-724-4934|jose.castillo-mancilla@cuanschutz.edu|
301301|NCT02012686|Department of Anesthesiology and Pain Medicine, Gangnam Severance Hospital, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, Republic of Korea|Dr Dong Woo Han|82-2-2019-3549|HANESTH@yuhs.ac|
301302|NCT02012959|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
301303|NCT02013037|Cedars Sinai Smidt Heart Institute|Dr. Jignesh Patel|310-248-8300|jignesh.patel@cshs.org|
301304|NCT02013050|Soligenix, Inc.|Dr. Richard Straube||rstraube@soligenix.com|
301305|NCT02013180|Catalca Ilyas Cokay State Hospital|Dr. Mustafa Zafer Temiz|+90 212 787 19 12|dr_mustafazafertemiz@hotmail.com|1178
301306|NCT02013206|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301307|NCT02013245|Centre Hospitalier Universitaire Vaudois (CHUV)|Dr. François Spertini, Associate Professor, Division Immunology & Allergy|+41 21 31 40 799|Francois.Spertini@chuv.ch|
301308|NCT02013375|University of Illinois at Chicago|Dr Damiano Rondelli|312-996-6179|drond@uic.edu|
301309|NCT02013388|Nivalis Therapeutics, Inc.|Nivalis Therapeutics, Inc. (Formerly N30 Pharma)|720-945-7700|steven.shoemaker@nivalis.com|
301310|NCT02013531|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
301311|NCT02013544|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
310928|NCT02823600|University of North Carolina at Chapel Hill|Seema Garg, MD, PhD|919-966-5296|sgarg@med.unc.edu, ashton.madison@alumni.duke.edu|
310929|NCT02823964|Anthera Pharmaceuticals|Nicole Ramza|510-856-5600|info@anthera.com|
310930|NCT02824198|Sanofi Pasteur|Medical Director|800-633-1610|Contact-US@sanofi.com|ext 1#
310931|NCT02824224|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
310932|NCT02824432|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
310933|NCT02824562|UAB|Jessica Merlin|2059967894|jmerlin@uabmc.edu|
310934|NCT02824913|Parion Sciences|Jose Boyer|919-313-1182|jboyer@parion.com|
310935|NCT02825212|Icahn School of Medicine at Mount Sinai|Dr. Peter D. Gorevic|212-241-0968|peter.gorevic@mountsinai.org|
310936|NCT02825251|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
310937|NCT02825420|Pharma Mar S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|0034 91846 60 00|clinicaltrials@pharmamar.com|
310938|NCT02825550|Department of Internal Medicine, National Cheng Kung University|Dr. Xi-Zhang Lin|886-6-2353535|linxz@mail.ncku.edu.tw|3624/5603
310939|NCT02825680|VA Center for Clinical Management Research|Laura Damschroder|734-845-3603|Laura.Damschroder@va.gov|
310940|NCT02825849|UCSF|Heather Huddleston|415-353-3040|heather.huddleston@ucsf.edu|
310941|NCT02825966|ZOLL|Director, Clinical Operations|4129683333|mosz@zoll.com|
310942|NCT02825992|Acutus Medical, Inc.|Steve McQuillan, Sr. Vice President Regulatory, Clinical, & Quality Assurance|763-331-4344|steven.mcquillan@acutus.com|
310943|NCT02826421|Alcon, A Novartis Division|Sr Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
310944|NCT02826603|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
310945|NCT02826694|The University of North Carolina at Chapel Hill|Dr. Cynthia M. Powell|9199667646|powellcm@med.unc.edu|
310946|NCT02826798|VBI|Bebi Yassin-Rajkumar|613-749-4200|byassin-rajkumar@vbivaccines.com|151
310947|NCT02827500|Duke Clinical Research Institute|Dr. Robert Mentz|919-668-7121|robert.mentz@duke.edu|
310948|NCT02827708|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
310949|NCT02828020|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
310950|NCT02828111|PellePharm, Inc.|Chief Medical Officer|(510) 502-6144|clinical@pellepharm.com|
310951|NCT02828137|Inha University Hospital|Dr. Sung Woo Kwon|821031133363|kwonswdr@gmail.com|
310952|NCT02828241|Dr. Reddy's Laboratories|Katherine D'Angelo|609-282-1400|kdangelo@drreddys.com|
310953|NCT02828267|Duke University Medical Center|Catherine Staton|9196845537|catherine.staton@duke.edu|
310954|NCT02828358|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
291264|NCT01352741|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223||
291265|NCT01352793|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291266|NCT01352845|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291267|NCT01353079|GREER Laboratories, Inc.|Terrance Coyne, M.D., Executive Vice President of Research & Development; Chief Medical Officer|(828) 759-7495|tcoynemd@greerlabs.com|
291268|NCT01353144|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
291269|NCT01353196|VA Medical Center VA Maryland Health Care System, Baltimore, MD|Brajesh K. Lal, MD|410-605-7000|blal@som.umaryland.edu|
291270|NCT01353222|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
291271|NCT01353274|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301312|NCT02013609|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
301313|NCT02013622|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
301314|NCT02013674|ISCI / University of Miami Miller School of Medicine|Marietsy pujol / Senior Regulatory Specialist|305-243-7273|mpujol@med.miami.edu|
301315|NCT02013687|Fraunhofer USA Center for Molecular Biotechnology|Dr. Jessica Chichester, Senior Scientist Immunology|302-369-3635|jessica.chichester@fhcmb.org|
301316|NCT02013765|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301317|NCT02013778|University of Pennsylvania|Gregory Nadolski, MD, Principal Investigator|215-662-7892|gregory.nadolski@pennmedicine.upenn.edu|
301318|NCT02013791|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
301319|NCT02013817|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301320|NCT02013830|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
310955|NCT02828436|University of Minnesota|Manda Keller-Ross|612-625-3175|kell0529@umn.edu|
310956|NCT02828644|Akili Interactive Labs|Kathryn Jenkins|7742666693|kjenkins@akiliinteractive.com|
310957|NCT02828917|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
310958|NCT02829034|University of Pennsylvania|Yuchi Han, PI of the study|215-615-3417|yuchi.han@uphs.upenn.edu|
310959|NCT02829138|University of Guelph|Dr. David M Mutch|+1-519-824-4120|dmutch@uoguelph.ca|53322
310960|NCT02829294|Eosera Inc|Joseph Griffin PhD|8447327929|info@eosera.com|
310961|NCT02829307|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310962|NCT02829320|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310963|NCT02829463|Third Xiangya Hospital of Central South University|Dr. Jinshen He|8613517470997|jinshen.he@hotmail.com|
310964|NCT02829775|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
310966|NCT02829944|Duke University Medical Center|Emily Barney|9709031869|ezb2@duke.edu|
310967|NCT02829983|Universidade Estadual Paulista Júlio de Mesquita Filho|Mauro Pedrine Santamaria|3947-9033|mauro.santamaria@ict.unesp.br|
310968|NCT02829996|Inotek Pharmaceuticals Corp.|Roni Cohen|781-676-2100|rcohen@inotekpharma.com|
310969|NCT02830074|John D. Dingell VA Medical Center|Dr. M.Safwan Badr, MD, Ph.D.|3135763548|m.badr@va.gov|
310970|NCT02830087|Wake Forest University Health Sciences|Maxwell Langfit, MD||mlangfit@wakehealth.edu|
310971|NCT02830438|AlbertEHN|Mario Naranjo-Tovar|2157965542|mario.edu6@hotmail.com|
310972|NCT02830776|Formerly - Tulane University Department of Dermatology. Currently - Suzanne Bruce and Associates, PA|Megan Couvillion, MD, FAAD|504-473-2915|megan.couvillion@gmail.com|
310973|NCT02830880|Emory University|David Schuster, MD|(404) 712-4859|dschust@emory.edu|
310974|NCT02830893|University of California Irvine|Dr. Steven Cramer|(949) 824-8423|SCCramer@mednet.ucla.edu|
310975|NCT02831257|Massachusetts General Hospital|Scott Plotkin|617-724-5369|splotkin@mgh.harvard.edu|
310976|NCT02831387|Parion Sciences|Jose Boyer|919-313-1182|jboyer@parion.com|
310977|NCT02831569|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310978|NCT02831660|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310979|NCT02831816|Zurex Pharma, Inc.|Andrew Morgan|16082039090|amorgan@zurexpharma.com|
310980|NCT02831855|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
310981|NCT02831998|Zurex Pharma, Inc.|Andrew Morgan|16082039090|amorgan@zurexpharma.com|
310982|NCT02832037|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
310983|NCT02832115|Aultman Hospital|Dr. Prabhakaran Gopalakrishnan|3304548076|prab.gopalakrishnan@aultman.com|
310984|NCT02832154|Wake Forest University Health Sciences|Study coordinator|336-713-5061|drlittle@wakehealth.edu|
291272|NCT01353495|Wright Medical Technology, Inc.|Jonette Hodge, MSN, RN, CCRP, Director, Medical Affairs|8002387188|jonette.hodge@wmt.com|4747
291273|NCT01353508|Novartis|Study Director|862-778-1873||
291274|NCT01353586|Biosense Webster, Inc|Kendra McInnis, Manager, Clinical Operations|909-839-7284|kmcinnis@its.jnj.com|
291275|NCT01353664|Celgene Corporation|Anne McClain|1-888-260-1599|clinicaltrialdisclosure@celgene.com|
291276|NCT01353703|GlaxoSmithKline|GSK Response Center|866-435-7343||
291277|NCT01353859|Hoffmann- LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
291278|NCT01353898|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291279|NCT01353911|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301321|NCT02014051|None|Director of Clinical Trials|+81-3-5472-1127|kgoto.34@symbiopharma.com|
301322|NCT02014116|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
301323|NCT02014129|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
301324|NCT02014272|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
301325|NCT02014363|e-Therapeutics plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
301326|NCT02014376|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
301327|NCT02014402|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
301328|NCT02014441|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
301329|NCT02014467|GlaxoSmithKline|GSK Response Center|866-435-7343||
301330|NCT02014480|GlaxoSmithKline|GSK Response Center|866-435-7343||
301331|NCT02014519|GlaxoSmithKline|GSK Response Center|866-435-7343||
301332|NCT02014584|GlaxoSmithKline|GSK Response Center|866-435-7343||
301333|NCT02014597|Baylor College of Medicine|Dr. Benjamin Frankfort|713-798-3453|benjamin.frankfort@bcm.edu|
301334|NCT02014740|University of Miami|Prof Gianluca Iacobellis|3052433636|giacobellis@med.miami.edu|
301335|NCT02015039|National Institutes of Health|Dr. Mark Hallett|301-496-9526|hallettm@ninds.nih.gov|
301336|NCT02015065|National Cancer Institute|Dr. Brigitte Widemann|240-760-6203|widemanb@nih.gov|
301337|NCT02015104|National Cancer Institute|Dr. Vladimir Valera Romero|240-858-3947|vladimir.valeraromero@nih.gov|
301338|NCT02015195|Division of Emergency Medicine, Department of Surgery, Stanford University School of Medicine|Paul Auerbach, MD|650.725.9445|auerbach@stanford.edu|
301339|NCT02015221|Tactile Medical|Director of Clinical Research|6123555121|shoy@tactilemedical.com|
301340|NCT02015234|Tonix Pharmaceuticals|Gregory M. Sullivan, Chief Medical Officer|212 980 9155|greg.sullivan@tonixpharma.com|117
301341|NCT02015390|Texas Medical Branch, University of, Galveston|Study PI|409-747-5760|zgugala@utmb.edu|
301342|NCT02015442|Imperial College London|Prof Gary Frost|020 7594 0959|g.frost@imperial.ac.uk|
310985|NCT02832167|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
310986|NCT02832284|Boston Scientific Corporation|G Mark Grubb, RN, CCRA|412 749 1423|grubbm@bsci.com|
310987|NCT02832375|GlaxoSmithKline|GSK Response Center|866-435-7343||
310988|NCT02832622|Abbott|Kwangdeok Lee, PhD|1-972-526-9673|kwangdeok.lee@abbott.com|
310989|NCT02832674|ThermiGen LLC|Toni Fournier, Sr. VP New Products|214-888-0634|TFournier@Thermi.com|
310990|NCT02833077|Allergan|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
310991|NCT02833337|Centro de Implantologia, Cirugia Oral y Maxilofacial|Alberto Monje|+41798836264|amonjec@umich.edu|
310992|NCT02833350|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
310993|NCT02833415|University of Texas Southwestern Medical Center|Ian J. Neeland MD|214-645-1267|ian.neeland@utsouthwestern.edu|
310994|NCT02833844|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
310995|NCT02833857|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
310996|NCT02833922|Institute for Reproductive Health|Dr. Victoria Jennings|2026871392|Victoria.Jennings@georgetown.edu|
310997|NCT02833948|The Heart Center - Rigshospitalet, Copenhagen, Denmark|Ole De Backer, MD, PhD|+45-35457086|ole.debacker@gmail.com|
310998|NCT02833974|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
310999|NCT02834247|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
311000|NCT02834390|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
311001|NCT02834624|University of Missouri-Columbia|Dr. Naomi Lauriello|573-882-2272|lauriellon@health.missouri.edu|
311002|NCT02834663|Wonkwang University Hospital|Dr. Seung Joon Lee|010-5004-8165|eunilsa@hanmail.net|
311003|NCT02834806|Medinol|Dina Kofler, VP Clinical Affairs|+97237679032|dinak@medinol.com|
311004|NCT02834819|Children's Hospital Colorado/University of Colorado|Cortney Braund, MD|4406696880|Cortney.Braund@childrenscolorado.org|
311005|NCT02835092|Medifast|Linda Arterburn, VP Scientific & Clinical Affairs|443-379-5191|linda.arterburn@medifastinc.com|
311006|NCT02835274|Boston Scientific|Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
311007|NCT02835339|Oregon Health and Science University|Kathleen Brookfield, MD, PhD, MPH|503-494-2101|brookfie@ohsu.edu|
311008|NCT02835495|Wake Forest School of Medicine|Mara Z. Vitolins, DrPH, MPH, RDN|(336) 716-2886|mvitolinn@wakehealth.edu|
311009|NCT02835625|Cancer Registry of Norway|Prof. Solveig Hofvind|+47 22928828|solveig.hofvind@kreftregisteret.no|
311010|NCT02835677|VA Medical Center|Dr. Linda Nichols, Co-Director Caregiver Center|901 523-8990|linda.nichols@va.gov|5082
311011|NCT02835820|University of Alabama at Birmingham|Shannon Morrison|12059967841|samorris@uab.edu|
311012|NCT02835846|Loyola University Chicago|Alan J Wolfe|7082165814|awolfe@luc.edu|
311013|NCT02836249|Gilead Sciences|Gilead Clinical Study Information Center||GileadClinicalTrials@gilead.com|
301343|NCT02015481|Bioblast Pharma|Warren Wasiewski|717-368-0780|Warren.wasiewski@bioblastpharma.com|
311014|NCT02836496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
291280|NCT01353963|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|18007181021|ClinicalTrials.gov_Inquiries@pfizer.com|
291281|NCT01353976|AmDerma Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amderma.com|
291282|NCT01354015|Tulane University|Dr Vivian Fonseca|5049884026|vfonseca@tulane.edu|
291283|NCT01354028|University of Arkansas for Medical Sciences|Dr Richard W Hall MD, Professor of Neonatology|501-680-7894|HallRichardW@uams.edu|
291284|NCT01354106|cyberDERM|Dr. Gary Grove|610-325-0112|GGrove@cyberderm-inc.com|
291285|NCT01354132|Beth Israel Deaconess Medical Center|Larry Seidman, PhD|617 754-1238|lseidman@bidmc.harvard.edu|
291286|NCT01354145|Bioiberica|Marta Herrero - Clinical R&D Manager|+34934904908|mherrero@bioiberica.com|
291287|NCT01354197|Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand|Kaweesak Chittawatanarat|053-935533|kchittaw@gmail.com|
291288|NCT01354223|Foresight Regulatory Strategies, Inc.|William J. Gleason, O.D.|978-658-6888||151
291289|NCT01354314|The Johns Hopkins University|Dr. Ned Sacktor|410-550-1045|sacktor@jhmi.edu|
301344|NCT02015520|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
301345|NCT02015546|Duke University Medical Center|Dr. Ashwin Patkar|919-681-0613|ashwin.patkar@duke.edu|
301346|NCT02015637|Melinta Therapeutics, Inc.|Susan K. Cammarata, M.D. (Chief Medical Officer)|1-844-MELINTA (1-844-635-4682)|clinicaltrials@melinta.com|
301347|NCT02015676|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301348|NCT02015754|Yale University|Jean-Francois Geschwind, MD|203-785-5865|jeff.geschwind@yale.edu|
311015|NCT02836613|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
311016|NCT02836652|Abbott|Poornima Sood|7818528334|poornima.sood@abbott.com|
311017|NCT02836769|Sunnybrook Research Institute|Dr. Sara McEwen|416-226-6780|sara.mcewen@sunnybrook.ca|7957
311018|NCT02836873|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
311019|NCT02836990|University at Buffalo, SUNY|Dr Linda Harris|7168594207|lmharris@buffalo.edu|
311020|NCT02837237|KBP Biosciences Co., Ltd.|Vincent J. Benn|2677996545|vince.benn@kbpbiosciences.com|
311021|NCT02837328|University of Minnesota|Pamela Lutsey, PhD MPH|612-624-5812|lutsey@umn.edu|
311022|NCT02837731|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
311023|NCT02837744|Axio Biosolutions Pvt. Ltd.|Shailee Mehta, Clinical Research Manager|9879009940|shailee.m@axiobio.com|
311024|NCT02837913|Cedars-Sinai Medical Center|Dr. Mark Zakowski|310-423-5841|mark.zakowski@cshs.org|
311025|NCT02837952|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
311026|NCT02838017|NorthShore University HealthSystem|Lena Braginsky|2245952705|lena.braginsky.mfm@gmail.com|
311027|NCT02838134|Radboud University Medical Center|Dr M.C. Warlé|+31-24362415333|Michiel.Warlé@radboudumc.nl|
311028|NCT02838407|GlaxoSmithKline|GSK Response Center|866-435-7343||
311029|NCT02838420|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
311030|NCT02838628|Almirall S.A.|Head of Global Clinical Development|+34932913000|rd@almirall.com|
311031|NCT02838901|Wake Forest School of Medicine|Dr. Cheryl Bushnell|336-716-4101|cbushnel@wakehealth.edu|
311032|NCT02839200|Idorsia Pharmaceuticals|Clinical Trial Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
311033|NCT02839330|Seqirus|Seqirus Clinical Trial Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
311034|NCT02839681|National Cancer Institute|Dr. Raffit Hassan|240-760-6232|raffit_hassan@nih.gov|
311035|NCT02839746|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311036|NCT02839772|University of Hull|Jill Brooks. PhD student,|01491 839044|jb284@btinternet.com|
311037|NCT02839798|Butler Hospital|Dr. Linda Carpenter|401-455-6349|Linda_Carpenter_MD@brown.edu|
311038|NCT02839876|Duke University Medical Center|Dr. Jeff Gadsden|919-681-6437|jeff.gadsden@duke.edu|
311039|NCT02839889|Four Seasons Compassion for Life|Janet Bull, MD|8286926178|jbull@fourseasonscfl.org|302
311040|NCT02839902|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
311041|NCT02840097|University of California, Davis|Daniel Nishijima, Study Co-PI|916.734.3884|dnishijima@ucdavis.edu|
311042|NCT02840253|Nationwide Children's Hospital|Joseph D. Tobias, MD|614-722-4200|Joseph.Tobias@nationwidechildrens.org|
311043|NCT02840461|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
311044|NCT02840474|Vaccine Research Center, NIAID, NIH|Martin Gaudinski, MD|(301) 451-8715|martin.gaudinski@nih.gov|
311045|NCT02840721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
311046|NCT02840916|Kaohsiung Chang Gung Memorial Hospital|Dr. Wen-Long Hu|+886-7-731-7123|oolonghu@gmail.com|2334
311047|NCT02841033|Boston Medical Center|Vaishali Sanchorawala, MD|617-638-8213|vaishali.sanchorawala@bmc.org|
311048|NCT02841046|Guangzhou Panyu central Hospital|Dr. Yang Lin|+8615915721012|salinyangyl@163.com|
311049|NCT02841189|Indiana University|Nicole Horn MD|317-944-9981|nhorn@iupui.edu|
311050|NCT02841241|Intermountain Medical Center|Office of Research|8015077000|officeofresearch@imail.org|
311051|NCT02841267|Hugo W. Moser Research Institute at Kennedy Krieger Inc.|Dr. Kathryn R. Wagner|443-923-9525|wagnerk@kennedykrieger.org|
311052|NCT02841397|Masimo Corporation|Cristina Johnson|(949) 297-7000|clinicalresearchdept@masimo.com|
311053|NCT02841449|University of Bath|Dr Harriet Carroll|+447706548573|hac38@bath.ac.uk|
311054|NCT02841709|Idorsia Pharmaceuticals Ltd|Clinical Trials Disclosure Desk|+41 588 441977|clinical-trials-disclosure@idorsia.com|
291290|NCT01354353|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291291|NCT01354431|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
291292|NCT01354444|Johns Hopkins University|Paul Rosenberg, MD|410-550-9883|prosenb9@jhmi.edu|
291293|NCT01354496|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
291294|NCT01354652|AsanMC|Dr. Han Chu Lee|82230103915|hch@amc.seoul.kr|
291295|NCT01354691|Bar Ilan University|Jonathan Rabinowitz, PhD||jonathan.rabinowitz@biu.ac.il|
291296|NCT01354899|Molnlycke Health Care AB|Tina Kjellen|+46317223098|tina.kjellen@molnlycke.com|
291297|NCT01354938|Abbott|Esther Oppermann, Clinical Trial Manager|49 511 6750 3954||
291298|NCT01354964|Albert Einstein College of Medicine|Dr. Meredith Hawkins|7184302903|meredith.hawkins@einsteinmed.org|2903
291299|NCT01354990|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301349|NCT02015793|AbbVie|Global Medical Services|800-633-9110||
301350|NCT02015819|City of Hope Medical Center|Dr. Jana Portnow|6262189200|jportnow@coh.org|
301351|NCT02016105|Sandoz|Global Program Medical Director|+49 8024 476|biopharma.clinicaltrials@sandoz.com|0
301352|NCT02016170|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
301353|NCT02016183|Takeda|Medical Director|1-877-825-3327|trialdisclosures@takeda.com|
301354|NCT02016235|Mayo Clinic|John C. Lieske, M.D.|507-266-7960|Lieske.John@mayo.edu|
301355|NCT02016300|Stanford University|Jason Dragoo, MD|650-721-3430|jdragoo@stanford.edu|
301356|NCT02016482|AbbVie|Global Medical Services|800-633-9110||
301357|NCT02016560|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
301358|NCT02016612|Bengtson Center|Dr Bradley Bengtson|616 588 8880|drb@bengtsoncenter.com|
301359|NCT02016625|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301360|NCT02016690|AbbVie|Global Medical Services|800-633-9110||
301361|NCT02016716|Amgen Inc.|Study Director|866-572-6436||
301362|NCT02016755|AnGes USA, Inc.|Dr. Susan Pitman Lowenthal|240-780-9025|spitmanlowenthal@anges-usa.com|
301363|NCT02016885|Dermira Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
301364|NCT02016898|Duke University Health System|Michael Quist, MD|718-490-7657|michael.quist@duke.edu|
301365|NCT02016963|Human Genome Sciences Inc.|GSK Response Center|866-435-7343||
301366|NCT02017015|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
301367|NCT02017093|University of Haifa|Prof. Eli Carmeli|972-4-8288-397|ecarmeli@univ.haifa.ac.il|
301368|NCT02017171|Joslin Diabetes Center|Dr. Alessandro Doria (Sponsor and PI of the study)|617-319-0970|alessandro.doria@joslin.harvard.edu|
311055|NCT02841787|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
311056|NCT02842060|University of Pennsylvania|Dr. Jose Bauermeister|215-898-9993|bjose@upenn.edu|
311057|NCT02842073|University of North Carolina at Chapel Hill|James C Garbutt, MD|984-974-2201|jc_garbutt@med.unc.edu|
311058|NCT02842086|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311059|NCT02842151|Alcon, A Novartis Division|Senior Global Brand Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
311060|NCT02842242|MyoKardia Inc.|Dr. Amy Sehnert|650-741-7798|asehnert@myokardia.com|
311061|NCT02842736|Channel Medsystems|Clinical and Regulatory Affairs|510-338-9301|clinreg@channelmedsystems.com|
311062|NCT02842853|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
311063|NCT02842866|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
311064|NCT02843178|Stanford University|Mandy Murphy Carroll, Study Coordinator|(650) 509-0004|mandyiam@stanford.edu|
311065|NCT02843529|Altoida Inc.|Ioannis Tarnanas|+18325975076|Ioannis@altoida.com|
311066|NCT02843659|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
311067|NCT02844439|Kadmon Corporation|Miranda Ross|724-778-6170|Miranda.Ross@kadmon.com|
311068|NCT02844543|Stanford University|Dr. Jamshid Ghajar, MD, PhD|(650) 725-5562|acrevelt@stanford.edu|
311069|NCT02844569|University of North Carolina at Chapel Hill|Dr. Thiago Morelli|919-537-3727|thiago_morelli@unc.edu|
311070|NCT02844582|University of California, Davis|Analyst|916-734-8053|nlogihara@ucdavis.edu|
311071|NCT02844920|Gynesonics|Taraneh G. Farazi, Ph.D. (Vice President, Clinical Affairs)|650-216-3878|tfarazi@gynesonics.com|
311072|NCT02844998|Ankara TRH|Dr. Muhammet Fatih Kilinc|+90 312 595 3700|mdfatihkilinc@yahoo.com|3724
311073|NCT02845336|Johns Hopkins University|Timothy J McCulley, MD|4105503000|tmccull5@jhmi.edu|
311074|NCT02845375|Leiden University Medical Center|Dr Albert Dahan|+31715262301|a.dahan@lumc.nl|
311075|NCT02845674|Sun Pharma Advanced Research Company Limited|SPARC|+912266455645|Clinical.Trials@Sparcmail.com|
301369|NCT02017210|Garvan Institute of Medical Research|Dr. Dorit Samocha-Bonet|+61292958309|d.samochabonet@garvan.org.au|
301370|NCT02017223|University of Southern California|Donna Spruijt-Metz, MFA PhD|310-577-6248|dmetz@usc.edu|
311076|NCT02845700|Florida State University|Dr. Wen Li|850-645-1409|wenli@neuro.fsu.edu|
301371|NCT02017327|Laboratoires Thea|Director of medical operation|+473985089|J.auger@laboratoires-thea.fr|
291300|NCT01355068|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291301|NCT01355081|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
291302|NCT01355159|Ottawa Hospital Research Institute|Dr. Mark Walker|6137378899|mwalker@ohri.ca|76655
291303|NCT01355224|Boston University School of Public Health|Dr. Catharine Wang|617-638-5187|clwang@bu.edu|
291304|NCT01355289|Eisai Call Center|Eisai Inc.|888-422-4743||
291305|NCT01355302|Eisai Inc.|Eisai Medical Services|888-422-4743||
291306|NCT01355419|CHU St Pierre|Dr Marie Bruyneel|00325354219|Marie_BRUYNEEL@stpierre-bru.be|
291307|NCT01355458|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
291308|NCT01355471|Galderma|Michael Graeber, MD|609-860-8201|michael.graeber@galderma.com|
301372|NCT02017444|University of Birmingham|Professor Alex Sinclair|+44 121 415 9125|a.b.sinclair@bham.ac.uk|
301373|NCT02017535|University of Minnesota|Meredith Gunlicks-Stoessel|612-273-9844|mgunlick@umn.edu|
301374|NCT02017574|Baltimore Veterans Affairs|Jeremy Rietschel, PhD|410-605-7000|jeremy.rietschel@va.gov|3233
301375|NCT02017860|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
301376|NCT02017899|GSK Vaccines Institute for Global Health S.r.l.|Dr. Audino Podda|+39 0577 243496|audino.p.podda@gsk.com|
301377|NCT02018042|Columbia University Department of Dermatology Clinical Research Unit|Grace Ulerio, CCRC|212-305-6593|gu2102@cumc.columbia.edu|
301378|NCT02018107|Brigham & Women's Hospital INC|Paul Shyn, MD|6177326304|PSHYN@BWH.HARVARD.EDU|
301379|NCT02018315|University of Texas Southwestern Medical Center|Juan Pascual, M.D., Ph.D.|214-648-3550|juan.pascual@utsouthwestern.edu|
301380|NCT02018445|SeaSpine|Sara Tish Mikoczi|760-216-5652|tish.mikoczi@seaspine.com|
301381|NCT02018458|Baylor Scott and White Health|Dr. Joyce O'Shaughnessy|214-818-8472|joyce.oshaughnessy@usoncology.com|
301382|NCT02018562|Johns Hopkins University|Vinciya Pandian PhD, MSN, RN, ACNP-BC, FAAN|4436553482|vpandia1@jhu.edu|
301383|NCT02018627|Massachusetts General Hospital|Courtney Balliro, BS, RN, CDE|617-726-1242|cballiro@partners.org|
301384|NCT02018653|University of Texas (UT) MD Anderson Cancer Center|Sai-Ching J. Yeung, MD||CR_Study_Registration@mdanderson.org|
301385|NCT02018809|University of Pennsylvania|Dr. Peter P. Reese|215-898-6086|peter.reese@uphs.upenn.edu|
301386|NCT02018822|University of Rochester|Hans Malmstrom|585-275-5087|hans_malmstrom@urmc.rochester.edu|
301387|NCT02018887|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
301388|NCT02019069|Stanford University|Rondeep Singh Brar|(650) 498-6000|rbrar@stanford.edu|
301389|NCT02019108|University of British Columbia|Dr. Michael Hunt|604-827-4721|michael.hunt@ubc.ca|
301390|NCT02019264|Eisai Ltd|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
301391|NCT02019277|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
301392|NCT02019420|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301393|NCT02019472|Janssen-Cilag International N.V.|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
301394|NCT02019550|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
301395|NCT02019563|The Hospital for Sick Children|Trang Nguyen|6473300825|trang.nguyen@easternhealth.ca|
301396|NCT02019602|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
301397|NCT02019667|National Institutes of Health|Dr. William Theodore|301-496-1505|theodorw@ninds.nih.gov|
301398|NCT02019719|GlaxoSmithKline|GSK Response Center|866-435-7343||
301399|NCT02019758|University of North Carolina at Chapel Hill|Evan S. Dellon, MD MPH|919-966-2513|edellon@med.unc.edu|
301400|NCT02019888|NCRAR|M. Patrick Feeney|503-273-5306|Patrick.Feeney@va.gov|
301401|NCT02019927|Will Eye Hopsital|Ann Murchison MD|267-733-9617|Visionresearch@willseye.org|
301402|NCT02019940|Yale School of Medicine|Chadi Abdallah|347-987-0717|chadi.abdallah@yale.edu|
301403|NCT02019979|Icahn School of Medicine at Mount Sinai|Dr. Anish Parikh|(212) 241-4705|anish.parikh@mountsinai.org|
301404|NCT02020018|Mayo Clinic|Dr. Hartzell V. Schaff|507-255-7066|schaff.hartzell@mayo.edu|
301405|NCT02020031|Mayo Clinic|Dr. Mark J. Spanghel|480-301-5685|Spangehl.Mark@mayo.edu|
301406|NCT02020135|Progenics Pharmaceuticals, Inc.|Dr. Vincent A. DiPippo|(646) 975-2502|vdipippo@progenics.com|
301407|NCT02020252|University of Chicago Medicine|Toni M Cipriano|574-339-0652|tcipriano@uchicago.edu|
301408|NCT02020278|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
301409|NCT02020304|Wake Forest School of Medicine|Vernon H Ross MD|336-718-8278|vhross@wakehealth.edu|
301410|NCT02020369|LFB USA Inc.|Jeffry Lawrence, MD, Vice President, Clinical Development|+1.508.370.5113|jeffry.lawrence@lfb-usa.com|
301411|NCT02020408|UCSD Department of Psychiatry|Walter H. Kaye, MD|858-534|wkaye@ucsd.edu|8019
301412|NCT02020512|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
301413|NCT02020577|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301414|NCT02020590|Bone Therapeutics|Chief Medical Officer|+32 71 12 10 00|regulatory@bonetherapeutics.com|
301415|NCT02020616|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
301416|NCT02020785|Geisinger|Alex Chang, MD|570-271-8026|achang@geisinger.edu|
301417|NCT02020863|University of California, Irvine Health|Maxime Cannesson, PhD|714- 456-5059|mcanness@uci.edu|
301418|NCT02020889|GlaxoSmithKline|GSK Response Center|866-435-7343||
301419|NCT02020941|IndianaU|Dr. Attaya Suvannasankha|317-944-0920|asuvanna@iu.edu|
301420|NCT02020967|Ipsen|Ipsen Medical Director|see email|clinical.trials@ipsen.com|
301421|NCT02021071|Philips|Rami Nachabe, PhD|+1-513-926-1486|Rami.Nachabe@philips.com|
301422|NCT02021292|Actelion Pharmaceuticals Ltd.|Clinical Trial Disclosure Desk||clinical-trials-disclosure@actelion.com|
291309|NCT01355484|GTx Inc.|Senior Director, Clinical Operations|1-901-261-3795|mdesordi@gtxinc.com|
291310|NCT01355497|GTx Inc.|Senior Director, Clinical Operations|1-901-261-3795|mdesordi@gtxinc.com|
291311|NCT01355523|Herlev Hospital, Department of Surgery|MD Melissa Voigt Hansen|+45 20661119|melissa.voigt.hansen@regionh.dk|
291312|NCT01355575|Imperial College London|Dr Jeremy Cobbold|+44 1865228756|jeremy.cobbold@ndm.ox.ac.uk|
291313|NCT01355588|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
291314|NCT01355627|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
291315|NCT01355679|NMTRC at Spectrum Health|Giselle Sholler, MD|616-267-0334|giselle.sholler@helendevoschildrens.org|
291316|NCT01355705|Stanford University|Michaela Liedtke, MD|650-498-6000|mliedtke@stanford.edu|
291317|NCT01355796|University of Iowa|Janice Launspach|319-356-2047|janice-launspach@uiowa.edu|
291318|NCT01355978|Clinical Research Consuting|Richard J. Morishige, MS, RRT|510-606-0374|rjmorishige@gmail.com|
291319|NCT01356147|Stanford University School of Medicine/Division of Neonatology|Dr. Melissa Scala|650-724-9653|mscala@stanford.edu|
301423|NCT02021318|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0)20 3379 8000|Astellas.resultsdisclosure@astellas.com|
301424|NCT02021331|University of Michigan|Dr. Robert Eber|734-647-4023|reber@umich.edu|
301425|NCT02021461|BIAL - Portela & Cª, S.A.|Director R&D|351-22-9866100|clinical.trials@bial.com|
301426|NCT02021565|Atlanta VA Medical Center|Patricia C. Griffiths|404-321-6111|Patricia.Griffiths@va.gov|7138
301427|NCT02021643|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
301428|NCT02021656|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
301429|NCT02021669|Washington University School of Medicine|Robert M. Carney, Ph.D|314-286-1305|carneyr@wustl.edu|
301430|NCT02021812|W.L. Gore & Associates|Jennifer Gorman|928-863-8483|jgorman@wlgore.com|
301431|NCT02021929|University of Pennsylvania|Dr. Steven Kawut|215-573-0258|kawut@upenn.edu|
301432|NCT02021942|Klinik und Poliklinik für Neurologie der Universitaet Regensburg|Prof. Dr. Berthold Schalke|+49 941 941|berthold.schalke@medbo.de|3010
301433|NCT02021955|VA Puget Sound Health Care Sysem|Margaret Collins|206.764.2085|margaret.collins@va.gov|
301434|NCT02022007|Woman''s Hospital|Dr Karen Elkind-Hirsch|225-231-5275|karen.elkind-hirsch@womans.org|
301435|NCT02022020|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301436|NCT02022033|Brown University Oncology Research Group|Howard Safran, MD|401-863-3000|BrUOG@BROWN.EDU|
301437|NCT02022085|Radboud University Medical Centre, Nijmegen, The Netherlands|Professor Emmanuel Mylanus|+31 24 361 1111|Emmanuel.Mylanus@radboudumc.nl|
301438|NCT02022111|Emory University|Mohammed Kumail Ali, MD|404-727-9776|mkali@emory.edu|
301439|NCT02022657|Skaggs School of Pharmacy, University of Colorado Anschutz Medical Campus, Aurora|Dr. Peter Anderson|3037246821|peter.anderson@ucdenver.edu|
301440|NCT02022670|University of Colorado Boulder|Dr. Allison DeVan|303-735-6410|allison.devan@colorado.edu|
301441|NCT02022735|University of Miami|Corneliu Luca, MD, PhD|305-243-6732|cluca@med.miami.edu|
301442|NCT02022748|AstraZeneca Pharmaceuticals LP|Naeem Khan, MD|+1 302-885-8976|Naeem.Khan@astrazeneca.com|
301443|NCT02022826|Medtronic|Michal Kedar-Datel|+972-4-9097952|michal.kedar-datel@medtronic.com|
301444|NCT02023099|AbbVie|Global Medical Services|800-633-9110||
301445|NCT02023112|AbbVie|Global Medical Information|800-633-9110||
301446|NCT02023125|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
301447|NCT02023151|Johns Hopkins University|Sarbjit Saini|4105502191|ssaini@jhmi.edu|
311077|NCT02845752|The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center|Dr. Harry Rossiter|3102228200|hrossiter@lundquist.org|
311078|NCT02846233|University of California San Francisco, Fresno Medical Education Program|SOE NAING|5593239236|snaing@fresno.ucsf.edu|
311079|NCT02846324|Global Blood Therapeutics|Nick Vlahakis|1 650 8228756|nvlahakis@gbt.com|
311080|NCT02846415|School of Nursing, The Hong Kong Polytechnic University|Dr Daphne Cheung|+852 27664534|cheungdaphne@polyu.edu.hk|
311081|NCT02846558|Johns Hopkins Department of Neurology|Dr. Ellen Mowry, M.D., M.C.R.|410-502-0675|emowry1@jhmi.edu|
311082|NCT02846714|Huntsman Cancer Institute University of Utah|Dr. Yelena Wu|8012135653|yelena.wu@utah.edu|
311083|NCT02846740|University of Maryland Baltimore|Nithin krishna|4103286661|nkrishna@som.umaryland.edu|
311084|NCT02846779|Brigham and Women's Hospital|Niteesh K. Choudhry, MD, PhD|617-278-0930|nkchoudhry@bwh.harvard.edu|
311085|NCT02846792|University of Washington|Research Manager|206-606-7445|smasters@seattlecca.org|
311086|NCT02847169|CooperVision Inc.|Senior Manager Global Medical Scientific Affairs|925 621-3761|javega@coopervision.com|
311087|NCT02847182|Duke University|Jesse D. Troy, PhD, MPH|919-668-1102|cordbloodtherapyinfo@dm.duke.edu|
311088|NCT02847260|United Therapeutics Corporation|Leigh Peterson, Director, Product Development, Product Development & Global Clinical Operations|919-425-8165|lpeterson@unither.com|
311089|NCT02847494|Montefiore Health|Benjamin W. Friedman, MD|17189206626|befriedm@montefiore.org|
311090|NCT02847650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
311091|NCT02847858|University of California San Francisco|Dr. Kathleen Tebb|415-514-0941|Kathleen.Tebb@ucsf.edu|
311092|NCT02848079|Yale University|Dr. Jeremy Kortmansky|1 (203) 407-8002|jeremy.kortmansky@yale.edu|
311093|NCT02848222|University of Alabama at Birmingham|Dr Jason Nichols|205-975-3497|jjn@uab.edu|
311094|NCT02848313|Stealth BioTherapeutics, Inc|Jim Carr, Pharm.D. Chief Clinical Development Officer|1-617-600-6888|jim.carr@stealthbt.com|
311095|NCT02848326|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
291320|NCT01356277|McGill University Health Centre|Dr. Bethany Foster|514-412-4461|bethany.foster@mcgill.ca|
291321|NCT01356407|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
301448|NCT02023242|Ivantis, Inc.|Richard Hope|949-333-1310|rhope@ivantisinc.com|
291322|NCT01356498|Savient Pharmaceuticals, Inc.|Chief Medical Officer|732-418-9300||
291323|NCT01356589|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
291324|NCT01356602|Novartis Pharmaceuticals|Study Director|862-778-8300||
291325|NCT01356628|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Avnish Bhatia|215-955-8874|avnish.Bhatia@jefferson.edu|
291326|NCT01356940|MS Center at Evergreenhealth|Theodore R. Brown, MD|425-899-5350|trbrown@evergreenhealth.com|
291327|NCT01356966|Emory University|Dr. Jeanie Park|404-727-1386|jeanie.park@emory.edu|
291328|NCT01357135|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291329|NCT01357148|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291330|NCT01357161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291331|NCT01357239|Novartis Pharmaceuticals|Study Director|862-778-8300||
301449|NCT02023268|Laboratoires Théa|Dr Pascale Pouliquen|04 73 98 14 36|p.pouliquen@laboratoires-thea.fr|
301450|NCT02023411|PGIMER|Dr Ashu Rastogi|9781001046|ashuendo@gmail.com|
301451|NCT02023515|UKentucky|Kelly Webber, PhD, RD, LD|859-257-4351|kelly.webber@uky.edu|859
301452|NCT02023697|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
301453|NCT02023801|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
301454|NCT02023866|Horizon Pharma USA, Inc.|Evelyn Olson, Director|224- 383-3000|clinicaltrials@horizonpharma.com|
301455|NCT02023879|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
301456|NCT02023918|UCSF|Dr. Ethan Weiss|4155140819|ethan.weiss@ucsf.edu|
301457|NCT02023944|Bedford Veterans Hospital|Maureen K. O'Connor|781-687-2830|maureen.oconnor@va.gov|
301458|NCT02023983|Municipal Hospital Ostrava|dr. Kamil Novobílský|+420 59 619 2660|k.novobilsky@mnof.cz|
301459|NCT02024087|Acceleron Pharma|SVP Regulatory Affairs|617-649-9200|jdesiderio@xlrn.com|9293
301460|NCT02024165|Winnie Palmer Hospital for Women and Babies|John Busowski, MD|407-435-1485|john.busowski@orlandohealth.com|
301461|NCT02024204|NYU Langone|Joan Reibman, MD|212-263-6479|joan.reibman@nyumc.org|
301462|NCT02024386|Duke University School of Medicine|Richard Moon, MD|919-684-6726|richard.moon@duke.edu|
301463|NCT02024477|The George Washington University|Dr Saby Sen|202-994-8560|ssen1@gwu.edu|
301464|NCT02024607|Sumitomo Dainippon Pharma Oncology|Tegan Nguyen|617-674-8745|tnguyen@bostonbiomedical.com|
301465|NCT02024646|Bausch Health|Director of Clinical Trials|310-770-7750|anya.loncaric@bauschhealth.com|
301466|NCT02024698|CooperVision, Inc.|Manager Global Medical/Scientific Affairs|925-621-3761|javega@coopervision.com|
301467|NCT02024711|Bausch Health|Study Director||susan.harris@bauschhealth.com|
301468|NCT02024724|Northwestern University, Feinberg School of Medicine|Antoun Nader, M.D.|312-695-4814|a-nader2@northwestern.edu|
301469|NCT02024750|University of Wisconsin School of Medicine and Public Health|Elizabeth Cox|608-263-9104|ecox@wisc.edu|
301470|NCT02024867|University at Buffalo|Dr. Lucy Holmes|716-878-7277|LHolmes@upa.chob.edu|
301471|NCT02024932|Novartis Pharmaceuticals|Study Director|862-778-1873||
301472|NCT02024971|Takeda Pharmaceuticals Company Limited|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
301473|NCT02025075|Massachusetts General Hospital|Marcos Vidal Melo, MD, PhD|617-726-8980|VidalMelo.Marcos@mgh.harvard.edu|
301474|NCT02025179|Northwestern University|Dr. Thomas Schnitzer|312-503-2315|tjs@northwestern.edu|
301475|NCT02025205|Pulmonx|Narinder Shargill, Vice President, Global Medical and Clinical Affairs|650-216-0108|nshargill@pulmonx.com|
301476|NCT02025426|Duke University, School of Medicine, Department of Anesthesiology|Dr. Ashraf Habib|(919) 681-4544|ashraf.habib@duke.edu|
301477|NCT02025439|Edward Hines VA Hospital|Theresa Bender-Pape|708-202-4953|Theresa.BenderPape@va.gov|
301478|NCT02025530|University of Manchester|Professor Alexander Heazell|+441612766484|alexander.heazell@manchester.ac.uk|
301479|NCT02025621|Duke Clinical Research Institute|Rajendra Mehta, MD Study Principal Investigator|919-668-8971|raj.mehta@dm.duke.edu|
301480|NCT02025634|AdventHealth|Brad Homan|407-303-4270|Brad.Homan.MD@AdventHealth.com|
311096|NCT02848599|University Hospital Osijek, Croatia|Dr. Gordana Kristek|+385915115746|gordanaldrmed@yahoo.com|
311097|NCT02848651|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
311098|NCT02848664|James Madison University|Dr. Erin Kamarunas|540-568-8846|kamaruee@jmu.edu|
311099|NCT02848729|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
311100|NCT02848833|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311101|NCT02849080|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
311102|NCT02849184|Jichi Medical University School of Medicine|Professor Kazuomi Kario|+81-285-58-7538|kkario@jichi.ac.jp|
311103|NCT02849418|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311104|NCT02849509|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311105|NCT02849678|University of Pittsburgh Medical Center Department of Anesthesiology|Jacques E. Chelly, MD, PhD, MBA|412-623-6382|chelje@anes.upmc.edu|
311106|NCT02849704|Children's Hospital of Philadelphia|Virginia Stallings, MD|267.425.1633|stallingsv@email.chop.edu|
311107|NCT02849938|Billings Clinic|Patricia M Notario, MD|406-238-2143|pnotario@billingsclinic.org|
311108|NCT02850068|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
311109|NCT02850159|Samsung Medical Center|Dr. Won Hyuk Chang|82234102818|wh.chang@samsung.com|
311110|NCT02850276|Icahn School of Medicine at Mount Sinai|Dr. Jessica Robinson-Papp|212-241-8390|jessica.robinson-papp@mssm.edu|
311111|NCT02850601|BWH|Dr. Herve Sroussi|617 5256864|hsroussi@bwh.harvard.edu|
301481|NCT02025647|NCS Pearson|Dr. Paul E Williams, Sr. Research Director|952-681-4553|paul.e.williams@pearson.com|
291332|NCT01357356|Serenity Pharmaceuticals|Chief Medical Officer|8456396760|sfein@serenitypharma.com|17
291333|NCT01357512|Oulu University Hospital and Univeristy of Oulu|Chief urologist Markku Vaarala|+3588315|markku.vaarala@oulu.fi|2840
291334|NCT01357525|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
291335|NCT01357551|Durham VA Medical Center|Dr. Corrine Voils|9192860411|corrine.voils@va.gov|5196
291336|NCT01357564|Center of Innovation on Disability and Rehabilitation Research, Department of Veterans Affairs; St. Catherine University, Department of Occupational Therapy|Dr. Paul Arthur|3176881499|pbarthur824@stkate.edu|
291337|NCT01357577|VA National Center for PTSD|Jessica L. Hamblen, PhD|8022965132|jessica.hamblen@va.gov|
291338|NCT01357616|Alcon Research, Ltd.|Mandy Ye, Head, Clinical Trial Management, Asia|1-888-451-3739|alcon.medinfo@alcon.com|
291339|NCT01357655|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
291340|NCT01357720|Crucell Switzerland AG|Medical Affairs Director|+41(0)319086111|info@crucell.com|
291341|NCT01357850|GlaxoSmithKline|GSK Response Center|866-435-7343||
291342|NCT01357889|GlaxoSmithKline|GSK Response Center|866-435-7343||
301482|NCT02025725|Evoke|Chief Medical Officer|858-345-1494|mcarlson@evokepharma.com|206
301483|NCT02025751|Evoke Pharma|Chief Medical Officer|8589457189|mcarlson@evokepharma.com|
301484|NCT02025829|Riley Hospital for Children|Dr. James Chmiel|317-948-7180|jfchmiel@iu.edu|
301485|NCT02025907|Janssen Research & Development, LLC|Senior Director, Clinical Leader||ClinicalTrialDisclosure@its.jnj.com|
301486|NCT02025985|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
301487|NCT02026011|University of California, Los Angeles|Lara Ray|310-794-5383|lararay@psych.ucla.edu|
301488|NCT02026063|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD|281-863-3000|plapuerta@lexpharma.com|
301489|NCT02026141|University of Saskatchewan-Department of Anesthesia|Dr. Ian Chan|306-717-8028|iac549@mail.usask.ca|
301490|NCT02026193|Rambam health Care campus|Dr Shahar Kol , Director IVF Unit|97247773232|skol@rambam.health.gov.il|
301491|NCT02026206|Pusan Natinal University Yangsan Hospital|Professor Yong-Il Shin|82-55-360-2872|rmshin01@gmail.com|
301492|NCT02026258|UConn Health|Flavio Uribe|8606793656|furibe@uchc.edu|
301493|NCT02026297|Brigham and Women's Hospital|Dr. Michaela K. Farber|6177591609|mfarber@bwh.harvard.edu|
301494|NCT02026453|Cedars-Sinai Medical Center|Dr. Joshua M. Pevnick|310-423-6976|Joshua.Pevnick@cshs.org|
301495|NCT02026687|Dept of anaesthesia, Linköping University Hospital, Sweden|Dr Lena Nilsson|0046101030000|lena.nilsson@regionostergotland.se|
301496|NCT02027025|Sun Pharma Advanced Research Company Limited|Mudgal Kothekar|912266455645|mudgal.kothekar@sparcmail.com|
301497|NCT02027311|Digestive Disease Center and Department of Internal Medicine, Cheju Halla General Hospital|Dr. Byung Hyo Cha, Director of ETOMI-1 study|+82-64-740-8050|drhyo@hotmail.com|
301498|NCT02027376|Spanish Breast Cancer Research Group|Scientific Director / Medical Lead / Project Manager|+34916592870|geicam@geicam.org|
301499|NCT02027402|Seoul St Mary's hospital|Teaho Hong|821052065266|gshth@catholic.ac.kr|
301500|NCT02027428|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
301501|NCT02027545|VA Ann Arbor Healthcare System|Sameer D. Saini, MD, MS|734-845-5865|sameer.saini@va.gov; sdsaini@med.umich.edu|
301502|NCT02027558|VA Greater Los Angeles Healthcare System|Cathy Alessi, MD|818-891-7711|Cathy.Alessi@va.gov|39311
301503|NCT02027623|Washington University|Linda van Dillen, PT, PhD, FAPTA; Research Division Director|314-286-1427|vandillenl@wustl.edu|
301504|NCT02027701|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
301505|NCT02027844|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Deagu, Repulic of Korea|Sun Mee Jung, M.D.|+82-53-620-3368|applejsm@gmail.com|
301506|NCT02027883|Wellmont CVA Heart Institute|Terrie Walker, Director of Clinical Research|423-230-5643|twalker@mycva.com|
301507|NCT02028065|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301508|NCT02028169|AbbVie|Global Medical Services|800-633-9110||
311112|NCT02850965|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311113|NCT02850978|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311114|NCT02851069|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
311115|NCT02851108|Heidelberg University|Prof. Dr. Olaf Müller|+49 6221 56 4904|olaf.mueller@urz.uni-heidelberg.de|
311116|NCT02851615|Cincinnati Children's Hospital Medical Center|Dr. Lori Crosby|513-636-5380|Lori.Crosby@cchmc.org|
311117|NCT02851823|Izmir Katip Celebi University, Dentistry Faculty|Assoc.Prof.Dr. Mehmet Sağlam|+90 530 324 99 48|dtmehmetsaglam@gmail.com|
311118|NCT02852005|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
311119|NCT02852265|University of California, Davis|Dr. Melissa Chen|916-734-6670|mejchen@ucdavis.edu|
311120|NCT02852330|Cochlear|Bernadette Pickering|+61296115909|bpickering@cochlear.com|
311121|NCT02852434|Stanford University Division of Family Planning Services and Research|Stanford University, Department of OB/GYN|6507211562|familyplanningresearch@stanford.edu|
311122|NCT02852967|Kadmon Corporation, LLC|Olivier Schueller, Senior Vice President, CMC & Clinical Pharmacology|724-778-6170|olivier.schueller@kadmon.com|
311123|NCT02853032|University of Texas Health -- San Antonio|Felipe S. Salinas, Ph.D.|210-567-8214|salinasf@uthscsa.edu|
311124|NCT02853123|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311125|NCT02853305|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
311126|NCT02853318|Roswell Park Comprehensive Cancer Institute|Katy Wang, Statistician, M.A.|7168451300|katy.wang@roswellpark.org|6269
311127|NCT02853435|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
291343|NCT01357915|GlaxoSmithKline|GSK Response Center|866-435-7343||
291344|NCT01357980|Ipsen|Medical Director Neurology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
291345|NCT01358175|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
291346|NCT01358266|Santen Inc.|Clinical Operations|+1-415-268-9100|clinicaltrials@santen.com|
291347|NCT01358331|Merck Sharp & Dohme Corp.|Clinical Trials Disclosure||ClinicalTrialsDisclosure@merck.com|
291348|NCT01358357|Sunovion Pharmaceuticlas Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
301509|NCT02028182|Allerderm(dba) SmartPractice|Kathryn Shannon|6022250595|kshannon@smarthealth.com|
301510|NCT02028208|Allerdern (dba) SmartPractice|Kathryn Shannon|602 225 0595|kshannon@smarthealth.com|7208
301511|NCT02028221|University of Arizona|Sherry Chow, PhD|5206263358|schow@azcc.arizona.edu|
301512|NCT02028247|Baylor College of Medicine|Dr. Eric Storch|7137983579|eric.storch@bcm.edu|
301513|NCT02028325|Indiana University|Aaron Cohen-Gadol, MD, MSc|317-362-8760|acohen@goodmancampbell.com|
301514|NCT02028676|Medical Research Council|Professor Ann Sarah Walker|+44 20 7670 4726|rmjlasw@ucl.ac.uk|
301515|NCT02028715|Aultman Hospital|Director of Research Programs|330-363-7274|mary.amos@aultman.com|
301516|NCT02028754|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
301517|NCT02028767|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301518|NCT02028780|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301519|NCT02028871|University of Illinois at Chicago|Dr. Ajna Hamidovic|312-355-1713|ahamidov@uic.edu|
301520|NCT02029040|UT Southwestern Medical Center|Mohamed Badawy, MD|2144567106|Mohamed.Badawy@UTsouthwestern.edu|
301521|NCT02029196|Fontem Ventures|Dr Ana Cravo|+441173322528|AnaMaria.Cravo@fontemventures.com|
301522|NCT02029235|Penn State Health Milton S. Hershey Medical Center|Alexander Payatakes, MD|717-531-4805|apayatakes@pennstatehealth.psu.edu|
301523|NCT02029274|Novartis Pharmaceuticals|Study Director|862-778-8300||
301524|NCT02029417|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
301525|NCT02029495|Valeant Pharmaceuticals|Director of Clinical Trials|908|binu.alexander@valeant.com|
301526|NCT02029521|Intermountain Healthcare|Clark Bishop|385 224 7343|clark.bishop@imail.org|
301527|NCT02029638|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
301528|NCT02029703|Cleveland Clinic|M. Elaine Husni, MD, MPH|216-445-1853|HUSNIE@CCF.ORG|
301529|NCT02029755|Taipei medical university hospital|Dr. Hsiao-Chien Tsai|+886-2-27372181|hctsai.anes@gmail.com|8310
301530|NCT02029872|Johns Hopkins University School of Nursing|Dr. Jason Farley|4105027563|jfarley1@jhu.edu|
301531|NCT02029911|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
301532|NCT02029976|George Mason University, College of Health and Human Services|Dr. Martha Y Kubik, Professor and Director School of Nursing|703-993-1971|mkubik@gmu.edu|
301533|NCT02029989|UMN, College of Pharmacy|Dr. Mark E. Schneiderhan|8452540458|meschnei@d.umn.edu|
301534|NCT02030002|University of Minnesota|Thorsten Gruenheid|612-625-3903|tgruenhe@umn.edu|
301535|NCT02030041|PGIMER|Anil Bhansali|01722756583|ashuendo@gmail.com|
301536|NCT02030080|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@upenn.edu|
301537|NCT02030119|Division of General Internal Medicine, Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@upenn.edu|
301538|NCT02030288|VA Boston Healthcare System|Nicholas Livingston|857-364-6360|nicholas.livingston@va.gov|
301539|NCT02030405|Stanford University Medical Center|Bruno Carneiro de Medeiros, MD|650-498-6000|bruno.medeiros@stanford.edu|
311128|NCT02853760|University of Innsbruck, Department of Sport Science|Martin Niedermeier||martin.niedermeier@uibk.ac.at|
311129|NCT02853929|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311130|NCT02854059|Hansa Biopharma AB|Elisabeth Sonesson (Director Clinical Operations)|+46 (0)708 54 86 46|elisabeth.sonesson@hansabiopharma.com|
311131|NCT02854527|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311132|NCT02854540|Stanford School of Medicine|Dr. Marlyanne Pol-Rodriguez|650-721-7144|mpr@stanford.edu|
311133|NCT02854605|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311134|NCT02854631|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311135|NCT02854800|West Virginia University|Dr. Melissa Blank|304-293-8341|Melissa.Blank@mail.wvu.edu|
311136|NCT02855060|Atrium Health|Rachel Seymour|74-355-6969|rachel.seymour@atriumhealth.org|
311137|NCT02855086|Stanford University Medical Center|Gordon Li, MD, Associate Professor of Neurosurgery|650-721-1020|gordonli@stanford.edu|
311138|NCT02855164|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
311139|NCT02855281|Hospital Bethanien Solingen, Clinic of Pneumology and Allergology, Center for Sleep Medicine and Respiratory Care, Solingen, Germany|Dr. Lars Hagmeyer|0212636004|institut@klinik-bethanien.de|
311140|NCT02855359|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
311141|NCT02855437|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
311142|NCT02855450|Dompè|Flavio Mantelli, MD, PhD|+39 02583831|info@dompe.com|
311143|NCT02855541|University of Colorado Boulder|James Peterman, PhD|303-735-0358|james.peterman@colorado.edu|
311144|NCT02855567|Icahn School of Medicine at Mount Sinai|Dr. Charles Ascher-Walsh|212-241-2827|Charles.ascher-walsh@mssm.edu|
311145|NCT02856035|Department of Veterans Affairs, N Fl/S Georgia VA Medical Center|Dr. Janis J Daly|216 402 8940|jjd17@case.edu|
311146|NCT02856282|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311147|NCT02856490|Joylux|Colette Courtion|206.219.6444|sophia@joylux.com|
291349|NCT01358526|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
291350|NCT01358578|Novartis|Study Director|862-778-8300||
291351|NCT01358708|Aptalis Pharma US, Inc.|Robert Winkler MD, VP, Clinical Development and Operations|(908) 429-4479|rwinkler@aptalispharma.com|4175
291352|NCT01358721|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
291353|NCT01358734|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@celgene.com|
291354|NCT01358760|Endoceutics|Director of Data Analysis|418-653-0033|celine.martel@endoceutics.com|215
291355|NCT01358825|GlaxoSmithKline|GSK Response Center|866-435-7343||
291356|NCT01358864|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291357|NCT01358877|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
291358|NCT01358968|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
301540|NCT02030535|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301541|NCT02030574|Brown Oncology Research Groupl|Kristen M. Mitchell|4018633000|kristen_mitchell@brown.edu|
301542|NCT02030600|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
301543|NCT02030821|Duke University|Michael Bolognesi, M.D.|919-668-4732|michael.bolognesi@duke.edu|
301544|NCT02030834|University of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
301545|NCT02030847|Abramson Cancer Center of the University of Pennsylvania|Noelle Frey, MD|215-662-6901|noelle.frey@uphs.upenn.edu|
301546|NCT02030886|Yale School of Medicine|Dr James Liu|+1 203 785 2020|liu.ji@yale.edu|
301547|NCT02031146|University of Washington|Christina Marra, MD|206-744-3251|cmarra@uw.edu|
301548|NCT02031237|University of Michigan Comprehensive Cancer Center|Dr. Yue Cao|(734) 936-8695|yuecao@umich.edu|
311148|NCT02856555|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311149|NCT02856802|Upsher-Smith Laboratories, LLC|Clinical Operations|(763) 315-2000|uslinfo@upsher-smith.com|
311150|NCT02856828|Duke University Health Systems|Dr. Rachel Reilly|919-668-0291|rachel.reilly@duke.edu|
311151|NCT02856880|GlaxoSmithKline|GSK Response Center|866-435-7343||
311152|NCT02857283|UNC Center for Environmental Medicine, Asthma and Lung Biology|Michelle Hernandez, MD|919-843-5383|michelle_hernandez@med.unc.edu|
311153|NCT02857816|Medtronic Pelvic Health & Gastric Therapies|Beth Michaud / Sr. Principal Clinical Research Specialist|763.526.8102|beth.m.michaud@medtronic.com|
311154|NCT02858050|Saint Michael's Medical Center|Jihad Slim, MD|9738772663|jsmdsmmc@gmail.com|
291359|NCT01358981|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
301549|NCT02031276|Boehringer Ingelheim|Boehringer Ingelheim Call Center|+1 800 243 0127|clintriage.rdg@boehringer-ingelheim.com|
291360|NCT01359007|University of Oklahoma|Ingrid Block - CTO Directo|405-271-8777|ingrid-block@ouhsc.edu|
291361|NCT01359046|Mayo Clinic|Dr. John Gebhart|507-266-7711|gebhart.john@mayo.edu|
291362|NCT01359111|PATH|Courtney Jarrahian|206-285-3500|cjarrahian@path.org|
291363|NCT01359150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291364|NCT01359371|VA Center for Clinical Management Research Health Services|Sonia A. Duffy, Ph.D., R.N., FAAN|734.395.0613|Sonia.Duffy@va.gov|
291365|NCT01359410|Washington University School of Medicine|William Hawkins, M.D.|314-362-7046|hawkinsw@wustl.edu|
291366|NCT01359449|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
291367|NCT01359592|SWOG Statistics and Data Management Center|Lymphoma Committee Statistician|206-667-4623|lymph@crab.org|
291368|NCT01359644|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Trials@bms.com|
301550|NCT02031302|Boston Scientific Corp.|Blessie Concepcion, Director Clinical Trials|408-385-8604|Blessie.Concepcion@bsci.com|
301551|NCT02031432|Grünenthal GmbH|Director of Clinical Trials|+49 241 569 3223|Clinical-Trials@grunenthal.com|
301552|NCT02031458|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
301553|NCT02031471|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
301554|NCT02031536|ECOG-ACRIN Statistical Office|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
301555|NCT02031627|Tactile Medical|Susy Peters, Clinical Trial Manager|612-540-7175|speters@tactilemedical.com|
301556|NCT02031640|Teva Branded Pharmaceutical Products, R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
301557|NCT02031679|Johns Hopkins University School of Medicine|Dr. Eric Oliver|410-550-2300|eolive15@jhmi.edu|
301558|NCT02031770|University of Colorado Denver|Dr. Jessica Kendrick|3037244837|Jessica.Kendrick@ucdenver.edu|
301559|NCT02031978|USDA Food and Nutrition Service|Courtney Paolicelli|7036054370|Courtney.Paolicelli2@usda.gov|
301560|NCT02032173|Novartis Pharmaceuticals|Study Director|862-778-1873||
301561|NCT02032212|Imperial Tobacco Group|Tanvir Walele|0044 177 933 7589|tanvir.walele@uk.imptob.com|
301562|NCT02032238|OD-OS GmbH|Ulrike Weber|+49 332831282|ulrike.weber@od-os.com|100
301563|NCT02032407|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
301564|NCT02032420|University of New Mexico|Dr. Nicholas Lam|505-272-2610|nlam@salud.unm.edu|
301565|NCT02032433|NYU School of Medicine|John Rotrosen|646-754-4763|john.rotrosen@nyumc.org|
301566|NCT02032550|University of Pennsylvania|Ravishankar Jayadevappa|215-898-3798|jravi@pennmedicine.upenn.edu|
301567|NCT02032641|Bascom Palmer Eye Institute|Dr. Sara T. Wester|3053266132|SWester2@med.miami.edu|
301568|NCT02032680|VA, University of Pittsburgh|Dr. Armando Rotondi|412-360-2494|ArmandoRotondi1@gmail.com|
301569|NCT02032706|Advanced Brain Monitoring, Inc.|Daniel Levendowski|760 720 0099|dan@b-alert.com|x6040
301570|NCT02032758|Mayo Clinic in Arizona|Dr. Charles H. Adler|480-301-8100|cadler@mayo.edu|
301571|NCT02032810|H. Lee Moffitt Cancer Center and Research Institute|Dr. Nikhil I. Khushalani|813-745-3437|nikhil.khushalani@moffitt.org|
301572|NCT02032875|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
301573|NCT02032888|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
301574|NCT02032901|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
301575|NCT02033005|Imperial College London|Dr Chris Gale|+44 (0) 2033153519|christopher.gale@imperial.ac.uk|
301576|NCT02033083|Planned Parenthood of New York City|Director of Clinical Training and Research|212-274-7340|ctri@ppnyc.org|
301577|NCT02033174|IiSGM|Dr Alvarez-Sala|+34 915868287|luisantonio.alvarezsala@salud.madrid.org|
311155|NCT02858076|JAEB CENTER FOR HEALTH RESEARCH|Adam Glassman|8139758690|drcrnet@jaeb.org|
311156|NCT02858154|Cincinnati Children's Hospital Medical Center|Dr. Neepa Gurbani|513-736-1814|Neepa.Gurbani@cchmc.org|
311157|NCT02858180|Duke University|Andrew Muir, MD|919-684-2052|muir0002@duke.edu|
301578|NCT02033200|Vivus Inc|VP of Development|650-934-5200||
291369|NCT01359735|Smith & Nephew|Jaime E Dickerson, PhD|1-817-302-3914|Jaime.Dickerson@smith-nephew.com|
291370|NCT01359748|Aguiflai Iberica, SL|Angel Pons Ferré|+34 93 7540370|calidad@keito.com|
291371|NCT01359904|MUHC|Sameena Iqbal|5149341934|sameena.iqbal@mcgill.ca|44034
291372|NCT01359943|Novartis Pharmaceuticals|Study Director|862-778-8300||
291373|NCT01359956|NCI Naples|Paolo A Ascierto, M.D., Ph.D|+39 081 5903431|p.ascierto@istitutotumori.na.it|
291374|NCT01360021|Astrazeneca|Goran Eckerwall, MD||aztrial_results_posting@astrazeneca.com|
291375|NCT01360229|University of Colorado School of Medicine|Dr. Benzi Kluger|3037242194|benzi.kluger@ucdenver.edu|
291376|NCT01360398|GlaxoSmithKline|GSK Response Center|866-435-7343||
291377|NCT01360450|Johns Hopkins Medical Institution|Estelle B Gauda|4106140151|egauda1@jhmi.edu|
291378|NCT01360554|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
301579|NCT02033213|KBC Zagreb|Maja Karaman Ilić, MD PhD|00385 1 2385 122|majakilic1@gmail.com|
301580|NCT02033317|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
301581|NCT02033369|NYSPI|Franklin Schneier, MD|646-774-8041|fschneier@nyspi.columbia.edu|
301582|NCT02033382|NYU Langone Health|Principal Investigator|646-754-4843|donald.goff@nyumc.org|
301583|NCT02033499|University of North Carolina at Chapel Hill|Dr. Katrina Donahue|919-966-5090|Katrina_Donahue@med.unc.edu|
301584|NCT02033694|Infraredx, A Nipro Company|Priti Shah|781-345-9646|pshah@infraredx.com|646
301585|NCT02033759|Mercy Integrative Medicine|Sarah Stolker, MSPT, CLT-LANA|13145402858|sarah@stolker.com|
301586|NCT02033850|'L. Sacco' Department of Biomedical and Clinical Sciences University of Milan|Prof. Leonardo Pantoni, Principal Investigator|0039-02-50319865|leonardo.pantoni@unimi.it|
301587|NCT02033876|Mayo Clinic|Dr. Michael Camilleri|507-284-2687|camilleri.michael@mayo.edu|
301588|NCT02033889|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301589|NCT02033993|Canadian Cancer Trials Group|Dr. Wendy Parulekar|613-533-6430|wparulekar@ctg.queenus.ca|
301590|NCT02034006|Novartis Pharmaceuticals|Study Director|862-778-8300||
301591|NCT02034019|Ocular Therapeutix, Inc.|Director, Clinical Affairs|781-357-4000|dmulani@ocutx.com|
301592|NCT02034058|Stryker Neurovascular|Alice Lin, Clinical Program Manager|510 413 2673|alice.lin@stryker.com|
301593|NCT02034162|Janssen R&D US|DIRECTOR CLINICAL LEAD||ClinicalTrialDisclosure@its.jnj.com|
301594|NCT02034175|Somnarus Inc|Maria Merchant|4087610884|somnarus@gmail.com|
301595|NCT02034409|VA Salt Lake City Health Care System|Daniel Clegg, MD|801-582-1565|daniel.clegg@va.gov|
301596|NCT02034435|Vanderbilt University Medical Center|Dr. James M. Luther, MD|(615) 936-3420|james.luther@vumc.org|
301597|NCT02034474|NYSPI|Ragy Girgis,MD|6467745553|ragy.girgis@nyspi.columbia.edu|
301598|NCT02034513|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
301599|NCT02034552|Bayer|Therapeutic Area Head|(+)1-888-84 22937|clinical-trials-contact@bayer.com|
301600|NCT02034565|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
301601|NCT02034578|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
301602|NCT02034591|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
301603|NCT02034708|Guerbet|Corinne Dubourdieu, PharmD, Head of Clinical Projects and Medical|+33 (0) 1 45 91 51 84|corinne.dubourdieu@guerbet-group.com|
301604|NCT02034799|Ethicon, Inc|Senior Director of Ethicon Clinical R&D|(908) 218-2492|jbatill2@its.jnj.com|
301605|NCT02034877|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
301606|NCT02034916|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
301607|NCT02035202|UCSD|Colin Depp|858 822 4251|cdepp@ucsd.edu|
311158|NCT02858349|University of Cincinnati|Pierce Boyne|5135587499|Pierce.Boyne@uc.edu|
311159|NCT02858362|Summit Therapeutics|Clinical Disclosure|Please Email|clinicaltrials@summitplc.com|
311160|NCT02858401|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311161|NCT02858440|GlaxoSmithKline|GSK Response Center|866-435-7343|lrs54533@gsk.com|
311162|NCT02858492|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311163|NCT02858713|Department of Dermatology, Odense University Hospital|M.D. Mathias Tiedemann Svendsen|+45 61265827|m_tiedemann@hotmail.dk|
311164|NCT02858726|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
311165|NCT02859142|University of Chicago|Andrea King, Ph.D.|7737026181|aking@yoda.bsd.uchicago.edu|
311166|NCT02859246|Massachusetts Eye and Ear Infirmary|Dr. Reza Dana|617-573-4331|Reza_Dana@meei.harvard.edu|
311167|NCT02859324|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
311168|NCT02859441|National Institutes of Health|Henry E Wiley, M.D., Principal Investigator, NEI|301-496-6583|wileyhe@nei.nih.gov|
311169|NCT02859454|National Cancer Institute|Scott Norberg, DO|301-275-9668|scott.norberg@nih.gov|
311170|NCT02859597|Montefiore Medical Center|Dr.Jay Berger|7189204316|jberger@montefiore.org|
291379|NCT01360632|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
291380|NCT01360645|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
301608|NCT02035267|Allergan, Inc|Beta Bowen|1-714-246-4446|Bowen_Beta@allergan.com|
301609|NCT02035332|Minerva Surgical, Inc.|Dr. Eugene Skalnyi, VP Medical Affairs|(1) 650-284-3500|eugenes@minervasurgical.com|
301610|NCT02035345|Massachusetts General Hospital|Dr. Aleena Banerji|6177263850|abanerji@mgh.harvard.edu|
291381|NCT01360762|Institute of Tropical Medicine Antwerp|Johan Van Griensven|+32(0)32476426|jvangriensven@itg.be|
291382|NCT01360840|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
291383|NCT01360866|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|609 524 6788|clinicaltransparency@otsuka-us.com|
291384|NCT01360996|Woman's Hospital|Dr Karen Elkind-Hirsch|225-231-5275|karen.elkind-hirsch@womans.org|
291385|NCT01361009|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291386|NCT01361048|UAB|Dr. Jane Schwebke|205-975-5665|schwebke@uab.edu|
291387|NCT01361113|UNC Lineberger Comprehensive Cancer Center|Robin V. Johnson|919-966-1125|Robin_V_Johnson@med.unc.edu|
291388|NCT01361126|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
291389|NCT01361178|University of Pittsburgh|Andrej Petrov, MD|412-648-6215|petrovaa@upmc.edu|
301611|NCT02035475|OhioHealth|Dr. Ronney Abaza|614-544-8104|ronney.abaza@ohiohealth.com|
301612|NCT02035553|ACADIA Pharmaceuticals Inc.|James Youakim, Vice President, Clinical Development|609-250-6900|jyouakim@acadia-pharm.com|
301613|NCT02035696|Seqirus|Clinical Trial Disclosure Manager||Seqirus.ClinicalTrials@Seqirus.com|
301614|NCT02035748|Alcon, a Novartis company|EMEA Medical Affairs Lead, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
301615|NCT02036294|Johns Hopkins University|Principle Investigator|410-637-7152|habouma1@jhmi.edu|
301616|NCT02036320|Johnson and Johnson Vision Care Inc.|Meredith Jansen,O.D.,M.S., FAAO|904-443-3500|mjanse12@ITS.JNJ.com|1396
301617|NCT02036424|Raj K. Maturi, MD, PC|Raj K. Maturi, MD|317-817-1414|rmaturi@gmail.com|
301618|NCT02036502|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301619|NCT02036515|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301620|NCT02036541|Allergan plc|Rupali Nangia|714-246-6020|rupali.nangia@allergan.com|
301621|NCT02036580|AstraZeneca|Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
301622|NCT02036645|AstraZeneca Pharmaceuticals|Michael Pomfret, Project Director, IMED Neuroscience||Clinicaltrialstransparency@astrazeneca.net|
301623|NCT02036775|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301624|NCT02036840|Nationwide Children's Hospital|Ralph Beltran, MD|614-722-4200|Ralph.Beltran@nationwidechildrens.org|
301625|NCT02036853|Cook Children's Health Care System|Director of Research Operations|682-885-2103|CookChildrensResearch@cookchildrens.org|
301626|NCT02037061|Cleveland Clinic|Dr. Cecile Unger|216-444-0542|ungerc@ccf.org|
301627|NCT02037165|Boehringer Ingelheim pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301628|NCT02037204|UMC Utrecht|Prof. Daniel Saris|000000000000000000|d.saris@umcutrecht.nl|
301629|NCT02037230|University of Michigan Rogel Cancer Center|Theodore Lawrence, M.D., Ph.D.|734-647-9955|tsl@umich.edu|
301630|NCT02037256|Barbara Ann Karmanos Cancer Institute|Dr. Divaya Bhutani|501-680-9229|db3203@cumc.columbia.edu|
301631|NCT02037295|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Jonathan Krakoff, M.D.|(602) 200-5217|jkrakoff@mail.nih.gov|
301632|NCT02037347|Yale University|Brett King MD|203-785-4092|brett.king@yale.edu|
301633|NCT02037425|Clinvest/A Division of Banyan Group Inc.|Dr. Roger Cay, M.D.|417-883-7889|rcady@banyangroupinc.com|
301634|NCT02037438|Stanford University|Dr. Clete Kushida|650-721-7560|clete@stanford.edu|
301635|NCT02037477|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
301636|NCT02037555|Grifols Therapeutics, LLC|Miquel Barceló, PhD|+34 935.712.368|Miquel.Barcelo@grifols.com|
301637|NCT02037568|University of Colorado Denver|Mark L. Laudenslager, PhD|303-724-9277|biel@ucdenver.edu|
301638|NCT02037607|Indiana University|Heather Cero, Research Nurse Manager|317-396-1298|hcero@iupui.edu|
301639|NCT02037776|Osaka Medical College|Kazunari Tominaga, M.D., Ph. D.|+81-72-683-1221|in2139@osaka-med.ac.jp|8096
311171|NCT02860130|Baxter Healthcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
311172|NCT02860286|Epizyme|Kemly Calixte|617-500-0608|kcalixte@epizyme.com|
311173|NCT02860507|Merck Pharmaceuticals|Chadwick Neal / Medical Affairs Director|2056010605|chadwick.neal@merck.com|
311174|NCT02860546|Taiho Oncology, Inc.|Taiho Central|609-250-7336|clinicaltrialinfo@taihooncology.com|
311175|NCT02860845|Laboratorios Ordesa|Roser De Castellar|+34 902105243|Roser.DeCastellar@ordesa.es|
311176|NCT02860988|University of Kentucky|Dr. Joseph Calvert|(859) 323-5771|joe.calvert@uky.edu|
311177|NCT02861118|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
311178|NCT02861131|Oregon Health & Science University|Brandon Togioka|5034944572|togioka@ohsu.edu|
311179|NCT02861534|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
311180|NCT02861586|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
311181|NCT02861664|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311182|NCT02861807|University of New Mexico|Katie Witkiewitz|505-277-4121|katiew@unm.edu|
311183|NCT02861937|Krishnadevaraya college of dental sciences|Dr. Rudrakshi C|080-28467083|drrudrakshi@rediffmail.com|
311184|NCT02862080|The University of Texas Health Science Center at Houston|Marcie Kern, PT, MSPT|713-799-6995|neurorecoveryresearch@memorialhermann.org|
311185|NCT02862106|Institute of Immunology，PLA|Dr.Wu|02368752230|wuyuzhang@yahoo.com|86
311186|NCT02862535|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311187|NCT02862548|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311188|NCT02862574|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
291390|NCT01361217|University of Washington|Nina Isoherranen|206-5432517|ni2@uw.edu|
291391|NCT01361308|Noven Therapeutics, LLC|Sailaja Bhaskar, Executive Director, Clinical Research|(212) 287-0798|sbhaskar@noven.com|
291392|NCT01361464|H. Lee Moffitt Cancer Center and Research Institute|Jeffrey Lancet, M.D.|813-745-6841|jeffrey.lancet@moffitt.org|
291393|NCT01361568|Cara Therapeutics|Frédérique Menzaghi, PhD; Vice President, Research & Development|203-567-1502|fmenzaghi@caratherapeutics.com|
291394|NCT01361594|Emory University|Dr. Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
291395|NCT01361607|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
291396|NCT01361620|George Washington University|Dr. Timothy McCaffrey|(202) 994-8919|mcc@email.gwu.edu|
291397|NCT01361633|Anxiety Disorders Center, Institute of Living/Hartford Hospital|Gretchen Diefenbach, Ph.D.|860-545-7685|gdiefen@harthosp.org|5-7396
301640|NCT02037893|Pernix Therapeutics|Senior Director, Medical and Scientific Affairs|8007932145|egould@pernixtx.com|
301641|NCT02037984|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301642|NCT02038010|Northwestern University|William Gradishar, MD|312 695 4541|w-gradishar@northwestern.edu|
301643|NCT02038023|AUERBACH HEMATOLOGY ONCOLOGY ASSOC|Dr Michael AUERBACH|410-780-4050|MAUERBACHMD@ABHEMONC.COM|
301644|NCT02038036|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
301645|NCT02038049|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
301646|NCT02038075|University of Utah|Dr. Craig Bryan|8015877978|craig.bryan@utah.edu|
301647|NCT02038179|University of Alabama at Birmingham|Dr. Elizabeth Rahn|205-996-6552|elizabethrahn@uabmc.edu|
301648|NCT02038218|DEKK-TEC, Inc.|Dr. Lee Roy Morgan|504-583-6135|lrm1579@aol.com|
311189|NCT02862600|Heart Metabolics, Ltd.|Mark G. Midei, MD, Executive Director and Head of Cardiology|4103715357|markgmidei@gmail.com|410
311190|NCT02862730|Oregon Health and Science University|Dr. Jessica Castle|503-494-7072|castleje@ohsu.edu|
311191|NCT02862912|Columbia University|Dr. Allison Lee|212-305-6494|al3196@cumc.columbia.edu|
311192|NCT02863198|Benha university|dr khalid M Salama|01225861026|dr.khalid_sleem@yahoo.com|
311193|NCT02863263|Mundipharma Singapore Holding Pte. Limited|Valerie Anne Leck|+65 6511 1165|info.rma@mundipharma.com.sg|
311194|NCT02863289|NHS Tayside|Mr Benedict Clift|01382 660111|ben.clift@nhs.net|35160
311195|NCT02863328|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
311196|NCT02863354|Retina Consultants of Houston|Dr. Charles C. Wykoff|713-524-3434|ccwmd@houstonretina.com|
311197|NCT02863419|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
311198|NCT02863575|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
311199|NCT02864069|UCSD|Dr. Amy Jak|8586423742|ajak@ucsd.edu|
311200|NCT02864082|Timber Pharmaceuticals|Alan Mendelsohn, MD|2673004249|amendelsohn@timberpharma.com|
311201|NCT02864316|Sidney Kimmel Comprehensive Cancer Center|Patrick Forde, MBBCh|410-955-3974|pforde1@jhmi.edu|
311202|NCT02864342|AstraZeneca|Medical Director|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
311203|NCT02864355|The Medical University of South Carolina|George Guldan, MD|843-876-5744|guldan@musc.edu|
311204|NCT02864368|Duke University Medical Center|Principal Investigator|(919) 684-5301|dukebrain1@duke.edu|
311205|NCT02864381|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311206|NCT02864394|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
311207|NCT02864706|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
311208|NCT02864732|University of Pittsburgh|Research Assistant|412 4822283|mza7@pitt.edu|
311209|NCT02865187|Wright State University|Steven R Lindheim|858-740-1083|doclalalindheim@gmail.com|
311210|NCT02865343|Harvard Medical School|Dr J. Andrew Taylor|6177585503|jandrew_taylor@hms.harvard.edu|
311211|NCT02865434|Navidea Biopharmaceuticals|Bonnie Abbruzzzese|6147937500|babbruzzese@navidea.com|
311212|NCT02865499|Univ TX Health Science Center San Antonio|Dean L. Kellogg, Jr, MD, PhD|2106175197|kelloggd@uthscsa.edu|
311213|NCT02865538|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
311214|NCT02865590|Department MESVA - University of L'Aquila|Enrico Marchetti DDS, PhD|+39862433304|enrico.marchetti@univaq.it|
311215|NCT02865720|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
311216|NCT02865811|Dana-Farber Cancer Institute|Dr. Ursula Matulonis|617-632-2334|ursula_matulonis@dfci.harvard.edu|
311217|NCT02866175|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
311218|NCT02866643|Stanford University|Clinical Research Manager|6507247826|gynresearch@stanford.edu|
311219|NCT02866695|University of California San Francisco Dept. of Dermatology|Dr. Sarah Arron, MD, PhD|415-353-9684|sarah.arron@ucsf.edu|
311220|NCT02866942|Imperial College London|Dr Paul Turner|+44 20 3312 7754|p.turner@imperial.ac.uk|
311221|NCT02867059|Medicines for Malaria Venture|Andrew Slade|+41 22 555 0415|sladea@mmv.org|
311222|NCT02867150|Optimal Health and Weight Center|Dr. Ellyn Levine M.D.|(619) 567-6914|dr.levine@teamtsfl.com|
311223|NCT02867163|University of New Mexico|Dr. David Siegel|505-272-2610|dsiegel@salud.unm.edu|
311224|NCT02867202|the 1st affiliated hospital of Wenzhou Medical University.|the 1st affiliated hospital of Wenzhou Medical University.|0886-0577-88069525|zfy983023@hotmail.com|
311225|NCT02867605|Cleveland Clinic Foundation|Dr. Carol De la Motte|216 444-5374|delamoc@ccf.org|
311226|NCT02867618|Columbia University|Ana Ignat|212-305-3612|ai2111@cumc.columbia.edu|
311227|NCT02867709|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
291398|NCT01361711|Northwestern University|Shuo Ma, MD, PhD|312-908-5250|shuo-ma@northwestern.edu|
301649|NCT02038543|Mayo Clinic|Dr. John C. Lieske|507-284-2064|Lieske.John@mayo.edu|
291399|NCT01361854|CHU St Pierre|Dr Marie Bruyneel|003225354219|Marie_BRUYNEEL@stpierre-bru.be|
291400|NCT01361867|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@partners.org|
301650|NCT02038569|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
291401|NCT01361919|St. Michael's Hospital|Dr. Paul Dorian|416-864-5104|dorianp@smh.ca|
291402|NCT01362049|University of Vermont Medical Center, Burlington, VT|Dr. Sharon M. Henry|(802) 847-7633|Sharon.Henry@uvm.edu|
291403|NCT01362062|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
291404|NCT01362127|Karolinska Institutet|Fredrik Klevebro|+46858580000|fredrik.klevebro@ki.se|11111
301651|NCT02038647|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
291405|NCT01362140|Amgen Inc.|Study Director|866-572-6436||
291406|NCT01362192|Main Line Center for Laser Surgery|Eric F. Bernstein, M.D., M.S.E.|610-645-5551|dermguy@dermguy.com|
291407|NCT01362205|Denver Health Medical Center|Katie Overdier RN|303 602 1479|Katie.Overdier@dhha.org|
301652|NCT02038764|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
301653|NCT02038790|Indivior, Inc.|Global Director Clinical Development|804-379-1090||
301654|NCT02038829|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
301655|NCT02038881|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
301656|NCT02038894|Cincinnati Children's Hospital Medical Center|Dr. Mario Patino|5132538190|mario.patino@cchcm.org|
301657|NCT02038907|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
301658|NCT02038920|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
301659|NCT02038933|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
301660|NCT02038959|University of Rochester|Ray Dorsey, MD|585-276-6824|ray.dorsey@chet.rochester.edu|
301661|NCT02039115|Center for Interventional Endoscopy|Robin (Barron-Nelson) Kangas|407.303.5503|Robin.Barron@flhosp.org|
301662|NCT02039219|Indiana University School of Medicine|Naga Chalasani, MD|(317) 278-0414|nchalasa@iu.edu|
301663|NCT02039375|Johns Hopkins University School of Medicine|Victor C. Urrutia, MD|4109552228|vurruti1@jhmi.edu|
301664|NCT02039414|Western Kentucky University|Dr. Rachel Tinius, Assistant Professor|2707455026|rachel.tinius@wku.edu|
301665|NCT02039427|Department of Anesthesiology and Pain medicine, Yeungnam University School of Medicine, Daegu, Republic of Korea|Sung Mee Jung, M.D|+82-53-620-3368|applejsm@gmail.com|
301666|NCT02039505|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
301667|NCT02039674|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
311228|NCT02867995|Boston Medical Center|Dr. Manishi Desai|671-414-8806|Manishi.Desai@bmc.org|
311229|NCT02868216|Cardiologia (Institute of Cardiology of Rio Grande do Sul/University Foundation of Cardiology|Dra Marcia Moura Schmidt|5551 32333600|mmoura22@terra.com.br|3765
311230|NCT02868229|Novo Nordisk A/S|Clinical Transparency and Medical Writing Office|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
311231|NCT02868242|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311232|NCT02868281|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311233|NCT02868554|University of North Carolina at Chapel Hill|Ching-Chang Ko, DDS, PhD|919-537-3763|ching-chang_ko@unc.edu|
311234|NCT02869295|Nektar Therapeutics|Study Director|415-482-5300|medicalaffairs@nektar.com|
311235|NCT02869334|Nathan Kline Institute|Dr. Daniel Javitt|8453986534|javitt@nki.rfmh.org|
311236|NCT02869438|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
311237|NCT02869451|Duke University Medical Center|Angela Kirby|919-286-0411|angela.kirby@duke.edu|5526
311238|NCT02869893|Cincinnati Children's Hospital Medical Center|Dr. Andrew Trout|513-803-3004|andrew.trout@cchmc.org|
311239|NCT02870101|UCLA David Geffen School of Medicine and Fielding School of Public Health|Jeffrey D. Klausner, MD, MPH|310-557-2273|JDKlausner@mednet.ucla.edu|
311240|NCT02870205|Glenmark Pharmaceuticals Ltd|Study Director|(201) 684-8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
311241|NCT02870283|Universidade Federal do Rio Grande do Sul|Dra. Ana Flávia Silva Lima|+5551999185180|afbslima@gmail.com|
311242|NCT02870309|Grifols Therapeutics LLC|Susan Sorrells|919-316-6582|susan.sorrells@grifols.com|
311243|NCT02870920|Canadian Cancer Trials Group|Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
311244|NCT02870933|National Cardiovascular Center Harapan Kita|Tri Wisesa Soetisna, M.D, MHA, PhD|+62215684093|tricts2000@yahoo.com|
311245|NCT02870972|BioCryst Pharmaceuticals Inc|Study Director|+1 919-859-1302|clinicaltrials@biocryst.com|
311246|NCT02871011|SaNOtize Research & Development Corp.|Dr Chris Miller|778-899-0607|chris@sanotize.com|
311247|NCT02871128|Chung Shan Medical University|Dr. You-Cheng Shen|+886-4-24730022|youcheng@csmu.edu.tw|12107
311248|NCT02871375|Alcon, A Novartis Division|Franchise Head, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
311249|NCT02871440|University of New South Wales|Dr Jacqueline Tan|+61 (02) 9385 6551|jacqueline.tan@unsw.edu.au|
311250|NCT02871479|Santalis Pharmaceuticals|Dr. Paul Castella|2103992316|paulc@satalispharma.com|101
311251|NCT02871492|AiCuris Anti-infective Cures GmbH|Information Desk|+4920231763|info@aicuris.com|0
311252|NCT02871570|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
311253|NCT02871635|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291408|NCT01362244|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
291409|NCT01362270|Oregon Health & Science University|Samantha Underwood, Research Manager|503-494-8481|underwos@ohsu.edu|
291410|NCT01362296|GlaxoSmithKline|GSK Response Center|866-435-7343||
291411|NCT01362322|GlaxoSmithKline|GSK Response Center|866-435-7343||
291412|NCT01362348|GlaxoSmithKline|GSK Response Center|866-435-7343||
291413|NCT01362439|Janssen-Cilag SpA, Cologno Monzese, Milan - Italy|Therapeutic Area Medical Manager|+39 0225101||
291414|NCT01362491|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291415|NCT01362517|Crucell Switzerland AG|Medical Affairs Director|+41(0)319806111|info@crucell.com|
291416|NCT01362530|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291417|NCT01362608|Novartis|Clinical Disclosure Office|862-778-8300||
301668|NCT02039687|Araim Pharmaceuticals, Inc.|Chief Medical Officer|914-762-7586|info@araimpharma.com|
301669|NCT02039726|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
301670|NCT02039778|Mount Sinai Beth Israel|Dr. Rahul Parikh|732-253-3939|parikhrr@cinj.rutgers.edu|
301671|NCT02039817|Conatus Pharmaceuticals|Jean L. Chan, MD|858 376 2632|jchan@conatuspharma.com|
301672|NCT02039856|VA Greater Los Angeles Healthcare System|Elizabeth M. Yano, PhD, MSPH|(818) 891-7711|elizabeth.yano@va.gov|36031
301673|NCT02039908|Florida International University|William E. Pelham, Jr., Ph.D.|305-348-0477|wpelham@fiu.edu|
301674|NCT02039947|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
301675|NCT02040077|Johns Hopkins University School of Medicine|Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
301676|NCT02040090|Kamada|Eran Schenker, VP Medical Director|+972-8-9406472|Erans@kamada.com|
301677|NCT02040116|Wake Forest Baptist Medical Center|LeAnne Kennedy|336-713-3400|lakenned@wakehealth.edu|
301678|NCT02040259|Stryker Neurovascular|Minyi Ji, Biostatistician, Clinical Evidence|+1 (510) 980-5689|minyi.ji@stryker.com|
301679|NCT02040298|UCSF|Tracy Tran, BA|415-353-2707|tracy.tran@ucsf.edu|
301680|NCT02040428|Ethicon, Inc.|Richard Kocharian, MD, PhD|1 (908) 218-2013|rkochar1@ITS.JNJ.com|
301681|NCT02040532|MGH Center for Women's Mental Health|Dr. Lee Cohen|617-724-0816|lcohen2@partners.org|
301682|NCT02040623|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
301683|NCT02040766|Teva Branded Pharmaceutical Products R&D, Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
301684|NCT02040779|Teva Branded Pharmaceutical Products R&D|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
301685|NCT02040805|University of California, San Francisco|Dr. Kevin L. Delucchi|415-476-4180|kevin.delucchi@ucsf.edu|
301686|NCT02040844|Circassia Ltd|VP Clinical Operations|+44 1865 405560|info@circassia.com|
301687|NCT02040857|Dana-Farber Cancer Institute|Project Manager|617-632-5313|ctopm@dfci.harvard.edu|
301688|NCT02040870|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
301689|NCT02041091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
301690|NCT02041104|Mlinotest d. d.|Ana Velikonja|0038651321785|anaa.velikonja@gmail.com|
301691|NCT02041221|SPARC|Dr Shravanti Bhowmik|+91 22 66455645||
301692|NCT02041286|Ascensia Diabetes Care|Carmine Greene, Senior Clinical Research Scientist|574-257-3040|carmine.greene@ascensia.com|
301693|NCT02041299|Chiesi Canada Corp.|Fernando Tricta, MD|1-416-558-6342|ftricta@chiesi.com|
301694|NCT02041325|BVARI|Dr. Nikhil C. Munshi|857-203-6172|nikhil_munshi@va.gov|
301695|NCT02041377|Ascensia Diabetes Care|Jane Wallace, Deputy Director for Global Clinical Affairs|574-257-3063|jane.wallace@ascensia.com|
301696|NCT02041429|Dana-Farber Cancer Institute|Beth Overmoyer, MD|617.632.380|Beth_Overmoyer@DFCI.HARVARD.EDU|
301697|NCT02041494|University of California, San Francisco|Dr. Hobart W. Harris, Chief of General Surgery|(415) 514-3891|hobart.harris@ucsf.edu|
301698|NCT02041520|Instituto Mexicano del Seguro Social, UMAE HE No. 1 Bajio|Dr. Norma Amador|+524777174800|norma.amador@imss.gob.mx|31315
301699|NCT02041533|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
301700|NCT02041702|Abbott (formerly St. Jude Medical)|Clinical Project Leader Asia|0085229967605|lyim@sjm.com|
301701|NCT02041923|University of Illinois at Chicago|Rosemary White-Traut|312-996-7935|rwt@uic.edu|
301702|NCT02041962|University of Michigan|Amy Kilbourne, PhD|734-845-3452|amykilbo@umich.edu|
301703|NCT02042014|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
301704|NCT02042131|The University of Utah|Craig Bryan|801-587-7978|craig.bryan@utah.edu|
301705|NCT02042183|Mallinckrodt Pharmaceuticals|Clinical Team Leader|800-844-2830|clinicaltrials@mnk.com|5
301706|NCT02042274|University of Guelph|Dr. David Mutch, Associate Professor|519-824-4120|dmutch@uoguelph.ca|53322
301707|NCT02042404|EarLens Corporation|Dr. Suzanne Levy, Director of Clinical Research|650 366 9000|slevy@earlenscorp.com|
301708|NCT02042443|SWOG Statistics & Data Management Center|SWOG Statistician|206-667-4408||
301709|NCT02042534|Asan Medical Center, University of Ulsan|Sun U. Kwon, MD, PhD, Prof|82-2-3010-3960|sukwon@amc.seoul.kr|
301710|NCT02042872|James J. Peters VA Medical Center|William A. Bauman, M.D.|718-584-9000|william.bauman@va.gov|5428
301711|NCT02042911|SymBio Pharmaceuticals|Toshihiko Nagase|+81-3-5472-1127||
301712|NCT02043015|Emory University|Patrick S Sullivan PhD/DVM|404-727-2038|pssulli@emory.edu|
301713|NCT02043132|Beaumont Health|Dr. J. Michael Wiater|248-551-3140|J.Michael.Wiater@beaumont.edu|
301714|NCT02043145|Allergan, Inc|Vice President GSE,|714-246-4500|clinicaltrials@allergan.com|
291418|NCT01362686|Regenstrief Insitute|Dr. Noll Campbell|317-274-9051|cambenl@regenstrief.org|
301715|NCT02043197|Abbott|Tatiana V. Vladimirova|+74952584280|tatiana.vladimirova@abbott.com|
301716|NCT02043301|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
301717|NCT02043366|Tianjin Medical University General Hospital|Dr. Guolin Wang|+8615822855556|wangguolinghad@hotmail.com|
291419|NCT01362790|National Cancer Institute|Dr. Raffit Hassan|301-451-8742|raffit_hassan@nih.gov|
291420|NCT01362894|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-800-241-7629||
291421|NCT01362907|Alcon Research|Joachim Nick, Dipl. Ing. (FH)|+49 6022 240 520|joachim.nick@cibavision.com|
291422|NCT01362946|Penn State Hershey Medical Center|Dr. Dan Waschbusch|7175318514|dwaschbusch@hmc.psu.edu|
291423|NCT01362959|Department of Intensive care, Deventer Hospital|Dr. Huub van den Oever|+31 570 535346|h.vandenoever@dz.nl|
291424|NCT01363011|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
291425|NCT01363050|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
291426|NCT01363076|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|
291427|NCT01363128|The University of Texas MD Anderson Cancer Center|Elias Joseph Jabbour, MD/ Professor|7137924764|ejabbour@mdanderson.org|
301718|NCT02043379|UAB Pediatric Cardiac Critical Care Medicine|Jeffrey Alten, MD|(205) 975-3123|jalten@peds.uab.edu|
301719|NCT02043509|University of East Anglia|Dr Joanne Emery||joanne.emery@uea.ac.uk|
301720|NCT02043548|University of Pittsburgh|Chester Oddis, MD|412-383-8861|cvo5@pitt.edu|
301721|NCT02043574|South Texas Veterans Health Care System|Monica Serra|210-617-5300|monica.serra@va.gov|15313
301722|NCT02043652|CDC|Alexande Macedo de Oliveira|404 718 4751|acq7@cdc.gov|
301723|NCT02043704|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
301724|NCT02043782|Coloplast A/S|Medical Director|+45 4911 1395|dkbir@coloplast.com|
301725|NCT02043808|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301726|NCT02043899|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
301727|NCT02043938|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
301728|NCT02044094|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
301729|NCT02044159|Children's Hospital of Eastern Ontario|Katie O'Hearn, Research Coordinator|613-737-7600|kohearn@cheo.on.ca|4006
301730|NCT02044367|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301731|NCT02044380|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301732|NCT02044393|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301733|NCT02044419|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
301734|NCT02044458|Aurora Health Care, Inc.|Jessica J F Kram, MPH|414-219-5594|jessica.kram@aurora.org|
301735|NCT02044510|Lawson Research Institute|Mary McKibbon|5196466367|mary.mckibbon@sjhc.london.on.ca|
301736|NCT02044796|Fred Hutchinson Cancer Research Center|Roland B. Walter|1-206-667-3599|rwalter@fredhutch.org|
301737|NCT02044874|Arena Pharmaceuticals, Inc|Head of Document Operations|858-453-7200|ct.gov@arenapharm.com|
301738|NCT02044991|Loyola University|Colleen Fitzgerald, M.D., M.S.|708-216-2180|cfitzgerald@lumc.edu|
301739|NCT02045095|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
301740|NCT02045108|The Mind Research Network|Dr. Eric Claus|505-272-5028|eclaus@mrn.org|
301741|NCT02045212|Regenera Pharma Ltd|Dr Konstantin Adamsky|+972 8 9316306|kostia@Regenerapharma.com|
301742|NCT02045238|Hospital Universitario - Sao Paulo University|Dr. Mateus Deckers Leme|X551130919200|mateusdl@gmail.com|9451
301743|NCT02045264|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
301744|NCT02045277|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
301745|NCT02045433|UT Southwestern/Simmons Cancer Center-Dallas|Dr.Kevin Albuquerque|2146458499|Kevin.Albuquerque@UTSouthwestern.edu|
301746|NCT02045511|Johns Hopkins University School of Medicine Dept. Otolaryngology-HNS|Carrie Nieman|3025368362|cnieman1@jhmi.edu|
301747|NCT02045732|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
301748|NCT02045836|GlaxoSmithKline|GSK Response Center|866-435-7343||
311254|NCT02871739|Massachusetts General Hospital Health Decision Sciences Center|Karen Sepucha|617-724-3350|ksepucha@partners.org|
291428|NCT01363258|UAB School of Nursing|Rita Jablonski|205-975-9019|rjablonski@uabmc.edu|
291429|NCT01363297|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291430|NCT01363349|BioLineRx LTD|Dr. Arnon Aharon|972-2-548-9100|arnona@biolinerx.com|135
291431|NCT01363388|ChemoCentryx|Study Director|650-210-2900||
291432|NCT01363401|Hanyang University Seoul Hospital|Seung-Hyun Kim, M.D., Ph.D.|+82-2-2290-8114|kimsh1@hanyang.ac.kr|
291433|NCT01363440|Regeneron|Clinical Trial Management|914 847 7000|clinicaltrials@regeneron.com|
291434|NCT01363479|Helsinn Healthcare SA|Marco Palmas MD, Head of Clinical Development|+41919852121|marco.palmas@helsinn.com|
291435|NCT01363492|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
291436|NCT01363661|ECSOR|Jacques Bruhwyler, Project Manager|3267444093|Jacques.Bruhwyler@ecsor.com|
291437|NCT01363700|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
301749|NCT02045862|Astellas Pharma Europe B.V.|Clinical Trial Disclosure|+44 (0) 20 3379 8000|astellas.resultsdisclosure@astellas.com|
301750|NCT02045875|Asthma Management Systems|Andrew G Weinstein MD|302 893 5455|agwmd@aol.com|
301751|NCT02045979|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301752|NCT02046005|Brigham and Women's Hospital|Dr. Elizabeth Karlson|617-732-5078|ekarlson@bwh.harvard.edu|
301753|NCT02046070|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
301754|NCT02046122|Duke University|Anthony Sung, MD|919-668-1002|anthony.sung@duke.edu|
301755|NCT02046135|Cohen Children's Medical Center|Dr. James Schneider|7184703330|jschneide2@northwell.edu|
301756|NCT02046148|GlaxoSmithKline|GSK Response Center|866-435-7343||
301757|NCT02046174|The Rogosin Institute|Betty-Jane Sloan, Clinical Research Manager|646-317-0701|bjsloan@nyp.org|
301758|NCT02046200|UCLA Department of Psychology|Dr. Lara Ray|310-794-5383|lararay@psych.ucla.edu|
301759|NCT02046265|University of Pennsylvania School of Nursing|Dr. Anne Teitelman|215-898-1910|teitelm@nursing.upenn.edu|
301760|NCT02046317|The University of Texas Health Science Center at Houston|Carlos J Roldan, MD|713-745-7246|Carlos.J.Roldan@uth.tmc.edu|
301761|NCT02046369|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialsdisclosure@sunovion.com|
301762|NCT02046382|TriHealth|Clinical Research Specialist|513-862-2341|ganga_devaiah@trihealth.com|
301763|NCT02046525|Washington University in St. Louis|Kimberly Reske, MPH|3147474041|kreske@wustl.edu|
301764|NCT02046564|Otsuka Pharmaceutical Co. Ltd.|Director of Clinical Trials|+81-3-6361-7366||
301765|NCT02046603|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
301766|NCT02046616|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
301767|NCT02046772|Hospital Universitario Príncipe de Asturias|Antonio Rodríguez Miguel|+34 91 887 81 00|antonio.hupa@gmail.com|2610
301768|NCT02046863|Great Lakes NeuroTechnologies Inc|Biomedical Research Manager|2163615410|dheldman@glneurotech.com|
301769|NCT02046902|Saint Luke's Mid America Heart Institute|Carole Decker|(816) 932-5440|c1decker@saint-lukes.org|
301770|NCT02046941|VANCHCS|Juliana Baldo|925-372-4649|juliana.baldo@va.gov|
301771|NCT02046980|Daegu Kyungbook Dizziness society|Dr. Hyun Ah Kim|+82-53-250-7475|kha0206@dsmc.or.kr|
301772|NCT02046993|Kwong Wah Hospital|Dr Lorna Ng|(852) 23322311|ngl@ha.org.hk|
301773|NCT02047032|Gunang'anmen Hospital|Zhishun Liu|86 88002331|liuzhishun@aliyun.com|
301774|NCT02047045|Guang'anmen Hospital, China Academy Chinese Medical Sciences|Zhishun Liu|+86 010 88002331|liuzhishun@aliyun.com|
301775|NCT02047110|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
301776|NCT02047227|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
301777|NCT02047253|University of Alabama at Birmingham|Pam Dixon, RN, BSN, OCN|205-975-9875|pamdixon@uab.edu|
301778|NCT02047305|Medtronic MITG-RGI|Senior Director of Clinical Affairs|303-581-7064|Tumordirectedtherapiesclinical@Medtronic.com|
301779|NCT02047318|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
301780|NCT02047344|Golden Biotechnology Corp.|Howard Cheng|+886-2-28086006|howard@goldenbiotech.com|
301781|NCT02047500|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
301782|NCT02047604|Valeant Pharmaceuticals|VP Clinical Services|9089271162|christine.hnatko@valeant.com|
301783|NCT02047643|Stanford University|Bruce Buckingham, M.D.|408-356-0911|buckingham@stanford.edu|
301784|NCT02047734|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
301785|NCT02047903|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301786|NCT02047929|Carolinas HealthCare System|Dr. Thomas Ludden|704-608-2390|tom.ludden@carolinashealthcare.org|
301787|NCT02047981|UCSF F.I. Proctor Foundation|Ying Lin|4155144709|ying.lin@ucsf.edu|
301788|NCT02048072|Cantonal Hospital of St. Gallen|Jochen Vehoff|0041714941111|jochen.vehoff@kssg.ch|
311255|NCT02872012|University of Michigan Kellogg Eye Center|Dr. Anjali Shah|734-763-8122|arshah@med.umich.edu|
311256|NCT02872103|Generon|Jianmin Chen|7327100262|jianmin_chen@generonbiomed.com|
311257|NCT02872142|Grifols Bioscience Industrial Group|Michael Woodward|+34 938008784|michael.woodward@grifols.com|
311258|NCT02872285|Lycera Corp.|H. Jeffrey Wilkins MD, Chief Medical Officer|484-243-6222|wilkins@lycera.com|
311259|NCT02872311|Marshfield Clinic Research Institute|Project Manager|715-389-5088|king.jennifer@marshfieldresearch.org|
311260|NCT02872857|The University of Texas Health Science Center at Houston|HuiMahn Alex Choi, Associate Professor|713-500-5638|Huimahn.A.Choi@uth.tmc.edu|
311261|NCT02872909|University of Dundee|Professor Sally Ibbotson|01382 383499|s.h.ibbotson@dundee.ac.uk|
301789|NCT02048241|New York State Psychiatric Institute|Stephen J. Donovan, MD|646-774-8078|sd45@columbia.edu|
301790|NCT02048670|Mayo Clinic|Dr. Devin L. McCaslin|507-284-3410|mccaslin.devin@mayo.edu|
301791|NCT02048722|Northwestern University|Mark Agulnik, MD|312-695-6182|magulnik@nm.org|
291438|NCT01363713|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group|+81-6-4802-9341|clinical@santen.co.jp|
291439|NCT01363765|InCo-TB project, Gama Filho University|Anete Trajman|5521-82189194|atrajman@gmail.com|
291440|NCT01363843|BrUOG|William Sikov, MD and Kimberly Perez, MD|4018633000|kayla_rosati@brown.edu|
291441|NCT01363908|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
291442|NCT01363986|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
291443|NCT01363999|DalCor Pharmaceuticals|Ryan Black||rblack@dalcorpharma.com|
291444|NCT01364090|Viral Hepatits Clinical Research Program - The Kirby Institute - UNSW Sydney|Dr. Jason Grebely|+61 2938 50957|Jgrebely@kirby.unsw.edu.au|
291445|NCT01364207|Massachusetts Eye and Ear Infirmary|Dr. Louis R. Pasquale|617-573-4240|aliya_jiwani@meei.harvard.edu|4240
291446|NCT01364233|Medline Industries, Inc.|Ed Drower|847-643-3874|edrower@medline.com|
291447|NCT01364259|Stanford University Cancer Center|Dr. Scott G. Soltys, Assistant Professor|650.724.1569|sgsoltys@stanford.edu|
301792|NCT02048826|University of California at Irvine|Prof. David Reinkensmeyer|949-824-5218|dreinken@uci.edu|
301793|NCT02048878|University of Chicago|Eve Van Cauter, PhD|773-702-0169|evcauter@bsd.uchicago.edu|
301794|NCT02048891|Rambam health Care campus|Shahar Kol Director IVF Unit|97247773232|skol@rambam.health.gov.il|
301795|NCT02049151|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Centre|496151725200|service@merckgroup.com|
301796|NCT02049307|Hennepin Healthcare Research Institute|Jason Baker|612-873-2705|baker@umn.edu|
301797|NCT02049385|National Institute of Mental Health|Zarate, Carlos|+1 301 451 0861|zaratec@mail.nih.gov|
301798|NCT02049437|University Hospitals Cleveland Medical Center|Marijke Frederix, PhD|(216) 844-0383|marijke.frederix@UHhospitals.org|
301799|NCT02049450|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
301800|NCT02049476|Wilmer Eye Institute, Johns Hopkins University School of Medicine|Jennifer E. Thorne, MD, PhD; Professor of Ophthalmology & Epidemiology,Director of Ocular Immunology|410-955-2966|jthorne@jhmi.edu|
301801|NCT02049502|Emory University|Dr. Shaffer|404-778-5033|virginia.o.shaffer@emory.edu|
301802|NCT02049749|Children's Hospital of Philadelphia|Dr. Joanne Wood, PI|267-426-3107|woodjo@email.chop.edu|
301803|NCT02049814|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
301804|NCT02049866|Columbia University|Mariana Bucovsky|212-305-7225|mb3523@cumc.columbia.edu|
301805|NCT02049931|Seoul National University|Professor Jin S. Yeom|82-31-787-7195|highcervical@gmail.com|
301806|NCT02049944|Memorial Care|Dr. Morgan Swank|5624808460|morganswankmd@gmail.com|
301807|NCT02049957|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
301808|NCT02050048|NorthShore Univeristy HealthSystem|Dr. Russell Brown|847-657-1900|rbrown@northshore.org|
301809|NCT02050321|University of Arizona Cancer Center|Dr. Lee Cranmer|520 626-0501|lcranmer@uacc.arizona.edu|
301810|NCT02050334|Chemigen|Consultant|317 293-0852|farlowds@yahoo.com|
301811|NCT02050373|UFGoias|Daniella Salvador|556235583272|danirnsalvador@gmail.com|
301812|NCT02050841|Octapharma|Michael Eppolito|2016041155|michael.eppolito@octapharma.com|
301813|NCT02050919|OHSU Knight Cancer Institute|Christopher Ryan, MD|503-494-8487|ryanc@ohsu.edu|
301814|NCT02051296|VA HCS Palo Alto|Dr Catherine Curtin|650-493-5000|ccurtin@stanford.edu|
301815|NCT02051335|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
301816|NCT02051426|Herzog Hospital|Uriel Heresco-Levy, M.D.|+972-2-5316906|urielh@ekmd.huji.ac.il|
301817|NCT02051452|Harvard Medical School|Dr. Ken Solt, MD, Associate Professor of Anaesthesia|6177264359|ksolt@mgh.harvard.edu|
301818|NCT02051595|University of Florida|Dr. Ettore Crimi|617-697-2861|ettorecrimi@gmail.com|
301819|NCT02051686|University of Missouri, Department of Orthopaedics|Brett Crist, MD|573-882-6562|cristb@health.missouri.edu|
301820|NCT02051764|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
311262|NCT02872935|University of Iowa|Dr. Kokila Thenuwara|319-384-5876|kokila-thenuwara@uiowa.edu|
311263|NCT02873104|Cutera|Lourdes Moldre, NP|415-971-5118|lmoldre@cutera.com|
311264|NCT02873208|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
311265|NCT02873221|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
311266|NCT02873286|Bavarian Nordic A/S|Program Lead, Clinical Operations|+45 3326|info@bavarian-nordic.com|8383
311267|NCT02873338|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
311268|NCT02873377|University of Miami|Taghrid Asfar|305-243-3826|tasfar@med.miami.edu|
311269|NCT02873429|University of Pittsburgh|Carol M. Greco, Associate Professor of Psychiatry|412-623-6873|grecocm@upmc.edu|
311270|NCT02873481|Virginia Commonwealth University School of Nursing|Dr. Patricia Kinser, Assistant Professor|804-828-9140|kinserpa@vcu.edu|
311271|NCT02873585|University of North Carolina at Chapel Hill|Angela Broome, DDS, MS|9195373160|abroome@unc.edu|
311272|NCT02873689|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
311273|NCT02873702|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
311274|NCT02873754|Duke University School of Medicine|Angela Kirby|919-286-0411|angela.kirby@duke.edu|5526
311275|NCT02873923|Institut Bergonié|Dr Carine Bellera|33 5 56 33 04 95|c.bellera@brodeaux.unicancer.fr|
311276|NCT02873936|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311277|NCT02874066|National Taiwan University Hospital|Chen-Hua Liu|+886-972651880|jacque_liu@mail2000.com.tw|
311278|NCT02874092|NYU Langone|Dr. Jeffrey Berger|212-263-0855|Jeffrey.Berger@nyulangone.org|
311279|NCT02874404|University of Nebraska Medical Center|Dr. Matthew Lunning, DO, Associate Professor|402-559-7164|mlunning@unmc.edu|
311280|NCT02874534|University of North Carolina at Chapel Hill|Gabriel S. Dichter, PhD|9194450132|dichter@med.unc.edu|
311281|NCT02874794|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
291448|NCT01364298|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
301821|NCT02051790|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
301822|NCT02051816|LSU School of Medicine New Orleans|David Janz, MD, MSc|504-568-3167|djanz@lsuhsc.edu|
301823|NCT02052011|Yale School of Medicine|Dr. Basmah Safdar|2037853453|basmah.safdar@yale.edu|
301824|NCT02052141|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
301825|NCT02052310|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1200|063study@fibrogen.com|
301826|NCT02052414|The Center for Clinical Research|James M. North MD|3367656181|jnorth1@ccrpain.com|
301827|NCT02052440|Denver Veterans Administration Medical Center|Daniel Heppe MD|303 399 8020|daniel.heppe@ucdenver.edu|3940
301828|NCT02052466|Cleveland Clinic Foundation|Dr. Eric Ricchetti|2164456915|ricchee@ccf.org|
301829|NCT02052544|DSM Nutritional Products Ltd Branch Pentapharm|Anne Brisset|41 61 706 4837|Anne.Brisset@pentapharm.com|
301830|NCT02052557|Des Moines University|Grants and Contracts Manager|5152711657|mlyon@dmu.edu|
301831|NCT02052596|GlaxoSmithKline|GSK Response Center|866-435-7343||
301832|NCT02052635|AstraZeneca AB|Anders Himmelmann, MD PhD|+46 31 7761000|ClinicalTrialTransparency@astrazeneca.com|
301833|NCT02052661|GlaxoSmithKline|GSK Response Center|866-435-7343||
301834|NCT02052752|GlaxoSmithKline|GSK Response Center|866-435-7343||
301835|NCT02052895|Mochida Pharmaceutical|Hironori Sato|+81-3-3225-6331|hnsato@mochida.co.jp|
301836|NCT02052960|Glycotope GmbH|Senior Director Clinical Department|0049309489|contact@glycotope.com|2600
301837|NCT02053077|MUG|Thomas Pieber|004331638512383|thomas.pieber@medunigraz.at|
301838|NCT02053168|BD Interventional - Surgery|Dawn Heimer|401-825-8681|Dawn.Heimer@crbard.com|
301839|NCT02053259|Arizona State University|Dr. Marc Adams|602-827-2470|marc.adams@asu.edu|
301840|NCT02053376|UPMC Hillman Cancer Center|Barbara Stadterman, Regulatory Supervisor|412-647-5554|stadtermanbm@upmc.edu|
301841|NCT02053493|Duke Clinical Research Insitute|Dr. Adrian Hernandez|919-668-7515|Adrian.Hernandez@duke.edu|
301842|NCT02053610|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
301843|NCT02053753|Amgen Inc.|Study Director|866-572-6436||
301844|NCT02054130|MedImmune, LLC|Fred Reid|+44 (0) 203 749 6512|information.center@astrazeneca.com|
301845|NCT02054156|Seattle Children's Hospital|Margaret Kloster|2068847862|margaret.kloster@seattlechildrens.org|
311282|NCT02874846|Aerie Pharmaceuticals, Inc.|Nancy Ramirez-Davis, Director of Clinical Project Management|908-947-3543|nramirez@aeriepharma.com|
311283|NCT02874924|Univ TX Health Science Center San Antonio|Dean L. Kellogg, Jr, MD, PhD|2106175197|kelloggd@uthscsa.edu|
311284|NCT02875028|Medical University of Vienna|Bernd Jilma|+4314040029910|bernd.jilma@meduniwien.ac.at|
311285|NCT02875080|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
311286|NCT02875340|ValiSeek Limited|Suzanne Dilly|+442030084416|suzanne.dilly@valirx.com|
311287|NCT02875366|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
311288|NCT02875392|Taipei Municipal Wanfang Hospital|Ming-Shun Wu|+886229307930|vw1017@gmail.com|
311289|NCT02875613|UC San Diego - Moores Cancer Center|Dr. Assuntina Sacco|858-822-5210|agsacco@ucsd.edu|
311290|NCT02875834|AstraZeneca|AstraZeneca Clinical|1-877-240-9479|information.center@astrazeneca.com|
311291|NCT02875977|Loyola University Medical Center|Cynthia Brincat, M.D., Ph.D.|708-216-2180|cbrincat@lumc.edu|
311292|NCT02876055|Mayo Clinic|Dr. Jason K. Panchamia|507-284-9698|panchamia.jason@mayo.edu|
311293|NCT02876159|Emory University|Dr. Mark J. Mulligan, M.D., F.I.D.S.A|404-712-1370|mmulli2@emory.edu|
311294|NCT02876575|Medtronic|Melody LaBeau, Director of Clinical Operations|7635262931|melody.a.labeau@medtronic.com|
311295|NCT02876601|Medical University of Vienna|Univ.Prof. Dr. Bernd Jilma|+4314040029810|bernd.jilma@meduniwien.ac.at|
311296|NCT02876757|ICES Western|Blayne Welk|5196466000|blayne.welk@sjhc.london.on.ca|
311297|NCT02876887|Northwestern University|Mary McDermott, MD, Jeremiah Stamler Professor|1 312 503 6419|mdm608@northwester.edu|6419
311298|NCT02876900|Noven Pharmaceuticals|George Harb, MD, MPH - Executive Director, Clinical Development|1-551-233-2656|gharb@noven.com|
311299|NCT02876926|Brown University School of Public Health|Dr. Tyler Wray|401-863-6659|tyler_wray@brown.edu|
311300|NCT02877004|Mayo Clinic|Dr. Ivana Croghan|507-266-1944|nicotineresearch@mayo.edu|
311301|NCT02877082|Emory University/Winship Cancer Institute|Zaid Al-Kadhimi, MD|404-778-1900|zalkadh@emory.edu|
311302|NCT02877095|Duke Clinical Research Institute|Rachel Olson, Project Leader|919-309-5544|rachel.e.olson@duke.edu|
311303|NCT02877485|Stanford Facial Plastic and Reconstructive Surgery|Sam P. Most MD|650-736-3223|smost@stanford.edu|
311304|NCT02877680|Baylor College of Medicine|Marisa Hilliard, Associate Professor of Pediatrics|832-824-7209|marisa.hilliard@bcm.edu|
311305|NCT02877927|Paratek Pharmaceuticals, Inc.|Dr. Paul McGovern; Vice President, Clinical Affairs|484-751-4935|Paul.Mcgovern@paratekpharma.com|
311306|NCT02878057|Department of Breast Oncology, Peking University Cancer Hospital and Institute|Dr. Huiping Li|86-10-88196739|huipingli2012@hotmail.com|
311307|NCT02878213|EPD Solutions|Chen Sagy Bross|+972-50-5560073|chensb@epd-medical.com|
311308|NCT02878330|MedImmune, LLC|M. Pamela Griffin|+1 301-398-4059|information.center@astrazeneca.com|
311309|NCT02878382|University of Sao Paulo Medical School Brazil|Dr Luis Torezan Associate Professor Dermatology|+551138491888|torezanluis@uol.com.br|
311310|NCT02878486|University of Kansas|Amber Watts, PhD|785-864-2604|amberwatts@ku.edu|
301846|NCT02054325|UPECLIN|Dr. Matheus Bertanha|+55 14 38116305|matheus.fameca@ig.com.br|
301847|NCT02054338|Institut de Recherche Pierre Fabre|Karim Keddad|+33 5 34 50 61 69|karim.keddad@pierre-fabre.com|
301848|NCT02054481|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291449|NCT01364389|Novartis Pharmaceuticals|Study Director|862-778-8300||
291450|NCT01364428|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
291451|NCT01364467|Virginia Commonwealth University|Kelley M. Dodson, MD, FACS|804-828-3965|kelley.dodson@vcuhealth.org|
291452|NCT01364558|University of Minnesota|Dr. James Cloyd, Director for Center for Orphan drug research|612-624-4609|cloyd001@umn.edu|
301849|NCT02054520|NewLink Genetics Corporation|Manager, Clinical Operations|515-598-5020|csmith@linkp.com|2624
291453|NCT01364584|University of Colorado School of Medicine|Judith G Regensteiner, PhD|303-724-2247|judy.regensteiner@ucdenver.edu|
291454|NCT01364623|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Vice President, Scientific Affairs|1-416-679-0776|nbryson@aceruspharma.com|
291455|NCT01364649|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
291456|NCT01364727|Stanford University Medical Center|Heather A Wakelee, MD|650-736-7221|hwakelee@stanford.edu|
291457|NCT01364740|Stanford University|Clete A. Kushida, MD, PhD|650-721-7560|clete@stanford.edu|
291458|NCT01364870|University of Iowa College of Nursing|Barbara Rakel, PhD, RN, FAAN|319-335-7036|barbara-rakel@uiowa.edu|
301850|NCT02054572|Amgen Inc.|Study Director|866-572-6436||
301851|NCT02054702|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
301852|NCT02054715|University of Rochester Medical Center|Gary R. Morrow, PhD, MS; Deans Professor of Oncology|585-275-9961|Gary_Morrow@urmc.rochester.edu|
301853|NCT02054754|e-Therapeutics Plc|Clinical Operations Manager|+44 1993 880000|contact@etherapeutics.co.uk|
301854|NCT02054897|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)||clinicaltrials@novonordisk.com|
311311|NCT02878590|InnoMed Healthscience|Javier Collazo|9547739656|jcollazo@innomedhs.com|
311312|NCT02878603|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
311313|NCT02879032|Bangabandhu Sheikh Mujib Medical University|Dr. Md. Mashiul Alam|+8801724490475|mashiull@gmail.com|
311314|NCT02879318|Canadian Cancer Trials Group|Chris O'Callaghan|6135336430|cocallaghan@ctg.queensu.ca|
311315|NCT02879383|Fractyl Laboratories, Inc.|Sarah Hackett, Director of Clinical Operations|(781) 902-8840|shackett@fractyl.com|
311316|NCT02879578|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
311317|NCT02879747|Queen Silvia Children´s Hospital and University of Gothenburg|Dr Jovanna Dahlgren, PI and director of Department of Pediatrics|+46702750233|jovanna.dahlgren@gu.se|
311318|NCT02879812|Emory University|Dr. Rachel Patzer|404-727-6047|rpatzer@emory.edu|
311319|NCT02879994|Jonsson Comprehensieve Cancer Center|Dr. Edward Garon|(310)586-2098|egaron@mednet.ucla.edu|
311320|NCT02880137|Mayo Clinic|Dr. Jonathan Johnson|507-255-7013|johnson.jonathan@mayo.edu|
311321|NCT02880176|Fox Chase Cancer Center|Dr. Marshall Strother|555-555-5555|m12912988@gmail.com|
311322|NCT02880189|Mayo Clinic|Dr. Barham K. Abu Dayyeh|507-284-1825|AbuDayyeh.Barham@mayo.edu|
311323|NCT02880228|Mayo Clinic|Shaji K Kumar MD|5072842511|kumar.shaji@mayo.edu|
311324|NCT02880254|Baystate Medical Center|Rushika Conroy MD|413 794 5437|rushika.conroy@bhs.org|
311325|NCT02880475|Mundipharma (China) Pharmaceutical Co. , Ltd|Junjiao Ma|01065636711|Junjiao.Ma@mundipharma.com.cn|
311326|NCT02880514|Intersect ENT, Inc.|James Stambaugh, Vice President of Clinical & Medical Affairs|650-641-2103|jstambaugh@intersectent.com|
311327|NCT02880761|Continuous Quality Improvement Experts Congress of Changping District|Director of Continuous Quality Improvement Experts Congress of Changping District|+861069006549|zhangdongliang@pkuih.edu.cn|1069006789
311328|NCT02880852|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311329|NCT02880865|PATH|Jorge Flores, MD|(202) 822-0033|jeflores@path.org|
311330|NCT02881008|MYR GmbH|Dr. med. Alexander Alexandrov|+491777168259|alexandrov@myr-pharma.com|
311331|NCT02881047|Hospital of the University of Pennsylvania|Study Coordinator|215-662-6722|leahyd@uphs.upenn.edu|
311332|NCT02881112|Regenesis Biomedical|Clinical Operations Manager|602-428-7041|heather.vanderploeg@regenesisbio.com|
311333|NCT02881567|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
311334|NCT02881658|The University of Hong Kong|Dr Cheung Ching Lung|(852)28315085|lung1212@hku.hk|
311335|NCT02881775|University of North Carolina at Chapel Hill|Deborah Givens, PhD|919-843-8660|deborah_givens@med.unc.edu|
311336|NCT02881840|Acacia Pharma Ltd|Dr Gabriel Fox|+44-(0)1223-919764|GabrielFox@acaciapharma.com|
311337|NCT02881957|University of Utah|Dr. Michael Karsy|801-581-6908|michael.karsy@hsc.utah.edu|
311338|NCT02881996|Children's Mercy Hospital|Shawn St. Peter|816-234-3000|sspeter@cmh.edu|3575
311339|NCT02882152|University of São Paulo|Dr. Joaquim Edson Vieira|+55 11 3061 8716|joaquimev@usp.br|
311340|NCT02882178|Institut Bergonié|Pr Simone Mathoulin-Pélissier|0556333333|s.mathoulin@bordeaux.unicancer.fr|
311341|NCT02882633|University of Pennsylvania|Ignacio Badiola|215-893-7251|Ignacio.Badiola@uphs.upenn.edu|
311342|NCT02882711|The University of Texas Health Science Center at Houston|Salih Selek, M.D.|713-741-3936|salih.selek@uth.tmc.edu|
311343|NCT02882854|Vanderbilt University Medical Center|Stephen Harvey, MD|(615) 936-3198|stephen.harvey@vumc.org|
311344|NCT02883244|Sunstar Americas, Inc.|Senior Manager of R&D|8477944276|akane.takemura@us.sunstar.com|
311345|NCT02883400|Atrium Health|Dr. Mark Russo,|704-355-6649|mark.russo@atriumhealth.org|
311346|NCT02883452|Celltrion, Inc.|SungHyun Kim|+82 32 850 5778|sunghyun.kim@celltrion.com|
311347|NCT02884089|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
311348|NCT02884414|Stanford University|Jennifer Hledik|650-493-5000|jerhart@stanford.edu|62388
311349|NCT02884427|Universidad Andrés Bello|Professor Hernán Andrés de la Barra O., DC,PT,Mg|56226618402|quiropraxiayequilibrio@gmail.com|
311350|NCT02884492|Columbia University Medical Center (Taub Institute)|William C. Kreisl, MD|212-305-9194|wck2107@cumc.columbia.edu|
311351|NCT02885012|Medical University of South Carolina|John Terrill Huggins|(843) 792-2296|hugginjt@musc.edu|
291459|NCT01364896|University of Pittsburgh|Ross Cranston|412-383-1675|rdc27@pitt.edu|
291460|NCT01364922|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
291461|NCT01365039|Bausch & Lomb Incorporated|Robert Steffen, OD, MS|(585) 338-6399|robert.steffen@bausch.com|
291462|NCT01365052|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
291463|NCT01365091|AstraZeneca Pharmaceuticals|Boaz Hirschberg||ClinicalTrialTransparency@astrazeneca.com|
291464|NCT01365130|BrUOG|Howard Safran, MD|4018633000|Hsafran@lifespan.org|
291465|NCT01365273|Monlycke Health Care|Joan Wilson, MSN, MHA, RN|706 504 8997|joan.wilson@molnlycke.com|
291466|NCT01365455|Novartis Pharmaceuticals|Study Director|862-778-8300||
291467|NCT01365468|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
301855|NCT02055118|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
301856|NCT02055157|BioMarin Pharmaceutical Inc.|Alice Hunstman-Labed|+44 207 4203392|alice.huntsmanlabed@bmrn.com|
301857|NCT02055352|Novartis Pharmaceuticals|Study Director|862-778-8300||
301858|NCT02055365|Icahn School of Medicine at Mount Sinai|Brad Rosenberg, MD, PhD||brad.rosenberg@mssm.edu|
301859|NCT02055404|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|1-888-451-3937|alcon.medinfo@alcon.com|
301860|NCT02055430|Cairo University|dr Mohammed Said ElSheemy|01006117755|mohammedshemy@yahoo.com|
301861|NCT02055638|Azevan Pharmaceuticals, Inc.|Dr. Neal Simon, CEO|(610) 419-1057|ngsimon@azevan.com|
301862|NCT02055781|CTI BioPharma Corp.|Beth Ziemba||bziemba@ctibiopharma.com|
301863|NCT02055820|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
301864|NCT02055898|Imperial College London|Keith Boland||k.boland@imperial.ac.uk|
301865|NCT02055976|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
301866|NCT02056171|Weill Cornell Medicine|Chani Traube|212-746-3056|chr9008@med.cornell.edu|
301867|NCT02056288|Baylor College of Medicine|Chris D. Glover, MD, MBA, Principal Investigator|832-824-5800|cdglover@texaschildrens.org|
301868|NCT02056301|Baylor College of Medicine|Chris Glover, MD, MBA|832-824-5800|cdglover@bcm.edu|
301869|NCT02056340|Beth Israel Deaconess Medical Center|Dr Maureeen Chase, Assistant professor of Emergency Medicine|6177542298|mchase1@bidmc.harvard.edu|
301870|NCT02056392|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
301871|NCT02056431|Kaiser Permanente Division of Research|Dr. Alyce S. Adams|510-891-5921|Alyce.S.Adams@kp.org|
301872|NCT02056626|University of Rochester|John Bisognano|585-341-7800|john_bisognano @ urmc.rochester.edu|
301873|NCT02056639|University of Pennsylvania|Bridget Nolan|2156623324|bridget.nolan@uphs.upenn.edu|
301874|NCT02056652|University of Pennsylvania|Bridget Nolan|2156623324|bridget.nolan@uphs.upenn.edu|
301875|NCT02056834|Synthes GmbH|Clinical Research Scientist Biomaterials|0041327204465|clinicalaffairs.emea@synthes.com|
301876|NCT02057042|VA Center for Clinical Managment Research|Paul Pfeiffer|7348453649|paul.pfeiffer@va.gov|
301877|NCT02057068|Atlanta Department of Veterans Affairs Medical Center CVNR|Patricia C. Griffiths, PhD|6783615462|pcgriff@emory.edu|
301878|NCT02057081|VISN 5 Mental Illness Research, Education, and Clinical Center|Dr. Amy Drapalski|410-637-1855|amy.drapalski@va.gov|
301879|NCT02057198|Duke University Medical Center|Daniel Sexton, M.D.|919-684-4596|sexto002@mc.duke.edu|
301880|NCT02057250|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
301881|NCT02057393|Penn State Hershey Medical Center|Colette Pameijer, Associate Professor of Surgery|717-531-5272|cpameijer@pennstatehealth.psu.edu|
301882|NCT02057406|Duke University Medical Center|Dr. Wei Jiang|919-668-0762|jiang001@mc.duke.edu|
301883|NCT02057458|Augusta University|Ryan Harris, PhD|7067215998|ryharris@augusta.edu|
301884|NCT02057523|Loyola University Medical Center|Sanjeev Akkina|7082166389|sanjeev.akkina@lumc.edu|
301885|NCT02057549|The University of Texas Houston Health Science Center|Dr. Carlos J. Roldan MD|713-792 6070|croldan@mdanderson.org|
301886|NCT02057575|Aerie Pharmaceuticals, Inc|Theresa GH Heah, MD, MBA|908-947-3844|theah@aeriepharma.com|
301887|NCT02057640|Cleveland Clinic Taussig Cancer Center|Jason Valent, MD|216-445-7238|valentj3@ccf.org|
301888|NCT02057666|Ipsen|Medical Director, Oncology|clinical.trials@ipsen.com|clinical.trials@ipsen.com|
301889|NCT02057692|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
301890|NCT02057718|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
301891|NCT02057757|National Institute of Allergy and Infectious Diseases (NIAID)|Dr. John Beigel|301-451-9881|jbeigel@niaid.nih.gov|
301892|NCT02057835|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
301893|NCT02057939|Duke University|Andrew Armstrong, MD ScM|919-668-4615|andrew.armstrong@duke.edu|
301894|NCT02057952|Regenstried Institute|Daniel O. Clark, PhD|317-274-9292|daniclar@iu.edu|
301895|NCT02058069|MAKO Surgical Corp.|Michael Conditt|7132408675|michael.conditt@stryker.com|
301896|NCT02058095|Mayo Clinic|Horng H. Chen, M.D.|507-284-8896|chen.horng@mayo.edu|
301897|NCT02058108|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
301898|NCT02058147|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
301899|NCT02058160|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
301900|NCT02058251|Medical University of South Carolina|Dr. Sudie Back|843-792-5915|backs@musc.edu|
301901|NCT02058290|Pacira Pharmaceuticals, Inc.|Erol Onel, MD|858-625-2424|erol.onel@pacira.com|
301902|NCT02058368|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
291468|NCT01365481|Novartis Pharmaceuticals|Study Director|862 -778 -8300||
301903|NCT02058498|Mayo Clinic Jacksonville|Jennifer Serotta, DNP, ARNP|904-956-3200|serotta.jennifer@mayo.edu|
301904|NCT02058511|UCSF|Matthias Behrends|415 476 3761|matthias.behrends@ucsf.edu|
301905|NCT02058563|GlaxoSmithKline|GSK Response Center|866-435-7343||
301906|NCT02058589|GlaxoSmithKline|GSK Response Center|866-435-7343||
291469|NCT01365494|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
291470|NCT01365507|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
291471|NCT01365546|Octapharma|Director of Clinical Operations|4152609577|sylvia.werner@octapharma.com|
291472|NCT01365585|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291473|NCT01365611|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
291474|NCT01365624|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D|610-650-4200|dbregman@lpicrd.com|828
291475|NCT01365650|Luitpold Pharmaceuticals, Inc.|David Bregman, M.D., Ph.D.|610-650-4200|dbregman@lpicrd.com|828
291476|NCT01365793|University of California, Davis (UC Davis Health)|Nathan Kuppermann|916-734-1535|nkuppermann@ucdavis.edu|
291477|NCT01365819|UCLA, Dept of Family Medicine|Dr. Steve Shoptaw|310-794-0619|sshoptaw@mednet.ucla.edu|
301907|NCT02058628|GlaxoSmithKline|GSK Response Center|866-435-7343||
301908|NCT02058836|Wake Forest University Health Sciences|Dr. Ryan Terlecki|336-716-2011|rterlecki@wakehealth.edu|
301909|NCT02058849|University of Kentucky|Dr. Travis Thomas, Associate Professor|859-218-0863|dth225@uky.edu|
301910|NCT02058940|The University of North Carolina at Chapel Hill|Nicole R. Pinelli|919-962-1641|nickipinelli@unc.edu|
301911|NCT02058966|Veterans Affairs Portland Healthcare System|Dr. William Hoffman|503-220-8262|hoffmanw@ohsu.edu|56491
301912|NCT02058992|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
301913|NCT02059005|Treatment Research Institute|Adam Brooks, PhD|215-399-0980|abrooks@tresearch.org|128
301914|NCT02059057|Boston Scientific|Kristi Winterfeldt|+1 763-494-1165|kristi.winterfeldt@bsci.com|
301915|NCT02059070|Wayne State University, School of Medicine|Pranav Patel|313-745-7233|gmckelve@dmc.org|
301916|NCT02059135|LFB USA|Laura Massey, Sr. Clinical Project Manager|508-370-5157|laura.massey@lfb-usa.com|
301917|NCT02059148|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
301918|NCT02059161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301919|NCT02059174|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301920|NCT02059187|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301921|NCT02059213|University of Michigan Rogel Cancer Center|Phillip Palmbos, M.D., Ph.D.|734-936-3591|ppalmbos@umich.edu|
301922|NCT02059239|Weill Cornell Medicine|Dr. Tsiporah Shore|646-962-7950|tbs2001@med.cornell.edu|
301923|NCT02059278|Point Guard Partners LLC|Jeremy Brace|727-458-2823|jbrace@pointguardllc.com|
301924|NCT02059291|Novartic Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
301925|NCT02059395|The Ottawa Hospital|Dr. Sylvain Boet|6137985555|sboet@toh.on.ca|14775
301926|NCT02059408|University of California, San Francisco|Carmen Peralta, Professor of Medicine|415-221-4810|carmenalicia.peralta@ucsf.edu|23678
301927|NCT02059434|AstraZeneca|AstraZeneca Clinical Study Information Center||ClinicalTrialTransparency@astrazeneca.com|
301928|NCT02059512|First Pavlov State Medical University of St. Petersburg|Vladimir V Komok, Ph.D|8-904-632-19-00|vladimir_komok@mail.ru|
301929|NCT02059642|Alcobra|Dr. Jonathan Rubin|610-940-1631|jrubin@alcobra-pharma.com|
301930|NCT02059902|Health Partners|Dr. William J Mohr|(651)454-5304|William.J.Mohr@healthpartners.com|
301931|NCT02059928|Health Partners|Dr. Ralph J Frascone|6512545304|ralph.j.frascone@healthpartners.com|
301932|NCT02059980|University of Wisconsin-Milwaukee|Dr. Han Joo Lee|414-229-5858|leehj@uwm.edu|
301933|NCT02059993|State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College|Zhihong Liu|+86-01088398196|zhihongliufuwai@163.com|
301934|NCT02060058|Kaohsiung Medical University Hospital|Hepatitis Center and Hepatobiliary Division, Department of Internal Medicine|+886-7-3121101|hsmonyan@gmail.com|6770
301935|NCT02060370|University of Texas MD Anderson Cancer Center|Dr. Eric Jonasch, MD/Professor, Genitourinary Medical Oncology|713-792-2830|ejonasch@mdanderson.org|
301936|NCT02060383|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
301937|NCT02060461|Cleveland Clinic|William J Dupps, Jr, MD, PhD|216-444-8396||
301938|NCT02060526|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
301939|NCT02060539|CooperVision|Cheryl McKinnon|925-251-2034|cmckinnon@coopervision.com|
301940|NCT02060838|Nationwide Children's Hospital|Aymen Naguib, MD|(614) 722-0596|Aymen.Naguib@nationwidechildrens.org|
301941|NCT02060890|University of California, San Francisco|Nicholas Butowski MD Professor of Neuro-Oncology|414-353-2966|Thelma.Munoz@ucsf.edu|
301942|NCT02060903|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
301943|NCT02061202|Icahn School of Medicine at Mount Sinai|Dr. Jeffrey Glassberg|212-241-3650|jeffrey.glassberg@mountsinai.org|
301944|NCT02061280|Nemours Children's Specialty Care|Kathryn Blake, Pharm.D.|9046865047|kathryn.blake@nemours.org|904
301945|NCT02061358|Emergent BioSolutions|Timothy Babinchak, MD, Vice President Clinical and Medical Affairs|1-484-318-8851|babinchakt@ebsi.com|
301946|NCT02061384|University of Washington School of Medicine|Dr. John Amory|2066161727|jamory@uw.edu|
301947|NCT02061397|University of Pennsylvania|Dr. Vera Krymskaya|215-573-9861|krymskay@pennmedicine.upenn.edu|
301948|NCT02061540|Mirum|Study Physician|1 650-667-4085|medinfo@mirumpharma.com|
311352|NCT02885025|VA Greater Los Angeles Healthcare System|Joseph Yusin Chief division Allergy Immunology|3104783711|joseph.yusin2@va.gov|40230
311353|NCT02885181|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311354|NCT02885246|GlaxoSmithKline|GSK Response Center|866-435-7343|gskclinicalhd@gsk.com|
291478|NCT01365845|University of Florida Proton Therapy Institute|Dr. Julie Bradley|904-588-1800|jbradley@floridaproton.org|
291479|NCT01365910|Vanderbilt-Ingram Cancer Center|Dr. Jordan Berlin|615-343-4128|jordan.berlin@vanderbilt.edu|
291480|NCT01366196|Hss|Dr. Michael Urban|(212) 606-1000|UrbanM@hss.edu|
291481|NCT01366209|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
291482|NCT01366417|CareFusion|Jennifer Raeder-Devens|847-454-4939|jennifer.raeder-devens@carefusion.com|
291483|NCT01366443|University of Utah Medical Center, Dept. of OB/GYN|Dr. Michael Draper, MD University of Utah Medical Center, Dept. of OB/GYN|801-581-7647|mike.draper@hsc.utah.edu|
291484|NCT01366495|Friends Research Institute|Dr. Michael S. Gordon, Senior Research Scientist|410-837-3977|mgordon@friendsresearch.org|251
291485|NCT01366521|GlaxoSmithKline|GSK Response Center|866-435-7343||
291486|NCT01366534|GlaxoSmithKline|GSK Response Center|866-435-7343||
301949|NCT02061592|Johnson & Johnson Vision Care, Inc|Brian Pall, OD, MS, FAAO - Senior Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|1290
301950|NCT02061683|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
301951|NCT02061696|Borgess Heart Institute|Frank Saltiel, MD|269-381-3963||
301952|NCT02061748|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311355|NCT02885350|Helsinki University Central hospital/Women's hospital/anaesthesia|Dr Antti Vaananen|358504271850|antti.vaananen@hus.fi|
311356|NCT02885506|Medicines for Malaria Venture|Dr Cristina Donini|0041 22 555 0312|doninic@mmv.org|
311357|NCT02885636|Mayo Clinic|Dr. Barry Borlaug|507-284-8846|borlaug.barry@mayo.edu|
311358|NCT02886234|The Miriam Hospital|Dr. Michael Carey|401793-8218|michael_carey@brown.edu|
311359|NCT02886338|TMU|Fat-Moon, Suk|29307930|fmsuk@tmu.edu.tw|7923
311360|NCT02886494|Charsire Biotechnology Corp.|R&D associate|+886-6-702-0817|cs42@charsire.com|
311361|NCT02886624|Hôpital Saint Antoine|Prof. Karine Lacombe|+33 1 49 28 24 38|karine.lacombe2@aphp.fr|
311362|NCT02886702|Fougera Pharmaceuticals Inc.|Angela C Kaplan|631-659-2256|angela.kaplan@sandoz.com|
311363|NCT02886715|Fougera Pharmaceuticals Inc.|Angela C Kaplan|631-659-2256|angela.kaplan@sandoz.com|
311364|NCT02886728|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311365|NCT02886923|Johnson & Johnson Vision|Ross Franklin - PRINCIPAL RESEARCH OPTOMETRIST|904 4431768|RFrankl1@its.jnj.com|
311366|NCT02887183|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
311367|NCT02887404|Cleveland Clinic Foundation|Dr. Kamal Maheshwari|216-4454311|maheshk@ccf.org|
311368|NCT02887521|Mayo Clinic|Roberto Benzo, MD, MSc|(507) 284-0561|benzo.roberto@mayo.edu|
311369|NCT02887989|Cedars-Sinai Health System|Garth Fuller|3236003890|garth.fuller@cshs.org|
311370|NCT02888080|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
311371|NCT02888093|University of Iowa Hospitals and Clinics|Dr. Joseph Kowalski|3193561616|joseph-kowalski@uiowa.edu|
311372|NCT02888106|Hepatera LLC|Yana Deloveri|+7 495 762 52 53|deloveri@hepatera.ru|42-14
311373|NCT02888171|University of Alabama at Birmingham|Orlando M. Gutierrez, MD|205-996-2736|ogutierrez@uabmc.edu|
311374|NCT02888665|Northwestern University|Seth Pollack, MD, Director of Sarcoma Program|312-503-5320|seth.pollack@northwestern.edu|
311375|NCT02888691|Steno Diabetes Center Copenhagen|Dr Signe Schmidt|+4551174785|signe.schmidt@regionh.dk|
311376|NCT02888756|Erasmus MC|Dr R.A. Gruters|+31 10 7032100|r.gruters@erasmusmc.nl|
311377|NCT02889289|Washington DC VA Medical Center|Dr. Shane Chanpimol|202-745-8000|shane.chanpimol@va.gov|55854
311378|NCT02889393|University of Miami|Dr. D. Dante Yeh|3055851178|dxy154@med.miami.edu|
311379|NCT02889510|Dynamic Science S.L|Anna Royo|+34680603119|a.royo@dynasolutions.com|
311380|NCT02889562|Sanford Health|Todd Chapin PharmD|701-417-2351|todd.chapin@sanfordhealth.org|
311381|NCT02889796|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311382|NCT02889861|Immunocore, LLC|Chris Holland, Executive Director Head of Biometrics|1-267-589-9204|chris.holland2@immunocore.com|
311383|NCT02889900|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazenca.com|
311384|NCT02890303|Mynosys Cellular Devices, Inc.|Daniel Marinsik|(510) 857-6296|dmarinsik@mynosys.com|
311385|NCT02890381|Family Health International (FHI 360)|Melissa Allen, Director, IMPAACT Operations Center|(919) 405-1429|mallen@fhi360.org|
311386|NCT02890992|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
311387|NCT02891070|Baxter Healtcare|Baxter Clinical Trials Disclosure Call Center|(224) 948-7359|Global_CORP_ClinicalTrialsDisclosure@baxter.com|
311388|NCT02891174|University of Michigan|Dr. Elizabeth Langen|734-764-3406|elangen@med.umich.edu|
311389|NCT02891200|Johns Hopkins University|Principle Investigator|410-637-7152|habouma1@jhmi.edu|
311390|NCT02891408|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311391|NCT02891629|EyeFree Assisting Communication|Or Retzkin, CEO|+972526490093|or@eyecontrol.co.il|
311392|NCT02891681|Washington University School of Medicine|Quing Zhu, Ph.D.|314-935-7519|zhu.q@wustl.edu|
311393|NCT02891850|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
311394|NCT02891863|Boston Scientific CRM|Greg Voss|651-581-3068|gregory.voss@bsco.com|
311395|NCT02891915|Vanderbilt Vaccine Research Program|Dr. C. Buddy Creech|615-343-0332|buddy.creech@vanderbilt.edu|
311396|NCT02892019|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
311397|NCT02892110|MUSC|Amanda Wagner, Program Manager|843-792-0484|wagne@musc.edu|
311398|NCT02892344|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
301953|NCT02061774|TTUHSC CRI|Cathy Lovett|806-743-4222|cathy.lovett@ttuhsc.edu|
301954|NCT02061813|Dr. Reddy's Laboratories Inc.|Dr Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
301955|NCT02061969|Emory University|Saumeth Cardona MD|404-616-4827|scardon@emory.edu|
291487|NCT01366638|Janssen Pharmaceutical K.K., Japan|Director|81 3 44115639||
291488|NCT01366846|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
291489|NCT01366872|Orthopaedic Associates of Michigan, PC|Dr. John G. Anderson|616-459-7101|John.Anderson@oamichigan.com|797
291490|NCT01366885|OHSU|Dr. Gene Stubbs|503-939-7351|stubbsgene@comcast.net|
291491|NCT01366976|Vanderbilt University School of Medicine|Mias Pretorius|16153220758|mias.pretorius@vanderbilt.edu|
291492|NCT01367080|Dong Wha Pharm. Co. Ltd.|Cheol-Hee Lim. Clinical Research Manager (CRM)|+82-2-2021-9300|cheolhee.lim@dong-wha.co.kr|551
291493|NCT01367119|Mayo Clinic|Dr. Keith G. Rassmussen|507-284-2933|rasmussen.keith@mayo.edu|
291494|NCT01367158|Novartis Vaccines|Posting Director||RegistryContactVaccineUS@novartis.com|
291495|NCT01367236|Imperial College London|Professor Alan Winston|+44 (0)20 3312 1603|a.winston@imperial.ac.uk|
301956|NCT02062008|University of California San Francisco|miguel hernandez pampaloni|4153531886|miguel.pampaloni@ucsf.edu|
301957|NCT02062151|USF Pediatrics|Laura Weathers|813/844-3046|lweathers@health.usf.edu|
301958|NCT02062177|Università Vita-Salute San Raffaele|Professor Testoni Pier Alberto|+390226432756|testoni.pieralberto@hsr.it|
301959|NCT02062294|Hoffmann-LaRoche|Clinical Operations Department|800-821-8590|switzerland.clinical-research@roche.com|
301960|NCT02062359|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
301961|NCT02062385|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301962|NCT02062398|BlueWind Medical|Amit Korner, VP Clinical Research|+972.74.7218905|amit.korner@bluewindmedical.com|
301963|NCT02062437|Tornier SAS|Nathalie Trétout|+33 4 76 71 35 00|nathalie.tretout@tornier.com|
301964|NCT02062450|TORNIER SAS|Nathalie TRETOUT|+33 4 76 71 35 00|nathalie.tretout@tornier.com|
301965|NCT02062502|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
301966|NCT02062580|University of Cape Town and University of Washington|Heather Jaspan|+2721 4066823|hbjaspan@gmail.com|
301967|NCT02062593|Imperial College London|Rasha Al-Lamee|+447976276923|r.al-lamee13@imperial.ac.uk|
301968|NCT02062606|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
301969|NCT02062632|Mayo Clinic|Terence T. Sio, MD, MS|507/284-2511|sio.terence@mayo.edu|
301970|NCT02062645|Novartis Pharmaceuticals|Study Director|862-778-8300||
301971|NCT02062658|Stanford University|Dr. Carolyn Rodriguez, Assistant Professor|6507236158|carolynrodriguez@stanford.edu|
301972|NCT02062710|Montefiore Medcial Center|Peter Dicpinigaitis, MD|718-904-2676|pdicpini@montefiore.org|
301973|NCT02062801|Sharp HealthCare|Dr. David R. Gambling|858-395-5668|david.gambling@sharp.com|
301974|NCT02062879|UC Health University of Cincinnati Medical Center|Sheila Takieddine|513-585-6195|Sheila.Takieddine@UCHealth.com|
301975|NCT02062905|Ocular Therapeutix, Inc.|Director, Clinical Affairs|781-357-4000|dmulani@ocutx.com|
301976|NCT02063035|Massachusetts General Hospital, Boston, MA, USA|Dr. Kirkham B. Wood|617-726-2000|kbwood@stanford.edu|+1
301977|NCT02063087|Mayo Clinic|Dr. Erik Hess|507-255-6501|hess.erik@mayo.edu|
301978|NCT02063178|University of Tennessee Health Science Center|Rebecca Krukowski|9014482426|rkrukows@uthsc.edu|
301979|NCT02063217|Washington University School of Medicine|Dr. Brendan Lucey|314-362-4342|luceyb@wustl.edu|
301980|NCT02063230|AstraZeneca|Gabriella Mariani|+44 7818 523 899|ClinicalTrialTransparency@astrazeneca.com|
301981|NCT02063516|tianjinMUGH|Dr. Haiyun Wang|008613752211206|wanghy819@hotmail.com|
301982|NCT02063659|Lexicon Pharmaceuticals, Inc.|Pablo Lapuerta, MD||plapuerta@lexpharma.com|
301983|NCT02063672|Lutonix|Heidi Ronhovde|7634632900|heidi.ronhovde@crbard.com|
301984|NCT02063698|Mayo Clinic|Aminah Jatoi, MD|(507) 284-7202|Jatoi.Aminah@mayo.edu|
301985|NCT02063737|Carolinas HealthCare System|Dr. Daniel Patterson|704-446-0433|Daniel.Patterson@carolinas.org|
301986|NCT02063828|Wake Forest NCORP Research Base|Emily Dressler, PhD|336 716-0891|ncorp@wakehealth.edu|
301987|NCT02063854|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
301988|NCT02063867|University of California, Irvine|Susan Huang, Principal Investigator & Medical Director of Epidemiology and Infection Prevention|949-824-5073|sshuang@uci.edu|
301989|NCT02063880|University of Washington|Grace John-Stewart|206 5434278|gjohn@uw.edu|
301990|NCT02063984|Geisel School of Medicine at Dartmouth Center for Technology and Behavioral Health|Alan J. Budney, Ph.D|603-646-7088|alan.budney@dartmouth.edu|
301991|NCT02064166|Brigham & Women's Hospital|Peter Novak, MD PhD|617-732-8896|pnovak2@bwh.harvard.edu|
301992|NCT02064205|TNO|W.J. Pasman, PhD|+31888665129|wilrike.pasman@tno.nl|
301993|NCT02064231|Coloplast A/S|Birte Petersen Jakobsen, MD|+45 4911 1395|dkbir@coloplast.com|
301994|NCT02064270|University of Missouri, Department of Orthopaedic Surgery|Stacee Clawson, Research Manager|5738849017|clawsons@health.missouri.edu|
301995|NCT02064439|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
301996|NCT02064582|UT Southwestern Medical Center|Kevin Courtney, MD|214-648-4180|Kevin.Courtney@utsouthwestern.edu|
301997|NCT02064816|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
301998|NCT02064855|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
301999|NCT02064868|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
302000|NCT02064894|CHU Ste-Justine Hospital|Dr. Sylvie Le May|514-343-6384|sylvie.lemay@umontreal.ca|
302001|NCT02064907|Takeda Study Registration Call Center|Takeda|+1-877-825-3327|medicalinformation@tpna.com|
302002|NCT02064920|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
311399|NCT02892409|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
291496|NCT01367249|Bausch & Lomb Incorporated|James Gow|949-788-6000|james.gow@bausch.com|
291497|NCT01367262|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291498|NCT01367275|University of Texas (UT) MD Anderson Cancer Center|Dr. Michael Overman, Associate Professor, GI Medical Oncology|713-792-2828|CR_Study_Registration@mdanderson.org|
291499|NCT01367444|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
291500|NCT01367457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|001
291501|NCT01367665|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
291502|NCT01367704|Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center|Dr. Elizabeth Miller|412-692-8504|elizabeth.miller@chp.edu|
291503|NCT01367834|UNC Chapel Hill|Rebecca Knickmeyer Santelli|9199662216|rebecca_knickmeyer@med.unc.edu|
291504|NCT01367847|University of North Carolina at Chapel Hill|Deborah Jones, PhD|919-962-3995|djjones@email.unc.edu|
291505|NCT01367860|IOT/HC University of SãoPaulo|Dr. Alexandre Cristante Fogaça|+55 11 2661-6951|aacristante@uol.com.br|
291506|NCT01367886|Washington University School of Medicine|H. Henry Lai, MD|314-362-8295|laih@wudosis.wustl.edu|
291507|NCT01368042|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
302003|NCT02064959|The University of Texas Health Science Center at Houston|Georgene W. Hergenroeder, Ph.D., Associate Professor|713-500-6230|lisa.h.schmitt@uth.tmc.edu|
302004|NCT02064985|Pharmaceutical Product Development, LLC.|Rong Fu|86-021-80135112|rong.fu@ppdi.com|
302005|NCT02065245|University of Miami, Miller School of Medicine - Interdisciplinary Stem Cell Institute (ISCI)|Joshua M Hare, MD|305-243-5579|JHare@med.miami.edu|
302006|NCT02065336|Arrowhead Pharmaceuticals, Inc.|Chief Operating Officer|626-304-3400||
302007|NCT02065453|Saint Louis University|M. Brigid Holloran-Schwartz, MD|314-781-8605|holloran@slu.edu|1
302008|NCT02065479|University of Florida|Dr. Dominick Angiolillo|904-244-3378|dominic.angiolillo@jax.ufl.edu|
302009|NCT02065518|University of Tennessee Health Science Center|Dr. Laura Talbot|901-448-3630|ltalbot@uthsc.edu|
302010|NCT02065557|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
302011|NCT02065570|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
302012|NCT02065622|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
302013|NCT02065687|NRG Oncology|Christopher Purdy on behalf of Michael Sill, PhD|(716) 845-1300|purdyc@nrgoncology.org|2296
302014|NCT02065713|Instituto Medicina Molecular|Elsa Vieira-Sousa|00351 217999544|elsa-sousa@hotmail.com|47221
302015|NCT02065791|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
302016|NCT02065895|Boston Children's Hospital|Garry M. Steil, PhD|617-355-7504|garry.steil@childrens.harvard.edu|
302017|NCT02066051|Mayo Clinic|Dr. Joanne F. Shen|480-301-8377|shen.joanne@mayo.edu|
302018|NCT02066129|Penn State University Dept of Public Health Sciences|David Mauger, PhD|717.531.3584|dmauger@psu.edu|
302019|NCT02066233|Mayo Clinic|Dr. Prasad G. Iyer|507-284-6469|Iyer.Prasad@mayo.edu|
302020|NCT02066298|Penn State University|David Mauger|717-531-7178|dmauger@psu.edu|
302021|NCT02066311|The Feinstein Institute for Medical Research|Dr. Meggan Mackay|516-562-3838|mmackay@northwell.edu|
302022|NCT02066389|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
302023|NCT02066402|Bayer|Therapeutic Area Head|+49 30 300139003|clinical-trials-contact@bayer.com|
302024|NCT02066415|Amgen Inc.|Study Director|866-572-6436||
302025|NCT02066467|Boston Scientific|Caroline Beaudoint|+32479904163|Caroline.Beaudoint@bsci.com|
302026|NCT02066727|Tianjin Medical University General Hospital|Dr Yuechun LU|15902233666|luyuechun@sina.com|
302027|NCT02066740|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
302028|NCT02066792|Institute for Mental Health Research and Department of Psychology, The University of Texas at Austin|Dr. Jasper Smits|512-475-8095|smits@utexas.edu|
302029|NCT02066857|Emory University|Claude Jarrett, M.D.|404-778-8099|CJarrett@wilmingtonhealth.com|
302030|NCT02066896|Federal University of Sao Paulo|Tania Sales de Alencar Fidelix|11991346992|fidelixtania@gmail.com|11
302031|NCT02066922|Alcon Research, Ltd.|Clinical Lead, Vision Care Development|1-888-451-3937|alcon.medinfo@alcon.com|
311400|NCT02892422|H. Lundbeck A/S|Email contact via|+45 36301311|LundbeckClinicalTrials@Lundbeck.com|
311401|NCT02892448|The Ottawa Hospital Research Institute|Dr. Paul E Beaule|613-737-8899|pbeaule@toh.ca|73265
311402|NCT02892513|Medical College of Wisconsin|Carrie Y. Peterson, MD, MS|414-955-5783|cypeterson@mcw.edu|
311403|NCT02892734|Northwestern University|William Gradishar, MD|312 695 4541|w-gradishar@northwestern.edu|
311404|NCT02892760|The University of Texas Health Science Center at Houston|Gerard Francisco, MD|713-797-7636|Gerard.E.Francisco@uth.tmc.edu|
311405|NCT02893878|GlaxoSmithKline|GSK Response Center|866-435-7343||
311406|NCT02894502|University of Rome Tor vergata, Rome, Italy|Dr. Ercole Vellone|+393387491811|ercole.vellone@uniroma2.it|
311407|NCT02894840|Mahidol university|Prof.Punnee Pitisuttithum|662 6435599|punnee.pit@mahidol.ac.th|
311408|NCT02895035|Penn State Hershey Eye Center|Seth Pantanelli|717-531-5690|spantanelli@pennstatehealth.psu.edu|
311409|NCT02895100|Protagonist Therapeutics, Inc|Director Clinical Development|(+1) 888-899-1543|ptgxclintrials@ptgx-inc.com|
311410|NCT02895295|Stanford University|Dr. M. Kate Bundorf|6507250067|bundorf@stanford.edu|
311411|NCT02895347|GWU Medical Faculty Associates|Dr. Gaby Moawad|202-741-2500|jebert@mfa.gwu.edu|
311412|NCT02895360|Basilea Pharmaceutica International Ltd.|Thomas Kaindl, MD, Global Medical Director, Oncology|+41615671505|Thomas.Kaindl@basilea.com|
311413|NCT02895945|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
311414|NCT02896075|University of Texas at Austin|Stephanie Lapierre|512-471-8594|stephlap1116@gmail.com|
311415|NCT02896127|Novartis PharmaAG|Study Lead|+41613241111|novartis.email@novartis.com|
311416|NCT02896296|Indivior, Inc.|Global Director, Clinical Development|804-379-1090|Robert.Bauer@Indivior.com|
311417|NCT02896361|Abbott Neuromodulation|Filippo Agnesi, PhD|972-526-4860|filippo.agnesi@abbott.com|
311418|NCT02896400|Yale School of Medicine|Steven L. Bernstein, MD|203-737-3574|steven.bernstein@yale.edu|
311419|NCT02896569|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
291508|NCT01368081|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291509|NCT01368211|Transfusion Service Rigshospitalet - Dept of Immunology, Copenhagen Denmark|Dr. Pär Johansson|+45 35452030|per.johansson@rh.regionh.dk|
291510|NCT01368263|Washington University School of Medicine|Timothy Pluard, M.D.|314-362-5645|tpluard@saint-lukes.org|
291511|NCT01368276|Amgen, Inc.|Study Director|866-572-6436||
291512|NCT01368406|Programa de Esquizofrenia PROESQ UNIFESP|Cecilia Attux|551155733599|cattux@gmail.com|
291513|NCT01368432|Johns Hopkins University & school of Medicine|Vani Rao|410-550-2288|vrao@jhmi.edu|
291514|NCT01368497|University of Pittsburgh|Dr. Steven Belle|412-624-3758|belle@edc.pitt.edu|
291515|NCT01368536|Novartis Pharmaceuticals|Study Director|862-778-8300||
291516|NCT01368562|Bausch Health Companies|Director of Clinical Operations||Lindsey.Mathew@bauschhealth.com|
291517|NCT01368614|Philips|Jeff Jasko|412-542-3651|jeff.jasko@philips.com|
302032|NCT02067000|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAPtrial@fphcare.co.nz|7044
302033|NCT02067039|CDC|Robin MacGowan|404-639-1920|rmacgowan@cdc.gov|
302034|NCT02067273|Stanford University School of Medicine|Sean Mackey, Chief, Division of Pain Medicine, Director, Stanford Systems Neuroscience and Pain Lab|(650) 498-6477|smackey@stanford.edu|
302035|NCT02067468|Universidad de Antioquia|Dr Gloria I Sanchez|+57 (4) 219 6062|sanchezg@une.net.co|
302036|NCT02067533|Isfahan University of Medical Sciences|Amin Nemati|00989131009918|nemati@med.mui.ac.ir|
302037|NCT02067585|Royal Alexandra Hospital|Xinzhe Shi|7807356735|xinzhe.shi@ahs.ca|
302038|NCT02067663|Stanford University School of Medicine|Lisa Goldthwaite|541-515-1825|lgoldthw@stanford.edu|
302039|NCT02067676|Enteric Disease Department, Naval Medical Research Center|Ramiro Gutierrez, MD|301-319-3193|ramiro.l.gutierrez.mil@mail.mil|
302040|NCT02067728|University of Illinois College of Medicine at Peoria|Dr. Amy L. Christison|309-655-3613|alc@uicomp.uic.edu|
302041|NCT02067806|Sintetica SA|Dr.Elisabetta Donati, Corporate Director Scientific Affairs|+41.91.640.42.50|edonati@sintetica.com|
302042|NCT02067858|University of Pittsburgh|Karen Holeva|412-623-1275|holevakd@upmc.edu|
302043|NCT02068027|BDSI|Vice President Clinical Operations|919-582-0294|twarneke@bdsi.com|
302044|NCT02068118|CDM e-Health|Clinical Development Physician|33 (0) 1 39 07 62 86|fralsi-ctpublication@airliquide.com|
302045|NCT02068157|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
302046|NCT02068222|AbbVie|Global Medical Information|800-633-9110||
302047|NCT02068352|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
302048|NCT02068443|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
311420|NCT02896595|Virginia Commonwealth University Health Department of Anesthesiology|Praveen Prasanna|804-828-2207|praveen.prasanna@vcuhealth.org|
311421|NCT02896907|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. James Posey|215-503-6442|James.Posey@jefferson.edu|
311422|NCT02897115|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
311423|NCT02897141|Columbia University|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
311424|NCT02897349|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311425|NCT02898077|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
311426|NCT02898103|University California San Diego|Brian Ilfeld, MD, MS|858-822-0776|bilfeld@ucsd.edu|
311427|NCT02898116|Ludwig Institute for Cancer Research|Mary Macri, Director, Clinical Trials Management|(212) 450-1546|mmacri@licr.org|
311428|NCT02898259|Clevleland|Dr. Brian Hill|1-866-223-8100|TaussigResearch@ccf.org|
311429|NCT02898454|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
311430|NCT02898597|University of Massachusetts Boston|Dr. Sun Kim|617-287-6831|sun.kim@umb.edu|
311431|NCT02898662|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
311432|NCT02898740|VA Boston Healthcare System|Dr. David Sparrow|857-364-6400|david.sparrow@va.gov|
311433|NCT02898974|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
311434|NCT02899156|University of California Davis Medical Center|Kendra Schomer, PharmD|916-734-2243|kjschomer@ucdavis.edu|
311435|NCT02899195|PrECOG|Dr. Zhuoxin Sun|617-632-3012|zhuoxin@jimmy.harvard.edu|
311437|NCT02899338|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311438|NCT02899377|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|1
311439|NCT02899650|University of Texas at Austin|Koichiro Hayashi|512-471-8594|k-hayashi@kokugakuin.ac.jp|
311440|NCT02899689|UTMB|Antonio F Saad|4097720982|afsaad@utmb.edu|
311441|NCT02899884|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
311442|NCT02899962|LEO Pharma A/S|Clinical Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
311443|NCT02899988|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
311444|NCT02900092|Massachusetts General Hospital|Karen K. Miller, MD|617-726-3870|KKMiller@mgh.harvard.edu|
311445|NCT02900170|Albert Einstein Medical Center|Basma Abdulhadi|215456500|abdulhab@einstein.edu|
311446|NCT02900378|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
311447|NCT02901054|Washington University School of Medicine|Simon Haroutounian, PhD|3142861715|simon.haroutounian@wustl.edu|
311448|NCT02901080|Electromedical Products International, Inc.|Science and Education Director|8174583295|josh@epii.com|
311449|NCT02901249|Universidade Federal do Rio Grande do Sul|D.r. Ana Flávia Barros da Silva Lima|51999185180|afbslima@gmail.com.br|
311450|NCT02901275|Johns Hopkins University School of Medicine|Dr. Kelly Dunn|410-550-2254|kdunn9@jhmi.edu|
311451|NCT02901431|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
291518|NCT01368653|Rutgers, The State University of New Jersey|Danielle E. McCarthy, Ph.D.|848-932-5870|demccart@rci.rutgers.edu|
291519|NCT01368809|Department of Anesthesiology at Cedars-Sinai Medical Center in Los Angeles|Paul F White|214-7703775|paul.white@cshs.org|
291520|NCT01368835|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
291521|NCT01368874|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
291522|NCT01368900|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
291523|NCT01368965|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
291524|NCT01369030|Pamlab, Inc.|Lori W Barrentine, MS, PA-C, Director of Clinical Affairs|985-867-5788|lbarrentine@pamlab.com|
302049|NCT02068495|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
291525|NCT01369069|University of Virginia|Karen C. Johnston, MD|434 924-5323|kj4v@virginia.edu|
291526|NCT01369108|3M Oral Care Solutions Division|Rolf Halvorson|651-733-3384|rhhalvorson@mmm.com|
291527|NCT01369199|University of Pittsburgh|Dr. Steven Belle|412-624-5419|belle@edc.pitt.edu|
302050|NCT02068508|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302051|NCT02068599|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
302052|NCT02068729|Stryker Spine|Marissa Conrad, Senior Director of Clinical and Medical Affairs|201-749-8162|marissa.conrad@stryker.com|
302053|NCT02068768|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
302054|NCT02068820|Florida Hospital Gynecologic Oncology|Robert W. Holloway|407-303-2400|robhollowaymd@gmail.com|
302055|NCT02068846|University of North Carolina at Chapel Hill|Jennifer Webster-Cyriaque, DDS, PhD|(919) 537-3492|jwebster@email.unc.edu|
302056|NCT02068885|Boston Children's Hospital|Cara Ebbeling, PhD, Co-Director, New Balance Foundation Obesity Prevention Center|617-919-3457|Cara.Ebbeling@childrens.harvard.edu|
302057|NCT02069015|Wayne State University|Julie Gleason-Comstock|313-577-6681|jgleason@med.wayne.edu|
302058|NCT02069041|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
302059|NCT02069093|Novartis Pharmaceuticals|Study Director|862-778-8300||
302060|NCT02069119|Otsuka Pharmaceutical Co., Ltd.|Director of Clinical Trials|+81-3-6361-7366||
302061|NCT02069184|Montefiore Medical Center|Jeffrey Bernstein|718-920-4317|JBernste@montefiore.org|
302062|NCT02069353|University of Pittsburgh|Jonathan Elmer|412-647-9489|elmerjp@upmc.edu|
302063|NCT02069379|University of Michigan|Alison Berent-Spillson|(734) 936-4400|berent@umich.edu|
302064|NCT02069392|University of Maryland School of Medicine|Britta Hahn, Ph.D.|4104026112|bhahn@som.umaryland.edu|
302065|NCT02069704|mAbxience|Susana Millan|+34917711500|susana.millan@mabxience.com|
302066|NCT02069847|Mayo Clinic|Michael B. Wallace|507-953-2221|wallace.michael@mayo.edu|
302067|NCT02070237|Memorial Care|Dr. Jennifer McNulty|562-933-2730|jjmcnulty@sbcglobal.net|
302068|NCT02070276|Hôpitaux Universitaires de Genève|Dr. med. Samuele Ceruti|0765661181|samuele.ceruti@me.com|
302069|NCT02070302|Arizona Arthritis & Rheumatology Research, PLLC|Amanda Santimaw|4806266653|amanda.santimaw@azarthritis.com|
302070|NCT02070380|Bracco Diagnostics, Inc.|Gianpaolo Pirovano, MD|609-514-2226|gianpaolo.pirovano@diag.bracco.com|
302071|NCT02070484|OhioHealth|Josepha Shehadi, MD|614-220-5648|joseph@drshehadi.com|
302072|NCT02070588|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
302073|NCT02070640|The Ohio State University Wexner Medical Center|Associate Professor|614-293-3230|raaja.narula@osumc.edu|
302074|NCT02070692|Oregon Health & Science University|Dr. Katharine Simmons|404-718-6619|simmonka@ohsu.edu|
302075|NCT02070744|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
302076|NCT02070757|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
311452|NCT02901899|Northwestern University|Daniela Matei, MD|312.472.4684|daniela.matei@northwestern.edu|
311453|NCT02901951|GlaxoSmithKline|GSK Response Center|866-435-7343|sk994601@gsk.com|
311454|NCT02902081|University of Chicago|Harriet de Wit|7737023560|dewitlab@yoda.bsd.uchicago.edu|
302077|NCT02070965|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
302078|NCT02070978|Merck KGaA Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
291528|NCT01369225|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291529|NCT01369329|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com|
302079|NCT02070991|Actelion Pharmaceuticals Ltd|Clinical Trial Disclosure Desk|+41 61 565 6565|clinical-trials-disclosure@its.jnj.com|
291530|NCT01369342|Janssen Research & Development, LLC|Vice President||ClinicalTrialDisclosure@its.jnj.com|
291531|NCT01369355|Janssen Research & Development, LLC|Vice President|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
291532|NCT01369433|AVEO Pharmaceuticals, Inc.|Chief Medical Officer|857-400-0101|Clinical@aveooncology.com|
291533|NCT01369485|Ethicon Surgical Care|John Lombard, Manager Clinical Research|908 218 2877|Jlombar8@its.jnj.com|
291534|NCT01369498|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
291535|NCT01369511|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291536|NCT01369615|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
302080|NCT02071082|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
302081|NCT02071095|Icahn School of Medicine at Mount Sinai|Dr. Nina Bhardwaj|212-824-8427|nina.bhardwaj@mssm.edu|
302082|NCT02071108|Shockwave Medical, Inc.|Gheda Sahyun, Director of Clinical Affairs|510-624-9073|gsahyun@shockwavemedical.com|
302083|NCT02071173|Boston Scientific|Kelly Aspinwall|1-800-CARDIAC|kelly.aspinwall@bsci.com|
302084|NCT02071225|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
302085|NCT02071290|St. Michael's Hospital|Dr. Ori Rotstein|416-864-6060|rotsteino@smh.ca|5304
302086|NCT02071420|University of Iowa|Lucas Carr, PhD|319-353-5432|lucas-carr@uiowa.edu|
302087|NCT02071706|GE Healthcare|Yvonne Celestial|+33625023857|MarieYvonne.CELESTIAL@ge.com|
302088|NCT02071771|Alcon Research, Ltd.|Sr Global Brand Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
302089|NCT02071810|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
302090|NCT02071823|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
302091|NCT02071849|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
302092|NCT02071914|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
302093|NCT02072096|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
302094|NCT02072174|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
302095|NCT02072200|Mundipharma Korea Ltd|Kim Bu Yeon|+82 2 568 5689|BuYeon.Kim@mundipharma.co.kr|
302096|NCT02072226|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
302097|NCT02072421|Harvard Clinical Research Institute|Priscilla Driscoll-Shemp|617-307-5200|priscilla.driscoll-shempp@hcri.harvard.edu|
311455|NCT02902146|HHRI|Audrey Hendrickson|6128737448|audrey.hendrickson@hcmed.org|
311456|NCT02902172|St. Louis University|Dr. Jennifer Goldkamp|3149772200|jen.goldkamp@health.slu.edu|
311457|NCT02902237|Department of Medicine A, University Hospital Muenster, Germany|Prof. Dr. Wolfgang Berdel, Professor of Medicine|+49 251 835|berdel@uni-muenster.de|2672
311458|NCT02902770|Maimonides Medical Center|Antonios Likourezos|7182836896|alikourezos@maimonidesmed.org|
311459|NCT02902809|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
311460|NCT02902913|University of California, Davis|Roberta R Holt|530-752-4950|rrholt@ucdavis.edu|
311461|NCT02902965|Pharmacyclics Switzerland GmbH|Dr. Bernhard Hauns, Medical Monitor|+41 52 556 0800|bhauns@pcyc.com|
311462|NCT02903030|Nisonger Center|Dr. L. Eugene Arnold, MD, MED. Professor Emeritus College of Medicine|614-685-6701|l.arnold@osumc.edu|
311463|NCT02903121|Oregon Health and Science University|Alison Edelman, MD, MPH|5034943666|edelmana@ohsu.edu|
311464|NCT02903238|Northwestern University Medical School|Dr. Apkar Vania Apkarian|(312) 503-0404|a-apkarian@northwestern.edu|
311465|NCT02903368|Dana-Farber Cancer Institute|Mary-Ellen Taplin, MD|617-582-7221|mtaplin@partners.org|
311466|NCT02903394|Duke University|Kengyeh Chu|919-681-2093|ken.chu@duke.edu|
311467|NCT02903407|Duke University|Angela Lowenstern|919-684-0111|angela.sandelin@duke.edu|
311468|NCT02903420|Edwards Lifesciences|Director of Research|949-250-2500|THV_CT.gov@edwards.com|
311469|NCT02903446|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Angelo Gaffo, MD; Associate Professor|205-996-6086|agaffo@uab.edu|
311470|NCT02903511|"University of Colorado Denver | Anschutz"|Godela Brosnahan, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
311471|NCT02903836|Wockhardt|Dr Manishkumar D Shah|02226534444|manish.shah@wockhardt.com|6893
311472|NCT02903966|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311473|NCT02904057|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
311474|NCT02904096|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.com|
311475|NCT02904200|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
311476|NCT02904226|Jounce Therapeutics|Dr. Ellen Hooper, Senior Medical Director|857-320-2548|ehooper@jouncetx.com|
311477|NCT02904265|Mayo Clinic|Dr. Katherine Nickels|5072660774|nickels.katherine@mayo.edu|
311478|NCT02904512|Veterans Affairs Medical Center|Dr. Ilias (Elias) Spanakis|(617) 319-9731|ispanakis@som.umaryland.edu|
311479|NCT02904902|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
311480|NCT02904915|The University of Texas Health Science Center at Houston|Pamela D. Berens, MD|713-500-6471|Pamela.D.Berens@uth.tmc.edu|
311481|NCT02904954|Weill Cornell Medicine|Cathy Spinelli, RN BSN|212-746-3328|caf2007@med.cornell.edu|
311482|NCT02905006|Cares|UCB|+1877 822|UCBCares@ucb.com|9493
311483|NCT02905149|Instituto de Investigación Sanitaria La Fe|Maria Cortell|961246611|investigacion_clinica@iislafe.es|
311484|NCT02905266|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
311485|NCT02905331|Janssen Research & Development, LLC|Senior Director, Immunology General|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
291537|NCT01369680|Medical University of South Carolina|Dr. Amy-Lee Bredlau|843-792-2957|bredlau@musc.edu|62872
291538|NCT01369706|Deutsches Herzzentrum München|Prof. Dr. Christof Kolb|+49891218|kolb@dhm.mhn.de|2020
291539|NCT01369732|Yonsei University College of Medicine|Dr. Yon Hee Shim|82220193547|tren125@yuhs.ac|
291540|NCT01369745|Zalicus|Margaret Lee,PhD|617-301-7142|mlee@zalicus.com|
291541|NCT01369758|Hologic, Inc|Christina Mastandrea|508-263-8772|Christina.Mastandrea@Hologic.com|
291542|NCT01369784|Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea (GELTAMO)|Dr. Carlos Panizo|+ 34 948 25 54 00|cpanizo@unav.es|
291543|NCT01369849|Mayo Clinic|Wei Ding, MBBS, PhD||ding.wei@mayo.edu|
291544|NCT01369875|National Cancer Institute, National Institutes of Health|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
291545|NCT01369888|National Cancer Institute|Dr. Steven Rosenberg|301-496-4164|sar@mail.nih.gov|
291546|NCT01370005|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302098|NCT02072434|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@dsi.com|
302099|NCT02072668|University of Tennessee Center for the Heath Sciences|Dr. Kenneth Ataga|901.448.3181|kataga@uthsc.edu|
302100|NCT02072824|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302101|NCT02072928|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
302102|NCT02072941|University of California San Francisco|Dr. Rebecca Sudore|(415) 221-4810|rebecca.sudore@ucsf.edu|23475
302103|NCT02072980|Alcon Research, Ltd.|Cecile Maissa, Global Brand Medical Affairs Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
302104|NCT02073162|The Cleveland Clinic Foundation|Dr. Daniel Sessler|216-444-4900|ds@or.org|
302105|NCT02073331|Aziyo Biologics, Inc.|Clinical Director|510-730-7973|clinical@aziyo.com|
302106|NCT02073435|Northwestern University|Donna Woods, MD|312-503-5550|woods@northwestern.edu|
302107|NCT02073448|Galderma K.K|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
302108|NCT02073461|Galderma K.K.|Clinical Project Manager|+81 3 5937 3850|GaldermaKK.ClinDev@galderma.com|
302109|NCT02073487|Houston Methodist|Jenny Chang|713-441-0681|jcchang@houstonmethodist.org|
302110|NCT02073565|OrbusNeich|Debbie Morrell, Clinical Research Manager|954-730-0711|DMorrell@OrbusNeich.com|
302111|NCT02073643|Rush University Medical Center|Brad Appelhans, PhD|312-942-3477|brad_appelhans@rush.edu|
302112|NCT02073656|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
302113|NCT02073682|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|1-908-992-6400|CTRinfo@DSI.com|
302114|NCT02073747|University Medical Center of Southern Nevada|Emergency Department Research Coordinator|702-224-7124|wesley.forred@umcsn.com|
302115|NCT02073929|Center of Endocrinology and Metabolism, Dept. of Internal Medicine, Herlev Gentofte Hospital, Denmark|Professor Jens Faber|+4538689016|jens.faber@regionh.dk|
302116|NCT02074059|Windtree Therapeutics, Inc.|Executive Director, Biostatistics & Data Management|215-488-9300|psimmons@windtreetx.com|9477
302117|NCT02074345|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
311486|NCT02905435|PolyNovo Biomaterials Pty Ltd|Tim Barker, PhD|+61386814054|tim.b@polynovo.com|
311487|NCT02905825|Exalenz Bisocience|Avraham Hershkowitz|972-8-9737513|avrahamh@exalenz.com|
311488|NCT02905981|Rockwell Medical|Ray Pratt, MD|248 960-9009|rpratt@rockwellmed.com|405
311489|NCT02906358|The University of Texas Health Science Center at San Antonio|Barbara J Turner|210-562-5551|turner@uthscsa.edu|
311490|NCT02906566|Stanford University|Dr. Anne L. Chang|650-721-7195|alschang@stanford.edu|
311491|NCT02906579|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
311492|NCT02906644|Duke University|Clinical Research Coordinator|(919) 668-5055|al.salley@duke.edu|
311493|NCT02906670|Symphogen AS|Medical Director|004545265050|info@symphogen.com|
311494|NCT02906696|The University of Texas MD Anderson Cancer Center|Philip Thompson, MD/Assistant Professor|713-792-7430|PAThompson2@mdanderson.org|
311495|NCT02906709|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
311496|NCT02906813|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
311497|NCT02906917|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
311498|NCT02906930|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
311499|NCT02907073|Mayo Clinic|Dr. Timothy R. DeGrado|507-293-3793|DeGrado.Timothy@mayo.edu|
311500|NCT02907177|Actelion Pharmaceuticals Ltd (a Janssen Pharmaceutical Company of Johnson & Johnson)|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
311501|NCT02907216|GlaxoSmithKline|GSK Response Center|866-435-7343|kap69137@gsk.com|
311502|NCT02907268|ICLS|Shantel Demay|905-842-2262|s.demay@icls.ca|
311503|NCT02907463|Edwards Lifesciences, LLC|Mary Edwards, VP Clinical and Regulatory Affairs, Surgical Structural Heart|949-250-2500|mary_edwards@edwards.com|1536
311504|NCT02907489|Cairo university|Mohamed Omaia Ahmed|00201224474609|mohamed.omaia@dentistry.cu.edu.eg|
311505|NCT02907619|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
311506|NCT02907814|Rutgers New Jersey Medical School|Dr. Elliot Crane|973-972-2020|cranees@njms.rutgers.edu|
311507|NCT02907892|University of Minnesota|Dr. Rachel Vogel|6513345982|isak0023@umn.edu|
311508|NCT02907918|Washington University School of Medicine|Foluso O. Ademuyiwa, M.D., MPH|314-454-8313|bisiademuyiwa@wustl.edu|
311509|NCT02908100|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
311510|NCT02908178|Yale University|Shi-Yi Wang, MD, PhD|2037852886|shiyi.wang@yale.edu|
311511|NCT02908269|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
311512|NCT02908347|MetrioPharm Deutschland GmbH|Clinical Disclosure Officer|+49303384395|info@metriopharm.com|36
311513|NCT02908464|Beth Israel Deaconess Medical Center|Brian O'Gara, MD, MPH|617-754-3189|bpogara@bidmc.harvard.edu|
291547|NCT01370018|Institute for Human Genetics and Biochemistry|Cynthia L. Bristow, MS, PhD|6314446238|cynthia.bristow@alpha1biologics.com|
291548|NCT01370083|Toronto Rehabilitation Institute - University Health Network|Prof. Catriona Steele|4165973422|catriona.steele@uhn.ca|7603
302118|NCT02074358|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
302119|NCT02074384|Park Nicollet Institute|Dr. Deborah Mullen|952-993-2070|deborah.mullen@parknicollet.com|
302120|NCT02074514|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
302121|NCT02074553|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
302122|NCT02074709|University of Texas Southwestern Medical Center|Irina Gasanova|214-590-0064|Irina.Gasanova@UTSouthwestern.edu|
302123|NCT02074735|UT Southwestern Medical Center|E. Sherwood Brown, MD, PhD|214-645-6950|sherwood.brown@utsouthwestern.edu|
302124|NCT02074982|Novartis Pharmaceuticals|Study Director|862-778-8300||
302125|NCT02074995|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
302126|NCT02075008|Novartis Pharmaceuticals|Study Director|862-778-8300||
302127|NCT02075047|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302128|NCT02075073|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534||
302129|NCT02075125|Department of Cardiology, College of Medicine, Dong-A University.|Dr. Moo Hyun Kim; Director of Global Clinical Trial Center Dong-A University Hospital.|+82 (51) 240-2976|kimmh@dau.ac.kr|
302130|NCT02075203|SATVI|Dr. Mark Hatherill|+27214066145|mark.hatherill@uct.ac.za|
302131|NCT02075255|AstraZeneca|Mitchell Goldman, Global Clinical Lead Benralizumab|+1 301 398 0323|Mitchell.Goldman@astrazeneca.com|
302132|NCT02075320|UNC School of Medicine Department of Radiology|Dr. Yueh Lee|(919) 537-3730|yueh_lee@med.unc.edu|
302133|NCT02075463|GlaxoSmithKline|GSK Response Center|866-435-7343||
302134|NCT02075476|Hospital Gregorio Marañón|Dr. Carlos Álvarez|0034915868000|calvargon@gmail.com|
302135|NCT02075515|GlaxoSmithKline|GSK Response Center|866-435-7343||
302136|NCT02075541|GlaxoSmithKline|GSK Response Center|866-435-7343|lp542096@gsk.com|
302137|NCT02075554|Globus Medical Inc.|Brandon Bucklen|610-930-1800|bbucklen@globusmedical.com|2517
302138|NCT02075606|Ipsen|Medical Director|00441753627777|clinical.trials@ipsen.com|
302139|NCT02075632|GlaxoSmithKline|GSK Response Center|866-435-7343||
302140|NCT02075658|UCI Health Department of Urology|Clinical Research Coordinator|714-456-8176|yoonrh@uci.edu|
302141|NCT02076022|University of Pittsburgh Plastic Surgery|Patsy Simon|412-648-9207|simopa@upmc.edu|
302142|NCT02076100|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302143|NCT02076113|Lahey Hospital & Medical Center|Zoher Ghogawala, MD|781-744-8984|zoher.ghogawala@lahey.org|
302144|NCT02076152|Massachusetts General Hospital|Elizabeth Gerstner, MD|617-724-2887|EGERSTNER@PARTNERS.ORG|
302145|NCT02076165|VA Greater Los Angeles Healthcare System|Dr. Jennifer Martin|818 891-7711|Jennifer.Martin@va.gov|36080
311514|NCT02908490|University of Pittsburgh|Kimberly P. Liang, MD, MS|412-586-3550|liangkp@upmc.edu|
311515|NCT02908529|Brigham and women's Hospital|Luigi Taranto Montemurro, MD|6177326541|ltarantomontemurro@bwh.harvard.edu|
311516|NCT02908620|University of Pennsylvania, School of Dental Medicine|Elliot V Hersh, DMD, Ph.D., Director Clinical Pharmacology Research|215-898-9686|evhersh@pobox.upenn.edu|
311517|NCT02908841|Western Connecticut Health Network|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
311518|NCT02908880|Essential Medical, Inc.|Sam Nardone|6105571009|sam@essmedclosure.com|
311519|NCT02909101|Duke University School of Medicine|Dr. Sheri Towe|919-668-4030|sheri.towe@duke.edu|
311520|NCT02909140|Wilmer Eye Institute|Dr. Fasika Woreta|(410) 955-5650|fworeta1@jhmi.edu|
311521|NCT02909153|Rockwell Medical|clinical project manager|248-960-9009|sgrimberg@rockwellmed.com|
311522|NCT02909439|Stony Brook Medicine|Ramon Abola, Clinical Associate Professor|631-444-2975|ramon.abola@stonybrookmedicine.edu|
311523|NCT02909504|University Hospitals Cleveland Medical Center|Dr. Keming Gao, MD, PhD|2168442865|keming.gao@UHhospitals.org|
311524|NCT02909764|Monell Chemical Senses Center|Julie A. Mennella|2675194880|mennella@monell.org|
311525|NCT02909907|Cleveland Clinic Foundation|Hubert H Fernandez|2164451108|FERNANH@ccf.org|
311526|NCT02909959|University of North Carolina at Chapel Hill|Laura Politte, MD|919-350-1726|lpolitte@wakemed.org|
311527|NCT02910011|University of Florida|Dr. Anna DeBenedetto|352 594 1500|adebenedetto@dermatology.ufl.edu|
311528|NCT02910037|The University of California, San Francisco|Dr. Charles Chiu|(415) 514-8219|charles.chiu@ucsf.edu|
311529|NCT02910063|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
311530|NCT02910089|Astrazeneca Pharmaceuticals|Susan Thomas, MD|302-886-5589|Susan.Thomas2@astrazeneca.com|
311531|NCT02910102|Axovant Sciences, Inc.|Director, Clinical Development|1-833-296-8268|clinicaltrials@axovant.com|
311532|NCT02910167|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311533|NCT02910362|Arizona Eye Consultants|Sean McCafferty, MD|(520) 791-7401|sjmccafferty66@hotmail.com|
311534|NCT02910466|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
311535|NCT02910674|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|303.724.6713|satish.garg@ucdenver.edu|
311536|NCT02910713|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
311537|NCT02910739|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
311538|NCT02911025|Brigham and Women's Hospital|Dr. Milena Pavlova|6174772129|mpavlova@bwh.harvard.edu|
311539|NCT02911116|National Institutes of Health|H. Nida Sen, MD, MHSc, Principal Investigator, NEI|301-402-3254|senh@nei.nih.gov|
311540|NCT02911285|Medical University of South Carolina|Stacey Sellers, Program Manager|843-792-5807|sellersst@musc.edu|
311541|NCT02911324|Columbia University/New York State Psychiatric Institute|Reilly Kayser, MD|646-774-8118|reilly.kayser@nyspi.columbia.edu|
311542|NCT02911519|SAMEIN|Dr. Jenny Garcia|+57 4 219 6014|jenny.garcia@udea.edu.co|
291549|NCT01370174|University of Maryland|Dr. Vicki Gray Principal Investigator|4107063778|vicki.gray@som.umaryland.edu|
291550|NCT01370213|Masonic Cancer Center, University of Minnesota|Dr. Jeffrey Miller|612-626-4024|mille011@umn.edu|
291551|NCT01370265|Mayo Clinic|Dr. Panithaya Chareonthaitawee|507-284-1648|chareonthaitawee.panithaya@mayo.edu|
291552|NCT01370317|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291553|NCT01370356|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291554|NCT01370369|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
291555|NCT01370408|Blood and Marrow Transplant Group of Georgia|Dr. Scott Solomon|404-255-1930|ssolomon@bmtga.com|
291556|NCT01370460|Henry Ford Health System|Andrew Georgiadis, MD|313-916-7520|ageorgi1@hfhs.org|
302146|NCT02076243|Icahn School of Medicine at Mount Sinai|Dr. Philip Friedlander|212-824-8584|philip.friedlander@mssm.edu|
302147|NCT02076321|University of Missouri, Department of Orthopaedics|Dr. Daniel Hoernschemeyer|(573)882-1351|hoernschemeyerd@health.missouri.edu|
302148|NCT02076334|University University Chapel Hill|Abbie Smith-Ryan, PhD|919-962-2574|abbsmith@email.unc.edu|
311543|NCT02911688|Center for Environmental Medicine Asthma and Lung Biology|Carole Robinette Assistant Director of Clinical Research|919 966-5638|carole_robinette@med.unc.edu|
311544|NCT02911753|University of Arizona|David O. Garcia, PhD, FACSM|520-626-4641|davidogarcia@email.arizona.edu|
311545|NCT02911818|The University of Pennsylvania Center for Weight and Eating Disorders|Dr. Thomas Wadden|215-746-5046|wadden@pennmedicine.upenn.edu|
311546|NCT02911844|University of Pennsylvania|Dr. Steven Kawut|215-573-0258|kawut@upenn.edu|
311547|NCT02911857|Novartis Pharmaceuticals|Study Director|862-778-1873|Novartis.email@novartis.com|
311548|NCT02911909|University of Missouri|Ennio Rizzo|573-882-7615|eardvb@health.missouri.edu|
311549|NCT02911922|Weill Cornell Medicine - New York Presbyterian Hospital|Josephine Kang, M.D. Ph.D.|212-746-3607|jok9106@med.cornell.edu|
311550|NCT02911948|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
311551|NCT02912195|Alameda Health System|Andrew Herring|510 437-8356|aherring@alamedahealthsystem.org|
311552|NCT02912364|Stanford University|Kimford Meador|650-725-6648|kmeador@stanford.edu|
311553|NCT02912455|Cleveland Clinic|Dr. Sangeeta Kashyap|(216) 445-2679|kashyas@ccf.org|
311554|NCT02912468|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1
270262|NCT00116779|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
270263|NCT00116805|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
291557|NCT01370499|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291558|NCT01370525|AstraZeneca|Gerard Lynch|1625 518062|aztrial_results_posting@astrazeneca.com|+44
291559|NCT01370538|AstraZeneca|Gerard Lynch|1625 518062|aztrial_results_posting@astrazeneca.com|+44
291560|NCT01370564|Medtronic|Todd Fonseca, VP Clinical|763-526-8151|todd.fonseca@medtronic.com|
291561|NCT01370616|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291562|NCT01370629|Correvio International|Head of Clinical Development|+41 (0) 22 907 79 70|info@correvio.com|
291563|NCT01370642|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291564|NCT01370655|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302149|NCT02076399|Rigel|Anne-Marie Duliege, MD|650-624-1100|clinicaltrials@rigel.com|
302150|NCT02076412|Rigel|Anne-Marie Duliege, MD|6506241100|clinicaltrials@rigel.com|6506241100
302151|NCT02076425|Early Emotional Development Program at Washington University School of Medicine|Dr. Joan Luby|3142862730|lubyj@wustl.edu|
302152|NCT02076776|Cleveland Clinic|Dr. Jay Alberts|216 445-3222|albertj@ccf.org|
302153|NCT02076919|Alcon Research, Ltd.|Principal Clinical Scientist, CA CSI ID|1-888-451-3937|alcon.medinfo@alcon.com|
302154|NCT02076997|Baylor College of Medicine|Dr. Jennifer Foster|832-824-4646|jhfoster@texaschildrens.org|
302155|NCT02077140|Medtronic Spine and Biologics|Clinical Affairs|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
302156|NCT02077374|Conatus Pharmaceuticals Inc.|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
302157|NCT02077465|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
302158|NCT02078102|IndianaU|Dr. Sherif Farag|(317) 278-0460|ssfarag@iu.edu|
302159|NCT02078180|University of Michigan|Dr. Duxin Sun|734-763-9783|pharmacy.research@umich.edu|
302160|NCT02078193|East Carolina University, Division of Nephrology|Austin Rice|252-744-1904|riceau15@ecu.edu|
302161|NCT02078219|Study Information Center AstraZeneca|Fredrik Erlandsson, MD|+1 877-240-9479|information.center@astrazeneca.com|
302162|NCT02078284|Pugent Sound Blood Center|Sherrill Slichter|206-292-6541|sjslichter@psbc.org|
302163|NCT02078492|Maimonides Medical Center|Dr. Sergey Motov|718-283-8693|smotov@maimonidesmed.org|
302164|NCT02078557|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302165|NCT02078713|University of California, San Francisco|Dr. Christine Dehlendorf, Principal Investigator|415-206-8712|christine.dehlendorf.@ucsf.edu|
302166|NCT02078726|University of California, San Francisco|John Cello, MD|628-206-4767|John.Cello@ucsf.edu|
311555|NCT02912650|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
311556|NCT02913105|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
311557|NCT02913222|Washington University School of Medicine|Marcie Harris-Hayes, PT, DPT, MSCI, Professor, Physical Therapy and Orthopaedic Surgery|314-286-1435|harrisma@wustl.edu|
311558|NCT02913326|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311559|NCT02913521|Egeen|Kalev Kask|16504690600|kalev.kask@egeeninc.com|
311560|NCT02913924|New York State Psychiatric Institute|John Mariani MD|646-774-8181|john.mariani@nyspi.columbia.edu|
311561|NCT02914119|Herlev Hospital, research unit, anesthesia|Dr. JLD Thomsen|004538633863|prs@demants.dk|
311562|NCT02914132|ExThera Medical Corporation|Sr. Director of Regulatory and Clinical Affairs|9258392079|erdie@extheramedical.com|
311563|NCT02914184|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311564|NCT02914210|Duke Clinical Research Institute|Janet Bettger, ScD|919-613-0379|janet.bettger@duke.edu|
311565|NCT02914236|Aerin Medical, Inc.|Scott Wolf, M.D., Chief Medical Officer|650-597-0111|swolf@aerinmedical.com|
311566|NCT02914275|Seqirus|Clinical Study Disclosure Manager|1-855-358-8966|Seqirus.ClinicalTrials@Seqirus.com|
311567|NCT02914457|Medtronic Bakken Research Center|Richard Cornelussen|+31433566651|richard.cornelussen@medtronic.com|
311568|NCT02914509|Ocular Therapeutix, Inc.|Clinical Project Manager|781-357-4000|clinicalaffairs@ocutx.com|
311569|NCT02914522|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311570|NCT02914548|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
311571|NCT02914795|Medical University of Grazt|Assoc. Prof. Dr. Dirk von Lewinski|+43 316 385|dirk.von-lewinski@medunigraz.at|80684
311572|NCT02914834|University of Illinois Chicago|Judith Schlaeger, PhD|3124134669|jschlaeg@uic.edu|
311573|NCT02915016|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
311574|NCT02915029|University of New Mexico|Dr Vallabh Shah|505-272-9615|vshah@salud.unm.edu|
311575|NCT02915159|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
311576|NCT02915302|Sanofi Pasteur Inc.|Medical Director|800-633-1610|RegistryContactUs@sanofipasteur.com|1#
311577|NCT02915705|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
311578|NCT02915744|Nektar Therapeutics|Study Director|415-482-5416|medicalaffairs@nektar.com|
311579|NCT02915835|University of Michigan|Dr. Cathie Spino|7346155469|spino@umich.edu|
311580|NCT02915874|University of Iowa|Jess G Fiedorowicz, MD, PhD|319-384-9267|jess-fiedorowicz@uiowa.edu|
311581|NCT02915978|Insys Therapeutics, Inc.|Director, Clinical Development|480-500-3105|gdecastro@insysrx.com|
311582|NCT02916056|vTv Therapeutics|Ann Gooch PhD, VP Clinical Development & Regulatory Operations|336-841-0300|agooch@vtvtherapeutics.com|80544
311583|NCT02916407|Inje University, Haeundae Paik hospital|Dr Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
291565|NCT01370694|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291566|NCT01370733|University of California Los Angeles|Dr. Andrew Leuchter, MD|(310) 825-0207|afl@ucla.edu|
302167|NCT02078752|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291567|NCT01370837|Maastricht University Medical Center|Kristy Pickwell|+31433877019|k.pickwell@mumc.nl|
291568|NCT01370863|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
291569|NCT01371006|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291570|NCT01371032|Cedars Sinai Medical Center|Dr. Roya Yumul, MD, PhD|310-423-1682|Roya.Yumul@cshs.org|
291571|NCT01371110|Baylor College of Medicine (previously Icahn School of Medicine at Mount Sinai)|Wayne Goodman|713-798-4945|wayne.goodman@bcm.edu|
291572|NCT01371539|Alcon Research, Ltd.|Stacie Cummings, O.D.|1-800-241-7629||
291573|NCT01371552|Alcon Research, Ltd.|Joachim Nick, Dipl. Ing.|+49 6022 240 520|joachim.nick@cibavision.com|
302168|NCT02078817|University of Minnesota|Katherine Cullen|612-273-9732|rega0026@umn.edu|
302169|NCT02078882|University of California Davis|Christopher L Bowlus|9167348696|clbowlus@ucdavis.edu|
302170|NCT02078960|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
302171|NCT02079025|Exact Imaging|Manager, Clinical Research|905-415-0030|bwodlinger@exactimaging.com|204
302172|NCT02079038|Vertiflex|Steve Reitzler|442-325-5934|Stephen.reitzler2@bsci.com|
302173|NCT02079077|University of Manitoba|Keith Fowke|204-789-3296|keith.fowke@umanitoba.ca|
302174|NCT02079246|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@lundbeck.com|
302175|NCT02079311|Universitätsklinikum Gießen und Marburg GmbH|Prof Alexander Torossian|(+49) 06421 - 286 9864|alexander.torossian@med.uni-marburg.de|
302176|NCT02079519|Hoffmann-La Roche|Medical Communications|800 821-8590||
302177|NCT02079532|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
302178|NCT02079610|University of Pittsburgh School of Medicine|Kymberly Young, PhD|412-648-6179|youngk@pitt.edu|
302179|NCT02079636|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
302180|NCT02079649|Alcon Research, Ltd.|Clinical Project Lead, Pharma, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
302181|NCT02079805|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302182|NCT02079844|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
302183|NCT02079909|FUJIFILM Toyama Chemical|Project Manager|+81-3-6427-6245|fftc-clinicaltrial-info1@fujifilm.com|
302184|NCT02079987|University of Florida|Donna L. Carden, MD, MPH|352-265-5911|dcarden@ufl.edu|
302185|NCT02080091|Alimera Sciences, Ltd.|Andrew Joyson - Associate Director, Clinical Operations Europe|+44 1252 354 026|Andrew.Joyson@alimerasciences.com|
302186|NCT02080195|The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins|Javier Bolaños Meade, MD|410-614-6398|fbolano2@jhmi.edu|
302187|NCT02080221|Brown University Oncology Research Group|Howard Safran, MD|4018633000|BrUOG@BROWN.EDU|
311584|NCT02916433|Western Connecticut Health Network|Joann Petrini|203-739-6882|Joann.Petrini@wchn.org|
311585|NCT02916498|Boston Scientific|Director, Clinical Sciences and Scientific Communication|855-213-9890|BSNClinicalTrials@bsci.com|
311586|NCT02916563|Barbara Davis Center for Childhood Diabetes|Dr. Satish K. Garg|3037246713|satish.garg@ucdenver.edu|
311587|NCT02916693|Johns Hopkins University|Dr. Arthur L. Burnett|410-614-3986|aburnet1@jhmi.edu|
311588|NCT02916745|on behalf of Concordia Laboratories Inc./Advanz Pharma|Kim McDonald-Taylor|647-267-2942|kmcdonald-taylor@rogers.com|
311589|NCT02916927|Alameda Health Systemt - Highland Hospital|Dr. Andrew Herring|(510) 437-4564|aherring@alamedahealthsystem.org|
311590|NCT02917031|AstraZeneca R&D|AstraZeneca R&D|+46 766 346712|clinicaltrialtransparency@astrazeneca.com|
311591|NCT02917122|National Cheng Kung University|Dr. Kao Chin Chen|+886-6-2353535|andchen@mail.ncku.edu.tw|5213
311592|NCT02917265|Oklahoma Medical Research Foundation|Aikaterini Thanou, MD|405-271-7805|aikaterini-thanou@omrf.org|
311593|NCT02917278|Purdue University|Kathleen Hill Gallant|765-494-0101|hillgallant@purdue.edu|
311594|NCT02917447|VA Puget Sound Health Care System|Keren Lehavot, PhD|206-277-1511|keren.lehavot@va.gov|
311595|NCT02917603|UMissouri|Debra Parker Oliver; PI|573-356-6719|oliverdr@missouri.edu|
311596|NCT02917642|University of São Paulo|Dr. Ericka T. Pinheiro|551126488293|erickapinheiro@usp.br|
311597|NCT02917941|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
311598|NCT02918071|AstraZeneca|Ubaldo Martin, Global Clinical Lead Benralizumab|+1 301 398 0163|Ubaldo.Martin@astrazeneca.com|
311599|NCT02918097|Universidade Federal do Rio Grande do Sul|D.r. Ana Flávia Barros da Silva Lima|5551999185180|afbslima@gmail.com.br|
311600|NCT02918266|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
311601|NCT02918279|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
311602|NCT02918318|Janssen Pharmaceutical K.K., Japan|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
311603|NCT02918357|University of California, San Francisco|Dr. Thomas Hope|(415) 221-4810|thomas.hope@ucsf.edu|2264
311604|NCT02918396|Johns Hopkins University|Dr. Tarek Zghaib|410-955-5000|tzghaib1@jhmi.edu|
311605|NCT02918552|University of Pittsburgh|Tara Sheila Stakich|412-864-2082|tss54@pitt.edu|
311606|NCT02918617|University of Texas Health San Antonio|Bennett Amaechi, DDS|210-567-3185|amaechi@uthscsa.edu|
311607|NCT02918630|The University of Texas Health Science Center at Houston|Jin Ho Yoon, PhD|(713) 486-2796|Jin.Ho.Yoon@uth.tmc.edu|
311608|NCT02918656|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
311609|NCT02918669|Paradigm Spine|Fran Magee, DVM|212-367-7274|fran.magee@paradigmspine.com|
311610|NCT02918721|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
311611|NCT02918773|Emory University|Andi L Shane MD/MPH/MSc|404-727-9880|ashane@emory.edu|
291574|NCT01371565|Corcept Therapeutics|Medical Director|650-327-3270|info@corcept.com|
291575|NCT01371643|NYU Langone Medical Center|David Kleinberg|212 263 6772|David.Kleinberg@nyumc.org|
291576|NCT01371656|Children's Oncology Group|Results Reporting Coordinator|352-273-0567|resultsreportingcoordinator@childrensoncologygroup.org|
291577|NCT01371708|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
291578|NCT01371721|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291579|NCT01371734|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291580|NCT01371747|Relypsa, Inc.|Medical Information|1-844-relypsa|medinfo@relypsa.com|
291581|NCT01371786|Sunovion|Respiratory Medical Director|1-866-503-6351||
291582|NCT01371825|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
291583|NCT01371838|AstraZeneca Pharmaceuticals|Melnick, David A / Exec Dir Med Science|+1 302 886 5627|David.Melnick@astrazeneca.com|
291584|NCT01371851|University of Arkansas for Medical Sciences|Alison Oliveto, PhD|501-526-8441|olivetoalison@uams.edu|
302188|NCT02080260|Levine Cancer Institute|Chair of Biostatistics Department|9804422371|james.symanowski@atriumhealth.org|
302189|NCT02080273|Colgate Palmolive Company|Maria Ryan|732-878-7766|maria_ryan@colpal.com|
302190|NCT02080312|UCSD|Julie Bykowski|619-543-6766|jbykowski@ucsd.edu|
302191|NCT02080364|vTv Therapeutics LLC|Ann Gooch PhD,RAC,CCRP; Vice President Clinical Development & Regulatory Operations|336-841-0300|agooch@vtvtherapeutics.com|80544
302192|NCT02080403|Dexcel Pharma|Clinical Trial Department Manager|972-4-6364000|sigalit.melcer@dexcel.com|467
302193|NCT02080455|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-242-5142|alison.long@aegerion.com|
302194|NCT02080468|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|617-500-5142|alison.long@aegerion.com|
302195|NCT02080481|Cleveland Clinic|Aplarslan Turan, MD|216-445-9857|turana@ccf.org|
302196|NCT02080507|Emory University|Dr. William McDonald|404-712-6945|wmcdona@emory.edu|
302197|NCT02080546|Duke University Medical Center|Dr Paula S Lee|919-684-3765|paula.s.lee@duke.edu|
302198|NCT02080637|Duke University|Kevin Hill, M.D.|919-668-8305|kevin.hill@duke.edu|
302199|NCT02080780|Ventrus Biosciences|Ventrus|646-706-5208|VEN307@ventrusbio.com|
302200|NCT02080819|Virginia Commonwealth University|Dr. Liangsuo Ma|8048282871|liangsuo.ma@vcuhealth.org|
302201|NCT02080832|VCU|F. Gerard Moeller, M.D.|804-828-4134|frederick.moeller@vcuhealth.org|
302202|NCT02080871|W.L. Gore & Associates|Hector R Novoa|928-864-3867|hnovoa@wlgore.com|
302203|NCT02081001|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP for Drug Development|512-498-2675|mcummins@xerispharma.com|
302204|NCT02081014|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP Drug Development|512-498-2675|mjcummins@xerispharma.com|
302205|NCT02081079|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
311612|NCT02918851|Stony Brook Medicine|Dr. Elliott Bennett-Guerrero|6314442979|elliott.bennett-guerrero@stonybrookmedicine.edu|
311613|NCT02918877|Beth Israel Deaconess Medical Center|Dr. Brian P. O'Gara|617-549-2974|bpogara@bidmc.harvard.edu|
311614|NCT02918968|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
311615|NCT02919007|Home Skinovations|Dr Liora Levi|+97249097470|LioraL@silkn.com|
311616|NCT02919111|University of California, San Francisco|Dr. Thomas Hope, MD|(415) 221-4810|Thomas.Hope@ucsf.edu|22648
311617|NCT02919267|Institut universitaire de cardiologie de de pneumologie de Québec|Dr Jean Bussières|418-656-8711|jbuss@criucpq.ulaval.ca|2944
311618|NCT02919423|University of Arkansas for Medical Sciences|Merideth Addicott, Assistant Professor|501-526-8436|maddicott@uams.edu|
311619|NCT02919475|Akros Pharma Inc.|Kazuhiro Okamiya|609-919-6123|okamiya@akrospharma.com|
311620|NCT02919657|Medfit Rx|David Michael|9196109893|dmichael@medfitrx.net|
311621|NCT02919696|Eli Lilly and Company|Chief Medical Officer|(800) 545-5979|ClinicalTrials.gov@lilly.com|
311622|NCT02919761|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
311623|NCT02919813|Oregon Health & Science University|OB/Gyn Regulatory Specialist|503-494-3666|whru@ohsu.edu|
311624|NCT02919826|Queen's University|Dr. Muhammad Ayub|613-549-7944|ma84@queensu.ca|
311625|NCT02919995|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|
311626|NCT02920476|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
311627|NCT02920528|Lundquist Institute|David Tanen|310-222-3624|dtanen@emedharbor.edu|
311628|NCT02920749|Department of Anaesthesiology and Intensive Therapy, University of Pecs|Dr. Timea Bocskai|36 72 507374|bocskai.timea@pte.hu|
311629|NCT02920918|Virginia Commonwealth University|Salvatore Carbone|804 628 3980|scarbone@vcu.edu|
311630|NCT02920957|CooperVision Inc|Sr.Manager Global Medical Scientific Affairs|(925) 621-3761|javega@coopervision.com|
311631|NCT02920970|CooperVision Inc.|Sr. Manager Global Medical Scientific Affairs|925-621-3761|javega@coopervision.com|
291585|NCT01371877|University of Nebraska Medical Center|Dr. Jill Poole|402-559-4087|japoole@unmc.edu|
291586|NCT01371994|Astellas Pharma Global Development, Inc.|Medical Director, Urology||clinicaltrials@us.astellas.com|
291587|NCT01372085|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291588|NCT01372150|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291589|NCT01372202|SKCCC|Ronan Kelly, MD|443-287-0005|rkelly25@jhmi.edu|
302206|NCT02081196|Zeltiq Aesthetics|Kerrie Jiang, Executive Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|kerrie.jiang@allergan.com|
291590|NCT01372254|University of Maryland|Laura MacPherson|6198578425|lauramac.phd@gmail.com|
291591|NCT01372384|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
291592|NCT01372410|GlaxoSmithKline|GSK Response Center|866-435-7343||
291593|NCT01372462|Clinical Research Consulting|Richard J. Morishige, MS, RRT|510-606-0375|rjmorishige@gmail.com|
291594|NCT01372501|GI Dynamics, Inc.|Clinical Affairs Manager|781.357.3261|pkeating@gidynamics.com|
291595|NCT01372605|University of North Carolina-Chapel Hill|Dr. Brian Pence|9199667446|bpence@unc.edu|
302207|NCT02081248|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
302208|NCT02081365|Maurice H. Kornberg School of Dentistry, Temple University|Marisol Tellez M. BDS, MPH, Ph.D|215-707-1773|marisol@temple.edu|
302209|NCT02081417|Department of Psychiatry and Behavioral Sciences, University of New Mexico|Annette Crisanti, PhD|505-850-7430|acrisanti@salud.unm.edu|
302210|NCT02081443|University of Florida College of Medicine-Jacksonville|Dominick J. Angiolillo, MD, PhD|+1-904-244-3933|dominick.angiolillo@jax.ufl.edu|
302211|NCT02081456|Cayuga Medical Center|Dr. Michael Costello, PT, DSc, OCS, MTC|607-252-3500|mcostellopt@gmail.com|
302212|NCT02081534|Ardelyx|Chief Development Officer|6175134929|drosenbaum@ardelyx.com|
302213|NCT02081573|University of Pittsburgh School of Nursing|Judith A. Callan|412-383-5321|callanja@pitt.edu|
302214|NCT02081586|University of Pittsburgh School of Nursing|Dr. Judith A. Callan PhD, RN|412-383-5321|callanja@pitt.edu|
302215|NCT02081599|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
302216|NCT02081638|National Institute of Allergy and Infectious Diseases|Dr. Irini Sereti|301-496-5533|isereti@niaid.nih.gov|
302217|NCT02081677|Johnson & Johnson Vision Care Inc.|Tawnya Wilson, Principal Research Optometrist|904-443-1834|TWilson@ITS.JNJ.com|
302218|NCT02081690|Actelion Pharmaeuticals Ltd.|Clinical Trial Disclosure Manager||clinical-trials-disclosure@actelion.com|
302219|NCT02081807|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302220|NCT02081846|Cincinnati Children's Hospital Medical Center|Dr. Heidi Sucharew (Biostatistician)|513-803-1920|heidi.sucharew@cchmc.org|
302221|NCT02081859|Cleveland Clinic|Lynn Borzi (Research Administrator)|216-445-3158|BORZIL@ccf.org|
302222|NCT02081950|Chemi SpA (Part of Italfarmaco Group)|Paolo Bettica, MD|+39 02 64431|p.bettica@italfarmaco.com|
302223|NCT02081963|Department of Respiratory Medicine, Qilu Hospital of Shandong University|Dr.Yu Li|13791122770|qlliyu@163.com|
311632|NCT02920983|CooperVision Inc.|Jose Vega, O.D., MSc., FAAO|9256213761|jvega2@coopervision.com|
311633|NCT02921061|Fred Hutchinson Cancer Research Center|Roland B. Walter|1-206-667-3599|rwalter@fredhutch.org|
311634|NCT02921087|SUNY College of Optometry Clinical Vision Research Center|Danielle Iacono, OD|212-938-5936|diacono@sunyopt.edu|
311635|NCT02921295|University of Pittsburgh|Dr. Goeran Fiedler|4126246475|gfiedler@pitt.edu|
311636|NCT02921386|Clarus Therapeutics Inc.|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
311637|NCT02921412|CooperVision|Jose Vega, O.D., MSc., FAAO|9256213761|JVega2@coopervision.com|
311638|NCT02921425|University of Miami|Dr. Joseph Sharit|305-284-6472|jsharit@miami.edu|
311639|NCT02921490|Mayo Clinic|Vance Lehman|1-507-284-2511|lehman.vance@mayo.edu|
311640|NCT02921737|University of Florida|Allison Allegra|352-294-5691|allisonallegra3@ufl.edu|
311641|NCT02921750|Mölnlycke Health Care|Maria Åberg Håkansson|+46 31722 3000|maria.aberghakansson@molnlycke.com|
311642|NCT02921841|Rhode Island Hospital|Larry K. Brown, MD|(401) 793 - 8808|lkbrown@lifespan.org|
311643|NCT02922153|AtriCure|Nfii Ndikitum|513-644-8192|nndikintum@atricure.com|
311644|NCT02922582|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
311645|NCT02922634|BWH|Dr. Gregory Crosby|617-732-7330|gcrosby@bwh.harvard.edu|
311646|NCT02922738|University of Vermont|Marianne Burke|802-236-0075|marianne.burke@uvm.edu|
311647|NCT02922868|Wake Forest|Dr Gopal Badlani|3367165928|gbadlani@wakehealth.edu|
311648|NCT02922959|University of Cincinnati Addiction Sciences Division|Theresa Winhusen|5135858292|winhust@ucmail.uc.edu|
311649|NCT02923115|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
311650|NCT02923167|Spaulding Rehabilitation Hospital|Paolo Bonato|617-952-6319|pbonato@mgh.harvard.edu|
311651|NCT02923180|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Dr. Emmanuel Antonarakis|410-502-8341|eantona1@jhmi.edu|
311652|NCT02923245|Brown University|Almaz Dessie, MD||almaz@brown.edu|
311653|NCT02923271|University of Pennsylvania|Dr. M. Kit Delgado|215-746-8256|Mucio.Delgado@uphs.upenn.edu|
291596|NCT01372748|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
291597|NCT01372774|Mayo Clinic|Paul D. Brown, M.D.|(713) 563-2415|brown.paul@mayo.edu|
291598|NCT01372813|National Cancer Institute, National Institutes of Health|Marston Linehan, M.D.|301-496-6353|linehanm@mail.nih.gov|
291599|NCT01372878|Given Imaging|"Ravit Peled | Biostatistics and Data Management Manager"|+972 (4) 909-7894|ravit.peled@givenimaging.com|7894
291600|NCT01372995|Emory University|Jenny Han, MD|404-616-0821|jehan2@emory.edu|
291601|NCT01373164|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
291602|NCT01373229|Duke University Medical Center|Danielle Brander, MD|919-286-6897|danielle.brander@duke.edu|
291603|NCT01373242|University of North Carolina at Chapel Hill|Edwin Kim, MD; Director UNC Food Allergy Initiative|919-537-3193|edwinkim@email.unc.edu|
291604|NCT01373281|Sanofi Pasteur Inc.|Medical Director||Contact-US@sanofi.com|
291605|NCT01373294|H. Lee Moffitt Cancer Center and Research Institute|Dr. Mayer Fishman|813-745-8311|mayer.fishman@moffitt.org|
291606|NCT01373346|Gangnam severance hospital|Seung Ho Choi, M.D., Ph.D.|82-2-2019-3374|choish@yuhs.ac|
302224|NCT02082119|Humanitas Cancer Center|Dr. Marta Scorsetti|+390282248524|marta.scorsetti@hunimed.eu|
302225|NCT02082145|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
302226|NCT02082158|National Center for Occupational Health and Infection Control|Aaron Eagan|352-376-1611|aaron.eagan@va.gov|4973
302227|NCT02082184|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993 863164|joe.bugler@abbott.com|
302228|NCT02082210|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
302229|NCT02082262|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
302230|NCT02082288|al-azhar university|wael mohamed hamed|002-01001556162|wael79hamed@yahoo.com|
302231|NCT02082340|American University of Armenia|Dr. Harutyunyan||aharutyunyan@aua.am|
302232|NCT02082392|New York State Psychiatric Institute|Bret Rutherford|6467748660|brr8@cumc.columbia.edu|
302233|NCT02082483|Kidney Transplant Research|Dr. John Gill|6046822344|jgill@providencehealth.bc.ca|64706
302234|NCT02082522|At the request of Concordia Laboratories Inc.|Dr. Michelle Depot||michelle.depot@advanzpharma.com|
302235|NCT02082678|UT Southwestern|E. Sherwood Brown. MD, PhD, MBA|(214) 645-6950|Sherwood.Brown@UTSouthwestern.edu|
302236|NCT02082717|Baptist Health South Florida|Diana D'Orazio-Garcia|786-594-9737|DianaDO@baptisthealth.net|
302237|NCT02082769|Department of Endocrinology, Xijing Hospital, Fourth Military Medical University|Qiuhe Ji|+86-29-84775213|qiuheji@hotmail.com|
302238|NCT02082912|Emory University|Dr. Andrew John Butler|404-413-1415|ajbutle@emory.edu|
302239|NCT02082977|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311654|NCT02923349|Incyte Corporation Call Centre|Incyte Biosciences International Sàrl|8554633463|RA@incyte.com|
291607|NCT01373450|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270264|NCT00116831|GlaxoSmithKline|GSK Response Center|866-435-7343||
291608|NCT01373489|Medical College of Wisconsin|Jennifer Campbell|4149558829|jacampbell@mcw.edu|
291609|NCT01373580|ReVision Optics|Tracy Shwaery, Global Clinical Research Manager|9497072740|tshwaery@revisionoptics.com|157
291610|NCT01373671|Siemens Medical Solutions USA, Inc.|Director of Clinical Affairs|610-448-6468|lesley.ewing@siemens.com|
291611|NCT01373918|University of California, Los Angeles|Dr. Kara L. Calkins|310 825-9330|KCalkins@mednet.ucla.edu|
291612|NCT01373931|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291613|NCT01374087|Ipsen|Medical Director|use email|clinical.trials@ipsen.com|
291614|NCT01374178|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291615|NCT01374217|Carolinas HealthCare System|Nilanjan Ghosh, MD|9804422000||
291616|NCT01374269|Grupo Rehabilitacion en Salud|Dr. Fabio Salinas Duran|5742196475|fabios@une.net.co|
302240|NCT02083107|AinShams University|Dr. Mohamed S. Sweed, Dr.Mourad M.El-Said, Dr.Amgad E. Abou-Gamrah, Dr.Mohamed M. Abd-El-Hamid|01001222047|drmsweed@gmail.com|+2
302241|NCT02083185|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302242|NCT02083263|Karolinska University Hospital|Maria Cecilia Rodriguez Hortal|0046709558699|cecilia.rodriguez-hortal@karolinska.se|
302243|NCT02083380|Medical University of Vienna, Division of Infectious Diseases and Tropical Medicine|Associate Professor Dr Michael Ramharter|+43140400-44400|michael.ramharter@meduniwien.ac.at|
302244|NCT02083406|Medicines for Malaria Venture (MMV)|Fiona Macintyre, PhD|+41 22 555 0319|macintyref@mmv.org|
302245|NCT02083653|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
302246|NCT02083679|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
302247|NCT02083783|Tris Pharma, Inc.|Antonio Pardo MD|732-823-4755|apardo@trispharma.com|
302248|NCT02083809|University of Hawaii|Dr.|8082036500|whrc@ucera.org|
311655|NCT02923427|DorkuzEU|Anaesthesiology and Intensive Care, Sule Ozbilgin|905055252901|ozbilginsule@gmail.com|
311656|NCT02923895|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311657|NCT02923921|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
311658|NCT02924051|University of Kentucky|Dr. Frances Hardin-Fanning|(859) 257-4866|fdbowe2@uky.edu|
311659|NCT02924129|Saluda Medical|Angela Leitner|651-208-4223|angela.leitner@saludamedical.com|
311660|NCT02924350|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311661|NCT02924428|Venus Concept Ltd.|Director, Clinical Affairs|416-222-6144|mgronski@venusconcept.com|517
311662|NCT02924688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311663|NCT02924883|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
311664|NCT02925078|University of Michigan|Clinical Research Coordinator|7347633346|aliceou@umich.edu|
311665|NCT02925117|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
311666|NCT02925143|Herlev Hospital|Dr. Jakob Thomsen|004538683868|dr.j@demants.dk|
311667|NCT02925312|Medstar Health Research Institute|Dr Michelle Magee|2028772383|michelle.f.magee@medstar.net|
311668|NCT02925403|University of Oxford|Adrian V Hill, DPhil FRCP|+44 1865 617610|vaccinetrials@ndm.ox.ac.uk|
311669|NCT02925455|Case Western Reserve University and MetroHealth System|Michael Fu|215-368-0355|mjf24@case.edu|
311670|NCT02925494|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
311671|NCT02925611|PGIMER|Dr. Steve Joys|7087617352|stevejoys@gmail.com|91
311672|NCT02925741|Cleveland Clinic|Mary Montague|216-444-1878|montagm@ccf.org|
311673|NCT02925858|Jewish General Hospital|Dr Matthew Cameron|514-340-8222|matthew.cameron@mcgill.ca|25701
311674|NCT02925923|University of Alabama at Birmingham|Leah Pogwizd|(205) 996-4410|leahpogwizd@uabmc.edu|
311675|NCT02926027|Lundquist Institute|Matthew Budoff|3102224107|mbudoff@lundquist.org|
311676|NCT02926209|GI View Ltd.|CEO, Dr. Tal Simchony|+97235753199|tal@giview.com|
311677|NCT02926573|Washington University School of Medicine|Melanie Townsend, M.D.|314-362-4470|townsendm@wustl.edu|
311678|NCT02926677|Stanford University|Hilit Kletter|650-723-5511|hkletter@stanford.edu|
311679|NCT02926937|Lexicon Pharmaceuticals, Inc,|Medical Affairs|338-6064|medical-information@lexpharma.com|(510)
311680|NCT02926950|Lexicon Pharmaceuticals, Inc.|Medical Affairs|(510) 338-6064|medical-information@lexpharma.com|
311681|NCT02927080|Acceleron Pharma|SVP Regulatory Affairs|617-649-9200|jdesiderio@acceleronpharma.com|
311682|NCT02927171|University of Colorado Denver|Dr. Jennifer Stevens-Lapsley|303.724.9170|jennifer.stevens-lapsley@cuanschutz.edu|
311683|NCT02927223|Vanderbilt University Medical Center|Dr. Prince Kannankeril|615-322-7447|prince.kannankeril@vumc.org|
311684|NCT02927301|Genentech|Medical Communications|800-821-8590|genentech@druginfo.com|
311685|NCT02927327|GE Healthcare|John Strohmeyer|609-865-7423|john.strohmeyer@ge.com|
311686|NCT02927366|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
311687|NCT02927431|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311688|NCT02927457|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311689|NCT02927639|Children's Hospital of Philadelphia|Tara Kaushal, MD|6177322603|tara.kaushal@joslin.harvard.edu|
311690|NCT02927795|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311691|NCT02927834|Loma Linda University|Dr. Kristin Seiberling|9095582002|kseiberling@llu.edu|
291617|NCT01374425|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
302249|NCT02083861|Pain Management Associates|Dr. Ralph Ortiz|(607) 844-9979|rodoc@cnymail.com|
291618|NCT01374438|Metabolic Solutions Development Company|Dr. Jerry Colca|269.343.8732|jcolca@msdrx.com|
291619|NCT01374451|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
291620|NCT01374490|Bausch Health|Study Director||susan.harris@bauschhealth.com|
291621|NCT01374516|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
291622|NCT01374568|UAB|Dr. Amy Warriner|2059964004|awarriner@uabmc.edu|
291623|NCT01374802|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291624|NCT01374906|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
291625|NCT01374919|Auerbach Hematology Oncology Assoc|Dr. Michael Auerbach|410-780-4050|mauerbachmd@abhemonc.com|
291626|NCT01374971|Nathan Wei, MD, PA dba Arthritis Treatment Center|Nathan Wei, MD|301-694-5800|nwei@arthritistreatmentcenter.com|
291627|NCT01375010|Columbia University|Elizabeth Shane, MD|212-305-6289|es54@cumc.columbia.edu|
302250|NCT02083926|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
302251|NCT02083965|Bioverativ|Bioverativ Study Medical Director||clinicaltrials@bioverativ.com|
302252|NCT02084056|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302253|NCT02084069|Seyyed-al-Shohada Heart Center, Urmia University of Medical Sciences|Yousef Rezaei|+989126231864|yousefrezaei1986@gmail.com|
302254|NCT02084082|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302255|NCT02084134|Washington University School of Medicine|Dr. Julie Silverstein|314-747-7006|jsilverstein@wustl.edu|
302256|NCT02084160|Exalenz|Avrahm Hershkowitz/ Clinical Trial Manager|972-8-9737500|avrahamh@exalenz.com|
302257|NCT02084238|Peking University People's Hospital|Dr. Jing He|86|hejing1105@126.com|1861170734
302258|NCT02084511|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302259|NCT02084628|Bayer AG|Therapeutic Area Head||clinical-trials-contact@bayer.com|
302260|NCT02084706|Brigham and Women's Hospital|Dr. Philip Blazar|617-732-5384|pblazar@partners.org|
302261|NCT02084797|Oakland University|Tamara Hew-Butler|248-364-8686|hew@oakland.edu|
302262|NCT02085070|Yale Cancer Center|Director, Clinical Trials Office|12037372572|Joyce.Tull@yale.edu|
302263|NCT02085135|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
302264|NCT02085161|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302265|NCT02085252|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302266|NCT02085356|University of Miami Miller School of Medicine|Violeta Rodriguez|3052432188|vjrodriguez@med.miami.edu|
302267|NCT02085447|University Hospitals Cleveland Medical Center|Dr. Martha Sajatovic|2168442808|martha.sajatovic@uhhospitals.org|
302268|NCT02085460|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
302269|NCT02085473|MedImmune, LLC|Meena Jain|+44 (0) 1223 895966|jainm@medimmune.com|
302270|NCT02085551|Penumbra, Inc.|Michaella Corso|+1 510-995-2079|mcorso@penumbrainc.com|
302271|NCT02085720|Chinese University of Hong Kong|Dr Susanna Ng SS|85226322211|drsssng123@yahoo.com.hk|
302272|NCT02085785|Department of Veterans Affairs|Dr. Alyson Littman, Research Health Scientist|206-277-4182|alyson.littman@va.gov|
302273|NCT02085980|The Christ Hospital - Cincinnati, OH|Dr. Mickey Karram|(513) 463-2500|mickey.karram@thechristhospital.com|
302274|NCT02086110|University of California, Davis Health System|Dr. Kathleen Angkustsiri|916-703-0278|kangkustsiri@ucdavis.edu|
302275|NCT02086162|Dartmouth-Hitchcock|Dr. Mary F. Brunette|603-229-5419|mary.f.brunette@hitchcock.org|
302276|NCT02086175|Dana-Farber Cancer Institute|Caron A. Jacobson, MD|617-632-6404|cajacobson@partners.org|
302277|NCT02086331|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
302278|NCT02086500|University of Pittsburgh|Dr. Jason Sperry MD, MPH|4128028270|sperryjl@upmc.edu|
302279|NCT02086565|University of Pennsylvania|Andrea J Apter, MD|215 349-5120|andrea.apter@uphs.upenn.edu|
302280|NCT02086591|University of Rochester|Carla Casulo|585-273-3258|carla_casulo@urmc.rochester.edu|
302281|NCT02086682|Mayo Clinic|Dr. Marie Hogan|507-266 -1963|Hogan.Marie@mayo.edu|
302282|NCT02086708|Massachusetts General Hospital|Dr. Uzma Shah|617-726-1450|USHAH@mgh.harvard.edu|
302283|NCT02086786|Rovi S.A. Laboratorios Farmacéuticos|Jordi Llaudó Garín ( Clinical Development Manager)|+34913756230|jllaudo@rovi.es|
302284|NCT02086968|Luitpold Pharmaceuticals, Inc.|Angelia Butcher|610-650-4200|abutcher@lpicrd.com|811
302285|NCT02087046|Abbott|Clinical Research Scientist|972-309-8000|mike.frassica@abbott.com|
302286|NCT02087059|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
302287|NCT02087085|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
302288|NCT02087150|Acclarent|Patricia Chen|949-453-6408|pchen126@its.jnj.com|
302289|NCT02087163|Align Technology|Allison Mossing|4084701056|amossing@aligntech.com|
302290|NCT02087176|SCRI Development Innovations|Charles H. Davis|+615-524-4341|charles.davis2@scri-innovations.com|
302291|NCT02087241|SCRI Development Innovations|Charles H. Davis|+615-524-4341|charles.davis2@scri-innovations.com|
302292|NCT02087306|Chimerix, Inc.|Chief Medical Officer|919-806-1074|dmoore@chimerix.com|101
302293|NCT02087423|AstraZeneca|Phillip Dennis, MD, PhD|+1 301 398-5549|ClinicalTrialTransparency@astrazeneca.com|
302294|NCT02087514|Columbia University Medical Center|Dr. Eldad Hod|(212) 342-5648|eh2217@cumc.columbia.edu|
302295|NCT02087670|Universidad de Antioquia|Jesus Alberto Plata Contreras|5742196478|rehabilitacionsalud@siu.udea.edu.co|
302296|NCT02087748|Lotus Clinical Research, LLC|Anne Arriaga, VP of Clinical Operations|626-397-3412|anne@lotuscr.com|
302297|NCT02087774|Marshall University|Rebecca Hayes, M.D.|3046173570|hayes79@live.marshall.edu|
302298|NCT02087904|AbbVie|Global Medical Services|AbbVie|abbvieclinicaltrials@abbvie.com|
302299|NCT02087943|CelgeneCorp|Anne McClain, Senior Manager, Clinical Trial Disclosure|1-888-260-1599|amcclain@celgene.com|
291628|NCT01375049|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
291629|NCT01375075|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291630|NCT01375127|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291631|NCT01375140|The University of Texas MD Anderson Cancer Center|Srdan Verstovsek, MD/Professor|713-745-3429|sverstov@mdanderson.org|
291632|NCT01375205|Oregon Health & Science University|Eric Simpson, MD, MCR|503-494-3968|simpsone@ohsu.edu|
302300|NCT02087956|University of Rochester|Dr. Ellen Poleshuck|585-275-3138|ellen_poleshuck@urmc.rochester.edu|
291633|NCT01375374|UCB|UCB Clinical Trial Call Center|+1 877 822 9493||
291634|NCT01375491|University of California, San Diego|Dr. Karen Louise Herbst|858-552-8585|kaherbst@gmail.com|7384
302301|NCT02087995|Dexcom, Inc|Andrew Balo/ EVP|8582000203|abalo@dexcom.com|
302302|NCT02088034|Northwestern University|Matthew J. O'Brien, MD|312-503-5046|matthew.obrien1@northwestern.edu|
302303|NCT02088047|University of Arkansas for Medical Sciences|Betholyn Gentry|(501) 603-1010|bfgenry@uams.edu|
302304|NCT02088073|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
281727|NCT00819039|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302305|NCT02088177|NYSPI|Dr. Frances R. Levin||frl2@cumc.columbia.edu|
302306|NCT02088216|Qilu Hospital of Shandong University|Yu Li|13791122770|qlliyu@163.com|
302307|NCT02088385|Changi General Hospital|Dr Andrew Kwek Boon Eu|6788 8833|andrew_kwek@cgh.com.sg|
302308|NCT02088541|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
302309|NCT02088697|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
302310|NCT02088788|Geisinger|Melissa Troup|570-214-5433|matroup@geisinger.edu|
302311|NCT02088905|University of Pittsburgh|Benjamin L. Handen, PhD|412-235-5445|handenbl@upmc.edu|
302312|NCT02089113|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
302313|NCT02089191|Alcon Research, Ltd.|Global Medical Affairs Brand Lead - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
302314|NCT02089230|The University of Texas MD Anderson Cancer Center|Farhad Ravandi-Kashani MD/Professor|713-745-0394|fravandi@mdanderson.org|
302315|NCT02089334|Rexahn Pharmaceuticals Inc.|Doug Swirsky/ Chief Executive Officer|240-268-5300|swirskyd@rexahn.com|
302316|NCT02089347|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
302317|NCT02089464|Nexstim Plc|Vice President, Medical Affairs||jarmo.laine@nexstim.com|
302318|NCT02089659|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302319|NCT02089737|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
302320|NCT02089997|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302321|NCT02090075|Los Angeles Biomedical Research Institute at Harbo|Dr Matthew Budoff|3102224107|mbudoff@labiomed.org|
302322|NCT02090088|Amgen Inc.|Study Director|866-572-6436||
302323|NCT02090283|Amicus Therapeutics, Inc.|Patient Advocacy|+1-609-662-2000|clinicaltrials@amicusrx.com|
302324|NCT02090374|Imperial College London|Professor Trevor Hansel|+44 (0)20 3312 5733|t.hansel@imperial.ac.uk|
302325|NCT02090413|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
302326|NCT02090426|Massachusetts Institute of Technology|Amy Finkelstein, PhD|6173246995|jgubb@mit.edu|
302327|NCT02090634|UCSD HIV Neurobehavioral Research Program (HNRP)|Dr. David J Moore, Professor of Psychiatry|619-543-5093|djmoore@ucsd.edu|
302328|NCT02090725|Dartmouth-Hitchcock|Jeffrey A. Cohen, MD|603-650-4211|jeffrey.a.cohen@hitchcock.org|
302329|NCT02090764|Ferrer Internacional, S.A.|Clinical Research Manager|+34 93 509 32 75|nalbareda@ferrer.com|
311692|NCT02927873|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311693|NCT02927925|Janssen Research & Development, LLC|Global Medical Head|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
311694|NCT02927938|Levine Cancer Institute|Dr. James Symanowski; Chair, Department of Cancer Biostatistics|9804422371|james.symanowski@atriumhealth.org|
311695|NCT02928029|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
311696|NCT02928055|MetroHealth Medical Center|Richard Wilson, MD|216-778-4414|rwilson@metrohealth.org|
311697|NCT02928380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311698|NCT02928536|Istituto di Ricerche Farmacologiche Mario Negri|Silvano Gallus, head of the Laboratory of Lifestyle Epidemiology|0039023901|silvano.gallus@marionegri.it|4657
311699|NCT02928770|Stanford University|Clete A. Kushida, M.D., Ph.D.|6507217560|clete@stanford.edu|
311700|NCT02928848|University of Pennsylvania|Dr. H. Branch Coslett|2156623606|hbc@pennmedicine.upenn.edu|
311701|NCT02928952|VAPHS, Center for Heath Equity Research and Promotion|Monica DiNardo PhD, Primary Investigator|412 360-2262|monica.dinardo@va.gov|
311702|NCT02929329|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
311703|NCT02929407|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
311704|NCT02929498|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311705|NCT02929667|University of Iowa|Dr. Rup Sainju|319-356-4337|rup-sainju@uiowa.edu|
311706|NCT02929823|PPD|Joseph Pollard|+1 910 558 4428|joseph.pollard@ppdi.com|
311707|NCT02929979|VA Palo Alto Healthcare System|Adrienne Heinz|9196306847|adrienneheinz@gmail.com|
311708|NCT02930005|The University of Texas Health Science Center at Houston|Dr. Olaoluwa O. Okusaga|(713) 741-3952|Olaoluwa.O.Okusaga@uth.tmc.edu|
281728|NCT00819052|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281729|NCT00819091|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
281730|NCT00819156|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
281731|NCT00819182|Indiana University|Janet S Carpenter, PhD, RN, FAAN|317-278-6093|carpentj@iupui.edu|
291635|NCT01375569|National Cancer Institute|Dr. Tim Greten|301-451-4723|gretentf@mail.nih.gov|
291636|NCT01375608|NIH, NHLBI, MCHB|Dr Matthew Hsieh|301-402-7687|matthewhs@nhlbi.nih.gov|
291637|NCT01375660|Jesse Brown VA Medical Center|Dr. Barengolts, Attending Endocrinologist, Chief, Section of Endocrinology|312-569-7651|Elena.Barengolts@va.gov|
302330|NCT02090777|Duke Eye Center|Jullia Rosdahl MD PhD|919-684-8850|jullia.rosdahl@duke.edu|
291638|NCT01375673|WJB Dorn VAMC (VHA)|Andrea M. Boyd, PhD, Asscoaite Nurse Executive, Research/Education|803.776.4000|andrea.boyd@va.gov|5654
291639|NCT01375751|Amgen Inc.|Study Director|866-572-6436||
291640|NCT01375764|Amgen Inc.|Study Director|866-572-6436||
291641|NCT01375777|Amgen Inc.|Study Director|866-572-6436||
291642|NCT01375946|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
302331|NCT02090855|GE Healthcare|Paul Sherwin, M.D.|1-609-514-6489|Paul.Sherwin@ge.com|
291643|NCT01376037|Center for Clinical and Cosmetic Research|Mark S. Nestor, M.D., Ph.D|305-933-6716|nestormd@ADMCORP.com|
291644|NCT01376050|Regulatory Insight, Inc.|Clinical Consultant|615-712-9743|elvira@reginsight.com|
302332|NCT02090894|Indiana University School of Medicine|Dr. Ally-Khan Somani|317-944-7744|somania@iupui.edu|
302333|NCT02090959|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
302334|NCT02091089|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
302335|NCT02091102|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
302336|NCT02091167|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios, Coordinator of Clinical Trials|+55 27 3335-7337|emnpalacios@gmail.com|
302337|NCT02091206|GW Research Ltd.|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
302338|NCT02091284|Federal University of Espírito Santo|Dr. Ester Miyuki Nakamura-Palacios|+55 27 3335-7337|emnpalacios@gmail.com|
302339|NCT02091362|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
302340|NCT02091375|GW Research Ltd.|Medical Enquires||medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
302341|NCT02091414|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
302342|NCT02091440|Osaka University Hospital|Prof. Yoshiki Sawa|+81 668793160|sawa@surg1.med.osaka-u.ac.jp|
302343|NCT02091466|Faculdade de Ciências Médicas da Santa Casa de São Paulo|Dr. Ricardo Caio Gracco De Bernardis|55-11-21767280|rcaiog@yahoo.com.br|
302344|NCT02091531|Memorial Sloan Kettering Cancer Center|Dr. Dana Rathkopf, MD|646-422-4379|rathkopd@mskcc.org|
302345|NCT02091726|University of New England|Peter S. Millard, MD, PhD|2072992131|pmillard@mac.com|
302346|NCT02091739|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
302347|NCT02091778|Podiatry and Foot health, Stott Lane Salford ,UK|Paul Chadwick|0161 206 4710|paul.chadwick@salford.nhs.uk|
302348|NCT02091856|West University of Timisoara|Dr. Bogdan Tudor Tulbure|+040745753061|btulbure@gmail.com|
311709|NCT02930018|NoNO Inc.|Michael Tymianski, MD PhD|4165831687|mtymianski@nonoinc.ca|
311710|NCT02930174|University of Michigan Health System|Carl Haas|734-936-5234|chaas@med.umich.edu|
311711|NCT02930226|University of Cincinnati|Jose A. Cancelas, M.D., Ph.D.|513-558-1324|Jose.Cancelas@cchmc.org|
311712|NCT02930343|JIPMER|Dr Pooja Belani|8940482248|drpoojabelani@gmail.com|
311713|NCT02930590|Clinical Research Center for Hair and Skin Science, Department of Dermatology and Allergology Charité - Universitätsmedizin Berlin|Dr. Jan Kottner|+49 30 450 518218|jan.kottner@charite.de|
311714|NCT02930824|University of Florida|Dr. Larisa Cavallari|(352) 273-8245|LCavallari@cop.ufl.edu|
311715|NCT02930837|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311716|NCT02930941|University of California, Davis Medical Center|Aimee Moulin, MD|916-703-6110|akmoulin@ucdavis.edu|
311717|NCT02930980|Medtronic EMEA RCC|Valentina Amori, Medical Writer|+39 06 32814236|valentina.amori@medtronic.com|
311718|NCT02931045|1st Chair and Department of Cardiology, Medical University of Warsaw|Aleksandra Gasecka, MD, PhD|+48225991951|alesandra.gasecka@wum.edu.pl|
311719|NCT02931253|The Donald Guthrie Foundation for Education and Research|Pramod Deshmukh, MD|570 887 2284|Pramod.Deshmukh@guthrie.org|
311720|NCT02931396|University of Pittsburgh|Alicia Koontz|4128223700|akoontz@pitt.edu|
311721|NCT02931539|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
311722|NCT02931565|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
311723|NCT02931838|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
311724|NCT02932228|VA Palo Alto Health Care System|Dr Donna Zulman|650-493-5000|Donna.Zulman@va.gov|29113
311725|NCT02932267|Galderma|Rajeev Chavda|0033|rajeev.chavda@galderma.com|492382928
311726|NCT02932306|Bausch Health Americas, Inc.|Clinical Operations Director|1-510-259-5284|aloncaric@bauschhealth.com|
311727|NCT02932332|UT MD Anderson Cancer Center|David Hui, MD, Associate Professor/Palliative Care Med|713-792-6258|dhui@mdanderson.org|
311728|NCT02932462|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
311729|NCT02932787|Sheffield Hallam University|Martin Lamb|01142552782|m.lamb@shu.ac.uk|
311730|NCT02932878|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
311731|NCT02932891|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
311732|NCT02932904|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
311733|NCT02932943|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
311734|NCT02933034|Stanford University|Phillip C. Yang|(650) 498-8008|phillip@stanford.edu|
311735|NCT02933060|Cooper University Health System|Dr. Christopher Jones|856-342-2627|jones-christopher@cooperhealth.edu|
311736|NCT02933320|Cancer Research UK Centre for Drug Development|Regulatory Affairs Manager|+44 203 4696878|regulatory@cancer.org.uk|
311737|NCT02933372|U of Michigan|Dr. Cathie Spino, Research Professor of Biostatistics|7346155469|spino@umich.edu|
311738|NCT02933450|Emergency Department, Baylor College of Medicine|Dr Zubaid Rafiue|7138732626|zubaidrafique@gmail.com|
291645|NCT01376089|GE Healthcare|Lauren Lim, PharmD|1-626-356-1937|lauren.lim@ge.com|
291646|NCT01376167|GlaxoSmithKline|GSK Response Center|866-435-7343||
291647|NCT01376245|GlaxoSmithKline|GSK Response Center|866-435-7343||
291648|NCT01376297|Helsinn Healthcare SA|Head of Clinical Development|+41 91 9852121|marco.palmas@helsinn.com|
302349|NCT02091869|University of Arkansas for Medical Sciences|Dr. Tamara T. Perry|501-364-1538|perrytamarat@uams.edu|41538
302350|NCT02091882|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
302351|NCT02091921|University of Southern California|Leonardo Clavijo, MD|3234426130|lclavijo@usc.edu|
302352|NCT02091986|AstraZeneca|Global Clinical Lead Göran Eckerwall||ClinicalTrialTransparency@astrazeneca.com|
302353|NCT02092025|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302354|NCT02092116|Bionor Pharma ASA|Maja Sommerfelt|+4723010960|ms@bionorpharma.com|
302355|NCT02092168|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
302356|NCT02092181|Evergreenhealth|Gowri Rajendran|425-899-5370|grajendran@evergreenhealth.com|
302357|NCT02092220|Massachusetts General Hospital|Dr Steven J Russell|617-726-1848|sjrussell@partners.org|
302358|NCT02092285|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302359|NCT02092298|UT MD Anderson Cancer Center|Brian Badgwell,Professor, Surgical Oncology|713-745-3715|csentonn@mdanderson.org|
302360|NCT02092311|OMID FERTILITY CENTER|Dr.Navid Pooyan|00989124474032|navidpooyan@yahoo.com|
302361|NCT02092324|OHSU|Dr. Kim-Hien Dao|503-494-5074|daok@ohsu.edu|
302362|NCT02092350|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
302363|NCT02092389|AbbVie|Global Medical Information|1-800-633-9110||
302364|NCT02092415|Oregon Health & Science University|Jonathan Lindner MD|503 595-8750|lindnerj@ohsu.edu|
302365|NCT02092441|Brooke Army Medical Center|Dr. Michael D. April|210-916-6129|Michael.D.April@post.harvard.edu|
302366|NCT02092467|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302367|NCT02092610|Radboud University Hospital Nijmegen Medical Centre|Dr. Myrthe Hol|(024) 36 14934|Myrthe.Hol@radboudumc.nl|
302368|NCT02092649|University of Guelph|Sebastian Jannas-Vela MSc|(519)-824-4129|sjannas@uoguelph.ca|53907
302369|NCT02092662|University of Haifa|Sharon Israely|972-523-755-091|sharonis@mh.org.il|
302370|NCT02092857|University of Alberta|Dr. Tom Clandinin|7804925188|tclandin@ualberta.ca|
302371|NCT02092909|Idera Pharmaceuticals|Idera Medical Monitor|617-679-5500|clinicaltrials@iderapharma.com|
302372|NCT02092961|AstraZeneca Pharmaceuticals|Dave Goldstraw|+44 (0)1625 512415|dave.goldstraw@astrazeneca.com|
302373|NCT02092987|Columbia University Medical Center|Jose Luchsinger|212-305-4730|jal94@cumc.columbia.edu|
302374|NCT02093026|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
302375|NCT02093221|Grifols Therapeutics LLC|Kimberly Steinmann, MD|919-308-5444|kimberly.steinmann@grifols.com|
302376|NCT02093234|GW Medical Faculty Associates|Richard Katz, MD|202-741-2323|RKatz@mfa.gwu.edu|
302377|NCT02093351|AstraZeneca Pharmaceuticals|Dr Carsten Goessl, Indication Lead||clinicaltrialtransparency@astrazeneca.com|
302378|NCT02093390|Takeda|Medical Director, Clinical Science|+1-877-825-3327|clinicaltrialregistry@tpna.com|
302379|NCT02093520|Vertos Medical|VP of Clinical Affairs|9493490008|kdavis@vertosmed.com|
302380|NCT02093663|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
302381|NCT02093702|Barrie and Community Family Health Team|Dr. Andrew Wozniak|(705) 728-2618|andrew.wozniak@barriefht.ca|
302382|NCT02093793|Boston Scientific|Director of Clinical Sciences|6619494350|roshini.jain@bsci.com|
302383|NCT02093819|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302384|NCT02093897|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
302385|NCT02093923|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
302386|NCT02093949|Saint joseph hospital|Dr Julien Seitz|+330491807044|jseitz@hopital-saint-joseph.fr|
302387|NCT02093962|Threshold Pharmaceuticals|Thomas Wilson|302-359-0565|twilson@thresholdpharm.com|
302388|NCT02094118|Mayo Clinic|Dr. Daryl Kor|507-255-6051|kor.daryl@mayo.edu|
302389|NCT02094300|Cook Research Incorporated|Scott Snyder, PhD, Director of Clinical Science and Biostatistics|765-463-7537|SSnyder@medinst.com|
302390|NCT02094326|Hospital Virgen de la Macarena|Dr. Federico Navarro Sarabia|+34 955 00 80 00|federico.navarro.sarabia@gmail.com|
302391|NCT02094417|Kyowa Kirin Korea Co. Ltd.,|Clinical Development Team, Clinical Development Department|82221912918|kyungmo.lee.m6@kyowakirin.com|
302392|NCT02094443|Debiopharm International S.A.|Vice President Clinical Research & Development|4121 321 01 11|info-international@debiopharm.com|
302393|NCT02094534|Orange County Research Center|Joel M. Neutel, M.D., Study Director|714-550-9990|jmneutel@aol.com|
302394|NCT02094573|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302395|NCT02094586|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research|204-275-4589|dcassie@ebsi.com|
302396|NCT02094612|Kaiser Permanente Division of Research|Monique Does, Project manager|510-891-3612|monique.does@kp.org|
302397|NCT02094664|UCLA Mattel Children's Hospital|Dr. Diana Chen|3108255930|dychen@mednet.ucla.edu|
302398|NCT02094677|Coopervision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
302399|NCT02094716|Mylan Pharmaceuticals Pvt Ltd|Clinical Sciences Program Lead||prasannac.ganapathi@mylan.in|
302400|NCT02094755|University of Southern California|Dr. Leonardo Clavijo|3234426130|lclavijo@usc.edu|
302401|NCT02094872|Yale University|Manuel Avedissian, M.D.|203-737-3669|manuel.avedissian@yale.edu|
311739|NCT02933476|Stanford School of Medicine|Raumin Neuville|6507236709|raumin@stanford.edu|
302402|NCT02094885|Ethicon, Inc|Jonathan Batiller, Senior Clinical Director|+1 908 218-2492|JBatill2@its.jnj.com|
291649|NCT01376310|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
291650|NCT01376349|Alliance for Clinical Trials in Oncology|Debra Barton, R.N., Ph.D.||debbartn@med.umich.edu|
291651|NCT01376362|National Institutes of Health|Hatice Nida Sen, Principal Investigator, National Eye Institute|(301) 402-3254|senh@nei.nih.gov|
291652|NCT01376388|GlaxoSmithKline|GSK Response Center|866-435-7343||
291653|NCT01376557|Lexicon Pharmaceuticals, Inc.|Dr. Paul Strumph|(281) 863-3302|pstrumph@lexpharma.com|
291654|NCT01376700|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
291655|NCT01376804|Hoffman-LaRoche|Medical Communications|800-821-8590||
291656|NCT01376908|BioMarin Pharmaceutical Inc.|Medical Information Services|+1-800-983-4587|medinfo@bmrn.com|
291657|NCT01377012|Novartis|Study Director|862-778-8300||
291658|NCT01377194|Forest Research Institute|Carl Gommoll, MS, Sr. Dir. Clinical Development Psychiatry|201-427-8000|carl.gommoll@frx.com|8124
302403|NCT02094898|Mayo Clinic|William V. Bobo, M.D.|507-538-9041|Bobo.William@mayo.edu|
302404|NCT02094937|GlaxoSmithKline|GSK Response Center|866-435-7343||
311740|NCT02933489|ECOG-ACRIN|Director Clinical Research Administration|800-227-5463|dhartfeil@acr.org|4765
311741|NCT02933502|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
311742|NCT02933528|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
311743|NCT02933866|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
311744|NCT02933879|Taro Pharmaceuticals U.S.A. Inc|Natalie Yantovskiy|+1 914-345-9001|Natalie.Yantovskiy@Taro.com|6849
311745|NCT02934178|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
311746|NCT02934191|Children's Hospital of Philadelphia|Dr. John Germiller|215-590-3440|germiller@email.chop.edu|
311747|NCT02934347|Glan Clwyd Hospital, Betsi Cadwaladr University Health Board|Dr Raj Reddy|01745 583910|Rajashekhar.Reddy@wales.nhs.uk|
311748|NCT02934555|Beth Israel Deaconess Medical Center|Dr. Michael Donnino|6177542882|mdonnino@bidmc.harvard.edu|
311749|NCT02934698|MUSC|Patrick Flume|843-792-3167|flumepa@musc.edu|
311750|NCT02935036|Taro Pharmaceuticals U.S.A., Inc.|Manager, Clinical Research|9143459001|Businessdevelopment@taro.com|
311751|NCT02935062|Federal University of Santa Maria|Márcia Keske-Soares|55 55 999726370|marcia-keske.soares@ufsm.br|
311752|NCT02935088|Abbott Vascular|Tarn Teraphongphom, Sr. Clinical Scientist|408-9310504|tarn.teraphongphom@abbott.com|
311753|NCT02935179|Taipei Medical University|Dr. Sing-Chung Li|886-2-27361661|sinchung@tmu.edu.tw|6560
311754|NCT02935192|Institute of Virology, Vaccines and Sera, Torlak|Katarina Ilic|+381 11 3953 700|kilic@torlak.rs|214
291659|NCT01377233|H. Lundbeck A/S|Study director||LundbeckClinicalTrials@Lundbeck.com|
291660|NCT01377389|UT MD Anderson Cancer Center|Aparicio,Ana,M.D. / Genitourinary Medical Oncology|713-792-7734|AAPARICIO@MDANDERSON.ORG|
302405|NCT02095106|Orthopaedic Institute for Children|Dr. Mauricio Silva|213-742-1109|msilva@mednet.ucla.edu|
270265|NCT00116844|GlaxoSmithKline|GSK Response Center|866-435-7343||
270266|NCT00116857|Washington University School of Medicine|Robert M. Carney, Ph.D.|314-286-1313|carneyr@bmc.wustl.edu|
302406|NCT02095145|University of Wisconsin Carbone Cancer Center|David Jarrard|608-262-0759|jarrard@urology.wisc.edu|
302407|NCT02095158|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
302408|NCT02095197|Northwestern University, Feinberg School of Medicine|David Walega, MD|312-695-2500|d-walega@northwestern.edu|
291661|NCT01377402|Stavanger University Hospital|Dennis WT Nilsen, MD, phd, professor|+4795777735|dnilsen1@getmail.no|
291662|NCT01377467|University Hospital Zürich|Prof. Rudolf P. Wüthrich|+41 44 255 33 84|rudolf.wuethrich@usz.ch|
291663|NCT01377480|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291664|NCT01377584|University of Pittsburgh|Faith Luyster, PhD|412-624-7910|fsl3@pitt.edu|
291665|NCT01377623|UMDNJ-New Jersey Medical School|Alex Bekker|973-972-5007|alex.bekker@nyumc.org|
291666|NCT01377636|New York University Langone Medical Center, Anesthesiology|Patrick Linton, MD, Director of Adult Off-Site Anesthesia Services|212-263-5072|Patrick.Linton@nyumc.org|
291667|NCT01377844|Theracos Sub, LLC|Albert Collinson, Ph.D.|(508) 688-4221|acollinson@theracos.com|
291668|NCT01377922|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
291669|NCT01377987|Brigham and Women's Hospital|Dr. Scott Sands|617 278 0911|sasands@bwh.harvard.edu|
291670|NCT01378065|Coloplast Corp|Cathy Bartz|612-834-3127|uscmba@coloplast.com|
302409|NCT02095223|University of Miami|Christopher Kuenze|5174325018|kuenzech@msu.edu|
302410|NCT02095340|University of Houston|Andres G Viana, Ph.D., Associate Professor|832-842-0234|agviana@uh.edu|
302411|NCT02095535|UBC Department of Anesthesia - BC Women's Hospital|Tashya De Silva|604-875-2158|tashya.desilva@cw.bc.ca|
302412|NCT02095561|INSTITUTO NACIONAL DEL CÁNCER, ARGENTINA|Silvina Arrossi, Phd|541152390562|silviarrossi2020@gmail.com|
302413|NCT02095678|Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center|Dr. Vikas Gulani|+1 216-844-3312|Vikas.Gulani@UHhospitals.org|
302414|NCT02095691|Biosense Webster, EMEA|Liesbeth Vanderlinden, Manager Clinical Research|+32(0)2 7463527|lvanderl@its.JNJ.com|
302415|NCT02095873|University of Warwick|Paul J Thornalley|+442476968594|P.J.Thornalley@warwick.ac.uk|
302416|NCT02095951|Wayne State University School of Medicine - Children's Hosp. of Michigan|Eric McGrath, MD|313-745-5862|emcgrath@med.wayne.edu|
302417|NCT02096003|Icahn School of Medicine at Mount Sinai|Dr. Yaakov Beilin|212-241-7467|yaakov.beilin@mountsinai.org|
302418|NCT02096029|Medical University of South Carolina|Amy Boatright, Program Coordinator|843-876-2440|boatrigh@musc.edu|
302419|NCT02096081|Merz North America, Inc.|Michelle Widmann|919-582-8238|Michelle.Widmann@merz.com|
302420|NCT02096107|Medical University of South Carolina|David Taber|843-792-3368|taberd@musc.edu|
302421|NCT02096263|GlaxoSmithKline|GSK Response Center|866-435-7343||
302422|NCT02096276|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
302423|NCT02096458|Takeda Development Center Americas, Inc.|Takeda Study Registration Call Center|800-778-2860|medicalinformation@tpna.com|
302424|NCT02096471|The Univ of Alabama at Birmingham|Gary Cutter, PhD|205.975-5048|cutterg@uab.edu|
302425|NCT02096575|U of New Mexico - Dept of OBGYN/Family Planning|Michel Paves, HS Research Specialist|505-272-9703|MDaliva@salud.unm.edu|
302426|NCT02096588|SKCCC SOM Onc Breast and Ovarian Cancer|Dr. Karen Smith ; Clinical Associate|2026606500|ksmith60@jhmi.edu|
302427|NCT02096679|AstraZeneca|Dr Mireille Cantarini||ClinicalTrialTransparency@astrazeneca.com|
302428|NCT02096692|Biotronik, Inc.|Clinical Studies Engineer|503-451-8049|justin.michalski@biotronik.com|
302429|NCT02096705|AstraZeneca|Anna Maria Langkilde||ClinicalTrialTransparency@astrazeneca.com|
302430|NCT02096718|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302431|NCT02096731|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302432|NCT02096744|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302433|NCT02096835|Huashan Hospital Fudan University Shanghai, China|Dr.Xiaoyu Yang|086-021-52889999|yangxiaoyu@huashan.org.cn|7693
302434|NCT02096861|Celltrion, Inc.|BoYoung Choi / Clinical Operation Team Leader|+82-32-850-6594|BoYoung.Choi@celltrion.com|
302435|NCT02096900|Loma Linda University|Amgad H. Hanna, MD|909-558-4475|ahanna@llu.edu|
302436|NCT02096952|Massachusetts General Hospital|Dr. Gahan Joshi|617-726-8392|joshi.gagan@mgh.harvard.edu|
302437|NCT02097030|CooperVision|Jose A. Vega, OD, Sr. Manager Global Medical Scientific Affairs|(925) 621-3761|jvega@coopervision.com|
302438|NCT02097056|Eisai Korea Inc.|Youngji Pyo|+82-2-3451-5533|y-pyo@eisaikorea.com|
302439|NCT02097108|AGMT|Public contact Daniela Wolkersdorfer|00436626404411|d.wolkersdorfer@agmt.at|
302440|NCT02097238|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
302441|NCT02097277|Bristol-Myers Squibb|Study Director||clinical.trials@bms.com|
302442|NCT02097290|Boston Scientific|Gregory Voss|6515813068|Gregory.Voss@bsci.com|
302443|NCT02097303|Carolina Research Professionals, LLC|Dr. Neal D. Shore, MD, FACS, CPI|843-449-1010|nshore@carolinaresearchprofessionals.com|243
302444|NCT02097472|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
302445|NCT02097485|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|9084585362|srinivassidgiddi@drreddys.com|
302446|NCT02097537|Santen Pharmaceutical Co., Ltd.|General Manager of Clinical Development Group||clinical@santen.co.jp|
302447|NCT02097641|University of California San Francisco|Michael A. Matthay, MD|415-502-7434|michael.matthay@ucsf.edu|
302448|NCT02097719|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
311755|NCT02935452|University of Southampton|Ms Lindsay Welch|07881205106|lw13e14@soton.ac.uk|
311756|NCT02935543|Univ. of Pennsylvania|Regulatory Lead|215-662-4484|psom-ind-ide@pobox.upenn.edu|
311757|NCT02935673|Janssen Research & Development, LLC|Medical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
311758|NCT02935699|TerSera Therapeutics|Medical Affairs|844-334-4035|tersera@medinfodept.com|
311759|NCT02935738|Barz IVF Center for Embryo Research and Infertility Treatment|Dr. Saeeda A. Muhsen-Alanssari|9798201303|barzivfcenter@gmail.com|
311760|NCT02935842|University Hospital Basel|Prof. Peter Fuhr|0041 61 265|peter.fuhr@usb.ch|41 66
311761|NCT02935894|USDA, ARS Western Human Nutrition Research Center|Dr. John W. Newman|530-752-1009|john.newman@ars.usda.gov|
291671|NCT01378104|the Catholic University of Korea|Dr. Kwon|+82322805886|doctorkwon@catholic.ac.kr|
291672|NCT01378117|EUSOM|Guillermo Umpierrez, MD|4047781665|geumpie@emory.edu|
291673|NCT01378195|Photozig, Inc.|Bruno Kajiyama|650-694-7496|info@photozig.com|
291674|NCT01378221|Heart and Diabetes Center North Rhine-Westphalia, Germany|Dr. Armin Zittermann|+49 5731 97|azittermann@hdz-nrw.de|1912
291675|NCT01378273|University of Washington|Sandra Juul MD, PhD|2062216814|sjuul@uw.edu|
291676|NCT01378299|Michael E. DeBakey VA Medical Center|Reina Villareal, MD|713-794-7534|reina.villareal@va.gov|
291677|NCT01378325|AUBMC|Sahar Siddik-Sayyid|9611350000|ss01@aub.edu.lb|6380
291678|NCT01378377|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
291679|NCT01378416|Eisai Inc.|Yufang Lu, MD PhD|1-888-422-4743||
291680|NCT01378429|Sunovion|Respiratory Medical Director|866-503-6351||
302449|NCT02097732|University of Michigan Comprehensive Cancer Center|Dr. Christopher Lao, MD, MPH|(734) 936-4498|clao@med.umich.edu|
302450|NCT02097745|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
302451|NCT02097823|Prevea Health/St Vincent Hospital|Dr. Catherine Long|9204338670|cathy.long@prevea.com|
302452|NCT02097849|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
302453|NCT02097992|University of Miami|Adam Wanner|(305)243-3045|awanner@med.miami.edu|
302454|NCT02098109|Washington University School of Medicine|Camille Abboud, M.D.|314-454-8304|cabboud@wustl.edu|
302455|NCT02098304|Clark & Watson Dental Practice|Dr Charles Ormond|+44 (0)1324 623445|charlesormond@nhs.net|
302456|NCT02098369|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-0637|jakris@uic.edu|
302457|NCT02098395|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
302458|NCT02098733|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302459|NCT02098746|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302460|NCT02098993|University of Pittsburgh|Craig Seaman, MD|412-209-7308|seamanc@upmc.edu|
302461|NCT02099006|University of Rochester|Adrienne Bonham MD|(585) 273-3314|adrienne_bonham@urmc.rochester.edu|
302462|NCT02099084|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
302463|NCT02099110|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302464|NCT02099266|University of Kansas Cancer Center|Dr. Omar Aljitawi|(913) 588-6030|SWILLIAM@kumc.edu|
302465|NCT02099461|Amgen Inc.|Study Director|866-572-6436||
302466|NCT02099682|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
302467|NCT02099708|Takeda|Medical Director, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
302468|NCT02099721|Medtronic CRHF|Katy Muckala, Sr. Clinical Research Specialist|(763) 526-1767|katy.a.muckala@medtronic.com|
302469|NCT02099786|VA RR&D National Center for Rehabilitative Auditory Research|Dr. Dawn Konrad-Martin|503-220-8262|dawn.martin@va.gov|52962
302470|NCT02099799|VA Boston Healthcare System|Marilyn Moy, MD, MSc|857-203-6622|marilyn.moy@va.gov|
302471|NCT02099838|Huazhong University of Science and Technology|Dr. Yu|027-83662883|xfyu188@163.com|
302472|NCT02099864|Oregon Health & Science University|Shawna Bailey, Data Manager|(503) 418-9104|bailesh@ohsu.edu|
302473|NCT02100007|MEI Pharma Inc|Richard Ghalie, MD, Sr Vice President Clinical Development|858 369-7116|rghalie@meipharma.com|
302474|NCT02100072|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
302475|NCT02100124|Penn State College of Medicine|Dr. Cynthia Chuang|7175318161|CChuang@psu.edu|
302476|NCT02100189|OHSU|John Hunter, MD|503-494-4937|hunterj@ohsu.edu|
302477|NCT02100228|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302478|NCT02100280|SNUBH|Dr. Bon-wook Koo|+82-10-7227-1379|tendong2@gmail.com|
302479|NCT02100319|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302480|NCT02100410|Alcon Research, Ltd.|Joachim Nick, Dipl.-Ing. (FH), Clinical Lead|1-888-451-3937|alcon.medinfo@alcon.com|
302481|NCT02100475|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
302482|NCT02100514|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302483|NCT02100579|Northwestern University, Feinberg School of Medicine|Antoun Nader|312-695-3045|a-nader2@northwestern.edu|
302484|NCT02100631|Emergent BioSolutions Canada Inc.|David Cassie, Scientist, Clinical Research||dcassie@ebsi.com|
302485|NCT02100644|GlaxoSmithKline|GSK Response Center|866-435-7343||
302486|NCT02100657|Pharma Mar S.A.|Pharma Mar S.A.|00 34 91846 60 00|clinicaltrials@pharmamar.com|
302487|NCT02100670|GlaxoSmithKline|GSK Response Center|866-435-7343||
302488|NCT02100696|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
302489|NCT02100748|Trevena, Inc.|Kelly Arscott|6103548840|karscott@trevena.com|
311762|NCT02936037|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33180401440|frederic.sedel@medday-pharma.com|
311763|NCT02936076|The Miriam Hospital|Dr. Jessica Unick|401-793-8966|junick@lifespan.org|
311764|NCT02936479|NYU Langone Health- Transplant Institute|Cecilia Deterville, MS, CCRC|212.263.3620|Cecilia.Deterville@nyulangone.org|
311765|NCT02936635|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
311766|NCT02936648|Department of Veterans Affairs, CHOIR and BridgeQUERI|Vera Yakovchenko|781.687.3374|vera.yakovchenko@va.gov|
302490|NCT02100813|LEO Pharma A/S|Clinical Trial Disclosure Specialist|+45 44945888|disclosure@leo-pharma.com|
291681|NCT01378520|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
291682|NCT01378858|Albert Einstein College of Medicine|Shadi Nahvi, MD, MS|718 920 5379|snahvi@montefiore.org|
302491|NCT02100826|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
302492|NCT02100839|Linear Clinical Research Ltd|Dr. Janakan Krihnarajah, MBBS (Hons), FRACP|800 393 8820|JKrishnarajah@linear.org.au|
302493|NCT02100930|Memorial Sloan Kettering Cancer Center|Dr. Brian Kushner, MD|212-639-6793|kushnerb@mskcc.org|
291683|NCT01378962|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
291684|NCT01378975|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
291685|NCT01378988|Hospira|Marcelo Garcia de Rocha MD, Global Medical Director|224-212-4424|marcelo.rocha@hospira.com|
291686|NCT01379183|Mayo Clinic|Dr. Jeff L. Fidler|507-284-5010|fidler.jeff@mayo.edu|
291687|NCT01379222|Medtronic|Thushari Alahapperuma|763.526.8119|thushari.r.alahapperuma@medtronic.com|
291688|NCT01379508|Novartis|Clinical Disclosure Office|862-778-8300||
291689|NCT01379521|Novartis Pharmaceuticals|Study Director|862-778-8300||
291690|NCT01379534|Novartis|Study Director|862-778-8300||
291691|NCT01379573|NYU Langone Health|Jill Buyon|+1 212 263 0746|Jill.Buyon@nyulangone.org|
302494|NCT02100969|University of Kansas Medical Center|Dr. Mazen Dimachkie|913-588-6970|mdimachkie@kumc.edu|
302495|NCT02101008|Huntsman Cancer Institute|Kenneth Grossmann|801-587-4289|kenneth.grossmann@hci.utah.edu|
302496|NCT02101021|Sierra Oncology, Inc.|Medical Monitor MMB|1 833 633 2086|medicalmonitorMMB@sierraoncology.com|
302497|NCT02101034|Washington University School of Medicine|Douglas R. Adkins, M.D.|314-362-4471|dadkins@wustl.edu|
302498|NCT02101060|Salem VA Medical Center|Dr. Krisann Oursler|540-982-2463|krisann.oursler@va.gov|4981
302499|NCT02101112|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
302500|NCT02101190|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
302501|NCT02101281|Dompé|Flavio Mantelli, MD, PhD|+39 513138|info@dompe.it|
302502|NCT02101294|Finger Relief|Molly Choate Summers|703-517-8951|summers.molly@gmail.com|
311767|NCT02936869|World Bank|Dr. Adanna Chukwuma|9173712931|adc785@mail.harvard.edu|
311768|NCT02937116|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
311769|NCT02937168|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
311770|NCT02937194|The University of Hong Kong|Prof Wong, May Chun Mei|852-28590422|mcmwong@hku.hk|
311771|NCT02937350|University of Washington|Dr. Ian de Boer|206-616-5403|IDeBoer@Nephrology.washington.edu|
311772|NCT02937454|Vifor (International) AG.|FER-CARS-06 Clinical Study Team|+41 588 518 000|FER-CARS-06.study@viforpharma.com|
311773|NCT02937506|Mount Carmel Health System|Anantha Padmanabhan, MD|614-234-1079|apadmanabhan@mchs.com|
311774|NCT02937545|Duke University School of Medicine|Susanne B Haga|919-684-0325|susanne.haga@duke.edu|
311775|NCT02937558|Xeris Pharmaceuticals, Inc.|Khaled Junaidi|312-517-1461|xerisclintrials@xerispharma.com|
311776|NCT02937584|AstraZeneca|Stephan Stenglein, MD|+46 (0)31 776 1000|stephan.stenglein@astrazeneca.com|
311777|NCT02937623|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311778|NCT02937636|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311779|NCT02937701|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
311780|NCT02937740|Acerus Pharmaceuticals Corporation|Dr. Nathan Bryson, Chief Scientific Officer|1-416-679-0776|nbryson@aceruspharma.com|
311781|NCT02937766|AMAG Pharmaceuticals, Inc.|Medical Information|1-877-411-2510|amag@druginfo.com|
311782|NCT02937870|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311783|NCT02938052|Massachusetts General Hospital|Dr. Christopher Celano|617-726-6485|ccelano@partners.org|
311784|NCT02938169|Department of Rehabilitation Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine|Dr. Juseok Ryu|+82-10-4382-2328|jseok337@snu.ac.kr|
311785|NCT02938494|Bausch Health|Study Director||anya.loncaric@bauschhealth.com|
311786|NCT02938520|GlaxoSmithKline|GSK Reponse Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
311787|NCT02938585|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
311788|NCT02938949|Virginia Commonwealth University|Cory Trankle, MD|804-213-2679|cory.trankle@vcuhealth.org|
311789|NCT02939014|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
311790|NCT02939079|Isfahan University of Medical Sciences|Dr. Vahid Shaygannejad|+98 913 313 3550|shaygannejad@med.mui.ac.ir|
311791|NCT02939105|Zeltiq Aesthetics|Kerrie Jiang, Sr. Director, Regulatory, Clinical and Medical Affairs|(925) 621-7462|Kerrie.Jiang@allergan.com|
311792|NCT02939131|Family Health International (FHI 360)|IMPAACT Clinicaltrials.gov Coordinator|(919) 405-1429|IMPAACT.ctgov@fstrf.org|
311793|NCT02939170|Alcon, A Novartis Division|Clinical Project Lead, Clinical Affairs|1-888-451-3937|alcon.medinfo@alcon.com|
311794|NCT02939326|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|
311795|NCT02939560|Medical University of South Carolina|McLeod F. Gwynette, MD|843-792-9162|gwynette@musc.edu|
311796|NCT02939599|Novartis Pharmaceuticals|Study Director|8627788300|Novartis.email@novartis.com|
311797|NCT02939651|Fox Chase Cancer Center|Namrata Vijayvergia|+1 215-214-4283|Namrata.Vijayvergia@fccc.edu|
311798|NCT02939716|University of Nottingham|Robin Spiller|01158231090|robin.spiller@nottingham.ac.uk|
311799|NCT02939781|Great Ormond Street Hospital NHS Trust|Dr Samiran Ray|4420274059200|samiran.ray@gosh.nhs.uk|8213
311800|NCT02939937|assistant|dr.alireza gholizade|989112550646|a.gholizade13@yahoo.com|
311801|NCT02939950|Bausch Health Americas, Inc.|Director of Clinical Operations|(585) 338-5306|Daniel.Donatello@bausch.com|
311802|NCT02940249|King's College London|Dr Wendy Hall|020 7836 5454|wendy.hall@kcl.ac.uk|
311803|NCT02940327|University of Leicester|Clinical Trials Co-ordinator|0116 250 2427|ha200@le.ac.uk|
311804|NCT02940392|Boston Scientific|Director, Clinical Operations|9529306000|teresa.takle-flach@bsci.com|
311805|NCT02940522|AMAG Pharmaceuticals, Inc.|Medical Information|1-877-411-2510|amag@druginfo.com|
311806|NCT02940574|KU Leuven|Prof. Dr. Kaat Alaerts|16 37 64 46|kaat.alaerts@kuleuven.be|+32
311807|NCT02940626|X4 Pharmaceuticals (merged with Arsanis)|Vice President, Clinical Operations|(857) 529-8300|rnd@x4pharma.com|
311808|NCT02940691|Kirby Institute|Professor Jason Grebely|+61 2 9385 0957|jgrebely@kirby.unsw.edu.au|
291692|NCT01379625|Oregon Health & Science University|Dr. Melanie Gillingham|503-494-1682|gillingm@ohsu.edu|
291693|NCT01379651|Unit of Pediatrics, Fatebenefratelli Hospital, Benevento, Italy|Dr. Iride Dello Iacono|+39 824 771111|iridedello@hotmail.com|
291694|NCT01379664|Cleveland Clinic Foundation|Daniel Sessler|216-444-4900|DS@OR.org|
302503|NCT02101359|Laboratoires Thea|Medical director|33-4-73-98-14-36|p.pouliquen@laboratoires-thea.fr|
291695|NCT01379703|Abbott|Global Medical Services|1-800-633-9110||
291696|NCT01379768|Alcon Research|Director of Alcon Clinical, Atlanta|1-800-241-7629||
291697|NCT01379781|Columbia University Medical Center|Catherine Monk, Ph.D., Assoc Professor|(646) 774-8941|cem31@columbia.edu|
291698|NCT01379924|Boston Children's Hospital|Dr. Joanne Cox|6173557701|joanne.cox@childrens.harvard.edu|
291699|NCT01379937|GlaxoSmithKline|GSK Response Center|866-435-7343||
291700|NCT01379963|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
291701|NCT01380080|ACTG Network Coordinating Center, Social & Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
291702|NCT01380093|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302504|NCT02101411|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
302505|NCT02101437|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
302506|NCT02101515|George Washington University School of Medicine and Health Sciences|Alexis Gimovsky, MD|2027412603|agimovsk@mfa.gwu.edu|
302507|NCT02101554|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302508|NCT02101918|UT MD Anderson Cancer Center|Dr. Daniel M. Halperin/ GI Medical Oncology|713-792-2828|DMHalperin@mdanderson.org|
302509|NCT02101983|University of Rochester|Deborah Mulford|585-275-5823|deborah_mulford@urmc.rochester.edu|
302510|NCT02102100|Yale University|Mehmet Sofuoglu, M.D.,Ph.D.|203-932-5711|mehemt.sofuoglu@yale.edu|4809
302511|NCT02102204|Amgen Inc.|Study Director|866-572-6436||
302512|NCT02102230|VA Palo Alto Health Care System|Kimberly Babson, PhD|831-325-1540|kimberly.babson@gmail.com|
302513|NCT02102399|Federal University of Bahia|Lilian Paternostro|+55 (71) 8191-9730|lilian_fono@hotmail.com|
302514|NCT02102464|TearScience, Inc.|VP Clinical and Regulatory Affairs|919-467-4007|regulatory@tearscience.com|
302515|NCT02102490|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
302516|NCT02102724|Rush University College of Nursing|Barbara Swanson|3129428977|BARBARA_A_SWANSON@RUSH.EDU|
302517|NCT02102932|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
302518|NCT02103062|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
302519|NCT02103114|Duke University|Dr. Edmund Jooste|919-681-4877|edmund.jooste@duke.edu|
302520|NCT02103127|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
302521|NCT02103153|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
302522|NCT02103218|UNC Greensboro|Lisa Goble Director Office of Research Integrity|336-256-1173|lagoble@uncg.edu|
302523|NCT02103270|The Sean N. Parker Center for Allergy Research at Stanford|Dr Andres Alvarez Pinzon, Director of Regulatory Affairs and Translational Medicine|9544465645|andresap@stanford.edu|
302524|NCT02103309|Alcon Japan, Ltd.|Director of Clinical Trials|1-888-451-3937|alcon.medinfo@alcon.com|
302525|NCT02103439|Biocad|Yulia Linkova Medical Director|+7 (495) 992 66 28|linkova@biocad.ru|930
302526|NCT02103478|Astex Pharmaceuticals, Inc.|Medical Monitor|925-560-0100|Harold.Keer@astx.com|
302527|NCT02103608|Tennesse clinical research center|Dr. Michael Gold|615-383-2400|drgold@goldskincare.com|
302528|NCT02103816|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
302529|NCT02103855|Indiana University|Jeanne Chen|317-944-3570|jchen@iuhealth.org|
302530|NCT02104141|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
302531|NCT02104167|Zimmer Biomet|Clinical Affairs|303-501-8571|tammy.stinson2@zimmerbiomet.com|
302532|NCT02104180|Mylan Medical SAS|Benoit LA ROCHE|+33 1 46 25 86 76|benoit.la-roche@mylan.com|
311809|NCT02940730|University of Colorado|Dr. Tyree Kiser|3037242883|ty.kiser@ucdenver.edu|
311810|NCT02940860|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
311811|NCT02940886|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
311812|NCT02941523|Noxopharm Limited|Clinical Manager|+61 499005049|marinella.messina@noxopharm.com|
311813|NCT02941614|Kaiser Permanente Southern California Department of Research and Evaluation|Erin Hahn|626-564-3505|Erin.E.Hahn@kp.org|
311814|NCT02941627|Oticon Medical|Clinical Research Director|+33 4 93 95 18 18|mhoe@oticonmedical.com|
311815|NCT02941640|University Clinical Center Tuzla|Samir Delibegovic|+387 61 149 131|delibegovic.samir@gmail.com|
311816|NCT02941692|Medical University of South Carolina|Dr. Julianne Flanagan|843-792-5569|Hellmuth@musc.edu|
311817|NCT02942160|Endo Pharmaceuticals|Saji Vijayan, MBBS|800-462-3636|ClinicalTrials@Endo.com|
311818|NCT02942264|National Cancer Institute|Dr. Jing Wu|240-760-6036|jing.wu3@nih.gov|
311819|NCT02942407|Duke Universitey|Christopher Granger, MD|919-668-8900|christopher.granger@duke.edu|
311820|NCT02942485|University of Helsinki|Dr. Svetlana Vakkilainen|+358407693375|svetlanakostjukovitch@gmail.com|
311821|NCT02942576|Contact for Clinical Trial Information|Daiichi Sankyo|1-908-992-6400|CTRinfo@dsi.com|
311822|NCT02942654|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
311823|NCT02942771|University of Kentucky|Dr. Linda Van Eldik|(859) 257-5566|linda.vaneldik@uky.edu|
311824|NCT02942979|VA Bedford Medical Center|David Smelson|781-687-2845|david.smelson@va.gov|
311825|NCT02943070|Boston Scientific Corporation|Director, Clinical Operations|952-930-6000|teresa.takle-flach@bsci.com|
311826|NCT02943096|New York State Psychiatric Institute|Dr. Bret R. Rutherford|646-774-8660|brr8@cumc.columbia.edu|
302533|NCT02104219|Alexion Pharmaceuticals|Senior Medical Director, Clinical Development|203-272-2596|clinicaltrials@alxn.com|
311827|NCT02943213|Cycle Pharmaceuticals Ltd|James Price|+44 1223 803638|james.price@cyclepharma.com|
291703|NCT01380106|Boston VA Research Institute, Inc.|Nikhil C. Munshi, M.D.|6176325607|nikhil.munshi@dfci.harvard.edu|
291704|NCT01380145|Ludwig Institute for Cancer Research|Andrew Park, PharmD, Clinical Project Manager|(212) 450-1587|apark@licr.org|
291705|NCT01380184|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291706|NCT01380197|Morehouse School of Medicine|Iris Buchanan|404-398-9578|ibuchanan@msm.edu|
291707|NCT01380327|DAIT/NIAID|Associate Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
291708|NCT01380366|Northwestern University|Dr. Jonathan Fryer, MD|312-695-2125|jfryer@nmh.org|
291709|NCT01380379|Stanford University|Dr. Jennifer Keller|650-724-0070|jkeller@stanford.edu|
291710|NCT01380535|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
291711|NCT01380639|Schön Klinik Berchtesgadener Land|Dr. Klaus Kenn|+49 8652 931541|kkenn@schoen-kliniken.de|
302534|NCT02104414|Mount Sinai St. Luke's|Dr. Ali Shariat|914-409-5023|alishariatmd@gmail.com|
302535|NCT02104427|TaiGen Biotechnology Co., Ltd.|Li-Wen Chang|+886-2-8177-7072|lwchang@taigenbiotech.com|1227
302536|NCT02104505|Center for Environmental Medicine, Asthma and Lung Biology; University of North Carolina, Chapel Hill|Allison Burbank, MD|919-843-2714|allison_burbank@med.unc.edu|
302537|NCT02104557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302538|NCT02104583|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
302539|NCT02104739|The University of Texas Health Science Center at Houston|Absalon D Gutierrez, MD|(713) 500-6641|Absalon.D.Gutierrez@uth.tmc.edu|
302540|NCT02104752|VA Greater Los Angeles Healthcare System/UCLA|Jonathan K. Wynn, Ph.D.|(310) 478-3711|jkwynn@ucla.edu|44957
302541|NCT02104765|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
302542|NCT02104804|AstraZeneca|Eva Johnsson, MD, PhD, Global Clinical Lead||Eva.Johnsson@astrazeneca.com|
302543|NCT02104817|AstraZeneca|AstraZenenca Information Center|1-877-240-9479|information.center@astrazeneca.com|
302544|NCT02104830|Biocad|Roman Ivanov, Director of Clinical Trials|+7 (812) 380 49 33|ivanov@biocad.ru|950
302545|NCT02104895|Radiation-Oncology Unit, AOU Careggi, Florence University, Florence, Italy|Dr. Icro Meattini|+39055794|icro.meattini@unifi.it|7719
302546|NCT02104947|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302547|NCT02105012|Pearl Therapeutics Inc.|Paul Dorinsky, MD, FCCP|650-305-2600|pdorinsky@pearltherapeutics.com|
302548|NCT02105246|San Francisco VA Healthcare System|Dr. Mary Whooley|415-221-4810|mary.whooley@va.gov|
311828|NCT02943226|The University of Texas Health Science Center at Houston|Joseph P. Hasapes, M.D.|(713) 566-5440|Joseph.P.Hasapes@uth.tmc.edu|
311829|NCT02943447|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311830|NCT02943460|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311831|NCT02943473|Icahn School of Medicine at Mount Sinai|Dr. Ajai Chari|(212) 241-7873|ajai.chari@mountsinai.org|
311832|NCT02943499|Brown University|Dr. Judson Brewer|401-863-2826|judson_brewer@brown.edu|
311833|NCT02943564|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
311834|NCT02943577|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
311835|NCT02943668|Fred Hutch Cancer Research Center|Dr. Bart Scott|206.667.1990|bscott@fredhutch.org|
311836|NCT02943941|Medtronic Inc|Verla Laager|(800) 328.2518|verla.l.laager@medtronic.com|
311837|NCT02944383|NeuroBo Pharmaceuticals|Vice President Clinical Operations|+1 (857) 702-9600|info@neurobopharma.com|
311838|NCT02944448|Cara Therapeutics|Frédérique Menzaghi, PhD|203-406-3700|clinicaltrials.gov@caratherapeutics.com|
311839|NCT02944461|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
311840|NCT02944513|Brigham and Women's Hospital|Dr. Robert Jamison|617-732-9046|rjamison@bwh.harvard.edu|
311841|NCT02944565|The Ohio State University Comprehensive Cancer Center|Hallie Barr, PharmD BCOP|614-685-5803|Hallie.Barr@osumc.edu|
311842|NCT02944656|Emory University|Tiffany Hailstorks, MD, MPH|404-778-1385|tiffany.p.hailstorks@emory.edu|
311843|NCT02944968|Johnson and Johnson Medical NV/SA|Nathalie Macours, Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
311844|NCT02945046|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
311845|NCT02945150|Massachusetts General Hospital|Dr. Raymond Chung|617-724-7562|Chung.Raymond@mgh.harvard.edu|
311846|NCT02945254|Brigham and women's Hospital|Andrew Wellman|6174078483|awellman@rics.bwh.harvard.edu|
311847|NCT02945410|Technical University of Munich|Dr. Karsten Koehler|+49 89 289 24488|karsten.koehler@tum.de|
311848|NCT02945553|University of Vermont College of Medicine|Michael Toth|802-656-7989|michael.toth@med.uvm.edu|
311849|NCT02945657|Medimetriks Pharmaceuticals, Inc.|Director of Clinical Development|973-882-7512|clinicaltrials.gov_inquiries@medimetriks.com|524
311850|NCT02946021|Tactile Medical|Jill Christensen|(612) 355-5123|jchristensen@tactilemedical.com|
311851|NCT02946034|Massachusetts General Hospital|Dr. Raymond Chung|617-726-5925|Chung.Raymond@mgh.harvard.edu|
311852|NCT02946073|Braeburn|Susan Franks, SVP, Head of Regulatory Affaires|6104678719|sfranks@braeburnrx.com|
311853|NCT02946229|GE Healthcare|Sean Lucas - Research Manager|1-248-533-5575|sean.lucas@ge.com|
311854|NCT02946385|GlaxoSmithKline|GSK Response Center|866-435-7343|anand.n.harpalani@gsk.com|
291712|NCT01380691|Eli Lilly Company|Chief Medical Officer|800-545-5979||
291713|NCT01380730|Amgen Inc.|Study Director|866-572-6436||
291714|NCT01380743|Patient Advocacy|Amicus Therapeutics|+1-609-662-2000|clinicaltrials@amicusrx.com|
291715|NCT01380769|Cerulean Pharma Inc.|Adrian Senderowicz|617 551 9600|asenderowicz@ceruleanrx.com|
291716|NCT01380782|Dana-Farber Cancer Institute|Patrick Y. Wen, MD|6176322166|pwen@partners.org|
291717|NCT01380834|Children's Hospital of UPMC|Dr. Mihaela Visoiu|412-692-5260|visoium@upmc.edu|
291718|NCT01380899|Facultad de Medicina, Universidad Autonoma de San Luis Potosi|Ildefonso Rodriguez-Leyva|+52 4442043016|ildefonso.rodriguez@uaslp.mx|
291719|NCT01380990|UCL Institute of Child Health|Dr Claire Booth|+44207 905 2198|C.Booth@ucl.ac.uk|
291720|NCT01381016|University of Colorado Denver|Associate Professor|(303) 724-2037|alex.polotsky@ucdenver.edu|
291721|NCT01381068|UCSD|Neil Finer||nfiner@ucsd.edu|
302549|NCT02105272|Otsuka Pharmaceutical Co., Ltd.|Deputy General Manager, Headquarters of Clinical Development|+81-3-6361-7366||
302550|NCT02105285|Otsuka Pharmaceutical Co., Ltd.|Deputy General Manager, Headquarters of Clinical Development|+81-3-6361-7366||
302551|NCT02105324|Massachusetts General Hospital|Dr. Steven J. Russell|617.726.1848|sjrussell@partners.org|
302552|NCT02105415|Mayo Clinic|Dr. Nathan Smischney|507-255-4305|smischney.nathan@mayo.edu|
302553|NCT02105454|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302554|NCT02105467|Merck Sharp & Dohme, Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302555|NCT02105558|The University of Texas Health Science Center at Houston|Madhumani Rupasinghe, MD|(713) 500-6200|Madhumani.Rupasinghe@uth.tmc.edu|
302556|NCT02105662|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302557|NCT02105688|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302558|NCT02105701|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302559|NCT02105740|Universidade de Brasília|Gil Montenegro|556181487323|prof.gilmontenegro@gmail.com|
302560|NCT02105948|GlaxoSmithKline|GSK Response Center|866-435-7343||
302561|NCT02105961|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
302562|NCT02105974|GlaxoSmithKline|GSK Response Center|866-435-7343||
302563|NCT02105987|GlaxoSmithKline|GSK Response Center|866-435-7343||
291722|NCT01381120|Barrie Urology Associates|Dr. Joseph Zadra||joezadra@rogers.com|
302564|NCT02106065|VA Palo Alto Health Care System|Dr. Kaci Fairchild|6504935000|jenniferkaci.fairchild@va.gov|63432
302565|NCT02106156|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
302566|NCT02106325|New York University School of Medicine|Stephen Ross, MD/ Principal Investigator|212 562 4097|Stephen.Ross@nyumc.org|
302567|NCT02106351|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
302568|NCT02106390|GlaxoSmithKline|GSK Response Center|866-435-7343||
302569|NCT02106403|GlaxoSmithKline|GSK Response Center|866-435-7343||
302570|NCT02106442|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302571|NCT02106455|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302572|NCT02106494|Heron Therapeutics|Robert Geller, M.D.|650-366-2626|rgeller@herontx.com|
302573|NCT02106728|Toronto General Hospital|Dr. Gina Dimitropoulos|416-340-3749|gdimit@ucalgary.ca|
302574|NCT02106832|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
302575|NCT02106884|UZ Leuven|Prof. Dr. Eric Van Cutsem|0032 16 344418|eric.vancutsem@uzleuven.be|
302576|NCT02106910|University of North Carolina at Chapel Hill|Nicholas J. Shaheen, MD|919-966-7655|nicholas_shaheen@med.unc.edu|
302577|NCT02106923|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
311855|NCT02946463|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
311856|NCT02946489|New York State Psychiatric Institute|Elias Dakwar, MD|6467748728|elias.dakwar@nyspi.columbia.edu|
311857|NCT02946515|University of Minnesota - Division of Epidemiology and Community Health|Dr. Nancy E. Sherwood, Associate Professor|612-625-4567|sherw005@umn.edu|
311858|NCT02946580|Massachusetts General Hospital|Dr. Kyle Staller|617-724-7556|kstaller@mgh.harvard.edu|
311859|NCT02946892|UTSW|Ryan Butts|2144565822|ryan.butts@utsouthwestern.edu|
311860|NCT02946918|UT Southwestern Medical Center|Dr. Alex Tessnow-ASSOC PROFESSOR|214/648-3685|Alex.Tessnow@UTSouthwestern.edu|
311861|NCT02947984|Massachusetts General Hospital|Nina Sanford, MD||NSANFORD@PARTNERS.ORG|
311862|NCT02947997|Massachusetts General Hospital|Gary Tearney, MD|617-724-2979|gtearney@partners.org|
311863|NCT02948257|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|408-470-7119|Terry_Alverson@cardivamedical.com|
311864|NCT02948426|National Cancer Institute|Dr. Christina Annunziata|240-760-6125|christina.annunziata@nih.gov|
311865|NCT02948582|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
302578|NCT02106962|California Insitute of Renal Research, Inc.|Mark M. Boiskin, M.D.|858-637-4600|mboiskin@bnmg.org|
291723|NCT01381172|Impulse Dynamics (USA) Inc|Sr. Director, Clinical and Data Operations|8453592389|angelas@impulse-dynamics.com|
291724|NCT01381406|GlaxoSmithKline|GSK Response Center|866-435-7343||
291725|NCT01381471|GlaxoSmithKline|GSK Response Center|866-435-7343||
291726|NCT01381549|GlaxoSmithKline|GSK Response Center|866-435-7343||
291727|NCT01381562|GlaxoSmithKline|GSK Response Center|866-435-7343||
291728|NCT01381575|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
291729|NCT01381692|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
291730|NCT01381718|Children's Hospital Boston/Harvard Medical School|Nicole J. Ullrich, MD, PhD|617-355-3193|Nicole.Ullrich@childrens.harvard.edu|
291731|NCT01381861|TRACON Pharmaceuticals|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
291732|NCT01381874|Janssen Research & Development, LLC|Senior Director Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
291733|NCT01381900|Janssen Research & Development, LLC|Vice President, Franchise Medical Leader, Cardiovascular & Metabolism Franchise|1-800-526-7736||
302579|NCT02106975|Virginia Commonwealth University School of Medicine|Alpha A Fowler, III, MD|804-828-9071|alpha.fowler@vcuhealth.org|
302580|NCT02107014|University of Alabama at Birmingham|Dr. Jarred Younger|2059755821|younger@uab.edu|
302581|NCT02107092|ZS Pharma, Inc.|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
302582|NCT02107131|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|
302583|NCT02107157|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
302584|NCT02107196|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
302585|NCT02107274|Ministry of Health of Malaysia|Dr. Albert Iruthiaraj L. Anthony|+60174633410|albert5409@yahoo.com|
302586|NCT02107300|Medical University of South Carolina|Chitra Lal|(843) 792-7776|lalch@musc.edu|
311866|NCT02948634|UT Southwestern|Jason Zafereo|14-648-1002|jason.zafereo@utsouthwestern.edu|2146481002
311867|NCT02948777|Helsinki University and Helsinki University Hospital|Prof. Marja-Riitta Taskinen|+358-9-47171990|marja-riitta.taskinen@helsinki.fi|
311868|NCT02948829|Takeda|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
311869|NCT02948959|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
311870|NCT02949011|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
311871|NCT02949024|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
311872|NCT02949128|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
311873|NCT02949141|Patan Academy of Health Science|Darlene R House, MD|+977 9810339799|dhouse@iupui.edu|
311874|NCT02949219|Mayo Clinic|Robert R. McWilliams, M.D.|507-266-9161|mcwilliams.robert@mayo.edu|
311875|NCT02949271|Duke University|Ashraf Habib, M.D.|919-681-4544|ashraf.habib@duke.edu|
311876|NCT02949362|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
311877|NCT02949518|Hospital for Special Surgery|Dr. Ellen Soffin|212-606-1206|soffine@hss.edu|
311878|NCT02949674|Instituto Mexicano del Seguro Social|Dr. Juan Lopez|+5257473500|juanlopez110@hotmail.com|25538
311879|NCT02949908|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
311880|NCT02949921|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
311881|NCT02949973|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
311882|NCT02950025|Washington University School of Medicine|Michael C. Roach, M.D.|314-747-1786|roachm@wustl.edu|
311883|NCT02950467|UCSF|Michelle Matvey|4152214810|michelle.matvey@ucsf.edu|24117
311884|NCT02950545|University of Virginia|Principal Investigator|434-924-8021|djc4f@virginia.edu|
311885|NCT02950558|University of Cincinnati|Jun-Ming Zhang, MD, MSc|5135582427|jun-ming.zhang@uc.edu|
311886|NCT02950753|UMCSouthernNevada|Dr. Tony Zitek|702-383-7885|zitek10@gmail.com|3
311887|NCT02950831|St. Jude Medical|Filippo Agnesi|14694184987|filippo.agnesi@abbott.com|
311888|NCT02951143|University of Kentucky|Mikhail Koffarnus|8593236402|koffarnus@uky.edu|
311889|NCT02951156|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
311890|NCT02951182|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
311891|NCT02951195|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
311892|NCT02951273|Rigshospitalet|Niels D. Olesen|004520262459|niels.damkjaer.olesen.01@regionh.dk|
311893|NCT02951312|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
311894|NCT02951351|Mayo Clinic|Margaret M. Reynolds, MD|507-284-2733|margaretmmreynolds@gmail.com|
311895|NCT02951429|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
311896|NCT02951481|Fundación de investigación Hospital Universitario 12 de Octubre|MD, PhD José María Aguado García|913908000|jaguadog1@gmail.com|4632
311897|NCT02951533|Janssen-Cilag GmbH|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
311898|NCT02951702|St. Luke's Hospital|Ryan Medas, Pharm.D.|314-205-6053|ryan.medas@stlukes-stl.com|
311899|NCT02951780|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
311900|NCT02951819|Janssen Scientific Affairs|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
311901|NCT02951884|Loyola University Medical Center|William Lack, M.D.|708-216-1175|wlack@luc.edu|
311902|NCT02951988|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
311903|NCT02952001|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
311904|NCT02952261|Shanghai Pulmonary Hospital affiliated to Tongji university|Dr. Chang Chen|+86 13816869003|chenthoracic@163.com|
311905|NCT02952313|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
291734|NCT01381926|UAB|Dr. Amy Warriner|205-996-4004|awarriner@uabmc.edu|
311906|NCT02952586|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291735|NCT01381952|Karolinska University Hospital|Dr. Söderman|+46851774037|michael.soderman@karolinska.se|
291736|NCT01382108|Centre for Contact Lens Research|Kathy Dumbleton|519-888-4567|kdumble@uwaterloo.ca|32694
291737|NCT01382186|Center of Innovation on Disability and Rehabilitation Research|Dr. Jolie Haun|813-558-7622|jolie.haun@va.gov|
291738|NCT01382212|AbbVie|Global Medical Information|800-633-9110||
291739|NCT01382225|Alcon Research, Ltd.|Michela Montecchi-Palmer, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
291740|NCT01382251|Department of Anesthesiology, The Ottawa Hospital|Dr. Gregory L Bryson|613.761.4169|glbryson@ottawahospital.on.ca|
302587|NCT02107313|Prana Biotechnology|Dr Caroline Herd|+61393494906|info@pranabio.com|
302588|NCT02107339|NorthShore University HealthSystem|Glenn Murphy|847-570-2760|dgmurphy2@yahoo.com|
302589|NCT02107443|University of Rochester, Medical Center|Dr. Supriya Mohile, Professor of Medicine|585-275-0394|URCC_COACH@URMC.Rochester.edu|
302590|NCT02107482|Tufts Medical Center|Nicole Dumont|617 636 7462|ndonovan1@tuftsmedicalcenter.org|
302591|NCT02107599|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
302592|NCT02107703|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
302593|NCT02107859|PTC Therapeutics, Inc.|Patient Advocacy|1-866-562-4620|medinfo@ptcbio.com|
302594|NCT02107898|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
302595|NCT02108171|Guangzhou First People's Hospital, Affiliated Hospital of Guangzhou Medical College|Dr. Xiangcai Ruan|+8620-81048306|xc_ruan@hotmail.com|
302596|NCT02108223|Sisli etfal training anf research hospital|Fatma yazıcı yılmaz|+905079234033|fatmayazc@gmail.com|
302597|NCT02108262|CSLBehring|Trial Registration Coordinator|610-878-4000|clinicaltrials@cslbehring.com|
302598|NCT02108288|Otsuka Pharmaceutical Co., Ltd|Director of Clinical Research and Development|+81-3-6361-7366||
302599|NCT02108457|University of Pennsylvania|Lilie Lin, MD|215-662-6515|lin@xrt.upenn.edu|
302600|NCT02108522|AlloVir|Iain Fraser, MD|833-409-2281|ClinicalTrials@allovir.com|
302601|NCT02108600|University of California, San Francisco|Sindhu Chandran|4153538374|sindhu.chandran@ucsf.edu|
302602|NCT02108691|Hanyang University|Dr. Yongsoon Park|82-2-2220-1205|yongsoon@hanyang.ac.kr|
302603|NCT02108821|Children's Mercy Hospital, Kansas City|Alka Goyal MD|816-302-3069|agoyal4@stanford.edu|
302604|NCT02108912|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS|214-648-1559|karen.mccain@utsouthwestern.edu|
302605|NCT02108951|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
302606|NCT02108977|Health Services Research & Development, Durham VAMC|Dr. Santanu Datta, Health Sciences Research Specialist, HSR&D|(919) 286-0411|Santanu.Datta@va.gov|7580
302607|NCT02109029|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
302608|NCT02109042|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
302609|NCT02109107|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
302610|NCT02109133|Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine,Severance Hospital, Yonsei University Health System|Dr. Sun-Jun, Bae|+82-02-2228-4438|SJBAI1@yuhs.ac|
302611|NCT02109159|London School of Hygiene and Tropical Medicine|Dr Junko Kiriya|+442076368636|junko.kiriya@lshtm.ac.uk|
302612|NCT02109419|Pennington Biomedical Research Center|Dr. Corby K. Martin|225-763-2585|corby.martin@pbrc.edu|
302613|NCT02109432|Pennington Biomedical Research Center|Corby Martin, Associate Professor|225-763-2585|corby.martin@pbrc.edu|
302614|NCT02109445|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302615|NCT02109458|Johns Hopkins University School of Medicine|Dr. Lonny Yarmus|4105025224|lyarmus@jhmi.edu|
302616|NCT02109484|Chris Hani Baragwanath Academic Hospital|Michelle J. Groome, MD, PhD|+27 11 983 4283|groomem@rmpru.co.za|
302617|NCT02109497|Prana Biotechnology|Dr Caroline Herd|+6133494906|info@pranabio.com|
302618|NCT02109562|Indivior, Inc.|Global Director, Clinical Development|804-379-1090||
302619|NCT02109640|University of Edinburgh|Hugh M Paterson|44 131 537 1000|hugh.paterson@ed.ac.uk|
311907|NCT02952820|Eisai, Inc.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
311908|NCT02952872|Wayne State University|Dr. Emily Grekin|313-577-2820|grekine@wayne.edu|
311909|NCT02952898|Gage Development Company|Gage Development Company|1-847-999-0600|clinicalinfo@capstonedevservices.com|
311910|NCT02953262|Center for Healthcare Organization and Implementation Research (CHOIR) United States Department of Veterans Affairs VA Bedford Healthcare System|Stephanie Shimada, PhD|781-687-2208|Stephanie.Shimada@va.gov|
311911|NCT02953314|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
311912|NCT02953418|Medtronic MITG-RGI|Director of Clinical Affairs|303-882-6759|Tumordirectedtherapiesclinical@Medtronic.com|
311913|NCT02953548|GW Research Ltd|Medical Enquires|+44 01223 238170; 1877886281|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
311914|NCT02953561|The University of Texas MD Anderson Cancer Center|Naval Daver MD./Associate Professor|713-794-4392|ndaver@mdanderson.org|
311915|NCT02953639|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
311916|NCT02953678|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
311917|NCT02953782|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311918|NCT02953821|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
311919|NCT02953860|University of Colorado|Professor Anthony Elias|720-848-0347|anthony.elias@cuanschutz.edu|
311920|NCT02953873|Medical University of South Carolina|Caitlin Schaffner|843-792-7558|schaffne@musc.edu|
311921|NCT02953886|University of Michigan|Emily Yanca|734-763-3988|emthorpe@umich.edu|
311922|NCT02953938|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
311923|NCT02954172|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
291741|NCT01382303|Ajou University|Kwan Woo Lee|82-31-219-4526|LKW65@ajou.ac.kr|
291742|NCT01382446|SJHMC|Tracy L. Thomas MSN RN CCRN ACNS-BC|602-406-2567|Tracy.Thomas007@dignityhealth.org|
291743|NCT01382602|Cook MyoSite Incorporated|Ron Jankowski, PhD|412-963-7380|Ron.Jankowski@CookMyosite.com|
291744|NCT01382719|Palatin Technologies, Inc.|Jeffrey Edelson, MD, FRCPC|(609) 495-2200|jedelson@palatin.com|
291745|NCT01382901|Luitpold Pharmaceuticals, Inc.|Mark Falone, MD|601-650-4200|mfalone@luitpold.com|
291746|NCT01382940|Hoffmann-La Roche|Medical Communications|800 821-8590||
291747|NCT01383005|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
291748|NCT01383018|Boston Scientific|Amanda Vail, Clinical Project Manager|612-749-5366|amanda.vail@bsci.com|
302620|NCT02109731|University of Rochester|Dr. Suzanne Karan|5852751384|suzanne_karan@urmc.rochester.edu|
302621|NCT02109939|Assurex Health|Lindsey Burns|5137015068|lindsey.burns@myriad.com|
302622|NCT02110095|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
302623|NCT02110108|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
302624|NCT02110121|Cynosure|Jamie Trimper|800-886-2966|jamie.trimper@cynosure.com|
302625|NCT02110147|Wellstat Therapeutics Corporation|Wellstat Medical Information|800.914.0071|medinfo@wellstat.com|
302626|NCT02110225|Dompé|Flavio Mantelli, MD, PhD|+39 583831|info@dompe.it|
302627|NCT02110238|Seikagaku|Junko Takamura||junko.takamura@seikagaku.co.jp|
302628|NCT02110264|UCLA|David Farabee|3109630009|dfarabee@mednet.ucla.edu|
302629|NCT02110381|University of Michigan|Dr. Elizabeth Jackson|734-998-7411|lisjacks@med.umich.edu|
302630|NCT02110485|Nationwide Children's Hospital|Beth Fischer|614-355-0338|beth.fischer@nationwidechildrens.org|
302631|NCT02110693|Friends Research Institute|Robert Schwartz|410-837-3977|rschwartz@friendsresearch.org|276
302632|NCT02110706|Yale School of Medicine|Dr. Richard Nowak, MD,MS|203-785-4085|richard.nowak@yale.edu|
302633|NCT02110732|Helsinki University Hospital|Anne Pitkäranta|+358406430511|anne.pitkaranta@hus.fi|
302634|NCT02110758|National Committee for Quality Assurance|Sarah Hudson Scholle|202-955-1726|scholle@ncqa.org|
302635|NCT02110901|Proteon Therapeutics, Inc|Steven Burke, MD|781-890-0102|Clinical@ProteonTx.com|
302636|NCT02111083|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
302637|NCT02111096|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
302638|NCT02111174|Johns Hopkins SKCCC|Thomas Smith, M.D.|410-955-2091|tsmit136@jhmi.edu|
302639|NCT02111187|Associate professor of oncology and urology|Emmanuel Antonarakis|443-287-0553|eantona1@jhmi.edu|
302640|NCT02111200|Baylor|Mahshid Azamian|832-822-1529|azamian@bcm.edu|
302641|NCT02111213|Stanford University|Principal Investigator|6507232880|desparza@stanford.edu|
302642|NCT02111252|Takeda|Medical Director, Clinical Science|800-778-2860|trialdisclosures@takeda.com|
302643|NCT02111369|Emory University|Dr. Michael Johns|323-865-9839||
302644|NCT02111447|GLA|Research Coordinator|7163236570|tgensler@greatlakesanes.com|
302645|NCT02111564|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
302646|NCT02111577|SOTIO a.s.|Prof. Radek Spisek, M.D., Ph.D.|+420 2241 75101|spisek@sotio.com|
302647|NCT02111603|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
302648|NCT02111746|The University of Texas Health Science Center at Houston|Dr. Kristofer M Charlton-Ouw|(713) 486-5100|Kristofer.CharltonOuw@uth.tmc.edu|
311924|NCT02954198|Medical University of South Carolina|Dr. David Taber|843-792-4003|taberd@musc.edu|
311925|NCT02954354|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|Shionogiclintrials-admin@shionogi.co.jp|
311926|NCT02954458|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@takeda.com|
311927|NCT02954575|Octapharma AG|Cristina Solomon|+41 (0)55 451 21 89|Cristina.Solomon@octapharma.com|
311928|NCT02954601|Oramed|Chief Scientific Officer|+972-2-566-0001|miriam@oramed.com|
311929|NCT02954653|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
311930|NCT02954848|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
311931|NCT02954887|GW Research Ltd|Medical Enquires|+44 01223 238170; 18778862810|medinfo@gwpharm.com, medinfo@greenwichbiosciences.com|
311932|NCT02955069|Novartis Pharmaceuticals|Study director|862-778-8300|Novartis.email@novartis.com|
311933|NCT02955147|Mass General Hospital|Dr. Sebastian Unizony|(617) 726-7938|sunizony@mgh.harvard.edu|
311934|NCT02955186|Yale School of Medicine|Dana Cavallo, Project Coordinator|203-610-9788|dana.cavallo@yale.edu|
311935|NCT02955212|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
311936|NCT02955329|University of California, San Francisco|Dr. Gideon St. Helen|628-206-2687|gideon.sthelen@ucsf.edu|
311937|NCT02955797|Sanofi Pasteur Inc.|Medical Director|800-633-1610|Contact-US@sanofi.com|1#
311938|NCT02956044|Translational Medicine Group|Program Director|617-726-4236|yhalvorsen@ccib.mgh.harvard.edu|
311939|NCT02956057|Tomas Bata Hospital|Kojecky Vladimir|+420577552512|kojecky@bnzlin.cz|
311940|NCT02956070|Universidade Federal Fluminense|Dr. Luiz Augusto Poubel|55 21 981113344|luizpoubel@id.uff.br|
311941|NCT02956122|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
311942|NCT02956278|University of California San Francisco|Kathy Giacomini, PhD|415-514-4363|kathy.giacomini@ucsf.edu|
311943|NCT02956460|CooperVision|Jose Vega, O.D., MSc., FAAO|925-621-3761|JVega2@coopervision.com|
311944|NCT02956486|Eisai Ltd.|Eisai Medical Information|+1-888-274-2378|esi_medinfo@eisai.com|
311945|NCT02956616|Montefiore Medical Center|Peter S. Bernstein, MD, MPH|718-904-2767|pbernste@montefiore.org|
311946|NCT02956629|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
311947|NCT02956746|Synermore Biologics Co., Ltd.|Director of Clinical Trials|+886 2 2659 0988|achuang@synermore.com|
311948|NCT02956837|GlaxoSmithKline|GSK Response Center|866-435-7343|shm60684@gsk.com|
311949|NCT02956967|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291749|NCT01383096|Nucleus Network|Peter Hodsman|+ 613 9076 8900|businessdevelopment@nucleusnetwork.com.au|
291750|NCT01383161|University of California, Los Angeles|Gary Small, MD|310-825-0291|gsmall@mednet.ucla.edu|
291751|NCT01383174|University of California San Francisco|Dr. Anna Maria Napoles|415-476-6290|anapoles@ucsf.edu|
291752|NCT01383200|Bascom Palmer Eye Institute|Dr. Sonia Yoo|305-243-2020|syoo@med.miami.edu|
291753|NCT01383213|IRCCS Fondazione Cà Granda Policlinico Milano|Dr Roberto Cosentini|+390255033618|r.cosentini@gmail.com|3618
291754|NCT01383317|Wake Forest University Health Sciences|Dr. Scott Miller|3367167437|scmiller@wakehealth.edu|
291755|NCT01383356|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291756|NCT01383421|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
302649|NCT02111772|University of Virginia|Dr. Peter W. Heymann|434-242-8209|pwh5a@virginia.edu|
302650|NCT02111785|Department of Neurosurgery, University of Virginia Health System|Dr. Daniel Raper|4349823244|raper@virginia.edu|
302651|NCT02111798|Johns Hopkins University School of Medicine|Dr. Kelly Dunn, Ph.D., MBA|410-550-2254|kdunn9@jhmi.edu|
302652|NCT02111811|Crescenz VA Medical Center|David Oslin, MD|215-823-8594|dave.oslin@va.gov|
302653|NCT02111863|National Cancer Institute|Dr. Steven A. Rosenberg|301-496-4164|steven-rosenberg@nih.gov|
302654|NCT02111980|UC San Diego School of Medicine|Dr. Ulrika Birgersdotter-Green|858-657-5310|ubgreen@ucsd.edu|
302655|NCT02111993|UC San Diego School of Medicine|Ulrika Birgersdotter-Green, MD|858-657-5310|ubgreen@ucsd.edu|
302656|NCT02112045|Washington University School of Medicine|Meagan Jacoby, M.D., Ph.D.|314-454-8304|mjacoby@wustl.edu|
302657|NCT02112370|Seoul National University Hospital Department of Surgery|Dr. Kyu Eun Lee|+82)-2-2072-2817|kyueunlee@snu.ac.kr|
302658|NCT02112448|Advocate Children's Hospital|Jamie Penk|7086845580|jamie.penk@advocatehealth.com|
302659|NCT02112838|Rigel Pharmaceuticals|Sandra Tong|1-650-624-1207|stong@rigel.com|
302660|NCT02112877|Boston Scientific|Nancy O'Connell, Sr. Clinical Research Manager|763-494-2706|nancy.oconnell@bsci.com|
302661|NCT02112994|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
302662|NCT02113007|Sarah Cannon Development Innovations|Charles H. Davis, RAC|615-524-4341|charles.davis2@scri-innovations.com|
302663|NCT02113124|The Transitional Learning Center at Galveston|Dr. Brent Masel|409-762-6661|bmasel@tlcgalveston.org|411
302664|NCT02113189|University of Texas Southwestern Medical Center|Karen McCain, PT, DPT, NCS|2146481559|karen.mccain@utsouthwestern.edu|
302665|NCT02113241|INSTITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
302666|NCT02113410|Florida Atlantic University|Dr. Juyoung Park|561-297-4537|jpark14@fau.edu|
302667|NCT02113436|GlaxoSmithKline|GSK Response Center|866-435-7343||
302668|NCT02113449|GlaxoSmithKline|GSK Response Center|866-435-7343||
302669|NCT02113579|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
302670|NCT02113956|Center for Innovative Public Health Research|Dr. Michele Ybarra|877-302-5858|michele@innovativepublichealth.org|801
302671|NCT02114151|Janssen Infectious Diseases - Diagnostics BVBA|Associate Director||ClinicalTrialDisclosure@its.jnj.com|
302672|NCT02114164|OhioHealth|Dr. Oscar Martinez|(614) 544-8104|oscar.martinez@ohiohealth.com|
302673|NCT02114177|Janssen Infectious Diseases BVBA|Associate Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
302674|NCT02114203|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302675|NCT02114216|Seoul National University Hospital|Dr. Jinjoo Kim|82-10-6261-6483|jjkim0727@gmail.com|
302676|NCT02114268|MedImmune, LLC|M. Pamela Griffin, MD, Senior Director|301-398-0000|information.center@astrazeneca.com|
302677|NCT02114307|Imperial College London|Dr Tristan Lane|02033117317|tristan.lane@imperial.ac.uk|
311950|NCT02957123|Institute of Fundamental and Clinical Immunology|Alexander A Ostanin, MD, PhD|+7 (383) 236-03-29|ostanin62@mail.ru|
311951|NCT02957136|Duke University Health System|Christopher Polage|919-668-5008|christopher.polage@duke.edu|
311952|NCT02957305|Dep. of Obstetrics and Gynecology, Universidade Federal do Rio Grande do Sul, Porto Alegre - RS - Brazil|Ricardo Francalacci Savaris|+5551997781966|rsavaris@hpca.edu.br|
311953|NCT02957331|UCHealth|Thomas J. Schroeppel, MD, MS|719 365 2422|thomas.schroeppel@uchealth.org|
311954|NCT02957357|The University of North Carolina at Chapel Hill|Dr. Ronald Chen|984-974-0400|ronald_chen@med.unc.edu|
270267|NCT00117143|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
291757|NCT01383486|Bayer HealthCare LLC, Consumer Care|Head Clinical and Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
291758|NCT01383499|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291759|NCT01383616|Hospital for Special Surgery|Brian Rebolledo, MD|212-606-1172|rebolledob@hss.edu|
291760|NCT01383707|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
291761|NCT01383720|Boston Scientific Corporation|Director of Clinical Trials, Valves|408-370-1550||
291762|NCT01383759|Memorial Sloan Kettering Cancer Center|Dr. Hani Hassoun|212-639-3228|hassounh@mskcc.org|
291763|NCT01383928|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
291764|NCT01383954|Brigham and Women's Hospital|Ajay D. Wasan, M.D., M.Sc.||awasan@partners.org|
291765|NCT01383993|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302678|NCT02114385|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302679|NCT02114515|University of Illinois at Chicago|Jerry A. Krishnan, MD, PhD|312-413-3291|partner@uic.edu|
311955|NCT02957682|Regeneron Pharmaceuticals, Inc|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
311956|NCT02957747|VISN 17 Center of Excellence for Research on Returning War Veterans|Dr. Suzannah Creech, Ph.D.|254-297-3025|Suzannah.Creech@va.gov|
311957|NCT02957942|University of Minnesota|Mo Chen|612-624-5220|mchen@umn.edu|
311958|NCT02958267|OhioHealth|Joseph J Ruane, DO|614-566-3810|joseph.ruane@ohiohealth.com|
311959|NCT02958345|Tulane University|Dr. Luis Balart|504-988-3047|lbalart@tulane.edu|
311960|NCT02958527|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
311961|NCT02958553|Ottobock Healthcare|Russ Lundstrom|512-806-2606|russ.lundstrom@ottobock.com|
291766|NCT01384019|Seoul national university Bundang hospital|Dr. Chang-Hwan Yoon|+82-31-787-7052|changhwanyoon@snubh.org|
291767|NCT01384292|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
291768|NCT01384539|University of Colorado|Dr. Jessica Kendrick|303-602-5012|Jessica.Kendrick@ucdenver.edu|
291769|NCT01384591|University of Texas Medical Branch|Melinda Sheffield-Moore|409-772-8126|melmoore@utmb.edu|
291770|NCT01384734|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
291771|NCT01384760|ChineseUHK|Dr Susanna S Ng|(852) 98075787|drsssng123@yahoo.com.hk|
291772|NCT01384877|BC Cancer|Dr. Philippa Hawley|604-877-6000|phawley@bccancer.bc.ca|67-2752
291773|NCT01385098|Houston Methodist Hosptial|Sherman Vadim|713-441-5514|vsherman@tmhs.org|
291774|NCT01385137|SWOG Statistical Center|Study Statistician|206-667-4623||
291775|NCT01385189|George Washington University|Dr. David J. Diemert, Associate Professor|202.994.2909|ddiemert@gwu.edu|
302680|NCT02114606|University of North Carolina at Chapel Hill|Evan Dellon, MD|919-966-2511|evan_dellon@med.unc.edu|
302681|NCT02114684|CAPRISA|Mrs Nonhlanhla Yende-Zuma|0027312604392|Nonhlanhla.Yende@caprisa.org|
302682|NCT02114814|The Ohio State University|Dr. Jie Hu|6146880394|hu.1348@osu.edu|
302683|NCT02114879|Washington University|Emily Lenard|314-747-5706|lenarde@wustl.edu|
302684|NCT02114892|Institute of Experimental andl Clinical Therapeutics|Dr. Manuel González Ortiz|+52-33-10-58-52-00|uiec@prodigy.net.mx|34212
302685|NCT02114931|Amgen Inc.|Study Director|866-572-6436||
302686|NCT02115048|Translational Research In Oncology (TRIO)|Director, Project Management|+33 1 58 10 09 09|TRIO020.contact@trioncology.org|
302687|NCT02115113|Novartis Pharmaceuticals|Study Director|862-778-8300||
302688|NCT02115139|MFAR Clinical Research|Pau Doñate||investigacion@mfar.net|
302689|NCT02115256|Icahn School of Medicine at Mount Sinai|Dr. Yaakov Beilin|212-241-7467|yaakov.beilin@mountsinai.org|
311962|NCT02958787|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, MD|734-232-5244|sprattda@umich.edu|
311963|NCT02958826|University of Missouri|Dr. Hope Gole|573-882-8030|golehk@health.missouri.edu|
311964|NCT02958956|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
311965|NCT02958969|BWH|Gregory Piazza|6177326984|gpiazza@bwh.harvard.edu|
311966|NCT02958982|Rhizen Pharmaceuticals S.A.|Dr. Prajak Barde|+41 32 580 0113|pjb@rhizen.com|
311967|NCT02958995|Takeda|Medical Director|+1-877-825-3327|clinicaltrialregistry@tpna.com|
311968|NCT02959138|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
311969|NCT02959177|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
311970|NCT02959190|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
311971|NCT02959307|Massachusetts General Hospital|Dr. Paolo Cassano|617-643-9622|pcassano@mgh.harvard.edu|
311972|NCT02959437|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
311973|NCT02959671|University of Minnesota|Thorsten Gruenheid, DDS, PhD|612-625-3903|tgruenhe@umn.edu|
311974|NCT02959814|Skejby University Hospital, Denmark|Niels Ramsing Holm, MD|004526849066|Niels.holm@clin.au.dk|
311975|NCT02959827|Bayer|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
311976|NCT02959840|Rutgers-Robert Wood Johnson Medical School|Dr. Shaul Cohen, M.D., Professor of Clinical Anesthesiology, Director of Obstetric Anesthesia|732-937-8841|cohensh@rwjms.rutgers.edu|
311977|NCT02959853|Baylor College of Medicine|Rui Chen|812-239-1855|rui.chen2@bcm.edu|
311978|NCT02959866|St. Michael's Hospital|Anne Rucchetto, Research Coordinator|416-864-6060|rucchettoa@smh.ca|76155
311979|NCT02959892|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
311980|NCT02959970|Almirall LLC|Ayman Grada|610-840-7107|ayman.grada@almirall.com|
311981|NCT02959983|Allergan, Inc|Therapeutic Area Head|714-246-4500|IR-CTRegistration@allergan.com|
311982|NCT02959996|Massachussetts General Hospital|Malavika Prabhu|6177249028|mprabhu@mgh.harvard.edu|
311983|NCT02960217|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
311984|NCT02960295|Kaiser Permanente Southern California|Steven Jacobsen MD, PhD. Director, Department of Research and Evaluation|626-564-3470|Steven.J.Jacobsen@nsmtp.kp.org|
311985|NCT02960438|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
311986|NCT02960490|Eisai Co., Ltd.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
311987|NCT02960854|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|please email|Clinical.Trials@bms.com|
311988|NCT02960893|Biohaven Pharmaceuticals|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
311989|NCT02960997|Stanford University|Joyce Teng, MD, PhD|(650) 724-9627|jteng3@stanford.edu|
311990|NCT02961062|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
311991|NCT02961218|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
270268|NCT00117156|Dana-Farber Cancer Institute|Jennifer R. Brown, MD, PhD|(617) 632-3316|Jennifer_Brown@dfci.harvard.edu|
270269|NCT00117286|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
270270|NCT00117312|Clinical Development Support|Ferring Pharmaceuticals||DK0-Disclosure@ferring.com|
302690|NCT02115269|Abbott|Jean-Pascal Berrou, Global Medical Director CNS/Pain|+41614870457|jean-pascal.berrou@abbott.com|
291776|NCT01385202|Biosense Webster, Inc.|Robert Stagg, Manager, Clinical Operations|(800) 729-9010|RStagg@its.jnj.com|8611
291777|NCT01385293|Duke University|Andrew J. Armstrong, MD ScM FACP|919 668 4667|andrew.armstrong@duke.edu|
291778|NCT01385306|electroCore LLC|Clinical Affairs|+1 973 355 6683|clinical@electrocorellc.com|
291779|NCT01385371|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
291780|NCT01385566|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291781|NCT01385579|Northwestern University|Dr. Muriel Jean-Jacques, Assistant professor|312-503-9642|mjean@nmff.org|
291782|NCT01385644|The Prince Chalres Hospital|Assoc Professor Daniel Chambers|+61 7 3139 4000|daniel.chambers@health.qld.gov.au|
291783|NCT01385696|Almirall S.A.|Clinical Project Leader and Trial Manager|+34 93 291 3200||
291784|NCT01385748|Onxeo|Berangere Vasseur, MD|+33 (0)1 45 58 76 00|b.vasseur@onxeo.com|
302691|NCT02115282|ECOG-ACRIN Cancer Research Group|Study Statistician|6176323012|eatrials@jimmy.harvard.edu|
302692|NCT02115308|Cardiovascular Imaging Technologies, LLC|Joseph Soltys, PhD|816-531-2842|jsoltys@cvit.com|103
291785|NCT01385995|Brigham and Women's Hospital|Dr. Susan Redline|857-307-0352|sredline1@rics.bwh.harvard.edu|
302693|NCT02115321|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302694|NCT02115347|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302695|NCT02115373|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
302696|NCT02115386|Novartis Pharmaceuticals|Clinical Disclosure Office|(862) 778-8300|Novartis.email@novartis.com|
302697|NCT02115542|Moffitt Cancer Center|Richard Kim, MD|813-745-1432|Richard.Kim@moffitt.org|
302698|NCT02115581|Children's Medical Center|Giv Heidari-Bateni MD/MPH|3142991984|givhb@yahoo.com|
302699|NCT02115607|Sidney Kimmel Cancer Center at Thomas Jefferson University|Flemming Forsberg, PhD|215-955-4870|flemming.forsberg@jefferson.edu|
311992|NCT02961244|Dokuz Eylul University Medicine Faculty, General Surgery Department|Ali Kadir Degirmenci|+902324122901|alikadir@hotmail.com|
311993|NCT02961374|Cancer Prevention Network (CPN) - Mayo Clinic College of Medicine|Paul J. Limburg, M.D., M.P.H.|507-284-2511|limburg.paul@mayo.edu|
311994|NCT02961751|University of California, Los Angeles|Jeffrey D. Klausner, MD, MPH|310-267-0409|jdklausner@mednet.ucla.edu|
311995|NCT02961764|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
311996|NCT02961790|Mayo Clinic|Charles L. Loprinzi, M.D|507/284-4565|loprinzi.charles@mayo.edu|
311997|NCT02961894|Rex Medical|Colin Valentis|610-629-6051|cvalentis@rexmedical.com|
311998|NCT02961920|Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University|Dr Junju Choi|82324603624|jjchoi2@gilhospital.com|
311999|NCT02961946|Massachusetts General Hospital|Dr. Brian Ghoshhajra|617-726-5954|BGHOSHHAJRA@mgh.harvard.edu|
312000|NCT02962284|Sun Pharma Global FZE|Harin Mehta|97145520096, 912266455645|clinicaltrials@sparcmail.com, harin.mehta@sparcmail.com|
312001|NCT02962427|University of Colorado|Cristina Wood, MD|7208483323|cristina.wood@ucdenver.edu|
312002|NCT02962609|Istanbul University|Duygu Gözen (Associate Professor)|+902124400000|dgozen@istanbul.edu.tr|27082
312003|NCT02962648|Pharmacosmos A/S|Clinical trial disclosure desk|+45 5948 5935|trial@pharmacosmos.com|
312004|NCT02962674|seleon gmbh|Annegret Genger|+49 175 934 91 83|Annegret.Genger@seleon.de|
312005|NCT02962687|Durham VA HSR&D|Susan N Hastings|919-286-6986|susan.hastings@va.gov|
312006|NCT02962739|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
312007|NCT02962765|Octapharma|Sigurd Knaub, Senior VP CR&D Haematology|01554512141|Sigurd.Knaub@octapharma.com|
312008|NCT02962882|Molnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
312009|NCT02962908|PepTcell Ltd (trading as SEEK)|Dr Olga Pleguezuelos, Chief Scientific Officer|+44 020 7153 6601|olga.pleguezuelos@seekacure.com|
312010|NCT02962934|University of Queensland Center for Clinical Research|Professor Jason Roberts|+61 7 334 65032|j.roberts2@uq.edu.au|
312011|NCT02962960|AstraZeneca AB|Global Clinical Lead|301-398-5799|ClinicalTrialTransparency@astrazeneca.com|
312012|NCT02963311|The Medicines Company|Frank Bosley, Vice-President, Regulatory Operaions|9732906016|frank.bosley@themedco.com|
312013|NCT02963376|NuvOx Pharma|Evan Unger, MD|520-624-6688|eunger@nuvoxpharma.com|
312014|NCT02963441|IDx LLC|IDx President, Dr. Michael Abramoff|319-248-5620|info@eyediagnosis.net|
312015|NCT02963506|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
312016|NCT02963597|Albert Einstein Healthcare Network|Dr Sunil Sharma|2154566950|sharmasu@einstein.edu|
312017|NCT02963701|Boehringer Ingelheim|Boehringer Ingelheim Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312018|NCT02963922|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
312019|NCT02963935|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
291786|NCT01386008|Clinical Research Center (CRC) UC Berkeley School of Optometry|Meng Lin, OD, PhD|(510) 642-9731||
291787|NCT01386528|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
291788|NCT01386554|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
291789|NCT01386606|Repros Therapeutics Inc.|Jennifer L. Wike|281-719-3402|jwike@reprosrx.com|
291790|NCT01386632|Sanford Clinical Research|Dr. Steven Powell|605-328-8000|patientquestionsSHDCA@sanfordhealth.org|
291791|NCT01386645|VA Puget Sound Hlthcare System|Kristina Utzschneider|206-277-3568|kutzschn@uw.edu|6-3568
291792|NCT01386788|EKoch|Ernst Koch|++49 6257 1788|Ernst.MW.Koch@t-online.de|
291793|NCT01386944|UCB|UCB Clinical Trial Call Center|++1 877 822 9493||
291794|NCT01386970|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
291795|NCT01386983|GlaxoSmithKline|GSK Response Center|866-435-7343||
302700|NCT02115633|RxFunction, Inc.|Lars Oddsson, PhD|8572340382|loddsson@rxfunction.com|
291796|NCT01387022|CAPRISA|Head of Statistics and Data Management|+27 31 260 4392|nonhlanhla.yende@caprisa.org|
302701|NCT02115646|MGH Wellman Center|Kachiu Lee, MD|4018303128|klee52@partners.org|
302702|NCT02115750|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
302703|NCT02115815|MedImmune, LLC|Judith Falloon, MD|301-398-5000|falloonj@medimmune.com|
302704|NCT02115828|Johns Hopkins University|Emmanuel Antonarakis, MD|410-502-7528|eantona1@jhmi.edu|
302705|NCT02115984|Institute of Cytology and Genetics, Siberian Branch of the Russian Academy of Sciences|Dr. Sergey S. Bogachev|+7-963-946-57-69|labmolbiol@mail.ru|
302706|NCT02116205|WRAIR Clinical Trials Center|Dr. Kristin Mills, Principal Investigator|301-319- 2039|Kristin.t.mills.ctr@mail.mil|
302707|NCT02116309|Johns Hopkins University|Dr. Vikesh Singh|4106146708|vakshin1@jhmi.edu|
302708|NCT02116322|Johns Hopkins Hospital|Dr. Mouen Khashab|443-287-1960|mkhasha1@jhmi.edu|
302709|NCT02116361|Allergan, Inc|Arlene Lum, PMP|714-246-5548|lum_arlene@allergan.com|
312020|NCT02963974|University of North Carolina at Chapel Hill|Lisa Park, AuD, CCC-A|984-215-2871|lisa_park@med.unc.edu|
312021|NCT02963987|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
312022|NCT02964234|University of Illinois at Chicago|Dr. Yamile Molina|312-355-2679|ymolin2@uic.edu|
312023|NCT02964247|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
312024|NCT02964312|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
312025|NCT02964325|Terumo Blood and Cell Technologies|Robert Cortes, Jr. MD|+1.303.231.4353|Robert.Cortes@terumobct.com|
312026|NCT02964338|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
312027|NCT02964416|Aga Khan University|Dr Asma Abdus Salam|+92-21-34864715|asma.salam.azhar@gmail.com|4639
312028|NCT02964767|SinghRK|Dr. Ranjan K Singh|91+9431263911|dr_ranjankumarsingh@yahoo.com|
270271|NCT00117325|GlaxoSmithKline|GSK Response Center|866-435-7343||
291797|NCT01387074|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
302710|NCT02116530|Indiana University School of Medicine South Bend|Rudolph M. Navari, MD, PhD, FACP|574-252-7225|rmnavari@gmail.com|
291798|NCT01387139|Ucolorado|Keith Weisz|303-724-2592|keith.weisz@childrenscolorado.org|
291799|NCT01387178|GlaxoSmithKline|GSK Response Center|866-435-7343||
291800|NCT01387230|GlaxoSmithKline|GSK Response Center|866-435-7343||
291801|NCT01387269|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
291802|NCT01387282|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
291803|NCT01387347|ReGenTree, LLC|Won S. Yang, President & CEO|609-734-4328|wonsyang@regentreellc.com|
291804|NCT01387464|InSite Vision|Senior Manager, Clinical Sciences||manjiri.desai@sparcmail.com|
291805|NCT01387516|University of Rhode Island|Dr. Lynda Stein, Ph.D.|401-874-5562|lynda_stein@uri.edu|
302711|NCT02116582|Astellas Pharma Europe B.V.|Executive Medical Director|+31 (0) 71 5455 050|Astellas.resultsdisclosure@astellas.com|
291806|NCT01387542|Janssen-Cilag Ltd.: 106 Moo 4 Lad Krabang Industrial Estate, Chalongkrung Rd., Lamplatew, Lad Krabang, Bangkok 10520|Medical Affairs Director|+66 2 7397200||5888
291807|NCT01387581|MelaSciences|Mrinalini Roy|800-729-8849|mishti@melasciences.com|
302712|NCT02116608|University of Colorado Denver|Jeremy Prager, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
302713|NCT02116621|University of California, Davis|Richard Kravitz, MD, MSPH|916-734-1248|rlkravitz@ucdavis.edu|
302714|NCT02116660|Merck Sharp & Dohme Corp.|Senior Vice President,Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302715|NCT02116777|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
302716|NCT02116803|Novartis Pharmaceuticals|Study Director|862-778-8300||
302717|NCT02116972|Flexion Therapeutics|Scott Kelley, VP of Medical Affairs|781-305-7142|skelley@flexiontherapeutics.com|
312029|NCT02964910|Shandong Center for Disease Control and Prevention, Jinan, China|Shandong Provincial Key Laboratory of Infectious Disease Control and Prevention|0531-82679606|aqxuepi@163.com|
312030|NCT02965144|Rigshospitalet|Karin Piil|0045612078067|Karin.Piil@regionh.dk|
312031|NCT02965378|SWOG Statistics and Data Management Center|Lung Committee Statistician|2066674623|kmini@fredhutch.org|
312032|NCT02965456|Bausch Health Americas, Inc.|Clinical Operations Director|1-510-259-5284|aloncaric@bauschhealth.com|
312033|NCT02965534|University of Applied Sciences Jena|Philipp Hessler|+4916097089677|philipp@hessler.de|
312034|NCT02965573|argenx BVBA|Regulatory Manager|+32 93103400|regulatory@argenx.com|
312035|NCT02965599|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312036|NCT02965781|Squarex LLC|Hugh McTavish|6512078270|hmctavish@squarex-pharma.com|
312037|NCT02965820|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
312038|NCT02965833|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
312039|NCT02965924|Mayo Clinic|Arthur J. Sit, MD|507-284-2787|Sit.Arthur@mayo.edu|
312040|NCT02965989|Hospital Universitario 12 de Octubre de Madrid|Ph.D. Ignacio Zaragoza-García|913908000|izaragoz@ucm.es|4646
312041|NCT02966002|University of Michigan|Adam Lubert|734-764-5177|luberta@med.umich.edu|
312042|NCT02966015|Clinical operations,Medical Affairs|Head of clinical operations|+45 49113267|dkphl@coloplast.com|
312043|NCT02966028|Sanifit|SVP Clinical Development Operations|18582815976|Claire.Padgett@sanifit.com|
312044|NCT02966275|MGH|Courtney Balliro BS, RN, CDE|617-726-1242|cballiro@partners.org|
312045|NCT02966314|University of Wisconsin - Madison|Ravi Viswanathan|(608) 263-1081|rviswanathan@medicine.wisc.edu|
312046|NCT02966340|UW Madison|John J. Curtin|608-262-0387|jjcurtin@wisc.edu|
312047|NCT02966353|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
312048|NCT02966509|Stanford University and VA Palo Alto Health Care System|Dr. Manali Patel|650-723-4000|manalip@stanford.edu|
312049|NCT02966795|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
312050|NCT02966834|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312051|NCT02967016|Rutgers SUNJ|Dr. Antonio Gonzalez|4133869415|ajantoni@gmail.com|
312052|NCT02967055|University of Colorado Anschutz Medical Campus|Aaron Lazorwitz|3037242019|aaron.lazorwitz@cuanschutz.edu|
312053|NCT02967354|Uppsala University Hospital|Dr Per-Ola Carlsson|+46184714425|per-ola.carlsson@mcb.uu.se|
312054|NCT02967367|CHU Saint-pierre|Pr. Marie Bruyneel|00325354219|marie_bruyneel@stpierre-bru.be|
291808|NCT01387594|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
291809|NCT01387607|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291810|NCT01387672|Womens' College Hospital|Dr. Sophie Jamal|416-351-3732|sophie.jamal@wchospital.ca|2873
291811|NCT01387737|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
291812|NCT01387789|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
291813|NCT01387815|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
291814|NCT01387932|Merit Medical Systems, Inc.|Vicky Brunk RN, Vice President, Medical Affairs, Merit Medical|+1 (717) 873-3309|vicky.brunk@merit.com|
291815|NCT01388166|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291816|NCT01388335|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291817|NCT01388361|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
302718|NCT02117024|Clinical Development|Lori McDermott|919-794-8950|lmcdermott@heatbio.com|
302719|NCT02117193|Federal University of Rio Grande do Sul|Dr Marco Aurélio Vaz|555133085860|marcovaz@esef.ufrgs.br|
302720|NCT02117310|The Ohio State University|Dr. Daniel Prevedello, Associate Professor|(614) 685-1965|daniel.prevedello@osumc.edu|
302721|NCT02117349|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
302722|NCT02117414|Medtronic, Inc|Evera MRI Clinical Research Specialist|800-328-2518|medtronicCRMtrials@medtronic.com|62813
302723|NCT02117427|Aevi Genomic Medicine|Garry A Neil|610-254-4208|garry.neil@aevigenomics.com|
302724|NCT02117479|Incyte Corporation|Study Director|855 463-3463||
302725|NCT02117544|Alcon Research, Ltd|Clinical Project Lead, Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
302726|NCT02117570|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021||
302727|NCT02117648|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
302728|NCT02117687|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
302729|NCT02117713|Mirum Pharmaceuticals|Mirum Clinical Trials|650-667-4085|medinfo@mirumpharma.com|
302730|NCT02117934|Dynavax Technologies, Inc.|Robert Janssen MD \ VP & Chief Medical Officer|510-848-5100||
302731|NCT02117999|Studio Italiano di Oftalmologia|Marco Lombardo|+39 331 34 38 300|mlombardo@visioeng.it|
302732|NCT02118012|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)|Christopher Koh, M.D.|(301) 443-9402|kohchris@mail.nih.gov|
302733|NCT02118337|MedImmune, LLC|Farzana Walcott|+1 301-398-3063|information.center@astrazeneca.com|
302734|NCT02118428|Terumo BCT Biotechnologies, LLC|Ray Goodrich, PhD|(303) 231-4832|ray.goodrich@terumobct.com|
302735|NCT02118441|Department of Anesthesia, St. Paul's Hospital|S. K. W. Schwarz, MD, PhD|604-806-8337|stephan.schwarz@ubc.ca|
302736|NCT02118597|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
302737|NCT02118714|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
302738|NCT02118766|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302739|NCT02118792|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302740|NCT02118831|California Retina Consultants|Director of Research|8059631648|gabe@californiaretina.com|3034
302741|NCT02118896|Astellas Pharma Europe Limited|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
302742|NCT02118961|Mitsubishi Tanabe Pharma Corporation / The Research Foundation for Microbial Diseases of Osaka University|Clinical Trials, Information Desk / Clinical Development counter||cti-inq-ml@ml.mt-pharma.co.jp/clinicaldevelopment@mail.biken.or.jp|
302743|NCT02119026|Medical University Vienna, Internal Med. I, Dep. of Oncology|Werner Scheithauer, MD|+43 1 40400|werner.scheithauer@meduniwien.ac.at|54620
302744|NCT02119104|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302745|NCT02119156|GlaxoSmithKline|GlaxoSmithKline|866-435-7343|GSKClinicalSupportHD@gsk.com|1
302746|NCT02119260|GlaxoSmithKline|GSK Response Center|866-435-7343||
302747|NCT02119286|GlaxoSmithKline|GSK Response Center|866-435-7343||
302748|NCT02119299|Scientific Intake|Richard P. Schneider|917-676-6251|rschneider@scientificintake.com|
312055|NCT02967393|Vanderbilt University Medical Center|Kathryn M. Edwards MD|615-322-8792|kathryn.edwards@vanderbilt.edu|
312056|NCT02967458|Sidney Kimmel Cancer Center at Thomas Jefferson University|Dr. Ethan Halpern|215-955-5345|ethan.halpern@jefferson.edu|
312057|NCT02967510|ITF Research Pharma SLU|Javier Suárez Almarza|+34 916572323|jsuarez@itfsp.com|
312058|NCT02967562|King's College London|Professor Anne Greenough|02032999000|anne.greenough@kcl.ac.uk|
312059|NCT02967679|MedDay Pharmaceuticals|Dr Frédéric SEDEL, Chief Scientific Officer and Co-founder|+33 1 80 40 14 40|frederic.sedel@medday-pharma.com|
312060|NCT02967991|University Hospitals Case Western Reserve|Shaffer Mok|4404065500|Shaffer.Mok@UHHospitals.org|
312061|NCT02968004|OPKO Health Inc|OPKO Health Inc|3055754100|contact@opko.com|
312062|NCT02968134|The University of Queensland|Prof. Jason Roberts|+61 7 3646 4108|j.roberts2@uq.edu.au|
312063|NCT02968173|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
312064|NCT02968277|Rehabilitation Institute of Chicago|Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes|3122386875|ajayaraman@ricres.org|
312065|NCT02968368|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
312066|NCT02968420|Vaccine Evaluation Center|Dr. Manish Sadarangani|604-875-2422|msadarangani@bcchr.ubc.ca|
312067|NCT02968433|Stanford University|Dr. Helen Bronte-Stewart|650-723-6709|hbsmovlab@gmail.com|
312068|NCT02968576|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@ucdenver.edu|
312069|NCT02968758|GenePOC|Dr Keith Chiasson, PhD|418-650-3535|keith.chiasson@genepoc.ca|322
312070|NCT02968914|AstraZeneca Clinical Study Information Center|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
291818|NCT01388478|University of Kansas Medical Center|Jeffrey Burns, M.D., M.S.|913-588-0555|KUAMP@kumc.edu|
291819|NCT01388530|David Geffen School of Medicine at UCLA|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
291820|NCT01388543|"University of Colorado | Skaggs School of Pharmacy and Pharmaceutical Sciences"|Dr. Peter Anderson|3037246128|peter.anderson@cuanschutz.edu|
291821|NCT01388647|Vector Oncology|Vice President of Scientific Affairs|901-435-5550|mwalker@vectoroncology.com|1759
291822|NCT01388777|UT MD Anderson Cancer Center|Hwang, Rosa, M.D.|713-792-7734|CR_Study_Registration@mdanderson.org|
291823|NCT01388790|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
291824|NCT01388816|Proprietary Products, Dr. Reddy's Laboratories, Inc.|Kent Allenby, MD|609-375-9855|kallenby@drreddys.com|
291825|NCT01388907|Sofradim Production COVIDIEN|Patrice BECKER, Global Director, Clinical Affairs|+33 4 74 08 92 38|patrice.becker@covidien.com|
291826|NCT01388946|Aretaieo Hospital University of Athens|Argyro Fassoulaki|+30 6936701333|fassoula@aretaieio.uoa.gr|
302749|NCT02119325|GlaxoSmithKline|GSK Response Center|866-435-7343||
302750|NCT02119442|UCLA|Soraya Sadeghi|3108255950|smsadeghi@mednet.ucla.edu|
302751|NCT02119455|University of Connecticut- Division of Orthodontics|Dr. Flavio Uribe|8606792550|furibe@uchc.edu|
302752|NCT02119468|City of Hope National Medical Center|Dr. Amrita Krishnan|626-256-4673|AKrishnan@coh.org|62405
302753|NCT02119650|Incyte Corporation|Study Director|855 463-3463||
302754|NCT02119663|Incyte Corporation|Study Director|855 463-3463||
302755|NCT02119676|Incyte Corporation|Study Director|855 463-3463||
302756|NCT02119819|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
302757|NCT02119871|Department of Cardiothoracic Surgery, Lund University|Maya Landenhed Smith|+4646173639|maya.landenhed_smith@med.lu.se|
302758|NCT02119936|UNC Chapel Hill|Holly Krohn|919-445-0218|holly_krohn@med.unc.edu|
302759|NCT02120001|Massachusetts General Hospital|Robert Kacmarek, Director Respiratory Care|(617) 726-2000|rkacmarek@mgh.harvard.edu|
302760|NCT02120027|MENARINI Group|Angela Capriati, MD PhD - Corporate Director Clinical Research|+39 055 5680|acapriati@menarini-ricerche.it|9990
312071|NCT02968979|CHUGAI PHARMA FRANCE|Dr Luz BOBADILLA, Medical Affairs Director|+33 1 56 37 05 28|bobadilla@chugai-pharm.fr|
312072|NCT02968992|Johns Hopkins University|Jeremy D. Waltson, MD|410-550-1003|jwalston@jhmi.edu|
312073|NCT02969018|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312074|NCT02969031|Dana-Farber Cancer Institute|Julie Goldman|617-632-5563|Julie_Goldman@dfci.harvard.edu|
312075|NCT02969044|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
312076|NCT02969187|Cleveland Clinic|Dr. Philip R. Schauer|216-444-4794|schauep@ccf.org|
312077|NCT02969317|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312078|NCT02969356|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
312079|NCT02969382|Sunovion Pharmaceuticals, Inc.|CNS Medical Director|1-866-503-6351|CLINICALTRIALDISCLOSURE@SUNOVION.COM|
312080|NCT02969408|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
312081|NCT02969421|Duke University Medical Center|Tashima Lambert, MD|484-201-9332|dr.tlambert@gmail.com|
312082|NCT02969499|University of British Columbia|Dr. Simon Woo|604-520-4662|simon.woo@fraserhealth.ca|
312083|NCT02969525|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
312084|NCT02969590|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
312085|NCT02969655|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312086|NCT02969707|Stanford University|Dr. David Spiegel|650-723-6421|dspiegel@stanford.edu|
312087|NCT02969863|MGH|Courtney Balliro, BS RN CDE|617-726-1242|cballiro@partners.org|
312088|NCT02969876|Massachusetts General Hospital|Dr. Andrew Nierenberg|6175122641|anierenberg@mgh.harvard.edu|
312089|NCT02970006|The Ohio State University- Neurological Institute|Vibhor Krishna, MD|6142939274|Vibhor.Krishna@osumc.edu|
312090|NCT02970032|University of Utah Health|Corinne Bertolaccini, PharmD|801-581-2167|Corinne.Bertolaccini@hsc.utah.edu|
312091|NCT02970162|Catalyst Pharmaceuticals, Inc.|Gary Ingenito|305-420-3200|gingenito@catalystpharma.com|
312092|NCT02970292|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261-2897|medicalinformation@acadia-pharm.com|
312093|NCT02970305|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|+1-858-261|medicalinformation@acadia-pharm.com|2897
312094|NCT02970422|McGill University|Emilie Michalovic, Ph.D. Candidate|514-941-6450|emilie.michalovic@mail.mcgill.ca|
312095|NCT02970552|University of North Carolina at Chapel Hill|Joan Price, MD, MPH|919-962-4717|joni@email.unc.edu|
312096|NCT02970669|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
312097|NCT02970812|Family Medicine Clinic, Pusan National University Yangsan Hospital|Sang Yeoup Lee|3601442|saylee@pnu.edu|55
312098|NCT02970942|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
312099|NCT02971007|Matinas Biopharma|Director Clinical Development|9082953235|jjohnson@matinasbiopharma.com|
312100|NCT02971163|Mount Sinai Medical Center|Dr. Marc A. Probst|212-824-8094|marc.probst@mssm.edu|
312101|NCT02971202|Vanderbilt University Medical Center|Justin M. Gregory MD MSCI|615-875-9669|justin.m.gregory.1@vumc.org|
312102|NCT02971228|Zealand Pharma A/S|Kim Mark Knudsen|+45 5060 3780|KMKnudsen@zealandpharma.com|
312103|NCT02971293|AstraZeneca|Dr Ioannis Psallidas, MD, PhD|1-877-240-9479|Information.centre@astrazeneca.com|
312104|NCT02971488|Hospital Universitario Infanta Leonor|Pablo Ryan|0034616832148|pablo.ryan@salud.madrid.org|
312105|NCT02971605|Johns Hopkins University School of Medicine|Frederick Barrett, Ph.D., Principal Investigator|4105509777|fbarret2@jhmi.edu|
312106|NCT02971631|University of Cambridge|Mr Geoffrey Roberts|01223767176|geoffroberts@cantab.net|
312107|NCT02971670|Biomedizinische Forschungsgesellschaft mbH|Dr. Martha M. Eibl|+43-1-4081091|martha.eibl@meduniwien.ac.at|
291827|NCT01388985|Institute of Tropical Medicine Antwerp|Dr. Patrick Soentjens|+32 3 247 66 41|psoentjens@itg.be|
291828|NCT01389076|University of Michigan Comprehensive Cancer Center|Dr. Mark Kaminski, M.D.|734-936-5310|mkaminsk@umich.edu|
291829|NCT01389102|KV Pharmaceutical Company|Jim Joffrion|314-645-6600|jjoffrion@kvph.com|3410
291830|NCT01389128|University of São Paulo|Dr. Silvana Maria Quintana|+55(16)36022813|quintana@fmrp.usp.br|
291831|NCT01389232|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
291832|NCT01389245|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
302761|NCT02120157|Johns Hopkins University|Heather Symons, MD|410-502-9961|hsymons2@jhmi.edu|
291833|NCT01389258|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
291834|NCT01389284|Bayer HealthCare LLC, Consumer Care|Head Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
291835|NCT01389323|BristolMyers Squibb|BristolMyers Squibb Study Director||Clinical.Trials@bms.com|
302762|NCT02120261|The University of Texas Health Science Center at Houston|Carlos J. Roldan, MD||Carlos.J.Roldan@uth.tmc.edu|
302763|NCT02120287|UPMC Hillman Cancer Center|Barbara Stadterman|412-647-5554|stadtermanbm@upmc.edu|
302764|NCT02120300|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
302765|NCT02120352|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
302766|NCT02120417|Incyte Corporation|Study Director|855 463-3463||
302767|NCT02120443|ivWatch, LLC|Garret T. Bonnema|1.855.489.2824|garret.bonnema@ivwatch.com|7018
302768|NCT02120456|LEO Pharma A/S|Clinical Trial Disclosure Specialist||disclosure@leo-pharma.com|
302769|NCT02120625|Nimbus Concepts, LLC|J. Scott Bainbridge, MD (PI)|303-522-5219|jscottbainbridge@gmail.com|
302770|NCT02120664|Avid Radiopharmaceuticals, Inc.|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
302771|NCT02120716|University of Michigan|Golfo Tzilos, PhD|7349987120|gtzilos@med.umich.edu|
302772|NCT02120781|Castle Creek Biosciences|Head, Research and Development|13128471291|medinfo@castlecreekbio.com|
302773|NCT02120794|Medtronic Minimed|Suiying Huang, Statistician|8184763319|suiying.huang@medtronic.com|
302774|NCT02120833|Johnson & Johnson Consumer and Personal Products Worldwide|Chirstopher Nunez, PhD/Study Director|973-385-7984 USA EST|cnunez1@its.jnj.com|
302775|NCT02120898|Teva Pharmaceuticals Inc. USA|Director, CE Studies|1-888-483-8279|USMedInfo@tevapharm.com|
302776|NCT02120924|Teva Pharmaceuticals USA, Inc.|Director, CE Studies|1-888-483-8279|USMedinfo@tevapharm.com|
302777|NCT02120950|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
302778|NCT02121002|Amneal Pharmaceuticals|Candis Edwards|631-974-7949|cedwards@amneal.com|
302779|NCT02121041|UNC Chapel Hill|Dr. Anthony Viera|984-974-4636|viera@med.unc.edu|
302780|NCT02121067|University of North Carolina|Matthew Zerden, MD, MPH|6179352394|mzerden@gmail.com|
302781|NCT02121210|Sanofi|Trial Transparency Team||Contact-US@sanofi.com|
302782|NCT02121262|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
302783|NCT02121301|Ciurem Pharma Inc|Gosse B. Bruinsma|613-866-9609|gbb@CIUREM.COM|
302784|NCT02121392|University of Chicago Medical Center|Dr. Hue Luu|773-702-6937|hluu@bsd.uchicago.edu|
302785|NCT02121418|University of Washington|Dr. Pamela Becker|206-606-7273|pbecker@u.washington.edu|
302786|NCT02121483|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302787|NCT02121509|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302788|NCT02121522|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302789|NCT02121535|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
302790|NCT02121756|University of Pittsburgh Department of Medicine|Sharon Riddler, MD|412-383-1675|riddler@pitt.edu|
302791|NCT02121795|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230|ClinicalTrialDisclosures@gilead.com|
302792|NCT02121808|Laval University|Jean S. Bussières|418 656-8711|jbuss@criucpq.ulaval.ca|
302793|NCT02121834|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
302794|NCT02121847|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
302795|NCT02121860|Conatus Pharmaceuticals|Jean L. Chan, MD|(858) 376-2632|jchan@conatuspharma.com|
302796|NCT02121912|Fisher and Paykel Healthcare|Clinical Research Scientist|+64 09 574 0123|CPAPtrial@fphcare.co.nz|
302797|NCT02122146|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302798|NCT02122341|USC Intitute of Urology|Dr. Matthew Dunn|323-865-3700|mdunn@med.usc.edu|
302799|NCT02122380|Vanderbilt University Medical Center|Dr. Jessica Devin|970-875-2708|jessica.devin@vumc.org|
302800|NCT02122406|University of Pavia|Vittorio Grosso MD|+393332605945|vittorio.grosso@gmail.com|
302801|NCT02122445|Sport and Spine Rehab Clincal Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
302802|NCT02122471|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
302803|NCT02122549|ZOLL|Vice President of Medical Affairs|412-968-3333|stevens@zoll.com|14400
302804|NCT02122770|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302805|NCT02122783|MossRehab|Mukul Talaty|2156636682|mctalaty@einstein.edu|
302806|NCT02122796|Allina Health|Director of Integrative Health Reseach Center|612-262-2354|jeffery.dusek@allina.com|
302807|NCT02122887|Bar Ilan University|Moran Influs|972-35317943|moran.influs@gmail.com|
302808|NCT02122952|AveXis, Inc.|Doug Feltner, MD|833-828-3947|medinfo@avexis.com|
302809|NCT02123017|Cumberland Pharmaceuticals, Inc.|Amy Rock, PhD|615-255-0068|arock@cumberlandpharma.com|
302810|NCT02123134|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
302811|NCT02123251|University of Hawaii, Center on Disability Studies|Dr. Chuan Chinn|8089565379|chuanc@hawaii.edu|
302812|NCT02123329|Qatar University College of Pharmacy|Dr. Maguy El Hajj|0097444035577|maguyh@qu.edu.qa|
302813|NCT02123446|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291836|NCT01389596|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291837|NCT01389752|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291838|NCT01389765|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291839|NCT01389856|Actelion Pharmaceuticals Ltd|Pegah Nowbakht/Senior Clinical Trial Scientist|+41 61 565 68 41|pegah.nowbakht@actelion.com|
291840|NCT01389882|Seoul National University Hospital|Dr. Juyoung Lee|lamb4122@snu.ac.kr|lamb4122@snu.ac.kr|
291841|NCT01389973|Janssen, R&D, LLC, Spring House, PA|Senior Director, Clinical Development, Immunology||ClinicalTrialDisclosure@its.jnj.com|
291842|NCT01390038|Tornier/Wright Medical|Josh Myers|9529217119|josh.myers@wright.com|
291843|NCT01390064|University of Arkansas for Medical Sciences|Dr. Laura Hutchins|5016868274|hutchinslauraf@uams.edu|
291844|NCT01390077|University of California, San Diego|William Leo Nyhan, M.D., Ph.D.|(619)543-5337|wnyhan@ucsd.edu|
291845|NCT01390220|Proximagen, LLC|David Sequeira|952-658-7438|dsequeira@proximagen.com|
302814|NCT02123459|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
302815|NCT02123472|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
302816|NCT02123485|Department of Affective Disorder, Aarhus University Hospital, Denmark|Dr Poul Erik Buchholtz|21474299|Buchholtz.Hansen@ps.rm.dk|
302817|NCT02123511|Mayo Clinic|Michele Halyard, M.D.; Robert Foote, M.D.|480-301-4567|mhalyard@mayo.edu; foote.robert@mayo.edu|
302818|NCT02123576|The Pennsylvania State University Division of Gastroenterology and Hepatology Milton S. Herhsey Medical Center|Dr. Jonathan G. Stine|717-531-0003|jstine@pennstatehealth.psu.edu|28-9478
302819|NCT02123745|ivWatch, LLC|Garret T. Bonnema|1.855.489.2824|garret.bonnema@ivwatch.com|7018
302820|NCT02123797|Baptist Cancer Center|Dr. Raymond Osarogiagbon|901-752-6131|Raymond.Osarogiagbon@bmg.md|
302821|NCT02123849|University of Arizona|Dr. Sherry Chow|5206263358|schow@azcc.arizona.edu|
302822|NCT02123966|Dana-Farber Cancer Institute|Nathaniel S. Treister, DMD, DMSc|617-632-2806|ntreister@partners.org|
302823|NCT02124018|First Department of Cardiology, School of Medicine, National and Kapodistrian University of Athens|Professor Konstantinos A. Gatzoulis|6944580369|kgatzoul@med.uoa.gr|0030
302824|NCT02124044|NIH Clinical Center|Masur, Henry|+1 301 496 9320|HMasur@cc.nih.gov|
302825|NCT02124083|National Institute of Child Health and Human Development|Porter, Forbes|+1 301 435 4432|fdporter@mail.nih.gov|
302826|NCT02124122|Tulane SPHTM|Richard Oberhelman|5049882511|oberhel@tulane.edu|
302827|NCT02124161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1--800--718--1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302828|NCT02124265|Johns Hopkins University School of Medicine|Carisa Cooney|443-287-4629|ccooney3@jhmi.edu|
302829|NCT02124304|Sport & Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
302830|NCT02124460|Massachusetts General Hospital|Dr. Elsie Taveras|617-726-8555|elsie.taveras@mgh.harard.edu|
302831|NCT02124512|University of Kentucky|Philip Kern|859-323-2232|pake222@uky.edu|
302832|NCT02124564|Cares|UCB|+1844599|UCBCares@ucb.comTokyo|2273
302833|NCT02124603|Casa di Cura Di Stefano|Dr.Marcello Santocono|+393356070002|santocono.m@alice.it|
302834|NCT02124707|UNC Lineberger Comprehensive Cancer Center|Robin Johnson|919-966-1125|robin_v_johnson@med.unc.edu|
302835|NCT02124746|Sierra Oncology, Inc.|Dr. Barbara Klencke|1-604-558-6536|bklencke@sierraoncology.com|
302836|NCT02124759|UTHSC San Antonio|Dr. Nicolas Musi|630-5001|musi@uthscsa.edu|210
302837|NCT02124772|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
302838|NCT02124798|GlaxoSmithKline|GSK Response Center|866-435-7343||
302839|NCT02124811|Emory University|Robert Cotes, MD|(404) 616-4752|robert.o.cotes@emory.edu|
302840|NCT02124863|vrije universiteit brussel|filip van ginderdeuren|+3224763916|filip.vanginderdeuren@telenet.be|
302841|NCT02124889|WakeForest|Dr. Adolfo Fernandez|336-716-6099|afernand@wakehealth.edu|336
302842|NCT02125279|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
312108|NCT02971683|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
312109|NCT02971735|Linkou Chang Gung Memorial Hospital|Dr. Li-Ang Lee|886 33281200|5738@cgmh.org.tw|3972
312110|NCT02971800|CHU de Québec|Dr Philippe Laberge|+1(418)525-4444|philippe.laberge@fmed.ulaval.ca|
312111|NCT02972242|WRNMMC Cardiology|Hampton Crimm|301-295-4500|hampton.a.crimm.mil@mail.mil|
312112|NCT02972359|Grünenthal GmbH|Clinical Trial Helpdesk|+49 241 569|clinical-trials@grunenthal.com|3223
312113|NCT02972502|OhioHealth Research Institute|Chelsea Blessing, PhD|(513) 461-1772|chelsea.blessing@ohiohealth.com|
312114|NCT02972515|University of Arizona|Judith Gordon|520-626-4970|judithg@email.arizona.edu|
312115|NCT02972554|University of North Carolina at Chapel Hill|Dr. Keely A. Muscatell|919-843-9113|kmuscatell@unc.edu|
312116|NCT02972632|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
312117|NCT02972658|AstraZeneca|AstraZeneca Information Center|877-240-9479|information.center@astrazeneca.com|
312118|NCT02973048|Centre Hospitalier Universitaire Saint Pierre|Panayota Kapessidou|+32.2.535|pkapessi@ulb.ac.be|3750
312119|NCT02973087|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
312120|NCT02973100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312121|NCT02973321|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|
312122|NCT02973438|University of Miami|Mark S. Nash, Ph.D.|3052433628|mnash@med.miami.edu|
312123|NCT02973477|University of Michigan|Lynn Ang|734-232-8058|angly@med.umich.edu|
312124|NCT02973503|CHU Clermont-Ferrand|Armand Abergel|+33473750523|aabergel@chu-clermontferrand.fr|
312125|NCT02973516|Guerbet|Jing Hao, MD, Head of Global Medical Affairs and Clinical Development|+33 (0) 1 45 91 50 00|jing.hao@guerbet.com|
302843|NCT02125292|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
302844|NCT02125331|GE Healthcare|Clinical Affairs Project Manager|262-443-7008|stephanie.karwedsky@ge.com|
291846|NCT01390233|University of Arizona (Investigator has changed institutions - study completed at University of South Carolina)|Meg Hill, MBBS|520 626 6174|meghanhill@obgyn.arizona.edu|
291847|NCT01390246|University of Texas Medical Branch|Dr. Tatiana Nanovskaya, PhD|409-772-3908|tnnanovs@utmb.edu|
291848|NCT01390259|University of Virginia|Marc Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
302845|NCT02125604|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
302846|NCT02125721|NYU Langone Health|David Goldfarb|212 263 0744|David.Goldfarb@nyulangone.org|
302847|NCT02125734|Novartis Pharmaceuticals|Study Director|862-778-8300||
302848|NCT02125838|DorkuzEU|Sule Ozbilgin|902324122836|ozbilginsule@gmail.com|
312126|NCT02973802|Apitope International|CEO|+44(0)1291 635511|info@apitope.com|
312127|NCT02974010|NeuroRx|Martin Brecher|+1 484 254 6134|mbrecher@neurorxpharma.com|
312128|NCT02974088|Medical Entomology Centre|Ian Burgess|+44 1223 810070|ian@insectresearch.com|
312129|NCT02974114|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312130|NCT02974140|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
312131|NCT02974153|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
312132|NCT02974296|Columbia University|DR. Marta Moreno-Ortega|9142187311|mm4355@cumc.columbia.edu|
312133|NCT02974543|University of Michigan|Susan Shore, Professor of Otolaryngology|734 647-2116|sushore@umich.edu|
312134|NCT02974634|University of Pennsylvania|Dr. Robert Krouse|215-615-4573|robert.krouse@pennmedicine.upenn.edu|
312135|NCT02974842|nVision Medical|Surbhi Sarna|408 655 3577|surbhi@nvisionmedical.com|
312136|NCT02974855|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312137|NCT02974868|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312138|NCT02975206|Menlo Therapeutics Inc.|Anna Gururajan|(650) 486-1416|agururajan@menlotx.com|
312139|NCT02975297|The University of Texas Health Science Center at Houston|Luba Yammine, PhD, APRN, FNP-C, Associate Professor|(713) 500-2005|Luba.Yammine@uth.tmc.edu|
312140|NCT02975336|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
312141|NCT02975349|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
312142|NCT02975557|Ophthalmology and Visual Sciences, University of Illinois, Chicago, IL|Dr. Sandeep Jain|312-996-4476|jains@uic.edu|
312143|NCT02975700|Daiichi Sankyo, Inc.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
312144|NCT02975804|The Hong Kong Polytechnic University|Dr tamis W Pin|85227666751|tamis.pin@polyu.edu.hk|
312145|NCT02975973|Baylor College of Medicine|Raymond Cho|713-798-7781|Raymond.Cho@bcm.edu|
312146|NCT02976103|Dana-Farber Cancer Institute|Donna Berry, PhD, RN|617-632-1909|donna_berry@dfci.harvard.edu|
312147|NCT02976181|Medtronic|Carina Leone, Latam CVG Trial Leader|+5411 5789 8521|carina.leone@medtronic.com|
312148|NCT02976519|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312149|NCT02977507|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
312150|NCT02977572|INTENSIVE CARE UNIT. HOSPITAL GENERAL UNIVERSITARI CASTELLO|Dr. Alberto Belenguer Muncharaz|0034-964-725000|belengueralberto8@gmail.com|
312151|NCT02978157|Kaohsiung Veterans General Hospital|Dr. Ping-I Hsu|+886-7-3422121|pihsu@vghks.gov.tw|8233
312152|NCT02978183|Noveome Biotherapeutics, Inc|David Steed, MD|4124029913|dsteed@noveome.com|
312153|NCT02978339|Mayo Clinic|John E. Eaton, M.D.|507-284-3917|Eaton.John@mayo.edu|
312154|NCT02978417|Duke University|Michele Easter, Ph.D.|919-385-0862|michele.easter@duke.edu|
291849|NCT01390272|Durham VA Medical Center, Durham, NC|Dr. George Lee Jackson, PhD MHA|919-286-0411|George.Jackson3@va.gov|7091
291850|NCT01390298|Wake Forest School of Medicine|James C. Eisenach, M.D.|336-716-4498|jimeisenach@gmail.com|
291851|NCT01390389|McLean Hospital|Cara McCabe|617-855-2410|cfmccabe@partners.org|
291852|NCT01390402|University of Texas (UT) MD Anderson Cancer Center|Richard E. Champlin, MD/Chair, Stem Cell Transplantation||CR_Study_Registration@mdanderson.org|
291853|NCT01390428|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291854|NCT01390441|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291855|NCT01390584|ECOG-ACRIN Biostatistics Center|Study Statistician|617-632-3012|eatrials@jimmy.harvard.edu|
291856|NCT01390649|CSL Behring|Clinical Trial Disclosure Manager|Use email contact|clinicaltrials@cslbehring.com|
302849|NCT02125877|Novartis|Study Director|862-778-8300||
302850|NCT02126306|HMO|Dr Gadi Lalazar|97226777337|lalazar@hadassah.org.il|
302851|NCT02126319|Fox Chase Cancer Center|Dr. Suzanne M. Miller|215 728-4069|Suzanne.Miller@fccc.edu|
302852|NCT02126670|Promius Pharma, LLC|Director of Clinical Operations|609-282-1476|kgulbronson@promiuspharma.com|
302853|NCT02126748|Vrije Universiteit Brussel|Filip Van Ginderdeuren|+3224763916|filip.vanginderdeuren@uzbrussel.be|
302854|NCT02126826|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302855|NCT02126839|Teva Branded Pharmaceutical Products, R&D Inc|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
302856|NCT02126969|University of Kentucky|Dr. Susanne Arnold|8592579568|smarno0@uky.edu|
302857|NCT02127125|San Antonio Geriatric Research, Education, and Clinical Center|Dr. Nicolas Musi|(210) 562-6140|musi@uthscsa.edu|
302858|NCT02127281|Cleveland Clinic|Alison K. Klika, MS, Research Manager, Department of Orthopaedic Surgery|(216) 444-4954|klikaa@ccf.org|
302859|NCT02127307|GE Healthcare|Jose M Zubeldia, M.D.|011-44-1494-5431347|jose.zubeldia@ge.com|
302860|NCT02127372|Duke University Medical Center|Gordana Vlahovic, MD|919-681-4047|Gordana.vlahovic@dm.duke.edu|
302861|NCT02127567|Assistance publique hopitaux de paris|Isabelle Boutron|+33 1 42 34 78 33|isabelle.boutron@htd.aphp.fr|
302862|NCT02127632|DorkuzEU|Anaesthesiology and Reanimation|90.505.525.29.01|ozbilginsule@gmail.com|
302863|NCT02127710|AstraZeneca|Senior Medical Director, Savolitinib||ClinicalTrialTransparency@astrazeneca.com|
302864|NCT02127723|Q-Med AB|Q-Med AB|+46 18 474 9000|medicalinfo.q-med@alderma.com|
302865|NCT02127892|Children's Hospital Los Angeles|Neena Kapoor, M.D.|323-361-2546|nkapoor@chla.usc.edu|
302866|NCT02127931|CogCubed|Monika Roots, MD|6122509737|monika.d.heller@gmail.com|
302867|NCT02127970|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
302868|NCT02128074|Keryx Biopharmaceuticals, Inc|Keryx Medical Information|1-844-44-KERYX (844-445-3799)|medicalinfo@keryx.com|
312155|NCT02978508|Mayne Pharma LLC|Associate Director, Clinical Operations|919 573 7948|phoevos.hughes@maynepharma.com|
312156|NCT02979054|Laboratoires Théa|Clinical Development Director|+33(0)473981414|Corentin.LECAMUS@theapharma.com|
312157|NCT02979197|Kitov Pharma Ltd.|J. Paul Waymack, M.D., Chief Medical Officer|(202) 965-2215|paul@kitovpharma.com|
312158|NCT02979249|Icahn School of Medicine at Mount Sinai|Dr. Hetanshi Naik|212-659-8512|hetanshi.naik@mssm.edu|
312159|NCT02979262|Yale University Child Study Center|Dr. Carla Stover|2037853486|carla.stover@yale.edu|
312160|NCT02979301|Mayo Clinic|Dr. Carrie Hruska|507-293-4719|hruska.carrie@mayo.edu|
312161|NCT02979431|Ablynx NV|Medical Monitor|+32 (0)9262 00 00|clinicaltrials@ablynx.com|
291857|NCT01390779|UCSD|Mona Moshtaghi|858 534-6290|momoshta@ucsd.edu|
291858|NCT01390818|Merck Serono, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+496151725200|service@merckgroup.com|
291859|NCT01390844|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
291860|NCT01390857|GlaxoSmithKline|GSK Response Center|866-435-7343||
291861|NCT01390870|GlaxoSmithKline|GSK Response Center|866-435-7343||
291862|NCT01390909|GlaxoSmithKline|GSK Response Center|866-435-7343||
291863|NCT01390948|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
291864|NCT01391000|Istituto Ortopedico Rizzoli|Dr Roberta Monesi|0516366694|cristiana.forni@ior.it|0039
291865|NCT01391013|Jan-Cil Italy|Therapeutic Area Medical Manager|39 02 2510589||
302869|NCT02128217|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
302870|NCT02128230|University of Arkansas for Medical Sciences|Frits Van Rhee, MD|501-526-2873|vanrheefrits@uams.edu|
302871|NCT02128269|Alexion|Alexion Medical Monitor|617-613-1071|Bert.Yao@alexion.com|
302872|NCT02128490|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302873|NCT02128542|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
302874|NCT02128724|University of Oxford|Stasya Ng|+441865 617083|octo-BKM120@oncology.ox.ac.uk|
302875|NCT02128763|University of Pennsylvania|Maureen G. Maguire, PhD|215-615-1501|maguirem@pennmedicine.upenn.edu|
302876|NCT02128828|University of Hawaii|Dr. Cecilia Shikuma|808 692-1328|shikuma@hawaii.edu|
302877|NCT02128867|vrije universiteit brussel|filip van ginderdeuren|+3224763916|filip.vanginderdeuren@uzbrussel.be|
302878|NCT02128919|Nathan Kline institute for Psycghatric Research|Robert C Smith MD|845-398-6531|rsmiith@nki.rfmh.org|
302879|NCT02128932|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
302880|NCT02128997|UPENN|Valerie Riis|2154989099|valerie.armendariz@uphs.upenn.edu|215
302881|NCT02129062|UT MD Anderson Cancer Center|Jan Burger, MD/ UT MD Anderson Associate Professor, Leukemia|713-794-4329|CR_Study_Registration@mdanderson.org|
302882|NCT02129075|Fred Hutchinson Cancer Research Center|Dr. Martin A. Cheever|206-667-4141|mcheever@fredhutch.org|
302883|NCT02129192|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302884|NCT02129205|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302885|NCT02129348|New York State Psychiatric Institute|Davangere Devanand, MD|646.774.8656|dpd3@cumc.columbia.edu|
302886|NCT02129426|University of Louisville|John W. Berkenbosch|502-852-3720|john.berkenbosch@louisville.edu|
302887|NCT02129478|The Hospital for Sick Children|Dr. Laura Lee Dupuis|416-813-7654|lee.dupuis@sickkids.ca|309355
302888|NCT02129556|International Breast Cancer Study Group (IBCSG)|Heidi Roschitzki-Voser|+41 31 511 94 18|heidi.roschitzki@ibcsg.org|
302889|NCT02129608|Mayo Clinic|Ivana Croghan|507-266-1944|domcro@mayo.edu|
302890|NCT02129660|Dermira, Inc.|Eugene A. Bauer, MD, Chief Medical Officer|650-421-7202|eugene.bauer@dermira.com|
302891|NCT02129725|Vanderbilt University Medical Center|Nancy J. Brown, M.D.|615-343-8701|nancy.j.brown@vanderbilt.edu|
302892|NCT02129777|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302893|NCT02129803|Virginia Commonwealth University|Bruce K. Rubin MEngr, MD, MBA, FRCPC|804 828 9604|bruce.rubin@vcuhealth.org|
302894|NCT02130024|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
302895|NCT02130063|Pharmacosmos|Chief Medical Officer|+45 5948 5959|llt@pharmacosmos.com|
302896|NCT02130193|GlaxoSmithKline|GSK Response Center|866-435-7343||
302897|NCT02130258|Massachusetts General Hospital|Dr. Yi Zhang|617-724-6102|yzhang20@partners.org|
302898|NCT02130284|Medtronic Minimed|Suiying Huang, Statistician|818-576-3319|suiying.huang@medtronic.com|
302899|NCT02130297|Icahn School of Medicine at Mount Sinai|Dr. Hooman Khorasani|347-574-8500|hooman.khorasani@mountsinai.org|
302900|NCT02130427|University of Pennsylvania|Dr. Wei Zou|800-789-7366|Wei.Zou@pennmedicine.upenn.edu|
302901|NCT02130557|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
302902|NCT02130570|Brigham and Women's Hospital|Dr. Jeffrey L Schnipper, MD, MPH, FHM|617-732-7063|jschnipper@partners.org|
302903|NCT02130583|Alpert Brown Medical School|Shirley Yen, Ph.D., Principal Investigator|4014441915|Shirley_Yen_PhD@Brown.edu|
302904|NCT02130635|GlaxoSmithKline|GSK Response Center|866-435-7343||
302905|NCT02130687|Yale University|Nancy J. Brown, M.D.|16153644022|nancy.j.brown@yale.edu|
302906|NCT02130765|Abbott|Senior Clinical Research Scientist|6517562885|amber.miller@abbott.com|
302907|NCT02130986|University of Pittsburgh|David T Huang, MD, MPH, Associate Professor|412-647-6818|huangdt@upmc.edu|
302908|NCT02130999|Vince and Associates Clinical Research|Melodie Armstrong, MD, MPH|913-696-1601||
302909|NCT02131064|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
302910|NCT02131129|IndianaU|Dr. Michael Francis|317-880-8495|mmfranci@iupui.edu|
302911|NCT02131233|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302912|NCT02131259|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302913|NCT02131272|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
302914|NCT02131311|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
302915|NCT02131324|Dr. Reddy's Lab, Inc|Srinivas Sidgiddi, MD|609-375-9900|srinivassidgiddi@drreddys.com|
302916|NCT02131402|Optics Department, University of Valencia 46100 Valencia, Spain|Dr. Robert Montés-Mico O.D., MPhil, PhD|34-9635-44764|robert.montes@uv.es|
302917|NCT02131532|University of Edinburgh|Dr Simiao Wu|0044-131-242-6371|simiao.wu@ed.ac.uk|26371
302918|NCT02131636|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
302919|NCT02131662|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
291866|NCT01391130|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
291867|NCT01391273|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
291868|NCT01391286|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
291869|NCT01391299|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
291870|NCT01391312|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
291871|NCT01391325|Ardea Biosciences, Inc.|Vice President, Clinical Research and Development|858.652.6587|sbaumgartner@ardeabio.com|
291872|NCT01391364|Bausch Health|Study Director||robert.steffen@bausch.com|
291873|NCT01391468|China Medical University|II-Kuan Wang|88975681050|ikwang@seed.net.tw|
291874|NCT01391507|Janssen Research & Development, LLC|Associate Director Biostatistics||ClinicalTrialDisclosure@its.jnj.com|
291875|NCT01391546|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302920|NCT02131766|UVA|Sue Brown, MD|434-982-0602|sab2f@virginia.edu|
302921|NCT02132117|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
302922|NCT02132130|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
302923|NCT02132169|Nicox Ophthalmics Inc.|Michael V.W. Bergamini, PhD - Chief Scientific Officer/Executive Vice President|817-529-9315|bergamini@nicox.com|
302924|NCT02132195|Emory University|Dr. Greenbaum|404-712-6374|LGREEN6@emory.edu|
302925|NCT02132247|IBSA Pharma Inc.|Christopher Jones, Ph.D.|(202) 753-6475|chris.jones@ibsapharma.com|7005
302926|NCT02132312|Omeros Corporation|Omeros Clinical Trial Information|ctinfo@omeros.com|ctinfo@omeros.com|
302927|NCT02132468|Mateon Therapeutics|Clinical Operations|6506357000|ca@mateon.com|
302928|NCT02132520|University of Minnesota|Bin He|612-626-1115|binhe@umn.edu|
302929|NCT02132533|UT Southwestern Medical Center|Chet Edward Wells, MD|214-648-2316|dawn.wilson@utsouthwestern.edu|
302930|NCT02132572|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
302931|NCT02132598|UPMC Hillman Cancer Center|Barbara Stadterman, MPH MCCR|412-647-5554|stadtermanbm@upmc.edu|
302932|NCT02132637|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
302933|NCT02132650|Malcom Randall VA Medical Center|Dr. David Clark|352-376-1611|davidclark@ufl.edu|105244
302934|NCT02132676|VA Ann Arbor Healthcare System Center for Clinical Management & Research|Dr. Michele Heisler|734-845-3502|mheisler@umich.edu|
302935|NCT02132754|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302936|NCT02132767|Icahn School of Medicine at Mount Sinai|Annetine C. Gelijns, PhD|212-659-9568|annetine.gelijns@mssm.edu|
302937|NCT02132832|The University of Texas Health Science Center at Houston|Scott D. Lane, PhD|(713) 486-2535|Scott.D.Lane@uth.tmc.edu|
302938|NCT02132910|DVCIPM|Chester Buckenmaier|301-816-4710|cbuckenmaier@dvcipm.org|
302939|NCT02132936|LEO Pharma A/S|Clinical Trial Disclosure Manager|+45 44945888|ctr.disclosure@leo-pharma.com|
302940|NCT02132949|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
302941|NCT02133001|Janssen Research & Development, LLC|Senior Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
302942|NCT02133066|Children's Hospital of Philadelphia|Aaron Chen|2674260383|chena2@email.chop.edu|
302943|NCT02133131|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialDisclosure@merck.com|
302944|NCT02133235|NTUH|YJ Cheng|886-2-23123456|chengyj@ntu.edu.tw|62158
302945|NCT02133352|Boston University|Kimberly Finch|617-638-4475|kimtobin@bu.edu|
302946|NCT02133508|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
302947|NCT02133664|Oregon Health & Science University|Lynne Shinto, ND, MPH|503-494-5035|shintol@ohsu.edu|
312162|NCT02979444|Northwestern University Feinberg School of Medicine|Darius Tandon, PhD|410-852-0399|dtandon@northwestern.edu|
312163|NCT02979522|Millennium Pharmaceuticals, Inc.|Study Director|+1-877-825-3327|trialdisclosures@takeda.com|
312164|NCT02979535|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
312165|NCT02979613|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
312166|NCT02979626|University of Colorado Denver|Dr. Suchitra Rao|7207771234|suchitra.rao@childrenscolorado.org|
312167|NCT02979639|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312168|NCT02979899|TRACON Pharmaceuticals Inc|Charles Theuer, Medical Monitor|8585500780|ctheuer@traconpharma.com|
312169|NCT02979925|VA San Diego Healthcare System|Albert Leung, MD|858-552-8585|albert.leung@va.gov|3866
312170|NCT02980042|University of Colorado Anschutz, Neurology Department|Dr. Timothy Vollmer|3037242187|timothy.vollmer@ucdenver.edu|
312171|NCT02980107|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
312172|NCT02980133|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
312173|NCT02980211|University of Iowa College of Dentistry|Dr. Gustavo Avila-Ortiz, Professor and Chair, Department of Periodontics|3193357241|gustavo-avila@uiowa.edu|
312174|NCT02980224|Brace Consulting Group Inc.|Jeremy Brace, President|7274582823|jbrace@braceconsultinggroup.com|
312175|NCT02980523|Laboratorios Sophia|Clinical pharmacologist|+52 (33) 3001 4200|ricardo.llamas@sophia.com.mx|1259
312176|NCT02980601|Wake Forest Baptist Health|Joseph Molnar|336-716-4171|jmolnar@wakehealth.edu|
312177|NCT02980692|Sun Pharma Advanced Research Company Limited|Head-Clinical Development|912266455645|clinical.trials@sparcmail.com|
312178|NCT02980705|Sun Pharma Advanced Research Company Limited|Dr Mudgal Kothekar|912266455645|clinical.trials@sparcmail.com|
312179|NCT02980783|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
312180|NCT02980874|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
312181|NCT02980978|Minneapolis Heart Institute Foundation|Population Health Program Manager|612-863-4222|gbenson@mhif.org|
291876|NCT01391559|Dartmouth-Hitchcock|Donald A. Mahler, M.D.|603 650-5533|Donald.a.mahler@hitchcock.org|
291877|NCT01391611|Stanford University Medical Center|Kristen Ganjoo, MD|650-725-6413|kganjoo@stanford.edu|
291878|NCT01391663|Takeda Global Research and Development Center, Inc.|Sr. VP, Clinical Science|800-778-2860|clinicaltrialregistry@tpna.com|
291879|NCT01391793|UPMC Children's Hospital of Pittsburgh|Nader Shaikh, MD, MPH|412-692-8111|nader.shaikh@chp.edu|
291880|NCT01391819|GlaxoSmithKline|GSK Response Center|866-435-7343||
291881|NCT01391832|University of Texas at Dallas|Dr. John Hart, Jr.|972-883-4853|jill.ritter@utdallas.edu|
291882|NCT01391858|UTexas Southwestern Medical Center|Babatunde Ogunnaike|(214) 590|Babatunde.Ogunnaike@UTSouthwestern.edu|8536
291883|NCT01392053|Universidade de São Paulo|Prof Silvana Quintana|55 16 3602-2813|quintana@fmrp.usp.br|
291884|NCT01392183|UT MD Anderson Cancer Center|Amado J. .Zurita-Saavedra, MD/ Associate Professor, Genitourinary Medical Oncology|713- 563-6966|azurita@mdanderson.org|
291885|NCT01392300|Merz Pharmaceuticals GmbH|Public Disclosure Manager|+49 69 1503 1|clinicaltrials@merz.de|
302948|NCT02133742|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312182|NCT02981342|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312183|NCT02981368|Lantheus Medical Imaging / Progenics Pharmaceuticals|David Myl|914-582-1120|david.myl@lantheus.com|
312184|NCT02981524|Sidney Kimmel Cancer Center at Johns Hopkins|Nilofer Azad, MD|410-614-9169|nazad2@jhmi.edu|
312185|NCT02981602|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312186|NCT02981953|Edwards Lifesciences|Ted Feldman|949-250-2500|Feldman_Info@edwards.com|
312187|NCT02982018|Johnson & Johnson Vision|John Buch- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1707|JBUCH@its.jnj.com|
312188|NCT02982187|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312189|NCT02982213|Northwestern University|Feyce Peralta, MD|312-472-3585|feyce.peralta@northwestern.edu|
312190|NCT02982239|Sleep and Health Research Program - University of Arizona|Dr. Michael Grandner|5206260105|grandner@psychiatry.arizona.edu|
312191|NCT02982590|HOSPITAL UNIVERSITI SAINS MALAYSIA|DR W YUS HANIFF W ISA|09-767 3000|wyhaniff@usm.my|
312192|NCT02982772|Florida International University|Maria Jose Miguez|561-839-0223|mjmiguez@fiu.edu|
312193|NCT02982863|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312194|NCT02982928|Nationwide Children's Hospital|Ahsan Syed, MD|614-722-4200|Ahsan.Syed@nationwidechildrens.org|
312195|NCT02982954|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email|Clinical.Trials@bms.com|
312196|NCT02983058|New York State Psychiatric Institute|Marlene Carlson, MPH|646-774-8436|marlene.carlson@nyspi.columbia.edu|
312197|NCT02983227|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
312198|NCT02983305|University of Michigan|Sara|734-936-7567|weisssar@umich.edu|
312199|NCT02983448|University of Oklahoma Health Sciences Center|Dr. Stavros Stavrakis|405-271-4742|stavros-stavrakis@ouhsc.edu|37507
312200|NCT02983552|Jaeb Center for Health Research|Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center|813-975-8690|rkraker@jaeb.org|
312201|NCT02983604|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
312202|NCT02983825|University of Pennsylvania|Nicolas Bamat, MD MSCE|2155904010|bamatn@email.chop.edu|
312203|NCT02983877|Case Western Reserve University|Dr. Jennifer Levin|2168445057|jennifer.levin@uhhospitals.org|
312204|NCT02983981|Psoriasis Treatment Center of Central New Jersey|Jerry Bagel Director of Clinical Trials|6094434500|dreamacres1@aol.com|
312205|NCT02984267|Arizona Anesthesia Consultants|Dr. Thomas Vernon|480-570-7082|tvernon@azanesthesia.net|
312206|NCT02984644|University of Texas Health Science Center at San Antonio|Dr. Eugenio Cersosimo|210-358-7200|cersosimo@uthscsa.edu|
312207|NCT02984683|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|option 6
312208|NCT02984709|Vanderbilt University Medical Center|Sarah Jaser|615-343-6775|sarah.jaser@vanderblit.edu|
312209|NCT02984878|Prollenium Medical Technologies, Inc.|Ario Khoshbin, President|866-353-3015||
312210|NCT02984943|David Grant Medical Center, Travis Air Force Base|Dr. Michelle Sit|707-423-3875|michelle.t.sit.mil@mail.mil|
312211|NCT02984982|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
312212|NCT02984995|Daiichi Sankyo Co., Ltd.|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
312213|NCT02985021|VA Puget Sound HCS|Dr. Bruce Montgomery, PI|2062776878|rbmontgo@uw.edu|
312214|NCT02985398|H. Lundbeck A/S|Email contact via|+4536301311|LundbeckClinicalTrials@Lundbeck.com|
312215|NCT02985450|Carla Coffin|Dr.|403-220-7808|cscoffin@ucalgary.ca|
312216|NCT02985710|Massachusetts General Hospital|PI|6177260580|akaraa@mgh.harvard.edu|
312217|NCT02985827|Ora|Senior Director of Research and Development|9786858900|klane@oraclinical.com|
312218|NCT02985879|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
312219|NCT02985996|Emory University|Dr. Colleen Kelley|404-712-1823|colleen.kelley@emory.edu|
312220|NCT02986074|Abbott|Yagna Pathak|+1-469-243-0088|yagna.pathak@abbott.com|
312221|NCT02986139|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
312222|NCT02986282|Warsaw Medical University|Dr Jacek Lewandowski|5992828|jlewandowski@wum.edu.pl|+48 22
312223|NCT02986373|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
312224|NCT02986711|Penn State University College of Medicine|Jessica Yingst|7175310003|jmy5048@psu.edu|289511
312225|NCT02986802|Kaiser Permanente Division of Research|De-Kun Li, MD, PhD|510.891.3755|De-Kun.Li@kp.org|
312226|NCT02986854|GlaxoSmithKline|GSK Response Center|866-435-7343|mb116236@gsk.com|
312227|NCT02986958|Johns Hopkins Bloomberg School of Public Health|Research Program Manager|410-614-7910|dechava1@jhu.edu|
312228|NCT02987205|Prollenium Medical Technologies, Inc.|Ario Khoshbin, President|866-353-3015||
312229|NCT02987231|Institute of Science and Technology of São José dos Campos (Unesp)|Dr. Mauro P. Santamaria|+55 (16) 981937777|mauro.santamaria@unesp.br|
291886|NCT01392326|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
291887|NCT01392378|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291888|NCT01392443|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
291889|NCT01392469|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
291890|NCT01392495|Novartis Pharmaceuticals|Study Director|862-778-8300||
291891|NCT01392547|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
291892|NCT01392560|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291893|NCT01392573|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
291894|NCT01392625|ISCI / University of Miami Miller School of Medicine|Joshua M. Hare, MD|305-243-5579|JHare@med.miami.edu|
291895|NCT01392677|AstraZeneca|Eva Johnsson||ClinicalTrialTransparency@astrazeneca.com|
302949|NCT02133781|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
302950|NCT02134015|Daiichi Sankyo, Inc.|Global Clinical Leader|9089926400|DataSharing@dsi.com|
302951|NCT02134028|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
302952|NCT02134119|University of Georgia|Jamie Cooper|7065424903|jamie.cooper@uga.edu|
302953|NCT02134184|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
302954|NCT02134210|Coherus BioSciences, Inc|Barbara K. Finck, MD Chief Medical Officer|650-649-3529|Bfinck@coherus.com|
302955|NCT02134314|Cedars-Sinai Medical Center|Noriko Ammerman, PharmD|310-248-8186|noriko.ammerman@cshs.org|
302956|NCT02134353|Pharmaxis|Dr Brett Charlton|+61 2 9454 7200|Brett.Charlton@pharmaxis.com.au|210
302957|NCT02134522|Yale University|Nicola Santoro|2037376356|nicola.santoro@yale.edu|
302958|NCT02134587|School of Pharmaceutical Scientes of Universidade Estadual Paulista Júlio de Mesquita Filho, Araraquara, SP (Brazil)|Fabiana Rossi Varallo|5516997629496|varallo.f.r@gmail.com|
302959|NCT02134756|University of South Florida|Marcus Kilpatrick|(813) 362-6696|mkilpatrick@usf.edu|
302960|NCT02134951|New York State Psychiatric Institute|Marlene Carlson|646-774-8436|mc157@columbia.edu|
302961|NCT02134977|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302962|NCT02135016|First Hospital of CMU|Dr. Jun Wang|8602483283100|wjun2000@hotmail.com|
302963|NCT02135094|Pain Management Associates|Dr. Ralph Ortiz|(607) 844-9979|rodoc@cnymail.com|
302964|NCT02135107|Eisai Co., Ltd. and EA Pharma Co., Ltd.|Public Relations Group (EA Pharma Co., Ltd.)|+81-(0)3-6280-9600|contact_ea@eapharma.co.jp|
302965|NCT02135146|University of Colorado|Nick Naughton, Professional Research Assistant|3037200833|nick.naughton@cuanschutz.edu|
302966|NCT02135432|University of Alabama at Birmingham|Steven M. Rowe|205-975-6385|smrowe@uab.edu|
302967|NCT02135445|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
302968|NCT02135614|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
302969|NCT02135653|University of Pennsylvania|Dr. Neha Vapiwala|(215) 662-2337|Neha.Vapiwala@pennmedicine.upenn.edu|
302970|NCT02135692|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
302971|NCT02135848|GlaxoSmithKline|GSK Response Center|866-435-7343||
302972|NCT02135861|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
302973|NCT02135900|Staten Island University Hospital|Michel Chalhoub, MD|7182269000|chalhoubmichel@gmail.com|
302974|NCT02136004|Weill Cornell Medical College|S. Chiu Wong, MD|212-746-4644|scwong@med.cornell.edu|
302975|NCT02136238|University of South Florida|Jason Highsmith|813-974-3806|mhighsmi@health.usf.edu|
302976|NCT02136420|Massachusetts Eye and Ear Infirmary|Faisal Karmali|617-573-5593|faisal_karmali@meei.harvard.edu|
312230|NCT02987374|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
312231|NCT02987543|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
312232|NCT02987621|Colorado State University|Manager of Research Operations|9704912242|Laurie.Biela@colostate.edu|
312233|NCT02987660|Alcon, A Novartis Division|Sr. Global Brand Medical Affairs Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
312234|NCT02987829|Tracon Pharmaceuticals Inc.|Charles Theuer, MD PhD|8585500780|ctheuer@traconpharma.com|
312235|NCT02987868|Pennington Biomedical Research Center|Dr. Frank Greenway, Chief of Outpatient Clinic|225-763-2578|Frank.Greenway@pbrc.edu|
312236|NCT02987959|Fox Chase Cancer Center|Protocol Developer|215-214-1439|manisha.saini@fccc.edu|
312237|NCT02987972|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
312238|NCT02988050|Menoufia University|Professor Ezzeldin Ibrahim, Professor of Anaesthesia|00201006303178|ezzeldin7@yahoo.com|
312239|NCT02988115|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
312240|NCT02988193|Optima Integrated Health|Gabriela Voskerician|6502233588|gxv4@case.edu|
312241|NCT02988219|Warsaw Medical University|Dr. Karolina Dobronska|48 22 502 17 21|karolinapladzyk@gmail.com|
312242|NCT02988349|Sichuan University|Dr. Xin Xu|86-28-85503494|xin.xu@scu.edu.cn|
312243|NCT02988622|Univeristy of Iowa, Hospitals and Clinics|Dr. Marta VanBeek|(319) 384-6012|marta-vanbeek@uiowa.edu|
312244|NCT02988843|Masonic Cancer Center, University of Minnesota|Dr. Shilpa Gupta|612 624 0123|guptash@umn.edu|
312245|NCT02988856|Massachusetts Eye and Ear|Kevin Houston|617-573-4177|kevin_houston@meei.harvard.edu|
312246|NCT02988882|Ocular Therapeutix|Jamie L. Metzinger, Medical Affairs|781-357-4000|jmetzinger@ocutx.com|
291896|NCT01392703|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
302977|NCT02136498|Group Health Research Institute|Principle Investigator|206-287-2737|mcclure.j@ghc.org|
302978|NCT02136576|Tufts University School of Dental Medicine|Dr. Britta Magnuson|617-636-3878|britta.magnuson@tufts.edu|
291897|NCT01392742|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
291898|NCT01392859|Children's Mercy Hospital|Dr. Bridgette Jones|816-302-3811|bljones@cmh.edu|
291899|NCT01392963|Seton Family of Hospitals|Katherine Sebastian|512-324-9999|krsebastian@seton.org|89612
291900|NCT01392989|Stanford University|Everett Meyer, Assistant Professor of Medicine (Blood and Marrow Transplantation)|650) 725-5816|evmeyer@stanford.edu|
291901|NCT01393106|Gilead Sciences|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
291902|NCT01393132|Wayne State Univeristy, Detroit, MI|Gabriel Sosne, MD|248-594-6702|gsosne@med.wayne.edu|
291903|NCT01393158|Oregon Health & Science University|Dr. Eric Simpson,|503-494-2121|simpsone@ohsu.edu|
291904|NCT01393301|Massachusetts General Hospital|Dr. Conall O'Cleirigh, PI|(617) 643-0385|cocleirigh@mgh.harvard.edu|
291905|NCT01393392|Rutgers Robert Wood Johnson Medical School|Dr. Nina Cooperman|732-235-8569|cooperna@rwjms.rutgers.edu|
302979|NCT02136680|University of Maryland Baltimore, School of Medicine|Dr. Carla Alexander|410-328-7129|calexand@medicine.umaryland.edu|
302980|NCT02136810|Yale School of Medicine|Dr. Robert Schonberger, PI|203-785-2802|robert.schonberger@yale.edu|
302981|NCT02136914|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
302982|NCT02137226|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302983|NCT02137369|Emory University|Dr. Dunlop|404-727-8969|bdunlop@emory.edu|
302984|NCT02137382|Abbott|Suntje Sander - Struckmeier|+49 (0) 511 6750 3254|suntje.sander-struckmeier@abbott.com|
302985|NCT02137447|Massachusetts General Hospital|Dr. Daniel Dante Yeh, Assistant Professor of Surgery|6177248604|dyeh2@partners.org|
302986|NCT02137486|cardiovascular section|taipei city hospital Ren-Ai branch|0088627093600|chenyuehchung.tw@yahoo.com.tw|3741
302987|NCT02137499|Imperial College London|Miss Kate Williams||k.williams@imperial.ac.uk|
302988|NCT02137512|Jaeb Center for Health Research|John Lum, Artificial Pancreas Project Director|8139758690|jlum@jaeb.org|
302989|NCT02137538|Stanford University|E Kirk Neely|650-723-5791|neely@stanford.edu|
302990|NCT02137603|All Children's Hospital Johns Hopkins Medicine|Dr. Nicole Chandler|727-767-4170|Nicole.Chandler@jhmi.edu|
302991|NCT02137772|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
302992|NCT02137785|DUSA Pharmaceuticals Inc., a Sun Pharma Co.|Anna Houlihan|9147608796|anna.houlihan@sunpharma.com|
302993|NCT02137837|SWOG Statistics and Data Management Center|Breast Committee Statistician|2066674623|dlew@fredhutch.org|
302994|NCT02138006|Karolinska Institutet Södersjukhuset|Thomas Nyström|+46704325214|thomas.nystrom@sodersjukhuset.se|
302995|NCT02138097|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
302996|NCT02138110|InVivo Therapeutics Corporation|Dr. Rich Toselli|(617) 863-5540|rtoselli@invivotherapeutics.com|
302997|NCT02138136|Mallinckrodt Pharmaceuticals|Clinical Team Leader|800-556-3314|clinicaltrials@mnk.com|
302998|NCT02138214|University of Wisconsin, Madison|Dr. Rebecca Sippel|608-263-1387|sippel@surgery.wisc.edu|
312247|NCT02988986|Houston Methodist Hospital|Dr. Jenny Chang, Director of Houston Methodist Cancer Center|713-441-0681|jcchang@houstonmethodist.org|
312248|NCT02989168|Global Blood Therapeutics|Nick Vlahakis|16508228756|nvlahakis@gbt.com|
312249|NCT02989246|Children's Hospital Los Angeles|Dr Robinder Khemani, Associate Director of Research ACCM|323-361-2376|rkhemani@chla.usc.edu|
312250|NCT02989389|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312251|NCT02989493|University of Wisconsin|John Curtin|608-262-0387|jjcurtin@wisc.edu|
312252|NCT02989545|Shaare Zedek Medical Center|Dr. Dan Livovsky|+972525622398|danlivo@szmc.org.il|
312253|NCT02989610|Abbott|Edward Karst, Clinical Research Director|+1 9725264663|Edward.karst@abbott.com|
312254|NCT02989649|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
291906|NCT01393405|University of North Carolina, Chapel Hill, NC|Dr. Hans Herfarth|9199666806|hherf@med.unc.edu|
291907|NCT01393444|University of Pittsburgh|Jennifer Collinger|412-383-1274|collingr@pitt.edu|
291908|NCT01393457|The University of Texas Health Science Center at Houston|Charles Green, PhD|713-500-6402|charles.green@uth.tmc.edu|
291909|NCT01393600|Neurocrine Biosciences, Inc.|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
291910|NCT01393613|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
291911|NCT01393626|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291912|NCT01393704|Brigham and Women's Hospital|Dr. Jon Einarsson|617-525-8582|jeinarsson@partners.org|
291913|NCT01393717|City of Hope National Medical Center|Dr. Robert Chen|626-256-4673|RChen@coh.org|82405
291914|NCT01393730|Dana-Farber Cancer Institute|Dr. Mary-Ellen Taplin|617-582-7221|mary_taplin@dfci.harvard.edu|
291915|NCT01393743|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
302999|NCT02138227|Temple University|Dr. Laura Siminoff|(215) 204-8726|lasiminoff@temple.edu|
303000|NCT02138240|Johns Hopkins University School of Medicine|Kimberly Gudzune|443-287-7238|gudzune@jhu.edu|
303001|NCT02138253|Conatus Pharmaceuticals, Inc.|Steven Mento, Ph.D., CEO|858-376-2622|smento@conatuspharma.com|
303002|NCT02138461|MDbackline, LLC|John A. Hovanesian, MD|949 951 9248|jhovanesian@mdbackline.com|
303003|NCT02138578|University of Michigan Comprehensive Cancer Center|Dr. Daniel Spratt, M.D.|734-936-4300|sprattda@med.umich.edu|
303004|NCT02138747|Astellas Pharma US, Inc.|Clinical Trial Disclosure||Astellas.resultsdisclosure@astellas.com|
303005|NCT02138786|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
303006|NCT02138825|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
303007|NCT02138838|Amgen Inc.|Study Director|866-572-6436||
303008|NCT02138890|Zimmer Biomet|Mr. Cahit Akbas|+31622981737|Cahit.Akbas@zimmerbiomet.com|
303009|NCT02138916|AstraZeneca|Ulbaldo Martin|1.301.398.0163|ulbaldo.martin@astrazeneca.com|
303010|NCT02139007|UAB|Jeff Foster|205-996-6086|pjfoster@uabmc.edu|
303011|NCT02139046|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303012|NCT02139124|Purdue Pharma|Dr Lance Payne|1-800-384-5349|Lance.Payne@purdue.ca|
303013|NCT02139137|SDSU/UCSD Joint Doctoral Program in Clinical Psychology|Jessica Bomyea|8585528585|jbomyea@ucsd.edu|3720
303014|NCT02139176|UNC Chapel Hill/UNC Project Lilongwe|Nora Rosenberg, PhD|+265 (0)99 109 0676|Nora_Rosenberg@unc.edu|
303015|NCT02139228|Novartis Vaccines and Diagnostics Srl|Posting Director||RegistryContactVaccinesUS@novartis.com|
303016|NCT02139280|Dartmouth-Hitchcock Medical Center|Kenneth Meehan, MD|603.650.4628|Kenneth.R.Meehan@hitchcock.org|
303017|NCT02139306|PTC Therapeutics, Inc|Joseph McIntosh|908 912-9138|jmcintosh@ptcbio.com|
303018|NCT02139358|H. Lee Moffitt Cancer Center and Research Institute|Dr. Hatem Soliman|813-745-4933|hatem.soliman@moffitt.org|
312255|NCT02989714|University of Michigan Rogel Cancer Center|Ajjai Alva, MD|734-936-0091|ajjai@umich.edu|
312256|NCT02989727|Univeristy of Saskatchewan|Dr. Evyn Peters|13062904493|evyn.peters@usask.ca|
312257|NCT02989805|Emory University|Benjamin Druss, MD, MPH|404-712-9602|bdruss@emory.edu|
312258|NCT02990000|University of Massachusetts Amherst|Dr. Michael J. Constantino|4135451388|mconstantino@psych.umass.edu|
312259|NCT02990338|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
312260|NCT02990910|the Children's Hospital of Fudan University|Dr.Wang Xuan|18017591058|744734170@qq.com|
312261|NCT02991040|Prollenium Medical Technologies Inc.|Mr. Ario Khoshbin|+1 (905) 508-1469|ario@prollenium.com|
312262|NCT02991118|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
312263|NCT02991729|UNC School of Medicine Maternal Fetal Medicine|Laura Carlson, MD|8643503140|lauramosbycarlson@gmail.com|
312264|NCT02991820|Nationwide Children's Hospital|Joseph D. Tobias, MD|6147224200|Joseph.Tobias@nationwidechildrens.org|
312265|NCT02991859|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312266|NCT02991898|Masonic Cancer Center, University of Minnesota|Claudio Brunstein|612-625-3918|bruns072@umn.edu|
312267|NCT02992067|Zhejiang Cancer Hospital|Yu Xingfei|057188122001|yuxf1177@zjcc.org.cn|+86
312268|NCT02992119|MORU|Lorenz von Seidlein|662036663|Lorenz@tropmedres.ac|
312269|NCT02992132|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
312270|NCT02992197|The University of Vermont College of Medicine|Benjamin Lee|8026567748|blee7@uvm.edu|
312271|NCT02992236|Nephrology University Erlangen Germany|Prof Dr Rroland Schmieder|+49 9131 8536207|roland.schmieder@uk-erlangen.de|
303019|NCT02139540|Washington University|Principal Investigator|7737022544||
303020|NCT02139592|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
291916|NCT01393821|Mayo Clinic|Aminah Jatoi, M.D.|(507) 284-7202|Jatoi.Aminah@mayo.edu|
291917|NCT01393899|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291918|NCT01393964|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
291919|NCT01393990|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291920|NCT01394003|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291921|NCT01394081|Tuscaloosa VA Medical Center|Lori L. Davis, MD|205-554-2000|Lori.Davis@va.gov|3819
291922|NCT01394159|Center for Interventional Endoscopy, Florida Hospital|Dr Shyam Varadarajulu|407-303-2570|svaradarajulu@yahoo.com|
291923|NCT01394185|Johns Hopkins University|Ryan Vandrey|410-550-4036|rvandrey@jhmi.edu|
291924|NCT01394250|The Chidren's Hospital of Philadelphia|Deb Potts|215-590-7098|pottsd@email.chop.edu|
291925|NCT01394276|F. Hoffmann-La Roche AG|Roche Trial Information Hotline|+41 61 6878333|global.trial_information@roche.com|
303021|NCT02139644|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
303022|NCT02139800|Children's Hospital of Philadelphia (CHOP)|Dr. Haresh Kirpalani|215-590-2455|kirpalanih@email.chop.edu|
303023|NCT02139826|Ixchelsis Limited|Chief Medical Officer|44(0)1227-832760|ian.osterloh@ixchelsis.com|
303024|NCT02139878|University of Prince Edward Island|Kim S. Stote PhD, MPH, RD|518-587-2100|Kim.Stote@esc.edu|2873
303025|NCT02139943|Janssen Research & Development, LLC|Senior Director Clinical Research||ClinicalTrialDisclosure@its.jnj.com|
303026|NCT02139969|Boston Scientific Corporation|Laura Olson, Clinical Project Manager|9529306428|laura.olson2@bsci.com|
303027|NCT02139982|The Second Affiliated Hospital & Yuying Children hospital of Wenzhou Medical University|Dr. Ting Li|008613587876896|liting1021@aliyun.com|
303028|NCT02140060|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Pharma|1-888-451-3937|alcon.medinfo@alcon.com|
303029|NCT02140164|National Institutes of Health|Catherine Cukras, MD, PhD, Principal Investigator, NEI|301-435-5061|cukrasc@nei.nih.gov|
303030|NCT02140372|NYU School of Medicine|Binita Shah|212-263-4235|binita.shah@nyumc.org|
303031|NCT02140411|Novartis Pharmaceuticals|Study Director|862-778-1873||
303032|NCT02140567|Imperial College Healthcare NHS Trust in London, United Kingdom|Dr. Phang Boon Lim|+44|p.b.lim@imperial.ac.uk|(0)20 3313
303033|NCT02140593|Herlev and Gentofte Hospital University of Copenhagen|Dr. Matias Vested Madsen|+4538683868|matias.vested.madsen@regionh.dk|
303034|NCT02140645|Boehringer Ingelheim (BI)|Boehringer Ingelheim Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
303035|NCT02140762|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
303036|NCT02140775|New York State Psychiatric Institute|Dr. Martin McElhiney|646.774.8035|mcelhin@nyspi.columbia.edu|
303037|NCT02140957|St. Michael's Hospital|Dr. Jonathon Maguire|(416) 919-3462|jonathon.maguire@utoronto.ca|
312272|NCT02992288|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
312273|NCT02992418|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
312274|NCT02992691|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312275|NCT02992899|Emory University|Dr. Douglas Bremner|404-712-9569|doug.bremner@emory.edu|
312276|NCT02993224|Novartis Pharmaceuticals|Study director|862-778-8300|novartis.email@novartis.com|
312277|NCT02993250|Janssen Pharmaceutical K.K., Japan|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
312278|NCT02993302|Dr. Cipto Mangunkusumo Hospital|Dyah Purnamasari|62213907703|dyah_p_irawan@yahoo.com|
312279|NCT02993445|Temple University Hospital|Dr. Jeffrey Henderer|267-418-9126|Jeffrey.Henderer@tuhs.temple.edu|
291926|NCT01394510|VA Puget Sound Health Care System|Kristina Utzschneider, MD|206-277-3568|kutzschn@uw.edu|6-3568
291927|NCT01394523|Nationwide Children's Hospital|Tarun Bhalla, MD|6147224200|Tarun.Bhalla@nationwidechildrens.org|
291928|NCT01394614|Center for Advanced Research in Sleep Medicine|Dr. Jacques Montplaisir|514-388-2693|jy.montplaisir@umontreal.ca|
291929|NCT01394627|Brigham and Women's Hospital|Gail Adler|617-732-5661|gadler@partners.org|
291930|NCT01394692|Johann Wolfgang Goethe University|Dr. Christian Senft|+49 69 63015939|c.senft@med.uni-frankfurt.de|
291931|NCT01394705|Boston Children's Hospial|Tracy Curran|617355-5445|tracy.curran@cardio.chboston.org|
291932|NCT01394718|Children's Hospital of Philadelphia|Athena Zuppa, MD, MSCE|267-426-7359|zuppa@email.chop.edu|
291933|NCT01394939|Sillajen Biotherapeutics Inc.|Kyoung Soo Ha, Head of Clinical Development|+1-415-281-8886|ksha@kr.sillajen.com|
291934|NCT01394952|Eli Lilly and Company|Chief Medical Officer|800-545-5979|www.ClinicalTrials.gov@lilly.com|
291935|NCT01394978|Davol, Inc.|Dawn Heimer, PhD|+1-401-825-8681|Dawn.Heimer@CRBard.com|
291936|NCT01394991|Johnson and Johnson PRD|Clinical Development Team Lead|1 908 218 6097||
291937|NCT01395017|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
291938|NCT01395030|The Queen's Medical Center|Program Director for PET Research|808-691-5466|skwee@queens.org|
291939|NCT01395043|Aalborg Hospital|Dr Nils Bjerregaard|004522860649|niheb@rn.dk|
291940|NCT01395277|University of Texas at Austin|Dr. R. Matthew Brothers|512-232-6016|r.m.brothers@austin.utexas.edu|
291941|NCT01395316|University of Chicago|Dr. Adil Javed||ajaved@neurology.bsd.uchicago.edu|
291942|NCT01395329|University of Colorado|Dr. Christopher DeSouza|303-492-2988|desouzac@colorado.edu|
291943|NCT01395368|Washington University in St. Louis|Dr. Jay F. Piccirillo, Professor|314 362-8641|piccirilloj@ent.wustl.edu|
291944|NCT01395394|Emory University|Kathryn Coakley|404-778-1286|kcoakle@emory.edu|
291945|NCT01395524|AstraZeneca|Mark Sostek||aztrial_results_posting@astrazeneca.com|
291946|NCT01395537|Case Comprehensive Cancer Center|David Adelstein MD|216-444-9310|adelstd@ccf.org|
291947|NCT01395758|ArQule, Inc.|Brian Schwartz, MD Chief Medical Officer|781-994-0300|ClinicalTrials@arqule.com|
291948|NCT01395784|New York State Psychiatric Institute|Jermaine Jones, PhD|646 774-6113|jonesje@nyspi.columbia.edu|
291949|NCT01395797|New York State Psychiatric Institute|Sandra Comer PhD|646 774-6146|sdc10@columbia.edu|
303038|NCT02140970|University of Colorado|Dr. Kyle Rove|720 777 5893|kyle.rove@childrenscolorado.org|
303039|NCT02141204|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
303040|NCT02141217|GlaxoSmithKline|GSK Response Center|866-435-7343||
303041|NCT02141295|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
303042|NCT02141360|GE Healthcare|Chief Medical Officer - Head Health Initiative|262-544-3633|Victor.Miranda@ge.com|
312280|NCT02993471|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312281|NCT02993731|Sumitomo Dainippon Pharma Oncology|Cindy Oh|617-674-8628|coh@bostonbiomedical.com|
312282|NCT02993757|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
312283|NCT02993783|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
312284|NCT02993926|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
312285|NCT02994056|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
312286|NCT02994108|Florida State University College of Medicine|Mary Gerend|8506451541|mary.gerend@med.fsu.edu|
312287|NCT02994238|Northwestern University|Kathy Boon- Clinical Research Associate|312-503-4687|kathy.boon@northwestern.edu|
312288|NCT02994394|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
312289|NCT02994654|AVITA Medical|VP Clinical Research|661-367-9170|USClinicalTrials@avitamedical.com|
291950|NCT01395810|Novo Nordisk A/S|Global Clinical Registry (GCR, 1452)||clinicaltrials@novonordisk.com|
291951|NCT01395823|Dialysis Clinic Inc|Karen Majchrzak|615-342-0483|karen.majchrzak@dciinc.org|
291952|NCT01395888|GlaxoSmithKline|GSK Response Center|866-435-7343||
291953|NCT01395901|Helsinn Healthcare SA|Salvatore Chessari|+41 91 985 21 21|salvatore.chessari@helsinn.com|
291954|NCT01395914|Helsinn Therapeutics (US), Inc.|Richard K. Bourne, Ph.D.|732-603-2852|richard.bourne@helsinn.com|
291955|NCT01395966|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
291956|NCT01396005|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6327|ClinicalTrialsDisclosure@merck.com|
291957|NCT01396044|Northwestern University|Dr. Curtis Weiss|(312) 695-6439|curtisweiss@northwestern.edu|
291958|NCT01396057|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
291959|NCT01396070|Stanford University Medical Center|Youn H Kim, MD|650-521-3545|younkim@stanford.edu|
291960|NCT01396083|Novartis Pharmaceuticals|Study Director|862-778-8300|trialandresults.registries@novartis.com|
291961|NCT01396148|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291962|NCT01396161|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291963|NCT01396187|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291964|NCT01396226|AstraZeneca|Gerard Lynch||aztrial_results_posting@astrazeneca.com|
291965|NCT01396239|Sarepta Therapeutics, Inc.|Edward M. Kaye MD, Interim CEO, SVP & Chief Medical Officer|+1-888-727-3782|clinicaltrials@sarepta.com|
291966|NCT01396265|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
291967|NCT01396317|Hospital for Special Surgery|Dr. Robert Spiera|212-774-2048|spierar@hss.edu|
291968|NCT01396382|Vanderbilt-Ingram Cancer Center|Dr. Ronald Walker|615-343-8516|ronald.walker@vanderbilt.edu|
291969|NCT01396395|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
291970|NCT01396421|Otsuka Pharmaceutical Development & Commercialization, Inc|Global Medical Affairs|800 562-3974||
291971|NCT01396434|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
291972|NCT01396447|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
291973|NCT01396486|Massachusetts General Hospital|Dr. Janet Wozniak|617-724-5600|jwozniak@partners.org|
291974|NCT01396512|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
291975|NCT01396525|AbbottVascular|David R Rutledge|408-845-3820|david.rutledge@av.abbott.com|
291976|NCT01396551|Varian Medical Systems|Julie Allen|206-330-2605|julie.allen@varian.com|
291977|NCT01396837|RedDress|Saron Sirota, Clinical Team Leader|+972-54-5800765|sharon@reddress.co.il|
291978|NCT01397071|UCLA Department of Medicine/Center for Human Nutrition|Zhaoping Li|310-206-1987|zli@mednet.ucla.edu|
291979|NCT01397084|AstraZeneca|James Armbrust||aztrial_results_posting@astrazeneca.com|
291980|NCT01397253|University of Pittsburgh|Kenneth J Smith, MD, MS|4126474794|smithkj2@upmc.edu|
291981|NCT01397409|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
291982|NCT01397422|Adamas Pharmaceuticals, Inc.|Head, Regulatory Affairs|+1 (510) 450-3500|drugsafety@adamaspharma.com|
291983|NCT01397448|Eisai Co., Ltd.|Nobuyuki Sugisaki|+81-3-3817-3908||3908
291984|NCT01397461|Ferrer Internacional, S.A.|Clinical Research Manager|+34 93 509 32 75|nalbareda@ferrer.com|
291985|NCT01397591|OHSU Knight Investigational Cancer Services|Jeff Donovan|503-494-7702|mastersj@ohsu.edu|
291986|NCT01397617|Nobel Biocare Services AG|Head Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
291987|NCT01397656|Ottawa Hospital Research Institute|Dr. Christian Vaillancourt|613-798-5555|cvaillancourt@ohri.ca|17012
291988|NCT01397747|Exact Sciences|Director of Clinical Operations|608-284-5700|tvaughn@exactsciences.com|
291989|NCT01397786|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
291990|NCT01397825|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
291991|NCT01397851|independent|Richard Sedlmayr|6468412169|richard.sedlmayr@gmail.com|
291992|NCT01397890|AstraZeneca|Nongluk Yimsuan|66 2 7397400|ClinicalTrialTransparency@astrazeneca.com|429
291993|NCT01398059|University of Prince Edward Island|Dr. Travis Saunders|902-566-0641|trsaunders@upei.ca|
291994|NCT01398176|UFlorida|Dr. Susan S. Percival|352-392-1991|percival@ufl.edu|201
291995|NCT01398280|UCSD Dermatology Clinical Trials|UCSD Dermatology Clinical Trials Manager|(858)657-8390|dermstudies@ucsd.edu|
291996|NCT01398358|University of Michigan|Julie Lumeng, MD|jlumeng@umich.edu|jlumeng@umich.edu|
291997|NCT01398410|Eisai Co., Ltd.|Nobuyuki Sugisaki|+81-3-3817-3908||3908
291998|NCT01398475|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
291999|NCT01398514|Massachusetts General Hospital|Dr. Naomi Simon|617-726-7913|nsimon@partners.org|
292000|NCT01398566|The Ohio State University|Lise Worthen-Chaudhari|614-304-1421|liseworthen@gmail.com|
303043|NCT02141399|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
303044|NCT02141451|Masonic Cancer Center, University of Minnesota|Dr. Veronika Bachanova|612-625-5469|bach0173@umn.edu|
303045|NCT02141490|National Cancer Institute|Dr. Ismail B. Turkbey|240-760-6112|turkbeyi@nih.gov|
303046|NCT02141516|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
303047|NCT02141555|University of California, San Diego|Dr. Sheila Mody||smody@ucsd.edu|
303048|NCT02141581|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
312290|NCT02994732|Biomed Valley Discoveries|Associate Director of Translational Sciences|636-887-6429|Dknoerzer@biomed-valley.com|
312291|NCT02994940|UC Davis Anesthesiology & Pain Medicine|Richard L. Applegate II MD|916-734-5028|rapplegate@ucdavis.edu|
312292|NCT02994979|The New Jewish Home|Dr. Kenneth Boockvar|212-870-5062|kenneth.boockvar@mssm.edu|
312293|NCT02995915|Duke University Medical Center|Angela Kirby, MS|(919) 824-7729|angela.kirby@duke.edu|
312294|NCT02995980|University of Alabama at Birmingahm|Rachael Lancaster, MD|205-934-4080|mvetrano@uabmc.edu|
312295|NCT02996097|Johns Hopkins School of Medicine|Dr. Ginette Okoye|9142158980|ginette.okoye@howard.edu|
312296|NCT02996448|NIAID, NIH|Alexandra Freeman|301-594-9045|freemaal@mail.nih.gov|
312297|NCT02996474|National Heart Lung and Blood Institute|Christopher Hourigan|+1 301 451 0257|christopher.hourigan@nih.gov|
312298|NCT02996500|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312299|NCT02996591|Hospital for Special Surgery|George Birch|2127747377|birchg@hss.edu|
312300|NCT02996682|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
312301|NCT02996864|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
312302|NCT02996968|TriHealth Inc.|Abigail Shatkin-Margolis, MD|513-463-4300|Abigail_Shatkin-margolis@trihealth.com|
312303|NCT02997085|Baylor Scott & White Research Institute|Dr. Mark Powers|2148652409|Mark.Powers1@bswhealth.org|
312304|NCT02997163|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312305|NCT02997176|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312306|NCT02997722|University of Mississippi Medical Center|Allen Richert, MD|(601) 984-4820|arichert@umc.edu|
312307|NCT02997735|Children's Hospital of Philadelphia|Brian Jenssen, MD MSHP|215-554-4390|JenssenB@email.chop.edu|
312308|NCT02997904|Piedmont Pharmaceuticals|Dr. Kathy Palma|336 544 0320|kpalma@piedmontpharma.com|202
312309|NCT02998021|University of Pittsburgh|Alicia Koontz, PhD|4128223700|akoontz@pitt.edu|
312310|NCT02998151|Cincinnati Children's Hospital Medical Center|Dr. Craig Erickson|513-636-0523|craig.erickson@cchmc.org|
312311|NCT02998476|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
312312|NCT02998541|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
312313|NCT02998554|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
312314|NCT02998671|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
312315|NCT02998684|Medical University of South Carolina|Dr. Jane Joseph|843-792-7683|josep@musc.edu|
312316|NCT02998996|Eurocine Vaccines AB|Anna-Karin Maltais|+46 76 233 81 62|annakarin.maltais@eurocine-vaccines.com|
312317|NCT02999100|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312318|NCT02999178|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312319|NCT02999191|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312320|NCT02999633|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
312321|NCT02999672|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
312322|NCT02999763|Syneron Medical|Director of Clinical Affairs|+972-73-2442347|shlomitm@syneron-candela.com|
312323|NCT03000010|University of Michigan|G. Ying Li|734-936-5715|yingyuli@med.umich.edu|
312324|NCT03000075|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
312325|NCT03000088|Ajou University School of Medicine|Dr. Jiyoung Lee|82-31-219-5689|leejiyoung0616@gmail.com|667
312326|NCT03000166|University of Wisconsin-Milwaukee|Jeanne M. Erickson, PhD, RN|414-229-6920|ericksoj@uwm.edu|
312327|NCT03000283|Allina Health|Dr. Jesse Corry|651-241-6550|Jesse.Corry@allina.com|
312328|NCT03000309|Skin Sciences, PLLC|M. McAllister|5024519000|mmdermresearch@yahoo.com|
312329|NCT03000348|NovaBiotics Ltd|Dr Deborah O'Neil, CEO|01224 711 377|deborah@novabiotics.co.uk|
312330|NCT03000452|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
312331|NCT03000608|Santalis Pharmaceuticals|Dr. Paul Castella|2103992316|paulc@santalispharmaceuticals.com|101
312332|NCT03000673|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
312333|NCT03000686|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
292001|NCT01398787|Alcon Research, Ltd.|Sharon Holden Thomas, Sr. Principal Clinical Scientist|1-888-451-3937|alcon.medinfo@alcon.com|
292002|NCT01398943|Augusta University|Ryan Harris, Ph.D.|706-721-5998|ryharris@augusta.edu|
292003|NCT01398956|UCB Cares|UCB (Study Director)|+1887822||9493
292004|NCT01398982|UHN|Kate Butler|416-340-4800|kbutler@uhnresearch.ca|2343
292005|NCT01399008|Metabolex|Mary Jean Stempien, M.D., Acting Chief Medical Officer|510-293-8800|mjstempien@metabolex.com|
292006|NCT01399047|University of Rochester Medical Center|Erika Augustine, MD, MS|585-275-2808|erika_augustine@urmc.rochester.edu|
292007|NCT01399099|Neodyne Biosciences|Kristin Prosak|650-543-7129|kprosak@neodynebio.com|126
292008|NCT01399125|Novartis Pharmaceuticals|Study Director|8627788300||
292009|NCT01399190|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
292010|NCT01399229|Reproductive Research Technologies, LP|Jack McCrary|7136800200|jmc@innovalp.com|
292011|NCT01399268|HSS|Dr. Jules|212.606.1206|JulesK@hss.edu|
303049|NCT02141620|University of Kentucky|William W. Stoops|859-257-5388|william.stoops@uky.edu|
303050|NCT02141633|University of Miami|Dr Adam Wanner Professor of Medicine Division of Pulmonary and Critical Care Medicine|(305) 243-3045|awanner@med.miami.edu|
303051|NCT02141659|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303052|NCT02141672|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
303053|NCT02141854|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
303054|NCT02141867|South African Surgical Outcomes Study|Prof Bruce Biccard|+27312604328|biccardb@ukzn.ac.za|
312334|NCT03001011|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
312335|NCT03001076|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
312336|NCT03001219|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
312337|NCT03001258|BRAC|Anita Sharif Chowdhury/Research Fellow of BRAC Research and Evaluation Division|+88029846448|anita.sc@brac.net|3719
312338|NCT03001453|American Hip Institute|Dr. Benjamin Domb|630-455-7130|drdomb@americanhipinstitute.org|
312339|NCT03001557|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_medinfo@eisai.com|
312340|NCT03001674|Tufts Medical Center|Dr. Navin Kapur|617 636 0720|nkapur@tuftsmedicalcenter.org|
312341|NCT03001778|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
312342|NCT03001843|University of Florida|Joshua Sappenfield, MD|352-273-5259|jsappenfield@anest.ufl.edu|
312343|NCT03002012|University of Minnesota|David Boulware|612-624-1966|boulw001@umn.edu|
312344|NCT03002038|Isfahan University of Medical Sciences|Dr. Vahid Shaygannejad|+98 913 313 3550|shaygannejad@med.mui.ac.ir|
312345|NCT03002077|Allergan|Therapeutic Area, Head|714-246-4500|IR-CTRegistration@allergan.com|
312346|NCT03002194|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
312347|NCT03002311|WASHINGTON UNIVERSITY MEDICAL SCHOOL|Brian F. Gage, MD|3144548697|bgage@wustl.edu|
312348|NCT03002454|Winnipeg Regional Health Authority|Dr. Sandor Demeter|1 (204) 787-3375|sdemeter@hsc.mb.ca|
312349|NCT03002506|Texas Tech UHSC|Ronald Hall, PharmD, MSCS|214-358-9009|ronald.hall@ttuhsc.edu|
312350|NCT03002610|University of Split School of Medicine|Ivan Buljan|+385989027209|ibuljan@mefst.hr|
312351|NCT03002623|National Cancer Institute|Dr. Naris Nilubol|301- 451-2355|niluboln@nih.gov|
312352|NCT03002753|Christoph-Dornier-Stiftung Münster|Christian Rupp, M. Sc.|00492514183440|rupp@cds-muenster.de|
292012|NCT01399372|NRG Oncology|Wendy Seiferheld|215-574-3208|seiferheldw@nrgoncology.org|
292013|NCT01399593|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
292014|NCT01399619|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
292015|NCT01399697|Hoffmann-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
292016|NCT01399723|KEMRI-Wellcome Trust Research Prorgamme|Dr. Ambrose Agweyu|254202715160|aagweyu@kemri-wellcome.org|
292017|NCT01399736|Maasstad Hospital|Dr.Pieter Smits|+31102913322|SmitsP@maasstadziekenhuis.nl|
292018|NCT01399788|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292019|NCT01399827|Massachusetts General Hospital|Craig Surman, MD|617-726-8392|csurman@partners.org|
292020|NCT01399866|Massachusetts General Hospital - Harvard Medical School|A. Eden Evins, MD, MPH. Director of the MGH-Harvard Center for Addiction Medicine|6176434679|a_eden_evins@hms.harvard.edu|
292021|NCT01399905|Oregon Health and Science University|John G. Nutt, MD|503-494-9054|nuttj@ohsu.edu|
292022|NCT01400113|St. Joseph's Hospital Health Center|Michael Pratts, MD|315-726-8610|michael.pratts@sjhsyr.org|
292023|NCT01400139|Purdue Pharma L.P.|Clinical Leader|800-733-1333||
292024|NCT01400243|Southern Illinois University Carbondale|David G. Gilbert|618-453-3527|dgilbert@siu.edu|
292025|NCT01400412|ACTG Network Coordinating Center, Social and Scientific Systems|ACTG Clinicaltrials.gov Coordinator|301-628-3313|ACTGCT.Gov@s-3.com|
292026|NCT01400425|Avid Radiopharmaceuticals|Chief Medical Officer|215-298-0700|clinicaloperations@avidrp.com|
292027|NCT01400451|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
292028|NCT01400477|University of Colorado|Dr. Robert Freedman|393 724 1000|robert.freedman@ucdenver.edu|
292029|NCT01400503|Janssen Research & Development, LLC|Clinical Leader|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
292030|NCT01400516|Brigham and Women's Hospital|Daniel H Solomon, MD, MPH||dsolomon@partners.org|
292031|NCT01400698|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merck.de|
292032|NCT01400815|22nd Century Group, Inc.|Karen Delaney|716-270-1523|kdelaney@xxiicentury.com|
292033|NCT01400841|Biostable Science and Engineering, Inc.|John Wheeler|512-386-1996|John.wheeler@biostable-s-e.com|
292034|NCT01400880|University of Florida|Dr. Tony Gregg|352-265-0111|greggar@ufl.edu|
292035|NCT01400893|CytoPherx, Inc|H. David Humes|734-997-7055|dhumes@cytopherx.com|302
292036|NCT01400906|GlaxoSmithKline|GSK Response Center|866-435-7343||
292037|NCT01400919|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
292038|NCT01400932|GlaxoSmithKline|GSK Response Center|866-435-7343||
292039|NCT01400958|H. Lee Moffitt Cancer Center and Research Institute|Peter A. Forsyth, M.D.|813-745-3063|peter.forsyth@moffitt.org|
292040|NCT01400971|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
292041|NCT01401010|Michigan State University|Gary E Stein|517-353-5126|Gary.Stein@hc.msu.edu|
303055|NCT02141984|AbbVie|Global Medical Services|800-633-9110||
303056|NCT02141997|AbbVie|Global Medical Information|1-800-633-9110||
303057|NCT02142049|Pharmacyclics, LLC|Director of Clinical Operations|408-774-0330|Clinical_Directors@pcyc.com|
303058|NCT02142153|F2G|Dr Anthony Kennedy|0044 161 785 1273|TKennedy@f2g.com|
303059|NCT02142283|Stryker Neurovascular|Cheryl Fontana, Sr. Manager, Clinical Services|510-413-2948|cheryl.fontana1@stryker.com|
303060|NCT02142361|Optometry Research Group (GIO)|Robert Montés-Mico O.D., MPhil, PhD Optometry|34-9635-44764|robert.montes@uv.es|
303061|NCT02142387|Laboratory of Emergency Medical Services, Seoul National University Hospital Biomedical Research Institute|Dr. Gwan Jin Park|82-10-7477-3293|pkj83531@naver.com|
303062|NCT02142504|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303063|NCT02142608|Bracco Diagnostics Inc.|Maria Luigia Storto, MD, Executive Director X-Ray and Ultrasound|609-514-2262|marialuigia.storto@diag.bracco.com|
303064|NCT02142712|University of New Mexico - Neurology Department|Dr. Vishnumurthy Shushrutha Hedna|505-272-3342|Drshushrutha@gmail.com|
303065|NCT02142738|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
303066|NCT02142894|QIAGEN Sciences|Clinical Study Coordinator|301-944-7094|andrew.schumacher@qiagen.com|
303067|NCT02143024|UC Davis Department of Psychiatry and Behavioral Sciences|Ladson Hinton, MD|(916) 734-3485|lwhinton@ucdavis.edu|
303068|NCT02143102|Elucid Bioimaging|Andrew J. Buckler|978-468-0508|andrew.buckler@elucidbio.com|
303069|NCT02143141|Wake Forest School of Medicine|Dr. Jessica Booth|3367188278|jbooth@wakehealth.edu|
303070|NCT02143310|FontemVentures|Tanvir Walele|01779337589|tanvir.walele@fontemventures.com|
303071|NCT02143583|ANERGIS SA|G. DELLA CORTE Clinical Development Director|+41 21 651 92 30|gilles.dellacorte@anergis.ch|
303072|NCT02143648|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
303073|NCT02143713|AbbVie|Global Medical Services|800-633-9110||
303074|NCT02143778|Exalenz Bisocience|Clinical Trial Manager|97289737500|avrahamh@exalenz.com|
303075|NCT02143843|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
303076|NCT02143947|Quinnipiac University|Juan C Garbalosa, PT, PhD, Director Motion Analysis Laboratory|203 582 8552|juan.garbalosa@quinnipiac.edu|
303077|NCT02143973|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
303078|NCT02144012|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
303079|NCT02144077|Biofrontera Bioscience GmbH|Clinical Trial Department|+49 214 876 32 66|ameluz@biofrontera.com|
303080|NCT02144220|University of Rochester|Ray Dorsey, MD|585-275-0663|ray.dorsey@chet.rochester.edu|
303081|NCT02144233|University of Santiago de Compostela. A Coruña. SPAIN|Professor Urbano Santana Penín|+34647344093|urbano.santana@usc.es|
303082|NCT02144259|University of Pennsylvania|Dr. Courtney Schreiber|215-615-5234|courtney.schreiber@uphs.upenn.edu|
303083|NCT02144285|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292042|NCT01401023|Michigan State University|Dr. Gary Stein, Pharm D|517-353-5126|steing@msu.edu|
303084|NCT02144337|University of Nottingham (UK)|Helen Quirk|01157484325|ntxhq1@nottingham.ac.uk|
303085|NCT02144519|University of South Carolina|Michael W Beets|8037773003|beets@mailbox.sc.edu|
303086|NCT02144597|Imperial College London|Prof Gary Frost|07872850308|g.frost@imperial.ac.uk|
303087|NCT02144610|AnGes USA, Inc.|Dr. Susan Pitman Lowenthal|240-780-9025|spitmanlowenthal@anges-usa.com|
303088|NCT02144675|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
303089|NCT02144701|Rutgers Cancer Institute of New Jersey|Roger Strair, MD, PhD|732-235-7298|strairrk@cinj.rutgers.edu|
303090|NCT02144714|Samsung Bioepis|Samsung Bioepis|+82 31 8061 4534|sbregistry@samsung.com|
303091|NCT02145026|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
303092|NCT02145039|University of Minnesota Cancer Center|Dr. Claudio Brunstein|612-625-8942|bruns072@umn.edu|
303093|NCT02145078|Barbara Ann Karmanos Cancer Institute|Gerold Bepler|(313)576-8670|beplerg@karmanos.org|
303094|NCT02145156|University of Colorado Denver|Julie A. Maertens|303-724-7319|julie.maertens@ucdenver.edu|
303095|NCT02145182|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.||clinicaltrials@alexion.com|
303096|NCT02145247|UCSDMED|R. Jeffrey Chang|858-534-8930|rjchang@ucsd.edu|
312353|NCT03002818|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
312354|NCT03002974|Swedish Orphan Biovitrum|Kineret Clinical Program Leader|+46(8)6972000|info@sobi.com|
292043|NCT01401062|NYU Langone Medical Center|Nelly Huppert|212-731-5003|Nelly.Huppert@nyumc.org|
292044|NCT01401101|RAND Corporation|Lisa S. Meredith, PhD|310.393.0411|seidel@rand.org|7365
292045|NCT01401153|Research Institute of Child Nutrition|Prof. Dr. Mathilde Kersting|+49-231-792210-18|kersting@fke-do.de|
292046|NCT01401166|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
292047|NCT01401257|Hôpital La Timone, Marseille|Pr Shahram ATTARIAN|04 91 38 65|shahram.attarian@ap-hm.fr|79
292048|NCT01401283|Hamburg Eppendorf University Hospital|Daniel A. Reuter, MD|+49-40-7410-0|dreuter@uke.de|
292049|NCT01401322|Stanford University|Bruno C. Medeiros|650-498-6000||
292050|NCT01401361|St. Jude Medical|Nancy Ouch|+19497695041|NOuch@sjm.com|
292051|NCT01401452|AbbVie (prior sponsor Abbott)|Global Medical Services|800-633-9110||
292052|NCT01401465|Sunovion|Respiratory Medical Director|1-866-503-6351||
292053|NCT01401478|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
292054|NCT01401517|TheraVasc Inc.|Tony Giordano|318-349-3851|tgiordano@theravasc.com|
292055|NCT01401530|Eisai Inc.|Eisai Medical Services Inc.|1-888-422-4743|esi_medinfo@eisai.com|
292056|NCT01401543|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
303097|NCT02145299|Yale School of Medicine|Dr. Alexandra Lansky|203-737-2142|alexandra.lansky@yale.edu|
292057|NCT01401582|Geman Centr for Neurodegenerative Diseases (DZN)|PD Dr. JR Thyrian|+49383486|rene.thyrian@dzne.de|7592
292058|NCT01401595|Perelman School of Medicine at the University of Pennsylvania|Kelly C. Allison, Ph.D.|215-898-2823|kca@mail.med.upenn.edu|
292059|NCT01401647|University of Washington, Resuscitation Outcomes Consortium|Dr. Susanne May|206-685-1302|rochelp@uwctc.org|
303098|NCT02145429|University of Pittsburgh|Charles F. Reynolds, MD|(412) 246-6414|reynoldscf@upmc.edu|
303099|NCT02145468|GlaxoSmithKline|GSK Response Center|866-435-7343||
303100|NCT02145676|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
303101|NCT02145754|University Medical center Ljubljana, Infectious Diseases Department|Daša Stupica|+386 1 522 21 10|dasa.stupica@kclj.si|
303102|NCT02146001|University of Pittsburgh|Dr. Bethany Barone Gibbs|412-383-4002|bbarone@pitt.edu|
303103|NCT02146105|McMaster University|Dr. Monica Maly|905-525-9140|mmaly@mcmaster.ca|27823
303104|NCT02146131|Medical University of South Carolina|Kate Taylor|843-792-2297|Talykat@musc.edu|
303105|NCT02146248|OHSU|Jeffrey T. Jensen|503-629-4058|jensenje@ohsu.edu|
303106|NCT02146274|Duke University School of Medicine|Vice Dean of Clinical Research|919-684-4979|awindham@duke.edu|
303107|NCT02146326|Indiana University|Michelle Salyers, PhD / Professor, Department of Psychology|317-274-2904|mpsalyer@iupui.edu|
303108|NCT02146352|Boston Scientific Corp.|Lina Ginnetti|508-683-4512|Lina.Ginnetti@bsci.com|
303109|NCT02146365|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
303110|NCT02146430|Daiichi Sankyo, Inc.|Daiichi Sankyo US Contact for Clinical Trial Results|+1 (908) 992-6400|CTRinfo@DSI.com|
303111|NCT02146482|Stanford University|Grant Ognibene|9518343465|grantog@stanford.edu|
303112|NCT02146599|Abbott Medical Optics|Anne Buteyn; Manager, Clinical Research|949-505-2029|anne.buteyn@abbott.com|
303113|NCT02146833|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
303114|NCT02147067|Emory University|Habib Samady, MD|(404) 778-1237|hsamady@emory.edu|
303115|NCT02147093|Johnson & Johnson Vision Care INC.|Tom Karkkainen, OD, MS, FAAO|904-443-3500|TKarkkai@its.jnj.com|3402
303116|NCT02147132|UC COM Psychiatry Dept. -- Addiction Sciences Division|Jeff Theobald|5135858281|theobajy@ucmail.uc.edu|
303117|NCT02147158|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
303118|NCT02147197|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
303119|NCT02147288|Yale University|Dr. Marc Walker||marc.walker@yale.edu|
303120|NCT02147301|University of California, San Francisco|Curt Johanson|415-353-2310|curt.johanson@ucsf.edu|
303121|NCT02147353|Icahn School of Medicine at Mount Sinai|Dr. Shelbi C. Jim On|212-241-6500|shelbi.jimon@mountsinai.org|
303122|NCT02147522|USC Suzanne Dworak-Peck School of Social Work|Kathleen Ell, DSW, Principle Investigator|760-399-0263|ell@usc.edu|
303123|NCT02147561|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
303124|NCT02147587|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312355|NCT03003000|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312356|NCT03003130|Q-Med AB|Head of Development|+ 46 (0) 18 474 90 00|reception.seupp@galderma.com|
312357|NCT03003390|Yale University|Dr. E. Vincent S Faustino|203-785-4651|vince.faustino@yale.edu|
312358|NCT03003494|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312359|NCT03003676|Targovax|Dr. Lone H. Ottesen, Chief Development Officer|+44 7920567911|lone.ottesen@targovax.com|
312360|NCT03003793|Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen|Lise Gether, MD||lise.gether.01@regionh.dk|
312361|NCT03003949|University of North Carolina at Chapel Hill|Susan Girdler, PhD|919-590-0813|rachel_kozik@med.unc.edu|
312362|NCT03004469|Polichem S.A.|Francesco Scarci|+41 091 9864 005|francesco.scarci@almirall.com|
312363|NCT03004534|Translational Research In Oncology (TRIO)|Director, Project Management|33 158 10 09 09|030@trioncology.org|
312364|NCT03004638|MedImmune LLC|Richard George|+1-301-398-5681|information.center@astrazenea.com|
312365|NCT03004846|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312366|NCT03004911|School of Medicine at the University of Sao Paulo|Amélia Pasqual Marques|+55 11 3091 7451|pasqual@usp.br|
312367|NCT03004924|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
312368|NCT03005041|GlaxoSmithKline|GSK Response Center|866-435-7343||
312369|NCT03005054|Mallinckrodt|Medical Information Call Center|800-844-2830|clinicaltrials@mnk.com|5
312370|NCT03005067|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
292060|NCT01401699|Massachusetts General Hospital|Gary Tearney, PI|617-724-2979|gtearney@partners.org|
292061|NCT01401842|University of South Florida|John M. Mayer, DC, PhD / Study Director|813-974-3818|jmayer2@health.usf.edu|
303125|NCT02147613|Arizona State University - Downtown Phoenix Campus|Siddhartha S. Angadi, PhD., FACSM|6028272254|sangadi@asu.edu|
303126|NCT02147626|Brigham and Women's Hospital|Dr. Janet Rich-Edwards|6175258264|jr33@partners.org|
292062|NCT01401907|MGH|Jennifer Temel MD|617-724-4000|jtemel@partners.org|
292063|NCT01401959|Sarah Cannon Development Innovations|Senior Director, Regulatory Science|844-710-6157|CANN.InnovationsMedical@sarahcannon.com|
292064|NCT01402011|University of British Columbia Department of family practice|Dr. Helene Bertrand, M.D., CCFP, LM|604-985-5381|dr.hbertrand@gmail.com|
292065|NCT01402050|Phoenix Perinatal Associates - Mednax|Ana Braescu|602-614-0488|ana_braescu@mednax.com|
292066|NCT01402063|Brown University Oncology Research Group (BrUOG)|Howard Safran, MD|4018633000|kayla_rosati@brown.edu|
292067|NCT01402102|Clinical trial center for Functional Food in Chonbuk Nat'l University Hospital|Dr. Dal-Sik Kim|82-63-250-1793|dskim@chonbuk.ac.kr|
292068|NCT01402115|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Dal-Sik Kim, MD|82-63-276-8284|dskim@chonbuk.ac.kr|
292069|NCT01402128|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Soo-Wan Chae, MD|82-63-276-8284|soowan@jbnu.ac.kr|
292070|NCT01402141|Clinical Trial Center for Functional Foods; Chonbuk National University Hospital|Dr. Baek-Hwan Cho, MD|82-63-250-1579|chobh@jbnu.ac.kr|
292071|NCT01402284|National Cancer Institute|Dr. Dickran Kazandijian|301-480-8870|kazandijiandg@mail.nih.gov|
303127|NCT02147691|DermResearch, PLLC|Leon H. Kircik, M.D.|502-451-9000|wedoderm@yahoo.com|
303128|NCT02147769|Stanford University|Valerie Chock, MD|650-723-5711|vchock@stanford.edu|
303129|NCT02147899|Symbiomix Therapeutics|VP Clinical Operations|609-722-7250|nadetoro@symbiomix.com|112
303130|NCT02147990|Clovis Oncology, Inc.|Medical Information Department|+1 415 409 7220|medinfo@clovisoncology.com|
303131|NCT02148107|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
303132|NCT02148211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
303133|NCT02148250|University of Minnesota|Elizabth Seaquist, MD|612-624-9176|seaqu001@umn.edu|
303134|NCT02148302|SerenaGroup|Thomas E. Serena, MD|617-945-5225|serena@serenagroups.com|
303135|NCT02148445|Department of Preventive Medicine & Public Health|Edward F. Ellerbeck, MD, MPH, Chair|913-588-2829|eellerbe@kumc.edu|
303136|NCT02148523|University of Pennsylvania|Dr. Peter P. Reese|215-898-6086|peter.reese@uphs.upenn.edu|
303137|NCT02148588|Washington University School of Medicine|Simon Haroutounian|3142861715|simon.haroutounian@wustl.edu|314
303138|NCT02148718|AbbVie|Global Medical Services|800-633-9110||
303139|NCT02148809|HospitalSS|Dr. Friedrich Boettner|2127742127|boettnerf@HSS.edu|
303140|NCT02148835|Preventive Cardiology, University of Munich|Prof. Dr. C. von Schacky|+49 89 44005 2165|clemens.vonschacky@med.uni-muenchen.de|
303141|NCT02148874|The Ohio State University Wexner Medical Center|Lisa Christian, PhD|614-293-0936|lisa.christian@osumc.edu|
303142|NCT02148952|Ariadne Labs|Dr. Katherine Semrau|617-384-6555|betterbirth@ariadnelabs.org|
303143|NCT02149108|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
303144|NCT02149173|University of Washington|Hannah M Linden|206-606-2053|hmlinden@uw.edu|
312371|NCT03005106|Mallinckrodt|Medical Information Call Center|800-844-2830|MedInfo@mnk.com|
312372|NCT03005288|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
312373|NCT03006341|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312374|NCT03006393|Emory University|Dr. Michael Treadway|(404) 727-3166|mtreadway@emory.edu|
312375|NCT03006458|CooperVision|Myhanh Nguyen|9257306716|MNguyen@coopervision.com|
312376|NCT03006471|INSITITUTO DE TERAPEUTICA EXPERIMENTAL Y CLINICA, UNIVERSITY OF GUADALAJARA|DR. MANUEL GONZALEZ ORTIZ|+52 3310585200|uiec@prodigy.net.mx|34212
312377|NCT03006562|Johns Hopkins Brady Urological Institute|Dr. Mohamad Allaf|410-955-6100|mallaf@jhmi.edu|
312378|NCT03006848|St Jude Children's Research Hospital|Dr. Michael Bishop|866-278-5833|referralinfo@stjude.org|
312379|NCT03006887|Eisai, Inc.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
312380|NCT03006926|Eisai Co., Ltd.|Inquiry Service||eisai-chiken_hotline@hhc.eisai.co.jp|
312381|NCT03007225|Ain Shams University|Dr Iman Montasser, Assistant professor of Tropical Medicine member of HCC clinic and group , Ain Sha|0020201065065333|imanfawzy2@gmail.com|
312382|NCT03007394|National Institute on Drug Abuse|David McCann, Ph.D.|301-827-5934|dmccann@nida.nih.gov|
312383|NCT03007472|Cochlear|Cochlear Clinical Studies|(303) 790-9010|clinicalstudies@cochlear.com|
312384|NCT03007953|Department of Veterans Affairs|Dr. Lynn F. Reinke|206-277-4186|Lynn.Reinke1@va.gov|
312385|NCT03007966|Wake Forest University Health Sciences|Christopher Edwards|336-716-4498|chedward@wakehealth.edu|
312386|NCT03007979|Washington University School of Medicine|Cynthia X. Ma, M.D., Ph.D.|314-362-9383|cynthiaxma@wustl.edu|
312387|NCT03008070|Inventiva S.A.|Dr Michael Cooreman, Chief Medical Officer|+33380447616|native.public@inventivapharma.com|
312388|NCT03008174|Johns Hopkins University|Vinciya Pandian|4436553482|vpandia1@jhu.edu|
312389|NCT03008213|UCSD|Eric Roeland, MD|858- 534-7079|eroeland@ucsd.edu|
312390|NCT03008460|Ipsen|Ipsen Medical Director|use email|clinical.trials@ipsen.com|
312391|NCT03008590|VA Boston Healthcare System|Dr Paul Monach, Chief, Rheumatology Section|857-364-5552|Paul.Monach@va.gov|
312392|NCT03008707|University of Pusa|Dario Tartaglia|+393334491229|dario261184@gmail.com|
312393|NCT03008837|VAORD|Dr. Anna Woodbury|404-321-6111|anna.woodbury@va.gov|
312394|NCT03008889|Emory University|Dr. Lawrence Scahill|404-785-9336|lawrence.scahill@emory.edu|
270272|NCT00117507|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
270273|NCT00117559|VA Boston Healthcare System|Amy Silberbogen, Ph.D.|857-364-4797|amy.silberbogen@va.gov|
292072|NCT01402375|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-6626|achang3@yahoo.com|
292073|NCT01402427|State Health Center, Hungary|Istvan Hizoh, MD, PhD / Senior Consultant|+36 1 4651800|ihizoh@web.de|71773
292074|NCT01402492|UCLA Integrated Substance Abuse Programs|Walter Ling, MD|310-267-5888|lwalter@ucla.edu|
292075|NCT01402544|Univeristy of California, San Diego|Dr. Henry Ferreyra|858-822-7982|hferreyra@ucsd.edu|
292076|NCT01402570|University of Michigan|Claire Z. Kalpakjian|734-763-0153|clairez@umich.edu|
303145|NCT02149199|AstraZeneca AB|Stefan Ivanov|000000000000|information.center@astrazeneca.com|
292077|NCT01402700|Medtronic|Stephanie Cihlar|763-398-7932|stephanie.a.cihlar@medtronic.com|
292078|NCT01402817|Indiana University School of Medicine - Pediatrics|Chie-Schin Shih, MD|317-948-8568|shih2@iu.edu|
292079|NCT01402869|Loma Linda University|Dr. Lauren Gutenberg|909-558-4690|lgutenberg@llu.edu|
292080|NCT01402908|Medigen Biotechnology Corp.|Clinical Research Manager|886-2-77361234|Doyce.Chen@medigen.com.tw|
303146|NCT02149264|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
303147|NCT02149290|ZOLL LifeVest|VP of Medical Affairs|412-968-3333|stevens@zoll.com|14400
303148|NCT02149303|Boehringer Ingelheim|Boehringer Ingelheim Call Center|800-243-0127|clintriage.rdg@boehringer-ingelheim.com|+1
312395|NCT03008915|Columbia University|Dr. Carrie Pistenmaa|212-342-4162|"cp2346@atcumc.columbia.edu"|
312396|NCT03009162|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312397|NCT03009396|Redhill Biopharma|Reza Fathi, Sn. VP Research and Development|972-(0)3-541-3131|reza@redhillbio.com|
312398|NCT03010137|UC Davis Medical Center|Dr. Yunfeng Xue|408-603-0507|yunxue@ucdavis.edu|
312399|NCT03010254|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
312400|NCT03010462|Nexstim Plc|Vice President, Medical Affairs|+358927271710|jarmo.laine@nexstim.com|
312401|NCT03010488|New York State Psychiatric Institute|David Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
312402|NCT03010501|Laboratory for the Study of Human Ingestive Behavior, The Pennsylvania State University|Dr. Barbara J. Rolls|814-863-8481|bjr4@psu.edu|
312403|NCT03010527|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
312404|NCT03010631|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
312405|NCT03010683|2nd Cardiology Department, National and Kapodistrian University of Athens, Attikon Hospital|Dr Ignatios Ikonomidis|+30 6944805732|ignoik@gmail.com|
312406|NCT03010800|Oklahoma University Health Science Center|Dr. Robert Hurst|405-271-3930|Robert-Hurst@ouhsc.edu|
312407|NCT03011099|UT health PM&R|Chang, Shuo-Hsiu, PT, PhD|713-799-7016|Shuo-Hsiu.Chang@uth.tmc.edu|
312408|NCT03011333|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
312409|NCT03011840|Tata Memorial Hospital, Mumbai|Dr. Sumitra Bakshi|+912224177058|sumitrabakshi@yahoo.com|
312410|NCT03011892|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
312411|NCT03012061|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312412|NCT03012191|University of Southern California Department of Dermatology|Dr. David Woodley|(323)442-0084|dwoodley@med.usc.edu|
312413|NCT03012334|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312414|NCT03012477|Dana-Farber Cancer Institute|Sara Tolaney, MD, MPH|(877) 442-3324|Sara_Tolaney@dfci.harvard.edu|
312415|NCT03012594|Northwell health|Dr.Larry Miller|5165620334|lmiller7@northwell.edu|
312416|NCT03012672|University of Washington|Anna Halpern, MD|206-606-1978|halpern2@uw.edu|
312417|NCT03012828|Medicines Development Limited|Sally Kinrade, Vice President (Clinical Development)|+613 9629 6111|sally.kinrade@medicinesdevelopment.com|
312418|NCT03012841|Medtronic|Mary Sauline, Clinical Research Specialist|440-596-3529|mary.k.sauline@medtronic.com|
312419|NCT03013985|Emory University|Dr. Guillermo Umpierrez|404-778-1665|GEUMPIE@emory.edu|
312420|NCT03014011|Bispebjerg Hospital|MD Malin Nilsson|50595861|mnil0028@regionh.dk|0045
312421|NCT03014180|Microport CRM|Director of Scientific Communication|0677164209|anne.rousseauplasse@crm.microport.com|
312422|NCT03014206|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312423|NCT03014453|Shengjing Hospital of China Medical University|Dr. Shucheng Zhang|862496615|zhangshucheng76@126.com|57911
312424|NCT03014479|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
312425|NCT03014492|Cincinanti Childrens Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
312426|NCT03014674|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312427|NCT03014700|Stanford university School of Medicine|Glyn David Williams|650-723-5728|jumbo@stanford.edu|
312428|NCT03015116|Landstuhl Regional Medical Center|Dr. Ann Kobiela Ketz|8022656263|annketz@gmail.com|
312429|NCT03015142|Philips|Rami Nachabe|+1-513-926-1486|rami.nachabe@philips.com|
312430|NCT03015181|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
312431|NCT03015194|National Heart Lung and Blood Institute (NHLBI)|Robert Lederman, M.D. Principal Investigator, NIH, NHLBI|301.402.6769|ledermar@nhlbi.nih.gov|
312432|NCT03015220|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
312433|NCT03015363|CardioVascular Research New Brunswick (CVR-NB)|Sohrab Lutchmedial, MD, FRCP(C)|506-648-6101|sohrab.lutchmedial@horizonnb.ca|
312434|NCT03015532|Heron Therapeutics, Inc.|Vice President, Clinical Operations|858-251-7232|svisonneau@herontx.com|
312435|NCT03015649|Envision Healthcare Scientific Intelligence, Inc.|Women's Imaging Director|9549397729|clinicaltrials@shcr.com|
312436|NCT03015961|Pacira Pharmaceuticals, Inc.|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
292081|NCT01402947|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
292082|NCT01402986|MedImmune, LLC|Meena Jain, MB BChir, Director, Clinical Development,|301-398-0000|JainM@medimmune.com|
292083|NCT01403051|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
292084|NCT01403064|CSL Behring|Study Director|610-878-4000|clinicaltrials@cslbehring.com|
292085|NCT01403090|BiO2 medical|Luis Angel, MD|2102139778|langel@bio2medical.com|
292086|NCT01403116|Clarus Therapeutics|Theodore Danoff, MD, PhD|847-562-4300|tdanoff@clarustherapeutics.com|
292087|NCT01403246|GIMEMA|Alfonso Piciocchi|+393203671224|a.piciocchi@gimema.it|
292088|NCT01403376|Sanofi|Trial Transparency Team||Contact_US@sanofi.com|
292089|NCT01403441|Stanford University|Dr. Hugh Brent Solvason|650 776 4793|solvason@stanford.edu|
292090|NCT01403584|Universitätsklinik, Essen|Prof. Helmut Teschler|0201 433 4001|teschlerh@t-online.de|
303149|NCT02149342|Helsinki university central hospital|Md, PhD Noora Neittaanmäki-Perttu|+358407190362|noora.neittaanmaki@fimnet.fi|
303150|NCT02149420|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
303151|NCT02149524|Samsung Bioepis Co., Ltd.|Director of Clinical Trials||sbregistry@samsung.com|
303152|NCT02149810|London Health Sciences Centre|Dr. Akshya Vasudev|519-685-8500|akshya.vasudev@lhsc.on.ca|75504
303153|NCT02149836|Icahn School of Medicine at Mount Sinai|Dr. James W. Murrough|212-241-6539|james.murrough@mssm.edu|
303154|NCT02149875|Shanghai Sixth People's Hospital|Dr. Hao Chen|02164369181|chenhao_316@aliyun.com|8405
303155|NCT02150044|Acclarent, Inc.|Director of Clinical Research|650-687-5888|lenglan1@its.jnj.com|
303156|NCT02150057|Andrews Institute for Orthopaedics & Sports Medicine|Dr. Roger Ostrander|850-916-3700|rostrander@flboneandjoint.com|3725
303157|NCT02150109|Ascensia Diabetes Care|Jane Wallace, Deputy Director Clinical Trials|574-257-3063|jane.wallace@ascensia.com|
303158|NCT02150213|Novartis|Study Director|862-778-8300||
303159|NCT02150343|Circassia Ltd|VP Clinical Operations|+44 1865 405560|kirsten.evans@circassia.com|
303160|NCT02150460|National Eye Centre, Kaduna. Nigeria|Dr Aminatu Ali AbdulRahman|+2348037878367|aaaminatu@yahoo.com|
303161|NCT02150499|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351|clinicaltrialsdisclousre@sunovion.com|
303162|NCT02150759|Inje University, Haeundae paik hospital|Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
303163|NCT02150837|Medifast|Chris Coleman|410-504-8161|ccoleman@choosemedifast.com|
303164|NCT02150954|Duke University Medical Center|Chad Grotegut , MD||chad.grotegut@dm.duke.edu|
303165|NCT02151058|Johnson & Johnson Consumer and Personal Products Worldwide|Michael Lynch, DMD, PhD/Study Director|908-433-6423 USA EST|mlynch23@its.jnj.com|
303166|NCT02151110|MedImmune LLC|David Howe, MBChB, MD, MRCOG|+44 (0) 1223 895980|information.center@astrazenea.com|
303167|NCT02151149|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
312437|NCT03016078|Mölnlycke Health Care|Global Clinical Research Director|+46 31 722 30 00|info@monlycke.com|
312438|NCT03016325|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
312439|NCT03016403|Latino Research and Policy Center, University of Colorado Denver|Evelinn Borrayo, Associate Director|303-724-0884|Evelinn.Borrayo@cuanschutz.edu|
312440|NCT03016598|Portland VA|Delaney.McKechnie@va.gov|360-696-4061|Delaney.McKechnie@va.gov|32017
312441|NCT03017079|THE SECOND AFFILIATED HOSPITAL ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE|Dr|18817821529|hm198699@126.com|
312442|NCT03017235|Ferring Pharmaceuticals|Global Clinical Compliance|+1 833-548-1402|DKO-Disclosure@ferring.com|
312443|NCT03017261|Think Surgical|Valentina Campanelli|510-249-2314|vcampanelli@thinksurgical.com|
312444|NCT03017508|Yale University|Angeli Landeros|203-737-4809|angeli.landeros@yale.edu|
312445|NCT03017612|Ms.|Tracy Shwaery, Global Clinical Research Manager|9497072740|tshwaery@revisionoptics.com|157
312446|NCT03017846|Albert Einstein College of Medicine|Anthony Guzman, MD|7189208352|anguzman@montefiore.org|
312447|NCT03017924|Cincinnati Childrens Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
312448|NCT03017937|Cincinnati Chidren's Hospital|Kim Foss|5136365971|kim.foss@cchmc.org|
312449|NCT03018028|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
312450|NCT03018106|Emory University|Gina Northington, MD|(404) 778-5770|gina.northington@emory.edu|
312451|NCT03018223|Moffitt Cancer Center|Nelli Bejanyan, MD|813-745-7208|Nellie.Bejanyan@moffitt.org|
312452|NCT03018249|NRG Oncology|Linda Gedeon for Virginia Filiaci, PhD|716-845-1169|linda.gedeon@roswellpark.org|
312453|NCT03018340|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
312454|NCT03018691|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
292091|NCT01403610|UT Health San Antonio|Andrew Brenner|210-450-1000|regulatoryaffairs@uthscsa.edu|
292092|NCT01403805|Department of Dentistry, Yubari Kibounomori, Japan|Dr. Masahiro Hatta|+81-123-52-4339|masahiro.hatta@hotmail.co.jp|
303168|NCT02151253|Duke University Health System|Andrew D. Krystal, MD, MS|919-971-4355|andrew.krystal@duke.edu|
292093|NCT01403987|Boston Medical Center|Brian Jacobson, MD, Principal Investigator|617-6386563|brian.jacobson@bmc.org|
292094|NCT01404039|Spaulding Rehabilitation Hospital|Felipe Fregni|6179526156|felipe.fregni@ppcr.hms.harvard.edu|
292095|NCT01404078|St John's Research Institute|Dr. Alben Sigamani|+918049467080|alben@sjri.res.in|
292096|NCT01404208|MGH|Dr. Daniel Geller|617 724 5141|dan.geller@mgh.harvard.edu|
292097|NCT01404234|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
292098|NCT01404260|Shanghai Chest Hospital|Shun LU|86-2162821990|shun_lu11@163.com|
303169|NCT02151266|Emory University|Dr. Gary|404-727-8360|ragary@emory.edu|
303170|NCT02151331|University of Michigan|Amy Kilbourne, PhD|734-845-3452|amykilbo@umich.edu|
303171|NCT02151448|UPMC Hillman Cancer Center|Barbara Stadterman, MPH, MCCR, Regulatory Supervisor, CRS|412-647-5554|stadtermanbm@upmc.edu|
303172|NCT02151461|NuSirt Biopharma|Barbara Cannon|6156567898|BCannon@nusirt.com|
303173|NCT02151487|UT Southwestern Medical Center|Dawood Nasir|214-590-5352|Dawood.Nasir@UTSouthwestern.edu|
303174|NCT02151526|bluebird bio, Inc.|Study Medical Director|339-499-9300|medinfo@bluebirdbio.com|
303175|NCT02151591|YALE UNIVERSITY SCHOOL OF MEDICINE|Dr. Lisa Fucito|203-200-1470|Lisa.fucito@yale.edu|
303176|NCT02151643|Shield Therapeutics|Mark Sampson|+44 (0) 207 186 8500|msampson@shieldtx.com|
303177|NCT02151682|Grünenthal GmbH|Clinical Trial Helpdesk|+49-(0)241-569|clinical-trials@grunenthal.com|3223
303178|NCT02151773|Takeda|Takeda Study Registration Call Center|+1-877-825-3327|medicalinformation@tpna.com|
303179|NCT02151786|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303180|NCT02151851|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
303181|NCT02151877|Advocate Health Care|Chawki Elzein, MD, FACS|7086843029|chawki.elzein@advocatehealth.com|
303182|NCT02151903|Alopexx Oncology, LLC|Chief Medical Officer||daniel.vlock@alopexx.com|
303183|NCT02151981|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
303184|NCT02151994|BIAL-Portela & Ca, S.A.,|Head of Clinical Research|(+351)-22-9866100|clinical.trials@bial.com|
303185|NCT02152007|TransDerm, Inc.|Roger Kaspar, PhD|831-420-1684|roger.kaspar@transderminc.com|
303186|NCT02152085|University of Colorado Boulder|Roger Enoka|3034927232|enoka@colorado.edu|
303187|NCT02152137|Mayo Clinic|Robert C. Smallridge, M.D.|904-953-2392|smallridge.robert@mayo.edu|
303188|NCT02152163|Delray Medical Center|Russell Weisz, MD|561-213-9371|rdweisz@gmail.com|
312455|NCT03018925|Institut d'Investigació Biomèdica de Girona - Hosp Univ Dr Josep Trueta|MD PhD X Aldeguer|34972940200|xaldeguer.girona.ics@gencat.cat; abahi@idibgi.org|2401
312456|NCT03018938|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312457|NCT03019055|Froedtert Hospital and the Medical College of Wisconsin|Dr. Nirav Shah, MD|414-805-8900|cccto@mcw.edu|
312458|NCT03019107|Liberate Medical|Angus Mclachlan|+1 (833) 203-4663|info@liberatemedical.com|
312459|NCT03019289|Prilenia|Prilenia|+972 775558|info@prilenia.com|482
312460|NCT03019406|Genzyme, a Sanofi Company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6#
312461|NCT03019458|Sunshine Care Foundation|Dr. Patrick Acuna|+63 947 959-1851|patrick_acuna@hotmail.com|
312462|NCT03019549|Eli Lilly and Compnay|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
312463|NCT03019627|Dompé|Valeria Motta, PhD|02583831|info@dompe.it|
312464|NCT03019744|Fondazione Don Carlo Gnocchi|Dr Maurizio Ferrarin|+390240308305|mferrarin@dongnocchi.it|
312465|NCT03019783|Brigham and Women's Hospital|Dr. Joshua Beckman|617-732-5500|joshua.a.beckman@vanderbilt.edu|
312466|NCT03019796|University of Castilla-La Mancha|Proffessor|925268800|ricardo.mora@uclm.es|
312467|NCT03019887|Okada hospital|Dr. Ryota Ataniya|+81-4-7124-6151|ryotaataniya@pbt.nir.jp|
312468|NCT03019939|The University of Texas MD Anderson Cancer Center|Prithviraj Bose MD/Associate Porfessor|713-792-7747|PBose@mdanderson.org|
312469|NCT03019965|CISMexico|Dr. Yazmín Fuentes|55276900|yazmin_fuentes@hotmail.com|22462
312470|NCT03020004|Ascletis Pharmaceuticals Co., Ltd|Clinical Trial Disclosures|+86057185389732|yicheng.zhao@ascletis.com|
312471|NCT03020069|NYU Langone Health|Jeniece Ilkowitz RN, MA, CDE|212-263-9910|Jeniece.ilkowitz@nyulangone.org|
312472|NCT03020082|Ascletis Pharmaceticals Co., Ltd|Clinical Trial Disclosures|86057187707910|xin.li@ascletis.com|
312473|NCT03020095|Ascletis Pharmaceticals Co., Ltd|Clinical Trial Disclosures|86057187707910|xin.li@ascletis.com|
281732|NCT00819234|AstraZeneca|Peter Ohman, Medical Science Director||ClinicalTrialTransparency@astrazeneca.com|
281733|NCT00819247|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
281734|NCT00819260|Dartmouth-Hitchcock|Carolyn L. Kerrigan MD|603-650-5148|carolyn.kerrigan@hitchcock.org|
281735|NCT00819286|Biomet Microfixation|Brian Hatcher|904-741-4400|brian.hatcher@biomet.com|
281736|NCT00819390|ACTG Network Coordinating Center, Social and Scientific Systems|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
281737|NCT00819403|Univ Maryland|Dr Michael Miller|410 328-6299|mmiller@medicine.umaryland.edu|
292099|NCT01404325|Novartis Pharmaceuticals|Study Director|8627788300||
292100|NCT01404429|PGIMER, India|Varun Dhir, Assistant Professor, Internal Medicine|+91-8872229998|varundhir@gmail.com|
292101|NCT01404559|University of South Florida|William S. Quillen|8139749863|wquillen@health.usf.edu|
303189|NCT02152345|Columbia University Irving Medical Center|Dr. Mark A. Hardy|(212) 305-5502|mah1@cumc.columbia.edu|
303190|NCT02152371|Eli Lilly and Company|Chief Medical Officer|1-800-545-5979||
303191|NCT02152384|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
281738|NCT00819507|Oregon Health & Science University|Eric Simpson|503-494-2121|simpsone@ohsu.edu|
303192|NCT02152540|DVBIC, VA Palo Alto/Stanford School of Medicine|Dr. Maheen M. Adamson|6502136307|madamson@stanford.edu|
303193|NCT02152605|GlaxoSmithKline|GSK Response Center|866-435-7343||
303194|NCT02152631|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
303195|NCT02152696|Yale University|Heping Zhang, PhD|203-785-5185|heping.zhang@yale.edu|
303196|NCT02152761|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
303197|NCT02152826|The Procter & Gamble Company|Clinical Trial Manager|513-622-2489|peters.j.2@pg.com|
303198|NCT02153073|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303199|NCT02153086|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303200|NCT02153099|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303201|NCT02153112|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303202|NCT02153346|GlaxoSmithKline|GSK Response Center|866-435-7343||
303203|NCT02153359|Johns Hopkins University|Dr. Sonali Bose|410-550-2708|kladson1@jhmi.edu|
303204|NCT02153398|Biometrics Department, Science Affairs Division, R&D, AstraZeneca Japan|Masahiro Nii||Masahiro.Nii@astrazeneca.com|
303205|NCT02153476|Allegro Ophthalmics, LLC|Director of Clinical Research|949-444-5722|lkarageozian@allegroeye.com|
303206|NCT02153489|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
303207|NCT02153528|Institute of Tropical Medicine Antwerp|Clinical Trials Unit ITM|0032 32470778|jbuyze@itg.be|
303208|NCT02153671|PATH|Jorge Flores|(202) 822-0033|jeflores@path.org|
303209|NCT02153710|University of Washington|Diane Kendall|2066160537|dkendall@uw.edu|
303210|NCT02153723|Montefiore Medical Center|Aleksandra Djukic|718 920 4378|adjukic@montefiore.org|
303211|NCT02153736|Virginia Commonwealth University|Stacey Dusing, PT, PhD, PCS, Director Motor Development Lab|804-628-3632|scdusing@vcu.edu|
303212|NCT02153788|Duke University Medical Center|Andrew Krystal, MD|919-681-8742|andrew.krystal@duke.edu|
303213|NCT02153827|University of St. Augustine|Eric Chaconas|904-826-0084|echaconas@usa.edu|1275
303214|NCT02153905|National Cancer Institute|Dr. Steven Rosenberg|240-858-3080|sr78a@nih.gov|
303215|NCT02153918|National Cancer Institute|Dr. Peter Pinto|301-496-6353|pintop@nih.gov|
303216|NCT02153983|NICHD, National Institutes of Health|Dr. Jack Yanovski|13014960858|yanovskj@mail.nih.gov|
303217|NCT02154048|Duke University|Steve Melton, MD|919.668.2047|steve.melton@duke.edu|
312474|NCT03020407|Department of Emergency Medicine, Faculty of Medicine, Chulalongkorn University|Dr. Khrongwong Musikatavorn|+6626494000|kmusikatavorn@yahoo.com|83058
312475|NCT03020472|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
312476|NCT03020498|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
312477|NCT03020524|University of Pennsylvania|Regulatory Lead|215.662.4484|psom-ind-ide@pobox.upenn.edu|
312478|NCT03020537|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
312479|NCT03020550|University of California, Davis|Michelle Dossett, MD, PhD|916-734-5367|mdossett@ucdavis.edu|
312480|NCT03020576|Columbia University Medical Center/ Dept. of Rehabilitation & Regenerative Medicine|Lauri Bishop, PT, DPT Research Physical Therapist|212-305-6095|LB2413@cumc.columbia.edu|
312481|NCT03020615|St. Jude Children's Research Hospital|Jeremie Estepp, MD|(901) 595-5703|jeremie.estepp@stjude.org|
312482|NCT03020641|Ramon y Cajal University Hospital|Characterization of changes in peritoneal cells gene expression after standard versus low pressure l|610 312962|aserranor@salud.madrid.org|+34
312483|NCT03020719|Seattle Children's Hospital|Arthur Baines|2068841431|Arthur.Baines@seattlechildrens.org|
312484|NCT03020745|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312485|NCT03020888|Endomag|Dr Matthew Womack|+44 7851 247439|mwomack@endomag.com|
312486|NCT03020966|Hospital for Special Surgery|Dr. Jacques Yadeau|(212) 774-2224|Yadeauj@hss.edu|
312487|NCT03020992|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
312488|NCT03021005|Johns Hopkins University|Dr. Yu-Hsiang Hsieh|410-735-6413|yhsieh1@jhmi.edu|
312489|NCT03021018|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
312490|NCT03021187|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
312491|NCT03021265|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312492|NCT03021304|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312493|NCT03021343|Khalidi Hospital & Medical Center|Dr. Ramzi Tabbalat|00962795535522|ramzi_md@yahoo.com|
312494|NCT03021499|Aurinia Pharmaceuticals|Rashieda Gluck|1 (250) 744-2487|clinicaltrials@auriniapharma.com|
312495|NCT03021538|Cleveland Clinic|Michael Tong, M. D.|216-445-0807|tongz@ccf.org|
281739|NCT00819585|Novartis Pharmaceuticals|Study Director|862-778-8300||
281740|NCT00819637|Henry Ford Health System, Detroit, Michigan|Richard M Nowak MD|313 881 0023|rnowak1@hfhs.staff|
281741|NCT00819741|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
281742|NCT00819767|Novartis Pharmaceuticals|Study Director|862 778-8300||
281743|NCT00819780|Amgen Inc.|Study Director|866-572-6436||
281744|NCT00819793|Abbott|Poornima Sood||psood@sjm.com|
281745|NCT00819910|Brooke Army Medical Center|Ahmad Slim, MD|2109164717|ahmad.slim@us.army.mil|
292102|NCT01404572|Bristol-Myers Squibb (BMS)|BMS Study Director||Clinical.Trials@bms.com|
292103|NCT01404611|Laboratorios SALVAT|Enrique Jimenez, Medical Director|+34933946470|ejimenezv@salvatbiotech.com|
303218|NCT02154061|Emory University|Nadine Rouphael, MD|404-712-1435|nroupha@emory.edu|
292104|NCT01404650|Sarah Cannon Research Institute|Johanna Bendell, MD|877-691-7274|asksarah@sarahcannon.com|
292105|NCT01404832|Dallas VAMC|Stuart Spechler|214-374-7799|sjspechler@aol.com|
303219|NCT02154139|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303220|NCT02154243|HSS|Dr. Haskins|(212) 606-1000|HaskinsS@hss.edu|
303221|NCT02154347|Kissei Pharmaceutical Co., Ltd|Clinical Development Division|Email only|rinsyousiken@pharm.kissei.co.jp|
303222|NCT02154386|UT Health Science Center San Antonio (School of Dentistry)|Dr. Brian Mealey|210-567-3567|mealey@uthscsa.edu|
303223|NCT02154425|Cares|UCB|+1877 822||9493
303224|NCT02154477|SLU|sandeep dhindsa|314-977-4911|dhindsa@slu.edu|
303225|NCT02154581|UT Health San Antonio|Research Compliance Coordinator-Senior|210-567-8554|NijlandK@uthscsa.edu|
303226|NCT02154672|Yale University School of Medicine|Dr. Preston Sprenkle|2037852815|preston.sprenkle@yale.edu|
303227|NCT02154763|The Ottawa Hospital|Dr.Joseph Mamazza|613-798-5555|jmamazza@toh.on.ca|
303228|NCT02154906|UT Health Science Center San Antonio|Brian L. Mealey|210-567-3567|mealey@uthscsa.edu|
303229|NCT02155010|Haeundae paik hospital, Inje University|Ki Hwa Lee|82-51-797-0421|tedy3333@naver.com|
303230|NCT02155101|University of Liverpool|Professor Anna Maria Geretti|+44(0)151 795 9625|Geretti@liverpool.ac.uk|
303231|NCT02155257|Wake Forest University Health Sciences|Dr. James Eisenach|3367164182|eisenach@wakehealth.edu|
303232|NCT02155283|Radiancy Ltd|Dr. Daniele Perl-Treves, Clinical Director|972-97757556|daniele@radiancy.com|
303233|NCT02155309|Henry Jackson Military Foundation for Naval Medical Research Unit - Dayton|Daniel Geyer, MPH|(937) 938-3922|daniel.geyer.1.ctr@us.af.mil|
303234|NCT02155322|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
303235|NCT02155335|Merck Sharp & Dohme|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
303236|NCT02155465|Memorial Sloan Kettering Cancer Center|Dr. Helena Yu, MD|646-888-4274|YuH@mskcc.org|
303237|NCT02155543|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
303238|NCT02155608|University of California, Los Angeles|James McGough, M.D.|310-794-7841|jmcgough@mednet.ucla.edu|
303239|NCT02155647|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
303240|NCT02155660|AstraZeneca|Ulbaldo Martin|1.301.398.0163|ulbaldo.martin@astrazeneca.com|
303241|NCT02155712|Stryker Orthopaedics|Ellen Axelson, Director, Clinical Operations|201-831-5401|ellen.axelson@stryker.com|
303242|NCT02155725|LFB Biomédicaments|Medical Director France|33 169827229|zitounis@lfb.fr|
303243|NCT02155738|University of Pittsburgh|Halina Zyczynski|412-641-1440|hzyczynski@mail.magee.edu|
303244|NCT02155829|USUHS|Dr. David M. Benedek|(301) 295-3294|david.benedek@usuhs.edu|
303245|NCT02155881|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
303246|NCT02155985|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
303247|NCT02156076|Bristol-Myers Squibb|Study Director||Clinical.Trials@bms.com|
303248|NCT02156154|Cleveland Clinic|Alparslan Turan, MD|216-445-0998|turana@ccf.org|
312496|NCT03021564|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Maxime Leloup|+33 (0)5 46 45 66 09|maxime.leloup@ght-atlantique17.fr|
312497|NCT03021642|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
312498|NCT03021668|Johns Hopkins Hospital|Dr. Matthew J. Weiss|4106143368|mweiss5@jhmi.edu|
312499|NCT03021759|University of Pennsylvania|Rebecca Pepe|215-360-0951|peper@pennmedicine.upenn.edu|
312500|NCT03022045|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
312501|NCT03022084|VA RR&D National Center for Rehabilitative Auditory Research|Dr. James Henry|503-220-8262|James.Henry@va.gov|
312502|NCT03022370|SAMRC|Dr Andrew Gibbs|+27(0)312034899|andrew.gibbs@mrc.ac.za|
312503|NCT03022396|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
312504|NCT03022422|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
312505|NCT03022435|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker.|650-724-4437|cdekker@stanford.edu|
312506|NCT03022526|University of Pittsburgh|Dr. Grace Lim|412-641-2179|limkg2@upmc.edu|
312507|NCT03022617|University of Alabama at Birmingham|Dr. Boni Elewski|205-502-9960|dermresearch@uabmc.edu|
312508|NCT03022630|Vanderbilt University Medical Center|Dr. Cheryl Gatto|6153432252|cheryl.l.gatto.1@vumc.org|
312509|NCT03022799|Kainos Medicine, Inc|Dr. JaeMoon Lee|+1 408 202 4017|jlee@kainosmedicine.com|
312510|NCT03022916|UAB|Director of Clinical Trials, UAB Dermatology|2055029960|Lmroop@uabmc.edu|
312511|NCT03022981|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
312512|NCT03023137|Hospital Federal dos Servidores do Estado|Dr. Silvia Hoirisch-Clapauch|5521999737500|sclapauch@gmail.com|
312513|NCT03023176|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker.|650-724-4437|cdekker@stanford.edu|
312514|NCT03023397|University of North Carolina at Chapel Hill|Allison Burbank, MD|919-962-5136|allison_burbank@med.unc.edu|
312515|NCT03023423|Janssen Research & Development, LLC|Executive Medical Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
312516|NCT03023488|Marmara University, School of Medicine, Department of Urology|Dr. Tarik Emre Sener|+905337620712|dr.emresener@gmail.com|
312517|NCT03023553|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
312518|NCT03023683|Stanford University School of Medicine, Dept. of Pediatrics|Dr. Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
292106|NCT01404923|Laboratoires Mayoly Spindler|Clinical trials Manager|33 134805555|contact_essais_cliniques@mayoly-spindler.fr|
292107|NCT01404936|UT MD Anderson Cancer Center|Anas Younes, MD / Professor||CR_Study_Registration@mdanderson.org|
292108|NCT01404949|Memorial Sloan Kettering Cancer Center|Dr. Jae Park, MD|646-608-3743|parkj6@mskcc.org|
292109|NCT01404988|VA New York Harbor Healthcare System|Sundar Natarajan, MD, M.Sc.|212-951-3395|sundar.natarajan@va.gov|
292110|NCT01405027|Chronic Liver Disease Foundation|Dr. Fred Poordad|732-381-8887|poordad@txliver.com|
292111|NCT01405053|Eisai Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
292112|NCT01405196|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292113|NCT01405313|ResMed|Director Medical Affairs|+6128841000|adamb@resmed.com.au|
292114|NCT01405456|Massachusetts General Hospital|Dr. Steven K. Grinspoon|6177249109|sgrinspoon@mgh.harvard.edu|
303249|NCT02156167|Cochlear|Christiane D'hondt, Clinical Research Specialist|+32 15 76 55 14|cdhondt@cochlear.com|
303250|NCT02156258|Fujifilm Medical Systems USA, Inc.|Randy Vader|360-356-6821|randy.vader@fujifilm.com|
303251|NCT02156271|Duke University Medical Center|Dr. Andrew Krystal|919-681-8742|andrew.krystal@duke.edu|
303252|NCT02156466|Merck Healthcare, a business of Merck KGaA, Darmstadt, Germany|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
303253|NCT02156492|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
303254|NCT02156674|Masonic Cancer Center, University of Minnesota|Elizabeth Braunlin MD, PhD|612 626 2755|braun002@umn.edu|
303255|NCT02156687|Cleveland Clinic|Cecile Ferrando, M.D.|216-444-0642|ferranc2@ccf.org|
303256|NCT02156804|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email|Clinical.Trials@bms.com|
303257|NCT02156908|Nathan Kline Institute|Joshua Kantrowitz|646-774-6738|josh.kantrowitz@nki.rfmh.org|
303258|NCT02157103|Emory University|William L. Read, MD, Principal Investigator|404-778-1900|william.l.read@emory.edu|
303259|NCT02157168|University of Arizona|Dr. Ada Wilkinson-Lee, Co-Investigator|(520) 626-7766|adaw@email.arizona.edu|
303260|NCT02157298|AstraZeneca K.K.|Yuji Ageishi|+81-3-6268-2740|Yuji.Ageishi@astrazeneca.com|
303261|NCT02157376|AstraZeneca|Barry Traxler||barry.traxler@astrazeneca.com|
303262|NCT02157506|Bristol-Myers Squibb International Corporation|EU Study Start-Up Unit||clinical.trials@bms.com|
303263|NCT02157519|Massachusetts General Hospital Cancer Center|Joseph Greer, PhD|617-643-2143|jgreer2@mgh.harvard.edu|
303264|NCT02157623|Cleveland Clinic|Edward Maytin, MD, PhD|216-445-6676|maytine@ccf.org|
303265|NCT02157779|Providence VA Medical Center|M. Tracie Shea, PhD|401-273-7100|MaryTracie.Shea@va.gov|6248
303266|NCT02157909|Alcon Research, Ltd.|Head Clinical Development, Vision Care, GCRA|1-888-451-3937|alcon.medinfo@alcon.com|
303267|NCT02157935|AstraZeneca|Tor Skärby||tor.skarby@astrazeneca.com|
303268|NCT02157948|Amgen Inc.|Study Director|866-572-6436||
303269|NCT02158039|Mayo Clinic|Dr. Mark Topazian|507-284-7602|topazian.mark@mayo.edu|
303270|NCT02158091|Dana-Farber Cancer Institute|Matthew Davids, MD|617-632-6331|matthew_davids@dfci.harvard.edu|
303271|NCT02158247|The Catholic University of Korea|Dr. Oh Saecheol|+88-42-220-9046|oscane0822@gmail.com|
303272|NCT02158273|The Scripps Research Institute|Dr. Barbara Mason|(858) 784-7324|mason@scripps.edu|
303273|NCT02158364|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303274|NCT02158442|Osprey Medical|Michele Shepard|952.955.8236|mshepard@ospreymed.com|
303275|NCT02158494|University of Wisconsin - Madison|Mitchell Tyler|608-262-5112|metyler1@wisc.edu|
303276|NCT02158520|Mayo Clinic|Svetomir N. Markovic MD, PhD|507/266-0800|markovic.svetomir@mayo.edu|
303277|NCT02158533|Alkermes|Eva Stroynowski|781-609-7000|Eva.Stroynowski@alkermes.com|
303278|NCT02158546|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
303279|NCT02158572|Agile Therapeutics|Michelle Previtera, Associate Director of Clinical Development|609-683-1880|mprevitera@agiletherapeutics.com|
303280|NCT02158663|James A. Haley VA Hospital|F. Andrew Kozel|(813) 972-2000|FRANK.KOZEL@VA.GOV|
303281|NCT02158728|Medtronic|Clinical Research Specialist L. Vainer|+31 43 3566752|lidwien.vainer@medtronic.com|
303282|NCT02158806|University of Auckland|Professor Andrew Jull|+64 9 923 4259|a.jull@auckland.ac.nz|
303283|NCT02158884|Major Extremity Trauma and Rehabilitation Consortium|Susan Collins (Study Manager)|410 502 8966|scolli21@jhu.edu|
303284|NCT02158936|Novartis Pharma AG|Study Director|862-778-8300||
303285|NCT02158949|University of Southern California|Elizabeth Burner|3234096667|eburner@usc.edu|
303286|NCT02158975|University of Michigan Comprehensive Cancer Center|Dr. Ryan Wilcox, M.D.|734-615-1482|rywilcox@umich.edu|
303287|NCT02159053|Novartis Pharmaceuticals|Study Director|8627788300||
303288|NCT02159079|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
303289|NCT02159118|The University of Texas Health Science Center|Chatchawin Assanasen, MD|210-567-7456|assanasen@uthscsa.edu|
303290|NCT02159183|ZMK University of Bern, Clinic of Periodontology|Prof. Dr. med. dent., Dr. h.c., M.S. Anton Sculean|004131 632 25 72|anton.sculean@zmk.unibe.ch|77
303291|NCT02159352|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
303292|NCT02159365|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
312519|NCT03023709|Stanford University School of Medicine, Dept. of Pediatrics|Dr Cornelia Dekker|650-724-4437|cdekker@stanford.edu|
312520|NCT03023722|Yale University|Stacey Stein, MD|203 737-1600|stacey.stein@yale.edu|
312521|NCT03023813|Cleveland Clinic|Glen Taksler PhD|216-445-7499|taksleg@ccf.org|
312522|NCT03023826|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312523|NCT03023878|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
303293|NCT02159469|Antares Pharma, Inc.|Jonathan Jaffe, MD|609-359-3020|jjaffe@antarespharma.com|
303294|NCT02159482|Duke University|Dr. Michael Morse|919-681-3480|morse004@mc.duke.edu|
312524|NCT03023891|Vanderbilt University Medical Center|Vivian Kawai|(615) 322-3304|vivian.k.kawai@vumc.org|
292115|NCT01405469|University Hospital Hamburg-Eppendorf|Prof. Dr. Thomas Rösch, Principal Investigator|+49 40 7410 50098|t.roesch@uke.de|
292116|NCT01405508|UCB Cares|UCB (Study Director)|+1 887 822 9493||
292117|NCT01405560|Merck Sharp & Dohme Corp|Vice President, Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292118|NCT01405742|University of Pittsburgh|Margaret V. Ragni, MD, MPH|412-209-7288|ragni@pitt.edu|
292119|NCT01405768|Washington University School of Medicine|L. Stewart Massad, M.D.|314-362-3181|massadl@wudosis.wustl.edu|
292120|NCT01405794|University of Utah|Dr. Mark Munger|801-581-6165|mmunger@hsc.utah.edu|
292121|NCT01405820|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
292122|NCT01405898|Queen Mary University London|Professor Amrita Ahluwalia|02078825720|a.ahluwalia@qmul.ac.uk|
292123|NCT01405911|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
303295|NCT02159521|EKOS Corporation|David Hahn|4254153100|David.Hahn@btgplc.com|
303296|NCT02159547|Akdeniz University|Cenker EKEN|00905321593948|cenkereken@akdeniz.edu.tr|
303297|NCT02159703|University of Pennsylvania|Alexander Lin, MD|(215) 662-3198|alexander.lin@uphs.upenn.edu|
303298|NCT02159729|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
303299|NCT02159768|National University Hospital|Senior Consultant|+65 67724200|eugene_liu_hc@nuhs.edu.sg|
303300|NCT02159807|Icahn School of Medicine at Mount Sinai|Dr. Barbara Orlando|917-496-7490|barbara.orlando@mountsinai.org|
303301|NCT02159859|Beaumont Health|Lama Hsaiky, Pharm.D. (Primary investigator)|313-593-7264|lama.hsaiky@beaumont.org|
303302|NCT02159872|The University of Texas MD Anderson Cancer Center|Elias Jabbour MD/Professor|713-792-4764|ejabbour@mdaderson.org|
303303|NCT02159898|Merit Medical, Inc|Casey Holland|7816817983|casey.holland@merit.com|
303304|NCT02159950|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300||
303305|NCT02159976|Department of Internal Medicine, Seoul National University Bundang Hospital|Nayoung Kim, M.D., Ph.D.|+ 82-31-787-7008|nayoungkim49@empas.com|
303306|NCT02160002|Wayne State University|Seetha Shankaran|(313) 745-1436|sshankar@med.wayne.edu|
303307|NCT02160041|Novartis Pharmaceuticals|Study Director|+1 (800) 778-8300|novartis.email@novartis.com|
303308|NCT02160145|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Devlopment|609 524 6788|clinicaltransparency@otsuka-us.com|
303309|NCT02160288|Massachusetts General Hospital|Dr Liliana Bordeianou|6176430541|lsavitt@mgh.harvard.edu|
303310|NCT02160314|Procter & Gamble Company Global Clinical Sciences|Mylissa Trowbridge||trowbridge.mm@pg.com|
303311|NCT02160535|University of Washington|Dr. Sylvia Lucas, MD, PhD|206-598-9260|lucass@uw.edu|
303312|NCT02160626|Aclaris Therapeutics Inc.|Judith Schnyder|+1-484-329-2144|jschnyder@aclaristx.com|
303313|NCT02160730|Cedars-Sinai Medical Center|Dr. Ning-Ai Liu|310-423-7382|ning-ai.liu@cshs.org|
303314|NCT02160782|Mirum Pharmaceuticals|Mirum Clinical Trials|1 650-667-4085|medinfo@mirumpharma.com|
303315|NCT02160808|Dartmouth-Hitchcock Medical Center|Timothy B. Gardner MD MS|603-650-6472|timothy.b.gardner@hitchcock.org|
303316|NCT02160847|Georgia State University|Dr. Jenelle Shanley Chatham|404-413-1340|jshanley@gsu.edu|
303317|NCT02160873|Florida State University|Dr. Michael J. Ormsbee|(850) 645-5000|mormsbee@fsu.edu|
303318|NCT02160899|Ionis Pharmaceuticals, Inc.|Ionis Pharmaceuticals, Inc.|800-679-4747|patients@ionisph.com|
303319|NCT02160977|Peking University Third Hospital|Dr. Jia-Kuo Yu|86-10-82267392|yujiakuo@126.com|
303320|NCT02160990|Mayo Clinic|Dr. Michael Camilleri|507-284-6218|camilleri.michael@mayo.edu|
303321|NCT02161133|Veterans Affairs New Jersey Healthcare System|Lisa McAndrew|862-400-3317|lisa.mcandrew@va.gov|
303322|NCT02161146|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
303323|NCT02161185|Proximagen, LLC|David Sequeira,|952-658-7437|dsequeira@proximagen.com|
303324|NCT02161406|University of Michigan DCC (SABER)|Dr. Cathie Spino|734-615-5469|spino@umich.edu|
303325|NCT02161458|University of Pennsylvania|Yvette Sheline, Principal Investigator|215-746-2637|cndslab@pennmedicine.upenn.edu|
303326|NCT02161484|University of Pittsburgh|Dr. Rita Merman, P.I.|41256322137|MermanRB@upmc.edu|
303327|NCT02161536|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|+972 526145354|ravit@motusgi.com|
303328|NCT02161549|MotusGI|Ravit Peled -Director of Clinical Trial|+972 (0)4 6214447|ravit@motusgi.com|203
303329|NCT02161562|Novartis Pharmaceuticals|Study Director|862-778-8300||
303330|NCT02161575|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
303331|NCT02161705|Johns Hopkins University School of Medicine|Dr. Pathik Aravind|4437879385|paravin1@jhmi.edu|
303332|NCT02161718|Alkermes|Director, Corporate and R&D Communications|781-609-7000|Gretchen.Murphy@alkermes.com|
303333|NCT02161731|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
312525|NCT03024112|University of Colorado, Denver|Dr. Jason Brainard|720-848-3257|Jason.Brainard@ucdenver.edu|
312526|NCT03024606|Saint Louis University|Research Nurse|314-977-2090|jathompson@slu.edu|
312527|NCT03024970|CooperVision, Inc.|Myhanh Nguyen, OD, FAAO|925-730-6716|mnguyen@coopervision.com|
312528|NCT03025217|Massachusetts General Hospital|Dr. Michelle Dossett|617-643-6034|mdossett@mgh.harvard.edu|
312529|NCT03025945|Arizona Eye Consultants|Sean McCafferty, MD|520-327-3487|sjmccafferty66@hotmail.com|
312530|NCT03026075|Motus GI Medical Technologies Ltd.|Ravit Peled -Director of Clinical Trial|0733243823|ravit@motusgi.com|203
312531|NCT03026088|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
312532|NCT03026166|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
312533|NCT03026257|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Clin Dev Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
312534|NCT03026283|Northwell Health|Pamela Noack|212 434 4926|pnoack@northwell.edu|
312535|NCT03026530|Region Ostergotland|Dr. Kihlstedt Pasquier|0046101041000|ebba.kihlstedt.pasquier@regionostergotland.se|
303334|NCT02161757|AstraZeneca|Global Clinical Lead|+1 301-398-0582|ClinicalTrialTransparency@astrazeneca.com|
292124|NCT01405924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292125|NCT01405937|Merck Sharp & Dohme Corp|Vice President, Late Stage Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292126|NCT01405950|Acorda Therapeutics, Inc.|Herbert Henney, PharmD|914-347-4300|hhenney@acorda.com|5138
292127|NCT01406015|Brigham and Women's Hospital|Dr. Rajesh K. Garg||RGARG@bwh.harvard.edu|
292128|NCT01406223|Duke University Medical Center|Principal Investigator|919-668-3987|francis.mcclernon@duke.edu|
292129|NCT01406444|Massachusetts General Hospital|Dr. Karen Klahr Miller|6177263870|kkmiller@mgh.harvard.org|
292130|NCT01406574|Otsuka Pharmaceutical Co., Ltd|"Leader of Department of Small Global Clinical Development"|+81-3-6361-7366||
292131|NCT01406652|Geneva University Hospitals|Dr.med Ilker Uçkay|+412237123311|ilker.uckay@hcuge.ch|
292132|NCT01406717|SPIL|Clinical Trials|912266455645|clinical.trials@sparcmail.com|
303335|NCT02162433|Massachusetts Eye and Ear|Dr. Makara Cayer|617-573-3380|makara_cayer@meei.harvard.edu|
303336|NCT02162446|Ipsen|Medical Director|see email|clinical.trials@ipsen.com|
303337|NCT02162576|Propeller Health|Dr. Meredith Barrett|415-409-9258|meredith.barrett@propellerhealth.com|
303338|NCT02162667|Celltrion|Head of Clinical Planning Department|82328505000|contact@celltrion.com|
303339|NCT02162680|Duke University Medical Center|Julia Aucoin, DNS|1 919 613 6406|julia.aucoin@dm.duke.edu|
303340|NCT02162719|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
303341|NCT02162758|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303342|NCT02162771|CELLTRION, Inc.|Dr. Sung Hyun Kim|+82-32-850-5000|contact@celltrion.com|
303343|NCT02162862|University of Pittsburgh Medical Center|Dr. Eva Szigethy|412-802-6696|szigethye@upmc.edu|
303344|NCT02162992|H. Germans Trias i Pujol|Dr. Roger Villuendas|+34 4978398|rogervilluendas@hotmail.com|
303345|NCT02163057|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
303346|NCT02163226|UT MD Anderson Cancer Center|Dr. Quynh-Nhu Nguyen, MD,Associate Professor, Radiation Oncology Department|(713) 563-2450|qnnguyen@mdanderson.org|
303347|NCT02163395|Clinical Research|Intsitut Straumann AG|0041619651111|research@straumann.com|
303348|NCT02163421|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
312536|NCT03026556|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312537|NCT03026777|LSUHSC New Orleans|Dr. David Janz|504-913-5006|djanz@lsuhsc.edu|
312538|NCT03026803|City of Hope|Jeffrey Longmate, Ph.D.|626-256-4673|jlongmate@coh.org|62478
312539|NCT03027466|National Cancer Institute|William Klein|2402766972|kleinwm@mail.nih.gov|
312540|NCT03027557|Aalborg University Hospital|Professor Peter Vestergaard|+45 97 66 36 00|p.vestergaard@rn.dk|
312541|NCT03027661|University of Tennessee Health and Science Center|Elaine Todd, Director of Sponsored Programs - Contracts and research agreements|9014483303|ElaineTodd@uthsc.edu|
312542|NCT03028012|University of Utah Physical Medicine and Rehabilitation Orthopedics|Dr. Daniel Cushman|8015852373|heidi.hansen@hsc.utah.edu|
312543|NCT03028025|VALBHS|Dr. Arnold Seto|562-826-8000|arnold.seto@va.gov|
312544|NCT03028103|Epizyme|Kemly Calixte|617-500-0608|kcalixte@epizyme.com|
312545|NCT03028129|Federal University of Mato Grosso do Sul|Julio Croda|+5567981229959|julio.croda@ufms.br|
312546|NCT03028142|Verona Pharma plc|Brian Maurer|+19147675037|brian.maurer@veronapharma.com|9147675037
312547|NCT03028220|Imperial College London|Prof Nick Oliver|02075942460|nick.oliver@imperial.ac.uk|
312548|NCT03028324|University of Miami|Joyce Rios Gomes-Osman|305-284-2632|j.gomes@miami.edu|
312549|NCT03028363|Eli Lilly and Company.|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312550|NCT03028415|Ferring Pharmaceuticals|Global Clinical Compliance|-+1 833-548-1402|DK0-Disclosure@ferring.com|
312551|NCT03028467|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312552|NCT03028636|Pelvalon|Clinical Management|650-276-0130|steve@pelvalon.com|
312553|NCT03028870|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|steven.ripa@pharma.com|
312554|NCT03028974|Stanford University|Cornelia Dekker, MD|650-724-4437|cdekker@stanford.edu|
292133|NCT01406795|Stanford University|Rusty Hofmann|6507366096|lhofmann@stanfordhealthcare.org|
292134|NCT01406873|University of Rochester|Charles Thornton, MD|585-275-2542|Charles_Thornton@urmc.rochester.edu|
292135|NCT01406938|Novartis Pharmaceutical|Study Director|862-778-8300|trialandresults.registries@novartis.com|
292136|NCT01406990|Creighton University|Dr. Katie Packard, PharmD|402-280-4566|kathleenpackard@creighton.edu|
292137|NCT01407068|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
292138|NCT01407094|University of Texas Southwestern Medical Center|Dr. Madhukar H. Trivedi|214-648-0188|madhukar.trivedi@UTSouthwestern.edu|
292139|NCT01407107|University of Texas Southwestern Medical Center|Dr. Jonathan Dowell|214-648-7097|jonathan.dowell@utsouthwestern.edu|
292140|NCT01407276|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292141|NCT01407354|University Maryland Rehabilitation and Orthopaedic Institute|Paula Richley Geigle PT PhD|410 448 6773|pgeigle@umm.edu|
292142|NCT01407367|University of Maryland Baltimore|Jeffrey C. Fink MD, MS; Principal Investigator|410-382-4822|jfink@som.umaryland.edu|
303349|NCT02163434|University at Buffalo|Dr. Thomas Guttuso, Jr.|7169326080|tguttuso@gmail.com|
303350|NCT02163447|UCSF|Dr. Grant Dorsey|415-206-4680|grant.dorsey@ucsf.edu|
303351|NCT02163486|DorkuzEU|Bahar Kuvaki|902324122836|ozbilginsule@gmail.com|
303352|NCT02163499|ZS Pharma, Inc|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
303353|NCT02163538|University Louisville|Dr. Resad Pasic|502-561-7465|resad.pasic@louisville.edu|
303354|NCT02163577|Ultragenyx Pharmaceutical Inc|Medical Information|1-888-756-8567|medinfo@ultragenyx.com|
303355|NCT02163759|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
303356|NCT02163811|VA Puget Sound Health Care System|Dr. Aaron Turner|(206) 277-6134|Aaron.Turner@va.gov|
303357|NCT02163824|Kala Pharmaceuticals, Inc|VP, Clinical Development||Results001@kalarx.com|
303358|NCT02163837|Chu St Pierre|Dr Marie Bruyneel|003225354219|marie_bruyneel@stpierre-bru.be|
303359|NCT02163902|Allergan, Inc|Beta Bowen|714-246-4446|Bowen_Beta@allergan.com|
303360|NCT02163915|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303361|NCT02163967|Weill Cornell Medical College|Margaret Altemus|646-209-6277|maltemus@med.cornell.edu|
303362|NCT02163993|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
303363|NCT02164240|DFCI|Suzanne George|617-632-5204|Suzanne_George@dfci.harvard.edu|
303364|NCT02164318|Duke University Medical Center|Dr. Jeffrey Lawson|919-681-2533|lawso006@mc.duke.edu|
303365|NCT02164383|University of Wisconsin Center for Tobacco Research and Intervention|Tanya Schlam, PhD|608-262-4149|trschlam@ctri.wisc.edu|
303366|NCT02164396|Johnson & Johnson Vision Care Inc.|Brian Pall, O.D., M.S.- Senior Principal Research Optometrist|904-443-3500|BPALL@its.jnj.com|190
303367|NCT02164422|Yale School of Medicine|Dr. Sherry McKee|2037373529|sherry.mckee@yale.edu|
303368|NCT02164513|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
303369|NCT02164539|GlaxoSmithKline|GSK Response Center|866-435-7343||
312555|NCT03028987|Stanford University School of Medicine, Dept. of Pediatrics|Cornelia Dekker, MD|6507244437|cdekker@stanford.edu|
312556|NCT03029091|Cincinnati Children's Hospital Medical Center|Marc E. Rothenberg, MD, PhD|513 636-7177|marc.rothenberg@cchmc.org|
312557|NCT03029143|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
312558|NCT03029208|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312559|NCT03029247|GlaxoSmithKline|GSK Response Center|8664357343|GSKClinicalSupportHD@gsk.com|1
312560|NCT03029585|US Biotest, Inc.|Gere S. diZerega, MD, Responsible Medical Officer|1-805-595-1300|gere.dizerega@usbiotest.com|
312561|NCT03029624|Valencia Technologies|Stacy Chambliss, Chief of Clinical Trials|661-775-1414|schambliss@valenciatechnologies.com|1002
312562|NCT03029650|University of Iowa|Nicole Brogden|319-335-8752|nicole-brogden@uiowa.edu|
312563|NCT03029715|Menoufia Univeristy|Dr Ezzeldin Ibrahim|0021006303178|ezzeldin7@yahoo.com|
312564|NCT03029780|Bristol Myer-Squibb|Nivolumab plus Ipilimumab in Subjects with Renal Cell Carcinoma|Please email|Clinical.Trials@bms.com|
312565|NCT03029819|Georgia State University School of Public Health|Claire Spears|4044139335|cspears@gsu.edu|
312566|NCT03029988|Navidea Biopharmaceuticals|Bonnie Abbruzzese Senior Director|614.793.7500|babbruzzese@navidea.com|147
312567|NCT03030183|Ra Pharmaceutical, Inc|Sponsor Ra Pharmaceutical, Inc|1 617 401 4060|trials@rapharma.com|
312568|NCT03030599|Jazz Pharmaceuticals|Director, Clinical Trial Disclosure & Transparency|2158709177|ClinicalTrialDisclosure@JazzPharma.com|
312569|NCT03030638|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312570|NCT03030989|University of Chicago|Randee Estes, Study Coordinator|773-702-1209|restes@medicine.bsd.uchicago.edu|
312571|NCT03031431|Boston Children's Hospital|Dr. Anne Hansen|(617)-355-6027|Anne.Hansen@childrens.harvard.edu|
312572|NCT03031496|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312573|NCT03031678|MED-EL Corporation|Allison Racey|1-888-633-3524|research.us@medel.com|
312574|NCT03031795|OhioHealth|John O. Elliott PhD, MPH Research Specialist Medical Education|614-566-3643|john.elliott@ohiohealth.com|
312575|NCT03031899|The Oxford Dental college|Dr. Anisha Yaji|9480718531|dr.anishayaji@gmail.com|
312576|NCT03031938|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312577|NCT03032263|Wake Forest University Health Sciences|Dr. Thomas Templeton|336-716-4285|ttemplet@wakehealth.edu|
312578|NCT03032380|Shionogi Inc.|Shionogi Clinical Trials Administrator|800-849-9707|shionogiclintrials-admin@shionogi.co.jp|
312579|NCT03032393|Youngstown State University|Associate Professor|330941-2702|wge@ysu.edu|
312580|NCT03032523|Yale University|Laura Nally, MD, Instructor in Pediatrici Endocrinology|9728324734|laura.nally@yale.edu|
312581|NCT03032965|University of Michigan|Hamid Ghanbari|734-963-7141|ghhamid@med.umich.edu|
312582|NCT03033108|Kubota Vision Inc.|Clinical Trials Helpdesk|(206) 805-8310|clinicaltrials@kubotavision.com|
312583|NCT03033134|Boston Scientific Japan|Yutaka Gomi|+81.3.6853.7500|Yutaka.Gomi@bsci.com|
292143|NCT01407523|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
292144|NCT01407575|University of Pittsburgh|Jordan F. Karp, MD|412-246-6048|karpjf@upmc.edu|
292145|NCT01407926|McMaster University|Maureen Markle-Reid, Associate Professor and Canada Research Chair, School of Nursing|905-525-9140|mreid@mcmaster.ca|22306
292146|NCT01407952|Mayo Clinic|Bernard Bendok, MD|3129269441|bendok.bernard@mayo.edu|
292147|NCT01408030|Cure HHT|James R. Gossage, MD, Medical Director of Cure HHT|706-721-6789|jgossage@augusta.edu|
292148|NCT01408043|Case Comprehensive Cancer Center|Navneet Majhail|216-444-2199|majhain@ccf.org|
303370|NCT02164721|University of Rochester|Valentina Kutyifa MD, PhD|585-275-2676|valentina.kutyifa@heart.rochester.edu|
303371|NCT02164864|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
303372|NCT02164916|SWOG Statistics & Data Management Center|SWOG Statistician|206-667-4408|smcdonou@fredhutch.org|
303373|NCT02164929|Duke University Medical Center|Timothy Miller, MD||timothy.miller2@duke.edu|
303374|NCT02164981|Massachusetts General Hospital|Maurizio Fava, MD|617-724-2513|MFAVA@mgh.harvard.edu|
303375|NCT02165072|Texas Tech university Health Sciences Center, Lubbock, TX|Dr Kenneth Nugent|(806) 743-6847|Kenneth.nugent@ttuhsc.edu|
303376|NCT02165111|Johns Hopkins University|Dr. Ricardo J. Bello|4109557566|rbello@jhmi.edu|
303377|NCT02165124|Johns Hopkins Univesity|Dr. Clifford Weiss|4106141046|cweiss@jhmi.edu|
303378|NCT02165202|PATH|Heather Kelly|650-392-2510|hkelly@path.org|
303379|NCT02165384|Preceptis Medical|CEO|6123274795|steve@preceptismedical.com|
303380|NCT02165397|Pharmacyclics LLC, An AbbVie Company|Lori Styles|(408) 215-3770|lstyles@pcyc.com|
303381|NCT02165462|Universidad Católica San Antonio de Murcia|Rubén Cuesta-Barriuso, PhD|+34 913146508|ruben.cuestab@gmail.com|
303382|NCT02165605|UT Southwestern Medical Center|Sarmistha Sen|214-645-1477|Sarmistha.Sen@UTSouthwestern.edu|
303383|NCT02165722|University of Pittsburgh|Richard K. Zimmerman, MD, MPH, MA|412-383-2354|zimmer@pitt.edu|
303384|NCT02165735|University of Rochester|Dr. Kevin Fiscella, PI|5853244563|kevin_fiscella@urmc.rochester.edu|
303385|NCT02165761|W.L. Gore and Associates, Inc.|Suzy Palmer, CCRP|928-864-3670|supalmer@wlgore.com|
303386|NCT02165826|AstraZeneca|AstraZeneca Clinical Study Information Center|1-877-240-9479|information.center@astrazeneca.com|
303387|NCT02165839|Stanford University|Oxana Palesh, Associate Professor of Psychiatry and Behavioral Sciences|(650) 725-7011|oxana.palesh@stanford.edu|
303388|NCT02165904|Hospital Universitario Puerta de Hierro Majadahonda, Madrid|Dr. Vaquero Crespo|91 191 7760|jesus.vaquero@salud.madrid.org|
303389|NCT02166047|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
303390|NCT02166333|Johns Hopkins University|Dr. Lawrence Appel|410-955-4156|lappel@jhmi.edu|
303391|NCT02166346|Johns Hopkins University|Michael Levy, Principal Investigator|443-287-4412|mlevy@jhmi.edu|
303392|NCT02166476|The Medicines Company|Global Health Science Center|888-977-6326|medical.information@themedco.com|
303393|NCT02166606|Boston Scientific|Dipl.-Ing. (FH) Jens Goetzke|+49171|jens.goetzke@bsci.com|5426813
303394|NCT02166697|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303395|NCT02167035|Cornerstone Healthcare|Michael Tepedino, MD|336-802-2255|mtepedino@wakehealth.edu|
303396|NCT02167074|Erasmusm MC University Medical Center Rotterdam|Dr. P. van Riet|0031648237608|p.vanriet@erasmusmc.nl|
303397|NCT02167139|Samsung Bioepis|Director, Clinical Development|+82 31 8061 4534|dh01.shin@samsung.com|
303398|NCT02167204|University of Washington|Hannah Linden|206-606-2053|hmlinden@uw.edu|
303399|NCT02167217|Washington University School of Medicine|Anne M. Connolly, MD FAAN|314-362-6981|connollya@wustl.edu|
303400|NCT02167256|Yale University|Stephen Strittmatter|2037854878|stephen.strittmatter@yale.edu|
303401|NCT02167451|Cincinnati Children's Hospital Medical Center|Pooja Khandelwal, MD|513-803-4762|Pooja.Khandelwal@cchmc.org|
312584|NCT03033394|Imperial College London|Richard Wilson|02033132732|richard.wilson@imperial.ac.uk|
312585|NCT03033511|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
312586|NCT03033745|CSL Behring|Trial Registration Coordinator|610 878-4000|clinicaltrials@cslbehring.com|
312587|NCT03033784|The University of Toledo|Elissar Andari, PhD|419-383-5227|elissar.andari@Utoledo.edu|
312588|NCT03034018|Brigham and Women's Hospital|Hadine Joffe, MD MSc|617-732-4906|hjoffe@bwh.harvard.edu|
312589|NCT03034044|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312590|NCT03034057|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312591|NCT03034135|Cantex Pharmaceuticals|Stephen Marcus MD|9543153660|smarcus@cantex.com|
312592|NCT03034460|Galderma|Clinical Operations|817 961 5000|Clinical.Studies@galderma.com|+1
312593|NCT03034577|The University of Melbourne|Prof Colin Royse|+61408467548|Colin.Royse@unimelb.edu.au|
312594|NCT03034772|Wills Eye Physicians, Mid Atlantic Retina|Jason Hsu, MD|215-928-3092|research@midatlanticretina.com|
312595|NCT03034915|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312596|NCT03034928|Alcon, A Novartis Division|Sr CDMA Project Lead, GCRA - Vision Care|1-888-451-3937|Alcon.medinfo@alcon.com|
312597|NCT03034954|University of Michigan|Dr. Annalise Rahman-Filipiak|734-763-9259|rahmanam@med.umich.edu|
312598|NCT03034967|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312599|NCT03035032|Astellas Pharma Sinagpore Pte Ltd|Clinical Trial Disclosure|+65 6500 9330|astellas.resultsdisclosure@astellas.com|
312600|NCT03035318|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-287-1149|IANNOTJ@ccf.org|
312601|NCT03035487|Exact Imaging|Manager, Clinical Research|905-415-0030|bwodlinger@exactimaging.com|204
312602|NCT03035708|National Institute on Alcohol Abuse and Alcoholism|Health Scientist Administrator|301-443-0788|falkde@mail.nih.gov|
312603|NCT03035760|University of Iowa|Patricia Winokur, MD|319-384-1735|patricia-winokur@uiowa.edu|
312604|NCT03035864|Dompé|Mauro P. Ferrari, Pharm D|02583831|info@dompe.it|
292149|NCT01408147|Cal Poly|Suzanne Phelan|805 756 2087|sphelan@calpoly.edu|
292150|NCT01408277|Smith & Nephew Biotherapeutics|Jaime E Dickerson, Jr, PhD|817-302-3914|jaime.dickerson@smith-nephew.com|
292151|NCT01408303|AstraZeneca Pharmaceuticals|Torbjörn Lundström||ClinicalTrialTransparency@astrazeneca.com|
292152|NCT01408329|Stanford University|Anne L Friedlander|650-725-7531|afriedlanderCW@gmail.com|
292153|NCT01408459|University of Illinois at Chicago|Dr. Phyllis E. Bowen|708-524-0586|pbowen@uic.edu|
292154|NCT01408485|St. Jude Medical|Nancy Ouch, Senior Clinical Project Manager|949-769-5000|NOuch@sjm.com|
303402|NCT02167594|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
292155|NCT01408537|Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Thailand|Dr. Pornthep Chanthavanich|6623549161|tmpct@mahidol.ac.th|
292156|NCT01408563|Massachusetts General Hospital|Dr. Zachariah DeFilipp|617-643-3944|ZDEFILIPP@mgh.harvard.edu|
292157|NCT01408576|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
292158|NCT01408628|University of Kansas Medical Center|Virginia Lewis|913-588-2097|vlewis@kumc.edu|
303403|NCT02167815|Nemocnice Podlesí|MuDr Jan Stryja|+420 558 304 111|Jan.stryja@atlas.cz|
303404|NCT02167867|Regulatory Insight, Inc.|Elvira Walls, Clinical Consultant|615-712-9743|elvira@reginsight.com|
303405|NCT02167893|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303406|NCT02168062|University of California, San Francisco|Li Zhang, PhD|(415) 476-5339|Li.Zhang@ucsf.edu|
303407|NCT02168101|Sarah Cannon Development Innovations, LLC|Sarah Cannon|844-710-6157|CANNDLClinicalScience@HCAHealthcare.com|
303408|NCT02168153|Palmer Center for Chiropractic Research|Dr. Cyndy Long|563-884-5157|Long_C@palmer.edu|
303409|NCT02168309|Central Coast Perinatology|Kathryn Sharma|8058980258|katy.jones@gmail.com|
303410|NCT02168361|Center for Hepatitis C|Dr. Brian Pearlman|4042651044|brianpearlman3@hotmail.com|
303411|NCT02168387|Duke University Medical Center|Ira M. Cheifetz, MD, FCCM, FAARC|919-681-4080|ira.cheifetz@dm.duke.edu|
303412|NCT02168439|Children's Hospital of Pittsburgh of UPMC|Desiree Neville|4126927692|desiree.neville@chp.edu|
303413|NCT02168478|Medimetriks|Noah L. Rosenberg, MD, Chief Medical Officer|2019194083|Noahrosie@yahoo.com|
303414|NCT02168491|Medical University Vienna, Austria|Prof. Dr. Michael Krebs|+ 43 1 40400|michael.krebs@meduniwien.ac.at|43120
303415|NCT02168660|UT Southwestern Medical Center|Dr Perrin C White, Professor of Pediatrics|2146486875|perrin.white@utsouthwestern.edu|
303416|NCT02168777|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
303417|NCT02168803|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
303418|NCT02168816|Loyola University Medical Center|Michael Pinzur, M.D.|708-216-4993|mpinzu1@lumc.edu|
303419|NCT02168842|University of Rochester Medical Center, Department of Biostatistics and Computational Biology|David Oakes, PhD|5852752405|david_oakes@urmc.rochester.edu|
303420|NCT02168855|University of Arkansas|Dr. Brian Primack|479-575-3208|bprimack@uark.edu|
303421|NCT02168933|University of Utah, Derpartment of Dermatology|Kristina Callis-Duffin|8015816465||
303422|NCT02168946|Rempex Pharmaceuticals, A Wholly Owned Subsidiary of Melinta Therapeutics, Inc.|Global Health Science Center|1-844-633-6568|medinfo@melinta.com|
303423|NCT02169115|Charité- Dpt. of Dermatology and Allergy|Professor Martin Metz|+49 30 450 518 159|martin.metz@charite.de|
303424|NCT02169219|Massachusetts General Hospital, Division of Rheumatology|Dr. John Stone|617-643-2140|adfernandes@mgh.harvard.edu|
303425|NCT02169271|UT MD Anderson Cancer Center|Dr. Therese Bevers / Clinical Cancer Prevention Department|713-745-8048|tbevers@mdanderson.org|
303426|NCT02169284|University of Wisconsin Carbone Cancer Center|Dr. Tracy Downs|608-263-9534|downs@urology.wisc.edu|
303427|NCT02169336|Recro Pharma, Inc|Randall Mack|484-395-2400|rmack@recropharma.com|
303428|NCT02169414|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
303429|NCT02169427|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
303430|NCT02169440|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
303431|NCT02169453|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
312605|NCT03035916|China-Japan Unit Hospital of Jilin University|Dr. Guoqing Zhao|0435-84995117|zhaogq65@126.com|
312606|NCT03035929|Vanderbilt University Medical Center|Grace Henderson, Study Coordinator|615-936-5356|grace.henderson@vumc.org|
312607|NCT03035942|Pontificia Catholic University of Sao Paulo|Dr. Eduardo Toshiyuki Moro|+5515997728015|edumoro85@gmail.com|
292159|NCT01408706|Wheaton Franciscan Healthcare - All Saints|Dr. James Taylor|262-687-5000|james.taylor@wfhc.org|
292160|NCT01408719|Agriculture and Agri-food Canada|Dr. Nancy Ames|204-474-7187|nancy.ames@agr.gc.ca|
292161|NCT01408732|University of Minnesota|Holly Boyer, MD|612-725-2000|boyer011@umn.edu|
292162|NCT01408862|Institute of Medical Research (UBA-CONICET)|Dr. Carlos Jose Pirola|541145148701|cpirola@ciudad.com.ar|167
292163|NCT01408888|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292164|NCT01408901|Northwestern University|Mary McDermott MD|312-503-6419|mdm608@northwestern.edu|
292165|NCT01408914|Harvard Medical School|Carole Mitnick|617-432-6018|Carole_Mitnick@hms.harvard.edu|
292166|NCT01408992|Khon Kaen University|Dr. Kwanchanok Yimtae|66-43348396|kwayim@kku.ac.th|
292167|NCT01409096|University of Texas Southwestern Medical Center|E. Sherwood Brown, MD, PhD|2146466948|sherwood.brown@utsouthwestern.edu|
303432|NCT02169466|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|clinical.trials@bial.com|
303433|NCT02169479|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
303434|NCT02169505|UT MD Anderson Cancer Center|Ahmed,Sairah,MD / Stem Cell Transplantation|713-792-7734|sahmed3@mdanderson.org|
303435|NCT02169674|Vaccine Evaluation Center|Director of Vaccine Evaluation Center|604-845-2422||
303436|NCT02169739|University of California Los Angeles|Latisha Sharma, MD|310-794-6379|lali@mednet.ucla.edu|
303437|NCT02169791|Northside Hospital|Scott R. Solomon, MD|404-255-1930|ssolomon@bmtga.com|
303438|NCT02169869|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
303439|NCT02169895|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
303440|NCT02170025|BAYER|Therapeutic Area Head||clinical-trials-contact@bayer.com|
303441|NCT02170051|Professor of Psychiatry, UC San Diego|Elizabeth W Twamley, PhD|858-642-3848|etwamley@health.ucsd.edu|
303442|NCT02170064|BIAL - Portela & Cª, SA|Head of Clinical Research|+351-22 9866100|clinical.trials@bial.com|
303443|NCT02170077|BIAL - Portela & Cª, SA|Head of Clinical Research|+351 22 9866100|clinical.trials@bial.com|
303444|NCT02170207|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303445|NCT02170220|Takeda|Medical Director, Clinical Science|+1-877-825-3327|trialdisclosures@takeda.com|
303446|NCT02170363|St. Jude Medical|Poornima Sood|+17818528334|PSood@sjm.com|
303447|NCT02170376|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|jose.rocha@bial.com|
303448|NCT02170389|Roswell Park Cancer Institute|Senior Administrator, Compliance - Clinical Research Services|716-845-2300|Adrienne.Groman@RoswellPark.org|
312608|NCT03035955|WakeForest|Director of Clinical Trials|336-716-3775||
312609|NCT03036072|Maine Medical Center|Alexa Craig, MD|207-396-6920|craiga@mmc.org|
312610|NCT03036124|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|information.center@astrazeneca.com|
312611|NCT03036150|AstraZeneca|AstraZeneca Clinical Study Information Center|+1-877-240-9479|Information.center@astrazeneca.com|
312612|NCT03036163|Nearmedic Plus|Viсtoria Shcherbakova|+7 (495) 741 49 89|Viktoriya.Shcherbakova@nearmedic.ru|3869
312613|NCT03036215|HealthPartners Institute|James Fricton, DDS, Senior Research Investigator|6126191678|james.r.fricton@healthpartners.com|
312614|NCT03036293|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
312615|NCT03036384|Centre Hospitalier Universitaire Saint Pierre|Panayota Kapessidou|+32.2.535|pkapessi@ulb.ac.be|3750
312616|NCT03036813|Global Blood Therapeutics|Margaret Tonda, PharmD, Sr. Director, Clinical Science|(650) 741-7761|mtonda@gbt.com|
312617|NCT03036839|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
312618|NCT03036852|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
312619|NCT03037203|Jazz Pharmaceuticals|Director, Disclosure & Transparency|2159707145|ClinicalTrialDisclosure@JazzPharma.com|
312620|NCT03037281|University of Leicester|Dr Christopher Hebbes|0116 252 2522|christopher.hebbes@le.ac.uk|
312621|NCT03037307|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312622|NCT03037489|Medivir AB|Linda Basse, Cheif Medical Officer|+46 8 546 831 00|linda.basse@medivir.com|
312623|NCT03037541|Wake Forest University Health Sciences|Joseph Jorizzo, MD|336-716-3775|jjorizzo@wakehealth.edu|
312624|NCT03037580|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
312625|NCT03037619|University of South Carolina|Christine Pellegrini|803-777-0911|cpellegrini@sc.edu|
312626|NCT03037905|Cleveland Clinic|Christian N. Burchill, PhD, RN, CEN|216-445-9317|burchic@ccf.org|
312627|NCT03037983|Palo Alto VA|Jong Yoon|510-220-7086|jhyoon1@stanford.edu|
312628|NCT03038113|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
312629|NCT03038126|University of Maryland Baltimore|Jeffrey C. Fink, MD MS; Principal Investigator|410-328-4822|jfink@som.umaryland.edu|
312630|NCT03038308|Columbia University|Gabrielle Page-Wilson, MD|212-305-3725|gp2287@cumc.columbia.edu|
312631|NCT03038399|ReveraGen BioPharma Inc.|Dr. Eric Hoffman|301-762-7980|ericphoffman@gmail.com|
312632|NCT03038620|UT Southwestern Medical Center|Dr. Parag Joshi|2146458000|parag.joshi@utsouthwestern.edu|
312633|NCT03038815|Institute for Biomechanics ETH Zürich|Silvio Lorenzetti|078 608 14 84|sl@ethz.ch|
312634|NCT03038867|Weill Cornell Medical College|Research coordinator|212-746-5385|mac4015@med.cornell.edu|
312635|NCT03038880|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
312636|NCT03039023|Cleveland Clinic Foundation|Jennifer Wilcox|216-636-6153|kirsopj@ccf.org|
312637|NCT03039088|Rheumatology department, Cochin Hospital, APHP|Doctor Anna MOLTO|0158412617|anna.molto@aphp.fr|
312638|NCT03039179|Istituto Ortopedico Rizzoli|Head of the Research Nursing Unit|0516366694|cristiana.forni@ior.it|0039
312639|NCT03039192|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
292168|NCT01409213|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292169|NCT01409239|The Ohio State University|Kathleen Dungan|614-685-3333|kathleen.dungan@osumc.edu|
303449|NCT02170519|Duke University Medical Center|Neil MacIntyre, MD|919-681-2720|neil.macintyre@dm.duke.edu|
292170|NCT01409291|Creighton University|Kathleen Packard, PharmD, MS, BCPS (AQ Cardiology)|402-481-3915|kathleenpackard@creighton.edu|
292171|NCT01409382|Hospital Federal dos Servidores do Estado|Dr. Silvia Hoirisch-Clapauch|55-21-999737500|sclapauch@gmail.com|
292172|NCT01409434|University of Florida|Dr. Rhonda Cooper-DeHoff|352-273-6184|dehoff@cop.ufl.edu|
292173|NCT01409564|Seoul National University Hospital|Prof. Jung Seok Choi|82-2-870-3461|choijs@neuroimage.snu.ac.kr|
292174|NCT01409707|University of Mississippi Medical Center|Dr. Scott Coffey|601-815-5588|scoffey@umc.edu|
292175|NCT01409811|City of Hope|Carolyn Behrendt, Ph.D.|626-218-1148|cbehrendt@coh.org|
292176|NCT01409837|University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu|Dr. Anthony Mbah, Principal investigator|2348051519065|cmd_unth@yahoo.com|
303450|NCT02170532|Duke University Medical Center|Neil MacIntyre, MD|(919) 681-2720|macin001@mc.duke.edu|
303451|NCT02170649|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|clinical.trials@bial.com|
303452|NCT02170662|Duke University Medical Center|Dr. Elise Olsen|919-668-5613|elise.olsen@dm.duke.edu|
303453|NCT02170688|Duke University Medical Center|Lisa Ho, MD|919-684-7890|lisa.ho@duke.edu|
303454|NCT02170727|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
303455|NCT02170779|VA Research and Development|Cinda Hugos, Physical Therapist|503-220-8262|hugosc@ohsu.edu|52338
303456|NCT02170870|Mayo Clinic|Dr. Adil E. Bharucha, Principal Investigator|507-284-2687|bharucha.adil@mayo.edu|
303457|NCT02171065|Lund University|Principal Investigator: David Erlinge, MD, PhD|+46-733746165|david.erlinge@gmail.com|
303458|NCT02171130|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
303459|NCT02171195|BIAL - Portela & Cª, S.A.|Head of Clinical Research|+351 22 9866100|francisco.rocha@bial.com|
303460|NCT02171234|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
312640|NCT03039283|Cochlear|Nicole Neben|+4951154277220|nneben@cochlear.com|
312641|NCT03039543|Seoul National University Bundang Hospital|Dr. Junghee Ryu, Associate Professor|82-31-787-7497|jinaryu74@gmail.com|
312642|NCT03039569|University of Nebraska-Lincoln|Weiwen Chai|402-472-7822|wchai2@unl.edu|
312643|NCT03039621|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
312644|NCT03039686|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
312645|NCT03039699|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
312646|NCT03039738|Medtronic|Anne Kinney|+1-303-876-8904|anne.r.kinney@medtronic.com|
312647|NCT03040011|Magee-Womens Hospital of UPMC|Dr. Lauren Giugale, PI|412-641-1498|giugalele@upmc.edu|
312648|NCT03040024|Emory University|Dr. Amit Prabhakar|404-686-2747|amit.prabhakar@emory.edu|
312649|NCT03040154|Children's Hospital Los Angeles|Joyce R. Javier, MD, MPH, MS|(323)669-2113|jojavier@chla.usc.edu|
312650|NCT03040336|Pittsburgh VA Healthcare System, CHERP|Dr. Daniel E Hall|4123602016|daniel.hall2@va.gov|
312651|NCT03040362|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312652|NCT03040414|HealthPartners Institute|Amy Becker LaFrance, Sr. Manager, Research Project Management Office|952.967.5079|Amy.B.LaFrance@healthpartners.com|
312653|NCT03040427|Cleveland Clinic Foundation|Dr. Wael A. Jaber|216.444.8305|jaberw@ccf.org|
312654|NCT03040466|UCSF|Dr. Thomas Chi|415-476-1611|tom.chi@ucsf.edu;manint.usawachintachit@ucsf.edu|
303461|NCT02171247|Duke University Medical Center|Daniel T Boll, MD|919-684-2711|daniel.boll@duke.edu|
292177|NCT01409915|"University of Colorado Denver | Anschutz Medical Campus"|John O'Shaughnessy, MS, Clinical Research Services Principal Professional|3037247924|john.oshaughnessy@cuanschutz.edu|
292178|NCT01409928|UTSW|Olga T. Gupta|(214) 648-8718|olga.gupta@utsouthwestern.edu|
292179|NCT01409993|Vanderbilt University Medical Center|Nancy J. Brown, M.D., Principal Investigator|6153438701|nancy.j.brown@vanderbilt.edu|
292180|NCT01410058|University of Zimbabwe College of Health Sciences|Tsitsi G Monera-Penduka|307148|moneratg@yahoo.co.uk|
292181|NCT01410084|Wake Forest School of Medicine|Dr. Denise Houston|336-713-8558|dhouston@wakehealth.edu|
292182|NCT01410097|Wake Forest University|Stephen B. Kritchevsky, PhD|336-713-8548|skritche@wakehealth.edu|
292183|NCT01410110|Yale University School of Medicine|Morris Bell, Ph.D.|203-932-5711|morris.bell@yale.edu|2281
292184|NCT01410227|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
303462|NCT02171260|Eisai, Inc.|Eisai Medical Services|1-888-422-4743|esi_medinfo@eisai.com|
303463|NCT02171429|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
303464|NCT02171611|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
303465|NCT02171819|IVAC|Dr. Le Van Be||ivaclevanbe@gmail.com|
303466|NCT02172040|Kitov Pharmaceuticals, Ltd.|J. Paul Waymack, M.D., Chief Medical Officer|(202) 965-2215|paul@kitovpharma.com|
303467|NCT02172625|Georgia State University|Dr. Gerald S. Zavorsky|404-413-1271|zavorsky@gsu.edu|
303468|NCT02172664|Indiana University School of Dentistry|Dr. Jeffrey Platt|3172747229|jplatt2@iu.edu|
303469|NCT02172742|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
303470|NCT02172755|Bial - Portela & Cª, S.A.|Head of Clinical Research|+351 229 866 100|francisco.rocha@bial.com|
303471|NCT02172820|The University of Vermont|Diann Gaalema, Ph.D., PI|802-656-9874|Diann.Gaalema@med.uvm.edu|
303472|NCT02172911|Inovio Pharmaceuticals|Study Director|267-440-4237|clinical.trials@inovio.com|
312655|NCT03040479|Eli Lilly and Company|Chief Medical Officer|800-545-5979|clinicaltrials.gov@lilly.com|
312656|NCT03040674|Lung Health Institute|Melissa Rubio, PhD, APRN|2145042117|pidallas@thelunghealthinstitute.com|
312657|NCT03040687|Johns Hopkins University|Kawsar Talaat|410-502-9627|ktalaat@jhu.edu|
312658|NCT03040713|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
312659|NCT03040804|Montefiore Medical Center|Steven R. Cohen, MD, MPH|7189208352|srcohen@montefiore.org|
312660|NCT03040986|National Cancer Institute|Dr. Udo Rudloff|240-760-6238|udo.rudloff@nih.gov|
312661|NCT03041025|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312662|NCT03041038|Northwestern University|Dr. Amy Paller|3126953721|NUderm-research@northwestern.edu|
312663|NCT03041090|Saint Louis University|Medhat Osman, MD, PhD - Professor of Radiology, Director of Nuclear Medicine and PET/CT|314-577-8047|medhat.osman@health.slu.edu|
312664|NCT03041116|Retrophin, Inc.|Clinical Trial Information Desk|+1-877-659-5518|medinfo@retrophin.com|
312665|NCT03041181|Hoosier Cancer Research Network|Clinicaltrials.gov Results Coordinator|317-643-5842|jsmith@hoosiercancer.org|41
312666|NCT03041298|Guerbet GmbH|Oliver Heine, MD, Radiology & Scientific Affairs Manager|+49 6196 76250|oliver.heine@guerbet-group.com|
312667|NCT03041441|Duke University Dept of Radiology|Research Coordiantor|(919) 684-7732|christopher.vallanat@duke.edu|
312668|NCT03041467|Medtronic|Joshua Popp, Clinical Study Manager|763.398.7713|joshua.j.popp@medtronic.com|
312669|NCT03041636|The University of Texas MD Anderson Cancer Center|Zeev Extrov MD./Professor|713-794-1675|zestrov@mdanderson.org|
312670|NCT03041792|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312671|NCT03041896|MCRA|Glenn Stiegman|2025525800|gstiegman@mcra.com|
312672|NCT03041909|Global Blood Therapeutics|Margaret Tonda, Sr. Director, Clinical Science|650-741-7761|mtonda@gbt.com|
292185|NCT01410240|Baxter BioScience|Maurice Bagot D'Arc, MD, Sr Medical Director Medical Affairs , BioSurgery||maurice_bagot_d'arc@baxter.com|
292186|NCT01410344|The Emmes Corporation|Adam Mendizabal, PhD|301-251-1161|amendizabal@emmes.com|
292187|NCT01410357|Case Western Reserve University School of Medicine and Neurological Institute|Dr. Martha Sajatovic|216-844-2808|martha.sajatovic@uhhospitals.org|
292188|NCT01410409|Aalborg University Hospital|Dr. Søren T. Skou|+4523708640|sots@rn.dk|
292189|NCT01410448|Novartis Pharmaceuticals|Study Director|862-778-8300||
303473|NCT02172950|CSL Behring|Clinical Trial Disclosure Manager|use email contact|clinicaltrials@cslbehring.com|
303474|NCT02173054|Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University|Papapit Tuchinda|+662-419-4333|papapitt@gmail.com|
303475|NCT02173158|Aegerion Pharmaceuticals, Inc.|Alison Long, MD - VP Clinical|857-242-5142|alison.long@aegerion.com|
303476|NCT02173379|Abbott Vascular|Siok Hwee Tan|408-571-9281|siokwee.tan@abbott.com|
303477|NCT02173392|Valeant Pharmaceuticals|Director of Clinical Trials|908|lindsey.mathew@valeant.com|
303478|NCT02173522|University of Miami|Shivank Bhatia|305-243-7500|sbhatia1@med.miami.edu|
303479|NCT02173535|Johnson & Johnson Vision Care Inc.|Charis Lau, Pharm.D., O.D., FAAO|(904) 443-1293|MLau87@ITS.JNJ.com|
312673|NCT03042299|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
281746|NCT00820040|Medtronic|Heather McManus|2038213323|heather.mcmanus@medtronic.com|
312674|NCT03042312|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
312675|NCT03042559|Loma Linda University|Dr. Everett Lohman III|9095584632|elohman@llu.edu|83171
312676|NCT03042702|Innovation Pharmaceuticals|Arthur P. Bertolino MD, PhD, MBA|9789214125|abertolino@IPharmInc.com|
312677|NCT03042715|Massachusetts General Hospital|Areej El-Jawahri|617-724-4000|ael-jawahri@partners.org|
312678|NCT03042767|Emory University|Dr. Miriam Vos|404-727-5383|mvos@emory.edu|
312679|NCT03042910|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312680|NCT03043079|University of Pennsylvania|Dr. John P Fischer|2156627300|john.fischer2@uphs.upenn.edu|
281747|NCT00820170|Memorial Sloan Kettering Cancer Center|Dr. Monica Fornier|646-888-4563|fornierm@mskcc.org|
281748|NCT00820222|Novartis Pharmaceuticals|Clinical Disclosure Office|862-778-8300||
281749|NCT00820235|Dentsply Sirona Implants, Mölndal, SWEDEN|Manager Global Clinical Research|0046313763500|ClinicalResearchMolndal@dentsplysirona.com|
281750|NCT00820248|Canadian Cancer Trials Group|Wendy Parulekar|613-533-6430|wparulekar@ctg.queensu.ca|
281751|NCT00820443|MicroPort Orthepedics|Matt C. Paul, Project Manager|(901) 867-4350|mpaul@ortho.microport.com|
292190|NCT01410474|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
303480|NCT02173548|Virginia Commonwealth University|Antonio Abbate, MD, PhD|(804) 828-0513|antonio.abbate@vcuhealth.org|
292191|NCT01410552|LivaNova|Scientific Communication manager|33146013082|Anne.rousseauplasse@sorin.com|
292192|NCT01410565|Spectrum Pharmaceutical Inc.|Gajanan Bhat|949-743-9219|gajanan.bhat@sppirx.com|
292193|NCT01410604|Hospital Regional de Alta Especialidad del Bajio|M.D. Maria L. Evia-Viscarra|+52 (477) 267-2000|evialola@hotmail.com|1405
292194|NCT01410773|Ascensia Diabetes Care|Jane Wallace|574-257-3063|jane.wallace@ascensia.com|
292195|NCT01410812|University of Pennsylvania|Katherine L. Milkman, Ph.D.|215-573-9646|kmilkman@wharton.upenn.edu|
292196|NCT01410890|Sanofi|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
292197|NCT01411085|Geisel School of Medicine at Dartmouth|Alan I Green, MD|603-650-7549|alan.i.green@dartmouth.edu|
292198|NCT01411137|Impax Laboratories, Inc.|Michelle Landolfi, Senior Director, Regulatory Affairs|(510) 240-6496|Michelle.Landolfi@impaxlabs.com|
303481|NCT02173704|GlaxoSmithKline|GSK Response Center|866-435-7343||
303482|NCT02173769|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
303483|NCT02174198|Columbia University|Nurit Bittner, DDS, MS, Dip.ABP|212-342-2763|nb2203@cumc.columbia.edu|
303484|NCT02174276|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
303485|NCT02174419|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
303486|NCT02174432|Trevi Therapeutics|Thomas Sciascia, MD|203-304-2499|thomas.sciascia@trevitherapeutics.com|
303487|NCT02174510|Shanghai Xuhui Central Hospital, Drug Clinical Trial Institution|Prof.Hu Chaoying|13816319160|cyhu@shxh-centerlab.com|
303488|NCT02174523|Phase I Clinical Research Unit , Shanghai Xuihui Central Hospital|Dr.Hu Chaoying|021-54036058|cyhu@shxh-centerlab.com|
312681|NCT03043105|Peking Union Medical College Hospital|Dr. Jian Li|86-010-69155027|lijian@pumch.cn|
312682|NCT03043274|University of Kentucky|Dr. Khaled M. Ziada|8593236036|khaled.ziada@uky.edu|
312683|NCT03043365|National Heart Lung and Blood Institute (NHLBI)|Marcelo J. Amar, M.D. Principal Investigator, NIH, NHLBI|301-402-0521|mamar@nhlbi.nih.gov|
312684|NCT03043534|WakeForest|Dr Amy McMichael|336-716-3775|amcmicha@wakehealth.edu|
312685|NCT03043560|Icahn School of Medicine at Mount Sinai|Dr, James Murrough|212-585-4640|james.murrough@mssm.edu|
312686|NCT03043651|United Therapeutics|Louis Holdstock|919-425-8866|lholdstock@unither.com|
312687|NCT03043872|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
312688|NCT03043885|UCSF|Daniel Clark|415.476.1101|daniel.clark@ucsf.edu|
312689|NCT03044028|Cleveland Clinic|Carlos Higuera|954-659-5430|higuerc@ccf.org|
312690|NCT03044106|University of North Carolina at Chapel Hill|Nicholas Wise, DC|(864) 494-1001|nicholas_wise@med.unc.edu|
312691|NCT03044197|UTexasGalveston|Lori Simon|409-772-1978|lasimon@utmb.edu|
312692|NCT03044249|Mediti Pharma Inc.|Chief Executive Officer|1-514-993-7207|ivan.shaw@meditipharma.com|
312693|NCT03044353|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312694|NCT03044418|University of Pecs|Dr. Timea Bocskai|+36 72 507374|timokeri@gmail.com|
312695|NCT03044431|Lung Institute|Melissa Rubio, PhD, APRN|214-504-2117|pidallas@lunginstitute.com|
312696|NCT03044574|Pirogov Russian National Researching Medical University|Dr. Kirill Lobastov, Associated professor at the Department of General Surgery and Radiology|+7-985-211-63-31|lobastov_kv@hotmail.com|
312697|NCT03044691|Unversity of Florida|Assistant Professor|(352) 294-4997|rsalloum@ufl.edu|
312698|NCT03044730|Northwestern University, Feinberg School of Medicine|William John Gradishar, MD, FACP, FASCO|(312) 695-4541|w-gradishar@northwestern.edu|
312699|NCT03044886|Department of Stomatology, Beijing Chao-yang Hospital, Capital Medical University|Dr. Wang Zuomin|+86-010-85231492|wzuomin@sina.cn|
312700|NCT03045081|University of Washington|Dale J. Langford, PhD; Research Assistant Professor|2066160158|dalejwl@uw.edu|
312701|NCT03045302|Ipsen|Medical Director|Use email address below|clinical.trials@ipsen.com|
312702|NCT03045328|Stanford University|Steven Edward Coutre, Professor of Medicine (Hematology)|650-498-6000|coutre@stanford.edu|
312703|NCT03045653|Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative innovation center for Cancer Medicine|Zhongyu Yuan|+8613798027658|yuanzhy@sysucc.org.cn|
312704|NCT03045809|University of Liverpool|Prof. Janneke van de Wijgert, Chief Investigator|+447557195108|j.vandewijgert@liverpool.ac.uk|
312705|NCT03045861|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312706|NCT03045887|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312707|NCT03045926|Ipsen Pharma SAS|Medical Director|+33 (0)158335000|clinical.trials@ipsen.com|
312708|NCT03046056|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
312709|NCT03046212|Hospital de Clínicas de Porto Alegre|Graciele Sbruzzi|55 51 9423-9420|graciele.sbruzzi@ufrgs.br|
312710|NCT03046225|Hospital de Clínicas de Porto Alegre|Graciele Sbruzzi|55 51 9423-9420|graciele.sbruzzi@ufrgs.br|
312711|NCT03046446|Flexion Therapeutics|Scott Kelley, Chief Medical Officer|781-305-7142|skelley@flexiontherapeutics.com|
312712|NCT03046472|Maccabi Health services and Wingate college|Neta Vitman|0508955529|vitmanan@gmail.com|
312713|NCT03046966|University of Arkansas for Medical Sciences|Jennifer Rumpel, MD|501-364-2980|Jarumpel@uams.edu|
312714|NCT03047174|Department of Radiation Oncology, University of Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|dirk.rades@uksh.de|45401
312715|NCT03047447|Bristlecone Health, Inc,|Dr. Kelly Gibas, Director or Clinical Trials|(763) 424-2474|kgibas@bristleconefitness.com|
312716|NCT03047551|Columbia University|Carolyn Westhoff, MD|212-305-4805|clw3@cumc.columbia.edu|
312717|NCT03047720|Indiana University|Dr Benjamin Whittam|317.944.8896|bwhittam@iupui.edu|
312718|NCT03047980|Kennedy Krieger Institute|Research Assistant|443-923-9569|vedmurthyp@kennedykrieger.org|3-9569
292199|NCT01411215|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292200|NCT01411228|Target Health Inc.|Glen Park|212-681-2100|gpark@targethealth.com|
292201|NCT01411241|Sanofi Pasteur|Director||Contact-US@sanofi.com|
292202|NCT01411267|Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) / Children's Hospital Los Angeles|Peggy Romano, BA, CCRP|323-361-5505|promano@chla.usc.edu|
292203|NCT01411319|University of Miami|Alan Pollack, MD, PhD|305-243-4916|apollack@med.miami.edu|
292204|NCT01411488|Cleveland Clinic|Nancy Albert|216-444-7028|albertn@ccf.org|
292205|NCT01411501|Guang'an Men Hospital Affiliated to China Academy of Chinese Medical Sciences|Liu Zhishun|8610-010-88001124|liuzhishun@aliyun.com|
292206|NCT01411527|Rigshospitalet|Anders Juul|+45 3545 5085|Anders.Juul@regionh.dk|
292207|NCT01411592|University of Kiel|Dr. Martin Sasse, D.M.D., Assistant Professor|+494315972874|sekretariat@proth.uni-kiel.de|
303489|NCT02174562|Thomas Jefferson University|Barry Rovner, MD|215-503-1243|Barry.Rovner@Jefferson.edu|
303490|NCT02174627|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
303491|NCT02174731|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
303492|NCT02174848|Chiesi Canada Corp.|Fernando Tricta, MD|416--558-6342|f.tricta@chiesi.com|
303493|NCT02174861|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
303494|NCT02174913|Mahidol University|Department of Anesthesiology, Siriraj Hospital|66-2-41979889|manee95@hotmail.com|501
303495|NCT02175121|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
303496|NCT02175199|Alcon Research, Ltd.|Global Brand Lead, GCRA, Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
303497|NCT02175212|Hospital Universitario de la Princesa; Health Research Institute IIS from Hospital Universitario de la Princesa|Dr. Almudena Zapatero|+34 91 520 23 15|almudena.zapatero@salud.madrid.org|
303498|NCT02175225|Beth Israel Deaconess Medical Center|Magdy Selim, MD, PhD|617-632-8913|mselim@bidmc.harvard.edu|
312719|NCT03048006|Guerbet GmbH|Oliver Heine, MD, Radiology & Scientific Affairs Manager|+49 6196 76250|oliver.heine@guerbet-group.com|
312720|NCT03048058|Wake Forest University Health Sciences|Irma M. RIchardson, MHA;|336-716-2903|irichard@wakehealth.edu|
312721|NCT03048383|University of Utah|Dr. P. Daniel Ward|801-581-8471|PDanielWard@hsc.utah.edu|
312722|NCT03048500|Northwestern University|Young Chae, MD|312-695-1301|young.chae@northwestern.edu|
312723|NCT03048747|Otsuka Pharmaceutical Co., LTD.|Director of Clinical Trials|+81-3-6361-7366|CL_OPCJ_RDA_Team@otsuka.jp|
312724|NCT03049215|Vanderbilt University Medical Center|Sharee Burkeen, Research Program Manager|(615) 875-7515|sharee.k.burkeen@vumc.org|
312725|NCT03049280|Intuitive Surgical|Intuitive Surgical Clinical Affairs|408-523-2100|sylvie.akiel-fu@intusurg.com|
312726|NCT03049488|Vaccine Research Center, NIAID, NIH|Martin Gaudinski, MD|(301) 451-8715|martin.gaudinski@nih.gov|
312727|NCT03049501|University of Miami|David Loewenstein|305-355-7016|dloewenstein@miami.edu|
312728|NCT03049748|Johns Hopkins University (Former Faculty at University of Michigan)|Dr. Jesus Casida|3132047665|jcasida1@jhu.edu|
312729|NCT03049852|Cloudbreak Therapeutics, LLC|Dr, Jinsong Ni|9496789752|Ni-Jinsong@cloudbreaktherapeutics.com|
312730|NCT03049917|University of Washington|Dr.|206-422-5564|jsyker@uw.edu|
312731|NCT03050203|Istituto Ortopedico Rizzoli|Cristiana Forni|0039516366|cristiana.forni@ior.it|694
312732|NCT03050216|Masonic Cancer Center, University of Minnesota|Dr.Claudio G. Brunstein MD, PhD|612 625 3918|bruns072@umn.edu|
312733|NCT03050294|Wake Forest Baptist Health|Steven R. Feldman|336-716-7740|sfeldman@wakehealth.edu|
312734|NCT03050307|Takeda|Study Director|+1-877-825-3327|TrialDisclosures@takeda.com|
312735|NCT03050320|McMaster University/University of Waterloo|Dr. Monica Maly|519-888-4567|mrmaly@uwaterloo.ca|37916
312736|NCT03050359|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
312737|NCT03050372|Medical University of South Carolina|Thomas W. Uhde, M.D.|843-792-0028|uhde@musc.edu|
312738|NCT03050450|Johns Hopkins All Children's Hospital (St. Petersburg, FL)|Dr Stacie Stapleton|17274701017|stacie.stapleton@jhmi.edu|
312739|NCT03050541|University of Chicago|Office of Clinical Research|(773) 834-1238|tkyeo@bsd.uchicago.edu|
312740|NCT03050619|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312741|NCT03050697|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
312742|NCT03050775|Mayo Clinic|Jean M. Guyer, DNP|507-255-5716|guyer.jean@mayo.edu|
312743|NCT03050801|National Institutes of Health|Dr. Eric Wassermann|301-496-0151|wassermanne@ninds.nih.gov|
312744|NCT03050918|Vanderbilt University Medical Center|Maame Yaa Yiadom|615-936-0087|maya.yiadom@vumc.org|
312745|NCT03051100|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
312746|NCT03051165|Emory University|Raj Dedhia, MD, MS|(404) 778-3381|raj.dedhia@emory.edu|
312747|NCT03051256|Relmada Therapeutics|Chief Medical Officer|646-876-3459|info@relmada.com|
312748|NCT03051607|Acorda Therapeutics|Christopher Kenney, Senior Vice President - Medical Affairs|9143265775|ckenney@acorda.com|
312749|NCT03051620|Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Denmark|Anne Sophie Sølling|+45 78 45 54 75|annesoel@rm.dk|
312750|NCT03051633|Colorado State University|Dr. Meghan Crabtree|2105875584|meghan.crabtree@colostate.edu|
312751|NCT03051646|Columbia University Medical Center|Victoria M. Leavitt|212 342 1351|vl2337@cumc.columbia.edu|
312752|NCT03051672|Dana-Farber Cancer Institute|Dr. Sara Tolaney|6176323800|sara_tolaney@dfci.harvard.edu|
292208|NCT01411696|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
292209|NCT01411774|Baylor College of Medicine|Dr. Eric Storch|727-767-8230|eric.storch@bcm.edu|
292210|NCT01411839|University of California, San Francisco|Dr. John A. Sauceda|415-460-6045|john.sauceda@ucsf.edu|
292211|NCT01411852|Resuscitation Outcomes Consortium|Susanne May, PhD, Principal Investigator|206-685-1302|sjmay@uw.edu|
292212|NCT01411891|University of Wisconsin School of Medicine and Public Health, Department of Anesthesiology|Dr. Kristopher Schroeder|608-263-8100|kmschro1@wisc.edu|
292213|NCT01411917|University of Wisconsin School of Medicine, Department of Anesthesiology|Kristopher Schroeder|608-232-1542|kmschro1@wisc.edu|
292214|NCT01411995|Washington University School of Medicine|Dr Colleen McNicholas|314-747-1331|mcnicholasc@wudosis.wustl.edu|
292215|NCT01412021|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
292216|NCT01412060|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
292217|NCT01412086|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
303499|NCT02175277|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
303500|NCT02175368|Ivoclar Vivadent AG|Dr. Erik Braziulis||erik.braziulis@ivoclarvivadent.com|
303501|NCT02175472|PhotoPharmics, Inc.|Dan Adams|801-770-6960|dan.adams@photopharmics.com|
303502|NCT02175641|Washington Universtiy in St. Louis|Leopoldo J. Cabassa, Associate Professor|314-935-2829|ljcabassa@wustl.edu|
303503|NCT02175745|Stanford University|Erik Mittra, MD, PhD|650-736-2859|emittra@stanford.edu|
303504|NCT02175758|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
303505|NCT02175771|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-215-591-3000|ustevatrials@tevapharm.com|
303506|NCT02175966|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||clinical.trials@bms.com|
303507|NCT02175979|Catharina Hospital|dr Misha Luyer|+31402399111|misha.luyer@catharinaziekenhuis.nl|
303508|NCT02176005|Da Volterra|Dr. Annie Ducher, Chief Medical Officer|+33 1 58 39 32 20|annie.ducher@davolterra.com|
312753|NCT03052257|Durham VA Medical Center, Durham, NC|Dr. Kelly Muir|919-286-0411|Kelly.Muir@va.gov|174035
312754|NCT03052322|Fresenius Kabi Swiss BioSim GmbH|Eugenia Kunina, senior clinical development manager|+41791093376|clinical.development@fresenius-kabi.com|
303509|NCT02176018|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
303510|NCT02176031|Dana-Farber Cancer Institute|Dr. Corey Cutler|617-632-3470|CSCUTLER@PARTNERS.ORG|
292218|NCT01412151|Massachusetts General Hospital|Steven M. Hersch, MD, PhD|617-726-1254|hersch@helix.mgh.harvard.edu|
292219|NCT01412164|Shanghai Microport Medical (Group) Co.,Ltd.|Kefei Li|+86-21-38954600×6700|kfli@microport.com|
292220|NCT01412229|UNC Lineberger|Robin Johnson|(919) 966-1125|Robin_V_Johnson@med.unc.edu|
292221|NCT01412281|Crucell Switzerland|Medical Affairs Director|+41(0)319806111|info@crucell.com|
303511|NCT02176083|University of California, San Diego|Irene Su, MD MSCE|8588225986|hisu@ucsd.edu|
292222|NCT01412372|University of Utah|Dr. Ashok Tuteja|801-581-5679|Ashok.Tuteja@hsc.utah.edu|
292223|NCT01412424|Cedars-Sinai Medical Center|Shlomo Melmed, MD|310 423-4691|melmed@csmc.edu|
292224|NCT01412541|Becton Dickinson|Anna Lovas|7634452382|anna.lovas@bd.com|
292225|NCT01412554|Oslo University Hospital Ullevål, Norway|MD PhD Tonje Amb Aksnes|+22119101|tonjeaksnes@hotmail.com|47
292226|NCT01412710|Florida International University|Fatma G. Huffman|305-348-3877|huffmanf@fiu.edu|
292227|NCT01412801|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
303512|NCT02176226|Northwestern University|David C. Mohr, PhD|312-503-1403|d-mohr@northwestern.edu|
303513|NCT02176291|University of Pittsburgh|Dr. Jordan F. Karp|412-246-6048|karpjf@upmc.edu|
303514|NCT02176343|Alcon Research, Ltd.|Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
303515|NCT02176356|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
303516|NCT02176382|Massachusetts General Hospital|Dr. Joy Tsai|6177266723|jntsai@mgh.harvard.edu|
303517|NCT02176408|NYU Langone Health|Kristin Szuhany|6467545161|kristin.szuhany@nyulangone.org|
303518|NCT02176421|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
303519|NCT02176486|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
312755|NCT03052426|West Virginia University|Dr. Brandy Brown|304-293-1955|bkenned2@hsc.wvu.edu|
312756|NCT03052517|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
312757|NCT03052530|OrbusNeich|Debbie Morrell, Clinical Research Manager|954-730-0711|DMorrell@OrbusNeich.com|
312758|NCT03052725|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
312759|NCT03052751|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
312760|NCT03052764|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
312761|NCT03052816|UH Hospitals Cleveland Medical Center/MetroHealth Medical Center at time of study protocol|Andrey Petrikovets MD|323 243 9091|andrepetrikovets@yahoo.com|
312762|NCT03052959|Unity Health Toronto|Dr. Aisha Lofters|4163236400|aisha.lofters@utoronto.ca|3832
312763|NCT03052972|Avid Radiopharmaceuticals, Inc.|Medical Director|215-298-0700|clinicaloperations@avidrp.com|
312764|NCT03053050|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
312765|NCT03053063|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
312766|NCT03053102|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
312767|NCT03053180|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
312768|NCT03053271|Millendo Therapeutics|Clinical Trial Information|+1 734 845-9000|millendo@millendo.com|
312769|NCT03053401|Akron Children's Hospital|Dr. Rami Karroum|330-543-8823|rkarroum@akronchildrens.org|
312770|NCT03053427|Astellas Pharma Inc.|Clinical Trial Disclosure|+81 3-3244-0512|astellas.resultsdisclosure@astellas.com|
312771|NCT03053492|Medical University of South Carolina|Michelle Woodbury|843-792-1671|woodbuml@musc.edu|
312772|NCT03054051|Emory University|Kate Winskell Enger PhD|404-727-5286|swinske@emory.edu|
312773|NCT03054064|Parker Hannifin Corporation|Ryan J. Farris, Ph.D., P.E.|2168963335|ryan.farris@parker.com|
312774|NCT03054077|Virginia Commonwealth University|Debra Shockey|804-828-3744|dpshockey@vcu.edu|
312775|NCT03054103|Wake Forest University Health Sciences|Dr. Timothy Harwood|3367164498|tharwood@wakehealth.edu|
312776|NCT03054337|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
312777|NCT03054350|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
312778|NCT03054428|Regeneron Pharmaceuticals, Inc.|Clinical Trial Management|844-734-6643|clinicaltrials@regeneron.com|
312779|NCT03054506|Massachusetts General Hospital|Dr. Kyle Staller|617-726-3080|kstaller@mgh.harvard.edu|
312780|NCT03054649|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
312781|NCT03054740|Aultman Health Foundation|Jane Sewell|330 363 0000|Jane.Sewell@aultman.com|3334
312782|NCT03054805|Chang Gung Memorial Hospital|Dr. Hsun-Chin Chao|88633281200|chaohero@yahoo.com|8969
312783|NCT03054844|Columbia University|Dr. Daniel Tsze|212-305-9825|dst2141@columbia.edu|
312784|NCT03054857|King Chulalongkorn Memorial Hospital|Dr.Yada Thongsuk|+66817738629|thongsuk.y@hotmail.com|
312785|NCT03054870|Cyclomedica Australia Pty Ltd|James McBrayer|+61 2 9541 0411|clinicaltrials@cyclomedica.com|
292228|NCT01412866|DArtmouth-Hitchcock|Mary F. Brunette|603-27105747|mary.f.brunette@dartmouth.edu|
303520|NCT02176525|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
292229|NCT01412879|SWOG Statistical Center|Lymphoma Committee Statistician|206-667-4623||
292230|NCT01412918|Medical College of Wisconsion|Dr. David Friedland|414-805-|dfriedland@mcw.edu|
292231|NCT01412944|Novartis|Study Director|862-778-8300||
303521|NCT02176642|Duke University|Nazema Siddiqui MD||nazema.siddiqui@duke.edu|
292232|NCT01412957|Amgen Inc.|Study Director|866-572-6436||
292233|NCT01412983|Bausch & Lomb|Dr. Robert Steffen|1 585 338 6399|robbert.steffen@bausch.com|
292234|NCT01413087|Anchiano Therapeutics Israel Ltd.|Dr. David Kerstein|857-259-4626|david.kerstein@anchiano.com|
292235|NCT01413178|U.T. MD Anderson Cancer Center|Dr. Muzaffar H. Qazilbash / Stem Cell Transplantation and Cellular Therapy|713-745-3219|mqazilba@mdanderson.org|
292236|NCT01413191|UT MD Anderson Cancer Center|Dr. Sapna Patel, MD - Associate Professor, Melanoma Medical Oncology|713-792-2921|SPPatel@mdanderson.org|
292237|NCT01413204|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
303522|NCT02176655|Clinvest/A Division of Banyan Group Inc.|Heather Manley|417-841-3664|hmanley@clinvest.com|
303523|NCT02176837|Hope Pharmaceuticals|Craig Sherman, MD|4806071970|sherman@hopepharm.com|
303524|NCT02176928|University of Miami|Shirin Shafazand, MD, MS|305-243-7888|sshafazand@med.miami.edu|
303525|NCT02177032|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
303526|NCT02177123|InnFocus, Inc.|Sharon Herbert, Associate Director of Clinical Operations|(415) 268-9059|sharon.herbert@santen.com|
303527|NCT02177136|Intercept Pharmaceuticals, Inc.|Medical Information|844-782-4278|medinfo@interceptpharma.com|
303528|NCT02177201|Adnan Menders University, Anesthesiology and Reanimation Department|Dr. Sinan Yılmaz|+905055954374|dr_snnylmz@hotmail.com|
303529|NCT02177786|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
303530|NCT02177812|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312786|NCT03054922|Nationwide Children's Hospital|David P. Martin, MD|614-722-4200|david.martin@nationwidechildrens.org|
312787|NCT03055000|National Institute of Allergy and Infectious Diseases|Memoli, Matthew|+1 301 443 5971|mm982v@nih.gov|
312788|NCT03055156|Stanford University|Dr. Seiji Nishino|650-725-8602|nishino@stanford.edu|
312789|NCT03055195|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312790|NCT03055221|United Therapeutics, Corp.|Leigh Peterson, PhD||lpeterson@unither.com|
312791|NCT03055260|University of Minenesota|Russel Giveans|5042314007|russell.giveans@gmail.com|
312792|NCT03055338|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
312793|NCT03055494|Novartis Pharmaceuticals|Study Director|+1 (862) 778-8300|novartis.email@novartis.com|
312794|NCT03055624|UCSD|Andrew Picel MD|619-543-3436|apicel@stanford.edu|
312795|NCT03055650|Alcon Research, LLC|Senior CDMA Project Lead, CDMA Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
312796|NCT03055806|Ixchelsis Limited|Chief Medical Officer|44 (0) 1227-832760|ian.osterloh@ixchelsis.com|
312797|NCT03055832|TearFilm Innovations, Inc.|Rob Thornhill|844-458-9776|rthornhill@tearfilm.com|
312798|NCT03055858|Abbott Laboratories|Ebony Kargbo|612-209-8185|Ebony.Kargbo@abbott.com|
312799|NCT03055897|Alcon Research, LLC|Senior CDMA Project Lead, CDMA Ocular Health|1-888-451-3937|alcon.medinfo@alcon.com|
312800|NCT03055936|Orion Corporation, Orion Pharma|Clinical Study Director|+358104264184|clinicaltrials@orionpharma.com|
312801|NCT03055988|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312802|NCT03056040|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
312803|NCT03056144|The Hong Kong Polytechnic University|Dr Tamis W Pin|85227666751|tamis.pin@polyu.edu.hk|
312804|NCT03056300|Ethicon|Michael Schwiers|513-337-1172|mschwier@its.jnj.com|
312805|NCT03056352|Montefiore Health|Benjamin W. Friedman, MD|718-920-6626|befriedm@montefiore.org|
312806|NCT03056456|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312807|NCT03056573|Abbott|Angelic Roach, Clinical Program Director|+16517563379|angelic.roach@abbott.com|
312808|NCT03056690|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
312809|NCT03057132|Cancer Treatment Centers of America|Joseph Rudolph, BSN, RN, CWOCN, DWC|(215) 537-4678|Joe.Rudolph@ctca-hope.com|
312810|NCT03057366|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
312811|NCT03057496|Schepens Eye Research Institute of Massachusetts Eye and Ear|Alex Bowers|617 912 2512|alex_bowers@meei.harvard.edu|
312812|NCT03057613|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Shlomo Koyfman|1-866-223-8100|TaussigResearch@ccf.org|
312813|NCT03057704|Wake Forest University School of Medcine|Timothy N. Harwood MD|3367164498|tharwood@wakehealth.edu|
312814|NCT03057977|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312815|NCT03058679|University of Pennsylvania|Dr. James D. Lewis|215-573-5137|lewisjd@pennmedicine.upenn.edu|
312816|NCT03058692|Baylor College of Medicine|Robert L. Atmar, M.D.|713-798-6849|ratmar@bcm.edu|
312817|NCT03058991|Boston University Charles River Campus|Dr. Michael Otto|617-353-9610|mwotto@bu.edu|
312818|NCT03059810|Johnson & Johnson Vision|Thomas Karkkainen- SR PRINCIPAL RESEARCH OPTOMETRIST|904 443-3402|TKarkkai@its.jnj.com|
312819|NCT03059901|Klein Buendel|Valerie Myers, PhD|3035654343|vmyers@kleinbuendel.com|
312820|NCT03060447|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
312821|NCT03060486|AOU Careggi|Riccardo Pace, DMD|00390557945608|riccardo.pace@unifi.it|
312822|NCT03060512|AstraZeneca Pharmaceutical LP|Catherine J. Datto, MD, MS, Movantik Medical Head, USMA|+1 302 885 1180|Information.Center@astrazeneca.com|
312823|NCT03060551|Department of Plastic Surgery, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea|Suk-Ho Moon|821090803527|nasuko@catholic.ac.kr|
292238|NCT01413360|Seoul National University Hospital|Jung-Hwan Yoon|+82-2-2072-2228|yoonjh@snu.ac.kr|
292239|NCT01413503|University of California, San Francisco|Paul A. Fitzgerald, MD|415-665-1136|Paul.Fitzgerald2@ucsf.edu|
292240|NCT01413516|Stanford University|Judith Prochaska|6507243608|jodi.prochaska@stanford.edu|
292241|NCT01413542|Department of Medicine Vanderbilt University Medical Center|Dr. Nancy J. Brown|615-343-8701|nancy.j.brown@vanderbilt.edu|
292242|NCT01413750|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
292243|NCT01413958|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292244|NCT01414010|Beth Israel Deaconess Medical Center|Ciaran Kelly, MD|617-667-1272|ckelly2@bidmc.harvard.edu|
292245|NCT01414036|Boston Medical Center|Karen E. Lasser|617-414-6688|karen.lasser@bmc.org|
292246|NCT01414075|FibroGen, Inc.|Clinical Trial Information Desk|415-978-1441||
292247|NCT01414114|Amgen, Inc|Study Director|866-572-6436||
303531|NCT02177838|Rutgers Cancer Institute of New Jersey|Sung Kim, MD|732-235-3986|sk1375@cinj.rutgers.edu|
303532|NCT02177942|GlaxoSmithKline|GSK Response Center|866-435-7343||
303533|NCT02178059|AstraZeneca R&D|Göran Eckerwall, Medical Science Director|1-800-236-9933|Goran.Eckerwall@astrazeneca.com|
303534|NCT02178241|City of Hope|Paul Frankel, Ph.D.|626-218-5265|pfrankel@coh.org|
303535|NCT02178475|Amgen Inc.|Study Director|866-572-6436||
303536|NCT02178540|Novartis Pharmaceuticals|Study Director|862-778-8300||
303537|NCT02178553|Mayo Clinic Rochester|Dr. James D. Hannon|507-284-7289|hannon.james@mayo.edu|
303538|NCT02178592|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
303539|NCT02178696|University of Michigan|Jon-Kar Zubieta||JONKAR.ZUBIETA@hsc.utah.edu|
312824|NCT03060759|Massachusetts General Hospital|Farrah J. Mateen, MD, PhD, Associate Professor of Neurology|617-724-8653|fmateen@mgh.harvard.edu|
312825|NCT03061097|Microbiome Health Research Institute|Majdi Osman, MD, MPH|617-575-2201|majdi@openbiome.org|
312826|NCT03061175|Rutgers Cancer Institute of New Jersey|Dr. Sharon Manne, Associate Director, Population Science|732-235-6759|mannesl@cinj.rutgers.edu|
312827|NCT03061188|Northwestern University, Feinberg School of Medicine|Young Kwang Chae, MD, MPH, MBA|312-926-4248|YCHAE@nm.org|
312828|NCT03061214|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
312829|NCT03061331|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
312830|NCT03061513|Weill Cornell Medical College|Claire Henchcliffe|2127462584|clh2007@med.cornell.edu|
312831|NCT03061812|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
312832|NCT03062228|Global Innovations for Reproductive Health & Life|Dr. Allan Kember, Director of Programs|+1-902-580-8385|allan.kember@mail.utoronto.ca|
312833|NCT03062267|University of Washington|Principal Investigator|(206) 685-9655|dbenzeev@uw.edu|
312834|NCT03062488|Nemours Children's Healthcare System|Carlos A. Archilla, MD|4076507646|carlos.archilla@nemours.org|
312835|NCT03062605|UCLA|Dr. Vladimir W. Spolsky|310-794-0700|vspolsky@dentistry.ucla.edu|
312836|NCT03062891|University of Notre Dame|Dan Denis|6178066484|ddenis@nd.edu|
312837|NCT03062917|Imperial College NHS trust|Study PI Simon Nadel|02033126202|s.nadel@imperial.ac.uk|
312838|NCT03063086|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
312839|NCT03063125|University of Kansas Medical Center|Katie Glavin|913-588-8721|kglavin@kumc.edu|
312840|NCT03063255|Department of Anesthesiology, NF/SG Veterans Health System|Dr. Jose R. Soberon, Jr.|352-413-2317|jsoberon@anest.ufl.edu|
312841|NCT03063294|Veterans Affairs Greater Los Angeles Healthcare System|David Avram Ganz, MD, PhD|310-478-3711|David.Ganz@va.gov|
312842|NCT03063385|University of Pennsylvania School of Nursing|Dr. Antonia M. Villarruel|2158988283|amvillar@nursing.upenn.edu|
312843|NCT03063437|Microbiome Health Research Institute|Majdi Osman, MD, MPH|6175752201|majdi@openbiome.org|
312844|NCT03063476|Vanderbilt University Medical Center|Dr. Jane Ferguson|6158759896|jane.f.ferguson@vanderbilt.edu|
312845|NCT03064152|Brigham and Women's Hospital|Dr. Michaela K. Farber|6177591609|mfarber@bwh.harvard.edu|
312846|NCT03064438|Accuitis, Inc.|Chief Science Officer|678-812-1492|info@accuitis.com|
312847|NCT03064451|Johnson and Johnson Medical NV/SA|Nathalie Macours / Clinical Research Director|+32 2 746 35 27|nmacours1@its.jnj.com|
292248|NCT01414153|Lpath, Inc.|Susan E. Hazel|858-926-3205|shazel@lpath.com|
312848|NCT03064841|Boehringer Ingelheim|Boehringer Ingelheim Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312849|NCT03065023|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
303540|NCT02178787|Beth Israel Deaconess Medical Center|Dr. Vera Novak|617-632-8680|vnovak@bidmc.harvard.edu|
303541|NCT02178800|Fred Hutch Cancer Research Center|Gordon Chau|2066672118|gchau@fredhutch.org|
270274|NCT00117572|UC San Diego Moores Cancer Center|Dr. Ezra E.W. Cohen||ecohen@ucsd.edu|
303542|NCT02178956|Sumitomo Dainippon Pharma Oncology|Marilyn Fontaine|617-674-8556|mfontaine@bostonbiomedical.com|
270275|NCT00117585|Portland VA Medical Center|Dr. David Hickam|(503) 721-7817|david.hickam@va.gov|
270276|NCT00117598|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
270277|NCT00117637|BAYER|Therapeutic Area Head||clinical-trials-contact@bayerhealthcare.com|
303543|NCT02178995|Stanford University|Jesse Adams, MD|2069144771|jadamsuw@stanford.edu|
292249|NCT01414205|Hoffman-LaRoche|Medical Communications|800-821-8590|genentech@druginfo.com|
292250|NCT01414244|Tulane University|QiQi Zhou|988-7800|qiqi06@gmail.com|
292251|NCT01414257|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292252|NCT01414413|Liverpool School of Tropical Medicine|Dr Peter MacPherson|0044151 705 3100|p.macpherson@liv.ac.uk|
292253|NCT01414426|UChicago|Dr. Alexander Pearson|855-702-8222|apearson5@medicine.bsd.uchicago.edu|
292254|NCT01414634|Neuroimmunology and MS Research, Department of Neurology, University Hospital Zürich, 8091 Zürich, Switzerland|Roland Martin|044 255 11 25|roland.martin@usz.ch|
292255|NCT01414738|UT Southwestern Medical Center|Dr. Robert Timmerman|214/645-7637|ROBERT.TIMMERMAN@UTSouthwestern.edu|
292256|NCT01414855|Genentech, Inc.|Medical Communications|800-821-8590|genetech@druginfo.com|
303544|NCT02179047|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
303545|NCT02179177|Duke University|Nirmish Shah, MD|919-668-5178|nirmish.shah@duke.edu|
303546|NCT02179190|Medtronic Plc|Senior Manager, Clinical Project Management|949-680-1274|darren.j.lacour@medtronic.com|
303547|NCT02179398|Geneva University Hospital|Dr. Laurence Lacroix|+41223725082|laurence.lacroix@hcuge.ch|
303548|NCT02179424|University of Hong Kong|Professor Lam Tai-Hing|39179287|hrmrlth@hku.hk|
312850|NCT03065075|University of Massachusetts|Dr. Tania Sierra|508-334-9840|tania.sierra@umassmemorial.org|
312851|NCT03065179|UT Southwestern Medical Center|Dr. Hans Hammers|214/645-7445|Hans.Hammers@UTSouthwestern.edu|
312852|NCT03065205|University of Colorado|Heather Hoch MD|720-777-4108|heather.hoch@childrenscolorado.org|
312853|NCT03065283|Department of Physical Therapy|Prof. Dr. Pedro Lima|558533668091|pedrolima@ufc.br|
312854|NCT03065400|Icahn School of Medicine at Mount Sinai|Mikaela Dougherty|212-241-8839|Mikaela.dougherty@mssm.edu|
292257|NCT01415232|UPittsburgh'|Dr. Manuel Vallejo|4126414260|vallejomc@anes.upmc.edu|
292258|NCT01415349|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
292259|NCT01415401|Alcon Research, Ltd.|Doug Hubatsch, Global Brand Leader|1-888-451-3937|alcon.medinfo@alcon.com|
292260|NCT01415427|BioMarin Pharmaceutical Inc.|Peter Slasor/Sr Director, Biostatistics, Global Clinical Sciences|415-506-6765|pslasor@bmrn.com|
292261|NCT01415440|NYSPI|Jonathan Posner, MD|6467745735|jonathan.posner@nyspi.columbia.edu|
303549|NCT02179515|National Cancer Institute|Dr. James Gulley|301-480-8870|James_Gulley@nih.gov|
292262|NCT01415453|Columbia University Medical Center|Dr Ronald Silverman|2123055484|rs3072@columbia.edu|
292263|NCT01415518|AstraZeneca|Goran Eckerwall||ClinicalTrialTransparency@astrazeneca.com|
292264|NCT01415531|Forest Research Institute|Tatjana Lukic, MD, MSc|(201) 427-8649|tanya.lukic@frx.com|
292265|NCT01415583|Massachusetts Eye and Ear Infirmary|Dr. Christopher Hartnick, Division Director, Pediatric Otolaryngology Director, Pediatric Airway, V|617-573-4206|christopher_hartnick@meei.harvard.edu|
303550|NCT02179671|AstraZeneca|Phillip Dennis|1 + 301-398-5549|Phillip.Dennis@astrazeneca.com|
303551|NCT02179788|University of Cincinnati|Dr. Laurie Nommsen-Rivers|513-558-0461|laurie.rivers@uc.edu|
303552|NCT02179892|Emory University|Dr. Colette Curtis|404-778-3900|ccurti3@emory.edu|
303553|NCT02179918|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
303554|NCT02180061|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
303555|NCT02180100|Peking University Shenzhen Hospital|Prof. Shangrong Fan|86755-83923333|fanshangrong@163.com|5502
303556|NCT02180165|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
303557|NCT02180230|Nobel Biocare|Head of Clinical Trial Management|+41 43 211 42 00|isabelle.arrighi@nobelbiocare.com|
303558|NCT02180438|University of Washington|Dr. Geoffrey S Gottlieb. MD PhD (PI)|1-206-616-2631|gottlieb@uw.edu|
312855|NCT03065530|The First Affiliated Hospital of Nanjing Medical University|Dr. Shijiang Liu, Dr. Mei Gao|+862568303569|liushijiang1983@hotmail.com|
312856|NCT03065647|University of Michigan|Robert Neumar|734-936-0253|neumar@umich.edu|
312857|NCT03066102|National Yang Ming University|Dr. Yi-Fen Shih|+886-2-28267340|yfshih@ym.edu.tw|
312858|NCT03066193|Yale University|Dr. Michael H. Bloch|2037374539|michael.bloch@yale.edu|
312859|NCT03066609|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
312860|NCT03066778|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
312861|NCT03066804|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
312862|NCT03066830|Lexicon Pharmaceuticals, Inc.|Medical Affairs|510-338-6064|medical-information@lexpharma.com|
312863|NCT03066947|BriaCell Therapeutics Corporation|Dr. William Williams|1-888-485-6340|williams@briacell.com|
312864|NCT03066999|PUR Clinic|Dr Sijo Parekattil|3525368761|sijo@orlandohealth.com|
312865|NCT03067129|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
312866|NCT03067311|University of North Carolina at Chapel Hill|David Penn, PhD|(919) 843-7514|dpenn@email.unc.edu|
312867|NCT03067441|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
312868|NCT03067506|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
312869|NCT03067948|Johns Hopkins University SOM (Adjunct)|Anne Monroe MD|202-994-0251|amonroe@gwu.edu|
312870|NCT03067987|University of Miami|Ranjith Ramasamy|3052434873|ramasamy@miami.edu|
312871|NCT03068091|University of Missouri|Talissa Altes|573 882 1026|ALTEST@HEALTH.MISSOURI.EDU|
312872|NCT03068312|Vertex Pharmaceuticals Incorporated|Medical Monitor|+1 617 341 6777|medicalinfo@vrtx.com|
312873|NCT03068455|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
312874|NCT03068468|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
312875|NCT03068611|Brown University|Christopher Kahler|401 863-6651|christopher_kahler@brown.edu|
312876|NCT03068715|Stanford University|Dr. Nolan Williams|650-723-1147|nolanw@stanford.edu|
312877|NCT03068754|Mallinckrodt|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|5
312878|NCT03068767|Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation|Chief of internal medicine department|+886-2-6628-9779|uld888@yahoo.com.tw|2317
312879|NCT03068897|Montefiore|Dr. Benjamin W. Friedman|718-920-6626|befriedm@montefiore.org|
312880|NCT03068949|University of Rochester|Dr. Angela Branche|5852750526|angela_branche@urmc.rochester.edu|
312881|NCT03069313|Cleveland Clinic Florida|Zeina Nahleh, MD (previoulsy PI at Texas Tech university HSC-EP)|9546595840|nahlehz@ccf.org|
312882|NCT03069352|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
312883|NCT03069365|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
312884|NCT03069482|Duke University Psychiatry & Behavioral Sciences|Dr. Roger Vilardaga|9196813441|roger.vilardaga@duke.edu|
312885|NCT03069677|University of Pennsylvania|Veena Graff MD, MS|(215) 662-8244|veena.graff@uphs.upenn.edu|
312886|NCT03069716|Vanderbilt University Medical Center|Dr. Evan L. Brittain|(615) 322-4382|Evan.brittain@vumc.org|
312887|NCT03069989|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312888|NCT03070171|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312889|NCT03070236|Dana-Farber Cancer Institute (DFCI)|Ann H. Partridge, MD, MPH|617-632-3800|Ann_Partridge@dfci.harvard.edu|
312890|NCT03070392|Immunocore, Ltd|Study Director|1-844-IMMUNO-1|clinicaltrials@immunocore.com|
312891|NCT03070431|Department of Radiation Oncology, University of Lübeck, Lübeck, Germany|Prof. Dr. med. Dirk Rades|0049 451 500|rades.dirk@gmx.net|45400
312892|NCT03070470|U.S. Food and Drug Administration|Jose Vicente, PhD|301-796-8442|Jose.VicenteRuiz@fda.hhs.gov|
292266|NCT01415908|Medtronic Spinal and Biologics|Clinical Department|1800-876-3133|msbkclinicalresearch@medtronic.com|6068
292267|NCT01415921|New York University School of Medicine|Stuart Katz, MD|212-263-3946|stuart.katz@nyumc.org|
292268|NCT01415934|University of Colorado|Carrie Brill|303 808 9708|CARRIE.BRILL@UCDENVER.EDU|
292269|NCT01415960|Grand Strand Urology Carolina Urology Reseearch Centre|Dr. Neal Shore MD|+1 843 839 1679|nshore@grandstrandurology.com|
292270|NCT01416025|JohnHopkinsU|Dr. Darin Ostrander|(443) 287-6217|dostrander@jhu.edu|
292271|NCT01416129|University of South Florida|Jason Highsmith|813-974-3806|mhighsmi@health.usf.edu|
292272|NCT01416142|Bausch & Lomb Incorporated|Dr. William Reindel|(585) 338-8129|william.reindel@bausch.com|
292273|NCT01416155|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
292274|NCT01416181|Biogen|Biogen Study Medical Director||clinicaltrials@biogen.com|
292275|NCT01416194|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
303559|NCT02180646|University of Missouri|Dr Jill Kanaley|573-882-2519|kanaleyj@missouri.edu|
303560|NCT02180659|Titan Pharmaceuticals|Kate Beebe DeVarney|650-244-4990|kdevarney@titanpharm.com|
303561|NCT02180672|The Children's Hospital of Philadelphia|Ignacio Tapia, MD, Principal Investigator, Associate Professor|(267) 426-5842|tapia@chop.edu|
303562|NCT02180828|Peking University|Shangrong Fan|860755-83923333|fanshangrong@163.com|5502
303563|NCT02180867|Children's Oncology Group|Results Reporting Coordinator|626-447-0064|resultsreportingcoordinator@childrensoncologygroup.org|
303564|NCT02180893|NYU Langone Medical Center|Peter Neuberger|212 263 5821|Peter.Neuburger@nyumc.org|
303565|NCT02181075|Oncology Clinical Trials Group|Sarah Pearson, Trial Management Director|01865 227160|sarah.pearson@oncology.ox.ac.uk|
303566|NCT02181127|Massachusetts General Hospital|Dr Steven J Russell|617-726-1848|sjrussell@partners.org|
303567|NCT02181140|Interdisciplinary Endoscopy Department and Clinic University Hospital Hamburg-Eppendorf|Professor Dr. Thomas Rösch|+4940 7410|t.roesch@uke.de|50098
312893|NCT03070483|Loyola University Chicago|Dr. Holly Kramer|7083279039|hkramer@lumc.edu|
312894|NCT03070548|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_inquiries@pfizer.com|
312895|NCT03070730|Beth Israel Deaconess Medical Center|Dr. Roy Freeman|617-632-8454|rfreeman@bidmc.harvard.edu|
312896|NCT03070782|Akcea Therapeutics|Study Director|617-207-0289|clinicalstudies@akceatx.com|
312897|NCT03070964|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
312898|NCT03071094|Transgene|Associate Medical Director|+ 33 (0)3 88 27 91 00|clinical.trials@transgene.fr|
312899|NCT03071263|Vifor Pharma Inc.|Clinical Support & Regulatory Intelligence, Regulatory Affairs Director|+1 250 708 4296|Clive.Burge@viforpharma.com|
312900|NCT03071276|St. Jude Children's Research Hospital|Jeffrey E. Rubnitz, MD, PhD|901-595-2388|jeffrey.rubnitz@stjude.org|
312901|NCT03071744|UCSD|Eric Roeland, MD|(858) 534-7079|eroeland@ucsd.edu|
312902|NCT03071887|Massachusetts General Hospital|Dr. Christina Psaros|617.726.7458|cpsaros@mgh.harvard.edu|
312903|NCT03072160|National Cancer Institute|Dr. Ravi Madan|301-480-7168|rm480i@nih.gov|
312904|NCT03072186|Ohio State University Wexner Medical Center|Dr. Daniel Prevedello, MD|(614) 293-7190|Daniel.Prevedello@osumc.edu|
312905|NCT03072550|DeviceFarm|Jeffrey N Roe|925-895-1584|jeffnroe1@devicefarmtech.com|
312906|NCT03072602|UNIVERSITY OF ALABAMA AT BIRMINGHAM|Dr. Pankaj Arora|12059754720|parora@uabmc.edu|
312907|NCT03072719|GlaxoSmithKline|GSK Response Center|866-435-7343||
312908|NCT03072732|ZOLL|Project Manager|14127216444|moszm@yahoo.com|
312909|NCT03072875|Evidence-Based Practice Institute|Linda Dimeff, PhD|206-455-7934|research@ebpi.org|83
312910|NCT03072953|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
312911|NCT03073005|Northwestern University|Dr. Jeffrey H Barsuk|312-926-5924|jbarsuk@nm.org|
312912|NCT03073109|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312913|NCT03073148|Tangible Science|Director of Research and Development|650-241-1045|kelly@tangiblescience.com|108
312914|NCT03073200|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312915|NCT03073213|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312916|NCT03073486|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312917|NCT03073759|Johns Hopkins University|Mohammad Khoshnoodi|410-955-5460|mkhoshn1@jhmi.edu|
312918|NCT03073798|Johns Hopkins University|Nadia N Hansel, MD MPH|410-550-2935|nhansel@jhmi.edu|
312919|NCT03073876|City University of New York - Queens College and The Graduate Center|Nancy S. Foldi, PhD; Professor|718.997.3253|nfoldi@qc.cuny.edu|
292276|NCT01416389|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292277|NCT01416441|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
292278|NCT01416571|GlaxoSmithKline|GSK Response Center|866-435-7343||
292279|NCT01416584|Johns Hopkins University School of Medicine|Kenneth Silverman|410-550-2694|ksilverm@jhmi.edu|
292280|NCT01416610|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
292281|NCT01416636|SciPharm SàRL|Bianca Tan||b.tan@scipharm.eu|
292282|NCT01416805|University of South Florida|Dr. Eric Storch|727-767-8230|Eric.Storch@bcm.edu|
303568|NCT02181231|Washington University School of Medicine|Dr. Eric Lenze|314-362-1671|lenzee@wustl.edu|
292283|NCT01416987|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
292284|NCT01417000|Aduro Biotech, Inc.|Corporate Communications|510-848-4400||
292285|NCT01417026|Children's Hospital of Philadelphia|Robert Schultz, PhD|267-426-7540|schultzrt@email.chop.edu|
292286|NCT01417078|Acorda Therapeutics, Inc.|Executive Medical Director - Clinical Development & Medical Affairs|914-347-4300|dsquillacote@acorda.com|5367
303569|NCT02181296|University of Pennsylvania|Dr. Nabil M Elkassabany|(215) 662-3793|Nabil.Elkassabany@uphs.upenn.edu|
303570|NCT02181387|Wake Forest School of Medicine|Peter H. Pan, MD, MSEE|336-718-8278|ppan@wakehealth.edu|
303571|NCT02181400|Sydney Eye Hospital|Maria Willilams|02 9382 7309|maria.williams@sydney.edu.au|
303572|NCT02181413|Takeda|Medical Director|+1-866-835-2233|trialdisclosures@takeda.com|
303573|NCT02181426|Medical University of South Carolina, Department of Anesthesia and Perioperative Medicine|Research Coordinator for Anesthesia and Perioperative Medicine|843-792-2322|joneswr@musc.edu|
312920|NCT03074162|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312921|NCT03074331|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
312922|NCT03074409|University of Electronic Science and Technology of China|Dr. Shuxia Yao|+8618111297596|yaoshuxia@uestc.edu.cn|
312923|NCT03074500|Marmara University School of Medicine|Gulseren Derya Akyuz|+90 216 657 06 06|girayesra@hotmail.com|1628
312924|NCT03074630|AmsterdamUMC|Erik van Bommel|+31 20 4444444|e.vanbommel@amsterdamumc.nl|
312925|NCT03074682|Yale University|Dr. Marc Auerbach|203-688-3333|marc.auerbach@yale.edu|
312926|NCT03075085|University of Arkansas for Medical Sciences|Dr. Taren Swindle|870-236-0997|tswindle@uams.edu|
312927|NCT03075163|UC Davis Anesthesiology & Pain Medicine|Neal Fleming, MD, PhD|916 734-5046|nwfleming@ucdavis.edu|
312928|NCT03075267|Pearl Therapeutics, Inc.|Pearl Therapeutics, Inc.|1-877-240-9479|information.center@astrazeneca.com|
312929|NCT03075410|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312930|NCT03075449|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
312931|NCT03075501|University of Illinois at Chicago|Emma Childs|312-355-2726|echilds@uic.edu|
312932|NCT03075527|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|6176323468|mark_awad@dfci.harvard.edu|
312933|NCT03075553|Mayo Clinic|Stephen M Ansell MD PhD|507/284-2511|ansell.stephen@mayo.edu|
312934|NCT03075644|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
312935|NCT03075761|The University of Texas Southwestern Medical Center|Ayesha Zia, MD|214-456-7000|Ayesha.Zia@UTSouthwestern.edu|
312936|NCT03075839|Yale University|Krysten Bold|203-974-7603|Krysten.bold@yale.edu|
312937|NCT03075878|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
312938|NCT03075891|Galderma|Rajeev Chavda|0033492382928|rajeev.chavda@galderma.com|
312939|NCT03075904|Alexion Pharmaceuticals, Inc.|Alexion Pharmaceuticals, Inc.|855-752-2356|clinicaltrials@alexion.com|
312940|NCT03076190|Stanford University|Dr. Beth Darnall|6507365494|bdarnall@stanford.edu|
312941|NCT03076333|Joint UNC/NC State Department of Biomedical Engineering|David S Lalush|919-513-7671|dslalush@ncsu.edu|
312942|NCT03076359|Vanderbilt University|Carolyn Audet|615-343-2418|carolyn.m.audet@vanderbilt.edu|
312943|NCT03076515|Theranica Bio-Electronics Ltd|Dagan Harris|+972723909755|daganh@theranica.com|
312944|NCT03076970|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
312945|NCT03076983|Drägerwerk AG & Co. KGaA|Mr. Robin Hüwel|+49 451 882 6830|ClinicalAffairs@draeger.com|
312946|NCT03076996|FHI 360|Dr. Lisa Dulli|919-544-7040|ldulli@fhi360.org|11396
312947|NCT03077165|IlkosTherapeutic Inc.|Monique Champagne|450-680-3381|mchampagne@ilkostherapeutic.com|2910
312948|NCT03077438|Sanofi Pasteur Inc.|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
312949|NCT03077607|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
312950|NCT03077646|Children's Hospital at Montefiore|Alyssa Silver, MD|718-741-2304|alysilve@montefiore.org|
312951|NCT03077659|NanOlogy, LLC|Gere S. diZerega, MD|805-595-1300|gere.dizerega@usbiotest.com|
312952|NCT03077711|Lehigh Valley Health Network|Dr. Carolyn Botros, DO|4845917480|carolyn.botros@lvhn.org|
312953|NCT03077724|Vanderbilt University Medical Center|Harvey J Murff|615 936 8319|harvey.j.murff@vanderbilt.edu|
312954|NCT03077893|Regenesis Biomedical|Heather M Vander Ploeg|602-428-7041|heather.vanderploeg@regenesisbio.com|
292287|NCT01417104|The Ohio State University|Sanjay Rajagopalan, MD|614-247-7760|sanjay.rajagopalan@osumc.edu|
292288|NCT01417156|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
292289|NCT01417195|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
292290|NCT01417234|KCI|VP, Global Clinical Development|12102555595|jane.hart@acelity.com|
292291|NCT01417455|Instituto de Medicina Molecular|João Eurico Fonseca|+351217999544|jecfonseca@gmail.com|47221
292292|NCT01417481|Instituto Nacional de Enfermedades Respiratorias|Dr. Mario H. Vargas|(+55)54871771|mhvargasb@yahoo.com.mx|
292293|NCT01417741|OHSU department of APOM|Dr. Christine Martin, assistant professor|503 494 7641|martich@ohsu.edu|
292294|NCT01417780|Atox Bio, Ltd.|Wayne M Dankner, MD, Chief Medical Officer|1 919-219-6377|wayned@atoxbio.com|
303574|NCT02181504|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
303575|NCT02181517|Allergan, Inc|Clinical Trials Registry Team|1-800-347-4500|IR-CTRegistration@allergan.com|
303576|NCT02181530|Allergan, Inc|Vice President Medical Affairs,|714-246-4500|clinicaltrials@allergan.com|
312955|NCT03077919|RTI International|Kristine L. Rae Olmsted, MSPH|919-541-8035|krolmsted@rti.org|
312956|NCT03078075|UT Southwestern Medical Center|Dr. Madhukar Trivedi|214/648-0188|Madhukar.Trivedi@UTSouthwestern.edu|
312957|NCT03078127|University of North Carolina at Chapel Hill|Scott Donaldson, MD|984-974-9198|scott_donaldson@med.unc.edu|
312958|NCT03078504|Saint Louis University|Dr.Zafar Jamkhana|314-577-8856|zafar.jamkhana@health.slu.edu|
312959|NCT03078556|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312960|NCT03078582|Ra Pharmaceuticals, Inc|Sponsor Ra Pharmaceuticals, Inc.|+1 617 401 4060|trials@rapharma.com|
312961|NCT03078595|Johann Wolfgang Goethe-University Frankfurt|Prof. Dr. med. dent. Peter Eickholz|+4915112433230|eickholz@med.uni-frankfurt.de|
312962|NCT03078647|Candela Corporation|Director of Clinical Marketing|(949) 599-7646|doranr@candelamedical.com|
312963|NCT03078751|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
312964|NCT03078816|UCSF Movement Disorders|Aaron Viser|415 353 9453|aaron.viser@ucsf.edu|
312965|NCT03078907|Actelion Pharmaceuticals Ltd|Clinical Registry group|844-434-4210|clinical-trials-disclosure@its.jnj.com|
312966|NCT03078946|Ain-Shams University Hospitals|Dr. Ibrahim Mamdouh Esmat|01001241928|ibrahim_mamdouh@med.asu.edu.eg|
312967|NCT03079375|OdenseUH|Lene V. Ravn-Nielsen clinical pharmacist|+4523467925|lene.ravn-nielsen@rsyd.dk|
312968|NCT03079531|Stanford University|Anne Lynn Chang, MD|650-723-6316|alschang@stanford.edu|
312969|NCT03080142|UC Davis Medical Center, Department of Anesthesiology|Jon Zhou MD|9167035028|jonzhou@ucdavis.edu|
312970|NCT03080454|Feinstein Institute for Medical Research at Northwell Health|Bruce Volpe|516-562-3384|bvolpe1@northwell.edu|
312971|NCT03080493|University of California, Davis|Mitchell Creinin, MD|916-734-6670|mdcreinin@ucdavis.edu|
312972|NCT03080961|CLJI WORLDWIDE|Ty Cross, President & CEO|305-397-8880|tycross@cljiworldwide.com|
312973|NCT03081117|Johns Hopkins University|Dr. Leah Rubin, Associate Professor of Neurology, Psychiatry, and Epidemiology|410-955-7311|lrubin@jhu.edu|
312974|NCT03081884|Emory University|David M. Schuster, MD|404-712-4859|dschust@emory.edu|
312975|NCT03082196|Advantage Silver Dental Arrest, LLC|Dr. Peter Milgrom|206-251-6831|drmilgrom@silverarrest.com|
312976|NCT03082261|Abbott|Robyn Capobianco|+15129343941|robyn.capobianco@abbott.com|
312977|NCT03082586|Department of Radiation Oncology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China|Dr tingfeng Chen|86-021-37798364|tingfeng138138@163.com|
312978|NCT03082599|Carolina Eyecare Physicians, LLC|Dr. Helga P Sandoval, Director of Research|8438813937|helga.sandoval@carolinaeyecare.com|
312979|NCT03083093|LUMC|F.A. Klok, MD PhD|003171 526 9111|f.a.klok@LUMC.nl|
312980|NCT03083132|University of Arkansas for Medical Sciences|Dr. Tuhin Virmani|501-686-7235|tvirmani@uams.edu|
312981|NCT03083379|University of Virginia Health System|Daniel D. Rowley, MSc, RRT-ACCS, FAARC|434-465-7235|ddr8a@virginia.edu|
312982|NCT03083470|US Biotest, Inc.|Gere diZerega, MD; President & CEO|805-595-1300|gere.dizerega@usbiotest.com|
312983|NCT03083483|Duke University|Hannah Palmer|919-613-7665|hlp14@duke.edu|
312984|NCT03083639|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
312985|NCT03083769|Southern Medical University|Dr. Liang Li|86 20 61648510|liliang@smu.edu.cn|
312986|NCT03083847|National Institute of Allergy and Infectious Diseases|Patrick Duffy|(301) 761-5089|Patrick.Duffy@nih.gov|
312987|NCT03083990|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
312988|NCT03084302|University of Pittsburgh|Bethany Barone Gibbs, Associate Professor, University of Pittsburgh|412-383-4002|bbarone@pitt.edu|
312989|NCT03084315|University of Minnesota|Anne Joseph, MD, MPH|612-625-3789|lagre010@umn.edu|
312990|NCT03084796|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
312991|NCT03085017|Loma Linda University Health Care|David G. Rabkin, MD FACS|909-558-4354|drabkin@llu.edu|
312992|NCT03085238|MTrap|Vice President, RA/QA/CA|3013258537|cmitchell@m-trap.com|
312993|NCT03085758|Adrenomed AG|Jens Zimmermann|+49 (0) 3302 20 77 810|jzimmermann@adrenomed.com|
312994|NCT03085797|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
312995|NCT03085836|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
312996|NCT03085914|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
312997|NCT03085927|Indiana University School of Nursing|Dr. Sheri Robb, MT-BC|317-274-3152|shrobb@iu.edu|
312998|NCT03086018|Bernafon AG|Julie Tantau|+41 31 998 1646|juta@bernafon.com|
312999|NCT03086057|Brown University|Dr. Katie Biello|401-863-3082|katie_biello@brown.edu|
292295|NCT01417936|Symphogen A/S|Chief Scientific Officer|+45 8838 2600|info@symphogen.com|
303577|NCT02181556|FFCD|Mrs Karine Le Malicot, Head of biostatistics|+33 3 80 39.34.79|karine.le-malicot@u-bourgogne.fr|
303578|NCT02181634|ECOG-ACRIN Biostatistics Center|PrECOG Statistician|617-632-3633|pcata@jimmy.harvard.edu|
303579|NCT02181673|Janssen Research & Development, LLC|Senior Director Clinical Development||ClinicalTrialDisclosure@its.jnj.com|
292296|NCT01418001|Memorial Sloan Kettering Cancer Center|Dr. William Tap|646-888-4163|tapw@mskcc.org|
292297|NCT01418209|Brigham and Women's Hospital|Hadine Joffe, MD, MSc|617-732-4906|hjoffe@partners.org|
292298|NCT01418339|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
292299|NCT01418352|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|1-609-524-6788|clinicaltransparency@otsuka-us.com|
292300|NCT01418365|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
292301|NCT01418378|DePuy Synthes|Dave Whalen|574-372-7028|dwhalen@its.jnj.com|
292302|NCT01418482|Uppsala Akademiska Hospital, Dept. of Plastic Surgery|Fredrik Huss|+46 771 405 405|Fredrik.Huss@surgsci.uu.se|
292303|NCT01418703|University of Virginia|Marc D Breton, Ph.D.|434-982-6484|mb6nt@virginia.edu|
303580|NCT02181738|Bristol Myer-Squibb|Non-Comparative, Multi-Cohort, Single-Arm, Open-Label, Phase 2 Study of|Please email|Clinical.Trials@bms.com|
303581|NCT02181803|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
313000|NCT03086135|Radboud University Medical center, Nijmegen|Professor Emmanuel Mylanus|+31 24 361 49 34|Emmanuel.Mylanus@radboudumc.nl|
313001|NCT03086213|Shenzhen Third People,s Hospital|Thoracic surgical department|13823135410|daoren_000113@126.com|
313002|NCT03086265|Stanford University|Vladimir Nekhendzy, M.D., FASA|650-498-4055|nek@stanford.edu|
313003|NCT03086330|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
313004|NCT03086343|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
313005|NCT03086356|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313006|NCT03086408|Stanford University|Vladimir Nekhendzy, M.D., FASA|650-498-4055|nek@stanford.edu|
313007|NCT03086447|Johnson & Johnson Vision|Kristy Canavan- SENIOR PRINCIPAL RESEARCH OPTOMETRIST|904 443-1474|KCANAVA2@its.jnj.com|
313008|NCT03086460|Chiesi Farmaceutici S.p.A.|Clinical Trial Transparency|+ 39 0521 2791|clinicaltrials_info@chiesi.com|
313009|NCT03086551|University of Waterloo, Waterloo, Ontario, Canada|Sean K Meehan, PhD|5198884567|skmeehan@uwaterloo.ca|39278
313010|NCT03086707|Philip Morris Products S.A.|Julia Hoeng, PhD|+41 (58) 242 11 11|ClinicalTrials.PMI@pmi.com|
313011|NCT03087019|Dana-Farber Cancer Institute|Jonathan Schoenfeld, MD, MPH|617-632-3591|jonathan_schoenfeld@dfci.harvard.edu|
292304|NCT01418937|GlaxoSmithKline|GSK Response Center|866-435-7343||
303582|NCT02181816|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303583|NCT02181829|Memorial Sloan Kettering Cancer Center|Suzanne Wolden, MD|212-639-5148|woldens@MSKCC.ORG|
303584|NCT02181842|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
303585|NCT02182115|University of Minnesota|Dr. Susan Kline|612-626-3662|kline003@umn.edu|
292305|NCT01419015|Edwards Lifesciences|Aya Saeki||Aya_Saeki@edwards.com|
292306|NCT01419028|Alexion International Sarl|Alexion Pharmaceuticals||clinicaltrials@alxn.com|
292307|NCT01419080|UMKC|Kim Smolderen|816-932-5846|smolderenk@umkc.edu|
292308|NCT01419171|Peter Maurer, Director Clinical Trials|Peter Maurer, Director Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
292309|NCT01419184|Cubist Pharmaceuticals|Vice President, Clinical Research|1.781.860.8660||
292310|NCT01419197|Hoffmann-La Roche|Medical Communications|800 821-8590||
292311|NCT01419236|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292312|NCT01419249|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
292313|NCT01419275|Stanford University|Dr. Greg Zaharchuk|650-736-6172|susanmir@stanford.edu|
292314|NCT01419314|Texas Woman's University|Roberto Sandoval PT|713-859-9351|rsandoval@mail.twu.edu|
313012|NCT03087513|Toronto Western Hospital/University Health Network|Study Coordinator|416-603-5800|emad.alazazi@uhnresearch.ca|6237
313013|NCT03087604|Wake Forest University Health Sciences|Dr. Sean Dobson|3367168834|sdobson@wakehealth.edu|
313014|NCT03087643|University of Verona|Dr. Massimo Venturelli|00390458415114|massimo.venturelli@univr.it|
313015|NCT03087786|Niconovum USA|Dr. Abraham Varghese|336-741-2315|varghea@rjrt.com|
313016|NCT03087851|Dep. of Endocrinology and Internal Medicine, Aarhus University Hospital|MD Anne Sophie Sølling|78 45 54 75|annesoel@rm.dk|
313017|NCT03088137|IVFarma LLC|Mikhail Polzikov (PhD)|+74996455342|mikhail.polzikov@ivfarma.ru|1
313018|NCT03088267|Tris Pharma, Inc.|Antonio Pardo MD|16107502210|apardo@trispharma.com|
313019|NCT03088345|Medical College of Wisconsin/Children's Hospital of Wisconsin|Dr. Amee Bigelow|5136364200|amee.bigelow@cchmc.org|
313020|NCT03088748|University of Tennessee|Dr. Michael LaCour|8659742093|mlacour@utk.edu|
313021|NCT03088800|Maimonides Medical Center|Sergey Motov, MD|7182836000|smotov@maimonidesmed.org|
313022|NCT03088917|Radboudumc|Prof. dr. J.P.H. Drenth|0031243613999|joost.drenth@radboudumc.nl|
313023|NCT03089047|Duke University|Ian Welsby, M.D.|919-681-6752|ian.welsby@duke.edu|
313024|NCT03089216|Federal University of Goias|Dr. Terezinha de Jesus Esteves Barata|+55 62 3209-6325|terezinhabarata@yahoo.com.br|
313025|NCT03089580|University of Michigan / Kellogg Eye Center|Sarah Wood|734-615-2479|skwood@med.umich.edu|
313026|NCT03089697|Institute of iNtRON Biotechnology|Jun SooYoun, Ph.D. / Executive Director/ Principal researcher|+82-31-739-5332|jsy@intron.co.kr|
313027|NCT03089853|University of Alabama at Birmingham|Surya P Bhatt|205-934-5555|sbhatt@uabmc.edu|
313028|NCT03089879|GlaxoSmithKline|GSK Response Center|866-435-7343|ass77028@gsk.com|
313029|NCT03089944|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
313030|NCT03090100|Janssen Research & Development, LLC|Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
313031|NCT03090256|Alcon Research|Expert Clinical Project Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
313032|NCT03090620|UColorado|Dr. George Sam Wang|303-724-9967|george.wang@childrenscolorado.org|
313033|NCT03090958|UNC-Chapel Hill|Lisa Hightow Weidman, MD|919 966 2536|lisa_hightow@med.unc.edu|
313034|NCT03091179|Stanford University|Vladimir Nekhendzy|650-498-4055|nek@stanford.edu|
313035|NCT03091348|Men|Abraham Morgentaler|617-277-5000|research@menshealthboston.com|
313036|NCT03091361|MolecuLight Inc.|Liis Teene|416.542.5530|lteene@moleculight.com|
313037|NCT03091400|Icahn School of Medicine at Mount Sinai|James F Sumowski, PhD|212-241-6854|james.sumowski@mssm.edu|
313038|NCT03091439|Allergan|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
313039|NCT03091478|Johns Hopkins Sidney Kimmel Comprehensive Cancer Center|Rachel Levy, MS, CCRP|410-502-8738|rlevy16@jhmi.edu|
313040|NCT03091673|Xeris Pharmaceuticals, Inc.|Martin J. Cummins, VP, Clinical Development|806-282-2120|mcummins@xerispharma.com|
313041|NCT03091738|Virginia Commonwealth University|Jasmohan Bajaj, MD|804-828-4060|jasmohan.bajaj@vcuhealth.org|
313042|NCT03091751|Grifols Therapeutics Inc|Henry Li, PhD|+1 919 316 6042|henry.li@grifols.com|
313043|NCT03091777|Gage Development Company|Gage Development Company|1-847-999-0600|clinicalinfo@capstonedevservices.com|
313044|NCT03091920|Cyclerion Therapeutics, Inc.|Senior Medical Director|1-857-327-8778|info@cyclerion.com|
313045|NCT03092024|Lady Davis Institute|Dr. Brett Thombs|514-340-8222|brett.thombs@mcgill.ca|25112
313046|NCT03092089|University of Alberta Hospital|Dr Kevin Bainey|780-407-2176|Kevin.Bainey@albertahealthservices.ca|
313047|NCT03092375|UF Hepatology Research at CTRB|Lauren Morelli|3522739508|LAUREN.MORELLI@MEDICINE.UFL.EDU|
313048|NCT03092479|Geisinger Clinic|Michelle Lent, PhD|5702141004|mrlent1@geisinger.edu|
313049|NCT03092726|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
313050|NCT03092752|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313051|NCT03092791|Takeda|Senior Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
313052|NCT03092934|Eli Lilly and Company|Chief Medical Officer|800-595-5979|ClinicalTrials.gov@lilly.com|
313053|NCT03092960|Stanford University|Lisa Goldman Rosas|(650) 721-8415|lgrosas@stanford.edu|
313054|NCT03093025|Taisho Pharmaceutical R&D Inc.|Taisho Pharmaceutical R&D Inc. Study Director|800-602-0203|ClinicalTrials@taisho-rd.com|
292315|NCT01419535|NIDDK, NIH|Lynnette Nieman MD|301-496-8935|NiemanL@nih.gov|
292316|NCT01419626|Johnson & Johnson Consumer and Personal Products Worldwide|DIRECTOR ORAL HEALTH, MEDICAL AFFAIR & CLINICAL RESEARCH|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
292317|NCT01419639|NYU Langone Medical Center|Matthias A. Karajannis|212 263 9959|matthias.karajannis@nyumc.org|
292318|NCT01419665|Hexal AG / Novartis Pharmaceuticals|Study Director|+41613241111|novartis.email@novartis.com|
292319|NCT01419717|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
292320|NCT01419769|Boston Scientific Corp.|Lina Ginnetti|508-683-4512|Lina.Ginnetti@bsci.com|
292321|NCT01419795|Fred Hutchinson Cancer Research Center|Dr. Mohamed Sorror|206-667-6298|msorror@fredhutch.org|
292322|NCT01419977|Duke University Medical Center|Nirmish Shah, MD|919-684-5350|nirmish.shah@duke.edu|
292323|NCT01420016|HealthPartners Institute|Dr. Patrick O'Connor|952-967-5034|patrick.j.oconnor@healthpartners.com|
292324|NCT01420068|Noden Pharma DAC|Ciara Walsh|+ 353 1 9121573|cwalsh@nodenpharma.com|
292325|NCT01420081|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292326|NCT01420146|Institut Jules Bordet|Dr Géraldine Gebhart|025413095|geraldine.gebhart@bordet.be|+32
313055|NCT03093181|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313056|NCT03093207|São Paulo State University - Unesp|Dr Mauro Pedrine Santamaria|+5516981937777|mauro.santamaria@unesp.br|
313057|NCT03093272|Dana-Farber Cancer Institute|Lauren Harshman, MD|617-632-2429|laurenc_harshman@dfci.harvard.edu|
313058|NCT03093324|Biogen|Biogen Study Medical Director|866-633-4636|clinicaltrials@biogen.com|
313059|NCT03093350|Baylor College of Medicine|Shaun Bulsara|713-798-8014|sbulsara@bcm.edu|
313060|NCT03093415|Oregon Health and Sciences University|Andrew Seaman, MD|1 (971) 271 - 6102|seaman@ohsu.edu|
313061|NCT03093454|Duke Health|Scott Hollenbeck, MD|919-681-5079|scott.hollenbeck@duke.edu|
313062|NCT03093480|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
313063|NCT03093662|Brooke Army Medical Center|Dr. Derek Brown|2109160808|Derek.J.Brown1.mil@mail.mil|
313064|NCT03093870|ASLAN Pharmaceuticals|Study Director|+65 6222 4235|contact@aslanpharma.com|
313065|NCT03094195|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
313066|NCT03094325|NYU Langone Health|Daniel Swistel, MD|646-754-7217|Daniel.Swistel@nyulangone.org|
313067|NCT03094611|The University of Texas MD Anderson Cancer Center|Elias Jabbour, MD./ Professor, Leukemia|713-792-4764|ejabbour@mdanderson.org|
313068|NCT03094637|The University of Texas MD Anderson Cancer Center|Guillermo Garcia-Manero MD/Professor|713-745-3428|ggarciam@mdanderson.org|
313069|NCT03094806|New York Methodist Hospital|Jeremy A Weingarten, MD|718-780-5835|jaw9031@nyp.org|
313070|NCT03095027|Alcon, A Novartis Division|Senior Clinical Project Lead, GCRA - Vision Care|1-888-451-3937|alcon.medinfo@alcon.com|
313071|NCT03095053|Antalya IVF|Kevin Coetzee|090 530 764 3135|kevincoetzee61@yahoo.co.nz|
313072|NCT03095118|Mayo Clinic|Dr. Fernando C. Fervenza|507-266-1045|Fervenza.Fernando@mayo.edu|
313073|NCT03095508|Sandoz|Study Director|+41613241111|Sandoz.email@sandoz.com|
313074|NCT03095521|Sandoz|Study Director|+41613241111|Sandoz.email@sandoz.com|
313075|NCT03095599|IVAC|Le Van Be|(+84 90) 3501529|ivaclevabe@dng.vnn.vn|
313076|NCT03095638|ViiV Healthcare|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313077|NCT03095651|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
313078|NCT03095885|Allena Pharmaceuticals, Inc|Allena Medical Affairs|6174674577|AllenaMedInfo@allenapharma.com|
313079|NCT03095976|Indiana University School of Dentistry|Dr. Yusuke Hamada|317-274-5121|yuhamada@iupui.edu|
313080|NCT03096314|Massachusetts General Hospital|Nancy Ringwood, CCC Project Manager|617-724-9836|nringwood@mgh.harvard.edu|
313081|NCT03096353|National Center for Complementary and Integrative Health|Catherine Bushnell|+1 301 496 2222|mary.bushnell@nih.gov|
313082|NCT03096444|University of Miami|Leigh Nattkemper|3055889734|Lxn202@med.miami.edu|
313083|NCT03096483|GE Healthcare|Beth Heckel|2623127269|beth.heckel@ge.com|
313084|NCT03096730|Tianjin Medical University General Hospita|Dr. Guolin Wang|13002211205|1464322162@qq.com|
313085|NCT03096847|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
313086|NCT03096873|The University of Nebraska at Omaha|Dr. Song-Young Park|402-554-3374|song-youngpark@unomaha.edu|
313087|NCT03097029|Children's Hospital of Philadelphia|Dr. Nina Sainath|267.426.1736|sainathn@email.chop.edu|
313088|NCT03097133|Janssen Research & Development, LLC|Senior Director|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
313089|NCT03097289|Terumo BCT, Inc.|Ned Cosgriff, MD|+1 303-239-2316|ned.cosgriff@TerumoBCT.com|
313090|NCT03097315|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
313091|NCT03097341|Aronora, Inc.|Christina U. Lorentz, PhD, Senior Scientist and Project Manager|503-964-0250|christina.lorentz@aronorabio.com|
313092|NCT03097484|University of Kentucky|John Bauer, MD|859-218-2927|john.bauer@uky.edu|
313093|NCT03097588|Department of Pharmacy Services, Oregon health & Science University Hospital|Joseph Bubalo, PharmD (Oncology Clinical Pharmacy Specialist)|5034948007|bubaloj@ohsu.edu|
313094|NCT03097614|Allergan Sales LLC|Therapeutic Area Head|877-277-8566|IR-CTRegistration@allergan.com|
313095|NCT03097653|Istituto di Ricerche Farmacologiche Mario Negri IRCCS|Dr. Paola Mosconi and Dr. Anna Roberto|+390239014503|donnainformata-mammografia@marionegri.it; paola.mosconi@marionegri.it|
313096|NCT03097783|Q-Med AB|Head of Development|+46184749000|reception.seupp@galderma.com|
313097|NCT03097861|Mallinckrodt Pharmaceuticals|Medical Information Call Center|800-556-3314|clinicaltrials@mnk.com|
292327|NCT01420289|Calvary Hospital|Oscar M. Alvarez PhD, Director Center for Curative and Palliative Wound Care|718-518-2577|oalvarez@calvaryhospital.org|
292328|NCT01420536|Araraquara Dental School -Universidade Estadual Paulista (Sao Paulo State University)|Prof. Marco Antonio Compagnoni|+55-16-3331-6411|compagno@foar.unesp.br|
292329|NCT01420549|Aché Laboratórios Farmacêuticos S. A.|Antonio Carlos Amedeo Vattimo|+55 11 26088111|antonio.vattimo@ache.com.br|
292330|NCT01420627|Leadiant Biosciences, Inc.|Scott Rodgers, MS, CCRA, ACRP-PM / Sr Director Clinical Operations|301-670-1565|scott.rodgers@leadiant.com|
292331|NCT01420653|AFT Pharmaceuticals Ltd.|Jennifer Zhang|+ 64 9 488 0232|jenniferz@aftpharm.com|710
292332|NCT01420679|Spectrum Pharmaceuticals, Inc|Gajanan Bhat|949-743-9219|gajanan.Bhat@sppirx.com|
292333|NCT01420848|University of São Paulo|Leonice Fumiko Sato Kurebayashi|(5511 991126023)|fumie_ibez@yahoo.com.br|
292334|NCT01420926|Weill Medical College of Cornell University|Gail Roboz, M.D||gar2001@med.cornell.edu|
292335|NCT01421017|NYU Langone Health|Sylvia Adams|212-731-5795|sylvia.adams@nyumc.org|
313098|NCT03098030|United Therapeutics Corporation|Program Manager, Oncology|919-485-8350|kmaher@unither.com|
313099|NCT03098173|Tokyo University|Dr. Ryota Niikura|+81-3-3815-5411|niikura-dky@umin.ac.jp|
313100|NCT03098420|University of Alabama at Birmingham|Dr. Joel Feinstein|205-934-4696|jfeinstein@uabmc.edu|
313101|NCT03098433|Virginia Commonwealth University|Francesco S. Celi, MD, MHSc.|804-828-9696|francesco.celi@vcuhealth.org|
313102|NCT03098550|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please Email:|Clinical.Trials@bms.com|
313103|NCT03098615|UAB|Leslie Roop|2059754917|lmroop@uabmc.edu|
313104|NCT03098641|Groupe Hospitalier de la Rochelle Ré Aunis|Dr Philippe Ferry|+33 5 46 45 50 50|philippe.ferry@ch-larochelle.fr|
313105|NCT03098745|CooperVision Inc.|Dr.Jose A.Vega O.D., MSc., FAAO|9256213761|javega@coopervision.com|
313106|NCT03098966|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
270278|NCT00117676|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
292336|NCT01421134|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
292337|NCT01421147|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292338|NCT01421186|MorphoSys AG|Dr Winrich Rauschning, Clinical Project Lead (external)|+4989 89927|winrich.rauschning@external.morphosys.com|0
292339|NCT01421225|Boston Children's Hospital|Garry Steil (Assistant Prof. of Pediatrics)|617-355-7504|garry.steil@childrens.harvard.edu|
292340|NCT01421277|Merck Sharp & Dohme Corp|Senior Vice President, Global Clinical Development|1-800-672-6327|ClinicalTrialsDisclosure@merck.com|
292341|NCT01421303|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292342|NCT01421342|VA Cooperative Studies Program Coordinating Center, West Haven, CT|Gary R. Johnson, MS|(203) 932-5711|gary.johnson4@va.gov|3774
292343|NCT01421355|Brigham and Women's Hospital|Joshua Beckman, MD|617-732-6320|jbeckman@partners.org|
292344|NCT01421459|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
313107|NCT03098979|Bayer|Therapeutic Area Head|1-888-8422937|clinical-trials-contact@bayer.com|
313108|NCT03099096|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313109|NCT03099161|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
313110|NCT03099187|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
313111|NCT03099369|University of North Carolina at Chapel Hill|David Lee, MD|347-882-8010|dave.lee0530@gmail.com|
313112|NCT03099538|Mayo Clinic|Aaron R. Mangold, MD|480-301-4256|mangold.aaron@mayo.edu|
313113|NCT03099655|Medtronic|Erika Pouliot|+17635261270|erika.pouliot@medtronic.com|
313114|NCT03099694|Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Key Laboratory of Pediatrics in Chongqing|Prof. Shi Yuan|13508300283|15084335697@163.com|
313115|NCT03100058|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
313116|NCT03100123|Ottawa Hospital Research Institute|Dr. Leslie Skeith|403-944-5246|laskeith@ucalgary.ca|
313117|NCT03100344|Galderma|Kenny Frazier|817-961-5120|Kenny.frazier@galderma.com|
313118|NCT03100500|Novartis Pharmaceuticals|Director|862-778-8300|novartis.email@novartis.com|
313119|NCT03100825|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
313120|NCT03100838|USFDA|Dr. Minori Kinjo|240-40269118|minori.kinjo@fda.hhs.gov|
313121|NCT03100864|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313122|NCT03100942|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
313123|NCT03100968|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
313124|NCT03101020|Faculdade de Ciências Médicas da Santa Casa de São Paulo|Lucas Villalta Santos|+5515998197899|lucasvillalta.s@gmail.com|
313125|NCT03101033|Xijing Hospital, the Fourth Military Medical University|Dr yan lu|029-84775337|yanlu001@fmmu.edu.cn|029-847753
313126|NCT03101111|Themis Bioscience|Christiane Thomasser|01 236 7151|christiane.thomasser@themisbio.com|
313127|NCT03101150|King Fahd Medical City|Consultant Obstetritian and Gynecologist|00966539417217|amali@kfmc.med.sa|
313128|NCT03101241|Jazz Pharmaceuticals|Director, Disclosure & Transparency|215-870-9177|ClinicalTrialDisclosure@JazzPharma.com|
313129|NCT03101267|Astellas Pharma Inc.|Clinical Trial Disclosure|+81-3-3244-6500 Japanese only|astellas.resultsdisclosure@astellas.com|
313130|NCT03101293|Neurocrine Biosciences|Neurocrine Medical Information|877-641-3461|medinfo@neurocrine.com|
313131|NCT03101358|US Biotest, Inc.|Gere diZerega, MD|805.595.1300|gere.dizerega@usbiotest.com|
313132|NCT03101371|University of Colorado, Anshcutz Medical Campus|Saketh Guntupalli, MD|303-724-2033|saketh.guntupalli@cuanschutz.edu|
313133|NCT03101462|Saint Louis University|Daniel F. Hoft, MD, PhD|314-977-5500|daniel.hoft@health.slu.edu|
313134|NCT03101514|the first affiliated hospital of Harbin medical university|Dr. Zhi-Ping Liu|+8613936034546|as150001@aliyun.com|
313135|NCT03101592|David Geffen School of Medicine at UCLA|Dr. Risa Hoffman, MD, MPH; Director of GHP; Associate Professor of Clinical Medicine|310 825-7225|rhoffman@mednet.ucla.edu|
313136|NCT03102190|Massachusetts Eye and Ear Infirmary|Project Manager, Clinical Trials|617-573-6981|elizabeth_grimm@meei.harvard.edu|
313137|NCT03102411|TriHealth Inc.|Rachel Pauls MD|513-463-4300|Rachel_Pauls@trihealth.com|
313138|NCT03102437|Impulse Dynamics|Angela Stagg|18453592389|astagg@impulsedynamics.com|
313139|NCT03102645|Department of Clinical Pharmacology, University Hospital Bispebjerg and Frederiksberg|Jonatan Kornholt|+4538635604|jonatan.kornholt@regionh.dk|
313140|NCT03102710|Massachusetts General Hospital, Harvard Medical School|Jian Kong, Principal Investigator|617-726-7893|jkong2@mgh.harvard.edu|
313141|NCT03102736|Icahn School of Medicine at Mount Sinai|Dr. James Murrough|212-585-1640|james.murrough@mssm.edu|
313142|NCT03102762|Cairo University|Dr. Hussein Ghanem, Directer of this clinical trial|01001176111|hmhghanem@gmail.com|
313143|NCT03102879|Universidad de los Andes|Claudia Brizuela|56 2 26181166|clau@cibrizuela.com|
313144|NCT03102918|Beth Israel Deaconess Medical Center|Dr. Kevin Hill|617-667-1504|khill1@bidmc.harvard.edu|
313145|NCT03103061|Medical University of South Carolina|Hunter Gray, Program Coordinator|843-876-3185|grayhu@musc.edu|
313146|NCT03103100|University of Alabama at Birmingham|Dr. Mark Powell|205-975-3328|mfpowell@uabmc.edu|
292345|NCT01421472|Merrimack Pharmaceuticals|Clinical Trial Manager|617-441-1000|smathews@merrimack.com|
292346|NCT01421498|Shire (Note: Lifitegrast was divested to Novartis in 2019)|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
292347|NCT01421511|Cubist Pharmaceuticals, Inc.|Philippe Prokocimer, MD|858-452-0370|philippe.prokocimer@cubist.com|241
292348|NCT01421589|Massachusetts General Hospital|Hideo Makimura, MD, PhD|617-726-8277|hmakimura@partners.org|
313147|NCT03103282|3-D Matrix Europe SAS|Florian REBECA|+33617587769|frebeca@puramatrix.com|
303586|NCT02182440|AM-Pharma B.V.|JAcques Arend MD, DiMD, Chief Medical Officer|+31302598836|j.arend@am-pharma.com|
303587|NCT02182492|Department of ENT of Tongji Hospital Tongji Medical College Huazhong University of Science and Technology|Dr. Zheng Liu|86 027 83663807|zhengliuent@hotmail.com|
303588|NCT02182804|Division of Gastroenterology. Department of Medicine. Faculty of Medicine. Chulalongkorn University.|Dr. Piyapan Prueksapanich|6622564000|mpkus1@gmail.com|81001
303589|NCT02182830|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
303590|NCT02182843|Zimmer Biomet Spine|Clinical Affairs|303-501-8571|spinemedinfo@zimmerbiomet.com|
313148|NCT03103438|Biocad|Nadezhda Kravtsova|+7 (812) 380 49 33|kravtsovana@biocad.ru|
313149|NCT03103503|BIOTRONIK|Clinical Studies Engineer Manager|800-547-0394|crystal.miller@biotronik.com|
313150|NCT03103542|Swedish Orphan Biovitrum AB|Medical Information|+468 6972000|medical.info@sobi.com|
313151|NCT03103763|Penobscot Bay Medical Center|Caroline Knight, RN, Clinical Research Manager|207-301-8959|cknight@pbmc.org|
313152|NCT03103906|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313153|NCT03103919|Cares|UCB|+1844 599|UCBCares@ucb.com|2273
313154|NCT03104192|Dartmouth-Hitchcock|John A. Batsis, MD|603-650-5000|john.batsis@gmail.com|
292349|NCT01421641|Oregon Health & Science University|Paula Bednarek|(503) 418-4500|bednarek@ohsu.edu|
292350|NCT01421654|ResMed|Amy Blase/Clinical Research Manager|858-836-6715|amy.blase@resmed.com|
292351|NCT01421667|Seattle Genetics, Inc.|Chief Medical Officer|855-473-2436|medinfo@seagen.com|
292352|NCT01421719|Stanford University|Rodney U. Anderson, MD|6504984240|rua@stanford.edu|
292353|NCT01422070|Università degli Studi di Ferrara|Dr Maurizia Capuzzo|+393355932642|cpm@unife.it|
292354|NCT01422135|Agile Therapeutics|Joseph Chiodo III, Senior Medical Director|609-683-1880|jachiodo@agiletherapeutics.com|
313155|NCT03104322|patientMpower|Chief Scientific Officer|+353872599131|colin@patientmpower.com|
313156|NCT03104647|Shaare Zedek Medical Center|Dr. Yair Barzilay, PI|+972-2-6555166|barzilay@szmc.org.il|
313157|NCT03104725|National Institutes of Health/NINDS|Dr. David Goldstein|301-496-2103|goldsteind@ninds.nih.gov|
313158|NCT03104738|The Ohio State University|Ana Mavarez-Martinez, PostDoctoral Reseacher|614-293-3559|ana.mavarezmartinez@osumc.edu|
313159|NCT03104816|USCalifornia|Eugenia Ayrian|8186363161|eayrian@med.usc.edu|
313160|NCT03104985|State Scientific Center of Laser Medicine, Russia, Moscow|Sergey Moskvin|+7-905-770-1860|7652612@mail.ru|
313161|NCT03105297|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313162|NCT03105362|Boston Children's Hospital|Dr. Christopher Duggan|617-355-7612|christopher.duggan@childrens.harvard.edu|
313163|NCT03105479|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
281752|NCT00820534|Novartis Consumer Health|Head of Clinical Research|+4122363311||
281753|NCT00820573|University of Texas HSC at San Antonio|Eugenio Cersosimo, MD PhD|210 358 7200|Eugenio.cersosimo@uhs-sa.com|
281754|NCT00820599|Edwards Lifesciences|Edwards THV Clinical Affairs|949-250-2500|THV_CT.gov@edwards.com|
281755|NCT00820612|University of Michigan|B. Joseph Elmunzer, MD.|735 615 6652|badihe@umich.edu|
281756|NCT00820664|Merck Sharp & Dohme Corp|Executive Vice President, Clinical and Quantitative Sciences|1-800-672-6372||
292355|NCT01422161|New York University School of Medicine|Preeti Raghavan, MD|212 598 6206|raghap01@nyumc.org|
303591|NCT02182895|Brigham and Women's Hospital|Dr. Rajesh Garg, MD|617-732-5584|rgarg@partners.org|
292356|NCT01422187|Target Health Inc.|Glen Park|212-681-2100|gpark@targethealth.com|
292357|NCT01422200|Cincinnati Children's Hospital Medical Center|Dr. Brenda Wong|5136364222|brenda.wong@cchmc.org|
292358|NCT01422213|H. Lundbeck A/S|H. Lundbeck A/S|+45 3630 1311|LundbeckClinicalTrials@lundbeck.com|
313164|NCT03105518|Brigham and Women's Hospital/Harvard Medical School|Lawrence Tsen, MD|617.732.8216|ltsen@bwh.harvard.edu|
292359|NCT01422226|University of Colorado Denver|Christina Gavito|303-724-5559|christina.gavito@ucdenver.edu|
292360|NCT01422239|Yale University School of Medicine|Andrea Weinberger, Ph.D.|203-974-7598|andrea.weinberger@yale.edu|
292361|NCT01422304|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292362|NCT01422356|Melbourne Sexual Health Centre, Alfred Health|Associate Professor Marcus Chen|+61 3 9341 6260|mchen@mshc.org.au|
303592|NCT02182947|Children's Mercy Hospital|Nadia Hijaz|3139204958|nmhijaz@cmh.edu|
303593|NCT02182973|University of Louisville|Paula Radmacher|5028525532|paula.radmacher@louisville.edu|
313165|NCT03106077|UT MD Anderson Cancer Center|Stacy Moulder, Professor, Breast Medical Oncology|(713) 792-2817|smoulder@mdanderson.org|
313166|NCT03106337|Massachusetts General Hospital|Antonia Stephen, MD||ASTEPHEN@PARTNERS.ORG|
313167|NCT03106636|University of Oregon|Dr. Philip Fisher|541-346-4968|philf@uoregon.edu|
313168|NCT03106753|Icahn School of Medicine at Mount Sinai|Dr. Natalie Porat|973-919-6166|poratnat@gmail.com|
313169|NCT03106844|Brigham and Women's Hospital|Jessica Allegretti MD MPH|617-525-7322|jallegretti@bwh.harvard.edu|
313170|NCT03106870|Ain Shams University|Dr.Rehab Mohamed Abdelrahman|+201004992772|rehababdulrahman.rm@gmail.com|
313171|NCT03107026|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
313172|NCT03107052|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|1-888-483-8279|USMedInfo@tevapharm.com|
313173|NCT03107091|BioVie|Penelope Markham|17035989972|pmarkham@biovieinc.com|
313174|NCT03107377|Evofem|Chief Medical Officer|858-550-1900|kculwell@evofem.com|
313175|NCT03107611|Mylan Pharmaceuticals Pvt Ltd|Prasanna C Ganapathi, Clinical Sciences Program Lead|+91 9148448200|PrasannaC.Ganapathi@mylan.in|
313176|NCT03107715|University Hospitals Rainbow Babies and Children's Hospital|Lydia Furman MD, PI|216-844=8260|lydia.furman@uhhospitals.org|
313177|NCT03107754|University of Hawaii|Dr. Reni Soon|808-983-6000|rsoon@hawaii.edu|
313178|NCT03107793|Janssen Research & Development, LLC|European Medicines Agency (EMEA) Advisor Immunology|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
313179|NCT03108027|Novartis Pharmaceutical|Study Director|862-778-8300|novartis.email@novartis.com|
313180|NCT03108157|ProcreaTec|Dr. Alexandra Izquierdo, Medical and Scientific Director at ProcreaTec|0034651879266|endoscratchtrial@gmail.com|
313181|NCT03108469|Clinvest Research|Jim Sly|4178413673|jsly@clinvest.com|
313182|NCT03108482|Esteve Pharmaceuticals, S.A.|Dr. Neus Gascon|+34934446000|ngascon@esteve.com|
313183|NCT03108521|Department of Pharmacy, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital|Dr. Xingwei Wu and Professor Enwu Long|+8615928017367|wuxw1988@126.com|
313184|NCT03108924|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
313185|NCT03109015|Duke University|Michael Harrison, MD|919-668-8108|michael.harrison@duke.edu|
313186|NCT03109184|NORTHEASTERN UNIVERSITY|DR. CHRISTIE RIZZO|(617) 373-2486|C.RIZZO@NORTHEASTERN.EDU|
313187|NCT03109769|Riyadh Colleges of Dentistry and Pharmacy|Omar Alkadhi|966505154754|omar.alkadhi@riyadh.edu.sa|
313188|NCT03109951|International St. Mary's Hospital, Catholic Kwandong University|Myong Ki Baeg|82-10-6391-9010|baegmk@gmail.com|
313189|NCT03110003|University of Alabama at Birmingham|Dr. Mark Powell|205-975-3328|mfpowell@uabmc.edu|
313190|NCT03110029|UAB|Leslie Roop|2059754917|lmroop@uabmc.edu|
313191|NCT03110185|Washington University School of Medicine Department of Anesthesiology|Dr. Ben Palanca|314-273-9076|palancab@wustl.edu|
313192|NCT03110458|Sensorion|Director of Regulatory Affairs|+33 4 67 20 77 30|contact@sensorion-pharma.com|
313193|NCT03110471|swansea university|sue jordan|+44 (0) 1792 518541|s.e.jordan@swansea.ac.uk|
313194|NCT03110562|Karyopharm Therapeutics Inc.|Jatin Shah, MD|(617) 658-0600|jshah@karyopharm.com|
313195|NCT03110601|Stimgenics|VP of Clinical Affairs|309-662-4321|clinicalSG@stimgenics.com|217
313196|NCT03110692|Perelman School of Medicine, University of Pennsylvania|Dr. Mitesh S. Patel|215-898-3367|mpatel@pennmedicine.upenn.edu|
313197|NCT03110770|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Allison Beck, PA-C, MPAS, Deputy Chief of Clinical Affairs, Clinical Development Unit, CTP|(301) 761-7158|allison.beck@nih.gov|
313198|NCT03111108|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
313199|NCT03111316|University of Oklahoma Health Sciences Center|Director of Women's Health Research|4052718001|christy-zornes@ouhsc.edu|48137
313200|NCT03111381|Yale Urology|Jamil Syed|2037852815|Jamil.syed@yale.edu|
313201|NCT03111407|Zimmer Biomet|Emilie Rohmer, Clinical Operations Manager|+41 58 85 48210|Emilie.Rohmer@zimmerbiomet.com|
303594|NCT02182999|Department of Orthopedic Surgery, Medical University of Innsbruck|Dr. Matthias Braito|0043 512 504|matthias.braito@gmail.com|81214
303595|NCT02183519|University of Florida Communicative Disorders|Karen Hegland, PhD|352-273-3710|kwheeler@ufl.edu|
303596|NCT02183675|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
303597|NCT02183792|University of Southern California School of Pharmacy|Tien Ng, Pharm.D.|3234421840|tienng@usc.edu|
303598|NCT02184143|Vanderbilt University Medical Center|Kristin Archer|(615) 322-2732|kristin.archer@Vanderbilt.Edu|
303599|NCT02184169|Boston Childrens Hospital|John Kheir|6173556000|john.kheir@childrens.harvard.edu|
292363|NCT01422369|Kowa Research Institute, Inc|Roger Morgan, MD FACS|919-433-1600|RMorgan@kowaus.com|
292364|NCT01422382|Kowa Research Institute, Inc|Roger Morgan, MD FACS|919-433-1600|RMorgan@kowaus.com|
292365|NCT01422408|Knight Cancer Institute, Oregon Health & Science University|Emile Latour|503-418-9601|latour@ohsu.edu|
292366|NCT01422434|LEO Pharma A/S|Clinical trial disclosure manager|00 45 44 94 58 88|ctr.disclosure@leo-pharma.com|
292367|NCT01422538|Merz Pharmaceuticals|Public Disclosure Manager||clinicaltrials@merz.com|
292368|NCT01422720|BIAL - Portela & Cª S.A.|Director R&D|+351-229866100|clinical.trials@bial.com|
292369|NCT01422824|Hoffmann-LaRoche|Medical Communications|800 821-8590|genentech@druginfo.com|
292370|NCT01422850|CytoVac A/S|Christer Lundell-Ek, Project Manager - Clinical Development||cle@cytovac.dk|
292371|NCT01422876|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
292372|NCT01422889|Boston Scientific|Peter Maurer, MPH; Director, Clinical Trials|508-683-6678|Peter.Maurer@bsci.com|
313202|NCT03111550|Johnson & Johnson Surgical Vision|Devi Priya Janakiraman,OD, FAAO|+1 714-247-8628|djanaki1@its.jnj.com|
313203|NCT03111628|JohnsHopkinsU|Sarbjit S. Saini|410550-2129|ssaini@jhmi.edu|
313204|NCT03111940|Oxford Heart Centre, John Radcliffe Hospital|Prof Adrian Banning|01865 228934|Adrian.Banning@ouh.nhs.uk|
313205|NCT03112473|Department of Rehabilitation Science, The Hong Kong Polytechnic University|Prof. Shamay Ng|27664889|shamay.ng@polyu.edu.hk|
313206|NCT03112863|UC Davis Dermatology|Iryna Rybak|916-551-2636|irybak@ucdavis.edu|
313207|NCT03112993|University of Missouri|Dr. Boris Mraovic, MD, Professor of Clinical Anesthesiology|573-882-2568|mraovicb@health.missouri.edu|
313208|NCT03113656|TriHealth|Nurse Researcher|513-569-6191|Rachel_Baker2@trihealth.com|
313209|NCT03113916|Kaiser Permanente Center for Health Research|Nangel Lindberg|503 528 3961|Nangel.M.Lindberg@kpchr.org|
313210|NCT03114124|UF Health- Jacksonville|Andrea Goosen|904-244-5617|andrea.ggosen@jax.ufl.edu|
313211|NCT03114488|University of Minnesota|Elias Boroda|763-498-4176|borod002@umn.edu|
313212|NCT03114657|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
313213|NCT03114683|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
313214|NCT03114969|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313215|NCT03114995|Cardiovascular Center, Seoul National University Bundang Hospital|Dr. Tae-Jin Youn|+82-31-787-7031|ytjmd@snubh.org|
313216|NCT03115112|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
313217|NCT03115177|Rush University Medical Center|Dr. Allison Rao|608-445-0545|allison.rao@gmail.com|
313218|NCT03115411|Stanford University School of Medicine|Dr. Subhas Banerjee, MD|650-723-2623|sbanerje@stanford.edu|
313219|NCT03115476|LEO Pharma|Clinical Trial Disclosure|+45 4494 5888|disclosure@leo-pharma.com|
313220|NCT03115580|Icahn School of Medicine at Mount Sinai|Annapoorna S. Kini, MD|212-241-4181|annapoorna.kini@mountsinai.org|
313221|NCT03115801|Weill Cornell Medicine|Sharanya Chandrasekhar|6469623110|shc2043@med.cornell.edu|
313222|NCT03115827|Vanderbilt University Medical Center|Dr. Katherine McDonell|615-875-7987|katherine.mcdonell@vumc.org|
313223|NCT03116152|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+8613382419112|jessica.yi@innoventbio.com|
313224|NCT03116230|Stanford University|Thomas Andriacchi|650-|tandriac@stanford.edu|
313225|NCT03116698|Dr. Reddy's Laboratories Inc.|Dr. Srinivas Sidgiddi|6093759910|srinivassidgiddi@drreddys.com|
313226|NCT03116828|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|clinicaltrialdisclosure@sunovion.com|
313227|NCT03116841|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313228|NCT03117140|Univesity of Iowa Hospitals and Clinics|Melinda Seering|3193561616|melinda-seering@uiowa.edu|
313229|NCT03117361|Pharma Mar, S.A.|Clinical Developtment, Department of PharmaMar´s Oncology., Business Unit.|+34 918466000|clinicaltrials@pharmamar.com|
313230|NCT03117517|Khyber Medical University|Dr. Mohsin Shah (Associate Professor)|3429620074|mohsin.ibms@kmu.edu.pk|+92
313231|NCT03117569|Viral Hepatitis Clinical Research Program Kirby Institute|Clinical Trials Manager|+61 9385 0900|pmarks@kirby.unsw.edu.au|
313232|NCT03117634|Singapore National Eye Center|Gemmy Cheung, Principal Investigator|+65 6322 8335|gemmy.cheung.c.m@singhealth.com.sg|
313233|NCT03117738|Nature Cell co., ltd|Project Manager|02-545-4137|tin50@stemcellbio.com|
313234|NCT03118297|WashingtonU|Intervention To End Recurrent Unscheduled bleeding Trial (INTERRUPT): A randomized-controlled trial|3143228697|rachelezig@gmail.com|
313235|NCT03118466|Massachusetts General Hospital|Andrew Brunner MD|6177241124|abrunner@mgh.harvard.edu|
313236|NCT03118518|Medtronic|Erika Pouliot|17635261270|erika.pouliot@medtronic.com|
313237|NCT03118596|University Hospitals Coventry & Warwickshire NHS Trust|Dr Cyprian Mendonca|02476964000|cyprian.mendonca@hotmail.com|25871
313238|NCT03118739|AstraZeneca R&D|Fredrik Erlandsson, Global Clinical Lead|+46317762365|Fredrik.Erlandsson@astrazeneca.com|
313239|NCT03118765|Glenmark Pharmaceuticals Ltd.|Study Director|201-684 8000|clinicaltrialsdisclosuredesk@glenmarkpharma.com|
313240|NCT03118843|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
313241|NCT03118934|Alcon, A Novartis Division|Head, CDMA Vision Care Franchise|1-888-451-3937|alcon.medinfo@alcon.com|
313242|NCT03118947|ACADIA Pharmaceuticals Inc.|Sr. Dir. Medical Information and Medical Communications|858-261-2897|medicalinformation@acadia-pharm.com|
313243|NCT03119025|Institute of Fundamental and Clinical Immunology|Alexander A Ostanin, MD, PhD Study Principal Investigator|383-236-03-29|ct_lab@mail.ru; ostanin62@mail.ru|+7
313244|NCT03119168|Texas Tech University Health Sciences Center at El Paso|The Effect Of Adding High Dose Simethicone To A Standard Polyethylene Glycol Preparation On Adenoma|915-215-4678|antonio.mendoza-ladd@ttuhsc.edu|
313245|NCT03119181|Tusker Medical|Laura England, PhD|(650) 223-6909|lengland@tuskermed.com|
313246|NCT03119389|University of Maryland|Kerri Thom|410-706-6124|kthom@som.umaryland.edu|
313247|NCT03119571|University of Minnesota|Demetri Yannopoulos, MD|6126261382|yanno001@umn.edu|
292373|NCT01422915|BrighamHospital|Dr. Peter V. Tishler|617-525-2123|repvt@channing.harvard.edu|
292374|NCT01423084|Novartis Vaccines|Posting Director||RegistryContactVaccinesUS@novartis.com|
292375|NCT01423162|Food and Nutrition Research Institute|Trinidad P. Trinidad|6328372071|trinidadtp@yahoo.com.ph|2281
292376|NCT01423253|Sunovion|1-866-503-6351|1-866-503-6351|clinicaltrialdisclosure@sunvion.com|
292377|NCT01423604|Incyte Corporation|Study Director|1-855-463-3463||
292378|NCT01423617|Analyze & Realize|Dr Christof Jänicke|+49 30 40 00 83 23|cj@a-r.com|
292379|NCT01423760|Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
292380|NCT01423773|Alcon Research|Head, Clinical Trial Management|1-800-241-7629||
313248|NCT03119610|UT Health San Antonio|Sara Espinoza, MD|210-617-5197|espinozas2@uthscsa.edu|
313249|NCT03119649|Galapagos NV|Evelyn Fox|0032 15 34 29 00|evelyn.fox@glpg.com|
313250|NCT03119688|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313251|NCT03119701|Faron Pharmaceuticals Ltd|Chief Medical Officer|+3584005529411|medical@faron.com|
313252|NCT03119831|Department of Periodontology, School of Dentistry, National and Kapodistrian University of Athens, Greece|Dr. Anastasios M. Gkatzonis|6976486314|gkatzonis.tasos@gmail.com|0030
313253|NCT03120013|University of Brescia|Prof. Barbara Borroni|+39 0303995631|bborroni@inwind.it|
313254|NCT03120351|ClevelandCF|Bruce Vrooman|216-444-2200|vroomab@ccf.org|
270279|NCT00117715|Children's Mercy Hospital|J. Steven Leeder|816-234-3059|sleeder@cmh.edu|
270280|NCT00117793|Dept. of Veterans Affairs, Rehabilitation Research & Development Service|Glenn K. Klute, PhD|206-277-6724|Glenn.Klute@va.gov|
292381|NCT01423812|The Ruth M. Rothstein CORE Center|Gregory Huhn, MD|312-572-4575|ghuhn@cookcountyhhs.org|
292382|NCT01423916|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
292383|NCT01424033|University of Michigan|Jan Stevens|7349365566|janstev@med.umich.edu|
292384|NCT01424072|University of São Paulo|Leonice Fumiko Sato Kurebayashi|5511 991126023|fumie_ibez@yahoo.com.br|
313255|NCT03120520|Bausch Health Americas, Inc|Clinical Operations Director|908-927-0873|lindsey.mathew@bauschhealth.com|
292385|NCT01424189|Alcon Research, Ltd.|Expert Clinical Project Lead, GCRA, Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
292386|NCT01424215|Maimonides|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
292387|NCT01424228|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
292388|NCT01424293|Maimonides Medical Center|Danny Sherwinter|7182837952|dsherwinter@maimonidesmed.org|
292389|NCT01424306|Fred Hutchinson Cancer Research Center|Mario Kratz|206-667-7362|mkratz@fredhutch.org|
292390|NCT01424397|GlaxoSmithKline|GSK Response Center|866-435-7343||
292391|NCT01424501|GlaxoSmithKline|GSK Response Center|866-435-7343||
292392|NCT01424514|GlaxoSmithKline|GSK Response Center|866-435-7343||
313256|NCT03120832|Senseibio|Ramzi Melhem MD Medical Director|9168336928|rmelhem@senseibio.com|
313257|NCT03121144|Masimo Corporation|Vikram Ramakanth|(949) 297-7000|clinicalresearchdept@masimo.com|
313258|NCT03121365|The Children's Hospital of Phiadelphia|Dr. James Guevara|215-590-1130|Guevara@email.chop.edu|
313259|NCT03121612|Arnolda Consulting|Dr Gaston Arnolda|+61 2 8068 4963|gaston.arnolda@gmail.com|
313260|NCT03121820|GEROPHARM|GEROPHARM Clinical Leader|+7(812) 703-79-75|inform@geropharm.ru|
313261|NCT03121950|The Ohio State University|Deb Kegelmeyer|614-293-0214|kegelmeyer.1@osu.edu|
313262|NCT03122145|Holy Cross Hospital|Lauren Tabor Gray|954 542 3429|lauren.tabor@holy-cross.com|
313263|NCT03122171|Rutgers-New Jersey Medical School|Alice Chu, MD|(973) 972-2076|chual@njms.rutgers.edu|
313264|NCT03122184|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
313265|NCT03122223|Fred Hutchinson Cancer Research Center|Jessica Andriesen, PhD, Associate Director of HVTN SDMC Operations|206-667-5812|jandries@fredhutch.org|
313266|NCT03122457|Icahn School of Medicine at Mount Sinai|Dr. Anjali Vekaria|212-241-3288|anjali.shroff@mssm.edu|
313267|NCT03122535|University of Utah|Elizabeth Nuttall|8012133461|elizabeth.nuttall@hsc.utah.edu|
313268|NCT03122548|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
313269|NCT03122587|University of North Carolina at Chapel Hill|Stacey Daughters, PhD|9199629924|daughter@unc.edu|
313270|NCT03122860|Biosplice Therapeutics, Inc.|Christopher Swearingen, PhD, VP of Biometrics|858.926.2952|chris.swearingen@biosplice.com|
313271|NCT03122886|Mayo Clinic|Aminah Jatoi, MD|507/284-2511|Jatoi.Aminah@mayo.edu|
313272|NCT03123055|Rainier Therapeutics|Chief Medical Officer|510-878-2486|Sabella@RainierRx.com|
313273|NCT03123068|Stanford University|Professor of Anesthesia|650-723-6412|ang@stanford.edu|
313274|NCT03123120|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313275|NCT03123263|TTUHSC-El Paso|Sumit Gaur|9152155200|sumit.gaur@ttuhsc.edu|
313276|NCT03123354|Masimo Corporation|Vikram Ramakanth|1 (949) 297-7416|clinicalresearchdept@masimo.com|
313277|NCT03123471|Celgene Corporation|Anne McClain, Senior Manager|888-260-1599|ClinicalTrialDisclosure@Celgene.com|
313278|NCT03123588|Incyte Corporation|Call Center|1.855.463.3463|medinfo@incyte.com|
313279|NCT03123614|University of Utah Moran Eye Center|Mark Mifflin, MD|801-213-4152|Mark.Mifflin@hsc.utah.edu|
313280|NCT03123848|Janssen Pharmaceutical K.K.|Director, IDV Department|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
313281|NCT03123861|University of North Carolina at Chapel Hill|Jennifer Wu, MD, MPH, Professor of OBGYN|919-966-0014|jennifer_wu@med.unc.edu|
313282|NCT03123874|Cornell University|Sarah Reyes|208-921-4967|smr296@cornell.edu|
313283|NCT03123939|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
313284|NCT03124069|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
313285|NCT03124108|Genfit SA|Clinical Head|+33320164000|clinicaltrial@genfit.com|
313286|NCT03124121|Guy's & St Thomas' Hospital|Dr Mark Samaan|07740637713|mark.samaan@gstt.nhs.uk|
313287|NCT03124199|Hospital Universitario de la Princesa|Mercedes Ramas|913093911|mercedesramas@gmail.com|
313288|NCT03124342|VANDERBILT UNIVERSITY MEDICAL CENTER|Matthew W. Semler, MD, MSc|(615) 322-3412|matthew.w.semler@vumc.org|
313289|NCT03124368|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
313290|NCT03124381|Johnson & Johnson Consumer Inc.|Ali Fassih, Ph.D.|908-904-3259|Afassih@its.jnj.com|
313291|NCT03124407|Vizuri Health Sciences|Vice President Clinical Operations|919-397-4782|twarneke@vizuriusa.com|
313292|NCT03124459|Acceleron Pharma Inc.|SVP Regulatory Affairs|617-649-9200|jdesiderio@acceleronpharma.com|
313293|NCT03124537|Brandeis University|Alycia Bisson|781 736 3284|lifespanlab@brandeis.edu|
313294|NCT03124550|Brandeis University|Dr. Margie E. Lachman|7817363255|lachman@brandeis.edu|
313295|NCT03124563|Brandeis University|Dr. Margie E. Lachman|7817363255|lachman@brandeis.edu|
313296|NCT03124602|Masimo|Tala Harake|9492977459|studies@masimo.com|
313297|NCT03124693|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
313298|NCT03124758|Masimo|Tala Harake||studies@masimo.com|
313299|NCT03124771|Masimo|Tala Harake||studies@masimo.com|
313300|NCT03124784|Masimo Corporation|Tala Harake|949-297-7000|studies@masimo.com|
313301|NCT03124797|Masimo|Tala Harake||studies@masimo.com|
292393|NCT01424566|GW Pharmaceuticals Ltd.|Medical Enquiries||medinfo.USA@gwpharm.com|
292394|NCT01424644|Novartis Vaccines and Diagnostics|Posting Director||RegistryContactVaccinesUS@novartis.com|
313302|NCT03124823|Masimo|Tala Harake||studies@masimo.com|
313303|NCT03124836|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
313304|NCT03124901|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
313305|NCT03124927|Masimo Corporation|Vikram Ramakanth||clinicalresearchdept@masimo.com|
313306|NCT03124966|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
313307|NCT03124979|Masimo|Tala Harake||studies@masimo.com|
292395|NCT01424670|Otsuka Pharmaceutical Development & Commercialization, Inc.|Global Clinical Development|+1-609-524-6788|clinicaltransparency@otsuka-us.com|
292396|NCT01424722|Abbott Medical Devices|Clinical Program Director|972-309-8087|clay.cohorn@abbott.com|
292397|NCT01424813|Teva Branded Pharmaceutical Products, R&D Inc.|Director, Clinical Research|215-591-3000|ustevatrials@tevapharm.com|
292398|NCT01424930|Janssen R&D US|Senior Director||ClinicalTrialDisclosure@its.jnj.com|
292399|NCT01424943|Institute for Families in Society, University of South Carolina|Dr. Cheri Shapiro|803-777-8760|cshapiro@mailbox.sc.edu|
292400|NCT01425190|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292401|NCT01425203|Merck Sharp & Dohme Corp.|Vice President, Late Stage Development Group Leader|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292402|NCT01425229|University of Heidelberg|Prof. Gerd Mikus|4962215639197|gerd.mikus@med.uni-heidelberg.de|
313308|NCT03125005|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
313309|NCT03125018|Masimo|Tala Harake||studies@masimo.com|
313310|NCT03125031|Masimo|Tala Harake||studies@masimo.com|
313311|NCT03125200|ADC Therapeutics|ADC Therapeutics|954-903-7994|clinical.trials@adctherapeutics.com|
313312|NCT03125226|University of Washington School of Medicine|Dr. Jing Zeng|2065985998|jzeng13@uw.edu|
313313|NCT03125395|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
313314|NCT03125629|Stanford University|Andrei Iagaru|650-725-4711|aiagaru@stanford.edu|
313316|NCT03125915|Hunter College, CUNY|Tyrel Starks, Associate Professor|212-206-7919|tstarks@hunter.cuny.edu|934
313317|NCT03125941|rigshospitalet|kristin steinthorsdottir, md|31666112|kjs@dadlnet.dk|
313318|NCT03126227|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
313319|NCT03126344|Shanghai ninth people's hospital|Sun Yu|13611895542|dr_sunyu@163.com|+86
313320|NCT03126370|University of Colorado Anschutz Medical Campus|Jennifer Kiser, PharmD, PhD|3037246131|jennifer.kiser@cuanschutz.edu|
313321|NCT03126448|Indiana University Health|Dr. Roman Natoli|713-516-8973|rnatoli@IUHealth.org|
313322|NCT03126539|Johns Hopkins University|Dr. Anna Chien|410-502-7546|CTReP@jhmi.edu|
313323|NCT03126682|DukeUMC|Steven T Szabo|3524540101|steven.szabo@duke.edu|3524540101
313324|NCT03126760|Mallinckrodt|Medical Information Call Center|800-844-2830|medinfo@mnk.com|
313325|NCT03126786|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
313326|NCT03127228|University of Michigan|Dr. Chin-Wei Wang|734-763-2105|jeffwa@umich.edu|
313327|NCT03127358|Albert Einstein College of Medicine|Julia Arnsten, MD|718-920-6641|jarnsten@montefiore.org|
313328|NCT03127384|Q-Med AB|Clinical Project Manager|+46184749000|reception.seupp@galderma.com|
313329|NCT03127514|Amylyx Pharmaceuticals|Amylyx Pharmaceuticals, Head of Clinical R&D|(617) 682-0917|medinfo@amylyx.com|
313330|NCT03127644|AstraZeneca|Global Clinical Lead|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
313331|NCT03127943|UNC Department of Oral and Maxillofacial Surgery|Raymond P. White Jr DDS, PhD|919-537-3944|ray_white@unc.edu|
313332|NCT03127956|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
313333|NCT03128008|Duke University Health System|Linda Kaltenbach, PhD|(919) 681-6804|Linda.Kaltenbach@duke.edu|
313334|NCT03128086|HOSPITAL UNIVERSITARIO GENERAL DE CASTELLÓN, SPAIN. CONSELLERIA SANITAT|DR. ALBERTO BELENGUER-MUNCHARAZ|964 72 50 00|belengueralberto8@gmail.com|
313335|NCT03128099|Vanderbilt University|Dr. Sohee Park, Project Director|6153223435|sohee.park@vanderbilt.edu|
313336|NCT03128307|Zyppah|Jonathan Greenburg, DDS|(818) 414- 4817|jgreenburg@outlook.com|
313337|NCT03128372|Medtronic|Julia Katilius|1 303-305-2278|julia.z.katilius@medtronic.com|
313338|NCT03128411|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
313339|NCT03128723|JnJ Worldwide|Gboyega Adenaike|908-874-1214|aadenaike@its.jnj.com|
313340|NCT03128892|Masimo Corporation|Chelsea Frank|949-297-7000|studies@masimo.com|
313341|NCT03128931|Masimo Corporation|Vikram Ramakanth|949-297-7416|clinicalresearchdept@masimo.com|
313342|NCT03129100|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
313343|NCT03129178|University of Portsmouth|Dr Anthony Shepherd|02392 84|ant.shepherd@port.ac.uk|5289
313344|NCT03129321|Mylan Inc.|Abhijit Barve, Head of Global Clinical Research||abhijit.barve@mylan.com|
313345|NCT03129568|Okayama University Hospital|Dr. Hidemasa Oh|086-235-6506|hidemasa@okayama-u.ac.jp|6506
313346|NCT03129945|University of California, Irvine|Judith Chung|714-456-8695|judithc@hs.uci.edu|
313347|NCT03130257|Kaiser Permanente Washington Health Research Institute|Beverly B. Green, MD, MPH|206-287-2997|Bev.B.Green@kp.org|
313348|NCT03130738|Hill Dermaceuticals, Inc.|Rosario G Ramirez, MD|407-323-1887|nini.ramirez@hillderm.com|
313349|NCT03130959|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
313350|NCT03131167|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
313351|NCT03131206|Dana-Farber Cancer Institute|Mark Awad, MD, PhD|6176323468|mark_awad@dfci.harvard.edu|
292403|NCT01425268|AirXpanders|Director of Clinical Affairs|650-390-9000|kkelley@airxpanders.com|9003
292404|NCT01425281|Abbott Vascular International BVBA|Susan Veldhof|+31653428610|susan.veldhof@av.abbott.com|
292405|NCT01425307|The University of Texas School of Public Health|Barry Robert Davis|713-500-9515|barry.r.davis@uth.tmc.edu|
292406|NCT01425359|Gilead Sciences, Inc.|Clinical Trial Disclosures||ClinicalTrialDisclosures@gilead.com|
292407|NCT01425463|UCB|UCB Clinical Trial Call Center|+1 877 822 9493 (UCB)||
292408|NCT01425528|University of utah|Kathryn Swoboda MD|801-585-9717|Swoboda@genetics.utah.edu|
292409|NCT01425632|Mitsubishi Tanabe Pharma Corporation|Clinical Trials, Information Desk||cti-inq-ml@ml.mt-pharma.co.jp|
292410|NCT01425723|Bioverativ Therapeutics Inc.|Bioverativ Study Medical Director|781-6631801|clinicaltrials@bioverativ.com|
292411|NCT01425749|University of Virginia|Craig L Slingluff Jr|434-924-1730|cls8h@virginia.edu|
313352|NCT03131219|Alexion Pharmaceuticals Inc.|Alexion Pharmaceuticals Inc.|855-752-2356|clinicaltrials@alexion.com|
313353|NCT03131453|Novartis Pharmaceuticals|Study Director|+ 1 862 778 8300|Novartis.email@Novartis.com|
313354|NCT03131479|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
270281|NCT00117806|James A. Haley Veterans' Hospital|Lisa Ottomanelli, PhD|813-558-3917|lisa.ottomanelli@va.gov|
270282|NCT00117845|National Cancer Institute, National Institutes of Health|Thomas Waldmann, M.D.|301-496-6656|tawald@mail.nih.gov|
270283|NCT00117949|Ferring Pharmaceuticals|Clinical Development Support||DK0-Disclosure@ferring.com|
270284|NCT00117962|Washington University School of Medicine|Dr. Ramaswamy Govindan||rgovinda@dom.wustl.edu|
270285|NCT00117988|UT MD Anderson Cancer Center|Dr. Anas Younes, MD / Professor||etubbs@mdanderson.org|
270286|NCT00118040|University of Wisconsin|Howard H. Bailey, M.D.|608-263-8624|hhbailey@wisc.edu|
270287|NCT00118092|Karmanos Cancer Institute at Wayne State University|Elisabeth Iljas Heath, M.D.||heathe@karmanos.org|
270288|NCT00118131|Cancer Institute of New Jersey|Dr. Joseph Aisner|732-235-8675|aisnerjo@cinj.rutgers.edu; rizzoji@cinj.rutgers.edu; zelinsta@cinj.rutgers.edu|
270289|NCT00118144|California Cancer Consortium|DCC Project Administrator|626-256-4673|CCCP@coh.org|60094
270290|NCT00118157|Barbara Ann Karmanos Cancer Institute|Sayeh Lavasani, M.D.|(313) 576-8751|lavasans@karmanos.org|
270291|NCT00118209|Washington University School of Medicine|Nancy Bartlett, M.D.|314-362-5654|nbartlet@wustl.edu|
270292|NCT00118248|Washington University School of Medicine|Jeffrey F. Moley, M.D.||moleyj@wustl.edu|
270293|NCT00118274|University of Virginia|Dr. Craig Slingluff|4349249311|cls8h@virginia.edu|
270294|NCT00118287|Fred Hutchinson Cancer Research Center|Bart Scott|206-667-1990|bscott@fredhutch.org|
270295|NCT00118352|Fred Hutchinson Cancer Research Center|Dr. Brenda M. Sandmaier|(206) 667-4961|bsandmai@fhcrc.org|
270296|NCT00118365|University of California, Irvine|Dr. Frank Meyskens, Jr.|714-456-6310|flmeyske@uci.edu|
270297|NCT00118378|New York State Psychiatric Institute|Dr. Judith Rabkin|212.543.5762|jgr1@columbia.edu|
270298|NCT00118404|The University of Texas Southwestern Medical Center|Dr. Robin B. Jarrett, Professor of Psychiatry|214-648-5345|Robin.Jarrett@UTSouthwestern.edu|
270299|NCT00118417|Massachusetts General Hospital|Naomi M. Simon, MD|617-726-7913|nsimon@partners.org|
270300|NCT00118430|Indiana University|Kurt Kroenke|3172749046|kkroenke@regenstrief.org|
270301|NCT00118482|University of Calgary|Dr. Robert S. Sheldon|403-2208191|sheldon@ucalgary.ca|
270302|NCT00118534|VA Puget Sound (Seattle)|Dr. Miles McFall|(206) 764-2177|Miles.McFall@va.gov|
270303|NCT00118703|GlaxoSmithKline|GSK Response Center|866-435-7343||
270304|NCT00118716|GlaxoSmithKline|GSK Response Center|866-435-7343||
270305|NCT00118742|Hoffmann-La Roche|Medical Communications|800-821-8590||
270306|NCT00118755|Hoffmann-La Roche|Medical Communications|800-821-8590||
281757|NCT00820755|Merck Serono, a division of Merck KGaA|Merck KGaA Communication Center|+49-6151-72-5200|service@merckgroup.com|
292412|NCT01425801|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
292413|NCT01425814|AstraZeneca|Study Director||ClinicalTrialTransparency@astrazeneca.com|
292414|NCT01425853|Bioiberica|Clinical R&D Manager|+34934904908|mherrero@bioiberica.com|
292415|NCT01425879|The Ohio State University|Tanios Bekaii-Saab, MD|614-293-9863|tanios.bekaii-saab@osumc.edu|
292416|NCT01426009|Sunovion Pharmaceuticals Inc.|Respiratory Medical Director|1-866-503-6351||
292417|NCT01426191|xiangbei welman pharmacuticol CO.,LTD|Directer of clinical trials|020-38868707|gap@welman.com.cn|
292418|NCT01426217|Dartmouth-Hitchcock Medical Center|Randy Loftus, MD|(603) 650-6177|Randy.W.Loftus@hitchcock.org|
292419|NCT01426230|Depomed|Head of R&D|510-744-8000|msweeney@depomed.com|
313355|NCT03131570|ROCKEFELLER UNIVERSITY|Dr. James G. Krueger|2123277409|KRUEGEJ@MAIL.ROCKEFELLER.EDU|
313356|NCT03131596|Fuxing Hospital, Capital Medical University, Beijing, China|Dr. Shi Xiaoyu|+86 18618496384|petershi1990@163.com|
313357|NCT03131648|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
313358|NCT03131687|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
313359|NCT03131713|Tufts Medical Center|Bichchau Nguyen, Principal Investigato|617-636-1286|bnguyen2@tuftsmedicalcenter.org|
313360|NCT03131895|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313361|NCT03131960|MicroTransponder Inc.|Study Director|8556289375|studies@microtransponder.com|
313362|NCT03131999|Medical University of South Carolina|Charlton Strange, MD|843-792-3174|strangec@musc.edu|
313363|NCT03132220|University of Colorado School of Medicine|Dr. Meredith Mealer|303-724-6857|Meredith.Mealer@cuanschutz.edu|
313364|NCT03132246|University of Maryland School of Medicine|Dr. Aaron Johnson|410-328-1868|ajohnson1@som.umaryland.edu|
313365|NCT03132298|Stony Brook University|Jessica Schleider|631-632-4131|jessica.schleider@stonybrook.edu|
313366|NCT03132571|Yale School of Medicine, Department of Psychiatry|Dr. Cenk Tek|(203) 974-7500|cenk.tek@yale.edu|
313367|NCT03133481|University of Alabama at Birmingham|Adam Sturdivant|205-934-4042|Adamsturdivant@uabmc.edu|
313368|NCT03133676|Calibr, a Division of Scripps Research|Study Director|(858) 242 1000|KA34ph1@scripps.edu|
313369|NCT03133767|University of Iowa|Nicholas Mohr|319-384-8285|nicholas-mohr@uiowa.edu|
313370|NCT03134092|University of Pennsylvania Perelman School of Medicine|Dr. Zachary Meisel|215-746-5618|zfm@pennmedicine.upenn.edu|
313371|NCT03134144|Institute of Occupational and Social Medicine and Health Services Research, University of Tübingen|Tessy Luger|004970712984364|Tessy.Luger@med.uni-tuebingen.de|
313372|NCT03134183|Virginia Commonwealth University|Frances Casey, MD|804-828-5076|frances.casey@vcuhealth.org|
313373|NCT03134209|NYU Langone Health|Ran Schwarzkopf, MD|646-356-9405|Ran.Schwarzkopf@nyulangone.org|
313374|NCT03134222|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
313375|NCT03134248|CooperVision|Jose A.Vega OD MSc., FAAO|9256213761|javega@coopervision.com|
313376|NCT03134313|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
313377|NCT03134326|Masimo|Vikram Ramakanth||clinicalresearchdept@masimo.com|
313378|NCT03134599|CooperVision|Jose Vega, O.D., MSc., FAAO|9252516213761|javega@coopervision.com|
313379|NCT03134703|Johns Hopkins All Children's Hospital|Sandra Brooks, MD|727-767-4313|sbrook36@jhmi.edu|
313380|NCT03134768|Danone Nutricia Research|Dr Elena Sandalova|6568309433|elena.sandalova@danone.com|
313381|NCT03134911|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313382|NCT03134963|University of Leicester|Dr Lucy Beishon|0116252|lb330@le.ac.uk|3134
313383|NCT03134989|Cochlear|Ruth English|0386633105|REnglish@cochlear.com|
313384|NCT03135015|Housey Healthcare ULC|Project Manager|2486637000|info@housey.com|
313385|NCT03135028|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
313386|NCT03135210|University of Minnesota|Amanda Sharp|(612) 626-4691|sharp@umn.edu|
313387|NCT03135379|Brooke Army Medical Center|Benjamin M. Krainin|210-916-0808|Benjamin.M.Krainin.mil@mail.mil|
313388|NCT03135431|Mayo Clinic|Vanessa Torbenson, M.D.|507-266-9873|Torbenson.Vanessa@mayo.edu|
313389|NCT03135522|The Johns Hopkins University School of Medicine|Dr. Robert A. Wise, M.D.|410-905-5688|rwise@jhmi.edu|
313390|NCT03135535|Baylor College of Medicine|Prof.|17137987536|bijan.najafi@bcm.edu|
313391|NCT03135548|Boehringer Ingelheim|Boehringer Ingelheim, Call Centre|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313392|NCT03135899|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313393|NCT03136068|UCSF|Director of Clinical Trials|414-206-8715|abby.sokoloff@ucsf.edu|
313394|NCT03136107|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313395|NCT03136159|Loyola University Medical Center|Dr Jean Goodman|7082165459|Jrgoodman@lumc.edu|
313396|NCT03136198|Indiana University|Peter S. Pang|317-880-3900|ppang@iu.edu|
313397|NCT03136328|Montefiore Medical Center|Charito Love, MD|718-406-8462|clove@montefiore.org|
313398|NCT03136367|Dartmouth College|Marie-Anne Durand|603-667-8601|marie-anne.durand@dartmouth.edu|
313399|NCT03136380|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
292420|NCT01426269|Galderma Laboratories, L.P.|Elizabeth M Nieman|817-961-5130|elizabeth.nieman@galderma.com|
292421|NCT01426347|Johns Hopkins University|Uzma Jalal Haque|410-550-0578|uhaque@jhmi.edu|
292422|NCT01426360|Sun Yat-sen University|Dr. Liu Hongchun|86-0-13826189071|hongchun751@sina.com|
292423|NCT01426373|Kythera Biopharmaceuticals, Inc.|Clinical Trial Disclosure||clinical_trials@kythera.com|
292424|NCT01426386|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
292425|NCT01426412|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292426|NCT01426425|Medtronic|Jo Krueger, Senior Clinical Research Specialist|7635261551|jo.krueger@medtronic.com|
292427|NCT01426438|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
313400|NCT03136484|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
313401|NCT03136861|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
313402|NCT03136913|Tufts University|Dr. Yong Hur|6176366531|Yong.Hur@tufts.edu|
313403|NCT03137069|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
313404|NCT03137121|Univ Alabama Birmingham|Rudolph M Navari|574-261-8385|rmnavari@gmail.com|
313405|NCT03137173|Basilea Pharmaceutica International Ltd.|Project Physician|+41616061111|kamal.hamed@basilea.com|
313406|NCT03137303|University of Illinois at Chicago|Min J. Joo, MD MPH|312-996-8039|joo@uic.edu|
313407|NCT03137459|Yale School of Medicine|Dr. Terri Fried|203-932-5711|terri.fried@yale.edu|5412
313408|NCT03137693|Moffitt Cancer Center|Michael Montejo, MD|813-745-8424|Michael.Montejo@moffitt.org|
313409|NCT03137784|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
313410|NCT03137992|Lupin Research Inc|Dr. Mark Lepore|(443) 740-9323|marklepore@lupin.com|
313411|NCT03138330|Danone Nutricia Research|Dr Elena Sandalova|6568309433|elena.sandalova@danone.com|
313412|NCT03138382|UCSD|Dr Paul McGeoch|858-232-3312|pdmcgeoch@ucsd.edu|
313413|NCT03138577|Weill Cornell Medical College|Dr. Tiffany Tedore|212-746-2725|tft9001@med.cornell.edu|
313414|NCT03138655|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313415|NCT03138798|Icahn School of Medicine at Mount Sinai|Dr. Eric Bergh|908-625-8148|eric.bergh@mssm.edu|
313416|NCT03138876|Mayo Clinic|Dr. William O. Tatum|904-953-2498|tatum.william@mayo.edu|
313417|NCT03138967|UT MD Anderson Cancer Center|Dr. Farzin Goravanchi / Anesthesiology & Perioperative Medicine|713-291-1163|fgoravan@mdanderson.org|
313418|NCT03139032|Arena Pharmaceuticals, Inc.|Head of Document Operations|858-453-7200|ct.gov@arenapharm.com|
313419|NCT03139240|Oregon Health & Science University|Ob/Gyn Regulatory Specialist|5034940757|mccrimmo@ohsu.edu|
313420|NCT03139279|Department of Anesthesiology, SUNY Downstate Medical Center|Dennis Dimaculangan, MD|718-270-3765|dennis.dimaculangan@downstate.edu|
313421|NCT03139448|Vanderbilt University Medical Center|Koffi Kla, MD|615-343-9419|koffi.m.kla@vumc.org|
313422|NCT03139552|University of Colorado Anschutz Health and Wellness Center|John C. Peters, PhD|303-724-9160|john.c.peters@ucdenver.edu|
313423|NCT03139578|Johnson & Johnson Vision|Anna Sulley BSc MCOptom FAAO|+44 1344864043|asulley1@its.jnj.com|
313424|NCT03139604|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
313425|NCT03140254|Becton Dickinson|Erin Zook|201-847-5351|erin.zook@bd.com|
313426|NCT03140631|Michigan Medicine|Dr. Hakan Oral|734-936-8214|oralh@med.umich.edu|
313427|NCT03140722|Akebia Therapeutics|Akebia Therapeutics|(617) 844-6128|trials@akebia.com|
313428|NCT03141086|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
313429|NCT03141151|Vanderbilt University Medical Center|William Heerman, MD MPH|615-322-7080|bill.heerman@vumc.org|
313430|NCT03141242|University of Colorado|Hillary Lum, MD, PhD|3037241911|hillary.lum@cuanschutz.edu|
313431|NCT03141281|Florida State University|Dr. Neil Charness|850-644-6686|charness@psy.fsu.edu|
313432|NCT03141307|University of Utah|Dr. Bob Wong|801-587-9666|bob.wong@nurs.utah.edu|
313433|NCT03141372|Cleveland Clinic Florida|Sara Farag, Fellow in Minimally Invasive Gynecologic Surgery|8147691904|faragsara@gmail.com|
313434|NCT03141528|Inselspital|Dr. Tina Pedersen|+4522125797|tinaheidipedersen@yahoo.dk|
313435|NCT03141788|3M|Elaine Egging|651-737-0263|eegging@mmm.com|
313436|NCT03141905|University of Maryland, Baltimore|Jeffrey C. Fink MD, MS (Principal Investigator)|410-328-4822|jfink@som.umaryland.edu|
313437|NCT03141931|University of New South Wales|Dr Jacqueline Tan|+61 (02) 9385 6551|jacqueline.tan@unsw.edu.au|
313438|NCT03142438|Fisher & Paykel Healthcare|Hanie Yee|+64 9 574 0123|Hanie.Yee@fphcare.co.nz|7909
313439|NCT03142451|Foamix Pharmaceuticals, Inc.|Iain Stuart, PhD.|1 800-775-7936|Iain.Stuart@foamix.com|
313440|NCT03142750|Children's Hospital Colorado|Pediatric Surgery Research Fellow|720-777-5371|youngmeeyoungmee@gmail.com|
313441|NCT03142932|Johns Hopkins University School of Medicine|Dr. Jonathan E. Golub|(443) 287-2969|jgolub@jhmi.edu|
313442|NCT03143101|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
313443|NCT03143166|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313444|NCT03143569|WASHINGTON UNIVERSITY|Thomas J Graetz|3147474155|graetzt@wustl.edu|
313445|NCT03143855|Virginia Commonwealth University|Dr. F. Gerard Moeller|804-828-4134|fgmoeller@vcu.edu|
313446|NCT03143894|Johns Hopkins University|Tracy Vannorsdall, PhD|410-502-3701|TVannor1@jhmi.edu|
313447|NCT03144089|University of Iowa Hospitals and Clinics|Ron Abrons, MD|(319) 353-8061|ron-abrons@uiowa.edu|
313448|NCT03144180|Texas Tech University Health Sciences Center at El Paso|Associate Director of Ob/Gyn Research|9152155103|christina.bracamontes@ttuhsc.edu|
313449|NCT03144518|University of Nottingham|Dr Kieran Ayling|+44 1158466908|kieran.ayling@nottingham.ac.uk|
313450|NCT03144635|Kyushu University Hospital|Dr. Eiichi Ogawa / Assistant Professor|81926425909|eogawa@gim.med.kyushu-u.ac.jp|
292428|NCT01426581|University of Chicago|Valerie G. Press, MD, MPH|73-702-5170|vpress@medicine.bsd.uchicago.edu|
292429|NCT01426763|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
292430|NCT01426789|Novartis Pharmaceuticals|Study Director|862-778-8300||
313451|NCT03144687|Incyte Corporation|Study Director|1-855-463-3463|medinfo@incyte.com|
313452|NCT03144804|Massachusetts General Hospital|Aparna Parikh, MD|617-339-8452|aparna.parikh@mgh.harvard.edu|
292431|NCT01426828|University of Pennsylvania|CCI @ University of Pennsylvania|(215)662-4000||
292432|NCT01426854|Alcon (China) Ophthalmic Product Co., Ltd.|Terence Li, Clinical Research Manager, Development & Medical Affairs, China|+86 10 5829 1452|Terence.li@alcon.com|
292433|NCT01426867|Alcon Research, Ltd.|Matt Walker, PhD, Clinical Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
292434|NCT01426958|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
292435|NCT01427296|Valeant Pharmaceuticals|Johnson Varughese|9089271400||
313453|NCT03145064|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
313454|NCT03145207|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
292436|NCT01427309|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
292437|NCT01427504|University of Colorado|Dr. Jennifer Kiser|303-724-6131|jennifer.kiser@ucdenver.edu|
292438|NCT01427517|University of Minnesota|Mary Holmay|612-812-5854|holma101@umn.edu|
292439|NCT01427595|University of Virginia Center for Research in Reproduction|Dr. Christine Burt Solorzano|4342436911|pcos@virginia.edu|
292440|NCT01427608|Weill Cornell Medicine|Dr. George S. Alexopoulos|(914) 997-5767|gsalexop@med.cornell.edu|
292441|NCT01427738|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG Clinicaltrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
292442|NCT01427751|Allergan, Inc|Allergan Inc.,||clinicaltrials@allergan.com|
292443|NCT01427803|Bayer HealthCare LLC, Consumer Care|Head Medical Affairs||clinical-trials-contact@bayerhealthcare.com|
292444|NCT01427881|Fred Hutchinson Cancer Research Center|Marco Mielcarek, MD|206-667-2827|mmielcar@fredhutch.org|
313455|NCT03145259|University of Maryland, Baltimore School of Pharmacy|Dr. Audra Stinchcomb|410-706-2646|astinchc@rx.umaryland.edu|
313456|NCT03145766|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
313457|NCT03145818|Providence VA Medical Center|James Rudolph, MD, Principal Investigator|401-273-7100|James.Rudolph@va.gov|6406
313458|NCT03146403|Genocea|Jennifer LaVin|617-876-8191|jennifer.lavin@genocea.com|
313459|NCT03146585|University Hospital Hradec Kralove|Dr. David Astapenko|+420608177374|astapenko.d@seznam.cz|
313460|NCT03146663|NuCana Plc|Medical and Scientific Affairs Department|01313571116|info@nucana.com|
313461|NCT03146741|University of Pennsylvania|Dr. Peter Reese|215-900-3782|peter.reese@uphs.upenn.edu|
313462|NCT03146806|Emory University|Vinita Singh, MD|404-686-2410|vinita.singh@emory.edu|
313463|NCT03147248|Celltrion. Inc.|SungHyun Kim|+82 32 850 5778|SungHyun.Kim@celltrion.com|
313464|NCT03147495|PLA Institute of Orthopaedics, Xijing Hospital, Fourth Military Medical University, No.17, Changle West Road, Xincheng District, Xi'an, Shanxi Province, China|Dr. Cheng Huang|0086-57427754027|jfj113hc@163.com, jfj906hc@163.com|
313465|NCT03147690|Boston Children's Hospital|Dr. David Mooney, MD MPH|617-355-7800|david.mooney@childrens.harvard.edu|
313466|NCT03148067|University of Sao Paulo|Physician|551126616900|priscila.rosalba@hc.fm.usp.br|
313467|NCT03148236|Virginia Commonwealth University|Cory Trankle, MD|804-213-2679|cory.trankle@vcuhealth.org|
313468|NCT03148262|UT Southwestern Medical Center|Dr. Christina Riccio|214-590-7284|Christina.Riccio@UTSouthwestern.edu|
313469|NCT03148470|University of Fribourg|Prof. Dr. Jean-Marie Annoni|++4126 306 3802|jean-marie.annoni@unifr.ch|
313470|NCT03148691|Aclaris Therapeutics|Executive Director, Clinical Operations|4843247933|jschnyder@aclaristx.com|
313471|NCT03148756|Allergan|Therapeutic Area, Head|714-246-4500|clinicaltrials@allergan.com|
313472|NCT03149042|University at Buffalo|Dr. Ciprian Ionita|7164004283|cnionita@buffalo.edu|
313473|NCT03149055|Memorial Sloan Kettering Cancer Center|Genovefa Papanicolaou MD|212-639-8361|papanicg@mskcc.org|
313474|NCT03149172|Tufts University|Dr. Yong Hur|6176366531|Yong.Hur@tufts.edu|
313475|NCT03149328|University of Alberta|Dr. Kara Schick-Makaroff|1-780-492-9043|kara.schickmakaroff@ualberta.ca|
313476|NCT03149848|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313477|NCT03149887|UPittsburgh|Dr. Steven L. Orebaugh|412-877-5832|orebaughsl@anes.upmc.edu|
313478|NCT03149991|Massachusetts General Hospital|Dr. Rebecca Hock|617-872-3711|rhock@mgh.harvard.edu|
313479|NCT03150043|UTMB|Katherine Jelliffe|2146635394|katherine.emilie@gmail.com|
313480|NCT03150056|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313481|NCT03150082|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313482|NCT03150108|Shire|Study Director|+1 866 842 5335|ClinicalTransparency@shire.com|
313483|NCT03150199|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
313484|NCT03150485|Johnson & Johnson Vision|Thomas Karkkainen - SR PRINCIPAL RESEARCH OPTOMETRIST|904 443-3402|TKarkkai@its.jnj.com|
313485|NCT03150589|Samsung Bioepis Co., Ltd|Director of Clinical Trials|+82-32-728-0371|sbregistry@samsung.com|
313486|NCT03150719|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
313487|NCT03150758|Cleveland Clinic|Dr. Eric Klein|1-800-223-2273|CancerCenterResearch@ccf.org|
313488|NCT03150875|Innovent Biologics (Suzhou) Co., Ltd. (seal)|Yi Bo|+86 13382419112|jessica.yi@innoventbio.com|
313489|NCT03151148|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
313490|NCT03151265|dorsaVi Ltd|Sangeeth Wanasinghage|+61 1800 367 728|support@dorsavi.com|
313491|NCT03151395|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313492|NCT03151434|Indiana University Department of Anesthesiology|Dr. Yar Luan Yeap|3172740275|yyeap@iupui.edu|
313493|NCT03151551|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
313494|NCT03152019|Hospices Civils de Lyon|Dr Dupuis Girod|427856522|sophie.dupuis-girod@chu-lyon.fr|+33
313495|NCT03152084|AstraZeneca Clinical Study Information Center|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
313496|NCT03152110|University of Pittsburgh|Alicia Koontz|412-822-3700|akoontz@pitt.edu|
313497|NCT03152136|Cala Health|Paula Chidester|650-273-7436|paula@calahealth.com|
313498|NCT03152552|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
313499|NCT03152591|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
313500|NCT03153956|NYU Langone Health|Dennis A. Cardone, DO|+1 646 501 7223|Dennis.Cardone@nyulangone.org|
313501|NCT03154047|Prothena Biosciences|Wendy Curlin|650 837 8550|clinicaltrials@prothena.com|
313502|NCT03154086|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313503|NCT03154333|Castle Creek Pharmaceuticals, LLC|Dr. Mary Spellman|862 286 0400|mspellman@castlecreekpharma.com|
292445|NCT01427907|Fresenius Medical Care, North America|Mayuri Thakuria MD (MBBS), MPH|781-699-4645|mayuri.thakuria@fmc-na.com|
292446|NCT01427920|Novo Nordisk A/S|Public Access to Clinical Trials||clinicaltrials@novonordisk.com|
292447|NCT01427933|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
292448|NCT01427972|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
303600|NCT02184195|AstraZeneca AB|Global Clinical Leader|1-877-240-9479|information.center@astrazeneca.com|
303601|NCT02184208|Boston Children's Hospital|Brian Kendall Walsh|617-919-3692|brian.walsh@childrens.harvard.edu|
303602|NCT02184442|Edwards Life Sciences|Tenley Koepnick|949-250-6504|Tenley_Koepnick@Edwards.com|
313504|NCT03154476|Mayo Clinic|Dr. Alexander Egbe|507-284-3725|Egbe.Alexander@mayo.edu|
303603|NCT02184455|DeCell Technolpogies Inc.|Dr. Paul F. Gratzer, CSO|902-223-2179|pfgratzer@decelltechnologies.com|
303604|NCT02184494|Florida State University|Michael J. Ormsbee|6103313126|mormsbee@fsu.edu|
303605|NCT02184572|GlaxoSmithKline|GSK Response Center|866-435-7343||
313505|NCT03154658|University of Texas Southwestern|Anthony Machi M.D.|2146486400|anthony.machi@utsouthwestern.edu|
313506|NCT03154710|Weprom|Dr Katell LE DU|241682940|k.ledu@cjb72.org|0033
313507|NCT03155178|3M|Joan E. Paulson|651-736-6583|jepaulson@mmm.com|
313508|NCT03155269|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313509|NCT03155724|BIOTRONIK|Clinical Studies Engineer Manager|800-547-0394|crystal.miller@biotronik.com|
313510|NCT03155945|Arena Pharmaceuticals, Inc.|Arena CT.gov Administrator|+1 855-218-9153|ct.gov@arenapharm.com|
313511|NCT03156270|Dept. of Otolaryngology-Head and Neck Surgery, The Ohio State University|Kai Zhao, PhD.|614-293-3857|zhao.1949@osu.edu|
313512|NCT03156543|University of Michigan Medical School|Bethany Ruffino|734 615-0768|bruffino@med.umich.edu|
313513|NCT03156621|Regeneron Pharmaceuticals, Inc.|Clinical Trials Administrator|844 734 6643|clinicaltrials@regeneron.com|
313514|NCT03157089|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313515|NCT03157232|Masimo|Tala Harake||studies@masimo.com|
313516|NCT03157531|Eximo Medical|Oshrat Cohen|97286307639|oshratc@eximomedical.com|
313517|NCT03157583|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313518|NCT03158012|UCSD Dermatology|Teruaki Nakatsuji|8588227814|tnakatsuji@ucsd.edu|
313519|NCT03158038|MedImmune, LLC|Raburn Mallory|+1-301-398-5799|information.center@astrazeneca.com|
313520|NCT03158116|UCSF Benioff Children's Hospital Oakland|Rachna Wadia, MD|844-724-4140|rawadia@mail.cho.org|
313521|NCT03158220|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
313522|NCT03158272|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
313523|NCT03158311|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
313524|NCT03158714|Auburn University|Francesca Adler-Baeder|334-844-4151|adlerfr@auburn.edu|
313525|NCT03159091|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
313526|NCT03159143|University of Pittsburgh|Leonard Appleman, MD|412-648-6538|applemanlj@upmc.edu|
313527|NCT03159195|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
313528|NCT03159260|Sport and Spine Rehab Clinical Research Foundation|Jena Slaski|301-251-2777|jslaski@ssrehab.com|838
313529|NCT03159299|Yale School of Nursing|Robin Whittemore, PhD|203-737-2351|robin.whittemore@yale.edu|
313530|NCT03159455|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313531|NCT03159468|Arizona State University|Kelly Cue Davis|602-496-3217|Kelly.Cue.Davis@asu.edu|
313532|NCT03159611|Materia Medica Holding|Michael Putilovskiy, MD, PhD, Clinical and Medical Department Director|+74952761571|PutilovskiyMA@materiamedica.ru|302
313533|NCT03159624|University of Alabama at Birmingham|Dr. Brad Woodworth|205-801-7858|bwoodworth@uabmc.edu|
313534|NCT03160027|University of California, San Francisco & San Francisco VA Medical Center|Dr. Linda Chao|14152214810|linda.chao@ucsf.edu|24386
313535|NCT03160170|University of Miami Miller School of Medicine|Ian Cote|305-256-4492|Icote@med.miami.edu|
313536|NCT03160287|University of Washington|Oleg Zaslavsky|2066163242|ozasl@uw.edu|
313537|NCT03160560|Center for Dental Research, Loma Linda University|Yiming Li, DDS, MSD, PhD, Professor and Associate Dean for Research|909-558-8069||
313538|NCT03160573|University Health Resources Group|Sushma Nachnani, MS, PhD|(310) 645-8576|sushnach@yahoo.com|
313539|NCT03160703|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313540|NCT03160716|Q-Med AB|Reception|+46184749000|reception.seupp@galderma.com|
313541|NCT03160885|LEO Pharma A/S|Disclosure|+45 44945888|disclosure@leo-pharma.com|
313542|NCT03160898|Cytokinetics, Inc.|MD Cytokinetics|650-624-2929|medicalaffairs@cytokinetics.com|
313543|NCT03161158|Fresenius Medical Care Deutschland GmbH|Dr. Jennifer Braun|+49 6172 609 93488|Jennifer.Braun@fmc-ag.com|
313544|NCT03161327|Saint Louis University|Dr. Keith Pereira|314-268-5782|keith.pereira@health.slu.edu|
313545|NCT03161405|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313546|NCT03161483|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director|Please email:|Clinical.Trials@bms.com|
313547|NCT03161938|Rigshospitalet|Kristin steinthorsdottir|31666112|kjs@dadlnet.dk|
313548|NCT03162055|AstraZeneca|Vice President, Inhalation and Oral Respiratory|+1 302 885 1180|ClinicalTrialTransparency@astrazeneca.com|
313549|NCT03162328|Philips|Gary Garcia|6085129475|gary.garcia@philips.com|
313550|NCT03162354|Penn State College of Medicine, Penn State Health Children's Hospital|Kent P. Hymel, MD; Professor of Pediatrics; Study PI|7036748989|kphymel@gmail.com|
313551|NCT03162458|Materia Medica Holding|Mikhail Putilovskiy, MD, PhD, Head of department of clinical trials|+74952761571|PutilovskiyMA@materiamedica.ru|302
303606|NCT02184611|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
292449|NCT01428024|Q-Med AB|Head of Medical Affairs|+ 46 (0) 18 4749000|reception.SEUPP@galderma.com|
292450|NCT01428063|Bristol-Myers Squibb|Bristol-Myers Squibb Study Director||Clinical.Trials@bms.com|
292451|NCT01428076|BTG International Inc.|David Wright MB FRCS|610-278-1660|david.wright@btgplc.com|
292452|NCT01428115|AbbVie (prior sponsor, Abbott)|Global Medical Services|800-633-9110||
292453|NCT01428128|The University of Texas Health Science Center at San Antonio, Department of Radiation Oncology|Chul S. Ha, MD, Professor and Chair|210-450-1109|hac@uthscsa.edu|
292454|NCT01428193|University of Virginia|Clinical Research Coordinator|434-243-6911|pcos@virginia.edu|
292455|NCT01428219|University of Michigan Comprehensive Cancer Center|Dr. David C. Smith, M.D.|734-764-3066|dcsmith@umich.edu|
292456|NCT01428245|University of Virginia|Clinical Research Coordinator|434-243-6911|pcos@virginia.edu|
292457|NCT01428258|University of Wisconsin-Madison|Dr. Denise M Ney|608-262-4386|ney@nutrisci.wisc.edu|
292458|NCT01428336|Cleveland Clinic Foundation|Seenia Peechakara|216 4105901|peechas@ccf.org|
313552|NCT03162614|GlaxoSmithKline|GSK Response Center|877-379-3718|GSKClinicalSupportHD@gsk.com|
313553|NCT03162796|Janssen Research & Development, LLC|Head Rheumatology Clinical Development|844-434-4210|ClinicalTrialDisclosure@its.jnj.com|
313554|NCT03163017|The University of Texas Health Science Center at Houston|Joshua Gary, MD|713-486-6500|Joshua.L.Gary@uth.tmc.edu|
292459|NCT01428453|GlaxoSmithKline|GSK Response Center|866-435-7343||
303607|NCT02184624|GlaxoSmithKline|GSK Response Center|866-435-7343||
303608|NCT02184988|Evolus, Inc|Rui L. Avelar, MD|(805)689-8668|rui@evolusinc.com|
303609|NCT02185014|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
303610|NCT02185040|Celgene Corporation|Anne McClain, Senior Manager, Clinical Trial Disclosure|866-260-1599|ClinicalTrialDisclosure@Celgene.com|
292460|NCT01428583|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292461|NCT01428661|Vanda Pharmaceuticals Inc.|Curt Wolfgang, Ph.D.|202-734-3400|curt.wolfgang@vandapharma.com|
292462|NCT01428713|Baylor College of Medicine/TCH|Dr. Lakshmi Srivaths|832-822-1514|lvsrivat@txch.org|
292463|NCT01428765|Boehringer Ingelheim Pharmaceuticals|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
292464|NCT01428882|Hospital San Pedro de Alcantara, Caceres|Dr. Javier Molina-Infante|0034927621543|xavi_molina@hotmail.com|
292465|NCT01429051|Takeda|Medical Director|+1-800-778-2860|clinicaltrialregistry@tpna.com|
292466|NCT01429064|Orion Pharma, Development, R&D|Head of Oncology|+358 10 4261|mika.mustonen@orionpharma.com|
292467|NCT01429077|Rehabilitation Institute of Chicago|Leora R. Cherney, PhD|312-238-1117|Lcherney@ric.org|
313555|NCT03163134|University of Pittsburgh|Benita Valappil|412.864.1744|valappilb2@upmc.edu|
313556|NCT03163303|University of California, San Francisco|Dr. Derek Satre|(415) 476-7382|derek.satre@ucsf.edu|
313557|NCT03163342|Altimmune|Stephanie Holland, Clinical Project Manager|240|Sholland@altimmune.com|40
313558|NCT03163446|ContraFect|Medical Director|914-207-2300|clinicalstudies@contrafect.com|
313559|NCT03163472|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
313560|NCT03163758|Peking Union Medical College Hospital|Dr. Weihong Zhang|01069159581|ZhangWeiHong@pumch.cn|
313561|NCT03164538|Massachusetts General Hospital|Dr. Jeff Huffman|617-724-2910|JHUFFMAN@mgh.harvard.edu|
313562|NCT03164551|Merck KGaA, Darmstadt, Germany|Communication Center|+49-6151-72-5200|service@emdgroup.com|
313563|NCT03164629|University of Miami|Shivank Bhatia, MD|305-585-7500|SBhatia1@miami.edu|
313564|NCT03165045|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313565|NCT03165058|GI Clinical Research Enterprise|Tina Higginbotham|615-322-4643|tina.higginbotham@vumc.org|
313566|NCT03165110|Ascensia Diabetes|Jane Wallace|(574) 850-1467|jane.wallace@ascensia.com|
313567|NCT03165175|Naval Health Research Center|Suzanne Hurtado|619-553-7806|suzanne.l.hurtado.civ@mail.mil|
313568|NCT03165617|Seqirus|Seqirus Clinical Trial Manager|1-855-358-8966|seqirus.clinicaltrials@Seqirus.com|
313569|NCT03165955|Athenex Inc.|Regional Project Manager|+886-978365735|lmeiying@athenex.com|
313570|NCT03165981|Duke University|Dr. Emmanuel B. Walter|919-620-5346|chip.walter@duke.edu|
313571|NCT03166124|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
313572|NCT03166215|Takeda|Medical Director|877-825-3327|trialdisclosures@takeda.com|+1
313573|NCT03166735|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313574|NCT03167073|Washington University of St Louis (where research was conducted). Now at Brown University|Dr. Adam Lewkowitz|401-274-1122|alewkowitz@kentri.org|47447
313575|NCT03167151|Oxford University Hospitals NHS Foundation Trust|Dr Andrew S Protheroe|01865 253275|andrew.protheroe@oncology.ox.ac.uk|
313576|NCT03167359|Emory University|Dr. Mylin Torres|404-778-3473|matorre@emory.edu|
313577|NCT03167411|Theracos Sub, LLC|Albert Collinson|(508) 630-2129|acollinson@theracos.com|
313578|NCT03167541|Reckitt Benckiser Healthcare (UK) Ltd|Clinical Research Director, Clinical Research|+44 (0) 1482326151|clinicalrequests@rb.com|
313579|NCT03168022|Tonix Pharmaceuticals|Gregory Sullivan, MD||greg.sullivan@tonixpharma.com|
313580|NCT03168295|University of Texas Health San Antonio|Carolina Solis-Herrera|(210) 567-6691|solisherrera@uthscsa.edu|
313581|NCT03168308|University of Texas Southwestern|Tiffany Moon, MD|4694195790|Tiffany.Moon@UTSouthwestern.edu|
313582|NCT03168321|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
313583|NCT03168334|Bausch Health Americas, Inc|Study Director|510-259-5284|aloncaric@bauschhealth.com|
313584|NCT03168425|Vanderbilt University Medical Center|Sarah Osmundson, MD|+1 (615) 343-5700|sarah.osmundson@vumc.org|
313585|NCT03168542|Johnson & Johnson Vision Care, Inc.|Tom Karkkainen, OD MS, FAAO - Sr. Principal Research Optometrist|904 443-3402|TKarkkai@its.jnj.com|
313586|NCT03168711|Massachusetts General Hospital|Dr. Sabrina Paganoni|617-724-3914|spaganoni@mgh.harvard.edu|
313587|NCT03168841|Western University of Health Sciences|David Shofler|9097063898|dshofler@westernu.edu|
313588|NCT03168919|St. Jude Children's Reaserch Hospital|Asim K. Bag, MD Bag|9015953347|asim.bag@stjude.org|
313589|NCT03169062|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
313590|NCT03169153|Alcon Research|CDMA Project Lead|1-888-451-3937|alcon.medinfo@alcon.com|
313591|NCT03169244|University of North Carolina at Chapel Hill|James C. Garbutt, MD|919-445-0205|jc_garbutt@med.unc.edu|
313592|NCT03169816|New York State Psychiatric Institute|Frances R Levin, MD|6467746137|frl2@columbia.edu|
313593|NCT03170154|Alcon Research, LLC|Sr. Clinical Trial Lead, CDMA Surgical|1-888-451-3937|alcon.medinfo@alcon.com|
313594|NCT03170193|Amgen Inc.|Study Director|866-572-6436|medinfo@amgen.com|
313595|NCT03170219|Duke Clinical Research Institute|Rachel Olson, Project Leader|919-668-5590|rachel.e.olson@duke.edu|
313596|NCT03170232|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313597|NCT03170271|AstraZeneca|Global Clinical Lead|1-877-240-9479|information.center@astrazeneca.com|
313598|NCT03170388|Bausch Health Americas, Inc|Study Director|5102595284|aloncaric@bauschhealth.com|
313599|NCT03170544|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
270307|NCT00118898|ACTG Network Coordinating Center, Social and Scientific Systems, Inc.|ACTG ClinicalTrials.gov Coordinator|(301) 628-3313|ACTGCT.Gov@s-3.com|
270308|NCT00118911|Massachusetts General Hospital|Susan Sprich, Ph.D.|617-726-5991|ssprich@partners.org|
270309|NCT00119015|University of Chicago|Robert Naclerio|(773) 702-0080|rnacleri@surgery.bsd.uchicago.edu|
292468|NCT01429259|Hartford Hospital|Joseph L. Kuti, Pharm.D.|860-972-3612|joseph.kuti@hhchealth.org|
292469|NCT01429272|Laureate Institute for Brain Research|Jonathan Savitz; Principal Investigator|918 502 5104|jsavitz@laureateinstitute.org|
292470|NCT01429285|Department of Emergency Medicine, Albert Einstein College of Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
292471|NCT01429298|Department of Emergency Medicine, Montefiore Medical Center|Andrew Chang, MD, MS|718-920-7464|achang@montefiore.org|
292472|NCT01429350|Penumbra, Inc.|Michaella Corso|510-995-2079|mcorso@penumbrainc.com|
313600|NCT03170609|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292473|NCT01429441|ThromboGenics N.V.|Dr. Petra Kozma-Wiebe|+32 16 751 497|petra.kozma@thrombogenics.com|
313601|NCT03170661|LUMC|Drs. Maarten Honing|0715264038|g.h.m.honing@lumc.nl|
313602|NCT03171051|Venus Concept Ltd|Yoni Iger|888-907-0115|yoni@venusconcept.com|
313603|NCT03171415|Raziel Therapeutics|Racheli Gueta - Clinical Trials Manager|972-8-9126941|racheli@raziel-therapy.com|
313604|NCT03172130|University of Utah|Krishna Sundar|801-581-7806|krishna.sundar@hsc.utah.edu|
313605|NCT03172325|CinnaGen Co.|Dr. Nassim Anjidani|00989125477964|anjidani.n@orchidpharmed.com|
313606|NCT03172364|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313607|NCT03172481|Purdue Pharma L.P.|Clinical Leader|1-800-733-1333|steven.ripa@pharma.com|
313608|NCT03172494|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
313609|NCT03172702|AstraZeneca|Global Clinical Lead|+18772409479|information.center@astrazeneca.com|
313610|NCT03172780|Mylan Pharmaceuticals Pvt Ltd.|Dr. Prasanna C Ganapathi, Associate Vice President, Global Clinical Sciences|08066728952|PrasannaC.Ganapathi@mylan.in|28952
313611|NCT03172884|Bayer AG|Therapeutic Area Head|(+) 1-888-8422937|clinical-trials-contact@bayer.com|
313612|NCT03173170|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313613|NCT03173313|ZOLL Circulation, Inc.|Vice President of Clinical Affairs|(408) 541-2140|jcreech@zoll.com|
313614|NCT03173547|Therapeutics, Inc.|Clinical Project Manager|858-571-1800|ClinicalResearch@therapeuticsinc.com|
313615|NCT03173560|Eisai Inc.|Eisai Medical Information|1-888-274-2378|esi_oncmedinfo@eisai.com|
313616|NCT03174132|Galderma|Reception|+46184749000|reception.seupp@galderma.com|
313617|NCT03174158|Massachusetts General Hospital|Dr. Gina Kruse|6177243157|gkruse@partners.org|
313618|NCT03174366|Western University of Health Sciences|David Shofler|9097063898|dshofler@westernu.edu|
313619|NCT03174925|Stanford University Medical Center|Aya Kamaya, Professor of Radiology|650-725-1812|kamaya@stanford.edu|
313620|NCT03175120|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
313621|NCT03175172|Aduro Biotech, Inc.|Medical Affairs|510.809.2452|MedicalAffairs@aduro.com|
313622|NCT03175562|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313623|NCT03175731|Qilu Hospital of Shandong University|Prof. Gao|+86-531-82169386|gaoyanjing@sdu.edu.cn|
313624|NCT03176238|Novartis Pharmaceuticals|Study Director|888-669-6682|Novartis.email@novartis.com|
313625|NCT03176407|Ovesco Endoscopy AG|Prof. Dr. T. Gottwald|0049707196528||160
313626|NCT03176459|Pacira Pharmaceuticals|Pacira Medical Information|1-855-793-9727|MedInfo@pacira.com|
313627|NCT03176654|Loma Linda University Health|Everett Lohman, PhD. Professor||elohman@llu.edu|83171
313628|NCT03176784|University of Wisconsin School of Medicine and Public Health|Stevens S. Smith, Ph.D.|608-262-7563|sss@ctri.wisc.edu|
313629|NCT03177395|Pharmacology, Therapeutics and Toxicology Unit, Centre for Cardiovascular Science, University of Edinburgh, UK|Dr James Dear|+44(0)131 242 9214|james.dear@ed.ac.uk|
313630|NCT03177512|Bridge HIV, San Francisco Department of Public Health|Albert Liu|628-217-7408|albert.liu@sfdph.org|
313631|NCT03177603|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313632|NCT03177798|Vanderbilt University Medical Center|Dr. Jorge L. Gamboa|615-343-4176|jorge.gamboa@vumc.org|
313633|NCT03178045|Memorial Sloan Kettering Cancer Center|Brett Simon, MD|646-888-7011|simonb1@mskcc.org|
313634|NCT03178266|ZipLine Medical|Wendy Winters, Clinical Project Manager|4085061866|wwinters0@gmail.com|
313635|NCT03178344|Department of Psychiatry, UNC Chapel Hill|Jhana Parikh|919-966-9929|jhana_parikh@med.unc.edu|
313636|NCT03178487|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
313637|NCT03178669|InDex Pharmaceuticals|Karin Arnesson, Clinical Trial Manager|+46 8 122 038 57|karin.arnesson@indexpharma.com|
313638|NCT03178773|University of Southern California|Elizabeth Burner|3234096667|eburner@usc.edu|
313639|NCT03178851|Hoffmann-La Roche|Medical Communications|1-800-821-8590|genentech@druginfo.com|
313640|NCT03178942|Encube Ethicals Pvt ltd|GM-Strategy & Commercial|+91-22-6228-8000|Pratik.K@EncubeEthicals.com|8003
313641|NCT03179319|Brown University|Katie Biello|401-863-3082|katie_biello@brown.edu|
313642|NCT03179345|Depomed|Clinical Operations|510-744-8000|clinicaltrials@depomed.com|
313643|NCT03179410|Duke University|Andrew Armstrong, M.D.|919-668-8797|andrew.armstrong@duke.edu|
313644|NCT03179787|Otsuka Pharmaceutical Co., Ltd.|Section Chief of Pharmacovigilance|+81-3-6717-1400|Sugimoto.Yuna@otsuka.jp|
313645|NCT03179891|Aquestive Therapeutics|Director of Clinical Operations|908-941-1900|clinicaltrials@aquestive.com|
313646|NCT03180138|Johns Hopkins University|Sanjay K Jain|4105028241|sjain5@jhmi.edu|
313647|NCT03180385|Children's Hospitals and Clinics of Minnesota|Mark Lo Galbo, MPH, CCRP|(612)-813-7828|mark.logalbo@childrensmn.org|
313648|NCT03180489|Colorado State University|Christopher Bell|9704917522|christopher.bell@colostate.edu|
313649|NCT03180515|Stanford School of Medicine|Bronte-Stewart Lab|6507236709|hbsmovlab@gmail.com|
313650|NCT03180528|Stanford University|Kavita Yang Sarin|(650) 723-6316|ksarin@stanford.edu|
281758|NCT00820872|Mayo Clinic|Alvaro Moreno-Aspitia, M.D.|(904) 953-7291|morenoaspitia.alvaro@mayo.edu|
313651|NCT03180619|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
292474|NCT01429454|University of California San Diego|Dr. Kristin Cadenhead|(619) 543-6445|kcadenhead@ucsd.edu|
292475|NCT01429532|SunYat-senU|Prof. Yizhi Liu|+86-20-87330341|Reviewborad_SYsU@163.com|
292476|NCT01429584|University of Utah Department of Anesthesiology|Dr. Elizabeth Thackeray|(801) 581-6393|elizabeth.thackeray@hsc.utah.edu|
292477|NCT01429623|Bar Ilan University|Jonathan Rabinowitz, PhD|+972544643889|Jonathan.Rabinowitz@biu.ac.il|
292478|NCT01429792|Hoffman-La Roche|Medical Communications|8008218590|genentech@druginfo.com|
292479|NCT01429987|Synergy Pharmaceuticals Inc.|Dr. Patrick H. Griffin|212-297-0020||
292480|NCT01430091|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
313652|NCT03180645|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
292481|NCT01430104|Eli Lilly and Company|Chief Medical Officer|800-545-5979||
313653|NCT03180801|SEEK|Dr Olga Pleguezuelos|+44 020 7153 6601|olga.pleguezuelos@seekacure.com|
313654|NCT03181009|The Sean N. Parker Center for Allergy and Asthma Research at Stanford University|Dr Andres Alvarez Pinzon, Director of Regulatory Affairs and Translational Medicine|650 - 521 - 7237|andresap@stanford.edu|
292482|NCT01430130|Neodyne Biosciences|Kristin Prosak|650-543-7129|kprosak@neodynebio.com|126
292483|NCT01430169|Endo Pharmaceuticals, Inc.|Clinical Trial Coordinator||clinicalsite.inquiries@endo.com|
292484|NCT01430182|Baylor College of Medicine|Neil Bailard|713-798-7356|bailard@bcm.edu|
281759|NCT00820898|NRG Oncology|Angela Kuras on behalf of James Kauderer|716-845-5702|kurasa@nrgoncology.org|
292485|NCT01430299|SeaSpine|Vice President, Orthobiologics Research & Development|760.216.5138|frank.vizesi@seaspine.com|
313655|NCT03181308|TRACON Pharmaceuticals Inc|Medical Monitor|8585500780|clinicaltrials@traconpharma.com|
313656|NCT03181451|Shield Therapeutics|Jackie Mitchell MA DPhil|+44 (0) 191 511 8515|jmitchell@shieldtx.com|
313657|NCT03181503|Galderma|Clinical Operations|(0) 4 93 95 70 70|Clinical.Studies@galderma.com|+33
313658|NCT03181594|Stryker ENT|Principal Clinical Research & Publications Manager|763-463-1598|ellen.omalley@stryker.com|
313659|NCT03181724|Massachusetts General Hospital|Dr. Neal Chen|617-726-4700|nchen1@mgh.harvard.edu|
313660|NCT03181932|Savara Inc|Dhaval Desai, Head of Clinical Development|+1 302 442 2309|dhaval.desai@savarapharma.com|
313661|NCT03181958|Children's Hospital of Chongqing Medical University|Dr.Yuan Shi|+86 23 68757731|shiyuan@hospital.cqmu.edu.cn|
313662|NCT03182582|Stanford University|Geoffrey C. Gurtner, MD|650-736-2776|ggurtner@stanford.edu|
313663|NCT03182725|University of California - San Diego Health|Dr. Pam Taub|858-246-2342|ptaub@health.ucsd.edu|
313664|NCT03182738|Columbia University School of Nursing|Dr. Rebecca Schnall|212-342-6886|rb897@cumc.columbia.edu|
313665|NCT03182829|DOASENSE GmbH|Harenberg, Job Prof Dr.|+496221825|j.harenberg@doasense.de|9785
313666|NCT03182868|University of Miami|Michael Hoffer|305 243-1484|michael.hoffer@miami.edu|
313667|NCT03182920|Eli Lilly and Company|Chief Medical Officer|800-545-5979|ClinicalTrials.gov@lilly.com|
313668|NCT03182933|University of Wisconsin|Laura Zitur - research program manager|6082638118|lzitur@wisc.edu|
313669|NCT03183063|Beaumont Health|Joanne Gondert|248 551-0439|joanne.gondert@beaumont.org|
313670|NCT03183518|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313671|NCT03183869|Lawson Health Research Institute|Chantelle Graf, RN|519-685-8500|chantelle.graf@sjhc.london.on.ca|35352
313672|NCT03183908|Duke University|Dr. Kenneth Schmader|919-660-7572|kenneth.schmader@duke.edu|
313673|NCT03184077|Virginia Commonwealth University|Lindsay Morrell, MD|410-823-1120|lmorrellmcv@gmail.com|
313674|NCT03184428|Eyestylianides ophthalmology center|Christoforos Stylianides|0035725320244|Info@eyestylianides.com|
313675|NCT03184441|Boston Children's Hospital|Michele DeGrazia|617-919-1222|michele.degrazia@childrens.harvard.edu|
313676|NCT03184519|IVIValencia|LAURA CARACENA (STUDY COORDINATOR)|034 963050900|laura.caracena@ivirma.com|
313677|NCT03184558|BerGenBio ASA|BerGenBio Clinical Team|+47 559 61 159|trialsites@bergenbio.com|
313678|NCT03184701|Albert Einstein Healthcare Netwrok|Manisha Verma|2154561026|vermam@einstein.edu|
281760|NCT00821015|Icahn School of Medicine at Mount Sinai|Dr. Vivek Y Reddy|212-241-7114|vivek.reddy@mountsinai.org|
313679|NCT03184987|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313680|NCT03185065|Johns Hopkins University|Dr. Bardia Nourbakhsh|4106141522|bnourba1@jhmi.edu|
313681|NCT03185182|Lund University|Professor Håkan Axelson|+46 046 2226434|hakan.axelson@med.lu.se|
313682|NCT03185455|UPenn|Dr. Adi Hirshberg|917-553-9643|adi.hirshberg@uphs.upenn.edu|
313683|NCT03185481|Pfizer, Inc|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
313684|NCT03185546|Wake Forest School of Medicine|Eric Donny, PhD|336-713-1520|edonny@wakehealth.edu|
313685|NCT03186261|Faculty of Dentistry, Cairo University|Ali Mostafa Shamaa|+201005276468|alishamaa@hotmail.com|
313686|NCT03186378|Verrica Pharmaceuticals|Susan Cutler, VP, Medical Affairs|484-773-0898|scutler@verrica.com|
313687|NCT03186677|Catalyst Biosciences|Howard Levy, Chief Medical Officer|+1.650.266.6871|hlevy@catbio.com|
313688|NCT03186781|Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health|Martin Gaudinski, MD|301-451-8715|martin.gaudinski@nih.gov|
313689|NCT03187002|Stanford University|Research Manager|6507211567|fpresearch@stanford.edu|
313690|NCT03187119|West Virginia University|Dr. Christina Duncan|304-293-1289|Christina.Duncan@mail.wvu.edu|
313691|NCT03187132|CedarsSinaiMC|R. Brennan Spiegel|310-423-6784|Brennan.Spiegel@cshs.org|
313692|NCT03187197|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313693|NCT03187262|Dana-Farber Cancer Institute|Dr. Jorge Castillo|617-632-2681|jorgej_castillo@dfci.harvard.edu|
313694|NCT03187301|Sunovion Pharmaceuticals Inc.|CNS Medical Director|1-866-503-6351|ClinicalTrialDisclosure@sunovion.com|
313695|NCT03187418|Centre Hospitalier de l'Universite de Montreal (CHUM)|Dr. Michael Marchand, MD|514-890-8000|michael.marchand-gareau@umontreal.ca|
313696|NCT03187678|Actelion Pharmaceuticals Ltd|clinical trial disclosure desk|0041615656565|clinical-trials-disclosure@its.jnj.com|
313697|NCT03187730|NYU Langone|Elizabeth Vargas|310-486-9775|elizabeth.varagas@nyulangone.org|
313698|NCT03187756|Perlmutter Cancer Center, NYU Langone Health|David Kaminetzky, MD|212-731-5855|David.Kaminetzky@nyulangone.org|
313699|NCT03188055|University of Wisconsin, Madison|Margaret Lee Schwarze, MD, MPP, FACS|(608) 265-2358|schwarze@surgery.wisc.edu|
313700|NCT03188120|Boehringer Ingelheim|Boehringer Ingelheim, Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313701|NCT03188185|Alkermes|Eva Stroynowski|781-609-7000|eva.stroynowski@alkermes.com|
313702|NCT03188263|Northwestern University|Kristen Knutson|312-503-1526|kristen.knutson@northwestern.edu|
281761|NCT00821041|University of Manitoba|Study Coordinator|204-787-5098|NVincent@exchange.hsc.mb.ca|
292486|NCT01430325|Intermountain Healthcare|Lindell K. Weaver, MD|801-408-3623|lindell.weaver@imail.org|
292487|NCT01430403|DAIT/NIAID|Director, Clinical Research Operations Program|301-594-7669|DAITClinicalTrialsGov@niaid.nih.gov|
292488|NCT01430442|Biohaven Pharmaceuticals, Inc.|Chief Medical Officer|203-404-0410|clinicaltrials@biohavenpharma.com|
303611|NCT02185053|Allergan, Inc|Therapeutic Area Head|714-246-4500|clinicaltrials@allergan.com|
313703|NCT03188523|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
313704|NCT03188536|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313705|NCT03188718|University of Colorado Denver|Michelle Sobremonte-King, MD|3037241111|clinicalresearchsupportcenter@ucdenver.edu|
313706|NCT03188991|US Biotest, Inc.|Gere S. diZerega, MD|805.595.1300|gere.dizerega@usbiotest.com|
313707|NCT03189134|Boston Children's Hospital|Aditya K. Kaza, MD|617-355-7932|aditya.kaza@cardio.chboston.org|
313708|NCT03189446|Stephenson Cancer Center|Dr. Kathleen Moore|405-271-8777|Kathleen-Moore@ouhsc.edu|
313709|NCT03189524|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
313710|NCT03189589|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313711|NCT03189745|Pfizer Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
313712|NCT03190005|taipei city hospital|chen yueh-chung|88627093600|chenyuehchung.tw@yahoo.com.tw|3741
313713|NCT03190083|Cleveland Clinic, Case Comprehensive Cancer Center|Dr. Nidhi Sharma|+1 216-444-9014|sharman2@ccf.org|
313714|NCT03190213|Huntsman Cancer Institute Research Compliance Office|Data Manager|8015850601|compliance@hci.utah.edu|
313715|NCT03190369|Sanofi aventis recherche & développement|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
313716|NCT03190460|University of Washington School of Nursing|Dr. Hilaire Thompson|2066165641|hilairet@uw.edu|
313717|NCT03190993|Pennington Biomedical Research Center|John Apolzan|225-763-2827|john.apolzan@pbrc.edu|
313718|NCT03191396|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
313719|NCT03191552|Department of Physical medicine and Rehabilitation, Marmara University School of Medicine, Istanbul,Turkey|Esra Giray|+90216624545|girayesra@hotmail.com|6515
313720|NCT03191630|The Ohio State University|Dr. Tara O'Brien|6142928045|obrien.782@osu.edu|
313721|NCT03191799|Hoffmann-La Roche|Medical Communications|800-821-8590|genentech@druginfo.com|
313722|NCT03192137|InSite Vision|Senior Manager, Clinical Sciences|+91 9987096080|manjiri.desai@sparcmail.com|
313723|NCT03192150|Sun Pharma Global FZE|Head, Clinical development|91 2266455645|Clinical.Trials@sparcmail.com|
313724|NCT03192176|Astellas Pharma Global Development, Inc.|Clinical Trial Disclosure|800-888-7704|astellas.resultsdisclosure@astellas.com|
313725|NCT03192306|Benu BioPharma, Inc.|Dr. Eric Morrel, VP Clinical Research|5082085634|emorrel@benubio.com|
313726|NCT03192475|University of Pittsburgh|Elizabeth Mary Venditti PhD, Associate Professor of Psychiatry and Epidemiology|(412) 647-1027|vendittiem@upmc.edu|
313727|NCT03192488|Indiana University|Robert Chapman|812-856-2452|rfchapma@indiana.edu|
313728|NCT03192826|Patras Medical School|OPHTHALMOLOGY PATRAS|6975801961|cgeorg@upatras.gr|
313729|NCT03192904|Ruijin Hospital Shanghai JiaoTong University School of Medicine|Prof. Hecheng Li, Chair of Thoracic Surgery|(86)13917113402|lihecheng2000@hotmail.com|
313730|NCT03193021|Cardiva Medical|Terry Alverson, Director of Regulatory and Clinical|650-207-0563|Terry_Alverson@cardivamedical.com|
313731|NCT03193047|Esperion Therapeutics, Inc.|Medical Director|1-833-377-7633|medinfo@esperion.com|
313732|NCT03193398|BlackThorn Therapeutics, Inc.|Jane Tiller, MD; Study Director|(415) 548-5313|jane.tiller@blackthornrx.com|
313733|NCT03193593|Bonti|Wajdie Ahmad|9493796569|wajdie@bonti.com|
313734|NCT03193736|iSTAR Medical|Zubair Hussain, VP Clinical and Regulatory Affairs|+3210771658|zubair@istarmed.com|
313735|NCT03194217|BenevolentAI|Anne Phelan|+44 20 3781 9360|anne.phelan@benevolent.ai|
313736|NCT03194334|University Ghent|Prof. Wim Derave|+32/9/2646326|wim.derave@ugent.be|
313737|NCT03194373|University of Michigan Rogel Cancer Center|Paul Swiecicki, M.D.|734-647-1017|pswiecic@med.umich.edu|
313738|NCT03194464|VA Northern California Health Care System|Dr. Carolynn Patten (Principal Investigator)|916.724.5029|carolynn.patten@va.gov|
313739|NCT03194490|Loma Linda University|Dr. Everett Lohman III|(909) 558-4632|elohman@llu.edu|83171
313740|NCT03194503|The Children's Hospital of Philadelphia|Dr. Akira Nishisaki|267-426-0665|NISHISAKI@email.chop.edu|
313741|NCT03194698|Mayo Clinic|Joanne F. Shen, M.D.|480-301-8085|Shen.Joanne@mayo.edu|
313742|NCT03194737|Teleflex/NeoTract|Emily Friedland, Director, Global Clinical Operations|925.387.6014|emily.friedland@teleflex.com|
313743|NCT03194776|Novartis Pharmaceuticals|Study Director|862-778-8300|novartis.email@novartis.com|
313744|NCT03195010|FHCRC|Dr Bethany Samuelson Bannow|5034949925|samuelsb@ohsu.edu|
313745|NCT03195517|University of Perugia - Italy|Dr. Rita Lombardini|+39 075 578 4027|rita.lombardini@unipg.it|
303612|NCT02185105|CooperVision, Inc|Sr. Manager, Clinical Research|9257306754|pchamberlain@coopervision.com|
303613|NCT02185131|University of Pittsburgh|Jack R. Cornelius, M.D., M.P.H.|412-246-5149|corneliusjr@upmc.edu|
303614|NCT02185183|ENZO|Dr. Elazar Rabbani|2125830100|erabbani@enzo.com|
303615|NCT02185339|Department of Anesthesiology and Pain Medicine, The Catholic University of Korea College of Medicine, Seoul St. Mary's Hospital|Dr. Sanghyun Hong|82-2-2258-2236|shhong7272@gmail.com|
292489|NCT01430455|Depression Evaluation Service (New York State Psychiatric Institute)|Jonathan W. Stewart|646-774-8070|jws6@nyspi.columbia.edu|
292490|NCT01430468|Cleveland Clinic Foundation|Joseph P. Iannotti, MD, PhD|216-445-5151|iannotj@ccf.org|
292491|NCT01430559|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292492|NCT01430585|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292493|NCT01430611|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
292494|NCT01430624|Medical University of South Carolina|Heidi Resnick, Ph.D.|843-792-2945|resnickh@musc.edu|
292495|NCT01430741|Bedford VA|Dr. David Smelson, Professor|781-570-1903|david.smelson@va.gov|
292496|NCT01430754|Vanda Pharmaceuticals Inc.|Marlene Dressman, Ph.D.|202-734-3462|marlene.dressman@vandapharma.com|
292497|NCT01430819|Sanofi Pasteur Inc.|Medical Director||RegistryContactUs@sanofipasteur.com|
292498|NCT01431014|Chang Gung Memorial Hospital|Lun-Jou Lo, MD,Hye-Young Kim, MD||lunjoulo@cgmh.org.tw|
313746|NCT03196076|University of North Carolina at Chapel Hill|Associate Director of Clinical Research Operations, Department of Radiology|919-966-4997|rad_research@med.unc.edu|
313747|NCT03196193|Zimmer Biomet G.K.|Senior Manager of Clinical Affairs|+81-3-6402-6610|takahito.nakai@zimmerbiomet.com|
313748|NCT03196232|Stanford University|George A Fisher, Colleen Haas Chair in the School of Medicine|650) 725-9057|georgeaf@stanford.edu|
313749|NCT03196284|Novo Nordisk A/S|Clinical Reporting Anchor and Disclosure (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
313750|NCT03196297|Novo Nordisk A/S|Clinical Transparency and Medical Writing (1452)|(+1) 866-867-7178|clinicaltrials@novonordisk.com|
313751|NCT03196349|Duke University|Dr. Thomas Ortel|919-684-5350 ext 3|thomas.ortel@duke.edu|
313752|NCT03196505|University of California-San Francisco Fresno|Dr. Pearl Ma|5592614500|pma@fresno.ucsf.edu|
313753|NCT03196635|GE Healthcare|Sara Lam|262-548-2369|sara.j.lam@ge.com|
313754|NCT03196791|Korea university Anam Hospital|Dr. Shin Hoo Park|+82-10-6735-1824|bulsajo333@hanmail.net|
292499|NCT01431079|University of Cincinnati|Dr. Manoj Sharma, PI|513-556-3878|manoj.sharma@uc.edu|
292500|NCT01431105|UC San Diego|Adriana Tremoulet|858-246-0012|atremoulet@ucsd.edu|
292501|NCT01431131|University of Louisville|Dr. Henry Greenwell, Principal Investigator|502-852-6928|henry.greenwell@louisville.edu|
292502|NCT01431144|University of Louisville|Henry Greenwell, Principal Investigator|502-852-6928|henry.greenwell@louisville.edu|
313755|NCT03196973|Laboratorios Salvat, S.A.|Medical Director|933946400|ejimenez@svt.com|
292503|NCT01431170|NJMS, Rutgers University|Suqin Guo, MD|973-972-2031|guos1@njms.rutgers.edu|
292504|NCT01431209|University of Nebraska Medical Center|Dr. Julie M. Vose|402-559-3848|jmvose@unmc.edu|
292505|NCT01431274|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
292506|NCT01431287|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
292507|NCT01431300|Duke University Medical Center|Charles Kim|919-684-7284|charles.kim@duke.edu|
292508|NCT01431313|University of Pittsburgh|Marc A. Simon, MD|4128023131|SIMONMA@UPMC.EDU|
292509|NCT01431339|Durata Therapeutics|Michael Zelasky|203-871-4616|mzelasky@duratatx.com|
313756|NCT03197025|National Cancer Institute|Scott Norberg, DO|301-275-9668|scott.norberg@mail.nih.gov|
313757|NCT03197038|University of Illinois at Chicago|Dr. Ulf Bronas|312-355-5886|bronas@uic.edu|
313758|NCT03197129|Hadassah School of Dental Medicine, P.O.Box 12272|Dr. Avia Fux-Noy|+972-2-6776135|fuxavia@gmail.com|
313759|NCT03197324|Theracos Sub, LLC|Albert Collinson, Ph.D.|508-688-4221|acollinson@theracos.com|
313760|NCT03197376|PATH|Dr. Steve Lamola|+ 1 206.302.6067|slamola@path.org|
313761|NCT03197389|University Hospitals Leuven|Prof. Dr. Ann Smeets|003216340903|hanne.vos@uzleuven.be|
313762|NCT03197558|Tusker Medical|Laura England, PhD|(650) 223-6909|lengland@tuskermed.com|
313763|NCT03197883|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313764|NCT03198000|Johnson & Johnson Consumer Inc.|Amisha Parikh-Das, PhD, MPH|(973) 255-8701|AParikh1@its.jnj.com|
313765|NCT03198221|Cleveland Clinic|Dr. Carol Burke|216-444-6864|BurkeC1@ccf.org|
313766|NCT03198507|Redhill Biopharma Inc.|June Almenoff, Chief Scientific Officer|(984) 444 7010|jalmenoff@redhillus.com|
313767|NCT03198520|Solvay® Dental 360|Tim Shary Compliance and Product Specialist|770-772-8665|Tim.shary@solvay.com|
313768|NCT03198715|Daiichi Sankyo|Contact for Clinical Trial Information|908-992-6400|CTRinfo@dsi.com|
313769|NCT03198754|Icahn School of Medicine at Mount Sinai|Heiðdís B. Valdimarsdottir|(212) 659-5678|heiddis.valdimarsdottir@mssm.edu|
313770|NCT03198767|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
313771|NCT03198871|University of Pittsburgh School of Medicine / UPMC|Dr. Kathirvel Subramaniam MD MPH FASE|7247995852|subramaniamk@upmc.edu|
313772|NCT03198884|SIHF Healthcare|John Verna|618-337-8153|jverna@sihf.org|
313773|NCT03199079|Advanced Tactile Imaging, Inc.|Egorov Vladimir, Principal Investigator|609 883-0100|egorov@tactile-imaging.com|
313774|NCT03199118|Cairo University|Sarah Elbanna, assistant lecturer at the Oral Medicine and Periodontology department|+201000760002|srhelbanna@gmail.com|
313775|NCT03199872|RhoVac ApS|Steven Glazer, MD|+4525674434|sgl@rhovac.com|
313776|NCT03199911|University of California, San Francisco|Davin Ashraf MD|415-353-2800|davin.ashraf@ucsf.edu|
313777|NCT03199963|Besins Healthcare Ireland Ltd|Global Chief Medical Officer|+353 87 1039215|clinicaldevelopment@besins-healthcare.com|
313778|NCT03200366|Indiana University|Susan M. Rawl, PhD, RN, FAAHB, FAAN|317-278-2217|srawl@iu.edu|
313779|NCT03200535|Kaiser Permanente Colorado|Dr. Emily Schroeder|303-636-2478|emily.b.schroeder@kp.org|
313780|NCT03200860|University Medical Center Groningen - Department of Cardiology|Prof. dr. A.A. Voors|0031503616161|a.a.voors@umcg.nl|
313781|NCT03200912|Teva Pharmaceuticals Inc. USA|Senior Director, CE Studies|1-888-483-8259|USMedInfo@tevapharm.com|
292510|NCT01431391|Dendreon|Shabnam Vaziri|206-455-2323|svaziri@dendreon.com|
303616|NCT02185404|University of South Florida|Kyle B. Reed|813-974-2385|kylereed@usf.edu|
303617|NCT02185521|Philips Healthcare|Dr. Szymon Bieganski|978-284-3271|szymon.bieganski@philips.com|
303618|NCT02185534|AstraZeneca|Brilinta Global Clinical Leader|+46 31 776 1000|ClinicalTrialTransparency@astrazeneca.com|
303619|NCT02185729|Emory University|Guillermo Umpierrez|404-778-1665|geumpie@emory.edu|
303620|NCT02185794|Gilead Sciences|Gilead Clinical Study Information Center|1-833-445-3230 (GILEAD-0)|GileadClinicalTrials@gilead.com|
303621|NCT02186015|Loyola University Chicago|Patricia Sheean|708-216-0344|psheean1@luc.edu|
292511|NCT01431521|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292512|NCT01431534|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development|1-800-672-6372|ClinicalTrialsDisclosure@merck.com|
292513|NCT01431573|NYSPI|David Hellerstein|646-774-8069|david.hellerstein@nyspi.columbia.edu|
292514|NCT01431638|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
292515|NCT01431703|Shanghai Jiaotong university|Dr Ge zhi zheng|86021-34506250|shenyufeng303@gmail.com|
292516|NCT01431716|Actelion Pharmaceuticals Ltd|Thomas Pfister, PhD, Senior Clinical Scientist|+41 61 565 5932|thomas.pfister@actelion.com|
292517|NCT01431755|Q-Med AB|Head of Medical Affairs|+46 (0) 18 474 90 00|reception.SEUPP@galderma.com|
292518|NCT01431794|Johns Hopkins University School of Medicine|Dr. Ana De Jesus-Acosta|443-287-0411|adejesu1@jhmi.edu|
292519|NCT01431846|Eastern Colorado Health Care System|Dr. Michael Ho|720-857-5115|michael.ho@va.gov|
313782|NCT03200925|Kettering Health Network|Catherine Caponero, DO|937-723-4124|catherine.caponero@ketteringhealth.org|
313783|NCT03201003|Aimmune Therapeutics, Inc.|Director of Regulatory Affairs|650-409-5164|RegulatoryAffairs@aimmune.com|
313784|NCT03201211|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313785|NCT03201419|Ferring Pharmaceuticals|Global Clinical Compliance||DK0-Disclosure@ferring.com|
313786|NCT03201562|Presbyopia Therapies, LLC|Jerry Horn, MD|(847)-772-8885|visionxcl@icloud.com|
313787|NCT03201809|UC Davis|Dr. Granger Wong, Chief and Professor of Plastic Surgery|(916) 734-7289|gwong@ucdavis.edu|
313788|NCT03201900|Eisai, Inc.|Inquiry Service.||eisai-chiken_hotline@hhc.eisai.co.jp|
313789|NCT03202134|AZSintJanAV|Jan Mulier|003250452490|jan.mulier@azsintjan.be|
313790|NCT03202264|McMaster University|Dr. Dee Mangin|905-525-9140|mangind@mcmaster.ca|21219
313791|NCT03202472|Jonsson Comprehensive Cancer Center|Mark Glover|310 794-8742|mglover@mednet.ucla.edu|
313792|NCT03202511|Division of Clinical Pharmacology, School of Medicine, Indiana University|Dr. Zeruesenay Desta|317-274-2823|zdesta@iu.edu|
313793|NCT03202550|Johns Hopkins University|Katrina Thaler|410-550-8506|kstouff3@jhmi.edu|
313794|NCT03203291|Columbia University Irving Medical Center|Sunil Agrawal, PhD|(212) 854-2841|sunil.agrawal@columbia.edu|
313795|NCT03203447|Clearside Biomedical, Inc.|Thomas Ciulla, MD MBA|(678) 392-2318|thomas.ciulla@clearsidebio.com|
313796|NCT03203564|Isofol Medical AB|Chief Medical Officer|+46 (0)707646500|karin.ganlov@isofolmedical.com|
313797|NCT03203681|University of Miami|Dr. Ranjith Ramasamy|3052433670|ramasamy@miami.edu|
313798|NCT03204279|Helsinn Healthcare SA|Edwin de Wit - Head of Clinical Development|+41 91 985 2121|info-HHC@helsinn.com|
313799|NCT03204526|UC Davis Health|Kiarash Shahlaie, MD, PhD, FAANS, Bronte Professor of Neurological Surgery|916-734-6342|krshahlaie@ucdavis.edu|
313800|NCT03204643|Atrium Health|Dr. Jason Roberge|704-355-0268|Jason.Roberge@AtriumHealth.org|
270310|NCT00119041|Louis Stokes VA Medical Center|David C. Aron, MD, MS|(216) 791-2300|david.aron@va.gov|5702
270311|NCT00119106|CDC|Dr. Michael Martin|662 580 0669|ZND9@CDC.GOV|
270312|NCT00119158|The Children's Hospital of Philadelphia|Jonathan Spergel|215 590 1000|spergel@email.chop.edu|
270313|NCT00119262|Eastern Cooperative Oncology Group (ECOG) Statistical Office|Study Statistician|617-632-3012||
270314|NCT00119379|University Hospitals Case Medical Center|Dr. Grace McComsey|216-844-2739|mccomsey.grace@clevelandactu.org|
270315|NCT00119392|Fred Hutchinson Cancer Research Center|Ajay Gopal|206-288-2037|akgopal@fhcrc.org|
270316|NCT00119405|Case Western Reserve University|Grace McComsey|216-844-3607|mccomsey.grace@clevelandactu.org|
270317|NCT00119678|Bristol-Myers Squibb|BMS Study Director||Clinical.Trials@bms.com|
270318|NCT00119847|Stony Brook University|Dr. Eric J. Rashba|631-444-3575|eric.rashba@stonybrookmedicine.edu|
270319|NCT00120250|Massachusetts General Hospital|Dr. Mark Pollack|312-942-5372|mark_pollack@rush.edu|
292520|NCT01431950|GlaxoSmithKline|GSK Response Center|866-435-7343||
292521|NCT01431963|GlaxoSmithKline|GSK Response Center|866-435-7343||
292522|NCT01431976|GlaxoSmithKline|GSK Response Center|866-435-7343||
292523|NCT01431989|GlaxoSmithKline|GSK Response Center|866-435-7343||
292524|NCT01432015|Gynecologic Oncology Associates|John P. Micha, M.D.|949-642-5165|Research@gynoncology.com|
292525|NCT01432145|University of Oxford Clinical Trials & Research Governance|Ms Heather House|01865 572245|heather.house@admin.ox.ac.uk|
292526|NCT01432171|Dana-Farber Cancer Institute|Dr. Andrew Norden, M.D., M.P.H. - Lead Principal Investigator|617-632-2166|anorden@partners.org|
292527|NCT01432236|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292528|NCT01432262|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292529|NCT01432275|Abbott Diabetes Care|Snr Director, Clinical Development & Regulatory Affairs|01993863164|joe.bugler@abbott.com|
313801|NCT03204942|National Cancer Institute|Director of Ethical Committee|+201224276580|drsherryfanous@yahoo.com|
313802|NCT03204981|Icahn School of Medicine at Mount Sinai|Sam Cammack|212-824-8931|sam.cammack@mountsinai.org|
313803|NCT03205046|Acerta Pharma B.V.|Acerta Clinical Trials|1-888-292-9613|acertamc@dlss.com|
313804|NCT03205150|Novartis Pharmaceuticals|Study Director|862-778-8300|Novartis.email@novartis.com|
313805|NCT03205163|Bioverativ, a Sanofi company|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|6
313806|NCT03205358|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
313807|NCT03205371|Sanofi Pasteur|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
313808|NCT03205488|Northwestern University|Dr. Tanya Simuni|312-503-2970|Tatyana.Simuni@nm.org|
313809|NCT03205566|Guy's & St. Thomas' NHS Foundation Trust|Dr Julie Fox|020 7188 7188|julie.fox@gstt.nhs.uk|
313810|NCT03206749|Vertex Pharmaceuticals Incorporated|Medical Monitor|617-341-6777|medicalinfo@vrtx.com|
313811|NCT03206788|Kansas University Medical Center|Dr. Matthias Salathe|913 588 6045|msalathe@kumc.edu|
313812|NCT03206918|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
313813|NCT03206970|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
313814|NCT03207022|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
313815|NCT03207035|Cork University Hospital|Dr Anil Ranganath||drmrak.2@gmail.com|
313816|NCT03207074|Imperial College London|Dr Diana Marcus|07525133957|d.marcus16@imperial.ac.uk|
313817|NCT03207243|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313818|NCT03207386|University of Nebraska Lincoln|Dr. Katie Edwards|6034223207|katie.edwards@unl.edu|
313819|NCT03207399|Duke University Medical Center|Dr. Omar Mohamedaly|919-684-4589|omar.mohamedaly@duke.edu|
313820|NCT03207438|University of Saskatchewan|Evyn Peters|13068441312|evyn.peters@usask.ca|
313821|NCT03207750|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
313822|NCT03207763|Emory University|Evan Anderson, MD|404-727-1746|evanderson@emory.edu|
313823|NCT03207776|Atrium Health|Dr. Jason Roberge|704-898-3855|Jason.Roberge@AtriumHealth.org|
313824|NCT03208088|Johnson & Johnson Vision Care, Inc.|Thomas Karkkainen SR Principal Research Optometrist|1-800-843-2020|TKarkkai@its.jnj.com|
313825|NCT03208166|Medical University of South Carolina|Marc Chimowitz, MD|843-792-3020|mchimow@musc.edu|
313826|NCT03208192|Moscow Clinical Scientific Center|Mikhail Efanov, MD, PhD,|+79161058830|m.efanov@mknc.ru|
313827|NCT03208673|Allergan|Medical Director|714-246-4500|CTRegistration@allergan.com|
313828|NCT03208933|Hoffmann-La Roche|Medical Communications|800 821-8590|genentech@druginfo.com|
313829|NCT03209050|mmc medical international services|Clinical Research Organization and Trial Manager|9492805700|laura22@mmc-medical.com|
313830|NCT03209362|Seikagaku Corporation|Clinical Development Dept.|(81)3-5220-8948|taku.hosaka@seikagaku.co.jp|
313831|NCT03209492|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313832|NCT03209505|University of Houston College of Optometry|Eric Ritchey, OD, PhD|713-743-1933|erritche@central.uh.edu|
313833|NCT03209518|Takeda|Medical Director|+1-877-825-3327|trialdisclosures@takeda.com|
313834|NCT03209570|Insight Therapeutics, LLC|H. Edward Davidson, PharmD, MPH|7576246040|EDavidson@inther.com|
313835|NCT03209882|University of Texas at Arlington|Fenghua Tian|8178075271|fenghua.tian@gmail.com|
313836|NCT03209973|BeiGene|Study Director|+1-877-828-5568|clinicaltrials@beigene.com|
313837|NCT03210155|Texas A&M University Corpus Christi|Dr. Christina Murphey|316.825.3747|christina.murphey@tamucc.edu|
313838|NCT03210220|Department of Anesthesiology and Pain Medicine, Gil Medical Center, Gachon University|Dr Junju Choi|82-32-460-3636|jjchoi2@gilhospital.com|
313839|NCT03210259|Boehringer Ingelheim|Boehringer Ingelheim Call Center|1-800-243-0127|clintriage.rdg@boehringer-ingelheim.com|
313840|NCT03210337|Aclaris Therapeutics|Executive Director, Clinical Operations|4843292144|jschnyder@aclaristx.com|
281762|NCT00821093|Novartis Pharmaceuticals|Study Director|862 778-8300||
313841|NCT03210376|UT MD Anderson Cancer Center|Dr. Wendell H. Williams III / Anesthesiology & Perioperative Medicine|713-563-0034|WHWilliams@mdanderson.org|
292530|NCT01432327|Katholieke Universiteit Leuven|Karen Van Hoye|0032498617141|Karen.Vanhoye@faber.kuleuven.be|
292531|NCT01432366|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
292532|NCT01432379|Allergan, Inc|Therapeutic Area Head,|714-246-4500|clinicaltrials@allergan.com|
292533|NCT01432405|Baylor College of Medicine|Mandeep Bajaj|713-798-1712|bajaj@bcm.edu|
292534|NCT01432444|Otsuka Pharmaceutical Development and Commercialization, Inc.|Global Medical Affairs|800 562-3974||
292535|NCT01432457|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
313842|NCT03210519|Department of Nutrition, Chung Shan Medical University|Dr. Nae-Cherng Yang|886-0936810214|naeman@csmu.edu.tw|
313843|NCT03210701|School of Pharmacy, Memorial University|Dr. Debbie Kelly|709 864 7805|dvkelly@mun.ca|
313844|NCT03210961|Pfizer, Inc.|Pfizer ClinicalTrials.gov Call Center|1-800-718-1021|ClinicalTrials.gov_Inquiries@pfizer.com|
313845|NCT03211117|Mayo Clinic|Ashish V. Chintakuntlawar, MBBS, Ph.D.|(855) 776-0015|Chintakuntlawar.Ashish@mayo.edu|
313846|NCT03211156|University of Alabama at Birmingham|Jane Schwebke, MD|205-975-5665|schwebke@uab.edu|
313847|NCT03211234|Santen Inc|R&D Quality Manager|+1 415 268 9199|clinicaltrials@santen.com|
313848|NCT03211858|Trial Transparency Team|Trial Transparency Team|800-633-1610|Contact-US@sanofi.com|1#
313849|NCT03212261|Massachusetts General Hospital/Harvard Medical School|Dr. Giselle K. Perez|617-724-0765|gperez@mgh.harvard.edu|
313850|NCT03212326|Weill Cornell Medical College|Dr. Christopher Liu|212-746-2655|chl7001@med.cornell.edu|
313851|NCT03212365|University of Utah|Christopher Pannucci, MD|801 581 2121|christopher.pannucci@hsc.utah.edu|
313852|NCT03212521|AbbVie|Global Medical Services|800-633-9110|abbvieclinicaltrials@abbvie.com|
313853|NCT03212638|Eli Lilly and Company|Chief Medical Officer|800-545-5979|Clinicaltrials.gov@lilly.com|
313854|NCT03212690|GlaxoSmithKline|GSK Response Center|866-435-7343|GSKClinicalSupportHD@gsk.com|
270320|NCT00120289|Axio Research, LLC|Ruth McBride|206-577-0212|ruthm@axioresearch.com|
292536|NCT01432535|Merck Sharp & Dohme Corp.|Senior Vice President, Global Clinical Development||ClinicalTrialsDisclosure@merck.com|
